6,659 Matching Annotations
  1. Mar 2026
    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The integration of single-cell datasets across species is a powerful approach to understanding how cell types and patterns of gene expression have evolved. Current methods to perform such integrations require multiple steps: clustering, the integration itself, and downstream differential expression analysis. In this study, the authors describe a new approach, called ANTIPODE, that combines these steps by integrating deep learning with interpretable decoding and linear modeling. This method builds on previous deep learning approaches to dataset integration, namely SCVI and scANVI, that employ a variational autoencoder to model single-cell RNA-sequencing datasets. However, gene expression estimates from these previous methods are challenging to interpret due to non-linear decoding from the modeled latent space. ANTIPODE seeks to address this issue by using a single-layer decoder coupled to a linear model to estimate patterns of differential expression, e.g. differential expression by coexpression module, across cell types, etc.

      The authors apply their framework to a large single-cell RNA-seq dataset (~1.8M cells) containing cells from the central nervous systems of humans, macaques, and mice spanning in utero developmental time points. They identify a consensus set of cell clusters across each species. They find that ANTIPODE performs at least as well as SCVI in terms of species integration and batch correction. The authors demonstrate several use cases of this integrated approach by analyzing differential expression that correlates with gene structure, the evolution of expression differences in neuropeptide systems, and the anatomical and phylogenetic variation in neurodevelopmental timing.

      Strengths:

      ANTIPODE is a welcome addition to techniques that integrate large single-cell RNA-seq datasets across multiple species. The approach's simultaneous inference of cell clusters, integration manifolds, and differential expression should streamline analysis pipelines whose elements are often disjointed and sometimes work at cross purposes.

      Weaknesses:

      The authors note several limitations to their method that will be targets for future development. First, clustering "resolution" is inferred from the data and cannot be tuned as with other approaches. Second, because of the linear decoding, ANTIPODE does not accommodate combining datasets obtained from different modalities (e.g. single-cell with single-nucleus RNA-seq). Third, as currently implemented, ANTIPODE does not explicitly model phylogenetic relationships. However, the authors describe an extension that could enable this, enhancing the power of multiple species integrations. A weakness with the current manuscript is the organization and readability of the figures. The supplemental figures in particular need to be restructured and reformatted to increase their interpretability.

      We thank this reviewer for their positive feedback regarding the utility of the model and how it may simplify challenging evolutionary analysis.

      We acknowledge that the figures are a bit difficult to read, and we will improve annotation and tidiness to make them more accessible to the reader.

      We have implemented changes for an ANTIPODE version 0.2 version which includes regression of gene expression differences on a phylogeny. We have updated the github with this “antipode.phylo” module. For this study, the 3 species case is equivalent for flat or phylogenetic regression, where for example mouse up is equivalent to primate down, so we will do not plan to redo the analyses in the text using this new version.

      We have already provided examples for running ANTIPODE on our own and public datasets (https://github.com/mtvector/scANTIPODE/tree/main/real_examples), as well as in-line documentation of classes and functions, however it is true that these may be insufficient information for new users. We will provide true explanatory tutorials for both to address the reviewer’s concerns. ANTIPODE version 0.1 is currently installable from either github or PyPI.

      Reviewer #2 (Public review):

      Summary:

      This work presents ANTIPODE, a bilinear generative model developed for the simultaneous integration and identification of cell types across species and developmental stages using single-cell RNA-seq data. ANTIPODE is inspired by scANVI, a well-established semi-supervised framework for single-cell transcriptomics. After describing its implementation, the authors use ANTIPODE to integrate data from 15 species comprising 1,854,767 cells. Then, the authors benchmark ANTIPODE against commonly used methods (scVI, Harmony, and Scanorama) using two snRNAseq datasets and report comparable or superior performance. They then return to the initial integrated dataset and analyse patterns of gene expression evolution. Finally, they leverage the model to study the "later-is-larger" concept, evaluating the relationship between gene expression, developmental timing and structure size and finding gene expression signatures of this concept.

      Strengths:

      A major strength of the paper is that ANTIPODE employs a bilinear decoding architecture, which produces more interpretable model parameters while performing at least as well as existing, more opaque nonlinear integration approaches.

      The authors demonstrate the utility of ANTIPODE by integrating single-cell mRNA sequencing data from mouse, macaque, and human brains and confirming general principles regarding developmental timing and cell-type-specific gene expression divergence.

      They also propose a conceptually interesting framework for studying gene expression evolution: instead of focusing solely on differentially expressed genes between homologous cell types, they jointly model gene expression across developmental states and species-specific divergence, allowing them to define and analyse four categories of differential expression.

      Finally, the authors' conclusions are well supported by the analyses presented, although these conclusions remain relatively conservative and reinforce already established principles.

      Weaknesses:

      A central weakness of the paper is its limited accessibility to a broad audience. Despite attempting to keep computational details in the supplement, the main text still uses substantial jargon, undermining the goal of providing an intuitive explanation of the model. The figures are also insufficiently annotated (e.g., colour schemes in Figure 2 heatmap, bubble plot details in Figure 3, entropy definition in Figure 3), and the figure legends are overly brief and lack essential information. I strongly recommend that the authors revise both text and figures to improve clarity and readability.

      Similarly, the materials and methods lack a lot of information about the implementation of the model, the statistical tests used, the calculations of entropy, etc.

      The study sits between tool development and biological discovery but does not fully commit to either. As a result, it cannot be evaluated as a full benchmarking study, yet it also does not provide new biological insights that are validated experimentally.

      Finally, the GitHub repository for ANTIPODE is not yet functional and lacks documentation or tutorials, making it impossible to assess usability or reproducibility.

    1. Author response:

      We would like to thank the Editor and the three Reviewers for their detailed assessment of our manuscript and their constructive feedback. We found the suggestions valuable for refining our work. Before presenting the fully updated manuscript, we would like to clarify a few points in this initial response. This manuscript identifies a heat-induced, alternativelyspliced short isoform of PIF4 (PIF4-S) that contributes to the physiological responses observed in heat-stressed etiolated seedlings. First, we agree with all Reviewers that including PIF4 protein data will strengthen our findings an more definitely demonstrate the generation of a protein-coding alternative isoform under heat stress. Therefore, this will be one of our main priorities in the revision. Evidence for the functionality of this alternative isoform is clearly demonstrated by the distinct phenotypes exhibited by transgenic lines expressing either the long or the short versions of PIF4. Nevertheless, we agree that a more comprehensive characterization of these lines, as well as of the pif4 mutant lines, will further strengthen the demonstration of the functional relevance of this alternative splicing event. In addition, we will extend the phenotypic analysis of the PIF4-S lines to heat stress conditions. Importantly, the phenotypes observed in these lines suggest that additional molecular mechanisms may act in parallel with this alternative splicing event to regulate development in heat-stressed etiolated seedlings. As proposed by Reviewer #1, other PIFs may be involved in this response, and we will address this possibility. We will also provide new experimental data to show that alternative splicing in this gene is specific to heat stress and does not occur in other PIFs. Finally, we would like to clarify that the main scope of this manuscript is to demonstrate the functional relevance of the alternative isoform generated by splicing in PIF4 under heat stress. A detailed investigation of its molecular mode of action is beyond the scope of the present study. We sincerely appreciate the thoughtful feedback provided by all Reviewers. We will carefully consider their suggestions and use them to guide the inclusion of additional experiments and analyses in our revised manuscript to reinforce and clarify our conclusions.

    1. Author response:

      The following is the authors’ response to the original reviews

      eLife Assessment

      The manuscript by Shukla et al. provides important mechanistic insights into kinesin-1 autoinhibition and cargo-mediated activation. Using a convincing combination of protein engineering, computational modeling, biophysical assays, HDX-MS, and electron microscopy, the authors reveal how cargo binding induces an allosteric transition that propagates to the motor domains and enhances MAP7 binding. Despite limitations arising from conformational heterogeneity and structural resolution, the study presents a unified mechanism for kinesin-1 activation that will be of broad interest to the motor protein, structural biology, and cell biology communities.

      We are grateful for the time and effort from the reviewers and editors in providing fair and constructive comments that have helped to improve the manuscript. Our point-by-point response is provided below.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors aim to interrogate the sets of intramolecular interactions that cause kinesin-1 hetero-tetramer autoinhibition and the mechanism by which cargo interactions via the light chain tetratricopeptide repeat domains can initiate motor activation. The molecular mechanisms of kinesin regulation remain an important question with respect to intracellular transport. It has implications for the accuracy and efficiency of motor transport by different motor families, for example, the direction of cargos towards one or other microtubules.

      Strengths:

      The authors focus on the response of inactivated kinesin-1 to peptides found in cargos and the cascade of conformational changes that occur. They also test the effects of the known activator of kinesin-1 - MAP7 - in the context of their model. The study benefits from multiple complementary methods - structural prediction using AlphaFold3, 2D and 3D analysis of (mainly negative stain) TEM images of several engineered kinesin constructs, biophysical characterisation of the complexes, peptide design, hydrogen/deuterium-exchange mass spectrometry, and simple cell-based imaging. Each set of experiments is thoughtfully designed, and the intrinsic limitations of each method are offset by other approaches such that the assembled data convincingly support the authors' conclusions. This study benefits from prior work by the authors on this system and the tools and constructs they previously accrued, as well as from other recent contributions to the field.

      Weaknesses:

      It is not always straightforward to follow the design logic of a particular set of experiments, with the result that the internal consistency of the data appears unconvincing in places.

      For example, i) the Figure 1 AlphaFold3 models do not include motor domains whereas the nearly all of the rest of the data involve constructs with the motor domains;

      We appreciate the reviewer’s comment regarding the absence of the motor domains in the AlphaFold3 models shown in Figure 1. These domains were intentionally excluded to improve visual clarity and to better highlight the interaction between the TPR domains and CC1 in the inhibited kinesin-1 conformation. We felt that this simplified presentation in the main figure helps readers focus on the key mechanistic advance introduced in this work at the outset of the paper. For completeness, we have provided full-length kinesin-1 AlphaFold3 models that include the motor domains in the Supplementary Information (Fig. S1), and they are described in detail in the main text. In addition, we have added a note to the Figure 1 legend to explicitly direct readers to these full-length models.

      ii) the kinesin constructs are chemically cross-linked prior to TEM sample preparation - this is clear in the Methods but should be included in the Results text, together with some discussion of how this might influence consistency with other methods where crosslinking was not used.

      Thank you. Chemical crosslinking is typically important for obtaining high-quality negative-stain TEM grids of kinesin-1 complexes and has been employed in all prior EM studies by our group and others. While this was described in the Methods, we agree that it should also be stated explicitly in the Results. Accordingly, we have added a sentence to the Results section noting that the proteins were stabilized using the amine-to-amine crosslinker BS3 (“Proteins were also stabilised using the amine-to-amine crosslinker BS3 that was important for achieving reproducibly high-quality samples for imaging.”).

      Please see point below for acknowledgement of risks of using crosslinker.

      Can those cross-links themselves be used to probe the intramolecular interactions in the molecular populations by mass spec?

      We had considered this, however, cross-linking mass spectrometry (XL-MS) has been applied extensively to essentially identical kinesin-1 complexes by Tan et al. (eLife 2023). That work provided important insights into the overall architecture of the complex, including the new head–CC1 interactions. However, as fully acknowledged by the authors, significant ambiguity remained with respect to the positioning of the TPR domains, with many cross-links that could not be straightforwardly rationalized in a single model. These unresolved aspects provided part of the motivation for the present study, as highlighted in the Introduction.

      We believe that this ambiguity likely reflects an underlying conformational equilibrium of the kinesin-1 complex (e.g. opening/closing transitions) and/or dynamic docking and undocking of the TPR domains, and lysine-rich features of the TPR domains (most notably the loops that connect the TPR alpha helices) which may make them prone to lock in non-native states, which limits the interpretability of static cross-linking data in this system. In this context therefore, we feel that XL-MS has already been thoroughly explored for kinesin-1 and that its practical limitations in resolving these TPR interactions have been reached.

      This consideration was a primary motivation for pursuing cross-linker-free, solution-based approaches, particularly HDX-MS, which we argue provide the most relevant new insights into the assembly and conformational dynamics of the complex. To make this rationale clearer, we have added an explicit note in the HDX-MS section emphasizing that this is a cross-linker-free method. The added text reads:

      “To determine how the local structural changes from adaptor binding and shoulder dislocation affected the dynamics of kinesin-1 complexes in solution, as directly and least invasively as possible, and without the risk of cross-linker artefacts.”

      In general, the information content of some of the figure panels can also be improved with more annotations (e.g. angular relationship between views in Figure 1B, approximate interpretations of the various blobs in Fig 3F, and more thought given to what the reader should extract from the representative micrographs in several figures - inclusion of the raw data is welcome but extraction and magnification of exemplar particles (as is done more effectively in Fig S5) could convey more useful information elsewhere.

      We appreciate these suggestions. We have modified the figures throughout the manuscript in line with the reviewer’s points. Raw data is now provided at higher magnification throughout so the reader can better distinguish individual particles, angular relationships have been added and further annotations provided on 2D class averages. We do not want the reader to draw too many conclusions from images of single closed particles (with the exception of open vs closed in Fig S7) as these require averaging and 2D classification to obtain meaningful insights, and so we have not added zoom panels in these cases. Figure 3F has been annotated as requested.

      Reviewer #2 (Public review):

      Summary:

      In this paper, Shukla, Cross, Kish, and colleagues investigate how binding of a cargo-adaptor mimic (KinTag) to the TPR domains of the kinesin-1 light chain, or disruption of the TPR docking site (TDS) on the kinesin-1 heavy chain, triggers release of the TPR domains from the holoenzyme. This dislocation provides a plausible mechanism for transition out of the autoinhibited lambda-particle toward the open and active conformation of kinesin-1. Using a combination of negative-stain electron microscopy, AlphaFold modeling, biochemical assays, hydrogen-deuterium exchange mass spectrometry (HDX-MS), and other methods, the authors show how TPR undocking propagates conformational changes through the coiled-coil stalk to the motor domains, increasing their mobility and enhancing interactions with the microtubule-bound cofactor MAP7. Together, they propose a model in which the TDS on CC1 of the heavy chain forms a "shoulder" in the compact, autoinhibited state. Cargo-adaptor binding, mimicked here by KinTag, dislodges this shoulder, liberating the motor domains and promoting MAP7 association, driving kinesin-1 activation.

      Strengths:

      Throughout the study, the authors use a clever construct design - e.g., delta-Elbow, ElbowLock, CC-Di, and the high-affinity KinTag - to test specific mechanisms by directly perturbing structural contacts or affecting interactions. The proposed mechanism of releasing autoinhibition via adaptor-induced TPR undocking is also interrogated with a number of complementary techniques that converge on a convincing model for activation that can be further tested in future studies. The paper is well-written and easy to follow, though some more attention to figure labels and legends would improve the manuscript (detailed in recommendations for the authors).

      Weaknesses:

      These reflect limits of what the current data can establish rather than flaws in execution. It remains to be tested if the open state of kinesin-1 initiated by TPR undocking is indeed an active state of kinesin-1 capable of processive movement and/or cargo transport. It also remains to be determined what the mechanism of motor domain undocking from the autoinhibited conformation is, and perhaps this could have been explored more here. The authors have shown by HDX-MS that the motor domains become more mobile on KinTag binding, but perhaps molecular dynamics would also be useful for modelling how that might occur.

      We are grateful for the reviewer’s comments. We agree that the weaknesses the reviewer has outlined define the limitations of the study and establish important priorities for future work, that includes molecular dynamics simulations. An important prerequisite for the latter is a starting model that one has confidence in. We think that our study and earlier work now provide a good experimentally supported foundation for using AF3 generated assemblies for this purpose, by ourselves and others.

      Reviewer #3 (Public review):

      Summary:

      The manuscript by Shukla and colleagues presents a comprehensive study that addresses a central question in kinesin-1 regulation - how cargo binding to the kinesin light chain (KLC) tetratricopeptide repeat (TPR) domains triggers activation of full-length kinesin-1 (KHC). The authors combine AlphaFold3 modeling, biophysical analysis (fluorescence polarization, hydrogen-deuterium exchange), and electron microscopy to derive a mechanistic model in which the KLC-TPR domains dock onto coiled-coil 1 (CC1) of the KHC to form the "TPR shoulder," stabilizing the autoinhibited (λ-particle) conformation. Binding of a W/Y-acidic cargo motif (KinTag) or deletion of the CC1 docking site (TDS) dislocates this shoulder, liberating the motor domains and enhancing accessibility to cofactors such as MAP7. The results link cargo recognition to allosteric structural transitions and present a unified model of kinesin-1 activation.

      Strengths:

      (1) The study addresses a fundamental and long-standing question in kinesin-1 regulation using a multidisciplinary approach that combines structural modeling, quantitative biophysics, and electron microscopy.

      (2) The mechanistic model linking cargo-induced dislocation of the TPR shoulder to activation of the motor complex is well supported by both structural and biochemical evidence.

      (3) The authors employ elegant protein-engineering strategies (e.g., ElbowLock and ΔTDS constructs) that enable direct testing of model predictions, providing clear mechanistic insight rather than purely correlative data.

      (4) The data are internally consistent and align well with previous studies on kinesin-1 regulation and MAP7-mediated activation, strengthening the overall conclusion.

      Weaknesses:

      (1) While the EM and HDX-MS analyses are informative, the conformational heterogeneity of the complex limits structural resolution, making some aspects of the model (e.g., stoichiometry or symmetry of TPR docking) indirect rather than directly visualized.

      We agree with the reviewers point. Conformational heterogeneity is a significant challenge, and the model has been developed from multiple complementary approaches. A higher resolution cryoEM study remains a priority, but is challenging because of the size, shape and flexibility of the particle, but we hope that some the approaches used here (e.g. nanobody TPR stabilisation, ElbowLock) will provide a path to achieve this.

      (2) The dynamics of KLC-TPR docking and undocking remain incompletely defined; it is unclear whether both TPR domains engage CC1 simultaneously or in an alternating fashion.

      We agree that this is a limitation. We strongly suspect that the TPR domains dynamic and are working to overcome experimental challenges to resolve this important outstanding question. We have expanded the discussion section to better highlight this important priority.

      (3) The interplay between cargo adaptors and MAP7 is discussed but not experimentally explored, leaving open questions about the sequence and exclusivity of their interactions with CC1.

      We agree that this is a limitation but will be an important priority for future studies.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      There are a number of places where the text could be more precise or clear, or the figures could be designed to be more informative:

      (1) The word "unitarily" is used in several places, and I don't know what it means in this context.

      We have changed the phrasing throughout the manuscript to this term. We were attempting to contrast with presumed cooperative multivalent interactions in the context of the kinesin-1 tetramer but agree that this choice of word doesn’t quite achieve that.

      (2) On page 5 the phrase "We focused on the ElbowLock background" is introduced and needs to be explained more clearly.

      Thank you. We have amended the text to read “This KIF5C construct contains a short 5 amino acid deletion that restricts flexibility around the elbow and helps maintain particles in their lambda conformation, providing homogenous samples, and facilitating subsequent analysis (34).”

      (3) On page 6, the phrase "To improve the resolution of our images, we turned to single-particle cryoEM analysis" is imprecise - what do the authors mean by the resolution of the images? Cryo-EM data does not always guarantee a higher resolution structure, but it offers the possibility of visualising finer structural features. This is probably what is meant here, but needs to be stated more precisely.

      We have amended the text to ‘visualise finer structural details’ as suggested.

      (4) Page 7 - "suggesting that TPR domains had loosely dissociated from the core" - I don't think the evidence points to dissociation of KLCs from the complex, but the phrase "loosely dissociated" implies this - would benefit from rephrasing.

      We have changed this to ‘undocked’ for consistency with other descriptions in the manuscript.

      (5) Was the effect of the CC-Di insertion (ΔTDS) detectable by AlphaFold prediction? It would be interesting to include this, partly for completeness and partly because a slightly imperfect and maybe a more dynamic coiled-coil in this region of the molecule may be important in supporting the conformational changes required for activation.

      Thank you for this suggestion. Modelling of deltaTDS complex indeed shows displacement of the TPR domains. In the standard 5 output models, the TPR domains now occupy a variety of different positions, all with essentially zero confidence (high position error). Consistent with biochemical data, the CCDi insertion is modelled with with no overall disruption to the architecture or length of CC1 as expected. We think that this is a valuable addition to the study and have included it as a new supplementary figure (Fig S5), with main text reading.

      …. “Supporting this, models of ΔTDS complexes using AF3 showed the expected seamless insertion of CCDi into CC1, with displacement of the TPR domains to a variety of different positions, in 5 models, all with high position error with respect to KHC (Fig S5).”

      (6) Figure S1 has two sections designated (C) in the legend.

      Corrected

      (7) Figure S3 - given the resolution and level of interpretation of the 3D reconstructions, it is not relevant to include an FSC curve, but other standard information, such as angular distribution and any evidence of variability from 3D classifications (and how many particles per 3D class) should be included for all structures.

      Thank you, a complete workflow for all complexes has now been provided in Figure S8 with the information requested. In each case there were typically two ‘good’ classes. For ElbowLock, this included one without a prominent shoulder, consistent with 2D classification and quantification. We assume this may reflect a docking/undocking equilibrium. For the deltaTDS and KinTag particles, neither class showed the shoulder feature. The main text has been modified to reflect this and reads “For ElbowLock complexes, this resulted in classes with and without a prominent shoulder, in agreement with 2D classification. For ElbowLock-ΔTDS and ElbowLock-KinTag complexes, no prominent shoulder containing classes were observed.”

      Reviewer #2 (Recommendations for the authors):

      Overall, the figures would benefit from more labels for clarity, some examples and suggestions below:

      (1) Figure 1A - Connect motors to the rest of the structure e.g., wiggly lines.

      Corrected.

      (2) Figure 1B - Add arrows and angles to indicate different views of the model.

      Corrected.

      (3) Figure 1B - Label TPR1-6 (e.g., inset zoom in).

      Corrected.

      (4) Figure 2D and 3D - Label the lack of a shoulder in all averages (perhaps with an arrow instead of a circle to not obscure density), include an example average which shows prominent shoulder density.

      Corrected. Full sets of classes showing shoulder like features for deltaTDS and KinTag complexes are now shown in Figure S4.

      (5) Figure 3D: Label motor domains and elbow as in other figures.

      Corrected.

      (6) Methods: Include more information on how EM classes were compared to AF projections (e.g., Figure 1D). Was this done visually or computationally? Likewise, more information is needed on how classes were judged to have prominent/weak shoulder density (Figure 2D). In the figure legend, there is a statement that "Full sets of classes are provided in Fig. S4" but this is absent in the supplement.

      Thank you. This information has been added to the methods.

      “For comparison to the AF3 model, simulated density was generated using the molmap command in ChimeraX (73) filtering to 15 Å, and projections were generated/selected automatically using the Reference Based Auto Selected 2D function in CryoSPARC”.

      Full sets of classes are now provided in Figure S4.

      (7) Figure 1-3 - Raw micrographs are a very useful inclusion but would benefit from being a more zoomed-in view (e.g., Figure S5 scale). Particularly useful for 3C, where the mixture of open and closed would be good to see.

      Higher zoom micrographs have been provided throughout.

      (8) Figure 5D: Panels too small to see the result, suggest making full width and moving E below.

      Thank you. We have expanded the panel and moved the model to a new Figure 6.

      (9) Figure S1: PAE plot convincing, but pLDDT colour models needed.

      A representative model coloured for pLDDT has been added to Figure S1. Most of the structure sits within the light blue confident range (90 > pLDDT > 70) with the exception of the disordered regions and neck coil.

      (10) Figure 5B: Reason for the variable inputs?

      The reviewer raises an interesting point. The slightly reduced expression of deltaElbow and slightly increased expression of ElbowLock is a consistent feature of these experiments. We note that this effect is in the ‘opposite direction’ to the impact on binding to MAP7 and so does not affect our conclusions from the experiment. However, we wonder whether opening and closing of the complex may impact on turnover of kinesin proteins, which could have implications for their normal homeostasis and possible degradation after transport in polarised cells. We are considering how to explore this going forwards. We have added a note to the results section to highlight this interesting observation to the reader.

      “We also noted slightly elevated expression of ElbowLock complexes and slightly lower expression of DeltaElbow complexes, suggesting that opening/closing of the complex could impact on kinesin-1 turnover”

      (11) Figure legend 5B: Insufficient detail, the end result is stated, but the three separate gels are not described.

      Legend has been expanded.

      (12) Figure 3F: Currently somewhat problematic. It is unclear if the models are in the same view, and so comparison is difficult. Figure 1C (bottom right) shows class averages with a clear, separate CC density, so the relatively featureless model in this region is puzzling. A statement on how the three model views are related to each other, if aligned with each other, would be useful.

      We appreciate the reviewers point. Models were aligned in Chimera, using the fit in map command. Because of the limited features of the models presumably due to flexibility, achieving a good alignment for all three models was challenging, but we think that showing the 180-degree rotations is probably about the best we can achieve here.

      (13) The following statement is too strong: "Nonetheless, we obtained reference-free 2D class averages that appeared to show full-length 'side' views of the complex with clear definition of the elbow, hinge 2, and KHC-KLC (coiled-coil) interface features which enabled us to identify CC1 confidently (Fig. 1D)". Given that the negative-stain EM data were collected primarily to validate the AlphaFold model, the assignment of CC1 should be described as consistent with rather than confidently identified from the class averages. The resolution of the EM data does not independently support such an assignment, and the wording needs to be softened.

      We appreciate the reviewer’s point, we have softened the wording as suggested. The paragraph now reads.

      “To visualise finer structural details, we turned to single-particle cryoEM analysis of frozen-hydrated samples. We were unable to obtain optimal samples suitable for determining the complete structure. Nonetheless, we obtained reference-free 2D class averages that appeared to show full-length ‘side’ views of the complex with clear definition of the elbow, hinge 2, and KHC-KLC (coiled-coil) interface features (Fig. 1D). The motor domains were poorly resolved in these classes, suggesting that the head assembly is somewhat flexible relative to the coiled coil/TPR body. A comparison to low-pass filtered back-projections from the AF3 model (without motor domains) revealed density at a position concurrent with the docked TPR domains (Fig. 1D).”

      (14) There is a typo in the figure legend of Figure 3 - (E) and (F) should be (F) and (G).

      Corrected

      Reviewer #3 (Recommendations for the authors):

      I recommend the following additions:

      (1) Figure 1 labeling - In panel A, please label the "linker domain" and the "KLC subunits" explicitly to help orient the reader. In panel B, please mark the "TPR shoulder" corresponding to the docked TPR domains on CC1; this will help the reader connect parts B and C.

      Thank you, we have modified Figure 1A with this additional information.

      (2) The TPR docking site (TDS) is a central structural element, and its sequence boundaries are provided in the Methods. It would help to visualize this directly in Figure 2A or in an inset.

      We hope that the reviewer agrees that the zoomed in model in Figure 5A (alongside MAP7) provides a sufficiently detailed view of the structural interface to highlight the orientation of TPR1 with respect to CC1. The side chain contacts in the model are very plausible and confidently predicted (and can be straightforwardly reproduced in AF3 using the sequence information provided in the methods), but as our study has not explored this interaction at the single residue level, we would prefer not to imply this to the reader at this stage.

      (3) The authors' model of cargo-induced TPR dislocation is convincing. However, the Discussion could benefit from a clarification on whether both KLC-TPR domains are expected to be bound simultaneously or if a dynamic exchange occurs, as the EM data suggest potential asymmetry.

      Thank you, please see point 5 below where we have modified the discussion to reflect the reviewer’s thoughtful comments.

      (4) The HDX-MS analysis is comprehensive, but the authors may want to briefly comment on the coverage of low-signal regions (especially within CC2-CC3) to enhance clarity.

      We have added an additional supplementary figure (S10) showing sequence coverage. Overall, this is 88% but with some lower coverage around KHC-CC0 (neck) and the acidic linker that connects the KLC coiled-coil to the TPR. We have added a note to the main text to reflect this.

      “Sequence coverage was high (overall 88%) with the exception of KHC-CC0 (neck coil) and the acidic-linker region that connects the KLC coiled-coil to the TPR domains where coverage was lower”

      (5) In the Discussion, the proposed interplay between MAP7 and cargo adaptors is intriguing, especially considering the results from Anna Akhmanova's lab showing that MAP7 activates kinesin-1 processivity. Do the authors suggest that competition for CC1 is mutually exclusive or sequential? The answer has mechanistic implications.

      We have been considering questions for some time, and the short answer is that we don’t fully understand the dynamics yet. However, we appreciate the reviewer’s prompt to clarify our thinking on this. We have attempted to do this in a revised discussion section where we more explicitly outline these outstanding questions.

    1. Author response:

      eLife Assessment

      This manuscript provides an important contribution to the field of platelet biogenesis, and the convincing evidence will advance our understanding of signal transduction driving the development of late megakaryopoiesis and platelet reactivity that results in bleeding diathesis. The paper is noteworthy for analyzing two related, either singly or in combination, tyrosine phosphatases in this conditional, stage development gene knockout. Because SHP1 is a negative regulator and SHP2 is an activator, the synergistic effects found in the double knockout were surprising.

      We thank the reviewer for acknowledging the importance and novelty of our findings.

      Public Reviews:

      Reviewer #1 (Public review):

      Barré et al. investigated the role of Shp1 and Shp2 in megakaryocytes (MKs) and platelets by conditional knock-out of Shp1, Shp2, or both under the control of the Gp1ba promoter. Deletion of Shp1 and Shp2 in MKs and platelets was almost complete. The Shp1/Shp2 double knock-out mice displayed macrothrombocytopenia and increased bleeding, whereas the single knock-outs did not show significant defects. Platelet function was aberrant in DKOs, but not in single knock-outs, and so was ligand-induced signaling, particularly Syk phosphorylation.

      Megakaryocyte maturation was impaired in Shp1/Shp2 DKO mice. Ligand-induced signaling was impaired in Shp2 knock-out and DKO. Ex vivo formation of platelets and in vivo maturation of MKs were impaired in DKO mice. Pharmacological inhibitors of Shp1 and Shp2 had largely similar effects as observed in the single knock-outs. The authors conclude that Shp1 and Shp2 have synergistic functions in the MK/platelet lineage, and that Shp2 may be a potential therapeutic target in myeloproliferative neoplasms.

      Strengths:

      The data clearly show effects of the Shp1/Shp2 double knock-out on MKs and platelets.

      Weaknesses:

      There appears to be a discrepancy between the results with the Shp2 single knock-out and the Shp2 inhibitor: the Shp2 knock-out does not affect MKs and platelets, except Erk1/2 signaling, whereas the Shp2 inhibitors appear to affect MK function.

      This work is interesting and may have potential from a therapeutic point of view.

      Pharmacological effects do not always correlate with congenital anomalies arising for genetic defects. The Shp2 allosteric inhibitors used in our study only inhibit catalytically inactive Shp2, whereas targeted deletion of Ptpn11 results in a loss of total Shp2 expression, including catalytic and non-catalytic related functions, with developmental consequences. Further, Gp1ba-Cre+;Shp2fl/fl megakaryocytes express approximately 22% of normal Shp2 level, which likely also contributes to differences observed between pharmacological inhibition and genetic ablation of Shp2.

      We thank the reviewer for recognizing the therapeutic potential of our findings.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, Barré et al. investigate the roles of the phosphatases Shp1 and Shp2 in the megakaryocyte and platelet lineage using genetic depletion in mice. By employing Gp1ba-Cre-based models, the study builds on the authors' previous work and addresses some limitations associated with earlier Pf4-Cre approaches. The authors report relatively mild alterations in megakaryocyte and platelet parameters in mice lacking either Shp1 or Shp2 alone, whereas combined deletion of both phosphatases results in macrothrombocytopenia, mild bleeding, and impaired GPVI-dependent platelet aggregation accompanied by reduced Syk phosphorylation. The functional platelet defects are linked to reduced expression of GPVI and integrin α2, while thrombocytopenia is associated with impaired megakaryocyte maturation, reduced ploidy, defective proplatelet formation, and altered TPO-dependent Ras/MAPK signaling. Similar effects on megakaryopoiesis are also observed in vitro following treatment with newly developed Shp2 inhibitors.

      Strengths and Weaknesses:

      The study addresses an important biological question and presents a substantial dataset that could contribute to a better understanding of Shp1 and Shp2 function in platelet biology. However, several aspects of data presentation and interpretation would benefit from additional clarification. In particular, while the authors conclude that single genetic deletion or pharmacological inhibition of Shp1 has a limited impact and that the major phenotypes are specific to combined Shp1/2 deletion or Shp2 inhibition, some of the data suggest more nuanced effects that may warrant further discussion.

      We thank the reviewer for raising this point. The manuscript is being revised accordingly, including highlighting the potential role of Shp1 in megakaryopoiesis and thrombopoiesis under steady-state and stressed conditions, requiring more detailed investigation.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, Barré et al utilize the Gp1ba-Cre transgenic mouse model to build upon previous findings in a Pf4-Cre system to investigate the effects of individual and combined Shp1 and Shp2 deletion in megakaryocytes and platelets. They report decreased megakaryocyte maturation, macrothrombocytopenia, and increased bleeding primarily in association with the Shp1/Shp2 double-knockout condition. The authors further show that this phenotype appears to be driven primarily by Shp2 and implicate dysregulation of Mpl signaling and downstream Ras/MAPK pathways, including ERK1/2. Given the key role of these pathways in human diseases such as myeloproliferative neoplasms and the challenges associated with modulating such a central pathway, identification of a specific regulator of Mpl signaling poses intriguing questions for future studies on clinical applicability.

      We thank the reviewer for acknowledging the importance and novelty of our findings.

      Strengths:

      Overall, the experiments combine in vitro, in vivo, and ex vivo approaches and appear to have been carefully designed and carried out, with multiple technical and biological replicates where relevant. The authors make a compelling argument for using the Gp1baCre as opposed to the Pf4-Cre system and demonstrate both the dose- and stagedependent effects of Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis. They find that Shp1 and Shp2 are required in late-stage megakaryocyte maturation and that even low levels of expression compared to baseline are likely sufficient to yield generally normal megakaryocytes. Their findings also lead to specific future directions, such as the mechanism by which Shp1 regulates megakaryopoiesis and thrombopoiesis that is distinct from TPO-mediated signaling.

      Weaknesses:

      While the experiments have been thoughtfully designed and carried out, there is limited background explanation on relatively complex or niche pathways/mechanisms, such as the relationship between P-selectin, CRP, and PAR4p; the interactions between SFK, Syk, GPVI, and CLEC-2; and TPO, MPL, ERK1/2, AKT, and STAT3, which, while likely intuitive to experts in their respective fields, may be less obvious to a reader approaching this manuscript with a global interest in megakaryopoiesis/thrombopoiesis and thus detract from the impact of the findings.

      We thank the reviewer for raising this point. The manuscript is being revised, to better explain the rationale and molecular mechanisms linking these pathways and functions.

      With regard to the science itself, some of the conclusions feel premature based on the available data.

      (1) The section "Aberrant ITAM signaling in Shp1- and Shp2-deficient platelets" is challenging to follow for those not well-versed in ITAM signaling and associated pathways, and may take additional outside reading to follow the conclusion that Syk-dependent signaling is modulated downstream of GPVI and CLEC-2 based on lack of change in Src p-Tyr418, especially considering that Src p-Tyr418 was previously introduced as a measure of SFK rather than Syk. In the introduction, Shp1 is specifically mentioned as a negative regulator of the ITAM/Syk/phospholipase pathway. However, in Figure 4Ai and Bi, Syk phosphorylation/activation in Shp1 knockout cells did not appear to be different from Shp2 knockout cells, and is lower than the control, which is surprising for a negative regulator. It is also not clear why, in the section (Figure 4A-B), there is reduced Syk activation in Shp1 and Shp2 single knockout cells upon CLEC2 stimulation (but apparently not with CRP) when there was no difference in response to CLEC2 (but a difference in response to CRP) in the previous section (Figure 3A, C).

      We thank the reviewer for raising these important points. The manuscript is being revised accordingly, including clarifying the roles of SFKs, Shp1 and Shp2 in the ITAM-Syk-PLCg2 signaling pathway.

      Briefly, SFKs are essential for phosphorylating ITAMs, allowing SH2-dependent docking of Syk. Reduced reactivity of Shp1/2 DKO platelets to CRP and collagen is likely due to downregulation of the ITAM-containing GPVI-FcR g-chain complex and integrin a2 subunit, and concomitant reduction in Syk phosphorylation.

      However, the marginal albeit significant reduction in Syk phosphorylation downstream of CLEC-2 in Shp1 and Shp2 KO platelets was not determined and was insufficient to impact CLEC-2-mediated platelet aggregation under the conditions tested.

      Differences in the stoichiometry and docking of Syk to phosphorylated GPVI-FcR g-chain and CLEC-2 likely contribute to the differences in platelet reactivity and Syk phosphorylation downstream of the two receptors in the absence of Shp1 and Shp2.

      (2) In the section "Reduced Tpo signaling in Shp1/2-deficient MKs," only Western blot data for (p)ERK1/2, AKT, and STAT3 are presented before concluding that decreased ERK1/2 activity is a mechanistic explanation for thrombocytopenia seen in the Shp1/2 doubleknockout condition. Such a statement would benefit from additional experiments, such as protein or transcriptional levels of ERK1/2 targets specifically relevant to megakaryopoiesis, such as ETS, FOS, and JUN, to assess the consequences of decreased phosphorylated ERK1/2.

      We thank the reviewers for these constructive comments. Further experiments are being planned to determine the biological and transcriptional consequences of reduced ERK1/2 phosphorylation during megakaryopoiesis and thrombopoiesis.

      (3) Suggesting that "inhibiting Shp2 will not have any bleeding consequence in patients" and that Shp2 may be a therapeutic target in myeloproliferative neoplasms when none of these studies have been carried out in a human model is a bold conclusion. There are no data presented on, for example, whether Shp2 inhibition can help reverse the MPL/JAK/STAT pathway in the setting of gain-of-function mutations specifically associated with myeloproliferative neoplasms.

      This conclusion is being tempered in the revised manuscript. Genetic- and pharmacological-based approaches will be used to establish the therapeutic potential of inhibiting Shp1 and Shp2 in mouse models of MPN, including Jak2 gain-of-function mice. Bleeding and thrombotic complications of inhibiting Shp1 and Shp2 will be explored as part of these studies.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer # 1 (Public review):

      (1) Structure and Presentation of Results

      • I recommend reordering the visual-cue experiments to progress from simpler conditions (no cues) to more complex ones (cue-conflict). This would improve narrative logic and accessibility for non-specialist readers. The authors have chosen not to implement this suggestion, which I respect, but my recommendation stands.

      Thank you for this suggestion. We understand your point that presenting the experiments from simpler to more complex conditions may seem more intuitive. However, we have kept the original order because it better reflects the logic of the study itself. Our work first asked whether fall armyworms, like the Bogong moth, use a magnetic compass that is integrated with visual cues. Only after establishing this behavioral feature did we go on to test whether visual cues are required to maintain magnetic orientation. To make this reasoning clearer to readers, we have explicitly stated in the Introduction that magnetic orientation in the Bogong moth depends on the integration of visual cues, which provides clearer context for the experimental design.

      (2) Ecological Interpretation

      • The authors should expand their discussion on how the highly simplified, static cue setup translates to natural migratory conditions, where landmarks are dynamic, transient, or absent. Specifically, further consideration is needed on how the compass might function when landmarks shift position, become obscured, or are replaced by celestial cues. Additionally, the discussion would benefit from a more consolidated section with concrete suggestions for future experiments involving transient, multiple, or more naturalistic visual cues. This point was addressed partially in one paragraph of the Discussion, which reads as follows:

      "In nature, they are likely to encounter a range of luminance-gradient visual cues, including relatively stable celestial cues as well as transient or shifting local features encountered en route. Although such natural cues differ from our simplified laboratory stimulus, they may represent intermittently sampled visual inputs that can be optimally integrated with magnetic information, with the congruency between visual and magnetic cues likely playing a key role in maintaining a stable compass response. Whether the cues are static or changing, brief periods without them may still allow the subsequent recovery of a stable long-distance orientation strategy. Determining which types of natural visual cues support the magnetic-visual compass, and how they interact with magnetic information, including how their momentary alignment or angular relationship is integrated and how such visual cue-magnetic field interactions may require time to influence orientation, together with elucidating the genetic and ecological bases of multimodal orientation, will be important objectives for future research." While this paragraph is informative, the wording remains lengthy, somewhat unclear, and vague. Shorter, clearer statements would improve readability and impact. For example:

      • How could moths maintain direction during periods when only the magnetic field is present and visual landmarks are absent?

      • Could celestial cues (e.g., stars) compensate, and what happens if these are also obscured?

      • What role does saliency play when multiple visual landmarks are present simultaneously?

      • How might a complex skyline without salient landmarks affect orientation?

      Including simple, concise sentences that pose concrete open questions and suggest experimental designs would strengthen the discussion without creating space issues. In my view, a comprehensive discussion of how the simplified, static cue setup relates to natural migratory conditions-where landmarks are dynamic, transient, or absent-would add significant value to the paper.

      Thank you for this constructive and insightful comment. You correctly point out that our articulation of the ecological relevance of the simplified, static cue setup was not sufficiently clear. We also agree that the original wording in the Discussion remained overly general. In the revised Discussion, we updated the manuscript to incorporate recently published findings on the use of light–dark gradients for orientation in fall armyworms. However, we explicitly note that it remains unclear whether fall armyworms can exploit naturally occurring luminance gradients, such as those generated by the moon, for orientation under natural conditions. We further emphasize that during natural migration the visual environment is dynamic, with celestial cues available intermittently and local visual features changing continuously during flight. In this context, we outline several key unresolved questions, including whether celestial cues can compensate when local landmarks are absent; how multiple visual cues are weighted and integrated with geomagnetic information; how transient visual cues (like moving clouds or changing illumination) influence orientation; and how luminance gradients that are common in natural nocturnal environments interact with the geomagnetic field to support orientation. For each of these issues, we briefly suggest experimental approaches to guide future research.

      (3) Methodological Details and Reproducibility

      • The lack of luminance level measurements should be explicitly highlighted.

      Thank you for your helpful suggestion. You are right that luminance level is an important experimental parameter. We have stated this information in the Methods section under Behavioral apparatus: “The ambient light level in the experimental environment was measured to be below 1 lux using a Testo 540 lux meter (Testo SE & Co. KGaA, Titisee-Neustadt, Germany). Further work is still required to compare the illuminance used in this study with that under natural conditions, which are inherently variable.” This point is also clarified in the legend of Figure S3 in the supplementary material.

      • The authors chose not to adjust figure legends by replacing "magnetic South" with "magnetic North." While I believe this would be more conventional and preferable, this is ultimately a minor stylistic issue.

      Thank you very much for your suggestion. We understand your point and agree that using “magnetic North” would be more conventional. However, because our experiments focus on the orientation behavior of the autumn population, magnetic South is aligned with the landmark direction representing the potential migratory direction, which we believe makes the figures more intuitive for readers. We therefore consider this a minor stylistic issue.

      (4) Conceptual Framing and Discussion

      • Although the authors made a good attempt to explain the limitations of using an artificial visual cue, I believe there is room or a more explicit argument. For example, it could be stated clearly that this species is unlikely to encounter a situation in nature where a single, highly salient landmark coincides with its migratory direction. Therefore, how these findings translate to real migratory contexts remains an open question. A sentence or two making this point directly would strengthen the discussion.

      Thank you for your helpful suggestion. We now address this point explicitly in the Discussion, noting that fall armyworms are unlikely to experience a natural visual environment dominated by a single, static, and highly salient landmark coinciding with their migratory direction. Consequently, how these findings translate to real migratory contexts remains an open question.

      (5) Technical and Open-Science Points

      • Sharing the R code openly (e.g., via GitHub) should be seriously considered. The code does not need to be perfectly formatted, but making it available would be highly beneficial from an open-science perspective.

      Thank you for the suggestion. We agree that making code openly available is valuable from an open-science perspective. The MMRT script used in this study is Moore’s Modified Rayleigh Test, available from the original publication by Massy et al. (2021; https://doi.org/10.1098/rspb.2021.1805). In the previous version, we only cited this reference in the Materials and Methods section; we have now added a direct link to the script to improve clarity and accessibility. We have also provided a public link to the data-recording scripts used in the Flash Flight Simulator (https://doi.org/10.17632/6jkvpybswd.1). This repository additionally includes a map-based optical flow script that was not used in the present study but is shared for completeness.

      Reviewer #1 (Recommendations for the authors):

      • LL. 133-137 (end of paragraph starting with "The fall armyworm is a migratory crop pest native to the Americas"): Suggest splitting into shorter, clearer sentences. The limitations of this method could be better articulated here and elaborated in the Discussion.

      Thank you for this suggestion. We have revised this paragraph by splitting it into shorter, clearer sentences and by articulating the limitations of this method more explicitly. These limitations are further elaborated in the Discussion.

      • LL. 181-185 (end of paragraph starting with "To examine if fall armyworms integrate geomagnetic and visual cues for seasonal migratory orientation"): It would be helpful to state explicitly that season-specific headings have been confirmed in the lab using a flight simulator, but destination regions remain unknown without further tracking experiments.

      Thank you for this helpful suggestion. We have now clarified in the revised manuscript that season-specific orientation headings have been confirmed in the laboratory using a flight simulator, while the actual migratory destination regions remain unclear in the absence of tracking experiments.

      • LL. 230-234 (start of paragraph "Our previous research showed that fall armyworms reared under artificially simulated fall conditions…"): Clarify which migratory season is being referenced.

      Thank you for this helpful suggestion. We have clarified in the text that the migratory season referenced here is the autumn migratory season. In addition, we have added information in the Methods to specify the actual calendar season during which the insects were reared under the simulated conditions.

      • LL. 270-272 (middle of Fig. 2 caption): Suggest explicitly mentioning that for this population, the seasonally appropriate direction is southbound in autumn and northbound in spring, as this may not be clear to non-specialists.

      Thank you for this helpful suggestion. We have now explicitly stated the seasonally appropriate migratory directions for this population, indicating southbound migration in autumn and northbound migration in spring, to improve clarity for non-specialist readers.

      • LL. 421 (middle of paragraph starting with "We also considered the limitations of the Rayleigh test…"): Add that the groups lacking visual cues exhibited "lower directedness as per lower vector length (r)" in addition to lower flight stability.

      Thank you for this helpful suggestion. We further note that the conclusions drawn from the flight stability analysis are consistent with those based on individual r-value analyses.

      • LL. 499-501 ("unlike some vertebrates that can rely solely on magnetic information (Mouritsen, 2018)"): This point is slightly downplayed. It should be emphasized that nearly all tested vertebrates and invertebrates (e.g., birds, mole rats, fish, frogs, and other insects) demonstrate a magnetic compass without requiring visual landmarks. Moths are the only tested invertebrates so far that show landmark-magnetic field dependency for their magnetic compass to be manifested in a behavioural orientation response in Flight Simulator.

      Thank you for this important comment. We agree that this point represents a key synthesis in the Discussion, as it concerns how our findings relate to, and differ from, magnetic orientation demonstrated in other animal groups. We have therefore expanded the Discussion to note that studies have shown that some animals can exhibit directional preferences in simplified visual environments solely in response to changes in the magnetic field, and we now cite representative examples from birds and mole rats. At the same time, we also acknowledge important methodological and phenotypic differences among taxa. In particular, moths’ magnetic orientation has been assessed using a flight simulator, a setup in which stable directional behavior must be actively maintained during continuous movement. This is an important difference from orientation assays in birds during take-off or in terrestrial mammals such as mole rats. Moreover, whether birds and other animals rely on visual input to detect or calibrate magnetic information under certain conditions remains an open question. We therefore emphasize here both the phenotypic differences observed across experimental systems and the methodological considerations.

      • LL. 560-565 (paragraph starting with "Our flight simulator system (Dreyer et al., 2021) …"): Suggest clarifying what the Flash flight simulator system is and how it differs from the Mouritsen-Frost flight simulator.

      Thank you for this suggestion. We have added a brief clarification of the Flash flight simulator and how it differs from the Mouritsen–Frost system.

      • LL. 605-608 ("Spectral measurements …"): Explicitly mention that total illuminance was not measured and that further work is required to compare the illuminance used with natural conditions which of course vary.

      Thank you for this helpful suggestion. We agree that total illuminance is an important factor. We have now added a statement noting that the ambient light level in the experimental environment was measured to be below 1 lux using a Testo 540 lux meter, and we further acknowledge that additional work is required to compare the illuminance used in this study with that under naturally variable conditions.

      • LL. 628-641 (end of paragraph starting with "Electromagnetic noise at the experimental site ... "): Explain why this matters for interpreting behavioural responses. Highlight that although conditions were somewhat magnetically noisy which based on the past work may disrupt magnetic compass as it was shown in birds (eg Engels et al. 2014 Nature), the observed magnetic response under certain conditions indicates that the magnetic sense remained functional when landmark and magnetic field were aligned. This way you can pre-empt this criticism of your magnetic conditions being not ideal and noise on the left handside of the spectrum measured (which is not uncommon).

      Thank you for this helpful suggestion. We have now cited Engels et al. (2014, Nature) in this section and expanded the text to explain why electromagnetic noise at the experimental site is relevant for interpreting the behavioural responses. We also clarify the rationale for measuring electromagnetic noise and discuss the observed low-frequency (“left-hand side”) noise in the spectrum.

      • Fig. 51: Suggest adapting Y-axes and using violin or box plots (e.g., panels A/B starting from 30 up to 50, etc.).

      Thank you for this helpful suggestion. We have revised Fig. 5 accordingly by adapting the Y-axis scaling and replacing the original plots with box plots, as suggested.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      The researchers aimed to identify which neurotransmitter pathways are required for animals to withstand chronic oxidative stress. This work thus has important implications for disease processes that are caused/linked to oxidative stress. This work identified specific neurotransmitters and receptors that coordinate stress resilience, both prior to and during stress exposure. Further, the authors identified specific transcriptional programs coordinated by neurotransmission that may provide stress resistance.

      Strengths:

      The manuscript is very clearly written with a well-formulated rationale. Standard C. elegans genetic analysis and rescue experiments were performed to identify key regulators of the chronic oxidative stress response. These findings were enhanced by transcriptional profiling that identified differentially expressed genes that likely affect survival when animals are exposed to stress.

      We thank the reviewer for their positive assessment.

      Weaknesses:

      Where the gar-3 promoter drives expression was not discussed in the context of the rescue experiments in Figure 7.

      We now provide information about expression using 7.5 kb gar-3 promoter fragment  and compare directly with our analysis of endogenous gar-3 expression using the genome-modified gar-3::SL2::GFP strain (Page 16, new Figures 8 and S3).

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 3B is not mentioned in the text.

      Fixed. Figure 3B is now called out on page 10 of the revised manuscript.

      (2) The rationale for using the specific PQ concentration was not provided.

      We selected this concentration based on its use for chronic assays by other studies in the field to allow for direct comparison with our results. We now clarify this point in the Methods section (Page 26 of the revised text).

      (3) Transgenic animals injected with the unc-17βp::gar-3 transgene (25 ng/μL) displayed strikingly increased survival in the presence of 4 mM PQ compared to either gar-3 mutants or wild type (should have a Figure cited here)

      Fixed. Figure 9E is now referenced on Page 19 of the revised text.

      (4) The text describing Figure 7C details a comparison with the gar-3 single mutant but the graph shows the unc-17 single mutant

      Figure 7C is a comparison of the survival of gar-3 single mutants with either wild type or gar-3;ric-3 double mutants as described in the text.

      Reviewer #2 (public comments)

      In this paper, Biswas et al. describe the role of acetylcholine (ACh) signaling in protection against chronic oxidative stress in C. elegans. They showed that disruption of ACh signaling in either unc-17 mutants or gar-3 mutants led to sensitivity to toxicity caused by chronic paraquat (PQ) treatment. Using RNA seq, they found that approximately 70% of the genes induced by chronic PQ exposure in wild type failed to upregulate in these mutants. The overexpression of gar-3 selectively in cholinergic neurons was sufficient to promote protection against chronic PQ exposure in an ACh-dependent manner. The study points to a previously undescribed role for ACh signaling in providing organism-wide protection from chronic oxidative stress, likely through the transcriptional regulation of numerous oxidative stressresponse genes. The paper is well-written, and the data are robust, though some conclusions seem preliminary and do not fully support the current data. While the study identifies the muscarinic ACh receptor gar-3 as an important regulator of the response to PQ, the specific neurons in which gar-3 functions were not unambiguously identified, and the sources of ACh that regulate GAR-3 signaling and the identities of the tissues targeted by gar-3 were not addressed, limiting the scope of the study.

      We thank the reviewer for their positive assessment. We provide additional data and discussion of the points raised by the reviewer in the revised manuscript. In particular, as suggested by the reviewer, we conducted additional tissue-specific rescue experiments to try to better define GAR-3 site of action. We found that specific rescue of gar-3 expression in either cholinergic motor neurons or muscles each provide partial rescue. In addition, we quantified the expression of the nhr-185 and fbxa-73 genes, identified as upregulated by PQ in our RNA-seq studies, following oxidative stress (new Fig. S4). We observed increased expression of both genes following PQ exposure, providing independent confirmation for transcriptional upregulation of these genes as part of the stress response. See the responses to points #1 and #3 below for additional details.

      Major Comments:

      (1) The site of action of cholinergic signaling for protection from PQ was not adequately explored. The authors' conclusion that cholinergic motor neurons are protective is based on studies using overexpression of gar-3 and an unc-17 allele that may selectively disrupt ACh in cholinergic motor neurons (Figure 9F), but these approaches are indirect. To more directly address the site of action, the authors should conduct rescue experiments using well-defined heterologous promoters. Figure 7G shows that gar-3 expressed under a 7.5 kb promoter fragment fully rescues the defect of gar-3 mutants, but the authors did not report where this promoter fragment is expressed, nor did they conduct rescue experiments of the specific tissues where gar-3 is known to be expressed (cholinergic neurons, GABAergic neurons, pharynx, or muscles). UNC-17 rescue experiments could also be useful to address the site of action. Does expression of unc-17 selectively in cholinergic motor neurons rescue the stress sensitivity of unc-17 mutants (or restore resistance to gar-3(OE); unc-17 mutants)? These experiments may also address whether ACh acts in an autocrine or paracrine manner to activate gar-3, which would be an important mechanistic insight to this study that is currently lacking.

      We performed additional rescue experiments using heterologous promoters to drive gar-3 expression in cholinergic neurons or muscle and found that each provided a small, but significant degree of rescue as assessed from Kaplan-Meier survival curves. These results are presented in Figure 8 of the revised manuscript. We have not conducted similar unc-17 rescue experiments; however, we point out that cellspecific unc-17 knockdown by RNAi using the unc-17b promoter (expression largely restricted to ventral cord ACh motor neurons) increases sensitivity to PQ in our long-term survival assays (Figure 3A). Combined with our analysis of unc-17(e113) mutants, we believe these results support a requirement for unc-17 expression in cholinergic motor neurons.

      (2) The genetic pan-neuronal silencing experiments presented in Figure 1 motivated the subsequent experiments, but the authors did not relate these observations to ACh/gar-3 signaling. For example, the authors did not address whether silencing just the cholinergic motor neurons at the different times tested has the same effects on survival as pan-neuronal silencing.

      We used the pan-neuronal silencing to motivate further analysis of various neurotransmitter systems. Our genetic studies implicate both glutamatergic and cholinergic systems in protective responses to oxidative stress. The effects of pan-neuronal silencing on survival during long-term PQ exposure may therefore be derived solely from cholinergic neurons, glutamatergic neurons, or a combination of both neuronal populations. Distinguishing between these possibilities may be quite complicated and is not central to the main message of our paper. We therefore suggest this additional analysis lies outside the scope of this revision. Nonetheless, to address the reviewer’s point, in the revised text we expand our discussion relating the pan-neuronal silencing results to our analysis of ACh signaling (pages 21-22).

      (3) It is assumed that protection occurs through inter-tissue signaling of ACh to target tissues, where it impacts gene expression. While this is a reasonable assumption, it has not been directly shown here. It is recommended that the authors examine GFP reporter expression of a sampling of the genes identified in this study (including proteasomal genes that the authors highlight) that are regulated by unc-17 and gar-3. This would serve to independently confirm the RNAseq data and to identify target tissues that are subject to gene expression regulation by ACh, which would significantly strengthen the study.

      Agreed. To address this question, we investigated expression of the nhr-185 and fbxa-73 genes implicated as upregulated by oxidative stress in our RNA-seq studies. Consistent with our RNA-seq findings, we observed significantly increased expression of a nhr-185pr::GFP transcriptional reporter, primarily in the pharynx and anterior intestine, following 48 hrs of PQ exposure. These results support transcriptional upregulation of expression in these tissues as part of the stress response. fbxa-73 was among the proteasomal genes implicated as oxidative stress-responsive by RNA-seq. Consistent with this finding, by quantitative RT-PCR we observed a significant increase in fbxa-73 expression in wild type animals following 48 hrs of PQ treatment. These new results provide independent confirmation of the gene expression changes we observed by RNA-seq and are now included in new Figure S4 and discussed on Pages 17-18 of the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      (1) As an independent way of addressing whether enhanced ACh signaling is sufficient for protection, the authors could examine stress resistance in ace mutants, as was reported in PMID: 39097618, or in mutants with increased ACh secretion.

      We thank the reviewer for this suggestion. We are pursuing the impacts of increased cholinergic activation in a separate study. We are pursuing experiments along the lines the reviewer suggests as one facet of this independent study. Our findings here provide evidence that increasing GAR-3 signaling in ACh motor neurons by cell-specific overexpression enhances protection. 

      (2) To address the specificity of ACh signaling by gar-3 for this response, the authors could report survival data for mutants lacking each of the other two mACh receptors, gar-1 and gar-2.

      We thank the reviewer for this suggestion. We now include new data showing that gar-3;gar-2 double mutants have similar survival to gar-3 single mutants in the presence of PQ new Figure 7F). We agree that further studies of additional GPCRs (e.g. gar-1 and metabotropic glutamate receptors) will be required to definitively establish specificity for GAR-3 and we now acknowledge this point on page 15 of the revised text.

      (3) Do carbonylation levels correlate with toxicity? For example, do gar-3 mutants have more carbonylation and gar-3 OE have less?

      This is an interesting question. To try to address this, we performed additional protein carbonylation experiments for unc-17 and gar-3 mutants. We found a similar increase in protein carbonylation following PQ exposure for gar-3 mutants as observed for wild type; however, we also noted a higher level a batch-to-batch variability for gar-3 compared with wild type and are therefore hesitant to draw firm conclusions. We have not included these data in the revised manuscript but provide them for the reviewer’s information here (Author response image 1 shows our prior N2 data for comparison). We were not able to conduct similar experiments for unc-17 mutants because we noted local starvation when the animals were grown at the high density required to obtain the protein quantities needed for these experiments.

      Author response image 1.

      (4) Citations in text for Figures 4A and 8A are missing.

      Fixed. Figures 4A and 8A (now 9A) are cited on pages 10 and 17 of the revised text, respectively.

      (5) Figures 4-6 and 8 have limited information content. Condense or move to supplementary.

      While we acknowledge the reviewer’s viewpoint here, we believe that the analyses of the transcriptional responses described in Figures 4-6 and 8 are central to the study. To address reviewers’ comments, we have included a new Figure 8 and merged previous Figures 8 and 9 (new Figure 9) in the revised manuscript.

      (6) "expression of" is repeated in "Finally, transgenic expression of expression of a wild-type GAR-3::YFP"

      Fixed.

    1. Author response:

      The following is the authors’ response to the original reviews

      eLife Assessment

      This important study shows that orientation tuning of V1 neurons is suppressed during a continuous flash suppression paradigm, especially when the neurons have a binocular receptive field. However, the evidence presented is incomplete and, in particular, does not distinguish whether this suppression is due to reduced contrast or due to masking.

      This assessment is primarily based on the critique of Reviewer 2 that our results do not distinguish whether the impact of CFS is due to reduced contrast or due to masking. Reviewer 2 referred to Yuval-Greenberg and Heeger (2013), noting that: “V1 activity is, in fact, reduced during CFS … the mask reduces the gain of neural responses to the grating stimulus … making it invisible in the same way that reducing contrast makes a stimulus invisible.” To be precise, Yuval-Greenberg and Heeger (2013) used “akin to”, instead of “the same way”, in their abstract.

      We agree that CFS masking and contrast reduction can both lower the signal-to-noise ratio and thereby reducing visibility. However, these two factors operate in fundamentally different ways. According to gain control models by Heeger and others, reducing the physical contrast of a stimulus decreases the excitatory drive, while dichoptic masking increases the normalization pool. Our findings therefore reflect genuine masking-induced suppression and are not attributable to stimulus contrast reduction.

      Public Reviews:

      Reviewer #1 (Public review):

      Disclaimer: While I am familiar with the CFS method and the CFS literature, I am not familiar with primate research or two-photon calcium imaging. Additionally, I may be biased regarding unconscious processing under CFS, as I have extensively investigated this area but have found no compelling evidence in favor of unconscious processing under CFS.

      This manuscript reports the results of a nonhuman-primate study (N=2 behaving macaque monkeys) investigating V1 responses under continuous flash suppression (CFS). The results show that CFS substantially suppressed V1 orientation responses, albeit slightly differently in the two monkeys. The authors conclude that CFS-suppressed orientation information "may not suffice for high-level visual and cognitive processing" (abstract).

      The manuscript is clearly written and well-organized. The conclusions are supported by the data and analyses presented (but see disclaimer). However, I believe that the manuscript would benefit from a more detailed discussion of the different results observed for monkeys A and B (i.e., inter-individual differences), and how exactly the observed results are related to findings of higher-order cognitive processing under CFS, on the one hand, and the "dorsal-ventral CFS hypothesis", on the other hand.

      Thanks for reviewer’s helpful comments and suggestions. We added new contents discussing the inter-individual differences and the "dorsal-ventral CFS hypothesis" in the revision, and made other changes, which are detailed below.

      Major Comments:

      (1) Some references are imprecise. For example, l.53: "Nevertheless, two fMRI studies reported that V1 activity is either unaffected or only weakly affected (Watanabe et al., 2011; Yuval-Greenberg & Heeger, 2013)". "To the best of my understanding, the second study reaches a conclusion that is entirely opposite to that of the first, specifically that for low-contrast, invisible stimuli, stimulus-evoked fMRI BOLD activity in the early visual cortex (V1-V3) is statistically indistinguishable from activity observed during stimulus-absent (mask-only) trials. Therefore, high-level unconscious processing under CFS should not be possible if Yuval-Greenberg & Heeger are correct. The two studies contradict each other; they do not imply the same thing.

      Sorry we did not make our point clear. Our original concern was that the effects of CFS on V1 activity were underestimated, even in Yuval-Greenberg & Heeger (2013), as both studies compared monocular and dichoptic masking to estimate the influence of visibility. In contrast, in original psychophysical studies, the CFS effect was compared with or with dichoptic masking, which is expected to be stronger. We rewrote the paragraph to clarify.

      “Two prominent fMRI studies have examined the impact of CFS on V1 activity (Watanabe et al., 2011; Yuval-Greenberg & Heeger, 2013). Watanabe et al. (2011) compared monocular CFS masking (stimulus visible) and dichoptic CFS masking (stimulus invisible), and reported that V1 BOLD responses were largely insensitive to stimulus visibility when attention was carefully controlled. However, using similar experimental design, Yuval-Greenberg and Heeger (2013) observed reduced BOLD responses in V1 under dichoptic masking, suggesting that V1 activity changed with stimulus visibility. They attributed the difference of results between two studies mainly to differences in statistical power (~250 trials per condition vs. ~90 trials per condition). Nevertheless, these studies were not designed to quantify the pure effect of CFS on stimulus-evoked V1 responses, as they contrasted monocular and dichoptic masking conditions to equate stimulus input while manipulating perceptual visibility. In contrast, original psychophysical studies (Tsuchiya & Koch, 2005; Tsuchiya, Koch, Gilroy, & Blake, 2006) demonstrated CFS masking by contrasting the visibility of the target stimulus with and without the presence of dichoptic mask. It is apparent that the pure CFS impact in above fMRI studies would be the difference of BOLD signals between binocular masking and stimulus alone conditions. In other words, the impact of CFS on V1 activity should be larger than what has been reported by Yuval-Greenberg and Heeger (2013).” (lines 55-71)

      (2) Line 354: "The flashing masker was a circular white noise pattern with a diameter of 1.89°, a contrast of 0.5, and a flickering rate of 10 Hz. The white noise consisted of randomly generated black and white blocks (0.07 × 0.07 each)." Why did the authors choose a white noise stimulus as the CFS mask? It has previously been shown that the depth of suppression engendered by CFS depends jointly on the spatiotemporal composition of the CFS and the stimulus it is competing with (Yang & Blake, 2012). For example, Hesselmann et al. (2016) compared Mondrian versus random dot masks using the probe detection technique (see Supplementary Figure S4 in the reference below) and found only a poor masking performance of the random dot masks.

      Yang, E., & Blake, R. (2012). Deconstructing continuous flash suppression. Journal of Vision, 12(3), 8. https://doi.org/10.1167/12.3.8

      Hesselmann, G., Darcy, N., Ludwig, K., & Sterzer, P. (2016). Priming in a shape task but not in a category task under continuous flash suppression. Journal of Vision, 16, 1-17.

      In a previous human psychophysical study, we also used the same noise pattern and the CFS effect appeared to be robust (Xiong et al., 2016, https://doi.org/10.7554/eLife.14614). However, we believe that the reviewer made a good point, and weaker suppression due to the use of our stimulus pattern may have contributed to the weaker suppression in Monkey B. This issue is now discussed in the revision regarding the individual variability in our results.

      “In addition, the random-noise masker we used might not be as effective as Mondrian patterns (G. Hesselmann, Darcy, Ludwig, & Sterzer, 2016). If reduced stimulus contrast and a Mondrian masker were used, we predict that CFS suppression in Monkey B would strengthen, potentially approaching the level observed in Monkey A. Nevertheless, it is worth emphasizing that our main conclusions are primarily based on data from Monkey A, who exhibited much stronger CFS suppression.” (lines 321-327)

      (3) Related to my previous point: I guess we do not know whether the monkeys saw the CF-suppressed grating stimuli or not? Therefore, could it be that the differences between monkey A and B are due to a different individual visibility of the suppressed stimuli? Interocular suppression has been shown to be extremely variable between participants (see reference below). This inter-individual variability may, in fact, be one of the reasons why the CFS literature is so heterogeneous in terms of unconscious cognitive processing: due to the variability in interocular suppression, a significant amount of data is often excluded prior to analysis, leading to statistical inconsistencies.

      Yamashiro, H., Yamamoto, H., Mano, H., Umeda, M., Higuchi, T., & Saiki, J. (2014). Activity in early visual areas predicts interindividual differences in binocular rivalry dynamics. Journal of Neurophysiology, 111(6), 1190-1202. https://doi.org/10.1152/jn.00509.2013

      The individual difference issue is now explicitly addressed in the Discussion:

      “Interocular suppression under CFS is known to vary substantially across individuals (Blake, Goodman, Tomarken, & Kim, 2019; Gayet & Stein, 2017; Yamashiro et al., 2013). This inter-individual variability may contribute to the heterogeneity observed in the CFS literature. We also found that the strength of V1 response suppression during CFS differed between two monkeys, as reflected by population orientation tuning functions (Fig. 2C), Fisher information (Fig. 2F), and reconstruction performance by the transformer (Fig. 3E). Several experimental factors may have contributed to the relatively weaker suppression observed in Monkey B. Because monkeys viewed the stimuli passively, we could not determine the dominant eye for each monkey (instead we switched the eyes and averaged the results), and the target was presented at relatively high contrast. Both factors are known to reduce the effectiveness of CFS suppression (Yang, Blake, & McDonald, 2010; Yuval-Greenberg & Heeger, 2013). In addition, the random-noise masker we used might not be as effective as Mondrian patterns (G. Hesselmann, Darcy, Ludwig, & Sterzer, 2016). If reduced stimulus contrast and a Mondrian masker were used, we predict that CFS suppression in Monkey B would strengthen, potentially approaching the level observed in Monkey A. Nevertheless, it is worth emphasizing that our main conclusions are primarily based on data from Monkey A, who exhibited much stronger CFS suppression.” (lines 311-327)

      Moreover, the authors' main conclusion (lines 305-307) builds on the assumption that the stimuli were rendered invisible, but isn't this speculation without a measure of awareness?

      We agree. To correct, we have removed the original lines 305-307 discussing the consciousness perception and reframed the manuscript throughout to focus on the impact of CFS on neural coding rather than on perceptual awareness. For example, the title has been changed to:

      “Continuous flashing suppression of neural responses and population orientation coding in macaque V1”,

      and the ending line of Introduction was changed to:

      “This approach enabled us to investigate the potentially differential impacts of CFS on the responses of V1 neurons with varying ocular preferences, as well as apply machine learning tools to understand the impacts of CFS on V1 stimulus coding at the population level.” (lines 81-83)

      (4) The authors refer to the "tool priming" CFS studies by Almeida et al. (l.33, l.280, and elsewhere) and Sakuraba et al. (l.284). A thorough critique of this line of research can be found here:

      Hesselmann, G., Darcy, N., Rothkirch, M., & Sterzer, P. (2018). Investigating Masked Priming Along the "Vision-for-Perception" and "Vision-for-Action" Dimensions of Unconscious Processing. Journal of Experimental Psychology. General. https://doi.org/10.1037/xge0000420

      This line of research ("dorsal-ventral CFS hypothesis") has inspired a significant body of behavioral and fMRI/EEG studies (see reference for a review below). The manuscript would benefit from a brief paragraph in the discussion section that addresses how the observed results contribute to this area of research.

      Ludwig, K., & Hesselmann, G. (2015). Weighing the evidence for a dorsal processing bias under continuous flash suppression. Consciousness and Cognition, 35, 251-259. https://doi.org/10.1016/j.concog.2014.12.010

      In the revision, we added a new paragraph to discussion issues related to the dorsal-ventral CFS hypothesis.

      “A related issue is the dorsal-ventral CFS hypothesis, which proposes that CFS suppression may disproportionately affect ventral visual processing while relatively preserving dorsal pathways involved in visuomotor functions, potentially allowing category- or action-related information to remain accessible under suppression (Fang & He, 2005). However, subsequent fMRI studies have failed to provide consistent support for this dissociation, reporting either stream-invariant awareness effects (Guido Hesselmann & Malach, 2011; Ludwig et al., 2015; Tettamanti et al., 2017), residual signal in ventral rather than dorsal regions (Fogelson et al., 2014; Guido Hesselmann et al., 2011), or residual low-level feature information/partial visibility rather than preserved dorsal processing (Ludwig et al., 2015). Although our study does not directly test dorsal-ventral dissociations, our V1 results provide a constraint on what information downstream visual pathways could access under suppression. When CFS- induced interocular suppression was strong enough and stimuli reconstruction was markedly reduced, as in the case of Monkey A, the information required for category-level or action-related processing may not be sufficient for high-level cortical representation.” (lines 297-310)

      Reviewer #2 (Public review):

      Summary:

      The goal of this study was to investigate the degree to which low-level stimulus features (i.e., grating orientation) are processed in V1 when stimuli are not consciously perceived under conditions of continuous flash suppression (CFS). The authors measured the activity of a population of V1 neurons at single neuron resolution in awake fixating monkeys while they viewed dichoptic stimuli that consisted of an oriented grating presented to one eye and a noise stimulus to the other eye. Under such conditions, the mask stimulus can prevent conscious perception of the grating stimulus. By measuring the activity of neurons (with Ca2+ imaging) that preferred one or the other eye, the authors tested the degree of orientation processing that occurs during CFS.

      Strengths:

      The greatest strength of this study is the spatial resolution of the measurement and the ability to quantify stimulus representations during CSF in populations of neurons, preferring the eye stimulated by either the grating or the mask. There have been a number of prominent fMRI studies of CFS, but all of them have had the limitation of pooling responses across neurons preferring either eye, effectively measuring the summed response across ocular dominance columns. The ability to isolate separate populations offers an exciting opportunity to study the precise neural mechanisms that give rise to CFS, and potentially provide insights into nonconscious stimulus processing.

      Weaknesses:

      While this is an impressive experimental setup, the major weakness of this study is that the experiments don't advance any theoretical account of why CFS occurs or what CFS implies for conscious visual perception. There are two broad camps of thinking with regard to CFS. On the one hand, Watanabe et al. (2011) reported that V1 activity remained intact during CFS, implying that CFS interrupts stimulus processing downstream of V1. On the other hand, Yuval-Greenberg and Heeger (2013) showed that V1 activity is, in fact, reduced during CFS. By using a parametric experimental design, they measured the impact of the mask on the stimulus response as a function of contrast and concluded that the mask reduces the gain of neural responses to the grating stimulus. They presented a theoretical model in which the mask effectively reduced the SNR of the grating, making it invisible in the same way that reducing contrast makes a stimulus invisible.

      We used multi-class SVM (as suggested by reviewer 3) and a transformer-based model to examine the impact of CFS on the classification of 12 orientations spaced in 15o gaps, which resembles coarse orientation discrimination, as well as on stimulus reconstruction, which resembles stimulus perception necessary for high-level cognitive tasks, respectively. The results suggest that under CFS, an observer may still be able to perform coarse orientation discrimination but not high-level cognitive tasks. These findings provide new insights into the implications of CFS for conscious visual perception from a population decoding perspective.

      In the revision, we also added a new paragraph discussing the implications of our findings for the dorsal-ventral CFS hypothesis, as suggested by reviewer 1. We previously presented a gain control model for our neuronal data in a VSS talk. However, we later decided that, since there are already nice models by Heeger and others, it would be better present something more unique and novel (i.e., machine learning results), which has now become a major component of the manuscript. We welcome the reviewer’s comments on this part.

      An important discussion point of Yuval-Greenberg and Heeger is that null results (such as those presented by Watanabe et al.) are difficult to interpret, as the lack of an effect may be simply due to insufficient data. I am afraid that this critique also applies to the present study.

      We are very much puzzled by the reviewer’s critique. First, our main result is not a null effect. A null effect would mean that CFS masking had no impact on population orientation responses. Instead, we observed a significant suppression or abolished tuning, which clearly indicates a strong effect of dichoptic masking. Second, our findings are based on large neural populations recorded using two-photon imaging, providing extensive sampling and statistical power. Thus, we believe that the reviewer’s critique about “insufficient data” are not applicable to our study.

      Here, the authors report that CFS effectively 'abolishes' tuning for stimuli in neurons preferring the eye with the grating stimulus. The authors would have been in a much stronger position to make this claim if they had varied the contrast of the stimulus to show that the loss of tuning was not simply due to masking.

      We are sorry that we cannot follow the logic here either. Even if “the mask effectively reduced the SNR of the grating, making it invisible in the same way that (“akin to”, to be more precise according to the abstract of Yuval-Greenberg and Heeger (2013)) reducing contrast makes a stimulus invisible”, it does not necessarily mean that dichoptic masking and contrast reduction are the same process or are based on the same neuronal mechanisms. According to gain control models by Heeger and others, reducing the stimulus contrast decreases the excitatory drive, while dichoptic masking increases the normalization pool via interocular suppression, both of which lower SNR, but are two fundamentally distinct processes.

      Therefore, varying the stimulus contrast might reveal a main effect of contrast, and possibly an interaction between contrast and dichoptic masking, but it would neither prove nor disprove the main effect of dichoptic masking.

      So, while this is an incredibly impressive set of measurements that in many ways raises the bar for in vivo Ca2+ imaging in behaving macaques, there isn't anything in the results that constitutes a real theoretical advance.

      We sincerely hope that the reviewer would have a better judgment after reading our responses.

      Reviewer #3 (Public review):

      Summary:

      In this study, Tang, Yu & colleagues investigate the impact of continuous flash suppression (CFS) on the responses of V1 neurons using 2-photon calcium imaging. The report that CFS substantially suppressed V1 orientation responses. This suppression happens in a graded fashion depending on the binocular preference of the neuron: neurons preferring the eye that was presented with the marker stimuli were most suppressed, while the neurons preferring the eye to which the grating stimuli were presented were least suppressed. The binocular neuron exhibited an intermediate level of suppression.

      Strengths:

      The imaging techniques are cutting-edge, and the imaging results are convincing and consistent across animals.

      Weaknesses:

      I am not totally convinced by the conclusions that the authors draw based on their machine learning models.

      Thanks for pointing this issue. We have used a new multi-class SVM suggested by the reviewer to reanalyze the data and found similar results, which is detailed later.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Lines 56-63: "As a result, the dichoptic CFS masking, which is cortical, could be substantially stronger than monocular masking when accounting for the pre-cortical effects of monocular masking." I don't quite understand this argument. Could you please elaborate?

      We have revised our writing to address the reviewer’s first major comment, which the current issue is related. The elaboration is highlighted in the paragraph below.

      “Two prominent fMRI studies have examined the impact of CFS on V1 activity (Watanabe et al., 2011; Yuval-Greenberg & Heeger, 2013). Watanabe et al. (2011) compared monocular CFS masking (stimulus visible) and dichoptic CFS masking (stimulus invisible), and reported that V1 BOLD responses were largely insensitive to stimulus visibility when attention was carefully controlled. However, using similar experimental design, Yuval-Greenberg and Heeger (2013) observed reduced BOLD responses in V1 under dichoptic masking, suggesting that V1 activity changed with stimulus visibility. They attributed the difference of results between two studies mainly to differences in statistical power (~250 trials per condition vs. ~90 trials per condition). Nevertheless, these studies were not designed to quantify the pure effect of CFS on stimulus-evoked V1 responses, as they contrasted monocular and dichoptic masking conditions to equate stimulus input while manipulating perceptual visibility. In contrast, original psychophysical studies (Tsuchiya & Koch, 2005; Tsuchiya, Koch, Gilroy, & Blake, 2006) demonstrated CFS masking by contrasting the visibility of the target stimulus with and without the presence of dichoptic mask. It is apparent that the pure CFS impact in above fMRI studies would be the difference of BOLD signals between binocular masking and stimulus alone conditions. In other words, the impact of CFS on V1 activity should be larger than what has been reported by Yuval-Greenberg and Heeger (2013).” (lines 55-71)

      (2) Line 13 low-level stimulus (properties).

      Fixed, thanks.

      Reviewer #3 (Recommendations for the authors):

      Major comments:

      (1) My main comment is regarding the SVM classifiers. The pair-wise (adjacent orientation pairs) decoding approach is unrealistic in my opinion and likely explains the very high accuracies that are reported. I believe that a multi-way classification approach - Linear Discriminant Analysis, Decision Trees, etc. - is needed to draw reasonable conclusions. Even SVMs can be adapted for multi-way classification (e.g., Allwein et al., 2000, J. Machine Learning Research).

      Following the reviewer’s advice, we reanalyzed the data using a multi-class SVM with a one-vs-one (OvO) scheme to classify 12 orientations (Allwein et al., 2000), which yielded similar results.

      “For orientation classification, we trained an all-pair multiclass support vector machine (SVM) classifier to discriminate 12 orientations based on trial-by-trial population neural responses from all trials (Allwein, Schapire, & Singer, 2000). Decoders for different FOVs, ipsilateral/contralateral target presentations, and baseline vs. CFS conditions were trained separately. Under the baseline condition, the decoders achieved mean classification accuracies of 89.5 ± 2.0% and 91.5 ± 2.1% across ipsilateral and contralateral eye conditions in Monkeys A and B, respectively, in contrast to a chance level of 8.3% (1 out of 12). Under CFS, decoding accuracy slightly decreased in Monkey A (81.7 ± 1.9%) but remained stable in Monkey B (90.4 ± 2.1%, Fig. 3A). These results suggest that under CFS, there is still sufficient information for coarse orientation discrimination, even for Monkey A whose V1 neuronal responses were substantially suppressed.” (lines 171-181)

      (2) The inconsistent modeling results (Figure 3E,F) are puzzling and need to be adequately addressed.

      SSIM and orientation error in original Fig. 3E, F measured the same reconstruction quality, but these two indices go in opposite directions for the same modeling results. To avoid confusion, we have removed the orientation error metric and now only report SSIM.

      “We used a structural similarity index (SSIM) (Brunet, Vrscay, & Wang, 2012) to quantify the reconstruction performances. Across the grating-presenting ipsilateral and contralateral eyes, the baseline models reconstructed the grating with median SSIMs of 0.52 and 0.61 for the two FOVs of Monkey A, and 0.57 and 0.63 for the two FOVs of Monkey B, respectively, while the corresponding SSIMs for the CFS models were 0.16 and 0.19 for Monkey A, and 0.55 and 0.53 for Monkey B (Fig. 3E).” (lines 200-206)

      Minor points:

      (1) The phrase "perceptual consequences" in the title is somewhat strong and possibly misleading, since there are no behavioral measures in this study.

      To address this concern from this reviewer and reviewer 1, we now focus on the impact of CSF on population orientation coding rather than perceptual consequences, which is more appropriate describing our modeling results. For example, we changed the title to: “Continuous flashing suppression of neural responses and population orientation coding in macaque V1“. Other changes are also made throughout the manuscript accordingly.

      (2) Figure 4: Panel "F" is not marked in the figure.

      Fixed, thanks.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This study by Li and colleagues examines how defensive responses to visual threats during foraging are modulated by both reward level and social hierarchy. Using a naturalistic paradigm, the authors test how the availability of water or sucrose, with sucrose being more rewarding than water, shapes escape behavior in mice exposed to looming stimuli of different intensities, which are used to probe perceived threat level and defensive responses. In parallel, the study compares dominant and subordinate animals to assess how social rank biases the trade off between reward seeking and threat avoidance. By combining detailed behavioral analyses with computational modeling, the work addresses how reward level and social context jointly influence escape decisions in an ethologically relevant setting.

      Across the different experimental conditions, perceived threat level is the main determinant of behavior. The authors show that looming stimuli associated with higher threat (contrast) consistently elicit faster and more robust escape responses than lower threat stimuli. This effect is particularly evident during early exposures, when animals are highly vigilant and have not yet habituated to the looming stimulus (learned that it is not dangerous). Later they described that as animals gain experience and habituate, behavior becomes more flexible, and reward level begins to exert a graded modulation of the escape response. Importantly, the authors show that under high threat conditions increasing reward value leads to more frequent and faster escape rather than greater reward pursuit. This finding is particularly relevant, as it suggests that highly valued rewards can heighten vigilance and thereby enhance responsiveness to threat, highlighting that reward does not simply compete with defensive behavior but can also reshape it depending on the perceived level of danger, in contrast to low threat conditions, where threat can be more easily outweighed by reward. Thus, an important conceptual contribution of the study is the introduction of vigilance as a useful framework to interpret these effects. Vigilance is treated as a behavioral state reflecting heightened attention to potential danger. In line with what is known from natural foraging, mice initially maintain high vigilance when confronted with an innate threat. This perspective helps clarify a finding that might otherwise appear counterintuitive. One might expect higher rewards to motivate animals to tolerate risk, explore more, and habituate faster in any scenario. Instead, the data suggest that highly rewarding outcomes can elevate vigilance, making animals more responsive to threat and leading to faster or more frequent escape under high threat conditions. In this sense, reward does not simply compete with threat but can also amplify sensitivity to it, depending on the internal state of the animal.

      The social results are particularly interesting in this context as well. Dominant mice consistently prioritize avoidance over reward, showing stronger escape responses and slower habituation than subordinates. This behavior is well captured by the vigilance framework proposed by the authors: dominant animals appear to maintain higher vigilance, which biases decisions toward threat avoidance. The authors further suggest that stable social relationships sustain high vigilance and slow habituation, framing this as an evolutionarily conserved strategy that may enhance survival. This interpretation provides a valuable perspective on how social structure shapes defensive behavior beyond immediate physical interactions. At the same time, there are important limitations to this interpretation. All experiments were conducted in male mice, and it is possible that the relationship between social hierarchy, vigilance, and defensive behavior would differ substantially in females. In addition, the idea that stable social relationships maintain elevated vigilance does not straightforwardly align with broader views of social stability as protective for mental health and as a buffer against anxiety and stress. These points do not undermine the findings but suggest that the social effects described here should be interpreted with caution and within the specific context of the task and sex studied.

      We thank the reviewer for raising this important point. In the context of repeated looming exposure, slower habituation reflects more sustained vigilance over time. Compared to individually housed mice, group-housed mice exhibit slower habituation (Lenz et al., 2022), and pair-housed mice showed even slower habituation in our current work. Importantly, this pattern does not indicate that pair-housed mice have higher overall vigilance than individually housed animals. Although individually housed mice habituate more quickly, they display higher initial vigilance, as reflected by their increased probability of escaping in response to looming stimuli (Lenz et al., 2022). Thus, pair-housed mice exhibited reduced defensive responses compared to individually housed animals, consistent with a social buffering effect.

      Furthermore, in a separate study (Rank- and Threat-Dependent Social Modulation of Innate Defensive Behaviors; Li, Gao, Li, 2026, eLife 15:RP109571), we directly compared responses to looming stimuli when mice were tested alone versus in the presence of a social partner and observed clear evidence of social buffering.

      Another important limitation is that the neural mechanisms underlying these effects remain speculative. The manuscript includes an extensive discussion of candidate circuits, particularly involving the superior colliculus and downstream structures, but this section is necessarily based on prior literature rather than on data presented in the study. Given the complexity of the circuits involved in integrating internal state, reward, social context, and vigilance, the current work should be viewed as providing a strong behavioral and conceptual framework rather than direct insight into underlying neural mechanisms.

      We fully agree that the proposed neural mechanisms remain speculative and that the circuits involved in integrating internal state, reward, and social context are likely far more complex. We have revised the manuscript to acknowledge this limitation.

      Methodologically, the behavioral paradigm is well suited for studying escape decisions in socially housed animals, and the machine learning based classification of defensive responses is a clear strength. The computational model provides a useful formalization of how threat level, reward level, and vigilance interact and may be valuable for other laboratories studying escape, approach avoidance, or conflict situations, particularly as a way to classify behavioral outcomes after pose estimation. More generally, the work will be of interest to the neuroethology community for its detailed characterization of escape behavior under naturalistic conditions.

      Given the ethological nature of the study and the high inter individual variability reported by the authors, clarity and precision in the methods are especially important for reproducibility. While the revised manuscript addresses many earlier concerns, some aspects remain slightly difficult to follow. For example, the main text states that animals were not water deprived to avoid differences in internal state, whereas parts of the methods describe conditions in which animals were water deprived, suggesting that internal state manipulation may differ across experiments. Clearer separation and explanation of these conditions would further strengthen confidence in the work.

      To improve clarity, we have revised the Methods section to clearly distinguish between experimental conditions that involved water deprivation and those that did not.

      Overall, this study provides a rich and thoughtful analysis of how reward level and social hierarchy modulate defensive behavior through changes in vigilance. It offers a useful conceptual advance for thinking about escape behavior in naturalistic settings and lays a solid foundation for future work aimed at linking these behavioral states to underlying neural circuits.

      Reviewer #2 (Public review):

      Zhe Li and colleagues investigate how mice exposed to visual threats and rewards balance their decisions in favour of consuming rewards or engaging in defensive actions. By varying threat intensity and reward value, they first confirm previous findings showing that defensive responses increase with threat intensity and that there is habituation to the threat stimulus. They then find that water-deprived mice have a reduced probability of escaping from low contrast visual looming stimuli when water or sucrose are offered in the environment, but that when the stimulus contrast is high, the presence of sucrose or water increases the probability of escape. By analysing behaviour metrics such as the latency to flee from the threat stimulus, they suggest that this increase in threat sensitivity is due to increased vigilance. Analysis of this behaviour as a function of social hierarchy shows that dominant mice have higher threat sensitivity, which is also interpreted as being due to increased vigilance. These results are captured by a drift diffusion model variant that incorporates threat intensity and reward value.

      The main contribution of this work is quantifying how the presence of water or sucrose in water-deprived mice affects escape behaviour. The differential effects of reward between the low and high contrast conditions are intriguing, but I find the interpretation that vigilance plays a major in this process not supported by the data. The idea that reward value exerts some form of graded modulation of the escape response is also not supported by the data. In addition, there is very limited methodological information, which makes assessing the quality of some of the analyses difficult, and there is no quantification on the quality of the model fits.

      (1) The main measure of vigilance in this work is reaction time. While reaction time can indeed be affected by vigilance, reaction times can vary as a function of many variables, and be different for the same level of vigilance. For example, a primate performing the random dot motion task exhibits differences in reaction times that can be explained entirely by the stimulus strength. Reaction time is therefore not a sound measure of vigilance, and if a goal of this work is to investigate this parameter, then it should be measured. There is some attempt at doing this for a subset of the data in Figure 3H, by looking at differences in the action of monitoring the visual field (presumably a rearing motion, though this is not described) between the first and second trials in the presence of sucrose. I find this an extremely contrived measure. What is the rationale for analysing only the difference between the first and second trials? Also, the results are only statistically significant because the first trial in the sucrose condition happens to have zero up action bouts, in contrast to all other conditions. I am afraid that the statistics are not solid here. When analysing the effects of dominance, a vigilance metric is the time spent in the reward zone. Why is this a measure of vigilance? More generally, measuring vigilance of threats in mice requires monitoring the position of the eyes, which previous work has shown is biased to the upper visual field, consistent with the threat ecology of rodents.

      We agree that reaction time can be influenced by multiple factors, including stimulus strength. Consistent with this, reaction times (i.e. latencies to flee) were substantially shorter under high-contrast conditions (Figure 3E). However, even under the same high-contrast condition, reaction times were significantly shorter in the water condition compared to the no-reward condition, suggesting that other factors such as vigilance may contribute.

      Upward-directed attention includes rearing, up-stretching, and upward head orientation, which will be clarified in the Method section. To address concerns about statistical validity, we will quantify these behaviors across the first 10 trials rather than limiting the analysis to the first two.

      As for the dominance-related results, we interpret them as reflecting both enhanced vigilance and reduced reward-seeking behavior. Time spent in the reward zone is not a measure of vigilance but an indicator of reward-seeking motivation. We will clarify this in the revised manuscript.

      (2) In both low and high contrast conditions, there are differences in escape behaviour between no reward and water or sucrose presence, but no statistically significant differences between water and sucrose (eg: Figure 3B). I therefore find that statements about reward value are not supported by the data, which only show differences between the presence or absence of reward. Furthermore, there is a confound in these experiments, because according to the methods, mice in the no-reward condition were not water-deprived. It is thus possible that the differences in behaviour arise from differences in the underlying state.

      In Figure 3B, the difference between water and sucrose conditions did not reach statistical significance (p = 0.08). We plan to collect additional data to determine whether this is due to limited statistical power. It is also possible that some behavioral readouts are more sensitive to the differences between water and sucrose conditions. For example, Figure 3F shows that escape speed was significantly higher in the sucrose than in the water condition under high-contrast stimulation.

      Thank you for pointing this out. To control for the potential confounds related to internal state, mice were not water-deprived under any of the three conditions in Figures 3A-3H. We will clarify this in the main text and Methods. For Figures 3I-3M, which compare decision-making under no-reward and water conditions, we will conduct additional experiments using non-deprived mice in the water condition.

      (3) There is very little methodological information on behavioural quantification. For example, what is hiding latency? Is this the same are reaction time? Time to reach the safe zone? What exactly is distance fled? I don't understand how this can vary between 20 and 100cm. Presumably, the 20cm flights don't reach the safe place, since the threat is roughly at the same location for each trial? How is the end of a flight determined? How is duration measured in reward zone measures, e.g., from when to when? How is fleeing onset determined?

      Hiding latency was defined as the time from stimulus onset to the animal’s arrival at the safe zone. Reaction time was quantified as the latency to flee, measured from stimulus onset to the initiation of the first flight state. The flight state was defined as locomotion exceeding 10 cm at a speed greater than 10 cm/s. Distance fled was defined as the distance covered between stimulus onset and offset for all trials. However, in trials classified as no reaction or freezing, this measure does not accurately reflect escape behavior. We will therefore rename it as distance under threat to better capture its meaning. The reward zone was defined as the region within 15 cm of the reward port at the end of the arena. Duration in the reward zone was measured as the time spent within this region during the 20 seconds following stimulus onset. In Figure 4E, the percentage of time spent in the reward zone was calculated relative to the total time the mouse remained in the arena during the 2-hour social session.

      All definitions and additional details on behavioral quantification will be included in the revised Methods section.

      (4) There is little methodological information on how the model was fit (for example, it is surprising that in the no reward condition, the r parameter is exactly 0. What this constrained in any way), and none of the fit parameters have uncertainty measures so it is not possible to assess whether there are actually any differences in parameters that are statistically significant.

      We appreciate the comment and agree that further clarification is needed. We will provide a more detailed description of the model fitting procedure in the revised Methods section. Specifically, the drift rate parameter (r), which reflects the perceived reward value, was constrained to zero in the no-reward condition. To enable statistical comparison across conditions, we will report uncertainty measures for all fit parameters.

      Comments on the revised manuscript:

      The manuscript has been revised and improved significantly by the addition of methodological details and new analysis. I remain, however, unconvinced by the argument that increased vigilance in the presence of reward leads to heightened escape behaviour.

      In response to my criticism that the work does not measure vigilance directly, the authors have included measures of foraging interval and foraging speed, which they state are "two direct behavioral analyses of vigilance". I disagree - like reaction time, foraging speed and foraging interval can be modulated, for example, by changes in threat sensitivity. Increased threat sensitivity comes with diverse behavioral changes that may well include increased vigilance, but foraging interval and foraging speed can certainly change without the animal expressing increased vigilance behaviors. A bigger issue I still have though, is with the conclusion that the presence of reward increases "direct escape behaviors". Comparing the no reward, water and sucrose groups indeed shows a difference (which is now clear after the split into early and late phases), but the issue is that these are different mice. As the text is written, is sounds like introducing reward will acutely increase escape. But if we look at the raw data show in Figure 2C, what I think is happening is that the presence of reward is decreasing habituation to the stimulus. The data for trials 1 and 10 in the three conditions show this - there is habituation with no reward (reaction times are all shifting to the right), a bit less with water and very little with sucrose. This is interesting in its own right and we can speculate why it might be happening, but I think this is conceptually different from what the authors are proposing.

      We agree that vigilance is not directly observable as a single variable. Our intent was not to claim that foraging speed and foraging interval provide a direct measure of vigilance, but rather to suggest that they may serve as indirect behavioral correlates.

      We also considered an alternative interpretation: these two measures could reflect perceived reward value under high-threat conditions across distinct reward types. If that were the case, animals would be expected to exhibit shorter intervals and faster speeds across no reward, water, and sucrose conditions. However, our data do not support this interpretation (Figures 3L and 3M), suggesting that these measures are more likely correlated with vigilance. 

      Furthermore, it is unlikely that changes in foraging interval and speed are driven by altered threat sensitivity, as animals could not see the threat during most of the foraging bout and only encountered it at the end.

      Regarding the conclusion that the presence of reward increases direct escape behaviors, our interpretation is that increased reward value reduces habituation, thereby maintaining higher vigilance during the late phase. This was discussed in the second-to-last paragraph of the "Economic and social modulations of innate decision-making under threat" subsection in the Discussion.

      Reviewer #3 (Public review):

      Male mice were tested in a classic behavioral "flee the looming stimulus" paradigm. This is a purely behavioral study; no neural analyses were done. Mice were housed socially, but faced the looming stimulus individually, using an elegant automated tunnel (see videos for clarity).

      The additional changes made to the paper clarify the work done. While there are some limitations (male mice, weird stimulus), the general results are interesting and a valuable addition to the experimental literature. The main claim of the paper is that the different rewards (none, water, sucrose) did not change the escape properties early in learning, but did late, particularly that in the late (already experienced) conditions, reward value (assuming sucrose > water > no reward) interacted with the salience of the looming stimulus (light gray, dark gray). (Panels 3D, 3G, 3K, 3N).

      For readers, I want to note that one of the most interesting results is actually in Figure S2, where they find that a looming stimulus behind the mouse still makes a mouse run to the nest. In these conditions, the mouse runs past the looming stimulus to get to safety! (I also do love the video of the mouse running around the barriers like a snake to get home.)

      I have a few minor clarification questions and a few notes that I think would be useful additions for authors and readers to think about.

      Dominance: What does the mouse social science literature say about the "test tube" test? What can we conclude from this test? This would be useful when trying to understand what is causing the dominance/submissive difference in responses. Figure 4 shows that the dominant mice are more risk-averse than the submissive mice. Is "dominance" in the test-tube actually a measure of risk-seeking? Is the issue that the submissive mice don't think they can get back to the food-site easily, so they are less willing to sacrifice the current (if dangerous) foraging opportunity? Is the issue that the submissive mice can't get back to the nest? As I understand it, the nest was always available to all the mice, so I suspect inability to get to the nest is an unlikely hypotheses. Is the issue that the submissive mice also don't feel safe in the nest?

      The tube test is a widely used assay in the rodent social behavior literature to assess dominance hierarchies, operationally defined by the ability of one animal to force its opponent to retreat from a narrow tube. Importantly, this assay does not directly measure risk-seeking or anxiety-related traits, but rather competitive outcomes during social conflict. Furthermore, our data indicate that the behavioral responses of subordinate mice to looming stimuli are primarily driven by the visual threat itself rather than by social avoidance. This point was elaborated in the second paragraph of the “Social modulation of innate decision-making” subsection in the Results section.

      Limitations of the study: There is an acknowledged limitation to male mice, and the limitations of the small data sets that are typical of such experiments. In addition, however, it is also worth noting the strangeness of the looming stimulus, which is revealed clearly in the videos. The stimulus is a repeating growing circle, growing in a single location within the environment. The stimulus repeats 10 times, once per second. This is not what an attacking hawk or owl would look like. (I now have this image of an owl diving down, and then teleporting up and diving down again.) Note - I am fine with this stimulus. It produces an interesting experiment and interesting results. I do not think the authors need to change anything in their paper, but readers need to recognize that this is not a "looming predator".

      These "limitations" are better seen as "caveats" when folding these results in with the rest of the literature that has gone before and the literature to come. (Generally, I do not believe that science works by studies making discoveries that change how we think about problems - instead, science works by studies adding to the literature that we integrate in with the rest of the literature.) Thus, these caveats should not be taken as problems with the study or as fixes that need to be done. Instead, they are notes for future researchers to notice if differences are found in any future studies.

      Thus, my only suggestion is that I think authors could write a more careful paper by using the past and subjunctive tense appropriately. Experimental observations should be in past tense, as in "the influence of reward was context-dependent and emerged in the late phase" instead of "the influence of reward is context-dependent and emerges in the late phase" - it emerged in the late phase this once - it might not in future experiments, not due to any fault in this experiment nor due to replicability problems, but rather due to unexpected differences between this and those future experiments. At which point, it will be up to those future experiments to determine the difference. Similarly, large conclusions should be in the subjunctive tense, as in "these data suggest that threat intensity is likely to be the primary determinant of decision making" rather than "threat intensity is the primary determinant of decision making", because those are hypotheses not facts.

      We thank the reviewer for the helpful suggestions and have revised the Abstract accordingly.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study investigates how mice make defensive decisions when exposed to visual threats and how those decisions are influenced by reward value and social hierarchy. Using a naturalistic foraging setup and looming stimuli, the authors show that higher threat leads to faster escape, while lower threat allows mice to weigh reward value. Dominant mice behave more cautiously, showing higher vigilance. The behavioral findings are further supported by a computational model aimed at capturing how different factors shape decisions.

      Strengths:

      (1) The behavioral paradigm is well-designed and ethologically relevant, capturing instinctive responses in a controlled setting.

      (2) The paper addresses an important question: how defensive behaviors are influenced by social and value-based factors.

      (3) The classification of behavioral responses using machine learning is a solid methodological choice that improves reproducibility.

      Weaknesses:

      (1) Key parts of the methods are hard to follow, especially how trials are selected and whether learning across trials is fully controlled for. For example, it is unclear whether animals are in the nest during the looming stimulus presentations. The main text and methods should clarify whether multiple mice are in the nest simultaneously and whether only one mouse is in the arena during looming exposure. From the description, it seems that all mice may be freely exploring during some phases, but only one is allowed in the arena at a time during stimulus presentation. This point is important for understanding the social context and potential interactions, and should be clearly explained in both the main text and methods.

      We agree that these details are essential and have clarified them in the Methods. When the door system operated normally, only one mouse was allowed in the arena during looming exposure. Specifically, when all mice were in the nest, the nest-tunnel door was open and the tunnel-arena door was closed. Once a single mouse entered the tunnel, as detected by an OpenMV camera, the nest-tunnel door closed and the tunnel-arena opened, ensuring that only that mouse could enter the arena.

      Habituation was conducted over two days. On day 1, five mice were placed together in the nest for 30 minutes with all doors closed. Each mouse was then placed individually in the nest and allowed to freely explore the arena for 10 minutes under normal door operation. Finally, all mice were returned to the nest with all doors open and allowed for free exploration for 2 hours. On day 2, each mouse was placed individually in the nest and given an additional 1 hour of exploration under normal door operation.

      (2) It is often unclear whether the data shown (especially in the main summary figures) come from the first trial or are averages across several exposures. When is the cut-off for trials of each animal? How do we know how many trial presentations were considered, and how learning at different rates between individuals is taken into account when plotting all animals together? This is important because the looming stimulus is learned to be harmless very quickly, so the trial number strongly affects interpretation.

      We observed substantial inter-individual variability in habituation to looming stimuli, with a sharp decline in defensive responses over the first few trials followed by more gradual changes. To account for this, we segmented trials for each animal into two phases: an early rapidhabituation phase and a later stable phase. Analyzing these phases separately revealed that threat intensity dominates behavior in the early phase, whereas both threat and reward significantly influence behavior in the late phase. These results are now presented in revised Figures 2 and 3. Analyses restricted to first trials are included in Figure S5.

      (3) The reward-related effects are difficult to interpret without a clearer separation of learning vs first responses.

      As noted above, we have re-analyzed our data to account for learning effects.

      (4) The model reproduces observed patterns but adds limited explanatory or predictive power. It does not integrate major findings like social hierarchy. Its impact would be greatly improved if the authors used it to predict outcomes under novel or intermediate conditions.

      We have substantially revised the modeling analysis. The model is now fitted to behavioral data from the late phase and used to predict outcomes across additional conditions, including the early phase behavior and rank-dependent behavioral differences. The model successfully captures behavioral patterns across these conditions, supporting its predictive value beyond descriptive fitting.

      (5) Some conclusions (e.g., about vigilance increasing with reward) are counterintuitive and need stronger support or alternative explanations. Regarding the interpretation of social differences in area coverage, it's also possible that the observed behavioral differences reflect access to the nesting space. Dominant mice may control the nest, forcing subordinates to remain in the open arena even during or after looming stimuli. In this case, subordinates may be choosing between the threat of the dominant mouse and the external visual threat. The current data do not distinguish between these possibilities, and the authors do not provide evidence to support one interpretation over the other. Including this alternative explanation or providing data that addresses it would strengthen the conclusions.

      To support the interpretation of increased vigilance with reward under high-threat conditions, we analyzed additional behavioral measures beyond latency to flee. Rewarded mice showed longer foraging interval and slower foraging speed, both consistent with elevated vigilance (Figures 3L and 3M).

      To address the alternative explanation that subordinate mice may remain in the arena due to restricted nest access, we compared arena occupancy before, during, and after looming exposure. Although subordinates spent more time in the arena before looming, this difference disappeared during and after looming exposure (Figures 4C). Moreover, dominant and subordinate mice were

      equally likely to flee to the nest during escape trials. These findings rule out nest access restrictions as an explanation for the observed rank-dependent differences in defensive behaviors.

      (6) While potential neural circuits are mentioned in the discussion, an earlier introduction of candidate brain regions and their relevance to threat and value processing would help ground the study in existing systems neuroscience.

      We have revised the Introduction to incorporate relevant brain regions and neural circuits.

      (7) Some figures are difficult to interpret without clearer trial/mouse labeling, and a few claims in the text are stronger than what the data fully support. Figure 3H is done for low contrast, but the interesting findings will be to do this experiment with high contrast. Figure 4H - I don't understand this part. If the amount of time in the center after the loom changes for subordinate mice, how does this lead to the conclusion that they spend most of their time in the reward zone?. Figure 3A - The example shown does not seem representative of the claim that high contrast stimuli are more likely to trigger escape. In particular, the 10% sucrose condition appears to show more arena visits under low contrast than high contrast, which seems to contradict that interpretation. Also, the plot currently uses trials on the Y-axis, but it would be more informative to show one line per animal, using only the first trial for each. This would help separate initial threat responses from learning effects and clarify individual variability.

      We have substantially revised the figures. Results from trial segmentation based on individual habituation are now explicitly presented in Figures 2 and 3, and analyses using only the first trials are provided in Figure S5 to separate initial responses from learning effects.

      Regarding the original Figure 4H, we are not entirely certain about the concern. In this panel, we measured time spent in the reward zone, which is defined as the region within 10 cm of the reward port at the end of the arena, not the center of the arena, during looming exposure. Subordinate mice spent significantly more time in the reward zone than dominant mice. We have further clarified this in the revised manuscript.

      (8) The analysis does not explore individual variability in behavior, which could be an important source of structure in the data. Without this, it is difficult to know whether social hierarchy alone explains behavioral differences or if other stable traits (e.g., anxiety level, prior experiences) also contribute.

      We observed substantial individual variability in both dominant and subordinate mice, even on the first trial (Figure S7). Paired dominant–subordinate comparisons were used to isolate rankdependent effects.

      (9) The study shows robust looming responses in group-housed animals, which contrasts with other studies that often require single housing to elicit reliable defensive responses. It would be valuable for the authors to discuss why their results differ in this regard and whether housing conditions might interact with social rank or habituation.

      Robust looming-evoked defensive responses have been reported in both group- and singlehoused mice (Yilmaz and Meister, 2013, Lenzi et al., 2022), although single-housed mice habituate more rapidly. We have now discussed the potential interactions between housing conditions, social rank, and habituation in defensive behaviors in the revised manuscript.

      Reviewer #2 (Public review):

      Zhe Li and colleagues investigate how mice exposed to visual threats and rewards balance their decisions in favour of consuming rewards or engaging in defensive actions. By varying threat intensity and reward value, they first confirm previous findings showing that defensive responses increase with threat intensity and that there is habituation to the threat stimulus. They then find that water-deprived mice have a reduced probability of escaping from low contrast visual looming stimuli when water or sucrose are offered in the environment, but that when the stimulus contrast is high, the presence of sucrose or water increases the probability of escape. By analysing behaviour metrics such as the latency to flee from the threat stimulus, they suggest that this increase in threat sensitivity is due to increased vigilance. Analysis of this behaviour as a function of social hierarchy shows that dominant mice have higher threat sensitivity, which is also interpreted as being due to increased vigilance. These results are captured by a drift diffusion model variant that incorporates threat intensity and reward value.

      The main contribution of this work is to quantify how the presence of water or sucrose in waterdeprived mice affects escape behaviour. The differential effects of reward between the low and high contrast conditions are intriguing, but I find the interpretation that vigilance plays a major role in this process is not supported by the data. The idea that reward value exerts some form of graded modulation of the escape response is also not supported by the data. In addition, there is very limited methodological information, which makes assessing the quality of some of the analyses difficult, and there is no quantification of the quality of the model fits.

      (1) The main measure of vigilance in this work is reaction time. While reaction time can indeed be affected by vigilance, reaction times can vary as a function of many variables, and be different for the same level of vigilance. For example, a primate performing the random dot motion task exhibits differences in reaction times that can be explained entirely by the stimulus strength. Reaction time is therefore not a sound measure of vigilance, and if a goal of this work is to investigate this parameter, then it should be measured. There is some attempt at doing this for a subset of the data in Figure 3H, by looking at differences in the action of monitoring the visual field (presumably a rearing motion, though this is not described) between the first and second trials in the presence of sucrose. I find this an extremely contrived measure. What is the rationale for analysing only the difference between the first and second trials? Also, the results are only statistically significant because the first trial in the sucrose condition happens to have zero up action bouts, in contrast to all other conditions. I am afraid that the statistics are not solid here. When analysing the effects of dominance, a vigilance metric is the time spent in the reward zone. Why is this a measure of vigilance? More generally, measuring vigilance of threats in mice requires monitoring the position of the eyes, which previous work has shown is biased to the upper visual field, consistent with the threat ecology of rodents.

      We agree that reaction time can be influenced by multiple factors, including stimulus strength. Consistent with this, reaction times (i.e. latencies to flee) were substantially shorter under highcontrast conditions. However, even under the same high-contrast condition, reaction times were significantly shorter in the reward conditions compared to the no-reward condition, suggesting that other factors such as vigilance may contribute.

      Regarding the measurement of vigilance, in addition to the latency to flee, we analyzed two additional behavioral measures related to vigilance. First, we examined the foraging interval. Our hypothesis was that more vigilant animals would wait longer before re-entering the reward zone following threat exposure. Consistent with this prediction, mice under sucrose and water reward conditions showed significantly longer foraging intervals than those under no-reward conditions (Figure 3L). Second, we analyzed the foraging speed as mice approached the reward. Increased vigilance should lead to more cautious and therefore slower movements. Our results support this, as mice moved more slowly towards the reward under sucrose conditions (Figure 3M). Taken together, these three measures consistently indicate that mice exhibit increased vigilance under sucrose reward in high-threat conditions.

      (2) In both low and high contrast conditions, there are differences in escape behaviour between no reward and water or sucrose presence, but no statistically significant differences between water and sucrose (eg, Figure 3B). I therefore find that statements about reward value are not supported by the data, which only show differences between the presence or absence of reward. Furthermore, there is a confound in these experiments, because according to the methods, mice in the no-reward condition were not water deprived. It is thus possible that the differences in behaviour arise from differences in the underlying state.

      Our new analysis, which segments behavior into an early adaptive phase and a late stable phase, reveals a statistically significant difference between water and sucrose rewards in the late phase (Figure 3H), supporting a graded effect of reward value.

      To control for the potential confounds related to internal state, mice were not water-deprived in all reward conditions. We have clarified this in the revised manuscript.

      (3) There is very little methodological information on behavioural quantification. For example, what is hiding latency? Is this the same are reaction time? Time to reach the safe zone? What exactly is distance fled? I don't understand how this can vary between 20 and 100cm. Presumably, the 20cm flights don't reach the safe place, since the threat is roughly at the same location for each trial? How is the end of a flight determined? How is duration measured in reward zone measures, e.g., from when to when? How is fleeing onset determined?

      Hiding latency was defined as the time from stimulus onset to the animal’s arrival at the safe zone. Reaction time was quantified as the latency to flee, measured from stimulus onset to the initiation of the first flight state. The flight state was defined as locomotion exceeding 10 cm at a speed greater than 10 cm/s. Distance fled was defined as the distance covered between stimulus onset and offset for all trials. However, in trials classified as no reaction or freezing, this measure does not accurately reflect escape behavior. We will therefore rename it as distance under threat to better capture its meaning. The reward zone was defined as the region within 10 cm of the reward port at the end of the arena. Duration in the reward zone was measured as the time spent within this region during the 20 seconds following stimulus onset. In Figure 4E, the percentage of time spent in the reward zone was calculated relative to the total time the mouse remained in the arena during the 2-hour social session.

      All definitions and additional details on behavioral quantification have been included in the revised Methods section.

      (4) There is little methodological information on how the model was fit (for example, it is surprising that in the no reward condition, the r parameter is exactly 0. What this constrained in any way), and none of the fit parameters have uncertainty measures so it is not possible to assess whether there are actually any differences in parameters that are statistically significant.

      We have provided a detailed description of the model fitting procedure in the revised Methods section. Specifically, the reward-value parameter (r) was constrained to zero in the no-reward condition. We have plotted how the overall loss varies with differeent parameters (Figure S9).

      Reviewer #3 (Public review):

      Male mice were tested in a classic behavioral "flee the looming stimulus" paradigm. This is a purely behavioral study; no neural analyses were done. Mice were housed socially, but faced the looming stimulus individually. Drift-diffusion modeling found that reward-level interacted with threat level such that at low-threat levels, reward contrasted with threat as classically expected (high reward overwhelms low threat, low threat overwhelms low reward), but that reward aligned with threat at higher threat levels.

      Note that they define threat level by the darkness of the looming stimulus. I am not sure that darker stimuli are more threatening to mice. But maybe. Figure 3 shows that mice react more quickly to high contrast looming stimuli, but can the authors distinguish between the ability to detect the visual signal from considering it a more dangerous threat? (The fact that vigilance makes a difference in the high contrast condition, not the low contrast condition, actually supports the author's hypotheses here.)

      Regarding the interpretation of stimulus contrast as a proxy for threat level, we agree it is crucial to distinguish improved detection from heightened threat perception. To address this, we examined not only latency to flee but also escape distance and peak escape speed, two measures that reflect the intensity of the defensive response. If contrast only influenced detection, we would expect differences in latency but not in escape distance or speed. All three measures differed significantly across contrast conditions, supporting the interpretation that high-contrast stimuli are perceived as more threatening rather than simply more detectable. Furthermore, manual review of "no response" trials confirmed reliable detection in both conditions, with only three potential "missed" trials out of 117 under low contrast (Figure S3B). We have included this discussion in the revised manuscript.

      The drift-diffusion model (DDM) is fine. I note that the authors included a "leakage rate", which is not a standard DDM parameter (although I like including it). I would have liked to see more about the parameters. What were the distributions? What did the parameters correlate with behaviorally? I would have liked to see distributions of the parameters under the different conditions and different animals. Figure 2C shows the progression of learning. How do the fit parameters change over time as mice shift from choice to choice? How do the parameters change over mice? How do the parameters change over distance to the threat/distance to safety (as per Fanselow and Lester 1988)? They did a supplemental experiment where the threat arrived halfway along the corridor - we could get a lot more detail about that experiment - how did it change the modeling?

      Because our model is fit to the variance of latency distributions, it cannot be applied to singletrial data. Instead, we analyzed how decisions and latencies vary as functions of the fitted threat gain and reward value parameters (Figures 5G and 5H). We have also introduced a simplified deterministic model to further elucidate the decision-making process.

      Regarding the influence of distance to the threat, we conducted additional experiments, presenting the looming stimulus at the end of the arena when the mouse was at different distances from it (Figures S2C–G). We found that as the prey-threat distance increased, mice showed less direct escape behavior, with longer latencies to flee and slower escape speeds. This is consistent with the predatory imminence continuum theory (Fanselow and Lester, 1988), which describes graded defensive behaviors tuned to perceived threat level.

      Regarding the influence of distance to safety, our data indicate that it did not significantly affect defensive responses (Figures S2H and S2I). To test this further, we introduced barriers that lengthened the return path to the safe zone. We found that defensive decisions were not correlated with the distance to the safe zone (Figures S2J and S2K), suggesting that once a threat is detected, animals prioritize escape initiation over evaluating the exact path to safety.

      Overall, this is a reasonable study showing mostly unsurprising results. I think the authors could do more to connect the vigilance question to their results (which seems somewhat new to me).

      We have expanded our analysis of vigilance. In addition to escape latency, we examined the foraging interval and foraging speed. We hypothesized that more vigilant animals would wait longer before re-entering the reward zone following a threat and would approach the reward more slowly. Consistent with this prediction, mice in the sucrose- and water-reward conditions exhibited significantly longer foraging intervals and slower foraging speeds compared to those in the no-reward condition (Figures 3M and 3N). Together, these three measures consistently demonstrate that mice display heightened vigilance under high-threat, high-reward conditions.

      Although the data appear generally fine and the modeling reasonable, the authors do not do the necessary work to set themselves within the extensive literature on decision-making in mice retreating from threats.

      First of all, this is not a new paradigm; variants of this paradigm have been used since at least the 1980s. There is an *extensive* literature on this, including extensive theoretical work on the relation of fear and other motivational factors. I recommend starting with the classic Fanselow and Lester 1988 paper (which they cite, but only in passing), and the reviews by Dean Mobbs and Jeansok Kim, and by Denis Paré and Greg Quirk, which have explicit theoretical proposals that the authors can compare their results to. I would also recommend that the authors look into the "active avoidance" literature. Moreover, to talk about a mouse running from a looming stimulus without addressing the other "flee the predator" tasks is to miss a huge space for understanding their results. Again, I would start with the reviews above, but also strongly urge the authors to look at the Robogator task (work by June-Seek Choi and Jeansok Kim, work by Denis Paré, and others).

      Similarly, in their anatomical review, they do not mention the amygdala. Given the extensive literature on the role of the amygdala in retreating from danger, both in terms of active avoidance and in terms of encoding the danger itself, it would surprise me greatly if this behavior does not involve amygdala processing. (If there is evidence that the amygdala does not play a role here, but that the superior colliculus does, then that would be a *very* important result that needs to be folded into our understanding of decision-making systems and neural computational processing.)

      Second, there is an extensive economic literature on non-human animals in general and on rodents in particular. Again, the authors seem unaware of this work, which would provide them with important data and theories to broaden the impact of their results (by placing them within the literature). First, there are explicit economic literatures in terms of positively-valenced conflicts (e.g., neuroeconomics within the primate literature, sequential foraging and delaydiscounting tasks within the rodent literature), but also there is a long history within the rodent conditioning world, such as the classic work by Len Green and Peter Shizgal. I would strongly urge the authors to explore the motivational conflict literature by people like Gavin McNally, Greg Quirk, and Mark Andermann. Again, putting their results into this literature will increase the impact of their experiment and modeling.

      We have substantially revised the manuscript to contextualize our findings within the extensive literature on defensive behavior and decision-making. The revised Introduction and Discussion now integrate key theoretical frameworks, such as the predatory imminence continuum, and cite relevant work on active avoidance and other "flee the predator" paradigms (e.g., the Robogator task).

      We have also incorporated perspectives from neuroeconomics and motivational conflict, including literature on sequential foraging, delay-discounting tasks, and relevant rodent studies. Furthermore, we now discuss the potential contributions of specific brain regions, including the superior colliculus and the amygdala, to the economic and social modulation of innate defensive decisions in response to visual threats.

      Recommendations for the authors:

      Reviewing Editor Comments:

      These additional recommendations are generally consistent and overlapping across reviewers, particularly Reviewer #1 and 2, so it is advisable to undertake these changes/additions.

      Reviewer #1 (Recommendations for the authors):

      (1) Experimental methods and trial structure need clarification: It is often unclear how many trials were included per condition, per mouse, and whether the key behavioral effects (especially reward-related changes) were observed early in the session or after repeated stimulus exposure. For example, in several reward-related plots (e.g., Figure 3), it is not specified whether results are driven by early or later trials. Since the authors themselves report rapid learning of the looming stimulus (habituation), it is critical to state how many trials were included in each comparison, and to analyze whether effects hold on the first exposure and not the rest. Otherwise, conclusions about value-based behavior are hard to separate from learning effects, which may also differ between individuals. Specifically, the methods section is vague and hard to follow.

      We have substantially expanded the Methods section with additional details to improve clarity.

      To account for individual variability in habituation to the looming stimulus, we segmented trials for each animal into early and late phases. We demonstrate that threat level is the dominant factor driving behavioral responses in the early phase, while both threat level and reward condition shape behavior in the late phase. We have substantially revised Figures 2 and 3 to reflect these changes.

      (2) Add a summary of experimental design: A table or schematic summarizing the trial structure, experimental groups, reward/threat conditions, and the timeline of exposures would greatly improve clarity.

      We have added a schematic to Figure 2 summarizing the trial structure, experimental groups, reward and threat conditions, and the overall timeline.

      (3) Replot key results using only the first trial per mouse: This would allow readers to assess the first (not learned) responses and help control for habituation/suppression.

      We have replotted behavioral results using only the first trial from each mouse and included these analyses in Figure S5. These results confirm that threat level is the dominant factor driving the initial response to looming stimuli.

      (4) The model needs stronger justification and predictive value: As it stands, the model primarily fits the existing data and does not offer new insights beyond what is already evident from the behavioral results.

      Important findings, such as social hierarchy effects and habituation dynamics, are not captured in the model, reducing its relevance to the full dataset.

      The drift-diffusion framework is widely used, and in this implementation appears to have been adjusted post hoc to fit the observed data rather than generating new conceptual advances. No comparison with simpler models is included. Without testing simpler or alternative models, it is not clear whether the added complexity is necessary or justified.

      Use the model to generate and test predictions: to increase the model's contribution, the authors could simulate new conditions. Suggested experiments include:

      a) Predicting escape probability and latency at intermediate threat intensities to test whether behavior shifts gradually or abruptly.

      b) Using the model's habituation parameters to predict changes in escape behavior over repeated exposures.

      c) Adjusting vigilance or threat gain parameters to simulate dominant versus subordinate animals, and comparing model predictions to actual behavioral differences based on social rank.

      We have substantially revised the modeling section to address these concerns. The updated model is now fitted to behavioral data from the late phase of the reward–threat experiments and used to generate predictions for the early phase and for rank-dependent behavioral differences.

      The model accurately captures behavioral patterns across these conditions, demonstrating predictive power beyond descriptive fitting. Accordingly, we have removed the habituation component. Furthermore, we have introduced a simplified deterministic model in the revised manuscript to further understand the decision-making process.

      (5) Clarify housing and arena access conditions: It is unclear from the text whether all mice are in the nest during looming presentations and whether only one mouse is in the arena during the stimulus. This is important for understanding the social context of each trial and should be explained in the main text and methods.

      We have clarified this point in the Methods section. Under normal door operation, only one mouse was allowed in the arena during looming exposure. Specifically, when all mice were in the nest, the nest-tunnel door was open and the tunnel-arena door was closed. Once a single mouse entered the tunnel, as detected by an OpenMV camera, the nest-tunnel door closed and the tunnel-arena opened, ensuring that only that mouse could enter the arena.

      (6) Alternative interpretation of subordinate behavior: differences in area coverage and time in the reward zone may not reflect reduced vigilance, but rather avoidance of dominant mice. Subordinates may remain in the open arena to avoid conflict. The authors do not provide evidence distinguishing between these interpretations, and this should be addressed.

      To address the alternative explanation that subordinate mice may remain in the arena due to restricted nest access, we compared arena occupancy before, during, and after looming exposure (Figure 4C). Before looming exposure, subordinate mice spent significantly more time in the arena, consistent with the idea that they may perceive a social threat from the dominant mouse in the absence of any external threat. However, this difference disappeared during and after looming exposure. This shift suggests that the presence of an external threat alters the social dynamic, reducing the influence of dominance on nest access.

      To further assess whether dominant mice blocked subordinate access to the nest during threatdriven escapes, we analyzed the fraction of escape trials in which mice returned to the nest (Figure 4D). We found no significant difference between dominant and subordinate mice, indicating that dominant mice did not restrict nest access during these trials. Importantly, rank differences in reward-zone occupancy cannot be explained by nest exclusion, as mice do not need to return to the nest when escaping the threat—they can flee directly to the safe zone. Thus, nest access limitations do not account for the observed rank-dependent patterns.

      We agree with the reviewer that reward-zone occupancy should not be interpreted as reduced vigilance in subordinate mice; instead, it likely reflects higher perceived reward value. The manuscript has been revised accordingly.

      (7) Address why robust looming responses were observed in group-housed mice: previous studies often require single housing to elicit strong defensive responses. The authors should explain why their setup yields robust results in group-housed animals and whether housing conditions may interact with dominance or habituation.

      Looming exposure elicits robust defensive behaviors in both group- and single-housed mice (Yilmaz and Meister, 2013, Lenzi et al., 2022), with single-housed animals habituating more quickly to the stimulus (Lenzi et al., 2022). We have now discussed how housing conditions may interact with social rank and habituation to shape defensive behaviors in the revised manuscript.

      For the social-rank experiments, we intentionally co-housed dominant and subordinate mice to maintain a stable hierarchy. This choice was motivated by two considerations. First, our goal was to investigate how social rank modulates defensive responses under ethologically relevant conditions, where mice naturally live in groups. Single housing would remove this social context. Second, singly housing mice can destabilize or eliminate rank relationships, making it difficult to interpret rank-dependent behavioral differences.

      (8) Add analysis of individual variability: trial-by-trial variability or stable behavioral tendencies in individual animals are not explored. This could explain part of the variation currently attributed to social rank.

      We have analyzed individual variability in both dominant and subordinate mice. We observed substantial variability across all behavioral measurements for each group (Figure S7). To attribute the observed behavioral differences to social hierarchy rather than to other individual traits, we conducted paired comparisons between dominant and subordinate mice (Figure 4).

      (9)  Improve figure labeling and readability: some plots are ambiguous in terms of whether rows represent trials or animals. Overlapping points obscure the data in several figures, for example, Figure 3H, sucrose is n=4?- consider using jittered scatter plots, boxplots, or individual traces to improve clarity. Also same Figure axis Y is missing an 'e'.

      We have revised figures to improve clarity and corrected the typos.

      (10) Avoid overinterpretation of causal explanations: Statements such as "reward increases vigilance due to evolutionary pressure" or that "subordinates are less vigilant" go beyond what the current data can demonstrate and should be rephrased more cautiously.

      We have revised the manuscript to tone down the statement.

      Reviewer #2 (Recommendations for the authors):

      (1) Provide much more extensive methodological details on analyses and model fitting

      We have thoroughly revised the Methods section to provide extensive detail on both behavioral analyses and computational modeling, as outlined in our responses to points (3) and (4) of the Public Review.

      (2) Perform experiments or analyses that directly measure vigilance, if vigilance is to remain as a key explanation for the data.

      As detailed in our response to point (1) of the Public Review, we have supplemented the escape latency measure with two direct behavioral analyses of vigilance: foraging interval and foraging speed. This multi-metric approach robustly supports the interpretation of heightened vigilance.

      (3) Provide extra evidence for an effect of reward value, as opposed to the presence or absence of reward. Control for differences arising from the water deprivation state by performing the no reward condition experiments in water-deprived mice.

      All behavioral data in the reward–threat experiment were collected on normal (non-deprived) mice (Figures 2 and 3), which have been clarified in the revised manuscript. We have reanalyzed the data by segmenting trials into early and late phases for each animal. In the late phase, under low-threat conditions, the effect of reward value is reflected in significant differences between water and sucrose in terms of escape distance and time spent in the reward zone (Figures 3I and 3J). Under high-threat conditions, the reward value effect is reflected in significant differences in latency to flee and peak escape speed (Figures 3K and 3N).

      (4)  Using drift rate to describe the "r" variable is confusing because the drift rate of the drift diffusion process is also determined by terms alpha, beta, and h-terms.

      We have termed “r” as the reward value in the revised manuscript.

      Reviewer #3 (Recommendations for the authors):

      (1) I would tone down some of the extreme statements about the problems of previous experiments (such as that most decision-making is on 2AFC). Lots of people do decision-making in serial foraging, fleeing, and other behavioral tasks. The classic Morris water-maze or Barnesmaze are decision-making tasks that aren't 2AFC. Serial foraging tasks, such as the Restaurant Row task aren't 2AFC. And, actually, lots of mouse behavior tasks are deciding when to stop on a treadmill for a reward. And, for that matter, your task isn't all that "realistic" - mice aren't evolved to flee looming disks, they are evolved to flee hawks and owls. This doesn't invalidate your task at all. I just recommend making it about your work in a positive way rather than others in a negative way.

      We have revised the manuscript to adopt a more positive framing of our work.

      (2) I also don't think there's much use in bringing in crayfish in a mouse task. Spend your time connecting to the other rodent data (mice and rats) instead.

      We agree and have revised the manuscript accordingly, focusing our discussion on relevant rodent literature to provide a more appropriate context for our findings.

      Minor concerns:

      (1) The authors use the term "cognitive control" without making clear what they mean. In general, the authors seem to have a view on decision-making as either being "reflexes" or "cognitive control". This is a very outdated perspective. Modern perspectives include multiple decision-making systems competing, separating these based on their computational properties, such as planning, procedural, instinctual, and, yes, reflexive. Current views on the kinds of behaviors they are discussing generally see fleeing as a transition from reflexive (tonic immobility, freezing) and instinctual responses (freezing, fleeing) to deliberative (anxiety) and procedural (habit). The authors might take a look at the recent Calvin and Redish (2025) paper for some ideas on this.

      We appreciate the reviewer’s insight regarding the term “cognitive control.” In our study, we used this term to emphasize that defensive responses to looming threats are not purely reflexive. Mice exhibit four distinct types of defensive decisions within a short time window, and these decisions are systematically modulated by reward value and social rank. Notably, reward modulation is bidirectional: high reward suppresses defensive responses under low-threat conditions but enhances them under high-threat conditions, indicating that animals integrate multiple sources of information rather than relying solely on instinctive mechanisms.

      We did not observe mid-trajectory aborts in mice, as reported in rats by Calvin & Redish (2025). This difference may reflect species-specific behavior or the nature of the threat: our looming stimulus is purely visual and non-harmful, whereas the robotic predator in their study presents a physical threat. We have revised the Discussion to clarify our use of “cognitive control” and to incorporate these perspectives.

      (2) Only male mice were used. This limits the conclusions that can be drawn.

      We acknowledge the limitation of using only male mice and have discussed this limitation in the revised manuscript.

      (3) Did the authors observe darting behavior? (Gruene...Shansky 2015).

      We did not observe darting behavior, characterized by rapid movement, as reported during inescapable fear conditioning. In our experiment, the mice consistently escaped towards the nest, in most trials, ran directly to the nest without stopping. Occasionally, under low contrast conditions, mice paused once or twice but never moved towards the reward.

      (4) How was only one mouse allowed into the linear arena at a time?

      When all mice were in the nest, the nest-tunnel door was open while the tunnel-arena door remained closed. When a single mouse entered the tunnel, as detected by the RFID and OpenMV camera system, the nest-tunnel door closed and the tunnel-arena door opened, allowing only that mouse to enter the arena. We have clarified this protocol in the Methods section.

      (5) I would like to see more extensive analyses of the animal's responses as a function of distance to the threat (as per Fanselow and Lester 1988).

      As detailed in our response to the public review, we conducted new experiments analyzing behavior as a function of prey–threat distance. The finding that defensive responsiveness decreases with increasing prey–threat distance is now presented in Figures S2C–G and discussed in the context of the predatory imminence continuum.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      In this manuscript, the authors report that GPR55 activation in presynaptic terminals of Purkinje cells decrease GABA release at the PC-DCN synapse. The authors use an impressive array of techniques (including highly challenging presynaptic recordings) to show that GPR55 activation reduces the readily releasable pool of vesicle without affecting presynaptic AP waveform and presynaptic Ca<sup>2+</sup> influx. This is an interesting study, which is seemingly well-executed and proposes a novel mechanism for the control of neurotransmitter release. However, the authors' main conclusions are heavily, if not solely, based on pharmacological agents that most often than not demonstrate affinity at multiple targets. Below are points that the authors should consider in a revised version.

      We are happy to hear the encouraging comments from this reviewer, and thank for pointing out the important issues including the previous study design depending only on pharmacological agents. To address these, we have performed additional experiments, as detailed below.

      Major points:

      (1) There is no clear evidence that GPR55 is specifically expressed in presynaptic terminals at the PC-DCN synapse. The authors cited Ryberg 2007 and Wu 2013 in the introduction, mentioning that GPR55 is potentially expressed in PCs. Ryberg (2007) offers no such evidence, and the expression in PC suggested by Wu (2013) does not necessarily correlate with presynaptic expression. The authors should perform additional experiments to demonstrate the presynaptic expression of GPR55 at PC-DCN synapse.

      We completely agree with the reviewer in that our previous manuscript lacked the reliable information regarding presynaptic expression of GPR55 at PC boutons.

      To clarify the localization, we first tried immunostaining of GPR55 using commercially available antibodies, but unfortunately they did not provide clear labeling of neurons and also even in GPR55-transfected HEK cells (used as positive control). Thus, we gave up the direct immunostaining. Alternatively, we attempted to label PC axonal boutons by GPR55-targeting dye together with a complementary strategy based on gene knock-down. Specifically, we used T1117, a fluorescent derivative of AM251 which is a GPR55 ligand used in the manuscript, and clear fluorescent signals were evident at GFP-labeled PC terminals. Still, by itself it was not clear whether the labeling was mediated by association with GPR55. Therefore, we also attempted to specifically suppress gene expression of GPR55 using CRISPR/Cas9-mediated genome editing in PCs, based on acute DNA micro-injection of plasmids into nuclei of PCs to express gRNAs targeting GPR55 together with Cas9. As a result, 5 days after the knock-down, T1117 labeling at axon terminals was reduced by ~50% compared to Cas9-alone controls. All these data are now shown in new Figure 2, and explained in the text p5-6, lines 141-159. Further, the reduction of GPR55 expression abolished the AM251-mediated reduction of vesicular exocytosis, as shown in new Figure 3D, E.

      Taken together, these results essentially convince our main conclusions by strongly suggesting that GPR55 is present at PC axon terminals, where it negatively regulates the exocytosis upon activation by AM251.  

      (2) The authors' conclusions rest heavily on pharmacological experiments, with compounds that are sometimes not selective for single targets. Genetic deletion of GPR55 would be a more appropriate control. The authors should also expand their experiments with occlusion experiments, showing if the effects of LPI are absent after AM251 or O-1602 treatment. In addition, the authors may want to consider AM281 as a CB1R antagonist without reported effects at GPR55.

      We thank the reviewer for pointing out these important issues. First, as noted above to confirm the presence of GPR55 at axon terminals of PCs, we performed genetic deletion of GPR55 using CRISPR/Cas9 system. In PCs co-expressing Cas9 and two gRNAs targeting the ligand-binding domain of GPR55, AM251 failed to suppress the exocytosis at PC boutons, together with decreased T1117 labeling. Therefore, the idea that GPR55 negatively regulates transmitter release at PC boutons has now been strengthened. The new data is shown in Figure 3D and E, and explained in the text p6, lines 173-178.  

      As suggested, we also carried out the occlusion experiments with LPI and AM251. First, LPI similarly reduced the readily releasable pool (RRP) size as AM251 did. Then, applied together, LPI and AM251 did not further reduce the RRP size compared with the effect by either compound alone. Thus, LPI and AM251 seem to act through the same pathway, consistent with the idea for role of GPR55 activation. The data is shown in new Figure 5—figure supplement 1 and explained in the text, p7-8, lines 215-221.

      Regarding another point suggested by the reviewer, we applied AM281 and observed no effect on transmission at the PC–target neuron synapses (shown in new Figure 1F and I; explained in the text p5, lines 117-123), indicating that the effect of AM251 is likely to be mediated by GPR55, but not by CB1R.

      Taken together, our additional experiments based on genetic and pharmacological experiments have consolidated our conclusion that GPR55 suppresses the presynaptic neurotransmitter release in PC boutons.

      (3) It is not clear how long the different drugs were applied, and at what time the recordings were performed during or following drug application. It appears that GPR55 agonists can have transient effects (Sylantyev, 2013; Rosenberg, 2023), possibly due to receptor internalization. The timeline of drug application should be reported, where IPSC amplitude is shown as a function of time and drug application windows are illustrated.

      Thank you for suggesting the better presentation of data. Accordingly, we have re-organized figures showing time course of changes in IPSCs before and after the drug application (new Figure 1 and 4; p4, lines 94-97; p5, lines 110-115; p7, lines 193-197). The current data presentation clearly shows that the effect of AM251 becomes evident in a few minutes after application, and somehow reaches a saturated level.

      (4) A previous investigation on the role of GPR55 in the control of neurotransmitter release is not cited nor discussed (Sylantyev et al., (2013, PNAS, Cannabinoid- and lysophosphatidylinositolsensitive receptor GPR55 boosts neurotransmitter release at central synapses). Similarities and differences should be discussed.

      We are really sorry for failing to adequately discuss this important work in our previous manuscript, and deeply appreciate the reviewer for pointing this out. We have now cited and discussed the work by Sylantyev et al. (2013), in the text (p12, lines 380-389), as following:

      ‘Pioneering studies clarified an important role of GPR55 in synaptic transmission at hippocampal excitatory synapses, demonstrating presynaptic enhancement of glutamate release presumably by elevating the cytoplasmic residual Ca<sup>2+</sup> via release from intracellular stores (Sylantyev et al., 2013; Rosenberg et al., 2023), in contrast to the suppression of release in our observation. The lack of positive modulation of AP-triggered release through residual Ca<sup>2+</sup> in PC terminals might be due to abundant amount of potent Ca<sup>2+</sup> buffer calbindin (Fierro and Llano, 1996). Indeed, increased vesicular fusion only for the AP-insensitive spontaneous vesicular release (as mIPSCs) was observed upon the IP<sub>3</sub>-mediated Ca<sup>2+</sup> release from internal store (Gomez et al., 2020). Thus, minimal sensitivity of AP-triggered release to residual Ca<sup>2+</sup> in PC boutons would underlie the distinct effects of GPR55 activation at the presynaptic side.’  

      Minor point:

      (1) What is the source of LPI? What isoform was used? The multiple isoforms of LPI have different affinities for GPR55.

      Thank you for letting us know about the lack of important information in the previous manuscript. In our experiments, we used a soybean-derived LPI mixture containing approximately 58% C16:0 and 42% C18:0 or C18:2 species. According to Brenneman et al. (2025), these isoforms show moderate or strong effects in cultured DRG neurons, whereas the C20:4 isoform, reported to promote neuroinflammatory signaling, was contained only at very low levels. We have added this information to the revised manuscript and briefly discussed the influence of different LPI isoforms on the physiological outcomes of GPR55 activation (p5, lines 127-131; p15, lines 493-496).

      Reviewer #2 (Public review):

      Summary:

      This paper investigates the mode of action of GPR55, a relatively understudied type of cannabinoid receptor, in presynaptic terminals of Purkinje cells. The authors use demanding techniques of patch clamp recording of the terminals, sometimes coupled with another recording of the postsynaptic cell. They find a lower release probability of synaptic vesicles after activation of GPR55 receptors, while presynaptic voltage-dependent calcium currents are unaffected. They propose that the size of a specific pool of synaptic vesicles supplying release sites is decreased upon activation of GPR55 receptors.

      Strengths:

      The paper uses cutting-edge techniques to shed light on a little-studied, potentially important type of cannabinoid receptor. The results are clearly presented, and the conclusions are for the most part sound.

      We feel very happy to see the positive comments from the reviewer.  

      Weaknesses:

      The nature of the vesicular pool that is modified following activation of GPR55 is not definitively characterized.

      We agree with the reviewer in that our data cannot fully address the changes of vesicle pools caused by GPR55. As detailed in responses to comments in ‘Recommendations for the authors’ from the reviewer, we have added explanation and discussion in the main text of the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      Inoshita and Kawaguchi investigated the effects of GPR55 activation on synaptic transmission in vitro. To address this question, they performed direct patch-clamp recordings from axon terminals of cerebellar Purkinje cells and fluorescent imaging of vesicular exocytosis utilizing synaptopHluorin. They found that exogenous activation of GPR55 suppresses GABA release at Purkinje cell to deep cerebellar nuclei (PC-DCN) synapses by reducing the readily releasable pool (RRP) of vesicles. This mechanism may also operate at other synapses.

      Strengths:

      The main strength of this study lies in combining patch-clamp recordings from axon terminals with imaging of presynaptic vesicular exocytosis to reveal a novel mechanism by which activation of GPR55 suppresses inhibitory synaptic strength. The results strongly suggest that GPR55 activation reduces the RRP size without altering presynaptic calcium influx.

      We thank the reviewer for giving the encouraging comments on our study.

      Weaknesses:

      The study relies on the exogenous application of GPR55 agonists. It remains unclear whether endogenous ligands released due to physiological or pathological activities would have similar effects. There is no information regarding the time course of the agonist-induced suppression. There is also little evidence that GPR55 is expressed in Purkinje cells. This study would benefit from using GPR55 knockout (KO) mice. The downstream mechanism by which GPR55 mediates the suppression of GABA release remains unknown.

      We thank the reviewer for pointing out all of these important issues to be ideally addressed. As detailed in the responses to comments in the ‘Recommendations for the authors’ from the reviewers, we have addressed most of these weak points, and also added careful discussion in the text about the open questions to be solved in the future study.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      This is a high-quality paper that reports novel and interesting results. The authors should consider one main critique, related to Figure 6, as well as a number of minor points.

      We thank the reviewer for making very positive assessment of our study. We have carefully considered the main critique regarding presynaptic vesicle pools (related to previous Figure 6), as well as other points, and accordingly revised manuscript.

      Main critique:

      In Figure 6, it is said that GPR55 locks SVs in a state that is insensitive to VGCCs, based on a series of experiments with synapto-pHluorin. This conclusion is open to several critiques:

      The authors' model is shown in the diagram of Figure 6A. In this scheme, it appears as if recycled SVs eventually re-acidify in spite of the presence of bafilomycin, and that they are directed to a location close to the plasma membrane, but away from VGCCs. In fact, there is no evidence that the effects of bafilomycin could be limited in time. And there is a lot of evidence indicating that recycled SVs move back to release sites, close to VGCCs.

      We are so sorry for presenting misleading figure panel in the previous Figure 6A. As the reviewer says, the effect of bafilomycin should be expected to last for long, and then the endocytosed vesicles cannot be re-acidified. Now, in new Figure 8A, we have changed the panel for explanation about the experimental situation of vesicles in the presence of bafilomycin. Another insightful point, kindly suggested by the reviewer, regarding the quick recruitment of newly endocytosed vesicles to release sites, is highly related to the interpretation of our data, but is a different issue from the situation explained in new Figure 8A. To avoid confusion, the arrow drawn in the previous version indicating the endocytosed vesicle movement back to the docked situation has been omitted in the new panel, and this critical issue is now carefully discussed in terms of the mechanism of GPR55 action on the release machinery (p15, lines 480-482).

      The saturation of the train-induced signals is interpreted as reflecting an exhaustion of SVs initially close to VGCCs or more generally, susceptible to being released following VGCC activation.

      In an alternative scenario, saturation occurs because AP trains, or KCl applications, become unable to activate VGCCs. This could occur either because long illumination causes photodamage of VGCCs, or because repeated activation of VGCCs leads to their inactivation. The latter explanation is possible in spite of a publication from the authors' laboratory describing the facilitation of presynaptic VGCCs following paired stimulations in this synapse (Diaz-Rojas et al., 2015).

      We agree that it is an important control experiment to demonstrate that Ca<sup>2+</sup> increase upon repetitive AP trains is intact even during or after the long photo-illumination for imaging. To test this possibility, we have performed additional fluorescent Ca<sup>2+</sup> imaging at PC varicosities during individual 400-AP trains and also in response to 50 mM KCl following the series of AP trains. Now new data demonstrated that Ca<sup>2+</sup> influx remains constant across all AP trains (shown in Figure 8— figure supplement 1), arguing against VGCC inactivation or photodamage as a major factor underlying the saturated signal increase in the synapto-pHluorin. We have added explanation regarding this issue in the text p11, lines 327-329.

      The authors explain the larger effect of ionomycin compared with AP trains and KCl applications as reflecting a better capacity to increase the bulk calcium concentration. The above proposal for the inactivation of VGCCs offers an alternative explanation, in my view more likely.

      As noted above, our newly added Ca<sup>2+</sup> imaging data clearly showed that individual AP trains induced similar Ca<sup>2+</sup> influxes during repetitive trials, in line with our original interpretation. In addition, the Ca<sup>2+</sup> increase by KCl was shown to be more potent and broader in axon terminals and trunks. Nevertheless, the exocytic signal caused by ionomycin was clearly large, implying a critical effect of the source of Ca<sup>2+</sup> influx in PC boutons. Therefore, we suppose that the marked effect of ionomycin on release reflects higher elevation of bulk Ca<sup>2+</sup> in the cytoplasm arising from non-site selective Ca<sup>2+</sup>-ionophore (Figure 8—figure supplement 1, p11, lines 327-334; lines 342-349).

      In yet another scenario, recycled SVs in bafilomycin retain their fluorescence since they do not reacidify, but they come back to release sites to undergo new rounds of exocytosis. The new exocytosis events do not increase the fluorescence since the pH in the vicinity of synapto-pHluorin does not change. NH4Cl would then increase the fluorescence by revealing SVs that had not undergone exocytosis-endocytosis cycles during AP trains or KCl exposure. In this last scenario, the GPR55-sensitive SV pool would be a specific sub-pool of SVs that can be recycled by repetitive 400 AP trains.

      We deeply appreciate the reviewer for pointing out this important possibility. We completely agree that this scenario can also explain the pool which is sensitive to GPR55. Therefore, we have added explanation of this possibility in the text (p15, lines 474–482).

      Figure 6F shows calcium imaging measurements of PC varicosities. Unfortunately, crucial measurements are missing. It would have been revealing to compare calcium rises for the first and the last of the 8 400-AP trains. And to compare calcium rises elicited by 60 mM KCl before and after the series of 8 400-AP trains.

      This is an important control experiment. Therefore, we have performed additional Ca<sup>2+</sup> imaging during the eight 400-AP trains and KCl application. The new results shown in the present Figure 8—figure supplement 1 clearly suggest that Ca<sup>2+</sup> rises are comparable between the first and eighth trains, and that additional Ca<sup>2+</sup> influx (which was large in amplitude and wide in area) could still be evoked by KCl after the eight trains. The experiments are explained in the text p11, lines 327336.

      Minor points:

      (1) Introduction: The Introduction would benefit from a more substantial description of what is known about GPR55 and downstream signaling pathways. Right now, it is stated that GPR55 is 'potentially expressed in PCs': What are the arguments behind this statement? Also, the signaling pathway is discussed on p.12, much too late in the ms. Why not move this section to the Introduction?

      We thank the reviewer for the helpful suggestion. As recommended, in the revised manuscript, we have changed the Introduction by moving the sentences from other sections, including speculation about the expression of GPR55 in Purkinje cells (Ryberg et al., 2007; Wu et al., 2013) (p3-4, lines 71-75) and downstream signaling pathways (Gα<sub>q</sub>/PLC/IP<sub>3</sub>/Ca<sup>2+</sup> and Gα<sub>13</sub>/RhoA/ROCK) (p3, 63-68).  

      (2) Legend to Figures 1, 2, and 4: What is the EGTA concentration in these experiments?

      As suggested, the EGTA concentrations (0.5 or 5 mM) used in the individual experiments have now been clearly indicated both in the figure legends and in the Methods section (p18, lines 585586).

      (3) Fig. 3C: These experiments show that some SV pool is depleted by AM251. The authors state that this is the RRP, but other options are possible. In the calyx of Held, similar experiments are supposed to deplete not only the FRP (=RRP, presumably) but also the SRP.

      We thank the reviewer for pointing out the important aspect related to category for vesicle pools. In PC boutons, the membrane capacitance increases in response to different duration of depolarization pulses in a manner fitted by a single exponential curve (see Figure 5C for example). Our previous study (Kawaguchi and Sakaba, 2015) noted that the vesicle pools corresponding to FRP and SRP may not be easy to distinguish in PCs, suggesting apparently single component. That’s the reason why we simply describe the component as RRP in the present manuscript. Still, as suggested, careful discussion about typical fast- and slow components would be helpful to interpret our present findings. Therefore in the revised manuscript, we have added a sentence to explain this issue (p7, lines 211-214).

      (4) p. 8: When the 400 APs protocol is introduced, the corresponding frequency (20 Hz?) should be mentioned. This information comes only much later in the ms.

      We are sorry for our insufficient explanation in the previous manuscript. As suggested, we have clearly written the stimulation frequency ‘20 Hz’ in the main text where the 400 APs protocol first appears (p9, lines 277-278).

      (5) Figure 5, panels B and F: synapto-pHluorin is labelled twice 'synapto-pHluolin'.

      Sorry for careless typos. Now, those are corrected (new Figure 7).

      (6) Legend to Figure 5, last line: 'x' is missing in the last equation.

      Thank you for the careful and kind check. Now, ‘x’ has been added to the last equation in the legend for new Figure 7.

      (7) p. 7, Interpretation of EGTA effects: The authors frame their interpretation of EGTA effects around the distance between release sites and VGCCs. However since AM251 appears to alter the recruitment of SVs, a more parsimonious interpretation would be that EGTA modifies the calciumdependent movement of SVs towards release sites.

      Thank you for suggesting an insightful scenario. We agree that the capacitance jump upon long depolarization pulse would include exocytosis of substantial amount of vesicles which are newly recruited during the Ca<sup>2+</sup> increase. Then, as the reviewer states, EGTA possibly lowers the Ca<sup>2+</sup>dependent replenishment of synaptic vesicles, and this replenishment system might be the target of GPR55 activation. Therefore, we have now clearly added an explanation about this possibility in the text (p15, lines 474-482).

      (8) p. 13, Interpretation of GPR55 sensitive SV pool: The authors suggest a larger distance to VGCCs for this pool compared to naïve SVs. An alternative could be that in the presence of GPR55, the recruitment to release sites would be less efficient.

      This is also an insightful suggestion to speculate the causal relationship between the GPR55mediated reduction of vesicular release and the vesicle pools. Accordingly, we have revised the Discussion (see “Dynamics of synaptic vesicles among distinct functional pools”) by clearly telling about the possibility of decreased recruitment of vesicles to release sites after the GPR55 activation (p15, lines 474-482). By totally considering all the suggested scenario, we believe that the possible mechanisms for GPR55-mediated reduction of release are much more clearly explained in the revised manuscript.

      Reviewer #3 (Recommendations for the authors):

      (1) The time course of the agonist-induced suppression should be reported (Figure 1).

      This is an important point to show data clearly, as suggested also by the reviewer 1. Accordingly, we have changed the figure panels to show time courses of agonist-induced suppression (shown in new Figures 1 and 4).  

      (2) Show that the suppression of GABAergic transmission mediated by AM251 and LPI is eliminated in GPR55 KO mice.

      We appreciate the reviewer for putting us to try this important experiment. Owing to the suggestion, we attempted to knock-down the GPR55 expression using CRISPR/Cas9 in cultured Purkinje cells. To avoid potential developmental compensations, here we adopted the CRISPR/Cas9-based genome editing approach, rather than using global knock out mice. Those GPR55-KO cells, as noted above in response to the comment #2 of reviewer #1, showed decreased fluorescent labeling of PC axon terminals to fluorescent-variant of AM251 (shown in new Figure 2) and abolishment of AM251-mediated suppression of vesicle exocytosis (Figure 3D and E). These results are explained in the text p5-6, lines 141-159; p6, lines 173-178.  

      (3) Include references supporting AM251 and LPI as GPR55 agonists and specify the E50 concentrations for each agonist. Furthermore, provide details about the GPR55 antagonist CID16600046.

      As suggested, we have added references regarding GPR55 agonists, AM251 and LPI. In the text, the following information was added: AM251, originally characterized as an inverse agonist for CB1, has also been reported to act as a GPR55 agonist (Ryberg et al., 2007; Henstridge et al., 2009) (p5, lines 115-116). LPI is an established endogenous GPR55 agonist (Oka et al., 2007; Henstridge et al., 2009) (p5, lines 127-129). The reported EC<sub>50</sub> values are ~ 30 nM for LPI (Oka et al., 2007, HEK cell assay) and 39 nM for AM251 (Ryberg et al., 2007, HEK cell assay) (p4, lines 94-95; p5, lines 127-129). Regarding the GPR55 antagonist CID16020046, detailed information (IC<sub>50</sub> = 0.21 µM for GPR55 without significant effect on CB1 receptor) was added in the text with an appropriate citation (Kargl et al., 2013) (p5, lines 123-127). These points have also been added to the Methods section (p17, lines 587-589).

      (4) Regarding the onset delay (Figure 4C; page 8, lines 3-4), consider the following: "AM251 induced a modest yet significant synaptic delay, estimated by the time to the onset of release" (or something similar).

      We thank the reviewer for suggesting helpful explanation. Accordingly, we have changed the sentence to explain the delayed onset (p9, lines 264-265).

      These three points should be properly acknowledged in the Discussion:

      (1) Are action potentials (APs)/depolarizations and ionomycin applications comparable? Ionomycin mediates a large calcium rise significantly slower than the calcium rise mediated by fast depolarization. Such presynaptic calcium dynamics could account, in part, for the different results.

      The qualitative difference of Ca<sup>2+</sup> increase between APs/depolarization-mediated ones and ionomycin-mediated one is an important point. Thank you for pointing out this issue. In the revised manuscript, we have added an explanation about the possible difference arising from the distinct dynamics of Ca<sup>2+</sup> increases caused by direct depolarization of axon terminals or by ionomycin (p14, lines 452-453).

      (2) Previous studies on hippocampal CA3-CA1 pyramidal cell synapses indicate that GPR55 activation enhances glutamate release through presynaptic calcium modulation while diminishing inhibitory postsynaptic strength by reducing GABAA receptors (Sylantyev et al., PNAS 2013; Rosenberg et al., Neuron 2023). In contrast, Inoshita and Kawaguchi discovered that GPR35 suppresses PC-DCN inhibitory transmission by decreasing GABA release without affecting inhibitory postsynaptic strength. Some potential explanation for this discrepancy is warranted.

      We appreciate the reviewer for pointing out this important issue, and feel sorry for not providing an appropriate discussion about the possible interpretation in the previous manuscript. In the revised manuscript, we have added explanations for this discrepancy. First, PC terminals show only limited influence by elevated cytoplasmic Ca<sup>2+</sup> through ER store on GABA release (Gomez et al., 2020) probably due to abundant calbindin. Second, our present data clearly show the GPR55 signals at PC terminals (although indirect, see Figure 2), while hippocampal inhibitory neuronal boutons somehow showed lower GPR55 levels compared with excitatory neuronal boutons (Rosenberg et al., Neuron, 2023). Third, the subtypes and/or anchoring mechanism for postsynaptic GABA<sub>A</sub> receptors might be different between two distinct postsynaptic neurons in the hippocampus and the cerebellum. These factors are now clearly discussed in the text (p12, lines 380-396).

      (3) Earlier work has suggested that CB1 receptor activation can alter the release machinery. Therefore, the observation that GPR55 activation induces changes in the RRP is not entirely surprising.

      As pointed out, previous studies showed that CB1R influences the synaptic release machinery, rather than Ca<sup>2+</sup> influx (Ramirez-Franco et al., 2014). In that context, as the reviewer says, the GPR55-mediated RRP change can be regarded as a similar synaptic modulation mechanism as the CB1-mediated one. However, considering the different downstream signaling pathways, G<sub>12/13</sub>- or G<sub>q</sub>-mediated one and G<sub>i/o</sub>-mediated one, our findings would provide an important scope about the regulation mechanisms of release machinery, which should be further analyzed in the future study. Now we have added these points in discussion (p13-14, lines 435-439).

      (4) Add a section about the limitations of this study (see Weaknesses above).

      As suggested, we have added a section about the limitations of this study at present, which we could not address in the revision and should be addressed in the future (p15, lines 488-508). Particularly, the actual endogenous agonist to activate GPR55, and the physiological situation in which the agonist is produced, much more direct evidence for GPR55 presence at PC boutons, and the downstream mechanisms of GPR55-mediated suppression of GABA release are now clearly notified in that section.

      (5) Double-check grammar and typos ("anandamid").

      We are really sorry for the poor writings in the previous manuscript. Now, we have carefully checked the text.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The "number sense" refers to an imprecise and noisy representation of number. Many researchers propose that the number sense confers a fixed (exogenous) subjective representation of number that adheres to scalar variability, whereby the variance of the representation of number is linear in the number.

      This manuscript investigates whether the representation of number is fixed, as usually assumed in the literature, or whether it is endogenous. The two dimensions on which the authors investigate this endogeneity are the subject's prior beliefs about stimuli values and the task objective. Using two experimental tasks, the authors collect data that are shown to violate scalar variability and are instead consistent with a model of optimal encoding and decoding, where the encoding phase depends endogenously on prior and task objectives. I believe the paper asks a critically important question. The literature in cognitive science, psychology, and increasingly in economics, has provided growing empirical evidence of decisionmaking consistent with efficient coding. However, the precise model mechanics can differ substantially across studies. This point was made forcefully in a paper by Ma and Woodford (2020, Behavioral & Brain Sciences), who argue that different researchers make different assumptions about the objective function and resource constraints across efficient coding models, leading to a proliferation of different models with ad-hoc assumptions. Thus, the possibility that optimal coding depends endogenously on the prior and the objective of the task, opens the door to a more parsimonious framework in which assumptions of the model can be constrained by environmental features. Along these lines, one of the authors' conclusions is that the degree of variability in subjective responses increases sublinearly in the width of the prior. And importantly, the degree of this sublinearity differs across the two tasks, in a manner that is consistent with a unified efficient coding model.

      We thank Reviewer #1 for her/his comments and for placing our work in a broader context.

      Comments:

      (1) Modeling and implementation of estimation task

      The biggest concern I have with the paper is about the experimental implementation and theoretical account of the estimation task. The salient features of the experimental data (Figure 1C) are that the standard deviations of subjects' estimated quantities are hump-shaped in the true stimulus x and that the standard deviation, conditional on the true stimulus x, is increasing in prior width. The authors attribute these features to a Bayesian encoding and decoding model in which the internal representation of the quantity is noisy, and the degree of noise depends on the prior - as in models of efficient coding (Wei and Stocker 2015 Nature Neuro; Bhui and Gershman 2018 Psych Review; Hahn and Wei 2024 Nature Neuro).

      The concern I have is about the final "step" in the model, where the authors assume there is an additional layer of motor noise in selecting the response. The authors posit that the subject's selection of the response is drawn from a Gaussian with a mean set to the optimally decoded estimate x*(r), and variance set to a free parameter sigma_0^2. However, the authors also assume that the Gaussian distribution is "truncated to the prior range." This truncation is a nontrivial assumption, and I believe that on its own, it can explain many features of the data.

      To see this, assume that there is no noise in the internal representation of x, there is only motor noise. This corresponds to a special case of the authors' model in which υ is set to 0. The model then reduces to a simple account in which responses are drawn from a Gaussian distribution centered at the true value of x, but with asymmetric noise due to the truncation. I simulated such a model with sigma_0=7. The resulting standard deviations of responses for each value of x (based on 1000 draws for each value of x), across the three different priors, reproduce the salient patterns of the standard deviation in Figure 1C: i) within each condition, the standard deviation is hump-shaped and peaks at x=60 and ii) conditional on x, standard deviation increases in prior width. The takeaway is that this simple model with only truncated motor noise - and without any noisy or efficient coding of internal representations - provides an alternative channel through which the prior affects behavior.

      Of course, this does not imply that subjects' coding is not described by the efficient encoding and decoding model posited by the authors. However, it does suggest an important alternative mechanism for the authors' theoretical results in the estimation task. Moreover, some of the quantitative conclusions about the differences in behavior with the discrimination task would be greatly affected by the assumption of truncated motor noise.

      Turning to the experiment, a basic question is whether such a truncation was actually implemented in the design. That is, was the range of the slider bar set to the range of the prior? (The methods section states that the size on the screen of the slider was proportional to the prior width, but it was unclear whether the bounds of the slider bar changed with the prior). If the slider bar range did depend on the prior, then it becomes difficult to interpret the data. If not, then perhaps one can perform analyses to understand how much the motor noise is responsible for the dependence of the standard deviation on both x and the prior width. Indeed, the authors emphasize that their model is best fit at α=0.48, which would seem to imply that the best fitting value of υ is strictly positive. However, it would be important to clarify whether the estimation procedure allowed for υ=0, or whether this noise parameter was constrained to be positive (i.e., clarify whether the estimation assumed noisy and efficient coding of internal representations).

      We thank Reviewer #1 for her/his close attention to the motor-noise component of our model, in particular its truncation at the border of the prior. We agree that the truncated motor noise should be examined more closely as it affects the variance of responses. We address here the questions raised by the reviewer, and we detail the new analyses we have conducted.

      First, regarding the experimental paradigm, we note that this truncation was indeed implemented in the design, i.e., the range of the slider bar corresponded to the range of the prior (we now indicate this more clearly in the manuscript). Subjects thus were not able to select an estimate that was not in the support of the prior, and it is precisely for this reason that we model the selection step with a truncated distribution, so that the model is consistent with the experimental setup. This truncation naturally decreases the response variability near the bounds, and this may affect differently the overall variability for the different priors, as noted by the reviewer in her/his simulations. We have conducted a series of analysis to investigate this question.

      First, we consider a model in which there is no cognitive noise, but only motor noise. To answer one of the reviewer’s questions, the model-fitting procedure did allow for a vanishing cognitive noise (𝜈 = 0), i.e., it allowed for such a “motor-noise-only” mechanism to be the main account of the data. This value (𝜈 = 0), however, does not maximize the likelihood of the model, and thus this hypothesis is not the best account of the data. Nevertheless, we fit a model that enforces the absence of cognitive noise (i.e., with 𝜈 = 0). The BIC of this “motor-noise-only” model is higher than that of our best-fitting model by more than 1100, indicating very strong support for the best-fitting model, which features a positive cognitive noise (𝜈 > 0), and 𝛼 = 1/2, as in our theoretical proposal.

      Furthermore, the standard deviation of responses predicted by the motor-noise-only model overestimates substantially the variability of subjects' responses in the Narrow and Medium conditions (Figure 4, panel b), while the predictions of the best-fitting model are much closer to the behavioral data (panel a). Finally, the variances predicted by this model do not increase linearly with the prior width (contrary to the behavioral data). Instead, the variance increases more between the Narrow and the Medium priors than between the Medium and the Wide priors, as the effects of the bounds attenuate with the wider prior (panel c, solid green line).

      To further this analysis we fit in addition a model with no cognitive noise (𝜈 = 0), but in which we now allow the degree of motor noise, 𝜎<sub>0</sub>, to depend on the prior. Our reasoning is that if the truncated motor noise were the sole explanation for the increase in subjects' variance with the prior width, then we would expect the noise levels for the three priors to be roughly equal. We find instead that they are different (with values of 5.9, 8.3, and 9.8, for the prior widths 20, 40, and 60, respectively, when pooling subjects; and when fitting subjects individually the distributions of parameter values exhibit a clear increase; see panels c and d above). This model moreover yields a BIC higher by more than 590 than our best-fitting model. We note in addition that these parameter values differ in such a way that they result in response variances that are a linear function of the prior width, as found in the behavioral data, although they overestimate the subjects' variances (panel c, dotted green line). This linear increase is directly predicted by our best-fitting model, which has one less parameter (2 vs. 3), and which moreover accurately predicts the variability of subjects across priors (panel c, pink line). Hence the data do not support a model with no cognitive noise and with only a constant, truncated motor noise.

      We also consider another possibility, that in addition to truncated motor noise there is in fact a degree of cognitive noise, but one that is insensitive to the width of the prior. In other words, there is cognitive imprecision, but it does not efficiently adapt to the prior range, as in our proposal. This corresponds to setting 𝛼 = 0, in our model; but this specification of the model results in a poor fit, with a BIC higher by more than 300 than that of the best-fitting model, whose cognitive noise scales with the exponent 𝛼 = 1/2, consistent with our theory. Thus our data do not support the hypothesis of a cognitive noise that does not scale with the prior range; instead, subjects' responses support a model in which the variance of the cognitive noise increases linearly with the prior range.

      We note in addition that there is inter-subject variability: different subjects have different degrees of imprecision. But if the source of the imprecision was the truncated motor noise, then different degrees of truncated noise should result in different relationships between the behavioral variance and the prior widths: subjects with smaller noise should be relatively insensitive to the width of the prior, while subjects with greater noise should be more sensitive. In that case, when fitting the subjects with the model in which the imprecision scales as a power of the width, we should expect subjects to exhibit a diversity of best-fitting parameter values 𝛼. Instead, as noted, we find that the data is best captured by a single exponent 𝛼 = 1/2, equal for all the subjects. This suggests that although the “baseline level” of the imprecision may differ per subject, the way that their imprecision increases as a function of the prior width is the same for all the subjects, a behavior that is not explained by truncated noise alone.

      Furthermore, Prat-Carrabin, Harl, and Gershman 2025 present behavioral results obtained in a similar numerosity-estimation task, with the same prior ranges, but with the experimental difference that the slider was not limited to the range of the current prior: instead it had the same width in all three conditions, and covered in all trials a range wider than that of the Wide prior (from 25 to 95). The behavioral variance observed in this study increases linearly with the prior range, as in our results. Thus we conclude that the linear increase in subjects' variability does not originate in the bounds of the experimental slider.

      Finally, Prat-Carrabin et al. 2025 presents an fMRI study involving a similar numerosityestimation experiment. This study shows that numerosity-sensitive neural populations in human parietal cortex adapt their tuning properties to the current numerical range, resulting in less precise neural encoding when the range is wider. This substantiates the notion that the degree of imprecision in cognitive noise adapts to the prior range, as in our proposal.

      Overall, we conclude that the linear increase of behavioral variability that we document originates in the endogenous adaptation, across conditions, of the amount of imprecision in the internal encoding of numerosities.

      We now include these analyses in a new section of the Methods (p. 24-27), which we summarize in the main text (p. 7-8). The Figure above is now included (as Figure 4). We also now cite the references mentioned by Reviewer #1 and which we had not already cited (Bhui and Gershman 2018 Psych Review; Hahn and Wei 2024 Nature Neuro).

      References:

      Prat-Carrabin, A., Harl, M. V., & Gershman, S. J. (2025). Fast efficient coding and sensory adaptation in gain-adaptive recurrent networks (p. 2025.07.11.664261). bioRxiv. https://doi.org/10.1101/2025.07.11.664261

      Prat-Carrabin, A., de Hollander, G., Bedi, S., Gershman, S. J., & Ruff, C. C. (2025). Distributed range adaptation in human parietal encoding of numbers (p. 2025.09.25.675916). bioRxiv. https://doi.org/10.1101/2025.09.25.675916

      (2) Differences across tasks

      A main takeaway from the paper is that optimal coding depends on the expected reward function in each task. This is the explanation for why the degree of sublinearity between standard deviation and prior width changes across the estimation and discrimination task. But besides the two different reward functions, there are also other differences across the two tasks. For example, the estimation task involves a single array of dots, whereas the discrimination task involves a pair of sequences of Arabic numerals. Related to the discussion above, in the estimation task the response scale is continuous whereas in the discrimination task, responses are binary. Is it possible that these other differences in the task could contribute to the observed different degrees of sublinearity? It is likely beyond the scope of the paper to incorporate these differences into the model, but such differences across the two tasks should be discussed as potential drivers of differences in observed behavior.

      If it becomes too difficult to interpret the data from the estimation task due to the slider bar varying with the prior range, then which of the paper's conclusions would still follow when restricting the analysis to the discrimination task?

      There are indeed several differences between the estimation and discrimination tasks that could, in principle, contribute to the quantitative differences observed between them. The fact that the estimation task requires a continuous numerical report whereas the discrimination task involves a binary choice is captured in our model by incorporating distinct loss functions for the two tasks (Eq. 4). This distinction is a key element of the theoretical framework, as it determines the optimal allocation of representational precision. We agree with Reviewer #1 that another important difference is that the estimation task involves non-symbolic dot arrays while the discrimination task uses short sequences of Arabic numerals, which could also affect performance through distinct perceptual or cognitive processes. Although we cannot exclude this possibility, it is unclear why such a difference in stimulus format would produce the specific quantitative patterns that we observe — and that are predicted by our proposal, namely, the sublinear scalings with task-dependent exponents. Each experiment, taken independently, supports the model's central prediction that the precision of internal representations scales sublinearly with the width of the prior distribution. Taken together, the two tasks show that this dependence itself varies with the observer's objective, confirming that perceptual precision is endogenously determined by both the statistical context and the task goal.

      We agree with Reviewer #1 that this point should be mentioned; we now do so in the Discussion (p. 17-18).

      (3) Placement literature

      One closely related experiment to the discrimination task in the current paper can be found in Frydman and Jin (2022 Quarterly Journal of Economics). Those authors also experimentally vary the width of a uniform prior in a discrimination task using Arabic numerals, in order to test principles of efficient coding. Consistent with the current findings, Frydman and Jin find that subjects exhibit greater precision when making judgments about numbers drawn from a narrower distribution. However, what the current manuscript does is it goes beyond Frydman and Jin by modeling and experimentally varying task objectives to understand and test the effects on optimal coding. This contribution should be highlighted and contrasted against the earlier experimental work of Frydman and Jin to better articulate the novelty of the current manuscript.

      We thank Reviewer #1 and we agree that the work of Frydman and Jin is highly relevant to our study. Instead of comparing our contributions to theirs, we have decided to have a close look at their data, in light of our theoretical proposal. This enables us to test the predictions of our theory against human choices made in a rather different decision situation than that of our discrimination task.

      Thus we looked, in their data, at the participants' probability of choosing the risky lottery instead of the certain amount, as a function of the difference between the lottery's expected value (pX) and the certain amount (C; we also added a small bias term to the certain option; such bias was not necessary with our discrimination data, presumably because of the inherent symmetry of our task).

      We find, as did Frydman and Jin, and similarly to our discrimination task, that the participants are more precise when the proposed amounts are sampled from a Narrow prior, in comparison to a Wide prior (see figure above, first panel). But we also find, as in our discrimination task, that when normalizing the value difference by the prior width participants are more sensitive to this normalized difference in the Wide condition than in the Narrow one, suggesting that their imprecision scales across conditions by a smaller factor than the prior width (last panel). And we find, consistent with our discrimination data and with our theory, that choice probabilities in the two conditions match very well when normalizing the difference by the prior width raised to the exponent 3/4 (third panel).

      Model fitting supports this observation. We fit the data to our model (described by Eq. 3), with the addition of a lapse probability and of a bias, and with different values of the exponent 𝛼. The best-fitting model is the one with 𝛼 = 3/4. Its BIC (35,419) is lower than those of the models with 𝛼 = 1, ½, and 0 (by 142, 39, and 514, respectively). It is also lower by 2.14 than a model in which 𝛼 is left as a free parameter (in which case the bestfitting 𝛼 is 0.68, a value not far from 3/4). We emphasize that these BIC values indicate that the hypotheses 𝛼 = 0 and 𝛼 =1 are clearly rejected, i.e., the participants' imprecision increases with the prior width (𝛼 > 0), but sublinearly (𝛼 < 1). In other words, the responses collected by Frydman and Jin in a risky-choice task are quantitatively consistent with our results obtained in a number-discrimination task, and they further substantiate our model of endogenous precision.

      We moreover note that their proposed model is similar to ours, in that the decision-maker is allowed to optimize a noisy encoding scheme to the prior, subject to a ‘capacity constraint’ on the number 𝑛 of encoding signals that can be obtained. Crucially, this capacity constraint is assumed to be a property of the decision-maker that does not change across priors, and thus 𝑛 is fixed across prior widths. Therefore, their model predicts that the participants' imprecision should scale linearly with the prior width (this is also what we obtain in our model if we don’t optimize a similar parameter; see the revised presentation of the model on p. 12-13). We note that when they fit this parameter, 𝑛, separately across conditions, they find that it is larger with the wider prior. This is precisely what our model of endogenous precision predicts. In turn this predicts a sublinear scaling of the imprecision, instead of the linear one that would result from a fixed 𝑛, and indeed we find a sublinear scaling in both their dataset and ours. What is more, in both datasets the sublinear scaling is best captured by the exponent 𝛼 = 3/4, as we predict.

      This analysis of another independent dataset obtained with a different experimental paradigm significantly strengthens our conclusions. Thus we added to the Results section a new subsection discussing this analysis, and the figure above now appears as Figure 3. We also mention it in the Introduction (l. 87-89) and in the Discussion (l. 556-557).

      Reviewer #2 (Public review):

      Summary:

      This paper provides an ingenious experimental test of an efficient coding objective based on optimization as a task success. The key idea is that different tasks (estimation vs discrimination) will, under the proposed model, lead to a different scaling between the encoding precision and the width of the prior distribution. Empirical evidence in two tasks involving number perception supports this idea.

      Strengths:

      The paper provides an elegant test of a prediction made by a certain class of efficient coding models previously investigated theoretically by the authors.

      The results in experiments and modeling suggest that competing efficient coding models, optimizing mutual information alone, may be incomplete by missing the role of the task.

      We thank Reviewer #2 for her/his positive comments on our work.

      Weaknesses:

      The claims would be more strongly validated if data were present at more than two widths in the discrimination experiment.

      We agree that including additional prior widths would allow for a more detailed validation of the predicted scaling law, in particular in the discrimination task. Our design choices across the two experiments reflect a trade-off between the number of prior widths and the number of trials per condition. In the estimation task, we include three widths because this is necessary to identify all three parameters of the model: the variance of the motor noise , the baseline variance of internal imprecision (𝜈<sup>2</sup>), and the scaling exponent (𝛼). Extending both tasks to include additional prior widths would indeed provide a more robust test of the predicted scaling law. We now note this point in the revised Discussion (p. 17).

      A very strong prediction of the model -- which determines encoding entirely from prior and task -- is that Fisher Information is uniform throughout the range, strongly at odds with the traditional assumption of imprecision increasing with the numerosity (Weber/Fechner law). This prediction should be checked against the data collected. It may not be trivial to determine this in the Estimation experiment, but should be feasible in the Discrimination experiment in the Wide condition: Is there really no difference in discriminability at numbers close to 10 vs numbers close to 90? Figure 2 collapses over those, so it's not evident whether such a difference holds or not. I'd have loved to look into this in reviewing, but the authors have not yet made their data publicly available - I strongly encourage them to do so.

      Importantly, the inverse u-shaped pattern in Figure 1 is itself compatible with a Weber's-law-based encoding, as shown by simulation in Figure 5d in Hahn&Wei [1]. This suggests a potential competing variant account, in apparent qualitative agreement with the findings reported: the encoding is compatible with Fisher's law, and only a single scalar, the magnitude of sensory noise, is optimized for the task for the loss function (3). As this account would be substantially more in line with traditional accounts of numerosity perception - while still exhibiting taskdependence of encoding as proposed by the authors - it would be worth investigating if it can be ruled out based on the data gathered for this paper.

      References:

      [1] Hahn & Wei, A unifying theory explains seemingly contradictory biases in perceptual estimation, Nature Neuroscience 2024

      Indeed our efficient-coding model predicts that a uniform should result in a constant Fisher-information function, and we agree with Reviewer #2 that this is at odds with the common assumption that the imprecision increases with the magnitude. To investigate this possibility, we now consider, in the revised manuscript, a more general model of Gaussian encoding, in which the internal representation, 𝑟, is normally distributed around an increasing transformation of the number, 𝜇(𝑥), as

      𝑟|𝑥~𝑁(𝜇(𝑥), 𝜈<sup>2</sup>𝑤<sup>2 𝛼</sup>),

      where the encoding function, 𝜇(𝑥), can be either linear (𝜇(𝑥) = 𝑥) or logarithmic (𝜇(𝑥) = log (𝑥)). This allows us to test whether the data are better captured by a uniform Fisher information (as predicted by the linear encoding under a uniform prior) or by a compressed, Weber-like representation.

      We note, first, that in both tasks our conclusions regarding the dependence of the imprecision on the prior width remain unchanged, whether we choose the linear encoding or the logarithmic encoding. With both choice of encoding, the estimation task is best fit by a model with 𝛼 = 1/2, and the discrimination task by a model with 𝛼 = 3/4, implying a sublinear scaling of the variance with the width of the prior, in quantitative agreement with our theory.

      In the estimation task, the logarithmic encoding yields a significantly lower BIC than the linear one, by more than 380 (see Table 1). The results are less clear in the discrimination task, where the BIC with the logarithmic encoding is lower by 2.1 when pooling together the responses of all the subject, but it is larger by 2.6 when fitting each subject individually. We conduct in addition a “Bayesian model selection” procedure, to estimate the relative prevalence of each encoding among subjects. The resulting estimate of the fraction of the population that is best fit by the logarithmic encoding is 87.6% in the estimation task, and 45.9% in the discrimination task (vs. 12.4% and 54.1% for the linear encoding).

      To further investigate the behavior of subject in the Discrimination task, we look at their proportion of correct choices in the Wide and Narrow conditions, for the trials in which both averages are below the middle value of the prior, and for those in which both are above the middle value. We find no significant difference in the Narrow condition (see Figure below). In the Wide condition, the proportion of correct responses appear larger when the averages are small (with a significant difference when binning together the trials in which the absolute difference between the averages is between 4 and 12; Fisher's exact test p-value: 0.030).

      To complement this analysis, we fit a probit model with lapses, which is equivalent to our Gaussian model with linear encoding, but allowing the noise scale parameter to differ when both averages are above, or below, the middle value of the prior. We fit this model separately in each condition, only on the trials in which both averages are either above or below the middle value; and we test a more constrained model in which the scale parameter is equal for both small and large averages. In the Narrow condition, a likelihood-ratio test does not reject the null hypothesis that the scale parameter is constant (𝜒<sup>2</sup>(1) = 0.026, 𝑝 = 0.87), but in the Wide condition this hypothesis is rejected (𝜒<sup>2</sup> (1) = 7.6, 𝑝 = 0.006). In this condition the best-fitting scale parameter is 29% larger (9.4 vs. 6.3) with the large averages than with the small averages, pointing to a larger imprecision with the larger numbers.

      These results and the prevalence of the Weber/Fechner encoding prompt us to consider, in our efficient-coding model, the hypothesis that a logarithmic compression is an additional constraint on the possible encoding schemes. In our model, the internal representation (𝑟) could take any form as long as its Fisher information verified the constraint in Eq. 5 on the integral of its square-root. We now consider a strong, additional constraint: that over the support of the prior, the Fisher information of the signal must be of the form that one would obtain with a logarithmic encoding, i.e., 𝐼(𝑥) ∝ 1/𝑥<sup>2</sup>. (For the sake of generality we choose this specification instead of directly assuming a logarithmic encoding, because other types of encoding schemes yield a Fisher information of this form, e.g., one with “multiplicative noise” (Zhou et al., 2024); we do not seek, here, to distinguish between these different possibilities). We solve the same efficient-coding optimization problem (Eq. 6), but now with this additional constraint. We find that the resulting optimal Fisher information is approximately:

      , for the estimation task,

      and , for the discrimination task,

      for any 𝑥 on the support of the prior, and where 𝑥<sub>mid</sub> is the middle of the prior and 𝜃 is a constant. These Fisher-information functions differ from the one previously obtained without the additional constraint (Eq. 9), in that they fall off as 1/𝑥<sup>2</sup>, consistent with our additional constraint. However, we note that the dependence on the prior width, 𝑤, is identical: here also, the imprecision is proportional to , in the estimation task, and to 𝑤<sup>3/4</sup>, in the discrimination task.

      In its logarithmic variant (𝜇(𝑥) = log (𝑥)), the Fisher information of the model of Gaussian representations that we have considered throughout is 1/(𝑥 𝜈 𝑤<sup>𝛼</sup>)<sup>2</sup>. It is thus consistent with the predictions just presented, if 𝛼 = 1/2 for the estimation task, and 𝛼 = 3/4 for the discrimination task, i.e., the two values that best fit the data.

      This is precisely the model suggested by Reviewer #2. Overall, we conclude that with both linear and logarithmic encoding schemes, our efficient-coding model — wherein the degree of imprecision is endogenously determined — accounts for the task-dependent sublinear scaling of the imprecision that we observe in behavioral data. As for the imprecision across numbers, a sizable fraction of subjects, particularly in the estimation task, are best fit by the logarithmic encoding, consistent with previous reports that numbers are often represented on a compressed, approximately logarithmic scale. This encoding may itself reflect an efficient adaptation to a long-term environmental prior that is skewed, with smaller numbers occurring more frequently, leading to greater representational precision. This pattern is less clear in the discrimination task. It is possible that the rate at which the precision decreases across numbers itself depends on the task, such that not only the overall level of imprecision, but also its variation across numbers, may be modulated by the task's demands. In this study we have focused on the endogenous choice of the overall precision, but an avenue for future research would be to examine how this adaptation interacts with the detailed shape of the encoding across numbers.

      In the revised manuscript, we have modified the presentation of the model to include the transformation 𝜇(𝑥) (p. 6-7 and 10-11). We have updated accordingly Table 1 (shown above; p. 24), which reports the BICs of all the models for the estimation task (and which now includes the models with logarithmic encoding). There is now a section in the Results dedicated to the question of the logarithmic compression, which includes the efficientcoding model constrained by the logarithmic encoding (p. 15-16). The results on the performance of subjects with larger numbers are presented in Methods (p. 29-31), and mentioned in the main text (p. 14-15). The Methods also provides details about the efficient-coding model with logarithmic encoding (p. 32-33). These results are further commented on in the Discussion (p. 18). Finally, the data and code are now available online at this address: https://osf.io/d6k3m/ , which we note on p. 33.

      Reference

      Zhou, J., Duong, L. R., & Simoncelli, E. P. (2024). A unified framework for perceived magnitude and discriminability of sensory stimuli. Proceedings of the National Academy of Sciences, 121(25), e2312293121. https://doi.org/10.1073/pnas.2312293121

      Reviewer #3 (Public review):

      Summary:

      This work demonstrates that people's imprecision in numeric perception varies with the stimulus context and task goal. By measuring imprecision across different widths of uniform prior distributions in estimation and discrimination tasks, the authors find that imprecision changes sublinearly with prior width, challenging previous range normalization models. They further show that these changes align with the efficient encoding model, where decision-makers balance expected rewards and encoding costs optimally.

      Strengths:

      The experimental design is straightforward, controlling the mean of the number distribution while varying the prior width. By assessing estimation errors and discrimination accuracy, the authors effectively highlight how imprecision adjusts across conditions.

      The model's predictions align well with the data, with the exponential terms (1/2 and 3/4) of imprecision changes matching the empirical results impressively.

      We thank Reviewer #3 for his/her positive comments on our work.

      Weaknesses:

      Some details in the model section are unclear. Specifically, I'm puzzled by the Wiener process assumption where r∣x∼N(m(x)T,s^2T). Does this imply that both the representation of number x and the noise are nearly zero at the beginning, increasing as observation time progresses? This seems counterintuitive, and a clearer explanation would be helpful.

      In the original formulation of the model, indeed both the mean of the representation and its variance are nearly zero when T is also near zero, but in such a way that the Fisher information, 𝑇(𝑚′(𝑥)/𝑠)<sup>2</sup>, is proportional to 𝑇. We note that a different specification, with a mean 𝑚(𝑥) (instead of 𝑚(𝑥)𝑇) and a variance 𝑠<sup>2</sup>/𝑇 (instead of 𝑠<sup>2</sup>𝑇), i.e., 𝑟|𝑥~𝑁(𝑚(𝑥), 𝑠<sup>2</sup>/𝑇), for 𝑇 > 0, would result in the same Fisher information.

      In any event, in the revised manuscript, we now formulate the model differently. Specifically, we assume that the encoding results from an accumulation of independent, identically-distributed signals, but the precision of each signal is limited, and each of them entails a cost. Formally, we posit, first, that the Fisher information of one signal, 𝐼<sub>1</sub>(𝑥), is subject to the constraint:

      This constraint appears in many other efficient-coding models in the literature (Wei & Stocker 2015, 2016; Wang et al. 2016; Morais & Pillow, 2018; etc.), and it arises naturally for unidimensional encoding channels (Prat-Carrabin & Woodford, 2001; e.g., for a neuron with a sigmoidal tuning curve, it is equivalent to assuming that the range of possible firing rates is bounded). Second, we assume that the observer incurs a cost each time a signal is emitted (e.g., the energy resources consumed by action potentials). The total cost is thus proportional to the number of signals, which we denote by 𝑛. More signals, however, allow for a better precision: specifically, under the assumption of independent signals, the total Fisher information resulting from 𝑛 signals is the sum of the Fisher information of each signal, i.e., 𝐼(𝑥) = 𝑛𝐼<sub>1</sub>(𝑥).

      A tradeoff ensues between the increased precision brought by accumulating more signals, and the cost of these signals. We assume that the observer chooses the function 𝐼<sub>1</sub>(.) and the number 𝑛 of signals that solve the minimization problem subject to ,

      where 𝜆 > 0. We can first solve this problem for the Fisher information of one signal, 𝐼<sub>1</sub>(𝑥). In the case of a uniform prior of width 𝑤, we find that it is zero outside of the support of the prior, and

      for any 𝑥 on the support of the prior. This intermediate result corresponds to the optimal Fisher information of an observer who is not allowed to choose the number of signal, 𝑛, (and who receives instead 𝑛 = 1 signal). It is the solution predicted by the efficient-coding models mentioned above, that include the constraint on 𝐼<sub>1</sub>(𝑥), but that do not allow for the observer to choose the amount of signals, 𝑛. With this solution, the scale of the observer's imprecision, , is proportional to 𝑤, and it does not depend on the task — contrary to our experimental results.

      Solving the optimization problem for 𝑛, in addition to 𝐼<sub>1</sub>(𝑥), we find that with a uniform prior the optimal number is proportional to 𝑤 in the estimation task, and to in the discrimination task (specifically, treating 𝑛 as continuous, we obtain ). In other words, the observer chooses to obtain more signals when the prior is wider, and in a way that depends on the task. We give the general solution for the total Fisher information, 𝐼(𝑥) = 𝑛𝐼<sub>1</sub>(𝑥), in the case of a prior 𝜋(𝑥) that is not necessarily uniform:

      where 𝜃 = 𝜆/𝐾. This is of course the same solution that we obtained in the original manuscript.

      We hope that this new formulation of the efficient-coding model will seem more intuitive to the reader (p. 12-13 in the revised manuscript).

      The authors explore range normalization models with Gaussian representation, but another common approach is the logarithmic representation (Barretto-García et al., 2023; Khaw et al., 2021). Could the logarithmic representation similarly lead to sublinearity in noise and distribution width?

      We agree with Reviewer #3 that a common approach when modeling the perception of numbers is to consider a logarithmic encoding. We have conducted several analyzes that examine this proposal. These are presented in detail in our response to a comment of Reviewer #2, above (p. 11-14 of this document). We summarize shortly our findings, here:

      (i) A model with a logarithmic encoding better fits a majority of subjects in the estimation task, but a bit less than half the subjects in the discrimination task.

      (ii) The examination of the performance of subjects in the discrimination task, however, suggests that in the Wide condition they discriminate slightly better the small numbers, as compared to the larger numbers.

      (iii) We consider a constrained version of our efficient-coding model, in which the Fisher information must be consistent with that of a logarithmic encoding (i.e., decreasing as 1/𝑥<sup>2</sup>); we find that the resulting optimal Fisher information depends on the prior width in the same way than without the constraint, i.e., a scaling of the imprecision with , in the estimation task, and with 𝑤<sup>3/4</sup>, in the discrimination task.

      (iv) When considering the model with logarithmic encoding, we find that it best fits the data when its imprecision scales with the width with the same exponents, i.e., , in the estimation task (𝛼 = 1/2), and 𝑤<sup>3/4</sup>, in the discrimination task (𝛼 = 3/4). In other words, the data support the predictions of our theoretical model.

      In the revised manuscript, we have modified accordingly the presentation of the model (p. 6-7 and 10-11), the Tables 1 (p. 24) and 2 (p. 30) which report the BICs. There is now a section in the Results dedicated to the question of the logarithmic compression, including the efficient-coding model constrained by the logarithmic encoding (p. 15-16). The results on the performance of subjects with larger numbers are presented in Methods (p. 29-31), and mentioned in the main text (p. 15-16). The Methods also provides details about the efficient-coding model with logarithmic encoding (p. 32-33). These results are further commented on in the Discussion (p. 18). Finally, we now cite the articles mentioned by Reviewer #3 (Barretto-García et al., 2023; Khaw et al., 2021).

      Additionally, Heng et al. (2020) found that subjects did not alter their encoding strategy across different task goals, which seems inconsistent with the fully adaptive representation proposed here. I didn't find the analysis of participants' temporal dynamics of adaptation. The behavioral results in the manuscript seem to imply that the subjects adopted different coding schemes in a very short period of time. Yet in previous studies of adaptation, experimental results seem to be more supportive of a partial adaptive behavior (Bujold et al., 2021; Heng et al., 2020), which might balance experimental and real-world prior distributions. Analyzing temporal dynamics might provide more insight. Noting that the authors informed subjects about the shape of the prior distribution before the experiment, do the results in this manuscript suggest a top-down rapid modulation of number representation?

      We thank Reviewer #3 for his/her comment and for pointing to these articles. The Reviewer raises several points — that of the dynamics of adaptation, that of the adaptation to the prior, and that of the adaptation to the task. We address each of them.

      To investigate the dynamics of the subjects’ adaptation, we examined separately, in each task, the responses obtained in the trials in the first and second halves of each condition. In the estimation task, the standard deviations of responses, as a function of the presented number and of the prior width, are very similar in the two halves (see Figure 8, panel a). The Bonferroni-Holm-corrected p-values of Levene's tests of equality of the variances across the two halves are all above 0.13, and thus we do not reject the hypothesis that the variance in the first half of the trials is equal to the variance in the second half. Moreover, the variance in both halves appear to be a linear function of the width, rather than the squared width (panel b). We conclude that the behavior of subjects in the estimation task is stable across each experimental condition, including the sublinear scaling of their imprecision.

      In the discrimination task, the subjects' choice probabilities, as a function of the difference between the averages of the red and blue numbers, are similar in the first and second halves of trials (panel c). The Bonferroni-Holm-corrected p-values of Fisher exact tests of equality of proportions (in bins of the average difference that contain about 500 trials each) are all above 0.9, and thus we do not reject the hypothesis that the choice probabilities are equal, in the first and second halves of the trials. Furthermore, the choice probabilities as a function of the absolute average difference normalized by the prior width raised to the exponent 3/4 are all similar, across session halves and across prior widths, suggesting that the sublinear scaling that we find is a stable behavior of subjects (panel d).

      Overall, we conclude that the behavior we exhibit in both tasks is stable over the course of each experimental condition. We note that in both experiments, subjects were explicitly informed of the prior distribution at the beginning of each condition, and each condition included two preliminary training phases that familiarized them with the prior (the specifics for each task are detailed in the Methods section).

      As pointed out by Reviewer #3, Heng et al. (2020) and Bujold et al. (2021) report a partial adaptation of encoding to recently experienced distributions. We note that in our study, a sizable fraction of subjects, particularly in the estimation task, are best fit by the logarithmic encoding. This suggests that, while subjects adapt to the experimental prior, they retain a residual logarithmic compression — an encoding that itself would be efficient under a long-term, skewed prior in which smaller numbers are more frequent. In that sense our findings are thus consistent with the partial adaptation of Heng et al. (2020) and Bujold et al. (2021). At the same time, the same sublinear scaling of imprecision that we find in our study has been obtained in a numerosity-estimation task in which the prior was changed on every trial (Prat-Carrabin et al., 2025), indicating that the adaptation to the prior can occur quickly (on the order of a second) — possibly through a fast top-down modulation of the encoding, as suggested by Reviewer #3. These findings suggest that on a short timescale the encoding adapts efficiently to the prior (as evidenced by the scaling in imprecision), but within structural constraints (the logarithmic encoding).

      Regarding the adaptation to the task, Heng et al. (2020) indeed do not find subjects to be adapting their encoding, across two discrimination tasks (one in which the subject is rewarded for making the correct choice, and one in which the subject is rewarded with the chosen option). A difference with our paradigm is that their task involves simultaneous presentation of two dot arrays, while our discrimination task uses two interleaved sequences of Arabic numerals. More importantly, we do not directly compare the encoding between the estimation and discrimination tasks. Instead, we show that within each task, the adaptation to the prior is quantitatively consistent with the optimal coding predicted for that task's objective, as reflected in the task-specific sublinear scaling exponents. Directly contrasting the encoding across tasks would be a very interesting direction for future work.

      In the revised manuscript, we present the analysis on the stability of subjects’ behavior in the Methods section (p. 29), and we mention it in the main text when presenting the results of the estimation task (p. 5) and of the discrimination task (p. 8-10). In the Discussion, we cite Heng et al. (2020) and Bujold et al. (2021) and comment on the adaptation to the prior and to the task (p. 18).

      Barretto-García, M., De Hollander, G., Grueschow, M., Polanía, R., Woodford, M., & Ruff, C. C. (2023). Individual risk attitudes arise from noise in neurocognitive magnitude representations. Nature Human Behaviour, 7(9), 15511567. https://doi.org/10.1038/s41562-023-01643-4

      Bujold, P. M., Ferrari-Toniolo, S., & Schultz, W. (2021). Adaptation of utility functions to reward distribution in rhesus monkeys. Cognition, 214, 104764. https://doi.org/10.1016/j.cognition.2021.104764

      Heng, J. A., Woodford, M., & Polania, R. (2020). Efficient sampling and noisy decisions. eLife, 9, e54962. https://doi.org/10.7554/eLife.54962

      Khaw, M. W., Li, Z., & Woodford, M. (2021). Cognitive Imprecision and SmallStakes Risk Aversion. The Review of Economic Studies, 88(4), 19792013. https://doi.org/10.1093/restud/rdaa044

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) As mentioned above, the result of inverse u-shaped variability is in strong qualitative agreement with the predictions of a generic Bayesian encoding-decoding model of a flat prior, even under a standard encoding respecting Weber's law, as shown in Figure 5d in: Hahn & Wei, A unifying theory explains seemingly contradictory biases in perceptual estimation, Nature Neuroscience 2024. This paper should probably be cited.

      We now cite Hahn & Wei, 2024. We comment above on our analyzes regarding the logarithmic encoding.

      (2) "Requests for the data can be sent via email to the corresponding author" Why are the data not made openly available? Barring ethical or legal concerns (which are not apparent for this type of data), there is no reason not to make data and code open.

      "Requests for the code used for all analyses can be sent via email to the corresponding author." Same: why not make them open?

      We agree that it is good practice to make the data and code publicly available. They are now available here: https://osf.io/d6k3m/

      Reviewer #3 (Recommendations for the authors):

      The orange dot in Figure 1C does not appear to be described in the figure caption, although an explanation of it is mentioned in the main text.

      We thank Reviewer #3 for pointing out this omission. We now include explanations in the caption.

      I hope the authors will consider making their data publicly available on OSF or another platform.

      The data and code are now publicly available on OSF: https://osf.io/d6k3m/

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors aimed to assess the variability in the expression of surface protein multigene families between amastigote and trypomastigote Trypanosoma cruzi, as well as between individuals within each population. The analysis presented shows higher expression of multigene family transcripts in trypomastigotes compared to amastigotes and that there is variation in which copies are expressed between individual parasites. Notably, they find no clear subpopulations expressing previously characterised trans-sialidase groups. The mapping accuracy to these multicopy genes requires demonstration to confirm this, and the analysis could be extended further to probe the features of the top expressed genes and the other multigene families also identified as variable.

      Strengths:

      The authors successfully process methanol-fixed parasites with the 10x Genomics platform. This approach is valuable for other studies where using live parasites for these methods is logistically challenging.

      Weaknesses:

      The authors describe a single experiment, which lacks controls or complementation with other approaches and the investigation is limited to the trans-sialidase transcripts.

      It would be more convincing to show either bioinformatically or by carrying out a controlled experiment, that the sequencing generated has been mapped accurately to different members of multigene families to distinguish their expression. If mapping to the multigene families is inaccurate, this will impact the transcript counts and downstream analysis.

      We thank the reviewer for raising these important points.

      We agree that the analysis of multigene families at the single-cell level is an important question, particularly given the heterogeneity observed across several of them. However, the aim of this short report is not to provide a comprehensive analysis of the entire experiment, but rather to focus on what we consider an important biological phenomenon observed in TcTS genes.

      Regarding the mapping accuracy of the reads, we acknowledge that this can limit the disambiguation of highly similar multicopy transcripts. This is, in fact, a common challenge when analyzing transcriptomic data from T. cruzi.

      To address this issue, we analyzed the sequence identity of the 3′ ends of TcS transcripts (defined as the 3′UTR plus 20% of the CDS region). As shown in Author response image 1, these regions display a median sequence identity of approximately 25%, indicating that sufficient sequence divergence exists for mapping algorithms to use during read assignment.

      In addition, it is important to note that kallisto, the software used in our analysis, was specifically designed to address multimapping reads through pseudoalignment combined with an expectation-maximization algorithm that probabilistically assigns reads across compatible transcripts.

      To directly assess performance, we simulated reads from the T. cruzi transcriptome used in this study (3′UTRs plus 20% of the CDS regions) and compared two mapping/counting strategies: (a) transcriptome pseudoalignment using kallisto, and (b) genome alignment followed by counting using STAR + featureCounts. The latter approximates the strategy implemented in CellRanger, the standard pipeline for quantifying expression levels from 10X Genomics single cell RNA-seq data. We found that kallisto recovered the simulated “true” counts with substantially higher accuracy than STAR + featureCounts (Pearson correlation: all genes, 0.991 vs 0.595; surface protein genes, 0.9996 vs 0.827; trans-sialidase (TcS) genes, 0.9998 vs 0.773). These results indicate that pseudoalignment is currently the optimal strategy for recovering the relative expression of highly similar gene family members (Author response image 1 C).

      Author response image 1

      (A) Distribution of pairwise sequence identity values calculated among the 3′-end regions of all transcripts (defined as the 3′UTR plus 20% of the coding sequence). (B) Distribution of read mapping coordinates over all multigene family transcripts normalized as percentage of the gene length (C) Scatter plots showing the correlation between estimated transcript counts obtained using kallisto (red) and STAR + featureCounts (grey) versus the corresponding simulated ground-truth values.

      Reviewer #2 (Public review):

      Summary:

      This manuscript presents a valuable single-cell RNA-seq study on Trypanosoma cruzi, an important human parasite. It investigates the expression heterogeneity of surface proteins, particularly those from the trans-sialidase-like (TcS) superfamily, within amastigote and trypomastigote populations. The findings suggest a previously underappreciated level of diversity in TcS expression, which could have implications for understanding parasite-host interactions and immune evasion strategies. The use of single-cell approaches to delve into population heterogeneity is strong. However, the study does have some limitations that need to be addressed.

      The focus on single-cell transcriptional heterogeneity in surface proteins, especially the TcS family, in T. cruzi is novel. Given the important role of these proteins in parasite biology and host interaction, the findings have potential significance.

      Strengths:

      The key finding of heterogeneous TcS expression in trypomastigotes is well-supported. The analysis comparing multigene families, single-copy genes, and ribosomal proteins highlights the unusual nature of the variation in surface protein-coding genes.

      Weaknesses:

      While the manuscript identifies TcS heterogeneity, the functional implications of the different expression profiles remain speculative. The authors state it may reflect differences in infectivity, but no direct experimental evidence supports this.

      The manuscript lacks any functional validation of the single-cell findings. For instance, do the trypomastigote subpopulations identified based on TcS expression exhibit differences in infectivity, host cell tropism, or immune evasion? Such experiments would greatly strengthen the study.

      We thank the reviewer for their careful reading of the manuscript. We agree that obtaining experimental evidence on the influence of multiple multigene families would represent a significant advancement in the field. However, we would like to emphasize that this study is presented as a short communication centered on a specific and biologically relevant observation within a single multigene family. The aim of the manuscript is to highlight what we consider an important biological phenomenon that raises hypotheses to be tested in future work.

      The influence of phenotypic heterogeneity and its possible advantages under environmental pressures has been previously proposed for Trypanosoma cruzi, related trypanosomatids, and other biological systems, ranging from bacteria to tumors (Seco-Hidalgo 2015, doi: 10.1098/rsob.150190 and Luzak 2021, doi: 10.1146/annurev-micro-040821-012953, for a comprehensive review on this topic). While the reviewer is correct in noting that our model does not demonstrate a functional role for TcTS heterogeneity, the experimental approaches required to address this question in a large multigene family are highly complex. This is particularly challenging in T. cruzi, where the study of multigene families is limited by the restricted set of available molecular biology tools (such as RNAi). Therefore, further experimental validation of these observations falls outside the scope of this short report.

      In this revised version, we have included additional validation and clarification of the results, as well as a more explicit discussion of their limitations. In addition, we present a preliminary analysis exploring potential mechanisms that could coordinate the observed expression patterns of the TcTS family.

      The authors identify a subpopulation of TcS genes that are highly expressed in many cells. However, it is unclear if these correspond to previously characterized TcS members with specific functions.

      The TcS subgroup with a high frequency of detection comprises 31 genes, none of which belong to the catalytically active Group I trans-sialidases. Instead, this subgroup includes members of Groups II, III, IV, V, VI, and VIII. This information has been added to Supplementary Table 3 and is now stated in the revised manuscript.

      The authors hypothesize that observed heterogeneity may relate to chromatin regulation. However, the study does not directly address these mechanisms. There are interesting connections to be made with what they identify as the colocalization of genes within chromatin folding domains, but the authors do not fully explore this. It would be insightful to address these mechanisms in future work.

      In response to the reviewer’s and editorial team’s request for additional mechanistic insight into the regulatory processes that may be involved in the observed patterns, we have expanded the revised manuscript to discuss how the genomic context of TcS loci could contribute to the observed heterogeneity in TcS expression. As noted in the original version of the manuscript, TcS genes and other surface-protein gene families are largely partitioned into discrete genomic compartments, whose expression has been reported to be regulated by epigenetic control of chromatin-folding domains (doi.org/10.1038/s41564-023-01483-y). However, we previously showed that TcS genes detected in a high proportion of cells are, in most cases, dispersed throughout the genome, arguing against a model in which their preferential expression results from colocalization within a small number of ubiquitously activated chromatin domains. In response to the reviewer’s suggestion, we performed a more detailed analysis of the genomic locations of these TcS genes. We found that many of them are localized within the core compartment (new Figure 5). Because the core compartment is enriched for conserved, housekeeping genes that typically display more constitutive expression (doi.org/10.1038/s41564-023-01483-y), whereas the disruptive compartment is enriched for lineage-specific multigene families associated with variable, stage-specific, and recently reported stochastic expression (doi.org/10.1038/s41467-025-64900-2), our results are consistent with a model in which compartment-specific regulatory mechanisms (in addition to post-transcriptional regulation) influence the differential cellular expression of core- versus disruptive-located TcS genes. We have incorporated these results and discussion in the revised manuscript.

      The merging of technical replicates needs further justification and explanation as they were not processed through separate experimental conditions. While barcodes were retained, it would be informative to know how well each technical replicate corresponds with the other. If both datasets were sequenced on the same lane, the inclusion of technical replicates adds noise to the analysis.

      Regarding technical details, we now include the total number of mapped reads and average number of reads mapped per cell (new paragraph in the Methods section.

      The technical replicates consist of a single Illumina library that was sequenced in two separate runs. As this approach is expected to be highly reproducible, we merged both runs into a single count table. To support this decision, we assessed the concordance between the two sequencing runs and observed an almost perfect correlation between them (Author response image 2).

      Author response image 2.

      Correlation analysis of number of reads assigned to cells between technical replicate 1 and technical replicate 2.

      While the number of cells sequenced (3192) seems reasonable, it's not clear how much the conclusions are affected by the depth of sequencing. A more detailed description of the sequencing depth and its impact on gene detection would be valuable.

      We detected a mean of 1088 genes per cell. Based on the 15,319 annotated protein-coding genes in the reference genome, this represents 7.1% of the T. cruzi protein-coding gene complement detected in each cell.

      Across the entire dataset, a total of 14,321 genes were detected in at least one cell, representing 93.5% of all annotated protein-coding genes. This suggests that our experiment captured a broad representation of the parasite's transcriptome.

      This per-cell detection rate is characteristic of droplet-based scRNA-seq and is consistent with other trypanosomatid studies. For example, the T. brucei single-cell atlas (Hutchinson et al., 2021) reported a median detection of 1052 genes per cell. In the case of T. cruzi, the recently published pre-print of the T. cruzi single cell atlas from Laidlaw & García-Sánchez et al. reported a mean between 298 and 928 genes detected per cell (depending on the sample).

      This information is now included in Methods.

      While most of the methods are clear, the way in which the subsampled gene lists were generated could be more thoroughly described, as some details are not clear for the subsampling of single-copy genes.

      The subsampling method was originally described in the Figure 2 legend; to better highlight this approach, we have now moved its description to the Methods section.

      Some of the figures are difficult to interpret. For example, the color scaling in the heatmap of Supplementary Figure 3B is not self-explanatory and it is hard to extract meaningful conclusions from the graph.

      We agree with the reviewer in this assessment. We have now modified the figures to be more self-explanatory and better reflect the conclusions.

      Reviewer #3 (Public review):

      The study aimed to address a fundamental question in T. cruzi and Chagas disease biology - how much variation is there in gene expression between individual parasites? This is particularly important with respect to the surface protein-encoding genes, which are mainly from massive repetitive gene families with 100s to 1000s of variant sequences in the genome. There is very little direct evidence for how the expression of these genes is controlled. The authors conducted a single-cell RNAseq experiment of in vitro cultured parasites with a mixture of amastigotes and trypomastigotes. Most of the analysis focused on the heterogeneity of gene expression patterns amongst trypomastigotes. They show that heterogeneity was very high for all gene classes, but surface-protein encoding genes were the most variable. In the case of the trans-sialidase gene family, many sequence variants were only detected in a small minority of parasites. The biology of the parasite (e.g. extensive post-transcriptional regulation) and potential technical caveats (e.g. high dropout rates across the genome) make it difficult to infer what this might mean for actual protein expression on the parasite surface.

      We thank the reviewer for this important comment, highlighting a central challenge when studying trypanosomatid biology. We acknowledge that in most eukaryotes and particularly in T. cruzi, where there is a predominant role of post-transcriptional regulation, mRNA levels are not always directly correlated with protein abundance, as previously reported by us and others (10.1186/s12864-015-1563-8, 10.1128/msphere.00366-21, 10.1590/S0074-02762011000300002, 10.1042/bse0510031). Nevertheless, steady-state transcript levels obtained by RNA-seq remain informative for assessing differential gene expression, and this approach has been widely used as a proxy for the study of gene expression profiles in T. cruzi (10.7717/peerj.3017, 10.1371/journal.ppat.1005511, 10.1016/j.jbc.2023.104623, 10.3389/fcimb.2023.1138456, 10.1186/s13071-023-05775-4).

      It's also interesting to note that recent proteomic analyses (10.1038/s41467-025-64900-2) have revealed substantial heterogeneity in the expression of surface proteins, including trans-sialidases, supporting the idea that the transcriptional heterogeneity we observe reflects a genuine biological feature that propagates to the protein level.

      We have now added a sentence to the discussion acknowledging this limitation and discussed the results from Cruz-Saavedra, et al. in the revised manuscript.

      (1) Limit of detection and gene dropouts

      An average of ~1100 genes are detected per parasite which indicates a dropout rate of over 90%. It appears that RNA for the "average" single copy 'core' gene is only detected in around 3% of the parasites sampled (Figure 2c: ~100 / 3192). This may be comparable with some other trypanosome scRNAseq studies, but this still seems to be a major caveat to the interpretation that high cell-to-cell variability in gene expression is explained by biological rather than technical factors. The argument would be more convincing if the dropout rates and expression heterogeneity were minimal for well-known highly expressed genes e.g. tubulin, GAPDH, and ribosomal RNAs. Admittedly, in their Final Remarks, the authors are very cautious in their interpretation, but it would be good to see a more thorough discussion of technical factors that might explain the low detection rates and how these could be tested or overcome in future work.

      (2) Heterogeneity across the board

      The authors focus on the relative heterogeneity in RNA abundance for surface proteins from the multicopy gene families vs core genes. While multicopy gene sequences do show more cell-to-cell variability, the differences (Figure 2D) are roughly average Gini values of 0.99 vs 0.97 (single copy) or 0.95 (ribosomal). Other studies that have applied similar approaches in other systems describe Gini values of < 0.2-0.25 for evenly expressed "housekeeping" genes (PMIDs 29428416, 31784565). Values observed here of >0.9 indicate that the distribution for all gene classes is extremely skewed and so the biological relevance of the comparison is uncertain.

      We recognize the limitations imposed by gene dropout in our data, as highlighted by the reviewer. Unfortunately, gene dropout is an inherent limitation of 10x genomics data. Trypanosomatids are not an exception in this regard, and the general metrics of the single-cell RNA-seq data in other reports are equivalent to those obtained in our experiment.

      Despite this important limitation, we believe that our comparative analyses (the contrast between TcS and ribosomal protein expression) provide valuable insights into a biological phenomenon with potential functional relevance for the parasite. Furthermore, we are actively working on generating single-cell RNA-seq data using alternative methodologies that improve gene dropout rates. We anticipate that these future studies will help clarify the extent of the phenomenon described in this work.

      Our results reveal a small subset of TcS genes that are frequently detected across cells, a pattern that is not compatible with random detection unless these genes were highly expressed and preferentially captured by random sampling. However, as shown in Figure 4b, many genes expressed at comparable levels are not detected at high frequencies. In line with this, Figure 4c shows that within individual cells, the detected TcS genes exhibit similar expression levels. Finally, we confirmed that this frequently detected subset shows high read counts at the bulk RNA-seq level (Figure 4 - Figure Supplement 1), consistent with the fact that these TcS are frequent in the population even when they are not specially highly expressed within each cell. Taken together, these findings argue against a purely random sampling of TcS genes and support the interpretation that this pattern reflects an underlying biological feature. We agree that further validation will be required. Accordingly, since the initial submission, we have been careful to frame our conclusions conservatively, explicitly noting that dropout remains a limitation of these data that could influence the observed patterns. In the revised version, we have strengthened this point by including a specific statement in the final remarks. Our interpretation is presented as a working hypothesis that is fully compatible with the observations reported here and may be informative for the field. To better reflect this reasoning, we have revised Figure 4b, expanded the discussion, and explicitly included this limitation in the final remarks of the revised manuscript.

      Nevertheless, this study does provide some tantalising evidence that the expression of surface genes may vary substantially between individual parasites in a single clonal population. The study is also amongst the very first to apply scRNAseq to T. cruzi, so the broader data set will be an important resource for researchers in the field.

      We thank the reviewer for highlighting the relevance of our study and for their positive assessment of the potential significance of these observations. We also agree that the dataset generated here may represent a useful resource for the community.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) In Figures 1c and 1d, it would be useful to include the genes as the plot titles.

      We agree with the reviewer that including gene names in the plot makes the panels more self-explanatory. We have added gene names to the updated version of Figure 1.

      (2) Can you include the read lengths of the sequencing and whether this is sufficient to map accurately to very similar genes of the same multigene family? As stated in the public summary, this would make the data far more convincing as standard 10x chromium cannot distinguish similar gene copies unless a longer read 2 is used. Given that only the 3' end is targeted, is this enough to distinguish the TcS and other mutligene family transcripts?

      We thank the reviewer for raising this important point. We agree that short 3′ biased reads can limit the disambiguation of highly similar multicopy transcripts. This is, in fact, a common challenge when analyzing transcriptomic data from T. cruzi.

      To address this issue, we analyzed the sequence identity of the 3′ ends of TcS transcripts (defined as the 3′UTR plus 20% of the CDS region). As shown in Author response image 1, these regions display a median sequence identity of approximately 25%, indicating that sufficient sequence divergence exists for mapping algorithms to use during read assignment.

      In addition, it is important to note that kallisto, the software used in our analysis, was specifically designed to address multimapping reads through pseudoalignment combined with an expectation-maximization algorithm that probabilistically assigns reads across compatible transcripts.

      To directly assess performance, we simulated reads from the T. cruzi transcriptome used in this study (3′UTRs plus 20% of the CDS regions) and compared two mapping/counting strategies: (a) transcriptome pseudoalignment using kallisto, and (b) genome alignment followed by counting using STAR + featureCounts. The latter approximates the strategy implemented in CellRanger, the standard pipeline for quantifying expression levels from 10X Genomics single cell RNA-seq data. We found that kallisto recovered the simulated “true” counts with substantially higher accuracy than STAR + featureCounts (Pearson correlation: all genes, 0.991 vs 0.595; surface protein genes, 0.9996 vs 0.827; trans-sialidase (TcS) genes, 0.9998 vs 0.773). These results indicate that pseudoalignment is currently the optimal strategy for recovering the relative expression of highly similar gene family members (Author response image 1C).

      The length of the R2 read (91bp) was included in Methods (line 411).

      (3) It is stated that 'single copy' genes also include 'low copy number genes". What does this include exactly? Is it more actuate to say non-surface protein genes?

      The distinction we aim to make is between multigene families and the rest of the genome. Most multigene families encode surface proteins, but not all surface protein genes belong to multigene families. To clarify this point we included a sentence in methods to reflect that when we describe “surface proteins” we are referring to surface proteins coded by multigene families (line 453). In addition, long-read genomic DNA sequencing and assembly have revealed that many genes previously believed to be single-copy are actually duplicated at low copy numbers (doi.org/10.1099/mgen.0.000177). For this reason, we extend the concept of “single-copy” genes to include those that have only a few duplicates.

      (4) It is stated in line 127 that TcS have particular high heterogeneity - it does not look that way by eye compared to the other multigene families. Can statistic be used to prove this, or simply state the decision was made to focus on the TcS?

      As noticed by the reviewer, all multigene families show significantly higher heterogeneity compared to single-copy genes, as stated in the text and shown in figure legends from Figure 2, Supplementary Figure 1 and the new Supplementary Table 2.

      That said, it was not the statistical results that guided our decision to focus on TcS, but rather their well-established biological relevance in T. cruzi. As suggested, we have now emphasized this rationale more clearly in the revised text (lines 160-167).

      Besides, recent work has shown that TcS genes exhibit a bimodal distribution of expression levels using bulk RNA-seq data, in contrast to core genes and other multigene families (doi.org/10.1038/s41467-025-64900-2, doi.org/10.1038/s41564-023-01483-y). This distinct regulatory behavior further justifies our decision to examine TcS separately.

      (5) Expression of different TcS has been investigated between the different life cycle stages for a few individual genes previously (Freitas et al). Can the authors not extend this investigation to all the genes detect by scRNA-seq here to demonstrate those with higher/lower expression in amastigotes vs trypomastigotes building on Figure 2A? Are particular groups linked to either stage?

      We performed this analysis and did not observe any correlation between TcS groups and life cycle stage. In all cases TcS were more frequently detected in trypomastigotes. This difference was statistically significant for all groups except group VII, likely due to the low number of genes analyzed in this group (Author response image 3).

      Author response image 3.

      Per-gene number of expressing cells by TcS group and life-stage. Boxplots show, for each TcS group (I–VIII), the distribution across genes of the number of cells in which the gene is detected. Each point represents a single TcS; Amastigote cells: green points/boxes, Trypomastigote cells: salmon points/boxes. The y-axis is on log10 scale. Asterisks indicate statistically significant differences from the comparison between Amastigote and Trypomastigote within each TcS group, assessed using a paired two-sided Wilcoxon signed-rank test: * p < 0.05, ** p < 0.01, *** p < 0.001.

      (6) What exactly is the Z-score shown in Figure 2B?

      In this analysis num_multigene represents the number of multigene family genes detected in each individual cell. For every cell, we counted how many genes from our predefined multigene family gene list has detectable expression (more than zero UMI counts); in the UMAP plot, this value is reflected by the size of each point. On the other hand, z_multigene captures the relative expression level of multigene family genes within each cell. This metric is calculated by summing the UMI counts of all multigene family genes per cell and then standardizing this value across the dataset using a z-score transformation, such that positive values reflect above-average multigene family expression and negative values reflect below-average levels. In the UMAP plot, this metric determines the color scale of each point. Taking together num_multigene and z_multigene allow us to distinguish cells that express multigene family genes broadly (high gene counts), strongly (high relative expression), both, or neither, and to relate these patterns to identified cell populations.

      We included a short description in legend of the new version of Figure 2 (lines 176-180).

      (7) For the reclustering of trypomastigotes based on TcS genes alone, please show the UMAP and discuss why the resolution giving two clusters is chosen? I assume increasing the resolution does not reveal clusters of cells express one of the 8 groups of TcS for example?

      We appreciate the reviewer’s suggestion. In this analysis, our goal was to test whether the phenotypic heterogeneity previously reported in trypomastigotes could be recapitulated using TcS genes alone, as prior studies described two major transcriptomic phenotypes within this stage.

      Increasing the clustering resolution did not reveal subclusters corresponding to the eight TcS sequence groups. This might reflect the fact that these groups are defined based on sequence similarity rather than on expression patterns, as noted by Freitas et al. (doi:10.1371/journal.pone.0025914).

      (8) In Figure 4B, there may be an upward trend in the level of expression and the number of cells a transcript is detected in? It would be worth showing this is or is not the case with statistics if possible.

      The number of genes detected in a high proportion of cells is low, which limits the statistical power of this analysis. Also, substantial dispersion is observed within the 0-5% interval. Nevertheless, this figure is presented primarily to highlight that a considerable number of highly expressed genes are detected in only a small fraction of cells. If expression level were the main determinant of detection frequency across cells, one would expect very few highly expressed genes to fall within the 0-5% interval. Contrary to this expectation, among the 50 highest expressed TcS genes, 62% are detected in fewer than 5% of cells, and even among the top 10 most highly expressed TcS genes, 40% fall within this lowest detection group. To facilitate this interpretation, we modified the figure (new Figure 4b) to explicitly highlight the top 50 most expressed TcS genes and incorporated this discussion into the main text of the revised manuscript (lines 244-251), making the conclusion clearer to the reader.

      (9) Do the cells group instead by expression of any of the other multigene families not investigated in detail?

      It is possible that additional transcriptional substructure among trypomastigotes is driven by the expression of other multigene families beyond TcS. In this short report (with limited number of figures, words, etc.), we focused specifically on the trans-sialidase family as discussed earlier. A more comprehensive analysis including other large surface gene families (MASPs, mucins, GP63) is planned as part of ongoing work and will be presented in future reports.

      Reviewer #2 (Recommendations for the authors):

      This reviewer suggests the conduction of functional experiments in follow-up studies to establish links between TcS expression profiles and parasite behavior and into potential regulatory mechanisms responsible for the observed TcS heterogeneity, particularly focusing on epigenetic modifications. It would be interesting to correlate the highly expressed TcS members identified here with previously characterized TcS isoforms and provide more description regarding which particular groups and TcS members are driving the findings. It would benefit from further clarification regarding sequencing depth, technical replication merging, subsampling, and specific parameters for alignment methods and more information regarding the specific statistical tests and their applicability to the data.

      This is a promising single-cell study with potentially high significance. The manuscript is well-written, and the analyses are reasonably well-executed. However, the current manuscript is limited by a lack of functional validation and mechanistic insights. The addition of further analyses and experiments, as suggested, will strengthen the conclusions and increase the impact of the work.

      We thank the reviewer for their careful reading of the manuscript. As suggested, we have performed additional validation and clarification of the results, as well as a more explicit discussion of their limitations. In addition, we have included a preliminary analysis exploring potential mechanisms that could be coordinating the observed expression patterns of the TcS family (see below). Even though we consider relevant and interesting to experimentally validate these results, given the inherent difficulties in studying multigene families in T. cruzi, an organism with a very limited set of molecular biology tools (such as RNAi), further experimental validation of these observations is outside of the scope of this short report.

      Regarding the reviewer’s question, we studied if any TcS subgroup could be driving our observations. However, we did not find any correlations indicating that a particular group was associated with any of our findings. We now include TcS group information to Supplementary Table 3.

      Regarding technical details, we now included the total number of mapped reads (line 422) and average number of reads mapped per cell (new paragraph in the Methods section, line 432-436).  

      The technical replicates consist of a single Illumina library that was sequenced in two separate runs. As this approach is expected to be highly reproducible, we merged both runs into a single count table, as stated in line 424. To support this decision, we assessed the concordance between the two sequencing runs and observed an almost perfect correlation between them (Author response image 2).

      The subsampling method was originally described in the Figure 2 legend; to better highlight this approach, we have now moved its description to the Methods section (line 456).

      The specific kallisto parameters used are stated in Methods (line 418-419). We now included that default options were used unless otherwise specified (line 419-420).

      In response to the reviewer’s and editorial team’s request for additional mechanistic insight into the regulatory processes that may be involved in the observed patterns, we have expanded the revised manuscript to discuss how the genomic context of TcS loci could contribute to the observed heterogeneity in TcS expression. As noted in the original version of the manuscript, TcS genes and other surface-protein gene families are largely partitioned into discrete genomic compartments, whose expression has been reported to be regulated by epigenetic control of chromatin-folding domains (doi.org/10.1038/s41564-023-01483-y). However, we previously showed that TcS genes detected in a high proportion of cells are, in most cases, dispersed throughout the genome, arguing against a model in which their preferential expression results from colocalization within a small number of ubiquitously activated chromatin domains. In response to the reviewer’s suggestion, we performed a more detailed analysis of the genomic locations of these TcS genes. We found that many of them are localized within the core compartment (new Figure 5). Because the core compartment is enriched for conserved, housekeeping genes that typically display more constitutive expression (doi.org/10.1038/s41564-023-01483-y), whereas the disruptive compartment is enriched for lineage-specific multigene families associated with variable, stage-specific, and recently reported stochastic expression (doi.org/10.1038/s41467-025-64900-2), our results are consistent with a model in which compartment-specific regulatory mechanisms (in addition to post-transcriptional regulation) influence the differential cellular expression of core- versus disruptive-located TcS genes. We have incorporated these results and discussion in line 301-313 of the revised manuscript.

      Reviewer #3 (Recommendations for the authors):

      (1) The authors consistently refer to gene "expression" but somewhere they should acknowledge that in trypanosomes RNA abundance is less predictive of protein than in most other organisms.

      We thank the reviewer for this important comment, highlighting a central challenge when studying trypanosomatid biology. We acknowledge that in most eukaryotes and particularly in T. cruzi, where there is a predominant role of post-transcriptional regulation, mRNA levels are not always directly correlated with protein abundance, as previously reported by us and others (10.1186/s12864-015-1563-8, 10.1128/msphere.00366-21, 10.1590/S0074-02762011000300002, 10.1042/bse0510031). Nevertheless, steady-state transcript levels obtained by RNA-seq remain informative for assessing differential gene expression, and this approach has been widely used as a proxy for the study of gene expression profiles in T. cruzi (10.7717/peerj.3017, 10.1371/journal.ppat.1005511, 10.1016/j.jbc.2023.104623, 10.3389/fcimb.2023.1138456, 10.1186/s13071-023-05775-4).

      It's also interesting to note that recent proteomic analyses (10.1038/s41467-025-64900-2) have revealed substantial heterogeneity in the expression of surface proteins, including trans-sialidases, supporting the idea that the transcriptional heterogeneity we observe reflects a genuine biological feature that propagates to the protein level.

      We have now added a sentence to the discussion acknowledging this limitation and discussed the results from Cruz-Saavedra, et al. in linea 266-271 of the revised manuscript.

      (2) Line 29, in the abstract there is a strong statement that T. cruzi "does not employ antigenic variation". I don't think there is much evidence either way if we are thinking about antigenic variation in the broad sense rather than the extreme model of T. brucei VSG switching. Later in the abstract they state that "no recurrent combinations of TcS genes were observed between individual cells in the population", which sounds very much like a form of antigenic variation.

      We agree with the reviewer. Indeed, we meant to state that T. cruzi does not employ an antigenic variation mechanism such as the one from T. brucei. We change this statement as suggested in lines 28 - 32.

      (3) Line 29, "relies on a diverse array of cell-surface-associated proteins encoded by large multi-copy gene families (multigene families) essential for infectivity and immune evasion" and lines 55-58 "T. cruzi infection relies on a heterogeneous set of membrane proteins, encoded mainly by large multigene families ... most of which are involved in infection, tropism, and immune evasion". It would be worth adding a bit more detail on the nature and strength of the evidence that Tc "relies on" these various genes or that they are "essential" for infectivity, tropism, and immune evasion.

      Because the journal’s short format imposes word limits, we strengthened the original statement by adding specific references that document genomic, transcriptomic and functional evidence linking the major multigene families to infectivity, tropism and immune evasion (doi.org/10.1371/journal.pone.0025914; doi.org/10.1038/nrmicro1351; doi.org/10.1128/iai.05329-11; doi.org/10.1093/nar/gkp172, doi.org/10.1371/journal.ppat.1006767), in line 77.

      (4) Line 89, 1088 genes detected per cell - what is this as a % of genes in the genome?

      We detected a mean of 1088 genes per cell. Based on the 15,319 annotated protein-coding genes in the reference genome, this represents 7.1% of the T. cruzi protein-coding gene complement detected in each cell.

      Across the entire dataset, a total of 14,321 genes were detected in at least one cell, representing 93.5% of all annotated protein-coding genes. This suggests that our experiment captured a broad representation of the parasite's transcriptome.

      This per-cell detection rate is characteristic of droplet-based scRNA-seq and is consistent with other trypanosomatid studies. For example, the T. brucei single-cell atlas (Hutchinson et al., 2021) reported a median detection of 1052 genes per cell. In the case of T. cruzi, the recently published pre-print of the T. cruzi single cell atlas from Laidlaw & García-Sánchez et al. reported a mean between 298 and 928 genes detected per cell (depending on the sample).

      This information is now included in Methods (line 435).

      (5) Line 93-94, how many cells were assigned to clusters 0 and 1?

      Cluster 0 had 2201 cells and cluster 1 had 824 cells assigned.  We have now included these specific numbers in new version of the manuscript (line 114).

      (6) Line 96, cluster 2 ama-trypo transitioning parasites - were these observable by microscopy?

      We did not perform microscopy specifically to observe or quantify the putative ama/trypo transitioning subpopulation: microscopy was only used as a pre-experiment quality check to verify cell morphology and viability. The inference that cluster 2 reflects ama/trypo transitioning parasites is drawn from the transcriptomic profile (particularly from the pattern of stage-associated marker expression observed in that cluster) and should be considered a hypothesis generated by the data, that merits further analysis, as stated in the manuscript.

      (7) Line 106-107, "As expected, single-copy gene expression is high in both amastigotes and trypomastigotes and similar on average between both cell types".

      (8) Why as expected? For a broad journal it would be useful to explain this. Amastigotes are replicative and trypomastigotes are not, so would we not expect to see some differences that reflect this?

      (9) What do you mean by the expression being "high"? High compared to what?

      (10) "Similar on average between both cell types". This does not seem concordant with Figure 1a showing a highly significant difference between ama and trypo.

      We thank the reviewer for this helpful request for clarification for broader readers and the observations regarding global expression of single copy and multigene family genes.

      Figure 2a is intended as an experimental control where we show that our 10X Genomics data shows the previously reported upregulation of surface protein genes in trypomastigotes. We have now modified the text in order to highlight this (line 129). In turn, Supplementary Figure 1a is shown as a control that this upregulation is not a general feature of trypomastigote cells.

      Regarding comment 9, what we meant is that single-copy genes display relatively high expression in both amastigotes and trypomastigotes compared with surface protein-coding genes (see expression values in Figures 2a and Supplementary Figure 1a).

      Finally, differential expression between amastigotes and trypomastigotes at the transcriptomic level has been previously studied and has shown that most single copy genes do not show variation, explaining the overall pattern of Supplementary Figure 1a where average expression is similar between stages (mean fold change = 1.1). This is likely due to the fact that these genes are related to basic cellular functions. Genes related to stage specific functions such as replication in amastigotes or normalization effects may be causing the slight, but statistically significant increase observed in overall expression in amastigotes. This contrasts with the pattern observed for multigene families where there is a clear overexpression in trypomastigotes (mean fold change = 1.5).

      As observations commented on questions 9 and 10 have been described in previous studies and are not novel nor key points in our results, we decided not to focus on them and modified the text accordingly in lines 129-135.

      (11) Line 110, "with high variation". What does "high variation" mean here? Compared to what? For the two metrics (n cells +ve for each gene and total expression level) can they give an average and the SD? It would be useful to know how many parasites the "average" surface (and core) gene is expressed in, or more precisely for which the RNA is above the limit of detection.

      We refer to the comparison with the expression profile observed for single-copy genes. This point has now been clarified in the text, and we have included the mean and standard deviation for both TcS multigene family genes and single-copy genes in trypomastigotes for both metrics in the Figure 2 legend. The average and distribution of the number of cells in which each gene is detected are shown in Figure 2c and Supplementary Figure 1a. We also added a reference to this panel at the point in the text where the phenomenon is first described.

      (12) Line 134, Figure 2b legend needs more detail - what are num_multigene and z_multigene?

      Please see our response to Reviewer 1, Question 6. We have now added a clarification to the legends of Figure 1 and Supplementary Figure 1.

      (13) Figure 2c, correct the y-axis legend because it implies your values are log10 transformed. Also, it would be useful to have more markers on the y axis so the reader can better estimate the data ranges.

      We thank the reviewer for this observation. We have now corrected the y-axis label and markers.

      (14) If the y-axis of Figure 2D started at 0 instead of 0.8 and if Lorenz curves were provided then the reader would probably get a fuller sense of the expression heterogeneity in the dataset. The legend states the differences are statistically significant but the actual p-values are not shown.

      (15) Line 142-3, more precision is needed on the p-values.

      We thank the reviewer for this helpful suggestion. We agree that Lorenz curves provide a clearer representation of expression heterogeneity than the previous plot. Accordingly, we have replaced the original panel (Figure 2d) with Lorenz curves for the groups under comparison, and have made the same change in Supplementary Figure 1d. In addition, we have included gini index values and p-values for all comparisons in Supplementary Table 2.

      (16) Figure 3, as in Figure 1a it would be useful to add another UMAP plot to show the two trypo subpopulations.

      We thank the reviewer for this suggestion. We have now updated Figure 3 to include a UMAP plot showing the two trypomastigote subpopulations.

      (17) What is the observed proportion of broad vs slender trypomastigote morphologies for Dm28c? To be consistent with the speculation at line 162 then wouldn't it need to be approximately 50-50?

      The proportions of each trypomastigote subpopulation in the DM28c strain are currently unknown. The only available relevant data come from Brener, 1965 (doi.org/10.1080/00034983.1965.11686277), in which this strain was not included. In the strains analyzed in that study, the relative proportions of broad and slender trypomastigote morphologies were highly variable: across seven strains, broad forms ranged from 18.0% to 77.3%, while slender forms ranged from 2.3% to 71.6%. Given this wide variability and the lack of DM28c-specific data, we cannot assume any expected proportion for this strain.

      (18) Line 170, please state how many genes are in the TcS subgroup mentioned here. This is an interesting finding - does this include mostly catalytically active trans-sialidase genes or is it a mixture from across all the subfamilies?

      The TcS subgroup with a high frequency of detection comprises 31 genes, none of which belong to the catalytically active Group I trans-sialidases. Instead, this subgroup includes members of Groups II, III, IV, V, VI, and VIII. This information has been added to Supplementary Table 3 and is now stated in the revised manuscript (lines 227 - 228).

      (19) Line 175-176, "Gene dropouts might favor random patterns of gene family's detection in scRNA-seq experiments, particularly affecting genes with low expression" - I'm not sure if the authors mean the detection of a gene (or not) in an individual parasite is truly random (pure luck) or whether the term stochastic would be more appropriate because they seem to be referring to randomness around a certain threshold of RNA abundance/stability? They go on to rule this out, at least for TcS genes, essentially arguing that they have something resembling an ON or OFF pattern rather than a spectrum of expression levels. This is potentially very important and could advance the field in a major way, but the fact that so many core and ribosomal genes, which 'should' be always ON, cannot be detected in most cells is a concern. A version of Figure 4B for core and ribosomal genes could be informative - do they show a different pattern to TcS?

      Our results reveal a small subset of TcS genes that are frequently detected across cells, a pattern that is not compatible with random detection unless these genes were highly expressed and preferentially captured by random sampling. However, as shown in Figure 4b, many genes expressed at comparable levels are not detected at high frequencies. In line with this, Figure 4c shows that within individual cells, the detected TcS genes exhibit similar expression levels. Finally, we confirmed that this frequently detected subset shows high read counts at the bulk RNA-seq level (Supplementary Figure 2), consistent with the fact that these TcS are frequent in the population even when they are not specially highly expressed within each cell. Taken together, these findings argue against a purely random sampling of TcS genes and support the interpretation that this pattern reflects an underlying biological feature. We agree that further validation will be required. Accordingly, since the initial submission, we have been careful to frame our conclusions conservatively, explicitly noting that dropout remains a limitation of these data that could influence the observed patterns. In the revised version, we have strengthened this point by including a specific statement in the final remarks. Our interpretation is presented as a working hypothesis that is fully compatible with the observations reported here and may be informative for the field. To better reflect this reasoning, we have revised Figure 4b, expanded the discussion, and explicitly included this limitation in the final remarks of the revised manuscript.

      (20) Line 238-9, Add details of removing extracellular epimastigotes after cell infections.

      Only cellular trypomastigotes collected from the supernatant on day 6 were used for the secondary infection, at a 10:1 parasite-to-cell ratio. After 24 hours, the cultures were washed twice with PBS to remove any remaining extracellular parasites. Under these conditions, i.e. using exclusively trypomastigotes, at this infection ratio, and maintaining the cultures in mammalian medium, we do not expect the presence or survival of extracellular epimastigotes. We have included a sentence in the Methods section clarifying this information in the revised version of the manuscript, line 382.

      (21) Line 260, was methanol used to directly resuspend the parasite pellet, or was it resuspended first e.g. in a small volume of PBS?

      As described in lines 250-257 of the original manuscript, parasites were washed and resuspended in DPBS before methanol fixation. Methanol fixation was then carried out according to the 10X Genomics Methanol Fixation Protocol. We have now emphasized this more clearly in the revised text in line 400.

      (22) What was the doublet rate?

      We identified and removed 41 doublets, all belonging to cluster 2, and retained 3,151 singlets for downstream analysis (total cells before removal = 3,192). The resulting doublet rate was 1.28%. We have included a sentence in the Methods section clarifying this information in the revised version of the manuscript, line 439 -440.

      (23) What was the frequency of rRNA and kDNA-derived reads?

      Approximately 4.02% of the reads were derived from kDNA sequences, while 1.10% corresponded to rRNA-derived reads (Author response image 4).

      Author response image 4.

      Percentage of mitochondrial and ribosomal rRNA derived reads.

    1. Author response:

      Reviewer #1 (Public review):

      We thank the reviewer for the thoughtful and detailed evaluation of our manuscript. We are pleased that the continuous-time formulation and its methodological contributions were viewed as elegant and broadly applicable, and that the empirical analyses provide meaningful new insights into neural variability across the visual hierarchy. We appreciate the reviewer’s constructive suggestions and clarifications, which will help us improve the precision, clarity, and scope of the manuscript. Below we respond to each point in turn and outline the revisions we will make.

      (1) Extension to neural populations: We thank the reviewer for this important suggestion. We agree that extending the framework to population recordings is a natural next step. In this work, we focus on single-cell data to establish the model and validate inference. In the revised manuscript, we will expand the Discussion to outline how the framework could be generalized to population activity, for example by incorporating shared latent-variable structure.

      (2) Clarification regarding the Modulated Poisson model: We thank the reviewer for pointing this out. We agree that our description was not sufficiently precise and may have been unclear. The modulated Poisson model introduced in Goris et al. (2014) is indeed a generative process model that can be used to generate spike trains, and we apologize for the inaccurate characterization of this framework. Our intended point was that the original formulation assumes gain is constant within a trial (or counting window) and does not provide a principled mechanism for modeling continuously time-varying gain fluctuations within trials. In the revised manuscript, we will clarify this distinction and revise the relevant passages accordingly. We will also cite and discuss related extensions and analyses in Goris et al. (2018) and Hénaff et al. (2020) to provide a more accurate and complete characterization of prior work.

      (3) Continuous extensions of the Goris model: We thank the reviewer for this helpful clarification. We agree that the Goris model is not limited to homogeneous Poisson spiking and can incorporate a stimulus-dependent, time-varying firing rate within trials. We did not intend to imply otherwise, and we will revise the relevant text to avoid this misunderstanding. Our intended point was that, in formulating continuous-time extensions, we explicitly model the time-varying stimulus drive using a GP prior, as in the CMP framework, and then consider different assumptions about the temporal structure of the gain process, including constant and finely sampled gain. This highlights the distinction between piecewise-constant gain assumptions and the fully continuous gain process introduced in our model. We will clarify this distinction in the revised manuscript. We will also acknowledge related variants explored in Hénaff et al. (2020) and more clearly describe how our formulation differs, including the role of smoothness priors on the stimulus drive and gain processes.

      (4) Continuous-time extension: We thank the reviewer for the positive comment and are pleased that the continuous-time formulation was viewed as elegant.

      (5) Parameter recovery analysis: We thank the reviewer for emphasizing the importance of this result. We agree that demonstrating parameter recoverability is foundational to the paper. In the revised manuscript, we will move the Appendix 3 analysis into the main Results section and clearly illustrate how our inference procedure faithfully recovers the generative parameters in simulation studies.

      (6) Validation of gain–stimulus separation: We thank the reviewer for this insightful suggestion. We agree that verifying that the inferred gain does not capture stimulus-driven structure is an important validation of the model. In the revised manuscript, we will compute the trial-averaged inferred gain, to assess whether it exhibits systematic temporal structure. This analysis will provide an additional check that the partitioning between stimulus drive and gain fluctuations operates as intended.

      (7) Temporal evolution of gain variability: We thank the reviewer for this valuable suggestion. We agree that examining whether gain variability decreases following stimulus onset is an important and relevant analysis. In the revised manuscript, we will compute the temporal evolution of cross-trial gain variability from the inferred gain traces and assess whether a quenching effect is observed after stimulus onset. If present, we will report and illustrate this result.

      (8) Clarification of Baseline Poisson and Poisson-GP models: We thank the reviewer for this careful reading. Yes, this understanding is correct. The Baseline Poisson model uses a stimulus-conditioned PSTH as an estimate of the time-dependent firing rate and includes a Gamma prior to regularize rate estimates in conditions with sparse repeats. The Poisson-GP model retains the same structure but models the time-dependent firing rate using a stimulus-specific Gaussian process prior, which substantially improves goodness-of-fit. In the revised manuscript, we will clarify this description. We will also highlight that Figure 4 – figure supplement 2 illustrates how introducing a GP smoothness prior on the stimulus drive markedly improves model fit, even within the Goris-style model.

      Reviewer 2 (Public review):

      We thank the reviewer for the thoughtful and positive assessment of our work. We are pleased that the model development, empirical analyses, and presentation were found to be clear and rigorous. We appreciate the recognition that the continuous-time formulation meaningfully extends prior variability-partitioning approaches and enables a more precise characterization of how stimulus drive and internal gain dynamics evolve across temporal scales. We are also encouraged that the cross-area analyses and model comparisons were viewed as providing new insights and clear empirical improvements. Below, we address the specific suggestions raised by the reviewer.

      Positioning relative to prior work: Regarding the comment on incremental contribution, we agree that our framework builds directly on earlier variability-partitioning approaches. Our goal was to extend these models to continuous time and to develop a principled inference framework capable of characterizing how gain dynamics evolve across temporal scales. We will further clarify this positioning in the revised manuscript.

      Extension to sub-Poisson variability: We thank the reviewer for this suggestion. We agree that sub-Poisson variability is an important phenomenon observed in neural data. Because the CMP model builds on a Poisson observation model with stochastic gain modulation, it naturally captures Poisson and super-Poisson variability but cannot generate sub-Poisson spike count statistics in its existing form. We will clarify this limitation in the revised manuscript and expand the Discussion to outline potential extensions that could address sub-Poisson variability, such as incorporating spike-history effects, renewal-process models, or alternative count distributions.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      …It is unclear whether there are any systematic changes in preferences over the course of testing that could explain the observed changes in correlation with neural responses, such as changes due to learning (e.g., flavor nutrient conditioning, relief of neophobia), changes in deprivation state, or habituation to/proficiency with the BAT setup.

      For the revision, we will add analysis (including either additional panels for Figure 3 or as a new Figure between what are now Figures 3 & 4) testing the hypothesis that preference changes across testing days are non-random. Concretely, we will test: 1) whether the preference for palatable tastes increase with experience (a result that would make sense given research on neophobia; 2) whether the preference for aversive tastes decrease with experience; and 3) whether absolute consumption of any particular taste changes in a reliable direction from session to session.

      A secondary point is whether any changes in preference are attributed to internal individual versus external contextual factors. Both types of variation (i.e., across individuals and across time within an individual) are mentioned in the introduction, but it is not clear what the authors believe about the nature or neural representation of these sources of variation.

      While we assume that differences between rats are due to internal factors (given the controlled home-cage environment), we can’t be sure that some subtle, subthreshold (for us as observers) factor impacts taste preferences. Similarly, while changes across time within an individual is categorically within the individual, we cannot be sure whether some subtle facet of their experiences determines how preferences change (as opposed to it being purely internal). We will add prose to the Discussion session on this topic—including citation of Hilary Schiff’s recent work showing nurture-related preference changes as part of this new prose.

      With respect to neural data analysis, no individual animal/day data are shown, making it difficult to assess the extent to which differences in correlation match individual differences in preferences and/or changes in preference with time within individuals.

      The revision will include Figure panels (with analysis) showing the relationships between individual neural responses and consumption in the first and last BAT tests for 1-2 representative rats.

      The correlation analysis is also lacking control for the fact that there is a certain degree of "chance" associated with behavioral and neural measures having matching ranks.

      Certainly chance cannot explain our results, which consist mainly of within-rat differences in match (i.e., specific enhancement of that match for the most recent behavioral assessment)—a finding that is all the more surprising given that: 1) 2 weeks separate that behavior test and the electrophysiology session; and that 2) that 2-week gap is only 1-3 days less than the gap using the first behavioral test (that reliably correlates less well with the neural data). Nonetheless, we will add an independent, convergent analysis to the revision, testing whether the observed pattern vanishes when we shuffle the preference ranks in the behavioral data—if the result is based on chance, this shuffling should have no impact on the neural-behavioral match.

      Finally, …it is unclear to what extent changes in correlation may be attributed to overall changes in responsiveness of the neural population.

      We will include a new analysis in the revision testing the hypothesis that the reduction in match between the neural and behavioral rankings reflects changes in neural excitability—spontaneous and taste-driven—between the first and second electrophysiology sessions.

      Reviewer #2 (Public review):

      The manuscript could use additional corollary analyses to provide a more complete picture of the phenomenon. For instance, how many neurons (per animal and in total) have significant correlations with the final BAT patterns? And with the first BAT? Can a time course of such counts be provided? Can some decoding analyses be performed at a single session level to reconstruct a rat's behavioral preference pattern from its neural activity?

      These are all really good ideas. We are in the process of implementing all but the last; we will attempt the last as well, but can’t promise that we have large enough ensembles to provide stable results of such a subtle decoding task (reflecting the last BAT session’s preference pattern significantly better than the first session’s pattern).

      The manuscript could benefit from additional polishing, both in the text as well as in the figures.

      It is being done, on the basis of suggestions made by R2 in the non-public comments.

      Reviewer #3 (Public review):

      Without a behavioral measure collected after recording day 1 intraoral exposure, it is not possible to determine whether taste preference was altered by that experience…The authors' conclusion would be strengthened by adding an intervening brief access test between recording days 1 and 2.

      We very much appreciate Reviewer 3’s suggestion, but the primary authors involved in data collection on this project have moved on, and we won’t be able to collect the additional dataset that would be required. Instead, we will soften the conclusion that we reach in the last section, and suggest this experiment as a future direction.

      The current experimental design exposes animals to 3 distinct sets of substances … [that] differ in identity … and concentration. Because palatability is known to be comparative depending on the other substances available and concentration-dependent, this introduces challenges to interpretation, [and] without more clarity, it is difficult to evaluate whether the interaction of different tastes within the sets of stimuli biases the main conclusions.

      This is an interesting point. We hope that some of the work that we are undertaking in response to Reviewers 1 & 2 (see above) will shed light on whether there is any non-randomness in between-session preference changes; such non-randomness would imply that we might want to conclude that preferences change more with one battery than another. But we will perform a more direct test of this hypothesis, breaking the dataset apart and asking whether our phenomena are observed more with one battery than another. If it turns out that the magnitude of the impact of experience does depend on the nature of the taste battery (we predict not, for reasons that are in the manuscript), we shall introduce that complexity into our interpretation, and the Discussion thereof.

      Responses to sweet tastes are not reported in the electrophysiology data. This is seemingly the case because rats given set 1 received no sweet stimulus while rats given set 2 received to 2 distinct sweet tastes. Finally, rats given set 3 did not receive quinine, yet quinine is reported in electrophysiology data.

      We are unsure of the source of this confusion—in every case, the rat received the same tastes in the electrophysiology sessions that were delivered in the BAT preference tests—but we will modify the text to ensure: 1) that panels reflecting data from a single rat (panels that will therefore necessarily include only a subset of possible tastes) are clearly marked as such; and 2) that the nature of which taste batteries were delivered is more explicit.

      The choice of reporting average lick cluster size is problematic because the authors use thirsty rats with 10-second-long trials. Thirsty rats are likely to lick in relatively long clusters, especially for neutral and palatable tastes. If the rat is mid-cluster when the trial ends, the final cluster would be cut off prematurely, resulting in shorter overall average lick cluster size, disproportionately affecting neutral and palatable tastes over aversive tastes.

      We have ourselves been deeply concerned with this issue; we have recently published a paper that includes within it a direct test demonstrating that calculations of lick bout lengths from 10-sec BAT trials result in taste palatability estimates that are identical to (and less noisy than) those generated from more classically-used 15-min ad lib licking. We will cite this paper (Lin, et al., 2026) in the Methods section of the revision, along with text clarifying how we calculated lick clusters. That said, we are also planning to conduct an additional analysis that estimates taste preference after removing these “premature bouts” and will evaluate how this recalculation affects our results.

      Of course, even if 10-sec BAT trial data DIDN’T provide reliable preference measures, the result of clusters being cut short by the end of a trial would be an underestimation of the preference for the palatable tastes (which drive far more licking than aversive tastes and are therefore more likely to be mid-bout at the end of a trial). Such an underestimation would in turn be expected to reduce the observed neural-behavioral correlation. This fact actually highlights the robustness of our findings.

      Canonical palatability rankings may not apply to the concentrations selected in every stimulus set. This is particularly true for set 1, which included two concentrations of citric acid and quinine for the behavior. It is also not clear which concentrations are reported in Figures 3A2 and 3B2. Meanwhile, the concentrations of quinine and citric acid used for electrophysiology are quite low.

      In the revision Methods section, we will explicitly motivate our reasoning behind canonical rankings for each taste battery used (the added text will include citations). We have also added to the Discussion section prose concerning the possible impact of possibly getting those rankings wrong—i.e., the impact is minimal, given that our results are largely driven by differences between rats (and day-to-day differences within rat), and the resultant fact that almost any choice of canonical rankings would poorly reflect the behavior of individual rats on individual days.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors provide extensive immunoreactivity and expression data to map monoaminergic neurotransmitter production sites in Pristionchus pacificus. This nematode is relatively distantly related to the popular model nematode Caenorhabditis elegans, for which such information is already available. They find that dopamine, tyramine, and octopamine are present in the same neurons in both species, but differences are observed for serotonin. This forms the basis for a comparison of serotonergic neurons across 22 nematode species. In addition, they evaluate monoaminergic effects on egg-laying, head movement during reversals, and nictation behavior, to find that monoaminergic control over the latter differs between C. elegans and P. pacificus. This shows that some anatomical flexibility supports similar outcomes, whereas in other cases it is the basis of evolved regulatory differences.

      Strengths:

      The comparative efforts are laudable and valuable, including a thorough revisiting of old data and corrections of what is judged as a historic misannotation. The expected continued value of this work is also appreciated, because nematodes have similar anatomies and behaviors, cellular-resolution data of different species permits the study of functional evolution of neurotransmitter usage in homologous neurons.

      Despite the strong experimental approach, there are some points that require addressing:

      (1) Not all the concepts of the introduction ('feeding behaviors', to a lesser extent also 'evolution of neurotransmitter usage in homologous neurons') are followed up upon in the results or discussion sections.

      We will address the relative treatment of particular topics in the introduction and discussion in a revised version of the article.

      (2) The choice of nematodes ('only' 13 species) may affect what is perceived as ancestral.

      See above regarding ‘13 species’ (actually 22). Most species and genera were specifically selected previously (Loer and Rivard, 2007; Rivard et al., 2010) for broad phylogenetic coverage, representing different species and genera in 4 major clades within ‘clade V’ (Kiontke et al., 2007; Sudhaus, 2011): Anarhabditis (Caenorhabditis, including both the Elegans and Drosophilae species groups), Synrhabditis (Oscheius, Metarhabditis, Reiterina and Rhabditella), Pleiorhabditis (Teratorhabditis, Mesorhabditis, Rhomborhabditis and Pelodera), and Diplogastrids represented by P. pacificus. Among the outgroups to clade V, there are 3 distinct clades represented, each with at least two species and/or genera represented. Therefore, we believe that the determination of an ancestral condition is well-founded. We plan to add this rationale to the revised version to make this clearer.

      (2, continued) Also, identifying their cells based on comparisons with Ce or Ppa identifications only is understandable but mildly risky: there are many cells in the head, and mistakes would go unnoticed until detailed analysis in each species can provide conclusive evidence.

      We agree that there is a mild risk of incorrect identification but believe that appropriate caveats are noted in the text. Furthermore, the recent head EM reconstruction and complete embryonic cell lineage of the P. pacificus (Cook et al., 2025) shows a nearly 1-1 homology correspondence between head neurons (e.g., only a single head neuron is missing in the Ppa head relative to Cel due to altered apoptosis), and a quite high level of conservation of neurite morphology and soma position between Cel and Ppa suggests that identifications are likely correct when examining related nematodes. In cases for which a serotonin-immunoreactive cell is found in the predicted location (and often having apparent associated neurites), its homology to the matching Cel and Ppa cell is the most parsimonious interpretation: otherwise, one cell would have to lose expression and another nearby cell gain it.  

      (3) It is not reported whether the nictation-defective mutants have general locomotion defects; therefore, whether the reported problem is specific to this host-finding behavior or not.

      None of the mutants we tested for nictation behavior, including those that show severe defects in nictation (Ppa-cat-1, Ppa-tph-1, Ppa-tdc-1, Ppa-tbh-1), exhibited noticeable general locomotion defects either as dauers or non-dauers. Further clarification will be provided in a revised version of the article.

      (4) The section on RIP neurons makes sense for Ppa, but not for Ce (dauers in fact have weakened IL2-to-RIP connections) and should be revised. The nictation data also do not support the breadth of the conclusions, which should either be toned down or rephrased as hypothetical.

      We plan to address these concerns in a revised version of the article.

      (5) The discussion mostly reiterates the results, leaving little room for the author's interpretations and opinions. I would suggest reworking in favor of conceptual discussion.

      As noted above, we agree to address the relative treatment of matters in discussion in a revised version of the article.

      Reviewer #2 (Public review):

      Summary:

      This paper makes important contributions to our understanding of how nervous systems evolve, with a particular focus on whether changes in neurotransmitter usage within homologous neurons represent a mechanism for evolutionary adaptation without large-scale changes to circuitry. Comparing the predatory nematode P. pacificus with C. elegans, this study systematically examines monoamine-producing neurons, assesses how their neurotransmitter identities differ between homologous neural types, and determines how these differences relate to behavior.

      Strengths:

      The major strength of this work is its breadth, rigor, and data quality. It combines multiple, independent lines of evidence to assign neurotransmitter identity for neurons with homology grounded in lineage, morphology, and connectomics, which is essential for meaningful cross-species comparisons. Additionally, by extending the analysis beyond P. pacificus and C. elegans to other nematodes, the authors convincingly argue that features observed in P. pacificus likely reflect an ancestral state. This depth greatly enhances the significance of the conclusions.

      This work is likely to have a significant impact on the fields of comparative neurobiology and nervous system evolution. It demonstrates a powerful system and approach for linking molecular identity, cell-type homology, circuit context, and behavior across species. The data generated here will be a valuable resource for the community and provide a strong foundation for future mechanistic studies.

      More broadly, the study reinforces the idea that evolutionary change in nervous systems can occur through modulation of chemical signaling within conserved circuits, rather than through complete rewiring. This conceptual framework is likely to influence how researchers think about neural evolution in other systems.

      Weaknesses:

      Given the availability of detailed connectivity information for both species, a more explicit comparison of the local circuit context of key neurons would further strengthen the link between molecular identity and circuit function.

      We plan to address these concerns in a revised version of the article.

      Reviewer #3 (Public review):

      Summary:

      The study by Hong, Loer, Hobert, and colleagues is a comprehensive description of monoaminergic neurons in the nematode Pristionchus pacificus. The work used multiple, complementary approaches, including immunostaining and expression of genes involved in neurotransmitter synthesis or transport, to identify neurons that express a monoamine neurotransmitter. Moreover, this study characterized the phenotypes of various mutants to study their organismal function. Extensive comparisons are made to C. elegans, the nematode model that, in a way, anchors the model studied here, and new outgroup species were examined for some features so that the polarity of their evolution could be inferred. Although there is no simple or groundbreaking punchline to distill from the manuscript (i.e., other than some things are the same as in C. elegans, and some things are different), and while the study is basically descriptive in nature, the scope of the project warrants broad attention.

      Strengths:

      This manuscript offers a tremendous resource for those who use this species as a model, which, based on the author list alone, includes many labs. This study sets the bar for what can be done in a "satellite" model system.

      Given the complementarity of approaches used, such as the position of cell bodies, the connectivity and morphology of dendrites, and a previously published atlas of the connectome for this species, the identification of specific neurons (which, as the authors point out, can be easily mistaken) is convincing throughout. Likewise, appropriate caution is observed where neuron identities are ambiguous, e.g., unlabeled cells in Figure 5, or ambiguous identities in other species, as shown in Figure 10. There was a lot of data to unpack in this manuscript, but I could not find any obvious flaws in neuron identification.

      Also, the phenotypic assays were straightforward and informative.

      Weaknesses:

      No serious weaknesses were noted. One minor comment is that in general, I think the Methods could use some additional text to describe what the goal of any given technique was. For example, although there is a description of the HCR protocol in the methods, nowhere does it say what genes this method would be used for. In addition to what is shown in Figure 4, this information should be given in the Methods.

      More detailed methods will be provided in a revised version of the article.

    1. Author response:

      Public reviews:

      Reviewer #1 (Public review):

      (1) We agree that the current design does not allow us to cleanly dissociate whether the beneficial effect of retrieval practice on AC inference under stress reflects a selective enhancement of inferential processing or, instead, stronger memory for the underlying AB and BC premise pairs that supports later inference. We plan to revise the manuscript to remove wording that could be read as claiming that retrieval practice specifically protects inference independently of associative-memory strengthening.

      Our intended interpretation is more modest. As shown in Section 3.2.3, retrieval practice improved direct premise-memory performance, consistent with the well-established testing effect. In the present paradigm, successful AC inference necessarily depends on access to the AB and BC premise associations. Accordingly, strengthened premise memory is not an alternative explanation that can be excluded by our data, but rather a plausible mechanism through which retrieval practice may promote more resilient inference performance under stress.

      Because AC inference in our paradigm necessarily depends on retrieving and linking the AB and BC premise pairs, strengthened premise memory is not merely a competing explanation that can be separated from inference performance in the current dataset. Rather, it is a plausible mechanism through which retrieval practice may support inference, especially under stress. We therefore will revise the manuscript to avoid implying that retrieval practice protects inferential processing independently of associative-memory strengthening, and instead interpret the effect more conservatively as reflecting enhanced premise representations and/or more effective reactivation of bridge information during inference.

      We also agree that the post-inference direct memory test, which used a 2AFC format, provides only a coarse measure of premise-memory strength and allows some proportion of correct responses to arise from guessing. Therefore, restricting analyses to trials in which AB and BC were later answered correctly does not fully guarantee that those trials were supported by strong associative memories. We will acknowledge this limitation explicitly in the manuscript and have tempered our interpretation of these “successfully retrieved” premise trials accordingly. More stringent measures, such as cued recall, confidence-based memory judgments, or other continuous indices of premise-memory strength, would be better suited to this question in future work.

      Finally, we agree that the absence of a retrieval-practice benefit in the non-stress condition does not by itself rule out mediation through strengthened premise memory. Because the retrieval-practice manipulation was introduced in a follow-up study after completion of Study 1, the present dataset was not designed as a single fully crossed factorial experiment. In response to the reviewer’s suggestion, we will add an exploratory mediation analysis testing whether premise-memory performance statistically accounts for the relationship between retrieval practice and inference performance. We will report this analysis cautiously, given that premise memory was assessed using a post-inference 2AFC measure, and we note in the manuscript that a future fully crossed design with more sensitive premise-memory measures will be needed for a stronger test.

      (2) We apologize that the presentation of Figure 4A was not sufficiently clear and may have created the impression of below-chance inference performance. The values shown in Figure 4A do not represent raw 3-alternative forced-choice (3AFC) A-C inference accuracy, for which the theoretical chance level would be 0.33. Instead, Figure 4A plots a normalized inference index, calculated as inference performance relative to direct retrieval performance, to account for individual differences in the availability of the directly learned premise pairs. Therefore, the raw 3AFC chance level is not the appropriate reference for interpreting this measure. To avoid this confusion, we will clarify in the revised manuscript and figure legend that Figure 4A shows a normalized inference index rather than raw inference accuracy.

      (3) We agree that implementing retrieval practice in a separate experiment, rather than within a single 2 × 2 factorial design, limits the strength of the causal inference regarding retrieval practice and reduces our ability to formally test the retrieval practice × stress interaction within one unified design.

      In response, we will revise the manuscript to more explicitly acknowledge this limitation and to temper our interpretation throughout. Specifically, we now avoid overstating retrieval practice as definitively preventing the effects of stress, and instead describe the findings more cautiously as evidence that retrieval practice was associated with attenuation of stress-related inference impairments across experiments. We also will add a limitation statement in the Discussion noting that the current design cannot fully rule out cohort-related confounds and that a fully crossed factorial design will be necessary in future work to provide a more rigorous test of the interaction between retrieval practice and stress.

      At the same time, we have clarified that the two experiments were conducted under closely matched conditions: participants were recruited using the same protocol from the same campus population, demographic characteristics were matched, and both experiments were run in the same laboratory using the same EEG system, task procedures, and experimenter team. We agree, however, that these procedural consistencies reduce but do not eliminate the concern about between-experiment confounds.

      (4) We agree that the absence of a matched re-exposure/restudy control condition limits the mechanistic interpretation of the retrieval-practice effect. In the revised manuscript, we will make this limitation more explicit in the Discussion and temper our conclusions accordingly. Specifically, we clarify that the present design shows that a post-encoding retrieval-practice intervention buffered the impact of acute stress on later inference, but it does not allow us to determine whether this benefit is specific to retrieval practice per se, rather than to additional exposure to the AB and BC associations.

      We also agree that it is important to distinguish whether the effect operates at the level of specific practiced items or reflects a more global participant-level effect. In the current study, however, the retrieval-practice phase in Experiment 2 was implemented as a brief timed free-recall procedure rather than a trial-by-trial cued retrieval task, and the available records do not allow us to reliably link retrieval-practice success for individual associations to specific later AC inference trials. Therefore, we cannot directly compare later inference performance for successfully versus unsuccessfully retrieved items on a trial-by-trial basis.

      To address this issue as far as possible with the current dataset, we instead plan to conduct an additional item-level robustness analysis using mixed-effects models that accounted for variability across ABC associations. Specifically, we tested whether the critical stress-by-retrieval-practice effect remained after modeling triad-level variability, and whether there was evidence that this effect differed substantially across triads. This analysis does not provide a direct test of whether successfully retrieved items benefit more than unsuccessfully retrieved items, but it does help assess whether the observed effect is broadly distributed across associations or driven by only a small subset of items.

      (5) We agree that our current decoding approach does not justify a strong claim of item-specific reinstatement of a unique bridge memory. The classifier was trained to discriminate stimulus categories (faces vs. buildings) in the independent localizer and then applied during the inference phase. Therefore, the present analysis is better interpreted as indexing reactivation of bridge-related category information, rather than reinstatement of an item-specific episodic representation.

      Importantly, however, we believe this signal remains theoretically informative for the inferential process examined here. In our design, the bridge element B belonged to one of the trained categories, and the classifier was applied during the cue period when no face or building stimulus was physically present. Thus, successful decoding in this time window suggests that task-relevant bridge-related information was re-expressed online during inference, rather than reflecting concurrent perceptual processing. At the same time, we agree that, because only two categories were used, the decoding analysis cannot fully dissociate bridge-related category reactivation from broader category-level retrieval, strategic task differences, or attentional contributions.

      To address this concern, we plan to revise the manuscript in three ways. First, we will soften the interpretation throughout the Results and Discussion to avoid claims of item-specific bridge-memory reinstatement. Second, we now refer to the decoding effect more conservatively as bridge-related or category-level mnemonic reactivation during inference. Third, we have added an explicit limitation stating that the current design does not allow us to distinguish item-specific episodic reinstatement from category-level reactivation, and that future work using more fine-grained representational analyses and/or a larger stimulus set will be needed to resolve this issue more directly.

      Reviewer #2 (Public review):

      (1) We agree with this important point. The inference task was scheduled to begin approximately 20 minutes after stress onset based on prior human stress literature, with the intention of probing a time window commonly associated with glucocorticoid effects. However, as the reviewer notes, this period may also still reflect residual adrenergic/SAM influences. Because salivary cortisol was not collected due to the COVID-19-related safety protocol, we cannot disentangle the relative contributions of glucocorticoid and adrenergic responses to the observed stress-related effects on inference and neural reactivation. We will revise the manuscript to make this limitation more explicit in the Discussion and to avoid attributing the effects to a specific physiological component of the stress response.

      (2) In the revised manuscript, we will add asterisks (or equivalent significance annotations) to Figures 4 and 6 to improve clarity and readability.

      Reviewer #3 (Public review):

      (1) We thank the reviewer for highlighting this important reporting issue. We agree that the number of trials contributing to the behavioral and EEG analyses should be reported more explicitly, particularly because inference performance was analyzed in relation to direct retrieval performance and because direct retrieval differed across experiments.

      In the revised manuscript, we will report, for each group and experiment, the number of trials presented in the AC inference phase, the number of trials retained for the behavioral analyses, and the number of successfully retrieved direct-memory trials in the AB and BC tasks. These values will be summarized in the revised Results section and in Supplementary Tables.

      To directly address the reviewer’s concern, we will also compared trial counts across groups/experiments and evaluated whether differences in direct retrieval performance could account for the inference and EEG effects. To further address the concern about potential unequal trial numbers, we plan to repeat the analyses such as trial-count-matched subsets analyses to see whether results remained qualitatively unchanged.

      (2) We thank the reviewer for this important comment. We agree that our original title and some parts of the manuscript used language that was stronger than warranted by the data. Our results show that rapid reactivation of the bridge element is associated with successful inference and is modulated by stress and retrieval practice, but they do not by themselves establish a causal mechanistic role for reactivation. We therefore plan to revise the title and softened the relevant wording throughout the manuscript to better reflect the correlational nature of this evidence.

      Specifically, we plan to change the title from “Retrieval practice prevents stress-induced inference impairment by restoring rapid memory reactivation” to “for example, Retrieval practice prevents stress-induced inference impairment and preserves rapid bridge-item memory reactivation” We also revised the Abstract, Results, and Discussion to replace stronger mechanistic wording such as “prevents,” “restoring,” and “essential neural mechanism” with more cautious phrasing such as “buffers” or “attenuates,” “preserves” or “is associated with,” and “neural correlate” or “candidate process,” as appropriate. This revision will led us to temper the overall interpretation of the EEG findings: rather than claiming that reactivation is the mechanism by which retrieval practice prevents stress-related inference deficits, we now conclude that rapid bridge-item reactivation is a neural correlate of successful inference that is sensitive to stress and enhanced by retrieval practice.

      We also appreciate the reviewer’s concern regarding the use of one-tailed follow-up tests and the absence of multiple-comparison correction. With respect to the one-tailed t-tests, these follow-up comparisons were conducted because the relevant hypotheses were directional a priori. Based on prior work and our theoretical framework, we specifically predicted that acute stress would impair inference-related performance and neural reactivation, and that retrieval practice would mitigate these effects. The follow-up tests were therefore not exploratory post-hoc comparisons, but planned tests used to decompose the significant omnibus effects in the predicted direction. For this reason, we considered one-tailed testing appropriate for these comparisons.

      Similarly, we did not apply an additional multiple-comparison correction to these planned follow-up tests because they were limited in number, theory-driven, and conducted to evaluate specific directional predictions rather than to search broadly across many possible contrasts. Importantly, our interpretation does not depend on any isolated post-hoc comparison, but on the consistency of the results across behavioral inference measures, neural decoding of bridge-item reactivation, and theta-band analyses. We have revised the manuscript to make this rationale clearer and to ensure that the follow-up results are interpreted in the context of the full pattern of evidence.

      (3) We agree that, in the previous version, parts of the manuscript were not structured clearly enough, which may have made it difficult for readers to follow the logic of the study and the sequence of analyses without moving back and forth across sections. In the revised manuscript, we will reorganize the presentation to improve the overall narrative flow and readability. Specifically, we plan to clarify the study logic and analysis sequence, strengthened transitions between sections, and revised the relevant text in line with the #reviewer3’s detailed suggestions.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers and editors for their thoughtful comments, which substantially improved the quality and clarity of our manuscript. We have attempted to address each major concern with either new experiments or significant textual revisions.

      Reviewer 1 noted that “this research is conducted exclusively in HEK293 cells… including at least one additional cell line would significantly strengthen the main findings.” To directly address this concern, we repeated our RAB1A/B double-knockdown experiments in H4 neuroglioma cells, which endogenously express a tandem fluorescent-tagged LC3B reporter. Using flow cytometry to quantify autophagic flux, we confirmed that RAB1 depletion in H4 cells recapitulates the flux defects observed in HEK293 cells, thereby validating the generality of our findings across distinct lineages.

      To validate the robustness of the ATG2 DKO phenotype and the localization of ARFGAP1-positive membranes, we acquired an ATG2 double knockout HeLa cell line. We confirmed the presence of the characteristic large ATG2-deficient PAS compartment in HeLa cells, and the recruitment of ARFGAP1 membranes, but note that ARFGAP1 displays a solid distribution through the compartment in these cells, in contrast to the more peripheral enrichment observed in HEK293 cells. These data are now included and discussed in the revised manuscript.

      Multiple reviewers asked for greater clarity around the interaction between ATG2A and RAB1A. Although our original data showed that these proteins co-immunoprecipitate in cells, we had not established whether their association was direct. In response, we attempted in vitro co-immunoprecipitations from purified components.  As we could not detect interactions in this simplified system, we now speculate that the ATG2A–RAB1A interaction is indirect. This clarification is now incorporated into the results section.

      Multiple reviewers also raised questions regarding the nature of the membranes recruiting ARFGAP1 and the potential relationship to Arf1 and Golgi trafficking. In particular, Reviewer 3 asked: “(5) What about Arf1? … one would predict that Arf1 does not localize to these structures and does not affect ATG2A function.” To examine whether ARFGAP1 recruitment depends on Golgi integrity or Arf1-regulated trafficking, we perturbed the Golgi using three mechanistically distinct methods: Brefeldin A, mitotic entry, and SidM expression, each of which dissolves Golgi architecture. In each condition, ARFGAP1 localization to the enlarged PAS compartment in ATG2 DKO cells was unchanged. These results indicate that ARFGAP1 recruitment is independent of Golgi structure and provide indirect support for the notion that Arf1 does not participate in this process. Reviewer 3 also asked: “Is the curvature-sensitive region of ARFGAP1 required for its co-localization with ATG2A?” To address this, we generated ARFGAP1 mutants lacking either GAP catalytic activity or the ALPS curvature-sensing domain. When expressed in ATG2 DKO cells, all mutants retained full recruitment to the PAS compartment. Thus, neither GAP activity nor ALPS-mediated curvature sensing is required for ARFGAP1 localization in this context.

      Response to Reviewer 3 -“(2) Figure 3A/B: … is there another tool/assay to validate this result?”—we quantified autophagic flux following SAR1B(H79G) overexpression using the flow-cytometry tandem-fluorescent LC3 assay. These experiments confirmed that SAR1B(H79G) causes only a modest reduction in autophagic flux, consistent with partial inhibition of COPII, thereby supporting our original interpretation.

      We also took steps to improve the integration of our findings with prior literature. Reviewer 2 requested that we strengthen the manuscript by incorporating studies on ERES–ERGIC remodeling (“It would strengthen the manuscript to discuss previous studies…”). We now cite and discuss the studies corresponding to PMIDs 34561617 and 28754694, aligning our observations with mechanistic models of early secretory pathway remodeling. More broadly, Reviewer 1 commented that our discussion “overlooks some important aspects,” and Reviewer 3 asked, “Are the membranes to which ATG2A is recruited a form of ERGIC?” In response, we substantially rewrote the discussion, expanding our integration of existing literature and explicitly addressing models in which ATG2A acts at an ERGIC-derived membrane.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      (1) I found the bigger picture analysis to be lacking. Let us take stock: in other work, during active cognition, including at least one study from the Authors, TDLM shows significance sequenceness. But the evidence provided here suggests that even very strong localizer patterns injected into the data cannot be detected as replay except at implausible speeds. How can both of these things be true? Assuming these analyses are cogent, do these findings not imply something more destructive about all studies that found positive results with TDLM?

      Our focus here is on advancing methodology. Given the diversity of tasks and cognitive states in the TDLM literature, replay could exceed detection thresholds under specific conditions—especially when true event durations align with short analysis windows. While a comprehensive re-analysis of prior datasets is beyond our scope, we agree a concise synthesis can strengthen the paper.

      The previous TDLM literature uses a diverse set of tasks and addresses a broad spectrum of cognitive constructs/processes. As we acknowledge, it is perfectly possible that replay bursts in short time windows are well detectable by TDLM. However, we acknowledge that some commentary on this is warranted and have added the following paragraph to the discussion that addresses “improving TDLMs sensitivity”:

      “Finally, what do our simulations imply for the broader MEG replay literature? Our implementation successfully detects replay when boundary conditions are met, as shown in the simulation. But sensitivity depends critically on high fidelity between the analysis window and the density of replay events. A systematic evaluation of these conditions as they apply to prior studies remains beyond the scope of the current paper. Instead, our focus is on delineating boundary conditions that we hope will motivate conduct of power analyses in future work as well as inclusion of simulations that approximate realistic experimental conditions.”

      (2) All things considered, TDLM seems like a fairly 'vanilla' and low-assumption algorithm for finding event sequences. It is hard to see intuitively what the breaking factor might be; why do the authors think ground truth patterns cannot be detected by this GLM-based framework at reasonable densities?

      We agree with the overall sentiment of the referee. Our intuition is that one of the principal shortcomings of the method relates to spurious sequenceness induced by unknown factors at baseline, and poor transfer of the decoder to other modalities. and have a rough understanding of how they occur, we are currently not in a position to identify their nature. Note that we believe that these confounders are not exclusive to TDLM but are potentially threatening to all kinds of sequenceness analysis of longer time series that rely on decoders. Indeed, we suspect that classifier training is another bottleneck, as we don’t know the exact nature of the representations that are replayed, including the degree of overlap there is with a commonly used visual localizer. That said, this is not of relevance for the simulation in so far as we insert patterns that exceed the pattern strength in the localizer.

      Finally, a potential major drawback is the permutation test for significance testing. As the original authors of TDLM have noted, the current test which permutes states is overly conservative. It measures fixed effects and as it only considers the group level mean it is accordingly easily biased by individual outliers. This we have tried to account for by z-scoring sequenceness scores. We have also conferred on this with some of the authors of TDLM and discussed a yet unpublished method that aims to address this exact issue. The proposed new method uses a sign-flip permutation test at a group level and therefore implements a random-effects model of the data. This significance test has markedly increased power while still controlling for FWER. However, while we show in our power analysis that the new method is indeed more sensitive, it does not materially change the interpretation of the data. We have included this novel method in the paper and added it into the main analysis and most of the simulations.

      (3) Can the authors sketch any directions for alternative methods? It seems we need an algorithm that outperforms TDLM, but not many clues or speculations are given as to what that might look like. Relatedly, no technical or "internal" critique is provided. What is it about TDLM that causes it to be so weak?

      We believe there are several shortcomings and bottlenecks within TDLM that need to be evaluated and improved. While we highlight these issues in the discussion section titled “Improving TDLMs sensitivity,” we agree that we should provide a clearer outline of its current shortcomings. We have now added to the discussion to expand on that we think needs improvement (‘fixed time lag’) and also add a summary statement at the end of the relevant paragraph to recap the main issues needed for an improved successor method. The new paragraphs read:

      “Lastly, there are certain assumptions that TDLM makes that might not hold (see Methods Study II): Current implementations look for a fixed time lag that is the same across all participants and between all reactivation events. If time lags differ across participants, TDLM will fail to find them. Similarly, TDLM assumes a fixed sequence order and is not robust against slight within-sequence permutations or in-sequencemissing reactivation events. However, from other data sources., such as hippocampal place cell recordings, it is known that such permutations can occur where some states are skipped or fail to decode during replay. Similarly, it is assumed that each reactivation event lasts between 10-30 milliseconds, but the true temporal evolution of reactivation measured by TDLM is currently unknown. Future method development might focus on improving invariance to these assumptions.

      […]

      In summary, there are several areas where TDLM might be improved, including a restriction in its search space, improvement in classifiers, a validation of localizer representation transfer to other domains (e.g. memory representations), and the extension of TDLM to render it more robust against violations of its core assumptions.”

      Reviewer #2 (Public review):

      Weaknesses:

      The sample size is small (n=21, after exclusions), even for TDLM studies (which typically have somewhere between 25-40 participants). The authors address this somewhat through a power analysis of the relationship between replay and behavioural performance in their simulations, but this is very dependent on the assumptions of the simulation. Further, according to their own power analysis, the replay-behaviour correlations are seriously underpowered (~10% power according to Figure 7C), and so if this is to be taken at face value, their own null findings on this point (Figure 3C) could therefore just reflect under sampling as opposed to methodological failure. I think this point needs to be made more clearly earlier in the manuscript.

      We agree with the referee that our sample is smaller than previous studies due to participant exclusion criteria. However, the take-away message from our behavioural simulation and bootstrapping is that even with larger sample sizes, it is difficult to overcome baseline fluctuations of sequenceness, even if very strong replay patterns were detectable and sample sizes were of similar size to that of previous studies. Therefore, we are not convinced that that our null findings are fully explained by the smaller sample size compared to that of previous studies, Additionally, we show that even within the range of other studies, similar power would have been expected (Supplement Figure 11). However, it is true that in general null findings can be explained by under-sampling, under the assumption that an effect is present. To amplify this point, we have added the following to the Figure 3C:

      “[…]. NB, however, as our simulation shows, correlations of sequenceness with behavioural markers are likely to be underpowered and occur only with very high replay rates or much higher sample size. See our simulation discussion for a more detailed explanation on how correlations may be inherently biased, where fluctuations in baseline sequenceness overshadow individual scaling with behavioural markers.”

      Furthermore, we have added the following paragraph to the discussion to highlight this point and refer to a power analysis we have now added to the supplement (see next answer):

      “Sample sizes in previous TDLM literature usually range between 20 to 40 participants. A bootstrap power analysis shows that even at those sample sizes, power would remain low unless unrealistically high replay rates are assumed (Supplement Figure 11). Our bootstrap simulation shows that a correlation analysis between sequenceness and behaviour would in these cases be drastically underpowered, even under an assumption of high replay densities.”

      Finally, we have added a remark about the sample size to the limitations section, as naturally, an increase in sample size would yield higher power:

      “Finally, while initially planning for thirty participants, due to exclusion criteria, our study featured fewer participants than most previous studies using TDLM (i.e. usually 25-40, but 21 in our study). While we are confident that our simulation results hold under these sample sizes, as sample sizes of other studies show comparable power to ours (Fehler! Verweisquelle konnte nicht gefunden werden.), we cannot fully rule out a possibility that our null-findings are explained by a lack in power alone.”

      Relatedly, it would be very useful if one of the recommendations that come out of the simulations in this paper was a power analysis for detecting sequenceness in general, as I suspect that the small sample size impacts this as well, given that sequenceness effects reported in other work are often small with larger sample sizes. Further, I believe that the authors' simulations of basic sequenceness effects would themselves still suffer from having a small number of subjects, thereby impacting statistical power. Perhaps the authors can perform a similar sort of bootstrapping analysis as they perform for the correlation between replay and performance, but over sequenceness itself?

      We agree with the referee that this, in principle, is a great idea. However, the way that significance thresholds are calculated poses a conceptual problem for such an analysis: as for significance threshold we are defining the maximum sequenceness value across all participants, all time lags and all permutations. This sequenceness value is compared against the mean of all participants, disregarding the standard deviation. This maximum threshold would not change if we bootstrapped some of our samples. Additionally, the 95% would also not change significantly. To illustrate this point, we have added this analysis to the supplement, as Supplement Figure 10. However, the new sign-flip permutation test we now include allows for such a comparison, as it takes variance between participants into account as well! We have included all three variants of the power analysis and the figure description now reads:

      “Supplement Figure 11 Power analysis of sequenceness significance for bootstrapped samples sizes. A) Powermap for state-permutation thresholds. However, here the bootstrap approach suffers from a conceptual problem: significance thresholds are defined by the permutation maximum and/or 95-percentile of the maximums across all sequence-permutations across participants. If we resample bootstrap-participants from our existing pool, the maximum thresholds computed will remain relatively stable across resampled participants, as it only compares against the mean and disregards the standard deviation. B) The newly presented statistical approach is significantly more sensitive at higher sample sizes. Note that even then, 80% power is only reached with replay density of higher than 50 min-1 at a sample size of 60 participants. Additionally, the sign-flip permutation test assumes that the mean is at zero. As we observed a non-zero mean due to spurious oscillations, we subtracted the mean sequenceness of the baseline condition from each participant before permuting to achieve a null distribution with mean zero, as otherwise, we would have found significant replay effects in the baseline condition at increasing sample size. Nevertheless, due to the higher sensitivity, the new sign-flip test is recommended over the previous sequence-permutation-based test. Colours indicate the power from 0 to 1 for different bootstrapped sample sizes and densities. 80% power thresholds are outlined in black.”

      The task paradigm may introduce issues in detecting replay that are separate from TDLM. First, the localizer task involves a match/mismatch judgment and a button press during the stimulus presentation, which could add noise to classifier training separate from the semantic/visual processing of the stimulus. This localizer is similar to others that have been used in TDLM studies, but notably in other studies (e.g., Liu, Mattar et al., 2021), the stimulus is presented prior to the match/mismatch judgment. A discussion of variations in different localizers and what seems to work best for decoding would be useful to include in the recommendations section of the discussion.

      We agree and thank the referee for raising this issue. Note, we acknowledge we forgot to mention that these trials were excluded from classifier training. Our rationale of presenting the oddball during stimulus presentation, and not thereafter, was an assumption that by first presenting the audio and then the visual cue we would create more generalized representations that would be less modalitydependent. However, importantly, we excluded all trials that were oddballs from localizer training. Therefore we assume that this particular design choice will not greatly affect the decoder training. If some motor-preparation activity is present during the stimulus presentation, then it should be present equally across all trials and hence be ignored by the classifier as we balanced the transitions between images. We now added this information to the main text:

      “In each trial, a word describing the stimulus was played auditorily, after which the corresponding stimulus was shown. In ~11% of cases, there was a mismatch between word and image (oddball trials), and these trials were excluded from the localizer training.” Additionally in the methods section: “These oddball-trials were excluded from all further analysis and decoder training.”

      Nevertheless, we agree that the extant variety in localizer designs is underdiscussed where many assumptions of classifier training are not, as yet, fully validated. We have added a sentence highlighting different oddball paradigms to the section on the discussion of localizers and also add a summary statement with recommendations. The passage now reads:

      “Additionally, a wide variety of oddballs has been used (e.g. upside-down, scrambled, or mismatched images, cues presented visually, as words, auditorily, etc), and at this time it is unclear if these affect the representations that the classifier learns [...] In summary, we would expect a multimodal categorical localizer, and a classifier that isn’t trained on a specific timepoint, to generalize best.”

      Second, and more seriously, I believe that the task design for training participants about the expected sequences may complicate sequence decoding. Specifically, this is because two images (a "tuple") are shown together and used for prediction, which may encourage participants to develop a single bound representation of the tuple that then predicts a third image (AB -> C rather than A -> B, B -> C). This would obviously make it difficult to i) use a classifier trained on individual images to detect sequences and ii) find evidence for the intended transition matrix using TDLM. Can the authors rule out this possibility?

      We thank the reviewer for raising a possibility we have not considered! While there is some evidence that a single bound representation would have overlap with its constituents (especially before long term-consolidation) and therefore be detectable by the classifiers, we acknowledge the possibility that individual classifiers would fail to be sensitive to such a compound representation. In fact we find in the retrieval data some evidence for a combined replay of representations (where representations are replayed seemingly at the same time, see Kern 2024). We have added such a possibility to the interims-discussion of Study 1 as a qualification . However, this does not change the results or interpretation of our simulation which we consider is a key message of the paper.

      The relevant segment in the discussion section now reads:

      “Additionally, given that the stimuli were presented in combined triplets, participants may have formed a singular representation of associated items and subsequently replayed these (e.g., AB→C), instead of replaying item-by-item transitions (A→B→C). Under such a scenario, a classifier trained on individual items may fail to detect these newly formed bound representations, particularly if they diverge strongly from the single-item patterns. In our previous study where we address retrieval (Kern et al., 2024) we found that states were to varying extent co-reactivated, yet classifiers trained on single items retained sensitivity to detect these combined reactivation events. Consistent with this, prior work suggests that unified representations retain overlap with their constituent item representations (Dennis et al., 2024; Liang et al., 2020), however, there’s also evidence that different brain regions are involved if representational unitization occurs (Staresina & Davachi, 2010), potentially confusing classifiers. Therefore, we cannot exclude that rest-related consolidation replays engendered unitized representations that were insufficiently captured by our singleitem classifiers.“

      Participants only modestly improved (from 76-82% accuracy) following the rest period (which the authors refer to as a consolidation period). If the authors assume that replay leads to improved performance, then this suggests there is little reason to see much taskrelated replay during rest in the first place. This limitation is touched on (lines 228-229), but I think it makes the lack of replay finding here less surprising. However, note that in the supplement, it is shown that the amount of forward sequenceness is marginally related to the performance difference between the last block of training and retrieval, and this is the effect I would probably predict would be most likely to appear. Obviously, my sample size concerns still hold, and this is not a significant effect based on the null hypothesis testing framework the authors employ, but I think this set of results should at least be reported in the main text.

      We disagree that an absence or presence of replay might be inferred from an absolute memory enhancement. While consolidation can lead to absolute improvement of performance in, for example, motor memory domains one formulation is that in declarative learning tasks replay stabilizes latent memory traces, and in such a scenario would not necessarily lead to a boosted performance. While many declarative consolidation studies report an increase of performance compared to a control condition (i.e. without a consolidation window), this does not necessarily entail an absolute performance increase, as replay might just act to protect against loss of memory traces. Therefore, the modest increase we observe does not inference as to the presence of absence of replay absent a proper control condition.

      We did expect to find a correlation between replay and individual behavioural. Indeed, a weak correlation with performance and sequenceness can be detected. However, as we also show any such correlation is overshadowed by baseline fluctuations in sequenceness such that its overall validity is questionable, even under very high replay rates. We are therefore circumspect about this correlation, even if it was significant. Therefore, in the discussion, we chose to refrain from putting much focus on this correlation. Nevertheless, we do add a short statement to the corresponding figure label, discussing this precise issue. The segment now reads:

      “While we found a non-significant relation between a memory performance enhancement and post-learning forward sequenceness we are cautious not to overinterpret these results. As in the section “Correlation with behaviour only present at high replay speeds” the noted correlational measure oscillates heavily with baseline sequenceness fluctuations, and any true replay effect is likely to be overshadowed by such fluctuations.”

      I was also wondering whether the authors could clarify how the criterion over six blocks was 80% but then the performance baseline they use from the last block is 76%? Is it just that participants must reach 80% within the six blocks *at some point* during training, but that they could dip below that again later?

      We thank the reviewer for highlighting this point: The first block wherein participants reached >80% ended the learning blocks. After a maximum of six blocks the learning session was ended regardless of performance. Therefore, some participants’ learning blocks were ended after six blocks and without them reaching a performance of 80%.. While we described this in the Methods section, it was missing from the Results Study I section, which now contains:

      “[...] Participants then learned triplets of associated items according to a graph structure. Within the learning session, participants performed a maximum of six learning blocks, but the session was stopped if participants reached 80% memory performance (criterion learning,, up to a memory performance criterion of 80% (see Methods for details)”

      The Figure 2 description now contains

      “[...] Participants’ completed up to six blocks of learning trials. After reaching 80% in any block, no more learning blocks were performed (criterion learning) [...]”

      Lastly, there was a mistake in the Behavioural results section, which stated “All thirty participants, except one, [..] to criterion of 80%.” This is an error. In our preregistration, we defined to only include participants that successfully learned anything at all above chance. Here,we meant that only one participant failed to reach a criterion that we defined as “successful learning”. We fixed it and it now reads

      “with an accuracy above 50% (which we preregistered beforehand as an exclusion criterion for “successful learning above chance”).”

      Additionally, we have noted this for clarity in the methods section and excuse this mistake:

      “Additionally, as successful above-chance learning was necessary for the paradigm, we ensured all remaining participants had a retrieval performance of at least 50% (one participant had to be excluded, but was already excluded due to low decoding performance).”

      Because most of the conclusions come from the simulation study, there are a few decisions about the simulations that I would like the authors to expand upon before I can fully support their interpretations. First, the authors use a state-to-state lag of 80ms and do not appear to vary this throughout the simulations - can the authors provide context for this choice? Does varying this lag matter at all for the results (i.e., does the noise structure of the data interact with this lag in any way?)

      This was a deliberate choice but we acknowledge the reasoning behind this was not detailed in our initial submission. We chose a lag of 80 millisecond for three reasons: first, it is distant from the 9-11 Hz alpha oscillations we observed in our participants and does not share a harmonic with the alpha rhythm; second, we wanted to get a clear picture of the effect of simulated replay that is as isolated as possible from spurious sequenceness confounders present in the baseline condition. Thus, we chose a lag in which the sequenceness score was close to zero in the baseline condition; thirdly , in this revision, we subtracted the mean sequenceness value of the baseline such that any simulation effects would start, on average, at zero sequenceness. In this way, we could attribute any increase in sequenceness to the experimentally inserted replay, that was independent of spurious oscillations. Finally (but less importantly), as we observed that a correlation of sequenceness with behaviour was fluctuated strongly, for the reason detailed above, we chose a lag in which a correlation was as close as possible to zero. If we had not chosen a lag that adhered to these conditions, we were at risk of measuring simulated replay plus spurious sequenceness confounders.

      We have added a sentence to the main text detailing this justification:

      “We chose this timepoint (80 msec state to state lag) as its sequenceness value was close to zero in the baseline condition as well as being distant to the observed alpha rhythms of the participants (which varied between ~9-11 Hz). Additionally, we subtracted the mean sequenceness value of the baseline at 80 milliseconds lag such that any simulation effects would, on average, start at zero sequenceness “

      Additionally, we now add a more detailed explanation to the methods section.

      “This time lag (80 msec) was chosen in order to isolate precisely an effect of the experimentally inserted sequenceness. Thus, we chose a lag at which the mean baseline sequenceness was close to zero and where the correlation with behaviour was low. Additionally, we subtracted the mean sequenceness value (at 80 milliseconds) at baseline from the specific lag recorded for each participant, such that simulation effects would be initialized at zero sequenceness on average enabling any effects to be attributed purely to inserted replay. Additionally, we excluded time lags too close to the alpha rhythms of participants (which varied between ~9-11 Hz) or lags which would have a harmonic with the rhythm.”

      Second, it seems that the approach to scaling simulated replays with performance is rather coarse. I think a more sensitive measure would be to scale sequence replays based on the participants' responses to *that* specific sequence rather than altering the frequency of all replays by overall memory performance. I think this would help to deliver on the authors' goal of simulating an "increase of replay for less stable memories" (line 246).

      The referee makes an excellent point and our simulations could be rendered more realistic by inserting the actual tuples that participants answered correctly. If we understand the point correctly, there are two different ways replay might be impacted by performance: First, we can conjecture that there is greater replay if memory performance is not saturated. Second, replay only occurs for content that has actually been encoded!

      The main reasons why we chose to simulate the entire sequence being replayed for each participant is based on the following. TDLM is implemented such that the amount of replay alone is relevant, and actual transitions are not affecting the results beyond noise. Under the assumption that class-specific classifiers perform equally well, simulating A->B, B->C or simulating A->B, A->B yields equivalent results. However, results can differ if this assumption is violated. By drawing from the entire space of classes we insert, we minimize the risk of some classifiers being worse than others for some participants. For example, if we simulated only A->B for some participant instead of the whole sequence, and by chance classifier A performs suboptimally, we would then introduce additional unwanted variance into our results.

      Secondly, from our reading of the literature we infer that replay is increased generally (i.e. density of learning-specific replay is increased) for less stable memories. However, we do not have indicators of memory strength, but only a binary “remembered or not”. As TDLM is invariant to the actual transitions being replayed and only indexes the number of transitions, we chose to ignore which transitions we insert and only scaled the amount of replay.

      We have added an analysis to the Appendix that discusses this specific aspect of our study where we show that results are equivalent if we simulate replay of “A->B B->C C->D” or only “A->B A->B A->B A->B”. As we do not know how replay density interacts with memory trace stability, we opted to leave the current simulation as is. The corresponding paragraph and figure description now read:

      “From literature we know that replay is increased after learning and that less stable memories are replayed more often. We simulated this effect by scaling our replay density inversely with performance. However, for simplicity, in our simulation, we inserted sampled transitions from all valid transitions given by the graph structure, i.e., the following transitions were valid: However, this meant that some participants would have transitions inserted that they didn’t actually remember. To show that this would not change results, we simulated two scenarios: In the full sequence scenario, all valid graph transitions are inserted (i.e. all participant’s replay is sampled from 'A->B, B->C, C->D, D->E, E->F, F->G, G->E, E->H, H->I, I->B, B->J, J->A'). In the second scenario (memorized transitions) we only replayed transitions that the participant actually retrieved correctly during the post-resting state testing sessions (i.e. a participant’s replay would have been sampled from ‘A->B, B->C, G->E, E->H, H>I’, if those were the ones he remembered). In both scenarios, the number of events is kept constant. The results are equivalent as can be seen in Appendix A Figure 3. NB this only holds under the assumptions that classifiers are equally good at decoding each class.”

      […]

      “TDLM is insensitive towards which transitions are replayed and only sensitive to how many transitions are detected in total. Here we simulate transitions either sampled from the full graph (light orange/green) or participant-specific transitions of trials that participants correctly remembered (dark orange/green). Shaded areas denote the standard error across participants.”

      On the other hand, I was also wondering whether it is actually necessary to use the real memory performance for each participant in these simulations - couldn't similar goals (with a better/more full sampling of the space of performance) be achieved with simulated memory performance as well, taking only the MEG data from the participant?

      The decision to use real memory performance is indeed arbitrary. We could have also used randomly sampled values. However, as we wanted to understand our nullresults better we opted to use real performance to adhere as close as possible to the findings we previously reported. Using uniformly sampled memory performance would be less explanatory w.r.t to our actual results of the resting state data that are reported in the first study we report in the manuscript (Study I).

      Nevertheless, our current implementation already presents an approach that samples the entire performance range for the sub-analysis focusing on the correlation with behaviour. Here, in the section on “best-case”-scenario, we implement this such that it spans factors from 1 to 0 (i.e., a participant with 100% performance gets a replay scale factor of 0 and hence no replay simulated, and the worst performing participant with 50% performance has a replay rate multiplied by 1). We scale the amount of replay with this factor. As a correlation is invariant to linear scaling, statistically this is equivalent to stretching the performance distribution from 0 to 100%. We have added a sentence to the methods to provide further focus on this point:

      “To assess how performance might affect replay in our specific dataset, we chose to use the original participants’ performance values instead of uniformly sampling the performance space (which ranged from 50 to 100%). However, for the correlation analysis, we additionally added a “best-case” scenario, in which we scale replay from 0 to 1, an approach that is statistically equivalent to scaling values to the full space of possible performance (0 to 100%) (see Results Study II: Simulation).”

      Finally, Figure 7D shows that 70ms was used on the y-axis. Why was this the case, or is this a typo?

      Thanks, this is indeed a typo, we fixed it.

      Because this is a re-analysis of a previous dataset combined with a new simulation study on that data aimed at making recommendations about how to best employ TDLM, I think the usefulness of the paper to the field could be improved in a few places. Specifically, in the discussion/recommendation section, the authors state that "yet unknown confounders" (line 295) lead to non-random fluctuations in the simulated correlations between replay detection and performance at different time lags. Because it is a particularly strong claim that there is the potential to detect sequenceness in the baseline condition where there are no ground-truth sequences, the manuscript could benefit from a more thorough exploration of the cause(s) of this bias in addition to the speculation provided in the current version.

      We are currently working on a theoretical basis to explain these spurious sequenceness confounders in the baseline condition. Indeed, in our preliminary work, in certain contexts we can induce significant sequenceness in the absence of any replay signal during baseline. However, this work is at an early stage and we still have some conceptional problems to solve before we are confident enough with these data. We believe at present it would be premature to add these data to the current manuscript. Nevertheless, we now mention these spurious sequenceness confounders to raise awareness for the field and also add greater context to the discussion, highlighting one of the issues that we think is of importance:

      “[…] For example, if two classifiers’ probabilities oscillate at 10 Hz but at a different phase, a spurious time lag can be found reflecting this phase shift. We speculate that more complex interactions between classifiers oscillating at different phases are also conceivable.”

      In addition, to really provide that a realistic simulation is necessary (one of the primary conclusions of the paper), it would be useful to provide a comparison to a fully synthetic simulation performed on this exact task and transition structure (in addition to the recreation of the original simulation code from the TDLM methods paper).

      Thank you for this suggestion! We have now added a synthetic simulation, trying to keep as close as possible to the original simulation code in Liu et al. (2021), while also incorporating our current means of simulating the data (i.e. scaling by performance). We think this synthetic simulation greatly improves the paper and gives weight to our suggestion about the superiority of a hybrid approach. Additionally, it prompted us to look closer at patterns that are inserted in the synthetic simulation and perform a comparative analysis. We have now added the simulation to the main text, together with a methodological explanation of how we simulated the data in the methods section. We also added a discussion on the results and why we think a hybrid approach is currently superior to synthetic approach. The whole new section is too long to paste here – it is found after the main simulation section in the manuscript. We have also added another sentence to the abstract referring to this new inclusion.

      Finally, I think the authors could do further work to determine whether some of their recommendations for improving the sensitivity of TDLM pan out in the current data - for example, they could report focusing not just on the peak decoding timepoint but incorporating other moments into classifier training.

      While we do understand the desire to test further refinement to TDLM on the data directly, we intentionally do not include such analyses in the current paper. Our experience also informs us that there is an enormous branching factor of parameters when applying TDLM, with implications for significance of results in one or other direction. However, as there are currently only limited ways to know how well parameter changes actually improve the sensitivity to replay versus exacerbate potential underlying confounders that induce spurious sequenceness (e.g., we can get significant replay in the control condition with some parameter changes). To exclude such false positive findings, we opt for a relatively strict adherence to previously published approaches. Thus, in the current paper, we limit ourselves to assessing the reliability and robustness of previous approaches.

      Furthermore, while training on a later timepoint might increase sensitivity for a classifier when transferring between different modalities (e.g. visual to memory representation), this approach does not transfer well in our simulations, as the inserted patterns are from the same modality. We consider other, more bespoke studies, are better suited to improve classifier training. NB also see our recently started Kaggle challenge to tackle this problem: https://www.kaggle.com/competitions/the-imagine-decoding-challenge

      However, we have added a note about this dilemma to the improvement section. The section now includes:

      “Nevertheless, as the considerable branching factor poses a threat of increased falsepositive findings we opt to focus the current simulations on previously published pipelines and parameters. Future studies should systematically evaluate parameter choices on TDLM under different conditions, something that is beyond the remit of the current study.”

      Lastly, I would like the authors to address a point that was raised in a separate public forum by an author of the TDLM method, which is that when replays "happen during rest, they are not uniform or close." Because the simulations in this work assume regularly occurring replay events, I agree that this is an important limitation that should be incorporated into alternative simulations to ensure the lack of findings is not because of this assumption.

      The temporal distribution of replay throughout the resting state should not matter, as TDLM is invariant w.r.t to how replay events are distributed within the analysis window. Specifically, it does not matter if replay events occur in bursts or are uniformly distributed. Only the number of transitions is relevant, where they occur or if they are close to each other is not relevant to the numerical results (as long as the refractory window is kept, too short distances will lead to interactions between events and reduce sensitivity).). To emphasize this point, we have added another simulation which is shown in Appendix A.1 and Appendix A Figure 1. We have referenced it in the text and added the following paragraph in the Methods section

      Additionally, the timepoints of inserting replay within the resting state are sampled from a uniform distribution. Even though TDLM tracks reactivation events over time, at a macro-scale the algorithm is invariant to the temporal distribution. At each time step, the GLM regresses onto a future time step up to the maximum time lag of interest, yielding a predictor per lag. However, these predictors within the GLM are independently assessed, and hence, TDLM is, outside of the time lag window, relatively invariant to the temporal distribution of replay. To demonstrate our claim, we simulated uniform replay vs “bursty” replay that only occurs in some parts of the resting state, both yield equivalent sequenceness results (see Appendix A.1).

      Reviewer #3 (Public review):

      (1) I am still left wondering why other studies were able to detect replay using this method. My takeaway from this paper is that large time windows lead to high significance thresholds/required replay density, making it extremely challenging to detect replay at physiological levels during resting periods. While it is true that some previous studies applying TDLM used smaller time windows (e.g., Kern's previous paper detected replay in 1500ms windows), others, including Liu et al. (2019), successfully detected replay during a 5-minute resting period. Why do the authors believe others have nevertheless been able to detect replay during multi-minute time windows?

      (Due to similarity, we combined our responses with the first question of Reviewer 1)

      We are reluctant to make sweeping judgments in relation to previous literature as we wanted to prioritize on advancing methodology instead. The previous TDLM literature uses a diverse set of tasks and cognitive processes. As we state ourselves, it is possible that replay bursts in short time windows are well detectable by TDLM. We were intentionally cautious to directly critique previous studies without detailed re-analysis of their work and wanted to leave such a conclusion up to the reader. However, we realize that such a “thought-starter” might be warranted and improve the paper. Therefore, we have added the following paragraph to the discussion about “improving TDLMs sensitivity”:

      “Finally, what do our simulations imply for the broader MEG replay literature? Our implementation successfully detects replay when boundary conditions are met, as shown in the simulation. But sensitivity depends critically on high fidelity between the analysis window and the amount of replay events. A systematic evaluation of these conditions across prior studies is beyond the scope of this paper, so we do not want to adjudicate earlier findings and leave this assessment up to the reader. Instead, we delineate the boundary conditions and urge future work to conduct power analyses where possible and include simulations that approximate realistic experimental conditions.”

      For example, some studies using TDLM report evidence of sequenceness as a contrast between evidence of forwards (f) versus backwards (b) sequenceness; sequenceness was defined as ZfΔt - ZbΔt (where Z refers to the sequence alignment coefficient for a transition matrix at a specific time lag). This use case is not discussed in the present paper, despite its prevalence in the literature. If the same logic were applied to the data in this study, would significant sequenceness have been uncovered? Whether it would or not, I believe this point is important for understanding methodological differences between this paper and others.

      This approach was first introduced as part of a TDLM-predecessor that utilized crosscorrelations (Kurth-Nelson 2016), where this step is a necessity to extract any sequenceness signal at all by subtracting signals that are present in both (akin to an EEG reference). However, its validity is less clear when fwd and bkw are estimated separately, as is in the GLM case. The rationale behind subtracting here is the same as for autocorrelations: there are oscillatory confounds present in the data that introduce spurious sequenceness in both directions alike, i.e. at the same time lag, that can simply be removed by subtracting. However, this assumption only holds if the sole confounder is auto-correlations caused by a global signal that oscillates at all sensors at the same phase. In our own experience, and mentioned in the discussion, we do not think this assumption holds. Arguably, there are more complex interactions at play that cannot be removed by such a subtraction such as an increase in false positives if confounders are in an opposite direction at a specific time lag. This assumption-violation can be seen in our baseline condition, where other spurious sequenceness diverges in opposite directions for some time lags (e.g. at ~90 ms where forward sequenceness is negative and backward sequenceness is positive). We reasoned that oscillatory confounds are more stable when comparing pre vs post for the same direction than comparing within session between forward minus backward.

      Finally, we note issues introduced by the various ways that sequenceness has been analysed in previous papers: normalization of sequenceness (z-scoring across time lags or across participants or not at all), normalization of probabilities (taking raw decision scores, z-scoring, soft-max, dividing by mean, subtracting mean), taking a windowed approach and summing sequenceness scores, not to mention the various classifier choices that can be made, and all of this can be applied before subtracting conditions from each other or before subtraction. In our experience there is insufficient regard to control for multiple comparison when running all these analyses risking selectivity in reporting.

      Nevertheless, subtracting forward from backward replay is probably as valid as post minus pre. Therefore, we have added fwd-bkw plots to the supplement and explained some of the reasoning for not reporting them in the main text in the figure label. The figure label and reference now read:

      “Finally, we report forward minus backward sequenceness and our motivation for using an across-session post-pre comparison instead of within-session forwardbackward in Supplement Figure 10.”

      […]

      “Forward minus backward sequenceness within each resting state session. Previous papers often report subtraction of backward from forward sequenceness (fwd-bkw) as a means to remove oscillatory confounds that impact both sequenceness directions in synchrony. While required in early cross-correlation approaches (KurthNelson et al., 2016), its validity in GLM-based frameworks depends on an assumption that confounds are global and in-phase across sensors. We observed this assumption is violated in our baseline data, where spurious sequenceness occasionally diverges in opposite directions at specific time lags (e.g., ~90 ms). In such instances, subtraction would increase the false-positive rate rather than suppress noise. In Figure 3B, we prioritized the comparison of pre-task versus post-task sequenceness within the same direction, as oscillatory confounds appeared more stable across time within a single direction, as opposed to across directions within a single session. However, we consider both approaches are valid. We now provide the fwd-bkw plots for completeness and comparison with previous literature. A) forward minus backwards sequenceness for Control (left) and Post-Learning resting-state (right). B) T-value distribution of the sign-flip permutation test for Control (left) and Post-Learning resting-state (right)”

      (2) Relatedly, while the authors note that smaller time windows are necessary for TDLM to succeed, a more precise description of the appropriate window size would greatly improve the utility of this paper. As it stands, the discussion feels incomplete without this information, as providing explicit guidance on optimal window sizes would help future researchers apply TDLM effectively. Under what window size range can physiological levels of replay actually be detected using TDLM? Or, is there some scaling factor that should be considered, in terms of window size and significance threshold/replay density? If the authors are unable to provide a concrete recommendation, they could add information about time windows used in previous studies (perhaps, is 1500ms as used in their previous paper a good recommendation?).

      We currently do not have an empirical estimate of which window sizes are appropriate. While we used 1500ms in our previous paper, this was solely given by the experiment design which had a 1.5s wait period before the next stimulus. Our recommendation for best guidance on this matter would be to investigate related intracranial literature for SWR rate increases under similar experimental conditions. We have added the following paragraph to the discussion:

      “At this stage we cannot offer a general recommendation for window sizes as they are likely to depend on details of the research paradigm. However, intracranial recordings can be used as proxy to estimate the duration of replay bursts, for example as reported in (Norman et al., 2019) where increased SWRs were seen up to 1500 ms after retrieval cue onset”

      (3) In their simulation, the authors define a replay event as a single transition from one item to another (example: A to B). However, in rodents, replay often traverses more than a single transition (example: A to B to C, even to D and E). Observing multistep sequences increases confidence that true replay is present. How does sequence length impact the authors' conclusions? Similarly, can the authors comment on how the length of the inserted events impacts TDLM sensitivity, if at all?

      Good point! So far, most papers do not seem to include multi-step TDLM and in our experience rightfully, as it is conceptionally difficult to define clear significance thresholds while keeping in mind that shorter sub-sequences are contained within a longer sequence (e.g. ABC contains both AB and BC and a longer dependency of AC) that renders it difficult to define the correct way to create a null distribution for the permutation test. Therefore, we tried to stay as close as possible to previous approaches and only looked for single-step transitions. Nevertheless, we have added an analysis to the supplement comparing how TDLM behaves if we simulate A->B->C or A->B and separate B->C. It shows that TDLM is only sensitive to the number of transitions present in the data, and it does not matter if they are chained or chunked. The segment reads:

      “We intentionally designed our study to encourage replay of triplets. However, this begs the question as to whether it matters if triplets or individual chunks of a sequence are replayed at different time points? Here, we simulated two scenarios. In one, we inserted replay of single transitions alone with a refractory period, e.g. A->B and separate B->C transitions. In a second scenario, we simulate replay of chained triplets, e.g. A->B->C, with a distance of 80 milliseconds each. Importantly, we kept the number of transitions constant (i.e., A->B, … B->C and where A->B->C would both have 2 transitions. This creates a context wherein a four-minute resting state would have ~100 events of A->B->C inserted and ~200 events of A->B or B->C, such that in both cases this results in the same number of single step transitions. We found both are equivalent, with TDLM agnostic to the length of sequence trains, i.e., it does not matter if replay is chunked or chained under the assumption that the number of transitions remains fixed, as can be seen in Appendix A Figure 2”

      And the reference Figure description reads:

      “TDLM is invariant to the length of sequence replay trains under an assumption that the number of target transitions (e.g. single steps) is fixed. We simulated replay either as two temporally separate A->B, B->C events (light orange/green) or as a single A>B->C event (dark orange/green), both yielding equivalent sequenceness. Shaded areas denote the standard error across participants”

      For example, regarding sequence length, is it possible that TDLM would detect multiple parts of a longer sequence independently, meaning that the high density needed to detect replay is actually not quite so dense? (example: if 20 four-step sequences (A to B to C to D to E) were sampled by TDLM such that it recorded each transition separately, that would lead to a density of 80 events/min).

      Indeed, this is an interesting proposal. We intentionally kept our simulation close to the way previous simulations were set-up (i.e. Liu & Dolan et al 2021, Liu & Mattar 2021) by simulating one-step transitions and simulated them such that there is no overlap between separate events (e.g. by defining a refractory period). If the duration of replay is increased then we would also need to increase the length of the refractory period, resulting in a reduced upper limit of how much replay can occur in a 1-minute time window. This in turn would approximate roughly the same number of transitions that can be inserted into the resting state and, as detailed above, would yield the same results. Nevertheless, as we chose to use replay density and not transition density as a marker, the density would be reduced, even if the number of transitions stay the same. We have added an analysis using multi-step replay to the supplement and discuss its implications and caveats. In the main discussion we have added the following segment:

      “Similarly, in our simulation, for simplicity and to keep consistency with previousstimulations, we restricted replay events to span two reactivation events. While the characteristics of replay as measured by TDLM are unknown, it is conceivable that several steps can be replayed within one replay event. We show that the vanilla version of TDLM is fundamentally sensitive to the number of single-step transitions alone, and disregards if these are replayed chained or chunked (Appendix A.2 and Appendix A Figure 2). Nevertheless, if the number of reactivation events chained within a replay event increases, TDLMs sensitivity is increased relative to the replay density and thresholds are reached earlier (see Appendix A Figure 4). See Appendix A.4 for a simulation of multi-step replay events and our discussion of the caveats.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Please label the various significance thresholds in the legend of Figure 3.

      We have labelled all the thresholds in the figure legends.

      Reviewer #2 (Recommendations for the authors):

      I think that some of the clarity is hampered because there is a bit too much reliance on explanations from the previous paper using this task, which hampers clarity in the paper. For example, Figure 1 is not particularly useful for understanding the study in its current form; I found myself relying almost exclusively on Supplementary Figure 1 (which is from the previous paper). I'd recommend presenting some version of SF1 in the main text instead. Another example of this overreliance on the previous paper is that, as far as I can tell, the present paper never explicitly states which transitions are being tested in TDLM. In the prior work, it states "all allowable graph transitions", and so I assumed this was the same here, but the paper should standalone without having to go back to the other study. I'd recommend that the authors revise the paper in these and other places where the previous paper is mentioned.

      Thanks for raising this point! We were uncertain ourselves how to deal with the overlap in content and did not want to bloat the paper or plagiarize ourselves too much. On the advice of the referee have implemented the following to improve the manuscript and reduce a reliance on the previous paper:

      Supplement Figure 1 is indeed crucial to understanding the experiment. We have moved it to the methods section under Methods: Procedure

      Added more stimulus description to the Methods: Localizer section

      Included more details about the localizer and graph learning that were missing before

      We have added the note about which transitions we were looking for in the Methods section. Additionally, we have added this information to the Results section of Study 1.

      There are also a few typos I noticed:

      (1) Line 73: "during in the context of."

      (2) Line 287: " to exploring the."

      We fixed the typos.

      Reviewer #3 (Recommendations for the authors):

      (1) Why did the authors choose an 80ms state-to-state time lag for their simulation? I believe they should make the reason for this decision clear in the main text.

      Indeed, this point was also raised by the other reviewer. We have added a sentence to the main text about the rationale behind this decision:

      “We chose this timepoint (80 millisecond state-to-state lag) as its sequenceness value was close to zero in the baseline condition as well as being distant to the observed alpha rhythms of the participants (which varied between ~9-11 Hz). Additionally, we subtracted the mean sequenceness value of the baseline at 80 millisecond lag such that any simulation effects would, on average, start at zero sequenceness.“

      Additionally, we have added some further explanation to the Methods section.

      “This time lag (80 msec) was chosen in order to isolate precisely an effect of the experimentally inserted sequenceness. Thus, we chose a lag at which the mean baseline sequenceness was close to zero and where the correlation with behaviour was low. Additionally, we subtracted the mean sequenceness value (at 80 milliseconds) at baseline from the specific lag recorded for each participant, such that simulation effects would be initialized at zero sequenceness on average enabling any effects to be attributed purely to inserted replay. Additionally, we excluded time lags too close to the alpha rhythms of participants (which varied between ~9-11 Hz) or lags which would have a harmonic with the rhythm.“

      (2) Line 168: Can the authors define what these conservative and liberal criteria are in the text?

      We have added definitions of the criteria in the text. The text now reads:

      “[..] significance thresholds (conservative, i.e. the maximum sequenceness across all permutations and timepoints or liberal criteria, i.e. the 95% percentile of aforementioned sequenceness).”

      (3) Line 478: "calculate" instead of "calculated".

      (4) Figure 7 D: y-axis is labeled "70 ms" I believe it should be labeled 80 ms.

      Thanks, we fixed the two typos.

      (5) With replay defined as sequential reactivation at a compressed temporal timescale, many of the iEEG citations (lines 54-55) do not demonstrate replay (they show stimulus reinstatement or ripple activity, but not sequential replay). Replay studies in humans using intracranial methods have been mostly limited to those measuring single-unit activity, a good example being Vaz et al., 2020 (https://www.science.org/doi/10.1126/science.aba0672).

      We agree that, under a strict definition articulated by Genzel et al. that defines replay as sequential reactivation, many prior human iEEG studies are better described as stimulus reinstatement or ripple-related activity rather than true sequence replay. We have revised the text accordingly and now highlight the few intracranial microelectrode studies that demonstrate replay of firing sequences at the cellular/ensemble level in humans (Eichenlaub et al., 2020; Vaz et al., 2020), distinguishing these from macro-scale iEEG work providing indirect evidence alone.

      The revised paragraph now reads:

      “Replay has been shown using cellular recordings across a variety of mammalian model organisms (Hoffman & McNaughton, 2002; Lee & Wilson, 2002; Pavlides & Winson, 1989). Replay studies in humans using intracranial recordings are few, but include work demonstrating compressed replay of firing-pattern sequences in motor cortex during rest (Eichenlaub et al., 2020) as well as single-unit replay of trialspecific cortical spiking sequences during episodic retrieval (Vaz et al., 2020). By contrast, most iEEG studies report stimulus-specific reinstatement or ripple-locked activity changes without explicit demonstration of temporally compressed sequential replay (Axmacher et al., 2008; Staresina et al., 2015). As these methods are only applied under restricted clinical circumstances, such as during pre-operative neurosurgical assessments, this limits opportunities to investigate human replay. Therefore, this gives urgency to efforts aimed at developing novel methods to investigate human replay non-invasively.”

      (6) The expectations about replay frequency are grounded in literature on hippocampal replay sequences. However, MEG captures signals from across the entire brain, and the hippocampal contribution is likely relatively weak compared to all other signals. This raises an important question: is TDLM genuinely unable to detect replay at physiological (i.e., hippocampal) levels, or is it instead detecting a different form of sequential reactivation - possibly involving cortex or other regions - that may occur more frequently? More broadly, when we have evidence of replay from TDLM, do we believe it is the same thing as replay of CA1 place cell spiking sequences, as detected in rodents? Commenting on this distinction would help further develop theories of replay and what TDLM is measuring.

      This is indeed an important point that has garnered relatively little attention. While there is some evidence of a relation to hippocampal replay in form of high-frequency power increase in the hippocampus, ultimately it is not possible to know without intracranial recordings, as signal strength from those regions is rather poor in MEG.

      We have added the following segment to the manuscript that discusses these issues:

      “However, while we are using indices of SWRs as a proxy for replay density estimation, the relationship between hippocampal replay and replay detected by TDLM remains uncertain. While current decoding approaches measure replay-like phenomena on cortical sites, previous papers have reported a power increase in hippocampal areas coinciding with replay episodes as detected by TDLM. Nevertheless, it is conceivable that cortical replay found by TDLM could occur independently of hippocampal replay and SWRs and be generated by different mechanisms. Some TDLM-studies find a replay state-to-state time lag of above 100 ms, much slower than e.g. previously reported place cell replay. Future studies should employ simultaneous intracranial and cortical surface recordings to establish the relationship between hippocampal replay and replay found by TDLM.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Zeng et al. have investigated the impact of inhibiting lactate dehydrogenase (LDH) on glycolysis and the tricarboxylic acid cycle. LDH is the terminal enzyme of aerobic glycolysis or fermentation that converts pyruvate and NADH to lactate and NAD+ and is essential for the fermentation pathway as it recycles NAD+ needed by upstream glyceraldehyde-3-phosphate dehydrogenase. As the authors point out in the introduction, multiple published reports have shown that inhibition of LDH in cancer cells typically leads to a switch from fermentative ATP production to respiratory ATP production (i.e., glucose uptake and lactate secretion are decreased, and oxygen consumption is increased). The presumed logic of this metabolic rearrangement is that when glycolytic ATP production is inhibited due to LDH inhibition, the cell switches to producing more ATP using respiration. This observation is similar to the well-established Crabtree and Pasteur effects, where cells switch between fermentation and respiration due to the availability of glucose and oxygen. Unexpectedly, the authors observed that inhibition of LDH led to inhibition of respiration and not activation as previously observed. The authors perform rigorous measurements of glycolysis and TCA cycle activity, demonstrating that under their experimental conditions, respiration is indeed inhibited. Given the large body of work reporting the opposite result, it is difficult to reconcile the reasons for the discrepancy. In this reviewer's opinion, a reason for the discrepancy may be that the authors performed their measurements 6 hours after inhibiting LDH. Six hours is a very long time for assessing the direct impact of a perturbation on metabolic pathway activity, which is regulated on a timescale of seconds to minutes. The observed effects are likely the result of a combination of many downstream responses that happen within 6 hours of inhibiting LDH that causes a large decrease in ATP production, inhibition of cell proliferation, and likely a range of stress responses, including gene expression changes.

      Strengths:

      The regulation of metabolic pathways is incompletely understood, and more research is needed, such as the one conducted here. The authors performed an impressive set of measurements of metabolite levels in response to inhibition of LDH using a combination of rigorous approaches.

      Weaknesses:

      Glycolysis, TCA cycle, and respiration are regulated on a timescale of seconds to minutes. The main weakness of this study is the long drug treatment time of 6 hours, which was chosen for all the experiments. In this reviewer's opinion, if the goal was to investigate the direct impact of LDH inhibition on glycolysis and the TCA cycle, most of the experiments should have been performed immediately after or within minutes of LDH inhibition. After 6 hours of inhibiting LDH and ATP production, cells undergo a whole range of responses, and most of the observed effects are likely indirect due to the many downstream effects of LDH and ATP production inhibition, such as decreased cell proliferation, decreased energy demand, activation of stress response pathways, etc.

      We thank reviewer for the careful reading of our manuscript, the accurate summary of the prevailing model, and the positive assessment of the rigor of our measurements. We agree that much prior literature reports increased oxygen consumption following LDH inhibition, and we recognize that our finding—coordinated suppression of glycolysis, the TCA cycle, and OXPHOS—differs from this prevailing interpretation. We address below the reviewer’s main concern regarding the 6-hour time point and clarify the conceptual scope of our study.

      (1) Scope: steady-state metabolic regulation versus immediate transient effects

      The reviewer raises an important point that many metabolic perturbations can trigger rapid, transient responses within seconds to minutes, whereas our measurements were performed after sustained LDH inhibition. We agree that very early time points would be required if the primary goal were to isolate the most immediate, proximal consequence of LDH inhibition before downstream propagation. However, the objective of our study is different: we aim to characterize the metabolic steady state re-established after sustained inhibition of LDH activity, because this adapted steady state is more relevant for understanding long-term metabolic consequences and therapeutic outcomes of LDH inhibition in cancer cells.

      (2) Genetic LDHA/LDHB knockout: comparison of two steady states

      A related point applies to the LDHA/LDHB knockout models. We fully agree that the knockout process necessarily involves a temporal perturbation during cell line generation and adaptation. Nevertheless, the experimental comparison in our study is explicitly between two steady states: the baseline steady state of control cells and the steady state achieved after stable genetic disruption of LDHA or LDHB. The observation that LDHA or LDHB knockout alone had minimal effects on glycolysis and respiration indicates that partial reduction of LDH activity can be compensated in a steady-state manner, consistent with the exceptionally high catalytic capacity of LDH in cancer cells relative to upstream rate-limiting enzymes.

      (3) LDH-activity-dependent quantitative relationships support stable metabolic states

      Importantly, our conclusions do not rely on a single inhibitor condition at a single time point. Rather, we established quantitative steady-state relationships between residual LDH activity and pathway behavior across a wide range of LDH inhibition. These LDH-activity-dependent data strongly support that the system resides in stable metabolic states at different degrees of LDH activity, rather than reflecting non-specific collapse due to prolonged stress.

      Specifically, we observed that when LDH activity was reduced from 100% to approximately ~9% (e.g., by genetic perturbation and partial pharmacologic inhibition), glucose consumption and lactate production remained essentially unchanged, indicating maintenance of a steady-state glycolytic flux despite substantial LDH inhibition. Only when LDH activity was further reduced below this threshold did glycolytic flux decrease in a graded manner, consistent with a nonlinear control structure (Figure 8 A & B)).

      Likewise, the isotope tracing results showed distinct LDH-activity-dependent transitions in TCA cycle labeling patterns. Over the range in which LDH activity decreased from 100% to ~9%, the [<sup>13</sup>C<sub>6</sub>]glucose-derived labeling pattern of citrate remained largely unchanged, whereas deeper inhibition led to a decrease in m2 citrate with a compensatory rise in higher-order citrate isotopologues, consistent with altered flux entry versus cycling/retention in the TCA cycle (Figure 8C). Similarly, [<sup>13</sup>C<sub>5</sub>]glutamine tracing revealed that deeper LDH inhibition reduced the direct m5 contribution, accompanied by corresponding shifts in other isotopologues (Figure 8D). These graded, quantitative transitions—rather than an abrupt global failure—support the interpretation of distinct metabolic steady states across LDH activity levels, linking LDH inhibition to changes in both glycolysis and mitochondrial metabolism.

      (4) Reconciling discrepancies with prior studies

      We agree that multiple prior studies have reported increased oxygen consumption or enhanced oxidative metabolism following LDH inhibition in cancer cells. However, we note that this prevailing notion often persists because LDH inhibition is frequently discussed by analogy to the classical Pasteur and Crabtree effects, in which cells toggle between fermentation and respiration depending on oxygen and glucose availability. We believe this analogy can be misleading.

      In the Pasteur effect, the metabolic shift is primarily driven by oxygen limitation, i.e., restriction of the terminal electron acceptor for the mitochondrial electron transport chain, which enforces reliance on fermentation. In the Crabtree effect, high glucose availability suppresses respiration through regulatory mechanisms while glycolysis is strongly activated. Both phenomena are fundamentally controlled by oxygen availability and respiratory capacity, rather than by inhibition of a specific cytosolic enzyme.

      By contrast, LDH inhibition is mechanistically distinct: it directly perturbs cytosolic redox recycling by limiting NADH-to-NAD<sup>+</sup> regeneration and can therefore constrain upstream glycolytic flux (particularly at GAPDH) and reshape pathway thermodynamics. Under conditions where LDH inhibition sufficiently limits effective NAD<sup>+</sup> availability and reduces glycolytic flux into pyruvate, the downstream consequence is reduced carbon input into the TCA cycle and suppressed OXPHOS—consistent with our experimental measurements. We therefore suggest that divergent outcomes reported across studies likely reflect differences in residual LDH activity, cell-type–specific metabolic wiring, and the extent to which glycolytic flux remains sustained versus becoming redox-limited upstream, rather than a universal Pasteur/Crabtree-like “switch” from fermentation to respiration. Accordingly, interpreting LDH inhibition as a Pasteur/Crabtree-like toggle may oversimplify the biochemical consequences of disrupting cytosolic NAD<sup>+</sup> regeneration.

      We have revised the Discussion to clarify this conceptual distinction and to avoid relying on comparisons that are not mechanistically equivalent to LDH inhibition.

      Reviewer #2 (Public Review):

      Summary:

      Zeng et al. investigated the role of LDH in determining the metabolic fate of pyruvate in HeLa and 4T1 cells. To do this, three broad perturbations were applied: knockout of two LDH isoforms (LDH-A and LDH-B), titration with a non-competitive LDH inhibitor (GNE-140), and exposure to either normoxic (21% O2) or hypoxic (1% O2) conditions. They show that knockout of either LDH isoform alone, though reducing both protein level and enzyme activity, has virtually no effect on either the incorporation of a stable 13C-label from a 13C6-glucose into any glycolytic or TCA cycle intermediate, nor on the measured intracellular concentrations of any glycolytic intermediate (Figure 2). The only apparent exception to this was the NADH/NAD+ ratio, measured as the ratio of F420/F480 emitted from a fluorescent tag (SoNar).

      The addition of a chemical inhibitor, on the other hand, did lead to changes in glycolytic flux, the concentrations of glycolytic intermediates, and in the NADH/NAD+ ratio (Figure 3). Notably, this was most evident in the LDH-B-knockout, in agreement with the increased sensitivity of LDH-A to GNE-140 (Figure 2). In the LDH-B-knockout, increasing concentrations of GNE-140 increased the NADH/NAD+ ratio, reduced glucose uptake, and lactate production, and led to an accumulation of glycolytic intermediates immediately upstream of GAPDH (GA3P, DHAP, and FBP) and a decrease in the product of GAPDH (3PG). They continue to show that this effect is even stronger in cells exposed to hypoxic conditions (Figure 4). They propose that a shift to thermodynamic unfavourability, initiated by an increased NADH/NAD+ ratio inhibiting GAPDH explains the cascade, calculating ΔG values that become progressively more endergonic at increasing inhibitor concentrations.

      Then - in two separate experiments - the authors track the incorporation of 13C into the intermediates of the TCA cycle from a 13C6-glucose and a 13C5-glutamine. They use the proportion of labelled intermediates as a proxy for how much pyruvate enters the TCA cycle (Figure 5). They conclude that the inhibition of LDH decreases fermentation, but also the TCA cycle and OXPHOS flux - and hence the flux of pyruvate to all of those pathways. Finally, they characterise the production of ATP from respiratory or fermentative routes, the concentration of a number of cofactors (ATP, ADP, AMP, NAD(P)H, NAD(P)+, and GSH/GSSG), the cell count, and cell viability under four conditions: with and without the highest inhibitor concentration, and at norm- and hypoxia. From this, they conclude that the inhibition of LDH inhibits the glycolysis, the TCA cycle, and OXPHOS simultaneously (Figure 7).

      Strengths:

      The authors present an impressively detailed set of measurements under a variety of conditions. It is clear that a huge effort was made to characterise the steady-state properties (metabolite concentrations, fluxes) as well as the partitioning of pyruvate between fermentation as opposed to the TCA cycle and OXPHOS.

      A couple of intermediary conclusions are well supported, with the hypothesis underlying the next measurement clearly following. For instance, the authors refer to literature reports that LDH activity is highly redundant in cancer cells (lines 108 - 144). They prove this point convincingly in Figure 1, showing that both the A- and B-isoforms of LDH can be knocked out without any noticeable changes in specific glucose consumption or lactate production flux, or, for that matter, in the rate at which any of the pathway intermediates are produced. Pyruvate incorporation into the TCA cycle and the oxygen consumption rate are also shown to be unaffected.

      They checked the specificity of the inhibitor and found good agreement between the inhibitory capacity of GNE-140 on the two isoforms of LDH and the glycolytic flux (lines 229 - 243). The authors also provide a logical interpretation of the first couple of consequences following LDH inhibition: an increased NADH/NAD+ ratio leading to the inhibition of GAPDH, causing upstream accumulations and downstream metabolite decreases (lines 348 - 355).

      Weaknesses:

      Despite the inarguable comprehensiveness of the data set, a number of conceptual shortcomings afflict the manuscript. First and foremost, reasoning is often not pursued to a logical conclusion. For instance, the accumulation of intermediates upstream of GAPDH is proffered as an explanation for the decreased flux through glycolysis. However, in Figure 3C it is clear that there is no accumulation of the intermediates upstream of PFK. It is unclear, therefore, how this traffic jam is propagated back to a decrease in glucose uptake. A possible explanation might lie with hexokinase and the decrease in ATP (and constant ADP) demonstrated in Figure 6B, but this link is not made.

      We appreciate the reviewer's critical comment. In Figure 3C, there is no accumulation of F6P or G6P, which are upstream of PFK1. This is because the PFK1-catalyzed reaction sets a significant thermodynamic barrier. Even with treatment using 30 μM GNE-140, the ∆G<sub>PFK1</sub> (Gibbs free energy of the PFK1-catalyzed reaction) remains -9.455 kJ/mol (Figure 3D), indicating that the reaction is still far from thermodynamic equilibrium, thereby preventing the accumulation of F6P and G6P.

      We agree with the reviewer that hexokinase inhibition may play a role, this requires further investigation.

      The obvious link between the NADH/NAD+ ratio and pyruvate dehydrogenase (PDH) is also never addressed, a mechanism that might explain how the pyruvate incorporation into the TCA cycle is impaired by the inhibition of LDH (the observation with which they start their discussion, lines 511 - 514).

      We agree with the reviewer’s comment. In this study, we did not explore how the inhibition of LDH affects pyruvate incorporation into the TCA cycle. As this mechanism was not investigated, we have titled the study:

      "Elucidating the Kinetic and Thermodynamic Insights into the Regulation of Glycolysis by Lactate Dehydrogenase and Its Impact on the Tricarboxylic Acid Cycle and Oxidative Phosphorylation in Cancer Cells."

      It was furthermore puzzling how the ΔG, calculated with intracellular metabolite concentrations (Figures 3 and 4) could be endergonic (positive) for PGAM at all conditions (also normoxic and without inhibitor). This would mean that under the conditions assayed, glycolysis would never flow completely forward. How any lactate or pyruvate is produced from glucose, is then unexplained.

      This issue also concerned me during the study. However, given the high reproducibility of the data, we consider it is true, but requires explanation. The PGAM-catalyzed reaction is tightly linked to both upstream and downstream reactions in the glycolytic pathway. In glycolysis, three key reactions catalyzed by HK2, PFK1, and PK are highly exergonic, providing the driving force for the conversion of glucose to pyruvate. The other reactions, including the one catalyzed by PGAM, operate near thermodynamic equilibrium and primarily serve to equilibrate glycolytic intermediates rather than control the overall direction of glycolysis, as previously described by us (J Biol Chem. 2024 Aug8;300(9):107648).

      The endergonic nature of the PGAM-catalyzed reaction does not prevent it from proceeding in the forward direction. Instead, the directionality of the pathway is dictated by the exergonic reaction of PFK1 upstream, which pushes the flux forward, and by PK downstream, which pulls the flux through the pathway. The combined effects of PFK1 and PK may account for the observed endergonic state of the PGAM reaction.

      However, if the PGAM-catalyzed reaction were isolated from the glycolytic pathway, it would tend toward equilibrium and never surpass it, as there would be no driving force to move the reaction forward.

      Finally, the interpretation of the label incorporation data is rather unconvincing. The authors observe an increasing labelled fraction of TCA cycle intermediates as a function of increasing inhibitor concentration. Strangely, they conclude that less labelled pyruvate enters the TCA cycle while simultaneously less labelled intermediates exit the TCA cycle pool, leading to increased labelling of this pool. The reasoning that they present for this (decreased m2 fraction as a function of DHE-140 concentration) is by no means a consistent or striking feature of their titration data and comes across as rather unconvincing. Yet they treat this anomaly as resolved in the discussion that follows.

      GNE-140 treatment increased the labeling of TCA cycle intermediates by [<sup>13</sup>C<sub>6</sub>]glucose but decreased the OXPHOS rate, we consider the conflicting results as an 'anomaly' that warrants further explanation. To address this, we analyzed the labeling pattern of TCA cycle intermediates using both [<sup>13</sup>C<sub>6</sub>]glucose and [<sup>13</sup>C<sub>5</sub>]glutamine. Tracing the incorporation of glucose- and glutamine-derived carbons into the TCA cycle suggests that LDH inhibition leads to a reduced flux of glucose-derived acetyl-CoA into the TCA cycle, coupled with a decreased flux of glutamine-derived α-KG, and a reduction in the efflux of intermediates from the cycle. These results align with theoretical predictions. Under any condition, the reactions that distribute TCA cycle intermediates to other pathways must be balanced by those that replenish them. In the GNE-140 treatment group, the entry of glutamine-derived carbon into the TCA cycle was reduced, implying that glucose-derived carbon (as acetyl-CoA) entering the TCA cycle must also be reduced, or vice versa.

      This step-by-step investigation is detailed under the subheading "The Effect of LDHB KO and GNE-140 on the Contribution of Glucose Carbon to the TCA Cycle and OXPHOS" in the Results section in the manuscript.

      In the Discussion, we emphasize that caution should be exercised when interpreting isotope tracing data. In this study, treatment of cells with GNE-140 led to an increase labeling percentage of TCA cycle intermediates by [<sup>13</sup>C<sub>6</sub>]glucose (Figure 5A-E). However, this does not necessarily imply an increase in glucose carbon flux into TCA cycle; rather, it indicates a reduction in both the flux of glucose carbon into TCA cycle and the flux of intermediates leaving TCA cycle. When interpreting the data, multiple factors must be considered, including the carbon-13 labeling pattern of the intermediates (m1, m2, m3, ---) (Figure 5G-K), replenishment of intermediates by glutamine (Figure 5M-V), and mitochondrial oxygen consumption rate (Figure 5W). All these factors should be taken into account to derive a proper interpretation of the data.

      Reviewer #3 (Public Review):

      Hu et al in their manuscript attempt to interrogate the interplay between glycolysis, TCA activity, and OXPHOS using LDHA/B knockouts as well as LDH-specific inhibitors. Before I discuss the specifics, I have a few issues with the overall manuscript. First of all, based on numerous previous studies it is well established that glycolysis inhibition or forcing pyruvate into the TCA cycle (studies with PDKs inhibitors) leads to upregulation of TCA cycle activity, and OXPHOS, activation of glutaminolysis, etc (in this work authors claim that lowered glycolysis leads to lower levels of TCA activity/OXPHOS). The authors in the current work completely ignore recent studies that suggest that lactate itself is an important signaling metabolite that can modulate metabolism (actual mechanistic insights were recently presented by at least two groups (Thompson, Chouchani labs). In addition, extensive effort was dedicated to understanding the crosstalk between glycolysis/TCA cycle/OXPHOS using metabolic models (Titov, Rabinowitz labs). I have several comments on how experiments were performed. In the Methods section, it is stated that both HeLa and 4T1 cells were grown in RPMI-1640 medium with regular serum - but under these conditions, pyruvate is certainly present in the medium - this can easily complicate/invalidate some findings presented in this manuscript. In LDH enzymatic assays as described with cell homogenates controls were not explained or presented (a lot of enzymes in the homogenate can react with NADH!). One of the major issues I have is that glycolytic intermediates were measured in multiple enzyme-coupled assays. Although one might think it is a good approach to have quantitative numbers for each metabolite, the way it was done is that cell homogenates (potentially with still traces of activity of multiple glycolytic enzymes) were incubated with various combinations of the SAME enzymes and substrates they were supposed to measure as a part of the enzyme-based cycling reaction. I would prefer to see a comparison between numbers obtained in enzyme-based assays with GC-MS/LC-MS experiments (using calibration curves for respective metabolites, of course). Correct measurements of these metabolites are crucial especially when thermodynamic parameters for respective reactions are calculated. Concentrations of multiple graphs (Figure 1g etc.) are in "mM", I do not think that this is correct.

      We thank the reviewer’s comment and the following are clarification of the conceptual framework, the quantitative methodology, and the experimental basis supporting our conclusions.

      (1) “It is well established that glycolysis inhibition or forcing pyruvate into the TCA cycle… leads to upregulation of TCA/OXPHOS… (authors claim lowered glycolysis leads to lower TCA/OXPHOS)”

      This framing is not accurate in the context of our study. PDK inhibition and LDH inhibition are fundamentally different perturbations. PDK inhibition directly promotes mitochondrial pyruvate oxidation by enabling PDH flux, whereas LDH inhibition primarily perturbs cytosolic redox balance (free NADH/NAD<sup>+</sup>) and thereby constrains upstream glycolytic reactions, particularly the GAPDH step. Therefore, the metabolic outcomes of these interventions are not expected to be identical and should not be treated as interchangeable.

      Importantly, we do not “ignore” prior studies proposing increased OXPHOS after LDH inhibition; we explicitly cite and summarize this prevailing interpretation in the Introduction. Our study was motivated precisely because this interpretation does not resolve key quantitative inconsistencies, including (i) the large mismatch between glycolytic flux and mitochondrial oxidative capacity, and (ii) the exceptionally high catalytic capacity of LDH relative to upstream rate-limiting glycolytic enzymes. These constraints raise a mechanistic question: how does LDH inhibition actually suppress glycolytic flux in intact cancer cells, and what are the consequences for TCA cycle and OXPHOS?

      Our central contribution is the identification of a biochemical mechanism supported by integrated measurements of fluxes, metabolite concentrations, redox state, and reaction thermodynamics: LDH inhibition increases free NADH/NAD<sup>+</sup>, decreases free NAD<sup>+</sup> availability, inhibits GAPDH, drives accumulation/depletion patterns in glycolytic intermediates, shifts Gibbs free energies of near-equilibrium reactions (PFK1–PGAM segment), suppresses pyruvate production, and consequently reduces carbon input into TCA cycle and OXPHOS. These analyses are not provided by most prior work and directly address the mechanistic gap.

      (2) Lactate signaling (Thompson/Chouchani) and metabolic modeling (Titov/Rabinowitz)

      These research directions are valuable, but they address questions that are different from the one investigated here. Our manuscript focuses on steady-state biochemical control of metabolic flux by LDH inhibition through redox-linked kinetics and pathway thermodynamics.

      (3) Pyruvate in RPMI

      Pyruvate in standard medium does not invalidate our conclusions. All experimental comparisons were performed under identical conditions across groups, and the major conclusions rely on orthogonal measurements including glycolytic flux (glucose consumption/lactate production), OCR profiling, and isotope tracing with [<sup>13</sup>C<sub>6</sub>]glucose and [<sup>13</sup>C<sub>5</sub>] glutamine, which directly quantify carbon entry into lactate and TCA cycle intermediates. These tracer-based results are not confounded by unlabeled extracellular pyruvate in a way that would reverse the mechanistic conclusions.

      (4) LDH activity assay in homogenates and “many enzymes can react with NADH”

      This concern is overstated. In the LDH assay, substrates are pyruvate + NADH, and the measured signal reflects NADH oxidation coupled to pyruvate reduction. In cell lysates, LDH is uniquely abundant and catalytically efficient for this reaction pair, and the inhibitor-response behavior matches the known LDHA/LDHB selectivity of GNE-140 and the cellular phenotypes. Thus, the assay is mechanistically specific in this context.

      (5) Enzyme-coupled metabolite assays and request for LC–MS validation

      The reviewer’s implication that enzyme-coupled assays are intrinsically unreliable is incorrect. Enzymatic cycling assays are a widely used quantitative approach when performed with proper specificity and calibration, and they are particularly useful for labile glycolytic intermediates that are challenging to quantify reproducibly by MS without specialized quenching, derivatization, and isotope dilution standards.

      We agree that MS-based quantification is valuable, and we have developed LC–MS methods for selected metabolites. However, absolute quantification of these intermediates remains technically difficult due to the inherent limitation of this method and, in our hands, did not provide uniformly robust performance for all intermediates required for thermodynamic analysis.

      (6) Units (“mM”)

      The metabolite concentration units are correct.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      If the goal is to investigate the direct impact of LDH inhibition, then in my opinion, most of these experiments need to be repeated at a very early time point immediately after or a few minutes after LDH inhibition. I understand that this is a tremendous amount of work that the authors might not want to pursue. I do want to highlight that the quality of the experiments performed in this work is impressive. I hope the authors continue investigating this subject and look forward to reading their future manuscripts on this topic.

      We thank the reviewer for this thoughtful and constructive comment and for the positive assessment of the experimental quality of our work.

      We fully agree that measurements at very early time points after LDH inhibition would be required if the goal were to isolate an immediate, proximal molecular event occurring before downstream propagation. However, the primary objective of our study is not to dissect a single instantaneous biochemical consequence of LDH inhibition, but rather to characterize the metabolic steady state that is re-established after sustained suppression of LDH activity, which we believe is more relevant for understanding the long-term metabolic and therapeutic consequences of LDH inhibition in cancer cells.

      (1) Scope: steady-state metabolic regulation versus immediate transient effects

      The reviewer raises an important point that many metabolic perturbations can trigger rapid, transient responses within seconds to minutes, whereas our measurements were performed after sustained LDH inhibition. We agree that very early time points would be required if the primary goal were to isolate the most immediate, proximal consequence of LDH inhibition before downstream propagation. However, the objective of our study is different: we aim to characterize the metabolic steady state re-established after sustained inhibition of LDH activity, because this adapted steady state is more relevant for understanding long-term metabolic consequences and therapeutic outcomes of LDH inhibition in cancer cells.

      (2) Genetic LDHA/LDHB knockout: comparison of two steady states

      A related point applies to the LDHA/LDHB knockout models. We fully agree that the knockout process necessarily involves a temporal perturbation during cell line generation and adaptation. Nevertheless, the experimental comparison in our study is explicitly between two steady states: the baseline steady state of control cells and the steady state achieved after stable genetic disruption of LDHA or LDHB. The observation that LDHA or LDHB knockout alone had minimal effects on glycolysis and respiration indicates that partial reduction of LDH activity can be compensated in a steady-state manner, consistent with the exceptionally high catalytic capacity of LDH in cancer cells relative to upstream rate-limiting enzymes.

      (3) LDH-activity-dependent quantitative relationships support stable metabolic states

      Importantly, our conclusions do not rely on a single inhibitor condition at a single time point. Rather, we established quantitative steady-state relationships between residual LDH activity and pathway behavior across a wide range of LDH inhibition. These LDH-activity-dependent data strongly support that the system resides in stable metabolic states at different degrees of LDH activity, rather than reflecting non-specific collapse due to prolonged stress.

      Specifically, we observed that when LDH activity was reduced from 100% to approximately ~9% (e.g., by genetic perturbation and partial pharmacologic inhibition), glucose consumption and lactate production remained essentially unchanged, indicating maintenance of a steady-state glycolytic flux despite substantial LDH inhibition. Only when LDH activity was further reduced below this threshold did glycolytic flux decrease in a graded manner, consistent with a nonlinear control structure.

      Likewise, the isotope tracing results showed distinct LDH-activity-dependent transitions in TCA cycle labeling patterns. Over the range in which LDH activity decreased from 100% to ~9%, the [<sup>13</sup>C<sub>6</sub>]glucose-derived labeling pattern of citrate remained largely unchanged, whereas deeper inhibition led to a decrease in m2 citrate with a compensatory rise in higher-order citrate isotopologues, consistent with altered flux entry versus cycling/retention in the TCA cycle. Similarly, [<sup>13</sup>C<sub>5</sub>]glutamine tracing revealed that deeper LDH inhibition reduced the direct m5 contribution, accompanied by corresponding shifts in other isotopologues. These graded, quantitative transitions—rather than an abrupt global failure—support the interpretation of distinct metabolic steady states across LDH activity levels, linking LDH inhibition to changes in both glycolysis and mitochondrial metabolism.

      Reviewer #2 (Recommendations For The Authors):

      All in all, the authors would benefit from collaboration with a group more well-versed in quantitative aspects of metabolism (such as Metabolic Control Analysis) and modelling methods (such as flux analysis) to boost the interpretation and impact of their really nice data set.

      We sincerely thank the reviewer for this insightful and constructive suggestion. We fully agree that collaboration with groups specializing in quantitative metabolic analysis, such as Metabolic Control Analysis and flux modeling, would further expand the interpretative depth and broader impact of this work.

      The primary objective of the present work, however, was not to construct a global mathematical model, but to experimentally dissect the biochemical mechanism by which LDH inhibition coordinately suppresses glycolysis, the TCA cycle, and OXPHOS, integrating enzyme kinetics with thermodynamic constraints at steady state. Within this scope, we focused on experimentally demonstrable relationships between LDH activity, redox balance, GAPDH perturbation, thermodynamic shifts in near-equilibrium reactions, and emergent flux suppression.

      We fully recognize the power of MCA and related modeling approaches in formalizing control coefficients and system-level sensitivities, and we view our dataset as particularly well suited to support such future analyses. We therefore see this work as providing a robust experimental platform upon which more comprehensive quantitative modeling can be built, either in future studies or through collaboration with specialists in metabolic modeling.

      Reviewer #3 (Recommendations For The Authors):

      We sincerely thank the reviewer for the important suggestions.

      (1) I strongly disagree that "regulation of glycolytic flux".. "remained largely unexplored.”

      Our original wording was meant to emphasize not the absence of prior work on glycolytic flux regulation, but rather that the specific biochemical mechanism by which LDH regulates glycolytic flux—particularly through the integrated effects of enzyme kinetics, redox balance, and thermodynamic constraints within the pathway—has not been fully elucidated.

      To avoid any ambiguity or overstatement, we have revised the relevant text to more precisely reflect this intent. The revised wording now reads:

      “This study elucidates a biochemical mechanism by which lactate dehydrogenase influences glycolytic flux in cancer cells, revealing a kinetic–thermodynamic interplay that contributes to metabolic regulation.”

      We believe this revised phrasing more accurately acknowledges prior work while clearly defining the specific mechanistic contribution of the present study.

      (2) Very confusing in the Introduction section: "If LDH is inhibited at the LDH step..”

      We sincerely thank the reviewer for pointing out the potential confusion caused by the phrase “If LDH is inhibited at the LDH step” in the Introduction.

      Our intention was to contrast two conceptual models of LDH inhibition. The first is the conventional view, in which the effect of LDH inhibition is assumed to be confined to the LDH-catalyzed reaction itself, leading primarily to local accumulation of pyruvate and its redirection toward mitochondrial metabolism. The second, which is supported by our data, is that LDH inhibition initiates a system-wide biochemical response, perturbing redox balance, upstream enzyme kinetics, and the thermodynamic state of the glycolytic pathway, ultimately resulting in coordinated suppression of glycolysis, the TCA cycle, and OXPHOS.

      We agree that the original phrasing was ambiguous and potentially misleading. To improve clarity, we have revised the text as follows:

      “If the effect of LDH inhibition were confined solely to its catalytic step…”

      (3) The entire introduction part when the authors attempt to explain how decreased glycolysis will lead to decreased mitochondrial respiration is confusing.

      We would like to clarify that the Introduction does not attempt to explain how decreased glycolysis leads to decreased mitochondrial respiration. Rather, the final paragraph of the Introduction is intended to highlight an unresolved conceptual inconsistency in the existing literature and to motivate the central question addressed in this study.

      Specifically, we summarize the prevailing view that LDH inhibition redirects pyruvate toward mitochondrial metabolism and enhances oxidative phosphorylation, and then point out that this interpretation is difficult to reconcile with quantitative considerations, such as the large disparity between glycolytic and mitochondrial flux capacities and the excess catalytic activity of LDH relative to upstream glycolytic enzymes. These observations are presented to emphasize that the biochemical mechanism linking LDH inhibition to changes in glycolysis and mitochondrial respiration has not been fully resolved.

      Importantly, the Introduction does not propose a mechanistic explanation for the observed suppression of mitochondrial respiration; rather, it poses this as an open question, which is then systematically addressed through experimental analysis in the Results section.

      (4) Line 144: "which is 81(HeLa-LDHAKO) -297(HeLa-Ctrl) times"- here and in many other places wording is confusing to the reader.

      Our intention was to emphasize the significant redundancy of LDH activity relative to hexokinase (HK), the first rate-limiting enzyme in the glycolysis pathway, in cancer cells.

      Specifically, we wanted to express that in HeLa-Ctrl cells, the total LDH activity is 297 times that of HK activity; while in HeLa-LDHAKO cells, although the total LDH activity decreased, it was still 81 times that of HK activity. This data comes from supplement Table 1 in the paper and aims to provide quantitative evidence for "why knocking out LDHA or LDHB alone is insufficient to significantly affect glycolysis flux," because the remaining LDH activity is still far higher than the HK activity at the pathway entrance, sufficient to maintain flux.

      Based on your suggestion, we rewrite it in the revised draft with a more specific statement: "...the total activity of LDH in HeLa cells is very high, which is 297-fold higher than the first rate-limiting enzyme HK activity in HeLa-Ctrl cells and 81-fold higher in HeLa-LDHAKO cells.”

      (5) Line 153: "in the following four aspects:"- but what are these aspects, the text below has no corresponding subtitles, etc.

      Our intention was to indicate that after LDHA or LDHB knockout alone failed to affect the glycolysis rate, we further explored its potential impact on the glycolytic pathway from four deeper perspectives: the glucose carbon to pyruvate and lactate, the glucose carbon to subsidiary branches of glycolysis, the concentration of glycolytic intermediates and the thermodynamic state of the pathway, and the redox state of cytosolic free NADH/NAD<sup>+</sup>.

      Following your valuable suggestion, we have now added the aforementioned clear subtitles to these four aspects in the revised manuscript.

      (6) Lines 193, another example of the very confusing statement: "The results suggested that the loss of total LDH concentration was compensated.."

      The actual catalytic activity (reaction rate) of LDH is determined by both its enzyme concentration and substrate concentration (pyruvate and NADH). When the total LDH protein concentration (enzyme amount) in the cell is reduced through gene knockout, the reaction equilibrium is disrupted. To maintain sufficient lactate production flux to support a high glycolysis rate, the cell compensates by increasing the concentration of one of the substrates—free NADH (as shown in Figure 1I). This results in an increased substrate concentration, despite a reduction in the amount of enzyme, thus partially maintaining the overall reaction rate.

      We have revised the original statement to more accurately describe this kinetic equilibrium process: "The decrease in total LDH concentration was counterbalanced by a concomitant increase in the concentration of its substrate, free NADH, thereby maintaining the reaction velocity.”

      (7) Line 222-223: "did not or marginally significantly affect....”

      Our intention is to reflect the complexity of the data in Figure 1. Specifically: Regarding "did not affect": This means that there were no statistically significant differences in most key parameters, such as glycolytic flux (glucose consumption rate, lactate production rate). Regarding "or marginally significantly affected": This means that in a few indicators, although statistical calculations showed p-values less than 0.05, the absolute value of the difference was very small, with limited biological significance.

      To clarify this, we rewrite it as: "...did not significantly affect glucose-derived pyruvate entering into TCA cycle, neither significantly affect mitochondrial respiration, although statistically significant but minimal changes were observed in a few specific parameters (e.g., m3-pyruvate% in medium).”

      (8) It is very confusing to use the same colors for three GNE-140 drug concentrations (Figure 2a-b) and for 3 different cell lines right next to each other (Figure 2c-d).

      The figures have been revised accordingly.

      (9) Lines 263-273: nothing is new here as oxidized NAD+ is required for run glycolysis and LDH inhibition/KO leads to a high NADH/NAD+ ratio; Also below it is well known that reductive stress blocks serine biosynthesis;

      It is well established that oxidized NAD<sup>+</sup> is required for glycolysis, that LDH inhibition or knockout increases the NADH/NAD<sup>+</sup> ratio, and that reductive stress can suppress serine biosynthesis. We did not intend to present these observations as novel.

      The key point of this section is not the qualitative requirement of NAD<sup>+</sup> for GAPDH, but rather the mechanistic alignment between LDH inhibition, changes in free NAD<sup>+</sup> availability, and the emergence of GAPDH as a flux-controlling step within the glycolytic pathway under steady-state conditions. Previous studies have largely treated the increase in NADH/NAD<sup>+</sup> following LDH inhibition as a correlative or downstream effect, without directly demonstrating how this redox shift quantitatively propagates upstream to reorganize glycolytic flux distribution and thermodynamic driving forces.

      In our study, we explicitly link LDH inhibition to (i) an increase in free NADH/NAD<sup>+</sup> ratio, (ii) inhibition of GAPDH activity in intact cells, (iii) accumulation of upstream glycolytic intermediates, (iv) suppression of serine biosynthesis from 3-phosphoglycerate, and critically, (v) coordinated shifts in the Gibbs free energies of reactions between PFK1 and PGAM. This integrated kinetic–thermodynamic framework goes beyond the established qualitative understanding of NAD<sup>+</sup> dependence and provides a pathway-level mechanism by which LDH activity controls glycolytic flux.

      (10) Lines 368-370: "... we reached an alternative interpretation of the data.."- does not provide much confidence.

      Our intention was to prudently emphasize that we proposed a new interpretation based on detailed data, differing from conventional views. Our interpretation is grounded in key and consistent evidence from dual isotope tracing experiments using [<sup>13</sup>C<sub>6</sub>]glucose and [<sup>13</sup>C<sub>5</sub>]glutamine: The [<sup>13</sup>C<sub>6</sub>]glucose tracing data: the labeling pattern of citrate, the starting product of TCA cycle, showed a significant decrease in m+2 %. This directly reflects a reduction in the flux of newly generated acetyl-CoA from glucose entering the TCA cycle. Simultaneously, the sum of other isotopologues % (m+1/ m+3/ m+4/m+5/m+6) increased, indicating a longer retention time of the labeled carbon in the cycle, implying a simultaneous decrease in the flux of cycle intermediates effluxed for biosynthesis. [<sup>13</sup>C<sub>5</sub>]Glutamine tracing data: the labeling pattern of α-ketoglutarate showed a decrease in m+5 %, indicating a reduction in glutamine replenishment flux. The pattern of change in the total percentage of other isotopologues % (m+1/ m+2/ m+3/m+4) also supports the conclusion of reduced intermediate product efflux.

      These two sets of data corroborate each other, pointing to a unified conclusion: LDH inhibition not only reduces carbon source inflow into the TCA cycle but also decreases intermediate product efflux, leading to a decrease in overall cycle activity. Therefore, our "alternative interpretation" is a well-supported and more consistent explanation of our overall experimental results. We revise the original wording to: "Integrated analysis of dual isotope tracing data demonstrates that LDH inhibition reduces both influx and efflux of the TCA cycle..."

      (11) Lines 418-421: This entire discussion on how TCA cycle activity is decreased upon LDH inhibition is very confusing. I also would like to see these tracer studies when ETC is inhibited with different inhibitors.

      We would like to clarify that the mitochondrial respiration rate data presented in Figure 5W are based on studies using different ETC inhibitors, and the cell treatment conditions (including culture time, etc.) for these oxygen consumption measurements are consistent with the conditions for the [<sup>13</sup>C<sub>6</sub>]glucose and [<sup>13</sup>C<sub>5</sub>]glutamine isotope tracing experiments (Figure 5A-V). Therefore, the changes in TCA cycle flux revealed by the tracing data and the inhibition of OXPHOS rate shown by the respiration measurements are mutually corroborating evidence from the same experimental conditions.

      (12) Figure 6F, G - very limited representation of growth curves, why not perform these experiments with all corresponding cell lines and over multiple days. Especially since proliferation arrest vs cell death was implicated.

      We have provided the growth curves of the HeLa-Ctrl and HeLa-LDHAKO cell lines under the corresponding treatments in Figure 6—figure supplement 1, as a supplement to Figure 6F, G (HeLa-LDHBKO cells). The choice of 48 hours as the cutoff observation point is based on clear biological evidence: under the stress of hypoxia (1% O<sub>2</sub>) combined with GNE-140 treatment, HeLa-LDHBKO cells experienced substantial death within 24 to 48 hours, at which point the differences in the growth curves were already very significant.

      (13) Move most of the Supplementary tables into an Excel file - so values can be easily accessed.

      We have compiled the tables into an Excel file and submitted it along with the revised manuscript as supplementary material.

      (14) Consider changing colors to more appealing- especially jarring is a bright blue, red, black combination on many bar graphs.

      We have adjusted the color scheme of the figures (especially the bar graphs) in the paper, and have submitted them with the revised manuscript.

      (15) Double check y-axis on multiple graphs it says "mM".

      We have checked y-axis, the unit (mM) is correct.

      (16) Instead TCA cycle use the TCA cycle.

      In the revised manuscript, TCA cycle is used.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, Chengjian Zhao et al. focused on the interactions between vascular, biliary, and neural networks in the liver microenvironment, addressing the critical bottleneck that the lack of high-resolution 3D visualization has hindered understanding of these interactions in liver disease.

      Strengths:

      This study developed a high-resolution multiplex 3D imaging method that integrates multicolor metallic compound nanoparticle (MCNP) perfusion with optimized CUBIC tissue clearing. This method enables the simultaneous 3D visualization of spatial networks of the portal vein, hepatic artery, bile ducts, and central vein in the mouse liver. The authors reported a perivascular structure termed the Periportal Lamellar Complex (PLC), which is identified along the portal vein axis. This study clarifies that the PLC comprises CD34<sup>+</sup>Sca-1<sup>+</sup> dual-positive endothelial cells with a distinct gene expression profile, and reveals its colocalization with terminal bile duct branches and sympathetic nerve fibers under physiological conditions.

      Comments on revisions:

      The authors very nicely addressed all concerns from this reviewer. There are no further concerns or comments.

      We sincerely thank the reviewer for the positive evaluation of the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The present manuscript of Xu et al. reports a novel clearing and imaging method focusing on the liver. The Authors simultaneously visualized the portal vein, hepatic artery, central vein, and bile duct systems by injected metal compound nanoparticles (MCNPs) with different colors into the portal vein, heart left ventricle, vena cava inferior and the extrahepatic bile duct, respectively. The method involves: trans-cardiac perfusion with 4% PFA, the injection of MCNPs with different colors, clearing with the modified CUBIC method, cutting 200 micrometer thick slices by vibratome, and then microscopic imaging. The Authors also perform various immunostaining (DAB or TSA signal amplification methods) on the tissue slices from MCNP-perfused tissue blocks. With the application of this methodical approach, the Authors report dense and very fine vascular branches along the portal vein. The authors name them as 'periportal lamellar complex (PLC)' and report that PLC fine branches are directly connected to the sinusoids. The authors also claim that these structures co-localize with terminal bile duct branches and sympathetic nerve fibers and contain endothelial cells with a distinct gene expression profile. Finally, the authors claim that PLC-s proliferate in liver fibrosis (CCl4 model) and act as scaffold for proliferating bile ducts in ductular reaction and for ectopic parenchymal sympathetic nerve sprouting.

      Strengths:

      The simultaneous visualization of different hepatic vascular compartments and their combination with immunostaining is a potentially interesting novel methodological approach.

      Weaknesses:

      This reviewer has some concerns about the validity of the microscopic/morphological findings as well as the transcriptomics results, and suggests that the conclusions of the paper may be critically viewed. Namely, at this point, it is still not fully clear that the 'periportal lamellar complex (PLC)' that the Authors describe really exists as a distinct anatomical or functional unit or these are fine portal branches that connect the larger portal veins into the adjacent sinusoid. Also, in my opinion, to identify the molecular characteristics of such small and spatially highly organized structures like those fine radial portal branches, the only way is to perform high-resolution spatial transcriptomics (instead of data mining in existing liver single cell database and performing Venn diagram intersection analysis in hepatic endothelial subpopulations). Yet, the existence of such structures with a distinct molecular profile cannot be excluded. Further research with advanced imaging and omics techniques (such as high resolution volume imaging, and spatial transcriptomics/proteomics) are needed to reproduce these initial findings.

      We thank the reviewer for the thoughtful and constructive comments. In response to the reviewer’s concerns regarding the anatomical and molecular definition of the periportal lamellar complex (PLC), we have further clarified the scope and methodological boundaries of the present study in the revised manuscript.

      Regarding the key question raised by the reviewer—namely, whether the PLC represents an independent anatomical or functional unit, or merely small portal venous branches connecting larger portal veins to adjacent sinusoids—we provide below a more detailed explanation of the criteria used to define the PLC in this study. The identification of the PLC is primarily based on periportal structures that can be reproducibly recognized by three-dimensional imaging across multiple mice, exhibiting a relatively consistent spatial distribution within the periportal region. The PLC could be stably observed across different MCNP dye color assignments and independent experimental batches. In addition, three-dimensional CD31 immunofluorescence consistently revealed vascular-associated signal distributions in the same periportal region, indirectly supporting its spatial association with the periportal vascular system.

      At the morphological level, the PLC appears as a periportal vasculature-associated structure distributed around the main portal vein trunk and maintains a relatively consistent spatial proximity to portal veins, bile ducts, and neural components in three-dimensional space. This highly conserved spatial organization across multiple tissue systems supports the anatomical positioning of the PLC as a relatively distinct structural tissue unit within the periportal region.

      The present study primarily focuses on a descriptive characterization of the three-dimensional anatomical organization and spatial relationships of the PLC based on volumetric imaging and vascular labeling strategies. As a complementary exploratory analysis, we reanalyzed endothelial cell populations potentially associated with the PLC using existing liver single-cell transcriptomic datasets. This analysis was intended to provide molecular-level information consistent with the structural observations and to offer preliminary clues to its potential biological functions, rather than to independently define the PLC at the spatial level or to functionally validate it.

      We fully acknowledge the value of spatial transcriptomic and spatial proteomic technologies in revealing molecular heterogeneity within tissue architecture. However, under current technical conditions, these approaches are largely dependent on thin tissue sections and are limited by spatial resolution and signal mixing effects, which still pose challenges for resolving periportal structures with pronounced three-dimensional continuity, such as the PLC. In the future, further integration of high-resolution volumetric imaging with spatial omics technologies may enable a more refined understanding of the molecular features and potential functions of the PLC at higher spatial resolution.

      Reviewer #3 (Public review):

      Summary:

      In the revised version of the manuscript authors addressed multiple comments, clarifying especially the methodological part of their work and PLC identification as a novel morphological feature of the adult liver portal veins. Tet is now also much clearer and has better flow.

      The additional assessment of the smartSeq2 data from Pietilä et al., 2025 strengthens the transcriptomic profiling of the CD34+Sca1+ cells and the discussion of the possible implications for the liver homeostasis and injury response. Why it may suffer from similar bias as other scRNA seq datasets - multiple cell fate signatures arising from mRNA contamination from proximal cells during dissociation, it is less likely that this would happen to yield so similar results.

      Nevertheless, a more thorough assessment by functional experimental approaches is needed to decipher the functional molecules and definite protein markers before establishing the PLC as the key hub governing the activity of biliary, arterial, and neuronal liver systems.

      The work does bring a clear new insight into the liver structure and functional units and greatly improves the methodological toolbox to study it even further, and thus fully deserves the attention of the Elife readers.

      Strengths:

      The authors clearly demonstrate an improved technique tailored to the visualization of the liver vasulo-biliary architecture in unprecedented resolution.

      This work proposes a new morphological feature of adult liver facilitating interaction between the portal vein, hepatic arteries, biliary tree, and intrahepatic innervation, centered at previously underappreciated protrusions of the portal veins - the Periportal Lamellar Complexes (PLCs).

      Weaknesses:

      The importance of CD34+Sca1+ endothelial cell subpopulation for PLC formation and function was not tested and warrants further validation.

      We thank the reviewer for the careful and constructive comments regarding the functional validation of cell populations associated with the PLC. The central aim of this study is to establish and validate a novel volumetric imaging and vascular labeling strategy and to apply it to the periportal region of the liver, thereby revealing previously underappreciated structural organizational patterns at the three-dimensional level, rather than to perform a systematic functional validation of specific cellular subpopulations.

      We agree that the precise roles of the CD34<sup>+</sup>Sca-1<sup>+</sup> endothelial cell subpopulation in the formation and function of the periportal lamellar complex (PLC) have not been directly addressed through functional intervention experiments in the present study. Our conclusions are primarily based on three-dimensional imaging and spatial distribution analyses, which reveal a stable and consistent spatial association between this cell population and the PLC structure, but are not intended to independently support causal or functional inferences. The underlying functional mechanisms remain to be elucidated in future studies using genetic or functional perturbation approaches.

      In light of these considerations, we have further refined the relevant statements in the revised manuscript to more clearly define the functional scope and limitations of the current study in the Discussion section, and to avoid functional interpretations that extend beyond the direct support of the data. At the same time, we consider functional validation of the PLC to be an important and promising direction for future investigation.

      It should be emphasized that the present study is not primarily designed to provide direct functional validation, but rather to systematically characterize the three-dimensional structural features of the periportal lamellar complex (PLC) and its cellular associations using volumetric imaging and vascular labeling approaches. At this stage, we mainly provide spatial and histological evidence for the organizational relationship between the PLC structure and the CD34<sup>+</sup>Sca-1<sup>+</sup> endothelial cell population, while their specific roles in PLC formation and functional regulation await further investigation.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      I highly appreciate the Authors' endeavors to improve the manuscript. I am enlisting those points (from my original review) where I still have further comments.

      (2) I would suggest this sentence:

      "...the liver has evolved a highly complex and densely organized ductal vascular-neuronal network in the body, consisting primarily of the portal vein system, central vein system, hepatic artery system, biliary system, and intrahepatic autonomic nerve network [6, 7]."

      We thank the reviewer for the valuable suggestion. We have revised the relevant sentence accordingly, and the revised wording is as follows:

      “The liver has evolved a highly complex and densely organized vascular–biliary–neural network, primarily composed of the portal venous system, central venous system, hepatic arterial system, biliary system, and the intrahepatic autonomic neural network.”

      (3) I suggest renaming 'clearing efficiency' to 'clearing time', and revise the last sentence like:

      '...The results showed that the average transmittance increased by 20.12% in 1mm-thick cleared tissue slices.'

      We thank the reviewer for this helpful suggestion. Accordingly, we have replaced the term “clearing efficiency” with “clearing time” and revised the final sentence to reflect this change. The revised wording is as follows:

      “The results showed that the average transmittance increased by 20.12% in cleared tissue slices with a thickness of 1 mm.”

      (4) While the dye perfusion was indeed on full lobe, FigS1F also seems to be rather a thick section instead of a full 3d reconstruction. This is OK, but please, be clear and specific about this in the respective part of the ms.

      We thank the reviewer for the careful review and detailed comments. We would like to clarify that Fig. S1F shows whole-lobe imaging of the mouse left liver lobe obtained after dye perfusion at the whole-liver scale, rather than an image derived from a thick tissue section. Although this image does not represent a three-dimensional reconstruction, it does reflect imaging of the entire left liver lobe at the macroscopic level.

      In addition, for the reviewer’s reference, we have provided in this response a representative image of a 200 μm-thick liver tissue section to directly illustrate the morphological differences between thick-section imaging and whole-lobe imaging. We note that the third and fourth panels in Fig. 1G of the main text already show local imaging results from 200 μm-thick sections; in contrast, the comparative image provided here presents a larger field of view and overall morphology. To avoid redundancy, this additional image is included solely for clarification in the present response and has not been incorporated into the revised manuscript or the supplementary materials.

      (11) Regarding the 'transmission quantification':

      'Regarding the comparative quantification of different clearing methods, as the reviewer noted, nearly all aqueous or organic solvent based clearing techniques can achieve relatively uniform transparency in 1 mm thick tissue sections, so differences at this thickness are limited.'

      So, based on all these, I think, measuring/comparisons of clearing efficacy in the present form are kind of pointless --- one may consider omitting this part.

      We thank the reviewer for the valuable comments. The purpose of the transmittance quantification in this study was not to provide a comprehensive comparison among different tissue-clearing methods, but rather to serve as a quantitative reference supporting the optimization of the Liver-CUBIC protocol. Accordingly, we have narrowed and clarified the relevant statements in the revised manuscript to define their scope and avoid overinterpretation.

      The revised text now reads as follows:

      “Importantly, Liver-CUBIC treatment did not induce significant tissue expansion (Figure 1B–D). In addition, quantitative transmittance measurements in 1-mm-thick cleared tissue slices showed an average increase of 20.12% (P < 0.0001; 95% CI: 19.14–21.09; Figure 1E).”

      Author response image 1.

      (16) It is OK, but please, indicate this clearly in the Methods/Results because in its present form it may be confusing for the reader: which color means what.

      We thank the reviewer for this helpful request for clarification. We agree that the previous wording may have caused confusion regarding the meaning of different MCNP colors. Accordingly, we have revised the Methods section and the relevant figure legends to clearly state that the color assignment of MCNP dyes is not fixed across different experiments or figures. The use of different colors serves solely for visualization and presentation purposes, facilitating the distinction of anatomical structures in multichannel and three-dimensional imaging, and does not indicate any fixed or intrinsic correspondence between a specific color and a particular vascular or ductal system. We believe that this clarification will help prevent misinterpretation and improve the overall clarity of the manuscript.

      (17) Still I think the hepatic artery is extremely shrunk, while the portal vein is extremely dilated. Please, note that in the referring figure (from Adori et al), hepatic artery and portal vein are ca 50 micrometers and 250 micrometers in diameter, respectively. In your figure, as I see, ca. 9-10 micrometers and 125 micrometers, respectively. This means 5x (Adori) vs. 13-14x differences (you). I would not say that this is necessarily problematic --- but may reflect some perfusion issues that may be good to consider.

      We thank the reviewer for the careful comparison and acknowledge the quantitative differences pointed out. Compared with the study by Adori et al., the diameter ratio between the hepatic artery and the portal vein in our images does indeed differ to some extent. We believe that this discrepancy primarily arises from methodological differences in imaging and analysis strategies between the two studies.

      In the work by Adori et al., periportal vasculature identification and three-dimensional segmentation were mainly based on 488 nm autofluorescence signals acquired from inverted tissues. This signal predominantly reflects the overall outline of periportal tissue regions rather than direct imaging of the vascular lumen itself. Consequently, the measured “vessel diameter” largely represents a spatial domain delineated by surrounding periportal structures, and does not necessarily correspond to the actual or functional luminal diameter of the vessel.

      In contrast, the present study employed fluorescent MCNP dye perfusion under low perfusion pressure, combined with tissue clearing and three-dimensional optical imaging. Under these experimental conditions, the measured vessel diameters more closely reflect the perfusable luminal space of vessels in a fixed state, rather than their maximally dilated diameter, and are not defined by the morphology of surrounding tissues. This distinction is particularly relevant for the hepatic artery: as a high-resistance, smooth muscle–rich vessel, its diameter is highly sensitive to perfusion pressure and post-excision changes in vascular tone. In comparison, the portal vein exhibits greater compliance and is relatively less affected by these factors.

      Based on these methodological differences, the observation of relatively smaller apparent hepatic arterial diameters—and consequently a higher arterial-to-portal vein diameter ratio—under dye perfusion–based optical imaging conditions is an expected outcome. Importantly, the primary focus of the present study is the identification and characterization of the periportal lamellar complex (PLC) as a three-dimensional lamellar tissue structure that can be stably and reproducibly recognized across different samples and imaging conditions, rather than absolute comparisons of vascular diameters.

      (21) After the presented documentation, I still have some concerns that the 'periportal lamellar complex (PLC)' that the Authors describe is really a distinct anatomical or functional unit. The confocal panel in Fig. 4F is nice and high quality. However, as far as I see, it shows that CD34+/Sca-1+ immunostaining is not specific for the presumptive PLCs in the peri-portal region. Instead, Sca-1 immunoreactivity is highly abundant also in the midzone --- to which the supposed PLCs do not extend, according to the cartoon shown in panel D, same figure. Notably, this questions also the specificity of the single cell analysis.

      We thank the reviewer for this detailed and important comment regarding the specificity of CD34<sup>+</sup>/Sca-1<sup>+</sup> markers and the definition of the periportal lamellar complex (PLC).

      It should be emphasized that the PLC is not defined on the basis of any single molecular marker, but rather by a reproducible periportal lamellar anatomical structure consistently revealed by three-dimensional imaging across multiple samples. The co-expression of CD34 and Sca-1 is interpreted within this clearly defined anatomical context and is used to characterize the molecular features of endothelial cells associated with the PLC structure.

      As shown in Fig. 4F, the co-expression of CD34 and Sca-1 delineates a continuous, lamellar endothelial structure surrounding the portal vein. In contrast, outside the periportal region—including the midlobular areas—Sca-1 or CD34 expression can also be detected, but these signals appear scattered and discontinuous, lacking an organized lamellar topology.

      In the single-cell transcriptomic analysis, we treated CD34<sup>+</sup>/Sca-1<sup>+</sup> endothelial cells as an operational population to explore molecular features that may be enriched in the microenvironment of the periportal lamellar complex (PLC). Importantly, this analysis was intended to provide molecular clues associated with the PLC, rather than to precisely assign spatial locations or identities to individual cells.

      Occasional isolated Sca-1<sup>+</sup> signals detected outside the periportal region do not affect the anatomical definition of the PLC, nor do they alter the interpretation of the single-cell analysis. These analyses serve to provide supportive and exploratory molecular information for the structural identification of the PLC, rather than constituting decisive spatial evidence.

      (23) '....In the manuscript, we have carefully stated that this analysis is exploratory in nature and have avoided overinterpretation. In future studies, high-resolution spatial omics approaches will be invaluable for more precisely delineating the molecular characteristics of these fine structures.'

      I do not find these statements either in the Discussion or in the Results. I must reiterate my opinion that the applied methodical approach in the single cell transcriptomics part has severe limitations, and the readers must be aware of this.

      We thank the reviewer for this further comment. We understand and acknowledge the reviewer’s concerns regarding the methodological limitations of single-cell transcriptomic analyses, and we agree that these limitations should be clearly communicated to readers in the main text.

      We acknowledge that in the previous version of the manuscript, the exploratory nature of the single-cell transcriptomic analysis and its methodological boundaries were discussed only in the response to reviewers and were not explicitly stated in the manuscript itself. We thank the reviewer for pointing out this omission. In the revised manuscript, we have now added explicit clarifications in the main text to prevent potential overinterpretation of these results.

      In the present study, our primary effort is focused on the descriptive characterization of the three-dimensional anatomical organization and spatial relationships of the PLC using volumetric imaging and vascular labeling strategies. As a complementary exploratory analysis, we reanalyzed existing liver single-cell transcriptomic datasets to examine endothelial cell populations exhibiting PLC-associated features, and performed differential gene expression and Gene Ontology enrichment analyses. Importantly, these results are intended to provide molecular-level support for the structural identification of the PLC and to offer preliminary insights into its potential biological functions. Accordingly, we have narrowed the presentation and interpretation of the single-cell analysis in both the Results and Discussion sections of the revised manuscript.

      In addition, we have expanded the Discussion to address the limitations of current spatial transcriptomic approaches in validating a continuous three-dimensional structure such as the PLC. Most existing spatial transcriptomic methods rely on two-dimensional tissue sections of 8–10 μm thickness, whereas identification of the PLC depends on three-dimensional imaging of tissue volumes with thicknesses of ≥200 μm, making reliable reconstruction of its spatial continuity from single sections challenging. Furthermore, because each spatial transcriptomic capture spot often encompasses multiple adjacent cells, signal mixing effects further limit precise resolution of specific periportal microstructures.

      Overall, we agree with the reviewer’s central point that the limitations of single-cell transcriptomic analyses should be clearly understood by readers. By explicitly clarifying the methodological boundaries and refining the related statements in the main text, we believe this concern has now been adequately addressed in the revised manuscript. We thank the reviewer for identifying this omission, which has helped to improve the rigor and clarity of the study.

      Reviewer #3 (Recommendations for the authors):

      (1) While interesting observations, suitable for discussion, the following sections are speculations, given that no functional characterization of PLC importance has been performed yet. This is the most felt when commenting on the role in hematopoiesis, which transiently takes place in the liver during embryogenesis (Khan et al 2016) but ceases to exist after ligation of the umbilical inlet. Adult Liver hematopoiesis remains controversial, and more solid evidence would need to be presented to support its existence in PLC regions.

      265 - These findings suggest that the Periportal Lamellar Complex (PLC) is not only a morphologically and spatially distinct, low-permeability vascular unit surrounding the portal vein, but also likely serves as a critical nexus connecting the portal vein, hepatic artery, and liver sinusoids. Thus, the PLC constitutes a key node within the interactive vascular network of the mouse liver.

      We thank the reviewer for the comments and suggestions regarding the potential functional interpretation of the periportal lamellar complex (PLC), particularly its possible association with hematopoietic function. We would like to clarify that the statement on page 265 was intended solely to describe the structural characteristics and spatial organization of the PLC within the periportal vascular network. Specifically, the original wording aimed to summarize the morphological features of the PLC and its spatial relationships among the portal vein, hepatic artery, and hepatic sinusoids.

      Nevertheless, to minimize potential misunderstanding, we have revised this section to avoid unnecessary functional implications. The revised text now reads:

      “These results suggest that the periportal lamellar complex (PLC) is a morphologically and spatially distinct vascular structure that surrounds the portal vein and may serve as a key organizational node coordinating the spatial relationships among the portal vein, hepatic artery, and hepatic sinusoids. Accordingly, the PLC represents an important structural element within the interactive vascular network of the mouse liver.”

      This revision preserves the structural significance of the PLC while avoiding overinterpretation of its functional roles.

      (2) The same is true also for this section, following Figure 3 - no functional experiment tested this. For example, diphtheria toxin is expressed in the CD34+Sca1+ population. Or at least a careful mapping of the developing liver, which would indicate if the PLC precedes or follows the BD development.

      356 as a spatial positional cue guiding bile duct growth and branching but also as a regulatory node involved in coordinating bile drainage from the hepatic lobule into the biliary network.

      To avoid potential misunderstanding, we have further refined and revised the statements in the manuscript regarding the functional interpretation of the periportal lamellar complex (PLC) and its relationship to bile duct development. We agree that cell ablation strategies are of great importance for functional validation studies. However, it should be noted that CD34 and Sca-1 are relatively broadly expressed markers during liver development, labeling multiple endothelial, mesenchymal, and progenitor cell populations, and their expression is not restricted to the PLC. Owing to this broad expression pattern, ablation of CD34<sup>+</sup>Sca-1<sup>+</sup> cell populations would likely exert widespread effects on vascular and stromal structures, thereby complicating the distinction between direct PLC-specific effects and secondary developmental alterations. As such, this strategy may present technical limitations for specifically dissecting the role of the PLC in bile duct development. At the same time, given that the primary objective of this study is the systematic characterization of the three-dimensional anatomical features and spatial organization of the PLC, we have correspondingly revised the manuscript to restrict statements regarding the relationship between the PLC and bile ducts to spatial associations supported by the current data. Specifically, our results show that primary bile ducts run along the main portal vein trunk, secondary bile ducts exhibit directed branching toward the PLC region, and terminal bile duct branches tend to spatially cluster in the vicinity of the PLC, thereby forming a reproducible periportal spatial arrangement. Based on these observations, the PLC delineates a relatively conserved anatomical microenvironment within the portal region, whose spatial position is closely associated with the organization and terminal distribution of the intrahepatic bile duct network.

      We believe that these revisions more accurately reflect the experimental evidence and the defined scope of the present study.

      (3) The following statement ought to be rephrased or skipped, considering that CD34 and Sca1 (Ly6a) are markers of periportal endothelial cells (Pietilä et al., 2025, Gómez-Salinero et al., 2022) and as shown by the authors in their own Fig. 6D. In this context and the context of the CCL4 experiments, a "simple" proliferative progenitor portal vein endothelial cell phenotype, suggested also by the presence of DLL4 (Fig5A) and JAG1 (Pietilä et al., 2025) (Benedito et al., 2009) ought to be considered.

      409 Notably, CD34 and Sca-1 (Ly6a) were co-expressed exclusively within PLC structures surrounding the portal vein, but absent from central vein ECs and midzonal LSECs (Figure 4F).

      We thank the reviewer for pointing out the potential imprecision in this wording. We agree that both CD34 and Sca-1 (Ly6a) are well-established markers of periportal endothelial cells, as previously reported (Pietilä et al., 2025; Gómez-Salinero et al., 2022), and as also illustrated in Fig. 4F of our study.

      Accordingly, the original statement suggesting that CD34 and Sca-1 are co-expressed exclusively within the PLC structure may indeed represent an overinterpretation. Following the reviewer’s suggestion, we have revised the relevant text on page 409 by removing the exclusive phrasing (“only in”) and by emphasizing instead that CD34<sup>+</sup>Sca-1<sup>+</sup> endothelial cells are enriched in periportal regions associated with the PLC, rather than being specific to or confined within the PLC.

      In addition, in the context of the CCl<sub>4</sub>-induced liver fibrosis model, we agree with the reviewer that the observed expression of DLL4 and JAG1 under fibrotic conditions is more appropriately interpreted as reflecting an activated or proliferative periportal endothelial progenitor–like phenotype, rather than defining a novel endothelial lineage. The corresponding statements in the revised manuscript have been adjusted accordingly.

      (4) Again, these concluding sentences are based on correlative evidence of mRNA expression and literature but not experimental evidence.

      436 These findings suggest that this unique endothelial cell subset in the periportal region may possess dual regulatory functions in both metabolic and hematopoietic modulation

      441 results suggest that PLC endothelial cells may not only regulate periportal microcirculatory blood flow but also help establish a specialized microenvironment that potentially supports periportal hematopoietic regulation, contributing to stem cell recruitment, vascular homeostasis, and tissue repair.

      We thank the reviewer for this thoughtful comment. We agree that these statements are primarily based on transcriptomic correlation analyses and support from previous literature, rather than direct functional experimental evidence.

      Accordingly, in the revised manuscript, we have appropriately toned down and adjusted the relevant concluding statements to more accurately reflect their inferential nature. The revised wording emphasizes associations and potential involvement, rather than definitive functional roles. These changes preserve the overall scientific interpretation while aligning the level of inference more closely with the available evidence.

      The revised text now reads:

      “Finally, we found that the main trunk of the PLC is primarily composed of CD34<sup>+</sup>Sca-1<sup>+</sup>CD31<sup>+</sup> endothelial cells (Fig. 4J). These CD34<sup>+</sup>Sca-1<sup>+</sup> double-positive cells are mainly distributed in the basal region of the PLC structure and exhibit molecular features associated with hematopoiesis. Taken together, these results suggest that PLC endothelial cells may contribute to the establishment of a local microenvironment related to periportal hematopoietic regulation and may play potential roles in stem cell recruitment and maintenance of vascular homeostasis.”

      (5) The following part is speculative and based on re-analysis from the dataset that was gathered after 6 more weeks of CCL4 treatment (12weeks Su et al., 2021), then in the linked experiments from the manuscript. And should be moved to discussion or removed.

      504 Moreover, single-cell transcriptomic re-analysis revealed significant upregulation of bile duct-related genes in the CD34<sup>+</sup>Sca-1<sup>+</sup> endothelium of PLC in fibrotic liver, with notably high expression of Lgals1 (Galectin-1) and Hgf (Figure 5G). Previous studies have shown that Galectin-1 is absent in normal liver parenchyma but highly expressed in intrahepatic cholangiocarcinoma (ICC), correlating with tumor dedifferentiation and invasion (Bacigalupo, Manzi, Rabinovich, & Troncoso, 2013; Shimonishi et al., 2001). Additionally, hepatocyte growth factor (HGF), particularly in combination with epidermal growth factor (EGF) in 3D cultures, promotes hepatic progenitor cells to form bile duct-polarized cystic structures (N. Tanimizu, Miyajima, & Mostov, 2007). Together, these findings suggest the PLC endothelium may act as a key regulator of bile duct branching and fibrotic microenvironment remodeling in liver fibrosis.

      Collectively, our results demonstrate that the PLC, situated between the portal vein and periportal sinusoidal endothelium, constitutes a critical vascular microenvironmental unit. It may not only colocalize with bile duct branches under normal physiological conditions, but also through its basal CD34<sup>+</sup>Sca-1<sup>+</sup> double-positive endothelial cells, potentially orchestrate bile duct epithelial proliferation, branching morphogenesis, and bile acid transport homeostasis via multiple signaling pathways. Particularly during liver fibrosis progression, the PLC exhibits dynamic structural extension, serving as a spatial scaffold facilitating terminal bile duct migration and expansion into the hepatic parenchyma (Figure 5H). These findings highlight the PLC endothelial cell population and the vascular-bile duct interface as key regulatory hubs in bile duct regeneration, tissue repair, and pathological remodeling, providing novel cellular and molecular insights for understanding bile duct-related diseases such as ductular reaction, cholangiocarcinoma, and cholestatic disorders, and offering potential targets for therapeutic intervention.

      We thank the reviewer for this careful and thought-provoking comment. We understand and agree with the reviewer’s assessment that this section involves a degree of inference, as the analysis is based on a re-analysis of a previously published single-cell transcriptomic dataset from a CCl<sub>4</sub>-induced liver fibrosis model (Su et al., 2021), rather than on experimental data directly generated in the present study.

      In response to the reviewer’s suggestion, we have carefully re-examined and revised the relevant paragraphs. Without altering the overall structure of the manuscript, we have appropriately moderated the wording to clarify that these results primarily describe the transcriptional features of PLC-associated CD34<sup>+</sup>Sca-1<sup>+</sup> endothelial cells under fibrotic conditions, and their associations with bile duct–related gene expression, rather than providing direct functional evidence for their roles in bile duct branching or microenvironmental remodeling.

      In addition, we have explicitly clarified in the main text the data source and methodological limitations of the single-cell transcriptomic analysis, and emphasized that these findings should be interpreted in conjunction with the spatial information revealed by three-dimensional imaging. Through these revisions, we aim to retain the value of this analysis in providing complementary molecular insight into PLC characteristics, while avoiding potential over-interpretation of its functional implications.

      Formal suggestions:

      (6) The following sentence would benefit from being more clearly written.

      263 - The formation of PLC structures in the adventitial layer may participate in local blood flow regulation, maintenance of microenvironmental homeostasis.

      We thank the reviewer for this helpful suggestion. The sentence has been revised to improve clarity by correcting the parallel structure and refining the wording.

      The formation of PLC structures in the adventitial layer may participate in local blood flow regulation and the maintenance of microenvironmental homeostasis.

      (7) The following sentence is misleading as it implies cell sorting, and "subsetted" rather than "sorted" should be used.

      414 Based on this, we sorted CD34<sup>+</sup>Sca-1<sup>+</sup> endothelial populations from the total liver EC pool (Figure 4G).

      Thank you for your comment.

      We have revised the term as suggested. This avoids the misleading implication of physical sorting, as our operation was analytical subsetting of the target subpopulation.

      We appreciate your careful review.

      (8) Correct typos, especially in the results section related to Fig. 6. and formatting issues in the discussion.

      730 Morphologically, the PLC shares features with previously described telocytes (TCs)- 731 a recently identified class of interstitial cells in the liver observed via transmission electron

      We thank the reviewer for pointing out this textual error. In the submitted version, the sentence describing the morphological similarity between the PLC and previously reported telocytes was inadvertently interrupted due to a punctuation issue. This has now been corrected to ensure sentence integrity and consistent formatting.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study by Xu et al. focuses on the impact of clathrin-independent endocytosis in cancer cells on T cell activation. In particular, by using a combination of biochemical approaches and imaging, the authors identify ICAM1, the ligand for T cell-expressed integrin LFA-1, as a novel cargo for EndoA3-mediated endocytosis. Subsequently, the authors aim to identify functional implications for T cell activation, using a combination of cytokine assays and imaging experiments.

      They find that the absence of EndoA3 leads to a reduction in T cell-produced cytokine levels. Additionally, they observe slightly reduced levels of ICAM1 at the immunological synapse and an enlarged contact area between T cells and cancer cells. Taken together, the authors propose a mechanism where EndoA3-mediated endocytosis of ICAM1, followed by retrograde transport, supplies the immunological synapse with ICAM1. In the absence of EndoA3, T cells attempt to compensate for suboptimal ICAM1 levels at the synapse by enlarging their contact area, which proves insufficient and leads to lower levels of T cell activation.

      Strengths:

      The authors utilize a rigorous and innovative experimental approach that convincingly identifies ICAM1 as a novel cargo for Endo3A-mediated endocytosis.

      Weaknesses:

      The characterization of the effects of Endo3A absence on T cell activation appears incomplete. Key aspects, such as surface marker upregulation, T cell proliferation, integrin signalling and most importantly, the killing of cancer cells, are not comprehensively investigated.

      We agree with the reviewer that the effects of EndoA3 depletion on T cell activation were not characterized enough. In new data presented in Fig.S4G-J, we explored additional activation markers and proliferation parameters. We didn’t observe any difference for the surface markers PD-1, CD137 and Tim-3 between LB33-MEL EndoA3+ cells treated with control and EndoA3 siRNAs. Regarding proliferation (Fig. S4J), although the proliferation index seems slightly lower upon EndoA3 depletion, we didn’t observe any significant difference either. Degranulation has also been monitored (Fig. S4K), but we didn’t observe any significant differences. In the new Fig. 3F however, we performed chromium release assays to assess the killing of cancer cells. Very interestingly, we observed an ~15% higher lysis of LB33-MEL EndoA3+ cells after EndoA3 depletion, when compared to the control condition at a ratio of 3:1 T cells:target cells (where the maximal effect is observed). These data are further discussed in the discussion section (new §6-9).

      As Endo- and exocytosis are intricately linked with the biophysical properties of the cellular membrane (e.g. membrane tension), which can significantly impact T-cell activation and cytotoxicity, the authors should address this possibility and ideally address it experimentally to some degree.

      Evaluating changes in the biophysical properties of cancer cell plasma membrane upon EndoA3 depletion is not trivial. An indirect way to address this question is by observing the area and shape of cells after siRNA treatment. In the new data added in the new Fig. S4B-D, we compared the area, aspect ratio and roundness of LB33-MEL EndoA3+ cells treated with negative control or EndoA3 siRNAs. While we observed a slight cell area reduction upon EndoA3 depletion, no significant changes were observed regarding the aspect ratio and the roundness. Hence, we think that the biophysical properties of cancer cells are not drastically modified by EndoA3 depletion.

      Crucially, key literature relevant to this research, addressing the role of ICAM1 endocytosis in antigen-presenting cells, has not been taken into consideration.

      We thank the reviewer for this important point. We have now considered and cited the relevant literature (Discussion, Page no.9).

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Xu et al. studies the relevance of endophilin A3-dependent endocytosis and retrograde transport of immune synapse components and in the activation of cytotoxic CD8 T cells. First, the authors show that ICAM1 and ALCAM, known components of immune synapses, are endocytosed via endoA3-dependent endocytosis and retrogradely transported to the Golgi. The authors then show that blocking internalization or retrograde trafficking reduces the activation of CD8 T cells. Moreover, this diminished CD8 T cell activation resulted in the formation of an enlarged immune synapse with reduced ICAM1 recruitment.

      Strengths:

      The authors show a novel EndoA3-dependent endocytic cargo and provide strong evidence linking EndoA3 endocytosis to the retrograde transport of ALCAM and ICAM1.

      Weaknesses:

      The role of EndoA3 in the process of T cell activation is shown in a cell that requires exogenous expression of this gene. Moreover, the authors claim that their findings are important for polarized redistribution of cargoes, but failed to show convincingly that the cargoes they are studying are polarized in their experimental system. The statistics of the manuscript also require some refinement.

      We fully acknowledge that the requirement for exogenous expression of EndoA3 in our immunological model represents a limitation of our study. Unfortunately, it remains challenging to identify cancer cell lines for which autologous CD8 T cells are available and that endogenously express all molecular players investigated (in particular EndoA3). At this stage, we do not have access to any other cancer cell line/autologous CD8⁺ T cell pairs that are sufficiently well characterized. In future studies, it would be valuable to investigate tumor types with high endogenous EndoA3 expression (such as glioblastomas, gliomas, and head and neck cancers) for which autologous CD8 T cells could be obtained, but this remains technically challenging.

      To address the reviewer’s second point regarding polarized redistribution of cargoes, we have added new data in the new Figure 4 and Movies S8-9. Using high-speed spinningdisk live-cell confocal microscopy, we captured the movement of ICAM1-positive tubulovesicular carriers in cancer cells at the moment of contact with CD8 T cells. Capturing such events is technically challenging, as T cell–cancer cell contacts form randomly and transiently. Successful imaging requires that the cancer cell be well spread and express ICAM1–GFP at an optimal level (as it is transiently expressed as a GFP-tagged construct), while acquisition must occur precisely at the moment when the T cell initiates contact. Despite these technical constraints, we successfully imaged early stages of immune synapse formation, enabling visualization of ICAM1 vesicular transport.

      The data reveal a flux of ICAM1-positive carriers emerging from the perinuclear region (corresponding to the Golgi area) and moving toward the contact site with the CD8 T cell, with fusion events of vesicles occurring at the developing immune synapse. AI-based segmentation and tracking analyses showed that ICAM1-positive carrier trajectories were predominantly oriented toward the forming immune synapse, whereas carriers moving toward other cellular regions were markedly less frequent. These results provide direct evidence for polarized ICAM1 transport via vesicular trafficking toward the immune synapse.

      Reviewer #3 (Public review):

      Summary:

      Shiqiang Xu and colleagues have examined the importance of ICAM-1 and ALCAM internalization and retrograde transport in cancer cells on the formation of a polarized immunological synapse with cytotoxic CD8+ T cells. They find that internalization is mediated by Endophilin A3 (EndoA3) while retrograde transport to the Golgi apparatus is mediated by the retromer complex. The paper is building on previous findings from corresponding author Henri-François Renard showing that ALCAM is an EndoA3dependent cargo in clathrin-independent endocytosis.

      Strengths:

      The work is interesting as it describes a novel mechanism by which cancer cells might influence CD8+ T cell activation and immunological synapse formation, and the authors have used a variety of cell biology and immunology methods to study this. However, there are some aspects of the paper that should be addressed more thoroughly to substantiate the conclusions made by the authors.

      Weaknesses:

      In Figure 2A-B, the authors show micrographs from live TIRF movies of HeLa and LB33MEL cells stably expressing EndoA3-GFP and transiently expressing ICAM-1-mScarlet. The ICAM-1 signal appears diffuse across the plasma membrane while the EndoA3 signal is partially punctate and partially lining the edge of membrane patches. Previous studies of EndoA3-mediated endocytosis have indicated that this can be observed as transient cargo-enriched puncta on the cell surface. In the present study, there is only one example of such an ICAM-1 and EndoA3 positive punctate event. Other examples of overlapping signals between ICAM-1 and EndoA3 are shown, but these either show retracting ICAM1 positive membrane protrusions or large membrane patches encircled by EndoA3. While these might represent different modes of EndoA3-mediated ICAM-1 internalization, any conclusion on this would require further investigation.

      We agree with the reviewer that the pattern of cargoes during endocytosis (puncta vs large patches) as observed by live-cell TIRF microscopy may be confusing. Actually, a punctate pattern has been observed quasi systematically when we monitored the uptake of endogenous cargoes via antibody uptake assays (whatever the imaging approach: TIRF, spinning-disk, classical confocal or lattice light-sheet microscopy). For example:

      - ALCAM: Fig.1e-h, Supplementary Figure 5 and Supplementary Movies 1-3 and 6 in Renard et al. 2020, https://doi.org/10.1038/s41467-020-15303-y; Fig.1D and Movie 2 in Tyckaert et al. 2022, https://doi.org/10.1242/jcs.259623.

      - L1CAM: Fig.2 and 3D, Movies S1-4 in Lemaigre et al. 2023, https://doi.org/10.1111/tra.12883.

      In rare examples, bigger clusters of antibodies were observed, where EndoA3 was observed to surround them, delineate them in a “lasso-like” pattern, and the clusters were progressively taken up:

      - ALCAM: Supplementary Movie 4 in Renard et al. 2020, https://doi.org/10.1038/s41467-020-15303-y.

      However, bigger patches of cargoes were more often observed when uptake was observed using transient expression of GFP-/mCherry-tagged versions of cargoes. In these cases, EndoA3 was predominantly observed to delineate cargo patches as a “lasso-like” pattern, progressively triming those patches leading to endocytosis. For example:

      - L1CAM: Fig.3E, Movie S5-7 in Lemaigre et al. 2023, https://doi.org/10.1111/tra.12883.

      - We also observed this pattern with CD166-GFP (unpublished).

      The fact that we observed rather patches than punctate patterns upon transient expression of fluorescently-tagged constructs of cargoes is likely due to the elevated expression level of the cargoes.

      Therefore, the patchy pattern observed for ICAM1 and ALCAM, transiently expressed in fusion with fluorescent proteins, and surrounded by EndoA3 in Fig.2A-B and old Movies S1-3, is not surprising. Of note, upon anti-ALCAM antibody uptake, we observed a more punctate pattern (Fig.2C), as previously described. Unfortunately, the lower quality of commercial anti-ICAM1 antibody did not allow us to proceed to uptake assays as for ALCAM.

      Regarding Fig.S2 and old Movies S4-5, we agree with the reviewer that these data may be misleading, as they represent phenomena happening at protrusions and contact zones between two adjacent cells. We have now replaced these images with other examples where we avoid contact zones (Fig.S2 and new Movies S5-7).

      These different patterns (patches vs dots) are still unexplained at the current stage, and may indeed represent different modes of endocytosis. We think these various patterns may depend on the abundance/expression level of cargoes and their degree of clustering. This will be investigated in future studies. Still, whatever the pattern, these data demonstrate and confirm the association between EndoA3 and cargoes (such as ICAM1 or ALCAM), even in the absence of antibodies.

      Moreover, in Figure 2C-E, uptake of the previously established EndoA3 endocytic cargo ALCAM is analyzed by quantifying total internal fluorescence in LB33-MEL cells of antibody labelled ALCAM following both overexpression and siRNA-mediated knockdown of EndoA3, showing increased and decreased uptake respectively. Why has not the same quantification been done for the proposed novel EndoA3 endocytic cargo ICAM-1? Furthermore, if endocytosis of ICAM-1 and ALCAM is diminished following EndoA3 knockdown, the expression level on the cell surface would presumably increase accordingly. This has been shown for ALCAM previously and should also be quantified for ICAM-1.

      As correctly pointed by the reviewer, anti-ICAM1 antibody uptake assays would have been great. We have tried to do them many times. Unfortunately, all commercial antibodies we tested did not yield satisfying results in uptake experiments. Either the labeling was too week/non-specific, or the antibody was not effectively stripped from the cell surface by acid washes, i.e. the acid-wash conditions required for efficient stripping were too harsh for the cells to tolerate. We have tried other approaches using the same commercial antibody which do not require acid washes (loss of surface assays by FACS, or uptake assays using surface protein biotinylation) or based on insertion of an Alfa-tag in the extracellular part of ICAM1 by CRISPR-Cas9 and detection of ICAM1 with an antiAlfa-tag nanobody (unpublished approach; collaboration with the lab of Prof. Leonardo Almeida-Souza, University of Helsinki, who developed the approach), but without success. However, we were more successful with the SNAP-tag-based approach to follow retrograde transport, for which the commercial anti-ICAM1 antibody worked properly. In Fig. 1F, we could show that retrograde transport of ICAM1 (and thus most likely its endocytosis step) was significantly decreased upon EndoA3 depletion in HeLa cells, indirectly demonstrating that ICAM1 is effectively an EndoA3-dependent cargo.

      Regarding the fact that surface level of ICAM1 should increase upon perturbation of EndoA3-mediated endocytosis, we agree with the reviewer that this could be an expected result. However, this is not necessarily systematic, as the surface level of a protein cargo is always the result of a balance between its endocytosis, recycling to plasma membrane, and lysosomal degradation. We also have to take into account the neosynthesized protein flux. One must also consider that multiple endocytic mechanisms exist in parallel, and that the perturbation of one mechanism (EndoA3-mediated CIE, here) may be partially compensated by others, as cargoes can often be taken up via multiple endocytic doors. Hence, an increased abundance at the cell surface is not always guaranteed upon endocytosis perturbation. Anyway, we measured the cell surface level of both ICAM1 and ALCAM in LB33-MEL EndoA3+ cells treated with negative control or EndoA3 siRNAs (Fig. S4E-F). Only minor differences were observed.

      In Figure 4A the authors show micrographs from a live-cell Airyscan movie (Movie S6) of a CD8+ T cell incubated with HeLa cells stably expressing HLA-A*68012 and transiently expressing ICAM1-EGFP. From the movie, it seems that some ICAM-1 positive vesicles in one of the HeLa cells are moving towards the T cell. However, it does not appear like the T cell has formed a stable immunological synapse but rather perhaps a motile kinapse. Furthermore, to conclude that the ICAM-1 positive vesicles are transported toward the T cell in a polarized manner, vesicles from multiple cells should be tracked and their overall directionality should be analyzed. It would also strengthen the paper if the authors could show additional evidence for polarization of the cancer cells in response to T-cell interaction.

      A similar point was raised by reviewer #2. We have revised this section accordingly. In the new Fig. 4 and Movies S8-9, we replaced the live-cell Airyscan confocal data with highspeed spinning-disk confocal imaging data, enabling a more accurate analysis of cargo polarized redistribution and at a higher time resolution.

      Using this approach, we captured the movement of ICAM1-positive tubulo-vesicular carriers in cancer cells at the moment of contact with CD8 T cells. Capturing such events is technically challenging, as T cell–cancer cell contacts form randomly and transiently. Successful imaging requires that the cancer cell be well spread and express ICAM1–GFP at an optimal level (as it is transiently expressed as a GFP-tagged construct), while acquisition must occur precisely at the moment when the T cell initiates contact. Despite these technical constraints, we successfully imaged early stages of immune synapse formation, enabling visualization of ICAM1 vesicular transport.

      The data reveal a flux of ICAM1-positive carriers emerging from the perinuclear region (corresponding to the Golgi area) and moving toward the contact site with the CD8 T cell, with fusion events of carriers occurring at the developing immune synapse.

      AI-based segmentation and tracking analyses showed that ICAM1-positive carrier trajectories were predominantly oriented toward the forming immune synapse, whereas carriers moving toward other cellular regions were markedly less frequent. These results provide direct evidence for polarized ICAM1 transport via vesicular trafficking toward the immune synapse.

      Finally, in Figures 4D-G, the authors show that the contact area between CD8+ T cells and LB33-MEL cells is increased in response to siRNA-mediated knockdown of EndoA3 and VPS26A. While this could be caused by reduced polarized delivery of ICAM-1 and ALCAM to the interface between the cells, it could also be caused by other factors such as increased cell surface expression of these proteins due to diminished endocytosis, and/or morphological changes in the cancer cells resulting from disrupted membrane traffic. More experimental evidence is needed to support the working model in Figure 4H.

      Regarding the cell surface expression of both ICAM1 and ALCAM, as already explained above, only minor differences were observed (Fig. S4E-F). Regarding morphological changes of cancer cells upon EndoA3 depletion (Fig. S4B-D), we compared the area, aspect ratio and roundness of LB33-MEL EndoA3+ cells treated with negative control or EndoA3 siRNAs. While we observed a slight cell area reduction upon EndoA3 depletion, no significant changes were observed regarding the aspect ratio and the roundness. Cancer cell morphology is thus not drastically modified by EndoA3 depletion. All these new data are now discussed in the manuscript.

      Recommendations for the authors:

      Reviewing Editor Comments:

      The reviewers discussed the paper and all agreed it was incomplete in supporting the conclusions. Additional data needed to support the conclusions were:

      (1) Better characterisation of Endo3A-expressing and knock-down cells such as morphology, ICAM-1, and ALCAM surface levels to name two parameters.

      As discussed above, we have now added new data addressing these points:

      - Morphology: Fig. S4B-D

      - ICAM1 and ALCAM surface levels: Fig. S4E-F These new data are discussed in the main text.

      (2) Better characterisation of the ICAM-1 polarisation process. Does this require interaction with LFA-1 can ICAM-1 be delivered to the synapse without this?

      As discussed above, we have now added new data better addressing the characterization of ICAM1 polarized trafficking to the immune synapse, that can be found in the new Fig. 4 (high-speed spinning-disk confocal imaging of ICAM1 trafficking upon conjugate formation between CD8 T cell and cancer cell). The text has been modified accordingly. The dependency on LFA-1 has not been addressed directly, but we may suppose it is indeed important as (i) it has already been addressed in other cellular systems by previous studies (Jo et al. 2010), and (ii) we observed a denser flux of ICAM1-positive carriers in the cancer cell toward regions involved in immune synapses with CD8 T cells, than other regions. As we didn’t address this question more directly in our study, we briefly mentioned this point in the Discussion section.

      (3) Better characterisation of T cell response- activation markers, cytotoxicity assays.

      As discussed above, we have now added new data addressing these points:

      - Cell surface activation markers: Fig. S4G-I

      - Proliferation: Fig. S4J

      - Degranulation: Fig. S4K

      - Cytotoxic activity: Fig. 3F

      These new data are discussed in the main text.

      (4) Citing relevant literature.

      The relevant literature (in particular the paper by Jo et al. 2010) is now cited and discussed.

      (5) Number of donors evaluated - is it true there was only one blood donor? For human studies better to have key results on >4 donors.

      Our immunological working model indeed originates from a single patient (Baurain et al., 2000), from whom both a cancer cell line (LB33-MEL) and autologous CD8 T cells were derived. These CD8 T cells specifically recognize an HLA molecule presenting a defined antigenic peptide (MUM-3) on the surface of the cancer cells. This provides us with a unique and fully natural experimental system that allows us to faithfully reconstitute cytotoxic T lymphocyte (CTL)-mediated killing of cancer cells in vitro.

      Using CD8 T cells from other donors would not be meaningful in this context, as they would not recognize the LB33-MEL cells. Conversely, testing the same CD8 T cells on other cancer cell lines requires engineering these lines to express the appropriate HLA molecule and to be exogenously pulsed with the correct antigenic peptide – which is precisely what we did with the HeLa cell line.

      Therefore, increasing the number of donors would require obtaining both cancer cell lines and CD8 T cells from each donor, ideally with evidence that the donor’s T cells recognize their own tumor cells. This is technically challenging and not trivial, although it would indeed be highly valuable to diversify immunological models in future studies.

      Importantly, the high specificity of our autologous co-culture system, where cancer cells interact with their naturally matched CD8 T cells, offers clear advantages over commonly used in vitro models such as Jurkat (T) and Raji (B) cell lines, which rely on artificial stimulation with a superantigen to enforce immunological synapse formation and T cell activation.

      (6) How does the binding of antibodies to ICAM-1 and ALCAM impact their trafficking?

      As IgG antibodies are bivalent and can bind two target antigens, they may induce clustering, which could in turn affect endocytosis. To address this concern, we performed an uptake assay based on surface protein biotinylation using a cleavable biotin reagent (with a reducible linker). Briefly, after allowing endocytosis for different time intervals, cell surface–exposed biotins were removed by treatment with the cellimpermeable reducing agent MESNA, while internalized (endocytosed) biotinylated proteins remained protected. These internalized proteins were then recovered by affinity purification on streptavidin resin and analyzed by Western blot to detect the protein of interest.

      Importantly, this uptake assay can be performed in the absence or presence of an anticargo antibody, allowing assessment of its potential influence on endocytosis. Author response image 1 shows the results for ALCAM uptake in HeLa cells, with and without anti-ALCAM antibody:

      Author response image 1.

      Antibody binding to an extracellular epitope of ALCAM increases its endocytosis. HeLa cellsurface proteins were biotinylated on ice using EZ-Link Sulfo-NHS-SS-Biotin (Pierce) and then incubated at 37 °C for the indicated times to allow endocytosis. Internalization was assessed in the absence or presence of an anti-ALCAM antibody (Ab) added to the extracellular medium. Endocytosis was stopped by returning the cells to ice, and surface-exposed biotin was removed by treatment with the cell-impermeable reducing agent MESNA. Internalized, MESNA-resistant biotinylated proteins were affinity-purified on streptavidin resin and analyzed by Western blot to detect ALCAM. The “unstripped” condition shows the total amount of ALCAM at the cell surface at the beginning of the experiment (signal at ~95 kDa). Quantification of the time course (normalized to the no-antibody condition) shows increased ALCAM endocytosis in the presence of antibody at 15 and 30 min. Blot is representative of two independent experiments; quantifications include data from both experiments.

      We observed that the anti-ALCAM antibody slightly enhanced ALCAM uptake. A similar experiment was attempted for ICAM1, but we were unable to detect the protein by Western blot using the available commercial antibody.

      Although this outcome was expected, it highlights a potential caveat in using antibodies to monitor endocytosis. Alternative tools such as nanobodies, while monovalent and theoretically less perturbing, are not yet available for many cargo proteins and may still influence cargo conformation or dynamics. Therefore, antibodies remain the current gold standard in endocytosis studies. Nevertheless, data obtained with antibodies should always be validated by complementary approaches that do not rely on antibody binding, as we have done in this study (e.g. live-cell imaging of fluorescently tagged proteins).

      The work is of interest and we look forward to your response/revision.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Thank you for submitting your manuscript which I had the pleasure to review. While I enjoyed your work, I feel that it would strongly benefit by addressing the following points:

      (1) In-depth characterization of T cell responses upon Endo3A depletion: The characterization should be expanded to include surface marker upregulation, T cell proliferation, and, most importantly, tumor cell cytotoxicity. I was wondering if the incomplete characterization of T-cell responses is due to limited supplies of antigenspecific T-cells? My understanding is that these cells have been derived from a single patient. This also raises concerns in terms of reproducibility as all data are practically from a single biological replicate. My suggestion would be to use an additional system of specific cell-cell contacts to complement the current findings. For instance, HeLa cells could be transfected to express CD19 or EpCAM, for both of which bispecific T cell engagers (Invivogen) exist that would allow specific contact formation, thereby allowing the study of the effect of Endo3A depletion across T cells from different donors and through a more complete set of assays.

      We refer the reviewer to our responses above, where these points have been addressed in detail. We sincerely thank the reviewer for the excellent suggestion of transfecting HeLa cells with CD19 or EpCAM and using bispecific T-cell engagers. However, after careful consideration, we concluded that this approach falls outside the scope of the present study, which was specifically designed to investigate the most natural system, cancer cells and their autologous CD8 T cells. We nevertheless appreciate this insightful suggestion and will certainly consider it for future studies.

      (2) Alterations in membrane tension as an alternative explanation: Endo- and exocytosis have been found to influence the biophysical properties of cells, such as membrane tension (e.g., Djakbaravo et al., 2021, PMID: 33788963), which in turn influences their susceptibility to cytotoxic T cells with lower tension corresponding to reduced cytotoxicity (e.g., Basu & Whitlock, 2016, PMID: 26924577). Thus, interference with endocytic pathways could arguably lead to changes in membrane tension that could contribute to the observed effects. These possible effects should be discussed and addressed experimentally to a degree. While measuring membrane tension directly requires specialized expertise (e.g., tether pulling experiments) and is not within the scope of this study, membrane tension affects cell spreading and actin organization. Thus, I would suggest conducting a thorough comparative phenotypical and morphological characterization of the Endo3A+ and Endo3A- cancer cells to estimate the possible effect of changes in membrane tension (if any) on the results.

      We refer the reviewer to our responses above, where these points have been addressed in detail. New data have been added and the text of our manuscript has been modified accordingly.

      (3) Citation and consideration of earlier work: Jo & Kwon et al., 2010 (PMID: 20681010) have previously shown that ICAM1 undergoes clathrin-independent recycling and repolarization to the immunological synapse in APCs. Furthermore, they provided evidence that actin-based transport, but not lateral diffusion, together with recycling is crucial for the repolarization of ICAM1 to the immunological synapse. This important earlier work has to be cited. Actin-based transport on the cell surface has not been considered in the current manuscript. In light of these earlier findings, it is unclear in Figure 4A if ICAM1 is delivered to the T cell from within- or from the surface of the cancer cell. I would suggest changing the imaging modalities in this experiment to be able to differentiate cell surface from internal ICAM1, e.g., by detaching the cancer cells from the surface as has been done in Fig. 4B, E, and F.

      We refer the reviewer to our responses above, where these points have been addressed in detail. New data have been added and the text of our manuscript has been modified accordingly.

      Reviewer #2 (Recommendations for the authors):

      Major comments:

      (1) The authors should be more careful with their claims about the importance of their results for cell polarity as their evidence for this is scarce (i.e. The live-cell imaging in Figure 4A is not quantified and the ICAM1 polarization effect shown in figure 4B-C is, albeit significant, small and not very convincing).

      We refer the reviewer to our responses above, where these points have been addressed in detail. New data have been added and the text of our manuscript has been modified accordingly.

      (2) The absence (or very low expression) of EndoA3 on the LB33-MEL cell suggests that EndoA3-mediated recycling of immune synaptic components is not required for T-cell activation. The fact that EndoA3 exogenous expression in LB33-MEL cells leads to increased cytokine production in T cells is, however, interesting.

      We fully agree with the reviewer’s observation. Although EndoA3 is not expressed in some cellular contexts, its cargoes may still be present. It is therefore reasonable to assume that alternative endocytic mechanisms can compensate for its absence. It is now widely accepted that many cargoes can be internalized through multiple endocytic routes, and that the relative contribution of each pathway depends strongly on the cellular and physiological context.

      For example, we have shown that ALCAM and L1CAM, although primarily internalized via clathrin-independent pathways, present a minor fraction (< 25%) undergoing clathrinmediated endocytosis (Renard et al., 2020; Lemaigre et al., 2023). Moreover, we observed that inhibition of macropinocytosis enhances EndoA3-mediated endocytosis of ALCAM, indicating a crosstalk between specific EndoA3-mediated clathrin-independent endocytosis (CIE) and non-specific macropinocytosis (Tyckaert et al., 2022).

      Thus, even in the absence of EndoA3, its cargoes are likely internalized through alternative endocytic routes. Nonetheless, our data clearly demonstrate that EndoA3 expression markedly enhances the endocytosis and intracellular trafficking of its cargoes, ultimately leading to modified CD8 T cell responses.

      (3) For the statistics in bar graphs (graphs 1C, D, E &F; 3E, 3F, S1C-I, and S3C), one cannot have all values for controls simply normalized to 1. This procedure hides the variance for the controls between each replicate and makes any statistics meaningless.

      We thank the reviewer for this important remark. Regarding Figures 1C–F, S1C–I, and S3C, which correspond to quantifications from Western blots, it is standard practice to normalize the quantification to a control condition set to 1 (or 100%). Absolute signal intensities cannot be directly compared across different blots due to the variability inherent to this semi-quantitative technique. For this reason, we chose to keep the data presented in normalized form. However, we agree that this type of data require the careful choice of a convenient statistical analysis approach. Here, we choose one-sample T tests, allowing to test the hypothesis that the various siRNA conditions are different from 100% (the normalized value of the siCtrl condition). We adapted the statistical analysis accordingly in the different figures mentioned.

      Regarding old Figures 3E–F (now Fig. 3E and 3G), which correspond to IFNγ secretion assays, we agree that representing IFNγ secretion as a fold change relative to a control condition may obscure inter-experimental variability. However, this format was intentionally chosen to facilitate data interpretation, as IFNγ secretion was quantified by ELISA and also displayed inter-experimental variability. For completeness, we now provide below the corresponding graphs showing absolute IFNγ concentrations, which retain the information on inter-experimental variability (Author response image 2). As you can see, the overall conclusions remain unchanged.

      Author response image 2.

      IFNg secretion data corresponding to Fig. 3E and 3G, expressed in absolute values (pg/mL)

      Minor comments:

      (1) What happens to surface and total levels of ICAM1 and ALCAM in the retromer or EndoA3 knockdown/overexpression conditions? This information would put the effects described into context.

      We refer the reviewer to our responses above, where these points have been addressed in detail. New data have been added and the text of our manuscript has been modified accordingly.

      (2) The authors should clearly indicate that BFA means bafilomycin A in the figure legend or methods.

      BFA corresponds to Brefeldin A. We have now clarified this information in legends and methods.

      (3) In the sentence: "These data demonstrate that retromer-mediated retrograde transport is critical for trafficking ALCAM and ICAM1 to the Golgi and that this process requires the full secretory capacity of the TGN." What do the authors mean by full secretory capacity?

      We have modified the sentence: “Together, these data demonstrate that retromermediated retrograde transport is critical for trafficking ALCAM and ICAM1 to the Golgi and that this process requires efficient secretion from the TGN (as evidenced by the involvement of Rab6).”

      (4) The method used for retrograde transport seems to be a variation of the original protocol (reference 43). The manuscript would benefit from a thorough explanation of this assay, rather than citing the original protocol.

      We did not modify the original SNAP-tag–based protocol used to monitor retrograde transport. A comprehensive methodological paper has been published (ref. 44), and we have followed it strictly. Additionally, we briefly summarized the rationale of the approach in Figure 1A and in the first paragraph of the Results section.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In their manuscript, Richter and colleagues comprehensively investigate the cell wall recycling pathway in the model alphaproteobacterium Caulobacter crescentus using biochemical, imaging, and genetic approaches. They clearly demonstrate that this organism encodes a functional peptidoglycan recycling pathway and demonstrate the activities of many enzymes and transporters within this pathway. They leverage imaging and growth assays to demonstrate that mutants in peptidoglycan recycling have varying degrees of beta-lactam sensitivity as well as morphological and cell division defects. They propose that, rather than impacting the levels or activity of the major beta-lactamase, BlaA, defects in PG recycling lead to beta-lactam sensitivity by limiting the availability of new cell wall precursors. The findings will be of interest to those in the field of bacterial cell wall biochemistry, antibiotics and antibiotic resistance, and bacterial morphogenesis.

      Strengths:

      Overall, the manuscript is laid out logically, and the data are comprehensive, quantitative, and rigorous. The mutants and their phenotypes will be a valuable resource for Caulobacter researchers.

      Thank you for this positive evaluation. Previous work has mostly focused on the role of PG recycling in the regulation of ampC expression. However, our study and recent work in A. tumefaciens (Gilmore & Cava, 2022) and C. crescentus (Modi et al, 2025) demonstrates that β-lactam resistance is heavily influenced by PG recycling and the metabolic state of the cell, even in the presence of high levels of β-lactamase activity. It is likely that these effects are not limited to the two alpha­proteo­bacterial species investigated to date but may be more widely applicable. Therefore, we believe that our results are relevant beyond the Caulobacter field and may help to stimulate similar analyses in other, medi­cally more relevant species.

      Weaknesses:

      The only major missing piece is the complementation of mutants to demonstrate that loss of the targeted gene is responsible for the observed phenotypes.

      In our initial manuscript, we showed that the replacement of the native AmiR and NagZ genes with mutant alleles encoding catalytically inactive variants of the two proteins gave rise to the same pheno­types as gene deletions. This finding indicates that the defects observed were due to the loss of AmiR or NagZ activity, respectively. To rule out artifacts from polar effects, we have now also conducted the requested complementation analysis for the ΔampG, ΔamiR and ΔnagZ mutants. The results obtained show that deletion mutants carrying an ectopically expressed wild-type gene copy behave essentially like the wild-type strain, thereby verify­ing the validity of our conclusions (new Figure 4-figure supple­ment 1).

      Reviewer #2 (Public review):

      Summary:

      Pia Richter et al. investigated the peptidoglycan (PG) recycling metabolism in the alpha-proteobacterium Caulobacter crescentus. The authors first identified a functional recycling pathway in this organism, which is similar to the Pseudomonas route, and they characterized two key enzymes (NagZ, AmiR) of this pathway, showing that AmiR differs in specificity from the AmpD counterpart of E. coli. Further, they studied the effects of deletions within the PG recycling pathway (ampG, amiR, nagZ, sdpA, blaA, nagA1, nagA2, amgK, nagK mutants), showing filamentation and cell widening, thereby revealing a link between PG recycling and cell division. Finally, they provide a link between PG recycling and beta-lactam sensitivity in C. crescents that is not caused by activation of a beta-lactamase, but rather is a result of reduced supply of PG building blocks increasing the sensitivity of penicillin-binding proteins.

      Strengths:

      This work adds to the understanding of the role of PG recycling in alpha-proteobacteria, which significantly differ in their mode of cell wall growth from the better studied gamma-proteobacteria.

      Thank you for pointing out the relevance of our work. As mentioned above, we believe that our work goes beyond understanding the PG recycling pathway in alphaproteobacteria. Importantly, together with previous work, our results demonstrate a so-far largely neglected critical role of PG recycling in β-lactam resistance that goes beyond the mere regula­tion of β-lactamase gene expression. It will be interesting to determine the conservation of this phenomenon among other bacteria and to see whether blocking PG recycling could represent a potential strategy to combat β-lactam resistant pathogens.

      Weaknesses:

      The findings are not entirely novel as recent studies by Modi et al. 2025 mBio (studying C. crescentus) and Gilmore & Cava 2022 Nat. Commun. (studying Agrobacterium tumefaciens) came to similar conclusions.

      Gilmore & Cava have made the seminal finding that blocking anhydro-muropeptide import affects cell wall integrity in a manner that is partly independent of its effect on ampC expression. We now extend this finding by investigating various critical steps in the PG recycling pathway of C. cres­centus, a species lacking an AmpC homolog. Interestingly, by characterizing a variety of different mutants, we show that the morphol­ogical and ampicillin resistance defects they exhibit are not strictly con­nected and vary substantially between strains, suggesting that different steps in PG recycling differ in their importance for cellular fitness and cell wall integrity. This finding suggests that the phenotypes observed are not simply determined by the efficiency of PG recycling but likely result from a combination of factors. Based on the results obtained, we propose a model that highlights the different factors that may be at play and suggests a mechanism explaining their effects on β-lactam resistance and cell division. Our findings partly overlap with the recent study by Modi et al., but there are various points in which we disagree with their findings and conclusions. The need to rigorously validate our differing results led to a signi­ficant delay in the submission of our manuscript.

      Reviewer #1 (Recommendations for the authors):

      Major Comment

      Genetic complementation is lacking for deletion mutants throughout. Could you please provide complemented strains for mutants in key figures where deletion phenotypes are central to the conclusions (e.g., Figure 4 and related supplements).

      As explained above, we have not performed the requested comple­mentation experiments and included the data as Figure 4-figure supplement 1.

      Other minor comments:

      (1) Figure 1

      (a) This is a busy schematic; please consider visually separating PG biosynthesis vs. recycling (e.g., a faint divider line or shaded boxes).

      We have now simplified the schematic and visually separated the PG recycling and de novo biosyn­thesis pathways.

      (b) Please label "Fructose-6-phosphate" and "Glucosamine-6-phosphate (GlcN-6-P)" on the figure, since they are referenced in the caption (line 1410).

      The symbols for fructose, glucosamine and phosphate are given in the legend on the right. For consistency, we would therefore prefer not to additionally label these compounds in the figure.

      (c) Define all abbreviations in the caption: CM, GTase, TPase; and clarify the legend conventions (e.g., bold vs. regular font; red vs. black text).

      The structure of PG and the different lytic enzymes have now been removed from Figure 1. All remaining abbreviations have now been defined in the legend.

      (2) Figure 2 - Figure Supplement 2

      (a) Panel B: Please include the full chromatogram (it seems to be cropped at 10 min?). For AmiR in particular, it is important to show there are no nearby peaks at earlier retention times (eg GlcNAc).

      The region before 10 min is cropped in many published muropeptide profiles because the peaks contained in it are known to correspond to salts, i.e., borate from the reduction step and phos­phate, which are poorly retained on the C18 column (Figure 2–figure supplement 2). As the reviewer stated, free GlcNAc would elute in this region and would not be recognized if it were produced by AmiR. However, AmiR cleaves free anhydro-muropeptides between anhMurNAc and the peptide, and the experiment in Figure 2–figure supplement 2 shows that it does not cleave the bond between MurNAc and peptides in intact peptidoglycan.

      (b) Caption line 1439: with AmiR OR the catalytically...

      Done.

      (3) Figure 3

      Panel A: Label the products as NagZ-treated.

      In this analysis, we quantify specific intermediates from the total cellular pool of PG recycling inter­mediates. Since the products were not specifically treated with NagZ, we would prefer to keep the figures as it is.

      (4) Figure 4 (and Fig. 4-Figure Supplement 1, 2)

      (a) Please add complemented strains for ΔampG, ΔamiR, and ΔnagZ under the same conditions.

      As described in more detail above, we have now performed the requested complementation analysis.

      (b) Figure 4 - Figure S1 - Please include images of all strains quantified in B (e.g. control WT).

      Done.

      (c) Figure 4 - Figure S2: A. Please include images of all strains quantified in B. Please include spotting dilutions on minimal medium to assess the importance of PG recycling under nutrient limitation, especially given apparent lysis in ΔamiR and ΔampG.

      The length distributions of cells grown in PYE medium are taken from Figure 3 and only shown for comparison (as mentioned in the figure legend). To avoid the duplication of images, we would prefer to keep panel A as it is.

      We have now performed the requested serial-dilution spot assay on minimal (M2G) medium. The results show that ampicillin resistance de­creases even more dramatically for all strains in this condi­tion. The new data are presented in Figure 4-figure supplement 3C.

      (d) Figure 4 - Figures S3: A and B. Please include WT control.

      We have now added images of the wild-type strain to panel B of this figure. The serial dilution spot assays shown in panel A were performed on the same plates as those depicted in Figure 4 (as men­tioned in the figure legend). To avoid the duplication of images, we would prefer to keep this panel as it is.

      (5) Figure 5

      A, C - please include images of WT control.

      We have now added images of the wild-type strain to panel A of this figure. The serial dilution spot assays shown in panel C were performed on the same plates as those depicted in Figure 4 (as men­tioned in the figure legend). To avoid the duplication of images, we would prefer to keep this panel as it is.

      (6) Figure 6:

      (a) A, C - please include images of WT control.

      We have now added images of the wild-type strain to panel A of this figure. The serial dilution spot assays shown in panel C were performed on the same plates as those depicted in Figure 4 (as men­tioned in the figure legend). To avoid the duplication of images, we would prefer to keep this panel as it is.

      (b) It would be informative to test ΔamgK and ΔanmK on minimal medium (spotting and/or growth curves) to position these steps within the nutrient-dependent fitness landscape.

      We have now analyzed the ampicillin sensitivity of the ΔamgK, ΔnagK and ΔamgK ΔnagK strains on minimal medium (see Author response image 1). Consistent with the results obtained for other mutants in the PG recycling pathway, growth on minimal (M2G) medium plates leads to increased ampicillin sensi­tivity of the ΔamgK mutant. By contrast, ΔnagK and, to a lesser extent, ΔamgK ΔnagK cells show an in­creased tolerance to ampicillin under these conditions compared to growth on PYE plates.

      This phenomenon may be explained by the strong stimulatory effect of GlcNAc-6-P on NagB acti­vity. In the absence of NagK, GlcNAc-6-P levels drop, leading to reduced activation of NagB1/2. This effect, combined with abundant glucose to support central carbon metabolism may promote the GlcN-6-P biosynthesis through GlmS, thereby increasing the flux of meta­bol­ites into the de novo PG biosynthesis pathway and thus boosting ampicillin tolerance. However, more re­search is required to fully under­stand the molecular basis of this effect. Given that the results are likely to reflect complex interactions bet­ween dysregulated enzyme activity and altered metabolite pools caused by increased glucose avail­ability, they provide only limited insight into the role of PG recycling in ampicillin resistance. We therefore propose excluding this experiment from the present manuscript to avoid confusion.

      Author response image 1.

      Serial-dilution spot assay investigating the ampicillin resistance of the indicated mutant strains on minimal (M2G) medium plates.

      (c) Could Figures 6 and 7 be combined for better comparison and since there is no WT control? If so, could you also include the MurNAc cytoplasmic level quantification for the double mutant (Figure 7)?

      We would prefer to keep the two figures separated to avoid creating an overly large figure that contains a total of nine panels. However, we have now included an additional panel in Figure 7 show­ing the levels of MurNAc in the double mutant.

      (7) Figure 7. A, C

      Please include images of WT control.

      We have now added images of the wild-type strain (now panel B). The serial dilution spot assays (now panel D) were performed on the same plates as those depicted in Figure 4 (as men­tioned in the figure legend). To avoid the duplication of images, we would prefer to keep this panel as it is.

      (8) Figure 8-S1D, F

      Please include images of WT control.

      Panel F of this figure already contains a wild-type control.

      (9) Figure 10 A, C

      Please include images of WT control and ∆amiR (A).

      Done.

      (10) Figure 11

      Consider adding or highlighting in this figure (in a simplified manner) the major PG recycling differences in Caulobacter? The current model doesn't really show any difference that is unknown.

      This figure presents a model of the mechanism underlying the increased β-lactam sensitivity of PG recycling-deficient cells. Since the PG recycling pathway of C. crescentus is already presented in detail in Figure 1, we would like to keep this figure simple and thus leave it as it is.

      (11) Comments by lines:

      (a) Line 192: Clarify that NagZ is also part of the rate-limiting step since there is no difference between AmiR or NagZ order of hydrolysis?

      We have now omitted the statement that AmiR catalyzes the rate-limiting step in the PG recycling process, because our data do not allow definitive conclusions on this point.

      (b) Line 201: Define "considerable fraction" since this is known, please and cite original reference(s).

      Done.

      (c) Line 203: Please also cite the primary papers where they have found that disruption of the PG recycling pathway in E. coli and P. aeruginosa doesn't result in morphological defects.

      Since there are a number of papers that report PG recycling-deficient mutants of E. coli and P. aeru­ginosa, we would like to keep citing reviews to support this statement. However, we have now addi­tionally included a review by Park & Uehara (2008), which provides a detailed overview of PG recycling in bacteria.

      (d) Line 220-223: Though there are no obvious morphological defects, several mutants (e.g., ΔamiR, ΔampG) appear to be lysing or stressed under minimal conditions. Could you include spotting assays and/or growth curves on minimal medium (Figure 4, Figure S2) to quantify fitness under nutrient limitation?

      Have performed the requested serial dilution spot assays on minimal (M2G) medium plates and now present the data obtained in Figure 4-figure supplement 3C.

      (e) Line 224: PG recycling has been found to contribute to the regulation of B-lactam resistance in several organisms, not just those two. Perhaps add "including C. freundii and P. aeruginosa"

      Done.

      (12) Typographical errors:

      (a) Line 284: "caron" should be carbon.

      Done.

      (b) Line 323: "Figure C" needs a figure number.

      Done.

      (c) Line 33: "regulaton" should be regulation.

      Done.

      Reviewer #2 (Recommendations for the authors):

      (1) The study is well conducted and describes a number of experiments that significantly deepen previous findings. The conclusions of this paper are mostly well supported by data, but some experiments and data analysis may need to be clarified and extended.

      Thank you for this positive evaluation.

      (2) The data presented in Figures 2B and 2C show activities of AmiR and NagZ using LTase-cleaved cell wall preparations. Unfortunately, the preparations tested with the two enzymes should be identical, but apparently are not. Why aren't identical preparations used?

      We are sorry for the confusion. As stated in the Methods section (page 28, lines 757 and 773), the AmiR activity assays used LT products from PG sacculi isolated from E. coli D456, whereas the NagZ activity assays used LT-products from PG sacculi isolated from E. coli CS703-1. Both strains have a higher penta­peptide content than wild-type E. coli D456 lacks PBPs 4, 5 and 6 and has a moderate level of pentapeptides. CS703-1 lacks PBPs 1a, 4, 5, 6, 7 as well as AmpC and AmpH, and is known to have a higher pentapeptide content than D456. These differences are the reason for the distinct muro­peptide profiles in panel B and C of Figure 2.

      (3) I am missing a control experiment where muropeptides treated with NagZ were further digested with AmiR? This would show whether AmiR is able or not to cleave MurNAc-peptides. This is not evident from the provided experiments.

      We have now tested the activity of AmiR towards anhMurNAc-tetrapeptide in vitro. The results show that AmiR efficiently cleaves this GlcNAc-free anhydro-muropeptide species, verifying that it can also act on turnover products that have been previously processed by NagZ. The new data are shown in Figure 2–figure supplement 5.

      (4) The claim that PG recycling is critical, particularly upon transition to the stationary phase and under nutrient limitation, is not justified. It conflicts with the obvious morphological effects also in the exponential phase and with the absence of morphological defects in minimal medium: pronounced defects in rich PYE medium (Figure 4A/B) disappear in minimal M2G medium (Figure 4_figure supplement 2). It seems that catabolite repression effects apply here. Is the morphological effect in rich PYE medium reversed by adding glucose?

      We agree that PG recycling is not considerably more important in stationary phase and have removed this statement. Interestingly, while PG recycling-deficient mutants show no obvious mor­phol­ogical defects in minimal (M2G) medium, their ampicillin sensitivity even increases under this condi­tion (new Figure 4-figure supplement 3C), confirming that morphological and resistance defects are not strictly coupled. Preliminary data indicate that the morphological defects of the mutant cells are also abolished upon growth in PYE+glucose medium. High glucose availability may promote increased de novo synthesis of PG precursors, thereby partially restoring the PG precursor pool. We propose that the morphological and resistance phenotypes develop at different degrees of PG precursor depletion. However, future research is required to clarify the precise molecular basis of this phenomenon.

      (5) Figure 4: Why is the contribution of AmpG to ampicillin resistance much lower than for amiR or nagZ, despite ampG mutants showing the largest morphological defects? Does the accumulation of UDP-MurNAc or UDP-MurNAc-peptide correlate with ampicillin resistance, whereas the morphological effects correlate with the lack of precursors?

      The exact reason why the ΔampG mutant shows such a strong discrepancy in the severity of its morphol­ogical and resistance defects compared to the ΔamiR and ΔnagZ mutants remains unclear, because all of these deletions completely block the recycling of anhydro-muropeptides. The major difference in the ΔampG mutant is its inability to import anhydro-muropeptides, causing their accu­mu­lation in the periplasm. We propose that periplasmic anhydro-muropeptides, in particular the penta­peptide-containing species, can interact with the substrate-binding sites of PG metabolic enzymes, thereby interfering with proper PG biosyn­thesis. Conversely, by interacting with transpep­tidases, they may reduce their accessibility to ampicillin and thus preserve their acti­vity under β-lactam stress, particularly under conditions in which low PG precursor availability reduces binding site occupancy and thus facilitates antibiotic association.

    1. Author response:

      The following is the authors’ response to the previous reviews

      eLife Assessment

      This important study introduces an advance in multi-animal tracking by reframing identity assignment as a self-supervised contrastive representation learning problem. It eliminates the need for segments of video where all animals are simultaneously visible and individually identifiable, and significantly improves tracking speed, accuracy, and robustness with respect to occlusion. This innovation has implications beyond animal tracking, potentially connecting with advances in behavioral analysis and computer vision. The strength of support for these advances is compelling overall, although there were some remaining minor methodological concerns.

      To tackle “minor methodological concerns” mentioned in the Editorial assessment and Reviewer 3, the new version of the manuscript includes the following changes:

      a) The new ms does not anymore use the word “accuracy” but “IDF1 scores”. See, for example, Lines 46, 161, 176, and 522 for our new wording as “IDF1 scores”.

      b) Instead of comparing softwares using mean accuracy over the benchmark, Reviewer 3 proposes to use medians or even boxplots. We now provide boxplot results with mean, median, percentiles and outliers (Figure 1- figure Supplement 2).

      Additionally, we also include in the text the other recommendations from Reviewer 3:

      a) We now more explicitly describe the problems of the original idtracker.ai v4 in the benchmark (lines 66-68). Around half of the videos had a high accuracy in the original dtracker.ai (v4) but the other half of the videos had lower accuracies (Figure 1a, blue). The new idtracker.ai has high accuracy values for all the videos (Figure 1a, magenta).

      Also, the videos with high accuracy in the old idtracker.ai had very long tracking times (Figure 1b, blue) and the new version does not (Figure 1b, magenta). So the benchmark allows us to distinguish the new idtracker.ai as having a better accuracy for all videos and lower tracking times, making it a much more practical system than previous ones. 

      b) We further clarified the occlusion experiment (lines 188-190 and 277-290).

      c) We explain why we measure accuracies with and without animal crossings (lines 49-62).

      d) We added a Discussion section (lines 223-244).

      We believe the new version has clarified the minor methodological concerns.

      Reviewer #3 (Public review):

      The authors have reorganized and rewritten a substantial portion of their manuscript, which has improved the overall clarity and structure to some extent. In particular, omitting the different protocols enhanced readability. However, all technical details are now in appendix which is now referred to more frequently in the manuscript, which was already the case in the initial submission. These frequent references to the appendix - and even to appendices from previous versions - make it difficult to read and fully understand the method and the evaluations in detail. A more self-contained description of the method within the main text would be highly appreciated.

      In the new ms, we have reduced the references to the appendix by having a more detailed explanation in one place, lines 49-62.

      Furthermore, the authors state that they changed their evaluation metric from accuracy to IDF1. However, throughout the manuscript they continue to refer to "accuracy" when evaluating and comparing results. It is unclear which accuracy metric was used or whether the authors are confusing the two metrics. This point needs clarification, as IDF1 is not an "accuracy" measure but rather an F1-score over identity assignments.

      We thank the reviewer for noticing this. Following this recommendation, we changed how we refer to the accuracy measure with “IDF1 score” in the entire ms. See, for example, lines 46, 161, 176, and 522.

      The authors compare the speedups of the new version with those of the previous ones by taking the average. However, it appears that there are striking outliers in the tracking performance data (see Supplementary Table 1-4). Therefore, using the average may not be the most appropriate way to compare. The authors should consider using the median or providing more detailed statistics (e.g., boxplots) to better illustrate the distributions.

      We thank the reviewer for asking for more detailed statistics. We added the requested box plot in Figure 1- figure Supplement 2 to provide more complete statistics in the comparison.

      The authors did not provide any conclusion or discussion section. Including a concise conclusion that summarizes the main findings and their implications would help to convey the message of the manuscript.

      We added a Discussion section in lines 223-244.

      The authors report an improvement in the mean accuracy across all benchmarks from 99.49% to 99.82% (with crossings). While this represents a slight improvement, the datasets used for benchmarking seem relatively simple and already largely "solved". Therefore, the impact of this work on the field may be limited. It would be more informative to evaluate the method on more challenging datasets that include frequent occlusions, crossings, or animals with similar appearances.

      Around half of the videos also had a very high accuracy in the original dtracker.ai (v4) but the other half of the videos had lower accuracies (Figure 1a, blue). For example, we found IDF1 scores of 94.47% for a video of 100 zebrafish with thousands of crossings (z_100_1), 93.77% for a video of 4 mice (m_4_2) and 69.66% for a video of 100 flies (d_100_3). The new idtracker.ai has high accuracy values for all the videos (Figure 1a, magenta).

      Importantly, the tracking times for the majority of videos was very high in the original idtracker.ai (Figure 1b, blue), making the use of the tracking system limited in practice. The new system manages both a high accuracy in all videos (Figure 1a, magenta) and much lower tracking times (Figure 1b, magenta), making it a much more practical system..

      We have added a sentence of the limitations of the original idtracker.ai as obtained from the benchmark, lines 66-68.

      The accuracy reported in the main text is "without crossings" - this seems like incomplete evaluation, especially that tracking objects that do not cross seems a straightforward task. Information is missing why crossings are a problem and are dealt with separately.

      We have now added an explanation on why we measure accuracy without crossings and why we separated it from the accuracy for all the trajectory in lines 49-62. The reason is that the identification algorithm being presented in this ms only identifies animal images outside the crossings. This algorithm makes robust animal identifications through the video despite the thousands of animal crossings typically existing in each of our videos used in the benchmark. It is a second algorithm (that hasn’t changed since the first idTracker in 2014) the one that assigns animal positions during crossings once the first algorithm has made animal identifications before and after the crossings.

      There are several videos with a much lower tracking accuracy, explaining what the challenges of these videos are and why the method fails in such cases would help to understand the method's usability and weak points.

      Some videos had low accuracy on previous versions (Figure 1a, blue), but the new idtracker.ai has high accuracy in all of them (Figure 1a, magenta).

      Reviewer #3 (Recommendations for the authors):

      (1) As described before, the authors claim to use IDF1 as their metric in the whole manuscript (lines 414-436) but only refer to accuracy when presenting the results. It is not clear, whether accuracy was used as a metric instead of IDF1 or the authors are confusing these metrics.

      Following this recommendation, we replaced “accuracy” with “IDF1 score” , see lines 46, 161, 176, and 522.

      (2) In the introduction, a brief explanation why crossings need to be dealt with separately would help to understand the logic of the method design.

      We added such an explanation in lines 49-62.

      (3) Figure 3: We asked about how the tracking accuracy is being assessed with occlusions. The authors responded with that only the GT points inside the ROI are taken into account when computing the accuracy. Does this mean, that the occluded blobs are still part of the CNN training and the clustering? This questions the purpose of this experiment, since the accuracy performance would therefore only change, if the errors, that their approach is doing either way, are outside the ROI and, therefore, not part of the metric evaluation.

      The occluded blobs are not part of any training because they are erased from the video, they do not exist. We made this more clear in lines 188-190 and 277-290.

      (4) Figure 1: The fact that datasets are connected with a line is misleading - there is no connection between the data along the x-axis. A line plot is not an appropriate way to present these results.

      The new ms clarifies that the lines are for ease of visualization, see last line in the caption of Figure 1.

      (5) Lines 38-39: It is not clear how the CNN can be pretrained for the entire video if there are no global segments or only short ones. Here, the distinction between "no segments", "only short segments" and "pretraining on the entire video" is not explained.

      This pretraining protocol is not used in the version of the software we present, so details of this are not as relevant.

      (6) Figure 2a: The authors are showing "individual fragments" and individual fragments in a global fragment." However, it seems there are a few blue borders missing. In the text (l. 73-79), they note, that they are displaying them as "examples" but the absence of correct blue borders is confusing.

      In the new ms, we have replaced the label “Individual fragments in a global fragment” with “Individual fragments in an example global fragment” in the legend of Figure 2.

      (7) Lines 61-63, 148-151, and 162-164: Could the authors clarify why they used the average instead of median when comparing the speedups of the new version and the old ones?

      We thank the reviewer for asking for more detailed statistics. We added the requested box plot in Figure 1- figure Supplement 2 to provide more complete statistics in the comparison of accuracies and tracking times for old and new systems.

      (8) Lines 140-144: The post-processing steps are not clear. The authors should rather state clearly which processes of the old versions they are using. Then the authors could shortly explain them.

      We removed this paragraph and explained in more detail in lines 49-62 which parts of the software are new and which ones are not.

      (9) Lines 239-251: Here, the authors are clarifying on a section 1-2 pages before. This information should be directly in that section instead.

      Following this recommendation, we clarified the occlusion experiment in the main text (lines 188-191) to make it more self-contained. Still, the flow of the main text is better with some details in Methods.

      (10) Line 38: It is not clear how the CNN can be pretrained for the entire video if there are no global segments or only short ones. Here, the distinction between "no segments"

      "only short segments" and "pretraining on the entire video" is a bit misleading/underexplained.

      See number 5.

      (11) Figure 2a: The authors are showing "individual fragments" and individual fragments in a global fragment." However, it seems there are a few blue borders missing. In the text (l. 73-79), they note, that they are displaying them as "examples" but the absence of correct blue borders is confusing.

      See number 6.

      (12) Figure 2c and line 115-118: "Batches" itself is not meaningful without any information of the batch size. The authors should rather depict the batch size and then the number of epochs. The Figure 2 contains the info 400 positive and 400 negative pairs of images per batch. However, there is no information about the total number of images.

      Furthermore, these metrics are inappropriate here, since training is carried out from scratch (or already pre-trained) for every new video, each video has different number of animals, different number of images.

      Following this recommendation, we clarified the number of images in each batch (Figure 1c caption and lines 134-138), why we do not work with epochs (lines 700-702), and the idea that the clusters in Figure 2 represent an example and the number of batches needed for the clusters to form depends on the video details.

      Appendix 1-figure 1: why do the methods fail? It looks that for certain videos the method is fairly unreliable. What is the reason for the methods to crash and how to avoid this?

      Those failures are only for the old idtracker.ai and Trex, not for the method presented here. Our new contrastive algorithm does not fail in any of the videos in the benchmark.

      We thank the reviewer for the detailed suggestions. We believe we have incorporated all of them in the new version of the ms.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper by Karimian et al proposes an oscillator model tuned to implement binding by synchrony (BBS*) principles in a visual task. The authors set out to show how well these BBS principles explain human behavior in figure-ground segregation tasks. The model is inspired by electrophysiological findings in non-human primates, suggesting that gamma oscillations in early visual cortex implement feature-binding through a synchronization of feature-selective neurons. The psychophysics experiment involves the identification of a figure consisting of gabor annuli, presented on a background of gabor annuli. The participants' task is to identify the orientation of the figure. The task difficulty is varied based on the contrast and density of the gabor annuli that make up the figure. The same figures (without the background) are used as inputs to the oscillator model. The authors report that both the discrimination accuracy in the psychophysics experiment and the synchrony of the oscillators in the proposed model follow a similar "Arnold Tongue" relationship when depicted as a function of the texture-defining features of the figure. This finding is interpreted as evidence for BBS/gamma synchrony being the underlying mechanism of the figure-ground segregation.

      Note that I chose to use "BBS" over gamma synchrony (used by the authors) in this review, as I am not convinced that the authors show evidence for synchronization in the gamma-band.

      We thank the reviewer for their careful assessment of our manuscript and useful comments that we believe have served to strengthen our work.

      Strengths:

      The design of the proposed model is well-informed by electrophysiological findings, and the idea of using computational modeling to bridge between intracranial recordings in non-human primates and behavioral results in human participants is interesting. Previous work has criticized the BBS synchrony theory based on the observation that synchronization in the gamma-band is highly localized and the frequency of the oscillation depends on the visual features of the stimulus. I appreciate how the authors demonstrate that frequency-dependence and local synchronization can be features of BBS, and not contradictory to the theory. As such, I feel that this work has the potential to contribute meaningfully to the debate on whether BBS is a biophysically realistic model of feature-binding in visual cortex.

      Weaknesses:

      I have several concerns regarding the presented claims, assessment of meaning and size of the presented effects, particularly with regard to the absence of a priori defined effect sizes.

      Firstly, the paper makes strong claims about the frequency-specificity (i.e., gamma synchrony) and anatomical correlates (early visual cortex) of the observed effects. These claims are informed by previous electrophysiological work in non-human primates but are not directly supported by the paper itself. For instance, the title contains the word "gamma synchrony", but the authors do not demonstrate any EEG/MEG or intracranial data in from their human subjects supporting such claims, nor do they demonstrate that the frequencies in the oscillator model are within the gamma band. I think that the paper should more clearly distinguish between statements that are directly supported by the paper (such as: "an oscillator model based on BBS principles accounts for variance in human behavior") and abstract inferences based on the literature (such as "these effects could be attributed to gamma oscillations in early visual cortex, as the model was designed based on those principles").

      We thank the reviewer for this helpful comment and agree that the scope of our claims should be clearly delineated between what is directly supported by our data and what is theoretically inferred from prior literature.

      We revised the Abstract, Introduction, and early Discussion to moderate the strength of our statements and make the distinction explicit. The revised title now emphasizes that our study tests principles derived from prior work on gamma synchrony rather than directly demonstrating gamma activity in humans. Throughout the text, we use more cautious phrasing that highlights potential mechanisms and theoretical predictions. The intention of our study was not to position synchrony as the only viable mechanism of figure–ground perception. Rather, our goal was to reinvigorate it as a potential contender by showing that features often cited as limitations of synchrony-based binding may in fact be essential properties of the mechanism. We updated phrasing throughout the manuscript to make this clearer and avoid overstating the study’s contribution.

      Importantly, our model is not agnostic with respect to frequency band. Oscillator frequencies exhibited by model units are within the gamma range by design. Frequency emerges directly from the contrast within each oscillator’s receptive field, following an empirically established relationship between stimulus contrast and gamma frequency. To our knowledge, such a robust, quantitative relationship between stimulus features to exact oscillation frequency has not been consistently demonstrated for other frequency bands. This relationship yields gamma-band frequencies for all contrasts used in our simulations. The model is thus indeed a gamma oscillator model of V1, not a generic instantiation of Binding by Synchrony (BBS) principles.

      That said, we fully agree with the reviewer that our study cannot demonstrate a direct link between gamma synchrony in visual cortex and human behavior. Our behavioral and modeling results instead show that synchronization principles derived from gamma-band physiology in V1 can predict perceptual performance patterns. We now make this distinction explicit throughout the revised manuscript.

      Secondly, unlike the human participants, the model strictly does not perform figure-ground segregation, as it only receives the figure as an input.

      We thank the reviewer for the opportunity to clarify our modeling approach. We chose not to model the background to reduce computational cost, since including it requires a substantially larger number of oscillators without changing the model’s predictions. The model thus indeed only receives the figure region as input. We aimed to test the local grouping mechanism predicted by TWCO, rather than to simulate a full figure–ground segregation process including a read-out stage. Our model therefore isolates the conditions under which local synchrony emerges within the figure region, assuming that a downstream read-out mechanism (not explicitly modeled here) would detect regions of coherent activity. The exact nature of such a read-out mechanism was beyond the scope of our work.

      To confirm that our simplified model is a valid proxy, we ran additional simulations including the background and found that a coherent figure assembly reliably emerges, as can be seen in the phase-locking patterns relative to a reference oscillator at the center of the figure. This validates that the principles of local grouping we studied in isolation hold even when the figure is embedded in a noisy surround. We have added an explicit note in the Results (paragraph 2) that we only simulate the figure and added Supplementary Figure S1 showing the additional simulations.

      Finally, it is unclear what effect sizes the authors would have expected a priori, making it difficult to assess whether their oscillator model represents the data well or poorly. I consider this a major concern, as the relationship between the synchrony of the oscillatory model and the performance of the human participants is confounded by the visual features of the figure. Specifically, the authors use the BBS literature to motivate the hypothesis that perception of the texture-defined figure is related to the density and contrast heterogeneity of the texture elements (gabor annuli) of the figure. This hypothesis has to be true regardless of synchrony, as the figure will be easier to spot if it consists of a higher number of high-contrast gabors than the background. As the frequency and phase of the oscillators and coupling strength between oscillators in the grid change as a function of these visual features, I wonder how much of the correlation between model synchrony and human performance is mediated by the features of the figure. To interpret to what extent the similarity between model and human behavior relies on the oscillatory nature of the model, the authors should find a way to estimate an empirical threshold that accounts for these confounding effects. Alternatively, it would be interesting to understand whether a model based on competing theories (e.g., Binding by Enhanced Firing, Roelfsema, 2023) would perform better or worse at explaining the data.

      We thank the reviewer for these insightful and constructive comments, which have prompted additional analyses that we believe substantially strengthen our work. The reviewer raises two main points: (1) the need for a benchmark to assess our model’s performance, and (2) the concern that the relationship between model synchrony and behavior might be a non-causal “confound” of the visual features. We address each point below.

      (1) Benchmarking model performance

      We agree that it is important to assess how well our model performs relative to the data and included this in the original manuscript. We did not predefine an absolute good fit threshold because absolute agreement depends on irreducible noise and inter-subject variability, making a universal cutoff arbitrary. Instead, we had benchmarked model performance in two complementary ways. First, the noise ceiling shown in Figure 5 provides an empirical benchmark for the maximum fit any model could achieve on our data. Simulated Arnold tongues (based on synchrony) approach this ceiling achieving 89% of possible similarity for correlation and 79% of possible similarity for weighted Jaccard similarity, respectively. Second, the parameter sweep (Figure 3) situates our model’s performance within the broader parameter space. It shows that the model, whose key parameters were fixed a priori from independent macaque neurophysiological data, lies close to the optimal regime for explaining the human data. It also provides an estimate of the lower bound (worst-performing point) on the fit that a misspecified model implementing the identical mechanism would achieve. Our model with fixed a priori parameters does 1.41 times better than a misspecified model for the correlation fit metric and 3 times better for weighted Jaccard similarity.

      (2) Synchrony as mechanism vs. potential confound

      We appreciate the reviewer’s suggestion to test whether synchrony explains behavior beyond stimulus features. In our framework, synchrony is a near-deterministic function of the manipulated stimulus features given fixed model parameters. As a result, synchrony and the stimulus features are collinear (R<sup>2</sup>≈0.8) leaving no independent variance for synchrony to explain once stimulus features are included. Adding both into one statistical model yields unstable coefficients and no out-of-sample improvement.

      Mechanistically, we believe the relevant question is not whether synchrony explains behavior beyond stimulus features but whether synchrony is the correct transformation of the stimulus features to reproduce the behavioral pattern. Please note that in our design we ensured that mean contrast and luminance are identical in the figure and the background such that there are not more high-contrast Gabors in the figure than in the background. We did this with the aim to render mean contrast not a relevant feature. However, there are more high-contrast Gabors in the background, and it is conceivable that the absence of such high contrasts in the figure drives the detection/discrimination of the figure. We therefore agree that testing alternative models would further clarify the unique explanatory value of the synchrony mechanism. To that end, we derived two alternative rate-based readouts from the same V1 simulations of our model from which we derived synchrony. First, average firing rates inside the figure and second, the difference between average firing rates inside the figure and average firing rates in the background (rate difference). We analyzed each individually as predictors of behavior and performed a model comparison based on out-of-sample predictions. While rate difference (but not average firing) showed meaningful associations with performance when considered alone, the synchrony readout had a larger effect size and was favored by the model comparison. We added a new subsection comparing synchrony to rate-based alternatives in the Results (paragraphs 7-9), including additional Bayesian analyses and LOO-CV model comparison. Please note that the model comparison we added to the manuscript provides an additional benchmark beyond the map-level ceiling analysis. It indicates that the mapping from stimulus features to behavior via synchrony generalizes best without requiring an a priori good-fit threshold.

      We agree that formally comparing our model to a sophisticated rate-based alternative, such as an instantiation of the Binding by Enhanced Firing model, is an important direction for future work. However, it remains an open and non-trivial question whether such a model could quantitatively reproduce the precise shape of the behavioral Arnold tongue that emerges from the systematic manipulation of our stimulus parameters. Implementing and parameterizing such a model in a comparable, biologically grounded framework is a substantial undertaking that lies beyond the scope of the current study. Therefore, our goal here was not to claim exclusivity for synchrony-based mechanisms, but rather to re-evaluate their plausibility by showing that features often seen as limitations (stimulus dependence and frequency heterogeneity) are, in fact, essential characteristics of the TWCO framework that can predict complex behavioral outcomes.

      We would also like to clarify that our stimulus features were derived from theory rather than psychophysical literature. Starting from the principles of TWCO, we mapped frequency detuning and coupling strength onto known anatomical and physiological properties of early visual cortex, and only then derived the corresponding stimulus manipulations (contrast heterogeneity and grid coarseness). Demonstrating that these features predict behavior is therefore not trivial but constitutes a first empirical confirmation that the core TWCO variables match perception.

      Apart from adding analyses of additional rate-based readouts of our model, we also refined our discussion of the relationship between these and a synchrony-based mechanism.

      Reviewer #2 (Public review):

      The authors aimed to investigate whether gamma synchrony serves a functional role in figure-ground perception. They specifically sought to test whether the stimulus-dependence of gamma synchrony, often considered a limitation, actually facilitates perceptual grouping. Using the theory of weakly coupled oscillators (TWCO), they developed a framework wherein synchronization depends on both frequency detuning (related to contrast heterogeneity) and coupling strength (related to proximity between visual elements). Through psychophysical experiments with texture discrimination tasks and computational modeling, they tested whether human performance follows patterns predicted by TWCO and whether perceptual learning enhances synchrony-based grouping.

      We thank the reviewer for their thoughtful and constructive review. We believe the comments have served to improve our work.

      Strengths:

      (1) The theoretical framework connecting TWCO to visual perception is innovative and well-articulated, providing a potential mechanistic explanation for how gamma synchrony might contribute to both feature binding and separation.

      (2) The methodology combines psychophysical measurements with computational modeling, with a solid quantitative agreement between model predictions and human performance.

      (3) In particular, the demonstration that coupling strengths can be modified through experience is remarkable and suggests gamma synchrony could be an adaptable mechanism that improves with visual learning.

      (4) The cross-validation approach, wherein model parameters derived from macaque neurophysiology successfully predict human performance, strengthens the biological plausibility of the framework.

      Weaknesses:

      (1) The highly controlled stimuli are far removed from natural scenes, raising questions about generalisability. But, of course, control (almost) excludes ecological validity. The study does not address the challenges of natural vision or leverage the rich statistical structure afforded by natural scenes.

      We agree with the reviewer that the insights of the present study are limited to texture stimuli and have made adjustments in the Discussion (final two paragraphs) to avoid claiming generalizability to natural stimuli. We have also adjusted the title to specifically limit our results to texture stimuli. To establish the principles of TWCO, we needed tight control over the stimulus, but are intrigued by the idea to investigate natural scenes. We have added to our Discussion (paragraph 9) that future should evaluate to what extent the principles we investigate here apply to natural scenes. Synchrony-based mechanisms have been successfully used for image segmentation tasks in machine vision, showing that the proposed mechanism can in principle work for natural scenes.

      (2) The experimental design appears primarily confirmatory rather than attempting to challenge the TWCO framework or test boundary conditions where it might fail.

      We thank the reviewer for this important point. Our primary motivation was to address the neurophysiological properties of gamma synchrony that have been suggested to severely challenge the binding by synchrony mechanism. Particularly the strong dependence of gamma oscillations and synchrony on stimulus features. Our goal was to show that from the perspective of TWCO, these challenges become expected components of the mechanism. In essence, we wanted to promote a conceptual shift that converts what pushes a theory to its limit into something that is actually its central tenet. To facilitate this shift, we designed the experiment to directly test this core tenet.

      While our approach was designed to test a central prediction of TWCO rather than explicitly challenge its boundaries, we respectfully argue that it was far from a simple confirmatory experiment. The design incorporated high-risk elements that provided considerable room for both the theory and our model to fail. First, the core prediction itself was non-obvious and highly specific. We did not simply test whether contrast heterogeneity and grid coarseness affect perception. We tested the stronger hypothesis that they would reflect a specific, interactive trade-off (the behavioral Arnold tongue) as specified by TWCO. Second, our modeling approach was deliberately constrained to provide a further stringent test. We did not post-hoc optimize the model's key parameters to fit our behavioral data. Instead, we fixed them a priori based on independent neurophysiological data from macaques. This was a high-risk choice, as a mismatch between a priori model predictions and the human data would have seriously challenged the framework's generalizability.

      We agree that future research should further challenge TWCO. For instance, by using stimuli that require segregating several objects simultaneously or objects that cover more extensive regions of the visual field.

      (3) Alternative explanations for the observed behavioral effects are not thoroughly explored. While the model provides a good fit to the data, this does not conclusively prove that gamma synchrony is the actual mechanism underlying the observed effects.

      We agree that our results do not conclusively show that gamma synchrony is the actual mechanism underlying figure-ground segregation. We admit that the original phrasing used throughout the manuscript was too strong and gave the impression that we wanted to establish exactly that. However, the goal of our work was only to reinvigorate gamma synchrony as a potential contender by showing that features often cited as limitations of synchrony-based binding may in fact be essential properties of the mechanism. We have revised the title and made adjustments throughout the manuscript to better reflect this more moderate goal.

      Additionally, we added tests of alternatives (Results, paragraphs 7–9) to clarify the unique explanatory value of the synchrony mechanism. To that end, we derived two alternative rate-based readouts from the same V1 simulations of our model. First, we extracted average firing rates inside the figure. Second, we computed the difference between average firing rates inside the figure and average firing rates in the background (rate difference). We analyzed each individually as predictors of behavior and performed a model comparison between these two and synchrony based on out-of-sample predictions. While the rate difference (but not average firing) showed meaningful associations with performance when considered alone, the synchrony readout had a larger effect size and was favored by the model comparison.

      (4) Direct neurophysiological evidence linking the observed behavioral effects to gamma synchrony in humans is absent, creating a gap between the model and the neural mechanism.

      We agree that the model only provides a how-possibly account linking stimulus features to performance. Showing that the brain actually relies on this mechanism would require showing that cortical synchrony mediates the effect of stimulus features on behavior beyond firing rates. Collecting such data would constitute a major effort that would go beyond the scope of this study. We acknowledge the need for electrophysiological data and the mediation analysis in the updated Discussion.

      Achievement of Aims and Support for Conclusions:

      The authors largely achieved their primary aim of demonstrating that human figure-ground perception follows patterns predicted by TWCO principles. Their psychophysical results reveal a behavioral "Arnold tongue" that matches the synchronization patterns predicted by their model, and their learning experiment shows that perceptual improvements correlate with predicted increases in synchrony.

      The evidence supports their conclusion that gamma synchrony could serve as a viable neural grouping mechanism for figure-ground segregation. However, the conclusion that "stimulus-dependence of gamma synchrony is adaptable to the statistics of visual experiences" is only partially supported, as the study uses highly controlled artificial stimuli rather than naturalistic visual statistics, or shows a sensitivity to the structure of experience.

      Likely Impact and Utility:

      This work offers a fresh perspective on the functional role of gamma oscillations in visual perception. The integration of TWCO with perceptual learning provides a novel theoretical framework that could influence future research on neural synchrony.

      The computational model, with parameters derived from neurophysiological data, offers a useful tool for predicting perceptual performance based on synchronization principles. This approach might be extended to study other perceptual phenomena and could inspire designs for artificial vision systems.

      The learning component of the study may have a particular impact, as it suggests a mechanism by which perceptual expertise develops through modified coupling between neural assemblies. This could influence thinking about perceptual learning more broadly, but also raises questions about the underlying mechanism that the paper does not address.

      Additional Context:

      Historically, the functional significance of gamma oscillations has been debated, with early theories of temporal binding giving way to skepticism based on gamma's stimulus-dependence. This study reframes this debate by suggesting that stimulus-dependence is exactly what makes gamma useful for perceptual grouping.

      The successful combination of computational neuroscience and psychophysics is a significant strength of this study.

      The field would benefit from future work extending (if possible) these findings to more naturalistic stimuli and directly measuring neural activity during perceptual tasks. Additionally, studies comparing predictions from synchrony-based models against alternative mechanisms would help establish the specificity of the proposed framework.

      Recommendations for the authors:

      Reviewing Editor Comments:

      In a joint discussion to integrate the peer reviews and agree on the eLife recommendations, both reviewers agreed that the work is valuable, but they were on the fence about whether the strength of evidence was incomplete or solid, eventually settling on incomplete. The reviewers make several recommendations for improving these ratings, which I (Reviewing Editor) have organised into 3 points below, with point 1 of particular importance. Underneath the summary, please see the individual recommendations of the reviewers.

      (1) Strengthen evidence for the unique role of gamma synchrony in explaining the data, and ensuring claims are directly supported by relevant data:

      Reviewers 2 and 3 both note the lack of direct evidence for gamma involvement, and reviewer 2 observes that the fit with behaviour may trivially be explained by a relationship between contrast heterogeneity and grid coarseness without need for oscillation. The reviewers felt that the approach of fitting the model to human data could be strengthened to help address this issue - and they offer various solutions, e.g., more principled a-priori criteria around good vs bad fit of the model to both main task and training data, and comparison to alternative binding models (Reviewer 2), identifying and testing boundary conditions of the model (Reviewer 3). There is also the possibility of collecting direct human neurophysiological evidence linking the behavioural data to neural mechanisms. Our discussion also highlighted the need to weaken claims (including in the title) where links are not directly demonstrated by methods from the present study, e.g., resting on indirect comparisons to primate literature.

      We agree with the editor and reviewers that this was a critical point. To address it, we have made several major revisions.

      As suggested, we have weakened claims where the links are not directly demonstrated by our data. The title has been revised to be more specific, and we have carefully edited the abstract, introduction, and discussion to distinguish between our model's predictions and direct neurophysiological evidence.

      To address the concern that our model's fit might be trivially explained by visual features, we have performed a new analysis comparing the synchrony-based readout to two alternative rate-based readouts from the same V1 simulations. This new comparison shows that the synchrony readout provides a superior out-of-sample prediction of human behavior.

      While a full implementation of a competing theory like "Binding by Enhanced Firing" would be a valuable next step, we note that parameterizing such a model in a comparably grounded framework is a substantial undertaking beyond the scope of the present study. Our new analysis provides an important first step in this direction.

      (2) Make explicit and address the limitations of the stimuli:

      Include that the model is not extracting the figure from the background, and the controlled stimuli may limit generalizability.

      To address the concern that our model was not performing true figure-ground extraction, we performed a new set of simulations that included both the figure and the immediate background. The results confirm that synchrony dynamics within the figure region are not affected by the presence of the background. We added these validation results as supplementary materials. We have additionally made the modeling choice and its justification more explicit in the Results and Methods sections.

      We have revised the Discussion to be more explicit about the limitations of using highly controlled texture stimuli. We now clearly state that our findings are specific to this context and that further research is required to determine if these principles generalize to the segregation of objects in natural scenes.

      (3) Some clarifications to make more accessible:

      Include the figure explaining the framework (Reviewers 1&2), and also the model details (Reviewer 2).

      We have revised Figure 1 and its caption to more clearly illustrate the links from TWCO principles to their neural implementation in V1 and the resulting behavioral predictions.

      We have expanded the Methods section to provide a more detailed and accessible description of the model's construction. We now clarify precisely how the oscillator grid was defined in visual space, how eccentricity-dependent receptive field sizes were implemented, and how these were mapped onto a retinotopic cortical surface to determine coupling strengths.

      Reviewer #1 (Recommendations for the authors):

      (A) Major concerns:

      (1) My main concern:

      My main concern is the repeated claims that the observed findings can be attributed to gamma synchrony in the early visual cortex. I find this claim misleading as the authors do not report any electrophysiological data that directly supports such claims. As stated in my public review, I feel that the authors should be clear about direct evidence versus more abstract inferences based on the literature.

      In particular, I recommend changing claims about "gamma synchrony" to "Binding by Synchrony" That being said, the authors can outline that the model was built under the assumption that this synchrony is mediated by gamma in early visual cortex, but I don't think it should be part of their main conclusions.

      We appreciate that TWCO’s general principles are frequency-agnostic and can be viewed as binding by synchrony in a broad sense. Our work, however, specifically instantiates these principles in V1 gamma: the model reflects TWCO dynamics together with V1 anatomy/physiology and the well-established contrast–frequency relationship in the gamma range (which, to our knowledge, has not been demonstrated with comparable specificity for other bands). In that sense, it is a gamma oscillator model of V1, rather than a generic BBS instantiation. Moreover, stimulus dependencies often cited as challenges to BBS have been used in particular to argue against gamma; showing that these very dependencies are integral to the TWCO mechanism is central to our contribution, and we therefore keep our conclusions focused on the gamma-specific instantiation tested here.

      (2) Mediation of the observed effects by the visual features of the figure:

      The authors motivate the hypothesis that BBS predicts that the perception of texture-defined objects depends on the density of texture elements and their contrast heterogeneity. This hypothesis seems trivial as those are the features that distinguish figure from ground. I think it would be important to clarify how this hypothesis is unique to BBS and not explained by competing theories, such as Binding by Enhanced Firing (Roelfsema, 2023). The authors should be clear about what part of the hypothesis is not trivial based on the task and clearly attributable to oscillators and synchrony.

      Our stimulus features were derived from theory rather than psychophysical literature. Starting from the principles of TWCO, we mapped frequency detuning and coupling strength onto known anatomical and physiological properties of early visual cortex, and only then derived the corresponding stimulus manipulations (contrast heterogeneity and grid coarseness). We agree that grid coarseness (element distance) is an established facilitator of figure–ground perception. By contrast, contrast heterogeneity (feature variance) is less commonly emphasized as a figure–ground cue, compared to mean-based cues, but follows directly from TWCO’s frequency detuning. Importantly, mean contrast and luminance were matched exactly between figure and background in our stimuli. Demonstrating that contrast heterogeneity and grid coarseness not only independently affect figure-ground perception, but reflect a trade-off where higher heterogeneity needs to counteracted by reduced grid coarseness in the way TWCO specifies is therefore non-obvious and provides an initial empirical indication that the core TWCO variables might shape perception. We also agree that alternative models would further clarify the unique explanatory value of synchrony. In the revised manuscript, we compare rate-based readouts (mean figure rate; figure–background rate difference) with the synchrony readout from the same simulations. Rate difference indeed constitutes a predictor of performance, but the synchrony readout showed a larger effect and was preferred by out-of-sample model comparison.

      Using a linear model, the authors assess the relationship between discrimination accuracy and synchrony. Did the authors also include the factors grid coarseness and contrast heterogeneity in this model? Again, as both the task performance (as shown by the GEE analysis) and oscillatory synchrony depend on these features, the relationship between model and behavioral performance will be mediated by the visual features.

      Thank you for raising this. In our framework, detuning (via contrast heterogeneity) and coupling (via grid coarseness) are the inputs, synchrony is the proposed mechanistic mediator, and behavior is the output. Because synchrony in our model is a (near-)deterministic function of the manipulated features under fixed parameters, a joint features+synchrony regression is statistically ill-posed (perfect multicollinearity up to numerical error) and cannot add information. A proper mediation test would require trial-wise neural measurements of synchrony in the same task, which we do not have and acknowledge as a limitation in the Discussion. Accordingly, we show that both the features themselves (reflecting TWCO principles) and model-derived synchrony (realizing the proposed pathway) account for behavior.

      We agree this does not establish a unique contribution of synchrony. To probe alternatives, we added rate-based readouts and a model comparison to the revised manuscript. These additional analyses indicate that synchrony outperforms simple rate-based mappings. We do not claim this rules out more sophisticated rate-based mechanisms. Our aim is to demonstrate that synchrony is a viable, behaviorally informative readout for downstream processing. We do not assert it is the only mechanism the brain uses. Synchrony had been discounted due to its stimulus dependence; our results are intended to rule it back in. We have made changes throughout the manuscript to better reflect this more modest aim.

      (3) Goodness of fit measures are not established a prior:

      I have described this concern in my public review. It is hard to assess what the authors would have interpreted as a good or a bad fit, especially without accounting for the confound in the relationship between oscillator synchrony and behavior. Similarly, when assessing the similarity between the behavioral and dynamic Arnold Tongues across different coupling parameters, the authors found that the chosen parameters (based on macaque data) were not optimal. They offer the explanation that the human cortex has a lower coupling decay than the macaque cortex, and the similarity is higher for lower values of coupling decay. While this explanation is not entirely implausible, it is unclear where an oscillator model with human values would be in the presented plot, as the authors didn't estimate those values from the human studies. Moreover, the task used in the Lowet et al., 2017 paper is very different from the task presented here, which could also account for differences. Overall, the explanation appears hand-wavy considering the lack of empirically defined goodness of fit measures.

      Thank you for these concerns.

      We did indeed not provide a priori thresholds for what would be considered good fit. Instead, we used two complementary benchmarks; namely noise ceilings and parameter exploration. The former provides an upper bound on what any model (not just ours but based on completely different mechanisms) could achieve given our data. The parameter sweep provides an indication how well our concrete model can maximally fit the data and how bad it can be based on possible parameters. These benchmarks are more informative than a fixed a-priori cutoff, which would depend on unknown noise and inter-subject variability. Both the noise ceiling and the parameter exploration indicate that our model, using a priori fixed parameters, performs well. Additionally, we redid all our statistical analyses after z-normalizing every predictor to provide easier interpretation of effect sizes.

      Regarding the reason that key model parameters were not optimal, we believe our interpretation to be plausible. We agree that we currently do not have data to estimate the exact human decay factor and hence cannot establish how much model fit would be affected. However, the parameter exploration in Figure 3 shows that small to modest reductions in decay would improve model fit. We discuss this now in the revised manuscript.

      The reviewer’s suggestion is intriguing. While Lowet et al. (2017) used a different task, the parameters we took from their work (decay rate and maximum coupling) are intended to reflect anatomical properties and thus should not be task-dependent. That said, Lowet et al. ‘s data carry uncertainty, so our estimates may not be exact; we note this explicitly in the revised Discussion. Whether a different task would have yielded better parameter estimates is difficult to determine, but we considered Lowet’s paradigm appropriate because it was designed to target the same V1 anatomical and physiological properties that map onto TWCO.

      I have concerns about a similar confound in the training effects. If I'm not mistaken, the Hebbian Learning rule encourages synchronization between the oscillators in the grid. As such, it causes synchronization to increase over several simulations. Clearly, the task performance of the participants also improves over the sessions. Again, an empirical threshold would be required to assess whether the similarity in learning between model and performance goes beyond what is expected based on learning alone. How much of these effects can be attributed to the model being oscillatory?

      The reviewer is correct that, in our framework, learning operates via changes in coupling that increase synchrony. Enhanced synchrony is the proposed (and in our model also the actual) pathway by which learning impacts behavior. We agree that learning could, in principle, act through pathways other than synchrony. Demonstrating this would not be achieved by a mediation analysis here, because that requires independent, trial-level neural measurements of the candidate pathways (synchrony and alternatives). In the absence of such data, the appropriate approach would be model comparison between competing mechanistic readouts. We have added such a model comparison for a synchrony readout versus two rate-based readouts derived from the same simulations for the first session; i.e., focusing on the pathway from stimulus features to behavior. However, a similar model comparison is not possible for learning. As we show in the supplementary materials, rate-based readouts of our V1 model are not at all affected by coupling strength. As such, they are insensitive to changes in coupling and are thus not viable as alternative mechanisms to explain performance changes due to learning. A fair test of rate-based alternatives would require building a detailed rate-based figure–ground segregation model that predicts session-wise changes. We agree that this is an important next step but it is also substantial undertaking beyond the scope of the present study.

      (4) Similarly, for the comparison of the Arnold Tongue in the transfer session and the early session:

      In the first part of the Results section, it says: "Our model rests on the assumption that learning-induced structural changes in early visual cortex are specific to the retinotopic locations of the trained stimuli. We evaluated whether this assumption holds for our human participants using the transfer session following the main training period. [...] If learning is indeed local, participants' performance in the transfer session should resemble that of early training sessions, indicating a reset in performance for the new retinal location."

      The authors find that a model fit to session 3 explains the data in the transfer session best and consider this as evidence for the above-stated expectation. Again, it is unclear where the cutoff would have been for a session to be declared as early or late. For instance, had the participants only performed 4 sessions, would the performance be best explained by session 3 or session 1?

      A high number of statistical tests are used, which, firstly, need to be corrected for multiple comparisons (did the authors do this?). Secondly, I feel that the regression models could be improved. For instance, the authors fit one model per session and then assess how well each model explains the variance in the transfer session. I think the authors might want to opt for one model with the regressors contrast heterogeneity, grid coarseness, and session (and their interaction). Using this approach, the authors would still be able to assess which session predicts the data best. Similarly, interindividual variability could be accounted for by adding participant-specific random effects to the model (and using a mixed model), instead of fitting individual models per participant.

      We agree the “early vs late” cutoff was underspecified. In the revision, we predefine Session 2 as the early-learning reference, excluding Session 1 to avoid familiarization/response–mapping effects. We then fit a single Bayesian hierarchical model with contrast heterogeneity, grid coarseness, and session, plus a transfer indicator, and participant-level random effects. This allows us to place the transfer session on the same scale as training and to test a) whether the transfer session precedes the state in session 2 via the posterior contrast P(βtransfer<βSess2) and b) whether it is indistinguishable from the state in session two using an equivalence test derived from the fitted model. We find that the transfer session is equivalent to session 2. We added this updated analysis of the transfer session in the Results (paragraph 15).

      In response to the suggestion to use a hierarchical regression model for analyzing the transfer session, we have decided to use such a model for all our analyses in a Bayesian framework. In this Bayesian framework, inference is based on the joint posterior (credible intervals/equivalence) of all predictors in a model and additional post-hoc multiplicity corrections are not required.

      (5) Questions regarding the model:

      What does it mean that the grid was "defined in visual space"? How biologically plausible with regard to the retinotopy and organization of the oscillators do the authors claim the model to be?

      We are happy to clarify this point. We have a total of 400 oscillators reflecting neural assemblies in V1. We start by defining a regular, 20x20, grid of the receptive field (RF) centers of these oscillators inside the figure region. Each oscillator is then also assigned a RF size based on the eccentricity of its RF center. We use the threshold-linear relationship between RF eccentricity and RF size reported in [1] to assign RF sizes. Each oscillator thus has an individual, eccentricity-dependent, RF size.

      For the coupling between oscillators, we need to know their cortical distances. We obtain these by first determining the cortical location of each oscillator through a complex-logarithmic topographic mapping of neuronal receptive field coordinates onto the cortical surface [2,3]. For this mapping, we use human parameter values estimated by [4]. From these cortical locations, we then compute pairwise Euclidean distances.

      The model thus captures realistic retinotopy, eccentricity-dependent RF sizes, and distance-dependent coupling on the cortical surface. We have adjusted our Methods to make these steps clearer.

      (1) Freeman, J., & Simoncelli, E. P. (2011). Metamers of the ventral stream. Nature neuroscience, 14(9), 1195-1201.

      (2) Balasubramanian, M., & Schwartz, E. L. (2002). The isomap algorithm and topological stability. Science, 295(5552), 7. https://doi.org/10.1126/science.1066234

      (3) Schwartz, E. L. (1980). Computational anatomy and functional architecture of striate cortex: a spatial mapping approach to perceptual coding. Vision Research, 20(8), 645–669. http://www.sciencedirect.com/science/article/pii/0042698980900905

      (4) Polimeni, J. R., Hinds, O. P., Balasubramanian, M., van der Kouwe, A. J. W., Wald, L. L., Dale, A. M., & Schwartz, E. L. (2005). Two-dimensional mathematical structure of the human visuotopic map complex in V1, V2, and V3 measured via fMRI at 3 and 7 Tesla. Journal of Vision, 5(8), 898. https://doi.org/10.1167/5.8.898

      Similarly, do the authors claim that each gabor annuli stimulates a single receptive field in V1?

      We hope that with the additional explanation above, it is clearer that there is not a one-to-one mapping. Each oscillator samples the local image by pooling over all Gabor annuli that overlap its receptive field (partially or fully) and computes the average contrast within its RF. Conversely, a single annulus typically overlaps multiple RFs and contributes to each in proportion to the overlap.

      I am unsure how the oscillators were organized, if not retinotopically. How is the retinotopic input fed into the non-retinotopically arranged oscillators?

      We hope that with the additional explanation above, it is clearer that the network is strictly retinotopic.

      The frequency of each oscillator changes according to ω=2πv with ν=25+0.25C. How were the values for the linear regression in v chosen? Reference?

      The slope and intercept parameters for this equation were first reported in [5]. We added the reference to the Methods.

      (5) Lowet, E., Roberts, M., Hadjipapas, A., Peter, A., van der Eerden, J., & De Weerd, P. (2015). Input-dependent frequency modulation of cortical gamma oscillations shapes spatial synchronization and enables phase coding. PLoS computational biology, 11(2), e1004072.

      (6) Hebbian Learning Rule:

      I am confused about how the effective learning rate E= ∈t is calculated. It is said that it is estimated based on the similarity between the second experimental session and the distribution of synchrony after letting the model learn. How can the model learn without knowing epsilon and t?

      We agree with the reviewer that our procedure to estimate the effective learning rate requires further clarification. We performed a nested grid search. Essentially, we let the model learn between session 1 and 2 with each of 25 candidate effective learning rates and evaluate how well each of them allow the model to fit performance in session 2. We then select the best effective learning rate and create a new, smaller, grid around this value and repeat that procedure. In total we perform 5 nested grids to arrive at the final effective learning rate. We expanded the explanation in the Methods.

      (B) Minor concerns:

      (1) Small N: 2/3 of the studies that were cited to justify the small sample were notably different from the current experiment, i.e., Intoy 2020 is an eye movement task, Lange 2020 is a memory task (Tesileanu 2020 is more similar). I think a power analysis would be great to support, as the sample size seems quite low

      Our study uses a within-subject design with ~750 trials per session (≈6,000 total) per participant, analyzed with a hierarchical model that pools information across trials and participants. To assess adequacy, we ran a simulation-based design analysis using the fitted hierarchical model (i.e., post hoc, based on the observed variance components). This analysis indicated a detection probability >90% for all key effects. We now report the results of this design analysis in the (Supplementary Table 1) and note this in the Results (paragraph 1).

      Regarding the literature context, we agree the cited studies are not identical to ours; we referenced them to illustrate a common practice (small N with many trials) when targeting low-level, early-visual mechanisms. Intoy (pattern/contrast sensitivity) and Lange (perceptual learning in early vision) share that focus, while Tesileanu is methodologically closest.

      (2) Figure 1 could be more informative and better described in the text. The authors often don't refer to the panels in Figure 1. Maybe it would help to swap a and b to describe the Arnold tongue first? It might also be a good idea to add the coupling strength and frequency detuning axes

      We have swapped panels a and b and now refer to each panel in the main text to enhance clarity.

      (3) Values of rho (distance - is this degrees visual angle)? Do the authors assume that the size of the stimuli corresponds to receptive fields in V1? If so, how is this justified?

      The center-to-center distance between any pair of neighboring annuli is indeed expressed in degrees of visual angle. Rho is a scaling factor for this distance. With rho=1, the center-to-center distance corresponds to the diameter of the annuli; i.e., they touch but do not overlap each other. We do not assume any relation between the size of receptive fields and the size of the annuli. Receptive field sizes in our model are purely determined by their eccentricity and each oscillator can have several annuli within its receptive field while each annulus can fall within several overlapping receptive fields of different oscillators. We believe that the schematic illustration in Figure 1 might have given the impression that each oscillator sees exactly one annulus and added a note that this is not the case and merely an oversimplification to illustrate the relationship between contrast and intrinsic frequency.

      (4) Some equations are embedded in the text, and some are not. It might be easier to find the respective equation if they all have an index. For instance, the authors mention the psychometric function that relates model synchrony and performance in the results section. It would be easier to find if it had an index that the authors could refer to.

      We moved this equation as well as the contrast intrinsic frequency mapping from inline to displayed and numbered them.

      (5) Is there a reference for "Our model rests on the assumption that learning-induced structural changes in early visual cortex are specific to the retinotopic locations of the trained stimuli"? (If so, it should be cited.)

      We added references supporting this assumption.

      (6) Figure 2b: colorbar missing label.

      We added the label.

      Reviewer #2 (Recommendations for the authors):

      Cool work!

      (1) The reader would benefit from (a single) comprehensive figure that visually explains the entire conceptual framework-from TWCO principles to neural implementation to behavioural predictions-accessible to readers without specialised knowledge of oscillatory dynamics. This will give the paper a greater impact.

      We have adjusted Figure 1 in accordance with suggestions made by reviewer 1 and added further explanations to the caption and the Introduction to enhance clarity on how the principles of TWCO relate to neural implementation.

      (2) I think this paper would benefit from the audience eLife provides, but the paper could move closer to the audience.

      (3) Pride comes before the fall, but I am not the most uninformed reader, and it took me some effort to process everything.

      Thank you, we took this to heart. In the Introduction, we now state more explicitly how each variable is operationalized and how these map onto TWCO with improved reference to relevant panels in the schematic figure. We agree the framework is conceptually dense. TWCO principles reach the stimuli through specific V1 anatomy and physiology, so there are several links to keep in mind. Our goal with the revised introduction and figure is to make those links better visible.

      (4) You could consider discussing potential implications for understanding perceptual disorders characterized by altered neural synchrony (e.g., schizophrenia, autism) and how your learning paradigm might inform perceptual training interventions.

      Thank you for this suggestion. We have added that TWCO might provide a new lens to study perceptual disorders to the Discussion. We provide a concrete example of the relation between grouping, gamma synchrony (in light of TWCO) and lateral connectivity in schizophrenia

      (5) I think this paper has real strength, but rather than dispersing limitations throughout the discussion, create a dedicated section that systematically addresses ecological validity, alternative explanations, and generalisability concerns. This will also preempt criticism.

      We appreciate the suggestion. Our preference is to discuss limitations in context, next to the specific results they qualify, so readers see why each limitation matters and how it affects interpretation. Nevertheless, paragraph 7 on page 20 summarizes most limitations in a single paragraph.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer 1 (Public review):

      When do behavioral differences emerge between the task variants? Based on the results and discussion, the cues increase the salience of either the wins or the losses, biasing behavior in favor of either risky or optimal choice. If this is the case, one might expect the cues to expedite learning, particularly in the standard and loss condition. Providing an analysis of the acquisition of the tasks may provide insight into how the cues are "teaching" decision-making and might explain how biases are formed and cemented.

      While considerable differences in decision making emerge in early sessions of training, we do not observe any evidence that cuing outcomes expedites the development of stable choice patterns. Indeed, since the outcomes are cued across all four options, there is no categorical difference in salience between optimal and risky choices. Thus, our interpretation is that cuing wins and/or losses alters the integration of this feedback into choice preference, rather than the rate of the development of choice preference. To quantitatively address this point, we have included the following analysis:

      “To quantitatively examine choice variability during training, we binned sessions 1-5 and 6-10 and analyzed variability in choice patterns across task variants. Analysis of the first five sessions of training revealed a significant shift in decision score across sessions (F(3, 502) = 31.23, p <.0001), which differed between task variants (session x task: F(16, 502) = 2.13, p = .007). Conversely, while significant differences in overall score were observed between task variants in sessions 6-10 (task: F(5, 156) = 6.81, p <.0001), there was no significant variability across sessions (session: F(3, 481) = 2.06, p = .10, task x session: F(15, 481) = 0.78, p = .71). This indicates that the variability in choice preference (and presumably, learning about outcomes) is maximized in the first five sessions, and there are no obvious differences in the rate of development of stable choice patterns between task variants.”

      Does the learning period used for the modeling impact the interpretation of the behavioral results? The authors indicate that computational modeling was done on the first five sessions and used these data to predict preferences at baseline. Based on these results, punishment learning predicts choice preference. However, these animals are not naïve to the contingencies because of the forced choice training prior to the task, which may impact behavior in these early sessions. Though punishment learning may initially predict risk preference, other parameters later in training may also predict behavior at baseline.

      The first five sessions were chosen based on a previously developed method used in Langdon et al. (2019). When choosing the number of sessions to include, there is a balance between including more data points to improve estimation of parameters while also targeting the timeframe of maximal learning. As training continues, the impact of outcomes on subsequent choice should decrease, and the learning rate would trend towards zero. This can be observed in the reduction in inter-session choice variability as training progresses, as demonstrated in the analyses above. Once learning has ceased, presumably other cognitive processes may dictate choice (for example, habitual stimulus-response associations), which would not be appropriately captured by reinforcement learning models. It would be a separate research question to determine the point at which parameters no longer become predictive, requiring a larger dataset to thoroughly assess. We acknowledge that we did not provide sufficient justification for the learning period used for the modeling. In conjunction with the analysis of early sessions outlined above, we have added the following to the text:

      “We investigated differences in the acquisition of each task variant by fitting several reinforcement learning (RL) models to early sessions. Our modeling approach closely follows methods outlined in Langdon et al. (2019), in which a much larger dataset (>100 rats per task) was used to develop the RL models applied here. Due to the comparatively small n per group in the current study, we limited our model selection to those previously validated in Langdon et al. (2019), with minor extensions. As in previous work, models were fit to valid choices from the first five sessions. As training continues, the impact of outcomes on subsequent choice should decline, and parameter values may evolve over time (e.g., decreasing learning rate). To target the period of learning during which outcomes have maximal influence over choice, and parameters likely have fixed values, we limited our analyses to the first five sessions.”

      The authors also present simulated data from the models for sessions 18-20, but according to the statistical analysis section, sessions 35-40 were used for analysis (and presumably presented in Figure 1). If the simulation is carried out in sessions 35-40, do the models fit the data?

      Based on our experience, choice patterns are well instantiated by session 20, and training only continues to 30+ sessions to achieve stability in other task variables (e.g., latencies, premature responding, etc.). That being said, the discrepancy between session numbers is confusing, so we’ve extended the simulations to match the same session numbers that were analyzed in the experimental data.

      Finally, though the n's are small, it would be interesting to see how the devaluation impacts computational metrics. These additional analyses may help to explain the nuanced effects of the cues in the task variants. 

      Unfortunately, as the devaluation experiment is only one session, there are insufficient data to run the same models. Furthermore, changes in choice are subtle and not uniform across rats, making it difficult to reliably model this effect at the individual level. A separate experiment could investigate the specific cognitive processes underlying the devaluation effect.

      Reviewer #1 (Recommendations for the authors):

      The authors do not present individual data points for behavior. Including these data points would improve the interpretability of the results. Adding significant notations to the bar graphs would also help the reader. Although the stats are provided and significant comparisons highlighted, it isn't easy to go between the table and the figure to detect significant outcomes. If done, the statistics tables could be moved to the supplement. Including estimates of effect size for main findings in the main text would also benefit the reader. 

      We thank the reviewer for their feedback on our approach to the figures and significance reporting – we have updated the relevant figures to include individual data points. Furthermore, we’ve added significance notations for task variants that are significantly different from the uncued or standard cued tasks on the figures. We’ve also moved some statistics tables to the supplement, as suggested. 

      The authors allude to other metrics of the task (trials, omissions, etc.) but do not present these data anywhere. Including supplementary figures including individual data points and statistical analyses in the supplement is strongly encouraged.

      A supplementary figure visualizing these metrics (choice latency, trials completed, and omissions) has been added, with individual data points included. Statistical analyses are reported in the main text – no significant effect in the ANOVAs were observed for any of these metrics, so post hoc analyses were not performed. 

      Figure 4 is confusing. Presenting the WAIC values for each model rather than compared to the nonlinear model would be easier to understand. It is also unclear if statistical tests were used to assess differences in model fit as no test information is provided.

      Figure 4 has been updated to increase clarity and address feedback from another reviewer. Raw WAIC values are not ideal for visualization, as the task variants have differing amounts of data and thus would be difficult to include on the same Y-axis. Instead, we present each model’s difference in WAIC relative to a basic model with no timeout penalty transform, so that all three models are visible, and the direction of model improvement is clearly indicated. Statistical tests of WAIC differences are not standard, as the numerical differences themselves indicate a better fit.

      The authors do not provide a data availability statement.

      We thank the reviewer for calling our attention to this oversight. A data availability statement has been added. 

      Reviewer 2 (Public review):

      Additional support and evidence are needed for the claims made by the authors. Some of the statements are inconsistent with the data and/or analyses or are only weakly supportive of the claims.

      We appreciate the reviewer’s overarching concern that some claims in the original manuscript were insufficiently supported by the data or analyses. To address this, we have provided further rationale for the devaluation experiment and clarified our interpretation of those results, expanded the computational modeling analyses, and revised figures and wording to improve clarity. Below, we respond to the reviewer’s specific comments in detail.

      Reviewer #2 (Recommendations for the authors):

      Different variants of an RL model were used to understand how loss outcomes impacted choice behavior across the gambling task variants. Did the authors try different variants for rewarded outcomes? I wonder whether the loss specific RL effects are constrained to that domain or perhaps emerged because choice behavior to losses was better estimated with the different RL variants. For example, rewarded outcomes across the different choices may not scale linearly (e.g., 1, 2, 3, 4) so including a model in which Rtr is scaled by a free parameter might improve the fit for win choices.

      We agree that asymmetries in model flexibility could, in principle, contribute to the observed effects. While we are somewhat limited in our ability to develop and validate further models due to the small size of the datasets compared to the high degree of choice variability between rats, we have explored the possibility as far as the data allow by fitting a model that includes a scaling parameter for rewards in addition to punishments:

      “While we restricted our model selection to those previously validated on larger datasets, the specificity of the main finding to the punishment learning rate may be due to the greater flexibility afforded to loss scaling, rather than a true asymmetry in learning. To test this hypothesis, we fit a model featuring a scaling parameter for rewards, in addition to scaled costs:

      where mRew is a linear scaling parameter for reward size. A separate scaling parameter was used for timeout penalty duration (i.e., same as scaled cost model). Group-level parameter estimates (Figure S3) reflected similar differences in the punishment learning rate and reward learning rate as the scaled cost model (Figure S4). Furthermore, all 95% HDIs for the mRew scaling parameter included 1, indicating that at least at the group level, scaling of reward size across the P1-P4 options closely follows the actual number of earned sucrose pellets. Thus, we find no evidence that our results can be simply attributed to the increased parameterization of losing outcomes.”

      Additionally, I would like to see evidence that these alternative models provide a better fit compared to a standard delta-rule updating for unrewarded choices.

      Each model is now compared directly to a standard delta-rule update model in the WAIC figure to demonstrate that the current models are a better fit for the data.

      Could the authors provide some visualization of how variation in the r, m, or b parameters impact choices and/or patterns of choices?

      We have added a figure to the supplementary section to visualize how different values for the r, m, and b parameters could alter the size of updates to Q-values on each trial across the four different options, thereby impacting subsequent choice. 

      It was challenging to understand the impact of the reported effects and interpretation of the authors at various points in the manuscript. For example, the authors state that "only rats trained on tasks without win-paired cues exhibited shifts in risk preference following reinforcer devaluation". Figure 3 however seems to indicate that rats trained on the reverse-cued task show shifts in risk preference. 

      We agree the original wording did not fully capture the nuance apparent in the figure. While not significantly different from baseline, rats in the reverse-cued experiment could have indeed updated their choice patterns and we were underpowered to detect the effect. We have updated the results section to include this point, and to more specifically outline that win-paired cues that scale with reward size lead to insensitivity to reinforcer devaluation:

      “This indicates that pairing audiovisual cues with reward induces some degree of inflexibility in risk-preferring rats. Importantly, pairing cues with losses alone does not elicit rigidity in choice. Thus, in keeping with the observed effect on overall choice patterns, pairing cues with wins has a unique impact on sensitivity to reinforcer devaluation. Although not statistically significant, visual inspection of the reverse-cued task suggests that some choice flexibility may be present, and the study may be underpowered to detect this effect. Nonetheless, win-paired cues that scale with reward size reduce flexibility in choice patterns following reinforcer devaluation.”

      It was not clear to me why the authors did a devaluation test and what was expected. Adding details regarding the motivation for specific analyses and/or experiments would improve understanding of these exciting results.

      Further explanation has been added to the results section for the devaluation test to clarify the rationale and expected results:

      “We next tested whether pairing salient audiovisual cues with outcomes on the rGT impacts flexibility in decision making when outcome values are updated. Reinforcer devaluation, in which subjects are sated on the sugar pellet reinforcer prior to task performance (presumably devaluing the outcome), is a common test of flexibility of decision making (Adams & Dickinson, 1981). We have previously employed this method to demonstrate that rats trained on the standard-cued task are insensitive to reinforcer devaluation (i.e., choice patterns do not shift despite devaluation of the sugar pellet reward; Hathaway et al., 2021).”

      Some rats in the rGT become risk takers and some do not, but whether this is an innate phenomenon or emerges with training is not known. The authors report some correlations between the RL parameters and subsequent risk scores but this may be an artifact because the risk scores and many of the parameters differ between the experimental groups. Restricting these analyses to the rats in the standard procedure (or even conducting it in other rats that have been run in the rGT standard task) would alleviate this concern. The authors should also expand upon this result in the discussion. (if it holds up) and provide graphs of this relationship in the manuscript.

      In a previous paper on which these analyses were based (Langdon et al., 2019), analyses of the relationship between RL parameter estimates and final decision score were conducted separately for rats trained on either the uncued or standard cued task, as the reviewer has suggested here. Those analyses showed that parameters controlling the learning from negative outcomes were specifically related to final score in both tasks. While we don’t have the appropriate n per group to split the analyses by task variant in the current study, we have highlighted these previous findings in the results section to address this concern:

      “In Langdon et al. (2019), analyses were conducted to test whether parameters controlling sensitivity to punishment predicted final decision score at the end of training in the uncued and standard cued task variants. These analyses showed that across both task variants, there was evidence of reduced punishment sensitivity (i.e., lower m parameter or punishment learning rate) in risky versus optimal rats. We conducted similar analyses here to examine whether parameter estimates covary with decision score at end of training. To accomplish this, we fit simple linear regression models for each parameter and assessed whether the slopes were significantly different from zero.”

      I don't see a b parameter in the nonlinear cost model, but is presented in Figure 6 and also in the "Parameters predicting risk preference on the rGT". The authors either need to update the formula or clarify what the b parameter quantifies in the nonlinear model.

      We thank the reviewer for pointing out this oversight; the equation has been updated to include the b parameter.

      The risk score is very confusing as high numbers or % indicate less risk and lower (more negative numbers) indicate greater risk. I've had to reread the text multiple times to remind myself of this, so I anticipate the same will be true for other readers. Perhaps the authors can add a visual guide to their y-axis indicating more positive numbers are less risky choices.

      We acknowledge that this measure can be confusing – the calculation of this score is standard for the Iowa Gambling Task conducted in humans, on which the rGT is based, and was therefore adopted here. We’ve changed the name from “risk score” to “decision score”, along with including a visual guide to the y-axis in Figure 2, to address this point.

      Negative learning rate is confusing as it almost implies that the learning was a negative value, rather than being a learning rate for negative outcomes. Please revise in the figures and in the text.

      We have updated the text and figures where appropriate from “negative learning rate” to “punishment learning rate”. We have also changed the text from “positive learning rate” to “reward learning rate” to match this terminology.

      Reviewer 3 (Public review):

      There is a very problematic statistical stratagem that involves categorising individuals as either risky or optimal based on their choice probabilities. As a measurement or outcome, this is fine, as previously highlighted in the results, but this label is then used as a factor in different ANOVAs to analyse the very same choice probabilities, which then constitutes a circular argument (individuals categorised as risky because they make more risky choices, make more risky choices...).

      Risk status was included as a factor to test whether the effects of the cue paradigms differed between risky versus optimal rats (i.e., interaction effects), not as an independent predictor of choice preference. We focus on results showing a significant task x risk status interaction, and conducted follow-up analyses separately within each group, at which point risk status was no longer included as a factor. We do not interpret main effects or choice x status interactions, which would indeed be circular for the reason noted by the reviewer.

      A second experiment was done to study the effect of devaluation on risky choices in the different tasks. The results, which are not very clear to understand from Figure 3, would suggest that reward devaluation affects choices in tasks where the win-cue pairing is not present. The authors interpret this result by saying that pairing wins with cues makes the individuals insensitive to reward devaluation. Counter this, if an individual is prone to making risky choices in a given task, this points to an already distorted sense of value as the most rewarding strategy is to make optimal non-risky choices.

      We have included significance notations in Figure 3 and included further detail in the text to improve clarity of the findings for the devaluation test. The reviewer raises an interesting point that risk-preferring rats have a distorted sense of value, since they do not follow the optimal strategy. However, we believe that this is at least partially separable from insensitivity to devaluation, since risk-preferring rats trained on tasks that don’t feature win-paired cues still exhibit flexibility in choice. We have added the following point to the discussion to address this:

      “While risk-preferring rats exhibit some degree of distortion in reward valuation, as they do not follow the most rewarding strategy (i.e., selecting optimal options), we believe this to be at least partially separable from choice inflexibility, as risk-preferring rats on tasks that don’t feature win-paired cues remain sensitive to devaluation.”

      While the overall computational approach is excellent, I believe that the choice of computational models is poor. Loss trials come at a double cost, something the authors might want to elaborate more upon, firstly the lost opportunity of not having selected a winning option which is reflected in Q-learning by the fact that r=0, and secondly a waiting period which will affect the overall reward rate. The authors choose to combine these costs by attempting to convert the time penalty into "reward currency" using three different functions that make up the three different tested models. This is a bit of a wasted opportunity as the question when comparing models is not something like "are individuals in the paired win-cue tasks more sensitive to risk? or less sensitive to time? etc" but "what is the best way of converting time into Q-value currency to fit the data?" Instead, the authors could have contrasted other models that explicitly track time as a separate variable (see for example "Impulsivity and risk-seeking as Bayesian inference under dopaminergic control" (Mikhael & Gershman 2021)) or give actions an extra risk bonus (as in "Nicotinic receptors in the VTA promote uncertainty seeking" (Naude et al 2016)).

      We thank the reviewer for their thoughtful suggestions and agree that alternative modeling frameworks that explicitly track time or incorporate uncertainty bonuses would be highly informative for understanding the mechanisms underlying risky choice. However, the models employed here are drawn from previous work that required >100 rats per group for model development and validation. Due to the high degree of variability in decision making within the groups and the relatively small number of rats, this dataset is not well suited for substantial model innovation. Indeed, the most complex model from previous work had to be simplified to achieve model convergence. Testing models that greatly diverge from the previously validated RL models would make it difficult to determine whether poor model fit reflects a misspecified model or insufficient data.

      We’d also like to note that the driving question for this study is to investigate the impact of different cue variants on choice patterns – untangling the relationship between timing, uncertainty, and risky choice is an important and interesting question, but beyond the scope of the present work. 

      To address this limitation, we have expanded our justification of model choice in the results section to emphasize that we are applying previously developed models, with minor extensions:

      “We investigated differences in the acquisition of each task variant by fitting several reinforcement learning (RL) models to early sessions. Our modeling approach closely follows methods outlined in Langdon et al. (2019), in which a much larger dataset (>100 rats per task) was used to develop the RL models applied here. Due to the comparatively small n per group in the current study, we limited our model selection to those previously validated in Langdon et al. (2019), with minor extensions.”

      Another weakness of the computational section is the fact, that despite simulations having been made, figure 5 only shows the simulated risk scores and not the different choice probabilities which would be a much more interesting metric by which to judge model validity. 

      We have expanded Figure 5 to show the simulated choice of each option.

      In the last section, the authors ask whether the parameter estimates (obtained from optimisation on the early sessions) could be used to predict risk preference. While this is an interesting question to address, the authors give very little explanation as to how they establish any predictive relationship. A figure and more detailed explanation would have been warranted to support their claims.

      We have expanded this section to provide clearer detail on the methods used to conduct this analysis and added a figure. To address a point raised by another reviewer, the statistical approach has been revised to more closely align with that used in Langdon et al. (2019), and the results have been updated appropriately:

      “We next tested whether any of the subject-level parameter estimates in the nonlinear or scaled + offset model could reliably predict risk preference scores at the end of training. In Langdon et al. (2019), analyses were conducted to test whether parameters controlling sensitivity to punishment predicted final decision score at the end of training in the uncued and standard cued task variants. These analyses showed that across both task variants, there was evidence of reduced punishment sensitivity (i.e., lower m parameter or punishment learning rate) in risky versus optimal rats. We conducted similar analyses here to examine whether parameter estimates covary with decision score at end of training. To accomplish this, we fit simple linear regression models for each parameter and assessed whether the slopes were significantly different from zero.”

      Why were the simulated risk scores calculated for sessions 18-20 and not 35-39 as in the experimental data, and why were the models optimised only on the first sessions?

      These points were addressed in response to reviewer #1:

      Based on our experience, choice patterns are well instantiated by session 20, and training only continues to 30+ sessions to achieve stability in other task variables (e.g., latencies, premature responding, etc.). That being said, the discrepancy between session numbers is confusing, so we’ve extended the simulations to match the same session numbers that were analyzed in the experimental data.

      The first five sessions were chosen based on a previously developed method used in Langdon et al. (2019). When choosing the number of sessions to include, there is a balance between including more data points to improve estimation of parameters while also targeting the timeframe of maximal learning. As training continues, the impact of outcomes on subsequent choice should decrease, and the learning rate would trend towards zero. This can be observed in the reduction in inter-session choice variability as training progresses, as demonstrated in the analyses above. Once learning has ceased, presumably other cognitive processes may dictate choice (for example, habitual stimulus-response associations), which would not be appropriately captured by reinforcement learning models. It would be a separate research question to determine the point at which parameters no longer become predictive, requiring a larger dataset to thoroughly assess. We acknowledge that we did not provide sufficient justification for the learning period used for the modeling. In conjunction with the analysis of early sessions outlined above, we have added the following to the text:

      “We investigated differences in the acquisition of each task variant by fitting several reinforcement learning (RL) models to early sessions. Our modeling approach closely follows methods outlined in Langdon et al. (2019), in which a much larger dataset (>100 rats per task) was used to develop the RL models applied here. Due to the comparatively small n per group in the current study, we limited our model selection to those previously validated in Langdon et al. (2019), with minor extensions. As in previous work, models were fit to valid choices from the first five sessions. As training continues, the impact of outcomes on subsequent choice should decline, and parameter values may evolve over time (e.g., decreasing learning rate). To target the period of learning during which outcomes have maximal influence over choice, and parameters likely have fixed values, we limited our analyses to the first five sessions.”

      Concerning the figures, could you consider replacing or including with the bar plots, the full distribution of individual dots, or a violin plot, something to better capture the distribution of the data. This would be particularly beneficial for Figure 2B the risk score which, without a distribution suggests all individuals are optimal, something which in the text claim is not the case. 

      Individual data points have been added to the relevant figures.

      Is this not a case of compositional data where ANOVA is definitely not an appropriate method (compositional data consist in reporting proportions of different elements in a whole, eg this rock is 60% silicate, 20% man-made cement, etc.) because of violation of normality and mostly dependence between measurements (the sum must be 100% as in your case where knowing the proportions of P1, P2 and P3, I automatically deduce P4). I leave to you the care of finding a potential alternative. In any case, I also had difficulties understanding the varying degrees of freedom of the different reported F statistics which worry me that this has not been done properly.

      This is a fair criticism, as choice proportions across P1-P4 are not fully independent. While alternative approaches do exist, there is no widely adopted or straightforward method that has been validated for this task. Accordingly, ANOVA remains the standard analytical approach for this task, as it facilitates comparison with previous work and is readily understood by readers. As mentioned in the methods, an arcsine transformation was applied to the proportional data to mitigate issues associated with bounded measures (i.e., summing to 100%). We thank the reviewer for drawing our attention to the discrepancies in the degrees of freedom – these have now been corrected.

    1. Author response:

      The following is the authors’ response to the original reviews

      eLife Assessment

      This study provides a useful analysis of the changes in chromatin organization and gene expression that occur during the differentiation of two cell types (anterior endoderm and prechordal plate) from a common progenitor in zebrafish. Although the findings are consistent with previous work, the evidence presented in the study appears to be incomplete and would benefit from more rigorous interpretation of single-cell data, more in-depth lineage tracing, overexpression experiments with physiological levels of Ripply, and a clearer justification for using an explant system. With these modifications, this paper will be of interest to zebrafish developmental biologists investigating mechanisms underlying differentiation.

      We sincerely thank the editor and the reviewers for their valuable time and efforts. Their insightful comments were greatly appreciated and have been largely addressed in the revised manuscript. We are confident that these revisions have enhanced the overall quality and clarity of our paper.

      Reviewer #1 (Public review):

      Summary:

      During vertebrate gastrulation, mesendoderm cells are initially specified by morphogens (e.g. Nodal) and segregate into endoderm and mesoderm in part based on Nodal concentrations. Using zebrafish genetics, live imaging, and single-cell multi-omics, the manuscript by Cheng et al presents evidence to support a claim that anterior endoderm progenitors derive primarily from prechordal plate progenitors, with transcriptional regulators goosecoid (Gsc) and ripply1 playing key roles in this cell fate determination. Such a finding would represent a significant advance in our understanding of how anterior endoderm is specified in vertebrate embryos.

      We would like to thank reviewer #1 for his/her comments and positive feedbacks about our manuscript.

      Strengths:

      Live imaging-based tracking of PP and endo reporters (Figure 2) is well executed and convincing, though a larger number of individual cell tracks will be needed. Currently, only a single cell track (n=1) is provided.

      We thank the reviewer for the positive comments and the valuable suggestion. As the reviewer suggested, we re-performed live imaging analyses on the embryos of Tg(gsc:EGFP;sox17:DsRed). We tracked dozens of cells during their transformation from gsc-positive to sox17-positive. Furthermore, we performed quantification of the RFP/GFP signal intensity ratio in these cells over the course of development (Please see the revised Figure 2D and MovieS4).

      Weaknesses:

      (1) The central claim of the paper - that the anterior endoderm progenitors arise directly from prechordal plate progenitors - is not adequately supported by the evidence presented. This is a claim about cell lineage, which the authors are attempting to support with data from single-cell profiling and genetic manipulations in embryos and explants. The construction of gene expression (pseudo-time) trajectories, while a modern and powerful approach for hypothesis generation, should not be used as a substitute for bona fide lineage tracing methods. If the authors' central hypothesis is correct, a CRE-based lineage tracing experiment (e.g. driving CRE using a PP marker such as Gsc) should be able to label PP progenitor cells that ultimately contribute to anterior endoderm-derived tissues. Such an experiment would also allow the authors to quantify the relative contribution of PP (vs non-PP) cells to the anterior endoderm, which is not possible to estimate from the indirect data currently provided. Note: while the present version of the manuscript does describe a sox17:CRE lineage tracing experiment, this actually goes in the opposite direction that would be informative (sox:17:CRE-marked descendants will be a mixture of PP-derived and non-PP derived cells, and the Gsc-based reporter does not allow for long-term tracking the fates of these cells).

      We sincerely thank the reviewer for the professional comments and the constructive suggestions. As the reviewer indicated, utilizing the single-cell transcriptomic trajectory analyses on zebrafish embryos and Nodal-injected explants system, along with the live imaging analyses on Tg(gsc:EGFP;sox17:DsRed) embryos, we revealed that anterior endoderm progenitors arise from prechordal plate progenitors. To further verify this observation, we conducted two sets of lineage-tracing assays. Initial evidence came from the results of co-injecting sox17:Cre and gsc:loxp-STOP-loxp-mcherry plasmids. We observed RFP-positive cells at 8 hpf, demonstrating the presence of cells that had expressed both genes. To explicitly follow the proposed lineage, we then implemented a reciprocal strategy, as suggested by the reviewer, that constructed and co-injected sox17:loxp-STOP-loxp-mcherry and gsc:Cre plasmids. The appearance of RFP-positive cells in the anterior dorsal region at 8 hpf provides direct evidence for a transition from gsc-positive to sox17-positive identity. These results are now included in the revised manuscript (Please see Author response image 1 and Figure S4E). However, in accordance with the reviewer's caution, we acknowledge that this does not prove this is the sole origin of anterior endoderm. Consequently, we have revised the text to clarify that our findings demonstrate that anterior endoderm can be specified from prechordal plate progenitors, without claiming that it is the only source.

      Author response image 1.

      Characterization of anterior endoderm lineage by Cre-Lox recombination system.

      (2) The authors' descriptions of gene expression patterns in the single-cell trajectory analyses do not always match the data. For example, it is stated that goosecoid expression marks progenitor cells that exist prior to a PP vs endo fate bifurcation (e.g. lines 124-130). Yet, in Figure 1C it appears that in fact goosecoid expression largely does not precede (but actually follows) the split and is predominantly expressed in cells that have already been specified into the PP branch. Likewise, most of the cells in the endo branch (or prior) appear to never express Gsc. While these trends do indeed appear to be more muddled in the explant data (Figure 1H), it still seems quite far-fetched to claim that Gsc expression is a hallmark of endoderm-PP progenitors.

      We thank the reviewer for pointing out this issue. Our initial analysis proposed that the precursors of the prechordal plate (PP) and anterior endoderm (endo) more closely resemble a PP cell fate, as their progenitor populations highly express PP marker genes, such as gsc. The gsc gene is widely recognized as a PP marker[1]. The reviewer pointed out that in our analysis, these precursor cells do not initially exhibit high gsc expression; rather, gsc expression gradually increases as PP fate is specified.

      The reason for this observation is as follows: First, for the in vivo data, we used the URD algorithm to trace back all possible progenitor cells for both the PP and anterior endo trajectory. As mentioned in the manuscript, the PP and anterior endo are relatively distant in the trajectory tree of the zebrafish embryonic data. Consequently, this approach likely included other, confounding progenitor cells that do not express gsc (like ventral epiblast, Author response image 2). However, we further investigated the expression of gsc and sox17 along these two trajectories. The conclusion remains that gsc expression is indeed higher than sox17 in the progenitor cells common to both trajectories (Author response image 2). Combined with the live imaging analysis presented in this study, which shows that gsc expression increases progressively in the PP, this supports the notion that the progenitor cells for both PP and anterior endoderm initially bias towards a PP cell fate.

      On the other hand, in our previously published work using the Nodal-injected explant system, which specifically induces anterior endo and PP, the cellular trajectory analysis also revealed that the specifications of PP and anterior endo follow very similar paths. Therefore, we proceeded to analyze the Nodal explant data. Similarly, when using URD to trace the differentiation trajectories of PP and anterior endo cells, a small number of other progenitor cells were also captured. This explains why a minority of cells do not express gsc—these are likely ventral epiblast cells (Author response image 2). However, based on the Nodal explant data, gsc is specifically highly expressed in the progenitor cells of the PP and anterior endo. Its expression remains high in the PP trajectory but gradually decreases in the endoderm trajectory (Figure 1H).

      Author response image 2.

      (A) The expression of ventral epiblast markers in PP and anterior Endo URD trajectory. (B) The expression of gsc, sox32 and sox17 in the progenitors of PP and anterior endo in embryos and Nodal explants.

      (3) The study seems to refer to "endoderm" and "anterior endoderm" somewhat interchangeably, and this is potentially problematic. Most single-cell-based analyses appearing in the study rely on global endoderm markers (sox17, sox32) which are expressed in endodermal precursors along the entire ventrolateral margin. Some of these cells are adjacent to the prechordal plate on the dorsal side of the gastrula, but many (most in fact) are quite some distance away. The microscopy-based evidence presented in Figure 2 and elsewhere, however, focuses on a small number of sox17-expressing cells that are directly adjacent to, or intermingled with, the prechordal plate. It, therefore, seems problematic for the authors to generalize potential overlaps with the PP lineage to the entire endoderm, which includes cells in ventral locations. It would be helpful if the authors could search for additional markers that might stratify and/or mark the anterior endoderm and perform their trajectory analysis specifically on these cells.

      We thank the reviewer for these comments and suggestions. We fully agree with the reviewer's point that the expression of sox32 and sox17 cannot be used to distinguish dorsal endoderm from ventral-lateral endoderm cells. However, during the gastrulation stage, all endodermal cells express sox32 and sox17, and there are currently no specific marker genes available to distinguish between them.

      After gastrulation ends, the dorsal endoderm (i.e., the anterior endoderm) begins to express pharyngeal endoderm marker genes, such as pax1b. Therefore, in the analysis of embryonic data in vivo, when studying the segregation of the anterior endoderm and PP trajectory, we specifically used the pharyngeal endoderm as the subject to trace its developmental trajectory.

      In the case of Nodal explants, Nodal specifically induces the fate of the dorsal mesendoderm, which includes both the PP and pharyngeal endoderm (anterior endoderm). Precisely for this reason, we consider the Nodal explant system as a highly suitable model for investigating the mechanisms underlying the cell fate separation between anterior endoderm and PP. Thus, in the Nodal explant data, we included all endodermal cells for downstream analysis.

      To avoid any potential confusion for readers, we have revised the term "endoderm" in the manuscript to "anterior endoderm" as suggested by the reviewer.

      (4) It is not clear that the use of the nodal explant system is allowing for rigorous assessment of endoderm specification. Why are the numbers of endoderm cells so vanishingly few in the nodal explant experiments (Figure 1H, 3H), especially when compared to the embryo itself (e.g. Figures 1C-D)? It seems difficult to perform a rigorous analysis of endoderm specification using this particular model which seems inherently more biased towards PP vs. endoderm than the embryo itself. Why not simply perform nodal pathway manipulations in embryos?

      We sincerely thank the reviewer for raising this important question. In our study of the fate separation between the PP and anterior endoderm, we initially analyzed zebrafish embryonic data. However, when reconstructing the transcriptional lineage tree using URD, we observed that these two cell trajectories were positioned relatively far apart on the tree. Yet, existing studies have shown that the anterior endoderm and PP are not only spatially adjacent but also both originate from mesendodermal progenitor cells[2-4], and they share transcriptional similarities[5]. Therefore, as the reviewer pointed out, when tracing all progenitor cells of these two trajectories using the URD algorithm, it is easy to include other cell types, such as ventral epiblast cells (Author response image 2). For this reason, we concluded that directly using embryonic data to dissect the mechanism of fate separation between PP and anterior endoderm might not yield highly accurate results.

      In contrast, our group’s previous work, published in Cell Reports, demonstrated that the Nodal-induced explant system specifically enriches dorsal mesendodermal cells, including anterior endoderm, PP, and notochord[5]. Thus, we considered the Nodal explant system to be a highly suitable model for investigating the mechanism of fate separation between PP and anterior endoderm. Ultimately, by analyzing both in vivo embryonic data and Nodal explant data, we consistently found that the anterior endoderm likely originates from PP progenitor cells—a conclusion further validated by live imaging experiments.

      Regarding the reviewer’s concern about the relatively low number of endodermal cells in the Nodal explant system, we speculate that this is because the explants predominantly induce anterior endoderm. Since endodermal cells constitute only a small proportion of cells during gastrulation, and anterior endoderm represents an even smaller subset, the absolute number is naturally limited. Nevertheless, the anterior endodermal cells captured in our Nodal explants were sufficient to support our analysis of the fate separation mechanism between anterior endoderm and PP. Finally, to further strengthen the findings from scRNA-seq analyses, we subsequently performed live imaging validation experiments using both zebrafish embryos and the explant system.

      (5) The authors should not claim that proximity in UMAP space is an indication of transcriptional similarity (lines 207-208), especially for well-separated clusters. This is a serious misrepresentation of the proper usage of the UMAP algorithm. The authors make a similar claim later on (lines 272-274).

      We would like to extend our gratitude to the reviewer for their insightful comments. We have revised the descriptions regarding UMAP throughout the manuscript as suggested (Please see the main text in revised manuscript).

      Reviewer # 1 (Recommendations For The Authors):

      - Pseudotime trajectories constructed from single-cell snapshots are not true "lineage" measurements. Authors should refrain from referring to such data as lineage data (e.g. lines 99, 100, 103, 109, 112, 127, etc). Such models should be referred to as "trajectories", "hypothetical lineages", or something else.

      We are grateful to the reviewer for this comment. Following their recommendation, we have revised the terminology from "transcriptional lineage tree" to "trajectory" across the entire manuscript (Please see main text in revised manuscript).

      - The live imaging data presented in Figure 2 (and supplemental figures) are compelling and do seem to show that some cells can switch between PP and endo states. However, the number of cells reported is still too low to be able to ascertain whether or not this is just a rare/edge-case phenomenon. Tracks for just a single cell are reported in Figure 2C-D. This is insufficient. Tracks for many more cells should be collected and reported alongside this current sole (n=1) example. The choice of time window for these live imaging experiments should also be better explained. These live imaging experiments are being performed at or after 6hpf, but authors claim in the text that "... the segregation between PP and Endo has already occurred by 6hpf." (lines 126-127). Why not perform these live imaging experiments earlier, when the initial fate decision between PP and endo is supposedly occurring?

      We sincerely appreciate the reviewer’s insightful questions and constructive feedback. In response, we have made several important revisions. First, the reviewer noted that our original manuscript tracked only a single cell and suggested increasing the number of tracked cells. Following this recommendation, we repeated the live-imaging experiments and expanded the number of tracked endodermal cells (Please see the revised Movie S4 and Figure 2D). The experimental conditions were kept identical to the previous setup, and these cells consistently exhibited a gradual transition from a gsc+ fate to a sox17+ endodermal fate. In addition, the reviewer recommended performing live imaging at an earlier time point (Movie S5). Accordingly, we conducted additional experiments initiating live imaging at around 5.7 hours and observed the onset of a sox17 expression in gsc+ cells at approximately 6 hpf, which is consistent with our single-cell transcriptomic analysis.

      - The sections devoted to lengthy descriptions of GO terms (lines 131-146, 239-254) and receptor-ligand predictions (lines 170-185) are largely speculative. Consider streamlining.

      Thanks for the reviewer's comment. We have streamlined the content related to the GO analysis as suggested (Please see Lines 128-132, 157-167, 221-225).

      - The use of a "Nodal Activity Score" (lines 212-226) is clever but might actually be less informative than showing contributions from individual nodal target genes. The combining of counts data from 29 predicted nodal targets means that the contribution (or lack of contribution) from each gene becomes masked. The authors should include supplementary dot plots that break down the score across all 29 genes, allowing the reader to assess overall contributions and/or sub-clusters of gene co-expression patterns, if present.

      Thank you very much for the reviewer's positive feedback on our use of the "Nodal Activity Score" and the valuable suggestions provided. Following the recommendation, we analyzed the expression of the 29 Nodal direct targets used in our study across the WT, ndr1 knockdown (kd), and lft1 knockout (ko) groups. We found that the known axial mesoderm genes, such as chrd, tbxta, noto, and gsc, contributed significantly to the Nodal score. The newly conducted analysis has been included in the Supplementary Information (Please see Figure S7L).

      - The differential expression trends being reported for srcap (line 251) do not appear to be significant. Are details and P-values for these DEG tests reported somewhere in the manuscript?

      We thank the reviewer for raising this question. Based on the reviewer's comment, we performed statistical tests (Wilcoxon test) to compare the expression of srcap in PP and Endo. Our analysis revealed that while srcap expression is slightly higher in PP than in Endo, this difference is not statistically significant. The specific p-value and fold change have been indicated in the revised figure (Please see Figure 4J and S7H). Based on this analysis, we revised our description to state that srcap expression is slightly higher in the PP compared to in the anterior endoderm.

      - Following the drug experiments with the drug AU15330 (lines 254-263), authors have only reported #s of endodermal cells, which seem to have increased, which the authors suggest indicates a fate switch from PP to endo. However, the authors have not reported whether the numbers of PP cells decreased or stayed the same in these embryos. This would be helpful information to include, as it is very difficult to discern quantitative trends from the images presented in Fig 4H and 4L.

      Thank the reviewer for his/her comments and suggestions. Following the reviewer's suggestions, we performed Imaris analysis on the HCR staining results from the DMSO (control), 1μM AU15330-treated, and 5μM AU15330-treated groups. Our analysis focused on the number of frzb-positive cells (PP), and the comparison revealed that treatment with AU15330 significantly reduces the PP cell number. These findings have been incorporated into the revised manuscript and supplementary information (Please see Figures S7J and S7K).

      Reviewer #2 (Public review):

      Summary:

      During vertebrate gastrulation, the mesoderm and endoderm arise from a common population of precursor cells and are specified by similar signaling events, raising questions as to how these two germ layers are distinguished. Here, Cheng and colleagues use zebrafish gastrulation as a model for mesoderm and endoderm segregation. By reanalyzing published single-cell sequencing data, they identify a common progenitor population for the anterior endoderm and the mesodermal prechordal plate (PP). They find that expression levels of PP genes Gsc and ripply are among the earliest differences between these populations and that their increased expression suppresses the expression of endoderm markers. Further analysis of chromatin accessibility and Ripply cut-and-tag is consistent with direct repression of endoderm by this PP marker. This study demonstrates the roles of Gsc and Ripply in suppressing anterior endoderm fate, but this role for Gsc was already known and the effect of Ripply is limited to a small population of anterior endoderm. The manuscript also focuses extensively on the function of Nodal in specifying and patterning the mesoderm and endoderm, a role that is already well known and to which the current analysis adds little new insight.

      We would like to thank the reviewer #2 for the constructive comments and positive feedback regarding our manuscript.

      Strengths:

      Integrated single-cell ATAC- and RNA-seq convincingly demonstrate changes in chromatin accessibility that may underlie the segregation of mesoderm and endoderm lineages, including Gsc and ripply. Identification of Ripply-occupied genomic regions augments this analysis. The genetic mutants for both genes provide strong evidence for their function in anterior mesendoderm development, although these phenotypes are subtle.

      We thank the reviewer for recognizing our work, and we greatly appreciate the constructive suggestions from the reviewer.

      Weaknesses:

      The use of zebrafish embryonic explants for cell fate trajectory analysis (rather than intact embryos) is not justified. In both transcriptomic comparisons between the two fate trajectories of interest and Ripply cut-and-tag analysis, the authors rely too heavily on gene ontology which adds little to our functional understanding. Much of the work is focused on the role of Nodal in the mesoderm/endoderm fate decision, but the results largely confirm previous studies and again provide few new insights. Some experiments were designed to test the relationship between the mesoderm and endoderm lineages and the role of epigenetic regulators therein, but these experiments were not properly controlled and therefore difficult to interpret.

      We sincerely thank the reviewer for the comments. As we previously answered, in our study of the fate differentiation between the PP and the anterior endoderm, we initially analyzed zebrafish embryonic data. However, when we used URD to reconstruct the transcriptional trajectory tree, we found that these two cell trajectories were distantly located on the tree. Existing studies have shown that the anterior endoderm and the PP are not only spatially adjacent but also both originate from mesendodermal progenitor cells and share transcriptional similarities[2-4]. Therefore, when tracing all progenitor cells of these two trajectories using the URD algorithm, it is easy to include other cell types, such as ventral mesendodermal cells (Please see Author response image 2A). Based on this, we believe that directly using embryonic data to decipher the mechanism of fate differentiation between the PP and the anterior endoderm may not yield sufficiently precise results. In contrast, our group’s previous study published in Cell Reports demonstrated that the Nodal-induced explant system can specifically enrich dorsal mesendodermal cells, including the anterior endoderm, PP, and notochord[5]. Thus, we consider the Nodal explant system as an ideal model for studying the fate differentiation mechanism between the PP and the anterior endoderm. Ultimately, through comprehensive analysis of in vivo embryonic data and Nodal explant data, we consistently found that the anterior endoderm likely originates from PP progenitor cells—a conclusion further validated by live imaging experiments.

      Regarding the GO analysis, we have streamlined it as suggested by the reviewers. In the revised manuscript, we analyzed the expression of specific genes contributing to key GO functions. Additionally, in the revised version, we conducted more live imaging experiments and quantitative cell assays. We designed gRNA for srcap using the CRISPR CAS13 system to knock down srcap, which further corroborated the morpholino knockdown results, showing consistency with the morpholino data. We also performed Western blot validation of the SWI/SNF complex's response to the drug AU15330, confirming the drug's effectiveness. We hope these additional experiments adequately address the reviewers' concerns.

      Reviewer #2 (Recommendations For The Authors):

      (1) In the introduction, the authors state that mesendoderm segregates into mesoderm and endoderm in a Nodal-concentration dependent manner. While it is true that higher Nodal signaling levels are required for endoderm specification, A) this is also true for some mesoderm populations, and B) Work from Caroline Hill's lab has shown that Nodal activity alone is not determinative of endoderm fate. Although the authors cite this work, it is conclusions are not reflected in this over-simplified explanation of mesendoderm development. The authors also state that it is not clear when PP and endoderm can be distinguished transcriptionally, but this was also addressed in Economou et al, 2022, which found that they can be distinguished at 60% epiboly but not 50% epiboly.

      We sincerely thank the reviewer for raising this question and reminding us of the conclusions drawn from that excellent study. As the reviewer pointed out, Economou et al. demonstrated that Nodal signaling alone is insufficient to determine the cell fate segregation of mesendoderm[6]. However, their study primarily focused on the fate segregation of the ventral-lateral mesendoderm lineage. In contrast, we believe that the mechanisms underlying dorsal mesendoderm specification may differ.

      First, it is well-studied that in zebrafish embryos, the most dorsal mesendoderm is initially specified by the activity of the dorsal organizer. Notably, the Nodal signaling ligands ndr1 and ndr2 begin to be expressed in the dorsal organizer as early as the sphere stage[7]. In our study, through single-cell transcriptomic trajectory analysis and live imaging analysis, we observed that the cell fate segregation of the dorsal mesendoderm can be traced back to the shield stage.

      Second, the regulatory mechanisms governing dorsal mesendoderm fate differentiation may differ from those of the ventral-lateral mesendoderm. For instance, the gsc gene is exclusively expressed in the dorsal mesendoderm and is absent in the ventral-lateral mesendoderm. Given that gsc is a critical master gene, its overexpression in the ventral side can induce a complete secondary body axis. Similarly, ripply1, identified in our study, is also expressed early and specifically in the dorsal mesendoderm. Overexpression of ripply1 in the ventral side similarly induces a secondary body axis, albeit with the absence of the forebrain[5]. In this study, we found that gsc and ripply1 as the repressor, collectively inhibited dorsal (anterior) endoderm specified from PP progenitors.

      In summary, our study focuses on the regulatory mechanisms of fate segregation in the dorsal (anterior) mesendoderm, which differs from the mechanisms of ventral-lateral mesendoderm lineage segregation reported by Economou et al. We believe that this distinction represents a key novelty of our work.

      (2) As noted in the manuscript, Warga and Nusslein-Volhard determined long ago that PP and anterior endoderm share a common precursor. It is surprising that this close relationship is not apparent from the lineage trees in whole embryos but is apparent in lineage trees from explants. The authors speculate that the resolution of the whole embryo dataset is insufficient to detect this branch point and propose explants as the solution, but it is not clear why the explant dataset is higher resolution and/or more appropriate to address this question.

      We sincerely thank the reviewer for their thoughtful comments. As we mentioned previously, our investigation of fate differentiation between the PP and the anterior endoderm initially involved the analysis of zebrafish embryonic data. However, when we used URD to reconstruct the transcriptional trajectory tree, we observed that these two cell trajectories were located far apart. Previous elegant studies, as the reviewer mentioned, have shown that the anterior endoderm and the PP are not only spatially adjacent but also both originate from mesendodermal progenitor cells and share transcriptional similarities[2,3,8]. Consequently, when tracing all progenitor cells of these two trajectories using the URD algorithm, other cell types—such as ventral mesendodermal cells—are easily included. Based on this, we believe that directly using embryonic data to elucidate the mechanism of fate differentiation between the PP and the anterior endoderm may lack sufficient precision.

      In contrast, our group’s previous study published in Cell Reports demonstrated that the Nodal-induced explant system specifically enriches dorsal mesendodermal cells, including the anterior endoderm, PP, and notochord[5]. Therefore, we consider the Nodal explant system as an ideal model for studying the mechanism underlying fate differentiation between the PP and the anterior endoderm. Through comprehensive analyses of both in vivo embryonic and Nodal explant data, we consistently found that the anterior endoderm likely originates from PP progenitor cells—a conclusion further supported by live imaging experiments.

      (3) Much of the analysis of DEGs between the lineages of interest is focused on GO term enrichment. But this logic is circular. The endoderm lineage is defined as such because it expresses endoderm-enriched genes, therefore the finding that the endoderm lineage is enriched for endoderm-related GO terms adds no new insights.

      We thank the reviewer for these comments. As the reviewers suggested, in the revised manuscript, we indicated specific genes associated with key GO terms (Please see Figure 4B). Additionally, we have streamlined the content related to the GO analysis as suggested.

      (4) The authors describe the experiment in Figure S4 as key evidence that Gsc+ cells can give rise to endoderm, but no controls are presented. Only a few cells are shown that express mCherry upon injection of sox17:cre constructs. Is mCherry also expressed in the occasional cell injected with Gsc:lox-stop-lox-mCherry in the absence of cre? Although they report 3 independent replicates, it appears that only 2 individual embryos express mCherry. This very small number is not convincing, especially in the absence of appropriate controls.

      We thank the reviewer for raising this question. Following the reviewer's suggestion, we injected gsc:loxp-stop-loxp-mCherry into zebrafish embryos at the 1-cell stage as a control. After performing at least three independent replicates and analyzing no fewer than 100 embryos, we did not observe any mCherry-positive cells. Additionally, we co-injected gsc:loxp-stop-loxp-mCherry with sox17:cre and increased the sample size. Furthermore, we constructed plasmids of sox17:loxp-stop-loxp-mCherry and gsc:cre, and upon injection at the 1-cell stage, we observed RFP-positive cells at 8 hpf (Please see Author response image 1 and Figure S4E). Together with our live imaging data, these experiments collectively demonstrate that anterior endodermal cells can originate from PP progenitors.

      (5) The authors spend a lot of effort demonstrating that PP and anterior endoderm are Nodal dependent. First, these data (especially Figures 3E and 3I) are not very convincing, as the differences shown are very small or not apparent. Second, this is already well-known and adds nothing to our understanding of mesoderm-endoderm segregation.

      We sincerely thank the reviewer for their insightful questions. First, the reviewer mentioned that in the initial version of our manuscript, the effects of ndr1 knockdown and lefty1 knockout on Nodal signaling and cell fate—particularly prechordal plate (PP) and anterior endoderm (endo)—in Nodal-induced explants were not very pronounced. We recognize that the negative feedback mechanism between Nodal and Lefty signaling may explain why Nodal acts as a morphogen, regulating pattern formation through a Turing-like model[9]. Therefore, knocking down a Nodal ligand gene, such as ndr1 in this study, or knocking out a Nodal inhibitor, such as lft1, may only have a subtle impact on Nodal signaling[10].

      Accordingly, in this study, we performed extensive pSmad2 immunofluorescence analysis and observed that although the overall intensity of Nodal activity did not change dramatically, there was a statistically significant difference. Importantly, this subtle variation in Nodal signaling strength is precisely what we intended to capture, since PP and anterior endoderm are highly sensitive to Nodal signaling[11], and even minor differences may bias their fate segregation.

      This leads directly to the reviewer’s second concern. While numerous studies suggest that the strength of Nodal signaling influences mesendodermal fate—with high Nodal promoting endoderm and lower concentrations inducing mesoderm—most of these studies focus on ventral-lateral mesendoderm development[4,6,10]. In contrast, the mechanisms underlying dorsal mesendoderm fate specification differ, which is a key innovation of our study.

      Previous work by Bernard Thisse and colleagues demonstrated that even a slight reduction in Nodal signaling, achieved by overexpressing a Nodal inhibitor, is sufficient to cause defects in the specification of PP and endoderm[11]. This indicates that PP and endoderm require the highest levels of Nodal signaling for proper specification. Moreover, the most dorsal mesendoderm, PP and anterior endoderm are not only spatially adjacent but also share similar transcriptional states, making the regulation of their fate separation particularly challenging to study.

      The Dr. C.P. lab made important contributions to this issue, showing that the duration of Nodal exposure is critical for segregating PP and anterior endoderm fates: prolonged Nodal signaling promotes expression of the transcriptional repressor Gsc, which directly suppresses the key endodermal transcription factor Sox17, thereby inhibiting anterior endoderm specification[3]. They also found that tight junctions among PP cells facilitate Nodal signal propagation[8]. However, their studies revealed that Gsc mutants do not exhibit endodermal phenotypes, suggesting that additional factors or mechanisms regulate PP versus anterior endoderm fate separation[3].

      In our study, we first observed that subtle differences in Nodal concentration may bias the fate choice between PP and anterior endoderm. Given that ndr1 knockdown and lft1 knockout mildly reduce or enhance Nodal signaling, respectively, we reasoned that using these two perturbations in a Nodal-induced explant system combined with single-cell RNA sequencing could generate transcriptomic profiles under slightly reduced and enhanced Nodal signaling. This approach may help identify key decision points and transcriptional differences during PP and anterior endoderm segregation, ultimately uncovering the molecular mechanisms downstream of Nodal that govern their fate separation.

      (6) The authors claim that scrap expression differs between the 2 lineages of interest, but this is not apparent from Figure 4J-K. Experiments testing the role of SWI/SNF and scrap also require additional controls. Can scrap MO phenotypes be rescued by scrap RNA? Is there validation that SWI/SNF components are degraded upon treatment with AU15330?

      We are very grateful for the reviewers' questions. Using single-cell data from zebrafish embryos and Nodal explants, we compared the expression of srcap in the PP and anterior Endo cell populations. We found that srcap expression showed a slight increase in PP compared to anterior Endo, but the difference was not statistically significant (Please see Figure 4J and S7H). Therefore, we modified our description in the revised manuscript. However, we speculate that this slight difference might influence the distinct cell fate specification between PP and anterior endo. In the original version of the manuscript, we reported that either treatment with AU15330, an inhibitor of the SWI/SNF complex, or injection of morpholino targeting srcap—a key component of the SWI/SNF complex—enhanced anterior endo fate while reducing PP cell specification. During this round of revision, we initially attempted to follow the reviewer’s suggestion to co-inject srcap mRNA along with srcap morpholino to rescue the phenotype. However, we found that the length of srcap mRNA exceeds 10,000 bp, and despite multiple attempts, we were unable to successfully obtain the srcap mRNA. Therefore, we were unable to perform the rescue experiment and instead adopted an alternative approach to validate the function of srcap. We aimed to use anthor knockdown approach (CRISPR/Cas system) to determine whether a phenotype similar to that observed with morpholino knockdown could be achieved. Using the CRISPR/Cas13 system, we designed gRNA targeting srcap, knocked down srcap, and examined the cell specification of PP and anterior endo. We found that, consistent with our previous results, knocking down srcap obviously reduced PP cell fate while increasing anterior endo cell fate (Author response image 3). Additionally, the reviewer raised the question of whether the SWI/SNF complex is degraded after AU15330 treatment. Following the reviewer’s suggestion, we attempted to perform Western blot analysis on BRG1, one of the components of the SWI/SNF complex. However, despite multiple attempts, we were unable to achieve successful detection of the BRG1 protein by the antibody in zebrafish. Several studies have reported that knockdown or knockout of brg1 leads to defects in neural crest cell specification in zebrafish[12,13]. Therefore, alternatively, we treated zebrafish embryos at the one-cell stage with 0 μM (DMSO), 1 μM, and 5 μM AU15330, and examined the expression of sox10 and pigment development around 48 h. We found that treatment with 1 μM AU15330 reduced sox10 expression and pigment production, though not significantly, whereas treatment with 5 μM AU15330 significantly disrupted neural crest cell development. Thus, this experiment demonstrates that AU15330 is functional in zebrafish. (Author response image 3).

      Author response image 3.

      (A) Characterization of anterior endoderm and PP cells following CRISPR-Cas13d-mediated srcap knockdown. (B) Validation of srcap mRNA expression by RT‑qPCR following CRISPR‑Cas13d knockdown. (C) RT‑qPCR shows the expression of sox10 after treatment with increasing concentrations of AU15300. (D) Morphology of zebrafish embryos at 48 hpf after treatment with increasing concentrations of AU15300.

      (7) The authors conclude from their chromatin accessibility analysis that variations in Nodal signaling are responsible for expression levels of PP and endoderm genes, but they do not consider the alternative explanation that FGF signaling is playing this role. Such a function for FGF was established by Caroline Hill's lab, and the authors also show in Figure S5G that FGF signaling in enriched between these cell populations.

      Thank you very much for raising this issue. As the reviewer pointed out, Caroline Hill's lab has conducted elegant work demonstrating that FGF signaling plays a crucial role in the separation of ventral-lateral mesendoderm cell fates[4,6]. In contrast, our study primarily focuses on studying the mechanisms underlying the separation of dorsal mesendoderm cell fates. However, our research also reveals that FGF signaling significantly regulates the fate separation of the dorsal mesendoderm, as inhibiting FGF signaling suppresses PP cell specification while promoting anterior Endo fate. In our previously published work, we found that Nodal signaling can directly activate the expression of FGF ligand genes[5]. Therefore, we hypothesize that Nodal signaling, acting as a master regulator, activates various downstream target genes—including FGF—and how FGF signaling regulates the cell fate separation of the dorsal mesendoderm warrants further investigation in our further studies.

      (8) When interpreting the results of their Ripply cut-and-run experiment, the authors again rely heavily on GO term analysis and claim that this supports a role for Ripply as a transcriptional repressor. GO term enrichment does not equal functional analysis. It would be more convincing to intersect DEGs between WT and ripply-/- embryos with Ripply-enriched loci.

      Thanks for raising this important issue and the constructive suggestion. In response to the reviewer's valid concern regarding the GO term analyses from our CUT&Tag data, we implemented a more stringent filtering strategy. We identified peaks enriched in the treatment group and applied differential analysis, selecting genes with a log<sub>2</sub>FoldChange > 3, padj < 0.05, and baseMean > 30 as high-confidence Ripply1 binding targets. A GO enrichment analysis of these genes revealed significant terms related to muscle development, consistent with Ripply1's established role in somite development, thereby validating our approach. We supplemented the related gene list in the revised manuscript. Moreover, within this refined analysis, we found that sox32 met our binding threshold, while sox17 did not. Furthermore, as suggested, we examined mespbb—a known Ripply1-repressed gene—which was present, and gsc, a Nodal target used as a negative control, which was absent. This confirms the specificity of our analysis (Figure 6 and Figure S11). Consequently, our revised analyses support a model in which Ripply1 directly binds the sox32 promoter. Given that Sox32 is a known upstream regulator of sox17, this binding provides a plausible direct mechanism for the observed regulation of sox17 expression. We have updated the figures and text accordingly. We attempted to generate ripply1<sup>-/-</sup> mutants but found that homozygous loss results in embryonic lethality.

      (9) The way N's are reported is unconventional. N= number of embryos used in the experiment, n= number of embryos imaged. If an embryo was not imaged or analyzed in any way, it cannot be considered among the embryos in an experiment. If only 4 embryos were imaged, the N for that experiment is 4 regardless of how many embryos were stained. Authors should also report not only the number of embryos examined but also the number of independent trials performed for all experiments.

      Thank you very much for the reviewer's suggestion. As suggested, we have revised the description regarding the number of embryos and experimental replicates in the figure legends.

      (10) The authors should avoid the use of red-green color schemes in figures to ensure accessibility for color-blind readers.

      Thanks for the suggestions. We have updated the figures in our revised manuscript and adjusted the color schemes to avoid red-green combinations.

      Reviewer #3 (Public Review):

      Summary:

      Cheng, Liu, Dong, et al. demonstrate that anterior endoderm cells can arise from prechordal plate progenitors, which is suggested by pseudo time reanalysis of published scRNAseq data, pseudo time analysis of new scRNAseq data generated from Nodal-stimulated explants, live imaging from sox17:DsRed and Gsc:eGFP transgenics, fluorescent in situ hybridization, and a Cre/Lox system. Early fate mapping studies already suggested that progenitors at the dorsal margin give rise to both of these cell types (Warga) and live imaging from the Heisenberg lab (Sako 2016, Barone 2017) also pretty convincingly showed this. However, the data presented for this point are very nice, and the additional experiments in this manuscript, however, further cement this result. Though better demonstrated by previous work (Alexander 1999, Gritsman 1999, Gritsman 2000, Sako 2016, Rogers 2017, others), the manuscript suggests that high Nodal signaling is required for both cell types, and shows preliminary data that suggests that FGF signaling may also be important in their segregation. The manuscript also presents new single-cell RNAseq data from Nodal-stimulated explants with increased (lft1 KO) or decreased (ndr1 KD) Nodal signaling and multi-omic ATAC+scRNAseq data from wild-type 6 hpf embryos but draws relatively few conclusions from these data. Lastly, the manuscript presents data that SWI/SNF remodelers and Ripply1 may be involved in the anterior endoderm - prechordal plate decision, but these data are less convincing. The SWI/SNF remodeler experiments are unconvincing because the demonstration that these factors are differentially expressed or active between the two cell types is weak. The Ripply1 gain-of-function experiments are unconvincing because they are based on incredibly high overexpression of ripply1 (500 pg or 1000 pg) that generates a phenotype that is not in line with previously demonstrated overexpression studies (with phenotypes from 10-20x lower expression). Similarly, the cut-and-tag data seems low quality and like it doesn't support direct binding of ripply1 to these loci.

      In the end, this study provides new details that are likely important in the cell fate decision between the prechordal plate and anterior endoderm; however, it is unclear how Nodal signaling, FGF signaling, and elements of the gene regulatory network (including Gsc, possibly ripply1, and other factors) interact to make the decision. I suggest that this manuscript is of most interest to Nodal signaling or zebrafish germ layer patterning afficionados. While it provides new datasets and observations, it does not weave these into a convincing story to provide a major advance in our understanding of the specification of these cell types.

      We sincerely thank the reviewer for their thorough and thoughtful assessment of our work. The reviewer acknowledged several strengths of our study, such as the use of multiple technical approaches to demonstrate that anterior endoderm differentiates from PP progenitor cells, and recognized the value of the newly added single-cell omics data. The reviewer also raised some concerns regarding the initial version of our work, including the SWI/SNF remodeler experiments and the Ripply1 gain-of-function experiment. In the revised manuscript, we have supplemented these parts with additional control experiments to better support our conclusions. We hope that our updated manuscript adequately addresses the points raised by the reviewer.

      Major issues:

      (1) UMAPs: There are several instances in the manuscript where UMAPs are used incorrectly as support for statements about how transcriptionally similar two populations are. UMAP is a stochastic, non-linear projection for visualization - distances in UMAP cannot be used to determine how transcriptionally similar or dissimilar two groups are. In order to make conclusions about how transcriptionally similar two populations are requires performing calculations either in the gene expression space, or in a linear dimensional reduction space (e.g. PCA, keeping in mind that this will only consider the subset of genes used as input into the PCA). Please correct or remove these instances, which include (but are not limited to):

      p.4 107-110

      p.4 112

      p.8 207-208

      p.10 273-275

      We would like to thank the reviewer for raising this question. The descriptions of UMAP have been revised throughout the manuscript in accordance with the reviewer's suggestion (Please see the main text in the revised manuscript).

      (2) Nodal and lefty manipulations: The section "Nodal-Lefty regulatory loop is needed for PP and anterior Endo fate specification" and Figure 3 do not draw any significant conclusions. This section presents a LIANA analysis to determine the signals that might be important between prechordal plate and endoderm, but despite the fact that it suggests that BMP, Nodal, FGF, and Wnt signaling might be important, the manuscript just concludes that Nodal signaling is important. Perhaps this is because the conclusion that Nodal signaling is required for the specification of these cell types has been demonstrated in zebrafish in several other studies with more convincing experiments (Alexander 1999, Gritsman 1999, Gritsman 2000, Rogers 2017, Sako 2016). While FGF has recently been demonstrated to be a key player in the stochastic decision to adopt endodermal fate in lateral endoderm (Economou 2022), the idea that FGF signaling may be a key player in the differentiation of these two cell types has strangely been relegated to the discussion and supplement. Lastly, the manuscript does not make clear the advantage of performing experiments to explore the PP-Endo decision in Nodal-stimulated explants compared to data from intact embryos. What would be learned from this and not from an embryo? Since Nodal signaling stimulates the expression of Wnts and FGFs, these data do not test Nodal signaling independent of the other pathways. It is unclear why this artificial system that has some disadvantages is used since the manuscript does not make clear any advantages that it might have had.

      We sincerely thank the reviewers for their valuable comments. As mentioned in our manuscript, although a substantial number of studies have reported on the mechanisms governing the segregation of mesendoderm fate in zebrafish embryos—including the Dr. Hill laboratory’s work cited by the reviewers, which demonstrated the involvement of FGF signaling in the ventral mesendoderm fate specification—research on the regulatory mechanisms underlying anterior mesendoderm differentiation remains relatively limited. This is largely due to the challenges posed by the close physical proximity and similar transcriptional states of anterior mesendoderm cells, as well as their shared dependence on high levels of Nodal signaling for specification.

      Several studies from the Dr. C.P. Heisenberg’s laboratory have attempted to elucidate the fate segregation between anterior mesendoderm cells, namely the prechordal plate (PP) and anterior endoderm (endo) cells. They found that PP cells are tightly connected, facilitating the propagation of Nodal signaling[8]. Prolonged exposure to Nodal activates the expression of Gsc, which acts as a transcriptional repressor to inhibit sox17 expression, thereby suppressing endodermal fate[3]. However, they also noted that Gsc mutants do not exhibit endoderm developmental defects, suggesting the involvement of additional factors in this process.

      The reviewer inquired about our rationale for using the Nodal-injected explant system. In our investigation of the fate separation between the PP and the anterior endo, we initially analyzed zebrafish embryonic data. Using URD to reconstruct the transcriptional lineage tree, we found that these two cell types were positioned distantly from each other. However, existing literature indicates that the anterior endoderm and PP are not only spatially adjacent but also derive from common mesendodermal progenitors and exhibit transcriptional similarities[2,8]. As the reviewer noted, when tracing all progenitor cells of these two lineages using URD, it is easy to inadvertently include other cell types—such as ventral epiblast cells—which may compromise the accuracy of the analysis. We therefore concluded that directly using embryonic data to dissect the mechanism of fate separation between PP and anterior endoderm might not yield highly precise results.

      By contrast, our group’s earlier study published in Cell Reports demonstrated that the Nodal-induced explant system specifically enriches dorsal mesendodermal cells, including anterior endo, PP, and notochord[5]. This makes the Nodal explant system a highly suitable model for studying the fate separation between PP and anterior endo. Ultimately, by analysing in vivo embryonic data and Nodal explant data, we consistently found that the anterior endoderm likely originates from PP progenitors—a conclusion further supported by live imaging experiments.

      As we answered above, we first used the analyses of single-cell RNA sequencing and live imaging to demonstrate that anterior endoderm can originate from PP progenitor cells. Understanding the mechanism underlying the fate segregation between these two cell populations became a key focus of our research. We began by applying cell communication analysis to our single-cell data to identify signaling pathways that may be involved. This analysis specifically highlighted the Nodal-Lefty signaling pathway. Since Lefty acts as an inhibitor of Nodal signaling, we hypothesized that differences in Nodal signaling strength might regulate the fate of these two cell populations. By overexpressing different concentrations of Nodal mRNA and examining the fates of PP and anterior Endo cells, we confirmed this hypothesis.

      Thus, we propose that even subtle differences in Nodal signaling levels may influence anterior mesendoderm fate decisions. To test this, we generated systems with slightly reduced Nodal signaling (via ndr1 knockdown) and slightly elevated Nodal signaling (via lft1 knockout). Using these models, we precisely captured the critical stage of fate segregation between PP and anterior endo cells and identified a novel transcriptional repressor, Ripply1, which works in concert with Gsc to suppress anterior endoderm differentiation.

      (3) ripply1 mRNA injection phenotype inconsistent with previous literature: The phenotype presented in this manuscript from overexpressing ripply1 mRNA (Fig S11) is inconsistent with previous observations. This study shows a much more dramatic phenotype, suggesting that the overexpression may be to a non-physiological level that makes it difficult to interpret the gain-of-function experiments. For instance, Kawamura et al 2005 perform this experiment but do not trigger loss of head and eye structures or loss of tail structures. Similarly, Kawamura et al 2008 repeat the experiment, triggering a mildly more dramatic shortening of the tail and complete removal of the notochord, but again no disturbance of head structures as displayed here. These previous studies injected 25 - 100 pg of ripply1 mRNA with dramatic phenotypes, whereas this study uses 500 - 1000 pg. The phenotype is so much more dramatic than previously presented that it suggests that the level of ripply1 overexpression is sufficiently high that it may no longer be regulating only its endogenous targets, making the results drawn from ripply1 overexpression difficult to trust.

      We sincerely thank the reviewer for raising this question. First, we apologize for not providing a detailed description of the amount of HA-ripply1 mRNA injected in our previous manuscript. We injected 500 pg of HA-ripply1 mRNA at the 1-cell stage and allowed the embryos to develop until 6 hpf for the CUT&Tag experiment. In the supplementary materials, we included a bright-field image of an 18 hpf-embryo injected with HA-ripply1 mRNA, which morphologically exhibited severe developmental abnormalities. The reviewer pointed out that the amount of ripply1 mRNA we injected might be excessive, potentially leading to non-specific gain-of-function effects. The injection dose of 500 pg was determined based on conclusions from our previous study. In that study, injecting 24 pg of ripply1 mRNA into one cell of zebrafish embryos at the 16–32 cell stage was sufficient to induce a secondary axis lacking the forebrain[5]. From this, we estimated that an injection concentration of approximately 500–1000 pg would be appropriate at the 1-cell stage, so that after several rounds of cell division, each cell gained 20-30 pg mRNA at 32 cell stage. Additionally, we conducted supplementary experiments injecting 100 pg, 250 pg, and 500 pg of ripply1 mRNA, and observed 500 pg of ripply1 mRNA led to a dramatic suppression of endoderm formation (Author response image 4).

      Finally, our study focuses on the mechanism of cell fate segregation in the anterior mesendoderm, primarily during gastrulation. The embryos injected with ripply1 mRNA underwent normal gastrulation, and our CUT&Tag experiment was performed at 6 hpf. Therefore, we believe that the amount of ripply1 mRNA injected in this study is appropriate for addressing our research question.

      Author response image 4.

      Different concentrations of ripply1 mRNA were injected into zebrafish embryos at the one-cell stage, with RFP fluorescence labeling sox17-positive cells.

      (4) Ripply1 binding to sox17 and sox32 regulatory regions not convincing: The Cut and Tag data presented in Fig 6J-K does not seem to be high quality and does not seem to provide strong support that Ripply 1 binds to the regulatory regions of these genes. The signal-to-noise ratio is very poor, and the 'binding' near sox17 that is identified seems to be even coverage over a 14 kb region, which is not consistent with site-specific recruitment of this factor, and the 'peaks' highlighted with yellow boxes do not appear to be peaks at all. To me, it seems this probably represents either: (1) overtagmentation of these samples or (2) an overexpression artifact from injection of too high concentration of ripply1-HA mRNA. In general, Cut and Tag is only recommended for histone modifications, and Cut and Run would be recommended for transcriptional regulators like these (see Epicypher's literature). Given this and the previous point about Ripply1 overexpression, I am not convinced that Ripply1 regulates endodermal genes. The existing data could be made somewhat more convincing by showing the tracks for other genes as positive and negative controls, given that Ripply1 has known muscle targets (how does its binding look at those targets in comparison) and there should be a number of Nodal target genes that Ripply1 does not bind to that could be used as negative controls. Overall this experiment doesn't seem to be of high enough quality to drive the conclusion that Ripply1 directly binds near sox17 and sox32 and from the data presented in the manuscript looks as if it failed technically.

      We sincerely thank the reviewer for raising this question. We apologize that the binding regions of sox17 marked in our previous analysis were incorrect, and we have made the corresponding revisions in the latest version of the manuscript.

      The reviewer noted that our CUT&Tag data contain considerable noise. To address this, we further refined our data processing: we annotated all peaks enriched in the treatment group and performed differential analysis, selecting genes with log<sub>2</sub>FoldChange > 3, padj < 0.5, and baseMean > 30 as candidate targets of Ripply1 binding. Subsequent GO enrichment analysis of these genes revealed significant enrichment of muscle development-related GO terms, which is consistent with previously reported roles of Ripply1 in regulating somite development. Therefore, we believe our filtering method effectively removes a large number of noise peaks and their associated genes.

      Under these screening criteria, we found that sox32 meets the threshold, while sox17 does not. In addition, following the reviewer’s suggestion, we examined mespbb—a known gene repressed by Ripply1—and gsc, a Nodal target gene, as a negative control.

      Based on these new analyses, we have revised our figures and text accordingly. Our data now support the possibility that Ripply1 may directly bind to the promoter region of sox32. Since sox32 acts as a direct upstream regulator of sox17, this binding could influence sox17 expression (Figure 6 and Figure S11).

      Finally, we would like to note that studies have reported Ripply1 as a transcriptional repressor, which may function by recruiting other co-factors, such as Groucho, to form a complex[14,15]. This might explain why our CUT&Tag data detected Ripply1 binding to a broad set of genes.

      (5) "Cooperatively Gsc and ripply1 regulate": I suggest avoiding the term "cooperative," when describing the relationship between Ripply1 and Gsc regulation of PP and anterior endoderm - it evokes the concept of cooperative gene regulation, which implies that these factors interact with each biochemically in order to bind to the DNA. This is not supported by the data in this manuscript, and is especially confusing since Ripply1 is thought to require cooperative binding with a T-box family transcription factor to direct its binding to the DNA.

      We sincerely thank the reviewer for raising this important issue. The reviewer pointed out that the term "Cooperatively" may not be entirely appropriate in the context of our study. In accordance with the reviewer's suggestion, we have replaced "Cooperatively" with "Collectively" in the relevant sections.

      (6) SWI/SNF: The differential expression of srcap doesn't seem very remarkable. The dot plots in the supplement S7H don't help - they seem to show no expression at all in the endoderm, which is clearly a distortion of the data, since from the violin plots it's obviously expressed and the dot-size scale only ranges from ~30-38%. Please add to the figure information about fold-change and p-value for the differential expression. Publicly available scRNAseq databases show scrap is expressed throughout the entire early embryo, suggesting that it would be surprising for it to have differential activity in these two cell types and thereby contribute to their separate specification during development. It seems equally possible that this just mildly influences the level of Nodal or FGF signaling, which would create this effect.

      Thank the Reviewer for this question. As suggested, we performed Wilcoxon tests to compare srcap expression between PP and Endo populations. The analysis shows that while srcap expression is moderately elevated in PP compared to in Endo, this difference is not statistically significant. The corresponding p-value and fold change have now been included in the revised figure (Please see Figure 4J and S7H). Although the transcriptional level of srcap shows no significant difference between PP and anterior endoderm, our subsequent experiments—using AU15330 (an inhibitor of the SWI/SNF complex) and injecting morpholino targeting srcap, a key component of the SWI/SNF complex—demonstrated that its inhibition indeed promotes anterior endoderm fate while reducing PP cell specification. Therefore, we propose that subtle differences in the SWI/SNF complex may regulate the fate specification of PP and anterior endoderm through two mechanisms. First, as mentioned in our study, these chromatin remodelers modulate the expression of master regulators such as Gsc and Ripply1, thereby influencing cell fate decisions. Second, as noted by the reviewer, these chromatin remodelers may affect the interpretation of Nodal signaling, ultimately contributing to the divergence between PP and anterior endoderm fates.

      The multiome data seems like a valuable data set for researchers interested in this stage of zebrafish development. However, the presentation of the data doesn't make many conclusions, aside from identifying an element adjacent to ripply1 whose chromatin is open in prechordal plate cells and not endodermal cells and showing that there are a number of loci with differential accessibility between these cell types. That seems fairly expected since both cell types have several differentially expressed transcriptional regulators (for instance, ripply1 has previously been demonstrated in multiple studies to be specific to the prechordal plate during blastula stages). The manuscript implies that SWI/SNF remodeling by Srcap is responsible for the chromatin accessibility differences between these cell types, but that has not actually been tested. It seems more likely that the differences in chromatin accessibility observed are a result of transcription factors binding downstream of Nodal signaling.

      We thank the reviewer for recognizing the value of our newly generated data. Through integrative analysis of single-cell data from wild-type, ndr1 kd, and lft1 ko groups of Nodal-injected explants at 6 hours post-fertilization (hpf), we identified a critical branching point in the fate segregation of the prechordal plate (PP) and anterior endoderm (Endo), where chromatin remodelers may play a significant role. Based on this finding, we performed single-cell RNA and ATAC sequencing on zebrafish embryos at 6 hpf. Analysis of this multi-omics dataset revealed that transcriptional repressors such as Gsc, Ripply1, and Osr1 exhibit differences in both transcriptional and chromatin accessibility levels between the PP and anterior Endo. Subsequent overexpression and loss-of-function experiments further demonstrated that Gsc and Ripply1 collaboratively suppress endodermal gene expression, thereby inhibiting endodermal cell fate. Previous studies have reported that for the activation of certain Nodal downstream target genes, the pSMAD2 protein of the Nodal signaling pathway recruits chromatin remodelers to facilitate chromatin opening and promote further transcription of target genes[16]. Therefore, our data provide chromatin accessibility profiles for Gsc and Ripply1, offering a valuable resource for future investigations into their pSMAD2 binding sites.

      Minor issues:

      Figure 2 E-F: It's not clear which cells from E are quantitated in F. For instance, the dorsal forerunner cells are likely to behave very differently from other endodermal progenitors in this assay. It would be helpful to indicate which cells are analyzed in Fig F with an outline or other indicator of some kind. Or - if both DFCs and endodermal cells are included in F, to perhaps use different colors for their points to help indicate if their fluorescence changes differently.

      Thank you for the reviewer's suggestion. In the revised version of the figure, we have outlined the regions of the analyzed cells.

      Fig 3 J: Should the reference be Dubrulle et al 2015, rather than Julien et al?

      Thanks, we have corrected.

      References:

      Alexander, J. & Stainier, D. Y. A molecular pathway leading to endoderm formation in zebrafish. Current biology : CB 9, 1147-1157 (1999).

      Barone, V. et al. An Effective Feedback Loop between Cell-Cell Contact Duration and Morphogen Signaling Determines Cell Fate. Dev. Cell 43, 198-211.e12 (2017).

      Economou, A. D., Guglielmi, L., East, P. & Hill, C. S. Nodal signaling establishes a competency window for stochastic cell fate switching. Dev. Cell 57, 2604-2622.e5 (2022).

      Gritsman, K. et al. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97, 121-132 (1999).

      Gritsman, K., Talbot, W. S. & Schier, A. F. Nodal signaling patterns the organizer. Development (Cambridge, England) 127, 921-932 (2000).

      Kawamura, A. et al. Groucho-associated transcriptional repressor ripply1 is required for proper transition from the presomitic mesoderm to somites. Developmental cell 9, 735-744 (2005).

      Kawamura, A., Koshida, S. & Takada, S. Activator-to-repressor conversion of T-box transcription factors by the Ripply family of Groucho/TLE-associated mediators. Molecular and cellular biology 28, 3236-3244 (2008).

      Sako, K. et al. Optogenetic Control of Nodal Signaling Reveals a Temporal Pattern of Nodal Signaling Regulating Cell Fate Specification during Gastrulation. Cell Rep. 16, 866-877 (2016).

      Rogers, K. W. et al. Nodal patterning without Lefty inhibitory feedback is functional but fragile. eLife 6, e28785 (2017).

      Warga, R. M. & Nüsslein-Volhard, C. Origin and development of the zebrafish endoderm. Development 126, 827-838 (1999).

      References:

      (1) Steinbeisser, H., and De Robertis, E.M. (1993). Xenopus goosecoid: a gene expressed in the prechordal plate that has dorsalizing activity. C R Acad Sci III 316, 959-971.

      (2) Warga, R.M., and Nusslein-Volhard, C. (1999). Origin and development of the zebrafish endoderm. Development (Cambridge, England) 126, 827-838. 10.1242/dev.126.4.827.

      (3) Sako, K., Pradhan, S.J., Barone, V., Inglés-Prieto, Á., Müller, P., Ruprecht, V., Čapek, D., Galande, S., Janovjak, H., and Heisenberg, C.P. (2016). Optogenetic Control of Nodal Signaling Reveals a Temporal Pattern of Nodal Signaling Regulating Cell Fate Specification during Gastrulation. Cell reports 16, 866-877. 10.1016/j.celrep.2016.06.036.

      (4) van Boxtel, A.L., Economou, A.D., Heliot, C., and Hill, C.S. (2018). Long-Range Signaling Activation and Local Inhibition Separate the Mesoderm and Endoderm Lineages. Developmental cell 44, 179-191.e175. 10.1016/j.devcel.2017.11.021.

      (5) Cheng, T., Xing, Y.Y., Liu, C., Li, Y.F., Huang, Y., Liu, X., Zhang, Y.J., Zhao, G.Q., Dong, Y., Fu, X.X., et al. (2023). Nodal coordinates the anterior-posterior patterning of germ layers and induces head formation in zebrafish explants. Cell reports 42, 112351. 10.1016/j.celrep.2023.112351.

      (6) Economou, A.D., Guglielmi, L., East, P., and Hill, C.S. (2022). Nodal signaling establishes a competency window for stochastic cell fate switching. Developmental cell 57, 2604-2622 e2605. 10.1016/j.devcel.2022.11.008.

      (7) Schier, A.F., and Talbot, W.S. (2005). Molecular genetics of axis formation in zebrafish. Annual review of genetics 39, 561-613. 10.1146/annurev.genet.37.110801.143752.

      (8) Barone, V., Lang, M., Krens, S.F.G., Pradhan, S.J., Shamipour, S., Sako, K., Sikora, M., Guet, C.C., and Heisenberg, C.P. (2017). An Effective Feedback Loop between Cell-Cell Contact Duration and Morphogen Signaling Determines Cell Fate. Developmental cell 43, 198-211.e112. 10.1016/j.devcel.2017.09.014.

      (9) Muller, P., Rogers, K.W., Jordan, B.M., Lee, J.S., Robson, D., Ramanathan, S., and Schier, A.F. (2012). Differential diffusivity of Nodal and Lefty underlies a reaction-diffusion patterning system. Science (New York, N.Y.) 336, 721-724. 10.1126/science.1221920.

      (10) Rogers, K.W., Lord, N.D., Gagnon, J.A., Pauli, A., Zimmerman, S., Aksel, D.C., Reyon, D., Tsai, S.Q., Joung, J.K., and Schier, A.F. (2017). Nodal patterning without Lefty inhibitory feedback is functional but fragile. eLife 6. 10.7554/eLife.28785.

      (11) Thisse, B., Wright, C.V., and Thisse, C. (2000). Activin- and Nodal-related factors control antero-posterior patterning of the zebrafish embryo. Nature 403, 425-428. 10.1038/35000200.

      (12) Eroglu, B., Wang, G., Tu, N., Sun, X., and Mivechi, N.F. (2006). Critical role of Brg1 member of the SWI/SNF chromatin remodeling complex during neurogenesis and neural crest induction in zebrafish. Developmental dynamics : an official publication of the American Association of Anatomists 235, 2722-2735. 10.1002/dvdy.20911.

      (13) Hensley, M.R., Emran, F., Bonilla, S., Zhang, L., Zhong, W., Grosu, P., Dowling, J.E., and Leung, Y.F. (2011). Cellular expression of Smarca4 (Brg1)-regulated genes in zebrafish retinas. BMC developmental biology 11, 45. 10.1186/1471-213X-11-45.

      (14) Kawamura, A., Koshida, S., Hijikata, H., Ohbayashi, A., Kondoh, H., and Takada, S. (2005). Groucho-associated transcriptional repressor ripply1 is required for proper transition from the presomitic mesoderm to somites. Developmental cell 9, 735-744. 10.1016/j.devcel.2005.09.021.

      (15) Kawamura, A., Koshida, S., and Takada, S. (2008). Activator-to-repressor conversion of T-box transcription factors by the Ripply family of Groucho/TLE-associated mediators. Mol Cell Biol 28, 3236-3244. 10.1128/MCB.01754-07.

      (16) Ross, S., Cheung, E., Petrakis, T.G., Howell, M., Kraus, W.L., and Hill, C.S. (2006). Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J 25, 4490-4502. 10.1038/sj.emboj.7601332.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors aimed to elucidate the recruitment order and assembly of the Cdv proteins during Sulfolobus acidocaldarius archaeal cell division using a bottom-up reconstitution approach. They employed liposome-binding assays, EM, and fluorescence microscopy with in vitro reconstitution in dumbbellshaped liposomes to explore how CdvA, CdvB, and the homologues of ESCRT-III proteins (CdvB, CdvB1, and CdvB2) interact to form membrane remodeling complexes.

      The study sought to reconstitute the Cdv machinery by first analyzing their assembly as two subcomplexes: CdvA:CdvB and CdvB1:CdvB2ΔC. The authors report that CdvA binds lipid membranes only in the presence of CdvB and localizes preferentially to membrane necks. Similarly, the findings on CdvB1:CdvB2ΔC indicate that truncation of CdvB2 facilitates filament formation and enhances curvature sensitivity in interaction with CdvB1. Finally, while the authors reconstitute a quaternary CdvA:CdvB:CdvB1:CdvB2 complex and demonstrate its enrichment at membrane necks, the mechanistic details of how these complexes drive membrane remodeling by subcomplexes removal by the proteasome and/or CdvC remain speculative.

      Although the work highlights intriguing similarities with eukaryotic ESCRT-III systems and explores unique archaeal adaptations, the conclusions drawn would benefit from stronger experimental validation and a more comprehensive mechanistic framework.

      Strengths:

      The study of machinery assembly and its involvement in membrane remodeling, particularly using bottom-up reconstituted in vitro systems, presents significant challenges. This is particularly true for systems like the ESCRT-III complex, which localizes uniquely at the lumen of membrane necks prior to scission. The use of dumbbell-shaped liposomes in this study provides a promising experimental model to investigate ESCRT-III and ESCRT-III-like protein activity at membrane necks.

      The authors present intriguing evidence regarding the sequential recruitment of ESCRT-III proteins in crenarchaea-a close relative of eukaryotes. This finding suggests that the hierarchical recruitment characteristic of eukaryotic systems may predate eukaryogenesis, which is a significant and exciting contribution. However, the broader implications of these findings for membrane remodeling mechanisms remain speculative, and the study would benefit from stronger experimental validation and expanded contextualization within the field.

      We thank the Referee for his/her appreciation of our work.

      Weaknesses:

      This manuscript presents several methodological inconsistencies and lacks key controls to validate its claims. Additionally, there is insufficient information about the number of experimental repetitions, statistical analyses, and a broader discussion of the major findings in the context of open questions in the field.

      We have now added more controls, information about repetitions, and discussion.

      Reviewer #2 (Public review):

      Summary:

      The Crenarchaeal Cdv division system represents a reduced form of the universal and ubiquitous ESCRT membrane reverse-topology scission machinery, and therefore a prime candidate for synthetic and reconstitution studies. The work here represents a solid extension of previous work in the field, clarifying the order of recruitment of Cdv proteins to curved membranes.

      Strengths:

      The use of a recently developed approach to produce dumbbell-shaped liposomes (De Franceschi et al. 2022), which allowed the authors to assess recruitment of various Cdv assemblies to curved membranes or membrane necks; reconstitution of a quaternary Cdv complex at a membrane neck.

      We thank the Referee for his/her appreciation of the work.

      Weaknesses:

      The manuscript is a bit light on quantitative detail, across the various figures, and several key controls are missing (CdvA, B alone to better interpret the co-polymerisation phenotypes and establish the true order of recruitment, for example) - addressing this would make the paper much stronger. The authors could also include in the discussion a short paragraph on implications for our understanding of ESCRT function in other contexts and/or in archaeal evolution, as well as a brief exploration of the possible reasons for the discrepancy between the foci observed in their liposome assays and the large rings observed in cells - to better serve the interests of a broad audience.

      We have now added more controls, information about repetitions, and discussion.

      Reviewer #3 (Public review):

      Summary:

      In this report, De Franceschi et al. purify components of the Cdv machinery in archaeon M. sedula and probe their interactions with membrane and with one-another in vitro using two main assays - liposome flotation and fluorescent imaging of encapsulated proteins. This has the potential to add to the field by showing how the order of protein recruitment seen in cells is related to the differential capacity of individual proteins to bind membranes when alone or when combined.

      Strengths:

      Using the floatation assay, they demonstrate that CdvA and CdvB bind liposomes when combined. While CdvB1 also binds liposomes under these conditions, in the floatation assay, CdvB2 lacking its C-terminus is not efficiently recruited to membranes unless CdvAB or CdvB1 are present. The authors then employ a clever liposome assay that generates chained spherical liposomes connected by thin membrane necks, which allows them to accurately control the buffer composition inside and outside of the liposome. With this, they show that all four proteins accumulate in necks of dumbbell-shaped liposomes that mimic the shape of constricting necks in cell division. Taken altogether, these data lead them to propose that Cdv proteins are sequentially recruited to the membrane as has also been suggested by in vivo studies of ESCRT-III dependent cell division in crenarchaea.

      We thank the Referee for his/her appreciation of the work.

      Weaknesses:

      These experiments provide a good starting point for the in vitro study the interaction of Cdv system components with the membrane and their consecutive recruitment. However, several experimental controls are missing that complicate their ability to draw strong conclusions. Moreover, some results are inconsistent across the two main assays which make the findings difficult to interpret:

      (1) Missing controls.

      Various protein mixtures are assessed for their membrane-binding properties in different ways. However, it is difficult to interpret the effect of any specific protein combination, when the same experiment is not presented in a way that includes separate tests for all individual components. In this sense, the paper lacks important controls. For example, Fig 1C is missing the CdvB-only control. The authors remark that CdvB did not polymerise (data not shown) but do not comment on whether it binds membrane in their assays. In the introduction, Samson et al., 2011 is cited as a reference to show that CdvB does not bind membrane. However, here the authors are working with protein from a different organism in a different buffer, using a different membrane composition and a different assay. Given that so many variables are changing, it would be good to present how M. sedula CdvB behaves under these conditions.

      We thank the referee for raising this point. We have now added these data in Figure 1C. Indeed it turns out that CdvB from M. sedula exhibits clear membrane binding on its own in a flotation assay.

      Similarly, there is no data showing how CdvB alone or CdvA alone behave in the dumbbell liposome assay.

      Without these controls, it's impossible to say whether CdvA recruits CdvB or the other way around. The manuscript would be much stronger if such data could be added.

      We have now added these data in Figure 1E, 1F and 1G. Overall, we can confirm that CdvA binds the membrane better in the presence of CdvB (although both proteins can bind the membrane on their own). Both proteins appear to recognize the curved region of the membrane neck.

      (2) Some of the discrepancies in the data generated using different assays are not discussed.

      The authors show that CdvB2∆C binds membrane and localizes to membrane necks in the dumbbell liposome assay, but no membrane binding is detected in the flotation assay. The discrepancy between these results further highlights the need for CdvB-only and CdvA-only controls.

      We have now added these controls in Figure 1. In addition, we would like to clarify that the flotation assay and the SMS dumbbell assay serve different purposes and are not directly comparable in quantitative terms. In the flotation assay, all the protein present as input is eventually recovered and visualized. Thus, quantitative information on the proportion of the fraction of the total protein bound to lipids can be inferred from this assay. The SMS assay, in contrast, provides a very different kind of information. Because of the particular protocol required to generate dumbbells (De Franceschi, 2022), the total amount of protein in the inner buffer in dumbbells is not accurately defined, because protein that is not correctly reconstituted (e.g. which aggregates while still in the droplet phase) will interfere with vesicle generation, with the result that dumbbell with such aggregates is generally not formed in the first place. This renders it impossible to draw any quantitative conclusions about the proportion of the sample bound to lipids. The SMS is therefore not directly comparable to the flotation assay, and it is rather complementary to it. Indeed, the purpose of the SMS is to provide information about curvature selectivity of the protein.

      (3) Validation of the liposome assay.

      The experimental setup to create dumbbell-shaped liposomes seems great and is a clever novel approach pioneered by the team. Not only can the authors manipulate liposome shape, they also state that this allows them to accurately control the species present on the inside and outside of the liposome. Interpreting the results of the liposome assay, however, depends on the geometry being correct. To make this clearer, it would seem important to include controls to prove that all the protein imaged at membrane necks lie on the inside of liposomes. In the images in SFig3 there appears to be protein outside of the liposome. It would also be helpful to present data to show test whether the necks are open, as suggested in the paper, by using FRAP or some other related technique.

      We thank the Referee for his/her appreciation. The proteins are encapsulated inside the liposomes, not outside of them. While Figure S3 might give the appearance that there is some protein outside, this is actually just an imaging artifact. Author response image 1 (below) explains this: When the membrane and protein channel are shown separately, it is clear that the protein cluster that appeared to be ‘outside’ actually colocalizes with an extra small dumbbell lobe (yellow arrowhead). The protein appeared to be outside of it because (1) the protein fluorescent signal is stronger than the signal from the membrane, and (2) there is a certain time delay in the acquisition of the two channels (0.5-1 second), thus the membrane may have slightly shifted out of focus when the fluorescence was being acquired. We are confident that the protein is inside in these dumbbells because the procedure for preparing the dumbbells requires extensive emulsification by pipetting, which requires ≈ 1 minute. This time is more than sufficient for proteins with high affinity for the membrane, like ESCRT and Cdv, to bind the membrane. For an example of how fast binding under confinement can be, please see movie 2 from this paper: De Franceschi N, Alqabandi M, Miguet N, Caillat C, Mangenot S, Weissenhorn W, Bassereau P. The ESCRT protein CHMP2B acts as a diffusion barrier on reconstituted membrane necks. J Cell Sci. 2018 Aug 3;132(4):jcs217968.

      Moreover, in many instances, we observed that the protein is inside because, by increasing the gain in the images post-acquisition, a clear protein signal appear in the lumen (see Author response image 2).

      Author response image 1.

      Separate channels showing colocalization of protein and lipids (adapted from Figure S3). The zoom-in shows separate channels, highlighting that the CdvB2 cluster that seems to be ‘outside the dumbbell’ actually colocalizes with the small terminal lobe of the dumbbell, indicating that the protein is encapsulated within that lobe.

      Author response image 2.

      Residual protein present inside lumen of dumbbells as visualized by increasing the brightness post-acquisition.

      We are not sure what the referee means by “test whether the necks are open, as suggested in the paper”. We are confident that the lobes of dumbbells originated from a single floppy vesicle, and were therefore mutually connected with an open neck (at least at the onset of the experiment). We have performed extensive FRAP assays on dumbbells in previous papers (De Franceschi et al., ACS nano 2022 and De Franceschi et al., Nature Nanotech 2024) which unequivocally proved that these chains of dumbbells are connected with open necks. We now also performed a few FRAP assay with reconstituted Cdv proteins, which confirmed this point. We have added a movie of such an experiment to the manuscript (Movie 1).

      Investigating whether the necks are open or closed after Cdv reconstitution is indeed a very relevant question, that could be rephrased as “verify whether Cdv proteins or their combination can induce membrane scission”. This is however beyond the scope of this manuscript, as the current work merely addressed the question of hierarchical recruitment of Cdv proteins at the membrane. We plan to examine this in future work.

      (4) Quantification of results from the liposome assay.

      The paper would be strengthened by the inclusion of more quantitative data relating to the liposome assay. Firstly, only a single field of view is shown for each condition. Because of this, the reader cannot know whether this is a representative image, or an outlier? Can the authors do some quantification of the data to demonstrate this? The line scan profiles in the supplemental figures would be an example of this, but again in these Figures only a single image is analyzed.

      The images that we showed are indeed representative. The dumbbells that are generated by the SMS approach contain an “internal control”: in each dumbbell, the protein has the option of localizing at the neck or localizing elsewhere in the region of flat membrane. We see consistently that Cdv proteins have a strong preference for localizing at the neck.

      We would recommend that the authors present quantitative data to show the extent of co-localization at the necks in each case. They also need a metric to report instances in which protein is not seen at the neck, e.g. CdvB2 but not CdvB1 in Fig2I, which rules out a simple curvature preference for CdvB2 as stated in line 182.

      While the request for better quantitation is reasonable, this would require carrying out very significant new experiments at the microscope, which is rendered near-impossible since both first authors left the lab on to new positions.

      Secondly, the authors state that they see CdvB2∆C recruited to the membrane by CdvB1 (lines 184-187, Fig 2I). However, this simple conclusion is not borne out in the data. Inspecting the CdvB2∆C panels of Fig 2I, Fig3C, and Fig3D, CdvB2∆C signal can be seen at positions which don't colocalize with other proteins. The authors also observe CdvB2∆C localizing to membrane necks by itself (Fig 2E). Therefore, while CdvB1 and CdvB2∆C colocalize in the flotation assay, there is no strong evidence for CdvB2∆C recruitment by CdvB1 in dumbbells. This is further underscored by the observation that in the presented data, all Cdv proteins always appear to localize at dumbbell necks, irrespective of what other components are present inside the liposome. Although one nice control is presented (ZipA), this suggests that more work is required to be sure that the proteins are behaving properly in this assay. For example, if membrane binding surfaces of Cdv proteins are mutated, does this lead to the accumulation of proteins in the bulk of the liposome as expected?

      In the particular example of Figure 2I, it indeed appears that there are some clusters of CdvB2ΔC that do not contain CdvB1 (we indicated them in Author response image 3 by red arrowheads), while the yellow arrowheads indicate clusters that contain both proteins. It can be clearly seen that the clusters that do contain both proteins (yellow arrows) are localized at necks, while those that only contain CdvB2ΔC (red arrows) are not localized at necks. This is no coincidence. The clusters indicated by the red arrow do contain CdvB1. However, these clusters rapidly diffuse on the membrane plane because they are not fixed at the neck: therefore, they constantly shift in and out of focus. Because there is a time delay in the acquisition of each channel (between 0.5 and 1 second), these cluster were in focus when the CdvB2ΔC signal was being acquired, but sifted out of focus when the CdvB1 signal was being acquired. This implies that the clusters indicated by the yellow arrowheads are stably localized at necks, which is precisely the point we wished to make with this experiment: because Cdv proteins have an affinity for curved geometry, they preferentially and stably localize at necks. Why don’t all the clusters localize at necks then? We estimate that the simple answer is that, in this particular case, there are more clusters than there are necks, so some of the clusters must necessarily localize somewhere else.

      Author response image 3.

      Current Figure 2H, where clusters that are double-positive for both CdvB1 and CdvB2ΔC are indicated by yellow arrowheads, while cluster that apparently only contain CdvB2ΔC are indicated by red arrowheads. It is observed that all the double-positive clusters are localized at necks.

      (5) Rings.

      The authors should comment on why they never observe large Cdv rings in their experiments. In crenarchaeal cell division, CdvA and CdvB have been observed to form large rings in the middle of the 1 micron cell, before constriction. Only in the later stages of division are the ESCRTs localized to the constricting neck, at a time when CdvA is no longer present in the ring. Therefore, if the in vitro assay used by the authors really recapitulated the biology, one would expect to see large CdvAB rings in Figs 1EF. This is ignored in the model. In the proposed model of ring assembly (line 252), CdvAB ring formation is mentioned, but authors do not discuss the fact that they do not observe CdvAB rings - only foci at membrane necks. The discussion section would benefit from the authors commenting on this.

      The referee is correct: it is intriguing that we don’t see micron-sized rings for CdvA and CdvB. We do note that our EM data (Fig.S1) show that CdvA in its own can form rings of about 100-200nm diameter, well below the diffraction limit, that could well correspond to the foci that we optically resolve in Figure 1. We now added a brief comment on this to the manuscript on lines 256-264.

      (6) Stoichiometry

      It is not clear why 100% of the visible CdvA and 100% of the the visible CdvB are shifted to the lipid fraction in 1C. Perhaps this is a matter of quantification. Can the authors comment on the stoichiometry here?

      We agree that this was unclear. Since that particular gel was stained by coumassie, the quantitative signals might be unreliable, and hence we have repeated this experiment using fluorescently labelled proteins, which show indeed a less extreme distribution. This was also done to make the data more uniform, as requested by the referees.

      (7) Significance of quantification of MBP-tagged filaments.

      Authors use tagging and removal of MBP as a convenient, controllable system to trigger polymerisation of various Cdv proteins. However, it is unclear what is the value and significance of reporting the width and length of the short linear filaments that are formed by the MBP-tagged proteins. Presumably they are artefactual assemblies generated by the presence of the tag?

      Providing a measure of the changes induced by MBP removal, in fact, validates that this actually has an effect. But perhaps this places too much emphasis on the short filaments. We now opted for a compromise, removing the quantification of the width and length of short filaments formed by MBPtagged protein from the text, but keeping the supplementary figure showing their distribution as compared to the other filaments (Figure S2E, SF).

      Similar Figure 2C doesn't seem a useful addition to the paper.

      We removed panel 2C, and now merely report these values in the text.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      I would suggest the authors perform a deeper discussion about their findings, such as what are the evolutionary implications, how they think lipids from these archaea may affect the recruitment process,...

      Because there is no exact homology between Archaea Cdv proteins and Eukaryotic ESCRT-III proteins, we do not feel our work brings new evolutionary implications beyond what we already state in the manuscript. We also dis not perform experiments using Archaea lipids, thus we would rather not speculate on how they may potentially affect the recruitment of Cdv proteins.

      In general, the manuscript lacks information regarding some scale bars, number of experimental repetitions (n or N), statistical analysis when needed, information about protein concentrations used in their assays.

      We have now added this information in the manuscript.

      Below, I provide a list of comments that I think the authors should address to improve the manuscript:

      (1) Line 113-114: The authors test protein-membrane interactions using flotation assays with positively curved SUV membranes but encapsulate proteins in dumbbell-shaped liposomes with negative curvature at the connecting necks. Might the use of membranes with opposite curvatures affect the recruitment process? Since the proteins are fluorescently labeled, I suggest testing recruitment using flat giant unilamellar vesicles or supported lipid bilayers (with zero curvature) to validate their findings.

      We thank the referee for this suggestion. Please do note that we are not claiming in our paper that Cdv proteins recognize negative curvature. We merely observe that they localize at necks. The neck of a dumbbell exhibits the so-called “catenoid” geometry, which is characterized by having both positive and negative curvature.

      Experimentally, on the SUVs, we now realize there was a mistake in the method section: In the flotation assay we in fact used multilamellar vesicles, not SUVs, precisely for the reason mentioned by the referee. We apologize for the oversight and have now corrected this in the methods. Multilamellar vesicles are not characterized by a strong positive curvature as SUVs do, but we do agree that they likely don’t have negative curvature there either. Because of the heterogeneous nature of the multilamellar vesicles, they provide a binding assay that was rather independent of the curvature. Complementary to the flotation assay, the SMS approach was employed to reveal the curvature preference of proteins.

      Finally, we performed the experiment on large GUVs suggested by the referee using CdvB as an example, but this turned out to be inconclusive because the protein forms clusters: these clusters may be creating local curvature at the nanometer scale, which cannot be resolved by optical microscopy (Author response image 4). This is quite typical for proteins that recognize curvature (cf. for instance: De Franceschi N, Alqabandi M, Miguet N, Caillat C, Mangenot S, Weissenhorn W, Bassereau P. The ESCRT protein CHMP2B acts as a diffusion barrier on reconstituted membrane necks. J Cell Sci. 2018 Aug 3;132(4):jcs217968.)

      Author response image 4.

      Fluorescently labelled CdvB bound to giant unilamellar vesicle. The protein was added in the outer buffer. CdvB forms distinct clusters, which may generate a local region of high membrane curvature.

      (2) Line 138-139: How is His-ZipA binding the membrane? Wouldn't Ni<sup>2+</sup>-NTA lipids be required? If not, how is the binding achieved?

      Indeed, NTA-lipids were present. This is now stated both in the legend and in the methods.

      (3) In the encapsulated protein assays, why does the luminal fluorescence intensity of the encapsulated protein sometimes appear similar to the bulk fluorescence signal? Since only a small fraction of the protein assembles at membrane necks, shouldn't the luminal pool of unbound protein show higher fluorescence intensity inside the liposomes?

      We thank the referee for raising this point and giving us the opportunity to explain this. The reason is that Cdv proteins have a very high affinity for the neck, and when they cluster at the neck the fluorescence intensity of the cluster is many times higher than the background fluorescence. Because we were interested in imaging the clusters and avoiding overexposing them, we adjusted the imaging conditions accordingly, with the result that the fluorescence from both the lumen and the bulk is at very low level.

      By choosing different imaging conditions, however, it can be actually seen that the signal inside the lumen is clearly higher than the bulk: this can be seen for instance in Author response image 2, where the brightness has been properly adjusted.

      (4) Line 184-185: In Fig. 2I, some CdvB2ΔC puncta seem independent of CdvB1 and are not localized at membrane necks. How many such puncta exist? For example, in the provided micrograph, 2 out of 5 clusters are independent of CdvB1. This proportion is significant. Could the authors quantify the prevalence of these structures and discuss why they form?

      We thank the referee for giving us the opportunity to explain this apparent discrepancy. We’ll like to stress the fact that CdvB2ΔC and CdvB1 form an obligate heterodimer: in all our experiments, without exception, we find that they form a strong complex when we mix the two proteins. This is true both in dumbbells and in flotation assays.

      In the particular example of Figure 2I, it indeed appears that there are some clusters of CdvB2ΔC that do not contain CdvB1 (we indicated them in Author response image 3 by red arrowheads), while the yellow arrowheads indicate clusters that contain both proteins. It can be clearly seen that the clusters that do contain both proteins (yellow arrows) are localized at necks, while those that only contain CdvB2ΔC (red arrows) are not localized at necks. This is no coincidence. The clusters indicated by the red arrow do contain CdvB1. However, these clusters rapidly diffuse on the membrane plane because they are not fixed at the neck: therefore, they constantly shift in and out of focus. Because there is a time delay in the acquisition of each channel (between 0.5 and 1 second), these cluster were in focus when the CdvB2ΔC signal was being acquired, but sifted out of focus when the CdvB1 signal was being acquired. This implies that the clusters indicated by the yellow arrowheads are stably localized at necks, which is precisely the point we wished to make with this experiment: because Cdv proteins have affinity for curved geometry, they preferentially and stably localize at necks. Why don’t all the clusters localize at necks then?

      (5) Figure 1E and 1F: Why do lipids accumulate and colocalize with the proteins? How can the authors confirm lumen connectivity between vesicles? Performing FRAP assays could validate protein localization and enrichment at the lumen of the membrane necks.

      At first sight, indeed some lipid enrichment seems to be observed at the neck between lobes of dumbbells.

      This is, however, an imaging artifact due to the fact that the neck is diffraction limited. As shown in the Author response image 5, we are acquiring the membrane signal from both lobes at the neck region, and therefore the signal is roughly double, hence the apparent lipid enrichment.

      Author response image 5.

      Schematic illustrating that the neck between two lobes is smaller than the diffraction limit of optical microscopy (the size of a typical pixel is indicated by the green square). Because of this technical limitation, the fluorescence intensity of the membrane at the neck is twice that of a single membrane.

      The referee is correct in pointing out that these images do not prove that the lobes are connected, and that FRAP assays is the only way to prove this point. However, in previous papers we have confirmed extensively that in chains of dumbbells the lobes are connected:

      - De Franceschi N, Pezeshkian W, Fragasso A, Bruininks BMH, Tsai S, Marrink SJ, Dekker C. Synthetic Membrane Shaper for Controlled Liposome Deformation. ACS Nano. 2022 Nov 28;17(2):966–78. doi: 10.1021/acsnano.2c06125.

      - De Franceschi N, Barth R, Meindlhumer S, Fragasso A, Dekker C. Dynamin A as a one-component division machinery for synthetic cells. Nat Nanotechnol. 2024 Jan;19(1):70-76. doi: 10.1038/s41565023-01510-3.

      Random sticking of liposomes would also generate clusters of vesicles, not linear chains. We now provide also a Movie (Movie 1) supporting this point.

      Investigating whether the necks are open or closed after Cdv reconstitution is indeed a very relevant question, that could be rephrased as “verify whether Cdv proteins or their combination can induce membrane scission”. This is however beyond the scope of this manuscript, as the current work merely addressed the question of hierarchical recruitment of Cdv proteins at the membrane. We plan to examine this in future work.

      (6) Why didn't the authors use the same lipid composition, particularly the same proportion of negatively charged lipids, on the SUVs of the flotation assays and on the dumbbell-shaped liposomes?

      In flotation assays, it is typical to use a relatively large proportion of negatively charged lipids, to promote protein binding. This is because the aim is to maximize membrane coverage by the protein. The SMS procedure to generate dumbbell-shaped GUVs is completely different, however. Rather than covering the membrane with protein, the idea is to reduce the amount of protein to a minimum, so that any curvature preference can be best visualized. This is e.g. routinely done in tube pulling experiments, for the same reason (See for instance Prévost C, Zhao H, Manzi J, Lemichez E, Lappalainen P, Callan-Jones A, Bassereau P. IRSp53 senses negative membrane curvature and phase separates along membrane tubules. Nat Commun. 2015 Oct 15;6:8529. doi: 10.1038/ncomms9529).

      (7) Line 117-119: The suggestion that polymer formation between CdvA and CdvB facilitates membrane recruitment is intriguing. However, fluorescence microscopy experiments could better elucidate whether there is sequential recruitment of CdvB followed by CdvA, or if these proteins form a heteropolymer composite for membrane binding. Can CdvB bind membranes independently, or does this require synergy between CdvA and CdvB.

      We thank the referee for prompting us to perform this experiment. As we now show in Figure 1C, CdvB indeed is able to bind the membrane independently of CdvA. Whether this happens sequentially or simultaneously is an interesting question, but one that is impossible to address with either the SMS or the flotation assay, because in both cases we can only observe the endpoint of the recruitment.

      We would also like to clarify one specific experimental detail. Perhaps unsurprisingly, the results from the flotation assay are dependent on the way the assay is performed. In particular, we observed that the same protein can exhibit a different binding profile depending on whether it is being loaded either at the top or at the bottom of the gradient. This can be seen in Author response image 6. This is counterintuitive, since once the equilibrium is reached, the result should only depend on the density of the sample. We performed an overnight centrifugation (> 16 hours) on a short tube (< 3 cm tall), thus equilibrium is being reached (which is corroborated by the fact that CdvB1 and CdvB2 can float to the top of the gradient within this timespan, as shown in Figure 2C, 2E, 2G). We ascribe the difference between top and bottom loading to the fact that, when the sample is loaded at the bottom, it has to be mixed with a concentrated sucrose solution, while in the case of loading from the top, this is not done.

      In literature, both loading from top and from bottom have been used:

      - Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W. Helical structures of ESCRTIII are disassembled by VPS4. Science. 2008 Sep 5;321(5894):1354-7. doi: 10.1126/science.1161070

      - Moriscot C, Gribaldo S, Jault JM, Krupovic M, Arnaud J, Jamin M, Schoehn G, Forterre P, Weissenhorn W, Renesto P. Crenarchaeal CdvA forms double-helical filaments containing DNA and interacts with ESCRT-III-like CdvB. PLoS One. 2011;6(7):e21921. doi: 10.1371/journal.pone.0021921.

      - Senju Y, Lappalainen P, Zhao H. Liposome Co-sedimentation and Co-flotation Assays to Study LipidProtein Interactions. Methods Mol Biol. 2021;2251:195-204. doi: 10.1007/978-1-0716-1142-5_14. In performing the flotation assay for CdvB1 and CdvB2ΔC, or when using all 4 proteins together, we loaded the sample at the bottom, and we could detect reproducible binding to liposomes (Figures 2D, 2F, 2H, 3A). However, CdvB does not bind the membrane when loaded at the bottom. Thus, for the experiments shown in figure 1C, we loaded the proteins at the top. This experimental setup allowed us to highlight that CdvB indeed induce a stronger interaction between CdvA and the membrane.

      Author response image 6.

      CdvB binding to multilamellar vesicles in a flotation assay. In the left panel, the sample was loaded at the top of the sucrose gradient; in the right panel it was loaded at the bottom.

      (8) Line 165-173: The authors claim that filament curvature differs between CdvB2ΔC alone and the CdvB1:CdvB2ΔC complex. Are these differences statistically significant? What is the sample size (N)? Furthermore, how do the authors confirm interactions between these proteins in the absence of membranes based solely on EM micrographs?

      We can confirm that the filaments are composed by both proteins, because the filaments have different curvature when both proteins are present. However, as requested by referee 3, point (7), we removed the quantification of curvature from panel 2C. We report the N number in the text.

      (9) Line 121-123: Are the authors referring to positive or negative membrane curvatures? The cited literature suggests ESCRT-III proteins either lack curvature preferences (e.g., Snf7, CHMP4B) or prefer high positive curvature (e.g., late ESCRT-III subunits). This is confusing since the authors later test recruitment to negatively curved necks.

      We do not claim that Cdv proteins prefer positive or negative curvature, because the necks present in dumbbells have a catenoid geometry, which include both positive and negative curvature. We have now clarified this in the discussion.

      (10) Since the conclusions rely on the oligomeric state of the proteins, providing SEC-MALS spectra to show the protein oligomeric state right after the purification would strengthen the claims.

      While such SEC-MALDI experiments may be interesting, practical implementation of this is not possible since both first authors left the lab on to new positions.

      (11) Line 157-160: Suppl. Fig. 2 shows only a single EM micrograph of a small filament. Could the authors provide lower magnification images showing more filaments?

      As requested by Referee 3, point (7), we have toned down the importance of these short filaments.

      Also, why are the sample sizes for filament length (N=161) and width (N=129) different?

      Protein filaments formed by Cdv tend to stick to each other side by side, so that for some filaments the width could not be accurately assessed, and accordingly those were removed from the analysis.

      (12) The introduction states that CdvA binds membranes while CdvB does not. However, the results suggest CdvB facilitates membrane binding, helping CdvA attach. This discrepancy needs further explanation.

      We thank the referee for raising this point. We have now performed additional experiments (both SMS assay and flotation assays) showing that indeed CdvB from M. sedula is (unlike CdvB from Sulfolobus) able to bind the membrane on its own (Figure 1C, 1F).

      Reviewer #2 (Recommendations for the authors):

      Best practice would be to show single fluorescence channels in grayscale or inverted grayscale, retaining pseudocolouring only for the merged multichannel image.

      We decided to retain and standardize the colors, both for gels and for microscopy images, in order to have the same color-code for each protein. We believe this improves readability, and this was also a request from Referee 3. Thus, throughout the manuscript, CdvA is in grayscale, CdvB in yellow, CdvB1 in green, CdvB2ΔC in cyan and the membrane in magenta.

      It would be great to include a quantification of liposome curvature vs focal intensity of the various Cdv components - across figures.

      Quantification of liposome curvature at the neck can be done (De Franceschi et al., Nature Nanotech. 2024). However, in practice, this requires transferring of the sample post-preparation into a new chamber in order to increase the signal-to-noise ratio of the encapsulated dye, a procedure that drastically reduces the yield of dumbbells. The very sizeable amount of work required to obtain reliable measurements, especially considering all the proteins and protein combinations used in this study, indicates that this represents a project in itself, which goes well beyond the scope of this manuscript.

      Reviewer #3 (Recommendations for the authors):

      (1) We would encourage the authors to consider including the length of the scale bar next to the scale bar in each image and not in the figure description. This would greatly aid in clarity and interpretation of figures.

      We have now written the length of the scale bar in the figures.

      (2) In a similar vein, could the authors consider labeling panels throughout the manuscript, writing that sample is being presented? This goes mainly for the negative stain and the dumbbell fluorescence images, as having to continuously consult the figure legend again hinders clarity.

      We have now labelled the EM images as requested by the referee.

      (3) Lines 254-256: would the statement hold not only for CdvB2∆C, but for all imaged proteins? They all seem to localize to membrane necks, presumably favoring membrane binding to a specific membrane topology.

      We agree with the referee, and changed the phrasing accordingly.

      (4) CdvB2∆C construct - presumably this was a truncation of helix 5 of the ESCRT-III domain? Figure 1A shows that the ESCRT-III domain spans residues 34-170 and therefore implies that all five ESCRT-III helices (which make up the ESCRT-III domain) are present in the C-terminal truncation. Could the authors clarify?

      Indeed, the truncation was done at residue 170.

      (5) Results of the liposome flotation assays are presented inconsistently across the three figures (Figs 1C, 2DFH, and 3A). This makes it more difficult than it needs to be to interpret and compare results. Could the authors consider presenting the three gels in a more similar, standardized way across the three figures?

      To improve readability, we now standardized the colors, both for gels and for microscopy images, in order to have the same color-code for each protein. Thus, throughout the manuscript, CdvA is in grayscale, CdvB in yellow, CdvB1 in green, CdvB2ΔC in cyan and the membrane in magenta.

      (6) From the data presented in Fig 1EF, it cannot be concluded whether CdvB and CdvA colocalize, as only one protein is labelled. Is there a technical reason for this?

      We have now repeated the same experiment by having both proteins labelled, confirming that there is co-localization at the neck (Figure 1G).

      (7) Fig 2C: is the difference between the two samples significant

      As requested by Referee 3, we have removed Figure 2C.

      (8) Fig 2I is missing a 'merged' panel.

      We have now added the merged panel.

      (9) The fluorescence intensity plots in Supp Figs 1C and 3C would be easier to interpret if the lipid and protein signal would be plotted on the same plot (say, with normalized fluorescence intensity)

      It is not immediately obvious to us what the signal should be normalized to. What we wished to convey with these plots was that the intensity of proteins spikes at the neck region. In an attempt to improve clarity, we have now aligned the plots vertically, and highlighted the position of the neck.

      (10) CdvA should have a capital "A" in Figure 3A, panel 3.

      We have now corrected this.

      (11) The discussion doesn't comment on the need to truncate CdvB2.

      This is explained in the result session.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Kroeg et al. describe a novel method for 2D culture human induced pluripotent stem cells (hiPSCs) to form cortical tissue in a multiwell format. The method claims to offer a significant advancement over existing developmental models. Their approach allows them to generate cultures with precise, reproducible dimensions and structure with a single rosette; consistent geometry; incorporating multiple neuronal and glial cell types (cellular diversity); avoiding the necrotic core (often seen in free-floating models due to limited nutrient and oxygen diffusion). The researchers demonstrate the method's capacity for long-term culture, exceeding ten months, and show the formation of mature dendritic spines and considerable neuronal activity. The method aims to tackle multiple key problems of in vitro neural cultures: reproducibility, diversity, topological consistency, and electrophysiological activity. The authors suggest their potential in high-throughput screening and neurotoxicological studies.

      Strengths:

      The main advances in the paper seem to be: The culture developed by the authors appears to have optimal conditions for neural differentiation, lineage diversification, and long-term culture beyond 300 days. These seem to me as a major strength of the paper and an important contribution to the field. The authors present solid evidence about the high cell type diversity present in their cultures. It is a major point and therefore it could be better compared to the state of the art. I commend the authors for using three different IPS lines, this is a very important part of their proof. The staining and imaging quality of the manuscript is of excellent quality.

      We thank the reviewer for the positive comments on the potential of our novel platform to address key problems of in vitro neural culture, highlighting the longevity and reproducibility of the method across multiple cell lines.

      Weaknesses:

      (1) The title is misleading: The presented cultures appear not to be organoids, but 2D neural cultures, with an insufficiently described intermediate EB stage. For nomenclature, see: doi: 10.1038/s41586-022-05219-6. Should the tissue develop considerable 3D depth, it would suffer from the same limited nutrient supply as 3D models - as the authors point out in their introduction.

      We appreciate the opportunity to clarify this point. We respectfully disagree that the cultures do not meet the consensus definition of an organoid. In fact, a direct quote from the seminal nomenclature paper referenced by the reviewer states: “We define organoids as in vitro-generated cellular systems that emerge by self-organization, include multiple cell types, and exhibit some cytoarchitectural and functional features reminiscent of an organ or organ region. Organoids can be generated as 3D cultures or by a combination of 3D and 2D approaches (also known as 2.5D) that can develop and mature over long periods of time (months to years).” (Pasca et al, 2022 doi10.1038/s41586-022-05219-6). Therefore, while many organoid types indeed have a more spherical or globular 3D shape, the term organoid also applies to semi-3D or nonglobular adherent organoids, such as renal (Czerniecki et al 2018, doi.org/10.1016/j.stem.2018.04.022) and gastrointestinal organoids (Kakni et al 2022, doi.org/10.1016/j.tibtech.2022.01.006). Accordingly, the adherent cortical organoids described in the manuscript exhibit self-organization to single radial structures consisting of multiple cell layers in the z-axis, reaching ~200um thickness (therefore remaining within the limits for sufficient nutrient supply), with consistent cytoarchitectural topology and electrophysiological activity, and therefore meet the consensus definition of an organoid.

      (2) The method therefore should be compared to state-of-the-art (well-based or not) 2D cultures, which seems to be somewhat overlooked in the paper, therefore making it hard to assess what the advance is that is presented by this work.

      It was not our intention to benchmark this model quantitatively against other culture systems. Rather, we have attempted to characterize the opportunities and limitations of this approach, with a qualitative contrast to other culture methods. Compared to stateof-the-art 2D neural network cultures, adherent cortical organoids provide distinct advantages in:

      (1) Higher order self-organized structure formation, including segregation of deeper and upper cortical layers.

      (2) Longevity: adherent cortical organoids can be successfully kept in culture for at least 1 year, whereas 2D cultures typically deteriorate after 8-12 weeks.

      (3) Maturity, including the formation of dendritic mushroom spines and robust electrophysiological activity.

      (4) Cell type diversity including a more physiological ratio of inhibitory and excitatory neurons (10% GAD67+/NeuN+ neurons in adherent cortical organoids, vs 1% in 2D neural networks), and the emergence of oligodendrocyte lineage cells.

      On the other hand, limitations of adherent cortical organoids compared to 2D neural network cultures include:

      (1) Culture times for organoids are much longer than for 2D cultures and the method can therefore be more laborious and more expensive.

      (2) Whole cell patch clamping is not easily feasible in adherent cortical organoids because of the restrictive geometry of 384-well plates.

      (3) Reproducibility is prominently claimed throughout the manuscript. However, it is challenging to assess this claim based on the data presented, which mostly contain single frames of unquantified, high-resolution images. There are almost no systematic quantifications presented. The ones present (Figure S1D, Figure 4) show very large variability. However, the authors show sets of images across wells (Figure S1B, Figure S3) which hint that in some important aspects, the culture seems reproducible and robust.

      We made considerable efforts to establish quantitative metrics to assess reproducibility. We applied a quantitative scoring system of single radial structures at different time points for multiple batches of all three lines as indicated in Figure S1C. This figure represents a comprehensive dataset in which each dot represents the average of a different batch of organoids containing 10-40 organoids per batch. To emphasize this, we have adapted the graph to better reflect the breadth of the dataset. Additional quantifications are given in Figure S2 for progenitor and layer markers for Line 1 and in Figure 2 for interneurons across all three lines, showing relatively low variability. That being said, we acknowledge the reviewer’s concerns and have modified the text to reduce the emphasis of this point, pending more extensive data addressing reproducibility across an even broader range of parameters.

      (4) What is in the middle? All images show markers in cells present around the center. The center however seems to be a dense lump of cells based on DAPI staining. What is the identity of these cells? Do these cells persist throughout the protocol? Do they divide? Until when? Addressing this prominent cell population is currently lacking.

      A more comprehensive characterization of the cells in the center remains a significant challenge due to the high cell density hindering antibody penetration. However, dyebased staining methods such as DAPI and the LIVE/DEAD panel confirm a predominance of intact nuclei with very minimal cell death. The limited available data suggest that a substantial proportion of the cells in the center are proliferative neural progenitors, indicated by immunolabeling for SOX2 (Figure 2A,D;Figure S4C). Furthermore, we are currently optimizing the conditions to perform single cell / nuclear RNA sequencing to further characterize the cellular composition of the organoids.

      (5) This manuscript proposes a new method of 2D neural culture. However, the description and representation of the method are currently insufficient. (a) The results section would benefit from a clear and concise, but step-by-step overview of the protocol. The current description refers to an earlier paper and appears to skip over some key steps. This section would benefit from being completely rewritten. This is not a replacement for a clear methods section, but a section that allows readers to clearly interpret results presented later.

      We have revised the manuscript to include a more detailed step-by-step overview of the protocol.

      (b) Along the same lines, the graphical abstract should be much more detailed. It should contain the time frames and the media used at the different stages of the protocol, seeding numbers, etc.

      As suggested, we have adapted the graphical abstract to include more detail.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, van der Kroeg et al have developed a method for creating 3D cortical organoids using iPSC-derived neural progenitor cells in 384-well plates, thus scaling down the neural organoids to adherent culture and a smaller format that is amenable to high throughput cultivation. These adherent cortical organoids, measuring 3 x 3 x 0.2 mm, self-organize over eight weeks and include multiple neuronal subtypes, astrocytes, and oligodendrocyte lineage cells.

      Strengths:

      (1) The organoids can be cultured for up to 10 months, exhibiting mature dendritic spines, axonal myelination, and robust neuronal activity.

      (2) Unlike free-floating organoids, these do not develop necrotic cores, making them ideal for high-throughput drug discovery, neurotoxicological screening, and brain disorder studies.

      (3) The method addresses the technical challenge of achieving higher-order neural complexity with reduced heterogeneity and the issue of necrosis in larger organoids. The method presents a technical advance in organoid culture.

      (4) The method has been demonstrated with multiple cell lines which is a strength.

      (5) The manuscript provides high-quality immunostaining for multiple markers.

      We appreciate the reviewer’s acknowledgement of the strengths of this novel platform as a technical advance in organoid culture that reduces heterogeneity and shows potential for higher throughput experiments.

      Weaknesses:

      (1) Direct head-to-head comparison with standard organoid culture seems to be missing and may be valuable for benchmarking, ie what can be done with the new method that cannot be done with standard culture and vice versa, ie what are the aspects in which new method could be inferior to the standard.

      In our opinion, it would be extremely difficult to directly compare methods. Most notably, whole brain organoids grow to large and irregular globular shapes, while adherent cortical organoids have a more standardized shape confined by the geometry of a 384well. Moreover, it was not our intention to benchmark this model quantitatively against other culture systems. Rather, we have attempted to characterize the opportunities and limitations of this approach, with a qualitative contrast to other culture methods, as addressed in response to comment 2 of Reviewer 1 above.

      (2) It would be important to further benchmark the throughput, ie what is the success rate in filling and successfully growing the organoids in the entire 384 well plate?

      Figure S1 shows the success rate of organoid formation and stability of the organoid structures over time. In addition, we have added the number of wells that were filled per plate.

      (3) For each NPC line an optimal seeding density was estimated based on the proliferation rate of that NPC line and via visual observation after 6 weeks of culture. It would be important to delineate this protocol in more robust terms, in order to enable reproducibility with different cell lines and amongst the labs.

      Figure S1 provides the relationship between proliferation rate and seeding density, allowing estimation of seeding densities based on the proliferation rate of the NPCs. However, we appreciate the reviewers' feedback and have modified the methods to provide more detail.

      Reviewer #3 (Public review):

      Summary:

      Kroeg et al. have introduced a novel method to produce 3D cortical layer formation in hiPSC-derived models, revealing a remarkably consistent topography within compact dimensions. This technique involves seeding frontal cortex-patterned iPSC-derived neural progenitor cells in 384-well plates, triggering the spontaneous assembly of adherent cortical organoids consisting of various neuronal subtypes, astrocytes, and oligodendrocyte lineage cells.

      Strengths:

      Compared to existing brain organoid models, these adherent cortical organoids demonstrate enhanced reproducibility and cell viability during prolonged culture, thereby providing versatile opportunities for high-throughput drug discovery, neurotoxicological screening, and the investigation of brain disorder pathophysiology. This is an important and timely issue that needs to be addressed to improve the current brain organoid systems.

      We thank the reviewer for highlighting the strengths of our novel platform. We appreciate that all three reviewers agree that the adherent cortical organoids presented in this manuscript reliably demonstrate increased reproducibility and longevity. They also commend its potential for higher throughput drug discovery and neurotoxicological/phenotype screening purposes.

      Weaknesses:

      While the authors have provided significant data supporting this claim, several aspects necessitate further characterization and clarification. Mainly, highlighting the consistency of differentiation across different cell lines and standardizing functional outputs are crucial elements to emphasize the future broad potential of this new organoid system for large-scale pharmacological screening.

      We appreciate the feedback and have added more detail on consistency and standardization of functional outputs.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Minor points

      (1) As the preprint is officially part of the eLife review, I have to remark that the preprint which is made available on bioarxiv, suffers from some serious compatibility or format problem: one cannot highlight sentences as in a regular PDF and when trying to copypaste sentences from it jumbled characters are copied to the clipboard.

      The updated version of the paper on bioRxiv should not suffer from these compatibility issues.

      (2) Since the paper is presenting a new method it should briefly describe how each step, including the hiPSC culture was done, the reference to an earlier publication in this case is not sufficient, and this practice is generally best to avoid for methods papers.

      Each step in the culturing process has now been described in the methods.

      (3) The EB stage is insufficiently described. The "2D - 3D - 2D" transitions should be clearly explained.

      The methods section has been rewritten and expanded to include these processes in more detail.

      (4) Is there one FACS sorting in the protocol, or multiple (additional at IPS culture)? What markers each? What is the motivation for sorting and purifying the neural progenitors? Was the culture impure? What was purity? What cell types are expected after sorting, and what is removed?

      Only one FACS sorting step is performed at the NPC stage. This was added as an improvement to our original neural network protocol (Günhanlar et al 2018) to ensure consistency over different hiPSC source cell lines that can yield variable amounts of frontal cortical patterned NPCs. Positive sorting for neural lineage markers CD184 and CD24, and negative sorting for mesenchymal/neural crest CD217 and CD44 glial progenitor markers, according to Yuan et al 2011, ensures frontal-patterned cortical NPCs as confirmed for all batches by immunohistochemistry for SOX2, Nestin and FOXG1. We have added new text to the Methods section to clarify this more explicitly.

      (5) Seeding protocol and parameters are insufficiently described, and from what I read they are poorly defined: "Specifically, the optimal seeding density was determined by visual inspection of the organoids between 28 to 42 days after seeding a range of cell densities in the 384-well plate wells." For a new method, precise, actionable instructions are needed. I may have overlooked those elsewhere, in this case, please clarify these sections.

      The Methods section was rewritten and expanded to describe the methodology in greater detail with more actionable instructions.

      (6) The timeline in Figure 1 is not clearly delineated; I found it hard to understand which figure corresponds to which stage (e.g. facs sorting is not mentioned in the first part of the results but it is part of Figure 1A, neural rosette formation can happen both before and after facs sorting, simply referring to rosettes is not clear). Later parts of the manuscript 
> clearly introduce the terms sorting and seeding in the context of this method, and how ages (days) refer to these time points.

      Figure 1 was adapted to clarify the generation of Neural Progenitor Cells (NPCs) and subsequent seeding of NPCs to generate Adherent Cortical Organoids (ACOs).

      (7) The authors define: "cortical organized defined as a single radial structure." This is not a commonly used definition of organoids, for nomenclature, please see: doi: 10.1038/s41586-022-05219-6 (Pasca et al 2022).

      To clarify, the statement is not meant to reflect a definition of organoids in general, but rather the scoring of proper structure formation for Figure S1C. For discussion on nomenclature, see our response to point 1 of Reviewer 1 in the public review. We changed the wording to be more accurate.

      (8) In Figure S1d, the authors write: "the fraction of structurally intact cultures decreased to 50%", but I'm looking at that graph there seems to be no notable decrease, but huge variability. The authors should quantify claims of decrease by linear regression and an R square. Variation within and the cross-cell lines seem to be large. Also, it is unclear if dots are corresponding to the same wells/plates, in other words: is this a longitudinal experiment? What is the overall success rate? How is success determined? Are there clear criteria? to the same wells/plates, in other words: is this a longitudinal experiment? What is the overall success rate? How is success determined? Are there clear criteria?

      We agree with the reviewer that the claim on fraction of intact cultures decreasing over time to 50% is an overinterpretation due the large variability. We changed the wording in the manuscript to: While some later batches show moderately reduced success rates compared with the earliest batches, properly formed single-structure organoids were still obtained at 40–90% success across all examined time points (Figure S1C), indicating that long-term culture is feasible albeit with variable efficiency. The data are not longitudinal as each dot represents an endpoint of a different batch of organoids, totaling 18 independent batches across the three lines. We have clarified this in the figure legend. Success was defined at the well level as the presence of a single, continuous radial structure occupying the well, without obvious fragmentation or fusion events, as assessed by LIVE/DEAD that also confirmed viability. Wells were scored as successful only when the radial structure showed predominantly live signal with no large necrotic areas. Wells containing multiple radial structures, fused aggregates, or predominantly dead tissue were scored as unsuccessful.

      (9) Figure s1c: the numbering to this panel should be swapped, because it is referenced after other panels in the text. The reference is confusing: "Plotting the interaction between proliferation and the amount of NPCs required to be seeded for the successful generation of adherent cortical organoids" - success is not present in this graph at all? How is that measured?

      Figures S1C and S1D have been adapted to clarify the measure of ‘successful organoid formation’.

      (a) The description of this plot is confusing: "The doubling time of the NPCs explains more than half the variation (r2 = 0.67) of the required seeding density." What else is there? I thought that this was the formula the authors suggested to determine seeding density, but it seems not. Or is "manual inspection" the determinant, and that seems to correlate with this metric?

      Even though the rate of proliferation, measured as doubling time, is the main determinant of the seeding density, it is not the only determinant of the seeding density. For instance, intrinsic differences in differentiation potential could also play a role. Therefore, NPC lines with similar doubling times might still have slightly different optimal seeding densities. We have added clarification of this conclusion to the Results section.

      (b) Seeding density is a key parameter in many in vitro differentiation and culture protocols. This importance however does not mean that this density is attributable to differences in cell proliferation rate. Alternatively, the amount of cells determines the amount of secreted molecules and cell-to-cell contacts.

      Here, when we refer to the cell density, we specifically refer to the cell density needed to generate the ACO. We show that the most important contributor to the variation in ACO formation is the proliferation, measured here as the doubling time. We agree that there are other factors involved such as the secreted molecules, cell-to-cell contacts as well as the ability of a given NPC line to differentiate into a post-mitotic cell.

      (c) Is it mentioned which cell line this experiment corresponds to?

      The data in Figure S1D is from the 3 reported cell lines, as well as 2 clones from a fourth IPS cell line. This is detailed in the Methods section of the proliferation assay.

      (d) Without a more detailed explanation, seeding density and doubling time could be independent variables.

      These two variables are highly correlated as shown in Figure S1D, but it is true that there can be other variables that account for the observed variance, as discussed above in Point 9b.

      (e) In this figure the success rate is not visible at all so I have no idea how the autors arrive at a conclusion about success rate.

      We have adapted the figure legend to reflect which cell lines the dots in Fig. S1D represent. NPC lines can have substantial variation in proliferation rates. The figure reflects data of NPCs of 5 clones of 4 different hiPSC lines (as indicated in the Methods) with different proliferation rates. Also, the ACO success rate (operationally defined uniformly to the data shown in Fig. S1C) was also included.

      (10) Figure 2: Clean spatial segregation seems to be a strength of the system and therefore I would recommend putting more of the relevant microscopy images to the main figure, which are now currently in Figure S4.

      We have adapted Figure 2 accordingly, and included additional representative cortical layering images in Figure S4.

      (11) The variability in interneuron content seems to be significant, as currently presented in the figure. However, this may be due to a special organization. It would first quantify in consecutive rings around the centers whether interneurons have a tendency to be enriched towards the center or the edge of the culture. Maybe this explains the variability that is currently present in Figure s5b.

      We agree that spatial organization of interneurons could, in principle, contribute to variability. In our analysis, however, images were acquired from positions selected by a random sampling grid across the entire culture, rather than from specific central or peripheral regions. Each field contained on average 130.6 ± 16.1 NeuN+ nuclei, which provided a relatively large sampling volume per position. If interneurons were strongly enriched at the center or edge, we would expect systematic differences in interneuron fraction between fields assigned to central versus peripheral grid positions. We did not observe such a pattern in our dataset, suggesting that spatial organization is not the main driver of the observed variability.

      (12) Because in previous figures it seems like there is considerable variability across individual cultures and images here are coming from separate cultures, please use different shapes of the points coming from different cultures/wells, to see if maybe there is a culture-to-culture difference that explains the variability present in the figure.

      We have added different symbols per organoid for the interneuron quantifications and moved this quantification to main Figure 2.

      (13) I believe it is currently the standard error of the mean which is displayed in the figure, which is not an appropriate representation for variability, or the reproducibility across individual data points. SEM quantifies the reproducibility of the mean, not the reproducibility of the individual data points, which matters here. Mean refers to the mean of this quantification experiment and therefore it's not a biological entity. A box plot showing the interquartile range besides the individual data points would be an accurate representation of the spread of the data.

      We agree and have adapted the data, now in Figure 5, accordingly.

      (14) Again, in general, the main figures should contain much more of the quantification, as opposed to just raw images.

      Quantifications have been added in Figure 2 for the GAD67/NeuN for all cell lines as well as a time course quantification of GAD67/NeuN for 1 of the cell lines. In Figure 4, we have added excitatory and inhibitory synaptic quantifications.

      (15) Figure 2F-I the location of the center of the rosette should be marked with a star so that the conclusion about the direction of processes can be established.

      The suggested addition of a marker at the center of each rosette was evaluated but not implemented, because it reduced rather than improved figure clarity.

      (16) Figure 3 b and c:

      High magnification images of single cells, can't show changes in cell type morphology, and one cannot conclude that these cells are present in significant numbers across time. Zoomed-out images or quantification would be necessary for such a claim. The authors already have such images as presented in the next panels, so quantification without new experiments.
> I am uncertain about the T3 supplement here - do these images correspond to the same conditions?

      (a) It is unclear to me why different markers are used in the different panels, namely why NG2 is not used in any of the other images.

      NG2 was used at early developmental time points to show the presence of Oligodendrocyte Precursor Cells (OPCs). At later time points, the focus switched to MBP staining to indicate more mature oligodendrocyte lineage cells. Although NG2 and MBP are not in the same panels, the staining was performed for both antibodies at the same developmental time point (Day 119) as seen in Figure 3C and 3D.

      (b) Color coding in Figure 3G is ambiguous; the use of two blues should be avoided, and the Sub-sub panels should be individually labeled for the color code.

      We agree, and have now used different colors.

      (c) It is unclear if the presence of the t3 molecule is part of the standard procedure or if it was a side experiment to enhance the survival of oligodendrocytes. Are there no oligodendrocytes without? How does T3 affect other cell types, and the general health and differentiation of the cultures?

      Indeed, T3 is essential for oligodendrocyte formation. We did not observe obvious effects on the general health or differentiation potential of the cultures.

      (d) Is the 2ng/ml t3 from day one to the final day?

      Indeed, in the organoids cultured to study oligodendrocyte formation, T3 was added from Day 1. These details have now been clarified in the Methods and Results sections.

      (17) Figure 4:

      (a) Microscopy in this figure is high quality and very convincing about neural maturity.

      (b) The term "cluster" should be avoided. Unclear what it means here, but my best guess is "cells in a frame of view." Cluster is used with a different meaning in electrophysiology.

      This was adapted to ‘neurons in a field of view (FOV)’.

      (c) Panel J: I assume each row corresponds to a single cell? Could this be clarified? Are these selected cells from each frame, or all active cells are represented?

      Indeed, each row corresponds to a single cell, showing all active cells in the frame. This is now clarified in the legend.

      (d) How many Wells do these data correspond to, and in which line it was measured?

      As reported in the legend for Figure 5, these data correspond to 2 wells at Day 61 to which we have now added calcium imaging data from 3 wells from a different batch at Day 100. We have included in the legend that these recordings were from Line 1.

      (e) Panels G to I, again, the use of standard error of the mean is inappropriate and misleading: looking at the error bar one must conclude that there is minimal variation, which is the exact opposite of the conclusions, when one would look at the variability of the raw data points.

      As suggested, the graphs have been adapted as boxplots with interquartile ranges to highlight the distribution of data points.

      (f) It is unclear how many neurons and how many total actively firing neurons are present in the videos analyzed

      All neurons that were active in the field of view and showed at least one calcium event during the ~10 minute recording were included in the analysis. Using this method, we cannot comment on the proportion of neurons that were active from the total amount of neurons present, since the AAV virus we used does not transduce all neurons.

      (g) This figure shows the strength of the method in achieving neural maturity and function. There seems to be that there is considerable activity in the neuronal cultures analyzed. To conclude how reliably the method leads to such mature cultures one would need to measure at least a dozen wells (even if with some simpler and low-resolution method). Concluding reproducibility from one or two hand-picked examples is not possible.

      We agree with the reviewer that the number of wells used for calcium imaging analysis was limited. We are currently working on more advanced methods to increase the throughput of this analysis. However, we’ve now added another timepoint to the calcium imaging data in Figure 5 from an independent batch of 3 adherent cortical organoids, which demonstrates continued robust activity at Day 100, as well as Day 61.

      Methods:

      (1) Stem cell culture. The artist described that line 3 is grown on MEFs. Is this true for the other two lines, furthermore were they cultured in identical conditions?

      Line 2 and 3 were not grown on MEFs. We specifically chose different sources of NPCs to reflect the robust nature of the differentiation protocol. We have recently also adapted the protocol from Line 3 NPCs to confirm that the protocol also works starting from hiPSCs grown in feeder-free conditions in StemFlex medium, by adapting NPC differentiation according to our recent publication in Frontiers in Cellular Neuroscience (Eigenhuis et al 2023).

      (2) "NPCs were differentiated to adherent cortical organoids between passages 3 and 7 after sorting." Please clarify this sentence. I assume it refers to the first facs sorting of the protocol, but a section is not sufficiently detailed.

      We have adapted the methods to clarify that the FACS purification step occurs at the NPC stage.

      (3) I didn't fully understand: It seems to be that there are two steps of fact sorting involved, one after passage 3 and one after week 4. This should be represented in the graphical abstract of Figure 1.

      As outlined above, there is only 1 FACS sorting step at NPC stage. We have adapted this in the Methods and in the graphical abstract.

      (4) Neural differentiation: The authors write that optimal seeding density was determined by visual inspection of the organoids - this is.

      We have clarified the Methods section to better explain the process of optimizing the seeding density for each NPC line to generate the ACOs.

      (5) What does the following sentence mean: "Cells were refreshed every 2-3 days." Does it mean in replacement of the complete media? How much Media was added to the Wells?

      This is a very good point that we have now clarified in the Methods, as full replenishment of media is neither feasible, nor desirable. From the total volume of 110 µl per well, 80 µl is taken out and replaced with 85 µl to compensate for evaporation.

      (6) Calcium imaging: can the authors explain the decision to move the cultures one day before imaging into brainphys neural differentiation medium? In 3D organoid protocols, brainphys is gradually introduced to avoid culture shock (very different composition), and used for multiple months to enhance neural differentiation. For recording electrophysiological activity, artificial CSF is the most common choice.

      Indeed, for whole cell recordings of 2D neural networks as performed in Günhanlar et al 2018, we used gradual transition to aCSF. For the current ACOs, we found that using BrainPhys from the start of organoid differentiation prevents structure formation, probably because of increased speed of maturation disrupting proliferation and organization of radial glia differentiation. However, by changing the media to BrainPhys just one day before recording (reflecting a gradual change as not all medium is fully replenished and easier than switching to aCSF during recording), we saw greatly improved neuronal activity.

      (7) Statistical analysis : As I pointed out before, the standard error of the mean is not an appropriate metric to represent the variability of the data. It is meant to represent the variability of the estimated average. The following thought experiment should make it clear: I measured the expression of a gene in my system. 50 times I measured 0 and 50 times I measured 100. The average is 50, but of course it is a very bad representation of the data because no such data points exist with that value. Yet the standard error of the mean would be plus minus 5.

      We have revised Figures 5C–5D to boxplots displaying the interquartile range with all individual data points overlaid, which more accurately represents the variability in the dataset.

      Discussion

      (1) The discussion focuses on human cortical development, however, the methods presented by the authors entail dissociation and replating through multiple stages not part of brain development. I see the approach as more valuable as a possibly reliable method that generates both diverse and mature neural cultures.

      We have revised the Discussion to avoid explicitly invoking an in vitro recapitulation of human cortical development. Nevertheless, given that the NPCs from which the organoids originate exhibit frontal cortical identity, coupled with the timely emergence of cortical neuronal markers and rudimentary cortical layering, we are increasingly confident that the development of these cultures most likely mirrors that of the frontal cortex. To further substantiate this hypothesis, single-cell RNA sequencing experiments will be conducted in the future to provide additional insights.

      (2) One of the major claims of the authors is that the method is very reproducible. However, there is almost no data on reproducibility throughout the paper. Mostly single, high magnification images are presented, which therefore represent a small region of a single well of a single batch of a single cell line. Based on the data presented it is not possible to evaluate the reproducibility of the method.

      We agree that the original version did not sufficiently document reproducibility. To address this, we have refined and expanded our presentation of reproducibility data. The previous success-rate panel (original Figure S1D) has been moved and adapted as the new Figure S1C. In this updated version, each dot still represents the endpoint success rate of an independent batch, but dot size now scales with batch size (10–40 organoids), and the legend specifies the total numbers of organoids analyzed per line (line 1: n=248; line 2: n=70; line 3: n=70). Together with the distribution of success rates between ~40– 90% across multiple time points and three iPSC lines, this more detailed representation allows readers to directly assess the robustness of line-to-line and batch-to-batch performance. In addition, new time course quantifications of interneuron proportion (Figure 2G,H), synaptic marker densities (Figure 4H, I), and late-stage calcium imaging (Figure 5C,D,E) further demonstrate that key structural and functional read-outs show overlapping ranges across lines and independent differentiations, reinforcing that the method yields reproducible core phenotypes despite some biological variability.

      (3) The data presented is very promising, and it suggests that the authors derived optimal conditions for neural differentiation and neural culture diversification. I am confident that the authors can show that reproducibility, at least in a practical sense (e.g. in wells that form a culture) is high.

      Overall, this is a very promising and exciting work, that I am looking forward to reading in a mature manuscript.

      Reviewer #2 (Recommendations for the authors):

      (1) Direct head-to-head comparison with standard organoid culture seems to be missing and may be valuable for benchmarking, ie what can be done with the new method that cannot be done with standard culture and vice versa, ie what are the aspects in which new method could be inferior to the standard.

      We have now more clearly elaborated the differences with other methods. As addressed in our response to point 2 of Reviewer 1 in the public reviews, there are several limitations and advantages to the adherent cortical organoids model listed as follows:

      Advantages of adherent cortical organoids:

      (1) Higher order self-organized structure formation, including segregation of deeper and upper cortical layers.

      (2) Longevity: adherent cortical organoids can be successfully kept in culture for at least 1 year, whereas 2D cultures typically deteriorate after 8-12 weeks.

      (3) Maturity, including the formation of dendritic mushroom spines and robust electrophysiological activity.

      (4) Cell type diversity including a more physiological ratio of inhibitory and excitatory neurons (10% GAD67+/NeuN+ neurons in adherent cortical organoids, vs 1% in 2D neural networks), and the emergence of oligodendrocyte lineage cells.

      On the other hand, limitations of adherent cortical organoids compared to 2D neural network cultures include:

      (1) Culture times for organoids are much longer than for 2D cultures and the method can therefore be more laborious and more expensive.

      (2) Whole cell patch clamping is not easily feasible in adherent cortical organoids because of the restrictive geometry of 384-well plates.

      (2) It would be important to further benchmark the throughput, ie what is the success rate in filling and successfully growing the organoids in the entire 384 well plate?

      We have addressed this question in the current version of Fig. S1C, in which multiple batches of organoids of all three lines were scored for their success rate. The graph reflects the proportion of properly formed organoids of +/- 400 seeded wells scored at different timepoints, in which each timepoint is a different batch. As mentioned in the response to Reviewer 1, we have also added data on the number of organoids seeded per line in the figure legend.

      (3) For each NPC line an optimal seeding density was estimated based on the proliferation rate of that NPC line and via visual observation after 6 weeks of culture. It would be important to delineate this protocol in more robust terms, in order to enable reproducibility with different cell lines and amongst the labs.

      As outlined in the response to Reviewer 1, we have clarified the Methods and Discussion sections on seeding density and proliferation rate.

      Reviewer #3 (Recommendations for the authors):

      Kroeg et al. have introduced a novel method to produce 3D cortical layer formation in hiPSC-derived models, revealing a remarkably consistent topography within compact dimensions. This technique involves seeding frontal cortex-patterned iPSC-derived neural progenitor cells in 384-well plates, triggering the spontaneous assembly of adherent cortical organoids consisting of various neuronal subtypes, astrocytes, and oligodendrocyte lineage cells. Compared to existing brain organoid models, these adherent cortical organoids demonstrate enhanced reproducibility and cell viability during prolonged culture, thereby providing versatile opportunities for high-throughput drug discovery, neurotoxicological screening, and the investigation of brain disorder pathophysiology. This is an important and timely issue that needs to be addressed to improve the current brain organoid systems. While the authors have provided significant data supporting this claim, several aspects necessitate further characterization and clarification. Particularly, highlighting the consistency of differentiation across different cell lines and standardizing functional outputs are crucial elements to emphasize the future broad potential of this new organoid system for large-scale pharmacological screening.

      (1) Considering the emergence of astrocyte markers (GFAP, S100b) and upper layer neuron marker (CUX1) around Day 60, the overall differentiation speed is significantly faster compared to other forebrain organoid protocols. Are these accelerated sequences of neurodevelopment consistent across different hiPSC lines?

      As shown in Fig. S5, astrocytes are present around Day 60 for all three lines. For comparison with other organoid protocols, an important consideration is that the timeline for these organoids starts at NPC plating, while for other protocols timing often starts from the hiPSC stage. We have clarified the timeline in the graphical abstract in Figure 1A and in the Methods.

      (2) The calcium imaging results in Figure 4G were recorded at a single time point, Day 61, a relatively early time window compared to other forebrain organoid protocols (more than 100 days, PMID: 31257131; PMID: 36120104). Are the neurons in adherent cortical organoids functionally mature enough around Day 61? How consistent is this functional activity across different cell lines and independent differentiation batches?

      As discussed above in Point 1, it is important to consider that the specified timeline starts from NPC plating. In analogy to 2D neural networks, robust neuronal activity can be observed after ~8 weeks in culture. In addition, we have now added calcium imaging data for an additional batch of organoids at Day 100 in Figure 5, which exhibit comparable levels of neuronal activity as observed on Day 61.

      (3) Along the same line, Various cell types, such as oligodendrocytes and astrocytes, are believed to influence neuronal maturation. Therefore, longitudinal studies until the late stage are necessary to observe changes in electrophysiological activity based on the degree of neuronal maturation (at least two more later time points, such as 100 days and 150 days).

      As described in the previous points, we have now included a Day 100 time point in the calcium imaging data, in addition to the recordings at Day 61 (Figure 5C-E).

      (4) The authors assert that heterogeneity among organoids has been diminished using the human adherent cortical organoids protocol. However, there is inadequate quantitative data to prove the consistency of neuronal activities between different wells. Therefore, experiments quantifying the degree of heterogeneity between organoids, such as through methods like calcium imaging, are necessary to determine if neuron activity occurs consistently across each organoid well.

      We agree with the review and have added several quantitative experiments: a) we’ve added another timepoint to the calcium imaging data in Figure 5 from an independent batch of 3 adherent cortical organoids, which demonstrates continued robust activity at day 100, as well as day 61; b) we added synapse quantification in Figure 4, and c) interneuron quantification in Figure 2. We are currently also pursuing high throughput measures of activity to assess the longitudinal activity of ACOs in a larger number of wells. This way we can more definitively quantify the time-dependent variance in organoid activity.

      (5) Is this platform applicable to other functional measurements for neuronal activity, such as the MEA system? When observing the morphology of neurons formed in organoids, they appear to extend axons and dendrites in a consistent direction, suggesting a radial structure that demonstrates high reproducibility across wells. A culture system where neurons are arranged with such consistency in directionality could be highly beneficial for experiments utilizing the MEA system to assess parameters such as the speed of electrical activity transmission and stimulus-response. Therefore, there seems to be a need for a more detailed explanation of the utility of the structural characteristics of the culture system.

      The ACO platform is indeed suitable for MEA recordings. We are in the process of engineering the required geometry using HD-MEA systems through specialized inserts to generate ACOs on MEA systems.

      (6) In Figure 2E-I, authors suggest morphological diversity of GFAP+/S100b+ astrocyte, but the imaging data presented in Figure F-I is only based on GFAP immunoreactivity.

      Since GFAP is also expressed in radial glial cells at this stage (Figure 2I), many fibrous astrocytes and interlaminar astrocytes are likely radial glial neural progenitor cells instead of astrocytes. It appears necessary to perform additional staining using astrocyte markers such as S100B or outer radial glia markers such as HOPX to demonstrate that the figure depicts subtype-specific morphologies of astrocytes.

      In Figure 2M, we stained for GFAP and PAX6 to mark radial glia that look different than the astrocyte morphologies we describe in Figure 2J-L. We see a large overlap in GFAP and S100B staining in Figure 2I, in which most GFAP+ cells are double positive for S100B (yellow) that is more consistent with astrocyte maturation than radial glia. Furthermore, we have not seen PAX6 staining outside the dense edges of the center of the ACO.

      (7) In Figure 4D, the axon appears to exhibit directionality. Additional explanation regarding the organization of the axon is necessary. Further research utilizing sparse staining to examine the morphology of single neurons seems warranted.

      The polarized directionality of the axons is something we indeed have also noticed. We are looking into options to further investigate this intriguing property of the ACOs.

      (8) Figure 1E-F only showed cell viability in the early stages around Day 40-50. To demonstrate the superior long-term viability of ACO culture, it appears necessary to illustrate the ratio of dead cells to live cells over the course of a time course.

      Figure S1B shows LIVE/DEAD staining for ACOs of all three lines, revealing minimal DEAD staining at Day 56. A longitudinal time course experiment was not performed, however the line- and batch-specific quantifications over developmental timepoints in Figure S1C provide an indication of the robust long-term viability of the ACOs.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this fMRI study, the authors wished to assess neural mechanisms supporting flexible temporal construals. For this, human participants learned a story consisting of fifteen events. During fMRI, events were shown to them, and participants were instructed to consider the event from "an internal" or from "an external" perspective. The authors found distinct patterns of brain activity in the posterior parietal cortex (PPC) and anterior hippocampus for the internal and the external viewpoint. Specifically, activation in the posterior parietal cortex positively correlated with distance during the external-perspective task, but negatively during the internal-perspective task. The anterior hippocampus positively correlated with distance in both perspectives. The authors conclude that allocentric sequences are stored in the hippocampus, whereas egocentric sequences are supported by the parietal cortex.

      We thank the reviewer for the accurate summary of our study.

      Strengths:

      The research topic is fascinating, and very few labs in the world are asking the question of how time is represented in the human brain. Working hypotheses have been recently formulated, and the work tackles them from the perspective of construals theory.

      We appreciate the reviewer's positive and encouraging comments.

      Weaknesses:

      Although the work uses two distinct psychological tasks, the authors do not elaborate on the cognitive operationalization the tasks entail, nor the implication of the task design for the observed neural activation.

      We thank the reviewer for bringing this issue to our attention. In the revised manuscript, we have added a paragraph to the Discussion acknowledging this potential limitation of the study. Please see our response below.

      Reviewer #1 (Recommendations for the authors):

      Overall, I thank the authors for providing clear responses and much-needed detail on their original work, which enables a better understanding of their perspectives. I still have some detailed questions about the reported work, which I provide below. It could help clarify the work for a more general audience and its replicability by the community.

      We thank the reviewer for their positive evaluation of our previous revisions.

      Main general concern:

      I have one remaining core concern, which I distill as being a very different take on the usefulness of task design with neuroimaging. This concern follows from the authors' response to my original comment, which suggested possible confounds in fMRI data analysis and interpretation, as differences in task design and behavioral outcomes were not incorporated in the analytical approach.

      The authors confirmed that "there is a substantial difference between the two tasks" but argue that these differences are not relevant seing that "the primary goal of this study was not to directly compare these tasks to isolate a specific cognitive component " However, the authors do perform such contrasts in their analysis (e.g. p. 10: "We first directly contrasted the activity level between external- and internal-perspective tasks in the time window of...") and build inferences on brain activation from them (e.g., p. 10: "Compared with the internal-perspective task, the externalperspective task specifically activated the...").

      To clarify, my original concern was not about comparing neural activity in response to the two tasks but about the brain activity generated by two distinct tasks, which aim to reveal fundamentally distinct neural processes. The authors' response raises several concerns about the theoretical, methodological and empirical foundation of the work that are beyond the scope of a single empirical study and too long to detail here. Cognitive neuroscience relies on tasks to infer neural processes; this is the fertile and essential ground for using behavior in neuroscience to get to a mechanistic understanding of brain functions (e.g., Krakauer et al., 2017). In short, task design is fundamental because it shapes what neural processes are being investigated. Any inferences about brain activity recorded while a participant performs a task result from manipulated variables that should be under the control of the experimenter. Acknowledging that two tasks are distinct is acknowledging that different (neural) processes may govern their resolution. My initial remark was meant to highlight that, from basic signal detection theory, a same/different task and a temporal order task may not yield the same kind of basic biases and decision-making processes; these are far below and more basic than the posited sophisticated representations herein (construals, perspective taking).

      In short, the general approach is far coarser than the level of interpretational granularity being pushed forward in the paper would suggest.

      We greatly appreciate the reviewer’s comments and agree that this is a very fair point. We acknowledge that the two tasks differ in their underlying decision-making processes. In the revised manuscript, we have added a paragraph at the end of the Discussion to explicitly acknowledge this limitation and to outline possible avenues for future research (Page 23).

      “One limitation of the present study is that the external- and internal-perspective tasks differed not only in the type of perspective-taking they were intended to elicit, but also in their underlying decision-making processes. The external-perspective task explicitly required participants to compare two events with respect to external temporal landmarks and judge whether they occurred in the same or different parts of the day (i.e., a same/different judgment), whereas the internalperspective task explicitly required participants to project themselves into a reference event and judge whether the target event occurred in the future or the past relative to that reference (i.e., a temporal-order judgment). This task design ensured that participants adopted two distinct perspectives on the event series, but at the expense of coherence in the cognitive operations required to make the two types of judgments. One alternative approach would be to more closely align the response demands of the two tasks by drawing on McTaggart’s (1908) A-series and Bseries distinction: in the external-perspective task, participants could judge whether the target event occurred before or after the reference event (i.e., a before/after judgment), whereas in the internal-perspective task they could judge whether the target event occurred in the past or future relative to the reference event (i.e., a past/future judgment). Although such a design would improve coherence in the underlying decision-making processes (i.e., both are temporal-order judgments), it would reduce experimental control over the perspective-taking manipulation. For example, before/after judgments could still be made from an internal perspective. Future studies are therefore needed to determine whether findings obtained from these two task designs converge.”

      Additional clarifications:

      Intro/theory

      In this revised MS, the authors provided some clarifications of their theoretical perspective in the introduction. From my standpoint, the motivation remains insufficiently precise for a scientific report. Some theoretical aspects, such as construals or perspective taking remain evasive in relation to ego and allocentric representations. A couple of paragraphs dedicated to explaining what the authors mean precisely when using these terms would greatly help to situate the validity of the working hypothesis. In the absence of clear definitions, it remains difficult to evaluate what is being tested. For instance, what do the authors mean by "time construal"? How is a time construal the same or not as a "temporal distance" or a "temporal sequence"? This would greatly help the readership.

      Additionally, some assertions are not clearly identified or fairly attributed. For instance, the assertion that EST provides a means to spatialize time is the authors' point of view or interpretation of this work, not an original proposition of the theory. Another example is McTaggart's metaphysics on time series (in the ontology of time in physics) "echoed" in linguistics; it has effectively been proposed and popularized by L. Boroditskty. The prospective and retrospective views of time should not be attributed to Tsao et al but to Hicks or Block in the 70's, who studied the psychology of time in humans.

      We sincerely thank the reviewer for this criticism, which prompted us to clarify the relevant concepts in our manuscript. In the revised version, we made the following three main changes to the Introduction.

      In the second paragraph of the Introduction (page 3), we clarify that event segmentation theory is independent of, but related to, the spatial construal of time hypothesis. We also clarify what we mean by time construals and explain that the two temporal components—duration and sequence—can be represented within such time construals, rather than constituting time construals themselves. These revisions were intended to prevent potential misunderstandings for the reader. In addition, we incorporated Boroditsky’s contributions relevant to this framework:

      “One solution, which might be unique to humans, is to conceptualize time in terms of space (i.e., the spatial construal of time; e.g., Clark, 1973; Traugott, 1978; Lakoff & Johnson, 1980). Within this framework, time is usually first segmented into events—the basic temporal entities that observers conceive as having a beginning and an end (Zacks & Tversky, 2001). These temporal entities are then ordered in space, such that events occurring at different times can be maintained in working memory, allowing them to be flexibly accessed from different perspectives and easily referenced during communication (e.g., Casasanto & Boroditsky, 2008; Núñez & Cooperrider, 2013; Bender & Beller, 2014; Abrahamse et al., 2014; Figure 1A). The two core temporal components—duration and sequence—can be readily represented in such time construals.”

      In the third paragraph of the Introduction (pages 3-4), we acknowledge the contributions of earlier behavioral studies on prospective and retrospective timing by citing the work suggested by the reviewer (Block & Zakay, 1997), which indicates that two distinct cognitive systems underlie timing processes. These behavioral findings converge with the conclusions of more recent neuroimaging studies:

      “Unlike prospective timing tracking the continuous passage of time, durations in time construals are event-based (Sinha & Gärdenfors, 2014): the interval boundaries are constituted by events, and the event durations reflect their span (Figure 1A). Accumulating evidence suggests that distinct cognitive systems underlie these two types of duration (e.g., Block & Zakay, 1997). The motor and attentional system—particularly the supplementary motor area—has been associated with prospective timing (e.g., Protopapa et al., 2019; Nani et al., 2019; De Kock et al., 2021; Robbe, 2023), whereas the episodic memory system—particularly the hippocampus—is considered to support the representation of duration embedded within an event sequence (e.g., Barnett et al., 2014; Thavabalasingam et al., 2018; see also the comprehensive review by Lee et al., 2020).”

      Block, R. A., & Zakay, D. (1997). Prospective and retrospective duration judgments: A meta-analytic review. Psychonomic Bulletin & Review, 4(2), 184-197.

      In the fifth paragraph of the Introduction (page 5), we added a sentence to clarify the relationship between allocentric and egocentric reference frames and perspective taking:

      “However, the neural mechanisms that enable the brain to generate distinct construals of an event sequence remain largely unknown. Valuable insights may be drawn from research in the spatial domain, which posits the existence of stable allocentric representations that are independent of viewpoint, from which variable egocentric representations corresponding to different perspectives can be generated.”

      Methods:

      While more detail is provided in the Methods, some additional detail would be helpful to enable the replication of this work. For instance,

      - The table reports a sequence of phrases with assigned durations. Are the event phrases actual sentences given to participants? If so, how were participants made aware of the duration of the events, seeing that these sentence parts do not provide time information?

      We apologize that we did not make this clear. The full text used during the reading phase of learning has already been provided in Figure 1—source data 1, which includes the information about event durations. In the revised manuscript, we now explicitly refer to this information in the Methods section (page 38): In the reading phase, participants read a narrative describing the whole ritual on a computer screen twice (Figure 1—source data 1).

      - One of my original questions was about the narrative. In the Methods section, the authors state that participants read a text. Providing the full text would be helpful, also as a sanity check for sequentiality.

      As clarified in the previous response, the texts are provided in Figure 1—source data 1, which illustrates the texts for both even- and odd-numbered participants.

      - In the imagination phase, the authors introduce proportionality between imagination and experience (p. 37). What scale was used? What motivated it?

      We thank the reviewer for bringing this issue to our attention. In this study, participants did not directly experience the events; instead, they learned the event information through narrative reading or imagination to ensure experimental control and efficiency. As clarified in the Methods section, the ratio between imagination duration and actual event duration was 30 seconds to 1 hour. In the revised manuscript, we have further explained our motivation for this design choice (page 39):

      Here, we let participants learn the event information through narrative reading or imagination. Compared to learning through actual experience, this approach prioritizes experimental control and efficiency. The timing of the events is compressed, akin to the process of retrospectively recalling our experiences, in which we mentally traverse events without requiring the actual time they originally took. However, future studies may be needed to investigate whether the encoding of events from first- and second-hand experience differs.

      Results:

      - p. 10: the interpretation of the data on chunking and boundary effects should be properly referenced to e.g. Davachi's published work.

      We thank the reviewer for highlighting Davachi’s important work on event boundaries. We have appropriately cited these studies in the revised manuscript (page 10), as reflected in the following passage: This pattern can be interpreted as a categorical effect: sequential distances within the same part of the day were perceived as shorter (i.e., a chunking effect), whereas distances spanning different parts of the day were perceived as longer (i.e., a boundary effect). Similar boundary- or chunking-related effects on event cognition have been reported in previous studies (e.g., Ezzyat & Davachi, 2011; DuBrow & Davachi, 2013; Radvansky & Zacks, 2017).

      Ezzyat, Y., & Davachi, L. (2011). What constitutes an episode in episodic memory?. Psychological Science, 22(2), 243-252.

      DuBrow, S., & Davachi, L. (2013). The influence of context boundaries on memory for the sequential order of events. Journal of Experimental Psychology: General, 142(4), 1277.

      Radvansky, G. A., & Zacks, J. M. (2017). Event boundaries in memory and cognition. Current Opinion in Behavioral Sciences, 17, 133-140.

      Reviewer #2 (Public review):

      Summary:

      Xu et al. used fMRI to examine the neural correlates associated with retrieving temporal information from an external compared to internal perspective ('mental time watching' vs. 'mental time travel'). Participants first learned a fictional religious ritual composed of 15 sequential events of varying durations. They were then scanned while they either (1) judged whether a target event happened in the same part of the day as a reference event (external condition); or (2) imagined themselves carrying out the reference event and judged whether the target event occurred in the past or will occur in the future (internal condition). Behavioural data suggested that the perspective manipulation was successful: RT was positively correlated with sequential distance in the external perspective task, while a negative correlation was observed between RT and sequential distance for the internal perspective task. Neurally, the two tasks activated different regions, with the external task associated with greater activity in the supplementary motor area and supramarginal gyrus, and the internal condition with greater activity in default mode network regions. Of particular interest, only a cluster in the posterior parietal cortex demonstrated a significant interaction between perspective and sequential distance, with increased activity in this region for longer sequential distances in the external task but increased activity for shorter sequential distances in the internal task. Only a main effect of sequential distance was observed in the hippocampus head, with activity being positively correlated with sequential distance in both tasks. No regions exhibited a significant interaction between perspective and duration, although there was a main effect of duration in the hippocampus body with greater activity for longer durations, which appeared to be driven by the internal perspective condition. On the basis of these findings, the authors suggest that the hippocampus may represent event sequences allocentrically, whereas the posterior parietal cortex may process event sequences egocentrically.

      We sincerely appreciate the reviewers for providing an accurate, comprehensive, and objective summary of our study.

      Strengths:

      The topic of egocentric vs. allocentric processing has been relatively under-investigated with respect to time, having traditionally been studied in the domain of space. As such, the current study is timely and has the potential to be important for our understanding of how time is represented in the brain in the service of memory. The study is well thought out and the behavioural paradigm is, in my opinion, a creative approach to tackling the authors' research question. A particular strength is the implementation of an imagination phase for the participants while learning the fictional religious ritual. This moves the paradigm beyond semantic/schema learning and is probably the best approach besides asking the participants to arduously enact and learn the different events with their exact timings in person. Importantly, the behavioural data point towards successful manipulation of internal vs. external perspective in participants, which is critical for the interpretation of the fMRI data. The use of syllable length as a sanity check for RT analyses as well as neuroimaging analyses is also much appreciated.

      We thank the reviewer for the positive and encouraging comments.

      Suggestions:

      The authors have done a commendable job addressing my previous comments. In particular, the additional analyses elucidating the potential contribution of boundary effects to the behavioural data, the impact of incorporating RT into the fMRI GLMs, and the differential contributions of RT and sequential distance to neural activity (i.e., in PPC) are valuable and strengthen the authors' interpretation of their findings.

      My one remaining suggestion pertains to the potential contribution of boundary effects. While the new analyses suggest that the RT findings are driven by sequential distance and duration independent of a boundary effect (i.e., Same vs. Different factor), I'm wondering whether the same applies to the neural findings? In other words, have the authors run a GLM in which the Same vs. Different factor is incorporated alongside distance and duration?

      We thank the reviewer for their positive evaluation of our previous revisions and are pleased that the additional analyses adequately address the boundary effects in the behavioral data and the RT effects in the neural data.

      With respect to boundary effects in the neural data, we followed the reviewer’s suggestion and constructed a more complex GLM that incorporated the Same/Different part of the day as an additional regressors modulating the target events. Importantly, the same PPC region continued to show an interaction effect between Task Type and Sequential Distance. We have added this important control analysis in our revised manuscript (Pages 13–14):

      “To further assess whether the observed PPC reactivation can be attributed to boundary or chunking effects introduced by the Parts of the Day, as well as other behavioral outputs, we performed an additional control analysis. Using a more complex first-level model, we included two extra regressors modulating the target events in both internal- and external-perspective tasks, alongside Sequential Distance and Duration: (1) Same/Different parts of the day (coded as 1/−1) and (2) Future/Past (coded as 1/−1). Even with these additional controls, the same PPC region remained the strongest area across the entire brain, showing an interaction effect between Task Type and Sequential Distance, although the cluster size was slightly reduced (voxel-level p < 0.001; clusterlevel FWE-corrected p = 0.054).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers for their enthusiasm and insightful suggestions. Our responses to specific concerns and questions are detailed below.

      Public Reviews:

      Reviewer #1 (Public review):

      The authors use Flow cytometry and scRNA seq to identify and characterize the defect in gdT17 cell development from HEB f/f, Vav-icre (HEB cKO), and Id3 germline-deficient mice. HEB cKO mice showed defects in the gdT17 program at an early stage, and failed to properly upregulate expression of Id3 along with other genes downstream of TCR signaling. Id3KO mice showed a later defect in maturation. The results together indicate HEB and Id3 act sequentially during gdT17 development. The authors further showed that HEB and TCR signaling synergize to upregulate Id3 expression in the Scid-adh DN3-like T cell line. Analysis of previously published Chi-seq data revealed binding of HEB (and Egr2) at overlapping regulatory regions near Id3 in DN3 cells.

      The study provides insight into mechanisms by which HEB and Id3 act to mediate gdT17 specification and maturation. The work is well performed and clearly presented. We only have minor comments.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Selvaratnam et al. defines how the transcription factor HEB integrates with TCR signaling to regulate Id3 expression in the context of gdT17 maturation in the fetal thymus. Using conditional HEB ablation driven by Vav Cre, flow cytometry, scRNA-seq, and reanalysis of ChIP-seq data the authors, provide evidence for a sequential model in which HEB and TCR-induced Egr2 cooperatively upregulate Id3, enabling gdT17 maturation and limiting diversion to the ab lineages. The work provides an important mechanistic insight into how the E/ID-protein axis coordinates gd T cell specification and effector maturation.

      Strengths include:

      (1) The proposed model that HEB primes, TCR induces, and Id3 stabilizes gdT17 cells in embryonal development is elegant and consistent with the findings.

      (2) The choice of animal models and the study of a precise developmental window.

      (3) The cross-validation of flow, scRNA-seq, and ChIP-seq reanalyses strengthens the conclusions.

      (4) The study clarifies the dual role of Id3, first as an HEB-dependent maturation factor for gdT17 cells, and as a suppressor of diversion to the ab lineages.

      Weaknesses:

      (1) The ChIP-seq reanalysis indicates overlapping HEB, E2A, and Egr2 peaks ~60 kb upstream of Id3. Given that the Egr2 data are not generated using the same thymocyte subsets, some form of validation should be considered for the co-binding of HEB and Egr2, potentially ChIP-qPCR in sorted gdT17 progenitors.

      We agree that this is a valid concern and continue to work on confirming the mechanism from several other angles. Validating HEB/E2A and Egr2 co-binding in gdT17 cell progenitors by ChIP-qPCR would/will be a very precise and definitive experiment, but it will be very challenging to perform, in part due to the low numbers of gdT17 precursors in the fetal thymus (note the y-axis scales in Fig. 1F, J). As a complementary approach, we have analyzed additional ChIP-seq data for HEB/E2A binding in Rag2<sup>-/-</sup> DN3 cells retrovirally transduced with the KN6 gdTCR cultured with stroma expressing the weak KN6 ligand T10 for 4 days. This analysis revealed that the binding of HEB/E2A on those sites persisted after weak gdTCR signaling, strengthening the likelihood that concurrent binding of HEB/E2A and Egr2 occurs during this developmental transition. We noted that HEB/E2A binding was slightly dampened in Rag2<sup>-/-</sup> DN3 + gdTCR cells relative to Rag2<sup>-/-</sup> DN3 cells, consistent with the induction of Id3 and subsequent Id3-mediated disruption of E protein binding. We also located HEB/E2A and Egr binding sites in close proximity in the two regions that shared peaks between HEB/E2A and Egr2 analyses (HE1 and HE2), in line with the potential participation of these two transcription factors in an enhanceosome binding complex.

      Furthermore, we examined the chromatin landscape of the Id3 locus by sorting WT DN3 and DN4 cells, as well as Rag2<sup>-/-</sup> DN3 cells to provide a genuine pre-selection context, and performing ATAC-seq (Figure 7–suppl 7A). Given the known ability of E2A and HEB to induce chromatin remodeling, we also examined accessibility in DN3 and DN4 cells from HEB cKO mice. Alignment of ATAC-seq and ChIP-seq peaks in the Id3 locus revealed accessibility of HE1 and HE2 in Rag2<sup>-/-</sup>, WT DN3, and WT DN4 cells. However, accessibility of HE1 and HE2 was dampened in HEB cKO cells, especially at the DN3 stage, suggesting that HEB may be involved in remodeling the Id3 locus, resulting in a poised state that enables TCR-dependent transcription factors to induce Id3 proportionally to TCR signal strength. These data are now presented as a new “Figure 7 – figure supplement 1” with corresponding Results, Discussion, and Methods updates.

      Our next story will be focused on a finer dissection of the Id3 cis-regulatory elements and their combinatorial regulation by HEB/E2A and other transcription factors, and how they relate to specific signaling pathways. For this study, we will modify the language regarding Egr2 to reflect the open questions that still remain to be addressed.

      (2) E2A expression is not affected in HEB-deficient cells, raising the question of partial compensation, a point that should be specifically discussed.

      This confounding factor is always an issue with E proteins. We have now added a section to the discussion that highlights previous literature and relates it to our findings.

      (3) All experiments are done at E18, when fetal gdT17 development predominates. The discussion could address whether these mechanisms extend to neonatal or adult gdT17 subsets.

      In our 2017 paper (PMID 29222418) we showed that HEB cKO mice have defects in the production of functional gdT17 cells in fetal and neonatal thymus and in the adult periphery (in lungs and spleen). While the adult thymus does not support the development of fully functional innate gd T cells, it does contain gdTCR+ cells that have activated the Sox-Maf-Rorc network (Yang 2023, PMID 37815917). It will be very interesting to assess the impact of HEB loss on these cells, and we are actively pursuing this goal. For now, we will add a paragraph to the discussion addressing what we know from previous work and what is yet to be learned.

      Reviewer #3 (Public review):

      Summary:

      The authors of this manuscript have addressed a key concept in T cell development: how early thymus gd T cell subsets are specified and the elements that govern gd T17 versus other gd T cell subsets or ab T cell subsets are specified. They show that the transcriptional regulator HEB/Tcf12 plays a critical role in specifying the gd T17 lineage and, intriguingly, that it upregulates the inhibitor Id3, which is later required for further gd T17 maturation.

      Strengths:

      The conclusions drawn by the authors are amply supported by a detailed analysis of various stages of T cell maturation in WT and KO mouse strains at the single cell level, both phenotypically, by flow cytometry for various diagnostic surface markers, and transcriptionally, by single cell sequencing. Their conclusions are balanced and well supported by the data and citations of previous literature.

      Weaknesses:

      I actually found this work to be quite comprehensive. I have a few suggestions for additional analyses the authors could explore that are unrelated to the predominant conclusions of the manuscript, but I failed to find major flaws in the current work.

      I note that HEB is expressed in many hematopoietic lineages from the earliest progenitors and throughout T cell development. It is also noteworthy that abortive gamma and delta TCR rearrangements have been observed in early NK cells and ILCs, suggesting that, particularly in early thymic development, specification of these lineages may have lower fidelity. It might prove interesting to see whether their single-cell sequencing or flow data reveal changes in the frequency of these other T-cell-related lineages. Is it possible that HEB is playing a role not only in the fidelity of gdT17 cell specification, but also perhaps in the separation of T cells from NK cells and ILCs or the frequency of DN1, DN2, and DN3 cells? Perhaps their single-cell sequencing data or flow analyses could examine the frequency of these cells? That minor caveat aside, I find this to be an extremely exciting body of work.

      Excellent question, and the underlying answer is yes, loss of HEB renders the cells more open to divergence to non-T lineages, even at the DN3 stage. Although our datasets did not reveal those cells, we have examined this question previously. In our 2011 paper (Braunstein, 2011, PMID 21189289) where we identified “DN1-like” cells arising from HEB-/- DN3 cells in OP9-DL1 co-cultures. These cells responded to IL-15 and IL-7 by differentiating into cytotoxic NK-like cells. We did not detect TCRb rearrangements but did not look for gdTCR rearrangements. Subsequently, multiple papers from other labs showed that ILC2 were greatly expanded in the thymus using Id-overexpression transgenic mice and HEB/E2A-double deficient mice (Miyazaki, 2023, PMID 28514688; Miyazaki, 2025, PMID 39904558; Berrett, 2019, PMID 31852728; Qian, 2019, PMID 30898894; Peng, 2020, PMID:32817168). The ILCs in these mice had TCRg rearrangements, consistent with a shared origin with WT thymic-derived ILCs. In unpublished data from our lab, we found an increase in the numbers of ILC2 but not ILC3 in HEB cKO fetal thymic organ cultures. We did not follow up on this work any further since the topic was being heavily pursued in other labs, but remain very interested in this branchpoint, and will mention the literature in the discussion.

      Joint recommendations for the authors:

      (1) Experimental validation (for mechanistic clarity)

      The ChIP-seq reanalysis indicates overlapping HEB, E2A, and Egr2 peaks ~60 kb upstream of Id3. Given that the Egr2 data are not generated using the same thymocyte subsets, some form of validation should be considered for the co-binding of HEB and Egr2, potentially ChIP-qPCR in sorted gdT17 progenitors to substantiate the proposed cooperative mechanism.

      See above; new experiments with ATAC-seq and additional ChIP-seq analysis.

      (2) Figures

      Potential inconsistencies in Figure 1H: In the legend to Figure 1H, Vg1-Vg5- cells are considered Vg6+ cells. Flow plots show reduced A Vg1-Vg5- population in HEBc ko mice, but the accompanying bar plot shows increased frequency of Vg6+ cells.

      Vg6 cells are actually considered to be Vg4-Vg5-Vg1- cells (not Vg4- Vg1- cells, which is important in the fetal context). The flow plot shows the percentage of Vg6 cells out of the Vg1-Vg4- population, whereas the bar plot shows the percentage of Vg6 cells out of all gdTCR+ cells. The ratio of Vg6 to Vg5 cells decreases within the Vg1-Vg4- population, whereas the overall percentages and numbers of Vg6 cells in all gd T cells is increased in HEB cKO mice. We have now more clearly explained this in the text and the figure legend.

      Clarify which cells produce IL-17A in Figure 1L.

      This plot is gated on all gd T cells stimulated with PMA/ionomycin; this has been added to the results and figure legend.

      In Supplementary Figure 2, legend, do the authors mean that TRGV4 was depleted? The authors write TRDV4. Please check.

      Thank you for catching this mistake, we have corrected it.

      In Figure 7, the Author showed Id3 mRNA expression. Can the expression of Id2 be included?

      That is a really interesting question, and we will follow up on it in future studies.

      If Id1 or Id4 are relevant for any of these studies, can their expression be shown in Supplementary Figure 3A? If these are minimally expressed or not expressed, this could be mentioned.

      Id1 and Id4 were not detectable in our studies, this is now stated in the results section describing expression of E proteins and Id proteins.

      (3) Discussion

      Discuss possible redundancy between HEB and E2A, as E2A expression appears unaffected in HEB-deficient cells.

      See above

      Address whether the mechanisms identified at E18 (embryonic stage) also apply to neonatal or adult γδT17 subsets.

      See above

      Expand on how HEB function may relate to other hematopoietic or early lymphoid lineages (NK/ILC, DN1-DN3 stages), based on reviewer curiosity.

      See above

      (4) Methods and terminology

      Define the terms γδTe1 and γδTe2 (e.g., early effector subsets).

      This has been defined more clearly in several sections of the text.

      Add details to the scRNA-seq methods section (average number of cells analyzed and sequencing depth per cell).

      These details have been added.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We now performed new experiments that were included in the manuscript. Our new results show that that monocyte-derived dendritic cells primed in vivo during P. chabaudi infection, or in vitro with TNF express high levels or GLUT-1 (Figures 4M, 5D, 6L). Furthermore, our new data show that mice treated with 2-DG (na inhibitor of glycolysis) are more susceptible to infection (Figures 6N, O). In addition, new results of glucose uptake by muscle and adipose tissues were added to the manuscript. Finally, figure legends were revised, densitometric analysis performed, and other issues addressed in the text.

      Please see below a point-by-point reply to the Reviewers’ comments.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript by Kely C. Matteucci et al. titled "Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF-1α axis plays a key role in host resistance to Plasmodium infection" describes that TNF induces HIF-1α stabilization that increases GLUT1 expression as well as glycolytic metabolism in monocytic and splenic CD11b+ cells in P. chabaudi infected mice. Also, TNF signaling plays a crucial role in host energy metabolism, controlling parasitemia, and regulating the clinical symptoms in experimental malaria.

      This paper involves an incredible amount of work, and the authors have done an exciting study addressing the TNF-iNOS-HIF-1α axis as a critical role in host immune defense during Plasmodium infection.

      Reviewer #2 (Public Review):

      Summary:

      The premise of the manuscript by Matteucci et al. is interesting and elaborates on a mechanism via which TNFa regulates monocyte activation and metabolism to promote murine survival during Plasmodium infection. The authors show that TNF signaling (via an unknown mechanism) induces nitrite synthesis, which (via yet an unknown mechanism), and stabilizes the transcription factor HIF1a. Furthermore, HIF1a (via an unknown mechanism) increases GLUT1 expression and increases glycolysis in monocytes. The authors demonstrate that this metabolic rewiring towards increased glycolysis in a subset of monocytes is necessary for monocyte activation including cytokine secretion, and parasite control.

      Strengths:

      The authors provide elegant in vivo experiments to characterize metabolic consequences of Plasmodium infection, and isolate cell populations whose metabolic state is regulated downstream of TNFa. Furthermore, the authors tie together several interesting observations to propose an interesting model.

      Weaknesses:

      The main conclusion of this work - that "Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF1a axis plays a key role in host resistance to Plasmodium infection" is unsubstantiated. The authors show that TNFa induces GLUT1 in monocytes, but never show a direct role for GLUT1 or glucose uptake in monocytes in host resistance to infection (nor the hypoglycemia phenotype they describe).

      We kindly disagree with the Reviewer. There is a series of experiments showing that TNFR KO (Figures 1, 2, 4), HIF1a KO (Figure 5) and iNOS KO (Figure 6) mice have partially impaired inflammatory response and control of parasitemia (Figures Figures 1E, 5G and 6B).

      To further address the issue raised by the reviewer, we performed two sets of experiments. First, we show, in vitro, the impact of TNF stimulation on GLUT1 expression and glucose uptake (Figure 4M, 5D, 6L). Our results show that GLUT1 is increased after 18 hours with TNF (100 ng/mL) stimulation in MODCs from WT mice but not from iNOS KO, HIF1a KO e TNFR KO mice. Similar results were obtained with monocytic cells derived from infected mice (Figure 4L, 5C, 6K). The results support the discussion by demonstrating that TNF stimulation influences GLUT1 expression in monocytic cells. This aligns with the proposed mechanism that TNF signaling regulates HIF-1α stabilization and glycolytic metabolism via RNI. The absence of GLUT1 upregulation and glucose uptake in TNFR KO, iNOS KO and HIF-1α KO mice further reinforces the role of RNI in promoting HIF-1α stabilization, as suggested in the discussion.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Major points

      All Figure legends are not precise about the data express means {plus minus} standard errors of the means (SEM) or SD. Figure 1D shows no SD in the data from the uninfected group. It strongly suggests precise and improving all figure legends, giving more details in terms of including an explanation of all symbols, non-standard abbreviations, error bars (standard deviation or standard error), experimental and biological replicates, and the number of animals, and representative of the independent experiments.

      We apologize for the lack of details in the Figure legends. As requested, we are now indicating whether we used SEM or STDV, number of mice per group, number of replicate experiments. We also clarified the groups that are being compared, and the statistical significance indicated by the symbols. We also standardized symbols as asterisk only, and number of asterisk indicating the significance.

      Figure 1. The figure legend has no information about the organ for which TNF mRNA was measured (Figure 1D). Also, regarding the TNF data, Figure 1 C e 1D shows that the circulating levels of TNF and the expression of TNF mRNA in the liver peaked at the same time point, and after 6h, there is no difference between infected and uninfected mice. It would be expected that the TNF mRNA expression would be detected earlier than the protein, assuming that the primary source of TNF is from the liver. Is there another organ that could mainly source blood TNF levels? Did the authors have a chance to measure the blood TNF levels during infection (0-8dpi), besides the measurement at different times only on day 8?

      We included in the legend of Figure 1D that mRNA was extracted from liver.

      Liver and spleen are the main reservoir of infected erythrocytes and the main source of cytokines during the infection with the erythrocytic stage of malaria. The results presented in Figures 1C and 1D are from in vivo experiments, not a controlled cellular experiment in vitro. So, we can not conclude about exact time and synchronous production of TNF mRNA and protein. We have published earlier that during P. chabaudi infection, the peaks of TNF mRNA expression and the levels of circulating TNF protein occur between midnight and 6 am (Hirako at al., 2018). Hence the results are consistent in the results described here. In addition, this earlier study also shows that the same pattern of TNF at days 6 and 8 post-infection are similar. Furthermore, in another studies, we reported that the peak of TNF production occurs between days 6 and 10 post P. chabaudi infection (Franklin et al, PNAS, 2009; Franklin et al, Microbes and Infection, 2007). This is now clarified in the text (page 05, line 132):

      “As previously demonstrated, the circulating levels of TNF and expression of TNF mRNA in the liver peaked at 6 am (end of dark cycle) at 8 dpi (Figure 1C and 1D), and has been reported to peak between days 6 and 10 post-infection, with a consistent pattern observed on days 6 and 8.”

      Figure 2. "We observed that in naïve animals, all of these parameters were similar in TNFR<sup>-/-</sup> and C57BL/6 mice (Figures 2A-D, top panels, and Figures 2E-H)." Interestingly, the respiratory exchange rate of TNFR<sup>-/-</sup> uninfected mice seems higher in TNFR<sup>-/-</sup> uninfected mice than in naïve uninfected mice, and this pattern seems to be more pronounced in TNFR<sup>-/-</sup> uninfected mice. Is there any suggestion that could explain the change in respiratory exchange rate behavior without infection in those animals?

      At the moment, we have not investigated the basis of this difference between uninfected WT and TNFR KO mice, which goes beyond the scope of this research. This is indeed an interesting observation that should be pursued in the future by our group and elsewhere. We mentioned this difference, when describing the results (page 06, lines 155):

      “We observed that in naïve animals, all of these parameters were similar in TNFR<sup>-/-</sup> and C57BL/6 mice (Figures 2A-D, top panels and Figures 2E-H), with a slightly higher respiratory exchange rate in uninfected TNFR<sup>-/-</sup> mice. In contrast, all the evaluated parameters were decreased in infected C57BL/6 mice compared to their naïve counterparts during the light and dark cycles. When we analyzed only infected mice, the alterations in all parameters were milder in TNFR<sup>-/-</sup> compared to C57BL/6 mice (Figures 2A-D bottom panels and 2E-H).”

      Figure 3. To give an idea of the main population of non-parenchymal cells, it will be helpful to clarify briefly how non-parenchymal cells from the liver of infected or uninfected mice were isolated.

      We described in detail at Material and Methods (Page 19, Lines 566.)

      Figure 3, B, C, D, G and Figure 4K and Figure 5 A and B - Semi-quantitative data through the densitometric analysis of western blots should be included in all figures.

      Thank you for the suggestion. We now included the densitometric analysis for all Western blot results in Supplementary figure.

      Figure 4. The author describes, "We observed that except for Hexokinase-3, the expression of mRNAs of glycolytic enzymes (Hexokinase-1, PFKP, and PKM) was increased in C57BL/6 but not TNFR-/- 8dpi." Sometimes, it is hard to understand which groups have been compared to some data. Be precise in describing the statistical analysis between the groups. It seems that those genes were increased in "infected C57BL/6 in comparison to uninfected mice, but not TNFR-/- 8-dpi. Moreover, even though the authors include statistic symbols "ι, ιι, ιιι" in other legends, there is no explanation about statistic symbols in the legend of Figure 4.

      As mentioned above, we improved the descriptions of all figures in the legend, and when necessary in the main text describing the results.

      Figure 5. The authors describe, "We found that GLUT1 protein and glycolysis (ECAR) was impaired, respectively, in monocytic cells and splenic CD11b+ cells from infected, as compared to uninfected HIF-1aΔLyz2 mice (Figures 5C-5E)." The GLUT-1 expression was inhibited in both cells compared to HIF-1afl/fl mice but not even close to impaired GLUT-1 expression. There is still a robust amount of GLUT-1 expression, and significantly higher when compared to cells from uninfected mice.

      We tuned our statement to partially impaired, indicating that other host or parasite components maybe be also influencing GLUT-1 expression. In fact, we have recently published that IFNγ has also an important role in regulating GLUT1 expression in MO-DCs and this reference is mentioned in the text (page 10, line 291):

      “We found that glycolysis (ECAR) and GLUT1 expression were impaired, though partially, in monocytic and splenic CD11b+ cells from infected HIF-1aΔLyz2 mice (Figures 5C-5E) compared to infected WT mice. The level of GLUT1 expression that is still maintained is likely due to other host or parasite factors, such as IFN-γ (Ramalho 2024).”

      Figure 6. It is essential to have more information about the number of replicates in Figure 6A. However, there are just two dots replicates in the condition CD11b+ splenic cells from C57BL/6 stimulated with or without LPS (purple bars). It is essential to be precise regarding the number of experimental and biological replicates in each experiment and the statistical analysis that has been applied, including this group. Furthermore, the author concludes, "...these data demonstrated that RNI induces HIF-1α expression...." This conclusion needs a more careful description since no data supports that monocytic cells or splenic CD11b+ cells from iNOS-/- infected mice decrease stabilization of HIF-1αm using blotting, as shown in Figure 5 A.

      As mentioned above the number of replicates for each experiment was included in the figure legends.

      Minor Points.

      Figure 3. "Hepatocytes have an important role in glucose uptake from the circulation, and they do this primarily through GLUT2 (38), whose mRNA expression was downregulated (Figure 3A) and protein expression unchanged in response to Pc infection (Figure 4K)." I suggest moving the Figure 4K to Figure 3 to make it easy to follow the data description.

      We thank the reviewer for the suggestion. However, we chose to keep Figure 4K in Figure 4, as this panel includes data from TNF receptor deficient mice, and the analysis of TNF knockout models is first introduced and discussed in Figure 4. For clarity and consistency, we therefore maintained this panel within Figure 4.

      Line 433. Replace iNOS for iNOS-/- mice.

      iNOS is now replaced for iNOS-/- mice.

      Reviewer #2 (Recommendations For The Authors):

      The premise of the manuscript by Matteucci et al. is interesting and elaborates on a mechanism via which TNFa regulates monocyte activation and metabolism to promote murine survival during Plasmodium infection. The authors show that TNF signaling (via an unknown mechanism) induces nitrite synthesis, which (via yet an unknown mechanism), and stabilizes the transcription factor HIF1a. Furthermore, HIF1a (via an unknown mechanism) increases GLUT1 expression and increases glycolysis in monocytes. The authors demonstrate that this metabolic rewiring towards increased glycolysis in a subset of monocytes is necessary for monocyte activation including cytokine secretion, and parasite control.

      The main goal of this work is to study the interplay of TNF/HIF1a/iNOs in the pathogenesis in an experimental model of malaria. To dissect the molecular mechanism by which TNF induces reactive nitrogen species and regulates HIFa expression is beyond the scope of our research. Nevertheless, there is a vast literature addressing these issues. We now include in the discussion a paragraph describing the main conclusion of these studies published previously (page 12, line 363):

      "Previous studies have shown that TNF induces the production of RNI through the upregulation of iNOS via the NF-κB pathway (63, 64). TNF-mediated iNOS expression is critical for NO production, which in turn stabilizes HIF-1α by inhibiting prolyl hydroxylases (PHDs) even under normoxic conditions (58, 59). HIF-1α then upregulates the expression of glycolytic genes, including GLUT1 (22, 62).”

      Major comments

      Issues concerning novelty

      Some of the reported observations are not novel. TNFa and TNFa signaling has been demonstrated to contribute to the release of certain cytokines, and to contribute to the control parasitemia (PMID: 10225939). TNFa has been shown to increase glucose uptake in tissues (PMID: 2589544). There is a textbook about the role of INOS during the pathogenesis of malaria, including its association with parasite control (https://link.springer.com/chapter/10.1007/0-306-46816-6_15). Furthermore, other mechanisms controlling glycemia during Plasmodium infection have been shown (PMID: 35841892). The authors should adequately discuss other papers which have reported some of their findings.

      Thanks for the comments on previously existing literature. We are well aware of some of this earlier literature. Some of these earlier findings are mentioned in our manuscript. We emphasized these fundamental findings in the discussion, as requested (page 12, line 368):

      “TNF has been described as a critical mediator in malaria, driving cytokine release and parasitemia control (PMID: 10225939). It also enhances glucose uptake in tissues, aligning with our findings of increased glycolysis in monocytes (PMID: 2589544). The role of iNOS in malaria is well documented. IFN-γ and TNF induced the production of NO, which inhibits parasite growth but can cause tissue damage and organ dysfunction, especially in severe malaria (Mordmüller et al., 2002). Recent studies also highlight the complexity of glycemia regulation during Plasmodium infection describing its role in modulating parasite virulence and transmission (PMID:35841892). These studies demonstrate the critical function of TNF and iNOS in immune responses against Plasmodium, aligning with our findings of this axis and metabolic rewiring that are essential for monocyte activation and outcome of Pc infection.”

      The authors claim that "Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF1a axis plays a key role in host resistance to Plasmodium infection," and contributes significantly to their effector functions (particularly parasite clearing), and the systemic drop in glycemia observed during Pc infection. Although the authors show that TNFa does result in altered metabolism and increased GLUT1 levels in a subpopulation of monocytes, the evidence that TNFa-induced glylcolysis plays a key role in host resistance is correlative at best.

      This is an important question. We did show that TNFR KO have higher parasitemia. But TNF is pleiotropic cytokine and has multiple roles on innate and acquired immunity. The experiment we have performed and helps to address this issue is the in vivo treatment with 2DG. We found that treatment with this inhibitor of glycolysis results in a increase of parasitemia. These results are now included in Figure 6.

      When considering that the majority of monocytic populations are reduced in frequency and only a small subset (i.e., Monocyte-derived DCs) increase in frequency (Fig 3K) during Pc infection, this makes it very difficult to demonstrate that a cell population whose overall frequency reduces contributes significantly to the drop in glycemia during Pc infection. The authors should therefore include experiments that demonstrate that the inhibition of glycolysis induced by TNFa in monocytes is protective and/or contributes to a decrease in extracellular glucose. The authors could assess the impact of the loss of function of GLUT1 on activated monocytes and monocyte-derived DCs on glycemia upon TNFa stimulation.

      We agree. We focused on monocytes and the derived inflammatory monocytes and MO-DCs. In fact, the frequency of monocytes, considering the inflammatory monocytes and MO-DCs, is increased both in spleen and liver. One interesting result is that the HIF1a Lysm KO mice has impaired metabolism, attenuated hypoglycemia and increased parasitemia (Figure 5). Nevertheless, we agree that our current data thus not proof that the glycemia is due to the consumption of glucose by the activated monocytes, and that these are the only cells with increased glucose consumption. This is now added to the discussion (page 13, line 395):

      "Although the frequency of MO-DCs increases during infection, other cell populations may also contribute to glucose consumption. Further experiments, including the assessment of GLUT1 function in these populations, are needed to clarify their contribution to glucose consumption during infection."

      Furthermore, in the current state of the manuscript, it is unclear how activated monocyte populations uptake glucose. The authors claim that glucose uptake by activated monocytes is GLUT1-dependent, however, glucose transport via GLUT1 is insulin-dependent. Since Plasmodium infection is associated with insulin resistance, and almost unquantifiable levels of insulin (PMID: 35841892), and TNFa itself induces insulin resistance (PMCID: PMC43887), it is unclear how the activated monocyte population uptakes glucose. If the authors consider TNFa to be sufficient for GLUT1 induction, in vitro experiments (TNFa+monocytes) could bolster this claim (and support that GLUT1 is induced in an insulin-independent mechanism.

      There is significant evidences indicating that in contrast to GLUT4, induction of GLUT1 in mice is independent of insulin (PMID: 9801136). In our case, seems to be induced by the cytokines TNF and IFN𝛾(this study and Ramalho et al., 2024). We now performed experiments exposing monocytes to TNF and evaluating GLUT1 expression. The results indicate that monocytes exposed to TNF (100 ng/mL) for 18 hours from WT mice exhibited a significant increase in GLUT1 expression. This increase was comparable to the increased-GLUT1 phenotype observed in infected animals. The results of this experiment were included in the manuscript.

      A text was included to the discussion to clarify the issue of insulin dependence of GLUT1 expression (page 13, line 388):

      “GLUT1 expression is recognized as independent of insulin, in contrast to GLUT4 (PMID: 9801136). In our model, this regulation appears to be driven by pro-inflammatory cytokines, particularly TNF. Supporting this, our results show that in vitro stimulation with TNF, significantly increases GLUT1 expression in monocytes, accordingly to the ex vivo phenotype observed in infected animals.”

      Alternative hypothesis which might explain their phenotypes

      Figure 2 A-H: The metabolic effects of the genetic manipulations including INOS KO, TNFR KO, and HIF-1α∆Lyz2 could be explained by lesser disease morbidity owed to a reduction of inflammatory response during infection. Under this condition, the development of anorexia will not be as profound in the knock-outs compared with wild-type littermate controls, since anorexia of infection is tightly linked to the magnitude of inflammatory response. Accordingly, infected knock-out animals can keep eating, which presumably impacts glycemia, maintenance of core body temperature, and overall energetics of infected mice. The authors should exclude this possibility.

      We consider this possibility and the discussion now elaborates about this alternative hypothesis. We believe, that these two mechanisms are not mutually exclusive (page 16, line 474):

      “Although restored physical activity, food consumption and energy expenditure in knockout mice may contribute to the observed systemic metabolic parameters by altering energy balance, these effects are not mutually exclusive with the TNF-driven, cell-intrinsic metabolic mechanisms described here.”

      Minor comments

      The authors showed increased parasitemia upon TNFR and HIF1a depletion in the LyZ2 compartment. The same was observed upon organismal INOS depletion. This raises the question of whether the TNFHIF-INOS signaling axis is adaptive or maladaptive during Pcc infection. The authors should show host survival in mice lacking TNFR and HIF1a in the LyZ2 compartment, and in mice lacking INOS (presumably, they have these data).

      Despite the fact the various knockout mice have increased parasitemia and signs of disease, they all survive the infection. This is now included in the Figure legends.

      Are the higher tissue glucose levels specific to the liver and the spleen or this is a more general event? Have the authors looked at other organs?

      We now added the results of glucose uptake in the muscle and adipose tissues in figure 2. The fact that the glucose uptake is not increased in muscle and adipose tissue, further suggest that the increased glucose uptake in this model is insulin independent.

      Figure 1F: All core body temperatures are within the physiological range, i.e., >36 degrees C. This makes it unclear why the authors regarded this as hypothermia. The authors should present experiments demonstrating the development of hypothermia in Figure 1F, as they claim this.

      Temperature changes in mouse kept in animal house have been an issue discussed in the field. It is clear, however, that early in the morning (end of active period) mice have torpor. Lower temperature and physical activity.

      In Figure 4, since the authors already suggested that extra-hepatic cells, and not the liver parenchyma, contribute to glucose uptake, the authors should clarify why they analyzed the whole liver in Figure 4, and not extra-hepatic cells. Furthermore, the authors should quantify the hepatic monocytic population in non-infected versus infected wild-type animals.

      The reason we used whole liver, is that the number of non-parenchymal cells obtained from liver is limited for Western blot analysis. We thought that was important to show that expression of GLUT1 was decreased in the liver of TNFR KO mice. Nevertheless, the level of TNFR expression in different cell types in the liver was shown by flow cytometry. In addition, we performed the WB with cells extracted from the spleen, where lymphoid and myeloid cells are more abundant.

      Line 87: Phagocytizing parasitized what?

      This has been corrected in the manuscript.

      Line 111 Define RNI before being used.

      Is there a gender disparity in the TNFR KO phenotype? If yes, the authors should comment about this in their discussion.

      This has been defined and addressed in the manuscript

      Line 192: Did the authors mean 3B??

      In 3M, please plot monocytes from uninfected animals.

      The plot of uninfected animals are now included in Figure 3M

      Line 390 Remove the extra dash in HIF1a.

      Extra dash has been removed.

      Line 397 Define RA

      RA is now defined.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers for their careful reading of our manuscript and for the constructive and insightful feedback. In response, we performed several new experiments and analyses that significantly strengthen the study. First, we addressed the important question of optoLARG recruitment dynamics by generating a new cell line expressing optoLARG-mScarlet3 together with paxillin-miRFP, enabling us to directly quantify the dynamics of the optogenetic activator at focal adhesions and the plasma membrane. Second, we introduced a quantitative modeling framework to analyze RhoA activity dynamics during transient optogenetic stimulation. Using the measured optoLARG kinetics as input, we fitted activation and deactivation parameters for both WT and DLC1 KO cells, revealing a loss of negative feedback regulation in the KO condition. Together, these additions clarify the temporal relationships between optogenetic activation, RhoA signaling, and biosensor responses, and provide a more rigorous, mechanistic interpretation of our data. We rewrote large parts of the discussion section to reflect this new information.

      Below, we provide detailed, point-by-point responses to all reviewer comments.

      Recruitment dynamics optoLARG

      Reviewer #1:

      Public Review:

      For the optogenetic experiments, it is not clear if we are looking at the actual RhoA dynamics of the activity or at the dynamics of the optogenetic tool itself.

      Recommendations for the authors:

      For the transient optogenetic activations at FA and PM, it would be great to have one data set where the optoLARG is fused to a fluorescent protein, for example, mCherry, while FAs would be marked with paxillin-miRFP (by transient transfection to avoid making a new stable cell line). The dynamics of the optogenetic activator should be the same (on and off rates), but it can be possible that the activator is retained at FA for example. Such an experiment would help the understanding of the differential observed dynamics, where several timescales are involved: the dynamics of the opto tool, the dynamics of RhoA itself, and the dynamics of the biosensor.

      We agree with the reviewers, this is an essential control for this manuscript and the cell line will be useful in future studies. We developed a new construct containing with the recruitable SSpB domain tagged in red (optoLARG-mScarlet3) compatible with the iLid system, and paxilin-miRFP to locate the focal adhesions. From previous experiments we know that the anchor part of optoLARG system is distributed evenly across the cell membrane and is not affected by cytoskeletal structures like focal adhesions. As for the recruitable part of the optoLARG system, that translocates from the cytosol to the membrane upon blue light stimulation, we illuminated focal adhesion and non-focal adhesion regions, and quantified optoLARG dynamics. The same scripts were used for automated stimulation and analysis as were used for the rGBD recruitment experiments. We illustrate these results in the new Suppl. Fig S3. We found no significant difference in recruitment dynamics between focal adhesion/non-focal adhesion regions (Fig. S3B). We found the optoLARG dynamics fits well with inverse-exponential during recruitment under blue light stimulation, and exponential decay after blue light stimulation (disassociation phase), consistent with the expected iLID dynamics (Fig S3C). This experiment is described in detail at the end of the section "Optogenetic interrogation of the Rho GTPase flux in WT and DLC1 KO cells" (Lines 303-320). We then went on to use the optoLARG dynamics as input for the models describing RhoA activity dynamics (see next comment). This should help to untangle the measured RhoA dynamics from the dynamics of the optogenetic tool.

      Quantitative analysis RhoA activity dynamics

      Public Review:

      There is no model to analyze transient RhoA responses, however, the quantitative nature of the data calls for it. Even a simple model with linear activation-deactivation kinetics fitted on the data would be of benefit for the conclusions on the observed rates and absolute amounts.

      Recommendations for the authors:

      [...] for the transient optogenetic experiments, it would be great to make a simple model, or at least to fit the curves with an on rate, an off rate, and a peak value. This will clarify the conclusions drawn for the experiments. For example, the authors claim that they observe an increased Rho activation rate in DLC1 KO cells (see sections "Optogenetic interrogation of the Rho GTPase flux in WT and DLC1 KO cells" and "Discussion") but the rate is not well-defined. One can have two curves with the same activation rate but one that peaks higher (larger multiplicative prefactor) and it would resemble the presented data. This being said, the higher deactivation rate in DLC1 KO cells is evident from the data.

      We agree that a quantitative analysis and model would improve our understanding of the data. We fit the activation/deactivation kinetics and provide the values in the chapter "Optogenetic interrogation of the Rho GTPase flux in WT and DLC1 KO cells" (Lines 287-299). We then modeled the RhoA activity dynamics at focal adhesions and at the plasma membrane after transient optogenetic stimulation using a system of ODEs, using the new measurements of optoLARG kinetics as activation input. We find a close fit for the experimental data, with WT following classic Michaelis-Menten dynamics. Interestingly, when fitting the DLC1-KO data with the same model as for WT, the parameter modeling the negative feedback loop (active RhoA recruiting a GAP) is set to zero; in other words, the factor that deactivates RhoA is present at a constant concentration. We added an additional main Figure 5 describing the models and fits, and added a new Results section "Modeling indicates loss of negative RhoA autoregulation in DLC1-KO cells" (Lines 326-378), and also updated the Methods and Discussion section of the paper accordingly. We use the findings to more clearly ground the mathematical terms used to describe our results.

      Error figure 6E

      Recommendations for the authors:

      The scheme presented in Figure 6E is not supported by the data and should be modified. In this scheme, the authors show a strongly delayed peak in control cells versus DCL1 KO cells, whereas in the data the peaks appear to be at similar time points. Similarly, the authors show a strongly decreased rate of activation, whereas the initial rates appear identical in the data.

      The delayed peak we illustrated is an error, we thank the reviewers for catching it. The decreased rate of deactivation and activation, although exaggerated in the scheme, is however present in the data (and is now quantified, see answer above). We updated the figure accordingly (now Fig. 7E in the manuscript).

      Clarification term "signaling flux"

      Recommendations for the authors:

      It would be nice to define more precisely several terms that are used throughout the manuscript. For example, could the authors define what they mean by "signaling flux"? Is it the temporal derivative of the Rho levels? Or the spatial derivative?

      We agree that this was not clear in the previous version of the manuscript. We refer to "signaling flux" as the continuous cycle of RhoA activation by GEFs and inactivation by GAPs, processes that persist even when bulk RhoA activity appears steady, as introduced by Miller & Bement (2009). We now explicitly define "signaling flux" in the abstract (Lines 20-24).

      See: Miller, Ann L., and William M. Bement. "Regulation of cytokinesis by Rho GTPase flux." Nature cell biology 11.1 (2009): 71-77. https://doi.org/10.1038/ncb1814

      Recommendations for the authors:

      Also (see above) it would be nice to define precisely what are the rates: the activation rate is in general the k_on of a reaction scheme, but it will differ from the observed rate given by a biosensor. For example, with a k_on and a k_off the observed rate toward the steady-state will be given by the sum of the activation and deactivation rates. In the manuscript, the authors do not make the distinction between the activation rate with the rate of increase of the biosensor which is confounding for the reader and for the interpretation of the data.

      We update the results section to make this distinction more clear (Lines 288-300), and add a note explicitly highlighting the difference between biosensor signal dynamics and the underlying RhoA activation/deactivation rates (Lines 298-300). In addition, our newly introduced model helps disentangle the combined activation/deactivation rates into distinct GEF and GAP activity parameters.

      Improvements to figure 3

      Minor recommendation:

      In Figures 3 B and D, the stars (statistical differences) are not visible. It would be good to make them bigger or move them above the graphs.

      Thank you! We updated the graphics.

      Other changes

      Additional panel (Figure 5D) showing paxillin intensity does not change after weak optogenetic stimulation, to better illustrate the weak stimulation regime that does not trigger FA reinforcement (contrasting Figure 7). Additional small layout changes to Figure 5.

      Addition of authors that contributed to the revisions

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This study represents an important advance in our understanding of how certain inhibitors affect the behavior of voltage gated potassium channels. Robust molecular dynamics simulation and analysis methods lead to a new proposed inhibition mechanism with strength of support being mostly convincing, and incomplete in some aspects. This study has considerable significance for the fields of ion channel physiology and pharmacology and could aid in development of selective inhibitors for protein targets 

      We are encouraged by this favorable assessment and thank editors and reviewers for their constructive feedback and recommendations. We trust that the revisions made to the manuscript will clarify the aspects that had been perceived to be incomplete.

      Reviewer #1 (Public review):

      Summary: 

      This study seeks to identify a molecular mechanism whereby the small molecule RY785 selectively inhibits Kv2.1 channels. Specifically, it sought to explain some of the functional differences that RY785 exhibits in experimental electrophysiology experiments as compared to other Kv inhibitors, namely the charged and non-specific inhibitor tetraethylammonium (TEA). This study used a recently published cryo-EM Kv2.1 channel structure in the open activated state and performed a series of multi-microsecond-long all-atom molecular dynamics simulations to study Kv2.1 channel conduction under the applied membrane voltage with and without RY785 or TEA present. While TEA directly blocks K+ permeation by occluding ion permeation pathway, RY785 binds to multiple nonpolar residues near the hydrophobic gate of the channel driving it to a semi-closed non-conductive state. This mechanism was confirmed using an additional set of simulations and used to explain experimental electrophysiology data.

      Strengths:

      The total length of simulation time is impressive, totaling many tens of microseconds. The study develops forcefield parameters for the RY785 molecule based on extensive QM-based parameterization. The computed permeation rate of K+ ions through the channel observed under applied voltage conditions is in reasonable agreement with experimental estimates of the singlechannel conductance. The study performed extensive simulations with the apo channel as well as both TEA and RY785. The simulations with TEA reasonably demonstrate that TEA directly blocks K+ permeation by binding in the center of the Kv2.1 channel cavity, preventing K+ ions from reaching the SCav site. The conclusion is that RY785 likely stabilizes a partially closed conformation of the Kv2.1 channel and thereby inhibits the K+ current. This conclusion is plausible given that RY785 makes stable contact with multiple hydrophobic residues in the S6 helix. This further provides a possible mechanism for the experimental observations that RY785 speeds up the deactivation kinetics of Kv2 channels from a previous experimental electrophysiology study.

      Weaknesses:

      The study, however, did not produce this semi-closed channel conformation and acknowledges that more direct simulation evidence would require extensive enhanced-sampling simulations. The study has not estimated the effect of RY785 binding on the protein-based hydrophobic pore constriction, which may further substantiate their proposed mechanism. And while the study quantified K+ permeation, it does not make any estimates of the ligand binding affinities or rates, which could have been potentially compared to the experiment and used to validate the models. 

      As stated in the original manuscript, we concur that the mechanism we propose remains hypothetical until further studies of the complete conformational cycle of the channel are conducted. The recently determined structure of a Kv2.1 channel in the closed state (Mandala and MacKinnon, PNAS 2025) presents an excellent opportunity to do so. Indeed, a cursory analysis of that structure shows that a Pro-Ile-Pro motif in helix S6 marks the position of the intracellular gate, where the pore domain constricts maximally (aside from the selectivity filter). As illustrated in Fig. 5, this motif is precisely where the benzimidazole and thiazole moieties of RY785 bind in our simulations. The mechanism we outline in Fig. 7 thus seems very plausible, in our view; that is RY785 occludes the K<sup>+</sup> permeation pathway before the pore domain reaches the closed conformation, explaining the observed electrophysiological effects (see Discussion). The Discussion has been revised to note the recent discovery of the aforementioned structure, its implications for the mechanism we propose, and the opportunities for further research that are now open.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, Zhang et al. investigate the conductivity and inhibition mechanisms of the Kv2.1 channel, focusing on the distinct effects of TEA and RY785 on Kv2 potassium channels. The study employs microsecond-scale molecular dynamics simulations to characterize K+ ion permeation and compound binding inhibition in the central pore. 

      Strengths:

      The findings reveal a unique inhibition mechanism for RY785, which binds to the channel walls in the open structure while allowing reduced K+ flow. The study also proposes a long-range allosteric coupling between RY785 binding in the central pore and its effects on voltage-sensing domain dynamics. Overall, this well-organized paper presents a high-quality study with robust simulation and analysis methods, offering novel insights into voltage-gated ion channel inhibition that could prove valuable for future drug design efforts.

      Weaknesses:

      (1) The study neglects to consider the possibility of multiple binding sites for RY785, particularly given its impact on voltage sensors and gating currents. Specifically, there is potential for allosteric binding sites in the voltage-sensing domain (VSD), as some allosteric modulators with thiazole moieties are known to bind VSD domains in multiple voltage-gated sodium channels (Ahuja et al., 2015; Li et al., 2022; McCormack et al., 2013; Mulcahy et al., 2019).

      As noted in the manuscript, we designed our simulations to explore the possibility that RY785 binds within the pore domain, because TEA and RY785 are competitive and TEA is known to bind within the pore. That RY785 did in fact spontaneously and reproducibly bind within the pore was however not a predetermined outcome; if the site of interaction for the inhibitor was elsewhere in the channel, the simulation would not have shown a stable associated state, which would have prompted us to examine other possible sites, including the voltage sensors. It was also not predetermined or foreseeable a priori that the mode of interaction we observed in simulation provides a straightforward rationale for the electrophysiological effects of RY785. Based on our results, therefore, we believe that RY785 binds within the pore of Kv2. As stated by the reviewer, other allosteric modulators are known to bind instead to the sensors; to our knowledge, however, there is no precedent of a small-molecule inhibitor that simultaneously acts on the sensors and the pore domain. We therefore believe that future studies should focus on corroborating or refuting the mechanism we propose, through additional experimental and computational work; if, contrary to our claim, RY785 is found not to bind to the pore domain, it would be logical to explore other possible sites of interaction, as the reviewer suggests. The Discussion has been modified to address this point.

      (2) The study describes RY785 as a selective inhibitor of Kv2 channels and characterizes its binding residues through MD simulations. However, it is not clear whether the identified RY785-binding residues are indeed unique to Kv2 channels.

      To clarify this question, we have included a multiple sequence alignment as Supplementary Figure 1; the revised manuscript refers to this figure in the Discussion section. The alignment reveals that the cluster of residues forming contacts with RY785 (Val409, Pro406, Ile405, Ile401, and Val398) is indeed specific to Kv2.1. Among Kv channels, Kv3.1 and Kv4.1 exhibit the greatest similarity to Kv2.1 at these positions, but they differ in a crucial substitution: Ile405 in Kv2.1 is replaced by Val. This replacement shortens the sidechain, undoubtedly reducing the magnitude of the hydrophobic interaction between inhibitor and channel (Val is approximately 6 kcal/mol, i.e. 1,000 times, more hydrophilic than Ile). Kv5.1 differs from Kv2.1 at two positions: Pro406 is replaced by His, and Val409 by Ile. The introduction of His abolishes the hydrophobic interaction at that position, and the need for hydration likely perturbs all adjacent contacts with RY785. Lastly, Kv6-Kv10 and Cav channels feature entirely different residues at these positions. Consistent with these findings, a recent study by the Sack lab (https://elifesciences.org/articles/99410) has demonstrated that Kv5, Kv6, Kv8, and Kv9 pore subunits confer resistance to RY785, while a high-throughput electrophysiological study carried out by Merck (Herrington et al., 2011) reported that RY785 shows no significant activity against Cav channels. The sequence alignment offers a simple interpretation for these experimental observations, namely that RY785 is recognized by Kv2 channels through the abovementioned hydrophobic cluster within the pore domain.

      (3) The study does not clarify the details, rationale, and ramifications of a biasing potential to dihedral angles.

      We refer the reviewer to published work, for example Stix et al, 2023 and Tan et al, 2022. We provide additional comments below.

      (4) The observation that the Kv2.1 central pore remains partially permeable to K+ ions when RY785 is bound is intriguing, yet it was not revealed whether polar groups of RY785 always interact with K+ ions.

      We detected no persistent specific interactions between RY785 and the permeant K+ ions.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      The manuscript describes atomistic molecular dynamics (MD) simulations of a voltage-gated potassium channel Kv2.1 using its cryo-EM structure in the open activated state and its inhibition by a classical non-specific cationic blocker tetraethylammonium (TEA) as well as a novel selective inhibitor RY785. Using multi-microsecond-long all-atom MD runs under the applied membrane voltage of 100 mV the authors were able to confirm that the channel structure represents an open conducting state with the computed single-channel conductance lower than experimental values, but still in the same order of magnitude range. They also determined that both TEA and RY785 bind in the channel pore between the cytoplasmic hydrophobic gate and narrow selectivity filter (SF) region near the extracellular side. However, while TEA directly blocks a knock-on K+ conduction by physically obstructing ion access to the SF, the mechanism of action of RY785 is different. It does not directly prevent K+ access to the SF but rather binds to multiple residues in the hydrophobic gate region, which effectively narrows a pore and drives the channel toward a semi-closed nonconductive conformation, which might be distinct from one with the deactivated voltage sensors and closed pore observed at hyperpolarized membrane potentials. However, additional studies beyond the scope of this work might be needed to fully establish this mechanism as suggested by the authors.

      The manuscript is written very well and represents a significant advance in the field of ion channel research. I do not have any major issues, which need to be addressed. However, I have several suggestions.

      For the apo-channel K+ conduction MD simulation under the applied voltage, the authors seem to observe mostly a direct or Coulomb knock-on mechanism across the SF with almost no water copermeation. This is in line with computational electrophysiology studies with dual membrane setup by B. de Groot and others but in disagreement with multiple previous studies by B. Roux and others also using applied electric field and CHARMM force fields as in the present study. I wonder why the outcomes are so different. Is it related to the Kv2.1 channel itself, a relatively small applied electric field used (corresponding to a membrane potential of 100 mV vs. 500-750 mV used in many previous simulations), ion force field (e.g., LJ parameters), or some other factors? Could weak dihedral restraints on the protein backbone and side chains contribute to this mechanism? I also wonder if the authors might have considered different initial SF ion configurations. Related to that, I wonder if the authors observed any SF distortions in their simulations including frequently observed backbone carbonyl flipping and/or dilation/contraction.

      We are aware of these discrepancies between published simulation studies, but cannot offer a satisfactory explanation, beyond speculation. The reviewer is correct that the mechanism of ion permeation we observe is comparable to that reported by de Groot, as we noted in Tan et al, 2022 and Stix et al, 2023. Neither in this nor in those previous studies did we observe any persistent distortions of the selectivity filter – but that outcome was expected by construction. The weak biasing potentials acting on the mainchain dihedral angles allow for local fluctuations but not a persistent deformation, relative to the conductive form determined experimentally.

      For MD simulations with the ligand present, I wonder if the authors can comment on the effect of the ligand especially RY785 on the pore size or more importantly size of the hydrophobic gate. The presence of the ligand itself would definitely result in a narrower pore, but I also wonder if this would also lead to a rearrangement of pore sidechain and/or backbone residues, which would lead to a narrower pore from a protein itself thus confirming the proposed mechanism of driving the channel towards a semi-closed state. It is easy to compute but I wonder if the presence of weak dihedral restraints may preclude this analysis.

      Yes, while the simulation design used in this study allows for local fluctuations in the mainchain structure and nearly unrestricted sidechain dynamics, changes in either the secondary or tertiary structure of the channel are strongly disfavored. This approach is thus sufficient to examine ligand binding or ion flow in the microsecond timescale but not channel gating. In the revised version of the Discussion, we outline a roadmap for future computational studies of that gating process, on the basis of the open-channel structure we used and the recently determined structure of the closed state.

      The authors state that RY785 does not block K+ ion, but it does significantly slow the rate of K+ ion access to the pore Scav site. Is this not a part of the mechanism for inhibition of the channel? The authors seem to focus on the primary mechanism of inhibition as the RY785 promoting channel closing, but would it not also reduce K+ current in the open state by slowing the rate of K+ entry into the cavity and selectivity filter? The authors should address this point in the text. I am also somewhat confused that in the MD simulations performed by the authors, there is still some K+ conduction with RY785 in the pore, which is not in 100% agreement with electrophysiology experiments. Does it mean that the channel in the simulations has not yet reached that semiclosed state or a reduced K+ conduction is not observed experimentally?

      The salient experimental observation is RY785 abrogates K+ currents through Kv2 channels (Herrington et al, 2011; Marquis et al, 2022). In our view, that observation can be explained in one of two ways: either RY785 completely blocks the flow of K+ ions across the channel while the pore domain remains in the conductive, open state – like TEA does – or RY785 induces or facilitates the closing of the channel, thereby abrogating K+ flow. The fact that we observe K+ flow while RY785 is bound to the channel is therefore not in disagreement with the electrophysiological measurements, but it does rule out the first of those two possible interpretations of the existing experiments. As it happens, the second possible explanation, i.e. that RY785 facilitates the closing of the pore domain, also provides a rationale for another puzzling experimental observation, namely that RY785 shifts the voltage dependence of the currents produced by the voltage sensors as they reconfigure to open or close the intracellular gate.

      Also, I wonder if the authors considered that since there are 4 potential equivalent sites in the pore (although, overlapping) more than one RY785 might be needed to prevent K+ conduction, even though the experimental Hill coefficient of ~1 does not indicate cooperativity.

      Admittedly, our simulation design was based on the premise that only one RY785 molecule might be recognized within the pore. Based on the outcome of the simulations, we are confident that this assumption was valid, as the binding pose that we identified rules out multiple occupancy – which would be indeed consistent with a Hill coefficient of ~1.

      I also wonder if the authors considered estimating ligand binding affinities and/or "on" rates from their simulations to have a more direct comparison with experiments and test the accuracy of their models. There are multiple enhanced sampling techniques allowing to do that, although it can be a study on its own.

      We thank the reviewer for this suggestion, which we will consider for future studies.

      The authors also discussed that they could not study Kv2.1 deactivation in a reasonable simulation time. Indeed it is very challenging but they should cite previous studies e.g. 2012 Jensen et al paper (PMID: 22499946) on this subject. There are structures of Kv channels with the deactivated voltagesensing domains (VSDs) available, e..g of EAG1 channel (PDB 8EP1), although they do not have a domain-swapped architecture. There are structural modeling approaches including AlphaFold, which can be potentially used to get a Kv2.1 structure with deactivated VSDs, and targeted MD, string method etc. can be used to study transition between different states with and without bound ligands.

      As noted, a structure of a Kv2 channel with a closed pore has now been determined experimentally. In the revised Discussion, we comment on what this structure tells us about the mechanism of inhibition we propose, and how it could be leveraged in future studies.

      The authors should be commended for doing a thorough QM-based force field parameterization of RY785. However, a validation of the developed force field parameters is lacking. In terms of QM validation, a gas-phase dipole moment can be compared in terms of direction and magnitude (it's normal to be overestimated to implicitly reflect solvent-induced polarization). If there are any experimental data available for this compound, they can be tested as well.

      We agree with the reviewer that forcefield validation is important, but to our knowledge no experimental data exists for RY785 to compare with, such as hydration free energies. We did however compare the gas-phase dipole moment computed with QM and with the MM forcefield we developed based on atomic charges optimized to reproduce QM interactions with water. The MM model yields a gas-phase dipole moment of 3.94 D, which is 20% greater than the QM dipole moment, or 3.23 D. That deviation is within the typical range for electroneutral molecules (Vanommeslaeghe et al, 2010), and as the reviewer notes, reflects the solvent-induced polarization implicit in the derivation of atomic charges. As shown in Author response image 1, the orientation of the dipole moment calculated with MM (right, blue arrow) is also in good agreement with that predicted with QM (left)

      Author response image 1.

      (1) p. 3 "the last two helices in each subunit" -> "the last two transmembrane helices in each subunit".

      Thanks. Corrected.

      (2) p. 5 "and therefore do not cause large density variations e.g. 100-fold or greater.". I would be more specific here and indicate what are the actual variations in density or free energy encountered and how they are compared e.g. with thermal fluctuations (~kT).

      Thanks. The exact variations in K+ density had been included in the original manuscript, in Fig. 2C, but we failed to refer to this figure at this point in the description of the results. The ion density is plotted in a log scale to facilitate conversion to free-energy units. Corrected.

      (3) p. 6 Figure 1 caption "and along the perpendicular to the membrane" -> "perpendicular to the membrane normal"?. "The channel is an assembly of four distinct subunits (in colors);" -> "The channel is an assembly of four identical subunits (distinct by colors);". I would use the same protein coloring method in panels B and C as was used in panel A.

      Thanks. Corrected as needed.

      (4) p. 6 Figure 2 In panel B I would appreciate a representative complete ion permeation event trace. In panel C caption I would indicate corresponding sites "S0-S4, Scav" for each residue mentioned. I also would not use gray color for site names in the figure.

      We appreciate the suggestion, but believe the figure is clear as is. Panel B is meant to focused on the mechanism of knock-on. Panel A includes numerous complete permeation events. 

      (5) p. 7 Figure 3 caption. Please indicate which atoms of residues T373 and P406 were used to define SF and gate positions. Chemical structures of both TEA and RY785 would be useful. In panels C and F channel interacting residues (if any) would be helpful to show.

      The revised caption clarifies that the positions of T373 and P406 are represented by their carbonalpha atoms. A close-up view of the structures of TEA and RY785 is included in the Supplementary Information section.

      (6) p. 8. Figure 4 caption. Please indicate if N atoms ere used for density maps in panels B and C, and which value of the density was used to show meshes. In panel A please indicate what are the units of the density shown by color maps. 

      The caption has been revised to clarify these questions.

      (7) p. 9 "inside the protein" -> "inside the channel pore".

      Thanks. Corrected.

      (8) p. 10 "which lines the cavity" -> "which lines the water-filled cavity"

      We appreciate the suggestion but believe the wording is clear as is.

      (9) p.10 Fig. 5. It would be helpful to distinguish residues from different chains e.g. by different colors rather than using different colors for different residues. The S atom in RY785 is hard to recognize due to the yellow color used for C atoms. Figure 5B is very confusing. It is not clear what this plot represents. For instance, what does it mean that Pro405 has ~10 contacts in 20% of simulation snapshots? Does it mean 10 C..C/S interactions within 4.5 A? I am not sure what the value of this is. I think a bar or radar chart plot showing % of contacts with one, two, or more residues of each type would be more helpful. 

      Thanks. The revised caption ought to clarify how to interpret the plot.

      (10) p. 12 "Due to its 2-fold molecular symmetry". TEA has a tetrahedral point group or Td symmetry. It has several two-fold rotational axes though. 

      Thanks. Corrected.

      (11) p. 12 "it prevents K+ ions in the cytoplasmic space from destabilizing the K+ ions that reside in the selectivity filter" I am not sure if this statement is entirely accurate as there might be destabilization of a multi-ion SF configuration not ions per see.

      We believe this statement is clear as is.

      (12) p. 13 Fig. 7 caption "includes non-conductive or transiently inactivated states" - I am not sure what "transiently inactivated state" is as inactivation is a specific term used in ion channel research and it does not seem to be explicitly considered in this study.

      A reference has been included in the caption for readers interested in the process of inactivation.

      (13) p. 14 "the net charge of these constructs is thus zero". This would depend on the number of basic and acidic residues in the protein. 

      Yes, it does – and as a result the construct we model has a net zero charge.

      (14) p. 14 I wonder if the protein was constrained or heavily restrained during MARTINI membrane building and equilibration procedure. Otherwise, C-alpha mapping would be problematic and clashes with lipid membrane atoms might take place as well.

      It was indeed. When a protein is simulated using the MARTINI coarse-grained forcefield, its fold must be preserved through a network of strong ‘virtual’ bonds between adjacent carbon-alpha atoms. This is standard practice so we do not believe it requires further explanation.

      (15) p. 15 PME - please spell out and provide reference.

      Corrected.

      (16) p. 15 "with a smooth switching function" - is it a special or standard switching function? Also, was it used for energy or forces? 

      The switching function brings both forces and energies to a value of zero at the cut-off value, smoothly. We refer the reviewer to the NAMD manual for further details.

      (17) p. 15 '𝑘 = 1 𝑘B𝑇.' Please confirm that there is a factor of "1" there, which can be actually skipped if this is the case. 

      The value of k = 1 KBT is correct.

      (18) p. 15. Please cite PMID: 22001851 for the transmembrane electric field application technique.

      Corrected.

      (19) p. 15 "and CHARMM36m" -> "and CHARMM36m force field". 

      Corrected.

      (20) p. 16 "the four proteins subunits" -> "the four protein subunits". 

      Corrected.

      (21) p. 16. Please provide the reference for CGenFF. It's reference 49. 

      Corrected.

      Supporting Information (SI): CGenFF is misspelled in multiple figure captions in the SI. All potential energy scans indicate "angle", but some are bond angles while others are dihedral angles. Using subscripts for atom numbers is confusing and does not match the numbering scheme used in Fig. S1. So, please use the same style of numbering throughout, e.g. C46-C42-N43 (without subscripts). Please label the X and Y axes in Figsures S2-S19 and S21. In Figure S22 please perform a linear regression analysis and/or compute Pearson correlation coefficients and indicate trend lines. Table S1. It would be good to compute RMS or mean unsigned errors to get an idea about accuracy. Also, please indicate if reference QM values were scaled by 1.16 for energies or offset for distances. 

      The Supplementary Information has been corrected. We thank the reviewer for their detailed feedback. 

      Reviewer #3 (Recommendations for the authors):

      (1) The study needs to consider the possibility of multiple binding sites for RY785, particularly given its impact on voltage sensors and gating currents. Specifically, the potential for allosteric binding sites in the voltage-sensing domain (VSD) should be assessed, as some allosteric modulators with thiazole moieties are known to bind VSD domains in multiple voltage-gated sodium channels (Ahuja et al., 2015; Li et al., 2022; McCormack et al., 2013; Mulcahy et al., 2019). Molecular docking and/or MD simulations could quickly test this hypothesis. If this hypothesis is not true, a comprehensive search can exclude such a possibility, which can also confirm the long-range allosteric coupling between RY785 binding in the central pore and voltage-sensing domain dynamics. 

      Please see our response above.

      (2) The authors describe RY785 as a selective inhibitor of Kv2 channels and characterize its binding residues through MD simulations. To support this claim, Figure 5 needs to include a multiple sequence alignment with other Kv channels. This would help demonstrate whether the identified RY785-binding residues are indeed unique to Kv2 channels.

      Please see our response above.

      (3) The study applies a biasing potential to 𝜙, 𝜓, and 𝜒1 dihedral angles. Please clarify:

      (a) Is this potential solely to prevent selectivity filter collapse/degradation, as mentioned in a previous D. E. Shaw Research publication (Jensen et al., 2012)?

      Yes, that is correct.

      (b) If it applies to all amino acids, can this potential prevent other changes, such as in the voltagesensing domain?

      Yes, that is correct.

      (c) What specific "large-scale structural changes" does this potential preclude? 

      For example, it would preclude the spontaneous degradation of the secondary or tertiary structure of the protein. We have revised the Methods section to make these points clearer. 

      (d) Given that such biasing potentials on backbone dihedral angles can decrease conformational flexibility, and considering that Kv channel permeability/conductivity could be highly sensitive to filter flexibility, what insights can you provide about the impact of the force constant k on channel conductivity?

      In previous studies based on an identical methodology (Stix et al, 2023; Tan et al, 2022), we have observed good agreement between calculated and experimental conductance values – at least as good as can be hoped for, when all approximations are considered. Based on the data presented in those studies, we have no reason to believe our methodology inhibits the permeability of the channel, which is logical as the local structural fluctuations required for K+ flow across the selectivity filter are not impaired, by definition. To the contrary, the fact that these weak biasing potentials make the conductive form of the filter the most favorable state in simulation enable a clear-cut analysis of conductance under plausible simulation conditions, both in terms applied voltage and K+ concentration. We refer the reviewer to the abovementioned studies for further details and a discussion of this subject.

      (4) The observation that the Kv2.1 central pore remains partially permeable to K+ ions when RY785 is bound is intriguing. Given the compact nature of the central cavity when RY785 is bound, it would be valuable to investigate whether polar groups of RY785 (e.g., nitrogens from the amide, benzimidazole, and thiazole moieties) always interact with K+ ions. Characterizing these interactions could inform the design of similar compounds with differential modulation effects.

      We examined this possibility and detected no convincing interaction patterns between RY785 and K+ ions – logically, inhibitor and ions are in close proximity while residing concurrently within the pore, but we detected no evidence of specific interactions.

      Minor points:

      It is strongly recommended that the refined force field parameters for RY785 be shared as a separate supplementary file in CHARMM force field format. This addition would be valuable for the scientific community, allowing other researchers to use or compare these parameters in future studies.

      We agree entirely. Upon publication of the VOR for this article the forcefield parameters for RY785 will be made freely available for download at https://github.com/Faraldo-Gomez-Lab-atNIH/Download.

      The study uses a KCl concentration of 300 mM, which exceeds typical intracellular K+ levels. While this may be intentional to enhance K+ permeation probability, a brief justification for this choice should be included in the Methods section.

      Yes, what motivated this choice in this and in our previous studies of K+ channels was the expectation of a greater number of permeation events, for a given simulation length, and therefore greater confidence (i.e. statistical significance) in the observed ion conductance, or in the degree to which it might be inhibited by a blocker. It worth noting that 300 mM KCl, while atypical in the intracellular environment, is often used in electrophysiological studies. The Methods section has been amended to clarify this point.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Persistence is a phenomenon by which genetically susceptible cells are able to survive exposure to high concentrations of antibiotics. This is especially a major problem when treating infections caused by slow growing mycobacteria such as M. tuberculosis and M. abscessus. Studies on the mechanisms adopted by the persisting bacteria to survive and evade antibiotic killing can potentially lead to faster and more effective treatment strategies.

      To address this, in this study, the authors have used a transposon mutagenesis based sequencing approach to identify the genetic determinants of antibiotic persistence in M. abscessus. To enrich for persisters they employed conditions, that have been reported previously to increase persister frequency - nutrient starvation, to facilitate genetic screening for this phenotype. M.abs transposon library was grown in nutrient rich or nutrient depleted conditions and exposed to TIG/LZD for 6 days, following which Tnseq was carried out to identify genes involved in spontaneous (nutrient rich) or starvationinduced conditions. About 60% of the persistence hits were required in both the conditions. Pathway analysis revealed enrichment for genes involved in detoxification of nitrosative, oxidative, DNA damage and proteostasis stress. The authors then decided to validate the findings by constructing deletions of 5 different targets (pafA, katG, recR, blaR, Mab_1456c) and tested the persistence phenotype of these strains. Rather surprisingly only 2 of the 5 hits (katG and pafA) exhibited a significant persistence defect when compared to wild type upon exposure to TIG/LZD and this was complemented using an integrative construct. The authors then investigated the specificity of delta-katG susceptibility against different antibiotic classes and demonstrated increased killing by rifabutin. The katG phenotype was shown to be mediated through the production of oxidative stress which was reverted when the bacterial cells were cultured under hypoxic conditions. Interestingly, when testing the role of katG in other clinical strains of Mab, the phenotype was observed only in one of the clinical strains demonstrating that there might be alternative anti-oxidative stress defense mechanisms operating in some clinical strains.

      Strengths:

      While the role of ROS in antibiotic mediated killing of mycobacterial cells have been studied to some extent, this paper presents some new findings with regards to genetic analysis of M. abscessus susceptibility, especially against clinically used antibiotics, which makes it useful. Also, the attempts to validate their observations in clinical isolates is appreciated.

      Weaknesses:

      Amongst the 5 shortlisted candidates from the screen, only 2 showed marginal phenotypes which limits the impact of the screening approach.

      We appreciate the reviewer’s comments, but we note that 4 out of 5 genes displayed phenotypes concordant with findings of the Tn-Seq data, with katG and pafA, as well as MAB_1456c (during starvation only) and blaR (in rich media only) having decreased survival as shown in Figure 3A-D. We do agree that some of the phenotypes were more modest in a single-mutant context than in the pooled Tn-Seq screen. In addition, several mutants that had modest changes in survival also showed profound defects in resuming growth after removal of antibiotics, with the pafA mutants particularly impaired. (Figure 3 - figure supplement 1).

      While the role of KatG mediated detoxification of ROS and involvement of ROS in antibiotic killing was well demonstrated, the lack of replication of this phenotype in some of the clinical isolates limits the significance of these findings.

      While the role of katG varied among strains, the antibiotic-induced accumulation of ROS was seen in all three strains (Figure 6A). This suggests that in some strains other ROS-detoxification pathways are able to compensate for the loss of katG.

      (Figure 2—figure supplements 1–3)

      Figure 1—figure supplement 1.

      Reviewer #2 (Public review):

      Summary:

      The work set out to better understand the phenomenon of antibiotic persistence in mycobacteria. Three new observations are made using the pathogenic Mycobacterium abscessus as an experimental system: phenotypic tolerance involves suppression of ROS, protein synthesis inhibitors can be lethal for this bacterium, and levofloxacin lethality is unaffected by deletion of catalase, suggesting that this quinolone does not kill via ROS.

      Strengths:

      The ROS experiments are supported in three ways: measurement of ROS by a fluorescent probe, deletion of catalase increases lethality of selected antibiotics, and a hypoxia model suppresses antibiotic lethality. A variety of antibiotics are examined, and transposon mutagenesis identifies several genes involved in phenotypic tolerance, including one that encodes catalase. The methods are adequate for making these statements.

      Weaknesses:

      The work can be improved by a more comprehensive treatment of prior work, especially comparison of E. coli work with mycobacterial studies.

      Moreover, the work still has some technical issues to fix regarding description of the methods, supplementary material, and reference formating.

      See detailed responses below.

      Overall impact: Showing that ROS accumulation is suppressed during phenotypic tolerance, while expected, adds to the examples of the protective effects of low ROS levels. Moreover, the work, along with a few others, extends the idea of antibiotic involvement with ROS to mycobacteria. These are fieldsolidifying observations.

      Comments on revisions:

      The authors have moved this paper along nicely. I have a few general thoughts.

      It would be helpful to have more references to specific figures and panels listed in the text to make reading easier.

      Text modified to add more figure references.

      (1) I would suggest adding a statement about the importance of the work. From my perspective, the work shows the general nature of many statements derived from work with E. coli. This is important. The abstract says this overall, but a final sentence in the abstract would make it clear to all readers.

      We appreciate the suggestion and have added a line to the abstract.

      (2) The paper describes properties that may be peculiar to mycobacteria. If the authors agree, I would suggest some stress on the differences from E. coli. Also, I would place more stress on novel findings. This might be done in a section called Concluding Remarks. The paper by Shee 2022 AAC could be helpful in phrasing general properties.

      We have added mention of this in the discussion (lines 354-356).

      (3) Several aspects still need work to be of publication quality. Examples are the materials table and the presentation of supplementary material. Reference formatting also needs attention.

      We respond to the specific details below.

      Reviewer #3 (Public review):

      Summary:

      The manuscript demonstrates that starvation induces persister formation in M. abscesses.

      They also utilized Tn-Seq for the identification of genes involved in persistence. They identified the role of catalase-peroxidase KatG in preventing death from translation inhibitors Tigecycline and Linezolid. They further demonstrated that a combination of these translation inhibitors leads to the generation of ROS in PBS-starved cells.

      Strengths:

      The authors used high-throughput genomics-based methods for identification of genes playing a role in persistence.

      Weaknesses:

      The findings could not be validated in clinical strains.

      Comments on revisions: No more comments for the authors.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors are strongly encouraged to check the references. There is some systematic error in the citations of references. Started to list but then they were too many.

      For example Ln 51, Ref #11 cited, should be #10. Ln 59, #18 is wrongly cited. Should be - Ln 104. Ref #27 wrongly cited.

      Ref #26 and #28 identical.

      Even in discussion section a lot of references are mis-cited.

      We very much appreciate the reviewer catching this issue with the import of our references and we have corrected this.

      Reviewer #2 (Recommendations for the authors):

      Below I have listed comments on specific issues that I hope are useful during revision.

      Line 21 population is singular

      Text modified

      Line 21 comma after antibiotic (subordinate clause) Line

      Text modified

      25 is how singular?

      Text modified

      Impression of abstract: the work seems to confirm and therefore generalize concepts derived from studies with E. coli. If the authors agree, such a statement would be appropriate as a final sentence. I would also look for novel features to stress in the abstract.

      Line 41 this challenge is vague

      Text modified

      Line 43 comma such as (also comma at the end of the parenthetical statement). This type of comma error is common throughout the manuscript and slows reading.

      Text modified

      Line 60 paradoxically. Is this the best concept? Or is it the natural effect of evolution (assuming that mycobacteria or their ancestors were exposed to environmental antibiotics)?

      It is certainly problematic for clearing infection.

      Text not modified.

      Line 63 highlighted uncertainties ... meaning is unclear especially since you may have changed what "model" is referring to.

      Text modified

      Line 66 models.... Do you really mean systems? Models of what?

      This refers to mechanistic models. Text not modified.

      Line 67 arrest cell division. This is written as if it were true. Does the evidence point specifically to cell division or perhaps more accurately suppression of metabolism (see Ye et al 2025 mBio).

      Both have been postulated as important. Text modified to add concept of metabolism

      ... targeted by antibiotics non-essential... Do you think that antibiotics work by inactivating essential targets? That seems overly simplistic, as lethal action is more likely the metabolic response to the damage caused. By the end of the paragraph you come around to this view, but you have already misdirected the reader. The reader is not sure what to believe. Line 70 note that there are many inhibitors of transcription and translation that only block growth, they do not rapidly kill cells

      There can be both direct, and indirect secondary killing mechanisms. We devote a significant portion of the Discussion section to this topic.

      Line 71 debate. There was indeed a debate, but reference 22 is not a valid citation for this. I think you mislead the reader by not accurately describing the debate. It was basically about the inability of Kim Lewis and James Imlay to reproduce the work of ref. 22. A great deal of prior work and then subsequent work showed that the challenge to ref. 22 lacked substance.

      (1) Text modified to fix an error in the citation number related to direct β-lactam-mediated lysis.

      (2) We agree that there is a great deal of data supporting antibiotic-induced ROS as important for bactericidal activity in many circumstances and do not argue otherwise. This sentence points out that over the years the paradigm for how antibiotics kill bacteria has evolved.

      Line 80. It seems you are starting a new topic here. What about beginning a new paragraph?

      The paragraph introduces mycobacteria of which Mabs is one. Text not modified.

      Line 85 delete the comma: it implies a compound sentence that is not delivered.

      Text modified.

      Line 109 screen singular

      Text modified.

      Line 156 these conditions is imprecise and vague

      Conditions were described in paragraph above in the manuscript. Text not modified.

      Fig 2 it would be helpful to more clearly define the meaning of the coordinates

      Text modified.

      Line 230 and throughout please indicate the location of the data being cited for rapid reader reference

      Text modified.

      Lines 315-323 You could use this paragraph as the first of the Discussion. Some readers prefer to read the Discussion before the results. For them, a summary at the beginning of the Discussion is useful.

      Text modified.

      Line 328 without underlying mechanism... for E. coli refer to Zeng PNAS 2022. Depending on when the final version of this paper happens, there should be a figure in a Zhao Zhu mLife paper on purA that will have been published. Since it is not yet available, it cannot be cited.

      We agree that the Zeng et al study is interesting and have added this reference to our discussion. However, these findings related to broad Crp-regulated tolerance actually underscore the point that we are making: that there are multiple factors (Crp, RelA, Lon, TisB, MazE, others) that mediate antibiotic tolerance.

      Line 339 where are the data?

      These data are in Figure 5, panels C, D. We have clarified the text to indicate that only a single agent from each of these classes was tested.

      Line 346 here you are summarizing evidence for ROS in killing mycobacteria. You should include the moxifloxacin study by Shee et al 2022 AAC.

      Reference added.

      Line 348 refer to James Collins' work with E. coli in which his lab examined agents with a variety of mechanisms. There seems to be a fundamental difference between E. coli and mycobacteria with respect to rifampicin, a strictly static agent in E. coli but clearly lethal in mycobacteria. Note that chloramphenicol is static in E. coli and blocks ROS production. What does it do in mycobacteria? A brief discussion of this difference might be relevant at line 362

      Text modified.

      Lines 364-368 Here the idea might be simply that there are two modes of killing, one that is a direct extension of class-specific damage (chromosome fragmentation with fluoroquinolones, for example, or cell lysis by beta-lactams) and a second that is a metabolic response to the antibiotic damage (ROS accumulation). The second type is not class specific. Within this context, the mycobacterial killing by rifampicin might be a class-specific extension of inhibition of transcription that does not occur in E. coli.

      Agreed, text modified to include this.

      Line 400 The Key Resource table is not of publication quality. Precision and repeatability can be improved by spelling out the name of the vendor and its location (City, Country). In the present case, use of BD is lab jargon.

      We appreciate the reviewer’s precision. However, this is actually not lab jargon. Becton, Dickinson and Company now refers to itself as BD (see https://www.bd.com/en-us), and the American Type Culture Collection now refers to itself as ATCC (see https://www.atcc.org/about-us/who-we-are).

      Line 639 It would be good to have experienced colleagues critically review the manuscript, especially for English usage. Listing those persons here adds to the credibility of the work

      Text not changed.

      References: please refer to the journal style. Here you use italic for titles and scientific names, thereby obscuring the scientific names. Normally article titles are not italic and scientific names are ALWAYS italic unless prohibited by journal style.

      Our reference format is concordant with eLife submission guidelines, and all references are reformatted by the journal at the time of final publication (see https://elifesciences.org/insideelife/a43f95ca/elife-references-yes-we-take-any-format-no-we-re-not-rekeying).

      Supplemental Material: Please refer to journal style. Normally this is a stand-alone document that includes a title page and carefully crafted figure legends. Supplemental figures would be numbered as 1, 2, ... A professional appearing Supplemental Material section shows author publication experience not obvious in other parts of the paper. The text indicated MIC determinations. I would like to see a table of MIC values.

      (1) MIC table added as Supplemental Table 5.

      (2) The Supplemental figures are submitted and named in accordance with eLife instructions. Please note that for eLife, there is not a stand-alone supplementary figure section with a title page as you are requesting, but instead the figure supplements for each figure are provided as online files linked to each figure.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript by Feng et al. uses mouse models to study the embryonic origins of HSPCs. Using multiple types of genetic lineage tracing, the authors aimed to identify whether BM-resident endothelial cells retain hematopoietic capacity in adult organisms. Through an important mix of various labeling methodologies (and various controls), they reach the conclusion that BM endothelial cells contribute up to 3% of hematopoietic cells in young mice.

      Strengths:

      The major strength of the paper lies in the combination of various labeling strategies, including multiple Cdh5-CreER transgenic lines, different CreER lines (col1a2), and different reporters (ZsGreen, mTmG), including a barcoding-type reporter (PolyLox). This makes it highly unlikely that the results are driven by a rare artifact due to one random Cre line or one leaky reporter. The transplantation control (where the authors show no labeling of transplanted LSKs from the Cdh5 model) is also very supportive of their conclusions.

      We appreciate the Reviewer’s consideration of the strengths of our study supporting the identification of adult endothelial to hematopoietic transition (EHT) in the mouse bone marrow.

      Weaknesses:

      We believe that the work of ruling out alternative hypotheses, though initiated, was left incomplete. We specifically think that the authors need to properly consider whether there is specific, sparse labeling of HSPCs (in their native, non-transplant, model, in young animals). Polylox experiments, though an exciting addition, are also incomplete without additional controls. Some additional killer experiments are suggested.

      Recognizing the importance of the weaknesses pointed by the Reviewer, we provide below our response to the thoughtful recommendations rendered.

      Reviewer #1 (Recommendations for the authors):

      The main model is to label cells using Cdh5 (VE-cadherin) CreERT2 genetic tracing. Cdh5 is a typical marker of endothelial cells. The data shows that, when treating adults with tamoxifen, the model labels PBMCs after ~10 days, and the labeling kinetics plateau by day 14... The authors reach the main conclusion: that adult ECs are making hematopoietic cells.

      We agree that the main tool used in this study is to label endothelial cells (ECs) using Cdh5 (VE-Cadherin) CreERT2 genetic tracing in mice. Indeed, Cdh5 is recognized as a good marker of ECs. As a minor point, we wish to clarify that the results from treating adult Cdh5-CreERT2 mice with tamoxifen (Figure 1F) show that the ZsGreen labeling kinetics plateau by day 28 (not by day 14).

      Important controls should be shown to rule out alternative possibilities: namely, that the CreERT2 reporter is being sparsely expressed in HSPCs. Many markers, specific as they may seem to be, can show expression in non-specific lineages - particularly in the cases of BAC and PAC transgenic models, in which the transgene can be present in multiple tandem copies and subject to genome location-specific effects. As the authors remind readers, the Cdh5 gene is partly transcribed (though at low levels) in HSPCs, and even more clearly expressed in specific subpopulations such as CLPs, DCs, pDCs, B cells, etc. Some options would be to: i) check if the Cdh5-CreERT2 transgene (not endogenous Cdh5, but the BAC/PAC transgene) is expressed in LSKs (at least by qPCR), ii) verify if any CreERT2 protein levels are present in LSKs (e.g., by western blot), and iii) check if tamoxifen is labeling any HSPCs freshly after induction (e.g., flow cytometry data of ZsGreen LSKs at 24-48h post tamoxifen injection).

      We fully agree with the Reviewer that many markers, allegedly specific to a certain cell type, can show expression in other cell lineages. We also agree that excluding sparse or ectopic CreERT2 expression in hematopoietic stem and progenitor cells (HSPCs) is essential for interpreting lineage-tracing results. As suggested by the Reviewer, we have now examined if the Cdh5-CreERT2 transgene is expressed in bone marrow LSKs. To this end, we analyzed the Polylox single-cell RNAseq dataset presented in this study, containing ZsGreen<sup>+</sup> ECs and enriched ZsGreen<sup>+</sup> LSKs. As shown in the revised Figure S4D, CreERT2 transcripts were detected exclusively in Cdh5-expressing endothelial populations and were absent from Ptprc/CD45-expressing hematopoietic cells, except for plasmacytoid dendritic cells (pDCs; Figure S4E). These results are consistent with the RNAseq data from adult mouse bone marrow[1] showing that the Cdh5 gene is not expressed in HSPCs, CLPs, DCs, or B cells. Rather, among hematopoietic CD45<sup>+</sup> cells, Cdh5 is only expressed in a small subset of plasmacytoid dendritic cells (pDCs), which are terminally differentiated cells. These published results are described in the text.

      To further support this conclusion, we provide additional single-cell RNAseq analyses from our unpublished dataset of LSKs isolated from Cdh5-CreERT2/ZsGreen mice and not enriched for ZsGreen expression. These new analyses were performed after integrating the single-cell data from ECs and ZsGreen<sup>+</sup> hematopoietic cells from the Polylox dataset (current study). As shown in Author response images 1 and 2, CreERT2 expression closely matches the expression patterns of Cdh5, Pecam1, and Emcn and is not detected in Ptprc/CD45-expressing hematopoietic cells.

      Author response image 1.

      Expression of CreERT2, Cdh5, Ptprc and ZsGreen in BM cell populations enriched with ECs and hematopoietic cells. The single-cell RNAseq results are derived from ZsGreen-enriched BM ECs and ZsGreen-enriched BM hematopoietic cells were derived from Polylox lineage-tracing experiments (data shown in Fig. 5; 37,667 ECs and 48,065 BM hematopoietic cells) and from LSKs (23,017 cells) independently isolated from tamoxifen-treated Cdh5-CreERT2/ZsGreen mice without ZsGreen enrichment (unpublished data).

      Author response image 2.

      Expression of CreERT2, Cdh5, Ptprc, Pecam1, Emcn, ZsGreen1, Col1a2, Cd19, Cd3e, Itgam (CD11b), Ly6a (Sca-1), Kit(cKit), Cd34, Cd48, Slamf1 (CD150), and Siglech in enriched BM ECs and LSKs from Cdh5-CreERT2/ZsGreen mice treated with tamoxifen 4 weeks prior to harvest (same cell source as indicated in Author response image 1).

      Additionally, we functionally tested whether hematopoietic progenitors could acquire ZsGreen labeling following tamoxifen administration using transplantation assays (Figure 4A-D). ZsGreen<sup>-</sup> LSKs (purity 99%), sorted from Cdh5-CreERT2/ZsGreen donors that had never been exposed to tamoxifen to exclude background Cre leakiness, were transplanted into lethally irradiated wild-type recipients. After stable hematopoietic reconstitution, recipients were treated with tamoxifen. If transplanted HSPCs or their progeny expressed CreERT2, tamoxifen administration would be expected to induce ZsGreen labeling. However, no ZsGreen<sup>+</sup> hematopoietic cells were detected in these recipients, demonstrating that hematopoietic progenitors from Cdh5-CreERT2/ZsGreen and their descendants do not undergo tamoxifen-induced recombination.

      Together, the single-cell transcriptional and transplantation data demonstrate that CreERT2 expression and tamoxifen-induced recombination are restricted to Cdh5-expressing ECs (except for pDCs). These findings support the conclusion that ZsGreen<sup>+</sup> hematopoietic cells arise from adult bone marrow ECs rather than from contaminating hematopoietic progenitors.

      One important missing experiment is to trace how ECs actually do this hematopoietic conversion: meaning, which populations of HSPCs are being produced by adult ECs in the first instance? LT-HSCs? ST-HSCs? MPPs? GMPs? All of the above? What are the kinetics? Differentiation is likely to follow a hierarchical path, but this is unclear at the moment.

      We agree that defining the earliest EC-derived hematopoietic cell progenitors and the kinetics by which these progenitors appear (LT-HSC vs ST-HSC/MPP vs lineage-restricted progenitors) would provide important insights into adult EHT.

      In the current genetic labeling system, a rigorous kinetic analysis of hematopoietic cells first generated by EC-derived in vivo is not straightforward. Specifically, the low-level baseline reporter ZsGreen<sup>+</sup> fluorescence in hematopoietic cells (dependent on EHT occurring prenatally, perinatally or in young mice or other causes (Figure 1 A-D and Figure S1 D-I) impairs identification of newly generated ZsGreen<sup>+</sup> progenitors at early time points and distinguish them from baseline fluorescence. A potential solution might be to introduce serial harvests across multiple time-points in large mouse cohorts to capture rare transitional events with statistical significance.

      We wish to emphasize that the primary objective of this study was to establish whether adult bone marrow ECs have a hemogenic potential. Our data demonstrate adult EC-derived hematopoietic cell output that includes progenitor-containing fractions and multilineage mature progeny, under both steady-state conditions. We acknowledge that the current work does not resolve the order and kinetics of hematopoietic cell emergence following EHT. Therefore, under “Limitations of the study” we explicitly state this limitation and frame the identification of the earliest endothelial-derived progenitors and their kinetics as an important direction for future work.

      One warning sign is how rare the reported phenomenon is. Even when labeling almost 90% of the BM ECs, these make at most ~3% of blood (less than 1% in the transplants in Figure 4F, less than 0.5% in the col1a2 tracing in Figure 7). This means this is a very rare and/or transient phenomenon... The most major warning sign is the fast kinetics of labeling and the fast plateau. We know that: a) differentiation typically follows some hierarchy, b) in situ dynamics of blood production are slow (work by Rodewald and Höfer). Considering how fast these populations need to be replaced to reach a steady state so rapidly (as reported here, 2-4 weeks), the presumably specialized ECs would need to be steadily dividing and producing hematopoietic cells at a fast pace (as a side prediction, the adult "EHT" cluster would likely be highly Mki67+). More importantly, the ZsGreen LSKs produced by the ECs would have to undergo VERY rapid differentiation (much faster than normal LSKs) or otherwise, if 3% of them are produced by a top compartment (the BM ECs) every 4 weeks, then the labeled population would continue to grow with time. The authors could try to challenge this by testing if the ZsGreen LSKs undergo much faster differentiation kinetics or lower self-renewal (which does not seem to be the case, at least in their own transplantation data). We believe a more likely explanation is that the label is being acquired more or less non-specifically, directly across a bunch of HSPC populations.

      The Reviewer correctly notes that that the population of hemogenic ECs in the adult mouse bone marrow is small and the output of hematopoietic cells from these hemogenic ECs accounts for at most 3% of blood cells. We agree that delineating the kinetics by which hematopoietic cells are generated from adult EC is important, as this information would provide important insights into adult EHT.

      Nonetheless, we believe that the rapid appearance and early plateau of labeled blood cells in our experiments may not derive from a sustained, high-rate generation of labeled blood cells from self-renewing top-tier hematopoietic cell compartments, such as LT-HSCs. Rather, our data are more consistent with a predominantly lineage-restricted and biased hematopoietic progenitor cell population being the source of labeled blood cells. Supporting this interpretation, longitudinal analysis of peripheral blood shows that EGFP<sup>+</sup> PBMCs are consistently enriched with myeloid cells, whereas EGFP<sup>-</sup> PBMCs are predominantly B cells (Figure 4G and H). This myeloid lineage skewing is stable over time and contrasts with what would be expected if labeling were acquired broadly and nonspecifically across the hematopoietic hierarchy. Therefore, our results are more consistent with myeloid biased progenitors being among the first populations that EHT generates.

      We acknowledge that our studies do not identify the earliest endothelial-derived hematopoietic cells produced in vivo, and do not define their differentiation kinetics. Addressing rigorously these questions would require temporally resolved lineage tracing with sufficiently powered cohorts at early time point to statistically distinguish from baseline reporter background. These important experiments were beyond the scope of the present study. As noted above, under “Limitations of the study” we explicitly state this limitation and frame the identification of the earliest endothelial-derived progenitors and their kinetics as an important direction for future work.

      Transplant experiments in Figure 4 do offer a crucial experiment in support of the main conclusion of the manuscript. These experiments show that transplanted LSKs bearing the Cdh5-CreERT2 and ZsGreen reporter cannot acquire the tamoxifen-induced label post-transplantation - suggesting that the label is coming from ECs. However, it is also possible that the LSK Cdh5-CreERT expression is partly during the transplantation process... Indeed, we know through the aging data that the labeling is less active in aged mice. In any case, this would be verified by qPCR/western-blot (comparing native vs post-transplant LSKs).

      We agree with the Reviewer that the experiment in Figure 4A-D “offer a crucial experiment in support of the main conclusion of the manuscript.” The results of this experiment show that ZsGreen negative LSKs from the Cdh5-CreERT2-ZsGreen reporter mice do not acquire tamoxifen-induced ZsGreen fluorescence post transplantation, supporting the endothelial cell origin of blood ZsGreen<sup>+ </sup>cells.

      The Reviewer raises the possibility a “that the LSK Cdh5-CreERT expression is partly during the transplantation process... , and that this Cdh5-CreERT expression may occur slowly as learned “through the aging data that the labeling is less active in aged mice.” As we show in Figure 3F, tamoxifen administration induced a similar percentage of ZsGreen<sup>+ </sup>ECs in the bone marrow of Cdh5-Cre<sup>ERT2</sup>(BAC)/ZsGreen mice, whether tamoxifen was administered to 6-week-old, 16-week-old, 26-week-old or 36-week-old mice. Similar results with Cdh5-CreERT2 (BAC) mice are reported in the literature[2]. Since the mice transplanted with ZsGreen<sup>-</sup> LSKs were followed for 25 weeks after tamoxifen administration, we believe that the results in Figure 4A-D address the concern raised by the Reviewer.

      Supporting the conclusion that LSKs from the Cdh5-CreERT2-ZsGreen reporter mice do not express the Cdh5-CreERT2 under a native -non-transplant- setting, we now provide transcriptomic data from Cdh5-CreERT2/ZsGreen mice (not transplanted) showing that CreERT2 expression closely tracks with expression of canonical endothelial markers (Cdh5, Pecam1, Emcn) and is not detectable in Ptprc/CD45-expressing hematopoietic cells (Author response images 1 and 2). These data were obtained from non-transplanted mice treated with tamoxifen at ~12 weeks of age and analyzed four weeks later. Together, these results indicate that CreERT2 expression is endothelial-restricted in Cdh5-CreERT2-ZsGreen reporter mice.

      Figure 5 presents PolyLox experiments to challenge whether adult ECs produce hematopoietic cells through in situ barcoding. Several important details of the experiment are missing in the main text (how many cells were labeled, at which time point, how long after induction were the cells sampled, how many bones/BM-cells were used for the sample preparation, what was the sampling rate per population after sorting, how many total barcodes were detected per population, how many were discarded/kept, what was the clone-size/abundance per compartment). As presented, the authors imply that 31 out of ~200 EC barcodes are shared with hematopoietic cells... This would suggest that ~15% of endothelial cells are producing hematopoietic cells at steady state. This does not align well with the rarity of the behavior and the steady state kinetics (unless any BM EC could stochastically produce hematopoietic cells every couple of weeks, or if the clonality of the BM EC compartment would be drastically reduced during the pulse-chase overlap with mesenchymal cells. Important controls are missing, such as what would be the overlap with a population that is known to be phylogenetically unrelated (e.g., how many of these barcodes would be found by random chance at this same Pgen cut-off in a second induced mouse). Also, the Pgen value could be plotted directly to see whether the clones with more overlapping populations/cells (3HG, 127, 125, CBA) also have a higher Pgen. We posit that there are large numbers of hematopoietic clones that contribute to adult hematopoiesis (anywhere from 2,000-20,000 clones would be producing granulocytes after 16 weeks post chase), and it would be easy to find clones that overlap with granulocytes (the most abundant and easily sampled population) - HSPCs would be the more stringent metric.

      We thank the Reviewer for highlighting the need for a more detailed description of the Polylox experiments. To address this deficiency, we have compiled a document (Additional Supplementary Information file) containing all the specifics of the Polylox experimental and analytical parameters in one location. This includes: (i) the number of cells analyzed per population, (ii) the time points of induction and sample collection, (iii) the number of bones and total bone marrow cells used for preparation, (iv) the sampling rate following cell sorting, (v) the total number of detected barcodes per population, (vi) barcode filtering criteria and numbers retained or discarded, and (vii) clone-size and barcode number across cell compartments. We have updated the manuscript to refer readers to this Supplementary file.

      The Reviewer concluded from our results (Figure 5, Figure S5) that 31 out of ~200 endothelial cell (EC) barcodes shared with hematopoietic cells (HCs), implying that ~15% of ECs produce hematopoietic cell progeny at steady state. This interpretation in inconsistent with our data showing the rare nature of adult EHT and would require either that a large fraction of bone-marrow ECs can generate hematopoietic cells within short time windows, or that EC would clonally expand rapidly during the pulse-chase period, as noted by the Reviewer. The explanation for this apparent problem is technical. Briefly, the ~200 EC barcodes recovered do not represent all barcoded ECs. During Polylox barcode library construction, a mandatory size-selection step is applied prior to PacBio sequencing, retaining fragments that are approximately 800–1500 bp in length, whereas the full Polylox cassette spans ~2800 bp. This is mainly because the PacBio sequencer requires that the library be either 800-1500bp or over 2500bp, for optimal sequencing results. As described in the original Polylox publication[3,4], this size selection eliminates most (approximately 75%) longer barcodes, together with ~85% of the shorter barcodes. Thus, ECs harboring very long or short recombined barcodes are under-represented or excluded from sequencing. As a result, the 22 true barcodes linking ECs and HCs recovered from sequencing do not indicate that ~10–15% of ECs generate hematopoietic progeny. Rather, these barcodes represent a highly selected subset of ECs with barcode configurations compatible with library recovery and sequencing. The observed EC–HC barcode sharing thus reflects qualitative lineage connectivity, not the quantitative frequency of endothelial-derived hematopoiesis at steady state.

      The Reviewer correctly notes that true Polylox barcodes are shared by ECs and mesenchymal-type cells and asks that we examine whether this overlap could occur by chance alone. The Polylox filtering threshold (pGen < 1 × 10<sup>-6</sup>), that we have revised for stringency (from pGen < 1 × 10<sup>-4</sup>, without altering the essential results; new Figure S4 and revised Figure 5C-F) renders such overlap exceedingly unlikely. At this threshold, the expected number of random recombination events among 4,069 barcoded cells is approximately 0.004. Consequently, among the 87 mesenchymal cells identified here, fewer than 0.4 cells would be expected, to share a barcode with another cell by chance alone. Thus, the probability of recovering identical barcodes across unrelated lineages due to random recombination is vanishingly small, and the observed EC–mesenchymal barcode sharing substantially exceeds random expectation.

      Related to this observation, the Reviewer correctly notes that the endothelial and mesenchymal cell lineages are phylogenetically unrelated. However, endothelial-to-mesenchymal cell transition (EndMT), the process by which normal ECs completely or partially lose their endothelial identity and acquire expression of mesenchymal markers, is a well-established process that occurs physiologically and in disease states (Simons M Curr Opin Physiol 2023). In the bone marrow, the occurrence of EndMT has been documented in patients with myelofibrosis, and the process affects the bone marrow microvasculature (Erba BG et al The Amer J Patholl 2017). Single-cell RNAseq of non-hematopoietic bone marrow cells has shown the existence of a rare population of ECs that co-expresses endothelial cell markers (Cdh5, Kdr, Emcm and others) and the mesenchymal cell markers, as shown in Figure 6E and F.

      We fully agree with the Reviewer that given the large number of hematopoietic clones contributing to adult hematopoiesis -particularly granulocyte-producing clones- it may be relatively easy to detect barcode overlap with abundant mature populations, whereas overlap with HSPCs would represent a more stringent and informative metric of lineage relationships. The Polylox results presented here show the sharing of true barcodes between individual ECs and HSPC.

      Reviewer #2 (Public review):

      Summary:

      Feng, Jing-Xin et al. studied the hemogenic capacity of the endothelial cells in the adult mouse bone marrow. Using Cdh5-CreERT2 in vivo inducible system, though rare, they characterized a subset of endothelial cells expressing hematopoietic markers that were transplantable. They suggested that the endothelial cells need the support of stromal cells to acquire blood-forming capacity ex vivo. These endothelial cells were transplantable and contributed to hematopoiesis with ca. 1% chimerism in a stress hematopoiesis condition (5-FU) and recruited to the peritoneal cavity upon Thioglycolate treatment. Ultimately, the authors detailed the blood lineage generation of the adult endothelial cells in a single cell fashion, suggesting a predominant HSPCs-independent blood formation by adult bone marrow endothelial cells, in addition to the discovery of Col1a2+ endothelial cells with blood-forming potential, corresponding to their high Runx1 expressing property.

      The conclusion regarding the characterization of hematopoietic-related endothelial cells in adult bone marrow is well supported by data. However, the paper would be more convincing, if the function of the endothelial cells were characterized more rigorously.

      We thank the Reviewer for the supportive comments about our study.

      (1) Ex vivo culture of CD45-VE-Cadherin+ZsGreen EC cells generated CD45+ZsGreen+ hematopoietic cells. However, given that FACS sorting can never achieve 100% purity, there is a concern that hematopoietic cells might arise from the ones that got contaminated into the culture at the time of sorting. The sorting purity and time course analysis of ex vivo culture should be shown to exclude the possibility.

      We agree that FACS sorting can never achieve 100% cell purity and that sorting purity is critical for interpreting the ex vivo culture experiments presented in our study. As requested by the Reviewer, we have now documented the purity of the sorted endothelial cell (EC) population used in the ex vivo culture experiments. The post-sort purity of CD45<sup->/sup>VE-cadherin<sup>+</sup>ZsGreen<sup>+</sup> ECs was 96.5 %; this data is now shown in the revised Figure 2B (Post Sort Purity panel). This purity level is comparable to purity levels of sorted ECs shown in Figure S2I (94.5 %).

      While we agree that a detailed time-course analysis of hematopoietic cell output from EC cultures could further strengthen the conclusion that bone marrow ECs can produce hematopoietic cells ex vivo, we wish to call attention to the additional critical control in the experiment shown in Figure 2B-D. In this experiment, we co-cultured CD45<sup>+</sup>ZsGreen<sup>+</sup> hematopoietic cells from Cdh5-CreERT2/ZsGreen mice, rather than ECs, and examined if these hematopoietic cells could produce ZsGreen<sup>+</sup> cell progeny after 8-week culture under the same conditions used in EC co-cultures (conditions not designed to support hematopoietic cells long-term). Unlike ECs, the CD45<sup>+</sup>ZsGreen<sup>+</sup> hematopoietic cells did not generate ZsGreen<sup>+</sup> hematopoietic cells at the end of the 8-week culture, indicating that the culture conditions are not permissive for the maintenance, proliferation and differentiation of hematopoietic cells. This provides strong evidence that even if few hematopoietic cells contaminated the sorted ECs, these hematopoietic cells would not contribute to EC-derived production of hematopoietic cells at the 8-week time-point. We have revised the text of the results describing the results of Figure 2B-D.

      (2) Although it was mentioned in the text that the experimental mice survived up to 12 weeks after lethal irradiation and transplantation, the time-course kinetics of donor cell repopulation (>12 weeks) would add a precise and convincing evaluation. This would be absolutely needed as the chimerism kinetics can allow us to guess what repopulation they were (HSC versus progenitors). Moreover, data on either bone marrow chimerism assessing phenotypic LT-HSC and/or secondary transplantation would dramatically strengthen the manuscript.

      The original manuscript reported survival and engraftment up to 12 weeks post transplantation. The recipient mice have now been monitored for up to 10 months post transplantation. These extended survival and engraftment data are now included in the revised Figure 2I and J replacing the previous 10-week analyses.

      We agree with the Reviewer that the time-course kinetics of donor cell repopulation would help define adult endothelial to hematopoietic transition (EHT) and the hematopoietic cell types produced by adult (EHT). We did not perform serial time-course sampling of peripheral blood beyond the 10-week and the 10-month time-points. Given that the recipient mice were lethally irradiated with increased susceptibility to infection, we sought to minimize repeated interventions that could compromise animal health and survival. We therefore prioritized long-term survival and endpoint analysis over repeated longitudinal sampling. Nonetheless, the long-term survival,10 months, and multilineage hematopoietic cell reconstitution after lethal irradiation provides functional evidence that adult EHT produced at least some LT-HSC.

      We acknowledge that phenotypic assessment of bone marrow LT-HSC chimerism /or secondary transplantation would further strengthen the manuscript. We have clarified these limitations in the revised manuscript under “Limitations of the study”.

      (3) The conclusion by the authors, which says "Adult EHT is independent of pre-existing hematopoietic cell progenitors", is not fully supported by the experimental evidence provided (Figure 4 and Figure S3). More recipients with ZsGreen+ LSK must be tested.

      We agree with the Reviewer that, in most cases, a larger number of experimental data points is helpful to strengthen the conclusions, and that having additional mice transplanted with ZsGreen-enriched LSK would be desirable. However, we do not believe that additional mice transplanted with ZsGreen LSKs would strengthen the conclusions drawn from the experimental results shown in Figure 4D, in which we used 6 mice transplanted with ZsGreen-depleted (ZsGreen<sup>-</sup>) LSKs and 2 mice transplanted with ZsGreen<sup>+</sup>-enriched (ZsGreen<sup>+</sup>) LSKs. The independence of adult EHT from “pre-existing hematopoietic cell progenitors” is based on the following experimental results and conclusion from these results.

      First, ZsGreen<sup>-</sup> LSKs (purity 99%) isolated from Cdh5-CreERT2/ZsGreen mice were transplanted into lethally irradiated WT recipients (n = 6). These ZsGreen<sup>-</sup> LSKs robustly reconstituted hematopoiesis, demonstrating successful engraftment. Importantly, tamoxifen administration to the recipients of ZsGreen<sup>-</sup> LSKs produced no detectable ZsGreen<sup>+</sup> cells in the blood for up to 6 months post transplantation (Figure 4D, blue line encompassing the results of the 6 mice). This result demonstrates that the transplanted ZsGreen<sup>-</sup> hematopoietic progenitors and their progeny do not acquire ZsGreen labeling in vivo following tamoxifen treatment, indicating that they lack the Cre-recombinase. This result is consistent with the endothelial specificity of Cdh5 expression.

      Second, ZsGreen<sup>+</sup> LSKs (accounting for ~50% of the LSKs) isolated from Cdh5-CreERT2/ZsGreen mice were transplanted into lethally irradiated WT recipients (n = 2). This arm of the experiment was performed in part as a technical control to confirm successful engraftment and detection of ZsGreen<sup>+</sup> hematopoietic cells in the transplant setting. Importantly, tamoxifen administration to the two recipients of ZsGreen<sup>+</sup> LSKs (Figure 4D, two green lines reflecting these two mice) show that the level of ZsGreen<sup>+</sup> blood cells stabilized in each of the mice between week 10 and 24, showing equilibrium between the proportion of ZsGreen<sup>+</sup> and ZsGreen<sup>-</sup>cells in the blood. This indicates that pre-existing ZsGreen<sup>+</sup> LSK are not responsible for tamoxifen-induced increases in ZsGreen<sup>+</sup> hematopoietic cell in blood.

      Together, the results from this experiment demonstrate that in the setting of transplantation, tamoxifen does not induce ZsGreen labeling of ZsGreen- hematopoietic progenitors/their progeny. This result strongly supports the conclusion that ZsGreen⁺ hematopoietic cells arise independently of pre-existing or inducible hematopoietic progenitors. We have revised the text to clarify these experiments and to present the results in a simplified manner.

      Strengths:

      The authors used multiple methods to characterize the blood-forming capacity of the genetically - and phenotypically - defined endothelial cells from several reporter mouse systems. The polylox barcoding method to trace the adult bone marrow endothelial cell contribution to hematopoiesis is a strong insight to estimate the lineage contribution.

      Weaknesses:

      It is unclear what the biological significance of the blood cells de novo generated from the adult bone marrow endothelial cells is. Moreover, since the frequency is very rare (<1% bone marrow and peripheral blood CD45+), more data regarding its identity (function, morphology, and markers) are needed to clearly exclude the possibility of contamination/mosaicism of the reporter mice system used.

      We agree that the biological significance and functional roles of hematopoietic cells generated de novo from adult bone marrow ECs remain important open questions. We also agree that the output of hematopoietic cells from adult EHT is low, but rare events can be important, particularly as they pertain to stem/progenitor cell biology. Both points are described under “Limitations of the study”. The primary goal of the present study was to address the question whether adult bone marrow ECs can undergo EHT. We believe that the combination of various mouse transgenic lines, different Cre-ER, different reporters (ZsGreen and mTmG), including the s.c. barcoding reporter (PolyloxExpress), different approaches to evaluate hematopoiesis in vivo and ex vivo, makes it rather unlikely that our conclusions are driven by an artifact related to a specific leaky reporter, contamination, or problems with one of the Cre-lines. The experiment where we find no tamoxifen-induced labeling of transplanted ZsGreen<sup>-</sup> LSKs derived from the Cdh5-CreERT2/ZsGreen mice is strongly supportive of the existence of adult EHT, virtually excluding a contribution of contaminant hematopoietic cells.

      Reviewer 2 Recommendations for the authors:

      (1) There is a discrepancy in the proportion of peripheral blood composition between different reporters (mTmG and ZsGreen) (Figure 1G and Figure S1K), especially the contrasting B cell proportion between both models. The additional comments on this data should be mentioned.

      In the revised Results section, we now note that the mTmG and ZsGreen reporters show slightly different efficiencies or kinetics of labeling. These differences have previously been reported[5] and have been attributed to relative reporter leakiness, sensitivity to tamoxifen, or different kinetics of Cre recombination. As suggested, these comments have been added to the text following the description of (Figure S2A).

      (2) Experimental methods concerning cell transplantation/transfer need more information, such as: a) using or not using rescue cells and how many cells are they if using, b) single or split dose of irradiation, c) when were cells transplanted following irradiation, etc. Otherwise, the data are uninterpretable.

      We have ensured that the Material and Methods section under “Bone marrow ablation and transplantation” contains all the information requested by the Reviewer.

      (3) Some of the grouped data haven't been statistically analyzed.

      We have reviewed all data and performed appropriate statistical analyses where comparisons were made. In the revised figures and legends, all grouped datasets now include statistical tests and p-values are indicated (added to Fig. 3H and I; Figure 4G).

      (4) Some flowcytometry plot has the quantitative number, others do not. The quantitative information is absolutely needed in all flow cytometry plots.

      We have updated the flow cytometry figures to include quantitative values (percentages or absolute counts) in all relevant plots (2B (new figure, bottom left); 2C; S1G, S1H).

      (5) It is more relevant to present the Emcn/VE-Cadherin plot from gated CD45+/ZsGreen+, not the CD45-/ZsGreen+ fraction (Figure 2C), as the latter were not the EHT-derived offspring, but rather the common phenotypic endothelial cells

      As requested, we have added the suggested flow cytometry plot. The revised Figure 2C now includes an Emcn vs. VE-Cadherin plot from the gated CD45<sup>+</sup>ZsGreen<sup>+</sup> population. This complements the existing panel and confirms that the cells of interest retain endothelial cell markers after culture, while the CD45<sup>+</sup>ZsGreen<sup>+</sup> cells did not express endothelial markers. The figure legend has been updated to explain the new panel. We agree that this plot more directly highlights the phenotype of the presumed EHT-derived cells.

      (6) To show the effect of the ex vivo culture, the authors should present the absolute number of CD45+ZsGreen+ cells in the pre-/post-culture; otherwise, the data are uninterpretable (Figure 2D).

      Our interpretation of the Reviewer’s comment above (relative to the experiment shown in Figure 2B-D) is that the Reviewer would like that we provide the absolute number of CD45<sup>+</sup>ZsGreen<sup>+</sup> cells introduced into the co-culture (supplemented with unsorted BM cells, ZsGreen<sup>+</sup> hematopoietic cell or ZsGreen<sup>+</sup> ECs) and the absolute number of CD45<sup>+</sup>ZsGreen<sup>+</sup> cells recovered at the end of the 8-week culture. Currently, the results in Figure 2D show the absolute number of CD45<sup>+</sup>ZsGreen<sup>+</sup> cells recovered at the end of the 8-week culture. The input of CD45<sup>+</sup>ZsGreen<sup>+</sup> cells for unsorted BM cells was 2.93e6 on average; for ZsGreen<sup>+</sup> hematopoietic cells was 1.68e6 on average and from sorted ZsGreen<sup>+</sup> ECs was estimate up to 100.

      (7) It is confusing to see Figures 2F and 2G, which apparently show the data from the middle of the experimental procedure (Figure 2E). Those data should be labelled clearly regarding which procedures of the whole experiment protocol.

      As correctly noted by the Reviewer, Figures 2F and 2G provide data that relate to the middle of the graphical representation of the experiment shown in Figure 2E. We see how this may be confusing.

      Therefore, we have updated both the figure labeling and legend to explicitly indicate that Figure 2F and 2G provide the FACS sorting results for the cells used for transplantation. The revised legend now reads: “Representative flow cytometry plots of the non-adherent cell fraction after 8 weeks of co-culture (cells used for transplantation).”

      References

      (1) Kucinski, I., Campos, J., Barile, M., Severi, F., Bohin, N., Moreira, P.N., Allen, L., Lawson, H., Haltalli, M.L.R., Kinston, S.J., et al. (2024). A time- and single-cell-resolved model of murine bone marrow hematopoiesis. Cell Stem Cell 31, 244-259.e10. https://doi.org/10.1016/j.stem.2023.12.001.

      (2) Identification of a clonally expanding haematopoietic compartment in bone marrow | The EMBO Journal | Springer Nature Link https://link.springer.com/article/10.1038/emboj.2012.308.

      (3) Pei, W., Shang, F., Wang, X., Fanti, A.-K., Greco, A., Busch, K., Klapproth, K., Zhang, Q., Quedenau, C., Sauer, S., et al. (2020). Resolving Fates and Single-Cell Transcriptomes of Hematopoietic Stem Cell Clones by PolyloxExpress Barcoding. Cell Stem Cell 27, 383-395.e8. https://doi.org/10.1016/j.stem.2020.07.018.

      (4) Pei, W., Feyerabend, T.B., Rössler, J., Wang, X., Postrach, D., Busch, K., Rode, I., Klapproth, K., Dietlein, N., Quedenau, C., et al. (2017). Polylox barcoding reveals haematopoietic stem cell fates realized in vivo. Nature 548, 456–460. https://doi.org/10.1038/nature23653.

      (5) Álvarez-Aznar, A., Martínez-Corral, I., Daubel, N., Betsholtz, C., Mäkinen, T., and Gaengel, K. (2020). Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines. Transgenic Res 29, 53–68. https://doi.org/10.1007/s11248-019-00177-8.

    1. Author response:

      The following is the authors’ response to the original reviews

      eLife Assessment

      This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating with higher rates of autoimmune disease in females. The authors compare male and female TCR repertoires using bulk RNA sequencing, from sorted thymocyte subpopulations in pediatric and adult human thymuses; however, the results do not provide sufficient analytical rigor and incompletely support the central claims.

      The statement in the editorial assessment that our study “does not provide sufficient analytical rigor” surprised us. TCR repertoire analysis is indeed a highly complex domain, both experimentally and computationally. We consider ourselves to be leading experts in this field and have invested a great deal of effort to ensure the rigor and reproducibility of every analytical step.

      Specifically, our group has previously benchmarked and published validated methodologies for the following areas: (i) TCR repertoire generation (Barennes et al., Nat Biotechnol 2021), (ii) repertoire analysis (Six et al., Frontiers in Immunol, 2013; Chaara et al., Frontiers in Immunol, 2018; Ritvo et al., PNAS, 2018; Mhanna et al., Diabetes, 2021; Trück et al., eLife, 2021; Quiniou et al., eLife, 2023; Mhanna et al., Cell Rep Methods, 2024; Mhanna et al., Nat Rev Primers Methods, 2024), and (iii) the curation and quality control of public TCR databases (Jouannet et al., NAR Genomics and Bioinformatics 2025). The current study applies these optimized and peer-reviewed pipelines, along with additional internal quality controls that we have been implemented over the years, ensuring the highest possible analytical standards for TCR repertoire studies.

      We therefore respectfully feel that the phrase “insufficient analytical rigor” does not accurately reflect the methodological robustness of our work. This perception is also in contrast to the comment made by one of the reviewers, who explicitly noted that “overall, the methodologies appear to be sound.”

      We would therefore be grateful if, upon reviewing our detailed point-by-point responses, the editors could reconsider this statement and tone it down in the final editorial summary.

      With regard to comment that our results “incompletely support the central claims”, we will leave it to the reader’s judgement. We believe that our work provides a robust and transparent basis for future research into TCR repertoire, autoimmunity, and women’s health.

      Reviewer 1 (Public reviews):

      Summary

      The goal of this paper was to determine whether the T cell receptor (TCR) repertoire differs between a male and a female human. To address this, this group sequenced TCRs from doublepositive and single-positive thymocytes in male and female humans of various ages. Such an analysis on sorted thymocyte subsets has not been performed in the past. The only comparable dataset is a pediatric thymocyte dataset where total thymocytes were sorted.

      They report on participant ages and sexes, but not on ethnicity, race, nor provide information about HLA typing of individuals. Though the experiments themselves are heroic, they do represent a relatively small sampling of diverse humans. They observed no differences in TCRbeta or TCRalpha usage, combinational diversity, or differences in the length of the CDR3 region, or amino acid usage in the CD3aa region between males or females. Though they observed some TCRbeta CD3aa sequence motifs that differed between males and females, these findings could not be replicated using an external dataset and therefore were not generalizable to the human population.

      They also compared TCRbeta sequences against those identified in the past using computational approaches to recognize cancer-, bacterial-, viral-, or autoimmune-antigens. They found very little overlap of their sequences with these annotated sequences (depending on the individual, ranging from 0.82-3.58% of sequences). Within the sequences that were in overlap, they found that certain sequences against autoimmune or bacterial antigens were significantly over-represented in female versus male CD8 SP cells. Since no other comparable dataset is available, they could not conclude whether this is a finding that is generalizable to the human population.

      Strengths:

      This is a novel dataset. Overall, the methodologies appear to be sound. There was an attempt to replicate their findings in cases where an appropriate dataset was available. I agree that there are no gross differences in TCR diversity between males and females.

      We appreciate the positive feedback from the reviewer regarding these points.

      Weaknesses:

      Overall, the sample size is small given that it is an outbred population. The cleaner experiment would have been to study the impact of sex in a number of inbred MHC I/II identical mouse strains or in humans with HLA-identical backgrounds.

      We respectfully disagree with the reviewer’s statement. We firmly believe that the issue we are dealing with, namely sex-based differences in thymic TCR selection relevant to autoimmunity, should be investigated more thoroughly in the general human population than in inbred mouse models.

      While inbred mouse strains, being MHC I/II identical, eliminate the complexity of MHC variation, this comes at the cost of biological relevance. Firstly, a discrepancy in TCR generation or selection may only become apparent under specific MHC contexts, which could easily be overlooked when studying a single inbred strain. Secondly, inbred strains frequently contain fixed genetic variants that may influence thymic selection or immune regulation. This has the potential to introduce confounding effects rather than reducing them and not solving the generalization issue.

      We are in full agreement that an HLA-matched human cohort would reduce inter-individual variability. However, such sampling is impossible in practice, as our thymic tissues were obtained from deceased organ donors, a collection effort that was, as the reviewer rightly noted, “heroic”. Despite these inherent limitations, the patterns we observed were consistent across multiple analytical approaches, lending robustness to our findings.

      We now explicitly acknowledge this limitation in the Discussion of the revised manuscript and explain why, despite this constraint, our study provides meaningful and biologically relevant insights into human TCR selection and sex-related immune differences.

      It is unclear whether there was consensus between the three databases they used regarding the antigens recognized by the TCR sequences. Given the very low overlap between the TCR sequences identified in these databases and their dataset, and the lack of replication, they should tone down their excitement about the CD8 T cell sequences recognizing autoimmune and bacterial antigens being over-represented in females.

      The three databases used in this study - McPAS-TCR, IEDB, and VDJdb - provide complementary and partially non-overlapping specificity landscapes. McPAS-TCR is enriched for pathology-associated TCRs, while IEDB and VDJdb contain a higher proportion of viral specificities. Combining them therefore broadens the antigenic spectrum accessible for analysis and represents the most comprehensive approach currently possible to capture the diversity of TCR–antigen annotations.

      With regard to the limited overlap between our dataset and these databases, this observation should be interpreted with caution. While the overlap may appear minimal at first glance, it is a biologically significant phenomenon. The public databases collectively contain only a minute fraction of the total universe of TCR specificities, estimated to exceed 10<sup>15-21</sup> possible receptors in humans. In this context, the observation of any overlap at all, particularly with coherent biological patterns such as the overrepresentation of autoimmune- and bacterialassociated TCRs in females, is noteworthy.

      We have included a short clarification in the Discussion of the revised manuscript to make this point explicit and to further temper the language describing this finding.

      The dataset could be valuable to the community.

      We thank the reviewer for highlighting the potential value of this dataset to the community. It will be made publicly available on the NCBI website. We would like to clarify that our intention has always been to make this dataset publicly available; therefore, we take back any incorrect suggestions made in the original submission.

      Reviewer #1 (Recommendations for the authors):

      I would just recommend toning down the excitement about autoimmune TCRs being overrepresented in females. Then the conclusions will be in alignment with their results.

      We thank the reviewer for this constructive recommendation. We would like to express our full support for the editorial transparency policies of eLife, which allow readers to access to both the reviewers’ comments and our detailed responses, enabling them to form their own informed opinions regarding our conclusions.

      Nevertheless, we have moderated some of our wording.

      Reviewer #2 (Public review):

      Summary:

      This study addresses the hypothesis that the strikingly higher prevalence of autoimmune diseases in women could be the result of biased thymic generation or selection of TCR repertoires. The biological question is important, and the hypothesis is valuable. Although the topic is conceptually interesting and the dataset is rich, the study has a number of major issues that require substantial improvement. In several instances, the authors conclude that there are no sex-associated differences for specific parameters, yet inspection of the data suggests visible trends that are not properly quantified. The authors should either apply more appropriate statistical approaches to test these trends or provide stronger evidence that the observed differences are not significant. In other analyses, the authors report the differences between sexes based on a pulled analysis of TCR sequences from all the donors, which could result in differences driven by one or two single donors (e.g., having particular HLA variants) rather than reflect sex-related differences.

      Strengths:

      The key strength of this work is the newly generated dataset of TCR repertoires from sorted thymocyte subsets (DP and SP populations). This approach enables the authors to distinguish between biases in TCR generation (DP) and thymic selection (SP). Bulk TCR sequencing allows deeper repertoire coverage than single-cell approaches, which is valuable here, although the absence of TRA-TRB pairing and HLA context limits the interpretability of antigen specificity analyses. Importantly, this dataset represents a valuable community resource and should be openly deposited rather than being "available upon request."

      We thank the reviewer for highlighting the potential value of this dataset to the community. It will be made publicly available on the NCBI website. We would like to clarify that our intention has always been to make this dataset publicly available; therefore, we take back any incorrect suggestions made in the original submission.

      Weaknesses:

      Major:

      The authors state that there is "no clear separation in PCA for both TRA and TRB across all subsets." However, Figure 2 shows a visible separation for DP thymocytes (especially TRA, and to a lesser degree TRB) and also for TRA of Tregs. This apparent structure should be acknowledged and discussed rather than dismissed.

      We thank the reviewer for this careful observation. Discussing apparent “trends” rather than statistically significant results is indeed a nuanced issue, as over-interpretation of visual patterns is usually discouraged. We agree that, within the specific context of TCR repertoire analyses, visual structures in multivariate projections such as PCA can provide useful contextual information.

      However, we have not identified a striking trend in our representation. We therefore chose to avoid overemphasizing these visual impressions in the text.

      Supplementary Figures 2-5 involve many comparisons, yet no correction for multiple testing appears to be applied. After appropriate correction, all the reported differences would likely lose significance. These analyses must be re-evaluated with proper multiple-testing correction, and apparent differences should be tested for reproducibility in an external dataset (for example, the pediatric thymus and peripheral blood repertoires later used for motif validation).

      As is standard in exploratory immunogenomic studies, including TCR repertoire analyses, our objective was to uncover broad biological patterns rather than to establish definitive statistical associations. In analyses that are discovery-oriented, correction for multiple testing, while essential in confirmatory contexts, is not mandatory and may even obscure meaningful trends by inflating type II error rates. Our objective was therefore to highlight consistent directional patterns across analytical layers, to guide future confirmatory work rather than to make categorical claims.

      We also note that this comment somewhat contrasts with the earlier suggestion to discuss trends that are not statistically significant.

      With regard to the proposal to verify our observations using an external dataset, we are in full agreement that independent confirmation would be beneficial. However, as reviewer 1 rightly emphasized, the generation of such datasets from sorted human thymocyte subsets is “heroic” and has rarely, if ever, been achieved. We are aware of no existing dataset that provides comparable material or analytical depth.

      The available single-cell thymic dataset (Park et al., Science 2020) includes only a few hundred sequences per donor, which is significantly less than the number of sequences in our study. This limited dataset is not adequate for cross-validation or for representing the full complexity of thymic TCR repertoires.

      As with the pediatric thymus dataset, the lack of statistical power in the dataset due to the small number of female subjects (only three) means that sex-related differences in V/J usage cannot be evaluated.

      Finally, the peripheral blood dataset is not appropriate for validating thymic generation or selection processes, as it reflects post-thymic selection and antigen-driven remodeling, making it impossible to distinguish peripheral effects from thymic influences.

      For these reasons, none of the currently available datasets provides a sufficiently clean or powerful framework to test the reproducibility of subtle sex-associated effects on thymic TCR repertoires. Nevertheless, we fully agree that confirmation in an independent and larger cohort will be an important next step to refine these exploratory findings and assess their generalizability to a broader human population.

      Supplementary Figure 6 suggests that women consistently show higher Rényi entropies across all subsets. Although individual p-values are borderline, the consistent direction of change is notable. The authors should apply an integrated statistical test across subsets (for example, a mixed-effects model) to determine whether there is an overall significant trend toward higher diversity in females.

      We agree that Rényi entropies tend to show a consistent direction of change across subsets, with slightly higher values observed in females. In this section, our objective was to provide a descriptive overview of diversity patterns for each thymic subset. This is because these subsets are biologically distinct and therefore require individual analysis, as we previously demonstrated using the same dataset (Isacchini et al, PRX Life. 2024). Therefore, while a mixed-effects approach could in principle be applied to test for an overall trend, such an analysis would rely on the assumption of a common sex effect across heterogeneous cell types.

      It is important to note that the complete dataset has now been made publicly available, enabling interested researchers to perform additional integrative or model-based analyses to further explore these diversity trends.

      Figures 4B and S8 clearly indicate enrichment of hydrophobic residues in female CDR3s for both TRA and TRB (excluding alanine, which is not strongly hydrophobic). Because CDR3 hydrophobicity has been linked to increased cross-reactivity and self-reactivity (see, e.g., Stadinski et al., Nat Immunol 2016), this observation is biologically meaningful and consistent with higher autoimmune susceptibility in females.

      We thank the reviewer for this insightful comment.

      As correctly noted, increased hydrophobicity at specific CDR3β positions has been linked to enhanced cross-reactivity and self-reactivity, as described by Stadinski et al. (Nat Immunol 2016), and we reference this work in the manuscript.

      In our analysis corresponding to Figure 4B (TRB), hydrophobicity was quantified at the sequence level by computing, for each unique CDR3β sequence, the overall proportion of hydrophobic amino acids across the CDR3 loop. This approach aligns with that of Lagattuta et al. (Nat Immunol 2022), whose code we adapted to accommodate longer CDR3s. This global hydrophobicity metric captures overall composition, but, by its construction, does not account for positional context, the key mechanism implicated by Stadinski et al.

      As outlined in our original Figure 4C, the results were obtained through a position-based amino acid analysis. For each CDR3β sequence, we extracted the amino acid at every IMGTdefined CDR3 position (p104–p118) and quantified, at each position, the percentage of unique sequences containing each amino acid. Positions p109 and p110 correspond to the p6–p7 sites highlighted by Stadinski et al. as functionally relevant for self-reactivity. This analysis evaluates positional composition independently of clonotype frequency, focusing specifically on hydrophobic amino acid classes.

      Following the recommendation of the reviewer, the revised manuscript has removed alanine (which is only weakly hydrophobic) has been excluded from the hydrophobic residue set. With this refined definition, we observe a significant enrichment of hydrophobic amino acids at p109 in CD8 T cell repertoires from females, with similar but non-significant trends at p109 in DP and CD4 Teff cells and at p110 in CD8 cells (see new Figure 4C).

      As outlined in the revised Methods, Results, and Discussion sections, Figure 4C focuses exclusively on positional hydrophobic amino acid usage. This was previously implicit, although it was noted in the legend and visually represented in the plots.

      The majority of "hundreds of sex-specific motifs" are probably donor-specific motifs confounded by HLA restriction. This interpretation is supported by the failure to validate motifs in external datasets (pediatric thymus, peripheral blood). The authors should restrict analysis to public motifs (shared across multiple donors) and report the number of donors contributing to each motif.

      We fully agree that donor-specific and HLA-restricted motifs represent a major potential confounder in repertoire-level comparisons. To minimize this potential bias, our analysis was explicitly restricted to public motifs, as clearly stated in the Materials and Methods section:

      “Additional filters were applied so that: (i) a motif includes public CDR3aa sequences (shared by at least two individuals); (ii) a significant enrichment is detected (Fisher’s exact test, p < 0.01); and (iii) a usage difference between groups of at least twofold (Wilcoxon test, p < 0.05).”

      Accordingly, every motif reported in the manuscript is supported by at least two independent donors, ensuring that no motif reflects an individual- or HLA-specific effect (see Supplementary Figures 10-13[previously Supplementary Figure 9]). We have now added a more explicit mention of the number of donors contributing to each motif in the figure legend and have clarified this point in the revised Methods and Results sections to make this criterion more visible to readers.

      When comparing TCRs to VDJdb or other databases, it is critical to consider HLA restriction. Only database matches corresponding to epitopes that can be presented by the donor's HLA should be counted. The authors must either perform HLA typing or explicitly discuss this limitation and how it affects their conclusions.

      We respectfully disagree with the assertion that HLA typing is necessary for the type of comparative analysis we have conducted. While it is true that HLA molecules present peptides to TCRs and thereby contribute to the tripartite interaction determining T cell activation, extensive evidence indicates that the CDR3 region, particularly CDR3β, is the dominant determinant of antigen specificity. This finding is supported by structural and computational studies (Madi et al., eLife, 2017; Huang et al., Nat. Biotech., 2020; MayerBlackwell et al., Methods Mol. Biol., 2022) showing that CDR3β residues are responsible for the majority of peptide contacts, whereas CDR1 and CDR2 primarily interact with the MHC framework.

      As emphasized in several recent benchmarking studies (e.g., Springer et al., Front Immunol, 2021), CDR3β sequence composition alone captures most of the information required for specificity inference. Consequently, widely used and validated computational tools such as GIANA (Zhang et al. Nat. Commun. 2021), iSMART (Zhang et al. Clin. Cancer Res. 2020), and ATMTCR (Cai et al. Front. Immunol. 2022) rely exclusively on CDR3β aminoacid sequences and still achieve high predictive performance.

      Our analysis aligns with this well-established paradigm. While we agree that integrating donor HLA typing would refine epitope-level annotation and reduce potential noise, the absence of HLA data does not invalidate the comparative framework we used, which focuses on relative representation of annotated specificities across groups rather than on individual TCR–HLA–peptide triads.

      Although the age distributions of male and female donors are similar, the key question is whether HLA alleles are similarly distributed. If women in the cohort happen to carry autoimmuneassociated alleles more often, this alone could explain observed repertoire differences. HLA typing and HLA comparison between sexes are therefore essential.

      To address the issue of any potential differences in HLA background, we examined the subset of adult donors for whom HLA typing information was available (HLA-A, HLA-B, HLADR, and HLA-DQB; n = 16). Within this subset, the distribution of HLA alleles was relatively balanced between males and females (as illustrated by the heatmap showing HLA class II expression patterns and HLA class I family grouping in Author response image 1). This analysis suggests that the sex-associated differences in the repertoire observed in our study are unlikely to be driven solely by unequal representation of autoimmune-associated HLA alleles.

      We acknowledge, however, that complete HLA information was not available for all donors, which remains a limitation of the dataset.

      Author response image 1.

      In some analyses (e.g., Figures 8C-D) data are shown per donor, while others (e.g., Fig. 8A-B) pool all sequences. This inconsistency is concerning. The apparent enrichment of autoimmune or bacterial specificities in females could be driven by one or two donors with particular HLAs. All analyses should display donor-level values, not pooled data.

      While Figures 8A–B present pooled data to summarize global trends, the corresponding donor-level analyses were provided in Supplementary Figures 15B and 16 (previously Supplementary Figures 11B and 12). In these, each individual is shown separately, with each point representing an individual. It is important to note that these donor-resolved plots do not reveal any sample-specific driver: the patterns observed in the pooled data remain consistent across donors, without any single individual accounting for the apparent enrichments. As outlined in the revised manuscript, readers now directed to the relevant supplementary figures for further clarification.

      The reported enrichment of matches to certain specificities relative to the database composition is conceptually problematic. Because the reference database has an arbitrary distribution of epitopes, enrichment relative to it lacks biological meaning. HLA distribution in the studied patients and HLA restrictions of antigens in the database could be completely different, which could alone explain enrichment and depletions for particular specificities. Moreover, differences in Pgen distributions across epitopes can produce apparent enrichment artifacts. Exact matches typically correspond to high-Pgen "public" sequences; thus, the enrichment analysis may simply reflect variation in Pgen of specific TCRs (i.e., fraction of high-Pgen TCRs) across epitopes rather than true selection. Consequently, statements such as "We observed a significant enrichment of unique TRB CDR3aa sequences specific to self-antigens" should be removed.

      We respectfully disagree with the conclusion that our enrichment analysis lacks biological meaning. Our approach directly involves a direct comparison of the same set of observed TCR sequences between males and females. Consequently, any potential biases related to generation probability (Pgen), which affect all sequences equally, cannot account for the observed sex-specific differences. To summarize, because the comparison is performed on the same set of sequences, changes in the probability of generation across epitopes cannot explain the differences seen between the sexes.

      We do agree, however, that the composition of the reference databases may influence apparent enrichment patterns, as these resources contain uneven distributions of epitope categories and often incomplete information regarding HLA restriction. It should be noted that this limitation is inherent to all database-based annotation approaches, a fact which is explicitly acknowledged in the revised Discussion.

      The overrepresentation of self-specific TCRs in females is the manuscript's most interesting finding, yet it is not described in detail. The authors should list the corresponding self-antigens, indicate which autoimmune diseases they relate to, and show per-donor distributions of these matches.

      We thank the reviewer for this constructive suggestion.

      As recommended, we have expanded the description of the self-specific TCRs identified in our dataset and now provide this information in Supplementary Table 2 of the revised manuscript. Specifically, the table lists the corresponding self-antigens and the autoimmune diseases with which they are associated. In our curated database, these annotations primarily correspond to celiac disease and type 1 diabetes, which were the two autoimmune contexts explicitly defined in the manually curated reference datasets.

      For the “cancer” specificity group, we have clarified that antigen assignments were established based on (i) annotations available in the original databases (IEDB, VDJdb, McPAS-TCR) and (ii) cross-referencing with additional resources, including the Human Protein Atlas, the Cancer Antigenic Peptide Database (de Duve Institute), and the Cancer Antigen Atlas (Yi et al., iScience 2021), to ensure consistency in the classification of cancer and neoantigen specificities. Please refer to the Materials and Methods section for a full description of the procedure for this specific assignment.

      Donor-level distributions of these self-specific matches are now shown in Supplementary Figures 15B and 16 (previously Supplemental Figures 11B and 12), allowing direct visualization of inter-donor variability. Importantly, these plots confirm that the observed enrichment in females is not driven by a single individual, further supporting the robustness of the finding.

      The concept of poly-specificity is controversial. The authors should clearly explain how polyspecific TCRs were defined in this study and highlight that the experimental evidence supporting true polyspecificity is very limited (e.g., just a single TCR from Figure 5 from Quiniou et al.).

      We certainly agree (and regret) that the concept of TCR polyspecificity remains a subject of debate and often underappreciated in the field of immunology. As Don Mason famously discussed in his seminal essay “A very high cross-reactivity is an essential feature of the TCR” (doi: 10.1016/S0167-5699(98)01299-7) published over 25 years ago, both theoretical and experimental evidence indicates that each TCR can, in principle, recognize millions of distinct peptides, albeit with variable avidity.

      Although this principle is widely accepted, it is frequently overlooked in the field of experimental immunology. In this area, anything that deviates from strict monospecificity is often disregarded as noise.

      In our own analyses of large-scale TCR repertoires, we have repeatedly observed that many CDR3 sequences are annotated with multiple specificities across different databases, often corresponding to peptides from unrelated organisms. As demonstrated in Quiniou et al. (eLife 2023), such polyreactive TCRs exhibit distinctive features, including biased physicochemical composition, and tend to be enriched in various biological contexts. In our preliminary study of such TCRs, which have the capacity to be specific for multiple viral- and self- epitopes, we hypothesized that they may serve as a first line of defense against pathogens and also be involved in triggering autoimmunity. We therefore consider it important to report this phenomenon rather than omit it, especially given its potential relevance to both protective immunity and autoimmunity.

      In the present study, polyspecific TCRs were defined operationally as TRB CDR3aa sequences associated with a minimum of two distinct specificity groups, corresponding either to different microbial species or to multiple antigen categories within the curated database. Therefore, our definition captures broader antigenic groupings rather than epitope-level binding events.

      We fully acknowledge that direct experimental evidence for true molecular-level polyspecificity remains limited. Indeed, as the reviewer notes, only a single TCR with multiepitope reactivity has been rigorously demonstrated to date (Quiniou et al.2023). Consequently, our analysis does not make claims about structural promiscuity; instead, it uses database-annotated cross-reactivity as a proxy to explore broader repertoire-level patterns.

      As outlined in the Methods section, this definition has been clarified and its discussion expanded in the Discussion to explicitly address these conceptual and methodological nuances.

      Minor:

      Clarify why the Pgen model was used only for DP and CD8 subsets and not for others.

      As noted, computing Pgen values involves two steps: (i) training a generative model of V(D)J recombination using IGoR, and (ii) estimating generation probabilities with OLGA based on that model. Both steps require a significant amount of computing power, especially when applied to large repertoires across multiple subsets. For this reason, we focused the analysis on DP thymocytes, which represent the repertoire prior to thymic selection, and CD8 T cells after CD8 selection.

      The Methods section should define what a "high sequence reliability score" is and describe precisely how the "harmonized" database was constructed.

      Briefly, the annotated database used in this study was constructed in accordance with the procedure established in our previously published work (Jouannet et al., NAR Genomics and Bioinformatics, 2025). The study integrates three publicly available resources, IEDB, VDJdb, and McPAS-TCR, which were collected as of October 2023. These three datasets were then merged into a single harmonized compendium, undergoing extensive standardization. When entries shared identical information across databases (same V–CDR3–J for both TRA and TRB, same epitope, organism, PubMed ID, and cell subset), only one representative was kept; discrepant or incomplete entries were retained to preserve information. We then assigned a sequence reliability score, the Verified Score (VS), following the verification strategy used by IEDB. The scale ranges from 0 to 2 and reflects the concordance between calculated and curated TRA/TRB CDR3 sequences (2 = both TRA and TRB present are verified, 1.1 = only TRA verified, 1.2 = only TRB verified, 0 = no verified chain). A second score, the Antigen Identification Score (AIS), is used to rank antigen-identification methods on a scale of 0 to 5, according to the strength of the experimental evidence supporting them.

      In the present study, “high reliability” refers to sequences with a verified TRB CDR3aa chain (VS ≥ 1.2) and an AIS score corresponding to T cells in vitro stimulation with a pathogen, protein or peptide, or pMHC X-mer sorting (> 3.2, excluding categories 4.1 and 4.2), ensuring that downstream analyses were performed on a rigorously curated and biologically trustworthy dataset. The Methods section now explicitly details these criteria.

      The statement "we generated 20,000 permuted mixed-sex groups" is unclear. It is not evident how this permutation corrects for individual variation or sex bias. A more appropriate approach would be to train the Pgen model separately for each individual's nonproductive sequences (if the number of sequences is large enough).

      The objective of this analysis was to determine whether the enrichment of TRBV06-5 in females was due to random grouping of individuals or whether it was attributable to sex itself. To do so, we generated all possible perfectly mixed groups of donors (i.e., groups containing an equal number of male and female donors) for the concerned thymocyte subset, and then performed 20,000 random pairwise comparisons between such mixed groups. For each comparison, we tested the TRBV06-5 usage between the two mixed groups. This procedure directly evaluates whether group composition (independent of sex) could spuriously generate differences in TRBV usage. Notably, none of these 20,000 comparisons between the two mixed groups yielded a statistically significant difference in TRBV06-5 usage. In contrast, when comparing the true male and female groups, a significant difference was identified. This demonstrates that the signal we observe is not driven by random donor grouping or individual-level variation, but is specifically associated with sex. It is important to note that this analysis, which is designed to exclude spurious group effects, is rarely performed in published repertoire studies, yet it provides an important internal control for robustness.

      Reviewer #2 (Recommendations for the authors):

      (1) Data availability "upon request" is unacceptable. All raw and processed data, as well as scripts used for analysis and figure generation, must be publicly deposited before publication.

      We would like to clarify that our intention has always been to make this dataset publicly available. It was a mistake to suggest otherwise in the original submission.

      (2) At the beginning of the Results section, include a brief description of the dataset: number of donors, sex ratio, age range, number of samples per subset, and sorting strategy. Although Figure 1 shows this, the information should also be mentioned in the main text.

      In line with the recommendation, we have now added a summary of the cohort characteristics at the beginning of the Results section. This includes the number of donors, sex ratio, age range, number of samples per subset, and the sorting strategy used. While this information was already included in Figure 1, we concur that including it directly in the main text enhances readability.

      (3) Report the number of cells and unique clonotypes analyzed per individual. Rank-frequency plots (in log-log coordinates) would be helpful.

      We have now added, for each donor and each subset, the number of cells, and additionally for each chain, the number of total and unique clonotypes analyzed. This information is provided in the revised manuscript in a new supplementary table (Supplemental Table 1).

      These plots have been integrated into the revised manuscript as Supplementary Figure 2.

      (4) For analysis in Figure 4B, the total fraction of hydrophobic amino acids should be calculated for each patient separately, and values for men and women should be compared (analogously to Figure 4C, but for the whole CDR3 and excluding alanine).

      Please note that the TRB CDR3aa composition in Figure 4B has already been quantified at the individual level. For each unique TRB CDR3aa sequence, we computed the proportion of each of the 20 amino acids across the CDR3β loop, then summarized these values per donor (mean per individual). The log2 fold change displayed in Figure 4B (and supplemental Figure 9 for TRA) is calculated from the median donor-level values for females versus males, rather than from pooled CDR3s. It is intended as descriptive, “global” view of amino acid usage within the central CDR3 region. Hydrophobicity was not used directly in the computation, but is indicated only by bar color, based on the Kyte-Doolittle- derived IMGT classification. This provides an observational overview of amino acid composition in the central CDR3 region.

      As the mechanistic link between hydrophobicity and self-reactivity described by Stadinski et al. is explicitly position-dependent, we consider positional analyses to be the most appropriate method for formally interrogating this hypothesis, as we did in Figure 4C. Here, our primary focus was on the position-specific usage of hydrophobic amino acids at IMGT positions p109-p110. These positions correspond to the central p6-p7 positions described by Stadinski et al. For each individual, we computed the proportion of unique TRB CDR3aa sequences carrying a hydrophobic amino acid at a given position.

      Accordingly, in the revised manuscript we refined the Figure 4C by excluding alanine due to its weak hydrophobic property (as recommended by the reviewer) This positional composition analysis now reveals a statistically significant increase in hydrophobic usage at p109 in female CD8 repertoires, with similar, though non-significant, trends at p109 in DP and CD4Teff ad at p110 in CD8 cells. Figure 4B is therefore retained as an exploratory overview of amino acid composition usage along the CDR3 loop, while Figure 4C is used for the more specific question of hydrophobicity and potential cross-reactivity.

      The Methods section has been expanded to provide clearer descriptions of these computations, and the Results and Discussion sections corresponding to Figures 4B-C (and supplemental Figure 9) have been revised to make the rationale, implementation, and interpretation of these hydrophobicity analyses more explicit.

      (5) Figure 6 shows a trend toward higher clustering of Treg TCRs in males, which could relate to the lower incidence of autoimmunity in men. The authors could test whether specific Treg clusters are male-specific and shared among male donors.

      As shown in Figure 6, a clear trend towards higher similarity among Treg CDR3aa sequences in males is evident, as indicated by the proportion of sequences included in clusters and in the overall similarity density. However, identifying “male-specific clusters” shared across donors is not straightforward in our analytical framework.

      In our approach, for each cell subset, CDR3aa sequences were downsampled 100 times to the smallest sample size, and clustering was repeated at each iteration. Therefore, the clusters’ identities are not consistent across iterations. The clusters depend on the specific subset of sequences selected at each downsampling step, as well as on their underlying Pgen distribution. Therefore, it is not possible to reliably assess whether specific clusters are systematically “male-shared”. This is because cluster composition is a function of stochastic resampling rather than of biological structure. For this reason, a comparison of cluster identities across donors would not produce interpretable results.

    1. Author response:

      The following is the authors’ response to the original reviews

      We thank the reviewers for their constructive feedback, which has helped preparing a substantially improved manuscript. In response to concerns about the conceptual distinction between prediction and stimulus dependency, we have fundamentally restructured the paper around the notion of passive control systems. This involved rewriting the Abstract, Introduction, and large portions of the Results (~60% of text revised).

      Key changes:

      - New analyses on Goldstein et al. (2022) data. We demonstrate that our findings—including the insufficiency of proposed corrections—generalise to the original dataset (Figures S2B, S3B, S5C, S6B).

      - Clarified novel contribution. We now make explicit that prior control analyses (residualisation, bigram removal) do not address the concern, because hallmarks persist in passive systems that cannot predict.

      - Proposed criterion for future work. Pre-onset neural encoding can only count as evidence for prediction if it exceeds a passive baseline (e.g., acoustics).

      We believe the revision offers a clearer, more rigorous contribution and provides a constructive framework for evaluating claims of neural prediction.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This paper tackles an important question: What drives the predictability of pre-stimulus brain activity? The authors challenge the claim that "pre-onset" encoding effects in naturalistic language data have to reflect the brain predicting the upcoming word. They lay out an alternative explanation: because language has statistical structure and dependencies, the "pre-onset" effect might arise from these dependencies, instead of active prediction. The authors analyze two MEG datasets with naturalistic data.

      Strengths:

      The paper proposes a very reasonable alternative hypothesis for claims in prior work. Two independent datasets are analyzed. The analyses with the most and least predictive words are clever, and nicely complement the more naturalistic analyses.

      Weaknesses:

      I have to admit that I have a hard time understanding one conceptual aspect of the work, and a few technical aspects of the analyses are unclear to me. Conceptually, I am not clear on why stimulus dependencies need to be different from those of prediction. Yes, it is true that actively predicting an upcoming word is different from just letting the regression model pick up on stimulus dependencies, but given that humans are statistical learners, we also just pick up on stimulus dependencies, and is that different from prediction? Isn't that in some way, the definition of prediction (sensitivity to stimulus dependencies, and anticipating the most likely upcoming input(s))?

      We thank the reviewer for this comment, which highlights that the previous version wasn’t sufficiently clear. Conceptually, the difference is critical: it is the difference between passively encoding or representing the stimulus (like e.g., a spectrogram of the stimulus would), and actively generating predictions.

      We have substantially changed the framing of the paper to put the notion of control systems centre-stage. One such control system is the speech acoustics: they encode the stimulus (and thus its dependencies) but cannot predict. When we observe the "hallmarks of prediction" in acoustics, this demonstrates the hallmarks can arise without any prediction.

      This brings me to some of the technical points: If the encoding regression model is learning one set of regression weights, how can those reflect stimulus dependencies (or am I misunderstanding which weights are learned)? Would it help to fit regression models on for instance, every second word or something (that should get rid of stimulus dependencies, but still allow to test whether the model predicts brain activity associated with words)? Or does that miss the point? I am a bit unclear as to what the actual "problem" with the encoding model analyses is, and how the stimulus dependency bias would be evident. It would be very helpful if the authors could spell out, more explicitly, the precise predictions of how the bias would be present in the encoding model.

      Different weights are estimated per time point in the time-resolved regression. This allows the model to learn how the response to words unfolds, but also to learn different stimulus dependencies at each timepoint. Fitting on every second word would reduce but not eliminate the problem. Our control system approach provides a more principled test. We have clarified the mechanism in the Introduction (lines 82-90), explaining how correlations between neighbouring words allow the regression model to predict prior neural activity without assuming pre-activation.

      Reviewer #2 (Public Review):

      Summary:

      At a high level, the reviewers demonstrate that there is an explanation for pre-word-onset predictivity in neural responses that does not invoke a theory of predictive coding or processing. The paper does this by demonstrating that this predictivity can be explained solely as a property of the local mutual information statistics of natural language. That is, the reason that pre-word onset predictivity exists could simply boil down to the common prevalence of redundant bigram or skip-gram information in natural language.

      Strengths:

      The paper addresses a problem of significance and uses methods from modern NeuroAI encoding model literature to do so. The arguments, both around stimulus dependencies and the problems of residualization, are compellingly motivated and point out major holes in the reasoning behind several influential papers in the field, most notably Goldstein et al. This result, together with other papers that have pointed out other serious problems in this body of work, should provoke a reconsideration of papers from encoding model literature that have promoted predictive coding. The paper also brings to the forefront issues in extremely common methods like residualization that are good to raise for those who might be tempted to use or interpret these methods incorrectly.

      Weaknesses:

      The authors don't completely settle the problem of whether pre-word onset predictivity is entirely explainable by stimulus dependencies, instead opting to show why naive attempts at resolving this problem (like residualization) don't work. The paper could certainly be better if the authors had managed to fully punch a hole in this.

      We thank the reviewer for their assessment.

      We believe our paper does punch the hole that can be punched, which is a hole in the method. Our control demonstrates that adjusting the features (X matrix) cannot address dependencies that persist in the signal itself (Y matrix). Because the hallmarks emerge in a system that cannot predict (even after linearly removing the previous stimulus) attributing pre-onset encoding performance to neural prediction (rather than stimulus structure) is fundamentally ambiguous, and different (e.g. variance partitioning) approaches would suffer from the same ambiguity. We have reframed the manuscript to make this argument more clearly.

      Reviewer #3 (Public Review):

      Summary:

      The study by Schönmann et al. presents compelling analyses based on two MEG datasets, offering strong evidence that the pre-onset response observed in a highly influential study (Goldstein et al., 2022) can be attributed to stimulus dependencies, specifically, the auto-correlation in the stimuli—rather than to predictive processing in the brain. Given that both the pre-onset response and the encoding model are central to the landmark study, and that similar approaches have been adopted in several influential works, this manuscript is likely to be of high interest to the field. Overall, this study encourages more cautious interpretation of pre-onset responses in neural data, and the paper is well written and clearly structured.

      Strengths:

      (1) The authors provide clear and convincing evidence that inherent dependencies in word embeddings can lead to pre-activation of upcoming words, previously interpreted as neural predictive processing in many influential studies.

      (2) They demonstrate that dependencies across representational domains (word embeddings and acoustic features) can explain the pre-onset response, and that these effects are not eliminated by regressing out neighboring word embeddings - an approach used in prior work.

      (3) The study is based on two large MEG datasets, showing that results previously observed in ECoG data can be replicated in MEG. Moreover, the stimulus dependencies appear to be consistent across the two datasets.

      We’d like to thank the reviewer for their comments on our preprint.

      Weaknesses:

      (1) To allow a more direct comparison with Goldstein et al., the authors could consider using their publicly available dataset.

      We thank the reviewer for this suggestion. The Goldstein dataset was not publicly available when we conducted this research. However, we have now applied our control analyses to their stimulus material, and found that the exact same problem applies to their dataset, too.

      We have added analyses of the Goldstein et al. (2022) podcast stimulus throughout the paper. Results are shown in Figures S2B, S3B, S5C, and S6B. Critically, we observe the same pattern: both hallmarks emerge in the acoustic control system, and residualisation fails to eliminate them. This demonstrates that our findings generalise to the very dataset used to establish pre-onset encoding as evidence for neural prediction.

      (2) Goldstein et al. already addressed embedding dependencies and showed that their main results hold after regressing out the embedding dependencies. This may lessen the impact of the concerns about self-dependency raised here.

      We thank the reviewer for raising this point, as it reveals we failed to convey a central argument in the previous version. Goldstein et al.'s control analysis did not address the concern. We show that even after the control analyses that Goldstein et al. perform (removing bigrams, regressing out embedding dependencies) the "hallmarks of prediction" still emerge when applying the analysis to a passive control system that by definition does not predict: the speech acoustics. We now also show this in their data.

      To better convey this critical point, around the concept of "passive control systems". We now first establish that the hallmarks appear in acoustics (Figure 3), then show that residualisation fails to remove them (Figure 4). This makes explicit that any claim about "controlling for dependencies" must be validated against a system that cannot predict.

      (3) While this study shows that stimulus dependency can account for pre-onset responses, it remains unclear whether this fully explains them, or whether predictive processing still plays a role. The more important question is whether pre-activation remains after accounting for these confounds.

      We thank the reviewer for this question, and we agree that the question whether pre-activation occurs is an important and interesting one. However, we ask a different question in our study: Our goal is not to definitively establish whether the brain predicts during language processing; it is to scrutinise what counts as evidence for prediction, and to correct for some highly influential claims made in the literature. The reviewer asks whether pre-activation remains "after accounting for these confounds." But the point we are trying to make is that in this analytical framework, one cannot analytically account for these confounds: corrections to the X matrix leave dependencies in the data itself intact, as the acoustic control demonstrates.

      We do offer recommendations for future work. The passive control systems approach can serve as a benchmark: pre-onset neural encoding (or decoding) can only count as evidence for prediction if it exceeds what is observed in a passive control system like acoustics (which is not what we observe). Additionally, the field could move toward less naturalistic stimuli with tighter experimental controls, reducing the correlations that make this attribution so difficult. Developing a new definitive test is beyond the scope of our paper, but we believe applying this benchmark is a necessary first step.

      To make this clearer, we have rewritten the Discussion to explicitly state this criterion (lines 331-340) and to outline these recommendations for future work (lines 337-340). We have also added a paragraph extending our argument to decoding approaches (lines 343-354), noting that the same ambiguity applies regardless of analytical direction.

      Recommendations for Authors:

      Reviewer #1 (Recommendations for Authors):

      As per my "Weakness" point, I would appreciate engagement with the conceptual point related to the difference between prediction and stimulus correlations. Most importantly, I hope the authors will spell out more explicitly which predictions their proposal makes, and how exactly those would be present in an encoding model.

      Our proposal makes a clear prediction: if pre-onset encoding can be explained by stimulus dependencies (essentially a confound in the analysis) the same hallmarks should emerge in passive control systems that encode the stimulus but do not predict. We test this with word embeddings and speech acoustics, and both show hallmarks despite not doing any prediction.

      Reviewer #2 (Recommendations for Authors):

      I greatly enjoyed reading the paper and only have minor quibbles. The work is overdue and will no doubt be a valuable addition to the literature to push back on over-hyped claims about the implications of pre-word predictivity in neural response. I have few issues with the methods that the paper uses, they seem sensible and in line with previous work that has investigated these questions, and I did not find typos.

      One point I would like to raise is whether or not there is a more effective solution to resolving the issues behind residualization that the paper demonstrates. The authors show that removing next-word information does not effectively resolve the problem that local relationships in the stimulus dataset pose. The challenge to me here seems to be that it is difficult to get a model to "not learn" a relationship that is learnable. I wonder if a better solution to this is to not try to get a model to exclude a set of information but instead to do some sort of variance partitioning where you train a model to predict the next-word representation from the current-word representation (as in the self-predictivity analysis) and then build an encoding model out of the predicted representation. Then, compare the pre-word-onset encoding performance of the prediction with the pre-word-onset encoding performance of the original representation. If the performance of the two models roughly matches, that would be strong evidence that most of what these models are capturing before word onset is just explainable by the stimulus dependencies, no?

      We would like to thank the reviewer for their kind words and positive appraisal!

      The proposed analysis is that if a linear proxy representation, w_hat_t – predicted linearly from w_{t-1} – yields pre-onset predictivity comparable to the actual w_t vector, this would support that the effect can be explained by stimulus dependencies. While this is an interesting alternative analysis, we would be cautious about the inverse conclusion: that if w_t outperforms the linear proxy w_hat_t, the residual variance must reflect true neural prediction.

      This is because of our control system results. We show that even when we remove the "predictable" shared variance – which is similar to computing the difference between w_t and w_hat_t – the unique information still yields pre-onset predictivity, albeit reduced, in the passive acoustics that by definition cannot predict. Therefore, instead of developing an ever-more-clever way to "correct" for the problem by adjusting the X matrix, we focus on showing that the problem lies in the stimulus itself. For the revision, we focused on reframing the problem and hope we have punched a fuller hole in the logic by breaking down the fundamental issue more clearly and showing it applies to the stimulus material of Goldstein et al. (2022) as well.

      Additionally, I would say that I was a bit confused about what was going on in the methods figures, to the point where I do not see the value in having them, but thankfully, the text was clear enough to resolve that confusion.

      We are sad the methods illustration wasn’t helpful. In presentations we have found that the illustrations were generally helpful to bring the analysis across, e.g. the aspect of keeping the analysis identical but simply replacing the brain data with either word vectors (current Figure 2) and acoustics (current Figure 3). In the revision we have reorganised the schematics slightly, we introduce the acoustics as a control system earlier, to separately introduce residualisation and its insufficiency (Figure 4). We hope this helps

      Reviewer #3 (Recommendations for Authors):

      (1) My major concern is the extent to which this study offers new insights beyond what was already demonstrated in Goldstein's work. First, the embedding dependency highlighted by the authors seems somewhat expected, given how these embeddings are constructed: GloVe embeddings are based on word co-occurrence statistics, and GPT embeddings are combinations of embeddings of preceding words. More importantly, Goldstein et al. addressed this issue by regressing out neighboring word embeddings. This control was effective, as also confirmed by the current manuscript, and their main results remain. Therefore, the embedding dependency appears to have been properly accounted for in the earlier study.

      Building on the previous point, I appreciate the analysis of dependencies across representational domains, which I see as the main novel contribution of this manuscript. I would encourage the authors to explore this aspect more deeply. If I understand correctly, stimulus dependencies may persist even after regressing out neighboring word embeddings due to two potential factors:

      (a) Temporal dependencies in embeddings: since the regression of neighbor words is performed at the word level rather than over time, temporal dependency may remain.

      (b) Cross-feature dependencies - specifically, correlations between embeddings and acoustic features.

      Regarding the first factor, it is not entirely clear to me whether this is a real problem—i.e., whether word-level regression fails to remove temporal dependencies. A simulation could help clarify this and support the argument. While it's not essential, it would be valuable if the authors could propose a method to address this issue, or at least outline it as a direction for future work.

      For the second point, it would be helpful for the authors to explicitly explain the potential relationship between word embeddings and acoustic features. Additionally, while correlations between features are a common problem in speech research, they are typically addressed by regressing out acoustic features early in the analysis (Gwilliams et al., 2022). It would strengthen the current findings if the authors could test whether the self-predictability persists even after controlling for neighboring embeddings and acoustic features.

      We appreciate the extensive and detailed engagement with our work, which has been very useful in highlighting key unclarities and gaps we had to address.

      We do believe our study goes well beyond what was shown by Goldstein, by identifying a fundamental limitation in their analysis, and showing that their purported control analyses do not in fact control for the problem. We’ll address the reviewers' sub-questions in turn.

      (i) Why this offers crucial insights beyond Goldstein et al.

      While Goldstein et al. indeed addressed embedding dependencies via residualization (or in their case projection), their conclusion relied on the assumption that any neural encoding surviving this "fix" must reflect genuine predictive pre-activation. Our study invalidates this assumption. By applying the residualization fix, we show that the "hallmarks of prediction" persist just as robustly in a passive control system that cannot predict (the speech acoustics) as in the neural data. (We also show this for bigram removal.)

      This provides a key new insight: persistent pre-onset predictivity after “correction” is not evidence that the dependency issue was solved. Instead, because the same effect persists in a system that cannot predict (acoustics), the persistence of the hallmarks cannot be attributed to prediction. It demonstrates that the standard "fix" is mathematically insufficient to remove the confound, rendering the original evidence for neural prediction fundamentally ambiguous.

      (ii) Why do dependencies/hallmarks persist after residualization?

      Residualization successfully removes the linear dependency between the current embedding (w_t) and the previous embedding (w_{t-1}) within the feature space. However, it does not (and cannot) remove the dependency from language itself, and therefore from the brain which (in some format) encodes the linguistic stimulus. Language is massively redundant. Knowing the current word tells you something about what came before – acoustically, syntactically, semantically. As long as the embedding identifies the word, the regression model will re-learn this relationship. For instance, in the case of acoustics, even when using the corrected embedding, the regression will re-learn that certain words (e.g., "Holmes") tend to follow certain acoustic patterns (e.g., the acoustics of "Sherlock"). “This shows that correcting the embeddings is insufficient: the dependencies exist in language itself, and the model will re-learn them from any signal that encodes that language.”

      (iii) Why not regress out the acoustics?

      This is also why "regressing out acoustics" (as the reviewer suggests) would miss the point. We do not claim that acoustic features leak into the neural signal or that acoustics are a specific confound to be removed. Rather, we use acoustics as a “passive baseline”: a system that encodes the stimulus but cannot predict. That the method yields "hallmarks of prediction" in this baseline demonstrates these hallmarks are not valid evidence for prediction—regardless of what additional features one regresses out. This motivates our proposed criterion: future studies seeing evidence for neural pre-activation should not rest on finding pre-onset encoding per se, since passive systems show this too. Rather, it should require demonstrating that the brain signal contains more information about the upcoming word than the passive stimulus baseline.

      As these aspects are fundamental to the interpretation of our study, we have fundamentally re-organised and re-wrote large parts of the paper. We hope it is much clearer now.

      (2) To better compare to Goldstein's work, the author may consider performing the same analyses using their publicly available dataset.

      This is a good suggestion. When we initially conducted this research, the Goldstein dataset was not yet publicly available. It now is, and we have applied our analyses to their stimulus material. The same problem emerges: the hallmarks of prediction appear in the acoustics of their podcast stimuli. Even after applying the control analyses, pre-onset predictivity is robust in their acoustics (indeed, in correlation terms, higher than reported for the neural data, so there is not more predictivity in the brain than in the stimulus material), confirming that the issue we identify applies to the original dataset. Results are shown in Figures S2B, S3B, S5C, and S6B.

      (3) It is also interesting to show the predictability effect after word onsets for self-predictability analyses, for example, in Figure 2C. The predictability effect is not only reflected in pre-onset responses but also in post-onset responses, i.e., larger responses for unpredicted words. Whether the stimulus dependency mirror this effect?

      Our paper focuses specifically on temporal dependencies – the capacity of the current word to predict the previous stimulus signal (e.g., previous acoustics, previous embeddings) – and how this mimics neural pre-activation. Post-onset analyses, by contrast, concerns the mapping between the current word and its concurrent signal, which involves fundamentally different mechanisms (e.g., mapping fidelity, frequency effects, acoustic clarity, word length) and would require the consideration of covariates of the attributes of the word post-onset to meaningfully interpret. Post-onset, there can be differences between predictable and non predictable words – e.g. sometimes unpredictable words are pronounced with more emphasis – which is why surprisal studies include a large range of covariates. However, this is not about stimulus dependencies or pre-activation, so we consider it is beyond scope of our study.

      (4) The authors might consider reporting the encoding performance for the residual word embeddings, similar to Figure S6B in Goldstein's paper. This would allow us to determine whether pre-activation persists in the MEG responses and compare its pattern with the predictability of pre-onset acoustics.

      We do report this analysis, in the revised supplement it is shown in Figure S7. We placed it in the supplement precisely because residualized embeddings are not the "fix" they appear to be: as we show, they still yield strong pre-onset predictivity in the passive acoustic baseline (Figure 4, S6), undermining their use as a control.

      (5) The series of previous pre-activation analyses proposed fruitful findings, e.g., the difference between brain regions (Fig. S4, (Goldstein et al., 2022)) and the difference between listeners and speakers (Figure 2, (Zada et al., 2024)). Whether these observed differences can be explained by the stimulus dependency?

      We appreciate this question. Our goal is to address the general logic of using pre-onset encoding as evidence for prediction, rather than to critique every finding in specific papers, especially as it pertains to a specific author. But briefly:

      Speaker vs. Listener differences (Zada et al., 2024): Zada et al. report distinct temporal profiles: speaker encoding peaks pre-onset (planning?), whereas listener encoding peaks post-onset but shows a pre-onset "ramp." Our critique applies to interpreting this ramp as "prediction." However, this interpretation is not central to their paper, which focuses on speaker-listener coupling via shared embedding spaces. We leave the implications (which are clear enough) to the reader.

      Regional differences (Goldstein et al., 2022): Encoding timecourses do vary across electrodes, as we also observe across MEG sources (and participants). But our point is logical: because pre-onset encoding does not necessarily reflect prediction, finding a channel with stronger pre-onset encoding does not mean that channel performs “more prediction”. For instance, one subject in the Armeni dataset showed higher pre-onset than post-onset encoding (and indeed activity) overall – but it would be implausible to conclude this subject "only predicts" and does not “process” or “listen”. More likely, this reflects differences in signal-to-noise, integration windows, or source contributions. The exact sources of these morphological differences are interesting but unclear, and speculating on them is beyond our scope.

      (6) I appreciate that the authors have shared their code; however, some parts appear to be missing. For example, the script encoding_analysis.py only includes package-loading code.

      Thank you for noticing, we have updated our code database.

      (7) What do the error bars in the figures represent - for example, in Figure 1C? How many samples were included in the significance tests? The difference between the two curves appears small, yet it is reported as significant. Additionally, Figure S1 shows large differences between subjects and between the two MEG datasets. Do the authors have any explanation for these differences?

      The shaded areas in our previous Figure 1c) show 95% confidence intervals computed over the 100 MEG sources identified to be part of the bilateral language system and the 10 cross-validation splits.

      We do not have an elaborate explanation for the differences in encoding performance across the three subjects in the few-subject dataset. Instead, we interpret these differences as a likely consequence of substantial inter-individual variability in evoked responses, even at the source level, arising from differences in cortical folding and the orientation of underlying current dipoles. We deem this a likely explanation since different electrodes in Goldstein’s ECoG data also showed very different encoding profiles.

      With respect to the multi-subject dataset, we suspect that the large differences stem most likely from two substantial differences: First, the acoustics were purposefully manipulated by the experimenters to reduce temporal dependence. This made it harder for listeners to concentrate on the stories and thereby might have potentially led to lower quality neural data. Furthermore, it reduced one form of stimulus dependency, namely the acoustic temporal dependencies, which could be exploited by the encoding model to reach higher encoding accuracies. Secondly, MEG has a notoriously poor signal-to-noise ratio, and the amount of data per participant (7.745 words as opposed to 85.719 in the few-subject dataset) might not have been enough to produce reliably high encoding results.

      Finally, the current study is clear and convincing, and my suggestions are not intended to question its novelty or robustness. Rather, I believe the authors are in a strong position to address a critical question in language processing: whether pre-activation occurs. The authors have thoughtfully considered important confounds related to pre-onset responses. Adding some approaches to regressing out these confounds could be particularly helpful for determining whether a true pre-onset response remains.

      We thank the reviewer again for their constructive feedback, suggestions and questions. To clarify, however, our goal is *not* to definitively attest to whether pre-activation occurs. Our goal is simply to scrutinise a specific method to test for linguistic prediction. This method purports to be an improvement on conventional post-onset (e.g. surprisal-based) methods, as it can directly investigate effects occurring prior to word onset. We have demonstrated fundamental limitations in the underlying logic of this method. We propose passive control systems as baselines against which claims of prediction should be evaluated. Against this baseline, the current evidence does not show unequivocal support for prediction: pre-onset encoding in the brain does not exceed that in the passive control. However, we do not conclude from this that pre-activation does not exist — that would require a different study entirely. Our aim is more methodological: to establish what should count as evidence for prediction, not to settle whether prediction occurs.

      We would like to thank the reviewers and editors for their thoughtful feedback, which has been tremendously helpful in improving the paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We sincerely thank the editor and both reviewers for their time and thoughtful feedback on our manuscript. We have carefully addressed all the concerns raised in the responses below and incorporated the suggested revisions into the manuscript.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors investigated the population structure of the invasive weed Lantana camara from 36 localities in India using 19,008 genome-wide SNPs obtained through ddRAD sequencing.

      Strengths:

      The manuscript is well-written, the analyses are sound, and the figures are of great quality.

      Weaknesses:

      The narrative almost completely ignores the fact that this plant is popular in horticultural trade and the different color morphs that form genetic populations are most likely the result of artificial selection by humans for certain colors for trade, and not the result of natural selfing. Although it may be possible that the genetic clustering of color morphs is maintained in the wild through selfing, there is no evidence in this study to support that. The high levels of homozygosity are more likely explained as a result of artificial selection in horticulture and relatively recent introductions in India. Therefore, the claim of the title that "the population structure.. is shaped by its mating system" is in part moot, because any population structure is in large part shaped by the mating system of the organism, but further misleading because it is much more likely artificial selection that caused the patterns observed.

      The reviewer raises the possibility that the observed genetic patterns may have originated through the selection of different varieties by the horticultural industry. While it is plausible that artificial selection can lead to the formation of distinct morphs, the presence of a strong structure between them in the wild populations cannot be explained just based on selection. The observed patterns in the inbreeding coefficient and heterozygosity can indeed arise from multiple factors, including past bottlenecks, selection, inbreeding, and selfing. In the wild, different flower colour variants frequently occur in close physical proximity and should, in principle, allow for cross-fertilization. Over time, this gene flow would be expected to erode any genetic structure shaped solely by past selection. However, our results show no evidence of such a breakdown in structure. Despite co-occurring in immediate proximity, the flower colour variants maintain distinct genetic identities. This suggests the presence of a barrier to gene flow, likely maintained by the species' mating system. Moreover, the presence of many of these flower colour morphs in the native range—as documented through observations on platforms like iNaturalist—suggests that these variants may have a natural origin rather than being solely products of horticultural selection.

      While it is plausible that horticultural breeding involved efforts to generate new varieties through crossing—resulting in the emergence of some of the observed morphs—even if this were the case, the dynamics of a self-fertilizing species would still lead to rapid genetic structuring. Following hybridization, just a few generations of selfing are sufficient to produce inbred lines, which can then maintain distinct genetic identities. As discussed in our manuscript, such inbred lines could be associated with specific flower colour morphs and persist through predominant self-fertilization. This mechanism provides a compelling explanation for the strong genetic structure observed among co-occurring flower colour variants in the wild.

      To further validate this, we conducted a bagging experiment on Lantana camara inflorescences to exclude insect-mediated cross-pollination. The results showed no significant difference in seed set between bagged and open-pollinated flowers, supporting the conclusion that L. camara is primarily self-fertilizing in India. These results are included in the revised manuscript.

      As the reviewer rightly points out, the mating system of a species plays a crucial role in shaping patterns of genetic structure. However, in many natural populations, structuring patterns are often influenced by a combination of factors such as selection, barriers to gene flow, and genetic drift. In some cases, the mating system exerts a more prominent influence at the microgeographic level, while in others, it can shape genetic structure at broader spatial scales. What is particularly interesting in our study is that - the mating system appears to shape genetic structure at a subcontinental scale. Despite the species having undergone other evolutionary forces—such as a genetic bottleneck and expansion due to its invasive nature—the mating system exerts a more pronounced effect on the observed genetic patterns, and the influence of the mating system is remarkably strong, resulting in a clear and consistent genetic structure across populations.

      Reviewer #1 (Recommendations for the authors):

      Lantana camara is a globally invasive plant as the authors mention in their manuscript, but this study only focuses on India. This should be reflected in the title.

      The reviewer has suggested that the title should reflect the study area. Since our sampling covers nearly all regions in India, we believe the patterns observed here are likely representative of those in other parts of the invaded range. For this reason, we would prefer to retain the current heading.

      It would be helpful if the pictures of the flowers in Figure 3 were larger to more clearly see the different colors.

      As per the reviewers suggestion we have increased the size of the images to improve clarity.

      Figure 4 could probably be moved to supplemental material, it does not add much to the results.

      We feel it is important to reiterate that the patterns we observe in Lantana are consistent with what one would expect in any predominantly self-fertilizing species. It act as an additional proof and therefore, we believe it is important to retain this figure, as it effectively conveys this link.

      Reviewer #2 (Public review):

      Summary:

      The authors performed a series of population genetic analyses in Lantana camara using 19,008 genome-wide SNPs data from 359 individuals in India. They found a clear population structure that did not show a geographical pattern, and that flower color was rather associated with population structure. Excess of homozygosity indicates a high selfing rate, which may lead to fixation of alleles in local populations and explain the presence of population structure without a clear geographic pattern. The authors also performed a forward simulation analysis, theoretically confirming that selfing promotes fixation of alleles (higher Fst) and reduction in genetic diversity (lower heterozygosity).

      Strengths:

      Biological invasion is a critical driver of biodiversity loss, and it is important to understand how invasive species adapt to novel environments despite limited genetic diversity (genetic paradox of biological invasion). Lantana camara is one of the hundred most invasive species in the world (IUCN 2000), and the authors collected 359 plants from a wide geographical range in India, where L. camara has invaded. The scale of the dataset and the importance of the target species are the strengths of the present study.

      Weaknesses:

      One of the most critical weaknesses of this study would be that the output modelling analysis is largely qualitative, which cannot be directly comparable to the empirical data. The main findings of the SLiM-based simulation were that selfing promotes the fixation of alleles and the reduction of genetic diversity. These are theoretically well-reported knowledge, and such findings themselves are not novel, although it may have become interesting these findings are quantitatively integrated with their empirical findings in the studied species. In that sense, a coalescent-based analysis such as an Approximate Bayesian Computation method (e.g. DIY-ABC) utilizing their SNPs data would be more interesting. For example, by ABC-based methods, authors can infer the split time between subpopulations identified in this study. If such split time is older than the recorded invasion date, the result supports the scenario that multiple introductions may have contributed to the population structure of this species. In the current form of the manuscript, multiple introductions were implicated but not formally tested.

      Through our SLiM simulations, we aimed to demonstrate that a pattern of strong genetic structure within a location (similar to what we observed in Lantana camara) can arise under a predominantly self-fertilizing mating system. These simulations were not parameterized using species-specific data from Lantana but were intended as a conceptual demonstration of the plausibility of such patterns under selfing using SNP data. While the theoretical consequences of self-fertilisation have been widely discussed, relatively few studies have directly modelled these patterns using SNP data. Our SLiM simulations contribute to this gap and support the notion that the observed genetic structuring in Lantana may indeed result from predominant self-fertilisation. Therefore, we conducted these simulations ourselves for invasive plants to test whether the patterns we observed are consistent with expectations for a predominantly self-fertilising species.

      Additionally, as suggested by the reviewer, we have performed demographic history simulations using fastsimcoal2 to investigate the divergence among different flower colour morphs. The results have been incorporated into the revised manuscript.

      First, the authors removed SNPs that were not in Hardy-Weinberg equilibrium (HWE), but the studied populations would not satisfy the assumption of HWE, i.e., random mating, because of a high level of inbreeding. Thus, the first screening of the SNPs would be biased strongly, which may have led to spurious outputs in a series of downstream analyses.

      Applying a HWE filter is a common practice in genomic data analysis because it helps remove potential sequencing or genotyping artefacts, which can otherwise bias downstream analyses. However, we understand that HWE filtering can also remove biologically informative loci and potentially bias the analysis, especially when a stringent cutoff is used. A strict filter might retain only loci that perfectly fit Hardy–Weinberg expectations and exclude sites influenced by real evolutionary processes like selection and/or inbreeding.

      To balance this, we used a mild HWE filter, aiming to remove clear artefacts while retaining loci that may reflect genuine biological signals. Another reason for applying it is that many downstream tools, for example, admixture, assume the markers are neutral and not strongly deviating from HWE (although this assumption may not always hold). This helps in avoiding the complexity of the model.

      Second, in the genetic simulation, it is not clear how a set of parameters such as mutation rate, recombination rate, and growth rate were determined and how they are appropriate.

      We have cited the references for these values in the manuscript. However, for Lantana, many such baseline data are not available, so we used general values reported for plants, which is an accepted approach when working with understudied species. Moreover, the aim of these simulations was to develop a general understanding of how mating systems influence genetic diversity in invasive plants, rather than to parameterize the simulations specifically for Lantana.

      While we acknowledge that this simulation does not provide an exact representation of the species' evolutionary history, the goal of the simulation was not to produce precise estimates but rather to illustrate the feasibility of such strong genetic structuring resulting from self-fertilisation alone.

      Importantly, while authors assume the selfing rate in the simulation, selfing can also strongly influence the effective mutation rate (e.g. Nordborg & Donnelly 1997 Genetics, Nordborg 2000 Genetics). It is not clear how this effect is incorporated in the simulation.

      In genetic simulations, it is often best to begin with simpler scenarios involving fewer parameters, and we followed this approach. As the reviewer rightly pointed out, selfing can influence multiple factors such as mutation and recombination rates. However, to first understand the broad effects, we chose to work with simpler scenarios where both mutation and recombination rates were kept constant.

      Third, while the authors argue the association between flower color and population structure, their statistical associations were not formally tested.

      We thank the reviewer for this valuable suggestion. We have performed a MANOVA to test the association between flower colour and genetic structure. These results are incorporated in the revised manuscript.

      Also, it is not mentioned how flower color polymorphisms are defined. Could it be possible to distinguish many flower color morphs shown in Figure 1b objectively?

      We carefully considered this and defined our criteria based on flower colour. Specifically, we named morphs according to the colour of both young and old flowers. If both stages shared the same colour, we used that colour as the name. As shown in Figure 1b, it is possible to reliably distinguish between the different flower colour morphs. While one could also measure flower colour using a photometer, we believe both approaches yield similar results.

      I am concerned particularly because the authors also mentioned that flower color may change temporally and that a single inflorescence can have flowers of different colors (L160).

      The flower colour changes within an inflorescence, with young flowers shifting colour after pollination. However, this trend is consistent within a plant; for example, the yellow–pink morph always changes from yellow to pink. Based on this consistency, we incorporated a naming system that considers both the colour of younger and older flowers.

      Reviewer #2 (Recommendations for the authors):

      Figure 4: Figures a and b are not the "signatures of high inbreeding", because such patterns could also simply happen due to geographical isolation. The title of the figure could be changed. Figure 4c should be presented as a histogram.

      We have incorporated this suggestion into the manuscript and revised the figure title accordingly. However, we believe that presenting Figure 4c in its current form is more informative.

      L459 "in the introduced range, Lantana is self-compatible": is it self-incompatible in the native range? If it is known, it could be mentioned in the manuscript.

      A previous study from India demonstrated that self-fertilisation is possible in Lantana, providing an additional line of evidence for our findings. However, Lantana remains poorly studied in its native range, and to the best of our knowledge, only a single study has examined its pollination biology there, which we have cited in this paper.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this paper, Chen et al. identified a role for the circadian photoreceptor CRYPTOCHROME (cry) in promoting wakefulness under short photoperiods. This research is potentially important as hypersomnolence is often seen in patients suffering from SAD during winter times. The mechanisms underlying these sleep effects are poorly known.

      Strengths:

      The authors clearly demonstrated that mutations in cry lead to elevated sleep under 4:20 Light-Dark (LD) cycles. Furthermore, using RNAi, they identified GABAergic neurons as a primary site of cry action to promote wakefulness under short photoperiods. They then provide genetic and pharmacological evidence demonstrating that cry acts on GABAergic transmission to modulate sleep under such conditions.

      Weaknesses:

      The authors then went on to identify the neuronal location of this cry action on sleep. This is where this reviewer is much more circumspect about the data provided. The authors hypothesize that the l-LNvs which are known to be arousal-promoting may be involved in the phenotypes they are observing. To investigate this, they undertook several imaging and genetic experiments.

      Major concerns:

      (1) Figure 2 A-B: The authors show that knocking down cry expression in GABAergic neurons mimics the sleep increase seen in cryb mutants under short photoperiod. However, they do not provide any other sleep parameters such as sleep bout numbers, sleep bout duration, and more importantly waking activity measurements. This is an essential parameter that is needed to rule out paralysis and/or motor defects as the cause of increased "sleep". Any experiments looking at sleep need to include these parameters.

      Thank you for bringing up these points. We have now included these sleep parameters in Figure 2—figure supplement 3.

      (2) For all Figures displaying immunostaining and imaging data the resolution of the images is quite poor. This makes it difficult to assess whether the authors' conclusions are supported by the data or not.

      We apologize for the poor resolution. This is probably due to the compression of the figures in the merged PDF file. We are now uploading the figures individually and hopefully this can resolve the resolution issue.

      (3) In Figure 4-S1A it appears that the syt-GFP signal driven by Gad1-GAL4 is colabeling the l-LNvs. This would imply that the l-LNvs are GABAergic. The authors suggest that this experiment suggests that l-LNvs receive input from GABAergic neurons. I am not sure the data presented support this.

      We agree that this piece of data alone is not sufficient to demonstrate that the l-LNvs receive GABAergic inputs rather than the l-LNvs are GABAergic. However, when nlsGFP signal is driven by two independent Gad1-GAL4 lines (one generated by P element insertion while the other generated by GAL4 inserted into the Gad1 locus), we do not observe any prominent signal in the l-LNvs (Figure 5A and B; Figure 5-figure supplement 1A). We have also co-labeled using Gad1GAL4 and PdfLexA (Figure 5-figure supplement 1B). As can be seen, Gad1GAL4-driven GFP signal is present only in the s-LNvs but not the l-LNvs. This further supports the idea that the l-LNvs are not GABAergic, and that the syt-GFP signal likely arises from GABAergic neurons projecting to the l-LNvs.

      (4) In Figure 4-S1B. The GRASP experiment is not very convincing. The resolution of the image is quite poor. In addition, the authors used Pdf-LexA to express the post t-GRASP construct in l-LNvs, but Pdf-LexA also labels the s-LNvs, so it is possible that the GRASP signal the authors observe is coming from the s-LNvs and not the l-LNvs. The authors could use a l-LNvs specific tool to do this experiment and remove any doubts. Altogether this reviewer is not convinced that the data presented supports the conclusion "All in all, these results demonstrate that GABAergic neurons project to the l-LNvs and form synaptic connections." (Line 176). In addition, the authors could have downregulated the expression of Rdl specifically in l-LNvs to support their conclusions. The data they are providing supports a role for RDL but does not prove that RDL is involved in l-LNvs.

      Thank you for these wonderful suggestions. Again we apologize for the poor resolution and hopefully by uploading the images separately we can resolve this issue. We agree that the GRASP signal could be coming from the s-LNvs and not the l-LNvs but unfortunately we are not able to find a LexA that is specifically expressed in the l-LNvs. We believe the trans-Tango data further support the idea that GABAergic neurons project to and form synaptic connections with the l-LNvs. Nonetheless, we have changed our conclusion to “All in all, these results strongly suggest that GABAergic neurons project to the l-LNvs and form synaptic connections” to be more rigorous. In addition, we have obtained R78G01GAL4 which is specifically expressed in the l-LNvs, and using this GAL4 to knock down Rdl rescues the long-sleep phenotype of cry mutants (Figure 4—figure supplement 1D).

      (5) In Figures 4 A and C: it appears that GABA is expressed in the l-LNvs. Is this correct? Can the authors clarify this? Maybe the authors could do an experiment where they co-label using Gad1-GAL4 and Pdf-LexA to clearly demonstrate that l-LNvs are not GABAergic. Also, the choice of colors could be better. It is very difficult to see what GABA is and what is PDF.

      Thank you for this wonderful suggestion. We have now co-labeled using Gad1GAL4 and PdfLexA (Figure 5-figure supplement 1B). As can be seen, Gad1GAL4-driven GFP signal is present only in the s-LNvs but not the l-LNvs. We suspect the GABA signal at the l-LNvs may arise from the GABAergic projections received by these cells. We have now changed the color of the GABA/PDF signals in these images and have reduced the intensity of the PDF signal. Hopefully, it would be easier to visualize in this revised version.

      (6) Figure 4G: Pdf-GAL4 expresses in both s-LNvs and l-LNvs. So, in this experiment, the authors are silencing both groups, not only the l-LNvs. Why not use a l-LNvs specific tool?

      Thank you for bring up this important point. We have previously used c929GAL4 to express Kir2.1 and this led to lethality. We have now used two l-LNv-specific GAL4 drivers (R78G01GAL4 and R10H10GAL4) that we newly obtained to express Kir2.1 but did not observe significant effect on sleep. Please see Author response image 1 for the results.

      Author response image 1.

      Daily sleep duration of male flies expressing Kir2.1 in l-LNvs using R78G01GAL4 (A)(n = 40, 41, 30 flies) and R10H10GAL4 (B) (n = 40, 41, 32 flies) and controls, monitored under 4L20D. One-way ANOVA with Bonferroni multiple comparison test was used to calculate the difference between experimental group and control group.

      (7) Figure 4H-I: The C929-GAL4 driver expresses in many peptidergic neurons. This makes the interpretation of these data difficult. The effects could be due to peptidergic cells being different than the l-LNvs. Why not use a more specific l-LNvs specific tool? I am also confused as to why some experiments used Pdf-GAL4 and some others used C929-GAL4 in a view to specifically manipulate l-LNvs? This is confusing since both drivers are not specific to the l-LNvs.

      Thank you for bring up these important points. We have now used the l-LNv-specific R10H10GAL4 and the results are more or less comparable with that of c929GAL4 (Figure 4I and K), i.e. activating the l-LNvs blocks the long-sleep phenotype of cry mutants. The reason PdfGAL4 is used in 4G is because c929GAL4 leads to lethality while the l-LNv-specific GAL4 lines do not alter sleep.

      (8) Figure 5-S1B: Why does the pdf-GAL80 construct not block the sleep increase seen when reducing expression of cry in Gad1-GAL4 neurons? This suggests that there are GABAergic neurons that are not PDF expressing involved in the cry-mediated effect on sleep under short photoperiods.

      Yes, this is indeed the conclusion we draw from this result, and we commented on this in the Discussion: “Moreover, inhibiting cry RNAi expression in PDF neurons does not eliminate the long-sleep phenotype of Gad1GAL4/UAScryRNAi flies. Therefore, we suspect that cry deficiency in other GABAergic neurons is also required for the long-sleep phenotype. Given that the s-LNvs are known to express CRY and appear to be GABAergic based on our findings here, we believe that CRY acts at least in part in the s-LNvs to promote wakefulness under short photoperiod.”

      In conclusion, it is not clear that the authors demonstrated that they are looking at a cry-mediated effect on GABA in s-LNvs resulting in a modulation of the activity of the l-LNvs. Better images and more-suited genetic experiments could be used to address this.

      Thank you very much for all the comments. They are indeed quite helpful for improving our manuscript. Hopefully, with images of higher quality and the additional experiments described above, we have now provided more evidence supporting our major conclusion.

      Reviewer #2 (Public Review):

      Summary:

      The sleep patterns of animals are adaptable, with shorter sleep durations in the winter and longer sleep durations in the summer. Chen and colleagues conducted a study using Drosophila (fruit flies) and discovered that a circadian photoreceptor called cryptochrome (cry) plays a role in reducing sleep duration during day/night cycles resembling winter conditions. They also found that cry functions in specific GABAergic circadian pacemaker cells known as s-LNvs inhibit these neurons, thereby promoting wakefulness in the animals in the winter. They also identified l-LNvs, known as arousal-promoting cells, as the downstream neurons.

      Strengths:

      Detailed mapping of the neural circuits cry acts to mediate the shortened sleep in winter-like day/night cycles.

      Weaknesses:

      The supporting evidence for s-LNvs being GABAergic neurons is not particularly strong. Additionally, there is a lack of direct evidence regarding changes in neural activity for s-LNvs and l-LNvs under varying day/night cycles, as well as in cry mutant flies.

      Thank you very much for all the comments. We have now expressed nlsGFP by two independent Gad1-GAL4 lines (one generated by P element insertion while the other generated by GAL4 inserted into the Gad1 locus), and positive signals in the s-LNvs can be observed (Figure 5A and B; Figure 5-figure supplement 1A). Hopefully, this can provide some further support regarding the s-LNvs being GABAergic neurons.

      We have now examined GCaMP signals in the l- and s-LNvs of WT and cry mutants under 4L20D/12L12D. Please see Author response image 2 for the results. As can be seen, both WT and cry mutants show photoperiod-dependent changes. Interestingly, cry mutants show more prominent reduction of GCaMP signal in the l-LNvs compared to WT under 12L12D vs. 4L20D, but the sleep duration phenotype is observed only under 4L20D. Moreover, GCaMP signal is elevated in the s-LNvs of cry mutants relative to WT under 4L20D but decreased under 12L12D. These results indicate that there are distinct mechanisms regulating sleep under short vs. normal photoperiod (with CRY being dispensable under 12L12D), and the role of CRY in modulating the activity of these neurons are also photoperiod-dependent. Further in-depth characterizations are need to delineate these complex issues.

      Author response image 2.<br /> Quantification of GCaMP6m signal intensity normalized to that of tdTomato under 12L12D and 4L20D (n = 25-45 cells). Student’s t-test: compared to WT, #P < 0.05, ##P < 0.01; 12L12D vs. 4L20D, *P < 0.05, ***P < 0.001.

      Reviewer #3 (Public Review):

      Summary:

      In humans, short photoperiods are associated with hypersomnolence. The mechanisms underlying these effects are, however, unknown. Chen et al. use the fly Drosophila to determine the mechanisms regulating sleep under short photoperiods. They find that mutations in the circadian photoreceptor cryptochrome (cry) increase sleep specifically under short photoperiods (e.g. 4h light: 20 h dark). They go on to show that cry is required in GABAergic neurons. Further, they suggest that the relevant subset of GABAergic neurons are the well-studied small ventral lateral neurons that they suggest inhibit the arousal-promoting large ventral neurons via GABA signalling.

      Strengths:

      Genetic analysis to show that cryptochrome (but not other core clock genes) mediates the increase in sleep in short photoperiods, and circuit analysis to localise cry function to GABAergic neurons.

      Weaknesses:

      The authors' conclusion that the sLNvs are GABAergic is not well supported by the data. Better immunostaining experiments and perhaps more specific genetic driver lines would help with this point (details below).

      (1) The sLNvs are well known as a key component of the circadian network. The finding that they are GABAergic would if true, be of great interest to the community. However, the data presented in support of this conclusion are not convincing. Much of the confocal images are of insufficient resolution to evaluate the paper's claims. The Anti-GABA immunostaining in Fig 4 and 5 seem to have a high background, and the GRASP experiments in Fig 4 supplement 1 low signal.

      We apologize for the poor resolution. This is probably due to the compression of the figures in the merged PDF file. We are now uploading the figures individually and hopefully this can resolve the resolution issue. Unfortunately, the GABA immunostaining does not work very well in our hands and thus the background is high. We have now adjusted the images by changing the minimum lookup table (LUT) value in the green channel to 213, which removes all pixels below 213. This can remove background without changing the gray values, so the analysis is not affected. We have modified all images the exact same way and hopefully this can improve the contrast. Furthermore, we have now expressed nlsGFP by two independent Gad1-GAL4 lines (one generated by P element insertion while the other generated by GAL4 inserted into the Gad1 locus), and positive signals in the s-LNvs can be observed (Figure 5A and B; Figure 5-figure supplement 1A). Hopefully, this can provide some further support regarding the s-LNvs being GABAergic neurons.

      Transcriptomic datasets are available for the components of the circadian network (e.g. PMID 33438579, and PMID 19966839). It would be of interest to determine if transcripts for GAD or other GABA synthesis/transport components were detected in sLNvs. Further, there are also more specific driver lines for GAD, and the lLNvs, sLNVs that could be used.

      Thank you for these wonderful suggestions. Based on PMID 19966839, both the s-LNvs and l-LNvs express Gad1 and VGAT at a relatively low level, although here in our study Gad1GAL4 expression is observed only in the s-LNvs and not l-LNvs. We have commented on this in the 4th paragraph of Discussion: “One study using cell-type specific gene expression profiling demonstrates Gad1 and VGAT expression in both s-LNvs and l-LNvs, although with relatively low signal (Nagoshi et al., 2010). Here we observed that Gad1GAL4 is expressed in the s-LNvs, and their GABA intensity is reduced when we use R6GAL4 to knock down VGAT in these cells.” PMID 33438579 does not report expression of these genes in either s-LNvs or l-LNvs, likely due to insufficient sequencing depth. Furthermore, we have now used two l-LNv-specific GAL4 lines (R78G01GAL4 and R10H10GAL4) to conduct some of the experiments that we previously used c929GAL4 for, and obtained comparable results (Figure 4I and K).

      (2) The authors' model posits that in short photoperiods, cry functions to suppress GABA secretion from sLNvs thereby disinhibiting the lNVs. In Fig 4I they find that activating the lLNvs (and other peptidergic cells) by c929>NaChBac in a cryb background reduces sleep compared to activating lLNVs in a wild-type background. It's not clear how this follows from the model. A similar trend is observable in Fig 4H with TRP-mediated activation of lNVs, although it is not clear from the figure if the difference b/w cryb vs wild-type background is significant.

      Thank you for bring up this important point. This does appear to be counterintuitive. We suspect that in cry mutants, there is more inhibition occurring at the l-LNvs and thus the system may be particularly sensitive to their activation. Therefore, activating these neurons on the mutant background can result in a more prominent wake-promoting effect compared to that of WT.

      Recommendations for the authors:

      Our major concern centers around the claim that the sLNvs are GABAergic and secrete GABA onto the lLNVs. As it stands, this is not well supported by the data.

      The authors could substantiate these findings by using more specific driver lines for GAD / vGAT (MiMic based lines are available that should better recapitulate endogenous expression). Transcriptomic data for circadian neurons are available, the FlyWire consortium also predicts neurotransmitter identities for specific neural circuits. These datasets could be mined for evidence to support the claim of sLNvs being GABAergic

      Thank you for these wonderful suggestions. We have now used MiMic-based lines for Gad1 (BS52090, Mi{MIC}Gad1MI09277) and VGAT (BS23022, Mi{ET1}VGATMB01219) to knock down cry but unfortunately were not able to observe changes in sleep. Please see Author response image 3 for the results.

      Author response image 3.

      Daily sleep duration of male flies with cry knocked down in GABAergic neurons by Gad1GAL4 (A) (n = 30, 38, 50, 18, 31 flies) or VGATGAL4 (B) (n = 28, 38, 50, 18, 30 flies) monitored under 4L20D.One-way ANOVA with Bonferroni multiple comparison test: compared to UAS control, ###P < 0.001.

      Furthermore, we have now included another Gad1GAL4 line which is generated by knocking GAL4 transgene into the Gad1 locus. We are also able to observe increased sleep when using this GAL4 to knock down cry, and positive signals in the s-LNvs can be observed when using this GAL4 to drive nlsGFP (Figure 2B; Figure 5-figure supplement 1A).

      Based on PMID 19966839, both the s-LNvs and l-LNvs express Gad1 and VGAT at a relatively low level, although here in our study Gad1GAL4 expression is observed only in the s-LNvs and not l-LNvs. We have commented on this in the 4th paragraph of Discussion: “One study using cell-type specific gene expression profiling demonstrates Gad1 and VGAT expression in both s-LNvs and l-LNvs, although with relatively low signal (Nagoshi et al., 2010). Here we observed that Gad1GAL4 is expressed in the s-LNvs, and their GABA intensity is reduced when we use R6GAL4 to knock down VGAT in these cells.” The FlyWire does not have prediction for this particular circuit that we are interested in.

      Further, many of the immunostaining images have high background / low signal - so better confocal images would help, as would the use of more specific driver lines for the lNVs as it is sometimes hard to distinguish the lLNvs from sLNvs.

      We have now adjusted all images by changing the minimum lookup table (LUT) value in the green channel to 213 and that of the red channel to 279, which removes all pixels below 213 and 279, respectively. This can remove background without changing the gray values, so the analysis is not affected. We have modified all images the exact same way and hopefully this can improve the signal to noise ratio. We were not able to find a LexA line that is specifically expressed in the l-LNvs but we have found two l-LNv-specific GAL4 lines (R78G01GAL4 and R10H10GAL4). We used these lines to conduct some of the experiments that we previously used c929GAL4 for, and obtained comparable results (Figure 4I and 4K).

      Additional specific comments are in the reviews above.

      Minor points:

      (1) Line 55: CRYPTOCHROME is misspelled.

      This has been fixed.

      (2) Line 140: The authors need to provide the appropriate references for the use of THIP and SKF-97541.

      This has been added.

      (3) Line 149: there are multiple GABA-A receptors in flies, the authors should acknowledge that. What about LccH3 or Grd?

      Thank you for bring up this important point. Here we focused only on Rdl because it is the only GABA-A receptor known to be involved in sleep regulation. We have modified our description regarding this issue: “We tested for genetic interaction between cry and Resistant to dieldrin (Rdl), a gene that encodes GABA-A receptor in flies and has previously been shown to be involved in sleep regulation.”

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors developed a new autofocusing method, LUNA (Locking Under Nanoscale Accuracy), to address severe focus drift-a major challenge in time-lapse microscopy. Using this method, they tackle a fundamental question in bacterial cold shock response: whether cells halt growth and division following an abrupt temperature downshift. Overall, the experimental design, modeling, and data analysis are solid and well executed. However, several points require clarification or further support to fully substantiate the authors' conclusions.

      Strengths:

      (1) The LUNA method outperforms existing autofocusing systems with nanoscale precision over a large focusing range. The focusing time is reasonable for the presented experiments, and the authors note potential improvements by using faster motors and optimized control algorithms, suggesting broad applicability. The theoretical simulations and experimental validation provide solid support for the robustness of the method.

      (2) Using LUNA, the authors address a long-standing question in bacterial physiology: whether cells arrest growth and division after an abrupt cold shock. Single-cell analyses monitoring the entire course of cold adaptation and steady-state growth reveal features that are obscured in bulk-culture studies: cells continue to grow at reduced rates with smaller cell sizes, resulting in an apparently unchanged population-level OD. The experiments are well designed and analyses are generally solid and largely support the authors' conclusions.

      (3) The authors also propose a model describing how population-level OD measurements depend on cell dry mass density, volume, and concentration. This provides a valuable conceptual contribution to the interpretation of OD-based growth measurements, which remain a gold-standard method in microbiology.

      We thank the reviewer for acknowledging the strengths of our study.

      Weaknesses:

      (1) It is unclear whether the author's model explaining the population-level OD during acclimation is broadly applicable. Most analyses focus on a shift from 37˚C to 14˚C, where the model agrees well with experimental data. However, in the 37˚C to 12˚C experiment, OD600 decreases after cold shock (Fig. 5e), and the computed OD does not match the experimental measurements (Fig. S16a). Although the authors attribute this discrepancy to a "complicated interplay," no further explanation is provided, which limits confidence in the model's general applicability.

      Thank you for this careful evaluation regarding the model generality. In the experiment with a temperature shift from 37°C to 12°C, the measured OD600 values were 0.243 at 0 hours and 0.242 at 5 hours. In comparison, our model-computed OD600 values were 0.243 at 0 hours and 0.271 at 5 hours. The absolute difference between the measured and computed values at 5 hours is therefore 0.028.

      Given the typical experimental variability in OD600 measurements and the limited linear range of the OD-to-biomass approximation (generally considered reliable below ~0.5), this deviation is quantitatively modest. We appreciate your valuable feedback and are happy to provide further clarification if needed.

      (2) The manuscript proposes that cell-cycle progression becomes synchronized across the population after cold shock, but the supporting evidence is not fully convincing. If synchronization refers primarily to the uniform reduction in growth rate following cold shock, this could plausibly arise from global translation inhibition affecting all cells. However, the additional claim that "cells encountering a relatively late CSR will accelerate division to maintain synchronization" is not strongly supported by the presented data.

      We appreciate your critical reading, which has helped us identify ambiguities in our terminology and strengthen the clarity of our work. Regarding the term “synchronization”, we would like to clarify that it refers to two different scenarios: (i) the synchrony in the timing of growth rate changes after cold shock. The cells initiate the slowdown in growth almost simultaneously, suggesting a highly coordinated, non-stochastic population-level response to cold shock; (ii) the synchrony in division cycle progression.

      In the sentence you referenced “cells encountering a relatively late CSR will accelerate divisions to maintain synchronization”, we intended to describe that cells maintain consistent progression of the division cycle after cold shock, meaning that after the same number of elapsed cycles, different cells are at a similar stage in their division timing (Figure 4f, 4g, Figure S14). The term “accelerate” refers to our observation that cells which complete a given cycle later than others tend to have shorter subsequent inter-division intervals, thereby “catching up” to maintain alignment in cycle number across the population. We acknowledge that using “synchronization” in this scenario may be ambiguous, and we will replace it with more precise phrasing “progression of division cycle” to accurately convey this finding.

      (3) Several technical terms used in the method development section are not clearly defined and may be unfamiliar to a broad readership, which makes it difficult to fully understand the methodology and evaluate its performance. Examples include depth of focus, focusing precision, focusing time, focusing frequency, and drift threshold value. In addition, the reported average focusing time per location (~0.6 s) lacks sufficient context, limiting the reader's ability to assess its significance relative to existing autofocusing methods.

      Thank you for your valuable comments and suggestions. In response, we have added more detailed descriptions in the Methods section of the revised version.

      The reviewer noted that the reported average focusing time (~0.6 s) lacks sufficient context, which may limit readers’ ability to assess its significance relative to existing autofocusing methods. We would like to clarify that the core innovation of this work lies in the proposed theoretical framework for autofocusing, which offers advantages over existing methods in terms of focusing precision and range. While focusing time is a practically relevant performance metric, it is primarily presented here as an implementation-dependent parameter rather than a central theoretical contribution of this study. In our experimental setup, an average focusing time of 0.6 s proved sufficient for routine timelapse imaging in microscopy, thereby demonstrating the practical usability of LUNA.

      Reviewer #2 (Public review):

      Summary:

      This study presents LUNA, an autofocus method that compensates for focus drift during rapid temperature changes. Using this approach, the authors show that E. coli cells continue to grow and divide during cold shock, revealing a coordinated, multi-phase adaptation process that could not be deduced from traditional population measurements. They propose a scattering-theory-based model that reconciles the paradox between growth differences of the bacteria at the single-cell level vs population level.

      Strengths:

      (1) The LUNA approach is pretty creative, turning coma aberration from what is normally a nuisance into an exploit. LUNA enabled long-term single-cell imaging during rapid temperature downshifts.

      (2) The authors show that the long-assumed growth arrest during cold shock from population-level measurements is misleading. At the single-cell level, bacteria do not stop growing or dividing but undergo a continuous, three-phase adaptation process. Importantly, this behavior is highly synchronized across the population and not based on bet-hedging.

      (3) Finally, the authors propose a model to resolve a long-standing paradox between single-cell vs population behavior: if cells keep growing, why does optical density (OD) of the culture stop increasing? Using light-scattering theory, they show that OD depends not only on cell number but also on cell volume, which decreases after cold shock. As a result, OD can remain flat, or even decrease, despite continued biomass accumulation. This demonstrates that OD is not a reliable proxy for growth under non-steady conditions.

      We thank the reviewer for acknowledging the strengths of our study.

      Weaknesses:

      (1) While the authors theoretically explain the advantages of LUNA over existing autofocus methods, it is unclear whether practical head-to-head comparisons have been performed, apart from the comparison to Nikon PFS shown in Video S1. As written, the manuscript gives the impression that only LUNA can solve this problem, but such a claim would require more systematic and rigorous benchmarking against alternative approaches.

      Thank you for your insightful comment regarding the comparison of LUNA with other autofocus methods.

      In our study, we primarily compared LUNA with the Nikon PFS system (as shown in Video S1) because Nikon PFS is one of the most widely used commercial autofocus systems in single-cell time-lapse imaging, and its manufacturer provides well-defined performance parameters (e.g., focusing precision within 1/3 depth-of-focus, response time <0.7 s), which facilitates a quantitative comparison. For other commercial systems, such as Olympus ZDC, Zeiss Definite Focus, Leica AFC, and ASI CRISP, the publicly available specifications are often less clearly defined, or are measured under inconsistent conditions, making a direct head-to-head comparison challenging and potentially misleading. Additionally, in our preliminary experiments, we also tested an Olympus microscope and observed severe focus drift during slow cooling processes. From a physical perspective, LUNA is specifically designed to meet the demanding requirements of single-cell experiments, including a wide focusing range and high precision, while existing commercial systems may not physically achieve the combination of range and accuracy needed for such extreme conditions.

      (2) No mutants/inhibitors used to test and challenge the proposed model.

      We agree that such approaches would provide valuable mechanistic insights and further strengthen the validation of the model presented in this study. In the current work, our primary goal was to introduce LUNA autofocusing method and demonstrate its capability to resolve bacterial cold shock response at the single-cell level with unprecedented precision. As such, we focused on characterizing the wild-type physiological dynamics under cold shock, which already revealed several previously unreported phenomena. We acknowledge that the use of genetic mutants or chemical inhibitors targeting specific cold shock proteins or regulatory pathways would be a logical and powerful next step to dissect the underlying molecular mechanisms and test the causality of the observed growth dynamics. We plan to address this in future work by incorporating such perturbations to further test and refine the model.

      (3) Cells display a high degree of synchronization, but they are grown in confined microfluidic channels under highly uniform conditions. It is unclear to what extent this synchrony reflects intrinsic biology versus effects imposed by the microfluidic environment.

      The reviewer raises a pertinent question regarding whether the observed high degree of cell synchronization represents an intrinsic biological phenomenon or an artifact induced by the microfluidic environment.

      Over the past decade, microfluidic chips, including the specific design used in our work, have become a widely accepted and powerful tool in microbial physiology research. A broad consensus has emerged within the community that the microenvironment within these microchannels does not significantly interfere with or perturb the natural physiological behavior of microorganisms (Dusny, C. & Grünberger, Curr Opin Biotechnol. 63, 26-33 (2020)). This understanding is also supported by the fact that key findings obtained with microfluidic single-cell technologies are reproducible by other methods. For example, the adder model of cell-size homeostasis in E. coli firstly observed in microfluidic chips has been repeatedly validated by different methods (Taheri-Araghi, S. et al. Curr. Biol. 25, 385-391 (2015)). Therefore, while we acknowledge the importance of considering environmental effects, we are confident that the synchronization we report reflects the genuine biological dynamics of E. coli cells.

      (4) To further test and generalize the model, it would be informative to also examine bacterial responses at intermediate temperatures rather than focusing primarily on a single cold-shock condition.

      We thank the reviewer for this thoughtful suggestion. In designing our experiments, we aimed to study the bacterial cold shock response at the single-cell level. A key feature of this response is that it is typically triggered only when the temperature drops below a certain threshold within a short time duration. We therefore chose to lower the temperature from 37 °C to 14 °C as rapidly as possible. This approach allowed us to leverage the unique capabilities of LUNA while also providing an opportunity to explore this biological process in greater detail.

      We agree that investigating bacterial responses across intermediate temperatures would be highly informative for understanding how temperature changes affect cellular physiology. However, this direction addresses a distinct scientific question that lies beyond the scope of the current work. We fully acknowledge its value and do have the intention to explore it in future studies.

    1. Author response:

      (1) Claim regarding NNDSVD initialization

      Reviewer #1:

      The authors state that "MPS is the first implementation of Constrained Non-negative Matrix Factorization (CNMF) with Nonnegative Double Singular Value Decomposition (NNDSVD) initialization." However, NNDSVD initialization is the default method in scikit-learn's NMF implementation and is also used in CaIMAN. I recommend rephrasing this claim in the abstract to more accurately reflect MPS's novelty, which appears to lie in the specific combination of constrained NMF with NNDSVD initialization, rather than being the first use of NNDSVD initialization itself.

      We agree that our original phrasing was too broad. NNDSVD-family initialization is widely used in NMF implementations (e.g., scikit-learn) and is available within some pipeline components. We revised the abstract and main text to clarify our intended contribution: MPS seeds CNMF directly with NNDSVD-derived nonnegative factors as the primary initialization strategy, rather than relying on heuristic or greedy ROI-based seeding, integrated within a memory-efficient, end-to-end workflow for long-duration miniscope recordings.

      (2) Installation issue on macOS

      Reviewer #1:

      At present, there are practical issues that limit the usability of the software. The link to the macOS installer on the documentation website is not functional. Furthermore, installation on a MacBook Pro was unsuccessful, producing the following error: "rsync(95755): error: ... Permission denied ...unexpected end of file."

      We thank the reviewer for identifying the broken installer link and the macOS installation error. We fixed the macOS installer link on the documentation website and updated installation instructions to explicitly address common macOS permission-related failures (including rsync "Permission denied" errors that arise when attempting to write into protected directories without appropriate privileges). We re-tested installation on clean macOS systems and confirmed successful installation under the revised instructions.

      (3) Validation, benchmarking, and cross-pipeline comparison

      Reviewer #2:

      A major limitation of this manuscript is that the authors don't validate the accuracy of their source extraction using ground-truth data or any benchmark against existing pipelines... Without this kind of validation, it is impossible to truly determine whether MPS produces biologically acceptable results... Considering one of the main benefits of MPS is its low memory demand and ability to run on unsophisticated hardware, the authors should include a figure that shows how processing times and memory usage scale with dataset sizes and differing pipelines... runtime comparisons on identical datasets processed through MPS, CaImAn, Minian, or CaliAli would be necessary to substantiate performance claims of MPS being "10-20X faster".

      We thank the reviewers for their careful reading and for raising the question of biological validity, which we agree is central to any calcium imaging analysis tool. We would like to clarify, however, that MPS does not introduce a novel source extraction algorithm, and therefore the question of biological validity is not one that MPS alone can answer - nor should it be expected to. MPS is built on CNMF, the same mathematical framework underlying CaImAn and Minian. The contribution of MPS lies in its initialization strategy and parallelization architecture, which allow this proven framework to operate in the multi-hour recording regime.

      To address the reviewers' request for a direct qualitative comparison, we will run MPS, CaImAn, Minian, and MIN1PIPE on a representative 10-minute real recording with clearly visible neurons. The figure will show the spatial components (ROI footprints) and representative temporal traces (ΔF/F) for all four pipelines on identical data. We anticipate that the spatial layouts and temporal dynamics will be highly concordant across pipelines, demonstrating that MPS produces biologically consistent output. We believe this side-by-side comparison will provide a clear demonstration that MPS output is comparable in quality to established tools on tractable recordings.

      Regarding runtime comparison across pipelines, we will provide a table showing approximate processing times at three recording durations (5, 20, and 180 minutes). On short recordings, all pipelines are expected to complete successfully at different rates, whereas on long-duration recordings, this pipeline behavior is expected to diverge. We acknowledge that any single runtime benchmark reflects specific hardware and dataset characteristics and may not generalize to all configurations. We will therefore present these data as illustrative rather than definitive and will direct readers to the MPS documentation for guidance on hardware-specific tuning.

      (4) Dataset description and scope of generalizability

      Reviewer #2:

      The current datasets used for validating MPS are not described in the manuscript. The manuscript appears to have 28 sessions of calcium imaging, but it is unclear if this is a single cohort or even animal, or whether these data are all from the same brain region. Importantly, the generalizability of parameter choices and performance could vary for others based on brain region differences, use of alternative calcium indicators...

      We agree that the dataset description should be centralized and unambiguous. We added a dedicated Methods subsection stating that all results are based on a single, controlled experimental dataset consisting of 28 long-duration miniscope sessions acquired under consistent conditions (same brain region, calcium indicator, optical configuration, and acquisition parameters). This section explicitly specifies the number of animals, brain region, frame rate, field of view, session duration, and total data volume. We also clarified that conclusions are intended to evaluate MPS performance in this controlled long-duration setting rather than to claim universal parameter generalizability across brain regions, indicators, or optical systems.

      (5) Parameter guidance and documentation

      Reviewer #2:

      ...users should not be expected to blindly trust default or suggested parameter selections. Instead, users need guidance on what each modifiable parameter does to their data and how each step analysis output should be interpreted. Currently, the documentation and FAQ website linked to MPS installation does not do an adequate job of describing parameters or their optimization...

      We agree that users should not blindly trust default or suggested parameters. We substantially expanded and centralized documentation by adding a parameter-selection walkthrough that explains what each modifiable parameter does, how it affects intermediate and final outputs, and how diagnostic plots generated at each stage should be interpreted. Rather than prescribing dataset-specific parameter values, we explicitly framed parameter selection as an iterative, hypothesis-driven process informed by experimental factors such as calcium indicator kinetics, lens size and numerical aperture, field of view, recording duration, and expected neuronal density. We consolidated previously dispersed explanations from the GitHub repository into a single documentation site and expanded figure descriptions to guide interpretation by less experienced users. A representative sample dataset and accompanying analysis code were made publicly available at https://github.com/ariasarch/MPS_Sample_Code to support parameter exploration on tractable data.

      (6) Packaging and distribution

      Reviewer #1:

      ...current best practices in software development increasingly rely on continuous integration and continuous deployment (CI/CD) pipelines to ensure reproducibility, testing, and long-term maintenance. In this context, it has become standard for Python packages to be distributed via PyPI or Conda. Without dismissing the value of standalone installers, the overall quality and sustainability of MPS would be greatly enhanced by also supporting conventional environment-based installations.

      Regarding distribution more broadly: while our one-click installers are intended to reduce setup burden for non-programmers, we recognize the value of conventional environment-based distribution for longterm sustainability. We are exploring the feasibility of adding a standard PyPI and/or Conda installation pathway alongside the standalone installers. To ensure reproducibility across environments, all package dependencies are now explicitly version-pinned at installation time, eliminating environment drift as a source of irreproducibility.

      We would note, however, that PyPI distribution alone does not fully resolve the reproducibility challenges inherent to scientific Python software. Even with version-pinned dependencies, downstream changes in the Python interpreter itself, compiled extension modules, and platform-specific build toolchains can silently alter numerical behavior in ways that are difficult to anticipate or control. Our standalone installers address this by shipping a complete, fixed execution environment, and we believe this remains a meaningful architectural advantage for ensuring long-term reproducibility - particularly for non-developer users who may not be in a position to diagnose subtle environment-related failures. We see PyPI/Conda support and standalone installers as complementary rather than equivalent approaches, and will pursue both where feasible.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Taken altogether, the experimental evidence favors an erosion-dominated process. However, a few minor questions remain regarding the models. Why does the equalfragmentation model predict no biomass transfer between size classes? To what extent, quantitatively, does the erosion model outperform the equal fragments model at capturing the biomass size distributions? Finally, why does the idealized erosion fail to capture the size distribution at late stages in Supplemental Figure S9 - would this discrepancy be resolved if the authors considered individual colony variances in cell adhesion (for instance, as hypothesized by the authors in lines 133-137)? I do not believe these questions curb the other results of the paper.

      Our analysis in Figure 2 considers two size classes: small colonies (l < 5) and large colonies (l ≥ 5). The equal-fragment model predicts that the fracture of a large colony gives rise to two daughter fragments with half the biovolume. For an average colony of l = 25 in diameter, this corresponds to two daughter fragments with a diameter of l = 18, which is still in the large colony class. Sequential fragmentation events would be required to set a biomass transfer to the small size range (l < 5). However, the nearly exponential behavior of the fragmentation frequency function (Eq. 5) implies that subsequent fragmentation events are greatly slowed down. Therefore, the equal-fragments model predicts that the biomass transfer from large to small colonies during the first five hours of the experiment is negligible. This is in a sharp contrast with the erosion model, which transfers biomass to the small size class at every fragmentation event. The difference between the two fragmentation models is quantified in Figure 2D, with a negligible change in biomass size distribution for the equal-fragment model (horizontal dash-dotted line) and a strong increase of small colonies for the erosion model (curved dashed line). Hence, it is clear from Figure 2D that the erosion model outperforms the equal-fragment model by capturing the observed shift from large to small colonies. We have now described this more clearly in lines 231-233.

      Nevertheless, the performance of the idealized erosion model is limited at late stages (Fig. S9D). We agree with the reviewer that this limitation could potentially be overcome with the introduction of variance in cell adhesion among colonies (as we hypothesized in lines 140142). However, this is not a trivial thing to do, as it would require additional free parameters and reduce the simplicity of the model. Therefore, we chose to restrain our model to the common assumptions of idealized fragmentation models widely used in literature (e.g. references 53-55).

      Reviewer #2 (Public review):

      Especially the introduction seems to imply that shear force is a very important parameter controlling colony formation. However, if one looks at the results this effect is overall rather modest, especially considering the shear forces that these bacterial colonies may experience in lakes. The main conclusion seems that not shear but bacterial adhesion is the most important factor in determining colony size. The writing could have done more justice to the fact that the importance of adhesion had been described elsewhere. This being said, the same method can be used to investigate systems where shear forces are biologically more relevant.

      In this work we aimed to investigate the effects of shear forces over a wide range of values, extending beyond the regime of natural lakes into the strong mixing created by technological applications such as the bubble plumes that are applied in several lakes to suppress cyanobacterial blooms. The adhesion force between cells via, e.g., extracellular polysaccharides (EPS) play an essential role by controlling the resistance to shear-driven erosion, which has been quantified in our model by the fitting parameters S<sub>i</sub> and q<sub>i</sub>.

      We agree with the reviewer that we have missed some literature on Microcystis colony formation via cell aggregation (i.e., cell adhesion), for which we apologize. In our new revision, we have now included several new references [30-34,36] and we now describe the findings of these earlier studies. Specifically, in the Introduction we now pay more attention to the role of cell adhesion by writing (lines 53-60):

      “In contrast, cell aggregation (sometimes also called cell adhesion) can promote a rapid increase in colony size beyond the limit set by division rates, and may explain sudden rises in colony size in late bloom periods [26, 30, 31]. Aggregation rates depend on the stickiness of the colonies, which in turn is controlled by the EPS composition, pH, and ionic composition of water [27–29]. In particular, divalent cations such as Ca2+ can bridge negatively charged functional groups in EPS and therefore increase stickiness [32–34]. It has been shown that high levels of Ca2+ enhance cell aggregation in Microcystis cultures [35]. Moreover, cell aggregation can provide a fast defense against grazing [36]. Fluid flow plays an important role in cell aggregation by regulating the collision frequency between cells or colonies [6]. In addition, fluid flow ….”

      Furthermore, in the Conclusions we added (lines 374-376):

      “A previous study on colony aggregation at high Ca2+ levels observed similar morphological differences in colony formation [35]. There, an initial fast cell aggregation produced a sparse colony structure, followed by a more compact structure of the colonies associated with cell division”

      Finally, we would like to clarify a difference in terminology between the reviewer’s comment and our work. The term cell adhesion is commonly used in microbiology to refer to adhesion of cells with a solid substrate. In our work, the adhesion mediated by EPS occurs between free-floating cells and colonies. To avoid any confusion, we chose to refer to this process as cell aggregation, in line with other literature on suspended particles.

      Reviewer #2 (Recommendations for the authors):

      The authors have expanded on the image analysis process but now report substantially different correction factors (λ2 =2.79 compared to 73.13 in the previous submission; λ3 =0.52 compared to 13.71 in the previous submission). Could the authors comment on how the analysis changed? These correction factors for N<5 appear particularly relevant for the aggregation experiments presented in Figure 3. For measurements involving only small colonies, as in Figure 3, are these correction factors still valid? In addition, does the timing of image acquisition, i.e. when the colonies are imaged, influence the correction factors applied in this study?

      The description of the calibration process was improved in our earlier revision of the manuscript to improve clarity and remove unclear definitions. In the first version, the supplementary equation (S1) for the input variable N<sub>p</sub>[i] was defined as the number of features per frame. This variable is dependent on the frame dimension (2048x2048 px for large colonies, l>5, and 400x400 px for small colonies). We believe that a more suitable input is the concentration distribution, which is normalized by frame area, and therefore invariant to frame dimensions and less prone to misinterpretations. For this reason, we adjusted this definition of N<sub>p</sub>[i] in the revised version of the manuscript, so that it expresses the number of features per frame area (instead of per frame). These changes required the calibration constants, λ<sub>2</sub> and λ<sub>3</sub>, to be updated in the manuscript by a factor of (400 px/2048 px)<sup>2</sup>. This explains why these two calibration constants changed by a factor 0.038. This rescaling of the input variable N<sub>p</sub>[i] and the calibration constants did not affect the final results of our calculations (Figures 2 and 3).

      The authors use a moderate dissipation rate to stir the colonies, after which they allow them to sediment. How long were the particles allowed to sediment before measurements were taken? Intuitively, one might expect a greater number of colonies to be detected following sedimentation, yet the authors report only about one third of the colonies in the sedimented state. What accounts for this reduction? Furthermore, if higher shear rates are applied, do the results differ, for instance if particles are lifted further by the shear flow? Some more clarity would help other researchers to perform similar work.

      The sedimentation of particles following an initial stir was applied only for creating a reference size distribution, displayed in the supplementary Figures S8-C and D. As one intuitively would expect, a higher concentration of colonies was detected after sedimentation (Fig. S8-C and D) than during the shear flow (Fig. S8-A and B). During all other experiments in our work, the applied dissipation rate was sufficient to ensure a uniform distribution of colonies in suspension throughout the parameter range, as described in lines 461-473.

      In the caption of Figure S8 we have reported the number of colonies counted in small subsamples. These numbers are just small subsets of the total number of colonies contained in the entire volume of the cone-and-plate setup. A sub-sample with larger volume was measured during the shear flow in comparison to the sub-sample measured for the sedimented sample, leading to a larger number of counted colonies in panels A and B (N = 10776, combined) compared to panels C and D (N = 3066 and 1455, respectively).

      However, when normalized for the volume of the sub-samples, the calculated concentration of colonies is higher for panels C and D (as shown in the graphs). We understand that the earlier caption description of Figure S8 was misleading, for which we apologize. In the revised version, we have adjusted the caption to better describe the quantity:

      “Number of colonies counted during sampling …”

      Line 797 contains an unfinished edit ("Figure ADD") that should be corrected.

      The unfinished edit has been corrected in the newly revised manuscript. Thanks!

    1. Author response:

      The following is the authors’ response to the previous reviews

      We appreciate the authors' efforts in addressing the concerns raised, particularly including a variance partitioning approach to analyse their data. Detailed feedback on the revised manuscript are below and we include a brief list of comments that we think the authors could address in the text: 

      (1) Justify metric selection - Could you please include in the text and explanation for why only five behavioural metrics were highlighted out of the many you calculated?

      We have added explanations throughout the manuscript clarifying the rationale for selecting these behavioral parameters, including in lines 467ff. and 531ff. In short, the five highlighted metrics were chosen because they capture key aspects of the behavioral repertoire and, importantly, can be consistently measured across all experimental conditions. Other parameters were excluded as they were only applicable under specific contexts and thus not suitable for cross-condition comparisons.

      (2) Discuss ICC variation - We note that there is variation among the ICC scores for the different metrics you've studied. While this is expected, we ask that you acknowledge in the text that some traits show high repeatability and others low, and reflect this variation in the conclusions.

      We have added an additional paragraph in the Discussion (lines 743ff.) addressing the variation in ICC values among behavioral traits. This new section highlights that some metrics show high repeatability while others exhibit lower consistency, and we discuss how this heterogeneity informs our conclusions about individual behavioral stability across contexts.

      (3) Tone down general claims - Because of the above point, we recommend that you avoid overstating that individuality persists across all behaviours. Please clarify this in the Abstract and main text that it applies to some traits more than others.

      We carefully reviewed the entire manuscript and revised the phrasing wherever necessary to avoid overgeneralization. Statements about individuality have been adjusted to clarify that consistent individuality can be measured in some behavioral traits more strongly than to others, both in the Abstract and throughout the main text.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors state the study's goal clearly: "The goal of our study was to understand to what extent animal individuality is influenced by situational changes in the environment, i.e., how much of an animal's individuality remains after one or more environmental features change." They use visually guided behavioral features to examine the extent of correlation over time and in a variety of contexts. They develop new behavioral instrumentation and software to measure behavior in Buridan's paradigm (and variations thereof), the Y-maze, and a flight simulator. Using these assays, they examine the correlations between conditions for a panel of locomotion parameters. They propose that inter-assay correlations will determine the persistence of locomotion individuality.

      Strengths: 

      The OED defines individuality as "the sum of the attributes which distinguish a person or thing from others of the same kind," a definition mirrored by other dictionaries and the scientific literature on the topic. The concept of behavioral individuality can be characterized as: (1) a large set of behavioral attributes, (2) with inter-individual variability, that are (3) stable over time. A previous study examined walking parameters in Buridan's paradigm, finding that several parameters were variable between individuals, and that these showed stability over separate days and up to 4 weeks (DOI: 10.1126/science.aaw718). The present study replicates some of those findings, and extends the experiments from temporal stability to examining correlation of locomotion features betweendifferent contexts. 

      The major strength of the study is using a range of different behavioral assays to examine the correlations of several different behavior parameters. It shows clearly that the inter-individual variability of some parameters is at least partially preserved between some contexts, and not preserved between others. The development of highthroughput behavior assays and sharing the information on how to make the assays is a commendable contribution.

      Weaknesses:

      The definition of individuality considers a comprehensive or large set of attributes, but the authors consider only a handful. In Supplemental Fig. S8, the authors show a large correlation matrix of many behavioral parameters, but these are illegible and are only mentioned briefly in Results. Why were five or so parameters selected from the full set? How were these selected? Do the correlation trends hold true across all parameters? For assays in which only a subset of parameters can be directly compared, were all of these included in the analysis, or only a subset?

      The correlation analysis is used to establish stability between assays. For temporal retesting, "stability" is certainly the appropriate word, but between contexts it implies that there could be 'instability'. Rather, instead of the 'instability' of a single brain process, a different behavior in a different context could arise from engaging largely (or entirely?) distinct context-dependent internal processes, and have nothing to do with process stability per se. For inter-context similarities, perhaps a better word would be "consistency".

      The parameters are considered one-by-one, not in aggregate. This focuses on the stability/consistency of the variability of a single parameter at a time, rather than holistic individuality. It would appear that an appropriate measure of individuality stability (or individuality consistency) that accounts for the high-dimensional nature of individuality would somehow summarize correlations across all parameters. Why was a multivariate approach (e.g. multiple regression/correlation) not used? Treating the data with a multivariate or averaged approach would allow the authors to directly address 'individuality stability', along with the analyses of single-parameter variability stability.

      The correlation coefficients are sometimes quite low, though highly significant, and are deemed to indicate stability. For example, in Figure 4C top left, the % of time walked at 23°C and 32°C are correlated by 0.263, which corresponds to an R2 of 0.069 i.e. just 7% of the 32°C variance is predictable by the 23°C variance. Is it fair to say that 7% determination indicates parameter stability? Another example: "Vector strength was the most correlated attention parameter... correlations ranged... to -0.197," which implies that 96% (1 - R2) of Y-maze variance is not predicted by Buridan variance. At what level does an r value not represent stability?

      The authors describe a dissociation between inter-group differences and interindividual variation stability, i.e. sometimes large mean differences between contexts, but significant correlation between individual test and retest data. Given that correlation is sensitive to slope, this might be expected to underestimate the variability stability (or consistency). Is there a way to adjust for the group differences before examining correlation? For example, would it be possible to transform the values to ingroup ranks prior to correlation analysis?

      What is gained by classifying the five parameters into exploration, attention, and anxiety? To what extent have these classifications been validated, both in general, and with regard to these specific parameters? Is increased walking speed at higher temperature necessarily due to increased 'explorative' nature, or could it be attributed to increased metabolism, dehydration stress, or a heat-pain response? To what extent are these categories subjective?

      The legends are quite brief and do not link to descriptions of specific experiments. For example, Figure 4a depicts a graphical overview of the procedure, but I could not find a detailed description of this experiment's protocol.

      Using the current single-correlation analysis approach, the aims would benefit from rewording to appropriately address single-parameter variability stability/consistency (as distinct from holistic individuality). Alternatively, the analysis could be adjusted to address the multivariate nature of individuality, so that the claims and the analysis are in concordance with each other.

      The study presents a bounty of new technology to study visually guided behaviors. The Github link to the software was not available. To verify successful transfer or openhardware and open-software, a report would demonstrate transfer by collaboration with one or more other laboratories, which the present manuscript does not appear to do. Nevertheless, making the technology available to readers is commendable.

      The study discusses a number of interesting, stimulating ideas about inter-individual variability, and presents intriguing data that speaks to those ideas, albeit with the issues outlined above.

      While the current work does not present any mechanistic analysis of inter-individual variability, the implementation of high-throughput assays sets up the field to more systematically investigate fly visual behaviors, their variability, and their underlying mechanisms. 

      Comments on revisions:

      While the incorporation of a hierarchical mixed model (HMM) appears to represent an improvement over their prior single-parameter correlation approach, it's not clear to me that this is a multivariate analysis. They write that "For each trait, we fitted a hierarchical linear mixed-effects model in Matlab (using the fit lme function) with environmental context as a fixed effect and fly identity (ID) as a random intercept... We computed the intraclass correlation coefficient (ICC) from each model as the betweenfly variance divided by total variance. ICC, therefore, quantified repeatability across environmental contexts."

      Does this indicate that HMM was used in a univariate approach? Can an analysis of only five metrics of several dozen total metrics be characterized as 'holistic'?

      Within Figure 10a, some of the metrics show high ICC scores, but others do not. This suggests that the authors are overstating the overall persistence and/or consistency of behavioral individuality. It is clear from Figure S8 that a large number of metrics were calculated for each fly, but it remains unclear, at least to me, why the five metrics in Figure 10a are justified for selection. One is left wondering how rare or common is the 0.6 repeatability of % time walked among all the other behavioral metrics. It appears that a holistic analysis of this large data set remains impossible. 

      We thank the reviewer for the careful and thoughtful assessment of our work.

      We have added an additional paragraph in the Discussion (lines 743ff.) explicitly addressing the variation in ICC values among behavioral traits. This section emphasizes that while some metrics show high repeatability, others exhibit lower consistency, and we discuss how this heterogeneity informs our conclusions regarding individual behavioral stability across contexts.

      Regarding the reviewer’s concern about the analytical approach, we would like to clarify that the hierarchical linear mixed model (LMM) was applied in a univariate framework—each behavioral metric was analyzed separately to estimate its individual ICC value. This approach allows us to quantify repeatability for each trait across environmental contexts while accounting for individual identity as a random effect. Although this is not a multivariate model in the strict sense, it represents an improvement over the prior pairwise correlation approach because it explicitly partitions within- and between-individual variance.

      As for the selection of behavioral metrics, the five parameters highlighted (% time walked, walking speed, vector strength, angular velocity, and centrophobicity) were chosen because they represent key, biologically interpretable dimensions of locomotor and spatial behavior and, importantly, could be measured reliably across all tested conditions. Several other parameters that we routinely analyze (e.g., Linneweber et al., 2020) could not be calculated in all contexts—for instance, under darkness or when visual cues were absent—and therefore were excluded to maintain consistency across assays.

      We agree that a truly holistic multivariate comparison across all extracted parameters would be valuable; however, given the contextual limitations of some metrics, such an analysis was not feasible in the present framework. We have clarified these points in the revised manuscript to avoid potential misunderstandings.

      The authors write: "...fly individuality persists across different contexts, and individual differences shape behavior across variable environments, thereby making the underlying developmental and functional mechanisms amenable to genetic dissection." However, presumably the various behavioral features (and their variability) are governed by different brain regions, so some metrics (high ICC) would be amenable to the genetic dissection of individuality/variability, while others (low ICC) would not. It would be useful to know which are which, to define which behavioral domains express individuality, and could be targets for genetic analysis, and which do not. At the very least, the Abstract might like to acknowledge that inter-context consistency is not a major property of all or most behavioral metrics.

      We thank the reviewer for this helpful comment and agree that not all behavioral traits exhibit the same degree of inter-context consistency. We have clarified this point in the revised Abstract and ensured that it is also reflected in the main text. The Abstract now reads: 

      “We find that individuality is highly context-dependent, but even under the most extreme environmental alterations tested, consistency of behavioral individuality always persisted in at least one of the traits. Furthermore, our quantification reveals a hierarchical order of environmental features influencing individuality. We confirmed this hierarchy using a generalized linear model and a hierarchical linear mixed model. In summary, our work demonstrates that, similar to humans, fly individuality persists across different contexts (albeit worse than across time), and individual differences shape behavior across variable environments. The presence of consistency across situations in flies makes the underlying developmental and functional mechanisms amenable to genetic dissection.” 

      This revision clarifies that individuality is not uniformly expressed across all behavioral metrics, but rather in a subset of traits with higher repeatability, which are the most promising targets for future genetic analyses.

      I hold that inter-trial repeatability should rightly be called "stability" while inter-context repeatability should be called "consistency". In the current manuscript, "consistency" is used throughout the manuscript, except for the new edits, which use "stability". If the authors are going to use both terms, it would be preferable if they could explain precisely how they define and use these terms.

      We thank the reviewer for drawing attention to this inconsistency in terminology. We apologize for the oversight and have corrected it throughout the manuscript to ensure uniform usage.

      Reviewer #2 (Public review):

      Summary:

      The authors repeated measured the behavior of individual flies across several environmental situations in custom-made behavioral phenotyping rigs.

      Strengths:

      The study uses several different behavioral phenotyping devices to quantify individual behavior in a number of different situations and over time. It seems to be a very impressive amount of data. The authors also make all their behavioral phenotyping rig design and tracking software available, which I think is great and I'm sure other folks will be interested in using and adapting to their own needs.

      Weaknesses/Limitations: 

      I think an important limitation is that while the authors measured the flies under different environmental scenarios (i.e. with different lighting, temperature) they didn't really alter the "context" of the environment. At least within behavioral ecology, context would refer to the potential functionality of the expressed behaviors so for example, an anti-predator context, or a mating context, or foraging. Here, the authors seem to really just be measuring aspects of locomotion under benign (relatively low risk perception) contexts. This is not a flaw of the study, but rather a limitation to how strongly the authors can really say that this demonstrates that individuality is generalized across many different contexts. It's quite possible that rank-order of locomotor (or other) behaviors may shift when the flies are in a mating or risky context. 

      I think the authors are missing an opportunity to use much more robust statistical methods. It appears as though the authors used pearson correlations across time/situations to estimate individual variation; however far more sophisticated and elegant methods exist. The problem is that pearson correlation coefficients can be anticonservative and additionally, the authors have thus had to perform many many tests to correlate behaviors across the different trials/scenarios. I don't see any evidence that the authors are controlling for multiple testing which I think would also help. Alternatively, though, the paper would be a lot stronger, and my guess is, much more streamlined if the authors employ hierarchical mixed models to analyse these data, which are the standard analytical tools in the study of individual behavioral variation. In this way, the authors could partition the behavioral variance into its among- and withinindividual components and quantify repeatability of different behaviors across trials/scenarios simultaneously. This would remove the need to estimate 3 different correlations for day 1 & day 2, day 1 & 3, day 2 & 3 (or stripe 0 & stripe 1, etc) and instead just report a single repeatability for e.g. the time spent walking among the different strip patterns (eg. figure 3). Additionally, the authors could then use multivariate models where the response variables are all the behaviors combined and the authors could estimate the among-individual covariance in these behaviors. I see that the authors state they include generalized linear mixed models in their updated MS, but I struggled a bit to understand exactly how these models were fit? What exactly was the response? what exactly were the predictors (I just don't understand what Line404 means "a GLM was trained using the environmental parameters as predictors (0 when the parameter was not change, 1 if it was) and the resulting individual rank differences as the response"). So were different models run for each scenario? for different behaviors? Across scenarios? what exactly? I just harp on this because I'm actually really interested in these data and think that updating these methods can really help clarify the results and make the main messages much clearer!

      I appreciate that the authors now included their sample sizes in the main body of text (as opposed to the supplement) but I think that it would still help if the authors included a brief overview of their design at the start of the methods. It is still unclear to me how many rigs each individual fly was run through? Were the same individuals measured in multiple different rigs/scenarios? Or just one?

      I really think a variance partitioning modeling framework could certainly improve their statistical inference and likely highlight some other cool patterns as these methods could better estimate stability and covariance in individual intercepts (and potentially slopes) across time and situation. I also genuinely think that this will improve the impact and reach of this paper as they'll be using methods that are standard in the study of individual behavioral variation

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors): 

      I am delighted to see the authors have included hierarchical models in their analysis. I really think this strengthens the paper and their conclusions while simultaneously making it more accessible to folks that typically use these types of methods to investigate these patterns of individual behavior. It's also cool, and completely jives with my own experience measuring individual behavior in that the activity metrics show the highest repeatability compared to the more flexible behaviors (such as "exploration"). I think it's quite striking and interesting to see such moderate repeatability estimates in these behaviors across what could be very different environmental scenarios. I think this is a very strong and meaty paper with a lot of information to digest producinghowever a very elegant and convincing take-home message: individuals are unique in their behavior even across very different environments.

      We sincerely thank the reviewer for the positive and encouraging feedback, as well as for their valuable input throughout the review process. We are very pleased that the inclusion of hierarchical models and the resulting interpretations resonated with the reviewer’s own experience and perspective.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Our goal was to propose a possible computational mechanism underlying information integration in the claustrum, not to claim structural or causal equivalence between the model and the biological circuit. We acknowledge that some expressions in the original manuscript may have been interpreted as exceeding this intention, and we will revise the text to explicitly soften such statements.

      It is well established that behavior-trained RNNs can admit multiple internal solutions capable of producing the same behavioral output, and we fully agree with this point. Among the many possible solutions, we focused on networks that exhibited dynamical properties consistent with independently obtained behavioral and physiological findings. Thus, in our view, biological plausibility in this study is not grounded in structural isomorphism, but rather in whether the core population-level dynamical properties observed in the model are reproducible in actual claustral population activity.

      We also agree with the reviewer that our original qualitative comparison of GPFA-based latent trajectories did not provide sufficient quantitative support. In the revised manuscript, we have therefore added an eigenvalue-based quantitative analysis of the dimensional structure of population trajectories. This analysis does not depend on the identity of the dimensionality-reduction method itself, but instead focuses on quantifying the geometric structure of population-state trajectories as they evolve over time. Applying the same metric to both the RNN and biological claustrum data revealed consistent condition-specific differences in population dynamics.

      This quantitative addition strengthens the previous qualitative trajectory comparison and clarifies that the model implements a specific computational dynamical regime that directionally corresponds to claustral population activity. While this does not imply uniqueness of the model, we believe it suggests that the proposed computational principle represents a biologically realizable candidate mechanism.

      (1) Tone of model-data correspondence

      Numerous statements describe the RNN as "closely mimicking," "recapitulating," or being "nearly identical" to claustral neural dynamics, sometimes extending to claims about causal relationships between neural activity and behavior. Given that neural data were not used to train the model, and that only a small subset of trained networks showed the reported dynamics, these statements should be substantially softened throughout the manuscript. The RNN should be framed as providing one possible computational realization consistent with existing data, not as a close instantiation of the biological circuit.

      We agree with the reviewer’s concern. Expressions such as “closely mimicked,” “nearly identical,” and “recapitulate” will be replaced with more moderate language.

      (2) Non-uniqueness of RNN solutions

      The fact that only a small fraction of trained networks exhibited "claustrum-like" clusters deserves deeper discussion. This observation raises the possibility that the identified solution is fragile or highly specific rather than canonical. The authors should explicitly discuss the non-uniqueness of internal solutions in behavior-trained RNNs, including the range of alternative network dynamics that can reproduce the same behavior. In particular, it should be clarified why the specific network exhibiting "claustrum-like" clusters is informative about claustral computation, rather than representing one arbitrary solution among many.

      As the reviewer noted, behavior-trained RNNs can yield multiple internal solutions that generate the same behavioral output, and we acknowledge this non-uniqueness. However, we do not interpret the relatively low success rate (5/100 networks) as evidence of fragility. Rather, we interpret it as suggesting that the emergence of this particular dynamical regime requires stringent structural constraints.

      The computational demands of the task—specifically, the integration of temporally separated signals—drive convergence toward networks capable of sustaining persistent activity through recurrent excitatory connectivity. Indeed, all networks exhibiting a claustrum-like cluster shared a strong recurrent excitatory structure within Cluster 1, a structural feature consistent with our slice electrophysiology findings.

      Our criterion for selecting RNNs was their ability to reproduce behavioral and physiological observations from the delayed escape experiment. Excluded RNNs may reflect alternative information-processing strategies characteristic of other brain regions or artificial logical solutions. Importantly, claustrum-like dynamics were not explicitly enforced during training; they emerged spontaneously under behavioral constraints, suggesting that this solution is not arbitrary.

      Furthermore, the computational principles derived from the RNN were quantitatively consistent with in vivo single-neuron activity. Using an eigenvalue-based metric (λ<sub>3</sub>/Σλ), both the RNN and biological claustrum data showed effects in the same direction. Leave-one-neuron-out analyses further demonstrated that this pattern was broadly distributed across neurons in the claustrum. These convergent results suggest that the identified network captures a computational regime that is consistent with claustral population dynamics, rather than representing an arbitrary solution unrelated to the biological observations.

      (3) GPFA trajectory comparisons

      The qualitative similarity between RNN trajectories and GPFA-derived trajectories from sparse in vivo data is interesting but insufficient to support claims of robustness or population-level structure. Statements suggesting that these patterns are unlikely to arise from noise or random fluctuations are not justified, given the single-trial, pseudo-population nature of the data. Either additional quantitative controls should be added, or the interpretation should be substantially tempered.

      We agree that the original GPFA trajectory comparison in the biological claustrum data remained qualitative and did not sufficiently establish robustness or population-level structure. We have therefore added quantitative analyses in the revised manuscript.

      Before presenting these analyses, we clarify methodological limitations inherent in pseudopopulation and single-trial data. GPFA estimates latent trajectories based on covariance structure and temporal smoothness assumptions. In pseudopopulations, true simultaneously recorded covariance cannot be fully reconstructed. Although our dataset is based on single trials rather than trial-to-trial variability, we acknowledge that latent-space estimation depends on covariance structure.

      Therefore, the additional quantitative metric is not independent of the GPFA estimation stage; rather, it evaluates the geometric structure of single-trial latent trajectories estimated by GPFA.

      Specifically, for biological data, we reanalyzed GPFA-estimated latent trajectories in PCA space and computed an eigenvalue-based metric (λ<sub>3</sub>/Σλ). Across 20 time bins, a sliding window of 10 bins was applied. For each window, we computed the covariance matrix and extracted eigenvalues for PC1, PC2, and PC3. The third eigenvalue (λ<sub>3</sub>) was normalized by total variance (Σλ = λ<sub>1</sub> + λ<sub>2</sub> + λ<sub>3</sub>). This metric quantifies the extent to which trajectories deviate from a planar (two-dimensional) structure into a third dimension. An increase in λ<sub>3</sub>/Σλ indicates the formation of a higher-dimensional geometric structure.

      For RNN data, since all unit activities were simultaneously observed and sufficient trials were available, we directly applied PCA to population activity without GPFA. Mean trajectories across trials were computed, and the same λ<sub>3</sub>/Σλ metric was applied. Although the initial dimensionality-reduction steps differ, the final metric definition and computation are identical. Thus, the comparison focuses on geometric dimensional structure rather than the dimensionality-reduction method itself.

      Importantly, within the biological dataset, GPFA estimation, preprocessing, pseudopopulation construction, subsampling strategy, temporal alignment, and smoothing were applied identically across the CS and Neutral conditions. Under this common analysis framework, λ<sub>3</sub>/Σλ values were consistently higher in the CS condition than in the Neutral condition.

      For the RNN data, an identical analysis pipeline was applied across the CS+Open and Open-only conditions. In this case as well, λ<sub>3</sub>/Σλ values were significantly higher in the CS+Open condition than in the Open-only condition.

      If structural bias arose from covariance estimation or dimensionality reduction, it would be expected to affect conditions similarly within each dataset. The observation that λ<sub>3</sub>/Σλ increases selectively in the CS condition in biological data and in the CS+Open condition in the RNN therefore supports the interpretation that the effect reflects a condition-specific dynamical difference rather than an artifact of dimensionality reduction.

      To further examine whether the effect was driven by a small subset of neurons, we performed leave-one-neuron-out analyses in the biological dataset. In the CS group, most neurons contributed relatively evenly to the metric, whereas such distributed contribution was not observed in the Neutral group. This suggests that the three-dimensional structure reflects an organized population-level phenomenon rather than covariance dominated by a small number of outlier neurons.

      These results indicate that the consistent elevation of λ<sub>3</sub>/Σλ in the CS condition (biological data) and in the CS+Open condition (RNN) reflects a genuine dynamical feature rather than an artifact arising from pseudopopulation construction or dimensionality reduction.

      Taken together, the three-dimensional geometric structure observed in GPFA-based latent trajectories is unlikely to reflect random noise. The replication of the same quantitative metric in the RNN, using an independent dimensionality-reduction procedure, strengthens the correspondence between the two systems. We appreciate the reviewer’s suggestion for quantitative reinforcement, which has substantially strengthened the manuscript.

      (4) Scope of functional claims

      The discussion connecting the findings to broad theories of claustral function, global workspace, or consciousness extends well beyond the data presented. These speculative links should be clearly labeled as such and significantly reduced in strength and prominence.

      We agree with the reviewer and will clearly indicate that references to broader theoretical interpretations are speculative. We will substantially reduce their strength and emphasis.

      (5) Comment on Conceptual Interpretation of the Behavioral Paradigm:

      The manuscript repeatedly describes the delayed escape task as an "inference-based behavioral paradigm" and states that animals "infer that a value-neutral alternative space is likely to be safer" when the CS is presented in a novel environment. While I appreciate that the US-CS association was established in a different context and that the CS is then presented in a new environment, I am not convinced that the current behavioral evidence uniquely supports an inference interpretation.

      We agree with the reviewer’s concern. We will describe the delayed escape task as “a behavioral paradigm that requires integration of temporally separated task-relevant signals” and remove inference-related terminology throughout the manuscript.

      Reviewer #2 (Public review):

      We appreciate the reviewer’s constructive and well-balanced comments. We regret that some of our wording and the scope of our introduction and discussion may not have appropriately reflected the contributions of prior studies. We will revise the manuscript accordingly to ensure that previous literature is more accurately and fairly acknowledged. In addition, we will reorganize the figures to more clearly present the hypotheses being tested and will provide additional details regarding both the modeling framework and the experimental procedures.

      (1) This paper is based on behavioral results and neural recordings from their prior paper (Han et al.), but data, e.g., in Figure 1, are not clearly identified as new or as coming from that source. Figure 1A, for example, appears to be taken directly from Han et al. No methods are given in this manuscript for the behavioral testing or the in vivo electrophysiology.

      We will clarify more explicitly which data and methods originate from Han et al. (2024). In the original manuscript, Figure 1 panels A, D, E, F, and L (left) were indicated in the legend as originating from Han et al. (2024). We will further clarify this distinction in the main text. Additionally, we will briefly describe the behavioral experiments and in vivo electrophysiology performed in Han et al. in the Methods section, with appropriate citation.

      (2) Many other details are unclear. Examples include model training, the weight matrices and how these changed with training (p. 13), equations 2 and 3 (p. 13), the sources for the constants in the equations (p. 14), the methods (anesthesia, stereotaxic coordinates, injection specifics and details for "sparse expression") for the ChrimsonR injections.

      As requested, we will provide additional details regarding model training procedures, weight matrices and their evolution during training, equations (2) and (3), the origin of constants used in the equations, and detailed methods for ChrimsonR injection (anesthesia, stereotaxic coordinates, injection parameters, and clarification of “sparse expression”).

      (3) The explorations of model behavior are a catalog of everything tried rather than an organized demonstration of what the model can and cannot do. The figures could be reduced in number to emphasize the key comparisons of the different clusters and the model's behavior under different conditions, intended to "test" the model.

      We will reorganize the figures to emphasize core results and clarify that the primary goal is to test and validate the computational model.

      (4) On page 6, the E-E connectivity is argued from Shelton et al. (2025) and against Kim et al. (2016), but ignores Orman (2015), which, to this reviewer's knowledge, was the first to demonstrate such connectivity, including the long-duration events and impact of planes of section.

      We will cite Orman (2015) as suggested and note that persistent activity has been observed in slices cut at specific angles, consistent with our findings.

      (5) Whereas the authors are entitled to their own opinion of prior work (references 3-8), it is inappropriate to misrepresent prior work as only demonstrating a "limited function" of claustum. Additional papers by Mathur's group and Citri's group are ignored.

      We will remove wording implying “limited” prior work and appropriately acknowledge contributions from the Mathur and Citri groups.

      In summary, the authors have made a computational model that recapitulates the firing of a subset of potentially claustral neurons during a particular behavioral task (delayed escape is certainly not the only behavior that involves claustrum - see e.g., attention, salience, sleep). If the conclusion is that excitatory claustral cells must be connected to other excitatory claustral cells, such a conclusion is not new, and the electrophysiological E-E metrics are not well quantified (e.g., connectivity frequency, strength of connection). If the model is intended to predict how the claustrum might accomplish any other task, there is insufficient detail to evaluate the model beyond the evidence that the model creates a subset of cells that can sustain firing during the delay period in the delayed escape task.

      Across all whole-cell recordings, optogenetic responses were observed in 38 out of 43 patched cells (~90%), suggesting that a high proportion of claustral neurons receive intra-claustral excitatory input. However, precise connectivity frequency and strength cannot be determined from the current dataset.

      As the reviewer noted, our RNN is specialized for the delayed escape task, and we do not claim direct generalization to other proposed claustral functions such as attention, salience, or sleep. The goal of this study is to computationally characterize the temporal integration mechanism observed in this specific task.

      While our model is specific to the delayed escape task, the computational principle identified here—nonlinear trajectory-based temporal integration supported by recurrent excitatory connectivity—may represent a more general mechanism for integrating temporally separated signals. However, testing such generality lies beyond the scope of the present study and will be framed as a future direction in the revised Discussion.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The electrocardiogram (ECG) is routinely used to diagnose and assess cardiovascular risk. However, its interpretation can be complicated by sex-based and anatomical variations in heart and torso structure. To quantify these relationships, Dr. Smith and colleagues developed computational tools to automatically reconstruct 3D heart and torso anatomies from UK Biobank data. Their regression analysis identified key sex differences in anatomical parameters and their associations with ECG features, particularly post-myocardial infarction (MI). This work provides valuable quantitative insights into how sex and anatomy influence ECG metrics, potentially improving future ECG interpretation protocols by accounting for these factors.

      Strengths:

      (1) The study introduces an automated pipeline to reconstruct heart and torso anatomies from a large cohort (1,476 subjects, including healthy and post-MI individuals).

      (2) The 3-stage reconstruction achieved high accuracy (validated via Dice coefficient and error distances).

      (3) Extracted anatomical features enabled novel analyses of disease-dependent relationships between sex, anatomy, and ECG metrics.

      (4) Open-source code for the pipeline and analyses enhances reproducibility.

      Weaknesses:

      (1) The linear regression approach, while useful, may not fully address collinearity among parameters (e.g., cardiac size, torso volume, heart position). Although left ventricular mass or cavity volume was selected to mitigate collinearity, other parameters (e.g., heart center coordinates) could still introduce bias.

      (2) The study attributes residual ECG differences to sex/MI status after controlling for anatomical variables. However, regression model errors could distort these estimates. A rigorous evaluation of potential deviations (e.g., variance inflation factors or alternative methods like ridge regression) would strengthen the conclusions.

      (3) The manuscript's highly quantitative presentation may hinder readability. Simplifying technical descriptions and improving figure clarity (e.g., separating superimposed bar plots in Figures 2-4) would aid comprehension.

      (4) Given established sex differences in QTc intervals, applying the same analytical framework to explore QTc's dependence on sex and anatomy could have provided additional clinically relevant insights.

      We thank Reviewer 1 for their kind and constructive comments. While we have thoroughly addressed all specific recommendations below, in brief, we have added new analysis of the variance inflation factor in Supplementary Tables 2 and 3 to reassure readers that the chosen parameter sets exhibit low levels of collinearity, and provided more explanation for why the relative positional parameters were chosen to avoid this issue. We have added explanatory figures for all positional and orientational parameters to improve understanding of the technical details, and improved clarity of existing figures as detailed below. We welcome the suggestion to add QT interval to the manuscript – whilst this was only available in the UK Biobank for a single lead, we have included an analysis of both QT and QTc intervals in this lead to Page 10, and added some discussion of this to the second full paragraph of Page 14.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Comment 1: “Collinearity and Regression Analysis: It would be valuable to assess the collinearity among the regressed parameters (e.g., cardiac size, torso volume, heart center positions [x, y, z], and cardiac orientation angles) and evaluate whether alternative regression methods (e.g., ridge regression) might improve robustness. Additionally, cardiac digital twinning with electrophysiological models could help isolate the exact contribution of electrophysiology while enabling sensitivity analysis. Nonlinear regression or machine learning approaches might also enhance the predictive power of the analysis.”

      We thank the reviewer for drawing attention to the important issue of collinearity in the parameter sets used in the regression analysis. To address this, we have added Supplementary Tables 2 and 3, which detail the variance inflation factors for each of the parameter sets used. This was considered in the selection of anatomical parameters – e.g. using relative position not absolute distances between landmarks, which would be more collinear. As these are all below a value of 3.4, we believe that the effect of collinearity is limited, and thus to reduce subjectivity of parameter selection in more complex methods, and encourage interpretability, we have retained our linear regression analysis. In addition, we have added an explanation to the second full paragraph on Page 6 of how we calculated the relative, rather than absolute position of the cardiac centre partially to avoid the problem of collinearity when using multiple absolute distances. We concur that modelling and simulation techniques are well suited to explore the electrophysiological component further – as this is out of the scope of this work, we have addressed the role of these methods in future work in the final paragraph of Page 16.

      Comment 2: “Figure Clarity (Bar Plots): The superimposed bar plots in Figures 2-4 are difficult to interpret; separating the bars for each coefficient would improve readability.”

      We accept that the stacked bar plots could be improved in their clarity. Whilst plotting each anatomical parameter separately multiplies the number of plots by a factor of nine, and makes comparison between parameters more difficult, we have added clear horizontal grid lines in order to make values easier to read and interpret.

      Comment 3: “Feature Extraction Visualization: A schematic figure illustrating the steps for measuring heart positional parameters (e.g., with example annotations) would help readers better understand the feature extraction methodology.”

      We agree with the reviewer that the calculation of positional and orientational parameters is crucial to illustrate clearly. We have included additional Supplementary Figures 2 and 3 to better convey these parameters.

      Reviewer #2 (Public review):

      Summary:

      Missed diagnosis of myocardial ischemia (MI) is more common in women, and treatment is typically less aggressive. This diagnosis stems from the fact that women's ECGs commonly exhibit 12 lead ECG biomarkers that are less likely to fall within the traditional diagnostic criteria. Namely, women have shorter QRS durations and lower ST junction and T wave amplitudes, but longer QT intervals, than men. To study the impact, this study aims to quantify sex differences in heart-torso anatomy and ECG biomarkers, as well as their relative associations, in both pre- and post-MI populations. A novel computational pipeline was constructed to generate torso-ventricular geometries from cardiac magnetic resonance imaging. The pipeline was used to build models for 425 post-myocardial infarction subjects and 1051 healthy controls from UK Biobank clinical images to generate the population.

      Strengths:

      This study has a strength in that it utilizes a large patient population from the UK Biobank (425 postMI and 1051 healthy controls) to analyze sex-based differences. The computational pipeline is stateof-the-art for constructing torso-ventricular geometries from cardiac MR and is clinically viable. It draws on novel machine learning techniques for segmentation, contour extraction, and shape modeling. This pipeline is publicly available and can help in the large-scale generation of anatomies for other studies. This allows computation of various anatomical factors (torso volume, cavity volume, etc), and subsequent regression analysis on how these factors are altered before and after MI from the 12-lead ECG.

      Weaknesses:

      Major weaknesses stem from the fact that, while electrophysiological factors appear to play a role across many leads, both post-MI and healthy, the electrophysiological factors are not stated or discussed. The computational modeling pipeline is validated for reconstructing torso contours; however, potential registration errors stemming from ventricular-torso construction are not addressed within the context of anatomical factors, such as the tilt and rotation of the heart. This should be discussed as the paper's claims are based on these results. Further analysis and explanation are needed to understand how these sex-specific results impact the ECG-based diagnosis of MI in men and women, as stated as the primary reason for the study at the beginning of the paper. This would provide a broader impact within the clinical community. Claims about demographics do not appear to be supported within the main manuscript but are provided in the supplements. Reformatting the paper's structure is required to efficiently and effectively present and support the findings and outcomes of this work.

      We thank Reviewer 2 for their considered and detailed feedback. We greatly appreciate the invitation to elaborate on the electrophysiological factors, and we have added discussion of this matter to the second and third full paragraphs on Page 14, extending to Page 15 and first full paragraph on Page 15, and highlighted the role of modelling and simulation in future work on the third full paragraph of Page 16. We agree that registration errors are one reason behind remaining reconstruction errors and feel a strength of our study is that the large number of subjects used aided in reducing the effect of this noise, and have updated the second full paragraph of Page 16 to reflect this. We are wary of moving too many supplemental figures and tables describing demographic trends to the main manuscript for fear of diluting the specific answers to our research questions. We have however actioned the suggestions as detailed below to reformat the paper, including redressing the balance of supplemental versus main methodological sections, and thank the reviewer for their guidance in increasing our clarity.

      Reviewer #2 (Recommendations for the authors):

      (1) Please detail what "chosen to be representative of the underlying dataset" means in terms of a validation dataset.

      We thank the reviewer for addressing the lack of clarity in this matter. We have added a reference in the third full paragraph on Page 6 to Supplementary Appendix 1.1, where we have included full details of the selection criteria.

      (2) “Current guidelines ... further research [16]." The paragraph should begin with a broader statement that is relevant to the fact that the entire body of work focuses on ECG-based diagnosis differences in women, rather than LVEF through echocardiography.

      We have revised the introduction to Paragraph 3 on Page 3 to clarify our motivation for focusing on the ECG in order to shape proposals for novel ECG-based risk stratification tools.

      (3) The last paragraph of the introduction should more clearly state what was performed and how you aim to prove your hypothesis. There is no mention of the data, the regression model, or other key aspects important to the reader.

      We have added methodological details to Paragraph 5 on Page 3 in order to clarify our approach in testing our hypothesis.

      (4) An overview paragraph should be included in the Methods at the beginning.

      We thank the reviewer for this valuable suggestion – we have added an overview paragraph to the start of the methodology section on Page 5.

      (5) The computational pipeline portion of the methods should be written in full paragraphs instead of almost a bulleted list. In general, more details from the supplement should be provided in the methods.

      We thank the reviewer for raising important points concerning the balance of methodological description in the main manuscript and the supplementary materials. We have added detailed description of the reconstruction pipeline to Pages 5 and 6. We feel that the ordered format of the methods section adds to the reproducibility and transparency of our methodology.

      (6) The torso reconstruction method was already validated in Smith et al. [29]. What value does your additional validation bring to this methodology? Furthermore, how does the construction of the ventricular-torso reconstructions using the cardiac axes (not just the torso contours) influence ECG metrics?

      We apologise that this was not clear – we have clarified in Paragraph 4 on Page 5 that while Smith et al. 2022 provided a detailed validation to the contour extraction networks, it did not validate the torso reconstruction pipeline, as it only presents the reconstruction of two cases as a proof of concept. We have also expanded the second full paragraph on Page 6 to explain that the sparse (but not dense) cardiac anatomies were constructed in order to calculate the cardiac size, which we found was a key factor moderating many ECG biomarkers. We also specified that the cardiac position and orientation were necessary in order to relate these to the torso axes and positions of the ECG electrodes.

      (7) Include the details of the regression analysis in the main body of the methods for the readers. This is crucial to the claims and outcomes of the paper. Only a sentence is included in the results and one in the figure: "Each factor's contribution is calculated from the product of the regression coefficients and anatomical sex differences (Supplementary Appendix 1.5)." What specific contributions can I expect to see in the results figures? The results are filled with methodological aspects that should be in the results.

      We thank the reviewer again for this important comment regarding the balance of the main text methodology and supplementary methodology sections. We have added detail to the statistical analysis section of the main text on Pages 7 and 8 in order for the reader to understand the following results section without consulting the supplemental methods. We have also removed these details from the results section.

      (8) What is "the remaining estimated effect of electrophysiology". Did you do simulations on the electrophysiology, or how is this computed from the clinical data of patients? More explanation is needed, as without this, the paper is just focusing on anatomy.

      We have clarified this important point by moving the explanation of the methodology underpinning our estimation of the electrophysiological contributions using the clinical ECGs from the supplementary methods to the main manuscript on the second full paragraph on Page 7, and continuing to Page 8. We have also specified the role of simulations studies in future work on the final paragraph on Page 16.

      (9) Include an overview paragraph of the methods to create more structure.

      We thank the reviewer again for the further attention to this issue – as previously, we have added an overview paragraph to the methodology section on Page 5.

      (10) Only 19.8% of the patients were female, which is probably due to females having a more severe presentation of the disease. How does this impact, bias, or skew your results?

      This comment raises a very interesting point, and while the origin of this imbalance is of course multifactorial – women likely do have lower rates of MI events due to the cardioprotective role of estrogen and different health promoting behaviours, and our sex imbalance was reflective of wider trends in MI diagnosis. However, as mentioned in Paragraph 2 Page 3 of the text, there are more missed MI diagnoses in women, and we agree that this may lead to a more severe presentation of female MI pathophysiology. We have expanded the first full paragraph on Page 16 to specify the ECG and demographic impacts that this has on our results, and that it is a strength of this work that we may contribute to future adjustment of the diagnostic criteria, such that future investigations do not have this bias, and that clinical outcomes are improved.

      (11) A lot of extra information is provided in Tables 1 and 2. Include additional information in the supplements that is not directly relevant to your findings.

      We agree that Table 2 is supplementary, rather than critical information, and have moved it accordingly to the Supplementary Materials on Page 38. We do believe that Table 1 is central for understanding the extracted dataset.

      (12) Combine paragraphs 3 and 4 into a single paragraph. "Current guidelines..." and "T wave amplitude...". They are part of a single coherent concept.

      We have removed the paragraph break on Page 3 Paragraph 3.

      (13) Check all acronyms throughout the paper. The abbreviation for sudden cardiac death (SCD) is only used once in the same paragraph. Remove the acronym and type it out. T-wave amplitude (TWA) is introduced twice in a Figure caption and not introduced until the methods.

      Many thanks for this suggestion – we have reviewed all acronyms in the manuscript.

      (14) "Figure 1B showcases the capability of the computational pipeline to extract torso contours and reconstruct them into 3D meshes". Isn't this Figure 1A?

      We apologise that this was unclear, and have updated the sentence on the first full paragraph of Page 8 to clarify the purpose of Figure 1B.

      (15) No need to state: "Female y-axis limits have been adjusted by the difference in healthy QRS duration between sexes for ease of comparison" in the Figure 2 caption.

      We have removed this statement on all relevant captions.

      (16) The paragraph "For lead V6, 15.9% of healthy subjects..." can be combined with the previous section.

      We have removed this paragraph break on Page 9 to improve readability.

      (17) The only demographics I could find were age and BMI. State which demographics you used explicitly. This is especially true when the discussion makes claims like "Our findings suggest that corrected QRS duration taking into consideration demographics...". How did you take them into account?

      We accept that our previous description of the demographic adjustment to QRS duration in the discussion did not adequately reflect the comprehensiveness of our approach, and have adjusted the second paragraph on Page 14 to rectify this.

      (18) The results section is also almost a bulleted list that should be written and reformatted into paragraphs.

      The ordered style of our results section was designed to compare how our obtained data answers our research question differently for ECG intervals, amplitudes, and axis angles. Whilst we have adjusted paragraph breaks and moved methodological details to more appropriate sections, we have retained this stylistic choice.

      (19) The following sentence should be in the introduction: "Alterations to the polarity and amplitude of the T wave are used in the diagnosis of acute MI [42] and TWA affects proposed risk stratification tools, particularly markers of repolarization abnormalities [9, 43]."

      We thank the reviewer for this suggestion. We have included the discussion of how TWA is separately used in proposed risk stratification and current diagnostic tools in Paragraph 3 of Page 3.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this study, the authors trained rats on a "figure 8" go/no-go odor discrimination task. Six odor cues (3 rewarded and 3 non-rewarded) were presented in a fixed temporal order and arranged into two alternating sequences that partially overlap (Sequence #1: 5<sup>+</sup>-0<sup>-</sup>-1<sup>-</sup>-2<sup>+</sup>; Sequence #2: 3<sup>+</sup>-0<sup>-</sup>-1<sup>-</sup>-4<sup>+</sup>) - forming an abstract figure-8 structure of looping odor cues.

      This task is particularly well-suited for probing representations of hidden states, defined here as the animal's position within the task structure beyond superficial sensory features. Although the task can be solved without explicit sequence tracking, it affords the opportunity to generalize across functionally equivalent trials (or "positions") in different sequences, allowing the authors to examine how OFC representations collapse across latent task structure.

      Rats were first trained to criterion on the task and then underwent 15 days of self-administration of either intravenous cocaine (3 h/day) or sucrose. Following self-administration, electrodes were implanted in lateral OFC, and single-unit activity was recorded while rats performed the figure-8 task.

      Across a series of complementary analyses, the authors report several notable findings. In control animals, lOFC neurons exhibit representational compression across corresponding positions in the two sequences. This compression is observed not only in trial/positions involving overlapping odor (e.g., Position 3 = odor 1 in sequence 1 vs sequence 2), but also in trials/positions involving distinct, sequence-specific odors (e.g., Position 4: odor 2 vs odor 4) - indicating generalization across functionally equivalent task states. Ensemble decoding confirms that sequence identity is weakly decodable at these positions, consistent with the idea that OFC representations collapse incidental differences in sensory information into a common latent or hidden state representation. In contrast, cocaine-experienced rats show persistently stronger differentiation between sequences, including at overlapping odor positions.

      Strengths:

      Elegant behavioral design that affords the detection of hidden-state representations.

      Sophisticated and complementary analytical approaches (single-unit activity, population decoding, and tensor component analysis).

      Weaknesses:

      The number of subjects is small - can't fully rule out idiosyncratic, animal-specific effects.

      Comments

      (1) Emergence of sequence-dependent OFC representations across learning.

      A conceptual point that would benefit from further discussion concerns the emergence of sequence-dependent OFC activity at overlapping positions (e.g., position P3, odor 1). This implies knowledge of the broader task structure. Such representations are presumably absent early in learning, before rats have learned the sequence structure. While recordings were conducted only after rats were well trained, it would be informative if the authors could comment on how they envision these representations developing over learning. For example, does sequence differentiation initially emerge as animals learn the overall task structure, followed by progressive compression once animals learn that certain states are functionally equivalent? Clarifying this learning-stage interpretation would strengthen the theoretical framing of the results.

      We agree that the emergence of sequence-dependent OFC activity at overlapping positions (e.g., P3) implies knowledge of the broader task structure and therefore must depend on learning. Although we did not record during early acquisition in the current study, we can outline a learning-stage framework consistent with both prior work and the comparative analyses included here and include it in the discussion.

      We think the development of OFC representations is a multi-stage process. Early in learning, before animals have acquired the sequential structure of the task, OFC activity is likely dominated by local sensory features and immediate reinforcement history, with little differentiation between sequences at overlapping positions. As animals learn that odors are embedded within extended sequences that have utility for predicting future outcomes, OFC representations would begin to differentiate identical sensory cues based on their sequence context, giving rise to sequence-dependent activity at positions such as P3. This stage reflects acquisition of the broader task structure and the recognition that current cues carry information about future states.

      With continued training, however, OFC representations normally undergo a further refinement: positions that differ in sensory identity but are functionally equivalent become compressed, while distinctions that are irrelevant for guiding behavior are suppressed. Evidence for this later stage comes from our over-trained control animals, in which discrimination between overlapping positions is near chance across most trial epochs, and from prior work using the same task in less-trained animals, where sequence-dependent discrimination is more strongly preserved. Thus, sequence differentiation appears to emerge during structure learning but is subsequently down weighted as animals learn which distinctions are behaviorally irrelevant.

      Within this framework, prior cocaine exposure appears to interfere specifically with this later refinement stage. Cocaine-experienced rats exhibit OFC representations resembling those seen earlier in learning—retaining sequence-dependent discrimination at overlapping and functionally equivalent positions—despite extensive training. This suggests not a failure to acquire task structure per se, but rather an impairment in the ability to collapse across states that share common underlying causes.

      (2) Reference to the 24-odor position task

      The reference to the previously published 24-odor position task is not well integrated into the current manuscript. Given that this task has already been published and is not central to the main analyses presented here, the authors may wish to a) better motivate its relevance to the current study or b) consider removing this supplemental figure entirely to maintain focus.

      Thanks for your suggestion, we have removed this supplemental figure as suggested.

      (3) Missing behavioral comparison

      Line 117: the authors state that absolute differences between sequences differ between cocaine and sucrose groups across all three behavioral measures. However, Figure 1 includes only two corresponding comparisons (Fig. 1I-J). Please add the third measure (% correct) to Figure 1, and arrange these panels in an order consistent with Figure 1F-H (% correct, reaction time, poke latency).

      Thanks for your suggestion, we have included the related figure as suggested.

      (4) Description of the TCA component

      Line 220: authors wrote that the first TCA component exhibits low amplitude at positions P1 and P4 and high amplitude at positions P2 and P3. However, Figure 3 appears to show the opposite pattern (higher magnitude at P1 and P4 and lower magnitude at P2 and P3). Please check and clarify this apparent discrepancy. Alternatively, a clearer explanation of how to interpret the temporal dynamics and scaling of this component in the figure would help readers correctly understand the result.

      Thanks for your suggestion. We appreciate this point and agree that clearer guidance on how to interpret the temporal and scaling properties of the tensor components would help readers. In the TCA framework, each component is defined by three separable factors: a neuron factor, a temporal factor, and a trial (position) factor. The temporal factor reflects the shape of the activity pattern within a trial, indicating when during the trial that component is expressed, whereas the trial factor reflects how strongly that temporal pattern is expressed at each position and across trials.

      Importantly, the absolute scaling of these factors is not independently meaningful. Because TCA components are scale-indeterminate, the magnitude of the temporal factor and the trial factor should be interpreted relative to one another within a component, not across components. Thus, a large value in the trial factor does not imply stronger neural activity per se, but rather greater expression of that component’s characteristic temporal pattern at that position or trial.

      Accordingly, when a component shows similar temporal dynamics across groups but differs in its trial factor structure—as observed here—the interpretation is that the same within-trial dynamics are being differentially recruited across task positions, rather than that the timing of neural responses has changed.

      We have added a brief discussion of this in this section of the results in the manuscript.

      (5) Sucrose control

      Sucrose self-administration is a reasonable control for instrumental experience and reward exposure, but it means that this group also acquired an additional task involving the same reinforcer. This experience may itself influence OFC representations and could contribute to the generalization observed in control animals. A brief discussion of this possibility would help contextualize the interpretation of cocaine-related effects.

      We agree that sucrose self-administration is not a perfect neutral manipulation and that this experience could, in principle, influence OFC representations. In particular, sucrose self-administration involves instrumental responding for the same primary reinforcer used in the odor task, and thus may promote additional learning about reward predictability, action–outcome contingencies, or contextual structure that could facilitate generalization.

      Several considerations, however, suggest that the generalization observed in control animals primarily reflects learning-dependent refinement of task representations rather than a specific consequence of sucrose self-administration per se. First, the amount of sucrose administered during this phase was minimal (50 µl × 60 presses at most per session for 14 sessions) compared with the total sucrose reward obtained during task recording (100 µl × 160 trials per session for several dozen sessions). Second, all rats were extensively trained on the odor sequence task prior to any self-administration, and the key signatures of compression and generalization we report—near-chance discrimination between functionally equivalent positions—are consistent with prior studies using the same task in animals that did not undergo sucrose self-administration. Finally, comparisons to less-trained animals in earlier work show that OFC representations evolve toward greater abstraction with increasing task experience, indicating that generalization is a property of advanced learning rather than a unique outcome of sucrose exposure.

      Importantly, even if sucrose self-administration were to enhance generalization in OFC, this would not account for the primary finding that cocaine-experienced rats fail to show these signatures despite identical task training and parallel instrumental experience. Thus, the critical comparison is not between sucrose-trained animals and naive controls, but between two groups matched for self-administration experience, differing only in the pharmacological consequences of the reinforcer. Within this framework, the absence of position-general representations in cocaine-experienced rats reflects a disruption of normal learning-dependent abstraction rather than an artifact of the control condition.

      We have added a brief discussion acknowledging that sucrose self-administration may bias OFC toward abstraction, while emphasizing that cocaine exposure prevents the emergence or maintenance of these representations under otherwise comparable experiential conditions.

      (6) Acknowledge low N

      The number of rats per group is relatively low. Although the effects appear consistent across animals within each group, this sample size does not fully rule out idiosyncratic, animal-specific effects. This limitation should be explicitly acknowledged in the manuscript.

      We acknowledge that the number of animals per group is relatively small and therefore cannot fully rule out animal-specific effects. However, the key neural and behavioral signatures reported here were consistent across individual animals within each group and across multiple levels of analysis, and no outliers were observed. In addition, sample sizes of this scale are common in cocaine self-administration studies due to their technical and logistical constraints. We did not attempt to obscure this limitation and have now explicitly acknowledged it in the manuscript discussion.

      (7) Figure 3E-F: The task positions here are ordered differently (P1, P4, P2, P3) than elsewhere in the paper. Please reorder them to match the rest of the paper.

      Thank you for pointing this out. We agree that the ordering of task positions in Figures 3E–F should be consistent with the rest of the manuscript. We have reordered the positions to match the standard sequence order used elsewhere in the paper (P1, P2, P3, P4) to improve clarity and avoid confusion.

      Reviewer #2 (Public review):

      In the current study, the authors use an odor-guided sequence learning task described as a "figure 8" task to probe neuronal differences in latent state encoding within the orbitofrontal cortex after cocaine (n = 3) vs sucrose (n = 3) self-administration. The task uses six unique odors which are divided into two sequences that run in series. For both sequences, the 2nd and 3rd odors are the same and predict reward is not available at the reward port. The 1st and 4th odors are unique, and are followed by reward. Animals are well-trained before undergoing electrode implant and catheterization, and then retrained for two weeks prior to recording. The hypothesis under test is that cocaine-experienced animals will be less able to use the latent task structure to perform the task, and instead encode information about each unique sequence that is largely irrelevant. Behaviorally, both cocaine and sucrose-experienced rats show high levels of accuracy on task, with some group differences noted. When comparing reaction times and poke latencies between sequences, more variability was observed in the cocaine-treated group, implying animals treated these sequences somewhat differently. Analyses done at the single unit and ensemble level suggests that cocaine self-administration had increased the encoding of sequence-specific information, but decreased generalization across sequences. For example, the ability to decode odor position and sequence from neuronal firing in cocaine-treated animals was greater than controls. This pattern resembles that observed within the OFC of animals that had fewer training sessions. The authors then conducted tensor component analysis (TCA) to enable a more "hypothesis agnostic" evaluation of their data.

      Overall, the paper is well written and the authors do a good job of explaining quite complicated analyses so that the reader can follow their reasoning. I have the following comments.

      While well-written, the introduction mainly summarises the experimental design and results, rather than providing a summary of relevant literature that informed the experimental design. More details regarding the published effects of cocaine self-administration on OFC firing, and on tests of behavioral flexibility across species, would ground the paper more thoroughly in the literature and explain the need for the current experiment.

      We appreciate this suggestion and have tried to expand the Introduction to more explicitly situate the study within the existing literature on cocaine-induced changes in OFC function. In particular, prior work has shown that cocaine self-administration alters OFC firing properties and disrupts behavioral flexibility across species, including impairments in reversal learning, outcome devaluation, and sensory preconditioning. We have revised the Introduction to expand this literature review and more clearly articulate how these established findings motivated our focus on OFC representations of hidden task structure and generalization.

      For Fig 1F, it is hard to see the magnitude of the group difference with the graph showing 0-100%- can the y axis be adjusted to make this difference more obvious? It looks like the cocaine-treated animals were more accurate at P3- is that right?

      The concluding section is quite brief. The authors suggest that the failure to generalize across sequences observed in the current study could explain why people who are addicted to cocaine do not use information learned e.g. in classrooms or treatment programs to curtail their drug use. They do not acknowledge the limitations of their study e.g. use of male rats exclusively, or discuss alternative explanations of their data.

      We agree that the current 0–100% scale can make small differences difficult to discern. We will make it clear in the figure captions (We will adjust the y-axis to a narrower range to better highlight group differences). Across P3, cocaine-experienced rats were more accurate than controls.

      We appreciate the suggestion to expand the discussion. We have revised the concluding section to acknowledge key limitations, including the use of only male rats, the number of subjects, and to note that alternative explanations—such as differences in motivational state or attention—could also contribute to the observed effects. These revisions provide a more balanced interpretation while retaining the focus on OFC-mediated generalization as a potential mechanism for persistent, context-specific drug-seeking.

      Is it a problem that neuronal encoding of the "positions" i.e. the specific odors was at or near chance throughout in controls? Could they be using a simpler strategy based on the fact that two successive trials are rewarded, then two successive trials are not rewarded, such that the odors are irrelevant?

      We thank the reviewer for this point. While neuronal encoding of individual positions (specific odors) in control animals was comparatively lower, this does not indicate that the rats were using a simpler strategy based solely on reward patterns. First, rats were extensively trained on the odor sequence task prior to recordings, demonstrating accurate discrimination across all positions, and their trial-by-trial behavior reflects sensitivity to specific odors rather than only reward alternation. Second, the task design—with overlapping sequences and positions that differ in reward contingency across sequences—requires tracking odor-specific context to maximize reward; a purely “two rewarded, two non-rewarded” strategy would fail at overlapping positions and would not account for the compression of functionally equivalent positions observed in the OFC. Third, in the less-trained rats shown in Figure 3C, decoding accuracy was higher than in the sucrose group, indicating that these animals still differentiated negative positions. With additional training, decoding patterns suggested improved generalization across positions. Thus, the near-chance neural selectivity in controls reflects representation of latent task states rather than external sensory cues, consistent with the idea that OFC abstracts task-relevant structure and ignores irrelevant sensory differences.

      When looking at the RT and poke latency graphs, it seems the cocaine-experienced rats were faster to respond to rewarded odors, and also faster to poke after P3. Does this mean they were more motivated by the reward?

      At present, the basis of these response-time differences remains unclear, in part because motivation is difficult to define operationally. If motivation is indexed solely by reaction time or poke latency, then the data are consistent with increased response vigor in cocaine-experienced rats. Indeed, RT and poke-latency measures indicate that cocaine-experienced rats responded more quickly on some rewarded trials, including after P3. However, overall task performance was high in both groups, suggesting that these differences cannot be attributed simply to superior learning or engagement. Faster responses may also reflect differences in deliberation or strategy, with cocaine-experienced rats relying more on rapid, stimulus-driven responding and sucrose-trained rats engaging in more careful evaluation. In addition, altered reward sensitivity or persistent effects of cocaine exposure may contribute to these behavioral differences. Thus, the faster responses observed in cocaine-experienced rats likely reflect a combination of heightened reward responsivity and altered encoding of task structure, rather than a straightforward increase in motivation alone.

      Recommendations for the authors:

      The reviewers were very positive about the manuscript and emphasized the rigor and state of the art analyses. Two points that came up were the very small n (6 total and 3 per condition) and the exclusive use of males. Adding more subjects is not recommended. However, more discussion and acknowledgement of this issue is recommended. The main concern is that idiosyncratic differences between individuals (not differences in cocaine history) are responsible for the differences observed in OFC encoding.

      We acknowledge that the sample size (n = 3 per group) and use of only male rats limit generalizability and do not fully rule out idiosyncratic, individual-specific effects. However, the key neural and behavioral signatures we report were consistent across all animals within each group and across multiple analyses (single-unit, ensemble decoding, and TCA). We now explicitly note these limitations in the Discussion, emphasizing that while individual variability cannot be fully excluded, the convergence of results across multiple levels of analysis supports the interpretation that the observed differences reflect effects of prior cocaine exposure rather than idiosyncratic differences.

      Reviewer #2 (Recommendations for the authors):

      In the legend to figure 2, the authors state "Notably, rats could discriminate between the two sequences (S1 vs. S2) based solely on current sensory information at two task epochs ["Odor" at P3 and P4; black bars]. At all other task epochs, indicated by gray bars, the discrimination relied on an internal memory of events". I'm confused by this statement- how does the odor at P3 help to discriminate the sequences? Surely P1 and P4 are the times when the odor sampling indicates which sequence they are in?

      We thank the reviewer for pointing out this source of confusion. The statement in the original figure legend was imprecise, and we have removed the figure and revised the figure legends because the results in the left panel substantially overlapped with those shown in the right panel. In this task, odors at positions P1 and P4 are the only cues that directly signal sequence identity, whereas the odors presented at P2 and P3 are identical across sequences. Accordingly, discrimination observed during the “Odor” epoch at P3 does not reflect sensory differences but instead depends on the animal’s use of internal memory or sequence context to infer sequence identity.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1:

      Yet I think that important aspects of my critique of the first statement of the manuscript about the flaws of [SR] model remain unanswered.

      I believe that I have fully addressed the points in the earlier review. The reviewer had doubted that my results were correct, attributing them to “a poor setup of the model” on my part. The reviewer stated that if I were correct about the factor of >10<sup>43</sup> change in cmax, this would “naturally break down all the estimates and conclusions made in Siljestam and Rueffler” (S&R).

      It appears that the reviewer is now convinced that my results represent a faithful analysis of the models on which S&R based their claims. The reviewer now contends that these results, including the factor of >10<sup>43</sup>, present no difficulties for the claims of S&R after all. In fact, this enormous factor of >10<sup>43</sup> is now claimed to support the conclusions of S&R by invalidating my conclusions. I respond to these new and very different arguments in what follows.

      As I stated in the first round of review, the issue is not the enormity of this factor per se, but the fact that the compensatory adjustment of cmax conceals the true effects of changes in other parameters. These effects are large; small changes to the parameter values mostly eliminate the diversity that the model is claimed to explain.

      The model in [SR] is not phenomenological as none of the parameters or functional forms were derived empirically. Instead, it is a proof of principle demonstration that inevitably grossly simplifies the actual immune response.

      The hidden sensitivity of the results of S&R to paramater values is sufficient to invalidate them as a proof of principle. The manuscript goes further and explains how the problem "is not specific to the details of the models of Siljestam and Rueffler, but is inherent in the phenomenon invoked to allow high diversity" because "any change that affects condition by as much as the difference between MHC heterozygotes and homozygotes will eliminate high equilibrium diversity". This general principle addresses all of the reviewer's points.

      In reality, a new pathogen cannot reduce the "survival" by such a factor as it would wipe out any resident population. So to compensate for such an artifact, the additional factor cmax was introduced to buffer such an excess. There is no reason to fix cmax once for an arbitrary number of pathogens, because varying cmax basically reflects the observation that a well-adapted individual must have a reasonable survival probability.

      This is not a legitimate reason for making compensatory, diversity-promoting adjustments to cmax when evaluating sensitivity to other parameters. If the number of pathogens or their virulence changes, cmax obviously does not automatically change along with it. If the population or species consequently goes extinct, then it goes extinct. If it persists, it does so with the same value of cmax.

      The possibility of extinction arguably puts a minimum value on cmax, but it does not restrict it to a range of values that conveniently leads to high MHC diversity. In the examples that I analyzed, slightly decreasing the number of pathogens or their virulence, which increases survivability, eliminates diversity. This phenomenon obviously cannot be dismissed on the grounds that survivability would be too low for the species to exist.

      S&R in effect assume that the condition of the most fit homozygote remains fixed, regardless of the number of pathogens, their virulence, and myriad other differences between species. It is this assumption that is without justification.

      At the same time, there are many ways in which the numerical simulation may break down when the survival rates become of the order of 10^(-43) instead of one

      I am not sure what is meant by “the numerical simulation may break down”. Numerical error is not a tenable explanation of the lack of diversity observed in that simulation. The outcome is exactly what is expected from purely theoretical considerations: conditions of all genotypes fall on the steep part of the curve, making the mechanism proposed by S&R largely inoperative, so a pair of alleles forming a fit heterozygote comes to predominate. The numerical simulation is actually superfluous.

      Low survival rates are completely irrelevant to the effect of decreasing the number of pathogens or their virulence, which does not lower survival rates, but does eliminate diversity.

      so it comes to no surprise that the diversification, predicted by the adaptive dynamics, does not readily occur in the scenario with an addition or removal of the 8th pathogen with a very high virulence \nu=20.

      Whether or not it surprising, the lack of diversity is a problem for the claims of S&R, as there is no reason to expect the number of pathogens to have just the right value to produce high diversity. Furthermore, for many combinations of values of the other parameters (e.g., my v=19.5 and 20.5 examples), no number of pathogens leads to high diversity.

      Again, the general principle mentioned above makes the details that the reviewer refers to irrelevant. Nonetheless, some additional remarks are in order:

      (1) This comment ignores the fact that removal of a pathogen, or a slight decrease in “virulence”, eliminates diversity without lowering survival rates.

      (2) Small increases or decreases in v (virulence) eliminate diversity without having such large effects on condition.

      (3) In the example emphasized by the reviewer, mean survival rates are nowhere near as low as 10<sup>-43</sup>. Only homozygotes have such low fitness.

      (4) The adaptive dynamics predict the low diversity seen in the simulations, contrary to what the reviewer seems to suggest. Elimination of diversity is not an artifact of the simulation.

      (5) v\=20 was chosen because it is most favorable to the model of S&R in that it yields the highest diversity. Indeed, S&R only observed realistically high diversity with the narrow gaussians that the reviewer objects to. With lower values of v, diversity is much lower, but even this meager diversity is eliminated by small changes in parameter values (see below). If narrow gaussians and large effects of pathogens somehow invalidate results, then they invalidate the high-diversity results of S&R.

      I have doubts that the reported breakdown of the [SR] model with fixed cmax remains observable with less extreme values of m and \nu (say, for \nu=7 and m=3 plus or minus 1 used in Fig. 3 in the manuscript).

      These doubts are unwarrented. With the suggested parameter values, for example, increasing or decreasing m by 1 reduces the effective number of alleles to around 1 or 2. This can easily be checked using the simulation code of S&R, as detailed in my initial response and now in a Supplementary Text. Even without this result, the general principle mentioned above tells us that considering other regions of parameter space cannot rescue the conclusions of S&R.

      So I still find the claim that " the phenomenon that leads to high diversity in the simulations of Siljestam and Rueffler depends on finely tuned parameter values" is not well substantiated.

      What is unsubstantiated is the claim of S&R that “For a large part of the parameter space, more than 100 and up to over 200 alleles can emerge and coexist”. As my manuscript illustrates, this is an illusion created by the adjustment of one parameter to compensate for changes in others.

      The reviewer even acknowledges that “the choice of constants and functions...works in a limited range of parameter values”. Furthermore, the manuscript explains why this problem is inherent to the general phenomenon, not specific to the details of the model or parameter values.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      It appears obvious that with no or a little fitness penalty, it becomes beneficial to have MHC-coding genes specific to each pathogen. A more thorough study that takes into account a realistic (most probably non-linear in gene number) fitness penalty, various numbers of pathogens that could grossly exceed the self-consistent fitness limit on the number of MHC genes, etc, could be more informative.

      The reviewer seems to be referring to the cost of excessively high presentation breadth. Such a cost is irrelevant to the inferior fitness of a polymorphic population with heterozygote advantage compared to a monomorphic population with merely doubled gene copy number. It is relevant to the possibility of a fitness valley separating these two states, but this issue is addressed explicitly in the manuscript.

      An addition or removal of one of the pathogens is reported to affect "the maximum condition", a key ecological characteristic of the model, by an enormous factor 10^43, naturally breaking down all the estimates and conclusions made in [RS]. This observation is not substantiated by any formulas, recipes for how to compute this number numerically, or other details, and is presented just as a self-standing number in the text.

      It is encouraging that the reviewer agrees that this observation, if correct, would cast doubt on the conclusions of Siljestam and Rueffler. I would add that it is not the enormity of this factor per se that invalidates those conclusions, but the fact that the automatic compensatory adjustment of c</sub>max</sub> conceals the true effects of removing a pathogen, which are quite large.

      I am not sure why the reviewer doubts that this observation is correct. The factor of 2.7∙10<sup>43</sup> was determined in a straightforward manner in the course of simulating the symmetric Gaussian model of Siljestam and Rueffler with the specified parameter values. A simple way to determine this number is to have the simulation code print the value to which c</sub>max</sub> is set, or would be set, by the procedure of Siljestam and Rueffler for different parameter values. I have in this way confirmed this factor using the simulation code written and used by Siljestam and Rueffler. A procedure for doing so is described in the new Supplementary Text S1. In addition, I now give a theoretical derivation of this factor in Supplementary Text S2.

      This begs the conclusion that the branching remains robust to changes in cmax that span 4 decades as well.

      That shows at most that the results are not extremely sensitive to c</sub>max</sub> or K. They are, nonetheless, exquisitely sensitive to m and v. This difference in sensitivities is the reason that a relatively small change to m leads to such a large compensatory change in c</sub>max</sub>. It is evident from Fig. 4 of Siljestam and Rueffler that the level of diversity is not robust to these very large changes in c</sub>max</sub>, which include, as noted above, a change of over 43 orders of magnitude.

      As I wrote above, there is no explanation behind this number, so I can only guess that such a number is created by the removal or addition of a pathogen that is very far away from the other pathogens. Very far in this context means being separated in the x-space by a much greater distance than 1/\nu, the width of the pathogens' gaussians. Once again, I am not totally sure if this was the case, but if it were, some basic notions of how models are set up were broken. It appears very strange that nothing is said in the manuscript about the spatial distribution of the pathogens, which is crucial to their effects on the condition c.

      I did not explicitly describe the distribution of pathogens in antigenic space because it is exactly the same as in Siljestam and Rueffler, Fig. 4: the vertices of a regular simplex, centered at the origin, with unity edge length.

      The number in question (2.7∙10<sup>43</sup>) pertains to the Gaussian model with v\=20. As specified by Siljestam and Rueffler, each pathogen lies at a distance of 1 from every other pathogen, so the distance of any pathogen from the others is indeed much greater than 1/v. This condition holds, however, for most of the parameter space explored by Siljestam and Rueffler (their Fig. 4), and for all of the parameter space that seemingly supports their conclusions. Thus, if this condition indicates that “basic notions of how models are set up were broken”, they must have been broken by Siljestam and Rueffler.

      ...the branching condition appears to be pretty robust with respect to reasonable changes in parameters.

      It is clear from Fig. 4 of Siljestam and Rueffler that the branching condition is far from sufficient for high MHC diversity.

      Overall, I strongly suspect that an unfortunately poor setup of the model reported in the manuscript has led to the conclusions that dispute the much better-substantiated claims made in [SD].

      The reviewer seems to be suggesting that my simulations are somehow flawed and my conclusions unreliable. I have addressed the reasons for this suggestion above. Furthermore, I have confirmed the main conclusion—the extreme sensitivity of the results of Siljestam and Rueffler to parameter values--using the code that they used for their simulations, indicating that my conclusions are not consequences of my having done a “poor setup of the model”. I now describe, in Supplementary Text S1, how anybody can verify my conclusions in this way.

      Reviewer #2 (Public review):

      (1) The statement that the model outcome of Siljestam and Rueffler is very sensitive to parameter values is, in this form, not correct. The sensitivity is only visible once a strong assumption by Siljestam and Rueffler is removed. This assumption is questionable, and it is well explained in the manuscript by J. Cherry why it should not be used. This may be seen as a subtle difference, but I think it is important to pin done the exact nature of the problem (see, for example, the abstract, where this is presented in a misleading way).

      I appreciate the distinction, and the importance of clearly specifying the nature of the problem. However, as I understand it, Siljestam and Rueffler do not invoke the implausible assumption that changes to the number of pathogens or their virulence will be accompanied by compensatory changes to c</sub>max</sub>. Rather, they describe the adjustment of c</sub>max</sub> (Appendix 7) as a “helpful” standardization that applies “without loss of generality”. Indeed, my low-diversity results could be obtained, despite such adjustment, by combining the small change to m or v with a very large change to K (e.g., a factor of 2.7∙10<sup>43</sup>). In this sense there is no loss of generality, but the automatic adjustment of c</sub>max</sub> obscures the extreme sensitivity of the results to m and v.

      (2) The title of the study is very catchy, but it needs to be explained better in the text.

      I have expanded the end of the Discussion in the hope of clarifying the point expressed by the title.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      I would like to suggest to the author that they provide essential details about their simulations that would justify their claims, and to communicate with Mattias Siljestam and Claus Rueffler whether claims of the lack of robustness could be confirmed.

      The models simulated were modified versions of those of Siljestam and Rueffler. Thus, only the modifications were described in my manuscript. I have added a more detailed description of how c</sub>max</sub> was set in the simulations concerned with sensitivity to parameter values. In addition, the new Supplementary Text S1, which describes confirmation of the lack of robustness using the code of Siljestam and Rueffler, should remove any doubt about this conclusion.

      Reviewer #2 (Recommendations for the authors):

      I have no further recommendations. The manuscript is well written and clear.

      Thank you.

      Reviewer #3 (Recommendations for the authors):

      (1) Since this is a full report and not just a letter to the editor, it would benefit from a bit more introduction of what the MHC actually is and what the current understanding of its evolution is. Currently, it assumes a lot of knowledge about these genes that might not be available to every reader of eLife.

      I have added some more information to the opening paragraph. I would also note that this report was submitted as a “Research Advance”, which may only need “minimal introductory material”.

      (2) Some more recent literature on MHC evolution should be added, e.g., the review by Radwan et al. 2020 TiG, a concrete case of MHC heterozygote advantage by Arora et al. 2020 MolBiolEvol, and a simulation of MHC CNV evolution by Bentkowski et al. 2019 PLOSCompBiol.

      I have cited some additional literature.

      (3) Since much of the criticism hinges on the cmax parameter, its biological meaning or role (or the lack thereof) could be discussed more.

      I am not sure what I can add to what is in the first paragraph of the Discussion.

      (4) I find it difficult to grasp how the v parameter, which is intended to define pathogen virulence, if I understand it correctly, can be used to amend the breadth of peptide presentation. Maybe this could be illustrated better.

      I have attempted to make this clearer. The parameter v actually controls the breadth of peptide detection conferred by an allele, which, if not identical to the breath of presentation, is certainly affected by it. The basis of the “virulence” interpretation seems to be that narrower detection breadth can, according to the model, only decrease peptide detection probability, which increases the damage done by pathogens.

      (5) Please check sentences in lines 279ff on peptide detection and cost of . There seem to be words missing.

      There was an extraneous word, which I have removed. Thank you for pointing this out.

    1. Author response:

      Response to reviewer 1:

      We thank reviewer 1 for their thoughtful, detailed, and constructive evaluation of our manuscript. We appreciate their recognition of the strengths of the study, particularly the integration of noradrenergic recordings, optogenetic manipulation, and cross-species analyses. We are especially grateful for the reviewer’s careful attention to clarity, experimental interpretation, and control comparisons. The comments have helped us sharpen the framing of our hypotheses, clarify causal claims, improve statistical reporting, and better explain our closed-loop approach and heart rate analyses. We have addressed each point in detail below and believe that the revisions substantially strengthen the manuscript.

      Response reviewer 2:

      We thank reviewer 2 for their thoughtful comment regarding citation, positioning relative to prior work, and caution in mechanistic interpretation. We have made efforts to cite relevant foundational and related work throughout the manuscript, but we will of course further clarify the relationship between our findings and prior studies in the revision.

      Although prior work has demonstrated infraslow coupling between sigma activity and heart rate and established a role for the locus coeruleus (LC) in coordinating these oscillations, cardiac measures have typically been presented as secondary observations rather than as primary experimental targets. While we of course recognize all the prior efforts conducted, a central goal of the present study was to perform a targeted and highly systematic characterization of norepinephrine-mediated heart-rate dynamics during sleep, integrating infraslow relationships, sleep-wake transitions, and a range of physiological manipulations of LC activity. A major priority of ours was to link infraslow heart-rate fluctuations to the well-known very-low-frequency (VLF) component of heart rate variability (HRV). Within the clinical HRV field, VLF has remained comparatively under-characterized and mechanistically unresolved. Our findings provide a biologically grounded explanation for this component, which we believe may be informative for the broader HRV community.

      Second, a core aim of this work is to provide a translational tool: to determine whether cardiac dynamics alone can reflect the infraslow, memory-consolidating potential of sleep and thus serve as a non-invasive biomarker. Because direct LC recordings are not feasible in humans, HRV, including its VLF component, may offer a clinically accessible proxy of sleep’s memory-restorative capacity. By directly manipulating LC activity and demonstrating corresponding changes in heart-rate dynamics, we strengthen the mechanistic and translational rationale of this biomarker approach. Our findings suggest that heart-rate measures alone may provide an estimate of the infraslow memory-consolidating potential of sleep.<br /> In revision, we will ensure that the foundational findings underlying this manuscript are highlighted, while communicating our new findings more clearly.

    1. Author response:

      eLife Assessment

      This important study investigates the impact of BRCA1/2 mutations on immunotherapy in lung adenocarcinoma using multi-omics approaches. The detailed genetic analysis of two cancer genes (BRCA1 and BRCA2) demonstrated new roles for these genes in causing the tumor microenvironment in lung cancer. Further experimental explorations of the immune-related changes may still be required. The solid findings of this study provide a foundation for further developing drugs targeting BRCA1/2 in lung cancer therapy.

      We would like to express our sincere gratitude for your thoughtful and constructive comments on our manuscript. We will carefully consider each comment from these two reviewers and will revise the manuscript accordingly. Below, we provide a point-by-point response to each comment.

      Reviewer #1 (Public review):

      Summary:

      Liao et al. performed a large-scale integrative analysis to explore the function of two cancer genes (BRCA1 and BRCA2) in lung cancer, which is one of the cancers with an extremely high mortality rate. The detailed genetic analysis demonstrated new roles of BRCA1/2 in causing the tumor microenvironment in lung cancer. In particular, the discovery of different mechanisms of BRCA1 and BRCA2 provides an essential foundation for developing drugs that target BRCA1 or BRCA2 in lung cancer therapy.

      Strengths:

      (1) This study leveraged large-scale genomic and transcriptomic datasets to investigate the prognostic implications of BRCA1/2 mutations in LUAD patients (~2,000 samples). The datasets range from genomics to single-cell RNA-seq to scTCR-seq.

      (2) In particular, the scTCR-seq offers a powerful approach for understanding T cell diversity, clonal expansion, and antigen-specific immune responses. Leveraging these data, this study found that BRCA1 mutations were associated with CD8+ Trm expansion, whereas BRCA2 mutations were linked to tumor CD4+ Trm expansion and peripheral T/NK cell cytotoxicity.

      (3) This study also performed a comprehensive analysis of genomic variation, gene expression, and clinical data from the TCGA program, which provides an independent validation of the findings from LUAD patients newly collected in this study.

      (4) This study provides an exemplary integration analysis using both computational biology and wet bench experiments. The experimental testing in the A549 cell line further supports the robustness of the computational analysis.

      (5) The findings of this study offer a comprehensive view of the molecular mechanisms underlying BRCA1 and BRCA2 mutations in LUAD. BRCA1 and BRCA2 are two well-known cancer-related genes in multiple cancers. However, their role in shaping the tumor microenvironment, particularly in lung cancer, is largely unknown.

      (6) By focusing on PD-L1-negative LUAD patients, this study demonstrated the molecular mechanisms underlying resistance to immune therapy. These new insights highlight new opportunities for personalized therapeutic strategies to BRCA-driven tumors. For example, they found histone deacetylase (HDAC) inhibitors consistently downregulated 4-R genes in A549 cells.

      (7) The deposition of raw single-cell sequencing (including scRNA-seq and scTCR-seq) data will provide an essential data resource for further discovery in this field.

      Weaknesses:

      (1) The finding of histone deacetylase (HDAC) inhibitors suggests the potential roles of epigenetic regulation in lung cancer. It would be interesting to explore epigenetic changes in LUAD patients in the future.

      Thank you for your insightful comment. We fully agree that the specific situation of epigenetic dysregulation in LUAD needs to be explored. We believe that future investigations utilizing clinical specimens and animal models to map histone acetylation patterns and DNA methylation profiles will be crucial for identifying novel biomarkers and therapeutic targets unique to LUAD.

      (2) For some methods, more detailed information is needed.

      This is a valid point. We agree that additional details regarding are necessary for clarity and reproducibility. We will expand these method details in the revised manuscript.

      (3) There are grammar issues in the text that need to be fixed.

      We apologize for our irregular use of grammar. In the revised manuscript, we will carefully check the grammar and make corrections.

      (4) Some text in the figures is not labeled well.

      We appreciate the reviewers' comments. We will add labels to the revised version of the figures.

      Reviewer #2 (Public review):

      Summary:

      This study investigates the impact of BRCA1/2 mutations on immunotherapy in lung adenocarcinoma using multi-omics approaches. The work highlights distinct roles of BRCA1 and BRCA2 mutations in shaping immune-related processes, and is logically structured with clearly presented analyses. However, the conclusions rely primarily on descriptive computational analyses and would benefit from additional immunological validation.

      Strengths:

      By integrating public datasets with in-house data, this study examines the impact of BRCA1/2 mutations on immunotherapy in lung adenocarcinoma from multiple perspectives using multi-omics approaches. The analyses are diverse in scope, with a clear overall logic and a well-organized structure.

      Weaknesses:

      The study is largely descriptive and would benefit from additional immunological experiments or validation using in vivo models. The fact that the BRCA1 and BRCA2 samples were each derived from a single patient also limits the robustness of the conclusions.

      Thank you for this excellent suggestion. In the revised manuscript, we will supplement the additional immunological experiments or validation using in vivo models. In addition, we will elaborate on the limitations of our study in the Discussion section and provide reasonable explanations.

    1. Author response:

      eLife Assessment

      The findings of this study are important since they cover the repurposing of small molecules as snake venom metalloprotease and phospholipase inhibitors for early intervention in the treatment of bothropic envenoming in the Neotropics, and thus provide a strong rationale for the progression of these inhibitors into future preclinical and clinical evaluation for snakebite indications across various ecological zones. The strength of the evidence is solid; however, there are some weaknesses, such as a lack of translatability of the in vivo model and insufficient venom characterisation. Thus, the strength of the evidence can be enhanced by the use of a mouse model. The paper remains of interest to ophiologists, biochemists and medicinal chemists.

      We thank the editors and reviewers for their assessment of this manuscript, and for the positive words highlighting the value of undertaking evaluation of small molecule drugs for snakebite in the neotropics. We completely agree that the next steps for this work will be to evaluate the preclinical efficacy of the identified drugs in mouse models. The comment around insufficient venom characterisation seems somewhat misplaced – the objective of this project was not to characterise the venoms used, but to evaluate the in vitro inhibition of venom toxin family activities and identify the potential utility of specific repurposed drugs as therapeutics for snakebite in the Neotropics.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Small molecule therapeutics for snakebite have received a lot of attention for their potential to close the gap between bite and treatment, where antivenom is not immediately available.

      Strengths:

      There has been a lot of focus on Africa, Asia, and India, but very little work related to neotropical regions. The authors seek to begin filling this gap in the preclinical literature. The authors use well-developed methods for preclinical assessment.

      Weaknesses:

      A clearer and more focused discussion of the limitations of the overall present work would be desirable (e.g. protection vs. rescue, why marimastat over prinomastat for in vivo assays when both have been through clinical trials for other indications; real-world feasibility of nafamostat, which has a half-life of 1-2 minutes compared to camostat, which has a half-life of hours). All of this could be improved in a revision.

      We thank the reviewer for their shared opinion of the potential value of small molecules as snakebite envenoming therapeutics and their insight on the gap in focus in the neotropics, which this manuscript aims to address. Our work in this manuscript included the standard practice of pre-incubation between drug and venom for all in vitro studies, and sequential (i.e. not co-incubation) administration in the egg model. In our revised manuscript, we will make these distinctions clearer. Use of a ‘rescue’ approach in the in vitro assays is not feasible due to the rapid destruction of the substrates used for assay readouts. The clearest rationale for the use of rescue models relates to their power within in vivo preclinical models (i.e. murine envenoming models), which, following the in vitro characterisations presented in this paper, are the logical next step for evaluating small molecule drugs for inhibiting neotropical snake venoms.

      Although both marimastat and prinomastat are repurposed drugs that have undergone clinical evaluation for other indications, marimastat has been more extensively characterised preclinically than prinomastat for snakebite, and will soon enter Phase II clinical trial evaluation for this indication (https://www.ddw-online.com/ophirex-to-produce-snake-venom-inhibitor-for-lstm-study-40669-202602/). Marimastat also has a longer half-life in humans of 8-10 hours (Millar et al. 1998), compared to prinomastat (2-5h, Hande et al. 2004). We will more clearly highlight the rationale for selecting marimastat in the revised manuscript.

      Although we appreciate the reviewer’s point regarding the short half-life of nafamostat (which is typically given by continuous iv infusion due to its short half-life), in the manuscript we have already stated (Line 434 to 448) that we do not recommend the progression of nafamostat as a snake venom serine protease (SVSP) inhibitor candidate due its low efficacy and off target effects. We highlight the need for the community to identify other serine protease inhibitors that might have utility for snakebite.

      Reviewer #2 (Public review):

      Summary:

      The authors set out to test whether a defined set of small molecules can lessen damaging effects caused by venoms from several Bothrops species, and whether these effects are consistent enough to suggest a broadly applicable approach. They present a cross-venom dataset spanning in-vitro activity readouts and blood-based functional outcomes, and include a chicken embryo model to explore whether venom inhibition can translate into improved survival. The central message is that certain small molecules can reduce specific venom-driven effects across multiple samples, providing a comparative resource for the field and a basis for prioritizing future validation.

      Strengths:

      The main value of this work is the breadth and structure of the dataset, which places multiple venoms and multiple readouts into a single, comparable framework that should be useful for readers evaluating patterns across samples. The experimental flow is generally coherent, moving from activity measurements to functional outcomes and then to an in-vivo test, which helps the reader understand how the authors link mechanism-oriented assays to more integrated endpoints. The manuscript also provides practical information for the community by highlighting which readouts appear most consistently affected across venoms, which can help guide hypothesis generation and study design in follow-up work.

      Weaknesses:

      Several aspects of the study design and framing reduce the confidence with which readers can translate the findings beyond the specific experimental context presented. The evidence base is strongest in controlled in-vitro settings, while the bridge to real-world effectiveness remains limited, particularly for understanding performance under conditions that better reflect delayed treatment and systemic exposure. As a result, the manuscript is best interpreted as a well-organized comparative screening study with promising signals, rather than a definitive demonstration of a broadly effective, deployable intervention.

      We appreciate the reviewer’s opinion on the thorough and logical workflow we present in this manuscript and the value this pipeline providers the field for future and parallel work. We agree with the reviewer that this provides a well-organized comparative screening study applicable to different snake species or therapeutics. In relation to the comment on this manuscript being a ‘definitive demonstration of a broadly effective, deployable intervention’, we agree with their opinion and are happy to clarify that while the evidence presented in this manuscript is promising, there is much work still to do before such molecules are ready for deployment for treating snakebite. Ultimately, this manuscript supports the growing evidence of the promising utility of marimastat and varespladib, and extends this evidence to neotropical snake venoms in a comparative manner. The next step will be to evaluate the efficacy of these molecules within in vivo murine preclinical models, which will be crucial for further supporting the evidence base for onward translation.

      Reviewer #3 (Public review):

      In this work, the authors wanted to evaluate repurposed small molecule inhibitors for the treatment of envenomation by snakes of the Bothrops genus; one of the most medically relevant in the Americas. I believe the objectives of the research were clearly achieved, and compelling evidence for the ability of these molecules to neutralize enzymatic and toxic activities of metalloproteinases and phospholipases in all the tested venoms is provided. Furthermore, the work highlights the limited efficacy of the tested serine protease inhibitor, suggesting a need for drug discovery campaigns to address toxicity caused by this protein family. The methods are well designed and performed, and the use of both in vitro and in vivo methodologies makes this a thorough and robust work.

      These results are extremely relevant, since they take us one step further to a potential orally administered snakebite treatment. The existence of such a treatment could improve the outcomes for thousands of snakebite victims worldwide. I have a few comments and questions that I hope will be useful to the authors:

      We thank the author for their high regard for the purpose and execution of this work. Their insight in relation to questions are supportive for an improved manuscript and discussion points for the field.

      During the introduction, the authors mention that small-molecule inhibitors can neutralize the localized tissue damage via cytotoxicity of some venoms, and cite PLA2s, SVMPs and/or cytotoxic 3FTxs as the main causing agents of this pathology. I am not aware of any direct effect described by small molecule inhibitors on cytotoxic 3FTxs alone. Has this been observed at all? Or is it more likely that the small molecule inhibitors act on the enzymatic toxins only, preventing synergistic effects with 3FTxs?

      We apologise for this error on our behalf. While inhibitory molecules have been described for cytotoxic 3FTxs, these are not small molecules as alluded to in the previous version of the manuscript. We have amended this text in our revision.

      I think it would be relevant to address the effects of non-enzymatic PLA2s, such as myotoxin II, which have been described in detail within Bothrops venoms. I believe there is some evidence of Varespladib also having a neutralizing effect on the myotoxicity caused by these non-enzymatic PLA2s. I suggest adding a comment about the contribution of these toxins in the discussion or in the section where PLA2 activity of the venoms is compared. In my opinion, right now it seems like these were overlooked.

      We thank the reviewer for highlighting this point. We agree that this is highly relevant and would benefit from discussion in the revised manuscript given the nature of our assays and the non-enzymatic mechanism of action of certain Bothrops PLA<sub>2</sub>s.

      Regarding Marimastat and the other MP inhibitors, are there any studies showing that they don't have an effect on endogenous MPs? I understand they have been approved for human use before, but is there any indication that they would not have an effect at the doses that would be required to treat envenomation?

      Most matrix metalloproteinases inhibitors will act on endogenous MPs to at least some extent (variable potency on different MMPs). Marimastat has demonstrated activity against endogenous metalloproteinases, including MMP1, which was hypothesised to cause severe joint pain when used chronically (i.e. frequent dosing over many weeks) for indications such as cancer, though this effect was reversible within 8 weeks of cessation of drug administration (Wojtowicz-Praga, 1998). Thus long-term use of matrix metalloproteinases inhibitors can cause safety concerns. However, the anticipated duration of dosing for snakebite, which is an acute life-threatening condition, is a few days. It is therefore unlikely that prior safety concerns observed following chronic dosing in cancer studies would apply to its potential use as a snakebite field therapy.

      Regarding the quenched fluorescence substrate used for enzymatic activity. Is there a possibility that some of the SVMPs would not act on this substrate, and therefore their activity or neutralization is not observed? Would it be relevant to test other substrates, such as gelatin, collagen, or even specific clotting factors?

      It has been observed that certain SVMPs (specifically several PI SVMPs) are not active against this ES010 substrate in vitro. The substrate used in the in vitro SVMP assay is reported by the manufacturer as a substrate for a wide range of MMPs which target the extracellular matrix components mentioned by the reviewer, i.e. collagenases and gelatinases as well as matrilysins, stromelysins and elastate. This in vitro assay combined with the coagulation assays are complementary in covering the main targets of SVMPs (ECM and clotting cascade), prior to haemorrhagic assessment in the egg model. Thus, we are confident that activity for the broad range of SVMP isoforms will be captured through the screening pipeline we have developed.

      Finally, could the authors comment or provide some bibliography regarding the translatability of the chicken embryo model in the context of envenomation?

      Our current model is based on an earlier egg embryo model (Sells et al. 1997, Sells et al. 1998 and Sells et al. 2000) which described good correlations (p<0.01) with the standard WHO murine preclinical envenoming model. These studies have assessed correlations for minimal haemorrhagic doses (MHDs), LD50s and ED50s in both models for a selection of viper venoms. As chicken embryos at day 6 of development have incomplete neural arcs, the model is not well suited for assessing neurotoxic effects, but can be effectively used for addressing venom-induced haemorrhage and lethality and for testing therapeutics. In addition, a more recent study (Yusuf et al. 2023) reported almost identical LD50s for the venom of Bitis arietans between the two in vivo approaches. The model is also being pursued as a preclinical testing model by an antivenom manufacturer with the focus of reducing the use of rodents in batch release testing (Verity et al. 2021). We will provide further clarification on the rationale for using the egg model, including the supportive references outlined above, in the revised manuscript.

    1. Author response:

      General Statements

      We thank the reviewers for their thoughtful and constructive comments on our manuscript. We have thoroughly considered all points raised and have made extensive revisions to address them. These revisions have significantly strengthened the manuscript.

      In summary, the key revisions and clarifications include:

      (1) Developmental Time-Course: To address the need for earlier phenotypic analysis, we have performed new immunofluorescence experiments at 30 days after hatching (dah). This new data (Fig. S7) precisely pinpoints the onset of the Leydig cell differentiation defect in dhh<sup>-/-</sup> mutants, establishing ~30 dah as the critical window for Dhh action.

      (2) Role of Ptch1 and Ptch2: We have qualified our conclusions regarding receptor specificity throughout the text to accurately reflect our findings and the limitation posed by the early lethality of ptch1 mutants. The in vivo genetic evidence for Ptch2 (the rescue of dhh<sup>-/-</sup> by ptch2<sup>-/-</sup>) is emphasized, while we now explicitly state that a role for Ptch1 cannot be ruled out without future conditional knockout models.

      (3) Mechanism between Gli1 and Sf1: In direct response to the reviewers' request for stronger evidence, we have performed a new cold probe competition assay. This experiment provides dose-dependent, biochemical evidence for the specificity of Gli1 binding to the sf1 promoter (New Fig. 5E). Furthermore, we have revised the text throughout the manuscript to use more precise language (e.g., "Gli1 activates sf1 expression") and removed overstated claims of "direct" regulation.

      (4) Methodological Rigor and Controls: We have added crucial negative controls for all RNA-FISH experiments using sense probes (New Fig. S9), provided detailed quantification methods for immunofluorescence, clarified the number of biological replicates for transcriptomic analyses, and corrected statistical tests as recommended.

      (5) Clarity and Presentation: We have revised the text for clarity, expanded the description of the TSL cell line's validation in the Introduction, added missing details to figure legends and methods, and incorporated suggested key references.

      We believe that our detailed responses and the significant new data and textual revisions have fully addressed the reviewers' concerns and have substantially improved the quality and impact of our manuscript.

      Point-by-point description of the revisions

      Reviewer #1 (Evidence, reproducibility and clarity):

      Summary

      This manuscript by Zhao et. al investigates the canonical hedgehog pathway in testis development of Nile tilapia. They used complementary approaches with genetically modified tilapia and transfected TSL cells (a clonal stem Leydig cell line) previously derived from 3-mo old tilapia. The approach is innovative and provides a means to investigate DHH and each downstream component from the ptch receptors to the gli and sf1 transcription factors. They concluded that Dhh binds Ptch2 to stimulate Gli1 to promote an increase in Sf1 expression leading to the onset of 11-ketotesterone synthesis heralding the differentiation of Leydig cells in the developing male tilapia.

      Major comments:

      (1) Are the key conclusions convincing?

      Most results as reported are convincing; however, some conclusions are premature as additional experiments are required to satisfy their claims. For example, the phenotype of the dhh-/- testis is convincing in that Cyp1c1 cells are missing and the addition of ptch2-/- rescues the phenotype indicating a direct path. The link from gli to sf1, however, requires additional study to validate the direct relationship (see item 3 below).

      We thank the reviewer for the positive assessment that our principal findings are convincing. Regarding the connection between Gli1 and Sf1, we agree that additional validation was important. We have now performed new experiments and revised our text. As detailed in our response to item 3 below, we have incorporated a cold probe competition assay (new Fig. 5E) which provides dose-dependent evidence for the specificity of Gli1 binding to the sf1 promoter. Furthermore, we have toned down our conclusions in the manuscript.

      (2) Should the authors qualify some of their claims as preliminary or speculative, or remove them altogether?

      Major: Most significant premature claim is the statement that gli1 directly controls sf1 activity. Additional experiments are required to make this claim (see next statement).

      We agree with the reviewer that the claim of "direct" control was premature. We have therefore revised the manuscript accordingly. All statements claiming "direct" regulation of sf1 by Gli1 have been removed or replaced with more accurate descriptions, such as "Gli1 activates sf1 expression" and "Sf1 is a key transcriptional target of Gli1." These changes, coupled with the new functional data from the cold probe competition experiment (Fig. 5E) described in our response to item 3, now provide a robust and appropriately qualified account of our findings.

      Minor: As addressed in the discussion section, the ptch1 animals fail to survive limiting the ability to validate both ptch1 and ptch2 roles. Thus, the conclusion that only ptch2 is required should be qualified.

      We thank the reviewer for this rigorous comment. We fully acknowledge the limitation imposed by the early lethality of ptch1 mutants, which precludes a definitive in vivo assessment of its potential role in postnatal testis development. In direct response to this point, we have revised the text throughout the manuscript to more accurately reflect the strength of our conclusions. Specifically, in the Results section, we now state that “This differential receptor requirement implies that Ptch2 likely acts as the functional receptor for transducing Dhh signals in TSL cells” (lines 174–176). Furthermore, we have strengthened the Discussion by explicitly stating: “Therefore, while our findings strongly nominate Ptch2 as the principal receptor for Dhh in SLCs, a definitive exclusion of a role for Ptch1 will require future studies employing Leydig cell–specific conditional knockout models” (lines 265–268). We believe these revisions provide a appropriately qualified interpretation of our data while maintaining the compelling narrative of Ptch2's primary role.

      Major: There are a couple of key references missing however, please consider including:

      - Kothandapani A, Lewis SR, Noel JL, Zacharski A, Krellwitz K, Baines A, Winske S, Vezina CM, Kaftanovskaya EM, Agoulnik AI, Merton EM, Cohn MJ, Jorgensen JS.PLoS Genet. 2020 Jun 4;16(6):e1008810. doi: 10.1371/journal.pgen.1008810. eCollection 2020 Jun.PMID: 32497091

      - Park SY, Tong M, Jameson JL.Endocrinology. 2007 Aug;148(8):3704-10. doi: 10.1210/en.2006-1731. Epub 2007 May 10.PMID: 17495005

      We have included the key references: Kothandapani A, et al. (2020). PLoS Genet. and Park SY, et al. (2007). Endocrinology.

      (3) Would additional experiments be essential to support the claims of the paper? Request additional experiments only where necessary for the paper as it is, and do not ask authors to open new lines of experimentation. Additional experiments are suggested to strengthen the direct connection between gli1 and sf1:

      Major: Figure 5F shows evidence for increased sf1-luc activity upon co-transfection of OnGli1 in TSL cells. These data would be strengthened with evaluation of the same sf1 promoter that has each/both putative GLI binding sites mutated.

      We thank the reviewer for this insightful suggestion. To further strengthen the evidence for the functional connection between Gli1 and the sf1 promoter, we have performed a new cold probe competition experiment. Given the potential presence of other unpredicted Gli-binding motifs within the 5-kb sf1 promoter region and the practical constraints, we employed an alternative, robust biochemical approach. This assay used a wild-type oligonucleotide containing the canonical Gli-binding motif (GACCACCCA) as a specific competitor. As shown in the new Fig. 5E, this cold probe caused a significant, dose-dependent reduction in Gli1-induced sf1-luc activity, while a mutated control probe (TTAATTAAA) had no effect. This result provides strong evidence that Gli1-mediated transactivation of the sf1 promoter is dependent on its specific binding to this consensus motif.

      Furthermore, in response to the reviewer's comment, we have revised the manuscript text to use more precise language, such as "Gli1 activates sf1 expression" and "Sf1 is a key transcriptional target of Gli1," toning down any overstated claims of direct regulation. Together with the existing data-which includes the original luciferase assay, the new competition experiment, and key loss-of-function/gain-of-function genetic evidence from SLCs transplantation-we believe our study now provides a compelling and multi-faceted case for Gli1 being the key regulator of sf1 within this pathway. We are confident that these revisions have satisfactorily addressed the point raised.

      Major: All 8xGli-luciferase assays should include evaluation of the mutant 8xGli-luciferase plasmid as a negative control.

      We thank the reviewer for highlighting the importance of reporter assay controls. In our study, we included the empty vector pGL4.23, which lacks any Gli-binding sites, as the fundamental negative control. As shown in Fig. 4C, this vector showed minimal background activity that was unresponsive to Dhh, confirming that the strong luciferase induction in the 8xGli-reporter is entirely dependent on functional Gli-binding sites. While a mutated 8xGli construct is one valid approach, we think that the use of an empty vector is functionally equivalent and equally rigorous for establishing specificity. We are confident that our current data unambiguously demonstrate Gli-dependent activation. For clarity, we have explicitly stated in the figure legend and methods that pGL4.23 served as the negative control.

      Minor: Figure 5D experiment that includes TSL-gli1(also 2,3) +/- OnDhh; please examine whether the absence of Gli affects expression of sf1 in each condition. In other words, provide a loss-of-function of Gli connection to regulation of sf1.

      We measured the mRNA expression levels of sf1 in TSL-WT, TSL-gli1<sup>-/-</sup>, TSL-gli2<sup>-/-</sup>, and TSL-gli3<sup>-/-</sup> cells using qRT-PCR. The results are presented in the new Supplementary Figure S8A. The results show that the loss of gli1 leads to a significant reduction in the expression of sf1. In contrast, the knockout of gli2 or gli3 had no significant effect on sf1 expression levels.

      (4) Are the suggested experiments realistic in terms of time and resources? It would help if you could add an estimated cost and time investment for substantial experiments.

      Given the expertise, it is not anticipated that the suggested experiments would be a significant burden to this group.

      We appreciate the reviewer's considerations. Now, we have performed the additional key experiments, which have been incorporated into the revised manuscript. We believe these new data have fully addressed the points raised.

      (5) Are the data and the methods presented in such a way that they can be reproduced?

      Most methods are adequately described or referenced to previous detailed description. There were, however, some methods that could benefit from additional details:

      Major: IF quantification data: please provide details on how the number of positive cells were quantified and presented, for example, how many cells from how many sections for each genotype were included for the analysis?

      We have added relevant information in the "Materials and Methods" section in line 369-373: “For each biological replicate (n\=5-6 fish per genotype), three non-serial, non-adjacent testis sections were analyzed. From each section, three representative fields of view were captured to ensure non-overlapping sampling. All positive cells number of Vasa, Sycp3 and Cyp11c1 was quantified by Image J Pro 1.51 software using default parameters.”

      Major: FISH: No controls are present, for example, scrambled RNA probes. Further, please clarify or address the significant presence of message in the nucleus.

      As suggested, we have now included negative control experiments using sense RNA probes for all genes (ptch1, ptch2, gli1, gli2, gli3). These controls showed no specific signal, confirming the specificity of our antisense probe hybridization. These data are now presented in the new Supplementary Figure S9.

      Major: TSL cells: TSL-onDhh, -onSf1: provide evidence for increase in expression

      We measured the mRNA expression levels of dhh in TSL-WT and TSL-OnDhh, and sf1 in TSL-WT and TSL-OnSf1 using qRT-PCR. The results are presented in the new Supplementary Figure S8B. The results show that overexpression of Dhh and Sf1 significantly increased the mRNA expression levels of dhh and sf1, respectively.

      Major: TSL + SAG cells and other treatments in general: how long were they treated before transplantation?

      Response: We have added relevant information in the "Materials and Methods" section in line 398-399: “For the SAG treatment experiment, TSL cells were incubated with 0.5 μM SAG for 48 hours before transplantation.”

      Major: Transcriptome analyses: how many replicates were used for each cell line? Please clarify-the results presented in Fig 5E: how was this plot generated, it is interpreted that all three cell lines were combined and compared to the WT line. It is not clear how this was achieved.

      We have added relevant information in the "Materials and Methods" section in line 445-447: “For the SAG treatment experiment, TSL cells were incubated with 0.5 μM SAG for 48 hours before collection. For each genotype, cells from three independent culture wells were pooled.

      Added relevant information in the "Results" section in line 198-202: “…we performed transcriptomic profiling of TSL cells under conditions of pathway activation: Dhh overexpression (TSL-OnDhh), Gli1 overexpression (TSL-OnGli1), and SAG treatment (TSL+SAG). Comparative RNA-seq analysis identified a core set of 33 genes consistently upregulated across all three conditions.”

      (6) Are the experiments adequately replicated and statistical analysis adequate?

      Most are adequate and appropriate, some questions remain:

      - Transcriptomes-how many replicates (see above)?

      - IF quantification-how were cells identified/how many sections (see above)?

      Minor: Statistics: methods indicate that a student's t-test was used, but ANOVA's are also used, which is appropriate. There are data presented that should be reevaluated via an ANOVA: Figure 4D, 4N-R; Figure 5G-no stats indicated in figure legend.

      We sincerely thank the reviewer for highlighting the inappropriate use of statistical tests in our original submission. We have re-analyzed all data using the ANOVA-based methods as suggested in the specific detail. We confirm that these changes do not alter the overall interpretation of our results but provide a more robust and statistically sound foundation for our conclusions. We changed “Differences were determined by two-tailed independent Student's t-test” to “Statistical significance was determined by one-way ANOVA followed by Tukey's test (C, Q-U, different letters above the error bar indicate statistical differences at P < 0.05) or Student's t-test (D) (*, P < 0.05; **, P < 0.01; NS, no significant difference).”

      In lines 719-721 we added “Statistical significance was determined by one-way ANOVA followed by Tukey's test (E, different letters above the error bar indicate statistical differences at P < 0.05) or Student's t-test (B, H) (*, P < 0.05; **, P < 0.01; NS, no significant difference).” in line 745-747.

      Reviewer #1 (Significance):

      The data presented in this manuscript provides important context towards the connection between the DHH pathway, Sf1, and steroidogenesis.

      The audience would likely include developmental biologists, including those related to differentiation of any hormone producing cell type and especially those focused on steroidogenesis onset. Clinical interests will be related to sex determination and differentiation, especially related to male sex phenotype differentiation. Basic scientists will be especially interested.

      Expertise: mouse fetal testis differentiation and maturation, steroidogenesis, hedgehog, sf1. Good fit except for the animal model, but they are surprisingly similar.

      Reviewer #2 (Evidence, reproducibility and clarity):

      In this work, Zhao et al., investigated the role of Dhh signaling pathway in the proliferation and differentiation of leydig lineage cells in the testes of Nile tilapia, an economic important farmed fish. By generating dhh mutants, the authors showed that loss of Dhh in tilapia recapitulated mammalian phenotypes, characterized by testicular hypoplasia and androgen insufficiency. A previous established TSL line was used to rescue the deficits in dhh-/- testes, which demonstrated that Dhh regulates the differentiation of SLCs rather than their survival. By generating mutant TSL lines, the authors aimed to identify the downstream players under Dhh in tilapia. Based on the data, the authors propose that a dhh-ptch2-gli1-sf1 axis exists in leydig cell lineage development.

      How secreted dhh from Sertoli cells affect the Leydig cells remains elusive. While previous studies have revealed the paracrine role of Sertoli cell secreted Dhh in the regulation of Leydig cell development and maturation, the authors provided some new insights into the issue using tilapia as a model. Unfortunately, this work is not well performed, and the conclusions are not well supported by the current data. And to reach logic conclusions, more meaningful experiments should be performed, and more convincing data should be provided.

      Strength:

      The authors used genetic mutants, TSL lines, and cell transplantation techniques to address the questions. The manuscript is technically sound, and overall is well-written.

      Limitations:

      Experimental design should be optimized, and more convincing data should be provided to reach solid conclusion.

      (1) The SLCs (stem leydig cells) used in this work. The SLC line was established from 3-month-old immature XY tilapia. The authors claimed that this line is a SLC line only because they express a few Leydig markers such as pdgfra and nestin. However, in my opinion, the identity of the cell line is not clear. It is suggested to perform more experiments, including flow cytometry assay or single cell RNA sequencing analysis, to further characterize this line, to demonstrate that this line is a real SLCs that are equivalent to the SLCs in 3-month testes of tilapia. According to the previous publication (2020), the information about the line was not well presented.

      We thank the reviewer for this comment regarding the characterization of the TSL cell line. The identity of TSL as a stem Leydig cell line was rigorously established in our previous publication (Huang et al., 2020), which provided comprehensive molecular, in vitro, and in vivo functional evidence that meets the definitive criteria for an SLC. This includes its stable expression of established SLC markers (pdgfrα, nestin, coup-tfii), its capacity to differentiate into steroidogenic cells producing 11-KT in vitro, and most critically, its ability to colonize the testicular interstitium, differentiate into Leydig cells, and restore androgen production upon transplantation in vivo.

      In direct response to the reviewer's point, we have revised the Introduction of our manuscript to provide a more detailed and clear description of the TSL line's origin and validation (lines 95-105) as “Furthermore, a stem Leydig cell line (TSL) has been established from the testis of a 3-month-old Nile tilapia. TSL expresses platelet-derived growth factor receptor α (pdgfrα), nestin, and chicken ovalbumin upstream promoter transcription factor II (coup-flla), which are usually considered as SLC-related markers in several other species. Notably, this cell line exhibits the capacity to differentiate into 11-ketotestosterone (11-KT)-producing Leydig cells both in vitro and in vivo. When cultured in a defined induction medium, TSL cells differentiate into a steroidogenic phenotype, expressing key steroidogenic genes including star1, star2, and cyp11c1, and producing 11-KT; upon transplantation into recipient testes, TSL cells successfully colonize the interstitial compartment, activate the expression of steroidogenic genes, and restore 11-KT production”, ensuring that readers can fully appreciate its well-founded identity as a SLC model without needing to consult the original publication. We are confident that the existing body of evidence solidly supports all conclusions drawn from its use in this study.

      (2) How loss of dhh affects testicular and the leydig cell lineage development are not clearly investigated. In the current manuscript, the characterization of dhh mutant was not enough and lack of in-depth investigation. The authors primarily looked at testes at 90 dph when Leydig cell lineage was well developed. In my opinion, this time was too late. To investigate the earlier events that are affected by loss of dhh, I suggested to perform experiments at earlier time points, in particular around the initiation stages of the sex differentiation and Lyedig cell specification/maturation.

      We thank the reviewer for this insightful comment. We agree that a thorough developmental analysis is crucial. In response to this point, we have now performed an in-depth investigation at earlier stages to precisely define the phenotype onset.

      Our revised manuscript includes new data from a developmental time-course analysis. While our initial characterization included 5, 10, and 20 dah, we now identified 30 dah as the critical window for Leydig cell differentiation onset, which was also supported by prior work (Zheng et al.). Our new immunofluorescence data at 30 dah now clearly show that Cyp11c1-positive cells are present in wild-type testes but are entirely absent in dhh<sup>-/-</sup> mutants (Fig. S7). This finding pinpoints the initial failure of SLC differentiation.

      We have integrated this key finding into the Discussion (lines 234-239) as “To define the onset of Leydig cell differentiation, we performed a developmental time-course analysis. This revealed that Cyp11c1-positive steroidogenic cells first appear in wild-type testes at 30 dah, while being conspicuously absent in dhh<sup>-/-</sup> mutants at this same stage (Fig. S7). This clear temporal pattern establishes ~30 dah as the developmental window when SLCs initiate their differentiation program in the Nile tilapia.”

      Concurrently, our analysis of the 90 dah timepoint remains vital, as it represents a mature stage with robust spermatogenesis and a stabilized somatic niche. This allows for a comprehensive assessment of the ultimate functional consequences of the early differentiation block, including its impact on germ cell support and overall testicular architecture.

      Thus, our study now provides a complete developmental perspective: the 30 dah timepoint identifies the initiation of the Dhh-dependent defect, while the 90-dah analysis reveals the mature, functional outcomes within the intact testicular niche.

      (3) The authors claimed that there was a ptch2-gli1-sf1 axis. The conclusion was drawn largely based on data that generated from the in vitro cultured TSL line. More data from genetic mutant tilapia are required to support the conclusion.

      We thank the reviewer’s insightful comments regarding the need for robust in vivo validation. In fact, our conclusion of a Dhh-Ptch2-Gli1-Sf1 axis is supported by an integrated experimental strategy, combining key in vivo evidence with targeted in vitro analyses to build a coherent model.

      (1) Evidence for Ptch2 as the key receptor: The role of Ptch2 is supported by a pivotal in vivo genetic experiment. The observation that the dhh<sup>-/-</sup> testicular phenotype is fully rescued in dhh<sup>-/-</sup>;ptch2<sup>-/-</sup> double mutants provides compelling genetic evidence that Ptch2 is the essential receptor for Dhh in vivo (Fig. 4E-U). We acknowledge that the early embryonic lethality of global ptch1 mutation precludes its functional analysis in postnatal testis development. Therefore, while our data strongly nominate Ptch2 as the principal receptor, we have qualified our conclusions in the revised manuscript to reflect that a role for Ptch1 cannot be definitively excluded without Leydig cell-specific conditional knockout models.

      (2) Evidence for Gli1 and its regulation of Sf1: The role of Gli1 as the key transcriptional effector was efficiently identified using our well-characterized TSL system, a valid approach for dissecting this highly conserved signaling cascade. The functional connection between Gli1 and Sf1 is supported by multiple lines of evidence: transcriptomic profiling, promoter analysis, luciferase reporter assays (including a new cold probe competition experiment), and most importantly, in vivo functional validation via SLC transplantation. The latter demonstrated that Sf1 is both necessary and sufficient for SLC differentiation within the testicular niche (Fig. 5).

      In direct response to the reviewer's points, we have thoroughly revised the manuscript text to ensure all claims are accurately stated, particularly regarding the receptor specificity and the nature of the Gli1-Sf1 regulatory relationship. We believe our study provides a solid foundation for the proposed signaling axis.

      Overall, better experimental design should be planned, including the rescue experiments. Some key information was missed. For instance, the identity of the stem Leydig cells was not clearly presented.

      We have explained it in point #1.

      Figures:

      Figure 1: The authors described the phenotypes at 90 dph. Loss of dhh led to severe phenotypes in testicular formation, as evidenced by defective formation of Vasa, a germline stem cell marker; loss of expression of cyp11c1, a leydig cell marker; and loss of sycp3, a marker of meiosis of spermatogonia.

      However, in my opinion, 90 dph was too late. To investigate the role of dhh in Leydig cell lineage, the authors are suggested to focus on earlier developmental stages when the sex differentiation and maturation of leydig cells occur. This work is actually a development biology one that investigates how dhh loss in Sertoli cells affects the development of Leydig cells. The careful characterization of earliest testicular phenotypes of dhh mutant is very important.

      We have explained it in point #2.

      Figure 2: Please clarify the logic for performing rescue experiments using 11-KT. Provided the critical role of 11-KT in the testis development and spermatogenesis, it was not unexpected that 11-KT treatment can rescue most of the cell types in testes. If dhh is absolutely required for LC lineage development maturation, adding 11-KT at 30 dph will not have an effect. Why not perform rescue experiments using Dhh protein?

      We thank the reviewer for this insightful comment, which allows us to clarify the logical progression of our experimental design, a process central to genetic discovery.

      When we first characterized the dhh<sup>-/-</sup> mutant, we observed a complex suite of phenotypes: testicular hypoplasia, arrested germ cell development, a profound deficiency of Leydig cells, and drastically low androgen levels. A primary challenge was to distinguish which defects were direct consequences of losing Dhh signaling and which were secondary effects of the overall testicular failure.

      We therefore employed a classic genetic strategy: phenotypic dissection through targeted rescue. The 11-KT rescue experiment was designed to test a foundational hypothesis: Are the severe testicular defects in dhh<sup>-/-</sup> mutants primarily a consequence of the systemic androgen deficiency? The results provided a pivotal and clear answer: while 11-KT treatment partially rescued germ cell development and testicular structure, it completely failed to restore the population of Cyp11c1-positive Leydig cells. This critical finding allowed us to dissociate the phenotypes, demonstrating that the Leydig cell defect is a primary, cell-autonomous consequence of Dhh loss, not a secondary effect of low androgen.

      This conclusion logically propelled the next phase of our research: to shift focus from systemic hormone action to the local, niche role of Dhh in regulating the Leydig lineage directly. This led directly to the TSL transplantation experiments and the mechanistic dissection of the Ptch2-Gli1-Sf1 axis within SLCs.

      Regarding the use of Dhh protein, we agree it is a complementary approach. However, producing biologically active, recombinant Hedgehog ligand is challenging due to its essential dual lipid modification, which is required for solubility and activity. Our transplantation experiments with TSL-OnDhh cells (Fig. 3) functionally demonstrate that providing Dhh signaling in a cell-autonomous manner is sufficient to rescue differentiation, thereby directly addressing the core question without the need for recombinant protein.

      Figure 3. The authors showed that in dhh-/- testes, TSL engrafted equivalently but failed to express Cyp11c1. This result was strange which raised a question about the identity of the TSLs, as I have mentioned above. The authors claimed that the TSLs are stem Leydig cells, which I doubt. Additional data should provided to support the statement.

      In the testicular environment, the transplanted TSLs should be able to colonize and differentiate into more mature leydig cells. Only a small portion of the PKH26-labled TSLs became Cyp11c1 positive after transplantation, can the authors comment this observation?

      To address "Mutation of dhh blocks SLC differentiation", the authors should first carefully examine the TSL lineage development using dhh mutant. Then, investigate how loss of dhh disrupts the cross talk between Sertoli cells and Leydig cells. why bother performing transplanted TSLs? Please clarify. Why not perform rescue experiments using Dhh protein at appropriate developmental stages?

      We thank the reviewer for these comments, which allow us to clarify the rationale and interpretation of our key experiments.

      (1) We have provided comprehensive evidence establishing the TSL line as a SLC line (Response to Point #1). The observation that WT TSL cells engraft but fail to differentiate in the dhh<sup>-/-</sup> testicular environment is not strange; it is, in fact, the core and most crucial finding of this experiment. It provides direct functional evidence that the dhh<sup>-/-</sup> niche lacks the essential signals required to initiate SLC differentiation, consistent with the severe deficiency of endogenous Cyp11c1<sup>+</sup> cells in these mutants (Fig. 1I-J', N).

      (2) The reviewer's concern about "only a small portion" of cells differentiating is based on a misunderstanding. Our quantitative data (Fig. 3F) show that approximately 78% of the transplanted PKH26+ TSL cells successfully differentiated into Cyp11c1<sup>+</sup> cells in WT hosts. This high efficiency robustly demonstrates the differentiation potential of TSL cells and the permissiveness of the WT niche. The near-zero differentiation rate in the dhh<sup>-/-</sup> host (Fig. 3F) starkly highlights the specific and severe defect in the mutant microenvironment.

      (3) The TSL transplantation experiment was the most direct strategy to test why Cyp11c1<sup>+</sup> cells are absent in dhh<sup>-/-</sup> testes. It allowed us to distinguish between a failure in SLC differentiation and other possibilities (e.g., cell death). The finding that functional SLCs cannot differentiate in the mutant niche logically directed our subsequent focus onto the cell-intrinsic molecular mechanism (the Ptch2-Gli1-Sf1 axis) within the Leydig lineage. While Sertoli-Leydig crosstalk is an important area, it was beyond the scope of this study aimed at defining the intrinsic differentiation pathway.

      (4) Regarding Dhh protein rescue, generating bioactive, lipid-modified recombinant Hh protein is technically challenging. Our transplantation of TSL-OnDhh cells (Fig. 3) functionally demonstrates that providing Dhh signaling in a cell-autonomous manner is sufficient to rescue differentiation, effectively addressing this question without the need for recombinant protein.

      Figure S3. “To assess whether dhh mutation affects androgen-producing cells outside Leydig cells, 11-KT levels were analyzed during early testicular development before SLCs differentiation. IF analyses revealed that no Cyp11c1 positive cells were present in the testes of XY WT fish at 5, 10, and 20 dah, indicating that SLCs had not yet differentiated at these stages (Fig. S3A-C). Tissue fluid 11-KT levels showed no significant differences between WT and dhh-/- XY fish at 5, 10, and 20 dah (Fig. S3D)”. These observations suggested that loss of dhh does not affect the specification of SLCs, but affect its differentiation into mature LCs. The differentiation of Cyp11c1 should be later than 20 dah. So when is the earliest time point for formation of Cyp11c1 positive cells, and how loss of dhh affect this? These are important questions to answer.

      We agree with the reviewer's interpretation that our data suggest dhh loss affects SLC differentiation rather than initial specification. In direct response to the need for earlier timepoints, we have now performed and included an analysis at 30 dah, which we identified as the critical window for Leydig cell differentiation onset. Our new data (Fig. S7) show that Cyp11c1+ cells are present in WT testes but are entirely absent in dhh<sup>-/-</sup> mutants at this stage. This precisely pinpoints the initiation of the phenotypic divergence and establishes ~30 dah as the developmental window when Dhh signaling is required to drive SLC differentiation. Our study therefore now provides a complete developmental perspective, from the initial failure at 30 dah to the mature functional outcomes at 90 dah.

      Figure 4. The authors generated ptch1/2 mutant TSL lines, and luciferase assay was performed, and based on the results, the authors concluded that Ptch2, but not Ptch1, is specifically required for transducing Dhh signals in TSLs. The conclusion was only based on luciferase assay using TSLs. Whether this was the case in testes at animal level is not clear. Clearly, more genetic experiments, using ptch mutants, should performed to substantiate this.

      The authors stated “Ptch2 acts as the obligate receptor for Dhh signaling during testis development”. If ptch2 is required for TSL lineage, why ptch2-/- testes exhibited no significant differences in testicular histology and Leydig cell (Cyp11c1+) populations and serum 11-KT levels? This contradictory statement need to be addressed.

      We thank the reviewer for these critical comments, which allow us to clarify the logic underlying our conclusions regarding Ptch2.

      (1) In Vivo Genetic Evidence for Ptch2: Our conclusion that Ptch2 is the primary receptor for Dhh is not based solely on the TSL luciferase assays. It is definitively supported by a key in vivo genetic experiment: the complete phenotypic rescue in the dhh<sup>-/-</sup>;ptch2<sup>-/-</sup> double mutants (Fig. 4F-R). In genetic terms, the loss of the receptor (ptch2) suppressing the phenotype caused by the loss of the ligand (dhh) is classic evidence for a ligand-receptor relationship within a linear pathway. This in vivo evidence strongly substantiates Ptch2's role at the animal level. The early embryonic lethality of ptch1 mutants precludes a similar in vivo test for Ptch1 in postnatal testis development.

      (2) Addressing the Apparent Contradiction of the ptch2<sup>-/-</sup> Phenotype: The reviewer raises an excellent point, which stems from the fundamental biology of the Hh pathway as shown in Author response image 1. Ptch receptors are inhibitory. In the absence of ligand, Ptch suppresses pathway activity.

      Author response image 1.

      The canonical Hh signaling pathway. In the dhh<sup>-/-</sup> mutant, the pathway is suppressed due to unopposed Ptch activity, leading to a failure in SLC differentiation. In the ptch2<sup>-/-</sup> mutant, this key inhibitory brake is removed, leading to constitutive activation of the pathway. The fact that ptch2<sup>-/-</sup> testes are normally indicates that this level of pathway activation is not detrimental and, crucially, is sufficient to support wild-type levels of Leydig cell development and steroidogenesis. This lack of a phenotype in the receptor mutant, contrasted with the severe ligand mutant phenotype, is a common and expected observation in signaling pathways where the receptor acts as a tonic inhibitor.

      In summary, the normal development of ptch2<sup>-/-</sup> testes is not contradictory but is entirely consistent with its role as the inhibitory receptor for Dhh. The severe phenotype in dhh<sup>-/-</sup> mutants and its specific rescue by removing ptch2 provides compelling genetic evidence for their functional relationship. We have revised the text throughout the manuscript to ensure these conclusions are accurately stated.

      Figure 5. The authors generated gli1/2/3 mutant TSL lines, and luciferase assay was performed, and based on the results, the authors concluded that Gli1, but not Gli2/3, was specifically required for transducing Dhh signals in TSL cells. The conclusion is drawn, only based on luciferase assay using TSLs. Whether this was the case in testes at animal level is not clear. Clearly, more genetic experiments should performed to substantiate this, using the gli mutant fish.

      To identify Gli1-dependent targets in SLCs, the authors compared transcriptomes of TSLWT, Dhh-overexpressing (TSL-OnDhh), Gli1-overexpressing (TSL-OnGli1), and SAG-treated (TSL+ SAG) TSL cells. While this experiments can be used to identify dhh target genes, it is better to use gli mutant cell lines. Since the authors have generate gli1/2/3 mutants, why not using these mutant fish to identify/confirm the Gli targets?

      We thank the reviewer for these comments.

      (1) We acknowledge that Gli1 as the key transcriptional effector is primarily based on our in vitro evidence using the TSL cell line. We have revised the manuscript accordingly to ensure this is stated precisely, avoiding overstatement.

      (2) Concerning the transcriptomic analysis, the reviewer suggests using glis mutant cell lines. While this is a valid approach, our strategy of profiling pathway activation (via Dhh/Gli1 overexpression or SAG treatment) was deliberately chosen to provide a high signal-to-noise ratio for identifying genes that are positively upregulated during the differentiation process. Analyzing loss-of-function mutants under basal conditions can be confounded by potential compensatory mechanisms among the Gli family members, potentially masking the specific transcriptional signature of pathway activation we sought to capture.

      By the way, we have generated gli1/2/3 mutant TSL cell lines for the functional luciferase assays, but we have not generated the corresponding glis mutant fish lines, which would represent a substantial new line of investigation.

      Reviewer #2 (Significance):

      While previous studies have revealed the paracrine role of Sertoli cell secreted Dhh in the regulation of Leydig cell development and maturation, the authors provided some new insights into the issue using tilapia as a model.

      Reviewer #3 (Evidence, reproducibility and clarity):

      Summary

      The authors investigate the Dhh signaling pathway in Leydig cell differentiation in the tilapia model. They generated multiple mutant lines in different hedgehog pathway components and utilized a Leydig stem cell line to interrogate Leydig cell differentiation. Through this analysis, the authors demonstrate that Dhh regulates Leydig differentiation rather than survival. They also found that Ptch2 is the specific receptor that mediates signaling to promote Leydig differentiation and that Gli1 is the primary Gli involved. Furthermore, they show that a known regulator of Leydig cell development and function, SF1, is a downstream transcriptional target. Overall, the study identifies previously unknown information as to how Dhh signaling regulates Leydig cell development, which is necessary for testosterone production by the testis.

      Major Comments

      (1) In the RNAseq analysis is not clear exactly how the 33 "up-regulated" genes were identified. What was the methodology for identification of these genes? Some of the genes were down-regulated or not different in the OnGli condition and some in the OnDhh condition were not differentially expressed, as shown in Fig S8B. Therefore, it is unclear why all 33 genes are classified as upregulated "across all three conditions".

      We have clarified this methodology in the Materials and Methods section in line 452-454: “Differentially expressed genes (DEGs) were identified for each condition (TSL-OnDhh, TSL-OnGli1, TSL+SAG) compared to TSL-WT controls using edgeR (threshold: FDR < 0.05, |log2(foldchange)| ≥ 1.5). And we Added relevant information in the Results section in line 198-202: we performed transcriptomic profiling of TSL cells under conditions of pathway activation: Dhh overexpression (TSL-OnDhh), Gli1 overexpression (TSL-OnGli1), and SAG treatment (TSL+SAG). Comparative RNA-seq analysis identified a core set of 33 genes consistently upregulated across all three conditions (Fig. 5C, S6A).”

      We have also updated Fig. S8B to include a clear value and to better visualize the FPKM value levels of these 33 genes across the conditions.

      (2) In figure 4A (and possibly B), it appears that ptch RNA is in the nucleus of the cell. Why would the RNA be primarily in the nucleus? Is the RNA detection accurate? Were controls done? The methods state that sense probes were made but no how they compared to the antisense probes. This comment can also be applied to the gli FISH, particularly gli3 (Figure 5).

      This is an excellent observation. We speculate that the apparent nuclear signal may be due to strong transcriptional activity in the nucleus. To confirm the specificity of our FISH experiment, we performed FISH with sense RNA probes as negative controls for all genes (ptch1, ptch2, gli1, gli2, gli3), and no specific signals were observed (see New Fig. S9).

      Minor comments

      (1) In the introduction, please include information as to when tilapia reach sexual maturity

      We have added this information to the Introduction in line 91-92: early sexual maturity (approximately 3 months after hatching for males and 6 months after hatching for females).

      (2) When first mentioning experiments that use the PKH26 dye, please give a brief description of the dye in the text of the results. This is described in the methods but it would be helpful to have some information about what PKH26 is in the results to more easily understand the figure and experimental design.

      We have added a brief description in the Results section in line 151-152: “To dissect Leydig cell lineage impairment in dhh<sup>-/-</sup> testes, we transplanted the TSL labeled with PKH26 (a fluorescent red hydrophobic membrane dye that enables tracking of transplanted cells) into WT and dhh<sup>-/-</sup> testes (Fig. 3A).”

      (3) In the statistical analysis section of the methods, the authors state that two-tailed t-tests were performed however in the figure legends it states that ANOVA was done for some of the statistical analysis. Please clarify this.

      We have updated the Statistical Analyses section in Methods to clarify in line 472-476: “A two-tailed independent Student’s t-test was used to determine the differences between the two groups. One-way ANOVA, followed by Tukey multiple comparison, was used to determine the significance of differences in more than two groups. P < 0.05 was used as a threshold for statistically significant differences.”

      (4) Figures - in figures that have charts with the Y-axis labeled as "relative positive cells", or similar, please explain what exactly is meant by "relative". What is it relative to?

      We have revised all relevant Y-axis labels and figure legends to explicitly state the quantification method. For example, we now use: "Vasa<sup>+</sup> / DAPI<sup>+</sup> (%), Sycp3<sup>+</sup> / DAPI<sup>+</sup> (%) or Cyp11c1<sup>+</sup> / DAPI<sup>+</sup> (%).

      (5) Figure 1: please point out the testes in panels A and B

      We have indicated the position of the testes with arrows in Figures 1A and B.

      (6) In figure 4, it would be helpful for the WT images from S7 moved to fig 4.

      We have moved representative WT images from Fig. S7 into Fig. 4 for easier comparison with the mutant phenotypes.

      (7) Figure 4E: Are the yellow bars comparable to each other. Is there any significance to the increased luciferase with 8xGli in ptch2-/- as compared to the other genotypes?

      We thank the reviewer for this astute observation. Yes, the yellow bars are directly comparable, and the elevated basal luciferase activity of the 8xGli reporter in the ptch2<sup>-/-</sup> TSL cells is indeed significant and expected. The genetic ablation of ptch2 removes this inhibition, leading to ligand-independent, constitutive activation of the downstream signaling cascade. The observed increase in basal reporter activity in the ptch2<sup>-/-</sup> cells is a classic manifestation of this mechanism.

      The primary objective of this experiment was to test the cells' responsiveness to Dhh stimulation across genotypes. The key finding is that while wild-type and ptch1<sup>-/-</sup> cells showed a significant response to Dhh, the ptch2<sup>-/-</sup> cells-which already exhibited high basal activity-were completely unresponsive. This combination of constitutive activation and ligand insensitivity in the ptch2<sup>-/-</sup> genotype provides particularly strong genetic evidence that Ptch2 is the essential receptor mediating Dhh signal transduction in this system.

      (8) Figure 5G: please include what exactly what each construct name stands for in the figure legend

      We have expanded the legend for Fig. 5G to define each construct.

      (9) Figure S8B: please include what the values in the table are (eg are these the significance values?)

      We have updated the caption for Figure S8B (now Figure S6B): “The FPKM value for each gene in each sample is indicated within the squares. The color gradient from blue to red reflects low to high expression levels per row (gene).”

      Reviewer #3 (Significance):

      Strengths and limitations:

      The genetics of the tilapia system and the availability of the tilapia Leydig stem cell lines were particular strengths of this study. The study utilizes fish genetics to genetically interrogate the Dhh signaling pathway in Leydig cell development through generation and analysis of mutant lines. The tilapia Leydig stem cell line was an integral part of this study as it allowed for genetic and chemical manipulation of Dhh signaling in undifferentiated Leydig cells and, through transplantation into testes, allowed for analysis of how Leydig cell differentiation was affected.

      Advance:

      The study makes significant advances as to how Dhh signaling instructs Leydig cell differentiation, including identification of the Ptch receptor and Gli transcription factor that function downstream of Dhh in this process. Furthermore, they identify a direct link between Dhh signaling and Sf1 expression, which is known to important for Leydig cell function.

      Audience:

      This study will be of particular interest to reproductive biologists, endocrinologists, and developmental biologists. The study may also be of interest to researchers and physicians investigating cancers that are promoted by androgens produced by Leydig cells of the testis.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper aims to characterize the relationship between affinity and fitness in the process of affinity maturation. To this end, the authors develop a model of germinal center reaction and a tailored statistical approach, building on recent advances in simulation-based inference. The potential impact of this work is hindered by the poor organization of the manuscript. In crucial sections, the writing style and notations are unclear and difficult to follow.

      We thank the reviewer for their kind words, and have endeavored to address all of their concerns as to the structure and style of the manuscript.

      Strengths:

      The model provides a framework for linking affinity measurements and sequence evolution and does so while accounting for the stochasticity inherent to the germinal center reaction. The model's sophistication comes at the cost of numerous parameters and leads to intractable likelihood, which are the primary challenges addressed by the authors. The approach to inference is innovative and relies on training a neural network on extensive simulations of trajectories from the model.

      Weaknesses:

      The text is challenging to follow. The descriptions of the model and the inference procedure are fragmented and repetitive. In the introduction and the methods section, the same information is often provided multiple times, at different levels of detail.

      Thank you for pointing this out. We have rearranged the methods in order to make the presentation more linear, and to reduce duplication with the introduction.

      Specifically, we moved the affinity definition to the start, removed the redundant bullet point list, and moved the parameter value table to the end.

      This organization sometimes requires the reader to move back and forth between subsections (there are multiple non-specific references to "above" and "below" in the text).

      This is a great point, we have either removed or replaced all references to "above" or "below" with more specific citations.

      The choice of some parameter values in simulations appears arbitrary and would benefit from more extensive justification. It remains unclear how the "significant uncertainty" associated with these parameters affects the results of inference.

      We have clarified where various parameter values come from:

      “In addition to the four sigmoid parameters, which we infer directly, there are other parameters in Table 1 about which we have incomplete information. The carrying capacity method and the choice of sigmoid for the response function represent fundamental model assumptions. We also fix the death rate for nonfunctional (stop) sequences, which would be very difficult to infer with the present experiment. For others, we know precise values from the replay experiment for each GC (time to sampling, # sampled cells/GC), but use a somewhat wider range for the sake of generalizability. The mutability multiplier is a heuristic factor used to match the SHM distributions to data. The naive birth rate is determined by the sigmoid parameters, but has its own range in order to facilitate efficient simulation.

      For two of the three remaining parameters (carrying capacity and initial population), we can ostensibly choose values based on the replay experiment. These values carry significant uncertainty, however, partly due to inherent experimental uncertainty, but also because they may represent different biological quantities to those in simulation. For instance, an experimental measurement of the number of B cells in a germinal center might appear to correspond closely to simulation carrying capacity. However if germinal centers are not well mixed, such that competition occurs only among nearby cells, the "effective" carrying capacity that each cell experiences could be much smaller.

      Fortunately, in addition to the neural network inference of sigmoid parameters, we have another source of information that we can use to infer non-sigmoid parameters: summary statistic distributions. We can use the matching of these distributions to effectively fit values for these additional unknown parameters. We also include the final parameter, the functional death rate, in these non-sigmoid inferred parameters, although it is unconstrained by the replay experiment, and it is unclear whether it is uniquely identifiable.”

      In addition, the performance of the inference scheme on simulated data is difficult to evaluate, as the reported distributions of loss function values are not very informative.

      We thought of two different interpretions for this comment, so have worked to address both.

      First, the comment could have been that the distribution of loss functions on the training sample does not appear to be informative of performance on data-like samples. This is true, and in our revision we have emphasized the distinction between the two types of simulation sample: those for training, where each simulated GC has different (sampled) parameter values; vs the "data mimic" samples where all GCs have identical parameters. Since the former have different values for each GC, we can only plot many inferred curves together on the latter. We also would like to emphasize that the inference problem for one GC will have much more uncertainty than will that for an ensemble of GCs (as in the full replay experiment).

      “After building and training our neural network, we evaluate its performance on subsets of the training sample. While this evaluation provides an important baseline and sanity check, it is important to note that the training sample differs dramatically from real data (and the “data mimic” simulation sample that mimics real data). While real data consists of 119 GCs with identical parameters and thus response functions, we need the GCs in our training sample to span the space of all plausible parameter values. This means that while we must evaluate performance on individual GCs in the training and testing samples, in real data (and data mimic simulation) we combine results from 119 curves into a central (medoid) curve. Inference on the training sample will thus appear vastly noisier than on real data and data mimic simulation, and also cannot be plotted with all true and inferred curves together.”

      A second interpretation was that the reviewer did not have an intuitive sense of what a loss function value of, say, 1.0 actually means. To address this second interpretation, we have also added a supplement to Figure 2 with several example true and inferred response functions from the training sample, with representative loss values spanning 0.17 to 2.18. We have also added the following clarification to the caption of Figure 1-figure supplement 2:

      “The loss value is thus the fraction of the area under the true curve represented by the area between the true and inferred curves.”

      Finally, the discussion of the similarities and differences with an alternative approach to this inference problem, presented in Dewitt et al. (2025), is incomplete.

      We have expanded this section of the manuscript, and added a new plot directly comparing the methods.

      “In order to compare more directly to DeWitt et al. 2025, we remade their Fig.S6D, truncating to values at which affinities are actually observed in the bulk data, and using only three of the seven timepoints (11, 20, and 70, Figure 8, left). We then simulated 25 GCs with central data mimic parameters out to 70 days. For each such GC, we found the time point with mean affinity over living cells closest to each of three specific “target” affinity values (0.1, 1.0, 2.0) corresponding to the mean affinity of the bulk data at timepoints 11, 20, and 70. We then plot the effective birth rates of all living cells vs relative affinity (subtracting mean affinity) at the resulting GC-specific timepoints for all 25 GCs together Figure 8, right). Note that because each GC evolves at very different and time-dependent rates, we could not simply use the timepoints from the bulk data, since each GC slice from our simulation would then have very different mean affinity. The mean over GCs of these GC-specific chosen times is 10.9, 24.5, 44.4 (compared to the original bulk data time points 11, 20, 70). It is important to note that while the first two target affinities (0.1 and 1.0) are within the affinity ranges encountered in the extracted GC data, the third value (2.0) is far beyond them, and thus represents extrapolation to an affinity regime informed more by our underlying model than by the real data on which we fit it.”

      Reviewer #2 (Public review):

      Summary:

      This paper presents a new approach for explicitly transforming B-cell receptor affinity into evolutionary fitness in the germinal center. It demonstrates the feasibility of using likelihood-free inference to study this problem and demonstrates how effective birth rates appear to vary with affinity in real-world data.

      Strengths:

      (1) The authors leverage the unique data they have generated for a separate project to provide novel insights into a fundamental question. (2) The paper is clearly written, with accessible methods and a straightforward discussion of the limits of this model. (3) Code and data are publicly available and well documented.

      Weaknesses (minor):

      (1) Lines 444-446: I think that "affinity ceiling" and "fitness ceiling" should be considered independent concepts. The former, as the authors ably explain, is a physical limitation. This wouldn't necessarily correspond to a fitness ceiling, though, as Figure 7 shows. Conversely, the model developed here would allow for a fitness ceiling even if the physical limit doesn't exist.

      Right, whoops, good point. We've rearranged the discussion to separate the concepts, for instance:

      “While affinity and fitness ceilings are separate concepts, they are closely related. An affinity ceiling is a limit to affinity for a given antigen: there are no mutations that can improve affinity beyond this level. This would result in a truncated response function, undefined beyond the affinity ceiling. A fitness ceiling, on the other hand, is an upper asymptote on the response function. Such a ceiling would result in a limit on affinity for a germinal center reaction, since once cells are well into the upper asymptote of fitness they are no longer subject to selective pressure.”

      (2) Lines 566-569: I would like to see this caveat fleshed out more and perhaps mentioned earlier in the paper. While relative affinity is far more important, it is not at all clear to me that absolute affinity can be totally ignored in modeling GC behavior.

      This is a great point, we've added a mention of this where we introduce the replay experiment in the Methods:

      “It is important to note that this is a much lower level than typical BCR repertoires, which average roughly 5-10% nucleotide shm.”

      And expanded on the explanation in the Discussion:

      “Some aspects of behavior in the low-shm/early times regime of the extracted GC data are also potentially different to those at the higher shm levels and longer times found in typical repertoires. This is especially relevant to affinity or fitness ceilings, to which we likely have little sensitivity with the current data.”

      (3) One other limitation that is worth mentioning, though beyond the scope of the current work to fully address: the evolution of the repertoire is also strongly shaped by competition from circulating antibodies. (Eg: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600904/, http://www.sciencedirect.com/science/article/pii/S1931312820303978). This is irrelevant for the replay experiment modeled here, but still an important factor in general repertoires.

      Yes good point, we've added these citations in a new paragraph on between-lineage competition:

      “We also neglect competition among lineages stemming from different rearrangement events (different clonal families), instead assuming that each GC is seeded with instances of only a single naive sequence, and that neither cells nor antibodies migrate between different GCs. More realistically for the polyclonal GC case, we would allow lineages stemming from different naive sequences to compete with each other both within and between GCs (Zhang et al. 2013: McNamara et al. 2020; Barbulescu et al. 2025). Implementing competition among several clonal families within a single GC would be conceptually simple and computationally practical in our current software framework. Competition among many GCs, however, would be computationally prohibitive because our time required is primarily determined by the total population size, since at each step we must iterate over every node and every event type in order to find the shortest waiting time. For the monoclonal replay experiment specifically, however, all naive sequences are the same and so the current modeling framework is sufficient.”

      Recommendations for the authors:

      Reviewing Editor Comments:

      The authors are encouraged to follow the suggestions of manuscript re-organization by Reviewer 1, in order to improve readability. We would also like to suggest improving the discussion of the traveling wave model to explain it in a more self-contained way. In passing, please clarify what is meant by 'steady-state' in that model. A superficial understanding would suggest that the only steady state in that model would be a homogeneous population of antibodies with maximum affinity/fitness.

      These are great suggestions. We have substantially rearranged the text according to Reviewer 1's suggestions, especially the Methods, and expanded on and rearranged the traveling wave discussion. We've also clarified throughout that the traveling wave model is assuming steady state with respect to population. In the public response to reviewer 1 above we describe these changes in more detail.

      Reviewer #1 (Recommendations for the authors):

      I suggest that the organization of the paper be reconsidered. The current methods section is long and at times repetitive, making it impossible to parse in a single reading. Moving some technical details from the main text to an appendix could improve readability. Despite the length of the methods section, many important points, such as justification of choices in model specification or values of parameters, are treated only briefly.

      We have rearranged the methods section, particularly the discussion of our model, and have more clearly justified choices of parameter values as described in the public response.

      Discussion of similarities and differences with reference to Dewitt et al. 2025 should be revised, as it's currently unclear whether the method presented here has any advantages.

      We have expanded this comparison, and emphasized the main disadvantage of the traveling wave approach: there is no way of knowing whether by abstracting away so much biological detail it misses important effects. We have also emphasized that the two approaches use different types of data (time series vs endpoint) which are typically not simultaneously available:

      “The clear advantage of the traveling wave model is its simplicity: if its high level view is accurate enough to effectively model the relevant GC dynamics, it is far more tractable. But reproducing low-level biological detail, and making high-dimensional real data comparisons (e.g. Figure 5) to iteratively improve model fidelity, are also useful, providing direct evidence that we are correctly modeling the underlying biological processes. The two approaches also utilize different types of data: we use a single time point, and thus must reconstruct evolutionary history; whereas the traveling wave requires a series of timepoints. The availability of both types of data is a unique feature of the replay experiment, and provides us with the opportunity to directly compare the approaches.”

      The results obtained from the same data should be directly compared (can the response function be directly compared to the result in Figure S6D in Dewitt et al., 2025? If yes, it should be re-plotted here and compared/superimposed with Figures 6 and 7). The text mentions the results differ, but it remains ambiguous whether the differences are significant and what their implications are.

      We've added a new Figure 8, comparing a modified version of the traveling wave Fig S6D to a new plot derived from our results using the data mimic parameters. While the two plots represent fundamentally different quantities, they do put the results of the two methods on an approximately equal footing and we see nice concordance between them in regions with significant data (they disagree substantially for larger negative affinities). We have also added emphasis to the point that the traveling wave model uses an entirely separate dataset to what we use here.

      Other comments:

      (1) l. 80: "[in] around 10 days"?

      Text rearranged so this phrase no longer appears.

      (2) l. 96: "an intrinsic rate [given by?] the response function above".

      Text rearranged so this phrase no longer appears.

      (3) Figure 1: The. “specific model” could part be expanded and improved to help make sense of model parameters and the order of different processes in the population model. Example values of parameters can be plotted rather than loosely described, (e.g., y_h+y_c, the upper asymptotes can be plotted in place of the “yscale determines upper asymptotes” label.

      Great suggestion, we've changed the labels.

      (4) The cartoons in the other parts are somewhat cryptic or illegible due to small sizes.

      We have added text in the caption linking to the figures that are, in the figure, intended to be in schematic form only.

      “Plots from elsewhere in the manuscript are rendered in schematic form: those in “infer on data” refer to Figure 4-figure supplement 1, and those in “simulate with inferred parameters” to Figure 5.

      (5) L. 137: It's not helpful to give numerical values before the definition of affinity. (and these numbers are repeated later).

      Good point, we've moved the affinity definition to the previous section, and remove the duplicate range information.

      (6): Table 1: A number of notations are unclear, such as “#seqs/GC” or “mutability multiplier”. The double notation for crucial parameters doesn't help. At the moment the table is introduced, the columns make little sense to the reader, and it's not well specified what dictates the choice or changes of parameter values or ranges.

      We've moved the table further down until after the parameters have been introduced, and clarified the indicated names.

      (7) l. 147: Choices of model are not justified and appear arbitrary (e.g., why death events happen at one of two rate).

      We have clarified the reasoning behind having two death rates.

      (8) l.151: “happened on the edges of developing phylogenetic tree” - ambiguous: do they accumulate at cell divisions? What is a “developing tree”?

      We have removed this ambiguous phrasing.

      (9) l.161: This paragraph is particularly dense.

      We have rearranged this section of the methods, and split up this paragraph.

      (10) l. 164: All the different response functions for different event types? Or only the one for birth, as stated before?

      Yes. This has been clarified.

      (11) l.167: Does the statement in the bracket refer to a unit?

      This has been clarified.

      (12) l. 169: Discussion of the implementation seems too detailed.

      Hopefully the rearranged description is clearer, but we worry that removing the details of events selection would leave some readers confused.

      (13) l. 186: Why describe the methods that, in the end, were not used? Similarly, as a mention of “variety of response functions” seems out of place if only one choice is used throughout the paper. eq. (2): that's mˆ{-1} from eq. (1). Having the two equations using the same notation is confusing.

      We've moved the mention of alternatives to the Discussion, where it is an important source of uncontrolled systematic uncertainty, and removed the extra equation.

      (14) l. 206: Unclear what “thus” refers to.

      Removed.

      (15) l.211: What does “neglecting y_h” mean?

      This has been clarified.

      (16) l. 242: Unclear what “this” refers to.

      Clarified.

      (17) l. 261: What does “model independence” refer to in this context?

      From the sigmoid model. Clarified.

      (18) l. 306: What values for which parameters? References?

      We have clarified and updated this statement - it was out of date, corresponding to the analysis before we started fitting non-sigmoid parameters.

      “In addition to the four sigmoid parameters, which we infer directly, there are other parameters in Table 1 about which we have incomplete information. The carrying capacity method and the choice of sigmoid for the response function represent fundamental model assumptions. We also fix the death rate for nonfunctional (stop) sequences, which would be very difficult to infer with the present experiment. For others, we know precise values from the replay experiment for each GC (time to sampling, # sampled cells/GC), but use a somewhat wider range for the sake of generalizability. The mutability multiplier is a heuristic factor used to match the SHM distributions to data. The naive birth rate is determined by the sigmoid parameters, but has its own range in order to facilitate efficient simulation.

      For two of the three remaining parameters (carrying capacity and initial population), we can ostensibly choose values based on the replay experiment. These values carry significant uncertainty, however, partly due to inherent experimental uncertainty, but also because they may represent different biological quantities to those in simulation. For instance, an experimental measurement of the number of B cells in a germinal center might appear to correspond closely to simulation carrying capacity. However if germinal centers are not well mixed, such that competition occurs only among nearby cells, the "effective" carrying capacity that each cell experiences could be much smaller.

      Fortunately, in addition to the neural network inference of sigmoid parameters, we have another source of information that we can use to infer non-sigmoid parameters: summary statistic distributions. We can use the matching of these distributions to effectively fit values for these additional unknown parameters. We also include the final parameter, the functional death rate, in these non-sigmoid inferred parameters, although it is unconstrained by the replay experiment, and it is unclear whether it is uniquely identifiable.”

      (19) l. 326: "is interpreted as having" or "corresponds to"?

      Changed.

      (20) l. 340: Not sure what "encompassing" means in this context.

      Clarified.

      (21) l. 341: "We do this..." -- I think this sentence is not grammatical.

      Fixed.

      (22) l. 348: "on simulation" -- "from simulated data"?

      Indeed.

      (23) l. 351: "top rows", the figures only have one row.

      Fixed.

      (24) Figure 2: It's difficult to tell from the loss function itself whether inference on simulated data works well. Why not report the simulated and inferred response functions? The equivalent plots in Figure 5 would also be informative. Has inference been tested for different "sigmoid parameters" values?

      This is an important point that was not clear, thanks for bringing it up. We have expanded on and emphasized the differences between these samples and the reasoning behind their different evaluation choices. Briefly, we can't display true vs inferred response functions on the training samples since the curves for each GC are different -- the plot would be entirely filled in with very different response function shapes. This is why we do actual performance evaluation on the "data mimic" samples, where all GCs have the same parameters. Summary stats (like Fig 5) for the training sample are in Fig 5 Supplement 2.

      (25) l. 354: Unclear what "this" refers to.

      Removed.

      (26) l. 355: We assume the parameters are the same?

      Yes, we assume all data GCs have the same parameters. We have added emphasis of this point.

      (27) Figure 4: Is "lambda" the fitness? Should be typeset as \lambda_i?

      Our convention is to add the subscript when evaluating fitness on individual cells, but to omit it, as here, when plotting the response function as a whole.

      (28) l. 412: "[a] carrying capacity constraint".

      Fixed.

      Reviewer #2 (Recommendations for the authors):

      (1) In 2 places, you state that observed affinity ranged from -37 to 3, but I assume that the lower bound should be -3.7.

      The -37 was actually correct, but we had mistakenly missed updating it when we switched to the latest (current) version of the affinity model. We have updated the values, although these don't really have any effect on the model since we only infer within bounds in which we have a lot of points:

      “Affinity is ∅ for the initial unmutated sequence, and ranges from -12.2 to 3.5 in observed sequences, with a mean median of -0.3 (0.3).

      (2). I had to look up the Vols nicker paper to understand the tree encoding: It would be nice to spend another sentence or two on it here for those who aren't familiar.

      Great point, we have added the following:

      “We encode each tree with an approach similar to Lambert et al. (2023) and Thompson et al. (2024), most closely following the compact bijective ladderized vector (CBLV) approach from Voznica et al. (2022). The CBLV method first ladderizes the tree by rotating each subtree such that, roughly speaking, longer branches end up toward the left. This does not modify the tree, but rather allows iteration over nodes in a defined, repeatable way, called inorder iteration. To generate the matrix, we traverse the ladderized tree in order, calculating a distance to associate with each node. For internal nodes, this is the distance to root, whereas for leaf nodes it is the distance to the most-recently-visited internal node (Voznica et al., 2022, Fig. 2). Distances corresponding to leaf nodes are arranged in the first row of the matrix, while those from internal nodes form the second row.”

      (3) On line 351, you refer to the "top rows of Figure 2 and Figure 3," but each only has one row in the current version. I think it should now be "left panel.".

      Fixed.

      (4) How many vertical dashed lines are in the left panel of the bottom row of Figure 7? I think it's more than one, but can't tell if it is two or three...

      Nice catch! There were actually three. We've shortened them and added a white outline to clarify overlapping lines.

      (5) Would the model be applicable to GCs with multiple naive founders of different affinities? Or would more/different parameters be needed to account for that?

      The model would be applicable, but since the time required for our simulation scales roughly with the total simulated population size, we could probably only handle competition among at most a couple of GCs. Some sort of "migration strength" parameter would be required for competition among GCs (or within one GC if we don't want to assume it's well-mixed), but that doesn't seem a terrible impediment. We've added the following:

      “We also neglect competition among lineages stemming from different rearrangement events (different clonal families), instead assuming that each GC is seeded with instances of only a single naive sequence, and that neither cells nor antibodies migrate between different GCs. More realistically for the polyclonal GC case, we would allow lineages stemming from different naive sequences to compete with each other both within and between GCs (Zhang et al. 2013; McNamara et al. 2020; Barbulescu et al. 2025). Implementing competition among several clonal families within a single GC would be conceptually simple and computationally practical in our current software framework. Competition among many GCs, however, would be computationally prohibitive because our time required is primarily determined by the total population size, since at each step we must iterate over every node and every event type in order to find the shortest waiting time. For the monoclonal replay experiment specifically, however, all naive sequences are the same and so the current modeling framework is sufficient.”

    1. Author response:

      The following is the authors’ response to the current reviews.

      I thank the authors for their clarifications. The manuscript is much improved now, in my opinion. The new power spectral density plots and revised Figure 1 are much appreciated. However, there is one remaining point that I am unclear about. In the rebuttal, the authors state the following: "To directly address the question of whether the auditory signal was distracting, we conducted a follow-up MEG experiment. In this study, we observed a significant reduction in visual accuracy during the second block when the distractor was present (see Fig. 7B and Suppl. Fig. 1B), providing clear evidence of a distractor cost under conditions where performance was not saturated." 

      I am very confused by this statement, because both Fig. 7B and Suppl. Fig. 1B show that the visual- (i.e., visual target presented alone) has a lower accuracy and longer reaction time than visual+ (i.e., visual target presented with distractor). In fact, Suppl. Fig. 1B legend states the following: "accuracy: auditory- - auditory+: M = 7.2 %; SD = 7.5; p = .001; t(25) = 4.9; visual- - visual+: M = -7.6%; SD = 10.80; p < .01; t(25) = -3.59; Reaction time: auditory- - auditory +: M = -20.64 ms; SD = 57.6; n.s.: p = .08; t(25) = -1.83; visual- - visual+: M = 60.1 ms ; SD = 58.52; p < .001; t(25) = 5.23)." 

      These statements appear to directly contradict each other. I appreciate that the difficulty of auditory and visual trials in block 2 of MEG experiments are matched, but this does not address the question of whether the distractor was actually distracting (and thus needed to be inhibited by occipital alpha). Please clarify.

      We apologize for mixing up the visual and auditory distractor cost in our rebuttal. The reviewer is right in that our two statements contradict each other.

      To clarify: In the EEG experiment, we see significant distractor cost for auditory distractors in the accuracy (which can be seen in SUPPL Fig. 1A). We also see a faster reaction time with auditory distractors, which may speak to intersensory facilitation. As we used the same distractors for both experiments, it can be assumed that they were distracting in both experiments.

      In our follow-up MEG-experiment, as the reviewer stated, performance in block 2 was higher than in block 1, even though there were distractors present. In this experiment, distractor cost and learning effects are difficult to disentangle. It is possible that participants improved over time for the visual discrimination task in Block 1, as performance at the beginning was quite low. To illustrate this, we divided the trials of each condition into bins of 10 and plotted the mean accuracy in these bins over time (see Author response image 1). Here it can be seen that in Block 2, there is a more or less stable performance over time with a variation < 10 %. In Block 1, both for visual as well as auditory trials, an improvement over time can be seen. This is especially strong for visual trials, which span a difference of > 20%. Note that the mean performance for the 80-90 trial bin was higher than any mean performance observed in Block 2. 

      Additionally, the same paradigm has been applied in previous investigations, which also found distractor costs for the here-used auditory stimuli in blocked and non-blocked designs. See:

      Mazaheri, A., van Schouwenburg, M. R., Dimitrijevic, A., Denys, D., Cools, R., & Jensen, O. (2014). Region-specific modulations in oscillatory alpha activity serve to facilitate processing in the visual and auditory modalities. NeuroImage, 87, 356–362. https://doi.org/10.1016/j.neuroimage.2013.10.052

      Van Diepen, R & Mazaheri, A 2017, 'Cross-sensory modulation of alpha oscillatory activity: suppression, idling and default resource allocation', European Journal of Neuroscience, vol. 45, no. 11, pp. 1431-1438. https://doi.org/10.1111/ejn.13570

      Author response image 1.

      Accuracy development over time in the MEG experiment. During block 1, a performance increase over time can be observed for visual as well as for auditory stimuli. During Block 2, performance is stable over time. Data are presented as mean ± SEM. N = 27 (one participant was excluded from this analysis, as their trial count in at least one condition was below 90 trials).


      The following is the authors’ response to the previous reviews

      Reviewer #1 (Public review):

      In this study, Brickwedde et al. leveraged a cross-modal task where visual cues indicated whether upcoming targets required visual or auditory discrimination. Visual and auditory targets were paired with auditory and visual distractors, respectively. The authors found that during the cue-to-target interval, posterior alpha activity increased along with auditory and visual frequency-tagged activity when subjects were anticipating auditory targets. The authors conclude that their results disprove the alpha inhibition hypothesis, and instead implies that alpha "regulates downstream information transfer." However, as I detail below, I do not think the presented data irrefutably disproves the alpha inhibition hypothesis. Moreover, the evidence for the alternative hypothesis of alpha as an orchestrator for downstream signal transmission is weak. Their data serves to refute only the most extreme and physiologically implausible version of the alpha inhibition hypothesis, which assumes that alpha completely disengages the entire brain area, inhibiting all neuronal activity.

      We thank the reviewer for taking the time to provide additional feedback and suggestions and we improved our manuscript accordingly.

      (1) Authors assign specific meanings to specific frequencies (8-12 Hz alpha, 4 Hz intermodulation frequency, 36 Hz visual tagging activity, 40 Hz auditory tagging activity), but the results show that spectral power increases in all of these frequencies towards the end of the cue-to-target interval. This result is consistent with a broadband increase, which could simply be due to additional attention required when anticipating auditory target (since behavioral performance was lower with auditory targets, we can say auditory discrimination was more difficult). To rule this out, authors will need to show a power spectral density curve with specific increases around each frequency band of interest. In addition, it would be more convincing if there was a bump in the alpha band, and distinct bumps for 4 vs 36 vs 40 Hz band.

      This is an interesting point with several aspects, which we will address separately

      Broadband Increase vs. Frequency-Specific Effects:

      The suggestion that the observed spectral power increases may reflect a broadband effect rather than frequency-specific tagging is important. However, Supplementary Figure 11 shows no difference between expecting an auditory or visual target at 44 Hz. This demonstrates that (1) there is no uniform increase across all frequencies, and (2) the separation between our stimulation frequencies was sufficient to allow differentiation using our method.

      Task Difficulty and Performance Differences:

      The reviewer suggests that the observed effects may be due to differences in task difficulty, citing lower performance when anticipating auditory targets in the EEG study. This issue was explicitly addressed in our follow-up MEG study, where stimulus difficulty was calibrated. In the second block—used for analysis—accuracy between auditory and visual targets was matched (see Fig. 7B). The replication of our findings under these controlled conditions directly rules out task difficulty as the sole explanation. This point is clearly presented in the manuscript.

      Power Spectrum Analysis:

      The reviewer’s suggestion that our analysis lacks evidence of frequency-specific effects is addressed directly in the manuscript. While we initially used the Hilbert method to track the time course of power fluctuations, we also included spectral analyses to confirm distinct peaks at the stimulation frequencies. Specifically, when averaging over the alpha cluster, we observed a significant difference at 10 Hz between auditory and visual target expectation, with no significant differences at 36 or 40 Hz in that cluster. Conversely, in the sensor cluster showing significant 36 Hz activity, alpha power did not differ, but both 36 Hz and 40 Hz tagging frequencies showed significant effects These findings clearly demonstrate frequency-specific modulation and are already presented in the manuscript.

      (2) For visual target discrimination, behavioral performance with and without the distractor is not statistically different. Moreover, the reaction time is faster with distractor. Is there any evidence that the added auditory signal was actually distracting?

      We appreciate the reviewer’s observation regarding the lack of a statistically significant difference in behavioral performance for visual target discrimination with and without the auditory distractor. While this was indeed the case in our EEG experiment, we believe the absence of an accuracy effect may be attributable to a ceiling effect, as overall visual performance approached 100%. This high baseline likely masked any subtle influence of the distractor.

      To directly address the question of whether the auditory signal was distracting, we conducted a follow-up MEG experiment. In this study, we observed a significant reduction in visual accuracy during the second block when the distractor was present (see Fig. 7B and Suppl. Fig. 1B), providing clear evidence of a distractor cost under conditions where performance was not saturated.

      Regarding the faster reaction times observed in the presence of the auditory distractor, this phenomenon is consistent with prior findings on intersensory facilitation. Auditory stimuli, which are processed more rapidly than visual stimuli, can enhance response speed to visual targets—even when the auditory input is non-informative or nominally distracting (Nickerson, 1973; Diederich & Colonius, 2008; Salagovic & Leonard, 2021). Thus, while the auditory signal may facilitate motor responses, it can simultaneously impair perceptual accuracy, depending on task demands and baseline performance levels.

      Taken together, our data suggest that the auditory signal does exert a distracting influence, particularly under conditions where visual performance is not at ceiling. The dual effect—facilitated reaction time but reduced accuracy—highlights the complexity of multisensory interactions and underscores the importance of considering both behavioral and neurophysiological measures.

      (3) It is possible that alpha does suppress task-irrelevant stimuli, but only when it is distracting. In other words, perhaps alpha only suppresses distractors that are presented simultaneously with the target. Since the authors did not test this, they cannot irrefutably reject the alpha inhibition hypothesis.

      The reviewer’s claim that we did not test whether alpha suppresses distractors presented simultaneously with the target is incorrect. As stated in the manuscript and supported by our data (see point 2), auditory distractors were indeed presented concurrently with visual targets, and they were demonstrably distracting. Therefore, the scenario the reviewer suggests was not only tested—it forms a core part of our design.

      Furthermore, it was never our intention to irrefutably reject the alpha inhibition hypothesis. Rather, our aim was to revise and expand it. If our phrasing implied otherwise, we have now clarified this in the manuscript. Specifically, we propose that alpha oscillations:

      (a) Exhibit cyclic inhibitory and excitatory dynamics;

      (b) Regulate processing by modulating transfer pathways, which can result in either inhibition or facilitation depending on the network context.

      In our study, we did not observe suppression of distractor transfer, likely due to the engagement of a supramodal system that enhances both auditory and visual excitability. This interpretation is supported by prior findings (e.g., Jacoby et al., 2012), which show increased visual SSEPs under auditory task load, and by Zhigalov et al. (2020), who found no trial-by-trial correlation between alpha power and visual tagging in early visual areas, despite a general association with attention.

      Recent evidence (Clausner et al., 2024; Yang et al., 2024) further supports the notion that alpha oscillations serve multiple functional roles depending on the network involved. These roles include intra- and inter-cortical signal transmission, distractor inhibition, and enhancement of downstream processing (Scheeringa et al., 2012; Bastos et al., 2015; Zumer et al., 2014). We believe the most plausible account is that alpha oscillations support both functions, depending on context.

      To reflect this more clearly, we have updated Figure 1 to present a broader signal-transfer framework for alpha oscillations, beyond the specific scenario tested in this study.

      We have now revised Figure 1 and several sentences in the introduction and discussion, to clarify this argument.

      L35-37: Previous research gave rise to the prominent alpha inhibition hypothesis, which suggests that oscillatory activity in the alpha range (~10 Hz) plays a mechanistic role in selective attention through functional inhibition of irrelevant cortical areas (see Fig. 1; Foxe et al., 1998; Jensen & Mazaheri, 2010; Klimesch et al., 2007).

      L60-65: In contrast, we propose that functional and inhibitory effects of alpha modulation, such as distractor inhibition, are exhibited through blocking or facilitating signal transmission to higher order areas (Peylo et al., 2021; Yang et al., 2023; Zhigalov & Jensen, 2020; Zumer et al., 2014), gating feedforward or feedback communication between sensory areas (see Fig. 1; Bauer et al., 2020; Haegens et al., 2015; Uemura et al., 2021).

      L482-485: This suggests that responsiveness of the visual stream was not inhibited when attention was directed to auditory processing and was not inhibited by occipital alpha activity, which directly contradicts the proposed mechanism behind the alpha inhibition hypothesis.

      L517-519: Top-down cued changes in alpha power have now been widely viewed to play a functional role in directing attention: the processing of irrelevant information is attenuated by increasing alpha power in areas involved with processing this information (Foxe, Simpson, & Ahlfors, 1998; Hanslmayr et al., 2007; Jensen & Mazaheri, 2010).

      L566-569: As such, it is conceivable that alpha oscillations can in some cases inhibit local transmission, while in other cases, depending on network location, connectivity and demand, alpha oscillation can facilitate signal transmission. This mechanism allows to increase transmission of relevant information and to block transmission of distractors.

      (4) In the abstract and Figure 1, the authors claim an alternative function for alpha oscillations; that alpha "orchestrates signal transmission to later stages of the processing stream." In support, the authors cite their result showing that increased alpha activity originating from early visual cortex is related to enhanced visual processing in higher visual areas and association areas. This does not constitute a strong support for the alternative hypothesis. The correlation between posterior alpha power and frequency-tagged activity was not specific in any way; Fig. 10 shows that the correlation appeared on both 1) anticipating-auditory and anticipating-visual trials, 2) the visual tagged frequency and the auditory tagged activity, and 3) was not specific to the visual processing stream. Thus, the data is more parsimonious with a correlation than a causal relationship between posterior alpha and visual processing.

      Again, the reviewer raises important points, which we want to address

      The correlation between posterior alpha power and frequency-tagged activity was not specific, as it is present both when auditory and visual targets are expected:

      If there is a connection between posterior alpha activity and higher-order visual information transfer, then it can be expected that this relationship remains across conditions and that a higher alpha activity is accompanied by higher frequency-tagged activity, both over trials and over conditions. However, it is possible that when alpha activity is lower, such as when expecting a visual target, the signal-to-noise ratio is affected, which may lead to higher difficulty to find a correlation effect in the data when using non-invasive measurements.

      The connection between alpha activity and frequency-tagged activity appears both for auditory as well as visual stimuli and The correlation is not specific to the visual processing stream:

      While we do see differences between conditions (e.g. in the EEG-analysis, mostly 36 Hz correlated with alpha activity and only in one condition 40 Hz showed a correlation as well), it is true that in our MEG analysis, we found correlations both between alpha activity and 36 Hz as well as alpha activity and 40 Hz.  

      We acknowledge that when analysing frequency-tagged activity on a trial-by-trial basis, where removal of non-timelocked activity through averaging (which we did when we tested for condition differences in Fig. 4 and 9) is not possible, there is uncertainty in the data. Baseline-correction can alleviate this issue, but it cannot offset the possibility of non-specific effects. We therefore decided to repeat the analysis with a fast-fourier calculated power instead of the Hilbert power, in favour of a higher and stricter frequency-resolution, as we averaged over a time-period and thus, the time-domain was not relevant for this analysis. In this more conservative analysis, we can see that only 36 Hz tagged activity when expecting an auditory target correlated with early visual alpha activity.

      Additionally, we added correlation analyses between alpha activity and frequency-tagged activity within early visual areas, using the sensor cluster which showed significant condition differences in alpha activity. Here, no correlations between frequency-tagged activity and alpha activity could be found (apart from a small correlation with 40 Hz which could not be confirmed by a median split; see SUPPL Fig. 14 C). The absence of a significant correlation between early visual alpha and frequency-tagged activity has previously been described by others (Zhigalov & Jensen, 2020) and a Bayes factor of below 1 also indicated that the alternative hypotheses is unlikely.

      Nonetheless, a correlation with auditory signal is possible and could be explained in different ways. For example, it could be that very early auditory feedback in early visual cortex (see for example Brang et al., 2022) is transmitted alongside visual information to higher-order areas. Several studies have shown that alpha activity and visual as well as auditory processing are closely linked together (Bauer et al., 2020; Popov et al., 2023). Inference on whether or how this link could play out in the case of this manuscript expands beyond the scope of this study.

      To summarize, we believe the fact that 36 Hz activity within early visual areas does not correlate with alpha activity on a trial-by-trial basis, but that 36 Hz activity in other areas does, provides strong evidence that alpha activity affects down-stream signal processing.

      We mention this analysis now in our discussion:

      L533-536: Our data provides evidence in favour of this view, as we can show that early sensory alpha activity does not covary over trials with SSEP magnitude in early visual areas, but covaries instead over trials with SSEP magnitude in higher order sensory areas (see also SUPPL. Fig. 14).

      Reviewer #1 (Recommendations for the authors):

      The evidence for the alternative hypothesis, that alpha in early sensory areas orchestrates downstream signal transmission, is not strong enough to be described up front in the abstract and Figure 1. I would leave it in the Discussion section, but advise against mentioning it in the abstract and Figure 1.

      We appreciate the reviewer’s concern regarding the inclusion of the alternative hypothesis—that alpha activity in early sensory areas orchestrates downstream signal transmission—in the abstract and Figure 1. While we agree that this interpretation is still developing, recent studies (Keitel et al., 2025; Clausner et al., 2024; Yang et al., 2024) provide growing support for this framework.

      In response, we have revised the introduction, discussion, and Figure 1 to clarify that our intention is not to outright dismiss the alpha inhibition hypothesis, but to refine and expand it in light of new data. This revision does not invalidate the prior literature on alpha timing and inhibition; rather, it proposes an updated mechanism that may better account for observed effects.

      We have though retained Figure 1, as it visually contextualizes the broader theoretical landscape. while at the same time added further analyses to strengthen our empirical support for this emerging view.

      References:

      Bastos, A. M., Litvak, V., Moran, R., Bosman, C. A., Fries, P., & Friston, K. J. (2015). A DCM study of spectral asymmetries in feedforward and feedback connections between visual areas V1 and V4 in the monkey. NeuroImage, 108, 460–475. https://doi.org/10.1016/j.neuroimage.2014.12.081

      Bauer, A. R., Debener, S., & Nobre, A. C. (2020). Synchronisation of Neural Oscillations and Cross-modal Influences. Trends in cognitive sciences, 24(6), 481–495. https://doi.org/10.1016/j.tics.2020.03.003

      Brang, D., Plass, J., Sherman, A., Stacey, W. C., Wasade, V. S., Grabowecky, M., Ahn, E., Towle, V. L., Tao, J. X., Wu, S., Issa, N. P., & Suzuki, S. (2022). Visual cortex responds to sound onset and offset during passive listening. Journal of neurophysiology, 127(6), 1547–1563. https://doi.org/10.1152/jn.00164.2021

      Clausner T., Marques J., Scheeringa R. & Bonnefond M (2024). Feature specific neuronal oscillations in cortical layers BioRxiv :2024.07.31.605816. https://doi.org/10.1101/2024.07.31.605816

      Diederich, A., & Colonius, H. (2008). When a high-intensity "distractor" is better then a low-intensity one: modeling the effect of an auditory or tactile nontarget stimulus on visual saccadic reaction time. Brain research, 1242, 219–230. https://doi.org/10.1016/j.brainres.2008.05.081

      Haegens, S., Nácher, V., Luna, R., Romo, R., & Jensen, O. (2011). α-Oscillations in the monkey sensorimotor network influence discrimination performance by rhythmical inhibition of neuronal spiking. Proceedings of the National Academy of Sciences of the United States of America, 108(48), 19377–19382. https://doi.org/10.1073/pnas.1117190108

      Jacoby, O., Hall, S. E., & Mattingley, J. B. (2012). A crossmodal crossover: opposite effects of visual and auditory perceptual load on steady-state evoked potentials to irrelevant visual stimuli. NeuroImage, 61(4), 1050–1058. https://doi.org/10.1016/j.neuroimage.2012.03.040

      Keitel, A., Keitel, C., Alavash, M., Bakardjian, K., Benwell, C. S. Y., Bouton, S., Busch, N. A., Criscuolo, A., Doelling, K. B., Dugue, L., Grabot, L., Gross, J., Hanslmayr, S., Klatt, L.-I., Kluger, D. S., Learmonth, G., London, R. E., Lubinus, C., Martin, A. E., … Kotz, S. A. (2025). Brain rhythms in cognition – controversies and future directions. ArXiv. https://doi.org/10.48550/arXiv.2507.15639

      Nickerson R. S. (1973). Intersensory facilitation of reaction time: energy summation or preparation enhancement?. Psychological review, 80(6), 489–509. https://doi.org/10.1037/h0035437

      Popov, T., Gips, B., Weisz, N., & Jensen, O. (2023). Brain areas associated with visual spatial attention display topographic organization during auditory spatial attention. Cerebral cortex (New York, N.Y. : 1991), 33(7), 3478–3489. https://doi.org/10.1093/cercor/bhac285

      Salagovic, C. A., & Leonard, C. J. (2021). A nonspatial sound modulates processing of visual distractors in a flanker task. Attention, perception & psychophysics, 83(2), 800–809. https://doi.org/10.3758/s13414-020-02161-5

      Scheeringa, R., Petersson, K. M., Kleinschmidt, A., Jensen, O., & Bastiaansen, M. C. (2012). EEG α power modulation of fMRI resting-state connectivity. Brain connectivity, 2(5), 254–264. https://doi.org/10.1089/brain.2012.0088

      Spaak, E., Bonnefond, M., Maier, A., Leopold, D. A., & Jensen, O. (2012). Layer-specific entrainment of γ-band neural activity by the α rhythm in monkey visual cortex. Current biology : CB, 22(24), 2313–2318. https://doi.org/10.1016/j.cub.2012.10.020

      Yang, X., Fiebelkorn, I. C., Jensen, O., Knight, R. T., & Kastner, S. (2024). Differential neural mechanisms underlie cortical gating of visual spatial attention mediated by alpha-band oscillations. Proceedings of the National Academy of Sciences of the United States of America, 121(45), e2313304121. https://doi.org/10.1073/pnas.2313304121

      Zhigalov, A., & Jensen, O. (2020). Alpha oscillations do not implement gain control in early visual cortex but rather gating in parieto-occipital regions. Human brain mapping, 41(18), 5176–5186. https://doi.org/10.1002/hbm.25183

      Zumer, J. M., Scheeringa, R., Schoffelen, J. M., Norris, D. G., & Jensen, O. (2014). Occipital alpha activity during stimulus processing gates the information flow to object-selective cortex. PLoS biology, 12(10), e1001965. https://doi.org/10.1371/journal.pbio.1001965

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In their paper, Zhan et al. have used Pf genetic data from simulated data and Ghanaian field samples to elucidate a relationship between multiplicity of infection (MOI) (the number of distinct parasite clones in a single host infection) and force of infection (FOI). Specifically, they use sequencing data from the var genes of Pf along with Bayesian modeling to estimate MOI individual infections and use these values along with methods from queueing theory that rely on various assumptions to estimate FOI. They compare these estimates to known FOIs in a simulated scenario and describe the relationship between these estimated FOI values and another commonly used metric of transmission EIR (entomological inoculation rate).

      This approach does fill an important gap in malaria epidemiology, namely estimating the force of infection, which is currently complicated by several factors including superinfection, unknown duration of infection, and highly genetically diverse parasite populations. The authors use a new approach borrowing from other fields of statistics and modeling and make extensive efforts to evaluate their approach under a range of realistic sampling scenarios. However, the write-up would greatly benefit from added clarity both in the description of methods and in the presentation of the results. Without these clarifications, rigorously evaluating whether the author's proposed method of estimating FOI is sound remains difficult. Additionally, there are several limitations that call into question the stated generalizability of this method that should at minimum be further discussed by authors and in some cases require a more thorough evaluation.

      Major comments:

      (1) Description and evaluation of FOI estimation procedure.

      a. The methods section describing the two-moment approximation and accompanying appendix is lacking several important details. Equations on lines 891 and 892 are only a small part of the equations in Choi et al. and do not adequately describe the procedure notably several quantities in those equations are never defined some of them are important to understand the method (e.g. A, S as the main random variables for inter-arrival times and service times, aR and bR which are the known time average quantities, and these also rely on the squared coefficient of variation of the random variable which is also never introduced in the paper). Without going back to the Choi paper to understand these quantities, and to understand the assumptions of this method it was not possible to follow how this works in the paper. At a minimum, all variables used in the equations should be clearly defined. 

      We thank the reviewer for this useful comment. We plan to clarify the method, including all the relevant variables in our revised manuscript. The reviewer is correct in pointing out that there are more sections and equations in Choi et al., including the derivation of an exact expression for the steady-state queue-length distribution and the two-moment approximation for the queue-length distribution. Since only the latter was directly utilized in our work, we included in the first version of our manuscript only material on this section and not the other. We agree with the reviewer on readers benefiting from additional information on the derivation of the exact expression for the steady-state queue-length distribution. Therefore, we will summarize the derivation of this expression in our revised manuscript. Regarding the assumptions of the method we applied, especially those for going from the exact expression to the two-moment approximation, we did describe these in the Materials and Methods of our manuscript. We recognize from this comment that the writing and organization of this information may not have been sufficiently clear. We had separated the information on this method into two parts, with the descriptive summary placed in the Materials and Methods and the equations or mathematical formula placed in the Appendix. This can make it difficult for readers to connect the two parts and remember what was introduced earlier in the Materials and Methods when reading the equations and mathematical details in the Appendix. For our revised manuscript, we plan to cover both parts in the Materials and Methods, and to provide more of the technical details in one place, which will be easier to understand and follow.

      b. Additionally, the description in the main text of how the queueing procedure can be used to describe malaria infections would benefit from a diagram currently as written it's very difficult to follow. 

      We thank the reviewer for this suggestion. We will add a diagram illustrating the connection between the queueing procedure and malaria transmission.

      c. Just observing the box plots of mean and 95% CI on a plot with the FOI estimate (Figures 1, 2, and 10-14) is not sufficient to adequately assess the performance of this estimator. First, it is not clear whether the authors are displaying the bootstrapped 95%CIs or whether they are just showing the distribution of the mean FOI taken over multiple simulations, and then it seems that they are also estimating mean FOI per host on an annual basis. Showing a distribution of those per-host estimates would also be helpful. Second, a more quantitative assessment of the ability of the estimator to recover the truth across simulations (e.g. proportion of simulations where the truth is captured in the 95% CI or something like this) is important in many cases it seems that the estimator is always underestimating the true FOI and may not even contain the true value in the FOI distribution (e.g. Figure 10, Figure 1 under the mid-IRS panel). But it's not possible to conclude one way or the other based on this visualization. This is a major issue since it calls into question whether there is in fact data to support that these methods give good and consistent FOI estimates. 

      There appears to be some confusion on what we display in some key figures. We will clarify this further both here and in the revised text. In Figures 1, 2, and 10-14, we displayed the bootstrapped distributions including the 95% CIs. These figures do not show the distribution of the mean FOI taken over multiple simulations. We estimated mean FOI on an annual basis per host in the following sense. Both of our proposed methods require either a steady-state queue length distribution, or moments of this distribution for FOI inference. However, we only have one realization or observation for each individual host, and we do not have access to either the time-series observation of a single individual’s MOI or many realizations of a single individual’s MOI at the same sampling time. This is typically the case for empirical data, although numerical simulations could circumvent this limitation and generate such output. Nonetheless, we do have a queue length distribution at the population level for both the simulation output and the empirical data, which can be obtained by simply aggregating MOI estimates across all sampled individuals. We use this population-level queue length distribution to represent and approximate the steady-state queue length distribution at the individual level. Such representation or approximation does not consider explicitly any individual heterogeneity due to biology or transmission. The estimated FOI is per host in the sense of representing the FOI experienced by an individual host whose queue length distribution is approximated from the collection of all sampled individuals. The true FOI per host per year in the simulation output is obtained from dividing the total FOI of all hosts per year by the total number of all hosts. Therefore, our estimator, combined with the demographic information on population size, is for the total number of Plasmodium falciparum infections acquired by all individual hosts in the population of interest per year.

      We evaluated the impact of individual heterogeneity on FOI inference by introducing individual heterogeneity into the simulations. With a considerable amount of transmission heterogeneity across individuals (namely 2/3 of the population receiving more than 90% of all bites whereas the remaining 1/3 receives the rest of the bites), our two methods exhibit a similar performance than those of the homogeneous transmission scenarios.

      Concerning the second point, we will add a quantitative assessment of the ability of the estimator to recover the truth across simulations and include this information in the legend of each figure. In particular, we will provide the proportion of simulations where the truth is captured by the entire bootstrap distribution, in addition to some measure of relative deviation, such as the relative difference between the true FOI value and the median of the bootstrap distribution for the estimate. This assessment will be a valuable addition, but please note that the comparisons we have provided in a graphical way do illustrate the ability of the methods to estimate “sensible” values, close to the truth despite multiple sources of errors. “Close” is here relative to the scale of variation of FOI in the field and to the kind of precision that would be useful in an empirical context. From a practical perspective based on the potential range of variation of FOI, the graphical results already illustrate that the estimated distributions would be informative.

      d. Furthermore the authors state in the methods that the choice of mean and variance (and thus second moment) parameters for inter-arrival times are varied widely, however, it's not clear what those ranges are there needs to be a clear table or figure caption showing what combinations of values were tested and which results are produced from them, this is an essential component of the method and it's impossible to fully evaluate its performance without this information. This relates to the issue of selecting the mean and variance values that maximize the likelihood of observing a given distribution of MOI estimates, this is very unclear since no likelihoods have been written down in the methods section of the main text, which likelihood are the authors referring to, is this the probability distribution of the steady state queue length distribution? At other places the authors refer to these quantities as Maximum Likelihood estimators, how do they know they have found the MLE? There are no derivations in the manuscript to support this. The authors should specify the likelihood and include in an appendix an explanation of why their estimation procedure is in fact maximizing this likelihood, preferably with evidence of the shape of the likelihood, and how fine the grid of values they tested is for their mean and variance since this could influence the overall quality of the estimation procedure. 

      We thank the reviewer for pointing out these aspects of the work that can be further clarified. We will specify the ranges for the choice of mean and variance parameters for inter-arrival times as well as the grid of values tested in the corresponding figure caption or in a separate supplementary table. We maximized the likelihood of observing the set of individual MOI estimates in a sampled population given steady queue length distributions (with these distributions based on the two-moment approximation method for different combinations of the mean and variance of inter-arrival times). We will add a section to either the Materials and Methods or the Appendix in our revised manuscript including an explicit formulation of the likelihood.

      We will add example figures on the shape of the likelihood to the Appendix. We will also test how choices of the grid of values influence the overall quality of the estimation procedure. Specifically, we will further refine the grid of values to include more points and examine whether the results of FOI inference are consistent and robust against each other.

      (2) Limitation of FOI estimation procedure.

      a. The authors discuss the importance of the duration of infection to this problem. While I agree that empirically estimating this is not possible, there are other options besides assuming that all 1-5-year-olds have the same duration of infection distribution as naïve adults co-infected with syphilis. E.g. it would be useful to test a wide range of assumed infection duration and assess their impact on the estimation procedure. Furthermore, if the authors are going to stick to the described method for duration of infection, the potentially limited generalizability of this method needs to be further highlighted in both the introduction, and the discussion. In particular, for an estimated mean FOI of about 5 per host per year in the pre-IRS season as estimated in Ghana (Figure 3) it seems that this would not translate to 4-year-old being immune naïve, and certainly this would not necessarily generalize well to a school-aged child population or an adult population. 

      The reviewer is indeed correct about the difficulty of empirically measuring the duration of infection for 1-5-year-olds, and that of further testing whether these 1-5-year-olds exhibit the same distribution for duration of infection as naïve adults co-infected with syphilis. We will nevertheless continue to use the described method for duration of infection, while better acknowledging and discussing the limitations this aspect of the method introduces. We note that the infection duration from the historical clinical data we have relied on, is being used in the malaria modeling community as one of the credible sources for this parameter of untreated natural infections in malaria-naïve individuals in malaria-endemic settings of Africa (e.g. in the agent-based model OpenMalaria, see 1).

      It is important to emphasize that the proposed methods apply to the MOI estimates for naïve or close to naïve patients. They are not suitable for FOI inference for the school-aged children and the adult populations of high-transmission endemic regions, since individuals in these age classes have been infected many times and their duration of infection is significantly shortened by their immunity. To reduce the degree of misspecification in infection duration and take full advantage of our proposed methods, we will emphasize in the revision the need to prioritize in future data collection and sampling efforts the subpopulation class who has received either no infection or a minimum number of infections in the past, and whose immune profile is close to that of naïve adults, for example, infants. This emphasis is aligned with the top priority of all intervention efforts in the short term, which is to monitor and protect the most vulnerable individuals from severe clinical symptoms and death.

      Also, force of infection for naïve hosts is a key basic parameter for epidemiological models of a complex infectious disease such as falciparum malaria, whether for agent-based formulations or equation-based ones. This is because force of infection for non-naïve hosts is typically a function of their immune status and the force of infection of naïve hosts. Thus, knowing the force of infection of naïve hosts can help parameterize and validate these models by reducing degrees of freedom.

      b. The evaluation of the capacity parameter c seems to be quite important and is set at 30, however, the authors only describe trying values of 25 and 30, and claim that this does not impact FOI inference, however it is not clear that this is the case. What happens if the carrying capacity is increased substantially? Alternatively, this would be more convincing if the authors provided a mathematical explanation of why the carrying capacity increase will not influence the FOI inference, but absent that, this should be mentioned and discussed as a limitation. 

      Thank you for this question. We will investigate more values of the parameter c systematically, including substantially higher ones. We note however that this quantity is the carrying capacity of the queuing system, or the maximum number of blood-stage strains that an individual human host can be co-infected with. We do have empirical evidence for the value of the latter being around 20 (2). This observed value provides a lower bound for parameter c. To account for potential under-sampling of strains, we thus tried values of 25 and 30 in the first version of our manuscript.

      In general, this parameter influences the steady-state queue length distribution based on the two-moment approximation, more specifically, the tail of this distribution when the flow of customers/infections is high. Smaller values of parameter c put a lower cap on the maximum value possible for the queue length distribution. The system is more easily “overflowed”, in which case customers (or infections) often find that there is no space available in the queuing system/individual host upon their arrival. These customers (or infections) will not increment the queue length. The parameter c has therefore a small impact for the part of the grid resulting in low flows of customers/infection, for which the system is unlikely to be overflowed. The empirical MOI distribution centers around 4 or 5 with most values well below 10, and only a small fraction of higher values between 15-20 (2). When one increases the value of c, the part of the grid generating very high flows of customers/infections results in queue length distributions with a heavy tail around large MOI values that are not supported by the empirical distribution. We therefore do not expect that substantially higher values for parameter c would change either the relative shape of the likelihood or the MLE.

      Reviewer #2 (Public Review):

      Summary:

      The authors combine a clever use of historical clinical data on infection duration in immunologically naive individuals and queuing theory to infer the force of infection (FOI) from measured multiplicity of infection (MOI) in a sparsely sampled setting. They conduct extensive simulations using agent-based modeling to recapitulate realistic population dynamics and successfully apply their method to recover FOI from measured MOI. They then go on to apply their method to real-world data from Ghana before and after an indoor residual spraying campaign.

      Strengths:

      (1) The use of historical clinical data is very clever in this context. 

      (2) The simulations are very sophisticated with respect to trying to capture realistic population dynamics. 

      (3) The mathematical approach is simple and elegant, and thus easy to understand. 

      Weaknesses: 

      (1) The assumptions of the approach are quite strong and should be made more clear. While the historical clinical data is a unique resource, it would be useful to see how misspecification of the duration of infection distribution would impact the estimates. 

      We thank the reviewer for bringing up the limitation of our proposed methods due to their reliance on a known and fixed duration of infection from historical clinical data. Please see our response to reviewer 1 comment 2a.

      (2) Seeing as how the assumption of the duration of infection distribution is drawn from historical data and not informed by the data on hand, it does not substantially expand beyond MOI. The authors could address this by suggesting avenues for more refined estimates of infection duration. 

      We thank the reviewer for pointing out a potential improvement to the work. We acknowledge that FOI is inferred from MOI, and thus is dependent on the information contained in MOI. FOI reflects risk of infection, is associated with risk of clinical episodes, and can relate local variation in malaria burden to transmission better than other proxy parameters for transmission intensity. It is possible that MOI can be as informative as FOI when one regresses the risk of clinical episodes and local variation in malaria burden with MOI. But MOI by definition is a number and not a rate parameter. FOI for naïve hosts is a key basic parameter for epidemiological models. This is because FOI of non-naïve hosts is typically a function of their immune status and the FOI of naïve hosts. Thus, knowing the FOI of naïve hosts can help parameterize and validate these models by reducing degrees of freedom. In this sense, we believe the transformation from MOI to FOI provides a useful step.

      Given the difficulty of measuring infection duration, estimating infection duration and FOI simultaneously appears to be an attractive alternative, as the referee pointed out. This will require however either cohort studies or more densely sampled cross-sectional surveys due to the heterogeneity in infection duration across a multiplicity of factors. These kinds of studies have not been, and will not be, widely available across geographical locations and time. This work aims to utilize more readily available data, in the form of sparsely sampled single-time-point cross-sectional surveys.

      (3) It is unclear in the example how their bootstrap imputation approach is accounting for measurement error due to antimalarial treatment. They supply two approaches. First, there is no effect on measurement, so the measured MOI is unaffected, which is likely false and I think the authors are in agreement. The second approach instead discards the measurement for malaria-treated individuals and imputes their MOI by drawing from the remaining distribution. This is an extremely strong assumption that the distribution of MOI of the treated is the same as the untreated, which seems unlikely simply out of treatment-seeking behavior. By imputing in this way, the authors will also deflate the variability of their estimates. 

      We thank the reviewer for pointing out aspects of the work that can be further clarified. It is difficult to disentangle the effect of drug treatment on measurement, including infection status, MOI, and duration of infection. Thus, we did not attempt to address this matter explicitly in the original version of our manuscript. Instead, we considered two extreme scenarios which bound reality, well summarized by the reviewer. First, if drug treatment has had no impact on measurement, the MOI of the drug-treated 1-5-year-olds would reflect their true underlying MOI. We can then use their MOI directly for FOI inference. Second, if the drug treatment had a significant impact on measurement, i.e., if it completely changed the infection status, MOI, and duration infection of drug-treated 1-5-year-olds, we would need to either exclude those individuals’ MOI or impute their true underlying MOI. We chose to do the latter in the original version of the manuscript. If those 1-5-year-olds had not received drug treatment, they would have had similar MOI values than those of the non-treated 1-5-year-olds. We can then impute their MOI by sampling from the MOI estimates of non-treated 1-5-year-olds.

      The reviewer is correct in pointing out that this imputation does not add additional information and can potentially deflate the variability of MOI distributions, compared to simply throwing or excluding those drug-treated 1-5-year-olds from the analysis. Thus, we can include in our revision FOI estimates with the drug-treated 1-5-year-olds excluded in the estimation.

      - For similar reasons, their imputation of microscopy-negative individuals is also questionable, as it also assumes the same distributions of MOI for microscopy-positive and negative individuals. 

      We imputed the MOI values of microscopy-negative but PCR-positive 1-5-year-olds by sampling from the microscopy-positive 1-5-year-olds, effectively assuming that both have the same, or similar, MOI distributions. We did so because there is a weak relationship in our Ghana data between the parasitemia level of individual hosts and their MOI (or detected number of var genes, on the basis of which the MOI values themselves were estimated). Parasitemia levels underlie the difference in detection sensitivity of PCR and microscopy.

      We will elaborate on this matter in our revised manuscript and include information from our previous and on-going work on the weak relationship between MOI/the number of var genes detected within an individual host and their parasitemia levels. We will also discuss potential reasons or hypotheses for this pattern.

      Reviewer #3 (Public Review):

      Summary: 

      It has been proposed that the FOI is a method of using parasite genetics to determine changes in transmission in areas with high asymptomatic infection. The manuscript attempts to use queuing theory to convert multiplicity of infection estimates (MOI) into estimates of the force of infection (FOI), which they define as the number of genetically distinct blood-stage strains. They look to validate the method by applying it to simulated results from a previously published agent-based model. They then apply these queuing theory methods to previously published and analysed genetic data from Ghana. They then compare their results to previous estimates of FOI. 

      Strengths: 

      It would be great to be able to infer FOI from cross-sectional surveys which are easier and cheaper than current FOI estimates which require longitudinal studies. This work proposes a method to convert MOI to FOI for cross-sectional studies. They attempt to validate this process using a previously published agent-based model which helps us understand the complexity of parasite population genetics. 

      Weaknesses: 

      (1) I fear that the work could be easily over-interpreted as no true validation was done, as no field estimates of FOI (I think considered true validation) were measured. The authors have developed a method of estimating FOI from MOI which makes a number of biological and structural assumptions. I would not call being able to recreate model results that were generated using a model that makes its own (probably similar) defined set of biological and structural assumptions a validation of what is going on in the field. The authors claim this at times (for example, Line 153 ) and I feel it would be appropriate to differentiate this in the discussion. 

      We thank the reviewer for this comment, although we think there is a mis-understanding on what can and cannot be practically validated in the sense of a “true” measure of FOI that would be free from assumptions for a complex disease such as malaria. We would not want the results to be over-interpreted and will extend the discussion of what we have done to test the methods. We note that for the performance evaluation of statistical methods, the use of simulation output is quite common and often a necessary and important step. In some cases, the simulation output is generated by dynamical models, whereas in others, by purely descriptive ones. All these models make their own assumptions which are necessarily a simplification of reality. The stochastic agent-based model (ABM) of malaria transmission utilized in this work has been shown to reproduce several important patterns observed in empirical data from high-transmission regions, including aspects of strain diversity which are not represented in simpler models.

      In what sense this ABM makes a set of biological and structural assumptions which are “probably similar” to those of the queuing methods we present, is not clear to us. We agree that relying on models whose structural assumptions differ from those of a given method or model to be tested, is the best approach. Our proposed methods for FOI inference based on queuing theory rely on the duration of infection distribution and the MOI distribution among sampled individuals, both of which can be direct outputs from the ABM. But these methods are agnostic on the specific mechanisms or biology underlying the regulation of duration and MOI.

      Another important point raised by this comment is what would be the “true” FOI value against which to validate our methods. Empirical MOI-FOI pairs for FOI measured directly by tracking cohort studies are still lacking. There are potential measurement errors for both MOI and FOI because the polymorphic markers typically used in different cohort studies cannot differentiate hyper-diverse antigenic strains fully and well (5). Also, these cohort studies usually start with drug treatment. Alternative approaches do not provide a measure of true FOI, in the sense of the estimation being free from assumptions. For example, one approach would be to fit epidemiological models to densely sampled/repeated cross-sectional surveys for FOI inference. In this case, no FOI is measured directly and further benchmarked against fitted FOI values. The evaluation of these models is typically based on how well they can capture other epidemiological quantities which are more easily sampled or measured, including prevalence or incidence. This is similar to what is done in this work. We selected the FOI values that maximize the likelihood of observing the given distribution of MOI estimates. Furthermore, we paired our estimated FOI value for the empirical data from Ghana with another independently measured quantity EIR (Entomological Inoculation Rate), typically used in the field as a measure of transmission intensity. We check whether the resulting FOI-EIR point is consistent with the existing set of FOI-EIR pairs and the relationship between these two quantities from previous studies. We acknowledge that as for model fitting approaches for FOI inference, our validation is also indirect for the field data.

      Prompted by the reviewer’s comment, we will discuss this matter in more detail in our revised manuscript, including clarifying further certain basic assumptions of our agent-based model, emphasizing the indirect nature of the validation with the field data and the existing constraints for such validation.

      (2) Another aspect of the paper is adding greater realism to the previous agent-based model, by including assumptions on missing data and under-sampling. This takes prominence in the figures and results section, but I would imagine is generally not as interesting to the less specialised reader. The apparent lack of impact of drug treatment on MOI is interesting and counterintuitive, though it is not really mentioned in the results or discussion sufficiently to allay my confusion. I would have been interested in understanding the relationship between MOI and FOI as generated by your queuing theory method and the model. It isn't clear to me why these more standard results are not presented, as I would imagine they are outputs of the model (though happy to stand corrected - it isn't entirely clear to me what the model is doing in this manuscript alone). 

      We thank the reviewer for this comment. We will add supplementary figures for the MOI distributions generated by the queuing theory method (i.e., the two-moment approximation method) and our agent-based model in our revised manuscript.

      In the first version of our manuscript, we considered two extreme scenarios which bound the reality, instead of simply assuming that drug treatment does not impact the infection status, MOI, and duration of infection. See our response to reviewer 2 point (3). The resulting FOI estimates differ but not substantially across the two extreme scenarios, partially because drug-treated individuals’ MOI distribution is similar to that of non-treated individuals (or the apparent lack of drug treatment on MOI as pointed by the referee). We will consider potentially adding some formal test to quantify the difference between the two MOI distributions and how significant the difference is. We will discuss which of the two extreme scenarios reality is closer to, given the result of the formal test. We will also discuss in our revision possible reasons/hypotheses underlying the impact of drug treatment on MOI from the perspective of the nature, efficiency, and duration of the drugs administrated.

      Regarding the last point of the reviewer, on understanding the relationship between MOI and FOI, we are not fully clear about what was meant. We are also confused about the statement on what the “model is doing in this manuscript alone”. We interpret the overall comment as the reviewer suggesting a better understanding of the relationship between MOI and FOI, either between their distributions, or the moments of their distributions, perhaps by fitting models including simple linear regression models. This approach is in principle possible, but it is not the focus of this work. It will be equally difficult to evaluate the performance of this alternative approach given the lack of MOI-FOI pairs from empirical settings with directly measured FOI values (from large cohort studies). Moreover, the qualitative relationship between the two quantities is intuitive. Higher FOI values should correspond to higher MOI values. Less variable FOI values should correspond to more narrow or concentrated MOI distributions, whereas more variable FOI values should correspond to more spread-out ones. We will discuss this matter in our revised manuscript.

      (3) I would suggest that outside of malaria geneticists, the force of infection is considered to be the entomological inoculation rate, not the number of genetically distinct blood-stage strains. I appreciate that FOI has been used to explain the latter before by others, though the authors could avoid confusion by stating this clearly throughout the manuscript. For example, the abstract says FOI is "the number of new infections acquired by an individual host over a given time interval" which suggests the former, please consider clarifying. 

      We thank the reviewer for this helpful comment as it is fundamental that there is no confusion on the basic definitions. EIR, the entomological inoculation rate, is closely related to the force of infection but is not equal to it. EIR focuses on the rate of arrival of infectious bites and is measured as such by focusing on the mosquito vectors that are infectious and arrive to bite a given host. Not all these bites result in actual infection of the human host. Epidemiological models of malaria transmission clearly make this distinction, as FOI is defined as the rate at which a host acquires infection. This definition comes from more general models for the population dynamics of infectious diseases in general. (For diseases simpler than malaria, with no super-infection, the typical SIR models define the force of infection as the rate at which a susceptible individual becomes infected).  For malaria, force of infection refers to the number of blood-stage new infections acquired by an individual host over a given time interval. This distinction between EIR and FOI is the reason why studies have investigated their relationship, with the nonlinearity of this relationship reflecting the complexity of the underlying biology and how host immunity influences the outcome of an infectious bite.

      We agree however with the referee that there could be some confusion in our definition resulting from the approach we use to estimate the MOI distribution (which provides the basis for estimating FOI). In particular, we rely on the non-existent to very low overlap of var repertoires among individuals with MOI=1, an empirical pattern we have documented extensively in previous work (See 2, 3, and 4). The method of var_coding and its Bayesian formulation rely on the assumption of negligible overlap. We note that other approaches for estimating MOI (and FOI) based on other polymorphic markers, also make this assumption (reviewed in _5). Ultimately, the FOI we seek to estimate is the one defined as specified above and in both the abstract and introduction, consistent with the epidemiological literature. We will include clarification in the introduction and discussion of this point in the revision.

      (4) Line 319 says "Nevertheless, overall, our paired EIR (directly measured by the entomological team in Ghana (Tiedje et al., 2022)) and FOI values are reasonably consistent with the data points from previous studies, suggesting the robustness of our proposed methods". I would agree that the results are consistent, given that there is huge variation in Figure 4 despite the transformed scales, but I would not say this suggests a robustness of the method. 

      We will modify the relevant sentences to use “consistent” instead of “robust”.

      (5) The text is a little difficult to follow at times and sometimes requires multiple reads to understand. Greater precision is needed with the language in a few situations and some of the assumptions made in the modelling process are not referenced, making it unclear whether it is a true representation of the biology. 

      We thank the reviewer for this comment. As also mentioned in the response to reviewer 1’s comments, we will reorganize and rewrite parts of the text in our revision to improve clarity.

      References and Notes

      (1)   Maire, N. et al. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg., 75(2 Suppl):19-31 (2006).

      (2)   Tiedje, K. E. et al. Measuring changes in Plasmodium falciparum census population size in response to sequential malaria control interventions. eLife, 12 (2023).

      (3)   Day, K. P. et al. Evidence of strain structure in Plasmodium falciparum var gene repertoires in children from Gabon, West Africa. Proc. Natl. Acad. Sci. U.S.A., 114(20), 4103-4111 (2017).

      (4)   Ruybal-Pesántez, S. et al. Population genomics of virulence genes of Plasmodium falciparum in clinical isolates from Uganda. Sci. Rep., 7(11810) (2017).

      (5)   Labbé, F. et al. Neutral vs. non-neutral genetic footprints of Plasmodium falciparum multiclonal infections. PLoS Comput Biol 19(1) (2023).

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      The authors have adequately responded to all comments.

      We thank Reviewer 1 for their positive assessment of our previous round of revisions.

      Reviewer #2 (Public review):

      Summary:

      The authors combine a clever use of historical clinical data on infection duration in immunologically naive individuals and queuing theory to infer the force of infection (FOI) from measured multiplicity of infection (MOI) in a sparsely sampled setting. They conduct extensive simulations using agent based modeling to recapitulate realistic population dynamics and successfully apply their method to recover FOI from measured MOI. They then go on to apply their method to real world data from Ghana before and after an indoor residual spraying campaign.

      Strengths:

      - The use of historical clinical data is very clever in this context

      - The simulations are very sophisticated with respect to trying to capture realistic population dynamics

      - The mathematical approach is simple and elegant, and thus easy to understand

      Weakness:

      The assumptions of the approach are quite strong, and the authors have made clear that applicability is constrained to individuals with immune profiles that are similar to malaria naive patients with neurosyphilis. While the historical clinical data is a unique resource and likely directionally correct, it remains somewhat dubious to use the exact estimated values as inputs to other models without extensive sensitivity analysis.

      We thank reviewer 2 for their comments on our previous round of revisions. The statement here that “it remains somewhat dubious to use the exact estimated values as inputs to other models” suggests that we may not have been sufficiently clear on how infection duration is represented in our agent-based model (ABM) of malaria population dynamics. Because our analysis uses simulated outputs from the ABM to validate the performance of the two queuing-theory methods, we believe this point warrants clarification, which we provide below.

      When simulating with the ABM, we do not use empirical estimates of infection duration in immunologically naïve individuals from the historical clinical data as direct inputs. Instead, infection duration emerges from the within-host dynamics modeled in the ABM (lines 800-816, second paragraph of the subsection Within-host dynamics in Appendix 1-Simulation data of the previous revision). Briefly, each Plasmodium falciparum parasite carries approximately 50-60 var genes, each encoding a distinct variant surface antigen expressed during the blood stage of infection. Empirical evidence[1,2] indicates that these var genes are expressed largely sequentially. If a host has previously encountered the antigenic product of a given var gene and retains immunity to it, subject to waning at empirically estimated rates[3,4], the corresponding parasite subpopulation is rapidly cleared. Conversely, if the host is naïve to that gene, it takes approximately seven days for the immune system to mount an effective antibody response, resulting in a rapid decline or elimination of the expressed variant[5]. This seven-day timescale aligns with the duration of each successive parasitemia peak observed in Plasmodium falciparum infections[6,7], each arising primarily from the expression of a single var gene and occasionally from a small number of var genes.

      In our previous analyses, we therefore modeled an average expression duration of seven days per gene in naïve hosts. Specifically, the switching time to the next gene was drawn from an exponential distribution with a mean of seven days. Each var gene is represented as a linear combination of two epitopes (alleles), based on the empirical characterization of two hypervariable regions in the var tag region[8], and immunity is acquired against these alleles. Immunity to one allele of a given gene reduces its average expression duration by approximately half, whereas immunity to both alleles results in an immediate switch to another var gene within the infection. Consequently, the total duration of infection is proportional to the number of unseen alleles by the host across all var genes expressed during that infection (lines 800-816, second paragraph of the subsection Within-host dynamics in Appendix 1-Simulation data of the previous revision).

      Prompted by the reviewer’s comments, in this revision we additionally tested mean expression durations of 7.5 and 8 days per var gene, together with an extension of the within-host rules. These values were applied in combination with the extended within-host rules (see the next paragraph for motivation and details). Although differences among the three mean expression durations are modest at the per-gene level, when aggregated across all var genes expressed within an individual parasite, the resulting total infection duration can differ by on the order of several months. The resulting distributions of infection duration across immunologically naïve individuals and those aged 1-5 years, together with those generated under our previous simulation settings, span a range of means and variances that lies above and below, but encompasses, scenarios comparable to the historical clinical data from naïve neurosyphilis patients treated with P. falciparum malaria. We have provided example supplementary figures illustrating that the distributions of infection duration from the simulated outputs overlap with, and closely resemble, the empirical distribution from the historical clinical data (Appendix 1-Figure 27-32).

      We considered the following modification of the within-host rules. In our previous ABM simulations, we had assumed that an infection would clear only once the parasite had exhausted its entire var gene repertoire, that is, after every var gene had been expressed and recognized. However, biological evidence indicates that clearance can occur earlier for several reasons, including stochastic extinction before full repertoire exhaustion. Even if some var genes remain unexpressed, an infection can terminate due to demographic stochasticity once parasite densities fall to very low levels. This decline in parasite densities may result from non-variant-specific immune mechanisms or from cross-immunity among var genes that share sequence similarity or alleles[9,10,11], both of which can substantially reduce parasite numbers. To model the possibility of termination or clearance before full repertoire exhaustion, we implemented a simple scenario in which there is a small probability of clearing the current infection while a given var gene-whether non-final or final-is being expressed. This probability is a function of the host’s pre-existing immunity to the two epitopes (alleles) of that gene, thereby capturing in a parsimonious manner the effects of cross-immunity among sequence- or allele-sharing var genes in reducing parasitemia. Specifically, it is modeled as a Bernoulli draw whose success probability equals the immunity level against the gene (0 for no immunity to either epitope, 0.5 for immunity to one epitope, and 1 for immunity to both epitopes) multiplied by a constant factor of 0.025. Thus, the probability scales with pre-existing variant-specific immunity to the gene but remains small overall, while introducing additional variance into the emergent distribution of total infection duration across hosts.

      We acknowledge that the ABM used to simulate malaria population dynamics cannot capture all mechanisms and complexities underlying within-host processes, many of which remain poorly understood. However, we emphasize that the resulting distributions of infection duration generated by the ABM span a broad range of means, variances, and shapes, including distributions that closely match those observed in the clinical historical data. Because the queueing-theory methods rely on only the mean and variance of infection duration to estimate the force of infection (FOI), these scenarios, which collectively span and encompass values comparable to the empirical ones, provide an appropriate basis for evaluating the performance of the methods using simulated outputs. We have added supplementary figures (see Appendix 1-Figure 16-22) illustrating the corresponding FOI inference results when we allow for clearance before the complete expression of the var repertoire, and the accuracy of FOI estimation remains comparable across all the scenarios examined.

      Finally, we emphasize that the application of the queuing-theory methods to the simulated outputs and to the Ghana field survey data involve two self-contained steps. For the simulations, FOI is inferred directly from the emergent distributions of infection duration generated by the ABM. For the Ghana surveys, FOI is inferred using the historical clinical data, which remains one of the few credible and widely used empirical sources for infection duration in immunologically naïve individuals[6]. By exploring different mean expression durations and within-host rules in the ABM, which generates distributions of infection duration that span and encompass those comparable to the empirical distribution, we demonstrate that the queueing-theory methods perform comparably across diverse scenarios and are well suited for application to the Ghana field surveys.

      We expanded the section on within-host dynamics in Appendix 1 to elaborate on this point (Lines 817-854).

      Reviewer #3 (Public review):

      I think the authors gave a robust but thorough response to our reviews and made some important changes to the manuscript which certainly clarify things for me.

      We thank Reviewer 3 for their positive feedback on our previous round of revisions.

      References

      (1) Zhang, X. & Deitsch, K. W. The mystery of persistent, asymptomatic Plasmodium falciparum infections. Curr. Opin. Microbiol 70, 102231 (2022).

      (2) Deitsch, K. W. & Dzikowski, R. Variant gene expression and antigenic variation by malaria parasites. Annu. Rev. Microbiol. 71, 625–641 (2017).

      (3) Collins, W. E., Skinner, J. C. & Jeffery, G. M. Studies on the persistence of malarial antibody response. American journal of epidemiology, 87(3), 592–598 (1968).

      (4) Collins, W. E., Jeffery, G. M. & Skinner, J. C. Fluorescent Antibody Studies in Human Malaria. II. Development and Persistence of Antibodies to Plasmodium falciparum. The American journal of tropical medicine and hygiene, 13, 256–260 (1964).

      (5) Gatton, M. L., & Cheng, Q. Investigating antigenic variation and other parasite-host interactions in Plasmodium falciparum infections in naïve hosts. Parasitology, 128(Pt 4), 367–376 (2004).

      (6) Maire, N., Smith, T., Ross, A., Owusu-Agyei, S., Dietz, K., & Molineaux, L. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. The American journal of tropical medicine and hygiene, 75(2 Suppl), 19–31 (2006).

      (7) Chen D. S., Barry A. E., Leliwa-Sytek A., Smith T-A., Peterson I., Brown S. M., et al. A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa. PLoS ONE 6(2): e16629 (2011).

      (8) Larremore D. B., Clauset A., & Buckee C. O. A Network Approach to Analyzing Highly Recombinant Malaria Parasite Genes. PLoS Comput Biol 9(10): e1003268 (2013).

      (9) Holding T. & Recker M. Maintenance of phenotypic diversity within a set of virulence encoding genes of the malaria parasite Plasmodium falciparum. J. R. Soc. Interface.1220150848 (2015).

      (10) Crompton, P. D., Moebius, J., Portugal, S., Waisberg, M., Hart, G., Garver, L. S., Miller, L. H., Barillas-Mury, C., & Pierce, S. K. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annual review of immunology, 32, 157–187 (2014).

      (11) Langhorne, J., Ndungu, F., Sponaas, AM. et al. Immunity to malaria: more questions than answers. Nat Immunol 9, 725–732 (2008).

    1. Author response:

      We thank the three reviewers for their critical and in-depth assessment of our study. Below you find our comments to the public reviews and our revision plans.

      Public Reviews:

      Reviewer #1 (Public review):

      This manuscript adds to the recent, exciting developments in our understanding of the MmpL/S transporters from mycobacteria. This work provides solid support for the trimeric/hexameric arrangement of subunits in the complex, and reveals a possible pathway for substrate translocation.Overall, I think this manuscript is a solid body of work that adds to several recent studies from this team and others on the structure and mechanism of the MmpL/S transporter family, particularly MmpL4/S4. The combination of AF, disulfide engineering, and experimental structure is good, though it is a bit puzzling that the experimental structure based on disulfide stabilization of the AF prediction does not recapitulate key elements (MmpS periplasmic domain docking to MmpL, and altered CCD configuration).

      I have no major concerns about this manuscript.

      We thank reviewer#1 for this positive assessment of our work. The deviation of the AF prediction from the experimental structure is , in our view, not puzzling. AF does not take the physical properties of proteins into account, but predicts structures based on strong sequence alignments. It therefore does not have “knowledge” about the general flexibility of domains such as the CCD, which is also observed in the corresponding MmpL5 structures, nor does it have knowledge about preferred conformational states. Rather than “failing” to confirm the AF predictions, our cryo-EM structure revealed an unexpected tilted conformation of the CCD. As we outline in comments below, the physiological relevance of the tilted CCD is unclear. Its flexibility might be required to interact with (still elusive) outer membrane protein components to form the fully assembled efflux machinery.

      Reviewer #2 (Public review):

      Summary:

      The manuscript describes the structure of the Mycobacterium tuberculosis (MmpS4)3-(MmpL4)3 hetero-heximeric transporter complex. The structure was obtained by cryogenic electron microscopy using an engineered construct that cross-links MmpS4 to MmpL4 via a disulfide bond. The position of the disulfide bond was determined using an Alphafold2 model of the hetero-heximer. Although Alphafold2 predicts a symmetric hetero-heximer, the author found that the structure of the coiled-coil domain (CCD) is asymmetric, tilted at about 60° relative to the membrane domains, and only contains two of the three alpha helical hairpins, with the third being disordered.

      Strengths:

      The strategy of using Alphafold2 models to guide construct design for experimental structure determination is state-of-the-art, and this work provides a great example of its applications and limitations. I.e., the experimental structure does not fully recapitulate the prediction but provides unexpected results.

      The comparisons between the authors' structures and the previously published structures of the MmpL4 monomer and MmpL5 trimers strengthen the authors' findings.

      We thank reviewer#2 for this positive assessment of our work and agree that it is interesting that the experimental structures do not fully agree with the AF predictions (see also comment to reviewer#1).

      Weaknesses:

      A more detailed description of the current mechanistic hypothesis would strengthen the manuscript. The authors state that the two periplasmic domains "are expected to undergo rigid body movements that allow substrate transport through these periplasmic domains similar to the conformational changes observed in the E. coli multidrug efflux pump AcrB". A schematic of the proposed transport cycle, as a supplemental figure that shows the current hypothesis regarding transport, would be beneficial for understanding the previous structures and putting the current structure in context. Outside of "the mechanistic basis of how these conformational changes are coupled to protonation of the DY-pairs", what are the major controversies/open questions regarding the mechanism?

      We thank the reviewer for this valuable comment. We will add a new figure with the model of the MmpL4 transport cycle based on our new data and discuss the proposed molecular transport mechanism in more detail in the main.

      The authors provide evidence that the cysteine-depleted S4L4 construct is functional, but do not show that the construct with the introduced disulfide bond #5 (D39C MmpS4 and S434C MmpL4) is also functional. Demonstrating this would allow the authors to better interpret their resulting structures.

      In the revised version, we will include additional data to assess the functional consequences of cross-linking.

      The analysis presented in Figure 5 and Supplementary Figure 7 seems to suggest that the authors are proposing that the CCD central cavity acts as a transport pathway for the transported substrate, but I am not sure that this hypothesis is explicitly stated. This makes the reasoning behind the analysis presented unclear. Clarity could be improved by stating that the hypothesis of direct transport of substrate through the CCD central channel is being examined using the structure prediction, and what the implications are for the structure solved with the incompletely formed CCD.

      We state clearly in the discussion that the channel through the CCD seems too narrow to let large molecules like mycobactin and bedaquiline pass:[AG1]

      Line 318ff: “ The channel radius of the MmpL4 CCD is very narrow with a minimum of 1.1 Å according to the AlphaFold3 predition (Fig. 5). This is much smaller than the smallest axis of a molecular model of mycobactin molecule of ?? nm as determined from a model of iron-free mycobactin. In addition, the cryo-EM structure of MSMEG_1382 revealed a constriction in the CCD channel [21]. Even though the methionine side chains lining the channel wall are considered to be flexible{Aledo, 2019 #69594}, large conformational changes of the α-helical hairpins relative to each other would be required to allow passage of molecules as large as mycobactin and bedaquiline. The AcrAB-TolC efflux machinery provides an example for such large conformational changes to enable transport of large molecules by iris-like opening and closing movements the outer membrane channel-tunnel TolC [33]. Similar helical twisting may widen the channel of the CCD. Alternatively, it is conceivable that the substrates of MmpL4/MmpL5 are transported along the CCD surface, potentially requiring further protein partners. It is interesting to note that siderophore secretion and drug efflux by MmpL4/MmpL5 systems involves at least two additional proteins, namely the periplasmic protein Rv0455, which was shown to be essential for mycobactin efflux [34] and an outer membrane channel, whose identity remains elusive. A complete molecular understanding of the transport mechanism through the MmpL4/MmpL5 systems hence requires the identification of the missing components and structural information about their interactions.”

      The channel radius of the MmpL4 CCD is very narrow (minimum of 1.1 Å) according to the AlphaFold3 prediction (Fig. 5), and the cryo-EM [AG2] [MN3] structure of MSMEG_1382 revealed a further constriction in the CCD channel [21]. We therefore consider direct substrate transport through the CCD central channel to be physically implausible for molecules of the size of mycobactin and bedaquiline. Even accounting for the flexibility of the methionine side chains lining the channel wall, the large conformational changes of the α-helical hairpins relative to each other would be required to accommodate such large substrates. While iris-like opening movements have been described for TolC in the AcrAB-TolC system [33], those movements widen an already substantially larger channel, and even such dramatic conformational changes would be insufficient to open a channel as narrow as that of the MmpL4 CCD to a diameter permissive for substrate passage. We instead favor a model in which substrates are transported along the outer surface of the CCD, potentially with the assistance of additional protein partners. This is consistent with the observation that MmpL4/MmpL5-mediated siderophore secretion and drug efflux involves at least two further proteins: the periplasmic protein Rv0455, shown to be essential for mycobactin efflux [34], and an as-yet-unidentified outer membrane channel. In this context, the overall flexibility of the CCD - illustrated here by the tilted, incompletely formed conformation - may reflect the conformational dynamics required for interaction with these partner proteins, rather than being directly involved in forming a transport conduit. A complete mechanistic understanding will require identification of the missing components and structural characterization of the fully assembled efflux machinery.

      We do not think that the incompletely formed CCD represents a conformation that is relevant for transport. But it is a demonstration of the overall flexibility of the CCD, which may be required to further open the channel in case the substrates are transported within the CCD tube. Further in-depth experiments will be needed to clarify this interesting question, which is beyond the scope of this paper.

      Given that the results emphasize the flexibility of the CCD, the manuscript would be strengthened by 3D variability analysis either in cryoSPARC or using cryoDRGN (or both). This would allow the authors to better quantify the degree of motion in the CCD and how it may correlate to flexibility in other regions. Further 3D flex reconstruction in cryoSPARC may improve the map quality of the CCD.

      This is a great suggestion. We will include a 3D variability analysisin the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      This manuscript by Earp et al reports cryoEM structures of the hexameric (MmpS4)<sub>3</sub>-(MmpL4) )<sub>3</sub> complex from Mycobacterium tuberculosis, which belongs to the RND family of transporters and is known to have a role in the export of siderophores and contribute to drug resistance. The experimental workflow showcased involves the design of disulfide pairs using distance constraints obtained from the AlphaFold predicted structure of the hexameric complex. One such disulfide pair was used to determine the ~3.0 Å structures. The structure reveals density for the previously unresolved coiled-coil domain (CCD), a tilted CCD arrangement, and a cavity within the periplasmic domain, which the authors assert is occupied by detergent. Comparison of this complex with the monomer structure of MmpL4 shows conformational variations interpreted to implicate different domains and conserved residues involved in proton coupling, which might be related to the transport mechanism. While the methodological aspects of the manuscript are solid, enthusiasm for the overall advance/significance is less so, with doubts about the relevance of the tilted CCD structure, considering disulfide trapping and an incomplete validation of the claim that the titled CCD represents a stable intermediate conformation. A clear, updated transport mechanism is largely missing from the manuscript.

      We thank reviewer#3 for these useful comments, which we will address during the revision of the manuscript. In particular, we plan to include a scheme of an updated transport model.

      Strengths:

      Beautiful structures, AF prediction-experimental validation nexus that could be fine-tuned for different systems/difficult to target complexes.

      Weaknesses:

      Physiological relevance of the tilted CCD conformation. No clear mechanistic model for the transport. While the CCD may indeed be a stable intermediate, the fact that the rest of the trimeric arrangement is unaffected does not fully rule out disulfide trapping as a factor in promoting this. The findings would be strengthened if the same tilted conformation is seen using a different set of disulfides. The significance of the detergent molecule and the new cavity observed could also be better discussed in terms of an updated transport model.

      We believe that there was a misunderstanding about our interpretation of the tilted CCD. As a matter of fact, it must be a stable intermediate, otherwise no density would have been observed for it in the cryo-EM maps. Despite being a stable intermediate, it is indeed unlikely that it represents a conformational state that is relevant/required for transport. Firstly, only the upright, complete CCD can bridge the periplasm. because . Secondly, the structure was determined in detergent and lacks additional protein binder partners, which might stabilize the upright conformation of the CCD . It is also conceivable, as the reviewer pointed out, that disulfide cross-linking may have caused the tilt. However, as we wrote in the manuscript, we do not think that cross-linking caused this striking asymmetry of the CCD, because the three MmpL4 and MmpS4 chains are basically symmetrical in the C1-processed data (see also Figure 2E):

      Line 182 ff: “To assess whether there are asymmetries in other parts of the structure, we superimposed the individual protomers of the (MmpS4)3-(MmpL4)3 complex analyzed using C1 symmetry (Fig. 2E). Apart from the two resolved α-helical hairpins, the MmpL4 core domains and the resolved parts of MmpS4 differ by a RMSD of less than 0.6 Å and are therefore structurally identical considering the map resolution of around 3 Å. The fact that the core domains of MmpS4 and MmpL4 do not deviate between the protomers argues against the possibility that the cross-links established between them cause the (asymmetric) tilt of the CCD.”

      Regarding the DDM binding site, we will indeed include an updated transport model. That said, we wish to be cautious, because we lack experimental proof that MmpL4 can in fact transport DDM.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In "Drift in Individual Behavioral Phenotype as a Strategy for Unpredictable Worlds," Maloney et al. (2024) investigate changes in individual responses over time, referred to as behavioral drift within the lifespan of an animal. Drift, as defined in the paper, complements stable behavioral variation (animal individuality/personality within a lifetime) over shorter timeframes, which the authors associate with an underlying bet-hedging strategy. The third timeframe of behavioral variability that the authors discuss occurs within seasons (across several generations of some insects), termed "adaptive tracking." This division of "adaptive" behavioral variability over different timeframes is intuitively logical and adds valuable depth to the theoretical framework concerning the ecological role of individual behavioral differences in animals.

      Strengths:

      While the theoretical foundations of the study are strong, the connection between the experimental data (Figure 1) and the modeling work (Figure 2-4) is less convincing.

      Weaknesses:

      In the experimental data (Figure 1), the authors describe the changes in behavioral preferences over time. While generally plausible, I identify three significant issues with the experiments:

      (1) All of the subsequent theoretical/simulation data is based on changing environments, yet all the experiments are conducted in unchanging environments. While this may suffice to demonstrate the phenomenon of behavioral instability (drift) over time, it does not properly link to the theory-driven work in changing environments. An experiment conducted in a changing environment and its effects on behavioral drift would improve the manuscript's internal consistency and clarify some points related to (3) below.

      We have added further discussion of this to the discussion section.

      (2) The temporal aspect of behavioral instability. While the analysis demonstrates behavioral instability, the temporal dynamics remain unclear. It would be helpful for the authors to clarify (based on graphs and text) whether the behavioral changes occur randomly over time or follow a pattern (e.g., initially more right turns, then more left turns). A proper temporal analysis and clearer explanations are currently missing from the manuscript.

      We have added a figure (1F to better visualize the changes in handedness over days). We have also pointed out the connection between the power spectrum and the autoregressive model given by the Wiener-Khinchen theorem (which states that the autocorrelation function of a wide-sense stationary process has a spectral decomposition of its power spectrum).

      (3) The temporal dimension leads directly into the third issue: distinguishing between drift and learning (e.g., line 56). In the neutral stimuli used in the experimental data, changes should either occur randomly (drift) or purposefully, as in a neutral environment, previous strategies do not yield a favorable outcome. For instance, the animal might initially employ strategy A, but if no improvement in the food situation occurs, it later adopts strategy B (learning). In changing environments, this distinction between drift and learning should be even more pronounced (e.g., if bananas are available, I prefer bananas; once they are gone, I either change my preference or face negative consequences). Alternatively, is my random choice of grapes the substrate for the learning process towards grapes in a changing environment? Further clarification is needed to resolve these potential conflicts.

      We have discussed this further in the discussion.

      Reviewer #2 (Public review):

      Summary:

      This is an inspired study that merges the concept of individuality with evolutionary processes to uncover a new strategy that diversifies individual behavior that is also potentially evolutionarily adaptive.

      The authors use a time-resolved measurement of spontaneous, innate behavior, namely handedness or turn bias in individual, isogenic flies, across several genetic backgrounds.

      They find that an individual's behavior changes over time, or drifts. This has been observed before, but what is interesting here is that by looking at multiple genotypes, the authors find the amount of drift is consistent within genotype i.e., genetically regulated, and thus not entirely stochastic. This is not in line with what is known about innate, spontaneous behaviors. Normally, fluctuations in behavior would be ascribed to a response to environmental noise. However, here, the authors go on to find what is the pattern or rule that determines the rate of change of the behavior over time within individuals. Using modeling of behavior and environment in the context of evolutionarily important timeframes such as lifespan or reproductive age, they could show when drift is favored over bet-hedging and that there is an evolutionary purpose to behavioral drift. Namely, drift diversifies behaviors across individuals of the same genotype within the timescale of lifespan, so that the genotype's chance for expressing beneficial behavior is optimally matched with potential variation of environment experienced prior to reproduction. This ultimately increases the fitness of the genotype. Because they find that behavioral drift is genetically variable, they argue it can also evolve.

      Strengths:

      Unlike most studies of individuality, in this study, the authors consider the impact of individuality on evolution. This is enabled by the use of multiple natural genetic backgrounds and an appropriately large number of individuals to come to the conclusions presented in the study. I thought it was really creative to study how individual behavior evolves over multiple timescales. And indeed this approach yielded interesting and important insight into individuality. Unlike most studies so far, this one highlights that behavioral individuality is not a static property of an individual, but it dynamically changes. Also, placing these findings in the evolutionary context was beneficial. The conclusion that individual drift and bet-hedging are differently favored over different timescales is, I think, a significant and exciting finding.

      Overall, I think this study highlights how little we know about the fundamental, general concepts behind individuality and why behavioral individuality is an important trait. They also show that with simple but elegant behavioral experiments and appropriate modeling, we could uncover fundamental rules underlying the emergence of individual behavior. These rules may not at all be apparent using classical approaches to studying individuality, using individual variation within a single genotype or within a single timeframe.

      Weaknesses:

      I am unconvinced by the claim that serotonin neuron circuits regulate behavioral drift, especially because of its bidirectional effect and lack of relative results for other neuromodulators. Without testing other neuromodulators, it will remain unclear if serotonin intervention increases behavioral noise within individuals, or if any other pharmacological or genetic intervention would do the same. Another issue is that the amount of drugs that the individuals ingested was not tracked. Variable amounts can result in variable changes in behavior that are more consistent with the interpretation of environmental plasticity, rather than behavioral drift. With the current evidence presented, individual behavior may change upon serotonin perturbation, but this does not necessarily mean that it changes or regulates drift.

      However, I think for the scope of this study, finding out whether serotonin regulates drift or not is less important. I understand that today there is a strong push to find molecular and circuit mechanisms of any behavior, and other peers may have asked for such experiments, perhaps even simply out of habit. Fortunately, the main conclusions derived from behavioral data across multiple genetic backgrounds and the modeling are anyway novel, interesting, and in fact more fundamental than showing if it is serotonin that does it or not.

      We have adjusted our wording and contextualized our claims based on previous literature.

      To this point, one thing that was unclear from the methods section is whether genotypes that were tested were raised in replicate vials and how was replication accounted for in the analyses. This is a crucial point - the conclusion that genotypes have different amounts of behavioral drift cannot be drawn without showing that the difference in behavioral drift does not stem from differences in developmental environment.

      We have reanalyzed the behavioral data in a hierarchical model to account for batch effects. Accounting for batch effects (Fig 1G, S1G) we still observe differences between genotypes and for pharmaceutical manipulations of serotonin, though our data provides more equivocal evidence for the effects of trh<sup>n</sup> on drift.

      Reviewer #3 (Public review):

      Summary:

      The paper begins by analyzing the drift in individual behavior over time. Specifically, it quantifies the circling direction of freely walking flies in an arena. The main takeaway from this dataset is that while flies exhibit an individual turning bias (when averaged over time), their preferences fluctuate over slow timescales.

      To understand whether genetic or neuromodulatory mechanisms influence the drift in individual preference, the authors test different fly strains concluding that both genetic background and the neuromodulator serotonin contribute to the degree of drift.

      Finally, the authors use theoretical approaches to identify the range of environmental conditions under which drift in individual bias supports population growth.

      Strengths:

      The model provides a clear prediction of the environmental fluctuations under which a drift in bias should be beneficial for population growth.

      The approach attempts to identify genetic and neurophysiological mechanisms underlying drift in bias.

      Weaknesses:

      Different behavioral assays are used and are differently analysed, with little discussion on how these behaviors and analyses compare to each other.

      We have added text indicating that these two behavioral responses have previously been shown to be correlated to each other and that the spectral power analysis and autoregressive model are conceptually linked.

      Some of the model assumptions should be made more explicit to better understand which aspects of the behaviors are covered.

      We have added a table in the supplemental clarifying all of the parameters of modeling for each figure.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Highlights of the Consultation Session of 3 Reviewers

      In the consultation session, the reviewers discussed as particularly important the relative contribution of genotype and variable environment. Further analyses of the replicates of the genotypes were suggested to exclude the environment as the source of difference in the extent of drift between genotypes. If the difference in the extent of drift between replicates is greater than the difference in the extent of drift between genotypes, then one cannot really say that there is a genetic control over drift and that it would evolve (which is still an interesting result, but would be less exciting for a follow-up evolution experiment). If replicates differ, testing whether the relative difference in the extent of drift between genotypes is maintained across environments would also be strong evidence that the extent of behavioral drift is a property of a genotype and not a mere result of a fluctuating/variable environment. The authors do present two behavior paradigms that can serve the purpose of comparing the relative extent of drift between genotypes across the two paradigms that they already have. The authors might consider whether experimental data could be brought closer to theory by including an experiment in a variable environment (e.g temp or diet changes etc.).

      Reviewers also agreed in the consultation session that methods and definitions were somewhat cryptic, and it would be very helpful if they were more detailed. For example, linking the free walking analysis to the Ymaze and then the model1 to the model2 was not straightforward.

      We have added text to make more explicit the theoretical connection between the freewalking analysis, the ymaze analysis, and the model. We have added text and a supplemental table to clarify the methods.

      Reviewer #1 (Recommendations for the authors):

      (1) Line 161: The authors state in the supplement that they used DGRP strains, which are inbred and not isogenic. According to the original authors, they possess 99.3% genetic identity. The isoD1 strain has no known crossing scheme, so complete chromosome isogeneity remains questionable, especially after 12 or more years since its creation. The authors should refer to the strains as "near-isogenic" or a similar term.

      We have adjusted the language as suggested to be more accurate.

      (2) Lines 276, 338: The manuscript contains some unfinished sentences or remnants from the drafting process (e.g., "REFREF"). A thorough editorial review is recommended to eliminate such errors.

      We have cleaned up all references and made additional passes to adjust text.

      Reviewer #2 (Recommendations for the authors):

      (1) If the authors want to claim that serotonin is a regulator of drift, they should provide a negative control experiment, using equivalent perturbations of another neuromodulator and non-modulator. Alternatively, they could simply soften the claims revolving around serotonin and its putative direct role in modulating drift.

      We have softened the claims as suggested to avoid claiming our results show a specific role for serotonin.

      (2) I would suggest always using "behavioral drift" when referring to drift, especially in the context of modeling, because it can be easily confused with genetic drift and cause confusion when reading.

      We have adjusted the language throughout the manuscript per this suggestion.

      (3) It would be good to see in the methods if the 2-hour assays were always done at the same time of the fly's subjective day and when (e.g. how many hours after lights on).

      We have clarified this.

      (4) I understand that many experiments use methodology replicated from the group's previous work, but I would recommend elaborating the experimental methods section in the supplementary such that the reader can understand and reproduce the methods without having to sift through and look for them in previous papers.

      We have expanded on our discussion of the methodology in the methods section.

      Reviewer #3 (Recommendations for the authors):

      The paper begins by analyzing the drift in individual behavior over time. Specifically, it quantifies the circling direction of freely walking flies in an arena. The main takeaway from this dataset is that flies exhibit an individual turning bias (when averaged over time), yet their preferences fluctuate over slow timescales. However, it's unclear why the authors chose to switch to a different assay to compare strains. In particular, it's ambiguous whether the behavioral measure in one setup is comparable to that in the other; specifically, whether a bias in one setup reflects the same type of bias in the other. The behavior is also sampled differently across setups (though the details are unclear; see comments below) and analyzed using different methods. Consequently, it remains uncertain whether the slow fluctuations observed in the arena setup are also present in the Y maze. It appears that the analysis of the Y maze data only addresses individual behavioral variance or, at most, day-to-day changes, without accounting for longer-term correlations in bias-which I understood to be the primary interest in the arena setup. Some clarification is needed here (see specific comments below).

      In Figure 2, the authors attempt to show the potential advantage of individual drift for survival in unpredictable, fluctuating environments. They demonstrate that while bet-hedging provides an advantage over timescales matching the generation time (since reproduction is required), it offers less benefit on shorter timescales, where an increased individual drift could be advantageous. This approach is well-conceived, and the findings are convincing, though the model would benefit from further clarification and additional explanation in the text.

      Here are some more specific comments:

      PART 1:

      (1) L 223 one probably cannot see a circadian peak at 24h if the data were filtered at 24h, did they look with another low pass cutoff?

      We clarified in the text that the power spectrum analysis was performed on unfiltered data.

      (2) L 243 the spread in standard deviation is said to be consistent with drifting bias, however, I do not agree with this. The variation could be stochastic but independent across days, and show no temporal correlation. As done with the circular arena, a drift should be estimated as a temporal correlation in the behavior.

      It is consistent insofar as seeing a non-zero standard deviation is a necessary condition for drift. While it does not show that there is any consistency over time, this can be inferred from the autoregressive model (as well as previous work). We have added text to make this clearer.

      (3) In the autoregressive model this temporal aspect seems to be incorporated only to the first order (from day to day). Therefore, from what I understand, the drift term is not correlated over time. This seems very different from the spectral analysis done in the circular assay, and I wonder if it fits at all the initial definition of drift. For example, is the model compatible with a fixed mean and a similar power spectrum as in Figure 1C? The text should clarify that.

      can be made clear in the case of σ = 0 and ϕ = 1, where values wouldϕ ≠ be0 In an AR(1) process, datapoints day to day are correlated as long as . This perfectly correlated with each other across time. The AR(1) model and the PSD of circling can be related via the Wiener-Khinchin theorem. We have added text to make this connection clear.

      (4) Did serotonin have no role in turning bias? My understanding of previous work was that serotonin should affect the bet-hedg variance as well - the authors should discuss what is expected or not, especially given that the pharmacological and genetic approaches do not have the same effect on bet-edging (Figure 1H-I).

      As the pharmacological methods were only applied after eclosion, we do not find it surprising that we do not measure differences in the initially measured distribution of handedness in that case. We do see more evidence of it in the mutations, though the trh<sup>n</sup> experiments provide a less clear effect after our adjustments to account for batch effects.

      (5) Methods: It is unclear how flies were handled across days; e.g. in Y mazes: 2h each day for how many days? In the arena flies were imaged either twice daily for 2h per session, or continuously for 24h (L138) - but which data are used where?

      We will make this more clear, but all data in figure 1 was the continuous 24h data

      This part of the methods is not well explained and I think it should be described in more detail.

      (6) How many flies per genotype were tested in fig 1E?

      Information was added to the caption to duplicate information in the table.

      PART 2:

      (7) In Figure 2B I do not understand the formulation N(50−ϕ: 50, σ), N(phi-et: et, σ) or in general N(x: m, s): does this mean that the variable x has normal distribution with mean m and variance s? Usually this would be written as N(x|m, s) or N(x; m, s)

      If so then: N(50−ϕ: 50, σ) = N(ϕ: 0, σ) which has mean=0 while the figure caption says "from a normal distribution centred on the long term environmental mean" - what is the long term environmental mean?

      If this is correct, and, therefore, we are just centering the mean, what about N(et-phi: et, σ)?

      Et is the environment at the time, not the mean of the environment (which is 50). We have added more detail in supplementary methods to address this.

      (8) Should ϕ vary between 1-100? And is the environmental parameter in Figure 2C also varying between 1-100? These ranges should be written somewhere.

      While implied in the sigma notation, we have added more detail in supplementary methods to explain the situation.

      (9) As far as I understand the bounding envelope in Figure 2B is necessary to contain the drift model. In Figure 1F, a bounding effect was generated by the "tendency to revert to no bias." It is unclear to me whether these two formulations are equivalent. Moreover, none of these two models might be able to recapitulate the correlations observed in the circular arena and analyzed spectrally in Figure 1C. It would be necessary that the author make an effort to relate these models/quantifications one to another. My understanding of Figure 1B is that there are slow fluctuations around the mean. Is the bounded drift model in 2B not returning to the same mean? And do these models generate slow fluctuations? Further explanation could help clarify these points.

      We have added additional explanation to explain the connection between the power spectrum and the two methods of (phi and bounding envelop) of establishing stationarity.

      (10) Expanding on the above: I thought that the definition of individuality is based on some degree of stability over days. However, both models assume drift to occur from day to day (and also the analysis of the DGRP lines assumes so). Some clarification here could help: is the initial bet-edging variation maintained in the population? And is the mean individual bias still a thing or it is just drifting away all the time?

      The initial bet-hedging is maintained to some degree, based on the parameter of phi and the bounding envelope. We have added text to make this clearer.

      (11) In both Figures 2C and 2E the populations are always shrinking, is that correct? And if so, is it expected? Does the model allow growth in a constant environment?

      As the plotted values are the log, the optimal environments do allow growth (visible more clearly in 2D). We have added some text to make this clearer.

      (12) Growth is quantified only across 100 days (Figure 2D) but at day 100 there is not something like a steady state, how is 100 chosen? Would it make sense to check longer times to see if the system eventually takes off? And if not, why?

      (13) Related to the above: what is the growth range achieved in Figure 3A-B? Is the heatmap normalized to the same value across conditions? I think it would be important to consider the absolute range of variation of growth or at least the upper value across conditions.

      Moreover: is growth quantified at day 100? What happens at longer times? Does the temporal profile of the growth curve differ across environmental conditions? (I'm referring to a Figure as 2D).

      As we are plotting the log change, we are ultimately showing the growth rate. While a more realistic model would involve carrying capacity, we believe a simplified model showing growth or no growth captures the difference in growth rate between different strategies. We have added some text to make this clearer.

      (14) Suddenly at line 502, sexual maturity is introduced as a parameter, which was never mentioned before, called a_min in the figure legend of panel 3a, but it is unclear where this is in the model. And please also clarify if sex maturity is the same as generation time.

      Sexual maturity is the same as generation time, we have standardized terminology throughout the paper.

      (15) Regarding lines 505-508, could one simply conclude that in this model formulation, the generation time has the effect of a low pass filter on environmental fluctuation? The question is: is this filtering effect the only effect of generation time?

      While this seems to capture the high-frequency effect we see, it does not explain the shift from bet-hedging->drift we see at lower-frequency environmental fluctuations.

      (16) What reproductive rate is used for the PCA analysis? Is the variance associated with the drift so low because of choosing a fast reproductive rate? A comment in the main text would be helpful.

      We have clarified that these plots were done at 10 days.

    1. Author response:

      Thank you for the eLife assessment and the constructive reviews. We appreciate the reviewers’ valuable insights and the time they dedicated to providing such thoughtful feedback on our manuscript. The reviewers highlighted the technical rigor of our study, specifically the tracking of individual neurons across both anesthetized and awake states using two-photon imaging. They also emphasized the importance of our cell-type-specific analysis (excitatory, PV, and SOM neurons) and noted that the study provides solid evidence for isoflurane-induced shifts in preferred spatial frequency (SF).

      Based on our team's evaluation of the reviewers' comments, we would like to outline our planned revisions.

      (1) Expanded Population and Single-Neuron Analysis

      We will re-analyze our dataset to include all neurons that were responsive under anesthesia, in the awake state, or both. This will ensure our findings accurately represent the entire population of visually responsive neurons. We will also provide examples of individual tuning curves to clarify the relationship between tuning shape and SF shifts in individual neurons.

      (2) Addressing Methodological Scope and Behavioral Metrics

      Receptive Field Size and Dynamics: While we did not utilize a stimulus set specifically designed to map receptive field (RF) sizes, we intend to examine how other functional parameters co-varied with the shift in preferred SF within each cell type. Furthermore, although characterizing the precise temporal dynamics during anesthesia onset presents technical challenges, we will attempt to analyze the time-dependence of the observed changes to provide deeper insight into the transition between states.

      Behavioral Metrics: While pupil size is a well-established proxy for brain state, we will explore the inclusion of other available behavioral parameters.

      (3) Cell-type Specificity (SOM, PV, and VIP)

      SOM vs. PV Comparison: We will perform a detailed comparison of preferred SFs between SOM and PV interneurons, including those responsive only under anesthesia or only in the awake state.

      VIP Neurons: While VIP neurons are known to play critical roles in cortical circuits, such as disinhibition, we have decided not to conduct new recordings for VIP interneurons in the present study. Based on existing literature, the proportion of visually responsive VIP cells is too low to yield statistically reliable conclusions for this specific study (de Vries et al., Nature Neuroscience 23, 138-151, 2020). Additionally, we intend to focus our analysis on inhibitory interneuron subtypes that provide direct input to pyramidal cells.

      Histology: We will provide additional histological validation.

      (4) Refined Framing

      As suggested, we will focus the manuscript strictly on isoflurane anesthesia. This includes updating the title and abstract to reflect this specificity and discussing how our results compare with other anesthetics like urethane. Furthermore, we will substantially deepen our discussion on the potential mechanisms by which anesthesia induces a downward shift in preferred spatial frequency.

      We believe these additions will significantly strengthen the manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this work, Huang et al. revealed the complex regulatory functions and transcription network of 172 unknown transcriptional factors (TFs) in Pseudomonas aeruginosa PAO1. They have built a global TF-DNA binding landscape and elucidated binding preferences and functional roles of these TFs. More specifically, the authors established a hierarchical regulatory network and identified ternary regulatory motifs, and co-association modules. Since P. aeruginosa is a well known pathogen, the authors thus identified key TFs associated with virulence pathways (e.g., quorum sensing [QS], motility, biofilm formation), which could be potential drug targets for future development. The authors also explored the TF conservation and functional evolution through pan-genome and phylogenetic analyses. For the easy searching by other researchers, the authors developed a publicly accessible database (PATF_Net) integrating ChIP-seq and HT-SELEX data.

      Strengths:

      (1) The authors performed ChIP-seq analysis of 172 TFs (nearly half of the 373 predicted TFs in P. aeruginosa) and identified 81,009 significant binding peaks, representing one of the largest TF-DNA interaction studies in the field. Also, The integration of HT-SELEX, pan-genome, and phylogenetic analyses provided multi-dimensional insights into TF conservation and function.

      (2) The authors provided informative analytical Framework for presenting the TFs, where a hierarchical network model based on the "hierarchy index (h)" classified TFs into top, middle, and bottom levels. They identified 13 ternary regulatory motifs and co-association clusters, which deepened our understanding of complex regulatory interactions.

      (3) The PATF_Net database provides TF-target network visualization and data-sharing capabilities, offering practical utility for researchers especially for the P. aeruginosa field.

      Thank you for your positive feedback!

      Weaknesses:

      (1) There is very limited experimental validation for this study. Although 24 virulence-related master regulators (e.g., PA0815 regulating motility, biofilm, and QS) were identified, functional validation (e.g., gene knockout or phenotypic assays) is lacking, leaving some conclusions reliant on bioinformatic predictions. Another approach for validation is checking the mutations of these TFs from clinical strains of P. aeruginosa, where chronically adapted isolates often gain mutations in virulence regulators.

      Thank you for this valuable suggestion. We have performed the EMSA experiment to validate the binding result and also constructed the mutants for further functional validation. The details can be found in Figure S5.

      (2) ChIP-seq in bacteria may suffer from low-abundance TF signals and off-target effects. The functional implications of non-promoter binding peaks (e.g., coding regions) were not discussed.

      Thank you for this insightful comment regarding ChIP-seq data quality and non-promoter binding events. While we acknowledge that completely eliminating all non-specific binding signals is technically challenging in bacterial ChIP-seq experiments, we implemented stringent quality control measures including replicates, negative controls, and FDR cutoffs to minimize false positives.

      Although the coding binding peaks represent a smaller fraction of total binding events, they are functionally significant rather than mere technical artifacts. Our previous work systematically demonstrated that bacterial TFs can bind to coding sequences and regulate gene expression through multiple mechanisms, including modulating cryptic promoter activity and antisense RNA transcription, hindering transcriptional elongation, and influencing translational efficiency[1]. We have now expanded the Discussion section to address these regulatory mechanisms.

      (3) PATF_Net currently supports basic queries but lacks advanced tools (e.g., dynamic network modeling or cross-species comparisons). User experience and accessibility remain underevaluated. But this could be improved in the future.

      Thank you for this constructive feedback on PATF_Net. We acknowledge that more advanced features would further enhance the platform’s utility. To enhance the utility of PA_TFNet, we have implemented two new features: (1) a virulence pathway browser that allows users to explore TF binding across curated gene sets for key virulence pathways (quorum sensing, secretion systems, biofilm, motility, etc.), and (2) a target gene search function that enables rapid identification of all TFs regulating any gene of interest by locus tag query.

      Achievement of Aims and Support for Conclusions

      (1) The authors successfully mapped global P. aeruginosa TF binding sites, constructed hierarchical networks and co-association modules, and identified virulence-related TFs, fulfilling the primary objectives. The database and pan-genome analysis provide foundational resources for future studies.

      (2) The hierarchical model aligns with known virulence mechanisms (e.g., LasR and ExsA at the bottom level directly regulating virulence genes). Co-association findings (e.g., PA2417 and PA2718 co-regulating pqsH) resonate with prior studies, though experimental confirmation of synergy is needed.

      Thank you for your positive feedback! We have added experimental validation in the Results section.

      Impact on the Field and Utility of Data/Methods

      (1) This study fills critical gaps in TF functional annotation in P. aeruginosa, offering new insights into pathogenicity mechanisms (e.g., antibiotic resistance, host adaptation). The hierarchical and co-association frameworks are transferable to other pathogens, advancing comparative studies of bacterial regulatory networks.

      (2) PATF_Net enables rapid exploration of TF-target interactions, accelerating candidate regulator discovery.

      Thank you for your positive feedback!

      Reviewer #3 (Public review):

      Summary:

      The authors utilized ChIP-seq on strains containing tagged transcription factor (TF)-overexpression plasmids to identify binding sites for 172 transcription factors in P. aeruginosa. High-quality binding site data provides a rich resource for understanding regulation in this critical pathogen. These TFs were selected to fill gaps in prior studies measuring TF binding sites in P. aeruginosa. The authors further perform a structured analysis of the resulting transcriptional regulatory network, focusing on regulators of virulence and metabolism, in addition to performing a pangenomic analysis of the TFs. The resulting dataset has been made available through an online database. While the implemented approach to determining functional TF binding sites has limitations, the resulting dataset still has substantial value to P. aeruginosa research.

      Strengths:

      The generated TF binding site database fills an important gap in regulatory data in the key pathogen P. aeruginosa. Key analyses of this dataset presented include an analysis of TF interactions and regulators of virulence and metabolism, which should provide important context for future studies into these processes. The online database containing this data is well organized and easy to access. As a data resource, this work should be of significant value to the infectious disease community.

      Thank you for your positive feedback!

      Weaknesses:

      Drawbacks of the study include 1) challenges interpreting binding site data obtained from TF overexpression due to unknown activity state of the TFs on the measured conditions, 2) limited practical value of the presented TRN topological analysis, and 3) lack of independent experimental validation of the proposed master regulators of virulence and metabolism.

      We thank the reviewer for summarizing these key concerns. We acknowledge the limitations raised regarding TF overexpression, TRN topological analysis interpretation, and experimental validation. We provide detailed point-by-point responses to each of these concerns in our replies to the specific comments below, where we explain our rationale, the measures taken to address these limitations, and our plans for improvement.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Future Directions for the authors to consider for next steps:

      (1) Key TFs (e.g., PA1380, PA5428) should be validated via gene knock out experiments, fluorescent reporter assays, or animal models to confirm roles in virulence pathways.

      Thank you for this important suggestion. We agree that experimental validation is essential to confirm their regulatory roles and biological functions.

      Firstly, we selected a subset of key TFs, including PA0167, PA1380, PA0815, and PA3094, and performed Electrophoretic Mobility Shift Assays (EMSA) experiments to validate their direct binding to target promoters. These results confirmed the ChIP-seq-identified interactions and are now included as Figure S5A-F.

      We also constructed a clean deletion mutant of PA1380 and PA 3094 (ΔPA1380 and ΔPA3094) and their complementary strains (ΔPA1380/p and ΔPA3094/p). We then performed RT-qPCR analysis to validate their regulatory effects on key target genes. We found that PA1380 positively regulate the expression of cupB1 and cupB3 genes (Figure S5F). While the CupB cluster was known not be as important as CupA cluster in the biofilm information, so we did not find significant difference in biofilm formation between WT and ΔPA1380. Additionally, we found TF PA3094 also positively regulate lecA expression, which were shown in Figure S5G.

      We agree that comprehensive functional validation, including animal model studies, would further strengthen the biological significance of these findings. Such experiments are currently underway in our laboratory and will be the subject of follow-up studies.

      We have revised the Results section and Method section to include these validation experiments and their implications. Please see Figure S5 and Lines 283-300.

      “To experimentally validate the regulatory interactions identified by ChIP-seq, we performed biochemical and genetic analyses on selected TFs. First, we conducted Electrophoretic Mobility Shift Assays (EMSA) for four TFs, including PA0167, PA0815, PA1380, and PA3094, using DNA fragments containing their predicted binding sites from target gene promoters. These TFs showed specific binding to their cognate DNA sequences (Figure S5A-D), confirming the direct binding of the ChIP-seq-identified interactions.

      To further validate the functional regulatory roles of these TFs, we constructed clean deletion mutants of PA1380 and PA3094 (ΔPA1380 and ΔPA3094) along with their complemented strains (ΔPA1380/p and ΔPA3094/p). RT-qPCR analysis revealed that PA1380 positively regulates the expression of cupB1 and cupB3 (Figure S5E), two genes within the CupB fimbrial cluster identified as ChIP-seq targets. Similarly, PA3094 was confirmed to positively regulate lecA expression (Figure S5F), which encodes a lectin involved in biofilm formation and host interactions[2]. Expression of these target genes was restored to wild-type (WT) levels in the complemented strains, validating the regulatory relationships predicted by ChIP-seq. These combined biochemical and genetic validations demonstrate the accuracy and biological relevance of our TF binding data.”

      (2) Non-promoter binding events (e.g., coding regions) may regulate RNA stability, warranting integration with translatomics or epigenomics data.

      Thank you for this suggestion. We have now expanded the Discussion section to address this comment. Please see Lines 478-482.

      “Our analysis revealed that TF binding events occur within coding regions, which is consistent with our previous study demonstrating that bacterial TFs possess binding capabilities for coding regions and can regulate transcription through multiple mechanisms [1]. Besides, it may also regulate RNA stability, warranting integration with translatomics or epigenomics data.”

      (3) Incorporate strain-specific TF data (e.g., clinical isolates) and dynamic visualization tools to broaden PATF_Net's applicability.

      Thank you for this constructive suggestion. To enhance the utility of PA_TFNet, we have implemented two new features: (1) a virulence pathway browser that allows users to explore TF binding across curated gene sets for key virulence pathways (quorum sensing, secretion systems, biofilm, motility, etc.), and (2) a target gene search function that enables rapid identification of all TFs regulating any gene of interest by locus tag query. These features are now live on the database and described in the revised manuscript.

      Regarding strain-specific TF data, we agree this would be valuable for understanding regulatory diversity in clinical isolates. However, such an expansion would require ChIP-seq profiling across multiple strains. The current dataset is based on the reference strain PAO1, which serves as the foundation for most P. aeruginosa research and allows direct comparison with existing genomic and functional studies. We have added a statement in the revised manuscript acknowledging this limitation and highlighting strain-specific TF analysis as an important future direction for the field. Please see Lines 372-390.

      “The database offers multiple search modalities to facilitate data exploration: users can perform TF-centric searches to query binding sites, target genes, and regulatory networks for individual TFs, or utilize the target gene search function to identify all TFs that regulate any gene of interest by entering its locus tag. To connect regulatory data with biological function, we have implemented a virulence pathway browser that allows users to explore TF binding patterns across curated gene sets for major P. aeruginosa virulence pathways. Interactive visualization tools, including network graphs and binding profile plots, facilitate intuitive exploration of regulatory relationships. The primary purpose of PATF_Net is to store, search, and mine valuable information on P. aeruginosa TFs for researchers investigating P. aeruginosa infection. The current resource is based on the reference strain PAO1, which serves as the foundation for most P. aeruginosa molecular studies and allows direct integration with existing genomic annotations and functional data. However, P. aeruginosa exhibits substantial genomic diversity across clinical isolates, and strain-specific differences in TF binding patterns may contribute to phenotypic variation in virulence, antibiotic resistance, and host adaptation. Extension of this resource to include strain-specific regulatory maps from diverse clinical isolates would provide valuable insights into the regulatory basis and represents an important direction for future investigation.”

      (4) Phylogenetic analysis highlights TF conservation in bacteria; future work could explore functional homology in other Gram-negative pathogens (e.g., E. coli).

      Thank for this insightful suggestion. Our phylogenetic analysis revealed that P. aeruginosa TFs exhibit varying degrees of conservation across bacterial species, with some showing broad distribution across Gram-negative pathogens while others are lineage-specific.

      We agree that exploring functional homology of orthologous TFs across species would be highly valuable. Such comparative studies could address whether conserved TFs regulate similar target genes and biological processes across species, or whether regulatory networks have been rewired during evolution. For example, comparative ChIP-seq analysis of P. aeruginosa TFs and their orthologs in Klebsiella pneumoniae or even Gram-positive pathogen like Bacillus cereus could reveal conserved regulatory modules governing universal virulence or metabolic strategies versus species-specific adaptations. This represents an important direction for future investigation and would be facilitated by the comprehensive TF binding dataset we provide here. We have expanded the Discussion section to highlight this future direction. Please see Lines 539-550.

      “While our phylogenetic analysis reveals varying degrees of TF conservation across bacterial species, the functional implications of this conservation remain to be fully explored. Many P. aeruginosa TFs have clear orthologs in both Gram-negative (e.g., Klebsiella pneumoniae) and Gram-positive pathogens (e.g., Bacillus cereus), yet whether these orthologs regulate similar target genes and biological processes is largely unknown. Future comparative ChIP-seq profiling of orthologous TFs could reveal the extent to which regulatory network architecture is conserved versus rewired during bacterial evolution, potentially identifying core regulatory modules governing universal bacterial strategies versus species-specific innovations. Such cross-species comparisons would enhance our understanding of regulatory network evolution and enable functional prediction in less well-characterized pathogens based on homology to experimentally validated P. aeruginosa regulators.”

      Reviewer #3 (Recommendations for the authors):

      Major comments

      - Limitations of the ChIP-seq approach: With overexpression plasmids as an approach to TRN elucidation, there are always a set of concerns. First, TF expression is not enough to ensure regulatory activity - metabolite effects must be such that the TF is active which requires growing the cells in activating conditions. Second, the presence of a binding event does not mean that the binding has a regulatory effect - the authors are clearly aware of this as they specify binding sites in promoter regions, which should be helpful, but they also mention the possibility of regulatory binding events in coding regions. These issues should be listed as weaknesses of the approach in the Discussion.

      Thank you for these important suggestions. We agree that these limitations should be explicitly discussed. We have now added a dedicated paragraph in the Discussion section addressing these concerns. Please see Lines 492-501.

      “However, several limitations of the ChIP-seq approach should be acknowledged. Firstly, TF overexpression ensures sufficient protein levels for ChIP-seq signal detection but does not guarantee that all TFs are in their active conformational states, as many bacterial TFs require allosteric activation by metabolites, cofactors, or post-translational modifications. The cells under standard laboratory conditions which may not activate all TFs to their maximal regulatory states, potentially leading to underestimation of condition-specific binding peaks. Secondly, while we observed TF binding at thousands of genomic sites, binding per se does not equate to functional regulation, as chromatin context, cofactor availability, and competitive binding all influence regulatory outcomes.”

      - Lack of independent validation: The study seems to lack substantial independent validation of either the functional nature of the binding sites as well as the proposed physiological regulatory role of the TFs. For example, for the 103 identified TF motifs, do any of these agree with existing motifs in motif databases that may be homologous to P. aeruginosa TFs? The authors claim to have discovered master regulators of virulence and associated core regulatory clusters - but there does not seem to be any independent validation of the proposed associations. The authors selected the TF targets to cover TFs that had not yet been characterized; however, it would have been nice to have some overlap with previous studies so that consistency and data quality could be assessed.

      Thank you for raising these critical points about validation.

      As for motif validation, we compared the existing motifs in the RegPrecise database[3] and we found that the motif of PA3587 show significant similarity to homologous TFs in Pseudomonadaceae. We have added the related description in the Results section. Please see Figure S3B and Lines 228-231.

      As for the validation of master regulators, we have performed EMSA experiments for validating the binding events and constructed the mutants for function validation. We have added the related contents in Results section. Please see Figure S5 and Lines 283-300.

      We have discussed the overlap between our results and previous studies in the Discussion section. Please see Lines 530-538.

      “PA0797 is known to regulate the pqs system and pyocyanin production[4]. In the present study, it was also found to bind to the pqsH promoter region and its motif was visualised. PA5428 was found to bind to the promoter regions of aceA and glcB genes[5], which was also demonstrated in our ChIP-seq results. PA4381 (CloR) was found to be associated with polymyxin resistance in a previous study[6] and to be possibly related to ROS resistance in the present study. Furthermore, PA5032 plays a putative role in biofilm regulation and also forms an operon with PA5033, an HP associated with biofilm formation[7].”

      - Uncertain value of TRN topology analysis: The relationship between ternary motifs and pathogenicity of P. aeruginosa, and why the authors argue these results motivated TF-targeting drugs (the topic of the last paragraph of the Discussion), are unclear to me. The authors allude to possible connections between pathogenicity, growth, and drug resistance, but I don't see concrete examples here of related TF interactions that clearly represent these relationships. The sections "Hierarchical networks of TFs based on pairwise interactions" and "Ternary regulatory motifs show flexible relationships among TFs in P. aeruginosa" seem to not say much in terms of results that are actionable or possible to validate. A topological graph is constructed based on observed TF-TF connections in measured binding sites - however, it's unclear if any of these connections are physiologically meaningful. Line 178 - Why would there be any connection between the structural family of TF and its location in the proposed TRN hierarchy?

      Thank you for this valuable comment on TRN topology analysis. It is hard to quantify precisely how much this resource will accelerate P. aeruginosa research or drug development, but we believe providing this foundational network architecture has inherent value for the community, which is valued for enabling hypothesis generation even before comprehensive functional validation. We would like to clarify our perspective on these findings and have added the discussion in the revised manuscript to better describe their nature and value. Please see Lines 517-528.

      “Additionally, although the TRN analysis revealed organizational patterns in P. aeruginosa regulatory network, the functional significance these topological features, including their specific contributions to pathogenicity, metabolic adaptation, and antibiotic resistance remains to be experimentally determined in the future work. The hierarchical structure and regulatory motifs we identified represent objective network properties derived from our binding data, but translating these structural observations into mechanistic understanding will require condition-specific functional studies, genetic validation, and phenotypic characterization. Our analysis provided a systematic framework and generating testable hypotheses rather than definitive functional conclusions. Nevertheless, these network-level organizational principles provided value to the community as a foundational reference, similar to other regulatory network maps[8] that were useful even before comprehensive validation.”

      - Identification of "master" regulators: Line 527 on virulence regulators: "We first generated gene lists associated with nine pathways" - is this not somewhat circular, i.e. using gene lists generated from (I assume) co-regulated gene sets to identify regulators of those gene lists? I can't tell from the cited reference (80), which is their own prior review article, what the original source of these gene lists was. Somewhat related to this point - Line 32: 24 "master regulators" - if there are that many, is it still considered a master regulator? Line 270: This term "master regulator" would seem to require some quantitative justification. Identifying 24 (a large number of) "master" regulators of virulence would seem to dilute the implied power of the term.

      We apologize for the lack of clarity regarding the virulence pathway gene lists, and we have provided complete gene lists for virulence-related pathways, which were compiled from functional annotations, in our online PA_TFNet database.

      Additionally, we appreciate your concern about the use of “master” regulator. The usage is based on previous studies[9,10], and the master regulator is commonly known in the development of multicellular organisms as a subset of TFs that control the expression of multiple downstream genes and govern lineage commitment or key biological processes. We employed the term "master regulator" in an analogous manner to specify a class of functionally crucial TFs that participate in a pathway or biological event by regulating multiple downstream genes statistically enriched in that pathway. In line with this definition, we identified TFs whose targets were significantly enriched in genes associated with specific virulence pathways (hypergeometric test, P < 0.05).

      We understand the concern that identifying 24 master regulators might seem to dilute the term. However, we would like to clarify that each of these 24 TFs is a "master regulator" with respect to specific virulence pathways based on statistical criteria, not necessarily a global master regulator of multiple pathways of P. aeruginosa. We have revised the Method section. Please see Lines 604-612.

      - Line 234: "Genome-wide synergistic co-association of TFs in P. aeruginosa." This section was an interesting analysis. As I mention above, the weakness of an overexpression approach is not knowing whether the TF is active on the examined conditions. By looking at shared binding peaks across overexpression of different TFs, it should indeed be possible to glean some regulatory connections across TFs. Furthermore, the authors discuss specific examples that appear physiologically reasonable, which is appreciated.

      We thank the reviewer for this positive assessment of our co-association analysis. We agree with the limitation of the overexpression approach, which have been discussed in the Discussion section. We are pleased that the reviewer found the approach and specific examples valuable.

      Minor comments

      - Line 35 - "high-throughput systematic evolution of ligands by exponential enrichment" - no idea what this means. Is this related to the web-based database, or why is it mentioned in the same sentence?

      We apologize for the unclear presentation. To clarify: “High-throughput systematic evolution of ligands by exponential enrichment” (HT-SELEX) is an in vitro technique for determining TF DNA-binding motifs, which our group previously applied to a subset of P. aeruginosa TFs in a prior publication[11]. In the current study, we performed ChIP-seq for 172 TFs, which represent the majority of TFs not covered by the previous HT-SELEX study. Together, these two complementary approaches (HT-SELEX for in vitro binding motifs, ChIP-seq for in vivo genomic binding sites) provide near-complete coverage of the P. aeruginosa TF repertoire. Both datasets are integrated into our PA_TFNet database.

      Due to space constraints in the abstract, we could not provide detailed explanation of HT-SELEX, but we have now improved the clarity in the Introduction to better explain the relationship between our previous HT-SELEX work and the current ChIP-seq study, and why both are mentioned together in the context of the database. Please see Lines 99-105.

      - Line 193 - Only 9 auto-regulating TFs seems like a low number, given the frequency of negative auto-regulation in other organisms like E. coli. Could the authors comment on their expectations based on well-curated TRNs?

      Thank you for this comment. We agree that 9 auto-regulating TFs is lower than might be expected based on E. coli, where auto-regulation is more prevalent. This likely reflects technical limitations of ChIP-seq approach that our detection was limited to standard growth conditions rather than the diverse physiological states where auto-regulation often occurs. Therefore, the 9 TFs we report represent a high-confidence subset, and the true frequency of auto-regulation in P. aeruginosa likely is higher. We added the content in the revised manuscript. Please see Lines 193-196.

      “This number likely represents a conservative estimate, as experiments may not optimally capture auto-regulatory events that depend on native expression levels or specific physiological conditions.”

      - Line 230 - "This conservation suggests that TFs within the same cluster co-regulate similar sets of genes." - Why would clustering of TF binding site motifs need to be done to make this assessment? Couldn't the shared set of regulated genes be identified directly from the binding site data? Computing TF binding site motifs has obvious value, but I am struggling to understand the point of clustering the motifs. Is there some implied evolutionary or physiological connection here? No specific physiological roles or hypotheses are discussed in this section.

      Thank you for this important question. We agree that shared target genes can be identified directly from ChIP-seq binding data, which we also analyzed (co-association analysis). The motif clustering analysis serves a complementary and distinct purpose that provides information not directly obtainable from overlapped targets alone. Specifically, target overlap is inherently condition dependent, and motif clustering captures this intrinsic binding specificity, which reflects the structural similarity of DBDs, evolutionary relationships, and potential for functional redundancy or cooperativity under specific conditions. We have revised the related content in the manuscript, and please see Lines 236-242.

      “Clustering of TF binding motifs identified groups of TFs with similar intrinsic DNA-binding specificities. As expected, many clusters contained TFs from the same DBD families, reflecting evolutionary conservation and potential functional redundancy or competitive binding at shared regulatory elements. Notably, the clustering also uncovered associations between TFs from different DBD families, suggesting convergent evolution of binding specificity or novel regulatory interactions that warrant further investigation.”

      - Line 284 - should "metabolomic" be "metabolic"? I didn't see metabolomic data

      Yes, we have revised. Please see Line 311.

      - Several of the figures are too small (e.g. Fig S4A) or complex (Fig 2A) to see clearly or glean information from.

      Thank you for this comment. We acknowledge that Figure 2A and Figure S4A contain dense information due to the comprehensive nature of the regulatory network and the large number of TFs analyzed. We believe these overview figures serve an important purpose in conveying the scale and organization of the regulatory network, while the tables (Table S6 for Fig. S4A and Table S3 for Fig. 2A) provide the granular data needed for specific inquiries. We have also made the figures available in higher resolution and increased font sizes where possible without compromising the overall layout.

      - I don't understand the organization of the "Ternary regulatory motifs" in Supplementary Data File 4 - A table of contents explaining the tabs and columns would be welcome (for this as well as other supplementary files, some of which are more straightforward than others).

      Thank you for this suggestion. We have now revised all supplementary data files to include header and necessary annotations in the first row. Specifically for Supplementary Data File 4, the three columns (Top, Middle, Bottom) represent the left, middle, and right node, respectively, in each ternary regulatory motif.

      - I would have expected genomic locations of TF binding sites would have been one of the Supplementary Tables, to increase the accessibility of the data. However, the data is made available through their website, https://jiadhuang0417.shinyapps.io/PATF_Net/, which was easy to access and download the full dataset, so this is a minor issue.

      Thank for accessing our PA_TFNet database and for the positive feedback on data accessibility. We agree that providing genomic locations of TF binding sites is crucial. These data are fully available and downloadable through the web interface, which allows flexible searching, filtering, and batch download of binding sites. We felt that the interactive and database format provides more functionality than static supplementary tables (e.g., dynamic filtering by TF, genomic region, or binding strength), given the large scale of this dataset.

      References

      (1) Hua, C., Huang, J., Wang, T., Sun, Y., Liu, J., Huang, L. et al. Bacterial Transcription Factors Bind to Coding Regions and Regulate Internal Cryptic Promoters. Mbio 13, e0164322 (2022).

      (2) Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P. et al. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 77, 2065-2075 (2009).

      (3) Novichkov, P. S., Kazakov, A. E., Ravcheev, D. A., Leyn, S. A., Kovaleva, G. Y., Sutormin, R. A. et al. RegPrecise 3.0–a resource for genome-scale exploration of transcriptional regulation in bacteria. Bmc Genomics 14, 745 (2013).

      (4) Cui, G. Y., Zhang, Y. X., Xu, X. J., Liu, Y. Y., Li, Z., Wu, M. et al. PmiR senses 2-methylisocitrate levels to regulate bacterial virulence in Pseudomonas aeruginosa. Sci Adv 8 (2022).

      (5) Hwang, W., Yong, J. H., Min, K. B., Lee, K.-M., Pascoe, B., Sheppard, S. K. et al. Genome-wide association study of signature genetic alterations among pseudomonas aeruginosa cystic fibrosis isolates. Plos Pathog 17, e1009681 (2021).

      (6) Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E. et al. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob Agents Chemother 57, 2204-2215 (2013).

      (7) Zhang, L., Fritsch, M., Hammond, L., Landreville, R., Slatculescu, C., Colavita, A. et al. Identification of genes involved in Pseudomonas aeruginosa biofilm-specific resistance to antibiotics. PLoS One 8, e61625 (2013).

      (8) Galan-Vasquez, E., Luna, B. & Martinez-Antonio, A. The Regulatory Network of Pseudomonas aeruginosa. Microb Inform Exp 1, 3 (2011).

      (9) Fan, L. G., Wang, T. T., Hua, C. F., Sun, W. J., Li, X. Y., Grunwald, L. et al. A compendium of DNA-binding specificities of transcription factors in Pseudomonas syringae. Nat Commun 11 (2020).

      (10) Chan, S. S.-K. & Kyba, M. What is a master regulator? Journal of stem cell research & therapy 3, 114 (2013).

      (11) Wang, T. T., Sun, W. J., Fan, L. G., Hua, C. F., Wu, N., Fan, S. R. et al. An atlas of the binding specificities of transcription factors in Pseudomonas aeruginosa directs prediction of novel regulators in virulence. Elife 10 (2021).

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      There are a few remaining issues:

      (1) The manuscript quantifies changes over learning in prefrontal goal-selective cells (equated to "splitter" place cells in hippocampus) and task-phase selective cells (similar to non-splitter place cells that are not goal modulated). A subset of these task cells remain stable throughout learning, and are equated to schema representations in the study. In the memory literature, schemas are generally described as relational networks of abstract and generalized information, that enable adapting to novel context and inference by enabling retrieval of related information from previous contexts. The task-phase selective cells that stay stable throughout learning clearly will have a role in organizing task representations, but to this reviewer, denoting them as forming a schema is an unwarranted interpretation. By this definition, hippocampal non-splitter place cells that emerge early in learning and are stable over days would also form a schema. Therefore, schema notation cannot just be based on stability, it requires further evidence of abstraction such as cross-condition generalization.

      We agree with the reviewer that task phase selective cells (“non-splitter cells”) alone do not fulfill the “relationality” criterion of schemas. We found only few of them, and so we cannot really say something about how they covary. We, however, would like to stress that our finding that task phase selective cells have stable firing field comparing learned (task) and habituation (no-task) conditions can be considered as “cross-condition generalization.” We have further specified our discussion of schemas with a particular emphasis on a potential interpretation of the generalizing task phase cells as “potential building blocks of schemas.”

      (2) The quantification of prefrontal replay sequences during reward is useful, but it is still unconvincing that the distinction between existence of sequences in the odor sampling phase and reward phase is not trivially expected based on prior literature. This is odor guided task, not a spatial exploration task with no cues, and it is very well-established (as noted in citations in the previous review) that during odor sampling, animals' will sniff in an exploratory stage, resulting in strong beta and respiratory rhythms in prefrontal cortex. Not having LFP recordings in this task does not preclude considering prior literature that clearly shows that odor sampling results in a unique internal state network state, when animals are retrieving the odor-associated goal, vastly different from a reward sampling phase. The authors argue that this is not trivial since they see some sequences during sampling, although they also argue the opposite in response to a question from Reviewer 2 about shuffling controls for sequences, that 'not' seeing these sequences in the sampling phase is an internal control. The bigger issue here is equating these sequences during sampling to replay/ preplay or reactivation sequences similar to the reward phase, since the prefrontal network dynamics are engaged in odor-driven retrieval of associated goals during sampling, as has been shown in previous studies.

      We agree with the reviewer that sampling and reward phase represent two very different behavioral states. Nevertheless, correlations on short time scales could be similar, which we show is not the case and therefore we do not consider this result trivial. Regarding the interpretation of sequences, we apologize that we have not been sufficiently clear on distinguishing replay with pure sequences. While we find such sequences in the sampling phase (indicative of fast temporal correlation structure beyond cofiring quantified in Figure 3) they are NOT pre/replaying any task related information. Otherwise, our results are fully in line with previous literature on oscillations that we have included in the previous round of revisions. We added a similar explanation at multiple instances in the Results and Discussion section.

      Reviewer #2 (Public review):

      Comments on revisions:

      Further changes are needed to improve the description of the methods and the discussion needs to be extended to contrast the results with previously published results of the group. Some control figures would also be needed to quantitatively demonstrate, across the entire dataset, that sequence detection did not identify random events as sequences, even if the detection method was designed to exclude such sequences. For example, showing that sequences are not detected in randomised data with the current method would better convince readers of the method's validity.

      We have added control quantifications from time randomized sequences which produce a much lower amount of detected sequences. See response below.

      Although differences in the classification scheme relative to the Muysers et al. (2025) paper have been explained, the similarity (perhaps equivalence of results) is not sufficiently acknowledged - e.g., at the beginning of the discussion.

      We have added a paragraph at the beginning of the Discussion on how our results align with the Muysers et al. 2025 paper.

      Although the control of spurious sequences may have been built into the method, this is not sufficiently explained in the method. It is also not clear what kind of randomization was performed. Importantly, I do not see a quantification that shows that the detected sequences are significantly better than the sequence quality measure on randomized events. Or that randomized data do not lead to sequence clusters.

      In response to this question, we have added the requested shuffling control (Supplement 1B to Figure 4). In the shuffled data the amount of detected recurring sequence clusters is only about half of those in the original data. The amount of bursts assigned to clusters in the shuffled data only remains 46% of the originally assigned bursts on average, clearly indicating that the detected sequences in the non-randomized data cannot be explained without assuming stable temporal order.

      Some clusters, however, are still detected in randomized data, which, however, is expected if participation of cells is heterogeneous with some highly active cells occurring in more than half of the bursts. Then random sequences spuriously occur above chance level representing the clusters of random order of few highly active cells. In line with this interpretation, we see that

      (1) Bursts that were removed after shuffling have exactly 0 high-firing cells

      (2) Clusters derived from shuffled sequence have a less sparse contribution of high firing cells, i.e., high firing cells contribute to significantly more clusters in randomized data than in nonrandomized data.

      The difference in the distribution of high firing cells further indicates that sequences obtained with and without randomization are of different quality.

      The spurious (false positive) clusters detected after randomization nevertheless may have a physiological meaning as they identify rate coactivation patterns that were also picked up by analysis in Figure 3.

      Also, it is still not clear how the number of clusters was established. I understand that the previously published paper may have covered these questions; these should be explained here as well.

      The Methods sections states “The [cluster merging] procedure was repeated until no pair [of clusters] satisfied the merging criterion.”

      Also, the sequence similarity description is still confusing in the method; please correct this sentence "Only the l neurons active in both sequences of a pair were taken into account."

      We do not see what is wrong with this sentence. To avoid confusion.” we have replaced lower case l with upper case L as sequence length.

      Reviewer #3 (Public review):

      One comment is that the threshold for extracting burst events (0.5 standard deviations, presumably above the mean) seems lower than what one usually sees as a threshold for population burst detection, and the authors show (in Supplementary Fig 1) that this means bursts cover ~20-40% of the data. However, it is potentially a strength of this work that their results are found by using this more permissive threshold.

      We have added further specifications following the Reviewer’s suggestion and now mention that the threshold is permissive and “capturing large amount cofiring structure.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Most importantly, in accordance with questions raised by Reviewer 1, we now include a detailed comparison of the cell type frequencies between the two examined time points as well as comparison of the pseudotimes along those lineages. This is detailed in the new section “Many cell types are shared between day 8 and day 16 EBs” and illustrated in Supplementary Figure 6c and Supplementary Figures 7-8.

      Besides this new chapter and its accompanying methods part, we mainly edited the language and to clarify methods and assumptions according to the Reviewer suggestions.

      The main concern of Reviewer 2 was our use of the liftoff gene annotation. We explained our reasoning for this choice extensively in our public response to the Reviewer, but did not incorporate this into our manuscript because even though this is an important subject it is not within the main scope of our paper.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Jocher, Janssen, et al examine the robustness of comparative functional genomics studies in primates that make use of induced pluripotent stem cell-derived cells. Comparative studies in primates, especially amongst the great apes, are generally hindered by the very limited availability of samples, and iPSCs, which can be maintained in the laboratory indefinitely and defined into other cell types, have emerged as promising model systems because they allow the generation of data from tissues and cells that would otherwise be unobservable.

      Undirected differentiation of iPSCs into many cell types at once, using a method known as embryoid body differentiation, requires researchers to manually assign all cell types in the dataset so they can be correctly analysed. Typically, this is done using marker genes associated with a specific cell type. These are defined a priori, and have historically tended to be characterised in mice and humans and then employed to annotate other species. Jocher, Janssen, et al ask if the marker genes and features used to define a given cell type in one species are suitable for use in a second species, and then quantify the degree of usefulness of these markers. They find that genes that are informative and cell type specific in a given species are less valuable for cell type identification in other species, and that this value, or transferability, drops off as the evolutionary distance between species increases.

      This paper will help guide future comparative studies of gene expression in primates (and more broadly) as well as add to the growing literature on the broader challenges of selecting powerful and reliable marker genes for use in single-cell transcriptomics.

      Strengths:

      Marker gene selection and cell type annotation is a challenging problem in scRNA studies, and successful classification of cells often requires manual expert input. This can be hard to reproduce across studies, as, despite general agreement on the identity of many cell types, different methods for identifying marker genes will return different sets of genes. The rise of comparative functional genomics complicates this even further, as a robust marker gene in one species need not always be as useful in a different taxon. The finding that so many marker genes have poor transferability is striking, and by interrogating the assumption of transferability in a thorough and systematic fashion, this paper reminds us of the importance of systematically validating analytical choices. The focus on identifying how transferability varies across different types of marker genes (especially when comparing TFs to lncRNAs), and on exploring different methods to identify marker genes, also suggests additional criteria by which future researchers could select robust marker genes in their own data.

      The paper is built on a substantial amount of clearly reported and thoroughly considered data, including EBs and cells from four different primate species - humans, orangutans, and two macaque species. The authors go to great lengths to ensure the EBs are as comparable as possible across species, and take similar care with their computational analyses, always erring on the side of drawing conservative conclusions that are robustly supported by their data over more tenuously supported ones that could be impacted by data processing artefacts such as differences in mappability, etc. For example, I like the approach of using liftoff to robustly identify genes in non-human species that can be mapped to and compared across species confidently, rather than relying on the likely incomplete annotation of the non-human primate genomes. The authors also provide an interactive data visualisation website that allows users to explore the dataset in depth, examine expression patterns of their own favourite marker genes and perform the same kinds of analyses on their own data if desired, facilitating consistency between comparative primate studies.

      We thank the Reviewer for their kind assessment of our work.

      Weaknesses and recommendations:

      (1) Embryoid body generation is known to be highly variable from one replicate to the next for both technical and biological reasons, and the authors do their best to account for this, both by their testing of different ways of generating EBs, and by including multiple technical replicates/clones per species. However, there is still some variability that could be worth exploring in more depth. For example, the orangutan seems to have differentiated preferentially towards cardiac mesoderm whereas the other species seemed to prefer ectoderm fates, as shown in Figure 2C. Likewise, Supplementary Figure 2C suggests a significant unbalance in the contributions across replicates within a species, which is not surprising given the nature of EBs, while Supplementary Figure 6 suggests that despite including three different clones from a single rhesus macaque, most of the data came from a single clone. The manuscript would be strengthened by a more thorough exploration of the intra-species patterns of variability, especially for the taxa with multiple biological replicates, and how they impact the number of cell types detected across taxa, etc.

      You are absolutely correct in pointing out that the large clonal variability in cell type composition is a challenge for our analysis. We also noted the odd behavior of the orangutan EBs, and their underrepresentation of ectoderm. There are many possible sources for these variable differentiation propensities: clone, sample origin (in this case urine) and individual. However, unfortunately for the orangutan, we have only one individual and one sample origin and thus cannot say whether this germ layer preference says something about the species or is due to our specific sample. Because of this high variability from multiple sources, getting enough cell types with an appreciable overlap between species was limiting to analyses. In order to be able to derive meaningful conclusions from intra-species analyses and the impact of different sources of variation on cell type propensity, we would need to sequence many more EBs with an experimental design that balances possible sources of variation. This would go beyond the scope of this study.

      Instead, here we control for intra-species variation in our analyses as much as possible: For the analysis of cell type specificity and conservation the comparison is relative for the different specificity degrees (Figure 3C). For the analysis of marker gene conservation, we explicitly take intra-species variation into account (Figure 4D).

      The same holds for the temporal aspect of the data, which is not really discussed in depth despite being a strength of the design. Instead, days 8 and 16 are analysed jointly, without much attention being paid to the possible differences between them.

      Concerning the temporal aspect, indeed we knowingly omitted to include an explicit comparison of day 8 and day 16 EBs, because we felt that it was not directly relevant to our main message. Our pseudotime analysis showed that the differences of the two time points were indeed a matter of degree and not so much of quality. All major lineages were already present at day 8 and even though day 8 cells had on average earlier pseudotimes, there was a large overlap in the pseudotime distributions between the two sampling time points (Author response image 1). That is why we decided to analyse the data together.

      Are EBs at day 16 more variable between species than at day 8? Is day 8 too soon to do these kinds of analyses?

      When we started the experiment, we simply did not know what to expect. We were worried that cell types at day 8 might be too transient, but longer culture can also introduce biases. That is why we wanted to look at two time points, however as mentioned above the differences are in degree.

      Concerning the cell type composition: yes, day 16 EBs are more heterogeneous than day 8 EBs. Firstly, older EBs have more distinguishable cell types and hence even if all EBs had identical composition, the sampling variance would be higher given that we sampled a similar number of cells from both time points. Secondly, in order to grow EBs for a longer time, we moved them from floating to attached culture on day 8 and it is unclear how much variance is added by this extra handling step.

      Are markers for earlier developmental progenitors better/more transferable than those for more derived cell types?

      We did not see any differences in the marker conservation between early and late cell types, but we have too little data to say whether this carries biological meaning.

      Author response image 1.

      Pseudotime analysis for a differentiation trajectory towards neurons. Single cells were first aggregated into metacells per species using SEACells (Persad et al. 2023). Pluripotent and ectoderm metacells were then integrated across all four species using Harmony and a combined pseudotime was inferred with Slingshot (Street et al. 2018), specifying iPSCs as the starting cluster. Here, lineage 3 is shown, illustrating a differentiation towards neurons. (A) PHATE embedding colored by pseudotime (Moon et al. 2019). (B) PHATE embedding colored by celltype. (C) Pseudotime distribution across the sampling timepoints (day 8 and day 16) in different species.

      (2) Closely tied to the point above, by necessity the authors collapse their data into seven fairly coarse cell types and then examine the performance of canonical marker genes (as well as those discovered de novo) across the species. However some of the clusters they use are somewhat broad, and so it is worth asking whether the lack of specificity exhibited by some marker genes and driving their conclusions is driven by inter-species heterogeneity within a given cluster.

      Author response image 2.

      UMAP visualization for the Harmony-integrated dataset across all four species for the seven shared cell types, colored by cell type identity (A) and species (B).

      Good point, if we understand correctly, the concern is that in our relatively broadly defined cell types, species are not well mixed and that this in turn is partly responsible for marker gene divergence. This problem is indeed difficult to address, because most approaches to evaluate this require integration across species which might lead to questionable results (see our Discussion).

      Nevertheless, we attempted an integration across all four species. To this end, we subset the cells for the 7 cell types that we found in all four species and visualized cell types and species in the UMAPs above (Author response image 2).

      We see that cardiac fibroblasts appear poorly integrated in the UMAP, but they still have very transferable marker genes across species. We quantified integration quality using the cell-specific mixing score (cms) (Lütge et al. 2021) and indeed found that the proportion of well integrated cells is lowest for cardiac fibroblasts (Author response image 3A). On the other end of the cms spectrum, neural crest cells appear to have the best integration across species, but their marker transferability between species is rather worse than for cardiac fibroblasts (Supplementary Figure 9). Cell-type wise calculated rank-biased overlap scores that we use for marker gene conservation show the same trends (Author response image 3B) as the F1 scores for marker gene transferability. Hence, given our current dataset we do not see any indication that the low marker gene conservation is a result of too broadly defined cell types.

      Author response image 3.

      (A) Evaluation of species mixing per cell type in the Harmony-integrated dataset, quantified by the fraction of cells with an adjusted cell-specific mixing score (cms) above 0.05. (B) Summary of rank-biased overlap (RBO) scores per cell type to assess concordance of marker gene rankings for all species pairs.

      Reviewer #2 (Public review):

      Summary:

      The authors present an important study on identifying and comparing orthologous cell types across multiple species. This manuscript focuses on characterizing cell types in embryoid bodies (EBs) derived from induced pluripotent stem cells (iPSCs) of four primate species, humans, orangutans, cynomolgus macaques, and rhesus macaques, providing valuable insights into cross-species comparisons.

      Strengths:

      To achieve this, the authors developed a semi-automated computational pipeline that integrates classification and marker-based cluster annotation to identify orthologous cell types across primates. This study makes a significant contribution to the field by advancing cross-species cell type identification.

      We thank the reviewer for their positive and thoughtful feedback.

      Weaknesses:

      However, several critical points need to be addressed.

      (1) Use of Liftoff for GTF Annotation

      The authors used Liftoff to generate GTF files for Pongo abelii, Macaca fascicularis, and Macaca mulatta by transferring the hg38 annotation to the corresponding primate genomes. However, it is unclear why they did not use species-specific GTF files, as all these genomes have existing annotations. Why did the authors choose not to follow this approach?

      As Reviewer 1 also points out, also we have observed that the annotation of non-human primates often has truncated 3’UTRs. This is especially problematic for 3’ UMI transcriptome data as the ones in the 10x dataset that we present here. To illustrate this we compared the Liftoff annotation derived from Gencode v32, that we also used throughout our manuscript to the Ensembl gene annotation Macaca_fascicularis_6.0.111. We used transcriptomes from human and cynomolgus iPSC bulk RNAseq (Kliesmete et al. 2024) using the Prime-seq protocol (Janjic et al. 2022) which is very similar to 10x in that it also uses 3’ UMIs. On average using Liftoff produces higher counts than the Ensembl annotation (Author response image 4A). Moreover, when comparing across species, using Ensembl for the macaque leads to an asymmetry in differentially expressed genes, with apparently many more up-regulated genes in humans. In contrast, when we use the Liftoff annotation, we detect fewer DE-genes and a similar number of genes is up-regulated in macaques as in humans (Author response image 4B). We think that the many more DE-genes are artifacts due to mismatched annotation in human and cynomolgus macaques. We illustrate this for the case of the transcription factor SALL4 in Author response image 4C, D. The Ensembl annotation reports 2 transcripts, while Liftoff from Gencode v32 suggests 5 transcripts, one of which has a longer 3’UTR. This longer transcript is also supported by Nanopore data from macaque iPSCs. The truncation of the 3’UTR in this case leads to underestimation of the expression of SALL4 in macaques and hence SALL4 is detected as up-regulated in humans (DESeq2: LFC= 1.34, p-adj<2e-9). In contrast, when using the Liftoff annotation SALL4 does not appear to be DE between humans and macaques (LFC=0.33, p.adj=0.20).

      Author response image 4.

      (A) UMI-counts/ gene for the same cynomolgus macaque iPSC samples. On the x-axis the gtf file from Ensembl Macaca_fascicularis_6.0.111 was used to count and on the y-axis we used our filtered Liftoff annotation that transferred the human gene models from Gencode v32. (B) The # of DE-genes between human and cynomolgus iPSCs detected with DESeq2. In Liftoff, we counted human samples using Gencode v32 and compared it to the Liftoff annotation of the same human gene models to macFas6. In Ensembl, we use Gencode v32 for the human and Ensembl Macaca_fascicularis_6.0.111 for the Macaque. For both comparisons we subset the genes to only contain one-to-one orthologs as annotated in biomart. Up and down regulation is relative to human expression. C) Read counts for one example gene SALL4. Here we used in addition to the Liftoff and Ensembl annotation also transcripts derived from Nanopore cDNA sequencing of cynomolgus iPSCs. D) Gene models for SALL4 in the space of MacFas6 and a coverage for iPSC-Prime-seq bulk RNA-sequencing.

      (2) Transcript Filtering and Potential Biases

      The authors excluded transcripts with partial mapping (<50%), low sequence identity (<50%), or excessive length differences (>100 bp and >2× length ratio). Such filtering may introduce biases in read alignment. Did the authors evaluate the impact of these filtering choices on alignment rates?

      We excluded those transcripts from analysis in both species, because they present a convolution of sequence-annotation differences and expression. The focus in our study is on regulatory evolution and we knowingly omit marker differences that are due to a marker being mutated away, we will make this clearer in the text of a revised version.

      (3) Data Integration with Harmony

      The methods section does not specify the parameters used for data integration with Harmony. Including these details would clarify how cross-species integration was performed.

      We want to stress that none of our conservation and marker gene analyses relies on cross-species integration. We only used the Harmony integrated data for visualisation in Figure 1 and the rough germ-layer check up in Supplementary Figure S3. We will add a better description in the revised version.

      Reference

      Janjic, Aleksandar, Lucas E. Wange, Johannes W. Bagnoli, Johanna Geuder, Phong Nguyen, Daniel Richter, Beate Vieth, et al. 2022. “Prime-Seq, Efficient and Powerful Bulk RNA Sequencing.” Genome Biology 23 (1): 88.

      Kliesmete, Zane, Peter Orchard, Victor Yan Kin Lee, Johanna Geuder, Simon M. Krauß, Mari Ohnuki, Jessica Jocher, Beate Vieth, Wolfgang Enard, and Ines Hellmann. 2024. “Evidence for Compensatory Evolution within Pleiotropic Regulatory Elements.” Genome Research 34 (10): 1528–39.

      Lütge, Almut, Joanna Zyprych-Walczak, Urszula Brykczynska Kunzmann, Helena L. Crowell, Daniela Calini, Dheeraj Malhotra, Charlotte Soneson, and Mark D. Robinson. 2021. “CellMixS: Quantifying and Visualizing Batch Effects in Single-Cell RNA-Seq Data.” Life Science Alliance 4 (6): e202001004.

      Moon, Kevin R., David van Dijk, Zheng Wang, Scott Gigante, Daniel B. Burkhardt, William S. Chen, Kristina Yim, et al. 2019. “Visualizing Structure and Transitions in High-Dimensional Biological Data.” Nature Biotechnology 37 (12): 1482–92.

      Persad, Sitara, Zi-Ning Choo, Christine Dien, Noor Sohail, Ignas Masilionis, Ronan Chaligné, Tal Nawy, et al. 2023. “SEACells Infers Transcriptional and Epigenomic Cellular States from Single-Cell Genomics Data.” Nature Biotechnology 41 (12): 1746–57.

      Street, Kelly, Davide Risso, Russell B. Fletcher, Diya Das, John Ngai, Nir Yosef, Elizabeth Purdom, and Sandrine Dudoit. 2018. “Slingshot: Cell Lineage and Pseudotime Inference for Single-Cell Transcriptomics.” BMC Genomics 19 (1): 477.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 1B: the orangutan tubulin stain looks a bit unusual - just confirming that this is indeed the right image the authors want to include here.

      We agree, this unfortunately also reflects the findings from the scRNA-seq analysis in that we found hardly any cells that we would classify as proper neurons.

      (2) Typo on line 90: 'loosing' should be 'losing'.

      Fixed

      (3) Line 118: why do the authors believe that using singleR will give better results than MetaNeighbour? This certainly seems supported by the data in S4 and S5, but the reasoning is not clear.

      We think that this might depend on the signal to noise ratio, which is a property specific to each dataset. Here we just wanted to state that our approach seems to work better for our developmental data, but we didn’t test out other data and thus cannot generalize.

      (4) Figure 2B: there are some coloured lines on the first filled black bar from the left - do they mean anything? I couldn't work it out from looking at the figure.

      Indeed this is a bit misleading the colors on the left represent the species identity: this was to illustrate the mixing of the of species for each cell type: The legend reads now: “Each line represents a cell which are colored by their species of origin on the left and by their current cell type assignment during the annotation procedure on the right.”

      (5) Figure 3: I did not understand how the seven bins of the cell type specificity metric were derived until much later - it is just the number of cell types in which a gene is expressed, yes? Might be worth making this clearer earlier in the text.

      We made this more explicit in the legend. “Boxplot of expression conservation of genes according to the number of different cell types in which a gene is expressed in humans (cell type specificity).”

      (6) It would be great to provide a bit more thorough documentation for the shiny app, so it can serve as a stand-alone resource and not require going back and forth with the paper to make sure one knows what one is doing at every point.

      Agree, this would be a good idea. We are on it.

      (7) Line 477: I think this is unclear - the authors retain over 11000 cells per species but then set the maximum number of cells in a cluster for pairwise comparison to 250... which is a lot fewer. What happens to all the other cells? This probably needs some rewriting to clarify it.

      We did this to minimize the power differences due to cell numbers and thus make the results more comparable across species. We added this explanation to the methods section for Marker gene detection.

      Reviewer #2 (Recommendations for the authors):

      How was the clustering resolution (0.1) determined?

      This resolution was only used for the initial rough check up of the germ layers as reported in Figure 1 and Supplementary Figures S3. We chose this resolution because it yielded roughly the same number of clusters as the number of cell types that we got from classification with the Rhodes et al data.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This study provides evidence that cerebellar projections to the thalamus are required for learning and execution of motor skills in the accelerating rotarod task. This important study adds to a growing body of literature on the interactions between the cerebellum, motor cortex, and basal ganglia during motor learning. The data presentation is generally sound, especially the main observations, with some limitations in describing the statistical methods and a lack of support for two separate cerebello-thalamic pathways, which is incomplete in supporting the overall claim.

      We completed the MS by adding a double retrograde labelling study showing that the two pathways have limited overlap and by addressing the other concerns.

      Public Reviews:

      Reviewer #1 (Public review):

      This is an interesting manuscript tackling the issue of whether subcircuits of the cerebellum are differentially involved in processes of motor performance, learning, or learning consolidation. The authors focus on cerebellar outputs to the ventrolateral thalamus (VL) and to the centrolateral thalamus (CL), since these thalamic nuclei project to the motor cortex and striatum respectively, and thus might be expected to participate in diverse components of motor control and learning. In mice challenged with an accelerating rotarod, the investigators reduce cerebellar output either broadly, or in projection-specific populations, with CNO targeting DREADD-expressing neurons. They first establish that there are not major control deficits with the treatment regime, finding no differences in basic locomotor behavior, grid test, and fixed-speed rotarod. This is interpreted to allow them to differentiate control from learning, and their inter-relationships. These manipulations are coupled with chronic electrophysiological recordings targeted to the cerebellar nuclei (CN) to control for the efficacy of the CNO manipulation. I found the manuscript intriguing, offering much food for thought, and am confident that it will influence further work on motor learning consolidation. The issue of motor consolidation supported by the cerebellum is timely and interesting, and the claims are novel. There are some limitations to the data presentation and claims, highlighted below, which, if amended, would improve the manuscript.

      We thank the reviewer for the positive comments and insightful critics.

      (1) Statistical analyses: There is too little information provided about how the Deming regressions, mean points, slopes, and intercepts were compared across conditions. This is important since in the heart of the study when the effects of inactivating CL- vs VL- projecting neurons are being compared to control performance, these statistical methods become paramount. Details of these comparisons and their assumptions should be added to the Methods section. As it stands I barely see information about these tests, and only in the figure legends. I would also like the authors to describe whether there is a criterion for significance in a given correlation to be then compared to another. If I have a weak correlation for a regression model that is non-significant, I would not want to 'compare' that regression to another one since it is already a weak model. The authors should comment on the inclusion criteria for using statistics on regression models.

      We thank the reviewer for pointing out this weakness of description. The description of the Methods has thus been expanded and better justified in the “Quantification and statistical analysis” section.

      We agree with the reviewer that comparison between Deming regressions would be fragile due to the weakness of these regression in treatment groups (while they are quite robust for control groups) and they are not included in the MS, although Deming regression coefficients with their confidence intervals are now provided for all groups in the statistical tables. As now more clearly explained in the Methods, the comparisons between groups are based on the distribution of residuals around regressions of the control regression lines. If we understand correctly the reviewer’s request, the control groups are all included.

      (2) The introduction makes the claim that the cerebellar feedback to the forebrain and cortex are functionally segregated. I interpreted this to mean that the cerebellar output neurons are known to project to either VL or CL exclusively (i.e. they do not collateralize). I was unaware of this knowledge and could find no support for the claim in the references provided (Proville 2014; Hintzer 2018; Bosan 2013). Either I am confused as to the authors' meaning or the claim is inaccurate. This point is broader however than some confusion about citation.

      The references are not cited in the context of collaterals from the DCN but for the output channels of the basal ganglia and cerebellum: “They [basal ganglia and cerebellum] send projections back to the cortex via anatomically and functionally segregated channels, which are relayed by predominantly non-overlapping thalamic regions (Bostan, Dum et al. 2013, Proville, Spolidoro et al. 2014, Hintzen, Pelzer et al. 2018).” Indeed, the thalamic compartments targeted by the basal ganglia and cerebellum are distinct, and in the Proville 2014, we showed some functional segregation of the cerebello-cortical projections (whisker vs orofacial ascending projections). Hintzen et al. have indeed performed an extensive review indicating the limited overlap between cerebellar- and basal ganglia-recipient territories. The sentence has been corrected to clarify what the “They” referred to.

      The study assumes that the CN-CL population and CN-VL population are distinct cells, but to my knowledge, this has not been established. It is difficult to make sense of the data if they are entirely the same populations, unless projection topography differs, but in any event, it is critical to clarify this point: are these different cell types from the nuclei? how has that been rigorously established?; is there overlap? No overlap? Etc. Results should be interpreted in light of the level of this knowledge of the anatomy in the mouse or rat.

      There is indeed a paragraph devoted to the discussion of this point (last part of the section “A specific impact on learning of CL-projecting CN neurons.”). Briefly, we actually know from the literature that there is a degree of collateralization (CN neurons projecting to both VAL and CL, see refs cited above), but as the reviewer says, it does not seem logically possible that the exact same population would have different effects, which are very distinct during the first learning days. The only possible explanation is the CN-CL and CN-VAL infections recruit somewhat different populations of neurons. We have now added more experiments to support our finding using retrograde infections using two rAAV viruses expressing red and green fluorescent reporter. These experiments confirm the limited overlap of the two populations of interest obtained by retrograde infection. We feel thus confident that while some CN neurons may project to both structures, retrograde infection strategies thus appear to differentially infect CN populations.

      (3) It is commendable that the authors perform electrophysiology to validate DREADD/CNO. So many investigators don't bother and I really appreciate these data. Would the authors please show the 'wash' in Figure 1a, so that we can see the recovery of the spiking hash after CNO is cleared from the system? This would provide confidence that the signal is not disappearing for reasons of electrode instability or tissue damage/ other.

      The recordings were not extended to the wash period, but examination of the firing rate before CNO on successive days did not evidence major changes in the population firing rate (this is now shown in a new supplementary figure 6).

      (4) I don't think that the "Learning" and "Maintenance" terminology is very helpful and in fact may sow confusion. I would recommend that the authors use a day range " Days 1-3 vs 4-7" or similar, to refer to these epochs. The terminology chosen begs for careful validation, definitions, etc, and seems like it is unlikely uniform across all animals, thus it seems more appropriate to just report it straight, defining the epochs by day. Such original terminology could still be used in the Discussion, with appropriate caveats.

      Since reference to these time windows is repeatedly used in the text we have shifted to “Early” and “Late” phase terminology.

      (5) Minor, but, on the top of page 14 in the Results, the text states, "Suggesting the presence of a 'critical period' in the consolidation of the task." I think this is a non-standard use of 'critical period' and should be removed. If kept, the authors must define what they mean specifically and provide sufficient additional analyses to support the idea. As it stands, the point will sow confusion.

      This has been corrected to: “suggesting the cerebellar contribution to the consolidation of the task is critical early in the learning process and cannot be easily reinstated later”

      Reviewer #2 (Public review):

      Summary:

      This study examines the contribution of cerebello-thalamic pathways to motor skill learning and consolidation in an accelerating rotarod task. The authors use chemogenetic silencing to manipulate the activity of cerebellar nuclei neurons projecting to two thalamic subregions that target the motor cortex and striatum. By silencing these pathways during different phases of task acquisition (during the task vs after the task), the authors report valuable findings of the involvement of these cerebellar pathways in learning and consolidation.

      Strengths:

      The experiments are well-executed. The authors perform multiple controls and careful analysis to solidly rule out any gross motor deficits caused by their cerebellar nuclei manipulation. The finding that cerebellar projections to the thalamus are required for learning and execution of the accelerating rotarod task adds to a growing body of literature on the interactions between the cerebellum, motor cortex, and basal ganglia during motor learning. The finding that silencing the cerebellar nuclei after a task impairs the consolidation of the learned skill is interesting.

      We thank the reviewer for the positive comments and insightful critics below.

      Weaknesses:

      While the controls for a lack of gross motor deficit are solid, the data seem to show some motor execution deficit when cerebellar nuclei are silenced during task performance. This deficit could potentially impact learning when cerebellar nuclei are silenced during task acquisition.

      One of our key controls are the tests of the treatment on fixed speed rotarod, which provides the closest conditions to the ones found in the accelerating rotarod (the main difference between the protocols being the slow steady acceleration of rod rotation in the accelerating version). Indeed, small but measurable deficits are found at the highest speed in the fixed speed rotarod in the CN-VAL group, while there was no measurable effect on the CN-CL group, which actually shows lower performances from the second day of learning; we believe this supports our claim that the CN-CL inhibition impacted more the learning process than the motor coordination. In contrast, the CN-VAL group only showed significantly lower performance on day 4 consistent with intact learning abilities. Yet, under CNO, CN-VAL mice could stay for more than a minute and half at 20rpm, while in average they fell from the accelerating rotarod as soon as the rotarod reached the speed of ~19rpm (130s). Overall, we focused our argument on the first days of learning where the differences between the groups are more pronounced. We clarified the discussion (section “A specific impact on learning of CL-projecting CN neurons.”)

      Separately, I find the support for two separate cerebello-thalamic pathways incomplete. The data presented do not clearly show the two pathways are anatomically parallel. The difference in behavioral deficits caused by manipulating these pathways also appears subtle.

      There is indeed a paragraph devoted to the discussion of this point (last part of the section “A specific impact on learning of CL-projecting CN neurons.”). Briefly, we actually know from the literature that there is a degree of collateralization (CN neurons projecting to both VAL and CL, see refs cited above), but it does not seem logically possible that the exact same population would have different effects, which are very distinct during the first learning days. The only possible explanation is the CN-CL and CN-VAL infections recruit somewhat different populations of neurons. We have now added more experiments to support our finding using retrograde infections using two rAAV viruses expressing red and green fluorescent reporter. These experiments confirm the limited overlap of the two populations of interest obtained by retrograde infection. We feel thus confident that while some CN neurons may project to both structures, retrograde infection strategies thus appear to differentially infect CN populations.

      While we agree that after 3-4 days of learning the difference between the groups becomes elusive, we respectfully disagree with the reviewer that in the early stages these differences are negligible.

      Reviewer #3 (Public review):

      Summary:

      Varani et al present important findings regarding the role of distinct cerebellothalamic connections in motor learning and performance. Their key findings are that:

      (1) Cerebellothalamic connections are important for learning motor skills

      (2) Cerebellar efferents specifically to the central lateral (CL) thalamus are important for shortterm learning

      (3) Cerebellar efferents specifically to the ventral anterior lateral (VAL) complex are important for offline consolidation of learned skills, and

      (4) That once a skill is acquired, cerebellothalamic connections become important for online task performance.

      The authors went to great lengths to separate effects on motor performance from learning, for the most part successfully. While one could argue about some of the specifics, there is little doubt that the CN-CL and CN-VAL pathways play distinct roles in motor learning and performance. An important next step will be to dissect the downstream mechanisms by which these cerebellothalamic pathways mediate motor learning and adaptation.

      Strengths:

      (1) The dissociation between online learning through CN-CL and offline consolidation through CN-VAL is convincing.

      (2) The ability to tease learning apart from performance using their titrated chemogenetic approach is impressive. In particular, their use of multiple motor assays to demonstrate preserved motor function and balance is an important control.

      (3) The evidence supporting the main claims is convincing, with multiple replications of the findings and appropriate controls.

      We thank the reviewer for the positive comments and insightful critics below.

      Weaknesses:

      (1) Despite the care the authors took to demonstrate that their chemogenetic approach does not impair online performance, there is a trend towards impaired rotarod performance at higher speeds in Supplementary Figure 4f, suggesting that there could be subtle changes in motor performance below the level of detection of their assays.

      This is now better acknowledged in the discussion in the section “A specific impact on learning of CL-projecting CN neurons.” However, we want to underline that the strongest deficit in learning is found in animals with CN->CL inhibition which latency to fall saturates at about 100s on the rotarod; this indicates that mice fall as soon as the accelerating rotarod speed reaches about 16rpm. In fixed speed rotarod, the inhibition of CN->CL neurons shows not even a trend of difference at 15rpm with control mice, and the animals run 2 minutes without falling at this speed. This makes us confident that the CN->CL pathway interfers more with the learning than with the actual locomotor function on the rotarod.

      (2) There is likely some overlap between CN neurons projecting to VAL and CL, somewhat limiting the specificity of their conclusions.

      This issue is treated in the discussion. (see also replies to reviewers 1 and 2 above). We added experiments with simultaneous retro-AAV infections in CL and VAL and the data are presented in Supplementary Figure 5. We found that retrograde infection targeted different populations of CN neurons; although collaterals in both CL and VAL may be present for (some of) these two populations of neurons, they are likely strongly biased toward one or the other thalamic regions, explaining the differential retrograde labelling in the CN. We hope these experiments will answer the reviewer’ s concern.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) Multiple studies have reported on the effect of cerebellar nuclei (CN) manipulation on locomotion. Here the authors perform several controls and careful analysis to rule out gross motor deficits caused by DREADD-mediated CN silencing. As the authors point out in the discussion, part of the difference from prior studies could be the mild degree of inhibition here. However, it is possible that the CN inhibition here induces a subtle motor deficit and the accelerating rotarod task is challenging and more readily reveals this motor deficit, rather than a deficit in motor learning per se. Two pieces of data seem to suggest this:

      (a) under CN inhibition during the task (Figure 1i), mice could never achieve the level of performance as mice under CN inhibition after the task, even after several days of training, which suggests the CN inhibition is interfering with task performance;

      (b) in highly trained mice (after learning), applying the CN inhibition impaired performance to a similar extend as mice in Figure 1i (Figure 4).

      Can the authors rule out the possibility that CN inhibition during the task is impairing motor execution rather than motor learning?

      We do not rule out a contribution of impaired motor coordination at the highest speed (last paragraph of the section “A specific impact on learning of CL-projecting CN neurons.”). Indeed, most of our argument in favor of deficit in learning is primarily in the first days (Early phase), particularly for the CN->CL CNO group (Fig 3h). A crucial control in our work is the use of fixed speed rotarod, where no deficit is observed. The difference between the fixed and accelerating rotarod is rather minimal since the acceleration of the rotarod is rather small (0.12rpm/s for speed up to >20 rpm).

      Interpreting the effect of treatment reversal is challenging. If the only effect of CNO was a motor deficit, the animals who learned under CNO should rapidly regain higher performance under saline, which is not observed. When switching from CNO to Saline after 7 days of training, it is difficult to disentangle which part is due to a crude motor deficit (which would not show in fixed speed rotarod), and which part is due to an unability to resume motor learning after the task has been (mis-)consolidated.

      (2) The separation of the cerebellar pathways to the intralaminar thalamus (IL) and ventral thalamus (VAL) is not clear to me. It is not clear the CN neurons projecting to these nuclei are distinct. In addition, although IL projects to the striatum and VAL does not, both IL and VAL project to motor cortex. It is unclear to what extent these pathways can be separated. The argument for distinct pathways (as laid out in the discussion) is the distinct behavior deficits when manipulating these two pathways, but this difference seems subtle (point 3).

      We now clarify that CN populations are different help to retrograde labelling experiments (new Suppl Fig 5). A discussion on the differences in IL and VAL projections is now discussed in the last paragraph of the section “A specific impact on learning of CL-projecting CN neurons.” Briefly, we argue that the despite some overlap of their targets, the profiles of the CL and VAL differ substantially.

      (3) The pattern of behavioral deficits induced by CN->CL and CN->VAL neurons appear similar in Figure 3b-c and e-f. I have difficulty seeing how these data lead to the differences in the regression fits in panels 3g-k, which seem to show distinct patterns of performance change within and across sessions. One notable difference in Figure 3b-c and e-f seems to be that CN->VAL CNO treated mice exhibit lower performance on the very first trial for most days. Somehow, this pattern is present even after the CNO treatment is switched to saline (Figure 3f). I wonder if this data point is driving the difference. One control analysis the authors could do is to exclude the 1st trial and test if the effects are preserved.

      Since the learning is cumulative and involves varying degree of consolidation it is indeed difficult to substantiate the difference from the average performance: a performance on day 3 may be limited by slow learning and perfect consolidation or good learning and imperfect consolidation. That is why we designed an analysis which takes into account the observed relationships between initial performance, within session gain of performance and acrosssession carry-over of this gain of performance (Fig 2). This analysis focuses on the first days of learning, before the performance plateau is reached in the CNO groups. While a clear deficit in consolidation is observed with full CN inhibition, this is not the case for the CN→CL CNO groups, despite their weaker performance after 3 days, similar to that seen with full CN inhibition. In contrast, normal learning is observed in the CN→VAL CNO group during these three days. The consolidation deficit in the CN→VAL CNO group is more subtle than in the CN CNO group and is indeed largely driven by the first data point. This is consistent with the idea that CN→VAL inhibition only partially impairs consolidation (compared to full CN inhibition), leaving some “savings” that allow rapid reacquisition.

      (4) The quantification of locomotion in Figure S2 needs more information. What is linear movement? What is sigma? What is the alternation coefficient? These are not defined in the legends or the Methods as far as I can tell. Related to point 1 above, the authors should provide some analysis of the stride length and hindlimb to forelimb distance as measures of locomotion execution.

      These measures were taken from Simon J Neurosci 2004 24(8):1987-1995 which is now cited and their description is now provided in the Methods.

      Minor:

      (5) To help readers follow the logic of experimental design, please explain why CNO was switched to saline after day 4 in Figures 1j, 3c, and f. Specifically, is the saline manipulation meant to test something as opposed to applying CNO throughout the entire course of the behavioral test?

      Since we had no difference between the groups at the end of the Early phase, we decided to test whether the skill consolidated under CNO remained available when the CNO was removed (and it indeed was). This is now more clearly stated in the Results.

      (6) I have difficulty understanding what is plotted in Figure 4b and d. The legend says the change in performance is calculated the same way as in Figure 2a, so the changes are presumably the regression slopes. But how are the regression slopes calculated for daily start (1st trial) and daily end (last trial)?

      Skill level at the beginning and end of each trial correspond to the values of the regression line for abscissae values of trial 1 and trial 7 (green points). This has been added to the figure legend.

      (7) Do CN-CL and CN-VAL neurons also project to other brain regions besides the thalamus? Might these pathways also contribute to learning and consolidation of the accelerating rotarod task? Please discuss.

      This is now discussed in more detail in the last paragraph of the section “A specific impact on learning of CL-projecting CN neurons.”

      Reviewer #3 (Recommendations for the authors):

      (1) Please check the anatomic evidence for the strict dichotomy between intralaminar (specifically central lateral nucleus) nuclei projecting to the striatum and the ventral-anteriorlateral (VAL) complex projecting to the cortex. For example, while the Chen et al paper shows that there are cerebellar-intralaminar-striatal projections, it does not exclude intralaminar cortex projections, which have at least been demonstrated in rats. Similarly, VAL has projections to striatum (see, e.g., Smith et al, "The thalamostriatal system in normal and diseased states", Frontiers in Systems Neuroscience, 2014). It may be that some of these projections are stronger, but I don't think it's true that these pathways are as well-separated as the authors suggest. I also don't think this changes the fundamental conclusions but is important for potential mechanisms by which differential learning could occur and necessitate modification of Figure 5.

      We have toned down the interpretation of CL and VAL relaying specifically to different brain structures and mostly put forward the duality of the pathways. The connections with the cortex are now discussed at the end of the section “A specific impact on learning of CL-projecting CN neurons.”

      (2) Please provide more details on the spike sorting. By what metrics were single units declared to be well-separated? How many units were identified under each condition? What was the distribution of firing rates with and without CNO treatment? Are the units shown in panel 1f from before and after CNO as in panel E or are just 2 examples of isolated units? The units by themselves are not very helpful to the reader. Showing sample auto and/or crosscorrelograms for units recorded on the same electrode would be more helpful to show how well-isolated the units are.

      Single units were considered well-isolated based on quantitative quality metrics computed after MountainSort 4 spike sorting (Phyton 3.8). Units were required to have a signal-to-noise ratio (SNR) greater than 5, inter-spike interval (ISI) violations less than 1%, an amplitude cutoff below 0.1, a presence ratio above 0.9, a firing rate greater than 0.1 Hz, and at least 50 detected spikes. In addition, units were assessed for temporal stability across the recording using autocorrelograms and presence over the recording, ensuring there were no prolonged periods of total inactivity. Units meeting these criteria were deemed well-separated and reliable for further analysis. This has been added to the Methods.

      Cell numbers are provided with the statistics in the supplementary table for fig panel 1g. Panels are from the same unit before and after CNO. Example of auto- crosscorr- are provided in the new Supplementary Figure 6.

      (3) Panel 2g - "firing rate modulation" is unclear. I think the authors are showing the mean firing rate with DREADD+CNO treatment divided by the mean firing rate in the pre-CNO condition for the same group (I couldn't find that in the Methods, my apologies if I missed it)? However, firing rate modulation to me means variability in firing rate within a recording. Perhaps "relative firing rate" or "% pre-CNO firing rate" would be clearer?

      The definition has been added to the Method and the axis has been changed to ‘Change in FR induced by SAL/CNO’

      (4) Figure 3f - why does consolidation appear to be impaired after the transition from CNO to saline between sessions, when in panel 1j suppressing the CN does not have a similar effect once CNO is switched to saline? Could this be driven by a small number of mice? Since a central conclusion of the paper is that CN-VAL connections are uniquely important for posttraining consolidation, this discrepancy is important to explain - if the results post-saline are spurious, how do we know that the results post-CNO aren't also spurious? Panels similar to Figure 4b and d showing all the data from the last/first trial of each session I think would be convincing.

      Our results overall indicate that the overnight consolidation of the improvement in performance seem only effective in the early phase (as pointed out on the summary figure 5). We do not believe then that the saline results are spurious.

      It can be seen indeed in the control groups of the figure 1; to make this more visible, we plot in Author response image 1 the difference between trial 7 and trial 1 the next day. An overnight drop in performance becomes visible in the late phase.

      Author response image 1.

      The decrement on the first trial in the first 3 days is visible for the majority of the mice. The plot asked by the reviewer is represented in the Author response image 2.

      Author response image 2.

      Minor points:

      (5) In panel 1a, the solid yellow line obscures a lot of the image and I don't think adds anything.

      We assume this was referring to a line on fig1d, which has been removed.

      (6) Panel 2a - color selection could present problems for those with red-green color blindness.

      This has been fixed.

      (7) Supplementary Figure 3 - what are the arrows and arrowheads indicating?

      These have been removed.

      (8) In the Discussion: "Studies of cerebellar synaptic plasticity provide clearly support the involvement of cerebellum in rotarod learning..." Delete the word "provide"

      This has been fixed

      (9) "This indicates that either the distinct functional roles of VAL-projecting or CLprojecting." The second "of" should be "or", I think.

      This has been fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Fecal virome transfer (FVT) has the potential to take advantage of microbiome associated phages to treat diseases such as NEC. However, FVT is also associated with toxicity due to the presence of eukaryotic viruses in the mixture, which are difficult to filter out. The authors use a chemostat propagation system to reduce the presence of eukaryotic viruses (these become lost over time during culture). They show in pig models of NEC that chemostat propagation reduce the incidence of diarrhea induced by FVTs.

      Strengths:

      The authors report an innovative yet simple approach that has the potential to be useful for future applications. Most of the experiments are easy to follow and performed well.

      Weaknesses:

      The biggest weakness is that the authors show that their technique addresses safety, but they are unable to demonstrate that they retain efficacy in their NEC model. This could be due to technical issues or perhaps the efficacy of FVT reported in the literature is not robust. If they cannot demonstrate efficacy of the chemostat propagated virome mixture, the value of the study is compromised.

      We appreciate the reviewer’s assessment and fully acknowledge that our inability to demonstrate NEC protection by FVT is a limitation to the study. If technical issues cover the variability in disease phenotype in our animal model, which is of a spontaneous nature, then yes we fully agree. Issues with FVT preparation are however unlikely, as this is performed per protocol. The effect of FVT on NEC has hitherto only been demonstrated by our research group in two individual studies using separate donor fecal material, so it is indeed too early to speculate about robustness in FVT response. We have briefly mentioned this in the results (lines 563-565) and discussion (lines 777-779), but agree that it needs further elaboration. We have now revised the discussion and conclusion to better emphasize the extent and consequences of this limitation (lines 793-797 + lines 817-818). Importantly, we show that inclusion of specific nutrients, such as milk oligosaccharides, impacts the resulting propagated fecal-derived virome. One can argue that this is not surprising, but it has nevertheless not been shown before – and it opens up possibilities for future “tailor-made” fecal-derived viromes with predictable profiles and effects.

      Even though we do not demonstrate an effect of the chemostat-propagated virome, we still believe that the study provides valuable insights as a proof-of-concept. Specifically, we demonstrate that in vitro chemostat propagation can significantly modulate the safety profile of FVT, while still driving changes in the microbiome, e.g., by decreasing C. perfringens.

      The above issue is especially concerning because the chemostat propagation selected for bacteria that may not necessarily be the ones that harbor the beneficial phages. Without an understanding of exactly how FVT works, is it possible to make any conclusion about the usefulness of the chemostat approach?

      The chemostat work was based on the idea that if we culture a fecal inoculum under suitable conditions, then the phageome would propagate alongside and allow for a scalable production method for standardized donor-independent FVT. We are cognizant that the chemostat end-culture diverged quite markedly from the fecal inoculum. In reality, such divergence is unavoidable when performing in vitro simulation of intestinal growth conditions. On the positive side, we showed that we could drive an expansion of Bacteroides spp. by supplementing the media with human milk oligosaccharides. We have previously shown that Bacteroides spp. engraft FMT recipients that are in turn protected from NEC. However, there is much room for refinement of the chemostat culture condition; i.e. to preserve the rich repertoire of lactobacilli from the inoculum e.g. by means of lowering the pH. Moreover, the loss of viral diversity in the chemostat end-culture also needs to be addressed, potentially by lowering the chemostat dilution-rate to allow the time for phage propagation. Based on these insights, we will in the near future invest heavily in improving the chemostat procedure to end up with a propagated fecal virome with better resemblance to the fecal inoculum.

      Finally, can the authors rule out that their observations in THP-1 cells are driven by LPS or some other bacterial product in the media?

      We thank the reviewer for raising this point. To minimize the influence of bacterial contaminants such as LPS or other small bacterial products, we implemented several steps during sample preparation. Specifically, we performed ultrafiltration using a 300 kDa molecular weight cut-off, which should remove small molecules, including LPS, bacterial metabolites, and other potential soluble immunomodulators. Hereafter, all viral preparations underwent endotoxin removal procedures prior to cell exposure. These precautions reduce the likelihood that our observed effects in THP-1 cells are attributable to bacterial products rather than viral components. This is explained in the referenced article (20), but we have now added the clarification to the Methods section of the revised manuscript (lines 222 and 227). The immune expression profile differs markedly between the viral preparations and the E. coli control, e.g. IFNG, TLR3, TLR8, making it highly likely that viral epitopes are the major drivers of the viral preparations with less impact by any potential bacterial epitope contaminant. This is now mentioned in the results section (line 541-543):

      Reviewer #2 (Public review):

      Major revision

      (1) As authors state that the aim of the research is 'We hypothesized that chemostat propagated viromes could modulate the GM and reduce NEC lesions while avoiding potential side effects, such as earlier onset of diarrhea'.

      (a) For the efficacy, in Fig 5, there are no significance in stomach pathology and enterocolitis between groups, even between control group and experimental groups, is it because of the low incidence of NEC? This may affect the statistical power of the conclusions. Therefore, it is unclear how one can draw the conclusion that chemostat can reduce NEC lesions?

      Thank you for highlighting this important point. We fully agree and would like to clarify that it is not our intention to conclude that chemostat propagation reduces NEC lesions under the experimental settings within this paper. Rather, this was our initial hypothesis, which could not be confirmed. The unexpectedly low incidence of NEC across groups in Piglet Experiment 1 did not allow for a clear conclusion, but the second Piglet Experiment 2 failed to show a NEC-reducing effect. We have stated this important point in the following sections:

      - Abstract (line 42-44): “However, these signatures were lost in recipients of chemostat-propagated viromes, and only minor microbiome effects and no NEC prevention were observed.”

      - Results (line 699): “This highlights that while chemostat propagation effectively mitigates virus-associated diarrhea, the method needs further optimization to targt NEC.”

      - Discussion (lines 773–775): “However, the MO-propagated chemostat virome did not increase Bacteroides or Parabacteroides spp. in the recipient’s gut, nor did it provide NEC protection.”

      - We have rephrased this to emphasize the importance of Experiment 2.

      - To avoid any potential misinterpretation, we have rephrased line 598 to reflect that we observed “a difference in the clinical side effect pattern” rather than implying efficacy.

      - Furthermore, we have updated the summary title for Figure 8 (line 704) to clearly state: “MO-propagated virome modestly exacerbates gastric injury and fails to improve NEC.”

      - Also, we have added the following section to the discussion (lines 793-797): “However, we acknowledge that the absence of demonstrated NEC prevention by the native donor virome is a significant limitation to conclusions regarding efficacy. Without a protective baseline, we cannot assess whether the virome efficacy was lost during chemostat propagation. Consequently, we cannot confirm or dismiss the hypothesis that chemostats can preserve a phage community capable of preventing NEC.”

      - Lastly, we have updated the conclusion (lines 817-818): “However, as neither the chemostat-propagated viromes nor the native donor virome demonstrated NEC prevention, the efficacy of the chemostat approach remains inconclusive.”

      - These changes should clarify that while the study demonstrates improved safety via reduced diarrhea, NEC efficacy was not obtained.

      (b) More convincing pathology images would be helpful.

      Since we did not observe a protective effect against NEC with either of the treatments, we opted not to include pathology images. However, extensive examples can be found in the cited paper (reference 37), which describes our NEC scoring methodology in the Methods section (lines 268-271): https://doi.org/10.1016/j.yexmp.2024.104936.

      (c) For the safety, such as body weight development, FVT had no statistical significance difference from control, CVT, and CVT-MO, so how can you drawn the conclusion that chemostat can avoid potential side effects?

      We appreciate the reviewer’s observation. To clarify, we do not claim that chemostat propagation completely avoids all potential side effects, but rather that it mitigates them. As shown in Fig. 5G, FVT recipients exhibited significantly reduced body weight gain compared to controls, CVT, and CVT-MO specifically on day 4, but not on day 5. This transient effect suggests that side effects such as reduced growth and early-onset diarrhea are delayed, not entirely prevented, by chemostat propagation. This is stated in the results section in lines 593-595. We also believe that this is consistent with the paper title and the conclusion that the chemostat process minimizes the adverse effects associated with native FVT (line 813).

      (d) There is lack of evidence to convince the reader that there is a decrease of eukaryotic viruses. More quantitative data here would be useful.

      Apart from the fact that it is impossible for eukaryotic viruses to shed in a system devoid of eukaryotic cells, and that the chemostat runs continuously exchanges the culture, thereby diluting any substance incapable of propagation, we agree that quantitative data to demonstrate a reduction of eukaryotic virus load is lacking.

      However, in this case we believe the relative viral abundance data are almost as convincing. To make this even clearer, we have produced new graphs showing 1) the eukaryotic viral abundance relative to total viral abundance and 2) observed eukaryotic viral species, both after medium subtraction. Eukaryotic viral relative abundances decrease from around 0.4% to approach zero already in the batch phase, and similarly number of eukaryotic viral species decrease from around 10 in the fecal inoculum to zero midway through the chemostat phase. These new graphs are now part of Supplementary figure S3 B-C. Moreover, an error in the eukaryotic viral heatmaps presented in Figure 3F now means that the relative abundance of each sample (column) now sums up to 100%. Please also notice from the lower heatmap (where the virome signature of the medium is subtracted) that no eukaryotic viruses are identified from the sequencing data of the samples from the chemostat from 50 hours and onwards.

      However, for future experiments we will consider adding a known quantity of a marker virus to the inoculum and monitoring its concentration (e.g., by qPCR) throughout the culture process. Importantly, if the resulting virome is meant for in vivo testing, this marker virus should be inert to the receiving organism.

      (2) Questions regarding Fig 3F,

      (a) How can the medium have 'the baseline viral content' ?

      As we have previously seen persistent eukaryotic viral signals in metagenomics sequencing data from chemostat experiments, we sampled and sequenced the culture medium. As is seen from Figure 3F, this only concerns Dicistroviridae, as the patterns of the remaining eukaryotic viral signals before and after medium subtraction are virtually similar. For some reason, a component of the culture medium contains a genetic signal from this entity. Since all culture components are sterilized, it is most likely genomic traces that are then continuously supplied with the medium and appears in all culture samples. As it is unlikely to derive from intact viruses, the in vivo implications are deemed minimal.

      (b) What is the statistical significance of relative abundance of specific eukaryotic viruses?

      The same as any statistical comparison on single OTU level in a nucleotide sequencing dataset. As commented above, it does not prove a quantitative depletion of eukaryotic virus throughout the chemostat process but given the context a reduction in relative abundance supports the notion that eukaryotic viruses are indeed depleted when the culture medium is exchanged. The relevant question to us is: What is the magnitude of depletion? Which is particularly relevant since the clinical data indicates a delay and not a prevention of side effects after transplantation. Hence, as proposed above, the use of a marker virus would provide us with that answer.

      (c) The hosts for some of the listed eukaryotic viruses are neither pigs or human, as such the significance of a decrease in these viruses to humans is unclear.

      Dicistroviridae is not present in the inoculum and shows up only when medium is added. Picobirnavirus and Astrovirus are relevant mammalian intestinal viruses, whereas Smacoviridae is less well described (dois: 10.3389/fvets.2020.615293 and 10.3390/v8020042). Genomoviridae as a fungal virus indeed appears to be less relevant in the case of the mammalian intestine. Indeed, at any given time point in any given individual, be it a pig or a human, it would carry with it several viral species that are incapable of infecting it, most likely transiting after being ingested with food, or in the case of pigs through rummaging. It is no secret that we have been searching for a causative agent responsible for the clinical side effect patterns related with FVT, but there seems to be no consistent viral agent that is overabundant in diarrheal piglets. Hence, in this study, we are mostly interested in the proof-of-concept for overall eukaryotic virus reduction through chemostat propagation, and we believe we have presented data in support of this.

      (3) In this study, pH 6.5 was selected as the pH value for chemostat cultivation, but considering the different adaptability of different bacteria to pH, it is recommended to further explore the effect of pH on bacteria and virus groups. In particular, it was optimized to maintain the growth of beneficial bacteria such as Lactobacillaceae and Bacteroides in order to improve the effect of chemostat cultivation.

      We agree that pH is a key parameter in shaping microbial communities during chemostat cultivation. As noted, we selected pH 6.5 to balance physiological relevance and bacterial viability, but we acknowledge that this pH may not be optimal for supporting the growth of certain potentially beneficial taxa such as Lactobacillaceae. We explicitly address this in the discussion (lines 736–741), where we state that the selected pH may have limited engraftment and that future studies should investigate pH optimization to better support bacterial groups and improve the overall effectiveness of the cultivation system.

      (4) Please improve the quality of the images, charts, error bars and statistical significance markers throughout and mark the n's. used in each experiment.

      We have carefully reviewed all figures and could not identify any general image quality issues. If some specific images or panels appear unclear or problematic, we would appreciate it if the reviewer could point them out so we can address them directly.

      Regarding sample sizes, the number of animals (n) is indicated in Fig. 5A and its legend, as well as in Fig. 8A. We have now also added this information to the legend of Fig. 8 for clarity.

      To improve the clarity of statistical findings, we have added asterisks to denote significance in panels 6A, 6F, and 7A, as requested.

      To improve the clarity of Fig. 3B, we have added a dashed line to separate LAC and LAC-MO.

      Reviewer #3 (Public review):

      Major revisions

      This study investigated the in vitro amplification of donor fecal virus using chemostat culturing technology, aiming to reduce eukaryotic virus load while preserving bacteriophage community diversity, thereby optimizing the safety and efficacy of FVT. The research employed a preterm pig model to evaluate the effects of chemostat-propagated viromes (CVT) in preventing necrotizing enterocolitis (NEC) and mitigating adverse effects such as diarrhea.

      Strengths:

      Enhanced Safety Profile: Chemostat cultivation effectively reduced eukaryotic virus load, thereby minimizing the potential infection risks associated with virome transplantation and offering a safer virome preparation method for clinical applications.

      Process Reproducibility: The chemostat system achieved stable amplification of bacteriophage communities (Bray-Curtis similarity >70%), mitigating the impact of donor fecal variability on therapeutic efficacy.

      Weaknesses:

      Loss of Phage Functionality: The chemostat cultivation resulted in a reduction in phage diversity (e.g., the loss of Lactobacillaceae phages), which may compromise their protective effects against NEC (potentially linked to the immunomodulatory functions of Lactobacilli). The authors should explicitly address this limitation in the discussion section, particularly if additional experiments cannot be conducted to resolve it within the current study.

      We appreciate the reviewer’s concern and agree that the loss of phage diversity during chemostat cultivation, especially phages targeting Lactobacillaceae, is an important limitation with potential implications for NEC protection.

      We already described the depletion of Lactobacillaceae in the chemostat and its implications in the discussion (lines 742-751 + 787-793), along with our plans to address this in future work by adjusting culture pH. However, we acknowledge that the significance of losing phage diversity deserves more explicit attention. Accordingly, we have expanded the discussion to highlight the possible consequences of this loss and its impact on phage functionality (see lines 758–762), as suggested by the reviewer.

      Limitations in Experimental Design: The low incidence of NEC lesions in the control group reduced the statistical power of the study. This limitation undermines the ability to conclusively evaluate the efficacy and safety of the chemostat-propagated virome as a novel intervention for NEC. Future studies should optimize experimental conditions (e.g., using a more NEC-susceptible model or diet) to ensure adequate disease incidence for robust statistical comparisons.

      We agree that the low NEC incidence in Experiment 1 limited the statistical power to evaluate efficacy. To address this, we designed Experiment 2 using a more NEC-inducing diet (formula 2), which resulted in a higher level of baseline lesions. This allowed for a more conclusive assessment, demonstrating that the MO-propagated chemostat virome did not provide NEC protection when using the donor feces and culture conditions applied in this experiment.

      We acknowledge that this was too unclear in the original manuscript. Please see the response to the first comment by Reviewer 2, where we have highlighted several revisions to improve clarity.

      However, we do believe the data are robust enough to conclude that the level of diarrhea — and thereby safety — was improved in the piglet model, which is why we chose to focus on this aspect in the paper’s title.

      Recommendations for the authors:

      Reviewer #3 (Recommendations for the authors):

      The manuscript presents a well-structured study investigating the feasibility of using chemostat-based culturing of the fecal virome to reduce the transfer of eukaryotic viruses during fecal virome transfer (FVT). Utilizing both in vitro fermentation systems and a preterm piglet model, the authors explore whether this method could be a safer and equally effective alternative to raw FVT for treating neonatal intestinal diseases, such as necrotizing enterocolitis (NEC). This study introduces a novel mitigation strategy for FVT through chemostat fermentation. However, a significant revision is recommended before the manuscript can be considered for publication.

      Major Changes:

      - A central aim of the study was to assess whether chemostat-cultured viromes maintain protective effects against NEC. However, this key outcome remains "unresolved" due to the low incidence of NEC in the control group. The discussion should address this limitation.

      We fully acknowledge this limitation and agree that our study cannot conclude whether the NEC effect of FVT was maintained without demonstrating an effect of this native virome. Please see our response to a similar concern raised by Reviewer 1, where we describe the revisions made to the discussion (lines 793-797) and conclusion (lines 817-818).

      - The section on viral particle enrichment should be expanded and discussed in more detail. It would be beneficial to examine its efficiency in separating bacteria from viral-like particles (VLPs) compared to findings from previously reported studies. The authors should clarify the rationale behind the selected dose of VLPs used in the experiments and their role in virus engraftment results.

      We selected the virome isolation method based on previous experiments within our lab, demonstrating efficient separation of bacteria and virus particles, using a 0.45 um filter syringe. Filtrates were quality assessed by fluorescence microscopy, showing absence of intact bacteria. Using a diverse mock virus community, we also showed a high degree of preservation of infective viruses in the FVT following the isolation procedures. We have now expanded the description of the separation method in the results section with a reference to this work (lines 188-190). We did however choose to increase the molecular weight cut off (MWCO) to enhance the exclusion of non-viral components.

      We acknowledge that the rationale and importance of the VLP dose was lacking in the discussion. This has now been added (line 758-762).

      - The viral richness of chemostat viromes was significantly lower than that of native feces. The authors should discuss how this may impact microbiome and virome outcomes.

      We have included this point in the new section about VLP dose in the discussion. Please see lines 758-762.

      - The immune response was assessed through THP-1 cells and a limited piglet cytokine panel. These may not fully represent the intestinal epithelial or mucosal immune responses. Thus, authors should acknowledge these limitations in the discussion section.

      Thank you for the comment. The limitation of using THP-1 cells as an in vitro model is already acknowledged in the results section (line 545): “Since fecal-derived eukaryotic viruses mainly infect intestinal cells, an

      in vivo stimulation may reveal a different response pattern. ”

      The limited panel of porcine cytokines was not intended as a comprehensive assessment of the mucosal immune response, but rather as supportive data for NEC-associated inflammation, as we have previously demonstrated (reference 37: https://doi.org/10.1016/j.yexmp.2024.104936). To obtain a comprehensive view of the immune response, a few days after diarrhoea onset, we additionally performed RNA-Seq analyses of the intestinal lymph node.

      - While the manuscript is comprehensive, it is also lengthy and text-heavy. Some sections could be condensed for clarity.

      The manuscript has been through multiple revisions by authors. While it is indeed lengthy, we have removed non-essential information and redundancies and now feel that the balance between data, text, figures, and supplementary information is acceptable.

      - Several figures (e.g., Figs. 1-5) contain significant data but need clearer summaries in their captions.

      We appreciate the suggestion and have revised the captions for Figs. 1-8 to provide clearer, more informative summaries of the data they present.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We sincerely thank the reviewer for the thorough and constructive evaluation of our manuscript. We greatly appreciate the recognition of our work's strengths, particularly the integration of experiments and mathematical modeling, the stochastic framework for describing sloughing events, and the insights into pressure-driven detachment dynamics.

      We have carefully considered each point raised and provide detailed responses below. In response to the reviewer's comments, we have revised the Methods section to better clarify our approach to three-dimensional assessment. We believe these revisions have improved the clarity of the manuscript.

      Below, we address each of the specific concerns raised by the reviewer:

      Public Reviews:

      Reviewer #1 (Public review):

      Weaknesses:<br /> The study achieves its primary goal of integrating experiments and modeling to understand the coupling between flow and biofilm growth and detachment in a microfluidic channel, but it should have highlighted the weaknesses of the methods. I list the ones that, in my opinion, are the main ones:

      The study does not consider biofilm porosity, which could significantly affect the flow and forces exerted on the biofilm. Porosity could impact the boundary conditions, such as the no-slip condition, which should be validated experimentally.

      Porosity is indeed a key component of biofilm structures, resulting from the polymeric nature of the EPS matrix, mechanical forces, and biological processes such as cell death or predation. When considering flow-biofilm interactions, this porosity may allow fluid flow through the biofilm, with reported permeability values spanning an extremely broad range from 1015 to 10-7 m2 (Kurz et al., 2023).

      However, we argue that biofilm permeability is not the primary driver in our system:

      (1) In microscopy visualization, our biofilms form dense structures where flow around the biofilm through narrow channels dominates over flow through the porous biofilm matrix.

      (2) We performed microrheology experiments in these biofilms by imaging the Brownian motion of nanoparticles in the biofilm. Their trajectories indicate that, in our conditions, the viscoelastic flow of the biofilm itself largely dominates over the flow of culture medium through the biofilm matrix.

      (3) We argue that the extreme variability in reported permeability values (spanning several orders of magnitude, Kurz et al., 2023) reflects not only differences in experimental systems, but also fundamental challenges in defining and measuring permeability for viscoelastoplastic biofilms (the biofilm itself is actually flowing). Given this uncertainty, incorporating permeability into our model would introduce parameters that cannot be reliably constrained from literature or independently measured in our setup. Our approach (i.e. treating the biofilm as impermeable and focusing on flow obstruction) avoids this parametrization complexity while successfully capturing the observed dynamics.

      (4) Our model successfully predicts the observed scaling laws (φmax ∝ Q1/2, Fig. 7f) and hydraulic resistance dynamics (Fig. 3) without invoking permeability, suggesting that flow obstruction rather than flow penetration is the dominant mechanism.

      Reference: Kurz, D. L.; Secchi, E.; Stocker, R.; Jimenez-Martinez, J. Morphogenesis of biofilms in porous media and control on hydrodynamics. Environ. Sci. Technol. 2023, 57 (14), 5666−5677.

      The research suggests EPS development as a stage in biofilm growth but does not probe it using lectin staining. This makes it impossible to accurately assess the role of EPS in biofilm development and detachment processes.

      We respectfully disagree that lectin staining is necessary to assess the role of EPS in our system, and we argue that our approach using genetic mutants is superior for the following reasons. Lectin staining has significant limitations. While widely used, lectin staining (e.g., concanavalin A) is non-specific (binding not only to EPS polysaccharides but also to bacterial cell surfaces) and is non-quantitative. It can confirm the presence of polysaccharides but cannot establish causal relationships between specific EPS components and mechanical properties or detachment dynamics. We performed preliminary experiments with ConA-rhodamine (data not shown), which showed widespread presence of polysaccharides. However, this provided limited insight beyond confirming EPS production, which is well-established for P. aeruginosa PAO1 biofilms. We employed a more rigorous genetic approach to directly assess the role of EPS composition. We used Δpel and Δpsl mutants (strains lacking key exopolysaccharides that are the primary structural components of the PAO1 matrix). Our results demonstrate that both mutants show significantly reduced maximum clogging compared to wild-type. The Δpsl mutant is particularly affected, with near-complete detachment at certain flow rates. These differences directly link EPS composition to mechanical stability and detachment dynamics. This genetic approach provides causal, quantitative evidence for the role of specific EPS components in biofilm development and detachment, information that lectin staining cannot provide. We believe this addresses the reviewer's concern more rigorously than lectin staining would.

      While the force and flow are three-dimensional, the images are taken in two dimensions. The paper does not clearly explain how the 2D images are extrapolated to make 3D assessments, which could lead to inaccuracies.

      We thank the reviewer for this important observation. We would like to clarify our methodological approach. Our primary three-dimensional measurement is the hydraulic resistance R(t), obtained from pressure drop measurements across the biofilm-containing channel section. This pressure-based measurement inherently captures the three-dimensional flow obstruction caused by the biofilm. We then employ a geometric model (uniform biofilm layer on all channel walls) to convert R(t) into volume fraction φ(t).

      The two-dimensional fluorescence imaging serves to validate this model-based approach rather than being the basis for three-dimensional extrapolation. The uniform layer assumption is supported by three independent lines of evidence: (i) the excellent quantitative agreement between predicted and measured scaling laws (φmax ∝ Q1/2, Fig. 7f), obtained without adjustable parameters; (ii) the high reproducibility of φmax values across different flow rates and replicates; and (iii) the strong correlation between model-derived φ(t) from pressure measurements and integrated fluorescence intensity (Fig. 3b-d).

      We have added clarifying text in the Methods section (subsection "Data analysis for the calculation of the hydraulic resistance and volume fraction") to better explain this approach and emphasize that pressure measurements provide the three-dimensional information, with the geometric model serving as the link to volume fraction.

      Although the findings are tested using polysaccharide-deficient mutants, the results could have been analyzed in greater detail. A more thorough analysis would help to better understand the role of matrix composition on the stochastic model of detachment.

      We thank the reviewer for this suggestion. Our mutant analysis demonstrates that Δpsl and Δpel strains have significantly reduced φmax and altered detachment dynamics compared to wild-type (Fig. 8), directly linking EPS composition to mechanical stability as predicted by our model. A rigorous quantitative connection between matrix composition and the stochastic parameters (interevent times, jump amplitudes) would require: (i) substantially more sloughing events for statistical power, (ii) independent mechanical characterization of each mutant, and (iii) a mechanistic model linking EPS composition to detachment parameters. We are currently developing microrheology approaches to characterize mutant mechanical properties, which could enable such refinement in future work.

      However, this represents a substantial study beyond the scope of the current manuscript, which establishes the self-sustained sloughing-regrowth cycle and its stochastic nature. The mutant results serve their intended purpose: demonstrating that EPS composition affects detachment, consistent with our model's framework.

      Reviewer #2 (Public review):

      This manuscript develops well-controlled microfluidic experiments and mathematical modelling to resolve how the temporal development of P. aeruginosa biofilms is shaped by ambient flow. The experiment considers a simple rectangular channel on which a constant flow rate is applied and UV LEDs are used to confine the biofilm to a relatively small length of device. While there is often considerable geometrical complexity in confined environments and feedback between biofilm/flow (e.g. in porous media), these simplified conditions are much more amenable to analysis. A non-dimensional mathematical model that considers nutrient transport, biofilm growth and detachment is developed and used to interpret experimental data. Regimes with both gradual detachment and catastrophic sloughing are considered. The concentration of nutrients in the media is altered to resolve the effect of nutrient limitation. In addition, the role of a couple of major polysaccharide EPS components are explored with mutants, which leads results in line with previous studies.

      There has been a vast amount of experimental and modelling work done on biofilms, but relatively rarely are the two linked together so tightly as in this paper. Predictions on influence of the non-dimensional Damkohler number on the longitudinal distribution of biofilm and functional dependence of flow on the maximum amount of biofilm (𝜙max) are demonstrated. The study reconfirms a number of previous works that showed the gradual detachment rate of biofilms scales with the square root of the shear stress. More challenging are the rapid biofilm detachment events where a large amount of biofilm is detached at once. These events occur are identified experimentally using an automated analysis pipeline and are fitted with probability distributions. The time between detachment events was fitted with a Gamma distribution and the amplitude of the detachment events was fitted with a log-normal distribution, however, it is not clear how good these fits are. Experimental data was then used as an input for a stochastic differential equation, but the output of this model is compared only qualitatively to that of the experiments. Overall, this paper does an admirable job of developing a well-constrained experiments and a tightly integrated mathematical framework through which to interpret them. However, the new insights this provides the underlying physical/biological mechanisms are relatively limited.

      We thank the reviewer for the thorough evaluation of our work and for highlighting the tight integration between experiments and modeling. We appreciate the constructive feedback regarding the goodness-of-fit for the probability distributions.

      To address the concern that "it is not clear how good these fits are," we have added quantile-quantile (Q-Q) plots for the Gamma distribution fits of inter-event times to the Supplementary Materials (Supplementary Figure S20). These plots demonstrate that the sample quantiles track the theoretical Gamma quantiles across all flow rates (0.2, 2, and 20 μL/min), indicating that the Gamma distribution provides a reasonable approximation of the overall distributional behavior. For detachment amplitudes, we selected the lognormal distribution based on the observed high skewness and kurtosis in the data, which are characteristic signatures of lognormal processes.

      Formal goodness-of-fit tests (chi-square, Kolmogorov-Smirnov) yielded mixed results across datasets, passing for some while failing for others. This variability reflects inherent noise from measurements, discrete temporal sampling, automated detection thresholds, and intrinsic biological variability. Importantly, our goal is to capture essential distributional characteristics for input into the stochastic model, not to achieve perfect statistical fit across all individual datasets. The Q-Q plots confirm that these distributions provide reasonable approximations, and the qualitative agreement between model predictions and experimental observations validates this modeling approach. We have revised the Methods section to clarify this rationale.

      We respectfully disagree that “new insights this provides the underlying physical/biological mechanisms are relatively limited.” Beyond confirming previous findings (e.g., scaling for gradual detachment), we believe our work provides several novel mechanistic insights. First, the Pe/Da criterion enables quantitative prediction of nutrient limitation regimes, allowing systematic decoupling of nutrient effects from other phenomena in biofilm studies. Second, we demonstrate that pressure, not shear, drives sloughing detachment events, a mechanism overlooked in previous studies where the notion of “shear-induced detachment” clearly dominates. Third, we show that sloughing-regrowth cycles occur even in single channels, establishing pressure-driven fluctuations as a signature of confined biofilm growth, independent of geometric complexity. Finally, the stochastic description of sloughing demonstrates that, while instantaneous biofilm states are irreproducible, the underlying randomness is predictable, therefore addressing a fundamental challenge in biofilm research.

      Recommendations For The Authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) In the abstract, I suggest clarifying the term "bacteria development." It is unclear if it refers to bacterial growth, biofilm formation, or biofilm detachment. The concept is expressed more clearly at the end of the Introduction.

      We have modified the entire abstract to make it clearer. The abstract now explicitly establishes the key processes - growth ('nutrients necessary for growth', 'growing bacteria obstruct flow paths') and detachment ('mechanical stresses that cause detachment', 'flow-induced detachment', 'sloughing') - before using 'bacterial development' as a collective term to refer to these coupled spatiotemporal dynamics. We believe the abstract is now clear as written.

      (2) Findings from Sanfilippo et al. (2019) were slightly questioned by Padron et al. (PNAS, 2023), who discovered that H2O2 transport is responsible for fro operon upregulation.

      Thanks for the clarification, which is indeed significant. The new sentence now reads: Pseudomonas aeruginosa has been found to regulate the fro operon in response to flow-modulated H2O2 concentrations (Sanfilippo et al. 2019, Padron et al. 2023).

      (3) Additionally, Kurz et al. (2022) account for pressure buildup as the mechanism controlling sloughing.

      We respectfully disagree and note that Kurz et al. (2022) identify shear stress, not pressure buildup, as the primary mechanism controlling sloughing. Besides the title, key sentences include “opening was driven by a physical process and specifically by the shear forces associated with flow through the biofilm”, “The opening of the PFPs is driven by flow-induced shear stress, which increases as a PFP becomes narrower due to microbial growth, causing biofilm compression and rupture.” While pressure differences are measured as indicators of system state and do contribute to normal compression stresses, their mechanistic explanation emphasizes that narrowing PFPs experience increased shear rates that eventually exceed the biofilm's yield stress, triggering viscoplastic deformation and detachment. The pressure buildup is a hydraulic consequence of narrowing rather than the direct cause of sloughing. In contrast, our work demonstrates that in confined geometries, pressure differences generate tangential stresses at the biofilm-solid interface that directly drive detachment.

      (4) The flow control strategy represented in Fig. 1 is not explained and should be detailed in the Methods section.

      The methods section reads as follows. Inoculation and flow experiments BHI suspensions were adjusted at optical density at OD640nm= 0.2 (108 CFU/mL) and inoculated inside the microchannels from the outlet, up to approximately ¾ of the channel length in order to keep a clean inlet. The system was let at room temperature (25°C) for 3h under static conditions. Flow experiments were then performed at 0.02, 0.2, 2, 20 and 200 μL/min constant flow rates for 72h in the microchannels at room temperature. For the experiments at 0.2, 2, 20 and 200 μL/min, the fluidic system was based on a sterile culture medium reservoir pressurized by a pressure controller (Fluigent FlowEZ) and connected with a flow rate controller (Fluigent Flow unit). The flow rate was maintained constant by using a controller with a feedback loop adjusting the pressure in the liquid reservoir. The reservoir was connected to the chip using Tygon tubing (Saint Gobain Life Sciences Tygon™ ND 100-80) of 0.52 mm internal diameter and 1.52 mm external diameter, along with PEEK tubing (Cytiva Akta pure) with 0.25 mm inner diameter adapters for flow rate controller. The waste container was also pressurized by another independent pressure controller to reduce air bubble formation in the inlet part. For the experiments at 0.02 μL/min, we used an Harvard Phd2000 syringe pump for the flow.

      (5) Including images of the actual biofilms formed in a portion of the channel would aid in understanding the analysis presented in Fig. 2.

      Images are introduced later on (eg Figure 5). There is also supplementary material showing videos.

      (6) The boundary conditions used to calculate the stress in the developed model should be discussed. The authors should specify why biofilm porosity is neglected.

      We have added a detailed discussion in the supplementary (Section I.2).

      (7) In the first section of the Results, the authors hypothesize that heterogeneity in biofilm development could be due to oxygen limitation. However, given the high oxygen permeability of PDMS, this hypothesis is later denied by their data. It would be prudent to avoid this hypothesis initially to streamline the presentation. Additionally, the authors should specify how oxygen levels at the inlet and outlet are measured.

      We appreciate this comment and agree that streamlining would simplify the presentation. However, after careful consideration, we have chosen to retain the oxygen limitation hypothesis for the following reasons: (1) oxygen limitation is a frequently invoked mechanism in biofilm systems and deserves explicit consideration, (2) it is not immediately obvious that oxygen remains non-limiting in larger microchannels where transverse gradients could develop, and (3) systematically eliminating this plausible alternative hypothesis strengthens our mechanistic conclusion that BHI drives the observed heterogeneity. Regarding oxygen measurements: we did not directly measure dissolved oxygen concentrations. Our approach is only indirect.

      (8) What is the standard deviation of the doubling time measured at different flows (page 9)?

      We have indicated the standard deviation in the text. Note that the graph shows the SEM.

      (9) What is the "zone of interest" in the channel mentioned on page 9?

      We have added the following sentence to clarify: To further understand this effect, let us consider the mass balance of biofilm in the zone of interest -- the zone where biofilm grows in between the two UVC irradiation zones -- in the channel.

      (10) Minor and major detachment events should be classified based on a defined threshold or criteria, and their frequency should be measured.

      We appreciate the reviewer's concern about quantitative rigor. However, we respectfully disagree that imposing arbitrary thresholds to classify 'minor' vs. 'major' events would improve our analysis. Detachment events in our system span a continuum of magnitudes, and any threshold would be artificial and potentially misleading. Our quantitative characterization of detachment dynamics is provided through the statistical analysis of interevent times, which we show follow a gamma distribution. This stochastic framework captures the full spectrum of detachment behavior without requiring arbitrary binning. The terms 'minor' and 'major' in our manuscript are used qualitatively to illustrate the range of observed phenomena, not as formal classifications.

      (11) Have the authors identified a reason for the peaks in the volume fraction in the Δpsl mutants at the highest flow rate?

      The biofilm thickness following these sloughing events is below our detection limit, consistent with a residual layer of cells. However, these cells grow, leading to a time window where the fraction is measurable, before a new detachment event occurs. Our understanding is that the psl mutant forms a weaker matrix with a much lower threshold for sloughing.

      (12) The fit of the probability density function for the relative density function does not match the data well. The authors should comment on this.

      We have added quantile-quantile (Q-Q) plots for the Gamma distribution fits of inter-event times to the Supplementary Materials (Supplementary Figure S20). These plots demonstrate that the sample quantiles track the theoretical Gamma quantiles across all flow rates (0.2, 2, and 20 μL/min), indicating that the Gamma distribution provides a reasonable approximation of the overall distributional behavior. For detachment amplitudes, we selected the lognormal distribution based on the observed high skewness and kurtosis in the data, which are characteristic signatures of lognormal processes. Formal goodness-of-fit tests (chi-square, Kolmogorov-Smirnov) yielded mixed results across datasets, passing for some while failing for others. This variability reflects inherent noise from measurements, discrete temporal sampling, automated detection thresholds, and intrinsic biological variability. Importantly, our goal is to capture essential distributional characteristics for input into the stochastic model, not to achieve perfect statistical fit across all individual datasets. The Q-Q plots confirm that these distributions provide reasonable approximations, and the qualitative agreement between model predictions and experimental observations validates this modeling approach. We have revised the Methods section to clarify this rationale.

      (13) Additionally, the simulated fraction appears very flat, with limited detachments compared to experiments. Why?

      The model captures the essential dynamics of growth-detachment cycles, including the characteristic timescales and volume fraction ranges. Some event-to-event variability in the experimental data likely reflects biological stochasticity not captured by our current approach—for example, variations in local biofilm mechanical properties or matrix composition that affect the precise stress at which sloughing occurs. While incorporating such biological variability as a stochastic parameter would improve detailed agreement, it would require extensive additional characterization beyond the scope of this study. The current model successfully reproduces the key qualitative and semi-quantitative features of the system.

      (14) The methods section should include a more detailed explanation of how the model was validated against experimental data.

      Model validation was performed by comparing predicted biofilm volume fraction time series and sloughing event statistics against experimental observations across multiple flow rates. The model reproduces the characteristic growth-sloughing cycles, timescales, and steady-state volume fractions without additional parameter fitting beyond the experimentally measured distributions.

      (15) It would be useful to include information on the reproducibility of the experiments and any variations observed between replicates.

      Experiments were performed in N=3 biological replicates. Individual time series for all replicates are shown in Supplementary Figures, demonstrating consistent behavior across replicates.

      (16) A discussion of the limitations of the study, particularly regarding the assumptions made in the modeling and their potential impact on the results, would strengthen the paper.

      We have added a discussion on why we chose to neglect the porosity of the biofilm, and strengthened parts on the uniform biofilm layer assumption.

      Reviewer #2 (Recommendations For The Authors):

      Page 2: "A vast" —> "The vast"

      Changed.

      The text and line widths on many of the figures are far too small. I printed it out at normal size, but had to look at a PDF and magnify to actually see what the graphs are showing. Fig. 9c is particularly illegible.

      Changed.

      Fig. 1 caption "photonic" —> "optical"?

      Changed

      Can you spell out the actual mathematical definition of 𝜙 on page 5 when it is introduced? Currently it just says the "cross section volume fraction of the biofilm", but that seems potentially ambiguous. It is valid to say that this is "fraction of the cross section occupied by the biofilm"?

      Changed

      Bottom of page 5: can you state the physical interpretation of the assumption that M is bounded between 0 and 1. i.e. that growth is larger than detachment?

      There is a comment on that in the paper. It reads “In assuming that M ∈ ]0, 1] and eliminating cases where M > 1, we have not considered situations of systematic detachment 𝜙equ = 0 for any value of the concentration, since this is not a situation that we encountered experimentally.” This comes just after presenting the expression on the only non-trivial steady-state, as it becomes easier to explain the consequences of the initial choice at this point.

      Currently the choice of detachment initially used in the model is a bit confusing. You say that you are going to assume a (1-𝜙)-1 model for simplicity (bottom of page 5), but then later you find that the (1-𝜙)3/4 model is more accurate (page 16). Since the latter has already been confirmed in numerous other studies, why not start with that one from the beginning?

      We thank the reviewer for this important question, which highlights an area where our presentation could be clearer. We did not find that the (1-φ)-3/4 model is "more accurate." Rather, we deliberately chose the (1-φ)-1 scaling because it captures pressure-induced detachment, which we hypothesized would dominate in confined flows where biofilms clog a large portion of the channel. The (1-φ)-3/4 scaling, widely used in previous studies, describes shear stress at the biofilm/fluid interface and was developed primarily for reactor systems where pressure effects are negligible. Our analysis on page 16 validates this choice by demonstrating that pressure stress indeed exceeds shear stress when volume fraction is large, which corresponds to late Stage I and all of Stage II precisely where our model is applied. The excellent quantitative agreement between predicted and measured φmax values across flow rates (Fig. 7f, Table 1) further supports the (1-φ)-1 scaling. We recognize that our initial presentation may have suggested the (1-φ)-1 choice was merely for "simplicity." We have revised this section to emphasize that this scaling was chosen specifically to capture pressure-driven detachment in confined geometries, with the physical justification provided by the stress analysis that follows. We have also clarified our ideas on page 16 to express clearly that (1-φ)-3/4 is never used. We could alternatively use a multi-modal detachment function combining both scalings, but the data do not require this additional complexity.

      In general, the models you derived in this study could be better contrasted with that from previous works. e.g. can you compare your Eqn (4) with the steady-state solutions obtained by other previous studies? Is this consistent with previous works or different? (aside from framing the biofilm thickness in terms of 𝜙)

      We are currently working on a paper dedicated to modeling biofilm development in confined flows, which will do a better job at comparing approaches.

      Top of page 6 - you assume K* = 0.1 - Does this assume that cells grow at half the rate in 0.1X BHI as they do in 1X BHI? Has this been confirmed experimentally or is this just a guess?

      This was estimated rather than measured directly. Model predictions were a lot more sensitive to the Damköhler number, than to the value of K.

      "radial" is used widely in this paper, but you are using a square geometry. Is "transverse" a better choice?

      Yes it clearly is. It’s been changed.

      Fig 3. Are panels (a) and (b) showing different bioreps of the same condition? If so, please spell that out in the caption.

      There was an error here in the caption of fig a. This has been changed. The correspondence is between a and c, and these are exactly the same, not bioreps.

      In multiple places it noted that the change in hydraulic resistance is correlated with the "change in biofilm colonization." Why not demonstrate this directly using a cross correlation analysis? How is the latter connected to the 𝜙 parameter? (e.g. is this d(𝜙)/dt?)

      We thank the reviewer for this suggestion. To clarify: φ(t) represents the volume fraction of biofilm in the channel. We measure this in two independent ways: (1) φ(t) from hydraulic resistance (black line in Fig. 3) i.e. calculated from pressure measurements using φ = 1 - √(R₀/R(t)), assuming uniform layer growth (see Methods section "Data analysis for the calculation of hydraulic resistance and volume fraction") and (2) φ(t) from fluorescence (green squares in Fig. 3) i.e. estimated from integrated GFP intensity or image segmentation of the glass/liquid interface. The reviewer is correct that we should quantify this relationship directly. We have now added correlation analysis between these two independent measurements of φ (new Supplementary Figure S21). The analysis shows strong positive correlation, with r-values ranged from 0.68 to 0.77 across all flow rates. This validates two key aspects of our approach: (1) the uniform layer assumption used to convert R(t) to φ(t) is reasonable, and (2) the pressure-based measurements accurately capture the dynamics visible in fluorescence imaging, including both growth phases and sloughing events. The strong agreement is particularly notable given that these measurements probe different aspects of the biofilm: hydraulic resistance is sensitive to the three-dimensional obstruction of flow, while fluorescence captures primarily the biofilm attached to the glass surface within our focal plane. Their correlation supports the model assumptions. We have revised the manuscript to clarify this relationship and present the correlation analysis.

      Top of page 9 - a doubling time of 110 mins is reported in liquid culture - is this in shaken or static conditions? Can you provide some data on how this was calculated? (e.g. on a plate reader?) Do you think your measurements in the microfluidics could be affected by attachment/detachment of cells, rather than being solely driven by division. It is curious that your apparent growth rate varies by a factor of two across the different flow rates and there is not a monotonic dependency. Both attachment and detachment would depend on the flow rate (with some non-trivial dependencies).e.g. https://www.pnas.org/doi/10.1073/pnas.2307718120 https://doi.org/10.1016/j.bpj.2010.11.078

      Given that your doubling time in the microfluidics is sole based on changes in cell number (rather than directly tracking cell divisions) it seems possible your results here are measuring the combined effect of growth, attachment and detachment, rather than just growth.

      We agree with those comments regarding the doubling time measurement. We have added a description of how we performed the doubling time measurement in the Methods section.

      Page 9 - you discuss the role of EPS here, but the effect of EPS is not demonstrated here and this is muddled with a discussion about the non-linearity of the putative dependency. Maybe this would be on a firmer footing if you save the discussion of EPS for the section on the Psl and Pel mutants?

      Changed.

      Middle of page 9: Please define what "smooth detachment" means and contrast it with catastrophic sloughing. Also, please define what you mean by "flow, seeding, and erosion" detachment are and how these three things differ from one another.

      We have clearly defined each term in the revised version.

      The results from wavelet scalograms seem to be underutilised and not well described. Can you clearly say what time series this analyses has been calculated on the caption? e.g. hydraulic resistance? Other than simply pointing out the "blue stripes", what can be gained from this analyses that could not be obtained with another method? It would be great if the basic features of this plot could more fully discussed (e.g. is the curved envelope at the bottom caused by edge effects?)

      We have improved the text, captions and method section following the reviewer’s comment.

      Fig. 5 a and b - please list the time at which each of these images were taken. Do these have the same dt between the two sets of images?

      Yes the dt is the same (30 minutes). It’s been indicated in the caption.

      Fig. 6: you have significant 2D variation in the biofilm width along the length of the channel. The relative contribution of pressure and shear based detachment will be different at different positions along the length. However, this variation is ignored in your model. Can you please comment on this in our manuscript and how it might affect the interpretation of your results? e.g. would the longitudinally averaged description yield the same result as one that takes the geometry into account (on average)?

      Our model indeed assumes longitudinally averaged properties. A more detailed spatially resolved model would be valuable for capturing heterogeneities and will be explored in future work.

      Bottom of page 11: you say standard deviations are in the range of 10-3. How does this jibe with the error bars on the middle flow rate in Fig. 7e?

      This extremely low standard deviation only applies to the maximum value of 𝜙 and is a completely different measurement from the whisker boxes presented in fig7e.

      Fig. 7: You are calculating the "Fraction" here. Is this "𝜙"? If so, can you put that on the y-axis instead? You calculate the volume fraction two different ways e.g. with hydraulic resistance and with imaging. Is only one of these shown in (e)? Is the same powerlaw dependence shown in (f) conserved when the other measurement of the "fraction" is used? Can you include both in Fig. 7e?

      We have modified the axis and indicated 𝜙.

      (e) is calculated only from hydraulic resistance. This is the most precise measurement to evaluate 𝜙 quantitatively.

      Related to the previous comment: Some of the estimates of 𝜙max in Table 1 are obtained by fitting the model to integrated fluorescence data (Fig. 2b), while others are estimated from measurements of the hydraulic resistance. The former yields non-unique sets of parameters. Can the biofilm fraction instead actually be estimated directly from fluorescent imaging by segmenting biofilm and directly calculating how much of the cross section is occupied by cells on average across the length? This seems like a more direct measure of this quantity. Given there are multiple ways of estimating the same parameter, it would be better consistency checking to make sure that different methods actually yield the same result.

      We have now added in Fig S21 a direct comparison of these two measurement methods. These are strongly correlated. Microscopy is more direct but only provides 2D pictures. Hydraulic resistance provides a 3D measurement, but relies on a model of biofilm distribution. Both are imperfect, but correlate well. In particular, we see that the 2D measurement does capture sloughing.

      You cite a large number of supplemental figures (e.g. Fig. S21 on page 12), but the figures in your SI only go up to 11.

      We have revised references to supplementary figures.

      Bottom of page 11: Your data from liquid culture suggests that your psl mutant grows at half the rate of WT cells. Is that consistent with your microfluidic data (e.g. Fig. 8)? If not, might this be a sign that your growth rate analyses from the microfluidics might be affected by attachment/detachment? (see comment above) Psl cells should detach much more easily.

      The approach taken to measure doubling times in the microfluidic system does not rely on the macroscopic measurements presented in figure 8, but rather on the approach presented in fig 4. These measurements require specific imaging (different magnification and time stepping) and we did not perform such experiments for the mutants.

      In analyses of sloughing, you fit the times between the jumps and the relative amplitude. Are these two random variables correlated with one another? Might that influence your results? Your methods say that "jumps were identified through through the selection of local maxima" of the derivative. Do you to say "minima" here? Did you keep all local maxima/minima or did you have a threshold?

      These are two random variables, not correlated with another. This is an assumption, and it would be interesting to analyze whether these are correlated. To perform this analysis, we believe that we would first need to acquire even more data and more replications to improve the statistical analysis.

      Yes, it was minima (in the code we make everything positive, hence the confusion).

      Yes, there is a threshold on the value of the jump itself. This value is extremely low and essentially filters out noise.

      Fig. 9 - can you make it clearer in the caption what timeseries you are analysing here? I understand from the methods this that is the "volume fraction." The data/fits are difficult to see in Fig. 9 b and impossible to see in Fig. 9c because the green bars get in the way of the other two data sets. Can this visualisation be improved? It is not clear to me how good of a job the Gamma and log-normal fits are actually doing.

      We have clarified that histograms are calculated from all experiments/replicates.

      We have slightly modified the graph to make it clearer. This comparison is intrinsically hard, partly because it compares discrete data with continuous PDFs.

      Aside from noting the results from the stochastic sloughing model are 'strikingly similar to experimental data', which seems to be based on a qualitative analysis of the lines in Fig. 7 d, e, and f. However, experimental data is not plotted in the same graph nor is the experimental data that we should be comparing this to cited in the text/caption.

      We have added a note in the caption to indicate which figure it can be compared to.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Matsen et al. describe an approach for training an antibody language model that explicitly tries to remove effects of "neutral mutation" from the language model training task, e.g. learning the codon table, which they claim results in biased functional predictions. They do so by modeling empirical sequence-derived likelihoods through a combination of a "mutation" model and a "selection" model; the mutation model is a non-neural Thrifty model previously developed by the authors, and the selection model is a small Transformer that is trained via gradient descent. The sequence likelihoods themselves are obtained from analyzing parent-child relationships in natural SHM datasets. The authors validate their method on several standard benchmark datasets and demonstrate its favorable computational cost.

      They discuss how deep learning models explicitly designed to capture selection and not mutation, trained on parent-child pairs, could potentially apply to other domains such as viral evolution or protein evolution at large.

      Strengths:

      Overall, we think the idea behind this manuscript is really clever and shows promising empirical results. Two aspects of the study are conceptually interesting: the first is factorizing the training likelihood objective to learn properties that are not explained by simple neutral mutation rules, and the second is training not on self-supervised sequence statistics but on the differences between sequences along an antibody evolutionary trajectory. If this approach generalizes to other domains of life, it could offer a new paradigm for training sequence-to-fitness models that is less biased by phylogeny or other aspects of the underlying mutation process.

      Thank you for your kind words.

      Weaknesses:

      Some claims made in the paper are weakly or indirectly supported by the data. In particular, the claim that learning the codon table contributes to biased functional effect predictions may be true, but requires more justification.

      Thank you for this comment, which made us realize that we had not adequately explained the key insight of Figure S3. We have expanded the caption of Figure S3 to clarify:

      “DASM selection factors match the pattern seen in experimental measurements, while masked language models show artifacts from the codon table.

      The experimental data (left two panels) show a slight decrease in median scores for amino acids requiring multiple nucleotide mutations (“multiple”) versus single mutations (“single”).

      DASM captures this pattern, showing similar distributions for both categories.

      In contrast, AbLang and ESM assign radically lower scores to multinucleotide amino acid substitutions, consistent with the masked language modeling objective learning codon-level mutation probabilities as described in the main text (Figure 1a).”

      This figure directly supports our claim: the experimental fitness data show similar distributions for single-mutation vs multiple-mutation amino acids, yet AbLang2 and ESM assign dramatically different scores to these groups, while DASM does not.

      Additionally, the paper could benefit from additional benchmarking and comparison to enhanced versions of existing methods, such as AbLang plus a multi-hit correction.

      It's an interesting idea to consider enhancing existing models. However, this approach faces some challenges. Most fundamentally, it is difficult to recast AbLang and other such models in an evolutionary framework: the masked language objective is simply not an evolutionary one. We have written a whole paper working to do this (https://doi.org/10.1371/journal.pcbi.1013758) and the results were middling despite our best efforts. Specifically regarding multihit, the effects of multihit are minor compared to the codon table effects, and those require the structure of codon-based evolutionary model.

      Further descriptions of model components and validation metrics could help make the manuscript more readable.

      We have clarified several aspects of the model in the revision: we now describe the Thrifty neutral model in the introduction, clarify the transformer architecture and wiggle activation function in the Methods, and explain the joint branch-length optimization procedure.

      In the introduction we now describe Thrifty:

      “This fixed model uses convolutions on 3-mer embeddings to deliver wide context sensitivity without needing a large number of parameters: the variant we use has around the same number of parameters as the classic S5F 5-mer model.”

      In the Methods we clarify the architecture:

      “We parameterize the DASM f using the standard transformer-encoder architecture: an amino-acid embedding, sinusoidal positional encodings, and PyTorch's TransformerEncoder module.

      The only non-standard component to this architecture is a custom “wiggle” activation function to the output layer that prevents extreme selection factors as previously described.

      This function asymptotes to zero for highly deleterious mutations and grows sub-linearly for beneficial ones.”

      And the joint optimization:

      “This joint optimization is performed cyclically, in which a complete cycle consists of neural network optimization followed by branch length optimization for every parent-child pair.

      The parent sequence and the child sequence are pre-estimated, fixed, and used as training data.

      The branch lengths are independent and so are optimized in parallel.”

      Reviewer #2 (Public review):

      Summary:

      Endowing protein language models with the ability to predict the function of antibodies would open a world of translational possibilities. However, antibody language models have yet to achieve breakthrough success, which large language models have achieved for the understanding and generation of natural language. This paper elegantly demonstrates how training objectives imported from natural language applications lead antibody language models astray on function prediction tasks. Training models to predict masked amino acids teaches models to exploit biases of nucleotide-level mutational processes, rather than protein biophysics. Taking the underlying biology of antibody diversification and selection seriously allows for disentangling these processes through what the authors call deep amino acid selection models. These models extend previous work by the authors (Matsen MBE 2025) by providing predictions not only for the selection strength at individual sites, but also for individual amino acid substitutions. This represents a practically important advance.

      Strengths:

      The paper is based on a deep conceptual insight, the existence of a multitude of biological processes that affect antibody maturation trajectories. The figures and writing a very clear, which should help make the broader field aware of this important but sometimes overlooked insight. The paper adds to a growing literature proposing biology-informed tweaks for training protein language models, and should thus be of interest to a wide readership interested in the application of machine learning to protein sequence understanding and design.

      Thank you for your kind words.

      Weaknesses:

      Proponents of the state-of-the-art protein language models might counter the claims of the paper by appealing to the ability of fine-tuning to deconvolve selection and mutation-related signatures in their high-dimensional representation spaces. Leaving the exercise of assessing this claim entirely to future work somewhat diminishes the heft of the (otherwise good!) argument.

      This is an interesting idea! However, it seems to us that this approach has some fundamental limitations. Existing models operate on amino acid sequences with no nucleotide representation, so while they can be implicitly biased by the codon table, they have no signal to separate selection from effects related to the codon table and SHM rates.

      We interpret this comment as proposing that we could use fine-tuning on functional data to pull out the selection components (that would only affect the functional data) versus the mutation component. That sounds like an interesting research project. We would be concerned that there are correlations between mutability and selective effects (e.g., CDRs are both more mutable and under different selection), creating identifiability problems unless separate data sources are used as we do here.

      Additionally, the fine-tuning approaches we are aware of are taskspecific: they require labeled data from a specific assay (binding to antigen X, expression in system Y) that may or may not relate to the general evolutionary selection signal. Also, such approaches are limited to the specific data used and may not do a good job of guiding the model to a signal that is not present in the training data.

      By structuring the model as we do, we obtain the evolutionary interpretation directly from phylogenetic signal without requiring taskspecific supervision.

      In the context of predicting antibody binding affinity, the modeling strategy only allows prediction of mutations that improve affinity on average, but not those which improve binding to specific epitopes.

      We agree, and this is fundamental to any general purpose model. Predictions of binding patterns for a specific target requires information about that target to be specified in the training data. We look forward to developing such task-specific models in the future.

      We have added a paragraph to the Discussion clarifying this limitation:

      “The current generation of DASM model does not use any antigen-labeled training data.

      The signal that it leverages to infer some limited ability to predict binding comes from natural affinity maturation.

      This affinity maturation comes through natural repertoires and so represents a mix of all of the antigens to which the sampled individuals have been exposed.”

      Reviewer #3 (Public review):

      Summary:

      This work proposes DASM, a new transformer-based approach to learning the distribution of antibody sequences which outperforms current foundational models at the task of predicting mutation propensities under selected phenotypes, such as protein expression levels and target binding affinity. The key ingredient is the disentanglement, by construction, of selection-induced mutational effects and biases intrinsic to the somatic hypermutation process (which are embedded in > a pre-trained model).

      Strengths:

      The approach is benchmarked on a variety of available datasets and for two different phenotypes (expression and binding affinity). The biologically informed logic for model construction implemented is compelling, and the advantage, in terms of mutational effects prediction, is clearly demonstrated via comparisons to state-of-the-art models.

      Thank you.

      Weaknesses:

      The gain in interpretability is only mentioned but not really elaborated upon or leveraged for gaining insight.

      We are also excited about the ability of these models to provide interpretable predictions. We have dedicated an entire paper to this direction: “A Sitewise Model of Natural Selection on Individual Antibodies via a Transformer-Encoder" in MBE (https://doi.org/10.1093/molbev/msaf186). The interpretations offered by that paper overturn some of the oversimplified dogma about how natural selection works in antibodies (purifying in FWK and diversifying in CDR), giving a more nuanced sitewise perspective. The paper also highlights the importance of specific structural features of the antibodies.

      This eLife paper, on the other hand, is focused on comparison to antibody language models and benchmarking zero-shot prediction on functional tasks.

      We have better highlighted this new paper in our revision with:

      “We have dedicated a companion paper to leveraging this interpretability to provide new perspectives on the operating rules of affinity maturation (Matsen et al., MBE 2025): that work provides a nuanced sitewise perspective on natural selection in antibodies that challenges classical oversimplified views of selection patterns.”

      The following aspects could have been better documented: the hyperparametric search to establish the optimal model; the predictive performance of baseline approaches, to fully showcase the gain yielded by DASM.

      We appreciate the concern and the desire to reveal all the factors that lead to a strong performance result. For this particular paper, we feel that this is less of a concern because we are optimizing according to an evolutionary objective function and then evaluating according to a functional one. We now describe how other than model size, hyperparameters stayed the same as in our previous paper (Matsen et al., MBE 2025).

      Regarding baseline approaches, our previous paper includes comparisons to simpler models for the evolutionary objective. Here we focus on comparison to antibody language models for functional prediction. Comparing between state-of-the-art models is the standard practice for papers in this field.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      We recommend modest amounts of revision, discussed below:

      Major comments:

      (1) In the first section of the results, there is extensive discussion on shortcomings of existing antibody language models like AbLang2 that seems to associate all of the performance gap with the inability to separate non-synonymous mutations separated by 1 or 2+ substitutions.

      In reality, some of the lower likelihoods in the 2+ substitution case could actually reflect real fitness deficits (while others could indeed be rarer occurrences in the training data). The authors should either moderate these claims or do an analysis that leverages antibody deep mutational scanning data to show that, conditioned on the fitness of the antibody (probably expression) being the same (either all high or all low), AbLang2 still artefactually considers rarer-training/less-codon-accessible variants to be less fit.

      As described above, we believe that this is addressed by Figure S3, but if not please correct us.

      (2) Some in the machine learning for antibody community might view the set of benchmarked datasets to be incomplete and somewhat arbitrarily selected, though we do think this is a good start, and the results are promising. A dataset commonly used in this field that is missing from this paper is from Shehata et al. (https://pubmed.ncbi.nlm.nih.gov/31553901/). A binding affinity experiment that is also commonly used in the field is from Phillips et al. (https://elifesciences.org/articles/71393) - this dataset measures combinatorial changes of framework regions on binding, which may be especially relevant here.

      We're glad to have the opportunity to clarify this, thanks.

      We based our evaluations on the April 2024 version of the FLAb benchmarking project (https://doi.org/10.1101/2024.01.13.575504) which preceded our work and thus was not subject to selection bias by us. We took the largest data sets in that repository. After this we became aware of the rich data sets offered by the Whitehead lab that provided binding measurements for many variants for a number of antigens, and added that to the evaluation set.

      We have clarified this in the manuscript:

      “We based our evaluations on the April 2024 version of the FLAb benchmarking project, which preceded our work and thus was not subject to selection bias by us.

      We also benchmarked high-throughput binding data (more recent than FLAb) from the Whitehead lab that provided affinity measurements across many variants and antigens.”

      The Shehata dataset is interesting but doesn't fit so much in the DASM mold: it is a survey of biophysical properties across many independent antibodies rather than a deep investigation of point mutants of a smaller collection of focal antibodies.

      FLAb has grown to include the Phillips dataset. We are working full-tilt on the next version of DASM and will be including many other datasets in our paper on DASM2. Thanks for the tip!

      (3) Similar to the above comment, we were also extremely curious as to why the authors did not test data from DeWitt et al. (https://pubmed.ncbi.nlm.nih.gov/40661619/). Instead, the authors only make a cryptic reference to this study on lines 201-6, but we could not even find a figure describing the results discussed on these lines. It would be great to actually include this data.

      We agree, however, our model is for human rather than mouse. We would like to train a mouse model in the future but have not yet lined up the appropriate data.

      (4) The authors should comment on potential data leakage if the SHM trajectories used in training have a similar sequence or antigen similarity to the benchmark expression/binding datasets.

      This is a good question that we should clarify. Our model is trained only on evolutionary trajectories and not functional data. Evaluation is then done on functional data without fine-tuning. Because these evaluation data are categorically different from the training data and thus data leakage is not a problem. Recall that our model is zero-shot: it only considers evolutionary trajectories and not functional data as such. In a similar way, other self-supervised models such as MLMs do not exclude seeing an antibody in the training data when they are doing functional prediction.

      We have clarified this in the manuscript with

      “Because the DASM is trained exclusively on evolutionary trajectories rather than functional measurements, evaluation on expression and binding benchmarks is strictly zero-shot with no risk of data leakage.”

      Relatedly, what happens if this approach is applied to completely de novo antibodies?

      We direct this reviewer to the Shanehsazzadeh dataset that involves antibodies that were suggested by an AI algorithm rather than observed in nature.

      If the reviewer is referring to completely synthetic antibody molecules, such as those generated by inverse folding, we have not attempted this.

      (5) It makes sense that you included the multihit correction as a response to your earlier instantiation (without this correction) underestimating the probabilities of multiple mutations in a codon associated with a single amino acid substitution (lines 476-477).

      However, this could potentially make for a somewhat unfair comparison to existing methods: if, say, we took AbLang (or another comparator) and also applied a multi-hit correction (even in some naive way at inference time), how would that compare to DASM? If this comparison favors DASM, it would show that models need more than just such a correction on top of existing methods to do good sequence scoring--which would only amplify the impact of the results.

      Thank you for this suggestion. We believe that we have addressed it in the response to the public reviews, but please let us know if not.

      Minor comments:

      (1) It would be worth explicitly defining/summarizing the mutation model used in the study, e.g. giving an overview of Thrifty in the introduction or where it first appears.

      Thanks, we have done this:

      “Our approach separates mutation and selection processes by encoding functional effects in a Deep Amino acid Selection Model (DASM) while explicitly modeling mutation using a separate fixed model trained on neutrally evolving data.

      This fixed model uses convolutions on 3-mer embeddings to deliver wide context sensitivity without needing a large number of parameters: the variant we use has around the same number of parameters as the classic S5F (Yaari et al., 2013) 5-mer model.”

      (2) Paragraph starting on line 58: it sounds like you're suggesting that masked deep learning models will learn certain features of genomes in a certain order. We suggest that you weaken the language, giving examples of various things the model could learn, not implying that such models will necessarily learn the most useful features after the less useful ones.

      We have fixed this by removing the "First... Second... Third... Finally" ordering:

      “It could memorize the germline genes and learn about the probabilities of V(D)J recombination.

      It could learn the codon table, as according to this table some aminoacid mutations are much more likely than others. It could learn rates of somatic hypermutation...

      It could also learn about the impact of amino acid mutations on antibody function through natural selection in the course of affinity maturation, which is the desired signal.

      However, this desired signal is confounded by the preceding factors.”

      (3) Line 72: You make a strong claim that existing models conflate mutation and selection without knowing for sure that they didn't successfully learn these components separately (it seems this would require a lot of mechanistic interpretability). The language could be softened here.

      We believe that we have addressed this in the response to public reviews, but please let us know if not.

      (4) Line 79: Say a bit more about the separate fixed mutation model here. Why shouldn't we worry about this choice (especially the word "fixed") biasing your results? Does the empirical performance of your method suggest this doesn't really matter?

      We have added to the description of the fixed mutation model, as described above.

      As described in the public response, training SHM models on out-of-frame sequences is an established methodology for characterizing mutation in the absence of selection. In principle one could jointly train a model of SHM and selection, but one could have identifiability problems as there is a correlation between more mutable sites (e.g. in the CDRs) and those under relaxed selection. Using out-of-frame sequences gives a clean an independent description of the SHM process.

      (5) Line 81: on what benchmarks does it outperform? State briefly.

      Great suggestion. Done:

      “The DASM, trained on substantially less data, outperforms AbLang2 and general protein language models including ESM2 and ProGen2-small. This outperformance holds on the largest benchmark datasets of the FLAb collection and on recent high-throughput binding assays.”

      (6) Paragraph starting on line 90: The topic sentence reads a bit vague to us. Do you mean that you want to learn the extent to which models are regurgitating nucleotide similarity of AAs in determining the scores associated with AAs at masked sites?

      Thank you. We have updated to

      "We first sought to understand the extent to which processes such as neutral mutation rate and the codon table influence antibody language model prediction at masked sites."

      (7) Paragraph starting on line 108: feels speculative and maybe better for the discussion...

      We appreciate this comment, but we have decided to keep the content where it is. Although this would make sense as a Discussion item we feel like it fits well here right next to the evidence, and the structure of our Discussion doesn't really have a place for it.

      (8) Paragraph starting on line 116: don't say "sequences from [12]" or "method of [15]." Explain what these are before giving the citation.

      Whoops! Thanks. We have fixed these.

      (9) Line 134: Consider giving a brief definition of perplexity?

      Thanks. We added our favorite definition:

      “Perplexity (as defined in the Methods) is the standard way of evaluating the plausibility of a sequence according to a model: it is the acrosssite geometric mean of the inverse probability of the observed amino acid.”

      (10) Line 154: A citation here could be useful to support the claim that these models are learning phylogeny.

      We have replaced with the more clearly established "codon table":

      “We implemented a model to learn amino-acid preferences of antibodies without being influenced by germline genes, the codon table, or SHM biases.”

      (11) Lines 161-162: Given that phylogenetic inference methods can be tough to scale, we're curious how you managed to get 2 million PCPs from the data? Did you construct a bunch of different phylogenies (in > parallel)?

      Indeed! We now clarify in the methods section that these trees were run in parallel across clonal families:

      “As in our previous work, tree inference and ancestral sequence reconstruction were performed per clonal family with the K80 substitution model...

      Because these clonal families are independent these phylogenetic inferences were run in parallel.”

      (12) Line 173-174: Can you say more about the joint optimization of the branch lengths? Are you conditioning on a phylogenetic tree topology only, and leaving the branch lengths unknown? Do you account for the fact that these branch lengths in the same phylogenetic tree aren't independent?

      Thanks for pointing out the need to clarify these points. We have done so in the methods section and provided a pointer to the methods section in the main text.

      In the main text we now say:

      “We trained DASMs of several sizes (~1M, ~4M, ~7M) using joint optimization of branch length t and parameters of the DASM (see Methods for details).”

      And in the Methods:

      “This joint optimization is performed cyclically, in which a complete cycle consists of neural network optimization followed by branch length optimization for every parent-child pair.

      The parent sequence and the child sequence are pre-estimated, fixed, and used as training data.

      The branch lengths are independent and so are optimized in parallel.”

      (13) Line 358: Yes, in a trivial sense, separating mutation and selection means that we know exactly how each of those two components has been learned. We would be curious if you could say anything about mechanistic interpretability within the deep learning selection model. If not, could this be a future research direction?

      We believe that we have addressed this in the response to public reviews, but please let us know if not.

      (14) Lines 384-386--indeed. Do you have any proposals for how a phylogeny could be constructed at this scale?

      As above this is not one big phylogeny but many, which invites parallelization.

      Reviewer #2 (Recommendations for the authors):

      (1) I agree that a full study of fine-tuning strategies for all possible alternative models is beyond the scope of the paper. However, a little bit of fine-tuning would go a long way to demonstrate how easy (or hard) it is to extract the relevant signal from a general protein language model embedding.

      As described in our response to the public reviews, we appreciate this point but have decided to focus on the core novelty of the paper and leave fine-tuning experiments to future work.

      (2) The authors might want to add some discussion about what signals their models capture with regard to binding affinity (averages), and how this limitation might be addressed in future work.

      As described in our response to the public reviews, we have added a paragraph to the Discussion clarifying this limitation.

      Reviewer #3 (Recommendations for the authors):

      (1) Introduction: I think more references have to be provided re: Antibody "foundation" language models, e.g. adding AntiBERTy and the two versions of AntiBERTa.

      We have added citations to those two models, although we weren't sure what the second version of AntiBERTa was. There are very many antibody language models. If we could use number ranges we would cite a dozen or more, but I hesitate to add many of them in the eLife format, which has parenthetical citations. If there are others that you consider essential don't hesitate to suggest them.

      (2) A key point of the approach is the disentanglement of “mutation” and “selection”, as mentioned in the introduction. However, the explanation of what the authors mean by mutation and selection comes only later. I would anticipate it in the introduction for clarity.

      This is a great point. The revised intro has this in the second sentence:

      “Natural antibodies are generated through V(D)J recombination, and refined by somatic hypermutation and affinity-based selection in germinal centers.”

      and the "While the masked..." paragraph now more clearly calls out selection.

      (3) Line 133: expression of what? Could the authors also explain mechanistically why expression should be impacted by a mutation? In what conditions do these data sample expression?

      We have clarified that it is expression in a phage display library:

      “To do so, we used the largest dataset of the FLAb collection of benchmarks, which measures the effect of single mutations on expression in a phage display library.”

      (4) Line 142: Clarify that 0.49 and 0.3 are correlation coefficients. Also, what type of correlation coefficient is this?

      Thanks for the catch! They are Pearson correlations as we now describe.

      (5) Line 173: The hyperparametric search should have been more documented (with a description of how it was carried out and plots).

      As described in our response to the public reviews, we are optimizing according to an evolutionary objective function and then evaluating according to a functional one. Other than model size, hyperparameters stayed the same as in our previous paper (Matsen et al., MBE 2025).

      (6) Line 358: The authors say that 'DASMs provide direct interpretability'. However, this is not really inspected. A valuable addition would be to show how such interpretability is made possible, how it can recapitulate existing biological knowledge or provide hints for antibody engineering.

      As described above, this is addressed in detail in our previous paper.

      (7) Line 398: 'Inferred insertions or deletions were reversed, so that all sequences align to the naive sequence without gaps.' Could the authors comment on whether this is a limitation of the approach, why it wasn't dealt with and whether it could be the direction of future work?

      Funny you should mention this! We have been planning out such an extension in detail recently. We have added a sentence in the discussion:

      “We also have plans to extend the DASM framework to estimate the effect of natural selection on insertion and deletion events.”

      (8) Line 430-431: Could the authors clarify 'shared' over what? Also, I believe these two lines really describe the DASM architecture. This should be spelt out more clearly and tied to the description provided in lines 173-175. A diagram of the architecture would be a valuable addition to provide a full picture of the model (this could be added to the general diagram of the modelling approach of Figure S8).

      We have clarified in the text that this is indeed a description of the DASM architecture -- thanks for the catch:

      “We parameterize the DASM f using the standard transformer-encoder architecture: an amino-acid embedding, sinusoidal positional encodings, and PyTorch's TransformerEncoder module.

      The only non-standard component to this architecture is a custom “wiggle” activation function to the output layer that prevents extreme selection factors as previously described.”

      The architecture is very “stock” - just the default torch TransformerEncoder, so I don't think that it merits a diagram. We have expanded our discussion of the simple architecture in the revision. This sits in contrast to the setup for the loss function, which is quite custom and is the subject of Figure 2 and Figure S8.

      (9) Another general remark is that, to fully showcase the predictive advantage offered by DAMS with all the modelling choices entailed, one could show the performance of simpler models, like the mutation model alone (with no selection factors), or models where selection factors are just learnt independently for each site, or are learnt with a simple linear layer instead of a transformer (these are just ideas of some simpler approach that can set baselines over which DASM improvement can be shown).

      This is a great suggestion. The primary focus of this paper is in comparing to alternate antibody language models in terms of functional prediction.

      These simpler models could be used for comparing the evolutionary objective, which we did in our previous paper (https://doi.org/10.1093/molbev/msaf186). We note that a sitewise model with fixed sites cannot really be appropriately formulated due to sequences being of different lengths.

      Additional changes

      In addition to the reviewer-requested changes, we added a comparison of ESM2 model sizes (650M vs 3B parameters) on the Koenig benchmark. We found that scaling ESM2 from 650M to 3B parameters did not improve performance. Indeed, the larger model showed slightly degraded correlations, particularly for light chain predictions. This is consistent with recent observations that medium-sized protein language models can outperform larger ones on transfer learning tasks (Vieira et al., Sci. Rep. 2025). We added Table S2 documenting these results and cite this finding in the main text to justify our use of the 650M model throughout the analyses. After doing this, we realized for the Shanehsazzadeh evaluation we had accidentally used ESM2-3B instead of ESM2-650M. The corrected ESM2-650M values are slightly lower (0.191 and 0.308 for sequence lengths 119 and 120, respectively, compared to the previous values of 0.248 and 0.337). This correction does not affect our conclusions, as DASM substantially outperforms ESM2 on this benchmark before and after the change.

      We also realized in the course of revision that we had been scoring AbLang2 using the masked-marginals pseudo-perplexity approach for the single-mutant Koenig dataset (Figure 1c), rather than the standard persequence pseudo-perplexity used elsewhere in the paper. For maskedmarginals, probabilities are computed using only wild-type context, whereas standard pseudo-perplexity uses each variant's own context.

      The masked-marginals approach has a simple interpretation: for singlemutation variants, it is a linear transformation of the log ratio of the variant amino acid probability to the wild-type amino acid probability, both evaluated under wild-type context. This log-odds ratio directly measures how much the model prefers the mutation over the original residue.

      We found that masked-marginals performed better for AbLang2 on this dataset, so we continued using it for Figure 1c. However, for the benchmarking table (Table 1), we switched to per-sequence pseudoperplexity as for the other comparisons in the paper, following the standard benchmarking protocol defined in FLAb (Chungyoun et al., 2024). We document both approaches in the Methods section:

      “An alternative “masked-marginals” approach scores variants using only wild-type context.

      For a wild-type sequence w, masked-marginals computes . for all amino acids a at each position i once, then uses these wild-type-derived probabilities to compute pseudoperplexity for any variant x...

      For a single-mutation variant x that differs from wild-type w only at position j, all terms except position j cancel when comparing to wild-type, giving . Thus, the log-probability difference between variant and wild-type amino acids equals, up to an additive constant that depends only on the wild-type sequence, negative n times the log pseudo-perplexity of the variant.

      For Figure 1c on the single-mutant Koenig dataset, we found that this approach gave a higher correlation for AbLang2 and so used it in that figure.

      For benchmarking comparisons (Table 1), we followed standard practice and used per-sequence pseudo-perplexity.”

    1. Author response:

      Updated Response, March 3, 2026

      In the midst of considering the thoughtful and insightful reviews of our manuscript and updating our work accordingly, we wanted to provide an interim update.

      In the reviews of our paper, each of the reviewers brought up questions about the specificity and sensitivity of a new "TFD-Seq" assay for protein-DNA specificity in vivo that we had developed for this work and applied here for the first time with a complex eukaryote (Figure 4). While we remain strong proponents of developing in vivo assays for protein-DNA interaction, we took to heart the concerns that the reviewers had expressed. We have therefore, in the past few weeks, done a rather "deep dive" into both the technical aspects of the TFD-Seq data and the conceptual and statistical aspects of how TFD mutation data can be interpreted. From this analysis, we find ourselves in agreement with the concerns. In particular, our "deep dive" has suggested that conclusions from TFD data (particularly negative conclusions on the presence of binding sites) will require a better understanding of signal and noise in the kind assay used in Figure 4.

      As the work is current in the submitted/preprint stage, we look forward to spending some time working (as appropriate) on both improvements to current protocols and alternative experiments to support the novel assay. An updated preprint which (for now) conveys the body of work and conclusions (which are not substantially altered), while avoiding the complexities of the TFD-seq assay is available at BioRXIV, and we will look forward to sending a version-of-record over the next few months as we have had a chance to provide robust tests for the macromolecular targets/interactors for ZNF-236 factor that was identified in this study.

      We again thank the reviewers (peer review is indeed really a good thing) and look forward to updating everyone soon.

      Updated bioRxiv preprint: https://www.biorxiv.org/content/10.1101/2025.10.22.683740v3

      Original Response, January 5, 2026

      We thank the reviewers for their insights and suggestions. We appreciate that the reviewers were engaged by both the observations and their interpretation, and consider their interest in further analysis and clarified discussion to be the best possible compliment to this work.

      As noted by the reviewers, the working hypothesis of a nuclear organization role for ZNF-236 is just one model. Clarifying this model and potential alternatives will certainly add to the manuscript and this will be a key part of the revision.  Beyond this, several suggested analyses should explore extant models, while providing context for considering alternatives.  We look forward to carrying out such analyses as feasible and will report them in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      In this manuscript, Qin and colleagues aim to delineate a neural mechanism by which the internal satiety levels modulate the intake of sugar solution. They identified a three-step neuropeptidergic system that downregulates the sensitivity of sweet-sensing gustatory sensory neurons in sated flies. First, neurons that release a neuropeptide Hugin (which is an insect homolog of vertebrate Neuromedin U (NMU)) are in an active state when the concentration of glucose is high. This activation does not require synaptic inputs, suggesting that Hugin-releasing neurons sense hemolymph glucose levels directly. Next, the Hugin neuropeptides activate Allatostatin A (AstA)-releasing neurons via one of Hugin's receptors, PK2-R1. Finally, the released AstA neuropeptide suppresses sugar response in sugar-sensing Gr5a-expressing gustatory sensory neurons through AstA-R1 receptor. Suppression of sugar response in Gr5a-expressing neurons reduces the fly's sugar intake motivation (measured by proboscis extension reflex). They also found that NMU-expressing neurons in the ventromedial hypothalamus (VMH) of mice (which project to the rostral nucleus of the solitary tract (rNST)) are also activated by high concentrations of glucose, independent of synaptic transmission, and that injection of NMU reduces the glucose-induced activity in the downstream of NMU-expressing neurons in rNST. These data suggest that the function of Hugin neuropeptide in the fly is analogous to the function of NMU in the mouse.

      Generally, their central conclusions are well-supported by multiple independent approaches. The parallel study in mice adds a unique comparative perspective that makes the paper interesting to a wide range of readers. It is easier said than done: the rigor of this study, which effectively combined pharmacological and genetic approaches to provide multiple lines of behavioral and physiological evidence, deserves recognition and praise.

      A perceived weakness is that the behavioral effects of the manipulations of Hugin and AstA systems are modest compared to a dramatic shift of sugar solution-induced PER (the behavioral proxy of sugar sensitivity) induced by hunger, as presented in Figure 1B and E. It is true that the mutation of tyrosine hydroxylase (TH), which synthesizes dopamine, does not completely abolish the hunger-induced PER change, but the remaining effect is small. Moreover, the behavioral effect of the silencing of the Hugin/AstA system (Figure Supplement 13B, C) is difficult to interpret, leaving a possibility that this system may not be necessary for shifting PER in starved flies. These suggest that the Hugin-AstA system accounts for only a minor part of the behavioral adaptation induced by the decreased sugar levels. Their aim to "dissect out a complete neural pathway that directly senses internal energy state and modulates food-related behavioral output in the fly brain" is likely only partially achieved. While this outcome is not a shortcoming of a study per se, the depth of discussion on the mechanism of interactions between the Hugin/AstA system and the other previously characterized molecular circuit mechanisms mediating hunger-induced behavioral modulation is insufficient for readers to appreciate the novelty of this study and future challenges in the field.

      We thank the reviewer for the thoughtful comment. We agree that the behavioral effects of manipulating the Hugin–AstA system alone were considerably weaker than the pronounced PER shifts induced by starvation. We have revised our Discussion to address it by positioning our findings within the broader context of energy regulation.

      More specifically, we discuss that feeding behavior is controlled by two distinct, yet synergistic, types of mechanisms:

      (1) Hunger-driven 'accelerators': as the reviewer notes, pathways involving dopamine and NPF are powerful drivers of sweet sensitivity. These systems are strongly activated by hunger to promote food-seeking and consumption.

      (2) Satiety-driven 'brakes': our study identifies the counterpart to those systems above, aka. a satiety-driven 'brake'. The Hugin–AstA pathway acts as a direct sensor of high internal energy (glucose), which is specifically engaged during satiety to actively suppress sweet sensation and prevent overconsumption.

      This framework explains the seemingly discrepancy in effect size. The dramatic PER shift seen upon starvation is a combined result of engaging the 'accelerators' (hunger pathways like TH/NPF) while simultaneously releasing the 'brake' (our Hugin–AstA pathway being inactive).

      Our manipulations, which specifically target only the 'brake' system, are therefore expected to have a more modest effect than this combined physiological state. Thus, rather than being a "minor part," the Hugin–AstA pathway is a mechanistically defined, satiety-specific circuit that is essential for the precise "braking" required for energy homeostasis. We will update our Discussion to emphasize how these 'accelerator' and 'brake' circuits must work in concert to ensure precise energy regulation.

      In this context, authors are encouraged to confront a limitation of the study due to the lack of subtype-level circuit characterization, despite their intriguing finding that only a subtype of Hugin- and AstA-releasing neurons are responsive to the elevated level of bath-applied glucose.

      We thank the reviewer for highlighting the critical issue of subtype-level specialization within the Hugin and AstA populations.

      We fully agree that the Hugin system is known for its functional heterogeneity (pleiotropy), with different Hugin neuron subclusters implicated in regulating a variety of behaviors, including feeding, aversion, and locomotion (e.g., Anna N King, Curr Biol, 2017, Andreas PLoS Biol, Sebastian et al., 2016, Nat Comm). Our finding that only a specific subcluster of Hugin neurons is responsive to glucose elevation provides a crucial first step in functionally dissecting this complexity.

      we have added a dedicated paragraph to elaborate on this functional partitioning in the discussion. We propose that this subtype-level specialization allows the Hugin system to precisely link specific physiological states (like high circulating glucose) to appropriate behavioral outputs (like the suppression of sweet taste), demonstrating an elegant solution to coordinating multiple survival behaviors. Future work using high-resolution tools such as split-GAL4 and single-cell sequencing will be invaluable in fully mapping the specific functional roles corresponding to each Hugin and AstA subcluster.

      Reviewer #2 (Public review):

      Summary:

      The question of how caloric and taste information interact and consolidate remains both active and highly relevant to human health and cognition. The authors of this work sought to understand how nutrient sensing of glucose modulates sweet sensation. They found that glucose intake activates hugin signaling to AstA neurons to suppress feeding, which contributes to our mechanistic understanding of nutrient sensation. They did this by leveraging the genetic tools of Drosophila to carry out nuanced experimental manipulations and confirmed the conservation of their main mechanism in a mammalian model. This work builds on previous studies examining sugar taste and caloric sensing, enhancing the resolution of our understanding.

      Strengths:

      Fully discovering neural circuits that connect body state with perception remains central to understanding homeostasis and behavior. This study expands our understanding of sugar sensing, providing mechanistic evidence for a hugin/AstA circuit that is responsive to sugar intake and suppresses feeding. In addition to effectively leveraging the genetic tools of Drosophila, this study further extends their findings into a mammalian model with the discovery that NMU neural signaling is also responsive to sugar intake.

      Weaknesses:

      The effect of Glut1 knockdown on PER in hugin neurons is modest, and does not show a clear difference between fed and starved flies as might be expected if this mechanism acts as a sensor of internal energy state. This could suggest that glucose intake through Glut1 may only be part of the mechanism.

      We thank the reviewer for this insightful comment and agree that the modest behavioral effect of Glut1 knockdown is a critical finding that warrants further clarification. This observation strongly supports the idea that internal energy state is monitored by a sophisticated and robust network, not a single, fragile component. We believe the effect size is modest for two main reasons, which we have addressed in revised Discussion.

      Firstly, the effect size is likely attenuated by technical and molecular redundancy. Specifically, the RNAi-mediated knockdown of Glut1 may be incomplete, leaving residual transporter function. Furthermore, Glut1 is likely only one part of the Hugin neuron's intrinsic sensing mechanism; other components, such as alternative glucose transporters or downstream K<sub>ATP</sub> channel signaling, may provide molecular redundancy, meaning that the full energy-sensing function is not easily abolished by a single manipulation.

      Secondly, and more importantly, the final feeding decision is an integrated output of competing circuits. While hunger-sensing pathways like the dopamine and NPF circuits act as powerful "accelerators" to drive sweet consumption, the Hugin–AstA pathway serves as a satiety-specific "brake." The modest effect of partially inhibiting just one component of this 'brake' system is the hallmark of a precisely regulated, multi-layered homeostatic system. We have clarified in the Discussion that the Hugin pathway represents one essential inhibitory circuit within this cooperative network that works together with the hunger-promoting systems to ensure precise control over energy intake.

      Reviewer #3 (Public review):

      Summary:

      This study identifies a novel energy-sensing circuit in Drosophila and mice that directly regulates sweet taste perception. In flies, hugin+ neurons function as a glucose sensor, activated through Glut1 transport and ATP-sensitive potassium channels. Once activated, hugin neurons release hugin peptide, which stimulates downstream Allatostatin A (AstA)+ neurons via PK2-R1 receptors. AstA+ neurons then inhibit sweet-sensing Gr5a+ gustatory neurons through AstA peptide and its receptor AstA-R1, reducing sweet sensitivity after feeding. Disrupting this pathway enhances sweet taste and increases food intake, while activating the pathway suppresses feeding.

      The mammalian homolog of neuromedin U (NMU) was shown to play an analogous role in mice. NMU knockout mice displayed heightened sweet preference, while NMU administration suppressed it. In addition, VMH NMU+ neurons directly sense glucose and project to rNST Calb2+ neurons, dampening sweet taste responses. The authors suggested a conserved hugin/NMU-AstA pathway that couples energy state to taste perception.

      Strengths:

      Interesting findings that extend from insects to mammals. Very comprehensive.

      Weaknesses:

      Coupling energy status to taste sensitivity is not a new story. Many pathways appear to be involved, and therefore, it raises a question as to how this hugin-AstA pathway is unique.

      The reviewer is correct that several energy-sensing pathways are known. However, we now clarify that these previously established mechanisms, such as the dopaminergic and NPF pathways, primarily function as hunger-driven "accelerators." They are activated by low-energy states to promote sweet sensitivity and drive consumption.

      The crucial, missing piece of the puzzle—which our study provides—is the satiety-specific "brake" mechanism. We identify the Hugin–AstA circuit as one of the “brakes”: a dedicated, central sensor that responds directly to high circulating glucose (satiety) to suppress sweet sensation and prevent overconsumption.

      Thus, our work is unique because it defines the essential counterpart to the hunger pathways. In the revised Discussion, we have explained how these 'accelerator' (hunger) and 'brake' (satiety) systems work in concert to allow for the precise, bidirectional regulation of energy intake. Furthermore, by demonstrating that this Hugin/NMU 'brake' circuit is evolutionarily conserved in mice, our findings reveal a fundamental energy-sensing strategy and suggest that this pathway could represent a promising new therapeutic target for managing conditions of excessive food intake.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Considering the comments from all three reviewers, new experiments are not necessary, but the authors are welcome to provide new pieces of evidence that would strengthen their conclusions. To assist the authors with their revisions, the comments have been categorized from the highest to lowest priority based on the concerns raised by reviewers 1, 2, and 3.

      High priority:

      (1) Acknowledgement of partial phenotypes by the genetic manipulations, especially relative to other neuromodulators that are involved in the adjustment of sugar sensitivity after starvation (1, 2).

      Please see our responses to the Public Review 1 for details.

      (2) Detailed discussion on the novelty of the present work, also in light of previous studies both in flies and mammals (known Drosophila modulators, as well as NMU-rNST circuit on sugar sensation) (1, 2, 3).

      Please see our responses to the Public Review 3 for details.

      (3) Medium priority:

      • Discussions on the subtype-specific function of hugin neurons (1).

      Please see our responses to the Public Review 1 for details.

      • Discussions on the pleiotropic effect of changes in the level of circulating sugar (including release of other sugar types) (2, 3).

      We agree that circulating sugars represent a complex, systemic signal with broad, pleiotropic effects, and we have expanded our Discussion to address this.

      We will discuss the functional distinction between key hemolymph sugars, such as trehalose (the main circulating sugar, critical for stress/flight) and glucose (the primary, rapidly mobilized energy currency). While various sugars collectively influence metabolic status, our study’s unique focus is on the direct neural link between internal energy and sweet taste modulation. We clarify that our work precisely identifies glucose as the direct, key ligand for the Hugin satiety circuit, thus providing a concrete, mechanistically defined link from systemic energy complexity to the specific regulation of sweet sensation.

      • Illustration or clear explanations of sugar application methods in mouse experiments (ex. Figure 5F vs Figure 5M), as well as discussion on the concentration of sugar solutions used (3).

      We have added the relevant details in the figure legends and explain the rationale for using this concentration of sugar in the results.

      • Less saturated image for Figure 5K (3).

      We have adjusted Figure 5K to reduce image saturation for clarity.

      • Discussions on the modest effect of NMU on rNST neurons (Figure 5M) (3).

      In the revised results, we have discussed that the modest suppression of rNST activity likely reflects partial peptide diffusion and the heterogeneous composition of sweet-responsive rNST neurons.

      (4) Low priority:

      • Systematic quantification of multiple types of sugars after starvation (3).

      We agree that circulating sugars represent a complex metabolic milieu, and a fully systematic biochemical quantification of individual hemolymph sugars after starvation would be informative. While such analyses are beyond the scope of the present study, we have addressed this point at the functional level by systematically pre-feeding flies with different types of dietary sugars prior to PER assays.

      We find that multiple sugars are capable of suppressing PER, indicating that satiety-related behavioral inhibition is not unique to a single carbohydrate source. Notably, sucrose produces the strongest suppression, consistent with its rapid metabolic conversion and effectiveness in elevating internal glucose levels. These results support the notion that diverse dietary sugars converge on a common satiety-signaling mechanism, while our mechanistic analyses specifically identify glucose as the key ligand engaging the Hugin satiety circuit.

      We now clarify this distinction in the revised Discussion.

      • Testing Gr64f neurons or mutants (3).

      Our results indicate that energy sensing in the CNS suppresses sweet-sensing neuron activity (e.g., via hyperpolarization) rather than directly blocking sugar binding to receptors. Thus, sweet perception—not sugar detection—is inhibited. As evidence, in Figure supplementary4 we measured the PER to fructose and trehalose. Although Gr5a and Gr64a differ in their sensitivity to these sugars, the CNS energy state consistently suppresses sweet perception for both. As Reviewer 3 noted, Gr5a and Gr64f are co-expressed in sweet neurons; while they respond to different sugars, their labeling of the neurons is largely equivalent.

      • Testing sugar preference (glucose vs. other sugars) (3)

      Since our primary goal was to identify a direct satiety-sensing and sensory-modulating circuit—the "brake" mechanism—PER served as the most suitable and mechanistically specific readout. While manipulation of the Hugin–AstA circuit influences internal state, and therefore likely alters long-term sugar preference, investigating the integration of this pathway with reward and post-ingestive signaling is a critical question that lies beyond the scope of the current study.

      • Cell type-specific knockout of NMU (3).

      Achieving a cell type-specific knockout of NMU using the Cre approach is not feasible in the short term. While previous studies have reported the role of NMU in the VMH region in regulating feeding, our contribution lies in revealing how these neurons sense energy. We also show that these neurons project to the vicinity of Calb2 neurons and that the neuropeptide can suppress Calb2 neuronal activity. This essentially demonstrates that the hugin–Gr5a pathway in Drosophila is conserved in mice. We believe that a detailed dissection of the precise circuitry in mice is more appropriate to address in a subsequent study.

      • Explanation of NMU detection in Figure 5K (3): this is GFP expressed by the Cre-dependent virus.

      We have revised the Figure 5K legend to clarify that NMU<sup>+</sup> neurons are labeled by GFP expression from a Cre-dependent AAV2/1-DIO-GFP, which undergoes anterograde trans-synaptic transfer. We further explain that GFP expression in rNST neurons requires local AAV-Cre injection, enabling identification of postsynaptic Calb2<sup>+</sup> target neurons.

      • Neuronal manipulation of NMU neurons by optogenetics or DREADD.

      Please see our responses to the question “Cell type-specific knockout of NMU.”

      Reviewer #1 (Recommendations for the authors):

      A major concern about the study is that the effect of genetic manipulations on Hugin/AstA system appears to account for only a small part of the dramatic shift of PER probability toward smaller concentrations of sucrose solutions among starved flies. In Figure 1B and E, PER probability is significantly higher among starved flies in response to 10-200mM of sucrose solutions than fed flies. Compared to this, RNAi knockdown of glucose transporter in hugin neurons (Figure 2C), PK2-R1 pan-neuronally (Figure 3C) or in AstA-releasing neurons (Figure 3G), AstA-R1 in Gr5a neurons (Figure 4E), systemic mutation of PK-R2 (Figure Supplement 10) and AstA-R1 (Figure Supplement 12) all produce relatively minor behavioral changes. Consistent with previous works, the mutation of TH causes a robust decrease of PER across the entire range of sucrose concentration tested (Figure Supplement 1).

      These discrepancies can be caused by many technical limitations that cannot be readily addressed. For instance, the large effect of TH can be confounded by the pleiotropic behavioral effect of the lack of dopamine. RNAi can suffer from incomplete elimination of targeted genes. However, the relatively small behavioral effect size of these manipulations cannot be entirely ignored in light of previous publications, which point to the importance of other neuromodulators such as dopamine, serotonin, Akh, and NPF, on sugar sensitivity (Marella et al., 2012; Inagaki et al., 2014; Yao et al., 2022), as well as other potentially parallel glucose-sensing systems, including Gr43a-expressing cells (Miyamoto et al., 2012) and sNPF-expressing CN neurons (Oh et al., 2019). While the neuropeptides initially tested (Figure 1) are not poor choices, it is a missed opportunity that so many other neuromodulators were excluded from the initial search.

      We appreciate the reviewer’s detailed analysis and agree that the magnitude of behavioral effects produced by manipulating the hugin–AstA pathway is smaller than the dramatic shift in PER observed under starvation conditions. This comparison is important and highlights a central conceptual point of our study.

      Starvation represents a compound physiological state that simultaneously engages multiple hunger-promoting neuromodulatory systems—most prominently dopaminergic and NPF pathways—while also releasing satiety-associated inhibitory signals. As shown previously and confirmed here (Figure supplementary 1), manipulation of dopamine synthesis produces a broad and robust reduction in PER across sucrose concentrations, consistent with its role as a powerful hunger-driven modulator.

      By contrast, our genetic manipulations specifically target a satiety-associated inhibitory circuit—the hugin–AstA pathway—that is selectively engaged by high internal glucose levels. Manipulating this pathway alone therefore isolates a single “brake” component of feeding regulation, rather than recapitulating the full physiological state of starvation, which combines both accelerator activation and brake release. Accordingly, the more modest behavioral effects we observe are an expected consequence of dissecting one defined regulatory module from a larger, cooperative network.

      We agree that multiple neuromodulators, including dopamine, serotonin, Akh, NPF, and others, as well as parallel glucose-sensing systems such as Gr43a-expressing cells and sNPF-expressing CN neurons, contribute to the regulation of sugar sensitivity. Rather than aiming to exhaustively screen all neuromodulators, our study was designed to identify and mechanistically define a central, glucose-responsive satiety sensor that directly links internal energy state to sweet taste modulation. In the revised discussion, we now explicitly position the hugin–AstA circuit as one essential, satiety-specific component within this broader regulatory landscape and discuss how it functionally complements previously characterized hunger-driven pathways.

      I am also confused by the results of Shibirets1-mediated silencing of Hugin and AstA neurons (Figure Supplement 13B, C). It is unclear to me why a feeding assay was used instead of PER, like the activation experiments. Feeding (ingestion) and PER are qualitatively different types of behavior, which cannot be directly compared. Moreover, the definition of "fold change" is not provided either in the figure legend or in the Materials and Methods section, making it difficult to understand what the figure means.

      We thank the reviewer for pointing out this important issue regarding the interpretation of the Shibire^ts1-mediated silencing experiments. We agree that proboscis extension reflex (PER) and feeding/ingestion assays reflect qualitatively different behavioral processes and should not be directly compared.

      In the original submission, feeding assays were used to assess the effect of neuronal silencing, which led to ambiguity when comparing these results with PER-based activation experiments. To directly address this concern and ensure consistency across behavioral readouts, we have now performed additional PER experiments under the same Shibire^ts1-mediated silencing conditions.

      These new data demonstrate that acute silencing of hugin neurons significantly enhances PER responses to sucrose (Figure supplementary 13B), indicating increased sweet sensitivity. This result is fully consistent with our activation experiments and supports the conclusion that the hugin–AstA pathway suppresses sweet taste perception under satiety conditions.

      In addition, we have revised the figure legend to explicitly define the “fold change” metric used in the behavioral analysis, clarifying how the values were calculated and normalized. Together, these changes resolve the ambiguity raised by the reviewer and strengthen the behavioral consistency of our conclusions.

      Of note, Marella et al. (2012) reported that silencing of Hugin-releasing neurons did not affect PER. It is therefore possible that the Hugin system is sufficient, but not necessary, for modulating PER under food deprivation.

      We agree that their observation—that silencing Hugin-releasing neurons does not alter PER in starved flies—is consistent with a state-dependent role of the Hugin system in feeding regulation.

      In starved animals, dopaminergic TH<sup>+</sup> neurons are strongly activated and promote high PER responsiveness, while circulating glucose levels are low, placing Hugin neurons in a relatively inactive state. Under such conditions, further silencing of Hugin neurons would be expected to produce minimal additional effects on PER, which likely explains the results reported by Marella et al.

      Importantly, our data show that preventing the starvation-associated reduction in Hugin neuronal activity—by thermogenetic activation of Hugin<sup>+</sup> neurons (Hugin–TrpA1; Figure 1D)—significantly suppresses the hunger-induced enhancement of PER. These results indicate that dynamic downregulation of Hugin neuronal activity is a critical component of the normal behavioral shift in sweet sensitivity in response to food deprivation. Thus, while Hugin neurons may not be required to further modulate PER once animals are already in a strongly starved state, their regulated activity change is essential for mediating state-dependent modulation of sweet taste behavior. We have added discussion in the revised manuscript.

      While no new experiments are requested, it is important for authors to acknowledge the limited effect size of Hugin/AstA manipulation. In the current manuscript, the authors briefly mention the previous works (lines 460-462, 472-474), which is insufficient. Discussions must include how the Hugin/AstA system may "complement these established mechanisms (line 460)" (described in the references listed above), under what situations this novel Hugin/AstA system can be relevant for controlling PER, and why the fly is equipped with seemingly redundant systems for sensing internal glucose levels and controlling feeding behavior. Without these discussions, it is difficult to recognize the novelty of the presented work. The data appears largely to be a minor and incremental progress on an already mature field.

      In the revised manuscript, we have substantially expanded the Discussion to explicitly acknowledge this limited effect size and to clarify the functional role of the Hugin–AstA pathway within the broader energy-regulatory network. We now emphasize that this circuit represents a satiety-specific inhibitory branch that complements, rather than replaces, previously described hunger-promoting systems such as dopaminergic, NPF, and AKH circuits.

      Importantly, we discuss the specific physiological conditions under which the Hugin–AstA system is most relevant—namely, post-feeding and high-glucose states. Unlike hunger circuits that amplify sweet sensitivity during starvation, the Hugin–AstA pathway directly senses circulating glucose and rapidly suppresses sweet taste perception when energy is sufficient, thereby acting as a brake to prevent overconsumption.

      We further address the apparent redundancy among internal sugar-sensing systems. Rather than being redundant, these pathways form a coordinated and layered network with distinct sugar specificities, temporal dynamics, and functional roles. For example, Gr43a<sup>+</sup> neurons primarily detect fructose, whereas hemolymph glucose represents the principal energetic currency in Drosophila. The use of multiple internal sugar sensors allows flies to fine-tune feeding decisions across different nutritional contexts and timescales.

      Finally, we expand the Discussion to highlight that although the Hugin–AstA circuit constitutes only one branch of the energy-sensing network, its disruption leads to excessive energy intake (Figure supplementary 13C-E, G) and increased fat accumulation (Figure S13F), underscoring its physiological relevance. We also discuss how this pathway likely interacts with other neuromodulatory systems, including TH<sup>+</sup> dopaminergic and NPF<sup>+</sup> neurons, to collectively orchestrate adaptive feeding behavior and energy homeostasis.

      Together, these additions clarify that our work does not simply add another neuromodulator to an already mature field, but instead identifies a distinct glucose-sensing, satiety-linked mechanism that fills a conceptual gap between internal energy state detection and sensory modulation.

      Another perceived weakness is the lack of subtype-level dissection among Hugin- and AstA-releasing neurons. I make a justified request to narrow down the behaviorally relevant neuron to one (or one type), which is based on a widespread but unreasonable and dangerous assumption that every behavior must be controlled by one neuron. However, the authors present very interesting data that only a subset of Hugin- and AstA-releasing neurons responds to higher levels of sucrose (Figure 1H, Figure Supplement 7A, B), which leads to a hypothesis that a specific subtype within each peptidergic neuronal group is responsible for starvation-induced behavioral change. The authors only briefly touch upon this (lines 217-218), but this is an important hypothesis that requires further discussion.

      We thank the reviewer for highlighting the importance of neuronal heterogeneity within the Hugin- and AstA-releasing populations. We fully agree that the observation that only a subset of Hugin<sup>+</sup> and AstA<sup>+</sup> neurons responds to elevated sucrose levels (Figure 1H; Figure Supplement 7A, B) strongly suggests functional specialization within these peptidergic groups.

      In the revised Discussion, we now explicitly propose that distinct subtypes of Hugin and AstA neurons differentially contribute to energy sensing and feeding modulation. We suggest that glucose-responsive subpopulations may be specifically engaged in satiety signaling, whereas other neurons within the same genetic classes may participate in additional physiological or behavioral processes. This heterogeneity provides a plausible explanation for the partial behavioral effects observed following population-level manipulations. Although we did not perform subtype-specific perturbations in this study, our findings provide a foundation for identifying these subtypes in future work using split-GAL4 lines and connectomic datasets.

      These issues are more important than the sprawling and unfocused review of various hunger and satiety-controlling systems across species in the Introduction. Lines 53-108 contain only tangential information to the main conclusion of the paper. Both the Introduction and Discussion sections must be completely restructured so that readers understand what is already known about hunger-induced changes in feeding-related behavior, what is a missing gap of knowledge in neural mechanisms controlling behavioral adaptation under starvation, and why Hugin/NMU is an interesting target in this context.

      We thank the reviewer for this important structural critique. We agree that, in the original manuscript, the Introduction placed disproportionate emphasis on a broad survey of hunger- and satiety-regulating systems across species, which may have obscured the central conceptual advance of this study.

      In the revised manuscript, we have substantially restructured both the Introduction and the Discussion to sharpen the narrative focus and clarify the specific knowledge gap addressed by our work.

      First, the Introduction has been streamlined to focus on what is already known about hunger-induced modulation of feeding-related behaviors, particularly sweet taste sensitivity and PER in Drosophila. We now emphasize that prior studies have predominantly characterized hunger-activated, feeding-promoting pathways (e.g., dopaminergic, NPF, AKH systems) that act as accelerators of food-seeking behavior.

      Second, we explicitly define the missing gap in knowledge: while hunger-driven mechanisms are well studied, it remains unclear how satiety states—specifically elevated internal glucose levels—are directly sensed by central neurons and translated into suppression of sensory gain and feeding behavior.

      Third, we reposition Hugin/NMU as an attractive and conceptually distinct target because of its peptidergic nature, evolutionary conservation, and previously reported but mechanistically unresolved links to feeding regulation. This framing motivates our central question: whether Hugin/NMU neurons function as a direct internal energy sensor that actively implements a satiety-specific inhibitory control over taste perception.

      In parallel, the Discussion has been reorganized to avoid an unfocused review of feeding circuits across species and instead to interpret our findings within a clear conceptual framework. We now emphasize that the Hugin–AstA (and NMU) pathway represents a satiety-driven “brake” that complements, rather than duplicates, established hunger-driven “accelerator” circuits. This restructuring clarifies both the novelty of our findings and their relevance within the existing literature.

      Reviewer #2 (Recommendations for the authors):

      When discussing the results of Figure 1, such as lines 203-204, "These results demonstrate that sugar intake inhibits sweet sensation, probably via increasing circulating sugar levels" it may be worth discussing the known impact of sweet sensation experience on future sweet taste responses. With the data shown here, it is difficult to conclusively separate blood glucose levels from the sweet sensation that happens during the re-feeding. The "normal diet minus sucrose" does not blunt the starved PER effect, but that could potentially be impacted by either/both sugar intake or sweet taste.

      We thank the reviewer for this thoughtful and important point. We agree that sweet taste experience itself can influence subsequent sweet sensitivity, and that separating the contribution of sensory experience from nutrient-derived internal energy is non-trivial.

      In the revised manuscript, we have clarified the experimental timing by explicitly stating that PER was assessed 15 minutes after refeeding. At this time point, hemolymph glucose levels have returned to baseline (Figure supplementary 5), supporting the physiological relevance of glucose-dependent activation of Hugin neurons under our experimental conditions.

      We also acknowledge that sweet taste exposure can induce sensory adaptation and modulate future taste responses. To directly address this potential confound, we performed additional control experiments during revision (Figure supplementary 4B) in which starved flies were refed with sorbitol (caloric but not sweet) or arabinose (sweet but non-nutritive). We found that both manipulations partially reduced PER, but neither recapitulated the full suppressive effect of sucrose refeeding.

      These results indicate that sweet taste experience and metabolic energy contribute in parallel to the regulation of sweet sensitivity. Importantly, the incomplete effects of sorbitol or arabinose alone suggest that neither sensory adaptation nor caloric value is sufficient by itself to fully account for the observed PER suppression.

      Accordingly, we have revised the Discussion to clarify that the Hugin–AstA pathway likely operates within a broader, multi-layered regulatory framework, integrating internal metabolic state with sensory experience, rather than acting as a sole determinant of post-feeding sweet sensitivity. This clarification avoids over-attribution of the behavioral effect to circulating glucose alone while preserving the central conclusion that internal energy state is a key modulator of sweet perception.

      Blocking cellular sugar intake or metabolism could be impacting the ability of neurons to function, distinct from any specific intracellular regulatory mechanism that glucose or its derivatives might be involved with. That may be a caveat worth mentioning in the results or discussion.

      We thank the reviewer for raising this important caveat. We agree that blocking cellular sugar uptake or metabolism could, in principle, impair neuronal function in a nonspecific manner, independent of any dedicated intracellular glucose-sensing mechanism.

      In the revised manuscript, we now explicitly acknowledge this possibility and clarify the scope of our interpretation. Several features of our data argue against a generalized loss of neuronal function as the primary explanation. First, the behavioral and physiological effects observed upon manipulation of glucose transport or K<sub>ATP</sub> channel activity are rapid and reversible, consistent with state-dependent modulation rather than chronic metabolic failure. Second, these manipulations selectively affect sweet sensitivity and feeding-related behaviors, without causing gross deficits in proboscis extension or neuronal responsiveness.

      Accordingly, we have revised the Results to emphasize that while intracellular glucose metabolism is required for normal neuronal activity, our findings specifically support a role for glucose-dependent modulation of neuronal excitability in satiety signaling, rather than a nonspecific energetic impairment.

      Minor suggestions:

      (1) Figure 2G: "Pryuvate" -> "Pyruvate."

      We have corrected “Pryuvate” to “Pyruvate”

      (2) "Fly" methods section: it says that flies were kept on 2% agar for 12 hours for starvation, but in the Figure 1A description, it says 24 hours.

      We have corrected the description in Figure 1A.

      Reviewer #3 (Recommendations for the authors):

      (1) SEZ Hugin+ and AstA+ neurons were activated by glucose (Figures 1G, 1I), yet hemolymph also contains trehalose and fructose. For instance, DH44 neurons respond broadly to all hemolymph sugars (Dus et al., 2015), while Gr43a neurons specifically detect fructose (Miyamoto et al., 2012). The present study does not clarify whether Hugin+ or AstA+ neurons are similarly sugar-specific or more broadly tuned. A systematic analysis is needed to determine whether these circuits are selective for glucose.

      We thank the reviewer for raising this important question regarding sugar specificity. We agree that hemolymph contains multiple sugars, including trehalose and fructose, and that distinct neural systems have been shown to differ in their tuning breadth. To address this issue, we performed additional experiments during revision in which starved wild-type flies were refed with different sugars—including sucrose, fructose, trehalose, and sorbitol—followed by PER measurements. We found that sucrose refeeding produced the strongest suppression of PER, whereas fructose, trehalose, and sorbitol induced weaker effects (Figuresupplementary 4A).

      We interpret these results as suggesting a preferential sensitivity of the Hugin/AstA pathway to glucose availability rather than a broad responsiveness to all circulating sugars. One plausible explanation is that fructose, trehalose, and sorbitol require peripheral metabolic conversion before contributing to intracellular glucose levels in neurons, whereas sucrose feeding rapidly restores hemolymph glucose within the 15-minute time window used in our experiments (Figure supplementary 5).

      Importantly, we now clarify in the revised Results and Discussion that our data support a functional preference for glucose under physiological conditions, rather than excluding the possibility that other sugars may influence this circuit indirectly or on longer timescales.

      (2) The authors state that SEZ, but not VNC, Hugin+ neurons regulate AstA activity (lines 318-319). However, comparison of Figure Supplement 8B with the severing sample in Figure Supplement 11B shows a more pronounced reduction of sweet sensation under hug>TrpA1 activation. Although the absolute response in Figure 3F (in vivo) is higher than that in the cut-off preparation (Figure S11), comparison of Figure S11C with Figure 3F indicates that hug+ neurons drive an AstA+ calcium transient more than fourfold greater in the presence of VNC neurons. Thus, the contribution of Hugin+ VNC neurons cannot be dismissed, and the conclusion should be revised accordingly.

      We thank the reviewer for this careful and quantitative comparison. We agree that our original wording overstated the exclusivity of SEZ Hugin<sup>+</sup> neurons in regulating AstA activity.

      Upon closer examination of the data, we now acknowledge that VNC Hugin<sup>+</sup> neurons likely contribute to AstA activation. As the reviewer points out, the AstA<sup>+</sup> calcium response evoked by Hugin activation is substantially larger when VNC neurons are intact (Figure supplementary11C) compared with the cut preparation (Figure 3F), indicating that descending inputs from the VNC can potentiate AstA neuronal activity.

      Accordingly, we have revised the manuscript to state that SEZ Hugin<sup>+</sup> neurons play a predominant role in driving AstA responses relevant to sweet sensation, while VNC Hugin<sup>+</sup> neurons provide additional modulatory input that enhances the overall magnitude of Hugin signaling. These revisions have been made in the Results to more accurately reflect the contributions of distinct Hugin subpopulations.

      (3) In Figure 4D, you show AstA-R1 co-localized with Gr5a-expressing cells. However, Gr5a-expressing cells also co-express Gr64f in labellum (Fuji et al., 2015, Current Biology). Are the authors sure that the sweet sensation they described is Gr5a-specific? Testing Gr64f is essential. Moreover, Fuji et al. demonstrated that Gr5a loss-of-function mutation impairs not only sucrose but also maltose, fructose, and trehalose sensation. This raises a question of whether the Hug+ and AstA+ neurons identified in the current study contribute to sensing sugars beyond sucrose. Additional experiments are required to clarify this point.

      Please see our responses to the Reviewing Editor Comments (4).

      (4) While nutritive sugar sensors such as Dh44 neurons have been directly implicated in sugar preference (Dus et al., 2015, Neuron), this study examines the hug+,AstA+, Gr5a neuronal circuit only in the context of PER responses. Why is sugar preference not assessed here, especially given that in mice, the comparison was made using preference tests?

      We thank the reviewer for this insightful question. We agree that sugar preference assays provide important information about feeding decisions and reward-based behavior. In the present study, however, we deliberately focused on the proboscis extension reflex (PER) because it offers a direct, quantitative, and temporally precise readout of sweet sensory sensitivity at the sensory–motor level.

      PER allows us to isolate changes in taste perception itself, largely independent of post-ingestive reinforcement, learning, or motivational state, all of which strongly influence preference-based assays. This distinction is particularly important given our central goal of identifying a circuit that directly links internal energy sensing to modulation of peripheral sweet-sensing neurons.

      By contrast, sugar preference reflects an integrated behavioral outcome combining sensory input, internal state, and post-ingestive reward signals, including those mediated by DH44 neurons and other nutritive sensing pathways. We therefore chose PER as the most mechanistically specific assay to dissect the Hugin–AstA–Gr5a pathway. We now explicitly acknowledge in the revised Discussion that determining how this satiety-linked sensory modulation interacts with reward and post-ingestive circuits to shape long-term sugar preference will be an important direction for future studies.

      Several other concerns:

      (5) The intraperitoneal injection of NMU is interpreted as reflecting a brain-specific NMU effect, but such systemic delivery cannot exclude peripheral actions. In Figure 5D, the use of whole-body KO mice is insufficient; targeted manipulations (e.g., NMU-Cre-driven inactivation) are required to establish circuit-specific behavioral roles.

      Please see our responses to the Reviewing Editor Comments (Low priority)

      (6) In Figure 5F and 5M, neural activity is measured under different conditions: gastric glucose infusion in 5F versus glucose licking in 5M. To establish that NMU VMH neurons and Calb2 rNST neurons belong to the same circuit, this discrepancy in stimulation timing must be resolved to support the conclusions.

      We thank the reviewer for pointing out this important issue regarding stimulation paradigms in Figures 5F and 5M. We agree that the difference between gastric glucose infusion and glucose licking requires explicit clarification.

      In the revised manuscript, we now clearly state that these two paradigms were intentionally designed to probe complementary levels of the same NMU–Calb2 circuit. In Figure 5F, gastric glucose infusion was used to isolate the internal energy-sensing property of VMH NMU<sup>+</sup> neurons, independent of oral sensory input, motor behavior, or reward expectation. This experiment establishes that NMU<sup>+</sup> neurons are directly activated by elevated circulating glucose.

      By contrast, Figures 5M examined how activation of this NMU pathway modulates downstream Calb2<sup>+</sup> rNST neurons under physiologically relevant feeding conditions, in which sweet taste signals are naturally evoked by licking. This design allows us to test the functional consequence of NMU signaling on sweet-responsive rNST neurons during normal sensory processing.

      Although the route and timing of glucose delivery differ, both paradigms converge on a unified circuit model: internal glucose elevation activates VMH NMU<sup>+</sup> neurons, and NMU signaling suppresses sweet-driven activity in Calb2<sup>+</sup> rNST neurons. We have revised the Results and figure legends to explicitly describe this layered experimental logic and to clarify that Figures 5F and 5M together establish distinct but connected nodes of the same circuit.

      (7) Figure 5I-J. The glucose concentration used appears excessively high. In mammals, blood glucose in the sated state is ~7-8 mM. It is unclear whether the observed responses represent physiological effects or artifacts of supraphysiological stimulation. Additional experiments with lower glucose concentrations would strengthen the study.

      We thank the reviewer for raising this important concern regarding the glucose concentration used in Figure 5I–J. We agree that the concentration applied in ex vivo slice experiments exceeds the typical physiological range of circulating glucose.

      This higher concentration was intentionally chosen to ensure reliable neuronal activation in acute brain slices, where glucose diffusion, uptake, and metabolic access are substantially slower than in vivo. Similar approaches have been widely used in studies of glucose-sensitive hypothalamic neurons to overcome these technical limitations (e.g., Kim et al., 2025., Neuron).

      Importantly, the physiological relevance of our findings is supported by in vivo fiber photometry experiments, which demonstrate that VMH NMU⁺ neurons are robustly activated following normal sugar ingestion under physiological conditions. Thus, while supraphysiological glucose was used to establish glucose responsiveness ex vivo, our in vivo data confirm that NMU⁺ neurons respond to glucose elevations within the normal physiological range.

      (8) Figure 5K. The VMH images are inconsistently oriented compared with Figure 5E, lacking a 3v landmark. The NMU detection method (IHC or FISH) is not specified in the legend. The GFP-Calb2 signal is heavily saturated, making it difficult to distinguish true signals from artifacts. These issues undermine interpretability.

      We thank the reviewer for pointing out these issues. In the revised manuscript, VMH images in Figure 5K have been reoriented to match Figure 5E, and the third ventricle (3v) is now indicated as an anatomical landmark. The figure legend has been revised to clarify that NMU<sup>+</sup> neurons are identified by GFP expression from a Cre-dependent AAV2/1-DIO-GFP injected into NMU-Cre mice, rather than by NMU immunohistochemistry or FISH. In addition, GFP–Calb2 images have been reprocessed to clearly distinguish true signals from background and imaging artifacts.

      (9) Figure 5L-M. Details of the NMU injection method are absent (route, dose, delivery parameters). The number of animals (n) is also not reported. Furthermore, AUC reduction alone is not sufficient evidence of robust inhibition. To convincingly demonstrate causality, NMU-IRES-Cre mice should be combined with DREADD or optogenetic approaches to directly inhibit NMU neurons and test whether rNST Calb2 activity is reduced.

      We thank the reviewer for these helpful comments. We have revised the manuscript to include all missing methodological details. These details are now clearly described in the Methods section and figure legend.

      We fully acknowledge that cell-type–specific manipulations, such as DREADD or optogenetic inhibition of NMU neurons, would provide more definitive causal evidence. However, our main goal in the mouse experiments was to demonstrate that NMU<sup>+</sup> neurons can directly sense glucose and modulate sweet sensitivity, thereby supporting the evolutionary conservation of the Hugin mechanism identified in Drosophila. Detailed dissection of the downstream circuit architecture and behavioral consequences in mammals is indeed an important direction for future research, but it lies beyond the current study’s primary focus on cross-species conservation.

      (10) In Drosophila, hugin neurons respond selectively to nutritive glucose (Fig. 2H), but whether NMU neurons share this property is unknown. Notably, Calb2 neurons in the rNST respond to the artificial sweetener AceK (Hao Jin et al., 2021, Cell), leaving open whether the NMU-rNST circuit is calorie-dependent or calorie-independent.

      We have added a statement in the Discussion acknowledging this limitation and emphasizing that future work will be needed to test whether the NMU–Calb2 circuit is selectively engaged by metabolically active sugars or also by sweet taste signals independent of caloric value.

      Minor comments

      (11) All bar graphs should include individual data points.

      We have added individual data points to all bar graphs.

      (12) In Figures 3E, 4C, and 4D, it appears that a combination of GAL4 and LexA was used, but the information about the fly lines is missing.

      We have now included the complete list of fly lines used for these experiments, including their genotypes and sources.

      (13) The source for PK2-R1 KO, AstA-R1 KO fly lines and NMU-IRES-Cre, Calb2-IRES-Cre mice is missing.

      We have added the complete source information for all genetic lines mentioned.

      (14) Figure 5B-D, This is a sucrose preference test, so why is the y-axis labeled as glucose? Is this an error, or were the values converted to glucose equivalents?

      We thank the reviewer for catching this mistake. The assay shown in Figure 5B–D measured sucrose preference, not glucose preference. The inconsistency resulted from a typographical error in the Methods description. In the revised manuscript, we have corrected this error to clearly state that sucrose was used in the preference test,

      (15) Supplementary Figure 15. The NMU images are of poor quality and should be improved.

      The punctate appearance of NMU signals in Supplementary Figure 15 is not due to poor image quality but rather reflects the physiological distribution of the NMU neuropeptide. As NMU is stored in secretory vesicles within neuronal terminals and somata, its immunostaining typically appears as discrete puncta rather than diffuse cytoplasmic labeling.

      Editor's note:

      Should you choose to revise your manuscript, if you have not already done so, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and, where appropriate, 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.<br /> Readers would also benefit from noting that the mice were male and discussion of the exclusion of females.

      In the revised manuscript, we have included full statistical reporting for all key experiments in the resource data. Regarding animal sex, we confirm that all mouse experiments were conducted using male mice. This choice was made to minimize variability caused by hormonal cycles in females, which can influence feeding behavior and glucose metabolism. We have now explicitly stated this information in the Methods section and included a brief discussion noting that sex-specific differences in NMU–Calb2 circuitry and feeding regulation represent an important question for future investigation.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The paper uses rigorous methods to determine phase dynamics from human cortical stereotactic EEGs. It finds that the power of the phase is higher at the lowest spatial phase. The application to data illustrates the solidity of the method and their potential for discovery.

      Comments on revised submission:

      The authors have provided responses to the previous recommendations.

      We thank the reviewer for reviewing our manuscript again, and for their positive evaluation.

      Reviewer #3 (Public review):

      Summary:

      The authors propose a method for estimating the spatial power spectrum of cortical activity from irregularly sampled data and apply it to iEEG data from human patients during a delayed free recall task. The main findings are that the spatial spectra of cortical activity peak at low spatial frequencies and decrease with increasing spatial frequency. This is observed over a broad range of temporal frequencies (2-100 Hz).

      Strenghs:

      A strength of the study is the type of data that is used. As pointed out by the authors, spatial spectra of cortical activity are difficult to estimate from non-invasive measurements (EEG and MEG) and from commonly used intracranial measurements (i.e. electrocorticography or Utah arrays) due to their limited spatial extent. In contrast, iEEG measurements are easier to interpret than EEG/MEG measurements and typically have larger spatial coverage than Utah arrays. However, iEEG is irregularly sampled within the three-dimensional brain volume and this poses a methodological problem that the proposed method aims to address.

      Weaknesses:

      Although the proposed method is evaluated in several indirect ways, a direct evaluation is lacking. This would entail simulating cortical current source density (CSD) with known spatial spectrum and using a realistic iEEG volume-conductor model to generate iEEG signals.

      Comments on revised version:

      In my original review, I raised the following issue:

      "The proposed method of estimating wavelength from irregularly sampled three-dimensional iEEG data involves several steps (phase-extraction, singular value-decomposition, triangle definition, dimension reduction, etc.) and it is not at all clear that the concatenation of all these steps actually yields accurate estimates. Did the authors use more realistic simulations of cortical activity (i.e. on the convoluted cortical sheet) to verify that the method indeed yields accurate estimates of phase spectra?"

      And the authors' response was:

      "We now included detailed surrogate testing, in which varying combinations of sEEG phase data and veridical surrogate wavelengths are added together. See our reply from the public reviewer comments. We assess that real neurophysiological data (here, sEEG plus surrogate and MEG manipulated in various ways) is a more accurate way to address these issues. In our experience, large scale TWs appear spontaneously in realistic cortical simulations, and we now cite the relevant papers in the manuscript (line 53)."

      The point that I wanted to make is not that traveling waves appear in computational models of cortical activity, as the authors seem to think. My point was that the only direct way to evaluate the proposed method for estimating spatial spectra is to use simulated cortical activity with known spatial spectrum. In particular, with "realistic simulations" I refer to the iEEG volume-conductor model that describes the mapping from cortical current source density (CSD) to iEEG signals, and that incorporates the reference electrodes and the particular montage used.

      Although in the revised manuscript the authors have provided indirect evidence for the soundness of the proposed estimation method, the lack of a direct evaluation using realistic simulations with ground truth as described above makes that remain sceptical about the soundness of the method.

      We thank the reviewer for reviewing our manuscript again.

      We have reviewed the literature again on volume conduction effects in LFP measures of cortical activity. In all publications we reviewed, the conclusion is that the range of the effect is <1cm. We now mention the range of volume conduction in the Methods section dealing with the surrogate models (lines 1054-9) as well as added emphasis in the Discussion (lines 594-9).

      The highest spatial frequency we consider in the present research is 50c/m, which corresponds to a cortical distance of 2cm. This is well outside the range of volume conduction effects in LFPs. Mathematically speaking, blurring (e.g. Gaussian) acts as a low-pass filter, attenuating higher spatial frequency components. But only for components within the spatial range of the Gaussian blurring i.e. for LFPs, higher than 100c/m. There will therefore be negligible effects (mathematically speaking, zero effect) of volume conduction in the results reported by us. If the veracity of these studies on volume conduction with LFPs is accepted, then the reviewer’s requested simulation reduces to “estimating spatial spectra [using] simulated cortical activity with known spatial spectrum.” This is what we have done, in a direct and simple manner.

      If the ubiquity and importance of spatio-temporal dynamics in cortex is accepted, then it is insufficient to describe “the mapping from cortical current source density (CSD) to iEEG signals”, since this presumes a model of cortical activity that does not capture the correlations in space and time that we assume are critical to cortical function. We are aware the CSD approach has a long and successful history of unravelling brain mechanisms. However, an emphasis on traveling waves (and spatio-temporal dynamics in general) is in part a challenge to this approach (and the idea of localized sources in general). CSD approaches carry similar assumptions (but at a smaller scale, <1cm) as those elaborated in Zhigalov and Jensen (2023) for extra-cranial measures. In both cases, removal of volume conduction effects emphasizes standing wave activity (localized static, oscillatory sources) over traveling wave activity. In this manner, these methods tend to confirm their starting assumptions (as does our own approach, of course). What is required is external empirical validation to break any circular confirmation of initial theoretical choice of basis. All this is a way of saying that CSD approaches are not the unproblematic, direct methods that the reviewer asserts.

      We did understand the reviewer’s request to model the effects of volume conduction. Our own view of realistic cortical simulations differs from the reviewer’s, setting aside the final step in the forward modeling pipeline which would add the effects of volume conduction in the grey matter. By simulating real-time dynamics, it should be possible to untangle the effects of volume conduction from true spatio-temporal correlations. This is because the volume conduction effects are essentially instantaneous, compared to the relatively slow motion of traveling waves. So, the measurement of purely spatial phase vectors is prone to smearing artefact, but following the trajectory of a wave over one cycle can more accurately determine the range of true interactions. One could, for example, compare the usual CSD forward modelling with TWs in simulations, see which is the best predictor of future activity, and compare these to empirical measurements. Here, the CSD analysis would remove the volume conduction effects but also emphasize standing activity over motion, even where the motion was veridical in the simulation.

      Even so, these tests are only relevant in <1cm range.

      Another issue is ephaptic coupling, which we mention in the discussion. This means that some of the local volume conduction effects are not merely artefacts from the point of view of cortical function, but have a real causal effect. The strength of the word ‘some’ has yet to be completely resolved in the literature, and it would be technically challenging to include these effects in any simulation.

      Finally, simulation should be an adjunct to empirical studies, or used when empirical studies are not possible. We do not think, in this case, they are the ‘only direct’ way to evaluate our method. We, rather, rely on the converging evidence from empirical studies of volume conduction in LFPs which show this effect is outside the range of our reported results.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      The authors present an approach that uses the transformer architecture to model epistasis in deep mutational scanning datasets. This is an original and very interesting idea. Applying the approach to 10 datasets, they quantify the contribution of higher-order epistasis, showing that it varies quite extensively.

      Suggestions:

      (1) The approach taken is very interesting, but it is not particularly well placed in the context of recent related work. MAVE-NN, LANTERN, and MoCHI are all approaches that different labs have developed for inferring and fitting global epistasis functions to DMS datasets. MoCHI can also be used to infer multidimensional global epistasis (for example, folding and binding energies) and also pairwise (and higher order) specific interaction terms (see 10.1186/s13059-024-03444-y and 10.1371/journal.pcbi.1012132). It doesn't distract from the current work to better introduce these recent approaches in the introduction. A comparison of the different capabilities of the methods may also be helpful. It may also be interesting to compare the contributions to variance of 1st, 2nd, and higher-order interaction terms estimated by the Epistatic transformer and MoCHI.

      We thank the reviewer for the very thoughtful suggestion.

      Although these methods are conceptually related to our method, none of them can be realistically used to perform the type of inference we have done in the paper on most the datasets we used, as they all require explicitly enumerating the large number of interaction terms.

      We have included new text (Line 65-74) in the introduction to discuss the advantages and disadvantages of these models. We believe this has made our contribution better placed in the broader context of the field.

      (2) https://doi.org/10.1371/journal.pcbi.1004771 is another useful reference that relates different metrics of epistasis, including the useful distinction between biochemical/background-relative and backgroundaveraged epistasis.

      We have included this very relevant reference in the introduction. We also pointed out the limitation of these class of methods is that they typically require near combinatorically complete datasets and often have to rely on regularized regression to infer the parameters, making the inferred model parameters disconnected from their theoretical expectations. Line 49-56.

      (3) Which higher-order interactions are more important? Are there any mechanistic/structural insights?

      We thank the reviewer for pointing out this potential improvement. We have now included a detailed analysis of the GRB2-SH3 abundance landscape in the final section of the results. In particular, we estimated the contribution of individual amino acid sites to different orders (pairwise, 3-4th order, 4-8th order) of epistasis and discuss our finding in the context of the 3D structure of this domain. We also analyzed the sparsity of specific interactions among subsets of sites.

      Please see Results section “Architecture of specific epistasis for GRB2-SH3 abundance.”

      Reviewer #2 (Public review):

      Summary:

      This paper presents a novel transformer-based neural network model, termed the epistatic transformer, designed to isolate and quantify higher-order epistasis in protein sequence-function relationships. By modifying the multi-head attention architecture, the authors claim they can precisely control the order of specific epistatic interactions captured by the model. The approach is applied to both simulated data and ten diverse experimental deep mutational scanning (DMS) datasets, including full-length proteins. The authors argue that higher-order epistasis, although often modest in global contribution, plays critical roles in extrapolation and capturing distant genotypic effects, especially in multi-peak fitness landscapes.

      Strengths:

      (1) The study tackles a long-standing question in molecular evolution and protein engineering: "how significant are epistatic interactions beyond pairwise effects?" The question is relevant given the growing availability of large-scale DMS datasets and increasing reliance on machine learning in protein design.

      (2) The manuscript includes both simulation and real-data experiments, as well as extrapolation tasks (e.g., predicting distant genotypes, cross-ortholog transfer). These well-rounded evaluations demonstrate robustness and applicability.

      (3) The code is made available for reproducibility.

      We thank the reviewer for the positive feedback.

      Weaknesses:

      (1) The paper mainly compares its transformer models to additive models and occasionally to linear pairwise interaction models. However, other strong baselines exist. For example, the authors should compare baseline methods such as "DANGO: Predicting higher-order genetic interactions." There are many works related to pairwise interaction detection, such as: "Detecting statistical interactions from neural network weights", "shapiq: Shapley interactions for machine learning", and "Error-controlled nonadditive interaction discovery in machine learning models."

      We thank the reviewer for this very helpful comment. These references are indeed conceptually quite similar to our framework. Although they are not directly applicable to the types of analyses we performed in this paper (partitioning contribution of epistasis into different interaction orders in terms of variance components), we have included a discussion of these methods in the introduction (Line 70-74). We believe this helps better situate our method within the broader conceptual context of interpreting machine learning models for epistatic interactions.

      (2) While the transformer architecture is cleverly adapted, the claim that it allows for "explicit control" and "interpretability" over interaction order may be overstated. Although the 2^M scaling with MHA layers is shown empirically, the actual biological interactions captured by the attention mechanism remain opaque. A deeper analysis of learned attention maps or embedding similarities (e.g., visualizations, site-specific interaction clusters) could substantiate claims about interpretability.

      Again, we thank the reviewer for the thoughtful comment. We have addressed this comment together with a related comment by Reviewer1 by including a detailed analysis of the GRB2-SH3 landscape using a marginal epistasis framework, where we quantified the contribution of individual sites to different orders of epistasis as well as the sparsity of epistatic interactions. We also present these results in the context of the structure of this protein. Please see Results section “Architecture of specific epistasis for GRB2-SH3 abundance.”

      (3) The distinction between nonspecific (global) and specific epistasis is central to the modeling framework, yet it remains conceptually underdeveloped. While a sigmoid function is used to model global effects, it's unclear to what extent this functional form suffices. The authors should justify this choice more rigorously or at least acknowledge its limitations and potential implications.

      We agree that the under parameterization of the simple sigmoid function could be be potentially confounding. We did compare different choices of functional forms for modeling global epistasis. Overall, we found that there is no difference between a simple sigmoid function with four trainable parameters and the more complex version (sum of multiple sigmoid functions, used by popular methods such as MAVENN). Therefore, all results we presented in the paper were based on the model with a single scalable sigmoid function.

      We have added relevant text; line 153-158. We have also included side-by-side comparisons of the model performance for the GRB-abundance and the AAV2 dataset to corroborate this claim (Supplemental Figure 1).

      (4) The manuscript refers to "pairwise", "3-4-way", and ">4-way" interactions without always clearly defining the boundaries of these groupings or how exactly the order is inferred from transformer layer depth. This can be confusing to readers unfamiliar with the architecture or with statistical definitions of interaction order. The authors should clarify terminology consistently. Including a visual mapping or table linking a number of layers to the maximum modeled interaction order could be helpful.

      We thank the reviewer for the thoughtful suggestion. We have rewritten the description of our metrics for measuring the importance of "pairwise", "3-4-way", and ">4-way" interactions; Line 232-239.

      We have also added a table to improve clarity, as suggested; Table 2.

      Reviewer #3 (Public review):

      Summary:

      Sethi and Zou present a new neural network to study the importance of epistatic interactions in pairs and groups of amino acids to the function of proteins. Their new model is validated on a small simulated data set and then applied to 10 empirical data sets. Results show that epistatic interactions in groups of amino acids can be important to predict the function of a protein, especially for sequences that are not very similar to the training data.

      Strengths:

      The manuscript relies on a novel neural network architecture that makes it easy to study specifically the contribution of interactions between 2, 3, 4, or more amino acids. The study of 10 different protein families shows that there is variation among protein families.

      Weaknesses:

      The manuscript is good overall, but could have gone a bit deeper by comparing the new architecture to standard transformers, and by investigating whether differences between protein families explain some of the differences in the importance of interactions between amino acids. Finally, the GitHub repository needs some more information to be usable.

      We thank the reviewer for the thoughtful comments. We have listed our response below in the “Recommendations for the authors” section.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Some of the dataset labels are confusing. For example, GRB is actually the protein GRB2 and more specifically just one of the two SH3 domains from GRB2 (called GRB2-SH3 in Faure et al.).

      We thank the reviewer for catching this. Our original naming of the datasets followed the designation of library number in the Faure et al paper (which constructed 3 variant libraries and performed different assays on them). To avoid confusion (and also save space in the figure titles), we have now renamed the datasets using this mapping:

      Author response table 1.

      Reviewer #3 (Recommendations for the authors):

      (1) What is the cost of the interpretability of the model? It would be interesting to evaluate how a standard transformer, complete with its many non-linearities, performs on the simulated 13-position data, using the r2 metric. This is important as the last sentence of the discussion seems to suggest that the model proposed by the authors could be used in other contexts, where perhaps interpretability would be less important.

      We thank the reviewer for this suggestion. We have run a generic transformer model on the GRBabundance and AAV2 datasets. Overall, we found minimal difference between the generic model and our interpretable model, suggesting that fitting the interpretable transformer does not incur significant cost in performance.

      We have included a side-by-side comparison of the performance of the generic transformer and our three-layer model in Supplemental Figure 5 and a discussion of this finding in Line 256-259.

      (2) The 10 data sets analyzed by the authors differ in their behaviour. I was wondering whether the proteins have different characteristics, beyond the number and distribution of mutants in the data sets. For instance, do high-order interactions play a bigger role in longer proteins, in proteins with more secondary structures, in more hydrophobic proteins?

      We fully agree that this is a highly relevant question. Unfortunately, the paucity of datasets suitable for the type of analyses we performed in the paper limit our ability to draw general conclusions. Furthermore, the differences in genotype distribution among the 10 datasets may be the main driving factor in the behaviors of the models.

      We included our thoughts on this issue in the discussion (Line 477-481).

      We will definitely revisit this question if this type of high-order combinatorial DMS data becomes more available in the (hopefully) near future.

      (3) Although the code appears to be available in the repository, there is no information about the content of the different folders, about what the different scripts do, or about how to reproduce the article's results. More work should be done to clarify it all.

      Thank you for pointing this out. We have substantially improved our github repository and included many annotations for reproducibility.

      (4) Typos and minor comments:

      (a) p3 "a multi-peak fitness landscapes": landscape.

      (b) p3 "Here instead of directly fitting the the regression coefficients in Eq. 2": remove 'the'.

      (c) p3 "neural network architectures do not allow us to control the highest order of specific epistasis": a word is missing.

      (d) p6 "up to 1,926, 3,014, and 4,102 parameters, respectively-all smaller than the size of the training dataset": it's not very clear what size of the dataset means: number of example sequences?

      (e) p6 "This results confirm": This result confirms.

      (f) p6 "to the convergence of of the variance components of the model landscape to the ground truth.": remove 'of'.

      (g) p7 "to characterize the importance higher-order interactions": the importance of.

      (h) p7 "The improvement varies across datasets and range": and ranges.

      (i) p9 "over the pairwise model is due to the its ability": remove 'the'.

      (j) p13 "This results suggest that pairwise": result suggests.

      (k) p13 "although the role assessed by prediction for randomly sampled genotypes seems moderate": sampled. Also, I'm not sure I understand this part of the sentence: what results are used to support this claim? It's not 6b, which is only based on the mutational model.

      This is in Supplemental Figure 7.

      (l) p13 "potentially by modeling how the these local effects": remove the.

      (m) p13 "We first note that the the higher-order models": remove the.

      (n) p15 "M layers of MHA leads to a models that strictly": lead to a model.

      (o) Supp Figure 1: "Solid lines shows the inverse": show.

      (p) Supp p 10 "on 90% of randomly sample data": sampled.

      (q) Supp p11 "Next, assume that Eq. 5 is true for m > 0. We need to show that Eq. 5 is also true for m + 1.": shouldn't it be m>=0 ? It seems important to start the recursive argument.

      Good catch.

      (r) Supp p11 "Since the sum in line 9 run through subsets": runs.

      (s) Supp p11 "we can further simplify Eq. 11 it to": remove it.

      We have fixed all these problems. We very much appreciate the reviewer’s attention.

    1. Author response:

      eLife Assessment

      This study uses the yeast two-hybrid assay to identify proteins that may interact with yeast Set1 and other subunits of COMPASS/Set1C, the histone H3K4 methyltransferase, providing also some evidence for Set1 sumoylation and a role of SET1C methylating other factors in vitro. The results are valuable, and they should contribute to understanding the functions of the conserved SET1C complex, as they suggest potential functional connections with RNA biogenesis, chromatin remodeling, and non-histone methylation, whose implications would yet need to be explored. Nevertheless, apart from the fact that only a small subset of the Y2H interactions is further examined, the validating experiments are only partial or inconclusive, the strength of evidence being at this point incomplete.

      We thank the reviewers for their thoughtful comments, which primarily raise three major concerns: the overinterpretation of the Y2H data, issues related to validation, and the manuscript’s structure. At the same time, the reviewers acknowledge that the dataset is extensive and that aspects of the validation work are valuable. Below, we provide point-by-point responses to the public reviews. We will prepare a revised version of the manuscript that carefully addresses the public comments and incorporates the referees’ recommendations.

      Public Reviews:

      Reviewer #1 (Public review):

      The manuscript by Luciano et al is a collection of experiments about the yeast histone 3 lysine 4 methyltransferase, Set1, starting with 10 yeast two-hybrid screens (Y2H). Y2H screens were briefly popular 20+ years ago, but the persistently unfavourable false-to-true positive ratios limited their utility, and the conclusion emerged that Y2H is an unreliable approach for gathering protein-protein interaction data. Y2H outcomes are candidate interaction lists at best, strongly contaminated by false positives. Here, the authors employed a company (Hybridomics) to perform the Y2H screens.

      The primary data is not presented, and the outcomes are summarized using the Hybridomics in-house quality scoring system in Figure 1A. It is not possible to evaluate these data, and the manuscript presents cartoon summaries that the reader must accept as valuable.

      We agree that false positives contaminate the list of potential interactors. Some interactions may also be indirect through a common interactor and do not reflect a physiological interaction. Nevertheless, some positives reflect real interactions that can occur under specific physiological conditions. This is the case, for example, with the interaction between Spp1 and Mer2 (from this screen), which has led to major discoveries (Acquaviva et al. Science 2013; Sommermeyer et al. Mol Cell 2013). The publication of these 10 screens should be viewed as a valuable resource for the broader community.

      Hybrigenics brings extensive experience from conducting numerous screens, enabling the team to recognize recurring false positives that commonly arise in screening assays.

      (1) Based on the extensive knowledge about Set1C/COMPASS acquired from genetics and biochemistry by many labs (including the Geli lab), the results presented here from the 10 Y2H screens are notably patchy. Of the 7 subunits of this complex, only one (Spp1) was identified using Set1 as bait. Conversely, as baits, Swd2, Spp1, Shg1, captured Set1, and the Bre2-Sdc1 interaction was reciprocally identified. These interactions were scored at the highest confidence level, which lends some confidence to the screens. However, the missing interactions, even at the third confidence level, indicate that any Y2H conclusions using these data must be qualified with caution. The authors do not appear to be cautious in their lengthy evaluations of these candidate interactions, which are illustrated with cartoons in Figures 2 and 3, with some support from the literature but almost without additional evidence. Snf2 is a particularly interesting candidate, which the authors support with pull-down experiments after mixing the two proteins in vitro (Figure 4). After Y2H, this is the least convincing evidence for a protein-protein interaction, and no further, more reliable evidence is supplied.

      We agree with referee 1 that more caution is needed, and we will take this into account in the revised version. We agree that Y2H interaction is an indication of potential interaction and not proof of interaction. We have therefore made a significant effort to compile elements from the literature that may support the interaction. Once again, this study can be considered a resource.

      (2) Figure 5 continues the cartoon summary of extrapolations from the Y2H screens, again without supporting evidence, except that the authors state, "We have refined the interaction region between Set1, Prp8 and Prp22, showing that Prp8 and Prp22 interact strongly with Set1-F4 (n-SET). Prp22 interacts in addition with Set1-F1 (Figure S2)." However, Figure S2 does not show this evidence and is incoherent.

      When we say that we have refined the interaction region between Set1, Prp8, and Prp22, we mean that we have restricted the interaction regions according to Y2H criteria. Indeed, we have not shown the spots illustrating the results. This will be corrected in the revised version.

      The figure legends for Figure S2B and C (copied here in bold) do not correspond to the figure.

      We agree that the legend for Figure S2 is unclear and does not accurately describe the panels shown in the figure. We will revise the legend accordingly in the updated version to ensure it accurately reflects the content of all panels.

      (B) Expression of the F1-F5 fragments in yeast cells. Fusion proteins were detected with an anti-GAL4 monoclonal antibody. TOTO yeast cells (Hybrigenics) were transformed with the different pB66-Set1-F1 to F5 plasmids and subsequently with either P6, pP6-Snf2 762-968, pP6-Prp8 37-250, or pP6-Prp22 379-763 that were identified in the Y2H screens. Transformed cells were incubated 3 days at 30{degree sign}C on SD-LEU-TRP and then restreaked on SD-LEU-TRP-HIS with 3AT. Cell growth was monitored after 2 days at 30{degree sign}C.

      (C) Solid and dotted arrows indicate that transformed TOTO cells transformed with pB66-Set1-F1 to F5 and the indicated prey (Snf2, Prp8, and Prp22) are growing in the presence of 20 mM and 5 mM of AT, respectively.

      Figure S2D is two almost featureless dark grey panels accompanied by the figure legend D) Control experiment showing that TOTO cells transformed with p6 and pB66-Set1-F4 are not gowing (sic) in the presence of 5 mM or 20 mM AT.

      Line 343. Interestingly, the two-hybrid screens reveal that Set1 1-754 interacted with Gag capsid-like proteins of Ty1 (Figure S5), raising the possibility that Set1 binding to Ty1 mRNA is linked to the interaction of Set1 1-754 with Gag.

      This is another example of the primary mistake repeatedly made by the authors -Y2H interactions are candidate results and not conclusive evidence.

      This statement is supported by our previous findings demonstrating that Set1 binds Ty1 mRNA independently of it dRRM and represses Ty1 mobility at a post-transcriptional stage (Luciano et al., Cell Discovery, 2017 PMID:29071121). Binding of Set1 to Ty1 mRNA could stem from the interaction between Set1 1-754 and the Gag capsid-like protein.

      To further illustrate this point, the authors highlight the candidate interaction between Nis1 and 3 Set1C subunits.

      While we agree that the Nis1-Set1C interaction has not been demonstrated beyond doubt, we feel that our Y2H and in vitro binding experiments provide reasonable evidence that the interactions may be relevant. It is important to consider that any interaction assay can provide negative (and false positive) results, this includes Y2H, in vitro binding and mass-spec analysis of purified complexes from cells. We feel that it is not appropriate to only trust protein interactions that are strong and stable enough to be demonstrated via purified complexes. It is clear that some protein interactions do occur in transient and weak manner and therefore are not compatible with biochemical purification approach. This indeed is the strength of alternative methods like Y2H and in vitro binding assays, that interactions can be identified and tested even if the physiological context of the interaction may be more complex.

      (3) After multiple speculations based on the Y2H candidates, the authors changed to focus on sumoylation of Set1, which has previously reported to be sumoylated. Evidence identifying two sumoylation sites in Set1, in the N-SET and SET domains, is valuable and adds important progress to the role of sumoylation in the regulation of H3K4 methyltransferase, relevant for all eukaryotes. This illuminating part of the manuscript is only tenuously connected to the preceding Y2H screens and concomitant speculations.

      We thank Referee 1 for their comment. While it is true that there is only a modest connection between Set1 interactors involved in direct or indirect sumoylation and the characterization of Set1 SUMOylation sites, we believe that this does not constitute a weakness of the manuscript.

      (4) The manuscript then describes a red herring exercise involving Set1 methylation of Nrm1. In an already speculative and difficult manuscript, it is exasperating to read a paragraph about a failed idea. Apart from panel E, Figure 7 is a distraction, and I believe it should not be shared.

      According to this comment, we will remove Fig. 7 panels A-D.

      (5) However, despite the failure with Nrm1, Line 443 - The H3K4-like domain in Nrm1 raised our attention to other yeast proteins that carry such sequences.

      This line of thinking is even less connected to the Y2H screens than the sumoylation work.

      However, the authors present a reasonable evaluation of the yeast proteome screened for six amino acids similar to the known H3K4 motif ARTKQT (Figure 7e).

      (6) However, this evaluation goes nowhere and has no connection with the next section of the manuscript, which is entirely speculation about the regulation of metabolism and stress responses based on the Y2H results and selected evidence from the literature.

      We will take into account of these remarks (points 5 and 6) in the revised version.

      (7) The manuscript then describes more failed experiments regarding lysine methylation of Snf2 by Set1C, which unexpectedly reports arginine methylation rather than lysine. The manuscript does not currently meet the standard expected for this type of paper - the composition is somewhat incoherent and there are no previous reports of arginine methylation by SET domain proteins.

      We respectfully disagree with referee 1. We have integrated extensive in vitro reconstruction experiments with complementary in vivo studies, all conducted according to the rigorous standards expected by leading journals. These approaches have allowed us to reach the conclusions presented in this manuscript. While some of these findings are unexpected, they are supported by the data. We have carefully discussed the results and their limitations to provide a comprehensive interpretation.

      The manuscript presents a very experienced grasp of the literature and a sophisticated appreciation of the forefront issues, but a surprising failure to eliminate uninformative failures and peripheral distractions. The overinterpretation of Y2H results is a dominating failure. There are some valuable parts within this manuscript, and hopefully, the authors can reformat to eliminate the defects and appropriately qualify the candidate data.

      We thank Referee 1 for these insightful comments. In the revised version, we will follow the advice to remove non-informative failures and peripheral distractions. Additionally, we will exercise greater caution to avoid overinterpreting the Y2H results.

      Reviewer #2 (Public review):

      Summary:

      This paper starts with a large-scale yeast two-hybrid (Y2H) screen using Set1 (full-length and smaller parts) and other Set1C/COMPASS subunits as bait. There are hundreds of possible interactions identified, but only a small number are given any follow-up. While it's useful to document all the possible interactions, the unfocused and preliminary nature of the results makes the paper feel scattered and incomplete.

      Strengths:

      The Y2H screen was very comprehensive, producing lots of interesting possible leads for further experiments.

      Weaknesses:

      The results are useful but incomplete because only a small subset of the Y2H interactions is further examined. Even in the case of those that were further tested, the validating experiments are only partial or inconclusive.

      Referee 2’s comments align in some respects with those of Referee 1. We will follow the detailed Referee 2 suggestions to reduce the scattered nature of the manuscript.

      We will follow his/her recommendations, in particular we will provide and AlphaFold model of the interaction between the Set1 N-term 1-754 with the SID domain of Kap104 that involves the proposed Set1 PY-NLS sequence.

      Reviewer #3 (Public review):

      The SET1C/COMPASS complex is the histone H3K4 methyltransferase in Saccharomyces cerevisiae, where it plays pivotal roles in transcriptional regulation, DNA repair, and chromatin dynamics. While its canonical function in histone methylation is well-established, its full interactome remains poorly defined. Moreover, whether SET1C methylates non-histone substrates has been an open question. In this study, Luciano et al. employ systematic yeast two-hybrid (Y2H) screening to uncover novel interactors and functions of SET1C. Their findings reveal potential functional connections to RNA biogenesis, chromatin remodeling, and non-histone methylation.

      The authors performed multiple Y2H screens using Set1 (full-length, N-terminal, and C-terminal fragments) and each of its seven subunits as baits. They identified high-confidence interactors that link SET1C to diverse cellular processes, including chromatin regulation (e.g., the SWI/SNF complex via Snf2), DNA replication (e.g., Mcm2, Orc6), RNA biogenesis (e.g., spliceosome components Prp8 and Prp22; polyadenylation factors Pta1 and Ref2), tRNA processing (e.g., Trm1, Trm732), and nuclear import/export (e.g., importins Kap104 and Kap123). Some of these interactions were further validated by immunoprecipitation or in vitro assays.

      Given the interaction of Set1 with Slx5 and Wss1 - proteins involved in SUMO-dependent processes - the authors investigated and convincingly demonstrated that Set1 is sumoylated. This modification may influence the function and regulation of the SET1C complex.

      Finally, the authors provide evidence that SET1C methylates proteins beyond histone H3K4, notably Nrm1, a transcriptional corepressor, and Snf2, the catalytic subunit of the SWI/SNF chromatin remodeling complex. Although Nrm1 contains a domain resembling the H3K4-methylated sequence (H3K4-like domain), this region does not appear to be required for its methylation. The search for other proteins containing similar domains as potential methylation candidates (p.12, first paragraph) seems less justified, given the lack of evidence supporting the requirement for the H3K4-like domain in methylation.

      This study offers valuable insights into the interactome of SET1C, suggesting potential links between the complex and a wide range of cellular processes. However, the functional implications of the Y2H interactions remain to be explored further. Additionally, the study provides intriguing information on the possible regulation of Set1 by sumoylation. The discovery of Nrm1 and Snf2 as methylation substrates could significantly expand the known targets and functions of SET1C.

      The results are supported by high-quality data.

      We thank referee 3 for his/her positive comments

    1. Author response:

      We sincerely appreciate the constructive comments and valuable suggestions from the editors sand reviewers. We highly value the feedback and will carefully address all concerns in our revised manuscript.

      (1) We will supplement more details of the processing steps and key results in the analyses of sCCA and SVR to improve the transparency and reproducibility of our methods.

      (2) According to the reviewers’ suggestions, we will adjust and present a more conventional and cautious conclusion regarding clinical specificity and neuroplasticity reserve.

      (3) We will supplement the results of structural connections (termed “symptom-related network” in the manuscript) across the three subgroups to strengthen the interpretation of subgroup-specific neurobiological characteristics.

      (4) All the suggestions from the reviews will be respected, and we will carefully revise our manuscript to improve its clarity, rigor, and scientific quality.

      We believe these revisions will significantly improve the quality of our work.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers for their thoughtful comments and constructive suggestions. We describe how we have addressed each point below and are grateful for the guidance on areas where our work could be clarified or expanded. In particular, we note the following:

      Selection scan summary statistics: In our revised manuscript, we have included summary statistics from the selection scans. We believe this addition will enhance transparency and provide additional context for readers.

      Reporting of outliers: As highlighted by the editor, the reviewers expressed differing views on the most appropriate way to report outliers. To provide a comprehensive and balanced presentation, we now report both the empirical selection statistics and the corresponding converted p-values in either the main text or supplement, and both outputs are also provided in the full summary files. This dual approach will allow readers to fully interpret the results under both perspectives.

      Expanded discussion of admixture timing and population structure: We have carefully considered the reviewers' suggestions to incorporate additional descriptions of population structure or demographic analyses, and have done so in our revisions where possible. These changes strengthen the rigor and clarity of the analyses.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The paper reports an analysis of whole-genome sequence data from 40 Faroese. The authors investigate aspects of demographic history and natural selection in this population. The key findings are that the Faroese (as expected) have a small population size and are broadly of Northwest European ancestry. Accordingly, selection signatures are largely shared with other Northwest European populations, although the authors identify signals that may be specific to the Faroes. Finally, they identify a few predicted deleterious coding variants that may be enriched in the Faroes.

      Strengths:

      The data are appropriately quality-controlled and appear to be of high quality. Some aspects of the Faroese population history are characterized, in particular, by the relatively (compared to other European populations) high proportion of long runs of homozygosity, which may be relevant for disease mapping of recessive variants. The selection analysis is presented reasonably, although as the authors point out, many aspects, for example differences in iHS, can reflect differences in demographic history or population-specific drift and thus can't reliably be interpreted in terms of differences in the strength of selection.

      Weaknesses:

      The main limitations of the paper are as follows:

      (1) The data are not available. I appreciate that (even de-identified) genotype data cannot be shared; however, that does substantially reduce the value of the paper. Minimally, I think the authors should share summary statistics for the selection scans, in line with the standard of the field.

      We agree with the reviewer that sharing the selection scan results is important, so we have now made the selection scan summary statistics publicly available, and clearly lay out the guidelines and research questions for which the data can be accessed in our Data Availability statement.

      (2) The insight into the population history of the Faroes is limited, relative to what is already known (i.e., they were settled around 1200 years ago, by people with a mixture of Scandinavian and British ancestry, have a small effective population size, and any admixture since then comes from substantially similar populations). It's obvious, for example, that the Faroese population has a smaller bottleneck than, say, GBR.

      More sophisticated analyses (for example, ARG-based methods, or IBD or rare variant sharing) would be able to reveal more detailed and fine-scale information about the history of the populations that is not already known. PCA, ADMIXTURE, and HaplotNet analysis are broad summaries, but the interesting questions here would be more specific to the Faroes, for example, what are the proportions of Scandinavian vs Celtic ancestry? What is the date and extent of sex bias (as suggested by the uniparental data) in this admixture? I think that it is a bit of a missed opportunity not to address these questions.

      We clarify that we did quantify the proportions of various ancestry components as estimated by HaploNet in main text Figure 5 and supplemental figures S6 and S7. To better highlight this result, we now also include the average global ancestry of the various components in the Main Text - Results - Fine-Scale Structure and Connections to Ancient Genomes.

      We agree that more fine-scale demographic analyses would be informative. We now additionally provide an estimation of the admixture date in the Main Text - Results - Fine-Scale Structure and Connections to Ancient Genomes and discussion using the DATES software which is optimized for ancient genomes.

      We have encountered problems with using different standard date estimation software, including DATES, which give very inconsistent and unstable results. As we note in our text, we suspect this might be due to the strong bottleneck experienced in the history of the Faroe Islands, low LD differentiation between the source populations, or multiple pulses of admixture, which may be breaking one or more of the assumptions of these methods. Assessing the limitations of these methods is beyond the scope of this current manuscript; however, we will continue working on this problem for future studies, possibly using simulations to assess where the problem might be. We recognize that our relatively small sample size places limits on the fine-scale demographic analyses that can be performed. We are addressing this in ongoing work by generating a larger cohort, which we hope will enable more detailed inference in the future.

      (3) I don't really understand the rationale for looking at HLA-B allele frequencies. The authors write that "ankylosing spondylitis (AS) may be at a higher prevalence in the Faroe Islands (unpublished data), however, this has not been confirmed by follow-up epidemiological studies". So there's no evidence (certainly no published evidence) that AS is more prevalent, and hence nothing to explain with the HLA allele frequencies?

      We agree that no published studies have confirmed a higher prevalence of ankylosing spondylitis (AS) in the Faroe Islands. Our recruitment data suggest that AS might be more common than in other European populations, but we understand that this is only based on limited, unpublished observations and what we are hearing from the community. We emphasized in our original manuscript that this is based on observational evidence from the FarGen project. However, as this reviewer pointed out, we can be more clear that this prevalence has not been formally studied.

      In revision, we clarify in the Main Text - Results - HLA-B Allele Frequencies and Discussion that our recruitment data suggest a higher prevalence of AS may be possible, but more formal epidemiological studies are needed to confirm this observation. The reason we study HLA-B allele frequencies is to see if the genetic background of the Faroese population could help explain this possible difference, since HLA-B27 is already known to play a strong role in AS.

      Reviewer #2 (Public review):

      In this paper, Hamid et al present 40 genomes from the Faroe Islands. They use these data (a pilot study for an anticipated larger-scale sequencing effort) to discuss the population genetic diversity and history of the sample, and the Faroes population. I think this is an overall solid paper; it is overall well-polished and well-written. It is somewhat descriptive (as might be expected for an explorative pilot study), but does make good use of the data.

      The data processing and annotation follows a state-of-the-art protocol, and at least I could not find any evidence in the results that would pinpoint towards bioinformatic issues having substantially biased some of the results, and at least preliminary results lead to the identification of some candidate disease alleles, showing that small, isolated cohorts can be an efficient way to find populations with locally common, but globally rare disease alleles.

      I also enjoyed the population structure analysis in the context of ancient samples, which gives some context to the genetic ancestry of Faroese, although it would have been nice if that could have been quantified, and it is unfortunate that the sampling scheme effectively precludes within-Faroes analyses.

      We note that although the ancestry proportions were not originally specified in the main text, we did quantify ancestry proportions in the modern Faroese individuals and other ancient samples, and we visualized these proportions in Figure 5 and Supplementary Figures S6 and S7. As stated in our response to Reviewer #1, in our revisions, we now more clearly state the average global ancestry of the various components in the Main Text - Results - Fine-Scale Structure and Connections to Ancient Genomes.

      I am unfortunately quite critical of the selection analysis, both on a statistical level and, more importantly, I do not believe it measures what the authors think it does.

      Major comments:

      (1) Admixture timing/genomic scaling/localization:

      As the authors lay out, the Faroes were likely colonized in the last 1,000-1,500 years, i.e., 40-60 generations ago. That means most genomic processes that have happened on the Faroese should have signatures that are on the order of ~1-2cM, whereas more local patterns likely indicate genetic history predating the colonization of the islands. Yet, the paper seems to be oblivious to this (to me) fascinating and somewhat unique premise. Maybe this thought is wrong, but I think the authors miss a chance here to explain why the reader should care beyond the fact that the small populations might have high-frequency risk alleles and the Faroes are intrinsically interesting, but more importantly, it also makes me think it leads to some misinterpretations in the selection analysis.

      See response to point #3

      (2) ROH:

      Would the sampling scheme impact ROH? How would it deal with individuals with known parental coancestry? As an example of what I mean by my previous comment, 1MB is short enough in that I would expect most/many 1MB ROH-tracts to come from pedigree loops predating the colonization of the Faroes. (i.e, I am actually quite surprised that there isn't much more long ROH, which makes me wonder if that would be impacted by the sampling scheme).

      The sampling scheme was designed to choose 40 Faroese individuals that were representative of the different regions and were minimally related. There were no pairs of third-degree relatives or closer (pi-hat > 0.125) in either the Faroese cohort or the reference populations. It is possible that this sampling scheme would reduce the amount of longer ROHs in the population, but we should still be able to see overall patterns of ROH reflective of bottlenecks in the past tens of generations. Additionally, based on this reviewer's earlier comment, 1 Mb ROHs would still be relevant to demographic events in the last 40-60 generations given that on average 1 cM corresponds to 1 Mb in humans, though we recognize that is not an exact conversion.

      That said, the “sum total amount of the genome contained in long ROH” as we described in the manuscript includes all ROHs greater than 1Mb. Although we group all ROHs longer than 1Mb into one category in Main Text Figure 2, we now additionally provide the distribution in ROH lengths across all individuals for each cohort in a new Supplemental Figure S3. As this plot shows, there certainly are ROHs longer than 1Mb in the Faroese cohort, and on average there is a higher proportion of long ROH particularly in the 5-15 Mb range in the Faroese cohort relative to the other cohorts. As the reviewer points out, these longer ROHs are possibly indicative of a more recent or stronger bottleneck in the Faroes relative to the comparison cohorts. We highlight this result in Main Test - Results - Population Structure and Relatedness.

      (3) Selection scan:

      We are talking about a bottlenecked population that is recently admixed (Faroese), compared to a population (GBR) putatively more closely related to one of its sources. My guess would be that selection in such a scenario would be possibly very hard to detect, and even then, selection signals might not differentiate selection in Faroese vs. GBR, but rather selection/allele frequency differences between different source populations. I think it would be good to spell out why XP-EHH/iHS measures selection at the correct time scale, and how/if these statistics are expected to behave differently in an admixed population.

      The reviewer brings up good points about the utility of classical selection statistics in populations that are admixed or bottlenecked, and whether the timescale at which these statistics detect selection is relevant for understanding the selective history of the Faroese population. We break down these concerns separately.

      (1) Bottlenecks: Recent bottlenecks result in higher LD within a population. However, demographic events such as bottlenecks affect global genomic patterns while positive selection is expected to affect local genomic patterns. For this reason, iHS and XP-EHH statistics are standardized against the genome-wide background, to account for population-specific demographic history.

      (2) Admixture: The term “admixture” has different interpretations depending on the line of inquiry and the populations being studied. Across various time and geographic scales, all human populations are admixed to some degree, as gene flow between groups is a common fixture throughout our history. For example, even the modern British population has “admixed” ancestry from North / West European sources as well, dating to at least as recently as the Medieval & Viking periods (Gretzinger et al. 2022, Leslie et al. 2015), yet we do not commonly consider it an “admixed” population, and we are not typically concerned about applying haplotype-based statistics in this population. This is due to the low divergence between the source populations. In the case of the Faroe Islands, we believe admixture likely occurred on a similar timescale or even earlier, based on the DATES estimates. We see low variance in ancestry proportions estimated by HaploNet, both from the historical Faroese individuals (dated to 260 years BP) and the modern samples. This indicates admixture predating the settlement of the Faroe Islands, where recombination has had time to break up long ancestry tracts and the global ancestry proportions have reached an equilibrium. That is, these ancestry patterns suggest that the modern Faroese are most likely descended from already admixed founders. In the original manuscript, we mentioned this as a likely possibility in the Main Text - Discussion: “This could have occurred either via a mixture of the original “West Europe” ancestry with individuals of predominantly “North Europe” ancestry, or a by replacement with individuals that were already of mixed ancestry at the time of arrival in the islands (the latter are not uncommon in Viking Age mainland Europe).” In our revisions, we further included the DATES estimations of the timing of admixture in the modern and historical Faroese samples, which pre-date the timing of settlement in both cases. We highlight these points in the Discussion. And, as with the case of the British population, the closely-related ancestral sources for the Faroese founders were likely not so diverged as to have differences in allele frequencies and long-range haplotypes that would disrupt signals of selection from iHS or XP-EHH.

      (3) Time scale: It is certainly possible, and in fact likely, that iHS measures selection older than the settlement of the Faroe Islands. In our manuscript, we calculated iHS in both the Faroese and the closely related British cohort, and we highlight in the main Main Text that the top signals, with the exception of LCT, are shared between the two cohorts, indicative of selection that began prior to the population split (Discussion and Results - Signals of Positive Selection). iHS is a commonly calculated statistic, and it is often calculated in a single population without comparing to others, so we feel it is important to show our result demonstrating these shared selection signals. In our revisions, we now clarify in the Discussion the limitations and time-scale at which the iHS statistic may detect selection. As far as XP-EHH, it is a statistic designed to identify differentiated variants that are fixed or approaching fixation in one population but not others. The time-scale of selection that XP-EHH can detect would therefore be dependent on the populations used for comparison. As XP-EHH has the best power to identify alleles that are fixed or approaching fixation in one population but not others, it is less likely to detect older selection events / incomplete sweeps from the source populations. We highlight this point in the Discussion.

      (4) Similarly, for the discussion of LCT, I am not convinced that the haplotypes depicted here are on the right scale to reflect processes happening on the Faroes. Given the admixture/population history, it at the very least should be discussed in the context of whether the 13910 allele frequency on the Faroes is at odds with what would be expected based on the admixture sources.

      We agree that more investigation into the LCT allele frequency in the other ancient samples may provide some insight into the selection history, particularly in light of ancient admixture. Please note, we did look at the allele frequency of the LCT allele rs4988235 and stated in the main text that it was present at high frequencies in the historical (250BP) Faroese samples. The frequency of this allele in the imputed historical Faroese samples is 82% while the allele is present at ~74% frequency in modern samples. We originally did not report the exact percentage in the main text because the sample size of the historical samples (11 individuals) is small and coverage of ancient samples is low, leading to potential errors in imputation.

      However, given the reviewer’s comment, we have now included the frequencies as well as these caveats in the Discussion. We additionally calculated the LCT allele frequency in other ancient samples, and assuming that we had good proxies for the sources at the time of admixture, we calculated the expected allele frequency in the admixed ancestors of the Faroese founders (Discussion), but again note the limitations in using such a calculation in this context.

      (5) I am lacking information to evaluate the procedure for turning the outliers into p-values. Both iHS and XP-EHH are ratio statistics, meaning they might be heavy-tailed if one is not careful, and the central limit theorem may not apply. It would be much easier (and probably sufficient for the points being made here) to reframe this analysis in terms of empirical outliers.

      Given that there are disagreements on the best approach to reporting selection scan results from the reviewers, in our revision, we have additionally supplied both the standardized iHS / XP-EHH values in Supplementary Fig. S10 as well as these values transformed to p-values in Main Text Fig. 3. Additionally, both outputs are provided in the publicly available selection scan results files. We provide the method for obtaining p-values in the subsection “Selection scan” from the Methods section - we used a method developed earlier by Fariello et al.

      (6) Oldest individual predating gene flow: It seems impossible to make any statements based on a single individual. Why is it implausible that this person (or their parents), e.g., moved to the Faroes within their lifetime and died there?

      We agree with the reviewer that this is a plausible explanation, and in our revisions, we have updated the Main Text - Discussion to acknowledge this possibility.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Please note that there was disagreement among the reviewers regarding the reporting of outliers.

      As stated in our response to the public reviews, given the disagreement, we include both the empirical selection statistics as well as the converted p-values in the main text, supplement and selection scan files.

      Reviewer #2 (Recommendations for the authors):

      (1) Figure 2:

      Define labels / explain why they differ from 1000k populations / make them consistent throughout the manuscript.

      We apologize for the error in labels for Figure 2. These are the same populations used in other figures and analyses. We have fixed this in our revisions so that the labels are consistent with the rest of the manuscript.

      (2) Figure S2 label:

      "The matrix is rescaled after subsetting the individuals, so although the scales are different, the overall structure remains the same." I do not understand this sentence. The samples are different, the scale is different, the apparent pattern is different - what overall structure is supposed to be the same?

      We apologize that the language was not clear in the figure label. The scales between panels A and B are different, because popkin rescales the kinship labels after subsetting so that the minimum kinship is zero. This is necessary when subsetting individuals from an already estimated kinship matrix particularly when subsetting from global populations to a single region. From the popkin documentation: “This rescaling is required when subsetting results in a more recent Most Recent Common Ancestor (MRCA) population compared to the original dataset (for example, if the original data had individuals from across the world but the subset only contains individuals from a single continent)” (https://rdrr.io/cran/popkin/man/rescale_popkin.html).

      We also described this in the Methods - Population Genetics - Kinship and runs of homozygosity section: “When calculating the kinship matrix for the Faroese WGS cohort only, we used the rescale_kinship() function, which will change the most recent common ancestor and give different absolute values, but the overall relationship structure in the subpopulation remains the same.”

      That is, the relative kinship within the Faroese cohort remains consistent, despite the different scale.

      It is difficult to see the kinship of Faroese individuals in the larger plot with all cohorts, which is why we subset and visualize the Faroese cohort alone. We have updated the Fig. S2 label language to make this more clear.

      (3) "Iron Age Wet Europe"

      We have corrected this typo to “Iron Age West Europe.”

      I'm confused if the ancient Faroese were part of the imputation panel: Figure 5 legend implies they are, methods imply they are not.

      The ancient samples are not imputed with the modern Faroese and reference samples, but they are the imputed data downloaded from Allentoft et al. and merged with the modern Faroese cohort. We specify that we downloaded imputed ancient samples in both the Methods - Fine-scale structure estimation using ancient genomes and in the Main Text - Results - Fine-Scale Structure and Connections to Ancient Genomes. The description of the imputation panel in the Methods - Bioinformatics - Variant calling and imputation refers only to the modern samples.

      (4) Kinship:

      The kinship of the Faroes is useful (and nice) as a QC analysis showing the genetic data matches the expectations from the pedigree. I don't know what I should learn from the kinship of the 1000kg samples (I'd assume one could learn something about bottleneck strength from this), but it's not developed/discussed.

      The global kinship matrix provides complementary information to PCA and ROH, as another way to quantify and visualize the relationships within and between populations. Additionally, as the reviewer mentioned, bottlenecks increase kinship within populations. Given that popkin estimates kinship measured from a Most Recent Common Ancestor, we can best observe this increase in kinship when comparing to other global populations. We more clearly delineate what can be observed from Fig. S2A versus Fig. S2B in the Results - Population Structure and Relatedness.

      Reference

      (1) Gretzinger, J. et al. The Anglo-Saxon migration and the formation of the early English gene pool. Nature 610, 112–119 (2022)

      (2) Leslie, S. et al. The fine-scale genetic structure of the British population. Nature 519, 309–314 (2015).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Henshall et al. delete the highly abundant merozoite surface protein PfMSP2 from two Plasmodium falciparum laboratory lines (3D7 and Dd2) using CRISPR-Cas9. Parasites lacking MSP2 replicate and invade red cells normally, opposing the experimental history that suggests MSP2 is essential. Unexpectedly, the knock-outs become more susceptible to several inhibitory antibodies - most strikingly those that target the apical antigen AMA1-while antibodies to other surface or secreted proteins are largely unaffected. Recombinant MSP2 added in vitro can dampen AMA1-antibody binding, supporting a "conformational masking" model. The reported data suggest that MSP2 helps shield key invasion ligands from host antibodies and may itself be a double-edged vaccine target.

      Reviewer 1 did not have any comments we needed to address.

      Reviewer #2 (Public review):

      (1) The section describing Laverania and avian Plasmodium MSP2 comparison is a lengthy section and could be told much more concisely for clarity in delivering the key message, i.e., that conservation in distantly related Plasmodium species could indicate an important function. The identification of MSP2-like genes in avian Plasmodium species was highlighted previously in the referenced Escalante paper, so it is not entirely novel, although this paper goes into more detailed characterisation of the extent of conservation. Overall, this section takes up much more space in the manuscript than is merited by the novelty and significance of the findings.

      As outlined in point (1) for Reviewer 1 (Recommendations for the authors), we have cut back through this section and focussed on the important comparisons rather than the general observation. We have also moved the elements of Table 1 to Supplementary Figures 2, 3 and 4 to streamline the manuscript. Further description of the changes is available in the Reviewer #1 (Recommendations for the authors).

      (2) Characterisation of the knockout strains is generally thorough, though relatively few interactions were followed by live microscopy (Figures 3E-H). A minimum of 30 merozoites were followed in each assay (although the precise number is not specified in the figure or legend), but there are intriguing trends in the data that could potentially have become significant if n was increased.

      In the Figure 3 Legend we have now indicated the number of merozoite invasions followed as per the following:

      “(E-H) Key parameters of merozoite invasion were measured for both PfDd2 WT (n = 43) and PfDd2 ΔMSP2 (n = 35) parasites that had successfully invaded a RBC using live cell imaging of merozoite invasion.”

      We have also removed the more general description of ‘a minimum of 30 merozoites’ from the same Figure Legend.

      The number of schizont ruptures and subsequent merozoite invasions followed for each experiment is in line with previous studies that have investigated phenotypes with invasion inhibitors and gene knock-outs (e.g. Weiss et al. 2015, PLoS Pathogens). It is important to note that the data refers to merozoites that have completed invasion, and not just the number of merozoites that have been released from a schizont which is typically 2-4 times more than have invaded. This means we are comparing the kinetics of invasion across a relatively large sample size compared to other studies of inhibitory phenotypes. While it is possible that increasing the number of merozoites being filmed might lead to some statistical significance for some of the trends, we note that there is a limited growth phenotype overall in both short and long-term culture and this fits with the limited defect we are seeing. In order to better address this, as outlined in our response to point (7) for Reviewer 2 (Recommendations for the authors), we now discuss the trends seen in the data in additional detail.

      (3) The comparative RNAseq data is interesting, but is not followed up to any significant degree. Multiple transcripts are up-regulated in the absence of PfMSP2, but they are largely dismissed because they are genes of unknown function, not previously linked to invasion, or lack an obvious membrane anchor. Having gone to the lengths of exploring potentially compensatory changes in gene expression, it is disappointing not to validate or explore the hits that result.

      While we understand the reviewers comment, as outlined in the text we did not identify any upregulated proteins that looked like strong candidates to compensate for loss of MSP2 to explore in this manuscript. Instead, we chose to further investigate any potential loss of MSP2 phenotype that yielded the observations around improved potency of antibodies targeting some merozoite antigens with loss of MSP2. This will be explored in future studies as we try and understand the role of MSP2 in more detail and the interactions between proteins and antibodies on the merozoite surface.

      (4) Given the abundance of PfMSP2 on the merozoite surface, it would have been interesting to see whether the knockout lines have any noticeable difference in surface composition, as viewed by electron microscopy, although, of course, this experiment relies on access to the appropriate facilities.

      We agree with the reviewer, but this lies outside the scope of this manuscript and optimisation of the imaging platform used to gain biologically useful insights would take a considerable amount of work based on feedback from people working with these techniques.

      (5) One of the key findings is that deletion of PfMSP2 increases inhibition by some antibodies/nanobodies (some anti-CSS2, some anti-AMA1) but not others (anti-EBA/RH, anti-EBA175, anti-Rh5, anti-TRAMP, some anti-CSS2, some anti-AMA1). The data supporting these changes in inhibition are solid, but the selectivity of the effect (only a few antibodies, and generally those targeting later stages in invasion) is not really discussed in any detail. Do the authors have a hypothesis for this selectivity? The authors make attempts to explore the mechanisms for this antibody-masking (Figure 7), but the data is less solid. Surface Plasmon Resonance was non-conclusive, while an ELISA approach co-incubating MSP2 and anti-AMA1 antibodies to wells coated with AMA1 lacks appropriate controls (eg, including other merozoite proteins in similar experiments).

      As outlined in our response to point (7) for Reviewer 2 (Recommendations for the authors), we have repeated the ELISA based assessment of recombinant MSP2s impact on anti-AMA1 antibody binding. In addition, we have included two comparator control proteins, the intrinsically disordered MSP4 of P. falciparum and the globular domain of the neural cell adhesion molecule (NCAM, CD56, 16 kDa), and found these proteins did not impact binding of anti-AMA1 antibodies. This strengthens the data that links the presence of MSP2 to reduced activity of anti-AMA1 antibodies.

      As covered in our response to point (7) for Reviewer 2 (Recommendations for the authors) we provide additional discussion of this phenotype. We note that the list of inhibitory antibodies tested is not exhaustive, and additional antibodies may be identified where loss of MSP2 could improve potency. So although we see a consistent effect with a relatively small number of antibody targets, this does not rule out additional examples that may act earlier in invasion (for example, we noticed a small, but not statistically significant, trend for mildly inhibitory antibodies targeting MSP1-19 as well) and this makes speculating on why these two initial antibody targets at this time problematic.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) If feasible, perform ex vivo assays to demonstrate that the masking effect operates with physiologically relevant antibodies.

      For this manuscript, we focussed on characterising the MSP2 knock-out parasites using the best reagents available. We remain interested in understanding whether these lines can be used to investigate the activity of functional antibodies from malaria exposed human serum and this will be the subject of future studies.

      Reviewer #2 (Recommendations for the authors):

      (1) As noted in the Public Review, the section describing MSP2 orthologues in other Laverania and avian Plasmodium species is overly long and not the most novel section of the manuscript. It could be really radically trimmed back.

      We have taken this suggestion for the reviewer on board and have significantly cut back on our descriptions of the basic similarity properties of the conserved N and C-terminal regions as well as the description of the central variable region. Effectively, we have cut back the number of words through this section from 864 across 3 paragraphs to 478 across 2 paragraphs. While we have chosen to greatly economise our description of the N and C-terminal conserved regions, we have maintained much of the description of the similarities and differences in the central variable region as we believe the observation that this variant region still maintaining repeats, though they differ in size, number and amino acid composition, across such evolutionary distances is of interest.

      Taking the reviewers comment on board, we have also removed Table 1 from the manuscript (shows amino acid sequence properties of these regions) and instead have inserted the tables relevant for each alignment in Supplementary Figures 2, 3 and 4 as appropriate. This will streamline the main manuscript and better align amino acid property and alignment data in the one Figure. We thank the reviewer for this feedback and believe that this has helped focus the text on the most important observations.

      (2) Figure 2C - As MSP2 has stage-specific expression, it could be informative to incorporate an antibody targeting another gene with a similar stage-specific expression pattern, such as AMA,1 into the blot. This would confirm that both protein samples were collected at a similar point during blood stage development.

      We have modified Figure 2C to include both the original comparison using PfAldolase as the loading control and also the merozoite expressed PfGAP45 as a loading/stage specific control as per the Figure.

      (3) Figure 2D - Magenta and red are hard to distinguish in the merge channel. Is it possible to pseudocolour one of these channels a different colour? Also, it would be simpler to keep PfMSP2 a consistent colour in both rows.

      Thank you for this suggestion and we agree that the comparison could be made clearer. For this figure, we have coloured DAPI to label the nuclei (Cyan), and antibodies targeting PfMSP2 (Magenta), PfAMA1 and PfMSP1-19 (Yellow). This is also reflected in the merged image. The Figure legend now reads:

      “(D) Distribution of key merozoite surface proteins in the presence or absence of PfMSP2 was visualised by immunofluorescence. PfMSP2 (magenta), the nucleus stained by DAPI (cyan) and PfAMA1 (yellow, top two rows) or PfMSP1-19 (yellow, bottom two rows), and the coloured merge of the preceding panels. Scale bar = 0.7 µm. Representative images shown from a minimum of 10 schizonts imaged per condition.”

      (4) Figure 2F - Static growth relative to shaking growth is plotted in this panel; perhaps this could be more clearly described in the legend or mentioned in the text that there was not a significant alteration in growth in static or shaking conditions.

      As suggested, we have clarified the result in the Figure legend text as follows:

      “(E-F) Growth of Pf3D7 WT compared to Pf3D7 ΔMSP2 P. falciparum parasites, measured as fold increase in parasitaemia, over one (48 hrs) or two (96 hrs) cycles in either standard (still- (E)) or shaking (F) conditions, with no measurable difference between parasite growth rates seen between standard or shaking conditions.”

      Please also describe the shaking conditions used (i.e., speed, culture size, and vessel) in the methods.

      We have updated the methods to provide information on the growth conditions used in the standard versus shaking growth assays:

      “The initial parasitemia of cultures was determined by flow cytometry and then measured again after the 50 mL cultures in 96 well plates were maintained under standard (still) or shaking (50 rpm) conditions for 48 hrs or 96 hrs of growth.”

      (5) Figure 3G - Annotate legend for strength of deformation to describe what 1,2, or 3 refers to.

      We have added the following to the Figure legend of Figure 3G:

      “Deformation scores are as defined by Weiss et al (Weiss et al., 2015), with 1 = weak deformation of the RBC membrane at the point of contact, 2 = strong deformation leading to the RBC membrane extending up the sides of the merozoite and changes in RBC membrane curvature beyond the point of contact and 3 = extreme deformation indicated by the merozoite being deeply embedded in the RBC membrane and strong deformation of the RBC well beyond the point of contact.”

      There is a small visible shift in the deformation event scores. Is this also not significant? Even if deformation is not significantly longer, could this small effect alter the exposure of epitopes on other proteins for antibody targeting?

      We did test the deformation event scores and the differences were non-significant. We have considered this possibility raised by the reviewer, but we are cautious in over interpreting the possibility that these trends might contribute to the increased potency of certain antibodies in the absence of additional data. We note that, although deformation may happen over a slightly longer timescale and show more aggressive deformations with PfMSP2 knock-out, this also seems to translate into a weak trend for faster overall entry for those merozoites that go on to invade. Therefore, although deformation may be longer and stronger, antibodies may have less time to block invasion overall. We are not confident that we can interpret around what might be happening at the molecular scale here based on this data and have chosen not to discuss this possibility in the manuscript. However, we have added the following to the results to better explain the phenotype the phenotype we observed.

      “This analysis showed that, although there was a trend for PfDd2 ΔMSP2 knock-out parasites to have a higher mean time to attach to the RBC, as well as for the length and strength of RBC deformation, these trends did not reach significance. For those merozoites that did invade the RBC, on average it took less time for PfDd2 ΔMSP2 knock-out parasites to invade then PfDd2 WT, but this again did not reach significance (Figure 3 E-H). Together these data show PfMSP2 is not essential for blood-stage replication in vitro in two P. falciparum laboratory isolates from different geographical regions and knock-out of PfMSP2 does not seem to significantly impact parasite growth or merozoite invasion in vitro.”

      (6) Figure 4C - Legend refers to black lines, but on the figure, they are red? Is the horizontal red line in the correct place, or should some of the dots below it be black rather than blue if they fall outside the adjusted p-value significance cut-off? Were 4 schizont harvests performed in total, or 4 for each cell line?

      We thank the reviewer for pointing this out and we have now changed the text to say red lines. We have also provided more information in the Figure legend to more clearly define what data is represented. In short, 4 harvests were performed for each cell line (8 in total across the 2 cell lines) and the data represents the distribution from one of these harvests. The blue shaded genes are those that, on average, across the 4 Pf3D7 WT and Pf3D7 ΔMSP2 paired harvests show up or down-regulated expression. This is why some of the blue shaded genes lie near or below the cut-off values represented by the red line. The Figure legend text has now been modified as follows.

      “(C) Log2(fold change) for differentially expressed genes, including multigene families, between the transcriptome of Pf3D7 WT and Pf3D7 ΔMSP2 schizonts. Plot represents the results for one of four independent schizont RNA harvests for Pf3D7 WT and Pf3D7 ΔMSP2 parasites and red lines differentiate genes with a log2 (fold change) > 0.5 and < -0.5 with adjusted p-value < 0.01. Genes shaded blue represent those genes that were found to have an average log2 (fold change) > 0.5 (dark blue) or < -0.5 (light blue) across the four replicate samples compared. Significance determined as below p< 0.05 after correction for multiple testing.”

      (7) Figure 7D - ELISA results don't show a convincing concentration-dependent inhibition, and repeating with another recombinant protein is essential before inferring that the effect is specific to PfMSP2

      We have repeated the ELISA experiment using recombinant PfMSP2 to reduce variability across the assay and again found a dose dependent reduction of anti-PfAMA1 binding with increasing concentrations of recombinant PfMSP2. It should be noted that this is a completely new set of experiments that recapitulate the original findings. See updated Figure 7D.

      We agree with the reviewer that the experiment and interpretation of the data would be strengthened by comparing any potential inhibitory impact on anti-PfAMA1 binding to a different recombinant protein. Therefore, we have completed identical experiments using the similarly intrinsically disordered PfMSP4 recombinant protein (40 kDa) and the highly structured 16 kDa immunoglobulin domain of human neural cell adhesion molecule (NCAM). We find that there is no dose dependent loss of anti-PfMAMA1 binding to recombinant PfAMA1 with addition of PfMSP4 or NCAM immunoglobulin domain recombinant protein. These controls are contained in Supplementary Figure 6, the relevant text is provided below.

      ‘In contrast, increasing concentrations of the intrinsically disordered MSP4 from P. falciparum 3D7 (40 kDa) and the highly structured immunoglobulin domain of neural cell adhesion molecule (NCAM, CD56, 16 kDa) recombinant proteins did not impact on binding of anti-PfAMA1 antibodies to recombinant AMA1 (Supplementary Figure 6).’

      (8) Again, as noted in the public review, the target-specificity of the inhibition-masking effect is perhaps the most surprising aspect of the data - this could do with much more thorough discussion. Why only these proteins, both of which function late in invasion?

      Overall, we tested several growth inhibitory and non-inhibitory antibodies shown to bind specifically to individual or some combination of nine P. falciparum merozoite surface and secreted proteins. However, we do not consider this to be an exhaustive list of potentially invasion inhibitory antibodies by any means. We mostly did not observe any non-inhibitory antibodies becoming significantly more growth inhibitory to PfMSP2 KO lines, indicating that these antibodies were not impacted by loss of PfMSP2 or had no functional inhibitory effect in these assays.

      What we do demonstrate here is that we see a consistent impact with different rabbit, mouse monoclonal and i-body growth inhibitory antibodies targeting PfAMA1, indicating that it is not a spurious result from a single antibody or antibody type. We also find a second example, with nanobodies targeting the PfPCRCR complex protein PfCSS potentiated with loss of PfMSP2. This opens up the possibility that other growth inhibitory antibodies to the antigens tested here, or growth inhibitory antibodies targeting other antigens involved in merozoite invasion, may also become more potent with MSP2KO. Although both PfAMA1 and PfCSS function late in invasion, it is too early to say whether this is a functional trend or an observation that is related to the panel of antibodies tested. Therefore, further testing using lines developed in this study could yield additional examples of antibodies that become more inhibitory with MSP2 KO and provide additional information on the potential impact that MSP2 may have on their vaccine potential. In order to address this, we have added the following text to the discussion:

      “Here we show consistent potency improvement with PfMSP2 knock-out for growth inhibitory rabbit, mouse monoclonal and i-body antibodies targeting PfAMA1, as well as demonstrate improved activity for and Fc-tagged nanobody targeting PfCSS, indicating that these are not outlier results from a single antibody or antibody type. However, increased antibody potency was not shared across all antibodies tested, possibly because the specific function or localisation of a target protein, the region that an antibody binds to or the functional activity (or lack thereof) of an antibody may all play a role in determining whether loss of PfMSP2 can potentiate growth inhibitory activity. Further investigation using the parasite lines developed in this study and a wider panel of antibodies that target different stages of the merozoite invasion process could shed more light on this potentially novel mechanism of vaccine derived antibody efficacy.”

      (9) Typos/minor editorial points:

      L111 – conserved

      This text has been modified.

      L235-237 - check the wording in this sentence for clarity

      This text has been modified.

      Figure 3E - 'attachment' on axis

      This Figure has been modified.

      L350 - mentions eight 'proteins' having expression increase, instead 'transcripts' should be referred to when describing RNAseq data, as transcript levels may not correspond directly with protein levels. Also, be careful when referring to transcript or protein throughout this paragraph.

      This text has been modified.

      Figure 4A - instead of 'transcription during schizonts', better to say 'schizont transcript abundance'

      This text has been modified.

      L514 - 'detectable binding to PfAMA1'

      This text has been modified.

      L589 - Is it a mouse Fc region or a human Fc region that is added? The human Fc region is mentioned in the results.

      In the growth inhibition assays anti-AMA1 WD34 i-body with a human FC region was used and in the ELISA assays anti-AMA1 WD34 i-body with a mouse FC region (to enable detection of AMA1 binding use the same secondary anti-body for both the WD34 i-body and the 4G2 mouse monoclonal antibody) was used. The text has been been checked and modified accordingly to clearly say this.

      Supplementary figure 3 - 'repeats'

      This text has been modified.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, the authors describe the generation of a Drosophila model of RVCL-S by disrupting the fly TREX1 ortholog cg3165 and by expressing human TREX1 transgenes (WT and the RVCL-S-associated V235Gfs variant). They evaluate organismal phenotypes using OCT-based cardiac imaging, climbing assays, and lifespan analysis. The authors show that loss of cg3165 compromises heart performance and locomotion, and that expression of human TREX1 partially rescues these phenotypes. They further report modest differences between WT and mutant hTREX1 under overexpression conditions. The study aims to establish Drosophila as an in vivo model for RVCL-S biology and future therapeutic testing.

      Strengths:

      (1) The manuscript addresses an understudied monogenic vascular disease where animal models are scarce.

      (2) The use of OCT imaging to quantify fly cardiac performance is technically strong and may be useful for broader applications.

      (3) The authors generated both cg3165 null mutants and humanized transgenes at a defined genomic landing site.

      (4) The study provided initial in vivo evidence that human TREX1 truncation variants can induce functional impairments in flies.

      Weaknesses:

      (1) Limited mechanistic insight.

      RVCL-S pathogenesis is strongly linked to mislocalization of truncated TREX1, DNA damage accumulation, and endothelial/podocyte cellular senescence. The current manuscript does not examine any cellular, molecular, or mechanistic readouts - e.g. DNA damage markers, TREX1 subcellular localization in fly tissues, oxidative stress, apoptosis, or senescence-related pathways. As a result, the model remains largely phenotypic and descriptive.

      We thank the reviewers for these suggestions. We are planning to perform experiments addressing the RVCL-S linked cellular deviations. We will examine DNA damage markers on cellular level and perform TUNEL tissue staining to visualize apoptosis, etc.

      To strengthen the impact, the authors should provide at least one mechanistic assay demonstrating that the humanized TREX1 variants induce expected molecular consequences in vivo.

      Yes, we are planning to demonstrate the distinct effects from TREX1 and TREX1 V235G expression on molecular level.

      (2) The distinction between WT and RVCL-S TREX1 variants is modest.

      In the cg3165 rescue experiments, the authors do not observe differences between hTREX1 and the V235Gfs variant (e.g., Figure 3A-B). Phenotypic differences only emerge under ubiquitous overexpression, raising two issues:

      i) It is unclear whether these differences reflect disease-relevant biology or artifacts of strong Act5C-driven expression.

      Thanks for pointing out this issue. We will discuss the differences between two expression models in the revised manuscript.

      ii) The authors conclude that the model captures RVCL-S pathogenicity, yet the data do not robustly separate WT from mutant TREX1 under physiological expression levels.

      We will provide more details related to the RVCL-S disease development and agerelated manifestations.

      The authors should clarify these limitations and consider additional data or explanations to support the claim that the model distinguishes WT vs RVCL-S variants.

      We will address the reviewer concerns and re-write the related manuscript sections to provide more clarity.

      (3) Heart phenotypes are presented as vascular defects without sufficient justification.

      RVCL-S is a small-vessel vasculopathy, but the Drosophila heart is a contractile tube without an endothelial lining. The authors refer to "vascular integrity restoration," but the Drosophila heart lacks vasculature.

      We will expand the model justification section and will be more careful with our statements to avoid misunderstanding of the experimental conclusions.

      The manuscript would benefit from careful wording and from a discussion of how the fly heart phenotypes relate to RVCL-S microvascular pathology.

      We thank the reviewer for pointing to this issue. Justifying Drosophila usage for human disease modelling is always challenging. We will re-write the corresponding parts of the manuscript.

      (4) General absence of tissue-level or cellular imaging.

      No images of fly hearts, brains, eyes, or other tissues are shown. TREX1 nuclear mislocalization is a hallmark of RVCL-S, yet no localization studies are included in this manuscript. Adding one or two imaging experiments demonstrating TREX1 localization or tissue pathology would greatly enhance confidence in the model.

      As suggested by the reviewers,we will add tissue imaging experiments to illustrate the pathological effects of RVCL linked TREX1 expression. We are also planning to utilize CRIMIC line CR70804 to visualize fly TREX1 tissue distribution.

      Reviewer #2 (Public review):

      Summary:

      The authors used the Drosophila heart tube to model Retinal vasculopathy with the goal of building a model that could be used to identify druggable targets and for testing chemical compounds that might target the disease. They generated flies expressing human TREX1 as well as a line expressing the V235G mutation that causes a C-terminal truncation that has been linked to the disease. In humans, this mutation is dominant. Heart tube function was monitored using OCM; the most robust change upon overexpression of wild-type or mutant TREX1was heart tube restriction, and this effect was similar for both forms of TREX1.

      Our results are consistent with the human disease nature, RVCL-S carriers and non-carriers are both healthy and asymptomatic at young age; however, the accumulation of physiological stress becomes obvious in midlife, leading to premature death in 40s and 50s. We will expand the discussion section focusing on RVCL-S manifestations in aged animals.

      Lifespan and climbing assays did show differential effects between wt and mutant forms when they were strongly and ubiquitously expressed by an actin-Gal4 driver. Unfortunately, these types of assays are less useful as drug screening tools. Their conclusion that the primary effect of TREX is on neuronal function is inferential and not directly supported by the data.

      We will revise this experiment discussion and plan to include additional experiments to strengthen the conclusions.

      The authors do not show that CG3165 is normally expressed in the heart. Further fly heart tube function was similarly restricted in response to expression of either wild-type or mutant TREX1. The fact that expression of any form of human TREX1 had deleterious effects on heart function suggests that TREX1 serves different roles in flies compared to humans. Thus, in the case of this gene, it may not be a useful model to use to identify targets or use it as a drug screening tool.

      We will examine the expression of cg3165, human TREX1 transgenes in whole organism to demonstrate tissue expression profiles, as noted above. We will also expand the relevant manuscript sections to address the systemic manifestations of RVCL.

      The significant effects on lifespan and climbing that did show differential effects required ubiquitous overexpression using an actin-gal4 driver that does not allow the identification of tissue-specific effects.

      We plan to carry out additional experiments to determine cg3165, and human TREX1 tissue expression profile.

      Thus, their assertion that the results suggested a strong positive correlation between Drosophila neuromotor regulation and transgenic hTREX1 presence and a negative impact from hTREX1 V235G" is not supported by these data.

      Thanks for pointing this out. We will revise our conclusions appropriately after we include the results from additional new experiments.

      Also worrisome was the inability to identify the mutant TREX1 protein by Western blot despite the enhanced expression levels suggested by qPCR analysis. Mutant TREX1 cannot exert a dominant effect on cell function if it isn't present.

      We will try to resolve this issue by technical means.

      There are also some technical problems. The lifespan assays lack important controls, and the climbing assays do not appear to have been performed correctly.

      We would disagree with this statement. We will re-write the method description for better clarity.

      It is unclear what the WT genetic background is in Figure 1-3, so it is unclear if the appropriate controls have been used. Finally, the lack of information on the specific statistical analyses used for each graph makes it difficult to judge the significance of the data.

      We will provide clearer descriptions of our controls and procedures.

      Overall, the current findings establish the Retinal vasculopathy disease model platform, but with only incremental new data and without any mechanistic insights.

      We will include additional experiments addressing the mechanism (see previous responses above).

      Reviewing Editor Comments:

      I (Hugo Bellen) also read your paper and noted that you do not document the expression pattern in the nervous system and other tissues, such as the heart. The stock https://flypush.research.bcm.edu/pscreen/crimic/info.php?CRname=CR70804 may help you do this and should allow you to compare the GAL4 induced expression of the stock you created and this stock. If compatible, you should consider reporting expression patterns.

      Thank you for the suggestion. We will obtain the line and will use it for expression visualization.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      (1) The authors appear to be excluding a significant fraction of the TCRlow gamma delta T cells from their analysis in Figure 1A. Since this population is generally enriched in CD25+ gamma delta T cells, this gating strategy could significantly impact their analysis due to the exclusion of progenitor gamma delta T cell populations.

      We were cautious in our gating strategy since the TCR𝛿+ CD3e+ subset is rather small and so low signal/background noise ratio can be an issue if the gates used are too broad/generous. There is some inevitable low level background staining with the TCR𝛿 that sits just above the bulk of the negative population and is CD3ε -ve. Although this background represents a tiny fraction of total cells, we were wary of gate contamination into our TCR𝛿+ CD3e<sup>+</sup> subset and we wanted a gating strategy that could be applied across other organs too. We do not, however, believe this conservative strategy is impacting on measurements progenitor numbers across strains or our conclusions, since the size of this progenitor population in the various IKKΔT<sup>CD2</sup> and Casp8ΔT<sup>CD2</sup> strains was never impacted by the mutations. But to reassure the reviewer, we show our conservative gate as compared with a very broad TCR𝛿 gate and see we are not missing a substantial population of CD25+ cells just below our gate. This also helps illustrate how close the background from the CD27<sup>int</sup> expressing αβ thymocytes (right column) comes to the TCR𝛿+ CD3+ gate and the importance of tight lineage gating.

      Author response image 1.

      (2) The overall phenotype of the IKKDeltaTCd2 mice is not described in any great detail. For example, it is not clear if these mice possess altered thymocyte or peripheral T cell populations beyond that of gamma delta T cells.

      Given that gamma delta T cell development has been demonstrated to be influenced by gamma delta T cells (i.e, trans-conditioning), this information could have aided in the interpretation of the data.

      Apologies for not being clearer on this point. We have studied conventional αβ T cell development in these strains in considerable detail, and these studies are published and discussed in some detail in the introduction in paragraph 3 on page 3-4 and in cited references Schmidt-Supprian et al 2004, SIlva et al 2014, Xing et al 2016, Webb et al 2019, Carty et al 2023. These detail how IKK expression is critical for thymic development of αβ T cells and their peripheral survival, and dissects the role of NF-κB activation and cell death regulation by IKK. However, we now add new discussion (page 11-12) that considers the potential impact of altered αβ T cell development in the strains used for this study.

      We agree that trans-conditioning is also an important consideration, since CD4 TH17 T cells can enhance type 17 𝛾𝛿 T cell development (10.1038/icb.2011.50). This is of relevance to the limited conclusions we draw concerning type 17 𝛾𝛿 T cells. The REL and IKK deficient strains do lack effector populations, including type 17 αβ T cells, so it is possible that the absence of type 17 αβ T cells in these strains does contribute to the modest impact of IKK deletion in the type 17 𝛾𝛿 subset. We now highlight this information and discuss in the manuscript (page 11-12).

      Related to this, it would have been helpful if the authors provided a comparison of the frequencies of each of the relevant subsets, in addition to the numbers.

      We now provide both the absolute frequencies of different 𝛾𝛿 subsets and their relative frequencies to one another, as supplementary figure 2. We still believe assessing absolute numbers is the gold standard, since the differential impact of gene deletions on the αβ T cell compartments in different strains will effect whether or not αβ T cells are present, and therefore overall representation of 𝛾𝛿 T cells can vary considerably between strains. Hence, absolute numbers are more reliable measure of cell abundance.

      (3) The manner in which the peripheral gamma delta T cell compartment was analyzed is somewhat unclear. The authors appear to have assessed both spleen and lymph node separately. The authors show representative data from only one of these organs (usually the lymph node) and show one analysis of peripheral gamma delta T cell numbers, where they appear to have summed up the individual spleen and lymph node gamma delta T cell counts. Since gamma deltaT17 and gamma deltaT1 are distributed somewhat differently in these compartments (lymph node is enriched in gamma deltaT17, while spleen is enriched in gamma deltaT1), combining these data does not seem warranted. The authors should have provided representative plots for both organs and calculated and analyzed the gamma delta T cell numbers for both organs separately in each of these analyses.

      We did of course process and calculate numbers of different subsets in both lymph nodes and spleen. Where we saw loss of peripheral 𝛾𝛿 subsets, or rescue, this was reflected in seperate analysis of both organs and we did not see any organs specific effects in the mouse strains analysed. We therefore took the initial view that presenting aggregate data was most efficient and least repetitive representation of data. However, we very much recognise the reviewers concern, and interest to see these data, so have now included representative plots across both organs for figure 1D, and show cell numbers of lymph nodes and spleen separately, as well as together, for figures 1, 2, 4 and 7, and these plots reflect the differences observed when we combined data. We did not break down the data for all figures (e.g. figures 3 and 5) as it was more cumbersome for more complex multi-strain comparisons and so attempt to balance clarity and transparency against unnecessary repetitive data presentation.

      (4) The authors make extensive use of surrogate markers in their analysis. While the markers that they choose are widely used, there is a possibility that the expression of some of these markers may be altered in some of their genetic mutants. This could skew their analysis and conclusions. A better approach would have been to employ either nuclear stains (Tbx21, RORgammaT) or intracellular cytokine staining to definitively identify functional gamma deltaT1 or gamma deltaT17 subsets.

      We did share a similar concern, but think this is not an issue where subsets disappear and are almost completely absent, such as in IKK1/2 KO and Casp8 KO settings. Where we saw rescue with RIPK1<sup>D138N</sup> in Casp8ΔT<sup>CD2</sup> strains, we were keen to demonstrate that the populations we saw restored did exhibit their expected function, and so confirmed this in figure 5C by intracellular cytokine staining after a short 4h restimulation in vitro. This also served to validate our gating strategy, since what we designated as Type 1 cells - CD27+CD122+CD44<sup>int</sup> cells were the only source of IFN-gamma, while CD27–CD44<sup>hi</sup> CD122<sup>lo</sup> cells were the only source of IL-17. Adaptive/ naive cells made neither cytokine. So while we did not include nuclear stains, we were satisfied that the cytokine assays validated the gating strategy.

      (5) The analysis and conclusion of the data in Figure 3A is not convincing. Because the data are graphed on log scale, the magnitude of the rescue by kinase dead RIPK1 appears somewhat overstated. A rough calculation suggests that in type 1 game delta T cells, there is ~ 99% decrease in gamma delta T cells in the Cre+WT strain and a ~90% decrease in the Cre+KD+ strain. Similarly, it looks as if the numbers for adaptive gamma delta T cells are a 95% decrease and an 85% decrease, respectively. Comparing these data to the data in Figure 5, which clearly show that kinase dead RIPK1 can completely rescue the Caspase 8 phenotype, the conclusion that gamma delta T cells require IKK activity to repress RIPK1-dependent pathways does not appear to be well-supported. In fact, the data seem more in line with a conclusion that IKK has a significant impact on gamma delta T cell survival in the periphery that cannot be fully explained by invoking Caspase8-dependent apoptosis or necroptosis. Indeed, while the authors seem to ultimately come to this latter conclusion in the Discussion, they clearly state in the Abstract that "IKK repression of RIPK1 is required for survival of peripheral but not thymic gamma delta T cells." Clarification of these conclusions and seeming inconsistencies would greatly strengthen the manuscript. With respect to the actual analysis in Figure 3A, it appears that the authors used a succession of non-parametric t-tests here without any correction. It may be helpful to determine if another analysis, such as ANOVA, may be more appropriate.

      Yes, we completely agree with this assessment and conclusion. While kinase dead RIPK1 does provide some rescue, this appears relatively modest, and instead supports the view, validated in figure 7, that maybe the dominant function of IKK in 𝛾𝛿 T cells is to activate NF-κB dependent survival signals. Nevertheless, RIPK1<sup>D138N</sup> does provide some significant rescue, which allows some peripheral cells to repopulate and demonstrates that IKK is repressing RIPK1 mediated cell death. It is actually not trivial to assess the relative importance of IKK-RIPK1 and IKK-NF-κB functions. In the IKKΔT<sup>CD2</sup> RIPK1<sup>D138N</sup> mice, we prevent RIPK1 induced death, but still lack the NF-κB-dependent survival signal. Consistent with this, the ~1log reduction in 𝛾𝛿 numbers between WT and IKKΔT<sup>CD2</sup> RIPK1<sup>D138N</sup> mice is actually similar to what we observe in the absence of REL subunits (Fig. 7) which is a smaller reduction than we observe in IKKΔT<sup>CD2</sup> mice. What would have been ideal is to have a scenario where IKK regulation of RIPK1 was defective but NF-κB survival signalling was intact. This would reveal the full impact of loosing IKK dependent regulation of RIPK1 alone, which we suspect would result in substantial cell death that could not be blocked by NF-κB. Unfortunately, we not have or know of suitable mouse mutants to test this. This is quite a nuanced discussion and we now clarify the scope and extent of conclusions we can draw (p. 7, 11).

      (6) The conclusion that the alternative pathway is redundant for the development and persistence of the major gamma delta T cell subsets is at odds with a previous report demonstrating that Relb is required for gamma delta T17 development (Powolny-Budnicka, I., et al., Immunity 34: 364-374, 2011). This paper also reported the involvement of RelA in gamma delta T17 development. The present manuscript would be greatly improved by the inclusion of a discussion of these results.

      Thank you - we include a discussion of these papers now (p12).

      (7) The data in Figures 1C and 3A are somewhat confusing in that while both are from the lymph nodes of IKKdeltaTCD2 mice, the data appear to be quite different (In Figure 3A, the frequency of gamma delta T cells increases and there is a near complete loss of the CD27+ subset. In Figure 1A, the frequency of gamma delta T cells is drastically decreased, and there is only a slight loss of the CD27+ subset.)

      Yes, we agree these do like quite different and could be confusing. The lymph nodes from IKKΔT<sup>CD2</sup> lack αβ T cells and B cells, and so the cellularity is much lower than normal. Consequently, the percentage representation of remaining cells can be more noisy, while total cellularity calculations are more consistent. This is not an issue in the other strains that all have more cells in lymph nodes. We now show plots from spleen of the same mice which appear better aligned with additional splenic data shown in Figure 1.

      Reviewer #2 (Public review):

      (1) All approaches used confer changes to the entire T cell compartment. Therefore, the authors are unable to resolve whether the observations are mediated by direct and/or indirect effects (e.g., disorganized lymphoid architecture impacting maintenance/survival/homing).

      We address this important point in the discussion (p11-12). The impacts of gene deletions upon αβ and 𝛾𝛿 T cells operate independently of one another (as also discussed in response to reviewer 1). For instance, the phenotype of αβ T cells is identical in IKKΔT<sup>CD2</sup> and IKKΔT<sup>CD4</sup> mice - 𝛾𝛿 T cells are only targeted in IKKΔT<sup>CD2</sup> mice. Similarly, the phenotype of 𝛾𝛿 T cells is similar in IKKΔT<sup>CD2</sup> vs Casp8.IKKΔT<sup>CD2</sup> strains. αβ T cells are absent from IKKΔT<sup>CD2</sup> but present in near normal numbers in Casp8.IKKΔT<sup>CD2</sup> mice. Others have also noted that 𝛾𝛿 T cell development is normal in Rag deficient mice (10.1126/science.1604321). In any case, an absence of αβ T cells is expected to promote 𝛾𝛿 T cell survival in the absence of competition for common utilised cytokines such as IL-7 and IL-15, though we do not see much evidence for this in mice with and without αβ T cells such as IKKΔT<sup>CD2</sup> vs Casp8. IKKΔT<sup>CD2</sup> strains. We do now discuss the potential contribution of trans-conditioning for type 17 𝛾𝛿 T cell development (p12).

      (2) Assessment of factors that impact T cell numbers in the periphery is necessary. Are there observable changes to the proliferation, survival, and migration of gd T cell subsets?

      In IKKΔT<sup>CD2</sup> and Casp8. IKKΔT<sup>CD2</sup> deficient strains, we infer a defect in survival, since they lack peripheral 𝛾𝛿 T cells, despite normal thymic development. Their absence made it hard to assess proliferation and migration, though 𝛾𝛿 T cells were absent from all lymphoid organs. The conclusions that defective survival is responsible for the absence of 𝛾𝛿 T cells in the different strains is also supported by the rescue of IKKΔT<sup>CD2</sup> and Casp8ΔT<sup>CD2</sup> strains by kinase dead RIPK1D138N. Furthermore, the presence of small numbers of residual populations in lymph nodes and spleen of IKKΔT<sup>CD2</sup> and Casp8ΔT<sup>CD2</sup> strains demonstrates that migration patterns were normal. Were cells unable to recirculate, they might be expected to fail to leave the thymus, or to accumulate in the spleen. We so no evidence of either of these scenarios.

      (3) TCRd chain usage, especially among type 3 gd T cells, should be assessed.

      We did not unfortunately, assess chain usage, choosing rather to rely of phenotypic identity of specific subsets, which we show in figure 5C, was extremely robust. IL-17 was only secreted by CD27– CD44<sup>hi</sup> 𝛾𝛿 T cells, while IFN-gamma was only secreted by CD27+ CD44<sup>hi</sup> 𝛾𝛿 T cells. We argue that the production of these key effector cytokines is the most direct test of a subsets functional identity and the phenotypic designation is robust.

      (4) The functional consequences of IKK signaling on gd T cells were largely unaddressed. Cytokine analyses were performed only in the RIPK1D138N Casp8∆TCD2 model, leaving open the question of how canonical NF-κB-dependent signaling impacts the long-term functionality of gd T cells.

      Yes, we agree this remains an open question around the transcriptional mechanisms by which NFκB signalling promotes cell survival, and one best addressed in future studies. We did not perform cytokine staining more widely, because the cytokine assay relies on short term re-stimulation of T cells with PMA and ionomycin. PMA activates PKC which in turn activates NF-κB signalling to elicit the cytokine response measured in this assay. As such, the results of such assays would be hard to interpret. We agree it would be interesting to investigate the functional consequences of REL deficiency in future studies, although this may need a more nuanced setting where 𝛾𝛿 T cells are not lost as a result of their defective survival.

      (5) The authors suggest that Caspase 8 is required for the development and maintenance of type 3 gd T cells. While the authors discussed the limitations of assessing adult mice in interpreting the data, it seems like a relatively straightforward experiment to perform.

      We did attempt these experiments with collaborators by analysing type 17 𝛾𝛿 T cell development in fetal thymic organ culture (FTOC). However, the GM mice are not so easy to breed and generating the large numbers of embryos required to set up the FTOCs proved too challenging and we were unable to generate these data.

      (6) While analyses of Casp8∆TCD2 RIPK1D138N mice suggest that loss of adaptive and type 1 gamma delta T cells in Casp8∆TCD2 animals is due to necroptosis, the contribution of RIPK3 kinase activity remains unexamined. RIPK3 activity determines whether cells die via necroptosis or apoptosis in RIPK1/Caspase8-dependent signaling, and inclusion of this analysis would strengthen mechanistic insights.

      Given time and resources, it would have been ideal to confirm necroptotic cell death by alternative knockouts, such as RIPK3 or MLKL. However, formation of the necrosome is dependent on kinase active RIPK1, since autophosphorylation of RIPK1 changes its conformation to allow recruitment of RIPK3 and MLKL and formation of the necrosome. Therefore, the rescue of CASPASE8 deficient T cells from cell death by kinase dead RIPK1 is very solid genetic evidence of necroptosis.

      (7) Canonical NF-κB signaling through cRel alone was not evaluated, leaving a gap in the understanding of transcriptional pathways required for gd T cell subsets.

      This was assessed in p105/RelA knockout strain, which only express cREL. What we lacked was an assessment of what RelA/p50 dimers can support in the absence of cREL. We do however, show the impact of RelA single deficiency, and RelA/p50 deficiency.

      In truth, we had many REL deficient strains and it was challenging to make all the combinations we wanted. However, we try to compensate for this by discussing what cREL:cREL dimers and cREL:P50 dimers are capable of doing by analysing 𝛾𝛿 T cell development in p105/RELA DKO and RELA KO mice - these do show that cREL:P50 can compensate in the absence of RELA, but cREL:cREL cannot.

      Reviewer #3 (Public review):

      Weaknesses:

      The paper would benefit greatly from a graphical abstract that could summarize the key findings, making the key findings accessible to the general immunology or biochemistry reader. Ideally, this graphic would distinguish the requirements for NF-κB signals sustaining thymic γδ T cell differentiation from peripheral maintenance, taking into account the various subsets and signaling pathways required. In addition, the authors should consider adding further literature comparing the requirements for NF-κB /necroptosis pathways in regulating other non-conventional T cell populations, such as iNKT, MAIT, or FOXP3+ Treg cells. These data might help position the requirements described here for γδ T cells compared to other subsets, with respect to homeostatic cues and transcriptional states.

      Thank you - we have added such discussions. We are happy to add a graphical abstract if journal constraints permit this.

      Last and least, there are multiple grammatical errors throughout the manuscript, and it would benefit from further editing. Likewise, there are some minor errors in figures (e.g., Figure 3A, add percentage for plot from IKKDT.RIPK1D138N mouse; Figure 7, “Adative").

      Thank you !

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      The central pair apparatus of motile cilia consists of two singlet microtubules, termed C1 and C2, each of which is associated with a set of projections, referred to as the C1 and C2 projections. Each projection comprises multiple distinct structural domains, designated a, b, c, and so on. Biochemical studies combined with genetic analyses in Chlamydomonas identified three proteins as the major components of the C2a projection, and subsequent cryo-EM studies confirmed these findings.

      In this paper, the authors aim to study the homologues of these three proteins-CCDC108/CFAP65, CFAP70, and MYCBPAP/CFAP147-using knockout mouse models. Biochemical and cell biological analyses demonstrate that, as in Chlamydomonas, these proteins are components of the C2 projection and form a complex that depends on the presence of each other. In addition, the authors use affinity purification to identify two previously uncharacterized proteins and show that they are central pair apparatus proteins that associate with the aforementioned complex. Knockout mice lacking any of the three core proteins exhibit phenotypes consistent with primary ciliary dyskinesia (PCD).

      Overall, the manuscript is clearly written, and the data are convincing and support the authors' conclusions. However, given the previous findings in Chlamydomonas, this work provides limited conceptual advances to the field. Nonetheless, it represents a useful and well-documented resource for understanding the conserved organization of the central pair apparatus in motile cilia. It will be of interest to cell and developmental biologists, biochemists, and clinicians studying and treating human ciliopathies.

      We thank the reviewer for their positive comments on our work.

      Reviewer #2 (Public review):

      Summary:

      This manuscript investigates the protein composition and functional role of the C2a projection of the central apparatus (CA) in vertebrate motile cilia. Using three knockout mouse models (Ccdc108, Mycbpap, and Cfap70), the authors demonstrate that these genes - homologs of Chlamydomonas FAP65, FAP147, and FAP70 - are required for normal motile cilia function in ependymal and tracheal multiciliated cells. Specifically, the authors show that:

      (1) Knockout mice for each gene exhibit primary ciliary dyskinesia phenotypes (hydrocephalus and sinusitis), accompanied by abnormal ciliary motion and reduced ciliary beat frequency. 

      (2) CCDC108, MYCBPAP, and CFAP70 physically interact and localize to the axonemal central lumen, consistent with the C2a projection. 

      (3) Loss of any one of these proteins destabilizes the others and disrupts CA integrity in a tissue-specific manner. 

      (4) ARMC3 and MYCBP are C2a-associated proteins. 

      Strengths:

      (1) Clarity: the results are presented in a coherent sequence that facilitates understanding of both the rationale and conclusions. 

      (2) Genetic rigor: three independent knockout mouse lines that exhibit consistent motile cilia phenotypes provide in vivo support for the proposed role of these proteins. 

      (3) Integration of structural and functional analyses: combination of ultrastructural (TEM) and immunofluorescence data with CBF measurements provides convincing correlation between structural defects and impaired ciliary function. 

      (4) Mutual dependency model: reciprocal destabilization of CCDC108, MYCBPAP, and CFAP70 supports their interdependence in the C2a assembly. 

      (5) Expansion of the vertebrate C2a proteome: the identification of ARMC3 and MYCBP as C2a-associated proteins provides a foundation for future mechanistic studies. 

      We appreciate our reviewer's positive comments.

      Weaknesses:

      (1) Mechanistic depth: the data show a convincing correlation between C2a and ciliary function, but the cell type-specificity of CCDC108, MYCBPAP, and CFAP70 knockout effects is underdeveloped. This is an interesting observation that raises mechanistic/structural questions not addressed in the study, such as what is the role of C2a in CP nucleation, maintenance, or mechanical stabilization? Is C2a composition different in different cell types? 

      We agree with our reviewer and value their insightful comments. Indeed, CP-MT defects, including the loss of one or both CP-MTs, were only observed in a subset of mouse ependymal cells (mEPCs) at day 10 post-serum starvation, and were rare in tracheal multiciliated cells, although the C2a projections were severely damaged in these tracheal cells. Based on these observations, we hypothesize that the loss of CP-MTs is probably a secondary effect caused by mechanical stress during ciliary movement. To investigate the role of C2a in CP-MT nucleation, maintenance, or mechanical stabilization, we plan to examine the axoneme structures of mEPCs at day 5 post-serum starvation using TEM. By comparing axoneme defects in these cells at days 5 and 10, we hope to gain insights into this question. Based on our findings and previous findings in Chlamydomonas, we speculate that the core components (CCDC108/FAP65, MYCBPAP/FAP147, and CFAP70/FAP70) of the C2a projection are highly conserved across species, but the peripheral associated C2a proteins may vary among different cell types. Therefore, we will perform co-immunoprecipitation using mEPCs and mouse tracheal epithelial cells to investigate potential cell-type-specific differences and expand the related discussion.

      (2) Cell model choice: co-immunoprecipitation was performed using mouse testis lysates. While this is a reasonable source of CA proteins from flagellated cells, the functional analyses in this study focus on ependymal and tracheal multiciliated cells. It would therefore be helpful for the authors to clarify the extent to which these interactions are expected to be conserved across ciliated cell types, and to discuss potential tissue-specific differences in CA assembly.

      We appreciate our reviewer's insightful comments. We will follow their suggestion and perform co-immunoprecipitation using mEPCs and mouse tracheal epithelial cells to investigate potential cell-type-specific differences and expand the related discussion.

      (3) Statistical analysis: the manuscript states "Statistical significance was defined as P < 0.5", which is likely a typo, but should be P < 0.05. In general, the statistical methods require more clarification. In several figures (e.g., 2B, 2D, 5J, 5K), multiple knockout genotypes are compared with WT, yet unpaired t-tests are reported. When more than two groups are analyzed, multiple pairwise t-tests inflate Type I error unless appropriately corrected; a one-way ANOVA with post hoc comparisons (e.g., Dunnett's test for WT-referenced comparisons) would be more appropriate. Furthermore, the analysis of ciliary movement modes (Figure 2D) involves categorical data, for which a t-test is not statistically appropriate. These comparisons could instead be evaluated using chi-square or Fisher's exact tests. Addressing these issues is important to ensure accurate statistical inference.

      We thank our reviewer for pointing out these errors. We will double-check our statistical results and perform new analyses following their suggestion.

      (4) Methods section: does not sufficiently describe how image-based quantifications were performed. For example, the criteria used to define cilia number, basal body number, and rotational beating are not specified, nor is how CBF measurements were analyzed. The authors should also provide details regarding analysis software and imaging parameters used (and whether they were kept constant across genotypes). 

      We apologize for overlooking these method details. We will expand the relevant method section to include this information.

    1. Author response:

      We thank the reviewer for the thoughtful and constructive evaluation of our work and for recognizing its potential interest to researchers working on cardiac development and regeneration. We are planning to address the specific concerns as noted by the reviewers in the following way:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript addresses an important question in cardiac biology: whether distinct cardiomyocyte (CM) subpopulations play specialized roles during heart development and regeneration. Using single-cell RNA sequencing and newly generated genetic tools, the authors identify phlda2 as a specific marker of primordial cardiomyocytes in the adult zebrafish heart. They further show that these primordial CMs function are essential for myocardial morphogenesis and coronary vascularization but are dispensable for myocardial regeneration or revascularization after injury. These findings indicate that heart regeneration doesn't simply recapitulate developmental processes.

      Strengths:

      A major strength of the study is the generation of a phlda2 BAC reporter, which provides a specific and reliable marker for primordial cardiomyocytes. The lack of genetic tools has previously limited functional analysis of this CM population. By using phlda2 regulatory elements to generate reporter and NTR-based ablation lines, the authors can visualize and selectively manipulate primordial CMs in vivo. This enables a direct functional interrogation rather than relying on lineage tracing or correlative evidence. Through genetic ablation, the authors convincingly demonstrate that primordial CMs are essential for myocardial morphogenesis and coronary vascular organization during development but are not necessary for heart regeneration.

      Weaknesses:

      (1) The manuscript would benefit from clarifying whether the primordial cardiomyocytes ablation affects epicardial cell behaviors during heart development, given that the well-established role of the epicardium in supporting coronary vessel growth, it is possible that the vascular phenotypes observed after primordial CM ablation may be affected, at least in part, by altered epicardial cells.

      We thank the reviewer for this thoughtful comment and agree that primordial cardiomyocyte ablation may indirectly affect coronary vessel growth through changes in epicardial cell behavior. Therefore, we will perform additional analyses to examine epicardial cell behaviors, including epicardial coverage and migration following primordial cardiomyocyte ablation using the established epicardial reporter line tcf21:nucEGFP during heart development.

      (2) Because primordial cardiomyocytes form a dense, single-cell-thick layer covering the ventricular surface, it would be informative to determine whether their loss alters the spatial distribution or inward migration of coronary endothelial cells or epicardial cells.

      We thank the reviewer for this important comment. We will analyze the spatial distribution and inward migration of coronary endothelial and epicardial cells after primordial cardiomyocyte ablation using high-resolution imaging and quantitative analysis

      (3) The manuscript carefully examines the relationship between primordial CMs and gata4⁺ cardiomyocytes during regeneration. However, their relationship during heart development should be more fully addressed.

      We appreciate the suggestion and will carefully investigate the relationship between primordial cardiomyocytes and gata4<sup>+</sup> cardiomyocytes during heart development.

      (4) As loss of cardiomyocytes is known to induce gata4:GFP activation during regeneration, it would be important to determine whether ablation of primordial cardiomyocytes alone triggers gata4:GFP expression in neighboring cardiomyocytes. This analysis would further support the conclusion that primordial cardiomyocytes are not required for regenerative responses.

      We acknowledge the reviewer’s comments and will test whether primordial cardiomyocyte ablation induces gata4:GFP activation in neighboring cardiomyocytes in the adult heart.

      Reviewer #2 (Public review):

      Summary:

      In the manuscript "Primordial Cardiomyocytes orchestrate myocardial morphogenesis and vascularization but are dispensable for regeneration", Sun et al. identify a novel marker of primordial cardiomyocytes and use it to visualize and ablate the population during development and regeneration. The role of the primordial layer has not been investigated because the tools to manipulate this population have not existed. The manuscript is straightforward, easy to understand, and addresses an important question that has not been explored.

      While the manuscript provides important insights into the role of primordial CMs, backed by a convincing methodology, the authors should clarify their requirements for heart development and maturation. Specifically, is the primordial layer required for the fish to survive?

      We thank the reviewer for this important question. We will examine the survival of fish following primordial cardiomyocyte ablation during development.

      Do primordial CMs regenerate when ablated during development, and do the defects observed (in trabecular and compact CMs and coronary vessels) resolve after 10 days post-treatment when they were detected?

      We thank the reviewer for this valuable comment. We will perform additional analyses to determine whether primordial cardiomyocytes regenerate after ablation during development and to assess the extent and dynamics of their recovery. We will also evaluate whether the defects in trabecular and compact myocardium and coronary vasculature persist or resolve in adult hearts following primordial cardiomyocyte ablation during development.

      Reviewer #3 (Public review):

      Summary:

      The authors performed single-cell RNA sequencing of adult zebrafish hearts and identified markers for distinct cardiomyocyte subpopulations. One marker, phlda2, marks primordial cardiomyocytes. They generated transgenic reporter lines to characterize phlda2 expression patterns and a phlda2-NTR ablation line to determine the functional requirement of primordial cardiomyocytes during heart regeneration. They found that phlda2+ primordial cardiomyocytes are essential for myocardial morphogenesis and coronary vessel development. Interestingly, when phlda2+ primordial cardiomyocytes are ablated during heart regeneration, gata4+ cortical cardiomyocytes, coronary vessel revascularization, and scar tissue formation are not affected.

      Strengths:

      The authors identified a new primordial cardiomyocyte marker, phlda2. They further demonstrated that primordial cardiomyocytes are important for heart morphogenesis but dispensable for heart regeneration. Their findings reveal a potential difference between heart development and regeneration programs.

      Weakness:

      Despite the interesting findings, the authors did not provide supplemental data for their scRNAseq to demonstrate the data quality and support their conclusions, and some results are not well described.

      We appreciate the reviewer’s comment. We will include supplemental data to demonstrate the quality of our single-cell RNA sequencing. Additionally, we will provide more detailed descriptions of the key results in the main text and figure legends to clearly support our conclusions regarding primordial cardiomyocytes and their roles in heart morphogenesis and regeneration.

    1. Author response:

      Public reviews:

      Reviewer #1 (Public review):

      In the manuscript entitled "Flexible and high-throughput simultaneous profiling of gene expression and chromatin accessibility in single cells," Soltys and colleagues present easySHARE-seq, a method described as an improvement upon SHARE-seq for the simultaneous measurement of RNA transcripts and chromatin accessibility.

      The authors demonstrate the utility of easySHARE-seq by profiling approximately 20,000 nuclei from the murine liver, successfully annotating cell types and linking cis-regulatory elements to target genes. The authors claim that easySHARE-seq supports longer read lengths potentially enabling better variant discovery or allele-specific signal assessment, though they do not provide direct evidence to support these specific claims.

      A key strength of the protocol is enhanced sequencing efficiency, achieved by shortening the Index 1 read from 99 to 17 nucleotides. This reduction does not come at a significant cost to barcode diversity, retaining approximately 3.5 million combinations. Additionally, the approach allows for the sequencing of a sub-library to assess quality prior to final barcoding and sequencing which seems quite clever.

      While the increase in RNA transcript recovery is substantial, it appears to come at a cost: there is a notable decrease in ATAC fragments per cell compared to the original SHARE-seq (and other platforms). Likely as a result, the dimensionality reduction (UMAP) shows good resolution for RNA profiles but relatively poor resolution for accessibility profiles. Furthermore, the presented data suggests potential ambient RNA contamination; specifically, the detection of Albumin in HSCs and B cells is likely an artifact of the protocol rather than a biological signal.

      Overall, the study is well-presented and represents a promising advance. However, there are significant shortcomings that should be addressed, particularly regarding "leaky" transcript recovery and reduced ATAC performance.

      Recommendations:

      (1) To provide a comprehensive view of the current field, the authors should include Scale Biosciences (Scale Bio) in their discussion of available commercial platforms.

      (2) A head-to-head comparison with the 10x Genomics Multiome platform would be of significant interest to the single-cell genomics community and would better contextualize the performance of easySHARE-seq.

      (3) Optimizing ATAC Performance: I strongly suggest exploring methods to improve ATAC sensitivity. As the authors note, the improvement in RNA recovery may result from fewer processing steps and stronger fixation. It would be valuable to test if decreasing fixation back to 2% (as in the original SHARE-seq) recovers ATAC data quality, and to determine if the fixation level or the number of steps is the key variable in preserving transcripts.

      (4) The authors allude to the possibility of scaling this assay using a barcoded poly(T). Explicit inclusion or demonstration of this capability would dramatically increase interest in this protocol. Perhaps ATAC could be scaled using a barcoded Tn5?

      (5) The number of HSCs and B cells expressing Albumin is problematic and suggests significant ambient RNA issues that need to be addressed or computationally corrected.

      We thank reviewer #1 for his comments and critique. We will include a direct comparison of easySHARE-seq with the 10x Multiome platform by adding this comparison to Fig. 1 E&F and more directly point to Table 1 as a comparison of overall assay possibilities. We will also more explicitly state and describe the possibilities and limitations of how to scale this assay up. We also thank the reviewer for raising the possible issue of ambient RNA contamination. We aim to quantify ambient RNA contamination and explore its impact as well as possibilities to correct for it if needed. Unfortunately, external circumstances make it difficult to perform further wetlab experiments in order to optimize ATAC-seq performance. We will thus update our discussion to include possibilities on how to improve ATAC-seq data quality.

      Reviewer #2 (Public review):

      Aims:

      The authors sought to optimize SHARE-seq, a multimodal single-cell method, to improve the simultaneous profiling of gene expression and chromatin accessibility. Their goal was to enhance barcode design for better sequencing efficiency and cost savings, while improving overall data quality. They then applied their optimized method, easySHARE-seq, to study liver sinusoidal endothelial cells (LSECs) to demonstrate its utility in examining gene regulation and spatial zonation.

      Strengths:

      The improved barcode design is an advance, increasing the proportion of sequencing reads dedicated to biological information rather than barcode identification. This modification offers practical benefits in terms of sequencing costs and read length, potentially reducing alignment errors. The method also demonstrates improved RNA detection compared to the original SHARE-seq protocol. The biological applications showcase how simultaneous measurement of both modalities enables analyses that would be practically impossible with single-modality approaches, particularly in examining how chromatin states change along developmental or spatial trajectories.

      Weaknesses:

      There is a notable reduction in chromatin accessibility detection compared to the original SHARE-seq method, likely limiting the broad use of the method. While the authors are transparent about this tradeoff, additional discussion would be helpful regarding how this affects data interpretation. Comparisons showing consistency between easySHARE-seq and SHARE-seq chromatin accessibility patterns at the single-cell level would strengthen confidence in the method.

      We thank reviewer #2 for his comments and great suggestions for further analyses. We will emphasize ATAC-seq data quality issues further in our discussions and more explicitly discuss the resulting implications and shortcomings. We agree with reviewer #2 that this dataset allows exploration of enhancer logic. We aim to incorporate the suggested analyses regarding RNA-ATAC correlations, expand our exploration of enhancer biology and include these results in our revisions. We will also improve clarity of our zonation analysis procedure.

      Overall:

      The authors achieve their aim of creating an optimized protocol with improved barcode design and enhanced RNA detection. The method represents a useful advance for specific experimental contexts where the tradeoffs are appropriate.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In the ecological interactions between wild plants and specialized herbivorous insects, structural innovation-based diversification of secondary metabolites often occurs. In this study, Agrawal et al. utilized two milkweed species (Asclepias curassavica and Asclepias incarnata) and the specialist Monarch butterfly (Danaus plexippus) as a model system to investigate the effects of two N,S-cardenolides - formed through structural diversification and innovation in A. curassavica-on the growth, feeding, and chemical sequestration of D. plexippus, compared to other conventional cardenolides. Additionally, the study examined how cardenolide diversification resulting from the formation of N,S-cardenolides influences the growth and sequestration of D. plexippus. On this basis, the research elucidates the ecophysiological impact of toxin diversity in wild plants on the detoxification and transport mechanisms of highly adapted herbivores.

      Strengths:

      The study is characterized by the use of milkweed plants and the specialist Monarch butterfly, which represent a well-established model in chemical ecology research. On one hand, these two organisms have undergone extensive co-evolutionary interactions; on the other hand, the butterfly has developed a remarkable capacity for toxin sequestration. The authors, building upon their substantial prior research in this field and earlier observations of structural evolutionary innovation in cardenolides in A. curassavica, proposed two novel ecological hypotheses. While experimentally validating these hypotheses, they introduced the intriguing concept of a "non-additive diversity effect" of trace plant secondary metabolites when mixed, contrasting with traditional synergistic perspectives, in their impact on herbivores.

      Weaknesses:

      The manuscript has two main weaknesses. First, as a study reliant on the control of compound concentrations, the authors did not provide sufficient or persuasive justification for their selection of the natural proportions (and concentrations) of cardenolides. The ratios of these compounds likely vary significantly across different environmental conditions, developmental stages, pre- and post-herbivory, and different plant tissues. The ecological relevance of the "natural proportions" emphasized by the authors remains questionable. Furthermore, the same compound may even exert different effects on herbivorous insects at different concentrations. The authors should address this issue in detail within the Introduction, Methods, or Discussion sections.

      Second, the study was conducted using leaf discs in an in vitro setting, which may not accurately reflect the responses of Monarch butterflies on living plants. This limitation undermines the foundation for the novel ecological theory proposed by the authors. If the observed phenomena could be validated using specifically engineered plant lines-such as those created through gene editing, knockdown, or overexpression of key enzymes involved in the synthesis of specific N,S-cardenolides - the findings would be substantially more compelling.

      Reviewer #2 (Public review):

      This study examined the effects of several cardenolides, including N,S-ring containing variants, on sequestration and performance metrics in monarch larvae. The authors confirm that some cardenolides, which are toxic to non-adapted herbivores, are sequestered by monarchs and enhance performance. Interestingly, N,S-ring-containing cardenolides did not have the same effects and were poorly sequestered, with minimal recovery in frass, suggesting an alternate detoxification or metabolic strategy. These N,S-containing compounds are also known to be less potent defences against non-adapted herbivores. The authors further report that mixtures of cardenolides reduce herbivore performance and sequestration compared to single compounds, highlighting the important role of phytochemical diversity in shaping plant-herbivore interactions.

      Overall, this study is clearly written, well-conducted and has the potential to make a valuable contribution to the field. However, I have one major concern regarding the interpretations of the mixture results. From what I understand of the methods, all tested mixtures contain all five compounds. As such, it is not possible to determine whether reduced performance and sequestration result from the complete mixture or from the presence of a single compound, such as voruscharin for performance and uscharin for sequestration. For instance, if all compounds except voruscharin (or uscharin) were combined, would the same pattern emerge? I suspect not, since the effects of the individual N,S-containing compounds alone are generally similar to those of the full mixture (Figure S3). By taking the average of all single compounds, the individual effects of the N,S-containing ones are being inflated by the non-N,S-containing ones (in the main text, Figure 4). In the mix, of course, they are not being 'diluted', as they are always present. This interpretation is further supported by the fact that in the equimolar mix, the relative proportion of voruscharin decreases (from 50% in the 'real mix'), and the target measurements of performance and sequestration tend to increase in the equimolar mix compared to the real mix.

      Despite this issue, the discussion of mixtures in the context of plant defence against both adapted and non-adapted herbivores is fascinating and convincing. The rationale that mixtures may serve as a chemical tool-kit that targets different sets of herbivores is compelling. The non-N,S cardenolides are effective against non-adapted herbivores and the N,S-containing cardenolides are effective against adapted herbivores. However, the current experiments focus exclusively on an adapted species. It would be especially interesting to test whether such mixtures reduce overall herbivory when both adapted and non-adapted species are present.

      It remains possible that mixtures, even in the absence of voruscharin or uscharin, genuinely reduce sequestration or performance; however, this would need to be tested directly to address the abovementioned concern.

      Thanks for these insightful reviews and your summary assessment. We certainly agree that ours was a laboratory study with a single specialized insect, and both mixtures types had all five compounds (controlling for total toxin concentration). Thus, our conclusion that combined effects of naturally occurring toxins (within the cardenolide class) have non-additive effects for the specialized sequestering monarch are constrained by our experimental conditions. In our assay we used two mixture types, equimolar and “natural” proportions. We acknowledge that the natural proportions will vary with plant age, damage history, etc. of the host plant, Asclepias curassavica. Our proportions were based on growing the plants a few different times under variable conditions. Although we did not conduct these experiments on non-adapted insects, we discuss a related experiment that was conducted with wild-type and genetically engineered Drosophila (Lopez-Goldar et al. 2024, PNAS). In sum, we appreciate the reviewers’ comments.

      Recommendations for the authors:

      Reviewing Editor Comments:

      (i) More convincingly justify the choice and ecological relevance of the "natural" cardenolide ratios, (ii) Clarify the interpretation of mixture effects, and (iii) more explicitly discuss the limitations of leaf-disc assays and the absence of non-adapted herbivores in light of the broader coevolutionary claims.

      Thank you for these suggestions. We have added several sentences of text to the Discussion section to make these points.

      Reviewer #1 (Recommendations for the authors):

      (1) Statistical analysis is missing from Figure 3 and Figure S3, making it difficult to assess the significance of the data.

      Much of the data in Fig. 3 is meant for descriptive presentation, with the main statistical analysis (contrast between N,S and non-N,S cardenolides given in the main text of the results. We have added treatment differences between the sequestration efficiencies to the figure as well.

      (2) To help readers intuitively understand how certain results (such as ECD and sequestration efficiency) were calculated, the authors can provide the equations used for these computations.

      Thank you, this was given in the methods and we have added it to the Result on first mention as well.

      (3) For Figure 4, we suggest presenting the results of the equal mixture treatment and the realistic mixture treatment separately, rather than averaging the results from these two types of treatments.

      We understand and appreciate this comment – all of the treatment means are given in Fig. S3. For this particular figure we have opted to stick with the binary comparison (singles vs. mixed) to maximize replication for statistical tests (typically n = 25 vs. 10).

      Reviewer #2 (Recommendations for the authors):

      Given the interpretations and discussion generally, I feel the manuscript would benefit from either additional experiments (mixtures w/o N-S compounds), inclusion of non-adapted herbivore performance, or reframing of the explicit interpretations from your findings.

      We have added some caveats to the text but not added any additional experiments.

      Also, for all treatments/mixtures are concentrations above the IC50? Perhaps this could be calculated from the information presented, but it may be best to explicitly mention this.

      This is an interesting question. IC50’s are estimated from in vitro assays (with the enzyme and toxins in microplate wells) and so are not translatable to foliar concentrations. As indicated in the text, we chose cardenolide levels based on foliar concentrations to match A. curassavica.

      Some minor points:

      (1) Although the intact N,S-ring-containing compounds are recovered in low amounts in frass (and not sequestered), is there evidence of N,S-ring components being otherwise traceable in the frass? For example, can excess S or N be detected in frass? This could provide insight into differential detoxification or reincorporation of these elements, potentially explaining variation between voruscharin and uscharin.

      Great question! We have not been able to detect breakdown projects. In other experiments we have conducted mass spectrometric analysis of bodies and frass, but have not been able to find the features representing breakdown products. Nonetheless, as mentioned below, the main conversion products are evident and measurable, as in this study.

      (2) As a point of curiosity, is there evidence of interconversion between such compounds? For instance, if monarchs are fed only voruscharin, can other cardenolides be detected in their tissues?

      Yes, we have tried to make this more clear in the text. Both uscharin and voruscharin are converted to calotropin and calactin.

    1. Author response:

      General Statements

      Our study provides important mechanistic insights into how the perinuclear actomyosin network PANEM facilitates the interaction of unfavorably positioned chromosomes, i.e. peripheral and polar chromosomes, with the mitotic spindle in early mitosis to ensure their correct segregation in subsequent anaphase. All reviewers agree that our study makes important contribution to the field of mitosis and chromosome segregation. They make positive comments on our manuscript, for example, ‘The work highlights the PANEM as a key spatial and temporal element of chromosome congression’, ‘The work is an excellent addition to the field’, and ‘the concept of PANEM could be integrated into textbooks and models of chromosome congression’. All three reviewers also acknowledge the high quality of the data, rigorous and accurate analyses, and convincing quantification in our study. Reviewers 1 and 3 give several comments and suggestions for revision of our manuscript. Please find our point-by-point revision plan of the manuscript from page 3.

      Description of the planned revisions

      Reviewer #1 (Evidence, reproducibility and clarity):

      Summary

      Sheidaei and colleagues report a novel and potentially important role for an early mitotic actomyosin-based mechanism, PANEM contraction, in promoting timely congression of chromosomes located at the nuclear periphery, particularly those in polar positions. The manuscript will interest researchers studying cell division, cytoskeletal dynamics, and motor proteins. Although some data overlap with the group's prior work, the authors extend those findings by optimizing key perturbations and performing more detailed analyses of chromosome movements, which together provide a clearer mechanistic explanation. The study also builds naturally on recent ideas from other groups about how chromosome positioning influences both early and later mitotic movements.

      In its current form, however, the manuscript is not acceptable for publication. It suffers from major organizational problems, an overcrowded and confusing Results section and figures, and a lack of essential experimental controls and contextual discussion. These deficiencies make it difficult to evaluate the data and the authors' conclusions. A substantial structural revision is required to improve clarity and persuasiveness. In addition, several key control experiments and more conceptual context are needed to establish the specificity and relevance of PANEM relative to other microtubule- and actin-based mitotic mechanisms. Testing PANEM in additional cell lines or contexts would also strengthen the claim. I therefore recommend Major Revision, addressing the structural, conceptual, and experimental issues detailed below.

      Major Comments

      A. Structural overhaul and figure reorganization

      The Results section is overly dense, lacks clear structure, and includes descriptive content that belongs in the Methods. Many figure panels should be moved to Supplementary Materials. A substantial reorganization is required to transform the manuscript into a focused, "Reports"-type article.

      Figure 4I: This panel is currently unclear and should be drastically simplified.

      We will follow this suggestion and simplify this figure. For example, we plan to remove the column of “Start” because it is obvious and does not provide much new information.

      I recommend to reorganize figures as follows:

      Figure I: Keep as single figure but simplify. Figure 1D and 1E could be combined, move unnormalized SCV to supplementary materials. Same goes for 1F.

      We will follow this suggestion and reorganize Figure 1 accordingly.

      New Figure 4: Combine Figures 7A, 7B, 7D, 7E, 7F, expanded Supplementary Figure S7, and new data to demonstrate that PANEM actively pushes peripheral chromosomes inward which is important for efficient chromosome congression in diverse cellular contexts.

      As suggested, we will conduct new experiments to demonstrate the role of PANEM in diverse cellular contexts, as detailed below. We will then combine the new results with Figure S7 to make the new Figure 8.

      On the other hand, in our view, combining Figure 7A-E and the extended Figure S7 would be confusing because the two parts address different topics. Although we respect this suggestion from the reviewer, we would like to keep Figure 7 and the extended Figure S7 (i.e. Figure 8) separate.

      C. Expansion of PANEM functional analysis

      To strengthen the conclusions and broaden the study beyond the group's previous work, PANEM function should be tested in additional contexts (some may be considered optional but important for broader impact): [underlined by authors]

      Test PANEM function in at least one additional cell line that displays PANEM to rule out cellline-specific effects.

      As suggested, we will study the effect of PANEM contraction in one or two additional cell lines that form PANEM during prophase. For example, we plan to inhibit the PANEM contraction and study the outcome, focusing on the generation of polar chromosomes, which is the major defect after the inhibition of PANEM contraction in U2OS cells.

      Evaluate PANEM contraction role in unsynchronized U2OS cells, where centrosome separation can occur before NEBD in a subset of cells (Koprivec et al., 2025), and in other cell types with variable spindle elongation timing.

      As suggested, we will investigate the outcome (e.g. generation of polar chromosomes) of reduced PANEM contraction in unsynchronized U2OS cells, and address whether the two subsets of cells, where centrosomes’ separation occurs before and after NEBD, show any difference in the outcome.

      D. Conceptual integration in Introduction and Discussion

      The manuscript should better situate its findings within the context of early mitotic chromosome movements:

      Clearly state in the Introduction and elaborate in the Discussion that initiation of congression is coupled to biorientation (Vukušić & Tolić, 2025). This provides essential context for how PANEM-mediated nuclear volume reduction supports efficient congression of polar chromosomes.

      To explain the new interpretation of our results more clearly, we plan to add a new diagram to a supplemental figure in the revised manuscript.

      Minor Comments

      Sixth subheading (currently in Discussion): Move the final paragraph of the Discussion into the Results and expand it with preliminary analyses linking PANEM contraction to congression efficiency across untreated cell types or under mild nocodazole treatment.

      As suggested, we will move the final paragraph of the Discussion to make a new final section in the Results. Moreover, as suggested, we will study the outcome of inhibiting PANEM contraction in cell lines other than U2OS, and add the results to the new final section in the Results.

      Significance

      Advance

      This study's main strength is its novel and potentially important demonstration that contraction of PANEM, a peripheral actomyosin network that operates contracts early mitosis, contributes to the timely initiation of chromosome congression, especially for polar chromosomes. While PANEM itself was previously described by this group, this manuscript provides new mechanistic evidence, improved perturbations, and detailed chromosome tracking. To my knowledge, no prior studies have mechanistically connected this contraction to polar chromosome congression in this level of detail. The work complements dominant microtubule-centric models of chromosome congression and introduces actomyosin-based forces as a cooperating system during very early mitosis. However, the impact of the study is currently limited by major organizational issues, insufficient controls, and incomplete contextualization within existing literature. Addressing these issues will substantially improve clarity and credibility. [underlined by authors]

      We have addressed or will address the underlined criticisms as detailed above.

      Audience

      Primary audience of this study will be researchers working in cell division, mitosis, cytoskeleton dynamics, and motor proteins. The findings may interest also the wider cell biology community, particularly those studying chromosome segregation fidelity, spindle mechanics, and cytoskeletal crosstalk. If validated and clarified, the concept of PANEM could be integrated into textbooks and models of chromosome congression and could inform studies on mitotic errors and cancer cell mechanics.

      Expertise

      My expertise lies in kinetochore-microtubule interactions, spindle mechanics, chromosome congression, and mitotic signaling pathways.

      Reviewer #2 (Evidence, reproducibility and clarity):

      In this manuscript, Sheidaei et al. reported on their study of chromosome congression during the early stages of mitotic spindle assembly. Building on their previous study (ref. #15, Booth et al., Elife, 2019), they focused on the exact role of the actin-myosin-based contraction of the nuclear envelope. First, they addressed a technical issue from their previous study, finding a way to specifically impair the actomyosin contraction of the nuclear membrane without affecting the contraction of the plasma membrane. This allowed them to study the former more specifically. They then tracked individual kinetochores to reveal which were affected by nuclear membrane contraction and at what stage of displacement towards the metaphase plate. The investigation is rigorous, with all the necessary controls performed. The images are of high quality. The analyses are accurate and supported by convincing quantifications. In summary, they found that peripheral chromosomes, which are close to the nuclear membrane, are more influenced by nuclear membrane contraction than internal chromosomes. They discovered that nuclear membrane contraction primarily contributes to the initial displacement of peripheral chromosomes by moving them towards the microtubules. The microtubules then become the sole contributors to their motion towards the pole and subsequently the midplane. This step is particularly critical for the outermost chromosomes, which are located behind the spindle pole and are most likely to be missegregated.

      Significance

      While the conclusions are somewhat intuitive and could be considered incremental with regard to previous works, they are solid and improve our understanding of mitotic fidelity. The authors had already reported the overall role of nuclear membrane contraction in reducing chromosome missegregation in their previous study, as mentioned fairly and transparently in the text. However, the reason for this is now described in more detail with solid quantification. Overall, this is good-quality work which does not drastically change our understanding of chromosome congression, but contributes to improving it. Personally, I am surprised by the impact of such a small contraction (of around one micron) on the proper capture of chromosomes and wonder whether the signalling associated with the contraction has a local impact on microtubule dynamics. However, investigating this point is clearly beyond the scope of this study, which can be published as it is. [underlined by authors]

      The suggested topic (underlined) is intriguing. However, we agree with the reviewer that it is beyond the scope of this paper. The reviewer recommends publication of our manuscript as it is. So, we do not plan a revision based on this reviewer’s comments.

      Reviewer #3:

      Sheidaei et al., report how chromosomes are brought to positions that facilitate kinetochoremicrotubule interactions during mitosis. The study focusses on an important early step of the highly orchestrated chromosome segregation process. Studying kinetochore capture during early prophase is extremely difficult due to kinetochore crowding but the team has taken up the challenge by classifying the types of kinetochore movements, carefully marking kinetochore positions in early mitosis and linking these to map their fate/next-positions over time. The work is an excellent addition to the field as most of the literature has thus far focussed on tracking kinetochore in slightly later stages of mitosis. The authors show that the PANEM facilitates chromosome positioning towards the interior of the newly forming spindle, which in turn facilitates chromosome congression - in the absence of PANEM chromosomes end up in unfavourable locations, and they fail to form proper kinetochore-microtubule interactions. The work highlights the perinuclear actomyosin network in early mitosis (PANEM) as a key spatial and temporal element of chromosome congression which precedes the segregation process.

      Major points

      (4) The work has high quality manual tracking of objects in early mitosis- if this would be made available to the field, it can help build AI models for tracking. The authors could consider depositing the tracking data and increasing the impact of their work.

      As suggested, we will include kinetochore tracking data as supplemental data in the revised manuscript.

      Minor points

      (2) Discussion point: If cells had not separated their centrosomes before NEBD, would PANEM still be effective? Perhaps the cancer cell lines or examples as shown in Figure 6A have some clues here.

      The same question has been raised by Reviewer #1’s major point. We will undergo new experiments to directly address this question in a revised manuscript. If we do not obtain interpretable results, we will discuss this issue further in the Discussion, as suggested.

      (3) Figure 7 cartoon shows misalignment leading to missegregation. It may be useful to consider this in the context of the centrosome directed kinetochore movements via pivoting microtubules. Is this process blocked in azBB-treated cells?

      This issue is closely relevant to point 2 above. As discussed above, we will first address this issue experimentally. If we do not obtain interpretable results, we will discuss this issue further in the Discussion.

      Description of the revisions that have already been incorporated in the transferred manuscript

      Reviewer #1 (Evidence, reproducibility and clarity):

      Summary

      Sheidaei and colleagues report a novel and potentially important role for an early mitotic actomyosin-based mechanism, PANEM contraction, in promoting timely congression of chromosomes located at the nuclear periphery, particularly those in polar positions. The manuscript will interest researchers studying cell division, cytoskeletal dynamics, and motor proteins. Although some data overlap with the group's prior work, the authors extend those findings by optimizing key perturbations and performing more detailed analyses of chromosome movements, which together provide a clearer mechanistic explanation. The study also builds naturally on recent ideas from other groups about how chromosome positioning influences both early and later mitotic movements.

      In its current form, however, the manuscript is not acceptable for publication. It suffers from major organizational problems, an overcrowded and confusing Results section and figures, and a lack of essential experimental controls and contextual discussion. These deficiencies make it difficult to evaluate the data and the authors' conclusions. A substantial structural revision is required to improve clarity and persuasiveness. In addition, several key control experiments and more conceptual context are needed to establish the specificity and relevance of PANEM relative to other microtubule- and actin-based mitotic mechanisms. Testing PANEM in additional cell lines or contexts would also strengthen the claim. I therefore recommend Major Revision, addressing the structural, conceptual, and experimental issues detailed below.

      Major Comments

      A. Structural overhaul and figure reorganization

      The Results section is overly dense, lacks clear structure, and includes descriptive content that belongs in the Methods. Many figure panels should be moved to Supplementary Materials. A substantial reorganization is required to transform the manuscript into a focused, "Reports"-type article.

      Remove repetitive statements that simply restate that later phenotypes arise as consequences of delayed Phase 1 (applicable to subheadings 3 onward).

      As suggested, we have removed the statement for the delayed start of Phase 2 for peripheral kinetochores in azBB-treated cells (Page 9, second paragraph). We have also simplified the statement for the delayed start of Phase 3 and Phase 4 to avoid repetition (Page 9, third paragraph; Page 10, second paragraph).

      B. Specificity and redundancy of actin perturbation

      To establish the specificity and relevance of PANEM, the authors should include or discuss appropriate controls:

      Apply global actin inhibitors (e.g., cytochalasin D, latrunculin A) to disrupt the entire actin cytoskeleton. These perturbations strongly affect mitotic rounding and cytokinesis but only modestly influence early chromosome movements, as reported previously (Lancaster et al., 2013; Dewey et al., 2017; Koprivec et al., 2025). The minimal effect of global inhibition must be addressed when proposing a localized actomyosin mechanism. Comment if the apparent differences in this approach and one that the authors were using arises due to different cell types.

      We did experiments along this line, using a dominant-negative LINC construct, in our previous study (Booth et al eLife 2019). LINC-DN should more specifically remove/reduce PANEM than the global actin inhibitors mentioned above. LINC-DN attenuated the reduction of CSV soon after NEBD and increased the number of polar chromosomes (Booth et al eLife 2019); i.e. in this regard, the outcome was similar to azBB treatment in the current study. One can expect that global actin inhibitors would also inhibit the PANEM formation and show effects similar to LINC-DN. By contrast, the indicated references reported that global actin inhibitors strongly affect mitotic rounding and cytokinesis but only modestly influence early chromosome movements, as pointed out by the reviewer. Such a difference may have arisen due to different cell types (e.g. some cells form the PANEM and others do not: Figure S7), a different extent in the inhibition of PANEM formation, and/or the inhibition of cell rounding and cytokinesis (e.g. if cytokinesis is more sensitive to inhibitors than is the PANEM formation, we may not observe the possible effects on early chromosome movements due to PANEM inhibition while cytokinesis is still affected). As suggested, we discussed this topic in the Discussion (page 15, second paragraph). 

      Clarify why spindle-associated actin, especially near centrosomes, as reported in prior studies using human cultured cells (Kita et al., 2019; Plessner et al., 2019; Aquino-Perez et al., 2024), was not observed in this study. The Myosin-10 and actin were also observed close to centrosomes during mitosis in X.laevis mitotic spindles (Woolner et al., 2008). Possible explanations include differences in fixation, probe selection, imaging methods, or cell type. Note that some actin probes (e.g., phalloidin) poorly penetrate internal actin, and certain antibodies require harsh extraction protocols. Comment on possibility that interference with a pool of Myo10 at the centrosomes is important for effects on congression.

      As the reviewer implies, we cannot rule out that we could not detect actin associated with the spindle or centrosomes because of the difference in methods or cell lines between the current study and the literature mentioned by the reviewer. We have therefore moderated our claim in the Discussion that ‘we did not detect any actin network inside the nucleus, on the spindle or between chromosomes’ by adding ‘at least, using the method and the cell line in the current study’ to this statement (Page 13, second paragraph). We have also cited the three references mentioned by the reviewer in the Discussion (Page 13, second paragraph). Regarding Myosin10, azBB (blebbistatin variant) should have negligible effects on class-X myosin, including Myosin-10 (Limouze et al 2004 [PMID 15548862]). It is therefore unlikely that the effects of azBB that we observed in the current study are due to the inhibition of Myosin-10. We have cited Woolner et al 2008 and another paper and discussed this topic in the Discussion (Page 13, second paragraph).

      C. Expansion of PANEM functional analysis

      Quantify not only the percentage of affected cells after azBB but also the number of chromosomes per cell with congression defects in the current and future experiments.

      It is tricky to count the number of chromosomes because they frequently overlap. Counting kinetochores is more feasible, but kinetochore signals show some non-specific background (e.g. those outside of the nucleus in prophase). We therefore quantified the chromosome volume at polar regions in azBB-treated cells (Figure 6C).

      D. Conceptual integration in Introduction and Discussion

      The manuscript should better situate its findings within the context of early mitotic chromosome movements:

      Clearly state in the Introduction and elaborate in the Discussion that initiation of congression is coupled to biorientation (Vukušić & Tolić, 2025). This provides essential context for how PANEM-mediated nuclear volume reduction supports efficient congression of polar chromosomes.

      It has been a widely accepted view in the field that chromosome congression precedes biorientation, since the publication in 2006 (Kapoor et al Science 2006). Very recently, this view has been challenged by the new publication (Vukušić & Tolić, Nat comm 2025), as indicated by this reviewer. We have mentioned this new model and discussed the new interpretation of our results based on this new model, in the Discussion (page 14; ‘It has been a widely accepted view…’).

      To explain the new interpretation of our results more clearly, we plan to add a new diagram to a supplemental figure in the revised manuscript.

      Explain that PANEM is most critical for polar chromosomes because their peripheral positions are unfavorable for rapid biorientation (Barišić et al., 2014; Vukušić & Tolić, 2025).

      We have included such a statement in the Discussion, as a part of the new interpretation of our results based on the new model that chromosome biorientation precedes congression (see above). We have also cited the indicated two papers.

      Discuss how cell lines lacking PANEM (e.g., HeLa and others) nonetheless achieve efficient congression, and what alternative mechanisms compensate in the absence of PANEM. For example, it is well established that cells congress chromosomes after monastrol or nocodazole washout, which essentially bypasses the contribution of PANEM contraction.

      Following this suggestion, we discussed three possible mechanisms that could compensate for a lack of PANEM and facilitate kinetochore-MT interaction and chromosome congression, based on previous literature (Page 16): 1) the enhanced assembly rate of spindle MTs may facilitate kinetochore-MT interactions in N-CIN+ cancer cells, 2) chromosome biorientation may precede congression more frequently to promote the congression towards the spindle midplane, and 3) the balance between CENP-E, Dynein and chromokinesin’s activities may incline to greater chromosome-arm ejection forces towards the spindle midplane.

      Minor Comments

      These issues are more easily addressable but will significantly improve clarity and presentation.

      Introduction

      Remove the reference to Figure 1A in the Introduction. The portion of Figure 1 and related text that recapitulates the authors' previous work should be incorporated into the Introduction, not the Results.

      As suggested in the second sentence of this comment, we have moved most of the second paragraph of the first section of Results to Introduction (Page 4) and cited Figure 1A and 1B in Introduction. We would like to keep the reference to Figure 1A in the Introduction, because showing the PANEM images at the beginning of the manuscript would help readers’ understanding of our study. In addition, citing Figure 1A in the Introduction is more consistent with the suggestion in the second sentence of this comment.

      Results (by subheading)

      First subheading: When introducing the ~8-minute early mitotic interval, cite additional studies that have characterized this period: Magidson et al., 2011 (Cell); Renda et al., 2022 (Cell Reports); Koprivec et al., 2025 (bioRxiv); Vukušić & Tolić, 2025 (Nat Commun); Barišić et al., 2013 (Nat Cell Biol).

      As suggested, we cited these references at the indicated part of the first section of the Results (page 5).

      Second subheading: Cite key reviews and foundational research on kinetochore architecture and sequential chromosome movement during early mitosis: Mussachio & Desai, 2017

      (Biology); Itoh et al., 2018 (Sci Rep); Magidson et al., 2011 (Cell); Vukušić & Tolić, 2025 (Nat Commun); Koprivec et al., 2025 (bioRxiv); Rieder & Alexander, 1990 (J Cell Biol); Skibbens et al., 1993 (J Cell Biol); Kapoor et al., 2006 (Science); Armond et al., 2015 (PLoS Comput Biol); Jaqaman et al., 2010 (J Cell Biol).

      Rieder & Alexander, 1990 (J Cell Biol) and Kapoor et al., 2006 (Science) have already been cited in the second section of the Results in the original manuscript. We agree that all other references should be cited in this manuscript, and they are now cited in the Introduction and/or Discussion where they fit best (e.g. Mussachio & Desai 2017 reviews the kinetochore in general and is therefore best cited in the Introduction).

      Third subheading: Clarify why some kinetochores on Figure 3A appear outside the white boundaries if these boundaries are intended to represent the nuclear envelope.

      We interpret that these are background signals in the cytoplasm, which do not come from kinetochores, because 1) before NEBD, they were outside of the nucleus, and 2) after NEBD, they did not show any characteristic kinetochore motions such as those towards a spindle pole (Phase 2) and the spindle mid-plane (Phase 4). We have commented on these background signals in the legend for Figure 3A.

      Fifth subheading: Cite studies on polar chromosome movements: Klaasen et al., 2022 (Nature); Koprivec et al., 2025 (bioRxiv). Clarify that Figure 5F displays only those kinetochores that initiated directed congression movements.

      These two references have already been cited and discussed in this Result section of our original manuscript. However, considering this suggestion, we have discussed more about polar chromosome movements reported by Koprivec et al (page 11). Meanwhile, the reviewer is correct about Figure 5F, and we have clarified this point in the Figure 5F legend.

      Discussion

      When discussing cortical actin, cite key reviews on its presence and function during mitosis:

      Kunda & Baum, 2009 (Trends Cell Biol); Pollard & O'Shaughnessy, 2019 (Annu Rev Biochem); Di Pietro et al., 2016 (EMBO Rep).

      As suggested, we have cited all these review papers in the Discussion (page 15), and mentioned the role of the cortical actin on the spindle orientation and positioning (Kunda & Baum, 2009; Di Pietro et al., 2016), as well as the function of the actomyosin ring on cytokinesis (Pollard & O'Shaughnessy, 2019).

      Significance

      Advance

      This study's main strength is its novel and potentially important demonstration that contraction of PANEM, a peripheral actomyosin network that operates contracts early mitosis, contributes to the timely initiation of chromosome congression, especially for polar chromosomes. While PANEM itself was previously described by this group, this manuscript provides new mechanistic evidence, improved perturbations, and detailed chromosome tracking. To my knowledge, no prior studies have mechanistically connected this contraction to polar chromosome congression in this level of detail. The work complements dominant microtubule-centric models of chromosome congression and introduces actomyosin-based forces as a cooperating system during very early mitosis. However, the impact of the study is currently limited by major organizational issues, insufficient controls, and incomplete contextualization within existing literature. Addressing these issues will substantially improve clarity and credibility. [underlined by authors]

      We have addressed or will address the underlined criticisms as detailed above.

      Audience

      Primary audience of this study will be researchers working in cell division, mitosis, cytoskeleton dynamics, and motor proteins. The findings may interest also the wider cell biology community, particularly those studying chromosome segregation fidelity, spindle mechanics, and cytoskeletal crosstalk. If validated and clarified, the concept of PANEM could be integrated into textbooks and models of chromosome congression and could inform studies on mitotic errors and cancer cell mechanics.

      Expertise

      My expertise lies in kinetochore-microtubule interactions, spindle mechanics, chromosome congression, and mitotic signaling pathways.

      Reviewer #2 (Evidence, reproducibility and clarity):

      In this manuscript, Sheidaei et al. reported on their study of chromosome congression during the early stages of mitotic spindle assembly. Building on their previous study (ref. #15, Booth et al., Elife, 2019), they focused on the exact role of the actin-myosin-based contraction of the nuclear envelope. First, they addressed a technical issue from their previous study, finding a way to specifically impair the actomyosin contraction of the nuclear membrane without affecting the contraction of the plasma membrane. This allowed them to study the former more specifically. They then tracked individual kinetochores to reveal which were affected by nuclear membrane contraction and at what stage of displacement towards the metaphase plate. The investigation is rigorous, with all the necessary controls performed. The images are of high quality. The analyses are accurate and supported by convincing quantifications. In summary, they found that peripheral chromosomes, which are close to the nuclear membrane, are more influenced by nuclear membrane contraction than internal chromosomes. They discovered that nuclear membrane contraction primarily contributes to the initial displacement of peripheral chromosomes by moving them towards the microtubules. The microtubules then become the sole contributors to their motion towards the pole and subsequently the midplane. This step is particularly critical for the outermost chromosomes, which are located behind the spindle pole and are most likely to be missegregated.

      Significance

      While the conclusions are somewhat intuitive and could be considered incremental with regard to previous works, they are solid and improve our understanding of mitotic fidelity. The authors had already reported the overall role of nuclear membrane contraction in reducing chromosome missegregation in their previous study, as mentioned fairly and transparently in the text. However, the reason for this is now described in more detail with solid quantification. Overall, this is good-quality work which does not drastically change our understanding of chromosome congression, but contributes to improving it. Personally, I am surprised by the impact of such a small contraction (of around one micron) on the proper capture of chromosomes and wonder whether the signalling associated with the contraction has a local impact on microtubule dynamics. However, investigating this point is clearly beyond the scope of this study, which can be published as it is. [underlined by authors]

      The suggested topic (underlined) is intriguing. However, we agree with the reviewer that it is beyond the scope of this paper. The reviewer recommends publication of our manuscript as it is. So, we do not plan a revision based on this reviewer’s comments.

      Reviewer #3:

      Sheidaei et al., report how chromosomes are brought to positions that facilitate kinetochoremicrotubule interactions during mitosis. The study focusses on an important early step of the highly orchestrated chromosome segregation process. Studying kinetochore capture during early prophase is extremely difficult due to kinetochore crowding but the team has taken up the challenge by classifying the types of kinetochore movements, carefully marking kinetochore positions in early mitosis and linking these to map their fate/next-positions over time. The work is an excellent addition to the field as most of the literature has thus far focussed on tracking kinetochore in slightly later stages of mitosis. The authors show that the PANEM facilitates chromosome positioning towards the interior of the newly forming spindle, which in turn facilitates chromosome congression - in the absence of PANEM chromosomes end up in unfavourable locations, and they fail to form proper kinetochore-microtubule interactions. The work highlights the perinuclear actomyosin network in early mitosis (PANEM) as a key spatial and temporal element of chromosome congression which precedes the segregation process.

      Major points

      (1) The complexity of tracking has been managed by classifying kinetochore movements into 4 categories, considering motions towards or away from the spindle mid-plane. While this is a very creative solution in most cases, there may be some difficult phases that involve movement in both directions or no dominant direction (eg Phase3-like). It is unclear if all kinetochores go through phase1, 2, 3 and 4 in a sequential or a few deviate from this pattern. A comment on this would be helpful. Also, it may be interesting to compare those that deviate from the sequence, and ask how they recover in the presence and absence of azBB.

      To respond to this comment, we would like to first clarify how we selected kinetochores for our analysis. We selected kinetochores that can be individually tracked. If kinetochore tracking was difficult (before the start of Phase 4 in control and azBB-treated cells or before observing the extended Phase 3 in azBB-treated cells) because of kinetochore crowding, we did not choose such kinetochores. We also did not include kinetochores close to spindle poles (within 4 µm) at NEBD in our analysis for the following two reasons: First, these kinetochores often did not show clear and rapid movements towards a spindle pole, which we used to define Phase 2. Second, although we referred to kinetochore co-localization with a microtubule signal for the start of Phase 2, this was difficult for kinetochores close to spindle poles because of a high density of microtubules. As requested, we have added this comment to the Method section (page 23).

      With the above selection, all selected kinetochores without azBB treatment (control) showed the poleward motion (Phase 2) and congression (Phase 4) in this order, though their extents were varied among kinetochores. All selected kinetochores with azBB treatment also showed the poleward motion (Phase 2), and some of them showed congression (Phase 4) after Phase 2. Then, Phase 1 and Phase 3 were defined as intervals between NEBD and Phase 2 and between Phase 2 and Phase 4, respectively. If no Phase 4 was observed with azBB, we judged that Phase 3 continued till the end of tracking. We have added this comment to the Method section (page 23-24).

      (2) Would peripheral kinetochore close to poles behave differently compared to peripheral kinetochore close to the midplane (figure S4)? In figure 3D, are they separated? If not, would it look different?

      Since we did not include kinetochores close to spindle poles (at NEBD), for which it was difficult to define Phase 2 (see our response to the above major point 1), in our analysis, the suggested comparison is not feasible.

      (3) Uncongressed polar chromosomes (eg., CENPE inhibited cells) are known to promote tumbling of the spindle. In figure 5B with polar chromosomes, it will be helpful to indicate how the authors decouple spindle pole movements from individual kinetochore movements.

      In contrast to CENPE-inhibited cells, azBB-treated cells did not show much tumbling of the spindle, though both cells showed uncongressed polar chromosomes. The reason for this difference may be fewer uncongressed polar chromosomes in azBB-treated cells. There were still modest spindle motions in azBB-treated cells. However, because kinetochore motions were assessed relative to a spindle pole (and other reference points on the spindle) in our study (Figure 2A, C), the modest spindle motions were offset in our analyses of kinetochore motions. We have clarified the underlined part in the Method section (page 22).

      Minor points

      (1) It will be helpful for readers to see how many kinetochores/cell were considered in the tracking studies. Figure legends show kinetochore numbers but not cell numbers.

      As suggested, we have now mentioned the number of cells, where the kinetochore motions were analyzed, in the legends for Figures 3, 4, 5, S4 and S5.

      (4) Are all the N-CIN- lines with PANEM highly sensitive to azBB? In other words, is PANEM essential for normal congression in some of these lines.

      We checked the sensitivity of cell lines in Figure S7B to blebbistatin (the original form of azBB) on DepMap. There was no plausible difference between PANEM+ and PANEM- cell lines, although the blebbistatin sensitivity data were available only for 4 cell lines (HCT116, MCF7, U2OS and HT29) in Figure S7B. Nonetheless, because blebbistatin could kill cells by inhibiting cytokinesis, the blebbistatin sensitivity may not necessarily reflect how essential the PANEM contraction is for chromosome congression.

      (5) Are congression times delayed in lines that naturally lack PANEM?

      For example, it takes 10-20 min for HeLa cells (lacking PANEM) to complete chromosome congression after the NEBD (Bancroft et al 2025: https://doi.org/10.1242/jcs.163659). This is not significantly different from the time (8-18 min) for chromosome congression we observed in U2OS cells (forming PANEM). We assume that cells lacking PANEM have developed a compensatory mechanism for efficient chromosome congression – we have newly discussed possible compensatory mechanisms in the last paragraph of the Discussion (page 16).

      (6) Page 23 "we first identified the end of congression" how does this relate to kinetochore oscillations that move kinetochores away from the metaphase plate?

      The start of kinetochore oscillation was defined as the end of Phase 4 if we could track the kinetochore until that point. In some cases where the kinetochore became close to the midplane (< 2.5 µm), it was not possible to track it further due to kinetochore crowding around the spindle mid-plane – in such cases, the end of Phase 4 was assigned as the end of tracking. In the original manuscript, it was not clear that the end of Phase 4 was defined in the same way for both non-polar and polar kinetochores, while the start of Phase 4 was defined differently for the two groups. This was confusing in the original manuscript. We have now clarified these points in the Method section (page 23).

      (7) Are spindle pole distances (spindle sizes) different in early and late mitotic cells (4min vs 6min after NEBD) in control vs azBB-treated cells? Please comment on Figure S2E (mean distance) in the context of when phase 4 is completed. Does spindle size return to normal after congression?

      In Figure S2E, we did not observe a significant difference in the spindle-pole distance (the spindle size) between control and azBB-treated cells at any individual time points. The smallest p-value was 0.094 at 6.0 min. As suggested, we have explained this in the legend for Figure S2E.

      Significance:

      The current work builds upon their previous work, in which the authors demonstrated that an actomyosin network forms on the cytoplasmic side of the nuclear envelope during prophase. This work explains how the network facilitates chromosome capture and congression by tracking motions of individual kinetochores during early mitosis. The findings can be broadly useful for cell division and the cytoskeletal fields.

      Description of analyses that authors prefer not to carry out

      Reviewer #1 (Evidence, reproducibility and clarity):

      Summary

      Sheidaei and colleagues report a novel and potentially important role for an early mitotic actomyosin-based mechanism, PANEM contraction, in promoting timely congression of chromosomes located at the nuclear periphery, particularly those in polar positions. The manuscript will interest researchers studying cell division, cytoskeletal dynamics, and motor proteins. Although some data overlap with the group's prior work, the authors extend those findings by optimizing key perturbations and performing more detailed analyses of chromosome movements, which together provide a clearer mechanistic explanation. The study also builds naturally on recent ideas from other groups about how chromosome positioning influences both early and later mitotic movements.

      In its current form, however, the manuscript is not acceptable for publication. It suffers from major organizational problems, an overcrowded and confusing Results section and figures, and a lack of essential experimental controls and contextual discussion. These deficiencies make it difficult to evaluate the data and the authors' conclusions. A substantial structural revision is required to improve clarity and persuasiveness. In addition, several key control experiments and more conceptual context are needed to establish the specificity and relevance of PANEM relative to other microtubule- and actin-based mitotic mechanisms. Testing PANEM in additional cell lines or contexts would also strengthen the claim. I therefore recommend Major Revision, addressing the structural, conceptual, and experimental issues detailed below.

      Major Comments

      A. Structural overhaul and figure reorganization

      The Results section is overly dense, lacks clear structure, and includes descriptive content that belongs in the Methods. Many figure panels should be moved to Supplementary Materials. A substantial reorganization is required to transform the manuscript into a focused, "Reports"-type article.

      Move methodological and descriptive details (e.g., especially from the second Results subheading and Figure 2) to the Methods or Supplementary Materials.

      In these parts, we define four phases of kinetochore motion in early mitosis. Without such a description in the main text, readers would be confused about subsequent analyses. Figure 2 is also important to show examples of how the four phases develop. Although we respect this suggestion from the reviewer, we would like to keep these parts in the main text and main figure.

      New Figure 2: Combine current Figures 2A, 3A, 3C, 3D, 4C, 4F, and 4H to illustrate how PANEM contraction facilitates initial interactions of peripheral chromosomes with spindle microtubules which increases speed of congression initiation.

      If we were to follow this suggestion, we would lose Figure 2B, D, Figure 3B and Figure 4A, where examples of kinetochore motions are shown in images and 3D diagrams. The new Figure would mostly consist of only graphs. Without examples of images and 3D diagrams, readers would have difficulty understanding the study. Although we respect this suggestion from the reviewer, we would like to keep Figures 2, 3 and 4, as they are (except for making Figure 4I simpler; see above).

      New Figure 3: Combine current Figures 5A, 5C, 5D, 5F, 6B, 6C, and lower panels of 4H to show how PANEM contraction repositions polar chromosomes and reduces chromosome volume in early mitosis to enable rapid initiation of congression.

      If we were to follow this suggestion, we would lose Figure 5B and Figure 6A, where examples of kinetochore/chromosome dynamics are shown in images and 3D diagrams. For the same reason as above, we would like to keep Figure 5 and 6 as they are, although we respect this suggestion from the reviewer.

      New Figure 4: Combine Figures 7A, 7B, 7D, 7E, 7F, expanded Supplementary Figure S7, and new data to demonstrate that PANEM actively pushes peripheral chromosomes inward which is important for efficient chromosome congression in diverse cellular contexts.

      As suggested, we will conduct new experiments to demonstrate the role of PANEM in diverse cellular contexts, as detailed below. We will then combine the new results with Figure S7 to make the new Figure 8.

      On the other hand, in our view, combining Figure 7A-E and the extended Figure S7 would be confusing because the two parts address different topics. Although we respect this suggestion from the reviewer, we would like to keep Figure 7 and the extended Figure S7 (i.e. Figure 8) separate.

      B. Specificity and redundancy of actin perturbation

      To establish the specificity and relevance of PANEM, the authors should include or discuss appropriate controls:

      Examine higher-ploidy or binucleated cells to determine whether multiple PANEM contractions are coordinated and if PANEM contraction contributes more in cells of higher ploidies or specific nuclear morphologies.

      This is an interesting suggestion, but it takes lots of time to conduct such a study, and it goes beyond the scope of this paper.

      Investigate dependency on nuclear shape or lamina stiffness; test whether PANEM force transmission requires a rigid nuclear remnant.

      This is an interesting suggestion, but it takes lots of time to conduct such a study, and it goes beyond the scope of this paper.

      Analyze PANEM's contribution under mild microtubule perturbations that are known to induce congression problems (e.g., low-dose nocodazole).

      In the current study, we found that PANEM contraction affects chromosome motions in Phase 1 and Phase 3 but not Phase 2 or Phase 4. Mild microtubule perturbation itself could affect chromosome motions in all four Phases. We do not think it would be so informative to study what additional effects the reduced PANEM contraction shows when combined with mild microtubule perturbation.

      D. Conceptual integration in Introduction and Discussion

      The manuscript should better situate its findings within the context of early mitotic chromosome movements:

      Minor Comments

      These issues are more easily addressable but will significantly improve clarity and presentation.

      Results (by subheading)

      Fourth subheading: Note that congression speed is lower for centrally located kinetochores because they achieve biorientation more rapidly (Barišić et al., 2013, Nat Cell Biol; Vukušić & Tolić, 2025, Nat Commun).

      We respect this comment. However, if biorientation were established more rapidly for centrally located kinetochores, it would advance the initiation of congression, but would not necessarily change congression speed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We greatly appreciate the reviewers’ constructive comments and have followed their recommendations to improve our manuscript. These improvements include additional experiments, new analyses, and a rewriting of the text. We believe these changes significantly improved the paper and hope the editor and the reviewers agree. The following is a summary of the major changes made and our point-by-point response to reviewers’ comments.

      Summary of major changes:

      (1) Expanded labeling options: We generated a new nMAGIC vector containing miRFP680 as an infrared fluorescent protein (IFP) marker. We used gRNA-40D2(IFP) to demonstrate clones labeled by this marker in the wing imaginal disc (Figure 1M). This vector is available via Addgene for the generation of new gRNA-markers with our recommended or customer-designed gRNA target sequences.

      (2) Validated Gal80 potency: We provide new data in Figure 1E demonstrating complete suppression of pxn-Gal4>CD4-tdTom by tub-GAL80-DE-SV40. The exact transgenes used in the comparisons are clarified in the figure and figure legend.

      (3) Verified clone fitness: We compared the sizes of nMAGIC twin spots in wing discs and found no intrinsic growth or viability bias between marker/marker and WT/WT clones (Figure 1O).

      (4) Methodological Schematics: We added supplemental figures to Figure 1 to illustrate the principle of MAGIC, the difference between pMAGIC and nMAGIC, and an example of pMAGIC crossing scheme.

      (5) Inducible induction: We provide new data (Figure 3J-K’) showing the induction of sparse neuronal clones in the adult brain by heat shock (hs)-Cas9.

      (6) We revised texts to incorporate all other recommendations suggested by the reviewers. We also made other small changes to the manuscript to improve its readability.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, Shen et al. have improved upon the mitotic clone analysis tool MAGIC that their lab previously developed. MAGIC uses CRISPR/Cas9-mediated double-stranded breaks to induce mitotic recombination. The authors have replaced the sgRNA scaffold with a more effective scaffold to increase clone frequency. They also introduced modifications to positive and negative clonal markers to improve signal-to-noise and mark the cytoplasm of the cells instead of the nuclei. The changes result in increase in clonal frequencies and marker brightness. The authors also generated the MAGIC transgenics to target all chromosome arms and tested the clone induction efficacy.

      Strengths:

      MAGIC is a mitotic clone generation tool that works without prior recombination to special chromosomes (e.g., FRT). It can also generate mutant clones for genes for which the existing FRT lines could not be used (e.g., the genes that are between the FRT transgene and the centromere).

      This manuscript does a thorough job in describing the method and provides compelling data that support improvement over the existing method.

      Weaknesses:

      It would be beneficial to have a greater variety of clonal markers for nMAGIC. Currently, the only marker is BFP, which may clash with other genetic tools (e.g., some FRET probes) depending on the application. It would be nice to have far-red clonal markers.

      We thank the reviewer for the positive comments about our study. We agree with the reviewer that adding a far-red option for nMAGIC increases the flexibility of this method. We replaced the BFP coding sequence in the nMAGIC cloning vector pAC-U63-QtgRNA2.1-tubBFP(HA) with that of miRFP680-T2A-HO1. We then used the resulting cloning vector to make a gRNA-40D2(IFP) transgene and tested it in the wing disc. Result showing clones in the wing disc are now in Figure 1M. The new cloning vector, along with others reported in our study, are available from Addgene.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors present the latest improvement of their previously published methods, pMAGIC and nMAGIC, which can be used to engineer mosaic gene expression in wild-type animals and in a tissue-specific manner. They address the main limitation of MAGIC, the lack of gRNA-marker transgenes, which has hampered the broader adoption of MAGIC in the fly community. To do so, they create an entire toolkit of gRNA markers for every Drosophila chromosome and test them across a range of different tissues and in the context of making Drosophila species hybrid mosaic animals. The study provides a significant and broadly useful improvement compared to earlier versions, as it broadens the use-cases for transgenic manipulation with MAGIC to virtually any subfield of Drosophila cell biology.

      Strengths:

      Major improvements to MAGIC were made in terms of clone induction efficiency and usability across the Drosophila model system, including wild-type genotypes and the use in non-melanogaster species.

      Notably, mosaic mutants can now be created for genes residing on the 4th chromosome, which is exciting and possibly long-awaited by 4th chromosome gene enthusiasts.

      Selection of the standard set of gRNA markers was done thoughtfully, using non-repetitive conserved and unique sequences.

      The authors demonstrate that MAGIC can be used easily in the context of interspecific hybrids. I believe this is a great advancement for the Drosophila community, especially for evolutionary biologists, because this may allow for easy access to mechanistic, tissue-specific insight into the process of a range of hybrid incompatibilities, an important speciation process that is normally difficult to study at the level of molecular and cell biology.

      In the same way, because it is not limited to usage in any particular genetic background, genome-wide MAGIC can be potentially used in wild-type genotypes relatively easily. This is exciting, especially because natural genetic diversity is rarely investigated more mechanistically and at the scale/resolution of cells or specific tissues. Now, one can ask how a particular naturally occurring allele influences cell physiology compared to another (control) while keeping the global physiological context of the particular genetic background largely intact.

      Weaknesses:

      It is not entirely clear how functionally non-critical regions were evaluated, besides that they are selected based on conservation of sequence between species. It may be useful to directly test the difference in viability or other functionally relevant phenotype for flies carrying different markers. Similarly, the frequency of off-targets could be investigated or documented in a bit more detail, especially if one of the major use-cases is meant for naturally derived, diverse genetic backgrounds. It is, at the moment, unclear how consistently the clones are induced for each new gRNA marker across different WT genetic backgrounds, for example, a set of DGRP genotypes, which could be highly useful information for future users.

      We thank the reviewer for the positive comments about our study. The reviewer raises an excellent point regarding the consistency of clone induction and potential background effects in diverse genetic backgrounds. As a standard step in building the MAGIC kit, we tested all gRNA-marker transgenes with the Cas9-LEThAL assay (Poe et al., Genetics, 2019), in which the gRNA-marker transgene was crossed to lig4 Act5C-Cas9 homozygotes. All crosses led to viable and apparently healthy female progeny, suggesting that ubiquitously mutating the chosen gRNA targeting sites does not cause obvious defects.

      For standard mutant analysis, we recommend researchers to use a well-characterized wildtype chromosome as a negative control. For studies utilizing diverse wildtype backgrounds where a standard control chromosome is inapplicable (e.g., DGRP screens), we recommend an internal validation strategy: researchers should confirm their key phenotypic findings by inducing clones with a second, independent gRNA-marker located on the same chromosomal arm (e.g., comparing clones induced by gRNA-40D2 vs. gRNA-40D4 ). This ensures that any observed phenotypes or variations in clone induction are linked to the selected genetic background rather than an off-target artifact or target-site specific effect.

      We admit that the above approach may not resolve concerns about off-targets. Performing deep sequencing to map empirical off-targets for all 34 gRNA pairs across multiple genetic backgrounds is experimentally prohibitive for a toolkit resource. However, our in silico selection pipeline strictly required target sequences to be unique within the D. melanogaster genome to mathematically minimize off-target probability. In addition, our requirement that target sequences be conserved in closely related Drosophila species acts as a stringent filter against intraspecies variation. Sequences conserved across species are subject to purifying selection, substantially reducing the likelihood that SNPs within the DGRP lines will disrupt the PAM or seed sequences required for Cas9 induction.

      Reviewer #3 (Public review):

      Summary:

      In the manuscript by Shen, Yeung, and colleagues, the authors generate an improved and expanded Mosaic analysis by gRNA-induced crossing-over (MAGIC) toolkit for use in making mosaic clones in Drosophila. This is a clever method by which mitotic clones can be induced in dividing cells by using CRISPR/Cas9 to generate double-strand breaks at specific locations that induce crossing over at those locations. This is conceptually similar to previous mosaic methods in flies that utilized FRT sites that had been inserted near centromeres along with heat-shock inducible FLPase. The advantage of the MAGIC system is that it can be used along with chromosomes lacking FRT sites already introduced, such as those found in many deficiency collections or in EMS mutant lines. It may also be simpler to implement than FRT-based mosaic systems. There are two flavors of the MAGIC system: nMAGIC and pMAGIC. In nMAGIC, the main constituents are a transgene insertion that contains gRNAs that target DNA near the centromere, along with a fluorescent marker. In pMAGIC, the main constituents are a transgenic insertion that contains gRNAs that target DNA near the centromere, along with ubiquitous expression of GAL80. As such, nMAGIC can be used to generate clones that are not labelled, whereas pMAGIC (along with a GAL4 line and UAS-marker) can be used much like MARCM to positively label a clone of cells. This manuscript introduces MAGIC transgenic reagents that allow all 4 chromosomes to be targeted. They demonstrate its use in a variety of tissues, including with mutants not compatible with current FLP/FRT methods, and also show it works well in tissues that prove challenging for FLP/FRT mosaic analyses (such as motor neurons). They further demonstrate that it can be used to generate mosaic clones in non-melanogaster hybrid tissues. Overall, this work represents a valuable improvement to the MAGIC method that should promote even more widespread adoption of this powerful genetic technique.

      Strengths:

      (1) Improves the design of the gRNA-marker by updating the gRNA backbone and also the markers used. GAL80 now includes a DE region that reduces the perdurance of the protein and thus better labeling of pMAGIC clones. The data presented to demonstrate these improvements is rigorous and of high quality.

      (2) Introduces a toolkit that now covers all chromosome arms in Drosophila. In addition, the efficiency of 3 target different sites is characterized for each chromosome arm (e.g., 3 different gRNA-Marker combinations), which demonstrate differences in efficiency. This could be useful to titrate how many clones an experimenter might want (e.g., lower efficiency combinations might prove advantageous).

      (3) The manuscript is well written and easy to follow. The authors achieved their aims of creating and demonstrating MAGIC reagents suitable for mosaic analysis of any Drosophila chromosome arm.

      (4) The MAGIC method is a valuable addition to the Drosophila genetics toolkit, and the new reagents described in this manuscript should allow it to become more widely adopted.

      Weaknesses:

      (1) The MAGIC method might not be well known to most readers, and the manuscript could have benefited from schematics introducing the technique.

      We thank the reviewer for the positive evaluation of our study and for making this kind suggestion. We have added diagrams that explain the principle of MAGIC and the difference between pMAGIC and nMAGIC in Figure 1 - Figure Supplement 1.

      (2) Traditional mosaic analyses using the FLP/FRT system have strongly utilized heat-shock FLPase for inducible temporal control over mitotic clones, as well as a way to titrate how many clones are induced (e.g., shorter heat shocks will induce fewer clones). This has proven highly valuable, especially for developmental studies. A heat-shock Cas9 is available, and it would have been beneficial to determine the efficiency of inducing MAGIC clones using this Cas9 source.

      We thank the reviewer for suggesting this experiment. We agree that demonstrating inducible clone induction in the adult brain is an effective way for people to compare MAGIC with the MARCM method they are probably more familiar with. We used a heat shock Cas9 developed by the Tzumin Lee group (Chen et al., Development, 2020) to experiment with clone induction, and the results are shown in the new Figure 3 (K and J). We show that, with a pan-neuronal Gal4, heat shock during the wandering 3rd instar larval stage induced more clones than during the pupal stage, and the later heat shock readily produced sparsely labeled neurons whose single-cell morphology can be easily visualized.

      Recommendations for the authors:

      Reviewing Editor Comments:

      The following are some consolidated review remarks after discussions amongst all three reviewers:

      The reviewers feel the evidence level could be raised from 'convincing' to 'compelling' if the following key (and partially shared) suggestions by the reviewers are followed adequately:

      (1) Expand labeling options for nMAGIC, which is currently just a BFP marker. This would increase the utility of the method. A far-red marker would be very helpful. Could the authors just do this for one chromosome arm and make the reagent available for others to generate other chromosome arms?

      We agree with the editor and reviewers that adding a far-red option for nMAGIC increases the flexibility of this method. We replaced the BFP coding sequence in the nMAGIC cloning vector pAC-U63-QtgRNA2.1-tubBFP(HA) with that of miRFP680-T2A-HO1. We then used the resulting cloning vector to make a gRNA-40D2(IFP) transgene and tested it in the wing disc. Result showing clones in the wing disc are now in Figure 1M. The new cloning vector, along with others reported in our study, will be available from Addgene.

      (2) Verify that destabilized GAL80 is potent enough to suppress GAL4. Repeat Figure 1C-E with tub-GAL80-DE-SV40.

      We replaced the experiment using gRNA-42A4-tDES, which successfully achieved complete suppression of pxn>CD4-tdTom (Figure 1E).

      (3) Concern about the health of the induced mitotic clones. This is an important consideration, but the reviewers were not sure what the necessary experiments would be. To gauge twin-spot clone sizes? Please address.

      We agree that clone fitness is an important consideration for MAGIC experiments. To test it, we generated WT clones in the wing imaginal disc using nMAGIC and quantified the sizes of the twin spots (BFP/BFP and WT/WT clones). Our results show that there is no statistical difference between these two types of clones. Thus, there is no intrinsic growth disadvantage to either type of mitotic clones generated by MAGIC.

      (4) Include a schematic of the MAGIC method as Figure 1 or add it to Figure 1. Many may not be familiar with the method, so to promote its adoption, the authors should clearly introduce the MAGIC method in this paper (and not rely on readers to go to previous publications). For this paper to become a MAGIC reference paper, it should be self-contained.

      We thank the reviewers for this suggestion. We have added diagrams that explain the principle of MAGIC and the difference between pMAGIC and nMAGIC in Figure 1 - Figure Supplement 1.

      (5) Determine the utility of using a hs-Cas9 line for temporal induction of MAGIC clones. This is a traditional method for mitotic clone induction (with hsFLP/FRTs), and its use with the MAGIC system (especially pMAGIC) could also make it more attractive, especially to label small populations of neurons born at known times. To this point, the authors could generate pMAGIC clones using hs-Cas9 for commonly used adult target neurons, such as projection neurons, central complex neurons, or mushroom body neurons. The method to label small numbers of these adult neurons is well worked out with known GAL4 lines, and demonstrating that pMAGIC could have similar results would capture the attention of many not familiar with the pMAGIC method.

      We agree that demonstrating inducible clone induction in the adult brain is an effective way for people to compare MAGIC with the MARCM method they are probably more familiar with. We used a heat shock Cas9 developed by the Tzumin Lee group (GarciaMarques, Espinosa-Medina et al. 2020) to experiment with clone induction, and the results are shown in the new Figure 3 (J-K’). We show that, with a pan-neuronal Gal4, heat shock during wandering 3rd instar larval stage induced more clones than during the pupal stage, and the later heat shock readily produced sparsely labeled neurons whose single-cell morphology can be easily visualized.

      Reviewer #1 (Recommendations for the authors):

      This is a marked improvement over the existing methods that the authors' lab has previously generated. It will be a nice addition to the Drosophila genetic tool kit after minor revisions.

      We appreciate the reviewer’s recognition of the new tools we developed.

      Minor issues:

      (1) In the data in Figures 1G and H, it is not ideal to compare the effect of different modifications on two different transgenes. uH and uDEH are compared in gRNA-40D2, whereas uDEH, tDEH, and tDES are compared in gRNA-42A4. If the transgenics are already available, it would be better to compare the uH, uDEH, tDEH, and tDES on either gRNA-40D2 or gRNA-42A4.

      We appreciate the reviewer’s concern. These transgenes were developed during different phases of this project. We first adopted the uDEH design during improvement of gRNA40D2, which solved both the leaky activity of pxn-Gal4 and dim epidermal clones. However, when we tried to expand this design to 2R (such as 42A4), we found that the clones were still too dim (probably due to positional effects). Thus, we next used uDEH in gRNA-42A4 as a base for further improvements. We did not make a uH version for gRNA-42A4 because we already knew that it is inferior to uDEH. Because of this history, we did not have the full set for gRNA42A4.

      Despite the lack of uH for gRNA-42A4, we believe our comparisons of different designs are still valid, given that uH and uDEH were compared with identical sequences elsewhere in the transgenic vector (including the gRNA target sequence) and in the identical insertion site.

      (2) It is not clear whether the authors tested destabilized Gal80 is potent to suppress Gal4 (e.g., in suppressing pxn>CD4-tdTom in hemocytes). The results in Figure 1C-E should be repeated with tub-Gal80-DE-SV40.

      We apologize for omitting the transgene identities in these experiments. We have redone the experiment using gRNA-42A4-tDES and updated the figures to clearly indicate which transgenes were used.

      (3) The difference in sgRNA scaffolds can be better explained in the text. The explanation here is very bare bones and reads like jargon. (i.e., changing F+E gRNA scaffold with gRNA2.1 scaffold is not a sufficient explanation).

      We have added more explanations to the differences between the scaffolds as suggested.

      (4) The stocks should be sent to Bloomington Stock Center to ensure widespread adoption of the method. This includes the Cas9 lines that are generated and used.

      It is our plan to freely share the reagents developed in this study with the community. Most of the fly lines are already available at Bloomington (https://bdsc.indiana.edu/stocks/misc/magic.html and https://bdsc.indiana.edu/stocks/genome_editing/crispr_cas9.html). We are in the process of depositing the remaining ones to BDSC.

      In conclusion, this is a nicely written manuscript that improves currently available tools and should be of interest to the readership of this journal.

      Reviewer #2 (Recommendations for the authors):

      Typos spotted:

      Line 163 issues -> tissues

      Line 613 significance -> significant

      We thank the reviewer for catching these typos. We have corrected them.

      Reviewer #3 (Recommendations for the authors):

      This is a welcome update to the MAGIC system, which is a brilliant method that has not been as widely adopted as it should be. The authors validate and introduce updates to this system to increase clonal efficiency and more robust labeling (for both pMAGIC and nMAGIC). The data presented are robust and convincing.

      We appreciate the reviewer’s positive comments about our study.

      Suggestions to improve the presentation and adoption of this work:

      (1) The MAGIC system might not be well known, and the manuscript would have benefited from an introductory schematic of how the system works. I realize this was already done in the PLoS Biology paper, but the authors should not assume readers will know that paper, or be willing to look it up. So a standalone schematic, as Figure 1, or something added to Figure 1, would greatly aid in understanding how this system works and what the new updates are doing.

      We thank the reviewer for this kind suggestion. We have added diagrams that explain the principle of MAGIC and the difference between pMAGIC and nMAGIC in Figure 1 - figure supplement 1.

      (2) There were many instances where abbreviations were not clearly defined, especially in the Figures and Figure legends. The main text is well-written, and while the information is in there, it is beneficial when the Figures and Figure legends can stand alone. For example:

      (a) Figure 1. DE, not defined in the Figure or Figure legend.

      (b) Figure 1. 'p' and 'n' not defined in the Figure legend.

      (c) The different Cas9 lines or GAL4 lines used-a brief description of their expression patterns might be helpful in the legend. E.g., zk-Cas9, vas-Cas9, gcm-Cas9, R38F11-GAL4, RabX4Gal4.

      We apologize for omitting the details mentioned. They have been added to the figures and figure legends.

      (3) "Traditional" mosaic analyses took advantage of hsFLP for inducible induction and to control the number of mitotic clones that were induced. A hs-Cas9 line does exist (as correctly pointed out by the authors), and it would be a valuable addition if the authors tested the utility of this reagent with the MAGIC system. Many possible adopters may not like the idea that an alwayson Cas9 line is used, which could result in too many clones, especially if one wanted to label very few cells. Granted, one could use a 'worse' gRNA-Marker line as mentioned in the manuscript, but this might still be hard to titrate, as well as an inducible system that uses a heatshock promoter. A hs promoter is especially useful for birthdating cells during development.

      We thank the reviewer for suggesting this experiment. We agree that demonstrating inducible clone induction in the adult brain is an effective way for people to compare MAGIC with the MARCM method they are probably more familiar with. We used a heat shock Cas9 developed by the Tzumin Lee group (Chen et al., Development, 2020) to experiment with clone induction, and the results are shown in the new Figure 3 (K and J). We show that, with a panneuronal Gal4, heat shock during wandering 3rd instar larval stage induced more clones than during the pupal stage, and the later heat shock readily produced sparsely labeled neurons whose single-cell morphology can be easily visualized.

      (4) Lines 61-63. "However, most of these mutant chromosomes cannot be analyzed by traditional mosaic techniques due to the lack of FRT sites or incompatibility with the FRT/Flp system." It might also be worth mentioning that recombining existing reagents (e.g., mutants, etc) onto an FRT chromosome can be labor and time-intensive. A brilliant advantage of MAGIC is that it can be used with any existing stock, such as from classical EMS mutant screens, Df screens (as pointed out), etc. So the more the authors can emphasize a new way of thinking (e.g, you don't need to recombine your mutant of interest onto an FRT stock before you can get started), the better!

      We thank the reviewer for this kind suggestion. As suggested, we have expanded our introduction and discussion to emphasize the advantages of the MAGIC system over traditional mosaic techniques.

      (5) One incredible advantage of the MAGIC system is that it can direct where recombination occurs. So if one had two mutations on a chromosome arm, it could be possible to make the most distal homozygous mutant while the other remains heterozygous. This is not possible with current FRT-based methods. It's not necessary to demonstrate this, but perhaps the authors could mention it as a possible next step? This was somewhat implied by lines 66-67 "In comparison, MAGIC can potentially be used to study these genes because the crossover site in MAGIC can be flexibly defined by users".

      Again, we thank the reviewer for this nice suggestion. We have added this point to the discussion.

      (6) How stable are the MAGIC lines? If gRNA (with Cas9 expressed) induced a germline mutation of the target site, the MAGIC line would break down. How often is this observed? Some mention of this would be appreciated, especially to end users, if caution is necessary and gRNA-marker stocks should not be maintained in the same flies as an x-Cas9 line.

      The reviewer made a very important point. Keeping gRNA and Cas9 in the same strain will risk mutating the target sequence in the germline, if the Cas9 has any activity in the germline. Thus, it is not recommended to keep gRNA and Cas9 in the same flies over multiple generations. For MAGIC experiments, this concern is lessened because by crossing gRNA + Cas9 flies to another strain containing the chromosome of interest, clones can still be induced (possibly with less efficiency) because the chromosome of interest is still cuttable by Cas9. Nevertheless, to address this concern, we have recently developed anti-CRISPR tools to suppress Cas9 activity in such strains. These tools will be reported in a separate study.

      In the revised manuscript, we added this point in Discussion to caution users.

      (7) Line 157, "identify efficient gRNAs for every chromosomal arm.". What is considered "efficient"? Is this quantifiable? Eg., >= 10 clones.

      Thanks for pointing this out! “Efficient” is an arbitrary evaluation, as different experiments may require different efficiencies. But operationally, we consider any gRNA that can generate >= 10 neuronal clones per larva as being efficient. We have clarified it in the text.

      (8) Line 163, "highly packed _issues_ such as the brain"; spelling, should be "tissues"

      Thanks for catching this typo. It has been corrected.

      (9) The authors use ey-Cas9 for their demonstration of adult brain labeling. Additional adult brain examples would increase exposure of this method and attract wider attention- targeting structures that have been well characterized, such as projection neurons (GH146-GAL4), central complex, mushroom bodies, etc. Especially if hs-Cas9 could be utilized to mimic previous MARCM clones (for example).

      We thank the reviewer for suggesting heat shock-induced clones in the adult brain. We have conducted the experiment as explained above and shown in Figure 3J-3K’. We showed a single neuronal clone that resembles lateral horn Leucokinin neurons.

      (10) Line 216, "Despite these advances, existing mutations on FRT-lacking 4th chromosomes still cannot be analyzed by the FRT/Flp system." For context, it might be worth pointing out that meiotic recombination is exceedingly rare on the 4th chromosome, which means it is practically impossible to recombine existing 4th chromosome mutations onto an FRT chromosome.

      We thank the reviewer for this kind suggestion. We have added a note about the difficulty of recombining FRT onto the 4th chromosome.

      (11) Figure 2 legend. What is the full genotype for D and E? eg, what is RabX4>MApHS?

      We apologize for being brief with the details. RabX4-Gal4 is a pan-neuronal driver. UAS-MApHS is a membrane fluorescent marker (UAS-pHluorin-CD4-tdTom). The genotypes have been added to the figure legend.

      (12) It would be good to include the Bloomington Stock numbers for the MAGIC toolkit, especially in Table 1. And include an HTML reference to their MAGIC page at Bloomington

      (https://bdsc.indiana.edu/stocks/misc/magic.html).

      Thank you for this suggestion! We have done as suggested.

      (13) Similarly, the key plasmids to create the improved gRNA-marker insertions should be deposited to Addgene (or similar repository) and their ID numbers included in the resources table.

      The plasmids have been deposited to Addgene and are currently being validated.

      (14) The authors might consider including (perhaps as supplementary to Figure 1 or Figure 2) a crossing scheme for one of their MAGIC experiments. This will make it even clearer how a MAGIC experiment could be set up using existing fly reagents.

      This is a good suggestion! We have added an example crossing scheme in Figure 1 – figure supplement 1C.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The manuscript "Synaptotagmin 1 and Synaptotagmin 7 promote MR1-mediated presentation of Mycobacterium tuberculosis antigens", authored by Kim et al., showed that the calcium-sensing trafficking proteins Synaptotagmin (Syt) 1 and Syt7 specifically promote (are critical for) MAIT cell activation in response to Mtb-infected bronchial epithelial cell line BEAS-2B (Fig. 1) and monocyte-like cell line THP-1 (Figure 3) . This work also showed co-localization of Syt1 and Syt7 with Rab7a and Lamp1, but not with Rab5a (Figure 5). Loss of Syt1 and Syt7 resulted in a larger area of MR1 vesicles (Figure 6f) and an increased number of MR1 vesicles in close proximity to an Auxotrophic Mtb-containing vacuoles during infection (Figure 7ab). Moreover, flow organellometry was used to separate phagosomes from other subcellular fractions and identify enrichment of auxotrophic Mtb-containing vacuoles in fractions 42-50, which were enriched with Lamp1+ vacuoles or phagosomes (Figures 7e-f).

      Strengths:

      This work nicely associated Syt1 and Syt7 with late endocytic compartments and Mtb+ vacuoles. Gene editing of Syt1 and Syt7 loci of bronchial epithelial and monocyte-like cells supported Syt1 and Syt7 facilitated maintaining a normal level of antigen presentation for MAIT cell activation in Mtb infection. Imaging analyses further supported that Syt1 and Syt7 mutants enhanced the overlaps of MR1 with Mtb fluorescence, and the MR1 proximity with Mtb-infected vacuoles, suggesting that Syt1 and Syt7 proteins help antigen presentation in Mtb infection for MAIT activation.

      Weaknesses:

      Additional data are needed to support the conclusion, "identify a novel pathway in which Syt1 and Syt7 facilitate the translocation of MR1 from Mtb-containing vacuoles" and some pieces of other evidence may be seen by some to contradict this conclusion.

      We thank the reviewer for their positive and constructive comments. Because MR1 presents small molecule metabolites, specifically identifying MR1 molecules loaded with antigens derived from intracellular Mtb infection remains a significant technical challenge. Therefore, we agree that some of our approaches measure antigen-loaded MR1 indirectly. For example, IFN-γ release from a MAIT cell clone serves as a sensitive surrogate readout for the presence of antigen-loaded MR1 at the cell surface. This has been demonstrated in previous work showing that IFN-γ release from MAIT cells correlated with loaded MR1 molecules measured using flow cytometry and a TCR based tetramer (Kulicke et al., 2024). In this context, Syt1 and Syt7 represent the first endosomal trafficking proteins we have identified that play a specific role in MR1-mediated presentation of Mtb-derived metabolites. Syt1 and Syt7 do not contribute to the presentation of an exogenously delivered MR1 ligands, such as Ac-6-FP loaded in the ER or M. smegmatis supernatant. In Syt1 and Syt7 knockout cells expressing MR1-GFP, larger MR1 vesicles are observed, but MR1 continues to co-localize with LAMP1 similar to wildtype cells. Furthermore, Syt1 and Syt7 knockout cells exhibit an increased number of MR1 vesicles near the Mtb-containing vacuoles compared to wildtype cells. To increase the statistical power of our microscopy analyses, we have analyzed additional cells. Although the absolute magnitude of the observed effects is modest, T cell activation is highly sensitive to the number of loaded antigen presenting molecules at the cell surface. Also, a complementary approach using flow organellometry confirmed increased MR1 expression within Mtb<sup>+</sup>LAMP1<sup>+</sup> vesicles in Syt7 knockout cells. Thus, these findings suggest a mechanism whereby Syt1 and Syt7 facilitate the trafficking of loaded MR1 molecules from the Mtb-containing vacuoles to the plasma membrane. This specialized mechanism may be analogous to the previously described role of Syt7 in MHC class II trafficking (Becker et al., 2009). In our model, we observed increased accumulation and expression of MR1 within Mtb-containing vacuoles in Syt7 knockout cells.

      Reviewer #2 (Public review):

      Summary:

      The study demonstrates that calcium-sensing trafficking proteins Synaptotagmin (Syt) 1 and Syt7 are involved in the efficient presentation of mycobacterial antigens by MR1 during M. tuberculosis infection. This is achieved by creating antigen-presenting cells in which the Syt1 and Syt7 genes are knocked out. These mutated cell lines show significantly reduced stimulation of MAIT cells, while their stimulation of HLA class I-restricted T cells remains unchanged. Syt1 and Syt7 co-localize in a late endo-lysosomal compartment where MR1 molecules are also located, near M. tuberculosis-containing vacuoles.

      Strengths:

      This work uncovers a new aspect of how mycobacterial antigens generated during infection are presented. The finding that Syt1 and Syt7 are relevant for final MR1 surface expression and presentation to MR1-restricted T cells is novel and adds valuable information to this process. The experiments include all necessary controls and convincingly validate the role of Syt1 and Syt7. Another key point is that these proteins are essential during infection, but they are not significant when an exogenous synthetic antigen is used in the experiments. This emphasizes the importance of studying infection as a physiological context for antigen presentation to MAIT cells. An additional relevant aspect is that the study reveals the existence of different MR1 antigen presentation pathways, which differ from the endoplasmic reticulum or endosomal pathways that are typical for MHC-presented peptides.

      Weaknesses:

      The reduced MAIT cell response observed with Syt1 and Syt7-deficient cell lines is statistically significant but not completely abolished. This may suggest that only some MR1-loaded molecules depend on these two Syt proteins. Further research is needed to determine whether, during persistent M. tuberculosis infection, enough MR1-loaded molecules are produced and transported to the plasma membrane to sufficiently stimulate MAIT cells. The study proposes that other Syt proteins might also play a role, as outlined by the authors. However, exploring potential redundant mechanisms that facilitate MR1 loading with antigens remains a challenging task.

      We appreciate the reviewer’s comments and feedback. Syt1 and Syt7 knockout cells do not completely abolish MR1-mediated presentation of Mtb-derived metabolites. We agree that the likely explanation is that there are redundancies within the antigen presentation pathways. Whether these redundancies are due to other endosomal trafficking proteins or other intracellular compartments where MR1 loading can occur remains unknown. Moreover, Mtb-derived antigens can access the ER, where Syt1 and Syt7 are not involved, thereby enabling an ER-mediated pathway for MR1 antigen presentation. It is also important to note that relatively few (<10) loaded MHC class I molecules are sufficient to trigger T cell activation (Brower et al., 1994; Sykulev et al., 1995; Sykulev et al., 1996). A major challenge in exploring these mechanisms is due to the inability to directly track small molecule Mtb-derived antigens as they are loaded onto MR1 and presented at the cell surface. These hurdles are briefly outlined in the discussion as future directions. Nonetheless, Syt1 and Syt7 are the first endosomal trafficking proteins identified to have a specific effect on MR1-mediated presentation of Mtb-derived antigens.

      Reviewer #3 (Public review):

      Summary:

      In the submitted manuscript, the authors investigate the role of Synaptotagmins (Syt1) and (Syt7) in MR1 presentation of MtB.

      Strengths:

      In the first series of experiments, the authors determined that knocking down Syt1 and Sy7 in antigenpresenting cells decreases IFN-γ production following cellular infection with Mtb. These experiments are well performed and controlled.

      Weaknesses:

      Next, they aim to mechanistically investigate how Syt1 and Syt7 affect MtB presentation. In particular, they focus on MR1, a non-classical MHC-I molecule known to present endogenous and exogenous metabolites, including MtB metabolites. Results from these next series of experiments are less clear. Firstly, they show that knocking down Syt1 and Sy7 does not change MtB phagocytosis as well as MR1 ER-plasma membrane translocation. Based on this, they suggest that Syt1 and Syt7 may affect MR1 trafficking in endosomal compartments. However, neither subcellular compartment analysis nor flow organelleometry clearly establishes the role of Syt1 and Syt7 in MtB trafficking. Altogether, the notion that Synaptotagmins facilitate MR1 interaction with Mtb-containing compartments and its vesicular transport was already known. As such, the manuscript should add additional insight on where/how the interaction occurs. The reviewer is left with the notion that Syt1 and Sy7 may affect MR1 presentation, facilitating the trafficking of MR1 vesicles from endosomal compartments to either the cell surface or other endosomal compartments. The analysis is observational and additional data or discussion could address what the insight gained beyond what is already known from the literature.

      We thank Reviewer 3 for their comments. Our hypothesis is that Syt1 and Syt7 mediate MR1 trafficking rather than Mtb trafficking. While Syt7 has previously been implicated in MHC class II trafficking and vesicular transport, this study is the first to explore in detail the roles of Syt1 and Syt7 in MR1-mediated presentation of Mtb-derived metabolites. Since current technologies do not allow direct tracking of Mtbderived antigens loaded onto MR1, we relied on complementary approaches including IFN-γ release from MAIT cells, flow cytometry, fluorescence microscopy, and flow organelleometry. Both flow organelleometry and fluorescence microscopy show increased MR1 expression at Mtb-containing vacuoles in Syt7 knockout cells. Since total MR1 expression measured by flow cytometry and the overall number of MR1 vesicles remain unchanged, these data support a mechanism in which Syt7 facilitates the trafficking of antigen-loaded MR1 from Mtb-containing vacuoles to the cell surface, consistent with the observed reduction in MAIT cell IFN-γ release.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Concern 1, the data in the current manuscript have not been sufficient to "identify a novel pathway in which Syt1 and Syt7 facilitate the translocation of MR1 from Mtb-containing vacuoles, potentially to the cell surface for antigen presentation" (Last part of Abstract). To conclude this, additional pieces of data are needed: (a) Mtb-containing vacuoles associate with MR1 protein expression; (b) MR1+ vesicles traffic from one subcellular location to another; (c) Syt1 or Syt7 KO reduces MR1 vesicles at a downstream subcellular location, e.g., the cell surface. Important evidence supporting the "facilitation of translocation" is missing on whether Syt1 or Syt7 KO reduces MR1 vesicle traffic from one location to another.

      We thank the reviewer for their detailed suggestions to improve our proposed model. We would like to clarify that Figure 7g demonstrates increased MR1 protein expression in Syt7 knockout cells, as assessed by flow organellometry. This approach allowed us to specifically distinguish AuxMtb<sup>+</sup>LAMP1<sup>+</sup> compartments (Mtb-containing vacuoles) and to quantify MR1 expression using geometric mean fluorescence intensity. Moreover, in both Syt1 and Syt7 knockout cells, MR1+ vesicles are retained within lysosomal compartments, characterized by vesicle enlargement and accumulation. Therefore, we did not observe trafficking of MR1+ vesicles to other subcellular locations or to the plasma membrane. A key limitation, however, is the lack of current technologies that allow direct measurement of MR1 surface expression specifically during intracellular Mtb infection via flow cytometry. Given this limitation, IFN-γ ELISpot is a sensitive surrogate and supports the conclusion that loss of Syt1 and Syt7 results in decreased MR1 presentation of Mtb-derived antigens at the plasma membrane.

      The results "a significant increase in the number of MR1 vesicles within 1 μm of AuxMtb for Syt1 (1.13 {plus minus} 0.46) and Syt7 KO (1.31 {plus minus} 0.46) cells compared to WT cells (Fig.7b)." and "the surface of MR1 vesicles in Syt1 and Syt7 KO cells showed a 3-fold increase in overlap area with Mtb surfaces (Fig.7d)." may need to be further elaborated on whether MR1+vacuoles and Mtb+ vacuoles are overlapped or are adjacent. Figure 7b shows several groups of vacuoles with the same distance. This needs a larger sample size to randomize this distance measurement, for example, calculating 50~100 Mtb+ vacuoles.

      We appreciate the reviewer’s critical comments and suggestions. To quantify distance and surface overlap, the microscopy images were acquired from a single optical plane rather than full z-stacks. As a result, it is not possible to definitively determine whether MR1+ vesicles and Mtb-containing vacuoles are directly overlapping or adjacent. In response to the reviewer’s suggestion, we increased the sample size for both distance (n=51-53) and surface overlap analyses (n=51-53). Using the larger sample size, we observed a significant increase in the number of MR1 vesicles located within 1μm of AuxMtb in both Syt1 (1.23±0.21) and Syt7 knockout (1.28±0.22) cells. Also, there was an approximately 4-fold increase in MR1-Mtb surface overlap area compared to wildtype cells.

      Results from "performed flow organellometry to separate phagosomes from other subcellular fractions and identified enrichment of Mtb-containing vacuoles in fractions 42-50 (Fig.7e-f)" could not distinguish the difference between WT and Syt1/Syt7 KO, or further support the role of Syt1/Syt7 in endocytic trafficking. More specifically, authors claimed that "enhanced MR1 expression in Mtb+LAMP1+ compartments via flow organellometry in Syt1 and Syt7 KO cells.", may not be supported by Figure 7f, which does not show a difference in MR1 expression between Syt1 KO or Syt7 KO and WT.

      We appreciate the reviewer’s concerns and would like to clarify the interpretation of Figures 7f and 7g. Figure 7f demonstrates: (a) enrichment Mtb-containing vacuoles within fractions 42-50, (b) coenrichment of LAMP1+ vesicles within these Mtb-containing fractions, and (c) comparable subcellular fractionation profiles across wildtype, Syt1 knockout, and Syt7 knockout cells, indicating no major differences in fraction distribution. Differences in MR1 expression are shown in Figure 7g, which compares MR1 expression as the geometric mean fluorescence intensity within the fraction exhibiting the highest percentage of AuxMtb<sup>+</sup>LAMP1<sup>+</sup> across all fractions. We observed significant increase in MR1 expression in Syt7 knockout cells compared to wildtype cells.

      Concern 2, in abstract, "Loss of Syt1 and Syt7 results in enlarged MR1 vesicles and an increased number of MR1 vesicles in close proximity to Mtb-containing vacuoles during infection.". Although numbers of MR1 vesicles within 1um of Mtb increase (Figure 7b) and areas of MR1+ vacuoles for WT and KO cells enhance (Figure 6f), but numbers of MR1 vesicles/cells are not different between WT and Syt1 and Sy7 KO (Fig. 7c). These imaging analyses, including other figure panels, need more explicit presentation of (most if not all) random images for calculation, annotation of MR1-vacuoles for calculation, and raw statistical data for mean and p value calculation. These raw data can be presented in supplemental figure panels.

      We thank the reviewer for these suggestions. We have included more details on randomization, technical procedures, and statistical analyses in methods section for “Fluorescence Microscopy,” “Image Analysis,” and “Statistical Analysis.” Raw data collection and statistical data are presented in the supplemental data.

      Concern 3, additional evidence that does not support the conclusion "This study identifies a novel pathway in which Syt1 and Syt7 facilitate the translocation of MR1 from Mtb-containing vacuoles" (the last part of Abstract). This additional unsupportive evidence includes: (a) MR1 expression on the cell surface is not impacted or not different among WT, Syt1 KO, and Syt7 KO of BEAS-2B cells (Fig. 6d). (b) "Live-cell imaging showed no differences in MR1 cellular distribution in the presence or absence of Ac-6FP between WT, Syt1, and Syt7 KO BEAS-2B:TET-MR1GFP cells as MR1 translocated from the ER and vesicles to the cell surface as expected (Figure 6c).

      We thank the reviewer for this comment and would like to clarify our use of Ac-6-FP. Figures 6c and 6d examine MR1 cellular distribution and surface expression in the presence or absence of Ac-6-FP. Ac-6-FP is a small MR1 ligand that is loaded in the ER and promotes MR1 surface stabilization and trafficking to the cell membrane. In contrast, Mtb primarily resides within membrane-bound phagosomes. MR1 presentations of soluble/exogenously delivered ligands versus intracellular Mtb-derived antigens have shown to involve distinct pathways and endosomal trafficking proteins (Harriff et al., 2016; Karamooz et al., 2019; Karamooz et al., 2025). Findings from Figures 6c and 6d show that Syt1 and Syt7 do not contribute to the presentation of small soluble and ER-loaded ligands such as Ac-6-FP. Instead, they specifically contribute in MR1 presentation of Mtb-derived metabolites by translocating MR1 from Mtbcontaining vacuoles in the context of intracellular Mtb infection

      Other concerns:

      (1) Figure 1a uses Ct value to measure Syt1 and Syt7 expression levels, but a comparison with GAPDH Ct cycle numbers in different cell types will be helpful for understanding.

      We appreciate the reviewer’s suggestion of including GADPH Ct cycle numbers. We have revised Figure 1a to show Ct values for Syt1, Syt7, and GAPDH in both BEAS-2B and THP-1 cells.

      (2) Figure 1b indel, shown with an ICE method, should be confirmed with protein expression levels to interpret functional results.

      We thank the reviewer for raising this concern. We attempted to assess protein levels by western blot using multiple antibodies from both Abcam and Synaptic Systems. However, we were unable to identify a suitable antibody that reliably detected endogenous Syt1 or Syt7 protein levels.

      (3) Figure 1c. HLA-B45-restricted T cell clones also show some marginal reduction of IFN-γ spot responses and are more different in Figure 6b. Please discuss this conflicting data. Also, need a reference to support whether the exogenous CFP peptide antigen is presented via surface or endocytic antigen loading.

      We agree with the reviewer that there are some marginal reductions of IFN-γ responses for HLA-B45restricted T cell clones. Since T cell clones are used from frozen, there can be differences in maximal responses between T cell clones and expansions of the same T cell clone. However, the comparisons include a control arm and pool data from multiple experiments to reach statistical power and validity. In addition, Figure 6b shows Syt1 and Syt7 KO cells in the background of BEAS-2B MR1KO:tetMR1-GFP clone D4 cells, which overexpresses MR1 that may contribute to variability and potentially account for the observed differences. With respect to exogenous CFP peptide loading, earlier studies on peptides and antigen presenting cells demonstrated that peptides can be loaded onto fixed cells and subsequently presented to T cells (Shimonkevitz et al., 1983; Watts et al., 1985). Based on these findings, it is reasonable to assume that substantial peptide exchange occurs at the cell surface when exogenous peptides are added to antigen presenting cells.

      (4) Figure 2e: Delta CT values of Syt1, Syt7 in WT, KO cells can be shown together with Ct values of GAPDH or B2m house-keeping genes to help readers determine the efficiency of Syt1 and 7 mutation at the gene expression level. Also, in Figure 4a, the baseline of Ct values for GAPDH can be plotted together.

      As suggested by the reviewer, we have revised Figure 2e and 4a to include CT values for the genes of interest as well as housekeeping gene GAPDH.

      (5) Figure 3c and Figure 1d: M.smeg infection can be shown to be more comparable with Mtb infection.

      We thank the reviewer for this thoughtful comment. Although M. smegmatis infection could serve as a comparable control, M. smegmatis secretes large amounts of MR1 ligands derived from riboflavin metabolism. This makes it difficult to distinguish between extracellular and intracellular antigens, and to directly compare with Mtb infection, which is specifically an intracellular infection model.

      (6) Figure 4e: It appears Esyt2 Knockdown shows strong inhibition of MAIT activation mediated by BEAS2B cells with Mtb infection and M.smeg supernatant stimulation. Please add other relevant data, such as MR1 cell surface expression and colocalization, and discuss these results with Syt proteins.

      We appreciate the reviewer’s suggestion to include relevant data for Esyt2 knockdown. We performed flow cytometry analysis of Esyt2 knockdown cells and found surface MR1 expression under basal conditions. Treatment with Ac-6-FP resulted in increased MR1 surface stabilization, but MR1 surface level was significantly lower than those observed in missense control cells. Therefore, Esyt2 is not specific to MR1 presentation of Mtb-derived metabolites and instead may play a broader role in overall MR1 antigen presentation, including intracellular Mtb-derived antigens, exogenous antigens, and ER-loaded Ac-6-FP.

      (7) Figure 5 colocalization computational analyses can be more explicitly presented regarding randomization, technical procedures, and statistical analyses, as stated in Concern 2.

      As suggested, we have included more details in methods section and added the supplemental data.

      (8) Figure 6a: Syt1 and Syt7 protein expressions are also suggested to confirm the mutation, similar to the confirmation for Figures 1 and 3.

      We thank the reviewer for raising this concern. As discussed previously, we have not identified a suitable antibody for human Syt1 and Syt7. We have tested multiple antibodies from Abcam and Synaptic Systems.

      (9) For statistical analyses, "non-linear regression analysis comparing best-fit values of top and EC50 were used to calculate p-values by extra sum-of-squares F test" (Figure 6b) and "non-linear regression analysis of pairwise comparison to WT on best-fit values of top and EC50 were used to calculate p-values by extra sum-of-squares F test." (Figure 3bc), readers may need more specific demonstration in supplemental figures on how statistical analyses have been performed.

      We appreciate the reviewer’s suggestion to include more detailed information regarding the statistical analyses. For clarification, data presented in Figures 6b and 3bc were analyzed using the same statistical analysis in Prism 10. Specifically, nonlinear regression (curve fit) was performed using the [Agonist] vs. response model with three parameters. Best-fit values for the top and EC<sub>50</sub> parameters were compared using an extra sum-of-squares F test.No constraints were applied to the bottom and top parameters, and the EC<sub>50</sub> parameter was constrained to be greater than 0 for p-value calculation. We have revised the Statistical Analysis section of the Methods to more clearly describe this approach.

      (10) In discussion, the background section for Syt1 and Syt7 is more appropriate to be in the introduction. This will allow readers to better understand the association of Syt proteins with MR1 and the necessity to study the impact of Syt on MR1 trafficking.

      We thank the reviewer for this suggestion. We believe that the basic background and relevance of Syt1 and Syt7 in MR1 trafficking are covered in the introduction; however, we have added details to help readers understand their impact.

      Reviewer #2 (Recommendations for the authors):

      This reviewer has no requests for implementation and congratulates the authors on this nice piece of work.

      We thank the reviewer for the positive comments.

      Reviewer #3 (Recommendations for the authors):

      Complete trafficking experiments to pinpoint the trafficking relationship between Syt 1 and 7 and MR1 in MtB infection.

      We appreciate the reviewer’s insightful comment. As this study represents the first detailed investigation into the roles of Syt1 and Syt7 in MR1-mediated presentation of Mtb-derived metabolites, we agree that a fully resolved trafficking mechanism has not yet been established. A major limitation is the inability to directly track Mtb-derived antigens as they are loaded onto MR1 and trafficked to the cell surface. Therefore, we relied on complementary functional and microscopy-based approaches, including IFN-γ ELISpot assays, flow cytometry, fluorescence microscopy, and flow organellometry, to infer the trafficking relationships between Syt1, Syt7, and MR1 during intracellular Mtb infection. Our data support a model that Syt1 and Syt7 facilitates the trafficking of MR1 from Mtb-containing vacuoles to the plasma membrane. This interpretation is supported with the increased accumulation of MR1 in Mtb-containing vacuoles and reduction in MAIT cell IFN-γ release observed in Syt1 and Syt7 knockout cells.

      References

      (1) Becker, S. M., Delamarre, L., Mellman, I., & Andrews, N. W. (2009). Differential role of the Ca(2+) sensor synaptotagmin VII in macrophages and dendritic cells. Immunobiology, 214(7), 495–505.

      (2) Brower, R. C., England, R., Takeshita, T., Kozlowski, S., Margulies, D. H., Berzofsky, J. A., & Delisi, C. (1994). Minimal requirements for peptide-mediated activation of CD8+ CTL. Molecular immunology, 31(16), 1285–1293.

      (3) Harriff, M. J., Karamooz, E., Burr, A., Grant, W. F., Canfield, E. T., Sorensen, M. L., Moita, L. F., & Lewinsohn, D. M. (2016). Endosomal MR1 Trafficking Plays a Key Role in Presentation of Mycobacterium tuberculosis Ligands to MAIT Cells. PLoS pathogens, 12(3), e1005524.

      (4) Karamooz, E., Harriff, M. J., Narayanan, G. A., Worley, A., & Lewinsohn, D. M. (2019). MR1 recycling and blockade of endosomal trafficking reveal distinguishable antigen presentation pathways between Mycobacterium tuberculosis infection and exogenously delivered antigens. Scientific reports, 9(1), 4797.

      (5) Karamooz, E., Kim, S. J., Peterson, J. C., Tammen, A. E., Soma, S., Soll, A. C. R., Meermeier, E. W., Khuzwayo, S., & Lewinsohn, D. M. (2025). Two-pore channels in MR1-dependent presentation of Mycobacterium tuberculosis infection. PLoS pathogens, 21(8), e1013342.

      (6) Kulicke, C. A., Swarbrick, G. M., Ladd, N. A., Cansler, M., Null, M., Worley, A., Lemon, C., Ahmed, T., Bennett, J., Lust, T. N., Heisler, C. M., Huber, M. E., Krawic, J. R., Ankley, L. M., McBride, S. K., Tafesse, F. G., Olive, A. J., Hildebrand, W. H., Lewinsohn, D. A., Adams, E. J., … Harriff, M. J. (2024). Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation. Communications biology, 7(1), 228.

      (7) Shimonkevitz, R., Kappler, J., Marrack, P., & Grey, H. (1983). Antigen recognition by H-2restricted T cells. I. Cell-free antigen processing. The Journal of Experimental Medicine, 158(2), 303–316.

      (8) Sykulev, Y., Cohen, R. J., & Eisen, H. N. (1995). The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 92(26), 11990–11992.

      (9) Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J., & Eisen, H. N. (1996). Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity, 4(6), 565– 571.

      (10) Watts, T. H., Gariépy, J., Schoolnik, G. K., & McConnell, H. M. (1985). T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentation. Proceedings of the National Academy of Sciences of the United States of America, 82(16), 5480–5484.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable work investigates the role of protein N-glycosylation in regulating T-cell activation and function and suggests that B4GALT1 is a potential target for tumor immunotherapy. The strength of evidence is solid, and further mechanistic validation could be provided.

      We sincerely thank the editor and reviewers for their time and constructive feedback. Your recognition of our work is much appreciated. We clarify our mechanistic studies as stated below.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The study by Yu et al investigated the role of protein N-glycosylation in regulating T-cell activation and functions is an interesting work. By using genome-wide CRISPR/Cas9 screenings, the authors found that B4GALT1 deficiency could activate expression of PD-1 and enhance functions of CD8+ T cells both in vitro and in vivo, suggesting the important roles of protein N-glycosylation in regulating functions of CD8+ T cells, which indicates that B4GALT1 is a potential target for tumor immunotherapy.

      Strengths:

      The strengths of this study are the findings of novel function of B4GALT1 deficiency in CD8 T cells.

      Weaknesses:

      However, authors did not directly demonstrate that B4GALT1 deficiency regulates the interaction between TCR and CD8, as well as functional outcomes of this interaction, such as TCR signaling enhancements.

      We are very sorry that we did not highlight our results in Fig. 5f-h enough. In those figures, we demonstrated the interaction between TCR and CD8 increased significantly in B4GALT1 deficient T-cells, by FRET assays. To confirm the important role of TCR-CD8 interaction in mediating the functions of B4GALT1 in regulating T-cell functions, such as in vitro killing of target cells, we artificially tethered TCR and CD8 by a CD8β-CD3ε fusion protein and tested its functions in both WT and B4GALT1 knockout CD8<sup>+</sup> T-cell. Our results demonstrate that such fusion protein could bypass the effect of B4GALT1 knockout in CD8<sup>+</sup> T-cells (Fig. 5g-h). Together with the results that B4GALT1 directly regulates the galactosylation of TCR and CD8, those results strongly support the model that B4GALT1 modulates T-cell functions mainly by galactosylations of TCR and CD8 that interfere their interaction.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors identify the N-glycosylation factor B4GALT1 as an important regulator of CD8 T-cell function.

      Strengths:

      (1) The use of complementary ex vivo and in vivo CRISPR screens is commendable and provides a useful dataset for future studies of CD8 T-cell biology.

      (2) The authors perform multiple untargeted analyses (RNAseq, glycoproteomics) to hone their model on how B4GALT1 functions in CD8 T-cell activation.

      (3) B4GALT1 is shown to be important in both in vitro T-cell killing assays and a mouse model of tumor control, reinforcing the authors' claims.

      Weaknesses:

      (1) The authors did not verify the efficiency of knockout in their single-gene KO lines.

      Thank reviewer for reminding. We verified the efficiency of some gRNAs by T7E1 assay. We will add those data in supplementary results in revised version later.

      (2) As B4GALT1 is a general N-glycosylation factor, the phenotypes the authors observe could formally be attributable to indirect effects on glycosylation of other proteins.

      Please see response to reviewer #1.

      (3) The specific N-glycosylation sites of TCR and CD8 are not identified, and would be helpful for site-specific mutational analysis to further the authors' model.

      Thank reviewer for suggestion! Unfortunately, there are multiple-sites of TCR and CD8 involved in N-glycosylation (https://glycosmos.org/glycomeatlas). We worry that mutations of all these sites may not only affect glycosylation of TCR and CD8 but also other essential functions of those proteins.

      (4) The study could benefit from further in vivo experiments testing the role of B4GALT1 in other physiological contexts relevant to CD8 T cells, for example, autoimmune disease or infectious disease.

      Thank reviewer for this great suggestion to expand the roles of B4GALT1 in autoimmune and infection diseases. However, since in current manuscript we are mainly focusing on tumor immunology, we think we should leave these studies for future works.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The study by Yu et al investigated the role of protein N-glycosylation in regulating T-cell activation and functions is an interesting work. By using genome-wide CRISPR/Cas9 screenings, the authors found that B4GALT1 deficiency could activate expression of PD-1 and enhance functions of CD8+ T cells both in vitro and in vivo, suggesting the important roles of protein N-glycosylation in regulating functions of CD8+ T cells, which indicates that B4GALT1 is a potential target for tumor immunotherapy. However, authors need to directly demonstrate that B4GALT1 deficiency regulates the interaction between TCR and CD8, as well as functional outcomes of this interaction, such as TCR signaling enhancements. In addition, blocking PD1 has been shown to enhance antitumor effect, whereas the presented data in this study suggest that the activation of PD1 expression in the condition of B4GALT1 deficiency in T cells enhanced antitumor effect. How to reconcile this discrepancy? Finally, several minor questions need to be addressed to strengthen the conclusions in this manuscript.

      (1) We used a FRET (Fluorescence Resonance Energy Transfer) assay to measure interaction between TCR and CD8. FRET signals of TCR-CD8 increased significantly in B4GALT1 deficient T-cells, compared with control cells (Fig. 5f). For functional outcomes of this interaction, we observed enhanced T-cell killing activities in B4GALT1 deficient CD8<sup>+</sup> T-cells (Fig. 3f and Fig. 5h).

      To confirm whether reduced TCR-CD8 interaction is the major cause of TCR activation phenotypes in B4GALT1 knockout CD8<sup>+</sup> T-cells, we generated a construct in which we fused the CD8b ectodomain (ECD) with CD3e to artificially tether TCR with CD8 (Fig.5g). Overexpression of such CD8β-CD3ε fusion led to enhanced in vitro killing activities in control wild-type CD8<sup>+</sup> T-cells. On the other hand, in B4GALT1 deficient CD8<sup>+</sup>T-cells, such enhanced T-cell killing activities by fusion construct was significantly diminished (Fig.5h), suggesting it bypassed the regulation by B4GALT1.

      (2) PD-1 is both an early T-cell activation marker upon TCR activation and a T-exhausted marker under consecutive or repeated stimulations. In our screenings, PD-1 was used as an early activation marker for T-cells.

      We have clarified this in new Discussion section.

      (1) The present data relies on statistical graphs (e.g., bar and line charts) for all data, excluding the bioinformatics analysis. Including data such as flow cytometry plots, photomicrographs, or immunohistochemistry staining images will provide more direct support for the conclusions.

      Thank the reviewer for valuable suggestions! We added original flow cytometry gating strategies for Cas9 screening sorting (Fig. S1a), TIL analysis (Fig.S5), and FRET assay (Fig. S8) in revised version to provide more direct support for our conclusions.

      (2) To further validate the enhanced tumor infiltration phenotype resulting from B4GALT1 knockout, the following data would strengthen the manuscript:

      (a) Flow cytometric analysis of TILs or immunofluorescence data from tumor sections.

      Thank the reviewer for valuable suggestion! We added original flow cytometry gating strategies for TILs in Fig. S5 in revised version.

      (b) Assessment of in vivo T cell proliferation, for example, by tracking changes in the proportion of CD8+ T cells in the peripheral blood over time.

      We analyzed in vivo T-cell proliferation within tumor by CFSE (carboxyfluorescein succinimidyl ester) analysis. As shown in Fig. S6b, 6 days after infusion, B4GALT1 knockout OT-I T-cell showed increased proliferation within tumors, comparing with wild type control OT-I cells.

      (c) Evaluation of the proliferation and activation status of OT-1 CD8+ T cells specifically in the draining lymph nodes of the mouse model.

      Thank the reviewer for valuable suggestion! We plan to perform this experiment in the future.

      (3) The authors provide evidence that B4GALT1 knockout enhances CD8+ T cell function in both mouse models and human TCR-T cells (in vitro). Definitive support for the translational potential of this strategy would come from showing that B4GALT1-knockout human TCR-T cells also mediate potent in vivo function (NSG tumor-bearing model may be a better choice).

      Thank the reviewer for valuable suggestion! We are going to perform those experiments in the future. However, we do not expect that in vitro and in vivo (NSG mice) experiments will show much different results, which may also not add too much for current manuscript.

      (4) It would be preferable to include data on T cell activation and effector function (e.g., flow cytometry for IL-2, TNF-α, and IFN-γ, or ELISPOT) following stimulation with an OVA-specific peptide or co-culturing of OVA-expressing tumor cells with B4GALT1-knockout OT-1 CD8 T cells, especially the changes in the TILs compared with the non-targeting control group.

      Following co-culturing of B16-OVA tumor cells with B4GALT1-knockout or wild-type OT-I CD8<sup>+</sup> T-cells, the RNA levels and secretion levels of TNFα and IFNγ were detected by RT-qPCR and ELISA, respectively (Fig. 3c). B4GALT1-deficient OT-I T-cells showed increased expression of T-cell activation and cytotoxic markers such as IFNγ and TNFα.

      (5) What is the correlation between the expression of B4GALT1, PD-1, and TCR activation markers at various time points during a long-term T cell co-culture with tumor cells?

      Thanks for the reviewer for valuable suggestion! We don’t have this data now. While we agree that exploring this might be interesting, we think it falls outside the scope of the current study.

      (6) In line 136: Regarding the genetic targeting of B4GALT1 in T cells, it is unclear whether single or multiple gRNAs were used and if potential off-target effects were assessed. To fully validate the model, it would be important to clarify these strategies, and it is essential to include data on the knockout efficiency at both the protein (e.g., Western blot) and mRNA levels.

      We are sorry about the unclear statements for gene knockout strategy. In current study, single sgRNAs were used in all experiments for gene knockout. B4galt1 sg2 was used in Fig. 3a. Both B4galt1 sg1 and sg2 were used in Fig. S1d. We clarified this in each figure legend in revised version.

      The phenotypes of B4galt1 knockout T-cells could be rescued by overexpression of either a short or long isoform of mouse B4galt1 cDNA (Fig. 3b), indicating that potential off-target effects could be excluded.

      The sgRNA knockout efficiencies were confirmed by T7E1 assay in revised version (Fig. S2). Regrettably, anti-mouse B4galt1 antibody didn’t work in western blot.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      (1) Rationale for excluding clades G and H and clarification of clade definitions

      We appreciate this important request for clarification. In the revised manuscript, we now explicitly state (Methods, Tree generation) that the phylogenetic framework used in this study follows the clade definitions established by Techtmann et al. (Front. Microbiol. 2012, 3, 132), which classify [NiFe]-CODHs into clades based on high supporting values in nodes (bootstrap >75). We deem Techtmann et al.’s work as best lead, since their approach with two different types of trees (ML vs. Bayesian) gives solid support to this classification of clades. We ourselves did not perform Bayesian statistics, instead we used the known clades from literature to assign ours.

      Clades G and H were not deliberately excluded from downstream genomic-context and operon analyses. They were excluded by our pipeline, because their data did not fulfil our initial quality assessments, such as: host classified down to species level (https://github.com/boehmax/protein-per-organism), and protein exists in the IPG database of NCBI (https://github.com/boehmax/protein-to-genome).

      Clade G and H are both represented by only a very small number of sequences, most of which derive from fragmented or poorly annotated genomes, preventing reliable assessment of operon organization and gene neighbourhood conservation. As a result, inclusion of these clades would not allow statistically meaningful or biologically interpretable comparisons with clades A–F.

      To improve transparency, we have added a brief explanation of these limitations in the Results (Results, Neighbor analysis).

      (2) Presentation and interpretation of co-occurrence data

      We agree that the presentation of the co-occurrence data required improvement. In the revised supplementary material, we now include a table in the long format that might be easier to interpret than a matrix representation as seen in Fig. 3B.

      We have also revised the Results text to more precisely reflect the numerical trends. Specifically, we clarify that clade D shows co-occurrence with clades A, E and F, while clade C only displays co-occurrence with clade E. The statement that clades C and D “more often co-occur” has been removed and rephrased to avoid overgeneralization and to better align with the quantitative data shown in Figure 3B and the supplementary table (Results, Co-occurrence and Correlation).

      (3) Rationale for operon-level rather than organism-level analysis

      We thank the reviewer for highlighting this conceptual point. In the revised manuscript, we now explicitly state that our analysis was conducted at the operon level because individual genomes frequently encode multiple CODH operons that are phylogenetically and functionally distinct. Treating each operon as an independent functional unit allows us to capture this intra-genomic diversity and to associate specific gene neighbourhoods with individual CODH clades. We furthermore discuss in the introduction explicitly technical reasons why we decided to limit this study to the operon level for more transparency.

      Nevertheless, we acknowledge that this approach may overlook higher-level regulatory or physiological interactions among multiple CODHs encoded within the same genome. This limitation is now discussed explicitly, and we acknowledge that operon-level analysis should be a complementary, not exhaustive, framework for functional inference.

      Reviewer #2 (Public review):

      We thank Reviewer #2 for their positive assessment of the conceptual clarity and methodological utility of our approach, as well as for their thoughtful discussion of its limitations.

      Regarding incomplete genome assemblies, limited representation of class II HCPs, and potential omission of distal pathway components, we agree fully. We stress that our conclusions are probabilistic and hypothesis-generating rather than definitive functional assignments.

      In response to the concern about reproducibility of the visual filtering step, we have added a more explicit description (Methods, Data collection and refinement) of the criteria used to exclude non-CODH homologs (e.g., absence of conserved active-site motifs, unknown folds predicted with AlphaFold3, extremely long tree branches). This clarification improves transparency and facilitates replication of the analysis.

      Finally, we concur that extrapolating enzymatic activity or inactivity from a limited number of characterized representatives should be done cautiously. We have revised the wording throughout the manuscript to further temper such generalizations and to frame our interpretations explicitly as predictions that require experimental validation.

      Once again, we thank both reviewers for their constructive feedback, which has significantly improved the clarity, rigor, and transparency of the manuscript. We believe that the revisions address all concerns raised and strengthen the overall contribution of this work.

      Recommendation from authors:

      Reviewer #1 (Recommendations for the authors):

      All suggested editorial and stylistic corrections were implemented. These include refinements to the wording in the Abstract, grammatical corrections, streamlined phrasing, standardized figure callouts and supplementary file references, corrected abbreviations, and consistent formatting of references and author names. The only exception concerns the suggested change from MetCODH to MtCODH. We have retained MetCODH, as this abbreviation is well established in the literature for the Methanothermobacter thermophila CODH and is commonly used in prior studies (e.g., https://doi.org/10.1073/pnas.2410995121 ). MtCODH has historically been referring to CODH from Neomoorella thermoacetica (previously Moorella thermoacetica, hence the abbreviation Mt). We chose to rename that to NtCODH but to avoid confusion, keep MetCODH for Methanothermobacter thermophila.

      Reviewer #2 (Recommendations for the authors):

      We likewise addressed the majority of recommendations. We now report the versions of all software tools and databases used, standardized capitalization and naming of software and platforms (e.g., GitHub, eggNOG), clarified the BLAST implementation and database employed, and added direct repository links for custom scripts in both the Methods section and the bibliography. Overall grammatical consistency and formatting were improved throughout the manuscript. In addition, the criteria and procedure used for visual inspection to remove non-CODH sequences are now described more explicitly to enhance reproducibility, and several methodological sections were streamlined as suggested. Minor textual redundancies were removed, and phrasing was simplified where appropriate.

      Figure legends and formatting were revised to improve clarity and consistency. Adjustments to color usage and font consistency were made where feasible to enhance readability. The color scheme in Figure 1 was adjusted as suggested, and darker shades were chosen for clade H and G. This change was also implemented in the Supplementary File 9_Tree5. Figure 3A was retained, as it provides information on the frequency of multiple CODHs from the same clade within genomes, which cannot be inferred from the probability matrix shown in Figure 3B; together, these panels offer complementary insights. We adjusted the figure caption to make this clearer. We increased the visibility of data points in Figure 4B. To allow inclusion of the full dataset we did not collapse the x-axis as suggested. Figure 4C was retained in its original format to emphasize the characteristic operon “fingerprints” of each CODH clade, which is a central focus of this work. A table is supplied in Supplementary File 2, which allows data exploration with the preferred focus of the reader.

      A small number of suggestions were therefore not implemented exactly as proposed, primarily where alternative revisions were judged to better preserve clarity or analytical intent. These decisions are minor and do not affect the conclusions or reproducibility of the study.

      Overall, we believe that these revisions have substantially improved the manuscript’s readability, transparency, and technical rigor, and we thank the reviewers again for their careful and constructive feedback.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This study compares four models - VALOR (dynamic visual-text alignment), CLIP (static visual-text alignment), AlexNet (vision-only), and WordNet (text-only) - in their ability to predict human brain responses using voxel-wise encoding modeling. The results show that VALOR not only achieves the highest accuracy in predicting neural responses but also generalizes more effectively to novel datasets. In addition, VALOR captures meaningful semantic dimensions across the cortical surface and demonstrates impressive predictive power for brain responses elicited by future events.

      Strengths:

      The study leverages a multimodal machine learning model to investigate how the human brain aligns visual and textual information. Overall, the manuscript is logically organized, clearly written, and easy to follow. The results well support the main conclusions of the paper.

      (1) My primary concern is that the performance difference between VALOR and CLIP is not sufficiently explained. Both models are trained using contrastive learning on visual and textual inputs, yet CLIP performs significantly worse. The authors suggest that this may be due to VALOR being trained on dynamic movie data while CLIP is trained on static images. However, this explanation remains speculative. More in-depth discussion is needed on the architectural and inductive biases of the two models, and how these may contribute to their differences in modeling brain responses.

      Thank you for this thoughtful comment. We agree that attributing VALOR’s advantage over CLIP solely to ‘dynamic (video) versus static (image) pretraining’ would be incomplete, and that the architectural and inductive biases of the two models are central to understanding the observed performance gap.

      Both VALOR and CLIP use contrastive learning to align visual and textual representations, but they differ in several key inductive biases that are particularly relevant for modeling brain responses during continuous movie viewing. First, VALOR is trained to align temporally extended video segments with text, introducing an explicit temporal integration window that aggregates information across consecutive frames. This encourages representations that maintain context, stabilize semantics across time, and encode event-level structure. Second, VALOR’s alignment operates at the level of multi-second narrative units, rather than isolated visual snapshots, biasing the model toward representations that are sensitive to unfolding events and cross-frame consistency.

      In contrast, CLIP processes frames independently and aligns single static images with text. As a result, it lacks an intrinsic mechanism for temporal binding, context accumulation, or event-level representation. While CLIP can capture rich visual–semantic associations at the image level, it is less well suited to represent higher-order temporal structure, which is known to strongly drive responses in association cortex during naturalistic narrative perception.

      We therefore interpret VALOR’s superior encoding performance as reflecting not only exposure to dynamic audiovisual data, but also inductive biases—temporal integration and event-level alignment—that more closely match how the brain integrates information over time during movie watching. We have revised the Discussion (p. 16) to articulate these architectural and representational differences explicitly, rather than attributing the effect solely to training data modality.

      (On page 16) “Additionally, VALOR exceeds the performance of CLIP, a leading static multimodal model, as its training objective aligns multi-second video–text units, enforcing a temporal integration window and event-level semantics that maintain cross-frame consistency and narrative context, whereas CLIP’s image-level alignment provides no intrinsic mechanism for such temporal continuity.”

      (2) The methods section lacks clarity regarding which layers of VALOR and CLIP were used to extract features for voxel-wise encoding modeling. A more detailed methodological description is necessary to ensure reproducibility and interpretability. Furthermore, discussion of the inductive biases inherent in these models-and their implications for brain alignment - is crucial.

      Thank you for this comment. We agree that reproducibility and interpretability require precise specification of which model representations were used for voxel-wise encoding, as well as clearer discussion of the inductive biases inherent in these models and their implications for brain alignment.

      In the revised Methods, we now explicitly specify the feature sources for both models. For CLIP (ViT-B/32), we use the final pooled image embedding after projection into the shared image–text space, extracted frame-by-frame; one representative frame is sampled per TR, and its projected embedding serves as the regressor. For VALOR, we use the final joint video–text projection head, yielding a 512-dimensional embedding computed at the segment/TR level that integrates information across consecutive frames and aligns each multi-second video segment with its associated text. These procedures are now described step-by-step in the Methods (p. 21).

      In addition, we expanded the Discussion (p. 16) to explicitly articulate the models’ inductive biases and their relevance for brain alignment. In particular, we contrast CLIP’s image-level, framewise alignment—which lacks intrinsic temporal integration—with VALOR’s event-level, temporally extended video–text alignment, which biases representations toward context maintenance and narrative continuity. This distinction helps explain why the two models differ in their ability to predict neural responses during continuous movie viewing.

      (Methods, On page 21)

      “(1) Video–text alignment features (VALOR): To extract video-based multimodal features, we used VALOR (VALOR-large checkpoint), an open-source pretrained video–text alignment model24. VALOR combines visual encoders (CLIP and Video Swin Transformer) for extracting visual features and a text encoder (BERT) for extracting textual features 23,51,52. These representations are aligned in a shared embedding space through contrastive learning. We segmented each movie at the TR level and, for each segment, extracted VALOR’s projected video–text embedding from the final projection head of the alignment module to obtain a 512-dimensional feature vector. These embeddings were then time-aligned to the corresponding BOLD responses.

      (2) CLIP features: To compare with static image-based multimodal models, we utilized CLIP (ViT-B/32), which aligns visual and textual representations through contrastive learning but processes individual frames independently without capturing temporal context. One video frame was sampled per TR, and the pooled image embedding after CLIP’s projection into the shared image–text space was extracted to obtain a 512-dimensional feature vector. These TR-aligned vectors were used directly as regressors in the voxel-wise encoding models.”

      (Discussion, On page 16)

      “Additionally, VALOR exceeds the performance of CLIP, a leading static multimodal model, as its training objective aligns multi-second video–text units, enforcing a temporal integration window and event-level semantics that maintain cross-frame consistency and narrative context, whereas CLIP’s image-level alignment provides no intrinsic mechanism for such temporal continuity. More broadly, this difference reflects distinct inductive biases in how the two models represent visual–linguistic information. CLIP is optimized for framewise image–text correspondence, encouraging representations that emphasize instantaneous visual semantics but remain agnostic to temporal structure. In contrast, VALOR is explicitly biased toward aggregating information over multiple consecutive frames and aligning representations at the level of temporally extended events. These inductive biases favor context maintenance, semantic stabilization, and narrative coherence over time, which are known to be critical for driving responses in association cortex during continuous movie perception.”

      (3) A broader question remains insufficiently addressed: what is the purpose of visual-text alignment in the human brain? One hypothesis is that it supports the formation of abstract semantic representations that rely on no specific input modality. While VALOR performs well in voxel-wise encoding, it is unclear whether this necessarily indicates the emergence of such abstract semantics. The authors are encouraged to discuss how the computational architecture of VALOR may reflect this alignment mechanism and what implications it has for understanding brain function.

      Thank you for this important conceptual question. We agree that improved voxel-wise encoding performance does not, by itself, imply the emergence of fully amodal or modality-independent semantic representations in the brain. In the revision, we therefore avoid framing our findings as evidence for abstract amodal semantics and instead clarify a more constrained interpretation.

      Specifically, we suggest that visual–text alignment may support the stabilization and coordination of scene-level meaning across modalities and over time, rather than the formation of modality-free semantic codes. From this perspective, VALOR’s advantage reflects inductive biases that promote (i) integration of visual information over multi-second windows and (ii) alignment of temporally extended visual events with linguistic descriptions, yielding representations that are more temporally stable, context-sensitive, and constrained by language.

      We therefore interpret VALOR’s superior encoding performance as identifying cortical regions whose responses are better captured by temporally stabilized, cross-modal representations, rather than as evidence that these regions encode fully abstract semantics independent of input modality. We have expanded the Discussion (p. 16) to articulate this interpretation and to clarify the implications of video–text alignment for understanding how the brain integrates perception and language during naturalistic cognition.

      (On page 16) “Together, the relative gains over AlexNet (purely visual), WordNet (manual semantic annotation), and CLIP (static image–text alignment) indicate cortical systems whose responses are best captured by multi-second, multimodal integration, and highlight regions that accumulate and stabilize narrative context over time. At the same time, these findings do not imply that visual–text alignment in the brain gives rise to fully amodal, modality-independent semantic representations. Instead, we suggest that alignment between visual and linguistic signals may serve to stabilize and coordinate scene-level meaning across modalities and over time. From this perspective, VALOR’s architecture—by integrating visual information over multi-second windows and aligning temporally extended video segments with language—provides a computational proxy for how the brain may use linguistic constraints to organize, disambiguate, and maintain coherent representations of unfolding events. The observed encoding gains therefore highlight regions engaged in temporally stabilized, cross-modal integration during naturalistic perception, rather than providing evidence for abstract semantic codes divorced from sensory input.”

      (4) The current methods section does not provide enough details about the network architectures, parameter settings, or whether pretrained models were used. If so, please provide links to the pretrained models to facilitate reproducible science.

      We appreciate this comment and agree that our original description of model sources and implementation details was not sufficiently explicit. These details are essential for both reproducibility and interpretability. We have now made these specifications explicit in the revised Methods.

      In particular, we now state for each model:

      VALOR. We use the publicly released pretrained VALOR-large checkpoint. For each movie segment, we extract the joint video–text projection head output (512-D) that encodes the aligned segment-level audiovisual semantics. We report the checkpoint source, the segment duration (in frames/seconds), and how these segment-level embeddings are temporally aligned to TRs for voxel-wise encoding.

      CLIP (ViT-B/32). We use the standard pretrained CLIP weights. For each video frame, we extract the final pooled image representation after projection into CLIP’s shared image–text embedding space (512-D). We also clarify that one representative frame is sampled and aligned to each TR, and that these projected embeddings are used as regressors in the encoding model.

      AlexNet. We use the ImageNet-pretrained AlexNet. We take activations from conv5, and then apply PCA to reduce them to 512 dimensions before mapping them to the fMRI time series.

      For each model, the revised Methods now specify: the pretrained source/checkpoint, the layer or head from which features were taken, output dimensionality, any preprocessing or dimensionality reduction, and the temporal alignment procedure used to generate TR-level regressors. These revisions appear in the updated Methods (page 21).

      (On page 21) “(1) Video–text alignment features (VALOR): To extract video-based multimodal features, we used VALOR (VALOR-large checkpoint), an open-source pretrained video–text alignment model24. VALOR combines visual encoders (CLIP and Video Swin Transformer) for extracting visual features and a text encoder (BERT) for extracting textual features 23,51,52. These representations are aligned in a shared embedding space through contrastive learning. We segmented each movie at the TR level and, for each segment, extracted VALOR’s projected video–text embedding from the final projection head of the alignment module to obtain a 512-dimensional feature vector. These embeddings were then time-aligned to the corresponding BOLD responses.

      (2) P features: To compare with static image-based multimodal models, we utilized CLIP (ViT-B/32), which aligns visual and textual representations through contrastive learning but processes individual frames independently without capturing temporal context. One video frame was sampled per TR, and the pooled image embedding after CLIP’s projection into the shared image–text space was extracted to obtain a 512-dimensional feature vector. These TR-aligned vectors were used directly as regressors in the voxel-wise encoding models.

      (3) AlexNet features: Visual features were extracted by sampling frames at the TR level and processing them with AlexNet, an eight-layer convolutional neural network comprising five convolutional layers followed by three fully connected layers. Features from all five convolutional layers were evaluated in preliminary analyses; the fifth convolutional layer showed the best performance and was used in subsequent analyses. Intra-image z-score normalization was applied to reduce amplitude effects. Principal component analysis (PCA) was used to reduce dimensionality, retaining the top 512 components to match the dimensionality of multimodal feature spaces. This pipeline was implemented using the DNNBrain toolkit 53.

      (4) WordNet features: Semantic features were obtained from publicly available WordNet annotations provided with the HCP dataset (7T_movie_resources/WordNetFeatures.hdf5), following the procedure of Huth et al. (2012). Each second of the movie clips was manually annotated with WordNet categories according to predefined guidelines: (a) identifying clear objects and actions in the scene; (b) labeling categories that dominated for more than half of the segment duration; and (c) using specific category labels rather than general ones. A semantic feature matrix was constructed with rows corresponding to time points and columns to semantic categories, with category presence coded as binary values. More specific categories from the WordNet hierarchy were added to each labeled category, yielding a total of 859 semantic features. These features were used directly as regressors. We also evaluated a PCA-reduced 512-dimensional variant (fit within each training fold to avoid leakage); because this version performed slightly worse, we report results from the full 859-dimensional representation in the main text. For the generalization analysis in Study 2, annotations for the SFM dataset were aligned to the same WordNet category space to ensure consistency.”

      Reviewer #2 (Public review):

      Fu and colleagues have shown that VALOR, a model of multimodal and dynamic stimulus features, better predicts brain responses compared to unimodal or static models such as AlexNet, WordNet, or CLIP. The authors demonstrated the robustness of their findings by generalizing encoding results to an external dataset. They demonstrated the models' practical benefit by showing that semantic mappings were comparable to another model that required labor-intensive manual annotation. Finally, the authors showed that the model reveals predictive coding mechanisms of the brain, which held a meaningful relationship with individuals' fluid intelligence measures.

      Strengths:

      Recent advances in neural network models that extract visual, linguistic, and semantic features from real-world stimuli have enabled neuroscientists to build encoding models that predict brain responses from these features. Higher prediction accuracy indicates greater explained variance in neural activity, and therefore a better model of brain function. Commonly used models include AlexNet for visual features, WordNet for audio-semantic features, and CLIP for visuo-semantic features; these served as comparison models in the study. Building on this line of work, the authors developed an encoding model using VALOR, which captures the multimodal and dynamic nature of real-world stimuli. VALOR outperformed the comparison models in predicting brain responses. It also recapitulated known semantic mappings and revealed evidence of predictive processing in the brain. These findings support VALOR as a strong candidate model of brain function.

      (1) The authors argue that this modeling contributes to a better understanding of how the brain works. However, upon reading, I am less convinced about how VALOR's superior performance over other models tells us more about the brain. VALOR is a better model of the audiovisual stimulus because it processes multimodal and dynamic stimuli compared to other unimodal or static models. If the model better captures real-world stimuli, then I almost feel that it has to better capture brain responses, assuming that the brain is a system that is optimized to process multimodal and dynamic inputs from the real world. The authors could strengthen the manuscript if the significance of their encoding model findings were better explained.

      We thank the reviewer for this thoughtful comment and agree with the premise that a model preserving multimodal and temporal structure might a priori be expected to better predict brain responses to naturalistic stimuli. Our intent is not to claim that higher accuracy alone explains brain function, but rather that where and how VALOR improves prediction provides diagnostic insight into cortical processing. We have revised the Discussion to make this distinction explicit.

      Specifically, we clarify three ways in which VALOR’s gains are scientifically informative rather than merely unsurprising:

      (1) Anatomical specificity of improvement. VALOR’s advantage is not uniform across the cortex; gains are largest in regions implicated in multi-second, cross-modal integration. This spatial pattern constrains where the brain accumulates information over time and stabilizes visual representations using linguistic context.

      (2) Model as a computational probe. Beyond prediction accuracy, VALOR’s feature space recovers large-scale semantic organization without manual annotation and enables targeted tests of predictive processing. Features reflecting upcoming content selectively improve fits in specific regions, consistent with anticipatory coding during continuous narrative perception.

      (3) Link to individual differences. Individuals whose neural responses are better captured by anticipatory features show higher fluid intelligence, suggesting that VALOR indexes meaningful variability in forward-looking representations rather than merely tracking stimulus complexity.

      Accordingly, we have revised the Discussion (p. 16) to frame VALOR as a tool for mapping cortical integration profiles, probing semantic and predictive structure, and linking representational dynamics to cognition, rather than asserting that higher encoding accuracy alone explains brain function.

      (On page 16) “Together, the relative gains over AlexNet (purely visual), WordNet (manual semantic annotation), and CLIP (static image–text alignment) indicate cortical systems whose responses are best captured by multi-second, multimodal integration, and highlight regions that accumulate and stabilize narrative context over time.”

      (2) In Study 3, the authors show high alignment between WordNet and VALOR feature PCs. Upon reading the method together with Figure 3, I suspect that the alignment almost has to be high, given that the authors projected VALOR features to the Huth et al.'s PC space. Could the authors conduct non-parametric permutation tests, such as shuffling the VALOR features prior to mapping onto Huth et al.'s PC space, and then calculating the Jaccard scores? I imagine that the null distribution would be positively shifted. Still, I would be convinced if the alignment is higher than this shifted null distribution for each PC. If my understanding of this is incorrect, I suggest editing the relevant Method section (line 508) because this analysis was not easy to understand.

      Thank you for this helpful comment and for pointing out a potential source of confusion. We apologize that the original Methods description was not sufficiently clear. Importantly, VALOR features were never projected into the Huth et al. PC space, and no optimization or rotation toward the WordNet basis occurred at any stage.

      The analysis proceeded as follows:

      (1) VALOR PCs. We first fit voxel-wise encoding models using VALOR features on the Huth et al. dataset. We then applied PCA to the resulting cortical weight maps, yielding spatial components (‘VALOR PCs’) that summarize shared patterns of VALOR feature weights across the cortex.

      (2) WordNet PCs. We used the semantic principal components reported by Huth et al. (2012) directly as published, with no refitting, projection, or modification using VALOR.

      (3) Correspondence analysis. Only after obtaining these two independent sets of cortical maps did we threshold each to their top-loading vertices and compute Jaccard overlap between VALOR PCs and WordNet PCs.

      Although a permutation that shuffles VALOR features prior to projection addresses a scenario that does not apply here, we agree that the Methods description should more clearly convey the independence of the two decompositions. We have therefore revised the Methods (p. 24) to describe the procedure step-by-step and explicitly state that no projection, refitting, or optimization toward the WordNet basis was performed.

      (On page 24) “We first fit voxel-wise encoding models using VALOR features for each of the five participants in the Huth et al. dataset. For each participant, this yielded a weight map linking each VALOR feature to each voxel. We then stacked these weight maps across participants to form a single voxel-by-feature weight matrix and applied principal component analysis (PCA). The top four principal components from this analysis (“VALOR PCs”) captured shared spatial patterns of VALOR feature weights across cortex. To interpret these components, we projected VALOR feature vectors from >20,000 video segments in the VALOR training set onto each VALOR PC, which revealed dominant semantic axes (e.g., mobility, sociality, civilization). For comparison, we used the semantic principal components reported by Huth et al. (2012) from their WordNet-based encoding model; these “WordNet PCs” were taken directly from the published work and were not refit or reweighted using VALOR.”

      (3) In Study 4, the authors show that individuals whose superior parietal gyrus (SPG) exhibited high prediction distance had high fluid cognitive scores (Figure 4C). I had a hard time believing that this was a hypothesis-driven analysis. The authors motivate the analysis that "SPG and PCu have been strongly linked to fluid intelligence (line 304)". Did the authors conduct two analyses only-SPG-fluid intelligence and PCu-fluid intelligence-without relating other brain regions to other individual differences measures? Even if so, the authors should have reported the same r-value and p-value for PCu-fluid intelligence. If SPG-fluid intelligence indeed holds specificity in terms of statistical significance compared to all possible scenarios that were tested, is this rationally an expected result, and could the authors explain the specificity? Also, the authors should explain why they considered fluid intelligence to be the proxy of one's ability to anticipate upcoming scenes during movie watching. I would have understood the rationale better if the authors had at least aggregated predictive scores for all brain regions that held significance into one summary statistic and found a significant correlation with the fluid intelligence measure.

      We thank the reviewer for this careful and constructive comment and agree that greater transparency about analytic intent, specificity, and rationale is needed. We have revised the manuscript accordingly.

      (1) Analytic scope and a priori restriction. The analysis in Fig. 4C was hypothesis-driven and restricted a priori to two regions — superior parietal gyrus (SPG) and precuneus (PCu) — based on convergent evidence linking frontoparietal and medial parietal systems to fluid reasoning, relational integration, and domain-general cognitive control. Importantly, we did not conduct a whole-brain search across regions or behaviors to identify the strongest correlation post hoc.

      (2) Specificity and reporting. In response to the reviewer’s request, we now report the full results for both hypothesized regions. Prediction horizon in SPG showed a statistically reliable association with fluid intelligence, whereas PCu showed a positive but weaker trend that did not survive correction. Reporting both results makes the regional specificity explicit rather than implicit.

      (3) Why SPG over PCu? Although both regions are implicated in fluid cognition, SPG has been more consistently linked to active maintenance and manipulation of relational structure and top-down attentional control, whereas PCu is more often associated with internally oriented and mnemonic processes. We therefore interpret the stronger SPG association as consistent with a role for sustained, externally driven predictive processing during continuous perception, rather than as evidence of exclusivity.

      (4) Why fluid intelligence? We do not equate fluid intelligence with “anticipation” per se. Rather, we used gF as an a priori proxy for domain-general capacities — maintaining and updating relational context over multi-second windows, integrating multiple constraints, and exerting flexible control — that are plausibly recruited when anticipating upcoming events during naturalistic narratives. The reported relationship is associative and hypothesis-consistent, not causal.

      (5) Why not aggregate across regions? We agree that aggregation could reveal more global relationships; however, our goal in this analysis was to test whether predictive timescales in theoretically motivated control regions relate to individual differences, rather than to maximize correlation by pooling heterogeneous regions. We now clarify this rationale in the Results.

      These clarifications and additional statistics have been incorporated in the revised Results section (p. 14).

      (On page 14) “Finally, we examined whether prediction horizons were linked to individual differences in cognition. We focused on fluid intelligence (gF) because gF is widely taken to index domain-general capacities such as maintaining and updating relational context over several seconds, integrating multiple constraints, and exerting flexible top-down control — functions that should support anticipating what will happen next in a continuous narrative. We targeted two parietal regions, the SPG and the PCu, which have both been repeatedly linked to gF and high-level cognitive control in the individual-differences literature 36,37. For each participant, we correlated fluid cognition scores with that participant’s average prediction horizon in each region. As shown in Fig. 4c, individuals with longer prediction horizons in SPG showed higher fluid cognition scores (SPG: r = 0.172, FDR-corrected p = 0.047). PCu showed a similar positive trend (PCu: r = 0.111, FDR-corrected p = 0.146) but did not reach significance. These associations suggest that the ability to sustain a longer predictive timescale during naturalistic perception co-varies with broader fluid cognitive capacity. No additional brain regions or behavioral measures were examined in this analysis.”

      Reviewer #3 (Public review):

      In this work, the authors aim to improve neural encoding models for naturalistic video stimuli by integrating temporally aligned multimodal features derived from a deep learning model (VALOR) to predict fMRI responses during movie viewing.

      Strengths:

      The major strength of the study lies in its systematic comparison across unimodal and multimodal models using large-scale, high-resolution fMRI datasets. The VALOR model demonstrates improved predictive accuracy and cross-dataset generalization. The model also reveals inherent semantic dimensions of cortical organization and can be used to evaluate the integration timescale of predictive coding.

      This study demonstrates the utility of modern multimodal pretrained models for improving brain encoding in naturalistic contexts. While not conceptually novel, the application is technically sound, and the data and modeling pipeline may serve as a valuable benchmark for future studies.

      (1) Lines 95-96: The authors claim that "cortical areas share a common space," citing references [22-24]. However, these references primarily support the notion that different modalities or representations can be aligned in a common embedding space from a modeling perspective, rather than providing direct evidence that cortical areas themselves are aligned in a shared neural representational space.

      We thank the reviewer for this important clarification. We agree that the cited works do not provide direct evidence that cortical areas themselves are aligned in a single neural representational space. Rather, they demonstrate that representations derived from different modalities can be mapped into a shared embedding space from a modeling and computational perspective.

      We have therefore revised the text to avoid overstatement and to more precisely reflect what these studies support. In the revised manuscript (p. 4), we now frame the claim in terms of a shared representational framework or feature space used for modeling, rather than implying that cortical areas themselves intrinsically share a unified neural space. This clarification aligns the conceptual claim with the scope of the cited literature.

      (On page 4) “As a result, researchers are turning to multimodal deep learning, which learns from visual, linguistic, and auditory streams to model complex brain functions. This trend is supported by neuroscience evidence that cortical responses across regions can be jointly modeled within a common representational space.”

      (2) The authors discuss semantic annotation as if it is still a critical component of encoding models. However, recent advances in AI-based encoding methods rely on features derived from large-scale pretrained models (e.g., CLIP, GPT), which automatically capture semantic structure without requiring explicit annotation. While the manuscript does not systematically address this transition, it is important to clarify that the use of such pretrained models is now standard in the field and should not be positioned as an innovation of the present work. Additionally, the citation of Huth et al. (2012, Neuron) to justify the use of WordNet-based annotation omits the important methodological shift in Huth et al. (2016, Nature), which moved away from manual semantic labeling altogether. Since the 2012 dataset is used primarily to enable comparison in study 3, the emphasis should not be placed on reiterating the disadvantages of semantic annotation, which have already been addressed in prior work. Instead, the manuscript's strength lies in its direct comparison between data-driven feature representations and semantic annotation based on WordNet categories. The authors should place greater emphasis on analyzing and discussing the differences revealed by these two approaches, rather than focusing mainly on the general advantage of automated semantic mapping.

      Thank you for this thoughtful and constructive comment. We agree with the reviewer that the field has largely transitioned away from manual semantic annotation toward features derived from large-scale pretrained models (e.g., CLIP, GPT-style architectures), and that this shift is now standard rather than a novelty of the present work.

      We have revised the manuscript to clarify this positioning. Our goal is not to claim automated semantic extraction as an innovation, but rather to demonstrate how a multimodal, temporally informed video–text model can be used as a direct feature space for voxel-wise encoding of naturalistic movie fMRI data. VALOR is used as a representative example of this broader class of pretrained models, and our emphasis is on the general modeling approach rather than on promoting a specific architecture.

      We also agree that our original discussion underemphasized the important methodological shift introduced in Huth et al. (2016, Nature), which moved away from manual semantic labeling in the context of continuous spoken narratives. We now explicitly acknowledge this work and clarify that our use of WordNet-based annotations from Huth et al. (2012) serves a different purpose: it provides an interpretable, historically grounded benchmark for comparison in Study 3, rather than a claim that semantic annotation remains necessary or state-of-the-art.

      In response to the reviewer’s suggestion, we have revised the Results (p.10) and Discussion (p.18) to place greater emphasis on what is revealed by directly comparing data-driven multimodal features with category-based semantic annotation under matched conditions. Specifically, we focus on how these two approaches converge at the level of large-scale semantic organization while differing in their flexibility, temporal resolution, and dependence on human-defined categories. These revisions better reflect the current state of the field and sharpen the manuscript’s central contribution as a principled comparison between modeling approaches, rather than a general argument for automated semantic mapping.

      (On page 10) “Study 3: Comparing data-driven multimodal representations with category-based semantic annotation

      A central question in naturalistic encoding is how data-driven feature representations derived from pretrained models relate to more interpretable, category-based semantic annotations that have historically been used to study cortical semantic organization. Although recent work has shown that pretrained language and vision–language models can capture semantic structure without explicit annotation, category-based approaches such as WordNet remain valuable as interpretable reference frameworks. Here, we leverage the WordNet-based semantic components reported by Huth et al. (2012) 5 not as a state-of-the-art alternative, but as a historically grounded benchmark, allowing a controlled comparison between data-driven multimodal representations and manually defined semantic categories under matched naturalistic movie stimuli.”

      (On page 18) “Study 3 demonstrates the utility of video–text alignment models for probing higher-order semantic representations during naturalistic perception. Our comparison between VALOR-derived representations and WordNet-based semantic components highlights an important distinction between data-driven and category-based approaches to modeling meaning in the brain. While multimodal pretrained models offer flexible, high-dimensional representations that capture semantic structure without explicit annotation, category-based frameworks provide interpretability and theoretical anchoring 4,48. Using WordNet-based labeling from prior work as an interpretable reference point, we show that VALOR automatically extracts semantic dimensions—including mobility, sociality, and civilization—that closely mirror those identified using manual semantic categories (Fig. 3). The observed alignment between VALOR PCs and WordNet semantic components suggests that large-scale semantic organization emerges consistently across these approaches, even though they differ in how semantic structure is defined and learned. This convergence supports the use of pretrained multimodal models as practical encoding tools for naturalistic stimuli, while also underscoring the continued value of interpretable semantic benchmarks for understanding which aspects of meaning are represented across cortex. We do not argue that semantic annotation is required for modern encoding models; rather, WordNet-based features serve here as a historically grounded and interpretable reference for contextualizing data-driven multimodal representations.”

      (3) The authors use subject-specific encoding models trained on the HCP dataset to predict group-level mean responses in an independent in-house dataset. While this analysis is framed as testing model generalization, it is important to clarify that it is not assessing traditional out-of-distribution (OOD) generalization, where the same subject is tested on novel stimuli, but rather evaluating which encoding model's feature space contains more stimulus-specific and cross-subject-consistent information that can transfer across datasets.

      We thank the reviewer for this helpful clarification and agree that the type of generalization tested here should be described more precisely. Our analysis does not assess classical within-subject out-of-distribution (OOD) generalization, in which the same individual is tested on novel stimuli.

      Instead, for each HCP participant we train a subject-specific encoding model and transfer it to predict group-mean responses in an independent in-house dataset collected at a different site, with different participants, different movies, and different acquisition conditions. This design evaluates which encoding model’s feature space contains stimulus-locked representations that are consistent across individuals and robust to changes in dataset and experimental context, rather than within-subject stimulus novelty per se.

      We have revised the Results (p. 10) and Discussion section (p. 17) to explicitly describe this analysis as a test of cross-subject and cross-dataset transferability of stimulus representations, and to clarify the distinction from traditional OOD generalization.

      (On Page 10) “Although this analysis is not a classical within-subject out-of-distribution generalization test, it evaluates the extent to which different feature spaces capture stimulus-locked representations that are consistent across subjects and transferable across datasets, stimuli, and acquisition environments.”

      (On Page 17) “By contrast, VALOR exhibited stronger generalization in a cross-cohort, cross-stimulus, and cross-site transfer evaluation.”

      (4) Within this setup, the finding that VALOR outperforms CLIP, AlexNet, and WordNet is somewhat expected. VALOR encodes rich spatiotemporal information from videos, making it more aligned with movie-based neural responses. CLIP and AlexNet are static image-based models and thus lack temporal context, while WordNet only provides coarse categorical labels with no stimulus-specific detail. Therefore, the results primarily reflect the advantage of temporally-aware features in capturing shared neural dynamics, rather than revealing surprising model generalization. A direct comparison to pure video-based models, such as Video Swin Transformers or other more recent video models, would help strengthen the argument.

      We thank the reviewer for this baseline-focused comment and agree that, in naturalistic movie paradigms, a temporally structured audiovisual model would be expected to outperform static or unimodal feature spaces. Our intent in this comparison is therefore not to claim a surprising advantage, but to isolate which inductive biases matter for cross-dataset transfer of movie-evoked neural responses.

      The baseline models were chosen deliberately to span feature spaces that are widely used and interpretable in cognitive neuroscience: AlexNet (vision-only, frame-based), WordNet (human-defined semantic categories without learned visual features), and CLIP (static image–text alignment without temporal context). Comparing VALOR against these established baselines under matched preprocessing, TR alignment, and dimensionality control allows us to attribute performance differences specifically to temporal integration and audiovisual alignment, rather than to generic model capacity.

      We agree that a direct comparison with purely visual spatiotemporal encoders (e.g., Video Swin or TimeSformer-style models) would further dissociate the contribution of temporal visual processing from cross-modal video–text alignment. We now explicitly note this as an important direction for future work and frame VALOR as one representative of a broader class of multimodal video models, rather than as a uniquely optimal solution (Discussion, p. 16).

      (On page 16) “Second, we did not directly compare VALOR to state-of-the-art video-only spatiotemporal models (e.g., Video Swin Transformer, VideoMAE, and related architectures) that are designed to capture temporal visual structure without language grounding; such comparisons will be important for isolating the specific contributions of temporal visual processing versus cross-modal video–text alignment in naturalistic neural responses.”

      (5) Moreover, while WordNet-based encoding models perform reasonably well within-subject in the HCP dataset, their generalization to group-level responses in the Short Fun Movies (SFM) dataset is markedly poorer. This could indicate that these models capture a considerable amount of subject-specific variance, which fails to translate to consistent group-level activity. This observation highlights the importance of distinguishing between encoding models that capture stimulus-driven representations and those that overfit to individual heterogeneities.

      Thank you for this thoughtful observation. We agree with the reviewer’s interpretation. In our analyses, WordNet-based models perform reasonably well when fit and evaluated within individual HCP participants, but their performance degrades substantially when transferred to predict group-averaged responses in the independent SFM dataset. This dissociation suggests that, while WordNet annotations capture meaningful variance at the individual level, a larger fraction of that variance may be subject-specific or idiosyncratic, and therefore does not translate into consistent, stimulus-locked responses at the group level.

      One motivation for our cross-dataset, cross-subject evaluation is precisely to distinguish encoding models that primarily capture shared stimulus-driven structure from those whose apparent performance depends more strongly on individual heterogeneity. In this context, the reduced transferability of WordNet-based models highlights a potential limitation of category-based semantic features for capturing population-consistent neural dynamics during naturalistic viewing.

      We note that this effect likely reflects multiple factors rather than a single failure mode, including differences in annotation schemes, labeling granularity, and semantic coverage across datasets. By contrast, video–text models provide time-aligned linguistic features directly from the stimulus itself, reducing reliance on dataset-specific human annotation and exhibiting stronger transfer across cohorts. We have clarified this interpretation in the revised Discussion (p. 17).

      (Page 17) “Together, these findings underscore the importance of distinguishing encoding models that primarily capture shared, stimulus-driven neural structure from those whose performance relies more heavily on subject-specific heterogeneity, particularly when evaluating generalization across participants and datasets.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) In the Methods section, please clarify which specific layer of VALOR the 512-dimensional feature vector was extracted from.

      Thank you for this suggestion. We have revised the Methods to state explicitly that the 512-dimensional feature vector is extracted from VALOR’s joint video–text projection head, i.e., the final projection layer of the contrastive alignment module that maps video and text representations into a shared embedding space. We also clarify that these 512-D embeddings are computed at the segment/TR level and then time-aligned to the BOLD signal (Methods, p. 21).

      (On page 21) “We segmented each movie at the TR level and, for each segment, extracted VALOR’s projected video–text embedding from the final projection head of the alignment module to obtain a 512-dimensional feature vector. These embeddings were then time-aligned to the corresponding BOLD responses.”

      (2) It would be helpful to include more detailed descriptions of the network architectures and parameters for all models used.

      Thank you for the suggestion. We have revised the Methods to include model-specific subsections for all feature spaces used (VALOR, CLIP, AlexNet, and WordNet). For each model, we now explicitly report (i) the backbone architecture and training objective, (ii) the exact feature source (layer or projection head) and output dimensionality, and (iii) how features were temporally aligned to the BOLD signal. All models were used with their publicly released pretrained parameters, without additional fine-tuning. These additions are intended to improve transparency and reproducibility (Methods, p. 21).

      (On page 21) “Movie Feature Extraction

      (1) Video–text alignment features (VALOR): To extract video-based multimodal features, we used VALOR (VALOR-large checkpoint), an open-source pretrained video–text alignment model24. VALOR combines visual encoders (CLIP and Video Swin Transformer) for extracting visual features and a text encoder (BERT) for extracting textual features 23,51,52. These representations are aligned in a shared embedding space through contrastive learning. We segmented each movie at the TR level and, for each segment, extracted VALOR’s projected video–text embedding from the final projection head of the alignment module to obtain a 512-dimensional feature vector. These embeddings were then time-aligned to the corresponding BOLD responses.

      (2) CLIP features: To compare with static image-based multimodal models, we utilized CLIP (ViT-B/32), which aligns visual and textual representations through contrastive learning but processes individual frames independently without capturing temporal context. One video frame was sampled per TR, and the pooled image embedding after CLIP’s projection into the shared image–text space was extracted to obtain a 512-dimensional feature vector. These TR-aligned vectors were used directly as regressors in the voxel-wise encoding models.

      (3) AlexNet features: Visual features were extracted by sampling frames at the TR level and processing them with AlexNet, an eight-layer convolutional neural network comprising five convolutional layers followed by three fully connected layers. Features from all five convolutional layers were evaluated in preliminary analyses; the fifth convolutional layer showed the best performance and was used in subsequent analyses. Intra-image z-score normalization was applied to reduce amplitude effects. Principal component analysis (PCA) was used to reduce dimensionality, retaining the top 512 components to match the dimensionality of multimodal feature spaces. This pipeline was implemented using the DNNBrain toolkit 53.

      (4) WordNet features: Semantic features were obtained from publicly available WordNet annotations provided with the HCP dataset (7T_movie_resources/WordNetFeatures.hdf5), following the procedure of Huth et al. (2012). Throughout this manuscript, we use the term “semantic features” to refer to such human-annotated, category-based representations of scene content, and we reserve the term “linguistic features” for continuous language embeddings derived automatically from pretrained language or vision–language models. Each second of the movie clips was manually annotated with WordNet categories according to predefined guidelines: (a) identifying clear objects and actions in the scene; (b) labeling categories that dominated for more than half of the segment duration; and (c) using specific category labels rather than general ones. A semantic feature matrix was constructed with rows corresponding to time points and columns to semantic categories, with category presence coded as binary values. More specific categories from the WordNet hierarchy were added to each labeled category, yielding a total of 859 semantic features. These features were used directly as regressors. We also evaluated a PCA-reduced 512-dimensional variant (fit within each training fold to avoid leakage); because this version performed slightly worse, we report results from the full 859-dimensional representation in the main text. For the generalization analysis in Study 2, annotations for the SFM dataset were aligned to the same WordNet category space to ensure consistency.”

      (3) In Figure 3, consider following Huth et al.'s approach by using 3-4 distinct colors to visualize semantic representations across the cortical surface more clearly.

      Thank you for this excellent suggestion. We have generated an alternative visualization using a discrete 3–4 color scheme following Huth et al. to display the semantic components on the cortical surface. This version makes the spatial correspondence between components and the boundaries between cortical territories easier to see. We now include this visualization in the Supplement (Fig. S3)

      (4) In Figure 2, the brain renderings are too small. Please consider creating a separate, enlarged figure with clearer delineation of relevant ROIs.

      We appreciate this suggestion and agree that clear delineation of ROIs is important. We evaluated larger brain renderings; however, within the multi-panel layout of Fig. 2, enlarging them compressed accompanying plots/legends and introduced visual crowding, which reduced overall readability. To preserve a balanced layout and consistent typography across panels, we have kept the current rendering size in the main text and added Fig. S4 with enlarged brain renderings showing clearer ROI boundaries for the same ROIs.

      Reviewer #2 (Recommendations for the authors):

      (1) From the introduction, I feel like naïve readers would have a hard time understanding what semantic models (e.g., WordNet) are, which the authors write are based on "labor-intensive and subjective manual annotation of semantic content". It would be straightforward to explain the process-how scientists have written descriptions or denoted categories of what's happening within a TR and transformed these into embedding vectors based on language models. This description would explain what the authors mean by "labor-intensive, time-consuming, and subjective". Related to this point, the authors seem to be using the words "semantic model/feature" and "linguistic model/feature" interchangeably, which may exacerbate the confusion.

      Thank you for this helpful suggestion. We agree that naïve readers would benefit from a clearer explanation of how “semantic” models such as WordNet are constructed and from a more precise distinction between semantic and linguistic features.

      In response, we expanded the Introduction (p. 3) to explicitly describe the process by which semantic features are generated via dense human annotation (i.e., raters label objects, actions, and events within each TR and map these labels onto a predefined ontology to form feature vectors), clarifying why this approach is labor-intensive, time-consuming, and subject to rater variability.

      To avoid disrupting the conceptual flow of the Introduction, we placed the explicit terminology clarification in the Methods section (p. 22), where feature extraction is described. There, we now define semantic features as human-annotated, category-based representations of scene content, and linguistic features as continuous language embeddings derived automatically from pretrained language or vision–language models. These revisions are intended to improve clarity and consistency for both expert and non-expert readers.

      (On page 3) “Critically, semantic models often rely on dense human annotation. In early naturalistic encoding studies, trained raters watched the stimulus and labeled what was happening within each TR or short time window—for example, identifying objects, actions, or events present in the scene. These labels were then mapped onto a predefined semantic ontology (such as WordNet), yielding high-dimensional categorical feature vectors that served as regressors in encoding models. While this approach provides interpretable semantic features, it is labor-intensive, time-consuming, and inherently subjective, as annotations depend on rater judgment, labeling guidelines, and dataset-specific conventions, limiting scalability and reproducibility.”

      (On page 22) “Throughout this manuscript, we use the term “semantic features” to refer to such human-annotated, category-based representations of scene content, and we reserve the term “linguistic features” for continuous language embeddings derived automatically from pretrained language or vision–language models.”

      (2) Figure 1A does not look like an accurate schematic of the encoding method. For example, shouldn't the "Train" give rise to weight matrices, and Movies come from moments at Test? I would appreciate it if this schematic figure would explain what the encoding model is to naïve readers.

      (3) Figure 1B emphasizes that VALOR is utilizing multimodal features, but does not emphasize that the model is trained on dynamic video. The current figure looks like the model extracted visual and linguistic features from a screenshot of the video, much like the CLIP model.

      Thank you for this helpful comment. We agree that the original Fig. 1A did not sufficiently clarify what is learned during training versus what is applied during testing, and that this distinction is particularly important for naïve readers unfamiliar with encoding models. We also agree that the original Fig. 1B did not sufficiently emphasize that VALOR is trained on dynamic video segments, and that the schematic could be misinterpreted as aligning a single video frame with text, similar to CLIP-style image–text models.

      We have revised Fig. 1A (p. 6) to make the encoding procedure explicit and pedagogical. Specifically, we now clearly depict that, during the training phase (HCP dataset), voxel-wise encoding models learn feature-to-voxel weight matrices from stimulus features and BOLD responses. These learned weights are explicitly labeled as voxel-wise weight matrices and visually associated with the training stage. In the testing/generalization phase (SFM dataset), we now indicate that these learned weights are held fixed and applied to features extracted from novel movies to generate predicted BOLD responses. Additional labels were added to distinguish “Training (learn weights)” from “Testing/Transfer (apply fixed weights)” and to clarify that the encoding model implements a linear mapping from stimulus features to voxel responses. We have also rewritten the Fig. 1 legend (p. 6) to explicitly explain the encoding workflow in words, including (i) the learning of voxel-specific weights during training, (ii) their reuse during cross-dataset transfer, and (iii) how generalization performance is evaluated. These changes are intended to ensure that Fig. 1A accurately reflects the encoding methodology and is understandable to readers without prior experience with encoding models.

      We have revised Fig. 1B (p. 6) to explicitly highlight the temporal nature of the video input used by VALOR. In the updated schematic, the visual stream is depicted as a sequence of consecutive frames spanning multiple seconds, grouped into a video segment, rather than as a single static image. Additional labels indicate that VALOR encodes temporally extended video clips and aligns them with corresponding textual descriptions in a shared embedding space via contrastive learning. We have also updated the figure legend (p. 6) to clarify that VALOR operates on multi-frame video segments and explicitly models temporal structure, distinguishing it from static image–text models such as CLIP. These changes are intended to make clear that VALOR’s advantage derives not only from multimodality, but also from learning representations over time.

      (4) Regarding Figure 2, why were paired t-tests conducted in one-sided comparisons? Shouldn't this be two-sided, given that there is no reason to assume one is higher or lower than another?

      Thank you for raising this point. We agree that, in the absence of a preregistered directional hypothesis, paired comparisons should be evaluated using two-sided statistical tests.

      In response, we have re-run all paired comparisons reported in Figure 2 (p. 9) using two-sided paired t-tests, recomputed the corresponding p-values and false discovery rate (FDR) corrections, and updated the significance markers in the figure and captions accordingly. Importantly, this change does not alter the qualitative pattern of results or the main conclusions reported in the manuscript.

      (5) Regarding Study 4, I am curious whether the results are specific to forward-looking representations (predictive coding) or whether the results broadly reveal regions that are sensitive to contexts. For example, if the authors were to incorporate nearby past scenes in the analysis rather than the nearby future scenes, would different brain regions light up?

      Thank you for this thoughtful question. We agree that it is important to distinguish forward-looking (predictive) representations from more general sensitivity to temporal context. In Study 4, we deliberately operationalized prediction using future-aligned features, such that only information from upcoming scenes was incorporated into the encoding model. Accordingly, the reported effects should be interpreted as reflecting forward-oriented representations rather than generic context sensitivity.

      To make this interpretive scope explicit, we have added a clarifying sentence at the beginning of the Study 4 paragraph in the Discussion (p.18), noting that our analysis incorporates only future-aligned features and that directly contrasting past- and future-aligned features will be an important direction for future work. This clarification is intended to clearly bound our claims while addressing the reviewer’s conceptual distinction..

      (On page 18) “In Study 4, we used a video-text alignment model to investigate predictive coding mechanisms. Because our analysis incorporates only future-aligned features, the reported effects should be interpreted as reflecting forward-oriented representations rather than generic sensitivity to temporal context; directly contrasting past- and future-aligned features will be an important direction for future work.”

      (6) In the paragraph starting in line 447, were WordNet feature time series also reduced to 512 dimensions like the rest of the model features?

      Thank you for the question. In the main analyses, WordNet feature time series were not reduced to 512 dimensions and were instead used at their full dimensionality (859 features).

      For comparability with the other feature spaces, we additionally conducted a control analysis in which WordNet features were reduced to 512 dimensions using PCA. The PCA was fit within each training fold to avoid information leakage, and the resulting 512-D features were evaluated using the same encoding pipeline. This PCA-reduced version performed slightly worse than the full 859-D WordNet representation. Accordingly, we report results from the full 859-D WordNet features in the main text. We have clarified this point in the Methods section (p. 22).

      (On page 22) “We also evaluated a PCA-reduced 512-dimensional variant (fit within each training fold to avoid leakage); because this version performed slightly worse, we report results from the full 859-dimensional representation in the main text.”

      (7) I don't think authors have written what VALOR stands for.

      Thank you for the reminder. We now define the VALOR acronym at its first mention in the Abstract and Introduction and use the abbreviation thereafter.

      (On page 2) “Using a state-of-the-art deep learning model (VALOR; Vision-Audio-Language Omni-peRception)”

      (On page 5) “To answer this, we apply a video-text alignment encoding framework, using VALOR (Vision-Audio-Language Omni-peRception)—a high-performing, open-source model that aligns visual and linguistic features over time—to predict brain responses during movie watching.”

      (8) When calculating equation (3), please make sure that the correlation values are Fisher's r-to-z transformed.

      Thank you for this reminder. We confirm that all correlation coefficients used in Equation (3) are now Fisher r-to-z transformed prior to any averaging, contrasts, or statistical testing, and this procedure is now explicitly stated in the Methods. We have also updated Fig. 4a (p. 15) to reflect this transformation. Importantly, applying the r-to-z transformation does not change the qualitative pattern of results or their statistical significance.

      (9) I wasn't able to check the OSF data/codes because it required permission.

      Thank you for flagging this, and we apologize for the inconvenience. We have removed the permission restriction and set the OSF repository to public read-only access, which should resolve the issue.

      Reviewer #3 (Recommendations for the authors):

      (1) The current approach extracts features from a single "best" layer of each model, which may be suboptimal for predicting neural responses. Prior work has shown that combining features across multiple layers through optimized fusion strategies (e.g., St-Yves et al., 2023) or using model ensembles (e.g., Li et al., 2024) can substantially improve encoding performance. The authors may consider these more comprehensive approaches either as additional baselines or as alternative directions to enhance model accuracy.

      Thank you for this constructive suggestion. We agree that combining features across multiple layers or using optimized fusion and ensemble strategies, as demonstrated in recent work (e.g., St-Yves et al., 2023; Li et al., 2024), can substantially improve absolute encoding performance.

      In the present study, however, we intentionally evaluated each model using its single best-performing layer within a matched encoding pipeline. This design choice was made to maintain model-agnostic comparability and interpretability, and to ensure that performance differences could be attributed primarily to the type of representation (e.g., temporally informed video–text features versus static or unimodal features), rather than to differences in model complexity, parameter count, or fusion strategy. Importantly, this constraint was applied uniformly across all models and therefore does not favor VALOR over the baselines.

      We now explicitly note in the Discussion (p. 19) that multilayer fusion and ensemble approaches represent a natural and promising extension of our framework and are likely to further improve absolute prediction accuracy. Our goal in the current work was to establish the practical utility and generalizability of temporally aligned video–text features for naturalistic movie fMRI under a controlled and comparable evaluation setting..

      (On page 19) “Third, for comparability across models we evaluated each model using its single best-performing layer within a matched encoding pipeline rather than using multilayer fusion or ensembling, which allowed us to attribute performance differences to representational format but likely underestimates the absolute performance ceiling.”

      (2) Given the naturalistic video-based task, the manuscript would benefit from including state-of-the-art video-only models (e.g., Video Swin Transformer, VideoMAE, and other more recent architectures) as explicit baselines. These models are designed to capture spatiotemporal structure without relying on language input and would provide a more targeted comparison to assess the specific contribution of temporal visual processing.

      Thank you for this thoughtful suggestion. We agree that state-of-the-art video-only spatiotemporal models (e.g., Video Swin Transformer, VideoMAE) are highly relevant baselines for naturalistic movie paradigms and would provide a more targeted comparison for isolating the contribution of temporal visual processing independent of language input.

      In the present study, our primary goal was not to exhaustively benchmark all possible video architectures, but to evaluate whether temporally informed video–text features can serve as a practical and general-purpose encoding framework that improves upon the models most commonly used in cognitive neuroscience for naturalistic fMRI (e.g., AlexNet for vision, WordNet for semantic annotation, and CLIP for static multimodal alignment). Using these established baselines allowed us to place our results in direct continuity with prior neuroimaging work and to attribute performance differences to representational format under a controlled encoding pipeline.

      We agree that incorporating modern video-only spatiotemporal encoders is an important next step, particularly for disentangling the relative contributions of temporal visual structure and cross-modal video–text alignment. We now explicitly note this point in the Discussion (p.19) as a limitation and future direction, and view such comparisons as a natural extension of the current framework within the same TR-aligned encoding setup.

      (On page 19) “Second, we did not directly compare VALOR to state-of-the-art video-only spatiotemporal models (e.g., Video Swin Transformer, VideoMAE, and related architectures) that are designed to capture temporal visual structure without language grounding; such comparisons will be important for isolating the specific contributions of temporal visual processing versus cross-modal video–text alignment in naturalistic neural responses.”

      (3) An additional consideration is the scale of the AI models used for feature extraction. Previous studies (e.g., Matsuyama et al., 2023) have indicated that model size - particularly the number of parameters - can influence neural prediction performance, independently of architecture. A discussion or analysis of how model size contributes to the observed encoding gains would help clarify whether improvements are due to the representational quality of the model or simply its scale

      Thank you for this important point. We agree that model scale—particularly parameter count—can influence neural prediction performance independently of architecture, as noted in prior work (e.g., Matsuyama et al., 2023).

      In the present study, our primary goal was to evaluate whether temporally informed video–text representations provide practical advantages over unimodal and static multimodal baselines that are widely used in cognitive neuroscience for naturalistic movie fMRI, under a matched encoding pipeline. We did not perform a systematic scale-controlled analysis in this revision because doing so would require training or evaluating multiple size-matched variants across video-only and video–text architectures, which is beyond the scope of the current work.

      We therefore agree that part of the observed performance gains may reflect model capacity in addition to representational format, and we caution against attributing all improvements solely to cross-modal alignment or temporal structure. We now explicitly acknowledge this limitation in the Discussion and note that comparing size-matched video-only and video–text models within the same pipeline is an important next step for disentangling model scale from representational content.

      (On page 19) “Finally, part of VALOR’s advantage may reflect model capacity: larger pretrained models often yield higher encoding accuracy, so repeating these analyses with size-matched image-only and image–text models will be critical for disentangling model scale from representational content.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In the current study, Huang et al. examined ACC response during a novel discrimination-avoid task. The authors concluded that ACC neurons primarily encode post-action variables over extended periods, reflecting the animal's preceding actions rather than the outcomes or values of those actions. Specifically, they identified two subgroups of ACC neurons that responded to different aspects of the actions. This work represents admirable efforts to investigate the role of ACC in task-performing mice. However, in my opinion, alternative explanations of the data were not sufficiently explored, and some key findings were not well supported.

      Strengths:

      The development of the new discrimination-avoid task is applauded. Single-unit electrophysiology in task-performing animals represents admirable efforts and the datasets are valuable. The identification of different groups of encoding neurons in ACC can be potentially important.

      Weaknesses:

      One major conclusion is that ACC primarily encodes the so-called post-action variables (specifically shuttle crossing). However, only a single example session was included in Figure 2, while in Supplementary Figure 2 a considerable fraction of ACC neurons appears to respond to either the onset of movement or ramp up their activity prior to movement onset. How did the authors reach the conclusion that ACC preferentially respond to shuttle crossing?

      We now include more example sessions and the main results from individual animals (Fig. 3; Figs. S2–S3; Fig. 8). Overall, the results are consistent across recording sessions and animals.

      While shuttle crossings were the primary reference for most analysis, using shuttle initiation as a reference led to similar conclusions (Fig.4). Namely, we found that most ACC neurons exhibit either robust (22%; Types 1a & 2a) or moderate (51%; Types 1b & 2b) post-shuttle activity changes (Fig.4), while only a subset exhibits ramping pre-shuttle activity (16%; Types 3b & 3c). Therefore, our conclusion was intended to highlight the role of post-shuttle activity in learning. While we do not exclude the possibility that pre-shuttle ACC activity contributes to learning, its involvement is likely more limited.

      In Figure 4, it was concluded that ACC neurons respond to action independent of outcome. Since these neurons are active on both correct and incorrect shuttle but not stay trials, they seem to primarily respond to overt movement. If so, the rationale for linking ACC activity and adaptive behavior/ associative learning is not very clear to me. Further analyses are needed to test whether their firing rates correlated with locomotion speed or acceleration/deceleration. On a similar note, to what extent are the action state neurons actually responding to locomotion-related signals? And can ACC activity actually differentiate correct vs. incorrect stays?

      In this study, we highlight two distinct groups of ACC neurons: action-state and action-content neurons. Both groups of neurons tend to show sustained activity even when the animals remain immobile after completing shuttle behaviors, suggesting that their activity is not directly driven by locomotion. Furthermore, action-content neurons are selectively engaged in only one of the two shuttle categories, either rooms A→B or B→A shuttles. Therefore, differences in neuronal activity are unlikely to reflect locomotor differences, given that both shuttle types involve similar movement patterns. Finally, we analyzed ACC neuronal activity in relation to locomotion speed. Our results indicate that only a small fraction of neurons (<15%) show speed-correlated activity (Fig.5), suggesting that most ACC neurons do not encode movement-related information. Taken together, these findings support the distinction between ACC activity and locomotion encoding.

      As for the small subset of speed-related neurons, it remains unclear whether these speed-related neurons represent a distinct subpopulation within the ACC or reflect recordings from the nearby motor cortex. Postmortem examination of the recording sites suggests that most neurons were recorded from the ACC, while a small subset may be located at the border between the ACC and motor cortex (Fig. S2). Therefore, it is possible that the small fraction of speed-related neurons originated from the motor cortex.

      Lastly, given that the ACC neurons display no or limited activity during stay trials, their activity generally does not differentiate correct vs. incorrect stays (Fig.S7). However, ACC activity does show moderate differentiation between room-A vs. room-B stays (Fig.S7).

      Given that a considerable amount of ACC neurons encode 'action content', it is not surprising that by including all neurons the model is able to make accurate predictions in Figure 6. How would the model performance change by removing the content neurons?

      We thank the reviewer for this thoughtful analysis idea. Excluding action-content neurons drastically reduces decoding accuracy (Fig.8), suggesting that they are the main drivers for differentiating rooms AB vs. BA shuttles.

      Moving on to Figure 7. Since Figure 4 showed that ACC neurons respond to movement regardless of outcome, it is somewhat puzzling how ACC activity can be linked to future performance.

      As discussed earlier (point #2), ACC activity does not simply reflect locomotion itself. We interpret the post-shuttle ACC activity as encoding both the preceding shuttle state (shuttle or stay) and shuttle content (rooms AB or BA). Regardless of the outcome (safety or shock), such encoding is essential for cue–action–outcome associative learning, because both positive and negative feedback can drive learning. The level of post-shuttle ACC activity may reflect task engagement, with greater engagement facilitating learning and improving future performance.

      Two mice contributed about 50% of all the recorded cells. How robust are the results when analyzing mouse by mouse?

      We have added further analysis of highlighting the results of each mouse. Although the total number of recorded neurons varied across mice, the major findings were consistent. In every mouse, we observed sustained post-shuttle ACC activity (Fig.S2), and population-level ACC activity reliably decoded shuttle contents (rooms AB vs. BA; Fig.8).

      Lastly, the development of the new discrimination-avoid task is applauded. However, a major missing piece here is to show the importance of ACC in this task and what aspects of this behavior require ACC.

      We appreciate this feedback. We are currently conducting additional experiments to determine whether inhibiting ACC activity during distinct time windows disrupts task learning. We hope to publish a follow-up paper on these findings in the near future.

      Reviewer #2 (Public review):

      Summary:

      The current dataset utilized a 2x2 factorial shuttle-escape task in combination with extracellular single-unit recording in the anterior cingulate cortex (ACC) of mice to determine ACC action coding. The contributions of neocortical signaling to action-outcome learning as assessed by behavioral tasks outside of the prototypical reward versus non-reward or punished vs non-punished is an important and relevant research topic, given that ACC plays a clear role in several human neurological and psychiatric conditions. The authors present useful findings regarding the role of ACC in action monitoring and learning. The core methods themselves - electrophysiology and behavior - are adequate; however, the analyses are incomplete since ruling out alternative explanations for neural activity, such as movement itself, requires substantial control analyses, and details on statistical methods are not clear.

      Strengths:

      (1) The factorial design nicely controls for sensory coding and value coding, since the same stimulus can signal different actions and values.

      (2) The figures are mostly well-presented, labeled, and easy to read.

      (3) Additional analyses, such as the 2.5/7.5s windows and place-field analysis, are nice to see and indicate that the authors were careful in their neural analyses.

      (4) The n-trial + 1 analysis where ACC activity was higher on trials that preceded correct responses is a nice addition, since it shows that ACC activity predicts future behavior, well before it happens.

      (5) The authors identified ACC neurons that fire to shuttle crossings in one direction or to crossings in both directions. This is very clear in the spike rasters and population-scaled color images. While other factors such as place fields, sensory input, and their integration can account for this activity, the authors discuss this and provide additional supplemental analyses.

      Weaknesses:

      (1) The behavioral data could use slightly more characterization, such as separating stay versus shuttle trials.

      We appreciate this feedback. In the revised manuscript, we present data separating stay versus shuttle trials (Fig.1). Additionally, we provide new data from extended training sessions (Fig.S2).

      (2) Some of the neural analyses could use the necessary and sufficient comparisons to strengthen the authors' claims.

      We have now used the necessary and sufficient comparisons where applicable. In the SVM decoding analysis, we show that population ACC activity is sufficient to decode AB or BA shuttles. We also show that excluding action-content, but not other ACC neurons, drastically reduces decoding accuracy, suggesting that these neurons are necessary for the decoding (Fig.8).

      (3) Many of the neural analyses seem to utilize long time windows, not leveraging the very real strength of recording spike times. Specifics on the exact neural activity binning/averaging, tests, classifier validation, and methods for quantification are difficult to find.

      We chose to perform our neural analyses on a longer time scale, given the sustained activity we see in the data. To further justify that decision, we now provide additional results highlighting the sustained activity of ACC neurons in our task (Fig.2; Fig.S2). Additionally, we now provide more specifics of the neural analyses in Methods section.

      (4) The neural analyses seem to suggest that ACC neurons encode one variable or the other, but are there any that multiplex? Given the overwhelming evidence of multiplexing in the ACC a bit more discussion of its presence or absence is warranted.

      This is an interesting point of discussion, and we thank the reviewer for pointing this out. Overall, our results suggest that individual ACC neurons preferentially engage in only one of the proposed functions, rather than multiplexing across them. For example, action-state and action-content ACC neurons primarily engage in action monitoring, but not in decision-making, planning, or outcome tracking. Nevertheless, we cannot rule out the possibility that other ACC neurons, through their distinct connectivity or location in different ACC subregions, engage in other proposed functions. Thus, when considering the ACC as a whole, its function may still be multiplexed.

      Another possible reason we do not see clear multiplexing of neurons may be due to the dynamic nature of our task. Unlike established tasks that often assign fixed positive or negative values to cues, the cues in our task are not inherently associated with valence. Instead, their meaning is dynamically determined by the animal’s location (context) at the time of cue presentation. Since values are not fixed and change based on context, value-related responses may not be reflected in the ACC in our tasks.

      We have now incorporated the above discussions into our revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      The authors record from the ACC during a task in which animals must switch contexts to avoid shock as instructed by a cue. As expected, they find neurons that encode context, with some encoding of actions prior to the context, and encoding of neurons post-action. The primary novelty of the task seems to be dynamically encoding action-outcome in a discrimination-avoidance domain, while this is traditionally done using operant methods. While I'm not sure that this task is all that novel, I can't recall this being applied to the frontal cortex before, and this extends the well-known action/context/post-context encoding of ACC to the discrimination-avoidance domain.

      While the analysis is well done, there are several points that I believe should be elaborated upon. First, I had questions about several details (see point 3 below). Second, I wonder why the authors downplayed the clear action coding of ACC ensembles. Third, I wonder if the purported 'novelty' of the task (which I'm not sure of) and pseudo-debate on ACC's role undermines the real novelty - action/context/outcome encoding of ACC in discrimination-avoidance and early learning.

      Strengths:

      Recording frontal cortical ensembles during this task is particularly novel, and the analyses are sophisticated. The task has the potential to generate elegant comparisons of action and outcome, and the analyses are sophisticated.

      Weaknesses:

      I had some questions that might help me understand this work better.

      (1) I wonder if the field would agree that there is a true 'debate' and 'controversy' about the ACC and conflict monitoring, or if this is a pseudodebate (Line 34). They cite 2 very old papers to support this point. I might reframe this in terms of the frontal cortex studying action-outcome associations in discrimination-avoidance, as the bulk of evidence in rodents comes from overtrained operant behavior, and in humans comes from high-level tasks, and humans are unlikely to get aversive stimuli such as shocks.

      We appreciate this feedback. We have revised the Introduction and Discussion.

      (2) Does the purported novelty of the task undermine the argument? While I don't have an exhaustive knowledge of this behavior, the novelty involves applying this ACC. There are many paradigms where a shock triggers some action that could be antecedents to this task.

      We argue our newly designed discrimination–avoidance task is unique for several reasons. First, it requires animals to discriminate both sensory cues and environment contexts. Unlike established tasks that often assign fixed positive or negative values to cues, the cues in our task are not inherently associated with valence. Instead, their meaning is dynamically determined by the animal’s location (context) at the time of cue presentation, which reflects a conceptual advance over previous techniques. Furthermore, by removing valence from the cues, this design helps disentangle the ACC’s potential role in value encoding from other cognitive functions.

      Second, this task involves robust, ethologically relevant actions (i.e., shuttles), unlike many established paradigms that rely on less naturalistic behaviors such as saccades or lever presses. We view this as a key distinction from prior approaches, as even previous paradigms that utilize shutting responses or other naturalistic responses, fail to incorporate dynamic integration of cues and contexts.

      Finally, the clear temporal separation between actions and outcomes further helps disentangle the ACC’s roles in action monitoring vs. outcome tracking.

      (3) The lack of details was confusing to me:

      (a) How many total mice? Are the same mice in all analyses? Are the same neurons? Which training day? Is it 4 mice in Figure 3? Five mice in line 382? An accounting of mice should be in the methods. All data points and figures should have the number of neurons and mice clearly indicated, along with a table. Without these details, it is challenging to interpret the findings.

      We are sorry for the confusion. We now provide additional details and clear N numbers for each analysis to improve clarity.

      (b) How many neurons are from which stage of training? In some figures, I see 325, in some ~350, and in S5/S2B, 370. The number of neurons should be clearly indicated in each figure, and perhaps a table.

      All data were obtained from well-trained mice. For some analyses, the N is smaller because certain task sessions contained very few incorrect trials (≤3), which prevented us from examining ACC activity during those trials. We have modified figure legend so that neuron count is clear.

      (c) Were the tetrodes driven deeper each day? The depth should be used as a regressor in all analyses?

      Yes, the tetrodes were driven slightly deeper across task sessions (~80 µm per step; 2–4 depths per mouse). Given limited depth changes, preliminary analyses indicate no clear differences in ACC activity across these recording depths. However, we cannot rule out potential dorsal–ventral subregion differences if recordings were to span larger depth ranges.

      (d) Was is really ACC (Figure 2A)? Some shanks are in M2? All electrodes from all mice need to be plotted as a main figure with the drive length indicated.

      We have now included a supplementary figure showing all recording sites (Fig.S2). It is likely that a small subset of neurons was recorded at the ACC/M2 border area. Unfortunately, we are unable to separate them out due to blind recording design of our tetrode arrays.

      (e) It's not clear which sessions and how many go into which analysis

      We have now specified the number of task sessions for each analysis (see Methods).

      (f) How many correct and incorrect trials (<7?) are there per session?

      We have now specified the number of correct and incorrect trials per session (see Methods).

      (g) Why 'up to 10 shocks' on line 358? What amplitudes were tried? What does scrambled mean?

      We decided to use up to 10 mild shocks per trial because mice do not necessarily shuttle to the safe room after one or even a few shocks during the early stages of training. This design allows mice to efficiently learn the concept of the task (i.e., one room is safe while the other delivers shocks). Each shock was specified in the Methods section as 0.5 mA, 0.1 s. A “scrambled shock” refers to an electric shock delivered through multiple floor bars in a randomized pattern, effectively preventing the animal from avoiding the stimulus.

      (4) Why do the authors downplay pre-action encoding? It is clearly evident in the PETHs, and the classifiers are above chance. It's not surprising that post-shuttle classification is so high because the behavior has occurred. This is most evident in Figure S2B, which likely should be a main figure.

      We did not intend to downplay pre-action encoding. Our analysis shows that most ACC neurons exhibit either robust (22%; Types 1a & 2a) or moderate (51%;Types 1b & 2b) post-shuttle activity changes (Fig.4). Although a subset of ACC neurons exhibits ramping pre-shuttle activity, they represent a much smaller fraction (16%; Types 3b & 3c). Therefore, our conclusion was intended to highlight the role of post-shuttle activity in learning. While we do not exclude the possibility that pre-shuttle ACC activity contributes to learning, its involvement is likely more limited

      (5) The statistics seem inappropriate. A linear mixed effects model accounting for between-mouse variance seems most appropriate. Statistical power or effect size is needed to interpret these results. This is important in analyses like Figure 7C or 6B.

      We appreciate this feedback. We now use appropriate statistics and report effect size.

      (6) Better behavioral details might help readers understand the task. These can be pulled from Figures S2 and S5. This is particularly important in a 'novel' task.

      We now provide more details to help better understand the task and have added new figures (Fig.1; Figs. S1&S2).

      (7) Can the authors put post-action encoding on the same classification accuracy axes as Figure 6B? It'd be useful to compare.

      We appreciate the comment, but we are unsure what clarification is being requested.

      (8) What limitations are there? I can think of several - number of animals, lack of causal manipulations, ACC in rodents and humans.

      We now include discussions on limitation of our study. One caveat of our study is that the discrimination–avoidance task requires weeks of training in mice. By the time they master the task, ACC activity may reflect modified neural circuits. Investigating ACC activity during early phase of learning, such as by introducing a new pair of cues or contexts, could provide further insights into ACC’s role in learning and cognitive processes. Additionally, a limitation of the current study is the lack of evidence for the causal role of post-action ACC activity in complex associative learning. Future investigations using closed-loop strategies to selectively disrupt ACC activity during the post-action phase could help address this question.

      Minor:

      (1) Each PCA analysis needs a scree plot to understand the variance explained.

      We have added a scree plot for each PCA analysis.

      (2) Figure 4C - y and x-axes have the same label?

      We have corrected the y-axis label.

      (3) What bin size do the authors use for machine learning (Not clear from line 416)?

      The bin sizes used were 2.5, 5, 7.5, or 10 sec which have now been discussed in the Methods section.

      (4) Why not just use PCA instead of 'dimension reduction' (of which there are many?)

      We have adjusted the phrasing where appropriate.

      (5) Would a video enhance understanding of the behavior?

      We appreciate this feedback. We now include a few videos to accompany our paper.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Is Figure 1C sufficiently powered?

      We have now included data from additional mice and updated the figure accordingly.

      (2) Task performance was not plateaued after 10 sessions in Figure 1B. How variable is task performance in the datasets with ephys recordings (session to session, mouse to mouse).

      We have now included additional data from extended training (15 sessions; Fig.S2). Moderate variations across both sessions and mice are observed. Specifically, the total number of correct/incorrect shuttles used for ephys analysis are 19/5, 19/4, 21/5, 20/4 (mouse #1; 4 sessions); 20/7, 23/7, 20/7 (mouse #2; 3 sessions); 19/4, 16/2 (mouse #3; 2 sessions); 26/4, 23/4, 17/6, 25/5 (mouse #4; 4 sessions); 20/5, and 17/4 (mouse #5; 2 sessions), respectively.

      (3) Please quantify the results in Figure 3, for both within individual mice and across mice.

      We have calculated maximum trajectory length within the 3-D space (Fig. 3C).

      (4) What is the effect size in Figure 7C?

      We now report the effect size.

      (5) Please provide more details for spike sorting.

      We have now included more details in the Methods section.

      (6) More detailed cell type or correlation analysis in Figures 4 and 5 may be helpful. For example, if putative regular and fast-spiking neurons were simultaneously recorded, did the FS directly inhibit the RS to give rise to the apparent encoding properties?

      We recorded a small number of putative interneurons (n = 13) from only three mice, which precludes drawing meaningful conclusions, particularly given their heterogeneous responses during discrimination–avoidance tasks. Accordingly, we include only an example interneuron demonstrating discrimination between AB vs. BA shuttles (Fig. S5). Nevertheless, it is evident there are reciprocal monosynaptic connections between putative interneurons and certain pyramidal neurons, as indicated by short-latency (~2 ms) excitatory or inhibitory interactions (Fig. S5). That said, follow up studies with greater Ns are needed to parse out these details

      Reviewer #2 (Recommendations for the authors):

      (1) While I appreciate displaying the success rate for the sake of simplifying behavioral data in Figure 1B, it would be nice to also see these data broken out as correct vs incorrect for stay vs shuttle trials, since it is difficult to determine whether the performance increases are primarily driven by mice improving at stay vs shuttle responses

      We appreciate this feedback. In the revised manuscript, we present data separating stay versus shuttle trials (Fig.1; Fig.S2).

      (2) In Figure 2 the comparison between shuttle and stay is not particularly convincing, since the comparison is also essentially movement vs no movement and place1-->place2 vs place1-->place1. A more appropriate comparison might be action state neurons vs action content neurons during A-->B, B-->A, or both crossings. If it is true that these populations contain this information, then action state neurons should traverse a large component space in both directions, action content neurons only one direction, and so on.

      We agree that the comparison is not ideal due to differences in locomotion. However, it provides valuable information suggesting that the ACC plays a limited role during stay trials, despite these trials involve mental and cognitive processes comparable to shuttle trials. While we appreciate the reviewer’s suggestion, the proposed analysis is not particularly reliable given the relatively small number of simultaneously recorded action-state or action-content neurons.

      (3) I would say the above point applies to Figure 3 as well. I would also note that this reviewer greatly appreciates the rigor of showing ensemble activity in each subject.

      We appreciate this comment. See our response above.

      (4) In Figure 5 do these neurons show the same A-->B vs B-->A firing patterns during correct vs incorrect shuttles? The text describing the data in Figure 4 suggests this should be the case but even from a quick glance it sort of seems like the population dynamics during correct vs incorrect shuttles are not the same. My concern is that averaging neural activity over 5s windows washes out all these dynamics

      Preliminary analysis suggests that these firing patterns apply to both correct and incorrect shuttles. However, the main reason we did not compare correct and incorrect trials is the limited amount of data. In many sessions, there are only a few (≤5) incorrect shuttles, which include both AB or BA shuttles (Fig.1C; Fig.S2), thus lacking the statistical power for a meaningful comparison.

      (5) Some information on classifier validation is required - was this leave-out validation and if so how many trials were left-out vs tested? K-fold, and if so, how many folds? Was the trial order shuffled for each simulation? Classifiers will pick up within-session temporal information. In addition to this classifier accuracy during the different time points should be compared by a non-parametric test, and compared to the 95th percentile of the label-shuffled distribution.

      Yes, we use standard 10-fold cross-validation. We appreciate the suggestion on trial-order shuffling, and implementing this procedure does not change our original conclusion. Additionally, we have applied a non-parametric test.

      (6) How exactly were neurons classified as content vs state? Was it the average activity during the 5s following the shuttle? If this is stated I could not really find it easily so I might suggest clarifying.

      We now use a new method for classification of the two neuron types (Fig.7). We have included detailed methods in the revised manuscript.

      (7) Movement drives cortical neuron activity more than anything else I have ever seen. Really, more than anything else, it would be nice to demonstrate that it is not movement alone or movement multiplexed with place/sensory information/direction driving these responses.

      We have analyzed ACC neuronal activity in relation to locomotion speed. Our results indicate that only a small fraction of ACC neurons (<15%) show speed-correlated activity (Fig.5). It remains unclear whether these speed-related neurons represent a distinct subpopulation within the ACC or reflect recordings from nearby motor cortex. Postmortem examination of the recording sites suggests that most neurons were recorded from the ACC, while a small subset may be located at the border between the ACC and motor cortex. Therefore, it is possible that the small fraction of speed-related neurons originated from the motor cortex.

      Furthermore, we identify two distinct groups of ACC neurons: <iaction-state and action-content neurons, both of which tend to show sustained activity even when the animals remain immobile after completing shuttle behaviors. This prolonged activation in the absence of movement suggests that their activity is not directly driven by locomotion. Moreover, action-content neurons are selectively engaged in only one of the two shuttle categories, either rooms AB or BA shuttles. Therefore, differences in neuronal activity are unlikely to reflect locomotor differences, given that both shuttle types involve similar movement patterns.

      (8) In addition to the above, the place-field analysis in Supplemental Figure 5 only shows 4 neurons. Was the whole population analyzed? Is it possible to decode place from the population during the ITI? The data in this figure sort of look exactly like place fields - many cortical neurons and also some hippocampal neurons have more than 1 place field

      We have now provided additional place-field analysis. A comparison with hippocampal CA1 neurons (recorded during the same task) suggests that ACC neurons encode limited spatial information.

      (9) "a simple Pavlovian association strategy is unlikely to be sufficient for learning the task" ... is Pavlovian occasion setting not a simple association? Tones and contexts both readily act as Pavlovian occasion setters. Similarly positive/negative patterning might also explain how the task is learned.

      We appreciate this comment and have revised the sentence accordingly. It is possible that animals use multiple strategies to learn and perform the task effectively. In the early stages, animals may rely more heavily on sensory–spatial integration, whereas in later stages, sensory- or location-related Pavlovian associative strategies may contribute to performance, particularly when animals begin to show place preferences during inter-trial intervals.

      (10) I might suggest softening this language and others like it. For example, 2x2 factorial designs are not really novel.

      We have revised the language used to describe the task.

      (11) Some of the color-scale bars and figures do not have labels. For example, Supplementary Figure 3, Supplementary Figure 5. Please add labels.

      We have added the missing labels to all color bars.

      Reviewer #3 (Recommendations for the authors):

      (1) Some relevant papers that should be cited:

      https://doi.org/10.1523/JNEUROSCI.4450-08.2008

      10.1016/j.neuron.2018.11.016

      https://doi.org/10.1016/j.jphysparis.2014.12.001

      We appreciate these suggestions.

      (2) Where can we download the data and code?

      We will upload the essential data and MATLAB code to GitHub to accompany the publication of the final version of this paper.

    1. Author response:

      Thank you for the reviews of our article “PKMζ-PKCι/λ double-knockout demonstrates atypical PKC is crucial for the persistence of hippocampus LTP and spatial memory.” We will address all of the reviewers’ issues point-by-point in a revised version.

    1. Author response:

      We thank the reviewers for their insightful comments on our work.

      We agree with reviewer #1 that further experiments would be needed to figure out how the observations done on lab strains can apply to yeast in various ecological conditions and particularly in the wild. We here provide a proof of principle that multicellularity selection can arise as a side-effect. It obviously does not prove that it took place during yeast evolution, but we would like to emphasize that resource fluctuations are very common in ecological conditions, making it highly likely that the environmental conditions necessary for the selection of the side effects described have arisen.

      We agree with reviewer #2 that our work on yeast strains is “somewhat artificial” as often the case with model organisms under laboratory conditions. Importantly though, we showed that the effect found with the cln3 knock-out mutation can be phenocopied by overexpression of WHI5 (encoding the yeast equivalent of Rb). We propose that variations in the levels of cell cycle regulators during evolution may have played a role in multicellularity selection as a side effect. We agree that this is merely a hypothesis to explain the selection of multicellularity (just like predator escape) and that there is no direct evidence that this occurred in the history of the lineage. Nevertheless, our work provides a first evidence that such a selection of multicellularity as a side effect could be possible, and gives a framework to understand how multicellularity can persist in the wild, even when it is not the primary target of selection.

      We are currently working on the text and figure revisions suggested by the reviewers.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      In this paper, the authors use a doxycycline-inducible DLD1 cell line expressing a Clover-tagged RNA-binding-defective TDP-43 2KQ mutant that forms nuclear "anisosomes" (TDP-43 shell with HSP70 core) to carry out a small-molecule screen using the LOPAC 1280 library to identify compounds that reduce anisosome number or shift their morphology and dynamics. They also conducted a genome-wide siRNA screen to identify genetic modifiers of anisosome formation and dynamics. From these screens, the authors identify pathways in RNA splicing, translation, proteostasis (proteasome and HSP90), and nuclear transport, including XPO1. They then focus on XPO1 as their primary hit. Pharmacological inhibition of XPO1 using KPT-276, Verdinexor, and Leptomycin B reduces anisosome number while enlarging remaining condensates, which retain liquid-like behavior by FRAP and fusion assays. XPO1 overexpression causes fewer, enlarged TDP-43 puncta, including cytoplasmic puncta, with little or no FRAP recovery, interpreted as gel or solid-like aggregates. Anisosome induction reduces detectable nucleoplasmic XPO1 staining. Finally, the authors examine a homozygous TDP-43 K181E iPSC-derived forebrain organoid model, showing increased cytosolic pTDP-43 in K181E/K181E organoids compared to wild-type controls. Chronic low-dose KPT-276 reduces cytoplasmic pTDP-43 without changing total TDP-43 levels. Bulk RNA-seq shows only a modest fraction of dysregulated genes in K181E/K181E organoids are rescued by KPT-276. They conclude that nuclear export, via XPO1, is a key regulator of TDP-43 liquid-to-solid phase transitions and that cytoplasmic aggregation per se may contribute only modestly to TDP-43 proteinopathy, with RNA-processing defects being dominant.

      We thank the reviewer for carefully summarizing our study.

      The study presents well-executed chemical and genome-wide siRNA screens in a DLD1 TDP-43 2KQ anisosome model and follows up on nuclear transport, particularly XPO1, as a modulator of TDP-43 phase behavior and cytoplasmic aggregation. The screens are impressive in scale, and the microscopy and fluorescence recovery after photobleaching (FRAP) work is technically strong. However, the central mechanistic and disease-relevance claims are not yet sufficiently supported. There are major concerns about the heavy reliance on non-physiological, RNA-binding-defective, and acetylation-mimetic TDP-43 (2KQ) and a homozygous TDP-43 K181E organoid model. An underdeveloped and partly contradictory mechanistic link exists between XPO1 and TDP-43 phase transitions in the context of prior work showing TDP-43 is not a canonical XPO1 cargo. The paper also appears to overinterpret organoid data to conclude that cytoplasmic TDP-43 aggregation plays only a minor role in pathology, based largely on pTDP-43 antibody staining with limited sensitivity and relatively modest rescue readouts. A deeper mechanistic analysis and additional, more physiological validation are needed for this to reach the level of rigor and impact implied by the title and abstract. The work feels screen-rich but conceptually underdeveloped, with key claims outpacing the data. A major revision with substantial new data and tempering of conclusions is warranted. I outline several problematic areas below:

      (1) The central mechanistic discoveries are derived almost entirely from a DLD1 colon cancer cell line overexpressing an RNA-binding-defective, acetylation-mimetic TDP-43 2KQ mutant and homozygous TDP-43 K181E iPSC-derived organoids. Both systems are far from physiological. The 2KQ mutation is a synthetic double lysine-to-glutamine mutant originally designed to mimic acetylation and disrupt RNA binding. In this study, essentially all cell-based mechanistic data on phase behavior, screens, and XPO1 effects rely on 2KQ. Yet there is no quantification of how much endogenous TDP-43 is acetylated in degenerating human neurons, nor whether a 2KQ-like acetylation state is ever achieved in vivo. It is not established that the phase behavior of 2KQ recapitulates the physiological or pathological phase behavior of wild-type TDP-43 or genuine disease-linked mutants, which may retain partial RNA binding and different post-translational modification patterns. As a result, it is difficult to know whether the modifiers identified here regulate a highly artificial 2KQ condensate or physiologically relevant TDP-43 condensates. To address this concern, the paper would benefit from quantifying endogenous TDP-43 acetylation at the relevant lysines in control and ALS/FTD patient tissue or more disease-proximal models such as heterozygous TARDBP mutant iPSC neurons, which would justify the focus on an acetyl-mimetic mutant. Key phenomena, including XPO1 dependence of phase behavior, effects of proteasome and HSP90 inhibition, and effects of splicing and translation inhibitors, should be tested for wild-type TDP-43 expressed at near-physiological levels and for one or more bona fide ALS/FTD-linked TARDBP mutants that are not acetyl mimetics. At a minimum, the authors should show that endogenous TDP-43 in neuronally differentiated cells exhibits qualitatively similar responses to XPO1 modulation, rather than exclusively relying on DLD1 2KQ overexpression.

      Acetylation of endogenous TDP-43 was reported by several studies. Although it occurs at low levels under normal conditions, TDP-43 acetylation is upregulated under stress conditions (e.g. oxidative stress and proteotoxic stress) (PMID: 25556531; PMID: 28724966). Importantly, Cohen et al. reported the identification of acetylated TDP-43 in ALS patient spinal cord (PMID: 25556531), while Yu et al. showed that endogenous wildtype TDP-43 undergoes demixing when neurons were treated with either a deacetylase inhibitor or proteasome inhibitors (PMID: 33335017). These studies also show that acetylated TDP-43 is defective in RNA binding and more prone to aggregation. Furthermore, ectopic expression of acetylated TDP-43 mimetics in cells and mice induces cellular defects similar to those observed in disease models (PMID: 28724966). Thus, our findings, based on previously established TDP-43 mimetics, should provide valuable information regarding the regulation of TDP-43 phase behavior. We agree with the reviewers that the model used in this study has its limitations, and we will be happy to revise the manuscript to tone down some conclusions, and include more background information to justify the use of TDP-43 acetylation mimetics.

      (2) The organoid model is based on a homozygous K181E knock-in line. However, in patients, TARDBP mutations are overwhelmingly heterozygous. Homozygosity is thus a severe, arguably non-physiological sensitized background that may exaggerate nuclear RNA mis-splicing and phase defects and alter the relative contribution of cytoplasmic aggregation versus nuclear loss-of-function. In addition, it is not fully clear from this manuscript whether the structures in K181E organoids are bona fide anisosomes as defined in Yu et al. 2021, characterized by HSP70-enriched central liquid cores with TDP-43 shells and similar FRAP and fusion behavior to anisosomes in the DLD1 model. At present, the organoid section is framed as validation of "anisosome-bearing organoids," but the figures in this manuscript mainly show pTDP-43 puncta and total TDP-43 immunostaining, without detailed structural or biophysical characterization. The authors should explicitly compare heterozygous K181E/+ organoids or another heterozygous TARDBP mutant line with homozygous K181E/K181E organoids to assess whether XPO1 inhibition has similar effects in a genotype that more closely resembles patient genetics. They should provide direct evidence that the K181E condensates in organoids are anisosomes through HSP70 core immunostaining, three-dimensional reconstruction, and FRAP measurements, and clarify whether KPT-276 is acting on anisosome-like structures or more generic cytoplasmic aggregates or puncta. Without this, the leap from a DLD1 2KQ cancer cell model to human ALS/FTD-relevant neurons is not convincingly supported.

      The reviewer is correct that the use of homozygous K181E organoids generates a homogenous background that is more sensitive for detecting phosphor-TDP43. The goal of the experiment was to test whether XPO1 inhibition mitigates the aggregation of a TDP-43 disease mutant. For this purpose, we believe that our experimental setup is suitable. We agree that we should not extrapolate the result to overemphasize on its disease connections. We will revise the paper to tone down this part.

      Regarding the immunostained signals in K181E organoids, we did not report them as anisosomes. As widely documented in the literature, p-TPD-43 is widely used as a marker of pathological TDP-43 aggregation. P-TDP-43 is enriched in pathological aggregates in human ALS and FTLD patients, colocalized with other aggregation signatures such as ubiquitin and other aggregation prone proteins (PMID: 36008843), and is being used as a diagnostic marker for neurodegeneration (PMID: 31661037). Figure 7A showed that inhibiting nuclear export mitigates the accumulation of p-TDP-43 in mutant tissues. We will revise the subheading and the corresponding text to avoid the confusion.

      (3) The title and framing assert that "nuclear export governs TDP-43 phase transitions." However, prior studies such as Pinarbasi et al. 2018 and Duan et al. 2022 indicate that TDP-43 is not a canonical XPO1 cargo and that its export is largely passive, with active nuclear import being the dominant determinant of nuclear localization. The authors cite these studies but still position XPO1 as a central, quasi-direct regulator. The data presented are largely correlative or based on pharmacologic manipulation and overexpression in an overexpression mutant background, with no direct evidence that XPO1 engages TDP-43 in a specific, regulated manner. Even if XPO1 does not engage WT TDP-43, it could still engage the 2KQ variant, which needs to be tested.

      We did not conclude or imply the regulation of TDP-43 by XPO1 is direct. In fact, we explicatively mentioned on page 8 that the regulation is likely indirect and mediated by other factors. The sentence reads as “Since XPO1 does not bind TDP-43 directly (Pinarbasi et al., 2018), additional factors likely facilitate XPO1-mediated TDP-43 nuclear egression under this condition.” We can revise the part to make it clearer. We will also revise the title and change the framing accordingly. 

      (4) The XPO1 perturbations yield somewhat confusing phenotypes. XPO1 inhibition using Leptomycin B, KPT-276, and Verdinexor reduces anisosome number and enlarges remaining anisosomes, which remain liquid-like by FRAP recovery and fusion assays and stay nuclear. XPO1 overexpression causes fewer, enlarged puncta, but these are FRAP-impaired (gel-like) and redistribute to the cytoplasm. Thus, both decreased and increased XPO1 activity reduce anisosome number and enlarge puncta, but with opposite phase behaviors and subcellular localizations. The model presented in Figure 5L is relatively qualitative and does not resolve these issues. Moreover, XPO1 inhibition globally impairs nuclear export of many cargos and profoundly alters the nuclear environment, transcription, RNA processing, and chromatin. It is therefore difficult to conclude that the observed effects are specific to TDP-43 phase regulation as opposed to secondary consequences of broad nuclear export blockade.

      The reviewer correctly summarizes our data and interpretation: XPO1 loss-of-function and gain-of-function generate opposite phenotypes regarding TDP-43 phase behavior. We agree that additional studies are needed to elucidate the underlying mechanism (e.g. direct or indirect), but we feel that belong to a separate study. We plan to re-test the effect of nuclear export inhibition on the subcellular distribution of WT TDP-43 and the acetylation mimetics. We will also add more discussions about the potential indirect effect of XPO-1 inhibition on TDP-43 phase behavior.

      (5) The authors show that anisosome induction depletes nucleoplasmic XPO1 signal and that mCherry-XPO1 can be seen in some TDP-43 puncta. However, antibody penetration into anisosomes is limited, so XPO1 depletion from nucleoplasm could reflect sequestration in the anisosome shell or core, but this is not demonstrated. There is no demonstration of physical interaction, even indirect interaction, between XPO1 and TDP-43 or a defined adaptor, nor identification of a specific mutant of XPO1 that selectively disrupts this putative interaction while preserving other functions. The known TDP-43 NES has been shown to be weak and not a functional XPO1-dependent NES in multiple studies. If XPO1 is acting through an adaptor that recognizes 2KQ or K181E specifically, that by itself would bring into question the generality of the mechanism for wild-type TDP-43.

      We agree that our observation does not demonstrate an interaction between XPO1 and TDP-43. As mentioned above, we did discuss that the regulation of TDP-43 by XPO1 is likely indirect. We will revise our paper further to separate any speculative statements from the data and narrow our mechanistic claim.

      (6) To support a mechanistic claim that nuclear export governs TDP-43 phase transitions, more targeted evidence is needed. The authors should test whether siRNA knockdown or CRISPR interference of XPO1 in the DLD1 2KQ model reproduces the effects seen with Leptomycin B and KPT-276, including FRAP and fusion phenotypes, and verify on-target effects by rescue with an siRNA-resistant XPO1 construct. They should demonstrate that canonical XPO1 cargos behave as expected under the inhibitor conditions used, as a positive control, and that the concentrations used are not grossly toxic. They should attempt to identify or at least constrain candidate adaptors that might enable XPO1-dependent export of TDP-43 through proteomic analysis of XPO1 co-purifying with 2KQ condensates or loss-of-function studies of candidate adaptors from the siRNA screen. Finally, they should test whether a TDP-43 mutant that cannot bind the proposed adaptor still responds to XPO1 manipulation.

      The anisosome enlargement phenotype upon XPO1 depletion was seen in our siRNA screend, which was identified by machine-based image analyses using 6 distinct siRNAs. This, together with the chemical inhibition experiments, convinced us that the phenotype is specifically caused by XPO1 inactivation.

      When characterizing the effect of XPO1 inhibition on anisosome dynamics, we preferred chemical inhibitor because the effect is acute, and is therefore, less likely to be caused by secondary effects.

      Regarding the inhibitor concentration, a literature survey suggested that 50-200nM of Leptomycin B was commonly used. We chose 200nm to ensure a quick and complete inhibition of XPO1-mediated nuclear export (see Figure 3 in PMID: 9628873). This dose is also well tolerated by our cells, at least during the chosen time window.

      We did not propose any specific adaptor that mediates XPO1 interaction with TDP-43. The identification of such adaptor is out of the scope of this study. We will revise our paper to avoid this confusion.

      (7) Even with these data, what is currently shown is that global modulation of nuclear export capacity can alter the phase behavior and localization of a highly overexpressed RNA-binding-defective TDP-43 mutant and of K181E in organoids. This is important, but it is weaker than asserting that XPO1 directly governs TDP-43 phase transitions in physiological contexts. The title, abstract, and Discussion should be tempered to reflect that nuclear export is one of several pathways, alongside RNA splicing, translation, and proteostasis, that influence TDP-43 phase states in this model, and that the specific mechanism and cargo relationship between XPO1 and TDP-43 remain unresolved and may be indirect.

      We will revise the title, abstract, and discussion to temper the conclusion.

      (8) The authors conclude that cytoplasmic TDP-43 aggregation plays only a modest role in TDP-43 proteinopathies because in homozygous K181E organoids, chronic KPT-276 treatment almost abolishes cytoplasmic pTDP-43 puncta, yet bulk RNA-seq shows only a relatively small fraction of dysregulated genes are rescued. There are several issues with this inference. Relying primarily on pTDP-43 antibody staining to define cytoplasmic TDP-43 aggregation is limiting. pTDP-43 antibodies label only phosphorylated species and may miss non-phosphorylated, oligomeric, or amorphous TDP-43 species that could still be toxic. Different pTDP-43 antibodies vary in epitope accessibility depending on aggregate conformation and subcellular location. More sensitive approaches, such as high-affinity TDP-43 RNA aptamer probes developed by Gregory and colleagues, biochemical fractionation for SDS-insoluble and urea-soluble TDP-43, and filter-trap assays, would provide a more quantitative assessment of cytoplasmic aggregation and its reduction by KPT-276. Without these, it is not safe to assume that cytoplasmic aggregation has been eliminated, as opposed to one antigenic subclass.

      We agree with the reviewer that p-TDP-43 may not represent all aggregate species. However, p-TDP-43 antibodies detect the pathologically validated species most tightly associated with TDP-43 proteinopatheis. In human ALS and FTLD-TDP tissues, cytoplasmic inclusions are strongly immunoreactive for phosphorylated TDP-43 (typically S409/410, as used here). Additionally, p-TDP-43 immunohistochemistry is a routine diagnostic criterion in neuropathology. For these reasons, we believe that the observation that inhibition of XPO1 significantly reduces p-TDP-43 is a very significant finding, as it suggests that an improvement in TDP-43 proteinopathy can be achieved by the inhibition of nuclear transport. We plan to revise the text to better explain the significance of p-TDP-43 staining.

      (9) The treatment window, spanning from day 87 to 122 with 20 nanomolar KPT-276, may be too late or too mild to reverse entrenched nuclear RNA-processing defects, even if cytoplasmic inclusions are cleared. Once widespread cryptic exon inclusion and alternative polyadenylation misregulation are established, many downstream changes may become self-sustaining or only partially reversible. Moreover, XPO1 inhibition will massively rewire nucleocytoplasmic transport of many transcription factors, splicing factors, and RNA-binding proteins. Thus, the lack of full transcriptomic rescue cannot be cleanly interpreted as evidence that cytoplasmic aggregates are only modest contributors. It may instead reflect that nuclear dysfunction is primary and XPO1 inhibition does not correct, and may even exacerbate, certain nuclear defects.

      We agree with the reviewer that the lack of rescue may be caused by technical issues. We will remove the RNAseq data and related texts since it is not essential for our main conclusion.

      (10) To support a causal statement about the modest contribution of cytoplasmic aggregates, one would want more direct measures of neuronal health and function, such as cell death, neurite complexity, synaptic markers, and electrophysiology before and after KPT-276, not only transcriptomics. A way to selectively reduce cytoplasmic aggregation without globally inhibiting nuclear export would allow comparison of outcomes.

      We will remove the discussion regarding the role of cytoplasmic aggregates in disease.

      (11) Given these caveats, the concluding statements that cytoplasmic TDP-43 aggregation is only a modest contributor should be substantially softened. A more defensible interpretation is that in this homozygous K181E organoid model, chronic global XPO1 inhibition reduces pTDP-43-positive cytoplasmic puncta but only partially normalizes the steady-state transcriptome, suggesting that persistent nuclear RNA-processing defects and other pathways continue to drive pathology.

      We agree with the review and will revise this part accordingly.

      (12) The screens are a major strength but need more rigorous validation for key hits, especially nuclear transport factors. For the siRNA screen, hits are filtered by anisosome number per nucleus, but there is no direct demonstration in the main text that XPO1 or CSE1L knockdown is efficient at the messenger RNA or protein level. For the highlighted genes, Western blot or quantitative polymerase chain reaction validation and phenotypic rescue would strengthen confidence. For small-molecule hits, it is not systematically shown that anisosome modulation is independent of changes in total TDP-43 2KQ expression or gross toxicity. Translation inhibitors are tested for this, but for many other hits, including proteasome, HSP90, and kinase inhibitors, expression and general nuclear structure should be monitored. Given the reliance on anisosome count as a readout, secondary screens that specifically distinguish changes in TDP-43 expression levels, changes in nuclear morphology or cell cycle, and specific changes in anisosome phase behavior, including FRAP and fusion for top hits, would greatly increase interpretability.

      For the siRNA screen, each positive hit was confirmed by two rounds of screen with 6 independent siRNAs in total. Although we did not validate the knockdown efficiency due to the large number of hits, we routinely include a positive siRNA control in our study (siRNAdeath), which targets an essential gene. Transfection efficiency was controlled by measuring cell viability after knocking down this essential gene. In addition, the identification of XPO1 as a positive regulator of TDP-43 phase behavior was independently validated by our chemical genetic screens. We feel confident that XPO1 is a key modulator of TDP-43 phase behavior. For chemical treatment experiments, the anisosome fusion phenotypes could be detected as early as 5 h post treatment. Given the short treatment, we do not expect a significant change in protein level or toxicity.

      (13) The classification of condensates as liquid versus gel-like or solid is based almost entirely on FRAP recovery or lack thereof. While FRAP is appropriate, interpretations could be made more robust by including half-region-of-interest bleach controls and assessing mobile fractions and recovery kinetics more quantitatively across conditions. Complementing FRAP with other phase-behavior assays such as sensitivity to 1,6-hexanediol, shape relaxation after deformation, and coarsening behavior over longer timescales would strengthen the analysis. At present, some assignments, such as that XPO1 overexpression drives a gel-like transition, are reasonable but somewhat qualitative.

      In this study, we described two types of condensates formed by TDP-43 2KQ, one characterized previously as nuclear anisosome and the other as cytosolic puncta in XPO1 over-expressing cells. The two can be clearly distinguished by several features including the subcellular localization, shape, and mobility. We feel that our FRAP data clearly segregate these puncta into two distinctive types of assemblies. The difference in fluorescence recovery rate is huge. The proposed half-region-of-interest bleach is technically challenging for small anisosomes under normal conditions. When they were enlarged by Leptomycin B treatment, we did perform both whole anisosome bleach and partial bleach (Figure 5D, I). Both assays demonstrate that TDP-43 in these enlarged anisosomes is highly mobile.

      (14) For the Leptomycin B and KPT-276 experiments in cells and organoids, it would be important to confirm that canonical XPO1 cargo proteins accumulate in the nucleus and that the concentrations used are within a range that is not overtly toxic over the experimental timeframe. Assessing nuclear morphology, chromatin condensation, and general transcriptional activity through global RNA synthesis or key reporter genes would ensure that observed effects are not secondary to severe global nuclear export collapse.

      In Leptomycin B treatment experiments, we carefully chose a dose that was previously validated (see Figure 3 in PMID: 9628873). Based on our DAPI staining, the nuclear morphology appears normal (Figure 5A). Additionally, in cell line-based experiment, the effect of Leptomycin B on anisosomes was detected 6-8 hours post treatment. The change in global protein synthesis should be relatively minor at this time point. In the organoid experiment, the drug dose was determined by a pre-experiment in which the morphology of organoids was evaluated after prolonged treatment with different doses of the inhibitors.

      (15) In the organoid section, it is not clear how many independent iPSC clones and organoid batches were used per condition, nor whether batch effects were assessed in the bulk RNA-seq analysis. This should be fully specified and ideally controlled with isogenic wild-type and K181E clones. For transcriptional rescue, it is important to know whether the changes in wild-type organoids treated with KPT-276 are negligible. A direct wild-type comparison with or without KPT-276 is important to disentangle general drug effects from K181E-specific rescue. More detailed quantification of total TDP-43 and pTDP-43 in both nuclear and cytoplasmic fractions, including biochemical fractionation if possible, would strengthen the assertion that KPT-276 specifically reduces cytosolic pTDP-43 aggregates while sparing nuclear TDP-43.

      The organoid experiment was performed with two batches per condition. This is to reduce the effect of batch variation. The wildtype cells and K181E mutant are derived from the same genetic background. We will revise the text to clarify these issues. Given the cost of this experiment, we did not include drug-treated wild-type as a control. Given the criticisms by review 1 and 2 on the RNAseq data, we will remove this non-essential data from our revision.

      (16) Beyond the core issues above, several additions could greatly enhance the impact. The manuscript currently emphasizes XPO1, but the genetic and chemical data clearly implicate RNA splicing, translation, and proteostasis as equally strong or stronger regulators of TDP-43 phase states. A more integrated model that explains how these pathways intersect, for example, how splicing factor availability, ribosome loading, and proteasome capacity co-govern anisosome nucleation, growth, and hardening, would be valuable.

      We agree with the reviewer that these are important directions for future studies. We will include some discussions on a possible model that integrate these factors.

      (17) A key unresolved question is whether XPO1 is acting directly on TDP-43, or instead primarily regulates anisosomes by exporting other factors that more proximally control TDP-43 phase behavior. Given that TDP-43 is not a canonical XPO1 cargo and prior work indicates that its nuclear export is largely passive, it seems at least as plausible that XPO1 inhibition alters the nuclear concentration or localization of splicing factors, RNA-binding proteins, chaperones, or other modifiers identified in the screens, and that changes in these proteins secondarily reshape anisosome dynamics. In other words, XPO1 may be exporting a more direct regulator of anisome formation and hardening, rather than exporting TDP-43 itself in a specific, regulated way. The current data do not distinguish between these possibilities. Systematic identification of XPO1-dependent cargos that colocalize with or biochemically associate with anisosomes, combined with targeted perturbation of their nuclear export, would be needed to determine whether the relevant XPO1 substrate in this system is actually TDP-43 or an upstream modulator of its phase behavior.

      The reviewer raises an important point. We did include some discussions along this line in our paper. We can add more to further clarify this issue. Again, as mentioned in the original draft, we did not conclude there is an interaction between TDP-43 and XPO1.

      (18) Testing whether identified modifiers converge on nuclear TDP-43 concentration would be informative. Since phase separation is concentration-dependent, measuring nuclear versus cytoplasmic TDP-43 levels across key perturbations, including splicing inhibition, translation inhibition, proteasome inhibition, HSP90 inhibition, and XPO1 modulation, would help determine whether modifiers mainly work by changing nuclear TDP-43 concentration or by altering interaction networks and the material properties of condensates.

      We will measure the nuclear TDP-43 concentration in our imaging experiments and add the data to a revised version.

      (19) Examining other ALS-relevant RNA-binding proteins would be valuable. Given the role of XPO1 and other hits, it would be informative to briefly test whether similar principles apply to FUS, hnRNPA1, or other ALS-relevant RNA-binding proteins in the same cellular context, to argue for generality versus TDP-43-specific idiosyncrasies of the 2KQ system.

      We agree that this is an important issue but we feel the proposed experiments are beyond the scope of the study.

      (20) The Introduction sometimes implies that anisosomes are common and well-established intermediates en route to pathology. It would be helpful to more clearly state that, to date, anisosomes are primarily observed in overexpression and mutant systems and have not yet been unequivocally demonstrated in human patient tissue. The link between PDGFRβ, PAK4, GSK-3β, and YAP and TDP-43 phase dynamics is intriguing but only briefly mentioned. The authors should either expand on this or tone down the emphasis in the Results section.

      We will revise the introduction accordingly.

      (21) In the organoid methods, the authors should consider clarifying whether doxycycline is continuously used, which might alter TDP-43 expression and nuclear transport in a non-negligible way.

      The organoid model does not involve protein overexpression or doxycycline treatment. We measured endogenous p-TDP-43. We will revise to paper to avoid the confusion.

      (22) For statistical methods, it would be beneficial to indicate whether multiple-comparison corrections were applied for the many FRAP, anisosome count, and size comparisons beyond DESeq2 internal corrections for RNA-seq.

      We will add this information to the figure legends during revision.

      (23) Some figure legends could more clearly indicate whether the images shown are single z-planes or maximum intensity projections and how the thresholding for anisosome detection was performed.

      We will revise the figure legends to include this information. As for anisosome detection, because they are so obvious, standard thresholding was sufficient to identify them.

      (24) In its current form, the manuscript contains an impressive set of screens and some nicely executed imaging of TDP-43 condensates, highlighting nuclear export among other pathways as a modulator of TDP-43 phase behavior. However, the physiological relevance is undercut by heavy reliance on an acetylation-mimetic, RNA-binding-defective TDP-43 mutant and a homozygous K181E organoid model. The mechanistic link between XPO1 and TDP-43 remains largely inferential and partly at odds with prior work. The conclusion that cytoplasmic TDP-43 aggregation is only a modest contributor to disease is not firmly supported by the available data.

      We agree with the reviewer that the strength of the study is our unbiased approach that identify pathways capable of modulating TDP-43 phase separation behavior. We will revise our paper to carefully discuss the potential physiological relevance of our study and tone down some mechanistic conclusions, as suggested by the reviewer.

      (25) With substantial additional mechanistic work, particularly around XPO1, rigorous validation in more physiological TDP-43 contexts, more sensitive detection of cytoplasmic TDP-43 aggregates, and a tempering of the central claims, this study could make a meaningful contribution to understanding how nucleocytoplasmic transport and other cellular pathways influence TDP-43 phase transitions and aggregation. The work should be reframed as an important screening study that identifies nuclear export as one among several cellular processes that modulate TDP-43 phase behavior in a model system, rather than as a definitive demonstration that nuclear export governs pathological TDP-43 aggregation in disease.

      We will reframe the study as an important screening study that identifies nuclear export among several other pathways as modulators of TDP-43 phase behavior.

      Reviewer #2 (Public review):

      Summary:

      This manuscript addresses an important and timely question in TDP-43 biology by systematically identifying regulators of TDP-43 anisosome formation, with a particular focus on nuclear export via XPO1. Using a combination of unbiased chemical screening, genetic perturbation, and advanced imaging approaches, the authors propose that inhibition of nuclear export modulates the abundance and biophysical properties of TDP-43 anisosomes. The study is conceptually innovative and has potential relevance for neurodegenerative diseases characterized by TDP-43 pathology. However, significant concerns regarding experimental controls, reporting transparency, and model translatability currently limit the strength of the conclusions and the interpretability of several key findings.

      We thank the reviewer for acknowledging the significance and innovation of our study.

      Strengths:

      (1) The study employs an unbiased, hypothesis-free compound screen to identify regulators of TDP-43 anisosome formation, which is a major strength and reduces confirmation bias.

      (2) The authors combine chemical and genetic screening approaches, providing orthogonal validation of key pathways and increasing confidence in the biological relevance of top hits.

      (3) The focus on biophysical properties of TDP-43 assemblies, assessed through imaging and FRAP, moves beyond simple presence/absence of aggregates and provides mechanistic insight into the biophysical states of TDP-43.

      (4) The use of multiple experimental modalities, including live-cell imaging, FRAP, pharmacological perturbation, and transcriptomic analysis, reflects a technically sophisticated and ambitious study design.

      (5) The authors attempt to extend findings beyond immortalized cancer cell lines by incorporating organoid models, demonstrating awareness of disease relevance and translational importance.

      Overall, the manuscript is clearly written and logically structured, making complex experimental workflows accessible and the central hypotheses easy to follow.

      Weaknesses:

      Despite its strengths, the manuscript has several major limitations that affect data interpretation and confidence in the conclusions.

      (1) Lack of appropriate controls for overexpression experiments:

      A central concern is the absence of proper controls for TDP-43 and XPO1 overexpression. Prior studies (including those cited by the authors, Archbold et al.2018) show that overexpression of WT TDP-43 alone is toxic to neurons. Thus, the experimental system itself may induce anisosome formation independently of the mechanisms under study. Similarly, XPO1 overexpression lacks a suitable control (e.g., mCherry alone or mCherry fused to a protein known to be independent of TDP-43). The near-complete colocalization of XPO1 with TDP-43 anisosomes upon overexpression raises the possibility that these structures reflect non-physiological protein accumulation rather than regulated assemblies.

      As mentioned in our response to reviewer 1, point 1, we will add more discussion regarding the use of acetylation mimetics in our study. We agree with the reviewer that these large puncta (both anisosomes and gel-like structures) likely resulted from TDP-43 overexpression. Nevertheless, in a titration experiment done by Yu et al. 2020 (PMID: 33335017), they showed that ectopic TDP-43 undergo demixing even at concentrations lower than endogenous TDP-43, although the demixed puncta were very small. Their result suggested that overexpression per se does not change TDP-43 phase behavior, only enlarging the demixed TDP-43 structures. This is necessary for our screen and imaging-based characterization. We will revise the text to clarify this point.

      For XPO1, we did include mCherry alone control in the study but due to space limit in Figure 5, we did not include it. We can put the data in a Supplementary Figure during revision.

      (2) Insufficient experimental and analytical transparency:

      The manuscript frequently lacks clear reporting of experimental details. In multiple figures, the stated number of independent experiments does not match the number of data points shown, making it difficult to assess statistical validity. Concentrations used in the compound screen are not clearly defined, nor is it stated whether multiple concentrations were tested. It is unclear how many wells, cells, or independent cultures were analyzed. The criteria used to reduce 1,533 screening hits to 211 candidates via STRING analysis are not explained. Knockdown and overexpression efficiencies are not reported.

      We apologize for these omissions. We will add more experimental details to the figure legends and the method part. For the imaging experiments, data points reflect randomly selected individual cells imaged in 2-3 independent biological repeats. For chemical screens, we screened against NCATS libraries first at top concentration (10 mM) to ensure inhibitory efficacy for all compounds. In the follow-up study, we validated the top hits using a series of concentrations, as shown in Figure 1B.

      We will explain the STRING analysis in more detail. We did not check XPO1 knockdown efficiency in high through-put screens (HTS) for several reasons. Firstly, the large number of positive hits makes it impossible to check knockdown efficiency for all these hits. Secondly, the effect of XPO1 knockdown on anisosomes was seen with 6 different siRNAs in two rounds of screens. Thirdly, in the HTS protocol, we routinely included a transfection control (siRNAdeath) to indicate high transfection efficiency. We would only process the data if siRNAdeath control killed > 90% of the cells.

      (3) RNA-seq concerns:

      The RNA-seq experiments are particularly problematic. The number of biological replicates per condition is not stated, and heatmaps suggest that only one sample per group may have been used, which would preclude statistical analysis. No baseline comparison between WT and mutant TDP-43 is shown. Given that TDP-43 is an RNA-binding protein, splicing analyses would be far more informative than gene expression alone, yet no splicing data are presented. Moreover, nuclear retention of TDP-43 does not preclude nuclear aggregation, which may still impair its splicing function.

      We apologize for the lack of clarity regarding the RNA-seq design. For each condition, organoids of two independently differentiated batches were treated in triplicate. We pooled the organoids of the same treatment from the two batches to reduce the impact of batch variation.

      Given the criticisms from both reviewer 1 and 2 on the limitation of the RNAseq study, we plan to remove this data from the revised manuscript.

      (4) Limited translatability to neuronal biology:

      All anisosome analyses are performed in a cancer cell line, raising concerns about relevance to post-mitotic neurons. While organoids are used as a secondary model, the assays performed do not overlap with those used in cancer cells, making it difficult to assess whether anisosome-related mechanisms are conserved. Neuronal toxicity, a critical outcome given known TDP-43 biology, is not assessed. Prior work has shown that WT TDP-43 overexpression alone is toxic to neurons, yet this is not addressed.

      We agree with the reviewer that the model used in this study is not directly relevant to neurodegeneration. However, as pointed out by the reviewer, neurons are much more sensitive to TDP-43-associated toxicity. By contrast, the cell line used in this study can tolerate TDP-43 overexpression with no detectable cytotoxicity. This feature makes it feasible to evaluate how different cellular processes modulate TDP-43 phase behavior without the confounding effect from toxicity. The fact that TDP-43 expression was induced for a short period of time also help minimize the impact of toxicity. Notably, the processes identified by our screens are all house-keeping pathways that is present in neurons. Thus, we believe that the reported findings are likely applicable to neurons, though we will revise our paper to make sure that we don’t overstate the clinical relevance of our work.

      (5) Conceptual and interpretational gaps:

      The authors quantify anisosome number but also report conditions in which anisosome number decreases while size increases. The biological interpretation of larger anisosomes is not discussed, and whether this reflects improvement or worsening of pathology is unclear. Compounds targeting the same mechanism (e.g., nuclear export inhibition) are inconsistently used across experiments (KPT compounds, verdinexor, leptomycin B), raising concerns about reproducibility. In organoids, the experimental paradigm shifts to long-term treatment (35 days vs. 16 hours), further complicating interpretation.

      As pointed out by the reviewer 1 in point 4 above, we do not have evidence to establish a convincing correlation between the size of anisosomes and clinical phenotypes. Regarding the use of different drugs for different experiments, the initial screen identified KPT and Verdinexor because Leptomycin B was not in our library. In the follow-up studies, we switched to Leptomycin B because 1) it is commercially available; 2) it is highly potent and specific; 3) it was more commonly used as inhibitors of XPO1 according to the literature. However, for the organoid study, we had to switch back to KPT because of the toxicity issue associated with long-term application of Leptomycin B.

      (6) Overinterpretation of rescue effects:

      Although the authors state that they aim to test whether nuclear export inhibition rescues neuronal defects, no functional neuronal readouts are provided (e.g., viability, morphology, axon outgrowth, or electrophysiological measures). RNA-seq alone is insufficient to support claims of rescue.

      Our interpretation of the RNA-seq data was that the rescue effect by nuclear export inhibition was limited and likely insignificant. Given that this negative data is not conclusive, we will remove it from the revised manuscript.

      (7) Finally, the model does not appear to exhibit cytosolic TDP-43 aggregation at baseline. It remains unclear whether longer induction would produce cytosolic gel-like assemblies and whether these would be prevented by nuclear export inhibition. Long-term data are shown only in organoids, yet anisosome formation is not assessed there.

      The expression system used in the study reaches a steady state after 48 h of induction. At this point, we did not observe any gel-like structures. We can clarify this point during revision.

      Reviewer #3 (Public review):

      Summary:

      TDP-43 proteinopathy is broadly found in neurodegenerative diseases. This manuscript investigates how nuclear export influences the biophysical properties of TDP-43. The authors use a combination of chemical screening and genome-wide siRNA screening to identify pathways that modulate TDP-43 liquid-to-solid transitions. Overall, the study employs a broad array of approaches and addresses an important question in TDP-43 pathobiology. The identification of nuclear export as a central regulator is compelling and conceptually aligns with the emerging view that TDP-43 nucleocytoplasmic trafficking is a major defect in neurodegeneration.

      Strengths:

      This work integrates chemical and genetic screening to identify novel modifiers. The candidates were validated in both reporter cell lines and iPS-differentiated organoids. The findings support the nucleocytoplasmic transport is important for the biophysical properties of TDP-43.

      We thank the reviewer for acknowledging the significance and strength of our study.

      Weaknesses:

      The mechanisms underlying the connection between nuclear export and phase transition need further clarification. Broader consequences of XPO1 inhibition are not addressed.

      We agree that our study does not address how nuclear export inhibition affect TDP-43 phase behavior. As discussed in the paper, we proposed that the effect of nuclear export inhibition on TDP-43 phase separation is likely indirect. The most likely scenario is that inhibition of nuclear export changes the nuclear environment over time, which affects TDP-43 phase separation. We have tried to isolate nuclear extracts from control and LMB-treated cells and used mass spec to identify proteins that are differentially present in the nucleus. However, knockdown of the identified top candidates did not abolish LMB-induced phase alteration. Considering our observation that RNA splicing is another modulator of TDP-43 phase behavior, it is possible that it is the combined change of RNA and protein composition in the nucleus that alters TDP-43 phase behavior. However, defining the mechanism would require substantial work that is beyond the scope of the current study.

  2. Feb 2026
    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public review:

      Weaknesses:

      (1) Controls for the genetic background are incomplete, leaving open the possibility that the observed oviposition timing defects may be due to targeted knockdown of the period (per) gene but from the GAL4, Gal80, and UAS transgenes themselves. To resolve this issue the authors should determine the egg-laying rhythms of the relevant controls (GAL4/+, UAS-RNAi/+, etc); this only needs to be done for those genotypes that produced an arrhythmic egg-laying rhythm.

      (2) Reliance on a single genetic tool to generate targeted disruption of clock function leaves the study vulnerable to associated false positive and false negative effects: a) The per RNAi transgene used may only cause partial knockdown of gene function, as suggested by the persistent rhythmicity observed when per RNAi was targeted to all clock neurons. This could indicate that the results in Fig 2C-H underestimate the phenotypes of targeted disruption of clock function. b) Use of a single per RNAi transgene makes it difficult to rule out that off-target effects contributed significantly to the observed phenotypes. We suggest that the authors repeat the critical experiments using a separate UAS-RNAi line (for period or for a different clock gene), or, better yet, use the dominant negative UAS-cycle transgene produced by the Hardin lab (https://doi.org/10.1038/22566).

      We have followed the referee advice,repeating the experiments with the dominant negative UAS-cyc<sup>DN</sup>. They nicely confirm our conclusions: the abolition of the cellular clock in LNd neurons rule out the rhythmicity of oviposition. The results are presented in Fig. 3 of the new manuscript, panels H to N. We thank the reviewer for this suggestion that has definitely improved our paper, since it allows us to confirm our result using both a different driver and a different UAS sequence. In addition, we included the required GAL4 controls, which can be found in Panels E, L of the figure as well as average egglaying profiles for all genotypes involved (Panels B, D, F, I, K and M). Regarding the MB122Bsplit-Gal4>UAS-per<sup>RNAi</sup> experiment, we moved it to a supplementary figure (Figure 3S1). The paragraph where the new Figure 3 is discussed has been modified accordingly.

      (3) The egg-laying profiles obtained show clear damping/decaying trends which necessitates careful trend removal from the data to make any sense of the rhythm. Further, the detrending approach used by the authors is not tested for artifacts introduced by the 24h moving average used.

      The method used for the assessment of rhythmicity is now more fully explained and tested in the supplementary material. In particular, the issue of trend removal is treated in the second section of the SM, and the absence of "artifacts" (interpreted as the possibility of deciding that a signal is rhythmic when it is not, or vice versa) shown in figs. S3 to S5.

      (4) According to the authors the oviposition device cannot sample at a resolution finer than 4 hours, which will compel any experimenter to record egg laying for longer durations to have a suitably long time series which could be useful for circadian analyses.

      The choice of sampling every 4 hours is not due to a limitation imposed by the device used. In fact the device can be programmed to move at whatever times are desired. As mentioned in the Material and Methods section, "more frequent sampling gives rise to less consistent rhythmic patterns", because the number of eggs sampled at each time slot become too small. In particular, we have tested sampling at intervals of 2 hours, and we have observed that this doubles the work performed by the experimenter but does not lead to an improvement in the assessment of rhythmicity.

      (5) Despite reducing the interference caused by manually measuring egg-laying, the rhythm does not improve the signal quality such that enough individual rhythmic flies could be included in the analysis methods used. The authors devise a workaround by combining both strongly and weakly rhythmic (LSpower > 0.2 but less than LSpower at p < 0.05) data series into an averaged time series, which is then tested for the presence of a 16-32h "circadian" rhythm. This approach loses valuable information about the phase and period present in the individual mated females, and instead assumes that all flies have a similar period and phase in their "signal" component while the distribution of the "noise" component varies amongst them. This assumption has not yet been tested rigorously and the evidence suggests a lot more variability in the inter-fly period for the egg-laying rhythm.

      As stressed in the paper, and in the new Supplementary Material, the individual egg records are very noisy, which in general precludes the extraction of any information about the underlying period and phase. The workaround we (and others, e.g. Howlader et al. 2006) have used is analyzing average egg records for each genotype. Even though this implies assuming the same period and phase for all individuals, we have observed, using experiments with synthetic data, that small variations in individual periods (of the same amount as those present in real experiments where the period of some flies can be assessed individually) still allow us to use our method to decide if the genotype is rhythmic or not. This issue is discussed at length in the new Supplementary Material. There we also discuss an experiment with real flies, showing the individual records, and the corresponding periodograms, for each fly, for a rhythmic (Fig. S14) and an arrhythmic genotype (Fig. S17).

      (6) This variability could also depend on the genotype being tested, as the authors themselves observe between their Canton-S and YW wild-type controls for which their egg-laying profiles show clearly different dynamics. Interestingly, the averaged records for these genotypes are not distinguishable but are reflected in the different proportions of rhythmic flies observed. Unfortunately, the authors also do not provide further data on these averaged profiles, as they did for the wild-type controls in Figure 1, when they discuss their clock circuit manipulations using perRNAi. These profiles could have been included in Supplementary figures, where they would have helped the reader decide for themselves what might have been the reason for the loss of power in the LS periodogram for some of these experimental lines.

      We have added the individual periodograms of the arrhythmic lines to the Supplementary material (Figs. 3S2, 3S5 and panel G of Fig. 3S1), where they can be compared with their respective controls (Figs 3S3, 3S4, 3S6, 3S7 and panel F of Fig. 3S1).

      (7) By selecting 'the best egg layers' for inclusion in the oviposition analyses an inadvertent bias may be introduced and the results of the assays may not be representative of the whole population.

      We agree that the results may be biased for 'the best egg layers'. We remark however, that the flies that have been left out lay very few eggs, some of them even laying no eggs on a whole day. For these flies it is difficult to understand how one can even speak of egg laying rhythmicity (let alone how one can experimentally assess it). Thus, we think it might be misleading to speak of results as "representative of the whole population". Furthermore, it is even possible that the very concept of egg laying rhythmicity makes little sense if flies do not lay enough eggs.

      (8) An approach that measures rhythmicity for groups of individual records rather than separate individual records is vulnerable to outliers in the data, such as the inclusion of a single anomalous individual record. Additionally, the number of individual records that are included in a group may become a somewhat arbitrary determinant for the observed level of rhythmicity. Therefore, the experimental data used to map the clock neurons responsible for oviposition rhythms would be more convincing if presented alongside individual fly statistics, in the same format as used for Figure 1.

      In general, we have checked that there are no "outliers", in the sense of flies that lay many more eggs than the others in the experiment. But maybe the reviewer is referring to the possibility that a few rhythmic flies make the average rhythmic. This issue is addressed in the supplementary material, at the end of section "Example of rhythmicity assessment for a synthetic experiment". In short, we found that eliminating some of the most rhythmic flies from a rhythmic population makes the average a bit less rhythmic, but still significantly so. Conversely, if these flies are transferred to an arrhythmic population, the average is still non rhythmic.

      Regarding "the number of individual records that are included in a group may become a somewhat arbitrary determinant for the observed level of rhythmicity", we stress that we have not performed a selection of flies for the averages. All of the flies tested are included in the average, independently of their individual rhythmicity, provided only that they lay enough eggs.

      (9) The features in the experimental periodogram data in Figures 3B and D are consistent with weakened complex rhythmicity rather than arrhythmicity. The inclusion of more individual records in the groups might have provided the added statistical power to demonstrate this. Graphs similar to those in 1G and 1I, might have better illustrated qualitative and quantitative aspects of the oviposition rhythms upon per knockdown via MB122B and Mai179; Pdf-Gal80.

      We are aware that in the studies of the rhythmicity of locomotor activity the presence of two significant peaks is usually interpreted as a “complex rhythm”, i.e. as evidence of the existence of two different mechanisms producing two different rhythms in the same individual. In our case, since the periodograms we show assess the rhythmicity of the average time series of several individuals, the two non-significant peaks could also correspond to the periods of two different subpopulations of individuals. However, a close examination of the individual periodograms, now provided as Supplementary Figures 3S2 to 3S9, does not show any convincing evidence of any of these two possibilities.

      Another possibility could be that such peaks are simply an artifact of the method in the analysis of time series that consist of very few cycles and also few points per cycle. In the supplemenatry material we show that this can indeed happen. Consider, for example, periodograms 2 and 4 in Fig. S12 of the SM. Even though both of them display two non significant peaks, these periodograms correspond to two synthetic time series that are completely arrhythmic.

      We have added to the manuscript a paragraph discussing the issue of possible bimodality (next to last paragraph in subsection "The molecular clock in Cry+ LNd neurons is necessary for rhythmic egg-laying").

      Wider context:

      The study of the neural basis of oviposition rhythms in Drosophila melanogaster can serve as a model for the analogous mechanisms in other animals. In particular, research in this area can have wider implications for the management of insects with societal impact such as pests, disease vectors, and pollinators. One key aspect of D. melanogaster oviposition that is not addressed here is its strong social modulation (see Bailly et al.. Curr Biol 33:2865-2877.e4. doi:10.1016/j.cub.2023.05.074). It is plausible that most natural oviposition events do not involve isolated individuals, but rather groups of flies. As oviposition is encouraged by aggregation pheromones (e.g., Dumenil et al., J Chem Ecol 2016 https://link.springer.com/article/10.1007/s10886-016-0681-3) its propensity changes upon the pre-conditioning of the oviposition substrates, which is a complication in assays of oviposition rhythms that periodically move the flies to fresh substrate.

      We agree that social modulation can be important for oviposition, as has been shown in the paper cited by the reviewer. But we think that, in order to understand the contribution of social modulation to oviposition, it is important to know, as a reference for comparisons, what the flies do when they are isolated. Our aim in this work has been to provide such a reference.

      Recommendations for the authors:

      (1) The weaknesses identified in the Public review could be addressed as follows: etc.

      We have followed the suggestions of the editor and addressed each of the weaknesses mentioned (see details above).

      (2) Could the authors comment on their choice of using individual flies for their assay rather than (small) groups of flies? Is it possible that their assay would produce less noisy results with the latter?

      First we want to emphasize that our aim here was to assess the presence of individual rhythmicity, free from any external influences, whether arising from environmental external cues (such as light or temperature changes) or by social interactions (with other females or males). However, we were also curious about the behavior when males were put in the same chamber with each female. We performed a few tests and the results were very similar to what we obtained with single females.

      (3) Minor points:

      (a) Line 57-58 - "around 24 h and a peak near night onset (Manjunatha et al., 2008). Egglaying rhythmicity is temperature-compensated and remains invariant despite the nutritional state": Rephrase to something simpler like temperature and nutrition compensated.

      Corrected.

      (b) Line 56-57 - "The circadian nature of this behavior was revealed by its persistence under DD with a period around 24 h and a peak near night onset (Manjunatha et al., 2008)." A better reference here would be to Sheeba et al, 2001 for preliminary investigations into the egg-laying rhythms of individual flies and McCabe and Birley, 1998 for groups of flies under LD12:12 and DD.

      Suggestion accepted.

      (c) Line 65-67 - "We determined..... molecular clock in the entire clock network reduced the LNv did not." This suggests that it was unknown until now that LNv does not have a role, whereas Howlader et al 2006 already suggested that. The reader becomes aware of this at a later part of the manuscript. Please revise.

      This has been revised, and the citation to Howlader et al 2006 added to the new sentence.

      (d) Line 67 - "impairing the molecular clock in the entire clock network reduced the circadian rhythm of.."; saying "Reduced the power of the circadian rhythm" might be better phrasing."

      Suggestion accepted.

      (e) Line 72 - using the Janelia hemibrain dataset.

      Corrected

      (f) Line 72 typo "ussing", should be 'using'.

      Corrected.

      (g) Line 94: why is the periodic signal the same for all on the first day of DD?

      It is well known that in LD conditions activity is driven by the environmental light-dark cycle, which entrains the endogenous circadian clock of all flies. Even after the transition to DD, the effects of this entrainment persist for a few days, allowing the individual rhythmic patterns set by the light-dark cycle to remain synchronized for at least a few cycles. We are assuming that the same happens with oviposition. A sentence has been added explaining this (beginning of third paragraph of subsection "Egg-laying is rhythmic when registered with a semiautomated egg collection device").

      (h) Figure 1A-D, Were all flies included or only rhythmic flies? Please make this clear. How do you distinguish rhythmic and arrhythmic flies in Figure 1E? Their representative individual plots of egg number graphs are required. Why was the number of flies under DD decreased from 20 to 18?

      Throughout the paper, the analysis of average rhythmicity has been performed including all flies, since we postulate that even flies that individually can be classified as non rhythmic have a rhythm that is corrupted by noise, and that this noise can be partially subtracted by performing an average. The explanation of the characterization of rhythmic and arrhythmic individuals is in the Methods section, under the Data Analysis subsection. This is now fully developed in the Supplementary material, where the individual plots for some of the genotypes are included.

      Regarding the question of the number of flies having "decreased from 20 to 18?", there is a misunderstanding here. The results depicted in Figure 1, and in particular in panel E, correspond to two different experiments: one performed only in LD (7 days, n=20), and a second one performed for 5 days in DD, with one previous day in LD (n=18).

      (i) Figure E and K, Are n=20, 18, and n=30, 22 the total numbers of flies including both rhythmic and nonrhythmic? If so, it would be better to put them in the column, not in the rhythmic column.

      The figure has been corrected.

      (j) Line 107-108, please provide a citation for this statement.

      We have added two references: Shindey et al. 2016, and Deppisch et al. 2022.

      (k) Figure 1, 2, etc., please write a peak value inside the periodogram graph. This makes comparison easier.

      The peak values have been added in all Figures.

      (l) Line 184-185, Figure 2F, tau appears shorter in Clk4.1>perRNAi flies than in control, which suggests that DNp1 may play a role?

      As explained in the Supplementary Material, the particularities of oviposition records (discrete values, noise, few samples per period, etc.) preclude an accurate determination of the period if the record is considered as rhythmic. In particular, Fig. S4 shows that differences of 1 hour between the real and the estimated periods are not unusual.

      (m) Figure 4. Why are 2 controls shown? Please explain. Are they the same strains?

      The two controls shown are the UAS control and the GAL4 control. This information has now been added to the figure.

      (n) Line 314 'that' should be 'than'?

      Corrected.

      (o) Line 73-74 - Phrasing is not clear in: "LNds and oviposition neurons, consisting with, the essential role of LNds neurons in the control of this behavior.""

      Corrected.

      (p) Line 81-84 - "the experiments particularly demanding and labor-intensive. In this approach, eggs are typically collected every 4 hours (sometimes also every 2 hours), which usually implies transferring the fly to a new vial or extracting the food with the eggs and replacing it with fresh food in the same vial (McCabe and Birley, 1998; Menon et al., 2014)." McCabe and Birley had an automated egg collection device designed for groups of flies, which sampled eggs laid every hour for 6 days. Please remove this reference in this context

      Reference removed.

      (q) Line 91-92 - "The assessment of oviposition rhythmicity is challenging because the decision of laying an egg relies on many different internal and external factors making this behavior very noisy." This sentence makes it appear that 'assessment' is the limitation. Even locomotor activity is governed by many internal and external factors, yet we can obtain very robust rhythms. The sentence that follows is also not easy to digest. Can the authors frame the idea better?

      We have rewritten the corresponding paragraph in order to make it more clear (second paragraph of the Results section). Additionally, the Supplementary Material contains now a more detailed explanation and analysis of the method used.

      (r) Line 104-107 - rhythmic (with a period close to 24 h, Figure 1F) although the average egg record is strongly rhythmic with a period around 24 h (Figure 1B). Under DD condition, individual rhythmicity percentages are the same as in LD (Figure 1E) and their average record is also very rhythmic with a period of 24 h (Figure 1D). 'Strongly rhythmic' and 'very rhythmic' are less indicative of what is happening with the oviposition rhythm and can be phrased as robust instead, with a focus on their power measured.

      We have accepted the suggestion.

      (s) Line 108-110 - "Thus, egg-laying displays a much larger variability than locomotor activity, compounding the difficulty of observing the influence of the circadian clock on this behavior." The section discussed here does not illustrate the variability in egg-laying as much as the lack of robustness of the rhythm. The variation in rhythmicity going from CS flies (~70% rhythmic) to yw flies (~50% rhythmic) showcases the variability in this rhythm and how it is difficult to observe when compared to locomotor rhythms, which are usually consistently >90% rhythmic across multiple genotypes. These lines can be placed after the discussion about yw and perS flies. Moreover, previous studies using individual flies have reported that egg-laying rhythm is more variable than others Figure 1, Sheeba et al 2001.

      We have accepted the suggestion, replacing "Thus, egg-laying displays a much larger variability than locomotor activity..." by "This shows that, at the individual level, egg-laying is much less robust than locomotor activity ..."

      (t) Figure 1. Genotype notation within the figure panels is not consistent with the accepted / conventional notation or with the main text or legend notations throughout the manuscript.

      We are sorry for this mistake. We have corrected the genotype names in Figures and text in order to make notation consistent across the paper.

      (u) Supplementary Figure 1 Legend. Error in upper right corner? Not left corner? The photo does not clearly show the apparatus. The authors may wish to consider clearer images and more details about the apparatus including details of the 3D printing of the device and perhaps even include a short video where the motor moves the flies to a new chamber (This is only a suggestion to advertise the apparatus, not related to the review of the manuscript). They could also provide information about what fraction of females survived till the end of each trial when 21 flies were examined with 4-hour sampling across 4-5 cycles.

      In general, more than 80% of the females are alive at the end of a one week oviposition experiment. We have added this information in the Methods section at the end of the corresponding subsection ("Automated egg collection device"). Regarding the eggcollection device, we have replaced the photographs in what is now Supplementary Figure 1S1, and a short supplementary movie showing its operation.

      (v) The results depicted in Figure 2B are that of averaged time series. Hence the reader does not know 'the fact' that knocked-down animals are not completely rhythmic. Is the "not completely arrhythmic" in reference to flies with a power > 0.2 (weakly rhythmic) in their egg-laying rhythm or to the presence of ~40% of male flies (Supplementary Table 1) with a locomotor rhythm after perRNAi silencing of most of their clock neurons? This is confusing because no intermediate category of flies is discussed in Figure 2. Please edit for clarity.

      We were referring to the rhythmicity of the genotype, not of the individuals. We have rewritten the corresponding paragraph in order to make it clearer (last paragraph of the first subsection of the Results section).

      (w) Line 173 - ablation or electrically silencing all PDF+ neurons (Howlader et al., 2006). There were no experiments carried out using electrical silencing of PDF+ neurons in the referenced paper.

      We are sorry for this mistake. This has been corrected (we have deleted the mention to electrical silencing).

      (x) Line 173 - Shortening of period by nearly 3 hours cannot be considered minor.

      We agree, and we have deleted the word "minor".

      (y) Line 332-333 - "We also disrupted the molecular clock (or electrically silenced) in PDFexpressing neurons as well as in the DN1p group with no apparent effect on egg-laying rhythms". There was period shortening observed for pdf GAL4 > perRNAi manipulation so there was an effect on the egg-laying rhythm. Additionally, perRNAi based silencing does not electrically silence PDF neurons as the kir 2.1 was expressed only using Clk4.1 GAL4 in the Dn1ps. This line should be rewritten.

      We have rewritten the paragraph mentioned (third paragraph of the Discussion) in order to make it more accurate.

      (4) Page 22 - Data Analysis

      Since the number of eggs laid by a mated female tend to show a downward trend, we proceeded as follows, in order to detrend the data (see the Supplementary Material for further details). First, a moving average of the data is performed, with a 6 point window, and a new time series T is obtained. In principle, T is a good approximation to the trend of the data. Then, a new, detrended, time series D is generated by pointwise dividing the two series (i.e. D(i)=E(i)/T(i), where i indexes the points of each series)." Can the authors provide a reference for this method of detrending? Smoothing can frequently introduce artifacts in the data and give incorrect period estimates. Additionally, the trend visible in the data, especially in Figure 1, suggests a linear decay that can be easily subtracted. Also, there is no discussion of detrending in the Supplementary material attached.

      We are sorry for the confusion with the Supplementary materials. The method used for subtracting both noise and trend from the data is now fully explained in the new Supplementary Material. All the issues raised by the reviewer in this comment have been addressed there.

      (5) Figure by figure

      Page - Type (Figure or text) - Comment

      (a) Page 6 Figure 1C There is remarkable phase coherence seen in the average egg laying time series for CS flies 5 days into DD and as the authors note in Lines 94-95 in the text "Under light-dark (LD) conditions, or in the first days of DD, it can be that the periodic signal is the same for all flies". Since this observation is crucial to constructing the figures seen later in the paper, a note should be made about why this rhythm could persist across flies, so deep into DD.

      As mentioned above, we have added a couple of lines explaining why we think that the assumption of a synchronized periodic signal is reasonable, at least during the first cycles (second paragraph of the first subsection of section Results).

      (b) Figure 1 G The effect of period/phase decoherence seems to be showing up here in the average profile for yw flies as they seem to completely dampen out after 2 days in DD and yet have a 24-hour rhythm in the averaged periodogram. The authors should make a note here if the LS periodogram is over-representing the periodicity of the first few days in DD or if comparing the first 3 vs. the last 3 days in DD gives different results.

      The dampening observed in average oviposition records is a product of the dampening of the oviposition records, which is well known phenomenon, probably caused by the depletion of sperm in the female spermatheque. One of the aims of the method used in the paper was to avoid the bias introduced by this dampening, by means of a detrending procedure. This is explained in the Materials an Methods, and now full details are given in the new Supplementary Materials.

      (c) Figure 1E, K Is this data pooled across 2-3 experiments, as discussed in lines 500-01 under 'Statistical Analysis'? Also, what test is being performed to check for differences between proportions here, seeing as there are no error bars to denote error around a mean value and no other viable tests mentioned in Statistical Analysis?

      We are sorry for this omission. For the comparison of proportions we used the 'N-1' Chisquared test. We have added a sentence detailing this at the end of the Statistical analysis section.

      (d) Figure 1 F, L Can the total number of weakly and strongly rhythmic values be indicated in the scatter plot?

      Corrected.

      (e) Figure 1F, L (legend) Is the Chi-squared test being performed on the proportion values of Figure 1(E, K) or for Figure 1(F, L)?"

      The chi-squared test mentioned was used for Fig1 F-L. As explained above, for the comparison of proportions we used 'N-1' Chi-squared test. This has now been added to the legend of the figure

      (f) Page 8 Figure 2B Seeing as individual flies with a LS periodogram power < 0.2 are considered weakly rhythmic in Figure 1 F, L can Clk856 > perRNAi flies on average also be considered weakly rhythmic, as the peak in the periodogram is above 0.3?

      We prefer to use the weakly rhythmic class only for individual flies. Nevertheless, we agree that this periodogram shows that the genotype analyzed is not completely arrhythmic, and that this might be due to some remaining individual rhythmicity. As mentioned above, we have rewritten the last paragraph of the first subsection of section Results in order to discuss this.

      (g) Figure 2D Can the authors comment on why there is a shorter period rhythm when PDF neurons have a dysfunctional clock, whereas previous evidence (Howlader et al., 2004) suggested that these neurons play no role in egg-laying rhythm? They should also refer to McCabe and Birley, 1998 to see if their results (where they observed a shorter period of ~19h with groups of per0 flies), might be of interest in their interpretations.

      We have added a line commenting this in the corresponding subsection ("LNv and DN1 neurons are not necessary for egg-laying rhythmicity") of the Results, as well as a discussion of this in the third paragraph of the Discussion. In a nutshell, even though Howlader et al did not find a shortening when PDF neurons are ablated, they did find it in pdf01 flies.

      (h) Figure 2 F, H As the authors mention in their Discussion on Page 16, lines 340-45, the manipulation of DN1p neurons might abolish the circadian rhythm in oogenesis as reported by Zhang et al, which is why they looked at this circuit driven by Clk4.1 neurons and comment that "The persistence of the rhythm of oviposition implies that it is not based on the availability of eggs but is instead an intrinsic property of the motor program". However, no change in fecundity is reported for either kir2.1 or perRNAi-based manipulations of these neurons, to help the reader understand if egg availability (at the level of egg formation) is playing any role in the downstream (and seemingly independent) act of egg laying. The authors should report if they see any change in total fecundity for either set of flies w.r.t their respective controls. Also, is the reduction in power seen with electrical silencing vs perRNAi expression of any relevance? Does the percentage of rhythmic flies change between these two manipulations?

      In the line mentioned by the reviewer what we meant is that our results show that the rhythm of oviposition does not seem to be based in the rhythmic production of oocytes, which is not necessarily connected with the total number of eggs produced. We have modified the corresponding line in the paper, in order to avoid this misunderstanding. Regarding the "reduction in power" mentioned, it must be stressed that, in general, the height of the peak is correlated with the fraction of rhythmic individuals. The problem is that this fraction is a much more noisy output, and that is the reason why we have chosen to work with periodograms of averages.

      (i) Figure 2 E and G, a loss of rhythmicity could also be due to a decrease in fecundity in the experimental lines. Since the number of eggs laid for each genotype is already known, can the authors show statistically relevant comparisons between the experimental lines and their respective controls? In this vein, can the averaged time series profiles also be provided for all the genotypes tested (as seen previously in Figure 1 A, C, G, I), perhaps in the supplementary?

      We did not focus on fecundity in the present work. However, our observations do not seem to show any definite relationship with rhythmicity. We plan to address the issue of fecundity more systematically in a future work. The averaged time series profiles have now been added to the figure.

      (j) Scatter plots showing the average period and SEM as seen in Figure 1 (F, L) would help in understanding if these manipulations have any effect on variation in the period of the egg-laying rhythm across flies. Particularly for pdf GAL4 > perRNAi flies which have a net shorter period, (but this might vary across the 34 flies tested).

      We have added a Supplementary Figure (2S1) that shows that the shortening of oviposition period can be also observed at the individual level. We have also added a line commenting this in the corresponding subsection ("LNv and DN1 neurons are not necessary for egg-laying rhythmicity") of the Results, as well as a discussion of this in the third paragraph of the Discussion.

      (k) Page 11 Figure 3B Does the presence of two peaks in the LS periodogram at a power > 0.2 indicate the presence of weakly rhythmic flies with both a short(20h) and a long(~27h) period component or either one? The short-period peak is nearly at p < 0.05 level of significance. So then, do most of the flies in MB122B GAL4 > perRNAi line show a weakly rhythmic shorter period?

      (l) Figure 3D A similar peak is observed again at 20h (LS power > 0.2 and nearly at p < 0.05 significance level again) and a different longer one at (~30h) though this one is almost near 0.2 on the power scale. Given the consistency of this feature in both LNd manipulations, the authors should comment on whether this is driven by variation in periods detected or the presence of complex rhythms (splitting or change in period) in the oviposition time series for these lines.

      (m) Figure 3 General scatter plots showing average period {plus minus} SEM could help explain the bimodality seen in the periodograms. Additionally indicating just how many flies are weakly rhythmic vs. strongly rhythmic can also help to illustrate how important the CRY+ LnDs are to the oviposition rhythm's stability.

      For these three comments (k, l and m), we note that the issue of bimodality has been addressed above, in our response to Weakness 9.

      (o) Figure 4B Same as comments under Figure 1, what is the statistical test done to compare the proportions for these three genotypes?

      As mentioned above, for the comparison of proportions we used the 'N-1' Chi-squared test. We have added a sentence detailing this at the end of the Statistical analysis section.

      (p) Figure 4C Are all flies significantly rhythmic? The authors should also provide an averaged LS periodogram measure for each genotype, to help illustrate the difference in power between activity-rest and egg-laying rhythms.

      Yes, the points represent periods of (significantly) rhythmic flies. This has been added to the caption, to avoid misunderstandings. The differences that arise when assessing rhythmicity in activity records vs. egg-laying records is addressed at length in the Supplementary Material (see e.g. Fig S1).

      (q) Page 15 Figure 5 - general As the authors discuss the possible contribution of DN1ps to evening activity and control over oogenesis rhythm, investigating the connections of the few that are characterized in the connectome (or lack thereof) with the Oviposition neurons, can help illustrate the distinct role they play in the female Drosophila's reproductive rhythm.

      This information was in the text and the Supplementary Tables. Lines 273-275 of the old manuscript read: "The full results are displayed in Supplementary Tables 2 and Table 3, but in short, we found that whereas there are no connections between LNv or DN1 neurons and oviposition neurons..."

      (r) Minor: The dark shading of the circles depicting some of the clusters makes it difficult to read. Consider changing the colors or moving the names outside the circles.

      Figure corrected.

      (s) Line 38: The estimated number of clock neurons has been revised recently (https://www.biorxiv.org/content/10.1101/2023.09.11.557222v2.article-info).

      Thank you for the reference. We have corrected the number of clock neurons in the Introduction of the new manuscript.

    1. Author response:

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary: 

      In this study, Li et al. used genetically engineered murine intestinal organoids to investigate how the temporal order of oncogenic mutations influences cell state and tumourigenicity of colorectal epithelial cells. By sequentially introducing Apc and Trp53 loss-of-function mutations in alternate orders within a Kras^G12D background, the authors generated isogenic organoid lines for both in vitro and in vivo characterisation. Bulk RNA-seq reveals expected transcriptional changes with relatively modest differences between the two triple-mutant configurations (KAT vs KTA). The key finding emerges from transplantation assays: while KAT and KTA organoids show equivalent tumourigenic potential in immunodeficient mice, only KAT organoids form tumours in immunocompetent hosts (5/10 vs 0/10), suggesting that mutation order shapes susceptibility to immune-mediated clearance. The experiments are well-executed, and the conclusions are generally supported by the data. 

      Strengths: 

      The experimental system is well-designed for the question. By combining a Kras^G12D transgenic background with sequential CRISPR-mediated knockout of Apc and Trp53 in alternate orders, the authors generated truly isogenic organoid lines that differ only in mutational sequence. This is technically non-trivial and provides a clean platform for dissecting order effects, a question otherwise difficult to address experimentally. 

      The authors performed comprehensive baseline characterisation of these organoids, including morphological and histological assessment, quantification of organoid-forming efficiency and proliferation, and bulk RNA-seq profiling. While these analyses revealed no major differences between KAT and KTA organoids, and the observed enhancement of epithelial stemness upon Apc loss and proliferative advantage conferred by Trp53 loss are largely expected, the systematic nature of this characterisation establishes a useful methodological template for future organoid-based studies. 

      The authors further investigated the functional impact of mutational order using subcutaneous transplantation assays. By comparing tumour formation in immunodeficient versus immunocompetent hosts, the authors uncover a genuinely unexpected finding: KAT and KTA organoids behave equivalently in the absence of adaptive immunity, but diverge dramatically when immune pressure is applied (KAT: 5/10; KTA: 0/10). This observation is arguably the most compelling aspect of the study and opens an interesting line of inquiry. 

      We greatly appreciate your positive comments on our study.

      Weaknesses: 

      The authors acknowledge that initiating with Kras^G12D does not reflect the typical human sporadic CRC trajectory, where APC loss is usually the first event. While this design choice was pragmatic, it means the observed order effects are contextualised within an artificial starting point. It remains unclear whether the Apc/Trp53 order would matter in a Kras-wild-type background, or whether the Kras-driven cellular state is a prerequisite for these phenotypes to emerge. 

      We agree with the reviewer that initiating tumorigenesis with Kras<sup>G12D</sup> does not fully recapitulate the most common trajectory of sporadic human CRC, where APC loss typically occurs first. We had noted this point in the original Discussion and will further clarify it more explicitly in the Introduction part of the revised manuscript.

      Our experimental design was intended to establish a controlled and genetically tractable system to interrogate the principle of mutation order effects. In this context, Kras<sup>G12D</sup> activation provides a stable oncogenic baseline that facilitates sequential genome engineering and comparison of isogenic lines.

      Although APC loss is frequently the initiation event, a recent study has suggested that Kras<sup>G12D</sup> priming can reshape the selective landscape for subsequent driver events, including Apc alterations (PMID: 41339549). Consistent with this notion, our data indicate that Kras<sup>G12D</sup> activation induces a permissive oncogenic cellular state that may influence the phenotypic consequences of later mutations. We therefore speculate that the Kras<sup>G12D</sup>-primed context may contribute to the observed order-dependent effects.

      We agree that testing Apc/Trp53 order in a Kras-wild-type background would be an important future direction, and we will point this out explicitly in the revised Discussion.

      Subcutaneous implantation provides a tractable readout of tumourigenicity, but the cutaneous immune microenvironment differs substantially from that of the intestinal mucosa. Given that the central claim concerns immune-mediated selection, orthotopic transplantation would more directly test whether the observed order effects hold in a physiologically relevant context. 

      In the present study, we employed subcutaneous transplantation, which is a widely used platform to assess tumorigenic potential under controlled immune conditions. This approach offers high reproducibility, straightforward tumor monitoring, and has been broadly applied in organoid-based cancer studies in both immunodeficient (PMID: 23273993, 23776211, 32209571, 33055221) and immunocompetent (PMID: 32209571, 33055221, 41672595) settings.

      Importantly, our primary goal was to determine whether mutation order influences susceptibility to immune-mediated clearance, rather than to model the full complexity of the intestinal niche. The clear divergence between KAT and KTA specifically in immunocompetent hosts supports the existence of intrinsic mutation order-dependent immune vulnerability.

      Nevertheless, we fully agree with the reviewer that orthotopic transplantation would provide a more physiologically relevant immune microenvironment and represents also an important direction for future investigation. We will explicitly discuss this limitation and highlight orthotopic validation as an important future direction in the revised Discussion.

      The ssGSEA comparison involves only 14 ATK tumours, and the key comparisons (Figure 6E) yield borderline significance (p=0.052). More fundamentally, since mutation order cannot be inferred from the clinical samples, the authors are correlating organoid-derived IFN signatures with tumour immunophenotypes without direct evidence that these patients' tumours followed a KAT-like trajectory. The reasoning becomes circular: KAT organoids define the signature used to identify KAT-like clinical tumours. 

      We thank the reviewer for raising this important point. We would like to clarify that our intention was not to infer the actual mutation order in clinical samples, which indeed cannot be reliably reconstructed from bulk tumor RNA-seq data.

      Instead, our goal was to determine whether the transcriptional programs distinguishing KAT and KTA organoids could be observed in human CRC cohorts. In this context, the organoid-derived IFN-related signature was used as a molecular reference to assess potential clinical relevance, rather than to classify tumors by evolutionary trajectory.

      We agree that the statistical significance in Figure 6E is modest (p = 0.052), and we would like to revise the text to present this analysis more cautiously as a suggestive trend rather than definitive evidence. We will also clarify this limitation explicitly in the revised manuscript to avoid overinterpretation.

      Furthermore, the most striking finding of the study, that KTA organoids fail to form tumours in immunocompetent hosts while KAT organoids can, lacks a mechanistic follow-up. The transcriptomic differences between KAT and KTA are modest when cultured as monocultures, yet their in vivo fates diverge dramatically. The authors do not address why these subtle intrinsic differences translate into such divergent immune susceptibility, nor do they characterise the immune response adequately (beyond limited CD4/CD8 IHC at tumour peripheries). 

      We thank the reviewer for this important point. We agree that the mechanistic basis underlying the differential immune susceptibility between KAT and KTA remains incompletely resolved.

      A practical limitation of the current study is that KTA grafts failed to establish tumors in immunocompetent hosts, which precluded downstream histological and immune profiling of established lesions. As a result, our in vivo immune characterization of KTA grafts is nearly impossible.

      Nevertheless, our transcriptomic analyses indicate that KAT and KTA organoids differ in interferon-response and immune-related programs prior to transplantation, and those differentially expressed genes were consistently preserved in tumor cells derived from immunodeficient hosts. These results suggest the presence of intrinsic tumor-cell-autonomous differences may influence immune recognition and clearance.

      We will expand the Discussion to outline several non-mutually exclusive mechanisms that could account for this phenotype, including altered interferon responsiveness, differential antigen presentation capacity, and changes in tumor cell-intrinsic immune visibility programs. These hypotheses are consistent with the transcriptional differences observed prior to transplantation and provide a framework for future mechanistic investigation. We agree that deeper immune profiling (e.g., immune infiltrate composition, antigen presentation status, and functional immune assays) will be important to fully elucidate the mechanism and represents a key direction for future work.

      Reviewer #2 (Public review): 

      Summary: 

      This study addresses an important and timely question in colorectal cancer biology by systematically examining the effects of the common driver mutations APC, KRAS G12D, and TP53 in murine colorectal organoids, with particular emphasis on how the order of APC and TP53 acquisition influences tumor phenotype. These mutations are well known to be frequent, truncal, and often co-occurring in colorectal cancer. While it is increasingly appreciated that mutational order can shape tumor behavior, studies directly comparing the phenotypic consequences of alternative APC-TP53 mutation orders remain rare. This work, therefore, addresses a relevant and timely question. 

      Strengths: 

      A major strength of the study is its focus on previously unexplored biology, combined with the generation of multiple isogenic murine organoid models with controlled mutational sequences. The authors employ careful and robust quality control of the CRISPR-mediated alterations, and the inclusion of both in vitro and in vivo experiments strengthens the relevance of the work.

      We greatly appreciate your positive comments on our study.

      Weaknesses: 

      There are, however, several limitations that should be considered when interpreting the findings. First, KRAS G12D activation is used as the initiating alteration, whereas APC loss is generally believed to be the initiating event in most human colorectal cancers.

      We sincerely thank the reviewer for their insightful comments regarding the initiation of tumorigenesis with a Kras mutation rather than the more canonical Apc loss, which was also raised by the reviewer #1. We fully agree that the Apc-first represents the most prevalent sequence in human colorectal cancer (CRC), We will more clearly explain the rationale for our experimental design in the revised Introduction part as outlined in our response to reviewer #1.

      Second, the analysis is restricted to comparing only two mutation orders (KAT versus KTA), which limits the breadth of conclusions that can be drawn about mutation ordering more generally.

      We thank the reviewer for pointing this limitation out. However, as a proof-of-concept, study of Apc and Trp53 loss, two major oncogenic events in CRC, serves as a biologically meaningful starting point for dissecting order-dependent effects. Although it is of great significance to compare all six possible mutation orders of these three driver genes, generating and thoroughly characterizing all genotypes represents a substantial undertaking beyond the scope of this initial study.

      Finally, key RNA-sequencing and in vivo experiments rely on a single isogenic line, which substantially constrains interpretability. 

      The aim of the study was to systematically investigate how mutation accumulation and order influence colorectal cancer initiation. While the data suggest that the relative timing of APC and TP53 loss may be particularly important for tumor initiation, the absence of biological replication makes it difficult to draw robust conclusions. Engraftment efficiency and tumor behavior can be influenced by many factors for a single clone, including additional passenger mutations acquired during culturing, as well as epigenetic differences that are independent of the engineered mutations.

      We thank the reviewer for raising his/her concern. We apologize that we have not made a clear presentation of our data source. Indeed, for all major in vitro and in vivo assays of double and triple mutants (KA/KT/KAT/KTA), we analyzed at least two independently derived clones per genotype. These independent clones harbor distinct mutations in target genes and were treated as biological replicates throughout the study.

      To improve clarity and transparency, we will revise the relevant figures and figure legends to explicitly indicate the clonal origin of each data point.

    1. Author response:

      The following is the authors’ response to the original reviews

      We would like to sincerely thank the editor and reviewers for their thoughtful and constructive feedback on our manuscript. We are grateful not only for the close reading and insightful suggestions, but also for the open and generous way in which the reviewers engaged with our work. In revising the manuscript, we have clarified how our contribution is situated within the existing literature, conducted additional analyses to examine individual differences in exploration strategies, expanded and refined our description of the DDM analyses, and added correlations between strategies and other behavioral measures. We have also clarified methodological points, such as the estimation of thresholds, and provided new supplementary figures and analyses where appropriate. In several places, we have modified and qualified our interpretations in line with the reviewers’ comments. We believe these changes have significantly strengthened the manuscript, and we are grateful for the scientific dialogue with the reviewers.

      Review 1 (Public review):

      This manuscript reports on the behavior of participants playing a game to measure exploration. Specifically, participants completed a task with blocks of exploratory choices (choosing between two 'tables', and within each table, two 'card decks', each of which had a specific probability of showing cards with one color versus another) and test choices, where participants were asked to choose which of the two decks per table had a higher likelihood of one color. Blocks differed on how long (how many trials) the exploration phase lasted. Participants' choices were fit to increasingly complex models of next-trial exploration. Participants' choices were best fit by an intermediate model where the difference in uncertainty between tables influenced the choice. Next, the authors investigated factors affecting whether participants sought out or avoided uncertainty, their choice reaction times, and the relationship of these measures with performance during the test phase of each block. Participants were uncertainty-seeking (exploratory) under most levels of overall uncertainty but became less uncertainty-seeking at high levels of total uncertainty. Participants with a stronger tendency to approach uncertainty at lower levels of total uncertainty were more accurate in the test phase, while the tendency to avoid uncertainty when total uncertainty was high was also weakly positively related to test accuracy. In terms of reaction times, participants whose reaction times were more related to the level of uncertainty, and who deliberated longer, performed better. The individual tendency to repeat choices was related to avoidance of uncertainty under high total uncertainty and better test performance. Lastly, choices made after a longer lag were less affected by these measures.

      The authors note that their paradigm, which does not provide immediate rewarding feedback, is novel. However, the resulting behavior appears similar to other exploratory learning tasks, so it's unclear what this task design adds - besides perhaps showing that exploratory behavior is similar across types of reward environments. Several papers have shown that cognitive constraints modulate exploration (PMIDs: 30667262, 24664860, 35917612, 35260717); although this paper provides novel insights, it does not situate its findings in the context of this prior literature. As a result, what it adds to the literature is difficult to discern.

      We are grateful for your thoughtful reading of our paper and for pointing us to these relevant references. We appreciate the need to clarify how our work is situated within the existing literature. In brief, the novelty of our paper lies in measuring exploration in contexts where it is not in direct competition with the need to exploit knowledge for reward. This approach enables us to include orders of magnitude more exploration trials. With this increased power, we were able— for the first time— to distinguish between competing algorithms for addressing uncertainty, and we identified a novel tendency to avoid uncertainty when overall uncertainty is high. We now state this more clearly in the discussion section and cite the suggested papers.

      “While the literature on exploration is expansive, the paradigm presented here extends it in important ways. Researchers of reinforcement learning have previously examined exploration in the context of reward-seeking decisions. Using such paradigms as the bandit task Schulz and Gershman (2019), it was demonstrated that humans don't always choose the option they believe will yield the most reward, but also make random and directed choices with the aim of exploring other uncertain options (Schulz and Gershman, 2019; Wilson et al., 2014). Recently, studies using the bandit task have lent empirical support to the notion that exploration is difficult, as participants explore less under time pressure or cognitive load (Brown et al., 2022; Otto et al., 2014; Cogliati Dezza et al., 2019; Wu et al., 2022). Crucially, this literature has focused on cases where reward can be gained on each trial (Brown et al., 2022; Cohen et al., 2007; Daw et al., 2006; Schulz and Gershman, 2019; Song et al., 2019; Tversky and Edwards, 1966; Wilson et al., 2014; Wu et al., 2022). In such tasks, the motivation to exploit current knowledge predominates exploration, rendering it rare and difficult to measure (Findling et al., 2019). In contrast, our task was designed to remove the impetus to immediately exploit current knowledge , and as a result we were able to observe many exploratory choices. With this increased experimental power, we were able to compare different algorithms approximating the goal of approaching uncertainty, and describe how and when humans avoid uncertainty instead of approaching it.”

      Reviewer #1 (Recommendations For The Authors):

      Are all participants best fit by the delta uncertainty model? Since other parts of the paper focus on individual differences, it would be useful to examine if people differ in the computational complexity of their exploration strategies and if this difference relates to other behavior.

      We thank you for this helpful suggestion, which prompted us to conduct additional analyses. To address your question, we summarized point-wise predictive accuracy for each participant and compared it across the three models. The results are presented in the new Supplements 2 and 3 to Figure 6.

      These analyses show that, for the vast majority of participants, uncertainty was favored over exposure as a choice strategy, and for a sizable majority, it was also favored over EIG. As detailed in Figure 6 and its supplements, 125 participants were best described by uncertainty relative to EIG, 58 by EIG, and 11 showed inconclusive results. Similarly, 96 participants were better fit by uncertainty than exposure, while an additional 72 had negative exposure coefficients (consistent with uncertainty-based choice). Exposure was supported for 26 participants.

      We also examined how these strategies relate to other behavioral measures. Exposure was not strongly linked to test performance. EIG, by contrast, showed a positive association with test performance, perhaps because it is more closely correlated with uncertainty. Importantly, however, across posterior predictive checks in the main text and supplements, approaching uncertainty continues to provide the best overall description of participants’ strategies.

      The authors construct a hierarchy of exploratory strategies. Perseveration/switching is also an explore/exploit strategy that would lie above random exploration in the authors' hierarchy.

      We chose not to place perseveration within the hierarchy, as from a normative perspective it is not, strictly speaking, an exploration strategy. At its extreme, perseveration would lead a participant to repeatedly sample only one option, leaving the others entirely unexplored. Switching is represented in the hierachy by the equating exposure strategy – they are very similar.

      For the analyses examining uncertainty seeking vs. aversion by total uncertainty, how was the cut point determined? Did this differ across people?

      Thank you for highlighting the need for greater clarity on this point. The threshold was indeed fitted to the data and varied significantly across participants (see Table 6 in Appendix 3). For each participant, the threshold marks the point at which behavior shifts from approaching to avoiding uncertainty. This threshold is a key factor underlying individual differences in the tendency to avoid uncertainty when overall uncertainty is high, as illustrated in the analyses of Figure 6 and related results. We now make this point clearer in the methods section:

      “To quantify how the influence of Δ-uncertainty on choice varied with overall uncertainty, we fit a multilevel piecewise logistic regression model. This model estimated a threshold in overall uncertainty, treated as a free parameter, and allowed the slope of Δ-uncertainty on choice to differ below and above this threshold. Below the threshold, a positive slope reflects a tendency to approach uncertainty; above the threshold, a negative interaction captures the tendency to avoid Δ-uncertainty with higher values of overall uncertainty.”

      More details on the DDM analyses are needed - it's not clear how the outputs of the DDM correspond to what is stated in the text in the results.

      We agree that the section detailing the DDM analyses could be clarified. We analyzed two key parameters of the DDM: the drift rate, which we interpret as reflecting the efficacy of deliberation over uncertainty, and the bound separation, which corresponds to the tendency to deliberate rather than respond quickly. Our results show that good learners exhibit both higher drift rates and higher bounds. When participants repeat a previous choice, both the drift rate and bounds are lower. We changed the way we report the results:

      “We found that RTs indeed varied in relation to the absolute value of Δ-uncertainty as expected b=0.69, 95\% PI=[0.58,0.78]. Crucially, a stronger dependence of RT on the absolute value of Δ-uncertainty predicted better performance at test (drift-rate and test performance association b=0.81, 95% PI=[0.58,1.07]). We further found that participants who tended to deliberate longer for the sake of accuracy also tended to perform better at test (bound height and test perfromance association b=1.46, 95% PI=[0.58,2.34]; Figure8c). In summary, participants who were better at deliberating about uncertainty during exploration, and who deliberated for longer, performed better at test. Thus, making good exploratory choices that lead to efficient learning involves prolonged deliberation.”

      We also provide a detailed explanation of this correspondence in the Methods section:

      “The DDM explains RTs as the culmination of three interpretable terms. The first is the efficacy of a participant’s thought process in furnishing relevant evidence for the decision - in our case the efficacy of choosing according to Δ-uncertainty (the drift rate in DDM parlance). The second term governs the participant’s speed-accuracy tradeoff by determining how much evidence they require to commit to a decision. This can also be thought of as how long a participant is willing to deliberate when a decision is difficult (bound height). Finally, the portion of the RT not linked to the deliberation process is captured by a third term (non-decision time).”

      The authors note that "the three choice strategies prescribe different table choices on most trials" but (from what I can see) only provide a representative participant's plot in Figure 2. What was the overall correlation of predicted choices from the three models?

      Thank you for pointing out this oversight. The correlations are now shown in the supplement to Figure 2. In brief, correlations between exposure and the other two strategies are low, while the correlation between EIG and uncertainty is moderate. These dependencies motivated our decision to fit a separate logistic regression model for each strategy and to compare strategies using formal model comparison and posterior predictive checks, rather than including them all in a single regression model.

      It appears that the models are all constructed to predict table choices and not card deck choices. Can the authors clarify this? If so, what role do the card deck choices have?

      Indeed, the manuscript focuses on table choices, as these are the choices of primary interest from an exploration perspective. It is most straightforward to define the three exploration strategies with respect to table choices, whereas for deck choices it is not clear how to define EIG in respect to the perforamnce at test. The hierarchical structure of the task was originally chosen to increase complexity, with the goal of creating a rich task that engages cognitive resources. We have not formally tested this assumption, and do not expect that the patterns we observe should be absent in a flat version of the task.

      Reviewer 2 (Public review):

      Summary:

      This paper focuses on an interesting question that has puzzled psychologists for decades, that is, why do people demonstrate a mix of uncertainty approach and avoidance behavior, given the fact that reducing uncertainty could always gain information and seems beneficial? This paper designed a novel task to demonstrate behavioral signatures of uncertainty approaching and avoidance during the exploration phase within the same task at both a within-subject and betweensubject level. On the algorithmic level, this paper compared four different implementations of uncertainty-guided exploration and found that the model sensitive to relative uncertainty provides the best fit for human behavior compared to its counterparts using expected information gain or past exposure. This paper then links people's uncertainty attitude with accuracy and finds that uncertainty avoidance during exploration does not impair task performance, implying that uncertainty avoidance may be the output of a resource-rational decision-making process. To examine this account, this paper uses reaction time as an independent proxy of costly deliberation and shows that people deliberate shorter when engaging in repetitive choice, which presumably saves cognitive resources. Finally, the paper shows that people's tendency to engage in repetitive choice correlates with their tendency to avoid uncertainty, which supports the argument that avoiding uncertainty could be a strategy developed under the constraint of limited cognitive resources.

      Strengths:

      One of the highlights of this paper, as mentioned in the previous paragraph, is that the authors can establish the existence of the uncertainty approach and avoidance behavior within the same task whereas previous work usually focuses on one of them. This dissociation allows the authors to examine what situational factor is related to the emergence of the act of avoiding uncertainty, and extract parameters describing participants' attitude towards uncertainty during baseline as well as during situations where uncertainty avoidance is more common. Besides documenting the existence of uncertainty avoidance behavior, this paper also tried to explain this behavior by proposing under the resource rational framework and has carefully quantified different aspects (e.g., accuracy; choice speed) of participants' behavior as well as examined their relationships. Though more experiments are needed to fully understand human uncertainty avoidance behavior, this paper has provided both empirical and theoretical contributions toward a mechanistic understanding of how people balance approaching and avoiding uncertainty.

      Weaknesses:

      I have a couple of concerns related to this paper. First, there seems to exist an anticorrelation between total uncertainty and absolute relative uncertainty (Figure 5 panel C, \delta uncertainty is restricted to a small range when total uncertainty is high). It seems to be a natural product of the exploration process since the high total uncertainty phase is usually the period where the participant knows little about either option, leading to a less distinguishable relative uncertainty. However, it remains unknown whether the documented uncertainty avoidance still applies when extrapolating to larger absolute relative uncertainty.

      We sincerely thank you for your close reading of our manuscript and for highlighting its strengths. In the paradigm we study, overall and relative uncertainty are not anticorrelated. While the two are related—as in any finite-information exploration task, where the value of overall uncertainty constrains the possible range of relative uncertainty—they are not correlated and can therefore be used as predictors in a single regression model. We agree that strategies could differ substantially in a (near) infinite-information setting, such as when people seek semantic knowledge. The advantage of a finite-information task is its tractability, which enables the computational analyses we conducted. That said, the inherently greater intractability of an infinite-information task would likely alter human strategies, as it poses challenges both to participants and to researchers.

      It would be great if the experiment allows for a manipulation of uncertainty in the middle of the experiment (e.g., introducing a new deck/informing that one deck has been updated)

      We agree, and look forward to probing this question in the future. We’ve added the point to our discussion section:

      “Our theoretical analysis and experiments leave several open questions. One concerns the relationship between overall uncertainty and time on task: in our paradigm, overall uncertainty was correlated with the number of cards observed. Although our findings remain robust when trial number is included as a covariate in the regression models, future work could more directly disentangle these factors by orthogonalizing overall uncertainty and elapsed time. This might be achieved, for instance, by manipulating overall uncertainty within a game—such as by introducing new tables or altering outcome probabilities mid-round.”

      Relatedly, the current 'threshold' of uncertainty avoidance behavior, if I understand correctly, is found by empirically fitting participants' data. This brings the question: can we predict when people will demonstrate uncertainty avoidance behavior before collecting any data? Or, is it possible that by measuring some metrics related to cognitive cost sensitivity, we could predict the proportion of choices that participants will show uncertainty-avoidant behavior?

      Thank you again for probing our thinking further. The threshold of uncertainty is indeed fitted on an individual basis using a hierarchical model. We believe there should be ways to predict it. In the current data, we find that it is correlated with the baseline tendency to approach uncertainty: in other words, participants who perform better show a slightly stronger tendency to avoid uncertainty when overall uncertainty is high. This underscores the complexity of identifying correlates of a coping strategy, as it is intricately linked to the difficulty being coped with. We speculate that working memory capacity may play an important role in this strategy, as well as the interplay between working memory–based learning and slower incremental learning mechanisms. Beyond speculation, however, we currently have no data to test these ideas.

      Finally, regarding the analysis of different behavior patterns in the game, it seems that the authors try to link repetitive behavior, uncertainty attitude, and accuracy together by testing the correlation between the two of them. I wonder whether other multivariate statistical methods e.g., mediation analysis, will be better suited for this purpose.

      This was a very insightful comment. We revisited the data and fitted test performance using a multiple regression model, predicting performance from the three exploration-phase strategies simultaneously: baseline tendency to approach uncertainty, tendency to avoid uncertainty when overall uncertainty is high, and tendency to repeat previous choices. When adjusting for the baseline tendency to approach, we find that the tendency to avoid uncertainty is indeed associated with a slight decrement in test performance. However, in our sample, the better learners—who are more effective at approaching uncertainty—also tend to avoid it when overall uncertainty is high. This nuance highlights the point discussed earlier. We find similar results when fitting the data with a mediation model, but we favour the multiple regression approach, since have no strong convictions about which exploration strategy causes another. We have detailed this analysis in the main text and have accordingly modified and qualified our interpretation of this finding:

      “In contrast, the relationship between the tendency to avoid uncertainty and test performance was more nuanced. In both samples, participants who were more inclined to approach uncertainty also tended to avoid it when overall uncertainty was high r=0.43, p=5.42 x 10<sup>-10</sup>. Accordingly, avoidance was positively correlated with test performance at the population level b=1.18, 95% PI=[0.80, 1.58] Figure 7b; see Methods for parameter estimation). However, once we adjusted for the tendency to approach, avoidance was reliably associated with worse test performance b=-0.83, 95% PI=[-1.28,-0.40].”

      Reviewer #2 (Recommendations For The Authors):

      Could the authors elaborate more on why the negative relationship between exposure and choice (Figure 4a) is a natural phenomenon under the relative uncertainty model?

      Indeed, we believe this is a natural phenomenon under the uncertainty model. When simulating an uncertainty-driven agent, the negative relationship arises naturally. We interpret this as the agent repeatedly pursuing tables that are more difficult to learn—those with smaller probability differences. The agent is drawn to these tables precisely because they are harder to master. By contrast, an EIG-driven agent would not repeatedly return to tables that are too difficult to learn. We have revised the Results section to make this point clearer:

      “The simulations demonstrate that the surprising negative correlation between choice and Δ-exposure is an epiphenomenon of uncertainty-driven exploration: agents repeatedly return to harder-to-learn tables, gaining more exposure to them precisely because they remain more uncertain about these tables.”

      It would be great if the authors could provide the correlation between different uncertainty estimates to help the readers have a better sense of how different these estimates are.

      We’ve added this information in the supplement to Figure 2. In brief, correlations between exposure and the other two strategies are low, while the correlation between EIG and uncertainty is moderate. These dependencies motivated our decision to fit a separate logistic regression model for each strategy and to compare strategies using formal model comparison and posterior predictive checks, rather than including them all in a single regression model.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Pierre Despas et al. studied the role of Salmonella typhimurium LppB in outer membrane tethering. Using E. coli ∆lpp mutant the authors showed that Salmonella LppB is covalently attached to PG throug K58 and that these crosslinks are formed by the L,Dtranspeptidase LdtB, primarily. Additionally, authors demonstrate that LppB forms homodimers via a disulfide bond through C57, but when Lpp is present it can also form heterotrimers with it. Thus, suggesting a regulatory role in Lpp-PG crosslinking.

      Strengths:

      In my view, this is a nice piece of work that expands our understanding of the role of lpp homologs. The experiments were well-designed and executed, the manuscript is wellwritten and the figures are well-presented.

      Weaknesses:

      I have some suggestions to give a clearer message, because I think a few images don't reflect much of what the authors wrote.

      We thank Reviewer #1 for this important comment. We agree that several figures could more directly illustrate the points made in the text. In a revised version, we intend to revise the relevant figure panels and legends to better align the visual message with the conclusions, and we will adjust the corresponding text to explicitly state what each figure demonstrates and how the data support our interpretation. We anticipate that these changes will improve clarity and strengthen the alignment between figures and text.

      It'd be helpful for readers to see the phylogenetic tree of the rest of the organisms that harbor LppB homologs and Lpp.

      We thank Reviewer #1 for this suggestion. We examined the distribution of Lpp-family proteins across closely related Enterobacteriaceae. While species such as Escherichia fergusonii, Shigella flexneri and Shigella dysenteriae encode Lpp and as well as a paralogous small lipoprotein (YqhH, see Fig.S7), we find that LppB-like orthologs (equivalent to lppB from Salmonella) appear to be restricted to Salmonella species to our knowledge. Because LppB shows this lineage-specific distribution, inclusion of a broader phylogenetic tree would primarily highlight its restricted presence rather that provide additional evolutionary insight. We will clarify this point in the revised manuscript.

      Increased expression of LppB under low pH is subtle. This result would benefit from quantifying the blots (Fig. S1) and performing statistical analysis.

      We thank Reviewer #1 for this observation. We agree that the increase in LppB levels at acidic pH appears modest. We will carefully reassess this result across independent experiments and, where technically appropriate, provide quantitative information to better document the magnitude of the effect. Additionally, we will revise the text to more accurately described the observed difference.

      Similarly, the SDS-EDTA sensitivity result (Fig. S2) is not convincing; the image doesn't seem to show isolated colonies at low pH (Fig. S2B). Please measure CFU/mL and report endpoint growth graphs instead. Statistical analysis should also be presented.

      We thank Reviewer #1 for this suggestion. We agree that the SDS-EDTA sensitivity assay presented in Fig. S2 could benefit from a more quantitative assessment. We will perform CFU/mL measurements from independent biological replicates to better quantify the observed differences and include statistical analysis when appropriate. In addition, we will revise the corresponding text to more accurately reflect the magnitude of the phenotype.

      The reduction to PG crosslinking of the C57R mutant is unclear (Fig 4B lane 22). The authors state: "suggesting that additional features of the LppB C-terminal region underlie its reduced efficiency." Does this mean additional amino acids play a role? Did the authors try to substitute Cys with other amino acid residues like Ala or Ser and quantify protein levels to find a mutant with similar expression levels? Do these have less crosslinking too?

      We thank Reviewer #1 for this important comment. As correctly noted, the reduced abundance of the LppB<sub>C57R</sub> variant likely contributes to its reduced level of peptidoglycancrosslinked species. Therefore, we cannot formally distinguish whether the reduced peptidoglycan crosslinking reflects decreased intrinsic crosslinking efficiency or simply reduced protein abundance and stability. We will revise the text to clarify this point and explicitly acknowledge this limitation. The C57R substitution was chosen because arginine is present at the equivalent position in the Salmonella LppA homolog, allowing us to assess the functional consequences of a naturally occurring sequence variation between Lpp-family members. While substitutions such as C57A or C57S could further dissect the specific contribution of the cysteine residue, our use of the C57R substitution provides direct insight into the functional implications of this naturally occurring difference between Lpp homologs.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Pierre Despas and co-workers, reports the biochemical characterization of LppB a peculiar Lpp (Braun's lipoprotein) homolog found in Salmonella enterica. S. enterica encodes two Lpp homologs LppA and LppB: while LppA and Lpp function similarly, the role of LppB is less clear. LppB shares with Lpp the Cterminal Lys needed for covalent attachment to peptidoglycan (PG) but diverges in residues that precede the terminal Lys featuring a Cys residue at the penultimate position. By using E. coli as a surrogate model, the authors show that LppB can be covalently linked to PG via the terminal Lys residues and that the penultimate Cys residue can be used to form homodimer species when expressed alone and heterotrimeric complexes when co-expressed with Lpp. Interestingly, LppB expressed in E. coli seems to be stabilized at acidic pH a condition Salmonella encounters in macrophage phagosomes. Finally, based on decreased intensity of LppB-PG crosslinked bands as LppB expression increases the authors suggest that LppB is able to negatively modulate the outer membrane-peptidoglycan connectivity.

      Strengths:

      The manuscript is interesting, describes a novel strategy employed by bacteria to fine tuning outer membrane-PG attachment and provides new insights into how envelope remodeling processes can contribute to bacterial fitness and pathogenicity.

      Weaknesses:

      The analysis and quantification of muropeptides formed in E. coli strains overexpressing LppB would strengthen the main conclusion of the manuscript.

      We thank Reviewer #2 for this insightful comment. We agree that quantitative analysis of muropeptides in E. coli strains expressing LppB would strengthen the main conclusion. This point was also raised in the editorial assessment and by Reviewer #3, underscoring its importance. In a revised version, we plan to perform muropeptide profiling by HPLC, coupled where appropriate to mass spectrometry, to quantitatively assess peptidoglycan composition in the relevant strains.

      Reviewer #3 (Public review):

      Summary:

      The manuscript is interesting, and it is clearly written. While the experiments are well executed, a general flaw is that the LppA/B analyses are done in the E. coli K12 host as surrogate for Salmonella enterica. For the mechanistic and molecular analyses of LppB a surrogate host is certainly adequate, yet it limits extrapolation of the physiological implications of LppB in the natural context. 

      Strengths:

      The work convincingly demonstrates that LppB forms disulfide-based dimers and that it is crosslinked to PG via LdtB in E. coli. Moreover, dimerization is required for LppB abundance in E. coli and LppB can inhibit crosslinking of Lpp/A to PG in E. coli. 

      Weaknesses:

      Regarding the key conclusion of the work: while it is shown that LppB is oxidized in E. coli, whether envelope integrity (or OMV production) changes arise from switches in oxidation of the LppB cysteines remains to be shown, for E. coli let alone in the native host Salmonella. Does expression of LppB influence Lpp/A activity or OM tethering in E. coli? Since the inhibition of the Lpp/A linking to PG is not affected by the oxidation state of LppB, the abstract/title implies redox-control of envelope integrity which is a bit misleading and an overstatement. Both are features of LppB: i.e. it dimerizes through disulfide bond formation and it reduces PG binding of Lpp/A through trimerization. However, no link between the two is shown.

      We thank Reviewer #3 for this important comment and for highlighting the need to clarify the relationship between LppB oxidation, oligomerization, and its effect on peptidoglycan crosslinking. We agree that while our data demonstrate that LppB forms disulfide-linked oligomers and that LppB expression reduces Lpp/A attachment to peptidoglycan, our current results do not establish a direct causal link between the oxidation state of LppB and its ability to modulate outer membrane–peptidoglycan tethering. Therefore, we will revise the manuscript to avoid implying redox-dependent control of envelope integrity and to more clearly present these as distinct but potentially related properties of LppB.

    1. Author response:

      We thank the reviewers for their constructive feedback and careful evaluation of our manuscript. We are encouraged that the study was viewed as well designed and clearly presented, that its computational modeling approach was recognized as a strength, and that the key findings were appreciated. We agree that some claims would benefit from additional support and clarification. Below, we outline the main revisions we will undertake to strengthen the manuscript and address the points raised in the reviews. These revisions are intended to strengthen the evidential support for our conclusions and clarify aspects of the results and modeling.

      (1) Statistical support.

      Some claims were judged to lack sufficient statistical support [Reviewer 1]. In the revised manuscript, we will carefully review all inferential claims and ensure that they are supported by appropriate statistical analyses. Where necessary, we will implement additional statistical tests and expand statistical reporting to ensure that differences between conditions, models, or behavioral measures are formally evaluated and that key aspects of the data are appropriately described.

      (2) Modeling clarification.

      Some aspects of the modeling were considered insufficiently clear, particularly regarding how the models were implemented [Reviewers 1 and 2]. We will expand the Methods section to provide a clearer and more complete description of the Bayesian models and their implementation. In particular, we will clarify that full probability distributions were computed (without reduced approximations such as those used in simplified Bayesian variants), and that the only approximation concerns numerical discretization of continuous state spaces at fine resolution. We will clarify that variance is part of the joint multidimensional state space and is inferred jointly with the mean. We will also explicitly state that apparent learning rates are derived from predicted paddle responses in the same way as for participants, and are not directly computed within the Bayesian inference process.

      (3) Model fitting.

      The absence of direct model fitting to individual participants was identified as a limitation [Reviewers 1 and 3]. In response, we will implement individual-level model fitting (to the extent feasible in practice) and conduct formal model comparison based on the fitted models. We will further validate the fitted models by examining whether they reproduce the main behavioral signatures observed in the data.

      (4) Normative interpretation and control analyses.

      The interpretation of the models as normative was questioned in light of the response-probability mechanism [Reviewer 2]. In the revision, we will clarify the distinction between the normative inference component of the model and the response-level mechanism. We will revise the framing of the results accordingly and ensure that normative claims are restricted to the inference component. We will also expand the discussion to integrate relevant literature on perseveration and satisficing, and clarify how normative and non-normative mechanisms may jointly shape behavior. In addition, following the reviewer’s suggestion, we will include control analyses using standard Rescorla–Wagner models, with and without the response-probability mechanism, to evaluate whether the observed signatures can be accounted for by simpler learning rules.

      (5) Additional points.

      We will also address the additional points raised in the reviews. Specifically, we will include supplementary histograms of apparent learning rates [Reviewer 2]. We will provide additional clarification and analyses regarding the effects of stochasticity on learning [Reviewer 1]. Finally, we will explore hybrid or mixture models and strategies and expand the discussion of this possibility [Reviewer 3].

      We believe that these revisions will substantially strengthen the support for our claims and address the concerns raised in the current assessment. We are grateful for the reviewers’ engagement with our work and for their comments, which will allow us to significantly improve the clarity and strength of the manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work presents a GUI with SEM images of 8 Utah arrays (8 of which were explanted, and 4 of which were used for creating cortical lesions).

      Strengths:

      Visual comparison of electrode tips with SEM images, showing that electrolytic lesioning did not appear to cause extra damage to electrodes.

      Weaknesses:

      Given that the analysis was conducted on explanted arrays, and no functional or behavioural in vivo data or histological data are provided, any damage to the arrays may have occurred after explantation. This makes the results limited and inconclusive (firstly, that there was no significant relationship between degree of electrode damage and use of electrolytic lesioning, and secondly, that electrodes closer to the edge of the arrays showed more damage than those in the center).

      We agree insofar as we could not fully control the circumstances of each array during explantation. However, array explantation is potentially damaging, but not universally damaging, as demonstrated by some largely intact arrays in this paper. If electrolytic lesions were damaging to the array, they would be observed. All arrays examined in this paper were carefully stored as described in the paper. All analyses of this type require an explant surgery [?????]. Our conclusions remain as strong as any of the results of these analyses.

      Overall, these results do not add new insight to the field, although they do add more data and reference images.

      We respectfully disagree, as there is no extant SEM analysis on electrode arrays used for lesioning.

      Reviewer #2 (Public review):

      In this study, the authors used scanning electron microscopy (SEM) to image and analyze eleven Utah multielectrode arrays (including eight chronically implanted in four macaques). Four of the eight arrays had previously been used to deliver electrolytic lesions. Each intact electrode was scored in five damage categories. They found that damage disproportionately occurred to the outer edges of arrays. Importantly, the authors conclude that their electrolytic Lesioning protocol does not significantly increase material degradation compared to normal chronic use without lesion. Additionally, the authors have released a substantial public dataset of single-electrode SEM images of explanted Utah arrays. The paper is well-written and addresses an important stability issue for long-term chronically implanted array recordings and electrolytic lesioning, which is relevant to both basic science and translational research. By comparing lesioning and non-lesioning electrodes on the same array and within the same animal, the study effectively controls for confounds related to the animal and surgical procedures. The shared dataset, accessible via interactive plots, enhances transparency and serves as a valuable reference for future investigations. Below, we outline some major and minor concerns that could help improve the work.

      Major concerns:

      (1) Electrode impedance is a critical measurement to evaluate the performance of recording electrodes. It would be helpful if the authors could provide pre-explant and post-explant impedance values for each electrode alongside the five SEM damage scores. This would allow the readers to assess how well the morphological scores align with functional degradation.

      We agree, electrode impedance is very important in determining electrode performance. However, due to the multi-year, multi-subject nature of this work, we unfortunately do not have this data.

      (2) The lesion parameters differ across experiments and electrodes. It would be helpful if the authors could evaluate whether damage scores (and/or impedance changes) correlate with total charge, current amplitude, duration, or frequency.

      Thank you for this recommendation. We have included additional analyses in Supplementary Materials.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) ‘Both in vitro and in vivo testing of electrode arrays revealed environmental damage to these materials, such as cracking, textural defects, and degradation in response to the brain’s temperature and salinity [32]. The immune response of the brain also damages the electrodes due to effects like glial scarring (gliosis) and inflammation [33, 34]. This damage may be exacerbated by the surgical techniques used during implantation, which include pushing the electrode array into cortex and tethering the implant to the skull [33, 35, 36].’

      In the above text, several relevant references have been left out, e.g.:

      Barrese et al., 2013

      Patel et al., 2023

      Woeppel et al, 2021

      Chen et al., 2023

      Bjanes et al., 2025

      Thank you for this recommendation. This section has been updated.

      (2) ‘Aggressive electrical stimulation is known to dissolve platinum-based electrodes [37, 38]. Other studies have shown iridium oxide to be more resistant to stimulation-related damage, but not completely insusceptible [39, 40].’ Reference number 25 is relevant here.

      Thank you for this recommendation. This section has been updated.

      (3) ‘F’s and C’s PMd arrays were used for electrolytic lesioning experiments Monkey U was implanted with three 96-channel arrays; two in M1 and one in PMd.’ There seems to be a punctuation mark missing.

      Thank you for this recommendation. This section has been updated.

      (4) Methods: How much charge was injected via the electrodes that were used for lesioning? What current amplitudes, voltages, durations, and number of pulses were used? If more than 1 pulse was applied, what were the frequencies? Was the pulse cathode-only/ anode/only? What were the electrode impedance values at the time of stimulation? How many electrodes were used for lesioning at any given moment? How long after lesioning did the arrays remain in the tissue?

      Thank you for your questions. An additional supplemental table (Supplemental Table 6) detailing specific NHP lesions parameters has been added. A summary of the lesion procedure (DC, bipolar, two electrodes at a time) has also been included in Methods. All arrays remained in the subject until explant, which ranged between hours (same-day lesion and explant) to several years. Further details on the lesioning procedure are available in citation [?]. Explant dates are available in Supplemental Table 1. Unfortunately, we do not have the impedance values at time of lesioning as this is not a measure we record frequently after implant, though we agree the data would be useful to have.

      (5) Caption for Figure 1: ‘All array images are displayed with the wire bundle to the right side.’ I recommend adding this text from Figure 2 to the caption of Figure 1: ’electrode tips facing viewer’.

      Thank you for this recommendation. This section has been updated.

      (6) ‘Electrodes used for electrolytic lesioning are denoted with blue dots.’ Was stimulation carried out across all these electrodes simultaneously?

      No, stimulation was not carried out across all electrode simultaneously. Pairs of electrodes were stimulated at the same time to create lesions. Lesions were performed on different days. We have updated our methods section to reflect this. See the Methods section and citation [?] for more details.

      (7) For the control array, in Figure 1: ‘Click each column to view a close-up of the 5th row (from top to bottom) of electrodes:’ . It would be clearer to state: ’Click each column to view a close-up of a single electrode in the 5th row (from top to bottom):’.

      Thank you for this recommendation. This section has been updated.

      (8) Figure 2 caption: ‘Blank electrodes and electrodes with shank fractures are ignored and displayed in black, as they are not scored.’. What is a ‘blank’ electrode?

      A ‘blank’ electrode is an electrode on the array that physically exists but is not wire bonded at time of manufacture to produce recordings. The corner electrodes of the Utah array are all blank electrodes. We have updated this wording to ‘unwired’ for clarity.

      (9) I recommend incorporating Supplementary Figure 1 into Figure 2, so that the reader can immediately see where the rings are, without referring to the Supplementary Materials.

      Thank you for this recommendation. We have chosen to keep these figures separate for stylistic reasons.

      (10) Supplementary Figures: The figures should have the word ’Supplementary’ in the title, i.e., ‘Supplementary Figure X,’ not just ‘Figure X.’

      Thank you for this recommendation. These captions have been updated.

      (11) Throughout the results, the text is overly focused on the type of statistical test used and the p-values, e.g.: ‘When comparing lesioning and non-lesioning electrodes within the same array, each of the two nonparametric statistical tests (Mann-Whitney U-test, Levene Test) returned insignificant p-values for each category of damage as well as for total damage scores for all four arrays used in lesioning experiments.’.

      To make the findings more digestible for the reader, the text should be rephrased in terms of whether the metrics being compared were significantly different or not. E.g.: ‘For each category of damage, as well as for the total damage score, no significant difference was found between electrodes that were or were not used for lesioning (either the mean or the variance of the scores).’.

      Thank you for this recommendation. We have rephrased the text to reflect this note.

      (12) ‘In Monkey H, the Mann-Whitney U test resulted in an insignificant p-value for coating cracks and parylene C delamination scores, while the Levene test resulted in an insignificant p-value for abnormal debris, coating cracks, and parylene C cracking scores. In Monkey F, the Mann-Whitney U test resulted in an insignificant p-value for parylene C delamination scores, while the Levene test resulted in an insignificant p-value for coating cracks, parylene C delamination, and parylene C cracking scores. In Monkey U, the Mann-Whitney U test resulted in significant p-values for all scores, while the Levene test resulted in an insignificant p-value for abnormal debris, tip breakage, and coating cracks scores. Finally, in Monkey C, the Mann-Whitney U test resulted in an insignificant p-value for parylene C delamination and parylene C cracking scores, while the Levene test resulted in an insignificant p-value for abnormal debris, parylene C delamination, and parylene C cracking scores.’

      To point out another example, this chunk of text is highly repetitive and is unnecessary, as the reader can simply refer to Supplementary Table 4. It should be completely rephrased and summarized, to deliver the key message, i.e. briefly describe what kinds of damage occurred for which arrays. Also, what is the point of the two statistical tests? What are the authors trying to conclude?

      Thank you for this recommendation. We have rephrased and pared down the text to reflect this note.

      (13) Discussion: ‘Similarly, other work did not show significant differences in SEM-visible degradation between both platinum and iridium oxide coated electrodes used for stimulation [24, 25].’ What differences are being referred to here? Differences in degradation between stimulated Pt versus stimulated IrOx electrodes? Or between stimulated Pt and unstimulated PT electrodes? Stimulated IrOx and unstimulated IrOx? Or something else?

      Thank you for your questions. We are comparing platinum against iridium oxide in this sentence. The wording of our original text has been updated to clarify our intention.

      (14) Supplementary Tables: P-values lower than .05, .01, and .001 should simply be replaced with ¡.05, ¡.01, and ¡.001. The alpha value after a Bonferroni correction should be stated somewhere in each table or table caption.

      Thank you for this recommendation. We have edited the tables to reflect this note.

      (15) Title: ‘Material Damage to Multielectrode Arrays after Electrolytic Lesioning is in the Noise’ I don’t understand what the title means. What is in the noise? And what is ‘the noise’?

      “In the noise” is a colloquialism referring to how background information (“noise”) may obscure or distract from other features. This title conveys how material damage to multielectrode arrays due to electrolytic lesioning is largely obscured by the general damage observed on multielectrode arrays after implant and explant.

      (16) This reference has been left out altogether: Chen et al., 2014. The effect of chronic intracortical microstimulation on the electrode-tissue interface.

      Thank you, this reference is now included.

      Reviewer #2 (Recommendations for the authors):

      (1) The number of lesion electrodes is low, especially since there are only 2-10 lesion electrodes on three of the four arrays, yielding limited statistical power.

      We agree that the low number of lesioned electrodes limits statistical power. However, due to ethical considerations, it is unlikely for arrays to contain much more than this number of lesion electrodes.

      (2) The dataset includes both platinum and iridium oxide-coated electrodes. A direct comparison of their damage profiles would be informative.

      Thank you for this recommendation. We have included this additional analysis in Supplementary Materials.

      (3) It is unclear what “is in the Noise” in the title means without reading the manuscript. It is helpful to improve the clarity of the title.

      Thank you for this recommendation.

      (4) Please spell out “PMd” and “M1” at first mention to facilitate reading.

      Thank you for this note. The text has been updated to reflect this recommendation.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Using single-unit recording in 4 regions of non-human primate brains, the authors tested whether these regions encode computational variables related to model-based and model-free reinforcement learning strategies. While some of the variables seem to be encoded by all regions, there is clear evidence for stronger encoding of model-based information in the anterior cingulate cortex and caudate.

      Strengths:

      The analyses are thorough, the writing is clear, and the work is well-motivated by prior theory and empirical studies.

      Weaknesses:

      My comments here are quite minor.

      The correlation between transition and reward coefficients is interesting, but I'm a little worried that this might be an artifact. I suspect that reward probability is higher after common transitions, due to the fact that animals are choosing actions they think will lead to higher reward. This suggests that the coefficients might be inevitably correlated by virtue of the task design and the fact that all regions are sensitive to reward. Can the authors rule out this possibility (e.g., by simulation)?

      We fully agree with the reviewer that the task design has in-built correlations between transition and reward, and thus the correlation between neural selectivity for feedback and transition (Figure 3E) may be due to the different reward expectation after common or rare transitions. We did try to make this point in the manuscript:

      This suggests that the brain treats being diverted away from your current objective equivalent to losing reward, which is sensible as the subject would normally expect lower rewards on rare trials if their reward-seeking behaviour was efficient.

      We’ve now updated the wording of this statement to try and better make this point and avoid confusion that any non-reward-related encoding is involved:

      “As the reward expectation will be higher on common compared to rare trials, this demonstrates that the brain encodes being diverted to an area with a lower reward expectation equivalent to actually receiving a low reward (and vice versa).”

      We have also adjusted the significance test of this correlation to use a circular permutation test that accounts for correlations between the regressors. This test still found there to be significant correlation in all areas.

      We have described this new permutation test in Methods:

      “For comparing correlations between weights for different features (i.e., between transition and reward coding, Figure 3E), the null distribution of correlations observed in circularly shifted data was compared to the correlation seen in the actual data. This accounts for any correlations between features that existed in the task by preserving the structure of the design matrices.”

      And updated the text in Results accordingly:

      “All regions, but particularly ACC, encoded a common transition (at the time of transition) similar to a high reward (at the time of feedback), as there was a positive correlation between the coefficients for reward and transition (the transition parameter was signed such that common and rare transitions were equivalent to high and low rewards, respectively) (ACC r=0.4963, DLPFC r=0.3273, caudate r=0.4712, putamen, r=0.5052; all p<0.002 except DLPFC where p=0.006, circular permutation test; Figure 3E, S5).”

      The explore/exploit section seems somewhat randomly tacked on. Is this really relevant? If yes, then I think it needs to be integrated more coherently.

      We thank the reviewer for this comment. We agree that the motivation for the explore/exploit analysis was not sufficiently clear in the original version.

      Our aim was not to introduce this as a separate or tangential effect, but rather to highlight how the task’s reward structure (with outcome levels stable for 5–9 trials) naturally created alternating periods favoring exploitation of a known high-value option versus exploration when outcomes changed. This feature of the task is tightly linked to MB-RL computations, as it requires integration of state-transition knowledge and updating across trials.

      Importantly, we show previously in the manuscript that ACC encoded state-transition structure (i.e., common versus rare transition) and MB-value estimates (at choice epoch). However, here we aimed to highlight that the same region also modulated choice encoding as a function of whether the subject was in an exploratory or exploitative regime – by knowing another feature of the task that relies on state-transition and outcome. We have revised this section to better integrate it into the main logic of the paper:

      “In our task, the outcome level (high, medium, low) of each second-stage stimulus remained the same for 5-9 trials before potentially changing. This design naturally created periods where subjects could ‘exploit’ the same Choice 1 to maximize reward for several trials; and other periods where they had to ‘explore’ different second-stage stimuli to optimize reward (as contingencies shifted). In classical MB-RL, the transition between reward states can be learned by keeping counts of observed transitions from a current state-action pair to a subsequent state, yielding a maximum-likelihood estimate of the environment’s dynamics [42]. In fact, knowledge about the reward contingency schedule could support decision-making in both exploitation – by enabling efficient choice when rewards are stable; and exploration – by guiding alternative behaviour most likely to yield improved outcomes (this is different from MF learning, where exploration is more random since the agent lacks explicit state-transition knowledge).

      We thus repeated our decoding analysis of choice 1 stimulus identity, but this time limited trials to those where they had not received a high reward for the previous two trials (‘explore’ trials), and those where the previous two rewards had been the highest level (‘exploit’ trials). All regions encoded choice 1 for some duration of the choice epoch for both explore (p<0.002 in all cases, permutation test; Figure 7A) and exploit (p<0.002 in all cases; Figure 7B) conditions, but decoding accuracy was strongest in ACC. Choice 1 was less strongly decoded – particularly in ACC – in the former condition compared to the latter (p<0.002 for at least 140 ms in all cases, permutation test on differences observed; Figure 7C); and, also during exploitation, the ACC encoded choice 1 before the choice was even presented to the subject (Figure S8). This pre-choice ACC encoding in exploit trials may reflect the need to allocate cognitive (or attentive) resources to features – i.e., choice 1 stimulus identity – that are most certain predictors of important outcomes. As a control, we also decoded the direction of the Choice 1 (where choice was indicated via joystick movement), which was randomised each trial and therefore orthogonal to the stimulus that was chosen. Again, all four regions encoded its direction in both explore (p<0.002 in all cases; Figure 7D) and exploit (p<0.002 in all cases; Figure 7E). However, there were minimal differences in the strength of the representation between explore and exploit conditions (ACC, p=0.088, cluster-based permutation test; DLPFC p=0.016; caudate p=0.32; putamen p=1; Figure 7F). Therefore, exploit behaviour specifically upregulated relevant task parameters that were worth remembering across trials.”

      Reviewer #2 (Public review):

      Summary:

      The authors investigate single-neuron activity in rhesus macaques during model-based (MB) and model-free (MF) reinforcement learning (RL). Using a well-established two-step choice task, they analyze neural correlates of MB and MF learning across four brain regions: the anterior cingulate cortex (ACC), dorsolateral PFC (DLPFC), caudate, and putamen. The study provides strong evidence that these regions encode distinct RL-related signals, with ACC playing a dominant role in MB learning and caudate updating value representations after rare transitions. The authors apply rigorous statistical analyses to characterize neural encoding at both population and single-neuron levels.

      Strengths:

      (1) The research fills a gap in the literature, which has been limited in directly dissociating MB vs. MF learning at the single unit level and across brain areas known to be involved in reinforcement learning. This study advances our understanding of how different brain regions are involved in RL computations.

      (2) The study used a two-step choice task Miranda et al., (2020), which was previously established for distinguishing MB and MF reinforcement learning strategies.

      (3) The use of multiple brain regions (ACC, DLPFC, caudate, and putamen) in the study enabled comparisons across cortical and subcortical structures.

      (4) The study used multiple GLMs, population-level encoding analyses, and decoding approaches. With each analysis, they conducted the appropriate controls for multiple comparisons and described their methods clearly.

      (5) They implemented control regressors to account for neural drift and temporal autocorrelation.

      (6) The authors showed evidence for three main findings:

      (a) ACC as the strongest encoder of MB variables from the four areas, which emphasizes its role in tracking transition structures and reward-based learning. The ACC also showed sustained representation of feedback that went into the next trial. b) ACC was the only area to represent both MB and MF value representations.

      (c) The caudate selectively updates value representations when rare transitions occur, supporting its role in MB updating.

      (7) The findings support the idea that MB and MF reinforcement learning operate in parallel rather than strictly competing.

      (8) The paper also discusses how MB computations could be an extension of sophisticated MF strategies.

      Weaknesses:

      (1) There is limited evidence for a causal relationship between neural activity and behavior. The authors cite previous lesion studies, but causality between neural encoding in ACC, caudate, and putamen and behavioral reliance on MB or MF learning is not established.

      We agree with the reviewer that the present study does not establish causal relationships, and we do not claim otherwise in the manuscript. Our work was designed as a comprehensive characterization of neural activity across ACC, DLPFC, caudate, and putamen during reward-seeking decision-making. By systematically comparing MB- and MF- RL signals across these regions, we provide new insights into the division of labor and cooperative interactions within cortico-striatal networks.

      While causal manipulations (e.g., lesions, inactivations, stimulation) are indeed required to directly establish necessity or sufficiency, correlational studies such as ours play a crucial role in identifying where and how computationally relevant signals are represented. Importantly, our findings align with and extend prior causal work, for example showing that ACC and striatal lesions disrupt MB control. Thus, our study contributes a detailed functional mapping of MB and MF RL encoding across multiple nodes of this circuit, which serves as an important foundation for future causal investigations (e.g., using transcranial ultrasound stimulation).

      (2) There is a heavy emphasis on ACC versus other areas, but it is unclear how much of this signal drives behavior relative to the caudate.

      We appreciate the reviewer's observation regarding this matter. Our intention was not to place a heavy emphasis on ACC, rather this came naturally from the data. The ACC demonstrated considerably more robust and enduring neural activity compared to other brain regions – for instance, reward-related signals in the ACC continued well beyond individual trials (Fig. 2A-B), and encoding of state transitions remained active from the initial transition through to the feedback phase (Fig. 3A-B). By comparison, distinctions among other regions were less pronounced, which naturally resulted in the ACC receiving greater attention in our analytical findings.

      We acknowledge that the caudate plays an essential and complementary role in driving behavior, and we believe that this is emphasized in the two key subsections of our “Results”. First, caudate neurons encoded model-based choice values (Fig. 4A, 4C) and uniquely remapped these values following rare transitions (Fig. 5), reflecting flexible adjustment of action values. Second, decoding analyses showed that both ACC and caudate populations predicted first-stage choices (Fig. 6C), linking their activity directly to behavioral decisions. In the Discussion section, we also highlight that “the distinctive caudate signal of updating (flipping) the value estimates of the currently experienced option on rare trials” goes beyond a “general temporal-difference RPE” and rather supports “the role of caudate in MB valuation”.

      (3) The role of the putamen is somewhat underexplored here.

      Our analyses were conducted in an identical manner across all four recorded regions (ACC, DLPFC, caudate, and putamen), and we consistently reported the results for putamen alongside the others. For example, in the Results section we describe how “both caudate and putamen encoded the reward from the previous trial negatively during the feedback period of the current trial” (Fig. 2F-G), and that “all regions had a significant population of neurons that encoded MB-, but not MF-, derived value” including putamen (Fig. 4F). Similarly, we show that putamen, like caudate, encoded a dopamine-like RPE signal at feedback (“both caudate and putamen neurons clearly responded at feedback with the parametric features of a dopamine-like RPE”; Discussion). These findings align with previous work linking the putamen to MF learning and are discussed explicitly in the context of MF-MB dissociations. We therefore believe that the putamen was not underexplored, but rather that its contribution was more circumscribed relative to ACC and caudate because the signals observed were quantitatively weaker and less distinctive for MB computations.

      (4) The authors mention the monkeys were overtrained before recording, which might have led to a bias in the MB versus MF strategy.

      We agree that extensive training can influence the balance between MB and MF in choice behaviour and neuronal responses.

      In a previous comprehensive behavioral analysis of the same dataset (Miranda et al., 2020, PLoS Computational Biology - ref. 36, Figure S6B) we showed that both MB and MF strategies contributed to behavior, with MB dominance stable across weeks of testing – supporting that overtraining did not eliminate MF influences (but rather stabilized a mixed strategy with robust MB contributions).

      In the same manuscript, we have also: i) cautioned the readers when comparing our results to data from the original human studies; ii) acknowledged that our extensive training cannot address earlier phases of learning in which sensitivity to the task structure is first acquired; and iii) also provided task-related reasons for such MB dominance – as training made the transition structure well learned (making MB computationally less costly and faster to implement) and the non-stationary outcomes favored the flexibility of MB strategies.

      In the present manuscript, we also have acknowledged that overtraining may have shifted neural signals toward stronger MB representations, or alternatively enabled more sophisticated task representations:

      “On the other hand, MF-based estimates were neither as striking nor as specific to striatal regions as expected and observed in previous studies [18]. The monkeys were extensively trained on the task before recordings commenced, which may have caused a shift towards both MB behaviour and MB value representation within the striatum. Alternatively, this training may have allowed more sophisticated representations to occur, such as using latent states to expand the task space [54].”

      Importantly, we strongly believe that this possibility does not detract from our main finding that both MB and MF signals were present across regions, with ACC showing the strongest multiplexing of the two.

      (5) The GLM3 model combines MB and MF value estimates but does not clearly mention how hyperparameters were optimized to prevent overfitting. While the hybrid model explains behavior well, it does not clarify whether MB/MF weighting changes dynamically over time.

      We appreciate this comment and would like to note that, for completeness, we have on several occasions directed the reader to our prior behavioural analysis of the same dataset (Miranda et al., 2020, PLoS Computational Biology, ref 36). In that work, we provide a full and detailed description of both the task and the computational modeling approach (see particularly the “Model fitting procedures” section). Furthermore, our model-fitting was grounded in the MF/MB RL framework used in the original human two-step study (Daw et al., 2011); and the fitting procedures also followed previous studies (Huys et al., 2011).

      Hyperparameters – including the MB/MF weighting parameter (ω) - were estimated using maximum likelihood under two complementary approaches and with priors providing regularization across sessions. First, we performed a fixed-effects analysis, in which parameters were estimated independently for each session by maximizing the likelihood separately; secondly, we conducted a mixed-effects analysis, treating parameters as random effects across sessions within each subject. The effect of the prior procedure reduces the risk of overfitting by constraining parameters based on their empirical distributions, rather than allowing unconstrained session-by-session estimates. Finally, all model fitting procedures were verified on surrogate generated data.

      With regard to dynamic weighting, our approach – consistent with most two-step studies – assumed ω to be constant across trials within each session. This was a deliberate choice, both for comparability with prior work and because our subjects were extensively trained, making session-level stability of strategy weights a reasonable assumption. Indeed, our analyses showed no systematic drift in ω across sessions, suggesting that MB/MF balance was stable over sessions. While approaches that allow dynamic ω estimation are possible, we believe such extensions would likely have minimal impact in the current dataset.

      (6) It was unclear from the task description whether the images used changed periodically or how the transition effect (e.g., in Figure 3) could be disambiguated from a visual response to the pair of cues.

      All images were kept constant across sessions. Common/Rare transitions themselves were not explicitly cued, but rather each second-stage state was associated with a specific background colour, followed ~1s later by the presentation of two specific second-stage choice cues (Figure 1B). Hence the subject could infer whether they were transitioned down a Rare or Common path by the background colour, which can be disambiguated in time from the visual responses to the second-stage cues. We’ve updated the Results text to make this clearer:

      “Tracking the state-transition structure of the task is imperative for solving the task as a MB-learner. All four regions encoded whether the current trial’s first-stage choice transitioned to the common or rare second-stage state (which could be inferred by a change in background colour immediately after choice indicating which second stage state they had just entered, Figure 1A).”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 7 appears to be missing.

      We thank the reviewer for pointing this out. Figure 7 was inadvertently omitted in the previous version and has now been included in the revised manuscript.

      (2) No stats reported in the section on explore/exploit.

      We apologise for this oversight. This section now also reports the relevant statistics:

      “We thus repeated our decoding analysis of choice 1 stimulus identity, but this time limited trials to those where they had not received a high reward for the previous two trials (‘explore’ trials), and those where the previous two rewards had been the highest level (‘exploit’ trials). All regions encoded choice 1 for some duration of the choice epoch for both explore (p<0.002 in all cases, permutation test; Figure 7A) and exploit (p<0.002 in all cases; Figure 7B) conditions, but decoding accuracy was strongest in ACC. Choice 1 was less strongly decoded – particularly in ACC – in the former condition compared to the latter (p<0.002 for at least 140 ms in all cases, permutation test on differences observed; Figure 7C); and, also during exploitation, the ACC encoded choice 1 before the choice was even presented to the subject (Figure S8). This pre-choice ACC encoding in exploit trials may reflect the need to allocate cognitive (or attentive) resources to features – i.e., choice 1 stimulus identity – that are most certain predictors of important outcomes. As a control, we also decoded the direction of the Choice 1 (where choice was indicated via joystick movement), which was randomised each trial and therefore orthogonal to the stimulus that was chosen. Again, all four regions encoded its direction in both explore (p<0.002 in all cases; Figure 7D) and exploit (p<0.002 in all cases; Figure 7E). However, there were minimal differences in the strength of the representation between explore and exploit conditions (ACC, p=0.088, cluster-based permutation test; DLPFC p=0.016; caudate p=0.32; putamen p=1; Figure 7F).”

      (3) Make sure that error bars are explained in all figure captions where appropriate.

      We apologise that this information was absent. Error bars always represent the standard error of the mean. This has now been added to all relevant figure legends.

      Reviewer #2 (Recommendations for the authors):

      Overall, I think this is a great manuscript and was presented clearly and succinctly. I have some minor suggestions:

      (1) Typo: Abstract "ACC, DLPFC, caudate and striatum" I think should be "caudate and putamen".

      We have amended this incorrect reference in the introduction:

      “One such task that does enable the dissociation of MB and MF computations is Daw et al. (2011)’s ‘two-step’ task [18]. It contains a probabilistic transition between task states to uncouple MF learners (who would assign credit to which state was rewarded regardless of the transition) from MB learners (who would appropriately assign credit based on the reward and transition that occurred). Rodents [19], monkeys [36], and humans [18] all use MB-like behaviour to solve the task. Evidence in rodents suggests dorsal anterior cingulate cortex (ACC) tracks rewards, states, and the probabilistic transition structure, and that ACC is essential in implementing a MB-strategy [37]. Here, we compare primate single neuron activity of 4 different subregions implicated in reward-based learning and choice (ACC, dorsolateral PFC (DLPFC), caudate, and putamen) during performance of the classic two-step task, and demonstrate signatures of MB-RL primarily in ACC, and MF-RL signatures most notably in putamen.”

      (2) Could the authors provide a rationale for why they did the single-level encoding the way they did, instead of running an ANOVA?

      We thank the reviewer for this point. We are not entirely certain which specific ANOVA approach is being suggested, but our rationale for using a GLM-based encoding analysis is that such approach allows us to model continuous, trial-by-trial variables (e.g., value signals, prediction errors, transitions) while simultaneously controlling for multiple correlated predictors. This approach is widely used in systems neuroscience (particularly in decision-making research) offering analytical flexibility and comparability with prior approaches.

      (3) How were the 20 iterations for decoding decided? That seems low.

      We do not agree that 20 repetitions of 5-fold cross validation is low. The error bars in panels 6C-E demonstrate what low variance occurred across these 20 repetitions. It is the average of these low variance repetitions against which we performed statistics by performing a permutation test where these 20 repetitions were repeated a further 500 times.

      (4) It was unclear to me how the authors reached the conclusion "Thus, caudate activity appeared to represent the value of the state the subject was currently in." when the state value wasn't computed directly. I don't see how encoding the chosen and unchosen option is the same as the state the animal is in, which should also incorporate where the animal is in a block of trials or session, and the knowledge regarding the chosen and unchosen option.

      We agree with this point and have tempered this statement:

      “Thus, caudate’s encoding of an option’s value also reflected the availability of the option.”

      (5) Figures 1C, D, and E were not legible to me even at 200% zoom.

      We apologise for this oversight. We’ve now updated panels 1C-E to a more readable size:

      (6) There is a Figure 2H in the figure legend, but the panel appears to be missing from Figure 2.

      This text has been removed.

      (7) Figure 2: It would've been nice to see F and G for all areas.

      We have now added this data as additional panels in Figure 2.

      (8) Figure 3: How is the transition disambiguated from a visual response to the set of images?

      This was indicated by the background changing colour to that of the learned second stage state before the actual choices were presented. We’ve updated the Results text to make this clearer:

      “Tracking the state-transition structure of the task is imperative for solving the task as a MB-learner. All four regions encoded whether the current trial’s first-stage choice transitioned to the common or rare second-stage state (which was indicated by a change in background colour before the second stage choices were presented, Figure 1A).”

      (9) Figure 4F: Is this collapsed across time points? So neurons that were significant at any time? I'm confused how Figure 4A relates to 4F, as 4A shows much lower percentages of significant neurons.

      Figure 4F counts the total number of neurons that had a significant period of encoding at any timepoint over the epoch (as assessed with a length-based permutation test). Whereas, 4A shows the amount of significant encoding neurons at any one time point. Investigating this further, we found that the encoding was dynamic with different neurons encoding different parts of the epoch. We have now added a new supplementary figure to highlight this and refer to it in Results:

      “Examination of the strongest signal observed, ACC’s encoding of MB Q-values, showed a dynamic pattern with different neurons encoding the signal at different parts of the epoch (Figure S6). When aggregating the number of significant coders throughout the epoch, and examining the specificity of MB versus MF coding, we found that all regions had a significant population of neurons that encoded MB-, but not MF-, derived value (30, 18.72, 23 and 24% of neurons in ACC, DLPFC, caudate and putamen respectively; all p<0.0014 binomial test against 10% (as the strongest response to either of the two options was used); Figure 4F).“

      (10) Data/ code could be made publicly available instead of upon request.

      All data and code to reproduce figures are now available at https://github.com/jamesbutler01/TwoStepExperiment. The manuscript has been updated to reflect this:

      Data and materials availability:

      All data and code to reproduce figures are available at https://github.com/jamesbutler01/TwoStepExperiment.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors' goal was to advance the understanding of metabolic flux in the bradyzoite cyst form of the parasite T. gondii, since this is a major form of transmission of this ubiquitous parasite, but very little is understood about cyst metabolism and growth. Nonetheless, this is an important advance in understanding and targeting bradyzoite growth.

      Strengths:

      The study used a newly developed technique for growing T. gondii cystic parasites in a human muscle-cell myotube format, which enables culturing and analysis of cysts. This enabled the screening of a set of anti-parasitic compounds to identify those that inhibit growth in both vegetative (tachyzoite) forms and bradyzoites (cysts). Three of these compounds were used for comparative Metabolomic profiling to demonstrate differences in metabolism between the two cellular forms.

      One of the compounds yielded a pattern consistent with targeting the mitochondrial bc1 complex and suggests a role for this complex in metabolism in the bradyzoite form, an important advance in understanding this life stage.

      Weaknesses:

      Studies such as these provide important insights into the overall metabolic differences between different life stages, and they also underscore the challenge of interpreting individual patterns caused by metabolic inhibitors due to the systemic level of some of the targets, so that some observed effects are indirect consequences of the inhibitor action. While the authors make a compelling argument for focusing on the role of the bc1 complex, there are some inconsistencies in the patterns that underscore the complexity of metabolic systems.

      We agree with reviewer #1 that metabolic fingerprints are complex to interpret and we did try to approach this problem by including mock treatment and non-metabolic inhibitors as controls. We address specific concerns below.

      Reviewer #2 ( Public review):

      Summary:

      A particular challenge in treating infections caused by the parasite Toxoplasma gondii is to target (and ultimately clear) the tissue cysts that persist for the lifetime of an infected individual. The study by Maus and colleagues leverages the development of a powerful in vitro culture system for the cyst-forming bradyzoite stage of Toxoplasma parasites to screen a compound library for candidate inhibitors of parasite proliferation and survival. They identify numerous inhibitors capable of inhibiting both the disease-causing tachyzoite and the cyst-forming bradyzoite stages of the parasite. To characterize the potential targets of some of these inhibitors, they undertake metabolomic analyses. The metabolic signatures from these analyses lead them to identify one compound (MMV1028806) that interferes with aspects of parasite mitochondrial metabolism. The authors claim that MV1028806 targets the bc1 complex of the mitochondrial electron transport chain of the parasite, although the evidence for this is indirect and speculative. Nevertheless, the study presents an exciting approach for identifying and characterizing much-needed inhibitors for targeting tissue cysts in these parasites.

      Strengths:

      The study presents convincing proof-of-principle evidence that the myotube-based in vitro culture system for T. gondii bradyzoites can be used to screen compound libraries, enabling the identification of compounds that target the proliferation and/or survival of this stage of the parasite. The study also utilizes metabolomic approaches to characterize metabolic 'signatures' that provide clues to the potential targets of candidate inhibitors, although falls short of identifying the actual targets.

      Weaknesses:

      (1) The authors claim to have identified a compound in their screen (MMV1028806) that targets the bc1 complex of the mitochondrial electron transport chain (ETC). The evidence they present for this claim is indirect (metabolomic signatures and changes in mitochondrial membrane potential) and could be explained by the compound targeting other components of the ETC or affecting mitochondrial biology or metabolism in other ways. In order to make the conclusion that MMV1028806 targets the bc1 complex, the authors should test specifically whether MMV1028806 inhibits bc1-complex activity (i.e. in a direct enzymatic assay for bc1 complex activity). Testing the activity of MMV1028806 against other mitochondrial dehydrogenases (e.g. dihydroorotate dehydrogenase) that feed electrons into the ETC might also provide valuable insights. The experiments the authors perform also do not directly measure whether MMV1028806 impairs ETC activity, and the authors could also test whether this compound inhibits mitochondrial O2 consumption (as would be expected for a bc1 inhibitor).

      We thank the reviewer for highlighting this important aspect. To further investigate the effect of MMV1028806 on the mETC, we adapted a commercial oxygen consumption assay and demonstrated that MMV1028806, like Atovaquone and Buparvaquone, inhibits the ETC, leading to reduced oxygen consumption similar to Antimycin A, which inhibits the bc1-complex. These results are now included in the revised manuscript (Methods, lines 210–233; Results, lines 460–468).

      (2) The authors claim that compounds targeting bradyzoites have greater lipophilicity than other compounds in the library (and imply that these compounds also have greater gastrointestinal absorbability and permeability across the blood-brain barrier). While it is an attractive idea that lipophilicity influences drug targeting against bradyzoites, the effect seems pretty small and is complicated by the fact that the comparison is being made to compounds that are not active against parasites. If the authors are correct in their assertion that lipophilicity is a major determinant of bradyzoicidal compounds compared to compounds that target tachyzoites alone, you would expect that compounds that target tachyzoites alone would have lower lipophilicity than those that target bradyzoites. It would therefore make more sense to (statistically) compare the bradyzoicidal and dual-acting compounds to those that are only active in tachyzoites (visually the differences seem small in Figure S2B). This hypothesis would be better tested through a structure-activity relationship study of select compounds (which is beyond the scope of the study). Overall, the evidence the authors present that high lipophilicity is a determinant of bradyzoite targeting is not very convincing, and the authors should present their conclusions in a more cautious manner.

      Thank you for raising this excellent point. We performed a statistical test of tachyzoidal and both bradyzoidal and dually active compounds and find indeed no significant difference (P = 0.06). We altered the results text line 367-368 and the figure S2B caption to explicitly mention this.

      (3) Page 11 and Figure 7. The authors claim that their data indicate that ATP is produced by the mitochondria of bradyzoites "independently of exogenous glucose and HDQ-target enzymes." The authors cite their previous study (Christiansen et al, 2022) as evidence that HDQ can enter bradyzoites, since HDQ causes a decrease in mitochondrial membrane potential. Membrane potential is linked to the synthesis of ATP via oxidative phosphorylation. If HDQ is really causing a depletion of membrane potential, is it surprising that the authors observe no decrease in ATP levels in these parasites? Testing the importance of HDQ-target enzymes using genetic approaches (e.g. gene knockout approaches) would provide better insights than the ATP measurements presented in the manuscript, although would require considerable extra work that may be beyond the scope of the study. Given that the authors' assay can't distinguish between ATP synthesized in the mitochondrion vs glycolysis, they may wish to interpret their data with greater caution.

      We thank the reviewer for addressing this important point. The enzymatic assay used in our study cannot distinguish whether ATP is produced via glycolysis or mitochondrial respiration. However, we minimized glycolytic ATP production in bradyzoites by starving them for one week without glucose. After this period, amylopectin stores are depleted, forcing the parasites to utilize glutamine via the GABA shunt to fuel the TCA cycle and generate ATP predominantly through respiration. While minor ATP production via gluconeogenic fluxes cannot be excluded, the main ATP supply under these conditions is expected to originate from the mitochondrial electron transport chain. Indeed, ATP levels are lower in HDQ-treated bradyzoites, which we attribute to the compound’s impact on electron-supplying enzymes upstream of the bc1 complex, although this inhibition is not sufficient to fully abolish ATP production as observed with Atovaquone treatment.

      Reviewer #3 (Public review):

      Summary:

      The authors describe an exciting 400-drug screening using a MMV pathogen box to select compounds that effectively affect the medically important Toxoplasma parasite bradyzoite stage. This work utilises a bradyzoites culture technique that was published recently by the same group. They focused on compounds that affected directly the mitochondria electron transport chain (mETC) bc1-complex and compared them with other bc1 inhibitors described in the literature such as atovaquone and HDQs. They further provide metabolomics analysis of inhibited parasites which serves to provide support for the target and to characterise the outcome of the different inhibitors.

      Strengths:

      This work is important as, until now, there are no effective drugs that clear cysts during T. gondii infection. So, the discovery of new inhibitors that are effective against this parasite stage in culture and thus have the potential to battle chronic infection is needed. The further metabolic characterization provides indirect target validation and highlights different metabolic outcomes for different inhibitors. The latter forms the basis for new studies in the field to understand the mode of inhibition and mechanism of bc1-complex function in detail.

      The authors focused on the function of one compound, MMV1028806, that is demonstrated to have a similar metabolic outcome to burvaquone. Furthermore, the authors evaluated the importance of ATP production in tachyzoite and bradyzoites stages and under atovaquone/HDQs drugs.

      Weaknesses:

      Although the authors did experiments to identify the metabolomic profile of the compounds and suggested bc-1 complex as the main target of MMV1028806, they did not provide experimental validation for that.

      In our updated manuscript we performed additional experiments such as oxygen consumption assay to further qualify the bc1 complex as the target. We also toned down some of our statements to make sure that no false claims are made.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Introduction: It would be helpful to briefly describe what the pathogen Box is, what compounds are in it, and the rationale for using a drug screen to better understand mitochondrial function in cysts.

      Thank you for this suggestion, we added an introduction of the MMV pathogen box and outlined our rationale for our experimental approach in lines 90 to 99.

      Please explain why dual-active drugs were useful for understanding differences, rather than just seeking drugs that might target bradyzoites alone.

      We focused on dually active compounds for two reasons. First, these are the most promising and potent targets to develop drugs against. Both stages might occur simultaneously and these dually active drugs may eliminate the need for treatment with a drug combination. Second, we speculated that monitoring the responses to inhibition of the same process in both parasite stages would reveal its functional consequences. Dually active compounds enable this direct comparison. Bradyzoite-specific compounds may be interesting from a developmental perspective but may require a reverse genetic follow-up to compare differences between stages. The lack of a well-established inducible expression system in bradyzoites that allows short term and synchronized knock-down makes metabolomic approaches difficult. We added these two points in brief to the results section (line 378 – 381).

      Figure 4: this is a very important figure in understanding the significance of the work, but it is not well described in the legend. Even if these graphics have been used in other manuscripts, it would be helpful to provide better annotation in the figure legend.

      Thank you for pointing this out. We expanded the figure legend to explain the isotopologues data in more detail. Line 793 to 802.

      B,D: Explain what the three columns for each drug category represent.

      Addressed

      C,E: Explain what isotopologues are, what the M+ notation means, and what the pie charts represent. Other main figures have suitable legends.

      Addressed

      Discussion: there are several places where the reasoning is a bit hard to follow, and rearrangement to provide a clear logical flow would be helpful. In particular, the reasoning for why HDQ impairs active but non-essential processes could be laid out more clearly.

      We added additional clarifications to the discussion section and re-wrote the HDQ paragraph. We hope that our reasoning is now easier to follow.

      Abbreviations: A list of abbreviations for the entire manuscript would be helpful.

      This is a good idea and we now provide an abbreviations list.

      Minor typos:

      P12, 2d paragraph: sentence beginning with: Consistent with this hypothesis... "cysts" is used twice

      Corrected

      P15, top of the second paragraph: "nano" and "molar" should be one word

      Corrected

      Reviewer #2 (Recommendations for the authors):

      Major comments (not already covered in the weaknesses section of the public review)

      (1) Figure 2 and the related description of these experiments in the methods section (page 3). The approach for calculating IC50 values for the compounds against tachyzoites is unclear. How did the authors determine the time point for calculating IC50 vacuoles? Was this when the DMSO control wells reached maximum fluorescence? This could be described in a clearer manner. A concern with calculating IC50 values on different days is that parasites will have undergone more lytic cycles after 7 days compared to 4 days, which means that the IC50 values for fast- vs slow-acting compounds might be quite different between these days. As a more minor comment on these experiments, the methods section does not describe whether the test compound was removed after 7 days, as the experimental scheme in Figure S1A seems to imply. Please clarify in the methods section.

      This is a very good point and we clarified this in the methods section, line 157–160. In brief, we choose the latest time point when exponential growth could be observed in the fastest growing cultures, generally this was in mock treated cultures and at day 4 post infection. We also clarified that we changed media and removed treatment after 7 days.

      Minor Comments

      (2) Page 2. "we employed a recently developed human myotube-based culture system to generate mature T. gondii drug-tolerant bradyzoites". What makes these bradyzoites 'drug-tolerant' or to which drugs are they tolerant? This isn't clear from the description.

      We added these details in the introduction (line 94 to 96) and state that these cysts develop resistance against anti-folates, bumped kinase inhibitors and HDQ, a Co-enzyme Q analog.

      (3) Figure 1E. The number of compounds in this pie chart adds up to 384, whereas the methods describe that 371 compounds were tested. What explains this discrepancy in numbers?

      We understand the confusion. We now updated the pie chart to reflect only compounds that were included in the primary screen (371) as reflected in Supplementary Table S1. We separately analysed 29 compounds that were previously tested against tachyzoites by Spalenka et al., and found an additional 13 compound, that were originally included in the pie chart. In a secondary test the activity of 10 of these 13 compounds could be confirmed. All in all we found the 16 compounds shown in Fig. 2 E-G.

      (4) Page 3. The resazurin assays for measuring host cell viability could be explained in a clearer manner. What host cells were used? Were the host cells confluent when the drug was added (and the assay conducted) or was the drug added when the host cells were first seeded? How long were the host cells cultured in the candidate inhibitors before the assays were performed? What concentration (or concentration range) were the compounds tested? The host inhibition data are not easily accessible to the reader - the authors might consider including these data as part of Table S2D.

      The necessary information was added to the methods section (line 145 to 153). We tested for host toxicity in both HFF and KD3 myotubes during the primary screen at 10 µM in triplicates. The colorimetric assay was performed after tachyzoite growth assays in HFFs 7 days post infection and after completion of the 4 week re-growth phase of bradyzoites in myotubes. The resulting data is already part of Supplementary File 1. In addition, we performed concentration dependent resazurin assays after secondary concentration dependent growth inhibition assays and also included data in Supplementary File 1. For the bradyzoite growth assay we performed visual inspection after drug exposure for one week and before tachyzoite re-growth to detect missing or damaged monolayer. Also, this data is included in the Supplementary File 1. We also included the cytotoxicity data as suggested into Table S2D.

      (5) Page 7. "Except for four compounds (MMV021013, MMV022478, MMV658988, MMV659004), minimal lethal concentrations were higher in bradyzoites". The variation in these data seems quite large to be making this claim. Consider a statistical analysis of these data to compare potencies in tachyzoites vs bradyzoites.

      With this sentence we aimed to describe the results and not to make a statement. We toned down the sentence to “… minimal lethal concentrations appear generally higher in bradyzoites… “ line 344 to 347. We also added a line 1 µM in the charts to facilitate easier comparison of compound efficacies.

      (6) It would be helpful to readers to include the structures of hit compounds in the figures (perhaps as part of Figure 3).

      This is a good idea and would improve the manuscript. To not overburden figure 3 we added structures to Fig S3.

      (7) Page 8. "Infected monolayers were treated for three hours with a 3-fold of respective IC50 concentrations". 3-fold higher than IC50 concentrations? This isn't clear.

      Thank you for noticing this: We clarified the sentence and also corrected the concentration, corresponding to five times their IC50s as stated in the methods section: “Infected monolayers were treated for three hours with compound concentrations five times their respective IC<sub>50</sub> values or the solvent DMSO.” Line 374 - 376

      (8) Page 9. "buparvaquone, which we found to be dually active against T. gondii tachyzoites and bradyzoites, targets the bc1-complex in Theileria annulata (McHardy et al. 1985) and Neospora caninum (Müller et al. 2015) and was recently found active against T. gondii tachyzoites (Hayward et al. 2023)." The latter paper showed that buparvaquone targets the bc1 complex in T. gondii tachyzoites as well.

      Yes, it was found to inhibit O2 consumption rate in tachyzoites. We changed the sentence accordingly. Line 407 to 411.

      (9) Page 9. "Anaplerotic substrates were also affected by all three treatments, most notably a strong accumulation of aspartic acid." It is interesting that the M+3 isotopologue of aspartate (presumably synthesised from pyruvate) is the predominant form (rather than the M+2 and M+4 isotopologues that would derive from the TCA cycle, and as the diagram in Figure 4A seems to suggest). Given that aspartate is a precursor of pyrimidine biosynthesis that is upstream of the DHODH reaction, it is conceivable that its accumulation is related to the depletion of pyrimidine biosynthesis (so would tie into the point about the accumulation of DHO and CarbAsp noted earlier in the paragraph).

      Yes, we assume the same. We altered the text and summarized the changes in Asp as a result of DHOD inhibition, as we also already do in the next paragraph using <sup>15</sup>N-glutamine labelling. Line: 416 - 418

      (10) Figure 6 and Page 10. Regarding the metabolomic experiments that show increased levels of acyl-carnitines. The authors note that "Since [beta-oxidation] is thought to be absent in T. gondii, we attribute these changes to inhibition of host mitochondria". This is conceivable, although the T. gondii genome does encode homologs of the proteins necessary for beta-oxidation (e.g. see PMID 35298557). If the carnitine is coming from host mitochondria, is host contamination a concern for interpreting the metabolomic data? Or do the authors think that parasites are scavenging carnitine from host cells? It is curious that the carnitine accumulation is observed in parasites treated with buparvaquone (and MMV1028806) but not atovaquone, even though buparvaquone and atovaquone (and possibly MMV1028806) target the same enzyme. Do the authors have any thoughts on why that might be the case?

      Yes, thank you for raising this point. We changed the discussion elaborating on this and included the debated presence of beta-oxidation: line 640: “We also detect elevated levels of acyl-carnitines in BPQ and MMV1028806 treated bradyzoites. These molecules act as shuttles for the mitochondrial import of fatty acids for β-oxidation. However, this pathway has not been shown to be active and is deemed absent in T. gondii (35298557, 18775675). The presence of acyl-carnitines in bradyzoites might reflect import from the host. It is conceivable that their elevation in response to buparvaquone and MMV1028806 indicates compromised functionality of the host bc1-complex and subsequently accumulating β-oxidation substrates. Indeed, BPQ has a very broad activity across Apicomplexa (Hudson et al. 1985) and kinetoplastids (Croft et al. 1992).“ Regarding the existence of beta-oxidation: some potential enzymes might be conserved, but those could in part take part in branched chain amino acid degradation pathways. On a separate note: we looked extensively on beta-oxidation using stable isotope labelling and became convinced that any activity occurred in the host cell only but not in the parasite (unpublished).

      (11) Page 11. "the mitochondrial [electron] transport chain in bradyzoites".

      Corrected.

      (12) Figure S6B. Were these optimization experiments performed in tachyzoites or bradyzoites? If the former, and given that bradyzoites have apparently smaller amounts of ATP per parasite (Figure 7C), are these values in the linear range for 10^5 bradyzoites?

      Yes, we do think that the assay remains linear for these lower concentrations. Tachyzoites give a linear response starting from 10^3 parasites per sample. In the actual experiment we used 10^5 parasites, both tachyzoites and bradyzoites. Under the tested conditions bradyzoites maintain 10% of the ATP pools of tachyzoites, which should be well within the linear range of the assay. Also in Atovaquone-treated bradyzoites ATP concentration could be lower to 10% and still remain in the linear range of the assay. For practical reasons, we simply acknowledge this limitation and consider it acceptable within the scope of this study.

      Reviewer #3 (Recommendations for the authors):

      Major comments

      (1) The authors should provide a negative control for the experiment on Figure 5. I would suggest doing the same experiment with an inhibitor that has no effect on mitochondrial potential.

      We addressed this criticism by repeating the assay on tachyzoites and additionally including inhibitors that do not have the mitochondrial electron transport chain as their primary target (Pyrimethamine, Clindamycin, 6-Diazo-5-oxo-L-norleucin). The results are summarized in the supplementary Fig S5, line 445 – 449) and show that there is no effect of these inhibitors on the mitochondrial membrane potential. This supports the specificity of the assay and suggests that MMV1028806 and BPQ indeed target a mitochondrial process in this stage. Also, in this repetition ATQ, BPQ and MMV1028806 did significantly deplete the Mitotracker signal.

      (2) Figure 5 - Did the authors perform this experiment in 3 biological replicates? This requires clarification of the figure legend.

      No, we did not perform the experiment in 3 biological replicates. After establishing the assay thoroughly, we performed it once on tachyzoites and bradyzoites. The sampling was done on every vacuole we encountered during microscopy going through the slide from left to right. That is the reason the sample size varies from treatment to treatment. The sample size is mentioned in the caption of figure 5. However, we repeated the experiment with additional controls (see Fig. S5), which showed that the Mitotracker signals were significantly depleted in a very similar manner in ATQ, BPQ and MMV1028806 treated parasites.

      (3) The authors identify that MMV1028806 has bc1-complex as the main target. I suggest that they should perform a complex III activity assay to affirm this. Also, it would be good to test if other mETC complexes are affected by this compound to prove its specificity. There is only one paper showing complex III activity in tachyzoites (PMID:37471441) and no papers in bradyzoites. So if the authors cannot do this assay, I suggest that they should change the text indicating that bc-1 complex could be the main target of the compound but more experimental validation is needed.

      We hope to have satisfied the reviewer’s request by performing an oxygen consumption assay on tachyzoites. Together with metabolic profiling and labelling data, this shows that both upstream and downstream processes are impacted by MMV1028806 and strongly suggest the bc1-complex as a target (Fig 5E).

      (4) Figure S5 - Are the differences shown in the EM experiment statistically supported?

      We analyzed 28 images and measured the areas in 12 to 26 images. We substituted the table of means in Fig S6B by a graph showing individual values. These areas are indeed statistically different between DMSO and ATQ / MMV treated parasites. We changed the wording in the results section accordingly “Analysis by thin section electron microscopy revealed a largely unaffected sub-mitochondrial ultrastructure but the areas of mitochondrial profiles were changed in comparison to control after exposure with ATQ and MMV1028806 but not with BPQ (Fig. S6)“. The description of Fig S6B was changed to “(B) Measured areas of mitochondrial profiles from 21, 12, 15 and 26 images showing DMSO, ATQ, BPQ and MMV1028806 treated parasites (* denotes p < 0.05 in Mann-Whitney tests)”.

      Minor comments:

      (1) What was the criteria to choose the example compounds in Figure 1B and 1D? The authors should clarify this in the text.

      These graphs are shown for illustrative purposes and were chosen based on their display of different drug efficacies. We considered this helpful for interpreting the screening data.

      (2) Figure 2G - add statistical analysis.

      We added Mann-Whitney tests and updated the figure legend and results text accordingly in line 344 – 347.

      (3) The authors should provide more insights in the discussion about why this new compound is the next step in drug discovery compared to atovaquone or burvaquone - for example, do you expect better availability in the brain, etc.

      We used MMV1028806 and the other hits ATQ and BPQ to make the point that the bc1-complex is a good target in bradyzoites that allows curative treatment. We do not suggest that the compound itself is a good starting point. We point to other actively developed candidates such as ELQ series in the discussion, line 719.

      (4) Scale bars in Figure 5 should be aligned and have equal thickness.

      We re-formatted the scale bars and aligned them when not obscuring parasites.

      (5) The authors should be consistent with font sizes and styles in all the figures.

      We adjusted the font styles to match each other.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Both reviewers indicated broad approval of the revised work, for which we are grateful.

      Reviewer #1 requested no further changes.

      Reviewer #2’s Public review states:

      The authors indicate that the adaptors of inflammatory signalosomes act as energy reservoirs for signal amplification. This is not demonstrated, but it is assumed that the energy stored in the supersaturated state is released upon polymerization.

      The “assumed” link between supersaturation and energy release is in fact a thermodynamic necessity. Supersaturation is, by definition, a high free energy state. Our data shows that triggering nucleation via optogenetics results in an immediate avalanche of polymerization and cell death. This is not an assumption; it is a direct observation of work performed by the system when the kinetic barrier is removed.

      Reviewer #2 recommended:

      Ideally, signal amplification could be tested by determining the levels of the final product, e.g., cytokines, activated caspases...

      We did measure CASP3/7 activation, demonstrating a correlation with supersaturation of upstream adaptors. We do agree however that measuring the levels of other signaling products, including for each of the supersaturated pathways, would strengthen our claims. This will be the subject of future work.

      The authors indicate a significant anticorrelation between the saturating concentrations and the transcript abundances (Figure 2B), reporting an R = -0.285.

      This is correct… no change appears to be requested or warranted.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This is a high-quality and extensive study that reveals differences in the self-assembly properties of the full set of 109 human death fold domains (DFDs). Distributed amphifluoric FRET (DAmFRET) is a powerful tool that reveals the self-assembly behaviour of the DFDs, in non-seeded and seeded contexts, and allows comparison of the nature and extent of self-assembly. The nature of the barriers to nucleation is revealed in the transition from low to high AmFRET. Alongside analysis of the saturation concentration and protein concentration in the absence of seed, the subset of proteins that exhibited discontinuous transitions to higher-order assemblies was observed to have higher concentrations than DFDs that exhibited continuous transitions. The experiments probing the ~20% of DFDs that exhibit discontinuous transition to polymeric form suggest that they populate a metastable, supersaturated form in the absence of cognate signal. This is suggestive of a high intrinsic barrier to nucleation.

      Strengths:

      The differences in self-assembly behaviour are significant and likely identify mechanistic differences across this large family of signalling adapter domains. The work is of high quality, and the evidence for a range of behaviours is strong. This is an important and useful starting point since the different assembly mechanisms point towards specific cellular roles. However, understanding the molecular basis for these differences will require further analysis.

      An impressive optogenetic approach was engineered and applied to initiate self-assembly of CASP1 and CASP9 DFDs, as a model for apoptosome initiation in these two DFDs with differing continuous or discontinuous assembly properties. This comparison revealed clear differences in the stability and reversibility of the assemblies, supporting the hypothesis that supersaturation-mediated DFD assembly underlies signal amplification in at least some of the DFDs.

      The study reveals interesting correlations between supersaturation of DFD adapters in short- and long-lived cells, suggestive of a relationship between the mechanism of assembly and cellular context. Additionally, the comprehensive nature of the study provides strong evidence that the interactions are almost all homomeric or limited to members of the same DFD subfamily or interaction network. Similar approaches with bacterial proteins from innate immunity operons suggest that their polymerisation may be driven by similar mechanisms.

      Weaknesses:

      Only a limited investigation of assembly morphology was conducted by microscopy. There was a tendency for discontinuous structures to form fibrillar structures and continuous to populate diffuse or punctate structures, but there was overlap across all categories, which is not fully explored.

      We agree that an in-depth exploration of aggregate morphology would be interesting, but we feel it has limited relevance to the central findings of the manuscript. Our analysis established a relationship between discontinuous transitions and ordering based on the assumption that ordered assembly by DFDs involves polymerization, for which there is much precedent in the literature. Nevertheless, polymers of similar structure can form with different kinetics and hence, polymerization does not by itself imply an ability to supersaturate. We see this empirically in the “fibrillar” column in Fig. 1B. We have now elaborated this important point more fully in the relevant results section and in the discussion. Only five of the 108 DFDs in Fig. 1B warrant additional explanation. CASP4<sup>CARD</sup> and IFIH1<sup>tCARD</sup> lacked AmFRET but formed puncta; this could result from interactions with endogenous structures or condensates. DAPK1<sup>DD</sup> and UNC5A<sup>DD</sup> were classified as continuous (low) and fibrillar, but their AmFRET values are in fact higher than monomer control revealing that the fibrils simply comprise a small fraction of the protein. The puncta of UNC5A<sup>DD</sup> additionally do not resemble the fibrillar puncta of other DFDs; we suspect it may be a false-positive resulting from localization to mitochondrial or other intracellular membranes. Finally, CASP2<sup>CARD</sup> was inadvertently classified as punctate; this turns out to have been a technical artifact that has now been corrected (the fibrils wrapped around the cell perimeter to form ring-like puncta with anomalously low aspect ratios). We have now updated the methods section describing manual validation of our automated classification procedure, including which samples required reclassification. We have also now included all microscopy data in the public repository accompanying this manuscript.

      The methodology used to probe oligomeric assembly and stability (SDD-AGE) does not justify the conclusions drawn regarding stability and native structure within the assemblies.

      The reviewer is correct that SDD-AGE does not provide evidence against non-amyloid misfolding. It merely provides evidence that the DFDs are not forming amyloid (which are characteristically sarkosyl resistant). We have revised the sentence and further clarified that the distinction with amyloid specifically is important because amyloid is the only known form of ordered assembly (other than DFD polymers) with a nucleation barrier large enough to support deep supersaturation. Together with the series of interfacial mutants tested (and shown to impede assembly in all cases), the lack of sarkosyl-resistance provides evidence that the discontinuous DFDs are assembling through canonical DFD subunit interfaces.

      The work identifies important differences between DFDs and clearly different patterns of association. However, most of the detailed analysis is of the DFDs that exhibit a discontinuous transition, and important questions remain about the majority of other DFDs and why some assemblies should be reversible and others not, and about the nature of signalling arising from a continuous transition to polymeric form.

      We focused on discontinuous DFDs because this property allows for executive control over their respective pathways. They make signaling switch-like, which we argue is essential for innate immune responses. By contrast, and as illustrated in Figure 6D, supersaturation is required for a DFD to drive its own polymerization -- hence activation for a continuous DFD must be stoichiometrically coupled either with D/PAMP binding or positive feedback from downstream or orthogonal processes. We consider the principles underlying such regulation of signaling to be better established and understood than supersaturation, and hence built our narrative for this manuscript around the latter. Our original text addresses the fact that only a small fraction of DFDs are discontinuous. Specifically, this is expected in light of the fact that a) only one supersaturated DFD is needed to make a signaling pathway switch-like, and b) every supersaturated DFD renders the cell susceptible to spontaneous death. Evolution should therefore limit supersaturation to only the highly connected DFDs (i.e. adaptors), which is what is seen. In this view, the many nonsupersaturable DFDs have evolved to accessorize the central supersaturable DFDs with various sensor and effector modules. Our revised text attempts to further clarify this perspective.

      Some key examples of well-studied DFDs, such as MyD88 and RIPK,1 deserve more discussion, since they display somewhat surprising results. More detailed exploration of these candidates, where much is known about their structures and the nature of the assemblies from other work, could substantiate the conclusions here and transform some of the conclusions from speculative to convincing.

      We were likewise initially surprised about the inability of MyD88 and RIPK1 to supersaturate. We have now elaborated in the Discussion how our findings can be rationalized by the apparent supersaturability of other adaptors in MyD88 and RIPK1 signaling pathways. We additionally discuss prior evidence that MyD88 may indeed be supersaturable, and how our experimental system could have led to a false positive in the unique case of MyD88.

      The study concludes with general statements about the relationship between stochastic nucleation and mortality, which provide food for thought and discussion but which, as they concede, are highly speculative. The analogies that are drawn with batteries and privatisation will likely not be clearly understood by all readers. The authors do not discuss limitations of the study or elaborate on further experiments that could interrogate the model.

      We have now added to the discussion a section on the limitations of our study. We appreciate that our use of “privatisation” was confusing and have omitted it. However, we consider the battery analogy to accurately convey the newfound function of DFDs and anticipate that this analogy will ultimately prove valuable for biologists. To facilitate comprehension, we have now broadened our description of phase change batteries in the introduction.

      Reviewer #2 (Public review):

      Summary:

      The manuscript from Rodriguez Gama et al. proposes several interesting conclusions based on different oligomerization properties of Death-Fold Domains (DFDs) in cells, their natural abundance, and supersaturation properties. These ideas are:

      (1) DFDs broadly store the cell's energy by remaining in a supersaturated state;

      (2) Cells are constantly in a vulnerable state that could lead to cell death;

      (3) The cell's lifespan depends on the supersaturation levels of certain DFDs.

      Overall, the evidence supporting these claims is not completely solid. Some concerns were noted.

      Strengths:

      Systematic analysis of DFD self-assembly and its relationship with protein abundance, supersaturation, cell longevity, and evolution.

      Weaknesses:

      (1) On page 2, it is stated, "Nucleation barriers increase with the entropic cost of assembly. Assemblies with large barriers, therefore, tend to be more ordered than those without. Ordered assembly often manifests as long filaments in cells," as a way to explain the observed results that DFDs assemblies that transitioned discontinuously form fibrils, whereas those that transitioned continuously (low-to-high) formed spherical or amorphous puncta. It is unlikely to be able to differentiate between amorphous and structured puncta by conventional confocal microscopy. Some DFDs self-assemble into structured puncta formed by intertwined fibrils. Such fibril nets are more structured and thus should be associated with a higher entropic cost. Therefore, the results in Figure 1B do not seem to agree with the reasoning described.

      The formation of microscopically visible elongated structures necessitates ordering on the length scale of 100s of nanometers. Otherwise surface tension would favor rounded aggregates. Conventional confocal microscopy is in fact well-suited and widely used to distinguish ordered from disordered assemblies in cells based on this principle.1,2 We are unaware of any examples of isolated DFDs forming regular polymers that manifest as round puncta or nets. The reviewer may be referring to full-length ASC, which forms a roughly spherical mesh of filaments because it has two DFDs joined by a flexible linker. This is not applicable to our analysis with single DFDs. Single DFDs polymerize in effectively one dimension; hence a spherical punctum formed by a single DFD can only happen through noncanonical interactions or clustering of small filaments, both of which reduce order relative to long filaments.

      (2) Errors for the data shown in Figure 1B would have been very useful to determine whether the population differences between diffuse, punctate, and fibrillar for the continuous (low-to-high) transition are meaningful.

      We have now performed two statistical analyses to address this. First, using Fisher’s exact test, we observe a highly significant association between the DAmFRET and morphology classifications (p-value: 0.0001). Second, to specifically address whether the continuous (low to high) category has a preferred morphology, we applied an Exact Multinomial Test using the total frequencies of each morphology. This test revealed that all categories are significantly enriched for particular morphologies, as now indicated in the figure and legend.

      (3) A main concern in the data shown in Figure 1B and F is that the number of counts for discontinuous compared to continuous is small. Thus, the significance of the results is difficult to evaluate in the context of the broad function of DFDs as batteries, as stated at the beginning of the manuscript.

      Fig. 1B simply reports the numerical intersections between fluorescence distribution classifications and DAmFRET classifications. In Fig. 1F, our use of the chi-square test is justified by a sufficiently large sample size. Nevertheless, we obtain similar results with Fisher's exact test that accounts for smaller sample size (Odds Ratio: 75.0, P-value: < 0.0001). See also our response to the related critique by Reviewer 1 regarding the small number of discontinuous DFDs.

      (4) The proteins or domains that are self-seeded (Figure 1F) should be listed such that the reader has a better understanding of whether domains or full-length proteins are considered, whether other domains have an effect on self-seeding (which is not discussed), and whether there is repetition.

      We define and consistently use “DFDs” to refer to domains, and “FL” or “DFD-containing protein” to refer to FL proteins. The Figure 1 title and corresponding section title both indicate the data refer to “DFDs”. The text callout for Figure 1F also directs readers to Table S1 where we believe the self-seeding results and details of constructs are clearly presented. There is no repetition. We have modified the legend to clarify that “Each DFD was co-expressed with an orthogonally fluorescent μNS-fused version of the same DFD.” We did not systematically evaluate seeding of FL proteins. We did however previously test self-seeding on seven representative FL proteins, and have now included those data in a new supplemental figure (S5). In short, only FL proteins with discontinuous distributions are self-seedable. These are limited to adaptors that had discontinuous seedable DFDs, revealing no adverse effect of FL protein context on seedability of adaptors (unlike receptors and effectors).

      (5) The authors indicate an anticorrelation between transcript abundance and Csat based on the data shown in Figure 2B; however, the data are scattered. It is not clear why an anticorrelation is inferred.

      An anticorrelation is indicated by the clearly placed negative R value at the top of the graph and the figure legend describing the statistical analysis.

      (6) It would be useful to indicate the expected range of degree centrality. The differences observed are very small. This is specifically the case for the BC values. The lack of context and the small differences cast doubts on their significance. It would be beneficial to describe these data in the context of the centrality values of other proteins.

      The possible range of centrality scores is 0 - 1, where 1 represents a protein interacting with every other protein in the network (degree centrality) or is on the shortest path between every other pair of proteins in the network (betweenness centrality). The expected range is difficult to address, as centrality values strongly depend on the size and function of the network. We considered that the SAM domain network could provide the most relevant comparison to the DFD network, as SAM domains resemble DFDs in size and structure, function heavily in signaling, are comparably numerous (76 in humans), and many of them form homopolymers (but importantly of a geometry that does not support nucleation barriers). We found that SAM domains have much lower betweenness centrality in their physical interaction network as compared to discontinuous DFDs (p = 0. 0003) while their degree centrality is not significantly different (Figure S3F). Nevertheless, we stress that what matters for our conclusion is that the continuous and discontinuous values are significantly different among DFDs. Since there is a large overlap in the distributions of centrality scores between the two classes of DFDs, we performed a more robust permutation test with the Mann Whitney U statistic and n = 10000. These tests reiterated that continuous and discontinuous DFDs have significantly different centrality scores (Degree centrality p = 0.008; Betweenness centrality p = 0.028) (Figure S3E).

      (7) Page 3 section title: "Nucleation barriers are a characteristic feature of inflammatory signalosome adaptors." This title seems to contradict the results shown in Figure 2D, where full-length CARD9 and CARD11 are classified as sensors, but it has been reported that they are adaptor proteins with key roles in the inflammatory response. Please see the following references as examples: The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 8, 619-629 (2007), and Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease. Front Immunol. 2018 Sep 19;9:2105. However, both CARD9 and CARD11 show discontinuous to continuous behavior for the individual DFDs versus full-length proteins, respectively, in contrast to the results obtained for ASC, FADD, etc.

      We rigorously counter the inconsistent usage of the term “adaptor” in the signalosome literature by quantifying the centrality of each protein in the physical interaction network of DFD proteins. Such analysis shows that BCL10, which is also described as an adaptor, is the more central member of the CARD9 and CARD11 (CBM signalosome) pathways, and is therefore more “adaptor-like”. We have now elaborated this view in the text.

      FADD plays a key role in apoptosis but shows the same behavior as BCL10 and ASC. However, the manuscript indicates that this behavior is characteristic of inflammatory signalosomes. What is the explanation for adaptor proteins behaving in different ways? This casts doubts about the possibility of deriving general conclusions on the significance of these observations, or the subtitles in the results section seem to be oversimplifications.

      We agree that our initial presentation of these results and brief description of each protein’s function was insufficient to fully justify our conclusions. We have now elaborated that while FADD was historically considered an adaptor of extrinsic apoptosis, it is now appreciated as a pleiotropic molecule with both anti- and pro-inflammatory signaling functions. FADD’s pro-inflammatory roles include inflammasome activation and activating NF-kB through the FADDosome. We have now revised our section headings to avoid oversimplification.

      (8) IFI16-PYD displays discontinuous behavior according to Figure S1H; however, it is not included in Figure 2D, but AIM 2 is.

      We only tested a subset of FL proteins spanning different functions within diverse signalosomes. IFI16 was not included. Hence it could not be meaningfully included in Fig. 2D.

      (9) To demonstrate that "Nucleation barriers facilitate signal amplification in human cells," constructs using APAF1 CARD, NLRC4 CARD, caspase-9 CARD, and a chimera of the latter are used to create what the authors refer to as apoptsomes. Even though puncta are observed, referring to these assemblies as apoptosomes seems somewhat misleading. In addition, it is not clear why the activity of caspase-9 was not measured directly, instead of that of capsae-3 and 7, which could be activated by other means.

      We agree that describing our chimeric assemblies as “apoptosomes” could be misleading, and have now refrained from doing so. We measured caspase-3/7 instead of caspase-9 for purely technical reasons -- we were unable to find any reliable caspase-9 activity assays that were also compatible with our optogenetic and imaging wavelengths. In any case, our data with the widely used caspase3/7 reporter dyes confirm comparably effective signal propagation from the CASP9 versions to their relevant endogenous substrate for apoptotic signaling (pro-caspase-3/7). The subsequent differences in cell death efficiency between the two versions of CASP9 (Fig. 3E) cannot be attributed to indirect effects of blue light stimulation, because both versions received the same treatment. Note our stated justification for using these DFDs in the HEK293T background is that these cells lack NLCR4 and CASP1 proteins and therefore the activity we measure is due to the direct optogenetic activation.

      The polymerization of caspase-1 CARD with NLRC4 CARD, leading to irreversible puncta, could just mean that the polymers are more stable. In fact, not all DFDs form equally stable or identical complexes, which does not necessarily imply that a nucleation barrier facilitates signal amplification. Could this conclusion be an overstatement?

      Figure 3C shows that the polymers don’t simply persist following the transient stimulus -- they continue to grow. That is, the soluble protein continues to join the polymers for a net increase even though there is no longer a stimulus directing them to do so. This means the drive to polymerize is independent of the stimulus, i.e. the protein is supersaturated. In the absence of supersaturation, a difference in stability would simply change the rates at which the polymers shrink. That we see continued growth instead of shrinkage therefore cannot be explained just by a difference in stability. Nevertheless, the reviewer’s critique caused us to realize that increased persistence of the CASP1CARD polymers could contribute to signal amplification independently of supersaturation if they act catalytically (i.e. where each polymerized CASP9 subunit sequentially activates multiple CASP3/7 molecules), and we had not adequately considered this. Unfortunately, the relevant experimentalist has now moved on from the lab leaving us unable to conduct the necessary experiments to resolve these two effects in a timely fashion. Consequently, we have now tempered our interpretation of these data. 

      (10) To demonstrate that "Innate immune adaptors are endogenously supersaturated," it is stated on page 5 that ASC clusters continue to grow for the full duration of the time course and that AIM2-PYD stops growing after 5 min. The data shown in Figure 4F indicate that AIM2-PYD grows after 5 mins, although slowly, and ASC starts to slow down at ~ 13 min. Because ASC has two DFDs, assemblies can grow faster and become bigger. How is this related to supersaturation?

      That AIM2-PYD assemblies appear to grow somewhat (although not significantly statistically) would be consistent with AIM2-PYD’s sequestration into the growing ASC clusters. All that matters for our conclusion regarding ASC is that ASC assemblies grow following cessation of the stimulus, which we now describe quantitatively. Supersaturation is defined as the ratio of total concentration to saturating concentration, which is an equilibrium property. For a given protein concentration, the presence of two DFDs, each contributing their own interactions to overall stability of the assembly, will increase supersaturation relative to the individual DFDs. Importantly, growth will not occur if the protein concentration lies below its C<sub>sat</sub>, no matter how many DFDs it has.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      It isn't clear what is implied by the final sentence of the Abstract. Some of the conclusions have a speculative tone and would be better described in less certain terms. The final sentence of the abstract should be omitted.

      We have revised the abstract to add appropriate nuance but consider the final sentence to be both justified by our data and important to convey our findings to a broad audience.

      How does the size and nature of the seed influence the outcome of these DFD interactions? Although some non-seeded experiments are described, the majority of the results are derived from seeded experiments. Further details about the seeds should be included. How is the size of the nucleus controlled, and will seeds of smaller or larger size generate the same pattern of results?

      This is a very important question! The seeds comprised genetic fusions of each DFD to a condensate-forming domain, as described. While this system is insufficient to explore the size-dependence of nucleation, we are developing tools to do exactly that, for example our recently published multivalent nanobody against mEos3,[3] wherein we piloted its use to compare the size-dependence of ASC versus amyloid nucleation. Much further work will be needed to fully utilize this approach for the question of interest, and that is the subject of ongoing but open-ended work in the lab.

      What is the implication of the observation that only ~20% of the DFDs exhibited a discontinuous transition from no to high AmFRET signal? Further discussion of the DFDs that exhibit a continuous transition would enrich the manuscript.

      We consider the relationship to mortality important for understanding this observation. In the discussion we now explain that each supersaturated protein in a death-inducing pathway imposes a risk of unintentional death. We speculate that evolution therefore minimizes the number of supersaturated DFDs by restricting them to central nodes in the network. That way, a small number of supersaturable DFDs can be continuously “repurposed” with new receptor proteins for each D/PAMP. Additionally, as stated in our response to the related critique, we felt it was important to focus this manuscript on the novel concept of functional supersaturation necessarily at the expense of signaling regulation through better understood mechanisms.

      Were the initial experiments with DFDs unseeded (Figure S1, F-G)? Clarify this in the text. The morphologies of all the subcellular assemblies appear similar. It is not possible to distinguish between long filaments and spherical or amorphous puncta (Figure S1F-G). Higher magnification images that allow evaluation and comparison of morphology should be provided.

      The initial experiments were unseeded, as now clarified in the legend. We believe there was a misinterpretation resulting from both panels (S1F and G) showing fibrillar examples. To clarify, we have now added panel S1H showing representative DFDs classified as “punctate”, which we hope the reviewer agrees are clearly distinct from fibrillar.

      The ASC and CARD14 assemblies in Figure S1G show very distinct fibrillar structures emerging from the mNS-DFD seeds. Please provide further explanation of the nature of these. Do these resemble ASC and CARD assemblies generated as a result of native stimuli rather than mNS-DFD seeds?

      The μNS-DFD puncta contain numerous seeding competent sites, which presumably causes multiple fibrils to initiate and emanate from them. This and potential bundling of these fibrils produces the star-like shape. We have no reason to believe the internal structure of these fibers differs from native signalosome assemblies. For example, point mutations at native subunit interfaces that were previously shown to disrupt fibrilization and signaling likewise disrupt assembly in our DAmFRET experiments (Figure S2A). To our knowledge there exist no examples of high-resolution DFD fibril structures that were induced by native stimuli. However, recent work using super-resolution imaging confirmed that nigericin-triggered endogenous ASC specks comprise a network of filaments that superficially resembles our star-like assemblies.[4]

      Figure S2B is presented as evidence that assembly is mediated by native-like interfaces rather than amyloid-like misfolding. These SDD-Age gels cannot be used to infer a native-like structure for the protein within the assemblies, only that the assemblies are (mostly) solubilised by incubation with sarkosyl. Many misfolding but non-amyloid-structure assemblies could be consistent with these results. Additionally, several of the samples appear to show insoluble aggregates within the wells, which could also be consistent with amyloid-type structures. What is the nature of these aggregates? Why is the NLRP3PYD sample so much more intense than the others? Why was FL-ZBP1 included when it does not contain a DFD? Why were no sarkosyl-resistant assemblies observed with RIPK3-RHIM when this is known to be highly amyloidogenic?

      ZBP1 and RIPK3<sup>RHIM</sup> were one of multiple proteins inadvertently included on the complete gel shown in the original figure that is not relevant to the manuscript; we have now spliced out these unnecessary lanes (indicated with dashed lines) to avoid confusion. We have found that the specific fragment of RIPK3<sup>RHIM</sup> used in this experiment -- residues 446-464 -- does not allow for robust amyloid formation. We believe this is a steric artifact due to its small size (19 residues) relative to the fused mEos3, because a longer fragment (446-518) forms amyloid robustly. However the latter construct was not available at the time this experiment was done. Nevertheless, another known amyloid protein, RIPK1<sup>RHIM</sup>, does show the expected smears on this gel and suffices for the positive control for amyloid. We do not understand why the NLRP3<sup>PYD</sup> sample is more intense than the others. However, this anomaly does not impact our conclusion that DFDs do not form sarkosyl-resistant smears that would be indicative of amyloid.

      Expand on the concept of autoinhibited oligomerisation. Is this due to structural features? What might be the advantage of autoinhibited oligomerisation for these DFDs?

      We have elaborated on this section in the results.

      End of page 3, which "former set of adaptors" are referred to here? This is ambiguous.

      We have replaced “former” with “innate immune”.

      Page 5, the authors state that a kinetic barrier governs the activity of inflammatory signalosomes. While under the circumstances generated in this particular system, there is a kinetic barrier to the formation of large fibrillar complexes, can the same be said to be true in cells that respond to signals? They experience a specific triggering event. This should be redrafted to distinguish between the specific trigger in cells (downstream of a binding-driven event) and the kinetic barrier to self-association observed in this model system.

      Yes, our findings establish that a kinetic barrier governs signalosome activation. By engineering a triggering event that is more specific than natural triggering events (see Figure 3), we exclude the possibility that the cell first responds to the signal to create conditions that stabilize inflammasome formation. This means that regardless of what may happen with a natural trigger, the driving force for assembly clearly pre-exists and is therefore held in check by a kinetic barrier.

      On page 6, the statement "...lifespan may be limited by the thermodynamic drive for inflammatory signal amplification" is not clear. While this is strictly true following the initial triggering event, isn't lifespan limited by the stochastic activation? These very general statements stray beyond what can be substantiated on the basis of the data presented here.

      We believe the source of confusion here was our misuse of the term “lifespan”. We have now replaced it with “life expectancy”, which we believe is substantiated by our statements as written.

      Overall, the work presents a compelling, comprehensive analysis of the seeded self-assembly of DFDs. It identifies distinct properties for assembly of these domains that may underlie their particular physiological roles. However, some of the statements are quite general and not substantiated.

      Page 6. Is "end cell fate" the intended phrase?

      We have revised the phrase.

      The data regarding conservation of DFD-like modules and activity is interesting and probably deserves inclusion. However, without substantial evidence of expression levels (i.e., results) and a more complete understanding of these other systems, the statement "These results suggest that the function of DFDs as energy reservoirs preceded the evolution of animals" appears as an over-reach.

      We demonstrated that sequence-encoded nucleation barriers of DFDs are shared across animal signalosomes (human, zebrafish, sponge). This is not trivial as such nucleation barriers are uncommon even among targeted screens of prion-like proteins.5 Therefore, they appear to have existed in the basal animal. We have now omitted the data concerning bacterial DFDs as these systems are indeed much less understood, and the concerned pathways lack the tripartite architecture of animal signalosomes. We therefore revised the sentence in question by replacing “evolution” with “radiation”.

      Only a small number of DFDs exhibit this behaviour, so why is the conclusion drawn that energy storage for on-demand signalling may be the principal ancestral function of DFDs?

      The totality of the data supports this conclusion. Briefly (but elaborated in the text), 1) intrinsic nucleation barriers are unusual even among self-associating proteins, the vast majority of which (e.g. condensates) would suffice for the only other major function ascribed to DFDs -- bringing effectors close enough for proximity-dependent activation (which has been repeatedly demonstrated in DFD-replacement experiments), 2) nucleation barriers are nevertheless conserved in innate immune signaling pathway, 3) that they are limited to approximately one DFD in each pathway is consistent with evolutionary selection to minimize accidental death.

      Are there any other adapters like MyD88 that are inconsistent with this hypothesis? Are any others known to be controlled by oligomer formation? How strong is the evidence for hexameric oligomers? If there is a threshold size for oligomers, how does this differ from a stable seed/nucleus that triggers assembly, as in the discontinuous transition?

      These are all good questions related to critiques that we have now addressed.

      The use of the term "privatisation" is likely not consistently understood across the community and should be explained. Is it simply meant to imply independent operation? How is it actually different from other forms of deployment of DFDs that exhibit continuous assembly? Are they not also independent? What is implied by the opposite of privatisation here? The term may introduce ambiguity in this context.

      We have now omitted this term.

      Is there strong evidence that well-validated physiologically relevant LLPS systems exhibit supersaturation at concentrations that are very different from those of the DFDs examined in this study?

      No, and this is a major point. As discussed in the text (with references), LLPS is incompatible with cell-wide supersaturation to a comparable magnitude as crystalline transitions, which precludes them from driving signal amplification. This helps to explain why the active state of DFD assemblies is ordered, when it has been repeatedly demonstrated that signal propagation itself does not require ordering.

      The paragraph discussing TIR domains and functional amyloids would be enhanced with a comparison of amyloid systems where seeded nucleation results in assembly of a polymer with significant conformational change in the constituent monomers.

      We do not yet understand how DFDs (and TIR domains) in some cases exhibit amyloid-like nucleation barriers without overt conformational differences between monomers and polymers. Work is underway in the lab to test specific hypotheses, but such discussion would be too speculative for the present paper.

      The statement "High specificity also insulates pathways from each other" should be elaborated to discuss the issue of highly similar monomers that apparently assemble into filamentous forms with minimal structural rearrangement. How is the specificity generated?

      We have elaborated the paragraph.

      The final paragraph is speculative and utilises language that detracts from the quality and rigour of the study. While important principles have been revealed, more discussion of the limitations of the work would allow readers to evaluate the significance of the study and could be used to effectively stimulate further efforts to study the multiple different mechanisms that underpin critical signalling pathways in innate immunity and control cell fate.

      We have now revised the final paragraph and included an extensive discussion of the limitations of the work.

      Reviewer #2 (Recommendations for the authors):

      (1) For clarity, it would be useful to include the names of the proteins in the bottom table of STable1, and such information at the top and bottom tables can be connected.

      We are unable to determine what is meant by this suggestion. Table S1 does not have a “top” and “bottom table”. Every entry in Table S1 and S2 contains the protein name, its most frequently used alias in the literature (when not the official name), and the corresponding Uniprot protein ID.

      (2) The language used in the abstract makes analogies between scientific and mundane terms, which compromises clarity. For example, what is meant by the terms shown below?

      (a) "......specifically templated by other DFDs....."

      We have revised this phrase.

      (b) "...function like batteries, storing and converting energy for life-or-death decisions."

      Batteries convert chemical energy into electrical energy or thermal energy. What is the electrical energy produced by DFDs? Is there any evidence that DFDs change the temperature of the cells or transfer heat?

      We have now included a familiar example of a thermal battery that operates analogously to the manner we show for DFDs. As now elaborated extensively, such batteries operate via a physical rather than chemical process -- a change in the state of matter (solute to crystalline) of a supersaturated “phase change material” (this is an established term). This is exactly what we show is happening for DFDs. While it would be illustrative to measure the heat released upon DFD polymerization in cells, the much faster rate of heat transfer relative to molecular diffusion makes that impossible with present methods. Nevertheless, such measurements are unnecessary because disorder-to-order phase transitions are fundamentally exothermic.

      (c) "....privatizing..."

      We now avoid this term.

      Using appropriate scientific terms to explain the scientific results presented in this manuscript will increase clarity. Analogously, it is difficult to understand what the title of the manuscript means, "Protein phase change batteries..."

      We appreciate this critique and have removed “batteries” from the title to make the work more accessible to biologists. However, we reject the implication that such terminology is inappropriate. We presume the reviewer meant “unfamiliar” instead of “inappropriate”. The well-reasoned application of terms from other fields is standard practice and arguably essential to convey new concepts in biology. The modern biology lexicon is built on this. For example, Robert Hooke co-opted “cell” from the architecture of monasteries. More recently cell biologists appropriated “condensates” from soft matter physics. In both cases, the term while initially foreign to biologists usefully introduced a concept that lacked recognized precedent in biology. Similarly, “phase change battery” provides an accurate analogy for the central finding of our work, and we have now elaborated this analogy in the text.

      Bibliography

      (1) Garcia-Seisdedos, H., Empereur-Mot, C., Elad, N. & Levy, E. D. Proteins evolve on the edge of supramolecular self-assembly. Nature 548, 244–247 (2017).

      (2) Alberti, S., Halfmann, R., King, O., Kapila, A. & Lindquist, S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146–158 (2009).

      (3) Kimbrough, H. et al. A tool to dissect heterotypic determinants of homotypic protein phase behavior. Protein Sci. 34, e70194 (2025).

      (4) Glück, I. M. et al. Nanoscale organization of the endogenous ASC speck. iScience 26, 108382 (2023).

      (5) Posey, A. E. et al. Mechanistic inferences from analysis of measurements of protein phase transitions in live cells. J. Mol. Biol. 433, 166848 (2021).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Here the authors attempted to test whether the function of Mettl5 in sleep regulation was conserved in drosophila, and if so, by which molecular mechanisms. To do so they performed sleep analysis, as well as RNA-seq and ribo-seq in order to identify the downstream targets. They found that the loss of one copy of Mettl5 affects sleep and that its catalytic activity is important for this function. Transcriptional and proteomic analyses show that multiple pathways were altered, including the clock signaling pathway and the proteasome. Based on these changes the authors propose that Mettl5 modulate sleep through regulation of the clock genes, both at the level of their production and degradation.

      Strengths:

      The phenotypical consequence of the loss of one copy of Mettl5 on sleep function is clear and well-documented.

      Weaknesses:

      The imaging and molecular parts are less convincing.

      - The colocalization of Mettl5 with glial and neuronal cells is not very clear

      We truly appreciate your suggestion. We repeated the staining experiments. To ensure better results, we tried another antibody of ELAV (mouse) and optimized the experimental conditions. This result has been included in the Figure S1 of the revised version.

      - The section on gene ontology analysis is long and confusing

      The session is revised for clarity. To get a better flow of logic, we deleted the paragraph which describing the details of Figure S6.

      - Among all the pathways affected the focus on proteosome sounds like cherry picking. And there is no experiment demonstrating its impact in the Mettl5 phenotype

      Thank you for the comments. The changes of period oppositely at transcriptional versus translational levels puzzled us a while until we found the ubiquitin pathway components changes. The regulation of Period protein degradation by ubiquitin-proteasome pathway has been well documented (Grima et al., 2002; Ko et al., 2002; Chiu et al., 2008). In addition, previous reports indicated that N6 methyladenosine (m6A) regulates ubiquitin proteasome pathway in skeletal muscle physiology (Sun et al., 2023). This information has been included in the revised manuscript in the last paragraph under the title: Mettl5 regulates the clock gene regulatory loop.

      Indeed, we haven’t found a proper way to manipulate proteasome levels in genetic tests. Proteasome is a large protein complex which is composed of many subunits. Enhancing the its activity by overexpressing its components was not applicable. Moreover, proteasome has important function during many biological processed. Disrupting its function by simply MG132 treatment which we tried results in lots of side effects.

      In this study, we also noticed the codon usage alteration caused by mettl5 mutant. Please refer to the answers to the following question for details. Previous reports also found the regulation of mettl5 on translation in other systems (Rong et al, 2020; Peng et al., 2022). Based on these analyses, it is possible that both the regulation on translation and protein degradation contributed the period protein upregulation found in mettl5 mutant. This idea has been included in the Discussion session of the revised manuscript.

      References

      Sun J, Zhou H, Chen Z, et al. Altered m6A RNA methylation governs denervation-induced muscle atrophy by regulating ubiquitin proteasome pathway. J Transl Med. 2023;21(1):845. Published 2023 Nov 23. doi:10.1186/s12967-023-04694-3

      Grima, B. et al. The F-box protein slimb controls the levels of clock proteins period and timeless. Nature 420, 178–182 (2002).

      Ko, H. W., Jiang, J. & Edery, I. Role for Slimb in the degradation of Drosophila period protein phosphorylated by doubletime. Nature 420, 673–678 (2002).

      Chiu, J. C., Vanselow, J. T., Kramer, A. & Edery, I. The phosphooccupancy of an atypical SLIMB-binding site on PERIOD that is phosphorylated by DOUBLETIME controls the pace of the clock. Genes Dev. 22, 1758–1772 (2008).

      - The ribo seq shows some changes at the level of translation efficiency but there is no connection with the Mettl5 phenotypes. In other words, how the increased usage of some codons impact clock signalling. Are the genes enriched for these codons?

      Thank you for raising this point. In our analysis, we observed an increased usage of the codons for Asp in the Mettl5 mutant. Prior work has reported a possible connection between codon usage and per protein activity. In the report, a per version with optimized codon cannot rescue circadian rhythmicity caused by per mutant, in contrast to WT version (Fu J et al. 2016). Further study indicated that dPER protein levels were also elevated in the mutant flies, suggesting a role for codon optimization in enhancing dPER expression (Figure 2B in Fu J et al. 2016). Consistent with this, we analyzed the region of codon optimization in Fu J et al. 2016. The result indicated that that GAC has a relatively high usage rate in these regions (indicated in the following two Author response image charts by the red arrow), suggesting that the Mettl5 mutation may influence per protein accumulation through altered GAC usage. Further experiments are needed to confirm this possibility. We included these details in the second last paragraph of the Discussion session.

      Author response image 1.

      15-21

      SDSAYSN

      Author response image 2.

      43-316

      SSGSSGYGGKPSTQASSSDMIIKRNKEKSRKKKKPKCIALATATTVSLEGTEESPLPANGGCEKVLQELQDTQQLGEPLVVTETQLSEQLLETEQNEDQNKSEQLAQFPLPTPIVTTLSPGIGPGHDCVGGASGGAVAGGCSVVGAGTDKTSELIPGKLESAGTKPSQERPKEESFCCVISMHDGIVLYTTPSISDVLGFPRDMWLGRSFIDFVHHKDRATFASQITTGIPIAESRGCMPKDARSTFCVMLRRYRGLNSGGFGVIGRAVNYEPF

      Fu J, Murphy KA, Zhou M, Li YH, Lam VH, Tabuloc CA, Chiu JC, Liu Y. Codon usage affects the structure and function of the Drosophila circadian clock protein PERIOD. Genes Dev. 2016 Aug 1;30(15):1761-75.

      - A few papers already demonstrated the role of Mettl5 in translation, even at the structural level (Rong et al, Cell reports 2020) and this was not commented by the authors. In Peng et al, 2022 the authors show that the m6A bridges the 18S rRNA with RPL24. Is this conserved in Drosophila?

      Thanks for the reminder. We discussed and cited these papers in the revised version.

      Rong B, Zhang Q, Wan J, et al. Ribosome 18S m<sup>6</sup>A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Cell Rep. 2020;33(12):108544. doi:10.1016/j.celrep.2020.108544

      Peng H, Chen B, Wei W, et al. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022;4(8):1041-1054. doi:10.1038/s42255-022-00622-9

      - The text will require strong editing and the authors should check and review extensively for improvements to the use of English.

      Thanks. The text of the paper are thoroughly revised.

      Conclusion

      Despite the effort to identify the underlying molecular defects following the loss of Mettl5 the authors felt short in doing so. Some of the results are over-interpreted and more experiments will be needed to understand how Mettl5 controls the translation of its targets. References to previous works was poorly commented.

      Thanks for your suggestion. We have incorporated the references mentioned above. However, our efforts have thus far fallen short of elucidating a precise picture of METTL5's functional mechanism. To address this, the limitations of the current study have been discussed more thoroughly in the revised main text.

      Reviewer #2 (Public review):

      Summary:

      The authors define the m6A methyltransferase Mettl5 as a novel sleep-regulatory gene that contributes to specific aspects of Drosophila sleep behaviors (i.e., sleep drive and arousal at early night; sleep homeostasis) and propose the possible implication of Mettl5-dependent clocks in this process. The model was primarily based on the assessment of sleep changes upon genetic/transgenic manipulations of Mettl5 expression (including CRISPR-deletion allele); differentially expressed genes between wild-type vs. Mettl5 mutant; and interaction effects of Mettl5 and clock genes on sleep. These findings exemplify how a subclass of m6A modifications (i.e., Mettl5-dependent m6A) and possible epi-transcriptomic control of gene expression could impact animal behaviors.

      Strengths:

      Comprehensive DEG analyses between control and Mettl5 mutant flies reveal the landscape of Mettl5-dependent gene regulation at both transcriptome and translatome levels. The molecular/genetic features underlying Mettl5-dependent gene expression may provide important clues to molecular substrates for circadian clocks, sleep, and other physiology relevant to Mettl5 function in Drosophila.

      Weaknesses:

      While these findings indicate the potential implication of Mettl5-dependent gene regulation in circadian clocks and sleep, several key data require substantial improvement and rigor of experimental design and data interpretation for fair conclusions. Weaknesses of this study and possible complications in the original observations include but are not limited to:

      (1) Genetic backgrounds in Mettl5 mutants: the heterozygosity of Mettl5 deletion causes sleep suppression at early night and long-period rhythms in circadian behaviors. The transgenic rescue using Gal4/UAS may support the specificity of the Mettl5 effects on sleep. However, it does not necessarily exclude the possibility that the Mettl5 deletion stocks somehow acquired long-period mutation allelic to other clock genes. Additional genetic/transgenic models of Mettl5 (e.g., homozygous or trans-heterozygous mutants of independent Mettl5 alleles; Mettl5 RNAi etc.) can address the background issue and determine 1) whether sleep suppression tightly correlates with long-period rhythms in Mettl5 mutants; and 2) whether Mettl5 effects are actually mapped to circadian pacemaker neurons (e.g., PDF- or tim-positive neurons) to affect circadian behaviors, clock gene expression, and synaptic plasticity in a cell-autonomous manner and thereby regulate sleep. Unfortunately, most experiments in the current study rely on a single genetic model (i.e., Mettl5 heterozygous mutant).

      We believe that the multiple rescue experiments presented in Figure 1H-L and Figure 2H-L have effectively addressed the background concern. To further confirm this, we have subsequently repeated sleep and circadian rhythm assays using RNAi lines, aiming to further eliminate any remaining concerns in this regard. It appears to replicate the reduced sleep phenotype seen at night. This result has been included in the Figure S1. It is true that we have not specifically addressed whether the effects of Mettl5 are mapped to circadian pacemaker neurons in this study. We acknowledge this as a limitation and appreciate the importance of this question. Further investigations focusing on circadian pacemaker neurons, such as PDF- or tim-positive neurons, would be necessary to clarify the precise role of Mettl5 in regulating circadian behaviors and related molecular mechanisms.

      (2) Gene expression and synaptic plasticity: gene expression profiles and the synaptic plasticity should be assessed by multiple time-point analyses since 1) they display high-amplitude oscillations over the 24-h window and 2) any phase-delaying mutation (e.g., Mettl5 deletion) could significantly affect their circadian changes. The current study performed a single time-point assessment of circadian clock/synaptic gene expression, misleading the conclusion for Mettl5 effects. Considering long-period rhythms in Mettl5 mutant clocks, transcriptome/translatome profiles in Mettl5 cannot distinguish between direct vs. indirect targets of Mettl5 (i.e., gene regulation by the loss of Mettl5-dependent m6A vs. by the delayed circadian phase in Mettl5 mutants).

      In the revised version, we provided data collected at multiple time points. Specifically, we reexamined the per expression at both transcriptional and translational levels at different timepoints. The corresponding results were incorporated in Figure 4 D-F. We also dissected fly brains from UAS-DenMark, UAS-syt.eGFP/+; pdf-GAL4/+ and UAS-DenMark, UAS-syt.eGFP/+; pdf-GAL4/Mettl5<sup>1bp</sup> at these four time points to quantify the synaptic structures of PDF neurons. The result has been included in revised Figure 6.

      (3) The text description for gene expression profiling and Mettl5-dependent gene regulation was very detailed, yet there is a huge gap between gene expression profiling and sleep/behavioral analyses. The model in Figure 5 should be better addressed and validated.

      Thank you for your suggestion. We added data to better confirm the expression changes of PER protein at different time points. Indeed, what you mention is the weak point of this paper. We did analysis thoroughly during the revision process.

      The opposing changes in Period at the transcriptional versus translational levels puzzled us for some time until we identified alterations in the ubiquitin pathway components. The regulation of Period protein degradation by the ubiquitin-proteasome pathway is well-documented (Grima et al., 2002; Ko et al., 2002; Chiu et al., 2008). Additionally, previous studies have shown that N6-methyladenosine (m6A) modulates the ubiquitin-proteasome pathway in skeletal muscle physiology (Sun et al., 2023). We have incorporated this information into the revised manuscript in the last paragraph under the section titled: Clock gene regulatory loop regulating circadian rhythm was affected by Mettl5<sup>1bp</sup>

      Indeed, we have not yet identified an effective method to manipulate proteasome levels in genetic tests. The proteasome is a large protein complex composed of numerous subunits, making it impractical to enhance its activity simply by overexpressing individual components. Furthermore, the proteasome plays a critical role in many biological processes. Disrupting its function—such as through MG132 treatment, which we attempted—leads to significant off-target effects.

      Sun J, Zhou H, Chen Z, et al. Altered m6A RNA methylation governs denervation-induced muscle atrophy by regulating ubiquitin proteasome pathway. J Transl Med. 2023;21(1):845. Published 2023 Nov 23. doi:10.1186/s12967-023-04694-3

      Grima, B. et al. The F-box protein slimb controls the levels of clock proteins period and timeless. Nature 420, 178–182 (2002).

      Ko, H. W., Jiang, J. & Edery, I. Role for Slimb in the degradation of Drosophila period protein phosphorylated by doubletime. Nature 420, 673–678 (2002).

      Chiu, J. C., Vanselow, J. T., Kramer, A. & Edery, I. The phosphooccupancy of an atypical SLIMB-binding site on PERIOD that is phosphorylated by DOUBLETIME controls the pace of the clock. Genes Dev. 22, 1758–1772 (2008).

      Reviewer #3 (Public review):

      Xiaoyu Wu and colleagues examined the potential role in sleep of a Drosophila ribosomal RNA methyltransferase, mettl5. Based on sleep defects reported in CRISPR generated mutants, the authors performed both RNA-seq and Ribo-seq analyses of head tissue from mutants and compared to control animals collected at the same time point. While these data were subjected to a thorough analysis, it was difficult to understand the relative direction of differential expression between the two genotypes. In any case, a major conclusion was that the mutant showed altered expression of circadian clock genes, and that the altered expression of the period gene in particular accounted for the sleep defect reported in the mettl5 mutant. As noted above, a strength of this work is its relevance to a human developmental disorder as well as the transcriptomic and ribosomal profiling of the mutant. However, there are numerous weaknesses in the manuscript, most of which stem from misinterpretation of the findings, some methodological approaches, and also a lack of method detail provided. The authors seemed to have missed a major phenotype associated with the mettl5 mutant, which is that it caused a significant increase in period length, which was apparent even in a light: dark cycle. Thus the effect of the mutant on clock gene expression more likely contributed to this phenotype than any associated with changes in sleep behavior.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Some of the questions that the authors should address are the following ones:

      How does Mettl5 control the translation of the clock genes ? Why the level of some genes are specifically increased or decreased? What is the relation with the effect on uORF and dORF, overlapping and non overlapping ones? The observation of these defects is interesting but how they occurs and how they impact clock signaling is missing.

      Thank you for your suggestion. This is the weak point of this paper. We did analysis thoroughly during the revision process.

      The opposing changes in Period at the transcriptional versus translational levels puzzled us for some time until we identified alterations in the ubiquitin pathway components. The regulation of Period protein degradation by the ubiquitin-proteasome pathway is well-documented (Grima et al., 2002; Ko et al., 2002; Chiu et al., 2008). Additionally, previous studies have shown that N6-methyladenosine (m6A) modulates the ubiquitin-proteasome pathway in skeletal muscle physiology (Sun et al., 2023). We have incorporated this information into the revised manuscript in the last paragraph under the section titled: Clock gene regulatory loop regulating circadian rhythm was affected by Mettl5<sup>1bp</sup>.

      Indeed, we have not yet identified an effective method to manipulate proteasome levels in genetic tests. The proteasome is a large protein complex composed of numerous subunits, making it impractical to enhance its activity simply by overexpressing individual components. Furthermore, the proteasome plays a critical role in many biological processes. Disrupting its function—such as through MG132 treatment, which we attempted—leads to significant off-target effects.

      In this study, we also observed codon usage alterations caused by the mettl5 mutant. For details, please refer to our responses to 4th question of the weakness session above. Previous studies have reported mettl5's role in translational regulation in other systems (Rong et al., 2020; Peng et al., 2022). Based on these findings, we propose that both translational regulation and protein degradation may contribute to the upregulation of Period protein in the mettl5 mutant. This hypothesis has been included in the Discussion section of the revised manuscript.

      “The mechanism by which METTL5 regulates translation warrants further investigation. Previous studies have demonstrated that METTL5 influences translation (Rong et al., 2020; Peng et al., 2022), but whether the mechanisms identified here are conserved across other systems remains an intriguing question. In our analysis, we observed increased usage of aspartate (Asp) codons in Mettl5 mutants. Notably, prior work has linked codon usage to PER protein function—specifically, a codon-optimized version of PER failed to rescue circadian rhythmicity in per mutant flies, unlike the wild-type version (Fu et al., 2016). Further analysis revealed that PER protein levels were elevated in these mutants, suggesting that codon optimization enhances PER expression (Figure 2B in Fu et al., 2016). Strikingly, when we examined the codon-optimized region from Fu et al. (2016), we found that GAC (Asp) was highly enriched, raising the possibility that Mettl5 mutation affects PER protein accumulation by altering GAC codon usage. Additional experiments will be needed to validate this hypothesis. Furthermore, we detected changes in upstream open reading frames (uORFs) in Mettl5 mutants, but their relationship to translational regulation requires further exploration.”

      References

      Sun J, Zhou H, Chen Z, et al. Altered m6A RNA methylation governs denervation-induced muscle atrophy by regulating ubiquitin proteasome pathway. J Transl Med. 2023;21(1):845. Published 2023 Nov 23. doi:10.1186/s12967-023-04694-3

      Grima, B. et al. The F-box protein slimb controls the levels of clock proteins period and timeless. Nature 420, 178–182 (2002).

      Ko, H. W., Jiang, J. & Edery, I. Role for Slimb in the degradation of Drosophila period protein phosphorylated by doubletime. Nature 420, 673–678 (2002).

      Chiu, J. C., Vanselow, J. T., Kramer, A. & Edery, I. The phosphooccupancy of an atypical SLIMB-binding site on PERIOD that is phosphorylated by DOUBLETIME controls the pace of the clock. Genes Dev. 22, 1758–1772 (2008).

      Rong B, Zhang Q, Wan J, et al. Ribosome 18S m<sup>6</sup>A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Cell Rep. 2020;33(12):108544. doi:10.1016/j.celrep.2020.108544

      Peng H, Chen B, Wei W, et al. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022;4(8):1041-1054. doi:10.1038/s42255-022-00622-9

      Fu J, Murphy KA, Zhou M, Li YH, Lam VH, Tabuloc CA, Chiu JC, Liu Y. Codon usage affects the structure and function of the Drosophila circadian clock protein PERIOD. Genes Dev. 2016 Aug 1;30(15):1761-75.

      Reviewer #2 (Recommendations for the authors):

      Please find my comments to improve the quality of your manuscript.

      Major comments

      (1) The quality of text writing in English needs to be at publishable levels. It is not a trivial problem, but it literally impairs the readability of your work. So please have professionals edit your manuscript text appropriately.

      We have carefully revised the language throughout the manuscript during the revision process.

      (2) Fig 1O: please include the total sleep profile and other analyses for rebound sleep phenotypes in control vs. Mettl5 to better validate that both genotypes were comparably sleep-deprived, but the latter shows less sleep rebound.

      Thank you for your suggestion, The other reviewer also suggested to reanalyze the sleep rebound data. We did the analysis according to the following reference. We included data sleep profiles of both genotypes in original Fig 1O. Total sleep profile and other analyses for rebound sleep phenotypes are included in the revised panel. As shown in this revised panel (now Figure 1K, L), both genotypes were comparably sleep-deprived.

      Cirelli C, Bushey D, Hill S, Huber R, Kreber R, Ganetzky B, Tononi G. 2005. Reduced sleep in Drosophila Shaker mutants. Nature 434:1087-92.

      (3) Line 90: the authors did not actually address this critical question. Additional Gal4 mapping (e.g., Mettl5 rescue or Mettl5 RNAi) will determine which cells/neural circuits are important for Mettl5-dependent sleep.

      This sentence has been revised into “The observed expression pattern of Mettl5 further supports its sleep regulatory function.”

      (4) Fig 1H-L; Fig 2H-L: the authors should check if overexpression of wild-type or mutant Mettl5 in control backgrounds could affect nighttime sleep to better define the transgenic effects among overexpression, rescue, and dominant-negative.

      Thank you for the comment. We added the overexpression phenotypes in the revised version.

      (5) Lines 225-226. Fig S11: The neural projections from PDF-expressing neurons should be better imaged and quantified. Current images can visualize PDF projections onto the optic lobe but not others (e.g., dorsal, POT), so the conclusion is not validated.

      Thank you for the suggestion. We acknowledge the limitation in the current images of PDF-expressing neuronal projections. We included new, higher-resolution images to better visualize and quantify the neural projections, including the dorsal and POT regions, to ensure the conclusion is well-supported.

      (6) Lines 230-232: per RNA/PER protein expression oscillates daily, so the authors should perform time-point experiments to conclude Mettl5 effects on clock gene expression, including per.

      Thank you for the insightful comment. We performed experiments in the Mettl5 mutant background at four time points to analyze PER protein expression using both RT-PCR and Western blot (anti-PER). The updated results have been included in Figure 4D-F.

      (7) Lines 235-238: the authors should note that Mettl5 effects on sleep in Clk or per mutant backgrounds are actually opposite to those in w1118/control one. Mettl5 deletion promotes daytime or nighttime sleep in Clk or per mutants, respectively. Any explanation? 

      We are trying to use epistasis analysis to determine which gene is upstream here. Epistasis (or epistatic effect) in genetics refers to the interaction between different genes where the expression of one gene (the epistatic gene) masks or modifies the expression of another gene (the hypostatic gene). The epistatic gene (masking gene) usually functions downstream in the pathway because its effect overrides the output of the hypostatic gene. The double mutant showed the similar phenotype as downstream genes. Thus, Clk or per functions downstream of Mettl5.

      (8) Fig 6: The dorsal PDF projections actually show time-dependent plasticity. Results from the single time-point are not conclusive.

      Thank you for the insightful comment. we further dissected fly brains from UAS-DenMark, UAS-syt.eGFP/+; pdf-GAL4/+ and UAS-DenMark, UAS-syt.eGFP/+; pdf-GAL4/Mettl5<sup>1bp</sup> at these four time points to analyze the morphology of PDF neurons. The results have been included in figure 6.

      Minor comments

      (1) Please avoid simple bar graphs in the data presentation-include individual data points or use a different graph showing the distribution of raw data (e.g., violin plot, box plot, etc.).

      Thank you for the suggestion. In the revised version of the manuscript, we have included individual data points, violin plots, and box plots to present the data, effectively showing both the distribution and differences in the raw data.

      (2) Line 19: "Clock" indicates the gene name or general terminology such as "circadian clock". Please clarify it and revise the font accordingly.

      This has been revised into“clock”

      (3) The overall flow in the Abstract/Summary is somewhat challenging for a general audience to follow.

      We have revised the text, especially the overall flow in the Abstract/Summary.

      (4) Fonts for the names of genes and gene products (i.e., mRNA, protein) should be appropriately corrected throughout the manuscript.

      We have checked the text and made changes where necessary.

      (5) Methods: the authors should provide detailed information on the methods. For instance, there is little description of how they generate Mettl5 deletions (e.g., sgRNA/target sequence). Also, they should clarify whether they test heterozygous vs. homozygous mutants of Mettl5 deletions in each experiment since the genotype description in the figure appears mixed-up (e.g., Fig 1B vs. Fig 1I-L).

      Thank you for pointing this out. In the updated version, we provided detailed information about the strains used, including the sgRNA/target sequences for generating Mettl5 deletions. Regarding the genotypes, Figure 1B represents homozygous mutants, while Figures 1I-L represent heterozygous mutants. This distinction has been clarified in the figure legends, and the genotype notation for Figures 1I-L will be revised for consistency and clarity.

      (6) Fig 1: the figure panels should be re-arranged based on the order of their text description (i.e., Fig 1H-L should go after Fig 1M-O).

      Thank you for the suggestion. In the revised version, we rearranged the figure panels so that Figures 1H-L appear after Figures 1M-O, following the order of their description in the text.

      (7) Sleep education in Trmt112 RNAi looks different from that in Mettl5 mutant het. Any explanation?

      The functional divergence between Trmt112 and Mettl5 may also contribute to the observed sleep phenotype. While Trmt112 and Mettl5 share some downstream targets, they each regulate many unique genes, some of which could influence sleep. Sleep is a highly sensitive trait that can be modulated by numerous genetic factors. Previous studies have also suggested that sleep behaves more like a quantitative trait, reflecting the combined effects of multiple genes (Mackay and Huang, 2018).

      Mackay TFC, Huang W. Charting the genotype-phenotype map: lessons from the Drosophila melanogaster Genetic Reference Panel. Wiley Interdiscip Rev Dev Biol. 2018;7(1):10.1002/wdev.289. doi:10.1002/wdev.289

      Reviewer #3 (Recommendations for the authors):

      A detailed critique is provided below. Generally, the authors can greatly improve this manuscript if they focus more rigorously on the circadian phenotype associated with the Mettl5 mutant, which could be the basis for the apparent sleep phenotype.

      (1) Please provide more information as to how each of the mettl5 mutants were generated. This information should include, specifically, the gRNA sequences, plasmids generated for the 5' and 3' arms, and anything related to the CRISPR approach for generating the mutants. Was any sequencing done to verify the CRISPR alleles, or was this limited to the analysis of mettl5 expression and behavior? Please indicate where the qPCR primers (used in Fig 1B) are located relative to the mutant loci. The figure legend is also incomplete in that there is no reference to the boxed area in Fig 1A.

      In the updated version, we have provided detailed information about the how each of the mettl5 mutants were generated. The sequence was verified by sequencing following PCR. The following references to the boxed area were added in the revised version.

      Reference

      Iyer LM, Zhang D, Aravind L. Adenine methylation in eukaryotes: Apprehending the complex evolutionary history and functional potential of an epigenetic modification. Bioessays. 2016 Jan;38(1):27-40. doi: 10.1002/bies.201500104.

      (2) As noted, I am not in agreement with the interpretation of findings for the sleep defect reported in the mettl5[1b]/+ mutants. There is a clear increase in morning sleep in the mutants that may not have reached significance by lumping the data in 12h increments (Fig1C-E). Were the overall 24h sleep values between the mutants and controls the same? The sleep profile appears to be shifted, such that nighttime sleep onset in the mutants occurs much later than wild type, and daytime waking is also much later, all pointing to a long period phenotype, which is very strongly supported by the data in Table 1, as well as the RNA- and ribo-seq data. The implications for this leading to sleep disturbances in humans is very exciting. An additional suggestion to the authors here is to report the nighttime sleep latency values (time to onset of the first sleep bout after lights off).

      We appreciate your insightful observation. As shown in Table 1, the Mettl51bp/+ mutant exhibits a robust long-period phenotype, with circadian rhythms significantly extended to 28.3 ± 0.4 hours compared to the wild-type's 23.9 ± 0.05 hours. This prolonged period perfectly aligns with the observed behavioral phenotypes, including delayed nighttime sleep onset, later daytime waking, and the overall shift in sleep profile. This is indeed quite similar to previous report on Period3 variant (Zhang et al., 2016). We agree that the prolonged circadian period contributes to the observed sleep phenotype. However, since total sleep time was significantly reduced in the mutant, we cannot attribute the phenotype solely to period lengthening. Furthermore, our 24-hour PER expression analysis in mettl5 mutants revealed elevated PER protein levels at ZT1 and ZT18, while ZT6 and ZT12 showed no significant changes, with no apparent phase shift. These findings collectively suggest that the phenotype primarily results from PER protein stabilization and accumulation.

      Importantly, genetic rescue experiments restoring wild-type Mettl5 function (UAS-Mettl5/Mettl5-Gal4; Figure 1 and Table 1) completely normalized the circadian period to 24 ± 0.02 hours, providing compelling evidence that these phenotypes specifically result from loss of Mettl5 function. Together with the sleep architecture data, these findings establish Mettl5 as a crucial regulator of circadian rhythms, with important implications for understanding human sleep disorders. To further substantiate these observations, we have now included quantitative nighttime sleep latency measurements in the revised manuscript to better document the delayed sleep onset in mutants (Figure S1G).

      We have discussed this in the third paragraph of the Discussion session and included the reference in the revised manuscript.

      Zhang L, Hirano A, Hsu PK, et al. A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood trait. Proc Natl Acad Sci U S A. 2016;113(11):E1536-E1544. doi:10.1073/pnas.1600039113.

      (3) The description for how circadian behavior was measured and analyzed (Table 1) is missing from the methods section.

      We have included a detailed description of the methods used to measure and analyze circadian behavior, as presented in Table 1, in the revised methods “Sleep behavior assays” section.

      (4) Please explain what the "awake %" values reported in Figs 1G, 1L, Fig 2G, and 2L, Fig 4G and 4M are. Is this simply the number of flies that are awake at a given time point? This does not provide useful information beyond what is already reported for the sleep profiling in other parts of these figures. If it is an arousal threshold assay, as shown in supplementary Fig 1H, please indicate this. The description for "sleep arousal" in the methods (lines 368-371) is also concerning. If most of the mutant flies are already awake at ZT 14, then I would expect that this assay would not work at this time of day. A more suitable time point would be ZT 19, or later, when the mutants are falling asleep. Moreover, calculating the number of flies awakened as long as 5 minutes after a stimulus pulse cannot be distinguished from a spontaneous awakening, and so is not really a metric of arousal threshold. The number of sleeping flies awakened by the stimulus should be calculated within, at most, one minute afterward.

      Thank you for your suggestion. Regarding the 'awake %' metric, it indicates that at specific time points (e.g., ZT14), the percentage of awake fruit fly population at that moment. In the revised version, we further clarify the definition and significance of 'awake %'. Additionally, we have reevaluated the time points for the arousal threshold assay, selecting a more appropriate time (e.g., ZT19) to better reflect the sleep state of the mutants. Based on your suggestion, we calculate the number of flies awakened within one minute after the stimulus to ensure a more accurate measurement of arousal threshold. This has been included in the revised Figure 1M.

      (5) Fig1M-O is problematic. First, is it possible that expression of Mettl5 mRNA fluctuates with time-of-day and is not affected by sleep loss? There are no undisturbed controls collected at equivalent time points. The method used for quantifying sleep rebound in Fig 1O (lines 365-367) does not make sense, as negative values would be expected. Moreover, since the Mettl5 mutants show high sleep amounts in the morning and very low sleep amounts from ZT 12-18, this analysis would be severely confounded. Also, the sleep deprivation applied would not produce equivalent amounts of sleep loss as compared to wild type controls, so this also needs to be corrected. The authors should consider consulting Cirelli et al (2005, DOI: 10.1038/nature03486 ) as an approach for quantifying sleep homeostasis in a short-sleeping mutant. Please also show the sleep profiling in the mutants for these experiments.

      Thank you for your valuable suggestions. Regarding the possibility that Mettl5 mRNA expression fluctuates with circadian rhythms rather than being affected by sleep deprivation, we acknowledge that collecting undisturbed control samples at equivalent time points would provide critical insights. In the revised version, we included undisturbed controls to distinguish between circadian-driven fluctuations and the effects of sleep deprivation on Mettl5 expression.

      For the quantification of sleep rebound in Figure 1O, we agree that the current method may not fully capture the dynamics of sleep recovery, especially in Mettl5 mutants, where sleep patterns differ significantly from wild-type. We have referred to the method proposed by Cirelli et al. paper for quantifying sleep homeostasis in short-sleeping mutants, ensuring a more accurate evaluation of sleep rebound. The results have been included in Figure 1K-L of the revised version.

      (6) Fig 3B and C (minor) - while the volcano plots are clear, it is not clear whether "down" or "up" means for the mutant relative to wild type or the other way around? Please clarify. In Fig 3P, the legend indicates a depiction of the "top 5 pathway associated genes", but it seems there are 10 pathways depicted. Which of these are the "top 5"?

      In the volcano plots (Fig. 3B and 3C), “up” and “down” refer to genes that the mutant relative to the wild-type strain. In Fig. 3P, the legend was mislabeled as “top 5” pathway-associated genes. In fact, we displayed the top 10 pathway-associated genes. We apologize for the confusion and will correct both the figure legend and the corresponding text in our revised manuscript.

      (7) Fig 4 D-E, and F,G do not have sufficient information to draw the conclusion that Per mRNA/protein expression is increased in the Mettl5 mutant. Since both mRNA protein of this gene oscillates significantly throughout the day, it is still possible that the single time point shown in this figure might indicate a disruption in cycling rather than overall expression level. Please first indicate what time of day the tissue was collected, second, consider adding more time points to both assays. For the first part of this figure, A and B, per and Clock gene expression are expected to be in different phases, and so this aspect is not unexpected. However, it is notable that it is reversed in the mutant vs wild type. Again, an alternate interpretation of this finding that the authors have not considered is a change in period duration of gene cycling.

      Thank you for your suggestion. For the PER WB experiments, we have included multiple time points in the revised version to more comprehensively evaluate PER expression in the Mettl5 mutant and better understand its circadian rhythm changes. We appreciate your observation regarding the potential changes in the period duration of gene cycling. This has been discussed in the 3<sup>rd</sup> paragraph of the Discussion session of the revised version.

      (8) The data shown in Figs 4H-M does not support the conclusion that "Clock and Per genes were downstream of Mettl5" (line 236-237). The daytime sleep phenotype, in particular, appears additive between both circadian genes and mutant because the morning sleep of the double mutant is much higher than either mutant by itself. Statistical comparisons between the double mutant and each clock mutant are also noticeably missing. These data are difficult to interpret. One potential explanation is that Mettl5 alters gene expression of non-circadian genes, and that the phenotypes become additive when both clock and Mettl5 genes are missing. A full molecular analysis of clock gene cycling in the Mettl5 mutant may help improve understanding of the relationship between the circadian clock Mettl5 gene expression. It may also be worthwhile checking whether Mettl5 gene expression itself shows a daily oscillation.

      Thank you for your suggestion. In the revised version, we have included four additional time points to analyze the oscillatory expression of Per and Clock in the Mettl5 mutant, providing a more comprehensive understanding of their circadian rhythm changes. In Figs 4H-M, we are trying to use epistasis analysis to determine which gene is upstream here. Epistasis (or epistatic effect) in genetics refers to the interaction between different genes where the expression of one gene (the epistatic gene) masks or modifies the expression of another gene (the hypostatic gene). The epistatic gene (masking gene) usually functions downstream in the pathway because its effect overrides the output of the hypostatic gene. The double mutant showed the similar phenotype as downstream genes. Thus, Clk or per functions downstream of Mettl5. Statistical comparisons between the double mutant and each clock mutant are added.

      (9) In Fig 6, what time of day were the flies collected? PDF terminal morphology is known to change throughout the day; this is another piece of data that could indicate a defect in circadian function rather than a chronic change in synaptic morphology.

      The flies were collected around ZT14. We included additional dissection time points in future experiments. Differences between the control and Mettl5 mutants are observed consistently across multiple time points, suggesting that Mettl5 has an impact on synaptic plasticity.

      Minor:

      There are letter indicators, presumably for statistical comparisons, depicted in Figs 1 and 2 (panels I-L), but no explanation as to what these mean in the figure legends.

      We have added notes in the revised version.

      What is the purpose of the boxed regions shown in Fig S1A-F? There is no explanation of these in the figure legend nor in the text.

      The boxed regions highlight the significant co-localization of two proteins. We have included this explanation in the figure legend in the revised version.

      The statement (lines 310-311) that per and clock genes "exhibit more pronounced sleep rebound after sleep deprivation" is inaccurate. The article cited for this (Shaw et al 2002) showed that it was female mutants of the cycle gene which showed prolonged sleep rebound; other clock mutants were normal.

      Thank you for pointing out this. We revised the statement accordingly.

      Overall, the manuscript may benefit from editing or writing assistance to improve the language. There were many incomplete sentences, grammatical errors, etc.

      We have carefully refined the language throughout the manuscript during the revision process.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors report intracranial EEG findings from 12 epilepsy patients performing an associative recognition memory task under the influence of scopolamine. They show that scopolamine administered before encoding disrupts hippocampal theta phenomena and reduces memory performance, and that scopolamine administered after encoding but before retrieval impairs hippocampal theta phenomena (theta power, theta phase reset) and neural reinstatement but does not impair memory performance. This is an important study with exciting, novel results and translational implications. The manuscript is well-written, the analyses are thorough and comprehensive, and the results seem robust.

      Strengths:

      (1) Very rare experimental design (intracranial neural recordings in humans coupled with pharmacological intervention).

      (2) Extensive analysis of different theta phenomena.

      (3) Well-established task with different conditions for familiarity versus recollection.

      (4) Clear presentation of findings and excellent figures.

      (5) Translational implications for diseases with cholinergic dysfunction (e.g., AD).

      (6) Findings challenge existing memory models, and the discussion presents interesting novel ideas.

      Weaknesses:

      (1) One of the most important results is the lack of memory impairment when scopolamine is administered after encoding but before retrieval (scopolamine block 2). The effect goes in the same direction as for scopolamine during encoding (p = 0.15). Could it be that this null effect is simply due to reduced statistical power (12 subjects with only one block per subject, while there are two blocks per subject for the condition with scopolamine during encoding), which may become significant with more patients? Is there actually an interaction effect indicating that memory impairment is significantly stronger when scopolamine is applied before encoding (Figure 1d)? Similar questions apply to familiarity versus recollection (lines 78-80). This is a very critical point that could alter major conclusions from this study, so more discussion/analysis of these aspects is needed. If there are no interaction effects, then the statements in lines 84-86 (and elsewhere) should be toned down.

      The reviewer highlights important concerns regarding the statistical power of the behavioral effects. We address these concerns in the revised manuscript in two ways: (1) we provide a supplemental analysis using a matched number of blocks between the placebo and scopolamine conditions to avoid statistical bias related to differing trial counts, and (2) we include a supplemental figure illustrating paired comparisons between blocks.

      (2) Further, could it simply be that scopolamine hadn't reached its major impact during retrieval after administration in block 2? Figure 2e speaks in favor of this possibility. I believe this is a critical limitation of the experimental design that should be discussed.

      The reviewer raises an important methodological concern regarding the time required for scopolamine's effect to manifest and the subsequent impact on the study outcomes. Previous studies report that the average time to maximum serum concentration after intravenous (IV) scopolamine administration is approximately 5 minutes (Renner et al., 2005), with the corresponding clinical onset estimated at 10 minutes. In our study, the retrieval period in Block 2 commenced at 15 ± 0.2 post-injection across all subjects. Given this timing, there is sufficient reason to conclude that scopolamine had reached its major impact during the Block 2 retrieval phase. Furthermore, the observation of significant disruptions to theta oscillations during this same retrieval phase provides strong evidence that the drug was in full effect at that time.

      (3) It is not totally clear to me why slow theta was excluded from the reinstatement analysis. For example, despite an overall reduction in theta power, relative patterns may have been retained between encoding and recall. What are the results when using 1-128 Hz as input frequencies?

      Slow theta (2–4 Hz) was excluded from the reinstatement analysis to avoid potential confounding effects. Given the observed disruption to slow theta power following scopolamine administration, any subsequent changes in slow theta reinstatement would be causally ambiguous, potentially arising directly from the power effects. Therefore, we would be unable to determine whether changes in slow theta reinstatement were genuinely independent of changes in power.

      (4) In what way are the results affected by epileptic artifacts occurring during the task (in particular, IEDs)?

      To exclude abnormal events and interictal activity, a kurtosis threshold of 4 was applied to each trial, effectively filtering out segments exhibiting significant epileptic artifacts.

      Reviewer #2 (Public review):

      Summary:

      In this study, performed in human patients, the authors aimed at dissecting out the role of cholinergic modulation in different types of memory (recollection-based vs familiarity and novelty-based) and during different memory phases (encoding and retrieval). Moreover, their goal was to obtain the electrophysiological signature of cholinergic modulation on network activity of the hippocampus and the entorhinal cortex.

      Strengths:

      The authors combined cognitive tasks and intracranial EEG recordings in neurosurgical epilepsy patients. The study confirms previous evidence regarding the deleterious effects of scopolamine, a muscarinic acetylcholine receptor antagonist, on memory performance when administered prior to the encoding phase of the task. During both encoding and retrieval phases, scopolamine disrupts the power of theta oscillations in terms of amplitude and phase synchronization. These results raise the question of the role of theta oscillations during retrieval and the meaning of scopolamine's effect on retrieval-associated theta rhythm without cognitive changes. The authors clearly discussed this issue in the discussion session. A major point is the finding that the scopolamine-mediated effect is selective for recollection-based memory and not for familiarity- and novelty-based memory.

      The methodology used is powerful, and the data underwent a detailed and rigorous analysis.

      Weaknesses:

      A limited cohort of patients; the age of the patients is not specified in the table.

      To comply with human subject privacy protection policies, age was not reported; however, we did not find any significant effects of age on the behavioral or neural measures.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Regarding dosage, did you take the patients' body weight into account? Do the effects hold when controlling for it?

      We controlled for participant weight, yet the observed effects were more strongly correlated with the absolute scopolamine dosage, irrespective of weight. This outcome indicates that scopolamine likely rapidly crosses the blood-brain barrier, producing swift effects that are not initially influenced by metabolic variability.

      (2) Line 96: Corrected for what kind of multiple comparisons?

      We apologize for this confusion. The statistical analysis presented in this line does not require multiple-comparison correction, and we will therefore remove the annotation.

      (3) Line 165: These are very interesting results. How do they relate to Rizzuto et al., NeuroImage, 2006?

      Our findings show that successful retrieval is tied to an encoding-retrieval phase match, which is a refinement and application of the Rizzuto et al. (2006) work. Rizzuto et al. showed that memory events are phase-locked; we show that maintaining a specific, matched phase relationship between encoding and retrieval events is critical for memory success, and that this process is dependent on the cholinergic system.

      Reviewer #2 (Recommendations for the authors):

      Figure 1b: It would be useful for clarity to have the cartoon of the treatment paradigm for the encoding phase (blocks 3 and 4).

      The treatment paradigm only involved a single intravenous (IV) injection of scopolamine (or saline, for the placebo condition). The injections were administered by the participant's attending nurse, with a board-certified anesthesiologist present at the time of injection and available throughout the experiment. These details are fully documented in the Methods section.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      An interesting manuscript from the Carrington lab is presented investigating the behavior of single vs double GPI-anchored nutrient receptors in bloodstream form (BSF) T. brucei. These include the transferrin receptor (TfR), the HpHb receptor (HpHbR), and the factor H receptor (FHR). The central question is why these critical proteins are not targeted by host-acquired immunity. It has generally been thought that they are sequestered in the flagellar pocket (FP), where they are subject to rapid endocytosis - any Ab:receptor complexes would be rapidly removed from the cell surface. This manuscript challenges that assumption by showing that these receptors can be found all over the outer cell body and flagella surfaces, if one looks in an appropriate manner (rapid direct fixation in culture media).

      The main part of the manuscript focuses on TfR, typically a GPI1 heterodimer of very similar E6 (GPI anchored) and E7 (truncated, no GPI) subunits. These are expressed coordinately from 15 telomeric expression sites (BES), of which only one can be transcribed at a time. The authors identify a native E6:E7 pair in BES7 in which E7 is not truncated and therefore forms a GPI2 heterodimer. By in situ genetic manipulation, they generate two different sets of GPI1:GPI2 TfR combinations expressed from two different BESs (BES1 and BES7). Comparative analyses of these receptors form the bulk of the data.

      The main findings are:

      (1) Both GPI1 and GPI2 TfR can be found on the cell body/flagellar surface.

      (2) Both are functional for Tf binding and uptake.

      (3) GPI2 TfR is expressed at ~1.5x relative to GPI1 TfR

      (4) Ultimate TfR expression level (protein) is dependent on the BES from which it is expressed.

      Most of these results are quite reasonably explained in light of the hydrodynamic flow model of the Engstler lab and the GPI valence model of the Bangs lab. Additional experiments, again by rapid fixation, with HpHbR and FHR, show that these GPI1 receptors can also be seen on the cell surface, in contrast to published localizations.

      It is quite interesting that the authors have identified a native GPI2 TfR. However, essentially all of the data with GPI2 TfR are confirmatory for the prior, more detailed studies of Tiengwe et al. (2017). That said, the suggestion that GPI2 was the ancestral state makes good evolutionary sense, and begs the question of why trypanosomes prefer GPI1 TfR in 14 of 15 ESs (i.e., what is the selection pressure?)

      Strengths and weaknesses:

      (1) BES7 TfR subunit genes (BES7_Tb427v10): There are actually three (in order 5'3'): E7gpi, E6.1 and E6.2. E6.1 and E6.2 have a single nucleotide difference. This raises the issue of coordinate expression. If overall levels of E6 (2 genes) are not down-regulated to match E7 (1 gene), this will result in a 2x excess of E6 subunits. The most likely fate of these is the formation of non-functional GPI2 homodimers on the cell surface, as shown in Tiengwe et al. (2017), which will contribute to the elevated TfR expression seen in BES7.

      We would like to thank the reviewer for pointing out that there are two ESAG6 genes in BES7, we had relied on the publicly available annotation and should have known better.

      For transferrin expression levels, see the discussion in response to reviewer 1 point 3 below

      (2) Surface binding studies: This is the most puzzling aspect of the entire manuscript. That surface GPI2 TfR should be functional for Tf binding and uptake is not surprising, as this has already been shown by Tiengwe et al. (2017), but the methodology for this assay raises important questions. First, labeled Tf is added at 500 nM to live cells in complete media containing 2.5 uM unlabeled Tf - a 5x excess. It is difficult to see how significant binding of labeled TfR could occur in as little as 15 seconds under these conditions.

      The k<sub>on</sub> for transferrin is very rapid (BES1 TfR / bovine transferrin at pH7.4 = 4.5 x 10<sup>5</sup> M<sup>-1</sup>s<sup>-1</sup> (Trevor et al., 2019) and binding would occur to unoccupied receptors within 15 sec. The k<sub>off</sub> is also fast (BES1 TfR / bovine transferrin at pH7.4 = 3.6 x 10<sup>-2</sup> s<sup>-1</sup> (Trevor et al., 2019) and there would be exchange of transferrin within the time taken for endocytosis. These values are in vitro with purified proteins, the in vivo values may be affected by the VSG coat.

      The failure to bind canine transferrin (Supp. Figure 4B) acts as a control for specificity of the interaction.

      We have now performed a competition experiment as an additional control; cells in culture were supplemented with: A, 0.5 µM labelled transferrin; B, 0.5 µM labelled and 2.5 µM unlabelled transferrin; C, 0.5 µM labelled and 5 µM unlabelled transferrin, fixed after 60 s and visualised by fluorescence microscopy (Figure S4C). There was effective competition and greatly reduced binding of transferrin was seen in the presence of a 10-fold excess of unlabelled. We would like to thank the reviewer for suggesting this experiment.

      Second, Tiengwe et al. (2017) found that trypanosomes taken directly from culture could not bind labeled Tf in direct surface labelling experiments. To achieve binding, it was necessary to first culture cells in serum-free media for a sufficient time to allow new unligated TfR to be synthesized and transported to the surface. This result suggests that essentially all surface TfR is normally ligated and unavailable to the added probe.

      As part of the preliminary experiments for this paper we found that centrifugation followed by resuspension in either complete or serum free (but 1% BSA) medium resulted in a reduction is total cellular TfR and determined by western blotting. We have now included this experiment (Figure S4D). The inference from this experiment is that centrifugation and subsequently incubation will have an effect on receptor detection and endocytosis rates for a discreet time period.

      The amount of binding of labelled transferrin to cells in culture will depend on the specific activity of the labelled transferrin. This reasoning was behind the use of 0.5 µM labelled transferrin when roughly 1 in 6 molecules in the culture medium are labelled and there was only a small effect on the overall concentration of transferrin.

      Third, the authors have themselves argued previously, based on binding affinities, that all surface-exposed TfR is likely ligated in a natural setting (DOI:10.1002/bies.202400053). Could the observed binding actually be non-specific due to the high levels of fixative used?

      The absence of binding/uptake of canine transferrin argues against a non-specific interaction. In our previous publication, we did not pay enough attention to the on and off rates which allow for a degree of exchange and, here, TfR newly appearing on the cell surface has a 1 in 6 chance of binding a labelled transferrin.

      (3) Variable TfR expression in different BESs: It appears that native TfR is expressed at higher levels from BES7 compared to BES1, and even more so when compared to BES3. This raises the possibility that the anti-TfR used in these experiments has differential reactivity with the three sets of TfRs. The authors discount this possibility due to the overall high sequence similarities of E6s and E7s from the various ESs. However, their own analyses show that the BES1, BES3, and BES7 TfRs are relatively distal to each other in the phylogenetic trees, and this Reviewer strongly suspects that the apparent difference in expression is due to differential reactivity with the anti-TfR used in this work. In the grand scheme, this is a minor issue that does not impact the other major conclusions concerning TfR localization and function, nor the behavior of HpHbR and FHR. However, the authors make very strong conclusions about the role of BESs in TfR expression levels, even claiming that it is the 'dominant determinant' (line 189).

      This point is valid but exceptionally difficult to address at the protein level. As an orthogonal approach, we performed RNAseq analysis of the ‘wild type’ BES1, BES3, and BES7 cell lines to determine whether differences in receptor mRNA levels were consistent with the proposed difference in protein levels (Table S1). The analysis showed total ESAG6/7 mRNA levels to vary in a similar manner to the protein estimates with BES3 < BES1 < BES7 providing support for the differences in protein levels.

      The strongest evidence for the expression site determining the TfR level is the comparison of the cell lines in which the VSG were exchanged. This had no effect on TfR levels and so there is no evidence that the identity of the VSG alters TfR expression.

      (4) Surface immuno-localization of receptors: These experiments are compelling and useful to the field. To explain the difference with essentially all prior studies, the authors suggest that typical fixation procedures allow for clearance of receptor:ligand complexes by hydrodynamic flow due to extended manipulation prior to fixation (washing steps). Despite the fact that these protocols typically involve ice-cold physiological buffers that minimize membrane mobility, this is a reasonable possibility. Have the authors challenged their hypothesis by testing more typical protocols themselves? Other contributing factors that could play a role are the use of deconvolution, which tends to minimize weak signals, and also the fact that investigators tend to discount weak surface signals as background relative to stronger internal signals.

      We have added preliminary experiments that compared fixation protocols in two parts. First the effect on TfR levels of washing and resuspending cells discussed above (Figure S4D), and second how different fixation protocols alter apparent TfR immunolocalisation (Supp Figure S5A-B). The comparison shows that both the absence of glutaraldeyde and the use of washing alters the outcome.

      (5) Shedding: A central aspect of the GPI valence model (Schwartz et al., 2005, Tiengwe et al., 2017) is that GPI1 reporters that reach the cell body surface are shed into the media because a single dimyristoylglycerol-containing GPI anchor does not stably associate with biological membranes. As the authors point out, this is a major factor contributing to higher steady-state levels of cell-associated GPI2 TfR relative to GPI1 TfR. Those studies also found that the size/complexity of the attached protein correlated inversely with shedding, suggesting exit from the flagellar pocket as a restricting factor in cell body surface localization. The amount of newly synthesized TfR shed into the media was ~5%, indicating that very little actually exits the FP to the outer surface. In this regard, is it possible to know the overall ratio of cell surface:FP:endosomal localized receptors? Could these data not be 'harvested' from the 3D structural illumination imaging?

      A ratio could be determined but we did not do this as it would only be valid if the antibody has equal access to the internal TfR in a diluted VSG environment and the external VSG embedded in a densely packed and cross-linked VSG layer As such, we would have no confidence in the accuracy of any estimate.

      Reviewer #2 (Public review):

      The work has significant implications for understanding immune evasion and nutrient uptake mechanisms in trypanosomes.

      While the experimental rigor is commendable, revisions are needed to clarify methodological limitations and to broaden the discussion of functional consequences.

      The authors argue that prior studies missed surface-localized TfR due to harsh washing/fixation (e.g., methanol). While this is plausible, additional evidence would strengthen the claim.

      Preliminary experiments that compared fixation protocols are now included to show that method affects outcome.

      It remains unclear how centrifugation steps of various lengths (as in previous publications) can equally and quantitatively redistribute TfR into the flagellar pocket. If this were the case, it should be straightforward for the authors to test this experimentally.

      Not aware of previous studies that demonstrate equal and quantitative redistribution to the flagellar pocket. In previous reports, there is variation in cell surface/flagellar pocket localisation depending on expression levels, for example (Mussmann et al., 2003) (Mussmann et al., 2004), it’s worth noting that the increase in TfR expression in these papers is similar to the difference in the cell lines used here. In addition, most report the presence of TfR in endosomal compartments. In the experiments here, there are cells where the majority of signal from labelled transferrin is present in the flagellar pocket and the argument is that this is a stage of a continuous process in which the receptor picks up a transferrin on the cell surface and is swept towards the pocket.

      If TfR is distributed over the cell surface, live-cell imaging with fluorescent transferrin should be performed as a control. Modern detection limits now reach the singlemolecule level, and transient immobilization of live trypanosomes has been established, which would exclude hydrodynamic surface clearance as a confounding factor.

      This is non-trivial and is a longer-term aim. The immobilisation involves significant manipulation of the cells prior to restraining.

      In most images, TfR is not evenly distributed on the surface but rather appears punctate. Could this reflect localization to membrane domains? Immuno-EM with high-pressure frozen parasites could resolve this question and is relatively straightforward.

      There is a non-uniform appearance in the super-resolution images for both TfR and FHR. We cannot distinguish whether this represents random variation in receptor density over the cell surface or results from a biological phenomenon. Whatever the cause, the experiments showed unambiguous cell surface localisation.

      The authors might consider discussing whether differences in parasite life cycle stages (procyclic versus bloodstream forms) or culture conditions (e.g., cell density) affect localization. The developmentally regulated retention of GPI-anchored procyclin in the flagellar pocket might be worth mentioning.

      The aim of this paper was to determine the localisation of receptors in proliferating bloodstream form trypanosomes in culture. TfR and HpHbR are not expressed in insect stages in culture. FHR is expressed in insect stages and is present all over the cell surface (Macleod et al., 2020). A procyclin-based reporter was distributed over the whole cell surface in one report (Schwartz et al. 2005). In other reports, the retention of procyclin in the flagellar pocket of proliferating bloodstream forms is probably dependent on structure/sequence as other single GPI-anchored proteins, such as FHR (Macleod et al., 2020) and GPI-anchored sfGFP (Martos-Esteban et al., 2022) can access the surface.

      References:

      MacGregor, P., Gonzalez-Munoz, A. L., Jobe, F., Taylor, M. C., Rust, S., Sandercock, A. M., Macleod, O. J. S., Van Bocxlaer, K., Francisco, A. F., D’Hooge, F., Tiberghien, A., Barry, C. S., Howard, P., Higgins, M. K., Vaughan, T. J., Minter, R., & Carrington, M. (2019). A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasis. PLoS Neglected Tropical Diseases, 13(5), e0007373. https://doi.org/10.1371/journal.pntd.0007373

      Macleod, O. J. S., Bart, J.-M., MacGregor, P., Peacock, L., Savill, N. J., Hester, S., Ravel, S., Sunter, J. D., Trevor, C., Rust, S., Vaughan, T. J., Minter, R., Mohammed, S., Gibson, W., Taylor, M. C., Higgins, M. K., & Carrington, M. (2020). A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies. Nature Communications, 11(1), 1326. https://doi.org/10.1038/s41467-020-15125-y

      Martos-Esteban, A., Macleod, O. J. S., Maudlin, I., Kalogeropoulos, K., Jürgensen, J. A., Carrington, M., & Laustsen, A. H. (2022). Black-necked spitting cobra (Naja nigricollis) phospholipases A2 may cause Trypanosoma brucei death by blocking endocytosis through the flagellar pocket. Scientific Reports, 12(1), 6394. https://doi.org/10.1038/s41598-02210091-5

      Mussmann, R., Engstler, M., Gerrits, H., Kieft, R., Toaldo, C. B., Onderwater, J., Koerten, H., van Luenen, H. G. A. M., & Borst, P. (2004). Factors affecting the level and localization of the transferrin receptor in Trypanosoma brucei. The Journal of Biological Chemistry, 279(39), 40690–40698. https://doi.org/10.1074/jbc.M404697200

      Mussmann, R., Janssen, H., Calafat, J., Engstler, M., Ansorge, I., Clayton, C., & Borst, P. (2003). The expression level determines the surface distribution of the transferrin receptor in Trypanosoma brucei. Molecular Microbiology, 47(1), 23–35. https://doi.org/10.1046/j.13652958.2003.03245.x

      Schwartz, K. J., Peck, R. F., Tazeh, N. N., & Bangs, J. D. (2005). GPI valence and the fate of secretory membrane proteins in African trypanosomes. Journal of Cell Science, 118(Pt 23), 5499–5511. https://doi.org/10.1242/jcs.02667

      Trevor, C. E., Gonzalez-Munoz, A. L., Macleod, O. J. S., Woodcock, P. G., Rust, S., Vaughan, T. J., Garman, E. F., Minter, R., Carrington, M., & Higgins, M. K. (2019). Structure of the trypanosome transferrin receptor reveals mechanisms of ligand recognition and immune evasion. Nature Microbiology, 4(12), 2074–2081. https://doi.org/10.1038/s41564-019-0589-0

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Major Recommendations:

      (1) 2 E6 gene in BES7s: This does not affect the overall conclusions, but the text should be modified to reflect the existence of the second gene, and to discuss the ramifications.

      This has been corrected

      (2) Surface binding studies: To clarify this issue, two experimental approaches are strongly recommended. First: additional excess unlabelled Tf should be added. If binding is truly receptor-mediated, it must by definition be saturable at some experimentally achievable level. Second: TfR expression should be abrogated by RNAi silencing to show that binding is TfR-dependent. Without some validation of specific binding by one or both of these approaches, these counter-intuitive results must be questioned.

      The excess unlabelled transferrin experiment is now included (we would like to thank the reviewer for this suggestion). The absence of binding of canine transferrin provides strong evidence for the specificity.

      (3) Variable TfR expression in different BESs: To make such claims, quantitative RTPCR should be performed with conserved primers to assess the actual relative expression at the transcriptional level. Absent this, the claims should be eliminated, or at the very least greatly tempered.

      This has been done using an RNAseq analysis.

      (4) Surface immuno-localization of receptors: An example of discounting weak signals as background can be seen in Figure 8 of Duncan et al. (2024). It has also been shown that at least one other GPI1 reporter (procyclin) is readily detected on the outer cell surface under ectopic expression in BSF trypanosomes (Schwartz et al., 2005) using typical fixation procedures. This could be cited, and the authors could discuss the fact that procyclin is not a receptor and may not be susceptible to hydrodynamic drag.

      Yes

      Minor issues:

      (1) Fully appreciating the data presented requires an understanding of the hydrodynamic flow and GPI valence models of the Engstler and Bangs labs, respectively. For the uninitiated,d it might perhaps be useful to include brief summaries of each in the Introduction.

      Added to the introduction

      (2) Lines 110-112: ISG65 and ISG75 both have strong localizations in endosomal compartments. This should be noted with citation of any of the work from the Field lab.

      Added

      (3) Lines 121-132: This passage presents the role of GPI anchors (1 vs 2) in a rather digital manner (in or out). Schwartz et al (2005) present a much more nuanced view of what is likely taking place. This is one reason summaries of hydrodynamic flow and GPI valence would be helpful.

      Modified

      (4) Lines 182-184: The increased size of GPI-anchored E7 is in part due to the presence of the GPI itself, as the authors state, but there are also 24 additional amino acid residues in this protein that contribute.

      Modified

      (5) Lines 212-214: Do p>0.95 and p>0.99 indicate statistical significance? This must be a typo.

      Thank you, corrected

      (6) Lines 218-219: The better references documenting GPI number in regard to turnover/shedding are Schwartz et al. 2005 and Tiengwe et al. 2017.

      Changed

      (7) Line 241 and Figures 3, 4, and 6: The transverse sections add little to the presentation. That there is signal variation in all dimensions is readily apparent from the images themselves, and similar profiles would be obtained regardless of the transect. Was there some process/rationale in the selection of the individual transects intended to make a broader point? If so, a description of the process should be provided.

      The point was to show that the signal had a pattern consistent with plasma membrane (two distal peaks) as opposed to cytoplasm (single central peak). As such, we think it is important.

      (8) Lines 582-596: Methodology for quantitation of cellular fluorescent signals should be provided.

      Has been expanded

      Reviewer #2 (Recommendations for the authors):

      (1) As a less critical but still useful control, antibody accessibility assays on live versus fixed parasites could test whether VSG coats limit detection.

      This could only be quantified by using a range of monoclonal antibodies which are not available.

      (2) The rapid transferrin uptake (15-60 seconds) could reflect fast endocytic recycling rather than stable surface residency. A pulse-chase experiment tracking receptor movement would clarify this (though I acknowledge that this is technically challenging).

      We agree that endocytic recycling is probably the main source of unoccupied TfR on the cell surface. It is hard to see how the pulse chase experiment could be performed without centrifugation which will affect the outcome – see above.

      (3) Statistical and quantitative reporting

      Added as Table S2- S4

      (4) Report confidence intervals (e.g., for fluorescence intensity comparisons in Figure 3B) to contextualize claims of "no significant difference."

      We do not claim ‘no significant difference’ and the SD overlap due to a high level of variation in the population

      (5) Specify the number of biological replicates and cells analyzed per condition in the figure legends.

      Added

      (6) The study notes that surface-exposed receptors avoid antibody detection, but does not explore how.

      We don’t claim that receptors avoid detection and have published evidence to the contrary. The cell has evolved mechanisms to reduce/minimise the effect of antibody binding.

      (7) Comparing antibody binding to TfR in VSG221 versus VSG224 coats.

      This is already present in Figure 3D

      (8) Testing whether receptor shedding or conformational masking contributes to immune evasion.

      A lifetime’s work

      (9) Evolutionary trade-offs: Discuss why T. brucei maintains ~15 TfR variants if the GPI-anchor number has minimal impact on function (Figure 3).

      The possible reason for the evolution of ~15 TfR variants was discussed in a previous publication.

      (10) How do their findings align with recent studies on ISG75 surface exposure?

      If this refers to the finding that ISG75 is an Ig Fc receptor, this has been included

      (11) Add scale bars to 3D reconstructions (Figure 5).

      Added

      (12) Include a schematic summarizing key findings in the main text.

      Chosen not to do

      (13) Explicitly state where raw microscopy images, flow cytometry data, and analysis scripts are deposited.

      Microscope Images have deposited in Bioimage Archive repository at EMBL/EBI No flow cytometry used

      (14) Correct inconsistent GPI-anchor terminology (e.g., "glycosylphosphoinositol" to "glycosylphosphatidylinositol").

      Our typo, corrected

      (15) Clarify ambiguous phrases (e.g., "subtle mechanisms" in the Discussion).

      Corrected

    1. Author response:

      The following is the authors’ response to the original reviews.

      We sincerely appreciate your constructive feedback. Based on the comments from the three reviewers, we were able to substantially improve the manuscript. Below, we provide our point-by-point responses.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study examined the functional organization of the mouse posterior parietal cortex (PPC) using meso-scale two-photon calcium imaging during visually-guided and history-guided tasks. The researchers found distinct functional modules within the medial PPC: area A, which integrates somatosensory and choice information, and area AM, which integrates visual and choice information. Area A also showed a robust representation of choice history and posture. The study further revealed distinct patterns of inter-area correlations for A and AM, suggesting different roles in cortical communication. These findings shed light on the functional architecture of the mouse PPC and its involvement in various sensorimotor and cognitive functions.

      Strengths:

      Overall, I find this manuscript excellent. It is very clearly written and built up logically. The subject is important, and the data supports the conclusions without overstating implications. Where the manuscript shines the most is the exceptionally thorough analysis of the data. The authors set a high bar for identifying the boundaries of the PPC subareas, where they combine both somatosensory and visual intrinsic imaging. There are many things to compliment the authors on, but one thing that should be applauded in particular is the analysis of the body movements of the mice in the tube. Anyone working with head-fixed mice knows that mice don't sit still but that almost invariable remains unanalyzed. Here the authors show that this indeed explained some of the variance in the data.

      Weaknesses:

      I see no major weaknesses and I only have minor comments.

      Reviewer #2 (Public review):

      Summary:

      The posterior parietal cortex (PPC) has been identified as an integrator of multiple sensory streams and guides decision-making. Hira et al observe that dissection of the functional specialization of PPC subregions requires simultaneous measurement of neuronal activity throughout these areas. To this end, they use wide-field calcium imaging to capture the activity of thousands of neurons across the PPC and surrounding areas. They begin by delineating the boundaries between the primary sensory and higher visual areas using intrinsic imaging and validate their mapping using calcium imaging. They then conduct imaging during a visually guided task to identify neurons that respond selectively to visual stimuli or choices. They find that vision and choice neurons intermingle primarily in the anterior medial (AM) area, and that AM uniquely encodes information regarding both the visual stimulus and the previous choice, positioning AM as the main site of integration of behavioral and visual information for this task.

      Strengths:

      There is an enormous amount of data and results reveal very interesting relationships between stimulus and choice coding across areas and how network dynamics relate to task coding.

      Weaknesses:

      The enormity of the data and the complexity of the analysis make the manuscript hard to follow. Sometimes it reads like a laundry list of results as opposed to a cohesive story.

      Reviewer #3 (Public review):

      Summary: This work from Hira et al leverages mesoscopic 2-photon imaging to study large neural populations in different higher visual areas, in particular areas A and AM of the parietal cortex. The focus of the study is to obtain a better understanding of the representation of different task-related parameters, such as choice formation and short-term history, as well as visual responses in large neural populations across different cortical regions to obtain a better understanding of the functional specialization of neural populations in each region as well as the interaction of neural populations across regions. The authors image a large number of neurons in animals that either perform visual discrimination or a history-dependent task to test how task demands affect neural responses and population dynamics. Furthermore, by including a behavioral perturbation of animal posture they aim to dissociate the neural representation of history signals from body posture. Lastly, they relate their functional findings to anatomical data from the Allen connectivity atlas and show a strong relation between functional correlations on anatomical connectivity patterns.

      Strengths:

      Overall, the study is very well done and tackles a problem that should be of high interest to the field by aiming to obtain a better understanding of the function and spatial structure of different regions in the parietal cortex. The experimental approach and analyses are sound and of high quality and the main conclusions are well supported by the results. Aside from the detailed analyses, a particular strength is the additional experimental perturbation of posture to isolate history-related activity which supports the conclusion that both posture and history signals are represented in different neurons within the same region. Weaknesses: The main point that I found hard to understand was the fairly strong language on functional clusters of neurons while also stating that neurons encoded combinations of different types of information and leveraging the encoding model to dissociate these contributions. Do the authors find mixed selectivity or rather functional segregation of neural tuning in their data? More details on this and some other points are below.

      We thank the three reviewers for their accurate and expert evaluations.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) It wasn't clear to me why the authors focused on areas A and AM, but not RL. After all, at the beginning of the results, the authors ask: "PPC has been reported to have functions including visually guided decision-making and working memory. Do these functions differ among RL, A, and AM?".

      Thank you for the comment. The manuscript first characterizes AM as a region involved in visually guided decision-making and A as a region related to history and/or working memory. Subsequently, when discussing correlation structure, we stated the following:

      “In particular, based on the critical functional differences between A and AM that we found, A and AM may belong to distinct cortical networks that consist of different sets of densely interacting cortical areas.”

      Thus, the logical flow of our analysis is to first reveal the functional contrast between A and AM through comparative functional analyses across RL, A, and AM, and then to focus on this contrast. We speculate that RL may exhibit more distinctive functional properties in tasks that rely on whisker-based processing or related modalities. We have therefore revised the text as described below to avoid the impression that the manuscript places disproportionate emphasis on RL.

      Line 137: “PPC has been reported to have functions including visually guided decisionmaking and working memory. Do these functions differ among A, AM, and RL?”

      (2) Figures 2 E, F, and Figure 3A, could the authors indicate the trial structure better on these plots?

      Thank you for the comment. We have added explanations of the bar meanings to the figure legends.

      Figure 2:

      “(E) Representative vision neurons (ROI 1-4 in I). The red bars indicate sampling periods during video presentation, and the brown bars indicate sampling periods without video stimulation. Vertical black lines mark the onset of the sampling period. F. Representative choice neuron (ROI 5-8 in I) and a non-selective neuron (ROI 9). Light blue lines indicate the response periods in trials with left choices, and purple lines indicate the response periods in trials with right choices. Vertical black lines mark the onset of the response period.”

      Figure 3:

      “(A) The representative history neurons. Numbers correspond to that of panel B and C. Light blue lines indicate rewards delivered from the left lick port, and purple lines indicate rewards delivered from the right lick port. Vertical white lines mark the onset of the sampling period.”

      (3) There are several typos that need correcting. Also, small and big capital letters to demark the panel names in the legends have been mixed.

      Thank you for the comment. We have corrected the panel labels as described below.

      Figure 2 legend:

      “Representative choice neuron (ROI 5-8 in I) and a non-selective neuron (ROI 9)”

      Figure 3 legend:

      “..than the next choice. I. The decoding accuracy of the next choice …”

      Figure 3 legend:

      “Error bars, mean ± s.e.m. in I, 95% confidence interval in G. M, and O.”

      Supplementary Figure 6:

      “…neurons with rt ≥ 0.3 (blue) were shown. B. Trial-to-trial activity fluctuation … (rt ≥ 0.3, panel B) was color coded…”

      We thoroughly checked the manuscript for typographical errors and corrected the issues.

      (4) Many in the field still use the Paxinos nomenclature for PPC subfields, could the authors write something short about how these two nomenclatures correspond?

      We have described the relationship between our area definitions and those of Paxinos in the main text as follows.

      Line 702: “In addition to our definition, previous studies have also defined posterior parietal cortex (PPC) to include the higher visual areas A, AM, and RL (Glickfeld and Olsen, 2017; Wang et al., 2011). These areas partially overlap with the parietal association regions defined in the Paxinos atlas, including MPtA, LPtA, PtPD, and PtPR. For a detailed discussion of the correspondence and variability among these regional definitions, see Lyamzin and Benucci (2019).”

      (5) Analyzing choice history may be affected by the long fluorescence Ca transients and will depend on excellent event deconvolution. Could the authors show some more zoomed-in examples of how well their deconvolution works?

      We provide enlarged, trial-by-trial activity traces of the four example neurons shown in Figure 3A in Supplementary Figure 3G. In all neurons, multiple small calcium transients occur repeatedly throughout the delay period, which lasts longer than 10 s. If the sustained activity during the delay were simply due to a long decay time constant, one would expect a large calcium transient in the preceding trial that slowly decays over the delay period. However, such a pattern is not observed in the actual data. Also, since the decay time constant of GCaMP6s is on the order of ~1 s, signals persisting for ~10 s cannot be explained by slow decay alone.

      (6) The authors write: "the history neurons exhibited properties of working memory." However, note that this is not a working memory task since the mice don't need to keep evidence in memory, the direction to lick can be made at the very beginning of a trial.

      Behaviorally, demonstrating that an animal maintains working memory requires showing that its behavior changes based on retained information when new information is introduced, as in delayed match-to-sample tasks. In the present task, however, the correct action for the next trial is determined at the moment the action in the previous trial is completed, such that animals can simply switch to motor preparation at that point. Thus, from a strictly behavioral perspective, working memory is not required.

      On the other hand, during the inter-trial interval (ITI), information from the previous trial dominates over information from the upcoming trial (Fig. 3H), which is more consistent with retention of past information than with motor preparation. Moreover, trials in which neural activity maintained information about the previous trial’s action were associated with a higher probability of correct performance in the subsequent trial. In other words, retaining past information contributes to guiding correct behavior in the next trial.

      Based on these neural analyses, we interpret that mice retain information about their previous trial’s action history in working memory and use it to determine behavior in the subsequent trial. Accordingly, we consider ITI activity in PPC to reflect working memory rather than motor preparation. Nevertheless, we acknowledge that your concern is valid, and we have therefore revised the text as follows:

      Line 234: “These results suggest that the history neurons exhibited properties of working memory.”

      (7) In the section about the Choice History Task, the authors write: "Since the visual stimuli were randomly presented during the sampling period, the mice had to ignore the visual stimuli." Why continue to present the visual stimuli?

      Thank you for the suggestion. By designing the vision task and the history task to have identical structures, we can apply the same encoding and decoding models to both tasks, which facilitates direct comparison between them. This design makes it easier to examine how neuronal activity patterns change depending on task demands.

      Reviewer #2 (Recommendations for the authors):

      (1) I don't understand the logic of Figure S7 and the neuropil analysis in general. Neuropil activity is purported to represent input, so it seems unsurprising that nearby neurons would exhibit similar dynamics.

      Thank you for your comment. Your argument is correct, and it is not at all surprising that neuropil signals correlate with the activity of surrounding neurons. Here, we quantitatively examined the relationship between neuropil activity and the average activity of nearby neurons. In addition, in a separate analysis, we clarified the relationship between connectome information and neuropil activity. Taken together, these analyses reveal the relationship between connectome information and the local average of neuronal activity. We describe this point as follows:

      “Indeed, the trial-to-trial variation of a neuropil activity could be approximated by the average of 1,000–10,000 neurons within several hundred micrometers from the center (Figure S7).”

      Although we analyzed this phenomenon in the cases of areas A and AM, this finding should not be considered specific to A and AM but instead has broader, general significance. Accordingly, we added a new Results subsection and revised the manuscript as follows.

      Line 448: “Constraints and limits of anatomical connectivity on neuronal population activity Although we have so far focused on the differences between A and AM, our data provide broader insights into the relationship between anatomical connectivity and neuronal population activity. First, based on Figure S7 and the considerations above, anatomical input correlations strongly constrain the correlations between local averages of activity across thousands of neurons. We then asked whether this anatomical constraint extends beyond mean activity, and how anatomical input correlations relate to relationships between neuronal population activities (population vectors).

      The correlation between CC<sub>t</sub> and r<sub>anatomy</sub> was moderate (r = 0.60, Figure 6L). This moderate correlation did not change when the coupling neurons were eliminated (r = 0.61). Interestingly, the largest canonical component was the most unpredictable from the anatomical data (Figure 6M). Thus, while inter-area correlations based on the mean activity of neuronal populations are largely determined by anatomical input correlations, correlations between population vectors contain additional structure that cannot be captured by anatomical input correlations alone.

      One possible source of this additional structure is globally shared activity, which may reflect behavior, brain state, or levels of neuromodulators. To evaluate the contribution of global activity on the canonical correlation between areas, we first compared the canonical coefficient vectors (CCV). We found that the first CCV had a similar orientation, regardless of the paired areas (Figure6N). This indicates that the largest components of correlated activity in the CCA analysis are globally shared fluctuations. We also directly evaluated the correlated activity components across all 8 areas with generalized canonical correlation analysis. The first CCV also had a similar orientation to the first generalized canonical coefficient vector (GCCV) (Figure 6O). These results indicate that the largest canonical component reflects a global correlation across all cortical areas imaged. Such global correlations may be driven by factors beyond cortico-cortical or thalamo-cortical inputs, such as the animal’s behavioral state as we recently characterized (H. Imamura et al., 2025; F. Imamura et al., 2025). We also confirmed the robustness of these results by repeating analyses using only the 40% highly active neurons after denoising with non-negative deconvolution (36828 out of 91397 neurons; Figure S9).”

      (2) Furthermore, the neuropil signal likely contains signals from out-of-focus neurons that are presumably functioning similarly to the in-focus cells. Wouldn't the interesting question be to what extent the local neuropil signal in, for example, area A resembled that of neuronal activity in S1t?

      Thank you very much for your comment. We agree with your point. Based on the evaluation in Figure S7, the neuropil signal likely contains the average activity of several thousand local neurons, including out-of-focus contributions. The neuropil signal in area A may also partially reflect neuronal activity from the neighboring S1t area. In particular, neurons that show little correlation with the local population average (i.e., the neuropil signal) within the same area are sometimes referred to as “soloists” (M. Okun et al., 2015). If such soloist neurons were found to exhibit strong correlations with the neuropil signal of an adjacent area, this would be a highly interesting result. However, such an analysis would go beyond the scope of the present manuscript and would require a new line of discussion; therefore, we plan to address this issue in future work.

      (3) I generally found the final Results section (Relationship between mesoscale functional correlation and anatomical connections) to be hard to follow. The motivation for this analysis should be better explained.

      We fully incorporated your suggestion and rewrote the final section of the Results accordingly. Please refer to our responses to the two comments above.

      (4) The question of brain state/neuromodulation as a driver of the globally shared activity may be addressable by considering its correlation with pupillometry data.

      We fully agree with your suggestion. In our experiments, visual stimuli change continuously, and thus pupil diameter changes are most likely driven primarily by changes in visual input. Although state-dependent fluctuations of brain activity may also be present, they are likely masked by the larger effects induced by visual stimulation. Therefore, analyzing pupil-linked signals as a factor of globally shared activity would be more appropriately addressed in experiments without visual stimulation. We plan to investigate this issue in future studies. Here, we have added the following description regarding pupil dynamics and their associated relationships.

      Line 292: “We found that the neurons related to the tail and forepaws were similarly distributed around the parietal cortex including S1 and A, while the pupil-size related neurons were mapped around visual areas (Figure 4C). Changes in pupil diameter may influence neuronal activity through multiple mechanisms, including behavioral state or noradrenergic level [REF], nonlinear interactions with visual stimulation, and changes in the amount of light reaching the retina.”

      Minor issues

      (1) The authors deploy sophisticated mathematical techniques with essentially no explanation outside the Methods section. A brief introduction of jPCA and CCA in the main text would help the reader understand the value of these analyses.

      Thank you for the comment. We added the following explanation.

      Line 238: “In this task, left and right selection are alternated, so the activity of the history neuron is a sequence that repeats in two consecutive trials. We used jPCA<sup>49</sup> to visualize and quantify this activity pattern (Figure 3K). jPCA identifies low-dimensional projections of population activity that maximize rotational dynamics across time.”

      Line 374: “Next, to investigate r<sub>t</sub> of the population activity (r<sub>t_population</sub>), we first reduced the dimension of population activity in each area into 10 by using PCA (principal component analysis) (Figure S6B,C). Then, “fluctuation activity” was recalculated for each dimension and trial type, analogous to the single-neuron analysis described above, but here representing noise in population-level activation patterns. We applied CCA (canonical correlation analysis) to each pair of areas and obtained an average of 10 canonical correlations (CC<sub>t</sub>) as r<sub>t_population</sub>. CCA identifies pairs of linear combinations of population activity from two areas that maximize their correlation across trials, thereby capturing shared population-level fluctuations. The CC<sub>t</sub> structure between areas was similar across task types (Figure 5H) indicating that this structure reflects the underlying functional connectivity independent of the task. The CC<sub>t</sub> between A and S1t was the largest among all the pairs (Figure 5H), whereas when the CC<sub>t</sub> was averaged across all connections for each area, A and AM had the largest and second largest C<sub>t</sub>, respectively (Figure 5I). The dominance in CC<sub>t</sub> in A and AM disappeared when the neurons with r<sub>t_single</sub> >0.3 were removed. Notably, the CC<sub>t</sub> of AM and the other areas was uniform regardless of the paired areas across all 10 canonical components (Figure 5J). Thus, area AM is an integration hub of interareal communication, whereas A simply coupled with S1t, and such correlation structure at the population level critically depends on this subset of neurons.”

      (2) The manuscript contains numerous typos ("hoice"), spelling errors ("parameters", "costom"), abbreviations that are not defined (ex: RL/rostrolateral), and minor grammatical issues that should be addressed by a round of copy editing.

      We thank the reviewer for pointing this out. We have thoroughly corrected these typographical and grammatical errors, and have described the revisions in detail in our response to Reviewer 1, comment (3). In addition, we have clarified the abbreviations in the manuscript as follows.

      Line 94: “rostrolateral area (RL)”

      Figure 1 legend: “Abbreviations: RL, rostrolateral HVA; PM, posteromedial HVA; RSC, retrosplenial cortex.“

      (3) Figure 3K unlabeled axes.

      Thank you for the comment. We have added the axis labels.

      (4) Figure 3K caption, first "(right)" should be "(left)".

      Thank you very much for your careful attention to detail. We have made the requested correction.

      (5) Figure 6 is hard to read. Panel A is too small, and the interpretation of G is difficult.

      - For panel A, we added an enlarged view with images from a larger number of trials in Figure S7A.

      - G represents the connectivity matrix. The sources correspond to the injection sites, and the targets correspond to voxels in the cerebral cortex. Because the latter may not be immediately clear, we explicitly indicated in the figure that the targets are cortical voxels.

      (6) Figure S4C has a double compass.

      Thank you for the comment. We have revised the manuscript accordingly.

      Reviewer #3 (Recommendations for the authors):

      While I have some questions and additional suggestions to further improve the clarity of the manuscript, I already found it to be highly interesting and well done in its current form.

      Major points:

      (1) The t-SNE comes up rather abruptly and is not well-explained in the main text or the figure caption. It would be good to provide some more information on the rationale of this analysis and how to interpret it. In particular, I don't see clear clusters in Figure 2H although the description of the authors seems to indicate that they observe clear functional classes such as choice, stimulus, and history neurons. Similarly, in Figure 3B, I don't see a clear separation between history and choice neurons in the t-SNE map. The example cells in Figure 3A appear to be delayed or long-tailed choice neurons rather than a dedicated group of 'history neurons'. It would be helpful for the interpretation of the t-SNE plots to show different PSTHs for different regions of the t-SNE map to better illustrate what different regions within the t-SNE projection represent and what distinguishes these cells.

      Thank you for the comment. The absence of clearly defined clusters in the t-SNE map suggests that neuronal activity forms a continuum rather than discrete classes. Importantly, the purpose of the t-SNE map here is not to identify sharp clusters, but to demonstrate that the functional categorization provided by our encoding model broadly and comprehensively spans the major structures present in the unsupervised t-SNE map. We have revised the relevant text in the manuscript accordingly as follows.

      Line 158: “To examine whether the neuron groups labeled by this model broadly capture the diversity of neuronal activity, we performed unsupervised clustering of neuronal activity using t-SNE. The functional labels revealed by this encoding model were consistent with the t-SNE clusters, indicating the validity of the encoding model (Figure 2H; Figure S4B; materials and methods).”

      The issue regarding History neurons was also raised in Reviewer #1’s comment (5). We provide an enlarged view of Figure 3A in Figure S3A. Each History neuron exhibits multiple calcium transients repeatedly and asynchronously following the previous reward acquisition. Therefore, rather than being “choice neurons with a long tail,” these neurons are better interpreted as neurons whose activity is sustained during this delay period.

      (2) Although the authors mention that neurons represent a mixture of features, they then use the encoding model to isolate clusters, such as vision or choice neurons. In general, the language throughout the manuscript suggests that there are various clusters of functionally segregated neurons (vision, choice, history, or coupling neurons). However, it is not clear to me to what extent this is supported by the data. Couldn't a choice neuron also be a vision neuron if both variables make significant contributions to the model? Similarly, are 'history' and 'choice' separate labels from the encoding model, or could a cell be given multiple labels? If a cell could be given multiple labels how did the authors create the colored plots on the right-hand side of Figures 2H and 3B? The example history cells in Figure 3J also appear to be highly selective for the contralateral choice, so again this seems to argue against a clear separation of choice and history neurons.

      Each label is assigned based on whether the corresponding coefficient is significant in the encoding model, and therefore neurons that are both vision- and choice-selective do exist. The presence of mixed selectivity neurons in PPC is well established (e.g., MJ Goard et al., 2016 elife). In this manuscript, however, we focus not on functional overlap at the single neuron level, but on the spatial distribution of functional classes, and thus do not explicitly address mixed selectivity. Although the colors in Figure 2H and Figure 3B overlap, the underlying data for each are presented separately in Figure S4B and S4D, respectively. As shown there, each color generally occupies distinct regions in the t-SNE map.

      (3) The decoding analysis in Figure 3F also suggests that a potential reason why there are more choice history signals in areas S1 and A is that neural activity is simply larger rather than due to the activity of a dedicated group of history neurons. Are the authors interpreting this differently? Could the duration of stored choice information also be affected by the dynamics of the calcium indicator?

      Thank you for the comment. Simply having larger neural activity in S1t or A would not result in calcium transients with a ~1-s time constant persisting throughout a delay period lasting up to 10 seconds. As also noted in comment (1), History neurons exhibit sustained and repeated calcium transients, and therefore their activity cannot be explained merely by elevated neural activity levels. One could argue that all cortical areas carry history-related information but that the signal-to-noise ratio is higher in S1t or A, which might make such signals more detectable there. If this were the case, however, differences across areas in all forms of selectivity should similarly depend on signal-to-noise ratio. This is not what we observe in our data.

      (4) I'm confused as to why the decoding accuracy is so high for areas A and S1t at time -3 relative to the choice in Figure 3F. Shouldn't this be the same as predicting the next choice in Figure 3H? Why is the decoding accuracy lower in this case?

      Thank you for the comment. The analysis shown in Figure 3F includes only trials in which the choice was correct. This is the reason why the decoding performance in Figure 3H is lower. We have added this clarification to the main text.

      Figure 3F: “Decoding accuracy of choice, outcome, and visual stimuli by the activity of 20 neurons from each area using only correct trials, before and after the choice onset, reward delivery, and the end of the visual stimuli, respectively. Line colors corresponded to the areas shown in panel G.”

      (5) In general, the text is not very detailed about the statistics. While test scores and p-values are mentioned, it would be good to also state what is actually compared and what the n is (e.g. how many neurons, neuron pairs, areas, sessions, or animals) for each case. How do the authors account for the nested experiment design where many neurons are coming from a low number of animals?

      Thank you for the comment. In our decoding analyses, we generally treat the number of animals as the independent variable. In contrast, for the encoding model analyses, we treat the number of neurons as the independent variable. As you correctly pointed out, because we recorded activity from a large number of neurons, statistical tests that treat individual neurons as independent samples can readily yield significant p-values even with a small number of animals. We have therefore confirmed that our conclusions are not driven by a large effect from a single animal. When making qualitative claims, we rely not only on statistical significance (p-values) but also require clear differences in effect size. We have added the following clarification to the Statistics section accordingly.

      Line 1049: ”For the decoding analyses, the number of animals was treated as the independent variable, whereas for the encoding model analyses, the number of neurons was treated as the independent variable. To ensure that the results were not driven by a single animal, we repeated the statistical tests while systematically excluding data from one animal at a time and confirmed that statistical significance was preserved in all cases. Furthermore, qualitative interpretations were made only when differences in effect size were clearly observed.”

      (6) How was the grouping in Figure 2O done? Specifically, how were the thresholds for the dashed lines selected to separate PM and V1 from AM and RL as association areas? It seems to me like this grouping was done rather arbitrarily as the difference in choice decoding accuracy is not particularly large between these areas.

      This line does not have a specific quantitative basis, but we consider it useful as an illustrative aid. We have added this clarification to the figure legend.

      Figure 2O: “Decoding accuracies of time in video presentation and choice direction indicate that AM would be the best position for associating these two signals. The background color and dashed lines are provided as visual aids for illustrative purposes.”

      (7) The fact that neurons with high rt_single tend to share the same function might also indicate the approach is insufficient to remove all effects of tuning to trial types from the neural data. Since the authors subtract the average of each trial type, the average trial-type related information is removed but type-specific variations that are not equally presented in the average might remain. For choice neurons for example, attentive vs in-attentive choices could be represented differently and thus remain in the data since the average would be a mixture of both. The same goes for other factors that would drive a particular modulation in the choice - or stimulus - related part of the trial which could still tie these neurons together. One way to circumvent this concern could be to first compute the mean activity for all time points in each trial and then compute the trial-to-trial variability across all trials of the same type. Alternatively, I would be curious how the results play out when using data when the animal is not actively performing the task to compute rt_single.

      Thank you for the comment. The concern raised by the reviewer applies to all noise-correlation analyses and highlights an important limitation of this approach, namely that factors other than the observed variables are treated as noise. By subtracting the trial-averaged activity, information related to sensory input and the direction of the first lick at choice can be removed. However, other factors cannot be eliminated if they are not observed. For example, if right hindlimb movements tend to occur only in trials with visual stimulation combined with left choice, such effects cannot be removed because they are not measured. The same issue remains even when restricting the analysis to a single trial type. Based on these considerations, we have added the following text to the manuscript.

      Line 932: “Correlation of trial-to-trial variance of activity between a pair of single neurons was defined as r<sub>t_single</sub>. To calculate r<sub>t_single</sub>, we averaged the activity of individual neurons over the sampling period, and the average across each trial type was subtracted from this value. The trial types consisted of four sets of pairs of stimuli and responses, that is, the video stimulation and left choice, the video stimulation and right choice, the black screen and left choice, and the black screen and right choice. By this operation, we extracted the fluctuating components of single-neuron activity that are independent of the trial types. Although the finding that neurons with high r<sub>t_single</sub> tend to share the functional properties we propose is not a trivial consequence of the analysis. At the same time, it remains possible that high r<sub>t_single</sub> reflects the degree to which neurons share unobserved features, and that such features are correlated with our functional classification. Thus, while this analysis suggests that correlated fluctuations across cortical areas may contribute to the determination of functional types, establishing an exclusive conclusion will require more fine-grained behavioral measurements, tighter control of internal states, and causal identification through targeted interventions.”

      Minor points:

      (1) Why did the authors use the activity of 50 neurons for the decoder analysis in Figure 2K? Didn't they have many more neurons available? How were these selected?

      We found that the conclusions were identical when using datasets consisting of either 50 neurons or 20 neurons across all analyses. Because the total number of recorded PM neurons did not reach 100 in at least one mouse, we standardized the analyses to 50 neurons in order to match the number of neurons across all cortical areas and animals.

      (2) The authors mention that some PPC neurons showed complex dynamics rather than encoding a specific feature such as visual or choice information but do not mention actual numbers on this point. It would be good to quantify to what extent neurons in different regions represent such mixed selectivity and whether there are clear differences in selectivity. This would also be interesting to discuss in context to earlier work on mixed selectivity in the parietal cortex, such as Raposo et al 2015.

      Thank you for the comment. Your point is entirely valid. However, as explained in our response to your major comment, our analyses focus not on how individual neurons are classified, but rather on the spatial distribution of these functional categories.

      (3) I have a hard time understanding what the length of the bars in the right panel of Figure 2k indicates. Does this plot show more than the decoder accuracy before and after the choice? Is the bar length related to the standard deviation? The same question for the visualization in panel 2n. It looks nice but I'm confused about what it shows exactly.

      These bars represent confidence intervals. Although this is stated at the end of the Figure 2 legend, we agree that it may not be sufficiently clear, and we have therefore added this information to the Statistics section.

      Line 1046: “In Figure 2K and N, and Figure 3G, L, M, and O, the bars indicate the 95% confidence intervals. All other bars denote s.e.m., unless otherwise noted.”

      (4) Is Figure 3D showing the same association index as in Figure 2j, thus showing the same result as in the vision task or is this meant to show something new? It was not clear to me from the wording, so it would be good to clarify.

      You are correct that the magenta trace in Fig. 3D is the same as in Fig. 2J. This panel was included to explicitly illustrate that, in areas A and AM, the separation between History and Association approximately overlaps. We have added the following clarification to the figure legend accordingly.

      Figure 3D: “The percentage of history neurons and the association index (as defined in Fig. 2J) were overlaid for comparison.”

      (5) When computing the Pseudo R2 for regressor contribution, how was the null model computed? From shuffling all regressors in the model? I think this is fine but it's not fully clear what the intended effect of this procedure is. For the description of Figure 4C it would be good to add a sentence explaining how to interpret the pseudo R^2.

      The null model predicts a fixed value that is independent of the explanatory variables, i.e., it predicts only the intercept. This provides a useful correction term when performing cross-validation, particularly in cases where baseline values differ across folds. In Figure 4C, the analysis shows the contribution of adding body part positions and pupil diameter to the model for predicting neural activity. We have added the following text to the Methods section.

      Line 881: “To estimate the contribution of parameters for the left forelimb, the right forelimb, the tail, and the pupil, we repeated the same analysis with a reduced model where each set of predictors was eliminated from the full model (Figure 4B). Then, the pseudo-R<sup>2</sup> was obtained for each set of predictors by (MSE<sub>reduced</sub>MSE<sub>full</sub>) /MSE<sub>null</sub>, where MSE is the mean squared error, MSE<sub>reduced</sub> is MSE for the reduced model, MSE<sub>full</sub> is the MSE of the full model, and MSE<sub>null</sub> is the null model. The null model predicts a fixed value that is independent of the explanatory variables; specifically, it simply outputs the mean of the training data. For example, we constructed a regression model without the parameters regarding the left forelimb (green shade of Figure 4B), obtained MSE<sub>reduced</sub> for the left forelimb, and the pseudo-R<sup>2</sup> was calculated as above by comparing the MSE of the full model and the null model. This value reflects the extent to which the position of the left forelimb contributes to the prediction of neuronal activity.”

      (6) It seems surprising that the pupil-size-related neurons were mapped around visual areas although the pupil should carry clear luminance information. Is this because the luminancerelated information in the pupil can also be explained by the stimulus variable in the model?

      Pupil size changed markedly before and after visual stimulus presentation (Figure S5C), dilating during the black stimulus and constricting during the video stimulus. This likely reflects changes relative to the luminance of the gray screen presented in the absence of visual stimuli. In our encoding model, visual stimuli are included as independent regressors for each corresponding time window. Therefore, pupil fluctuations that are temporally locked to visual stimulation are explained by these visual regressors. Neuronal activity that is better explained by pupil size changes not accounted for by the visual regressors is classified as pupil-related. At least three mechanisms may underlie the influence of pupil size on neuronal activity. First, fluctuations in pupil diameter have been linked to behavioral state or noradrenergic level [REF], which can act as variables independent of visual stimulation. Second, pupil fluctuations may be amplified in a stimulus-dependent manner, reflecting nonlinear interactions between visual input and brain state. Third, changes in pupil diameter alter the amount of light reaching the retina, which can modulate activity in visual cortical areas. The latter two mechanisms are therefore expected to predominantly affect visual areas and may explain why pupil-related neurons are more frequently observed there. The first mechanism is likely related to global brain state, and its association with behavior may account for the presence of pupil-related neurons in S1. However, these interpretations require confirmation through more refined causal manipulations. Accordingly, we limited the addition to the manuscript to the following statement.

      Line 292: “We found that the neurons related to the tail and forepaws were similarly distributed around the parietal cortex including S1 and A, while the pupil-size related neurons were mapped around visual areas (Figure 4C). Changes in pupil diameter may influence neuronal activity through multiple mechanisms, including behavioral state or noradrenergic level [REF], nonlinear interactions with visual stimulation, and changes in the amount of light reaching the retina.”

      (7) What is meant by 'external control parameters such as a video frame' when explaining the encoding model?

      Thank you for the comment. We added the following explanation.

      Line 151: “In the encoding model, the activity of each neuron was fitted by a weighted sum of external control parameters, such as video frames, and behavioral parameters, such as choice and reward direction. Because the visual stimulus changes continuously over time, sliding time windows were placed during the visual stimulus period.”

      (8) What does the trace in Figure 2G show? Is this a single-cell example? What are the axes here?

      We added an explanation to the figure legend.

      Figure 2G: “Schematic of our encoding model. The bottom right panel shows an example of single-neuron activity with an overlay of the fitting obtained by the encoding model.”

      (9) There seems to be a word missing in the sentence that describes the results for Figure 3O in the main text.

      Thank you for the comment. We added the following description related to Fig. 3O.

      Line 247: “resulting in the decoding accuracy of time after a specific choice being lower than in A (Figure 3O).”

      (10) The abbreviation RP is used when describing Figure S5A. It should be mentioned that this refers to the response period.

      Thank you for the comment. We added the following description related to Figure S5A.

      Line 283: “We found that the angle of the tail was significantly different from the baseline values several seconds after the response period (RP) (Figure S5A)”

      (11) I can't see the color difference between the traces in Figure 2E. There are probably red and green but this is hard to see for readers with red-green color blindness. Does the black indicate the time of visual stimulation? Is the line in Figure 2F the time when the spouts move in?

      Thank you for the comment. In Fig. 2E, we improved visibility by changing the line opacity. In addition, the vertical line in Fig. 2E indicates the onset of the visual stimulus, and the vertical line in Fig. 2F indicates the onset of the response period. We have added the following explanations to the figure legend.

      Figure 2: E. “Representative vision neurons (ROI 1-4 in I). The red bars indicate sampling periods during video presentation, and the brown bars indicate sampling periods without video stimulation. Vertical black lines mark the onset of the sampling period. F. Representative choice neuron (ROI 5-8 in I) and a non-selective neuron (ROI 9). Light blue lines indicate the response periods in trials with left choices, and purple lines indicate the response periods in trials with right choices. Vertical black lines mark the onset of the response period.”

      (12) It might be useful to provide a short explanation in the results or methods of why the harmonic mean was used for the computation of the association index. I think it makes sense but since it is not commonly used this could be helpful for the reader to understand the approach.

      Thank you for the comment. We added the following explanation to the main text.

      Line 869: “The association index was determined by the harmonic mean of the rates of vision neurons and choice neurons. The harmonic mean approaches the arithmetic mean when the two values are similar, but becomes closer to the smaller value when the two values differ substantially. Therefore, the association index takes a large value when both vision neurons and choice neurons are abundant.”

      (13) I don't fully understand how coupling diversity is computed. If there are six preference vectors, what is meant by taking the average of angles between all pairs of the two vectors?

      Which two are meant here?

      Thank you for the comment. We revised the explanation as follows.

      Line 950: “To quantify the diversity of coupling patterns across clusters, we computed the angle between every pair of preference vectors. We then averaged these pairwise angles and defined this quantity as the “coupling diversity.”

      (14) The results text states that the high correlation between r_anatomy and r_neuropil (Figure 6I) is evidence for the functional correlations being driven by cortico-cortical connectivity. However, Figure 6J shows that correlations for either cortico-cortical or thalamo-cortical connectivity are below 0.94 and generally higher for thalamo-cortical connectivity. This doesn't negate the general point of the authors but it would be good to clarify this section so it is easier to understand if r_anatomy includes both cortico-cortical and thalamo-cortical data and how the results in Figure I and J go together with the description in the results section.

      You are correct. We have revised the text to clarify that the analysis reflects the combined effects of both cortico-cortical and thalamo-cortical inputs.

      Line 436: “This correspondence suggests that the mesoscale interarea correlation is determined by the cortico-cortical and thalamo-cortical common input at mesoscale. Figure S8: A. Using Allen connectivity atlas, the axonal density of cortico-cortical and thalamo-cortical projection was analyzed.”

      (15) I'm not very familiar with canonical correlation analysis and found this part hard to follow. Some additional explainer sentences would be helpful here. For example, what does it mean to take the average of the top 10 canonical correlations as rt_population? What exactly are the canonical correlation vectors? It was also not clear to me what exactly the results in Figure 5J signify.

      Thank you for the comment. We have clarified the description in the main text related to CCA and the associated analyses as follows.

      Line 374: “Next, to investigate r<sub>t</sub> of the population activity (r<sub>t_population</sub>), we first reduced the dimension of population activity in each area into 10 by using PCA (principal component analysis) (Figure S6B,C). Then, “fluctuation activity” was recalculated for each dimension and trial type, analogous to the single-neuron analysis described above, but here representing noise in population-level activation patterns. We applied CCA (canonical correlation analysis) to each pair of areas and obtained an average of 10 canonical correlations (CC<sub>t</sub>) as r<sub>t_population</sub>. CCA identifies pairs of linear combinations of population activity from two areas that maximize their correlation across trials, thereby capturing shared population-level fluctuations. The CC<sub>t</sub> structure between areas was similar across task types (Figure 5H) indicating that this structure reflects the underlying functional connectivity independent of the task. The CC<sub>t</sub> between A and S1t was the largest among all the pairs (Figure 5H), whereas when the CC<sub>t</sub> was averaged across all connections for each area, A and AM had the largest and second largest CC<sub>t</sub>, respectively (Figure 5I). The dominance in CC<sub>t</sub> in A and AM disappeared when the neurons with r<sub>t,single</sub> >0.3 were removed. Notably, the CC<sub>t</sub> of AM and the other areas was uniform regardless of the paired areas across all 10 canonical components (Figure 5J). Thus, area AM is an integration hub of interareal communication, whereas A simply coupled with S1t, and such a correlation structure at the population level critically depends on this subset of neurons.”

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #2 (Public review):

      In the manuscript, Ruhling et al propose a rapid uptake pathway that is dependent on lysosomal exocytosis, lysosomal Ca2+ and acid sphingomyelinase, and further suggest that the intracellular trafficking and fate of the pathogen is dictated by the mode of entry. Overall, this is manuscript argues for an important mechanism of a 'rapid' cellular entry pathway of S.aureus that is dependent on lysosomal exocytosis and acid sphingomyelinase and links the intracellular fate of bacterium including phagosomal dynamics, cytosolic replication and host cell death to different modes of uptake.

      Key strength is the nature of the idea proposed, while continued reliance on inhibitor treatment combined with lack of phenotype for genetic knock out is a major weakness.

      We agree with the reviewer that a S. aureus invasion phenotype in ASM K.O. cells would unequivocally demonstrate the importance of ASM for the process. In the revised manuscript, we report an invasion phenotype in ASM K.O. cells. The absence of an invasion phenotype in ASM K.O. cells in our original experiments was likely caused by SM accumulation in ASM-depleted cells originating from FBS (see Figure 2I, in the revised manuscript).

      We thus cultured cells for up to three days in 2% FBS and then reduced the concentration to 1% FBS one day prior to experimentation. Under these conditions reduced S. aureus invasion in ASM K.O.s was observed when compared to wildtype cells.

      This was not detected when we cultured the cells in medium containing the common concentration of 10% FBS. Our new data supports the results we acquired with three different ASM inhibitors.

      The invasion defect in ASM K.O.s cultured in low FBS was more pronounced at 10 min p.i. when compared to the 30 minute time point (Figure 2K), further corroborating that the ASM-dependent invasion pathway is relevant early in infection. This is consistent with the invasion dynamics we observed upon interference with lysosomal Ca<sup>2+</sup> signaling [TPC1 K.O. (Figure 1C), BAPTA-AM (Figure 3D)], lysosomal exocytosis [Syt7 K.O. (Figure 2F), Ionomycin (Figure 3D)] and ASM activity by inhibitor treatment (Figure 3D).

      Originally, we had hypothesized that changes in the sphingolipidome induced by absence of ASM may have caused the lack of an S. aureus invasion phenotype. We thus compared the sphingolipidome of ASM K.O.s cultured in 1% and 10% FBS. Indeed, SM accumulation was less severe when we cultured the cells in 1% FBS (Figure 2M and Supp. Figure 3). Hence, we think that strong SM accumulations in ASM K.O. cells cultured in 10% FBS may facilitate ASM-independent invasion mechanisms and thus, the absence of ASM-dependent invasion could not be detected by analyzing the number of invaded bacteria. This is supported by experiments, where we treated ASM K.O.s with the ASM inhibitor ARC39, which only slightly affected S. aureus invasion, whereas we detected a strong reduction of internalized bacteria by ARC39 treatment of WT cells (Figure 2 J). We think that this experiment and the reduced invasion in ASM K.O.s rule out an ASM/SM-independent effect of the inhibitors.

      - While the authors argue a role for undetectable nano-scale Cer platforms on the cell surface caused by ASM activity, results do not rule out a SM independent role in the cellular uptake phenotype of ASM inhibitors.

      We agree with reviewer that we do not show formation of ceramide-enriched platforms, and we thus changed the manuscript accordingly (see below).

      - The authors have attempted to address many of the points raised in the previous revision. While the new data presented provide partial evidence, the reliance on chemical inhibitors and lack of clear results directly documenting release of lysosomal Ca2+, or single bacterial tracking, or clear distinction between ASM dependent and independent processes dampen the enthusiasm.

      We shared the reviewer’s desire to discriminate between ASM-dependent and ASM-independent processes, but we are limited by cell biology and the simultaneous occurrence of processes - here the uptake of bacteria by multiple pathways.

      However, we were able to address ASM-dependency of our rapid uptake mechanism by observing a genetic phenotype in SMPD1 knockout-cells.

      We here do not make any assumptions on the centrality of the pathway and its importance in vivo. As scientists we were interested in the fact that such an ASM dependent pathway existed. In different as of yet still unidentified cell lines such a pathway may pose the main entry point for bacteria. Or maybe it represent an ASM-dependent mode of receptor uptake which we have identified with the bacteria piggy-backing into the cells.

      - I acknowledge the author's argument of different ASM inhibitors showing similar phenotypes across different assays as pointing to a role for ASM, but the lack of phenotype in ASM KO cells is concerning. The author's argument that altered lipid composition in ASM KO cells could be overcoming the ASM-mediated infection effects by other ASM-independent mechanisms is speculative, as they acknowledge, and moderates the importance of ASM-dependent pathway. The SM accumulation in ASM KO cells does not distinguish between localized alterations within the cells. If this pathway can be compensated, how central is it likely to be?

      We are convinced that our new genetic evidence of an S. aureus invasion phenotype in ASM K.O.s will eliminate the reviewer’s concerns about the role of ASM during the bacterial invasion.

      The new lipidomics data of ASM K.O.s cultured in 1% and 10% FBS (Figure 2, M, Supp. Figure 3) and inhibitor-treated WT cells (Figure 2L, Supp. Figure 3) show a correlation between SM accumulation and the invasion phenotype.

      We agree with the reviewer, however, that the reason why changes in sphingolipidome increase ASM-independent S. aureus internalization by host cells remains elusive. One possible explanation is a dysfunction of the lipid raft-associated protein caveolin-1 upon strong SM accumulation, which was previously shown to appear in ASM-deficient cells (1, 2). A lack of caveolin-1 results in strongly increased host cell entry of S. aureus (3, 4). Characterization of the mechanism behind these observations requires further experimentation and is beyond the scope of the current manuscript.

      Host cells possess mechanisms to prevent infections, while pathogens developed strategies to circumvent these defense processes. In the present scenario, a physiological membrane composition of the host cell represents such a pathogen defense mechanism (as shown e.g. for caveolin-1 that restricts invasion of S. aureus in healthy cells). If a defense mechanism is disabled (as we speculate it is the case upon strong SM accumulation in ASM K.O.s cultured in 10%FBS), infection is facilitated. In healthy WT cells, these mechanisms (e.g. caveolin-1) are functional and, hence, we would not expect a “compensation” of ASM-dependent invasion. We here analyze invasion events that cannot be prevented by host defense mechanisms as they occur in untreated WT cells and are absent upon interfering with the ASM-dependent invasion pathway (by inhibitors and genetic K.O.). Thus, we think the ASM-dependent pathway, which mediates 50-70% of bacteria internalized by healthy WT cells 10 min p.i., is central for the infection.

      - The authors allude to lower phagosomal escape rate in ASM KO cells compared to inhibitor treatment, which appears to contradict the notion of uptake and intracellular trafficking phenotype being tightly linked. As they point out, these results might be hard to interpret.

      We measured phagosomal escape of S. aureus JE2 in ASM K.O. cells cultured in 1% FBS. Again, we infected cells for 10 or 30 min and determined the escape rates 3h p.i. However, the results are similar to escape rates determined with 10% FBS (Author response image 1).

      Escape rates of S. aureus were significantly decreased in absence of ASM regardless of the FBS concentration in the medium. We therefore think that prolonged absence of ASM has other side effects. For instance, certain endocytic pathways could be up- or down-regulated to adapt for the absence of ASM or could be affected by other changes in the lipidome (that can be minimized but not completely prevented by culturing cells in 1% FBS). This could, for instance, affect maturation of S. aureus-containing phagosomes and hence phagosomal escape.

      Author response image 1.

      As it is unclear how prolonged absence of ASM can affect cellular processes, we think other experiments investigating the role of ASM-dependent invasion for phagosomal escape are more reliable. Most importantly, bacteria that enter host cell early during infection (and thus, predominantly via the “rapid” ASM-dependent pathway) possess lower phagosomal escape rates than bacteria that entered host cells later during infection (Figure 5, D and E). This is confirmed by higher escapes rates upon blocking ASM-dependent invasion with Vacuolin-1 (Figure 4E) and three different ASM inhibitors (Figure 4C and D). We further demonstrate that sphingomyelin on the plasma membrane during invasion influences phagosomal escape, while sphingomyelin levels in the phagosomal membrane did not change phagosomal escape (Figure5 a and b). This is summarized in Figure 5F.

      - Could an inducible KD system recapitulate (some of) the phenotype of inhibitor treatment ? If S. aureus does not escape phagosome in macrophages, could it provide a system to potentially decouple the uptake and intracellular trafficking effects by ASM (or its inhibitor treatment)?

      Inducible knock-downs in our laboratory are based on the vector pLVTHM in cells co-expressing the repressor TetR fused to a KRAB domain. It needs to be stated that for optimal knock-downs the induction has to be performed by doxycycline supplementation in the medium for 7 days thus leading to several days of growth of the cells, which will allow the cells to adapt their lipid metabolism thus reflecting a situation that we encounter for the K.O.s.

      ASM-dependent uptake of S. aureus in macrophages has been demonstrated before (5). However, the course of infection in macrophages differs from non-professional phagocytes (6). E.g. in macrophages, S. aureus replicates within phagosomes, whereas in non-professional phagocytes replicates in the host cytosol. Absence of ASM therefore may influence the intracellular infection of macrophages with S. aureus in a distinct manner.

      - The role of ASM on cell surface remains unclear. The hypothesis proposed by the authors that the localized generation of Cer on the surface by released ASM leads to generation of Cer-enriched platforms could be plausible, but is not backed by data, technical challenges to visualize these platforms notwithstanding. These results do not rule out possible SM independent effects of ASM on the cell surface, if indeed the role of ASM is confirmed by controlled genetic depletion studies.

      We agree with the reviewer that we do not show generation of ceramide-enriched platforms. We thus changed Figure 6F in the revised manuscript to make clear that it remains elusive whether ceramide-enriched platforms are formed. We also added a sentence to the discussion (line 615) to emphasize that the existence of these microdomains is still debated in lipid research.

      We think that the following observations support SM-dependent effects of ASM during S. aureus invasion:

      (i) reduced invasion upon removing SM from the plasma membrane (Figure 2N, Supp. Figure 2M)

      (ii) increased invasion in TPC1 and Syt7 K.O. (Figure 2, P) in presence of exogenously added SMase.

      However, we agree with the reviewer that we do not directly demonstrate ASM-mediated SM cleavage during S. aureus invasion. Hence, we added a sentence to the discussion that mentions a possible SM-independent role of ASM for invasion (line 556) that reads:

      “Since it remains elusive to which extent ASM processes SM on the plasma membrane during S. aureus invasion, one may speculate that ASM could also have functions other than SM metabolization during host cell entry of the pathogen. However, we did not detect a direct interaction between S. aureus and ASM in an S. aureus-host interactome screen (7).”

      - The reviewer acknowledges technical challenges in directly visualizing lysosomal Ca2+ using the methods outlined. Genetically encoded lysosomal Ca2+ sensor such as Gcamp3-ML1 might provide better ways to directly visualize this during inhibitor treatment, or S. aureus infection.

      We thank the reviewer for this suggestion. We included the following section in our discussion (line 593):

      “Since fluorescent calcium reporters allow to monitor this process microscopically (8, 9) ,future experiments may visualize this process in more detail and contribute to our understanding of the underlying signaling. mechanisms.”

      References

      (1) J. Rappaport, C. Garnacho, S. Muro, Clathrin-mediated endocytosis is impaired in type A-B Niemann-Pick disease model cells and can be restored by ICAM-1-mediated enzyme replacement. Mol Pharm 11, 2887-2895 (2014).

      (2) J. Rappaport, R. L. Manthe, C. Garnacho, S. Muro, Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery. Mol Pharm 12, 1366-1376 (2015).

      (3) C. Hoffmann et al., Caveolin limits membrane microdomain mobility and integrin-mediated uptake of fibronectin-binding pathogens. J Cell Sci 123, 4280-4291 (2010).

      (4) L.-P. Tricou et al., Staphylococcus aureus can use an alternative pathway to be internalized by osteoblasts in absence of β1 integrins. Scientific Reports 14, 28643 (2024).

      (5) C. Li et al., Regulation of Staphylococcus aureus Infection of Macrophages by CD44, Reactive Oxygen Species, and Acid Sphingomyelinase. Antioxid Redox Signal 28, 916-934 (2018).

      (6) A. Moldovan, M. J. Fraunholz, In or out: Phagosomal escape of Staphylococcus aureus. Cell Microbiol 21, e12997 (2019).

      (7) M. Rühling, F. Schmelz, A. Kempf, K. Paprotka, J. Fraunholz Martin, Identification of the Staphylococcus aureus endothelial cell surface interactome by proximity labeling. mBio 0, e03654-03624 (2025).

      (8) D. Shen et al., Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun 3, 731 (2012).

      (9) L. C. Davis, A. J. Morgan, A. Galione, NAADP-regulated two-pore channels drive phagocytosis through endo-lysosomal Ca(2+) nanodomains, calcineurin and dynamin. EMBO J 39, e104058 (2020).

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary: 

      The authors report the structure of the human CTF18-RFC complex bound to PCNA. Similar structures (and more) have been reported by the O'Donnell and Li labs. This study should add to our understanding of CTF18-RFC in DNA replication and clamp loaders in general. However, there are numerous major issues that I recommend the authors fix. 

      Strengths: 

      The structures reported are strong and useful for comparison with other clamp loader structures that have been reported lately. 

      Comments on revisions: 

      The revised manuscript is greatly improved. The comparison with hRFC and the addition of direct PCNA loading data from the Hedglin group are particular highlights. I think this is a strong addition to the literature.

      We thank the reviewer for their positive comments.  

      I only have minor comments on the revised manuscript. 

      (1) The clamp loading kinetic data in Figure 6 would be more easily interpreted if the three graphs all had the same x axes, and if addition of RFC was t=0 rather than t=60 sec.

      We now analyze and plot EFRET as a function of time after complex addition, effectively setting the loader addition to t = 0 for each trace (Figure 6 and Figs S10-14 in the new manuscript). Baseline (Ymin) and plateau (Ymax) EFRET values were obtained by averaging the stable signal regions immediately before and after clamp-loader addition, respectively. Traces are normalized to their own dynamic range before fitting.

      (2) The author's statement that "CTF18-RFC displayed a slightly faster rate than RFC" seems to me a bit misleading, even though this is technically correct. The two loaders have indistinguishable rate constants for the fast phase, and RFC is a bit slower than CTF18-RFC in the slow phase. However, the data also show that RFC is overall more efficient than CTF18-RFC at loading PCNA because much more flux through the fast phase (rel amplitudes 0.73 vs 0.36). Because the slow phase represents such a reduced fraction of loading events, the slight reduction in rate constant for the slow phase doesn't impact RFC's overall loading. And because the majority of loading events are in the fast phase, RFC has a faster halftime than CTF18-RFC. (Is it known what the different phases correspond to? If it is known, it might be interesting to discuss.)

      We removed the quoted statement. We avoid comparing amplitude partitions (A₁/A_T) for CTF18-RFC because (i) a substantial fraction of the reaction occurs within the <7 s dead time, and (ii) single- vs double-exponential identifiability differs across complexes. Instead, we report model-minimal progress times: RFC t<sub>0.5</sub> ≤ 7 s (faster onset), CTF18-RFC ~ 8 s, CTF18<sup>Δ165–194</sup>-RFC ~ 12 s; completion (t<sub>0.95</sub>): RFC ≈ 77 s, CTF18-RFC ≈ 77 s, mutant ≈ 145 s. This shows RFC has the steeper onset, while CTF18-RFC catches up in completion, and the mutant is slower overall. We briefly note that RFC’s phases have been assigned in prior stopped-flow work and are consistent with a rapid entry step and a slower repositioning/complex release phase; we do not assign phases for CTF18-RFC here and instead rely on model-minimal timing comparisons to avoid over-interpretation. 

      (3) AAA+ is an acronym for "ATPases Associated with diverse cellular Activities" rather than "Adenosine Triphosphatase Associated". 

      Corrected to ATPases Associated with diverse cellular Activities (AAA+).

      Reviewer #2 (Public review): 

      Summary 

      Briola and co-authors have performed a structural analysis of the human CTF18 clamp loader bound to PCNA. The authors purified the complexes and formed a complex in solution. They used cryo-EM to determine the structure to high resolution. The complex assumed an auto-inhibited conformation, where DNA binding is blocked, which is of regulatory importance and suggests that additional factors could be required to support PCNA loading on DNA. The authors carefully analysed the structure and compared it to RFC and related structures. 

      Strength & Weakness 

      Their overall analysis is of high quality, and they identified, among other things, a humanspecific beta-hairpin in Ctf18 that flexible tethers Ctf18 to Rfc2-5. Indeed, deletion of the beta-hairpin resulted in reduced complex stability and a reduction in a primer extension assay with Pol ε. Moreover, the authors identify that the Ctf18 ATP-binding domain assumes a more flexible organisation. 

      The data are discussed accurately and relevantly, which provides an important framework for rationalising the results. 

      All in all, this is a high-quality manuscript that identifies a key intermediate in CTF18-dependent clamp loading. 

      Comments on revisions: 

      The authors have done a nice job with the revision. 

      We thank the reviewer for their very positive comments.

      Reviewer #3 (Public review): 

      Summary: 

      CTF18-RFC is an alternative eukaryotic PCNA sliding clamp loader which is thought to specialize in loading PCNA on the leading strand. Eukaryotic clamp loaders (RFC complexes) have an interchangeable large subunit which is responsible for their specialized functions. The authors show that the CTF18 large subunit has several features responsible for its weaker PCNA loading activity, and that the resulting weakened stability of the complex is compensated by a novel beta hairpin backside hook. The authors show this hook is required for the optimal stability and activity of the complex. 

      Relevance: 

      The structural findings are important for understanding RFC enzymology and novel ways that the widespread class of AAA ATPases can be adapted to specialized functions. A better understanding of CTF18-RFC function will also provide clarity into aspects of DNA replication, cohesion establishment and the DNA damage response. 

      Strengths: 

      The cryo-EM structures are of high quality enabling accurate modelling of the complex and providing a strong basis for analyzing differences and similarities with other RFC complexes. 

      Weaknesses: 

      The manuscript would have benefited from a more detailed biochemical analysis using mutagenesis and assays to tease apart the differences with the canonical RFC complex. Analysis of the FRET assay could be improved. 

      Overall appraisal: 

      Overall, the work presented here is solid and important. The data is mostly sufficient to support the stated conclusions.

      We thank the reviewer for their mainly positive assessment. Following this reviewer suggestion, we have re-analysed the FRET assay data and amended the manuscript accordingly.

      Comments on revisions: 

      While the authors addressed my previous specific concerns, they have now added a new experiment which raises new concerns. 

      The FRET clamp loading experiments (Fig. 6) appear to be overfitted so that the fitted values are unlikely to be robust and it is difficult to know what they mean, and this is not explained in this manuscript. Specifically, the contribution of two exponentials is floated in each experiment. By eye, CTF18-RFC looks much slower than RFC1-RFC (as also shown previously in the literature) but the kinetic constants and text suggest it is faster. This is because the contribution of the fast exponential is substantially decreased, and the rate constants then compensate for this. There is a similar change in contribution of the slow and fast rates between WT CTF18 and the variant (where the data curves look the same) and this has been balanced out by a change in the rate constants, which is then interpreted as a defect. I doubt the data are strong enough to confidently fit all these co-dependent parameters, especially for CTF18, where a fast initial phase is not visible. I would recommend either removing this figure or doing a more careful and thorough analysis. 

      We appreciate the reviewer’s concern regarding potential overfitting of the kinetic data in Figure 6. To address this, we performed a model-minimal re-analysis designed specifically to avoid parameter covariance and over-interpretation (Figure 6 and Figs S11-14 in the new manuscript). Only data recorded after the instrument’s <7 s dead time were included in the fits, thereby excluding the partially obscured early region of the reaction. For each clamp loader complex, we selected the minimal kinetic model that produced residuals randomly distributed about zero. This approach yielded a single-exponential fit for CTF18-RFC, whereas RFC and CTF18<sup>Δ165–194</sup>-RFC required double-exponential fits; single-exponential models for the latter two complexes left structured residuals, clearly indicating the presence of an additional kinetic phase.

      Rather than relying on co-dependent amplitude and rate parameters, we quantified the reactions by reporting progress times (t<sub>0.5</sub>, t<sub>0.90</sub>, t<sub>0.95</sub>), which provide a model-independent measure of reaction speed. This directly addresses the reviewer’s concern and allows a fair comparison of the relative kinetics among the complexes.

      From this analysis, RFC exhibited the fastest onset (t<sub>0.5</sub> ≤ 7 s; lower bound), while CTF18RFC and CTF18<sup>Δ165–194</sup>-RFC showed progressively slower half-times of approximately 8 s and 12 s, respectively. Completion times further emphasized these differences: both RFC and CTF18-RFC reached 95 % completion at ~77 s, whereas the mutant required ~145 s. Despite these kinetic distinctions, CTF18-RFC and its β-hairpin deletion mutant achieved similar EFRET plateaus, indicating that the mutation slows reaction progression but does not reduce the overall extent of PCNA loading.

      Finally, we emphasize that our interpretation is deliberately conservative. We do not assign distinct kinetic phases to CTF18-RFC, as their molecular basis remains unresolved. RFC’s phases have been characterized in prior stopped-flow studies, but CTF18-RFC likely follows a distinct or simplified pathway. Our conclusions are thus limited to what the data unambiguously support: deletion of the Ctf18 β-hairpin decreases the rate—but not the extent—of PCNA loading, consistent with the reduced stimulation of Pol ε primer extension observed under single-turnover conditions.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public Review):

      General assessment of the work:

      In this manuscript, Mohr and Kelly show that the C1 component of the human VEP is correlated with binary choices in a contrast discrimination task, even when the stimulus is kept constant and confounding variables are considered in the analysis. They interpret this as evidence for the role V1 plays during perceptual decision formation. Choice-related signals in single sensory cells are enlightening because they speak to the spatial (and temporal) scale of the brain computations underlying perceptual decision-making. However, similar signals in aggregate measures of neural activity offer a less direct window and thus less insight into these computations. For example, although I am not a VEP specialist, it seems doubtful that the measurements are exclusively picking up (an unbiased selection of) V1 spikes. Moreover, although this is not widely known, there is in fact a long history to this line of work. In 1972, Campbell and Kulikowski ("The Visual Evoked Potential as a function of contrast of a grating pattern" - Journal of Physiology) already showed a similar effect in a contrast detection task (this finding inspired the original Choice Probability analyses in the monkey physiology studies conducted in the early 1990's). Finally, it is not clear to me that there is an interesting alternative hypothesis that is somehow ruled out by these results. Should we really consider that simple visual signals such as spatial contrast are *not* mediated by V1? This seems to fly in the face of well-established anatomy and function of visual circuits. Or should we be open to the idea that VEP measurements are almost completely divorced from task-relevant neural signals? Why would this be an interesting technique then? In sum, while this work reports results in line with several single-cell and VEP studies and perhaps is technically superior in its domain, I find it hard to see how these findings would meaningfully impact our thinking about the neural and computational basis of spatial contrast discrimination.

      We agree that single cell measurements allow for a spatially more detailed analysis, but they are not feasible in humans. Assuming we value insights into the relationship between neural activity and decision making in the human as well as non-human brain, we are restricted to non-invasive measurements such as EEG, which inevitably showcase the neural underpinnings of decision making at a coarser level of analysis. This was the challenge we met with our paradigm design. For example, we chose contrast as the task-relevant stimulus feature in this study because monotonic contrast response functions exist for sensory neurons throughout the visual system, and the aggregated measures that we could attain with EEG would reflect that contrast-sensitivity and hence provide a window onto the encoding of the main decision-relevant quantity. We were specifically interested in initial afferent, contrast-dependent V1 activity reflected in the C1 component (80-90 ms). As we point out in the Introduction, the C1 is unusual among EEG signals in the extent to which it is dominated by a single visual area, V1 (Jeffreys & Axford, 1972; Clark et al., 1994; Di Russo et al., 2002; Ales et al., 2010; Mohr et al., 2024), and even if other downstream areas also make a minor contribution in the C1 time period, it still represents a very low-level sensory response early in the sensory analysis pipeline, appropriate for addressing our primary question of whether such a low-level signal is used in the formation of perceptual decisions. The alternative hypothesis, that early responses are passed over in decision readout, relates to a fundamental debate about whether early sensory responses are separated from cognition. The possibility that late, but not early, representations are correlated with choices does not imply that the later sensory representations are divorced from the earlier ones, only that there is a noise component that is not shared between the two, such as that produced by the ensuing computations that generate the later representations. Instead, a lack of choice probability in early representations would imply that decision readout is selective in where it sources sensory evidence from, with some possible reasons being to maintain high quality standards for sensory evidence or to impose a layer of separation between cognition and sensation.

      As the reviewer points out, the animal literature is highly mixed on the topic of choice probability in V1. Even for orientation discrimination tasks where V1 is ostensibly highly suited given the existence of orientation columns in V1, and even when measurements are taken from V1 neurons with good neurometric performance and/or aggregated across a V1 population (Jasper et al 2019), some studies have reported little to no V1 choice probability. If our alternative hypothesis of no EEG-indexed V1 choice probability flies in the face of well-established anatomy and function of visual circuits, then so also do these empirical findings in the animal neurophysiology literature. 

      Although there are important aspects of choice probability that are accessible in single cell studies but not in EEG (e.g. noise correlations, details of circuit physiology), our EEG measurements tap into the same phenomenon, just at a different level of analysis, i.e. the neural population level. At this level, we have been able to address whether the full body of sensory responses at a particular stage of visual analysis is systematically related to perceptual decision outcomes. Very similar questions are in fact sometimes addressed in the animal neurophysiology literature; for example, Kang and Maunsell (2020) aggregated single-cell choice probability measurements within visual areas to investigate whether choice probability strength at the level of an entire visual area was sensitive to task demands. The global vantage point of EEG comes with the additional benefit of picking up signatures of other potentially mediating processes such as attention and being able to control for them in our analysis. Our human study thus provides a valuable complementary viewpoint alongside animal neurophysiology work in this area.

      Summary of substantive concerns:

      (1) The study of choice probability in V1 cells is more extensive than portrayed in the paper's introduction. In recent years, choice-related activity in V1 has also been studied by Nienborg & Cumming (2014), Goris et al (2017), Jasper et al (2019), Lange et al (2023), and Boundy-Singer et al (2025). These studies paint a complex picture (a mixture of positive, absent, and negative results), but should be mentioned in the paper's introduction.

      We thank the reviewer for highlighting these papers bearing on choice-related activity in V1, only two of which we had cited. The three additional studies do indeed lend further support to our description of the complex picture around V1-CP effects in the literature and we have now included them.

      (2) The very first study to conduct an analysis of stimulus-conditioned neural activity during a perceptual decision-making task was, in fact, a VEP study: Campbell and Kulikowski (1972). This study never gained the fame it perhaps deserves. But it would be appropriate to weave it into the introduction and motivation of this paper.

      We are aware of this paper, and indeed we ourselves have shown steady-state VEP (SSVEP) correlations with timing and selection of decision reports (O'Connell et al 2012; Grogan et al 2023), but SSVEPs do not provide an index of initial afferent V1 activity in the way that the C1 of the transient VEP does. SSVEPs are evoked by a rapid sequence of stimulus onsets, so that activity cannot be attributed to a particular stimulus onset nor its bottom-up latency resolved, and, being a response to an ongoing stimulus, it combines top-down and bottom-up influences from striate and extra striate areas (Di Russo et al 2007). Indeed, in Campbell and Kulikowski (1972) the SSVEP was almost entirely eliminated when the stimulus was undetected. This is in keeping with robust modulations of the SSVEP by spatial attention (Muller and Hillyard 2000). Cognitive influences of this magnitude are never observed in the C1, and in fact are often not observed at all even when later VEP components show robust modulations (Luck et al 2000), which motivated a recent meta-analysis to address the issue (Qin et al 2022). This highlights the important distinction between the earliest transient VEP activity reflecting mainly the initial afferent response in V1, and steady-state sensory activity reflecting a mix of bottom-up and top-down influences across visual cortex. Because of the importance of this distinction, we have added a reference to the above SSVEP papers to the 3rd paragraph of the introduction along with a statement about the distinction.

      (3) What are interesting alternative hypotheses to be considered here? I don't understand the (somewhat implicit) suggestion here that contrast representations late in the system can somehow be divorced from early representations. If they were, they would not be correlated with stimulus contrast.

      This same conundrum applies to single-cell studies of choice probability. Do studies showing choice probability in V4 but not V1 for example demonstrate that V4 is divorced from V1? In such studies, measurements are typically taken from large representative samples of neurons from both areas with good neurometric performance in both cases and the task often (though not always) involves a target stimulus feature that is encoded in V1 such as orientation. Why then should V4 but not V1 show choice probability when we know the vast majority of input to the visual cortex passes through V1? It must be that feature representation and choice formation are different things with one not inferring the other. This is true for an EEG study as much as it is for a single-cell study.

      The alternative hypothesis in our study is that the early sensory responses indexed by the C1 are not directly used in the formation of the perceptual decision at hand. As outlined in our comments above, this does not imply that those early responses are divorced from later responses. Of course, both are correlated with stimulus contrast and so would correlate with each other across changing contrast but this does not necessitate that their noise is correlated when contrast is held constant because new instantiations of noise can be generated by the computations performed at each stage of visual processing. Thus, the interesting alternative hypothesis is that information contained in the sensory representation generated during initial afferent V1 activity is not used directly to form decisions, and instead, decisions are read out from the outputs of computations performed further downstream. Such an outcome, if it had arisen in our data, would have been consistent with a separation between cognition and early visual processing. Instead, our results suggest a certain level of cognitive interfacing at the lowest and earliest cortical levels of visual processing. We have now added text to the Introduction to highlight the distinction between sensory representation and decision readout in order to make the alternative hypothesis clearer.

      (4) I find the arguments about the timing of the VEP signals somewhat complex and not very compelling, to be honest. It might help if you added a simulation of a process model that illustrated the temporal flow of the neural computations involved in the task. When are sensory signals manifested in V1 activity informing the decision-making process, in your view? And how is your measure of neural activity related to this latent variable? Can you show in a simulation that the combination of this process and linking hypothesis gives rise to inverted U-shaped relationships, as is the case for your data?

      We thank the reviewer for this suggestion of a simulation, which we carried out using the Matlab code. We have also included new Figure 1-Figure Supplement 1 in the revised manuscript.

      In our view, sensory signals in V1 are informing the decision-making process in this task from at least as early as the initial afferent response. The main point about C1 latency in relation to the response-time contingency of the choice probability effect is that the more time that elapses without a decision made (and therefore the more additional sensory processing that contributes to the decision), the more diluted is the contribution of the C1 to the decision by contributions from later representations, and thus choice probability reduces. Likewise, when response times are too quick for C1 evidence to contribute, choice probability is also absent, hence the inverted-U-shaped curve. Moreover, if the C1-choice correlation is mediated by a top-down factor such as attention rather than readout, the inverted-U-shaped curve is not expected because in such a case the relative timing of the C1 and choice commitment would not be relevant.

      Reviewer #2 (Public review):

      Summary:

      Mohr and Kelly report a high-density EEG study in healthy human volunteers in which they test whether correlations between neural activity in the primary visual cortex and choice behavior can be measured non-invasively. Participants performed a contrast discrimination task on large arrays of Gabor gratings presented in the upper left and lower right quadrants of the visual field. The results indicate that single-trial amplitudes of C1, the earliest cortical component of the visual evoked potential in humans, predict forced-choice behavior over and beyond other behavioral and electrophysiological choice-related signals. These results constitute an important advance for our understanding of the nature and flexibility of early visual processing.

      Strengths:

      (1) The findings suggest a previously unsuspected role for aggregate early visual cortex activity in shaping behavioral choices.

      (2) The authors extend well-established methods for assessing covariation between neural signals and behavioral output to non-invasive EEG recordings.

      (3) The effects of initial afferent information in the primary visual cortex on choice behavior are carefully assessed by accounting for a wide range of potential behavioral and electrophysiological confounds.

      (4) Caveats and limitations are transparently addressed and discussed.

      We would like to thank the reviewer for these positive remarks.

      Weaknesses:

      (1) It is not clear whether integration of contrast information across relatively large arrays is a good test case for decision-related information in C1. The authors raise this issue in the Discussion, and I agree that it is all the more striking that they do find C1 choice probability. Nevertheless, I think the choice of task and stimuli should be explained in more detail.

      We thank the reviewer for raising this point about the large stimulus arrays. As we said in our Discussion, it would seem that aggregation across a large stimulus region would be better suited to a downstream visual area with larger receptive fields, yet our setting of a strict deadline would put the emphasis back on earlier sensory representations. We now elaborate on this matter in the discussion, to say that although the small receptive fields and short, slow horizontal connections in V1 mean that the aggregation necessary for performing the task is unlikely to happen within V1 during the C1 timeframe, the aggregation would be readily achieved simply by convergence of the outputs of all relevant V1 neurons for a given stimulus array on the same decision process. In this sense, the design of our paradigm was such that the globally-measured C1 component on the scalp reflected the same aggregated evidence input as the summed V1 readout that we suppose would be entering the decision process.  

      We have also added further rationale in the Methods section on the practical benefits of the stimulus design, as the reviewer anticipates in their subsequent point, of yielding robust C1 signals. This concern was paramount in the design of this study because we expected the C1 difference metric that was of interest to be very small. We also needed a robust C1 to be measured in both the upper and lower visual field in as many individuals as possible and, in our experience, this is true less often when using smaller stimuli, even with a pre-mapping procedure.

      It also helped to homogenize C1 topography across individuals and ensure that topographies from the upper and lower visual field had sufficient overlap that there were electrodes with strong loading from both topographies where the C1 difference as a function of which array was brighter would be maximal.

      We have updated the methods section to provide these rationales while we describe the stimulus design.

      (2) In a similar vein, while C1 has canonical topographical properties at the grand-average level, these may differ substantially depending on individual anatomy (which the authors did not assess). This means that task-relevant information will be represented to different degrees in individuals' single-trial data. My guess is that this confound was mitigated precisely by choosing relatively extended stimulus arrays. But given the authors' impressive track record on C1 mapping and modeling, I was surprised that the underlying rationale is only roughly outlined. For example, given the topographies shown and the electrode selection procedure employed, I assume that the differences between upper and lower targets are mainly driven by stimulus arms on the main diagonal. Did the authors run pilot experiments with more restricted stimulus arrays? I do not mean to imply that such additional information needs to be detailed in the main article, but it would be worth mentioning.

      We thank the reviewer for their thoughtful consideration of this issue about individual variability in C1 retinotopy. Indeed, as the reviewer anticipated we expected the large stimulus coverage to mitigate this issue and we think that our response to the point above and the changes we made to the manuscript in response address this point also. Although we did not show this in the manuscript, we did in fact find that C1 topography was much more similar across individuals than it has been in previous C1 experiments we have carried out with smaller stimuli.

      However, we acknowledge the reviewer’s point that the signal measured at a specific electrode likely has a variable loading strength from the various gratings in the stimulus array and that the gratings of maximal loading may indeed vary from subject to subject. Such inter-subject variability cannot confound the choice probability effects because the latter are measured within-subject. Nevertheless, it could be a source of noise. We believe the impact of this is unlikely to be substantial for the following reasons:

      i) We designed the spatial spread of contrasts in such a way as to encourage participants to aggregate across the full array. In essence, to match the property of the C1 as an aggregate measure of V1 activity, we designed a task that involved aggregating across stimulus elements. Therefore, the decision weighting applied to any particular grating should be representative of the weighting applied to all gratings and, as such, the specific gratings that contribute most to the C1 signal for a particular participant should be relatively inconsequential.

      ii) By avoiding the horizontal and vertical meridians we avoided the regions of space where the shifts in C1 topography are largest.

      (3) Also, the stimulus arrangement disregards known differences in conduction velocity between the upper and lower visual fields. While no such differences are evident from the maximal-electrode averages shown in Figure 1B, it is difficult to assess this issue without single-stimulus VEPs and/or a dedicated latency analysis. The authors touch upon this issue when discussing potential pre-C1 signals emanating from the magnocellular pathway.

      Indeed, there are important differences in V1 properties between the upper and lower visual fields, visual acuity being another example in addition to conduction velocity as the reviewer points out. However, these differences appeared to be quite minimal in this case (Figure 1B does in fact include a single-stimulus VEP – the “1-stim” entry in the legend). Perhaps this is also due to the large stimulus array which may include a range of conduction velocities within it and thereby blur overall differences between the upper and lower visual field. The variability of contrast within each array was also quite high (+/-20% from the midpoint), which would have further increased within-array conduction velocity variability and blurred differences between arrays.

      Our staircasing procedure may have also helped in this regard to some extent as it included a bias parameter between the arrays to account for any behavioural response biases. Although the small contrast changes it usually incurred are likely much too small to change conduction velocities, it corrected for any effect on behaviour they may have.

      (4) I suspect that most of these issues are at least partly related to a lack of clarity regarding levels of description: the authors often refer to 'information' contained in C1 or, apparently interchangeably, to 'visual representations' before, during, or following C1. However, if I understand correctly, the signal predicting (or predicted by) behavioral choice is much cruder than what an RSA-primed readership may expect, and also cruder than the other choice-predictive signals entered as control variables: namely, a univariate difference score on single-trial data integrated over a 10 ms window determined on the basis of grand-averaged data. I think it is worth clarifying and emphasizing the nature of this signal as the difference of aggregate contrast responses that *can* only be read out at higher levels of the visual system due to the limited extent of horizontal connectivity in V1. I do not think that this diminishes the importance of the findings - if anything, it makes them more remarkable.

      This is true that a univariate measure may stick out in a field increasingly favouring multivariate analyses with the spread of machine learning, and so we have added a short qualifier in the methods section where we describe the C1 measurement to explicitly state that it is a scalar variable. What we have done in using this univariate measure is leverage the rich prior knowledge about V1 anatomy and neurophysiology, rather than trust in data-driven classifiers; interestingly, we found that such a classifier trained on all electrodes discriminates choices less well than our informed univariate measure during the C1 time-frame. 

      We also thank the reviewer for raising an interesting point about the nature of aggregation and readout in the context of our stimulus. We agree that it is not feasible that V1 activity would be aggregated locally in V1 across such large regions of space prior to being readout within the C1 time period. As we say above, the aggregation may instead be carried out through convergent transmission of the parallel, spatially-local V1 information to the decision process.

      (5) Arguably even more remarkable is the finding that C1 amplitudes themselves appear to be influenced by choice history. The authors address this issue in the Discussion; however, I'm afraid I could not follow their argument regarding preparatory (and differential?) weighting of read-outs across the visual hierarchy. I believe this point is worth developing further, as it bears on the issue of whether C1 modulations are present and ecologically relevant when looking (before and) beyond stimulus-locked averages.

      We thank the reviewer for their positive appraisal of this additional finding, which we also found remarkable. We agree that our description of our interpretation was too brief and lacked clarity. We have reworded it and expressed it in terms of the speed accuracy trade-off, with the new explanation given below. However, it is important to remember that this account is speculative and serves only to explain the response-time contingency of the bias. That the bias was present and constitutes a modulation of the C1 does not rest on this argument:

      […] “to explain the RT contingency for the C1 bias, we speculate that the speed-accuracy trade-off could fluctuate from trial to trial and that the corresponding decision bound fluctuations (Heitz and Schall 2012) could be implemented by pre-determining decision weights across visual areas. For example, to achieve faster decisions, the sensory evidence requirement could be reduced by placing greater emphasis on initial afferent V1 evidence. In such a case, the RT contingency of the above choice history bias could be explained if the C1 bias is exerted in proportion with the planned emphasis of C1 evidence for the upcoming decision.”

      Recommendations to the Authors:

      Reviewer #2 (Recommendations for the authors):

      (1) As someone whose first language is not English, I am somewhat hesitant to bring this up, but I found the use of 'readout' as both noun and verb somewhat confusing. I thought read-out was defined as 'that which is read out'.

      We agree that this dual use of the word readout may cause confusion. To avoid this, we have edited the manuscript to replace verbal forms of the word “readout” with “read out”.

      (2) I found it difficult to follow the reasoning for why intermediate RTs should be the ones most affected by C1-related information. Perhaps this could be described in more detail for the uninitiated reader.

      We appreciate that our reasoning for why intermediate RTs should be the ones most affected by C1-related information was difficult to follow. We have now added a simulation to showcase this rationale more clearly - see response to reviewer 1, and new figure supplement to figure 1. 

      (3) It would be interesting to compare the effect sizes observed here to those seen in single-cell studies and to discuss this comparison with regard to differences in the nature of EEG signals and single-cell firing rates.

      While we agree that such a comparison would be interesting if feasible, it would have to be for the same task settings, which have not been used in a single-cell study, and  the very different nature and extent of noise between the two recording modalities would make such a comparison difficult to interpret, e.g. background noise in EEG from ongoing processes unrelated to the task. 

      (4) Figure 1: It may be worth mentioning in the legend that only parts of the peripheral stimulus grid are shown for better visibility, as the Methods speak of 9 x 9 grids. Also, in panel B, it should be mentioned that waveshapes are calculated using individually selected maximal-difference electrodes.

      We thank the reviewer for spotting these. We have updated the caption for this figure to reflect these two observations.

      (5) Figure 4: The different shades of green may be difficult to distinguish when printed.

      Although this may be true, we chose shades of green that differ in luminance so they should still be distinguishable. Different colours may in fact be less distinguishable if they had the same luminance and the print was black-and-white. We chose different shades of the same colour to reflect the fact that we were plotting the same signals at different difficulty levels. In our opinion, this takes precedence since eLife is an online journal so the majority of readers will likely read it digitally.

      (6) Methods/Task: While the ITI of 780 ms is substantial, I was wondering why the authors decided against jittering this interval? It would be helpful to briefly discuss whether contrast adaptation for slow periodic stimulation may have affected the findings.

      We opted against jittering the ITI to avoid an additional source of inter-trial variability. While this may allow for adaptation effects of this source, this would be approximately constant across trials and therefore less of a concern for our design. We have added text to the methods section to state this rationale.

      (7) Methods/Stimuli: The authors convincingly argue that focusing on single arms of the stimuli is an unlikely strategy, but did they ask for participants' strategies during debriefing?

      We are glad that the reviewer found our argument about whether or not participants may have focused on a single arm of the stimuli convincing. We did not ask participants about their strategies but even with such a debriefing, there would still remain a possibility that a participant may have used that strategy but were unaware that they were doing so. In any case, if participants were doing this it would have dampened the strength of our choice probability result. 

      (8) Methods/Procedure, Difficulty Titration: Why did the authors opt for manually adapting the difficulty level in a separate session rather than constantly and automatically titrating difficulty?

      We did this because calculating choice probability requires a comparison of trials with different choice outcomes but the same stimulus so continuously staircasing difficulty level during the experiment would have created a confound. Although this could have been corrected for in our regression, this would have entailed greater noise that we could avoid by staircasing in advance.

    1. Author response:

      General Statements

      We thank the reviewers for their thoughtful and constructive comments, which will substantially improve our manuscript. In response, we will revise the text and figures throughout to address the points raised. Specifically, we will:

      i. Refine our definition of Inactivation/Stability Centers (I/SCs): We will limit this designation to loci where both Allelic Expression Imbalance (AEI) and Variable Epigenetic Replication Timing (VERT) are detected, either in the present study or in previously published work.

      ii. Expand methodological clarity: We will provide detailed descriptions of how VERT regions were identified, annotated, and quantified, including thresholds for allelic imbalance, replication timing variability, and sampling depth. We also justify the ≥80% AEI cutoff, which is based on recent studies showing that modest allelic biases can have biological and clinical significance.

      iii. Enhanced benchmarking and validation: In addition to the analysis of X inactivation in female ACP cells, we will include comparisons between imprinted and non-imprinted regions to benchmark the magnitude of allelic replication timing imbalance, demonstrating that the magnitude of imbalance observed at imprinted loci is comparable to that at the non-imprinted VERT regions.

      iv. Address tissue specificity and sampling limitations: We will discuss the limited number of clones, tissues, and individuals analyzed, emphasizing that while our data identify robust AEI and VERT patterns, additional tissues and individuals will be required to capture the full diversity of I/SC regulation.

      v. Clarify biological relevance: We will expand our discussion to highlight the consistency of AEI findings across cell types, including examples of genes implicated in neurodevelopmental and neurodegenerative disorders, and we will clarify our model of how I/SC regulation may contribute to haploinsufficiency, variable expressivity, and incomplete penetrance in human disease.

      vi. Improved figures and supplemental data: We will update figure legends for clarity, add a new supplementary figure comparing imprinted and non-imprinted regions, and cross-reference all supplemental tables.

      We believe these revisions strengthen the manuscript conceptually and experimentally, and we thank the reviewers and editors for their valuable feedback.

      Description of the planned revisions

      Reviewer #1:

      The existence of VERT regions is well supported, but the number of regions called as ISCs may be inflated by permissive thresholds (e.g., AEI {greater than or equal to} 0.8 or {less than or equal to} 0.2 in a single clone). This risks conflating transient stochastic differences with stable ISCs.

      We selected the >80% (or <20%) allelic imbalance threshold, along with the requirement of at least one biallelic clone, as our criterion for significant AEI. This choice was guided by a recent study demonstrating that allelic imbalance as low as a 65%/35% is enough to effect disease penetrance in humans (Nature 2025; 637:1186–1197). For completeness, results obtained using more stringent thresholds (>90% and >95% imbalance) are presented in Supplementary Table 2.

      Furthermore, it is unlikely that transient stochastic differences in allelic expression, such as those detected by single-cell RNA sequencing assays (Nat. Rev. Genet. 2015; 16:653–664), would be captured by our approach. Each clone in our study was expanded from a single cell to over one million cells before both RNA-seq and Repli-seq analysis, effectively averaging out transient transcriptional and/or replication fluctuations, and thus reflecting stable, mitotically heritable epigenetic states.

      More robust approaches would include using magnitude of imbalance, annotating VERTs by genomic location, applying stricter thresholds for replication timing, and benchmarking AEI distributions against the X chromosome.

      All VERT regions identified in this study were annotated according to both the magnitude of allelic imbalance and their genomic coordinates, using 250 kb windows for the human samples and 50 kb windows for the mouse samples (see Supplementary Tables 1 and 6). Figure 1c directly compares the magnitude of imbalance, defined as outliers in the standard deviation, for both allelic replication timing and allelic expression across autosomal and X-linked loci in female ACP cells.

      In addition, we will benchmark the magnitude of replication timing imbalance using autosomal imprinted regions as a second internal control. We detected allelic replication imbalance at 13 known imprinted loci, and the standard deviation of replication timing at these loci, measured in 250 kb windows, is comparable to that observed across the >350 VERT regions detected at non-imprinted sites. To illustrate this comparison, we will include a supplementary figure directly comparing imprinted and non-imprinted regions.

      Figures and text would benefit from improved clarity: axis labels are missing in places (e.g., Fig. 1c, Fig. 2g), legends should explain chromosome arm colors, and cluttered figures such as Fig. 1j could be re-visualized for interpretability.

      Figure labels will be added to Figs. 1c and 2g, and legends will be modified for clarity.

      “the claim of cell-type specificity is not convincingly demonstrated given the small sample size (n=4) and strong batch confounding between lymphoblastoid and cartilage progenitors.” And “Hierarchical clustering is confounded by batch and based on presence/absence calls that lack quantitative resolution.”

      We agree that the limited number of individuals and clones, as well as the comparison between only two distinct tissue types (LCLs and ACPs), have quantitative limitations. Our primary intent was to evaluate whether any I/SCs were shared between independently derived clonal datasets and to determine whether there is evidence of tissue-specific I/SC usage, rather than to make quantitative claims about global cell-type specificity.

      To address this concern, we will replace the hierarchical clustering analysis currently shown in Figure 1i with a Venn diagram that more directly illustrates the overlap and tissue-specific distribution of VERT regions detected in the different clonal sets. This revised representation avoids assumptions about clustering relationships and removes batch-driven bias, while still conveying the key observation that many VERT regions are shared across tissues and others appear tissue-restricted.

      While syntenic VERT regions across mouse and human are intriguing, they complicate interpretation of strong clustering by cell type. Sampling depth may also have exaggerated allelic imbalance calls.

      We note that the human LCLs used in our study are B cells, and immunoglobulin gene rearrangements were used to confirm the clonal uniqueness of each line. Similarly, the mouse replication timing data analyzed here was generated from pre-B cells, which also undergo immunoglobulin gene rearrangement. Thus, both the human LCL and mouse pre-B cell datasets were derived from B-cell lineages, providing a consistent cellular context for comparative analysis.

      Sequencing depth is an important consideration for all variant base calls. Without fully haplotype-resolved genomes, previous studies relied on calculating per-SNP calls of allelic imbalance based on reads covering a single nucleotide locus. To improve sequencing depth supporting the identification of VERT and AEI regions, we utilized fully haplotype-resolved genomes that allowed all informative allele-specific reads to be pooled across all heterozygous SNPs within genomic windows or expressed genes. For AEI, we set a minimum threshold of 20 informative allele-specific reads per gene, a minimum FDR-corrected p-value of <=0.05, and a minimum of 80% vs 20% allelic imbalance. Importantly, a recent study has shown that allelic imbalance as low as a 65%/35% is enough to effect disease penetrance in humans (Nature 2025; 637:1186–1197). We reiterate that more stringent thresholds (>90% and >95% imbalance) are presented in Supplementary Table 2.

      Gene set enrichment analysis should be restricted to avoid inflated significance from overly broad categories.

      Reviewer #2:

      Some of the GO terms presented are too broad to suggest any biological significance to the result, even if there is statistical significance (for example, the top term for LCL clones 'Cytoplasm' is associated with 12,000 genes, and the second term for mouse clones 'Membrane' is associated with 10,000). It would be helpful to focus on GO terms lower in the GO hierarchy.

      We will include our complete Gene Ontology analysis, with more specific biological categories, in Supplemental Table 5.

      Allelic imbalance has been referred to as AI, MAE (monoallelic expression), RMAE (random monoallelic expression) etc. The paper whose mouse data the authors make use of uses Asynchronous Stochastic Replication Timing (ASRT) instead of VERT to refer to the same phenomenon. Creating unnecessary jargon makes the paper more difficult to read and adds needless complexity to an already complex field.

      While we agree that allelic expression imbalance has been described by different investigators using many different phrases, we believe that MAE, RMAE and AI do not represent an accurate description of the phenomenon. In our study [and our previous study; Nat Commun. 2022; 13(1):6301] we used clonal analysis of allele-specific expression and found that while some clones display equivalent levels of expression between alleles of a given gene (i.e. bi-allelic expression) other clones express only one allele (i.e. mono-allelic expression), and yet other clones have undetectable expression (i.e. silent on both alleles). This pattern of allele-restricted expression indicates that each allele independently adopts either an expressed or silent state. Importantly, because these expression states are mitotically stable, allele-autonomous, and independent of parental origin, we refer to the choice of the expressed allele as stochastic. Given this variability, we believe that the phrase “Allelic Expression Imbalance” (AEI) represents a more accurate descriptor for this phenomenon. We also point out that “Allelic Expression Imbalance” has been used >120 times in the Pubmed database.

      In addition, the replication asynchrony that exists at these loci is not consistent with purely ASynchronous Replication Timing (ASRT) between alleles. We found that each allele can independently adopt either earlier or later replication timing in different clones. This variability results in some clones exhibiting pronounced asynchrony between alleles, while in others, the two alleles replicate synchronously, with both adopting either the earlier or later timing state. As reported in our previous study (Nat. Commun. 2022; 13:6301), this behavior reflects a stochastic and allele-autonomous process, leading us to describe these loci as exhibiting Variable Epigenetic Replication Timing (VERT), which we believe is a more accurate descriptor of this phenomenon.

      The point that allelic imbalance is enriched in VERTs would be enhanced if the authors could present the allelic ratio for all genes found in all VERTs, demonstrating how replication timing on either chromosome affects the allelic ratio.

      The stochastic nature of allelic expression and replication timing observed at VERT loci indicates that each allele independently acquires its epigenetic state. Specifically, the expressed or silent status of one allele does not predict the replication timing or expression status of the opposite allele. Accordingly, the Early/Late pattern of replication timing that we detect, both in this study and in our previous work (Nat. Commun. 2022; 13:6301), is not correlated with which allele is transcriptionally active. This supports our conclusion that asynchronous replication timing is not a downstream consequence of monoallelic transcription, but rather an independent epigenetic feature of I/SCs. Regardless, we will provide the combined expression ratios for all transcripts that are located within the VERT regions in a Supplemental Table.

      In addition, our analysis of imprinted loci reveals that even at genomic regions with parent-of-origin–specific expression, replication timing does not align with allelic activity: both early- and late-replicating alleles can be transcriptionally active, depending on the gene. This observation is consistent with the complex organization of many imprinted domains, where genes on opposite alleles exhibit reciprocal expression patterns. To illustrate this point, we will include a new supplemental figure demonstrating that imprinted loci harbor genes expressed from both the earlier- and later-replicating alleles.

      Figure 3 highlights the association of related gene clusters with VERTs but the VERTs are assigned based on variable replication timing in just 1 or 2 clones. This is an interesting observation, but to make the point that "VERT regions frequently coincide with gene clusters in the human genome" there needs to be a systematic assessment of replication timing at all gene clusters across all clones, and a statistical test for significance.

      Our intent in Figure 3 was not to suggest that all gene clusters are subject to VERT and AEI, but rather to highlight that several well-characterized multigene families that are known to exhibit random AEI, such as olfactory receptor and HLA gene clusters, coincide with VERT regions at their genomic locations. These examples serve as representative illustrations demonstrating that I/SC-associated regulation occurs at established AEI loci organized in gene clusters.

      To clarify this point, we will revise the text to explicitly state that Figure 3 presents illustrative examples of known AEI-associated gene clusters overlapping with VERT regions, rather than a comprehensive or statistically exhaustive analysis of all gene clusters across the genome.

      It is an interesting hypothesis that VERTs are conserved between species at synentic loci. If such regions are really conserved, one would expect that replication timing at these sites would be consistently asynchronous. However the data presented shows that in human clones these VERTs can be specific to an individual donor (as in 5A) or an individual clone (as in 5H).

      As discussed in our Limitations section, our analysis was restricted to a limited number of cell types, clones, and individuals, which may not capture the full diversity of I/SC usage across tissues and populations. While our dataset was sufficient to identify robust patterns of AEI and VERT, it likely represents only a subset of the broader landscape of I/SC regulation in both humans and mice. We anticipate that future studies incorporating a wider range of tissues, individuals, and clonal analyses will uncover an even greater degree of conservation and diversity in I/SC usage across genomes.

      In order to support the claim that neurodevelopmental disease associated genes reside in asynchronously replicating regions, and are thus more prone to allelic imbalance, the authors would need to demonstrate this phenomenon in neuronal cells.

      We make two points that address this critique: First, many of the neurodevelopmental disease genes located within or adjacent to VERT regions are not exclusively expressed in neuronal cells and have already been shown to exhibit AEI in non-neuronal contexts. For example, Gimelbrant and Chess (Science, 2007; 318:1136–1140) demonstrated AEI of the Parkinson disease genes SNCA and LRRK2 in lymphoblastoid cell lines (LCLs), and in our previous study, we detected AEI of DNAJC6, another Parkinson disease gene, in LCL cells (Nat. Commun. 2022; 13:6301). In the present study that used ACP cells, we identified VERT and AEI of several epilepsy-associated genes, including SCN1A, SCN2A (Fig. 6b), GABRA1(Fig. 6e), and SAMD12 (Fig. 6j), as well as a gene implicated in autism and neurodevelopmental disorders, SEMA5A (Fig. 5c).

      Second, independent studies from the E. Heard laboratory have provided further evidence that AEI occurs in neuronal lineages. Using mouse neural progenitor cells (NPCs), they identified genes subject to AEI (Dev. Cell, 2014; 28:366–380) and they later evaluated AEI of syntenic human neurodevelopmental disease genes, including Snca, App, Eya4, and Grik2 (Nat. Commun. 2021; 12:5330). In addition, they used the phrase “Allelic Expression Imbalance” to describe the epigenetic expression biases at these genes.

      Together, these findings reinforce that AEI, and by extension I/SC regulation, is not restricted to specific cell types, but rather represents a generalizable mechanism of stochastic epigenetic regulation that includes genes relevant to neurodevelopment and disease.

      However, the authors consistently lean on thin evidence (i.e. a single clone) within a modestly sized dataset (4 clones from 2 donors each) to propose a new model for haploinsufficiency in human disease. The consistent focus on limited elements in the data and perhaps an overreach in the interpretation makes it difficult to appreciate what is in fact a very good experiment.

      We agree that our analysis was conducted on a modest number of clones and individuals, which we explicitly acknowledge as a limitation of the present study. However, several key points support the robustness and broader relevance of our conclusions:

      i. Clonal Design and Replication: The strength of our approach lies in its clonal resolution. Each clone represents a single-cell–derived population expanded to over a million cells, enabling direct detection of stable, mitotically heritable allele-specific epigenetic states that would not be apparent in population-averaged data. Importantly, many of the VERT regions we identified are shared between independent clones from different donors and across distinct cell types (ACP and LCL), demonstrating reproducibility and biological consistency.

      ii. Cross-Species Validation: We further identified syntenic VERT regions in mouse pre-B cell clones, including at loci known to exhibit AEI in prior studies, providing independent validation and evolutionary conservation of the phenomenon.

      iii. Integration with Published Evidence: Our findings extend prior observations of AEI and variable replication timing (e.g. Gimelbrant et al. Science 2007; Heskett et al. Nat. Commun. 2022) and are fully consistent with known stochastic allelic expression imbalance of autosomal genes. We also draw parallels with the absence of cellular selection mechanisms that dictate dominant inheritance patterns for loss of function alleles for X linked disease genes (reviewed in: J Clin Invest, 2008, 20-23; and Nat Rev Genet. 2025, 26, 571–580). Our proposed model linking I/SC regulation to haploinsufficiency is therefore a synthesis of our results with an extensive body of published data, not an inference drawn from isolated observations.

      iv. Scope and Framing: We will revise the manuscript to clarify that our proposed model represents a mechanistic framework, not a definitive or exclusive explanation, for how stochastic allelic regulation could contribute to dosage-sensitive disease phenotypes. We will also explicitly discuss the need for larger datasets and additional tissues to refine and test this model.

      In summary, while we recognize the limited sampling inherent to clonal analyses, the consistency of our observations across donors, cell types, and species, together with prior corroborating studies, supports the validity of the conclusions and justifies the broader conceptual implications.

      Description of analyses that authors prefer not to carry out

      Reviewer #1:

      Cell-type specificity and mitotic stability both require stronger evidence; the latter is inferred indirectly from clonal expansion rather than shown directly, and orthogonal experiments (e.g., allele-specific ChIP-seq, DNA methylation) would be required.

      We disagree with this reviewer that the mitotic stability of the epigenetic states are “inferred indirectly from clonal expansion rather than shown directly”. Our experimental design inherently captures mitotically stable, allele-specific states because each clonal line is derived from a single progenitor cell and expanded to millions of cells before analysis. The allele-specific replication timing and expression profiles observed in these clones therefore reflect epigenetic states that are stably inherited across many cell divisions, rather than transient or stochastic fluctuations. This approach was also validated in our previous study (Nat. Commun. 2022; 13:6301), where the same clonal strategy demonstrated stable allele-restricted replication and expression patterns over extended passages.

      We agree that orthogonal assays such as allele-specific ChIP-seq or DNA methylation analyses would provide additional mechanistic detail on the nature of I/SC-associated regulation. However, these experiments fall outside the scope of the present study, which was designed specifically to identify and map autosomal loci that exhibit coordinated AEI and VERT, the defining epigenetic features of I/SCs. While we fully acknowledge that defining the precise molecular marks (e.g., histone modifications, DNA methylation, chromatin accessibility) that underlie I/SC regulation will be an important future direction, our current data provide a genome-wide, allele-resolved foundation upon which such mechanistic studies can build.

      In summary, the current dataset achieves the central goal of defining the genomic distribution and conservation of I/SCs based on functional readouts of replication timing and expression. Future work will extend these findings using allele-specific epigenomic profiling to characterize the epigenetic modifications associated with I/SC stability and cell-type specificity.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript by Kolb and Hasseman et al. introduces a significantly improved GABA sensor, building on the pioneering work of the Janelia team. Given GABA's role as the main inhibitory neurotransmitter and the historical lack of effective optical tools for real-time in vivo GABA dynamics, this development is particularly impactful. The new sensor boasts an enhanced signal-to-noise ratio (SNR) and appropriate kinetics for detecting GABA dynamics in both in vitro and in vivo settings. The study is well-presented, with convincing and high-quality data, making this tool a valuable asset for future research into GABAergic signaling.

      Strengths:

      The core strength of this work lies in its significant advancement of GABA sensing technology. The authors have successfully developed a sensor with higher SNR and suitable kinetics, enabling the detection of GABA dynamics both in vitro and in vivo.

      This addresses a critical gap in neuroscience research, offering a much-needed optical tool for understanding the most important inhibitory neurotransmitter. The clear representation of the work and the convincing, high-quality data further bolster the manuscript's strengths, indicating the sensor's reliability and potential utility. We anticipate this tool will be invaluable for further investigation of GABAergic signaling.

      Weaknesses:

      Despite the notable progress, a key limitation is that the current generation of GABA sensors, including the one presented here, still exhibits inferior performance compared to state-of-the-art glutamate sensors. While this work is a substantial leap forward, it highlights that further improvements in GABA sensors would still be highly beneficial for the field to match the capabilities seen with glutamate sensors.

      We thank Reviewer 1 for the positive assessment. We agree that further improvements in GABA sensor performance remain desirable. We acknowledge this limitation and outline directions for future development in the Discussion paragraph beginning "There are several promising avenues that could be taken to further optimize iGABASnFR."

      Reviewer #2 (Public review):

      Summary:

      This manuscript presents the development and characterization of iGABASnFR2, a genetically encoded GABA sensor with markedly improved performance over its predecessor, iGABASnFR1. The study is comprehensive and methodologically rigorous, integrating high-throughput mutagenesis, functional screening, structural analysis, biophysical characterization, and in vivo validation. iGABASnFR2 represents a significant advancement in GABA sensor engineering and application in imaging GABA transmission in slice and in vivo. This is a timely and technically strong contribution to the molecular toolkit for neuroscience.

      Strengths:

      The authors apply a well-established sensor optimization pipeline and iterative engineering strategy from single-site to combinatorial mutants to engineer iGABASnFR2. The development of both positive and negative going variants (iGABASnFR2 and iGABASnFR2n) offers experimental flexibility. The structure and interpretation of the key mutations provide insights into the working mechanism of the sensor, which also suggest optimization strategies. Although individual improvements in intrinsic properties are incremental, their combined effect yields clear functional gains, enabling detection of direction-selective GABA release in the retina and volume-transmitted GABA signaling in somatosensory cortex, which were challenging or missed using iGABASnFR1.

      Weaknesses:

      With minor revisions and clarifications, especially regarding membrane trafficking, this manuscript will be a valuable resource for probing inhibitory transmission.

      We thank Reviewer 2 for the positive assessment. Regarding membrane trafficking, we appreciate the suggestion to test different trafficking motifs. While such optimization represents a valuable direction for future development, it was beyond the scope of the present study and not feasible with the available time and resources. A different imaging modality would be needed to assess membrane trafficking efficiency or membrane-restricted expression, as the images presented in the manuscript (Figure 2a) are wide-field epifluorescence images, which lack the axial resolution required to distinguish membrane-localized signal from cytosolic fluorescence.

      We expect that the current characterization of iGABASnFR2 will nevertheless provide a strong foundation for future efforts to optimize membrane targeting and expression using alternative trafficking strategies.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) We noted an interesting inconsistency in the response of iGABASnFR1 and iGABASnFR2 when expressed as purified protein versus in mammalian cells. Such discrepancies are not uncommon for proteins exhibiting different behaviors in E. coli versus mammalian expression systems. We appreciate the authors' diligent effort in performing screening within a neuronal context. Similarly, the stark difference between the absolute affinity in purified form (∼0.778 μM) and on-cell measurements (6.4 μM) warrants further discussion. The authors may consider commenting on these observations in the discussion section.

      We have revised the Discussion (lines 401-410 in the ‘Tracked Changes’ document) to address the discrepancy between measurements obtained with purified protein and those from expression on the neuronal surface. As noted by the reviewer, such discrepancies are common, and our revision is intended to convey our empirical experience with this phenomenon rather than to offer a definitive mechanistic explanation.

      One factor to appreciate is that, when on the surface of neurons, the sensor is tethered to the membrane by an additional 60 amino acids. In addition to altering the local chemical environment, membrane tethering could impose entropic or mechanical constraints on the sensor. These constraints may damp conformational motions that underlie ligand binding and fluorescence changes. Beyond this, the local environment experienced by a membrane-anchored sensor differs substantially from that of soluble protein. There are potential electrostatic and steric effects arising from the plasma membrane and extracellular matrix, as well as post-translational modifications associated with mammalian expression. These effects on sensor performance are not readily predictable in either magnitude or direction, as illustrated by iGluSnFR, which exhibits a higher apparent affinity when membrane-tethered than in soluble form (Aggarwal et al 2023). For these reasons, we place greater emphasis on neuronal measurements as the most informative indicator of in vivo sensor performance.

      (2) Although iGABASnFR2 fluorescence exhibits pH dependence, its response appears less pH-dependent compared to the first-generation sensor. To enhance clarity, we suggest plotting the normalized response of both sensors across different pH values. This visual representation would be highly informative for readers.

      Thank you - we have implemented this, now showing the (F_sat - F_apo)/F_apo response as a function of pH for all three sensors in Fig 4 fig. supp 3b. This visualization nicely illustrates that the apo-to-sat response of iGABASnFR1 is much more influenced by pH than either iGABASnFR2 or iGABASnFR2n, which we note on lines 252-253 of the ‘Tracked Changes’ document.

      (3) To provide a more comprehensive characterization of the sensors, we recommend including a quantification of the decay times for all three versions of the sensors in Figure 2, specifically after panel 2c.

      Thank you - we now provide this in Fig 2d.

      (4) For improved readability of Figure 3a, we suggest adding distinct labels for iGABASnFR1 and iGABASnFR2 with corresponding colors.

      Good suggestion - we matched the color of the backbones to the rest of the manuscript (orange and green). We also added labels on the figure to ensure clarity.

      (5) The GABA released by SAC cells in Figure 5 looks amazing! We propose a minor modification to the cartoon in Figure 5b: mirroring the image horizontally (left to right). Given that the subsequent panels (e, h, and k) set the preferred direction of SAC movement as rightward, the current cartoon in Figure 5b inadvertently suggests stronger inhibition by SAC-released GABA when the spot moves left. Mirroring the image would align the cartoon more accurately with the subsequent data representations.

      Thanks - this is a nice streamlining. We have implemented the change.

      Reviewer #2 (Recommendations for the authors):

      (1) As sensor performance differs substantially between purified protein and neurons, a summary table comparing key properties (e.g., EC50, ∆F/F <sub>ax</sub>, response amplitude to # of AP) across purified protein and neurons would be highly informative.

      We discuss differences in sensor performance between purified protein and neurons in the Discussion (lines 401-410 in ‘Tracked Changes document) and, for the reasons outlined there, consider neuronal measurements to be far more predictive of in vivo performance. We therefore chose not to include a summary table directly comparing purified protein and neuronal data, as this would risk over-emphasizing in vitro measurements that we view primarily as qualitative signposts rather than more directly informative indicators of functional performance.

      (2) The authors should comment on the observed differences in performance between purified protein and neuronal expression. Would HEK293 cell measurements serve as a better predictor of in vivo performance than in vitro titrations? Insights here would benefit future sensor development pipelines.

      We have revised the Discussion to address this point (lines 401-410 in the ‘Tracked Changes’ document). We often observe differences in sensor performance between purified protein measurements and cellular or in vivo contexts. In our experience, titrations in primary neurons provide a better predictor of in vivo performance than in vitro protein titrations, as they more closely reflect relevant cellular factors. We do not have direct evidence that expression in heterologous systems such as HEK293 cells is generally more predictive, although this seems plausible; however, predictions inevitably become less reliable as sensors are translated to fully in vivo conditions.

      (3) Improved membrane localization likely contributes to the enhanced sensitivity of iGABASnFR2 in neurons beyond changes in EC50. In Figure 2a, membrane trafficking appears suboptimal. The authors should explore alternative trafficking motifs (e.g., ER2, Kv2.1, or motifs from other sensors) to further improve the membrane expression and consider adding a second fluorescent protein for quantifying membrane-localized brightness.

      Figure 2a presents wide-field epifluorescence images, which lack the axial resolution required to distinguish membrane-localized signal from cytosolic fluorescence. We therefore do not consider this imaging modality suitable for assessing membrane trafficking efficiency or membrane-restricted expression.

      We appreciate the suggestion to test different trafficking motifs to attempt to better capture biological signals. While such optimization represents a valuable direction for future development, it was beyond the scope of the present study and not feasible with the available time and resources. We expect that the current characterization of iGABASnFR2 will nevertheless provide a strong foundation for future efforts to further optimize membrane targeting and expression using alternative trafficking strategies.

      (4) Figure 4 - Supplement 2: The apparent EC50 of iGABASnFR2 seems affected by buffer composition and the presence of high concentrations of unrelated compounds. The authors should comment on this.

      We thank the reviewer for raising this point. Upon closer inspection, the EC50 of iGABASnFR2 in Fig 4 Supp 2 is measured at 1.4 μM, while in Fig 4a it is 1.1 μM - these mean values are quite close to one another, and within the range of experimental variability we expect for experiments done weeks or months apart. What differs most noticeably in this dataset is the shape of the dose–response curve rather than the EC50 itself; the origin of this difference is currently unclear. We have revised the Results text (lines 226-231 in ‘Tracked Changes document) to clarify this point and to emphasize that the key observation of Fig. 4–figure supplement 2 is that none of the additional compounds tested substantially impair GABA binding, indicating that they do not act as strong non-competitive allosteric antagonists or inhibitors.

      (5) The negative-going variant, iGABASnFR2n, is introduced but only briefly characterized. Including additional data or even a conceptual use case would clarify its potential utility.

      We have modified the discussion to provide more examples of conceptual use cases, clarifying how such a sensor could indeed be highly impactful. The full passage is lines 372-387 in the ‘Tracked Changes’ document; to summarize: a key application of the negative-going sensor is detecting decreases in ‘GABA tone’, which plays a key role in setting the excitation-inhibition balance across brain circuits. Reductions in extrasynaptic GABA are a well-documented feature of several biologically important brain-state transitions, including arousal, experience-dependent plasticity, and stress-related modulation of inhibition, and iGABASnFR2n could be an important tool for investigating these processes.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      BK channels are widely distributed and involved in many physiological functions. They have also proven a highly useful tool for studying general allosteric mechanisms for gating and modulation by auxiliary subunits. Tetrameric BK channels are assembled from four separate alpha subunits, which would be identical for homozygous alleles and potentially of five different combinations for heterozygous alleles (Geng et al., 2023, https://doi.org/10.1085/jgp.202213302). Construction of BK channels with concatenated subunits in order to strictly control heteromeric subunit composition had not yet been used because the N-terminus in BK channels is extracellular, whereas the C-terminus is intracellular. In this new work, Chen, Li, and Yan devise clever methods to construct and assemble BK channels of known subunit composition, as well as to fix the number of γ1 axillary subunits per channel. With their novel molecular approaches, Chen, Li and Yan report that a single γ1 axillary subunit is sufficient to fully modulate a BK channel, that the deep conducting pore mutation L312A exhibited a graded effect on gating with each addition mutated subunit replacing a WT subunit in the channel adding an additional incremental left shift in activation, and that the V288A mutation at the selectivity filter must be present on all four alpha subunits in order to induce channel inactivation. Chen, Li, and Yan have been successful in introducing new molecular tools to generate BK channels of known stoichiometry and subunit composition. They validate their methods and provide three examples of their use with useful observations.

      Strengths:

      Powerful new molecular tools for the study of channel gating have been developed and validated in the study.

      Weaknesses:

      (1) One example each of auxiliary, deep pore, and selectivity filter allosteric actions is presented, but this is sufficient for the purposes of the paper to establish their methods and present specific examples of applicability.

      We sincerely thank Reviewer #1 for the thoughtful and supportive evaluation of our work. We greatly appreciate the reviewer’s clear summary of the study and the recognition of the novelty and utility of our molecular concatemer strategy for controlling BK channel subunit composition and stoichiometry.

      We also appreciate the reviewer’s positive assessment that the three examples (auxiliary subunit modulation, deep pore mutation, and selectivity filter mutation) are sufficient to establish the method and demonstrate its applicability. We are encouraged that the reviewer found the new molecular tools to be powerful and well validated.

      We have no further changes to make in response to this review, but we are grateful for the reviewer’s constructive and encouraging comments.

      Reviewer #2 (Public review):

      Summary:

      This manuscript describes novel BK channel concatemers as a tool to study the stoichiometry of the gamma subunit and mutations in the modulation of the channel. Taking advantage of the modular design of the BK channel alpha subunit, the authors connected S1-S6/1st RCK as two- and four-subunit concatemers and coexpressed with S0-RCK2 to form normal function channels. These concatemers avoided the difficulty that the extracellular N-terminus of S0 was unable to connect with the cytosolic C-terminus of the gamma subunit, allowing a single gamma subunit to be connected to the concatemers. The concatemers also helped reveal the required stoichiometry of mutant BK subunits in modulating channel function. These include L312A in the deep pore region that altered channel function additively with each additional subunit harboring the mutation, and V288A at the selectivity filter that altered channel function cooperatively only when all four subunits were mutated. These results demonstrate that the concatemers are robust and effective in studying BK channel function and molecular mechanisms related to stoichiometry. The different requirement of the gamma subunit and the mutations stoichiometry for altering channel function is interesting, which may relate to the fundamental mechanism of how different motifs of the channel protein control function.

      Strengths:

      The manuscript presents well-designed experiments with high-quality data, which convincingly demonstrate the BK channel concatemers and their utility. The results are clearly presented.

      Weaknesses:

      This reviewer did not identify any major concerns with the manuscript.

      We sincerely thank Reviewer #2 for the careful reading of our manuscript and for the highly positive and supportive comments. We appreciate the reviewer’s detailed summary of our concatemer design strategy and its use in studying gamma subunit stoichiometry and mutation-dependent modulation of BK channel function.

      We are especially grateful for the reviewer’s recognition that the experiments are well designed, the data are of high quality, and the results demonstrate the robustness and utility of the concatemer approach. We also appreciate the reviewer’s thoughtful note on the mechanistic implications of the distinct stoichiometric requirements observed for the gamma subunit, L312A, and V288A.

      We are pleased that the reviewer identified no major concerns. We have no further changes to make in response to this review, and we thank the reviewer again for the positive evaluation.

      Recommendations for the authors:

      Reviewing Editor Comments:

      While the study presents a great methodological advancement, the phenomenological examples described could perhaps benefit from a little more mechanistic description/discussion. In particular, the functional effect of the V288A mutant is very novel. It could be useful to discuss whether this mutant impacts channel selectivity/conductance. It could be beneficial to also contrast the subunit dependence of V288A with that of the W434F mutant of the Shaker channel. In the latter, C-type inactivation gating is accelerated even when the mutant is present in a single subunit, which contrasts with the effect in V288A.

      We greatly appreciate the editor’s and reviewers’ thorough and constructive evaluation, and we have revised the manuscript accordingly.

      We added discussion with citation about the potential effect of V288A on selectivity (lines 348349). We also added the reported stoichiometric effects of mutations in Shaker and hERG1 channels on C-inactivation in discussion (lines 336-351). From these studies and our findings with V288A in BK channels, it is interesting to note that the stoichiometric effects of these mutations varies and those located near or within selectivity filter signature exhibited an all-or-none effect in both hERG1 and BK channels.

      The authors might also want to consider performing and showing immunoblots with the alpha_deltaM fragment co-expressed with the other channel fragments. Together with the GFP tag, this alpha_deltaM would perhaps be a ~90 kDa protein. It should be captured by anti-V5 IP and resolved on an SDS-PAGE gel (at least with the quad construct).

      We added supplemental data (Fig.1 – figure supplement 1) to show co-expression and co-IP of the α<sup>ΔM</sup>-GFP construct and a FLAG-tagged α<sub>M</sub> construct. The α<sup>ΔM</sup>-GFP displayed right size on SDS-PAGE. It is of note that the single unit α<sub>M</sub> construct tended to oligomerize even under denatured condition on SDS-PAGE.

      For Figure 4, providing details about the inter-pulse intervals and interpulse holding voltage would be helpful. I was not able to find this information in the methods or text.

      The inter-pulse intervals and holder voltage are now added in Fig. 4 legend (line 638).

      Reviewer #1 (Recommendations for the authors):

      (1) Submitted papers should have page numbers to facilitate reviewing.

      Both page and line numbers are added.

      (2) The designation of the various channel types, such as BKα and BKαM should be identical in the text and figures, so either drop BK in the text or add BK in the figures. Maybe drop BK in the text, as it is known that BK channels are the topic of this study.

      We appreciate the suggestion to be consistent in text and figures. We have dropped “BK” for “BKα<sub>M</sub>” throughout the text.

      (3) "Single Boltzmann fits of G-V curves" would be consistent with a homogenous channel population but do not necessarily suggest a single homogenous channel population of BK channels, as was shown by Geng et al. (2023) (https://doi.org/10.1085/jgp.202213302) where the G-V curve for simultaneous expression of five BK channel types with different V1/2s for each channel type was well approximated by a single Boltzmann function. The dogma that a single Boltzmann fit suggests one channel type needs to be reset. So wave a red flag here: whereas a single Boltzmann fit is consistent with a single channel type, it does not establish a single channel type nor even suggest a single channel type.

      We fully agree that a good Single Boltzmann fit doesn’t mean homogenous channel population. We have changed “suggesting” to “consistent with” (line 203) and “reflecting” to “agreeing with” (line 205).

      (4) Geng et al. (2023) demonstrated that the pore mutation G375R in BK channels gave a left shift in activation linearly related to the number of WT subunits replaced with mutant subunits. This should incremental shift in activation for G375R should be mentioned, as it is consistent with the incremental effects of the L312A deep pore mutation on activation as reported by the authors in their Figure 3D.

      We appreciate the pointing-out of this highly relevant publication. We have now included this reference and discussed together with L312A mutation (lines 309-313).

      (5) I went back and looked at the Lingle laboratory papers on the gamma subunit. An additional sentence or two on what the Lingle lab found and didn't find would be useful here for readers.

      In the Introduction, we have listed the Lingle lab’s findings and the limitations of their experimental methods that warrants the development of a concatenated construct method as proposed in this study (lines 84-88). We prefer to not discuss further in the Discussion as it will be redundant.

      (6) For the two examined mutations L312A and V288A, include in the Methods a 21 amino acid sequence for each mutation with the amino acid to be mutated (L or V) in the center, with beginning and end numbering at the beginning and end of each list. This will allow the reader/experimenter to readily locate the mutated residue on their BK amino acid sequences, which may have different numbering than U11058. Interestingly, for the so-called canonical sequence Q12791 · KCMA1_HUMAN that I found in UniProt starting with U11058, there is an L312, but I found no V288, but an F288. Am I doing this correctly? Do I have the correct sequence/isoform? The only sure way to identify an AA is with an extensive pre and post-sequence so that the chance of misidentification approaches zero.

      We verified that the listed Gene Bank IDs of U11058 for cDNA and AAB65837 for protein should point to the right sequences. In the section of Results, we have now included the peptide sequences of the selectivity filter signature motif and part of the S6 TM where V288 and L312A are located, respectively (lines 179 and 220).

      Reviewer #2 (Recommendations for the authors):

      The different stoichiometry of the gamma subunit and the mutations in regulating channel function raise important questions. For instance, what are the structural and energetic bases for their different stoichiometric requirements? Does the structure motif, such as the selectivity filter or deep pore, act as a unit? Or does a specific residue, such as V288 or L312, act individually to determine the different stoichiometric requirements? What molecular interactions are involved for these residues and subunit to influence the cooperativity among the four alpha subunits in channel function? Some of these questions are discussed in the manuscript, but it may help the readers to clarify what aspects of the mechanistic bases for the findings in this manuscript are known and what aspects remain to be studied.

      We agree that these are all important questions. We have now cited more previous studies on C-inactivation in other K<sup>+</sup> channels and on deep pore mutations in BK channels in terms of subunit stoichiometry (lines 336-351). The results appear to be consistent, suggesting shared properties among residues within the selectivity filter motif or among residues in deep pore region.

      Some minor comments are as follows.

      (1) Page 7, 2nd paragraph: "Page 2B" change to "Page 3B"? Also, "delay in deactivation" is not precise. The term "Delay" in channel kinetics has a specific meaning, and the use of this word here causes some confusion. The authors may want to delete "substantial delay in deactivation evident as a”.

      Corrected by changing Fig. 2B to Fig. 3B and deleting “a substantial delay in deactivation evident as” (line 191).

      (2) Page 9, 1st paragraph: "used in the voltage protocol used". Drop one of the instances of used".

      Corrected by deleting the first “used” (line 246).

      (3) Page 12, 1st paragraph: "Nonetheless, the tight inter-subunit cooperativity observed at the selectivity filter makes it a plausible candidate for serving as the activation gate, a property not yet demonstrated for the lower S6 segment." This seems to be an interesting idea. However, it is not clearly explained. The authors may want to clarify how the cooperativity is related to the activation gate.

      We have now added a sentence with citations to discuss the requirement of intersubunit cooperativity for an activation gate to function (lines 354-357).

      Other major changes: We updated immunoblot figures Fig1C and Fig2C for better presentation.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      The manuscript by Ma et al. provides robust and novel evidence that the noctuid moth Spodoptera frugiperda (Fall Armyworm) possesses a complex compass mechanism for seasonal migration that integrates visual horizon cues with Earth's magnetic field (likely its horizontal component). This is an important and timely study: apart from the Bogong moth, no other nocturnal Lepidoptera has yet been shown to rely on such a dual-compass system. The research therefore expands our understanding of magnetic orientation in insects with both theoretical (evolution and sensory biology) and applied (agricultural pest management, a new model of magnetoreception) significance.

      The study uses state-of-the-art methods and presents convincing behavioural evidence for a multimodal compass. It also establishes the Fall Armyworm as a tractable new insect model for exploring the sensory mechanisms of magnetoreception, given the experimental challenges of working with migratory birds. Overall, the experiments are well-designed, the analyses are appropriate, and the conclusions are generally well supported by the data.

      Strengths

      (1) Novelty and significance: First strong demonstration of a magnetic-visual compass in a globally relevant migratory moth species, extending previous findings from the Bogong moth and opening new research avenues in comparative magnetoreception.

      (2) Methodological robustness: Use of validated and sophisticated behavioural paradigms and magnetic manipulations consistent with best practices in the field. The use of 5-minute bins to study the dynamic nature of the magnetic compass which is anchored to a visual cue but updated with a latency of several minutes, is an important finding and a new methodological aspect in insect orientation studies.

      (3) Clarity of experimental logic: The cue-conflict and visual cue manipulations are conceptually sound and capable of addressing clear mechanistic questions.

      (4) Ecological and applied relevance: Results have implications for understanding migration in an invasive agricultural pest with an expanding global range.

      (5) Potential model system: Provides a new, experimentally accessible species for dissecting the sensory and neural bases of magnetic orientation.

      Weaknesses

      While the study is strong overall, several recommendations should be addressed to improve clarity, contextualisation, and reproducibility:

      We thank Reviewer #1 for the positive and encouraging evaluation of our study. We appreciate the recognition of our work’s strengths and are grateful for the constructive feedback on the remaining weaknesses, which will guide and strengthen our revisions.

      Structure and presentation of results

      Requires reordering the visual-cue experiments to move from simpler (no cues) to more complex (cue-conflict) conditions, improving narrative logic and accessibility for non-specialists.

      Thank you for this thoughtful suggestion. While we appreciate the rationale for presenting results from simpler to more complex conditions, we kept the original sequence because it aligns with the logic of our study. Our initial aim was to determine whether fall armyworms use a magnetic compass integrated with visual cues, as shown in the Bogong moth. After establishing this phenotype, we then examined whether visual cues are required for maintaining magnetic orientation. We have also clarified in the Introduction that magnetic orientation in the Bogong moth relies on integration with visual cues, which provides readers with clearer context and improves the overall narrative flow.

      Ecological interpretation

      (a) The authors should discuss how their highly simplified, static cue setup translates to natural migratory conditions where landmarks are dynamic, transient or absent.

      Thank you for raising this important point. We agree that natural migratory environments provide visual information that is often dynamic, transient, or intermittently absent, in contrast to the simplified and static cue used in our indoor experiments. Our intention in using a minimal, static cue was to isolate and test the fundamental presence of magnetic–visual integration in fall armyworms under fully controlled conditions.To address the reviewer’s concern, we have added a brief note in the Discussion indicating that fall armyworms may encounter both static and dynamic luminance-based visual cues in nature, such as light–dark gradients created by terrain features or more stable celestial patterns. Although these natural cues differ from our simplified laboratory stimulus, they may similarly provide asymmetric visual structure that can be integrated with magnetic information. We also note that determining which natural visual cues support the magnetic–visual compass will be an important direction for future work.

      (b) Further consideration is required regarding how the compass might function when landmarks shift position, are obscured, or are replaced by celestial cues. Also, more consolidated (one section) and concrete suggestions for future experiments are needed, with transient, multiple, or more naturalistic visual cues to address this.

      Thank you for this constructive suggestion. We appreciate the reviewer’s point that additional consideration of how the compass might function under shifting, obscured, or celestial visual cues would strengthen the manuscript. Given the limited evidence currently available for this species, we have incorporated a concise and appropriately cautious discussion addressing these possibilities.

      Methodological details and reproducibility

      (a) It would be better to move critical information (e.g., electromagnetic noise measurements) from the supplementary material into the main Methods.

      Thank you for this helpful suggestion. In the revised manuscript, we have added the key electromagnetic noise measurements information to the main Methods section.

      (b) Specifying luminance levels and spectral composition at the moth's eye is required for all visual treatments.

      Thank you for this helpful comment. We have clarified in the Methods as well as the legend of Fig. S3 that both luminance levels and spectral composition were measured at the position corresponding to the moth’s head.

      (c) Details are needed on the sex ratio/reproductive status of tested moths, and a map of the experimental site and migratory routes (spring vs. fall) should be included.

      Thanks. We have added the reproductive status of the tested moths in the Methods, specifying that all individuals used were unmated 2-day-old adults.

      (d) Expanding on activity-level analyses is required, replacing "fatigue" with "reduced flight activity," and clarifying if such analyses were performed.

      Thank you for this comment. In this context, the term “fatigue” referred to the possibility that moths might gradually lose motivation or attention to orient when flying for an extended period in a simplified, artificial environment with limited sensory cues. Such a decrease in orientation motivation over time could, in theory, lead to a loss of individual orientation and consequently to the observed loss of group orientation. To test this possibility, we analyzed the orientation performance of each individual moth across different phases using the Rayleigh test. The r-value was used as a measure of individual directedness (higher r-values indicate stronger orientation). Our results showed that mean r-values did not differ significantly among the experimental phases (multiple comparisons, Table S2). This indicates that 25min measurement itself was not responsible for the loss of orientation. We did not perform a quantitative activity-level analysis in this study. However, as mentioned in Methods, flight activity was continuously monitored during the experiments by observing fluctuations in the pointer values on the experimental software, which corresponded to the moth’s rotational movements. If the pointer values remained unchanged for more than 10 seconds, the experimenter checked for wing vibrations by sound; if the moth had stopped flying, gentle tapping on the arena wall was used to stimulate renewed flight. Only individuals that maintained active flight throughout the experiment, with fewer than four instances of wingbeat cessation, were included in the analysis. We also mentioned that activity level analysis was not performed due to technical difficulties in the revised manuscript.

      Figures and data presentation

      (a) The font sizes on circular plots should be increased; compass labels (magnetic North), sample sizes, and p-values should be included.

      Thank you for this helpful suggestion. Regarding the compass labels and statistical reporting, our analysis provides significance levels as ranges rather than exact p-values; therefore, we clarified in the figure legends that the two dashed circles correspond to thresholds for statistical significance p = 0.05 and p = 0.01, respectively. Sample sizes are already indicated within each panel. To avoid visual clutter caused by displaying both magnetic North and South, we show only the magnetic South direction (mS) consistently across panels, which can improve readability.

      (b) More clarity is required on what "no visual cue" conditions entail, and schematics or photos should be provided.

      Thank you for this comment. In our study, the “no visual cue” condition refers to the absence of the black triangular landmark inside the flight simulator. To improve clarity, we have updated the legend of Fig. 4 to explicitly state this and have referred readers to the schematic in Fig. 1, which illustrates the structure of the flight simulator. These additions clarify what the “no visual cue” condition entails without requiring additional schematics.

      (c) The figure legends should be adjusted for readability and consistency (e.g., replace "magnetic South" with magnetic North, and for box plots better to use asterisks for significance, report confidence intervals).

      Thank you. Regarding the choice of compass labeling, we intentionally used magnetic South (mS) rather than magnetic North (mN) because the main population tested in our experiments represents the autumn migratory generation. During autumn, fall armyworms orient southward when visual and magnetic cues are aligned. Using magnetic South in the plots therefore provides a clearer representation of cue alignment in this season and avoids potential confusion when interpreting the combined visual–magnetic information.

      Conceptual framing and discussion

      (a) Generalisations across species should be toned down, given the small number of systems tested by overlapping author groups.

      Thank you for this valuable comment. In the revised manuscript, we have softened such statements in both abstract and maintext.

      (b) It requires highlighting that, unlike some vertebrates, moths require both magnetic and visual cues for orientation.

      Thank you for this helpful suggestion. We have added a sentence to the Discussion explicitly highlighting that, unlike some vertebrates capable of using magnetic information in the absence of visual cues, moths require the integration of both magnetic and visual cues for accurate orientation. This clarification emphasizes the distinct multimodal nature of compass use in migratory moths.

      (c) It should be emphasised that this study addresses direction finding rather than full navigation.

      Thank you for this important clarification. We have now made it explicit in the manuscript that our experiments address direction finding (i.e., orientation) rather than full navigation. This distinction is stated in both the Introduction and Discussion to clearly define the scope of the study.

      (d) Future Directions should be integrated and consolidated into one coherent subsection proposing realistic next steps (e.g., more complex visual environments, temporal adaptation to cue-field relationships).

      Thank you for this constructive suggestion. We agree that outlining realistic next steps is valuable. However, given the limited scope of the current data, we have only slightly expanded the existing forward-looking statements in the Discussion.

      (e) The limitations should be better discussed, due to the artificiality of the visual cue earlier in the Discussion.

      Thank you for this comment. We agree that the artificiality of the visual cue is an important limitation of the present study. Rather than extending speculative discussion, we have clarified this limitation in the revised Discussion and highlighted the key questions that future work must address.

      Technical and open-science points

      Appropriate circular statistics should be used instead of t-tests for angular data shown in the supplementary material.

      Thank you for this comment. We have addressed this point (Fig. S1) in the revised supplementary material.

      Details should be provided on light intensities, power supplies, and improvements to the apparatus.

      Thank you. Light intensities are reported as spectral irradiance measurements in Supplementary Materials, which provide full wavelength-resolved information for the illumination used, although a separate measurement of total illuminance (lux) was not performed. We have also added the requested information on the power supplies.

      The derivation of individual r-values should be clarified.

      Thanks. We have clarified in the revised manuscript.

      Share R code openly (e.g., GitHub).

      Thanks. We are in the process of organizing the relevant R code, but have not been able to upload it to GitHub before the current revision deadline. The code is available from the corresponding author upon request.\

      Some highly relevant - yet missing - recent and relevant citations should be added, and some less relevant ones removed..

      Thanks. We added one recent relevant reference to the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      This work provided experimental evidence on how geomagnetic and visual cues are integrated, and visual cues are indispensable for magnetic orientation in the nocturnal fall armyworm.

      Strengths:

      Although it has been demonstrated previously that the Australian Bogon moth could integrate global stellar cues with the geomagnetic field for long-distance navigation, the study presented in this manuscript is still fundamentally important to the field of magnetoreception and sensory biology. It clearly shows that the integration of geomagnetic and visual cues may represent a conserved navigational mechanism broadly employed across migratory insects. I find the research very important, and the results are presented very well.

      We thank Reviewer #2 for the positive and encouraging evaluation of our study. We appreciate the recognition of our work’s strengths.

      Weaknesses:

      The authors developed an indoor experimental system to study the influence of magnetic fields and visual cues on insect orientation, which is certainly a valuable approach for this field. However, the ecological relevance of the visual cue may be limited or unclear based on the current version. The visual cues were provided "by a black isosceles triangle (10 cm high, 10 cm 513 base) made from black wallpaper and fixed to the horizon at the bottom of the arena". It is difficult to conceive how such a stimulus (intended to represent a landmark like a mountain) could provide directional information for LONG-DISTANCE navigation in nocturnal fall armyworms, particularly given that these insects would have no prior memory of this specific landmark. It might be a good idea to make a more detailed explanation of this question.

      We appreciate the constructive feedback on the weaknesses, which will guide and strengthen our revisions. To address the reviewer’s concern, we have added a brief note in the Discussion indicating that fall armyworms may encounter both static and dynamic luminance-based visual cues in nature, such as light–dark gradients created by terrain features or more stable celestial patterns. Although such natural cues differ from our simplified laboratory stimulus, they may represent intermittently sampled visual inputs that can be optimally integrated with magnetic information, whether the cues are static or changing, and brief periods without them may still allow the subsequent recovery of a stable long-distance orientation strategy.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Major to Medium Suggestions

      (a) Reordering of Visual Cue Tests

      The manuscript currently presents cue-conflict experiments before the simpler "no visual cue" tests. For non-specialist readers, it would be more logical to start with the basic condition (no visual cues) and then move to progressively more complex ones. This provides a clearer and more logically sound narrative.

      For example, the results could first demonstrate that without visual cues, the moths fail to orient (both in darkness and uniform light), and then show that introducing a single salient cue (a triangle on the horizon) restores directed behaviour. This would help readers understand the logic of the progression and should be better integrated throughout the Results and Discussion.

      Thanks. We have responded this comment in Public Reviews.

      (b) Translating Key Findings to Realistic Scenarios (LL 333-344 or where suitable in Discussion, and mentioning that we utilised a reductionist principle first in Intro, but clearly articulated that it is very simplified)

      The main text (eg Discussion) should address how these findings translate to real-world conditions. The experimental design used a single, highly salient, and static cue, always aligned with the migratory direction. In nature, such a consistent landmark is unlikely-mountains or other features would shift position relative to the moth's trajectory as it flies.

      Key questions arise which need to be addressed:

      - How would the compass system adapt to changing landmark positions as the moth moves?

      - What happens when no landmarks are visible (e.g. over flat plains or cloudy nights)?

      - Would stellar or other cues take over in such cases? Your hypotheses, please.

      Addressing these points - and proposing specific future experiments (e.g. with transient or multiple visual cues)-would strengthen the ecological relevance of the findings and show a clear way forward.

      Thanks for your kind comments. We now explicitly state in the Introduction that our study employs a reductionist approach using a simplified visual environment to isolate magnetic-visual interactions. As the ecological questions raised by the reviewer cannot be addressed with the current dataset, we avoid extended speculation but have added brief clarification in the Discussion and addressed these points in the Public Reviews response. We also indicate that future work will need to examine the types of visual cues that can support magnetic orientation and how such cues couple with geomagnetic information.

      Technical and Methodological Points

      (a) Incomplete Methods Section

      Critical technical information (e.g. electromagnetic noise measurements) currently appears only in supplementary figure legends. All such details should be included in the main Methods section if the word count allows (or include a short section in the main text with reference to more details in the supplementary material).

      Thanks for your kind comments. We have addressed this as suggested in the Public Reviews.

      (b) Lighting Conditions

      Specify luminance levels (the amount of light emitted and passing through in quanta per unit of surface, eg m2) at the moth's eye and indicate whether spectral composition was consistent between treatments (with and without the visual cue).

      Thanks for your comments. We have responded to this point in the Public Reviews.

      (c) Figures

      - Increase font sizes on circular histograms.

      - Add compass labels (ideally magnetic North, mN, not south, etc, as it is usual in pertinent literature), sample sizes, and p-values on each panel.

      - Replace "magnetic South" (mS) indicators with magnetic North (mN) to align with convention.

      Thanks for your comments. We have responded to this point in the Public Reviews.

      (d) Migratory Expectations

      Include expected compass bearings for spring and autumn migrations (with citations) to relevant figures (Figure 2, 4, S2).

      Thanks for your comments. We have added the information that “We recently found that fall armyworms from the year-round range in Southwest China (Yunnan) exhibit seasonally appropriate migratory headings when flown outdoors in virtual flight simulators, heading northward in the spring and southward in the fall, and this seasonal reversal is controlled by photoperiod (Chen et al., 2023).” in Introduction. Thus, we didn’t offer expected seasonal compass bearings in Results section.

      (e) Add a map showing the experimental site and known migratory routes, clearly labelling spring vs fall routes. It would help justify expected headings.

      Thank you for this suggestion. At present, there are no experimentally validated migratory routes (e.g., through mark-release-recapture or tracking approaches) for the specific fall armyworm population used in our study. Because these routes have not been biologically confirmed, we didn’t offer a presumed migratory map that may imply unwarranted certainty.

      (f) Composition of Test Groups

      Indicate sex ratios and reproductive status (mated/unmated) of tested moths, if known or comment if unknown, as both can affect migratory motivation and behaviour.

      Thank you for this suggestion. We have responded to this point in the Public Reviews.

      (g) Role and Nature of Visual Cues

      While the results clearly show that orientation disappears without visual cues, the triangle cue is highly artificial. Well-studied Bogong moths are known to rely on views of Australian mountain ranges during their nocturnal migrations, but there is no evidence that armyworms use a similar strategy. Even for bogongs, it is not just one salient mountain always in front of them on migration. Discuss whether Fall Armyworm would encounter comparable natural cues in the field along their migratory route, or whether the triangle might simply provide a frame of reference rather than a true landmark.

      Thank you for this comments. We have responded to this point in the Public Reviews.

      (h) Future work could test:

      - More naturalistic sky cues (moonlight, star fields).

      - Varying the landmark's position relative to the magnetic field - slowly moving along - transient landmarks. Also, less salient landmarks and a more complex skyline, as it is usually more complex than just a single salient peak.

      Thank you for this comments. We have responded to this point in the Public Reviews. Brief discussion as suggested has been added to the revised manuscript.

      Minor Comments and Line-by-Line Suggestions

      L70 - Check citation (possibly Mouritsen 2018). Missing in the list of references.

      Thanks. This point has been addressed.

      L75 - Consider citing the new and highly relevant preprint:

      Pakhomov, A., Shapoval, A., Shapoval, N., & Kishkinev, D. (2025). Not All Butterflies Are Monarchs: Compass Systems in the Red Admiral (Vanessa atalanta). bioRxiv.

      Thanks. We have cited this reference.

      LL81-82 - Clarify vague phrasing; specify criteria for "good" vs "poor" orientation ability. Or reword/leave out.

      Thanks for your comments.

      L85 - "but one," not "bar one." 

      Thanks. Corrected.

      L124 - The 2 genetic citations are weakly linked to magnetoreception. We do not have a clear understanding of the insect magnetoreceptor and its underlying mechanism, so we simply cannot interpret genetic associations very well to underpin them to magnetoreception. For example, does noctuid's magnetic sense require a magnetised-based receptor and genes involved in biomineralization? Consider removing or softening claims. 

      Thanks. Adressed.

      LL123-126 - Define what for YOU constitutes "strong evidence" for magnetoreception (e.g. adaptive directional behaviour consistent with migratory orientation?). Is there such a thing as strong evidence at all?

      Thanks for your comments. We agree that terms such as “confirmed” or “strong evidence” can overstate the certainty of magnetoreception findings, given the ongoing debates in the field. In the revised manuscript, we have toned down.

      L153 - Indicate whether coils in NMF condition were powered or inactive.

      Thanks for your comments. Addressed.

      L163 - Justify use of multiple 5-min phases (e.g. temporal resolution of behaviour). It is confusing at the start, where first mentioned, and becomes clearer only towards the end, but it should be clearer at the start.

      Thanks for your comments. The assay was divided into these 5-min segments to provide the temporal resolution needed to detect changes in flight orientation as the relative alignment of magnetic and visual cues was systematically altered. We now clarify this earlier in the Results.

      LL167-171 - This is a good place where you can provide a map (main or supplementary with referencing) showing the study site and migration routes.

      Thanks for your suggestion. We have responded to this point in the Public Reviews.

      L174 - Avoid repetition of "expected."

      Thanks. Addressed.

      LL176-177 - Report 95% confidence intervals or equivalent and clarify which test (e.g. Moore's paired test) each p-value refers to.

      Thanks for your suggestion.

      LL189-191 - explain what fatigue means. I would remove fatigue and substitute it with "lowered flight activity". Also, the same statement comes later, so avoid repetitiveness and remove it in one place. The analysis of directedness is good throughout, but what about the analysis of activity level? Could you explain whether you did it or not, and if not, why, or if angular changes can serve as an activity proxy? Replace "fatigue" with "reduced flight activity." Avoid repetition. Clarify if activity level analysis was performed or if it was not, e.g. due to technical difficulties.

      Thanks for your comments. We have responded to this point in the Public Reviews.

      L196 - Note whether 95% CI overlaps with the expected direction. This is a crucial outcome.

      Thanks for your comments.

      LL203-205 - unclear, better to stick to "congruency", especially "initial congruency for the relationship between mN and visual cue" throughout.

      Thanks for your suggestions.

      L206 - Better to introduce a new subheading: "Laboratory-Reared Animals.".

      Thanks for your suggestion. A new subheading has been added in the revised manuscript.

      LL207-208 - Clarify which cues were available in Chen et al. (2023) and how they differ here.

      Thanks for your comments. In Chen et al. (2023), the moths oriented under an artificial starry sky together with optic flow cues. In contrast, our experiments intentionally removed both the starry-sky pattern and optic flow to avoid introducing additional visual information when testing magnetic-visual integration for orientation. We have added further clarification regarding the conditions used in Chen et al. (2023) in the revised manuscript.

      L228 - Use "lab-reared" consistently throughout the entire MS. Do not mix with lab-raised.

      Thanks. Addressed by consistently using “lab-raised”.

      Figure 2 - Confusing in parts, especially for people coming from birds and other vertebrates orientation background. At 12 o'clock, you usually expect either mN / gN (magnetic or geographic North) or the animal's own initial directional response used as control to compare the same animal's direction post-treatment. Here, your 6 o'clock is magnetic South in the first place - non-conventional. At 12 o'clock, better use mN or gN. Avoid using non-conventional references such as magnetic south. Remind readers of seasonally appropriate headings and refer to the map.

      Thanks. We have responded to this point in the Public Reviews.

      LL232-234 - Emphasize that cue-magnetic congruency is key. Highlight the most important point that the congruency between the seasonal migratory direction and visual cues is key, not that in spring/fall, visual cues must be towards or opposite to the migratory goal. But the visual cue could be in the migratory direction or opposite, or at an angle - this is for future direction.

      Thanks. We have responded to this point in the Public Reviews.

      Figure 2 and associated main text - highlight that you only tested the designs when in all seasons the salient and single visual cue was in the migratory direction (in spring it coincided with mN but in fall it was towards the magnetic south). Other directions of visual cues have not been tested, but for simplicity and consistency, you chose to do these ones as the first step, perhaps.

      Thank you for this insightful comment. Yes, our experiments tested only the conditions in which the salient and single visual cue was aligned with the migratory direction. Other angular relationships between visual cues and the magnetic field were not examined in this study. For simplicity and consistency, we focused on this alignment as a first step toward understanding magnetic-visual cue integration in migratory orientation. We now highlight this in the Fig. 2 legend.

      Figures captures/legends - hard to tell from the main text now, better to italicize figure caption text and visually space them from the main text.

      Thanks for your suggestions.

      LL 250-251 - mention to people more familiar with r - lowercase - what is the expected range for R uppercase. It is not bound 0-1 as r. Could it be negative? How large can it be?

      Thanks. Thanks for the comment. After revisiting Moore (1980) we think that R* cannot take negative values. However, since R* = R*/N^ (3/2), it is not bounded between 0 and 1. We didn’t find any concept of an upper bound in the paper (https://doi.org/10.2307/2335330).

      Figure 3 - Consider adding a horizontal line indicating the 5% significance threshold.

      Thanks for your suggestions.

      L 261 - need to have some narrative after the subheading before you insert Figure 3.

      Thanks. Addreseed.

      LL274-275 - highlight that the timeline of this congruency between mN and a landmark and the effect of this on directedness is not explored here, but worth doing in future. How long does a new congruency or a relationship between mN and a visual cue need to be exposed to the animal to regain its directional response? Clearly, it is just a question of time of exposure so that a new association is established. Suggest future work on time-dependent adaptation to new cue-field relationships.

      Thanks for your suggestion. We have now included this point as a future direction in the revised Discussion.

      Figure 4 & S4 - Replace letters with asterisks/brackets for significance. The use of the letter is confusing and unconventional.

      Thanks for your suggestion.

      Figure 4 caption - Clarify the main takeaway.

      Thanks for your suggestion.

      Figure 4 - bare minimum is confusing. I understand that you wanted to avoid "no visual cues" because, as long as the animal sees things, there are things to be used as visual cues, even if this is not the intention of the experimenter. However, it needs clarification and rewording. Better to be more specific, like "no black triangle and horizon were used, just the uniformly white cylinder", or something like that.

      Thanks for your comments. In our setup it accurately describes the intentional removal of both the black triangle and the horizon, leaving only the uniformly white cylinder as the visual environment. This wording was chosen to reflect the practical limitations of producing a perfectly symmetrical flight simulator under laboratory conditions, and we therefore prefer to retain the original phrasing.

      L328 - Remove Xu et al. (2021) citation (not relevant). This is an in vitro study with a protein which may not work exactly as it is claimed in the paper in vivo.

      Thanks. Citation removed.

      L349-350 - Clarify what "no visual cue" means (e.g., uniformly white cylinder, no horizon line). Include a photo or a schematic of the inner surface of the cylinder for this condition in the Supplementary Materials.

      Thanks. We have responded to this point in the Public Reviews.

      L380 & throughout - Replace "barely minimum visual cues" (BMVC) with "no visual cues", clarifying limitations in Methods, meaning that you can explain that absolutely no visual cues is practically impossible because, as long as there is light, animals can use some asymmetries as cues even if this is not the intention of the experimenter.

      Thank you for this comment. We have decided to retain the term “barely minimum visual cues (BMVC)” because it accurately describes our experimental condition, which is distinct from a true “no visual cues” environment. In the revised Figure legend, we now clarify that BMVC refers to conditions in which obvious visual cues (i.e., features such as the black triangle in Fig. 1) were removed, while acknowledging that complete elimination of all visual information is not possible under illuminated conditions.

      L396 - Be cautious when generalizing from two species tested by a research group that is not absolutely independent (some authors in bogong and armyworm works overlap). We saw examples in diurnal migratory butterflies (Monarchs), a more studied species than the armyworm, that the findings do not entirely translate to Red Admirals (Pakhomov et al. 2025 preprint mentioned). Suggestion to tone down any claims of broad generalisation throughout the manuscript.

      Thank you for this comment. We have responded to this point in the Public Reviews.

      LL402-407 - Note that, unlike birds (e.g. European robins), moths appear to require both magnetic and visual cues for orientation, whereas birds, mole rats and some other animals can use magnetic cues alone.

      Thank you for this comment. We have responded to this point in the Public Reviews.

      L410 - Specify that this is correct only in the Northern Hemisphere.

      Thank you for this comment. Addressed.

      LL415-416 - Acknowledge artificiality of single-cue setup (see the major comments above); integrate earlier in the Discussion.

      Thank you for this comment. We have responded to this point in the Public Reviews.

      LL420-425 - Consolidate Future Directions into a single subsection; include more concrete experimental ideas, for example, using more naturalistic, numerous transient landmarks (could be done in a virtual maze with LEDs on the wall of the cylinder with cues moving with time). Multiple visual cues. Manipulating with salience of cues - less simplistic, less salient.

      Thank you for this comment. We have responded to this point in the Public Reviews.

      L431 - Does this paper support this statement? I think it just tested the use of stellar cues in a zero magnetic field. It also dealt with direction finding, not navigation, which is a position-finding ability - a much more complex feat and might not be the ability of moths (requires further studies like with geographic and magnetic displacements, etc). Reword and check this. Show the distinction between direction finding and navigation.

      Thank you for this comment. We have reworded the relevant sentence to use “orientation” instead of “navigation”.

      L436-437 - Specify "global visual cues" (stellar, lunar, etc.) and merge all future directions into one coherent section.

      Thank you for this comment. Addressed.

      LL443-446 - A bit early to plan such studies because migratory direction could well be a complex multigenetic trait, so that you cannot approach it simply with the knock out of a single gene. The genetic basis of magnetic direction needs to be first demonstrated, which leads you to the Future Directions section.

      Thank you for this helpful comment. We fully agree that migratory direction is likely a complex multigenic trait, and our intention was not to imply that knocking out a single gene would be sufficient to explain magnetic or migratory orientation. Our statement aimed only to highlight that identifying candidate genes is an important first step toward understanding the genetic basis of magnetic orientation.

      Line 496 - Clarify whether optic flow was used (unlike previous studies).

      Thank you for pointing this out. Clarified.

      LL499-511 - Clarify the improvements done in Chen's system and their relevance.

      Thank you for pointing this out. We reworded this sentence “The Flash flight simulator system was developed based on the early design of the Mouritsen-Frost flight simulator and adapted for our experiments in Yuanjiang”.

      Line 531 - Report and compare light intensities between indoor and outdoor experiments.

      Thanks for this comment. Unfortunately, due to the sensitivity limits of our current equipment, we were unable to reliably measure outdoor light intensities at night. However, we did not perform any open-top outdoor flight-simulator experiments; instead, we used field-captured moths but conducted all behavioral tests indoors.

      L549 - Add make/model of power supplies.

      Thanks. Addressed.

      LL582-585 - Specify whether R code will be shared; recommend open access (e.g., GitHub, other open repositories). Reiterate the importance of open science and sharing all scripts. Also here, add citations to some studies where MMRT has been used recently.

      Thank you for this comment. We have responded to this point in the Public Reviews.

      Line 592 - Explain how individual r-values were derived from optical encoder data.

      Thank you for this comment. Addressed.

      L842-843 - t-tests are inappropriate for angular data; use circular tests (Watson-Williams, Mardia-Watson-Wheeler, etc.).

      Thank you for this comment. Addressed.

      L865 - Reword to avoid repetition of "fall." Example: "In field captured armyworms during fall migration".

      Thank you for this comment. Addressed.

      LL882-885 - Improve phrasing and language here. Confirming that - no colon after. "Both the acrylic plate and diffusion paper." Confirm relevance of spectra to moth visual sensitivity - add relevant citation to original studies showing that.

      Thank you for this comment. Addressed.

      L886 - Reword "uniform" - does not look uniform to me.

      Thank you for this comment. Addressed.

      Reviewer #2 (Recommendations for the authors):

      The first two sentences of the abstract ("The navigational mechanisms employed by nocturnal insect migrants remain to be elucidated in most species. Nocturnal insect migrants are often considered to use the Earth's geomagnetic field for navigation, yet the underlying mechanisms of magnetoreception in insects remain elusive") are somewhat redundant. The authors may consider rewriting them.

      Thank you for pointing this out. We have rewritten this opening to provide a more concise and non-repetitive introduction.

    1. Author response:

      We would like to thank the reviewers for their supportive comments which largely agree with our main finding that a heterogeneous population of dendritic cells and Th2-skewed macrophages interact with the PDPN+ niche at the cribriform plate during EAE neuroinflammation. Additionally, they have provided several meaningful critiques to our study which we are now working on addressing in a newly revised manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #2 (Public review):

      Summary:

      This paper formulates an individual-based model to understand the evolution of division of labor in vertebrates. The model considers a population subdivided in groups, each group has a single asexually-reproducing breeder, other group members (subordinates) can perform two types of tasks called "work" or "defense", individuals have different ages, individuals can disperse between groups, each individual has a dominance rank that increases with age, and upon death of the breeder a new breeder is chosen among group members depending on their dominance. "Workers" pay a reproduction cost by having their dominance decreased, and "defenders" pay a survival cost. Every group member receives a survival benefit with increasing group size. There are 6 genetic traits, each controlled by a single locus, that control propensities to help and disperse, and how task choice and dispersal relate to dominance. To study the effect of group augmentation without kin selection, the authors cross-foster individuals to eliminate relatedness. The paper allows for the evolution of the 6 genetic traits under some different parameter values to study the conditions under which division of labor evolves, defined as the occurrence of different subordinates performing "work" and "defense" tasks. The authors envision the model as one of vertebrate division of labor.

      The main conclusion of the paper is that group augmentation is the primary factor causing the evolution of vertebrate division of labor, rather than kin selection. This conclusion is drawn because, for the parameter values considered, when the benefit of group augmentation is set to zero, no division of labor evolves and all subordinates perform "work" tasks but no "defense" tasks.

      Strengths:

      The model incorporates various biologically realistic details, including the possibility to evolve age polytheism where individuals switch from "work" to "defense" tasks as they age or vice versa, as well as the possibility of comparing the action of group augmentation alone with that of kin selection alone.

      Weaknesses:

      The model and its analysis are limited, which in my view makes the results insufficient to reach the main conclusion that group augmentation and not kin selection is the primary cause of the evolution of vertebrate division of labor. There are several reasons.

      (1) First, although the main claim that group augmentation drives the evolution of division of labor in vertebrates, the model is rather conceptual in that it doesn't use quantitative empirical data that applies to all/most vertebrates and vertebrates only. So, I think the approach has a conceptual reach rather than being able to achieve such a conclusion about a real taxon.

      We appreciate the reviewer’s point that our model does not incorporate quantitative empirical data across vertebrate taxa. This is indeed a limitation and reflects the current lack of fine-scale datasets on task division, the influence of life-history traits, and the fitness consequences of different cooperative activities in vertebrates. One of our aims, however, is precisely to stimulate such empirical work by highlighting the value of examining division of labor in species inhabiting harsh environments, considering age/size/dominance structure when evaluating variation in cooperative activities, and incorporating defense behaviors more consistently into analyses of helping, especially since defenders are often overlooked relative to the classic helpers-at-the-nest that provision offspring. The model therefore remains directly relevant to vertebrate systems because it departs from insect-inspired approaches that focus on fitness outcomes based solely in maximizing colony productivity. Instead, it incorporates direct fitness benefits to group members, an essential feature of vertebrate cooperative breeding and of other systems with fertile “workers,” as we clarified in the discussion.

      (2) Second, I think that the model strongly restricts the possibility that kin selection is relevant. The two tasks considered essentially differ only by whether they are costly for reproduction or survival. "Work" tasks are those costly for reproduction and "defense" tasks are those costly for survival. The two tasks provide the same benefits for reproduction (eqs. 4, 5) and survival (through group augmentation, eq. 3.1). So, whether one, the other, or both helper types evolve presumably only depends on which task is less costly, not really on which benefits it provides. As the two tasks give the same benefits, there is no possibility that the two tasks act synergistically, where performing one task increases a benefit (e.g., increasing someone's survival) that is going to be compounded by someone else performing the other task (e.g., increasing that someone's reproduction). So, there is very little scope for kin selection to cause the evolution of labor in this model. Note synergy between tasks is not something unusual in division of labor models, but is in fact a basic element in them, so excluding it from the start in the model and then making general claims about division of labor is unwarranted. In their reply, the authors point out that they only consider fertility benefits as this, according to them, is what happens in cooperative breeders with alloparental care; however, alloparental care entails that workers can increase other's survival *without group augmentation*, such as via workers feeding young or defenders reducing predator-caused mortality, as a mentioned in my previous review but these potentially kin-selected benefits are not allowed here.

      We understand the reviewer’s concern that our model restricts the scope for kin-selected benefits by not including task-specific synergy effects—specifically, help that directly increases the survival of group members (e.g., load-lightening via feeding young, or predator defense that reduces mortality of breeders or offspring independently of group augmentation). We agree that such effects can occur in some cooperative breeders, and that they can, in principle, generate indirect fitness benefits. However, even when helpers increase the survival of breeders or reduce parental investment per offspring, these effects generally translate into higher breeder productivity—either via increased fecundity, increased survival to the next breeding attempt, or increased investment in subsequent broods. Thus, although we treat benefits in terms of enhanced breeder productivity, this formulation implicitly captures a range of help-related effects that ultimately improve the reproductive output of the breeders, including those mediated through increased survival. For this reason, we believe that the model remains relevant for vertebrate systems despite not representing each pathway separately.

      (3) Third, the parameter space is understandably little explored. This is necessarily an issue when trying to make general claims from an individual-based model where only a very narrow parameter region of a necessarily particular model can be feasibly explored. As in this model the two tasks ultimately only differ by their costs, the parameter values specifying their costs should be varied to determine their effects. In the main results, the model sets a very low survival cost for work (yh=0.1) and a very high survival cost for defense (xh=3), the latter of which can be compensated by the benefit of group augmentation (xn=3). Some limited variation of xh and xn is explored, always for very high values, effectively making defense unevolvable except if there is group augmentation. In this revision, additional runs have been included varying yh and keeping xh and xn constant (Fig. S6), so without addressing my comment as xn remains very high. Consequently, the main conclusion that "division of labor" needs group augmentation seems essentially enforced by the limited parameter exploration, in addition to the second reason above.

      As we have explained in previous revisions, the costs associated with work and defense are not directly comparable because they affect different fitness components: work costs reduce dominance, whereas defense costs reduce survival. Whether a particular cost is “high” or “low” can only be evaluated by examining the evolved reaction norms and identifying the ranges over which these norms change. For this reason, we focused on parameter ranges that actually generate shifts in reaction norms rather than presenting large regions of parameter space where nothing changes.

      We also reiterate that we did in fact explore broader parameter ranges than those shown in the main text. Additional analyses, including those specifically designed to identify conditions under which division of labor evolves under kin selection alone, are provided in the Supplementary Material. Specifically, Figure S1 addresses the point raised by the “need” of group augmentation benefits for defense to evolve, by increasing the baseline survival x<sub>0</sub>.

      We now include one additional figure in the Supplementary Material with a lower value for the benefit of group size (x<sub>n</sub> = 1 instead of x<sub>n</sub> = 3), and we extended the range of x<sub>h</sub> to include lower values (x<sub>h</sub> = 1). As we can see in Figure S7 and Table S8, group augmentation benefits are still the primary reason for individuals to group (see dispersal values). For low benefits of group augmentation, defense evolves in harsh environments in the absence of kin selection, and in benign environments when both direct and indirect fitness benefits take place. We have also now expanded the results section to include these last results. Note that we also checked even lower values for x<sub>h</sub> under the only kin selection implementation, with results being qualitatively similar, but chose not to include them in the manuscript since it is already a very long Supplementary Material. Here are the averages for two examples with x<sub>h</sub> = 0.1 and when we promote division of labor:

      Author response table 1.

      In short, the conclusion that division of labor requires group augmentation is not an artifact of limited parameter exploration. It arises because kin selection alone favors division of labor only under highly restrictive parameter combinations, whereas including direct fitness benefits substantially expands the conditions under which division of labor evolves. This pattern is consistent across the full set of parameter combinations we examined.

      (4) Fourth, my view is that what is called "division of labor" here is an overinterpretation. When the two helper types evolve, what exists in the model is some individuals that do reproduction-costly tasks (so-called "work") and survival-costly tasks (so-called "defense"). However, there are really no two tasks that are being completed, in the sense that completing both tasks (e.g., work and defense) is not necessary to achieve a goal (e.g., reproduction). In this model there is only one task (reproduction, equation 4,5) to which both helper types contribute equally and so one task doesn't need to be completed if completing the other task compensates for it; instead, it seems more fitting to say that there are two types of helpers, one that pays a fertility cost and another one a survival cost, for doing the same task. So, this model does not actually consider division of labor but the evolution of different helper types where both helper types are just as good at doing the single task but perhaps do it differently and so pay different types of costs. In this revision, the authors introduced a modified model where "work" and "defense" must be performed to a similar extent. Although I appreciate their effort, this model modification is rather unnatural and forces the evolution of different helper types if any help is to evolve.

      In previous models of division of labor in eusocial insects, the implicit benefit is also colony-level productivity (see Beshers & Fewell, 2001, for a review of division of labor in insects). Even in humans, division of labor functions as a means to increase efficiency toward achieving a shared goal. Our model adopts this same interpretation, as outlined in the Introduction, but extends it by considering that different tasks may impose different fitness costs, an aspect that has been largely overlooked in the existing literature. It is precisely because fitness outcomes are not fully shared among group members in vertebrates that distinguishing these cost structures matters. Unlike eusocial insects with sterile workers, vertebrate helpers can obtain direct fitness benefits, and the model explicitly accounts for these direct benefits—something absent from most insect-inspired approaches even when direct fitness benefits can also arise in some of those systems. Thus, our framework is not simply evolving “two types of helpers doing the same task,” but instead evolving specialization in different cooperative roles that carry different fitness consequences. It is therefore suitable for our model to treat contributions to breeder productivity as a common currency, while allowing individuals to specialize in different cost-distinct forms of help.

      Finally, regarding synergy: with the extension introduced in the previous revision, we now incorporate the requirement that multiple forms of help must be performed for the group to achieve maximal reproductive output. This directly addressed the reviewer’s concern about synergistic dependencies between tasks and aligns our framework with the kinds of complementarity highlighted in other models of division of labor.

      In summary, the structure of the model is consistent with both the theoretical literature on division of labor and the biological realities of vertebrate cooperative systems. We believe it is important for future models to explicitly consider the different fitness benefits and costs associated with distinct cooperative behaviors, and hope that our framework encourages more targeted empirical research on division of labor in vertebrates (e.g. inclusion of data on defense, life-history traits and environmental challenges) to better inform future modelling efforts.

      I should end by saying that these comments don't aim to discourage the authors, who have worked hard to put together a worthwhile model and have patiently attended to my reviews. My hope is that these comments can be helpful to build upon what has been done to address the question posed.

      We appreciate the reviewer’s thoughtful and constructive comments, as well as the time invested in evaluating our work. These insights have greatly helped us improve the clarity and overall quality of the manuscript. We hope that the revisions and additional clarifications we have provided adequately address all remaining concerns.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      The authors aimed to characterize neurocomputational signals underlying interpersonal guilt and responsibility. Across two studies, one behavioral and one fMRI, participants made risky economic decisions for themselves or for themselves and a partner; they also experienced a condition in which the partners made decisions for themselves and the participant. The authors also assessed momentary happiness intermittently between choices in the task. Briefly, results demonstrated that participants' self-reported happiness decreased after disadvantageous outcomes for themselves and when both they and their partner were affected; this effect was exacerbated when participants were responsible for their partner's low outcome, rather than the opposite, reflecting experienced guilt. Consistent with previous work, BOLD signals in the insula correlated with experienced guilt, and insula-right IFG connectivity was enhanced when participants made risky choices for themselves and safe choices for themselves and a partner.

      Strengths:

      This study implements an interesting approach to investigating guilt and responsibility; the paradigm in particular is well-suited to approach this question, offering participants the chance to make risky v. safe choices that affect both themselves and others. I appreciate the assessment of happiness as a metric for assessing guilt across the different task/outcome conditions, as well as the implementation of both computational models and fMRI.

      We thank Reviewer 1 for their positive assessment of our manuscript.

      Weaknesses:

      In spite of the overall strengths of the study, I think there are a few areas in which the paper fell a bit short and could be improved.

      We thank Reviewer 1 for their comments, which we have used to improve our manuscript. We hope that these changes address the issues raised by the Reviewer.

      (1) While the framing and goal of this study was to investigate guilt and felt responsibility, the task implemented - a risky choice task with social conditions - has been conducted in similar ways in past research that were not addressed here. The novelty of this study would appear to be the additional happiness assessments, but it would be helpful to consider the changes noted in risk-taking behavior in the context of additional studies that have investigated changes in risky economic choice in social contexts (e.g., Arioli et al., 2023 Cerebral Cortex; Fareri et al., 2022 Scientific Reports).

      We certainly agree that several previously published studies have relied on risky choice tasks with social conditions. In this revised version, we now mention these two studies in the substantially revised Introduction.

      (2) The authors note they assessed changes in risk preferences between social and solo conditions in two ways - by calculating a 'risk premium' and then by estimating rho from an expected utility model. I am curious why the authors took both approaches (this did not seem clearly justified, though I apologize if I missed it). Relatedly, in the expected utility approach, the authors report that since 'the number of these types of trials varied across participants', they 'only obtained reliable estimates for [gain and loss] trials in some participants' - in study 1, 22 participants had unreliable estimates and in study 2, 28 participants had unreliable estimates. Because of this, and because the task itself only had 20 gains, 20 losses, and 20 mixed gambles per condition, I wonder if the authors can comment on how interpretable these findings are in the Discussion. Other work investigating loss aversion has implemented larger numbers of trials to mitigate the potential for unreliable estimates (e.g., Sokol-Hessner et al., 2009).

      We agree that we have not clearly justified why we have taken two approaches to assess risk preferences. In short, while the expected utility approach is a more comprehensive method to model a participant’s choices, we had not sufficiently considered the need for the large number of trials required to fit such models when designing our experiment. Calculating the risk premium was the less comprehensive, simpler alternative that we could calculate for all participants. We have now mentioned this fact in the Results section. As the only difference in risk aversion across conditions was found in Study 1 using the expected utility method, which could only be successfully applied in a minority of participants, we believe that this difference should not be taken as a strong finding. We have now mentioned this fact in the revised Discussion.

      (3) One thing seemingly not addressed in the Discussion is the fact that the behavioral effect did not replicate significantly in study 2.

      We agree that we had not sufficiently discussed the fact that there were (slight but significant) differences in risk preferences between the Solo and Social conditions in Study 1 but not in Study 2. We now do so in the revised Discussion, and write the following:

      “Participants made slightly more risk-seeking choices when deciding for themselves than for both themselves and the partner in Study 1, but this difference disappeared in Study 2. The ρ parameter on which this finding in Study 1 is based could only be estimated in a minority of participants due to a relatively low number of trials, which suggests that this finding may not be very reliable. The simpler and more robust method (evaluation of a risk premium) showed no difference in risk aversion across conditions in either study. Overall, we believe that we do not have strong evidence of differences in risk preferences across conditions.”

      (4) Regarding the computational models, the authors suggest that the Reponsibility and Responsibility Redux models provided the best fit, but they are claiming this based on separate metrics (e.g., in study 1, the redux model had the lowest AIC, but the responsibility only model had the highest R^2; additionally, the basic model had the lowest BIC). I am wondering if the authors considered conducting a direct model comparison to statistically compare model fits.

      We agree that we should run formal, direct model comparison tests. We now ran likelihood-ratio tests which showed that the Responsibility model was the best. We now report this in the Results section, just below Table 1:

      “A likelihood ratio test (Equation 9) revealed that the Responsibility model fitted better than all the other models, including the Responsibility Redux model (Study 1: all LR ≥ 47.36, p < 0.0001; Study 2: all LR ≥ 77.83, p < 0.0001).”

      (5) In the reporting of imaging results, the authors report in a univariate analysis that a small cluster in the left anterior insula showed a stronger response to low outcomes for the partner as a result of participant choice rather than from partner choice. It then seems as though the authors performed small volume correction on this cluster to see whether it survived. If that is accurate, then I would suggest that this result be removed because it is not recommended to perform SVC where the volume is defined based on a result from the same whole-brain analysis (i.e., it should be done a priori).

      As indicated in the manuscript, the small insula cluster centered at [-28 24 -4] and shown in Figure 4F survived corrections for multiple tests within the anatomically-defined anterior insula (based on the anatomical maximum probability map described in Faillenot et al., 2017), which is independent of the result of our analysis. Functionally defining the small volume based on the same data would indeed be circular and misleading “double-dipping”. We have most certainly NOT done this. The reason why we selected the anterior insula is because it is one of the regions most frequently associated with guilt (see the explanations in our Introduction, which refers for example to Bastin et al., 2016; Lamm & Singer, 2010; Piretti et al., 2023). Thus we feel that performing small-volume correction within the anatomically-defined anterior insula is a valid analysis. We fully acknowledge that, independently of any correction, the effect and the cluster are small. We now write:

      “We found a weak response in a small cluster within the left anterior insula (peak T = 3.95, d = 0.59, 22 voxels, peak intensity at [-28 24 -4]; Figure 4F). Given the documented association between anterior insula and guilt (see Introduction), we proceeded to test whether this result survived correction for family-wise errors due to multiple comparisons restricted to the left anterior insula gray matter [defined anatomically and thus independently from our findings, as the anterior short gyrus, middle short gyrus, and anterior inferior cortex in an anatomical maximum probability map (Faillenot et al., 2017)]. This correction resulted in a p value of 0.024. This result, although it is only a small effect in a small cluster, is consistent with the mixed model analysis reported earlier.”

      Reviewer #2 (Public review):

      Summary

      This manuscript focuses on the role of social responsibility and guilt in social decision-making by integrating neuroimaging and computational modeling methods. Across two studies, participants completed a lottery task in which they made decisions for themselves or for a social partner. By measuring momentary happiness throughout the task, the authors show that being responsible for a partner's bad lottery outcome leads to decreased happiness compared to trials in which the participant was not responsible for their partner's bad outcome. At the neural level, this guilt effect was reflected in increased neural activity in the anterior insula, and altered functional connectivity between the insula and the inferior frontal gyrus. Using computational modeling, the authors show that trial-by-trial fluctuations in happiness were successfully captured by a model including participant and partner rewards and prediction errors (a 'responsibility' model), and model-based neuroimaging analyses suggested that prediction errors for the partner were tracked by the superior temporal sulcus. Taken together, these findings suggest that responsibility and interpersonal guilt influence social decision-making.

      Strengths

      This manuscript investigates the concept of guilt in social decision-making through both statistical and computational modeling. It integrates behavioral and neural data, providing a more comprehensive understanding of the psychological mechanisms. For the behavioral results, data from two different studies is included, and although minor differences are found between the two studies, the main findings remain consistent. The authors share all their code and materials, leading to transparency and reproducibility of their methods.

      The manuscript is well-grounded in prior work. The task design is inspired by a large body of previous work on social decision-making and includes the necessary conditions to support their claims (i.e., Solo, Social, and Partner conditions). The computational models used in this study are inspired by previous work and build on well-established economic theories of decision-making. The research question and hypotheses clearly extend previous findings, and the more traditional univariate results align with prior work.

      The authors conducted extensive analyses, as supported by the inclusion of different linear models and computational models described in the supplemental materials. Psychological concepts like risk preferences are defined and tested in different ways, and different types of analyses (e.g., univariate and multivariate neuroimaging analyses) are used to try to answer the research questions. The inclusion and comparison of different computational models provide compelling support for the claim that partner prediction errors indeed influence task behavior, as illustrated by the multiple model comparison metrics and the good model recovery.

      We thank the reviewer very much for their comprehensive description of our study and the positive assessment of our study and approach.

      Weaknesses

      As the authors already note, they did not directly ask participants to report their feelings of guilt. The decrease in happiness reported after a bad choice for a partner might thus be something else than guilt, for example, empathy or feelings of failure (not necessarily related to guilt towards the other person). Although the patterns of neural activity evoked during the task match with previously found patterns of guilt, there is no direct measure of guilt included in the task. This warrants caution in the interpretation of these findings as guilt per see.

      We fully agree that not directly asking participants about feelings of guilt is a clear limitation of our study. While we already mention this in our Discussion, we have expanded our discussion of the consequences on the interpretation of our results along the lines described by the reviewer in the revised manuscript. We would like to thank the reviewer for proposing these lines of thought, and have now made the following changes to the text:

      In the first paragraph of the discussion, we now write: “Being responsible for choosing a lottery that yielded a low outcome for a partner made our participants feel worse than witnessing the same outcome resulting from their partner’s choice, which we interpret as interpersonal guilt; although we note that we have not asked participants specifically about which emotion they felt in these situations.

      Later on, in the third paragraph focusing on the anterior insula, we now write: “This replicates a large body of evidence associating aIns with feelings of guilt evoked during social decisions (see Introduction). Because we have neither asked our participants specifically what they felt in these situations, nor specifically whether they experienced guilt, we cannot exclude the possibility that they have instead or in addition felt empathy for their partner, a feeling of failure or bad luck, or some other emotion.”

      As most comparisons contrast the social condition (making the decision for your partner) against either the partner condition (watching your partner make their decision) or the solo condition (making your own decision), an open question remains of how agency influences momentary happiness, independent of potential guilt. Other open questions relate to individual differences in interpersonal guilt, and how those might influence behavior.

      How agency influences momentary happiness or variations thereof during the course of an experiment such as ours is an interesting question in itself. We now ran linear mixed models assessing agency (i.e. we compared happiness in conditions Solo & Social conditions vs. Partner condition), which revealed lower happiness in Solo and Social conditions (i.e. when it was the participant’s turn to decide) in both studies. This is interesting in itself and may reflect the drive behind responsibility aversion reported by Edelson et al.’s 2018 study: being assigned the role of the decider in a social setting may make people slightly unhappy, perhaps due to “weight of the responsibility”. We now report these findings in the Results section, including this proposed explanation; because we were not specifically interested in responsibility aversion, we do not discuss this further in the Discussion. The edited text is under the new subsection entitled ‘Momentary happiness: effects of agency, responsibility and guilt’, on page 12:

      “Next, we assessed whether happiness varied depending on the participant’s agency (Social + Solo vs. Partner), and found happiness to be lower when the participant chose, independent of the outcome (Study 1: t(3600) = -3.92, p = 0.00009, β = -0.14, 95% CI = [-0.20 -0.07]; Study 2: t(2870) = -6.07, p = 0.000000001, β = -0.24, 95% CI = [-0.31 -0.16]). . This is interesting in itself and may reflect the drive behind responsibility aversion reported by Edelson et al.’s 2018 study: being assigned the role of the decider in a social setting may make people slightly unhappy, perhaps due to “weight of the responsibility”. To specifically search for a sign of interpersonal guilt, [...]”

      Regarding individual differences: this is a very interesting topic that we have not addressed here due to the (relatively) small number of participants in our studies, but we might consider this for future follow-up studies, which we mention in the Discussion paragraph regarding open questions.

      This manuscript is an impressive combination of multiple approaches, but how these different approaches relate to each other and how they can aid in answering slightly different questions is not very clearly described. The authors could improve this by more clearly describing the different methods and their added value in the introduction, and/or by including a paragraph on implications, open questions, and future work in the discussion.

      We thank the reviewer for their appreciation of our complementary approach, and agree that we had not sufficiently explained the reasons why we used several methods. We have now added a paragraph explaining this at the end of the Introduction (page 5):

      “We analysed our behavioural data using several complementary methods: choices were modelled with mixed-effects regressions serving as manipulation checks; risk preferences expressed in choices were assessed using a comprehensive expected utility model as well as with a simpler, more robust “risk premium” approach; and happiness data were fitted, in addition to the computational models, with several linear mixed models to assess the impact of both the participant’s and their partner’s rewards, the impact of agency and their interactions. Inspired by findings reported in previous neuroimaging of social emotions, we also used several methods to analyse our fMRI data, including conventional methods (both region-of-interest and mass univariate); mixed-effects regression models; computational model-based analyses (inspired by e.g. Konovalov et al., 2021; Rutledge et al., 2014); and functional connectivity (e.g. Edelson et al., 2018; Konovalov et al., 2021). The behavioural modelling is thus complemented by neuroimaging analyses that offer insight about both the activity in regions associated with guilt as well as their place in a wider network, providing an in-depth comprehensive analysis of the mechanisms behind guilt evoked by social responsibility.”

      In addition, as suggested we added the following paragraph on open questions and future work in the Discussion:

      “Several open questions remain at the end of this study. As discussed above, asking participants directly about which emotions they have felt during the different stages of this task would allow us to link subjective experience with our analytical measures. Testing more participants would allow us to assess the impact of inter-individual variations in personality traits on the experience as well as the behavioural and neural correlates of guilt and responsibility. Using more trials in the experiment would allow separate modelling of risk preferences in gain and loss trials in each experimental condition using expected utility models, and could allow testing whether changes in momentary happiness affect subsequent choices. Varying partner identities (friends, strangers, artificial agent) could reveal the impact of social discounting on guilt and responsibility. In sum, we believe that this experimental approach lends itself very well to the study of several aspects of social emotions.”

      However, taken together, this study provides useful insights into the neural and behavioral mechanisms of responsibility and guilt in social decision-making and how they influence behavior. 

      We thank the reviewer again for their appreciation of our work and hope that our revisions improved the manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The majority of my suggestions are in the public review, so I will not repeat them here. But in general, I like the paper, and in addition to my other comments, I think that there should be more discussion of the potential limitations of the study and conclusions that can be drawn. I also thought parts of the results were a little hard to follow, particularly in the 'momentary happiness' section. Perhaps an additional subsection here might help with flow.

      We agree that we could have discussed further the limitations of our study and the conclusions that can be drawn from it, which we have now done in the last paragraphs of the Discussion in this revised version.

      To improve the structure of the section on ‘momentary happiness’, we separated this section into two, entitled: ‘Momentary happiness: links to reward‘ and ‘Momentary happiness: effects of agency, responsibility and guilt’, which should facilitate the reading of this long section. We proceeded in a similar manner for the Choices section, which is now subdivided into ‘Choices: manipulation check’ and ‘Choices: risk preferences’. We believe that these changes have indeed improved the readability of our manuscript.

      Reviewer #2 (Recommendations for the authors):

      Overall, I believe this manuscript was well-designed, consists of extensive analyses, and provides interesting new insights into the mechanisms underlying social decision-making. I mostly have some clarifying questions and minor comments, which are described below. 

      (1) Integration of prior findings in the first paragraphs of the Introduction. Although all the previous work described in the 2nd-5th paragraph introduction is interesting, it felt a bit like an enumeration of findings rather than an integrated introduction leading to the current research question. At the end of paragraph 5, it becomes clear how these findings relate to the current research question, but I believe it will improve the flow and readability of the introduction if this becomes clear earlier on.

      We agree that we could have integrated the cited previous work into the Introduction so that the text builds up to the research question. We have now extensively reworked several paragraphs in the Introduction (pages 3-5) and hope that these changes have made it easier to follow.

      (2) For the risk attitudes (Choices), you describe pooling the gains and losses and then comparing the social and solo conditions. I was wondering whether you also looked at potential differences between gains and losses (delta measure) for social versus the solo condition (so a comparison of the delta). Based on prior work, I can imagine that the difference in risk attitudes for gains and losses might differ when making decisions for yourself versus when you're doing it for a partner. In general, I was wondering how you explain these findings, as there is also a lot of work showing differences in risk-taking patterns for gains and losses.

      We agree that we could have compared delta measures between solo and social conditions. However, as we describe in the Results section and comment on in the Discussion, the relatively low number of trials made separate fitting of gain and loss trials across conditions difficult. While this question could thus be addressed in subsequent versions of our experiment with more trials, such a fine-grained analysis of the decisions was not the focus of our current study.

      (3) On page 11, you state: "in particular the partner's reward prediction errors resulting from the participants' decisions, i.e. those pRPE for which participants were responsible." From the results described in the paragraph above, this doesn't become clear (e.g., there's no distinction made between social_pRPE and partner_pRPE in the text), as it only discusses differences in weights between pRPE and sRPE. I would recommend including some more information in the main text on these main modeling findings, so one doesn't have to go to the Supplemental Materials to understand them.

      We did indeed fail to report these findings in the text! We thank the reviewer for pointing this out. We have now edited this passage as follows:

      “Crucially, we find here that the partner’s reward prediction errors (social_pRPE and partner_pRPE) contributed to explaining changes in participants’ momentary happiness: the Responsibility and ResponsibilityRedux models explained the data better than the models without these parameters (see Table 1). In particular, the partner’s reward prediction errors resulting from the participants’ decisions (social_pRPE), i.e. those pRPE for which participants were responsible, contributed to explaining our data (weights for social_pRPE were greater than 0: Responsibility model: Study 1: Z = 2.85, p = 0.004, Study 2: Z = 3.26, p = 0.001; Responsibility Redux model: Study 1: Z = 2.93, p = 0.003, Study 2: Z = 3.30, p = 0.001; weights for social_pRPE tended to be higher than weights for partner_pRPE: Responsibility model: Study 1: Z = 2.14, p = 0.033; Study 2: Z = 1.41, p = 0.16).”

      (4) The functional connectivity findings seem to come out of nowhere and are not introduced or described anywhere prior in the manuscript. It is therefore not completely clear why you conducted these analyses, or what they add above and beyond previous analyses. Already introducing this method earlier on would fix that.

      We agree that we could have introduced functional connectivity analyses earlier in the text, particularly given the many previous studies in our field using this technique. We have now done this at the end of a new last paragraph of the Introduction:

      “Inspired by findings reported in previous neuroimaging of social emotions, we also used several methods to analyse our fMRI data, including conventional methods (both region-of-interest and mass univariate); mixed-effects regression models; computational model-based analyses (inspired by e.g. Konovalov et al., 2021; Rutledge et al., 2014); and functional connectivity (e.g. Edelson et al., 2018; Konovalov et al., 2021). The behavioural modelling is thus complemented by neuroimaging analyses that offer insight about both the activity in regions associated with guilt as well as their place in a wider network, providing an in-depth comprehensive analysis of the mechanisms behind guilt evoked by social responsibility.”

      (5) For the functional connectivity findings: I was wondering why you only looked at the choice phase, and not at the feedback phase. I understand that previous work focused on the choice phase, but for the purpose of this study (focus on guilt), I can imagine it is also interesting to see what happens with feedback. In the discussion, you also state "How we feel when we witness our decisions' consequences on others is an important signal to consider when attempting to make good social decisions." (p. 19), which is more focused on the feedback rather than choice, and also supports the idea that looking at the feedback moment might be relevant.

      We agree that we could also have looked at the functional connectivity during the feedback phase. The main reason why we had originally not done so was time constraints. At the current time we would in addition point out that the manuscript is already very long and contains many analyses of behavioural and fMRI data. Adding this analysis would cost additional time and would further delay the publication of our manuscript, which we would prefer to avoid. However, one could of course look at these effects in subsequent analyses of the same data or in subsequent versions of this experiment. We have now mentioned this in the Discussion, in the paragraphs on open questions.

      Minor comments:

      (1) For some of the Figures, it would be helpful if the subtitles were more informative. For Figure 2 and Figure 3 for example, it would be nice if Study 1 and Study 2 were not only mentioned in the figure description but also in the actual figure. For Figures 3 and 4, it would be helpful to have significance stars for the bar plots as well.

      We agree that these changes make the figures more easily understandable and have implemented them all, except for adding stars on Figure 4, because all bar plots in panels C and E would have been labeled with two or more stars, which would have made the figure difficult to read. We have now mentioned the fact that all these coefficients were significant in the figure legend.

      (2) For some of the Supplementary Results, it would be very helpful if there was a legend or description. This is already the case for most of the SR, but not for all.

      We have now added a legend to all elements of the Supplementary Results.

      Some questions that came to mind while going through them:

      - Supplementary Table 1: which p-values correspond to the significance stars? This information is included for Supplementary Table 2, but not for ST1. 

      We have now added the missing information in ST1.

      - Supplementary Figure 1: do the colors correspond to different participants? 

      We have now specified that the colors do indeed correspond to different participants.

      - Supplementary Table 5 (final table): what do the - represent? As in, why is there no value for "run" for the MPFC? At first, I thought you only included the significant values, but then I noticed a few non-significant values as well, so it wasn't completely clear to me why some of the values were missing. This also applies to Supplementary Table 6.

      We have indeed forgotten to explain this. The ‘-’ in Supplementary Tables 4 and 6 indicate that the linear mixed model without the factor ‘run’ was the better-fitting one. We have now added the following explanation in the text accompanying Supplementary Table 4:

      “We tested these models both with and without the factor Run and associated interaction, and we report the best-fitting model in the table below: a dash (‘-’) in the row displaying parameters for the run and socialVsSolo:run regressors indicates that the model without factor run was better-fitting for this ROI.”

      (3) I came across a few minor typos or sentences that were not completely clear to me.

      - On page 3: "Patients with damage to ventromedial prefrontal cortex (vmPFC) seem insensitive to guilt when playing social economic games (Krajbich et al., 2009)." This sentence felt a bit out of nowhere and doesn't logically follow from the previous sentences. 

      We have now revised the descriptions of this previous study as well as several others and how they fit into the research question.

      - On page 3: "In another study, participant errors in a difficult perception task lead to a partner feeling pain and evoked activations in left aIns and dlPFC (Koban et al., 2013)." This sentence doesn't really flow, and from the wording, it is not completely clear whether it's the errors or the partner pain that led to the aIns and dlPFC activation.

      We have now revised the description of this study as well, as follows:

      “In another study, partners received painful stimuli when participants made errors during a difficult perception task. These errors evoked activations in the left aIns and dlPFC in the participants (Koban et al., 2013).”

      - Supplementary Figure 1: there is a missing period after the sentence "We then compared these new estimated parameters to the actual parameters from which the synthetic data were generated"

      We have now added a missing comma after “generated”.

      - On page 5: "We ran two experiments, Study 1 outside fMRI and Study 2 during fMRI, with separate groups of participants." I would change "outside fMRI" to outside the MRI scanner or something like that, as it's not completely correct to say "outside fMRI".

      We have changed the sentence to “outside the MRI scanner”.

      - On page 6: for the first result, there are currently two p-values reported (p < 2.5e-20 and p < 2e-16). I believe this is an error?

      This was indeed an error! We have re-run this analysis, noticed that also the degrees of freedom were miscalculated, and have updated this result and the effect of condition (solo vs social). Results are almost identical as previously and all conclusions hold. We have also checked the other analyses reported in this paragraph – all results replicate exactly.

      - On page 6: "Supplemental Table 1" should be "Supplementary Table 1" (for consistency).

      Done.

      On page 8: "participants in both conditions of both studies", I would change "of both studies" to "for both studies".

      Done.

      On page 8: for the "Momentary Happiness" paragraph, it would be helpful if you could briefly describe the Rutledge method here, for people who are unfamiliar with the approach.

      We now write the following at the beginning of this paragraph:

      “Following Rutledge and colleagues’ methodology, which considers that changes in momentary happiness in response to outcomes of a probabilistic reward task are explained by the combined influence of recent reward expectations and prediction errors arising from those expectations, we fitted computational models to each participant’s happiness data.”

      On page 10: "Wilkoxon sign-rank tests", should be "Wilcoxon".

      Done.

      We thank the reviewer for their careful reading of our manuscript. We believe that these changes have indeed improved our manuscript.

    1. Author response:

      We thank the reviewers for their thoughtful and constructive comments, which greatly helped us to clarify, quantify, and strengthen both our findings and interpretations. Below, we provide a point-by-point response to each comment and describe the corresponding changes made.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The manuscript by Rayan et al. aims to elucidate the role of RNA as a context-dependent modulator of liquid-liquid phase separation (LLPS), aggregation, and bioactivity of the amyloidogenic peptides PSMα3 and LL-37, motivated by their structural and functional similarities.

      Strengths:

      The authors combine extensive biophysical characterization with cell-based assays to investigate how RNA differentially regulates peptide aggregation states and associated cytotoxic and antimicrobial functions.

      Weaknesses:

      While the study addresses an interesting and timely question with potentially broad implications for host-pathogen interactions and amyloid biology, several aspects of the experimental design and data analysis require further clarification and strengthening.

      Major Comments:

      (1) In Figure 1A, the author showed "stronger binding affinity" based on shifts at lower peptide concentrations, but no quantitative binding parameters (e.g., apparent Kd, fraction bound, or densitometric analysis) are presented. This claim would be better supported by including: (i) A binding curve with quantification of free vs bound RNA band intensities ,(ii) Replicates and error estimates (mean {plus minus} SD).

      We thank the reviewer for this suggestion. To quantitatively support the binding differences observed in Figure 1A, we have now performed densitometric analysis of the EMSA data and included the results in Figure S1. The analysis showed that the Kd for PSMα3 binding to polyAU and polyA RNA is in the same order of magnitude but lower for the polyAU, indicating a stronger binding. A description was added to the results in lines 137-145 of the revised version.

      (2) The authors report droplet formation at low RNA (50 ng/µL) but protein aggregation at high RNA (400 ng/µL) through fluorescence microscopy. However, no intermediate RNA concentrations (e.g., 100-300 ng/µL) are tested or discussed, leaving a critical gap in understanding the full phase diagram and transition mechanisms.

      Our initial choice of 50 ng/µL (low RNA) and 400 ng/µL (high RNA) was guided by a broader RNA titration performed by turbidity measurements across 0, 10, 20, 50, 100, 200, and 400 ng/µL (Figure S2 in the revised version). In this screen, turbidity increased up to 50 ng/µL and then decreased dose-dependently from 100–400 ng/µL. We interpret this non-monotonic behavior as consistent with a transition from a dropletrich regime (maximal light scattering at intermediate dense-phase volume) toward conditions where assemblies become larger and/or more compact and sediment out of the optical path. This is described in lines 158-161 of the revised version.

      Of note, additional intermediate RNA conditions (100 and 200 ng/µL) are included in Figure S14 (of the revised version). While these experiments were performed under the heat-shock perturbation, they nevertheless support the central point that RNA tunes assembly state across intermediate concentrations rather than producing a binary low/high outcome.

      Importantly, we agree with the reviewer that a full phase diagram would be the most rigorous way to define the transition mechanism. However, establishing csat and constructing a complete phase diagram would require systematic measurements of dilute-phase concentrations (e.g., centrifugation/quantification or fluorescence calibration), controlled ionic strength titrations, and time-resolved mapping, which is beyond the scope of the present study. We have therefore revised the text to avoid implying that we provide a complete phase diagram. Instead, we frame our results as a qualitative with multi-assay characterization showing that RNA concentration drives a shift from liquid-like condensates (at low RNA) toward solid-like assemblies (at high RNA), with an intermediate regime suggested by the turbidity transition and supported by additional imaging under stress. Finally, to address the “critical gap” concern directly, we add a sentence (lines 239-241) stating that: “Future work will be required to quantitatively define the phase boundaries and delineate the dominant mechanisms, such as sedimentation, dissolution, or coarsening/aging, across intermediate RNA concentrations.

      (3) Additionally, the behaviour of PSMα3 in the absence of RNA under LLPS conditions is not shown. Without protein-only data, it is difficult to assess if droplets are RNA-induced or if protein has a weak baseline LLPS that RNA tunes. The saturation concentration (csat) for PSMα3 phase separation, either in the absence or presence of RNA, should be reported.

      In response to the reviewer’s request, we have added Figure 2F, which shows PSMα3 alone in the absence of RNA under the same conditions. PSMα3 does not form droplets in this condition, indicating that condensate formation is RNA-dependent in the tested conditions. This is referred to in the text in lines 190-193 of the revised version. Please see our response about determining the csat in the response to the previous comment.

      (4) For a convincing LLPS claim, it is important to show: Quantitative FRAP curves (mobile fraction and half-time of recovery) rather than only microscopy images and qualitative statements.

      We have included quantitative FRAP analysis in Figure S4 of the revised version, showing normalized recovery curves along with extracted mobile fractions and half-times of recovery (t₁/₂). These quantitative measurements support the dynamic nature of the PSMα3–RNA. This is referred to in the text in lines 179-184 of the revised version.

      (5) The manuscript highly relies on fluorescence microscopy to show colocalization. However, the colocalization is presented in a qualitative manner only. The manuscript would benefit from the inclusion of quantitative metrics (e.g., Pearson's correlation coefficient, Manders' overlap coefficients, or intensity correlation analysis).

      In response, we have added quantitative colocalization analysis to the revised manuscript. Specifically, we now report Pearson’s correlation coefficients and Manders’ overlap coefficients for the dual-channel fluorescence microscopy datasets in Figure S5 of the revised version. These metrics provide an objective measure of codistribution and complement the qualitative imaging.

      The analysis supports that at low RNA concentrations (droplet/condensate conditions), PSMα3 and RNA show strong colocalization, consistent with RNA being incorporated within, or closely associated with, the peptide-rich phase. In contrast, at high RNA concentrations, where the assemblies are more solid-like/amyloid-positive, the quantitative coefficients decrease, consistent with reduced overlap and an apparent spatial demixing in which RNA becomes partially excluded from the peptide-rich structures. This is referred to in the text in lines 194-203 of the revised version.

      (6) In Figures 3 B and 3C, the contrast between "no AT630 at 30 min, strong at 2 h" (50 ng/μL) and "strong at 30 min" (400 ng/μL) is compelling, but a simple quantification (e.g., mean fluorescence intensity per area) would greatly increase rigor.

      We have included quantitative analysis of AmyTracker630 fluorescence intensity in Figure S6 of the revised version, reporting the mean fluorescence intensity per area for the indicated conditions and time points. This quantification supports the qualitative differences observed in Figures 3B and 3C. This is now referred to in the text in lines 233-236 of the revised version.

      (7) In Figure S3 ssCD data, if possible, indicate whether the α-helical signal increases with RNA concentration or shows a non-linear dependence, which might link to the LLPS vs solid aggregate regimes.

      The ssCD spectra displayed in Figure S7 in the revised version (corresponding to Figure S3 in the original submission) show that the α-helical signature of PSMα3 is markedly enhanced in the presence of RNA compared to peptide alone, as evidenced by increased signal intensity, deeper minima, and more pronounced spectral features characteristic of α-helical structure. Importantly, this enhancement is more pronounced at 400 ng/µL Poly(AU) RNA than at 50 ng/µL, particularly after 2 hours of coincubation, indicating that RNA concentration influences the stabilization of α-helical assemblies. This is now more specifically detailed in the text in lines 258-263 of the revised version.

      We note that solid-state CD does not allow direct quantitative deconvolution of secondary structure content (e.g., % helix) in the same manner as solution CD, due to sample anisotropy, scattering, and orientation effects inherent to dried or aggregated films. Consequently, our interpretation is qualitative rather than strictly quantitative. The ssCD data therefore suggest a non-linear dependence on RNA concentration, rather than a simple linear dose–response. This is also expected considering that phase transition, suggested by the other findings, is intrinsically non-linear.

      (8) In Figure 5B, FRAP recovery in dying cells may reflect artifactual mobility rather than biological relevance. Additionally, the absence of quantification data limits interpretation; providing recovery curves would clarify relevance.

      We added quantitative FRAP analysis of the effect on PSMα3 within HeLa cells, shown in Figure S8 of the revised version. Compared to PSMα3 assemblies in vitro, nucleolar PSMα3 exhibits slower fluorescence recovery and a reduced mobile fraction. The nucleolus represents a highly crowded, RNA-rich cellular environment, which is expected to impose additional constraints on molecular mobility and likely contributes to the slower recovery kinetics observed in cells. This is now more specifically detailed in the text in lines 324-333 and discussed in lines 597-607 of the revised version.

      (9) The narrative conflates cytotoxicity endpoints (membrane damage, PI staining, aggregates) with localization data (nucleolar foci), creating ambiguity about whether nucleolar targeting drives toxicity or is a consequence of cell death. Separating toxicity assessment from localization analysis, or clearly demonstrating that nucleolar accumulation precedes cytotoxicity, would resolve this ambiguity.

      We thank the reviewer for raising this important point. We agree that, in the current dataset, cytotoxicity readouts (membrane damage, PI staining, aggregate formation) and subcellular localization (nucleolar accumulation) are observed in close temporal proximity, which limits our ability to unambiguously assign causality. In the experiments presented here, PSMα3 was applied at concentrations known to induce rapid membrane disruption and cytotoxicity in HeLa cells. Under these conditions, PSMα3 accumulates on cellular membranes and penetrates into the cell and nucleus on very short timescales (seconds to minutes), likely preceding the temporal resolution accessible by standard live-cell fluorescence microscopy. As a result, nucleolar accumulation and cytotoxic endpoints are detected essentially concurrently, precluding a definitive determination of whether nucleolar association actively drives toxicity or occurs as a downstream consequence of membrane permeabilization and cell damage.

      We therefore emphasize that, in this study, nucleolar localization is presented as a phenomenological observation consistent with RNA-rich compartment association, rather than as a demonstrated causal mechanism of cytotoxicity. We have revised the Discussion (lines 597-607) to clarify this distinction and to avoid implying that nucleolar targeting is the primary driver of cell death.

      We agree that resolving this ambiguity would require systematic time-resolved and concentration-dependent experiments, including analysis at sub-toxic PSMα3 concentrations below the membrane-disruptive threshold, combined with orthogonal imaging approaches. Such experiments are planned for future work but are beyond the scope of the present study.

      (10) In Figure 8, to strengthen the LLPS assignment for LL-37, additional evidence, such as FRAP analysis or observation of droplet fusion events, would be valuable. This is particularly relevant given that the heat shock conditions (65 °C for 15 minutes) could potentially induce partial denaturation or nonspecific coacervation.

      In response to this comment, we have added FRAP analysis of LL-37 assemblies in the revised manuscript (Figure S12), including representative images and corresponding fluorescence recovery curves. The FRAP measurements show minimal fluorescence recovery over the acquisition window, indicating that the LL-37–RNA assemblies formed under these conditions are largely immobile and solid-like, rather than liquid-like droplets. This is now referred to in the text in lines 458-462 of the revised version.

      Reviewer #2 (Public review):

      In this paper, Rayan et al. report that RNA influences cytotoxic activity of the staphylococcal secreted peptide cytolysin PSMalpha3 versus human cells and E. coli by impacting its aggregation. The authors used sophisticated methods of structural analysis and described the associated liquid-liquid phase separation. They also compare the influence of RNA on the aggregation and activity of LL-37, which shows differences from that on PSMalpha3.

      Strengths:

      That RNA impacts PSM cytotoxicity when co-incubated in vitro becomes clear.

      Weaknesses:

      I have two major and fundamental problems with this study:

      (1) The premise, as stated in the introduction and elsewhere, that PSMalpha3 amyloids are biologically functional, is highly debatable and has never been conclusively substantiated. The property that matters most for the present study, cytotoxicity, is generally attributed to PSM monomers, not amyloids. The likely erroneous notion that PSM amyloids are the predominant cytotoxic form is derived from an earlier study by the authors that has described a specific amyloid structure of aggregated PSMalpha3. Other authors have later produced evidence that, quite unsurprisingly, indicated that aggregation into amyloids decreases, rather than increases, PSM cytotoxicity. Unfortunately, yet other groups have, in the meantime, published in-vitro studies on "functional amyloids" by PSMs without critically challenging the concept of PSM amyloid "functionality". Of note, the authors' own data in the present study, which show strongly decreased cytotoxicity of PSMalpha3 after prolonged incubation, are in agreement with monomer-associated cytotoxicity as they can be easily explained by the removal of biologically active monomers from the solution.

      We thank the reviewer for this important critique and agree that direct cytotoxicity is most plausibly mediated by soluble PSM species, while extensive fibrillation generally reduces toxicity by depleting these forms, a conclusion supported by our data and by other studies (e.g., Zheng et al 2018 and Yao et al 2019). We do not propose mature amyloid fibrils as the primary toxic entities. Rather, we use the term functional amyloid in a regulatory sense, consistent with other biological amyloids whose fibrillar states modulate activity (e.g., hormone storage amyloids or RNA-binding proteins).

      In line with emerging findings, we interpret PSMα3 toxicity as arising from a dynamic assembly process rather than from a single static molecular species. We previously showed that PSMα3 forms cross-α fibrils that are thermodynamically and mechanically less stable than cross-β amyloids and readily disassemble upon heat stress, fully restoring cytotoxic activity (Rayan et al., 2023). This behavior contrasts with PSMα1, which forms highly stable cross-β fibrils that do not recover activity after heat shock, suggesting that the limited thermostability of PSMα3 is an evolved feature enabling reversible switching between inactive (stored) and active states.

      Consistent with this view, both PSMα1 and PSMα3 are cytotoxic in their soluble states, yet mutants unable to fibrillate lose activity, indicating that fibrillation is required but not itself the toxic end state (Tayeb-Fligelman et al., 2017, 2020; Malishev et al., 2018). Our other studies further show that cytotoxicity toward human cells correlates with inherent or lipid-induced α-helical assemblies, rather than with inert β-sheet amyloids (RagonisBachar et al., 2022, 2026; Salinas 2020, Bücker 2022). Together, these findings support a model in which membrane-associated, dynamic α-helical assembly, which requires continuous exchange between soluble species and growing fibrils, drives membrane disruption, potentially through lipid recruitment or extraction, analogous to mechanisms proposed for human amyloids such as islet amyloid polypeptide (Sparr et al., 2004).

      In the present study, we further show that RNA reshapes this dynamic landscape: while PSMα3 alone progressively loses activity upon incubation, co-incubation with RNA preserves cytotoxicity by stabilizing bioactive polymorphs and condensate-like states, whereas high RNA concentrations promote solid aggregation but nevertheless preserve activity. Thus, aggregation is neither inherently functional nor toxic, but context-dependent and environmentally regulated. Taken together, our data support a model in which PSMα3 amyloids act as a dynamic reservoir, enabling S. aureus to tune virulence by reversibly shifting between dormant and active states in response to environmental cues such as heat or RNA.

      This is now discussed in lines 56-76 and 523-553 of the revised version.

      (2) That RNA may interfere with PSM aggregation and influence activity is not very surprising, given that PSM attachment to nucleic acids - while not studied in as much detail as here - has been described. Importantly, it does not become clear whether this effect has biologically significant consequences beyond influencing, again not surprisingly, cytotoxicity in vitro. The authors do show in nice microscopic analyses that labeled PSMalpha3 attaches to nuclei when incubated with HeLa cells. However, given that the cells are killed rapidly by membrane perturbation by the applied PSM concentrations, it remains unclear and untested whether the attachment to nucleic acids in dying cells makes any contribution to PSM-induced cell death or has any other biological significance.

      We thank the reviewer for this important point and agree that PSM–nucleic acid interactions are not unexpected and that our data do not support a direct intracellular role for RNA binding in mediating cytotoxicity. Accordingly, we do not propose nucleolar or nuclear association of PSMα3 as a causal mechanism of cell death. At the concentrations used, PSMα3 induces rapid membrane disruption, and nucleic acid association is observed along with membrane attachment, precluding conclusions about intracellular function. This limitation is now explicitly clarified in the revised manuscript. The biological significance of our findings lies instead in extracellular and environmental contexts, where PSMα3 encounters abundant nucleic acids, such as RNA or DNA released from damaged host cells or present in biofilms as now addressed in lines 622631. Our data show that RNA modulates PSMα3 aggregation trajectories, shifting the balance between liquid-like condensates and solid aggregates, and thereby regulates the persistence and timing of cytotoxic activity. In this framework, RNA acts as a context-dependent regulator of virulence, rather than as an intracellular cytotoxic cofactor, an aspect which would be studied in depth in future work. This is now addressed in the text in lines 597-607 of the revised version.

      Reviewer #3 (Public review):

      Summary:

      The manuscript by Rayan et al. aims to investigate the role of RNA in modulating both virulent amyloid and host-defense peptides, with the objective of understanding their self-assembly mechanisms, morphological features, and aggregation pathways.

      Strengths:

      The overall content is well-structured with a logical flow of ideas that effectively conveys the research objectives.

      Weaknesses:

      (1) Figure 2 displays representative FRAP images demonstrating fluorescence recovery within seconds. To gain a more comprehensive understanding of how recovery after photobleaching varies under different conditions, it is recommended to supplement these images with corresponding quantitative fluorescence recovery curves for analysis.

      In response to this comment, we have supplemented the representative FRAP images with quantitative fluorescence recovery curves, reporting normalized recovery kinetics for the indicated conditions. These data are now provided in Figure S4 of the revised manuscript, allowing direct comparison of recovery behavior across conditions (shown by microscopy in Figure 2). In addition, we have included quantitative FRAP analyses for the cellular imaging shown in Figure 5 (presented in Figure S8) and for LL-37 assemblies formed under heat-shock conditions (Figure S12). Together, these additions provide a quantitative framework for interpreting the FRAP results and strengthen the distinction between liquid-like and solid-like assembly states.

      (2) Ostwald ripening typically leads to the shrinkage or even disappearance of smaller droplets, accompanied by the further growth of large droplets. However, the droplet size in Figure 2D decreases significantly after 2 h of incubation. This observation prompts the question, what is the driving force underlying RNA-regulated phase separation and phase transition?

      We thank the reviewer for this observation. Across multiple samples, we consistently observe a coexistence of small droplets and larger aggregates, rather than systematic growth of larger droplets at the expense of smaller ones or a uniform decrease in droplet size. In addition, the timescales examined do not allow us to reliably assess whether diffusion-driven droplet coalescence is fast enough to draw firm conclusions about droplet size evolution. This is now addressed in the text in lines 181-184 of the revised version.

      A decrease in droplet size over time is nevertheless observed in some instances and is more consistent with a time-dependent conversion of initially liquid-like condensates into more solid-like assemblies, which would reduce molecular mobility and suppress droplet coalescence. In parallel, progressive fibril formation may act as a sink for soluble peptide, leading to partial dissolution or shrinkage of less mature condensates. Together, these observations are consistent with a non-equilibrium aging process, in which RNAregulated assemblies evolve from dynamic condensates toward more solid structures rather than following equilibrium Ostwald ripening.

      (3) The manuscript aims to study the role of RNA in modulating PSMα3 aggregation by using solution-state NMR to obtain residue-specific structural information. The current NMR data, as described in the method and figure captions, were recorded in the absence of RNA. Whether RNA binding induces conformational changes of PSMα3, and how these changes alter the NMR spectra? Also, the sequential NOE walk between neighboring residues can be annotated on the spectrum for clarity.

      The solution-state NMR experiments were performed specifically to characterize the potential binding of EGCG to PSMα3. Due to the strong tendency of PSMα3 to undergo rapid aggregation and line broadening upon RNA addition, solutionstate NMR spectra in the presence of RNA could not be obtained at sufficient quality for residue-specific analysis. As suggested, we have updated and annotated the sequential NOE walk between neighboring residues on the relevant NOESY spectra to improve clarity.

      (4) The authors claim that LL-37 shares functional, sequence, and structural similarities with PSMα3. However, no droplet formation was observed of LL-37 in the presence of RNA only. The authors then applied thermal stress to induce phase separation of LL-37. What are the main factors contributing to the different phase behaviors exhibited by LL37 and PSMα3? What are the differences in the conformation of amyloid aggregates and the kinetics of aggregation between the condensation-induced aggregation in the presence of RNA and the conventional nucleation-elongation process in the absence of RNA for these two proteins?”

      We appreciate this important question and have clarified both the basis of the comparison and the origin of the divergent phase behaviors of LL-37 and PSMα3. While PSMα3 and LL-37 share key properties as short, cationic, amphipathic α-helical peptides that self-assemble and interact with nucleic acids, they differ fundamentally in their assembly architectures. PSMα3 is an amyloidogenic peptide that forms cross-α amyloid fibrils, in which α-helices stack perpendicular to the fibril axis. In contrast, LL-37 can form fibrillar or sheet-like assemblies (observed in cryo grids), but these lack canonical amyloid features without clear cross-α or cross-β amyloid order, as so far observed by crystal structures. This is now clarified in different parts of the text of the revised version. Thus, the comparison between the two peptides is functional and physicochemical rather than implying identical amyloid mechanisms. These structural differences likely underlie their distinct phase behaviors.

      Because LL-37 does not follow a classical amyloid nucleation–elongation pathway, and high-resolution structural information (e.g., cryo-EM) is currently lacking, partly due to its sheet-like, non-twisted morphology (unpublished results), it is not possible to directly compare aggregation kinetics or nucleation mechanisms between LL-37 and PSMα3. It is possible that amyloidogenic systems such as PSMα3 exhibit greater flexibility in prefibrillar and fibrillar polymorphism, enabling RNA-regulated phase behavior, whereas nonamyloid assemblies such as LL-37 are more prone to stress-induced solid aggregation. We note that this interpretation is necessarily tentative and does not imply a general rule, but rather reflects differences evident in the present system.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Reviewer #2 (Public review):

      This problem is evident in the presentation of the EAK specimens. In their response, the authors state that one EAK specimen shows "overlapping scars" and constitutes a "long bone flake"; however, these features are not clearly identifiable in the figures or captions as currently presented. The authors state that Figures S21-S23 clearly indicate human agency, including a long bone flake with overlapping scars and a view of the medullary surface, but it is unclear which specimens or surfaces these descriptions refer to. Figure S21 does appear to show green fracture and is described only as an "elephant-sized flat bone fragment with green-bone curvilinear break." Figure S22 shows the same bone and cortical surface in a different orientation, providing no additional information. In Figure S23, I cannot clearly identify a medullary surface or evidence of green-bone fracture from this image. None of these images clearly demonstrates overlapping scars, and the figures would be substantially improved by explicitly identifying the features described in the text. Even if both EAK specimens are accepted as green-broken, they do not demonstrate the co-occurrence of multiple diagnostic fracture traits such as multiple green breaks, large step fractures, hackle marks, and overlapping scars that the authors state is required to attribute dynamic percussive activity to hominins and address equifinality.

      We appreciate the reviewer’s careful evaluation of the EAK specimens. We acknowledge that the overlapping scars and medullary surface of the specimen originally shown in Figure S23 were not sufficiently clear. To address this, we have extensively revised Figure S23. In the updated Supplementary File, we have provided new annotations and line drawings that explicitly trace the outlines of the overlapping scars and clearly shows the green-bone fracture features. These enhancements ensure that the diagnostic traits discussed in the text are now directly identifiable in the visual record. This demonstrates the co-occurrence of traits: green-broken outlines and overlapping scars, which meet the criteria for identifying dynamic percussive activity. This is so following Reviewer´s 2 partial handling of our arguments; since we argued in our previous response that clear simple green-broken elephant long limb bones were an anthropogenic signature per se, given that currently no durophagous predator/scavenger (including spotted hyenas) are able to produce them. Additional secondary features like hackle marks are supportive but not necessary to attribute human agency.

      I appreciate that the authors are careful to state that spatial association between stone tools and fossils alone does not demonstrate hominin behavior, and that they treat the spatial analyses as supportive rather than decisive. While the association is intriguing, the problem is downstream: spatial association is used to strengthen an interpretation of butchery at EAK that still depends on fracture evidence that is not clearly documented at the assemblage level.

      The association is inferred (not demonstrated) by the strong statistical spatial association between lithics and bones. Additional taphonomic evidence (like cut marks or green-broken bones) do further support the inference but they do not demonstrate it, given the highly subjective nature of cut mark identification and the plethora of alternative scenarios: one green-broken bone would not demonstrate complete elephant butchery (it could result from a marginal exploitation of just that bone); one cutmarked bone could equally reflect several alternative access types to the remains. The reviewer recognized above the presence of green-broken elements at EAK; again, this supports anthropogenic agency better than any other alternative scenario, because one of the green-broken bones is a long bone and modern hyenas are not able to produce this kind of specimens.

      The critique concerning Nyayanga is not addressed in the revision. The manuscript proposes alternative explanations for the Nyayanga material but does not demonstrate why these are more plausible than the interpretation advanced by Plummer et al. (2023). I am not arguing that the Nyayanga material should be accepted as butchery; rather, showing that trampling is possible does not establish it as more probable than cut marks. In contrast, the EAK material is treated as evidence of butchery on the basis of evidence that, in my opinion, is more limited and less clearly demonstrated. Even if this is not the authors' intention, the uneven treatment removes an earlier megafaunal case from the comparison and strengthens the case for interpreting EAK as marking a behavioral shift toward megafaunal butchery by excluding other early cases.

      Again, it was never our intention to “demonstrate” anything. The reviewer is misusing this term. These types of arguments are epistemologically impossible to demonstrate. One can just discuss the heuristics of alternative scenarios. The point that we tried to make was that the Nyayanga purported cut marks on megafaunal remains are (as identified and published) impossible to differentiate from natural sedimentary abrasive marks (like trampling). Therefore, they cannot be argued to represent anthropogenic butchery on a secure basis. Especially, when they do not occur in conjunction with green-broken elements of clear dynamic loading nature.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors investigate how UVC-induced DNA damage alters the interaction between the mitochondrial transcription factor TFAM and mtDNA. Using live-cell imaging, qPCR, atomic force microscopy (AFM), fluorescence anisotropy, and high-throughput DNA-chip assays, they show that UVC irradiation reduces TFAM sequence specificity and increases mtDNA compaction without protecting mtDNA from lesion formation. From these findings, the authors suggest that TFAM acts as a "sensor" of damage rather than a protective or repair-promoting factor.

      Strengths:

      (1) The focus on UVC damage offers a clean system to study mtDNA damage sensing independently of more commonly studied repair pathways, such as oxidative DNA damage. The impact of UVC damage is not well understood in the mitochondria, and this study fills that gap in knowledge.

      (2) In particular, the custom mitochondrial genome DNA chip provides high-resolution mapping of TFAM binding and reveals a global loss of sequence specificity following UVC exposure.

      (3) The combination of in vitro TFAM DNA biophysical approaches, combined with cellular responses (gene expression, mtDNA turnover), provides a coherent multi-scale view.

      (4) The authors demonstrate that TFAM-induced compaction does not protect mtDNA from UVC lesions, an important contribution given assumptions about TFAM providing protection.

      Weaknesses:

      (1) The authors show a decrease in mtDNA levels and increased lysosomal colocalization but do not define the pathway responsible for degradation. Distinguishing between replication dilution, mitophagy, or targeted degradation would strengthen the interpretation

      We thank the reviewer for their careful reading of our manuscript and thoughtful suggestions. We agree that distinguishing between replication dilution, mitophagy, and/or targeted degradation would strengthen our understanding of how UV-induced DNA damage is handled in the mitochondria. Currently we are undertaking experiments to tease this apart, but consider the scope of those experiments to be beyond this manuscript and expect to publish them in a subsequent paper rather than this one. We added text explicitly stating that these possibilities are not distinguished by our results in pages 8-9 in the Discussion under the subsection ‘Mitochondria respond to UVC-induced mtDNA damage in the absence of apparent mitochondrial dysfunction’.

      (2) The sudden induction of mtDNA replication genes and transcription at 24 h suggests that intermediate timepoints (e.g., 12 hours) could clarify the kinetics of the response and avoid the impression that the sampling coincidentally captured the peak.

      We agree and have added additional timepoints of 12 hours and 18 hours post exposure. We have updated Figure 2 to include the new data and have added text on page 4 to include these results.

      (3) The authors report no loss of mitochondrial membrane potential, but this single measure is limited. Complementary assays such as Seahorse analysis, ATP quantification, or reactive oxygen species measurement could more fully assess functional integrity.

      We focused on membrane potential because loss of membrane potential is such a well-understood of mechanism for triggering mitophagy, but agree that these additional measurements are useful. We have added experiments to assess ATP levels, but did not see changes; we have added this data to Figure 2. We have also added text highlighting that we previously assessed mtROS following the same levels of UV exposure and observed no changes (in the results section on page 5 and in the discussion section on page 9). Given that we observe no changes in membrane potential or ATP, we have opted to not move forward with Seahorse analysis for the purposes of this paper.

      (4) The manuscript briefly notes enrichment of TFAM at certain regions of the mitochondrial genome but provides little interpretation of why these regions are favored. Discussion of whether high-occupancy sites correspond to regulatory or structural elements would add valuable context.

      We agree a discussion of these findings provides context and insight into where the field is currently in understanding TFAM sequence specificity. We have updated text in the discussion (pages 9-10) to include our thoughts on the drivers of TFAM sequence specificity with regard to the discrepancy with the anisotropy data and the lack of overlap with regulatory/structural elements.

      (5) It remains unclear whether the altered DNA topology promotes TFAM compaction or vice versa. Addressing this directionality, perhaps by including UVC-only controls for plasmid conformation, would help disentangle these effects if UVC is causing compaction alone.

      We have added an additional control making this comparison and updated the text on page 7 in the results section. UVC by itself (without TFAM being present) does not alter the plasmid compaction; see new supplemental Figure S16.

      (6) The authors provide a discrepancy between the anisotropy and binding array results. The reason for this is not clear, and one wonders if an orthogonal approach for the binding experiments would elucidate this difference (minor point).

      The discrepancy between anisotropy and the binding array results is certainly unusual and contrary to previous studies that have used these arrays. In addition to the anisotropy experiments, we selected a ‘high occupancy’ and ‘low occupancy’ sequence from the binding array and performed oligomerization experiments using atomic force microscopy, which allowed us to detect small changes in cooperativity (see supplemental Figure S15). We previously only discussed this briefly in the results section on page 6, but we have now updated the discussion section (pages 9-10) to highlight this finding and put forth ideas for the field as to why we think this might be the case. While we do see that the binding array data aligns with oligomerization and cooperativity of TFAM, we still do not know what it is about these sequences that would drive such differences in TFAM binding, but we speculate that it could have something to do with flexibility of the DNA sequences.

      Assessment of conclusions:

      The manuscript successfully meets its primary goal of testing whether TFAM protects mtDNA from UVC damage and the impact this has on the mtDNA. While their data points to an intriguing model that TFAM acts as a sensor of damaged mtDNA, the validation of this model requires further investigation to make the model more convincing. This is likely warranted for a follow-up study. Also, the biological impact of this compaction, such as altering transcription levels, is not clear in this study.

      We have updated wording in the Abstract, Introduction, and elsewhere in the text (as detailed in other portions of our response) to make as explicit and clear as possible which results are supported by the in vitro versus in vivo data, and which parts are conclusions supported by the data versus hypothesized models to be tested in future work.

      Impact and utility of the methods:

      This work advances our understanding of how mitochondria manage UVC genome damage and proposes a structural mechanism for damage "sensing" independent of canonical repair. The methodology, including the custom TFAM DNA chip, will be broadly useful to the scientific community.

      Context:

      The study supports a model in which mitochondrial genome integrity is maintained not only by repair factors, but also by selective sequestration or removal of damaged genomes. The demonstration that TFAM compaction correlates with damage rather than protection reframes an interesting role in mtDNA quality control.

      Reviewer #2 (Public review):

      Summary:

      King et al. present several sets of experiments aimed to address the potential impact of UV irradiation on human mitochondrial DNA as well as the possible role of mitochondrial TFAM protein in handling UV-irradiated mitochondrial genomes. The carefully worded conclusion derived from the results of experiments performed with human HeLa cells, in vitro small plasmid DNA, with PCR-generated human mitochondrial DNA, and with UV-irradiated small oligonucleotides is presented in the title of the manuscript: "UV irradiation alters TFAM binding to mitochondrial DNA". The authors also interpret results of somewhat unconnected experimental approaches to speculate that "TFAM is a potential DNA damage sensing protein in that it promotes UVC-dependent conformational changes in the [mitochondrial] nucleoids, making them more compact." They further propose that such a proposed compaction triggers the removal of UV-damaged mitochondrial genomes as well as facilitates replication of undamaged mitochondrial genomes.

      Strengths:

      (1) The authors presented convincing evidence that a very high dose (1500 J/m2) of UVC applied to oligonucleotides covering the entire mitochondrial DNA genome alleviates sequence specificity of TFAM binding (Figure 3). This high dose was sufficient to cause UV lesions in a large fraction of individual oligonucleotides. The method was developed in the lab of one of the corresponding authors (reference 74) and is technically well-refined. This result can be published as is or in combination with other data.

      (2) The manuscript also presents AFM evidence (Figure 4) that TFAM, which was long known to facilitate compaction of the mitochondrial genome (Alam et al., 2003; PMID 12626705 and follow-up citations), causes in vitro compaction of a small pUC19 plasmid and that approximately 3 UVC lesions per plasmid molecule result in a slight, albeit detectable, increase in TFAM compaction of the plasmid. Both results can be discussed in line with a possible extrapolation to in vivo phenomena, but such a discussion should include a clear statement that no in vivo support was provided within the set of experiments presented in the manuscript.

      We thank this reviewer for their careful reading and interpretation of the manuscript. We agree that discussion of in vivo implications and extrapolations need clear statements indicating where there is not currently in vivo support. We have updated the text throughout the paper to include this.

      Weaknesses:

      Besides the experiments presented in Figures 3 and 4, other results do not either support or contradict the speculation that TFAM can play a protective role, eliminating mitochondrial genomes with bulky lesions by way of excessive compaction and removing damaged genomes from the in vivo pool.

      To specify these weaknesses:

      (1) Figure 1 - presents evidence that UVC causes a reduction in the number of mitochondrial spots in cells. The role of TFAM is not assessed.

      We are working to understand the role of TFAM in vivo following UV irradiation, but believe that work should be included in follow up studies rather than this publication.

      (2) Figure 2 - presents evidence that UVC causes lesions in mitochondrial genomes in vivo, detectable by qPCR. No direct assessment of TFAM roles in damage repair or mitochondrial DNA turnover is assessed despite the statements in the title of Figure 2 or in associated text. Approximately 2-fold change in gene expression of TFAM and of the three other genes does not provide any reasonable support to suggestion about increased mitochondrial DNA turnover over multiple explanations on related to mitochondrial DNA maintenance.

      We agree and have updated the title of Figure 2 to better reflect the findings outlined in the figure as well as the text.

      The new title is, “UVC causes mtDNA damage that decreases over time and is associated with upregulation of mtDNA replication genes, in the absence of apparent mitochondrial dysfunction.”

      We agree that there are numerous mechanistic hypotheses that could explain the decrease in mtDNA damage over time. In Figure 1, we show that there is an overall decrease in mtDNA spots, and an increase in mtDNA-lysosome colocalization, suggestive of mtDNA degradation, which could serve to remove damaged genomes. One possibility is that TFAM is playing a role in the damage removal (but not repair per cell as these lesions are not repaired). Another is changes in mtDNA turnover via increasing the replication machinery in order the synthesize non-damaged mtDNA molecules to dilute out damage. These and other possibilities are not mutually exclusive. We have added text (pages 8-9) to make explicit that additional work will be required to distinguish these possibilities. We note that we have also added an additional experiment showing that TFAM knockdown affects mtDNA damage at baseline, as well as after UVC exposure (Figure 5J).

      (3) Figure 5. Shows that TFAM does not protect either mitochondrial nucleoids formed in vitro or mitochondrial DNA in vivo from UVC lesions as well as has no effect on in vivo repair of UV lesions.

      We agree that Figure 5 shows that TFAM does not protect DNA from UVC-induced lesions, and that a roughly 2-fold increase in TFAM protein does not alter damage reduction over time. We have added new data showing that in vivo, knockdown of TFAM results in an increase in baseline (control conditions) mtDNA damage, and also alters the rate of decrease of mtDNA damage over time after UVC (Figure 5J).

      (4) Figure 6: Based on the above analysis, the model of the role of TFAM in sensing mtDNA damage and elimination of damaged genomes in vivo appears unsupported.

      We have updated the legend for Figure 6 in which we outline our hypothesized role of TFAM in sensing mtDNA damage to ensure that readers know this has yet to be fully tested in vivo. We have also updated the Figure legend title from “proposed model” to “hypothesized model,” and changed the wording in the conclusion section (page 11) to highlight more clearly that this is a working model.

      (5) Additional concern about Figure 3 and relevant discussion: It is not clear if more uniform TFAM binding to UV irradiated oligonucleotides with varying sequence as compared to non-irradiated oligonucleotides can be explained by just overall reduced binding eliminating sequence specific peaks.

      We do not believe this is the case given the similar K<sub>D</sub> values for the sequences tested. In our hands and in other publications (reviewed in PMID: 34440420), it has been well established that TFAM binds damaged DNA very well—essentially just as well as nondamaged DNA or better.

      Additionally, a reduction in overall binding on these DNA arrays tends to make sequence specific peaks more apparent. We ran our experiments at both 30 nM and 300 nM TFAM specifically to be able to assess this question. The 300 nM data can be found in supplemental Figure S7. In this figure, we notice that the peaks appear more uniform at the high concentration (comparing Figure 3A to Figure S7A). That is presumably because there is so much more binding happening across the array that the peaks associated with the strongest binders become less pronounced. For the sake of brevity, we have not added this reasoning to the text, but are willing to do so if the Reviewers and Editor feel that it is important to include.

      Reviewer #3 (Public review):

      Summary:

      The study is grounded in the observations that mitochondrial DNA (mtDNA) exhibits a degree of resistance to mutagenesis under genotoxic stress. The manuscript focuses on the effects of UVC-induced DNA damage on TFAM-DNA binding in vitro and in cells. The authors demonstrate increased TFAM-DNA compaction following UVC irradiation in vitro based on high-throughput protein-DNA binding and atomic force microscopy (AFM) experiments. They did not observe a similar trend in fluorescence polarization assays. In cells, the authors found that UVC exposure upregulated TFAM, POLG, and POLRMT mRNA levels without affecting the mitochondrial membrane potential. Overexpressing TFAM in cells or varying TFAM concentration in reconstituted nucleoids did not alter the accumulation or disappearance of mtDNA damage. Based on their data, the authors proposed a plausible model that, following UVC-induced DNA damage, TFAM facilitates nucleoid compaction, which may serve to signal damage in the mitochondrial genome.

      Strengths:

      The presented data are solid, technically rigorous, and consistent with established literature findings. The experiments are well-executed, providing reliable evidence on the change of TFAM-DNA interactions following UVC irradiation. The proposed model may inspire future follow-up studies to further study the role of TFAM in sensing UVC-induced damage.

      Weaknesses:

      The manuscript could be further improved by refining specific interpretations and ensuring terminology aligns precisely with the data presented.

      (1) In line 322, the claim of increased "nucleoid compaction" in cells should be removed, as there is a lack of direct cellular evidence. Given that non-DNA-bound TFAM is subject to protease digestion, it is uncertain to what extent the overexpressed TFAM actually integrates into and compacts mitochondrial nucleoids in the absence of supporting immunofluorescence data.

      We would like to thank this reviewer for their comments and suggestions. We feel these specific language changes have strengthened the interpretability of the text. The TFAM overexpression cells used in this experiment were given to us by Isaac et al., who demonstrated that when TFAM was overexpressed in this specific cell line, the nucleoids were indeed more compact, measured by Fiber-seq (Isaac et al., 2024; PMID: 38347148). We have removed the claim “increased compaction” from the section title, Figure 5 legend title, and from line 322 (now on page 8), and have also added an additional sentence to ensure the reader knows these cells have been shown to have presumed increased compaction by other groups.

      (2) In lines 405 and 406, the authors should avoid equating TFAM overexpression with compaction in the cellular context unless the compaction is directly visualized or measured.

      We have updated the text to ensure that it is clear that this was tested by other groups. We also changed the wording to “inaccessible (presumably compacted) nucleoids.” While we did not demonstrate altered compaction in our study, we think that based on the results from Isaac et al., it is likely that there was increased compaction. In addition, some readers might not have the context to make the connection between compaction and accessibility, so eliminating all reference to compaction could obscure the point.

      (3) In lines 304 and 305 (and several other places throughout the manuscript), the authors use the term "removal rates". A "removal rate" requires a direct comparison of accumulated lesion levels over a time course under different conditions. Given the complexity of UV-induced DNA damage-which involves both damage formation and potential removal via multiple pathways-a more accurate term that reflects the net result of these opposing processes is "accumulated DNA damage levels." This terminology better reflects the final state measured and avoids implying a single, active 'removal' pathway without sufficient kinetic data.

      We agree and have updated the language throughout the text as well as the results heading for this section.

      (4) In line 357, the authors refer to the decrease in the total DNA damage level as "The removal of damaged mtDNA". The decrease may be simply due to the turnover and resynthesis of non-damaged mtDNA molecules. The term "removal" may mislead the casual reader into interpreting the effect as an active repair/removal process.

      We agree and have restructured this sentence for clarity. We do believe there is some removal happening, given the increase in mtDNA colocalization in lysosomes alongside decrease of mtDNA spots in our live cell imaging. We have written it to reflect the inclusion of removal and resynthesis of nondamaged mtDNA molecules (see pages 8-9).

      Recommendations for the authors:

      Reviewing Editor Comments:

      The reviewers appreciate the quality of the presented data but concur that they do not support the primary claims in the title and abstract. The reviewers also realize that in vivo evidence for the model would require extensive new experimentation that goes beyond a reasonable revision. The recommendation is to change the title and significantly revise text, figure titles and legends for transparency, and conclusions within results and discussion sections.

      We thank the editor and all the reviewers for their feedback. We have added additional experiments, updated text throughout the entire paper to ensure our claims are supported, and revised our title. We feel that the changes we have made have indeed made the paper stronger, more transparent, and that the evidence put forth in this paper provides support for all claims made.

      Reviewer #1 (Recommendations for the authors):

      (1) Clarify mitochondrial response kinetics by adding an intermediate (e.g., 12 hrs) recovery timepoint for transcriptional analysis to resolve when TFAM and replication genes are induced.

      We have added additional timepoints of 12 and 18 hours following exposure in Figure 2. These results strengthen our finding that the nuclear transcriptional program supporting mtDNA replication appears to be activated prior to the nuclear transcriptional program supporting mitochondrial transcription, in that POLG and TFAM come up before POLRMT and ND1.

      (2) Strengthen functional readouts by assessing additional parameters of mitochondrial function to substantiate the claim that UVC does not impair mitochondrial performance.

      We have referenced our previously-published data on mtROS and added a measurement of ATP following UVC exposure in Figure 2.

      (3) Consider exploring whether mtDNA degradation occurs via mitophagy, nucleoid-phagy, or another pathway-potentially by using inhibitors or markers of these processes.

      While we agree that this is an important follow up question and are currently working on experiments to address this, those experiments are outside the scope of this manuscript.

      (4) Provide additional details for the high occupancy TFAM sites. Provide brief annotation or discussion of genomic regions showing strong TFAM binding under non-irradiated conditions that are lost during UVC treatment. This would be helpful to the field as a whole.

      We have updated our discussion section to include this.

      (5) Include or discuss a control using UVC irradiated pUC19 without TFAM to confirm that observed compaction categories are TFAM dependent rather than an UVC induced DNA distortion.

      We have added in a supplemental figure (Figure S16) containing comparison of area analysis of control pUC19 and UV-irradiated pUC19 and we have added associated text in the results section of the paper.

      (6) It would be interesting to explore the link between compaction to transcriptional output. In the TFAM overexpression model, the authors could measure expression of mtDNA encoded transcripts (e.g., ND1, COX1) to connect increased compaction with altered mitochondrial transcription.

      While we agree that understanding how the compactional status alters mitochondrial transcription is worthwhile, we believe this is beyond the scope of this paper. Furthermore, this connection has previously been shown by Bruser et al., 2021 (PMID: 34818548) who showed that more compact nucleoids are not undergoing active transcription. It will be interesting to see in future work if mtDNA damage drives changes in both compaction as well as transcriptional activity.

      (7) Clarify quantitative presentation in figure 2F to explicitly note whether the observed increase in fluorescence intensity was statistically insignificant and confirm that the assay sensitivity is sufficient to detect small potential changes. As presented it is not clear if there is a change.

      We have changed the presentation of Figure 2F. There is a slight increase in membrane potential at the 24-hour time point and we have made that clear in the text as well. We included FCCP as a (standard) positive control, for which we can detect the associated decrease in membrane potential for. While it is always possible that a very small decrease occurred that we were unable to detect, we note that none of the six UVC-exposed groups that we tested even trended towards a decrease in MMP, making it less likely that there was an effect that we simply lacked the power or sensitivity to detect.

      (8) It would be interesting if the authors can comment on whether TFAM induced compaction after UVC might shield mtDNA from other, repairable lesions (e.g., oxidative or alkylation damage), offering a broader context for this mechanism beyond just UVC.

      In theory, we believe this is possible. It will also be interesting to see if the increased compaction following UVC also protects or shields the mtDNA from other enzymatic processes, such as repair proteins that may be searching for repairable lesions such as oxidative or alkylation damage. In this case, it seems as though the increased compaction would prevent the repair from happening at genomes harboring damage.

      In this study we show with our in vitro nucleoids that the increased compaction does not protect against UVC, but this is likely because UVC does not need physical access to the DNA in order to damage it, as the wavelengths of UVC (centered in this case at 254nm) are readily absorbed by proteins and thus can go right through the proteins. Currently, we know that increased compaction by TFAM makes the DNA inaccessible to the enzymes required to methylate DNA used in Fiber-seq (PMID: 38347148), but we do not know if the compaction is tight enough to prevent ROS or alkylating agents from damaging the DNA. We have updated text in the discussion on page 10 to highlight some of these ideas.

      Reviewer #2 (Recommendations for the authors):

      Please, go over all display items and text and clarify details that can help readers to understand important specifics of the experiments. Examples are provided below:

      (1) Abstract and Introduction - indicate species and cell line

      We have updated the text to include this information.

      (2) Table 1 "TFAM KD measurements"- title and footnotes are entirely cryptic. Please, clarify the experimental design, question(s) addressed and conclusions drawn from data.

      We have updated the title of Table 1 to "Binding of TFAM to array sequences, measured using fluorescence anisotropy,” and clarified the footnotes to make sure it is clear which sequences were selected for AFM oligomerization experiments.

      (3) Figure 3 and Material and Methods - specify UVC dose.

      We have added this information to both the figure legend and the methods section.

      (4) Figure 4 - specify UVC dose.

      We have added this information to the figure legend.

      (5) Figure 5. Panel B indicate which band is TFAM and which is HA-tag; Indicate clearly which panel is showing in vivo or in vitro results.

      We have updated the figure to label the untagged TFAM and HA-tagged TFAM and changed the panel titles to specify if they are in vivo results.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Reviewer #2 (Recommendations for the authors):

      Major:

      Over-interpretation of data. There are a few instances of this:

      The authors claim "Our work shows that MgdE interacts with both WDR5 and ASH2L and inhibits the methyltransferase activity of the COMPASS complex" (Line 318). However, they provide no biochemical analysis of methyltransferase activity to support this claim. While they cite Figure 4A-C and Figure 5, these data simply show (slightly) decreased cellular levels of H3K4Me. There are multiple ways H3K4Me could decrease including blocking recruitment of COMPASS to promoters or the enzymatic activity of MgdE itself.

      The data itself related to H3K4Me changes (Figure 5D) is difficult to interpret in light of the controls they now provide. Examining the blot itself there seems to be a massive increase in H3K4Me in control cells expressing GFP that is not reflected in the quantification that shows only a ~2x increase in GFP-expressing cells. In addition, there is very little decrease in H3K4Me in the MgdE-expressing cells relative to controls or site-mutant (no change apparent visually and ~10% change per their quantification). However, the authors interpret this as," revealed that cells expressing WT MgdE exhibited lower levels of H3K4me3". In both these cases I would recommend the authors consider modifying their interpretation of the data.

      We thank the reviewer for the comment.

      (1) We have now revised this interpretation in the manuscript as follows:

      Lines 311-312: “Our work shows that MgdE interacts with both WDR5 and ASH2L, leading to a decrease in H3K4me3 levels.”

      (2) Figure 5D presents the results of three independent biological replicates. The bar graph shows the average signal intensity of H3K4me3 normalized to the corresponding loading controls. Accordingly, we have revised the analysis and description of the experimental results.

      Lines 214-217: “Immunoblot analysis of nuclear extracts showed that cells expressing WT MgdE had ~25% lower H3K4me3 levels than EGFP-expressing cells and ~40% lower levels than those expressing the D244A/H47A mutant (Figure 5D).”

      Minor

      What is "CK"? Please clarify (Figure 2F).

      We thank the reviewer for the comment. In this context, "CK" refers to the uninfected control group, which serves as the negative control in the experiment. We have revised the label in Figure 2F.

      How many times was the BCG mouse experiment performed? This should be indicated in the figure legend? (Figure 7A).

      We thank the reviewer for the comment. The BCG mouse experiment was performed once, and we have added this information to the figure legend of Figure 7A.

      It is unclear why the secreted protein (after signal peptide removal) migrates at the same size as the full-length protein (Figure S2).

      We thank the reviewer for the comment. The precursors of secreted proteins after translation in the cytoplasm will be translated into the periplasm immediately. Therefore, MgdE or Ag85B obtained from the whole-cell lysate (Figure S2A) mostly have had the signal peptides removed. This is also validated in the case of Rv0455c secretion by Mtb (Zhang et al., Nature Communications, 2022). This explains why MgdE (or Ag85B) proteins from whole-cell lysates or from supernatants show same size in SDS-PAGE gels.

      It is still unclear why the transcripts with very little fold-change in expression (in grey) have the most significant p-values for being different (Figure 6).

      We thank the reviewer for the comment. The p-value calculation takes into account not only the magnitude of expression change but also the consistency of expression levels within each group and the number of biological replicates. When the variation among replicates is minimal, even a small difference in group means can result in a statistically significant p-value. In our RNA-seq analysis, we used DESeq2 with three biological replicates per group. DESeq2 employs a model based on the negative binomial distribution and accounts for multiple factors, including the mean expression level, within-group variance (dispersion), sample size, and normalization accuracy. As a result, it is common to observe that genes with small variability and strong consistency between replicates may show significant p-values even with modest fold changes. Conversely, genes with larger fold changes but greater variability might not reach statistical significance.

      Reference

      Zhang L, Kent JE, Whitaker M, Young DC, Herrmann D, Aleshin AE, Ko YH, Cingolani G, Saad JS, Moody DB, Marassi FM, Ehrt S, Niederweis M (2022) A periplasmic cinched protein is required for siderophore secretion and virulence of Mycobacterium tuberculosis Nat Commun 13(1):2255.

    1. Author response:

      We thank the reviewers for their thoughtful and constructive feedback. Addressing these points will strengthen the manuscript and improve its clarity.

      A primary concern involved the justification for using COS7 cell lysates in reconstitution approaches and iPSC-derived neuronal model systems as models for AD. We will clarify the language throughout the manuscript to more explicitly state the study’s goals, emphasize that these systems were selected as robust, well-controlled platforms to test the mechanisms through which tau hyperphosphorylation affects microtubule interactions and tau’s role in regulating intracellular transport, and the limitations of in vitro and iPSC models.

      Reviewers also raised the possibility that background phosphorylation could contribute to the effects observed in the pseudo-phosphorylation model. We cite two recent preprints that provide insight into this question through quantitatively assessing tau phosphorylation across expression systems. In the revised manuscript, we will elaborate on how their assessment of tau phosphorylation fits within the scope of our approach and clarify how our experimental controls effectively minimize uncertainty related to background phosphorylation.

      Another point concerned the potential influence of other microtubule-associated proteins in lysates and the impact of tau lattice occupancy on motility outcomes. To further strengthen this aspect, we will include additional analyses correlating tau intensity along microtubules with kinesin intensity and motility behavior, and we will more clearly explain how the AP and WT controls provide confidence in the robustness of the system.

      Detailed responses to each reviewer comment are provided below point by point. The planned revisions, which include clearer language, stronger justification of the experimental approaches, and additional supporting analyses, will substantially improve the clarity, rationale, and overall impact of the study.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work by Beaudet and colleagues aims at exploring the effect of phosphorylation on the formation of tau envelopes and consequently on axonal transport, both in vitro on reconstituted microtubules and in human excitatory neurons derived from IPSCs.

      The authors found that a relatively widely used construct in which 14 serine or threonine residues, often hyperphosphorylated in Alzheimer's disease, are mutated to alanines (phosphodeficient), increases the density of tau envelopes compared to wildtype tau, whereas a phosphomimetic (same residues mutated to glutamic acid) reduces envelope density both in vitro and in human excitatory neurons derived from IPSCs.

      By analysing the trafficking of different kinesins (KIF1a and KIF5C), they observed different effects of tau phosphorylation status on the movement of these two motors.

      They then analyse transport of lysosomes by employing live imaging of lysotracker in human excitatory neurons derived from IPSCs transfected with wildtype, phosphodeficient or phosphomimetic tau, observing that phosphodeficient tau seems to reduce transport of lysosomes while phosphomimetic increases transport compared to wildtype tau.

      Strengths:

      (1) The work aims to study a novel and underexplored topic in the tau field, tau envelopes, and investigate their relevance to Alzheimer's disease pathology.

      (2) Experiments are well conducted and of high quality.

      Weaknesses:

      Relying only on in vitro reconstituted microtubules and human neurons derived from IPSCs leaves some doubts about the relevance of these results for Alzheimer's disease, considering the embryonic state of IPSCs-derived neurons.

      We agree with the reviewer that iPSC-derived neurons represent an immature state compared with the neurons affected in Alzheimer’s disease. However, iPSC-derived neurons, together with in vitro reconstitution, provide insight into (1) whether tau hyperphosphorylation influences its association with microtubules and its ability to form envelope-like structures thought to regulate transport, (2) how tau hyperphosphorylation affects the motility of kinesin motors that are strongly inhibited by tau, and (3) how transport of endogenous degradative organelles such as lysosomes are impacted by tau hyperphosphorylation. We hope that our studies will help to inform future studies examining how tau-related dysfunction evolves in more mature neurons and contributes to the more severe pathological effects observed at later disease stages.

      We will include a paragraph in the Discussion section addressing the limitations of this study to better contextualize our findings within the broader effort to understand tauopathies and Alzheimer’s disease.

      Reviewer #2 (Public review):

      This manuscript examines how disease-associated hyperphosphorylation disrupts tau's role as a cooperative microtubule-binding regulator of intracellular transport. Using in vitro reconstitution assays and live-cell imaging in iPSC-derived neurons, the authors employ phosphomutant tau constructs (E14 to mimic hyperphosphorylation, AP to prevent phosphorylation) at 14 disease-associated residues to isolate phosphorylation effects independent of expression system-dependent PTM heterogeneity. The results show that hyperphosphorylated tau fails to form cooperative envelope-like structures on microtubules, instead binding diffusely and dissociating rapidly. In contrast, wild-type and phospho-resistant tau form cohesive envelopes that regulate motor protein access. At the single-molecule level, hyperphosphorylation reduces KIF5C inhibition while maintaining or enhancing KIF1A inhibition through altered processivity and detachment rates. In live neurons, hyperphosphorylated tau phenocopies tau knockout conditions, weakening tau-mediated inhibition of lysosome transport and increasing processive motility. The authors quantify tau binding using Gaussian mixture model-based image analysis and measure tau kinetics via FRAP, demonstrating that hyperphosphorylation-induced loss of cooperative binding correlates with dysregulated organelle transport. These findings establish a mechanism by which phosphorylation-driven disruption of tau's gatekeeper function on microtubules compromises axonal transport prior to aggregation in tauopathies. The paper provides interesting new knowledge for the field, but there are outstanding concerns that could be further addressed by the authors to strengthen and clarify the current manuscript:

      (1) Lack of Phosphatase-Treated Control and Explicit WT Phosphorylation Quantification

      Wild-type tau expressed in insect and mammalian cells is known to be phosphorylated by endogenous kinases (eg, GSK3, CDK5, MARK). The manuscript acknowledges this in the Discussion but provides no phosphatase-treated lysate control or quantification of endogenous phosphorylation on WT tau via phospho-specific Western blots. This leaves ambiguity about whether observed differences between WT and E14 reflect purely the introduced mutations or confounding baseline differences in phosphostate content.

      Tau contains ~85 putative phosphorylation sites and is modified by several kinases in cells. Studies by Siahaan et al. (2024) and Fan et al. (2025) provide detailed insight into tau phosphorylation, its role in protecting the microtubule lattice from severing enzymes, and the implications of phosphorylation patterns for aggregate formation. Specifically, Fan et al. (2025) show that HEK-expressed tau is phosphorylated by endogenous kinases at 58 residues, with most phospho-occupancy levels below 15%, indicating substantial heterogeneity among individual tau molecules. In the revised manuscript, we will (1) provide justification for the use of the pseudo-phosphorylation model system as an approach to limit heterogeneity among tau molecules, (2) clarify the importance of the WT and AP controls, (3) discuss that E14, WT, and AP tau likely exhibit similar degrees of background phospho-heterogeneity, with WT tau likely exhibiting some overlap between background phosphorylation and the 14 AD-associated sites examined, and (4) expand the discussion to emphasize that although background phosphorylation is present, our results do not suggest that it contributes significantly to the observations reported in this study.

      (2) Limited Normalization of Motor Effects to Measured Tau Lattice Occupancy

      Although kinesin trajectories are classified inside vs. outside tau envelopes (inherently normalizing to local tau density), motor parameters are not systematically reported as functions of tau fluorescence intensity across all constructs. Co-purifying MAPs or microtubule-modifying enzymes in cell lysates is not quantified or excluded, leaving residual uncertainty about tau-specificity of observed motor inhibition. This should be at least acknowledged in the results section.

      The reviewer raises a valid point. It is challenging to compare conditions where the occupancy of tau on microtubules is similar across conditions, as phosphorylation strongly effects the interaction between tau and microtubules. We will quantify and report tau intensity in single-molecule motility assays. On the second point, while effects from other MAPs or motor proteins could potentially affect kinesin motility, we would expect that these effects would be similar for all tau phosphomutant constructs, such that the effect of tau phospho-states on kinesin motility can be assessed.

      (3) Insufficient Citation of Prior Neuronal Tau Envelope Evidence

      In the Introduction, the authors state, "it was an open question if tau forms envelopes in neurons," but this understates existing evidence. Tan et al. (2019) report tau neuronal staining consistent with envelope formation, while Siahaan et al. (2021) provide more direct evidence in non-neuronal cells. The framing should acknowledge and integrate these prior findings.

      We agree with the reviewer that evidence from several studies using reconstitution systems, fixed neurons, and live cultured cells provides evidence of tau envelope formation in neurons. Specifically, tau envelopes have been observed along taxol-stabilized or GMPCPP-capped GDP microtubules in vitro (e.g., Dixit et al., 2008; Monroy et al., 2018; Tan et al., 2019; Siahaan et al., 2019), in 4% PFA-fixed and Triton X-100–extracted DIV7 mouse hippocampal neurons (Tan et al., 2019), and in live, non-neuronal U-2 OS cells following taxol treatment (Siahaan et al., 2022) or elevated pH (Siahaan et al., 2024). However, to our knowledge, our study is the first to demonstrate tau envelope formation in live neuronal cells under normal cell culture conditions. We will revise this sentence in the manuscript to more precisely position our findings within the context of prior studies.

      (4) Unclear Wording on Expression System-Dependent Phosphorylation

      The sentence "The phosphostate of tau is strongly dependent on the expression system" requires rewording. It is ambiguous whether this refers to the final phosphostate achieved after expression or the inherent phosphorylating capacity of each system. Clearer language would strengthen the methodological justification.

      We agree that the wording here is ambiguous and requires clarification. In the revised manuscript, we will clarify that tau phosphorylation depends on the expression system used; bacterial systems lack the capacity for many post-translational modifications compared with insect and mammalian systems. We will also emphasize that in insect and mammalian expression systems, tau phosphorylation occurs heterogeneously, as demonstrated in previous studies by Siahaan et al. (2024) and Fan et al. (2025).

      (5) Insufficient Quantification of Motor and Lysosome Transport Effect Magnitudes in Results Section

      The data on molecular motor motility and lysosome transport are densely described. The magnitude of effects (fold-changes, percentage differences) should be explicitly stated in the Results section when first presenting findings to orient readers to biological significance. For example, effect magnitudes for lysosome run lengths, velocities, and directional bias should be quantified in text, not left to figure inspection.

      Our initial justification for omitting quantitative data from the results text was to improve readability; however, in doing so, we may have reduced the accessibility and clarity regarding the significance of the findings. In the revised manuscript, we will incorporate the relevant quantifications and statistical significance for the motility data in the text.

      (6) Incomplete Discussion of Projection Domain Necessity for Envelope Formation

      The Discussion states the projection domain is "a critical regulator of both tau-tau and tau-microtubule interactions," but does not engage with prior domain dissection work. Tan et al. (2019) found that the entire projection domain is not necessary for envelope formation in vitro. The authors should discuss which projection domain regions are specifically regulated by phosphorylation vs. required for cooperativity, providing a more nuanced interpretation than implied by their current framing.

      We agree with the reviewer. Tan et al. (2019) demonstrated that the proline-rich region (residues 198–244) within the projection domain of full-length 2N4R tau is the minimal region required to maintain tau’s ability to form envelopes along microtubules. We will incorporate this work on the dissection of the projection domain and discuss how the phosphorylation sites examined in our study are primarily located within this region. Together, these data highlight the proline-rich region as a potential major regulator of tau–tau cooperativity.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Review of the manuscript titled " Mycobacterial Metallophosphatase MmpE acts as a nucleomodulin to regulate host gene expression and promotes intracellular survival".

      The study provides an insightful characterization of the mycobacterial secreted effector protein MmpE, which translocates to the host nucleus and exhibits phosphatase activity. The study characterizes the nuclear localization signal sequences and residues critical for the phosphatase activity, both of which are required for intracellular survival.

      Strengths:

      (1) The study addresses the role of nucleomodulins, an understudied aspect in mycobacterial infections.

      (2) The authors employ a combination of biochemical and computational analyses along with in vitro and in vivo validations to characterize the role of MmpE.

      Weaknesses:

      (1) While the study establishes that the phosphatase activity of MmpE operates independently of its NLS, there is a clear gap in understanding how this phosphatase activity supports mycobacterial infection. The investigation lacks experimental data on specific substrates of MmpE or pathways influenced by this virulence factor.

      We thank the reviewer for this insightful comment and agree that identification of the substrates of MmpE is important to fully understand its role in mycobacterial infection. MmpE is a putative purple acid phosphatase (PAP) and a member of the metallophosphoesterase (MPE) superfamily. Enzymes in this family are known for their catalytic promiscuity and broad substrate specificity, acting on phosphomonoesters, phosphodiesters, and phosphotriesters (Matange et al., Biochem J, 2015). In bacteria, several characterized MPEs have been shown to hydrolyze substrates such as cyclic nucleotides (e.g., cAMP) (Keppetipola et al., J Biol Chem, 2008; Shenoy et al., J Mol Biol, 2007), nucleotide derivatives (e.g., AMP, UDP-glucose) (Innokentev et al., mBio, 2025), and pyrophosphate-containing compounds (e.g., Ap4A, UDP-DAGn) (Matange et al., Biochem J., 2015). Although the binding motif of MmpE has been identified, determining its physiological substrates remains challenging due to the low abundance and instability of potential metabolites, as well as the limited sensitivity and coverage of current metabolomic technologies in mycobacteria.

      (2) The study does not explore whether the phosphatase activity of MmpE is dependent on the NLS within macrophages, which would provide critical insights into its biological relevance in host cells. Conducting experiments with double knockout/mutant strains and comparing their intracellular survival with single mutants could elucidate these dependencies and further validate the significance of MmpE's dual functions.

      We thank the reviewer for the comment. Deletion of the NLS motifs did not impair MmpE’s phosphatase activity in vitro (Figure 2F), indicating that MmpE's enzymatic function operates independently of its nuclear localization. Indeed, we confirmed that Fe<sup>3+</sup>-binding ability via the residues H348 and N359 is required for enzymatic activity of MmpE. We have expanded on this point in the Discussion section “MmpE is a bifunctional virulence factor in Mtb”.

      (3) The study does not provide direct experimental validation of the MmpE deletion on lysosomal trafficking of the bacteria.

      We thank the reviewer for the comment. To validate the role of MmpE in lysosome maturation during infection, we conducted fluorescence colocalization assays in THP-1 macrophages infected with BCG strains, including WT, ∆MmpE, Comp-MmpE, Comp-MmpE<sup>ΔNLS1</sup>, Comp-MmpE<sup>ΔNLS2</sup>, Comp-MmpE<sup>ΔNLS1-2</sup>. These strains were stained with the lipophilic membrane dye DiD, while macrophages were treated with the acidotropic probe LysoTracker<sup>TM</sup> Green (Martins et al., Autophagy, 2019). The result indicated that ΔMmpE and MmpE<sup>NLS1-2</sup> mutants exhibited significantly higher co-localization with LysoTracker compared to WT and Comp-MmpE strains (New Figure 5G), suggesting that MmpE deletion leads to enhanced lysosomal maturation during infection.

      (4) The role of MmpE as a mycobacterial effector would be more relevant using virulent mycobacterial strains such as H37Rv.

      We thank the reviewer for the comment. Previously, the role of Rv2577/MmpE as a virulence factor has been demonstrated in M. tuberculosis CDC 1551, where its deletion significantly reduced bacterial replication in mouse lungs at 30 days post-infection (Forrellad et al., Front Microbiol, 2020). However, that study did not explore the underlying mechanism of MmpE function. In our study, we found that MmpE enhances M. bovis BCG survival in macrophages (THP-1 and RAW264.7 both) and in mice (Figure 3, Figure 7A), consistent with its proposed role in virulence. To investigate the molecular mechanism by which MmpE promotes intracellular survival, we used M. bovis BCG as a biosafe surrogate and this model is widely accepted for studying mycobacterial pathogenesis (Wang et al., Nat Immunol, 2015; Wang et al., Nat Commun, 2017; Péan et al., Nat Commun, 2017).

      Reviewer #2 (Public review):

      Summary:

      In this paper, the authors have characterized Rv2577 as a Fe3+/Zn2+ -dependent metallophosphatase and a nucleomodulin protein. The authors have also identified His348 and Asn359 as critical residues for Fe3+ coordination. The authors show that the proteins encode for two nuclease localization signals. Using C-terminal Flag expression constructs, the authors have shown that the MmpE protein is secretory. The authors have prepared genetic deletion strains and show that MmpE is essential for intracellular survival of M. bovis BCG in THP-1 macrophages, RAW264.7 macrophages, and a mouse model of infection. The authors have also performed RNA-seq analysis to compare the transcriptional profiles of macrophages infected with wild-type and MmpE mutant strains. The relative levels of ~ 175 transcripts were altered in MmpE mutant-infected macrophages and the majority of these were associated with various immune and inflammatory signalling pathways. Using these deletion strains, the authors proposed that MmpE inhibits inflammatory gene expression by binding to the promoter region of a vitamin D receptor. The authors also showed that MmpE arrests phagosome maturation by regulating the expression of several lysosome-associated genes such as TFEB, LAMP1, LAMP2, etc. These findings reveal a sophisticated mechanism by which a bacterial effector protein manipulates gene transcription and promotes intracellular survival.

      Strength:

      The authors have used a combination of cell biology, microbiology, and transcriptomics to elucidate the mechanisms by which Rv2577 contributes to intracellular survival.

      Weakness:

      The authors should thoroughly check the mice data and show individual replicate values in bar graphs.

      We kindly appreciate the reviewer for the advice. We have now updated the relevant mice data in the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript titled "Mycobacterial Metallophosphatase MmpE Acts as a Nucleomodulin to Regulate Host Gene Expression and Promote Intracellular Survival", Chen et al describe biochemical characterisation, localisation and potential functions of the gene using a genetic approach in M. bovis BCG and perform macrophage and mice infections to understand the roles of this potentially secreted protein in the host cell nucleus. The findings demonstrate the role of a secreted phosphatase of M. bovis BCG in shaping the transcriptional profile of infected macrophages, potentially through nuclear localisation and direct binding to transcriptional start sites, thereby regulating the inflammatory response to infection.

      Strengths:

      The authors demonstrate using a transient transfection method that MmpE when expressed as a GFP-tagged protein in HEK293T cells, exhibits nuclear localisation. The authors identify two NLS motifs that together are required for nuclear localisation of the protein. A deletion of the gene in M. bovis BCG results in poorer survival compared to the wild-type parent strain, which is also killed by macrophages. Relative to the WT strain-infected macrophages, macrophages infected with the ∆mmpE strain exhibited differential gene expression. Overexpression of the gene in HEK293T led to occupancy of the transcription start site of several genes, including the Vitamin D Receptor. Expression of VDR in THP1 macrophages was lower in the case of ∆mmpE infection compared to WT infection. This data supports the utility of the overexpression system in identifying potential target loci of MmpE using the HEK293T transfection model. The authors also demonstrate that the protein is a phosphatase, and the phosphatase activity of the protein is partially required for bacterial survival but not for the regulation of the VDR gene expression.

      Weaknesses:

      (1) While the motifs can most certainly behave as NLSs, the overexpression of a mycobacterial protein in HEK293T cells can also result in artefacts of nuclear localisation. This is not unprecedented. Therefore, to prove that the protein is indeed secreted from BCG, and is able to elicit transcriptional changes during infection, I recommend that the authors (i) establish that the protein is indeed secreted into the host cell nucleus, and (ii) the NLS mutation prevents its localisation to the nucleus without disrupting its secretion.

      We kindly appreciate the reviewer for this insightful comment. To confirm the translocation of MmpE into the host nucleus during BCG infection, we first detected the secretion of MmpE by M. bovis BCG, using Ag85B as a positive control and GlpX as a negative control (Zhang et al., Nat commun, 2022). Our results showed that MmpE- Flag was present in the culture supernatant, indicating that MmpE is secreted by BCG indeed (new Figure S1C).

      Next, we performed immunoblot analysis of the nuclear fractions from infected THP-1 macrophages expressing FLAG-tagged wild-type MmpE and NLS mutants. The results revealed that only wild-type MmpE was detected in the nucleus, while MmpE<sup>ΔNLS1</sup>, MmpE<sup>ΔNLS2</sup> and MmpE<sup>ΔNLS1-2</sup> were not detectable in the nucleus (New Figure S1D). Taken together, these findings demonstrated that MmpE is a secreted protein and that its nuclear translocation during infection requires both NLS motifs.

      Demonstration that the protein is secreted: Supplementary Figure 3 - Immunoblotting should be performed for a cytosolic protein, also to rule out detection of proteins from lysis of dead cells. Also, for detecting proteins in the secreted fraction, it would be better to use Sauton's media without detergent, and grow the cultures without agitation or with gentle agitation. The method used by the authors is not a recommended protocol for obtaining the secreted fraction of mycobacteria.

      We kindly appreciate the reviewer for the advice. To avoid the effects of bacterial lysis, we cultured the BCG strains expressing MmpE-Flag in Middlebrook 7H9 broth with 0.5% glycerol, 0.02% Tyloxapol, and 50 µg/mL kanamycin at 37 °C with gentle agitation (80 rpm) until an OD<sub>600</sub> of approximately 0.6 (Zhang et al., Nat Commun, 2022). Subsequently, we assessed the secretion of MmpE-Flag in the culture supernatant, using Ag85B as a positive control and GlpX as a negative control (New Figure S1C). The results showed that GlpX was not detected in the supernatant, while MmpE and Ag85B were detected, indicating that MmpE is indeed a secreted protein in BCG.

      Demonstration that the protein localises to the host cell nucleus upon infection: Perform an infection followed by immunofluorescence to demonstrate that the endogenous protein of BCG can translocate to the host cell nucleus. This should be done for an NLS1-2 mutant expressing cell also.

      We thank the reviewer for the suggestion. We agree that this experiment would be helpful to further verify the ability of MmpE for nuclear import. However, MmpE specific antibody is not available for us for immunofluorescence experiment. Alternatively, we performed nuclear-cytoplasmic fractionation for the THP-1 cells infected with the M. bovis BCG strains expressing FLAG-tagged wild-type MmpE, as well as NLS deletion mutants (MmpE<sup>ΔNLS1</sup>, MmpE<sup>ΔNLS2</sup>, and MmpE<sup>ΔNLS1-2</sup>). The WT MmpE is detectable in both cytoplasmic and nuclear compartments, while MmpE<sup>ΔNLS1</sup>, MmpE<sup>ΔNLS2</sup> or MmpE<sup>ΔNLS1-2</sup> were almost undetectable in nuclear fractions (New Figure S1D), suggesting that both NLS motifs are necessary for nuclear import.

      (2) In the RNA-seq analysis, the directionality of change of each of the reported pathways is not apparent in the way the data have been presented. For example, are genes in the cytokine-cytokine receptor interaction or TNF signalling pathway expressed more, or less in the ∆mmpE strain?

      We thank the reviewer for the comment. The KEGG pathway enrichment diagrams in our RNA-seq analysis primarily reflect the statistical significance of pathway enrichment based on differentially expressed genes, but do not indicate the directionality of genes expression changes. To address this concern, we conducted qRT-PCR on genes associated with the cytokine-cytokine receptor interaction pathway, specifically IL23A, CSF2, and IL12B. The results showed that, compared to the WT strain, infection with the ΔMmpE strain resulted in significantly increased expression levels of these genes in THP-1 cells (Figure 4F, Figure S4B), consistent with the RNA-seq data. Furthermore, we have submitted the complete RNA-seq dataset to the NCBI GEO repository [GSE312039], which includes normalized expression values and differential expression results for all detected genes.

      (3) Several of these pathways are affected as a result of infection, while others are not induced by BCG infection. For example, BCG infection does not, on its own, produce changes in IL1β levels. As the author s did not compare the uninfected macrophages as a control, it is difficult to interpret whether ∆mmpE induced higher expression than the WT strain, or simply did not induce a gene while the WT strain suppressed expression of a gene. This is particularly important because the strain is attenuated. Does the attenuation have anything to do with the ability of the protein to induce lysosomal pathway genes? Does induction of this pathway lead to attenuation of the strain? Similarly, for pathways that seem to be downregulated in the ∆mmpE strain compared to the WT strain, these might have been induced upon infection with the WT strain but not sufficiently by the ∆mmpE strain due to its attenuation/ lower bacterial burden.

      We thank the reviewer for the comment. Previous studies have shown that wild-type BCG induces relatively low levels of IL-1β, while retaining partial capacity to activate the inflammasome (Qu et al., Sci Adv, 2020). Our data (Figures 3G) show that infection with the ΔMmpE strain results in enhanced IL-1β expression, consistent with findings by Master et al. (Cell Host Microbe, 2008), in which deletion of zmp1 in BCG or M. tuberculosis led to increased IL-1β levels due to reduced inhibition of inflammasome activation.

      In the revised manuscript, we have provided additional qRT-PCR data using uninfected macrophages as a baseline control. These results demonstrate that the WT strain suppresses lysosome-associated gene expression, whereas the ΔMmpE strain upregulates these genes, indicating that MmpE inhibits lysosome-related genes expression (Figure 4G). Furthermore, bacterial burden analysis revealed that ∆mmpE exhibited ~3-fold lower intracellular survival than the WT strain in THP-1 cells. However, when lysosomal maturation was inhibited, the difference in bacterial load between the two strains was reduced to ~1-fold (New Figures S6B and C). These findings indicate that MmpE promotes intracellular survival primarily by inhibiting lysosomal maturation, which is consistent with a previous study (Chandra et al., Sci Rep, 2015).

      (4) CHIP-seq should be performed in THP1 macrophages, and not in HEK293T. Overexpression of a nuclear-localised protein in a non-relevant line is likely to lead to several transcriptional changes that do not inform us of the role of the gene as a transcriptional regulator during infection.

      We thank the reviewer for the comment. We performed ChIP-seq in HEK293T cells based on their high transfection efficiency, robust nuclear protein expression, and well-annotated genome (Lampe et al., Nat Biotechnol, 2024; Marasco et al., Cell, 2022). These characteristics make HEK293T an ideal system for the initial identification of genome-wide chromatin binding profiles by MmpE.

      Further, we performed comprehensive validation of the ChIP-seq findings in THP-1 macrophages. First, CUT&Tag and RNA-seq analyses in THP-1 cells revealed that MmpE modulates genes involved in the PI3K–AKT signaling and lysosomal maturation pathways (Figure 4C; Figure S5A-B). Correspondingly, we found that infection with the ΔMmpE strain led to reduced phosphorylation of AKT (S473), mTOR (S2448), and p70S6K (T389) (New Figure 5E-F), and upregulation of lysosomal genes such as TFEB, LAMP1, and LAMP2 (Figure 4G), compared to infection with the WT strain, and lysosomal maturation in cells infected with the ΔMmpE strain more obviously (New Figure 5G). Additionally, CUT&Tag profiling identified MmpE binding at the promoter region of the VDR gene, which was further validated by EMSA and ChIP-qPCR. Also, qRT-PCR demonstrated that MmpE suppresses VDR transcription, supporting its role as a transcriptional regulator (Figure 6). Collectively, these data confirm the biological relevance and functional significance of the ChIP-seq findings obtained in HEK293T cells.

      (5) I would not expect to see such large inflammatory reactions persisting 56 days post-infection with M. bovis BCG. Is this something peculiar for an intratracheal infection with 1x107 bacilli? For images of animal tissue, the authors should provide images of the entire lung lobe with the zoomed-in image indicated as an inset.

      We thank the reviewer for the comment. The lung inflammation peaked at days 21–28 and had clearly subsided by day 56 across all groups (New Figure 7B), consistent with the expected resolution of immune responses to an attenuated strain like M. bovis BCG. This temporal pattern is in line with previous studies using intravenous or intratracheal BCG vaccination in mice and macaques, which also demonstrated robust early immune activation followed by resolution over time (Smith et al., Nat Microbiol, 2025; Darrah et al., Nature, 2020).

      In this study, the infectious dose (1×10<sup>7</sup> CFU intratracheal) was selected based on previous studies in which intratracheal delivery of 1×10<sup>7</sup> CFU produced consistent and measurable lung immune responses and pathology without causing overt illness or mortality (Xu et al., Sci Rep, 2017; Niroula et al., Sci Rep, 2025). We have provided whole-lung lobe images with zoomed-in insets in the source dataset.

      (6) For the qRT-PCR based validation, infections should be performed with the MmpE-complemented strain in the same experiments as those for the WT and ∆mmpE strain so that they can be on the same graph, in the main manuscript file. Supplementary Figure 4 has three complementary strains. Again, the absence of the uninfected, WT, and ∆mmpE infected condition makes interpretation of these data very difficult.

      We thank the reviewer for the comment. As suggested, we have conducted the qRT-PCR experiment including the uninfected, WT, ∆mmpE, Comp-MmpE, and the three complementary strains infecting THP-1 cells (Figure 4F and G; New Figure S4B–D).

      (7) The abstract mentions that MmpE represses the PI3K-Akt-mTOR pathway, which arrests phagosome maturation. There is not enough data in this manuscript in support of this claim. Supplementary Figure 5 does provide qRT-PCR validation of genes of this pathway, but the data do not indicate that higher expression of these pathways, whether by VDR repression or otherwise, is driving the growth restriction of the ∆mmpE strain.

      We thank the reviewer for the comment. In the updated manuscript, we have provided more evidence. First, the RNA-seq analysis indicated that MmpE affects the PI3K-AKT signaling pathway (Figure 4C). Second, CUT&Tag analysis suggested that MmpE binds to the promoter regions of key pathway components, including PRKCBPLCG2, and PIK3CB (Figure S5A). Third, confocal microscopy showed that ΔMmpE strain promotes significantly increased lysosomal maturation compared to the WT, a process downstream of the PI3K-AKT-mTOR axis (New Figure 5G).

      Further, we measured protein phosphorylation for validating activation of the pathway (Zhang et al., Stem Cell Reports, 2017). Our results showed that cells infected with WT strains exhibited significantly higher phosphorylation of Akt, mTOR, and p70S6K compared to those infected with ΔMmpE strains (New Figures 5E and F). Moreover, the dual PI3K/mTOR inhibitor BEZ235 abolished the survival advantage of WT strains over ΔMmpE mutants in THP-1 macrophages (New Figure S6B and C). Collectively, these results support that MmpE activates the PI3K–Akt–mTOR signaling pathway to enhance bacterial survival within the host.

      (8) The relevance of the NLS and the phosphatase activity is not completely clear in the CFU assays and in the gene expression data. Firstly, there needs to be immunoblot data provided for the expression and secretion of the NLS-deficient and phosphatase mutants. Secondly, CFU data in Figure 3A, C, and E must consistently include both the WT and ∆mmpE strain.

      We thank the reviewer for the comment. We have now added immunoblot analysis for expression and secretion of MmpE mutants. The result show that NLS-deficient and phosphatase mutants can detected in supernatant (New Figure S1C). Additionally, we have revised Figures 3A, 3C, and 3E to consistently include both the WT and ΔMmpE strains in the CFU assays (Figures 3A, 3C, and 3E).

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      The authors should attempt to address the following comments:

      (1) Please perform densitometric analysis for the western blot shown in Figure 1E.

      We sincerely thank the reviewer for the suggestion. In the updated manuscript, we have performed densitometric analysis of the western blot shown in New Figure 1F and G.

      (2) Is it possible to measure the protein levels for MmpE in lysates prepared from infected macrophages.

      We thank the reviewer for the comment. In the revised manuscript, we performed immunoblot analysis to measure MmpE levels in lysates from infected macrophages. The results demonstrated that wild-type MmpE was present in both the cytoplasmic and nuclear fractions during infection in THP-1 cells (New Figure S1D).

      (3) The authors should perform circular dichroism studies to compare the secondary structure of wild type and mutant proteins (in particular MmpEHis348 and MmpEAsn359.

      We thank the reviewer for this valuable suggestion. We agree that circular dichroism spectroscopy could provide useful information in comparison of the differences on the secondary structures. However, due to the technical limitations, we instead compared the structures of wild-type MmpE and the His348 and Asn359 mutant proteins predicted by AlphaFold. These structural models showed almost no differences in secondary structures between the wild-type and mutants (Figure S1B).

      (4) The authors should perform more experiments to determine the binding motif for MmpE in the promoter region of VDR.

      We thank the reviewer for this suggestion. In the current study, we have identified the MmpE-binding motif within the promoter region of VDR using CUT&Tag sequencing. This prediction was further validated by ChIP-qPCR and EMSA (Figure 6). These complementary approaches collectively support the identification of a specific MmpE-binding motif and demonstrate its functional relevance. Such approach was acceptable in many publications (Wen et al., Commun Biol, 2020; Li et al., Nat Commun, 2022).

      (5) Were the transcript levels of VDR also measured in the lung tissues of infected animals?

      We thank the reviewer for this suggestion. In the revised manuscript, we have performed qRT-PCR to assess VDR transcript levels in the lung tissues of infected mice (New Figure S8B).

      (6) How does MmpE regulate the expression of lysosome-associated genes?

      We thank the reviewer for this question. Our experiments suggested that MmpE suppresses lysosomal maturation probably by activating the host PI3K–AKT–mTOR signaling pathway (New Figure 5E–I). This pathway is well established as a negative regulator of lysosome biogenesis and function (Yang et al., Signal Transduct Target Ther, 2020; Cui et al., Nature, 2023; Cui et al., Nature, 2025). During infection, THP-1 cells infected with the WT showed increased phosphorylation of Akt, mTOR, and p70S6K compared to those infected with ΔMmpE (New Figure S5C, New Figure 5E and F), and concurrently downregulated key lysosomal maturation markers, including TFEB, LAMP1, LAMP2, and multiple V-ATPase subunits (Figure 4G). Given that PI3K–AKT–mTOR signaling suppresses TFEB activity and lysosomal gene transcription (Palmieri et al., Nat Commun, 2017), we propose that MmpE modulates lysosome-associated gene expression and lysosomal function probably by PI3K–AKT–mTOR signaling pathway.

      (7) Mice experiment:

      (a) The methods section states that mice were infected intranasally, but the legend for Figure 6 states intratracheally. Kindly check?

      (b) Supplementary Figure 7 - this is not clear. The legend says bacterial loads in spleens (CFU/g) instead of DNA expression, as shown in the figure.

      (c) The data in Figure 6 and Figure S7 seem to be derived from the same experiment, but the number of animals is different. In Figure 6, it is n = 6, and in Figure S7, it is n=3.

      We thank the reviewer for the comments.

      (a) The infection was performed intranasally, and the figure legend for New Figure 7 has now been corrected.

      (b) We adopted quantitative PCR method to measure bacterial DNA levels in the spleens of infected mice. We have now revised the legend.

      (c) We have conducted new experiments where each experiment now includes six mice. The results are showed in Figure 7B and C, as well as in the new Figure S8.

      (8) The authors should show individual values for various replicates in bar graphs (for all figures).

      We thank the reviewer for this helpful suggestion. We have now updated all relevant bar graphs to include individual data points for each biological replicate.

      (9) The authors should validate the relative levels of a few DEGs shown in Figure 3F, Figure 3G, and Figure S4C, in the lung tissues of mice infected with wild-type, mutant, and complemented strains.

      We thank the reviewer for this suggestion. In the revised manuscript, we have performed qRT-PCR to validate the expression levels of selected DEGs, including inflammation-related and lysosome-associated genes, in lung tissues from mice infected with wild-type, mutant, and complemented strains (New Figure S8C-H).

      (10) Did the authors perform an animal experiment using a mutant strain complemented with the phosphatase-deficient MmpE (Comp-MmpE-H348AN359H)?

      We appreciate the reviewer's comment. We agree that an additional animal experiment would be useful to assess the effects of the phosphatase. However, our study mainly focused on interpreting the function of the nuclear localization of MmpE during BCG infection. Additionally, we have assessed the role of the phosphatase of MmpE during infection with cell model (Figure 3E).

      Minor comment:

      The mutant strain should be verified by either Southern blot or whole genome sequencing.

      We thank the reviewer for this comment. We verified deletion of mmpE gene by PCR method (Figure S3A-D) which was acceptable in many publications (Zhang et al., PLoS Pathog, 2020; Zhang et al., Nat Commun, 2022).

      Reviewer #3 (Recommendations for the authors):

      (1) Line 195: cytokine.

      We thank the reviewer for the comments. We have now corrected it.

      (2) Line 225: rewording required.

      Corrected.

      (3) Figure 4A. "No difference" instead of "No different".

      Corrected.

      (4) "KommpE" should be replaced with "∆mmpE strain" (∆=delta symbol).

      Corrected.

      (5) Supplementary Figure 7. The figure legend states CFU assays, but the y-axis and the graph seem to depict IS1081 quantification.

      We thank the reviewer for the comment. The figure is based on IS1081 quantification using qRT-PCR, not CFU assays. We have now revised the legend for New Figure S8A.

      References

      Chandra P, Ghanwat S, Matta SK, Yadav SS, Mehta M, Siddiqui Z, Singh A, Kumar D (2015) Mycobacterium tuberculosis Inhibits RAB7 Recruitment to Selectively Modulate Autophagy Flux in Macrophages Sci Rep 5:16320.

      Darrah PA, Zeppa JJ, Maiello P, Hackney JA, Wadsworth MH 2nd, Hughes TK, Pokkali S, Swanson PA 2nd, Grant NL, Rodgers MA, Kamath M, Causgrove CM, Laddy DJ, Bonavia A, Casimiro D, Lin PL, Klein E, White AG, Scanga CA, Shalek AK, Roederer M, Flynn JL, Seder RA (2020) Prevention of tuberculosis in macaques after intravenous BCG immunization Nature 577:95-102. 

      Forrellad MA, Blanco FC, Marrero Diaz de Villegas R, Vázquez CL, Yaneff A, García EA, Gutierrez MG, Durán R, Villarino A, Bigi F (2020) Rv2577 of Mycobacterium tuberculosis Is a virulence factor with dual phosphatase and phosphodiesterase functions Front Microbiol 11:570794.

      Innokentev A, Sanchez AM, Monetti M, Schwer B, Shuman S (2025) Efn1 and Efn2 are extracellular 5'-nucleotidases induced during the fission yeast response to phosphate starvation mBio 16: e0299224.

      Keppetipola N, Shuman S (2008) A phosphate-binding histidine of binuclear metallophosphodiesterase enzymes is a determinant of 2',3'-cyclic nucleotide phosphodiesterase activity J Biol Chem 283:30942-9.

      Lampe GD, King RT, Halpin-Healy TS, Klompe SE, Hogan MI, Vo PLH, Tang S, Chavez A, Sternberg SH (2024) Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases Nat Biotechnol 42:87-98.

      Li Z, Sheerin DJ, von Roepenack-Lahaye E, Stahl M, Hiltbrunner A (2022) The phytochrome interacting proteins ERF55 and ERF58 repress light-induced seed germination in Arabidopsis thaliana Nat Commun 13:1656.

      Marasco LE, Dujardin G, Sousa-Luís R, Liu YH, Stigliano JN, Nomakuchi T, Proudfoot NJ, Krainer AR, Kornblihtt AR (2022) Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy Cell 185:2057-2070.e15.

      Martins WK, Santos NF, Rocha CS, Bacellar IOL, Tsubone TM, Viotto AC, Matsukuma AY, Abrantes ABP, Siani P, Dias LG, Baptista MS (2019) Parallel damage in mitochondria and lysosomes is an efficient way to photoinduce cell death Autophagy 15:259-279.

      Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V (2008) Mycobacterium tuberculosis prevents inflammasome activation Cell Host Microbe 3:224-32.

      Matange N, Podobnik M, Visweswariah SS (2015) Metallophosphoesterases: structural fidelity with functional promiscuity Biochem J 467:201-16.

      Niroula N, Ghodasara P, Marreros N, Fuller B, Sanderson H, Zriba S, Walker S, Shury TK, Chen JM (2025) Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis Sci Rep 15:3764.

      Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, Chaudhury A, Bajaj L, Bondar VV, Bremner L, Saleem U, Tse DY, Sanagasetti D, Wu SM, Neilson JR, Pereira FA, Pautler RG, Rodney GG, Cooper JD, Sardiello M (2017) mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases Nat Commun 8:14338.

      Péan CB, Schiebler M, Tan SW, Sharrock JA, Kierdorf K, Brown KP, Maserumule MC, Menezes S, Pilátová M, Bronda K, Guermonprez P, Stramer BM, Andres Floto R, Dionne MS (2017) Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infection Nat Commun 8:14642.

      Qu Z, Zhou J, Zhou Y, Xie Y, Jiang Y, Wu J, Luo Z, Liu G, Yin L, Zhang XL (2020) Mycobacterial EST12 activates a RACK1-NLRP3-gasdermin D pyroptosis-IL-1β immune pathway Sci Adv 6: eaba4733.

      Shenoy AR, Capuder M, Draskovic P, Lamba D, Visweswariah SS, Podobnik M (2007) Structural and biochemical analysis of the Rv0805 cyclic nucleotide phosphodiesterase from Mycobacterium tuberculosis J Mol Biol 365:211-25.

      Smith AA, Su H, Wallach J, Liu Y, Maiello P, Borish HJ, Winchell C, Simonson AW, Lin PL, Rodgers M, Fillmore D, Sakal J, Lin K, Vinette V, Schnappinger D, Ehrt S, Flynn JL (2025) A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity Nat Microbiol 10:468-481.

      Wang J, Ge P, Qiang L, Tian F, Zhao D, Chai Q, Zhu M, Zhou R, Meng G, Iwakura Y, Gao GF, Liu CH (2017) The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation Nat Commun 8:244.

      Wang J, Li BX, Ge PP, Li J, Wang Q, Gao GF, Qiu XB, Liu CH (2015) Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system Nat Immunol 16:237–245

      Wen X, Wang J, Zhang D, Ding Y, Ji X, Tan Z, Wang Y (2020) Reverse Chromatin Immunoprecipitation (R-ChIP) enables investigation of the upstream regulators of plant genes Commun Biol 3:770.

      Xu X, Lu X, Dong X, Luo Y, Wang Q, Liu X, Fu J, Zhang Y, Zhu B, Ma X (2017) Effects of hMASP-2 on the formation of BCG infection-induced granuloma in the lungs of BALB/c mice Sci Rep 7:2300.

      Zhang L, Hendrickson RC, Meikle V, Lefkowitz EJ, Ioerger TR, Niederweis M. (2020) Comprehensive analysis of iron utilization by Mycobacterium tuberculosis PLoS Pathog 16: e1008337.

      Zhang L, Kent JE, Whitaker M, Young DC, Herrmann D, Aleshin AE, Ko YH, Cingolani G, Saad JS, Moody DB, Marassi FM, Ehrt S, Niederweis M (2022) A periplasmic cinched protein is required for siderophore secretion and virulence of Mycobacterium tuberculosis Nat Commun 13:2255.

      Zhang X, He X, Li Q, Kong X, Ou Z, Zhang L, Gong Z, Long D, Li J, Zhang M, Ji W, Zhang W, Xu L, Xuan A (2017) PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications Stem Cell Reports 8:1256-1269.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public Review):

      Thank you for the authors' responses to my concerns. I do not have any further comments.

      We thank this reviewer for the positive and constructive evaluation of our manuscript.

      Reviewer #2 (Public Review):

      I have no further comment about this amended version, aside from suggesting to add (if known) the time at which biopsies were collected. Time-of-day is an important yet often overlooked parameter of gene expression variation, and along the same line, the imposed fasting to bariatric surgery patients is also a matter of variation of gene expression and of metabolite abundance. It is hoped that future investigations will more precisely characterize the role of the newly identified targets in MASLD.

      We agree with this and are fully aware that metabolism in the liver is controlled by circadian rhythm and therefore the time-of-day is an important parameter when liver samples are collected. All liver samples were collected between 8am and 1pm, and this information has been added to the Methods section. We are already working on the characterization of the newly identified targets. Thank you for the positive and constructive evaluation of our manuscript.

      Reviewer #3 (Public Review):

      (1) Confounders (such as (pre-)diabetes)

      The patient table shows significant differences in non-MASLD vs. MASLD individuals, with the latter suffering more often from diabetes or hypertriglyceridemia. Rather than just stating corrections, subgroup analyses should be performed (accompanied with designated statistical power analyses) to infer the degree to which these conditions contribute to the observations. I.e., major findings stating MASLD-associated changes should hold true in the subgroup of MASLD patients without diabetes/of female sex and so forth (testing for each of the significant differences between groups).

      Post-rebuttal update: The authors have performed the requested sub-group analysis and find the gene signatures hold for the non-diabetic sub-cohort, but not the diabetic subgroup. They denote a likely interaction between fibrosis and diabetes, that was not corrected for in the original analysis.

      (2) External validation

      Additionally, to back up the major GTPase signature findings, it would be desirable to analyze an external dataset of (pre)diabetes patients (other biased groups) for alternations in these genes. It would be important to know if this signature also shows in non-MASLD diabetic patients vs. healthy patients or is a feature specific to MASLD. Also, could the matched metabolic data be used to validate metabolite alterations that would be expected under GTPase-associated protein dysregulation?

      Post-rebuttal update: The authors confirm that with the present data, insulin resistance cannot be fully ruled out as a confounder to the GTPase related gene signature. They however plan future mouse model experiments to study whether the GTPase-fibrosis signature differs in diabetic vs. non-diabetic conditions.

      (3) 3D liver spheroid MASH model, Fig. 6D/E

      This 3D experiment is technically not an external validation of GTPase-related genes being involved in MASLD, since patient-derived cells may only retain changes that have happened in vivo. To demonstrate that the GTPase expression signature is specifically invoked by fibrosis the LX-2 set up is more convincing, however, the up-regulation of the GTPase-related genes upon fibrosis induction with TGF-beta, in concordance with the patient data, needs to be shown first (qPCR or RNA-seq). Additionally, the description of the 3D model is too uncritical. The maintenance of functional PHHs is a major challenge (PMID: 38750036, PMID: 21953633, PMID: 40240606, PMID: 31023926). It cannot be ruled out that their findings are largely attributable to either 1) the (other present) mesenchymal cells (i.e., mesenchyme-derived cells, such as for example hepatic stellate cells, not to be confused with mesenchymal stem cells, MSCs), or 2) related to potential changes in PHHs in culture, and these limitations need to be stated.

      Post-rebuttal update: To address the concern of other cells than hepatocytes contributing to the observed effects in culture, the authors performed TGF-beta treatment in independent mono-cultures (Figure R4): LX-2 and hepatocytes, and the spheroid system. Surprisingly, important genes highlighted in Figure 6E for the spheroid system (RAB6A, ARL4A, RAB27B, DIRAS2) are all absent from this qPCR(?) validation experiment. The authors evaluate instead RAC1, RHOU, VAV1, DOCK2, RAB32. -In spheroids, RHOU and RAB32 are down-regulated with TGF-B. In hepatocytes DOCK2 and RAC seemed up-regulated. They find no difference in these genes in LX-2 cells. Surprisingly, ACTA2 expression values are missing for LX-2 cells. Together, it is hard to judge which individual cell type recapitulates the changes observed in patients in this validation experiment, as the major genes called out in Figure 6E are not analyzed.

      All biological experiments show variations and especially when analyzing various cell types (lines), we are not completely surprised that not all results are completely aligned. In other words, some of the GTPases will be upregulated in hepatocytes, while other may be upregulated in hepatic stellate cells due to the complex signaling arrangement in each cell. To address this reviewer’s concerns, we have done qPCR for RAB6A, ARL4A, RAB27B, DIRAS2 in LX-2 cells and the results are shown in the revised now Figure 6– figure supplement 5. To align all three graphs displaying the same genes analyzed, we have now depicted the gene expression for the co-culture (hepatocytes, hepatic stellate cells, and Kupffer cells) and mono-culture (hepatocytes only) from RNAseq analysis.

      Unfortunately, the 3D liver spheroid model used (as presente-d in PMID39605182) lacks important functional validation tests of maintained hepatocyte identity in culture (at the very least Albumin expression and secretion plus CYP3A4 assay). This functional data (acquired at the time point in culture when the RNA expression analysis in 6E was performed) is indispensable prior to stating that mature hepatocytes cause the observed effects.

      We agree that the characterization of the liver spheroid model derived from human patient samples is important. The functional characterization has already been published in these papers:

      (1) Bell, C. C. et al. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab. Dispos. 45, 419–429 (2017).

      (2) Bell, C. C. et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci. Rep. 6, 25187 (2016). 3.Vorrink, S. U. et al. Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long‐term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. FASEB J. 31, 2696–2708 (2017).

      (4) Messner, S. et al. Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues. Appl. In Vitro Toxicol. 4, 1–12 (2018).

      (5) Bell, C. C. et al. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study. Toxicol. Sci. 162, 655–666 (2018). We have mentioned this now in the manuscript on page 18 to make this point clear.

      (4) Novelty / references

      Similar studies that also combined liver and blood lipidomics/metabolomics in obese individuals with and without MASLD (e.g. PMID 39731853, 39653777) should be cited. Additionally, it would benefit the quality of the discussion to state how findings in this study add new insights over previous studies, if their findings/insights differ, and if so, why.

      Post-rebuttal update: The authors have included the studies into their discussion.

      Recommendations for the authors:

      Reviewer #3 (Recommendations for the authors):

      (1) Add the plots showing diabetes/non-diabetes sub-group analysis and power estimates to the Supplementary Figures (rather than just as a Supplementary table)

      We have added this as Figure 5-figure supplement 2 in the revised manuscript (R2).

      (2) Add a short note on the validity of the results limiting to the non-diabetes subgroup to the limitations section

      We have done this in the revised manuscript (R2).

      (3) Add a short note on the missing adjustment for fibrosis/diabetes interactions in the study to the limitations paragraph

      We appreciate the reviewer’s suggestion to address the lack of adjustment for potential fibrosis–diabetes interaction. We added a note to the limitations paragraph in the Limitations section. Although diabetes considerably modulates the risk for steatohepatitis, only a small number of participants had diabetes (29 of 109) in our study, undermining statistical power to detect meaningful interaction effects.

      Author response table 1.

      (4) Fig S10/6E: In vitro TGF-b stimulation on spheroids, LX-2 cells, hepatocytes: evaluate expression of RAB6A, ARL4A, RAB27B, DIRAS2 genes from 6E to create consistency between the findings. Confirm ACTA2 up-regulation in LX-2 cells treated with TGF-β as a positive control. Also specify methods for gene expression analysis in spheroids and the cell types in the figure legends (RNA-Seq? qPCR?)

      To address this reviewer’s concerns, we have done qPCR for RAB6A, ARL4A, RAB27B, DIRAS2 in LX-2 cells stimulated with TGF-β and the results are shown in the revised now Figure 6–figure supplement 5. To align all three graphs displaying the same genes analyzed, we have now depicted the gene expression for the co-culture (hepatocytes, hepatic stellate cells, and Kupffer cells) and mono-culture (hepatocytes only) from RNAseq analysis. We have also updated the methods that we used in the figure legend.

      (5) Validate the functionality of hepatocytes in the 3D liver spheroid model used (PMID: 39605182) at the time points of which the experiments have been performed (e.g. Albumin secretion, CYP-assays).

      We agree that the characterization of the liver spheroids from human patients using fully differentiated cells, is important but this has already been done and is published in these papers:

      (1) Bell, C. C. et al. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab. Dispos. 45, 419–429 (2017).

      (2) Bell, C. C. et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci. Rep. 6, 25187 (2016). 3.Vorrink, S. U. et al. Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long‐term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. FASEB J. 31, 2696–2708 (2017).

      (4) Messner, S. et al. Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues. Appl. In Vitro Toxicol. 4, 1–12 (2018).

      (5) Bell, C. C. et al. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study. Toxicol. Sci. 162, 655–666 (2018).

      We have mentioned this now in the manuscript on page 18 and also the Limitation section to make this point clear.

      (6) Add a note on limitations of the PHH-spheroid and cell line in vitro models to the limitations section and discuss the need for future experiments to examine the cellular crosstalk and cell types potentially responsible for the proposed GTPase-gene dysregulation.

      We have added this to the limitation section on page 13 this in the revised manuscript (R2).

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The hippocampus, especially the ventral subregion, has been related to emotional processing. However, the specific circuitry involved deserves further investigation. By using a bidirectional optogenetic modulation, Kambali et al. have investigated the role of different inputs to vCA1 (i.e., from vCA3 and entorhinal cortex) in anxiety- and fear-related responses. The major findings of this work suggested that both inputs to vCA1 control fear-related responses, whereas only the projection between vCA3 and vCA1 controls anxiety-related behavior. Overall, the authors used an advanced methodological approach, which allows them to modulate specific brain circuits, to study specific hippocampal projections, providing some new information regarding the hippocampal function in anxiety and fear.

      Strengths:

      (1) The manuscript is well written, clear and has a detailed and specific discussion.

      (2) Results from each optogenetic manipulation are clear in different anxiety- and fear-related tasks, demonstrating the robustness of the findings.

      (3) The overall conclusions are very interesting and might be relevant for the field of mental health disorders accompanied by anxiety- and fear-related alterations.

      Weaknesses:

      (1) The major differences in basal behavioral performance in the different paradigms between the two optogenetic modulations prevent the achievement of strong conclusive results.

      The two projections of ventral CA1 were studied independently in different cohorts of animals tested at different times during the study. This difference in timing may have contributed to variations in the basal behavioral performance between the two projections. Importantly we found that within each cohort – control and optogenetic manipulation, the basal performance within each set of experiments (i.e., corresponding to projections) is highly consistent, e.g., basal cued and contextual freezing responses and responses to OFF conditions in Vogel conflict test. Moreover, the ANOVA statistics conducted across the baseline and ON conditions for each task revealed robust significant effects of bidirectional optogenetic modulation for each cohort. In case of the fear responses, a point to note is that the freezing levels in SHAM controls differ between projections but are consistent between two types of assessments (tone and context) within each projection. We will mention these limitations in the revised manuscript.

      (2) Data presentation and representative figures need a major revision.

      The figures will be rearranged according to the projections. The anxiety-related figures and fear response related figures will be grouped for each projection to improve clarity and readability. The revised manuscript will include representative heat maps for each behavioral task for both projections in addition to population quantification data.

      (3) No analysis has been performed to analyze potential sex differences in behavioral domains where sex is important.

      This assessment was not done in the original submission. We will perform statistical analysis for male and female mice separately and if the results are sex-dependent, we will present separate figures. Otherwise, the combined data presentation will be followed.

      Reviewer #2 (Public review):

      Summary:

      This paper uses an optogenetic approach to either activate or inhibit separate neural pathways projecting to the ventral CA1 hippocampal subregion, from either CA3 or the entorhinal cortex. The authors report that manipulation of the vCA3→vCA1 pathway affected behavioural performance on a number of tasks: elevated plus maze, open field, Vogel conflict test and freezing behaviour to both context and a trace CS cue. In contrast, optogenetic manipulation of neural activity in the EC→vCA1 pathway only affected behaviour on the trace CS/context fear memory test but had no effect on the elevated plus maze, open field or Vogel conflict test. The authors suggest different roles for these two ventral hippocampal pathways in fear versus anxiety.

      Strengths:

      This is an interesting study addressing an important question in a highly topical subject area. The experiments are well conducted and have generated interesting and important data.

      Weaknesses:

      While I am broadly sympathetic to the overall narrative of the paper, I have some questions/comments around the specific interpretation of the results presented. In my view, the authors' claims may not be completely supported by their data, but the data are interesting nonetheless.

      In terms of the framework presented by the authors for interpreting their data, many would argue that freezing (or at least reduced activity/behavioural inhibition) to the context provides a readout of conditioned anxiety rather than fear. In this sense, the context is a signal of potential threat (i.e. the context becomes associated with both shock and with the absence of shock) and thus generates anxiety rather than fear. Likewise, the trace CS cue could be considered as an ambiguous predictor of shock in that the shock doesn't occur straight away.

      In contrast, a punctate CS cue which co-terminates with shock would be a reliable signal of imminent threat and thus generates a fear response. Thus, it might be argued that all of the assays adopted by the authors are readouts of anxiety (albeit comprising tests of both conditioned and unconditioned anxiety).

      We agree with the reviewer that context and trace fear conditioning do not represent an “imminent” threat as severe as would likely be internalized in delay fear conditioning. However, the goal of the study was to probe hippocampal dependent processes (contextual and trace fear conditioning are strongly modulated by the hippocampus while delay conditioning is not). Consistent with several other studies, we believe the conditional nature of the task (context and trace are invariably linked to shock) provides support for a “non-ambiguous” relationship that is conducive for measuring the assessment of fear-based behavior.

      Several studies show clear differences in the involvement of amygdala and hippocampus in delay vs. trace fear conditioning. Inactivating amygdala led to deficits in contextual and delay conditioning but had no effect on trace conditioning. In contrast, inactivating hippocampus led to deficits in trace and contextual but not delay fear conditioning. These findings suggest that a temporal gap between the CS and US can generate amygdala-independent but hippocampal-dependent fear conditioning (Raybuck J. D., Lattal K. M 2011, PMID: 21283812). Lesions of the entorhinal cortex impair the acquisition of trace fear conditioning but not the acquisition of delay fear conditioning (Raybuck J. D., Lattal K. M 2011, PMID: 21283812) . Further, using single unit recording during fear retention tests after delay or trace fear conditioning, the study showed that entorhinal neurons specifically respond after trace but not after delay fear conditioning (Kong et al 2023, PMID: 36919333). These findings demonstrate that trace fear conditioning and delay fear conditioning may involve overlapping but largely different neuronal circuits. A knockdown of the expression of the α5-subunit–containing GABA<sub>𝐴</sub> receptors in the CA1 region (α5CA1KO mice) leads to improved spatial learning and enhanced trace fear conditioning memory, actually to the level of delay fear conditioning, suggesting that α5GABA<sub>𝐴</sub>Rs in CA1 pyramidal neurons normally constrain hippocampus-dependent memory processes and that trace fear conditioning in the absence of a5-GABA<sub>𝐴</sub> receptors in CA1 has the same effect size as delay fear conditioning (Engin et al 2020, PMID: 32934095), supporting the view that trace fear conditioning is not “ambiguous”.

      For example, from the authors' perspective, it is not clear a priori why the Vogel conflict test is considered anxiety, but contextual freezing is considered fear? Indeed, in the Discussion, the authors mention another study in which the data from the Vogel conflict test align with fear assays rather than anxiety tests. Can the authors elaborate on their distinction? I appreciate that, in practice, it might be difficult to distinguish between fear and anxiety at the behavioral level in rodents (although opposing effects of fear and anxiety on pain responses might be one option). At the very least, this issue merits further discussion.

      We will make this distinction clearer in the revisions. Briefly, behavioral actions in the Vogel conflict test are generally considered to be most pertinent to general anxiety disorders in humans and anxiolytics have high predictive validity in animals in this task. In particular, the robust actions of benzodiazepines and 5-HT<sub>1A</sub> partial agonists parallel their clinical efficacy in patients (McMillan and Brocco, 2003, PMID: 12600703).

      Our previous study (Engin et al 2016, PMID: 26971710) used global diazepam-induced neuronal inhibition and identified that positive modulation of α2-GABA<sub>𝐴</sub>Rs in dentate gyrus granule cells and CA3 pyramidal neurons is required to reduce anxiety-like behaviors while inhibition of positive modulation of α2-GABA<sub>𝐴</sub>Rs in CA1 pyramidal neurons is required to reduce fear-related behaviors. The effects were absent when α2-GABA<sub>𝐴</sub>Rs was knocked out in the respective subregions. These results indicate that these intrahippocampal subregions can modulate fear and anxiety-like behaviors independently of the amygdala. In the previous study we used conditional α2-GABA<sub>𝐴</sub>R knockouts in hippocampal subregions and subjected these mice to systemic diazepam. In these experiments, diazepam still acts on α1-, α3- and α5-<sub>𝐴</sub>Rs in the hippocampal subregions and cell types in which when α2-GABA<sub>𝐴</sub>Rs are lacking. Therefore, for example when α2CA1KO mice were administered diazepam, diazepam still led to inhibition of pyramidal neurons in CA3 and DG via α1-, α2-, α3- and α5- GABA<sub>𝐴</sub>Rs, and in addition, diazepam also inhibited α1-, α3- and α5- GABA<sub>𝐴</sub>Rs in CA1 itself. Diazepam also acted on GABA<sub>𝐴</sub>Rs in amygdala or other brain regions. These are fundamentally different experimental conditions compared to the optogenetic experiment described in this paper. Moreover, in contrast to the current paper, the previous work did not examine projections but used global diazepam-induced neuronal inhibition as a baseline. Moreover, whereas the previous paper examined whether a specific neuronal cell type was required for anxiolytic-like or fear-like actions, the current manuscript examined whether activation or inhibition of neuronal projections is sufficient to modulate anxiety- and fear-related behaviors. Overall, one cannot easily compare the results in the Vogel conflict test in both papers.

      Another question is whether rather than representing a qualitative difference between the contributions of the vCA3→vCA1 and EC→vCA1 pathways to different aspects of fear/anxiety behaviours, the different results reflect a quantitative difference between the magnitude of effects in vCA1 that are generated from optogenetic manipulation of the two pathways, coupled with the possibility that behaviour on the trace CS/context fear memory task is more sensitive to manipulation than the "anxiety tests". The possibility that vCA3→vCA1 stimulation is more effective is potentially supported by the c-fos measurements in vCA1. vCA3→vCA1 stimulation produced a much bigger vCA1 c-fos response (approx. 350% c-fos cell activation; see Figure 1E) compared to activation of the EC→vCA1 pathway (approx. 170% c-fos cell activation; see Figure 4E).

      Furthermore, in some studies, there seem to be quite large differences between the laser OFF conditions for the different groups (which presumably one would not expect to be different). For example, compare laser OFF for the Inhibition group for time in open arms of EPM in Figure 5C (> 40%) versus laser OFF for the Inhibition group for time in open arms of EPM in Fig. 2C (< 20%). This could potentially result in ceiling effects, such that it is very hard to see a further increase in time in the open arms from a level already above 40% when the laser is then switched on. This could complicate the interpretation of the laser ON condition.

      The magnitude of activation as evidenced by c-fos measurements differs between the two projections. This might reflect different levels of modulations of CA1 neuronal activity. The fact that the two projections were studied at different time points (see response to reviewer 1) may also have contributed to the difference. The revised manuscript will include a formal discussion about magnitude of modulation that could contribute to differential sensitivity for the modulation of anxiety-like behaviors. However, the inputs from these two projections systems target different regions of CA1 pyramidal neurons and each pathway has distinct roles in other processes (sensory versus memory-based completion) – thus a dissociation may also be present for other types of behavior as well including the modulation of anxiety-like behaviors.

      While it is possible that ceiling effects could impact our interpretation, we believe ceiling effects would only impact one direction of the optogenetic manipulation and there was no effect of activation (Fig. 5C) or bidirectional modulation of anxiety-related behavior in the novel open field test (Fig. 5F) which has levels of behavior comparable to Figure 2F.

      Likewise, there is a big difference between the behavioral performance of the two SHAM groups in Figure 3 (compare SHAM in 3 B, C and SHAM in 3 D, E). How is this explained? Could this generate a ceiling effect? This may also merit some discussion. More details on the SHAM procedure(s) in the main manuscript may also be helpful.

      With respect to contextual fear, ceiling effects are not a major factor as we still see enhanced freezing in the activation condition. With tone fear, we cannot formally exclude a ceiling effect, and this will be addressed as a potential confound in the manuscript.

      According to Figure 3A, the test of freezing response to the trace Tone CS is conducted in a different context from the conditioning context. The data presented in Figure 3 for tone fear are the levels of freezing during the presentation of this cue in different contexts. It would be important to present both pre-CS and CS freezing levels here to determine how much of the freezing is actually driven by the punctate tone CS. The pre-CS freezing levels in this different context would also provide a nice control for the contextual fear conditioning.

      We agree and will analyze and report the pre-CS freezing data in the revision.

      Reviewer #3 (Public review):

      Summary:

      In their paper entitled "Ventral hippocampal temporoammonic and Schaffer collateral pathways differential control fear- and anxiety-related behaviors" the authors use a bidirectional optogenetic approach to elucidate the role of temporammonic (TA) and Schaffer collateral (SC) inputs to the ventral hippocampus (CA1) in modulating both fear and anxiety-related behaviors. While fear and anxiety behaviors are often considered on a continuous spectrum, identifying neural pathways that are differentially activated represents an important open question in the field. The authors find that optogenetic stimulation or inhibition of the Schaffer Collateral pathway in the ventral hippocampus (CA3-CA1) bidirectionally modulates both fear-related and anxiety-related behavioral paradigms. More specifically, optogenetic excitation of the CA3-CA1 pathway using ChR2-expressing viral constructs increases anxiety-like behaviors in numerous behavioral paradigms (elevated plus maze, open field, Vogel conflict test). Conversely, optogenetic inhibition using halorhodopsin reduced anxiety-like behaviours. To examine fear behaviors, the authors examined contextual and trace fear conditioning. Similar to their results with anxiety-like behaviors, the authors observed bidirectional fear modulation following optogenetic stimulation of the vCA3-vCA1 pathway. The authors next examined the temporammonic pathway originating from the lateral entorhinal cortex to vCA1. Unlike with SC stimulation, stimulation of the TA pathway had no effect on anxiety-like behaviors but did bidirectionally modulate contextual fear conditioning. Together, these results differentiate the SC and TA pathways in the ventral hippocampus as distinct regulators of affective behavior.

      Strengths:

      The paper has numerous technical strengths, including dissecting the role of both excitation and inhibition of both pathways and the use of behavioral measures of anxiety and fear. This balanced and internally controlled design allows readers to evaluate the effects of both pathways in a single study, thereby reducing technical complications from experiments being completed across laboratories and experimental conditions.

      Weaknesses:

      There are a few limitations of the study, however, which bear discussion.

      (1) The authors use halorhodopsin to achieve optogenetic inhibition. Halorhodopsin is generally considered a first-generation optogenetic actuator, as it is a Cl- pump rather than an ion channel. This limits the degree of inhibition (i.e. by preventing shunting inhibition) and can result in altered chloride gradients in the period immediately following optogenetic stimulation. This is of particular concern in this paper as the stimulation parameters and behavioral analysis are not temporally correlated, therefore confounds of disrupted chloride cannot be experimentally accounted for or controlled.

      Choice of halorhodopsin was in part influenced by a report that spontaneous archaerhodopsin activation was paradoxically associated with increased spontaneous release of neurotransmitter from presynaptic terminals, whereas activation of chloride-reducing halorhodopsin triggered neurotransmitter release upon light onset (Mahn et al., PMID: 26950004), suggesting that halorhodospin may be advantageous in studies inhibiting presynaptic nerve terminals. Halorhodpsin has been used in several studies to effectively silence activity and had substantial influence on behavioral in our studies that was inversely proportional to ChR2 stimulation. While perhaps not optimal out of an abundance of caution, we chose it over Archaerhodopsin based on the cited literature.

      (2) The authors use an AAV-CaMKII-eGFP as a control (Sham) throughout the dataset; however, in the trace fear conditioning experiments, there are no AAV-CaMKII-ChR2-eYFP or AAV-CaMKII-eNpHR3.0-eYFP controls without optogenetic stimulation. Therefore, it is unclear the extent to which viral expression of optogenetic actuators impacts behavior. Additionally, the authors only provided optogenetic stimulation during contextual fear recall and tone fear recall. Additional experiments disrupting each pathway during trace conditioning would have provided additional insight into the role of each pathway in the initial encoding of fear memories.

      Thank you for your observation. We have used a SHAM control that was injected with the AAV vector without any opsins. In fear conditioning experiments we performed optogenetic manipulations only during the fear response either with context or cue recall. This aligned well with our hypothesis to test whether the intrahippocampal projections play any role in fear response modulation. Investigating the role of each pathway during acquisition of trace and/or contextual fear conditioning is also highly relevant; however, evaluating these projections in fear memory formation was beyond the scope of this study. The observation that we can bidirectionally modulate fear responses with light is consistent with (although it does not prove) a light-specific modulation. In any case, even if there were baseline effects without light, they would still be suggestive of the effects observed being mediated by the optogenetic actuators.

      (3) The location and extent of viral expression across animals were not systematically quantified.Overall, however, these weaknesses do not significantly detract from the main conclusions of the paper. The authors' data convincingly demonstrates that disruption of the trisynaptic circuit bidirectionally modulates both fear- and anxiety-like behaviors while disruption of the temporammonic pathway has no effect on anxiety-like behaviors but disrupts fear-related behaviors. It is interesting to note, however, that the TA activation had no effect on tone-related fear conditioning, suggesting a potential specialized role of the temporammonic pathway specifically in contextual fear memory.

      Thank you for your thoughtful description of the present study. It is true that TA pathway is distinct from vCA3 to vCA1 pathway in various ways, one being the synapse formation of these two projections are at different locations or layers on vCA1 neurons i.e., the TA pathway synapses on the stratum lacunosum-moleculare (LMol) layer while the vCA3 to vCA1 pathway synapses at stratum radiatum (Rad), close to the CA1 pyramidal cell layer, which is in line with differential functions of the two projections They modulate the pyramidal cell activity in a different way, with TA pathway synapses being distinct from vCA3 to vCA1 synapses on the pyramidal cell layer, which may result in different computational properties of the two projections. Additionally, TA projections are modulated by dopamine while projections from vCA3 are not, but the projections from vCA3 receive inputs from various sources including collaterals, and entorhinal via dentate gyrus. These distinct features of the two projections may contribute to differential modulation of vCA1 activity. We note that cue-related fear is not affected by the TA activation, however even in this case, the TA pathway activation by channelrhodopsin or inhibition by halorhodopsin results in a decrease or an increase of the contextual fear response, respectively.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study offers insights into the role of Leiomodin-1 (LMOD1) in muscle stem cell biology, advancing our understanding of myogenic differentiation and indicating LMOD1 as a regulator of muscle regeneration, aging, and exercise adaptation. The integration of in vitro and in vivo approaches, complemented by proteomic and imaging methodologies, is solid. However, certain aspects require further attention to improve the clarity, impact, and overall significance of the work, particularly in substantiating the in vivo relevance. This work will provide a starting point that will be of value to medical biologists and biochemists working on LMOD and its variants in muscle biology.

      Thank you for the positive feedback on our manuscript and the constructive criticism provided by the reviewers that helped us improve our manuscript.

      Public Reviews:

      Reviewer #1 (Public review):

      This manuscript by Ori and colleagues investigates the role of Lmod1 in muscle stem cell activation and differentiation. The study begins with a time-course mass spectrometry analysis of primary muscle stem cells, identifying Lmod1 as a pro-myogenic candidate (Figure 1). While the initial approach is robust, the subsequent characterization lacks depth and clarity. Although the data suggest that Lmod1 promotes myogenesis, the underlying mechanisms remain vague, and key experiments are missing. Please find my comments below.

      We thank the reviewer for the positive feedback on our manuscript and the helpful comments, which helped improve it.

      (1) The authors mainly rely on coarse and less-established readouts such as myotube length and spherical Myh-positive cells. More comprehensive and standard analyses, such as co-staining for Pax7, MyoD, and Myogenin, would allow quantification of quiescent, activated, and differentiating stem cells in knockdown and overexpression experiments. The exact stage at which Lmod1 functions (stem cell, progenitor, or post-fusion) is unclear due to the limited depth of the analysis. Performing similar experiments on cultured single EDL fibers would add valuable insights.

      We thank the reviewer for this comment. In addition to performing standard measurements such as staining for Myogenin and Myosin Heavy Chain (Figure S2H), we focused on morphological readouts, such as myotube formation, because LMOD1 is an actin cytoskeleton-associated protein. Therefore, we reasoned its function would be most directly reflected in structural changes during differentiation, rather than solely in early transcriptional markers. 

      Regarding the use of standard markers, we have already performed co-staining for Myogenin and Myosin Heavy Chain (MHC), which effectively quantifies early myogenic committed (Myogenin+/MHC-) and terminally differentiating (Myogenin+/MHC+) cells (Figure S2H). We did not include Pax7 as our primary culture system consists of already activated myoblasts, where Pax7 is not a reliable marker of quiescence. Our data also suggest that Lmod1 is important in regulating differentiation with comparably only mild effects on proliferation (S2D-E), therefore, we focused on this stage of myogenesis.

      Our focus on differentiation over activation is further supported by multiple lines of evidence. First, analysis of publicly available transcriptome datasets reveals that Lmod1 mRNA levels actually decrease upon Muscle Stem Cell (MuSC) activation, suggesting its primary role is not during this initial phase. We added this data for clarification to Figure S1B. This aligns perfectly with our in vivo data from cardiotoxin-induced muscle regeneration, where abundance of LMOD1 protein peaks at days 4-7 post-injury — a time point coinciding with new myofiber formation and maturation — rather than during the initial activation and proliferation phase (days 1-3) (Figure 4I).

      Given this strong evidence pointing to a primary role for LMOD1 during the later stages of differentiation, we believe our current analyses are the most relevant. While single EDL fiber cultures are valuable for studying the quiescence-to-activation transition, they would not provide significant additional insight into the specific differentiation-centric mechanism we are investigating here. We are confident that our chosen readouts appropriately address Lmod1's function in the differentiation of myoblasts and formation of myotubes.

      (2) In supplementary Figure 2E, the distinction between Hoechst-positive cells and total cell counts is unclear. The authors should clarify why Hoechst-positive cells increase and relabel "reserve cells," as the term is confusing without reading the legend.

      We thank the reviewer for pointing out the confusion regarding the naming of the cell populations and the increase in Hoechst-positive cells. We have now modified this and revised the terminology used in Figure S2E to improve clarity. Specifically, we have relabeled "reserve cells" as "non-proliferating myoblasts (Ki67-/Hoechst+)" to describe these cells more accurately without requiring the legend for interpretation. Regarding the increase in Hoechst-positive cells, we observed a slight (26%) but significant decrease in the number of proliferating myoblasts (Ki67+/Hoechst+) (Figures S2D and S2E). The relative increase in non-proliferating (Ki67-/Hoechst+) cells is a consequence of the significant reduction in the number of proliferating cells (Ki67+/Hoechst+) cells. Importantly, the total cell count (sum of Ki67-/Hoechst+) and (Ki67+/Hoechst+) remained stable. This has been clarified in the revised figure legend and main text as follows:

      “This was accompanied by a proportional increase in non-proliferating myoblasts (Ki67-/Hoechst+), while the total Hoechst-positive cell count (Ki67+/Hoechst+ and Ki67-/Hoechst+) remained unchanged (Figure S2E).”

      (3) The specificity of Lmod1 and Sirt1 immunostaining needs validation using siRNA-treated samples, especially as these data form the basis of the mechanistic conclusions.

      We have validated the specificity of the LMOD1 antibody using multiple approaches. Specifically, we performed immunofluorescence and immunoblotting on Lmod1 siRNA-transfected samples, where we observed a significant reduction in the Lmod1 protein signal compared to control conditions (see manuscript data from Figure S2G).

      Additionally, LMOD1 overexpression experiments demonstrated a corresponding increase in the signal for LMOD1 using immunofluorescence analyses, confirming the specificity of the antibody for detecting LMOD1.

      For the reviewers’ interest, we add Author response image 1:

      Author response image 1.

      Specificity of antibodies detecting LMOD1. Representative immunofluorescence images of LMOD1 in primary myoblast cultures following siLmod1 knockdown, LMOD1 overexpression, or controls transfected with a non-targeting siRNA (siCtrl) after one day of differentiation. LMOD1 (purple), SIRT1 (yellow), and nuclei (Hoechst, blue). Scale bar: 10 µm.

      For the SIRT1 antibody used in our immunostaining, the specificity was validated by transfecting primary myoblasts with siRNA targeting Sirt1 and performing immunoblot analyses (Figure S5A). These showed a significant reduction in SIRT1 protein levels, confirming both the effectiveness of the siRNA and, critically, the antibody's ability to specifically recognize and detect SIRT1 protein. Furthermore, the same SIRT1 antibody was utilized in our nuclear-cytoplasmic fractionation experiments (Figure S4C), and its ability to detect SIRT1 in the expected subcellular compartments further supports its specific binding to SIRT1. While direct immunofluorescence on Sirt1 siRNA-transfected samples was not performed, the robust demonstration of the antibody's specificity for Sirt1 protein via immunoblotting (i.e., correct molecular weight band, significantly reduced by Sirt1 siRNA) and its distribution in subcellular fractions, which is fully consistent with the localization immunostaining performed at the same time points (compare Figure S4C and 5A), provide strong evidence on the antibody’s specificity, also in immunofluorescence experiments.

      (4) The authors must test the effect of Lmod1 siRNA on Sirt1 localization, as only overexpression experiments are shown

      We carefully considered performing this experiment. However, the knockdown of Lmod1 significantly impairs myogenic differentiation, a crucial cellular process that itself can influence protein localization. Consequently, if SIRT1 localization would be altered following knockdown of Lmod1, it would be challenging to disentangle whether this was a direct result of LMOD1 absence impacting SIRT1 trafficking or an indirect consequence of the cells failing to differentiate properly. This would make it difficult to draw clear conclusions regarding a direct causal link between LMOD1 and SIRT1 localization from such an experiment. Therefore, we focused on overexpression experiments, where we could demonstrate that altering LMOD1 levels is sufficient to affect SIRT1 localization. Our nuclear-cytoplasmic fractionation experiments clearly show that LMOD1 overexpression leads to changes in SIRT1 distribution (Figure 5H-K). These findings provide evidence that LMOD1 can directly modulate SIRT1 localization, supporting our mechanistic conclusions.

      (5) In Figure S3, the biotin signal in LMOD2 samples appears weak. The authors need to address whether comparing LMOD1 and LMOD2 is valid given the apparent difference in reaction efficiency. It would also help to highlight where Sirt1 falls on the volcano plot in S3B.

      We agree that the overall biotin signal on the streptavidin blot for the LMOD2-BirA* sample appears weaker than for LMOD1-BirA*. To provide a more direct comparison of the bait proteins themselves, we have now added a bar graph to the revised Figure S3D, which quantifies the relative abundance of LMOD1 and LMOD2 bait proteins in the pull down experiments. This analysis shows that the levels of LMOD1-BirA* and LMOD2-BirA* were comparable in our BioID samples. Furthermore, the validity of the LMOD2 BioID experiment is strongly supported by the identification of several known LMOD1 and LMOD2 interaction partners. As shown in the dataset, well-established interactors such as TMOD1, TPM3, and TMOD3 were identified, with some even showing stronger enrichment with LMOD2 than with LMOD1. This confirms that the biotinylation reaction was efficient enough to capture proximal proteins for both baits.

      Regarding SIRT1, we have now highlighted in yellow its position on the volcano plot in the revised Figure S3E. As can be seen, SIRT1 was identified in the LMOD1-BirA sample and showed enrichment. We believe these clarifications, along with the additional expression data and the successful identification of known interactors, confirm the validity of our comparative BioID analysis.

      (6) The immunostaining data suggest that Lmod1 remains cytoplasmic throughout differentiation, whereas Sirt1 shows transient cytoplasmic localization at day 1 of differentiation. The authors should explain why Sirt1 is not constantly sequestered if Lmod1's cytoplasmic localization is consistent. It is also unclear whether day 1 is the key time point for Lmod1 function, as its precise role during myogenesis remains ambiguous.

      We thank the reviewer for this comment. We have no data explaining why SIRT1 is not constantly sequestered while LMOD1 remains consistently cytoplasmic. We can only speculate that the transient cytoplasmic localization of SIRT1 may be linked to the availability and functional role of LMOD1 throughout the differentiation process. While LMOD1 is present at low levels in proliferating primary myoblasts, its expression increases upon the initiation of differentiation (Figure 2A). Initially, during the early stages of differentiation, LMOD1 may not be required for actin nucleation as the major remodeling of the cytoskeleton has not yet begun. During this phase, LMOD1 might have the capacity to sequester SIRT1 in the cytoplasm.

      However, as differentiation progresses and morphological changes take place, LMOD1 may switch its functional role to actin nucleation, thereby releasing SIRT1. This transition could explain why SIRT1 is free to localize transiently to the cytoplasm, particularly at day 1, when cytoskeletal remodeling is beginning but not yet fully established.

      Additionally, as LMOD1 and SIRT1 are known to colocalize in the nucleus, they may exit the nucleus together. Once in the cytoplasm, LMOD1 may become engaged in actin nucleation, allowing SIRT1 to function independently, which could explain the transient nature of SIRT1’s cytoplasmic localization.

      We have acknowledged this gap in our understanding in the discussion of the revised manuscript:

      “Our immunostaining data show that while LMOD1 is consistently cytoplasmic, its partner SIRT1 is only transiently localized in the cytoplasm. This suggests that their interaction is dynamically regulated. We hypothesize that the function of LMOD1 is determined by the changing availability of its binding partners during differentiation. During the initial phase, LMOD1 may primarily function to sequester SIRT1, a key regulator of myogenic genes. As differentiation proceeds, the increased expression of cytoskeletal components, such as its canonical partners TMODs and TPMs, likely shifts the function of LMOD1 towards its role in actin nucleation. This molecular switch, potentially driven by a change in the interactome of LMOD1, could then result in the release of SIRT1 from the cytoplasm. Such a mechanism may coordinate transcriptional regulation with cytoskeletal remodeling during myoblast differentiation.”

      (7) The introduction does not sufficiently establish the motivation or knowledge gap this work aims to address. Instead, it reads like a narration of disparate topics in a single paragraph. The authors should clarify the statement in line 150, "since this protein has been...,".

      We thank the reviewer for requesting clarification regarding our focus on LMOD1 (Introduction and Line 150 in the original submission). In the revised manuscript, we shortened the introduction and more clearly emphasized the motivation of our study:

      “Although these mechanisms contribute to remodeling the cellular architecture of MuSCs, a comprehensive understanding of the temporal dynamics of proteome remodeling during differentiation remains lacking. To address this knowledge gap, we performed an unbiased proteomic analysis of the early stages of myogenic differentiation to identify previously unrecognized proteins involved in this process and to examine how they functionally interact with established regulatory pathways.”

      Our decision to focus on LMOD1 was driven by its significant upregulation in our temporal proteome dataset, together with its previously uncharacterized role in primary myoblasts. Furthermore, to strengthen the interpretation of LMOD1’s role, particularly in the context of aging, we have integrated a new analysis of published transcriptomic datasets. This can be found in the main text as follows:

      “Surprisingly, we detected LMOD1 in freshly isolated muscle stem cells (MuSCs), but not LMOD2. Additionally, we observed that the protein levels of LMOD1 increased in MuSCs isolated from older mice (Figure 2C and Figure S1B). We further analyzed published transcriptomic data sets that describe changes between young and old MuSCs in both quiescent and activated states in young and old animals (Liu et al. 2013; Lukjanenko et al. 2016). In these analyzed transcriptomic data sets, Lmod1 was found to be significantly downregulated during the activation of MuSCs in both young and old mice (see Figure S1B).

      To assess the in vivo relevance of our finding, we queried two proteomic datasets of freshly isolated MuSCs and four different skeletal muscles (gastrocnemius, G; soleus, S; tibialis anterior, TA; extensor digitorum longus, EDL) (Schüler et al. 2021). We found LMOD2 to be the most abundant leiomodin protein in whole skeletal muscle, consistent with data from (Tsukada et al. 2010; Nworu et al. 2015; Kiss et al. 2020), while the overall abundance of LMOD1 was lower since this protein has been mainly associated with smooth muscle cells (Nanda and Miano 2012; Conley et al. 2001; Nanda et al. 2018) (Figure 2B).”

      Overall, while the identification of Lmod1 as a pro-myogenic factor is convincing, the mechanistic insights are insufficient, and the manuscript would benefit from addressing these concerns.

      We thank the reviewer for their constructive criticism. In the revised manuscript, we have strengthened our mechanistic insights and the validation of our findings by implementing the suggestions of the reviewers and including new experimental data to address their concerns.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, the authors identify Leiomodin-1 (LMOD1) as a key regulator of early myogenic differentiation, demonstrating its interaction with SIRT1 to influence SIRT1's cellular localization and gene expression. The authors propose that LMOD1 translocates SIRT1 from the nucleus to the cytoplasm to permit the expression of myogenic differentiation genes such as MYOD or Myogenin.

      Strengths:

      A major strength of this work lies in the robust temporal resolution achieved through a time-course mass spectrometry analysis of in vitro muscle differentiation. This provides novel insights into the dynamic process of myogenic differentiation, often under-explored in terms of temporal progression. The authors provide a strong mechanistic case for how LMOD1 exerts its role in muscle differentiation which opens avenues to modulate.

      We thank the reviewer for the positive feedback on our manuscript and the insightful comments which helped to improve the manuscript!

      Weaknesses:

      One limitation of the study is the in vivo data. Although the authors do translate their findings in vivo for LMOD1 localization and expression, the cross-sectional imaging is not highly convincing. Longitudinal cuts or isolated fibers could have been more useful specimens to answer these questions. Moreover, the authors do not assess their in vitro SIRT1 findings in vivo. A few key experiments in regenerating or aged mice would strengthen the mechanistic insight of the findings.

      We agree that longitudinal cuts and isolated fibers can provide excellent morphological detail for specific questions. However, for our primary objective in this study, which was to assess the temporal expression and localization of LMOD1 across the tissue during the regeneration process, we decided that cross-sectional analysis provided the most robust and reliable overview. Cross-sectional imaging effectively captures the spatial distribution of LMOD1 across multiple myofibers and their surrounding microenvironment, simultaneously assessing the whole cross-sectional area. By using this approach, we were able to evaluate the broader tissue architecture and cellular context, which was essential for understanding the dynamic changes occurring during regeneration. We were also able to investigate all myofibers of a muscle, and not only a small proportion, which we would analyze with longitudinal sections and isolated myofibers. Therefore, we continued using cross-sections for further analyses.

      We fully agree with the reviewer that validating our in vitro SIRT1 findings in an in vivo context is an essential next step. To address this, we performed additional analyses on our existing regenerating muscle samples and incorporated new immunostainings for SIRT1 and PAX7 into the regeneration time-course (now shown in revised Figure 4I), providing further in vivo support for our proposed mechanism. We focused specifically on cross-sections collected at day 5 post-injury, a time point selected based on the peak in LMOD1 expression, to assess whether SIRT1 levels increase in parallel with LMOD1 during regeneration. Notably, SIRT1 abundance is elevated at day 5 post-injury, underscoring its involvement in early myogenic differentiation. This conclusion is further supported by the localization of SIRT1 within mononucleated cells and newly formed myofibers at this stage of regeneration.

      Finally, we agree that further mechanistic studies in vivo would be highly valuable. While we were able to address SIRT1 dynamics in our regeneration model as suggested, an aged mouse cohort was unfortunately not available to us for this kind of study. Furthermore, more extensive in vivo experiments, such as those involving genetic manipulation, were beyond the scope of the current study, partly due to constraints related to animal welfare regulations and our approved experimental protocols.

      Discussion:

      Overall, the study emphasizes the importance of understanding the temporal dynamics of molecular players during myogenic differentiation and provides valuable proteomic data that will benefit the field. Future studies should explore whether LMOD1 modulates the nuclear-cytoplasmic shuttling of other transcription factors during muscle development and how these processes are mechanistically achieved. Investigating whether LMOD1 can be therapeutically targeted to enhance muscle regeneration in contexts such as exercise, aging, and disease will be critical for translational applications. Additionally, elucidating the interplay among LMOD1, LMOD2, and LMOD3 could uncover broader implications for actin cytoskeletal regulation in muscle biology.

      We thank the reviewer for this excellent suggestion for future analyses. We have included these important considerations and future avenues in the Discussion of the revised manuscript:

      “Our immunostaining data show that while LMOD1 is consistently cytoplasmic, its partner SIRT1 is only transiently localized in the cytoplasm. This suggests that their interaction is dynamically regulated. We hypothesize that the function of LMOD1 is determined by the changing availability of its binding partners during differentiation. During the initial phase, LMOD1 may primarily function to sequester SIRT1, a key regulator of myogenic genes. As differentiation proceeds, the increased expression of cytoskeletal components, such as its canonical partners TMODs and TPMs, likely shifts the function of LMOD1 towards its role in actin nucleation. This molecular switch, potentially driven by a change in the interactome of LMOD1, could then result in the release of SIRT1 from the cytoplasm. Such a mechanism may coordinate transcriptional regulation with cytoskeletal remodeling during myoblast differentiation.”

      “Moreover, delineating the functional specialization and potential redundancy among leiomodin proteins represents an important next step. Our data indicate that LMOD1 primarily regulates early myogenic differentiation (Figure 3). In contrast, the lack of an early functional phenotype upon LMOD2 depletion, together with its upregulation at later stages (Figure S2A), suggests a temporal shift in regulatory control. Accordingly, a systematic comparative analysis of LMOD1, LMOD2, and LMOD3 will be required to elucidate their distinct roles in actin cytoskeleton regulation across the myogenic program, particularly with respect to myofibril maturation and maintenance.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Major Changes:

      (1) In Vivo Data on SIRT1:

      The inclusion of in vivo data on SIRT1 localization and expression would significantly strengthen the manuscript. Similar staining techniques used for LMOD1 could be applied to SIRT1. Additionally, imaging muscle specimens such as longitudinal sections or isolated myofibers would provide clearer insights into SIRT1's spatial distribution and improve upon the less convincing cross-sectional images currently presented (Figure 2).

      We fully agree that providing in vivo data on SIRT1 localization and expression is a crucial step to support our in vitro findings. Following the reviewer's suggestion, we have performed new experiments on muscle regeneration samples using the analyses of cross-sections as done for the analysis of LMOD1 localization. Specifically, we performed immunostaining for SIRT1 on cross-sections from muscle samples collected at day 5 post-injury, a time point selected based on the observed peak in LMOD1 expression. These new data (now included in revised Figure 4I) allowed us to assess whether SIRT1 levels increase during regeneration in parallel with an increase in LMOD1 abundance.

      Regarding the suggestion to use longitudinal sections or isolated myofibers, we agree that these preparations offer excellent answers for certain questions. For the primary goal of our study, to assess the temporal expression changes across the entire regenerating tissue at different time points, we found that cross-sections provided the most comprehensive and robust overview and therefore did not use longitudinal sections or isolated myofibers. 

      Performing additional animal experiments to obtain these specific preparations was beyond the scope of the current study and subject to constraints from our approved animal welfare protocols.

      (2) Morphology of siLmod1 Cells:

      The morphology of siLmod1-treated cells in vitro (Figure 3) raises concerns. Assessing cell viability or cell death in these experiments would help ensure that differences are not due to dead or unhealthy cells being quantified. There is also a notable discrepancy between the control panels in Figures 3C and 3H compared to the experimental conditions in 3F and 3K, particularly in terms of cell length and morphology. These inconsistencies should be addressed or clarified.

      We acknowledge the visual discrepancies in cell morphology noted by the reviewer (e.g., between Figures 3C/3H and 3F/3K). These differences can be attributed to biological variability between primary myoblast cultures isolated from different mice. Such variability includes differences in myogenic potential and the fact that cells are not synchronized, leading to variations in differentiation efficiency, baseline morphology, and cell length across cultures (Cornelison 2008; Vaughan and Lamia 2019). To account for this, we decided to use n=6 biological replicates, i.e., primary myoblast cultures isolated from 6 different mice, for immunofluorescence analysis, ensuring robust quantitative data. Furthermore, we confirmed that this phenotype was not an artifact of culture conditions, as we consistently observed the same effect of Lmod1 knockdown independently of the passage number of the myoblasts or the donor mouse.

      To address the concerns that morphological changes in siLmod1-treated cells might reflect cell death, we performed a TUNEL assay (transfection at day 1, analysis at day 3 of differentiation). This revealed no significant increase in TUNEL-positive (apoptotic) cells in siLmod1- (or siSirt1-) transfected samples versus siCtrl-transfected cells. These new data have been added to the revised manuscript as Supplementary Figure S2I. The TUNEL data indicate that the observed morphological changes upon knockdown of Lmod1 are not due to induced cell death. Supported by these results, our interpretation is that knockdown of Lmod1 impairs or arrests differentiation rather than causing cell death. Furthermore, our quantification of different cell populations showed shifts indicative of impaired differentiation (e.g., accumulation of cells at earlier stages) without exhibiting significant loss in cell numbers. For example, the numbers of myogenin+/MHC- and myogenin+/MHC+ cell populations, and differentiated myotubes, were not significantly reduced after transfection with siLmod1. A slight, not significant trend towards fewer non-proliferating myoblasts/reserve cells characterized by the expression of Myogenin-/MHC-Hoechst+ (Figure S2H) was noted. Overall, cells appeared to be 'stuck' in differentiation, consistent with the role of Lmod1 in impairing differentiation but not causing cell death. We have further clarified this aspect in the revised manuscript.

      (3) LMOD1 and SIRT1 Interaction in Myogenic Cells:

      Strengthening the connection between LMOD1 and SIRT1 within the myogenic system would enhance the manuscript. Could proximity ligation assays (PLA) be performed in myogenic cells, as was done in HEK293T cells? Additionally, investigating whether SIRT1 remains in the nucleus upon LMOD1 knockdown using siRNA would provide mechanistic insight into their interaction during myogenic differentiation.

      We would like to clarify that the Proximity Ligation Assays (PLA) shown in Figure 4H were indeed performed in primary myoblasts, confirming the LMOD1-SIRT1 interaction directly in a myogenic context. We have modified the text to clarify that primary myoblasts were used for the PLA assays.

      Minor Points:

      (1) Was Lmod1 knockdown confirmed in vivo?

      To target Lmod1 in Muscle Stem Cells (MuSCs) in vivo, we utilized self-delivering Accell siRNAs. This delivery system has been previously validated and shown to be highly effective for targeting MuSCs in regenerating muscle (Bentzinger et al., Cell Stem Cell, 2013).

      While this is an established method for delivery, confirming knockdown specifically within the rare MuSC population is technically challenging using bulk tissue analysis, as the target signal is diluted by numerous other cell types. 

      Therefore, to ensure the efficacy of our specific siRNA, we performed in vitro validation. For the reviewers' interest, we add Author response image 2 showing the efficiency of the respective siRNAs:

      Author response image 2.

      Knockdown efficiency of siRNAs targeting Lmod1 and Lmod2 following using the same self-delivering siRNA in proliferating primary myoblasts as used in in vivo experiments. Self-delivering Accell siRNA was added to primary myoblasts cultured in low serum media for 48 hours. Relative mRNA expression levels of Lmod1 and Lmod2 were measured after self-delivering Accell siRNA transfection targeting either Lmod1 (siLmod1) or Lmod2 (siLmod2). Expression levels were compared to control siRNA-transfected cells (siCtrl) and normalized to Gapdh expression.

      Based on the documented efficacy of this delivery system from prior literature and our own validation of the specific siRNAs used here, we are confident in the knockdown efficiency of the respective siRNAs. We decided not to perform additional animal experiments due to animal welfare considerations.

      (2) Some of the western blot bands do not appear to match the expected patterns for the tested proteins compared to controls (e.g., Figure S2J, S4C). Ensure that these are accurately labeled and include the entire membrane for transparency and reproducibility.

      Regarding Figure S2J, we agree that the presentation could be confusing to the reader. The blot shows LMOD1 and LMOD2 knockdown, while the bar plot quantifies only the change in LMOD2 levels. We have now revised the figure legend to explicitly state this. We hope this makes the presentation of our data clearer.

      For Figure S4C, we believe the concern about 'patterns' relates to loading variability. In this experiment, we manually counted the nuclei before lysis to ensure that each nuclear fraction started with an equal amount of material. We then loaded the cytoplasmic fractions in proportion to these counts. The purity of the fractions was additionally confirmed using nuclear (H4) and cytoplasmic (ALDOA) markers. As stated in the figure, the nuclear/cytoplasmic ratio of LMOD1 or SIRT1 was normalized across the entire lane of the Ponceau S staining, which we have now clarified in the relevant figure legends.

      Finally, regarding transparency, the presented immunoblot images are representative crops, which is standard practice for clarity. We are committed to reproducibility and will provide full, uncropped scans of all blots in the final version of the manuscript, in line with eLife publishing guidelines. 

      (3) Figure S1B appears to reuse images from Figure 2D (rotated). Verify that this is acceptable for the journal's guidelines, and if necessary, provide additional justification or clarification.

      We acknowledge that the image presented in Figure S1B was accidentally reused as a representative example in Figure 2D. To address this and prevent any potential redundancy or confusion, we have revised Figure S1B by replacing the duplicated image with a different, representative example from our dataset. The updated figure now contains unique image data, and we believe this revision fully resolves the concern.

      (4) Ensure consistent scale bars across images, particularly in Figures 3C and 3H, where discrepancies might affect interpretation.

      We thank the reviewer for pointing this out, we have now standardized all scale bars throughout the manuscript to ensure consistency. All immunofluorescence images of cultured cells (including Fig 3C and 3H) now have a 50 µm scale bar, and all tissue cross-sections have a 100 µm scale bar. This change has been implemented in the revised figures.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, the investigators identified LMOD1 as one of a subset of cytoskeletal proteins whose levels increase in the early stages of myogenic differentiation. Lmod1 is understudied in striated muscle and in particular in myogenic differentiation. Thus, this is an important study. It is also a very thorough study - with perhaps even too much data presented. Importantly, the investigators observed that LMOD1 appears to be important for skeletal regeneration, and myogenic differentiation and that it interacts with SIRT1. Both primary myoblast differentiation and skeletal muscle regeneration were studied. Rescue experiments confirmed these observations: SIRT1 can rescue perturbations of myogenic differentiation as a result of LMOD1 knockdown.

      Strengths:

      Particular strengths include: important topic, the use of primary skeletal cultures, the use of both cell culture and in vivo approaches, careful biomarker analysis of primary mouse myoblast differentiation, the use of two methods to probe the function of the Lmod1/SIRT1 pathway via using depletion approaches and inhibitors, and generation of six independent myoblast cultures. Results support their conclusions.

      We thank the reviewer for the positive assessment of our work and the helpful comments for improving our manuscript.

      Weaknesses:

      (1) Figure 1. Images of cells in Figure 1A are too small to be meaningful (especially in comparison to the other data presented in this figure). Perhaps the authors could make graphs smaller?

      We have adjusted the size of the images across all figure panels to ensure better visibility and clarity. We hope these adjustments improve the presentation of the data.

      (2) Line 148 "We found LMOD2 to be the most abundant Lmod in the whole skeletal muscle." This is confusing since most, if not all, prior studies have shown that Lmod3 is the predominant isoform in skeletal muscle. The two papers that are cited are incorrectly cited. Clarification to resolve this discrepancy is needed.

      We acknowledge that LMOD2 and LMOD3 are predominantly expressed in skeletal and cardiac muscles (Tsukada et al. 2010; Nworu et al. 2015), www.proteinatlas.org) and LMOD3’s transcription is directly regulated by MRTF/SRF and MEF2 to coordinate sarcomeric assembly (Cenik et al. 2015). However, our statement refers specifically to the analysis of the proteomic datasets from freshly isolated MuSCs and four distinct skeletal muscles (G, S, TA, EDL) generated by Schüler et al. 2021. Crucially, LMOD3 was not detected in the quantitative mass spectrometry data for the EDL, G, S, or TA muscle samples analyzed in this specific study. In the context of this particular dataset, LMOD2 was the most highly abundant Leiomodin isoform detected in the whole skeletal muscle samples. This finding suggests a differential expression and function between LMOD isoforms depending on the muscle type and/or developmental/regenerative state. We have revised and corrected this clarification in the manuscript, including correcting the initial citations.

      (3) Figure 2. Immunoflorescence (IF) panels are too small to be meaningful. Perhaps the graphs could be made smaller and more space allocated for the IF panels? This issue is apparent for just about all IF panels - they are simply too small to be meaningful. Additionally, in many of the immunofluorescence figures, the colors that were used make it difficult to discern the stained cellular structures. For example, in Figure S1, orange and purple are used - they do not stand out as well as other colors that are more commonly used.

      We agree that the IF panels were too small for optimal interpretation and have adjusted them in Figure 2 and throughout the manuscript. Regarding the color choices, we appreciate the reviewer's comments. Our initial selection (e.g., orange and purple in Figure S1) was intended to enhance accessibility for individuals with common color vision deficiencies, including red-green color blindness. However, we acknowledge the reviewer's point that these combinations provided insufficient contrast for discerning cellular structures. Therefore, we have revised the color schemes to use green, red, and blue, which should offer improved contrast.

      (4) There is huge variability in many experiments presented - as such, more samples appear to be required to allow for meaningful data to be obtained. For example, Figure S2. Many experimental groups, only have 3 samples - this is highly problematic - I would estimate that 5-6 would be the minimum.

      We thank the reviewer for the comment regarding experimental variability and sample size. In our study, n=3 biological replicates, i.e., independent primary cell cultures obtained from different mice, were primarily used for immunoblots. We acknowledge that variability can be observed between distinct primary cell cultures due to factors such as inherent differences in myogenic potential, cell cycle state (as cells were not synchronized), and passage number. Importantly, despite this inter-sample variation, the investigated phenotypes showed consistent trends across biological replicates. Rather than increasing the number of replicates for immunoblots, we opted for validating our key findings using independent approaches with a higher number of replicates. For instance, qRT-PCR analyses (to confirm knockdown efficiency) and immunofluorescence analyses were mostly performed using five to six independent myoblast cultures (biological replicates).

      (5) Ponceau S staining is often used as a loading control in this manuscript for western blots. The area/molecular weight range actually used should be specified. Not clear why in some experiments GAPDH staining is used, in other experiments Ponceau S staining is used, and in some, both are used. In some experiments, the variability of total protein loaded from lane to lane is disconcerting. For example, in Figure S4C there appears to be more than normal variability. Can the protein assay be redone and samples run again?

      We have clarified in the relevant figure legends that Ponceau S normalization, when used, was based on the quantification of the entire lane. Our standard loading control is GAPDH. We used Ponceau S for normalization only when GAPDH was deemed unsuitable, e.g., in nuclear-cytoplasmic fractionation experiments where GAPDH is not present in all fractions.

      Concerning the variability observed in Figure S4C, we manually counted the nuclei before lysis to ensure that each nuclear fraction started with an equal amount of material. We then loaded the cytoplasmic fractions in proportion to these counts. The purity of the fractions was additionally confirmed using nuclear (H4) and cytoplasmic (ALDOA) markers. The nuclear/cytoplasmic ratio of LMOD1 or SIRT1 was normalized across the entire lane of the Ponceau S staining, which we have now clarified in the relevant figure legends.

      (6) Figure S3 - Lmod3 is included in the figure but no mention of it occurs in the title of the figure and/or legend.

      We wish to clarify that the protein identified in Figure S3 is TMOD3 (Tropomodulin 3), not LMOD3. TMOD3 is a known pointed-end capping protein regulating the actin filament nucleation process together with LMODs (Fowler and Dominguez 2017; Boczkowska et al. 2015), so its presence in our dataset was expected and helps validate our results.

      (7) Abstract, line 25. "overexpression accelerates and improves the formation of myotubes". This is a confusing sentence. How is it improving the formation? A little more information about how they are different than developing myotubes in normal/healthy muscles would be helpful.

      We thank the reviewer for the comment. To clarify, we have revised the sentence in line 25 to "improves the initiation of myotube formation." This change reflects our observation that overexpression of LMOD1 leads to a more rapid onset of myotube formation, as evidenced by earlier expression of differentiation markers and accelerated fusion of myoblasts into myotubes compared to GFP overexpression myoblast cell line. These findings suggest that LMOD1 overexpression enhances the efficiency of the early stages of differentiation and fusion, thereby contributing to improved initiation of myotube formation.

      (8) It is impossible from the IF figures presented to determine where Lmod1 localizes in the myocytes. Information on its subcellular localization is important. Does it localize with Lmod2 and Lmod3 at thin filament pointed ends?

      Several publications suggest that LMODs are involved in actin nucleation and interact with TMODs at the thin filament pointed ends (Boczkowska et al. 2015; Fowler and Dominguez 2017; Fowler, Greenfield, and Moyer 2003; Tsukada et al. 2010; Rao, Madasu, and Dominguez 2014). We performed F-actin (Phalloidin) staining together with LMOD1 staining and observed possible co-localization (see Author response image 3). Specifically, we noted an accumulation of LMOD1 at the ends of myocytes, indicating that LMOD1 might play a role in the elongation and guidance of myotube differentiation. For the reviewer’s interest, we include Author response image 3 as it was not part of the original manuscript. While performing subcellular localization stainings, we added the F-actin/Phalloidin staining to explore potential interactions, but this aspect was not further investigated in the current study.

      Author response image 3.

      Co-staining of LMOD1 and Phalloidin in differentiating myocytes.Example image showing immunofluorescence staining of LMOD1 (purple) and F-actin (green; Phalloidin) in differentiating primary myocytes. LMOD1 appears to accumulate at the ends of elongated myocytes and co-localizes with actin structures (highlighted in boxes), suggesting a potential role in myotube elongation and guidance during differentiation.

      Our study focused on a distinct role for LMOD1, independent from its function in actin filament nucleation, and we therefore did not pursue further co-localization staining with LMOD2 or LMOD3. We recognize the potential importance of exploring these interactions and their relevance to thin filament organization in skeletal muscle. However, although this was beyond the scope of our current work, we will investigate this aspect in the future.

      References

      Boczkowska, Malgorzata, Grzegorz Rebowski, Elena Kremneva, Pekka Lappalainen, and Roberto Dominguez. 2015. “How Leiomodin and Tropomodulin Use a Common Fold for Different Actin Assembly Functions.” Nature Communications 6 (1): 8314.

      Cenik, Bercin K., Ankit Garg, John R. McAnally, John M. Shelton, James A. Richardson, Rhonda Bassel-Duby, Eric N. Olson, and Ning Liu. 2015. “Severe Myopathy in Mice Lacking the MEF2/SRF-Dependent Gene Leiomodin-3.” The Journal of Clinical Investigation 125 (4): 1569–78.

      Cornelison, D. D. W. 2008. “Context Matters: In Vivo and in Vitro Influences on Muscle Satellite Cell Activity.” Journal of Cellular Biochemistry 105 (3): 663–69.

      Fowler, Velia M., and Roberto Dominguez. 2017. “Tropomodulins and Leiomodins: Actin Pointed End Caps and Nucleators in Muscles.” Biophysical Journal 112 (9): 1742–60.

      Fowler, Velia M., Norma J. Greenfield, and Jeannette Moyer. 2003. “Tropomodulin Contains Two Actin Filament Pointed End-Capping Domains.” The Journal of Biological Chemistry 278 (41): 40000–9.

      Liu, Ling, Tom H. Cheung, Gregory W. Charville, Bernadette Marie Ceniza Hurgo, Tripp Leavitt, Johnathan Shih, Anne Brunet, and Thomas A. Rando. 2013. “Chromatin Modifications as Determinants of Muscle Stem Cell Quiescence and Chronological Aging.” Cell Reports 4 (1): 189–204.

      Lukjanenko, Laura, M. Juliane Jung, Nagabhooshan Hegde, Claire Perruisseau-Carrier, Eugenia Migliavacca, Michelle Rozo, Sonia Karaz, et al. 2016. “Loss of Fibronectin from the Aged Stem Cell Niche Affects the Regenerative Capacity of Skeletal Muscle in Mice.” Nature Medicine 22 (8): 897–905.

      Nworu, Chinedu U., Robert Kraft, Daniel C. Schnurr, Carol C. Gregorio, and Paul A. Krieg. 2015. “Leiomodin 3 and Tropomodulin 4 Have Overlapping Functions during Skeletal Myofibrillogenesis.” Journal of Cell Science 128 (2): 239–50.

      Rao, Jampani Nageswara, Yadaiah Madasu, and Roberto Dominguez. 2014. “Mechanism of Actin Filament Pointed-End Capping by Tropomodulin.” Science 345 (6195): 463–67.

      Schüler, Svenja C., Joanna M. Kirkpatrick, Manuel Schmidt, Deolinda Santinha, Philipp Koch, Simone Di Sanzo, Emilio Cirri, Martin Hemberg, Alessandro Ori, and Julia von Maltzahn. 2021. “Extensive Remodeling of the Extracellular Matrix during Aging Contributes to Age-Dependent Impairments of Muscle Stem Cell Functionality.” Cell Reports 35 (10): 109223.

      Tsukada, Takehiro, Christopher T. Pappas, Natalia Moroz, Parker B. Antin, Alla S. Kostyukova, and Carol C. Gregorio. 2010. “Leiomodin-2 Is an Antagonist of Tropomodulin-1 at the Pointed End of the Thin Filaments in Cardiac Muscle.” Journal of Cell Science 123 (Pt 18): 3136–45.

      Vaughan, Megan, and Katja A. Lamia. 2019. “Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants.” Journal of Visualized Experiments: JoVE, no. 152 (October). https://doi.org/10.3791/60310.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript describes critical intermediate reaction steps of a HA synthase at the molecular level; specifically, it examines the 2nd step, polymerization, adding GlcA to GlcNAc to form the initial disaccharide of the repeating HA structure. Unlike the vast majority of known glycosyltransferases, the viral HAS (a convenient proxy extrapolated to resemble the vertebrate forms) uses a single pocket to catalyze both monosaccharide transfer steps. The authors' work illustrates the interactions needed to bind & proof-read the UDP-GlcA using direct and '2nd layer' amino acid residues. This step also allows the HAS to distinguish the two UDP-sugars; this is very important as the enzymes are not known or observed to make homopolymers of only GlcA or GlcNAc, but only make the HA disaccharide repeats GlcNAc-GlcA.

      Strengths:

      Overall, the strengths of this paper lie in its techniques & analysis.

      The authors make significant leaps forward towards understanding this process using a variety of tools and comparisons of wild-type & mutant enzymes. The work is well presented overall with respect to the text and illustrations (especially the 3D representations), and the robustness of the analyses & statistics is also noteworthy.

      Furthermore, the authors make some strides towards creating novel sugar polymers using alternative primers & work with detergent binding to the HAS. The authors tested a wide variety of monosaccharides and several disaccharides for primer activity and observed that GlcA could be added to cellobiose and chitobiose, which are moderately close structural analogs to HA disaccharides. Did the authors also test the readily available HA tetramer (HA4, [GlcA-GlcNAc]2) as a primer in their system? This is a highly recommended experiment; if it works, then this molecule may also be useful for cryo-EM studies of CvHAS as well.

      The reviewer requested testing whether an HA tetratsaccharide could also serve as an glycosyl transfer acceptor for HAS. The commerically available HA tetrasaccharide (HA4) is terminated at its non-reducing end by GlcA, therein we proceeded to measure its effect on UDP-GlcNAc turnover kientics. Titration of HA4 failed to elicit any detectable change in UDP-GlcNAc turnover rate, indicating no priming. This is now mentioned in the main text and the data is shown in Fig. S9.

      Weaknesses:

      In the past, another report describing the failed attempt of elongating short primers (HA4 & chitin oligosaccharides larger than the cello- or chitobiose that have activity in this report) with a vertebrate HAS, XlHAS1, an enzyme that seems to behave like the CvHAS ( https://pubmed.ncbi.nlm.nih.gov/10473619/); this work should probably be cited and briefly discussed. It may be that the longer primers in the 1999 paper and/or the different construct or isolation specifics (detergent extract vs crude) were not conducive to the extension reaction, as the authors extracted recombinant enzyme.

      We apologize for the oversight. This reference is now cited (ref. 18) together with the description of the failed elongation of HA4 by CvHAS.

      There are a few areas that should be addressed for clarity and correctness, especially defining the class of HAS studied here (Class I-NR) as the results may (Class I-R) or may not (Class II) align (see comment (a) below), but overall, a very nicely done body of work that will significantly enhance understanding in the field.

      Done as requested

      Reviewer #2 (Public review):

      Summary:

      The paper by Stephens and co-workers provides important mechanistic insight into how hyaluronan synthase (HAS) coordinates alternating GlcNAc and GlcA incorporation using a single Type-I catalytic centre. Through cryo-EM structures capturing both "proofreading" and fully "inserted" binding poses of UDP-GlcA, combined with detailed biochemical analysis, the authors show how the enzyme selectively recognizes the GlcA carboxylate, stabilizes substrates through conformational gating, and requires a priming GlcNAc for productive turnover.

      These findings clarify how one active site can manage two chemically distinct donor sugars while simultaneously coupling catalysis to polymer translocation.

      The work also reports a DDM-bound, detergent-inhibited conformation that possibly illuminates features of the acceptor pocket, although this appears to be a purification artefact (it is indeed inhibitory) rather than a relevant biological state.

      Overall, the study convincingly establishes a unified catalytic mechanism for Type-I HAS enzymes and represents a significant advance in understanding HA biosynthesis at the molecular level.

      Strengths:

      There are many strengths.

      This is a multi-disciplinary study with very high-quality cryo-EM and enzyme kinetics (backed up with orthogonal methods of product analysis) to justify the conclusions discussed above.

      Weaknesses:

      There are few weaknesses.

      The abstract and introduction assume a lot of detailed prior knowledge about hyaluronan synthases, and in doing so, risk lessening the readership pool.

      A lot of discussion focuses on detergents (whose presence is totally inhibitory) and transfer to non-biological acceptors (at high concentrations). This risks weakening the manuscript.

      The abstract and parts of the introduction have been revised to address the reviewer’s concerns.

      Reviewer #1 (Recommendations for the authors):

      (1) As noted above, please state in title, abstract & introduction that this work is focused on a "Class I-NR HAS" (as described in Ref. #4), and NOT all HAS families...this is truly essential to note as someone working with the Pasteurella HAS version (Class II) would be totally misled & at this point, no one knows the Streptococcus HAS (Class-IR) mechanistic details which could be different due to its inverse molecular directionality of elongation compared to the CvHAS Class I-NR enzyme.

      Done as requested.

      (2) Page 6 - for the usefulness of the HAS mutants as being folded correctly, it was stated these mutants are suitable since they all 'purify' similarly...the use of the more proper term should probably be 'chromatograph', similarly suggesting similar hydrodynamic radii without massive folding issues.

      This has been revised to state that they all exhibited comparable size exclusion chromatography profiles.

      “All mutants share similar size exclusion chromatography profiles with the WT enzyme, suggesting that the substitutions do not cause a folding defect (Fig. S3).”

      (3) Page 7 - please check these sentences (& rest of paragraph?) as the meaning is not clear. "First, UDP-GlcNAc was titrated in the presence of excess UDP-GlcA, resulting in a response similar to the acceptor-free condition (Fig. 2C). However, the maximum reaction velocity at 20 mM UDP-GlcNAc was approximately 25% lower than that measured in the presence of UDP-GlcNAc only (Fig. 2C)."

      The paragraph has been revised to avoid confusion.

      (4) In Methods, please use an italicized 'g' for the centrifugation steps globally.

      Changed as requested

      (5) Please note the source/vendor for the HA standards on gels.

      Done

      (6) Page 35 - TLC section.

      (a) 'n-butanol' (with italic n) is the most widespread chemical name (not butan-1-ol).

      Done

      (b) Also, for all of the TLC images, the origin and the solvent front should be marked.

      Changed as suggested.

      Reviewer #2 (Recommendations for the authors):

      A number of minor issues should be addressed.

      (1) Abstract

      Two comments on the Abstract, which I found surprisingly weak given the quality of the work, and lacking a key detail.

      A major conceptual contribution of this work is the demonstration of how a single Type-I catalytic centre discriminates, positions, and transfers two chemically distinct substrates in an alternating pattern. This distinguishes HAS from dual-active-site (Type-II) glycosyltransferases and is important for understanding HA polymerization.

      However, this central point is not clearly articulated in the abstract. I suggest explicitly stating that HAS performs both GlcNAc and GlcA transfer reactions within a single catalytic site, and that the proofreading/inserted poses illuminate how this multifunctionality is achieved.

      The abstract currently ends with the observation of a DDM-bound, detergent-inhibited state. While this is interesting, it absolutely does not represent the central conceptual advance of the study and gives the abstract an artefactual ending.

      I strongly recommend revising the final sentences to emphasize the broader mechanistic insight and not an "artefact" (indeed, the enzyme is inactive in the presence of this detergent; it is thus a very unusual way to conclude an abstract).

      That is, finish with the wider implications of how HAS coordinates alternating substrate use, proofreading, and polymer translocation. Ending on the main mechanistic or biological significance would make the abstract considerably stronger and more aligned with the main message of the paper.

      The abstract has been revised thoroughly to reflect the important insights gained on CvHAS’ catalytic function and HA biogenesis in general.

      (2) Introduction

      The distinction between single active-centre enzymes, which transfer both sugars alternately, and twin catalytic domain enzymes that each perform one addition is surely central to the whole paper. But it is not discussed. Surely this has to be covered. There is a lot of work in this space, including, but not limited to:

      https://doi.org/10.1093/glycob/cwg085

      https://doi.org/10.1093/glycob/10.9.883

      https://doi.org/10.1093/glycob/cwad075 (includes this author team)

      Originally back to https://doi.org/10.1021/bi990270y

      If the authors instead assume such a level of knowledge for the reader, then surely they are writing for a specialist audience, not consistent with the wider readership ambitions of eLife?

      The Introduction has been revised as suggested by the reviewer, providing necessary background to frame our description of the Chlorella virus HAS. We made a deliberate effort to put new insights into a broader context.

      (3) Results and Discussion

      DDM "was observed for >50% of the analysed particles". I struggled with this. I couldn't understand how the authors selected particles that did or did not contain DDM. The main body text states: "To our surprise, careful sorting of the UDP-GlcA supplemented cryo EM dataset revealed a CvHAS subpopulation that was not bound to the substrate, but, instead, a DDM molecule near the active site (Fig 3A and S7). This was observed for >50% of the analyzed particles."

      That reads like there is one sample with two populations. But the figures and the methods section suggest differently: they suggest two samples with different data-collection regimes. That does not match the main text. Could this be clarified?

      Yes, that wasn’t explained well. We clarified the text to stress that the DDM-bound sample came from a dataset that was intended to resolve an UDP-GlcA-bound state, but instead revealed the inhibition by DDM.

      Also in this space, in the modern world, "nominal magnification" has no real meaning, and calibrated pixel size would be more appropriate. Can this be given, please?

      The relevant Methods section now states: “imaging of … was performed at a calibrated pixel size of 0.652 Å”.

      The discovery of DDM in the active site is surprising. But it is an inhibitory artefact. Is this section pushed a little too hard? Also, "The coordination of DDM's maltoside moiety, an αlinked glucose disaccharide, is consistent with priming by cellobiose and chitobiose." I'm not sure why an α-linked maltose is consistent with the binding of a β-linked cellobiose. That makes no sense. There will be no other enzymes where starch and cellulose oligos are mutually accepted. Consider rewriting.

      We like to stress the DDM coordination because it could lead to the development of compounds that can really function as inhibitors, either for HAS or other related enzymes. In the observed DDM binding pose, the alpha-linkage is not recognized. Instead, the reducing end glucosyl unit stacks against Trp342 while the non-reducing unit extends into the catalytic pocket. Hence, a similar binding pose is conceivable for cellobiose and potentially also for chitobiose. The relevant section has been reworded.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      This work shows that resistance profiles to a variety of drugs are variable between different mycobacterial species and are not correlated with growth rate or intrabacterial compound concentration (at least for linezolid, bedaquiline, and Rifampicin). Note that intrabacterial compound concentration does not distinguish between cytosolic and periplasmic/cell wall-associated drugs. The susceptibility profiles for a wide range of mycobacteria tested under the same conditions against 15 commonly used antimycobacterial drugs provide the first recorded cross-species comparison which will be a valuable resource for the scientific community. To understand the reasons for the high Rifampicin resistance seen in many mycobacteria, the authors confirm the presence of the arr gene known to encode a Rif ribosyltransferase involved in Rif resistance in M. smegmatis in the resistant mycobacteria after confirming the absence of on-target mutations in the RpoB RRDR. Metabolomic analyses confirm the presence of ribosylated Rif in some of the naturally resistant mycobacteria which may not be entirely surprising but an important confirmation. Presumably M. branderi is highly resistant despite lacking the arr homolog due to the rpoB S45N mutation. M. flavescens has an MIC similar to that of M. smegmatis, despite having both Arr-1 and Arr-X. Various Arr-1 and Arr-X proteins are expressed and characterized for catalytic activity which shows that Arr-X is a faster enzyme,, especially with respect to more hydrophobic rifamycins. M. flavescens has similar MIC values to Rifapentine and Rifabutin to M. smegmatis. Thus, the Arr-1 versus Arr-X comparison does not provide a complete explanation for the underlying reasons driving natural Rif resistance in mycobacteria. Downregulation of Arr-X expression in M. conceptionense confers increased sensitivity to Rifabutin confirming its role as a rifamycin-inactivating enzyme.

      Overall, the comparison of cross-species susceptibility profiles is novel; the demonstration that MIC is not correlated with intracellular drug concentration is important but not sufficiently interrogated, the demonstration that Arr-X is also a Rif ADP-ribosyltransferase is a good confirmation and shows that it is more efficient than Arr-1 on hydrophobic rifamycins is interesting but maybe not entirely surprising. The manuscript seems to have two parts that are related, but the rifamycin modification aspect of the work is not strongly linked to the first part since it interrogates the modification of one drug but not the common cause of natural resistance for other drugs.

      Reviewer #2 (Public review):

      Summary:

      The authors use a variety of methods to investigate the mechanisms of innate drug resistance in mycobacteria. They end up focusing on two primary determinants - drug accumulation, which correlates rather poorly with resistance for many species, and, for the rifamycins, ADP-ribosyltransferases. The latter enzymes do appear to account for a good deal of resistance, though it is difficult to extrapolate quantitatively what their relative contributions are.

      Overall, they make excellent use of biochemical methods to support their conclusions. Though they set out to draw very broad lessons, much of the focus ends up being on rifamycins. This is still a very interesting set of conclusions.

      Strengths:

      (1) A very interesting approach and set of questions.

      (2) Outstanding technical approaches to measuring intracellular drug concentrations and chemical modification of rifamycins.

      (3) Excellent characterization of variant rifamycin ADP-ribosyltransferases

      Weaknesses:

      (1) Figure 3c/d: These panels show the same experiment done twice, yet they display substantially different results in certain cases. For instance, M. smegmatis appears to show an order of magnitude lower RIF accumulation in panel d compared to M. flavescens, despite them displaying equal accumulation in panel c. The authors should provide justification for this variation, particularly as quantitative intra-species comparisons are central to the conclusions of this figure.

      The data in panels 3c and 3d are from different sets of experiments. The reviewer is correct with regards to M. smegmatis. The data indeed is ~ 1 order of magnitude different. However, the data for other species is very similar. The reviewer may also have noticed that the error bars are also larger in 3d, compared to 3c, indicating a greater variation between independent experiments use in 3d. We do not have a good explanation for this, other than the experiments shown in 3d were associated with greater biological variability.

      (2) There are several technical concerns with Figure 3 that affect how to interpret the work. According to the methods, the authors did not appear to normalize to an internal standard, only to an external antibiotic standard (which may account for some of the technical variation alluded to above).

      We agree that using a labeled drug as an internal standard (IS) would be ideal. However, the experiment initially followed an untargeted metabolomics approach, which later shifted to relative drug quantification. At that stage, normalizing with IS was impractical because proper implementation would require multiple IS across the chromatographic range. Therefore, we opted for total ion current (TIC) normalization, which accounts for variability in overall metabolite abundance—even though the experimental setup was already adjusted for each bacterial species’ growth rate. Additionally, we prepared external standard curves for each drug to enable quantification, and the amount of drug added to each plate was considered when reporting these values.

      Second, the authors used different concentrations of drug for each species to try to match the species' MICs. I appreciate the authors' thinking on this, but I think for an uptake experiment it would be more appropriate to treat with the same concentration of drug since uptake is likely saturable at higher drug concentrations. In the current setup, for the species with higher MIC, they have to be able to uptake substantially more antibiotics than the species with low MIC in order to end up with the same normalized uptake value in Figure 3d. It would be helpful to repeat this experiment with a single drug concentration in the media for all species and test whether that gives the same results seen here.

      We respectfully disagree with the reviewer. Experiments such as the one proposed by the review work well when MIC values are a few fold apart, for strains of the same species, but have not been tested when MIC values are 100-1000-fold apart, with different species. Furthermore, what would be the interpretation of compound uptake at 1000-fold the MIC for one species and MIC level for another? By using antibiotic concentrations at the respective MIC for each species we are at least under conditions where we know the biological effect of the antibiotic across species is the same, based on its potency.

      (3) Figure 4f: This panel seems to argue against the idea that the efficacy of RIF ribosylation is what's driving drug susceptibility. M. flavescens is similarly resistant to RIF as M. smegmatis, yet M. flavescens has dramatically lower riboslyation of RIF. This is perhaps not surprising, as the authors appropriately highlight the number of different rif-modifying enzymes that have been identified that likely also contribute to drug resistance. However, I do think this means that the authors can't make the claim that the resistance they observe is caused by rifamycin modification, so those claims in the text and figure legend should be altered unless the authors can provide further evidence to support them. This experiment also has results that are inconsistent with what appears to be an identical experiment performed in Supplemental Figure 5b. The authors should provide context for why these results differ.

      In regard to enzyme efficiency, the apparent rate of all Arr-1 is relatively similar in converting RIF into ADP-Ribosyl-Rif between species. However, Arr-X is much more efficient when compared to Arr-1 in both M. flavescents and M. conceptionense. This is indicated by the apparent rate measured and displayed on figure 5c.

      Proteomics data shows that there is upregulation of Arr-1 and Arr-X upon rifampicin treatment in M. flavescens and M. conceptionense. However, the same experiment was not performed in Arr-1 KD. Therefore, we can’t verify through this approach if the activity observed in vivo directly correlates with a higher expression of Arr-X alone. Of note, likely both enzymes contribute to resistance to rifamycins, as per our results with the Arr-X KD and sensitization of M. conceptionense to RIF.

      Author response image 1.

      It is also worth mentioning that there are other enzymes in the pathway of RIF ribosylation and their efficiency is unknown (Author response image 2). Therefore ADP-Ribosyl-RIF It is not an “end-metabolite” and maybe not the sole determinant of RIF resistance via ADP-ribosylation. Downstream enzymes can also account for the difference observed between M. flavescens and M. smegmatis.

      Author response image 2.

      It is correct that the Rifampicin MIC for M. flavescens is the same as M. smegmatis.

      (4) Fig 4f/5c: M. flavescens has both Arr-1 and Arr-X, yet it appears to not have ribosylated RIF. This result seems to undermine the authors' reliance on the enzyme assay shown in Fig 5c - in that assay, M. flavescens Arr-X is very capable of modifying rifampicin, yet that doesn't appear to translate to the in vivo setting. This is of importance because the authors use this enzyme assay to argue that Arr-X is a fundamentally more powerful RIF resistance mechanism than Arr-1 and that it has specificity for rifabutin. However, the result in Figure 4f would argue that the enzyme assay results cannot be directly translated to in vivo contexts. For the authors to claim that Arr-X is most potent at modifying rifabutin, they could test their CRISPRi knockdowns of Arr-X and Arr-1 under treatment with each of the rifamycins they use in the enzyme assay. The authors mentioned that they didn't do this because all the strains are resistant to those compounds; however, if Arr-X is important for drug resistance, it would be reasonable to expect to see sensitization of the bacteria to those compounds upon knockdown.

      The reviewer is reading Fig. 4f incorrectly, probably because it is plotted in a linear scale instead of logarithmic scale. Ribosylated Rif is present in M. flavescens, just at lower levels than M. conceptionense and M. smegmatis. In species where there is no Arr-1 or Arr-3, ribosylated RIF is not detected at all (e.g. M. tuberculosis), i.e., concentration is zero. Therefore, any detection of ribosylated RIF can be considered significant. In addition, as mentioned before, ADP-ribosylation of RIF is not the final product of the reaction and further studies need to be undertaken to understand subsequent reactions.

      (5) Figure 5d: The authors use this CRISRPi experiment to claim that ArrX from M. conceptionanse is more potent at inactivating rifabutin than Arr-1. This claim depends on there being equal degrees of knockdown of Arr-1 and Arr-X, so the authors should validate the degree of knockdown they get. This is particularly important because, to my knowledge, nobody has used this system in M. conceptionanse before.

      We agree with the reviewer that a qPCR should have been performed to define the extent of interference in the strain. generated Unfortunately, at this time a qPCR was not performed in the strains tested to confirm the extent of down regulation. Although it is the best practice to validate the strain KD, there is no indication that the effect observed is due to unspecific downregulation. The genetic environment in which Arr-X is positioned is different from Arr-1 and the targeting oligonucleotides are specific and would not promiscuously bind to Arr-1. Said that, this is indeed a fault in our setup.

      (6) The authors' arguments about Arr-X and Arr-1 would be strengthened by showing by LC/MS that Arr-X knockdown in M. conceptionense results in more loss of ribosyl-rifabutin than knockdown of Arr-1.

      We agree with the reviewer that performing the LC-MS analysis of the Arr-x knockdown would have strengthened the argument of our paper. Unfortunately, this experiment was not performed.

      Reviewer #3 (Public review):

      This manuscript presents a macroevolutionary approach to the identification of novel high-level antibiotic resistance determinants that takes advantage of the natural genetic diversity within a genus (mycobacteria, in this case) by comparing antibiotic resistance profiles across related bacterial species and then using computational, molecular, and cellular approaches to identify and characterize the distinguishing mechanisms of resistance. The approach is contrasted with "microevolutionary" approaches based on comparing resistant and susceptible strains of the same species and approaches based on ecological sampling that may not include clinically relevant pathogens or related species. The potential for new discoveries with the macroevolution-inspired approach is evident in the diversity of drug susceptibility profiles revealed amongst the selected mycobacterial species and the identification and characterization of a new group of rifamycin-modifying ADP-ribosyltransferase (Arr) orthologs of previously described mycobacterial Arr enzymes. Additional findings that intra-bacterial antibiotic accumulation does not always predict potency within this genus, that M. marinum is a better proxy for M. tuberculosis drug susceptibility than the commonly used saprophyte M. smegmatis, and that susceptibility to semi-synthetic antibiotic classes is generally less variable than susceptibility to antibiotics more directly derived from natural products strengthen the claim that the macroevolutionary lens is valuable for elucidating general principles of susceptibility within a genus.

      There are some limitations to the work. The argument for the novelty of the approach could be better articulated. While the opportunities for new discoveries presented by the identification of discrepant susceptibility results between related species are evident, it is less clear how the macroevolutionary approach is further leveraged for the discovery of truly novel resistance determinants. The example of the discovery of Arr-X enzymes presented here relied upon foundational knowledge of previously characterized Arr orthologs. There is little clarity on what the pipeline for identifying more novel resistance determinants would look like. In other words, what does the macroevolutionary perspective contribute to discovery from the point of finding interspecies differences in susceptibility? Does the framework still remain distinct from other discovery frameworks and approaches? If so, how?

      Thanks for pointing this out, as this is a critical feature of our study and method. Our approach relies on inter-species comparative genomics and phenotypes, and therefore, it is distinct from inter-strains comparison. This difference is dramatic, and it becomes clearer when we are comparing the core genome of M. tuberculosis (one species) 92% with the core genome of the genus, circa of 1%. While we focus on rifamycin in this manuscript, future manuscripts will investigate many of the other dozens of “inconsistencies” observed between the genetic makeup of different mycobacterial species and there actual performance in the presence of different antibiotics.

      While the experimentation and analyses performed appear well-designed and rigorous, there are a few instances in which broad claims are based on inferences from sample sets or data sets that are too limited to provide robust support. For example, the claim that rifampicin modification, and precisely ADP-ribosylation, is the dominant mechanism of resistance to rifampicin in mycobacteria may be a bit premature or an over-generalization, as other enzymatic modification mechanisms and other mechanisms such as helR-mediated dissociation of rifampicin-stalled RNA polymerases, efflux, etc were not examined nor were CRISPRi knockdown experiments conducted beyond an experiment to tease out the role of Arr-X and Arr-1 in one strain. The general claim that intra-bacterial antibiotic accumulation does not predict potency in mycobacteria may be another over-generalization based on the limited number of drugs and species studied, but perhaps the intended assertion was that antibiotic accumulation ALONE does not predict potency.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Major comments

      (1) The metabolomics is done using mycobacteria grown on filters. Initially, mycobacterial cells are grown on the filters for 5 doublings before being transferred to drug-containing (or free) agar for one doubling. Is this based on calculated doubling time in liquid culture or a true determination of the fact that the biomass increases to what would amount to 5 doublings?

      The doubling time used is the one determined in liquid media. Although it is possible that the growth kinetics in solid media is slightly different from liquid (±10%), this experimental design is well established for M. tuberculosis (since Proc Natl Acad Sci U S A. 2010 May 25;107(21):9819-24.) and M. smegmatis (unpublished). Therefore, we used the growth rate as a proxy for having the same biomass of cells for each species tested. A maximum difference of 10% was observed between M. tuberculosis growth in liquid and in solid media, however, cells grow exponentially for much longer in filters. This makes filter-based experiments more reliable, as few growth phase-derived differences are present.

      (2) The demonstration that intrabacterial drug concentrations vary between mycobacterial species in a manner not related to MIC for at least LZD and RIF, is an important finding. However, intrabacterial does not mean cytoplasmic since a considerable fraction could be present in the periplasmic/cell wall layers. Ideally, this would need to be determined but would of course be a massive undertaking since the method needs validation & optimization for each mycobacterial species. Nevertheless, this has to be mentioned. In addition, three drugs are limiting. Measuring additional drug concentrations in these 5 mycobacteria would at least establish some confirmation about the extent of this lack of correlation. Thus, could the authors measure concentrations of additional drugs with intracellular targets?

      Testing additional drugs can be beneficial and would be an expansion of our paper, which will definitely be on future plans for further studies focusing on other antibiotics described here. It would also provide new insights into other possible mechanisms of resistance in mycobacterial species. However, in this study we aimed to first determine the antibiotic response profile in different mycobacterial species, and once we identified interesting resistance phenotypes that could not be readily explained by known mechanisms of resistance, we narrowed it down to certain drugs and species that would potentially provide insights into new mechanisms of antibiotic resistance. Finally, exploring drug concentration across multiple bacterial compartments is a dauting task and it has not been done extensively with any species, not to mention with multiple species, many of which are still lacking any study of their actual cell envelope.

      (3) CRISPRi was used to reduce transcription in M. conceptionense. What was the level of gene downregulation?

      As mentioned previously, a setback from our setup is that the level of KD was not measured at this instance.

      Minor comments:

      (1) The introduction mentions the fast and slow-growing mycobacteria which are classified based on the time that it takes to observe colonies on solid agar. However, in liquid medium, there is less correlation between the reported growth on agar and doubling time in liquid (Figure 1b, Figure 2d). This could be mentioned in the results section. In Figure 2d, the filled circles represent fast-growers but this does not hold well for liquid culture and it might make more sense to not distinguish between fast- and slow-growers in these graphs. A small complication would also be the fact that the doubling time represents growth in a liquid medium with Tyloxapol as a detergent whereas the MIC and metabolomics are done on solid agar with no detergent. The metabolomics is done after a doubling but for those where agar growth and liquid growth have large discrepancies in growth rate, there could be some differences.

      Apologies for this misunderstanding. Fast- and slow-growth phenotypes are determined in Lowenstein-Jensen (LJ) agar, not in 7H10 agar (used in our study and most studies of mycobacteria). Furthermore, this is a qualitative definition, not a quantitative one. Therefore, our measurements do not need to correlate with fast- and slow-growth phenotypes, unless we had used that one specific medium. Furthermore, in liquid medium, we determined growth rate directly, which is never done with LJ medium.

      In addition to adding the same amount of cells to each filter, we also perform TIC normalization, which should account for how rich the samples were – and therefore how much material we had. Therefore, we do not observe discrepancies due to differences in growth rate and the presence/absence of detergent in the media.

      It is also worth mentioning that this experimental set up has been well established in many M. tuberculosis labs that study metabolism. Importantly, the use of detergent drastically affects mass spectrometry, and therefore cannot be used.

      (2) Figure 1g in the text should be Figure 1f.

      Apologies, it has been fixed.

      (3) Figure S1 would be ideal to have in (supplementary) table format.

      This data is now being provided in a table format.

      (4) Table S1 - ethambutol misspelt.

      Spelling has been corrected.

      (5) MIC for species such as M. abscessus could depend on medium (7H9-based medium can give different MIC values than CAMH).

      Indeed, different media can significantly change MIC values, and this is true for many bacterial species, if not all. For this study we used only species that could be grown in 7H9 broth containing 10 % ADC, 0.05% glycerol 0.05% tyloxapol and 7H10 plates containing 10% OADC and 0.05% glycerol. MIC<sub>99</sub> was determined in the latter as we found more efficient and robust to do our tests it in solid media. The goal of our experiment was not to the determined the “true” MIC for the antibiotics tested, as this value does not exist. It was to find lack of correlations between relative values and the presence of genes that can account for it.

      (6) The statement "the experiment was performed at a concentration of antibiotic equal to its MIC" initially seems confusing. It was not equal to the MIC but performed at 6-fold the respective MIC of the species in question. Maybe re-phrasing this would help.

      Apologies for this oversight. It has been corrected.

      (7) Note that some mutations outside the RRDR (eg. V170F and I491F) can also cause Rif resistance.

      Author response image 3.

      A Rainbow diagram of RpoB X-Ray structure coloured according to sequence conservation. Dark purple indicates high conservation, whereas dark orange indicates low conservation. RIF (showed in magenta) is bound to RpoB. Zoomed view displays that the RIF-binding pocket is considerably conserved. B RpoB protein sequence has an 81bp region called Rifampicin Resistance Determining Region (RRDR) that is known to be important for RIF binding and is where most mutations occur in drug-resistant TB. Sequence alignment displays that the RRDR region is conserved with the exception of M. branderi, which has an Asn instead of a Ser residue in position 456 (numbering is related to the M. tuberculosis sequence), highlighted in bold.

      Attached we have a structural alignment of RpoB of the species highlighted on this paper. Although there is variability within the sequences, which is also displayed in Author response image 3 with the conservation analysis, the residues that have been implicated with resistance (including V170 and I491) are conserved. Alignment sent on .fasta file that can be opened in jalview.

      (8) Discuss how the RpoB S450N mutation in M. branderi confers the observed level of resistance.

      That’s a great point, thank you. Now it reads as:

      “The rifampicin (RIF) binding pocket is generally conserved, but Mycobacterium branderi has an S450N mutation in the RRDR region. While this specific mutation hasn't been found in clinical isolates, it's located at the binding site and may confer resistance (273). Although both serine (S) and asparagine (N) have similar side chains, related mutations like S450Q have been linked to resistance (156). Thus, M. branderi may be RIF-resistant due to this mutation. In contrast, M. conceptionense, M. flavescens, and M. smegmatis show no target sequence differences that explain their resistance”

      (9) The statement that the three tested NTM are sensitive to rifabutin ("resistant to all rifamycins except for rifabutin") needs to be interpreted considering what sensitivity means. The MIC is still high (1.6-3.1 ug/mL) when compared to that of Mtb. The 2-fold differences in MIC between M. smegmatis and M. conceptionense do not really prove or disprove the role of Arr-X in rifabutin resistance.

      We fixed the sentence to be more careful with the language on the text. We agree, but it is worth mentioning that generally with bacteria there is a regulation by the CLSI. Each bacterial species has a range that is considered sensitive or resistant, but these are not available for the species used in this study. In general, bacteria with MIC values above 8 µg/mL are considered resistant to rifampin (J Antibiot 2014 67:625).

      (10) Figure 1d: It's hard to quantify the sensitivity of the plates. Can this be done by MIC? Was only rifabutin tested or also rifampicin?

      The initial experiments described on the paper were all performed using Rifampicin only. Then, the MIC for the remaining rifamycins was determined for M. smegmatis, M. flavescens and M. conceptionense, and can be perused on “Supplementary table 4”. Figure 5d is to illustrate the effect of the KD in M. conceptionense sensitivity to rifabutin.

      (11) Is there data to show the ADP-ribosylation of rifabutin in M. conceptionense and the CRISPRi strains?

      Unfortunately, we did not perform LC-MS analysis on M. conceptionense CRISPRi strains exposed to rifabutin to measure potential ADP-ribosylation.

      Reviewer #2 (Recommendations for the authors):

      (1) It would be useful if the authors would complete Figure 1A by determining growth rates for the remaining 18 strains that they currently omitted.

      These growth rates were obtained using roller bottles and in at least 3 independent experiments, unfortunately the throughput is far ideal. The goal of the experiment was to highlight difference in growth rate, beyond fast- and slow-growth, which we did. Adding the remaining values would not change this conclusion. Growth rate variation in 7H9 is significant and the point is made in our figure.

      (2) The authors should justify their choice of species used in Figures 3-4. It would be useful to know, for instance, if the authors chose these species in an unbiased fashion, or if they were chosen because the authors had already determined that they possess rifamycin-modifying enzymes of interest. In that case, they wouldn't necessarily be a representative sample to use for the correlation analysis of antibiotic uptake and potency in Figure 3.

      They were chosen because of their resistance profile for BDQ, LZD and RIF. This has been addressed in the text, which now reads “Given the antibiotic response profiles observed, we selected BDQ, LZD and RIF to explore the molecular causes of these dramatic changes in antibiotic potency observed across the Mycobacterium genus.”

      (3) Figure 4b: The data in this panel appear inconsistent - for instance, M. houstonense appears to grow at 10X Mtb MIC, but fails to grow at 1X Mtb MIC. Repeating this experiment would better establish the validity of the authors' claims about the relative susceptibility of these strains to RIF.

      The figures got rotated when exported from illustrator. Corrected figure is uploaded, and original plate photos are also uploaded for clarity.

      (4) Figure 4e: Does Arr-X get upregulated in these proteomic datasets? The authors' argument that proteomic upregulation correlates with important drug resistance genes would imply that it might be, so that would be useful information to provide.

      Arr-X is slightly upregulated, but not statistically significant – this could be due to the native expression of Arr-1. Data is displayed in a previous answer.

      (5) I wasn't able to find the supplementary tables that the authors allude to - not sure if that was a file mixup, but those tables would be useful for interpreting the manuscript.

      We are sorry that you couldn’t access the table. It must be a file corruption issues, as the other reviewers were able to. We will make sure that all tables are available and accessible.

      (6) For LC/MS, the authors use peak height instead of peak area, which they argue correlates better with the amount of drug in cells because of the poor peak shape they observed for linezolid. This is not standard practice, so the authors should provide evidence to support this claim by running an LC/MS standard curve, then showing the correlation between peak height and amount of compound added as well as the correlation between peak area and compound.

      Thank you for pointing that out, accuracy calculated and displayed. Both peak area and height can be used, but indeed area is standard practice.

      (7) The authors should provide methods information about the LC column and the gradient settings used for LC-MS, as well as the settings of the MS.

      The full method has been added to the paper.

      Reviewer #3 (Recommendations for the authors):

      I have only minor comments aside from the information in the Public Review:

      (1) Results, section on Intra-bacterial antibiotic accumulation, line 8: "experiment was performed at a concentration of antibiotic PROPORTIONAL to its MIC" would be more accurate?

      Agreed and adjusted according to Reviewer’s suggestion.

      (2) Results, section on A minor role for pre-existing target modification, last sentence: the mere presence of RIF-ribosylating enzymes does not, in and of itself indicate that "RIF modification, and precisely ADP-ribosylation, is the dominant mechanism of resistance to RIF in mycobacteria", as other mechanisms and other forms of modifying enzymes are known to confer rifamycin resistance, with redundancy (e.g., other rifampicin-modifying enzymes, or helR-mediated dissociation of rifampicin-stalled RNA polymerases from DNA). It would be more appropriate to suggest the results presented to this point indicate RIF modification is common among mycobacteria. The evidence from the CRISPRi knockdown of Arrs shown in Fig 5d is the kind of evidence that suggests ribosylation as a dominant mechanism, at least against rifabutin in this particular species.

      Absolutely, there are other possible modifying enzymes that could be encoded by these mycobacterial species. There is a possibility that M. flavescens and M. smegmatis encode for a putative helR (attached alignment) but further experiments would need to be carried out to confirm its ability to displace RIF in the RNAP. Interestingly, the presence of both Arr and HelR has been studied in M. abscessus and those mechanisms of resistance are independent from each other (Molecular Cell 2022 82(17):3166-3177.e5).

      (3) Discussion, 2nd sentence needs grammatical editing.

      Rephrased and it reads “Using our mycobacterial library, we identified for the first time high- and ultra-high-level intrinsic resistance (3) to many of the antibiotics tested. Of note, the resistant phenotype is naturally occurring and not a result of mutations due to exposure to the antibiotic in the clinic – which is the more traditional approach for probing mechanisms of antibiotic resistance. Our observations revealed that resistance profiles are highly variable across the genus and do not follow phylogeny, implicating HGT as the key mechanism for acquisition of resistance determinants and evolution of antibiotic resistance in mycobacteria (42).”

      (4) Discussion, page 7, first line: the inclusion of LZD and BDQ in this statement seems at odds with Figure 2c and the statements in the first paragraph of page 5 highlighting these as examples of drugs to which most mycobacteria are susceptible.

      Indeed, many of the species are susceptible, however the MIC<sub>99</sub> levels observed have never been reported before, and therefore we found it to be an interesting finding to highlight. From a treatment perspective, knowing which species are sensitive to which drugs is of course the most useful outcome of our study.

      (5) The next sentence..."We found that resistance to these antibiotics in mycobacteria cannot be explained by uptake/efflux mechanisms..." is a bit of an over-generalization and conflicts with the evidence presented earlier that efflux could be playing a role in BDQ resistance and the published evidence establishing a clinically significant role for efflux-mediated BDQ resistance in M. tuberculosis, M. avium complex and M. abscessus complex.

      We rephrased it to make it more specific to our findings. It reads “We found that resistance to these antibiotics in mycobacteria do not correlate with by uptake/efflux mechanisms in the species tested and it does not correlate with growth rate. Identification of mycobacterial species highly resistant to BDQ and LZD is worrisome as most of this species, if not all, have never been exposed to these drugs.”

      (6) Methods, section on In vitro activity assay of Arr enzymes, line 1: reference(s) should be provided for previously reported methods.

      Reference now added.

      (7) Figure 2d: the low end of the susceptibility range is not well defined.

      In this figure the susceptibility is not defined as the lowest area of the graph, but the lower concentrations are indeed harder to be defined. Hopefully supplementary figure 1 and the additional table containing the MIC can be informative to address this comment.

      (8) Figures 3c,d: the presentation of the relative antibiotic concentrations could be harmonized between the graphs in 3c and those in 3d to enable a more ready comparison.

      We disagree. The goal of these different panels is exactly to illustrate two distinct points. C gives the relative concentration of antibiotic, while D correlates relative concentration with MIC99. The use of log scale in D further clarifies that there is no correlation between intracellular antibiotic concentration and potency (MIC). This information is not present in C.

      (9) Figure 4f and Supplementary Figure 5b: it is difficult to understand the limited amount of ribsosyl-RIF in M. flavescens in Fig 4f relative to Supplementary Figure 5b (esp. when considering M. smeg as a common comparator); and, further, to understand the seeming lack of correlation between RIF susceptibility, ribosylation and Arr number and catalytic efficiency for these two strains without considering additional resistance mechanisms.

      In reality the difference between figure 4f and Supplementary figure 5b is mainly due to M. smegmatis – that has an apparent lower production of ribosyl-RIF in the experiment described in the supplementary figure. The values for M. flavescens are relatively similar. In addition, the ADP-Ribosyl-RIF is not the final metabolite of the pathway.

      In regards of having the entire picture, it is true that we were unable to completely unravel and correlate MIC value, expression of Arr-1, expression of Arr-3, efficiency of each enzyme, production of ADP-Ribosyl-RIF and the presence of other possible mechanisms of resistance and this is indeed a setback in our study, and of most studies ever published, which usually focus on one resistant determinant.

    1. Author response:

      The following is the authors’ response to the original reviews

      Many thanks for your helpful and constructive comments for our work examining the effect of inhibiting both the insulin receptor (IR) and IGF1 receptor (IGF1R) in the podocyte. We are pleased to submit an updated manuscript addressing your concerns.

      (1) A major concern was a lack of mechanistic insight into how deletion (or knock-down) of both receptors caused the spliceosomal phenotype (Reviewer 1 and Reviewer 3).

      We now think this is due to the lack of a network of insulin/IGF phospho-signalling events to a variety of spliceosomal proteins and kinases. The reasons for this are as follows:

      A. Since submitting our paper Turewicz et al have published a comprehensive phospho-proteomic paper examining the effects of 100nM insulin on human primary myotubes (DOI: 10.1038/s41467-025-56335-6). They discovered that multiple post-translational phosphorylation events occur in a variety of spliceosomal proteins at differing time points (1 minute to 60 minutes). Furthermore, they show that mRNA splicing is rapidly modified in response to insulin stimulation in their cells. This follows elegant work from Bastista et al who studied diabetic and non-diabetic iPSC derived human myositis and also detected a spliceosome phosphorylation signature (DOI: 10.1016/j.cmet.2020.08.007).

      B. We have examined phospho-proteosome changes that occur in wild -type podocytes (expressing both the IR and IGF1R) compared to double (IR and IGF1R) knockout cells using phosho-proteomics. We have done this 3 days after inducing receptor knockdown, before major cell loss, and have stimulated the cells with either 10nM insulin or 100mg IGF1.

      Interestingly, we detected several post-translational modifications (PTM) in our data set that are also present in Turewicz’s studies. Of note, 100nM insulin (as used by Turewicz) will signal through both the insulin and IGF1 receptor (and hybrid Insulin/IGF1 receptors) which is relevant to our studies.

      Our work shows a cascade of phospho- signalling events affecting multiple components of the spliceosomal complex and evidence of kinase modulation (phosphorylation) (New Figure 7 and supplementary Figure 5). Also new results section in paper (lines 391-425 in track changes version). We acknowledge that we only studied a single time point after stimulation (10 minutes) and could have missed other PTM in the spliceosomal complex and other kinases. This is mentioned in our new limitations of study section (lines 595-606). This will be a focus of future work. We did not find major PTM differences when stimulating with either insulin or IGF1 in our studies and suspect that the doses of insulin (10nM) and IGF1 (100mg) used are still able to signal through cognate receptors.

      Furthermore, we have examined the relative contributions of the insulin and IGF1 receptor in detail in the model (addressed in point 13 below).

      (2) The phenotype of the mouse is only superficially addressed. The main issues are that the completeness of the mouse KO is never assessed nor is the completeness of the KO in cell lines. The absence of this data is a significant weakness. (Reviewer 1)

      We apologise for not making this clear, but we did assess the level of receptor knockdown in both the animal and cell models. The in vivo model showed variable and non-complete levels of insulin receptor and IGF1 receptor podocyte knock down (shown in supplementary Figure 1C). This is why we made the in vitro floxed podocyte cell lines in which we could robustly knockdown both the IR and IGF1R. We show this using Western blotting (shown in Figure 2A). We agree that calling the models knockout is misleading and have changed all to knock down (KD) now.

      (3) The mouse experiments would be improved if the serum creatinine’s were measured to provide some idea how severe the kidney injury is. (Reviewer 1)

      There is variability in creatinine levels which is not uncommon in transgenic mouse models (probably partly due to variability in receptor knock down levels with cre-lox system). This is part of rationale of developing the robust double receptor knockout cell models where we robustly knocked out both receptors by >80%. We have added measured creatinine levels in a subset of mice in supplementary data (New Supplementary Figure 1E) and mention this in the text (lines 285-286). As some mice died we expect they may have developed acute kidney injury, but we did not serially measure the creatinine’s in every mouse over time. We could have assessed the GFR in a more sensitive way to look at differences. However, we consider the highly significant levels of albuminuria and histological damage observed in our models show a significant kidney phenotype.

      (4) An attempt to rescue the phenotype by overexpression of SF3B4 would also be useful. If this didn't work, an explanation in the text would suffice. (Reviewer 1).

      We did consider doing this but on reflection think it is very unlikely to rescue the phenotype as an array of different spliceosomal proteins quantitatively changed and were differentially phosphorylated / dephosphorylated throughout the complex (as we hope our revised work illustrates now). We think a single protein rescue is highly unlikely to work. We hope this is an appropriate explanation for this action. We have mentioned this in the text now in our discussion (lines 601-602).

      (5) As insulin and IGF are regulators of metabolism, some assessment of metabolic parameters would be an optional add-on. (Reviewer 1).

      Thank you for this suggestion. We did not extensively examine the metabolism of the mice however we did perform blood glucose measurement and weight which are included in the paper (Figure 1A and Figure 1B).

      (6) The authors should caveat the cell experiments by discussing the ramifications of studying the 50% of the cells that survive vs the ones that died. (Reviewer 1).

      We appreciate this and this was the rationale behind cells being studied after 3 days differentiation for total and phospho-proteomics before significant cell loss to avoid the issue of studying the 50% of cells that survive (which happened at 7 days). We have made this clearer in the manuscript. We also have added the data showing less cell death at 3 days in the cell model (New Supp Figure 2B).

      (7) It would be helpful to say that tissue scoring was performed by an investigator masked to sample identity. (Reviewer 2)

      We did this and have added to manuscript (line 113).

      (8) Data are presented as mean/SEM. In general, mean/SD or median/IQR are preferred to allow the reader to evaluate the spread of the data. There may be exceptions where only SEM is reasonable. (Reviewer 2)

      All graphs have now been changed to SD rather than SEM.

      (9) It would be useful to for the reader to be told the number of over-lapping genes (with similar expression between mouse groups) and the results of a statistical test comparing WT and KO mice. The overlap of intron retention events between experimental repeats was about 30% in both knock-out podocytes. This seems low and I am curious to know whether this is typical for this method; a reference could be helpful. (Reviewer 2)

      This is an excellent question. We had 30% overlap as the parameters used for analysis were very stringent. We suspect we could get more than 30% by being less stringent, which still be considered as similar events if requested. Our methods were based on FLAIR analysis (PMID: 32188845). We have added this reference to the manuscript (Line 242 & 680).

      (10) With the GLP1 agonists providing renal protection, there is great interest in understanding the role of insulin and other incretins in kidney cell biology. It is already known that Insulin and IGFR signaling play important roles in other cells of the kidney. So, there is great interest in understanding these pathways in podocytes. The major advance is that these two pathways appear to have a role in RNA metabolism, the major limitations are the lack of information regarding the completeness of the KO's. If, for example, they can determine that in the mice, the KO is complete, that the GFR is relatively normal, then the phenotype they describe is relatively mild. (Reviewer 1)

      Thank you. The receptor knock-out (KO) in the mice is highly unlikely to be complete (Please see comments above and Supplementary Figure 1C). There are many examples of “KO” animal models targeting other tissues showing that complete KO of these receptors seems difficult to achieve, particularly in reference to the IGF1 receptor. In the brain, which also contains terminally differentiated cells, barely 50% of IGF1R knockdown was achieved in the target cells (PMID:28595357). In ovarian granulosa cells (PMID:28407051) -several tissue specific drivers tried but couldn't achieve any better than 80%. The paper states that 10% of IGF1R is sufficient for function in these cells so they conclude that their knockdown animals are probably still responding to IGF1. Finally, in our recent IGF1R podocyte knockdown model we found Cre levels were important for excision of a single homozygous floxed gene (PMID: 38706850) hence we were not surprised that trying to excise two homozygous floxed genes (insulin receptor and IGF1 receptor) was challenging. This was the rationale for making the double receptor knockout cell lines to understand processes / biology in more detail. As stated earlier, we have changed our description of the mice and cell lines from knock-out to knock-down throughout the revised manuscript as this is more accurate.

      (11) For the in vivo studies, the only information given is for mice at 24 weeks of age. There needs to be a full-time course of when the albuminuria was first seen and the rate of development. Also, GFR was not measured. Since the podocin-Cre utilized was not inducible, there should be a determination of whether there was a developmental defect in glomeruli or podocytes. Were there any differences in wither prenatal post-natal development or number of glomeruli? (Reviewer 3)

      We have added further urinary Albumin:creatinine ratio (uACR) data at 12, 16 and 20 weeks to manuscript. We do not think there was a major developmental phenotype as albuminuria did not become significantly different until several months of age (new Supp Figure 1B). We did consider using a doxycycline inducible model but we know the excision efficiency is much less than the constitutive podocin-cre driven model Author response image 1. This would likely give a very mild (if any) phenotype when attempting to knockout both receptors and not reveal the biology adequately. We acknowledge the weaknesses of the animal model and this was the rationale for generating the cell models.

      (12) Although the in vitro studies are of interest, there are no studies to determine if this is the underlying mechanism for the in vivo abnormalities seen in the mice. Cultured podocytes may not necessarily reflect what is occurring in podocytes in vivo. (Reviewer 3)

      This is a good point. We have now immune-stained the DKD and WT mice for Sf3b4 (a spliceosomal change in our in vitro proteomics) and also find a significant reduction in this protein in podocytes of the DKD mice (New Figure 3F).

      (13) Given that both receptors are deleted in the podocyte cell line, it is not clear if the spliceosome defect requires deletion of both receptors or if there is redundancy in the effect. The studies need to be repeated in podocyte cell lines with either IR or IGFR single deletions. (Reviewer 3)

      We have now performed proteomics and phospho-proteomics in all 4 cell types (Wild-type, Insulin receptor knock down, IGF1R knockdown and double knockdown) at 3 days (New Figure 8 and supplementary Figure 6. Also new results section lines 425 to 450). This shows that both receptors contribute to the pathways (and hence there is a high level of compensation built into the system). For total proteins we detected that spliceosomal tri-snRNP was only reduced when both receptors were lacking but other proteins / pathways had an incremental effect of losing the insulin or IGF1 receptor. Likewise, the spliceosomal phospho-signaling events can go through either the insulin or igf1 receptors predominantly or through both. We think this reflects the complexity of this system and how evolutioatily it has developed in mammals to protect against its loss.

      Finally in revision we have rewritten the discussion with a “limitations of the study” section and hopefully in an easier to read fashion for the readership.

      Author response image 1.

      (A) mT/mG reporter mouse crossed to constitutional podocin Cre heterozygous mouse. Illustrates podocyte specificity for Cre driver and excision Of reporter Figure shows GFP expression in Cre producing cells (top panel scale bar=250vm; bottom panel scale bar=50pm). Cre expression causes GFP to be switched on. (B) mT/mG reporter mouse crossed to podocin RtTA— tet-o-cre heterozygous mouse shows podocyte specificity for driver and approximately 60% excision. (top and bottom panels scale bar=250pm; middle panel scale bar=50pm). Doxycycline required for expression showing not leaky.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors show that genetic deletion of the orphan tumor necrosis factor receptor DR6 in mice does not protect peripheral axons against degeneration after axotomy. Similarly, Schwann cells in DR6 mutant mice react to axotomy similarly to wild-type controls. These negative results are important because previous work has indicated that loss or inhibition of DR6 is protective in disease models and also against Wallerian degeneration of axons following injury. This carefully executed counterexample is important for the field to consider.

      Strengths:

      A strength of the paper is the use of two independent mouse strains that knock out DR6 in slightly different ways. The authors confirm that DR6 mRNA is absent in these models (western blots for DR6 protein are less convincingly null, but given the absence of mRNA, this is likely an issue of antibody specificity). One of the DR6 knockout strains used is the same strain used in a previous paper examining the effects of DR6 on Wallerian degeneration.

      The authors use a series of established assays to evaluate axon degeneration, including light and electron microscopy on nerve histological samples and cultured dorsal root ganglion neurons in which axons are mechanically severed and degeneration is scored in time-lapse microscopy. These assays consistently show a lack of effect of loss of DR6 on Wallerian degeneration in both mouse strains examined.

      Therefore, in the specific context of these experiments, the author's data support their conclusion that loss of DR6 does not protect against Wallerian degeneration.

      Weaknesses:

      (1) The major weaknesses of this paper include the tone of correcting previously erroneous results and the lack of reporting on important details around animal experiments that would help determine whether the results here really are discordant with previous studies, and if so, why.

      The authors do not report the genetic strain background of the mice used, the sex distributions of their experimental cohorts, or the age of the mice at the time the experiments were performed. All of these are important variables.

      (Response 1) We thank the reviewer for emphasizing the importance of reporting the sex, age, and genetic background of the experimental animals used in our axon protection analyses. We have incorporated this information into the revised manuscript wherever available. The sole exception concerns the genetic background of the conditional DR6 mice generated by Genentech, which remains unknown. The original publication describing these mice (Tam et al., 2012, Dev Cell, PMID 22340501) did not report this information, and we were unable to obtain it directly from Genentech. Details regarding the genetic background of the Wld<sup>S</sup> and aPhr1 mutant mice are provided in their respective original publications, which are cited in our manuscript. Because the Gamage et al. study from the Deppmann laboratory did not report the sex or age of the animals used, we were unable to assess whether these variables might contribute to the differences observed between the two studies. Moreover, we are not aware of published evidence identifying sex or age as modifiers of structural axon preservation in axotomized peripheral nerve stumps in mouse models of delayed Wallerian degeneration. Furthermore, in the original publications describing the phenotypes of transgenic Nmnat2 and Wld<sup>S</sup> mice, as well as Sarm1 or Phr1 knockout mice, sex and age of the animals used in the Wallerian degeneration assays were not reported (PMIDs 23995269, 12106171, 22678360, 23665224). Although, to our knowledge, no large-scale systematic studies have been conducted, over the last 15 years we have never observed any sex-based differences in Wallerian degeneration phenotypes in these mutants exhibiting prominent axon protection. This topic was discussed informally at conferences, and we are also not aware of other investigators having observed such effects.

      In response to the reviewer’s comment regarding “tone”, we made sure that our data and interpretations are presented in a professional, balanced, and objective manner, including a detailed discussion of potential alternative explanations for the discrepant findings.

      (2) The DR6 knockout strain reported in Gamage et al. (2017) was on a C57BL/6.129S segregating background. Gamage et al. reported that loss of DR6 protected axons from Wallerian degeneration for up to 4 weeks, but importantly, only in 38.5% (5 out of 13) mice they examined. In the present paper, the authors speculate on possible causes for differences between the lack of effect seen here and the effects reported in Gamage et al., including possible spontaneous background mutations, epigenetic changes, genetic modifiers, neuroinflammation, and environmental differences. A likely explanation of the incomplete penetrance reported by Gamage et al. is the segregating genetic background and the presence of modifier loci between C57BL/6 and 129S. The authors do not report the genetic background of the mice used in this study, other than to note that the knockout strain was provided by the group in Gamage et al. However, if, for example, that mutation has been made congenic on C57BL/6 in the intervening years, this would be important to know. One could also argue that the results presented here are consistent with 8 out of 13 mice presented in Gamage et al.

      (Response 2) As noted above, we now provide information on the genetic background of the mice in the revised manuscript, where available. We have not backcrossed the constitutive DR6 knockout mice obtained from the Deppmann laboratory (Gamage et al.) to a C57BL/6 background; our colony was maintained primarily through intercrosses of heterozygous animals. Similarly, the conditional DR6 mutant mice used in this study were also not backcrossed to C57BL/6 mice.

      We respectfully hold a different view regarding the reviewer’s final point. We understand it is not appropriate to infer consistency between two datasets by disregarding the subset of results that do not align. By the same logic, it would be flawed to draw conclusions from the Gamage et al. study based solely on the single Wld<sup>S</sup> mouse out of five that did not show axon preservation after nerve injury. Selectively omitting conflicting data does not provide a valid basis for establishing phenotype concordance across studies.

      To further strengthen our study, we note that we performed additional analyses on three more nerve samples from constitutive DR6 null mice during the revision process and have incorporated the resulting data in Fig. 1.

      (3) Age is also an important variable. The protective effects of the spontaneous WldS mutation decrease with age, for example. It is unclear whether the possible protective effects of DR6 also change with age; perhaps this could explain the variable response seen in Gamage et al. and the lack of response seen here.

      (Response 3) As discussed above, we now provide the age information for the mice used for the Wallerian degeneration assessments in the respective figure legends. To our knowledge, there are no prior reports suggesting that age is a significant determinant of structural axon preservation in the indicated mutants. Electrophysiological function and neuromuscular junction preservation decrease with age in axotomized Wld<sup>S</sup> mice (e.g., PMIDs 12231635, 19158292, 15654865), but these parameters are not subject of our study, and we have not studied them. Unfortunately, a direct comparison of ages between our DR6 mutant mice and those used in Gamage et al. (2017) is not possible, as the earlier study from the Deppmann laboratory did not report this information.

      (4) It is unclear if sex is a factor, but this is part of why it should be reported.

      (Response 4) We now report the requested sex information for our axon preservation analyses during nerve injury-induced Wallerian degeneration in the DR6 mouse models in Figs. 1 and 2.

      (5) The authors also state that they do not see differences in the Schwann cell response to injury in the absence of DR6 that were reported in Gamage et al., but this is not an accurate comparison. In Gamage et al., they examined Schwann cells around axons that were protected from degeneration 2 and 4 weeks post-injury. Those axons had much thinner myelin, in contrast to axons protected by WldS or loss of Sarm1, where the myelin thickness remained relatively normal. Thus, Gamage et al. concluded that the protection of axons from degeneration and the preservation of Schwann cell myelin thickness are separate processes. Here, since no axon protection was seen, the same analysis cannot be done, and we can only say that when axons degenerate, the Schwann cells respond the same whether DR6 is expressed or not.

      (Response 5) We appreciate the reviewer’s detailed comments. Our intention was not to directly compare our findings with those of Gamage et al. regarding the myelin behavior at these time points (because we never observed axon protection), but rather to note that we did not observe any DR6-dependent alterations in Schwann cell responses under conditions where axons undergo normal Wallerian degeneration. As the reviewer correctly points out, Gamage et al. analyzed Schwann cell myelin surrounding axons that were protected from degeneration for extended periods, a context fundamentally different from the complete lack of axon protection observed in our DR6-deficient models. Therefore, the specific dissociation between axon preservation and myelin maintenance claimed by Gamage et al. cannot be evaluated in our study. A statement to make this point clearer has been incorporated in the revised manuscript.

      We fully agree with the reviewer’s concluding point: in our experiments, once axons degenerate, Schwann cell responses proceed similarly regardless of DR6 expression. This agreement reinforces one of the central conclusions of our work.

      (6) The authors also take issue with Colombo et al. (2018), where it was reported that there is an increase in axon diameter and a change in the g-ratio (axon diameter to fiber diameter - the axon + myelin) in peripheral nerves in DR6 knockout mice. This change resulted in a small population of abnormally large axons that had thinner myelin than one would expect for their size. The change in g-ratio was specific to these axons and driven by the increased axon diameter, not decreased myelin thickness, although those two factors are normally loosely correlated. Here, the authors report no changes in axon size or g-ratio, but this could also be due to how the distribution of axon sizes was binned for analysis, and looking at individual data points in supplemental figure 3A, there are axons in the DR6 knockout mice that are larger than any axons in wild type. Thus, this discrepancy may be down to specifics and how statistics were performed or how histograms were binned, but it is unclear if the results presented here are dramatically at odds with the results in Colombo et al. (2018).

      (Response 6) Several points raised by the reviewer appear to reflect differences in interpretation of the findings reported in Colombo et al. (2018). That study did not report altered myelination in DR6 null mice at stages when myelination is largely complete (P21). Instead, modest changes were observed at P1, which were reduced by P7, and P21 mutants were reported to be indistinguishable from controls. No analyses of peripheral nerves in older animals were presented, and the authors concluded in the discussion that myelination in young adult DR6 null mice appears normal. In contrast, our analysis of constitutive DR6 null mice at P1 does not reproduce the increase in the number of myelinated fibers per unit area reported by Colombo et al. We obtained similar results in the independent conditional DR6 knockout mouse line. Differences in nerve tissue processing, embedding, staining, or in the microscopic imaging and quantification of thinly myelinated axons in P1 sciatic nerve cross-sections may have contributed to the observed discrepancy. However, because the relevant methodological details were not described in Colombo et al., the underlying reasons for these differences cannot be determined and remain speculative.

      (7) Finally, it is important to note that previously reported effects of DR6 inhibition, such as protection of cultured cortical neurons from beta-amyloid toxicity, are not necessarily the same as Wallerian degeneration of axons distal to an injury studied here. The negative results presented here, showing that loss of DR6 is not protective against Wallerian degeneration induced by injury, are important given the interest in DR6 as a therapeutic target, but they are specific to these mice and this mechanism of induced axon degeneration. The extent to which these findings contradict previous work is difficult to assess due to the lack of detail in describing the mouse experiments, and care should be taken in attempting to extrapolate these results to other disease contexts, such as ALS or Alzheimer's disease.

      (Response 7) We agree with the reviewer’s point and emphasize that our manuscript carefully differentiates our data regarding the function of DR6 in Wallerian degeneration from the potential involvement of DR6 in other forms of axon degeneration. Our findings do not conflict with previous work on DR6 in the context of in vitro beta-amyloid and prion toxicity as well as in vitro models of ALS and multiple sclerosis. We believe these distinctions are explicitly and appropriately articulated throughout the entire manuscript and in more detail in the discussion section.

      Reviewer #1 (Recommendations for the authors):

      (1) The authors should include additional information about the mice used, including strain background for both the DR6 mice and the Cre transgenes crossed into the DR6 conditional knockout, the age of the mice when the nerve crush experiments were performed, and the sex distributions of the experimental cohorts. This information is critical for reproducibility in animal experiments, and that point is compounded here, where the major focus of this paper is taking issue with the reproducibility of previous work.

      (Response 8) This information has been included in the revision. See above responses.

      (2) In the abstract, reference 5 is cited as a study on the response to Schwann cells to injury in a DR6 background, but this probably should be reference 10.

      (Response 9) This typo has been corrected.

      (3) "Site-by-site comparison" in line 201 should be side-by-side?

      (Response 10) This typo has been corrected.

      (4) The paper contains a lot of self-evaluative wording, "surprising contrast," "compelling evidence," "robust results." Whether those adjectives apply should be for the reader to decide, and a drier, more objective tone in the presentation would improve the paper.

      (Response 11) We agree that excessive self-evaluative wording can weaken objectivity. In the manuscript, such phrasing is used sparingly and intentionally to highlight differences from previously published studies, guide the reader, and convey scholarly judgment. We do not consider this limited use to be counterproductive. The adjectives “surprising,” “compelling,” and “robust” each appear only one to three times across the entire manuscript, and the specific phrase “robust results” does not appear at all.

      (5) In Figure 2A, DR6-/-, there is no significant difference, but there is also a lot of variability, and one could argue the authors are seeing axon protection comparable to WldS in 40% of their samples (2/5), which is very similar to Gamage et al.

      (Response 12) We respectfully disagree with this reasoning as it relies on selectively emphasizing only a subset of the data. Please also see our response #2 for more detailed discussion.

      (6) Overall, the data presented here are convincing and support the conclusions drawn, but the paper needs to focus more on the negative results at hand and less on bashing previous studies, particularly when the results presented here do definitively show that the previous studies were incorrect and plausible explanations for differences in outcome exist.

      (Response 13) We have carefully revisited the wording of the manuscript and are confident that our emphasis remains on the central negative finding that DR6 does not regulate axon degeneration and Schwann cell injury responses during Wallerian degeneration. We do not believe the manuscript “bashes” previous studies; nonetheless, we thoroughly re-examined all relevant sections to ensure that our language is neutral, accurate, and non-inflammatory. We believe the current phrasing presents our interpretations in an appropriately balanced, objective, and professional manner.

      Reviewer #2 (Public review):

      Summary:

      This manuscript by Beirowski, Huang, and Babetto revisits the proposed role of Death Receptor 6 (DR6/Tnfrsf21) in Wallerian degeneration (WD). A prior study (Gamage et al., 2017) suggested that DR6 deletion delays axon degeneration and alters Schwann cell responses following peripheral nerve injury. Here, the authors comprehensively test this claim using two DR6 knockout mouse models (the line used in the earlier report plus a CMV-Cre derived floxed ko line) and multiple WD assays in vivo and in vitro, aligned with three positive controls, Sarm1 WldS and Phr1/Mycbp2 mutants. Contrary to the prior findings, they find no evidence that DR6 deletion affects axon degeneration kinetics or Schwann cell dynamics (assessed by cJun expression or [intact+degenerating] myelin abundance after injury) during WD. Importantly, in DRG explant assays, neurites from DR6-deficient mice degenerated at rates indistinguishable from controls. The authors conclude that DR6 is dispensable for WD, and that previously reported protective effects may have been due to confounding factors such as genetic background or spontaneous mutations.

      Strengths:

      The authors employ two independently generated DR6 knockout models, one overlapping with the previously published study, and confirm loss of DR6 expression by qPCR and Western blotting. Multiple complementary readouts of WD are applied (structural, ultrastructural, molecular, and functional), providing a robust test of the hypothesis.

      Comparisons are drawn with established positive controls (WldS, SARM1, Phr1/Mycbp2 mutants), reinforcing the validity of the assays.

      By directly addressing an influential but inconsistent prior report, the manuscript clarifies the role of DR6 and prevents potential misdirection of therapeutic strategies aimed at modulating WD in the PNS. The discussion thoughtfully considers possible explanations for the earlier results, including colony-specific second-site mutations that could explain the incomplete penetrance of the earlier reported phenotype of only 36%.

      Weaknesses:

      (1) The study focuses on peripheral nerves. The manuscript frequently refers to CNS studies to argue for consistency with their findings. It would be more accurate to frame PNS/CNS similarities as reminiscences rather than as consistencies (e.g., line 205ff in the Discussion).

      (Response 14) Axon protection in all key genetic models of delayed axon degeneration, including Wld<sup>S</sup>, SARM1, Phr1/Mycbp2 mutants, has been demonstrated in both the peripheral and central nervous systems. This observation supports the view that core molecular mechanisms regulating axon degeneration are conserved across neuronal populations throughout the entire nervous system. We have scrutinized the wording in our manuscript and are not aware that we frequently refer to CNS studies in regards to axon degeneration. Nevertheless, we have replaced the term “consistent” to avoid potential ambiguity when we discuss the earlier study showing normal Wallerian degeneration in the optic nerves from DR6 knockout mice.

      (2) The DRG explant assays are convincing, though the slight acceleration of degeneration in the DR6 floxed/Cre condition is intriguing (Figure 4E). Could the authors clarify whether this is statistically robust or biologically meaningful?

      (Response 15) We thank the reviewer for noting this aspect of our in vitro data in Fig. 4. The difference observed in the DR6 floxed/Cre condition is statistically significant at the 6h time point following disconnection, as indicated by the p value shown in Fig. 4E. However, a similarly statistically significant acceleration of axon degeneration was not observed in DRG axotomy experiments using constitutive DR6 knockout preparations, although a trend toward more rapid axon breakdown is apparent at 6 h post-axotomy (Fig. 4B). These observations may suggest reduced stability of DR6-deficient axons in this specific neuron-only in vitro context. Further investigation would be required to determine the biological significance of this effect. In contrast, our in vitro quantitative analyses of the initiation and early phases of Wallerian degeneration (Fig. 2) revealed no evidence of accelerated axon disintegration in the DR6 mutant mouse models, highlighting potential differences between in vitro and in vitro systems.

      (3) In the summary (line 43), the authors refer to Hu et al. (2013) (reference 5) as the study that previously reported AxD delay and SC response alteration after injury. However, this study did not investigate the PNS, and I believe the authors intended to reference Gamage et al. (2017) (reference 10) at this point.

      (Response 16) Thanks for pointing this out. We have corrected this typo in the revised manuscript.

      (4) In line 74ff of the results section, the authors claim that developmental myelination is not altered in DR6 mutants at postnatal day 1. However, the variability in Figure S2 appears substantial, and the group size seems underpowered to support this claim. Colombo et al. (2018) (reference 11) reported accelerated myelination at P1, but this study likewise appears underpowered. Possible reasons for these discrepancies and the large variability could be that only a defined cross-sectional area was quantified, rather than the entire nerve cross-section.

      (Response 17) We confirm that the quantification of thinly myelinated axons was performed on entire sciatic nerves from P1 mouse pups, as described in the methods section in our original manuscript. The data shown in Fig. S2 were obtained from 5-9 pups per experimental group. Sample sizes were determined based on a priori power analyses using pilot data, which indicated that a minimum of five biological replicates was sufficient to detect statistically significant differences with acceptable confidence. Comparable sample sizes have been used in our previous studies and by other groups to assess early postnatal myelination (e.g., PMIDs 21949390, 28484008). Several published studies have reported analyses using 3-4 animals per group (e.g., PMIDs 28484008, 25310982, 29367382). For comparison, the study by Colombo et al. used 3-8 pups for the analysis presented in their Fig. 3. We note that the apparent variability in Fig. S2 may be accentuated by the scaling of the y-axis, which was chosen to ensure that individual data points are clearly resolved and visible.

      (5) The authors stress the data of Gamage et al. (2017) on altered SC responses in DR6 mutants after injury. They employed cJun quantification to show that SC reprogramming after injury is not altered in DR6 mutants. This approach is valid and the conclusion trustworthy. Here, the addition of data showing the combined abundance of intact and degenerated myelin does not add much insight. However, Gamage et al. (2017) reported altered myelin thickness in a subset of axons at 14 days after injury, which is considerably later than the time points analyzed in the present study. While, in the Reviewer's view, the thin myelin observed by Gamage et al. in fact resembles remyelination, the authors may wish to highlight the difference in the time points analyzed.

      (Response 18) We consider the additional quantification of the area occupied by intact myelin and myelin debris to provide complementary information that supports the c-Jun-based conclusion that Schwann cell injury responses are normal in DR6-deficient nerves following lesion. We agree with this reviewer that the thin myelin observed by Gamage et al. resembles remyelination, raising the possibility that axon regeneration occurred into the distal nerve stump at the studied 14d post-injury time point (see their Fig. 3). This may have been interpreted as axon protection in this study. In our study, it was impossible to examine such myelin effects since axon protection was never observed in any of the DR6 mutant models at any of the time point we investigated. We have incorporated appropriate additional text to highlight this difference. See also response #5 above.

      Reviewer #3 (Public review):

      Summary:

      The authors revisit the role of DR6 in axon degeneration following physical injury (Wallerian degeneration), examining both its effects on axons and its role in regulating the Schwann cell response to injury. Surprisingly, and in contrast to previous studies, they find that DR6 deletion does not delay the rate of axon degeneration after injury, suggesting that DR6 is not a mediator of this process.

      Overall, this is a valuable study. As the authors note, the current literature on DR6 is inconsistent, and these results provide useful new data and clarification. This work will help other researchers interpret their own data and re-evaluate studies related to DR6 and axon degeneration.

      Strengths:

      (1) The use of two independent DR6 knockout mouse models strengthens the conclusions, particularly when reporting the absence of a phenotype.

      (2) The focus on early time points after injury addresses a key limitation of previous studies. This approach reduces the risk of missing subtle protective phenotypes and avoids confounding results with regenerating axons at later time points after axotomy.

      Weaknesses:

      (1) The study would benefit from including an additional experimental paradigm in which DR6 deficiency is expected to have a protective effect, to increase confidence in the experimental models, and to better contextualize the findings within different pathways of axon degeneration. For example, DR6 deletion has been shown in more than one study to be partially axon protective in the NGF deprivation model in DRGs in vitro. Incorporating such an experiment could be straightforward and would strengthen the paper, especially if some of the neuroprotective effects previously reported are confirmed.

      (Response 19) We thank the reviewer for these suggestions. We would like to highlight that our study addresses the role of DR6 in Wallerian degeneration, whereas in vitro NGF deprivation has been used to model developmental axon pruning. Previous work indicates fundamental biological differences between these regressive pathways regulating the stereotyped removal of axon segments. We feel that studying this alternative form of axon degeneration is beyond the scope of the current work and could be addressed in a separate manuscript. Although additional tests will be needed, we note that our preliminary data using samples from both DR6 knockout mouse models suggest no axon protection after NGF-deprivation in DRG neuron preparations in our hands (deprivation of the growth factor and administration of anti-NGF antibody).

      (2) The quality of some figures could be improved, particularly the EM images in Figure 2. As presented, they make it difficult to discern subtle differences.

      (Response 20) We have pseudocolored intact (turquoise) and degenerated (magenta) myelinated fibers on the high-resolution semithin micrographs (not electron micrographs) in the new Fig. 2 to make the distinction between the two fiber categories clearer.

      Reviewer #3 (Recommendations for the authors):

      (1) Line 121: The authors mention toluidine blue staining, but it does not appear to be shown in Figure S5.

      (Response 21) This appears to be a misunderstanding. Fig. S5A shows the ultrastructure of dedifferentiated Schwann cells in transmission electron micrographs, while Figs. S5B and C show quantification of the area occupied by myelin sheaths and myelin debris profiles on osmium tetroxide and toluidine blue stained nerve sections from the two DR6 mutant models, based on semithin light microscopy. These are two different aspects of the analysis. The text has been modified in the revised manuscript to make the distinction clearer.

      (2) Line 175: The authors should add NMNAT2 to the list of enzymes implicated in the regulation of Wallerian degeneration in mammals.

      (Response 22) Nmnat2 and a literature reference (Milde et al., 2013) has been incorporated in the discussion of the revised manuscript to address this point.

      (3) Line 201: Please correct the typo "site-by-site" to "side-by-side."

      (Response 23) This typo has been corrected.

    1. Author response:

      We appreciate that the reviewers provided an overall positive assessment of our manuscript and offered constructive suggestions for improvement. All three reviewers noted that a key strength of our study is the implementation of a gut microbiome model for the characterization of interbacterial antagonism pathways such as the type VI secretion system (T6SS) that approaches natural complexity. They note our work represents a significant advance in microbiome research, and generates resources that will be of use to many researchers in the field. Two of the reviewers point out that the complexity of our model limits the nature of measurements we can make, and suggest we temper the strength of the some of the conclusions we draw. As noted in more detail below, in our revised manuscript, we will be more precise in the wording we use to characterize our findings, and we will be more explicit about what the measurements we are able to make allow us to conclude about the physiological role of the T6SS in the gut microbiome.

      Reviewer #1 (Public review):

      Summary:

      In this study, the authors investigate the physiological role of the Type VI secretion system (T6SS) in a naturally evolved gut microbiome derived from wild mice (the WildR microbiome). Focusing on Bacteroides acidifaciens, the authors use newly developed genetic tools and strain-replacement strategies to test how T6SS-mediated antagonism influences colonization, persistence, and fitness within a complex gut community. They further show that the T6SS resides on an integrative and conjugative element (ICE), is distributed among select community members, and can be horizontally transferred, with context-dependent effects on colonization and persistence. The authors conclude that the T6SS stabilizes strain presence in the gut microbiome while imposing ecological and physiological constraints that shape its value across contexts.

      This study is likely to have a significant impact on the microbiome field by moving experimental tests of T6SS function out of simplified systems and into a naturally co-evolved gut community. The WildR system, together with the strain replacement strategy, ICE-seq approach, and genetic toolkit, represents a powerful and reusable platform for future mechanistic studies of microbial antagonism and mobile genetic elements in vivo.

      The datasets, including isolate genomes, metagenomes, and ICE distribution maps, will be a valuable community resource, particularly for researchers interested in strain-resolved dynamics, horizontal gene transfer, and ecological context dependence. Even where mechanistic resolution is incomplete, the work provides a strong experimental foundation upon which such questions can be directly addressed.

      Overall, this study occupies a space between system building and mechanistic dissection. The authors demonstrate that the T6SS influences persistence and community structure in vivo, but the physiological basis of these effects remains unresolved. Interpreting the results as evidence of fitness costs or selective advantage, therefore, requires caution, as multiple ecological and host-mediated processes could produce similar abundance trajectories.

      Placing the findings within the broader literature on microbial antagonism, particularly work emphasizing measurable costs, benefits, and tradeoffs, would help readers better contextualize what is directly demonstrated here versus what remains an open question. Viewed in this light, the principal contribution of the study is to show that such questions can now be addressed experimentally in a realistic gut ecosystem.

      We thank the reviewer for this thoughtful summary of our study. We were glad to read they conclude our work will have a significant impact on the microbiome field and that the resources we have developed will be of value to the community.

      Strengths:

      A major strength of this study is that it directly interrogates the physiological role of the T6SS in a naturally evolved gut microbiome, rather than relying on simplified pairwise or in vitro systems. By working within the WildR community, the authors advance beyond descriptive surveys of T6SS prevalence and address function in an ecologically relevant context.

      The authors provide clear genetic evidence that Bacteroides acidifaciens uses a T6SS to antagonize co-resident Bacteroidales, and that loss of T6SS function specifically compromises long-term persistence without affecting initial colonization. This temporal separation is well designed and supports the conclusion that the T6SS contributes to maintenance rather than establishment within the community.

      Another strength is the identification of the T6SS on an integrative and conjugative element (ICE) and the demonstration that this element is distributed among, and exchanged between, community members. The use of ICE-seq to track distribution and transfer provides strong support for horizontal mobility and adds mechanistic depth to the study.

      Finally, the transfer of the T6SS-ICE into Phocaeicola vulgatus and the observation of context-dependent colonization benefits followed by decline is a compelling result that moves the study beyond simple "T6SS is beneficial" narratives and highlights ecological contingency.

      We appreciate this detailed and nuanced characterization of the strengths of our study.

      Weaknesses:

      Despite these strengths, there is a mismatch between the precision of the claims and the precision of the measurements, particularly regarding fitness costs, physiological burden, and the mechanistic role of the T6SS.

      We acknowledge that in some places, our manuscript could benefit from greater precision in the language we use when linking the outcomes we observe in our study to their potential underlying causes. Specific revisions we propose to address this concern are described below.

      First, while the authors conclude that the T6SS "stabilizes strain presence" and that its value is constrained by fitness costs, these costs are not directly measured. Persistence, abundance trajectories, and eventual loss are informative outcomes, but they do not uniquely identify fitness tradeoffs. Decline could arise from multiple non-exclusive mechanisms, including community restructuring, host-mediated effects, incompatibilities of the ICE in new hosts, or ecological retaliation, none of which are disentangled here.

      We agree that multiple mechanisms could explain why P. vulgatus carrying a T6SS-encoding ICE declines over time. Our use of the term “fitness cost” to describe this trend was not meant to imply any particular underlying mechanism, but was rather our attempt to characterize the phenotypic outcome we observed in simplified terms. We note that ecological context is an important determinant of the fitness cost or benefit of any given trait, and our study sheds light on the importance of the presence of the WildR community and the mouse intestinal environment to the fitness contribution of the ICE to P. vulgatus. Nonetheless, to avoid implying an overly simplistic interpretation of our results, we propose to modify the language used in the manuscript when describing the contribution of the T6SS to species persistence in WildR-colonized mice.

      Second, the manuscript frames the T6SS as having a defined physiological role, yet the data do not resolve which physiological processes are under selection. The experiments demonstrate that T6SS activity affects persistence, but they do not distinguish whether this occurs via direct killing, resource release, niche modification, or higher-order community effects. As a result, "physiological role" remains underspecified and risks being conflated with ecological outcome.

      We acknowledge that our study does not fully resolve the physiological processes under selection that mediate role of the T6SS in maintaining B. acidifaciens populations in WildR-colonized mice. Indeed, several of the outcomes of T6SS activity the reviewer lists, such as target cell killing and nutrient release, are inextricably linked and thus inherently difficult to disentangle. We note that we did attempt to measure higher-order community effects of T6SS activity with metagenomic sequencing, but acknowledge that this approach may not have been sufficiently sensitive to detect small community shifts mediated by a relatively low-abundance species. To address the concern that our current framing implies more of a mechanistic understanding that our study achieves, we propose to substitute “ecological” for “physiological” where appropriate when summarizing our key findings.

      Third, although the authors emphasize context dependence, the study offers limited quantitative insight into what aspects of context matter. Differences between native and recipient hosts, or between early and late colonization phases, are described but not mechanistically interrogated, making it difficult to generalize beyond the specific cases examined.

      We are not entirely clear what the reviewer means by “differences between native and recipient hosts”, but we agree that additional quantitative studies will be needed to address the generalizability of our findings. Future studies are also needed to address the mechanistic basis for the difference in the benefit conferred by the T6SS that we observed between P. vulgatus and B. acidifaciens.

      Fourth is the lack of engagement with recent experimental literature demonstrating functional roles of the T6SS beyond simple interference competition. While the authors focus on persistence and competitive outcomes, they do not adequately situate their findings within recent work demonstrating that T6SS-mediated antagonism can serve additional physiological functions, including resource acquisition and DNA uptake, thereby linking killing to measurable benefits and tradeoffs. The absence of this literature makes it difficult to place the authors' conclusions about physiological role and fitness cost within the current conceptual framework of the field. Without this context, the physiological interpretation of the results remains incomplete, and alternative functional explanations for the observed dynamics are underexplored.

      We thank the reviewer for specifically highlighting the potential pertinence of this literature to our study. Indeed, we did not cite studies indicating a link between T6SS activity and the uptake of DNA and other resources released by targeted cells. As we note above, the release of intracellular contents from target cells is an inevitable consequence of the delivery of lytic effectors. Thus, distinguishing between fitness benefits conferred from the elimination of competitor species and those arising from scavenging the nutrients released during this process is not straightforward. Measuring the benefits deriving from the uptake of certain released molecules, such as DNA, was not immediately feasible in the system employed in this study and instead we focused on the direct lytic consequences of the effectors delivered via the T6SS. We will revise our Discussion to include reference to how downstream consequences of T6SS activity on target cells could impact the community, and thus the adaptive role of the T6SS in the microbiome.

      A further limitation concerns the taxonomic scope of the functional analysis. The authors state that the role of the T6SS in the murine environment is functionally investigated using genetically tractable Bacteroides species, citing the lack of genetic tools for Mucispirillum schaedleri. While this is a reasonable, practical choice, it means that a substantial fraction of T6SS-encoding species in the WildR community are not experimentally interrogated. Consequently, conclusions about the role of the T6SS in the murine gut necessarily reflect the subset of taxa that are genetically accessible and may not fully capture community-level or niche-specific functions of T6SS activity. Given that M. schaedleri is represented as a metagenome-assembled genome, its isolation and genetic manipulation would be technically challenging. Nonetheless, explicitly acknowledging this limitation and slightly tempering claims of generality would strengthen the manuscript.

      The reviewer points out that studying the T6SS activity in M. schadleri would potentially expand the generality of our claims. We agree that having an isolate of this species along with genetic tools for its manipulation would allow us to probe the importance of the T6SS in the gut microbiome more broadly. At the suggestion of the reviewer, we will add explicit mention for the need to develop such tools, an endeavor that lies outside of the scope of the current study.

      Finally, several interpretations would benefit from more cautious language. In particular, claims invoking fitness costs, selective advantage, or physiological burden should be explicitly framed as inferences from persistence dynamics, rather than as direct measurements, unless supported by additional quantitative fitness or growth assays.

      We agree with the reviewer that invoking fitness costs, selective advantages or physiological burdens should be done cautiously, and in our revised manuscript we will carefully re-evalute our usage of those terms. However, we would also argue invoking fitness costs and benefits when describe strain persistence dynamics in mice has substantial precedent in the literature ((Feng et al. 2020, Brown et al. 2021, Park et al. 2022, Segura Munoz et al. 2022), to list a handful of representative examples published by different groups). It is unclear to us what additional in vivo growth measurements could be taken to substantiate our claim that the T6SS provides a fitness benefit to B. acidifaciens during prolonged gut colonization, or that carrying the ICE imposes a fitness cost on P. vulgatus during long-term colonization. Our in vitro experiments evaluating the competitiveness conferred by T6SS activity provide a measure of insight into its fitness benefits, but as our in vivo strain persistence data and the work of many others show, in vitro measurements do not necessarily capture in vivo parameters.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors set out to determine how a contact-dependent bacterial antagonistic system contributes to the ability of specific bacterial strains to persist within a complex, native gut community derived from wild animals. Rather than focusing on simplified or artificial models, the authors aimed to examine this system in a biologically realistic setting that captures the ecological complexity of the gut environment. To achieve this, they combined controlled laboratory experiments with animal colonization studies and sequencing-based tracking approaches that allow individual strains and mobile genetic elements to be followed over time.

      Strengths:

      A major strength of the work is the integration of multiple complementary approaches to address the same biological question. The use of defined but complex communities, together with in vivo experiments, provides a strong ecological context for interpreting the results. The data consistently show that the antagonistic system is not required for initial establishment but plays a critical role in long-term strain persistence. This insight that moves beyond traditional invasion-based views of microbial competition. The observation that transferable genetic elements can confer only temporary advantages, and may impose longer-term costs depending on community context, adds important nuance to current understanding of microbial fitness.

      We thank the reviewer for the positive feedback and are glad they agree our study provides new insight into the role of interbacterial antagonism in natural communities.

      Weaknesses:

      Overall, there is not a lack of evidence, but a deliberate trade-off between ecological realism and mechanistic resolution, which leaves some causal pathways open to interpretation.

      The reviewer makes a good point that the complexity of the experimental system we employ precludes some lines of experimentation that would yield more mechanistic information. As the reviewer notes, we were aware of the tradeoff between mechanistic resolution and ecological realism when selecting our experimental system. Our deliberate choice to favor biological complexity over mechanistic clarity in this study stemmed from our perception that a major gap in understanding of the T6SS and other antagonism pathways lies in defining their ecological function in complex microbial communities.

      Reviewer #3 (Public review):

      Summary:

      Shen et al. investigate the contribution of the type VI secretion system of Bacteroidales in the gut microbiome assembly and targeting of closely related species. They demonstrate that B. acidifaciens relies on T6SS-mediated antagonism to prevent displacement by co-resident Bacteroidales and other members of the microbiome, allowing B. acidifaciens to persist in the gut.

      Strengths:

      Using a gnotobiotic model colonized with a wild-mouse microbiome is a significant strength of this study. This approach allows tracking of microbiome changes over time and directly examining targeting by Bacteroidales carrying T6SS in a more natural setting. The development of ICE-seq for mapping the distribution of the T6SS in the microbiome is remarkable, enabling the study of how this bacterial weapon is transferred between microbiome members without requiring long-read metagenomics methods.

      We thank the reviewer for their enthusiasm toward our study.

      Weaknesses:

      Some conclusions are based on only four mice per condition. The author should consider increasing the sample size.

      We agree that in some experiments it would be beneficial to increase the sample size from four mice. However, the experiments we performed for this study are time and resource intensive. Additionally, the experiments on which we base our primary conclusions were all independently replicated with similar results. Given these factors, we determined that the extra confidence that might be afforded by increasing our sample size did not merit the delay in publication and investment in resources that would be required.

      Overall, the authors successfully achieved their objectives, and their experimental design and results support their findings. As mentioned in the discussion, it would be important to investigate the role of the T6SS in resilience to disturbances in the microbiome, such as antibiotics, diet, or pathogen invasion. This work represents a step forward in understanding how contact-dependent competition influences the gut microbiome in relevant ecological contexts.

      We agree that investigating the role of the T6SS during perturbations of the microbiome is a key next step for this work and thank the reviewer for highlighting this important future direction.

      References

      Brown, E. M., H. Arellano-Santoyo, E. R. Temple, Z. A. Costliow, M. Pichaud, A. B. Hall, K. Liu, M. A. Durney, X. Gu, D. R. Plichta, C. A. Clish, J. A. Porter, H. Vlamakis and R. J. Xavier (2021). "Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors." Cell Host Microbe 29(9): 1351-1365 e1311.

      Feng, L., A. S. Raman, M. C. Hibberd, J. Cheng, N. W. Griffin, Y. Peng, S. A. Leyn, D. A. Rodionov, A. L. Osterman and J. I. Gordon (2020). "Identifying determinants of bacterial fitness in a model of human gut microbial succession." Proc Natl Acad Sci U S A 117(5): 2622-2633.

      Park, S. Y., C. Rao, K. Z. Coyte, G. A. Kuziel, Y. Zhang, W. Huang, E. A. Franzosa, J. K. Weng, C. Huttenhower and S. Rakoff-Nahoum (2022). "Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite." Cell 185(3): 513-529 e521.

      Segura Munoz, R. R., S. Mantz, I. Martinez, F. Li, R. J. Schmaltz, N. A. Pudlo, K. Urs, E. C. Martens, J. Walter and A. E. Ramer-Tait (2022). "Experimental evaluation of ecological principles to understand and modulate the outcome of bacterial strain competition in gut microbiomes." ISME J 16(6): 1594-1604.

    1. Author response:

      We thank the editors and reviewers for their careful and constructive evaluation of our manuscript. We appreciate the recognition of the conceptual novelty and in vivo relevance of our findings. We have carefully considered all comments and outline below the major revisions and additional analyses we will undertake. For clarity, we address the reviewers’ comments in thematic sections.

      Cell-autonomous contribution of Tent5a to phenotype

      We agree that the use of a complete knockout model raises the possibility of indirect or non-cell-autonomous effects on tooth development, particularly given the observed dentin alterations. To address this point directly, we are generating and analyzing an ameloblast-specific conditional model we have already on shelf (Ambn-Cre; Tent5a<sup>flox/flox</sup>) to determine whether the enamel phenotype arises from cell-autonomous loss of TENT5A in the secretory epithelium. This approach will allow us to distinguish epithelial-intrinsic effects from potential secondary contributions of odontoblasts or mesenchymal tissues. Results from this model will be incorporated into the revised manuscript.

      Mechanistic basis and substrate specificity

      We agree that the mechanism underlying substrate selectivity of TENT5A requires further clarification. We have performed multiple classical RNA–protein interaction assays, including CLIP-based approaches, without identifying a clear sequence-specific recognition motif. In the revised manuscript, we will present substrate specificity as an open mechanistic question rather than implying a defined recognition mechanism.

      To strengthen this aspect, we will extend our analysis to include combined immunoprecipitation strategies and investigation of potential ribosome-associated or co-translational interactions of TENT5A.

      In addition, we will further validate selected high-confidence TENT5A interactors identified in our dataset in context of putative changes in AmelX-polyA tail length.

      Poly(A) tail length and functional causality

      We acknowledge that shortening of the poly(A) tail alone does not formally establish causality. However, our data consistently show that TENT5A-dependent shortening of poly(A) tails correlates with reduced mRNA and protein levels of key enamel matrix components. In the revised manuscript, we will clarify this mechanistic framework more explicitly, integrating poly(A) length, transcript abundance, and protein-level data in a structured manner, while clearly distinguishing correlation from formal proof of causality.

      We will also perform additional functional assays, including mRNA stability measurements in vitro in cells with genetic ablation of Tent5a, to further test the link between poly(A) shortening and reduced AmelX protein levels.

      Quantitative microCT and enamel morphology

      We will include quantitative microCT analyses of enamel thickness and mineral density from multiple biological replicates per genotype (n ≥ 3). Sample numbers will be explicitly stated throughout. Additional high-resolution scans of isolated incisors will be provided. We will also quantify occlusal angle and include whole-skull reconstructions to document malocclusion. Maxillary enamel will be analyzed and quantified alongside mandibular enamel.

      SEM terminology will be corrected (e.g., replacing “crystal structure” with “rod/interrod organization”), and structural parameters such as rod diameter and interprismatic matrix proportion will be quantitatively assessed.

      We agree that ultrastructural analysis of ameloblast secretory morphology is important. We have experience with TEM analysis of demineralized incisors and will perform additional ultrastructural examination to assess the integrity of Tomes’ processes and the secretory apparatus in Tent5a-deficient ameloblasts. These data will allow us to distinguish between primary alterations in secretory morphology and downstream effects on matrix organization.

      Amelx splice variants

      We will re-analyze our RNA-seq data with specific attention to exon 4-containing isoforms and clarify the distribution of splice variants in WT and KO samples. These findings will be explicitly discussed in the context of prior literature.

      Co-localization and self-assembly claims

      We agree that conventional light microscopy cannot directly resolve nanoscale self-assembly events. In Figure 3, our intention was to demonstrate differential subcellular distribution and partial segregation of AMELX and AMBN within secretory compartments, rather than to claim direct visualization of molecular self-assembly. In the revised manuscript, we will clarify this distinction, moderate the terminology accordingly, and provide explicit quantitative co-localization analyses across multiple biological replicates.

      TENT5 family paralogs

      To address potential redundancy within the TENT5 family, we will analyze published single-cell RNA-seq datasets (Sharir et al., 2019; Krivanek et al., 2020) to assess expression of TENT5 paralogs in ameloblasts. These findings will be validated using targeted transcriptional analyses.

      Human clinical relevance

      We appreciate the suggestion to examine potential human enamel phenotypes. We will pursue retrospective analysis of clinical and imaging data from patients carrying TENT5A variants through our collaborations with rare disease networks and specialized centers in Europe and the United States. Any relevant findings will be incorporated into the revised manuscript.

      Tissue sampling clarification

      We apologize for imprecise terminology regarding transcriptomic sampling. The analyzed tissue corresponds to the proximal incisor region up to the mineralization stage. We will include a schematic and clarify nomenclature throughout the manuscript.

      Language and data clarity

      The manuscript will be thoroughly revised for clarity, consistency of terminology, figure referencing, and accuracy of citations. We will explicitly clarify the methodology used for protein quantification, including normalization strategy and densitometric analysis, to address inconsistencies noted in the supplementary data. We will also expand the discussion to address the biological relevance of moderate poly(A) shortening, referencing established literature demonstrating that even subtle changes in tail length can significantly influence translational efficiency.

      Although AMELX is the most abundant enamel matrix protein and exhibits a consistent TENT5A-dependent poly(A) shortening phenotype, our data demonstrate that multiple secreted proteins are similarly affected. We will revise the text to clearly articulate that the enamel phenotype likely reflects the combined contribution of multiple TENT5A-regulated secretory factors rather than a single-gene effect.

      We believe these revisions will substantially strengthen the mechanistic, quantitative, and conceptual framework of the study and provide a clearer foundation for interpreting TENT5A-dependent regulation of enamel biomineralization.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      The data in Figure 1 is not novel, similar data has been reported elsewhere.

      We are grateful for the critical evaluation of our finding. Although there have been a few researches indicating the prevalence of FGFR2-amplified GC patients, our research provided a novel dataset of 161 GC patients using next-generation sequencing (NGS) in China, further emphasizing the high frequency of FGFR2 amplification in gastric cancer patients. Moreover, the proportion of FGFR2-amplified GC patients in our center (6.2%) is relatively higher than that of TCGA cohort (5%).

      We have transferred the original Figure 1C and 1D to the supplementary figures, and constructed a novel pie chart for Nanjing Drum Tower Hospital cohort to compare with the TCGA cohort.

      It is unclear why the two panels in Fig 2a and 2b can not be integrated into one panel, which will make it easier to compare the activities.

      Thanks for pointing this out. In the first figure of Figure 2a and 2b, we performed gradient concentration CCK8 detection on the cytotoxicity of SHP099 against tumor cells. In the second figure, we selected 10 μm (IC50) as the fixed concentration of SHP099 for combined efficacy testing with gradient concentration of AZD4547. Moreover, the units of the horizontal axis in both figure 2a and 2b cannot be unified. Therefore, we believe that the two figures in figures 2a and 2b are not suitable for merging into one figure.

      For the convenience of observation, we integrated the first panel of figure 2a and 2b into one panel, and integrated the second panel in the same way.

      The synergetic effects of azd4547 and shp099 are not significant in Fig 2e and 2f, as well as in Fig. 3g and fig. 4f

      In Fig 2e and 2f, we not only analyzed the synergetic effects of 3 nM (a relatively lower dose) AZD4547 and 10 μm SHP099, but also 10 nM (a relatively higher dose) AZD4547 and 10 μm SHP099. The synergetic effects of different dosage combinations should be compared correctly. From our perspective, the combination treatment led to a stronger inhibition of phospho-FGFR, phospho-SHP2 and FGFR2-initiated downstream signaling molecules, especially in KATOIII.

      For ease of comparison, we circled 10 μm SHP099, 10nM AZD4547 and 10nM AZD4547+10 μm SHP099 in red.

      Author response image 1.

      Author response image 2.

      We also circled 10μM SHP099, 3nM AZD4547 and 3nM AZD4547+10 μm SHP099 in blue.

      Author response image 3.

      Author response image 4.

      For ease of comparison, we also conducted grayscale value analysis and normalization using image J.

      Author response image 5.

      Author response image 6.

      Author response image 7.

      Author response image 8.

      In Fig. 3g, the combination therapy exhibited relatively stronger inhibitory effects on phospho-ERK, phospho-AKT and phospho-mTOR.

      For ease of comparison, we conducted grayscale value analysis and normalization using image J.

      The unclear effect of combination therapy may be due to the presence of impurities other than tumor cells in patient’s ascites.

      Author response image 9.

      In Fig. 4f, it was obvious that phospho-AKT and phospho-mTOR were further suppressed in combination group.

      For ease of comparison, we conducted grayscale value analysis and normalization using image J.

      Author response image 10.

      Therefore, in our opinions, our data could relatively sufficiently confirm the synergetic effects of AZD4547 and SHP099.

      Data in Fig. 5 is weak and can be removed. It is unclear why FGFR inhibitor has some activities toward t cells since t cells do not express FGFR.

      The activation effect of SHP099 on T cells has been validated in many articles. In a previous study published in Cancer Immunology Research, it was pointed out that the combination of FGFR2 inhibitor erdafitinib and PD-1 antibody can activate T cells and downregulate T cell surface exhaustion related factors (including PD-1) in vivo Therefore, the anti-tumor immune effect of FGFR2 inhibitor cannot be ignored. Although T cells do not express FGFR, FGFR2 inhibitors may still affect PD-1 expression on the surface of T cells in some other ways, which requires further research. We have deleted fig.5D in our article. We believe that the combination of FGFR2 inhibitor and SHP2 inhibitor not only has a direct killing effect on tumor cells, but also promotes anti-tumor immunity by activating T cells. Therefore, we believe that the in vitro data in Figure 5 is also meaningful.

      Reviewer #2 (Public review):

      Strengths:

      The data is generally well presented and the study invokes a novel patient data set which could have wider value. The study provides additional evidence to support the combined therapeutic approach of RTK and phosphatase inhibition.

      We sincerely thank the reviewer for the critical evaluation and appreciation of our findings.

      Weaknesses:

      Combined therapy approaches targeting RTKs and SHP2 have been widely reported. Indeed, SHP099 in combination with FGFR inhibitors has been shown to overcome adaptive resistance in FGFR-driven cancers. Furthermore, the inhibition of SHP2 has been documented to have important implications in both targeting proliferative signalling as well as immune response. Thus, it is difficult to see novelty or a significant scientific advance in this manuscript. Although the data is generally well presented, there is inconsistency in the interpretation of the experimental outcomes from ex vivo, patient and mouse systems investigated. In addition, the study provides only minor or circumstantial understanding of the dual mechanism.

      We acknowledge that our research on the mechanism of dual inhibition is not deep enough. There remain more in-depth mechanisms of the combination of SHP2 inhibitor and RTK inhibitors needed to be explored, and it would be the main direction of our future study.

      Using data from a 161 patient cohort FGFR2 was identified as displaying amplification of FGFR2 in ~6% with concomitant elevation of mRNA of patients which correlated with PTPN11 (SHP2) mRNA expression. The broader context of this data is of value and could add a different patient demographic to other data on gastric cancer. However, there is no detail on patient stratification or prior therapeutic intervention.

      Thanks for pointing this out and we have added a table on patients’ stratification such as age, gender and so on. Unfortunately, data on patients’ prior therapeutic intervention weren’t collected.

      In SNU16 and KATOIII cells the combined therapy is shown to be effective and appears to be correlated with increased apoptotic effects (i.e. not immune response).

      Fig 2E suggests that the combined therapy in SNU16 cells is a little better than FGFR2-directed AZD457 inhibitor alone, particularly at the higher dose.

      The individual patient case study described via Fig 3 suggests efficacy of the combined therapy (at very high dosage), however, the cell biopsies only show reduced phosphorylation of ERK, but not AKT. This is at odds with the ex vivo cell-based assays. Thus, it is not clear how relevant this study is.

      The mouse xenograft study shows a convincing reduction in tumor mass/volume and clear reduction in pAKT, whilst pERK remains largely unaffected by the combined therapeutic approach. This is in conflict with the previous data which seems to show the opposite effect. In all, the impact of the dual therapy is unclear with respect to the two pathways mediated by ERK and AKT.

      Thank you for the comment. Previous researches have confirmed that both RAS/ERK and PI3K/AKT pathways are two important downstream signaling of FGFR2. In Fig 2E and F, we observed that in FGFR2-amplified cell lines dual blockade had significant inhibitory effects both on p-ERK and p-AKT, and the inhibitory effect on p-ERK is greater than that on p-AKT. Similarly, in Fig 3G, dual blockade mainly suppressed p-ERK, and slightly inhibited p-AKT and p-mTOR in cancer cells derived from the individual patient. Thus, in the two types in-vitro models, dual inhibition simultaneously inhibited both RAS/ERK and PI3K/AKT pathways, and primarily inhibited RAS/ERK pathway, which is not contradictory.

      Author response image 11.

      Author response image 12.

      Author response image 13.

      For the in-vivo animal model. Although dual inhibition had inhibitory effects on both pathways, it mainly suppressed p-AKT.

      In both in vivo and in vitro models, combination therapy has a certain inhibitory effect on the RAS/ERK and PI3K/AKT pathways, but the emphasis on the two is not the same in vivo and in vitro. Considering the significant differences between in vivo and in vitro models, we believe that this difference in emphasis is understandable.

      Author response image 14.

      Finally, the authors demonstrate the impact of SHP2 on PD-1 expression and propose that the SHP099/AZD4547 combination therapy significantly induces the production of IFN-γ in CD8+ T cells. This part of the study is unconvincing and would benefit from the investigation of the tumor micro-environment to assess T cell infiltration.

      To investigate the tumor micro-environment to assess T cell infiltration, we have to establish our research model in immunocompetent mice. However, there is currently only one type of gastric cancer cell line derived from mice, MFC, which is not a cell line with FGFR2 amplification. We attempted to transfect FGFR2 amplification plasmids into MFC, but the transfection effect was poor, making it difficult to conduct in vivo animal experiments.

      Reviewer #3 (Public review):

      Strengths:

      The authors demonstrate that FGFR2 amplification positively correlates with PTPN11 in human gastric cancer samples, providing rationale for combination therapies. Furthermore, convincing data are provided demonstrating that targeting both FGFR and SHP2 is more effective than targeting either pathway alone using in vitro and in vivo models. The use of cells derived from a gastric cancer patient that progressed following treatment with an FGFR inhibitor is also a strength. The findings from this study support the conclusion that SHP2 inhibitors enhance the efficacy of FGFR-targeted therapies in cancer patients. This study also suggests that targeting SHP2 may also be an effective strategy for targeting cancers that are resistant to FGFR-targeted therapies.

      Weaknesses:

      The main caveat with these studies is the lack of an immune competent model with which to test the finding that this combination therapy enhances T cell cytotoxicity in vivo. Discussing this limitation within the context of these findings and future directions for this work, particularly since the combination therapy appears to work quite well without the presence of T cells in the environment, would be beneficial.

      Thank you for the great suggestion. To investigate the tumor micro-environment to assess T cell infiltration, we have to establish our research model in immunocompetent mice. However, there is currently only one type of gastric cancer cell line derived from mice, MFC, which is not a cell line with FGFR2 amplification. We attempted to transfect FGFR2 amplification plasmids into MFC, but the transfection effect was poor, making it difficult to conduct in vivo animal experiments.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Minor points. The manuscript is poorly written and loaded with language errors.

      We sincerely thank you for your constructive suggestion and we are sorry for the mistake. We have polished the article and corrected these language errors.

      Reviewer #2 (Recommendations for the authors):

      In addition to the comments made in the Public Review the manuscript lacks detail on statistical analysis of experimental results.

      Thank you for your advice. In response to the feedback, we have supplemented detail on statistical analysis of experimental results in the “Methods” part.

      Reviewer #3 (Recommendations for the authors):

      There are numerous grammatical errors throughout, and incorrect wording is used in some places (such as "syngeneic mouse tumor model" rather than "xenograft tumor model", line 253). Careful proofreading and editing of this manuscript is recommended.

      Thank you for your suggestion. We have made corrections to the relevant content of the article.

      AZD4547 is an FGFR-selective inhibitor and is not specific for FGFR2 as it also targets FGFR1 and FGFR3, this should be clarified in the text.

      Thank you for rasing this point. We have clarified that AZD4547 is an FGFR-selective inhibitor targeting FGFR1-3 in the “Introduction” part.

      The specific FGFR inhibitor(s) used to treat the patient with FGFR2 amplification, are the authors able to provide this information?

      Thank you for raising this important issue. Indeed, due to the difficulty of small molecule drug development, the fastest clinical progress currently is in FGFR pan inhibitors. Recently, Relay Therapeutics has also developed a highly FGFR2-selective inhibitor, RLY-4008, in phase I/II clinical trials, but lacks preclinical research on gastric cancer.

      Figure 2F: the p38 and p-p38 bands are cut off at the bottom

      We sincerely thank you for your thoughtful feedback. we have improved our experimental methods and retested the two p38 and p-p38 in Figure 2F by western blotting.

      Author response image 15.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper investigates the thermal and mechanical unfolding pathways of the doubly knotted protein TrmD-Tm1570 using molecular simulations, optical tweezers experiments, and other methods. In particular, the detailed analysis of the four major unfolding pathways using a well-established simulation method is an interesting and valuable result.

      Strengths:

      A key finding that lends credibility to the simulation results is that the molecular simulations at least qualitatively reproduce the characteristic force-extension distance profiles obtained from optical tweezers experiments during mechanical unfolding. Furthermore, a major strength is that the authors have consistently studied the folding and unfolding processes of knotted proteins, and this paper represents a careful advancement building upon that foundation.

      We appreciate and we thank the reviewer for reading our manuscript.

      Weaknesses:

      While optical tweezers experiments offer valuable insights, the knowledge gained from them is limited, as the experiments are restricted to this single technique.

      The paper mentions that the high aggregation propensity of the TrmD-Tm1570 protein appears to hinder other types of experiments. This is likely the reason why a key aspect, such as whether a ribosome or molecular chaperones are essential for the folding of TrmD-Tm1570, has not been experimentally clarified, even though it should be possible in principle.

      We appreciate the suggestion that clarifying the requirement for molecular chaperones or the ribosome in TrmD-Tm1570 folding is crucial. We are pleased to report that the experiment investigating the role of molecular chaperones in the folding of TrmD-Tm1570 is currently under investigation in our laboratory. These results will provide the clarification on this aspect and will be incorporated into a future manuscript.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, the authors combined coarse-grained structure-based model simulation, optical tweezer experiments, and AI-based analysis to assess the knotting behavior of the TrmD-Tm1570 protein. Interestingly, they found that while the structure-based model can fold the single knot from TrmD and Tm1570, the double-knot protein TrmD-Tm1570 cannot form a knot itself, suggesting the need for chaperone proteins to facilitate this knotting process. This study has strong potential to understand the molecular mechanism of knotted proteins, supported by much experimental and simulation evidence. However, there are a few places that appear to lack sufficient details, and more clarification in the presentation is needed.

      Strengths:

      A combination of both experimental and computational studies.

      We appreciate and we thank the reviewer for reading our manuscript.

      Weaknesses:

      There is a lack of detail to support some statements.

      (1) The use of the AI-based method, SOM, can be emphasized further, especially in its analysis of the simulated unfolding trajectories and discovery of the four unfolding/folding pathways. This will strengthen the statistical robustness of the discovery.

      We thank the reviewer for this observation. However, the AI-based method, SOM, was applied to obtain the main representative trajectories for the mechanical unfolding MD simulations. Specifically, for the TrmD, Tm1570, and fusion protein (TrmD-Tm1570) we extracted the representative conformational states by selecting the most highly populated SOM clusters shown in SI Figure 5 - figure supplement 3. Then, by identifying the cluster centroid, we selected the nearest point (simulations). These correspond to the clusters number 1 for Tm1570, number 11 for TrmD, and number 7 for TrmD-Tm1570. A sentence was added in the main manuscript to clarify how the main representative confirmation was obtained.

      On the other hand, no AI‑based methods were applied to the thermal unfolding simulations. The four thermal unfolding trajectories shown in Figure 3 were obtained as follows: (i) trajectories where TrmD unfolds first and its knot unties before Tm1570 unfolds, corresponding to pathway 1 (Figure 3A and E); (ii) trajectories where Tm1570 unfolds and unties first, followed by TrmD, corresponding to pathway 3 (Figure 3C and G); and (iii) trajectories where TrmD unfolds first, then Tm1570, after which the TrmD knot unties and finally the Tm1570 knot unties—this corresponds to pathway 2. Pathway 4 follows the same sequence but in the reverse order.

      (2) The manuscript would benefit from a clearer description of the correlation between the simulation and experimental results. The current correlation, presented in the paragraph starting from Line 250, focuses on measured distances. The authors could consider providing additional evidence on the order of events observed experimentally and computationally. More statistical analyses on the experimental curves presented in Figure 4 supplement would be helpful.

      We thank the reviewer for this suggestion. In response, we prepared additional statistical analyses in a table format reporting the average length‑change increments together with their standard deviations, and we clarified in the revised text that the ± values correspond to standard deviations. In addition, we quantified the percentage of TrmD, Tm1570, and TrmD-Tm1570 unfold completely, providing a clearer comparison of the order of events observed experimentally and computationally. These analyses have been incorporated into the revised manuscript, Tables 1 and 2.

      (3) How did the authors calibrate the timescale between simulation and experiment? Specifically, what is the value \tau used in Line 270, and how was it calculated? Relevant information would strengthen the connection between simulation and experiment.

      In our model time unit is defined by a relation , where m is the reduced mass unit, is an average average mass of an amino acid, m = 110 Da = 1.66 x 10<sup>-27</sup> kg, 𝜀 is the reduced energy unit, an average interaction energy between amino acids. We may assume that ε is around 2-3 kcal/mol = 2-3 x 6.95 x 10<sup>-21</sup> J, is a distance unit and is equal to 1 nm.

      After plugging this values into the equation defining 𝜏 , we get: 𝜏 = 3.2 ps.

      The definition of the time unit comes from the fact that this is how one can combine units of mass, distance and energy into an expression that has an unit of time.

      The pulling speeds used in the simulations (0.05–0.15 Å/) correspond to approximately 1.6 -4.7 m/s in real units. These speeds are necessarily much higher than the experimental pulling The pulling speeds used in the simulations (0.05–0.15 Å/ ) correspond to approximately 1.6 - speed (20 nm/s), which is a well‑known limitation of steered molecular dynamics. However, our coarse‑grained model is run in an implicit solvent regime and does not explicitly include hydrodynamic friction. As a consequence, the simulated dynamics do not reproduce absolute real time kinetics. Instead, the comparison between simulation and experiment is made through relative unfolding pathways, force extension behavior, and contour length changes, which remain robust across the range of simulated pulling speeds.

      Thus, 𝜏 = 3.2 ps is derived directly from the coarse‑grained model parameters rather than calibratedτ to experiment, and the connection between simulation and experiment is established through mechanistic agreement rather than matching absolute timescales.

      We have now added a clarifying sentence to the manuscript (Methods and Materials - Mechanical unfolding simulations) explaining how the timescale was defined and how the value of  was obtained.

      Reference: 

      Szymczak, P., and Marek Cieplak. "Stretching of proteins in a uniform flow." The Journal of chemical physics 125.16 (2006).

      (4) In Line 342, the authors comment that whether using native contacts or not, they cannot fold double-knotted TrmD-Tm1570. Could the authors provide more details on how non-native interactions were analyzed?

      To analyze the role of non‑native interactions, we calculated two non‑native contact maps, first using a distance cutoff criterion and second by identifying the highly frustrated contacts based on the frustration index using Frustratometer (http://frustratometer.qb.fcen.uba.ar/) - figure below. From this procedure, the non‑native interactions were incorporated in the SBM C-alpha model to potentially assist refolding or knot formation. However, in neither case we observe successful refolding or the formation of the double‑knotted native topology. These results indicate that the addition of these non‑native contacts are insufficient to drive the refolding of the TrmD–Tm1570 protein. This result may suggest that the protein needs the support of chaperones or the active role of ribosomes to tie the two knots. We have now clarified this point more explicitly in the revised manuscript .

      Author response image 1.

      Native and non‑native contact maps for TrmD–Tm1570. The upper triangle (blue dots) corresponds to the cutoff‑based contact map and shows only unique contacts not present in the native contact map. The lower triangle (red dots) represents highly frustrated contacts, again showing only unique contacts absent from the native map. Black dots indicate the native contacts derived from the structure, and the contact map was generated using the Shadow Contact Map software. The blue and orange shadows correspond to the knot position for TrmD and Tm1570 proteins, respectively. 

      (5) It appears that the manuscript lacks simulation or experimental evidence to support the statement at Line 343: While each domain can self-tie into its native knot, this process inhibits the knotting of the other domain. Specifically, more clarification on this inhibition is needed.

      Explaining this phenomenon remains challenging, and several contributing factors are likely.

      (1) The folding success rates of the individual TrmD and Tm1570 domains are low (<3%); folding of the double-knotted protein is therefore expected to be even less efficient. 

      (2) While formation of a single knot is observed when the two domains are examined, the folded domain adopts a native-like but not fully native conformation, regardless of whether it is TrmD or Tm1570. (2A) Fluctuations of the unfolded second domain may impose a destabilizing load, promoting unfolding of the folded domain. (2B) Conversely, folding of one domain restricts the conformational space available to the other. Such restriction may have either stabilizing or destabilizing effects: although reduced conformational space (crowding) is generally thought to increase the probability of knot formation in polymers, in this system the constraint is localized rather than global.

      (3) It is possible that extending the simulations to much longer timescales would allow formation of the second knot; however, within the timescales accessible here, unfolding of the first knot is observed instead.

      (4) The TrmD–Tm1570 protein forms a dimer with a well-defined interface, whereas our simulations were performed on a monomeric unit. Consequently, both domains are solvent-exposed, forming an open two-domain system with tRNA-binding elements that are not stabilized by intermolecular interactions.

      Taken together, these factors preclude a quantitative assessment of the dominant contribution. Our results suggest that efficient folding may require assistance from molecular chaperones or an active role of the ribosome in coordinating formation of the two knots.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The paper notes at the beginning of its results section that simulations aiming to fully fold the TrmD-Tm1570 protein from a denatured state were unsuccessful. While the failure to achieve complete folding is itself an instructive and important result, there is room for improvement in how it's presented. The authors provide no specific details on what actually occurred during these simulations. It is plausible that some intermediate state was reached, and one can imagine that the knotting of the C-terminal part, Tm1570, was partially completed. A more detailed description of these outcomes would have been beneficial.

      In the main manuscript (Figure 3), we reported the folding trajectories and the probability of native contact formation for the TrmD–Tm1570 protein, focusing on the four main observed unfolding pathways from our simulations. In addition to these common pathways, we also examined a small number of trajectories which one or both domains may refold. These are presented in Figure 3 - figure supplements 1 and 2, where we highlight a set of trajectories that we classify as rare events. In these rare trajectories, partial refolding and the formation of intermediate states can indeed be observed. However, as described in the main text, successful refolding of the fusion protein only occurs when the knot remains close to its native position and does not undergo large fluctuations along the chain. When the knot drifts significantly, refolding is not completed.

      Figure 3 - figure supplement 1 shows six representative examples of intermediate states sampled during these simulations. As the reviewer suggested, some intermediate conformations were reached, including partial reformation of structural elements. However, only the trajectory which maintains the knot sufficiently close to its native location is able to do substantial refolding. We have now clarified this point more explicitly in the revised manuscript to better explain why full folding was not achieved and how the knot dynamics constrain the refolding process.

      (2) Is it not possible to plot the degree of knot formation as a function of time or Q in Figure 3A-H? Doing so would make the verbally described results much clearer.

      We thank the reviewer for the suggestion. Based on your observation, we have added a new figure in the SI manuscript (Figure 3 - figure supplement 3) showing the knot translocation as a function of the frames with their respective structure representations from the transitions, from folded to unfolded state and knot untied processes.

      (3) Placement of a paragraph starting from line 250 looks odd to me. The paragraph describes simulation results of the mechanical unfolding, which is fully described in the following section. Specifically, the simulation result is discussed before describing its method/outline, which is to be avoided as far as possible.

      According to the standard journal style, the Method section is described after the Discussion section. However, in the simulation's results, a sentence addressing the methods was included to guide the reader through the text. 

      (4) This is only an optional request. It is highly desired to examine the in vitro folding of TrmD-Tm1570 with and without molecular chaperones. At least, authors can envision/discuss this direction.

      We agree that examining the in vitro folding of TrmD–Tm1570 with and without molecular chaperones would provide important mechanistic insights into the role of the fold of knotted proteins. We are planning to perform these experiments as part of our ongoing work, and in the revised manuscript we will add a discussion on this direction and its potential impact.

      Reviewer #2 (Recommendations for the authors):

      (1) Figure 6C was not referenced or discussed in the manuscript.

      We thank the reviewer for pointing this out. Figure 6C is indeed referenced and discussed in the manuscript.

      (2) Several places refer to figures in the Supporting Information, and should be updated to refer to the supplement figures associated with the main figures. 

      In the revised version we ensure that all references are updated and clearly labeled.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Since dimerization is essential for SARS-CoV-2 Mpro enzymatic activity, the authors investigated how different classes of inhibitors, including peptidomimetic inhibitors (PF-07321332, PF-00835231, GC376, boceprevir), non-peptidomimetic inhibitors (carmofur, ebselen, and its analog MR6-31-2), and allosteric inhibitors (AT7519 and pelitinib), influence the Mpro monomer-dimer equilibrium using native mass spectrometry. Further analyses with isotope labeling, HDX-MS, and MD simulations examined subunit exchange and conformational dynamics. Distinct inhibitory mechanisms were identified: peptidomimetic inhibitors stabilized dimerization and suppressed subunit exchange and structural flexibility, whereas ebselen covalently bound to a newly identified site at C300, disrupting dimerization and increasing conformational dynamics. This study provides detailed mechanistic evidence of how Mpro inhibitors modulate dimerization and structural dynamics. The newly identified covalently binding site C300 represents novelty as a druggable allosteric hotspot.

      Strengths:

      This manuscript investigates how different classes of inhibitors modulate SARS-CoV-2 main protease dimerization and structural dynamics, and identifies a newly observed covalent binding site for ebselen.

      Weaknesses:

      The major concern is the absence of mutagenesis data to support the proposed inhibitory mechanisms, particularly regarding the role of the inhibitor binding site.

      We thank the reviewer for the comments and recognition of our study. We agree that mutagenesis experiments are very helpful to validate the proposed mechanisms. We will perform site-directed mutagenesis of the key residue C300 and assess the effects of those C300 mutants on dimerization and enzymatic activity of Mpro, and integrate the results and discussion into the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      This is a mechanistic study that provides new insights into the inhibition of SARS-CoV-2 Mpro.

      Strengths:

      The identification of dimer interface stabilization/destabilization as distinct inhibitory mechanisms and the discovery of C300 as a potential allosteric site for ebselen are important contributions to the field. The experimental approach is modern, multi-faceted, and generally well-executed.

      We thank the reviewer for the positive comments and recognition of our study.

      Weaknesses:

      The primary weaknesses relate to linking the biophysical observations more directly to functional enzymatic outcomes and providing more quantitative rigor in some analyses. While the study is overall strong, addressing its weaknesses and limitations would elevate the impact and translational relevance of the current manuscript.

      We thank the reviewer for the comments that are very helpful for improving the quality and impact of our manuscript.

      (1) Correlation with Functional Activity:

      The most significant gap is the lack of direct enzymatic activity assays under the exact conditions used for MS and HDX. While EC50 values are listed from literature, demonstrating how the observed dimer stabilization (by peptidomimetics) or dimer disruption (by ebselen) directly correlates with inhibition of proteolytic activity in the same experimental setup would solidify the functional relevance of the biophysical observations. For instance, does the fraction of monomer measured by native MS quantitatively predict the loss of activity? Also, the single inhibitor concentration used in each MS experiment needs to be specified in the main text and legends. A discussion on whether the inhibitor concentrations required to observe these dimerization effects (in native MS) or structural dynamics (in HDX-MS) align with EC50 values would be helpful for contextualizing the findings.

      We thank the reviewer for the points and agree that directly linking our biophysical observations to functional outcomes under identical conditions would be more meaningful. We will perform enzymatic activity assays to investigate whether the fraction of monomer measured by native MS can predict the loss of activity. The inhibitor concentrations used in each MS experiment will be explicitly stated in the main text and figure legends, and we will also discuss how these concentrations relate to the EC50/IC50 values, providing content for the biophysical observations.

      (2) For the two Cys residues found to be targeted by ebselen, what are their respective modification stoichiometry related to the ebselen concentration? Especially for the covalent binding site C300, which is proposed in this study to represent a novel allosteric inhibition mechanism of ebselen, more direct experimental evidence is needed to support this major hypothesis. Does mutation or modification of C300 affect the Mpro dimerization/monomer equilibrium and alter the enzymatic activity? If ebselen acts as a covalent inhibitor linked to multiple Cys, why is its activity only in the uM range?

      We thank the reviewer for the insightful comments. To address the stoichiometry of ebselen modification, we will further analyze the data and discuss accordingly. To display more direct evidence of C300 as a novel allosteric inhibition site of ebselen, we will perform site-directed mutagenesis and investigate whether these C300 mutants affect the Mpro dimerization and enzymatic activity. Regarding the modification of C300, several independent studies have been cited in this manuscript and showed that oxidation (by glutathione, Davis et., 2021) or chemical modification of C300 (by glutathione bismuth drugs, Tao et al., 2021, and Tixocortol, Davis et., 2024) leads to Mpro inactivation and promotes monomer formation. We will cite and further discuss these studies in the Discussion. The µM-range activity of ebselen can be explained by its multi-target covalent binding to multiple cysteines. The variable efficacy of cysteine modification may account for ebselen's moderate potency, as not all modifications equally inhibit their targets.

      (3) For the allosteric inhibitor pelitinib with low-uM activity, no significant differences in deuterium uptake of Mpro were observed. In terms of the binding affinity, what is the difference between pelitinib and ebselen? Some explanations could be provided about the different HDX-MS results between the two non-peptidomimetic inhibitors with similar activities.

      Pelitinib has non-covalent binding with Mpro, while the binding between ebselen and Mpro is covalent. We will add some explanations and discussion about their different HDX-MS results in the revised version.

      (4) Native MS Quantification:

      The analysis of monomer-dimer ratios from native MS spectra appears qualitative or semi-quantitative. A more rigorous and quantified analysis of the percentage of dimer/monomer species under each condition, with statistical replicates, would strengthen the equilibrium shift claims. For native MS analysis of each inhibitor, the representative spectrum can be shown in the main figure together with quantified dimer/monomer fractions from replicates to show significance by statistical tests.

      We thank the reviewer for the suggestion, and we will perform a more rigorous and quantitative analysis of the monomer-dimer equilibrium. For each condition (unbound Mpro and Mpro bound to each inhibitor), native MS experiments will be shown in triplicate. As suggested, we will include a representative native MS spectrum for each condition. The quantified monomer/dimer ratios from replicates will be added. The results with statistical analysis will be provided to show significance.

      (5) Changes of HDX rates in certain regions seem very subtle. For example, as it states 'residues 296-304 in the C-terminal region of M pro were more flexible upon ebselen binding (Figure 4c)', the difference is barely observable. The percentage of HDX rate changes between two conditions (with p values) can be specified in the text for each fragment discussed, and any change below 5% or 10% is negligible.

      We agree with the reviewer about the need for quantitative rigor in reporting HDX changes. We will calculate the fractional deuterium uptake difference for each peptide fragment discussed in the text between the inhibitor-bound and unbound states. These values, along with their statistical significance (p-values from a two-tailed t-test), will be provided in the revised figures.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors have adequately addressed all of my concerns. I have no further questions or concerns.

      We thank the Reviewer #1. 

      Reviewer #2 (Recommendations for the authors):

      We thank the Reviewer #2 for thoughtful recommendations.

      (1) Figure 1A, 1B, 2B, 2C, etc.: The Y-axis label is confusing. I assume the intention was to make big numbers small by dividing by 1000. The comma makes the label confusing. Perhaps, make the label more "mathematical" as in "Avp density ((transcript/µm2) * 10-3)" or rearrange the math to be clearer as in "Avp density (transcript/1000 per µm2)".

      Great suggestion and done exactly as suggested in Figures 1, 2 and 4.

      (2) Figure 1B and 1C: The figure and legend do not match up. Either switch the figures or the legends. Currently, legend 1B describes image 1C.

      Agreed and done as suggested.

      (3) Figure 2A is broken up into separate pages/panels. It could be integrated better or separated to make A and B, then shift B and C to C and D.

      Great suggestion and we have done exactly as suggested.

      (4) Figure 2 legend: I recommend putting the scale bar info with (A) rather than at the end. The stars used in the figure are not explained in the legend.

      Good points. We have made all necessary changes as suggested.

      (5) Supplementary Figure 1B: The legend states that the data are the number of transcript-containing cells, but the figure states transcript number.

      We thank the Reviewer for pointing out this typo. We corrected all graph legends in the Supplementary Figure 1.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      (1) The authors use a confusing timeline for their behavioral experiments, i.e., day 1 is the first day of training in the MWM, and day 6 is the probe trial, but in reality, day 6 is the first day after the last training day. So this is really day 1 post-training, and day 20 is 14 days post-training.

      We have revised the timeline accordingly. Briefly, mice were trained in the Morris water maze (MWM) with a hidden platform for five consecutive days (training days 1–5). Probe tests were then conducted on day 6 and day 20, which correspond to post-training day 1 and post-training day 15, respectively. We clearly stated as such in the revised manuscript (see results, line 108 – 113) and figure S1 (see figure legend, line 1747 – 1749).

      (2) The authors inaccurately use memory as a term. During the training period in the MWM, the animals are learning, while memory is only probed on day 6 (after learning). Thus, day 6 reflects memory consolidation processes after learning has taken place.

      We have revised the manuscript to distinguish between "learning" and "memory". We refer to the performance during the 5-day training period as "spatial learning" and restrict the term "memory" to the probe tests on day 6, which reflect memory consolidation after learning has taken place.

      (3) The NAT10 cKO mice are useful... but all the experiments used AAV-CRE injections in the dorsal hippocampus that showed somewhat modest decreases... For these experiments, it would be better to cross the NAT10 floxed animals to CRE lines where a better knockdown of NAT10 can be achieved, with less variability.

      We want to clarify the reason for using AAV-Cre injection rather than Cre lines. Indeed, we attempted to generate Nat10 conditional knockouts by crossing Nat10<sup>flox/flox</sup> mice with several CNS-specific Cre lines. Crossing with Nestin-Cre and Emx1-Cre resulted in embryonic and premature lethality, respectively, consistent with the essential housekeeping function of NAT10 during neurodevelopment. We will use the Camk2α-Cre line which starts to express Cre after postnatal 3 weeks specifically in hippocampal pyramidal neurons (Tsien et al., 1996).

      (4) Because knockdown is only modest (~50%), it is not clear if the remaining ac4c on mRNAs is due to remaining NAT10 protein or due to an alternative writer (as the authors pose).

      Our results suggest the existence of alternative writers. As shown in Figure 6D, we identified a population of "NAT10-independent" MISA mRNAs (present in MISA but not downregulated in NASA). Remarkably, these mRNAs possess a consensus motif (RGGGCACTAACY) that is fundamentally different from the canonical NAT10 motif (AGCAGCTG). This distinct motif usage suggests that the residual ac4C signals are not merely due to incomplete knockdown of NAT10, but reflect the activity of other, as-yet-unidentified ac4C writers. We will perform ac4C immunostaining in Nat10-reporter mice which express red fluorescent proteins in Nat10-positive cells. The results that ac4C is expressed in both Nat10-positive and negative cells will support the presence of as-yet-unidentified ac4C writers.

      Reviewer #2 (Public review):

      (1) It is known that synaptosomes are contaminated with glial tissue... So the candidate mRNAs identified by acRIP-seq might also be mixed with glial mRNAs. Are the GO BP terms shown in Figure 3A specifically chosen, or unbiasedly listed for all top ones?

      This reviewer is correct that some ac4C-mRNAs identified by acRIP-seq from the synaptosomes are highly expressed in astrocytes, such as Aldh1l1, ApoE, Sox9 and Aqp4 (see list of ac4C-mRNAs in the synaptosomes, Table S3). In agreement, we found that NAT10 was also expressed in astrocyte in addition to neurons. We have provided a representative image showing NAT10-Cre expression in astrocytes in the revised manuscript (Figure 4F and H). In the figure 3A of original submission, we showed 10 out of 16 top BP items for MISA mRNAs. In the figure 3A of revised manuscript, we showed all the top 16 BP items for MISA mRNAs, which are unbiasedly chosen (also see Table S4).

      (2) Where does NAT10-mediated mRNA acetylation take place within cells generally? Is there evidence that NAT10 can catalyze mRNA acetylation in the cytoplasm?

      The previous studies from non-neuronal cells showed that NAT10 can catalyze mRNA acetylation in the cytoplasm and enhance translational efficiency (Arango et al., 2018; Arango et al., 2022). In this study, we showed that mRNA acetylation occurred both in the homogenates and synapses (see ac4C-mRNA lists in Table S2 and S3). However, spatial memory upregulated mRNA acetylation mainly in the synapses rather than in the homogenates (Fig. 2 and Fig. S2).

      (3) "The NAT10 proteins were significantly reduced in the cytoplasm (S2 fraction) but increased in the PSD fraction..." The small increase in synaptic NAT10 might not be enough to cause a decrease in soma NAT10 protein level.

      We showed that the NAT10 protein levels were increased by one-fold in the PSD fraction, but were reduced by about 50% in the cytoplasm after memory formation (Fig. 5J and K). The protein levels of NAT10 in the homogenates and nucleus were not altered after memory formation (Fig. 5F and I). Due to these facts, we hypothesized that NAT10 proteins may have a relocation from cytoplasm to synapses after memory formation, which was also supported by the immunofluorescent results from cultured neurons (Fig. S4). However, we agree with this reviewer that drawing such a conclusion may require the time-lapse imaging of NAT10 protein trafficking in living animals, which is technically challenging at this moment.

      (4) It is difficult to separate the effect on mRNA acetylation and protein mRNA acetylation when doing the loss of function of NAT10.

      This is a good point. We agree with this reviewer that NAT10 may acetylate both mRNA and proteins. We examined the acetylation levels of a-tubulin and histone H3, two substrate proteins of NAT10 in the hippocampus of Nat10 cKO mice. As shown in Fig S5C, E, and F, the acetylation levels of a-tubulin and histone H3 remained unchanged in the Nat10 cKO mice, likely due to the compensation by other protein acetyltransferases. In contrast, mRNA ac4C levels were significantly decreased in the Nat10 cKO mice (Figure S5G–H). These results suggest that the memory deficits seen in Nat10 cKO mice may be largely due to the impaired mRNA acetylation. Nonetheless, we believe that developing a new technology which enables selective erasure of mRNA acetylation would be helpful to address the function of mRNA acetylation. We discussed these points in the MS (see discussion, line 582-589).

      Reference

      Arango, D., Sturgill, D., Alhusaini, N., Dillman, A. A., Sweet, T. J., Hanson, G., Hosogane, M., Sinclair, W. R., Nanan, K. K., & Mandler, M. D. (2018). Acetylation of cytidine in mRNA promotes translation efficiency. Cell, 175(7), 1872-1886. e1824.

      Arango, D., Sturgill, D., Yang, R., Kanai, T., Bauer, P., Roy, J., Wang, Z., Hosogane, M., Schiffers, S., & Oberdoerffer, S. (2022). Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Molecular cell, 82(15), 2797-2814. e2711.

      Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., & Tonegawa, S. (1996). Subregion-and cell type–restricted gene knockout in mouse brain. Cell, 87(7), 1317-1326.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study examines the role of E2 ubiquitin enzyme, Uev1a in tissue resistance to oncogenic RasV12 in Drosophila melanogaster polyploid germline cells and human cancer cell lines. The incomplete evidence suggests that Uev1a works with the E3 ligase APC/C to degrade Cyclin A, and the strength of evidence could be increased by addressing the expression of CycA in the ovaries and the uev1a loss of function in human cancer cells. This work would be of interest to researchers in germline biology and cancer.

      Thank you for your valuable assessment. The requested data on CycA expression (Figure 4E-G) and uev1a loss-of-function in human cancer cells (Figure 8 and Figure 8-figure supplement 2) have been added to the revised manuscript.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study uncovers a protective role of the ubiquitin-conjugating enzyme variant Uev1A in mitigating cell death caused by over-expressed oncogenic Ras in polyploid Drosophila nurse cells and by RasK12 in diploid human tumor cell lines. The authors previously showed that overexpression of oncogenic Ras induces death in nurse cells, and now they perform a deficiency screen for modifiers. They identified Uev1A as a suppressor of this Ras-induced cell death. Using genetics and biochemistry, the authors found that Uev1A collaborates with the APC/C E3 ubiquitin ligase complex to promote proteasomal degradation of Cyclin A. This function of Uev1A appears to extend to diploid cells, where its human homologs UBE2V1 and UBE2V2 suppress oncogenic Ras-dependent phenotypes in human colorectal cancer cells in vitro and in xenografts in mice.

      Strengths:

      (1) Most of the data is supported by a sufficient sample size and appropriate statistics.

      (2) Good mix of genetics and biochemistry.

      (3) Generation of new transgenes and Drosophila alleles that will be beneficial for the community.

      We greatly appreciate your comments.

      Weaknesses:

      (1) Phenotypes are based on artificial overexpression. It is not clear whether these results are relevant to normal physiology.

      Downregulation of Uev1A, Ben, and Cdc27 together significantly increased the incidence of dying nurse cells in normal ovaries (Figure 5-figure supplement 2), indicating that the mechanism we uncovered also protects nurse cells from death during normal oogenesis.

      (2) The phenotype of "degenerating ovaries" is very broad, and the study is not focused on phenotypes at the cellular level. Furthermore, no information is provided in the Materials and Methods on how degenerating ovaries are scored, despite this being the most important assay in the study.

      Thank you for pointing out this issue. We quantified the phenotype of nurse cell death using “degrading/total egg chambers per ovary”, not “degenerating ovaries”. Normal nurse cell nuclei exhibit a large, round morphology in DAPI staining (see the first panel in Figure 1D). During early death, they become disorganized and begin to condense and fragment (see the second panel in Figure 1D). In late-stage death, they are completely fragmented into small, spherical structures (see the third panel in Figure 1D), making cellular-level phenotypic quantification impossible. Since all nurse cells within the same egg chamber are interconnected, their death process is synchronous. Thus, quantifying the phenotype at the egg-chamber level is more practical than at the cellular level. We have added the description of this death phenotype and its quantification to the main text (Lines 104-108).

      (3) In Figure 5, the authors want to conclude that uev1a is a tumor-suppressor, and so they over-express ubev1/2 in human cancer cell lines that have RasK12 and find reduced proliferation, colony formation, and xenograft size. However, genes that act as tumor suppressors have loss-of-function phenotypes that allow for increased cell division. The Drosophila uev1a mutant is viable and fertile, suggesting that it is not a tumor suppressor in flies. Additionally, they do not deplete human ubev1/2 from human cancer cell lines and assess whether this increases cell division, colony formation, and xenograph growth.

      We apologize for any misleading description. We aimed to demonstrate that UBE2V1/2, like Uev1A in Drosophilanos>Ras<sup>G12V</sup>+bam-RNAi” germline tumors, suppress oncogenic KRAS-driven overgrowth in diploid human cancer cells. Importantly, this function of Uev1A and UBE2V1/2 is dependent on Ras-driven tumors; there is no evidence that they act as broad tumor suppressors in the absence of oncogenic Ras. Drosophila uev1a mutants were lethal, not viable (see Lines 135-137), and germline-specific knockdown of uev1a (nos>uev1a-RNAi) caused female sterility without inducing tumors. These findings suggest that Uev1A lacks tumor-suppressive activity in the Drosophila female germline in the absence of Ras-driven tumors. We have revised the manuscript to prevent misinterpretation. Furthermore, we have added data demonstrating that the combined knockdown of UBE2V1 and UBE2V2 significantly promotes the growth of KRAS-mutant human cancer cells, as suggested (Figure 8 and Figure 8-figure supplement 2).

      (4) A critical part of the model does not make sense. CycA is a key part of their model, but they do not show CycA protein expression in WT egg chambers or in their over-expression models (nos.RasV12 or bam>RasV12). Based on Lilly and Spradling 1996, Cyclin A is not expressed in germ cells in region 2-3 of the germarium; whether CycA is expressed in nurse cells in later egg chambers is not shown but is critical to document comprehensively.

      We appreciate your critical comment. CycA is a key cyclin that partners with Cdk1 to promote cell division (Edgar and Lehner, 1996). Notably, nurse cells are post-mitotic endocycling cells (Hammond and Laird, 1985) and typically do not express CycA (Lilly and Spradling, 1996) (see the last sentence, page 2518, paragraph 3 in this 1996 paper). However, their death induced by oncogenic Ras<sup>G12V</sup> is significantly suppressed by monoallelic deletion of either cycA or cdk1 (Zhang et al., 2024). Conversely, ectopic CycA expression in nurse cells triggers their death (Figure 4C, D). These findings suggest that polyploid nurse cells exhibit high sensitivity to aberrant division-promoting stress, which may represent a distinct form of cellular stress unique to polyploid cells. In the revised manuscript, we have provided the CycA-staining data, comparing its expression in normal nurse cells versus cells undergoing oncogenic Ras<sup>G12V</sup>-induced death (Figure 4E-G).

      (5) The authors should provide more information about the knowledge base of uev1a and its homologs in the introduction.

      Thank you for your suggestion. In the revised introduction, we have provided a more detailed description of Uev1A (Lines 72-79). Additionally, we have introduced its human homologs, UBE2V1 and UBE2V2, in the main text (Lines 143-145).

      Reviewer #2 (Public review):

      Summary:

      The authors performed a genetic screen using deficiency lines and identified Uev1a as a factor that protects nurse cells from RasG12V-induced cell death. According to a previous study from the same lab, this cell death is caused by aberrant mitotic stress due to CycA upregulation (Zhang et al.). This paper further reveals that Uev1a forms a complex with APC/C to promote proteasome-mediated degradation of CycA.

      In addition to polyploid nurse cells, the authors also examined the effect of RasG12V-overexpression in diploid germline cells, where RasG12V-overexpression triggers active proliferation, not cell death. Uev1a was found to suppress its overgrowth as well.

      Finally, the authors show that the overexpression of the human homologs, UBE2V1 and UBE2V2, suppresses tumor growth in human colorectal cancer xenografts and cell lines. Notably, the expression of these genes correlates with the survival of colorectal cancer patients carrying the Ras mutation.

      Strength:

      This paper presents a significant finding that UBE2V1/2 may serve as a potential therapy for cancers harboring Ras mutations. The authors propose a fascinating mechanism in which Uev1a forms a complex with APC/C to inhibit aberrant cell cycle progression.

      We greatly appreciate your comments.

      Weakness:

      The quantification of some crucial experiments lacks sufficient clarity.

      Thank you for highlighting this issue. We have provided more details regarding the quantification data in the revised manuscript.

      References

      Edgar, B.A., and Lehner, C.F. (1996). Developmental control of cell cycle regulators: a fly's perspective. Science 274, 1646-1652.

      Hammond, M.P., and Laird, C.D. (1985). Chromosome structure and DNA replication in nurse and follicle cells of Drosophila melanogaster. Chromosoma 91, 267-278.

      Lilly, M.A., and Spradling, A.C. (1996). The Drosophila endocycle is controlled by Cyclin E and lacks a checkpoint ensuring S-phase completion. Genes Dev 10, 2514-2526.

      Zhang, Q., Wang, Y., Bu, Z., Zhang, Y., Zhang, Q., Li, L., Yan, L., Wang, Y., and Zhao, S. (2024). Ras promotes germline stem cell division in Drosophila ovaries. Stem Cell Reports 19, 1205-1216.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The figure legends insufficiently describe the figures. One example is Figure 3, where there are no details in the figure legend about what conditions apply to each panel and each lane of the gels.

      For clarity and brevity, detailed experimental conditions are described in the Materials and Methods section. Figure legends therefore focus on summarizing the key findings. Thank you for your understanding!

      (2) The font size on the figure is too small.

      Thank you for your constructive suggestion. In response, we have enlarged all font sizes to improve readability.

      (3) There are places where the authors overstate their results, and there are issues with the clarity of the text:

      (3a) Lines 170: "excessive" is not appropriate. Their prior study showed a mild increase in proliferation.

      “Excessive” has been removed in the revised manuscript (Lines 215-216).

      (3b) Line 187-8: The authors should restate this sentence. Here's a possibility. Over-expression of Uev1a suppressed the phenotypes caused by CycA over-expression.

      This sentence has been restated as “Notably, this cell death was suppressed by co-overexpression of CycA and Uev1A, indicating a genetic interaction between them”. (Lines 229-231).

      (3c) Lines 266-7: The properties of Uev1a (ie, lacking a conserved Cys) should be in the introduction.

      This information has been added to the revised introduction (Lines 74-76).

      (3d) Line 318: "markedly" is an overstatement of the prior results.

      Our quantification data revealed that “nos>Ras<sup>G12V</sup>; bam<sup>-/-</sup>” ovaries are three times larger than “nos>GFP; bam<sup>-/-</sup>” control ovaries (see Figure 4A-C in Zhang et al., Stem Cell Reports 19, 1205-1216). Given this substantial difference, we think that using "markedly" is not an overstatement.

      (4) Data not shown occurs in a few places in the text. Given the ability to supply supplemental information in eLife preprints, these data should be shown.

      Thanks for your suggestion. All “not shown” data have been added to the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      Major Comments

      (1) Cyclin A (CycA) is a key player in this study, but the authors do not provide evidence showing the upregulation of CycA following Ras overexpression in either polyploid or diploid cells. Data on CycA expression should be included.

      Thank you for your constructive suggestion. These data have been added to the revised manuscript (Figure 4E-G).

      (2) DNA replication stress, cellular senescence, and cell death should be assessed under Ras overexpression (RasOE) and RasOE + Uev1A RNAi conditions to support the model proposed in Figure 4F.

      We apologize for any confusion caused by our initial model. We do not have evidence that DNA replication stress and cellular senescence occur under these conditions. Cell death can be readily detected through the presence of fragmented nuclei and condensed DNA (see Figure 1D). The model has been updated accordingly (Figure 9E).

      (3) Appropriate controls should be performed alongside the experimental sets. The same nos>Ras+GFPi data set was repeatedly used in Figures 1I, 2B, 2H, and Figures 2, S2B, which is not ideal.

      All these experiments were performed under identical conditions. Therefore, we deem it appropriate to use the same control data across these analyses.

      (4) Overall, the microscopic images are too small and hard to see.

      Thank you for raising this important point. In the revised manuscript, all images and the font size on figures have been enlarged for improved clarity.

      (5) Figure 1H

      Why is the frequency of egg chamber degradation quite less in nos>RasG12V+GFP-RNAi (about 40%) than nos > RasG12V (about 80%)? And the authors do not show that there is a significant difference between those two conditions, although it should be there. We will need the explanation from the authors on why there is a difference here.

      These overexpression experiments were conducted using the GAL4/UAS system. While both “nos>Ras<sup>G12V</sup>+GFP-RNAi” and “nos>Ras<sup>G12V</sup>” contain a single nos-GAL4 driver, they differ in UAS copy number: the former incorporates two UAS elements compared to only one in the latter (see the detailed genotypes in Source data 2). These results demonstrate that UAS copy number impacts experimental outcomes in our system.

      In the previous paper (Zhang et al. (2024), Figure 7H shows that the frequency of egg chambers in nos>RasG12V is 33%, although this paper shows it as about 80%. There seems to be a difference in flies' age (previous paper: 7d, this paper: 3d), but this data raises the question of why nos>RasG12V shows more egg chamber degradation this time.

      We greatly appreciate your careful observation. The nurse-cell-death phenotype exhibits a spectrum from mild to severe manifestations [see Figure 1D and our response to weekness (2) in Reviewer #1’s public reviews]. While our 2024 paper exclusively quantified egg chambers with severe phenotypes as degrading, the current study included both mild and severe cases in this classification. We do not think fly age could account for this substantial phenotypic difference. A detailed description of the nurse-cell-death phenotype and its quantification have been added to the revised manuscript (Lines 104-108).

      In the following experiments, only nos>RasG12V+GFP-RNAi is used as a control (Figures 2B, H, S2B). I wonder if these results would give us a different conclusion if nos>RasG12V were used as a control.

      As explained above, the UAS copy number does matter in our analyses, so it is important to keep them identical for comparison.

      (6) In the abstract, the authors mention that uev1a is an intrinsic factor to protect cells from RasG12V-induced cell death. RasG12V does not induce much cell death of cystocytes with bam-gal4, whereas it induces a lot of nurse cells' death. Does it mean the intrinsic expression level of uev1a is low in nurse cells (or polyploid cells) compared to cystocytes (or diploid cells)?

      Overexpression of Ras<sup>G12V</sup> driven by bam-GAL4 exhibited only minimal nurse cell death (Figure 1D, E). Additionally, Uev1A exhibited low intrinsic expression levels in both cystocytes and nurse cells (Figure 3E and Figure 5-figure supplement 1).

      (7) Is uev1a-RNAi alone sufficient to induce egg chamber degradation? Or does it have any effect on ovarian development? (Related to question #1 in minor comments)

      While nos>uev1a-RNAi resulted in female sterility, it alone was insufficient to induce egg chamber degradation. However, simultaneous downregulation of Uev1A, Ben, and Cdc27 triggered significant egg chamber degradation (Figure 5-figure supplement 2).

      (8) Which stages of egg chambers get degraded with RasG12V induction?

      This is a good question. In our analyses, we noted that degrading egg chambers exhibited considerable size variability (Figure 1D). Because degradation disrupts normal morphological cues, precise staging of these egg chambers is nearly impossible.

      (9) I suggest testing the cellular senescence marker as well if the authors mention that CycA-degradation by Uev1a-APC/C complex prevents cellular senescence induced by RasG12V in a schematic image of Figure 4 (e.g., Dap/p21, SA-β-gal).

      As addressed in our response to your Major Comment (2), we lacked experimental evidence to support cellular senescence in this context. We have therefore revised the model accordingly (Figure 9E). While this study focuses specifically on cell death, investigating potential roles of cellular senescence remains an important direction for future research. Thank you for your suggestion!

      Minor Comments

      (1) Figure 1D: Df#7584

      It seems that the late-stage egg chamber is missing in this condition. Why does this occur without egg chamber degradation? Is there a possibility that we do not see egg chamber degradation because this deficiency line does not have a properly developed egg chamber that can have a degradation?

      While this image represents only a single sample, we have confirmed the presence of late-stage egg chambers in other samples. If “Df#7584/+” females were unable to support late-stage egg chamber development, complete sterility would be expected due to the lack of mature eggs. However, as shown in this image (Figure 1D), the ovary contains mature eggs, and the “Df#7584/+” fly strain remains fertile.

      (2) Based on the results that DDR signaling functions as keeping egg chambers from degradation, the authors may be better to check the DNA-damage markers in nos>RasG12V, nos>RasG12V +uev1a. (e.g. γ-H2AX)

      Thank you for your constructive recommendation. These data have been added to the revised manuscript (Figure 3C).

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #2 (Public review):

      Points to be addressed:

      (1) As a statistical test, the authors report having used unpaired t-tests; however, often three groups are compared for which t-tests are inadequate. This is faulty as, amongst other things, it does not take multiple comparison testing into account.

      We have adopted the reviewers' suggestions and conducted a variance analysis (ANOVA) to reanalyze the experimental results with three or more different condition groups. At the same time, we have retained the t-test results for experiments with only two condition groups.

      (2) Both B-Actin and GAPDH seem to have been used for protein-level normalization. Why? The Figure 2HL first panel reports B-actin, whereas the other three report GAPDH. The same applies to Figures 3E-F, where both are shown, and it is not mentioned which of the two has been used. Moreso, uncropped blots seem to be unavailable as supplementary data for proper review. These should be provided as supplementary data.

      In Figures 2G and 3E-F, β-actin and GAPDH both have been used for protein level normalization. The main issue is the mixed use of these two housekeeping proteins, without taking consistency into account in advance. In addition, the expression levels of these two proteins show no significant differences in response to different fluid shear stresses. The uncropped blot images have been organized and provided in the supplementary data.

      (3) LSS and MSS were compared based on transcriptomic analysis. Conversely, RNA sequencing was not reported for the HSS. Why is this data missing? It would be valuable to assess transcriptomics following HSS, and also to allow transcriptomic comparison of LSS and HSS.

      In the current study, we have only conducted the transcriptomic comparative analysis between LSS and MSS conditions, mainly considering that most of current researches focuses on the endothelial dysfunction and atherosclerosis under LSS. Since our HSS condition is overall about 24 dyn/cm<sup>2</sup>, which is also recognized within the normal physiological range in some reports. Moreover, the transcriptomic data are primarily used to identify the targets in our study. Interestingly, for these selected genes, they share the same trend involved in endothelial cell ferroptosis induced by LSS and HSS. At the same time, we strongly agree with the reviewer’s claim that the RNA sequencing results under HSS are also valuable. Therefore, in the future, we are planning to perform the transcriptomic sequencing analysis under the HSS or higher level of shear stress, aiming to discover new insights.

      (4) Actual sample sizes should be reported rather than "three or more". Moreso, it would be beneficial to show individual datapoints in bar graphs rather than only mean with SD if sample sizes are below 10 (e.g., Figures 1B-H, Figure 2G, etc.).

      After rechecking our original data, All analyzed results were from three biological replicates, so they are uniformly marked as 'n=3' in the article. According to the reviewer's suggestion, the position of each data point has been added in the chart of the statistical results along with the standard deviation bars.

      (5) The authors claim that by modifying the thickness of the middle layer, shear stress could be modified, whilst claiming to keep on-site pressure within physiological ranges (approx. 70 mmHg) as a hallmark of their microfluidic devices. Has it been experimentally verified that pressures indeed remain around 70 mmHg.

      It is a very interesting question. In this article, the cross-sectional areas of different tunnel-like channel is related to the thickness of the middle layer, resulting in different level of shear stress. Since all flow rates under three conditions keep same at 1.6 ml/min, the average pressure is calculated to be around 70 mmHg based on our previously reported formula (PMID: 37662690). To address the reviewer's question about the actual pressure values, we used a water-filled tube connected to a chip and measured the height of the water surface in the elevated end relative to the chip position, as shown in the Author response image 1. As expected, when the height of the middle layer bulging to the same value (0.7 mm) as under the LSS condition, the water level reaches to 900 mm, which is corresponding to about 70 mmHg.

      Author response image 1.

      Schematic diagram of on-chip pressure detection

      (6) A coculture model (VSMC, EC, monocytes) is mentioned in the last part of the results section without any further information. Information on this model should be provided in the methods section (seeding, cell numbers, etc.). Moreover, comparison of LSS vs LSS+KLF6 OE and HSS vs HSS+KLF6 OE is shown. It would benefit the interpretation of the outcomes if MSS were also shown. It would also be beneficial to demonstrate differences between LSS, MSS, and HSS in this coculture model (without KLF6 OE).

      The specific methods for constructing the co-culture models (vascular smooth muscle cells, endothelial cells, monocytes) mentioned in the results section have been introduced in our previous paper. For the convenience for reading this article, we have added a brief description in the section of “Methods and materials” in this paper, including cell seeding and numbers. In this study, the results of LSS vs LSS+KLF6 OE and HSS vs HSS+KLF6 OE are presented to verify the role of KLF6 in LSS- or HSS-induced promotion of early atherosclerotic events. In our previously published paper (PMID: 37662690), we have showed the effects of three different shear stresses on the atherosclerotic events (shown in Fig. 4 in that paper). Those results have demonstrated that both LSS and HSS significantly promote early atherosclerotic events compared with the MSS.

      (7) The experiments were solely performed with a venous endothelial cell line (HUVECs). Was the use of an arterial endothelial cell line considered? It may translate better towards atherosclerosis, which occurs within arteries. HUVECs are not accustomed to the claimed near-physiological pressures.

      The human umbilical vein endothelial cell (HUVEC) is a commonly used cell line for many in vitro studies of vascular endothelium under fluid shear stress conditions. Although human arterial endothelial cells (HAECs) may be more suitable than HUVECs for responding to physiologically relevant pressure, HUVECs are more easy to obtain and maintain. However, we are going to order HAECs and will use them to validate the conclusion for the potential translatability.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) Information on seeding of the microfluidic device is absent in the methods section (i.e., seeding, cell density, passage number, confluence, etc.). Moreso, treatment with Fer-1 is not reported in the methods section.

      We have described the cell seeding information in‘Preparation of cell culture in the microfluidic chip’ and the Fer-1 treatment in ‘Cell death assay’ in the Method section.

      (2) Figure 3F has "MSS", "HSS", and "LSS+KLF6" as groups on the x-axis; the latter should probably be "HSS+KLF6".

      Thank you for pointing out this error in Figure 3F. We have made the correction.

      (3) Data should be made available in online repositories rather than "making it available upon reasonable request". As it was not provided, the sequencing data could not be reviewed. In addition, it was stated that a preprint was available on BioRxiv, but I could not find it.

      Thank you for the suggestion. We have uploaded the RNA-seq data to the NCBI GEO database, which was publicly available on December 9, 2025.

    1. Author response:

      eLife Assessment

      Using genome databases, the authors performed solid bioinformatic analyses to trace the genomic history of the clinically relevant Staphylococcus aureus tetracycline resistance plasmid pT181 over the last seven decades. They discovered that this element has transitioned from a multicopy plasmid to a chromosomally integrated element, and the work represents a valuable demonstration of the use of publicly available data to investigate plasmid biology and inform clinical epidemiology. This work will appeal to researchers interested in staphylococcal evolution and plasmid biology.

      Thank you, we agree with this overview. We also think this work is interesting to people interested in antimicrobial resistance and bacterial genome structure.

      Public Reviews:

      Reviewer #1 (Public review):

      The study provides a robust bioinformatic characterization of the evolution of pT181. My main criticism of the work is the lack of experimental validation for the hypotheses proposed by the authors.

      Comments on the study:

      (1) One potential reason for the decline in pT181 copy number over time may be a high cost associated with the multicopy state. In this sense, it would be interesting if the authors could use (or construct) isogenic strains differing only in the state of the plasmid (multicopy/integrated). With this system, the authors could measure the fitness of the strains in the presence and absence of tetracycline, and they could be able to understand the benefit associated with the plasmid transition. The authors discuss these ideas, but it would be nice to test them.

      We agree that the relative fitness of integrated versus multicopy plasmids is interesting and a costly multicopy state could explain the transition of independent pT181 replicons to chromosomal integration. This is a project we are exploring for a future study. However, we think that this additional experimental work goes beyond the scope of the paper.

      (2) It would be interesting to know the transfer frequencies of the multicopy mobilizable pT181 plasmid, compared to the transfer frequency of the plasmid integrated into the SSCmec element (which can be co-transferred, integrated in conjugative plasmids, or by transduction).

      We agree with the reviewer that this is an interesting question. However, we think inferring these rates from natural sequence data is not feasible in this case given the low heterogeneity of the plasmid sequence. A laboratory-based experimental study could not address the real transfers we observe over the course of decades, as in vitro S. aureus transfer rates are often not good proxies for in vivo (McCarthy et al., 2014). In addition, we do not know what is moving the integrated plasmid. pT181 could be moved by a phage or plasmid, so we are uncertain what the correct experiment would be to explore this.

      (3) One important limitation of the study that should be mentioned is that inferring pT181 PCN from whole genome data can be problematic. For example, some DNA extraction methods may underestimate the copy number of small plasmids because the small, circular plasmids are preferentially depleted during the process (see, for example, https://www.nature.com/articles/srep28063).

      We will investigate this issue further in the revisions. The kits used to extract DNA for the earlier-collected samples may possibly yield more plasmid DNA relative to the chromosome compared to newer ones on average; however, we think this is not driving the decline that we observe in multicopy pT181 copy number. Multiple BioProjects find the same result, where earlier samples have higher copy number compared to later samples. We expect extraction methods to be consistent within a BioProject, suggesting that this decline is genuine and not technical. In revisions, we intend to evaluate the effect of date of sequencing and additional metadata on copy number.

      Reviewer #2 (Public review):

      Summary:

      The authors performed bioinformatic analyses to trace the genomic history of the clinically relevant pT181 plasmid. Specifically, they:

      (1) Tracked the presence of pT181 across different S. aureus strain backgrounds through time. It was first found in one, later multiple strains, though this may reflect changes in sampling over time.

      (2) Estimated the mutation rate of the chromosome and plasmid.

      (3) Estimated the plasmid copy number of pT181, and found that it decreased over time. The latter was supported by two sets of statistical analyses, first showing that the number of single-copy isolates increased over time, and second, that the multicopy isolates demonstrated a lower PCN over time.

      (4) Reported the different integration sites at which pT181 integrated into the genome.

      As a caveat, they mentioned that identical plasmid sequences have variable plasmid copy numbers across different genomes in their dataset.

      Strengths:

      This is a very solid, well-considered bioinformatic study on publicly available data. I greatly appreciate the thoughtful approach the authors have taken to their subject matter, neither over- nor underselling their results. It is a strength that the authors focused on a single plasmid in a single bacterial species, as it allowed them to take into account unique knowledge about the biology of this system and really dive deep into the evolution of this specific plasmid. It makes for a compelling case study. At the same time, I think the introduction and discussion can be strengthened to demonstrate what lessons might be drawn from this case study for other plasmids.

      Weaknesses:

      The finding that the pT181 copy number declined over time is the most interesting claim of the paper to me, and not something that I have seen done before. While the authors have looked at some confounders in this analysis, I think this could be strengthened further in a revision.

      In the revisions, we will further explore the impact that technical variation could have in contributing to copy number variation and update our claims for the decline in copy number of the independent replicon over time and variation for the same plasmid sequence accordingly. Multiple BioProjects show earlier samples have higher copy number compared to later samples; we expect extraction methods to be consistent within a BioProject, supporting our initial findings that this decline over time is not due to technical variation.

      For the flow of the storyline, I also think the estimation of mutation rates (starting L181) and integration into the chromosome (starting L255) could be moved to the supplement or a later position in the main text.

      We will revisit the text organization for flow and clarity of storyline.

      Clearly, the use of publicly available data prevents the authors from controlling the growth and sequencing conditions of the isolates. It is striking that they observe a clear signal in spite of this, but I would have loved to see more discussion of the metadata that came with the publicly available sequences and even more use of that metadata to control for confounding.

      In revisions, we will further investigate possible contributors to the observed decline in copy number of multicopy pT181 over time. We have incorporated the date of sample collection and BioProject in our analysis, but not the date of sequencing or extraction technique.

      References

      McCarthy, A. J., Loeffler, A., Witney, A. A., Gould, K. A., Lloyd, D. H., & Lindsay, J. A. (2014). Extensive horizontal gene transfer during Staphylococcus aureus co-colonization in vivo. Genome Biology and Evolution, 6(10), 2697–2708. https://doi.org/10.1093/gbe/evu214

    1. Author response:

      We thank the reviewers for their thorough and constructive evaluation of our manuscript titled “PSD-95 drives binocular vision maturation critical for predation”. The reviewers raised several important conceptual and technical points. Here, we address and provide additional context on the major themes and outline our planned revisions.

      We acknowledge that the current prey capture task cannot directly adjudicate between PSD-95 binocular vision impairments or sensorimotor processing deficits. However, we did not observe any major impairment supporting a sensorimotor processing deficit, in contrast to a major impairment in line with binocular vision impairment. Evidence from Huang et al. (2015) [1], Favaro et al. (2018) [2] and our data with the visual water task (VWT) — thus requiring identical sensorimotor but differential visual processing—clearly demonstrated intact visual acuity but impaired orientation discrimination in PSD-95 KO mice. Therefore, we believe that a binocular integration deficit is the most likely explanation of PSD-95 KO binocular impairments. In line with this, it is unlikely that aberrations in binocular eye movements account for the observations. We appreciate that alternative explanations remain possible and merit explicit discussion. Accordingly, we intend to expand the discussion of these alternatives.

      Importantly, we will provide additional experimental data demonstrating that knock-down of PSD-95 in V1 but not in superior colliculus, significantly decreases orientation discrimination analyzed with the VWT, as we had shown for PSD-95 KO mice (while control knock-down does not have this effect). We believe that this new evidence better delineates the potential neuroanatomical locus of the PSD-95-associated deficits.

      Furthermore, we will provide additional head movement analyses, as suggested by Reviewer 1. Specifically, we will investigate the head angle in relation to the cricket (azimuth) in time (±1 second) around prey contact under light and dark conditions.

      We will also address the potential impact of PSD-95 KO learning deficits. We agree that there are more impairments in the PSD-95 KO brain, as has been published previously. But strikingly, the binocular impairment was dominating the sensory processing. This cannot be convincingly explained by learning deficits. In fact, we have observed improved learning of PSD-95 KO mice with some tasks (e.g. cocaine conditioned place preference) [3], but no significant differences in the VWT [1,2]. Learning differences were described for another PSD-95 mouse line, expressing the N-terminus with two PDZ domains [4]. To avoid potential learning dependent confounds, we have chosen salient stimuli, like water aversion, and prey capture to reduce impacts of potential learning defects.

      We agree on the strength of the random dot stereograms to isolate stereoscopic computations. However, it requires special filters in front of either eye, which renders it unsuitable for the VWT. The lengthy training with less silent stimuli of water reward, could potentially add additional confounds of PSD-95 KO deficits. Thus, we think that this would be something for future experiments to allow for integration of different visual inputs. However, the combined improved performance of WT mice with binocular vision for prey capture (depth percept) and orientation discrimination (summation) is already supporting the importance of binocular vision in mice and the dominant defect in PSD-95 KO mice.

      Finally, we will address the other points raised by the reviewers through clearer exposition and reorganization of the manuscript.

      Once again, we would like to thank the reviewers for their thoughtful and constructive feedback, which we believe will substantially strengthen the manuscript.

      (1) Huang, X., Stodieck, S. K., Goetze, B., Cui, L., Wong, M. H., Wenzel, C., Hosang, L., Dong, Y., Löwel, S., and Schlüter, O. M. (2015). Progressive maturation of silent synapses governs the duration of a critical period. Proc. Natl. Acad. Sci. 112, E3131–E3140. https://doi.org/10.1073/pnas.1506488112.

      (2) Favaro, P.D., Huang, X., Hosang, L., Stodieck, S., Cui, L., Liu, Y., Engelhardt, K.-A., Schmitz, F., Dong, Y., Löwel, S., et al. (2018). An opposing function of paralogs in balancing developmental synapse maturation. PLOS Biol. 16, e2006838. https://doi.org/10.1371/journal.pbio.2006838.

      (3) Shukla, A., Beroun, A., Panopoulou, M., Neumann, P.A., Grant, S.G., Olive, M.F., Dong, Y., and Schlüter, O.M. (2017). Calcium‐permeable AMPA receptors and silent synapses in cocaine‐conditioned place preference. EMBO J. 36, 458–474. https://doi.org/10.15252/embj.201695465.

      (4) Migaud, M., Charlesworth, P., Dempster, M., Webster, L.C., Watabe, A.M., Makhinson, M., He, Y., Ramsay, M.F., Morris, R.G.M., Morrison, J.H., et al. (1998). Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396, 433–439. https://doi.org/10.1038/24790.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Reviewer #1 (Public review):

      I am happy with the revisions the authors made, and believe that the manuscript is now stronger, representing an important contribution.

      We are truly thankful to this reviewer for the very constructive comments

      Reviewer #2 (Public review):

      In their response, the authors state that they do not treat the EAK evidence as decisive, yet the manuscript repeatedly characterizes the assemblage in very definitive terms. For example, EAK is described as "the oldest unambiguous proboscidean butchery site at Olduvai" and as "the oldest secure proboscidean butchery evidence." These phrases communicate a high level of confidence that does not align with the more qualified position articulated in the rebuttal and extends beyond what the documented evidence securely supports.

      We decided to sound less dogmatic and remove the emphasis by adding “potentially” the oldest…. We emphasize that even if we had documented cut marks, we would be on the same epistemological ground, since there is no 100% certainty that the marks identified as cut marks could be cut marks.

      I appreciate the authors' clarification regarding the fracture features, and I agree that these are well-established outcomes of dynamic hammerstone percussion. At the same time, several of these traits have been documented in non-anthropogenic contexts, including helicoidal spiral fractures resulting from trampling and carnivore activity (Haynes 1983), adjacent or flake-like scars created by carnivore gnawing (Villa and Bartram 1996), hackled break surfaces produced by heavy passive breakage such as trampling or sediment pressure (Haynes 1983), and impact-related bone flakes observed in carnivore-modified assemblages (Coil et al. 2020).

      We added this explanation to the final version of the article:

      “This interpretation is epistemologically problematic because it does not satisfy the fundamental criteria for valid analogy as outlined by Bunge (1981), namely substantial, structural, and environmental affinity. Specifically, the cited examples involve agents, materials, and contexts that differ markedly in composition, mechanical properties, and loading regimes from those considered here. Experimental and actualistic studies demonstrate that carnivores—rather than trampling—are also capable of producing spiral fractures and overlapping bone scarring, but these observations are restricted to faunal remains of substantially smaller body size than elephants, which they can gnaw (Haynes 1983; see also Figures S30–S36). To date, no carnivore has been documented as producing comparable fracture morphologies or surface damage on elephant bones. Consequently, the proposed analogy is not supported. Moreover, Haynes (1983) provides no empirical evidence that sediment pressure or trampling can generate hackled fracture surfaces. Such features are instead associated with dynamic loading conditions, whereas passive breakage processes have not been shown to produce these types of modifications. This reasoning also applies to impact flakes on elephant bones, which can only be produced by the sole modern agent documented to dynamically fracture green proboscidean long bones: humans.”

      One of the biggest issues is that there is no quantitative data or images of the bone fracture features that the authors refer to as the main diagnostic criteria at EAK. The only figures that show EAK specimens (S21, S22, S23) illustrate general green-bone fracture morphology but none of the specific traits listed in the text. In contrast, clear examples of similar features come from other Olduvai assemblages, which may be misleading to readers if they mistakenly interpret those as images from EAK. The manuscript also states that these traits "co-occur," but it is not defined whether this refers to multiple features on the same fragment or within the broader assemblage. Without images or counts that document these traits on EAK fossils, readers cannot evaluate the strength of the interpretation. Including that information would substantially strengthen the manuscript.

      The arguments were addressed in the general criteria criticized by the reviewer in his/her previous review encompassing all green broken elephant bones documented. If we restrict the arguments now to EAK, then suffice to rescue the arguments from the previous reply. Images (Figs S21-23) show the EAK broken specimens and clearly indicate their human agency by two factors: a) at least one of them is a long bone flake with overlapping scars (FS 23 is showing its medullary side), and b) elephant bones impacted by carnivores (namely, hyenas) have always shown intensive gnawing and tooth-marking; lack thereof in both EAK specimens refutes a non-human carnivore agency. The former argument is interpreted as human agency because carnivores have not documented to produce such features on elephant bones.

      Regarding the statement that "natural elephant long limb breaks have been documented only in pre or peri-mortem stages when an elephant breaks a leg, and only in femora (Haynes et al., 2021)," it is not entirely clear what this example is intended to illustrate in relation to the EAK assemblage. My understanding is that the authors are suggesting that naturally produced green bone fractures in elephants are very limited, perhaps occurring only in pre or peri-mortem broken leg cases, and that fractures on other elements should therefore be attributed to hominin activity. If that is not the intended argument, I would encourage clarifying this point. This appears to conflate pre-mortem injury with the broader issue of equifinality. My original comment was not referring to pre-mortem breaks but to the range of natural (i.e., non-hominin) and post-mortem processes that can generate spiral or green bone fractures similar to those described by the authors.

      We elaborated such argument addressing exclusively the reviewer´s previous argument that natural limb breaking produced spiral breaks on elephant long bones, which is correctly, as Haynes describes it, the only way not involving human agency that can generate a helicoidal spiral fracture on an elephant long bone. Non-human post-mortem processes on fresh bone do not generate these features. Neither have extant carnivores documented to produce these features on elephant bones.

      Finally, in considering the authors' response on the Nyayanga material, I still find the basis for their dismissal of that evidence difficult to follow and the contrasting treatment of the Nyayanga and EAK evidence raises concerns about interpretive consistency. Plummer et al. (2023) specify that bone surface modifications were examined using low-power magnification (10×-40×) and strong light sources to identify modifications and that they attributed agency (e.g., hominin, carnivore) to modifications only after excluding possible alternatives. The rebuttal does not engage with the procedures reported. The existence of newer analytical techniques does not diminish the validity of long-standing methods that have been applied across many studies. It is also unclear why abrasion is presented as a more likely explanation than stone tool cutmarks. The authors dismiss the Nyayanga images as "blurry," but this is irrelevant to the interpretation, since the analysis was based on the fossils, not the photographs. The Nyayanga dataset is dismissed without a thorough engagement, while the EAK material, despite similar uncertainties and potential for alternative explanations, is treated as definitive.

      We believe the rebuttal engages with these arguments. The protocol “bone surface modifications were examined using low-power magnification (10×-40×) and strong light sources to identify modifications and that they attributed agency (e.g., hominin, carnivore) to modifications only after excluding possible alternatives” does not guarantee that any derived interpretation is correct. These methods have consistently been used for decades now in contexts in which different researchers draw different conclusions on the same marks. The underlying variables used are subjectively interpreted and tallied, and equifinal when not considering overlapping factors, such as sediment abrasion and trampling. As an example, the same marks on the Nyayanga hippo bones interpreted by the original authors as cut marks, we see them undifferentiable from trampling marks from the image evidence published.

      It is clear in the final version of our article that the EAK evidence is not treated as definitive, since that would be dogmatic, and thus, non-scientific. We thank this reviewer for having given us the chance to reconsider our original phrasing.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary:

      This study investigates the molecular mechanism by which warm temperature induces female-to-male sex reversal in the ricefield eel (Monopterus albus), a protogynous hermaphroditic fish of significant aquacultural value in China. The study identifies Trpv4 - a temperature-sensitive Ca<sup>2+</sup> channel - as a putative thermosensor linking environmental temperature to sex determination. The authors propose that Trpv4 causes Ca<sup>2+</sup> influx, leading to activation of Stat3 (pStat3).pStat3 then transcriptionally upregulates the histone demethylase Kdm6b (aka Jmjd3), leading to increased dmrt1 gene expression and ovo-testes development. This work aims to bridge ecological cues with molecular and epigenetic regulators of sex change and has potential implications for sex control in aquaculture.

      Strengths:

      (1) This study proposes the first mechanistic pathway linking thermal cues to natural sex reversal in adult ricefield eel, extending the temperature-dependent sex determination paradigm beyond embryonic reptiles and saltwater fish.

      (2) The findings could have applications for aquaculture, where skewed sex ratios apparently limit breeding efficiency.

      We thank you for the encouraging comments of our work, and answering your questions has greatly improved the quality of the manuscript.

      Weaknesses:

      (A) Scientific Concerns:

      (1) There is insufficient replication and data transparency. First, the qPCR data are presented as bar graphs without individual data points, making it impossible to assess variability or replication. Please show all individual data points and clarify n (sample size) per group. Second, the Western blotting is only shown as single replicates. If repeated 2-3 times as stated, quantification and normalization (e.g., pStat3/Stat3, GAPDH loading control) are essential. The full, uncropped blots should be included in the supplementary data.

      We thank you for the critical comments. Now we have remade the bar graphs with individual data points, and added the sample size per group if possible. Quantification and/or normalization of the WB data based on at least two replicates were included. The representative uncropped blots have also been loaded as the supplementary data.

      (2) The biological significance of the results is not clear. Many reported fold changes (e.g., kdm6b modulation by Stat3 inhibition, sox9a in S3A) are modest (<2-fold), raising concerns about biological relevance. Can the authors define thresholds of functional relevance or confirm phenotypic outcomes in these animals?

      We thank you for the inspiring comments. Most of the experiments were transient in nature, for instance, warm temperature treatment of fish for 3-4 days, the fold change of gene expression were modest.

      We admit that there are some shortcomings in this work. The major one is lacking of data showing that Trpv4 inhibition/activation,or pStat3 inhibition/activation can cause a gonadal phenotype change, for instance, from ovary to ovotestis or causing females to intersex fish. We only showed that pharmacological or RNAi can lead to change in sex-biased gene expression or affect temperature-induced gene expression, but not gonadal transformation.

      In natural population, the sex change of ricefield eel may take several months to one year or even longer. We propose that the magnitude and duration of temperature exposure promote sex change of ricefield eel by driving the accumulation of testicular differentiation genes in sufficient quantities. In experimental condition, to realize the gonadal phenotype change, animals may need to be under repeated pharmaceutical treatment (3 day interval treatment) for longer time to reach a threshold. However, long term treatment significantly increases the death rate of the animals, caused by stress or frequent manipulation.

      Inspired by your comment, we are optimizing the experimental conditions in order to cause some phenotypic outcomes, thanks.

      (3) The specificity of key antibodies is not validated. Key antibodies (Stat3, pStat3, Foxl2, Amh) were raised against mammalian proteins. Their specificity for ricefield eel proteins is unverified. Validation should include siRNA-mediated knockdown with immunoblot quantification with 3 replicates. Homemade antibodies (Sox9a, Dmrt1) also require rigorous validation.

      We thank you for the comments about the specificity of the antibodies. First,when choosing the commercial antibodies, we have compared the immunogen of the animal with the corresponding amino acids of ricefield eel, making sure that it was conserved to some extent (at least> 85% similarity). Second, we have referred the published work, where the antibodies have been proven to work in zebrafish, frogs, and turtles et al. This was true for pStat3 and Stat3 antibodies (Weber et al. 2020; Ge et al., 2024). Third, the specificity for each antibody was assessed using WB, based on the predicted size of the protein and the correct control setting.

      For instance, we are very confident for the specificity for Dmrt1 antibody. First, Dmrt1 protein was readily detected in testes of males but barely detected in ovaries of females (Author response image 1). Second, Dmrt1 protein was not detected in ovary of fish at cool temperature, but clearly detected in nuclei of follicles in warm temperature-treated fish (Figure 3C, 4B), in line with our qPCR results. Third, by performing IF, Dmrt1 was not detected in females reared at lower temperature. By contrast, after warm temperature treatment or Trpv4 activation, it was detected in the nuclei in specific cell types but not everywhere (Figure 3E, 6C).

      Author response image 1.

      Although we have carefully evaluated the antibodies before experiments as described above, in response to your concerns, we went on to validate Amh, Dmrt1, Sox9a, and Stat3 antibodies using the corresponding siRNAs (Author response image 2). The results indicated that the antibodies, although not perfect, can be used in this work, as the expected band was gone or reduced in intensity. The experiments were repeated two times, and shown were representative.

      Author response image 2.

      (4) Most of the imaging data (immunofluorescence) is inconclusive. Immunofluorescence panels are small and lack monochrome channels, which severely limits interpretability. Larger, better-contrasted images (showing the merge and the monochrome of important channels) and quantification would enhance the clarity of these findings.

      We apologize for the poor quality of the IF images. At your suggestion, we have repeated the majority of the IF experiments, and imaging data with better quality were presented in the revised manuscript. Quantification of WB and IF was also included to enhance the clarity. Please see the revised manuscript, Thanks.

      (B) Other comments about the science: 

      (1) In S3A, sox9a expression is not dose-responsive to Trpv4 modulation, weakening the causal inference.

      We have repeated the experiments, and new data was included for the replacement of the old one in the revised manuscript.

      (2) An antibody against Kdm6b (if available) should be used to confirm protein-level changes.

      We thank you for the nice suggestion. Unfortunately, current commercial antibody for Kdm6b is for mammals, which was not working in ricefield eel. At your suggestion, we are going to make one in future.

      In sum, the interpretations are limited by the above concerns regarding data presentation and reagent specificity.

      Reviewer #2 (Public review):

      Summary:

      This study presents valuable findings on the molecular mechanisms driving the female-to-male transformation in the ricefield eel (Monopterus albus) during aging. The authors explore the role of temperature-activated TRPV4 signaling in promoting testicular differentiation, proposing a TRPV4-Ca<sup>2+</sup>-pSTAT3-Kdm6b axis that facilitates this gonadal shift.

      We thank you for the encouraging comments. Answering your questions has greatly improved our understanding of Trpv4 function in ricefield eel, and the quality of the manuscript.

      Strengths:

      The manuscript describes an interesting mechanism potentially underlying sex differentiation in M. albus.

      Weaknesses:

      The current data are insufficient to fully support the central claims, and the study would benefit from more rigorous experimental approaches.

      (1) Overstated Title and Claims:

      The title "TRPV4 mediates temperature-induced sex change" overstates the evidence. No histological confirmation of gonadal transformation (e.g., formation of testicular structures) is presented. Conclusions are based solely on molecular markers such as dmrt1 and sox9a, which, although suggestive, are not definitive indicators of functional sex reversal.

      We thank you for pointing out this. The title has been changed to “Trpv4 links environmental temperature to testicular differentiation in hermaphroditic ricefield eel.”

      (2) Temperature vs Growth Rate Confounding (Figure 1E):<br /> The conclusion that warm temperature directly induces gonadal transformation is confounded by potential growth rate effects. The authors state that body size was "comparable" between 25C and 33C groups, but fail to provide supporting data. In ectotherms, growth is intrinsically temperature-dependent. Given the known correlation between size and sex change in M. albus, growth rate-rather than temperature per se-may underlie the observed sex ratio shifts. Controlled growth-matched comparisons or inclusion of growth rate metrics are needed.

      We thank you for the critical comments. We have repeated the experiments, and have carefully compared the body length and weight, and results showed that there is no big difference between 25 and 33 degree groups. Please see Figure S1D-E, and the text in the last paragraph of “Warm temperature promotes gonadal transformation” section in the Results part.

      (3) TRPV4 as a Thermosensor-Insufficient Evidence:<br /> The characterisation of TRPV4 as a direct thermosensor lacks biophysical validation. The observed transcriptional upregulation of Trpv4 under heat (Figure 2) reflects downstream responses rather than primary sensor function. Functional thermosensors, including TRPV4, respond to heat via immediate ion channel activity-typically measurable within seconds-not mRNA expression over hours. No patch-clamp or electrophysiological data are provided to confirm TRPV4 activation thresholds in eel gonadal cells.

      We thank you for the critical comments. The patch-clamp or electrophysiological experiments require special equipment and well-trained expert, unfortunately, our lab members and nearby collaborators have no experience in performing the kind of experiments. The Trpv4 is a well-known cation channel protein that is activated by moderate heat (> 27 degree). And a body of published work has demonstrated its role in the regulation of Ca<sup>2+</sup> signals via change its configuration in response to temperature (J Physiol. 2017 Oct 25;595(22):6869–6885. doi: 10.1113/JP275052; Cell Death Dis 11, 1009 (2020). https://doi.org/10.1038/s41419-020-03181-7; Cell Death Dis 10, 497 (2019). https://doi.org/10.1038/s41419-019-1708-9; Cell calcium, https://doi.org/10.1016/j.ceca.2026.103108).

      Consistently, warm temperature increased calcium influx within an hour, similar to the Trpv4 agonist treatment (Figure 2E, 5D), and addition of ion channel Trpv4 inhibitor prevents the calcium signals by war temperature treatment. Moreover, calcium signaling activity is closely linked with pStat3 activity and expression of sex-biased genes (Figures 5G, 6F). Although we did not show biophysical data, these results implied that Trpv4 is a thermosensor, and regulate the downstream pathway via the regulation of calcium signals, in line with it functions as an ion channel.

      Additionally, the Ca<sup>2+</sup> imaging assay (Figure 2F) lacks essential details: the timing of GSK1016790A/RN1734 administration relative to imaging is unclear, making it difficult to distinguish direct channel activity from indirect transcriptional effects.

      We have added more information for Ca<sup>2+</sup> imaging assay (now Figure 2E and the corresponding text in Figure 2 legend, in the revised manuscript). In particular, we added the timing of treatment to better show that it was a direct effect.

      (4) Cellular Context of TRPV4 Activity Is Unclear:<br /> In situ hybridisation suggests TRPV4 expression shifts from interstitial to somatic domains under heat (Figures. 2H, S2C), implying potential cell-type-specific roles. However, the study does not clarify: (i) whether TRPV4 plays the same role across these cell types, (ii) why somatic cells show stronger signal amplification, or (iii) the cellular composition of explants used in in vitro assays. Without this resolution, conclusions from pharmacological manipulation (e.g., GSK1016790A effects) cannot be definitively linked to specific cell populations.

      We thank you for the inspiring comments. We have performed IF experiments using Trpv4 specific antibodies (antibody specificity was confirmed). It was clearly shown that Trpv4 was expressed in a portion of follicle cells. To explore the identity of Trpv4-expressing somatic cells, we have performed double IF experiments using Trpv4 and Foxl2, a granulosa cell marker. The results (Figure 2H) clearly showed that Trpv4-expressing cells are a portion of Foxl2-positive granulosa cells. We propose that Trpv4-expressing granulosa cells may play an important role in sensing the temperature, and that Trpv4-expressing granulosa cells transdifferentiate into Sertoli cells by warm temperature exposure, because Dmrt1, a Sertoli cell marker, started within follicles in a typical granulosa cell location. Unfortunately, current Dmrt1/Trpv4 antibodies are both produced from rabbit. To overcome this, we are ordering mouse Dmrt1 antibodies, and in future we will perform Trpv4/Dmrt1 double IF to show if Dmrt1 positive cells co-localize with Trpv4 expressing cells. We would like to update the results to you once the antibody was available.

      As our animal experiments (Figure 2H) have clearly shown the identify of Trpv4 expressing somatic cells, we did not repeat the experiments using explants, to explore the cellular composition of explants used in in vitro assays.

      (5) Rapid Trpv4 mRNA Elevation and Channel Function:<br /> The authors report a dramatic increase in Trpv4 mRNA within one day of heat exposure (Figures 4D, S2B). Given that TRPV4 is a membrane channel, not a transcription factor, its rapid transcriptional sensitivity to temperature raises mechanistic questions. This finding, while intriguing, seems more correlational than functional. A clearer explanation of how TRPV4 senses temperature at the molecular level is needed.

      We appreciate you for your inspiring comments. Actually, we are also wondering about how trpv4 mRNA was regulated by warm temperature. First of all, the up-regulation of trpv4 mRNA is true, as evidenced by multiple pieces of data using qPCR and ISH experiments. It appears that ovarian cells respond to the temperature changes by increasing calcium influx via Trpv4 ion channel,as well as by increasing trpv4 mRNA expression levels.

      Then, how trpv4 mRNA is regulated by heat? It is well-known that gene expression can be regulated by subtle temperature change via some direct temperature sensing genes (Haltenhof et al., 2020). We hypothesized that trpv4 is a downstream target of these thermosensors, displaying a mechanism similar to mammals. Actually, we have performed some experiments, and the preliminary data were obtained, which support our hypothesis.

      Because the mechanistic explanation study is undergoing and not published, we chose not to discuss it in detail in the revised manuscript. We wish to report it by the end of this year, and by then are pleased to update you with the progress.

      (6) Inconclusive Evidence for the Ca<sup>2+</sup>-pSTAT3-Kdm6b Axis: Although the authors propose a TRPV4-Ca<sup>2+</sup>-pSTAT3-Kdm6b-dmrt1 pathway, intermediate steps remain poorly supported. For example, western blot data (Figures 3C, 4B) do not convincingly demonstrate significant pSTAT3 elevation at 34C. Higher-resolution and properly quantified blots are essential. The inferred signalling cascade is based largely on temporal correlation and pharmacological inhibition, which are insufficient to establish direct regulatory relationships.

      We thank you for the critical comments. In response to your concerns, we have repeated experiments, and better resolution WB data with proper quantification were included in the revised manuscript. In particular, we convincingly demonstrate that 34 degree caused significant pStat3 elevation.

      To directly establish regulatory relationship of the members, at your suggestion, we provided some genetic and molecular biology data to support our conclusion in the revised manuscript. For instance, we have knockdown the stat3 gene by using siRNAs, and as shown in Figure 6F, we further showed that pStat3 is functionally downstream of Trpv4. Moreover, ChIP and luciferase assays were performed to show that pStat3 directly binds and activate kdm6b (Figure 7B-C). We have also performed various pharmacological inhibition to further strength our conclusion (Figures 6B-E).

      (7) Species-Specific STAT3-Kdm6b Regulation Is Unresolved:<br /> The proposed activation of Kdm6b by pSTAT3 contrasts with findings in the red-eared slider turtle (Trachemys scripta), where pSTAT3 represses Kdm6b. This divergence in regulatory direction between the two TSD species is surprising and demands further justification. Cross-species differences in binding motifs or epigenetic context should be explored. Additional evidence, such as luciferase reporter assays (using wild-type and mutant pSTAT3 binding motifs in the Kdm6b promoter) is needed to confirm direct activation.

      We thank you for the inspiring comments. At your suggestion, we have performed luciferase assay using kdm6b promotor that is intact or mutated. The results were in favor of our statement. Please see Figure 7C and the related text.

      A rescue experiment-testing whether Kdm6b overexpression can compensate for pSTAT3 inhibition-would also greatly strengthen the model.

      We thank you for the nice suggestion. It is technically challenging to perform kdm6b overexpression or any Kdm6b gain of function experiments (we have tried to make lentivirus, however, it was not working). There is no Kdm6b-specific agonists.

      Inspired by you, we are establishing constitutive kdm6b transgenic ricefield eel. Although it require at least a year to allow the fish to grow up for functional experiments, once it was established, we can directly answer some important questions.

      (8) Immunofluorescence-Lack of Structural Markers: <br /> All immunofluorescence images should include structural markers to delineate gonadal boundaries. Furthermore, image descriptions in the figure legends and main text lack detail and should be significantly expanded for clarity.

      We thank you for the critical comments. At your comments, we have first performed IF using beta-catenin as structural marker. However, the results were not good for some unknown reasons. Then, we used Vimentin as a structural maker, as it can label all the cells in gonads. Foxl2 was used as granulosa cell marker. Dmrt1 was used as Sertoli cell marker.

      Some essential description was added in the figure legend as requested. Please see detail in the revised manuscript.

      (9) Pharmacological Reagents-Mechanisms and References: <br /> The manuscript lacks proper references and mechanistic descriptions for the pharmacological agents used (e.g., GSK1016790A, RN1734, Stattic). Established literature on their specificity and usage context should be cited to support their application and interpretation in this study.

      These pharmacological agents have been used by others (Ge et al., 2017; Liu et al., 2021; Weber et al., 2020; Wu et al.,2024), and they are properly cited in the manuscript.

      (10) Efficiency of Experimental Interventions: <br /> The percentage of gonads exhibiting sex reversal following pharmacological or RNAi treatments should be reported in the Results. This is critical for evaluating the strength and reproducibility of the interventions.

      We thank you for the critical and important comments. Actually another reviewer has asked the same question. We admit that this was the big shortcoming of the work, as we did not provide data demonstrating that Trpv4 inhibition/activation, or pStat3 inhibition/activation can cause a gonadal phenotype change, for instance, from ovary to ovotestis or causing sex reversal of fish. We only showed that pharmacological or RNAi can lead to alteration of sex-biased gene expression or affect temperature induced gene expression.

      In wild population, the entire sex change of ricefield eel may take months to one year or even longer. We propose that the magnitude and duration of temperature exposure promote sex change of ricefield eel by driving the accumulation of testicular differentiation genes in sufficient quantities. In experimental condition, to realize the gonadal phenotype change, animals may need to be under repeated pharmaceutical treatment (3 day interval treatment) for longer time to reach a threshold, however, long term treatment significantly increases the death rate of the animals, caused by stress or frequent manipulation. Actually, my students have tried the experiments, unfortunately, either the number of sex-versing animals were small or the experiments lacked of repeat. So no percentage of gonadal transformation after treatment can be provided at this time, but we have indicated the number of samples when performing molecular experiments (showing expression of sex-biased genes).

      Inspired by your important comment, we are optimizing the experimental conditions in order to cause some phenotypic outcomes. By then, the percentage of gonads exhibiting sex reversal following pharmacological or RNAi treatments can be calculated, showing the biological significance.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Editorial Concerns: 

      (1) The term "sex reversal" should be clearly defined upfront as female-to-male, and the developmental consequences (e.g., increase in body size post-transition) should be explicitly stated early in the introduction.

      We thank our editorial for pointing out this. We have added those in the introduction Part. It reads “The species begins life as a female and then develops into a male through an intersex stage, thus displaying a female-to-male sex reversal during aging. Females are small in size (< 25 cm), and during and after sex change, there is a gradual increase in body size (> 55 cm for the majority of males).”

      Additional information was shown in the first and second paragraph in the results Part.

      (2) The manuscript references skewed sex ratios in cultured ricefield eel but fails to specify the direction (e.g., too many males or females). This should be clarified to contextualize the biological and commercial problem. 

      According to your suggestion, we now added additional information, and it reads “The reproductive mode of ricefield eel, which leads to much more females than males in spawning season, severely affects the sex ratio, and decreases the productivity of broodstock. Moreover, adult females lay limited eggs (~200) due to its small size.”

      (3) Define TSD (temperature-dependent sex determination) upon first use, not at the second mention.

      We have checked this, and make sure it was properly done.

      (4) The phrase "quality fries for aquaculture" should be reworded or defined; it is unclear to non-specialists.

      We thank you for pointing out this. Now it reads “adult females lay limited eggs (~200) due to its small size, which is a limiting factor for massive production of seedling for aquaculture industry”.

      (5) Several in-text citations (e.g., Weber 2020, Wu 2024) are absent from the bibliography. ]

      We have double checked the reference, thanks.

      (6) The inclusion of page and line numbers would facilitate peer review.

      We have now shown the page and line.

      (7) The discussion is written vaguely. Clarify species names when discussing comparative biology and consider breaking down complex sentences to aid comprehension for a broad audience, such as that of eLife. 

      We have added the species name, and try our best to use concise expression. Thanks.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Abdelmageed et al. investigate age-related changes in the subcellular localization of DNA polymerase kappa (POLK) in the brains of mice. POLK has been actively investigated for its role in translesion DNA synthesis and involvement in other DNA repair pathways in proliferating cells, very little is known about POLK in a tissue-specific context, let alone in post-mitotic cells. The authors investigated POLK subcellular distribution in the brains of young, middle-aged, and old mice via immunoblotting of fractioned tissue extracts and immunofluorescence (IF). Immunoblotting revealed a progressive decrease in the abundance of nuclear POLK, while cytoplasmic POLK levels concomitantly increased. Similar findings were present when IF was performed on brain sections. Further, IF studies of the cingulate cortex (Cg1), the motor cortex (M1, M2), and the somatosensory (S1) cortical regions all showed an age-related decline in nuclear POLK. Nuclear speckles of POLK decrease in each region, meanwhile, the number of cytoplasmic POLK granules decreases in all four regions, but granule size is increasing. The authors report similar findings for REV1, another Y-family DNA polymerase.

      The authors then investigate the colocalization of POLK with other DNA damage response (DDR) proteins in either pyramidal neurons or inhibitory interneurons. At 18 months of age, DNA damage marker gH2AX demonstrated colocalization with nuclear POLK, while strong colocalization of POLK and 8-oxo-dG was present in geriatric mice. The authors find that cytoplasmic POLK granules colocalize with stress granule marker G3BP1, suggesting that the accumulated POLK ends up in the lysosome.

      Brain regions were further stained to identify POLK patterns in NeuN+ neurons, GABAergic neurons, and other non-neuronal cell types present in the cortex. Microglia associated with pyramidal neurons or inhibitory interneurons were found to have a higher abundance of cytoplasmic POLK. The authors also report that POLK localization can be regulated by neuronal activity induced by Kainic acid treatment. Lastly, the authors suggest that POLK could serve as an aging clock for brain tissue, but POLK deserves further characterization and correlation to functional changes before being considered as a biomarker.

      Strengths:

      Investigation of TLS polymerases in specific tissues and in post-mitotic cells is largely understudied. The potential changes in sub-cellular localization of POLK and potentially other TLS polymerases open up many questions about DNA repair and damage tolerance in the brain and how it can change with age.

      Weaknesses:

      The work is quite novel and interesting, and the authors do suggest some potentially interesting roles for POLK in the brain, but these are in and of themselves a bit speculative. The majority of the findings of this paper draw upon findings from POLK antibody and its presumed specificity for POLK. However, this antibody has not been fully validated and needs further work. Further validation experiments using Polk-deficient or knocked-down cells to investigate antibody specificity for both immunoblotting and immunofluorescence should be performed. More mechanistic investigation is needed before POLK could be considered as a brain aging clock.

      We are thankful for the overall enthusiasm and positive comments.

      (a) Concern over POLK antibody characterization in mouse:

      We performed siRNA and shRNA knock downs in mouse primary cortical neurons as well as efficiently transfectable murine lines like 4T1 and Neuro-2A showing knock down of 99kDa and 120kDa bands recognized by sc-166667 anti-POLK antibody (exact figure number Figure 1 and S1). We show that in IF sc-166667 and A12052 (Figure S1G) shows similar immunostaining patterns and we used sc-166667 in all reported figures and western blots.

      (b) More mechanistic investigation is needed before POLK could be considered as a brain aging clock:

      We sincerely appreciate the valuable suggestion. We agree as a terminal assay POLK nucleo-cytoplasmic status is not practical for longitudinal studies. However, we believe it may serve an investigative/correlative endogenous signal for determining tissue age, that may be useful to "date" brain sections, since not many such cell biological markers exist. We have added clarification texts to address this.

      Reviewer #2 (Public review):

      Summary:

      Abdelmageed et al., demonstrate POLK expression in nervous tissue and focus mainly on neurons. Here they describe an exciting age-dependent change in POLK subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue. They argue that the cytosolic POLK is associated with stress granules. They also investigate the cell-type specific expression of POLK, and quantitate expression changes induced by cell-autonomous (activity) and cell nonautonomous (microglia) factors.

      I think it is an interesting report but requires a few more experiments to support their findings in the latter half of the paper. Additionally, a more mechanistic understanding of the pathways regulating POLK dynamics between the nucleus and cytosol, what is POLK doing in the cytosol, and what is it interacting with; would greatly increase the impact of this report. However, additional mechanistic experiments are mostly not needed to support much of the currently presented results, again, it would simply increase the impact.

      (a) Concern on more mechanistic understanding of the pathways regulating POLK dynamics between the nucleus and cytosol:

      We sincerely appreciate the reviewer’s enthusiasm and valuable guidance in helping us better understand the mechanism of nuclear-cytoplasmic POLK dynamics. Previously, we developed a modified aniPOND (accelerated native isolation of proteins on nascent DNA) protocol, which we termed iPoKD-MS (isolation of proteins on Pol kappa synthesized DNA followed by mass spectrometry), to capture proteins bound to nascent DNA synthesized by POLK in human cell lines (bioRxiv https://www.biorxiv.org/content/10.1101/2022.10.27.513845v3). In this dataset, we identified potential candidates that may regulate nuclear/cytoplasmic POLK dynamics. These candidates are currently undergoing validation in human cell lines, and we are preparing a manuscript on these findings. Among these, some candidates, including previously identified proteins such as exportin and importin (Temprine et al., 2020, PMID: 32345725), are being explored further as potential POLK nuclear/cytoplasmic shuttles. We are also conducting tests on these candidates in mouse cortical primary neurons to assess their role in POLK dynamics. In the revised version of the manuscript, we have included a discussion of our current understanding.

      (b) Question on “… what is POLK doing in the cytosol, and what is it interacting with …”: Our data so far indicate that POLK accumulates in stress granules and lysosomes. We are very grateful for the reviewer’s insightful suggestions and will make every effort to incorporate them in the revised manuscript. We characterized POLK accumulation in the cytoplasm using six additional endo-lysosomal markers, as recommended by the reviewer. This data is now part of entirely new Figure 3.

      Reviewer #3 (Public review):

      Summary:

      In this study, the authors show that DNA polymerase kappa POLK relocalizes in the cytoplasm as granules with age in mice. The reduction of nuclear POLK in old brains is congruent with an increase in DNA damage markers. The cytoplasmic granules colocalize with stress granules and endo-lysosome. The study proposes that protein localization of POLK could be used to determine the biological age of brain tissue sections.

      Strengths:

      Very few studies focus on the POLK protein in the peripheral nervous system (PNS). The microscopy approach used here is also very relevant: it allows the authors to highlight a radical change in POLK localization (nuclear versus cytoplasmic) depending on the age of the neurons. 

      The conclusions of the study are strong. Several types of neurons are compared, the colocalization with several proteins from the NHEJ and BER repair pathways is tested, and microscopy images are systematically quantified.

      Weaknesses:

      The authors do not discuss the physical nature of POLK granules. There is a large field of research dedicated to the nature and function of condensates: in particular numerous studies have shown that some condensates but not all exhibit liquid-like properties (https://www.nature.com/articles/nrm.2017.7, https://pubmed.ncbi.nlm.nih.gov/33510441/ https://www.mdpi.com/2073-4425/13/10/1846). The change of physical properties of condensates is particularly important in cells undergoing stress and during aging. The authors should discuss this literature.

      We highly appreciate the reviewer bringing up the context of biomolecular condensates. Our iPoKD-MS data referenced above suggests candidates from various biomolecular condensates that we are currently investigating. We appreciate the reviewer providing important literature cited these articles in text and potential biomolecular condensates are discussed in the revised version. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The work is quite novel and interesting, and the authors do suggest some potentially interesting roles for POLK in the brain, but these are in of themselves a bit speculative. The majority of the findings of this paper rely upon the POLK antibody and its specificity for POLK, which is not fully characterized and needs further work (validation of antibodies using immunoblots of Polk KO cells or siRNA KD of POLK in murine cells) to provide confidence in the authors' findings. 

      Points

      siRNA knockdown of Polk in primary neurons showed a dramatic reduction in signal by IF even though qPCR analysis showed a reduction of only ~35% at the transcript level. Typically many DNA repair genes need to be knocked down by 80% or more to see discernable differences at the protein level. siRNA knockdown in a murine cell line (MEFs, neurons, or some other easily transfectable cell type) needs to be performed with immunoblotting with whole cell and fractionated (nuclear/cytoplasmic) lysates in order to better validate the anti-POLK antibodies and which bands that are visualized during immunoblotting are specific to POLK.

      We performed siRNA and shRNA knock downs in mouse primary cortical neurons as well as efficiently transfectable murine lines like 4T1 and Neuro-2A showing knock down of 99kDa and 120kDa bands recognized by sc-166667 anti-POLK antibody (exact figure number Figure 1 and S1). We show that in IF sc-166667 and A12052 (Figure S1G) shows similar immunostaining patterns and we used sc-166667 in all reported figures and western blots.

      Figure 1B and C, it is not clear which antibody(ies) are used for the immunoblotting of nuclear and cytoplasmic fractions and for a blot with whole tissue lysates. Please place the antibody vendor or clone next to the corresponding blot or describe it in the figure legend. Bands of varying sizes are present in 1B (and Figure S1) but only a band at 99 kDa was shown in 1C. Because there are no bands of equivalent size present in the nuclear and cytoplasmic fractions in Figure 1B, please describe or denote which bands were used for quantification purposes for nuclear and cytoplasmic POLK.

      This has been clarified by using only one antibody throughout the manuscript sc-166667. We observed in whole cell lysate an intense ~99kDa and a faint ~120kDa band, which gets intense in nuclear fraction and is absent in cytoplasmic fraction. We have noted this in multiple human cell lines and hiPSC-derived neurons, which is our ongoing work. We do not know yet if the ~120kDa is a modification or isoform of POLK. We have hints from our proteomics data that it may be SUMOylated or ubiquitinylated or other post translational modifications. We added this in the discussion section.

      Figure 1I, is there a quantification beyond just the representative image? There is no green staining pattern outside the cytoplasm in the 1-month-old M1 images that is present in all the other images in the panel.

      Fig 1I is now Fig S1G in the revised manuscript. Since REV1 and POLH were not central to the study that focused on POLK, they were meant to be exploratory data panels and as such we did not quantify beyond the qualitative evaluation, which broadly resembled POLK’s disposition with age. We have noted there are some sample to sample variability in the background signal. In general, outside the cytoplasm as subcellularly segmented by fluorescent nissl expression, tends to be variable by brain areas but also higher in older brains

      "Association with PRKDC further suggests POLK's role in the "gap-filling" step in the NHEJ repair pathway in neurons." There is no strong evidence in the literature for mammalian POLK playing a role in NHEJ. Some description of a role in HR has been described, however. The reference regarding the iPoKD-MS data set that provides evidence of POLK associating with BER and NHEJ factors is listed as Paul, 2022 but is in the reference list as Shilpi Paul 2022.

      We removed this speculative statement and citation fixed.

      Figure 4A, what is the age of the mouse for the representative images?

      19 months and now mentioned in the figure legend

      Figure 4C, Could the data from the different ages be plotted side by side to better evaluate the differences for each cell type/region?

      Data is plotted side by side

      Why was the one-month time point chosen as this could still represent the developing and not mature murine brain? 

      Reviewer correctly noted that a 1 month brain is still developing, but mostly from the behavioral and circuit maturation standpoint. However, from cell division and neurogenesis perspective, that is considered to be complete by first postnatal month, with neuron production thereafter largely restricted to specialized adult niches in the dentate gyrus and subventricular zone–olfactory bulb pathway; these adult neurogenic stem cells are embryonically derived and are regulated in ways that are distinct from the early, expansionary developmental waves of neurogenesis. In our study we performed our measurements in the cortical areas only. (Caviness et al., 1995, PMID: 7482802; Ansorg et al., 2012, PMID: 22564330; Ming & Song, 2011, PMID: 21609825; Bond et al., 2015, PMID: 26431181; Bond et al., 2021, PMID: 33706926; Bartkowska et al., 2022, PMID: 36078144). Also, in Figure 6A it was incorrectly mentioned to be just 1month, we rechecked our metadata and noted that young brains were comprised of 1 and 2 month old brains and now it has been corrected.

      Furthermore, can the authors describe which sex of mice was used in these experiments and the justification if a single sex was used? If both sexes were used, were there any dimorphic differences in POLK localization patterns?

      This is an important aspect, but in the beginning to keep mice numbers within manageable limits, we were focusing more on the age component. While both males and female brains were assayed but due to uneven sample distribution between sexes, we could not estimate if there were any statistically significant sexual dimorphic differences in IN, PN and NNs. Future studies will investigate the sex component as a function of age.

      The suggestion of POLK as a brain aging clock may be a bit premature as the functional and behavioral consequences of cytoplasmic POLK sequestration are not fully known. Furthermore, investigation of POLK levels in other genetic models of neurodegeneration or with gerotherapeutics would be needed to establish if the POLK brain clock is responsive to changes that shift brain aging. Lastly, this clock may be impractical and not useful for longitudinal studies due to the terminal nature of assessing POLK levels.

      We agree as a terminal assay POLK nucleo-cytoplasmic status is not practical for longitudinal studies. However, we believe it may serve an investigative/correlative endogenous signal for determining tissue age, that may be useful to "date" brain sections, since not many such cell biological markers exist. We have added clarification text.

      Some discussion of the Polk-null mice is warranted, as they only have a slightly shortened lifespan, and any disease phenotypes were not reported. This stands in contrast to other DNA repair-deficient mice that mimic premature aging and show behavioral and motor deficits. This calls into question the role of POLK in brain aging.

      Discussion statements on Polk-null mice has been added.

      Please correct the catalog number for the SCBT anti-POLK antibody to sc-166667

      Typographical error has been corrected

      Reviewer #2 (Recommendations for the authors):

      Results:

      Figure by figure 

      (1) A progressive age-associated shift in subcellular localization of POLK The authors state that POLK has not been studied in nervous tissue before and they want to see if it is expressed, and if it changes subcellular location as a function of age. The authors argue age = stress like that seen in previous models using genotoxic agents and cancer cells. Indeed, POLK seems to convincingly change subcellular location from the nucleus to larger cytosolic puncta. 

      (2) Nuclear POLK co-localizes with DNA damage response and repair proteins This was a difficult dataset for me to decipher. To me, it appears as though POLK colocalizes with these examined proteins in the CYTOSOL, not the nucleus. Especially, in the oldest mice.

      We added in the discussion that DNA repair proteins were observed to be present in the cytoplasm and biomolecular condensates citing relevant reviews and primary references.

      (3) POLK in the cytoplasm is associated with stress granules and lysosomes in old brains LAMP1 has some issues as a lysosome marker. The authors even state it can be on endosomes. It would be nice to use a marker for mature lysosomes, some fluorescent reporter that is activated only by lysosomal proteases or pH. It is also of interest if POLK is localized to the membrane or the inside of these structures. The authors have access to an airyscan which is sufficient to examine luminal vs membrane localization on larger organelles like lysosomes.

      We thank the reviewer for pushing us to investigate the nature of cytoplasmic POLK in endo-lysosomal compartments. We have now added a full-page figure on the cell biological results from six different markers, subset (Cathepsin B and D) are known to present in the lumens of endo-lysosomes, in Figure 3. Further high-resolution membrane vs lumen was not pursued, which is perhaps better suited in cultured neurons rather than thick fixed tissues.

      (4) Differentially altered POLK subcellular expression amongst excitatory, inhibitory, and nonneuronal cells in the cortex.

      This seems fine. I don't see anything wrong with the author's statement that there is more POLK in neurons vs non-neuronal cells. 

      (5) Microglia associated with IN and PN have significantly higher levels of cytoplasmic POLK I don't see really any convincing evidence of the author's claim here. They find a difference at early-old age, but not at old-old, or other ages. This is explained by "However, this effect is lost in late-old age (Figure 5D), likely due to the MG-mediated removal of the INs.". But no trend being observed, no experiment to show sufficiency, and no experiment to uncover a directional relationship; this is a tough claim to stand by.

      Changes made in text to reflect speculative nature of this observation

      (6) Subcellular localization of POLK is regulated by neuronal activity

      Interesting and fairly difficult experiment. Can the authors talk more about what these values mean? I am confused as to why there is a decline in nuclear puncta at 80 min. Also, why are POLK counts in 6c similar at baseline between young and early-old? In Figures 5 and 6 I also worry about statistical analysis. Are all assumptions checked to use t-tests? Why not always use a test that has fewer assumptions?

      We have explained in the text the artificial nature of few hour long acute slice preparations is very different and inherently a stressful environment, especially for the old brains, compared to the vascular perfused PFA fixed brain tissues tested between young and old ages.

      We don’t have a proper explanation for the initial dip in nuclear puncta in both young and old brains at 80min of very similar magnitude. It could be a separate biological phenomenon that occurs at much shorter time scales that would not otherwise be captured in a fixed tissue assay and needs careful investigation using live tissue fluorescence imaging that is beyond the scope of this manuscript.

      We apologize for the typographical error in the figure legend. We rechecked our R code and the tests were all Wilcoxon rank-sum (Mann–Whitney U) two-sided nonparametric.

      Figure 6B & E had absurdly small p values due to large sample numbers. So, we implemented random sampling of 100 cells repeating for 200 times and presented the distribution of p values and Cohen’s d in the supplement and reported the median p value and Cohen’s in the main plot.

      (7) POLK as an endogenous "aging clock" for brain tissue

      Trainable model. What are the criteria for the model, and how does it work? The cutoffs it uses to classify each age group might be interesting in that the model may have identified a trait the researchers were unaware of. Otherwise, it is not especially useful. Maybe as an independent 'blind' analysis of the data?

      We have added a better description of the models, assumptions and how two different unsupervised approaches converge on the same set of features with high AUROCs.

      Minor questions:

      The cartoons (1a, 2a-b, 5a, 6a) help a lot. However, I still had to work a bit to understand some of the graphs (e.g., 5d, 6b-e, fig 7). Is there a simpler way to present them? Maybe simply additional labelling? I'm not sure.

      A more thorough discussion of statistical tests is warranted I think. I am not very clear why some were chosen (t-test vs nonparametric with fewer assumptions). Infinitesimally small p values also make me think maybe incorrect tests were done or no power analysis was performed beforehand. A fix for this is just discussing what went into the testing methods and why they were chosen.

      Statistical analysis for Fig2 (using Generalized Estimating Equations), and Fig6 (with random repeated subsampling; method explained in text, figure legend updated and supplementary data on the distribution of p values and cohen’s d are added) to address the very small p values. Descriptions rewritten in relevant text.

      In the absence of further mechanistic experiments, it would still be interesting to hear what the authors think is going on and what the significance of this altered subcellular location means. How do the authors think this is occurring? I think they are arguing that cytosolic localization of POLK is 100% detrimental to the neuron. ("The reduction of nuclear POLK in old brains is congruent with an increase in DNA damage markers") Do they have any idea what the 'bug' is in the POLK system then?

      Statements in the discussion has been added.

      Reviewer #3 (Recommendations for the authors):

      POLK is detected as small " as small "speckles" inside the nucleus at a young age (1-2 months) and larger "granules" can be seen in the cytoplasm at progressively older time points (>9 months). In the nucleus, is POLK bound to DNA? In the cytoplasm, how are the POLK molecules organized: are they bound to a substrate or are they just organized as a proteins condensate without DNA?

      In human U2OS cell line Dnase1 treatment leads to loss of POLK from the nucleus as well as its activity as reported in Fig5 of Paul, S. et. al. 2023 bioRxiv. While we haven’t reproduced these results in mouse primary neurons, we anticipate a similar situation which will be tested in the future. We have addressed limited aspects of the POLK in the cytoplasm in all new Fig3 with six endo-lysosomal markers, and added text.

      When POLK proteins accumulate in the cytoplasm in aging cells, do they also repair condensates in the cytoplasm? What is the function of cytoplasmic POLK granules? More generally, is it known if other granules or foci, such as repair foci are found in the cytoplasms in aging cells, or in cells under stress?

      Six markers for endo-lysosomes were tested to characterize the cytoplasmic granules now shown in Fig3.

      While the authors quantify the number and sizes of the POLK signal, they don't discuss their physical nature. Some membrane-less condensates exhibit liquid-like properties, such as stress granules, P-bodies, or in the nucleus some repair condensates. In some diseased tissues, some condensates lose their liquid properties and become solid-like. Is it known if POLK condensates behave like liquid condensates or they are simply formed by bound molecules on DNA? Since they are larger and fewer in the cytoplasm, is it because several small puncta fused together to form a larger one? It would be worthwhile to discuss these points.

      Discussion statements on the nature of condensates in context of the POLK cytoplasmic signal has been added.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      We thank the reviewer for great suggestions.

      (1) The X-axis labels in some panels in Figure 2C and Supplementary Figure 2B overlap, making them difficult to read. Adjusting the label spacing or formatting would improve clarity.

      We thank the reviewer for the comment. All panels including Figure 2C and Supplementary Figure 2B, have now been organized the way in which X-axis labels are easily read.

      (2) In the scatter dot plot bar diagrams, it appears that n=3 for most of the data. Does this represent the number of mice used or the number of tissue sections per sample? This should be clarified in the figure legends for better transparency. 

      Great suggestion. In Results (page 7, lines 135-136), we now clarified that quantification was performed on every tenth section of the brain from 3 female and 3 male mice. Additionally, in the legends for scatter dot plot bar diagrams we also mentioned that n=3 represents the number of mice used.

      (3) In Supplemental Figure 2B, the positive signals are not clearly visible. Providing higher-magnification images is recommended.

      Great suggestion. The revised Supplemental Figure 2B, but also Figure 2A, now provide higher magnification inset images with distinctive positive signals.

      Reviewer #2:

      We thank the reviewer for great and critical suggestions.

      (1) Introduction:

      Line 58: References should be provided for this statement as it is based on a robust field of research, not on a new concept.

      We thank the reviewer for the comment. We have now included relevant references as suggested (page 4, line 58).

      (2) Line 100-102: This sentence seems to make new, an idea that has been well-documented since the late 1970s. Posterior pituitary hormones oxytocin and vasopressin have long been known to have multiple peripheral targets, and at least a subset of vasopressin and oxytocin neurons have robust central projections. The central targets have been the focus of study for numerous labs. Reference 34 does not relate to posterior pituitary hormones and seems mis-cited.

      We have changed this sentence, excluded the reference that does not relate to posterior pituitary hormones and added 4 further references reporting other non-traditional roles of vasopressin and oxytocin (page 6, lines 100-102).

      (3) Lines 102-108: While the regulation of bone is an interesting example of an under-appreciated impact of vasopressin, the example does not build to the rationale for examining central Avp and Avpr1a expression.

      We mean no disrespect here, but we have recently reported neural brain-bone connections using the SNS-specific PRV152 virus (Ryu et al., 2024; PMID: 38963696) and submitted Single Transcript Level Atlas of Oxytocin and the Oxytocin Receptor in the Mouse Brain (doi: https://doi.org/10.1101/2024.02.15.580498). Surprisingly, we detected Avpr1a and Oxtr expression in certain brain areas (for example, PVH and MPOM) that connect to both bone and adipose tissue through the SNS—raising an important question regarding a central role of Avpr1a and Oxtr in bodily mass and fat regulation. 

      (4) Line 111: Avp expression and Avpr1a expression have both been studied using in situ hybridization. Thus, the overall concept is less novel than hinted at in the text. Avp expression has been studied quite extensively. Avpr1a expression has not been studied in an exhaustive fashion. 

      We thank the reviewer for this comment and absolutely agree that brain AVP expression has been studied extensively. As with the Avpr, we believe that RNAscope probe design and signal amplification system employed in our study allow for more specific and sensitive detection of individual RNA targets at the single transcript level with much cleaner background noise comparing to in situ hybridization method. 

      (5) Results:

      Line 143: RNAscope is indeed a powerful method of detecting mRNA at the single transcript level. However, using that single transcript resolution only to provide transcript per brain region analysis, losing all of the nuance of the individual transcript expression, seems like a poor use of the method potential.

      This is a good point and we did notice that Avpr1a transcript expression in several brain nuclei displayed individual pattern of expression versus more ubiquitous expression in most of the other brain areas. We noted this finding in Results (page 9, lines 164-168); however, because of the word limits in Discussion, we are not sure what would be dropped to make more room and whether this is truly necessary.

      (6 &7) Line 135: Sections were coded from 3 males and 3 females. I would argue that there is not enough statistical power to make inferences regarding sex differences or regional differences. In fact, the authors did not provide any statistical analysis in the manuscript at all, even though they stated they had completed statistical tests on the methods.

      150-157: All statements regarding sex differences in expression are made without statistical analyses, which, if conducted, would be underpowered. Given the limitations of performing and analyzing RNAscope data en masse a low n is understandable, but it requires a much more precise description of the data and a more careful look at how the results can be interpreted.

      We thank the reviewer for these comments. We mean no disrespect here, but while statistical analysis for main brain regions is relevant, it is not meaningful as far as nuclei, sub-nuclei and regions are concerned. It is noteworthy to mention that RNAscope data analysis in the whole mouse brain is an extremely drawn-out process requiring almost 2 months to conduct exhaustive manual counting of single Avpr1a transcripts in a single mouse brain—authors analyzed 6 brains. That said, statistical tests have been performed and exact P values are now shown in graphs.

      (8) Line 146: I am flagging this instance, but it should be corrected everywhere it occurs. Since we cannot know the gender of a given mouse, I would recommend referring to the mouse's "sex" rather than its "gender."

      Good suggestion. We made adequate changes throughout the manuscript.

      (9) Line 153: The authors switch to discussing cell numbers. Why is this data relegated to the supplemental material?

      Main figures in the manuscript report Avp and Avpr1a transcript density which has more important biological significance in terms of signal efficiency and cellular response dynamics. Due to the graph abundancy in the main text, we included all graphs with Avp and Avpr1a transcript counts in the supplemental material.

      (10) Methods:

      Line 369: "For simplicity and clarity, exact test results and exact P values are not presented." Simplicity or clarity is not a scientific rationale not to provide accurate statistics.

      We now provide exact P values in the graphs and the sentence in line 369 has been corrected accordingly (page 18, lines 379-380).

      (11) Line 362: The description of how data were analyzed is inadequate. More detail is needed.

      Agreed. We now included a detailed description on how data was analyzed (page 18, lines 365-374).

      (12) Discussion:

      Line 321: "This contrasts the rudimentary attribution of a single function per brain area." While brain function is often taught in such rudimentary terms to make the information palatable to students, I do not think the scientific literature on vasopressin function published over the past 50 years would suggest that we are so naïve in interpreting the functional role of vasopressin in the brain. Clearly, vasopressin is involved in numerous brain functions that likely cross behavioral modalities.

      Agreed and we removed this sentence.

      (13) Line 322: "The approach of direct mapping of receptor expression in the brain and periphery provides the groundwork." On its face, this statement is true, but the present data build on the groundwork laid by others (multiple papers from Ostrowski et al. in the early 1990s).

      Agreed.

      (14) Figures:

      Figure 1: 1B, I do not know the purpose of creating graphs with single bars (3V, ic, pir-male, and pir-female); there are no comparisons made in the graph. In the graphs with many brain regions, very little data can be effectively represented with the scale as it is. I recommend using tables to provide the count/density data and making graphs of only the most robust areas. In addition, although there is no statistical comparison, combining males and females in the same graphs might be beneficial to make a visual comparison easier. Why were cell counts only included in the supplemental material? Is that data not relevant?

      We thank the reviewer for this comment. Now all figures are presented in a more effective and aesthetically pleasing way.

      (15) There is a real missed opportunity to highlight some of the findings. For example, cell counts and density measures are provided for regions in the hippocampus, thalamus, and cortex that are not typically reported to contain vasopressin-expressing cells. Photomicrographs of these locations showing the RNAscope staining would be far more impactful in reporting these data. Are there cells expressing Avp, or is the Avp mRNA in these areas contained in fibers projecting to these areas from hypothalamic and forebrain sources?

      Great suggestion. We now see in Figure 1D showing novel Avp transcript expression in the hippocampus, thalamus and cortex. Based on counterstained hematoxylin staining, Avp mRNA transcripts were found in somata.

      (16) Figure 1C legend suggests images of the hippocampus and cortex, but all images are from the hypothalamus. Abbreviations are not defined.

      Thank you for the comment. We corrected Figure 1C legend and separately included Figure 1D showing novel Avp mRNA expression in the hippocampus and cortex.

      (17) Figure 2: The analysis of Avpr1a suffers from some of the same issues as the Avp analysis. In Figure 2A, the photomicrographs do not do a very good job of illustrating representative staining. The central canal image does not appear to have any obvious puncta, but the density of Avpr1a puncta suggests something different. The sex difference in the arcuate is also not clearly apparent in representative images. There is minimal visualization of the data for a project that depends so heavily on the appearance of puncta in tissue, coupled with the lack of clarity in the images provided, greatly diminished the overall enthusiasm for the data presentation. The figures in 2C would be more useful as tables with graphs used to highlight specific regions; as is, most of the data points are lost against the graph axis. Photomicrographs would also provide a better understanding of the data than graphs.

      Great suggestion. The revised Figure 2A but also Supplemental Figure 2B now provide higher magnification inset images with distinctive positive signals. As with Figures 2C, we arranged all graphs in a more effective and aesthetically pleasing manner.

      (18) Figure 3: Given the low number of animals and, therefore, low statistical power, I do not think that illustrating the ratios of male to female is a statistically valid comparison.

      Please see response to Point 6 & Point 7.

      (19) Figure 4: Pituitary is an interesting choice to analyze. However, why was only the posterior pituitary analyzed? Were Avp transcripts contained in terminals of vasopressin neuron axons or other cells? Was Avpr1a transcript present in blood vessel cells where Avp is released? A different cell type? Why not examine the anterior pituitary, which also expresses Avp receptors (although the literature suggests largely Avpr1b)?

      Thank you for the great comment. We included only posterior pituitary because there were no positive Avp/Avpr1a transcripts found in the anterior pituitary. Unfortunately, we have not performed cell type-specific staining, which would have enabled greater variation in AVP and its receptor expression across various cell types.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The manuscript titled, "Sleep-Wake Transitions Are Impaired in the AppNL-G-F Mouse Model of Early Onset Alzheimer's Disease", is about a study of sleep/wake phenomena in a knockin mouse strain carrying "three mutations in the human App gene associated with elevated risk for early onset AD". Traditional, in-depth characterization of sleep/wake states, EEG parameters, and response to sleep loss are employed to provide evidence, "supporting the use of this strain as a model to investigate interventions that mitigate AD burden during early disease stages". The sleep/wake findings of earlier studies (especially Maezono et al., 2020, as noted by the authors) were extended by several important, genotype-related observations, including age-related hyperactivity onset that is typically associated with increased arousal, a normal response to loss of sleep and to multiple sleep latency testing, and a stronger AD-like phenotype in females. The authors conclude that the AppNL-G-F mice demonstrate many of the human AD prodromal symptoms and suggest that this strain may serve as a model for prodromal AD in humans, confirming the earlier results and conclusions of Maezono et al. Finally, based on state bout frequency and duration analyses, it is suggested that the AppNL-G-F mice may develop disruptions in mechanism(s) involved in state transition.

      Strengths:

      The study appears to have been, technically, rigorously conducted with high quality, in-depth traditional assessment of both state and EEG characteristics, with the concordant addition of activity and temperature. The major strengths of this study derive from observations that the AppNL-G-F mice: (1) are more hyperactive in association with decreased transitions between states; (2) maintain a normal response to sleep deprivation and have normal MSLT results; and (3) display a sex specific, "stronger" insomnia-like effect of the knockin in females.

      Weaknesses:

      The weaknesses stem from the study's impact being limited due to its being largely confirmatory of the Maezono et al. study, with advances of importance to a potentially more focused field. Further, the authors conclude that AppNL-G-F mice have disrupted mechanism(s) responsible for state transition; however, these were not directly examined. The rationale for this conclusion is stated by the authors as based on the observations that bouts of both W and NREM tend to be longer in duration and decreased in frequency in AppNL-G-F mice. Although altered mechanism(s) of state transition (it is not clear what mechanisms are referenced here) cannot be ruled out, other explanations might be considered. For example, increased arousal in association with hyperactivity would be expected to result in increased duration of W bouts during the active phase. This would also predictably result in greater sleep pressure that is typically associated with more consolidated NREM bouts, consistent with the observations of bout duration and frequency.

      Reviewer 1 succinctly summarizes the advances of this study beyond the ground-breaking Maezono et al (2020) study of this “humanized” mouse model exhibiting amyloid deposition. Whereas Maezono et al. conducted sleep/wake studies on male App<sup>NL-G-F</sup> mice at 6 and 12 months of age, we had the unusual opportunity to study both sexes of homozygous App<sup>NL-G-F</sup> mice and WT littermates at 14-18 months of age and to conduct a longitudinal assessment of many of the same individuals at 18-22 months. In addition to baseline sleep/wake and EEG spectral analyses, we (1) measured subcutaneous body temperature and activity to obtain a broader picture of the physiology and behavior of this strain at advanced ages; (2) assessed baseline sleepiness in this strain using the murine version of the clinically-relevant Multiple Sleep Latency Test (MSLT); (3) evaluated the response of App<sup>NL-G-F</sup> mice and WT littermates to a perturbation of the sleep homeostat; (4) compared the sleep/wake characteristics of male vs. female App<sup>NL-G-F</sup> mice at 18-22 months and, (5) to assess the stability of the phenotypes, analyzed these data over a continuous 14-d recording rather than the conventional 24h recordings typical of most sleep/wake studies including Maezono et al. We found that a long wake/short sleep phenotype was characteristic of homozygous App<sup>NL-G-F</sup> mice at these advanced ages which is also evident in the Maezono et al. (2020) study at 12 months of age (but not at 6 months), although the authors do not comment on this phenotype and instead focus on the reduced REM sleep which is particularly evident in female App<sup>NL-G-F</sup> mice in our study. Remarkably, despite being awake ~20% longer per day, we find that App<sup>NL-G-F</sup> mice are no sleepier than WT mice as determined by the MSLT and that their sleep homeostat is intact when challenged by 6-h sleep deprivation. At both advanced ages, the long wake/short sleep phenotype is due primarily to longer Wake bouts and shorter bouts of both NREM and REM sleep during the dark phase. Moreover, hyperactivity develops in older in App<sup>NL-G-F</sup> mice, particularly females, which contributes to this phenotype. We agree with Reviewer 1 that “hyperactivity would be expected to result in increased duration of W bouts during the active phase” and that this could result in more consolidated NREM bouts and we will modify the manuscript to discuss this alternative. However, the suggestion of greater sleep pressure is not borne out by the MSLT studies as we did not observe the shorter sleep latencies and increased sleep during the nap opportunities on the MSLT that we have observed in other mouse strains. Moreover, due to their short sleep phenotype, App<sup>NL-G-F</sup> mice would be entering the sleep deprivation study with a greater sleep debt than WT mice, yet we did not observe greater EEG Slow Wave Activity in this strain during recovery from sleep deprivation. Thus, we have suggested that App<sup>NL-G-F</sup> mice are unable to transition from Wake to sleep as readily as their WT littermates. Our observations summarized above set the stage for subsequent mechanistic studies in aged App<sup>NL-G-F</sup> mice, although realistically, mice of this age and genotype are a rare commodity.

      Reviewer #2 (Public review):

      Summary:

      The authors have used a knock-in mouse model to explore late-in-life amyloid effects on sleep. This is an excellent model as the mutated genes are regulated by the endogenous promoter system. The sleep study techniques and statistical analyses are also first-rate.

      The group finds an age-dependent increase in motor activity in advanced age in the NLGF homozygous knock-in mice (NLGF), with a parallel age-dependent increase in body temperature, both effects predominate in the dark period. Interestingly, the sleep patterns do not quite follow the sleep changes. Wake time is increased in NLGF mice, and there is no progression in increased wake over time. NREMS and REM sleep are both reduced, and there is no progression. Sleep-wake effects, however, show a robust light:dark effect with larger effects in the dark period. These findings support distinct effects of this mutation on activity and temperature and on sleep. This is the first description of the temporal pattern of these effects. NLGF mice show wake stability (longer bout durations in the dark period (their active period) and fewer brief arousals from sleep. Sleep homeostasis across the lights-on period is normal. Wake power spectral density is unaffected in NLGF mice at either age. Only REM power spectra are affected, with NLGF mice showing less theta and more delta. There are interesting sex differences, with females showing no gene difference in wake bout number, while males show a gene effect. Similarly, gene effects on NREM bout number seem larger in males than in females. Although there was no difference in homeostatic response, there was normalization of sleep-wake activity after sleep deprivation.

      Strengths:

      Approach (model extent of sleep phenotyping), analysis.

      Weaknesses:

      The weaknesses are summarized below and are viewed as "addressable".

      (1) The term insomnia. Insomnia is defined as a subjective dissatisfaction with sleep, which cannot be ascertained in a mouse model. The findings across baseline sleep in NLGF mice support increased wake consolidation in the active period. The predominant sleep period (lights on) is largely unaffected, and the active period (lights off) shows increased activity and increased wake with longer bouts. There is a fantastic clue where NLGF effects are consistent with increased hypocretinergic (orexinergic) neuron activity in the dark period, and/or increased drive to hypocretin neurons from PVH.

      (2) Sleep-wake transitions are impaired: This should not be termed an impairment. It could actually be beneficial to have greater state stability, especially wake stability in the dark or active period. There is reduced sleep in the model that can be normalized by short-term sleep loss. It is fascinating that recovery sleep normalized sleep in the NLGF in the immediate lights-on and light-off period. This is a key finding.

      Reviewer 2 suggests a provocative hypothesis to test. Curiously, although a recent Science paper suggests that hyperexcitable hypocretin/orexin neurons in aging mice results in greater sleep/wake fragmentation, hyperexcitability of this system could result in hyperactivity and longer wake bouts in aged App<sup>NL-G-F</sup> mice.

      Reviewer #3 (Public review):

      Summary:

      In this study, Tisdale et al. studied the sleep/wake patterns in the biological mouse model of Alzheimer's disease. The results in this study, together with the established literature on the relationship of sleep and Alzheimer's disease progression, guided the authors to propose this mouse model for the mechanistic understanding of sleep states that translates to Alzheimer's disease patients. However, the manuscript currently suffers from a disconnect between the physiological data and the mechanistic interpretations. Specifically, the claim of "impaired transitions" is logically at odds with the observed increase in wake-state stability or possible hyperactivity. Additionally, the description of the methods, the quantification, and the figure presentation could be substantially improved. I detail some of my concerns below.

      Strengths:

      The selection of the knock-in model is a notable strength as it avoids the artifacts associated with APP overexpression and more closely mimics human pathology. The study utilizes continuous 14-day EEG recordings, providing a unique dataset for assessing chronic changes in arousal states. The assessment of sex as a biological variable identifies a more severe "insomniac-like" phenotype in females, which aligns with the higher prevalence and severity of Alzheimer's disease in women.

      Weaknesses:

      The study seems to lack a clear hypothesis-driven approach and relies mostly on explorative investigations. Moreover, lack of quantitative analytical methods as well as shaky logical conclusions, possibly not supported by data in its current form, leaves room for major improvement.

      Since this paper studied sleep states, the "Methods" section is quite unclear on what specific criteria were used to classify sleep states. There is no quantitative description of classifying sleep based on clear, reproducible procedures. There are many reasonably well-characterized sleep scoring systems used in rat electrophysiological literature, which could be useful here. The authors are generally expected to describe movement speed and/or EMG and/or EEG (theta/delta/gamma) criteria used to classify these epochs. The subjective (manual) nature of this procedure provides no verifiable validation of the accuracy and interpretability of the results.

      One of the bigger claims is that "state transition mechanism(s)" are impaired. However, Figure 7 shows that model mice exhibit significantly more long wake bouts (>260s) and fewer short wake bouts (<60s). Logically, an "impaired switch" (the flip-flop model, Saper et al., 2010) results in state fragmentation. The data here show the opposite: the wake state has become too stable. This suggests the primary defect is not in the transition mechanism itself, but possibly in a pathological increase in arousal drive (hyper-arousal), likely linked to the dark-phase hyperactivity shown in Figures 4 and 5. Also, a point to note is that this finding is not new.

      Figure 3 heatmaps lack color bars and units. Spectral power must be quantitatively defined and methods well-explained in the Methods section. Without these, the reader cannot discern if the "reduced power" in females is a global suppression of signal or a frequency-specific shift. Additionally, the representative example used to claim shorter sleep bouts lacks the statistical weight required for a major physiological conclusion. How does a cooler color (not clear what range and what the interpretation is) mean shorter sleep bout in female mice? The authors should clearly mark the frequency ranges that support their claims. In this figure, there is a question mark following the theta/delta range. The authors should avoid speculation and state their claims based on facts. They should also add the theta and delta ranges in the plot, such that readers can draw their own conclusions.

      Figure 8 and the MSLT results show that model mice are "no sleepier than WT mice" and have a functional homeostatic rebound. This presents a logical flaw in the "insomnia" narrative. True insomnia in AD patients typically involves a failure of the homeostatic process or a debilitating accumulation of sleep debt. If these mice do not show increased sleepiness (shorter latency) despite ~19% less sleep, the authors might be describing a "reduced need" for sleep or a "hyper-aroused" state, possibly not a clinical insomnia phenotype.

      In Figure 9, LFP power shown and compared in percentages is problematic, as LFP power distribution is known to be skewed (follows power law). This is particularly problematic here because all the frequencies above ~20 Hz seem to be totally flattened or nonexistent, which makes this comparison of power severely limited and biased towards the relative frequency in the highly skewed portion of the LFP power spectrum, i.e., very low frequency ranges like delta, theta, and possibly beta. This ignores low, mid, and high gamma as well as ripple band frequencies. NREM sleep is known to have relatively greater ripple band (100-250 Hz) power bursts in hippocampal regions, and REM sleep is known to have synchronous theta-gamma relationships.

      We agree with the reviewer that the “Classification of arousal states” section was missing the key description of how we scored the recordings into arousal states based on EEG, EMG and locomotor activity; this was an oversight as the corresponding text exists in all our previous sleep/wake studies published over several decades. Reviewer 1 also points out the alternative interpretation that “the wake state has become too stable.” However, I think we are using different words to say the same thing: that the transition from wake to sleep is impaired whether it is due to hyperarousal or to a defect in the flip/flop switch that results in greater Wake stability. We will revise Fig 3 (Reviewer 2 suggests combining with Fig 14) but note that the X-axis is labelled 0-25 Hz and that this figure was intended to be descriptive -- illustrating how unusual the female App<sup>NL-G-F</sup> mice are relative to WT -- rather than a quantitative analysis of spectral power as in Fig. 14. Both Reviewer 2 and 3 suggest that we are using “insomnia” incorrectly, which we have simply used to describe less sleep per 24h period. Reviewer 2 states that “Insomnia is defined as a subjective dissatisfaction with sleep” and Reviewer 3 suggests a narrow definition of insomnia as due only to “a failure of the homeostatic process or a debilitating accumulation of sleep debt.” In a revised manuscript, we will define “insomnia” as an operational term to succinctly mean “less sleep”. Regarding the problem of presenting spectral power in percentages, we completely agree with the reviewer. However, we intentionally presented spectral power density, a measure of relative power, as in Figure 3A and 3B of Maezono et al. (2020). At the risk of making Fig. 9 even more busy, we will revise Fig. 9 to add labels for all Y-axes.

      In addition to a revised Fig. 9, in the revised manuscript, we will reformat Tables 1-3, Figs. S1 and S2 for legibility and correct an error in Fig. 7.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study addresses an important clinical challenge by proposing muscle network analysis as a tool to evaluate rehabilitation outcomes. The research direction is relevant, and the findings suggest further research. The strength of evidence supporting the claims is, however, limited: the improvements in function are not directly demonstrated, the robustness of the method is not benchmarked against already published approaches, and key terminology is not clearly defined, which reduces the clarity and impact of the work.

      Comments:

      There are several aspects of the current work that require clarification and improvement, both from a methodological and a conceptual standpoint.

      First, the actual improvements associated with the rehabilitation protocol remain unclear. While the authors report certain quantitative metrics, the study lacks more direct evidence of functional gains. Typically, rehabilitation interventions are strengthened by complementary material (e.g., videos or case examples) that clearly demonstrate improvements in activities of daily living. Including such evidence would make the findings more compelling.

      We thank the reviewer for their careful consideration of our work. We agree that direct evidence for the functional gains achieved by patients is important for establishing the efficacy of a clinical intervention and that this evidence should provide comprehensive insights for clinicians, from videos to case examples as suggested. Our aim here was apply a novel computational framework to a cohort of patients undergoing rehabilitation, and in doing so, provide empirical support for its utility in standardised motor assessments. We have shown that our novel approach can identify distinct physiological responses to VR vs PT conditions across the post-stroke cohort (see Fig.2B and associated text). Hence, although the data contains virtual reality vs. conventional physical therapy experimental conditions which likely holds important insights into the clinical use case of virtual reality interventions, we did not focus on such complementary evidence in this study. In future work, research groups (including our own) investigating the important question of clinical intervention efficacy will likely gain unique and useful mechanistic insights using our approach.

      Moreover, a threshold of 5 points at the FMA-UE was considered as MCID, to distinguish between responder and non-responder patients, which represents an acknowledged and applicable measure in the clinical field. The use of single cases represents low evidence of change from the perspective of expert clinicians, raising concerns on the clinical meaningful of reported results. All this given, we chose to provide stronger evidence of clinical effect (i.e. comparison between responders and non-responders) interpreted from the perspective of muscle synergies, than to support our results in single selected cases, representing a bias in terms of translation to population of people survived to a stroke.

      Second, the claim that the proposed muscle network analysis is robust is not sufficiently substantiated. The method is introduced without adequate reference to, or comparison with, the extensive literature that has proposed alternative metrics. It is also not evident whether a simpler analysis (e.g., EMG amplitude) might produce similar results. To highlight the added value of the proposed method, it would be important to benchmark it against established approaches. This would help clarify its specific advantages and potential applications. Moreover, several studies have shown very good outcomes when using AI and latent manifold analyses in patients with neural lesions. Interpreting the latent space appears even easier than interpreting muscle networks, as the manifolds provide a simple encoding-decoding representation of what the patient can still perform and what they can no longer do.

      To address the reviewers concerns regarding adequate evidence for the claims made about the presented framework, we have now included an application of the conventional muscle synergy analysis approach based on non-negative matrix factorisation to the post-stroke cohort (see Supplementary materials Fig.5 and associated text). We made efforts to make this comparison as fair as possible by applying the conventional approach at the population level also and clustering the activation coefficients using a similar yet more conventional approach, agglomerative clustering. Accompanying the output of this application, we have included several points of where our framework improves significantly upon conventional muscle synergy analysis:

      “Comparison with conventional approaches

      To more directly illustrate the advantages of the proposed framework, we carried out a standardised pre-processing of the EMG data in line with conventional muscle synergy analysis. This included rectification, low-pass filtration (cut-off: 20Hz) and smooth resampling of EMG waveforms to 50 timepoints. All data for each participant at each session was separately normalised by channel-wise variance, concatenated together and input into non-negative matrix factorisation (NMF) ('nnmf' Matlab function, 10 replications) to extract 11 muscle synergies (W1-11 of Supplementary Materials Fig.5(Left)) and their time-varying activations. The number of components to extract was determined in a conventional way as the number of components required to explain >75% of the data variance. The extracted muscle synergies included distinct shoulder- (e.g. W2), elbow (e.g. W8) and forearm-level (e.g. W1) muscle covariation patterns along with more isolated muscle contributions (e.g. UT in W3, TL in W10).

      Regarding the clustering results of our framework and how they compare to conventional approaches, to facilitate this comparison we applied agglomerative clustering to the time-varying activation coefficients of all participants, trials, tasks separately for pre- and post-sessions and employed the 'evalclusters' Matlab function (Ward linkage clustering, Calinski Harabasz criterion, Klist search = 2:21) for each session. We identified two clusters both at pre-session (Criterion = 1.69) and post-session (Criterion = 1.81) as optimal fits to the population data (see Supplementary Materials Fig.5(Right)). We found no associations between pre- or post-session cluster partitions and participants FMA-UE scores. Nevertheless, we did identify significant associations between the pre-session clustering’s and S_Pre (X<sup>2</sup> = 7.08, p = 0.008) and between post-session clustering’s and conventionally-defined treatment responders (X<sup>2</sup> = 4.2, p = 0.04). These findings, along with the similar two-way clustering structure found using the NIF, highlights important commonalities between these approaches.

      To summarise the main advantages of our framework over this conventional approach:

      - Lower dimensionality and enhanced interpretability of extracted components.

      Our framework yields a lower number of population-level components that correspond more consistently to meaningful biomechanical and physiological functions.

      - Integration of pairwise muscle relationships.

      By incorporating muscle-pair level analysis, our framework captures coordinated interactions between primary and stabilising muscles—relationships that conventional NMF approaches overlook.

      - Separation of task-relevant and task-irrelevant activity.

      The NIF isolates task-relevant coordination patterns, distinguishing them from task-irrelevant interactions driven by biomechanical or task constraints. On the other hand, task-relevant and -irrelevant muscle contributions are intermixed in conventional muscle synergy analysis.

      - Ability to identify complementary functional roles.

      The NIF characterises whether muscle pairs act in similar or complementary ways, providing richer insight into motor control strategies.

      - Reduced dependence on variance-based optimisation.

      Unlike conventional methods that rely on maximising variance explained, our framework allows detection of subtle but functionally significant interactions that contribute less to total variance.

      - Improved detection of clinically relevant population structure.

      The clustering component of our framework revealed distinct post-stroke subgroups with important clinical relevance, distinguishing moderately and severely impaired cohorts and treatment responders and non-responders from pre-treatment data.”

      This supplementary analysis is referred to in the Methods section of the main text with reference to previous similar comparisons between our framework and conventional approaches:

      “Towards finding an effective approach to clustering participants in this data based on differences in impairment severity and therapeutic (non-)responsiveness, we found that conventional clustering algorithms (e.g. agglomerative, k-means etc.) could not provide substantive outputs (see Supplementary Materials Fig.5 and associated text for a direct comparison with conventional approaches), perhaps resulting from the complex interdependencies between the modular activations.”

      “To facilitate comparisons with existing approaches, we performed a conventional muscle synergy analysis on the post-stroke cohort (see Supplementary Materials Fig.5 and associated text). Further comparisons with conventional approaches can be found in our previous work (O’Reilly & Delis, 2022).”

      Further, we have also referred to a previous analysis of this post-stroke dataset using the conventional approach in the discussion section, where we point out how our approach can identify salient features of post-stroke physiological responses that conventional approaches cannot:

      “Further, the NIF demonstrated here an enhanced capability over traditional approaches to identify these crucial patterns, as earlier work on related versions of this dataset could not identify any differentiable fractionation events across the cohort (Pregnolato et al., 2025).”

      Overall, the utility of conventional muscle synergy analysis is well recognised across the field (Hong et al 2021). Our proposed approach builds on this conventional method by addressing key limitations to further enhance this clinical utility. We also agree that manifold learning approaches are an exciting area of research that we aim to incorporate into our framework in future research. Specifically, manifold learning methods like Laplacian eigenmaps can readily be applied to the co-membership matrix produced by our clustering algorithm, exploiting the geometry of this matrix to provide a continuous rather than discrete representation of population structure. We have highlighted this possibility in the discussion section:

      “Indeed, in future work, we aim to apply manifold learning approaches to the co-membership matrix derived from this clustering algorithm, providing a continuous representation of the population structure.”

      Third, the terminology used throughout the manuscript is sometimes ambiguous. A key example is the distinction made between "functional" and "redundant" synergies. The abstract states: "Notably, we identified a shift from redundancy to synergy in muscle coordination as a hallmark of effective rehabilitation-a transformation supported by a more precise quantification of treatment outcomes."

      However, in motor control research, redundancy is not typically seen as maladaptive. Rather, it is a fundamental property of the CNS, allowing the same motor task to be achieved through different patterns of muscle activity (e.g., alternative motor unit recruitment strategies). This redundancy provides flexibility and robustness, particularly under fatiguing conditions, where new synergies often emerge. Several studies have emphasized this adaptive role of redundancy. Thus, if the authors intend to use "redundancy" differently, it is essential to define the term explicitly and justify its use to avoid misinterpretation.

      We appreciate the reviewers concerns regarding the terminology employed in this study. Indeed, we agree that redundancy is seen in the motor control literature as a positive feature of biological systems, appearing to contradict the interpretations of the redundancy-to-synergy information conversion result we have presented. We also wish to highlight that across the motor control literature and beyond, the idea of redundancy is often conflated with the related but distinct notion of degeneracy. Traditional motor control research has also recognised this difference, for example, Latash has outlined this difference in the seminal work on motor abundance (https://doi.org/10.1007/s00221-012-3000-4). A key reference discussing this conflation and these two concepts in an information-theoretic way is found here: https://doi.org/10.1093/cercor/bhaa148. To summarise what their arguments mean for our work:

      - System degeneracy relates to the ability of different system components to contribute towards the same task in a context-specific way.

      - System redundancy corresponds to the degree of functional overlap among system components.

      Hence, conceptually speaking, informational redundancy as employed in our study (i.e. functionally-similar muscle interactions) links with system redundancy in that it quantifies the functional overlap of system components. This definition of system redundancy implies that it is an unavoidable by-product of degenerate systems (inefficient use of degrees of freedom) which should be minimised where possible. As a result of stroke, in our study and related previous work patients displayed increased informational redundancy, linking with the abnormal co-activations they typically experience for example and with previous results from traditional muscle synergy analysis showing fewer components extracted as a function of motor impairment post-stroke (i.e. higher informational redundancy) (Clark et al. 2010). Our novel contribution here is to convey how effective rehabilitation is underpinned by a redundancy-to-synergy information conversion across the muscle networks, relating in a loose sense conceptually to a reduction in system redundancy and enhancement of system degeneracy (i.e. functionally differentiated system components contributing towards task performance).

      Together, and alongside the mathematical descriptions of redundant (functionally-similar) and synergistic (functionally-complementary) information in what types of functional relationships they capture, we believe the intuition behind this finding has clear links with previous research showing a) the merging of muscle synergies in response to post-stroke impairment (i.e. functional de-differentiation), b) reduction in abnormal couplings with effective rehabilitation (i.e. functional re-differentiation). To communicate this more clearly to readers, we have included the following in the corresponding discussion section:

      “Previous research has shown that functional redundancy increases post-stroke (Cheung et al., 2012; Clark et al., 2010), reflecting the characteristic loss of functional specificity (i.e. functional de-differentiation) of muscle interactions post-stroke. Enhanced synergy with treatment here thus reflects the functional re-differentiation of predominantly flexor-driven muscle networks towards different, complementary task-objectives across the seven upper-limb motor tasks performed (Kim et al., 2024b), leading to improved motor function among responders.”

      Finally, we have screened the updated manuscript for consistent use of terminology including functional/redundant/synergistic.

      References

      Clark DJ, Ting LH, Zajac FE, Neptune RR, Kautz SA. Merging of healthy motor modules predicts reduced locomotor performance and muscle coordination complexity post-stroke. Journal of neurophysiology. 2010 Feb;103(2):844-57.

      Hong YN, Ballekere AN, Fregly BJ, Roh J. Are muscle synergies useful for stroke rehabilitation?. Current Opinion in Biomedical Engineering. 2021 Sep 1;19:100315.

      Latash ML. The bliss (not the problem) of motor abundance (not redundancy). Experimental brain research. 2012 Mar;217(1):1-5.

      O'Reilly D, Delis I. Dissecting muscle synergies in the task space. Elife. 2024 Feb 26;12:RP87651.

      Sajid N, Parr T, Hope TM, Price CJ, Friston KJ. Degeneracy and redundancy in active inference. Cerebral Cortex. 2020 Nov;30(11):5750-66.

      Reviewer #2 (Public review):

      Summary:

      This study analyzes muscle interactions in post-stroke patients undergoing rehabilitation, using information-theoretic and network analysis tools applied to sEMG signals with task performance measurements. The authors identified patterns of muscle interaction that correlate well with therapeutic measures and could potentially be used to stratify patients and better evaluate the effectiveness of rehabilitation.

      However, I found that the Methods and Materials section, as it stands, lacks sufficient detail and clarity for me to fully understand and evaluate the quality of the method. Below, I outline my main points of concern, which I hope the authors will address in a revision to improve the quality of the Methods section. I would also like to note that the methods appear to be largely based on a previous paper by the authors (O'Reilly & Delis, 2024), but I was unable to resolve my questions after consulting that work.

      I understand the general procedure of the method to be: (1) defining a connectivity matrix, (2) refining that matrix using network analysis methods, and (3) applying a lower-dimensional decomposition to the refined matrix, which defines the sub-component of muscle interaction. However, there are a few steps not fully explained in the text.

      (1) The muscle network is defined as the connectivity matrix A. Is each entry in A defined by the co-information? Is this quantity estimated for each time point of the sEMG signal and task variable? Given that there are only 10 repetitions of the measurement for each task, I do not fully understand how this is sufficient for estimating a quantity involving mutual information.

      We acknowledge the confusion caused here in how many datapoints were incorporated into the estimation of II. The number of datapoints included in each variable involved was in fact no. of timepoints x 10 repetitions. Hence for the EMGs employed in this analysis with a sampling rate of 2000Hz, the length of variables involved in this analysis could easily extend beyond 20,000 datapoints each. We have clarified this more specifically in the corresponding section of the methods:

      “We carried out this application in the spatial domain (i.e. interactions between muscles across time (Ó’Reilly & Delis, 2022)) by concatenating the 10 repetitions of each task executed on a particular side (i.e. variables of length no. of timepoints x 10 trials) and quantifying II with respect to this discrete task parameter codified to describe the motor task performed at each timepoint for each trial included.”

      In the previous paper (O'Reilly & Delis, 2024), the authors initially defined the co-information (Equation 1.3) but then referred to mutual information (MI) in the subsequent text, which I found confusing. In addition, while the matrix A is symmetrical, it should not be orthogonal (the authors wrote A<sup>T</sup>A = I) unless some additional constraint was imposed?

      We thank the reviewer for spotting this typo in the previous paper describing a symmetric matrix as A<sup>T</sup>A = I which is in fact related to orthogonality instead. To clarify this error, in the current study we have correctly described the symmetric matrix as A = A<sup>T</sup> here:

      “We carried out this application in the spatial domain (i.e. interactions between muscles across time (Ó’Reilly & Delis, 2022)) by concatenating the 10 repetitions of each task executed on a particular side (i.e. variables of length no. of timepoints x 10 trials) and quantifying II with respect to this discrete task parameter codified to describe the motor task performed at each timepoint for each trial included. This computation was performed on all unique m<sub>x</sub> and m<sub>y</sub> pairings, generating symmetric matrices (A) (i.e. A = A<sup>T</sup>) composed separately of non-negative redundant and synergistic values (Fig.5).”

      Regarding the reviewers point about the reference to MI after equation 1.3 of the previous paper where co-Information is defined, we were referring both to the task-relevant and task-irrelevant estimates analysed there collectively in a general sense as ‘MI estimates’ as they both are derived from mutual information, task-irrelevant being the MI between two muscles conditioned on a task variable (conditional mutual information) and task-relevant being the difference between two MI values (co-I is a higher-order MI estimate). This removed the need to continuously refer to each separately throughout the paper which may in its own way cause some confusion. For clarity, in the results of that paper we also provided context for each MI estimate on how they were estimated (see beginning of “Task-irrelevant muscle couplings” and “Task-redundant muscle couplings” and “Task-synergistic muscle couplings” results sections), referring throughout the Venn diagrams depicting them (see Fig.1 of previous paper). In the present study however, for brevity and focus we did not perform an analysis on task-irrelevant muscle interactions and so decided to focus our terminology on co-I (II), a higher-order MI estimate. We acknowledge that this may have caused some confusion but highlight the efforts made to communicate each measure throughout the previous and present study. We have explicitly pointed out this specific focus on task-dependent muscle couplings in this paper at the end of the introduction of the updated manuscript:

      “To do so, here we focussed our analysis on quantifying task-dependent muscle couplings (collectively referred to as II), extracting functionally-similar (i.e. redundant) and -complementary (i.e. synergistic) modules…”

      (2) The authors should clarify what the following statement means: "Where a muscle interaction was determined to be net redundant/synergistic, their corresponding network edge in the other muscle network was set to zero."

      We acknowledge this sentence was unclear/misleading and have now clarified this statement in the following way:

      “This computation was performed on all unique m<sub>x</sub> and m<sub>y</sub> pairings, generating sparse symmetric matrices (A) (i.e. A = A<sup>T</sup>) composed separately of non-negative redundant and synergistic values (Fig.5).” Additionally, we have now included an additional figure (fig.5) describing this text graphically.

      (3) It should be clarified what the 'm' values are in Equation 1.1. Are these the co-information values after the sparsification and applying the Louvain algorithm to the matrix 'A'? Furthermore, since each task will yield a different co-information value, how is the information from different tasks (r) being combined here?

      We thank the reviewer for their attention to detail. For clarity, at the related section of Equation 1.1, we have clarified that the input matrix is composed of co-I estimates:

      “The input matrix for PNMF consisted of the sparsified A on both affected and unaffected sides from all participants at both pre- and post-sessions concatenated in their vectorised forms. More specifically, the input matrix composed of redundant or synergistic values was configured such that the set of unique muscle pairings (1 … K) on affected and unaffected sides (m<sub>aff</sub> and m<sub>unaff</sub> respectively)…”.

      The co-I estimates in this input matrix are indeed those that survived sparsification in previous steps, however, for determining the number of modules to extract using the Louvain algorithm, this step has no direct impact or transformation on the co-I estimates and is simply employed to derive an empirical input parameter for dimensionality reduction. We refer the reviewer to the following part of this paragraph where this is described:

      “The number of muscle network modules identified in this final consensus partition was used as the input parameter for dimensionality reduction, namely projective non-negative matrix factorisation (PNMF) (Fig.1(D)) (Yang & Oja, 2010). The input matrix for PNMF consisted of the sparsified A on both affected and unaffected sides from all participants at both pre- and post-sessions concatenated together in their vectorised form.”

      Finally, as the reviewer has mentioned, the co-I estimates from the same muscles pairings but for different tasks, experimental sessions and participants are indeed different, reflecting their task-specific tuning, changes with rehabilitation and individual differences. To combine these representations into low-dimensional components, we employed projective non-negative matrix factorisation (PNMF). As outlined in the previous paper and earlier work on this framework (O’ Reilly & Delis, 2022), application of dimensionality reduction here can generate highly generalisable motor components, highlighting their ability to effectively represent large populations of participants, tasks and sessions, while allowing interesting individual differences mentioned by the reviewer to be buffered into the corresponding activation coefficients. These activation coefficients are for this reason the focus of the cluster analyses in the present study to characterise the post-stroke cohort. We have explicitly provided this reason in the methods section of the updated manuscript:

      “We focussed on $a$ here as the extraction of population-level functional modules enabled the buffering of individual differences into the space of modular activations, making them an ideal target for identifying population structure.”

      (4) In general, I recommend improving the clarity of the Methods section, particularly by being more precise in defining the quantities that are being calculated. For example, the adjacency matrix should be defined clearly using co-information at the beginning, and explain how it is changed/used throughout the rest of the section.

      We thank the reviewer for their constructive advice and have gone to lengths to improve the clarity of the methods section. Firstly, we have addressed all the reviewers comments on various specific sections of the methods, including more clearly the ‘why’ and ‘how’ of what was performed. Secondly, we have now included an additional figure illustrating how co-information was quantified at the network level and separated into redundant and synergistic values (see Fig.5 of updated manuscript). Finally, we have re-structured several paragraphs of the methods section to enhance flow with additional subheadings for clarity.

      (5) In the previous paper (O'Reilly & Delis, 2024), the authors applied a tensor decomposition to the interaction matrix and extracted both the spatial and temporal factors. In the current work, the authors simply concatenated the temporal signals and only chose to extract the spatial mode instead. The authors should clarify this choice.

      The reviewer is correct in that a different dimensionality reduction approach was employed in the previous paper. In the present study, we instead chose to employ projective non-negative matrix factorisation, as was employed in a preliminary paper on this framework (O’Reilly & Delis, 2022). This decision was made simply based on aiming to maintain brevity and simplicity in the analysis and presentation of results as we introduce other tools to the framework (i.e. the clustering algorithm). Indeed, we could have just as easily employed the tensor decomposition to extract both spatial and temporal components, however we believed the main take away points for this paper could be more easily communicated using spatial networks only. To clarify this difference for readers we have included the following in the methods section:

      “The choice of PNMF here, in contrast to the space-time tensor decomposition employed in the parent study (O’Reilly & Delis, 2024), was chosen simply to maintain brevity by focussing subsequent analyses on the spatial domain.”

      References

      Ó’Reilly D, Delis I. A network information theoretic framework to characterise muscle synergies in space and time. Journal of Neural Engineering. 2022 Feb 18;19(1):016031.

      O'Reilly D, Delis I. Dissecting muscle synergies in the task space. Elife. 2024 Feb 26;12:RP87651.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Both reviewers are concerned with the manuscript in its current form. They questioned the relevance of the current approach in providing functional or mechanistic explanations about the rehabilitation process of post-stroke patients. Our eLife Assessment would change if you include comparisons between your current method and classical ones, in addition to improving the description of your method to strengthen the evidence of its robustness.

      Reviewer #1 (Recommendations for the authors):

      There is a minor typographical error in Figure 2 ("compononents" should be corrected).

      This error has been rectified.

      Reviewer #2 (Recommendations for the authors):

      The authors should be able to address most of my concerns by providing a substantially improved version of the Methods section.

      See above responses to the reviewers comments regarding the methods section.

      However, I would like the authors to explain in full detail (potentially including a simulation or power analysis) the procedure for estimating the co-information quantity, and to clarify whether it is robust given the sample size used in this paper.

      We refer the reviewer to our previous responses outlining with greater clarity the number of samples included in the estimation of co-I. We would also like to mention here that our framework does not make inferences on the statistical significance of individual muscle couplings (i.e. co-I estimates). Instead, these estimates are employed collectively for the sole purpose of pattern recognition. Nevertheless, to generate reliable estimates of the muscle couplings, we have employed a substantial number of samples for each co-I estimate (>20k samples in each variable) addressing the reviewers main concern her.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The study by Wu et al. uses endogenous bruchpilot expression in a cell-type-specific manner to assess synaptic heterogeneity in adult Drosophila melanogaster mushroom body output neurons. The authors performed genomic on locus tagging of the presynaptic scaffold protein bruchpilot (BRP) with one part of splitGFP (GFP11) using the CRISPR/Cas9 methodology and co-expressed the other part of splitGFP (GFP1-10) using the GAL4/UAS system. Upon expression of both parts of splitGFP, fluorescent GFP is assembled at the N-terminus of BRP, exactly where BRP is endogenously expressed in active zones. For manageable analysis, a high-throughput pipeline was developed. This analysis evaluated parameters like location of BRP clusters, volume of clusters, and cluster intensity as a direct measure of the relative amount of BRP expression levels on site, using publicly available 3D analysis tools that are integrated in Fiji. Analysis was conducted for different mushroom body cell types in different mushroom body lobes using various specific GAL4 drivers. To test this new method of synapse assessment, Wu et al. performed an associative learning experiment in which an odor was paired with an aversive stimulus and found that, in a specific time frame after conditioning, the new analysis solidly revealed changes in BRP levels at specific synapses that are associated with aversive learning.

      Strengths:

      Expression of splitGFP bound to BRP enables intensity analysis of BRP expression levels as exactly one GFP molecule is expressed per BRP. This is a great tool for synapse assessment. This tool can be widely used for any synapse as long as driver lines are available to co-express the other part of splitGFP in a cell-type-specific manner. As neuropils and thus the BRP label can be extremely dense, the analysis pipeline developed here is very useful and important. The authors have chosen an exceptionally dense neuropil - the mushroom bodies - for their analysis and convincingly show that BRP assessment can be achieved with such densely packed active zones. The result that BRP levels change upon associative learning in an experiment with odor presentation paired with punishment is likewise convincing, and strongly suggests that the tool and pipeline developed here can be used in an in vivo context.

      Weaknesses:

      Although BRP is an important scaffold protein and its expression levels were associated with function and plasticity, I am still somewhat reluctant to accept that synapse structure profiling can be inferred from only assessing BRP expression levels and BRP cluster volume. Also, is it guaranteed that synaptic plasticity is not impaired by the large GFP fluorophore? Could the GFP10 construct that is tagged to BRP in all BRP-expressing cells, independent of GAL4, possibly hamper neuronal function? Is it certain that only active zones are labeled? I do see that plastic changes are made visible in this study after an associative learning experiment with BRP intensity and cluster volume as read-out, but I would be reassured by direct measurement of synaptic plasticity with splitGFP directly connected to BRP, maybe at a different synapse that is more accessible.

      We appreciate the reviewer’s comments. In the revised manuscript, we have clarified that Brp is an important, but not the only player in the active zone. We have included new data to demonstrate that split-GFP tagging does not severely affect the localization and plasticity of Brp and the function of synapses by showing: (1) nanoscopic localization of Brp::rGFP using STED imaging; (2) colocalization between Brp::rGFP and anti-Brp signals/VGCCs; (3) activity-dependent Brp remodeling in R8 photoreceptors; (4) no defect in memory performance when labeling Brp::rGFP in KCs; These four lines of additional evidence further corroborate our approach to characterize endogenous Brp as a proxy of active zone structure.

      Reviewer #2 (Public review):

      Summary:

      The authors developed a cell-type specific fluorescence-tagging approach using a CRISPR/Cas9 induced spilt-GFP reconstitution system to visualize endogenous Bruchpilot (BRP) clusters as presynaptic active zones (AZ) in specific cell types of the mushroom body (MB) in the adult Drosophila brain. This AZ profiling approach was implemented in a high-throughput quantification process, allowing for the comparison of synapse profiles within single cells, cell types, MB compartments, and between different individuals. The aim is to analyse in more detail neuronal connectivity and circuits in this centre of associative learning. These are notoriously difficult to investigate due to the density of cells and structures within a cell. The authors detect and characterize cell-type-specific differences in BRP-dependent profiling of presynapses in different compartments of the MB, while intracellular AZ distribution was found to be stereotyped. Next to the descriptive part characterizing various AZ profiles in the MB, the authors apply an associative learning assay and detect consequent AZ re-organisation.

      Strengths:

      The strength of this study lies in the outstanding resolution of synapse profiling in the extremely dense compartments of the MB. This detailed analysis will be the entry point for many future analyses of synapse diversity in connection with functional specificity to uncover the molecular mechanisms underlying learning and memory formation and neuronal network logics. Therefore, this approach is of high importance for the scientific community and a valuable tool to investigate and correlate AZ architecture and synapse function in the CNS.

      Weaknesses:

      The results and conclusions presented in this study are, in many aspects, well-supported by the data presented. To further support the key findings of the manuscript, additional controls, comments, and possibly broader functional analysis would be helpful. In particular:

      (1) All experiments in the study are based on spilt-GFP lines (BRP:GFP11 and UAS-GFP1-10).The Materials and Methods section does not contain any cloning strategy (gRNA, primer, PCR/sequencing validation, exact position of tag insertion, etc.) and only refers to a bioRxiv publication. It might be helpful to add a Materials and Methods section (at least for the BRP:GFP11 line). Additionally, as this is an on locus insertion the in BRP-ORF, it needs a general validation of this line, including controls (Western Blot and correlative antibody staining against BRP) showing that overall BRP expression is not compromised due to the GFP insertion and localizes as BRP in wild type flies, that flies are viable, have no defects in locomotion and learning and memory formation and MB morphology is not affected compared to wild type animals.

      We thank the reviewer for suggesting these important validations. We included details of the design of the construct and insertion site to the Methods section, performed several new experiments to validate the split-GFP tagging of Brp, and present the data in the revision.

      First, to examine whether the transcription of the brp gene is unaffected by the insertion of GFP<sub>11</sub>, we conducted qRT-PCR to compare the brp mRNA levels between brp::GFP<sub>11</sub>, UAS-GFP1-10 and UAS-GFP1-10 and found no difference (Figure 1 - figure supplement 1A).

      To further verify the effect of GFP<sub>11</sub> tagging at the protein level, we performed anti-Brp (nc82) immunohistochemistry of brains where GFP is reconstituted pan-neuronally. We found unaltered neuropile localization of nc82 signals (Figure 1 - figure supplement 1C). In presynaptic terminals of the mushroom body calyx, we found integration of Brp::rGFP to nc82 accumulation (Figure 1D). We performed super-resolution microscopy to verify the configuration of Brp::rGFP and confirmed the donut-shape arrangement of Brp::rGFP in the terminals of motor neurons (see Wu, Eno et al., 2025 PLOS Biology), corroborating the nanoscopic assembly of Brp::rGFP at active zones (Kittel et al., 2006 Science).

      Furthermore, co-expression of RFP-tagged voltage-gated calcium channel alpha subunit Cacophony (Cac) and Brp::rGFP in PAM-γ5 dopaminergic neurons revealed strong presynaptic colocalization of their punctate clusters (Figure 1E), suggesting that rGFP tagging of Brp did not damage key protein assembly at active zones (Kawasaki et al., 2004 J Neuroscience; Kittel et al., Science).

      These lines of evidence suggest that the localization of endogenous Brp is barely affected by the C-terminal GFP<sub>11</sub> insertion or GFP reconstitution therewith. This is in line with a large body of studies confirming that the N-terminal region and coiled-coil domains, but not the C-terminal, region of Brp are necessary and sufficient for active zone localization (Fouquet et al., 2009 J Cell Biol; Oswald et al., 2010 J Cell Biol; Mosca and Luo, 2014 eLife; Kiragasi et al., 2017 Cell Rep; Akbergenova et al., 2018 eLife; Nieratschker et al., 2009 PLoS Genet; Johnson et al., 2009 PLoS Biol; Hallermann et al., 2010 J Neurosci). We nevertheless report homozygous lethality and found the decreased immunoreactive signals in flies carrying the GFP<sub>11</sub> insertion (Figure 1 - figure supplement 1B).

      For these reasons, we always use heterozygotes for all the experiments therefore there is no conspicuous defect in locomotion as reported in the original study (Wagh et al., 2005 Neuron). To functionally validate the heterozygotes, we measured the aversive olfactory memory performance of flies where GFP reconstitution was induced in Kenyon cells using R13F02-GAL4. We found that all these transgenes did not alter mushroom body morphology (Figure 7 - figure supplement 1) or memory performance as compared to wild-type flies (Figure 7 - figure supplement 2), suggesting the synapse function required for short-term memory formation is not affected by split-GFP tagging of Brp.

      (2) Several aspects of image acquisition and high-throughput quantification data analysis would benefit from a more detailed clarification.

      (a) For BRP cluster segmentation it is stated in the Materials and Methods state, that intensity threshold and noise tolerance were "set" - this setting has a large effect on the quantification, and it should be specified and setting criteria named and justified (if set manually (how and why) or automatically (to what)). Additionally, if Pyhton was used for "Nearest Neigbor" analysis, the code should be made available within this manuscript; otherwise, it is difficult to judge the quality of this quantification step.

      (b) To better evaluate the quality of both the imaging analysis and image presentation, it would be important to state, if presented and analysed images are deconvolved and if so, at least one proof of principle example of a comparison of original and deconvoluted file should be shown and quantified to show the impact of deconvolution on the output quality as this is central to this study.

      We thank the reviewer for suggesting these clarifications. We have included more description to the revised manuscript to clarify the setting of segmentation, which was manually adjusted to optimize the F-score (previous Figure 1D, now moved to Figure 1 -figure supplement 5). We have included the code used for analyzing nearest neighbor distance, AZ density and local Brp density in the revised manuscript (Supplementary file 1), together with a pre-processed sample data sheet (Supplementary file 2).

      Regarding image deconvolution, we have clarified the differential use of deconvolved and not-deconvolved images in the revised manuscript. We have also included a quantitative evaluation of Richardson-Lucy iterative deconvolution (Figure 1 - figure supplement 4). We used 20 iterations due to only marginal FWHM improvement beyond this point (Figure 1 - figure supplement 4).

      (3) The major part of this study focuses on the description and comparison of the divergent synapse parameters across cell-types in MB compartments, which is highly relevant and interesting. Yet it would be very interesting to connect this new method with functional aspects of the heterogeneous synapses. This is done in Figure 7 with an associative learning approach, which is, in part, not trivial to follow for the reader and would profit from a more comprehensive analysis.

      (a) It would be important for the understanding and validation of the learning induced changes, if not (only) a ratio (of AZ density/local intensity) would be presented, but both values on their own, especially to allow a comparison to the quoted, previous AZ remodelling analysis quantifying BRP intensities (ref. 17, 18). It should be elucidated in more detail why only the ratio was presented here.

      We thank the reviewer for the suggestion on the presentation of learning-induced Brp remodeling. The reported values in Figure 7C are the correlation coefficient of AZ density and local intensity in each compartment, but not the ratio. These results suggest that subcompartment-sized clusters of AZs with high Brp accumulation (Figure 6) undergo local structural remodeling upon associative learning (Figure 7). For clarity, we have included a schematic of this correlation and an example scatter plot to Figure 6. Unlike the previous studies (refs 17 and 18), we did not observe robust learning-dependent changes in the Brp intensity, possibly due to some confounding factors such as overall expression levels and conditioning protocols as described in the previous and following points, respectively.

      (b) The reason why a single instead of a dual odour conditioning was performed could be clarified and discussed (would that have the same effects?).

      (c) Additionally, "controls" for the unpaired values - that is, in flies receiving neither shock nor odour - it would help to evaluate the unpaired control values in the different MB compartments.

      We use single odor conditioning because it is the simplest way to examine the effect of odor-shock association by comparing the paired and unpaired group. Standard differential conditioning with two odors contains unpaired odor presentation (CS-) even in the ‘paired’ group. We now show that single-odor conditioning induces memory that lasts one day as in differential conditioning (Figure 7B; Tully and Quinn, J Comp Phys A 1985).

      (d) The temporal resolution of the effect is very interesting (Figure 7D), and at more time points, especially between 90 and 270 min, this might raise interesting results.

      The sampling time points after training was chosen based on approximately logarithmic intervals, as the memory decay is roughly exponential (Figure 7B). This transient remodeling is consistent with the previous studies reporting that the Brp plasticity was short-lived (Zhang et al., 2018 Neuron; Turrel et al., 2022 Current Biol).

      (e) Additionally, it would be very interesting and rewarding to have at least one additional assay, relating structure and function, e.g. on a molecular level by a correlative analysis of BRP and synaptic vesicles (by staining or co-expression of SV-protein markers) or calcium activity imaging or on a functional level by additional learning assays.

      We thank the reviewer for raising this important point. We have performed calcium imaging of KC presynaptic terminals to correlate the structure and function in another study (see Figure 2 in Wu, Eno et al., 2025 PLOS Biology for more detail). The basal presynaptic calcium pattern along the γ compartments is strikingly similar to the compartmental heterogeneity of Brp accumulation (see also Figure 2 in this study). Considering colocalization of other active-zone components, such as Cac (Figure 1E), we propose that the learning-induced remodeling of local Brp clusters should transiently modulate synaptic properties.

      As a response to other reviewers’ interest, we used Brp::rGFP to measure different forms of Brp-based structural plasticity upon constant light exposure in the photoreceptors and upon silencing rab3 in KCs. Since these experiments nicely reproduced the results of previous studies (Sugie et al., Neuron 2013; Graf et al., Neuron 2009), we believe the learning-induced plasticity of Brp clustering in KCs has a transient nature.

      Reviewer #3 (Public review):

      Summary:

      The authors develop a tool for marking presynaptic active zones in Drosophila brains, dependent on the GAL4 construct used to express a fragment of GFP, which will incorporate with a genome-engineered partial GFP attached to the active zone protein bruchpilot - signal will be specific to the GAL4-expressing neuronal compartment. They then use various GAL4s to examine innervation onto the mushroom bodies to dissect compartment-specific differences in the size and intensity of active zones. After a description of these differences, they induce learning in flies with classic odour/electric shock pairing and observe changes after conditioning that are specific to the paired conditioning/learning paradigm.

      Strengths:

      The imaging and analysis appear strong. The tool is novel and exciting.

      Weaknesses:

      I feel that the tool could do with a little more characterisation. It is assumed that the puncta observed are AZs with no further definition or characterisation.

      We performed additional validation on the tool, including (1) nanoscopic localization of Brp::rGFP using STED imaging; (2) colocalization between Brp::rGFP and anti-Brp signals/VGCCs (Figure 1D-E); 3) activity-dependent active zone remodeling in R8 photoreceptors (Figure 1F). These will be detailed in our point-by-point response below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The authors keep stating, they profile or assess synaptic structure by analyzing BRP localization, cluster volume, and intensity. However, I do not think that BRP cluster volume and intensity warrant an educated statement about presynaptic structure as a whole. I do not challenge the usefulness of BRP cluster analysis for synapse evaluation, but as there are so many more players involved in synaptic function, BRP analysis certainly cannot explain it all. This should at least be discussed.

      It is correct that Brp is not the only player in the active zone. We have included more discussion on the specific role of Brp (line 84 to 89) and other synaptic markers (line 250) and edited potentially misunderstanding text.

      (2) I do see that changes in BRP expression were observed following associative learning, but is it certain, that synaptic plasticity is generally unaffected by the large GFP fluorophore? BRP is grabbing onto other proteins, both with its C- and N-termini. As the GFP is right before the stop codon, it should be at the N-terminus. How far could BRP function be hampered by this? Is there still enough space for other proteins to interact?

      We thank the reviewer for sharing the concerns. We here provided three lines of evidence to demonstrate that the Brp assembly at active zones required for synaptic plasticity is unaffected by split-GFP tagging.

      First, we assessed olfactory memory of flies that have Brp::rGFP labeled in Kenyon cells and found the performance comparable to wild-type (Figure 7 - figure supplement 2), suggesting the Brp function required for olfactory memory (Knapek et al., J Neurosci 2011) is unaffected by split-GFP tagging.

      Second, we measured Brp remodeling in photoreceptors induced by constant light exposure (LL; Sugie et al., 2015 Neuron). Consistent with the previous study, we found that LL decreased the numbers of Brp::rGFP clusters in R8 terminals in the medulla, as compared to constant dark condition (DD). This result validates the synaptic plasticity involving dynamic Brp rearrangement in the photoreceptors. We have included this result into the revised manuscript (Figure 1F).

      To further validate protein interaction of Brp::rGFP, we focused on Rab3, as it was previously shown to control Brp allocation at active zones (Graf et al., 2009 Neuron). To this end, we silenced rab3 expression in Kenyon cells using RNAi and measured the intensity of Brp::rGFP clusters in γ Kenyon cells. As previously reported in the neuromuscular junction, we found that rab3 knock-down increased Brp::rGFP accumulation to the active zones, suggesting that Brp::rGFP represents the interaction with Rab3. We have included all the new data to the revised manuscript (Figure 1 - figure supplement 3).

      (3) It may well be that not only active-zone-associated BRP is labeled but possibly also BRP molecules elsewhere in the neuron. I would like to see more validation, e.g., the percentage of tagged endogenous BRP associated with other presynaptic proteins.

      To answer to what extent Brp::rGFP clusters represent active zones, we double-labelled Brp::rGFP and Cac::tdTomato (Cacophony, the alpha subunit of the voltage-gated calcium channels). We found that 97% of Brp::rGFP clusters showed co-localization with Cac::tdTomato in PAM-γ5 dopamine neurons terminals (Figure 1E), suggesting most Brp::rGFP clusters represent functional AZs.

      (4) Z-size is ~200 nm, while x/y pixel size is ~75 nm during acquisition. How far down does the resolution go after deconvolution?

      The Z-step was 370 nm and XY pixel size was 79 nm for image acquisition. We performed 20 iterations of Richarson-Lucy deconvolution using an empirical point spread function (PSF). We found that the effect of deconvolution on the full-width at half maximum (FWHM) of Brp::rGFP clusters improves only marginally beyond 20 iterations, when the XY FWHM is around 200 nm and the XZ FWHM is around 450 nm (Figure 1 - figure supplement 4).

      (5) Figure Legend 7: What is a "cytoplasm membrane marker"? Does this mean membrane-bound tdTom is sticking into the cytoplasm?

      We apologize for the typo and have corrected it to “plasma membrane marker”.

      (6) At the end of the introduction: "characterizing multiple structural parameters..." - which were these parameters? I was under the assumption that BRP localization, cluster volume, and intensity were assessed. I do not see how these are structural parameters. Please define what exactly is meant by "structural parameters".

      We apologize for the confusion. By "structural parameters”, we indeed referred to the volume, intensity and molecular density of Brp::rGFP clusters. We have revised the sentence to “Characterizing the distinct parameters and localization of Brp::rGFP cluster.”

      (7) Next to last sentence of the introduction: "Characterizing multiple structural parameters revealed a significant synaptic heterogeneity within single neurons and AZ distribution stereotypy across individuals." What do the authors mean by "significant synaptic heterogeneity"?

      By “synaptic heterogeneity”, we refer to the intracellular variability of active zone cytomatrices reported by Brp clusters. For instance, the intensities of Brp::rGFP clusters within Kenyon cell subtypes were variable among compartments (Figure 2). Intracellular variability of the Brp concentration of individual active zones was higher in DPM and APL neurons than Kenyon cells (Figure 3). These variabilities demonstrate intracellular synaptic heterogeneity. We have revised the sentence to be more specific to the different characters of Brp clusters.

      (8) I do not understand the last sentence of the introduction. "These cell-type-specific synapse profiles suggest that AZs are organized at multiple scales, ranging from neighboring synapses to across individuals." What do the authors mean by "ranging from neighboring synapses to across individuals"? Does this mean that even neighboring synapses in the same cell can be different?

      We have revised the sentence to “These cell-type-specific synapse profiles suggest that AZs are spatially organized at multiple scales, ranging from interindividual stereotypy to neighboring synapses in the same cells.”

      By “neighboring synapses", we refer to the nearest neighbor similarity in Brp levels in some cell-types (Figure 6A-C), and also the sub-compartmental dense AZ clusters with high Brp level in Kenyon cells (Figure 6D-H). By “across individuals”, we refer to the individually conserved active zone distribution patterns in some neurons (Figure 5).

      (9) The title talks about cell-type-specific spatial configurations. I do not understand what is meant by "spatial configurations"? Do you mean BRP cluster volume? I think the title is a little misleading.

      By “spatial configuration”, we refer to the arrangement of Brp clusters within individual mushroom body neurons. This statement is based on our findings on the intracellular synaptic heterogeneity (see also response to comment #7). We have streamlined the text description in the revised manuscript for clarity.

      Reviewer #2 (Recommendations for the authors):

      (1) For Figure 3A: exemplary two AZs are compared here, a histogram comparing more AZs would aid in making the point that in general, AZ of similar size have different BRP level (intensities) and how much variation exists.

      We have included histograms for Brp::rGFP intensity and cluster volumes to Figure 3 in the revised manuscript.

      (2) Line 52: "endogenous synapses" is a confusing term; it's probably meant that the protein levels within the synapse are endogenous and not overexpressed. 

      We apologize for the confusion and have revised the term to “endogenous synaptic proteins.”

      (3) It is not clear from the Materials and Methods section, whether and where deconvolved or not-deconvolved images were used for the quantification pipeline. Please comment on this. 

      We have now revised the Method section to clarify how deconvolved or not-deconvolved images were differently used in the pipeline.

      (4) Line 664 (C) not bold.

      We have corrected the error.

      (5) 725 "Files" should be Flies.

      We have corrected the error.

      (6) 727 two times "first".

      We have corrected the error.

      (7) Figure 7. All (A) etc., not bold - there should be consistent annotation. 

      We want to thank the reviewer for the detailed proof and have corrected all the errors spotted.

      Reviewer #3 (Recommendations for the authors):

      (1) Has there been an expression of the construct in a non-neuronal cell? Astrocyte-like cell? Any glia? As some sort of control for background and activity?

      As the reviewer suggested, we verified the neuronal expression specificity of Brp::rGFP. Using R86E01-GAL4 and Amon-GAL4, we compared Brp::rGFP in astrocyte-like glia and neuropeptide-releasing neurons. We found no Brp::rGFP puncta in the neuropils in astrocyte-like glia compared to neurons, suggesting Brp::rGFP is specific to neurons. We have included this new dataset to the revised manuscript (Figure 1 - figure supplement 2).

      (2) Similarly, expression of the construct co-expressed with a channelrhodopsin, and induction of a 'learning'-like regime of activity, similarly in a control type of experiment, expression of an inwardly rectifying channel (e.g. Kir2.1) to show that increases in size of the BRP puncta are truly activity dependent? The NMJ may be an optimal neuron to use to see the 'donut' structures of the AZs and their increase with activity. Also, are these truly AZs we are seeing here? Perhaps try co-expressing cacophony-dsRed? If the GFP Puncta are active zones, then they should be surrounded by cacophony.

      We would like to clarify that we did not find Brp::rGFP size increase upon learning. Instead, we demonstrated that associative training transiently remodelled sub-compartment-sized AZ “hot spots” in Kenyon cells, indicated by the correlation of local intensity and AZ density (Figure 6-7).

      To demonstrate split-GFP tagging does not affect activity-dependent plasticity associated with Brp, we measured Brp remodeling in photoreceptors induced by constant light exposure (LL; Sugie et al., 2015 Neuron). Consistent with the previous study, we found that LL decreased the numbers of Brp::rGFP clusters in R8 terminals in the medulla, as compared to constant dark condition (DD). This result validates the synaptic plasticity involving dynamic Brp rearrangement in the photoreceptors (Figure 1F).

      As the reviewer suggested, we performed the STED microscopy for the larval motor neuron and confirmed the donut-shape arrangement of Brp::rGFP (Wu, Eno et al., PLOS Biol 2025).

      Also following the reviewer’s suggestion, we double-labelled Brp::rGFP and Cac::tdTomato (Cacophony, the alpha subunit of the voltage-gated calcium channels). We found that 97% Brp::rGFP clusters showed co-localization with Cac::tdTomato in PAM-γ5 dopamine neurons terminals (Figure 1E), suggesting most Brp::rGFP clusters represent functional AZs.

      (3) In the introduction: Intro, a sentence about BRP - central organiser of the active zone, so a key regulator of activity.

      We have included a few more sentences about the role Brp in the active zones to the revised manuscript.

      (4) Figure 1 E, line 650 'cite the resource here'. 

      We thank the reviewer for pointing out the error and we have corrected it.

      (5) Many readers may not be MB aficionados, and to make the data more accessible, perhaps use a cartoon of an MB with the cell bodies of the neurons around the MB expressing the constructs highlighted so that the reader can have a wider idea of the anatomy in relation to the MB.

      We appreciate these comments and have appended cartoons of the MB to figures to help readers understand the anatomy.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This useful study uses creative scalp EEG decoding methods to attempt to demonstrate that two forms of learned associations in a Stroop task are dissociable, despite sharing similar temporal dynamics. However, the evidence supporting the conclusions is incomplete due to concerns with the experimental design and methodology. This paper would be of interest to researchers studying cognitive control and adaptive behavior, if the concerns raised in the reviews can be addressed satisfactorily.

      We thank the editors and the reviewers for their positive assessment of our work and for providing us with an opportunity to strengthen this manuscript. Please see below our responses to each comment raised in the reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study focuses on characterizing the EEG correlates of item-specific proportion congruency effects. In particular, two types of learned associations are characterized. One being associations between stimulus features and control states (SC), and the other being stimulus features and responses (SR). Decoding methods are used to identify SC and SR correlates and to determine whether they have similar topographies and dynamics.

      The results suggest SC and SR associations are simultaneously coactivated and have shared topographies, with the inference being that these associations may share a common generator.

      Strengths:

      Fearless, creative use of EEG decoding to test tricky hypotheses regarding latent associations. Nice idea to orthogonalize the ISPC condition (MC/MI) from stimulus features.

      Thank you for acknowledging the strength in EEG decoding and design. We have addressed all your concerns raised below point by point.

      Weaknesses:

      (1a) I'm relatively concerned that these results may be spurious. I hope to be proven wrong, but I would suggest taking another look at a few things.

      While a nice idea in principle, the ISPC manipulation seems to be quite confounded with the trial number. E.g., color-red is MI only during phase 2, and is MC primarily only during Phase 3 (since phase 1 is so sparsely represented). In my experience, EEG noise is highly structured across a session and easily exploited by decoders. Plus, behavior seems quite different between Phase 2 and Phase 3. So, it seems likely that the classes you are asking the decoder to separate are highly confounded with temporally structured noise.

      I suggest thinking of how to handle this concern in a rigorous way. A compelling way to address this would be to perform "cross-phase" decoding, however I am not sure if that is possible given the design.

      Thank you for raising this important issue. To test whether decoding might be confounded by temporally structured noise, we performed a control decoding analysis. As the reviewer correctly pointed out, cross-phase decoding is not possible due to the experimental design. Alternatively, to maximize temporal separation between the training and test data, we divided the EEG data in phase 2 and phase 1&3 into the first and second half chronologically. Phase 1 and 3 were combined because they share the same MC and MI assignments. We then trained the decoders on one half and tested them on the other half. Finally, we averaged the decoding results across all possible assignments of training and test data. The similar patterns (Supplementary Fig.1) observed confirmed that the decoding results are unlikely to be driven by temporally structured noise in the EEG data. The clarification has been added to page 13 of the revised manuscript.

      (1b) The time courses also seem concerning. What are we to make of the SR and SC timecourses, which have aggregate decoding dynamics that look to be <1Hz?

      As detailed in the response to your next comment, some new results using data without baseline correction show a narrower time window of above-chance decoding. We speculate that the remaining results of long-lasting above-chance decoding could be attributed to trials with slow responses (some responses were made near the response deadline of 1500 ms). Additionally, as shown in Figure 6a, the long-lasting above-chance decoding seems to be driven by color and congruency representations. Thus, it is also possible that the binding of color and congruency contributes to decoding. This interpretation has been added to page 17 of the revised manuscript.

      (1c) Some sanity checks would be one place to start. Time courses were baselined, but this is often not necessary with decoding; it can cause bias (10.1016/j.jneumeth.2021.109080), and can mask deeper issues. What do things look like when not baselined? Can variables be decoded when they should not be decoded? What does cross-temporal decoding look like - everything stable across all times, etc.?

      As the reviewer mentioned, baseline-corrected data may introduce bias to the decoding results. Thus, we cited the van Driel et al (2021) paper in the revised manuscript to justify the use of EEG data without baseline-correction in decoding analysis (Page 27 of the revised manuscript), and re-ran all decoding analysis accordingly. The new results revealed largely similar results (Fig. 2, 4, 6 and 8 in the revised manuscript) with the following exceptions: narrower time window for separatable SC subspace and SR subspace (Fig. 4b), narrower time window for concurrent representations of SC and SR (Fig. 6a-b), and wider time window for the correlations of SC/SR representations with RTs (Fig. 8).

      (2) The nature of the shared features between SR and SC subspaces is unclear.

      The simulation is framed in terms of the amount of overlap, revealing the number of shared dimensions between subspaces. In reality, it seems like it's closer to 'proportion of volume shared', i.e., a small number of dominant dimensions could drive a large degree of alignment between subspaces.

      What features drive the similarity? What features drive the distinctions between SR and SC? Aside from the temporal confounds I mentioned above, is it possible that some low-dimensional feature, like EEG congruency effect (e.g., low-D ERPs associated with conflict), or RT dynamics, drives discriminability among these classes? It seems plausible to me - all one would need is non-homogeneity in the size of the congruency effect across different items (subject-level idiosyncracies could contribute: 10.1016/j.neuroimage.2013.03.039).

      Thank you for this question. To test what dimensions are shared between SC and SR subspaces, we first identify which factors can be shared across SC and SR subspaces. For SC, the eight conditions are the four colors × ISPC. Thus, the possible shared dimensions are color and ISPC. Additionally, because the four colors and words are divided into two groups (e.g., red-blue and green-yellow, counterbalanced across subjects, see Methods), the group is a third potential shared dimension. Similarly, for SR decoders, potential shared dimensions are word, ISPC and group. Note that each class in SC and SR decoders has both congruent and incongruent trials. Thus, congruency is not decodable from SC/SR decoders and hence unlikely to be a shared dimension in our analysis. To test the effect of sharing for each of the potential dimensions, we performed RSA on decoding results of the SC decoder trained on SR subspace (SR | SC) (Supplementary Fig. 4a) and the SR decoder trained on SC subspace (SC | SR) (Supplementary Fig. 4b), where the decoders indicated the decoding accuracy of shared SC and SR representations. In the SC classes of SR | SC, word red and blue were mixed within the same class, same were word yellow and green. The similarity matrix for “Group” of SR | SC (Supplementary Fig. 4a) shows the comparison between two word groups (red & blue vs. yellow & green). The similarity matrix for “Group” of SC | SR (Supplementary Fig. 4b) shows the comparison between two color groups (red & blue vs. yellow & green).

      The RSA results revealed that the contributions of group to the SC decoder (Supplementary Fig. 5a) and the SR decoder (Supplementary Fig. 5b) were significant. Meanwhile, a wider time window showed significant effect of color on the SC decoder (approximately 100 - 1100 ms post-stimulus onset, Supplementary Fig. 5a) and a narrower time window showed significant effect of word on SR decoder (approximately 100 - 500 ms post-stimulus onset, Supplementary Fig. 5b). However, we found no significant effect of ISPC on either SC or SR decoders. We also performed the same analyses on response-locked data from the time window -800 to 200 ms. The results showed shared representation of color in the SC decoder (Supplementary Fig. 5c) and group in both decoders (Supplementary Fig. 5c-d). Overall, the above results demonstrated that color, word and group information are shared between SC and SR subspaces.

      Lastly, we would like to stress that our main hypothesis for the cross-subspace decoding analysis is that SR and SC subspaces are not identical. This hypothesis was supported by lower decoding accuracy for cross-subspace than within-subspace decoders and enables following analyses that treated SC and SR as separate representations.

      We have added the interpretation to page 13-14 of the revised manuscript.

      (3) The time-resolved within-trial correlation of RSA betas is a cool idea, but I am concerned it is biased. Estimating correlations among different coefficients from the same GLM design matrix is, in general, biased, i.e., when the regressors are non-orthogonal. This bias comes from the expected covariance of the betas and is discussed in detail here (10.1371/journal.pcbi.1006299). In short, correlations could be inflated due to a combination of the design matrix and the structure of the noise. The most established solution, to cross-validate across different GLM estimations, is unfortunately not available here. I would suggest that the authors think of ways to handle this issue.

      Thank you for raising this important issue. Because the bias comes from the covariance between the regressors and the same GLM was applied to all time points in our analysis, we assume that the inflation would be similar at different time points. Therefore, we calculated the correlation of SC and SR betas ranging from -200 to 0 ms relative to stimulus onset as a baseline (i.e., no SC or SR representation is expected before the stimulus onset) and compared the post-stimulus onset correlation coefficients against this baseline. We hypothesized that if the positively within-trial correlation of SC and SR betas resulted from the simultaneous representation instead of inflation, we should observe significantly higher correlation when compared with the baseline. To examine this hypothesis, we first performed the linear discriminant analysis (Supplementary Fig. 7a) and RSA regression (Supplementary Fig. 7b) on the -200 - 0 ms window relative to stimulus onset. We then calculated the average r<sub>baseline</sub> of SC and SR betas on that time window for each participant (group results at each time point are shown in Supplementary Fig. 7c) and computed the relative correlation at each post-stimulus onset time point using (fisher-z (r) - fisher-z (r<sub>baseline</sub>)). Finally, we performed a simple t test at the group level on baseline-corrected correlation coefficients with Bonferroni correction. The results (Fig. 6c) showed significantly more positive correlation from 100 - 500 ms post-stimulus onset compared with baseline, supporting our hypothesis that the positive within-trial correlation of SC and SR betas arise from simultaneous representation rather than inflation. The related interpretation was added to page 17 of the revised manuscript.

      (4) Are results robust to running response-locked analyses? Especially the EEG-behavior correlation. Could this be driven by different RTs across trials & trial-types? I.e., at 400 ms poststim onset, some trials would be near or at RT/action execution, while others may not be nearly as close, and so EEG features would differ & "predict" RT.

      Thanks for this question. We now pair each of the stimulus-locked EEG analysis in the manuscript with response-locked analysis. To control for RT variations among trial types, when using the linear mixed model (LMM) to predict RTs from trial-wise RSA results, we included a separate intercept for each of the eight trial types in SC or SR. Furthermore, at each time point, we only included trials that have not generated a response (for stimulus-locked analysis) or already started (for response-locked analysis). All the results (Fig. 3, 5, 7, 9 in the revised manuscript) are in support of our hypothesis. We added these detailed to page 31 of the revised manuscript.

      (5) I suggest providing more explanation about the logic of the subspace decoding method - what trialtypes exactly constitute the different classes, why we would expect this method to capture something useful regarding ISPC, & what this something might be. I felt that the first paragraph of the results breezes by a lot of important logic.

      In general, this paper does not seem to be written for readers who are unfamiliar with this particular topic area. If authors think this is undesirable, I would suggest altering the text.

      To improve clarity, we revised the first paragraph of the SC and SR association subspace analysis to list the conditions for each of the SC and SR decoders and explain more about how the concept of being separatable can be tested by cross-decoding between SC and SR subspaces. The revised paragraph now reads:

      “Prior to testing whether controlled and non-controlled associations were represented simultaneously, we first tested whether the two representations were separable in the EEG data.

      In other words, we reorganized the 16 experimental conditions into 8 conditions for SC (4 colors × MC/MI, while collapsing across SR levels) and SR (4 words × 2 possible responses per word, while collapsing across SC levels) associations separately. If SC and SR associations are not separable, it follows that they encode the same information, such that both SC and SR associations can be represented in the same subspace (i.e., by the same information encoded in both associations). For example, because (1) the word can be determined by the color and congruency and (2) the most-likely response can be determined by color and ISPC, the SR association (i.e., association between word and most-likely response) can in theory be represented using the same information as the SC association. On the other hand, if SC and SR associations are separable, they are expected to be represented in different subspaces (i.e., the information used to encode the two associations is different). Notably, if some, but not all, information is shared between SC and SR associations, they are still separable by the unique information encoded. In this case, the SC and SR subspaces will partially overlap but still differ in some dimensions. To summarize, whether SC and SR associations are separable is operationalized as whether the associations are represented in the same subspace of EEG data. To test this, we leveraged the subspace created by the LDA (see Methods). Briefly, to capture the subspace that best distinguishes our experimental conditions, we trained SC and SR decoders using their respective aforementioned 8 experimental conditions. We then projected the EEG data onto the decoding weights of the LDA for each of the SC and SR decoders to obtain its respective subspace. We hypothesized that if SC and SR subspaces are identical (i.e., not separable), SC/SR decoding accuracy should not differ by which subspace (SC or SR) the decoder is trained on. For example, SC decoders trained in SC subspace should show similar decoding performance as SC decoders trained in SR subspace. On the other hand, if SC and SR association representations are in different subspaces, the SC/SR subspace will not encode all information for SR/SC associations. As a result, decoding accuracy should be higher using its own subspace (e.g., decoding SC using the SC subspace) than using the other subspace (e.g., decoding SC using the SR subspace). We used cross-validation to avoid artificially higher decoding accuracy for decoders using their own subspace (see Methods).” (Page 11-12).

      We also explicitly tested what information is shared between SC and SR representations (see response to comment #2). Lastly, to help the readers navigate the EEG results, we added a section “Overview of EEG analysis” to summarize the EEG analysis and their relations in the following manner:

      “EEG analysis overview. We started by validating that the 16 experimental conditions (8 unique stimuli × MC/MI) were represented in the EEG data. Evidence of representation was provided by above-chance decoding of the experimental conditions (Fig. 2-3). We then examined whether the SC and SR associations were separable (i.e., whether SC and SR associations were different representations of equivalent information). As our results supported separable representations of SC and SR association (Fig. 4-5), we further estimated the temporal dynamics of each representation within a trial using RSA. This analysis revealed that the temporal dynamics of SC and SR association representations overlapped (Fig. 6a-b, Fig. 7a-b). To explore the potential reason behind the temporal overlap of the two representations, we investigated whether SC and SR associations were represented simultaneously as part of the task representation, independently from each other, or competitively/exclusively (e.g., on some trials only SC association was represented, while on other trials only SR association was represented). This was done by assessing the correlation between the strength of SC and SR representations across trials (Fig. 6c, Fig. 7c). Lastly, we tested how SC and SR representations facilitated performance (Fig.8-9).” (Page 8-9).

      Minor suggestions:

      (6) I'd suggest using single-trial RSA beta coefficients, not t-values, as they can be more stable (it's a t-value based on 16 observations against 9 or so regressors.... the SE can be tiny).

      Thank you for your suggestion. To choose between using betas and t-values, we calculate the proportion of outliers (defined as values beyond mean ± 5 SD) for each predictor of the design matrix and each subject. We found that outliers were less frequent for t-values than for beta coefficients (t-values: mean = 0.07%, SD = 0.009%; beta-values: mean = 0.19%, SD = 0.033%). Thus, we decided to stay with t-values.

      (7) Instead of prewhitening the RTs before the HLM with drift terms, try putting those in the HLM itself, to avoid two-stage regression bias.

      Thank you for your suggestion. Because our current LMM included each of the eight trial types in SC or SR as separate predictors with their own intercepts (as mentioned above), adding regressors of trial number and mini blocks (1-100 blocks) introduced collinearity (as ISPC flipped during the experiment). We therefore excluded these regressors from the current LMM (Page 31).

      (8) The text says classical MDS was performed on decoding *accuracy* - is this accurate?

      We now clarify in the manuscript that it is the decoders’ probabilistic classification results (Page 28).

      (9) At a few points, it was claimed that a negative correlation between SC and SR would be expected within single trials, if the two were temporally dissociable. Wouldn't it also be possible that they are not correlated/orthogonal?

      We agree with the reviewer and revised the null hypothesis in the cross-trial correlation analysis to include no correlation as SC and SR association representations may be independent from each other (Page 17, 22).

      Reviewer #2 (Public review):

      Summary:

      In this EEG study, Huang et al. investigated the relative contribution of two accounts to the process of conflict control, namely the stimulus-control association (SC), which refers to the phenomenon that the ratio of congruent vs. incongruent trials affects the overall control demands, and the stimulus-response association (SR), stating that the frequency of stimulusresponse pairings can also impact the level of control. The authors extended the Stroop task with novel manipulation of item congruencies across blocks in order to test whether both types of information are encoded and related to behaviour. Using decoding and RSA, they showed that the SC and SR representations were concurrently present in voltage signals, and they also positively co-varied. In addition, the variability in both of their strengths was predictive of reaction time. In general, the experiment has a solid design, but there are some confounding factors in the analyses that should be addressed to provide strong support for the conclusions.

      Strengths:

      (1) The authors used an interesting task design that extended the classic Stroop paradigm and is potentially effective in teasing apart the relative contribution of the two different accounts regarding item-specific proportion congruency effect, provided that some confounds are addressed.

      (2) Linking the strength of RSA scores with behavioural measures is critical to demonstrating the functional significance of the task representations in question.

      Thank you for your positive feedback. We hope our responses below address your concerns.

      Weakness:

      (1) While the use of RSA to model the decoding strength vector is a fitting choice, looking at the RDMs in Figure 7, it seems that SC, SR, ISPC, and Identity matrices are all somewhat correlated. I wouldn't be surprised if some correlations would be quite high if they were reported. Total orthogonality is, of course, impossible depending on the hypothesis, but from experience, having highly covaried predictors in a regression can lead to unexpected results, such as artificially boosting the significance of one predictor in one direction, and the other one to the opposite direction. Perhaps some efforts to address how stable the timed-resolved RSA correlations for SC and SR are with and without the other highly correlated predictors will be valuable to raising confidence in the findings.

      Thank you for this important point. The results of proportion of variability explained shown in the Author response table 1 below, indicated relatively higher correlation of SC/SR with Color and Identity. We agree that it is impossible to fully orthogonalize them. To address the issue of collinearity, we performed a control RSA by removing predictors highly correlated with others. Specifically, we calculated the variance inflation factor (VIF) for each predictor. The Identity predictor had a high VIF of 5 and was removed from the RSA. All other predictors had VIFs < 4 and were kept in the RSA. The results (Supplementary Fig. 6) showed patterns similar to the results with the Identity predictor, suggesting that the findings are not significantly influenced by collinearity. We have added the interpretation to page 17 of the revised manuscript.

      Author response table 1.

      Proportion of variability explained (r<sup>2</sup>) of RSA predictors.

      (2) In "task overview", SR is defined as the word-response pair; however, in the Methods, lines 495-496, the definition changed to "the pairing between word and ISPC" which is in accordance with the values in the RDMs (e.g., mccbb and mcirb have similarity of 1, but they are linked to different responses, so should they not be considered different in terms of SR?). This needs clarification as they have very different implications for the task design and interpretation of results, e.g., how correlated the SC and SR manipulations were.

      Thank you for pointing out this important issue with how our operationalization captures the concept in questions. In the revised manuscript, we clarified the stimulus-response (SR) association is the link between the word and the most-likely response (i.e., not necessarily the actual response on the current trial). This association is likely to be encoded based on statistical learning over several trials. On each trial, the association is updated based on the stimulus and the actual response. Over multiple trials, the accumulated association will be driven towards the most-common (i.e., most-likely) response. In our ISPC manipulation, a color is presented in mostly congruent/incongruent (MC/MI) trials, which will also pair a word with a most-likely response. For example, if the color blue is MC, the color blue, which leads to the response blue, will co-occur with the word blue with high frequency. In other words, the SR association here is between the word blue and the response blue. As the actual response is not part of the SR association, in the RDM two trial types with different responses may share the same SR association, as long as they share the same word and the same ISPC manipulation, which, by the logic above, will produce the same most-likely response. These clarifications have been added to page 4 and 29 of the revised manuscript.

      In the revised manuscript (Page 17), we addressed how much the correlated SC and SR predictors in the RDM could affect the correlation analysis between SC and SR association representation strength. Specifically, we conducted the RSA using the same GLM on EEG data prior to stimulus onset (Supplementary Fig. 7a-b). As no SC and SR associations are expected to be present before stimulus onset, the correlation between SC and SR representation would serve as a baseline of inflation due to correlated predictors in the GLM (Supplementary Fig. 7c, also see comment #3 of R1). The SC-SR correlation coefficients following stimulus onset was then compared to the baseline to control for potential inflation (Fig. 6c). Significantly above-baseline correlation was still observed between ~100-500 ms post-stimulus onset, providing support for the hypothesis that SC and SR are encoded in the same task representation.

      Minor suggestions:

      (3) Overall, I find that calling SC-controlled and SR-uncontrolled representations unwarranted. How is the level controlledness defined? Both are essentially types of statistical expectation that provide contextual information for the block of tasks. Is one really more automatic and requires less conscious processing than the other? More background/justification could be provided if the authors would like to use these terms.

      Following your advice, we have added more discussion on how controlledness is conceptualized in this work and in the literature, which reads:

      “We consider SC and SR as controlled and uncontrolled respectively based on the literature investigating the mechanism of ISPC effect. The SC account posits that the ISPC effect results from conflict and involves conflict adaptation, which requires the regulation of attention or control (Bugg & Hutchison, 2013; Bugg et al., 2011; Schmidt, 2018; Schmidt & Besner, 2008). On the other hand, the SR account argues that ISPC effect does not require conflict adaptation but instead reflects contingency leaning. That is, the response can be directly retrieved from the association between the stimulus and the most-likely response without top-down regulation of attention or control. As more empirical evidence emerged, researchers advocating control view began to acknowledge the role of associative learning in cognitive control regarding the ISPC effect (Abrahamse et al., 2016). SC association has been thought to include both automatic that is fast and resource saving and controlled processes that is flexible and generalizable (Chiu, 2019). Overall, we do not intend to claim that SC is entirely controlled or SR is completely automatic. We use SC-controlled and SR-uncontrolled representations to align with the original theoretical motivation and to highlight the conceptual difference between SC and SR associations.” (Page 24-25)

      (4) Figures 3c and d: the figures could benefit from more explanation of what they try to show to the readers. Also for 3d, the dimensions were aligned with color sets and congruencies, but word identities were not linearly separable, at least for the first 3 axes. Shouldn't one expect that words can be decoded in the SR subspace if word-response pairs were decodable (e.g., Figure 3b)?

      Thank you for the insightful observation. We now clarified that Fig. 3c and d in the original manuscript (Fig. 4c and d in the current manuscript) aim to show how each of the 8 trial types in the SC and SR subspaces are represented. The MDS approach we used for visualization tries to preserve dissimilarity between trial types when projecting from data from a high dimensional to a low dimensional space. However, such projection may also make patterns linearly separatable in high dimensional space not linearly separatable in low dimensional space. For example, if the word blue has two points (-1, -1) and (1, 1) and the word red has two points (-1, 1) and (1, -1), they are not linearly separatable in the 2D space. Yet, if they are projected from a 3D space with coordinates of (-1, -1, -0.1), (1, 1, -0.1), (-1, 1, 0.1) and (1, -1, 0.1), the two words can be linearly separatable using the 3<sup>rd</sup> dimension. Thus, a better way to test whether word can be linearly separated in SR subspace is to perform RSA on the original high dimensional space. We performed the RSA with word (Supplementary Fig. 2) on the SR decoder trained on the SR subspace. Note that in Fig. 3c and d of the original script (Fig. 4c and d in the current manuscript) there are two pairs of words that are not linearly separable: red-blue and yellow-green. Thus, we specifically tested the separability within the two pairs using the one predictor for each pair, as shown in Supplementary Fig. 2. The results showed that within both word pairs individual words were presented above chance level (Supplementary Fig. 3). Considering that the decoders are linear, this finding indicates linear separability of the word pairs in the original SR subspace. The clarification has been added to page 13 (the end of the second paragraph) of the revised manuscript.

      References

      Abrahamse, E., Braem, S., Notebaert, W., & Verguts, T. (2016). Grounding cognitive control in associative learning. Psychological Bulletin, 142(7), 693-728.doi:10.1037/bul0000047.

      Bugg, J. M., & Hutchison, K. A. (2013). Converging evidence for control of color-word Stroop interference at the item level. Journal of Experimental Psychology:Human Perception and Performance, 39(2), 433-449. doi:10.1037/a0029145.

      Bugg, J. M., Jacoby, L. L., & Chanani, S. (2011). Why it is too early to lose control in accounts of item-specific proportion congruency effects. Journal of Experimental Psychology: Human Perception and Performance, 37(3), 844-859. doi:10.1037/a0019957.

      Chiu, Y.-C. (2019). Automating adaptive control with item-specific learning. In Psychology of Learning and Motivation (Vol. 71, pp. 1-37).

      Schmidt, J. R. (2018). Evidence against conflict monitoring and adaptation: An updated review. Psychonomic Bulletin & Review, 26(3), 753-771. doi:10.3758/s13423018-1520-z.

      Schmidt, J. R., & Besner, D. (2008). The Stroop effect: Why proportion congruent has nothing to do with congruency and everything to do with contingency. Journal of Experimental Psychology: Learning, Memory, and Cognition, 34(3), 514-523. doi:10.1037/0278-7393.34.3.514.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (Public review):

      Summary:

      In this article, Kawanabe-Kobayashi et al., aim to examine the mechanisms by which stress can modulate pain in mice. They focus on the contribution of noradrenergic neurons (NA) of the locus coeruleus (LC). The authors use acute restraint stress as a stress paradigm and found that following one hour of restraint stress mice display mechanical hypersensitivity. They show that restraint stress causes the activation of LC NA neurons and the release of NA in the spinal cord dorsal horn (SDH). They then examine the spinal mechanisms by which LC→SDH NA produces mechanical hypersensitivity. The authors provide evidence that NA can act on alphaA1Rs expressed by a class of astrocytes defined by the expression of Hes (Hes+). Furthermore, they found that NA, presumably through astrocytic release of ATP following NA action on alphaA1Rs Hes+ astrocytes, can cause an adenosine-mediated inhibition of SDH inhibitory interneurons. They propose that this disinhibition mechanism could explain how restraint stress can cause the mechanical hypersensitivity they measured in their behavioral experiments.

      Strengths:

      (1) Significance. Stress profoundly influences pain perception; resolving the mechanisms by which stress alters nociception in rodents may explain the well-known phenomenon of stress-induced analgesia and/or facilitate the development of therapies to mitigate the negative consequences of chronic stress on chronic pain.

      (2) Novelty. The authors' findings reveal a crucial contribution of Hes+ spinal astrocytes in the modulation of pain thresholds during stress.

      (3) Techniques. This study combines multiple approaches to dissect circuit, cellular, and molecular mechanisms including optical recordings of neural and astrocytic Ca2+ activity in behaving mice, intersectional genetic strategies, cell ablation, optogenetics, chemogenetics, CRISPR-based gene knockdown, slice electrophysiology, and behavior.

      Weaknesses:

      (1) Mouse model of stress. Although chronic stress can increase sensitivity to somatosensory stimuli and contribute to hyperalgesia and anhedonia, particularly in the context of chronic pain states, acute stress is well known to produce analgesia in humans and rodents. The experimental design used by the authors consists of a single one-hour session of restraint stress followed by 30 min to one hour of habituation and measurement of cutaneous mechanical sensitivity with von Frey filaments. This acute stress behavioral paradigm corresponds to the conditions in which the clinical phenomenon of stress-induced analgesia is observed in humans, as well as in animal models. Surprisingly, however, the authors measured that this acute stressor produced hypersensitivity rather than antinociception. This discrepancy is significant and requires further investigation.

      We thank the reviewer for evaluating our work and for highlighting both its strengths and weaknesses. As stated by the reviewer, numerous studies have reported acute stress-induced antinociception. However, as shown in a new additional table (Table S1) in which we have summarized previously published data using the acute restraint stress model employed in our present study, most studies reporting antinociceptive effects of acute restraint stress assessed behavioral responses to heat stimuli or formalin. This observation is consistent with the findings from our previous study (Uchiyama et al., Mol Brain, 2022 (PMID: 34980215)). The present study also confirms that acute restraint stress reduces behavioral responses to noxious heat (see also our response to Comment #2 below). In contrast to the robust and consistent antinociceptive effects observed with thermal stimuli, some studies evaluating behavioral responses to mechanical stimuli have reported stress-induced hypersensitivity (see Table S1), which aligns with our current findings. Taken together, these data support our original notion that the effects of acute stress on pain-related behaviors depend on several factors, including the nature, duration, and intensity of the stressor, as well as the sensory modality assessed in behavioral tests. We have incorporated this discussion and Table S1 into the revised manuscript (lines 344-353). Furthermore, we have slightly modified the text including the title, replacing "pain facilitation" with "mechanical pain hypersensitivity" to more accurately reflect our research focus and the conclusion of this study that LC<sup>→SDH</sup> NAergic signaling to spinal astrocytes is required for stress-induced mechanical pain hypersensitivity. Finally, while mouse models of stress could provide valuable insights, the clinical relevance of stress-induced mechanical pain hypersensitivity remains to be elucidated and requires further investigation. We hope these clarifications address your concerns.

      (2) Specifically, is the hypersensitivity to mechanical stimulation also observed in response to heat or cold on a hotplate or coldplate?

      Thank you for your important comment. We have now conducted additional behavioral experiments to assess responses to heat using the hot-plate test. We found that mice subjected to restraint stress did not exhibit behavioral hypersensitivity to heat stimuli; instead, they displayed antinociceptive responses (Figure S2; lines 95-98). These results are consistent with our previous findings (Uchiyama et al., Mol Brain, 2022 (PMID: 34980215)) as well as numerous other reports (Table S1).

      (3) Using other stress models, such as a forced swim, do the authors also observe acute stress-induced hypersensitivity instead of stress-induced antinociception?

      As suggested by the reviewer, we conducted a forced swim test. We found that mice subjected to forced swimming, which has been reported to produce analgesic effects on thermal stimuli (Contet et al., Neuropsychopharmacology, 2006 (PMID: 16237385)), did not exhibit any changes in mechanical pain hypersensitivity (Figure S2; lines 98-99). Furthermore, a previous study demonstrated that mechanical pain sensitivity is enhanced by other stress models, such as exposure to an elevated open platform for 30 min (Kawabata et al., Neuroscience, 2023 (PMID: 37211084)). However, considering our data showing that changes in mechanosensory behavior induced by restraint stress depend on the duration of exposure (Figure S1), and that restraint stress also produced an antinociceptive effect on heat stimuli (Figure S2), stress-induced modulation of pain is a complex phenomenon influenced by multiple factors, including the stress model, intensity, and duration, as well as the sensory modality used for behavioral testing (lines 100-103).

      (4) Measurement of stress hormones in blood would provide an objective measure of the stress of the animals.

      A previous study has demonstrated that plasma corticosterone levels—a stress hormone—are elevated following a 1-hour exposure to restraint stress in mice (Kim et al., Sci Rep, 2018 (PMID: 30104581)), using a stress protocol similar to that employed in our current study. We have included this information with citing this paper (lines 104-105).

      (5) Results:

      (a) Optical recordings of Ca2+ activity in behaving rodents are particularly useful to investigate the relationship between Ca2+ dynamics and the behaviors displayed by rodents.

      In the optical recordings of Ca<sup>2+</sup> activity in LC neurons, we monitored mouse behavior during stress exposure. We have now included a video of this in the revised manuscript (video; lines 111-114).

      (b) The authors report an increase in Ca2+ events in LC NA neurons during restraint stress: Did mice display specific behaviors at the time these Ca2+ events were observed such as movements to escape or orofacial behaviors including head movements or whisking?

      By reanalyzing the temporal relationship between Ca<sup>2+</sup> events and mouse behavior during stress exposure, we found that the Ca<sup>2+</sup> transients and escape behaviors (struggling) occurred almost simultaneously (video). A similar temporal correlation is also observed in Ca<sup>2+</sup> responses in the bed nucleus of the stria terminalis (Luchsinger et al., Nat Commun, 2021 (PMID: 34117229)). The video file has been included in the revised manuscript (video; lines 111-113, 552-553, 573-575).

      Additionally, as described in the Methods section and shown in Figure S2 of the initial version (now Figure S3), non-specific signals or artifacts—such as those caused by head movements—were corrected (although such responses were minimal in our recordings).

      (c) Additionally, are similar increases in Ca2+ events in LC NA neurons observed during other stressful behavioral paradigms versus non-stressful paradigms?

      We appreciate the reviewer's valuable suggestion. Since the present, initial version of our manuscript focused on acute restraint stress, we did not measure Ca<sup>2+</sup> events in LC-NA neurons in other stress models, but a recent study has shown an increase in Ca<sup>2+</sup> responses in LC-NA neurons by social defeat stress (Seiriki et al., BioRxiv, https://www.biorxiv.org/content/10.1101/2025.03.07.641347v1).

      (d) Neuronal ablation to reveal the function of a cell population.

      This method has been widely used in numerous previous studies as an effective experimental approach to investigate the role of specific neuronal populations—including SDH-projecting LC-NA neurons (Ma et al., Brain Res, 2022 (PMID: 34929182); Kawanabe et al., Mol Brain, 2021 (PMID: 33971918))—in CNS function.

      (e) The proportion of LC NA neurons and LC→SDH NA neurons expressing DTR-GFP and ablated should be quantified (Figures 1G and J) to validate the methods and permit interpretation of the behavioral data (Figures 1H and K). Importantly, the nocifensive responses and behavior of these mice in other pain assays in the absence of stress (e.g., hotplate) and a few standard assays (open field, rotarod, elevated plus maze) would help determine the consequences of cell ablation on processing of nociceptive information and general behavior.

      As suggested, we conducted additional experiments to quantitatively analyze the number of LC<sup>→SDH</sup>-NA neurons. We used WT mice injected with AAVretro-Cre into the SDH (L4 segment) and AAV-FLEx[DTR-EGFP] into the LC. In these mice, 4.4% of total LC-NA neurons [positive for tyrosine hydroxylase (TH)] expressed DTR-GFP, representing the LC<sup>→SDH</sup>-NA neuronal population (Figure S4; lines 126-127). Furthermore, treatment with DTX successfully ablated the DTR-expressing LC<sup>→SDH</sup>-NA neurons. Importantly, the neurons quantified in this analysis were specifically those projecting to the L4 segment of the SDH; therefore, the total number of SDH-projecting LC-NA neurons across all spinal segments is expected to be much higher.

      We also performed the rotarod and paw-flick tests to assess motor function and thermal sensitivity following ablation of LC<sup>→SDH</sup>-NA neurons. No significant differences were observed between the ablated and control groups (Figure S5; lines 131-134), indicating that ablation of these neurons does not produce non-specific behavioral deficits in motor function or other sensory modalities.

      (f) Confirmation of LC NA neuron function with other methods that alter neuronal excitability or neurotransmission instead of destroying the circuit investigated, such as chemogenetics or chemogenetics, would greatly strengthen the findings. Optogenetics is used in Figure 1M, N but excitation of LCLC<sup>→SDH</sup> NA neuron terminals is tested instead of inhibition (to mimic ablation), and in naïve mice instead of stressed mice.

      We appreciate the reviewer’s comment. The optogenetic approach is useful for manipulating neuronal excitability; however, prolonged light illumination (> tens of seconds) can lead to undesirable tissue heating, ionic imbalance, and rebound spikes (Wiegert et al., Neuron, 2017 (PMID: 28772120)), making it difficult to apply in our experiments, in which mice are exposed to stress for 60 min. For this reason, we decided to employ the cell-ablation approach in stress experiments, as it is more suitable than optogenetic inhibition. In addition, as described in our response to weakness (1)-a) by Reviewer 3 (Public review), we have now demonstrated the specific expression of DTRs in NA neurons in the LC, but not in A5 or A7 (Figure S4; lines 127-128), confirming the specificity of LCLC<sup>→SDH</sup>-NAergic pathway targeting in our study. Chemogenetics represent another promising approach to further strengthen our findings on the role of LCLC<sup>→SDH</sup>-NA neurons, but this will be an important subject for future studies, as it will require extensive experiments to assess, for example, the effectiveness of chemogenetic inhibition of these neurons during 60 min of restraint stress, as well as optimization of key parameters (e.g., systemic DCZ doses).

      (g) Alpha1Ars. The authors noted that "Adra1a mRNA is also expressed in INs in the SDH".

      The expression of α<sub>1A</sub>Rs in inhibitory interneurons in the SDH is consistent with our previous findings (Uchiyama et al., Mol Brain, 2022 (PMID: 34980215)) as well as with scRNA-seq data (http://linnarssonlab.org/dorsalhorn/, Häring et al., Nat Neurosci, 2018 (PMID: 29686262)).

      (h) The authors should comprehensively indicate what other cell types present in the spinal cord and neurons projecting to the spinal cord express alpha1Ars and what is the relative expression level of alpha1Ars in these different cell types.

      According to the scRNA-seq data (https://seqseek.ninds.nih.gov/genes, Russ et al., Nat Commun, 2021 (PMID: 34588430); http://linnarssonlab.org/dorsalhorn/, Häring et al., Nat Neurosci, 2018 (PMID: 29686262)), we confirmed that α<sub>1A</sub>Rs are predominantly expressed in astrocytes and inhibitory interneurons in the spinal cord. Also, an α<sub>1A</sub>R-expressing excitatory neuron population (Glut14) expresses Tacr1, GPR83, and Tac1 mRNAs, markers that are known to be enriched in projection neurons of the SDH. This raises the possibility that α<sub>1A</sub> Rs may also be expressed in a subset of projection neurons, although further experiments are required to confirm this. In DRG neurons, α<sub>1A</sub>R expression was detected to some extent, but its level seems to be much lower than in the spinal cord (http://linnarssonlab.org/drg/ Usoskin et al., Nat Neurosci, 2015 (PMID: 25420068)). Consistent with this, primary afferent glutamatergic synaptic transmission has been shown to be unaffected by α<sub>1A</sub>R agonists (Kawasaki et al., Anesthesiology, 2003 (PMID: 12606912); Li and Eisenach, JPET, 2001 (PMID: 11714880)). This information has been incorporated into the Discussion section (lines 317-319).

      (i) The conditional KO of alpha1Ars specifically in Hes5+ astrocytes and not in other cell types expressing alpha1Ars should be quantified and validated (Figure 2H).

      We have previously shown a selective KO of α<sub>1A</sub>R in Hes5<sup>+</sup> astrocytes in the same mouse line (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)). This information has been included in the revised text (line 166-167).

      (j) Depolarization of SDH inhibitory interneurons by NA (Figure 3). The authors' bath applied NA, which presumably activates all NA receptors present in the preparation.

      We believe that the reviewer’s concern may pertain to the possibility that NA acts on non-Vgat<sup>+</sup> neurons, thereby indirectly causing depolarization of Vgat<sup>+</sup> neurons. As described in the Method section of the initial version, in our electrophysiological experiments, we added four antagonists for excitatory and inhibitory neurotransmitter receptors—CNQX (AMPA receptor), MK-801 (NMDA receptor), bicuculline (GABA<sub>A</sub> receptor), and strychnine (glycine receptor)—to the artificial cerebrospinal fluid to block synaptic inputs from other neurons to the recorded Vgat<sup>+</sup> neurons. Since this method is widely used for this purpose in many previous studies (Wu et al., J Neurosci, 2004 (PMID: 15140934); Liu et al., Nat Neurosci, 2010 (PMID: 20835251)), it is reasonable to conclude that NA directly acts on the recorded SDH Vgat<sup>+</sup> interneurons to produce excitation (lines 193-196).

      (k) The authors' model (Figure 4H) implies that NA released by LC→SDH NA neurons leads to the inhibition of SDH inhibitory interneurons by NA. In other experiments (Figure 1L, Figure 2A), the authors used optogenetics to promote the release of endogenous NA in SDH by LC→SDH NA neurons. This approach would investigate the function of NA endogenously released by LC NA neurons at presynaptic terminals in the SDH and at physiological concentrations and would test the model more convincingly compared to the bath application of NA.

      We appreciate the reviewer’s valuable comment. As noted, optogenetic stimulation of LC<sup>→SDH</sup>-NA neurons would indeed be useful to test this model. However, in our case, it is technically difficult to investigate the responses of Vgat<sup>+</sup> inhibitory neurons and Hes5<sup>+</sup> astrocytes to NA endogenously released from LC<sup>→SDH</sup>-NA neurons. This would require the use of Vgat-Cre or Hes5-CreERT2 mice, but employing these lines precludes the use of NET-Cre mice, which are necessary for specific and efficient expression of ChrimsonR in LC<sup>→SDH</sup>-NA neurons. Nevertheless, all of our experimental data consistently support the proposed model, and we believe that the reviewer will agree with this, without additional experiments that is difficult to conduct because of technical limitations (lines 382-388).

      (l) As for other experiments, the proportion of Hes+ astrocytes that express hM3Dq, and the absence of expression in other cells, should be quantified and validated to interpret behavioral data.

      We thank the reviewer for raising this point. In our experiments, we used an HA-tag (fused with hM3Dq) to confirm hM3Dq expression. However, it is difficult to precisely analyze individual astrocytes because, as shown in Figure 3J, the boundaries of many HA-tag<sup>+</sup> astrocytes are indistinguishable. This seems to be due to the membrane localization of HA-tag, the complex morphology of astrocytes, and their tile-like distribution pattern (Baldwin et al., Trends Cell Biol, 2024 (PMID: 38180380)). Nevertheless, our previous study demonstrated that ~90% of astrocytes in the superficial laminae are Hes5<sup>+</sup> (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), and intra-SDH injection of AAV-hM3Dq labeled the majority of superficial astrocytes (Figure 3J). Thus, AAV-FLEx[hM3Dq] injection into Hes5-CreERT2 mice allows efficient expression of hM3Dq in Hes5<sup>+</sup> astrocytes in the SDH. Importantly, our previous studies using Hes5-CreERT2 mice have confirmed that hM3Dq is not expressed in other cell types (neurons, oligodendrocytes, or microglia) (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652); Kagiyama et al., Mol Brain, 2025 (PMID: 40289116)). This information regarding the cell-type specificity has now been briefly described in the revised version (lines 218-219).

      (m) Showing that the effect of CNO is dose-dependent would strengthen the authors' findings.

      Thank you for your comment. We have now demonstrated a dose-dependent effect of CNO on Ca<sup>2+</sup> responses in SDH astrocytes (please see our response to Major Point (4) from Reviewer #2 (Recommendations for the Authors) (Figure S7; lines 225-228). In addition, we also confirmed that the effect of CNO is not nonspecific, as CNO application did not alter sIPSCs in spinal cord slices prepared from mice lacking hM3Dq expression in astrocytes (Figure S7; lines 225-228).

      (n) The proportion of SG neurons for which CNO bath application resulted in a reduction in recorded sIPSCs is not clear.

      We have included individual data points in each bar graph to more clearly illustrate the effect of CNO on each neuron (Figure 3L, N).

      (o) A1Rs. The specific expression of Cas9 and guide RNAs, and the specific KD of A1Rs, in inhibitory interneurons but not in other cell types expressing A1Rs should be quantified and validated.

      In addition to the data demonstrating the specific expression of SaCas9 and sgAdora1 in Vgat<sup>+</sup> inhibitory neurons shown in Figure 3G of the initial version, we have now conducted the same experiments with a different sample and confirmed this specificity: SaCas9 (detected via HA-tag) and sgAdora1 (detected via mCherry) were expressed in PAX2<sup>+</sup> inhibitory neurons (Author response image 1). Furthermore, as shown in Figure 3H and I in the initial version, the functional reduction of A<sub>1</sub>Rs in inhibitory neurons was validated by electrophysiological recordings. Together, these results support the successful deletion of A<sub>1</sub>Rs in inhibitory neurons.

      Author response image 1.

      Expression of HA-tag and mCherry in inhibitory neurons (a different sample from Figure 3G) SaCas9 (yellow, detected by HA-tag) and mCherry (magenta) expression in the PAX2<sup>+</sup> inhibitory neurons (cyan) at 3 weeks after intra-SDH injection of AAV-FLEx[SaCas9-HA] and AAV-FLEx[mCherry]-U6-sgAdora1 in Vgat-Cre mice. Arrowheads indicate genome-editing Vgat<sup>+</sup> cells. Scale bar, 25 µm.

      (6) Methods:

      It is unclear how fiber photometry is performed using "optic cannula" during restraint stress while mice are in a 50ml falcon tube (as shown in Figure 1A).

      We apologize for the omission of this detail in the Methods section. To monitor Ca<sup>2+</sup> events in LC-NA neurons during restraint stress, we created a narrow slit on the top of the conical tube, allowing mice to undergo restraint stress while connected to the optic fiber (see video). This information has now been added to the Methods section (lines 552-553).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Scientific rigor:

      It is unclear if the normal distribution of the data was determined before selecting statistical tests.

      We apologize for omitting this description. For all statistical analyses in this study, we first assessed the normality of the data and then selected appropriate statistical tests accordingly. We have added this information to the revised manuscript (lines 711-712).

      (2) Nomenclature:

      (a) Mouse Genome Informatics (MGI) nomenclature should be used to describe mouse genotypes (i.e., gene name in italic, only first letter is capitalized, alleles in superscript).

      (b) FLEx should be used instead of flex.

      Thank you for the suggestion. We have corrected these terms (including FLEx) according to MGI nomenclature.

      Reviewer #2 (Public review):

      Summary:

      This study investigates the role of spinal astrocytes in mediating stress-induced pain hypersensitivity, focusing on the LC (locus coeruleus)-to-SDH (spinal dorsal horn) circuit and its mechanisms. The authors aimed to delineate how LC activity contributes to spinal astrocytic activation under stress conditions, explore the role of noradrenaline (NA) signaling in this process, and identify the downstream astrocytic mechanisms that influence pain hypersensitivity.

      The authors provide strong evidence that 1-hour restraint stress-induced pain hypersensitivity involves the LC-to-SDH circuit, where NA triggers astrocytic calcium activity via alpha1a adrenoceptors (alpha1aRs). Blockade of alpha1aRs on astrocytes - but not on Vgat-positive SDH neurons - reduced stress-induced pain hypersensitivity. These findings are rigorously supported by well-established behavioral models and advanced genetic techniques, uncovering the critical role of spinal astrocytes in modulating stress-induced pain.

      However, the study's third aim - to establish a pathway from astrocyte alpha1aRs to adenosine-mediated inhibition of SDH-Vgat neurons - is less compelling. While pharmacological and behavioral evidence is intriguing, the ex vivo findings are indirect and lack a clear connection to the stress-induced pain model. Despite these limitations, the study advances our understanding of astrocyte-neuron interactions in stress-pain contexts and provides a strong foundation for future research into glial mechanisms in pain hypersensitivity.

      Strengths:

      The study is built on a robust experimental design using a validated 1-hour restraint stress model, providing a reliable framework to investigate stress-induced pain hypersensitivity. The authors utilized advanced genetic tools, including retrograde AAVs, optogenetics, chemogenetics, and subpopulation-specific knockouts, allowing precise manipulation and interrogation of the LC-SDH circuit and astrocytic roles in pain modulation. Clear evidence demonstrates that NA triggers astrocytic calcium activity via alpha1aRs, and blocking these receptors effectively reduces stress-induced pain hypersensitivity.

      Weaknesses:

      Despite its strengths, the study presents indirect evidence for the proposed NA-to-astrocyte(alpha1aRs)-to-adenosine-to-SDH-Vgat neurons pathway, as the link between astrocytic adenosine release and stress-induced pain remains unclear. The ex vivo experiments, including NA-induced depolarization of Vgat neurons and chemogenetic stimulation of astrocytes, are challenging to interpret in the stress context, with the high CNO concentration raising concerns about specificity. Additionally, the role of astrocyte-derived D-serine is tangential and lacks clarity regarding its effects on SDH Vgat neurons. The astrocyte calcium signal "dip" after LC optostimulation-induced elevation are presented without any interpretation.

      We appreciate the reviewer's careful reading of our paper. According to the reviewer's comments, we have performed new additional experiments and added some discussion in the revised manuscript (please see the point-by-point responses below).

      Reviewer #2 (Recommendations for the authors):

      The astrocyte-mediated pathway of NA-to-astrocyte (alpha1aRs)-to-adenosine-to-SDH Vgat neurons (A1R) in the context of stress-induced pain hypersensitivity requires more direct evidence. While the data showing that the A1R agonist CPT inhibits stress-induced hypersensitivity and that stress combined with Aβ fiber stimulation increases pERK in the SDH are intriguing, these findings primarily support the involvement of A1R on Vgat neurons and are only behaviorally consistent with SDH-Vgat neuronal A1R knockdown. The role of astrocytes in this pathway in vivo remains indirect. The ex vivo chemogenetic Gq-DREADD stimulation of SDH astrocytes, which reduced sIPSCs in Vgat neurons in a CPT-dependent manner, needs revision with non-DREADD+CNO controls to validate specificity. Furthermore, the ex vivo bath application of NA causing depolarization in Vgat neurons, blocked by CPT, adds complexity to the data leaving me wondering how astrocytes are involved in such processes, and it does not directly connect to stress-induced pain hypersensitivity. These findings are potentially useful but require additional refinement to establish their relevance to the stress model.

      We thank the reviewer for the insightful feedback. First, regarding the role of astrocytes in this pathway in vivo, we showed in the initial version that mechanical pain hypersensitivities induced by intrathecal NA injection and by acute restraint stress were attenuated by both pharmacological blockade and Vgat<sup>+</sup> neuron-specific knockdown of A<sub>1</sub>Rs (Figure 4A, B). Given that NA- and stress-induced pain hypersensitivity is mediated by α<sub>1A</sub>R-dependent signaling in Hes5<sup>+</sup> astrocytes (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652); this study), these findings provide in vivo evidence supporting the involvement of the NA → Hes5<sup>+</sup> astrocyte (via α<sub>1A</sub>Rs) → adenosine → Vgat<sup>+</sup> neuron (via A<sub>1</sub>Rs) pathway. As noted in the reviewer’s major comment (2), in vivo monitoring of adenosine dynamics in the SDH during stress exposure would further substantiate the astrocyte-to-neuron signaling pathway. However, we did not detect clear signals, potentially due to several technical limitations (see our response below). Acknowledging this limitation, we have now added a new paragraph in the end of Discussion section to address this issue. Second, the specificity of the effect of CNO has now been validated by additional experiments (see our response to major point (4)). Third, the reviewer’s concern regarding the action of NA on Vgat<sup>+</sup> neurons has also been addressed (see our response to major point (3) below).

      Major points:

      (1) The in vivo pharmacology using DCK to antagonize D-serine signaling from alpha1a-activated astrocytes is tangential, as there is limited evidence on how Vgat neurons (among many others) respond to D-serine. This aspect requires more focused exploration to substantiate its relevance.

      We propose that the site of action of D-serine in our neural circuit model is the NMDA receptors (NMDARs) on excitatory neurons, a notion supported by our previous findings (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652); Kagiyama et al., Mol Brain, 2025 (PMID: 40289116)). However, we cannot exclude the possibility that D-serine also acts on NMDARs expressed by Vgat<sup>+</sup> inhibitory neurons. Nevertheless, given that intrathecal injection of D-serine in naïve mice induces mechanical pain hypersensitivity (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), it appears that the pronociceptive effect of D-serine in the SDH is primarily associated with enhanced pain processing and transmission, presumably via NMDARs on excitatory neurons. We have added this point to the Discussion section in the revised manuscript (lines 325-330).

      (2) Additionally, employing GRAB-Ado sensors to monitor adenosine dynamics in SDH astrocytes during NA signaling would significantly strengthen conclusions about astrocyte-derived adenosine's role in the stress model.

      We agree with the reviewer’s comment. Following this suggestion, we attempted to visualize NA-induced adenosine (and ATP) dynamics using GRAB-ATP and GRAB-Ado sensors (Wu et al., Neuron, 2022 (PMID: 34942116); Peng et al., Science, 2020 (PMID: 32883833)) in acutely isolated spinal cord slices from mice after intra-SDH injection of AAV-hSyn-GRABATP<sub>1.0</sub> and -GRABAdo<sub>1.0</sub>. We confirmed expression of these sensors in the SDH (Author response image 2a) and observed increased signals after bath application of ATP (0.1 or 1 µM) or adenosine (1 µM) (Author response image 2b, c). However, we were unable to detect clear signals following NA stimulation (Author response image 2b, c). The reason for this lack of detectable changes remains unclear. If the release of adenosine from astrocytes is a highly localized phenomenon, it may be measurable using high-resolution microscopy capable of detecting adenosine levels at the synaptic level and more sensitive sensors. Further investigation will therefore be required (lines 340-341).

      Author response image 2.

      Ex vivo imaging of GRAB-ATP and GRAB-Ado sensors.(a) Representative images of GRAB<sub>ATP1.0</sub> (left, green) or GRAB<sub>Ado1.0</sub> (right, green) expression in the SDH at 3 weeks after SDH injection of AAV-hSyn-GRAB<sub>Ado1.0</sub> or AAV-hSyn-GRAB<sub>Ado1.0</sub> in Hes5-CreERT2 mice. Scale bar, 200 µm. (b) Left: Representative fluorescence images showing GRAB<sub>ATP1.0</sub> responses before and after perfusion with NA or ATP. Right: Representative traces showing responses to ATP (0.1 and 1 µM) or NA (10 µM). (c) Left: Representative fluorescence images showing GRABAdo1.0 responses before and after perfusion with NA or adenosine (Ado). Right: Representative traces showing responses to Ado (0.01, 0.1, and 1 µM), NA (10 µM), or no application (negative control).

      (3) The interpretation of Figure 3D is challenging. The manuscript implies that 20 μM NA acts on Adra1a receptors on Vgat neurons to depolarize them, but this concentration should also activate Adra1a on astrocytes, leading to adenosine release and potential inhibition of depolarization. The observation of depolarization despite these opposing mechanisms requires explanation, as does the inhibition of depolarization by bath-applied A1R agonist. Of note, 20 μM NA is a high concentration for Adra1a activation, typically responsive at nanomolar levels. The discussion should reconcile this with prior studies indicating dose-dependent effects of NA on pain sensitivity (e.g., Reference 22).

      Like the reviewer, we also considered that bath-applied NA could activate α<sub>1A</sub>Rs expressed on Hes5<sup>+</sup> astrocytes. To clarify this point, we have performed additional patch-clamp recordings and found that knockdown of A<sub>1</sub>Rs in Vgat<sup>+</sup> neurons tended to increase the proportion of Vgat<sup>+</sup> neurons with NA-induced depolarizing responses (Figure S8). Therefore, it is conceivable that NA-induced excitation of Vgat<sup>+</sup> neurons may involve both a direct effect of NA activating α<sub>1A</sub>Rs in Vgat<sup>+</sup> neurons and an indirect inhibitory signaling from NA-stimulated Hes5<sup>+</sup> astrocytes via adenosine (lines 298-300).

      The concentration of NA used in our ex vivo experiments is higher than that typically used in vitro with αR-<sub>1A</sub>expressing cell lines or primary culture cells, but is comparable to concentrations used in other studies employing spinal cord slices (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652); Baba et al., Anesthesiology, 2000 (PMID: 10691236); Lefton et al., Science, 2025 (PMID: 40373122)). In slice experiments, drugs must diffuse through the tissue to reach target cells, resulting in a concentration gradient. Therefore, higher drug concentrations are generally necessary in slice experiments, in contrast to cultured cell experiments, where drugs are directly applied to target cells. Importantly, we have previously shown that the pharmacological effects of 20 μM NA on Vgat<sup>+</sup> neurons and Hes5<sup>+</sup> astrocytes are abolished by loss of α<sub>1A</sub>Rs in these cells (Uchiyama et al., Mol Brain, 2022 (PMID: 34980215); Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), confirming the specificity of these NA actions.

      Regarding the dose-dependent effect of NA on pain sensitivity, NA-induced pain hypersensitivity is abolished in Hes5<sup>+</sup> astrocyte-specific α<sub>1A</sub>R-KO mice (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), indicating that this behavior is mediated by α<sub>1A</sub>Rs expressed on Hes5<sup>+</sup> astrocytes. In contrast, the suppression of pain sensitivity by high doses of NA was unaffected in the KO mice (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), suggesting that other adrenergic receptors may contribute to this phenomenon. Clarifying the responsible receptors will require future investigation.

      (4) In Figure 3K-M, the CNO concentration used (100 μM) is unusually high compared to standard doses (1 to a few μM), raising concerns about potential off-target effects. Including non-hM3Dq controls and using lower CNO concentrations are essential to validate the specificity of the observed effects. Similarly, the study should clarify whether astrocyte hM3Dq stimulation alone (without NA) would induce hyperpolarization in Vgat neurons and how this interacts with NA-induced depolarization.

      We acknowledge that the concentration of CNO used in our experiments is relatively high compared to that used in other reports. However, in our experiments, application of CNO at 1, 10, and 100 μM induced Ca<sup>2+</sup> increases in GCaMP6-expressing astrocytes in spinal cord slices in a concentration-dependent manner (Figure S7). Among these, 100 μM CNO most effectively replicated the NA-induced Ca<sup>2+</sup> signals in astrocytes. Based on these findings, we selected this concentration for use in both the current and previous studies (Kohro et al., Nat Neurosci., 2020 (PMID: 33020652)). Importantly, to rule out non-specific effects, we conducted control experiments using spinal cord slices from mice that did not express hM3Dq in astrocytes and confirmed that CNO had no effect on Ca<sup>2+</sup> responses in astrocytes and sIPSCs in substantial gelatinosa (SG) neurons (Figure S7; lines 223-228). Thus, although the CNO concentration used is relatively high, the observed effects of CNO are not non-specific but result from the chemogenetic activation of hM3Dq-expressing astrocytes.

      In this study, we used Hes5-CreERT2 and Vgat-Cre mice to manipulate gene expression in Hes5<sup>+</sup> astrocytes and Vgat<sup>+</sup> neurons, respectively. In order to fully address the reviewer’s comment, the use of both Cre lines is necessary. However, simultaneous and independent genetic manipulation in each cell type using Cre activity alone is not feasible with the current genetic tools. We have mentioned this as a technical limitation in the Discussion section (lines 382-388).

      (5) The role of D-serine released by hM3Dq-stimulated astrocytes in (separately) modulating sub-types of neurons including excitatory neurons and Vgat positives needs more detailed discussion. If no effect of D-serine on Vgat neurons is observed, this should be explicitly stated, and the discussion should address why this might be the case.

      As mentioned in our response to Major Point (1) above, we have added a discussion of this point in the revised manuscript (lines 325-330).

      (6) Finally, the observed "dip" in astrocyte calcium signals below baseline following the large peaks with LC optostimulation should be discussed further, as understanding this phenomenon could provide valuable insights into astrocytic signaling dynamics in the context of single acute or repetitive chronic stress.

      Thank you for your comment. We found that this phenomenon was not affected by pretreatment with the α<sub>1A</sub>R-specific antagonist silodosin (Author response image 3), which effectively suppressed Ca<sup>2+</sup> elevations evoked by stimulation of LC-NA neurons (Figure 2F). This implies that the phenomenon is independent of α<sub>1A</sub>R signaling. Elucidating the detailed underlying mechanism remains an important direction for future investigation.

      Author response image 3.

      The observed "dip" in astrocyte Ca<sup>2+</sup> signals was not affected by pretreatment with the α<sub>1A</sub>R-specific antagonist silodosin. Representative traces of astrocytic GCaMP6m signals in response to optogenetic stimulation of LC-NAe<sup>→SDH</sup>rgic axons/terminals in a spinal cord slice. Each trace shows the GCaMP6m signal before and after optogenetic stimulation (625 nm, 1 mW, 10 Hz, 5 ms pulse duration, 10 s). Slices were pretreated with silodosin (40 nM) for 5 min prior to stimulation.

      Reviewer #3 (Public review):

      Summary:

      This is an exciting and timely study addressing the role of descending noradrenergic systems in nocifensive responses. While it is well-established that spinally released noradrenaline (aka norepinephrine) generally acts as an inhibitory factor in spinal sensory processing, this system is highly complex. Descending projections from the A6 (locus coeruleus, LC) and the A5 regions typically modulate spinal sensory processing and reduce pain behaviours, but certain subpopulations of LC neurons have been shown to mediate pronociceptive effects, such as those projecting to the prefrontal cortex (Hirshberg et al., PMID: 29027903).

      The study proposes that descending cerulean noradrenergic neurons potentiate touch sensation via alpha-1 adrenoceptors on Hes5+ spinal astrocytes, contributing to mechanical hyperalgesia. This finding is consistent with prior work from the same group (dd et al., PMID:). However, caution is needed when generalising about LC projections, as the locus coeruleus is functionally diverse, with differences in targets, neurotransmitter co-release, and behavioural effects. Specifying the subpopulations of LC neurons involved would significantly enhance the impact and interpretability of the findings.

      Strengths:

      The study employs state-of-the-art molecular, genetic, and neurophysiological methods, including precise CRISPR and optogenetic targeting, to investigate the role of Hes5+ astrocytes. This approach is elegant and highlights the often-overlooked contribution of astrocytes in spinal sensory gating. The data convincingly support the role of Hes5+ astrocytes as regulators of touch sensation, coordinated by brain-derived noradrenaline in the spinal dorsal horn, opening new avenues for research into pain and touch modulation.

      Furthermore, the data support a model in which superficial dorsal horn (SDH) Hes5+ astrocytes act as non-neuronal gating cells for brain-derived noradrenergic (NA) signalling through their interaction with substantia gelatinosa inhibitory interneurons. Locally released adenosine from NA-stimulated Hes5+ astrocytes, following acute restraint stress, may suppress the function of SDH-Vgat+ inhibitory interneurons, resulting in mechanical pain hypersensitivity. However, the spatially restricted neuron-astrocyte communication underlying this mechanism requires further investigation in future studies.

      Weaknesses

      (1) Specificity of the LC Pathway targeting

      The main concern lies with how definitively the LC pathway was targeted. Were other descending noradrenergic nuclei, such as A5 or A7, also labelled in the experiments? The authors must convincingly demonstrate that the observed effects are mediated exclusively by LC noradrenergic terminals to substantiate their claims (i.e. "we identified a circuit, the descending LC→SDH-NA neurons").

      (a) For instance, the direct vector injection into the LC likely results in unspecific effects due to the extreme heterogeneity of this nucleus and retrograde labelling of the A5 and A7 nuclei from the LC (i.e., Li et al., PMID: 26903420).

      We appreciate the reviewer's valuable comments. To address this point, we performed additional experiments and demonstrated that intra-SDH injection of AAVretro-Cre followed by intra-LC injection of AAV2/9-EF1α-FLEx[DTR-EGFP] specifically results in DTR expression in NA neurons of the LC, but not of the A5 or A7 regions (Figure S4; lines 127-128). These results confirm the specificity of targeting the LC<sup>→SDH</sup>-NAergic pathway in our study.

      (b) It is difficult to believe that the intersectional approach described in the study successfully targeted LC→SDH-NA neurons using AAVrg vectors. Previous studies (e.g., PMID: 34344259 or PMID: 36625030) demonstrated that similar strategies were ineffective for spinal-LC projections. The authors should provide detailed quantification of the efficiency of retrograde labelling and specificity of transgene expression in LC neurons projecting to the SDH.

      Thank you for your comment. As we described in our response to the weakness (5)-e) of Reviewer #1 (Public review), our additional analysis showed that, under our experimental conditions, expression of genes (for example DTR) was observed in 4.4% of NA (TH<sup>+</sup>) neurons in the LC (Figure S4; lines 126-127).

      The reasons for this difference between the previous studies and our current study is unclear; however, it is likely attributed to methodological differences, including the type of viral vectors employed, species differences (mouse (PMID: 34344259, our study) vs. rat (PMID: 36625030)), the amount of AAV injected into the SDH (300 nL at three sites (PMID: 34344259), and 300 nL at a single site (our study)) and LC (500 nL at a single site (PMID: 34344259), and 300 nL at a single site (our study)), as well as the depth of AAV injection in the SDH (200–300 µm from the dorsal surface of the spinal cord (PMID: 34344259), and 120–150 µm in depth from the surface of the dorsal root entry zone (our study)).

      (c) Furthermore, it is striking that the authors observed a comparably strong phenotypical change in Figure 1K despite fewer neurons being labelled, compared to Figure 1H and 1N with substantially more neurons being targeted. Interestingly, the effect in Figure 1K appears more pronounced but shorter-lasting than in the comparable experiment shown in Figure 1H. This discrepancy requires further explanation.

      Although only a representative section of the LC was shown in the initial version, LC<sup>→SDH</sup>-NA neurons are distributed rostrocaudally throughout the LC, as previously reported (Llorca-Torralba et al., Brain, 2022 (PMID: 34373893)). Our additional experiments analyzing multiple sections of the anterior and posterior regions of the LC have now revealed that approximately sixty LC<sup>→SDH</sup>-NA neurons express DTR, and these neurons are eliminated following DTX treatment (Figure S4; lines 126-128) (it should be noted that these neurons specifically project to the L4 segment of the SDH, and the total number of LC<sup>→SDH</sup>-NA neurons is likely much higher). Considering the specificity of LC<sup>→SDH</sup>-NAergic pathway targeting demonstrated in our study (as described above), together with the fact that primary afferent sensory fibers from the plantar skin of the hindpaw predominantly project to the L4 segment of the SDH, these data suggest that the observed behavioral changes are attributable to the loss of these neurons and that ablation of even a relatively small number of NA neurons in the LC can have a significant impact on behavior. We have added this hypothesis in the Discussion section (lines 373-382).

      Regarding the data in Figures 1H and 1K, as the reviewer pointed out, a statistically significant difference was observed at 90 min in mice with ablation of LC-NA neurons, but not in those with LC<sup>→SDH</sup>-NA neuron ablation. This is likely due to a slightly higher threshold in the control group at this time point (Figure 1K), and it remains unclear whether there is a mechanistic difference between the two groups at this specific time point.

      (d) A valuable addition would be staining for noradrenergic terminals in the spinal cord for the intersectional approach (Figure 1J), as done in Figures 1F/G. LC projections terminate preferentially in the SDH, whereas A5 projections terminate in the deep dorsal horn (DDH). Staining could clarify whether circuits beyond the LC are being ablated.

      As suggested, we performed DTR immunostaining in the SDH; however, we did not detect any DTR immunofluorescence there. A similar result was also observed in the spinal terminals of DTR-expressing primary afferent fibers (our unpublished data). The reason for this is unclear, but to the best of our knowledge, no studies have clearly shown DTR expression at presynaptic terminals, which may be because the action of DTX on the neuronal cell body is necessary for cell ablation. Nevertheless, as described in our response to the weakness (5)-f) by Reviewer 1 (Public review), we have now confirmed the specific expression of DTR in the LC, but not in the A5 and A7 regions (Figure S4; lines 127-128).

      (e) Furthermore, different LC neurons often mediate opposite physiological outcomes depending on their projection targets-for example, dorsal LC neurons projecting to the prefrontal cortex PFCx are pronociceptive, while ventral LC neurons projecting to the SC are antinociceptive (PMIDs: 29027903, 34344259, 36625030). Given this functional diversity, direct injection into the LC is likely to result in nonspecific effects.

      To avoid behavioral outcomes resulting from a mixture of facilitatory and inhibitory effects caused by activating the entire population of LC-NA neurons, we employed a specific manipulation targeting LC<sup>→SDH</sup>-NA neurons using AAV vectors. The specificity of this manipulation was confirmed in our previous study (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)) and in the current study (Figure S4). Using this approach, we previously demonstrated that LC neurons can exert pronociceptive effects via astrocytes in the SDH (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)). This pronociceptive role is further supported by the current study, which uses a more selective manipulation of LC<sup>→SDH</sup>-NA neurons through a NET-Cre mouse line. In addition, intrathecal administration of relatively low doses of NA in naïve mice clearly induces mechanical pain hypersensitivity. Nevertheless, we have also acknowledged that several recent studies have reported an inhibitory role of LC<sup>→SDH</sup>-NA neurons in spinal nociceptive signaling. The reason for these differing behavioral outcomes remains unclear, but several methodological differences may underlie the discrepancy. First, the degree of LC<sup>→SDH</sup>-NA neuronal activity may play a role. Although direct comparisons between studies reporting pro- and anti-nociceptive effects are difficult, our previous studies demonstrated that intrathecal administration of high doses of NA in naïve mice does not induce mechanical pain hypersensitivity (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)). Second, the sensory modality used in behavioral testing may be a contributing factor as the pronociceptive effect of NA appears to be selectively observed in responses to mechanical, but not thermal, stimuli (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)). This sensory modality-selective effect is also evident in mice subjected to acute restraint stress (Table S1). Therefore, the role of LC<sup>→SDH</sup>-NA neurons in modulating nociceptive signaling in the SDH is more complex than previously appreciated, and their contribution to pain regulation should be reconsidered in light of factors such as NA levels, sensory modality, and experimental context. In revising the manuscript, we have included some points described above in the Discussion (lines 282-291).

      Conclusion on Specificity: The authors are strongly encouraged to address these limitations directly, as they significantly affect the validity of the conclusions regarding the LC pathway. Providing more robust evidence, acknowledging experimental limitations, and incorporating complementary analyses would greatly strengthen the manuscript.

      We appreciate the reviewer’s comments. We fully acknowledge the limitations raised and agree that addressing them directly is important for the rigor of our conclusions on the LC pathway. To this end, we have performed additional experiments (e.g., Figure A and S4), which are now included in the revised manuscript. Furthermore, we have also newly added a new paragraph for experimental limitations in the end of Discussion section (lines 373-408). We believe these new data substantially strengthen the validity of our findings and have clarified these points in the Discussion section.

      (2) Discrepancies in Data

      (a) Figures 1B and 1E: The behavioural effect of stress on PWT (Figure 1E) persists for 120 minutes, whereas Ca2+ imaging changes (Figure 1B) are only observed in the first 20 minutes, with signal attenuation starting at 30 minutes. This discrepancy requires clarification, as it impacts the proposed mechanism.

      Thank you for your important comment. As pointed out by the reviewer, there is a difference between the duration of behavioral responses and Ca<sup>2+</sup> events, although the exact time point at which the PWT begins to decline remains undetermined (as behavioral testing cannot be conducted during stress exposure). A similar temporal difference was also observed following intraplantar injection of capsaicin (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)); while LC<sup>→SDH</sup>-NA neuron-mediated astrocytic Ca<sup>2+</sup> responses in SDH astrocytes last for 5–10 min after injection, behavioral hypersensitivity peaks around 60 min post-injection and gradually returns to baseline over the subsequent 60–120 min. These findings raise the possibility that astrocyte-mediated pain hypersensitivity in the SDH may involve a sustained alteration in spinal neural function, such as central sensitization. We have added this hypothesis to the Discussion section of the revised manuscript (lines 399-408), as it represents an important direction for future investigation.

      (b) Figure 4E: The effect is barely visible, and the tissue resembles "Swiss cheese," suggesting poor staining quality. This is insufficient for such an important conclusion. Improved staining and/or complementary staining (e.g., cFOS) are needed. Additionally, no clear difference is observed between Stress+Ab stim. and Stress+Ab stim.+CPT, raising doubts about the robustness of the data.

      As suggested, we performed c-FOS immunostaining and obtained clearer results (Figure 4E,F; lines 243-252). We also quantitatively analyzed the number of c-FOS<sup>+</sup> cells in the superficial laminae, and the results are consistent with those obtained from the pERK experiments.

      (c) Discrepancy with Existing Evidence: The claim regarding the pronociceptive effect of LC→SDH-NAergic signalling on mechanical hypersensitivity contrasts with findings by Kucharczyk et al. (PMID: 35245374), who reported no facilitation of spinal convergent (wide-dynamic range) neuron responses to tactile mechanical stimuli, but potent inhibition to noxious mechanical von Frey stimulation. This discrepancy suggests alternative mechanisms may be at play and raises the question of why noxious stimuli were not tested.

      In our experiments, ChrimsonR expression was observed in the superficial and deeper laminae of the spinal cord (Figure S6). Due to the technical limitations of the optical fibers used for optogenetics, the light stimulation could only reach the superficial laminae; therefore, it may not have affected the activity of neurons (including WDR neurons) located in the deeper laminae. Furthermore, the study by Kucharczyk et al. (Brain, 2022 (PMID: 35245374)) employed a stimulation protocol that differed from ours, applying continuous stimulation over several minutes. Given that the levels of NA released from LC<sup>→SDH</sup>-NAergic terminals in the SDH increase with the duration of terminal stimulation (as shown in Figure 2B), longer stimulation may result in higher levels of NA in the SDH. Considering also our data indicating that the pro- and anti-nociceptive effects of NA are dose dependent (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), these differences may be related to LC<sup>→SDH</sup>-NA neuron activity, NA levels in the SDH, and the differential responses of SDH neurons in the superficial versus deeper laminae (lines 388-395).

      (3) Sole reliance on Von Frey testing

      The exclusive use of von Frey as a behavioural readout for mechanical sensitisation is a significant limitation. This assay is highly variable, and without additional supporting measures, the conclusions lack robustness. Incorporating other behavioural measures, such as the adhesive tape removal test to evaluate tactile discomfort, the needle floor walk corridor to assess sensitivity to uneven or noxious surfaces, or the kinetic weight-bearing test to measure changes in limb loading during movement, could provide complementary insights. Physiological tests, such as the Randall-Selitto test for noxious pressure thresholds or CatWalk gait analysis to evaluate changes in weight distribution and gait dynamics, would further strengthen the findings and allow for a more comprehensive assessment of mechanical sensitisation.

      Thank you for your suggestion. Based on our previous findings that Hes5<sup>+</sup> astrocytes in the SDH selectively modulate mechanosensory signaling (Kohro et al., Nat Neurosci, 2020 (PMID: 33020652)), the present study focused on behavioral responses to mechanical stimuli using von Frey filaments. As we have not previously conducted most of the behavioral tests suggested by the reviewers, and as we currently lack the necessary equipments for these tests (e.g., Randall–Selitto test, CatWalk gait analysis, and weight-bearing test), we were unable to include them in this study. However, it will be of great interest in future research to investigate whether activation of the LC<sup>→SDH</sup>-NA neuron-to-SDH Hes5<sup>+</sup> astrocyte signaling pathway similarly sensitizes behavioral responses to other types of mechanical stimuli and also to investigate the sensory modality-selective pro- and antinociceptive role of LC<sup>→SDH</sup>-NAergic signaling in the SDH (lines 396-399).

      Overall Conclusion

      This study addresses an important and complex topic with innovative methods and compelling data. However, the conclusions rely on several assumptions that require more robust evidence. Specificity of the LC pathway, experimental discrepancies, and methodological limitations (e.g., sole reliance on von Frey) must be addressed to substantiate the claims. With these issues resolved, this work could significantly advance our understanding of astrocytic and noradrenergic contributions to pain modulation.

      We have made every effort to address the reviewer’s concerns through additional experiments and analyses. Based on the new control data presented, we believe that our explanation is reasonable and acceptable. Although additional data cannot be provided on some points due to methodological constraints and limitations of the techniques currently available in our laboratory, we respectfully submit that the evidence presented sufficiently supports our conclusions.

      Reviewer #3 (Recommendations for the authors):

      A lot of beautiful and challenging-to-collect data is presented. Sincere congratulations to all the authors on this achievement!

      Notwithstanding, please carefully reconsider the conclusions regarding the LC pathway, as additional evidence is required to ensure their specificity and robustness.

      We thank the reviewer for the kind comments and for raising an important point regarding the LC pathway. The reviewer’s feedback prompted us to conduct additional investigations to further strengthen the validity of our conclusions. We have incorporated these new data and analyses into the revised manuscript, and we believe that these revisions substantially enhance the robustness and reliability of our findings.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review): 

      Summary:

      In this study, Lamberti et al. investigate how translation initiation and elongation are coordinated at the single-mRNA level in mammalian cells. The authors aim to uncover whether and how cells dynamically adjust initiation rates in response to elongation dynamics, with the overarching goal of understanding how translational homeostasis is maintained. To this end, the study combines single-molecule live-cell imaging using the SunTag system with a kinetic modeling framework grounded in the Totally Asymmetric Simple Exclusion Process (TASEP). By applying this approach to custom reporter constructs with different coding sequences, and under perturbations of the initiation/elongation factor eIF5A, the authors infer initiation and elongation rates from individual mRNAs and examine how these rates covary.

      The central finding is that initiation and elongation rates are strongly correlated across a range of coding sequences, resulting in consistently low ribosome density ({less than or equal to}12% of the coding sequence occupied). This coupling is preserved under partial pharmacological inhibition of eIF5A, which slows elongation but is matched by a proportional decrease in initiation, thereby maintaining ribosome density. However, a complete genetic knockout of eIF5A disrupts this coordination, leading to reduced ribosome density, potentially due to changes in ribosome stalling resolution or degradation.

      Strengths:

      A key strength of this work is its methodological innovation. The authors develop and validate a TASEP-based Hidden Markov Model (HMM) to infer translation kinetics at single-mRNA resolution. This approach provides a substantial advance over previous population-level or averaged models and enables dynamic reconstruction of ribosome behavior from experimental traces. The model is carefully benchmarked against simulated data and appropriately applied. The experimental design is also strong. The authors construct matched SunTag reporters differing only in codon composition in a defined region of the coding sequence, allowing them to isolate the effects of elongation-related features while controlling for other regulatory elements. The use of both pharmacological and genetic perturbations of eIF5A adds robustness and depth to the biological conclusions. The results are compelling: across all constructs and conditions, ribosome density remains low, and initiation and elongation appear tightly coordinated, suggesting an intrinsic feedback mechanism in translational regulation. These findings challenge the classical view of translation initiation as the sole rate-limiting step and provide new insights into how cells may dynamically maintain translation efficiency and avoid ribosome collisions.

      We thank the reviewer for their constructive assessment of our work, and for recognizing the methodological innovation and experimental rigor of our study.

      Weaknesses:

      A limitation of the study is its reliance on exogenous reporter mRNAs in HeLa cells, which may not fully capture the complexity of endogenous translation regulation. While the authors acknowledge this, it remains unclear how generalizable the observed coupling is to native mRNAs or in different cellular contexts.

      We agree that the use of exogenous reporters is a limitation inherent to the SunTag system, for which there is currently no simple alternative for single-mRNA translation imaging. However, we believe our findings are likely generalizable for several reasons.

      As discussed in our introduction and discussion, there is growing mechanistic evidence in the literature for coupling between elongation (ribosome collisions) and initiation via pathways such as the GIGYF2-4EHP axis (Amaya et al. 2018, Hickey et al. 2020, Juszkiewicz et al. 2020), which might operate on both exogenous and endogenous mRNAs.

      As already acknowledged in our limitations section, our exogenous reporters may not fully recapitulate certain aspects of endogenous translation (e.g., ER-coupled collagen processing), yet the observed initiation-elongation coupling was robust across all tested constructs and conditions.

      We have now expanded the Discussion (L393-395) to cite complementary evidence from Dufourt et al. (2021), who used a CRISPR-based approach in Drosophila embryos to measure translation of endogenous genes. We also added a reference to Choi et al. 2025, who uses a ER-specific SunTag reporter to visualize translation at the ER (L395-397).

      Additionally, the model assumes homogeneous elongation rates and does not explicitly account for ribosome pausing or collisions, which could affect inference accuracy, particularly in constructs designed to induce stalling. While the model is validated under low-density assumptions, more work may be needed to understand how deviations from these assumptions affect parameter estimates in real data.

      We agree with the reviewer that the assumption of homogeneous elongation rates is a simplification, and that our work represents a first step towards rigorous single-trace analysis of translation dynamics. We have explicitly tested the robustness of our model to violations of the low-density assumption through simulations (Figure 2 - figure supplement 2). These show that while parameter inference remains accurate at low ribosome densities, accuracy slightly deteriorates at higher densities, as expected. In fact, our experimental data do provide evidence for heterogeneous elongation: the waiting times between termination events deviate significantly from an exponential distribution (Figure 3 - figure supplement 2C), indicating the presence of ribosome stalling and/or bursting, consistent with the reviewer's concern. We acknowledge in the Limitations section (L402-406) that extending the model to explicitly capture transcript-dependent elongation rates and ribosome interactions remains challenging. The TASEP is difficult to solve analytically under these conditions, but we note that simulation-based inference approaches, such as particle filters to replace HMMs, could provide a path forward for future work to capture this complexity at the single-trace level.

      Furthermore, although the study observes translation "bursting" behavior, this is not explicitly modeled. Given the growing recognition of translational bursting as a regulatory feature, incorporating or quantifying this behavior more rigorously could strengthen the work's impact.

      While we do not explicitly model the bursting dynamics in the HMM framework, we have quantified bursting behavior directly from the data. Specifically, we measure the duration of translated (ON) and untranslated (OFF) periods across all reporters and conditions (Figure 1G for control conditions and Figure 4G-H for perturbed conditions), finding that active translation typically lasts 10-15 minutes interspersed with shorter silent periods of 5-10 minutes. This empirical characterization demonstrates that bursting is a consistent feature of translation across our experimental conditions. The average duration of silent periods is similar to what was inferred by Livingston et al. 2023 for a similar SunTag reporter; while the average duration of active periods is substantially shorter (~15 min instead of ~40 min), which is consistent with the shorter trace duration in our system compared to theirs (~15 min compared to ~80 min, on average). Incorporating an explicit two-state or multi-state bursting model into the TASEP-HMM framework would indeed be computationally intensive and represents an important direction for future work, as it would enable inference of switching rates alongside initiation and elongation parameters. We have added this point to the Discussion (L415-417).

      Assessment of Goals and Conclusions:

      The authors successfully achieve their stated aims: they quantify translation initiation and elongation at the single-mRNA level and show that these processes are dynamically coupled to maintain low ribosome density. The modeling framework is well suited to this task, and the conclusions are supported by multiple lines of evidence, including inferred kinetic parameters, independent ribosome counts, and consistent behavior under perturbation.

      Impact and Utility:

      This work makes a significant conceptual and technical contribution to the field of translation biology. The modeling framework developed here opens the door to more detailed and quantitative studies of ribosome dynamics on single mRNAs and could be adapted to other imaging systems or perturbations. The discovery of initiation-elongation coupling as a general feature of translation in mammalian cells will likely influence how researchers think about translational regulation under homeostatic and stress conditions.

      The data, models, and tools developed in this study will be of broad utility to the community, particularly for researchers studying translation dynamics, ribosome behavior, or the effects of codon usage and mRNA structure on protein synthesis.

      Context and Interpretation:

      This study contributes to a growing body of evidence that translation is not merely controlled at initiation but involves feedback between elongation and initiation. It supports the emerging view that ribosome collisions, stalling, and quality control pathways play active roles in regulating initiation rates in cis. The findings are consistent with recent studies in yeast and metazoans showing translation initiation repression following stalling events. However, the mechanistic details of this feedback remain incompletely understood and merit further investigation, particularly in physiological or stress contexts. 

      In summary, this is a thoughtfully executed and timely study that provides valuable insights into the dynamic regulation of translation and introduces a modeling framework with broad applicability. It will be of interest to a wide audience in molecular biology, systems biology, and quantitative imaging.

      We appreciate the reviewer's thorough and positive assessment of our work, and that they recognize both the technical innovation of our modeling framework and its potential broad utility to the translation biology community. We agree that further mechanistic investigation of initiation-elongation feedback under various physiological contexts represents an important direction for future research.

      Reviewer #2 (Public review):

      Summary:

      This manuscript uses single-molecule run-off experiments and TASEP/HMM models to estimate biophysical parameters, i.e., ribosomal initiation and elongation rates. Combining inferred initiation and elongation rates, the authors quantify ribosomal density. TASEP modeling was used to simulate the mechanistic dynamics of ribosomal translation, and the HMM is used to link ribosomal dynamics to microscope intensity measurements. The authors' main conclusions and findings are:

      (1) Ribosomal elongation rates and initiation rates are strongly coordinated.

      (2) Elongation rates were estimated between 1-4.5 aa/sec. Initiation rates were estimated between 0.5-2.5 events/min. These values agree with previously reported values.

      (3) Ribosomal density was determined below 12% for all constructs and conditions.

      (4) eIF5A-perturbations (KO and GC7 inhibition) resulted in non-significant changes in translational bursting and ribosome density.

      (5) eIF5A perturbations resulted in increases in elongation and decreases in initiation rates.

      Strengths:

      This manuscript presents an interesting scientific hypothesis to study ribosome initiation and elongation concurrently. This topic is highly relevant for the field. The manuscript presents a novel quantitative methodology to estimate ribosomal initiation rates from Harringtonine run-off assays. This is relevant because run-off assays have been used to estimate, exclusively, elongation rates.

      We thank the reviewer for their careful evaluation of our work and for recognizing the novelty of our quantitative methodology to extract both initiation and elongation rates from harringtonine run-off assays, extending beyond the traditional use of these experiments.

      Weaknesses:

      The conclusion of the strong coordination between initiation and elongation rates is interesting, but some results are unexpected, and further experimental validation is needed to ensure this coordination is valid. 

      We agree that some of our findings need further experimental investigation in future studies. However, we believe that the coordination between initiation and elongation is supported by multiple results in our current work: (1) the strong correlation observed across all reporters and conditions (Figure 3E), and (2) the consistent maintenance of low ribosome density despite varying elongation rates. While additional experimental validation would be valuable, we note that directly manipulating initiation or elongation independently in mammalian cells remains technically challenging. Nevertheless, our findings are consistent with emerging mechanistic understanding of collision-sensing pathways (GIGYF2-4EHP) that could mediate such coupling, as discussed in our manuscript.

      (1) eIF5a perturbations resulted in a non-significant effect on the fraction of translating mRNA, translation duration, and bursting periods. Given the central role of eIF5a, I would have expected a different outcome. I would recommend that the authors expand the discussion and review more literature to justify these findings.

      We appreciate this comment. This finding is indeed discussed in detail in our manuscript (Discussion, paragraphs 6-7). As we note there, while eIF5A plays a critical role in elongation, the maintenance of bursting dynamics and ribosome density upon perturbation can be explained by compensatory feedback mechanisms. Specifically, the coordinated decrease in initiation rates that counterbalances slower elongation to maintain homeostatic ribosome density. We also discuss several factors that complicate interpretation: (1) potential RQC-mediated degradation masking stronger effects in proline-rich constructs, (2) differences between GC7 treatment and genetic knockout suggesting altered stalling resolution kinetics, and (3) the limitations of using exogenous reporters that lack ER-coupled processing, which may be critical for eIF5A function in endogenous collagen translation (as suggested by Rossi et al., 2014; Mandal et al., 2016; Barba-Aliaga et al., 2021). The mechanistic complexity and tissue-specific nature of eIF5A function in mammals, which differs substantially from the better-characterized yeast system, likely contributes to the nuanced phenotype we observe. We believe our Discussion adequately addresses these points.

      (2) The AAG construct leading to slow elongation is very surprising. It is the opposite of the field consensus, where codon-optimized gene sequences are expected to elongate faster. More information about each construct should be provided. I would recommend more bioinformatic analysis on this, for example, calculating CAI for all constructs, or predicting the structures of the proteins.

      We agree that the slow elongation of the AAG construct is counterintuitive and indeed surprising. Following the reviewer's suggestion, we have now calculated the Codon Adaptation Index (CAI) for all constructs (Renilla 0.89, Col1a1 0.78, Col1a1 mutated 0.74). It is therefore unlikely that codon bias explains the slow translation, particularly since we designed the mutated Col1a1 construct with alanine codons selected to respect human codon usage bias, thereby minimizing changes in codon optimality. As we discuss in the manuscript, we hypothesize that the proline-to-alanine substitutions disrupted co-translational folding of the collagen-derived sequence. Prolines are critical for collagen triple-helix formation (Shoulders and Raines, 2009), and their replacement with alanines likely generates misfolded intermediates that cause ribosome stalling (Barba-Aliaga et al., 2021; Komar et al., 2024). This interpretation is supported by the high frequency (>30%) of incomplete run-off traces for AAG, suggesting persistent stalling events. Our findings thus illustrate an important potential caveat: "optimizing" a sequence based solely on codon usage can be detrimental when it disrupts functionally important structural features or co-translational folding pathways.

      This highlights that elongation rates depend not only on codon optimality but also on the interplay between nascent chain properties and ribosome progression.

      (3) The authors should consider using their methodology to study the effects of modifying the 5'UTR, resulting in changes in initiation rate and bursting, such as previously shown in reference Livingston et al., 2023. This may be outside of the scope of this project, but the authors could add this as a future direction and discuss if this may corroborate their conclusions. 

      We thank the reviewer for this excellent suggestion. We agree that applying our methodology to 5'-UTR variants would provide a complementary test of initiation-elongation coupling, and we have now added this as a future direction in the Discussion (L417-420).

      (4) The mathematical model and parameter inference routines are central to the conclusions of this manuscript. In order to support reproducibility, the computational code should be made available and well-documented, with a requirements file indicating the dependencies and their versions. 

      We have added the Github link in the manuscript (https://github.com/naef-lab/suntag-analysis) and have also deposited the data (.ome.tif) on Zenodo (https://zenodo.org/records/17669332).

      Reviewer #3 (Public review):

      Disclaimer:

      My expertise is in live single-molecule imaging of RNA and transcription, as well as associated data analysis and modeling. While this aligns well with the technical aspects of the manuscript, my background in translation is more limited, and I am not best positioned to assess the novelty of the biological conclusions.

      Summary:

      This study combines live-cell imaging of nascent proteins on single mRNAs with time-series analysis to investigate the kinetics of mRNA translation.

      The authors (i) used a calibration method for estimating absolute ribosome counts, and (ii) developed a new Bayesian approach to infer ribosome counts over time from run-off experiments, enabling estimation of elongation rates and ribosome density across conditions.

      They report (i) translational bursting at the single-mRNA level, (ii) low ribosome density (~10% occupancy

      {plus minus} a few percents), (iii) that ribosome density is minimally affected by perturbations of elongation (using a drug and/or different coding sequences in the reporter), suggesting a homeostatic mechanism potentially involving a feedback of elongation onto initiation, although (iv) this coupling breaks down upon knockout of elongation factor eIF5A.

      Strengths:

      (1) The manuscript is well written, and the conclusions are, in general, appropriately cautious (besides the few improvements I suggest below).

      (2) The time-series inference method is interesting and promising for broader applications. 

      (3) Simulations provide convincing support for the modeling (though some improvements are possible). 

      (4) The reported homeostatic effect on ribosome density is surprising and carefully validated with multiple perturbations.

      (5) Imaging quality and corrections (e.g., flat-fielding, laser power measurements) are robust.

      (6) Mathematical modeling is clearly described and precise; a few clarifications could improve it further.

      We thank the reviewer for recognizing the novelty of the approach and its rigour, and for providing suggestions to improve it further.

      Weaknesses:

      (1) The absolute quantification of ribosome numbers (via the measurement of $i_{MP}$ ) should be improved.This only affects the finding that ribosome density is low, not that it appears to be under homeostatic control. However, if $i_{MP}$ turns out to be substantially overestimated (hence ribosome density underestimated), then "ribosomes queuing up to the initiation site and physically blocking initiation" could become a relevant hypothesis. In my detailed recommendations to the authors, I list points that need clarification in their quantifications and suggest an independent validation experiment (measuring the intensity of an object with a known number of GFP molecules, e.g., MS2-GFP MS2-GFP-labeled RNAs, or individual GEMs).

      We agree with the reviewer that the estimation of the number of ribosomes is central to our finding that translation happens at low density on our reporters. This result derives from our measurement of the intensity of one mature protein (i<sub>MP</sub>), that we have achieved by using a SunTag reporter with a RH1 domain in the C terminus of the mature protein, allowing us to stabilise mature proteins via actin-tethering. In addition, as suggested by the reviewer, we already validated this result with an independent estimate of the mature protein intensity (Figure 5 - figure supplement 2B), which was obtained by adding the mature protein intensity directly as a free parameter of the HMM. The inferred value of mature protein intensity for each construct (10-15 a.u) was remarkably close to the experimental calibration result (14 ± 2 a.u.). Therefore, we have confidence that our absolute quantification of ribosome numbers is accurate.

      (2) The proposed initiation-elongation coupling is plausible, but alternative explanations, such as changes in abortive elongation frequency, should be considered more carefully. The authors mention this possibility, but should test or rule it out quantitatively. 

      We thank the reviewer for the comment, but we consider that ruling out alternative explanations through new perturbation experiments is beyond the scope of the present work.

      (3) The observation of translational bursting is presented as novel, but similar findings were reported by Livingston et al. (2023) using a similar SunTag-MS2 system. This prior work should be acknowledged, and the added value of the current approach clarified.

      We did cite Livingston et al. (2023) in several places, but we recognized that we could add a few citations in key places, to make clear that the observation of bursting is not novel but is in agreement with previous results. We now did so in the Results and Discussion sections.

      (4) It is unclear what the single-mRNA nature of the inference method is bringing since it is only used here to report _average_ ribosome elongation rate and density (averaged across mRNAs and across time during the run-off experiments - although the method, in principle, has the power to resolve these two aspects).

      While decoding individual traces, our model infers shared (population-level) rates. Inferring transcript-specific parameters would be more informative, but it is highly challenging due to the uncertainty on the initial ribosome distribution on single transcripts. Pooling multiple transcripts together allows us to use some assumptions on the initial distribution and infer average elongation and initiation-rate parameters, while revealing substantial mRNA-to-mRNA variability in the posterior decoding (e.g. Figure 3 - figure Supplement 2C). Indeed, the inference still informs on the single-trace run-off time distribution (Figure 3 A) and the waiting time between termination events (Figure 3 - figure supplement 2C), suggesting the presence of stalling and bursting. In addition, the transcript-to-transcript heterogeneity is likely accounted for by our model better than previous methods (linear fit of the average run-off intensity), as suggested by their comparison (Figure 3 - figure supplement 2 A). In the future the model could be refined by introducing transcript-specific parameters, possibly in a hierarchical way, alongside shared parameters.

      (5) I did not find any statement about data availability. The data should be made available. Their absence limits the ability to fully assess and reproduce the findings.

      We have added the Github link in the manuscript (https://github.com/naef-lab/suntag-analysis) and have also deposited the data (.ome.tif) on Zenodo (https://zenodo.org/records/17669332).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      Major Comments:

      (1) Lack of Explicit Bursting Model

      Although translation "bursts" are observed, the current framework does not explicitly model initiation as a stochastic ON/OFF process. This limits insight into regulatory mechanisms controlling burst frequency or duration. The authors should either incorporate a two-state/more-state (bursting) model of initiation or perform statistical analysis (e.g., dwell-time distributions) to quantify bursting dynamics. They should clarify how bursting influences the interpretation of initiation rate estimates.

      We agree with the reviewer that an explicit bursting model (e.g., a two-state telegraph model) would be the ideal theoretical framework. However, integrating such a model into the TASEP-HMM inference framework is computationally intensive and complex. As a robust first step, we have opted to quantify bursting empirically based on the decoded single-mRNA traces. As shown in Figure 1G (control) and Figure 4G (perturbed conditions), we explicitly measured the duration of "ON" (translated) and "OFF" (untranslated) periods. This statistical analysis provides a quantitative description of the bursting dynamics without relying on the specific assumptions of a telegraph model. We have clarified this in the text (L123-125) and, as suggested, added a discussion (L415-417) on the potential extensions of the model to include explicit switching kinetics in the Outlook section.

      (2) Assumption of Uniform Elongation Rates

      The model assumes homogeneous elongation across coding sequences, which may not hold for stalling-prone inserts (e.g., PPG). This simplification could bias inference, particularly in cases of sequence-specific pausing. Adding simulations or sensitivity analysis to assess how non-uniform elongation affects the accuracy of inferred parameters. The authors should explicitly discuss how ribosome stalling, collisions, or heterogeneity might skew model outputs (see point 4).

      A strong stalling sequence that affects all ribosomes equally should not deteriorate the inference of the initiation rate, provided that the low-density assumption holds. The scenario where stalling events lead to higher density, and thus increased ribosome-ribosome interactions, is comparable to the conditions explored in Figure 2E. In those simulations, we tested the inference on data generated with varying initiation and elongation rates, resulting in ribosome densities ranging from low to high. We demonstrated that the inference remains robust at low ribosome densities (<10%). At higher densities, the accuracy of the initiation rate estimate decreases, whereas the elongation rate estimate remains comparatively robust. Additionally, the model tends to overestimate ribosome density under high-density conditions, likely because it neglects ribosome interference at the initiation site (Figure 2 figure supplement 2C). We agree that a deeper investigation into the consequences of stochastic stalling and bursting would be beneficial, and we have explicitly acknowledged this in the Limitations section.

      (3) Interpretation of eIF5A Knockout Phenotype

      The observation that eIF5A KO reduces initiation more than elongation, leading to decreased ribosome density, is biologically intriguing. However, the explanation invoking altered RQC kinetics is speculative and not directly tested. The authors should consider validating the RQC hypothesis by monitoring reporter mRNA stability, ribosome collision markers, or translation termination intermediates.

      We thank the reviewer for the comment, but we consider that ruling out alternative explanations through new experiments is beyond the scope of the present work.

      (4) To strengthen the manuscript, the authors should incorporate insights from three studies.

      - Livingston et al. (PMC10330622) found that translation occurs in bursts, influenced by mRNA features and initiation factors, supporting the coupling of initiation and elongation.

      - Madern et al. (PMID: 39892379) demonstrated that ribosome cooperativity enhances translational efficiency, highlighting coordinated ribosome behavior.

      - Dufourt et al. (PMID: 33927056) observed that high initiation rates correlate with high elongation rates, suggesting a conserved mechanism across cell cultures and organisms.

      Integrating these studies could enrich the manuscript's interpretation and stimulate new avenues of thought.

      We thank the reviewer for the valuable comment. We added citations of Livingston et al. in the context of translational bursting. We already cited Madern et al. in multiple places and, although its observations of ribosome cooperativity are very compelling, they cannot be linked with our observations of a feedback between initiation and elongation, and it would be very challenging to see a similar effect on our reporters. This is why we did not expressly discuss cooperativity. We also integrated Dufourt et al. in the Discussion about the possibility of designing genetically-encoded reporter. We also added a sentence about the possibility of using an ER-specific SunTag reporter, as done recently in Choi et al., Nature (2025) (https://doi.org/10.1038/s41586-025-09718-0).

      Minor Comments:

      (1) Use consistent naming for SunTag reporters (e.g., "PPG" vs "proline-rich") throughout.

      Thank you for the comment. However, the term proline-rich always appears together with PPG, so we believe that the naming is clear and consistent.

      (2) Consider a schematic overview of the experimental design and modeling pipeline for accessibility.

      Thank you for the suggestion. We consider that experimental design and modeling is now sufficiently clearly described and does not justify an additional scheme. 

      (3) Clarify how incomplete run-off traces are handled in the HMM inference.

      Incomplete run-off traces are treated identically to complete traces in our HMM inference. This is possible because our model relies on the probability of transitions occurring per time step to infer rates. It does not require observing the final "empty" state to estimate the kinetic parameters ɑ and λ. The loss of signal (e.g., mRNA moving out of the focal volume or photobleaching) does not invalidate the kinetic information contained in the portion of the trace that was observed. We have clarified this in the Methods section.

      Reviewer #2 (Recommendations for the authors):

      (1) Reproducibility:

      (1.1) The authors should use a GitHub repository with a timestamp for the release version.

      The code is available on GitHub (https://github.com/naef-lab/suntag-analysis).

      (1.2) Make raw images and data available in a figure repository like Figshare.

      The raw images (.ome.tif) are now available on Zenodo (https://zenodo.org/records/17669332).

      (2) Paper reorganization and expansion of the intensity and ribosome quantification:

      (2.1) Given the relevance of the initiation and elongation rates for the conclusions of this study, and the fact that the authors inferred these rates from the spot intensities. I recommend that the authors move Figure 1 Supplement 2 to the main text and expand the description of the process to relate spot intensity and number of ribosomes. Please also expand the figure caption for this image.

      We agree with the importance of this validation. We have expanded the description of the calibration experiment in the main text and in the figure caption.

      (2.2) I suggest the authors explicitly mention the use of HMM in the abstract.

      We have now explicitly mentioned the TASEP-based HMM in the abstract.

      (2.3) In line 492, please add the frame rate used to acquire the images for the run-off assays.

      We have added the specific frame rate (one frame every 20 seconds) to the relevant section.

      (3) Figures and captions:

      (3.1) Figure 1, Supplement 2. Please add a description of the colors used in plots B, C. 

      We have expanded the caption and added the color description.

      (3.2) In the Figure 2 caption. It is not clear what the authors mean by "traceseLife". Please ensure it is not a typo.

      Thank you for spotting this. We have corrected the typo.

      (3.3) Figure 1 A, in the cartoon N(alpha)->N-1, shouldn't the transition also depend on lambda?

      The transition probability was explicitly derived in the “Bayesian modeling of run-off traces” section (Eqs. 17-18), and does not depend on λ, but only on the initiation rate under the low-density assumption.

      (3.4) Figure 3, Supplement 2. "presence of bursting and stalling.." has a typo.

      Corrected.

      (3.5) Figure 5, panel C, the y-axis label should be "run-off time (min)."

      Corrected.

      (3.6) For most figures, add significance bars.

      (3.7) In the figure captions, please add the total number of cells used for each condition.

      We have systematically indicated the number of traces (n<sub>t</sub>) and the number of independent experiments (n<sub>e</sub>) in the captions in this format (n<sub>t</sub>, n<sub>e</sub>).

      (4) Mathematical Methods:

      We greatly thank the reviewer for their detailed attention to the mathematical notation. We have addressed all points below.

      (4.1) In lines 555, Materials and Methods, subsection, Quantification of Intensity Traces, multiple equations are not numbered. For example, after Equation (4), no numbers are provided for the rest of the equations. Please keep consistency throughout the whole document.

      We have ensured that all equations are now consistently numbered throughout the document.

      (4.2) In line 588, the authors mention "$X$ is a standard normal random variable with mean $\mu$ and standard deviation $s_0$". Please ensure this is correct. A standard normal random variable has a 0 mean and std 1. 

      Thank you for the suggestion, we have corrected the text (L678).

      (4.3) Line 546, Equation 2. The authors use mu(x,y) to describe a 2d Gaussian function. But later in line 587, the authors reuse the same variable name in equation 5 to redefine the intensity as mu = b_0 + I.

      We have renamed the 2D Gaussian function to \mu_{2D}(x,y) in the spot tracking section

      (4.4) For the complete document, it could be beneficial to the reader if the authors expand the definition of the relationship between the signal "y" and the spot intensity "I". Please note how the paragraph in lines 582-587 does not properly introduce "y".

      We have added an explicit definition of y and its relationship to the underlying spot intensity I in the text to improve readability and clarity.

      (4.5) Please ensure consistency in variable names. For example, "I" is used in line 587 for the experimental spot intensity, then line 763 redefines I(t) as the total intensity obtained from the TASEP model; please use "I_sim(t)" for simulated intensities. Please note that reusing the variable "I" for different contexts makes it hard for the reader to follow the text. 

      We agree that this was confusing. We have implemented the suggestion and now distinguish simulated intensities using the notation I<sub>S</sub> .

      (4.6) Line 555 "The prior on the total intensity I is an "uninformative" prior" I ~ half_normal(1000). Please ensure it is not "I_0 ~ half_normal(1000)."? 

      We confirm that “I” is the correct variable representing the total intensity in this context; we do not use an “I<sub>0</sub>” variable here.

      (4.7) In lines 595, equation 6. Ensure that the equation is correct. Shouldn't it be: s_0^2 = ln ( 1 + (sigma_meas^2 / ⟨y⟩^2) )? Please ensure that this is correct and it is not affecting the calculated values given in lines 598.

      Thank you for catching this typo. We have corrected the equation in the manuscript. We confirm that the calculations performed in the code used the correct formula, so the reported values remain unchanged.

      (4.8) In line 597, "the mean intensity square ^2". Please ensure it is not "the square of the temporal mean intensity."

      We have corrected the text to "the square of the temporal mean intensity."

      (4.9) In lines 602-619, Bayesian modeling of run-off traces, please ensure to introduce the constant "\ell". Used to define the ribosomal footprint?

      We have added the explicit definition of 𝓁 as the ribosome footprint size (length of transcript occupied by one ribosome) in the "Bayesian modeling of run-off traces" section.

      (4.10) Line 687 has a minor typo "[...] ribosome distribution.. Then, [...]"

      We have corrected the punctuation.

      (4.11) In line 678, Equation 19 introduces the constant "L_S", Please ensure that it is defined in the text.

      We have added the explicit definition of L<sub>S</sub> (the length of the SunTag) to the text surrounding Equation 19.

      (4.12) In line 695, Equation 22, please consider using a subscript to differentiate the variance due to ribosome configuration. For example, instead of "sigma (...)^2" use something like "sigma_c ^2 (...)". Ensure that this change is correctly applied to Equation 24 and all other affected equations.

      Thank you, we have implemented the suggestions.

      (4.13) In line 696, please double-check equations 26 and 27. Specifically, the denominator ^2. Given the previous text, it is hard to follow the meaning of this variable. 

      We have revised the notation in Equations 26 and 27 to ensure the denominator is consistent with the definitions provided in the text.

      (4.14) In lines 726, the authors mention "[...], but for the purposes of this dissertation [...]", it should be "[...], but for the purposes of this study [...]"

      Thank you for spotting this. We have replaced "dissertation" with "study."

      (4.15) Equations 5, 28, 37, and the unnumbered equation between Equations 16 and 17 are similar, but in some, "y" does not explicitly depend on time. Please ensure this is correct. 

      We have verified these equations and believe they are correct.

      (4.16) Please review the complete document and ensure that variables and constants used in the equations are defined in the text. Please ensure that the same variable names are not reused for different concepts. To improve readability and flow in the text, please review the complete Materials and Methods sections and evaluate if the modeling section can be written more clearly and concisely. For example, Equation 28 is repeated in the text.

      We have performed a comprehensive review of the Materials and Methods section. To improve conciseness and flow, we have merged the subsection “Observation model and estimation of observation parameters” with the “Bayesian modeling of run-off traces” section. This allowed us to remove redundant definitions and repeated equations (such as the previous Equation 28). We have also checked that all variables and constants are defined upon first use and that variable names remain consistent throughout the manuscript.

      Reviewer #3 (Recommendations for the authors):

      (1) Data Presentation

      (1.1) In main Figures 1D and 4E, the traces appear to show frequent on-off-on transitions ("bursting"), but in supplementary figures (1-S1A and 4-S1A), this behavior is seen in only ~8 of 54 traces. Are the main figure examples truly representative?

      We acknowledge the reviewer's point. In Figure 1D, we selected some of the longest and most illustrative traces to highlight the bursting dynamics. We agree that the term "representative" might be misleading if interpreted as "average." We have updated the text to state "we show bursting traces" to more accurately reflect the selection.

      (1.2) There are 8 videos, but I could not identify which is which.

      Thank you for pointing this out. We have renamed the video files to clearly correspond to the figures and conditions they represent.

      (2) Data Availability:

      As noted above, the data should be shared. This is in accordance with eLife's policy: "Authors must make all original data used to support the claims of the paper, or that are required to reproduce them, available in the manuscript text, tables, figures or supplementary materials, or at a trusted digital repository (the latter is recommended). [...] eLife considers works to be published when they are posted as preprints, and expects preprints we review to meet the standards outlined here." Access to the time traces would have been helpful for reviewers.

      We have now added the Github link for the code (https://github.com/naef-lab/suntag-analysis) and deposited the raw data (.ome.tif files) on Zenodo (10.5281/zenodo.17669332).

      (3) Model Assumptions:

      (3.1) The broad range of run-off times (Figure 3A) suggests stalling, which may be incompatible with the 'low-density' assumption used on the TASEP model, which essentially assumes that ribosomes do not bump into each other. This could impact the validity of the assumptions that ribosomes behave independently, elongate at constant speed (necessary for the continuum-limit approximation), and that the rate-limiting step is the initiation. How robust are the inferences to this assumption?

      We agree that the deviation of waiting times from an exponential distribution (Figure 3 - figure supplement 2C) suggests the presence of stalling, which challenges the strict low-density assumption and constant elongation speed. We explicitly explored the robustness of our model to higher ribosome densities in simulations. As shown in Figure 2 - figure supplement 2, while the model accuracy for single parameters deteriorates at very high densities (overestimating density due to neglected interference), it remains robust for estimating global rates in the regime relevant to our data. We have expanded the discussion on the limitations of the low density and homogeneous elongation rate assumptions in the text (L404-408).

      (3.2) Since all constructs share the same SunTag region, elongation rates should be identical there and diverge only in the variable region. This would affect $\gamma (t)$ and hence possibly affect the results. A brief discussion would be helpful.

      This is a valid point. Currently, our model infers a single average elongation rate that effectively averages the behavior over the SunTag and the variable CDS regions. Modeling distinct rates for these regions would be a valuable extension but adds significant complexity. While our current "effective rate" approach might underestimate the magnitude of differences between reporters, it captures the global kinetic trend. We have added a brief discussion acknowledging this simplification (L408-412).

      (3.3) A similar point applies to the Gillespie simulations: modeling the SunTag region with a shared elongation rate would be more accurate.

      We agree. Simulating distinct rates for the SunTag and CDS would increase realism, though our current homogeneous simulations serve primarily to benchmark the inference framework itself. We have noted this as a potential future improvement (L413-414).

      (3.4) Equation (13) assumes that switching between bursting and non-bursting states is much slower than the elongation time. First, this should be made explicit. Second, this is not quite true (~5 min elongation time on Figure 3-s2A vs ~5-15min switching times on Figure 1). It would be useful to show the intensity distribution at t=0 and compare it to the expected mixture distribution (i.e., a Poisson distribution + some extra 'N=0' cells). 

      We thank the reviewer for this insightful comment. We have added a sentence to the text explicitly stating the assumption that switching dynamics are slower than the translation time. While the timescales are indeed closer than ideal (5 min vs. 5-15 min), this assumption allows for a tractable approximation of the initial conditions for the run-off inference. Comparing the intensity distribution at t=0 to a zero-inflated Poisson distribution is an excellent suggestion for validation, which we will consider for future iterations of the model.

      (4) Microscopy Quantifications:

      (4.1) Figure 1-S2A shows variable scFv-GFP expression across cells. Were cells selected for uniform expression in the analysis? Or is the SunTag assumed saturated? which would then need to be demonstrated. 

      All cell lines used are monoclonal, and cells were selected via FACS for consistent average cytoplasmic GFP signal. We assume the SunTag is saturated based on the established characterization of the system by Tanenbaum et al. (2014), where the high affinity of the scFv-GFP ensures saturation at expression levels similar to ours.

      (4.2) As translation proceeds, free scFv-GFP may become limiting due to the accumulation of mature SunTag-containing proteins. This would be difficult to detect (since mature proteins stay in the cytoplasm) and could affect intensity measurements (newly synthesized SunTag proteins getting dimmer over time).

      This effect can occur with very long induction times. To mitigate this, we optimized the Doxycycline (Dox) incubation time for our harringtonine experiments to prevent excessive accumulation of mature protein. We also monitor the cytoplasmic background for granularity, which would indicate aggregation or accumulation.

      (4.3) The statements "for some traces, the mRNA signal was lost before the run-off completion" (line 195) and "we observed relatively consistent fractions of translated transcripts and trace duration distributions across reporters" (line 340) should be supported by a supplementary figure.

      The first statement is supported by Figure 2 - figure supplement 1, which shows representative run-off traces for all constructs, including incomplete ones.

      The second statement regarding consistency is supported by the quantitative data in Figure 1E and G, which summarize the fraction of translated transcripts and trace durations across conditions.

      (4.4) Measurements of single mature protein intensity $i_{MP}$:

      (4.4.1) Since puromycin is used to disassemble elongating ribosomes, calibration may be biased by incomplete translation products (likely a substantial fraction, since the Dox induction is only 20min and RNAs need several minutes to be transcribed, exported, and then fully translated).

      As mentioned in the “Live-cell imaging” paragraph, the imaging takes place 40 min after the end of Dox incubation. This provides ample time for mRNA export and full translation of the synthesized proteins. Consequently, the fraction of incomplete products generated by the final puromycin addition is negligible compared to the pool of fully synthesized mature proteins accumulated during the preceding hour.

      (4.4.2) Line 519: "The intensity of each spot is averaged over the 100 frames". Do I understand correctly that you are looking at immobile proteins? What immobilizes these proteins? Are these small aggregates? It would be surprising that these aggregates have really only 1, 2, or 3 proteins, as suggested by Figure 1-S2A.

      We are visualizing mature proteins that are specifically tethered to the actin cytoskeleton. This is achieved using a reporter where the RH1 domain is fused directly to the C-terminus of the Renilla protein (SunTag-Renilla-RH1). The RH1 domain recruits the endogenous Myosin Va motor, which anchors the protein to actin filaments, rendering it immobile. Since each Myosin Va motor interacts with one RH1 domain (and thus one mature protein), the resulting spots represent individual immobilized proteins rather than aggregates. We have now revised the text and Methods section to make this calibration strategy and the construct design clearer (L130-140).

      (4.4.3) Estimating the average intensity $i_{MP}$ of single proteins all resides in the seeing discrete modes in the histogram of Figure 1-S2B, which is not very convincing. A complementary experiment, measuring *on the same microscope* the intensity of an object with a known number of GFP molecules (e.g., MS2-GFP labeled RNAs, or individual GEMs https://doi.org/10.1016/j.cell.2018.05.042 (only requiring a single transfection)) would be reassuring to convince the reader that we are not off by an order of magnitude.

      While a complementary calibration experiment would be valuable, we believe our current estimate is robust because it is independently validated by our model. When we inferred i<sub>MP</sub> as a free parameter in the HMM (Figure 5 - figure supplement 2B), the resulting value (10-15 a.u.) was remarkably consistent with our experimental calibration (14 ± 2 a.u.). We have clarified this independent validation in the text to strengthen the confidence in our quantification (L264-272).

      (4.4.4) Further on the histogram in Figure 1-S2B:

      - The gap between the first two modes is unexpectedly sharp. Can you double-check? It means that we have a completely empty bin between two of the most populated bins.

      We have double-checked the data; the plot is correct, though the sharp gap is likely due to the small sample size (n=29).

      - I am surprised not to see 3 modes or more, given that panel A shows three levels of intensity (the three colors of the arrows).

      As noted below, brighter foci exist but fall outside the displayed range of the histogram.

      - It is unclear what the statistical test is and what it is supposed to demonstrate.

      The Student's t-test compares the means of the two identified populations to confirm they are statistically distinct intensity groups.

      - I count n = 29, not 31. (The sample is small enough that the bars of the histogram show clear discrete heights, proportional to 1, 2, 3, 4, and 5 --adding up all the counts, I get 29). Is there a mistake somewhere? Or are some points falling outside of the displayed x-range?

      You are correct. Two brighter data points fell outside the displayed range. The total number of foci in the histogram is 29. We have corrected the figure caption and the text accordingly.

      (5) Miscellaneous Points: 

      (5.1) Panel B in Figure 2-s1 appears to be missing.

      The figure contains only one panel.

      (5.2) In Equation (7), $l$ is not defined (presumably ribosome footprint length?). Instead, $J$ is defined right after eq (7), as if it were used in this equation.

      Thank you for pointing this out, we have corrected it.

      (5.3) Line 703, did you mean to write something else than "Equation 26" (since equation 26 is defined after)?

      Yes, this was a typo. We have corrected the cross-reference.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Drosophila larval type II neuroblasts generate diverse types of neurons by sequentially expressing different temporal identity genes during development. Previous studies have shown that the transition from early temporal identity genes (such as Chinmo and Imp) to late temporal identity genes (such as Syp and Broad) depends on the activation of the expression of EcR by Seven-up (Svp) and progression through the G1/S transition of the cell cycle. In this study, Chaya and Syed examined whether the expression of Syp and EcR is regulated by cell cycle and cytokinesis by knocking down CDK1 or Pav, respectively, throughout development or at specific developmental stages. They find that knocking down CDK1 or Pav either in all type II neuroblasts throughout development or in single-type neuroblast clones after larval hatching consistently leads to failure to activate late temporal identity genes Syp and EcR. To determine whether the failure of the activation of Syp and EcR is due to impaired Svp expression, they also examined Svp expression using a Svp-lacZ reporter line. They find that Svp is expressed normally in CDK1 RNAi neuroblasts. Further, knocking down CDK1 or Pav after Svp activation still leads to loss of Syp and EcR expression. Finally, they also extended their analysis to type I neuroblasts. They find that knocking down CDK1 or Pav, either at 0 hours or at 42 hours after larval hatching, also results in loss of Syp and EcR expression in type I neuroblasts. Based on these findings, the authors conclude that cycle and cytokinesis are required for the transition from early to late temporal identity genes in both types of neuroblasts. These findings add mechanistic details to our understanding of the temporal patterning of Drosophila larval neuroblasts.

      Strengths:

      The data presented in the paper are solid and largely support their conclusion. Images are of high quality. The manuscript is well-written and clear.

      We appreciate the reviewer’s detailed summary and recognition of the study’s strengths.

      Weaknesses:

      The quantifications of the expression of temporal identity genes and the interpretation of some of the data could be more rigorous.

      (1) Expression of temporal identity genes may not be just positive or negative. Therefore, it would be more rigorous to quantify the expression of Imp, Syp, and EcR based on the staining intensity rather than simply counting the number of neuroblasts that are positive for these genes, which can be very subjective. Or the authors should define clearly what qualifies as "positive" (e.g., a staining intensity at least 2x background).

      We thank the reviewer for this helpful suggestion. In the new version, we have now clarified how positive expression was defined and added more details of our quantification strategy to the Methods section (page 11, lines 380-388; lines 426-434 in tracked changes file). Fluorescence intensity for each neuroblast was normalized to the mean intensity of neighboring wild-type neuroblasts imaged in the same field. A neuroblast was considered positive for a given factor when its normalized nuclear intensity was at least 2× the local background. This scoring criterion was applied uniformly across all genotypes and time points. All quantifications were performed on the raw LSM files in Fiji prior to assembling the figure panels.

      (2) The finding that inhibiting cytokinesis without affecting nuclear divisions by knocking down Pav leads to the loss of expression of Syp and EcR does not support their conclusion that nuclear division is also essential for the early-late gene expression switch in type II NSCs (at the bottom of the left column on page 5). No experiments were done to specifically block the nuclear division in this study specifically. This conclusion should be revised.

      We blocked both cell cycle progression and cytokinesis, and both these manipulations affected temporal gene transitions, suggesting that both cell cycle and cytokinesis are essential. To our knowledge, no mechanism/tool exists that selectively blocks nuclear division while leaving cell cycle progression intact. We have added more clarification on page 4, line 123 onwards (lines 126 onwards in tracked changes file).

      (3) Knocking down CDK1 in single random neuroblast clones does not make the CDK1 knockdown neuroblast develop in the same environment (except still in the same brain) as wild-type neuroblast lineages. It does not help address the concern whether "type 2 NSCS with cell cycle arrest failed to undergo normal temporal progression is indirectly due to a lack of feedback signaling from their progeny", as discussed (from the bottom of the right column on page 9 to the top of the left column on page 10). The CDK1 knockdown neuroblasts do not divide to produce progeny and thus do not receive a feedback signal from their progeny as wild-type neuroblasts do. Therefore, it cannot be ruled out that the loss of Syp and EcR expression in CDK1 knockdown neuroblasts is due to the lack of the feedback signal from their progeny. This part of the discussion needs to be clarification.

      Thanks to the reviewer for raising this critical point. We agree and have added more clarification of our interpretations and limitations to our studies in the revised text on page 8, line 278-282 (lines 296-300 in tracked changes file)

      (4) In Figure 2I, there is a clear EcR staining signal in the clone, which contradicts the quantification data in Figure 2J that EcR is absent in Pav RNAi neuroblasts. The authors should verify that the image and quantification data are consistent and correct.

      When cytokinesis is blocked using pav-RNAi, the neuroblasts become extremely large and multinucleated. In some large pav RNAi clones, we observed a weak EcR signal near the cell membrane. However, more importantly, none of the nuclear compartments showed detectable EcR staining, where EcR is typically localized. We selected a representative nuclear image for the figure panel. To clarify this observation, we have now added an explanatory note to the discussion section on page 8, lines 283-291 (lines 301-309 in tracked changes file).

      Reviewer #2 (Public review):

      Summary:

      Neural stem cells produce a wide variety of neurons during development. The regulatory mechanisms of neural diversity are based on the spatial and temporal patterning of neural stem cells. Although the molecular basis of spatial patterning is well-understood, the temporal patterning mechanism remains unclear. In this manuscript, the authors focused on the roles of cell cycle progression and cytokinesis in temporal patterning and found that both are involved in this process.

      Strengths:

      They conducted RNAi-mediated disruption on cell cycle progression and cytokinesis. As they expected, both disruptions affected temporal patterning in NSCs.

      We appreciate the reviewer’s positive assessment of our experimental results.

      Weaknesses:

      Although the authors showed clear results, they needed to provide additional data to support their conclusion sufficiently.

      For example, they need to identify type II NSCs using molecular markers (Ase/Dpn).The authors are encouraged to provide a more detailed explanation of each experiment. The current version of the manuscript is difficult for non-expert readers to understand.

      Thanks for your feedback. We have now included a detailed description of how we identify type II NSCs in both wild-type and mutant clones. We have also added a representative Asense staining to clearly distinguish type 1 (Ase<sup>+</sup>) from type 2 (Ase<sup>-</sup>) NSCs see Figure S1. We have also added a resources table explaining the genotypes associated with each figure, which was omitted due to an error in the previous version of the manuscript. 

      Reviewer #3 (Public review):

      Summary:

      The manuscript by Chaya and Syed focuses on understanding the link between cell cycle and temporal patterning in central brain type II neural stem cells (NSCs). To investigate this, the authors perturb the progression of the cell cycle by delaying the entry into M phase and preventing cytokinesis. Their results convincingly show that temporal factor expression requires progression of the cell cycle in both Type 1 and Type 2 NSCs in the Drosophila central brain. Overall, this study establishes an important link between the two timing mechanisms of neurogenesis.

      Strengths:

      The authors provide solid experimental evidence for the coupling of cell cycle and temporal factor progression in Type 2 NSCs. The quantified phenotype shows an all-ornone effect of cell cycle block on the emergence of subsequent temporal factors in the NSCs, strongly suggesting that both nuclear division and cytokinesis are required for temporal progression. The authors also extend this phenotype to Type 1 NSCs in the central brain, providing a generalizable characterization of the relationship between cell cycle and temporal patterning.

      We thank the reviewer for recognizing the robustness of our data linking the cell cycle to temporal progression.

      Weaknesses:

      One major weakness of the study is that the authors do not explore the mechanistic relationship between the cell cycle and temporal factor expression. Although their results are quite convincing, they do not provide an explanation as to why Cdk1 depletion affects Syp and EcR expression but not the onset of svp. This result suggests that at least a part of the temporal cascade in NSCs is cell-cycle independent, which isn't addressed or sufficiently discussed.

      Thank you for bringing up this important point. We are equally interested in uncovering the mechanism by which the cell cycle regulates temporal gene transitions; however, such mechanistic exploration is beyond the scope of the present study. Interestingly, while the temporal switching factor Svp is expressed independently of the cell cycle, the subsequent temporal transitions are not. We have expanded our discussion on this intriguing finding (page 9, line 307-315; lines 345-355 in tracked changes file). Specifically, we propose that svp activation marks a cell-cycle–independent phase, whereas EcR/Syp induction likely depends on cell-cycle–coupled mechanisms, such as mitosis-dependent chromatin remodeling or daughter-cell feedback. Although further dissection of this mechanism lies beyond the current study, our findings establish a foundation for future work aimed at identifying how developmental timekeeping is molecularly coupled to cell-cycle progression.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      (1) Figure 1 C and D, it would be better to put a question mark to indicate that these are hypotheses to be tested. 

      We appreciate this suggestion and have added question marks in Figure 1C and 1D to clearly indicate that these panels represent hypotheses under investigation clearly.

      (2) Figure 2A-I, Figure 4A-I, Figure 5A-I and K-S, in addition to enlarged views of single type II neuroblasts, it would be more convincing to include zoomed-out images of the entire larval brain or at least a portion of the brain to include neighboring wild-type type II neuroblasts as internal controls. Also, it would be ideal to show EcR staining from the same neuroblasts as IMP and Syp staining. 

      We thank the reviewer for this valuable input. In our imaging setup, the number of available antibody channels was limited to four (anti-Ase, anti-GFP, anti-Syp, and antiImp). Adding EcR in the same sample was therefore not technically possible, we performed EcR staining separately. 

      (3) The authors cited "Syed et al., 2024" (in the middle of the right column on page 5), but this reference is missing in the "References" section and should be added. 

      The missing citation has been added to the reference section.  

      (4) It would be better to include Ase staining in the relevant figure to indicate neuroblast identity as type I or type II. 

      We agree and now include representative Ase staining for both type 1 and type 2 NSC clones in Figure S1, along with corresponding text updates that describe these markers.

      Reviewer #2 (Recommendations for the authors): 

      Major comments 

      (1) The present conclusion relies on the results using Cdk1 RNAi and pav RNAi. It is still possible that Cdk1 and Pav are involved in the regulation of temporal patterning independent of the regulation of cell cycle or cytokinesis, respectively. To avoid this possibility, the authors need to inhibit cell cycle progression or cytokinesis in another alternative manner. 

      We thank the reviewer for raising this important point. While we cannot completely exclude gene-specific, cell-cycle-independent roles for Cdk1 or Pav, we observe consistent phenotypes across several independent manipulations that slow or block the cell cycle. Also, earlier studies using orthogonal approaches that delay G1/S (Dacapo/Rbf) or impair mitochondrial OxPhos (which lengthens G1/S; van den Ameele & Brand, 2019) produce similar temporal delays. These concordant phenotypes strongly support the interpretation that altered cell-cycle progression—rather than specific roles of a single gene—is the primary cause of the defect. While we cannot exclude additional, gene-specific effects of Cdk1 or Pav, the concordant phenotypes across independent perturbations make the cell-cycle disruption model the most parsimonious interpretation. We have clarified this reasoning in the discussion section on pages 8-9, lines 293-305 (lines 311-343 in tracked changes file).

      (2) To reach the present conclusion, the authors need to address the effects of acceleration of cell cycle progression or cytokinesis on temporal patterning. 

      We thank the reviewer for this insightful suggestion. To our knowledge, there are currently no established genetic tools that can specifically accelerate cell-cycle progression in Drosophila neuroblasts. However, our results demonstrate that blocking the cell cycle impairs the transition from early to late temporal gene expression. These findings suggest that proper cell-cycle progression is essential for the transition from early to late temporal identity in neuroblasts.

      Minor comments 

      (3) P3L2 (right), ... we blocked the NSC cell cycle...

      How did they do it? 

      Which fly lines were used?

      Why did they use the line? 

      These details are now included in the Materials and Methods and the Resource Table (pages 11-13). We used Wor-Gal4, Ase-Gal80 to drive UAS-Cdk1RNAi and UASpavRNAi in type 2 NSCs 

      (4) P5L1(left), ... we used the flip-out approach...

      Why did they conduct it? 

      Probably, the authors have reasons other than "to further ensure." 

      We have clarified in the text on page 4, lines 137-139, that the flip-out approach was used to generate random single-cell clones, enabling quantitative analysis of type 2 NSCs within an otherwise wild-type brain. 

      (5) P5L8(left), ... type 2 hits were confirmed by lack of the type 1 Asense...  The authors must examine Deadpan (Dpn) expression as well. Because there are a lot of Asense (Ase) negative cells in the brain (neurons, glial cell, and neuroepithelial cells). 

      Type II NSCs can be identified as Dpn+/Ase- cells.

      We agree that Dpn is a helpful marker. However, we reliably distinguished type II NSCs by their lack of Ase and larger cell size relative to surrounding neurons and glia, which are smaller in size and located deeper within the clone. These differences, together with established lineage patterns, allow unambiguous identification of type 2 NSCs across all genotypes. We have now added representative type I and type 2 NSC clones to the supplemental figure S1 (E-G’) with Asense stains to demonstrate how we differentiate type I from type II NSCs. 

      (6) P5L32(left), To do this, we induced... 

      This sentence should be made more concise.

      Please rephrase it. 

      The sentence has been rewritten for clarity and concision.

      (7)  P5L42(left), ...lack of EcR/Syp expression (Figure 2).  However, EcR expression is still present (Figure 2I). 

      In some large pavRNAi clones, a weak EcR signal can be observed near the cell membrane; however, none of the nuclear compartments—where EcR is typically localized—show detectable staining. We selected a representative nuclear image for the figure and addressed this observation on page 8, lines 283-291 (lines 301-309 in tracked changes file).

      (8) P7L29(left), ......had persistent Imp expression...

      Imp expression is faint compared to that in Figure 2G.

      The differences between Figures 2G and 3G should be discussed. 

      We thank the reviewer for this comment. We have added a note in the Methods section clarifying that brightness and contrast were adjusted per panel for optimal visualization; thus, apparent differences in signal intensity do not reflect biological variation. Fluorescence intensity for each neuroblast was normalized to the mean intensity of neighboring wild-type neuroblasts imaged in the same field. A neuroblast was considered Imp-positive when its normalized nuclear intensity was at least 2× the local background. This scoring criterion was applied uniformly across all genotypes and time points. All quantifications were performed on the raw LSM files in Fiji prior to assembling the figure panels.

      (9) P8 (Figure 5)

      The Imp expression is faint compared to that in Figure 5Q.

      The difference between Figure 5G and 5Q should be discussed further. 

      As mentioned above, we have clarified our image processing approach in the Methods section to explain any differences in signal appearance between these figures.

      (10) P10 Materials and Methods

      The authors did not mention the fly lines used. This is very important for the readers. 

      We thank the reviewer for bringing this oversight to our attention. The Resource Table was inadvertently omitted from the initial submission. The complete list of fly lines and reagents used in this study is now provided in the updated Resource Table.

      Reviewer #3 (Recommendations for the authors): 

      Major points 

      (1) The authors mention that the heat-shock induction at 42ALH is well after svp temporal window and therefore the cell cycle block independently affects Syp and EcR expression. However, Figure 3 shows svp-LacZ expression at 48ALH. If svp expression is indeed transient in Type 2 NSCs, then this must be validated using an immunostaining of the svp-LacZ line with svp antibody. This is crucial as the authors claim that cell cycle block doesn't affect does affect svp expression and is required independently. 

      We thank the reviewer for bringing this important issue to our attention. As noted, Svp protein is expressed transiently and stochastically in type 2 NSCs (Syed et al., 2017), making direct antibody quantification challenging upon cell cycle block. Consistent with previous work (Syed et al., 2017), we used the svp-LacZ reporter line to visualize stabilized Svp expression, which reliably captures Svp expression in type 2 NSCs (Syed et al., 2017 https://doi.org/10.7554/eLife.26287, and Dhilon et al., 2024 https://doi.org/10.1242/dev.202504).

      (2) The authors have successfully slowed down the cell cycle and showed that it affects temporal progression. However, a converse experiment where the cell cycle is sped up in NSCs would be an important test for the direct coupling of temporal factor expression and cell cycle, wherein the expectation would be the precocious expression of late temporal factors in faster cycle NSCs. 

      We agree that such an experiment would be ideal. However, as noted above (Reviewer #2 comment 2), to our knowledge, no suitable tools currently exist to accelerate neuroblast cell-cycle progression without pleiotropic effects.

      Minor point 

      The authors must include Ray and Li (https://doi.org/10.7554/eLife.75879) in the references when describing that "...cell cycle has been shown to influence temporal patterning in some systems,...".  

      We thank the reviewer for this helpful suggestion. The cited reference (Ray and Li, eLife, 2022) has now been included and appropriately referenced in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Here, the authors aim to investigate the potential improvements of ANNs when used to explain brain data using top-down feedback connections found in the neocortex. To do so, they use a retinotopic and tonotopic organization to model each subregion of the ventral visual (V1, V2, V4, and IT) and ventral auditory (A1, Belt, A4) regions using Convolutional Gated Recurrent Units. The top-down feedback connections are inspired by the apical tree of pyramidal neurons, modeled either with a multiplicative effect (change of gain of the activation function) or a composite effect (change of gain and threshold of the activation function).

      To assess the functional impact of the top-down connections, the authors compare three architectures: a brain-like architecture derived directly from brain data analysis, a reversed architecture where all feedforward connections become feedback connections and vice versa, and a random connectivity architecture. More specifically, in the brain-like model the visual regions provide feedforward input to all auditory areas, whereas auditory areas provide feedback to visual regions.

      First, the authors found that top-down feedback influences audiovisual processing and that the brain-like model exhibits a visual bias in multimodal visual and auditory tasks. Second, they discovered that in the brain-like model, the composite integration of top-down feedback, similar to that found in the neocortex, leads to an inductive bias toward visual stimuli, which is not observed in the feedforward-only model. Furthermore, the authors found that the brain-like model learns to utilize relevant stimuli more quickly while ignoring distractors. Finally, by analyzing the activations of all hidden layers (brain regions), they found that the feedforward and feedback connectivity of a region could determine its functional specializations during the given tasks.

      Strengths:

      The study introduces a novel methodology for designing connectivity between regions in deep learning models. The authors also employ several tasks based on audiovisual stimuli to support their conclusions. Additionally, the model utilizes backpropagation of error as a learning algorithm, making it applicable across a range of tasks, from various supervised learning scenarios to reinforcement learning agents. Conversely, the presented framework offers a valuable tool for studying top-down feedback connections in cortical models. Thus, it is a very nice study that also can give inspiration to other fields (machine learning) to start exploring new architectures.

      We thank the reviewer for their accurate summary of our work and their kind assessment of its strengths.

      Weaknesses:

      Although the study explores some novel ideas on how to study the feedback connections of the neocortex, the data presented here are not complete in order to propose a concrete theory of the role of top-down feedback inputs in such models of the brain.

      (1) The gap in the literature that the paper tries to fill in the ability of DL algorithms to predict behavior: "However, there are still significant gaps in most deep neural networks' ability to predict behavior, particularly when presented with ambiguous, challenging stimuli." and "[...] to accurately model the brain."

      It is unclear to me how the presented work addresses this gap, as the only facts provided are derived from a simple categorization task that could also be solved by the feedforward-only model (see Figures 4 and 5). In my opinion, this statement is somewhat far-fetched, and there is insufficient data throughout the manuscript to support this claim.

      We can see now that the way the introduction was initially written led to some confusion about our goal in this study. Our goal here was not to demonstrate that top-down feedback can enable superior matches to human behaviour. Rather, our goal was to determine if top-down feedback had any real implications for processing ambiguous stimuli. The sentence that the reviewer has highlighted was intended as an explanation for why top-down feedback, and its impact on ambiguous stimuli, might be something one would want to examine for deep neural networks. But, here, we simply wanted to (1) provide an overview of the code base we have created, (2) demonstrate that top-down feedback does impact the processing of ambiguous stimuli.

      We agree with the reviewer that if our goal was to improve our ability to predict behaviour, then there was a big gap in the evidence we provided here. But, this was not our goal, and we believe that the data we provide here does convincingly show that top-down feedback has an impact on processing of ambiguous stimuli. We have updated the text in the introduction to make our goals more clear for the reader and avoid this misunderstanding of what we were trying to accomplish here. Specifically, the end of the introduction is changed to:

      “To study the effect of top-down feedback on such tasks, we built a freely available code base for creating deep neural networks with an algorithmic approximation of top-down feedback. Specifically, top-down feedback was designed to modulate ongoing activity in recurrent, convolutional neural networks. We explored different architectural configurations of connectivity, including a configuration based on the human brain, where all visual areas send feedforward inputs to, and receive top-down feedback from, the auditory areas. The human brain-based model performed well on all audiovisual tasks, but displayed a unique and persistent visual bias compared to models with only driving connectivity and models with different hierarchies. This qualitatively matches the reported visual bias of humans engaged in audio-visual tasks. Our results confirm that distinct configurations of feedforward/feedback connectivity have an important functional impact on a model's behavior. Therefore, top-down feedback captures behaviors and perceptual preferences that do not manifest reliably in feedforward-only networks. Further experiments are needed to clarify whether top-down feedback helps an ANN fit better to neural data, but the results show that top-down feedback affects the processing of stimuli and is thus a relevant feature that should be considered for deep ANN models in computational neuroscience more broadly.”

      (2) It is not clear what the advantages are between the brain-like model and a feedforward-only model in terms of performance in solving the task. Given Figures 4 and 5, it is evident that the feedforward-only model reaches almost the same performance as the brain-like model (when the latter uses the modulatory feedback with the composite function) on almost all tasks tested. The speed of learning is nearly the same: for some tested tasks the brain-like model learns faster, while for others it learns slower. Thus, it is hard to attribute a functional implication to the feedback connections given the presented figures and therefore the strong claims in the Discussion should be rephrased or toned down.

      Again, we believe that there has been a misunderstanding regarding the goals of this study, as we are not trying to claim here that there are performance advantages conferred by top-down feedback in this case. Indeed, we share the reviewer’s assessment that the feedforward only model seems to be capable of solving this task well. To reiterate: our goal here was to demonstrate that top-down feedback alters the computations in the network and, thus, has distinct effects on behaviour that need to be considered by researchers who use deep networks to model the brain. But we make no claims of “superiority” of the brain-like model.

      In-line with this, we’re not completely sure which claims in the discussion the reviewer is referring to. We note that we were quite careful in our claims. For example, in the first section of the discussion we say:

      “Altogether, our results demonstrate that the distinction between feedforward and feedback inputs has clear computational implications, and that ANN models of the brain should therefore consider top-down feedback as an important biological feature.”

      And later on:

      “In summary, our study shows that modulatory top-down feedback and the architectural diversity enabled by it can have important functional implications for computational models of the brain. We believe that future work examining brain function with deep neural networks should therefore consider incorporating top-down modulatory feedback into model architectures when appropriate.”

      If we have missed a claim in the discussion that implies superiority of the brain-like model in terms of task performance we would be happy to change it.

      (3) The Methods section lacks sufficient detail. There is no explanation provided for the choice of hyperparameters nor for the structure of the networks (number of trainable parameters, number of nodes per layer, etc). Clarifying the rationale behind these decisions would enhance understanding. Moreover, since the authors draw conclusions based on the performance of the networks on specific tasks, it is unclear whether the comparisons are fair, particularly concerning the number of trainable parameters. Furthermore, it is not clear if the visual bias observed in the brain-like model is an emerging property of the network or has been created because of the asymmetries in the visual vs. auditory pathway (size of the layer, number of layers, etc).

      We thank the reviewer for raising this issue, and want to provide some clarifications: First, the number of trainable parameters are roughly equal, since we were only switching the direction of connectivity (top-down versus bottom-up), not the number of connections. We confirmed the biggest difference in size is between models with composite and multiplicative feedback; models with composite feedback have roughly ~1K more parameters, and all models are within the 280K parameter range. We now state this in the methods.

      Second, because superior performance was not the goal of this study, as stated above, we conducted limited hyperparameter tuning. Given the reviewer’s comment, we wondered whether this may have impacted our results. Therefore, we explored different hyperparameters for the model during the multimodal auditory tasks, which show the clearest example of the visual dominance in the brainlike model (Figure 3).

      We explored different hidden state sizes, learning rates and processing times, and examined whether the core results were different. We found that extremely high learning rates (0.1) destabilize all models and that some models perform poorly under different processing times. But overall, the core results are evident across all hyperparameters where the models learn i.e the different behaviors of models with different connectivities and the visual dominance observed in the brainlike model. We now provide these results in a supplementary figure (Fig. S2, showing larger models trained with different learning rates, and Fig S3, which shows the effect of processing time on AS task performance).

      Reviewer #2 (Public review):

      Summary:

      This work addresses the question of whether artificial deep neural network models of the brain could be improved by incorporating top-down feedback, inspired by the architecture of the neocortex.

      In line with known biological features of cortical top-down feedback, the authors model such feedback connections with both, a typical driving effect and a purely modulatory effect on the activation of units in the network.

      To assess the functional impact of these top-down connections, they compare different architectures of feedforward and feedback connections in a model that mimics the ventral visual and auditory pathways in the cortex on an audiovisual integration task.

      Notably, one architecture is inspired by human anatomical data, where higher visual and auditory layers possess modulatory top-down connections to all lower-level layers of the same modality, and visual areas provide feedforward input to auditory layers, whereas auditory areas provide modulatory feedback to visual areas.

      First, the authors find that this brain-like architecture imparts the models with a light visual bias similar to what is seen in human data, which is the opposite in a reversed architecture, where auditory areas provide a feedforward drive to the visual areas.

      Second, they find that, in their model, modulatory feedback should be complemented by a driving component to enable effective audiovisual integration, similar to what is observed in neural data.

      Last, they find that the brain-like architecture with modulatory feedback learns a bit faster in some audiovisual switching tasks compared to a feedforward-only model.

      Overall, the study shows some possible functional implications when adding feedback connections in a deep artificial neural network that mimics some functional aspects of visual perception in humans.

      Strengths:

      The study contains innovative ideas, such as incorporating an anatomically inspired architecture into a deep ANN, and comparing its impact on a relevant task to alternative architectures.

      Moreover, the simplicity of the model allows it to draw conclusions on how features of the architecture and functional aspects of the top-down feedback affect the performance of the network.

      This could be a helpful resource for future studies of the impact of top-down connections in deep artificial neural network models of the neocortex.

      We thank the reviewer for their summary and their recognition of the innovative components and helpful resources therein.

      Weaknesses:

      Overall, the study appears to be a bit premature, as several parts need to be worked out more to support the claims of the paper and to increase its impact.

      First, the functional implication of modulatory feedback is not really clear. The "only feedforward" model (is a drive-only model meant?) attains the same performance as the composite model (with modulatory feedback) on virtually all tasks tested, it just takes a bit longer to learn for some tasks, but then is also faster at others. It even reproduces the visual bias on the audiovisual switching task. Therefore, the claims "Altogether, our results demonstrate that the distinction between feedforward and feedback inputs has clear computational implications, and that ANN models of the brain should therefore consider top-down feedback as an important biological feature." and "More broadly, our work supports the conclusion that both the cellular neurophysiology and structure of feed-back inputs have critical functional implications that need to be considered by computational models of brain function" are not sufficiently supported by the results of the study. Moreover, the latter points would require showing that this model describes neural data better, e.g., by comparing representations in the model with and without top-down feedback to recorded neural activity.

      To emphasize again our specific claims, we believe that our data shows that top-down feedback has functional implications for deep neural network behaviour, not increased performance or neural alignment. Indeed, our results demonstrate that top-down feedback alters the behaviour of the networks, as shown by the differences in responses to various combinations of ambiguous stimuli. We agree with the reviewer that if our goal was to claim either superior performance on these tasks, or better fit to neural data, we would need to actually provide data supporting that claim.

      Given the comments from the reviewer, we have tried to provide more clarity in the introduction and discussion regarding our claims. In particular, we now highlight that we are not trying to demonstrate that the models with top-down feedback exhibit superior performance or better fit to neural data.

      As one final note, yes, the reviewer understood correctly that the “only feedforward” model is a model with only driving inputs. We have renamed the feedforward-only models to drive only models and added additional emphasis in the text to ensure that the distinction is clear for all readers.

      Second, the analyses are not supported by supplementary material, hence it is difficult to evaluate parts of the claims. For example, it would be helpful to investigate the impact of the process time after which the output is taken for evaluation of the model. This is especially important because in recurrent and feedback models the convergence should be checked, and if the network does not converge, then it should be discussed why at which point in time the network is evaluated.

      This is an excellent point, and we thank the reviewer for raising it. We allowed the network to process the stimuli for seven time-steps, which was enough for information from any one region to be transmitted to any other. We found in some initial investigations that if we shortened the processing time some seeds would fail to solve the task. But, based on the reviewer’s comment, we have now also run additional tests with longer processing times for the auditory tasks where we see the clearest visual bias (Figure 3). We find that different process times do not change the behavioral biases observed in our models, but may introduce difficulties ignoring visual stimuli for some models. Thus, while process time is an important hyperparameter for optimal performance of the model, the central claim of the paper remains. We include this new data in a supplementary figure S3.

      Third, the descriptions of the models in the methods are hard to understand, i.e., parameters are not described and equations are explained by referring to multiple other studies. Since the implications of the results heavily rely on the model, a more detailed description of the model seems necessary.

      We agree with the reviewer that the methods could have been more thorough. Therefore, we have greatly expanded the methods section. We hope the model details are now more clear.

      Lastly, the discussion and testable predictions are not very well worked out and need more details. For example, the point "This represents another testable prediction flowing from our study, which could be studied in humans by examining the optical flow (Pines et al., 2023) between auditory and visual regions during an audiovisual task" needs to be made more precise to be useful as a prediction. What did the model predict in terms of "optic flow", how can modulatory from simple driving effect be distinguished, etc.

      We see that the original wording of this prediction was ambiguous, thank you for pointing this out. In the study highlighted (Pines et al., 2023) the authors use an analysis technique for measuring information flow between brain regions, which is related to analysis of optical flow in images, but applied to fMRI scans. This is confusing given the current study, though. Therefore, we have changed this sentence to make clear that we are speaking of information flow here. 

      Reviewer #3 (Public review):

      Summary:

      This study investigates the computational role of top-down feedback in artificial neural networks (ANNs), a feature that is prevalent in the brain but largely absent in standard ANN architectures. The authors construct hierarchical recurrent ANN models that incorporate key properties of top-down feedback in the neocortex. Using these models in an audiovisual integration task, they find that hierarchical structures introduce a mild visual bias, akin to that observed in human perception, not always compromising task performance.

      Strengths:

      The study investigates a relevant and current topic of considering top-down feedback in deep neural networks. In designing their brain-like model, they use neurophysiological data, such as externopyramidisation and hierarchical connectivity. Their brain-like model exhibits a visual bias that qualitatively matches human perception.

      We thank the reviewer for their summary and evaluation of our paper’s strengths.

      Weaknesses:

      While the model is brain-inspired, it has limited bioplausibility. The model assumes a simplified and fixed hierarchy. In the brain with additional neuromodulation, the hierarchy could be more flexible and more task-dependent.

      We agree, there are still many facets of top-down feedback that we have not captured here, and the modulation of hierarchy is an interesting example. We have added some consideration of this point to the limitations section of the discussion.

      While the brain-like model showed an advantage in ignoring distracting auditory inputs, it struggled when visual information had to be ignored. This suggests that its rigid bias toward visual processing could make it less adaptive in tasks requiring flexible multimodal integration. It hence does not necessarily constitute an improvement over existing ANNs. It is unclear, whether this aspect of the model also matches human data. In general, there is no direct comparison to human data. The study does not evaluate whether the top-down feedback architecture scales well to more complex problems or larger datasets. The model is not well enough specified in the methods and some definitions are missing.

      We agree with the reviewer that we have not demonstrated anything like superior performance (since the brain-like network is quite rigid, as noted) nor have we shown better match to human data with the brain-like network. This was not our intended claim. Rather, we demonstrated here simply that top-down feedback impacts behavior of the networks in response to ambiguous stimuli. We have now added statements to the introduction and discussion to make our specific claims (which are supported by our data, we believe) clear.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      I believe that the work is very nice but not so mature at this stage. Below, you can find some comments that eventually could improve your manuscript.

      (1) Intro, last sentence: "Therefore, top-down feedback is a relevant feature that should be considered for deep ANN models in computational neuroscience more broadly." I don't understand what the authors refer to with this sentence. There are numerous models (deep ANNs) that have been used to model the neural activity and are much simpler than the one proposed here which contains very complex models and connectivity. Although I do agree that the top-down connections are very important there is no data to support their importance for modeling the brain.

      Respectfully, we disagree with the reviewer that we don’t provide data to demonstrate the importance of top-down feedback for modelling. Indeed, we provided a great deal of data to show that top-down feedback in the networks has real functional implications for behaviour, e.g., it can induce a human-like visual bias. Thus, top-down feedback is a factor that one should care about when modelling the brain. But, we agree with the reviewer that more demonstration of the utility of using top-down feedback for achieving better fits to neural data would be an important next step. 

      (2) I suggest adding some extra supplementary simulations where, for example, the number of data for visual and auditory pathways is equal in size (i.e., the same number of examples), the number of layers is identical (3 per pathway), and also the number of parameters. Doing this would help strengthen the claims presented in the paper.

      In fact, all of the hyperparameters the reviewer mentions here were identical for the different networks, so the experiments the reviewer is requesting here were already part of the paper. We now clarify this in the text.

      (3) Results: I suggest adding Tables with quantifications of the presented results. For example, best performance, epochs to converge, etc. As it is now, it is very hard to follow the evidence shown in Figures.

      This is a good suggestion, we have now added this table to the start of the supplemental figures.

      (4) Figure 2e, 3e: Although VS3, and AS3 have been used only for testing, the plot shows alignments with respect to training epochs. The authors should clarify in the Methods if they tested the network with all intermediate weights during VS1/VS2 or AS1/AS2 training.

      Testing scenarios in this context meant that the model was never shown the scenario/task during training, but the models were indeed evaluated on the VS3 and AS3 after each training epoch. We have added clarifications to the figure legends.

      (5) Methods: It would be beneficial to discuss how specific hyperparameters were selected based on prior research, empirical testing, or theoretical considerations. Also, it is not clear how the alignment (visual or audio) is calculated. Do the authors use the examples that have been classified correctly for both stimuli or do they exclude those from the analysis (maybe I have missed it).

      As noted above, because superior performance was not the goal of this study, we conducted limited hyperparameter tuning. But we have extended the results with additional hyperparameter tuning in a supplementary figure, and describe the hyperparameter choices more thoroughly in the methods. As well, all data includes all model responses, regardless of whether they were correct or not. We now clarify this in the methods.

      (6) Code: The code repository lacks straightforward examples demonstrating how to utilize the modeling approach. Given that it is referred to as a "framework", one would expect it to facilitate easy integration into various models and tasks. Including detailed instructions or clear examples would significantly improve usability and help users effectively apply the proposed methodology.

      We agree with the reviewer, this would be beneficial. We have revised the README of the codebase to explain the model and its usage more clearly and included an interactive jupyter notebook with example training on MNIST.

      Some minor comments are given below. Generally speaking, the Figures need to be more carefully checked for consistent labels, colors, etc.

      (1) Page 4, 1st paragraph - grammar correction: "a larger infragranular layer" or "larger infragranular layers"

      Thank you for catching this, we have fixed the text.

      (2) Page 4, 2nd para - rephrase: "In three additional control ANNs" → "In the third additional control ANN"

      In fact, we did mean three additional control ANNs, each one representing a different randomized connectivity profile. We now clarify this in the text and provide the connectivity of the two other random graphs in the supplemental figures.

      (3) Page 4, VAE acronym needs to be defined before its first use

      The variational autoencoder is introduced by its full name in the text now.

      (4) Page 4: Fig. 2c reference should be Fig. 2b, Fig. 2d should be Fig. 2c, Fig. 2b should be Fig. 2d, VS4; Fig. 2b, bottom should be VS4; Fig. 2f, Fig. 2f to Fig. 2g. Double check the Figure references in the text. Here is very confusing for the reader.

      We have now fixed this, thank you for catching it.

      (5) Page 5, 1st para: "Altogether, our results demonstrated both" → "Altogether, our results demonstrated that both"

      This has been updated.

      (6) Figure 2: In the e and g panels the x label is missing.

      This was actually because the x-axis were the same across the panels, but we see how this was unclear, so we have updated the figure.

      (7) Figure 3: There is no panel g (the title is missing); In panels b, c, e, and g the y label is missing, and in panels e and g the x label is missing. Also, the Feedforward model is shown in panel g but it is introduced later in the text. Please remove it from Figure 3. Also in legend: "AV Reverse graph" → "Reverse graph". Also, "Accuracy" and "Alignment" should be presented as percentages (as in Figure 2).

      This has been corrected.

      (8) Figure 4; x labels are missing.

      As with point (6), this was actually because the x-axis were the same across the panels, but we see how this was unclear, so we have updated the figure.

      (9) Page 7; I can’t find the cited Figure S1.

      Apologies, we have added the supplemental figure (now as S4). It shows the results of models with multiplicative feedback on the task in Fig 5 (as opposed to models with composite feedback shown in the main figure).

      Reviewer #2 (Recommendations for the authors):

      (1) Discussion Section 3.1 is only a literature review, and does not really add any value.

      Respectfully, we think it is important to relate our work to other computational work on the role of top-down feedback, and to make clear what our specific contribution is. But, we have updated the text to try to place additional emphasis on our study’s contribution, so that this section is more than just a literature review.

      “Our study adds to this previous work by incorporating modulatory top-down feedback into deep, convolutional, recurrent networks that can be matched to real brain anatomy. Importantly, using this framework we could demonstrate that the specific architecture of top-down feedback in a neural network has important computational implications, endowing networks with different inductive biases.”

      (2) Including ipython notebooks and some examples would be great to make it easier to use the code.

      We now provide a demo of how to use the code base in a jupyter notebook.

      (3) The description of the model is hard to comprehend. Please name and describe all parameters. Also, a figure would be great to understand the different model equations.

      We have added definitions of all model terms and parameters.

      (4) The terminology is not really clear to me. For example "The results further suggest that different configurations of top-down feedback make otherwise identically connected models functionally distinct from each other and from traditional feedforward only recurrent models." The feedforward and only recurrent seem to contradict each other. Would maybe driving and modulatory be a better term here? I also saw in the code that you differentiate between three types of inputs, modulatory, threshold offset and basal (like feedforward). How about you only classify connections based on these three type? I was also confused about the feedforward only model, because I was unsure whether it is still feedback connections but with "basal" quality, or whether feedback connections between modalities and higher-to-lower level layers were omitted altogether.

      We take the reviewer’s point here. To clarify this, we have updated the text to refer to “driving only” rather than “feedforward only”, to make it obvious that what we change in these models is simply whether the connection has any modulatory impact on the activity. 

      (5) "incorporating it into ANNs can affect their behavior and help determine the solutions that the network can discover." -> Do you mean constrain? Overall, I did not really get this point.

      Yes, we mean that it constrains the solutions that the network is likely to discover.

      (6) "ignore the auditory inputs when they visual inputs were unambiguous" -> the not they

      This has been fixed. Thank you for catching it.

      (7) xlabel in Figure 4 is missing.

      This has been fixed, thank you for catching it.

      Reviewer #3 (Recommendations for the authors):

      Major:

      (1) How alignment is computed is not defined. In addition to a proper definition in the methods section, it would be nice to briefly define it when it first appears in the results section.

      We’ve added an explicit definition of how alignment is calculated in the methods and emphasized the calculation when its first explained in the results

      (2) A connectivity matrix for the feedforward-only model is missing and could be added.

      We have added this to Figure 1.

      (3) The connectivity matrix for each random model should also be shown.

      We’ve shown each of the random model configurations in the new supplemental figure S1.

      (4) Initial parameters are not defined, such as W, b etc. A table with all model parameters would be great.

      We have added a table to the methods listing all of the parameters.

      (5) Would be nice to show the t-sne plots (not just the NH score) for each model and each task in the appendix.

      We can provide these figures on request. They massively increase the file size of the paper pdf, as there’s 49 of them for each task and each model, 980 in total. An example t-SNE plot is provided in figure 6.

      Minor:

      (1) Page 4:

      "we refer to this as Visual-dominant Stimulus case 1, or VS1; Fig. 1a, top)." This should be Fig. 2a.

      (2) "In stimulus condition VS1, all of the models were able to learn to use the auditory clues to disambiguate the images (Fig. 2c)."

      This should be Fig. 2b.

      (3) "In comparison, in VS2, we found that the brainlike model learned to ignore distracting audio inputs quickly and consistently compared to the random models, and a bit more rapidly than the auditory information (Fig 2d)."

      This should be Fig. 2c.

      (4) "VS3; Fig. 2b, top"

      This should be Fig. 2d

      (5) "while all other models had to learn to do so further along in training (Fig. 2e)."

      It is not stated explicitly, but this suggests that the image-aligned target was considered correct, and that weight updates were happening.

      (6) "VS4; Fig. 2b, bottom"

      This should be Fig. 2f

      (7) "adept at learning (Fig. 2f)."

      This should be Fig. 2g

      (8) Figure 3:b,c,e y-labels are missing

      3f: both x and y labels are missing

      (9) Figure labeling in the text is not consistent (Fig. 1A versus Fig. 2a)

      (10) Doubled "the" in ""This shows that the inductive bias towards vision in the brainlike model depended on the presence of the multiplicative component of the the feedback"

      (11) Page 9 Figure 6: The caption says b shows the latent spaces for the VS2 task, whereas the main text refers to 6b as showing the latent space for the AS2 task. Please correct which task it is.

      (12) Methods 4.1 page 13

      "which is derived from the feedback input (h_{l−1})"

      This should be h_{l+1}

      (13) r_l, u_l, u and c are not defined to which aspects of the model they refer to

      Even though this is based on a previous model, the methods section should completely describe the model.

      Equations 1,2,3: the notation [x;y] is unclear and should be defined.

      Equation 5: u should probably be u_l.

      (14) Page 14 typo: externopyrmidisation.

      (15) It is confusing to use different names for the same thing: the all-feedforward model, the all feedforward network, the feedforward network, and the feedforward-only model are probably all the same? Consistent naming would help here.

      Thank you for the detailed comments! We’ve fixed the minor errors and renamed the feedforward models to drive-only models.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Comment 1: 5-HT2A Antibody Specificity

      Was this antibody validated to be 5-HT2A receptor-specific? Can the authors reason why the discrepancy may arise, and if the axonal expression is specific to the cultured neurons?

      We performed extensive validation of the anti-5-HT2A receptor antibody (Alomone #ASR-033), which is summarized in the accompanying Author response images:

      Positive findings (Author response image 1c-e, Author response image 2a): (1) Western blot showed a single band at the expected molecular weight (~50 kDa) in neural progenitors and iPSCderived neurons. (2) The blocking peptide (#BLP-SR033) abolished Western blot bands and markedly reduced immunofluorescence signals in neurons, confirming epitope-specific binding.

      Negative findings (Author response image 1a-b, Author response image 2a-b, Author response image 3): (1) We detected positive immunofluorescence signals in HEK293 and HeLa cells (Author response image 1a-b), which do not express 5-HT2AR. (2) Western blot also showed bands in HEK293 and HeLa cells (Author response image 2a-b). (3) Single-cell RNA-seq analysis of HEK293T cells confirmed complete absence of HTR2A expression (Author response image 3a). (4) qPCR showed no detectable HTR2A transcripts in iPSCs or HeLa cells (Ct > 36), while neural progenitors and neurons showed clear expression (Author response image 3b). (5) siRNA knockdown experiments failed to produce a corresponding decrease in immunofluorescence or Western blot signals, despite reduced HTR2A transcript levels (data not shown).

      BLAST analysis: Protein BLAST analysis of the 13-amino acid immunogenic peptide sequence identified the human 5-HT2A receptor as the top hit (9/13 amino acids overlap). However, shorter sequence similarities were also found with other proteins, including APPBP1 (6/9 amino acids), Immunoglobulin Heavy Chain (6/7 amino acids), and Interleukin31 receptor (6/8 amino acids). While these partial homologies do not provide a definitive mechanistic explanation for the observed off-target binding, they illustrate that the epitope sequence is not entirely unique to the 5-HT2A receptor.

      Conclusion: While our validation confirmed epitope-specific binding (blocking peptide effective in neurons), the antibody clearly detects something in cells that demonstrably lack HTR2A gene expression. This indicates off-target binding to other proteins sharing the epitope sequence. We have therefore removed all antibody-based 5-HT2A receptor experiments from the revised manuscript. This includes the receptor internalization data from Figure 1. The remaining findings (BDNF upregulation, gene expression changes, morphological effects, electrophysiology) are supported by independent methods including pharmacological blockade with ketanserin.

      Comment 2: Psilocin Dose Selection

      It would be helpful to specify the dose of psilocin tested, and describe how this dose was chosen.

      We used 10 µM psilocin based on: (1) The seminal study by Ly et al. (2018), which demonstrated neuroplasticity effects at this concentration in rat cortical neurons. (2) Our own dose-response experiments (Figure S2B) showing maximal BDNF increase at 10 µM compared to lower concentrations (10 nM, 100 nM, 1 µM). We have clarified this in the revised Methods section.

      Comment 3: Dose vs. Time Dependence

      Given that only one dose is tested, it is also possible that this reflects dose dependence, with the longer time exposure leading to higher dose exposure.

      We agree that dose dependence cannot be excluded with our current experimental design. This point is now moot as we have removed the 5-HT2A receptor internalization experiments from the manuscript. Future studies in our group will address dose-dependent effects on other readouts.

      Comment 4: Control Conditions

      What is the 'control' here? A more appropriate control would be 24 hours after vehicle application.

      The control condition is indeed a vehicle (DMSO) control collected at the same time point as the experimental condition (i.e., 24 hrs post-treatment). We have clarified this in the revised figure legends and Methods section to avoid confusion.

      Comment 5: Sample Size Description

      The sample size was not clearly described. Statistical analyses should consider that neurites from the same cells are not independent.

      We have expanded the sample size descriptions in the figure legends. Analyses were performed using 5-10 microscope images per condition, with 15 ROIs per image, across at least two independent differentiations from two genetic backgrounds. Regarding independence: each neurite segment exists within a distinct microenvironment and can be considered an independent measurement unit, consistent with established practices in the field (Paul et al., 2021, CNS Neurosci Ther). We acknowledge this increases statistical power and have noted this in the Methods.

      Reviewer #2:

      Comment 1: 5-HT2A Antibody Validation

      Without validation (using for example knockdown techniques to decrease expression of 5HT2A), the experiments using this antibody should be excluded from the manuscript.

      We agree with this assessment. As detailed in our response to Reviewer 1 (Comment 1) and documented in the Response to Reviewer Figure, our extensive validation attempts—including siRNA knockdown—could not conclusively demonstrate antibody specificity. We have removed all antibody-based 5-HT2A receptor experiments from the revised manuscript.

      Comment 2: Serotonin in Cell Media

      Did the authors evaluate whether 5-HT is present in the cell media?

      The cell culture media used in our experiments does not contain serotonin. We have explicitly stated this in the revised Methods section.

      Comment 3: Statistical Analysis of Figure S1F

      Some of the datasets are not statistically analyzed, such as Figure S1F.

      Figure S1F related to the 5-HT2A receptor experiments and has been removed from the revised manuscript along with the associated data.

      Comment 4: Translational Validity of Prolonged Exposure

      The authors continuously exposed cells to psilocin for hours or days. Since this is not the model of what occurs in vivo, the findings lack translational validity.

      We acknowledge this limitation. Most experiments (BDNF, gene expression, branching) were conducted 24–48 hrs after a brief 10-minute exposure, which better reflects the in vivo situation. Prolonged exposures (96 hrs) were used specifically for synaptogenesis experiments based on literature showing that repeated LSD administration enhances spine density (Inserra et al., 2022; De Gregorio et al., 2022). Our in vitro system lacks metabolizing enzymes and glial cells, which may introduce temporal biases. We have added a discussion of these limitations in the revised manuscript.

      Comment 5: Ketanserin Effect on BDNF

      In Figure 2E, ketanserin by itself seems to reduce BDNF density. How do the authors conclude that ketanserin blocks psi-induced effects?

      We identified that one cell line (Ctrl 1) with inherently higher BDNF density was inadvertently excluded from the ketanserin-only condition. After removing Ctrl 1 from all conditions and reanalyzing, the difference between Ctrl and Ket alone is no longer significant. The significant difference between Psi+Ket and Ket alone demonstrate that psilocin exerts effects that ketanserin can block, consistent with 5-HT2A receptor mediation. The revised figure and statistical analysis are included in the updated manuscript.

      Comment 6: mCherry Localization mCherry (Fig 4A) seems to be retained in the nucleus.

      The CamKII promoter drives expression of cytoplasmic mCherry, which fills the entire neuron including soma, dendrites, and axons. The apparent nuclear signal reflects mCherry accumulation in the soma, which surrounds the nucleus. The images clearly show mCherry extending into neurites, which was essential for our Sholl analysis of neuronal complexity.

      Comment 7: Reference 36

      Reference 36 is a review article that does not mention psilocin.

      Our statement refers broadly to serotonergic psychedelics increasing neurotrophic factors. Reference 36 (Colaço et al., 2020) examines ayahuasca, which contains the serotonergic psychedelic DMT. We have revised the text to clarify this point.

      Summary of Major Revisions

      (1) Removed all 5-HT2A receptor antibody-based experiments from Figure 1 and supplementary figures due to inconclusive specificity validation. An Author response image documenting our validation attempts is provided.

      (2) Clarified control conditions (vehicle controls at matched time points) in figure legends.

      (3) Expanded sample size descriptions in Methods and figure legends.

      (4) Re-analyzed ketanserin experiments with consistent cell line inclusion.

      (5) Added discussion of translational limitations.

      (6) Added new Figure S5 summarizing proposed signaling pathways.

      (7) Expanded discussion on the relevance of iPSC-derived neurons for drug development.

      Author response image 1.

      Immunostaining for 5-HT2A receptor across cell types and peptide-blocking control. (a) HEK293 cells display a positive immunofluorescent signal despite not endogenously expressing 5-HT2AR, indicating nonspecific antibody reactivity. (b) HeLa cells also exhibit a positive signal despite lacking endogenous 5-HT2AR expression, further demonstrating nonspecific antibody binding in non-expressing cell types. (c) Neural progenitor cells show clear positive 5-HT2AR staining. (d) iPSC-derived neurons exhibit robust and well-defined 5-HT2AR staining. (e) Application of the Alomone 5-HT2AR blocking peptide (#BLP-SR033) markedly reduces neuronal signal intensity, supporting epitope-specific binding.

      Author response image 2.

      Western blot analysis of 5-HT2A receptor abundance and peptide-blocking control. (a-b) In line with the immunofluorescence a single band is detected in iPSCs, HEK cells, neural progenitors, iPSC-derived neurons and (b) HeLa cells. (a) Preincubation of the primary antibody with the corresponding blocking peptide abolishes this band across all samples, consistent with specific binding of the antibody to its intended epitope.

      Author response image 3.

      Lack of detectable 5-HT2AR expression in HEK and HeLa cells. (a) Analysis of a human-only HEK293T single-cell RNA-seq dataset (10x Genomics; https://www.10xgenomics.com/datasets/293-t-cells-1-standard-1-1-0, accessed 2025-11-25) shows no meaningful HTR2A expression, whereas other genes such as GAPDH, TP53, MYC, and ACTB are robustly detected. Consistently, evaluation of a “Barnyard” dataset - an equal mixture of human HEK293T and mouse NIH3T3 cells (10x Genomics; https://www.10xgenomics.com/datasets/20-k-1-1mixture-of-human-hek-293-t-and-mouse-nih-3-t-3-cells-3-ht-v-3-1-3-1-high-6-1-0, accessed 2025-1125) reveals only ~4 of ~10,000 droplets with minimal HTR2A signal, confirming the absence of meaningful expression.(b) (b) qPCR analysis further demonstrates no detectable HTR2A transcripts in iPSCs or HeLa cells (Ct > 36), while neural progenitors and iPSC-derived cortical neurons show expression when normalized to housekeeping genes GAPDH and TBP.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the editor and the reviewers for the detailed and constructive comments. In revising the manuscript we have: (i) clarified what is new relative to prior stress tolerance work, (ii) made explicit that we observe phenotypic convergence without a shared genetic route, (iii) stated upfront that we evolved four independent lines plus two controls, and (iv) corrected figure legends, statistics, and the missing citations. Below we respond point-by-point.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript presents findings on the adaptation mechanisms of Saccharomyces cerevisiae under extreme stress conditions. The authors try to generalize this to adaptation to stress tolerance. A major finding is that S. cerevisiae evolves a quiescence-like state with high trehalose to adapt to freeze-thaw tolerance independent of their genetic background. The manuscript is comprehensive, and each of the conclusions is well supported by careful experiments.

      Strengths:

      This is excellent interdisciplinary work.

      Weaknesses:

      I have questions regarding the overall novelty of the proposal, which I would like the authors to explain.

      (1) Earlier papers have shown that loss of ribosomal proteins, that slow growth, leads to better stress tolerance in S. cerevisiae. Given this, isn’t it expected that any adaptation that slows down growth would, overall, increase stress tolerance? Even for other systems, it has been shown that slowing down growth (by spore formation in yeast or bacteria/or dauer formation in C. elegans) is an effective strategy to combat stress and hence is a likely route to adaptation. The authors stress this as one of the primary findings. I would like the authors to explain their position, detailing how their findings are unexpected in the context of the literature.

      We agree that the link between slower growth and higher stress tolerance has been well studied. What is distinctive here is that repeated, near-lethal freeze–thaw selected not only for a tolerant/quiescent-like state but also for a shorter lag on re-entry. In this regime of freeze–thaw–regrowth, cells that are tolerant but slow to restart would be outcompeted by naive fast growers. Our quiescence-based selection simulations reproduce exactly this constraint. We have added this explanation to the Results to make clear that the novelty is the co-evolution of a tolerant, trehaloserich state together with rapid regrowth under an alternating regime.

      (2) Convergent evolution of traits: I find the results unsurprising. When selecting for a trait, if there is a major mode to adapt to that stress, most of the strains would adapt to that mode, independent of the route. According to me, finding out this major route was the objective of many of the previous reports on adaptive evolution. The surprising part in the previous papers (on adaptive evolution of bacteria or yeast) was the resampling of genes that acquired mutations in multiple replicates of an evolution experiments, providing a handle to understand the major genetic route or the molecular mechanism that guides the adaptation (for example in this case it would be - what guides the overaccumulation of trehalose). I fail to understand why the authors find the results surprising, and I would be happy to understand that from the authors. I may have missed something important.

      Our surprise was precisely that we did not see the classical pattern of “phenotypic convergence + repeated mutations in the same locus/module.” All independently evolved lines converged on a trehalose-rich, mechanically reinforced, quiescence-like phenotype, but population sequencing across lines did not reveal a single repeatedly hit gene or small shared pathway, even when we increased selection stringency (1–3 freeze–thaw cycles per round). We have now stated in the manuscript that this decoupling (strong phenotypic convergence, non-overlapping genetic routes) is the central inference: selection is acting on a physiologically defined state that multiple genotypes can reach.

      (3) Adaptive evolution would work on phenotype, as all of selective evolution is supposed to. So, given that one of the phenotypes well-known in literature to allow free-tolerance is trehalose accumulation, I think it is not surprising that this trait is selected. For me, this is not a case of ”non-genetic” adaptation as the authors point out: it is likely because perturbation of many genes can individually result in the same outcome - up-regulation of trehalose accumulation. Thereby, although the adaptation is genetic, it is not homogeneous across the evolving lines - the end result is. Do the authors check that the trait is actually a non-genetic adaptation, i.e., if they regrow the cells for a few generations without the stress, the cells fall back to being similarly only partially fit to freeze-thaw cycles? Additionally, the inability to identify a network that is conserved in the sequencing does not mean that there is no regulatory pathway. A large number of cryptic pathways may exist to alter cellular metabolic states.

      This is a point in continuation of point #2, and I would like to understand what I have missed.

      We agree, and we have removed the wording “non-genetic adaptation.” The evolved populations retain high survival even after regrowth for ≥25 generations without freeze–thaw, so the adaptation is clearly genetically maintained. What our data show is that there is no single genetic route to the shared phenotype; different mutations can all drive cells into the same trehalose-rich, quiescencelike, mechanochemically reinforced state. We now describe this as “genetic diversification with phenotypic convergence.”

      (4) To propose the convergent nature, it would be important to check for independently evolved lines and most probably more than 2 lines. It is not clear from their results section if they have multiple lines that have evolved independently.

      We indeed evolved four independent lines and maintained two independent controls. We have added this information at the start of the Results so that the level of replication is immediately clear.

      (5) For the genomic studies, it is not clear if the authors sequenced a pool or a single colony from the evolved strains. This is an important point, since an average sequence will miss out on many mutations and only focus on the mutations inherited from a common ancestral cell. It is also not clear from the section.

      We sequenced population samples from the evolved lines. Our specific question was whether independently evolved lines would show the same high-frequency genetic solution, as is often seen in parallel evolution. Pool sequencing may under-sample rare/private variants, but it is appropriate for detecting such shared, high-frequency routes — and we do not find any. We have clarified this rationale in the Methods/Results.

      Reviewer #2 (Public review):

      Summary:

      The authors used experimental evolution, repeatedly subjecting Saccharomyces cerevisiae populations to rapid liquid-nitrogen freeze-thaw cycles while tracking survival, cellular biophysics, metabolite levels, and whole-genome sequence changes. Within 25 cycles, viability rose from ~2 % to ~70 % in all independent lines, demonstrating rapid and highly convergent adaptation despite distinct starting genotypes. Evolved cells accumulated about threefold more intracellular trehalose, adopted a quiescence-like phenotype (smaller, denser, non-budding cells), showed cytoplasmic stiffening and reduced membrane damage, and re-entered growth with shorter lag traits that together protected them from ice-induced injury. Whole-genome sequencing indicated that multiple genetic routes can yield the same mechano-chemical survival strategy. A population model in which trehalose controls quiescence entry, growth rate, lag, and freeze-thaw survival reproduced the empirical dynamics, implicating physiological state transitions rather than specific mutations as the primary adaptive driver. The study therefore concludes that extreme-stress tolerance can evolve quickly through a convergent, trehalose-rich quiescence-like state that reinforces membrane integrity and cytoplasmic structure.

      Strengths:

      The strengths of the paper are the experimental design, data presentation and interpretation, and that it is well-written.

      (1) While the phenotyping is thorough, a few more growth curves would be quite revealing to determine the extent of cross-stress protection. For example, comparing growth rates under YPD vs. YPEG (EtOH/glycerol), and measuring growth at 37ºC or in the presence of 0.8 M KCl.

      We thank the referee for the interesting suggestions. However, growth rates alone may be difficult to interpret since WT strains also show different growth rates under these conditions. Therefore, comparing the relative fitness or survival of the evolved strains versus the WT under these stresses would be more informative. In the present study we limited growth/survival measurements to what was needed to parameterize the adaptation model in YPD under the freeze–thaw regime. We have now added a statement in the Discussion that, given the shared trehalose/mechanical mechanism, such cross-stress assays are an expected and straightforward follow-up.

      (2) Is GEMS integrated prior to evolution? Are the evolved cells transformable?

      Yes. GEMs were integrated prior to evolution, because the non-integrated evolved population showed low transformation efficiency, likely due to altered cell-wall properties.

      (3) From the table, it looks like strains either have mutations in Ras1/2 or Vac8. Given the known requirements of Ras/PKA signaling for the G1/S checkpoint (to make sure there are enough nutrients for S phase), this seems like a pathway worth mentioning and referencing. Regarding Vac8, its emerging roles in NVJ and autophagy suggest another nutrient checkpoint, perhaps through TORC1. The common theme is rewired metabolism, which is probably influencing the carbon shuttling to trehalose synthesis.

      We appreciate the reviewer’s suggestion to consider pathways like Ras/PKA (linked to Ras1/2) and autophagy/TORC1 (linked to Vac8) as potential upstream modulators. While these pathways are involved in nutrient sensing and metabolic regulation, we choose not to emphasize them specifically. This is because (i) some evolved lines lack Ras1/2 or Vac8 variants, and (ii) none of the variants lies directly in trehalose synthesis/degradation pathways. Furthermore, direct links to trehalose accumulation are not well established for these specific variants in this context, and pathways like Ras are global regulators with broad effects. Together with the strongly convergent phenotype, this supports our main inference that multiple genetic/metabolic routes can feed into the same trehalose-rich, mechanochemically reinforced, quiescence-like state. We have added a note in the discussion regarding metabolic rewiring and trehalose.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Generally, the results sections should have more details. The figures should be corrected, and the legends should be checked for correctness. The manuscript seems to have been assembled in haste?

      We have expanded the relevant Results subsections with one-sentence motivations (why each measurement was performed) and we have corrected the figure legends for ordering and consistency.

      Figure 3: It will be good to have the correct p-values on the figure itself. P-values are typically less than 1, unless there is some special method (here the values presented are , etc). Please explain how the P-values were obtained in the figure legend itself.

      Figure 3 now shows the actual p-values. The legend specifies the details and the sample sizes used.

      Figure 5: It is not clear what the error bars show in 5B, E (different evolved population/ clones/ cells?). All the figure legends are mixed up, please correct them. It is difficult to follow the paper.

      Figure 5 legends now state clearly what the error bars represent (biological replicates) and which panels are from single-cell measurements. We have checked the panel lettering and legend order for consistency with the flow of the main text.

      Reviewer #3 (Recommendations for the authors):

      Overall, the paper is outstanding, well-written, and insightful.

      A point to address is that there are missing citations on lines 60, 91.

      We have added the missing citations at both locations. We apologize for the omission, which was due to a compilation error. This error has been fixed, and the bibliography has been corrected (now containing 74 references).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Authors state, "we identified ETF dehydrogenase (ETFDH) as one of the most dispensable metabolic genes in neoplasia." Surely there are thousands of genes that are dispensable for neoplasia. Perhaps the authors can revise this sentence and similar sentiments in the text.

      We agree with the reviewer and have corrected the text accordingly. Specifically, we rephrased the sentence: “Surprisingly, we observed that in contrast to muscle, ETFDH is one of the most non-essential metabolic genes in cancer cells.” to “Surprisingly, we observed that in contrast to muscle, ETFDH is a non-essential gene in acute lymphoblastic leukemia NALM-6 cells”

      Authors state, "These findings show that ETFDH loss elevates glutamine utilization in the CAC to support mitochondrial metabolism." While elevated glutamine to CAC flux is consistent with the statement that increased glutamine, the authors have not measured the effect of restoring glutamine utilization to baseline on mitochondrial metabolism. Thus, the causality implied by the authors can only be inferred based on the data presented. Indeed, the increased glutamine consumption may be linked to the increase in ROS, as glutamate efflux via system xCT is a major determinant of glutamine catabolism in vitro.

      Indeed. We changed the statement "These findings show that ETFDH loss elevates glutamine utilization in the CAC to support mitochondrial metabolism." to "Collectively, these data demonstrate that ETF insufficiency in cancer cells remodels mitochondrial metabolism and increases the glutamine consumption and anaplerosis."

      Authors state that the mechanism described is an example of "retrograde signaling". However, the mechanism seems to be related to a reduction in BCAA catabolism, suggesting that the observed effects may be a consequence of altered metabolic flux rather than a direct signaling pathway. The data presented do not delineate whether the observed effects stem from disrupted mitochondrial communication or from shifts in nutrient availability and metabolic regulation.

      Notwithstanding that the term “retrograde” was used to refer to signaling from mitochondria to mTORC1, rather than from mTORC1 to mitochondria [1], we have removed the term “retrograde signaling” throughout the manuscript.

      The authors should discuss which amino acids that are ETFDH substrates might affect mTORC1 activity or consider whether other ETFDH substrates might also affect mTORC1 in their discussion. Along these lines, the authors might consider discussing why amino acids that are not ETFDH substrates are increased upon ETFDH loss.

      Based on the literature, we expect that branched chain amino acids that are ETFDH substrates (e.g., leucine) are likely to play a major role in activating mTORC1 upon ETFDH abrogation. As expected, the aforementioned amino acids are among those that are the most highly upregulated in ETFDH deficient cells (Fig 3A). We have, however, never formally tested the role of branched chain amino acid in activating mTORC1 in the context of ETFDH disruption. The increase in amino acids that are not metabolized via ETFDH, is likely to stem from global metabolic rewiring of ETFDH-deficient cells and observed alterations in amino acid uptake (e.g., glutamine; Fig 2F). We discuss this in the revised version of the paper as follows:

      “Several metabolites can be sensed via signaling partners upstream of mTORC1, including leucine, arginine, methionine/SAM, and threonine [2]. Branched-chain amino acids (leucine, isoleucine, and valine), which are among the highest upregulated metabolites in ETFDH deficient cells (Fig 3A) serve as ETFDH substrates, and have been described to display strong activation capabilities towards mTORC1 in the literature [3,4]. Glutamine can also activate mTORC1 through Arf family of GTPases [5]. Indeed, glutamine can supplement the non-essential amino acid (NEAA) pool through transamination [6] and amino acid uptake [7]. Accordingly, the maintenance of NEAA that are non-ETFDH substrates may be supported by the global metabolic rewiring fueled by enhanced glutamine metabolism in ETFDH-deficient cells. Deciphering the mechanisms leading to accumulation of specific amino acids and their role in ETFDH-dependent mTORC1 modulation is warranted.”

      Reviewer #2 (Public review):

      The authors would strengthen the paper considerably by adding back catalytically inactive ETFDH to show that the activity of this enzyme is responsible for the increased growth phenotypes and changes in labeling that they observe.

      Based on the Reviewers’ suggestions we performed these experiments. Herein, we took advantage of Y304A/G306E ETFDH mutant that impairs electron transfer from ETF and cannot substitute for the wild type (WT) gene function in ETFDH-deficient myoblasts [8]. We expressed WT and Y304A/G306E ETFDH mutant in ETFDH KO HCT116 colorectal cancer cells and confirmed that they are expressed to a comparable level (Supplementary Figure 6C). Re-expression of WT decreased proliferation, while suppressing mTORC1 signaling and increasing 4E-BP1 levels relative to control (vector infected) ETFDH KO EV HCT116 cells (Supplementary Figure 6D). In contrast, proliferation rates, mTORC1 signaling and 4E-BP1 levels remained largely unchanged upon Y304A/G306E ETFDH mutant expression in ETFDH KO HCT116 cells (Supplementary Figure 6D). Similarly, re-expression of WT ETFDH disrupted the bioenergetic phenotype associated with ETFDH loss, in contrast to re-expression of Y304A/G306E ETFDH mutant, which exhibited similar bioenergetic profiles as ETFDH KO control (Supplementary Figure 6E-F). Collectively these findings argue that the ETFDH activity is required for its tumor suppressive effects.

      If nucleotide pool and labeling data are available, or can be obtained readily, this would significantly strengthen the tracing data already obtained.

      We followed Reviewer’s suggestion and measured nucleotide levels. This revealed that loss of ETFDH results in increase in steady-state nucleotide pools (Supplementary Figure 2K), consistent with increased aspartate labelling and accelerated tumor growth.

      References

      (1) Morita, M. et al. mTORC1 controls mitochondrial activity and biogenesis through 4EBP-dependent translational regulation. Cell Metab 18, 698-711 (2013). https://doi.org/10.1016/j.cmet.2013.10.001

      (2) Valenstein, M. L. et al. Structural basis for the dynamic regulation of mTORC1 by amino acids. Nature 646, 493-500 (2025). https://doi.org/10.1038/s41586-025-09428-7

      (3) Appuhamy, J. A., Knoebel, N. A., Nayananjalie, W. A., Escobar, J., & Hanigan, M. D. Isoleucine and leucine independently regulate mTOR signaling and protein synthesis in MAC-T cells and bovine mammary tissue slices. J Nutr 142, 484-491 (2012). https://doi.org/10.3945/jn.111.152595

      (4) Herningtyas, E. H. et al. Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. Biochim Biophys Acta 1780, 1115-1120 (2008). https://doi.org/10.1016/j.bbagen.2008.06.004

      (5) Jewell, J. L. et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 347, 194-198 (2015). https://doi.org/10.1126/science.1259472

      (6) Tan, H. W. S., Sim, A. Y. L. & Long, Y. C. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation. Nat Commun 8, 338 (2017). https://doi.org/10.1038/s41467-017-00369-y

      (7) Chen, R. et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation. J Cell Biol 206, 173-182 (2014).https://doi.org/10.1083/jcb.201403009

      (8) Herrero Martin, J. C. et al. An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis. Nat Metab 6, 209-225 (2024). https://doi.org/10.1038/s42255-023-00956-y

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (Public review):

      Summary:

      Schafer et al. tested whether the hippocampus tracks social interactions as sequences of neural states within an abstract social space defined by dimensions of affiliation and power, using a task in which participants engaged in narrative-based social interactions. The findings of this study revealed that individual social relationships are represented by unique sequences of hippocampal activity patterns. These neural trajectories corresponded to the history of trial-to-trial affiliation and power dynamics between participants and each character, suggesting an extended role of the hippocampus in encoding sequences of events beyond spatial relationships.

      The current version has limited information on details in decoding and clustering analyses which can be improved in the future revision.

      Strengths:

      (1) Robust Analysis: The research combined representational similarity analysis with manifold analyses, enhancing the robustness of the findings and the interpretation of the hippocampus's role in social cognition.

      (2) Replicability: The study included two independent samples, which strengthens the generalizability and reliability of the results.

      Weaknesses:

      I appreciate the authors for utilizing contemporary machine-learning techniques to analyze neuroimaging data and examine the intricacies of human cognition. However, the manuscript would benefit from a more detailed explanation of the rationale behind the selection of each method and a thorough description of the validation procedures. Such clarifications are essential to understand the true impact of the research. Moreover, refining these areas will broaden the manuscript's accessibility to a diverse audience.

      We thank the reviewer for these comments and have addressed them in various ways.

      First, we removed the spline-based decoding and spectral clustering analyses. As we detail in our response to the recommendations, these approaches were complex and raised legitimate interpretational concerns, making it unclear how they supported our core claims. The revised manuscript now focuses on a set of representational similarity analyses to show representations consistent with social dimension similarity (affiliation vs. power decision trials) and social location similarity (trajectory/map-like coding based on participant choices).

      Second, we expanded the Methods and Results to more clearly explain the analyses, the questions they address, and associated controls and robustness tests. The dimension similarity analysis tests whether hippocampal patterns differentiate affiliation and power decisions in a way consistent with an abstract dimension representation. The location similarity RSAs test whether within-character neural pattern distances scale with Euclidean distance in social space (relationship-specific trajectories), and whether pattern distances across all characters scale with location distances when distances are globally standardized, consistent with a shared map-like coordinate system.

      Third, we emphasize new controls. For the dimension similarity RSA, we test for potential confounds such as word count, text sentiment, and reaction time differences between affiliation and power trials. For the location similarity RSA, we control for temporal distance between trials and show (in the Supplement) that the reported effects cannot be explained by temporal autocorrelation in the fMRI data or by the relationship between temporal distance and behavioral location distance.

      We believe that these changes address the reviewer’s request for clearer rationale and validation.

      Reviewer #2 (Public review):

      Summary:

      Using an innovative task design and analysis approach, the authors set out to show that the activity patterns in the hippocampus related to the development of social relationships with multiple partners in a virtual game. While I found the paper highly interesting (and would be thrilled if the claims made in the paper turned out to be true), I found many of the analyses presented either unconvincing or slightly unconnected to the claims that they were supposed to support. I very much hope the authors can alleviate these concerns in a revision of the paper.

      Strengths & Weaknesses:

      (1) The innovative task design and analyses, and the two independent samples of participants are clear strengths of the paper.

      We thank the reviewer for this comment.

      (2) The RSA analysis is not what I expected after I read the abstract and tile of the result section "The hippocampus represents abstract dimensions of affiliation and power". To me, the title suggests that the hippocampus has voxel patterns, which could be read out by a downstream area to infer the affiliation and power value, independent of the exact identity of the character in the current trial. The presented RSA analysis however presents something entirely different - namely that the affiliation trials and power trials elicit different activity patterns in the area indicated in Figure 3. What is the meaning of this analysis? It is not clear to me what is being "decoded" here and alternative explanations have not been considered. How do affiliation and power trials differ in terms of the length of sentences, complexity of the statements, and reaction time? Can the subsequent decision be decoded from these areas? I hope in the revision the authors can test these ideas - and also explain how the current RSA analysis relates to a representation of the "dimensions of affiliation and power".

      We agree that this analysis needed to be better justified and explained. We have revised the text to clarify that by “represents the interaction decision trials along abstract social dimensions” we mean that hippocampal multivoxel patterns differentiate affiliation and power decisions in a way consistent with the conceptual framework of underlying latent dimensions. The analysis tests one simple prediction of this view – that on average these trial types are separable in the neural patterns. We have added details to the Methods, showing how the affiliation and power trials do not differ in word count or in sentiment, but do differ in their semantics, as assessed by a Large Language Model, as we expect from our task assumptions. Thanks to the reviewer’s comment, we also tested for and found a reaction time difference between affiliation and power trials, that we now control for.

      (3) Overall, I found that the paper was missing some more fundamental and simpler RSA analyses that would provide a necessary backdrop for the more complicated analyses that followed. Can you decode character identity from the regions in question? If you trained a simple decoder for power and affiliation values (using the LLE, but without consideration of the sequential position as used in the spline analysis), could you predict left-out trials? Are affiliation and power represented in a way that is consistent across participants - i.e. could you train a model that predicts affiliation and power from N-1 subjects and then predict the Nth subject? Even if the answer to these questions is "no", I believe that they are important to report for the reader to get a full understanding of the nature of the neural representations in these areas. If the claim is that the hippocampus represents an "abstract" relationship space, then I think it is important to show that these representations hold across relationships. Otherwise, the claim needs to be adjusted to say that it is a representation of a relationship-specific trajectory, but not an abstract social space.

      We appreciate this comment and agree on the value of clear, conceptually simple analyses. To address this concern, we have simplified our main analysis significantly by removing the spline-based analysis and substituting it with a multiple regression representational similarity analysis approach. We test whether within-character neural pattern distances scale with distance in social space (relationship-specific trajectories), and whether pattern distances across all characters scale with location distances when distances are globally standardized. We find evidence for both, consistent with a shared map-like coordinate system.

      We agree that decoding character identity and an across-participant decoding approach could be informative. However, our current task is not well designed for such analyses and as such would complicate the paper. Although we agree that these questions are interesting, they would test questions that are outside the scope of this paper. 

      (4) To determine that the location of a specific character can be decoded from the hippocampal activity patterns, the authors use a sequential analysis in a lowdimensional space (using local linear embedding). In essence, each trial is decoded by finding the pair of two temporally sequential trials that is closest to this pattern, and then interpolating the power/affiliation values linearly between these two points. The obvious problem with this analysis is that fMRI pattern will have temporal autocorrelation and the power and affiliation values have temporal autocorrelation. Successful decoding could just reflect this smoothness in both time series. The authors present a series of control analyses, but I found most of them to not be incisive or convincing and I believe that they (and their explanation of their rationale) need to be improved. For example, the circular shifting of the patterns preserves some of the autocorrelation of the time series - but not entirely. In the shifted patterns, the first and last items are considered to be neighboring and used in the evaluation, which alone could explain the poor performance. The simplest way that I can see is to also connect the first and last item in a circular fashion, even when evaluating the veridical ordering. The only really convincing control condition I found was the generation of new sequences for every character by shuffling the sequence of choices and re-creating new artificial trajectories with the same start and endpoint. This analysis performs much better than chance (circular shuffling), suggesting to me that a lot of the observed decoding accuracy is indeed simply caused by the temporal smoothness of both time series.

      We thank the reviewer for emphasizing this important concern; we agree that we did not sufficiently address this in the initial submission. This concern is one main reason we removed the spline-based analysis and now use regression-based representational similarity analyses in its place. In the revision, we report autocorrelation-related analyses in the supplement, and via controls and additional analysis show that temporal distance (or its square) cannot explain the location-like effects. This substantially improves our ability to interpret the findings.

      (5) Overall, I found the analysis of the brain-behavior correlation presented in Figure 5 unconvincing. First, the correlation is mostly driven by one individual with a large network size and a 6.5 cluster. I suspect that the exclusion of this individual would lead to the correlation losing significance. Secondly, the neural measure used for this analysis (determining the number of optimal clusters that maximize the overlap between neural clustering and behavioral clustering) is new, non-validated, and disconnected from all the analyses that had been reported previously. The authors need to forgive me for saying so, but at this point of the paper, would it not be much more obvious to use the decoding accuracy for power and affiliation from the main model used in the paper thus far? Does this correlate? Another obvious candidate would be the decoding accuracy for character identity or the size of the region that encodes affiliation and power. Given the plethora of candidate neural measures, I would appreciate if the authors reported the other neural measures that were tried (and that did not correlate). One way to address this would have been to select the method on the initial sample and then test it on the validation sample - unfortunately, the measure was not pre-registered before the validation sample was collected. It seems that the correlation was only found and reported on the validation sample?

      We agree that this analysis was too complicated and under constrained, and thus not convincing. We think that removing this cluster-based analysis is the most conservative response to the reviewer’s concerns and have removed it from the revised paper.

      Recommendations to the authors:

      Reviewer #1 (Recommendations for the authors):

      The manuscript's description of the shuffling analysis performed during decoding is currently ambiguous, particularly concerning the control variables. This ambiguity is present only in the Figure 4 legends and requires a more detailed explanation within the methods section. It is essential to clarify whether the permutation process was conducted within each character's data set or across multiple characters' data sets. If permutations were confined to within-character data, the conclusion would be that the hippocampus encodes context-specific information rather than providing a twodimensional common space.

      We thank the reviewer for this comment. We have now removed the spline analysis due to these and other problems and have replaced it with representational similarity analyses that are both more rigorous and easier to interpret. We think these analyses allow us to make the claim that the characters are represented in a common space. 

      In the methods, we explain the analyses (page 23-24, lines 475-500):

      “We also expected the hippocampus to represent the different characters’ changing social locations, which are implicit in the participant’s choices. We used multiple regression searchlight RSA to test whether hippocampal pattern dissimilarity increases with social location distance, based on participant-specific trial-wise beta images where boxcar regressors spanned each trial’s reaction time.”

      “We ran two complementary regression analyses to address two related questions. First, we asked whether the hippocampus represents how a specific relationship changes over time. For this analysis, for each participant and each searchlight, we computed character-specific (i.e., only for same character trial pairs) correlation distances between trial-wise beta patterns and Euclidean distances between the social location behavioral coordinates. Distances were zscored within character trial pairs to isolate character-specific changes. The second analysis asked whether the there is a common map-like representation, where all trials, regardless of relationship, are represented in a shared coordinate system. Here, we included all trial pairs and z-scored the distances globally. For both regression analyses, we included control distances to control for possible confounds. To account for generic time-related changes, we controlled for absolute scan-time difference, as this correlated with location distance across participants (see Temporal autocorrelation of hippocampal beta patterns in the supplement). Although the square of this temporal distance did not explain any additional variance in behavioral distances, we ran a robustness analysis including both temporal distance and its square and saw qualitatively the same clusters with similar effect sizes. As such, we report the main analysis only. We included binary dimension difference (0 = trial pairs of different dimension, 1 = trials pairs of the same dimension), to ensure effects could not be explained by dimension-related effects. In the group-level model, we controlled for sample and the average reaction time between affiliation and power decisions.”

      In the results, we describe the results and our interpretation (pages 11-12, lines 185208):

      “We have shown that the left hippocampus represents the affiliation and power trials differently, consistent with an abstract dimensional representation. Does it also represent the changing social coordinates of each character? To test this, we multiple-regression RSA searchlight to test whether left hippocampus patterns represent the characters’ changing social locations across interactions (see Figure 3). We restricted the distances to those from trial pairs from the same character and standardized the distances within character (see Figure 3BD). We controlled for temporal distance to ensure the effect was not explainable by the time between trials, and for whether the trials shared the same underlying dimension (affiliation or power; see Location similarity searchlight analyses for more details). At the group level, we controlled for sample and the average reaction time difference between affiliation and power trials. Using the same testing logic as the dimensionality similarity analysis, we first tested our hypothesis in the bilateral hippocampus and found widespread effects in both the left (peak voxel MNI x/y/z = -35/-22/-15, cluster extent = 1470 voxels) and right (peak voxel MNI x/y/z = 37/-19/-14, cluster extent = 1953 voxels) hemispheres. The whole-brain searchlight analysis revealed additional clusters in the left putamen (-27/-3/14, cluster extent = 131 voxels) and left posterior cingulate cortex (-10/-28/41, cluster extent = 304 voxels).”

      “We then asked a second, complementary question: does the hippocampus represent all interactions, across characters, within a shared map? To test for this map-like structure, we repeated the analysis but now included all trial pairs, z-scoring distances globally rather than within character (Figure 3E-F). The remainder of the procedure followed the same logic as the preceding analysis. The hippocampus analysis revealed an extensive right hippocampal cluster (27/27/-14, cluster extent = 1667 voxels). The whole-brain analysis did not show any significant clusters.”

      We also describe the results in the discussion (page 12, lines 220-226): 

      “Then, we show that the hippocampus tracks the changing social locations (affiliation and power coordinates), above and beyond the effects of dimension or time; the hippocampus seemed to reflect both the changing within-character locations, tracking their locations over time, and locations across characters, as if in a shared map. Thus, these results suggest that the hippocampus does not just encode static character-related representations but rather tracks relationship changes in terms of underlying affiliation and power.”

      The manuscript's description of the decoding analysis is unclear regarding the variability of the decoded positions. The authors appear to decode the position of a character along a spline, which raises the question of whether this position correlates with time, since characters are more likely to be located further from the center in later trials. There is a concern that the decoded position may not solely reflect the hippocampal encoding of spatial location, but could also be influenced by an inherent temporal association. Given that a character's position at time t is likely to be similar to its positions at t−1 and t+1, it is crucial that the authors clearly articulate their approach to separating spatial representation from temporal autocorrelation. While this issue may have been addressed in the construction of the test set, the manuscript does not seem to adequately explain how such biases were mitigated in the training set.

      We agree that temporal confounding needs to be better accounted for, as our claims depend on space-like signals being separable from time-like ones. We address this in several ways in the revised manuscript.

      First, we emphasize that this is a narrative-based task, where temporal structure is relevant. As such, our analyses aim to demonstrate that effects go beyond simple temporal confounds, like trial order or time elapsed.

      Despite the temporal structure to the task, the decisions for the same character are spaced in time, and interleaved with other characters’ decisions, reducing the chance that a simple temporal confound could explain trajectory-related effects. We now describe the task better in the revised methods (page 16, lines 314-318):

      “All six characters’ decision trials are interleaved with one another and with narrative slides. On average, after a decision trial for a given character, participants view ~11 narrative slides and complete ~3 decisions for other characters before returning to that same character, such that each character’s choices are separated by an average of ~20 seconds (range 12 seconds to 10 min).”

      To address temporal autocorrelation in the fMRI time series, we used SPM’s FAST algorithm. Briefly, FAST models temporal autocorrelation as a weighted combination of candidate correlation functions, using the best estimate to remove autocorrelated signal.

      We also now report the temporal autocorrelation profile of the hippocampal beta series in the supplement, including (pages 29-31, lines 593-656):

      “The Social Navigation Task is a narrative-based task, where the relationships with characters evolve over time; trial pairs that are close in time may have more similar fMRI patterns for reasons unrelated to social mapping (e.g., slow drift). It is important to account for the role of time in our analyses, to ensure effects go beyond simple temporal confounds, like the time between decision trials. To aid in this, we quantified how fMRI signals change over time using a pattern autocorrelation function across decision trial lags. We defined the left and right hippocampus and the left and right intracalcarine cortex using the HarvardOxford atlas and thresholded them at 50% probability. We chose intracalcarine corex as an early visual control region that largely corresponds to primary visual cortex (V1), as it is likely to be driven by the visually presented narrative. We used the same trial-wise beta images as in the location similarity RSA (boxcar regressors spanning each decision trial’s reaction time). For each participant and region-of-interest (ROI), we extracted the decision trial-by-voxel beta matrix and quantified three kinds of temporal dependence: beta autocorrelation, multivoxel pattern correlation and multivoxel pattern correlation after regressing out temporal distance.”

      “To estimate the temporal autocorrelation of the trial-wise beta values, we treated each voxel’s beta values as a time series across trials and measured how much a voxel’s response on one trial correlated (Pearson) with its response on previous trials. We averaged these voxel wise autocorrelations within each ROI. At one trial apart (lag 1), both the hippocampus and V1 showed small positive autocorrelations, indicating modest trial-to-trial carryover in response amplitude (see Supplemental figure 1) that by three trials apart was approximately 0.”

      “Because our representational similarity analyses depend on trial-by-trial pattern similarity, we also estimated how multivoxel patterns were autocorrelated over time. For each lag, we computed the Pearson correlation between each trial’s voxelwise pattern and the pattern from the trial that many trials earlier, then averaged those correlations to obtain a single autocorrelation value for that lag. At one trial apart, both regions showed positive autocorrelation, with V1 having greater autocorrelation than the hippocampus; pattern correlations between trials 3 or 4 trials apart reduced across participants, settling into low but positive values. Then, for each participant and ROI, we regressed out the effect of absolute trial onset differences from all pairwise pattern correlations, to mirror the effects of controlling for these temporal distances in regressions. After removing this temporal distance component, the short lag pattern autocorrelation dropped substantially in both regions. The similarity in autocorrelation profiles between the two regions suggests that significant similarity effects in the hippocampus are unlikely to be driven by generic temporal autocorrelation.”

      “Relationship between behavioral location distance and temporal distance “

      “We also quantified how temporal distances between trials relates to their behavioral location distances, participant by participant. Our dimension similarity analysis controls for temporal distance between trials by design (see Social dimension similarity searchlight analysis), but our location similarity analysis does not. To decide on covariates to include in the analysis, we tested whether temporal distances can explain behavioral location distances. For each participant, we computed the correlations between trial pairs’ Euclidean distances in social locations and their linear temporal distances (“linear”) and the temporal distances squared (“quadratic”), to test for nonlinear effects. We then summarized the correlations using one-sample t-tests. The linear relationship was statistically significant (t<sub>49</sub> = 12.24, p < 0.001), whereas the quadratic relationship was not (t<sub>49</sub> = -0.55, p = 0.586). Similarly, in participant specific regressions with both linear and quadratic temporal distances, the linear effect was significant (t<sub>49</sub> = 5.69, p < 0.001) whereas the quadratic effect was not (t<sub>49</sub> = 0.20, p = 0.84). Based on this, we included linear temporal distances as a covariate in our location similarity analyses (see Location similarity searchlight analyses), and verified that adding a quadratic temporal distance covariate does not alter the results. Thus, the reported location-related pattern similarity effects go beyond what can be explained by temporal distance alone.”

      How the free parameter of spectral clustering was determined, if there is any?

      The interpretation of the number of hippocampal activity clusters is ambiguous. It is suggested that this number could fluctuate due to unique activity patterns or the fit to behaviorally defined trajectories. A lower number of clusters might indicate either a noisier or less distinct representation, raising the question of the necessity and interpretability of such a complex analysis. This concern is compounded by the potential sensitivity of the clustering to the variance in Euclidean distances of each trial's position relative to the center. If a character's position is consistently near the center, this could artificially reduce the perceived number of clusters. Furthermore, the manuscript should address whether there is any correlation between the number of clusters and behavioral performance. Specifically, what are the implications if participants are able to perform the task adequately with a smaller number of distinct hippocampal representation states?

      The rationale for conducting both cluster analysis and position decoding as separate analyses remains unclear. While cluster analysis can corroborate the findings of position decoding, it is not apparent why the authors chose to include trials across characters for cluster analysis but not for decoding analysis. An explanation of the reasoning behind this methodological divergence would help in understanding the distinct contributions of each analysis to the study's findings.

      The paper by Cohen et al. (1997), which provides the questionnaire for measuring the social network index, is not cited in the references. Upon reviewing the questionnaire that the author may have used, it appears that the term "social network size" does not refer to the actual size but to a score or index derived from the questionnaire responses. It may be more appropriate to replace the term "size" with a different term to more accurately reflect this distinction.

      Thank you for seeking these clarifications. Given the complexity of this analysis, we have decided to drop it to focus instead on our dimension and location representational similarity analysis results.

      Reviewer #2 (Recommendations for the authors):

      How did the participants' decisions on previous trials influence the future trials that the subjects saw? If the different participants were faced with different decision trials, then how did you compare their decision? If two participants made the same decisions, would they have seen exactly the same sequence of trials (see point X on how the trial sequence was randomized).

      All participants experience the same narrative, with the same decisions (i.e., the same available options); their choices (i.e., the options they select) are what implicitly shape each character’s affiliation and power locations, and thus each character’s trajectory. In other words, the narrative is fixed; what changes is the social coordinates assigned to each trial’s outcome depending on the participant’s choice of how to interact from the two narrative options. This means that we can meaningfully compare participants' neural patterns, given that every participant received the same text and images throughout.

      We have now added details on the narrative structure, replacing more ambiguous statements with a clearer description (page 16, lines 309-318):

      “The sequence of trials, including both narrative and decision trials, were fixed across participants; all that differs are the choices that the participants make. Narrative trials varied in duration, depending on the content (range 2-10 seconds), but were identical across participants. Decision trials always lasted 12 seconds, with two options presented until the participant made a choice, after which a blank screen was presented for the remainder of the duration. All six characters’ decision trials are interleaved with one another, and with the narrative slides. On average, after a decision trial for a given character, participants view ~11 narrative slides and complete ~3 decisions for other characters before returning to another decision with the same character, such that each character’s choices are separated by an average of ~20 seconds (ranging from 12 seconds to 10 min).”

      Figure 2B: I assume that "count" is "count of participants"? It would be good to indicate this on the axis/caption.

      Thank you for noting this. We have now removed this figure to improve the clarity of our figures. 

      We have shown that the hippocampus represents the interaction decision trials along abstract social dimensions, but does it track each relationship's unique sequence of abstract social coordinates?". Please clarify what you mean by "represents the interaction decision trials”.

      By “represents the interaction decision trials along abstract social dimensions”, we mean that when the participant makes a choice during the social interactions the hippocampal patterns represent the current social dimension of the choice (affiliation vs power). In other words, the hippocampal BOLD patterns differentiate affiliation and power decisions, consistent with our hypothesis of abstract social dimension representation in the hippocampus. We have clarified this (page 11, lines 185-187):

      “We have shown that the left hippocampus represents the affiliation and power trials differently, consistent with an abstract dimensional representation.”

      Page 8: "Hippocampal sequences are ordered like trajectories": It is not entirely clear to me what is meant by the split midpoint. Is this the midpoint of the piece-wise linear interpolation between two points, or simply the mean of all piecewise splines from one character? If the latter, is the null model the same as simply predicting the mean affiliation and power value for this character? If yes, please clarify and simplify this for the reader.

      Page 8: "Hippocampal sequences track relationship-specific paths". First, I was misled by the "relationship-specific". I first understood this to mean that you wanted to test whether two relationships (i.e. the identity of the partner) had different representations in Hippocampus, even if the power/affiliation trajectories are the same. I suggest changing the title of this section.

      The analysis in this section also breaks any temporal autocorrelation of measured patterns - so I am not sure if this is a strong analysis that should be interpreted at all. This analysis seems to not address the claim and conclusion that is drawn from it. I assume that the random trajectories have different choices and different affiliation/power values than the true trajectories. So the fact that the true trajectories can be better decoded simply shows that either choices or affiliation and power (or both) are represented in the neural code - but not necessarily anything beyond this.

      Page 9: "Neural trajectories reflect social locations, not just choices". The motivation of this analysis is not clear to me. As I understand this analysis, both social location and choices are changed from the real trajectories. How can it then show that it reflects social locations, not just the choices?

      Figure 4 caption: "on the -based approximation" Is there a missing "point"-[based] here?

      We agree with the reviewer that this analysis is hard to interpret and does not adequately address concerns regarding temporal autocorrelation, and as such we have removed it from the manuscript. We describe the new results that include controlling for temporal distance between trials (pages 11-12, lines 185-208):

      “We have shown that the left hippocampus represents the affiliation and power trials differently, consistent with an abstract dimensional representation. Does it also represent the changing social coordinates of each character? To test this, we multiple-regression RSA searchlight to test whether left hippocampus patterns represent the characters’ changing social locations across interactions (see Figure 3). We restricted the distances to those from trial pairs from the same character and standardized the distances within character (see Figure 3BD). We controlled for temporal distance to ensure the effect was not explainable by the time between trials, and for whether the trials shared the same underlying dimension (affiliation or power; see Location similarity searchlight analyses for more details). At the group level, we controlled for sample and the average reaction time difference between affiliation and power trials. Using the same testing logic as the dimensionality similarity analysis, we first tested our hypothesis in the bilateral hippocampus and found widespread effects in both the left (peak voxel MNI x/y/z = -35/-22/-15, cluster extent = 1470 voxels) and right (peak voxel MNI x/y/z = 37/-19/-14, cluster extent = 1953 voxels) hemispheres. The whole-brain searchlight analysis revealed additional clusters in the left putamen (-27/-3/14, cluster extent = 131 voxels) and left posterior cingulate cortex (-10/-28/41, cluster extent = 304 voxels).”

      “We then asked a second, complementary question: does the hippocampus represent all interactions, across characters, within a shared map? To test for this map-like structure, we repeated the analysis but now included all trial pairs, z-scoring distances globally rather than within character (Figure 3E-F). The remainder of the procedure followed the same logic as the preceding analysis. The hippocampus analysis revealed an extensive right hippocampal cluster (27/27/-14, cluster extent = 1667 voxels). The whole-brain analysis did not show any significant clusters.”

      We emphasize that the results are robust to the inclusion of temporal distance squared, in the methods (pages 23-24, lines 493-496):

      “Although the square of this temporal distance did not explain any additional variance in behavioral distances, we ran a robustness analysis including both temporal distance and its square and saw qualitatively the same clusters with similar effect sizes.”

      Page 8: last paragraph: The text sounds like you have already shown that you can decode character identity from the patterns - but I do not believe you have it this point. I would consider this would be an interesting addition to the paper, though.

      This section has been removed, and we have been careful to not imply this in the current version of the manuscript. While we agree a character identity decoding would enrich our argument, we do not believe our task is well-suited to capture a character identity effect. Each character only has 12 decision trials, and these trials are partially clustered in time - this is one problem of temporal autocorrelation that we thank the reviewers for pushing us to consider in more detail. Dimension and location patterns, on the other hand, are more natural to analyze in our task, especially in representational similarity analyses that test whether the relevant differences scale with neural distances.

      Page 14ff: Why is "Analysis section" not part of "Materials and Methods"? I believe adding the analysis after a careful description of the methods would improve the clarity of this section.

      We agree with the reviewer and have now consolidated these two sections.

      Two or three examples of Affiliation and Power decision trials should be provided, so the reader can form a more thorough understanding of how these dimensions were operationalized. For the RSA analysis, it is important to consider other differences between these two types of trials.

      We agree that adding examples will clarify the operationalization of these dimensions. We now include example affiliation and power trials in a table (page 17-18).

      We thank the reviewer for noting the need to rule out alternative hypotheses; we have added several such tests. Affiliation and power trials were not different in word count (page 17, lines 329-332):

      “To ensure that any observed neural or behavioral differences were not confounded by trivial features of the text, we tested for differences between the affiliation and power trials (where the two options are concatenated). There were no differences in word count (affiliation average = 26.6, power average = 25.6; t-test p = 0.56).”

      They were also not different in their sentiment, as assessed by a Large Language Model (LLM) analysis (page 17, lines 332-335): 

      “The text’s sentiment also did not differ between these trial types (t-test p = 0.72), as quantified by comparing sentiment compound scores (from most negative, −1, to most positive, +1), using a Large Language Model (LLM) specialized for sentiment analysis [26]. “

      The affiliation and power trials were different in terms of semantic content, consistent with our assumptions (page 17, lines 337-347):

      “Our framework assumes that affiliation and power trials differ in their semantic content–that is, in the conceptual meaning of the text, beyond word count or sentiment. To test this assumption, we used an LLM-based semantic embedding analysis. Each decision trial was embedded into a semantic vector. We then measured the cosine similarity between pairs of trials and calculated the difference between average within-dimension similarity (affiliation-affiliation and power-power comparisons) and average between-dimension similarity (affiliationpower comparisons) and assessed its statistical significance with permutation testing (1,000 shuffles of trial labels). As expected, decision trials of the same dimension were more similar to each other than trials of different dimension, across multiple LLMs (OpenAI’s text-embedding-3-small [27]: similarity difference = 0.041, p < 0.001; all-MiniLM-L12-v2 [28]: similarity difference = 0.032, p < 0.001).”

      The affiliation and power trials were different in average reaction time. To control for this difference in the dimension RSA analysis, we added each participant’s absolute value reaction time difference between the trial types as a covariate. The results were nearly identical to what they were before. We updated the text to reflect this new control (page 23, lines 471-474):

      “However, there was a significant difference in the average reaction time between affiliation and power decisions across participants (t<sub>49</sub> = 6.92, p < 0.001; affiliation mean = 4.92 seconds (s), power mean = 4.51 s), so we controlled for this in the group-level analysis.”

      The exact implementation and timing of the behavioral tasks should be described better. How many narrative trials were intermixed with the decision trials? Which characters were they assigned to? How was the sequence of trials determined? Was it fixed across participants, or randomized?

      We agree that additional details are helpful. In the Methods, we now describe this with more detail (page 16, lines 301-318):

      “There are two types of trials: “narrative” trials where background information is provided or characters talk or take actions (a total of 154 trials), and “decision” trials where the participant makes decisions in one-on-one interactions with a character that can change the relationship with that character (a total of 63 trials). On each decision, participants used a button response box to select between the two options. The options (1 or 2, assigned to the index and middle fingers) choice directions (+/-1 arbitrary unit on the current dimension) were counterbalanced.”

      “The sequence of trials, including both narrative and decision trials, were fixed across participants; all that differs are the choices that the participants make. Narrative trials varied in duration, depending on the content (range 2-10 seconds), but were identical across participants. Decision trials always lasted 12 seconds, with two options presented until the participant made a choice, after which a blank screen was presented for the remainder of the duration. All six characters’ decision trials are interleaved with one another, and with the narrative slides. On average, after a decision trial for a given character, participants view ~11 narrative slides and complete ~3 decisions for other characters before returning to another decision with the same character, such that each character’s choices are separated by an average of ~20 seconds (ranging from 12 seconds to 10 min).”

      What is the exact timing of trials during fMRI acquisition - i.e. how long were the trials, what was the ITI, were there long phases of rest to determine the resting baseline? These are all important factors that will determine the covariance between regressors and should be reported carefully. Ideally, I would like to see the trial-by-trial temporal auto-correlation structure across beta-weights to be reported.

      We thank the reviewer for asking for this clarification. We have added the following text to clarify the trial timing (page 16, lines 314-318):

      “All six characters’ decision trials are interleaved with one another and with narrative slides. On average, after a decision trial for a given character, participants view ~11 narrative slides and complete ~3 decisions for other characters before returning to that same character, such that each character’s choices are separated by an average of ~20 seconds (range 12 seconds to 10 min).”

      We now describe the temporal autocorrelation patterns in the supplement, including how we decided on how to control for temporal distance in representational similarity analyses (pages 29-31, lines 593-656):

      “The Social Navigation Task is a narrative-based task, where the relationships with characters evolve over time; trial pairs that are close in time may have more similar fMRI patterns for reasons unrelated to social mapping (e.g., slow drift). It is important to account for the role of time in our analyses, to ensure effects go beyond simple temporal confounds, like the time between decision trials. To aid in this, we quantified how fMRI signals change over time using a pattern autocorrelation function across decision trial lags. We defined the left and right hippocampus and the left and right intracalcarine cortex using the HarvardOxford atlas and thresholded them at 50% probability. We chose intracalcarine corex as an early visual control region that largely corresponds to primary visual cortex (V1), as it is likely to be driven by the visually presented narrative. We used the same trial-wise beta images as in the location similarity RSA (boxcar regressors spanning each decision trial’s reaction time). For each participant and region-of-interest (ROI), we extracted the decision trial-by-voxel beta matrix and quantified three kinds of temporal dependence: beta autocorrelation, multivoxel pattern correlation and multivoxel pattern correlation after regressing out temporal distance.”

      “To estimate the temporal autocorrelation of the trial-wise beta values, we treated each voxel’s beta values as a time series across trials and measured how much a voxel’s response on one trial correlated (Pearson) with its response on previous trials. We averaged these voxel wise autocorrelations within each ROI. At one trial apart (lag 1), both the hippocampus and V1 showed small positive autocorrelations, indicating modest trial-to-trial carryover in response amplitude (see Supplemental figure 1) that by three trials apart was approximately 0.”

      “Because our representational similarity analyses depend on trial-by-trial pattern similarity, we also estimated how multivoxel patterns were autocorrelated over time. For each lag, we computed the Pearson correlation between each trial’s voxelwise pattern and the pattern from the trial that many trials earlier, then averaged those correlations to obtain a single autocorrelation value for that lag. At one trial apart, both regions showed positive autocorrelation, with V1 having greater autocorrelation than the hippocampus; pattern correlations between trials 3 or 4 trials apart reduced across participants, settling into low but positive values. Then, for each participant and ROI, we regressed out the effect of absolute trial onset differences from all pairwise pattern correlations, to mirror the effects of controlling for these temporal distances in regressions. After removing this temporal distance component, the short lag pattern autocorrelation dropped substantially in both regions. The similarity in autocorrelation profiles between the two regions suggests that significant similarity effects in the hippocampus are unlikely to be driven by generic temporal autocorrelation.”

      “Relationship between behavioral location distance and temporal distance “

      “We also quantified how temporal distances between trials relates to their behavioral location distances, participant by participant. Our dimension similarity analysis controls for temporal distance between trials by design (see Social dimension similarity searchlight analysis), but our location similarity analysis does not. To decide on covariates to include in the analysis, we tested whether temporal distances can explain behavioral location distances. For each participant, we computed the correlations between trial pairs’ Euclidean distances in social locations and their linear temporal distances (“linear”) and the temporal distances squared (“quadratic”), to test for nonlinear effects. We then summarized the correlations using one-sample t-tests. The linear relationship was statistically significant (t<sub>49</sub> = 12.24, p < 0.001), whereas the quadratic relationship was not (t<sub>49</sub> = -0.55, p = 0.586). Similarly, in participant specific regressions with both linear and quadratic temporal distances, the linear effect was significant (t<sub>49</sub> = 5.69, p < 0.001) whereas the quadratic effect was not (t<sub>49</sub> = 0.20, p = 0.84). Based on this, we included linear temporal distances as a covariate in our location similarity analyses (see Location similarity searchlight analyses), and verified that adding a quadratic temporal distance covariate does not alter the results. Thus, the reported location-related pattern similarity effects go beyond what can be explained by temporal distance alone.”

    1. Author response:

      We acknowledge the concerns raised by both reviewers and plan to address them in our revision:

      Regarding Reviewer #1's comments: We will strengthen the statistical framework and address the concerns about multiple comparison corrections. We will also expand our literature review to better motivate our hypotheses, particularly incorporating the work on lateralization patterns in MGN/LGN and the existing evidence on first-order thalamic nuclei in linguistic processing.

      Regarding Reviewer #2's comments: We acknowledge the valid concern that linguistic and non-linguistic stimuli differ beyond linguistic content, including some low-level sensory properties. We will elaborate on the creation and properties of these stimuli in the Methods section and upload stimuli examples to an online repository to provide transparency about differences. We will also add a discussion of this limitation in the Discussion section, acknowledging that disentangling effects of linguistic processing from low-level stimulus properties will require further testing in future research. Additionally, we will moderate part of our claims and reorganize the presentation of results as suggested, and clarify our contribution relative to existing literature.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Thach et al. report on the structure and function of trimethylamine N-oxide demethylase (TDM). They identify a novel complex assembly composed of multiple TDM monomers and obtain high-resolution structural information for the catalytic site, including an analysis of its metal composition, which leads them to propose a mechanism for the catalytic reaction.

      In addition, the authors describe a novel substrate channel within the TDM complex that connects the N-terminal Zn²-dependent TMAO demethylation domain with the C-terminal tetrahydrofolate (THF)-binding domain. This continuous intramolecular tunnel appears highly optimized for shuttling formaldehyde (HCHO), based on its negative electrostatic properties and restricted width. The authors propose that this channel facilitates the safe transfer of HCHO, enabling its efficient conversion to methylenetetrahydrofolate (MTHF) at the C-terminal domain as a microbial detoxification strategy.

      Strengths:

      The authors provide convincing high-resolution cryo-EM structural evidence (up to 2 Å) revealing an intriguing complex composed of two full monomers and two half-domains. They further present evidence for the metal ion bound at the active site and articulate a plausible hypothesis for the catalytic cycle. Substantial effort is devoted to optimizing and characterizing enzyme activity, including detailed kinetic analyses across a range of pH values, temperatures, and substrate concentrations. Furthermore, the authors validate their structural insights through functional analysis of active-site point mutants.

      In addition, the authors identify a continuous channel for formaldehyde (HCHO) passage within the structure and support this interpretation through molecular dynamics simulations. These analyses suggest an exciting mechanism of specific, dynamic, and gated channeling of HCHO. This finding is particularly appealing, as it implies the existence of a unique, completely enclosed conduit that may be of broad interest, including potential applications in bioengineering.

      Weaknesses:

      Although the idea of an enclosed channel for HCHO is compelling, the experimental evidence supporting enzymatic assistance in the reaction of HCHO with THF is less convincing. The linear regression analysis shown in Figure 1C demonstrates a THF concentration-dependent decrease in HCHO, but the concentrations used for THF greatly exceed its reported KD (enzyme concentration used in this assay is not reported). It has previously been shown that HCHO and THF can couple spontaneously in a non-enzymatic manner, raising the possibility that the observed effect does not require enzymatic channeling. An additional control that can rule out this possibility would help to strengthen the evidence. For example, mutating the THF binding site to prevent THF binding to the protein complex could clarify whether the observed decrease in HCHO depends on enzyme-mediated proximity effects. A mutation which would specifically disable channeling could be even more convincing (maybe at the narrowest bottleneck).

      We agree with the reviewer that HCHO and THF can react spontaneously in a non-enzymatic manner, and our experiments were not intended to demonstrate enzymatic channeling. The linear regression analysis in Figure 1C was designed solely to confirm that HCHO reacts with THF under our assay conditions. Accordingly, THF was titrated over a broad concentration range starting from zero, and the observed THF concentration–dependent decrease in HCHO reflects this chemical reactivity.

      We do not interpret these data as evidence that the enzyme catalyzes or is required for the HCHO–THF coupling reaction. Instead, the structural observation of an enclosed channel is presented as a separate finding. We have clarified this point in the revised text to avoid overinterpretation of the biochemical data (page 2, line 16).

      Another concern is that the observed decrease in HCHO could alternatively arise from a reduced production of HCHO due to a negative allosteric effect of THF binding on the active site. From this perspective, the interpretation would be more convincing if a clear coupled effect could be demonstrated, specifically, that removal of the product (HCHO) from the reaction equilibrium leads to an increase in the catalytic efficiency of the demethylation reaction.

      We agree that, in principle, a decrease in detectable HCHO could also arise from an indirect effect of THF binding on enzyme activity. However, in our study the experiment was not designed to assess catalytic coupling or allosteric regulation. The assay in question monitors HCHO levels under defined conditions and does not distinguish between changes in HCHO production and downstream consumption.

      Additionally, we do not interpret the observed decrease in HCHO as evidence that THF binding enhances catalytic efficiency, or that removal of HCHO shifts the reaction equilibrium. Instead, the data are presented to establish that HCHO can react with THF under the assay conditions. Any potential allosteric effects of THF on the demethylation reaction, or kinetic coupling between HCHO removal and catalysis, are beyond the scope of the current study, and are not claimed.

      While the enzyme kinetics appear to have been performed thoroughly, the description of the kinetic assays in the Methods section is very brief. Important details such as reaction buffer composition, cofactor identity and concentration (Zn<sup>2+</sup>), enzyme concentration, defined temperature, and precise pH are not clearly stated. Moreover, a detailed methodological description could not be found in the cited reference (6), if I am not mistaken.

      Thank you for the suggestion. We have added reference [24] to the methodological description on page 8. The Methods section has been revised accordingly on page 8 under “TDM Activity Assay,” without altering the Zn<sup>2+</sup> concentration.

      The composition of the complex is intriguing but raises some questions. Based on SDS-PAGE analysis, the purified protein appears to be predominantly full-length TDM, and size-exclusion chromatography suggests an apparent molecular weight below 100 kDa. However, the cryo-EM structure reveals a substantially larger complex composed of two full-length monomers and two half-domains.

      We appreciate the reviewer’s careful analysis of the apparent discrepancy between the biochemical characterization and the cryo-EM structure. This issue is addressed in Figure S1, which may have been overlooked.

      As shown in Figure S1, the stability of TDM is highly dependent on protein and salt conditions. At 150 mM NaCl, SEC reveals a dominant peak eluting between 10.5 and 12 mL, corresponding to an estimated molecular weight of ~170–305 kDa (blue dot, Author response image 1). This fraction was explicitly selected for cryo-EM analysis and yields the larger complex observed in the reconstruction. At lower salt concentrations (50 mM) or higher (>150 mM NaCl), the protein either aggregates or elutes near the void volume (~8 mL).

      SDS–PAGE analysis detects full-length TDM together with smaller fragments (~40–50 kDa and ~22–25 kDa). The apparent predominance of full-length protein on SDS–PAGE likely reflects its greater staining intensity per molecule and/or a higher population, rather than the absence of truncated species.

      Author response image 1.

      Given the lack of clear evidence for proteolytic fragments on the SDS-PAGE gel, it is unclear how the observed stoichiometry arises. This raises the possibility of higher-order assemblies or alternative oligomeric states. Did the authors attempt to pick or analyze larger particles during cryo-EM processing? Additional biophysical characterization of particle size distribution - for example, using interferometric scattering microscopy (iSCAT)-could help clarify the oligomeric state of the complex in solution.

      Cryo-EM data were collected exclusively from the size-exclusion chromatography fraction eluting between 10.5 and 12 mL. This fraction was selected to isolate the dominant assembly in solution. Extensive 2D and 3D particle classification did not reveal distinct classes corresponding to smaller species or higher-order oligomeric assemblies. Instead, the vast majority of particles converged to a single, well-defined structure consistent with the 2 full-length + 2 half-domain stoichiometry.

      A minor subpopulation (~2%) exhibited increased flexibility in the N-terminal region of the two full-length subunits, but these particles did not form a separate oligomeric class, indicating conformational heterogeneity rather than alternative assembly states (Author response image 2). Together, these data support the 2+2½ architecture as the predominant and stable complex under the conditions used for cryo-EM. Additional techniques, such as iSCAT, would provide complementary information, but are not required to support the conclusions drawn from the SEC and cryo-EM analyses presented here.

      Author response image 2.

      The authors mention strict symmetry in the complex, yet C2 symmetry was enforced during refinement. While this is reasonable as an initial approach, it would strengthen the structural interpretation to relax the symmetry to C1 using the C2-refined map as a reference. This could reveal subtle asymmetries or domain-specific differences without sacrificing the overall quality of the reconstruction.

      We thank the reviewer for this thoughtful suggestion. In standard cryo-EM data processing, symmetry is typically not imposed initially to minimize potential model bias; accordingly, we first performed C1 refinement before applying C2 symmetry. The resulting C1 reconstructions revealed no detectable asymmetry or domain-specific differences relative to the C2 map. In addition, relaxing the symmetry consistently reduced overall resolution, indicating lower alignment accuracy and further supporting the presence of a predominantly symmetric assembly.

      In this context, the proposed catalytic role of Zn<sup>2+</sup> raises additional questions. Why is a 2:1 enzyme-to-metal stoichiometry observed, and how does this reconcile with previous reports? This point warrants discussion. Does this imply asymmetric catalysis within the complex? Would the stoichiometry change under Zn<sup>2+</sup>-saturating conditions, as no Zn<sup>2+</sup> appears to be added to the buffers? It would be helpful to clarify whether Zn<sup>2+</sup> occupancy is equivalent in both active sites when symmetry is not imposed, or whether partial occupancy is observed.

      The observed ~2:1 enzyme-to-Zn<sup>2+</sup> stoichiometry likely reflects the composition of the 2 full-length + 2 half-domain (2+2½) complex. In this assembly, only the core domains that are fully present in the complex contribute to metal binding. The truncated or half-domains lack the Zn<sup>2+</sup> binding domain. As a result, only two metal-binding sites are occupied per assembled complex, consistent with the measured stoichiometry.

      We note that Zn<sup>2+</sup> was not deliberately added to the buffers, so occupancy may not reflect full saturation. Based on our cryo-EM and biochemical data, both metal-binding sites in the full-length subunits appear to be occupied to an equivalent extent, and no clear evidence of asymmetric catalysis is observed under these current experimental conditions. Full Zn<sup>2+</sup> saturation could potentially increase occupancy, but was not explored in these experiments.

      The divalent ion Zn<sup>2+</sup> is suggested to activate water for the catalytic reaction. I am not sure if there is a need for a water molecule to explain this catalytic mechanism. Can you please elaborate on this more? As one aspect, it might be helpful to explain in more detail how Zn-OH and D220 are recovered in the last step before a new water molecule comes in.

      Thank you for your suggestion. We revised our text in page 2 as bellow.

      Based on our structural and biochemical data, we propose a structurally informed working model for TMAO turnover by TDM (Scheme 1). In this model, Zn<sup>2+</sup> plays a non-redox role by polarizing the O–H bond of the bound hydroxyl, thereby lowering its pK<sub>a</sub>. The D220 carboxylate functions as a general base, abstracting the proton to generate a hydroxide nucleophile. This hydroxide then attacks the electrophilic N-methyl carbon of TMAO, forming a tetrahedral carbinolamine (hemiaminal) intermediate. Subsequent heterolytic cleavage of the C–N bond leads to the release of HCHO. D220 then switches roles to act as a general acid, donating a proton to the departing nitrogen, which facilitates product release and regenerates the active site. This sequence allows a new water molecule to rebind Zn<sup>2+</sup>, enabling subsequent catalytic turnovers. This proposed pathway is consistent with prior mechanistic studies, in which water addition to the azomethine carbon of a cationic Schiff base generates a carbinolamine intermediate, followed by a rate-limiting breakdown to yield an amino alcohol and a carbonyl compound, in the published case, an aldehyde (Pihlaja et al., J. Chem. Soc. Perkin Trans. 2, 1983, 8, 1223–1226).

      Overall, the authors were successful in advancing our structural and functional understanding of the TDM complex. They suggest an interesting oligomeric complex composition which should be investigated with additional biophysical techniques.

      Additionally, they provide an intriguing hypothesis for a new type of substrate channeling. Additional kinetic experiments focusing on HCHO and THF turnover by enzymatic proximity effects would strengthen this potentially fundamental finding. If this channeling mechanism can be supported by stronger experimental evidence, it would substantially advance our understanding and knowledge of biologic conduits and enable future efforts in the design of artificial cascade catalysis systems with high conversion rate and efficiency, as well as detoxification pathways.

      Reviewer #2 (Public review):

      Summary:

      The manuscript reports a cryo-EM structure of TMAO demethylase from Paracoccus sp. This is an important enzyme in the metabolism of trimethylamine oxide (TMAO) and trimethylamine (TMA) in human gut microbiota, so new information about this enzyme would certainly be of interest.

      Strengths:

      The cryo-EM structure for this enzyme is new and provides new insights into the function of the different protein domains, and a channel for formaldehyde between the two domains.

      Weaknesses:

      (1) The proposed catalytic mechanism in this manuscript does not make sense. Previous mechanistic studies on the Methylocella silvestris TMAO demethylase (FEBS Journal 2016, 283, 3979-3993, reference 7) reported that, as well as a Zn2+ cofactor, there was a dependence upon non-heme Fe<sup>2+</sup>, and proposed a catalytic mechanism involving deoxygenation to form TMA and an iron(IV)-oxo species, followed by oxidative demethylation to form DMA and formaldehyde.

      In this work, the authors do not mention the previously proposed mechanism, but instead say that elemental analysis "excluded iron". This is alarming, since the previous work has a key role for non-heme iron in the mechanism. The elemental analysis here gives a Zn content of about 0.5 mol/mol protein (and no Fe), whereas the Methylocella TMAO demethylase was reported to contain 0.97 mol Zn/mol protein, and 0.35-0.38 mol Fe/mol protein. It does, therefore, appear that their enzyme is depleted in Zn, and the absence of Fe impacts the mechanism, as explained below.

      The proposed catalytic mechanism in this manuscript, I am sorry to say, does not make sense to me, for several reasons:

      (i) Demethylation to form formaldehyde is not a hydrolytic process; it is an oxidative process (normally accomplished by either cytochrome P450 or non-heme iron-dependent oxygenase). The authors propose that a zinc (II) hydroxide attacks the methyl group, which is unprecedented, and even if it were possible, would generate methanol, not formaldehyde.

      (ii) The amine oxide is then proposed to deoxygenate, with hydroxide appearing on the Zn - unfortunately, amine oxide deoxygenation is a reductive process, for which a reducing agent is needed, and Zn2+ is not a redox-active metal ion;

      (iii) The authors say "forming a tetrahedral intermediate, as described for metalloproteinase", but zinc metalloproteases attack an amide carbonyl to form an oxyanion intermediate, whereas in this mechanism, there is no carbonyl to attack, so this statement is just wrong.

      So on several counts, the proposed mechanism cannot be correct. Some redox cofactor is needed in order to carry out amine oxide deoxygenation, and Zn<sup>2+</sup>cannot fulfil that role. Fe<sup>2+</sup> could do, which is why the previously proposed mechanism involving an iron(IV)-oxo intermediate is feasible. But the authors claim that their enzyme has no Fe. If so, then there must be some other redox cofactor present. Therefore, the authors need to re-analyse their enzyme carefully and look either for Fe or for some other redox-active metal ion, and then provide convincing experimental evidence for a feasible catalytic mechanism. As it stands, the proposed catalytic mechanism is unacceptable.

      We thank the reviewer for the detailed and thoughtful mechanistic critique. We fully agree that Zn<sup>2+</sup> is not redox-active, and cannot directly mediate oxidative demethylation or amine oxide deoxygenation. We acknowledge that the oxidative step required for the conversion of TMAO to HCHO is not explicitly resolved in the present study. Accordingly, we have revised the manuscript to remove any implication of Zn<sup>2+</sup>-mediated redox chemistry, and have eliminated the previously imprecise analogy to zinc metalloproteases.

      We recognize and now discuss prior biochemical work on TMAO demethylase from Methylocella silvestris (MsTDM), which proposed an iron-dependent oxidative mechanism (Zhu et al., FEBS 2016, 3979–3993). That study reported approximately one Zn<sup>2+</sup> and one non-heme Fe<sup>2+</sup> per active enzyme, implicated iron in catalysis through homology modeling and mutagenesis, and used crossover experiments suggesting a trimethylamine-like intermediate and oxygen transfer from TMAO, consistent with an Fe-dependent redox process. However, that system lacked experimental structural information, and did not define discrete metal-binding sites.

      In contrast,

      (1) Our high-resolution cryo-EM structures and metal analyses of TDM consistently reveal only a single, well-defined Zn<sup>2+</sup>-binding site, with no structural evidence for an additional iron-binding site as in the previous report (Zhu et al., FEBS 2016, 3979–3993).

      (2) To investigate the potential involvement of iron, we expressed TDM in LB medium supplemented with Fe(NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and determined its cryo-EM structure. This structure is identical to the original one, and no EM density corresponding to a second iron ion was observed. Moreover, the previously proposed Fe<sup>2+</sup>-binding residues are spatially distant (Figure S6).

      (3) ICP-MS analysis shows undetectable Iron, and only Zinc ion (Figure S5).

      (4) Our enzyme kinetics analysis with the TDM without Iron is comparable to that of from MsTDM (Figure 1A). The differences in Km and Vmax we propose is due to the difference in the overall sequence of the enzymes. Please also see comment at the end on a new published paper on MsTDM.

      While we cannot comment on the MsTDM results, our ‘experimental’ results do not support the presence of an iron-binding site. Our data indicate that this chemistry is unlikely to be mediated by a canonical non-heme iron center as proposed for MsTDM. We therefore revised our model as a structural framework that rationalizes substrate binding, metal coordination, and product stabilization, while clearly delineating the limits of mechanistic inference supported by the current data.

      The scheme 1 and proposal mechanism section were revised in page 4. Figure S6 was added.

      (2) Given the metal content reported here, it is important to be able to compare the specific activity of the enzyme reported here with earlier preparations. The authors do quote a Vmax of 16.52 µM/min/mg; however, these are incorrect units for Vmax, they should be µmol/min/mg. There is a further inconsistency between the text saying µM/min/mg and the Figure saying µM/min/µg.

      Thank you for the correction. We converted the V<sub>max</sub> unit to nmol/min/mg. and revised the text in page 2. We also compared with the value of the previous report in the TDM enzyme by revising the text on page 2. See also the note on a newly published manuscript and its comparison.

      (3) The consumption of formaldehyde to form methylene-THF is potentially interesting, but the authors say "HCHO levels decreased in the presence of THF", which could potentially be due to enzyme inhibition by THF. Is there evidence that this is a time-dependent and protein-dependent reaction? Also in Figure 1C, HCHO reduction (%) is not very helpful, because we don't know what concentration of formaldehyde is formed under these conditions; it would be better to quote in units of concentration, rather than %.

      We appreciate this important point. We have revised Figure 1C to present HCHO levels in absolute concentration units. While the current data demonstrate reduced detectable HCHO in the presence of THF, we agree that distinguishing between HCHO consumption and potential THF-mediated enzyme inhibition would require dedicated time-course and protein-dependence experiments. We have therefore revised the description to avoid overinterpretation and limit our conclusions to the observed changes in HCHO concentration in page 2, line 18-19.

      (4) Has this particular TMAO demethylase been reported before? It's not clear which Paracoccus strain the enzyme is from; the Experimental Section just says "Paracoccus sp.", which is not very precise. There has been published work on the Paracoccus PS1 enzyme; is that the strain used? Details about the strain are needed, and the accession for the protein sequence.

      Thank you for this comment. We now indicate that the enzyme is derived from Paracoccus sp. DMF and provide the accession number for the protein sequence (WP_263566861) in the Experimental Section (page 8, line 4).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The ITC experiment requires a ligand-into-buffer titration as an additional control. Also, maybe I misunderstood the molar ratio or the concentrations you used, but if you indeed added a total of 4.75 μL of 20 μM THF into 250 μL of 5 μM TDM, it is not clear to me how this leads to a final molar ratio of 3.

      We thank the reviewer for this suggestion. A ligand-into-buffer control ITC experiment was performed and is now included in Figure S8C, which shows no realizable signal.

      Regarding the molar ratio, it is our mistake. The experiment used 2.45 μL injections of 80 μM THF into 250 μL of 5 μM TDM. This corresponds to a final ligand concentration of ~12.8 μM, giving a ligand-to-protein molar ratio of ~2.6. We revised our text in page 9, ITC section.

      (2) Characterization/quality check of all mutant enzymes should be performed by NanoDSF, CD spectroscopy or similar techniques to confirm that proteins are properly folded and fit for kinetic testing.

      We appreciate the reviewer’s suggestion. All mutant proteins, including D220A, D367A, and F327A, were purified with yields similar to the wild-type enzyme. Additionally, cryo-EM maps of the mutants show well-defined density and overall structural integrity consistent with the wild-type. These findings indicate that the introduced mutations do not significantly affect protein folding, supporting their use for kinetic analysis. While NanoDSF might reveal differences in thermal stability due to mutations, it does not provide structural information. Our conclusions are not based on minor differences in thermostability. Our cryo-EM structures of the mutants offer much more reliable structural data than CD spectroscopy.

      (3) Best practice would suggest overlapping pH ranges between different buffer systems in the pH-dependence experiments to rule out buffer-specific effects independent of pH.

      We thank the reviewer for this helpful suggestion. We agree that overlapping pH ranges between different buffer systems can be valuable for excluding buffer-specific effects. In this study, the pH-dependence experiments were intended to provide a qualitative assessment of pH sensitivity rather than a detailed analysis of buffer-independent pKa values. While we cannot fully exclude minor buffer-specific contributions, the overall trends observed were reproducible and sufficient to support the conclusions drawn. We have added a clarifying statement to the revised manuscript to reflect this consideration, page 2, line 12.

      (4) Structural comparison revealed high similarity to a THF-binding protein, with superposition onto a T protein.": It would be nice to show this as an additional figure, as resolution and occupancy for THF are low.

      We thank the reviewer for this suggestion. To address this point, we have revised Figure S6 by adding an additional panel (C, now is Figure S7C) showing the structural superposition of TDM with the THF-binding T protein. This comparison is included to better illustrate the structural similarity, despite the limited resolution and partial occupancy of THF density in our map.

      (5) Editing could have been done more thoroughly. Some spelling mistakes, e.g. "RESEULTS", "redius", "complec"; kinetic rate constants should be written in italic (not uniform between text and figures); Prism version is missing; Vmax of 16.52 µM/min/mg - doublecheck units; Figure S1B: The "arrow on the right" might have gone missing.

      We corrected the spelling in page 2 ~ line 10, page 5 ~ line 34, page 6 ~ line40. Prism version was added. The arrow was added into figure S1B. The Vmax unit is corrected to nmol/min/mg.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors must re-examine the metal content of their purified enzyme, looking in particular for Fe or another redox-active metal ion, which could be involved in a reasonable catalytic mechanism.

      We thank the reviewer for this suggestion and have carefully re-examined the metal content of TDM. Elemental analyses by EDX and ICP-MS consistently detected Zn<sup>2+</sup> in purified TDM (Zn:protein ≈ 1:2), whereas Fe was below the detection limit across multiple independent preparations (Fig. S5A,B). To assess whether iron could be incorporated or play a functional role, we expressed TDM in E. coli grown in LB medium supplemented with Fe(NH<sub>4</sub>SO<sub>4</sub>)<sub>2</sub> and performed activity assays in the presence of exogenous Fe<sup>2+</sup>. Neither condition resulted in enhanced enzymatic activity.

      Consistent with these biochemical data, all cryo-EM structures reveal a single, well-defined metal-binding site coordinated by three conserved cysteine residues and occupied by Zn<sup>2+</sup>, with no evidence for an additional iron species or other redox-active metal site.

      (2) The specific activity of the enzyme should be quoted in the same units as other literature papers, so that the enzyme activity can be compared. It could be, for example, that the content of Fe (or other redox-active metal) is low, and that could then give rise to a low specific activity.

      Thank you for the suggestion, we quoted the enzyme units as similar with previous report. and revised the text in in page 2.

      Since the submission of our paper a new report on MsTDM has been published (Cappa et al., Protein Science 33(11), e70364). It further supports our findings. First, the reported kinetic parameters using ITC (Vmax = 0.309 μmol/s, approximately 240 nmol/min/mg; Km = 0.866 mM) are comparable to our observed (156 nmol/min/mg and 1.33 mM, respectively) in the absence of exogenous iron. Second, the optimal pH for enzymatic activity similar to that observed in our paraTDM. Third, the reported two-state unfolding behavior is consistent with our cryo-EM structural observations, in which the more dynamic subunits appear to destabilize prior to unfolding of the core domains. Based on these findings, we now propose that Zn<sup>2+</sup> appears to function primarily as an organizational cofactor at the core catalytic domain (revised Scheme 1).

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Review:

      Reviewer #1 (Public review):

      Ewing sarcoma is an aggressive pediatric cancer driven by the EWS-FLI oncogene. Ewing sarcoma cells are addicted to this chimeric transcription factor, which represents a strong therapeutic vulnerability. Unfortunately, targeting EWS-FLI has proven to be very difficult and better understanding how this chimeric transcription factor works is critical to achieving this goal. Towards this perspective, the group had previously identified a DBD-𝛼4 helix (DBD) in FLI that appears to be necessary to mediate EWS-FLI transcriptomic activity. Here, the authors used multi-omic approaches, including CUT&tag, RNAseq, and MicroC to investigate the impact of this DBD domain. Importantly, these experiments were performed in the A673 Ewing sarcoma model where endogenous EWS-FLI was silenced, and EWS-FLI-DBD proficient or deficient isoforms were re-expressed (isogenic context). They found that the DBD domain is key to mediate EWS-FLI cis activity (at msat) and to generate the formation of specific TADs. Furthermore, cells expressing DBD deficient EWS-FLI display very poor colony forming capacity, highlighting that targeting this domain may lead to therapeutic perspectives.

      This new version of the study comprises as requested new data from an additional cell line. The new data has strengthened the manuscript. Nevertheless, some of the arguments of the authors pertaining to the limitations of immunoblots to assess stability of the DBD constructs or the poor reproducibility of the Micro C data remain problematic. While the effort to repeat MicroC in a different cell line is appreciated, the data are as heterogeneous as those in A673 and no real conclusion can be drawn. The authors should tone down their conclusions. If DBD has a strong effect on chromatin organization, it should be reproducible and detectable. The transcriptomic and cut and tag data are more consistent and provide robust evidence for their findings at these levels. 

      We agree that the Micro-C data have more apparent heterogeneity within and across cell lines as compared to other analyses such as our included CUT&Tag and RNA-seq. We addressed the possible limitations of the technique as well as inherent biology that might be driving these findings in our previous responses. Despite the poor clustering on the PCA plots, our analysis on differential interacting regions, TADs and loops remain consistent across both cell lines. We are confident that these findings reflect the context of transcriptional regulation by the constructs, therefore the role of the alpha-helix in modulating chromatin organization. To address the concerns raised by the editors and reviewers for the strength of the conclusions we drew from the Micro-C findings we have made changes to the language used to describe them throughout the manuscript. Find these changes outlined below.

      • On lines 70-71, "is required to restructure" was changed to "is implicated in restructuring of"

      • On line 91, "is required for" was changed to "participates in"

      • On line 98, "is required for" changed to "is potentially required for"

      • On line 360-361, "is required for restructuring" changed to "participates in restructuring"

      Concerning the issue of stability of the DBD and DBD+ constructs, a simple protein half-life assay (e.g. cycloheximide chase assay) could rule out any bias here and satisfactorily address the issue.

      While we generally agree that a cycloheximide assay is a relatively simple approach to look at protein half-life, as we discussed last me the assays included in this paper are performed at equilibrium and rely on the concentration of protein at the me of the assay. This is particularly true for assays involving crosslinking, like Micro-C. As discussed in our prior response, western blots are semi quantitative at best, even when normalized to a housekeeping protein. In analyzing the relative protein concentration of DBD vs. DBD+ with relative protein intensities first normalized to tubulin and using the wildtype EWSR1::FLI1 rescue as a reference point, we find that there is no statistical difference in the samples used for micro-C here (Author responseimage 1A) or across all of the samples that we have used for publication (Author response image 1B). This does show that DBD generally has more variable expression levels relative to wildtype EWSR1::FLI1, and this is consistent with our experience in the lab.

      Nonetheless, we did attempt to perform the requested cycloheximide chase experiment to determine protein stability. Unfortunately, despite an extensive number of troubleshooting attempts, we have not been able to get good expression of DBD for these experiments. The first author who performed this work has left the lab and we have moved to a new lab space since the benchwork was performed. We continue to try to troubleshoot to get this experimental system for DBD and DBD+ to work again. When we tried to look at stability of DBD+ following cycloheximide treatment, there did appear to be some difference in protein stability (Author response image 2). However, these conditions are not the same conditions as those we published, they do not meet our quality control standards for publication, and we are concerned about being close to the limit of detection for DBD throughout the later timepoints. Additional studies will be needed with more comparable expression levels between DBD and DBD+ to satisfactorily address the reviewer concerns.

      Author response image 1.

      Expression Levels of DBD and DBD+ Across Experiments. Expression levels of DBD and DBD+ protein based on western blot band intensity normalized by tubulin band intensity. Expression levels are relative to wildtype EWSR1::FLI1 rescue levels and are calculated for (A) A673 samples used for micro-C and (B) all published studies of DBD and DBD+. P-values were calculated with an unpaired t-test.

      Author response image 2.

      CHX chase assay to determine the stability of DBD and DBD+. (A) Knock-down of endogenous EWSR1::FLI1 detected with FLI1 ab and rescue with DBD and DBD+ detected with FLAG ab. (B) CHX chase assay to determine the stability of DBD and DBD+ in A-673 cells with quantification of the protein levels (n=3). Error bars represent standard deviation. The half-lives (t1/2) of DBD and DBD+ were listed in the table.

      Suggestions:

      The Reviewing Editor and a referee have considered the revised version and the responses of the referees. While the additional data included in the new version has consolidated many conclusions of the study, the MicroC data in the new cell line are also heterogeneous and as the authors argue, this may be an inherent limitation of the technique. In this situation, the best would be for the authors to avoid drawing robust conclusions from this data and to acknowledge its current limitations.

      As discussed above, we have changed the language regarding our conclusions from micro-C data to soften the conclusions we draw per the Editor’s suggestion.

      The referee and Reviewing Editor also felt that the arguments of the authors concerning a lack of firm conclusions on the stability of EWS-FLI1 under +/-DBD conditions could be better addressed. We would urge the authors to perform a cycloheximide chase type assay to assess protein half-life. These types of experiments are relatively simple to perform and should address this issue in a satisfactory manner.

      As discussed above, we do not feel that differences in protein stability would affect the results here because the assays performed required similar levels of protein at equilibrium. Our additional analyses in this response shows that there are not significant differences between DBD and DBD+ levels in samples that pass quality control and are used in published studies. However, we attempted to address the reviewer and editor comments with a cycloheximide chase assay and were unable to get samples that would have passed our internal quality control standards. These data may suggest differences in protein stability, but it is unclear that these conditions accurately reflect the conditions of the published experiments, or that this would matter with equal protein levels at equilibrium.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study by Howe and colleagues investigates the role of the posterolateral cortical amygdala (plCoA) in mediating innate responses to odors, specifically attraction and aversion. By combining optogenetic stimulation, single-cell RNA sequencing, and spatial analysis, the authors identify a topographically organized circuit within plCoA that governs these behaviors. They show that specific glutamatergic neurons in the anterior and posterior regions of plCoA are responsible for driving attraction and avoidance, respectively, and that these neurons project to distinct downstream regions, including the medial amygdala and nucleus accumbens, to control these responses.

      Strengths:

      The major strength of the study is the thoroughness of the experimental approach, which combines advanced techniques in neural manipulation and mapping with high-resolution molecular profiling. The identification of a topographically organized circuit in plCoA and the connection between molecularly defined populations and distinct behaviors is a notable contribution to understanding the neural basis of innate motivational responses. Additionally, the use of functional manipulations adds depth to the findings, offering valuable insights into the functionality of specific neuronal populations.

      Weaknesses:

      There are some weaknesses in the study's methods and interpretation. The lack of clarity regarding the behavior of the mice during head-fixed imaging experiments raises the possibility that restricted behavior could explain the absence of valence encoding at the population level.

      We agree with idea that head-fixation may alter the state of the animal and the neural encoding of odor. To address this, we have provided further analysis of walking behavior during the imaging sessions, which is provided in Figure S2. Overall, we could not identify any clear patterns in locomotor behavior that are odor-specific. Moreover, when neural activity was sorted depending on the behavioral state (walking, pausing or fleeing) we didn’t observe any apparent patterns in odor-evoked neural activity. This is now discussed in the Results and Limitations sections of the manuscript.

      Furthermore, while the authors employ chemogenetic inhibition of specific pathways, the rationale for this choice over optogenetic inhibition is not fully addressed, and this could potentially affect the interpretation of the results.

      The rationale was logistical. First, inhibition of over a timescale of minutes is problematic with heat generation during prolonged optical stimulation. Second, our behavioral apparatus has a narrow height between the ceiling and floor, making tethering difficult. This is now explained the results section. The trade-off of using chemogenetics is that we are silencing neurons and not specific projections. However, because we find that NAc- and MeA- projecting neurons have little shared collateralization, we believe the conclusion of divergent pathways still stands. This is now discussed in the Limitations section.

      Additionally, the choice of the mplCoA for manipulation, rather than the more directly implicated anterior and posterior subregions, is not well-explained, which could undermine the conclusions drawn about the topographic organization of plCoA.

      We targeted the middle region of plCoA because it contains a mixture of cell types found in both the anterior and posterior plCoA, allowing us to test the hypothesis that cell types, not intra plCoA location, elicit different responses. Had we targeted the anterior or posterior regions, we would expect to simply recapitulate the result from activation of random cells in each region. As a result, we think stimulation in the middle plCoA is a better test for the contribution of cell types. We have now clarified this in the text.

      Despite these concerns, the work provides significant insights into the neural circuits underlying innate behaviors and opens new avenues for further research. The findings are particularly relevant for understanding the neural basis of motivational behaviors in response to sensory stimuli, and the methods used could be valuable for researchers studying similar circuits in other brain regions. If the authors address the methodological issues raised, this work could have a substantial impact on the field, contributing to both basic neuroscience and translational research on the neural control of behavior.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by the Root laboratory and colleagues describes how the posterolateral cortical amygdala (plCoA) generates valenced behaviors. Using a suite of methods, the authors demonstrate that valence encoding is mediated by several factors, including spatial localization of neurons within the plCoA, glutamatergic markers, and projection. The manuscript shows convincingly that multiple features (spatial, genetic, and projection) contribute to overall population encoding of valence. Overall, the authors conduct many challenging experiments, each of which contains the relevant controls, and the results are interpreted within the framework of their experiments.

      Strengths:

      - For a first submission the manuscript is well constructed, containing lots of data sets and clearly presented, in spite of the abundance of experimental results.

      - The authors should be commended for their rigorous anatomical characterizations and posthoc analysis. In the field of circuit neuroscience, this is rarely done so carefully, and when it is, often new insights are gleaned as is the case in the current manuscript.

      - The combination of molecular markers, behavioral readouts and projection mapping together substantially strengthen the results.

      - The focus on this relatively understudied brain region in the context is valence is well appreciated, exciting and novel.

      Weaknesses:

      - Interpretation of calcium imaging data is very limited and requires additional analysis and behavioral responses specific to odors should be considered. If there are neural responses behavioral epochs and responses to those neuronal responses should be displayed and analyzed.

      We have now considered this, see response above.

      - The effect of odor habituation is not considered.

      We considered this, but we did not find any apparent differences in valence encoding as measured by the proportion of neurons with significant valence scores across trials (see Figure 1J).

      - Optogenetic data in the two subregions relies on very careful viral spread and fiber placement. The current anatomy results provided should be clear about the spread of virus in A-P, and D-V axis, providing coordinates for this, to ensure readers the specificity of each sub-zone is real.

      We were careful to exclude animals for improper targeting. The spread of virus is detailed in Figures S3, S8 & S9.

      - The choice of behavioral assays across the two regions doesn't seem balanced and would benefit from more congruency.

      The choice of the 4-quadrant assay was used because this study builds off of our prior experiments that demonstrate a role for the plCoA in innate behavior. It is noteworthy that the responses to odor seen in this assay are generally in agreement with other olfactory behavioral assays, so one wouldn’t predict a different result. Moreover, the approach and avoidance responses measured in this assay are precisely the behaviors we wish to understand. We did examine other non-olfactory behavioral readouts (Figures S3, S8), and didn’t observe any effect of manipulation of these pathways.

      - Rationale for some of the choices of photo-stimulation experiment parameters isn't well defined.

      The parameters for photo-stimulation were based on those used in our past work (Root et al., 2014). We used a gradient of frequency from 1-10 Hz based on the idea that odor likely exists in a gradient and this was meant to mimic a potential gradient, though we don’t know if it exists. The range in stimulation frequencies appears to align with the actual rate of firing of plCoA neurons (Iurilli et al., 2017).

      Reviewer #3 (Public review):

      Summary:

      Combining electrophysiological recording, circuit tracing, single cell RNAseq, and optogenetic and chemogenetic manipulation, Howe and colleagues have identified a graded division between anterior and posterior plCoA and determined the molecular characteristics that distinguish the neurons in this part of the amygdala. They demonstrate that the expression of slc17a6 is mostly restricted to the anterior plCoA whereas slc17a7 is more broadly expressed. Through both anterograde and retrograde tracing experiments, they demonstrate that the anterior plCoA neurons preferentially projected to the MEA whereas those in the posterior plCoA preferentially innervated the nucleus accumbens. Interestingly, optogenetic activation of the aplCoA drives avoidance in a spatial preference assay whereas activating the pplCoA leads to preference. The data support a model that spatially segregated and molecularly defined populations of neurons and their projection targets carry valence specific information for the odors. The discoveries represent a conceptual advance in understanding plCoA function and innate valence coding in the olfactory system.

      Strengths:

      The strongest evidence supporting the model comes from single cell RNASeq, genetically facilitated anterograde and retrograde circuit tracing, and optogenetic stimulation. The evidence clear demonstrates two molecularly defined cell populations with differential projection targets. Stimulating the two populations produced opposite behavioral responses.

      Weaknesses:

      There are a couple of inconsistencies that may be addressed by additional experiments and careful interpretation of the data.

      Stimulating aplCoA or slc17a6 neurons results in spatial avoidance, and stimulating pplCoA or slc17a7 neurons drives approach behaviors. On the other hand, the authors and others in the field also show that there is no apparent spatial bias in odor-driven responses associated with odor valence. This discrepancy may be addressed better. A possibility is that odor-evoked responses are recorded from populations outside of those defined by slc17a6/a7. This may be addressed by marking activated cells and identifying their molecular markers. A second possibility is that optogenetic stimulation activates a broad set of neurons that and does not recapitulate the sparseness of odor responses. It is not known whether sparsely activation by optogenetic stimulation can still drive approach of avoidance behaviors.

      We agree that marking specific genetic or projection defined neurons could help to clarify if there are some neurons have more selective valence responses. However, we are not able to perform these experiments at the moment. We have included new data demonstrating that sparser optogenetic activation evokes behaviors similar in magnitude as the broader activation (see Figure S4).

      The authors show that inhibiting slc17a7 neurons blocks approaching behaviors toward 2-PE. Consistent with this result, inhibiting NAc projection neurons also inhibits approach responses. However, inhibiting aplCOA or slc17a6 neurons does not reduce aversive response to TMT, but blocking MEA projection neurons does. The latter two pieces of evidence are not consistent with each other. One possibility is that the MEA projecting neurons may not be expressing slc17a6. It is not clear that the retrogradely labeling experiments what percentage of MEA- and NACprojecting neurons express slc17a6 and slc17a7. It is possible that neurons expressing neither VGluT1 nor VGluT2 could drive aversive or appetitive responses. This possibility may also explain that silencing slc17a6 neurons does not block avoidance.

      We have now performed RNAscope staining on retrograde tracing to better define this relationship. Although the VGluT1 and VGluT2 neurons have biased projections to the MeA and NAc, respectively, there is some nuance detailed in Figure S10. Generally, MeA projecting neurons are predominately VGluT2+, whereas NAc projecting have about 20% that express both. Some (less than 35%) retrogradely labeled neurons were not detected as VGluT1 or VGluT2 positive, suggesting that other populations could also contribute. We agree that the discrepancy between MeA-projection and VGluT2 silencing is likely due to incomplete targeting of the MeA-projecting population with the VGluT2-cre line. This is included in the Discussion section.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Main:

      (1) For the head-fixed imaging experiments, what is the behavior of the mice during odor exposure? Could the weak reliability of individual neurons be due to a lack of approach or avoidance behavior? Could restricted behavior also explain the lack of valence encoding at the population level?

      We agree that this is a limitation of head-fixed recordings. In the revised manuscript we did attempt to characterize their behavioral response, and look for correlations in odor representation. Although we did find different patterns of odor-evoked walking behavior, these patterns were not reliable or specific to particular odors (Figure S2). For example, one might expect aversive odors to pause walking or elicit a fast fleeing-like response, but we did not observe any apparent differences for locomotion between odors as all odors evoked a mixture of responses (Figure S2A-D, text lines 208-232). We then examined responses to odor depending on the behavioral state (walking, pausing or fleeing) and didn’t observe any apparent patterns in odor responses (Figure S2E,F). Lastly, we acknowledge in the text that the lack of valence encoding may be an artifact of head-fixation (see lines 849-857).

      (2) For the optogenetic manipulations of Vglut1 and Vglut2 neurons, why was the injection and fiber targeted to the medial portion of the plCoA, if the hypothesis was that these glutamatergic neuron populations in different regions (anterior or posterior) are responsible for approach and avoidance? 

      We targeted the middle region of plCoA because it contains a mixture of cell types found in both the anterior and posterior plCoA, allowing us to test the hypothesis that cell types, not intraplCoA location, elicit different responses. Had we targeted the anterior or posterior regions, we would expect to simply recapitulate the result from activation of random cells in each region. As a result, we think stimulation in the middle plCoA is a better test for the contribution of cell types. We have clarified this in the text (Lines 417-419).

      Could this explain the lack of necessity with the DREADD experiments? 

      For the loss of function experiments, a larger volume of virus was injected to cover a larger area and we did confirm targeting of the appropriate areas. Though, it is always possible that the lack of necessity is due to incomplete silencing.

      Further, why was an optogenetic inhibition approach not utilized? 

      Although optogenetic inhibition could have plausibly been used instead, we chose chemogenetic inhibition for two reasons: First, for minutes-long periods of inhibition, optical illumination poses the risk of introducing heat related effects (Owen et al., 2019). In fact, we first tried optical inhibition but controls were exhibited unusually large variance. Second, it is more feasible in our assay as it has a narrow height between the floor and lid that complicates tethering to an optic fiber. Past experiments overcame this with a motorized fiber retraction system (Root et al., 2014), but this is highly variable with user-dependent effects, so we found chemogenetics to be a more practical strategy. We have added a sentence to explain the rationale (see lines 561-563).

      (3) The specific subregion of the nucleus accumbens that was targeted should be named, as distinct parts of the nucleus accumbens can have very different functions. 

      We attempted to define specific subregions of the nucleus accumbens and found that plCoA projection is not specific to the shell or core, anterior or posterior, rather it broadly innervates the entire structure. We have added a note about this in manuscript (see lines 470-471). Given that we did not find notable subregion-specific outputs within the NAc, targeting was directed to the middle region of NAc, with coordinates stated in the methods. 

      (4) Why was an intersectional DREADD approach used to inhibit the projection pathways, as opposed to optogenetic inhibition? The DREADD approach could potentially affect all projection targets, and the authors might want to address how this could influence the interpretation of the results.

      This is partly addressed above in point 2. As for interpretation, we acknowledge that the intersectional approach silences the neurons projecting to a given target and not the specific projection and we have been careful with the wording. Although this may complicate the conclusion, we did map the collaterals for NAc and MeA projecting neurons and find that neurons do not appreciably project to both targets and have minimal projections to other targets. We have now taken care to state that we silence the neurons projecting to a structure, not silencing the projection, and we acknowledge this caveat. However, since the MeA- and NAcprojecting neurons appear to be distinct from each other (largely not collateralizing to each other), the conclusion that these divergent pathways are required still stands. We have added discussion of this in the Limitations section (see lines 859-863).

      Minor:

      (1) Line 402 needs a reference.

      We have added the missing reference (now line 441).

      (2) The Supplemental Figure labeling in the main text should be checked carefully.

      Thank you for pointing this out. We have fixed the prior errors.

      (3) Panel letter D is missing from Figure 2.

      This has been fixed.

      Reviewer #2 (Recommendations for the authors):

      Major Concerns, additional experiments:

      - In the calcium imaging experiments mice were presented with the same odor many times. Overall responses to odor presentations were quite variable and appear to habituate dramatically (Figure S1F). The general conclusion from these experiments are a lack of consistent valence-specific responses of individual neurons, but I wonder if this conclusion is slightly premature. A few potential explanatory factors that may need additional attention are: -First, despite recording video of the mouse's face during experiments, no behavioral response to any odor is described. Is it possible these odors when presented in head-fixed conditions do not have the same valence?

      Yes, we agree that this is a possibility. We have added a discussion in the Limitations section (see lines 849-857). We have also added additional behavioral analysis discussed below.

      On trials with neural responses are there behavioral responses that could be quantified? 

      We have now added data in which we attempt to characterize their behavioral response, to look for correlations in odor representation (see lines 208-228). Although we did observe different patterns of odor-evoked walking behavior, these patterns were not reliable or specific to particular odors (Figure S2). One might expect aversive odors to pause walking or elicit a fast fleeing-like response, but we did not observe any apparent differences for locomotion between odors (Figure S2A-D). Next, we examined responses to odor depending on the behavioral state (walking, pausing or fleeing) and didn’t observe any meaningful differences in odor responses (Figure S2E,F). Lastly, we acknowledge that the odor representation may be different in freely moving animals that exhibit dynamic responses to odor (see lines 859-857).

      - Habituation seems to play a prominent role in the neural signals, is there a larger contribution of valence if you look only at the first delivery (or some subset of the 20 presentations) of an odor type for a given trial? 

      Indeed, we considered this, but we did not find any apparent differences in valence encoding as measured by the proportion of neurons with significant valence scores across trials (see Figure 1J).

      - Is it reasonable to exclude valence encoding as a possibility when largely neurons were unresponsive to the positive valence odors (2PE and peanut) chosen when looking at the average cluster response (Figure 1F)? 

      It is true that we see fewer neurons responding to the appetitive odors (Figure 1H) and smaller average responses within the cluster, but some neurons do respond robustly. If these were valence responses, we would predict that neural responses should be similarly selective, but we do not observe any such selectivity. The sparseness of responses to appetitive odors does cause the average cluster analysis (Figure 1F) to show muted responses to these odors, consistent with the decreased responsivity to appetitive odors. Moreover, single neuron response analysis reveals that a given neuron is not more likely to respond to appetitive or aversive odors with any selectivity greater than chance. For these reasons, we think it is reasonable to conclude an absence of valence responses, which is consistent with the conclusion from another report (Iurilli et al., 2017).

      - While the preference and aversion assay with 4 corners is an interesting set-up and provides a lot of data for this particular manuscript. It would be helpful to test additional behaviors to determine whether these circuits are more conserved. As it stands the current manuscript relies on very broad claims using a single behavioral readout. Some attempts to use head-fixed approaches with more defined odor delivery timelines and/or additional valenced behavioral readouts is warranted.

      We appreciate the suggestion, but are not able to perform these experiments at the moment. The choice of the 4-quadrant assay was used because it built off of our prior experiments that demonstrate a role for the plCoA in innate behavior. It is noteworthy that the responses to odor seen in this assay are generally in agreement with other olfactory behavioral assays, so one wouldn’t predict a different result. The approach and avoidance responses measured in this assay are precisely the behaviors we wish to understand. Moreover, we did examine other nonolfactory behavioral readouts (Figures S3, S8), and didn’t observe any effect of manipulation of these pathways. Lastly, we have tried to define parameters for head-fixed behavior that would permit correlation of neural responses with behavior, including longer stimulations and closed loop locomotion control of odor concentration, but were unsuccessful at establishing parameters that generated reliable behavioral responses. We acknowledge that one limitation of the study is the limited behavioral tests with two odors and whether the circuits are more broadly necessary for other odors. 

      Minor comments:

      • Please define PID in the Results when it is first introduced.

      Done (see line 154)

      • Line 412 Figure S5C-N should be Figure S6C-N.

      Fixed. Now Figure S8C-N due to additional figures (see line 451).

      • Throughout the Discussion it would be helpful if the authors referred to specific Figure panels that support their statements (e.g. lines 654-656 "[...] which is supported by other findings presented here showing that both VGluT2+ and VGluT1+ neurons project to MeA, while the projection to NAc is almost entirely composed of VGluT1+ neurons".

      Thank you for the suggestion. We have added figure references in the discussion.

      • Line 778 "producing" should be "produce".

      Corrected (see line 840)

      • The figures are very busy, especially all the manipulations. The authors are commended for including each data point, but they might consider a more subtle design (translucent lines only for each animal, and one mean dot for the SEM), just to reduce the overall clutter of an already overwhelming figure set. But this is ultimately left to the authors to resolve and style to their liking. 

      Thank you for the suggestion. We have tried some different styles but like the original best.

      Reviewer #3 (Recommendations for the authors):

      If within reach, I suggest that the author determine the percentage of retrogradely labeled neurons to NAc or MEA that expresses GluT1 and GluT2. 

      We have done this for the middle region plCoA that has the greatest mixture of cell types (See Figure S10, lines 504-517). We find that the MeA projecting neurons are mostly VGluT2+ with a minority that express both VGluT1 and VGlut2. NAc-projecting neurons are primarily VGluT1+ with about 20% expressing VGlut2 as well.

      It would also be nice to sparse label of aplCoA and pplCoA using ChR2 to see if sparse activation drives approach or avoidance. 

      We agree that it would be useful to vary the sparseness of the ChR2 expression, to see if produces similar results. We examined this using sparsely labeled odor ensembles, as previously done (Root et al., 2014). Briefly, we used the Arc-CreER mouse to label TMT responsive neurons with a cre-dependent ChR2 AAV vector targeted to the anterior or posterior regions, while previously we had broadly targeted the entirety of plCoA. We had established that this labeling method captures about half of the active cells detected by Arc expression, which is on the order of hundreds of neurons rather than thousands by broad cre-independent expression. Remarkably, we get effects similar in magnitude that are not significantly different from that with broader activation of the anterior or posterior domains (see new Figure S4, lines 267-288). It still remains possible that there is a threshold number of neurons that are necessary to elicit behavior, but that is beyond the scope of the current study. However, these data indicate that the effect of activating anterior and posterior domains is not an artifact of broad stimulation.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      We appreciate the positive assessment. We recognize that since all of the work in this manuscript was done in vitro, there are reasonable concerns about the translatability of these data to clinical settings. These results should not directly inform malaria policy, but we hope that these data bring new considerations to the approach for choosing strategic antimalarial combinations. We have modified the manuscript to clarify this distinction.

      Public Reviews

      Reviewer #1 (Public Review):

      We thank the reviewer for their thoughtful summary of this manuscript. It is important to note that DHA-PPQ did show antagonism in RSAs. In this modified RSA, 200 nM PPQ alone inhibited growth of PPQ-sensitive parasites approximately 20%. If DHA and PPQ were additive, then we would expect that addition of 200 nM PPQ would shift the DHA dose response curve to the left and result in a lower DHA IC50. Please refer to Figure 4a and b as examples of additive relationships in dose-response assays. We observed no significant shift in IC50 values between DHA alone and DHA + PPQ. This suggests antagonism, albeit not to the extent seen with CQ. We have modified the manuscript to emphasize this point. As the reviewer pointed out, it is fortunate that despite being antagonistic, clinically used artemisinin-4-aminoquinoline combinations are effective, provided that parasites are sensitive to the 4-aminoquinoline. It is possible that superantagonism is required to observe a noticeable effect on treatment efficacy (Sutherland et al. 2003 and Kofoed et al. 2003), but that classical antagonism may still have silent consequences. For example, if PPQ blocks some DHA activation, this might result in DHA-PPQ acting more like a pseudo-monotherapy. However, as the reviewer pointed out, while our data suggest that DHA-PPQ and AS-ADQ are “non-optimal” combinations, the clinical consequences of these interactions are unclear. We have modified the manuscript to emphasize the later point.

      While the Ac-H-FluNox and ubiquitin data point to a likely mechanism for DHA-quinoline antagonism, we agree that there are other possible mechanisms to explain this interaction.  We have addressed this limitation in the discussion section. Though we tried to measure DHA activation in parasites directly, these attempts were unsuccessful. We acknowledge that the chemistry of DHA and Ac-H-FluNox activation is not identical and that caution should be taken when interpreting these data. Nevertheless, we believe that Ac-H-FluNox is the best currently available tool to measure “active heme” in live parasites and is the best available proxy to assess DHA activation in live parasites. These points are now addressed in the discussion section. Both in vitro and in parasite studies point to a roll for CQ in modulating heme, though an exact mechanism will require further examination. Similar to the reviewer, we were perplexed by the differences observed between in vitro and in parasite assays with PPQ and MFQ. We proposed possible hypotheses to explain these discrepancies in the discussion section. Interestingly, our data corelate well with hemozoin inhibition assays in which all three antimalarials inhibit hemozoin formation in solution, but only CQ and PPQ inhibit hemozoin formation in parasites. In both assays, in-parasite experiments are likely to be more informative for mechanistic assessment.

      It remains unclear why K13 genotype influences RSA values, but not early ring DHA IC50 values. In K13<sup>WT</sup> parasites, both RSA values and DHA IC50 values were increased 3-5 fold upon addition of CQ. This suggests that CQ-mediated resistance is more robust than that conferred by K13 genotype. However, this does not necessarily suggest a different resistance mechanism. We acknowledge that in addition to modulating heme, it is possible that CQ may enhance DHA survival by promoting parasite stress responses. Future studies will be needed to test this alternative hypothesis. This limitation has been acknowledged in the manuscript. We have also addressed the reviewer’s point that other factors, including poor pharmacokinetic exposure, contributed to OZ439-PPQ treatment failure.

      Reviewer #2 (Public Review):

      We appreciate the positive feedback. We agree that there have been previous studies, many of which we cited, assessing interactions of these antimalarials. We also acknowledge that previous work, including our own, has shown that parasite genetics can alter drug-drug interactions. We have included the author’s recommended citations to the list of references that we cited. Importantly, our work was unique not only for utilizing a pulsing format, but also for revealing a superantagonistic phenotype, assessing interactions in an RSA format, and investigating a mechanism to explain these interactions. We agree with the reviewer that implications from this in vitro work should be cautious, but hope that this work contributes another dimension to critical thinking about drug-drug interactions for future combination therapies. We have modified the manuscript to temper any unintended recommendations or implications.

      The reviewer notes that we conclude “artemisinins are predominantly activated in the cytoplasm”. We recognize that the site of artemisinin activation is contentious. We were very clear to state that our data combined with others suggest that artemisinins can be activated in the parasite cytoplasm. We did not state that this is the primary site of activation. We were clear to point out that technical limitations may prevent Ac-H-FluNox signal in the digestive vacuole, but determined that low pH alone could not explain the absence of a digestive vacuole signal.

      With regard to the “reproducibility” and “mechanistic definition” of superantagonism, we observed what we defined as a one-sided superantagonistic relationship for three different parasites (Dd2, Dd2 PfCRT<sup>Dd2</sup>, and Dd2 K13<sup>R539T</sup>) for a total of nine independent replicates. In the text, we define that these isoboles are unique in that they had mean ΣFIC50 values > 2.4 and peak ΣFIC50 values >4 with points extending upward instead of curving back to the axis. As further evidence of the reproducibility of this relationship, we show that CQ has a significant rescuing effect on parasite survival to DHA as assessed by RSAs and IC50 values in early rings.

      Reviewer #3 (Public Review):

      We thank the reviewer for their positive feedback. We acknowledge that no combinations tested in this manuscript were synergistic. However, two combinations, DHA-MFQ and DHA-LM, were additive, which provides context for contextualizing antagonistic relationships. We have previously reported synergistic and additive isobolograms for peroxide-proteasome inhibitor combinations using this same pulsing format (Rosenthal and Ng 2021). These published results are now cited in the manuscript.

      We believe that these findings are specific to 4-aminoquinoline-peroxide combinations, and that these findings cannot be generalized to antimalarials with different mechanisms of action. Note that the aryl amino alcohols, MFQ and LM, were additive with DHA. Since the mechanism of action of MFQ and LM are poorly understood, it is difficult to speculate on a mechanism underlying these interactions.

      We agree with the reviewer that while the heme probe may provide some mechanistic insight to explain DHA-quinoline interactions, there is much more to learn about CQ-heme chemistry, particularly within parasites.

      The focus of this manuscript was to add a new dimension to considerations about pairings for combination therapies. It is outside the scope of this manuscript to suggest alternative combinations. However, we agree that synergistic combinations would likely be more strategic clinically.

      An in vitro setup allows us to eliminate many confounding variables in order to directly assess the impact of partner drugs on DHA activity. However, we agree that in vivo conditions are incredibly more complex, and explicitly state this.

      We agree that in the future, modeling studies could provide insight into how antagonism may contribute to real-world efficacy. This is outside the scope of our studies.

      Recommendations for the Authors:

      Reviewer #1 (Recommendations for the Authors):

      The key weaknesses identified in this manuscript are described in the 'weaknesses' section of the public review. The major one is the inconsistency around the H-FluNox response in the chemical vs biological experiments. I can't think of a simple experiment to resolve this issue, but it is good that this data is openly provided in the manuscript. I believe there could be more discussion to clarify this limitation with the current study, and the conclusions, and particularly the title, should be softened regarding the mechanism of antagonism being based on heme reactivity.

      We have softened the title and conclusions to take into account the limitations of our studies.

      (1) Please double-check the definitions for isobologram interpretation. In most antimicrobial interaction studies, I see the threshold for antagonism at sumFIC50 of 1.5, or even 2. 1.25 is often interpreted as additive in many studies.

      We acknowledge that different studies use various cutoff values. Our interpretations for additive versus antagonistic versus superantagonistic were based not only on mean ΣFIC50 values, but also isobologram shape. For example, the flat isoboles for MFQ-DHA were clearly distinct from the curved isoboles of PPQ-DHA. It is unclear what cutoff value(s) would be most clinically relevant.

      (2) For the MFQ-PPQ interaction study, please make it clear that these drugs have very long half-lives (weeks), so the 4 h pulse assay isn't really relevant to their overall activity. It probably shows a slower onset of action, but there is plenty of drug remaining for many days in the clinical scenario, so perhaps the data from the traditional 48h assay is more relevant. The same consideration applies to OZ439, which may impact the interpretation of that data.

      We have now included the half-lives of these compounds in the discussion section. Our intent was to use a pulsing format to make these isobolograms comparable with the other assays. It is important to note that pulses can reveal stronger phenotypes that might be missed with traditional methods. Thus, while 48 h assays may better mimic in vivo conditions, they could also mask important phenotypes.

      Reviewer #3 (Recommendations for the Authors):

      I have included most of my concerns in the public review. Below are some additional specific points for consideration:

      (1) It is expected to include a synergistic combination as a control (e.g., artemisinin + lumefantrine) to contextualize the degree of antagonism observed. The experimental design should show some synergistic profiles in comparison. Adding a few experiments by including a synergistic control is needed.

      Both MFQ-DHA and LM-DHA combinations were additive, which provides context for antagonistic combinations. This is now stated in the results section pertaining to Figure 1. We have also included a reference to our previous publication in which we demonstrated that proteasome inhibitor-peroxide combinations are synergistic to additive using this same pulsing format.

      (2) Consider in vivo validation or pharmacokinetic/pharmacodynamic modeling to strengthen the translational relevance of the findings when it comes to doses and the IC50 correlations.

      We agree that this would be useful to do in future, but it is outside the scope of the current study.

      (3) It would be beneficial to include a discussion section on how the findings are generalizable to different Plasmodium falciparum genotypes (3D7, Dd2, MRA-1284) and their relevance.

      Findings were consistent across three parasite backgrounds depending on PfCRT genotype. This point has been included in the discussion section. The background of these parasites is also provided in Table 1.

      (4) Potential evaluation criteria to understand where certain combinations should be reconsidered can be included as a suggestion for the wider audience.

      Our in vitro studies suggest that pulsing isobolograms would be a useful assay to include when evaluating combination therapies. While we believe that synergistic combinations would be more strategic than antagonistic combinations, we cannot provide evaluation criteria or make recommendations for reconsidering currently used combinations.

      (5) Further elaborate on the mechanistic basis of heme inactivation by quinolines. If data are available, please include more data on the specificity of the process.

      Despite our best efforts, we were unable to evaluate quinoline-heme interactions in parasites. Even in vitro, this interaction has remined elusive for decades. We agree that this would be an important future step towards supporting a specific mechanism for quinoline-DHA antagonism.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study generated 3D cell constructs from endometrial cell mixtures that were seeded in the Matrigel scaffold. The cell assemblies were treated with hormones to induce a "window of implantation" (WOI) state. Although many bioinformatic analyses point in this direction, there are major concerns that must be addressed.

      Strengths:

      The addition of 3 hormones to enhance the WOI state (although not clearly supported in comparison to the secretory state).

      Comments on revisions:

      The authors did their best to revise their study according to the Reviewers' comments. However, the study remains unconvincing, incomplete and at the same time still too dense and not focused enough.

      Reviewer #2 (Public review):

      Zhang et al. have developed an advanced three-dimensional culture system of human endometrial cells, termed a receptive endometrial assembloid, that models the uterine lining during the crucial window of implantation (WOI). During this mid-secretory phase of the menstrual cycle, the endometrium becomes receptive to an embryo, undergoing distinctive changes. In this work, endometrial cells (epithelial glands, stromal cells, and immune cells from patient samples) were grown into spheroid assembloids and treated with a sequence of hormones to mimic the natural cycle. Notably, the authors added pregnancy-related factors (such as hCG and placental lactogen) on top of estrogen and progesterone, pushing the tissue construct into a highly differentiated, receptive state. The resulting WOI assembloid closely resembles a natural receptive endometrium in both structure and function. The cultures form characteristic surface structures like pinopodes and exhibit abundant motile cilia on the epithelial cells, both known hallmarks of the mid-secretory phase. The assembloids also show signs of stromal cell decidualization and an epithelial mesenchymal transition, like process at the implantation interface, reflecting how real endometrial cells prepare for possible embryo invasion.

      Although the WOI assembloid represents an important step forward, it still has limitations: the supportive stromal and immune cell populations decrease over time in culture, so only earlypassage assembloids retain full complexity. Additionally, the differences between the WOI assembloid and a conventional secretory-phase organoid are more quantitative than absolute; both respond to hormones and develop secretory features, but the WOI assembloid achieves a higher degree of differentiation due to the addition of "pregnancy" signals. Overall, while it's a reinforced model (not an exact replica of the natural endometrium), it provides a valuable in vitro system for implantation studies and testing potential interventions, with opportunities to improve its long-term stability and biological fidelity in the future.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      This study generated 3D cell constructs (i.e., assembloids) that were treated with hormones to induce a 'window of implantation' (WOI) state. While the authors have made large efforts to address the reviewers' feedback, the study's findings remain unconvincing and incomplete.

      (1) The authors have appropriately revised the terminology from 'organoids' to 'assembloids' in several parts of the manuscript. However, this revision remains incomplete, as the main title, figure legends, and figure titles still contain the incorrect term. A thorough review of the entire manuscript is recommended to ensure consistent and accurate use of terminology.

      Thank you for your meticulous review. We have now conducted a full check and confirmed that terminology is used consistently and accurately throughout the text.

      (1) Previous comments raised concerns about the feasibility of robustly passaging assembloid structures - comprising epithelial, stromal and immune cells - under epithelial growth conditions. The authors responded by stating that they optimized the expansion medium with a stromal cell-promoting factor. Additionally, rather than conducting scRNA-seq on both early and late passages (P6-P10) as suggested, they performed immunofluorescence staining, which confirmed the persistence of stromal cells at passage 6. However, the presence of immune cells was not addressed. Confirmation of their presence is essential for all further claims. Moreover, a more zoomed-out view of the immunostaining would help clarify the overall cellular composition across the entire well and facilitate comparison with corresponding brightfield images.

      Whole-mount immunofluorescence of the 6th - generation assembloids revealed that CD45<sup>+</sup> immune cells surrounded FOXA2<sup>+</sup> glands, with a more zoomed-out view provided.

      Author response image 1.

      Whole-mount immunofluorescence showed that CD45<sup>+</sup> cells (immune cells) were arranged around the glandular spheres that were FOXA2<sup>+</sup>. Scale bar =50 μm (left) and 30 μm (right).

      In their response, the authors mention using the first three passages to ensure optimal cell diversity and viability. However, the manuscript states that 'assembloids derived from the first generation are used for experiments' (line 106). This discrepancy must be clarified.

      Thank you for your suggestion. We have revised the relevant content to “The assembloids derived from the first three generation are used for experiments” (Line 90-91).

      (2) The authors have made a commendable effort to bring more focus to the manuscript, which has improved readability.

      We thank you for your insightful suggestions, which have greatly improved the quality of our manuscript.

      (3) The "embryo implantation" part remains very unconvincing. How did authors define "the blastoids could grow within the endometrial assembloids and interact with them"? What did they mean with "grow"? Did blastoids further differentiate? Normally, blastoids cannot further "grow". "Survival rates of blastoids" is not equal to "growth". It is not clear how the survival rate was quantified. Besides, regarding the "interaction rates", how did authors define and quantify it? Actually, blastoids are able to attach to Matrigel efficiently (even without any endometrial cells), so authors cannot simply define the "interaction" as the co-localization of blastoids and assembloids via brightfield images. In addition, for the assembloids as the 3D structures grow in the Matrigel, the epithelial parts are normally apical-in, while the blastoids attach to the apical (lumen) side of the epithelial cells, so physiologically, blastoids should interact with the apical part of the epithelial cells instead of the outside of the assembloids.

      (1) What did they mean with "grow"? Did blastoids further differentiate?

      On the one hand, volume and morphology undergo continuous dynamic changes; on the other hand, only the inner cell mass and trophectoderm exist at the blastocyst stage, with the ICM further differentiating into OCT4<sup>+</sup> epiblast and GATA6<sup>+</sup> hypoblast.

      (2) Survival rates of blastoids" is not equal to "growth". It is not clear how the survival rate was quantified.

      The definition of "survival rate" is as follows: morphologically, the blastocoel remains noncollapsed and the cell boundaries are distinct (with no obvious cell detachment); molecularly, the markers of epiblast, hypoblast and trophectoderm are expressed. The survival rate is calculated as the ratio of viable embryoids to the total number of embryoids.

      (3) Besides, regarding the "interaction rates", how did authors define and quantify it? Actually, blastoids are able to attach to Matrigel efficiently (even without any endometrial cells), so authors cannot simply define the "interaction" as the co-localization of blastoids and assembloids via brightfield images.

      The criteria for determining interaction include not only attachment between the blastoids and assembloids observed via brightfield images, but also their sustained tight adhesion against external mechanical perturbations (e.g., medium replacement, immunostaining procedures).

      (4) In addition, for the assembloids as the 3D structures grow in the Matrigel, the epithelial parts are normally apical-in, while the blastoids attach to the apical (lumen) side of the epithelial cells, so physiologically, blastoids should interact with the apical part of the epithelial cells instead of the outside of the assembloids.

      You are absolutely correct. In vivo, the embryo indeed makes initial contact with the apical side of the epithelial cells. The introduction of the blastoid co-culture model herein is intended to demonstrate that this receptive endometrial assembloids can better support blastoid growth and development.

      (4) Previous comments highlighted the absence of distinct shifts in gene expression profiles between SEC assembloids and WOI assembloids, which contrasts with findings from primary endometrial tissue reported by Wang et al. (2020). While the authors have expanded their analysis using the Mfuzz algorithm and identified changes in mitochondria- and cilia-associated genes, the manuscript still lacks evidence of significant transcriptional changes in key WOI marker genes, as described in Wang et al. This discrepancy must be addressed and discussed in greater depth to clarify the biological relevance of their model.

      The endometrium in vivo involves complex crosstalk among multiple cell types and is tightly regulated by the hypothalamic-pituitary-ovarian (HPO) axis, thus exhibiting distinct shifts in gene expression during the peri-implantation period.

      In our in vitro model, alterations in mitochondria- and cilia-related genes were observed, which to a certain extent demonstrates that these window of implantation (WOI) assembloids possess receptive-phase characteristics and can be employed to investigate WOI-associated scientific questions or conduct in vitro drug screening.

      However, substantial efforts are still required to optimize the current model for fully recapitulating the dynamic changes in endometrial gene expression across different phases in vivo, and this aspect is further addressed in the Limitations section of our discussion (Line 342-353).

      “However, our WOI endometrial assembloids also exhibit some limitations. It is undeniable that the assembloids cannot perfectly replicate the in vivo endometrium, which comprises functional and basal layers with a greater abundance of cell subtypes, under superior regulation by hypothalamic-pituitary-ovarian (HPO) axis. Specifically, stromal and immune cells are challenging to stably passage, and their proportion is lower than in the in vivo endometrium. While the in vivo peri-implantation period exhibits intricate gene expression dynamics driven by systemic regulation, our models only partially recapitulate these changes, primarily in mitochondria- and cilia-associated genes. Nevertheless, to some extent, these WOI assembloids possess receptivity characteristics and can be utilized for investigating receptivity-related scientific questions or conducting in vitro drug screening. Further refinements are required to fully simulate the dynamic endometrial gene expression patterns across all menstrual cycle stages. We are looking forward to integrating stem cell induction, 3D printing, and microfluidic systems to modify the culture environment.”

      (5) In the authors' response document, they present data integrating their results with those of Garcia Alonso et al. (2021). However, these integrated analyses are not included in the revised manuscript (which should be, if answering a major concern).

      Thanks for your valuable suggestions. We have now integrated the findings of Garcia Alonso et al. (2021) into the revised manuscript (Line 132) and Figure S2E–F.

      (8) Fig 2D: The authors have clarified that CD45+ staining is used. However, they have not yet adapted the typo in the figure legend of the right picture.

      Thanks for your thorough review. The left panel of Figure 2D is stained with CD45 to label immune cells, while the right panel is stained with CD44. These details have been clearly indicated in both the manuscript and the figure legend.  

      (9) All quantification analyses (as described in the authors' response document) should be clearly described in the Materials & Methods section.  

      Thanks for your valuable suggestions. All quantification analyses have now been added to the Supporting Materials and Methods section (Line 94-104, Line 110-111, Line 241244).

      (10) The authors have provided clarification regarding their method for quantifying immunofluorescence staining (e.g., OLFM4 expression in Fig. 3C) in their response document. However, these methodological details are not included in the revised manuscript. It is important that such information is incorporated into the manuscript itself to ensure transparency and reproducibility for others.

      Thanks for your valuable suggestions. All quantification analyses have now been added to the Supporting Materials and Methods section (Line 94-104).

      (13) It is needed to include the author's response to the comment about literature showing the opposite of increased number of cilia during the WOI into the discussion part of the paper.

      We appreciate your suggestions. The relevant content has now been added to the Discussion section (Lines 319–323).

      (14) In the authors' response, they explain the difference between pinopodes and microvilli. They should include this explanation briefly in the manuscript. Moreover, Fig. 3F lacks a picture of cilia structure in CTRL condition. In addition, the structures that are indicated as cilia with an orange arrow seem to not be attached to the endometrial cells (anymore). It would be useful to show another more representative picture for the cilia.

      (1) Thank you for your valuable suggestions. The distinction between pinopodes and microvilli has now been added to the Supporting Materials and Methods section (Line 230-236).

      (2) You are probably referring to Figure 2F—we did not observe ciliary structures in the CTRL group.

      (3) The cilia structure was visualized via transmission electron microscopy (TEM), which requires ultrathin sectioning. Thus, the cilia shown in the image correspond to a single cross-section of the captured assembloids. Owing to technical limitations, three-dimensional visualization of cilia on the cells cannot be achieved.

      (17) The results on co-culturing blastoids with the WOI assembloids is not convincing. The blastoids are exposed to the basolateral side of the endometrial epithelial cells, while in vivo, blastocysts interact with the apical side of the endometrial epithelial cells first (apposition and attachment), followed by invasion into the endometrium. This means that the interaction shown here is not physiological. Therefore, it is not justified to say that this platform holds promise to investigate maternal-fetal interactions.

      We agree with your perspective that discrepancies exist between this model and the physiological processes in vivo. However, such differences do not negate the scientific value of the model.

      The core merit of this study lies in the successful establishment of co-culture systems for blastoids and WOI assembloids. Notably, genuine cross-talk occurs between the two components, thereby providing a practical and operational tool for subsequent research.

      Although the current contact orientation differs from that observed in vivo, future optimization of the cell culture protocol (via modulation of cell polarity) will enable the model to better recapitulate physiological conditions. Therefore, the innovation and operability of this model within specific research contexts still render it a robust platform for investigating maternal-fetal interactions.

      Overall, it is highly recommended that the authors carefully review the manuscript for grammatical errors, inconsistencies and issues with scientific phrasing. The language throughout the text requires substantial editing to improve clarity, readability and precision. 

      We appreciate your suggestions. A full manuscript check was performed to rectify grammatical errors, inconsistencies, and inappropriate scientific phrasing, with further language refinement by a native English-speaking specialist.

      Fig 1A: This overview is unclear. How many days do the assembloids grow before being stimulated with hormones? Are CTRL assembloids only kept in culture until day 2 and SEC and WOI assembloids until day 8? This is also not clear form the Materials and Methods section. Should be clarified.

      Thanks for your valuable suggestions. We have now updated the overview (Figure 1A) and Materials and Methods section (Line 370-371, Line 379-381).

      “Hormonal treatment was initiated following the assembly of the endometrial assembloids (about 7-day growth period).”

      “The CTRL group was cultured in ExM without hormone supplementation and subjected to parallel culture for 8 days along with the two aforementioned groups.”

      Fig 1B: From these brightfield images, it appears that the size of the assembloids remains relatively consistent from Day 0 to Day 3 and up to Day 11 (especially in CTRL). However, in Fig S1A, the assembloids on Day 11 appear significantly larger compared to those on Day 2 (or Day 4). Authors should clarify this discrepancy (since both of the figures are shown as "brightfield of endometrial assembloids").

      You are probably referring to the observation that the assembloids at Day 11 in Fig. S1A are smaller in size than those at Day 2 (or Day 4) in Fig. 1B. This discrepancy arises because the time points in Fig. 1B are calculated starting from the initiation of hormone treatment for the SEC and WOI groups, rather than from the beginning of the overall culture as in Fig. S1A. In addition, assembloids exhibit size variability during the same culture period due to individual heterogeneity.

      To eliminate ambiguity, we have now labeled “Hormone Day 0, Day 2, Day 8” in Fig. 1B and revised the corresponding figure legend to read: “Endometrial assembloids from the CTRL, SEC, and WOI groups, which were subjected to hormone treatment on Days 0, 2, and 8, exhibited comparable growth patterns throughout the culture period.”

      Fig 2G: authors still used the description "organoids" here instead of "assembloids".

      We appreciate your careful review. Corrections have been made accordingly.

      Fig. 3C: For the OLFM4 staining quantification, in the Y-axis authors wrote "proportion of OLFM4 (+) cells (OLFM4 (+)/total", but in the rebuttal letter they mention "its fluorescence intensity (quantified as mean grey value) was significantly stronger in both the SEC and WOI groups compared to the CTRL group". This is confounding and should be clarified.

      We apologize for incorrectly writing "fluorescence intensity" in the rebuttal letter; the correct term should be the "proportion of OLFM4 (+) cells (OLFM4 (+)/total)" as shown in Fig. 3C.

      Fig 5D: Acetyl-α-tubulin is the marker of ciliated cells and should be expressed in the cilia instead of the whole cells. It is very strange to quantify as "mean fluorescence intensity (acetyl-αtubulin/DAPI)" to assess the cilia. Please clarify.

      Thank you for your insightful comment. To clarify, the ratio "mean fluorescence intensity (acetyl-α-tubulin/DAPI)" was calculated within individual acetyl-α-tubulin<sup>+</sup> ciliated cells. Acetyl-αtubulin fluorescence was normalized to the DAPI signal of the same cell nucleus, not the wholecell population. This corrected for variations in cell number and staining efficiency to ensure data accuracy.

      Fig 5F: it is very bizarre that unciliated epithelium was transformed from ciliated epithelium, and CTRL was transformed from SEC and WOI. Should be clarified and discussed.

      Pseudotime analysis sorts discrete cells along a "pseudotime axis" based on similarities and differences in cellular gene expression, thereby simulating cell state transitions.

      Ciliated epithelium → unciliated epithelium: During the menstrual cycle, ciliated and unciliated epithelia undergo mutual transformation from the secretory phase (or mid-secretory phase) to the menstrual phase, and then to the proliferative phase. Here, we demonstrate the transition of ciliated cells to unciliated cells from the SEC and WOI stages to the CTRL stage.

      Notably, the two cell types coexist, and what is presented here merely reflects a transformation trend. Relative content has been incorporated into the Discussion section (Line 319-321).

      “Throughout the menstrual cycle, ciliated and unciliated epithelia undergo mutual transformation from the secretory phase (or mid-secretory phase) to the menstrual phase, and then to the proliferative phase.”

      Fig 5H: To show "enhanced invasion ability", authors must provide some quantification and statistic analysis. It is very hard to see the difference between the CTRL and SEC regarding ROR2Wnt5A.

      We appreciate your suggestion. Quantification and statistic analysis have been added to Figure 5H.

      Fig 6A: please elaborate the "mIVC1" and "mIVC2" in the figure legends.

      Additions have been made to the figure legends accordingly, as follows: "mIVC1: modified In Vitro Culture Medium 1; mIVC2: modified In Vitro Culture Medium 2."

      Fig S1D: Is the PAS staining also done in CTRL assembloids? In addition, it is stated that the assembloids secrete glycogen because of a positive PAS staining, while it could also be neutral mucins, glycoproteins, etc, which are all detected by PAS staining. So, the authors should be more careful in stating that it is glycogen, or a PAS staining with diastase digestion should be done.

      The PAS staining results for the CTRL group are presented in Fig. S1I. In addition, results of PAS staining with diastase digestion are included in Figure S1.

      Line 120: references?

      The reference has been added accordingly.

      Line 178: The term 'Endometrial Receptivity Test (ERT)' is used. Do the authors mean Endometrial Receptivity Analysis (ERA) test? ERA is the commonly used abbreviation for this test. Moreover, the authors describe ERA as 'a kind of gene analysis-based test.' This should be rephrased more scientifically correct.

      Thank you for your valuable suggestion. We have revised the term to ERA, and modified the phrase "a kind of gene analysis-based test" to "gene expression profiling-based diagnostic assay" (Lines 160–163).

      “We performed Endometrial Receptivity Analysis (ERA), a gene expression profiling-based diagnostic assay that integrates high-throughput sequencing and machine learning to quantify the expression of endometrial receptivity-associated genes.”

      Line 83: assemblies à assembloids

      We appreciate your suggestion. The text has been updated to “the endometrial assembloids progressed from epithelial organoids, to assemblies of epithelial and stromal cells and then to stem cell-laden 3D artificial endometrium”.

      The Materials and Methods section currently lacks the needed details. Authors should substantially expand this section to clearly describe all experimental and analytical procedures, including, aùmong others, immunofluorescence staining, quantification methods, bioinformatics analyses and statistical approaches. Providing comprehensive methodological information is essential.

      A detailed description of these methods is provided in the Supporting Materials and Methods section.

      Reviewer #2 (Recommendations for the authors): 

      The revised manuscript is much improved in clarity, focus, and experimental support. The authors have thoughtfully addressed the major concerns from the previous review. In particular, the logic and flow of the paper are clearer, it now guides the reader through the rationale (constructing a WOI model), the comparative analysis against in vivo tissue and simpler organoids, and the key features that distinguish the WOI assembloid. The added functional validation (especially the blastoid co-culture experiment) significantly strengthens the work by showing a tangible outcome of "receptivity" beyond molecular profiling. The distinction between the standard secretory-phase organoid and the WOI assembloid is now more convincing, as the authors highlight several specific differences in morphology (more cilia, pinopodes), metabolism, and implantation success that favor the WOI model. The manuscript also reads cleaner with the bioinformatic sections condensed to the most important findings (excess detail was trimmed or moved to supplements) and the rationale for gene/pathway selection explicitly stated.

      The manuscript has been significantly strengthened through the addition of functional assays (like the blastoid co-culture), clearer transcriptomic and proteomic data, and detailed analyses of hormone treatments, cilia biology, and stromal and immune cell behavior in early passages. These updates confirm that the WOI assembloid supports embryo attachment and outperforms standard secretory organoids, while integrating external references and clarifications on terminology. Minor suggestions remain, such as clarifying statistical significance and adding functional interpretations for certain observations, but overall, the manuscript is now more robust and biologically convincing.

      Remaining points for clarification: There are a few minor points that still merit attention:

      - Use of the Endometrial Receptivity Test (ERT): As previously mentioned, if the authors have ERT data for the SEC organoid group, including that information would further support the claim that the WOI assembloid is uniquely receptive. If not, it would be helpful to add a statement clarifying that the ERT was employed specifically as a confirmatory test for the WOI assembloids, rather than as a comparative measure across all groups.

      Thank you for your valuable suggestion. We have now supplemented the description in the Supporting Materials and Methods section (Lines 160–162) as follows: “ERA was employed specifically as a confirmatory test for the WOI assembloids, rather than as a comparative measure across all groups.”

      - Because the assembloids are created from primary tissue samples, it would be helpful to briefly comment on how consistent the findings were across different patient-derived samples. For example, did all biological replicates show similar expression of receptivity markers and comparable capacity to support blastoid attachment? Although this seems implied, including a sentence in the Methods or Results sections that specifies the number of donor lines tested would help readers assess the model's variability and reproducibility.

      We appreciated your advice. The relevant statement has been added to the Supporting Materials and Methods section. (Line 312-313).

      “All biological replicates (fourteen individuals) of endometrial assembloids show similar expression of receptivity markers and comparable capacity to support blastoid attachment.”

      - The authors mention promising future directions, such as integrating 3D printing and microfluidics to further enhance the model, which is an excellent forward-looking statement. It would also be valuable to suggest the inclusion of additional cell types, like more robust immune cell populations or endothelial components, as future improvements to create an even more comprehensive model of the endometrial lining.

      Thank you for your valuable suggestion. 3D printing and microfluidics serve as approaches for introducing multiple cell types. We have supplemented the following statement in the manuscript: “We are looking forward to integrating stem cell induction, 3D printing, and microfluidic systems to modify the culture environment.” (Line 352-353).

      We are grateful for your valuable feedback and constructive criticism, which have helped us improve the quality of our work in terms of content and presentation. We have diligently revised the manuscript and made necessary changes. Here, we have attached the revised manuscript, figures, and all supplementary materials for your re-evaluation. Thank you again for your continued support and look forward to your favorable decision.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper presents maRQup, a Python pipeline for automating the quantitative analysis of preclinical cancer immunotherapy experiments using bioluminescent imaging in mice. maRQup processes images to quantify tumor burden over time and across anatomical regions, enabling large-scale analysis of over 1,000 mice. The study uses this tool to compare different CAR-T cell constructs and doses, identifying differences in initial tumor control and relapse rates, particularly noting that CD19.CD28 CAR-T cells show faster initial killing but higher relapse compared to CD19.4-1BB CAR-T cells. Furthermore, maRQup facilitates the spatiotemporal analysis of tumor dynamics, revealing differences in growth patterns based on anatomical location, such as the snout exhibiting more resistance to treatment than bone marrow.

      Strengths:

      (1) The maRQup pipeline enables the automatic processing of a large dataset of over 1,000 mice, providing investigators with a rapid and efficient method for analyzing extensive bioluminescent tumor image data.

      (2) Through image processing steps like tail removal and vertical scaling, maRQup normalizes mouse dimensions to facilitate the alignment of anatomical regions across images. This process enables the reliable demarcation of nine distinct anatomical regions within each mouse image, serving as a basis for spatiotemporal analysis of tumor burden within these consistent regions by quantifying average radiance per pixel.

      Weaknesses:

      (1) While the pipeline aims to standardize images for regional assessment, the reliance on scaling primarily along the vertical axis after tail removal may introduce limitations to the quantitative robustness of the anatomically defined regions. This approach does not account for potential non-linear growth across dimensions in animals of different ages or sizes, which could result in relative stretching or shrinking of subjects compared to an average reference.

      Our answer to this comment is included in the Supplemental Methods. The standard deviation of the mouse pixels was calculated to ensure that the image processing steps did not alter the shape or size of the mice. Such consistency is particularly striking because our dataset was accrued by nine lab members over the last five years, before we conceived and carried out our analysis (c.f., answer to point #2). In fact, it is the very consistency of this IVIS measurement that led us to conceive our pipeline. As seen from Supplemental Figure 4G, there is minimal difference in the shape or size of the mice across 7,534 images. A total of 99 images were removed either due to being too slanted (91/7663, 1.2%) or due to processing errors (8/7633, 0.1%). Also, the vertical scaling was conducted while keeping the aspect ratio unchanged to prevent any non-anatomical scaling. Hence, we did not record any nonlinear growth of the mice that would warrant more convoluted alignment and/or batch correction for our images.

      (2) Furthermore, despite excluding severely slanted images, the pipeline does not fully normalize for variations in animal pose during image acquisition (e.g., tucked body, leaning). This pose variability not only impacts the precise relative positioning of internal anatomical regions, potentially making their definition based on relative image coordinates more qualitative than truly quantitative for precise regional analysis, but it also means that the bioluminescent light signal from the tumor will not propagate equally to the camera, as photons will travel differentially through the tissue. This differing light path through tissues due to variable positioning can introduce large variability in the measured radiance that was not accounted for in the analysis algorithm. Achieving more robust anatomical and quantitative normalization might require methods that control animal posture using a rigid structure during imaging.

      Reviewer #1 is correct that different mouse postures would be an issue when aligning the images and normalizing for size. However, all experiments are conducted for luminescence measurements in the IVIS system (i.e., this requires anesthesia and long integration time for imaging). In our experience and in our 1000+ mouse dataset, we noticed that all experiments (n=37) did place the anesthetized mice in a stretched/elongated position. Of note, these experiments were conducted by nine different researchers who were not instructed on how to place the mice on the machine for ideal image processing, thus showing that the standard protocol of imaging mice on IVIS does not introduce large variations in animal pose during image acquisition. We think the issue raised by Reviewer #1 is moot in the context of classical settings for mouse luminescence imaging.

      Reviewer #2 (Public review):

      Summary:

      The authors developed a method that automatically processes bioluminescent tumor images for quantitative analysis and used it to describe the spatiotemporal distribution of tumor cells in response to CD19-targeting CAR-T cells, comprising CD28 or 4-1BB costimulatory domains. The conclusion highlights the dependence of tumor decay and relapse on the number of injected cells, the type of cells, and the initial growth rate of tumors (where initial is intended from the first day of therapy). The authors also determined the spatiotemporal analysis of tumor response to CAR T therapy in different regions of the mouse body in a model of acute lymphoblastic leukemia (ALL).

      Strengths:

      The analysis is based on a large number of images and accounts for many variables. The results of the analysis largely support their claims that the kinetics of tumor decay and relapse are dependent on the CAR T co-stimulatory domain and number of cells injected and tumor growth rates. 

      Weaknesses:

      The study does not specify how a) differences in mouse positioning (and whether they excluded not-aligned mice) and b) tumor spread at the start of therapy influenced their data. The study does not take into account the potential heterogeneity of CAR T cells in terms of CAR T expression or T cell immunophenotype (differentiation, exhaustion, fitness...).

      See answer #2 to Reviewer #1.

      Author response image 1.

      Author response image 1 shows the average tumor radiance on day zero (when CAR-T cell therapy was administered) for all mice. While there is some spread, most mice had tumor localized to the liver or bone marrow.

      Reviewer #3 (Public review):

      Summary:

      The paper "The 1000+ mouse project: large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapies" is focused on developing a novel methodology for automatic processing of bioluminescence imaging data. It provides quantitative and statistically robust insights into preclinical experiments that will contribute to optimizing cell-based therapies. There is an enormous demand for such methods and approaches that enable the spatiotemporal evaluation of cell monitoring in large cohorts of experimental animals.

      Strengths:

      The manuscript is generally well written, and the experiments are scientifically sound. The conclusions reflect the soundness of experimental data. This approach seems to be quite innovative and promising to improve the statistical accuracy of BLI data quantification. 

      This methodology can be used as a universal quantification tool for BLI data for in vivo assessment of adoptively transferred cells due to the versatility of the technology.

      Weaknesses: 

      No weaknesses were identified by this Reviewer. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      In this paper, the authors propose a significant advancement in optical image data analysis by employing automation. They effectively demonstrate the valuable insights that can be gained from analyzing extensive datasets with a more unbiased methodology. At present, I do not have any specific suggestions for improvement.

      However, it is important to note that this work is limited in its operational scope. Specifically, it relies on predefined ROIs rather than aligning the signal site with anatomical systems. The scaling model and image cropping are simplistic, animal pose is not taken into account, and the data output needs to be called semi-quantitative or qualitative, and would have been stronger utilizing an AI agent. Nevertheless, this work underscores the potential of automated systems in preclinical image analysis, which is a crucial step towards developing more sophisticated approaches to optical image data analysis.

      While our analysis used predefined ROIs, the maRQup pipeline allows users to manually draw ROIs on the mouse image.

      Reviewer #2 (Recommendations for the authors):

      The writing and presentation of data are clear and accurate, but some additional information should be added regarding the imaging protocol used to acquire the original data. 

      The authors mention fluorescence in Figure 1. I expected all the data to be generated from bioluminescent NALM-6 tumors, since bioluminescence is indeed measured in average radiance and can be per pixel (p/sec/cm2/sr/pixel). Fluorescence should be measured using radiance efficiency (p/sec/cm2/sr)/(µW/cm2), a unit that compensates for non-uniform excitation light pattern in the instrument. Would the author find different results if fluorescence data were analyzed separately?

      Reviewer #2 is correct that the unit for fluorescence would be radiance efficiency. The word “fluorescent” was included in the label of Figure 1a  to highlight that our workflow could be applied to other types of light-generating methods (i.e., fluorescence vs. bioluminescence). However, in this study, measurements of bioluminescent tumors only were analyzed. If fluorescence measurements are to be analyzed, our methods of image acquisition and processing would be directly applicable.

      Did the author ever check the signal of the snout in mice with no tumor?

      In mice with no tumor, there is no detectable signal in the snout (or anywhere else, for that matter).

      The urine of mice contains phosphor, and might give a background signal, especially if longer exposure is used at the end of the study.

      For the mice with no tumor injection, the luminescence signal was below background (<10<sup>2</sup> p/sec/cm<sup>2</sup>/sr/pixel). In particular, we do not detect any signal in the bladder/urine. Additionally, as described in the Supplemental Methods and Figure 1b, only pixels that were on the mouse as determined from the brightfield image were used to calculate the tumor burden from the radiance of the luminescent image. This method ensures that any background signal (e.g., from phosphor in mouse urine) would be excluded in the radiance quantification and not bias the results.

      Additionally, as described in the Methods, the exposure time was held constant at 30 seconds for each IVIS measurement across all 37 experiments.

      The data using more than 2 million cells comes from only 10 mice, and maybe the biological relevance of this group is limited since it will not be achievable and translatable in humans (PMID: 33653113).

      We appreciate Reviewer #2’s attention to this issue. The effect observed in our study is large enough to reach statistical significance despite the small number of mice. Note that the dosing regimen used was optimized for the murine NSG model and would require appropriate scaling before clinical application. Nonetheless, NSG mice remain the gold standard for pre‑clinical in vivo evaluation and their use is generally required by regulatory agencies, such as the FDA, for assessing novel CAR‑T cell therapies; thus these findings are relevant for advancing such treatments.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review): 

      Strengths:

      (1) The use of chronic two-photon Ca<sup>2+</sup> imaging in awake, behaving mice represents a major technical strength, minimizing confounds introduced by anesthesia. The development of a Pf4Cre:GCaMP6s reporter line, combined with high-resolution intravital imaging, enables long-term and subcellular analysis of macrophage Ca<sup>2+</sup> dynamics in the meninges.

      (2) The comparison between perivascular and non-perivascular macrophages reveals clear niche-dependent differences in Ca<sup>2+</sup> signaling properties. The identification of macrophage Ca<sup>2+</sup> activity temporally coupled to dural vasomotion is particularly intriguing and highlights a potential macrophage-vascular functional unit in the dura.

      (3) By linking macrophage Ca<sup>2+</sup> responses to CSD and implicating CGRP/RAMP1 signaling in a subset of these responses, the study connects meningeal macrophage activity to clinically relevant neuroimmune pathways involved in migraine and other neurological disorders.

      Thank you for recognizing the strengths in our work.

      Weaknesses: 

      (1) The manuscript relies heavily on Pf4Cre-driven GCaMP6s expression to selectively image meningeal macrophages. Although prior studies are cited to support Pf4 specificity, Pf4 is not an exclusively macrophage-restricted marker, and developmental recombination cannot be excluded. The authors should provide direct validation of reporter specificity in the adult meninges (e.g., co-labeling with established macrophage markers and exclusion of other Pf4-expressing lineages). At minimum, the limitations of Pf4Cre-based labeling should be discussed more explicitly, particularly regarding how off-target expression might affect Ca<sup>2+</sup> signal interpretation.

      We acknowledge that PF4 is not an exclusively macrophage-restricted marker. Yet, among meningeal immunocytes, it is almost exclusively expressed in macrophages (1, 2). Furthermore, in the adult mouse meninges, Pf4<sup>Cre</sup>-based reporter lines label nearly all dural and leptomeningeal macrophages and almost no other cells (3, 4). This Cre line has also been used to target border-associated macrophages (2, 4). Moreover, a recent study suggests that the bacterial artificial chromosome used to generate the Pf4<sup>Cre</sup> line does not affect meningeal macrophage activity (4). Nonetheless, while we already discussed PF4 expression in meningeal megakaryocytes, in a revised version, we plan to discuss the possibility that a very small population of other meningeal immune cells may also be labeled.

      (2) The manuscript offers an extensive characterization of Ca<sup>2+</sup> event features (frequency spectra, propagation patterns, synchrony), but the biological significance of these signals is largely speculative. There is no direct link established between Ca<sup>2+</sup> activity patterns and macrophage function (e.g., activation state, motility, cytokine release, or interaction with other meningeal components). The discussion frequently implies functional specialization based on Ca<sup>2+</sup> dynamics without experimental validation. To strengthen the conceptual impact, a clearer framing of the study as a foundational descriptive resource, rather than a functional dissection, would improve alignment between data and conclusions.

      In our discussion, we indicated that “the exact link between the distinct Ca<sup>2+</sup> signal properties of meningeal macrophage subsets observed herein and their homeostatic function remains to be established”. In a revised version, we plan to further acknowledge that this is primarily a descriptive study that provides a foundational landscape of Ca<sup>2+</sup> dynamics in meningeal macrophages.

      (3) The GLM analysis revealing coupling between dural perivascular macrophage Ca<sup>2+</sup> activity and vasomotion is technically sophisticated and intriguing. However, the directionality of this relationship remains unresolved. The current data do not distinguish whether macrophages actively regulate vasomotion, respond to mechanical or hemodynamic changes, or are co-modulated by neural activity. Statements suggesting that macrophages may "mediate" vasomotion are therefore premature. The authors should reframe these conclusions more cautiously, emphasizing correlation rather than causation, and expand the discussion to explicitly outline experimental strategies required to establish causality (e.g., macrophage-specific Ca<sup>2+</sup> manipulation). 

      In the results section, we indicated that our data suggest that dural perivascular macrophages are functionally coupled to locomotion-driven dural vasomotion, either responding to it or mediating it. Furthermore, in our discussion, we discussed the possibilities that 1) macrophages sense vascular-related mechanical changes and 2) macrophage Ca<sup>2+</sup> signaling may regulate dural vasomotion. Moreover, we explicitly state that studying causality will require an experimental approach that has yet to be developed, enabling selective manipulation of dural perivascular macrophages.

      (4) The authors conclude that synchronous Ca<sup>2+</sup> events across macrophages are driven by extrinsic signals rather than intercellular communication, based primarily on distance-time analyses. This conclusion is not sufficiently supported, as spatial independence alone does not exclude paracrine signaling, vascular cues, or network-level coordination. No perturbation experiments are presented to test alternative mechanisms. The authors can either provide additional experimental evidence or rephrase the conclusion to acknowledge that the source of synchrony remains unresolved. 

      Thank you for this suggestion. In the revision, we will indicate that the source of synchrony remains unresolved.

      (5) A major and potentially important finding is that the dominant macrophage response to CSD is a persistent decrease in Ca<sup>2+</sup> activity, which is independent of CGRP/RAMP1 signaling. However, this phenomenon is not mechanistically explored. It remains unclear whether Ca<sup>2+</sup> suppression reflects macrophage inhibition, altered viability, homeostatic resetting, or an anti-inflammatory program. Minimally, the discussion should be more deeply engaged with possible interpretations and implications of this finding. 

      While we propose that the decrease in macrophage calcium signaling following CSD could indicate that a hyperexcitable cortex dampens meningeal immunity, in the revised version, we plan to elaborate on the possible implications of this finding.

      (6) The pharmacological blockade of RAMP1 supports a role for CGRP signaling in persistent Ca<sup>2+</sup> increases after CSD, but the experiments are based on a relatively small number of cells and animals. The limited sample size constrains confidence in the generality of the conclusions. Pharmacological inhibition alone does not establish cell-autonomous effects in macrophages. The authors should acknowledge these limitations more explicitly and avoid overextension of the conclusions. 

      We plan to acknowledge these limitations.

      Reviewer #2 (Public review): 

      Using chronic intravital two-photon imaging of calcium dynamics in meningeal macrophages in Pf4Cre:TIGRE2.0-GCaMP6 mice, the study identified heterogeneous features of perivascular and non-perivascular meningeal macrophages at steady state and in response to cortical spreading depolarization (CSD). Analyses of calcium dynamics and blood vessels revealed a subpopulation of perivascular meningeal macrophages whose activity is coupled to behaviorally driven diameter fluctuations of their associated vessels. The analyses also investigated synchrony between different macrophage populations and revealed a role for CGRP/RAMP1 signaling in the CSD-induced increase, but not the decrease, in calcium transients.

      This is a timely study at both the technical and conceptual levels, examining calcium dynamics of meningeal macrophages in vivo. The conclusions are well supported by the findings and will provide an important foundation for future research on immune cell dynamics within the meninges in vivo. The paper is well written and clearly presented.

      Thank you.

      I have only minor comments. 

      (1) Please indicate the formal definition of perivascular versus non-perivascular macrophages in terms of distance from the blood vessel. This information is not provided in the main text or the Methods. In addition, please explain how the meningeal vasculature was imaged in the main text. 

      We did not measure the exact distance of the perivascular macrophages from the blood vessels, but defined them as such based on previous data showing that these cells reside along the abluminal surface and maintain tight interactions with mural cells (5). We plan to provide this information in the revised manuscript.

      (2) Similarly, the method used to induce acute CSD (pin prick) is not described in the main text and is only mentioned in the figure legends and Methods. Additional background on the neurobiology of acute CSD, as well as the resulting brain activity and neuroinflammatory responses, could be helpful.

      We plan to add the method for inducing CSD (i.e., a pinprick in the frontal cortex) to the Results section and provide more background in the Introduction section.

      Reviewer #3 (Public review):

      Strengths: 

      Sophisticated in vivo imaging of meningeal immune cells is employed in the study, which has not been performed previously. A detailed analysis of the distinct calcium dynamics in various subtypes of meningeal macrophages is provided. Functional relevance of the responses is also noted in relation to CSD events.

      Thank you for recognizing the strengths of our paper

      Weaknesses:

      (1) The specificity of the methods used to target both meningeal macrophages and RAMP1 is limited. Additional discussion points on the functional relevance of the two subtypes of meningeal macrophages and their calcium responses are warranted. A section on potential pitfalls should be included. 

      We plan to address these issues in the revision

      References

      (1) H. Van Hove et al., A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci 22, 1021-1035 (2019).

      (2) F. A. Pinho-Ribeiro et al., Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion. Nature 615, 472-481 (2023).

      (3) G. L. McKinsey et al., A new genetic strategy for targeting microglia in development and disease. Elife 9,  (2020).

      (4) H. J. Barr et al., The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophages. bioRxiv,  (2025).

      (5) H. Min et al., Mural cells interact with macrophages in the dura mater to regulate CNS immune surveillance. J Exp Med 221,  (2024).

    1. Author response:

      Public reviews:

      Reviewer #1 (Public review):

      Weaknesses:

      (1) The assessment of liver and adipose tissue responses to DHH7 loss is insufficient to support claims that it alters systemic lipolysis. In this new mouse model, liver histology is necessary, especially given the cholesterol increase in the KO. As this is a newly established mouse line, common assessments of the liver during HFD feeding would be important for interpreting the phenotype.

      We will add the data of the liver histology in the revised version.

      (2) The data show DHH7 loss causes adipose tissue dysfunction and alterations in lipid metabolism. Beyond that, I suggest not stating more regarding the phenotype of the DHH7 mice for this work. A thorough analysis would be needed to determine which factor drives the obesity and changes in energy balance in the mice. For example, the KO mice had lower oxygen consumption (but no change in CO2 production, which is also usually similarly altered), suggesting a CNS component could drive obesity. However, since the data are not normalized for lean mass and there is no information about locomotor activity, this analysis is incomplete. RER may be informative if available. A broad conservative description of the KO phenotype would be more accurate since Pgr4 has many paracrine targets and likely has autocrine signaling in the liver.

      We will add the data of CO2 production, locomotor activity and RER in the revised version.

      (3) Most references to lipolysis or lipolysis flux systemically would be inaccurate. To suggest a suppression of lipolysis, serum NEFA would need to be measured, and in vivo or in vitro lipolysis assays performed to test the effect of DHH7 loss or the specificity of PGR4 action on adipocytes in vivo. To demonstrate adipose tissue dysfunction, analysis of lipogenesis markers, canonical markers for insulin sensitivity, and mitochondrial dysfunction should be performed/measured.

      We will measure the serum NEFA to test the effect of DHHC7. We will analyze the lipogenesis markers, canonical markers for insulin sensitivity, and mitochondrial dysfunction.

      (4) Line 179: The experiment was performed in brown adipocytes to show that Prg4 does not affect p-CREB Figure S8 under the heading: "DHHC7 controls hepatic PKA-CREB activity through Gαi palmitoylation to regulate Prg4 transcription." Unless repeated using liver lysate, the conclusions stated in the text throughout the paper should be revised.

      The figure S8 is to demonstrate that Prg4 has no impact on forskolin induced CREB phosphorylation at Ser133, and provide the evidence that the prg4 acts on the upstream of adenylyl cyclase. We will revise the description.

      (5) It appears that the serum and liver proteomics were only assessed for factors that increased in KO mice? Were proteins that were significantly decreased analyzed?

      We are analyzing the decreased proteins in the following project.

      (6) The beige adipocyte culture method is unclear. The methods do not describe the fat pad used, and the protocol suggests the cells would be differentiated into mature white adipocytes. If they are beige cells, a reference for the method, gene expression, and cell images could support that claim.

      We will add a reference for the method, gene expression, asn cell images.

      (7) The use of tamoxifen can confound adipocyte studies, as it increases beigeing and weight gain even after a brief initiation period. Both groups were treated with Tam, but another way to induce Cre would be ideal.

      We will use the Doxycycline-inducible systems in the future.

      (8) Evidence for the lack of the glucose phenotype is incomplete. One reason could be due to the IP route of glucose administration, which has a large impact on glucose handling during a GTT. To confirm the absence of a glucose tolerance phenotype, an OGTT should be performed, as it is more physiological. In addition, the mice should be fed for 16 weeks. Prg4 affects immune cells, changing how adipose tissue expands, and 12 weeks of HFD feeding is often not long enough to see the effects of adipose tissue inflammation spilling over into the system.

      We will perform the OGTT and feed the mice for 16 weeks in the future.

      (9) There may be liver-adipose tissue crosstalk in KO mice, but this was not fully assessed in this study and would be difficult to determine in any setting, given the diverse cell types that are targets of Pdg4. The crosstalk claim is unnecessary to share the basic premises; there is the DHH7 mechanism/phenotype and the Pgr4 mechanism/phenotype, and while there is no Pgr4 adipose direct mechanism, the paper can be successfully reframed.

      We will reframe the paper.

      (10) Although the DHH7 loss on the chow diet did not result in a phenotype, did the Pgr4 increase in the KO mice on chow? This would determine whether either i) the expression of Pgr4 is dependent on HFD/obesity, or ii) circulating Pgr4 has effects only in an HFD condition. The receptors may also change on HFD, especially in adipocytes.

      We will test the Prg4 in the KO mice on chow diet.

      Reviewer #2 (Public review):

      (1) Figures: All data should be presented in dot-boxplot format so the reader knows how many samples were analyzed for each assay and group. n=3 for some assays/experiments is incredibly low, particularly when considering the heterogeneity in responsiveness to HFD, food intake, etc.

      We will present the data in dot-boxplot format.

      (2) Figure 1E-F: It is unclear when the food intake measure was performed. Mice can alter their feeding behavior based on a myriad of environmental and biological cues. It would also be interesting to show food intake data normalized to body mass over time. Mice can counterregulate anorexigenic cues by altering neuropeptide production over time. It is not clear if this is occurring in these mice, but the timing of measuring food intake is important. Additionally, the VO2 measure appears to be presented as being normalized to total body mass, when in fact, it would probably be more accurate to normalize this to lean body mass. Normalizing to total body mass provides a denominator effect due to excessive adiposity, but white fat is not as metabolically active as other high-glucose-consuming tissues. If my memory serves me right, several reports have discussed appropriate normalizations in circumstances such as this.

      We will see how to be more accurate to normalize.

      (3) Figure 1J-N: It is not all that surprising that fasting glucose and/or TGs were found to be similar between groups. It is well-established that mice have an incredible ability to become hyperinsulinemic in an effort to maintain euglycemia and lipid metabolism dynamics. A few relatively easy assays can be performed to glean better insights into the metabolic status of the authors' model. First, fasting insulin concentrations will be incredibly helpful. Secondly, if the authors want to tease out which adipose depot is most adversely affected by ablation, they could take an additional set of CON and KO mice, fast them for 5-6 hours, provide a bolus injection of insulin (similar to that provided during an insulin tolerance test), and then quickly harvest the animals ~15 minutes after insulin injections; followed by evaluating AKT phosphorylation. This will really tell them if these issues have impairments in insulin signaling. The gold-standard approach would be to perform a hyperinsulinemic-euglyemic clamp in the CON and KO mice. I now see GTT and ITT data, but the aforementioned assays could help provide insight.

      We have the data for evaluating AKT phosphorylation and will add it in the revised version.

      (4) Figure 3A: This looks overexposed to me.

      We will replace it with short exposed one.

      (5) Figures 3-4: It appears that several of these assays could be complemented with culture-based models, which would almost certainly be cleaner. The conditioned media could then be used from hepatocyte cultures to treat differentiated adipocytes.

      We will perform the cell culture experiments for Figures 3-4

      (6) Figure 4: It is unclear how to interpret the phospho-HSL data because the fasting state can affect this readout. It needs to be made clear how the harvest was done. Moreover, insulin and glucagon were never measured, and these hormones have a significant influence over HSL activity. I suspect the KO mice have established hyperinsulinemia, which would likely affect HSL activity. This provides an example of why performing some of these experiments in a dish would make for cleaner outcomes that are easier to interpret.

      We will perform some experiments in cell culture dish.

      Reviewer #3 (Public review):

      Weaknesses:

      (1) Lack of a causal-effect study to generate evidence directly linking hepatocyte DHH7 and PRG4 in driving adipose expansion and obesity upon HFD feeding.

      We will perform the causal-effect study to demonstrate the hypothesis.

      (2) Lack of direct evidence to support that PRG4 inhibits adipocyte lipolysis via GPR146. A functional assay demonstrating adipocyte lipolysis is required.

      We will add the direct evidence in the revised version.

      (3) The conclusion is largely based on the correlation evidence.

      We will perform the experiment to strengthen the conclusion base on the a causal-effect study.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript by Lin et al. presents a timely, technically strong study that builds patientspecific midbrain-like organoids (MLOs) from hiPSCs carrying clinically relevant GBA1 mutations (L444P/P415R and L444P/RecNcil). The authors comprehensively characterize nGD phenotypes (GCase deficiency, GluCer/GluSph accumulation, altered transcriptome, impaired dopaminergic differentiation), perform CRISPR correction to produce an isogenic line, and test three therapeutic modalities (SapC-DOPS-fGCase nanoparticles, AAV9GBA1, and SRT with GZ452). The model and multi-arm therapeutic evaluation are important advances with clear translational value.

      My overall recommendation is that the work undergo a major revision to address the experimental and interpretive gaps listed below.

      Strengths:

      (1) Human, patient-specific midbrain model: Use of clinically relevant compound heterozygous GBA1 alleles (L444P/P415R and L444P/RecNcil) makes the model highly relevant to human nGD and captures patient genetic context that mouse models often miss.

      (2) Robust multi-level phenotyping: Biochemical (GCase activity), lipidomic (GluCer/GluSph by UHPLC-MS/MS), molecular (bulk RNA-seq), and histological (TH/FOXA2, LAMP1, LC3) characterization are thorough and complementary.

      (3) Use of isogenic CRISPR correction: Generating an isogenic line (WT/P415R) and demonstrating partial rescue strengthens causal inference that the GBA1 mutation drives many observed phenotypes.

      (4) Parallel therapeutic testing in the same human platform: Comparing enzyme delivery (SapC-DOPS-fGCase), gene therapy (AAV9-GBA1), and substrate reduction (GZ452) within the same MLO system is an elegant demonstration of the platform's utility for preclinical evaluation.

      (5) Good methodological transparency: Detailed protocols for MLO generation, editing, lipidomics, and assays allow reproducibility

      Weaknesses:

      (1) Limited genetic and biological replication

      (a) Single primary disease line for core mechanistic claims. Most mechanistic data derive from GD2-1260 (L444P/P415R); GD2-10-257 (L444P/RecNcil) appears mainly in therapeutic experiments. Relying primarily on one patient line risks conflating patient-specific variation with general nGD mechanisms.

      We thank the reviewer for highlighting the importance of genetic and biological replication. An additional patient-derived iPSC line was included in the manuscript, therefore, our study includes two independent nGD patient-derived iPSC lines, GD2-1260 (GBA1<sup>L444P/P415R</sup>) and GD2-10-257 (GBA1<sup>L444P/RecNcil</sup>), both of which carry the severe mutations associated with nGD. These two lines represent distinct genetic backgrounds and were used to demonstrate the consistency of key disease phenotypes (reduced GCase activity, elevated substrate, impaired dopaminergic neuron differentiation, etc.) across different patient’s MLOs. Major experiments (e.g., GCase activity assays, substrate, immunoblotting for DA marker TH, and therapeutic testing with SapC-DOPS-fGCase, AAV9-GBA1) were performed using both patient lines, with results showing consistent phenotypes and therapeutic responses (see Figs. 2-6, and Supplementary Figs. 4-5). To ensure clarity and transparency, a new Supplementary Table 2 summarizes the characterization of both the GD2-1260 and GD2-10-257 lines.

      (b) Unclear biological replicate strategy. It is not always explicit how many independent differentiations and organoid batches were used (biological replicates vs. technical fields of view).

      Biological replication was ensured in our study by conducting experiments in at least 3 independent differentiations per line, and technical replicates (multiple organoids/fields per batch) were averaged accordingly. We have clarified biological replicates and differentiation in the figure legends. 

      (c) A significant disadvantage of employing brain organoids is the heterogeneity during induction and potential low reproducibility. In this study, it is unclear how many independent differentiation batches were evaluated and, for each test (for example, immunofluorescent stain and bulk RNA-seq), how many organoids from each group were used. Please add a statement accordingly and show replicates to verify consistency in the supplementary data.

      In the revision, we have clarified biological replicates and differentiation in the figure legend in Fig.1E; Fig.2B,2G; Fig.3F, 3G; Fig.4B-C,E,H-J, M-N; Fig.6D; and Fig.7A-C, I.

      (d) Isogenic correction is partial. The corrected line is WT/P415R (single-allele correction); residual P415R complicates the interpretation of "full" rescue and leaves open whether the remaining pathology is due to incomplete correction or clonal/epigenetic effects.

      We attempted to generate an isogenic iPSC line by correcting both GBA1 mutations (L444P and P415R). However, this was not feasible because GBA1 overlaps with a highly homologous pseudogene (PGBA), which makes precise editing technically challenging. Consequently, only the L444P mutation was successfully corrected, and the resulting isogenic line retains the P415R mutation in a heterozygous state. Because Gaucher disease is an autosomal recessive disorder, individuals carrying a single GBA1 mutation (heterozygous carriers) do not develop clinical symptoms. Therefore, the partially corrected isogenic line, which retains only the P415R allele, represents a clinically relevant carrier model. Consistent with this, our results show that GCase activity was restored to approximately 50% of wild-type levels (Fig.4B-C), supporting the expected heterozygous state. These findings also make it unlikely that the remaining differences observed are due to clonal variation or epigenetic effects.

      (e) The authors tested week 3, 4, 8, 15, and 28 old organoids in different settings. However, systematic markers of maturation should be analyzed, and different maturation stages should be compared, for example, comparing week 8 organoids to week 28 organoids, with immunofluorescent marker staining and bulk RNAseq.

      We agree that a systematic analysis of maturation stages is essential for validating the MLO model. Our data integrated a longitudinal comparison across multiple developmental windows (Weeks 3 to 28) to characterize the transition from progenitors to mature/functional states for nGD phenotyping and evaluation of therapeutic modalities: 1) DA differentiation (Wks 3 and 8 in Fig. 3): qPCR analysis demonstrated the progression of DA-specific programs. We observed a steady increase in the mature DA neuron marker TH and ASCL1. This was accompanied by a gradual decrease in early floor plate/progenitor markers FOXA2 and PLZF, indicating a successful differentiation path from progenitors to differentiated/mature DA neurons. 2) Glycosphingolipid substrates accumulation (Wks 15 and 28 in Fig 2): To assess late-stage nGD phenotyping, we compared GluCer and GluSph at Week 15 and Week 28. This comparison highlights the progressive accumulation of substrates in nGD MLOs, reflecting the metabolic consequences of the disease at different mature stage. 3) Organoid growth dynamics (Wks 4, 8, and 15 in new Fig. 4): The new Fig. 4 tracks physical maturation through organoid size and growth rates across three key time points, providing a macro-scale verification of consistent development between WT and nGD groups. By comparing these early (Wk 3-8) and late (Wk 15-28) stages, we confirmed that our MLOs transition from a proliferative state to a post-mitotic, specialized neuronal state, satisfied the requirement for comparing distinct maturation stages.

      (f) The manuscript frequently refers to Wnt signaling dysregulation as a major finding. However, experimental validation is limited to transcriptomic data. Functional tests, such as the use of Wnt agonist/inhibitor, are needed to support this claim (see below).

      We agree that the suggested experiments could provide additional mechanistic insights into this study and will consider them in future work.

      (g) Suggested fixes / experiments

      Add at least one more independent disease hiPSC line (or show expanded analysis from GD2-10-257) for key mechanistic endpoints (lipid accumulation, transcriptomics, DA markers).

      Additional line iPSC GD2-10-257 derived MLO was included in the manuscript. This was addressed above [see response to Weaknesses (1)-a]. 

      Generate and analyze a fully corrected isogenic WT/WT clone (or a P415R-only line) if feasible; at minimum, acknowledge this limitation more explicitly and soften claims.

      We attempted to generate an isogenic iPSC line by correcting both GBA1 mutations (L444P and P415R). However, this was unsuccessful because the GBA1 gene overlaps with a pseudogene (PGBA) located 16 kb downstream of GBA1, which shares 96-98% sequence similarity with GBA1 (Ref#1, #2), which complicates precise editing. GBA1 is shorter (~5.7 kb) than PGBA (~7.6 kb). The primary exonic difference between GBA1 and PGBA is a 55-bp deletion in exon 9 of the pseudogene. As a result, the isogenic line we obtained carries only the P415R mutation, and L444P was corrected to the normal sequence. We have included this limitation in the Methods as “This gene editing strategy is expected to also target the GBA1 pseudogene due to the identical target sequence, which limits the gene correction on certain mutations (e.g., P415R)”. 

      References:

      (1) Horowitz M., Wilder S., Horowitz Z., Reiner O., Gelbart T., Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics (1989). 4, 87–96. doi:10.1016/0888-7543(89)90319-4

      (2) Woo EG, Tayebi N, Sidransky E. Next-Generation Sequencing Analysis of GBA1: The Challenge of Detecting Complex Recombinant Alleles. Front Genet. (2021). 12:684067. doi:10.3389/fgene.2021.684067. PMCID: PMC8255797.

      Report and increase independent differentiations (N = biological replicates) and present per-differentiation summary statistics.

      This was addressed above [see response to Weaknesses (1)-b, (1)-c]. 

      (2) Mechanistic validation is insufficient

      (a) RNA-seq pathways (Wnt, mTOR, lysosome) are not functionally probed. The manuscript shows pathway enrichment and some protein markers (p-4E-BP1) but lacks perturbation/rescue experiments to link these pathways causally to the DA phenotype.

      (b) Autophagy analysis lacks flux assays. LC3-II and LAMP1 are informative, but without flux assays (e.g., bafilomycin A1 or chloroquine), one cannot distinguish increased autophagosome formation from decreased clearance.

      (c) Dopaminergic dysfunction is superficially assessed. Dopamine in the medium and TH protein are shown, but no neuronal electrophysiology, synaptic marker co-localization, or viability measures are provided to demonstrate functional recovery after therapy.

      (d) Suggested fixes/experiments

      Perform targeted functional assays:

      (i) Wnt reporter assays (TOP/FOP flash) and/or treat organoids with Wnt agonists/antagonists to test whether Wnt modulation rescues DA differentiation.

      (ii) Test mTOR pathway causality using mTOR inhibitors (e.g., rapamycin) or 4E-BP1 perturbation and assay effects on DA markers and autophagy.

      Include autophagy flux assessment (LC3 turnover with bafilomycin), and measure cathepsin activity where relevant.

      Add at least one functional neuronal readout: calcium imaging, MEA recordings, or synaptic marker quantification (e.g., SYN1, PSD95) together with TH colocalization.

      We thank the reviewer for these valuable suggestions. We agree that the suggested experiments could provide additional mechanistic insights into this study and will consider them in future work. Importantly, the primary conclusions of our manuscript, that GBA1 mutations in nGD MLOs resulted in nGD pathologies such as diminished enzymatic function, accumulation of lipid substrates, widespread transcriptomic changes, and impaired dopaminergic neuron differentiation, which can be corrected by several therapeutic strategies in this study, are supported by the evidence presented. The suggested experiments represent an important direction for future research using brain organoids.

      (3) Therapeutic evaluation needs greater depth and standardization

      (a) Short windows and limited durability data. SapC-DOPS and AAV9 experiments range from 48 hours to 3 weeks; longer follow-up is needed to assess durability and whether biochemical rescue translates into restored neuronal function.

      We agree with the reviewer. Because this is a proof-of-principle study, the treatment was designed within a short time window. Long-term studies with more comprehensive outcome assessments will be conducted in future work.

      (b) Dose-response and biodistribution are under-characterized. AAV injection sites/volumes are described, but transduction efficiency, vg copies per organoid, cell-type tropism quantification, and SapC-DOPS penetration/distribution are not rigorously quantified.

      We appreciate the reviewer’s concerns. This study was intended to demonstrate the feasibility and initial response of MLOs to AAV therapy. A comprehensive evaluation of AAV biodistribution will be considered in future studies.

      The penetration and distribution of SapC-DOPS have been extensively characterized in prior studies. In vivo biodistribution of SapC–DOPS coupled CellVue Maroon, a fluorescent cargo, was examined in mice bearing human tumor xenografts using real-time fluorescence imaging, where CellVue Maroon fluorescence in tumor remained for 48 hours (Ref. #3: Fig. 4B, mouse 1), 100 hours (Ref. #4: Fig. 5), up to 216 hours (Ref. #5: Fig. 3). Uptake kinetics were also demonstrated in cells, with flow cytometry quantification showing that fluorescent cargo coupled SapC-DOPS nanovesicles, were incorporated into human brain tumor cell membranes within minutes and remained stably incorporated into the cells for up to one hour (Ref. # 6: Fig. 1a and Fig. 1b). Building on these findings, the present study focuses on evaluating the restoration of GCase function rather than reexamining biodistribution and uptake kinetics.

      References:

      (3) X. Qi, Z. Chu, Y.Y. Mahller, K.F. Stringer, D.P. Witte, T.P. Cripe. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein. Clin. Cancer Res. (2009) 15, 5840-5851. PMID: 19737950.

      (4) Z. Chu, S. Abu-Baker, M.B. Palascak, S.A. Ahmad, R.S. Franco, and X. Qi. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer. PLOS ONE (2013) 8, e75507. PMID: 24124494.

      (5) Z. Chu, K. LaSance, V.M. Blanco, C.-H. Kwon, B., Kaur, M., Frederick, S., Thornton, L., Lemen, and X. Qi. Multi-angle rotational optical imaging of brain tumors and arthritis using fluorescent SapC-DOPS nanovesicles. J. Vis. Exp. (2014) 87, e51187, 17. PMID: 24837630.

      (6) J. Wojton, Z. Chu, C-H. Kwon, L.M.L. Chow, M. Palascak, R. Franco, T. Bourdeau, S. Thornton, B. Kaur, and X. Qi. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma. Mol. Ther. (2013) 21, 1517-1525. PMID: 23732993.

      (c) Specificity controls are missing. For SapC-DOPS, inclusion of a non-functional enzyme control (or heat-inactivated fGCase) would rule out non-specific nanoparticle effects. For AAV, assessment of off-target expression and potential cytotoxicity is needed.

      Including inactive fGCase would confound the assessment of fGCase in MLOs by immunoblot and immunofluorescence; therefore, saposin C–DOPS was used as the control instead. 

      We agree that assessment of Off-target expression and potential cytotoxicity for AAV is important; this will be included in future studies.

      (d) Comparative efficacy lacking. It remains unclear which modality is most effective in the long term and in which cellular compartments.

      To address this comment, we have added a new table (Supplementary Table 2) comparing the four therapeutic modalities and summarizing their respective outcomes. While this study focused on short-term responses as a proof-of-principle, future work will explore long-term therapeutic effects. 

      (e) Suggested fixes/experiments

      Extend follow-up (e.g., 6+ weeks) after AAV/SapC dosing and evaluate DA markers, electrophysiology, and lipid levels over time.

      We appreciate the reviewer’s suggestions. The therapeutic testing in patient-derived MLOs was designed as a proof-of-principle study to demonstrate feasibility and the primary response (rescue of GCase function) to the treatment. A comprehensive, long-term therapeutic evaluation of AAV and SapC-DOPS-fGCase is indeed important for a complete assessment; however, this represents a separate therapeutic study and is beyond the scope of the current work.

      Quantify AAV transduction by qPCR for vector genomes and by cell-type quantification of GFP+ cells (neurons vs astrocytes vs progenitors).

      For the AAV-treated experiments, we agree that measuring AAV copy number and GFP expression would provide additional information. However, the primary goal of this study was to demonstrate the key therapeutic outcome, rescue of GCase function by AAV-delivered normal GCase, which is directly relevant to the treatment objective.

      Include SapC-DOPS control nanoparticles loaded with an inert protein and/or fluorescent cargo quantitation to show distribution and uptake kinetics.

      As noted above [see response to Weakness (3)-c], using inert GCase would confound the assessment of fGCase uptake in MLOs; therefore, it was not suitable for this study. See response above for the distribution and uptake kinetics of SapC-DOPS [see response to Weaknesses (3)-b].

      Provide head-to-head comparative graphs (activity, lipid clearance, DA restoration, and durability) with statistical tests.

      We have added a new table (Supplementary Table 2) providing a head-to-head comparison of the treatment effects. 

      (4) Model limitations not fully accounted for in interpretation

      (a) Absence of microglia and vasculature limits recapitulation of neuroinflammatory responses and drug penetration, both of which are important in nGD. These absences could explain incomplete phenotypic rescues and must be emphasized when drawing conclusions about therapeutic translation.

      We agree that the absence of microglia and vasculature in midbrain-like organoids represents a limitation, as we have discussed in the manuscript. In this revision, we highlighted this limitation in the Discussion section and clarified that it may contribute to incomplete phenotyping and phenotypic rescue observed in our therapeutic experiments. Additionally, we have outlined future directions to incorporate microglia and vascularization into the organoid system to better recapitulate the in vivo environment and improve translational relevance (see 7th paragraph in the Discussion).

      (b) Developmental vs degenerative phenotype conflation. Many phenotypes appear during differentiation (patterning defects). The manuscript sometimes interprets these as degenerative mechanisms; the distinction must be clarified.

      We appreciate the reviewer’s comments. In the revised manuscript, we have clarified that certain abnormalities, such as patterning defects observed during early differentiation, likely reflect developmental consequences of GBA1 mutations rather than degenerative processes. Conversely, phenotypes such as substrate accumulation, lysosomal dysfunction, and impaired dopaminergic maturation at later stages are interpreted as degenerative features. We have updated the Results and Discussion sections to avoid conflating developmental defects with neurodegenerative mechanisms.

      (c) Suggested fixes

      Tone down the language throughout (Abstract/Results/Discussion) to avoid overstatement that MLOs fully recapitulate nGD neuropathology.

      The manuscript has been revised to avoid overstatements.

      Add plans or pilot data (if available) for microglia incorporation or vascularization to indicate how future work will address these gaps.

      The manuscript now includes further plans to address the incorporation of microglia and vascularization, described in the last two paragraphs in the Discussion. Pilot study of microglia incorporation will be reported when it is completed.

      (5) Statistical and presentation issues

      (a) Missing or unclear sample sizes (n). For organoid-level assays, report the number of organoids and the number of independent differentiations.

      We have clarified biological replicates and differentiation in the figure legend [see response to Weaknesses (1)-b, (1)-c]. 

      (b) Statistical assumptions not justified. Tests assume normality; where sample sizes are small, consider non-parametric tests and report exact p-values.

      We have updated Statistical analysis in the methods as described below:

      “For comparisons between two groups, data were analyzed using unpaired two-tailed Student’s t-tests when the sample size was ≥6 per group and normality was confirmed by the Shapiro-Wilk test. When the normality assumption was not met or when sample sizes were small (n < 6), the non-parametric Mann-Whitney U test was used instead. For comparisons involving three or more groups, one-way ANOVA followed by Tukey’s multiple comparison test was applied when data were normally distributed; otherwise, the nonparametric Dunn’s multiple comparison test was used. Exclusion of outliers was made based on cut-offs of the mean ±2 standard deviations. All statistical analyses were performed using GraphPad Prism 10 software. Exact p-values are reported throughout the manuscript and figures where feasible. A p-value < 0.05 was considered statistically significant.”

      (c) Quantification scope. Many image quantifications appear to be from selected fields of view, which are then averaged across organoids and differentiations.

      In this work, quantitative immunofluorescence analyses (e.g., cell counts for FOXP1+, FOXG1+, SOX2+ and Ki67+ cells, as well as marker colocalization) were performed on at least 3–5 randomly selected non-overlapping fields of view (FOVs) per organoid section, with a minimum of 3 organoids per differentiation batch. Each FOV was imaged at consistent magnification (60x) and z-stack depth to ensure comparable sampling across conditions. Data from individual FOVs were first averaged within each organoid to obtain an organoid-level mean, and then biological replicates (independent differentiations, n ≥ 3) were averaged to generate the final group mean ± SEM. This multilevel averaging approach minimizes bias from regional heterogeneity within organoids and accounts for variability across differentiations. Representative confocal images shown in the figures were selected to accurately reflect the quantified data. We believe this standardized quantification strategy ensures robust and reproducible results while appropriately representing the 3D architecture of the organoids.

      In the revision, we have clarified the method used for image analysis of sectioned MLOs as below:

      “Quantitative immunofluorescence analyses (e.g., cell counts for FOXP1+, FOXG1+, SOX2+ and Ki67+ cells, as well as marker colocalization) were performed using ImageJ (NIH) on at least 3–5 randomly selected non-overlapping fields of view (FOVs) per organoid section, with a minimum of 3 organoids per differentiation batch. Each FOV was imaged at consistent magnification (60x) and z-stack depth to ensure comparable sampling across conditions. Data from individual FOVs were first averaged within each organoid to obtain an organoid-level mean, and then biological replicates (independent differentiations, n ≥ 3) were averaged to generate the final group mean ± SEM.”

      (d) RNA-seq QC and deposition. Provide mapping rates, batch correction details, and ensure the GEO accession is active. Include these in Methods/Supplement.

      RNA-seq data are from the same batch. The mapping rate is >90%. GEO accession will be active upon publication. These were included in the Methods.

      (e) Suggested fixes

      Add a table summarizing biological replicates, technical replicates, and statistical tests used for each figure panel.

      We have revised the figure legends to include replicates for each figure and statistical tests [see response in weaknesses (1)-b, (1)-c].

      Recompute statistics where appropriate (non-parametric if N is small) and report effect sizes and confidence intervals.

      Statistical analysis method is provided in the revision [see response in Weaknesses (5)-b].

      (6) Minor comments and clarifications

      (a) The authors should validate midbrain identity further with additional regional markers (EN1, OTX2) and show absence/low expression of forebrain markers (FOXG1) across replicates.

      We validated the MLO identity by 1) FOXG1 and 2) EN1. FOXG1 was barely detectable in Wk8 75.1_MLO but highly present in ‘age-matched’ cerebral organoid (CO), suggesting our culturing method is midbrain region-oriented. In nGD MLO, FOXG1 expression is significantly higher than 75.1_MLO, indicating that there was aberrant anterior-posterior brain specification, consistent with the transcriptomic dysregulation observed in our RNA-seq data.

      To further confirm midbrain identity, we examined the expression of EN1, an established midbrain-specific marker. Quantitative RT-PCR analysis demonstrated that EN1 expression increased progressively during differentiation in both WT-75.1 and nGD2-1260 MLOs at weeks 3 and 8 (Author response image 1). EN1 reached 34-fold and 373-fold higher levels than in WT-75.1 iPSCs at weeks 3 and 8, respectively, in WT-75.1 MLOs. In nGD MLOs, although EN1 expression showed a modest reduction at week 8, the levels were not significantly different from those observed in age-matched WT-75.1 MLOs (p > 0.05, ns).

      Author response image 1.

      qRT-PCR quantification of midbrain progenitor marker EN1 expression in WT-75.1 and GD2-1260 MLOs at Wk3 and Wk8. Data was normalized to WT-75.1 hiPSC cells and presented as mean ± SEM (n = 3-4 MLOs per group).ns, not significant.<br />

      (b) Extracellular dopamine ELISA should be complemented with intracellular dopamine or TH+ neuron counts normalized per organoid or per total neurons.

      We quantified TH expression at both the mRNA level (Fig. 3F) and the protein level (Fig. 3G/H) from whole-organoid lysates, which provides a more consistent and integrative measure across samples. These TH expression levels correlated well with the corresponding extracellular (medium) dopamine concentrations for each genotype. In contrast, TH⁺ neuron counts may not reliably reflect total cellular dopamine levels because the number of cells captured on each organoid section varies substantially, making normalization difficult. Measuring intracellular dopamine is an alternative approach that will be considered in future studies.

      (c) For CRISPR editing: the authors should report off-target analysis (GUIDE-seq or targeted sequencing of predicted off-targets) or at least in-silico off-target score and sequencing coverage of the edited locus. (off-target analysis (GUIDE-seq or targeted sequencing of predicted off-targets) or at least in-silico off-target score and sequencing coverage of the edited locus). 

      The off-target effect was analyzed during gene editing and the chance to target other off-targets is low due to low off-target scores ranked based on the MIT Specificity Score analysis. The related method was also updated as stated below:

      “The chance to target other Off-targets is low due to low Off-target scores ranked based on the MIT Specificity Score analysis (Hsu, P., Scott, D., Weinstein, J. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827–832 (2013).https://doi.org/10.1038/nbt.2647).”

      (d) It should be clarified as to whether lipidomics normalization is to total protein per organoid or per cell, and include representative LC-MS chromatograms or method QC.

      The normalization was to the protein of the organoid lysate. This was clarified in the Methods section in the revision as stated below:

      “The GluCer and GluSph levels in MLO were normalized to total MLO protein (mg) that were used for glycosphingolipid analyses. Protein mass was determined by BCA assay and glycosphingolipid was expressed as pmol/mg protein. Additionally, GluSph levels in the culture medium were quantified and normalized to the medium volume (pmol/mL).”

      Representative LC-MS chromatograms for both normal and GD MLOs have been included in a new figure, Supplementary Figure 2.

      (e) Figure legends should be improved in order to state the number of organoids, the number of differentiations, and the exact statistical tests used (including multiplecomparison corrections).

      This was addressed above [see response to Weaknesses (1)-b and (5)-b].

      (f) In the title, the authors state "reveal disease mechanisms", but the studies mainly exhibit functional changes. They should consider toning down the statement.

      The title was revised to: Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel Therapies

      (7) Recommendations

      This reviewer recommends a major revision. The manuscript presents substantial novelty and strong potential impact but requires additional experimental validation and clearer, more conservative interpretation. Key items to address are:

      (a) Strengthening genetic and biological replication (additional lines or replicate differentiations).

      This was addressed above [see response to Weaknesses (1)-a, (1)-b, (1)-c].

      (b) Adding functional mechanistic validation for major pathways (Wnt/mTOR/autophagy) and providing autophagy flux data.

      (c) Including at least one neuronal functional readout (calcium imaging/MEA/patch) to demonstrate functional rescue.

      As addressed above [see response to Weaknesses (2)], the suggested experiments in b) and c) would provide additional insights into this study and we will consider them in future work. 

      (d) Deepening therapeutic characterization (dose, biodistribution, durability) and including specificity controls.

      This was addressed above [see response to Weaknesses (3)-a to e].

      (e) Improving statistical reporting and explicitly stating biological replicate structure.

      This was addressed above [see response to Weaknesses (1)-b, (5)-b].

      Reviewer #2 (Public review):

      Sun et al. have developed a midbrain-like organoid (MLO) model for neuronopathic Gaucher disease (nGD). The MLOs recapitulate several features of nGD molecular pathology, including reduced GCase activity, sphingolipid accumulation, and impaired dopaminergic neuron development. They also characterize the transcriptome in the MLO nGD model. CRISPR correction of one of the GBA1 mutant alleles rescues most of the nGD molecular phenotypes. The MLO model was further deployed in proof-of-principle studies of investigational nGD therapies, including SapC-DOPS nanovesicles, AAV9-mediated GBA1 gene delivery, and substrate-reduction therapy (GZ452). This patient-specific 3D model provides a new platform for studying nGD mechanisms and accelerating therapy development. Overall, only modest weaknesses are noted.

      We thank the reviewer for the supportive remarks.

      Reviewer #3 (Public review):

      Summary:

      In this study, the authors describe modeling of neuronopathic Gaucher disease (nGD) using midbrain-like organoids (MLOs) derived from hiPSCs carrying GBA1 L444P/P415R or L444P/RecNciI variants. These MLOs recapitulate several disease features, including GCase deficiency, reduced enzymatic activity, lipid substrate accumulation, and impaired dopaminergic neuron differentiation. Correction of the GBA1 L444P variant restored GCase activity, normalized lipid metabolism, and rescued dopaminergic neuronal defects, confirming its pathogenic role in the MLO model. The authors further leveraged this system to evaluate therapeutic strategies, including: (i) SapC-DOPS nanovesicles for GCase delivery, (ii) AAV9-mediated GBA1 gene therapy, and (iii) GZ452, a glucosylceramide synthase inhibitor. These treatments reduced lipid accumulation and ameliorated autophagic, lysosomal, and neurodevelopmental abnormalities.

      Strengths:

      This manuscript demonstrates that nGD patient-derived MLOs can serve as an additional platform for investigating nGD mechanisms and advancing therapeutic development.

      Comments:

      (1) It is interesting that GBA1 L444P/P415R MLOs show defects in midbrain patterning and dopaminergic neuron differentiation (Figure 3). One might wonder whether these abnormalities are specific to the combination of L444P and P415R variants or represent a 

      general consequence of GBA1 loss. Do GBA1 L444P/RecNciI (GD2-10-257) MLOs also exhibit similar defects?

      We observed reduced dopaminergic neuron marker TH expression in GBA1 L444P/RecNciI (GD2-10-257) MLOs, suggesting that this line also exhibits defects in dopaminergic neuron differentiation. These data are provided in a new Supplementary Fig. 4E, and are summarized in new Supplementary Table 2 in the revision.

      (2) In Supplementary Figure 3, the authors examined GCase localization in SapC-DOPSfGCase-treated nGD MLOs. These data indicate that GCase is delivered to TH⁺ neurons, GFAP⁺ glia, and various other unidentified cell types. In fruit flies, the GBA1 ortholog, Gba1b, is only expressed in glia (PMID: 35857503; 35961319). Neuronally produced GluCer is transferred to glia for GBA1-mediated degradation. These findings raise an important question: in wild-type MLOs, which cell type(s) normally express GBA1? Are they dopaminergic neurons, astrocytes, or other cell types?

      All cell types in wild-type MLOs are expected to express GBA1, as it is a housekeeping gene broadly expressed across neurons, astrocytes, and other brain cell types. Its lysosomal function is essential for cellular homeostasis and is therefore not restricted to any specific lineage. (https://www.proteinatlas.org/ENSG00000177628GBA1/brain/midbrain). 

      (3) The authors may consider switching Figures 2 and 3 so that the differentiation defects observed in nGD MLOs (Figure 3) are presented before the analysis of other phenotypic abnormalities, including the various transcriptional changes (Figure 2).

      We appreciate the reviewer’s suggestion; however, we respectfully prefer to retain the current order of Figures 2 and 3, as we believe this structure provides the clearest narrative flow. Figure 2 establishes the core biochemical hallmarks: reduced GCase activity, substrate accumulation, and global transcriptomic dysregulation (1,429 DEGs enriched in neural development, WNT signaling, and lysosomal pathways), which together provide essential molecular context for studying the specific cellular differentiation defects presented in Figure 3. Presenting the broader disease landscape first creates a coherent mechanistic link to the subsequent analyses of midbrain patterning and dopaminergic neuron impairment.

      To enhance readability, we have added a brief transitional sentence at the start of the Figure 3 paragraph: “Building on the molecular and transcriptomic hallmarks of GCase deficiency observed in nGD MLOs (Figure 2), we next investigated the impact on midbrain patterning and dopaminergic neuron differentiation (Figure 3).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public reviews:

      (1) Stable annual dynamics vs. episodic outbreaks

      We agree that RVF is classically described as producing periodic epidemics interspersed with long inter-epidemic periods, often linked to extreme rainfall events. Our model predicts more regular seasonal dynamics, which reflects the endemic transmission patterns we have observed in The Gambia through serological surveys. In this revision, we have:

      - clarified that while epidemics occur in other parts of sub-Saharan Africa, our results are consistent with the epidemiological narrative of RVF in The Gambia, characterised by sustained, moderate transmission without resulting in substantial outbreaks (hyperendemicity).

      - discussed how model assumptions (e.g. seasonality, homogenous mixing) may bias our results toward an endemic quasi-equilibrium dynamic.

      - highlighted the implications of this for interpretation and for public health decision-making.

      (2) Use of network analysis

      We acknowledge the reviewer’s concern. The network analysis was conducted descriptively to characterize cattle movement patterns and the structure of herd connections, but it was not formally incorporated into the model. In this revision we have:

      - clarified this distinction in the manuscript to avoid overinterpretation.

      - emphasized the need for future modelling work using finer-scale movement data, which could support more realistic herd metapopulation dynamics and better capture heterogeneity in transmission.

      (3) RVFV reproductive impacts

      While RVF outbreaks are known to cause substantial abortions and neonatal deaths, these events occur during sporadic epidemics. In the Gambian context, where we’re not observing large outbreaks but rather low-level circulation, the annual impact of RVF infection on births is likely modest compared to baseline herd turnover. Moreover, cattle demography is partly managed, with replacement and movement buffering birth rates against short-term losses.

      Our model includes birth as a constant demographic process, it’s reasonable to assume stable population since we are not explicitly modelling outbreak-scale reproductive losses. This approach is consistent with other RVF transmission models that adopt a similar simplifying assumption. However, we have acknowledged this simplification as a limitation in the revised manuscript.

      (4) Missing ODEs for M herds in the dry season

      We thank the reviewer for identifying this omission. The ODEs for the M subpopulation in the dry season were not included in the appendix due to an oversight, though demographic turnover was implemented in the model code. We have now added the missing equations to the appendix.

      (5) Role of immunity loss and model structure (SIR vs. SIRS)

      We acknowledge that the decline of detectable antibodies over time (seropositivity decay) is an important consideration in RVFV serology; however, whether this decline reflects a true loss of protective immunity following natural infection remains unknown. Available evidence suggests that infected cattle likely develop long-lasting immunity, and findings in humans further support this assumption, although longitudinal field data regarding RVFV-specific antibody durability in animals are not available to the best of our knowledge. From a modelling perspective, our objective was to estimate FOI and use it to predict an age-seroprevalence curve consistent with the observed cross-sectional age-seroprevalence patterns. We therefore adopted a parsimonious SIR framework, interpreting loss of seropositivity as a potential explanation for discrepancies between observed and predicted age-seroprevalence rather than explicitly modelling waning immunity. We have now:

      - clarified this rationale, emphasising that there is no direct evidence for waning immunity following natural RVFV infection in cattle, although evidence of seropositivity decay has been suggested in human.

      - highlighted that while an SEIS/SIRS framework could theoretically generate different long-term dynamics, evaluating this approach requires stronger evidence for true immunity loss.

      (6) RVFV induced mortality in serocatalytic model

      We thank the reviewer for this comment and for raising an important conceptual point. However, the force of infection in our study is not estimated using a serocatalytic framework. Instead, FOI is estimated mechanistically within the transmission model as a function of the number of infectious cattle, rather than from age-stratified seroprevalence data.

      RVF-induced mortality is accounted for through its effect on the infectious compartment, where increased mortality reduces the number and duration of infectious cattle and therefore indirectly reduces FOI. Consequently, RVF-related cattle death does not need to be explicitly incorporated into the FOI expression itself. Seroreversion similarly does not influence FOI estimation under this modelling framework. We have clarified this distinction in the Methods section to avoid confusion between mechanistic transmission models and serocatalytic approaches.

      (7) Clarifying previous vs. current study components

      We have revised the Methods and Appendix to make clearer distinctions between our previous work (e.g. household survey data collection, seroprevalence estimates) and the analyses undertaken for this manuscript (e.g. model development and fitting).

      (8) Limitations paragraph

      We have expanded the limitations section to identify the sparse household movement data as contributing most to uncertainty. We have outlined how these limitations may have implications for our conclusions, and may lead to under- or over-estimation of periods of heightened transmission risk.

      (9) Movement ban simulations & suitability of model for vaccination interventions

      We appreciate the reviewer’s concerns regarding the movement ban simulation. On reassessment, we agree that our model structure might not ideally be suited to exploring a movement ban. In this revised manuscript, we have removed this analysis. We are currently developing separate work focused on RVF vaccination strategies in cattle, where this model structure might be more directly applicable, and will reserve a deeper investigation of vaccination interventions for that forthcoming publication.

      Reviewer #1 (Recommendations for the authors):

      We thank the reviewer for the recommendations regarding the Introduction, Methods, Results, and Supplementary Figures. We have addressed these points below and revised the manuscript accordingly.

      (1) Introduction: Should avoid describing as "inaccessible" the regions that are inhabited by nomadic and transhumant pastoralists.

      We have revised the wording to “hard-to-reach” regions.

      (2) Methods: Can the authors state what share of the animals included in the household survey data were cattle as opposed to other small ruminants? It would be helpful to understand what share of the data is "excluded"

      We have now included the total number of cattle sampled, providing clarity on the proportion of data used in the analyses.

      (3) Methods: When introducing the deterministic model, it seems unnecessary to mention the initialization conditions (i.e., introduction of a single infected individual at time 0) when this is later repeated in the Estimation of model parameters section, where it seems simulations were first conducted.

      We have removed the redundant description.

      (4) Results: Could the negative correlation between geographic distance of connected herds and mean seroprevalence simply indicate proximal exposure rather than common risk factors?

      We acknowledge that both mechanisms are plausible. RVFV transmission is strongly influenced by share environmental factors that shape mosquito dynamics; however, direct transmission between proximal cattle herds may also occur through close contact with infectious tissues, bodily fluids, or contaminated materials. We have clarified this interpretation in the Results section.

      (5) Figure S5: inconsistent notation for the scaling factor parameter (tau), which is expressed in equations and tables as psi.

      We thank the reviewer for identifying this issue and have corrected all instances to ensure consistent use of tau throughout the manuscript.

      (6) Figure S6: Why a density plot, isn't the number of temporary extinctions (x-axis) discrete?

      We have replaced the density plot with a bar plot in Figure S6.

    1. Author response:

      eLife Assessment

      This useful study examines whether the sugar trehalose, coordinates energy supply with the gene programs that build muscle in the cotton bollworm (Helicoverpa armigera). The evidence for this currently is incomplete. The central claim - that trehalose specifically regulates an E2F/Dp-driven myogenic program - is not supported by the specificity of the data: perturbations and sequencing are systemic, alternative explanations such as general energy or amino-acid scarcity remain plausible, and mechanistic anchors are also limited. The work will interest researchers in insect metabolism and development; focused, tissue-resolved measurements together with stronger mechanistic controls would substantially strengthen the conclusions.

      We thank the reviewer for the thoughtful and constructive evaluation of our work and for recognizing its potential relevance to researchers working on insect metabolism and development. We fully agree that our current evidence is preliminary and that the mechanistic link between trehalose and the E2F/Dp‑driven myogenic program needs to be strengthened.

      Our intention was to present trehalose-E2F/Dp coupling as a working model emerging from our data, rather than as a fully established pathway. We agree that systemic manipulations of trehalose and whole‑larval RNA‑seq cannot fully differentiate global metabolic stress from specific effects on myogenic programs. In the revision, we plan to include additional metabolic readouts (e.g., ATP/AMP ratio, key amino acids where available) to better discuss the overall energetic and nutritional state. We will reanalyze our RNA‑seq data to more clearly distinguish broad stress/metabolic signatures from cell‑cycle/myogenic signatures. Furthermore, we will reframe our discussion to explicitly state that we cannot completely rule out a contribution of general energy or amino‑acid scarcity at this stage.

      We acknowledge that, with our current experiments, the specificity for an E2F/Dp‑driven program is inferred mainly from enrichment of E2F targets among differentially expressed genes, and expression changes in canonical E2F partners and downstream cell‑cycle/myogenic regulators. To address this more rigorously, we are performing targeted qRT-PCR for a panel of well‑characterized E2F/Dp target genes and myogenic markers in larval muscle versus non‑muscle tissues, following trehalose perturbation. Where technically feasible, testing whether partial knockdown of HaE2F or HaDp modifies the effect of trehalose manipulation on selected myogenic markers. These data, even if limited, will help to provide a more direct functional link, and we will include them in the manuscript if completed in time. In parallel, we will soften statements that imply a fully established, trehalose‑specific regulation of E2F/Dp and instead present this as a strong candidate pathway suggested by the current data.

      We fully agree that tissue‑resolved analyses are essential to move from systemic correlations to causality in muscle. We are in the process of standardizing larval muscle dissections and isolating thoracic/abdominal body wall muscle for trehalose, glycogen, and expression assays. Comparing expression of key metabolic and myogenic genes in muscle versus fat body and midgut, under trehalose manipulation. These tissue‑resolved data will directly address whether the transcriptional changes we report are preferentially localized to muscle.

      We are grateful for the reviewer’s critical but encouraging comments. We will moderate our central claims, also explicitly consider and discuss alternative explanations. Further, we will add tissue‑resolved and more focused mechanistic data as far as possible within the current revision. We believe these changes will substantially strengthen the manuscript and better align our conclusions with the evidence we presently have.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this work by Mohite et al., they have used transcriptomic and metabolic profiling of H. armigera, muscle development, and S. frugiperda to link energy trehalose metabolism and muscle development. They further used several different bioinformatics tools for network analysis to converge upon transcriptional control as a potential mechanism of metabolite-regulated transcriptional programming for muscle development. The authors have also done rescue experiments where trehalose was provided externally by feeding, which rescues the phenotype. Though the study is exciting, there are several concerns and gaps that lead to the current results as purely speculative. It is difficult to perform any genetic experiments in non-model insects; the authors seem to suggest a similar mechanism could also be applicable in systems like Drosophila; it might be possible to perform experiments to fill some missing mechanistic details.

      A few specific comments below:

      The authors used N-(phenylthio) phthalimide (NPP), a trehalose-6-phosphate phosphatase (TPP) inhibitor. They also find several genes, including enzymes of trehalose metabolism, that change. Further, several myogenic genes are downregulated in bulk RNA sequencing. The major caveat of this experiment is that the NPP treatment leads to reduced muscle development, and so the proportion of the samples from the muscles in bulk RNA sequencing will be relatively lower, which might have led to the results. So, a confirmatory experiment has to be performed where the muscle tissues are dissected and sequenced, or some of the interesting targets could be validated by qRT-PCR. Further to overcome the off-target effects of NPP, trehalose rescue experiments could be useful.

      Thank you for this valuable comment. We will validate the gene expression data using qRT-PCR on muscle tissue samples from both treated and control groups. This will help determine whether the gene expression patterns observed in the RNA-seq data are muscle-specific or systemic.

      Even the reduction in the levels of ADP, NAD, NADH, and NMN, all of which are essential for efficient energy production and utilization, could be due to the loss of muscles, which perform predominantly metabolic functions due to their mitochondria-rich environment. So it becomes difficult to judge if the levels of these energy molecules' reduction are due to a cause or effect.

      We thank the reviewer for this thoughtful comment and agree that reduced levels of ADP, NAD, NADH, and NMN could arise either from a disturbance of energy metabolism or from loss of mitochondria‑rich muscles. Our current data cannot fully separate these two possibilities. Still, several studies support the interpretation that perturbing trehalose metabolism causes a primary systemic energy deficit that is coupled to mitochondrial function, not merely a passive consequence of tissue loss.

      For example:

      (1) Our previous study in H. armigera showed that chemical inhibition of trehalose synthesis results in depletion of trehalose, glucose, glucose‑6‑phosphate, and suppression of the TCA cycle, indicating reduced energy levels and dysregulated fatty‑acid oxidation (Tellis et al., 2023).

      (2) Chang et al. (2022) showed that trehalose catabolism and mitochondrial ATP production are mechanistically linked. HaTreh1 localizes to mitochondria and physically interacts with ATP synthase subunit α. 20‑hydroxyecdysone increases HaTreh1 expression, enhances its binding to ATP synthase, and elevates ATP content, while knockdown of HaTreh1 or HaATPs‑α reduces ATP levels.

      (3) Similarly, our previous study inhibition of Treh activity in H. armigera generates an “energy‑deficient condition” characterized by deregulation of carbohydrate, protein, fatty‑acid, and mitochondria‑related pathways, and a concomitant reduction in key energy metabolites (Tellis et al., 2024).

      (4) The starvation study in H. armigera has shown that reduced hemolymph trehalose is associated with respiratory depression and large‑scale reprogramming of glycolysis and fatty‑acid metabolism (Jiang et al., 2019).

      These findings support a direct coupling between trehalose availability and systemic energy/redox state. Therefore, the coordinated decrease in ADP, NAD, NADH, and NMN following TPS/TPP silencing is consistent with a primary disturbance of systemic energy and mitochondrial metabolism rather than exclusively a secondary consequence of muscle loss. We agree, however, that the present whole‑larva metabolite measurements do not allow a quantitative partitioning between changes due to altered muscle mass and those due to intrinsic metabolic impairment at the cellular level. Thus, tissue-specific quantification of these metabolites would allow us to directly test whether altered energy metabolites are a cause or consequence of muscle loss.

      References:

      (1) Tellis, M. B., Mohite, S. D., Nair, V. S., Chaudhari, B. Y., Ahmed, S., Kotkar, H. M., & Joshi, R. S. (2024). Inhibition of Trehalose Synthesis in Lepidoptera Reduces Larval Fitness. Advanced Biology, 8(2), 2300404.

      (2) Chang, Y., Zhang, B., Du, M., Geng, Z., Wei, J., Guan, R., An, S. and Zhao, W., 2022. The vital hormone 20-hydroxyecdysone controls ATP production by upregulating the binding of trehalase 1 with ATP synthase subunit α in Helicoverpa armigera. Journal of Biological Chemistry, 298(2).

      (3) Tellis, M., Mohite, S. and Joshi, R., 2024. Trehalase inhibition in Helicoverpa armigera activates machinery for alternate energy acquisition. Journal of Biosciences, 49(3), p.74.

      (4) Jiang, T., Ma, L., Liu, X.Y., Xiao, H.J. and Zhang, W.N., 2019. Effects of starvation on respiratory metabolism and energy metabolism in the cotton bollworm Helicoverpa armigera (Hübner)(Lepidoptera: Noctuidae). Journal of Insect Physiology, 119, p.103951.

      The authors have used this transcriptomic data for pathway enrichment analysis, which led to the E2F family of transcription factors and a reduction in the level of when trehalose metabolism is perturbed. EMSA experiments, though, confirm a possibility of the E2F interaction with the HaTPS/TPP promoter, but it lacks proper controls and competition to test the actual specificity of this interaction. Several transcription factors have DNA-binding domains and could bind any given DNA weakly, and the specificity is ideally known only from competitive and non-competitive inhibition studies.

      We thank the reviewer for this important comment and fully agree that EMSA alone, without appropriate competition and control reactions, cannot establish the specificity or functional relevance of a transcription factor-DNA interaction. In our study, we found the E2F family from GRN analysis of the RNA seq data obtained upon HaTPS/TPP silencing, suggesting a potential regulatory connection. After that, we predicted E2F binding sites on the promoter of HaTPS/TPP. The EMSA experiments were intended as preliminary evidence that E2F can associate with the HaTPS/TPP promoter in vitro. We will clarify this in the manuscript by softening our conclusion to indicate that our data support a “possible E2F-HaTPS/TPP interaction”. We also perform EMSA with specific and non‑specific competitors to confirm the E2F binding to the HaTPS/TPP promoter.

      The work seems to have connected the trehalose metabolism with gene expression changes, though this is an interesting idea, there are no experiments that are conclusive in the current version of the manuscript. If the authors can search for domains in the E2F family of transcription factors that can bind to the metabolite, then, if not, a chip-seq is essential to conclusively suggest the role of E2F in regulating gene expression tuned by the metabolites.

      A previous study in D. melanogaster, Zappia et al., (2016) showed vital role of E2F in skeletal muscle required for animal viability. They have shown that Dp knockdown resulted in reduced expression of genes encoding structural and contractile proteins, such as Myosin heavy chain (Mhc), fln, Tropomyosin 1 (Tm1), Tropomyosin 2 (Tm2), Myosin light chain 2 (Mlc2), sarcomere length short (sals) and Act88F, and myogenic regulators, such as held out wings (how), Limpet (Lmpt), Myocyte enhancer factor 2 (Mef2) and spalt major (salm). Also, ChiP-qRT-PCR showed upstream regions of myogenic genes, such as how, fln, Lmpt, sals, Tm1 and Mef2, were specifically enriched with E2f1, E2f2, and Dp antibodies in comparison with a nonspecific antibody. Further, Zappia et al. (2019) reported a chip-seq dataset that suggests that E2F/Dp directly activates the expression of glycolytic and mitochondrial genes during muscle development. Zappia et al., (2023) showed the regulation of one of the glycolytic genes, Phosphoglycerate kinase (Pgk) by E2F during Drosophila development.

      However, the regulation of trehalose metabolic genes by E2F/Dp and vice versa was not studied previously. So here in our study, we tried to understand the correlation of trehalose metabolism and E2F/Dp in the muscle development of H. armigera.

      References:

      (1) Zappia, M.P. and Frolov, M.V., 2016. E2F function in muscle growth is necessary and sufficient for viability in Drosophila. Nature Communications, 7(1), p.10509.

      (2) Zappia, M.P., Rogers, A., Islam, A.B. and Frolov, M.V., 2019. Rbf activates the myogenic transcriptional program to promote skeletal muscle differentiation. Cell reports, 26(3), pp.702-719.

      (3) Zappia, M. P., Kwon, Y.-J., Westacott, A., Liseth, I., Lee, H. M., Islam, A. B., Kim, J., & Frolov, M. V. (2023a). E2F regulation of the Phosphoglycerate kinase gene is functionally important in Drosophila development. Proceedings of the National Academy of Sciences, 120(15), e2220770120.

      Some of the above concerns are partially addressed in experiments where silencing of E2F/Dp shows similar phenotypes as with NPP and dsRNA. It is also notable that silencing any key transcription factor can have several indirect effects, and delayed pupation and lethality could not be definitely linked to trehalose-dependent regulation.

      Yes. It’s true that silencing of any key transcription factor can have several indirect effects. Our intention was not to argue that delayed pupation and lethality are exclusively due to trehalose-dependent regulation, but that E2F/Dp and HaTPS/TPP silencing showed a consistent set of phenotypes and molecular changes, such as (i) transcriptomic enrichment of E2F targets upon trehalose perturbation, (ii) reduced HaTPS/TPP expression following E2F/Dp silencing, (iii) reduced myogenic gene expression that parallels the phenotypes observed with HaTPS/TPP silencing and (iv) restoration of E2F and Dp expression in E2F/Dp‑silenced insects upon trehalose feeding in the rescue assay. Together, these findings support a functional association between E2F/Dp and trehalose homeostasis. At the same time, we fully acknowledge that these results do not exclude additional, trehalose‑independent roles of E2F/Dp in development.

      Trehalose rescue experiments that rescue phenotype and gene expression are interesting. But is it possible that the fed trehalose is metabolized in the gut and might not reach the target tissue? In which case, the role of trehalose in directly regulating transcription factors becomes questionable. So, a confirmatory experiment is needed to demonstrate that the fed trehalose reaches the target tissues. This could possibly be done by measuring the trehalose levels in muscles post-rescue feeding. Also, rescue experiments need to be done with appropriate control sugars.

      Yes, it’s possible that, to some extent, trehalose is metabolized in the gut. Even though trehalase is present in the insect gut, some of the trehalose will be absorbed via trehalose transporters on the gut lining. Trehalose feeding was not rescued in insects fed with the control diet (empty vector and dsHaTPP), which contains chickpea powder, which is composed of an ample amount of amino acids and carbohydrates. Insects fed exclusively on a trehalose-containing diet are rescued, but not on a control diet that contains other carbohydrates. We agree that direct measurement of trehalose in target tissues will provide important confirmation. In the manuscript, we will measure trehalose levels in muscle, gut, and haemolymph after trehalose feeding.

      No experiments are performed with non-target control dsRNA. All the experiments are done with an empty vector. But an appropriate control should be a non-target control.

      Yes, there was no experiment with non-target dsRNA. Earlier, we have optimized a protocol for dsRNA delivery and its effectiveness in target knockdown (concentration, time) experiment, and published several research articles using a similar protocol:

      (1) Chaudhari, B.Y., Nichit, V.J., Barvkar, V.T. and Joshi, R.S., 2025. Mechanistic insights in the role of trehalose transporter in metabolic homeostasis in response to dietary trehalose. G3: Genes, Genomes, Genetics, p. jkaf303.

      (2) Barbole, R.S., Sharma, S., Patil, Y., Giri, A.P. and Joshi, R.S., 2024. Chitinase inhibition induces transcriptional dysregulation altering ecdysteroid-mediated control of Spodoptera frugiperda development. Iscience, 27(3).

      (3) Patil, Y.P., Wagh, D.S., Barvkar, V.T., Gawari, S.K., Pisalwar, P.D., Ahmed, S. and Joshi, R.S., 2025. Altered Octopamine synthesis impairs tyrosine metabolism affecting Helicoverpa armigera vitality. Pesticide Biochemistry and Physiology, 208, p.106323.

      (4) Tellis, M.B., Chaudhari, B.Y., Deshpande, S.V., Nikam, S.V., Barvkar, V.T., Kotkar, H.M. and Joshi, R.S., 2023. Trehalose transporter-like gene diversity and dynamics enhances stress response and recovery in Helicoverpa armigera. Gene, 862, p.147259.

      (5) Joshi, K.S., Barvkar, V.T., Hadapad, A.B., Hire, R.S. and Joshi, R.S., 2025. LDH-dsRNA nanocarrier-mediated spray-induced silencing of juvenile hormone degradation pathway genes for targeted control of Helicoverpa armigera. International Journal of Biological Macromolecules, p.148673.

      The same vector backbone and preparation procedures were used for both control and experimental constructs, allowing us to specifically compare the effects of the target dsRNA. The phenotypes and gene expression changes we observed were specific to the target genes and were not seen in the empty vector controls, suggesting that the effects are not due to nonspecific responses of dsRNA delivery or vector components.<br /> We acknowledge your suggestions, and in future studies, we will keep non-target dsRNA as a control in silencing assays.

      Reviewer #2 (Public review):

      Summary:

      This study shows that the knockdown of the effects of TPS/TPP in Helicoverpa armigera and Spodoptera frugiperda can be rescued by trehalose treatment. This suggests that trehalose metabolism is necessary for development in the tissues that NPP and dsRNA can reach.

      Strengths:

      This study examines an important metabolic process beyond model organisms, providing a new perspective on our understanding of species-specific metabolism equilibria, whether conserved or divergent.

      Weaknesses:

      While the effects observed may be truly conserved across Lepidopterans and may be muscle-specific, the study largely relies on one species and perturbation methods that are not muscle-specific. The technical limitations arising from investigations outside model systems, where solid methods are available, limit the specificity of inferences that may be drawn from the data.

      Thank you for this potting out this experimental weakness. We will validate the gene expression data using qRT-PCR on muscle tissue samples from both treated and control groups. We will also perform metabolite analysis with muscle samples. This will help to determine whether the observed gene expression patterns and metabolite changes are muscle-specific or systemic.

      Reviewer #3 (Public review):

      The hypothesis is that Trehalose metabolism regulates transcriptional control of muscle development in lepidopteran insects.

      The manuscript investigates the role of Trehalose metabolism in muscle development. Through sequencing and subsequent bioinformatics analysis of insects with perturbed trehalose metabolism (knockdown of TPS/TPP), the authors have identified transcription factor E2F, which was validated through RT-PCR. Their hypothesis is that trehalose metabolism regulates E2F, which then controls the myogenic genes. Counterintuitive to this hypothesis, the investigators perform EMSAs with the E2F protein and promoter of the TPP gene and show binding. Their knockdown experiments with Dp, the binding partner of E2F, show direct effect on several trehalose metabolism genes. Similar results are demonstrated in the trehalose feeding experiment, where feeding trehalose leads to partial rescue of the phenotype observed as a result of Dp knockdown. This seems contradictory to their hypothesis. Even more intriguing is a similar observation between paramyosin, a structural muscle protein, and E2F/Dp - they show that paramyosin regulates E2F/Dp and E2F/Dp regulated paramyosin. The only plausible way to explain the results is the existence of a feed-forward loop between TPP-E2F/Dp and paramyosin-E2F/Dp. But the authors have mentioned nothing in this line. Additionally, I think trehalose metabolism impacts amino acid content in insects, and that will have a direct bearing on muscle development. The sequencing analysis and follow-up GSEA studies have demonstrated enrichment of several amino acid biosynthetic genes. Yet authors make no efforts to measure amino acid levels or correlate them with muscle development. Any study aiming to link trehalose metabolism and muscle development and not considering the above points will be incomplete.

      We appreciate the reviewer’s efforts in the careful evaluation of this manuscript and constructive comments. From our and earlier data we found it was difficult to consider linear pathway “trehalose → E2F → muscle,” but rather a regulatory module in which trehalose metabolism and E2F/Dp form an interdependent circuit controlling myogenic genes. E2F/Dp binds and activates trehalose metabolism genes (TPS/TPP, Treh1) and myogenic structural genes, consistent with EMSA (TPS/TPP-E2F) and predicted binding sites of E2F on metabolic genes, Treh1, Pgk, and myogenic genes such as Act88F, Prm, Tm1, Fln, etc. At the same time, perturbing trehalose synthesis reduces E2F/Dp expression and myogenic gene expression, and trehalose feeding partially restores all three. This bidirectional influence is similar to E2F‑dependent control of carbohydrate metabolism and systemic sugar homeostasis described in D. melanogaster, where E2F/Dp both regulates metabolic genes and is itself constrained by metabolic state (Zappia et al., 2023a; Zappia et al., 2021).

      The reciprocal regulation between Prm and E2F/Dp is indeed intriguing. Rather than a paradox, we interpret this as evidence that E2F/Dp couples metabolic genes and structural muscle genes within a shared module, and that key sarcomeric components (such as paramyosin) feed back on this transcriptional program. Similar cross‑talk between E2F‑controlled metabolic programs and tissue function has been documented in D. melanogaster muscle and fat body, where E2F loss in one tissue elicits systemic changes in the other (Zappia et al., 2021). For further confirmation of E2F-regulated Prm, we will perform EMSA on the Prm promoter with appropriate controls.

      We fully agree that amino‑acid metabolism is a critical missing piece. In the manuscript, we will quantify the amino acid levels and include the results: “Amino acids display differential levels showing cysteine, leucine, histidine, valine, and proline showed significant reductions, while isoleucine and lysine showed non-significant reductions upon trehalose metabolism perturbation. These results are consistent with previous reports published by Tellis et al. (2024) and Shi et al. (2016)”. We will reframe our conclusions more cautiously as establishing a trehalose-E2F/Dp-muscle development, while stating that “definitive causal links via amino‑acid metabolism remain to be demonstrated”.

      Reference:

      (1) Zappia, M. P., Kwon, Y.-J., Westacott, A., Liseth, I., Lee, H. M., Islam, A. B., Kim, J., & Frolov, M. V. (2023a). E2F regulation of the Phosphoglycerate kinase gene is functionally important in Drosophila development. Proceedings of the National Academy of Sciences, 120(15), e2220770120.

      (2) Zappia, M.P., Guarner, A., Kellie-Smith, N., Rogers, A., Morris, R., Nicolay, B., Boukhali, M., Haas, W., Dyson, N.J. and Frolov, M.V., 2021. E2F/Dp inactivation in fat body cells triggers systemic metabolic changes. elife, 10, p.e67753.

      (3)Tellis, M., Mohite, S. and Joshi, R., 2024. Trehalase inhibition in Helicoverpa armigera activates machinery for alternate energy acquisition. Journal of Biosciences, 49(3), p.74.

      (4) Shi, J.F., Xu, Q.Y., Sun, Q.K., Meng, Q.W., Mu, L.L., Guo, W.C. and Li, G.Q., 2016. Physiological roles of trehalose in Leptinotarsa larvae revealed by RNA interference of trehalose-6-phosphate synthase and trehalase genes. Insect Biochemistry and Molecular Biology, 77, pp.52-68.

      Author response image 1.

      The result section of the manuscript is quite concise, to my understanding (especially the initial few sections), which misses out on mentioning details that would help readers understand the paper better. While technical details of the methods should be in the Materials and Methods section, the overall experimental strategy for the experiments performed should be explained in adequate detail in the results section itself or in figure legends. I would request authors to include more details in the results section. As an extension of the comment above, many times, abbreviations have been used without introducing them. A thorough check of the manuscript is required regarding this.

      Thank you very much for pointing out this issue. We will revise the manuscript content according to these suggestions.

      The Spodoptera experiments appear ad hoc and are insufficient to support conservation beyond Helicoverpa. To substantiate this claim, please add a coherent, minimal set of Spodoptera experiments and present them in a dedicated subsection. Alternatively, consider removing these data and limiting the conclusions (and title) to H. armigera.

      We thank the reviewer for this helpful comment. We agree that, in this current version of the manuscript, the S. frugiperda experiments are not sufficiently systematic to support strong claims about conservation beyond H. armigera. Our primary focus in this study is indeed on H. armigera, and the addition of the S. frugiperda data was intended only as preliminary, supportive evidence rather than a central component of our conclusions. To avoid over‑interpretation and to keep the manuscript focused and coherent, we will remove all S. frugiperda data from the revised version, including the corresponding text and figures. We will also adjust the title, abstract, and conclusion to clearly state that our findings are limited to H. armigera.

      In order to check the effects of E2F/Dp, a dsRNA-mediated knockdown of Dp was performed. Why was the E2F protein, a primary target of the study, not chosen as a candidate? The authors should either provide justification for this or perform the suggested experiments to come to a conclusion. I would like to point out that such experiments were performed in Drosophila.

      Thank you for this thoughtful comment and the specific suggestion. We agree that directly targeting E2F would, in principle, be an informative complementary approach. In our study, however, we prioritized Dp knockdown for two main reasons. First, E2F is a large family, and E2F-Dp functions as an obligate heterodimer. Previous work in D. melanogaster has shown that depletion of Dp is sufficient to disrupt E2F-dependent transcription broadly, often with more efficient loss of complex activity than targeting individual E2F isoforms (Zappia et al., 2021; Zappia et al., 2016). Second, in our preliminary trials, we performed a dsRNA feeding assay with dsHaE2F, dsHaDp, and combined dsHaE2F plus dsHaDp. In that assay, we did not achieve silencing of E2F in dsRNA targeting HaE2F (dsHaE2F). So here, as E2F is a large family, other E2F isoforms may be compensating for the silencing effect of targeted HaE2F. However, HaE2F showed significantly reduced expression upon dsHaDp and combined dsHaE2F plus dsHaDp feeding (Figure A), whereas HaDp showed a significant reduction in its expression in all three conditions (Figure B).  As we observed reduced expression of both HaE2F and HaDp upon combined feeding of dsHaE2F and dsHaDp, we further performed a rescue assay by exogenous feeding of trehalose. We observed the significant upregulation of HaE2F, HaDp, trehalose metabolic genes (HaTPS/TPP and HaTreh1), and myogenic genes (HaPrm and HaTm2) (Figure C). For these reasons, we focused on Dp silencing as a more reliable way to impair E2F/Dp complex function in H. armigera.

      Author response image 2.

      References:

      (1) Zappia, M.P. and Frolov, M.V., 2016. E2F function in muscle growth is necessary and sufficient for viability in Drosophila. Nature Communications, 7(1), p.10509.

      (2) Zappia, M.P., Guarner, A., Kellie-Smith, N., Rogers, A., Morris, R., Nicolay, B., Boukhali, M., Haas, W., Dyson, N.J. and Frolov, M.V., 2021. E2F/Dp inactivation in fat body cells triggers systemic metabolic changes. elife, 10, p.e67753.

      Silencing of HaDp resulted in a significant decrease in HaE2F expression. I find this observation intriguing. DP is the cofactor of E2F, and they both heterodimerise and sit on the promoter of target genes to regulate them. I would request authors to revisit this result, as it contradicts the general understanding of how E2F/Dp functions in other organisms. If Dp indeed controls E2F expression, then further experiments should be conducted to come to a conclusion convincingly. Additionally, these results would need thorough discussion with citations of similar results observed for other transcription factor-cofactor complexes.

      Thank you for highlighting this point and for prompting us to examine these data more carefully. Silencing HaDp leading to reduced HaE2F mRNA is indeed unexpected if one only considers the canonical view of E2F/Dp as a heterodimer that co-occupies target promoters without strongly regulating each other’s expression. However, several lines of work suggest that transcription factor-cofactor networks frequently include feedback loops in which cofactors influence the expression of their partner TFs. First, in multiple systems, transcription factors and their cofactors are known to regulate each other’s transcription, forming positive or negative feedback loops. For example, in hematopoietic cells, the transcription factor Foxp3 controls the expression of many of its own cofactors, and some of these cofactors in turn facilitate or stabilize Foxp3 expression, forming an interconnected regulatory network rather than a simple one‑way interaction (Rudra et al., 2012). Second, E2F/Dp complexes exhibit non‑canonical regulatory mechanisms and can regulate broad sets of targets, including other transcriptional regulators. Several studies show that E2F/Dp proteins not only control classical cell‑cycle genes but also participate in diverse processes such as DNA damage signaling, mitochondrial function, and differentiation (Guarner et al., 2017; Ambrus et al., 2013; Sánchez-Camargo et al., 2021). In D. melanogaster, complete loss of dDP alters the expression of direct targets E2F/DP, including dATM (Guarner et al., 2017).

      All these reports indicate that the E2F-Dp complex sits at the top of multi‑layer regulatory hierarchies. Such architectures make it plausible that Dp silencing in H. armigera could modulate HaE2F expression in a non-canonical way.

      References:

      (1) Rudra, D., DeRoos, P., Chaudhry, A., Niec, R.E., Arvey, A., Samstein, R.M., Leslie, C., Shaffer, S.A., Goodlett, D.R. and Rudensky, A.Y., 2012. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nature immunology, 13(10), pp.1010-1019.

      (2) Guarner, A., Morris, R., Korenjak, M., Boukhali, M., Zappia, M.P., Van Rechem, C., Whetstine, J.R., Ramaswamy, S., Zou, L., Frolov, M.V. and Haas, W., 2017. E2F/DP prevents cell-cycle progression in endocycling fat body cells by suppressing dATM expression. Developmental cell, 43(6), pp.689-703.

      (3) Ambrus, A.M., Islam, A.B., Holmes, K.B., Moon, N.S., Lopez-Bigas, N., Benevolenskaya, E.V. and Frolov, M.V., 2013. Loss of dE2F compromises mitochondrial function. Developmental cell, 27(4), pp.438-451.

      (4) Sánchez-Camargo, V.A., Romero-Rodríguez, S. and Vázquez-Ramos, J.M., 2021. Non-canonical functions of the E2F/DP pathway with emphasis in plants. Phyton, 90(2), p.307.

      I consider the overall bioinformatics analysis to remain very poorly described. What is specifically lacking is clear statements about why a particular dry lab experiments were conducted.

      We again thank the reviewer for advising us to give a biological context/motivation for every bioinformatics analysis performed. The bioinformatics analyses devised here, try to explain the systems-level perturbations of HaTPS/TPP silencing to explain the observed phenotype and to discover transcription factors potentially modulating the HaTPS/TPP induced gene regulatory changes.

      (1) Gene set enrichment analyses:

      Differential gene expression analyses of the bulk RNA sequencing data followed by qRT-PCR confirmed the transcriptional changes in myogenic genes and gene expression alterations in metabolic and cell cycle-related genes. These perturbations merely confirmed the effect induced by HaTPS/TPP silencing in obviously expected genes. We wanted to see whether using an “unbiased” system-level statistical analyses like gene set enrichment analyses (GSEA), can reveal both expected and novel biological processes that underlie HaTPS/TPP silencing. GSEA results revealed large-scale transcriptional changes in 11 enriched processes, including amino acid metabolism, energy metabolism, developmental regulatory processes, and motor protein activity. GSEA not only divulged overall transcriptionally enriched pathways but also identified the genes undergoing synchronized pathway-level transcriptional change upon HaTPS/TPP silencing.

      (2) Gene regulatory network analysis:

      Although GSEA uncovered potential pathway-level changes, we were also interested in identifying the gene regulatory network associated with such large-scale process-level transcriptional perturbations. Interestingly, the biological processes undergoing perturbations were also heterogeneous (e.g., motor protein activity, energy metabolism, amino acid metabolism, etc.). We hypothesized that the inference of a causal gene regulatory network associated with the genes associated with GSEA-enriched biological processes should predict core/master transcription factors that might synchronously regulate metabolic and non-metabolic processes related to HaTPS/TPP silencing, thereby providing a broad understanding of the perturbed phenotype. The gene regulatory network analysis statistically inferred an “active” gene regulatory network corresponding to the GSEA-enriched KEGG gene sets. Ranking the transcription factors (TFs) based on the number of outgoing connections (outdegree centrality) within the active gene regulatory network, E2F family TFs were identified to be top-ranking, highly connected transcription factors associated with the transcriptionally enriched processes. This suggests that E2F family TFs are central to controlling the flow of regulatory information within this network. Intriguingly, E2F has been previously implicated in muscle development in insects (Zappia et al., 2016). Further extracting the regulated targets of E2F family TFs within this network revealed the mechanistic connection with the 11 enriched processes. This GRN analysis was crucial in discovering and prioritizing E2F TFs as central transcription factors mediating HaTPS/TPP silencing effects, which was not apparent using trivial analyses like differential gene expression analysis.

      As per the reviewer’s suggestions, we will add these outlined points in the text of the manuscript (Results section) to further give context and clarity to the bioinformatics analyses conducted in this study.

      In my judgement, the EMSA analysis presented is technically poor in quality. It lacks positive and negative controls, does not show mutation analysis or super shifts. Also, it lacks any competition assays that are important to prove the binding beyond doubt. I am not sure why protein is not detected at all in lower concentrations. Overall, the EMSA assays need to be redone; I find the current results to be unacceptable.

      Thank you for pointing out this issue. We will reperform the EMSA analysis with appropriate controls.  Although the gel image was not clear, there was a light band of protein (indicated by the white square) observed in well No. 8, where we used 8 μg of E2F protein and 75 ng of HaTPS/TPP promoter, upon gel stained with SYPRO Ruby protein stain, suggesting weak HaTPS/TPP-E2F complex formation.

      GSEA studies clearly indicate enrichment of the amino acid synthesis gene in TPP knockdown samples. This supports the plausible theory that a lack of Trehalose means a lack of enough nutrients, therefore less of that is converted to amino acids, and therefore muscle development is compromised. Yet the authors make no effort to measure amino acid levels. While nutrients can be sensed through signalling pathways leading to shut shutdown of myogenic genes, a simple and direct correlation between less raw material and deformed muscle might also be possible.

      We quantified amino acid levels as per the suggestion, and we observed differential levels of amino acids upon trehalose metabolism perturbation.

      However, we observed that insect were failed to rescue when fed a control chickpea-based artificial diet that contained nutrients required for normal growth and development. Based on this observation, we conclude that trehalose deficiency is the only possible cause for the defect in muscle development.

      The authors are encouraged to stick to one color palette while demonstrating sequencing results. Choosing a different color palette for representing results from the same sequencing analysis confuses readers.

      Thank you for the comment. We will revise the color palette as per the suggestion.

      Expression of genes, as understood from sequencing analysis in Figure 1D, Figure 2F, and Figure 3D, appears to be binary in nature. This result is extremely surprising given that the qRT-PCR of these genes have revealed a checker and graded expression.

      Thank you for pointing out this issue. We will revise the scale range for these figures to get more insights about gene expression levels and include figures as per the suggestion.

      In several graphs, non-significant results have been interpreted as significant in the results section. In a few other cases, the reported changes are minimal, and the statistical support is unclear; please recheck the analyses and include exact statistics. In the results section, fold changes observed should be discussed, as well as the statistical significance of the observed change.

      We will revise the analyses and include exact statistics as per the suggestion.

      Finally, I would add that trehalose metabolism regulates cell cycle genes, and muscle development genes establish correlation and causation. The authors should ensure that any comments they make are backed by evidence.

      We thank the reviewer for this insightful comment.  Although direct evidence in insects is currently lacking, multiple independent studies in yeast, plants and mammalian systems support a regulatory link between trehalose metabolism and the cell cycle. In budding yeast Saccharomyces cerevisiae, neutral Treh (Nth1) is directly phosphorylated and activated by the major cyclin‑dependent kinase Cdk1 at G1/S, routing stored trehalose into glycolysis to fuel DNA replication and mitosis (Ewald et al., 2016). CDK‑dependent regulation of trehalase activity has also been reported in plants, where CDC28‑mediated phosphorylation channels glucose into biosynthetic pathways necessary for cell proliferation (Lara-núñez et al., 2025). Furthermore, budding yeast cells accumulate trehalose and glycogen upon entry into quiescence and subsequently mobilize these stores to generate a metabolic “finishing kick” that supports re‑entry into the cell cycle (Silljé et al., 1999; Shi et al., 2010). Exogenous trehalose that perturbs the trehalose cycle impairs glycolysis, reduces ATP, and delays cell cycle progression in S. cerevisiae, highlighting a dose‑ and context‑dependent control of growth versus arrest (Zhang, Zhang and Li, 2020). In mammalian systems, trehalose similarly modulates proliferation-differentiation decisions. In rat airway smooth muscle cells, low trehalose concentrations promote autophagy, whereas higher doses induce S/G2–M arrest, downregulate Cyclin A1/B1, and trigger apoptosis, indicating a shift from controlled growth to cell elimination at higher exposure (Xiao et al., 2021). In human iPSC‑derived neural stem/progenitor cells, low‑dose trehalose enhances neuronal differentiation and VEGF secretion, while higher doses are cytotoxic, again highlighting a tunable impact on cell‑fate outcomes (Roose et al., 2025). In wheat, exogenous trehalose under heat stress reduces growth, lowers auxin, gibberellin, abscisic acid and cytokinin levels, and represses CycD2 and CDC2 expression, suggesting that trehalose signalling integrates with hormone pathways and core cell‑cycle regulators to restrain proliferation during stress (Luo, Liu, and Li, 2021). Together, these studies showed the importance of trehalose metabolism in cell‑cycle regulation to decide whether cells and tissues proliferate, differentiate, or remain quiescent.

      With respect to muscle development, previous work has implicated glycolytic metabolism in myogenesis and muscle growth. Tixier et al. (2013) showed that loss of key glycolytic genes results in abnormally thin muscles, while Bawa et al. (2020) demonstrated that loss of TRIM32 decreases glycolytic flux and reduces muscle tissue size. These findings indicate that carbohydrate and energy metabolism pathways are important determinants of muscle structure and growth. However, there are no previous studies about the role of trehalose metabolism in muscle development, other than as an energy source, so here we specifically set out to establish the involvement of trehalose metabolism in muscle development.

      References:

      (1) Ewald, J.C. et al. (2016) “The yeast cyclin-dependent kinase routes carbon fluxes to fuel cell cycle progression,” Molecular cell, 62(4), pp. 532–545.

      (2) Lara-núñez, A. et al. (2025) “The Cyclin-Dependent Kinase activity modulates the central carbon metabolism in maize during germination,” (January), pp. 1–16.

      (3) Silljé, H.H.W. et al. (1999) “Function of trehalose and glycogen in cell cycle progression and cell viability in Saccharomyces cerevisiae,” Journal of bacteriology, 181(2), pp. 396–400.

      (4) Shi, L. et al. (2010) “Trehalose Is a Key Determinant of the Quiescent Metabolic State That Fuels Cell Cycle Progression upon Return to Growth,” 21, pp. 1982–1990.

      (5) Zhang, X., Zhang, Y. and Li, H. (2020) “Regulation of trehalose, a typical stress protectant, on central metabolisms, cell growth and division of Saccharomyces cerevisiae CEN. PK113-7D,” Food Microbiology, 89, p. 103459.

      (6) Xiao, B. et al. (2021) “Trehalose inhibits proliferation while activates apoptosis and autophagy in rat airway smooth muscle cells,” Acta Histochemica, 123(8), p. 151810.

      (7) Roose, S.K. et al. (2025) “Trehalose enhances neuronal differentiation with VEGF secretion in human iPSC-derived neural stem / progenitor cells,” Regenerative Therapy, 30, pp. 268–277.

      (8) Luo, Y., Liu, X. and Li, W. (2021) “Exogenously-supplied trehalose inhibits the growth of wheat seedlings under high temperature by affecting plant hormone levels and cell cycle processes,” Plant Signaling & Behavior, 16(6).

      (9) Tixier, V., Bataillé, L., Etard, C., Jagla, T., Weger, M., DaPonte, J.P., Strähle, U., Dickmeis, T. and Jagla, K., 2013. Glycolysis supports embryonic muscle growth by promoting myoblast fusion. Proceedings of the National Academy of Sciences, 110(47), pp.18982-18987.

      (10) Bawa, S., Brooks, D.S., Neville, K.E., Tipping, M., Sagar, M.A., Kollhoff, J.A., Chawla, G., Geisbrecht, B.V., Tennessen, J.M., Eliceiri, K.W. and Geisbrecht, E.R., 2020. Drosophila TRIM32 cooperates with glycolytic enzymes to promote cell growth. elife, 9, p.e52358.

      Finally, we appreciate the meticulous review of this manuscript and constructive comments. We will perform the recommended experiments, data analysis, and revise the manuscript accordingly.

    1. Author response:

      We would like to thank the reviewers for their detailed reading of our manuscript and for the constructive comments they have provided.

      We plan to make structural changes to the introduction and the discussion. Reviewer #1 describes the “disconnect between the abstract/introduction and the discussion”. We agree that “the study's aims are not clearly or explicitly defined”. We will edit the introduction to state our aim of investigating the factors that affect using “crispants” in mouse functional genomics. In the discussion, we described how our findings inform sgRNA choice to ensure biallelic gene disruption in founders and how our extensive genotyping methods enabled us to determine the molecular basis for the observed phenotype (explaining why some founders showed the expected recessive trait and why it was partial or absent in others). We also concluded from our attempts of multiplexing that this had too great an impact on viability to be useful. We will edit the discussion to better address our aim and to elaborate on several points raised by the reviewers (discussed in more detail below). Specifically, we will provide examples of screening situations where generating crispant mice may be useful, e.g. preliminary in vivo studies to follow up candidates identified in large-scale cellular screens. We will also provide more context about our assumptions underlying our statement that the use of crispants will “dramatically reduce time, resources, and animal numbers” compared to ENU mutagenesis (where recessive traits require breeding of G2 females with G1 males to achieve homozygosity of de novo mutations in G3 offspring) and the work needed to validate this. We will more clearly acknowledge that our proof-of-principle study used visible phenotypes that can be assessed in individual animals and then discuss how the use of crispants could be extended to the investigation of quantitative or late-onset traits using cohorts of crispants (discussed further below). We will also discuss the assessment of non-null alleles to dissect protein function, building on our unexpected finding that a single round of CRISPR/Cas9mediated mutagenesis can generate an allelic series.

      Reviewer #1 asked us to address “how to interpret wild-type appearing founders”. We have discussed the mechanisms underlying the wild-type appearing founders generated in this study. This is linked with concerns in the field that incomplete editing, transcripts escaping nonsense-mediated decay, and/or the presence of in-frame mutations that don’t disrupt protein function may lead to founders that appear wild-type or have a partial phenotype. We have shown that our electroporation protocol results in very high levels of editing, but that this must always be assessed during genotyping. We found that by using an sgRNA that targets a critical protein domain, you can ensure that short in-frame indels also disrupt protein function. In future studies that determine how strain background modifies a phenotype that has been established on one strain (e.g. C57BL/6J), wild-type appearing founders would suggest that the new strain background rescues the null phenotype. In future studies that determine the consequence of targeting a second gene on a mutant background, wild-type appearing founders would indicate that the second mutation supresses the phenotype associated with the mutant background. We will add this to the discussion section where we describe possible screening situations in which crispant mice would be useful.

      Reviewer #3 states that “the relationship between the sgRNA/Cas9 concentrations delivered to the zygotes and the resulting editing efficiencies are not explicitly investigated.” Members of The Centre for Phenogenomics (TCP) Transgenic Production Core who co-author this study (Lauryl Nutter, Marina Gertsenstein and Lauri Lintott) have published detailed protocols on mouse model production, which we cite in this paper (PMID: 30040228; PMID: 33524495; PMID: 39999224). In PMID: 33524495, they tested a two-fold difference in Cas9 RNP concentrations for generating knock-out alleles. Using their optimised protocols for electroporation of one cell zygotes with RNPs, we achieved an extremely high editing rate. We did not vary the sgRNA/Cas9 concentrations as part of this study as our goal was to assess the ability to generate “complete” null animals. We do note, however, that by targeting two genes simultaneously whilst keeping the total RNP concentration constant (to avoid reagent toxicity), we halved the amount of each sgRNA and this did not lead to a decrease in editing efficiency. We will highlight this in the results/discussion section (as appropriate).

      Reviewer #1 asks about whether the use of crispants is applicable for “quantitative, late-onset, or more subtle phenotypes, including behavioral ones”. We are hopeful that this is possible and it is a priority for future studies. Crucially, cohorts of crispants can be generated in a single round of mutagenesis. Starting an experiment with ten donor females will produce ~100 zygotes, resulting in ~40 crispants. Power calculations must be performed to determine the size of the cohort required for the effect size and variability of the phenotype being studied, but many neurobehavioural studies use ~10 mutants vs ~10 controls. We note that sex and/or background genotype may mean that only some of the ~40 crispants produced can be used for phenotypic testing. This reviewer also raises the point about whether wild-type animals or mock-edited animals serve as the best controls. From work carried out by Lauryl Nutter and her colleagues from the IMPC (PMID: 37301944), we know that “wild-type” controls should ideally be from the same embryo pool as the crispants to avoid differences due to genetic drift within inbred colonies. This study also found that possible off-target mutations from CRISPR/Cas9-mediated mutagenesis is not an issue (despite a lot of attention in the literature). The suggestion of using mock-edited controls, resulting from zygotes that have gone through electroporation without RNP, addresses a possible need to control for the stress of undergoing the electroporation process. Our study shows that additional stress is caused by inducing and repairing a break in a neutral locus (EGFP). Controlling for these stressors may be particularly important when assessing behavioural phenotypes in crispants vs controls.

      Reviewer #2 states that “there could have been some discussion regarding how this approach would be impacted if mutations are dominant or embryonic lethal (for the latter, for example, F0 can be examined as embryos).” Our manuscript discusses how crispants could help with the study of genes that may be essential. Specifically, we stated that when CRISPR/Cas9-mediated mutagenesis fails to produce live pups, phenotypic assessment of crispant embryos could reveal whether targeting the gene impacts embryogenesis. Crispants can only be used to screen for recessive traits since both alleles are edited. The assessment of dominant traits is not addressed in our study and remains a challenge in the field. We note that CRISPRi screens in cultured cells reveal candidates that when partially downregulated lead to the desired phenotype. One possibility is to employ this set up in vivo using dCas9-KRAB transgenic mice (JAX stock #030000). We could add this point to the discussion section.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      (1) First, the concept of training or trained immunity refers to long-term epigenetic reprogramming in innate immune cells, resulting in a modified response upon exposure to a heterologous challenge. The investigations presented demonstrate phenotypic alterations in AMs seven days after ATP exposure; however, they do not assess whether persistent epigenetic remodeling occurs with lasting functional consequences. Therefore, a more cautious and semantically precise interpretation of the findings would be appropriate.

      In response, we have performed epigenetic analysis (ATAC seq analysis) as requested (Supp Fig. 1).

      (2) Furthermore, the in vivo data should be strengthened by additional analyses to support the authors' conclusions. The authors claim that susceptibility to Pseudomonas aeruginosa infection differs depending on the ATP-induced training effect. Statistical analyses should be provided for the survival curves, as well as additional weight curves or clinical assessments. Moreover, it would be appropriate to complement this clinical characterization with additional measurements, such as immune cell infiltration analysis (by flow cytometry), and quantification of pro-inflammatory cytokines in bronchoalveolar lavage fluid and/or lung homogenates.

      We have added the statistical analyses provided for the survival curves (new Fig. 1D), immune cell infiltration analysis, and quantification of pro-inflammatory cytokines in the lung (new Figs. 1, 2).

      (3) Moreover, the authors attribute the differences in resistance to P. aeruginosa infection to the ATP-induced training effect on AMs, based on a correlation between in vivo survival curves and differences in bacterial killing capacity measured in vitro. These are correlative findings that do not establish a causal role for AMs in the in vivo phenotype. ATP-mediated effects on other (i.e., non-AM) cell populations are omitted, and the possibility that other cells could be affected should be, at least, discussed. Adoptive transfer experiments using AMs would be a suitable approach to directly address this question.

      We have performed additional experiments and found that the numbers of lung macrophages were not significantly altered before and after ATP training (new Fig. 2), indicating the training effects are focused on lung resident macrophages.

      Reviewer #2 (Public review):

      (1) Missing details from methods/reported data: Substantial sections of key methods have not been disclosed (including anything about animal infection models, RNA-sequencing, and western blotting), and the statistical methods, as written, only address two-way comparisons, which would mean analysis was improperly performed. In addition, there is a general lack of transparency - the methods state that only representative data is included in the manuscript, and individual data points are not shown for assays.

      We have revised the methods and statistical analysis.

      (2) Poor experimental design including missing controls: Particularly problematic are the Seahorse assay data (requires normalization to cell numbers to interpret this bulk assay - differences in cell growth/loss between conditions would confound data interpretation) and bacterial killing assays (as written, this method would be heavily biased by bacterial initial binding/phagocytosis which would confound assessment of killing). Controls need to be included for subcellular fractionating to confirm pure fractions and for dye microscopy to show a negative background. Conclusions from these assays may be incorrect, and in some cases, the whole experiment may be uninterpretable.

      Seahorse assay methodology was updated to confirm the order of cell counting, time at seeding and cell counts. Methods were also updated to address the distinction between bacterial killing (Fig. 1B) and overall decrease in bacterial load.

      (3) The conclusions overstate what was tested in the experiments: Conceptually, there are multiple places where the authors draw conclusions or frame arguments in ways that do not match the experiments used. Particularly:

      (a) The authors discuss their findings in the context of importance for AM biology during respiratory infection but in vitro work uses cells that are well-established to be poor mimics of resident AMs (BMDM, RAW), particularly in terms of glycolytic metabolism.

      We have adjusted the text to reflect that the metabolic assay was performed on BMDMs. AMs are fragile for certain manipulations in vitro. We expect that the metabolic change is similar across several macrophage systems as well as the bacterial load reduction.

      (b) In vivo work does not address whether immune cell recruitment is triggered during training.

      We have performed immune cell infiltration analysis (new Fig. 2).

      (c) Figure 3 is used to draw conclusions about K+ in response to bacterial engulfment, but actually assesses fungal zymosan particles.

      We have corrected this in the manuscript.

      (d) Figure 5 is framed in bacterial susceptibility post-viral infection, but the model used is bacterial post-bacterial.

      We have corrected this in the manuscript.

      (e) In their discussion, the authors propose to have shown TWIK2-mediated inflammasome activation. They link these separately to ATP, but their studies do not test if loss of TWIK2 prevents inflammasome activation in response to ATP (Figure 4E does not use TWIK2 KO).

      We have now added the TWIK2 KO results (new Fig. 5E).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      As noted in the public review, it would be advisable to further characterize the in vivo phenotype in order to strengthen the conclusions. Specifically, it would be useful to quantify the bacterial load in the bronchoalveolar lavage fluid and lung homogenates, as well as to measure cytokine levels both in the respiratory compartment and systemically. Additionally, a broader characterization of the immune response in the presence or absence of ATP-induced training would be valuable. In the absence of direct evidence demonstrating that trained AMs mediate the observed phenotype, the authors should adopt a more cautious interpretation of their results. Moreover, careful attention to semantic accuracy is recommended. The concept of trained immunity refers specifically to long-term epigenetic reprogramming that leads to an altered response of target cells upon a secondary challenge, distant from the initial stress. The data presented do not fully demonstrate this phenomenon, and the interpretations should remain aligned with the evidence provided.

      Bacterial load has been quantified (see more details in the Methods part). And we also measured immune cell infiltration, quantification of pro-inflammatory cytokines in the lung (new Figs. 1, 2), and epigenetic evaluation of vehicle- and ATP-treated cells (Supp. Fig. 1).

      Reviewer #2 (Recommendations for the authors):

      (1) It cannot be overstated how lacking the methods are. This includes no discussion of IACUC approval for animal procedures, which must be included as part of research ethics. It also needs to be made clear where raw data is being archived. This notably includes an accession for deposited RNA-sequencing data, although unmanipulated microscopy and western blot images should also be shown. Methods should discuss any pre-processing that occurred with images.

      We have revised the methods in the manuscript.

      (2) Per statistics, in addition to generally providing more detail and adjusting analyses if they have not been correctly performed, please disclose if SD or SEM is shown. Reporting aggregate data versus representative data would provide more rigor. Perhaps replicate experiments could be included in the supplemental if they cannot, for some reason, be aggregated. Detailed statistical methods for RNA-seq analysis also need to be included.

      More details have been provided in the methods section.

      (3) It is unclear whether bacterial killing assays were correctly designed and can be interpreted. What does cells collected mean? If the assay was focused on intracellular macrophage bacterial load, it is critical to assess and report phagocytosis since different input loads would confound the assessment of killing. A rigorous wash or an antibiotic to eliminate extracellular bacteria should also have been performed and be described in this case. If the total bacterial burden was assessed, that would use cells+media and also needs to be clear and described. With the information provided, it is unclear whether the assays performed are sufficiently rigorous to assess bacterial killing. In addition, Figure 1B reports using an MOI of 50-100, but all data is compiled in one graph - data from different levels of infection should be separated. Figure 5A shows a model with E.coli followed by PA, but that does not appear to be how the assay was structured in B or C. This also does not match how the experiment is written in the results section, which references S. aureus. It is unclear what tissue (or cells) were assessed in Figure 5. Whole lung? BAL? As written, no data provided regarding bacterial killing is of sufficient quality to be considered valid.

      We have re-written the bacterial killing assay in the manuscript. The methodology was corrected to distinguish bacterial killing vs load decrease and generally accurate methodology.

      (4) The in vitro data provide reasonable evidence that BMDM/RAW macrophage training can occur in response to ATP exposure. However, it is unclear whether training is an important mechanism for resident AM in vivo, or whether, in vivo, a broader inflammatory response is generated, recruiting additional immune cells that persist and change infection susceptibility. The authors argue for resident AM immune training, but do not provide sufficient evidence to counter the latter possibility (resident AM are never themselves directly assessed, and the presence of other immune cells in vivo is not excluded). See Iliakis et al 2023 (PMID 37640788) for discussion of how this issue continues to drive uncertainty in the field. For this study, at least providing flow cytometry data quantifying myeloid and lymphoid immune populations in BALF before and after various treatments would help address this caveat. Without knowing this, it also confounds the interpretation of Figure 1B; if BAL is not pure AM after training, perhaps 1B could be repeated with ex vivo training or resident AM could be purified?

      We have performed immune cell infiltration analysis in the lung (both to BALF and in-tissue, new Fig. 2).

      (5) Figure 3A appears to show that fewer than 50% of cells express GFP. Is it expected that only a fraction of RAW cells express TWIK2-GFP? How was this addressed in the analyses for Figure 3? Were cells not appearing to express any significant GFP, included in phagosomal-negative or excluded from analysis? Please include in the methods.

      The RAW cells were transfected with TWIK2-GFP and variable GFP expression was expected. These cells were expressing a non-integrated transgene, which has been added to the methods as well as the consideration of cells for the analysis. Cells without visible GFP expression were excluded.

      (6) Why are many data points in Figure 3D negative? This suggests that settings were not optimized for microscopy - perhaps there is a very high background signal and the ION stain is barely above it. This is concerning for the quality of data. Further, is it expected that only some cells are positive for ION K+? The images shown clearly differentiate phagosomal K with ATP versus the absence of K without, but it is surprising that some cells appear not to contain any ION K+ signal (not completely clear given lack of brightfield or other cell staining) - this may again point to issues with imaging settings that confound data interpretation. This analysis should be carefully assessed.

      This has been updated in the methodology. In old Fig. 3D (new Fig. 4D), the presented data is the net intensity of the phagosome, subtracting the average cytoplasmic MFI from that of the area corresponding to an engulfed zymosan-af594 bead. Thus, a negative value has higher cytoplasmic IonK signal than that of the phagosome.

      (7) The Discussion states that it will be interesting to test whether ATP-TWIK2 is a common mechanism of training and specifically references LPS as an ATP-generating signal. However, Figure 2D data show that LPS induces only transient TWIK2 translocation; the authors have data suggesting that, in the context of LPS, TWIK2 'training' will not be engaged. This line of discussion shows incomplete consideration of the data.

      We have further limited this language in the text such that this may require differential sensitivity/damage sustained by macrophages as compared to that of epi/endothelial cells in response to bacterial endotoxin.

      (8) For RNA-sequencing, plots of the actual genes changed for the mitochondrial pathways of interest would be helpful information for readers, as would a heat map showing sample purity between groups for macrophage markers versus possible contaminant cells, which can also be generated from precursors in BMDM cultures. In general, information in Methods regarding how the analyses in Figure 4B were run is necessary, per cutoffs used to determine DEGs, number of samples in each group, sex of samples used, etc. Greater transparency of data would be appreciated, so plots that show variation between replicates, such as heat maps, would be ideal. Supplemental tables would also be nice.

      We have added to the methodology of the RNA sequencing analysis

      (9) The use of alternate DAMPs is a positive addition to the experimental design, but no data is given regarding the concentrations used. Ideally, positive controls showing histones/NAD are used at acutely activating concentrations could be included but at least references supporting the doses chosen or information about how doses were selected should be given. It is easy to find substantial literature on histones as a DAMP, but it was unclear why/how NAD was selected.

      We have added these concentrations and corresponding references.

      (10) The E.coli CFU reported in Figure 5B are extraordinarily low. In addition, CFU are generally shown on a log scale, but this appears to be linear. Please confirm that these data are correct. Perhaps improved methods might explain why? Is the second hit a low dose?

      These have been corrected in the new Fig. 6B.

      (11) Given that loss of either TWIK2 or Nlrp3 ablates bacterial protection, a link should be tested - experiments should test whether loss of TWIK2 prevents inflammasome activation in response to ATP (TWIK2 KO in 4E) and if loss of Nlrp3 changes TWIK2 translocation (Nlrp3 KO in at least some experiments of Figures 2/3).

      We have now added the TWIK KO results (new Fig. 5E).

      (12) One of the most striking data pieces is Figure 1D. It would, therefore, strengthen the paper to repeat those experiments (even just with the high-dose ATP) using TEIK2/P2X7/NLRP3 KO mice and really show the importance of these pathways in vivo. This is conceptually Figure 5, but the survival data of Figure 1 is far more convincing than the relatively weak bacterial load data of Figure 5.

      Unfortunately, our previous laboratory has been closed and we have trouble acquiring enough mice for additional survival data during the transition period. However, the bacterial load data has been adjusted to the same bacterial counts per 5 mg lung tissue instead of per individual sampling, giving a more contextual interpretation of the data.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public reviews):

      (1) The absence of replicate paired-end datasets limits confidence in peak localization.

      The reviewer was under the impression that that we did not perform biological replicates of our ChIP-seq experiments. All ChIP-seq (and ATAC-seq) experiments were performed with biological replicates and the Pearson’s correlations (all >0.9) between replicates were provided in Supplementary Table 1. We had indicated this in the text and methods but will try to make this even clearer.

      (2) The analyses are primarily correlative, making it difficult to fully assess robustness or to support strong mechanistic conclusions.

      Histone modifications are difficult to alter genetically because of the high copy number of histone genes and inhibition of HATs/HDACs in general leads to alterations in other histone modifications. It is an inherent challenge in establishing causality of histone modifications, especially histone acetylation marks.

      (3) Some claims (e.g., specificity for CpG islands, "dynamic" regulation during differentiation) are not fully supported by the analyses as presented.

      We have modified the text in response to this point. The new text reads: “Non-CGI promoters have lower overall levels of transcription compared to CGI promoters, and for this promoter class H3K115ac enrichment detected by ChIP is only really seen for the highest quartile of transcription (4SU) quartile of expression (Figure 1G). CGI promoters on the other hand, exhibit significant levels of detected H3K115ac even for the lowest quartile of expression. These results suggest a special link between CGI promoters and H3K115ac”.

      (4) Overall, the study introduces an intriguing new angle on globular PTMs, but additional rigor and mechanistic evidence are needed to substantiate the conclusions.

      We agree that the paper does not provide mechanistic details or solid causality of H3K115ac. We have only emphasized the potential role of H3K115ac in nucleosome fragility based on our in vivo data and previously published in-vitro experiments (Manohar et.al., 2009, Chatterjee et. al., 2015). We do provide the evidence that H3K115ac is enriched on subnucleosomal particles via sucrose gradient sedimentation of MNase-digested chromatin (Figure 3C-D).

      Reviewer #2 (Public review):

      (1) I am not fully convinced about the specificity of the antibody. Although the experiment in Figure S1A shows a specific binding to H3K115ac-modified peptides compared to unmodified peptides, the authors do not show any experiment that shows that the antibody does not bind to unrelated proteins. Thus, a Western of a nuclear extract or the chromatin fraction would be critical to show. Also, peptide competition using the H3K115ac peptide to block the antibody may be good to further support the specificity of the antibody. Also, I don't understand the experiment in Figure S1B. What does it tell us when the H3K115ac histone mark itself is missing? The KLF4 promoter does not appear to be a suitable positive control, given that hundreds of proteins/histone modifications are likely present at this region. It is important to clearly demonstrate that the antibody exclusively recognizes H3K115ac, given that the conclusion of the manuscript strongly depends on the reliability of the obtained ChIP-Seq data.

      ChIP-qPCR in S1B includes competition from native chromatin and shows high specificity to its target. We have provided antibody validation in three ways:

      - Western blot with dot-blot of synthetic peptides (Figure S1A).

      - Western blots with Whole cell extracts (Figure 4D).

      - ChIP-qPCR on native chromatin spiked with a cocktail of synthetic mono-nucleosomes, each carrying a single acetylation and a specific barcode (SNAP-ChIP K-AcylStat Panel).

      We could not include H3K115ac marked nucleosomes as they are not available in the panel. Figure S1B shows that the H3K115ac antibody exhibits negligible binding to known K-acyl marks, comparable to an unmodified nucleosome. Because of the absence of a H3K115ac modified barcoded nucleosome, we used the KLF4 promoter from mESCs as a positive control, in agreement with ChIP-seq signal shown in the genome browser profile (Figure 1E), the KLF4 promoter shows a significantly higher signal than the gene body.

      (2) The association of H3K115ac with fragile nucleosomes is based on MNase-sensitivity and fragment length, which are indirect methods and can have technical bias. Experiments that support that the H3K115ac modified nucleosomes are indeed more fragile are missing.

      We have performed ChIP-seq on MNase digested mESC chromatin fractionated on sucrose gradients and this shows that H3K115ac is enriched in fractions containing sub-nucleosomal and fragile nucleosomes but depleted in fractions containing stable nucleosomes (Figure 3D).

      (3) The comparison of H3K115ac with H3K122ac and H3K64ac relies on publicly available datasets. Since the authors argue that these marks are distinct, data generated under identical experimental conditions would be more convincing. At a minimum, the limitations of using external datasets should be discussed.

      H3K64ac and H3K122ac datasets were generated by us in a previous publication (Pradeepa et. al., 2016) using same native MNase ChIP protocol as used here. The ChIP-seq datasets for H3K122ac and H3K27ac are processed in an identical manner, with the same computational pipelines, to the H3K115ac data sets generated in this paper.

      (4) The enrichment of H3K115ac at enhancers and CTCF binding sites is notable but remains descriptive. It would be interesting to clarify whether H3K115ac actively influences transcription factor/CTCF binding or is a downstream correlate.

      We agree with the reviewer’s comment, but we have not claimed causality.

      (5) No information is provided about how H3K115ac may be deposited/removed. Without this information, it is difficult to place this modification into established chromatin regulatory pathways.

      Due to broad target specificity, redundancies and crosstalk among different classes of HATs and HDACs, it is not tractable to answer this question in the current manuscript.

      Reviewer #3 (Public reviews):

      Reviewer 3 is mistaken in thinking our ChIP experiments are performed under cross-linked conditions. As clearly stated in the main text and methods, all our ChIP-seq for histone modifications is done on native MNase-digested chromatin – with no cross-linking. This includes the spike-in experiment shown in Fig S1B to test H3K115ac antibody specificity against the bar-coded SNAP-ChIP® K-AcylStat Panel from Epicypher. We could not include H3K115ac bar-coded nucleosomes in that experiment since they are not available in the panel.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) I have two primary concerns that resound through the entire paper:

      (a) Overall, the manuscript is making strong claims based on entirely correlative datasets. No quantitative analyses are performed to demonstrate co-occupancy/localization. Please see more detailed descriptions below.

      Our responses to specific points are provided against each comment below.

      (b) Lack of paired-end replicates for H3K115ac ChIP-seq. While the reviewer token for the deposited data was not made accessible to me, looking at Supplementary Table 1, it appears there are two H3K115ac ChIP-seq datasets. One is paired-end and is single-read. So are peaks called with only one replicate of PE? Or are inaccurate peaks called with SR datasets? Either way, this is not a rigorous way to evaluate H3K115ac localization.

      We are sorry that this reviewer was not able to access the data – the token for the GEO accession was provided for reviewers at the journal’s request. All ChIP-seq (and ATAC-seq) experiments (paired and single-end) were performed with two biological replicates and the Pearson’s correlations (all >0.9) between replicates were provided in Supplementary Table 1. This was indicated in both the main text and in the methods. In the revised manuscript we have tried to make this even clearer and have put the relevant Pearsons coefficient (r) into the text at the appropriate places. For the reviewer’s information, here is the complete list of data samples in the GEO Accession:

      Author response image 1.

      While I agree that H3K115ac occupancy is high at +CGIs, the authors downplay that H3K122ac and H3K27ac is also more highly enriched at these locations (page 7, last sentence of first paragraph). I imagine this is all due to the more highly transcribed nature of these genes. Sub-stratifying the K27ac and K122ac by transcription (as in Figure 1G) would help to demonstrate a unique nature of H3K115ac. But even better would be to do an analysis that plots H3K115ac enrichment vs transcription for every individual gene rather than aggregate analyses that are biased by single locations. For example, make an XY scatterplot of RNAPII occupancy or 4SU-seq signal vs H3K115ac level, where each point represents a single gene. Because the interpretation that it is CGI-based and not transcription is confounded with the fact that -CGI are more lowly transcribed. So, looking at Figure 1G, even the -CGI occupancy of H3K115ac is correlated with transcription, but it is just more lowly transcribed.

      We thank the reviewer for these suggestions but point out that Figure 1G shows H3K115ac signal for CGI+ and CGI– TSS that are matched for expressions levels (quartiles of 4SU-seq). Fig 1F shows that H3k115ac is much more of a discriminator between CGI+ and – than H3K27ac or H3K122ac.

      (2) H3K115ac, H3K27ac, and H3K122ac are all more enriched (in aggregate) at +CGI locations (Fig 1F); so do these locations just have more positioned nucleosomes? More H3.3? So that these PTMs are just more enriched due to the opportunity?

      Positioned nucleosomes are generally found downstream of the TSS of active CpG island promoters, so what the reviewer suggests may well account for the relative enrichment of H327ac and H3K122ac at CGI+ vs CGI- promoters in Fig.1F. But H3K115ac localisation is distinct, with the peak at the nucleosome-depleted region not the +1 nucleosome. This is also confirmed by the contour plots in Fig 3. Our observation is also not explained by an enrichment of H3.3 at CGI promoters, since we show that H3K115ac is not specific to H3.3 (Fig 4D).

      (3) The authors note in paragraph 2 of page 7 that "H3K115ac does not scale linearly with gene expression..." but the authors never show a quantification of this; stratification in four clusters is not able to make a linear correlation. Furthermore, in the second line of page 7, the authors state that the levels do generally correlate with transcription. To claim it is a specific CGI link and not transcription is tricky, but I encourage the authors to consider more quantifiable ways, rather than correlations, to demonstrate this point, if it is observed.

      We thank the reviewer for this comment, and taking it into consideration, we have decided to re-phrase this paragraph. The new text reads: “Non-CGI promoters have lower overall levels of transcription compared to CGI promoters, and for this promoter class H3K115ac enrichment detected by ChIP is only really seen for the highest quartile of transcription (4SU) quartile of expression (Figure 1G). CGI promoters on the other hand, exhibit significant levels of detected H3K115ac even for the lowest quartile of expression. These results suggest a special link between CGI promoters and H3K115ac”.

      (4) The authors claim on page 7 that "on average, transcription increased from TSS that also gained H3K115ac but to a modest extent, compared with the more substantial loss of H3K115ac from downregulated TSS". However, both upregulated and downregulated are significant; the difference in magnitude could simply be due to more highly or more lowly transcribed locations, meaning that fold change could be more robustly detected. I caution the authors to substantiate claims like this rather than stating a correlation.

      We thank the reviewer for this comment which relates to the data in Fig 2A. It is Fig. 2B shows that the association of H3K115ac loss with downregulation is statistically stronger than H3K115ac gain with upregulation, but only for CGI promoters. With regard to the text on the original pg 7 that is referred to, we have now reworded this to read “Average levels of transcription increased from TSS that also gained H3K115ac, and there was loss of H3K115ac from downregulated TSS (Figure 2A).”

      (5) For Figure 2C, the authors argue that H3K115ac correlate with bivalent locations. So this is all qualitative and aggregate localization; please quantitatively demonstrate this claim.

      Figure S2D provides statistics for this (observed/expected and Fishers exact test).

      (6) The authors claim in Figure 2 that H3115ac is dynamic during differentiation (title of Figure 2). However, there are locations that gain and lose, or maintain H3K115ac. In fact, the most discussed locations are H3K115ac with no change (2C); which means it is NOT dynamic during differentiation. So what is the message for the role during differentiation? From Supplemental Table 1, it appears there is a single ChIP experiment for H3K115ac in NPC, and it is a single read. So this is also a difficult claim with one replicate. Related to this, in S2A, the authors show K115ac where there is no change in transcription; so what is the role of H3K115ac at TSSs relevant to differentiation - it is at both locations changed and unchanged in transcription, but H3K115ac levels itself do not change at these subsets. So, how is this dynamic? This is very confusing, and clearer analyses and descriptions are necessary to deconvolute these data.

      We apologise for the misleading title for Figure 2. This has now been amended to “Changes in H3K115ac during differentiation”. The message of this figure is that whilst changes in H3K115ac at TSS are small (panels A-C), at enhancers the changes are much more dramatic (panel D). The reviewer is incorrect about the number of replicates for NPCs – there are two biological replicates (see response to point 1b).

      (7) The authors go on to examine H3K115ac enrichment on fragile nucleosomes through sucrose gradient sedimentation. A control for H3K27ac or H3K122ac would be nice for comparison.

      We do not have the material available to perform these experiments

      (8) When discussing Figures 3 and SF3, the authors mention performing a different MNase for a second ChIP. Showing the MNase distribution for both the more highly digested and the lowly digested would be nice. a) Related to the above, the authors show input in SF3E to argue that the difference in H3K115ac vs H3K27ac is not due to the library, but they do not show the MNase digestion patterns, which is more important for this argument.

      Input libraries (first two graphs of FigS3E) are the MNase-digested chromatin. Comparison of nucleotide frequencies from millions of reads is more robust method than the fragment length patterns.

      (9) The authors move on to examine H3K115ac at enhancers. Just out of curiosity, given what was found at promoters, is H3K115ac enriched at +CGI enhancers? And what is the correlation with enhancer transcription?

      This is an interesting point, but the number of enhancers associated with CGI is not very high and so we did not focus on this. We have not analysed a correlation with eRNAs in this paper.

      (10) The authors state on page 14 that the most frequent changes in H3K115ac during differentiation are at these enhancers. So do these changes connect with differentiation-specific genes, and/or genes that have altered transcription during differentiation? Just trying to understand the functional role.

      Given the challenges of connecting enhancers with target genes, we have not addressed this question quantitatively. However, we draw the reviewer’s attention to the Genome Browser shots in Figures 2D and S2C, which show clear gain of H3K115ac (and ATAC-seq peaks) at intra and intergenic regions close to genes whose transcription is activated during the differentiation to NPCs.

      (11) Related, at the end of page 14, the authors state that the changes in H3K115ac correlate with changes in ATAC-seq; I imagine this dynamic is not unique for H3K115ac and this is observed for other PTMs (H3K27ac), so assessing and clarifying this, to again get to the specific interest of H3K115ac, would be ideal.

      We have not claimed that chromatin accessibility is unique to H3K115ac. It is the location of H3K115ac which is found inside the ATAC-seq peak region while H3K27ac is found only upstream/downstream of the ATAC peak that is so striking. This is apparent in Fig 4C.

      (12) The authors examine levels of H3K115ac in H3.3 KO cell lines via western blot (Figure 4D), but no replicates and/or quantification are shown.

      We now provide a biological replicate for the Western Blot (new FigS4H) together with an image of the whole gel for the data in Fig 4D

      (13) In Figure S4 and at the end of page 17, the authors are arguing that there is a link to pioneer TF complexes, based on Oct4 binding. First, while Oct4 has pioneering activity, not all Oct4 sites (or motifs) are pioneering; this has been established. So if you want to use Oct4, substratifying by pioneer vs no pioneer is necessary. Second, demonstrating this is unique to pioneer and not to non-pioneer TFs would be an important control.

      In response to the reviewer’s comment, we have removed the term “pioneer” from the manuscript.

      (14) Minor point: Figure 4 A and B, there are some formatting issues with the scale bars.

      We thank the reviewer for pointing this out, and the errors have been corrected in the revised figure.

      (15) Minor point is that it should be clear when single replicates of data are used and when PE/SR sequences are combined or which one is used in each analysis, as this was hard to discern when reading the paper and figure legends.

      We have clearly stated in the text that, after Figure2, we repeated all experiments in paired-end mode. All processing steps are defined separately for single end and paired end datasets in the method section. Details of biological replicates are provided in Sup. Table 1. These concerns are also addressed in our response to Reviewer’s public comment-1.

      (16) Minor point: it is surprising that different MNase and different units were used in the ChIP vs sucrose sedimentation. Could the authors clarify why?

      Chromatin prep for sucrose gradients were done on a much larger scale than for ChIP-seq and required different setups to obtain the right level of MNase digestion.

      (17) The authors note that fragile nucleosomes contain H2A.Z and H3.3, but they never perform an analysis of available data to demonstrate a correlation (or better a quantifiable correlation) between H3K115ac occupancy and these marks at the locations they identify H3K115ac.

      Since have shown (Fig. 4) that depletion of H3.3 does not affect overall levels of H3K115ac, we do not think there is value in further quantitative correlative analyses of H3K115ac and variant histones.

      (18) Minor point: What is the overlap in peaks for H3K115ac, H3K122ac, and H3K27ac (Figure 1C)?

      Nearly all H3K115ac peaks overlap with H3K122ac and/or H3K27ac. Its most distinct properties are its association with CGI promoters, fragile nucleosomes and its unique localisation within the NDRs, three points that the manuscript is focussed on.

      Reviewer #3 (Recommendations for the authors):

      (1) The western blot results in Figure 4D probing for H3, H3.3, and H3K115ac use Ponceau S staining, presumably of an area of the membrane where histones might be expected to migrate, as a measure of loading. However, the Ponceau S bands appear uniformly weaker in the H3.3KO lanes, yet despite this, blotting with H3.3 antibody detects a band in H3.3 knockout ESCs, suggesting that the antibody does not have a high degree of specificity. Again, a blocking experiment with appropriate peptides would instill more confidence in the specificity of these reagents, and/or the authors could provide independent validation of the knockout model to differentiate between a partial knockout or antibody cross-reactivity (e.g., by Sanger sequencing).

      In a revised Fig. S4H we now show the whole gel corresponding to this blot but including co-staining with an antibody for H4 to provide a better loading control. We also provide a biological replicate of this Western blot in the lower panel of Fig. S4H.

      (2) The manuscript would benefit from in vitro follow-up and validation, but if the authors intend to keep the manuscript primarily in silico, I suggest dedicating a few lines in each section to explain the plots, their axes, and their purpose, as well as to assist with interpretation, rather than directly discussing the results. This would make the manuscript more accessible and understandable for a broader audience in the field of epigenetics.

      In the revised version, we have tried to improve the text to make the data more accessible to a broad audience.

    1. eLife Assessment

      This potentially important study explores the specificity of olfactory perceptual learning. In keeping with previous work, the authors found that learning to discriminate between two enantiomers does not generalize across the nostrils or to unrelated enantiomers, whereas learning to discriminate odor mixtures does generalize across the nostrils and to other odor mixtures, with this learning effect persisting over at least two weeks. While the evidence presented to support these findings is convincing, it remains unclear why the results differ for enantiomers and why training on odor mixtures generalizes to other odor mixtures.

      Discrimination of odor enantiomers ultimately relies on the enantioselectivity of olfactory receptors, whereas mixture discrimination likely depends on relative differences in perceived configural odor notes. These processes probably engage plasticity at different stages of the olfactory pathway. The revised Discussion (p.16-18) now elaborates on this distinction and the potential underlying mechanisms. Please also refer to our responses to Reviewer 1’s Point 1 and Reviewer 2’s Points 2 and 3 below.

      Reviewer #1 (Public Review):

      This study extends a previous study by the same group on the generalization of odor discrimination from one nostril to the other. In their earlier study, the group showed that learning to discriminate between two enantiomers does not generalize across nostrils. This was surprising given the Mainland & Sobel 2001 study that found that detecting androstenone in people who do not detect it can generalize across the two nostrils. In this study, they confirmed their previous results and reported that, unlike enantiomers, learning to discriminate odor mixtures generalizes across nostrils, generalizes to other odor mixtures, and is persistent over at least two weeks.

      This interesting and important result extends our knowledge of this phenomenon and will likely steer more research. It may also help develop new training protocols for people with impairments in their sense of smell.

      We thank the reviewer for the encouraging remarks.

      The main weakness of this study is its scope, as it does not provide substantial insight into why the results differ for enantiomers and why training on odor mixtures generalizes to other odor mixtures.

      We thank the reviewer for this insightful comment. While the present study does not directly identify the neural mechanisms underlying these differences, it provides behavioral constraints on where specificity and generalization may arise within the olfactory system. Further neuroimaging and neurophysiological work will be needed to fully elucidate the underlying mechanisms.

      Reviewer #2 (Public Review):

      The manuscript from Chang et al. taps on an important issue in olfactory perceptual plasticity, named the generalization of perceptual learning effect by training using odors. They employed a discrimination training/learning task with either binary odor mixture or odor enantiomers, and tested for post-training effect at several time intervals. Their results showed contrasting patterns of specificity (enantiomers) and transfer (odor mixtures), and the learning effect persisted at 2 weeks post-training. They demonstrated that the effect was independent of task difficulty, olfactory adaptation and gender.

      Overall this was a well-controlled study and shows novel results. The strength of the study includes the consideration of odor structure and perceptual (dis)similarity and the control training condition.

      We appreciate the reviewer’s positive assessment of our work.

      I have two minor issues that hope the authors could address in the next version of the manuscript.

      (1). The author used a binary odor mixture with a ration 7:9 or 9:11, why is this ratio chosen and used for the experiment?

      This ratio was selected based on pilot testing and practical constraints. During piloting, we evaluated several mixing ratios to identify those that met two key criteria: (1) Baseline indiscriminability: Most participants were unable to reliably discriminate between the two binary mixtures in a:b and b:a ratios at baseline. (2)Trainability: With 1–5 weeks of training, participants could acquire the ability to discriminate between them.

      The a:b ratios of 7:9 and 9:11 were the ratios that met both criteria in our pilot testing, making them suitable for assessing training‑induced improvements in mixture discrimination. This clarification has been added to the revised Olfactory Stimuli subsection of the Materials and Methods (p.19-20 of the revised manuscript).

      (2) Over the course of training, has the valence of odor (odor mixture) changed, it would be helpful to include these results in the supplements. As the author indicated in the discussion, the potential site underlying the transfer effect is the OFC, which has been found to represent odor valence previously (Anderson, Christoff et al. 2003). It would be nice to see the author replicate the results with odor/odor mixture valence (change) controlled.

      Anderson, A. K., K. Christoff, I. Stappen, D. Panitz, D. G. Ghahremani, G. Glover, J. D. Gabrieli and N. Sobel (2003). "Dissociated neural representations of intensity and valence in human olfaction." Nat Neurosci 6(2): 196-202.

      Odor valence ratings were not collected in Experiments 1 and 2. However, we have since conducted a new experiment examining concentration discrimination learning (see our response to Reviewer 1, Point 1), using the constituents of the mixtures from Experiment 2 as stimuli (i.e., concentration pairs of acetophenone, 2 octanone, methyl salicylate, and isoamyl butyrate). In this new experiment (now incorporated as Experiment 3 in the revised manuscript), unilateral odor valence ratings were collected at baseline (Day 0) and at the post training test and retests on Days N, N+1, N+3, N+7, and N+14.

      For all odor pairs (training and controls), there was no significant change in perceived valence from baseline to Day N, regardless of nostril (ps > 0.05 for the main effects of session and nostril, as well as their interaction; Figure S5D). Moreover, odor valence ratings remained stable across the five post training test sessions (ps ≥ 0.29 for the main and interaction effects involving session), showing the same pattern as at baseline (Figure S5D, F). Thus, training appeared to have no measurable influence on odor valence perception. These results have been incorporated into the revised manuscript on p.14-15.

    1. Author response:

      Reviewer #1 (Public Review):

      The authors tested the hypothesis that at high elevations avian eggs will be adapted to prevent desiccation that might arise from loss of water to surrounding drier air. They used a combination of gas diffusion experiments and scanning electron microscopy to examine water vapour conductance rates and eggshell structure, including thickness, pore size, and pore density among 197 bird species distributed along an elevational gradient in the Andes. While there was a correlation between water vapour conductance and elevation among species, a decrease in water vapour conductance with elevation was not associated with eggshell thickness, pore size, and pore density, suggesting the variation in the structure of the eggshells is unlikely to do with among species differences in water loss along elevational gradients. This study is very interesting and timely, especially with increasing water vapour pressure due to climate warming. It is a very well-written study and easy to read. However, I have some concerns about the conclusions drawn from the results.

      There are more than twice as many species in low and medium-elevation sites compared to high-elevation sites, so the amount of variation in low and medium-elevation should be expected to be higher by default. The argument for a wider range of variation in lowelevation species will be stronger if the comparison was a similar sample size. Moreover, the pattern clearly breaks down within families. Note also that for Low and medium elevation there is no difference in the amount of variation in conductance residuals possibly because the sample sizes are similar. The seemingly strong positive correlation between eggshell conductance and egg mass may be driven by the five high and two medium-elevation species with large eggs. There seem to be hardly any high-elevation species with egg mass greater than 12g whereas species in low elevation egg size seem to be as high as 80g (Figure 2a). Since larger eggs (and thus eggs of larger birds) lose more water compared to smaller eggs, the correlation between water vapour conductance and elevation may be more strongly associated with body size distribution along elevational gradients rather than egg structure and function.

      We thank the reviewer for this thoughtful observation. As noted in our response to comment 3, we recognize that the higher number of species at low and mid-elevations reflects the natural turnover in species richness along elevational gradients, and we are transparent about this caveat in our revised Discussion section. Nevertheless, to address this specific concern, we conducted additional analyses excluding the species with large eggs (i.e., egg mass >12g, which are only present at low and mid-elevations in our dataset). These analyses are now included in the Supplementary Figure 1, and the main pattern of lower water vapor conductance at high elevations holds even when larger eggs are excluded.

      We agree that the well-known scaling relationship between egg mass and conductance (recognized since the 1970s) may partially explain the observed trends across the elevational gradient. Our aim was to explore whether the known relationship between egg size and conductance varies when incorporating environmental variables such as elevation, which brings with it changes in humidity and oxygen availability. While we acknowledge the possible confounding effect of body size distributions along the gradient, our results, even after controlling for egg size (residual analysis), still suggest a decrease in conductance at higher elevations, consistent with predictions based on environmental conditions.

      We have clarified these points in the revised Discussion, including the acknowledgment that disentangling the relative contributions of body size and elevation to conductance patterns remains challenging and warrants further study.

      Authors argue that the observed variation in the relationship between water vapour conductance and elevation among and within bird families suggests potential differences in the adaptive response to common selective pressures in terms of eggshell thickness and pore density, and size. The evidence for this is generally weak from the data analyses because the decrease in water vapour conductance with elevation was not consistent across taxonomic groups nor were differences associated with specific patterns in eggshell thickness and pore density, and size.

      We appreciate the reviewer’s comments on the observed variation in water vapor conductance across taxonomic groups. As mentioned in response to comment 7, we have removed the explicit analyses and figures showing within-family comparisons, as these were exploratory and not directly tied to a specific hypothesis. We have also toned down our speculations regarding the potential adaptive drivers of the observed variation. In the revised Discussion, we emphasize the need for further research to explore these patterns and acknowledge the limitations of our current dataset in making strong conclusions about the adaptive responses to selective pressures.

      It is not clear how the authors expected the relationship between water vapour conductance and elevation to differ among taxonomic groups and there was no attempt to explain the biological implication of these differences among taxonomic groups based on the specific traits of the species or their families. This missing piece of information is crucial to justify the argument that differences among taxonomic groups may be due to differences in adaptive response.

      We appreciate the reviewer’s point. To clarify, we were not expecting the relationship between water vapor conductance and elevation to differ among taxonomic groups. Rather, our primary hypothesis was that water vapor conductance would decrease with elevation due to the drier conditions in highland habitats, and we sought to link this pattern with structural characteristics of the eggshell. The suggestion of potential differences among taxonomic groups arose from the lack of a consistent pattern across families, which prompted us to consider possible adaptive variation. We now address this more clearly in the Discussion section, acknowledging the need for further exploration into the potential selective pressures driving this variation among taxonomic groups.

      Reviewer #2 (Public Review):

      This paper represents a strong advance for two main reasons. First, it provides evidence that egg physiology varies with elevation as predicted by the hypothesis that eggs are physiologically adapted to certain climatic conditions. This means egg physiological adaptation is a factor that could influence species' elevational ranges. Second, it is a proof-of-concept study that shows it is possible to measure eggshell physiology for a large number of species in the field in order to test hypotheses. As such, it should inspire many further tests that examine adaptation in egg physiology in the context of species' distributions along environmental gradients.

      There are two caveats that readers should be aware of. First, measuring these traits is difficult, and there remain questions about the efficacy of different methods. For example, the authors note that quantifying eggshell structures is very difficult, with several unresolved questions about their method of using scanning electron microscopy images to measure eggshell pores. Similarly, the authors mention that temperature variation may partially influence their main result that high-elevation eggs lose water at slower rates than low-elevation eggs (temperatures were colder for experiments at high elevations than for low elevations). Second, I regard the analyses of eggshell traits for specific families as exploratory. There are no a priori expectations for how different families might be expected to differ in their patterns. These analyses are fruitful in that they generate additional hypotheses that future work can test. However, it does mean that the statistical significance of eggshell trait relationships with elevation for specific families should be interpreted with caution.

      We thank Reviewer 2 for these insightful comments. As mentioned earlier, measuring these traits is indeed very challenging, and we acknowledge the limitations of our methods, particularly when it comes to using scanning electron microscopy to quantify eggshell structures. We are aware of the unresolved questions around these techniques, and we plan to continue refining these methods in future studies. Regarding the influence of temperature variation on water loss, we recognize that colder temperatures at high elevations may have influenced our results, and we address this potential confounding factor in the Discussion section, Line 257.

      We also agree with the reviewer’s point regarding the exploratory nature of the family-specific analyses. These analyses were not guided by specific hypotheses, other than the expectation of replicating the overall pattern, and we recognize that they should be interpreted with caution. They serve primarily to generate additional hypotheses for future studies. In the revised manuscript, we have toned down the emphasis on the statistical significance of eggshell trait relationships with elevation for specific families, and we emphasize the need for further research to confirm these patterns.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      The authors assess the effectiveness of electroporating mRNA into male germ cells to rescue the expression of proteins required for spermatogenesis progression in individuals where these proteins are mutated or depleted. To set up the methodology, they first evaluated the expression of reporter proteins in wild-type mice, which showed expression in germ cells for over two weeks. Then, they attempted to recover fertility in a model of late spermatogenesis arrest that produces immotile sperm. By electroporating the mutated protein, the authors recovered the motility of ~5% of the sperm; although the sperm regenerated was not able to produce offspring using IVF, the embryos reached the 2-cell state (in contrast to controls that did not progress past the zygote state).

      This is a comprehensive evaluation of the mRNA methodology with multiple strengths. First, the authors show that naked synthetic RNA, purchased from a commercial source or generated in the laboratory with simple methods, is enough to express exogenous proteins in testicular germ cells. The authors compared RNA to DNA electroporation and found that germ cells are efficiently electroporated with RNA, but not DNA. The differences between these constructs were evaluated using in vivo imaging to track the reporter signal in individual animals through time. To understand how the reporter proteins affect the results of the experiments, the authors used different reporters: two fluorescent (eGFP and mCherry) and one bioluminescent (Luciferase). Although they observed differences among reporters, in every case expression lasted for at least two weeks. The authors used a relevant system to study the therapeutic potential of RNA electroporation. The ARMC2-deficient animals have impaired sperm motility phenotype that affects only the later stages of spermatogenesis. The authors showed that sperm motility was recovered to ~5%, which is remarkable due to the small fraction of germ cells electroporated with RNA with the current protocol. The sperm motility parameters were thoroughly assessed by CASA. The 3D reconstruction of an electroporated testis using state-of-the-art methods to show the electroporated regions is compelling.

      The main weakness of the manuscript is that although the authors manage to recover motility in a small fraction of the sperm population, it is unclear whether the increased sperm quality is substantial to improve assisted reproduction outcomes. The authors found that the rescued sperm could be used to obtain 2-cell embryos via IVF, but no evidence for more advanced stages of embryo differentiation was provided. The motile rescued sperm was also successfully used to generate blastocyst by ICSI, but the statistical significance of the rate of blastocyst production compared to non-rescued sperm remains unclear. The title is thus an overstatement since fertility was never restored for IVF, and the mutant sperm was already able to produce blastocysts without the electroporation intervention.

      Overall, the authors clearly show that electroporating mRNA can improve spermatogenesis as demonstrated by the generation of motile sperm in the ARMC2 KO mouse model.

      We thank the reviewer for this thoughtful and constructive comment. We agree that our study demonstrates a partial functional recovery of spermatogenesis rather than a complete restoration of fertility. Our main objective was to establish and validate a proof-of-concept approach showing that mRNA electroporation can rescue the expression of a missing or mutated protein in post-meiotic germ cells and result in the production of motile sperm.

      To address the reviewer’s concern, we have the title and discussion to more accurately reflect the scope of our findings. The new title reads:

      “Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA”

      In the manuscript, we now emphasize that while motility recovery was significant, complete fertility restoration was not achieved. We have also clarified that:

      The 5% recovery in motile sperm represents a substantial improvement considering the small population of germ cells reached by the current electroporation method.

      The 2-cell embryo formation observed after IVF serves as a strong indication of partial functional recovery

      Finally, we now explicitly state in the Discussion that this approach should be considered a therapeutic proof-of-concept, demonstrating feasibility and potential, rather than a fully curative intervention.

      Reviewer #2 (Public review):

      The authors inject, into the rete testes, mRNA and plasmids encoding mRNAs for GFP and then ARMC2 (into infertile Armc2 KO mice) in a gene therapy approach to express exogenous proteins in male germ cells. They do show GFP epifluorescence and ARMC2 protein in KO tissues, although the evidence presented is weak. Overall, the data do not necessarily make sense given the biology of spermatogenesis and more rigorous testing of this model is required to fully support the conclusions, that gene therapy can be used to rescue male infertility.

      In this revision, the authors attempt to respond to the critiques from the first round of reviews. While they did address many of the minor concerns, there are still a number to be addressed. With that said, the data still do not support the conclusions of the manuscript.

      We thank the reviewer for their careful and detailed assessment of our manuscript. We appreciate the concerns raised regarding mRNA stability, GFP localization, and the interpretation of spermatogenesis stages, and we have addressed these points in the manuscript and in the responses below.

      (1) The authors have not satisfactorily provided an explanation for how a naked mRNA can persist and direct expression of GFP or luciferase for ~3 weeks. The most stable mRNAs in mammalian cells have half-lives of ~24-60 hours. The stability of the injected mRNAs should be evaluated and reported using cell lines. GFP protein's half-life is ~26 hours, and luciferase protein's half-life is ~2 hours.

      We thank the reviewer for this important comment. The stability of mRNA-GFP was assessed by RT-QPCR in HEK cells and seminiferous tubule cells (Fig. 5). mRNA-GFP was detected for up to 60 hours in HEK cells and for up to two weeks in seminiferous tubule cells (Fig. 5A). Together, these results suggest that the long-lasting fluorescence observed in our experiments reflects a combination of transcript stability, efficient translation within germ cells and the slow protein turnover that is typical of the spermatogenic lineage.

      (2) There is no convincing data shown in Figs. 1-8 that the GFP is even expressed in germ cells, which is obviously a prerequisite for the Armc2 KO rescue experiment shown in the later figures! In fact, to this reviewer the GFP appears to be in Sertoli cell cytoplasm, which spans the epithelium and surrounds germ cells - thus, it can be oft-confused with germ cells. In addition, if it is in germ cells, then the authors should be able to show, on subsequent days, that it is present in clones of germ cells that are maturing. Due to intracellular bridges, a molecule like GFP has been shown to diffuse readily and rapidly (in a matter of minutes) between adjacent germ cells. To clarify, the authors must generate single cell suspensions and immunostain for GFP using any of a number of excellent commercially-available antibodies to verify it is present in germ cells. It should also be present in sperm, if it is indeed in the germline.

      We thank the reviewer for this insightful comment. To directly address the concern, we performed additional experiments to assess GFP expression in germ cells following in vivo mRNA delivery. GFP-encoding mRNA was injected and electroporated into the testes on day 0. On day 1, testes were collected, enzymatically dissociated, and the resulting seminiferous tubule cell suspensions were cultured for 12 hours. Live cells were then analyzed by fluorescence microscopy (Fig. 10).

      We observed GFP expression in various germ cell types, including pachytene spermatocytes (53,4 %) (Fig 10 A-), round spermatids (25 %) (Fig 10B-E) and in elongated spermatids (11,4%) (Fig 10 C-E). The identification of these cell types was based on DAPI nuclear staining patterns, cell size fig 10 F, non-adherent characteristics, and the use of an enzymatic dissociation protocol.

      Fluorescence imaging revealed strong cytoplasmic GFP signals in each of these populations, confirming efficient transfection and translation of the delivered mRNA. These results demonstrate that the in vivo injection and electroporation protocol enables effective mRNA transfection across multiple stages of spermatogenesis. These results confirm that the injected mRNA is efficiently translated in germ cells at various stages of spermatogenesis. Together, these data validate the germ cell-specific nature of the GFP signal, supporting the Armc2 KO rescue experiments.

      As mentioned previously, we assessed the stability of mRNA-GFP using RT-QPCR in HEK cells and seminiferous tubule cells (see Fig. 5). mRNA-GFP was detected for up to 60 hours in HEK cells and for up to two weeks in seminiferous tubule cells. Together, these results suggest that the long-lasting fluorescence observed in our experiments reflects a combination of transcript stability and local translation within germ cells, as well as the slow protein turnover typical of the spermatogenic lineage.

      Other comments:

      70-1 This is an incorrect interpretation of the findings from Ref 5 - that review stated there were ~2,000 testis-enriched genes, but that does not mean "the whole process involves around two thousand of genes"

      We thank the reviewer for this helpful comment. We agree that our previous phrasing was imprecise. We have revised the sentence to clarify that approximately 2,000 genes show testis-enriched expression, rather than implying that the entire spermatogenic process is limited to these genes. The corrected sentence now reads:

      “Spermatogenesis involves the coordinated expression of a large number of genes, with approximately 2,000 showing testis-enriched expression, about 60% of which are expressed exclusively in the testes”

      74 would specify 'male':

      we have now specified it as you suggested.

      79-84 Are the concerns with ICSI due to the procedure itself, or the fact that it's often used when there is likely to be a genetic issue with the male whose sperm was used? This should be clarified if possible, using references from the literature, as this reviewer imagines this could be a rather contentious issue with clinicians who routinely use this procedure, even in cases where IVF would very likely have worked:

      We thank the reviewer for this important comment. Concerns about ICSI outcomes indeed reflect two partly overlapping causes: the procedure itself (direct sperm injection and associated laboratory manipulations) and the clinical/genetic background of couples undergoing ICSI (especially men with severe male-factor infertility). Large reviews and meta-analyses report a small increase in some perinatal and congenital risks after ART/ICSI, but these studies conclude that it is difficult to fully disentangle procedural effects from parental factors. Importantly, genetic or epigenetic abnormalities in the male (which motivate use of ICSI) likely contribute to adverse outcomes in offspring, while some studies also suggest that ICSI-specific manipulations may alter epigenetic marks in embryos. For these reasons professional bodies recommend reserving ICSI for appropriate male-factor indications rather than as routine insemination for non-male-factor cases

      We have revised the text accordingly to clarify this distinction:

      “ICSI can efficiently overcome the problems faced.  Nevertheless, concerns persist regarding the potential risks associated with this technique, including blastogenesis defect, cardiovascular defect, gastrointestinal defect, musculoskeletal defect, orofacial defect, leukemia, central nervous system tumors, and solid tumors [1-4]. Statistical analyses of birth records have demonstrated an elevated risk of birth defects, with a 30-40 % increased  likelihood in cases involving ICSI [1-4], and a prevalence of birth defects between 1 % and 4 % [3]. It is important to note, however, that the origin of these risks remains debated. Several large epidemiological and mechanistic studies indicate that both the procedure itself (direct microinjection and in vitro manipulation) and the underlying genetic or epigenetic abnormalities often present in men requiring ICSI contribute to the observed outcomes [1, 3] [5, 6] . To overcome these drawbacks, a number of experimental strategies have been proposed to bypass ARTs and restore spermatogenesis and fertility, including gene therapy [7-10].”

      199 Codon optimization improvement of mRNA stability needs a reference;

      We have added the references accordingly: [11-15]

      In one study using yeast transcripts, optimization improved RNA stability on the order of minutes (e.g., from ~5 minutes to ~17 minutes); is there some evidence that it could be increased dramatically to days or weeks?

      We agree with the reviewer that codon optimization can enhance mRNA stability, but available evidence indicates that this effect is moderate. In Saccharomyces cerevisiae, Presnyak et al. (2015) [16] showed that codon optimization increased mRNA half-life from approximately 5 minutes to ~17 minutes, representing a several-fold improvement rather than a shift to days or weeks. Similar codon-dependent stabilization has been observed in mammalian systems, where transcripts enriched in optimal codons exhibit longer half-lives and enhanced translation efficiency [11]; [17]). However, these studies consistently report effects on the scale of minutes to hours. In mammalian cells, the prolonged stability of therapeutic or vaccine mRNAs—lasting for days—is primarily achieved through additional features such as optimized untranslated regions, chemical nucleotide modifications (e.g., N¹-methylpseudouridine), and protective delivery systems, rather than codon usage alone ([18]; [19]).

      Other molecular optimizations that improve in vivo mRNA stability and translation include a poly(A) tail, which binds poly(A)-binding proteins to protect the transcript from 3′ exonuclease degradation and promotes ribosome recycling, and a CleanCap structure at the 5′ end, which mimics the natural Cap 1 configuration, protects against 5′ exonuclease attack, and enhances translational initiation [11-15]. Together, these modifications act synergistically to stabilize the transcript and support efficient translation.

      472-3 The reported half-life of EGFP is ~36 hours - so, if the mRNA is unstable (and not measured, but certainly could be estimated by qRT-PCR detection of the transcript on subsequent days after injection) and EGFP is comparatively more stable (but still hours), how does EGFP persist for 21 days after injection of naked mRNA??

      We thank the reviewer for this important comment. The stability of mRNA-GFP was assessed by RT-QPCR in HEK cells and seminiferous tubule cells (Fig. 5). mRNA-GFP was detected for up to 60 hours in HEK cells and for up to two weeks in seminiferous tubule cells (Fig. 5). Together, these results suggest that the long-lasting fluorescence observed in our experiments reflects a combination of transcript stability, efficient translation within germ cells and the slow protein turnover that is typical of the spermatogenic lineage.

      Curious why the authors were unable to get anti-GFP to work in immunostaining?

      We appreciate the reviewer’s question. We attempted to detect GFP using several commercially available anti-GFP antibodies under various standard immunostaining conditions. However, in our hands, these antibodies consistently produced either no signal or high background staining, making the results unreliable. We therefore relied on direct detection of GFP fluorescence, which provides a more accurate and specific readout of protein expression in our system.

      In Fig. 3-4, the GFP signals are unremarkable, in that they cannot be fairly attributed to any structure or cell type - they just look like blobs; and why, in Fig. 4D-E, why does the GFP signal appear stronger at 21 days than 15 days? And why is it completely gone by 28 days? This data is unconvincing.

      We would like to thank the reviewer for their comments. Figure 3–4 provides a global overview of GFP expression on the surface of the testis. The entire testis was imaged using an inverted epifluorescence microscope, and the GFP signal represents a composite of multiple seminiferous tubules across the tissue surface. Due to this whole-organ imaging approach, it is not possible to resolve individual structures such as the basement membrane or lumen, which is why the signals may appear as diffuse “blobs.”

      Regarding the time-course in Figure 4D–E, the apparent increase in GFP signal at 21 days compared with 15 days likely reflects accumulation and translation of the delivered mRNA in germ cells over time, whereas the absence of signal at 28 days corresponds to the natural turnover and degradation of GFP protein and mRNA in the tissue. We hope this explanation clarifies the observed patterns of fluorescence.

      If the authors did a single cell suspension, what types or percentage of cells would be GFP+? Since germ cells are not adherent in culture, a simple experiment could be done whereby a single cell suspension could be made, cultured for 4-6 hours, and non-adherent cells "shaken off" and imaged vs adherent cells. Cells could also be fixed and immunostained for GFP, which has worked in many other labs using anti-GFP.

      We thank the reviewer for this insightful comment. To directly address the concern, we performed additional experiments to assess GFP expression in germ cells following in vivo mRNA delivery. GFP-encoding mRNA was injected and electroporated into the testes on day 0. On day 1, testes were collected, enzymatically dissociated, and the resulting seminiferous tubule cell suspensions were cultured for 12 hours. Live cells were then analyzed by fluorescence microscopy (Fig. 10).

      We observed GFP expression in various germ cell types, including pachytene spermatocytes (53,4 %) (Fig 10 A-), round spermatids (25 %) (Fig 10B-E) and in elongated spermatids (11,4%) (Fig 10 C-E). The identification of these cell types was based on DAPI nuclear staining patterns, cell size fig 10 F, non-adherent characteristics, and the use of an enzymatic dissociation protocol.

      Fluorescence imaging revealed strong cytoplasmic GFP signals in each of these populations, confirming efficient transfection and translation of the delivered mRNA. These results demonstrate that the in vivo injection and electroporation protocol enables effective mRNA transfection across multiple stages of spermatogenesis.

      These results confirm that the injected mRNA is efficiently translated in germ cells at various stages of spermatogenesis. Together, these data validate the germ cell-specific nature of the GFP signal, supporting the Armc2 KO rescue experiments.

      As mentioned previously, we assessed the stability of mRNA-GFP using RT-QPCR in HEK cells and seminiferous tubule cells (see Fig. 5). mRNA-GFP was detected for up to 60 hours in HEK cells and for up to two weeks in seminiferous tubule cells. Together, these results suggest that the long-lasting fluorescence observed in our experiments reflects a combination of transcript stability and local translation within germ cells, as well as the slow protein turnover typical of the spermatogenic lineage.

      In Fig. 5, what is the half-life of luciferase? From this reviewer's search of the literature, it appears to be ~2-3 h in mammalian cells. With this said, how do the authors envision detectable protein for up to 20 days from a naked mRNA? The stability of the injected mRNAs should be shown in a mammalian cell line - perhaps this mRNA has an incredibly long half-life, which might help explain these results. However, even the most stable endogenous mRNAs (e.g., globin) are ~24-60 hrs.

      We did not directly assess the stability of luciferase mRNA, but we evaluated the persistence of GFP mRNA, which was synthesized and optimized using the same sequence optimization and chemical modification strategy as the luciferase mRNA. In these experiments, mRNA-GFP was detectable in seminiferous tubule cells for up to two weeks after injection. We therefore expect a similar stability profile for the luciferase mRNA. These findings suggest that the prolonged fluorescence or bioluminescence observed in our study likely reflects a combination of factors, including enhanced transcript stability, local translation within germ cells, and the inherently slow protein turnover characteristic of the spermatogenic lineage.

      527-8 The Sertoli cell cytoplasm is not just present along the basement membrane as stated, but also projects all the way to the lumina:

      we clarified the sentence " Sertoli cells have an oval to elongated nucleus and the cytoplasm presents a complex shape (“tombstone” pattern) along the basement membrane, with long projections that extend toward the lumen."

      529-30 This is incorrect, as round spermatids are never "localized between the spermatocytes and elongated spermatids" - if elongated spermatids are present, rounds are not - they are never coincident in the same testis section:

      We thank the reviewer for this important comment and for drawing attention to the detailed staging of the seminiferous epithelium. We agree that the spatial organization of germ cells varies depending on the stage of spermatogenesis. While round spermatids (steps 1–8) and elongated spermatids (steps 9–16) are typically associated with distinct stages, transitional stages of the seminiferous epithelium can contain both cell types in close proximity, reflecting the continuous and overlapping nature of spermatid differentiation (Meistrich, 2013, Methods Mol. Biol. 927:299–307). We have revised the text to clarify this point, indicating that the relative positioning of germ cell types depends on the stage of the seminiferous cycle rather than implying their constant coexistence within the same tubule section.

      Fig. 7. To this reviewer, all of the GFP appears to be in Sertoli cell cytoplasm In Figs 1-8 there is no convincing evidence presented that GFP is expressed in germ cells! In fact, it appears to be in Sertoli cells.

      We thank the reviewer for their observation. As previously mentioned, we have included an additional experiment specifically demonstrating GFP expression in germ cells (fig 10). This new data provides clear evidence that the GFP signal is not restricted to Sertoli cells and confirms successful uptake and translation of GFP mRNA in germ cells.

      Fig. 9 - alpha-tubuline?

      We corrected the figure.

      Fig. 11 - how was sperm morphology/motility not rescued on "days 3, 6, 10, 15, or 28 after surgery", but it was in some at 21 and 35? How does this make sense, given the known kinetics of male germ cell development??

      We note the reviewer’s concern regarding the timing of motile sperm appearance. Variability among treated mice is expected because transfection efficiency differed between spermatogonia and spermatids. Full spermiogenesis requires ~15 days, and epididymal transit adds ~8 days, consistent with motile sperm appearing around 21 days post-injection in some mice.

      And at least one of the sperm in the KO in Fig. B5 looks relatively normal, and the flagellum may be out-of-focus in the image? With only a few sperm for reviewers to see, how can we know these represent the population?

      We thank the reviewer for their comment. Upon closer examination of the image, the flagellum of the spermatozoon in question is clearly abnormally short and this is not due to being out of focus. Furthermore, the supplementary figure shows that the KO consistently lacks normal spermatozoa. These defects are consistent with previous findings from our laboratory [22], confirming that the observed phenotype is representative of the KO population rather than an isolated occurrence.

      Reviewer #3 (Public review):

      Summary:

      The authors used a novel technique to treat male infertility. In a proof-of-concept study, the authors were able to rescue the phenotype of a knockout mouse model with immotile sperm using this technique. This could also be a promising treatment option for infertile men.

      Strengths:

      In their proof-of-concept study, the authors were able to show that the novel technique rescues the infertility phenotype of Armc2 knockout spermatozoa. In the current version of the manuscript, the authors have added data on in vitro fertilisation experiments with Armc2 mRNA-rescued sperm. The authors show that Armc2 mRNA-rescued sperm can successfully fertilise oocytes that develop to the blastocyst stage. This adds another level of reliability to the data.

      Weaknesses:

      Some minor weaknesses identified in my previous report have already been fixed. The technique is new and may not yet be fully established for all issues. Nevertheless, the data presented in this manuscript opens the way for several approaches to immotile spermatozoa to ensure successful fertilisation of oocytes and subsequent appropriate embryo development.

      [Editors' note: The images in Figure 12 do not support the authors' interpretation that 2-cell embryos resulted from in vitro fertilization. Instead, the cells shown appear to be fragmented, unfertilized eggs. Combined with the lack of further development, it seems highly unlikely that fertilization was successful.]

      We thank the reviewer for their careful evaluation and constructive feedback. We appreciate the acknowledgment of the strengths of our study, particularly the proof-of-concept demonstration that Armc2-mRNA electroporation can rescue sperm motility in Armc2 knockout mice.

      Regarding the concern raised by the editor about Figure 12, we would like to clarify two technical points. First, the IVF experiments were performed using CD1 oocytes and B6D2 sperm. Due to strain-specific incompatibilities, fertilization of CD1 oocytes by B6D2 sperm typically does not progress beyond the two-cell stage (Fernández-González [23] et al., 2008, Biology of Reproduction). Therefore, the observation of two-cell embryos represents the expected limit of development in this cross and serves as a strong indication of successful fertilization, even though further development is not possible. Second, the oocytes used in these experiments were treated with collagenase to remove cumulus cells. This enzymatic treatment can sometimes affect the morphology of early embryos, which may explain why the two-cell embryos in Figure 12 appear less regular or somewhat fragmented. We also included a control showing embryos from B6D2 sperm with the same collagenase treatment on CD1 oocytes, which yielded similar appearances (Fig14 A4).

      To provide additional functional evidence, we complemented the IVF experiments with ICSI using rescued Armc2<sup>–/–</sup> sperm and B6D2 oocytes, which allowed embryos to develop to the blastocyst stage. In these experiments, 25% of injected oocytes reached the blastocyst stage with rescued sperm compared to 13% for untreated Armc2–/– sperm (Supplementary Fig. 9) These results support the functional competence of rescued sperm and demonstrate partial recovery of fertilization ability following Armc2 mRNA electroporation.

      We have clarified these points in the revised Results and Discussion sections to emphasize that the IVF data indicate partial functional recovery of rescued sperm rather than full fertility restoration. These clarifications address the editor’s concern while accurately representing the technical limitations of the strain combination used in our experiments.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Fig 12 and Supplementary Fig 9 are mislabeled in the text and rebuttal.

      We thank the reviewer for pointing this out. We have carefully checked the manuscript and the rebuttal text, and corrected all references to Figure 12 and Supplementary Figure 9 to ensure they are accurately labeled and consistent throughout the text.

      Reviewer #3 (Recommendations for the authors):

      The contribution of the newly added authors should be clarified. All other aspects of inadequacy raised in my previous report have been adequately addressed.

      No further comments.

      We thank the reviewer for noting this. The contributions of the newly added authors have been clarified in the Author Contributions section of the revised manuscript. All other points raised in the previous review have been addressed as indicated.

      References

      (1) Hansen, M., et al., Assisted reproductive technologies and the risk of birth defects--a systematic review. Hum Reprod, 2005. 20(2): p. 328-38.

      (2) Halliday, J.L., et al., Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies. Hum Reprod, 2010. 25(1): p. 59-65.

      (3) Davies, M.J., et al., Reproductive technologies and the risk of birth defects. N Engl J Med, 2012. 366(19): p. 1803-13.

      (4) Kurinczuk, J.J., M. Hansen, and C. Bower, The risk of birth defects in children born after assisted reproductive technologies. Curr Opin Obstet Gynecol, 2004. 16(3): p. 201-9.

      (5) Graham, M.E., et al., Assisted reproductive technology: Short- and long-term outcomes. Dev Med Child Neurol, 2023. 65(1): p. 38-49.

      (6) Palermo, G.D., et al., Intracytoplasmic sperm injection: state of the art in humans. Reproduction, 2017. 154(6): p. F93-f110.

      (7) Usmani, A., et al., A non-surgical approach for male germ cell mediated gene transmission through transgenesis. Sci Rep, 2013. 3: p. 3430.

      (8) Raina, A., et al., Testis mediated gene transfer: in vitro transfection in goat testis by electroporation. Gene, 2015. 554(1): p. 96-100.

      (9) Michaelis, M., A. Sobczak, and J.M. Weitzel, In vivo microinjection and electroporation of mouse testis. J Vis Exp, 2014(90).

      (10) Wang, L., et al., Testis electroporation coupled with autophagy inhibitor to treat non-obstructive azoospermia. Mol Ther Nucleic Acids, 2022. 30: p. 451-464.

      (11) Wu, Q., et al., Translation affects mRNA stability in a codon-dependent manner in human cells. eLife, 2019. 8: p. e45396.

      (12) Gallie, D.R., The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes & Development, 1991. 5(11): p. 2108-2116.

      (13) Henderson, J.M., et al., Cap 1 messenger RNA synthesis with co-transcriptional CleanCap® analog improves protein expression in mammalian cells. Nucleic Acids Research, 2021. 49(8): p. e42.

      (14) Stepinski, J., et al., Synthesis and properties of mRNAs containing novel “anti-reverse” cap analogs. RNA, 2001. 7(10): p. 1486-1495.

      (15) Sachs, A.B., P. Sarnow, and M.W. Hentze, Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell, 1997. 89(6): p. 831-838.

      (16) Presnyak, V., et al., Codon optimality is a major determinant of mRNA stability. Cell, 2015. 160(6): p. 1111-24.

      (17) Cao, D., et al., Unlock the sustained therapeutic efficacy of mRNA. J Control Release, 2025. 383: p. 113837.

      (18) Karikó, K., et al., Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther, 2008. 16(11): p. 1833-40.

      (19) Pardi, N., et al., mRNA vaccines — a new era in vaccinology. Nature Reviews Drug Discovery, 2018. 17(4): p. 261-279.

      (20) Meistrich, M.L. and R.A. Hess, Assessment of Spermatogenesis Through Staging of Seminiferous Tubules, in Spermatogenesis: Methods and Protocols, D.T. Carrell and K.I. Aston, Editors. 2013, Humana Press: Totowa, NJ. p. 299-307.

      (21) Au - Mäkelä, J.-A., et al., JoVE, 2020(164): p. e61800.

      (22) Coutton, C., et al., Bi-allelic Mutations in ARMC2 Lead to Severe Astheno-Teratozoospermia Due to Sperm Flagellum Malformations in Humans and Mice. Am J Hum Genet, 2019. 104(2): p. 331-340.

      (23) Fernández-Gonzalez, R., et al., Long-term effects of mouse intracytoplasmic sperm injection with DNA-fragmented sperm on health and behavior of adult offspring. Biol Reprod, 2008. 78(4): p. 761-72.

    1. Author response:

      Reviewer #1 (Public Review):

      The heterogeneity within the neutrophil population is becoming clear. However, it was not clear if neutrophil progenitors are also heterogenous. Because neutrophils are short-lived, it is technically challenging to tackle the question. This study used a system to isolate and expand clonal neutrophil progenitors (granulocyte-monocyte progenitors; GMPs) to achieve molecular and functional profiling. In the study, transcriptional profiling was performed by RNAseq and ATACseq. Functional assays were performed ex vivo to examine phagocytosis, ROS production, NET formation, and neutrophil swarming using Candida albicans, as well as C. glabrata and C. auris. The strengths of this study include the use of the neutrophil clone system to track GMPs developing into neutrophils. The clone-based approach made it possible to evaluate the functions of multiple neutrophil subpopulations. Limitations of this study include the dependency on ex vivo approaches and the modest degree of heterogeneity within presented neutrophils. Nevertheless, the finding - the heterogeneity of neutrophils can be traced back to the GMP stage - is significant.

      Reviewer #2 (Public Review):

      The stated goal of the authors is to establish and characterize an experimental system to study neutrophil heterogeneity in a manner that allows for functional outcomes to be probed. To do so, they start with murine GMPs that are conditionally immortalized by ER-HoxB8 expression and make single-cell clonal populations to ask whether those GMPs or neutrophils derived by differentiating such clonal GMPs harbor heterogeneity. At a conceptual level, this is an innovative approach that could shed light on mechanisms of neutrophil heterogeneity that have been described in both health and disease. They perform bulk multi-omics and functional analyses of both the clonal GMPs and neutrophil-like cells, including transcriptional and epigenetic profiling. However, the major weakness of the study is that the authors do not provide rigorous or convincing data that the cells they derive are truly mature neutrophils. To the contrary, the neutrophil-like cells lack Ly6G expression and so the authors fall back on using CD11b as the primary marker for delineating neutrophils; however, CD11b is expressed by both myeloid progenitors and some premature and mature myeloid lineages that are not neutrophils. They acknowledge this shortcoming, but they make an assumption that Ly6G expression is the only way in which the cells they derive are different from primary neutrophils without presenting any evidence indicating such. The authors use only SCF during the maturation of ER-HoxB8 GMPs into leukocytes, rather than including other cytokines such as G-CSF (or use in vivo maturation) that could have better-induced differentiation and maturation into granulocytes/neutrophils.

      Thank you. Of note, reviewer #1 also commented on the question of including other cytokines during the neutrophil differentiation process. We have included our response to reviewer #1 below, which includes the use of GM-CSF and IL-4.

      “We have now demonstrated enhanced Ly6G expression with GM-CSF and IL-4 treatment in a new Supplementary Figure 1.

      GMPs were washed out of estradiol-containing media and placed in fresh media containing 10 ng/ml GM-CSF and/or 1 ng/ml IL-4 for four days. Cells were collected and stained with CD117 (APC), F4/80 (AlexaFluor 488), Ly6G (PE), and CD11b (BV421). Neutrophil clones were run in biological triplicates, and undifferentiated GMPs were included as a negative control.

      GMPs stain as CD117POS / F4/80NEG / Ly6GNEG / CD11bNEG, indicating they are immature. The clones removed from estradiol differentiate and lose their CD117 expression. The mature cells remain F4/80NEG, as expected for mature neutrophils.

      The addition of GM-CSF to the media led to a significant increase in the expression of Ly6G. The addition of both GM-CSF + IL-4 did not further increase the proportion of Ly6G+ cells, and we have altered our statement slightly in the main text to reflect this finding (line 139).”

      The authors did not use their transcriptional analyses to further establish that the cells they derive from ER-HoxB8 GMPs are similar/different from primary murine neutrophils. Unfortunately, this shortcoming means that all of the analyses of neutrophil-like cells derived from clonal GMPs may or may not represent the transcriptional, epigenetic, etc. profile of a true mature neutrophil.

      Thank you. The ER-Hoxb8 system has been well-characterized by many authors at the function and at the transcriptional level, confirming that the cells highly reflect that same gene expression pattern as mature neutrophils. This was actually recently reviewed by Lail et al. (Traffic, 2022, PMID: 36117140). In terms of our analysis, we used transcriptional profiling to examine heterogeneity between different single-cell clones and not to re-validate the similarity with primary neutrophils.

      It is also not rigorously addressed whether what they call PMNs derived from clonal GMPs are a transcriptionally uniform population or if they harbor heterogeneity within the bulk population.

      Thank you. The reviewer poses an interesting, albeit challenging, question of whether even a single GMP clone can differentiate and result in mature neutrophil heterogeneity. To address this would require single cell sequencing of the resulting cells which we did not perform. We relied on single cell subcloning of the immature granulocyte monocyte progenitors to ensure a genetically identical clonal population. This was then additional confirmed by the retroviral insertional analysis. These analyses confirmed the clonal nature of our starting population, from which we posed the question of as whether the neutrophils derived from these clonal GMPs resulted in mature cells with consistent functional heterogeneity, which was indeed the case.

      Overall, while conceptually intriguing and in pursuit of an experimental system that would be impactful for the field, the study as performed has critical flaws.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Summary:

      In their study, the authors investigated the F. graminearum homologue of the Drosophila Misato-Like Protein DML1 for a function in secondary metabolism and sensitivity to fungicides.

      Strengths:

      Generally, the topic of the study is interesting and timely, and the manuscript is well written, albeit in some cases, details on methods or controls are missing.

      Weaknesses:

      However, a major problem I see is with the core result of the study, the decrease in the DON content associated with the deletion of FgDML1. Although some growth data are shown in Figure 6, indicating a severe growth defect, the DON production presented in Figure 3 is not related to biomass. Also, the method and conditions for measuring DON are not described. Consequently, it could well be concluded that the decreased amount of DON detected is simply due to decreased growth, and the specific DON production of the mutant remains more or less the same.

      To alleviate this concern, it is crucial to show the details on the DON measurement and growth conditions and to relate the biomass formation under the same conditions to the DON amount detected. Only then can a conclusion as to an altered production in the mutant strains be drawn.

      We appreciate it very much that you spent much time on my paper and give me good suggestions, we tried our best to revise the manuscript. I have revised my manuscript according to your suggestions. The point to point responds to the reviewer’s comments are listed as following. Our method for DON quantification was based on the amount per unit of mycelium. After obtaining the absorbance value from the ELISA reaction, the concentration of DON was calculated according to a standard curve and a formula, then divided by the dry weight of the mycelium to obtain the DON content per unit of mycelium, with the results finally expressed in µg/g.

      (1) Line 139f

      ... FgDML1 is a critical positive regulator of virulence ....

      Clearly, the deletion of FgDML1 impacts virulence, but it is too much of a general effect to say it is a regulator. DML1 acts high up in the cascade, impacting numerous processes, one of which is virulence. Generally, it has to be considered that deletion of DML1 causes a severe growth defect, which in turn is likely to lead to a plethora of effects. Besides discussing this fact, please also revise the manuscript to avoid references to "direct effects" or "regulator".

      Thank you very much for your advice. Our method for determining the amount of DON is based on the amount of mycelium per unit. After obtaining the absorbance value through Elisa reaction, we calculate the concentration of DON toxin according to the established standard curve and formula. Then, we divide it by the dry weight of mycelium to obtain the DON toxin content per unit mycelium, and finally present the results in µg/g. In summary, we conclude that the decrease in DON production by ΔFgDML is not due to slower hyphal growth, but rather a decrease in the ability of unit hyphae to produce DON toxins compared to the wild type. Given the decrease in DON toxin synthesis caused by FgDML1 deficiency, we believe that using a regulator is reasonable.

      (2) Line 143

      Please define "toxin-producing conditions".

      Thank you very much for your advice. We have accurately defined the conditions for toxin-producing conditions in the manuscript' toxin-inducing conditions '(28°C, 145 ×g, 7 days incubation)' (in L163-164)

      (3) Line 149

      A brief intro on toxisomes should be provided in the introduction to better integrate this into the manuscript's results.

      Thank you very much for your advice. We have added corresponding content about toxin producing bodies in the introduction section 'The biosynthesis of DON entails a reorganization of the endoplasmic reticulum into a specialized compartment termed the "toxisome" (Tang et al., 2018). The assembly of the toxisome coincides with the aggregation of key biosynthetic enzymes, which in turn enhances the efficiency of DON production. Concurrently, this compartmentalization serves as a self-defense mechanism, protecting the fungus from the autotoxicity of TRI pathway intermediates (Boenisch et al., 2017). The proteins TRI1, TRI4, TRI14, and Hmr1 are confirmed constituents of this structure(Kistler and Broz, 2015; Menke et al., 2013).' (in L86-93)

      (4) Line 153

      DON production decreases by about 80 %, but not to 0. Consequently, DML1 is important, but NOT essential for DON production.

      Thank you very much for your advice. We have made changes to the wording of the corresponding sections based on your suggestions. 'FgDML1 is essential for the biosynthesis of the DON toxin. '(in L161)

      (5) Line 168ff

      Please provide a reference for FgDnm1 being critical for mitochondrial fission and state whether such an interaction has been shown in other organisms.

      Thank you very much for your advice. We have made changes to the wording of the corresponding sections based on your suggestions. 'FgDnm1 is a key dynamin-related protein mediating mitochondrial fission(Griffin et al., 2005; Kang et al., 2023), suggesting that FgDML1 may form a complex with FgDnm1 to regulate mitochondrial fission and fusion processes. To our knowledge, this is the first report documenting an interaction between DML1 and Dnm in any fungal species, including model organisms such as S. cerevisiae. This novel finding provides new insights into the molecular mechanisms underlying mitochondrial dynamics in filamentous fungi. '(in L277-283)

      (6) Line 178

      Please specify whether Complex III activity was related to biomass and provide a p-value or standard deviation for the value.

      Thank you very much for your question. The activity determination of complex III was completed using a complex III enzyme activity kit (Solarbio, Beijing, China) (Li, et al 2022; Wang, et al 2022). Take 0.1 g of standardized mycelium as the sample for the experiment. Given that the mycelium has been homogenized, we believe that there is no necessary correlation between the activity and biomass of complex III. And we also refined the specific measurement steps in the article. ' Briefly, 0.1 g of mycelia was homogenized with 1 mL of extraction buffer in an ice bath. The homogenate was centrifuged at 600 ×g for 10 min at 4°C. The resulting supernatant was then subjected to a second centrifugation at 11,100 ×g for 10 min at 4°C. The pellet was resuspended in 200 μL of extraction buffer and disrupted by ultrasonication (200 W, 5 s pulses with 10 s intervals, 15 cycles). Complex III enzyme activity was finally measured by adding the working solution as per the manufacturer's protocol. Each treatment group contains three biological replicates and three technical replicates. '(in L511-517)

      Li C, et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2 axis. Cell Stem Cell. 2022 Jul 7; 29(7):1119-1134.e7. doi: 10.1016/j.stem.2022.06.004. PMID: 35803229.

      Wang K, et al. Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner. Nat Commun. 2022 Dec 13;13(1):7703. doi: 10.1038/s41467-022-35492-y. PMID: 36513690; PMCID: PMC9745290

      (7) Line 185

      Albeit this headline is a reasonable hypothesis, you actually did not show that the conformation is altered. Please reword accordingly.

      Please also add references for cyazofamid acting on the QI site versus other fungicides acting on the QO site.

      Thank you very much for your advice. We have made changes to the wording of the corresponding sections based on your suggestions. 'Overexpression of FgQCR2, FgQCR8, and FgQCR9 may alters the conformation of the QI site, resulting in reduced sensitivity to cyazofamid. '(in L212-213). For fungicides targeting Qi and QO sites, we have added corresponding descriptions in the respective sections 'Numerous fungicides have been developed to inhibit the Qo site (e.g., pyraclostrobin, azoxystrobin)(Nuwamanya et al., 2022; Peng et al., 2022) and the Qi site (e.g., cyazofamid)(Mitani et al., 2001) of the cytochrome bc1 complex. '(in L327-329)

      (8) Line 200

      This section on growth should be moved up right after introducing the mutant strain.

      Thank you very much for your advice. We have advanced the part of nutritional growth and sexual asexual development before DON toxin to promote better reading and understanding. We arranged the sequence in the previous way to emphasize the new discovery between mitochondria and DON toxin. We found a significant decrease in DON toxin in ΔFgDML1, defects in the formation of toxin producing bodies, and downregulation of FgTRis at both the gene and protein levels. In summary, we believe that the absence of FgDML1 does indeed lead to a decrease in the content of DON toxin, and FgDML1 plays a regulatory role in the synthesis of DON toxin. In addition, our measurements of DON toxin, acetyl CoA, ATP and other indicators are all based on the amount per unit hyphae, excluding differences caused by hyphal biomass or growth. We have further refined the materials and methods to facilitate better reading and understanding.

      (9) Line 203

      "... significantly reduced growth rates ..."

      This is not what was measured here. Figure 6A shows a plate assay that can be used to assess hyphal extension. In the figure, it is also visible that the mycelium of the deletion mutant is much denser, maybe due to increased hyphal branching. Please reword.

      Additionally, it is important to include a biomass measurement here under the conditions used for DON assessment. Hyphal extension measurements cannot be used instead of biomass.

      Thank you very much for your advice. We have made changes to the wording of the corresponding sections based on your suggestions. 'The ΔFgDML1 strain displayed a distinct growth phenotype characterized by retardation in radial growth and the formation of more compact, denser hyphal networks on all tested media compared to the PH-1 and ΔFgDML-C strains. '(in L136-138).

      (10) Line 217

      Please include information on how long the cultures were monitored. Given the very slow growth of the mutant, perithecia formation may be considerably delayed beyond 14 days.

      Thank you very much for your advice. Based on your suggestion, we have extended the incubation time for sexual reproduction to 21 days to more accurately evaluate its sexual reproduction ability. Our results show that even after 21 days, Δ FgDML1 still cannot produce ascospores and ascospores, which proves that the absence of FgDML1 does indeed cause sexual reproduction defects in F. graminearum.

      Author response image 1.

      Discussion

      (11) Please mention your summary Figure 8 early on in the discussion, and explain conclusions with this figure in mind. Please avoid repetition of the results section as much as possible.

      Also, please state clearly what was already known from previous research and is in agreement with your results, and what is new (in fungi or generally).

      Thank you very much for your advice. Based on your suggestion, we mentioned Fig8 earlier in the first half of the discussion and provided guidance for the following text. We also conducted a more comprehensive discussion by analyzing our research results and comparing them with previous studies. 'Our study defines a novel mechanism through which FgDML1 governs mitochondrial homeostasis. We demonstrate that FgDML1 directly interacts with the key mitochondrial fission regulator FgDnm1 and positively modulates cellular bioenergetic metabolism, as evidenced by elevated ATP and acetyl-CoA levels (Fig. 8). '(in L250-253). 'The Misato/DML1 protein family is evolutionarily conserved from yeast to humans and plays a critical role in mitochondrial regulation. In S. cerevisiae, DML1 is an essential gene; its deletion is lethal, while its overexpression results in fragmented mitochondrial networks and aberrant cellular morphology, underscoring its necessity for normal mitochondrial function (Gurvitz et al., 2002). Similarly, in Homo sapiens, the homolog Misato localizes to the mitochondrial outer membrane, and both its depletion and overexpression are sufficient to disrupt mitochondrial morphology and distribution (Kimura and Okano, 2007). '(in L241-244).

      (12) Line 262ff

      Please specify if this interaction was shown previously in other organisms and provide references.

      Thank you very much for your advice. We have clearly stated in the corresponding section that the interaction between FgDML and FgDnm is the first reported, and to our knowledge, no relevant reports have been found in other species so far. ' Notably, FgDML1 was found to interact with FgDnm1 (Fig. 5E), FgDnm1 is a key dynamin-related protein mediating mitochondrial fission(Griffin et al., 2005; Kang et al., 2023), suggesting that FgDML1 may form a complex with FgDnm1 to regulate mitochondrial fission and fusion processes. To our knowledge, this is the first report documenting an interaction between DML1 and Dnm in any fungal species, including model organisms such as S. cerevisiae. This novel finding provides new insights into the molecular mechanisms underlying mitochondrial dynamics in filamentous fungi. '(in L276-283)

      (13) Line 287ff

      There is no result that would justify this speculation. Please remove.

      Thank you very much for your advice. We have modified the corresponding wording in the corresponding section. 'In conclusion, our findings suggest that the overexpression of assembly factors FgQCR2, FgQCR7, and FgQCR8 in ΔFgDML1 potentially modifies the conformation of the Qi site, which specifically modulates the sensitivity of F. graminearum to cyazofamid. '(in L352-355)

      Materials and methods

      (14) A table with all primer sequences used in the study and their purpose is missing. For every experiment, the number of technical and biological replicates needs to be stated.

      Thank you very much for your advice. We have presented all the primers used in this study in Supplementary Table 1 (in Table S1) .We added the number of technical and biological replicates in the material and method descriptions for each experiment. 'For each sample, a total of 200 conidia were counted. The experiment included three biological replicates with three technical replicates each.'(in L434-436). 'Each treatment group contains three biological replicates. '(in L444-445). 'Each treatment group contains three biological replicates and three technical replicates. ' (in L463-464). 'Each treatment group contains three biological replicates and three technical replicates. '(in L474-475). 'Each treatment group contains three biological replicates. '(in L483). 'Each treatment group contains three biological replicates and three technical replicates.'(in L501-502). 'Each treatment group contains three biological replicates and three technical replicates. '(in L516-517). 'The experiment was independently repeated three times. '(in L533-534).

      (15) Line 369ff

      Please provide final concentrations used for assays here.

      Thank you very much for your advice. The final concentration has been displayed in the Figure (in Fig6. A, B) (in Fig. S3). And we have provided supplementary Table 2 to reflect the concentration in a more intuitive way.(in Table. S2)

      (16) Line 383

      Please provide a reference or data on the use of F2du for transformant selection and explain the abbreviation.

      Thank you very much for your advice. Based on your suggestion, we have provided the full name and references of F2du. 'Transformants were selected on PDA plates containing either 100 μg/mL Hygromycin B (Yeasen, Shanghai, China) or 0.2 μmol/mL 5-Fluorouracil 2'-deoxyriboside (F2du) (Solarbio, Beijing, China)(Zhao et al., 2022). '(in L405-407).

      (17) Line 407

      Please provide a reference for the method and at least a brief description.

      Thank you very much for your advice. Based on your suggestion, we have added references and provided a brief introduction to the method. 'As previously described (Tang et al., 2020; Wang et al., 2025), Specifically, coleoptiles were inoculated with conidial suspensions and incubated for 14 days, while leaves were inoculated with fresh mycelial plugs and incubated for 5 days, followed by observation and quantification of disease symptoms. DON toxin was measured using a Wise Science ELISA-based kit (Wise Science, Jiangsu, China) (Li et al., 2019; Zheng et al., 2018). '(in L466-471)

      (18) Line 414ff

      Also, here, the amount of biomass has to be considered for the measurement to be able to distinguish if actually less of the compounds were produced or if the effect seen was merely due to an altered amount of biomass present.

      Thank you very much for your advice. We believe that biomass is not within the scope of our measurement indicators, as we have measured and calculated based on unit hyphae. Therefore, we have ruled out experimental bias caused by a decrease in biomass.

      RNA and RT-qPCR

      (19) Line 461

      When the strains were transferred to AEA medium, was the biomass measured, at least wet weight, and in which culture volume was it done? It makes a big difference if the amount of (wet) biomass dilutes a small amount of fungicide-containing culture or if biomass is added in at least roughly equal amounts in sufficient growth medium to ensure equal conditions.

      Thank you very much for your question. Our sample processing controlled the wet weight of the samples before dosing, ensuring that the wet weight of the mycelium obtained from each sample before dosing was 0.2g. The mycelium was obtained through AEA with a volume of 100mL. This ensured consistency in the initial biomass between groups before dosing, and also ensured the accuracy of the drug concentration.

      (20) Line 466

      Please provide the name and supplier of the kit.

      Thank you very much for your advice. We have added corresponding content in the corresponding location. 'Mycelium was collected and total RNA was extracted following the instructions provided by the Total RNA Extraction Kit (Tiangen, Beijing, China).' (in L523-524).

      (21) All primer sequences must be provided in a table.

      Thank you very much for your advice. We have presented all the primers used in this study in Supplementary Table 1. (in Table S1).

      (22) For RT qPCR it is essential to check the RNA quality to be sure that the obtained results are not artifacts due to varying quality, which may exceed differences. Please state how quality control was done and which threshold was applied for high-quality RNA to be used in RTqPCR (like RIN factor, etc).

      Thank you very much for your question. We performed stringent quality control on the extracted total RNA. First, a micro-spectrophotometer was used to measure RNA concentration and purity, confirming that the A260/A280 ratio was between 1.8 and 2.0 and the A260/A230 ratio was greater than 2.0, indicating good RNA purity without significant protein or organic solvent contamination.Subsequently, verification by agarose gel electrophoresis revealed distinct 28S and 18S rRNA bands, demonstrating good RNA integrity and absence of degradation.

      Author response image 2.

      (B): Minor Comments:

      (1) Please increase the font size of the labels and annotations of the figures; it is hard to read as it is now.

      Thank you very much for your advice. We have increased the size of annotations or numerical labels in the corresponding images for better reading.

      (2) Throughout the manuscript: Please check that all abbreviations are explained at first use.

      Thank you very much for your advice. We have checked the entire text to ensure that abbreviations have their full names when they first appear.

      (3) I do hope that the authors can clarify all concerns and provide an amended manuscript of this interesting story.

      Thank you very much for your advice. Sincerely thank you for your suggestions and questions, which have been very helpful to us.

      Reviewer #2:

      The manuscript entitled "Mitochondrial Protein FgDML1 Regulates DON Toxin Biosynthesis and Cyazofamid Sensitivity in Fusarium graminearum by affecting mitochondrial homeostasis" identified the regulatory effect of FgDML1 in DON toxin biosynthesis and sensitivity of Fusarium graminearum to cyazofamid. The manuscript provides a theoretical framework for understanding the regulatory mechanisms of DON toxin biosynthesis in F. graminearum and identifies potential molecular targets for Fusarium head blight control. The paper is innovative, but there are issues in the writing that need to be addressed and corrected.

      We appreciate it very much that you spent much time on my paper and give me good suggestions, we tried our best to revise the manuscript. I have revised my manuscript according to your suggestions with red words. In the response comments, to highlight the specific positions of the revised parts in the manuscript with red line number. The point to point responds to the reviewer’s comments are listed as following.

      Weaknesses:

      (1) The authors speculate that cyazofamid treatment caused upregulation of the assembly factors, leading to a change in the conformation of the Qi protein, thus restoring the enzyme activity of complex III. But no speculation was given in the discussion as to why this would lead to the upregulation of assembly factors, and how the upregulation of assembly factors would change the protein conformation, and is there any literature reporting a similar phenomenon? I would suggest adding this to the discussion.

      Thank you very much for your advice. Based on your suggestion, we have added content related to the assembly factor of complex III in the discussion section and made modifications to the corresponding wording. 'Previous studies have reported that mutations in the Complex III assembly factors TTC19, UQCC2, and UQCC3 impair the assembly and activity of Complex III (Feichtinger et al., 2017; Wanschers et al., 2014). '(in L345-347). 'In conclusion, our findings suggest that the overexpression of assembly factors FgQCR2, FgQCR7, and FgQCR8 in ΔFgDML1 potentially modifies the conformation of the Qi site, which specifically modulates the sensitivity of F. graminearum to cyazofamid. '(in L352-355).

      (2) Would increased sensitivity of the mutant to cell wall stress be responsible for the excessive curvature of the mycelium?

      Thank you very much for your question. We believe that the sensitivity of ΔFgDML1 to osmotic stress is reduced, which may not be related to hyphal bending, as shown in the Author response image 3. During the conidia stage, ΔFgDML1 cannot germinate in YEPD, while the application of 1M Sorbitol promotes its germination. But it is caused by internal unknown mechanisms, which is also the focus of our future research.

      Author response image 3.

      (3) The vertical coordinates of Figure 7B need to be modified with positive inhibition rates for the mutants.

      Thank you very much for your advice. The display in Figure 7B truly reflects its inhibition rate. In the Δ FgDML1 mutant, when subjected to osmotic stress treatment, the inhibition rate becomes negative, indicating that the colony growth is greater than that of the CK. Therefore, the negative inhibition rate is shown in Figure 7B.

      (1) In Figure 1B, Figure 3C, and Figure 6C, the scale below the picture is not clear. In Figure 5D, the histogram is unclear, and it is recommended to redraw the graph.

      Thank you very much for your advice. The issue with the above images may be due to Word compression. We have changed the settings and enlarged the images as much as possible to better display them.

      (2) The full Latin name of the strain should be used in the title of figures and tables.

      Thank you very much for your advice. Based on your suggestion, we have used the full names of the strains appearing in the title of figures and tables.

      (3) Proteins in line 117 should be abbreviated.

      Thank you very much for your advice. Based on your suggestion, we have abbreviated the corresponding positions. 'The DML1 protein from S. cerevisiae was used as a query for a BLAST search against the Fusarium genome database, resulting in the identification of the putative DML1 gene FgDML1 (FGSG_05390) in F. graminearum. '(in L118-120).

      (4) The sentence in lines 187-189, which is supposed to introduce why the test is sensitive to the three drugs, is currently illogical.

      Thank you very much for your advice. Based on your suggestion, we have made modifications to the corresponding sections. 'Since Complex III is involved in the action of both cyazofamid (targeting the QI site) and pyraclostrobin (targeting the QO site), the sensitivity of ΔFgDML1 to cyazofamid and pyraclostrobin was investigated. ' (in L214-216).

      (5) The expression of FgQCR2, FgQCR7, and FgQCR8 was significantly upregulated in ΔFgDML1 at transcription levels. Do FgQCR2, FgQCR8, and FgQCR9 show upregulated expression at the protein level?

      Thank you very much for your question. Based on your suggestion, we evaluated the protein expression levels of FgQCR2, FgQCR7, and FgQCR8 in PH-1 and ΔFgDML1, and we found that the protein expression levels of FgQCR2, FgQCR7, and FgQCR8 in ΔFgDML1 were higher than those in PH-1. (in Fig. 6F).

      (6) In Figure 7B, it is recommended to adjust the position of the horizontal axis labels in the histogram.

      Thank you very much for your advice. Based on your suggestion, we have made modifications to the corresponding sections.(in Fig. 7B)

      (7) There are numerous errors in the writing of gene names in the text. Please check the full text and change the writing of gene names and mutant names to italic.

      Thank you very much for your advice. We have checked the entire text to ensure that all genes have been italicized.

      (8) All acronyms should be spelled out in figure and table captions. e.g., F. graminearum.

      Thank you very much for your advice. Based on your suggestion, we have used the full names of the strains appearing in the title of figures and tables.

      (9) In line 492, P should be lowercase and italic.

      Thank you very much for your advice. Based on your suggestion, we have made adjustments to the corresponding content.

      Reviewer #3:

      Summary:

      The manuscript "Mitochondrial 1 protein FgDML1 regulates DON toxin biosynthesis and cyazofamid sensitivity in Fusarium graminearum by affecting mitochondrial homeostasis" describes the construction of a null mutant for the FgDML1 gene in F. graminearum and assays characterising the effects of this mutation on the pathogen's infection process and lifecycle. While FgDML1 remains underexplored with an unclear role in the biology of filamentous fungi, and although the authors performed several experiments, there are fundamental issues with the experimental design and execution, and interpretation of the results.

      Strengths:

      FgDML1 is an interesting target, and there are novel aspects in this manuscript. Studies in other organisms have shown that this protein plays important roles in mitochondrial DNA (mtDNA) inheritance, mitochondrial compartmentalisation, chromosome segregation, mitochondrial distribution, mitochondrial fusion, and overall mitochondrial dynamics. Indeed, in Saccharomyces cerevisiae, the mutation is lethal. The authors have carried out multi-faceted experiments to characterise the mutants.

      Weaknesses:

      However, I have concerns about how the study was conceived. Given the fundamental importance of mitochondrial function in eukaryotic cells and how the absence of this protein impacts these processes, it is unsurprising that deletion of this gene in F. graminearum profoundly affects fungal biology. Therefore, it is misleading to claim a direct link between FgDML1 and DON toxin biosynthesis (and virulence), as the observed effects are likely indirect consequences of compromised mitochondrial function. In fact, it is reasonable to assume that the production of all secondary metabolites is affected to some extent in the mutant strains and that such a strain would not be competitive at all under non-laboratory conditions. The order in which the authors present the results can be misleading, too. The results on vegetative growth rate appeared much later in the manuscript, which should have come first, as the FgDML1 mutant exhibited significant growth defects, and subsequent results should be discussed in that context. Moreover, the methodologies are not described properly, making the manuscript hard to follow and difficult to replicate.

      We appreciate it very much that you spent much time on my paper and give me good suggestions, we tried our best to revise the manuscript. I have revised my manuscript according to your suggestions with red words. In the response comments, to highlight the specific positions of the revised parts in the manuscript with red line number. The point to point responds to the reviewer’s comments are listed as following.

      For weaknesses,we arranged the sequence in this way to emphasize the novel discovery between mitochondria and DON toxin. We found a significant decrease in DON toxin in Δ FgDML1, defects in the formation of toxin producing bodies, and downregulation of FgTRis at both the gene and protein levels. In summary, we believe that the absence of FgDML1 does indeed lead to a decrease in the content of DON toxin, and FgDML1 plays a regulatory role in the synthesis of DON toxin. In addition, our measurements of DON toxin, acetyl CoA, ATP and other indicators are all based on the amount per unit hyphae, excluding differences caused by hyphal biomass or growth. We have further refined the materials and methods to facilitate better reading and understanding.

      (1) Lines 37-39: The disease itself does not produce toxins; it is the fungus that causes the disease that produces toxins. Moreover, the disease symptoms observed are likely caused by the toxins produced by the fungus.

      Thank you very much for your advice. We have made modifications to the wording of the corresponding sections. 'Studies have shown that increased DON levels are positively correlated with the pathogenicity rate of F. graminearum.'(in L36-37).

      (2) Lines 82-87: While it is challenging to summarise the role of ATP in just a few words, this section needs improvement for clarity and accuracy. Additionally, I do not believe that drawing a direct link between mitochondrial defects and toxin production is an appropriate strategy in this case.

      Thank you very much for your advice. Based on your suggestion, we have added corresponding descriptions in the corresponding positions to provide more information on the relationship between ATP and toxins, in order to better prepare for the following text. 'Pathogen-intrinsic ATP homeostasis is recognized as a critical, rate-limiting determinant for toxin biosynthesis. Previous studies indicate that dual-target inhibition of ATP synthase (AtpA) and adenine deaminase (Ade) by a specific small-molecule probe effectively depletes intracellular ATP, consequently suppressing the synthesis of key virulence factors TcdA and TcdB transcriptionally and translationally(Marreddy et al., 2024). The systemic toxicity of Anthrax Edema Toxin (ET) is primarily attributed to its catalytic activity, which depletes the host cell's ATP reservoir, thereby triggering a bioenergetic collapse that culminates in cell lysis and death(Liu et al., 2025). '(in L78-86).

      (3) Lines 125-126: The manuscript does not clearly describe how subcellular localisation was determined. This methodology needs to be properly detailed.

      Thank you very much for your advice. The subcellular localization was validated through co-localization analysis with MitoTracker Red CMXRos, a mitochondrial-specific dye. The observed overlap between the FgDML1-GFP signal and the mitochondrial marker confirmed mitochondrial localization. Based on these results, we determined that FgDML1 is definitively localized to the mitochondria.We have incorporated this description in the appropriate section of the manuscript. 'Furthermore, subcellular localization studies confirmed that FgDML1 localizes to mitochondria, as demonstrated by colocalization with a mitochondria-specific dye MitoTracker Red CMXRos (Fig. 1B). '(in L125-127).

      (4) Regarding the organisation of the Results section, it needs to be revised. While I understand the authors' intention to emphasise the impact on virulence, the results showing how FgDML1 deletion affects vegetative growth, asexual and sexual reproduction, and sensitivity to stressors should be presented before the virulence assays and effects on DON production. Additionally, the authors do not provide any clear evidence that FgDML1 directly interacts with proteins involved in asexual or sexual reproduction, stress responses, or virulence. Therefore, it is misleading to suggest that FgDML1 directly regulates these processes. The observed phenotypes are, rather, a consequence of severely impaired mitochondrial function. Without functional mitochondria, the cell cannot operate properly, leading to widespread physiological defects. In this regard, statements such as those in lines 139-140 and 343-344 are misleading.

      Thank you very much for your advice. We have adjusted the order of the images based on your suggestion, placing the characterization of ΔFgDML1 in nutritional growth, sexual reproduction, and other aspects before DON toxin. And we have made adjustments to the corresponding statements. 'These findings demonstrate that FgDML1 is a positive regulator of virulence in F. graminearum. '(in L140-141).

      (5) Lines 185-186: The authors do not provide sufficient evidence to support the claim that FgQCR2, FgQCR8, and FgQCR9 overexpression is the main cause of reduced cyazofamid sensitivity. Although expression of these genes is altered, reduced sensitivity may result from changes in other proteins or pathways. To strengthen this claim, overexpression of FgQCR2, 8, and 9 in the wild-type background, followed by assessment of cyazofamid resistance, would be necessary. As it stands, there is no support for the claim presented in lines 329-332.

      Thank you very much for your advice. To establish a causal link between the overexpression of FgQCR2, FgQCR7, and FgQCR8 and the observed reduction in cyazofamid sensitivity, we first quantified the protein levels of these assembly factor. Western blot analysis confirmed their elevated expression in the ΔFgDML1 mutant compared to the wild-type PH-1. We further generated individual overexpression strains for FgQCR2, FgQCR7, and FgQCR8 in the wild-type PH-1 background. Fungicide sensitivity assays revealed that all three overexpression mutants displayed significantly reduced sensitivity to cyazofamid compared to the parental strain. These genetic complementation experiments confirm that upregulation of FgQCR2, FgQCR7, and FgQCR8 is sufficient to confer reduced cyazofamid sensitivity.We have incorporated these explanations and provided supporting images in the appropriate section of the manuscript. 'To further clarify whether the upregulated expression of FgQCR2, FgQCR7, and FgQCR8 genes affects their protein expression levels, we measured the protein levels. The results showed that the protein expression levels of FgQCR2, FgQCR7, and FgQCR8 in ΔFgDML1 were higher than those in PH-1(Fig. 6F). Subsequently, we overexpressed FgQCR2, FgQCR7, and FgQCR8 in the wild-type background, and the corresponding overexpression mutants exhibited reduced sensitivity to cyazofamid(Fig. 6E). '(in L205-211)(in Fig. 6E, F)

      (6) Lines 187-190: This segment is confusing and difficult to follow. It requires rewriting for clarity.

      Thank you very much for your advice. Based on your suggestion, we have made corresponding modifications in the corresponding locations. 'Since Complex III is involved in the action of both cyazofamid (targeting the QI site) and pyraclostrobin (targeting the QO site), the sensitivity of ΔFgDML1 to cyazofamid and pyraclostrobin was investigated. ''(in L214-216)

      (7) Lines 345-346: The authors state that in this study, FgDML1 is localised in mitochondria, which implies that in other studies, its localisation was different. Is this accurate? Clarification is needed.

      Thank you very much for your question. In previous studies, the localization of this protein was not clearly defined, and its function was only emphasized to be related to mitochondria. Whether in yeast or in Drosophila melanogaster. (Miklos et al., 1997; Gurvitz et al., 2002)

      Miklos GLG, Yamamoto M-T, Burns RG, Maleszka R. 1997. An essential cell division gene of drosophila, absent from saccharomyces, encodes an unusual protein with  tubulin-like and myosin-like peptide motifs. Proc Natl Acad Sci 94:5189–5194. doi:10.1073/pnas.94.10.5189

      Gurvitz A, Hartig A, Ruis H, Hamilton B, de Couet HG. 2002. Preliminary characterisation of DML1, an essential saccharomyces cerevisiae gene related to misato of drosophila melanogaster. FEMS Yeast Res 2:123–135. doi:10.1016/S1567-1356(02)00083-1

      Material and Methods Section

      (8) In general, the methods require more detailed descriptions, including the brands and catalog numbers of reagents and kits used. Simply stating that procedures were performed according to manufacturers' instructions is insufficient, particularly when the specific brand or kit is not identified.

      Thank you very much for your advice. We have added corresponding content based on your suggestion to more comprehensively display the reagent brand and complete product name. 'Transformants were selected on PDA plates containing either 100 μg/mL Hygromycin B (Yeasen, Shanghai, China) or 0.2 μmol/mL 5-Fluorouracil 2'-deoxyriboside (F2du) (Solarbio, Beijing, China)(Zhao et al., 2022). ' (in L405-407). 'DON toxin was measured using a Wise Science ELISA-based kit (Wise Science, Jiangsu, China) (Li et al., 2019; Zheng et al., 2018) '. (in L469-471)

      (9) Line 364: What do CM and MM stand for? Please define.

      Thank you very much for your advice. Based on your suggestion, we have made modifications in the corresponding locations. 'To evaluate vegetative growth, complete medium (CM), minimal medium (MM), and V8 Juice Agar (V8) media were prepared as described previously(Tang et al., 2020). '(in L385-387)

      Generation of Deletion and Complemented Mutants:

      (10) This section lacks detail. For example, were PCR products used directly for PEG-mediated transformation, or were the fragments cloned into a plasmid?

      Thank you very much for your question. We directly use the fused fragments for protoplast transformation after sequencing confirmation. We have clearly defined the fragment form used for transformation at the corresponding location. 'The resulting fusion fragment was transformed into the wild-type F. graminearum PH-1 strain via polyethylene glycol (PEG)-mediated protoplast transformation. '(in L403-405).

      (11) PCR and Southern blot validation results should be included as supplementary material, along with clear interpretations of these results.

      Thank you very much for your advice. In the supplementary material we submitted, Supplementary Figure 2 already includes the results of PCR and Southern blot validation.(in Fig. S2)

      (12) There is almost no description of how the mutants mentioned in lines 388-390 were generated.

      Thank you very much for your advice. Based on your suggestions, we have added relevant content in the appropriate sections to more comprehensively and clearly reflect the experimental process. 'Specifically, FgDML1, including its native promoter region and open reading frame (ORF) (excluding the stop codon), was amplified.The PCR product was then fused with the XhoI -digested pYF11 vector. After transformation into E. coli and sequence verification, the plasmid was extracted and subsequently introduced into PH-1 protoplasts. For FgDnm1-3×Flag, the 3×Flag tag was added to the C-terminus of FgDnm1 by PCR, fused with the hygromycin resistance gene and the FgDnm1 downstream arm, and then introduced into PH-1 protoplasts. The overexpression mutant was constructed according to a previously described method. Specifically, the ORF of FgDML1 was amplified and the PCR product was ligated into the SacII-digested pSXS overexpression vector. The resulting plasmid was then transformed into PH-1 protoplasts (Shi et al., 2023). For the construction of PH-1::FgTri1+GFP and ΔFgDML1::FgTri1+GFP, the ORF of FgTri1 was amplified and ligated into the XhoI-digested pYF11 vector as described above. The resulting vectors were then transformed into protoplasts of PH-1 or ΔFgDML1, respectively.'(in L413-426).

      Vegetative Growth and Conidiation Assays:

      (13) There is no information about how long the plates were incubated before photos were taken. Judging by the images, it appears that different incubation times may have been used.

      Thank you very much for your advice. Due to the slower growth of ΔFgDML1, we adopted different incubation periods and have supplemented the relevant content in the corresponding section. 'All strains were incubated at 25°C in darkness; however, due to ΔFgDML1 slower growth, the ΔFgDML1 mutant required a 5-day incubation period compared to the 3 days used for PH-1 and ΔFgDML1-C. '(in L490-493).

      (14) There is no description of the MBL medium.

      Thank you very much for your advice. Based on your suggestion, we have supplemented the corresponding content in the corresponding positions. 'Mung bean liquid (MBL) medium was used for conidial production, while carrot agar (CA) medium was utilized to assess sexual reproduction(Wang et al., 2011). '(in L387-389).

      DON Production and Pathogenicity Assays:

      (15) Were DON levels normalised to mycelial biomass? The vegetative growth assays show that FgDML1 null mutants exhibit reduced growth on all tested media. If mutant and wild-type strains were incubated for the same period under the same conditions, it is reasonable to assume that the mutants accumulated significantly less biomass. Therefore, results related to DON production, as well as acetyl-CoA and ATP levels, must be normalised to biomass.

      Thank you very much for your question. We have taken into account the differences in mycelial biomass. Therefore, when measuring DON, acetyl-CoA, and ATP levels, all data were normalized to mycelial mass and calculated as amounts per unit of mycelium, thereby avoiding discrepancies arising from variations in biomass.

      Sensitivity Assays:

      (16) While the authors mention that gradient concentrations were used, the specific concentrations and ranges are not provided. Importantly, have the plates shown in Figure 5 been grown for different periods or lengths? Given the significantly reduced growth rate shown in Figure 6A, the mutants should not have grown to the same size as the WT (PH-1) as shown in Figures 5A and 5B unless the pictures have been taken on different days. This needs to be explained.

      Thank you very much for your question. Due to the slower growth of ΔFgDML1, we adopted different incubation periods and have supplemented the relevant content in the corresponding section. 'All strains were incubated at 25°C in darkness; however, due to ΔFgDML1 slower growth, the ΔFgDML1 mutant required a 5-day incubation period compared to the 3 days used for PH-1 and ΔFgDML1-C. '(in L490-493).

      (17) Additionally, was inhibition measured similarly for both stress agents and fungicides? This should be clarified.

      Thank you very much for your question. We have supplemented the specific concentration gradient of fungicides. 'The concentration gradients for each fungicide in the sensitivity assays were set up according to Supplementary Table S2. '(in L493-494)(in Table. S2).

      Complex III Enzyme Activity:

      (18) A more detailed description of how this assay was performed is needed.

      Thank you very much for your advice. We have provided further detailed descriptions of the corresponding sections. 'Briefly, 0.1 g of mycelia was homogenized with 1 mL of extraction buffer in an ice bath. The homogenate was centrifuged at 600 ×g for 10 min at 4°C. The resulting supernatant was then subjected to a second centrifugation at 11,000 ×g for 10 min at 4°C. The pellet was resuspended in 200 μL of extraction buffer and disrupted by ultrasonication (200 W, 5 s pulses with 10 s intervals, 15 cycles). Complex III enzyme activity was finally measured by adding the working solution as per the manufacturer's protocol. '(in L511-517)

      (19) Were protein concentrations standardised prior to the assay?

      Thank you very much for your question. Protein concentrations for all Western blot samples were quantified using a BCA assay kit to ensure equal loading.

      (20) Line 448: Are ΔFgDML1::Tri1+GFP and ΔFgDML1+GFP the same strain? ΔFgDML1::Tri1+GFP has not been previously described.

      Thank you very much for your question. These two strains are not the same strain, and we have supplemented their construction process in the corresponding section. 'For the construction of PH-1::FgTri1+GFP and ΔFgDML1::FgTri1+GFP, the ORF of FgTri1 was amplified and ligated into the XhoI-digested pYF11 vector as described above. The resulting vectors were then transformed into protoplasts of PH-1 or ΔFgDML1, respectively. '(in L423-426)

      (21) Lines 460 and 468: Please adopt a consistent nomenclature, either RT-qPCR or qRT-PCR.

      Thank you very much for your advice. We have unified it and modified the corresponding content in the corresponding sections. 'Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) was carried out using the QuantStudio 6 Flex real-time PCR system (Thermo, Fisher Scientific, USA) to assess the relative expression of three subunits of Complex III (FgCytb, FgCytc1, FgISP), five assembly factors (FgQCR2, FgQCR6, FgQCR7, FgQCR8, FgQCR9), and DON biosynthesis-related genes (FgTri5 and FgTri6). '(in L526-531)

      (22) Lines 472-473: Why was FgCox1 used as a reference for FgCytb? Clarification is needed.

      Thank you very much for your question. FgCytb (cytochrome b) and FgCOX1 (cytochrome c oxidase subunit I) are both encoded by the mitochondrial genome and serve as core components of the oxidative phosphorylation system (Complex III and Complex IV, respectively). Their transcription is co-regulated by mitochondrial-specific mechanisms in response to cellular energy status. Consequently, under experimental conditions that perturb energy homeostasis, FgCOX1 expression exhibits relative, context-dependent stability with FgCytb, or at least co-varies directionally, making it a superior reference for normalizing target gene expression. In contrast, FgGapdh operates within a distinct genetic and regulatory system. Using FgCOX1 ensures that both reference and target genes reside within the same mitochondrial compartment and functional module, thereby preventing normalization artifacts arising from independent variation across disparate pathways.

      (23) Lines 476-477: This step requires a clearer and more detailed explanation.

      Thank you very much for your advice. We provided detailed descriptions of them in their respective positions. 'For FgDnm1-3×Flag, the 3×Flag tag was added to the C-terminus of FgDnm1 by PCR, fused with the hygromycin resistance gene and the FgDnm1 downstream arm, and then introduced into PH-1 protoplasts. '(in L417-419). 'The FgDnm1-3×Flag fragment was introduced into PH-1 and FgDML1+GFP protoplasts, respectively, to obtain single-tagged and double-tagged strains. '(in L541-543)

      Western blotting:

      (24) Uncropped Western blot images should be provided as supplementary material.

      Thank you very much for your advice. All Western blot images will be submitted to the supplementary material package.

      (25) Lines 485-489: A more thorough description of the antibodies used (including source, catalogue number, and dilution) is necessary.

      Thank you very much for your advice. The antibodies used are clearly stated in terms of brand, catalog number, and dilution. We have added the dilution ratio. 'All antibodies were diluted as follows: primary antibodies at 1:1000 and secondary antibodies at 1:10000. '(in L550-551)

      (26) The Western blot shown in Figure 3D appears problematic, particularly the anti-GAPDH band for FgDML1::FgTri1+GFP. Are both anti-GAPDH bands derived from the same gel?

      Thank you very much for your advice. We are unequivocally certain that these data derive from the same gel. Therefore, we are providing the original image for your inspection.

      Author response image 4.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      (1) I have to admit that it took a few hours of intense work to understand this paper and to even figure out where the authors were coming from. The problem setting, nomenclature, and simulation methods presented in this paper do not conform to the notation common in the field, are often contradictory, and are usually hard to understand. Most importantly, the problem that the paper is trying to solve seems to me to be quite specific to the particular memory study in question, and is very different from the normal setting of model-comparative RSA that I (and I think other readers) may be more familiar with.

      We have revised the paper for clarity at all levels: motivation, application, and parameterization. We clarify that there is a large unmet need for using RSA in a trial-wise manner, and that this approach indeed offers benefits to any team interested in decoding trial-wise representational information linked to a behavioral responses, and as such is not a problem specific to a single memory study.

      (2) The definition of "classical RSA" that the authors are using is very narrow. The group around Niko Kriegeskorte has developed RSA over the last 10 years, addressing many of the perceived limitations of the technique. For example, cross-validated distance measures (Walther et al. 2016; Nili et al. 2014; Diedrichsen et al. 2021) effectively deal with an uneven number of trials per condition and unequal amounts of measurement noise across trials. Different RDM comparators (Diedrichsen et al. 2021) and statistical methods for generalization across stimuli (Schütt et al. 2023) have been developed, addressing shortcomings in sensitivity. Finally, both a Bayesian variant of RSA (Pattern component modelling, (Diedrichsen, Yokoi, and Arbuckle 2018) and an encoding model (Naselaris et al. 2011) can effectively deal with continuous variables or features across time points or trials in a framework that is very related to RSA (Diedrichsen and Kriegeskorte 2017). The author may not consider these newer developments to be classical, but they are in common use and certainly provide the solution to the problems raised in this paper in the setting of model-comparative RSA in which there is more than one repetition per stimulus.

      We appreciate the summary of relevant literature and have included a revised Introduction to address this bounty of relevant work. While much is owed to these authors, new developments from a diverse array of researchers outside of a single group can aid in new research questions, and should always have a place in our research landscape. We owe much to the work of Kriegeskorte’s group, and in fact, Schutt et al., 2023 served as a very relevant touchpoint in the Discussion and helped to highlight specific needs not addressed by the assessment of the “representational geometry” of an entire presented stimulus set. Principal amongst these needs is the application of trial-wise representational information that can be related to trial-wise behavioral responses and thus used to address specific questions on brain-behavior relationships. We invite the Reviewer to consider the utility of this shift with the following revisions to the Introduction.

      Page 3. “Recently, methodological advancements have addressed many known limitations in cRSA. For example, cross-validated distance measures (e.g., Euclidean distance) have improved the reliability of representational dissimilarities in the presence of noise and trial imbalance (Walther et al., 2016; Nili et al., 2014; Diedrichsen et al., 2021). Bayesian approaches such as pattern component modeling (Diedrichsen, Yokoi, & Arbuckle, 2018) have extended representational approaches to accommodate continuous stimulus features or temporal variation. Further, model comparison RSA strategies (Diedrichsen et al., 2021) and generalization techniques across stimuli (Schütt et al., 2023) have improved sensitivity and inference. Nevertheless, a common feature shared across most of improvements is that they require stimuli repetition to examine the representational structure. This requirement limits their ability to probe brain-behavior questions at the level of individual events”.

      Page 8. “While several extensions of RSA have addressed key limitations in noise sensitivity, stimulus variance, and modeling (e.g., Diedrichsen et al., 2021; Schütt et al., 2023), our tRSA approach introduces a new methodological step by estimating representational strength at the trial level. This accounts for the multi-level variance structure in the data, affords generalizability beyond the fixed stimulus set, and allows one to test stimulus- or trial-level modulations of neural representations in a straightforward way”.

      Page 44. “Despite such prevalent appreciation for the neurocognitive relevance of stimulus properties, cRSA often does not account for the fact that the same stimulus (e.g., “basketball”) is seen by multiple subjects and produces statistically dependent data, an issue addressed by Schütt et al., 2023, who developed cross validation and bootstrap methods that explicitly model dependence across both subjects and stimulus conditions”.

      (3) The stated problem of the paper is to estimate "representational strength" in different regions or conditions. With this, the authors define the correlation of the brain RDM with a model RDM. This metric conflates a number of factors, namely the variances of the stimulus-specific patterns, the variance of the noise, the true differences between different dissimilarities, and the match between the assumed model and the data-generating model. It took me a long time to figure out that the authors are trying to solve a quite different problem in a quite different setting from the model-comparative approach to RSA that I would consider "classical" (Diedrichsen et al. 2021; Diedrichsen and Kriegeskorte 2017). In this approach, one is trying to test whether local activity patterns are better explained by representation model A or model B, and to estimate the degree to which the representation can be fully explained. In this framework, it is common practice to measure each stimulus at least 2 times, to be able to estimate the variance of noise patterns and the variance of signal patterns directly. Using this setting, I would define 'representational strength" very differently from the authors. Assume (using LaTeX notation) that the activity patterns $y_j,n$ for stimulus j, measurement n, are composed of a true stimulus-related pattern ($u_j$) and a trial-specific noise pattern ($e_j,n$). As a measure of the strength of representation (or pattern), I would use an unbiased estimate of the variance of the true stimulus-specific patterns across voxels and stimuli ($\sigma^2_{u}$). This estimator can be obtained by correlating patterns of the same stimuli across repeated measures, or equivalently, by averaging the cross-validated Euclidean distances (or with spatial prewhitening, Mahalanobis distances) across all stimulus pairs. In contrast, the current paper addresses a specific problem in a quite specific experimental design in which there is only one repetition per stimulus. This means that the authors have no direct way of distinguishing true stimulus patterns from noise processes. The trick that the authors apply here is to assume that the brain data comes from the assumed model RDM (a somewhat sketchy assumption IMO) and that everything that reduces this correlation must be measurement noise. I can now see why tRSA does make some sense for this particular question in this memory study. However, in the more common model-comparative RSA setting, having only one repetition per stimulus in the experiment would be quite a fatal design flaw. Thus, the paper would do better if the authors could spell the specific problem addressed by their method right in the beginning, rather than trying to set up tRSA as a general alternative to "classical RSA".

      At a general level, our approach rests on the premise that there is meaningful information present in a single presentation of a given stimulus. This assumption may have less utility when the research goals are more focused on estimating the fidelity of signal patterns for RSA, as in designs with multiple repetitions. But it is an exaggeration to state that such a trial-wise approach cannot address the difference between “true” stimulus patterns and noise. This trial-wise approach has explicit utility in relating trial-wise brain information to trial-wise behavior, across multiple cognitions (not only memory studies, as applied here). We have added substantial text to the Introduction distinguishing cRSA, which is widely employed, often in cases with a single repetition per stimulus, and model comparative methods that employ multiple repetitions. We clarify that we do not consider tRSA an alternative to the model comparative approach, and discuss that operational definitions of representational strength are constrained by the study design.

      Page 3. “In this paper, we present an advancement termed trial-level RSA, or tRSA, which addresses these limitations in cRSA (not model comparison approaches) and may be utilized in paradigms with or without repeated stimuli”.

      Page 4. “Representational geometry usually refers to the structure of similarities among repeated presentations of the same stimulus in the neural data (as captured in the brain RSM) and is often estimated utilizing a model comparison approach, whereas representational strength is a derived measure that quantifies how strongly this geometry aligns with a hypothesized model RSM. In other words, geometry characterizes the pattern space itself, while representational strength reflects the degree of correspondence between that space and the theoretical model under test”.

      Finally, we clarified that in our simulation methods we assume a true underlying activity pattern and a random error pattern. The model RSM is computed based on the true pattern, whereas the brain RSM comes from the noisy pattern, not the model RSM itself.

      Page 9. “Then, we generated two sets of noise patterns, which were controlled by parameters σ<sub>A</sub> and σ<sub>B</sub> , respectively, one for each condition”.

      (4) The notation in the paper is often conflicting and should be clarified. The actual true and measured activity patterns should receive a unique notation that is distinct from the variances of these patterns across voxels. I assume that $\sigma_ijk$ is the noise variances (not standard deviation)? Normally, variances are denoted with $\sigma^2$. Also, if these are variances, they cannot come from a normal distribution as indicated on page 10. Finally, multi-level models are usually defined at the level of means (i.e., patterns) rather than at the level of variances (as they seem to be done here).

      We have added notations for true and measured activity patterns to differentiate it from our notation for variance. We agree that multilevel models are usually defined at the level of means rather than at the level of variances and we include a Figure (Fig 1D) that describes the model in terms of the means. We clarify that the σ ($\sigma$) used in the manuscript were not variances/standard deviations themselves; rather, they were meant to denote components of the actual (multilevel) variance parameter. Each component was sampled from normal distributions, and they collectively summed up to comprise the final variance parameter for each trial. We have modified our notation for each component to the lowercase letter s to minimize confusion. We have also made our R code publicly available on our lab github, which should provide more clarity on the exact simulation process.

      (5) In the first set of simulations, the authors sampled both model and brain RSM by drawing each cell (similarity) of the matrix from an independent bivariate normal distribution. As the authors note themselves, this way of producing RSMs violates the constraint that correlation matrices need to be positive semi-definite. Likely more seriously, it also ignores the fact that the different elements of the upper triangular part of a correlation matrix are not independent from each other (Diedrichsen et al. 2021). Therefore, it is not clear that this simulation is close enough to reality to provide any valuable insight and should be removed from the paper, along with the extensive discussion about why this simulation setting is plainly wrong (page 21). This would shorten and clarify the paper.

      We have added justification of the mixed-effects model given the potential assumption violations. We caution readers to investigate the robustness of their models, and to employ permutation testing that does not make independence assumptions. We have also added checks of the model residuals and an example of permutation testing in the Appendix. Finally, we agree that the first simulation setting does not possess several properties of realistic RDMs/RSMs; however, we believe that there is utility in understanding the mathematical properties of correlations – an essential component of RSA – in a straightforward simulation where the ground truth is known, thus moving the simulation to Appendix 1.

      (6) If I understand the second simulation setting correctly, the true pattern for each stimulus was generated as an NxP matrix of i.i.d. standard normal variables. Thus, there is no condition-specific pattern at all, only condition-specific noise/signal variances. It is not clear how the tRSA would be biased if there were a condition-specific pattern (which, in reality, there usually is). Because of the i.i.d. assumption of the true signal, the correlations between all stimulus pairs within conditions are close to zero (and only differ from it by the fact that you are using a finite number of voxels). If you added a condition-specific pattern, the across-condition RSA would lead to much higher "representational strength" estimates than a within-condition RSA, with obvious problems and biases.

      The Reviewer is correct that the voxel values in the true pattern are drawn from i.i.d. standard normal distributions. We take the Reviewer’s suggestion of “condition-specific pattern” to mean that there could be a condition-voxel interaction in two non-mutually exclusive ways. The first is additive, essentially some common underlying multi-voxel pattern like [6, 34, -52, …, 8] for all condition A trials, and different one such pattern for condition B trials, etc. The second is multiplicative, essentially a vector of scaling factors [x1.5, x0.5, x0.8, …, x2.7] for all condition A trials, and a different one such vector for condition B trials, etc. Both possibilities could indeed affect tRSA as much as it would cRSA.

      Importantly, If such a strong condition-specific pattern is expected, one can build a condition-specific model RDM using one-shot coding of conditions (see example figure; src: https://www.newbi4fmri.com/tutorial-9-mvpa-rsa), to either capture this interesting phenomenon or to remove this out as a confounding factor. This practice has been applied in multiple regression cRSA approaches (e.g., Cichy et al., 2013) and can also be applied to tRSA.

      (7) The trial-level brain RDM to model Spearman correlations was analyzed using a mixed effects model. However, given the symmetry of the RDM, the correlations coming from different rows of the matrix are not independent, which is an assumption of the mixed effect model. This does not seem to induce an increase in Type I errors in the conditions studied, but there is no clear justification for this procedure, which needs to be justified.

      We appreciate this important warning, and now caution readers to investigate the robustness of their models, and consider employing permutation testing that does not make independence assumptions. We have also added checks of the model residuals and an example of permutation testing in the supplement.

      Page 46. “While linear mixed-effects modeling offers a powerful framework for analyzing representational similarity data, it is critical that researchers carefully construct and validate their models. The multilevel structure of RSA data introduces potential dependencies across subjects, stimuli, and trials, which can violate assumptions of independence if not properly modeled. In the present study, we used a model that included random intercepts for both subjects and stimuli, which accounts for variance at these levels and improves the generalizability of fixed-effect estimates. Still, there is a potential for systematic dependence across trials within a subject. To ensure that the model assumptions were satisfied, we conducted a series of diagnostic checks on an exemplar ROI (right LOC; middle occipital gyrus) in the Object Perception dataset, including visual inspection of residual distributions and autocorrelation (Appendix 3, Figure 13). These diagnostics supported the assumptions of normality, homoscedasticity, and conditional independence of residuals. In addition, we conducted permutation-based inference, similar to prior improvements to cRSA (Niliet al. 2014), using a nested model comparison to test whether the mean similarity in this ROI was significantly greater than zero. The observed likelihood ratio test statistic fell in the extreme tail of the null distribution (Appendix 3, Figure 14), providing strong nonparametric evidence for the reliability of the observed effect. We emphasize that this type of model checking and permutation testing is not merely confirmatory but can help validate key assumptions in RSA modeling, especially when applying mixed-effects models to neural similarity data. Researchers are encouraged to adopt similar procedures to ensure the robustness and interpretability of their findings”.

      Exemplar Permutation Testing

      To test whether the mean representational strength in the ROI right LOC (middle occipital gyrus) was significantly greater than zero, we used a permutation-based likelihood ratio test implemented via the permlmer function. This test compares two nested linear mixed-effects models fit using the lmer function from the lme4 package, both including random intercepts for Participant and Stimulus ID to account for between-subject and between-item variability.

      The null model excluded a fixed intercept term, effectively constraining the mean similarity to zero after accounting for random effects:

      ROI ~ 0 + (1 | Participant) + (1 | Stimulus)

      The full model included the same random effects structure but allowed the intercept to be freely estimated:

      ROI ~ 1 + (1 | Participant) + (1 | Stimulus)

      By comparing the fit of these two models, we directly tested whether the average similarity in this ROI was significantly different from zero. Permutation testing (1,000 permutations) was used to generate a nonparametric p-value, providing inference without relying on normality assumptions. The full model, which estimated a nonzero mean similarity in the right LOC (middle occipital gyrus), showed a significantly better fit to the data than the null model that fixed the mean at zero (χ²(1) = 17.60, p = 2.72 × 10⁻⁵). The permutation-based p-value obtained from permlmer confirmed this effect as statistically significant (p = 0.0099), indicating that the mean similarity in this ROI was reliably greater than zero. These results support the conclusion that the right LOC contains representational structure consistent with the HMAXc2 RSM. A density plot of the permuted likelihood ratio tests is plotted along with the observed likelihood ratio test in Appendix 3 Figure 14.

      (8) For the empirical data, it is not clear to me to what degree the "representational strength" of cRSA and tRSA is actually comparable. In cRSA, the Spearman correlation assesses whether the distances in the data RSM are ranked in the same order as in the model. For tRSA, the comparison is made for every row of the RSM, which introduces a larger degree of flexibility (possibly explaining the higher correlations in the first simulation). Thus, could the gains presented in Figure 7D not simply arise from the fact that you are testing different questions? A clearer theoretical analysis of the difference between the average row-wise Spearman correlation and the matrix-wise Spearman correlation is urgently needed. The behavior will likely vary with the structure of the true model RDM/RSM.

      We agree that the comparability between mean row-wise Spearman correlations and the matrix-wise Spearman correlation is needed. We believe that the simulations are the best approach for this comparison, since they are much more robust than the empirical dataset and have the advantage of knowing the true pattern/noise levels. We expand on our comparison of mean tRSA values and matrix-wise Spearman correlations on page 42.

      Page 42. “Although tRSA and cRSA both aim to quantify representational strength, they differ in how they operationalize this concept. cRSA summarizes the correspondence between RSMs as a single measure, such as the matrix-wise Spearman correlation. In contrast, tRSA computes such correspondence for each trial, enabling estimates at the level of individual observations. This flexibility allows trial-level variability to be modeled directly, but also introduces subtle differences in what is being measured. Nonetheless, our simulations showed that, although numerical differences occasionally emerged—particularly when comparing between-condition tRSA estimates to within-condition cRSA estimates—the magnitude of divergence was small and did not affect the outcome of downstream statistical tests”.

      (9) For the real data, there are a number of additional sources of bias that need to be considered for the analysis. What if there are not only condition-specific differences in noise variance, but also a condition-specific pattern? Given that the stimuli were measured in 3 different imaging runs, you cannot assume that all measurement noise is i.i.d. - stimuli from the same run will likely have a higher correlation with each other.

      We recognize the potential of condition-specific patterns and chose to constrain the analyses to those most comparable with cRSA. However, depending on their hypotheses, researchers may consider testing condition RSMs and utilizing a model comparison approach or employ the z-scored approach, as employed in the simulations above. Regarding the potential run confounds, this is always the case in RSA and why we exclude within-run comparisons. We have also added to the Discussion the suggestion to include run as a covariate in their mixed-effects models. However, we do not employ this covariate here as we preferred the most parsimonious model to compare with cRSA.

      Page 46 - 47. “Further, while analyses here were largely employed to be comparable with cRSA, researchers should consider taking advantage of the flexibility of the mixed-effects models and include co variates of non-interest (run, trial order etc.)”.

      (10) The discussion should be rewritten in light of the fact that the setting considered here is very different from the model-comparative RSA in which one usually has multiple measurements per stimulus per subject. In this setting, existing approaches such as RSA or PCM do indeed allow for the full modelling of differences in the "representational strength" - i.e., pattern variance across subjects, conditions, and stimuli.

      We agree that studies advancing designs with multiple repetitions of a given stimulus image are useful in estimating the reliability of concept representations. We would argue however that model comparison in RSA is not restricted to such data. Many extant studies do not in fact have multiple repetitions per stimulus per subject (Wang et al., 2018 https://doi.org/10.1088/1741-2552/abecc3, Gao et al, 2022 https://doi.org/10.1093/cercor/bhac058, Li et al, 2022 https://doi.org/10.1002/hbm.26195, Staples & Graves, 2020 https://doi.org/10.1162/nol_a_00018) that allow for that type of model-comparative approach. While beneficial in terms of noise estimation, having multiple presentations was not a requirement for implementing cRSA (Kriegeskorte, 2008 https://doi.org/10.3389/neuro.06.004.2008). The aim of this manuscript is to introduce the tRSA approach to the broad community of researchers whose research questions and datasets could vary vastly, including but not limited to the number of repeated presentations and the balance of trial counts across conditions.

      (11) Cross-validated distances provide a powerful tool to control for differences in measurement noise variances and possible covariances in measurement noise across trials, which has many distinct advantages and is conceptually very different from the approach taken here.

      We have added language on the value of cross-validation approaches to RSA in the Discussion:

      Page 47. “Additionally, we note that while our proposed tRSA framework provides a flexible and statistically principled approach for modeling trial-level representational strength, we acknowledge that there are alternative methods for addressing trial-level variability in RSA. In particular, the use of cross-validated distance metrics (e.g., crossnobis distance) has become increasingly popular for controlling differences in measurement noise variance and accounting for possible covariance structures across trials (Walther et al., 2016). These metrics offer several advantages, including unbiased estimation of representational dissimilarities under Gaussian noise assumptions and improved generalization to unseen data. However, cross-validated distances are conceptually distinct from the approach taken here: whereas cross-validation aims to correct for noise-related biases in representational dissimilarity matrices, our trial-level RSA method focuses on estimating and modeling the variability in representation strength across individual trials using mixed-effects modeling. Rather than proposing a replacement for cross-validated RSA, tRSA adds a complementary tool to the methodological toolkit—one that supports hypothesis-driven inference about condition effects and trial-level covariates, while leveraging the full structure of the data”.

      (12) One of the main limitations of tRSA is the assumption that the model RDM is actually the true brain RDM, which may not be the case. Thus, in theory, there could be a different model RDM, in which representational strength measures would be very different. These differences should be explained more fully, hopefully leading to a more accessible paper.

      Indeed, the chosen model RSM may not be the true RSM, but as the noise level increases the correlation between RSMs practically becomes zero. In our simulations we assume this to be true as a straightforward way to manipulate the correspondence between the brain data and the model. However, just like cRSA, tRSA is constrained by the model selections the researchers employ. We encourage researchers to have carefully considered theoretically-motivated models and, if their research questions require, consider multiple and potentially competing models. Furthermore, the trial-wise estimates produced by tRSA encourage testing competing models within the multiple regression framework. We have added this language to the Discussion.

      Page 46. ..”choose their model RSMs carefully. In our simulations, we designed our model RSM to be the “true” RSM for demonstration purposes. However, researchers should consider if their models and model alternatives”.

      Pages 45-46. “While a number of studies have addressed the validity of measuring representational geometry using designs with multiple repetitions, a conceptual benefit of the tRSA approach is the reliance on a regression framework that engenders the testing of competing conceptual models of stimulus representation (e.g., taxonomic vs. encyclopedic semantic features, as in Davis et al., 2021)”.

      Reviewer #2 (Public review):

      (1)  While I generally welcome the contribution, I take some issue with the accusatory tone of the manuscript in the Introduction. The text there (using words such as 'ignored variances', 'errouneous inferences', 'one must', 'not well-suited', 'misleading') appears aimed at turning cRSA in a 'straw man' with many limitations that other researchers have not recognized but that the new proposed method supposedly resolves. This can be written in a more nuanced, constructive manner without accusing the numerous users of this popular method of ignorance.

      We apologize for the unintended accusatory tone. We have clarified the many robust approaches to RSA and have made our Introduction and Discussion more nuanced throughout (see also 3, 11 and16).

      (2) The described limitations are also not entirely correct, in my view: for example, statistical inference in cRSA is not always done using classic parametric statistics such as t-tests (cf Figure 1): the rsatoolbox paper by Nili et al. (2014) outlines non-parametric alternatives based on permutation tests, bootstrapping and sign tests, which are commonly used in the field. Nor has RSA ever been conducted at the row/column level (here referred to by the authors as 'trial level'; cf King et al., 2018).

      We agree there are numerous methods that go beyond cRSA addressing these limitations and have added discussion of them into our manuscript as well as an example analysis implementing permutation tests on tRSA data (see response to 7). We thank the reviewer for bringing King et al., 2014 and their temporal generalization method to our attention, we added reference to acknowledge their decoding-based temporal generalization approach.

      Page 8. “It is also important to note that some prior work has examined similarly fine-grained representations in time-resolved neuroimaging data, such as the temporal generalization method introduced by King et al. (see King & Dehaene, 2014). Their approach trains classifiers at each time point and tests them across all others, resulting in a temporal generalization matrix that reflects decoding accuracy over time. While such matrices share some structural similarity with RSMs, they do not involve correlating trial-level pattern vectors with model RSMs nor do their second-level models include trial-wise, subject-wise, and item-wise variability simultaneously”.

      (3) One of the advantages of cRSA is its simplicity. Adding linear mixed effects modeling to RSA introduces a host of additional 'analysis parameters' pertaining to the choice of the model setup (random effects, fixed effects, interactions, what error terms to use) - how should future users of tRSA navigate this?

      We appreciate the opportunity to offer more specific proscriptions for those employing a tRSA technique, and have added them to the Discussion:

      Page 46. “While linear mixed-effects modeling offers a powerful framework for analyzing representational similarity data, it is critical that researchers carefully construct and validate their models and choose their model RSMs carefully. In our simulations, we designed our model RSM to be the “true” RSM for demonstration purposes. However, researchers should consider if their models and model alternatives. However, researchers should always consider if their models match the goals of their analysis, including 1) constructing the random effects structure that will converge in their dataset and 2) testing their model fits against alternative structures (Meteyard & Davies, 2020; Park et al., 2020) and 3) considering which effects should be considered random or fixed depending on their research question”.

      (4) Here, only a single real fMRI dataset is used with a quite complicated experimental design for the memory part; it's not clear if there is any benefit of using tRSA on a simpler real dataset. What's the benefit of tRSA in classic RSA datasets (e.g., Kriegeskorte et al., 2008), with fixed stimulus conditions and no behavior?

      To clarify, our empirical approach uses two different tasks: an Object Perception task more akin to the classic RSA datasets employing passive viewing, and a Conceptual Retrieval task that more directly addresses the benefits of the trialwise approach. We felt that our Object Perception dataset is a simpler empirical fMRI dataset without explicit task conditions or a dichotomous behavioral outcome, whereas the Retrieval dataset is more involved (though old/new recognition is the most common form of memory retrieval testing) and  dependent on behavioral outcomes. However, we recognize the utility of replication from other research groups and do invite researchers to utilize tRSA on their datasets.

      (5) The cells of an RDM/RSM reflect pairwise comparisons between response patterns (typically a brain but can be any system; cf Sucholutsky et al., 2023). Because the response patterns are repeatedly compared, the cells of this matrix are not independent of one another. Does this raise issues with the validity of the linear mixed effects model? Does it assume the observations are linearly independent?

      We recognize the potential danger for not meeting model assumptions. Though our simulation results and model checks suggest this is not a fatal flaw in the model design, we caution readers to investigate the robustness of their models, and consider employing permutation testing that does not make independence assumptions. We have also added checks of the model residuals and an example of permutation testing in the Appendix. See response to R1.

      (6) The manuscript assumes the reader is familiar with technical statistical terms such as Type I/II error, sensitivity, specificity, homoscedasticity assumptions, as well as linear mixed models (fixed effects, random effects, etc). I am concerned that this jargon makes the paper difficult to understand for a broad readership or even researchers currently using cRSA that might be interested in trying tRSA.

      We agree this jargon may cause the paper to be difficult to understand. We have expanded/added definitions to these terms throughout the methods and results sections.

      Page 12. “Given data generated with 𝑠<sub>𝑐𝑜𝑛𝑑,𝐴</sub> = 𝑠<sub>𝑐𝑜𝑛𝑑,B</sub>, the correct inference should be a failure to reject the null hypothesis of ; any significant () result in either direction was considered a false positive (spurious effect, or Type I error). Given data generated with , the inference was considered correct if it rejected the null hypothesis of  and yielded the expected sign of the estimated contrast (b<sub>B-𝐴</sub><0). A significant result with the reverse sign of the estimated contrast (b<sub>B-𝐴</sub><0) was considered a Type I error, and a nonsignificant (𝑝 ≥ 0.05) result was considered a false negative (failure to detect a true effect, or Type II error)”.

      Page 2. “Compared to cRSA, the multi-level framework of tRSA was both more theoretically appropriate and significantly sensitive (better able to detect) to true effects”.

      Page 25.”The performance of cRSA and tRSA were quantified with their specificity (better avoids false positives, 1 - Type I error rate) and sensitivity (better avoids false negatives 1 - Type II error rate)”.

      Page 6. “One of the fundamental assumptions of general linear models (step 4 of cRSA; see Figure 1D) is homoscedasticity or homogeneity of variance — that is, all residuals should have equal variance” .

      Page11. “Specifically, a linear mixed-effects model with a fixed effect  of condition (which estimates the average effect across the entire sample, capturing the overall effect of interest) and random effects of both subjects and stimuli (which model variation in responses due to differences between individual subjects and items, allowing generalization beyond the sample) were fitted to tRSA estimates via the `lme4 1.1-35.3` package in R (Bates et al., 2015), and p-values were estimated using Satterthwaites’s method via the `lmerTest 3.1-3` package (Kuznetsova et al., 2017)”.

      (7) I could not find any statement on data availability or code availability. Given that the manuscript reuses prior data and proposes a new method, making data and code/tutorials openly available would greatly enhance the potential impact and utility for the community.

      We thank the reviewer for raising our oversight here. We have added our code and data availability statements.

      Page 9. “Data is available upon request to the corresponding author and our simulations and example tRSA code is available at https://github.com/electricdinolab”.

      Reviewer #1 (Recommendations for the authors):

      (13) Page 4: The limitations of cRSA seem to be based on the assumption that within each different experimental condition, there are different stimuli, which get combined into the condition. The framework of RSA, however, does not dictate whether you calculate a condition x condition RDM or a larger and more complete stimulus x stimulus RDM. Indeed, in practice we often do the latter? Or are you assuming that each stimulus is only shown once overall? It would be useful at this point to spell out these implicit assumptions.

      We agree that stimulus x stimulus RDMs can be constructed and are often used. However, as we mentioned in the Introduction, researchers are often interested in the difference between two (or more) conditions, such as “remembered” vs. “forgotten” (Davis et al., https://doi.org/10.1093/cercor/bhaa269) or “high cognitive load” vs. “low cognitive load” (Beynel et al., https://doi.org/10.1523/JNEUROSCI.0531-20.2020). In those cases, the most common practice with cRSA is to construct condition-specific RDMs, compute cRSA scores separately for each condition, and then compare the scores at the group level. The number of times each stimulus gets presented does not prevent one from creating a model RDM that has the same rows and columns as the brain RDM, either in the same condition (“high load”) or across different conditions.

      (14) Page 5: The difference between condition-level and stimulus-level is not clear. Indeed, this definition seems to be a function of the exact experimental design and is certainly up for interpretation. For example, if I conduct a study looking at the activity patterns for 4 different hand actions, each repeated multiple times, are these actions considered stimuli or conditions?

      We have added clarifying language about what is considered stimuli vs conditions. Indeed, this will depend on the specific research questions being employed and will affect how researchers construct their models. In this specific example, one would most likely consider each different hand action a condition, treating them as fixed effects rather than random effects, given their very limited number and the lack of need to generalize findings to the broader “hand actions” category.

      Page 5. “Critically, the distinction between condition-level and stimulus level is not always clear as researchers may manipulate stimulus-level features themselves. In these cases, what researchers ultimately consider condition-level and stimulus-level will depend on their specific research questions. For example, researchers intending to study generalized object representation may consider object category a stimulus-level feature, while researchers interested in if/how object representation varies by category may consider the same category variable condition-level”.

      (15) Page 5: The fact that different numbers of trials / different levels of measurement noise / noise-covariance of different conditions biases non-cross-validated distances is well known and repeatedly expressed in the literature. We have shown that cross-validation of distances effectively removes such biases - of course, it does not remove the increased estimation variability of these distances (for a formal analysis of estimation noise on condition patterns and variance of the cross-nobis estimator, see (Diedrichsen et al. 2021)).

      We thank the reviewer for drawing our attention to this literature and have added discussions of these methods.

      (16). Page 5: "Most studies present subjects with a fixed set of stimuli, which are supposedly samples representative of some broader category". This may be the case for a certain type of RSA experiments in the visual domain, but it would be unfair to say that this is a feature of RSA studies in general. In most studies I have been involved in, we use a "stimulus" x "stimulus" RDM.

      We have edited this sentence to avoid the “most” characterization. We also added substantial text to the introduction and discussion distinguishing cRSA, which is nonetheless widely employed, especially in cases with a single repetition per stimulus (Macklin et al., 2023, Liu et al, 2024) and the model comparative method and explicitly stating that we do not consider tRSA an alternative to the model comparative approach.

      (17). Page 5: I agree that "stimuli" should ideally be considered a random effect if "stimuli" can be thought of as sampled from a larger population and one wants to make inferences about that larger population. Sometimes stimuli/conditions are more appropriately considered a fixed effect (for example, when studying the response to stimulation of the 5 fingers of the right hand). Techniques to consider stimuli/conditions as a random effect have been published by the group of Niko Kriegeskorte (Schütt et al. 2023).

      Indeed, in some cases what may be thought of as “stimuli” would be more appropriately entered into the model as a fixed effect; such questions are increasingly relevant given the focus on item-wise stimulus properties (Bainbridge et al., Westfall & Yarkoni). We have added text on this issue to the Discussion and caution researchers to employ models that most directly answer their research questions.

      Page 46. “However, researchers should always consider if their models match the goals of their analysis, including 1) constructing the random effects structure that will converge in their dataset and 2) testing their model fits against alternative structures (Meteyard & Davies, 2020; Park et al., 2020) and 3) considering which effects should be considered random or fixed depending on their research question. An effect is fixed when the levels represent the specific conditions of theoretical interest (e.g., task condition) and the goal is to estimate and interpret those differences directly. In contrast, an effect is random when the levels are sampled from a broader population (e.g., subjects) and the goal is to account for their variability while generalizing beyond the sample tested. Note that the same variable (e.g., stimuli) may be considered fixed or random depending on the research questions”.

      (18) Page 6: It is correct that the "classical" RSA depends on a categorical assignment of different trials to different stimuli/conditions, such that a stimulus x stimulus RDM can be computed. However, both Pattern Component Modelling (PCM) and Encoding models are ideally set up to deal with variables that vary continuously on a trial-by-trial or moment-by-moment basis. tRSA should be compared to these approaches, or - as it should be clarified - that the problem setting is actually quite a different one.

      We agree that PCM and encoding models offer a flexible approach and handle continuous trial-by-trial variables. We have clarified the problem setting in cRSA is distinct on page 6, and we have added the robustness of encoding models and their limitations to the Discussion.

      Page 6. “While other approaches such as Pattern Component Modeling (PCM) (Diedrichsen et al., 2018) and encoding models (Naselaris et al., 2011) are well-suited to analyzing variables that vary continuously on a trial-by-trial or moment-by-moment basis, these frameworks address different inferential goals. Specifically, PCM and encoding models focus on estimating variance components or predicting activation from features, while cRSA is designed to evaluate representational geometry. Thus, cRSA as well as our proposed approach address a problem setting distinct from PCM and encoding models”.

      (19) Page 8: "Then, we generated two noise patterns, which were controlled by parameters 𝜎 𝐴 and 𝜎𝐵, respectively, one for each condition." This makes little sense to me. The noise patterns should be unique to each trial - you should generate n_a + n_b noise patterns, no?

      We clarify that the “noise patterns” here are n_voxel x n_trial in size; in other words, all trial-level noise patterns are generated together and each trial has their own unique noise pattern. We have revised our description as “two sets of noise patterns” for clarity starting on page 9.

      (20) Page 9: First, I assume if this is supposed to be a hierarchical level model, the "noise parameters" here correspond to variances? Or do these \sigma values mean to signify standard deviations? The latter would make little sense. Or is it the noise pattern itself?

      As clarified in 4., the σ values are meant to denote hierarchical components of the composite standard deviation; we have updated our notation to use lower case letter s instead for clarity.

      (21) Page 10: your formula states "𝜎<sub>𝑠𝑢𝑏𝑗</sub>~ 𝙽(0, 0.5^2)". This conflicts with your previous mention that \sigmas are noise "levels" are they the noise patterns themselves now? Variances cannot be normally distributed, as they cannot be negative.

      As clarified in 4., the σ values are meant to denote hierarchical components of the composite standard deviation; we have updated our notation to use lower case letter s instead for clarity.

      (22) Page 13: What was the task of the subject in the Memory retrieval task? Old/new judgements relative to encoding of object perception?

      We apologize for the lack of clarity about the Memory Retrieval task and have added that information and clarified that the old/new judgements were relative to a separate encoding phase, the brain data for which has been reported elsewhere.

      Page 14. “Memory Retrieval took place one day after Memory Encoding and involved testing participants’ memory of the objects seen in the Encoding phase. Neural data during the Encoding phase has been reported elsewhere. In the main Memory Retrieval task, participants were presented with 144 labels of real-world objects, of which 114 were labels for previously seen objects and 30 were unrelated novel distractors. Participants performed old/new judgements, as well as their confidence in those judgements on a four-point scale (1 = Definitely New, 2 = Probably New, 3 = Probably Old, 4 = Definitely Old)”.

      (23) Page 13: If "Memory Retrieval consisted of three scanning runs", then some of the stimulus x stimulus correlations for the RSM must have been calculated within a run and some between runs, correct? Given that all within-run estimates share a common baseline, they share some dependence. Was there a systematic difference between the within-run and the between-run correlations?

      We have clarified in this portion of the methods that within run comparisons were excluded from our analyses. We also double-checked that the within-run exclusion was included in the description of the Neural RSMs.

      Page 14. “Retrieval consisted of three scanning runs, each with 38 trials, lasting approximately 9 minutes and 12 seconds (within-run comparisons were later excluded from RSA analyses)”.

      Page 18. “This was done by vectorizing the voxel-level activation values within each region and calculating their correlations using Pearson’s r, excluding all within-run comparisons.”

      (24) Page 20: It is not clear why the mean estimate of "representational strength" (i.e., model-brain RSM correlations) is important at all. This comes back to Major point #2, namely that you are trying to solve a very different problem from model-comparative RSA.

      We have clarified that our approach is not an alternative to model-comparative RSA, and that depending on the task constraints researchers may choose to compare models with tRSA or other approaches requiring stimulus repetition (see 3).

      (25) Page 21: I believe the problems of simulating correlation matrices directly in the way that the authors in their first simulation did should be well known and should be moved to an appendix at best. Better yet, the authors could start with the correct simulation right away.

      We agree the paper is more concise with these simulations being moved to the appendix and more briefly discussed. We have implemented these changes (Appendix 1). However, we are not certain that this problem is unknown, and have several anecdotes of researchers inquiring about this “alternative” approach in talks with colleagues, thus we do still discuss the issues with this method.

      (26) Page 26: Is the "underlying continuous noise variable 𝜎𝑡𝑟𝑖𝑎𝑙 that was measured by 𝑣𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 " the variance of the noise pattern or the noise pattern itself? What does it mean it was "measured" - how?

      𝜎𝑡𝑟𝑖𝑎𝑙 is a vector of standard deviations for different trials, and 𝜎𝑡𝑟𝑖𝑎𝑙 i would be used to generate the noise patterns for trial i. v_measured is a hypothetical measurement of trial-level variability, such as “memorability” or “heartbeat variability”. We have revised our description to clarify our methods.

      Reviewer #2 (Recommendations for the authors):

      (8) It would be helpful to provide more clarity earlier on in the manuscript on what is a 'trial': in my experience, a row or column of the RDM is usually referred to as 'stimulus condition', which is typically estimated on multiple trials (instances or repeats) of that stimulus condition (or exemplars from that stimulus class) being presented to the subject. Here, a 'trial' is both one measurement (i.e., single, individual presentation of a stimulus) and also an entry in the RDM, but is this the most typical scenario for cRSA? There is a section in the Discussion that discusses repetitions, but I would welcome more clarity on this from the get-go.

      We have added discussion of stimulus repetition methods and datasets to the Introduction and clarified our use of the terms.

      Page 8. “Critically, in single-presentation designs, a “trial” refers to one stimulus presentation, and corresponds to a row or column in the RSM. In studies with repeated stimuli, these rows are often called “conditions” and may reflect aggregated patterns across trials. tRSA is compatible with both cases: whether rows represent individual trials or averaged trials that create “conditions”, tRSA estimates are computed at the row level”.

      (9) The quality of the results figures can be improved. For example, axes labels are hard to read in Figure 3A/B, panels 3C/D are hard to read in general. In Figure 7E, it's not possible to identify the 'dark red' brain regions in addition to the light red ones.

      We thank the reviewer for raising these and have edited the figures to be more readable in the manner suggested.

      (10) I would be interested to see a comparison between tRSA and cRSA in other fMRI (or other modality) datasets that have been extensively reported in the literature. These could be the original Kriegeskorte 96 stimulus monkey/fMRI datasets, commonly used open datasets in visual perception (e.g., THINGS, NSD), or the above-mentioned King et al. dataset, which has been analyzed in various papers.

      We recognize the great utility of replication from other research groups and do invite researchers to utilize tRSA on their datasets.

      (11) On P39, the authors suggest 'researchers can confidently replace their existing cRSA analysis with tRSA': Please discuss/comment on how researchers should navigate the choice of modeling parameters in tRSA's linear mixed effects setting.

      We have added discussion of the mixed-effects parameters and the various and encourage researchers to follow best practices for their model selection.

      Page 46. “However, researchers should always consider if their models match the goals of their analysis, including 1) constructing the random effects structure that will converge in their dataset and 2) testing their model fits against alternative structures (Meteyard & Davies, 2020; Park et al., 2020) and 3) considering which effects should be considered random or fixed depending on their research question”.

      (12) The final part of the Results section, demonstrating the tRSA results for the continuous memorability factor in the real fMRI data, could benefit from some substantiation/elaboration. It wasn't clear to me, for example, to what extent the observed significant association between representational strength and item memorability in this dataset is to be 'believed'; the Discussion section (p38). Was there any evidence in the original paper for this association? Or do we just assume this is likely true in the brain, based on prior literature by e.g. Bainbridge et al (who probably did not use tRSA but rather classic methods)?

      Indeed, memorability effects have been replicated in the literature, but not using the tRSA method. We have expanded our discussion to clarify the relationship of our findings and the relevant literature and methods it has employed.

      Page 38. “Critically, memorability is a robust stimulus property that is consistent across participants and paradigms (Bainbridge, 2022). Moreover, object memorability effects have been replicated using a variety of methods aside from tRSA, including univariate analyses and representational analyses of neural activity patterns where trial-level neural activity pattern estimates are correlated directly with object memorability (Slayton et al, 2025).”

      (13) The abstract could benefit from more nuance; I'm not sure if RSA can indeed be said to be 'the principal method', and whether it's about assessing 'quality' of representations (more commonly, the term 'geometry' or 'structure' is used).

      We have edited the abstract to reflect the true nuisance in the current approaches.

      Abstract. Neural representation refers to the brain activity that stands in for one’s cognitive experience, and in cognitive neuroscience, a prominent method of studying neural representations is representational similarity analysis (RSA). While there are several recent advances in RSA, the classic RSA (cRSA) approach examines the structure of representations across numerous items by assessing the correspondence between two representational similarity matrices (RSMs): usually one based on a theoretical model of stimulus similarity and the other based on similarity in measured neural data.

      (14) RSA is also not necessarily about models vs. neural data; it can also be between two neural systems (e.g., monkey vs. human as in Kriegeskorte et al., 2008) or model systems (see Sucholutsky et al., 2023). This statement is also repeated in the Introduction paragraph 1 (later on, it is correctly stated that comparing brain vs. model is most likely the 'most common' approach).

      We have added these examples in our introduction to RSA.

      Page 3.”One of the central approaches for evaluating information represented in the brain is representational similarity analysis (RSA), an analytical approach that queries the representational geometry of the brain in terms of its alignment with the representational geometry of some cognitive model (Kriegeskorte et al., 2008; Kriegeskorte & Kievit, 2013), or, in some cases, compares the representational geometry of two neural systems (e.g., Kriegeskorte et al., 2008) or two model systems (Sucholutsky et al., 2023)”.

      (15) 'theoretically appropriate' is an ambiguous statement, appropriate for what theory?

      We apologize for the ambiguous wording, and have corrected the text:

      Page 11. “Critically, tRSA estimates were submitted to a mixed-effects model which is statistically appropriate for modeling the hierarchical structure of the data, where observations are nested within both subjects and stimuli (Baayen et al., 2008; Chen et al., 2021)”.

      (16) I found the statement that cRSA "cannot model representation at the level of individual trials" confusing, as it made me think, what prohibits one from creating an RDM based on single-trial responses? Later on, I understood that what the authors are trying to say here (I think) is that cRSA cannot weigh the contributions of individual rows/columns to the overall representational strength differently.

      We thank the reviewer for their clarifying language and have added it to this section of the manuscript.

      “Abstract. However, because cRSA cannot weigh the contributions of individual trials (RSM rows/columns), it is fundamentally limited in its ability to assess subject-, stimulus-, and trial-level variances that all influence representation”.

      (17) Why use "RSM" instead of "RDM"? If the pairwise comparison metric is distance-based (e..g, 1-correlation as described by the authors), RDM is more appropriate.

      We apologize for the error, and have clarified the Methods text:

      Page3-4. First, brain activity responses to a series of N trials are compared against each other (typically using Pearson’s r) to form an N×N representational similarity matrix.

      (18) Figure 2: please write 'Correlation estimate' in the y-axis label rather than 'Estimate'.

      We have edited the label in Figure 2.

      (19) Page 6 'leaving uncertain the directionality of any findings' - I do not follow this argument. Obviously one can generate an RDM or RSM from vector v or vector -v. How does that invalidate drawing conclusions where one e.g., partials out the (dis)similarity in e.g., pleasantness ratings out of another RDM/RSM of interest?

      We agree such an approach does not invalidate the partial method; we have clarified what we mean by “directionality”.

      Page 8. ”For instance, even though a univariate random variable , such as pleasantness ratings, can be conveniently converted to an RSM using pairwise distance metrics (Weaverdyck et al., 2020), the very same RSM would also be derived from the opposite random variable , leaving uncertain of the directionality (or if representation is strongest for pleasant or unpleasant items) of any findings with the RSM (see also Bainbridge & Rissman, 2018)”.

      (20) P7 'sampled 19900 pairs of values from a bi-variate normal distribution', but the rows/columns in an RDM are not independent samples - shouldn't this be included in the simulation? I.e., shouldn't you simulate first the n=200 vectors, and then draw samples from those, as in the next analysis?

      This section has been moved to Appendix 1 (see responses to Reviewer 1.13).

      (21) Under data acquisition, please state explicitly that the paper is re-using data from prior experiments, rather than collecting data anew for validating tRSA.

      We have clarified this in the data acquisition section.

      Page 13. “A pre-existing dataset was analyzed to evaluate tRSA. Main study findings have been reported elsewhere (S. Huang, Bogdan, et al., 2024)”.

      (22) Figure 4 could benefit from some more explanation in-text. It wasn't clear to me, for example, how to interpret the asterisks depicted in the right part of the figure.

      We clarified the meaning of the asterisks in the main text in addition to the existent text in the figure caption.

      Page 26. “see Figure 4, off-diagonal cells in blue; asterisks indicate where tRSA was statistically more sensitive then cRSA)”.

      (23) Page 38 "the outcome of tRSA's improved characterization can be seen in multiple empirical outcomes:" it seems there is one mention of 'outcomes' too many here.

      We have revised this sentence.

      Page 41. “tRSA's improved characterization can be seen in multiple empirical outcomes”.

      (24) Page 38 "model fits became the strongest" it's not clear what aspect of the reported results in the paragraph before this is referring to - the Appendix?

      Yes, the model fits are in the Appendix, we have added this in text citation.

      Moreover, model-fits became the strongest when the models also incorporated trial-level variables such as fMRI run and reaction time (Appendix 3, Table 6).

      References

      Diedrichsen, J., Berlot, E., Mur, M., Schütt, H. H., Shahbazi, M., & Kriegeskorte, N. (2021). Comparing representational geometries using whitened unbiased-distance-matrix similarity. Neurons, Behavior, Data and Theory, 5(3). https://arxiv.org/abs/2007.02789

      Diedrichsen, J., & Kriegeskorte, N. (2017). Representational models: A common framework for understanding encoding, pattern-component, and representational-similarity analysis. PLoS Computational Biology, 13(4), e1005508.

      Diedrichsen, J., Yokoi, A., & Arbuckle, S. A. (2018). Pattern component modeling: A flexible approach for understanding the representational structure of brain activity patterns. NeuroImage, 180, 119-133.

      Naselaris, T., Kay, K. N., Nishimoto, S., & Gallant, J. L. (2011). Encoding and decoding in fMRI. NeuroImage, 56(2), 400-410.

      Nili, H., Wingfield, C., Walther, A., Su, L., Marslen-Wilson, W., & Kriegeskorte, N. (2014). A toolbox for representational similarity analysis. PLoS Computational Biology, 10(4), e1003553.

      Schütt, H. H., Kipnis, A. D., Diedrichsen, J., & Kriegeskorte, N. (2023). Statistical inference on representational geometries. ELife, 12. https://doi.org/10.7554/eLife.82566

      Walther, A., Nili, H., Ejaz, N., Alink, A., Kriegeskorte, N., & Diedrichsen, J. (2016). Reliability of dissimilarity measures for multi-voxel pattern analysis. NeuroImage, 137, 188-200.

      King, M. L., Groen, I. I., Steel, A., Kravitz, D. J., & Baker, C. I. (2019). Similarity judgments and cortical visual responses reflect different properties of object and scene categories in naturalistic images. NeuroImage, 197, 368-382.

      Kriegeskorte, N., Mur, M., Ruff, D. A., Kiani, R., Bodurka, J., Esteky, H., ... & Bandettini, P. A. (2008). Matching categorical object representations in inferior temporal cortex of man and monkey. Neuron, 60(6), 1126-1141.

      Nili, H., Wingfield, C., Walther, A., Su, L., Marslen-Wilson, W., & Kriegeskorte, N. (2014). A toolbox for representational similarity analysis. PLoS computational biology, 10(4), e1003553.

      Sucholutsky, I., Muttenthaler, L., Weller, A., Peng, A., Bobu, A., Kim, B., ... & Griffiths, T. L. (2023). Getting aligned on representational alignment. arXiv preprint arXiv:2310.13018.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review): 

      In this manuscript, Dillard and colleagues integrate cross-species genomic data with a systems approach to identify potential driver genes underlying human GWAS loci and establish the cell type(s) within which these genes act and potentially drive disease. Specifically, they utilize a large single-cell RNA-seq (scRNA-seq) dataset from an osteogenic cell culture model - bone marrow-derived stromal cells cultured under osteogenic conditions (BMSC-OBs) - from a genetically diverse outbred mouse population called the Diversity Outbred (DO) stock to discover network driver genes that likely underlie human bone mineral density (BMD) GWAS loci. The DO mice segregate over 40M single nucleotide variants, many of which affect gene expression levels, therefore making this an ideal population for systems genetic and co-expression analyses. The current study builds on previously published work from the same group that used co-expression analysis to identify co-expressed "modules" of genes that were enriched for BMD GWAS associations. In this study, the authors utilize a much larger scRNA-seq dataset from 80 DO BMSC-OBs, infer co-expression-based and Bayesian networks for each identified mesenchymal cell type, focused on networks with dynamic expression trajectories that are most likely driving differentiation of BMSC-OBs, and then prioritized genes ("differentiation driver genes" or DDGs) in these osteogenic differentiation networks that had known expression or splicing QTLs (eQTL/sQTLs) in any GTEx tissue that colocalized with human BMD GWAS loci. The systems analysis is impressive, the experimental methods are described in detail, and the experiments appear to be carefully done. The computational analysis of the single-cell data is comprehensive and thorough, and the evidence presented in support of the identified DDGs, including Tpx2 and Fgfrl1, is for the most part convincing. Some limitations in the data resources and methods hamper enthusiasm somewhat and are discussed below. Overall, while this study will no doubt be valuable to the BMD community, the cross-species data integration and analytical framework may be more valuable and generally applicable to the study of other diseases, especially for diseases with robust human GWAS data but for which robust human genomic data in relevant cell types is lacking. 

      Specific strengths of the study include the large scRNA-seq dataset on BMSC-OBs from 80 DO mice, the clustering analysis to identify specific cell types and sub-types, the comparison of cell type frequencies across the DO mice, and the CELLECT analysis to prioritize cell clusters that are enriched for BMD heritability (Figure 1). The network analysis pipeline outlined in Figure 2 is also a strength, as is the pseudotime trajectory analysis (results in Figure 3). One weakness involves the focus on genes that were previously identified as having an eQTL or sQTL in any GTEx tissue. The authors rightly point out that the GTEx database does not contain data for bone tissue, but the reason that eQTLs can be shared across many tissues - this assumption is valid for many cis-eQTLs, but it could also exclude many genes as potential DDGs with effects that are specific to bone/osteoblasts. Indeed, the authors show that important BMD driver genes have cell-type-specific eQTLs. Furthermore, the mesenchymal cell type-specific co-expression analysis by iterative WGCNA identified an average of 76 co-expression modules per cell cluster (range 26-153). Based on the limited number of genes that are detected as expressed in a given cell due to sparse per-cell read depth (400-6200 reads/cell) and dropouts, it's hard to believe that as many as 153 co-expression modules could be distinguished within any cell cluster. I would suspect some degree of model overfitting here and would expect that many/most of these identified modules have very few gene members, but the methods list a minimum module size of 20 genes. How do the numbers of modules identified in this study compare to other published scRNA-seq studies that use iterative WGCNA? 

      In the section "Identification of differentiation driver genes (DDGs)", the authors identified 408 significant DDGs and found that 49 (12%) were reported by the International Mouse Knockout [sic] Consortium (IMPC) as having a significant effect on whole-body BMD when knocked out in mice. Is this enrichment significant? E.g., what is the background percentage of IMPC gene knockouts that show an effect on whole-body BMD? Similarly, they found that 21 of the 408 DDGs were genes that have BMD GWAS associations that colocalize with GTEx eQTLs/sQTLs. Given that there are > 1,000 BMD GWAS associations, is this enrichment (21/408) significant? Recommend performing a hypergeometric test to provide statistical context to the reported overlaps here. 

      We thank the reviewer for their constructive feedback and thoughtful questions. In regards to the iterativeWGCNA, a larger number of modules is sometimes an outcome of the analysis, as reported in the iterativeWGCNA preprint (Greenfest-Allen et al., 2017). While we did not make a comparison to other works leveraging this tool for scRNA-seq, it has been used broadly across other published studies, such as PMID: 39640571, 40075303, 33677398, 33653874. While model overfitting, as you mention, may be a cause for more modules, our Bayesian network analysis we perform after iterativeWGCNA highlights smaller aspects of coexpression modules, as opposed to focusing on the entirety of any given module.

      We did not perform enrichment or statistical tests as our goal was to simply highlight attributes or unique features of these genes for additional context.

      Reviewer #2 (Public review): 

      Summary: 

      In this manuscript, Farber and colleagues have performed single-cell RNAseq analysis on bone marrow-derived stem cells from DO Mice. By performing network analysis, they look for driver genes that are associated with bone mineral density GWAS associations. They identify two genes as potential candidates to showcase the utility of this approach. 

      Strengths: 

      The study is very thorough and the approach is innovative and exciting. The manuscript contains some interesting data relating to how cell differentiation is occurring and the effects of genetics on this process. The section looking for genes with eQTLs that differ across the differentiation trajectory (Figure 4) was particularly exciting. 

      Weaknesses: 

      The manuscript is in parts hard to read due to the use of acronyms and there are some questions about data analysis that need to be addressed. 

      We thank the reviewer for their feedback and shared enthusiasm for our work. We tried to minimize the use of technical acronyms as much as we could without compromising readability. Additionally, we addressed questions regarding aspects of data analysis. 

      Reviewer #1 (Recommendations for the authors):

      (1) For increased transparency and to allow reproducibility, it would be necessary for the scripts used in the analysis to be shared along with the publication of the preprint. Also, where feasible, sharing the processed data in addition to the raw data would allow the community greater access to the results and be highly beneficial. 

      Thank you for this suggestion. The raw data will be available via GEO accession codes listed in the data availability statement. We will make available scripts for some analyses on our Github (https://github.com/Farber-Lab/DO80_project) and processed scRNA-seq data in a Seurat object (.rds) on Zenodo (https://zenodo.org/records/15299631)

      (2) Lines 55-76: I think the summary of previous work here is too long. I understand that they would like to cover what has been done previously, but this seems like overkill. 

      Good suggestion. We have streamlined some of the summary of our previous work.

      (3) Did the authors try to map QTL for cell-type proportion differences in their BMSC-OBs? While 80 samples certainly limit mapping power, the data shown in Figs 4C/D suggest that you might identify a large-effect modifier of LMP/OB1 proportions. 

      We did try to map QTL for cell type proportion differences, but no significant associations were identified. 

      (4) Methods question: Does the read alignment method used in your analysis account for SNPs/indels that segregate among the DO/CC founder strains? If not, the authors may wish to include this in their discussion of study limitations and speculate on how unmapped reads could affect expression results. 

      The read alignment method we used does not account for SNPs/indels from the DO founder strains that fall in RNA transcripts captured in the scRNA-seq data. We have included this as a limitation in our discussion (line 422-424). 

      (5) Much of the discussion reads as an overview of the methods, while a discussion of the results and their context to the existing BMD literature is relatively lacking in comparison.

      We have added additional explanation of the results and context to the discussion (line 381-382, 396-407). 

      (6) Figure 1E and lines 146-149: Adjusted p values should be reported in the figure and accompanying text instead of switching between unadjusted and adjusted p values. 

      We updated Figure 1e to portray adjusted p-values, listed the adjusted p-values in legend of Figure 1e, and listed them in the main text (line 153-154).

      (7) Why do the authors bring the IMPC KO gene list into the analysis so late? This seems like a highly relevant data resource (moreso than the GTEx eQTLs/sQTLs) that could have been used much earlier to help identify DDGs. 

      Given that our scRNA-seq data is also from mice, we did choose to integrate information from the IMPC to highlight supplemental features of genes in networks (i.e., genes that have an experimentally-tested and significant effect on BMD in mice). However, our primary goal was to inform human GWAS and leverage our previous work in which we identified colocalizations between human BMD GWAS and eQTL/sQTL in a human GTEx tissue, which is why this information was used to guide our network analysis.

      (8) Does Fgfrl1 and/or Tpx2 have a cis-eQTL in your BMSC-OB scRNA-seq dataset? 

      We did not identify cis-eQTL effects for Fgfrl1 and Tpx2.

      (9) Figure 4B-C: These eQTLs may be real, but based on the diplotype patterns in Figure 4C, I suspect they are artifacts of low mapping power that are driven by rare genotype classes with one or two samples having outlier expression results. For example, if you look at the results in Fig 4C for S100a1 expression, the genotype classes with the highest/lowest expression have lower sample numbers. In the case of Pkm eQTL showing a PWK-low effect, the PWK genome has many SNPs that differ from the reference genome in the 3' UTR of this gene, and I wonder if reads overlapping these SNPs are not aligning correctly (see point 4 above) and resulting (falsely) in lower expression values for samples with a PWK haplotype. 

      As mentioned above, our alignment method did not consider DO founder genetic variation that is specifically located in the 3’ end of RNA transcripts in the scRNA-seq data. We have included this as a limitation in our discussion (line 422-424).

      In future studies, we intend to include larger populations of mice to potentially overcome, as you mention, any artifacts that may be attributable to low statistical power, rare genotype classes, or outlier expression.

      Reviewer #2 (Recommendations for the authors):

      Major Points 

      (1) The authors hypothesize "that many genes impacting BMD do so by influencing osteogenic differentiation or possibly bone marrow adipogenic differentiation". However, cell type itself does not correlate with any bone trait. Does this indicate that the hypothesis is not entirely correct, as genes that drive these phenotypes would not be enriched in one particular cell type? The authors have previously identified "high-priority target genes". So, are there any cell types that are enriched for these target genes? If not, this would indicate that all these genes are more ubiquitously expressed and this is probably why they would have a greater effect on the overall bone traits. Furthermore, are the 73 eGenes (so genes with eQTLs in a particular cell type that change around cell type boundaries) or the DDGs (Table 1) enriched for these high-priority target genes? 

      The bone traits measured in the DO mice are complex and impacted by many factors, including the differentiation propensity and abundance of certain cell types, both within and outside of bone. Though we did not identify correlations between cell type abundance and the bone traits we measured, we tailored our investigations to focus on cellular differentiation using the scRNA-seq data. However, future studies would need to be performed to investigate any connections between cellular differentiation, cell type abundance, and bone traits.

      We did not perform enrichment analyses of either the target genes identified from our other work or eGenes identified here, but instead used the target gene list to center our network analysis and the eGenes to showcase the utility of the DO mouse population.

      (2) The readability of the paper could be improved by minimising the use of acronyms and there are several instances of confusing wording throughout the paper. In many cases, this can be solved by re-organising sentences and adding a bit more detail. For example, it was unclear how you arrived at Fgfrl1 or Tpx2.

      One of the goals of our study was to identify genes that have (to our knowledge) little to no known connection to BMD. We chose to highlight Fgfrl1 and Tpx2 because there is minimal literature characterizing these genes in the context of bone, which we speak to in the results (line 296-297). Additionally, we prioritized these genes in our previous work and they were identified in this study by using our network analyses using the scRNA-seq data, which we mention in the results (line 276-279).

      (3) Technical aspects of the assay. In Figure 1d you show that the cell populations vary considerably between different DO mice. It would be useful to give some sense of the technical variance of this assay given that the assay involves culturing the cells in an exogenous environment. This could take the form of tests between mice within the same inbred strain, or even between different legs of the same DO mice to show that results are technically very consistent. It might also be prudent to identify that this is a potential limitation of the approach as in vitro culturing has the potential to substantially change the cell populations that are present. 

      We agree that in vitro culturing, in addition to the preparation of single cells for scRNA-seq, are unavoidable sources of technical variation in this study. However, the total number of cells contributed by each of the 80 DO mice after data processing does not appear to be skewed and the distribution appears normal (see added figures, now included as Supplemental Figure 3). Therefore, technical variation is at least consistent across all samples. Nevertheless, we have mentioned the potential for technical variation artifacts in our study in the discussion (line 414-416).

      (4) Need for permutation testing. "We identified 563 genes regulated by a significant eQTL in specific cell types. In total, 73 genes with eQTLs were also tradeSeq-identified genes in one or more cell type boundaries". These types of statements are fine but they need to be backed up with permutation testing to show that this level of enrichment is greater than one would expect by chance. 

      We did not perform enrichment tests as our only goal was to 1. determine if eQTL could be resolved in the DO mouse population using our scRNA-seq data and 2. predict in what cell type the associated eQTL and associated eGene may have an effect.

      (5) The main novelty of the paper seems to be that you have used single-cell RNA seq (given that you appear to have already detailed the candidates at the end). I don't think this makes the paper less interesting, but I think you need to reframe the paper more about the approach, and not the specific results. How you landed on these candidates is also not clear. So the paper might be improved by more robustly establishing the workflow and providing guidelines for how studies like this should be conducted in the future. 

      We sought to not only devise a rigorous approach to analyze our single cell data, but also showcase the utility of the approach in practice by highlighting targets for future research (i.e., Fgfrl1 and Tpx2).

      Our goal was to identify novel genes and we landed on these candidate genes (Fgfrl1 and Tpx2) because they had substantial data supporting their causality and they have yet to be fully characterized in the context of bone and BMD (line 295-297).

      In regards to establishing the workflow, we have included rationale for specific aspects of our approach throughout the paper. For example, Figure 2 itemizes each step of our network analysis and we explain why each step is utilized throughout various parts results (e.g., lines 168-170, 179-181, 191-193, 202-203, 257-260, 276-277).

      We have added a statement advocating for large-scale scRNA-seq from genetically diverse samples and network analyses for future studies (line 436-438).

      Minor Points 

      (1) In the summary you use the word "trajectory". Trajectories for what? I assume the transition between cell types, but this is not clear. 

      We added text to clarify the use of trajectory in the summary (line 34).

      (2) This sentence: "By 60 identifying networks enriched for genes implicated in GWAS we predicted putatively causal genes 61 for hundreds of BMD associations based on their membership in enriched modules." is also not clear. Do you mean: we predicted putatively causal genes by identifying clusters of co-expressed genes that were enriched for GWAS genes?" It is not clear how you identify the causal gene in the network. Is this just based on the hub gene? 

      The aforementioned sentence has since been removed to streamline the introduction, as suggested by Reviewer 1.

      In regards to causal gene identification, it is not based on whether it is hub gene. We prioritized a DDG (and their associated networks) if it was a causal gene that we identified in our previous work as having eQTL/sQTL in a GTEx tissue that colocalizes with human BMD GWAS.

      (3) Figure 3C. This is good but the labels are quite small. Would be good to make all the font sizes larger. 

      We have enlarged Figure 3C.

      (4) Line 341 in the Discussion should be "pseudotemporal". 

      We have edited “temporal” to “pseduotemporal”.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this fMRI study, the authors wished to assess neural mechanisms supporting flexible "temporal construals". For this, human participants learned a story consisting of fifteen events. During fMRI, events were shown to them, and they were instructed to consider the event from "an internal" or from "an external" perspective. The authors found opposite patterns of brain activity in the posterior parietal cortex and the anterior hippocampus for the internal and the external viewpoint. They conclude that allocentric sequences are stored in the hippocampus, whereas egocentric sequences are used in the parietal cortex. The claims align with previous fMRI work addressing this question.

      We appreciate the reviewer's concise summary of our research. We would like to offer two clarifications to prevent any potential misunderstandings.

      First, the activity patterns in the parietal cortex and hippocampus are not entirely opposite across internal and external perspectives. Specifically, the activation level in the posterior parietal cortex shows a positive correlation with sequential distance during external-perspective tasks, but a negative correlation during internal-perspective tasks. In contrast, the activation level in the anterior hippocampus positively correlates with sequential distance, irrespective of the observer's perspective. Therefore, our results suggest that the parietal cortex, with its perspective-dependent activity, supports egocentric representation; the hippocampus, with its consistent activity across perspectives, supports allocentric representation.

      Second, while some of our findings align with previous fMRI studies, to our knowledge, no prior research has explicitly investigated how the neural representation of time may vary depending on the observer's viewpoint. This gap in the literature is the primary motivation for our current study.

      Strengths:

      The research topic is fascinating, and very few labs in the world are asking the question of how time is represented in the human brain. Working hypotheses have been recently formulated, and this work seems to want to tackle some of them.

      We appreciate the reviewer's acknowledgment of the theoretical significance of our study.

      Weaknesses:

      The current writing is fuzzy both conceptually and experimentally. I cannot provide a sufficiently well-informed assessment of the quality of the experimental work because there is a paucity of details provided in the report. Any future revisions will likely improve transparency.

      (1) Improving writing and presentation:

      The abstract and the introduction make use of loaded terms such as "construals", "mental timeline", "panoramic views" in very metaphoric and unexplained ways. The authors do not provide a comprehensive and scholarly overview of these terms, which results in verbiage and keywords/name-dropping without a clear general framework being presented. Some of these terms are not metaphors. They do refer to computational concepts that the authors should didactically explain to their readership. This is all the more important that some statements in the Introduction are misattributed or factually incorrect; some statements lack attributions (uncited published work). Once the theory, the question, and the working hypothesis are clarified, the authors should carefully explain the task.

      We appreciate the reviewer's critics.

      The formulation of the scientific question in the introduction is grounded in the spatial construals of time hypothesis and conceptual metaphor theory (e.g., Traugott, 1978; Lakoff & Johnson, 1980; see recent reviews by Núñez & Cooperrider, 2013; Bender & Beller, 2014). These frameworks were originally developed through analyses of how spatial metaphors are used to describe temporal concepts in natural language. Consequently, it is theoretically motivated and largely unavoidable to introduce the two primary temporal construals—mental time travel and mental time watching— using metaphorical expressions.

      However, we do agree with the reviewer that the introduction in the original manuscript was overly long and that the working hypothesis was not clearly stated. In the revised manuscript, we have streamlined the introduction and substantially revised the following two paragraphs to clarify the formulation of our working hypothesis (Pages 5-6):

      “Recent studies have already begun to investigate the neural representation of the memorized event sequence (e.g., Deuker et al., 2016; Thavabalasingam et al., 2018; Bellmund et al., 2019, 2022; see reviews by Cohn-Sheehy & Ranganath, 2017; Bellmund et al., 2020). Yet, the neural mechanisms that enable the brain to construct distinct construals of an event sequence remain largely unknown. Valuable insights may be drawn from research in the spatial domain, which diPerentiates the neural representation in allocentric and egocentric reference frames. According to an influential neurocomputational model (Byrne et al., 2007; Bicanski & Burgess, 2018; Bicanski & Burgess, 2020), allocentric and egocentric spatial representations are dissociable in the brain—they are respectively implemented in the medial temporal lobe (MTL)—including the hippocampus—and the parietal cortex. Various egocentric representations in the parietal cortex derived from diPerent viewpoints can be transformed and integrated into a unified allocentric representation and stored in the MTL (i.e., bottom-up process). Conversely, the allocentric representation in the MTL can serve as a template for reconstructing diverse egocentric representations across diPerent viewpoints in the parietal cortex (i.e., top-down process).”

      “In line with the spatial construals of time hypothesis, several authors have recently suggested that such mutually engaged egocentric and allocentric reference frames (in the parietal cortex and the medial temporal lobe, respectively) proposed in the spatial domain might also apply to the temporal one (e.g., Gauthier & van Wassenhove, 2016ab; Gauthier et al., 2019, 2020; Bottini & Doeller, 2020). If this hypothesis holds, it could explain how the brain flexibly generates diverse construals of the same event sequence. Specifically, the hippocampus may encode a consistent representation of an event sequence that is independent of whether an individual adopts an internal or external perspective, reflecting an allocentric representation of time. In contrast, parietal cortical representations are expected to vary flexibly with the adopted perspective that is shaped by task demands, reflecting an egocentric representation of time.”

      In the revised manuscript, we also corrected statements in the Introduction that may have been misattributed (see Reviewer 2, comment 4(ii)) and added several relevant and important publications.

      (2) The experimental approach lacks sufficient details to be comprehensible to a general audience. In my opinion, the results are thus currently uninterpretable. I highlight only a couple of specific points (out of many). I recommend revision and clarification.

      (a) No explanation of the narrative is being provided. The authors report a distribution of durations with no clear description of the actual sequence of events. The authors should provide the text that was used, how they controlled for low-level and high-level linguistic confounds.

      We thank the reviewer for the suggestions. The event sequence for the odd-numbered participants is shown in the original Figure 1. In the revised manuscript, we added to Figure 1 the figure supplement 1 to illustrate the actual sequence of events for the participants with both odd and even numbers. We also added the narratives used in the reading phase of the learning procedures for the participants with both odd and even numbers (Figure 1—source data 1).

      To control for low-level linguistic confounds, we included the number of syllables as a covariate in the first-level general linear model in the fMRI analysis. To address high-level linguistic confounds, such as semantic information (which is difficult to quantify), we randomly assigned event labels to the 15 events twice, creating two counterbalanced versions for participants with even and odd numbers (see Comment 2b below).

      (b) The authors state, "we randomly assigned 15 phrases to the events twice". It is impossible to comprehend what this means. Were these considered stimuli? Controls? IT is also not clear which event or stimulus is part of the "learning set" and whether these were indicated to be such to participants.

      We apologize for any confusion in the Results section and the legend of Figure 1. Our motivation was explained in the "Stimuli" section of the Methods. In the revised manuscript, we have clarified this by adding an explanation to the legend of Figure 1 and including the supplementary Figure 1: " To minimize potential confounds between the semantic content of the event phrases and the temporal structure of the events, we randomly assigned the phrases to the events, creating two versions for participants with even and odd ID numbers. Both versions can be seen in Figure1—figure supplement 1 and Figure 1—source data 1."

      (c) The left/right counterbalancing is not being clearly explained. The authors state that there is counterbalancing, but do not sufficiently explain what it means concretely in the experiment. If a weak correlation exists between sequential position and distance, it also means that the position and the distance have not been equated within. How do the authors control for these?

      We thank the reviewer for highlighting this point and apologize for the lack of clarity in the original manuscript. In the current version (Page 40), we have provided further clarification: “We carefully selected two sets of 20 event pairs from the 210 possible combinations, assigning them to the odd and even runs of the fMRI experiment. Using a brute-force search, we identified 20 pairs in which sequential distance showed only weak correlations with positional information for both reference and target events (ranging from 1 to 15), as well as with behavioral responses (Same vs. Different or Future vs. Past, coded as 0 and 1), with all correlation coefficients below 0.2. At the same time, we balanced the proportion of correct responses across conditions: for the external-perspective task, Same/Different = 11/9 and 12/8; for the internal-perspective task, Future/Past = 12/8 and 8/12. Under these constraints, the sequential distances in both sets ranged from 1 to 5. To further mitigate spatial response biases, we pseudorandomized the left/right on-screen positions of the two response options within each task block, while ensuring an equal number of correct responses mapped to the left and right buttons (i.e., 10 per block).”

      The event pairs we selected already represent the best possible choice given all the criteria we aimed to satisfy. It is impossible to completely eliminate all potential correlations. For instance, if the target event occurs near the beginning of the day, it will tend to fall in the past, whereas if it occurs near the end of the day, it is more likely to fall in the future. To further ensure that the significant results were not driven by these weak confounding factors, we constructed another GLM that included three additional parametric modulators: the sequence position of the target event (ranging from 1 to 15) and the behavioral responses (Future vs. Past in the internal-perspective task; Same vs. Different in the external-perspective task, coded as 0 and 1). The significant findings were unaffected.

      (d) The authors used two tasks. In the "external perspective" one, the authors asked participants to report whether events were part of the same or a different part of the day. In the "internal perspective one", the authors asked participants to project themselves to the reference event and to determine whether the target event occurred before or after the projected viewpoint. The first task is a same/different recognition task. The second task is a temporal order task (e.g., Arzy et al. 2009). These two asks are radically different and do not require the same operationalization. The authors should minimally provide a comprehensive comparison of task requirements, their operationalization, and, more importantly, assess the behavioral biases inherent to each of these tasks that may confound brain activity observed with fMRI.

      We understand the reviewer’s concern. We agree that there is a substantial difference between the two tasks. However, the primary goal of this study was not to directly compare these tasks to isolate a specific cognitive component. Rather, the neural correlates of temporal distance were first identified as brain regions showing a significant correlation between neural activity and temporal distance using the parametric modulation analysis. We then compared these neural correlates between the two tasks. Therefore, any general differences between the tasks should not be a confound for our main results. Our aim was to examine whether the hippocampal representation of temporal distance remains consistent across different perspectives, and whether the parietal representation of temporal distance varies as a function of the perspective adopted.

      Therefore, the main aim of our task manipulation was to ensure that participants adopted either an external or an internal perspective on the event sequence, depending on the task condition. In the Introduction (Pages 6–7), we clarify this manipulation as follows: “In the externalperspective task, participants localized events with respect to external temporal boundaries, judging whether the target event occurred in the same or a different part of the day as the reference event. In the internal-perspective task, participants were instructed to mentally project themselves into the reference event and localize the target event relative to their own temporal point, judging whether the target event happened in the future or the past of the reference event (see Methods for details of the scanning procedure).”

      We believe this task manipulation was successful. Behaviorally, the two tasks showed opposite correlations between reaction time and temporal distance, resembling the symbolic distance versus mental scanning effect. Neurally, contrasting the internal- and external-perspective tasks revealed activation of the default mode network, which is known to play a central role in self-projection (Buckner et al., 2017).

      (e) The authors systematically report interpreted results, not factual data. For instance, while not showing the results on behavioral outcomes, the authors directly interpret them as symbolic distance effects.

      Thank you for this comment. In the original paper, we reported the relevant statistics before our interpretation: “Sequential Distance was correlated positively with RT in the external-perspective task (z = 3.80, p < 0.001) but negatively in the internal-perspective task (z = -3.71, p < 0.001).” However, they may have been difficult to notice, and we are including a figure for the RT analysis in the revised manuscript.

      Crucially, the authors do not comment on the obvious differences in task difficulty in these two tasks, which demonstrates a substantial lack of control in the experimental design. The same/different task (task 1 called "external perspective") comes with known biases in psychophysics that are not present in the temporal order task (task 2 called " internal perspective"). The authors also did not discuss or try to match the performance level in these two tasks. Accordingly, the authors claim that participants had greater accuracy in the external (same/different) task than in the internal task, although no data are shown and provided to support this report. Further, the behavioral effect is trivialized by the report of a performance accuracy trade off that further illustrates that there is a difference in the task requirements, preventing accurate comparison of the two tasks.

      As noted in Question 2d, we acknowledge the substantial difference between the two tasks. However, the primary goal of this study was not to directly compare these tasks to isolate a specific cognitive component. Instead, we first identified the neural correlates of temporal distance as brain regions showing a significant correlation between neural activity and temporal distance, independent of task demands. We then compared these neural correlates across the two task conditions, which were designed to engage different temporal perspectives. Therefore, any general differences between the tasks should not be a confound for our main findings and interpretation.

      Our aim was to investigate whether the hippocampal representation of temporal distance remains consistent across different perspectives and whether the parietal representation of temporal distance varies as a function of the perspective adopted. We do not see how this doubledissociation pattern could be explained by differences in task difficulty.

      While we do not consider the overall difference in task difficulty between the two tasks to be a confounding factor, we acknowledge the potential confound posed by variations in task difficulty across temporal distances (1 to 5). This concern arises from the similarity between the activity patterns in the posterior parietal cortex and reaction time across temporal distances. To address this, we conducted control analyses to test this hypothesis (see the second and third points from Reviewer 2 for details).

      On page 8, we present the behavioral accuracy data: “Participants showed significantly higher accuracy in the external-perspective task than in the internal-perspective task (external-perspective task: M = 93.5%, SD = 4.7%; internal-perspective task: M = 89.5%, SD = 8.1%; paired t(31) = 3.33, p = 0.002).”

      All fMRI contrasts are also confounded by this experimental shortcoming, seeing as they are all reported at the interaction level across a task. For instance, in Figure 4, the authors report a significant beta difference between internal and external tasks. It is impossible to disentangle whether this effect is simply due to task difference or to an actual processing of the duration that differs across tasks, or to the nature of the representation (the most difficult to tackle, and the one chosen by the authors).

      We thank the reviewer for pointing out this important issue. Like temporal distance, the neural correlates of duration were not derived from a direct contrast between the two tasks. Instead, they were identified by detecting brain regions showing a significant correlation between neural activity and the implied duration of each event using the parametric modulation analysis. Therefore, what is shown in Figure 4 reflects the significant differences in these neural correlations with duration between the two tasks.

      The observed difference in the neural representation of duration between the two tasks was unexpected. In the original manuscript, we provided a post hoc explanation: “Since the externalperspective task in the current study encouraged the participants to compare the event sequence with the external parallel temporal landmarks, duration representation in the hippocampus may be dampened.”

      However, we agree that this difference might also arise from other factors distinguishing the two tasks. In the revised manuscript, we have clarified this possibility as follows: “The difference in duration representation between the two tasks remains open to interpretation. One possible explanation is that the hippocampus is preferentially involved in memory for durations embedded within event sequences (see review by Lee et al., 2020). In the internal-perspective task, participants indeed localized events within the event sequence itself. In contrast, the externalperspective task encouraged participants to compare the event sequence with external temporal landmarks, which may have attenuated the hippocampal representation of duration.”

      Conclusion:

      In conclusion, the current experimental work is confounded and lacks controls. Any behavioral or fMRI contrasts between the two proposed tasks can be parsimoniously accounted for by difficulty or attentional differences, not the claim of representational differences being argued for here.

      We hope that our explanations and clarifications above adequately address the reviewer’s concerns. We would like to reiterate that we did not directly compare the two tasks. Rather, we first identified the neural representations of sequential distance and duration, and then examined how these representations differed across tasks. It is unclear to us how the overall difference in task difficulty or attentional demands could lead to the observed pattern of results.

      By determining where the neural representations were consistent and where they diverged, we were able to differentiate brain regions that encode temporal information allocentrically from those that represent temporal information in a perspective-dependent manner, modulated by task demands.

      Reviewer #2 (Public review):

      Summary:

      Xu et al. used fMRI to examine the neural correlates associated with retrieving temporal information from an external compared to internal perspective ('mental time watching' vs. 'mental time travel'). Participants first learned a fictional religious ritual composed of 15 sequential events of varying durations. They were then scanned while they either (1) judged whether a target event happened in the same part of the day as a reference event (external condition); or (2) imagined themselves carrying out the reference event and judged whether the target event occurred in the past or will occur in the future (internal condition). Behavioural data suggested that the perspective manipulation was successful: RT was positively correlated with sequential distance in the external perspective task, while a negative correlation was observed between RT and sequential distance for the internal perspective task. Neurally, the two tasks activated different regions, with the external task associated with greater activity in the supplementary motor area and supramarginal gyrus, and the internal condition with greater activity in default mode network regions. Of particular interest, only a cluster in the posterior parietal cortex demonstrated a significant interaction between perspective and sequential distance, with increased activity in this region for longer sequential distances in the external task, but increased activity for shorter sequential distances in the internal task. Only a main effect of sequential distance was observed in the hippocampus head, with activity being positively correlated with sequential distance in both tasks. No regions exhibited a significant interaction between perspective and duration, although there was a main effect of duration in the hippocampus body with greater activity for longer durations, which appeared to be driven by the internal perspective condition. On the basis of these findings, the authors suggest that the hippocampus may represent event sequences allocentrically, whereas the posterior parietal cortex may process event sequences egocentrically.

      We sincerely appreciate the reviewers for providing an accurate, comprehensive, and objective summary of our study.

      Strengths:

      The topic of egocentric vs. allocentric processing has been relatively under-investigated with respect to time, having traditionally been studied in the domain of space. As such, the current study is timely and has the potential to be important for our understanding of how time is represented in the brain in the service of memory. The study is well thought out, and the behavioural paradigm is, in my opinion, a creative approach to tackling the authors' research question. A particular strength is the implementation of an imagination phase for the participants while learning the fictional religious ritual. This moves the paradigm beyond semantic/schema learning and is probably the best approach besides asking the participants to arduously enact and learn the different events with their exact timings in person. Importantly, the behavioural data point towards successful manipulation of internal vs. external perspective in participants, which is critical for the interpretation of the fMRI data. The use of syllable length as a sanity check for RT analyses, as well as neuroimaging analyses, is also much appreciated.

      We thank the reviewer for the positive and encouraging comments.

      Weaknesses/Suggestions:

      Although the design and analysis choices are generally solid, there are a few finer details/nuances that merit further clarification or consideration in order to strengthen the readers' confidence in the authors' interpretation of their data.

      (1) Given the known behavioural and neural effects of boundaries in sequence memory, I was wondering whether the number of traversed context boundaries (i.e., between morning-afternoon, and afternoon-evening) was controlled for across sequential length in the internal perspective condition? Or, was it the case that reference-target event pairs with higher sequential numbers were more likely to span across two parts of the day compared to lower sequential numbers? Similarly, did the authors examine any potential differences, whether behaviourally or neurally, for day part same vs. day part different external task trials?

      We thank the reviewer for the thoughtful comments. When we designed the experiment, we minimized the correlation between the sequential distance between the target and reference events and whether the reference and target events occurred within the same or different parts of the day (coded as Same = 0, Different = 1). The point-biserial correlation coefficient between these two variables across all the trials within the same run were controlled below 0.2.

      To investigate the effect of day-part boundaries on behavior, as well as the contribution of other factors, we conducted a new linear mixed-effects model analysis incorporating four additional variables. They are whether the target and the reference events are within the same or different parts of the day (i.e., Same vs. Different), whether the target event is in the future or the past of the reference event (i.e., Future vs. Past), and the interactions of the two factors with Task Type (i.e., internal- vs. external-perspective task).

      The results are largely the same as the original one in the table: There was a significant main effect of Syllable Length, and the interaction effects between Task Type and Sequence Distance and between Task Type and Duration remain significant. What's new is we also found a significant interaction effect between Task Type and Same vs. Different.

      As shown in the Figure 2—figure supplement 1, this Same vs. Different effect was in line with the effect of Sequential Distance, with two events in the same and different parts of the day corresponding to the short and long sequential distances. Given that Sequential Distance had already been considered in the model, the effect of parts of the day should result from the boundary effect across day parts or the chunking effect within day parts, i.e., the sequential distance across different parts of the day was perceived longer while the sequential distance within the same parts of the day was perceived shorter. We have incorporated these findings into the manuscript.

      Neurally, to further verify that the significant effects of sequential distance were not driven by its weak correlation with the Same/Different judgment or other potential confounding factors, we constructed another GLM that incorporated three additional parametric modulators: the sequence position of the target event (ranging from 1 to 15) and the behavioral responses (Future vs. Past in the internal-perspective task; Same vs. Different in the external-perspective task, coded as 0 and 1). The significant findings were unaffected.

      (2) I would appreciate further insight into the authors' decision to model their task trials as stick functions with duration 0 in their GLMs, as opposed to boxcar functions with varying durations, given the potential benefits of the latter (e.g., Grinband et al., 2008). I concur that in certain paradigms, RT is considered a potential confound and is taken into account as a nuisance covariate (as the authors have done here). However, given that RTs appear to be critical to the authors' interpretation of participant behavioural performance, it would imply that variations in RT actually reflect variations in cognitive processes of interest, and hence, it may be worth modelling trials as boxcar functions with varying durations.

      We appreciate the reviewer’s insightful comment on this important issue. Whether to control for RT’s influence on fMRI activation is indeed a long-standing paradox. On the one hand, RT reflects underlying cognitive processes and therefore should not be fully controlled for. On the other hand, RT can independently influence neural activity, as several brain networks vary with RT irrespective of the specific cognitive process involved—a domain-general effect. For example, regions within the multiple-demand network are often positively correlated with RT across different cognitive domains.

      Our strategy in the manuscript is to first present the results without including RT as a control variable and then examine whether the effects are preserved after controlling for RT. In the revised manuscript, we have clarified this approach (Page 13): “Here, changes in activity levels within the PPC were found to align with RT. Whether to control for RT’s influence on fMRI activation represents a well-known paradox. On the one hand, RT reflects underlying cognitive processes and therefore should not be fully controlled for. On the other hand, RT can independently influence neural activity, as several brain networks vary with RT irrespective of the specific cognitive process involved—a domain-general effect. For instance, regions within the multiple-demand network are often positively correlated with RT and task difficulty across diverse cognitive domains (e.g., Fedorenko et al., 2013; Mumford et al., 2024). To evaluate the second possibility, we conducted an additional control analysis by including trial-by-trial RT as a parametric modulator in the first-level model (see Methods). Notably, the same PPC region remained the only area in the entire brain showing a significant interaction between Task Type and Sequential Distance (voxel-level p < 0.001, clusterlevel FWE-corrected p < 0.05). This finding indicates that PPC activity cannot be fully attributed to RT. Furthermore, we do not interpret the effect as reflecting a domain-general RT influence, as regions within the multiple-demand system—typically sensitive to RT and task difficulty—did not exhibit significant activation in our data.”

      The reason we did not use boxcar functions with varying durations in our original manuscript is that we also applied parametric modulation in the same model. In the parametric modulation, all parametric modulators inherit the onsets and durations of the events being modulated. Consequently, the modulators would also take the form of boxcar functions rather than stick functions—the height of each boxcar reflecting the parameter value and its length reflecting the RT. We were uncertain whether this approach would be appropriate, as we have not encountered other studies implementing parametric modulation in this manner.

      For exploratory purposes, we also conducted a first-level analysis using boxcar functions with variable durations. The same PPC region remained the strongest area in the entire brain that shows an interaction effect between Task Type and Sequential Distance. However, the cluster size was slightly reduced (voxel-level p < 0.001, cluster-level FWE-corrected p = 0.0610; see the Author response image 1 below). The cross indicates the MNI coordinates at [38, –69, 35], identical to those shown in the main results (Figure 4A).

      Author response image 1.

      (3) The activity pattern across tasks and sequential distance in the posterior parietal cortex appears to parallel the RT data. Have the authors examined potential relationships between the two (e.g., individual participant slopes for RT across sequential distance vs. activity betas in the posterior parietal cortex)?

      We thank the reviewer for this helpful suggestion. As shown in the Author response image 2, the interaction between Task Type and Sequential Distance was a stronger predictor of PPC activation than of RT. Because PPC activation and RT are measured on different scales, we compared their standardized slopes (standardized β) measuring the change in a dependent variable in terms of standard deviations for a one-standard-deviation increase in an independent variable. The standardized β for the Task Type × Sequential Distance interaction was −0.30 (95% CI [−0.42, −0.19]) for PPC activation and −0.21 (95% CI [−0.30, −0.13]) for RT. The larger standardized effect for PPC activation indicates that the Task Type × Sequential Distance interaction was a stronger predictor of neural activation than of behavioral RT.

      Author response image 2.

      A more relevant question is whether PPC activation can be explained by temporal information (i.e., the sequential distance) independently of RT. To test this, we included both Sequential Distance and RT in the same linear mixed-effects model predicting PPC Activation Level. As shown in the Author response table 1, although RT independently influenced PPC activation (F(1, 288) = 4.687, p = 0.031), the interaction between Task Type and Sequential Distance was a much stronger independent predictor (F(1, 290) = 19.319, p < 0.001).

      Author response table 1.

      PPC Activation Level Predicted by Sequential Distance and RT

      (3) Linear Mixed Model Formula: PPC Activation Level ~ 1 + Task Type * (Sequential Distance + RT) + (1 | Participant)

      (4) There were a few places in the manuscript where the writing/discussion of the wider literature could perhaps be tightened or expanded. For instance:

      (i) On page 16, the authors state 'The negative correlation between the activation level in the right PPC and sequential distance has already been observed in a previous fMRI study (Gauthier & van Wassenhove, 2016b). The authors found a similar region (the reported MNI coordinate of the peak voxel was 42, -70, 40, and the MNI coordinate of the peak voxel in the present study was 39, -70, 35), of which the activation level went up when the target event got closer to the self-positioned event. This finding aligns with the evidence suggesting that the posterior parietal cortex implements egocentric representations.' Without providing a little more detail here about the Gauthier & van Wassenhove study and what participants were required to do (i.e., mentally position themselves at a temporal location and make 'occurred before' vs. 'occurred after' judgements of a target event), it could be a little tricky for readers to follow why this convergence in finding supports a role for the posterior parietal cortex in egocentric representations.

      We appreciate the reviewer’s comments. In the revised manuscript, we have provided a more detailed explanation of Gauthier and van Wassenhove’s study (Page 17): “The negative correlation between the activation level in the right PPC and sequential distance has already been observed in a previous fMRI study by Gauthier & van Wassenhove (2016b). In their study, the participants were instructed to mentally position themselves at a specific time point and judge whether a target event occurred before or after that time point. The authors identified a similar brain region (reported MNI coordinates of the peak voxel: 42, −70, 40), closely matching the activation observed in the present study (MNI coordinates of the peak voxel: 39, −70, 35). In both studies, activation in this region increased as the target event approached the self-positioned time point, which aligns with the evidence suggesting that the posterior parietal cortex implements egocentric representations.”

      (ii) Although the authors discuss the Lee et al. (2020) review and related studies with respect to retrospective memory, it is critical to note that this work has also often used prospective paradigms, pointing towards sequential processing being the critical determinant of hippocampal involvement, rather than the distinction between retrospective vs. prospective processing.

      We sincerely thank the reviewer for highlighting these important points. In response, we have revised the section of the Introduction discussing the neural underpinnings of duration (Pages 3-4). “Neurocognitive evidence suggests that the neural representation of duration engages distinct brain systems. The motor system—particularly the supplementary motor area—has been associated with prospective timing (e.g., Protopapa et al., 2019; Nani et al., 2019; De Kock et al., 2021; Robbe, 2023), whereas the hippocampus is considered to support the representation of duration embedded within an event sequence (e.g., Barnett et al., 2014; Thavabalasingam et al., 2018; see also the comprehensive review by Lee et al., 2020).”

      (iii) The authors make an interesting suggestion with respect to hippocampal longitudinal differences in the representation of event sequences, and may wish to relate this to Montagrin et al. (2024), who make an argument for the representation of distant goals in the anterior hippocampus and immediate goals in the posterior hippocampus.

      We thank the reviewer for bringing this intriguing and relevant study to our attention. In the Discussion of the manuscript, we have incorporated it into our discussion (Page 21): “Evidence from the spatial domain has suggested that the anterior hippocampus (or the ventral rodent hippocampus) implements global and gist-like representations (e.g., larger receptive fields), whereas the posterior hippocampus (or the dorsal rodent hippocampus) implements local and detailed ones (e.g., finer receptive fields) (e.g., Jung et al., 1994; Kjelstrup et al., 2008; Collin et al., 2015; see reviews by Poppenk et al., 2013; Robin & Moscovitch, 2017; see Strange et al., 2014 for a different opinion). Recent evidence further shows that the organizational principle observed along the hippocampal long axis may also extend to the temporal domain (Montagrin et al., 2024). In that study, the anterior hippocampus showed greater activation for remote goals, whereas the posterior hippocampus was more strongly engaged for current goals, which are presumed to be represented in finer detail.”

      Reviewing Editor Comments:

      While both reviewers acknowledged the significance of the topic, they raised several important concerns. We believe that providing conceptual clarification, adding important methodological details, as well as addressing potential confounds will further strengthen this paper.

      We thank the editor for the suggestions.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Please, provide the actual ethical approval #.

      We have added the ethical approval number in the revised manuscript (P 36): “The ethical committee of the University of Trento approved the experimental protocol (Approval Number 2019-018),”

      (2) Thirty-two participants were tested. Please report how you estimated the sample size was sufficient to test your working hypothesis.

      We thank the editor for pointing out this omission. In the revised manuscript, we have added an explanation for our choice of sample size (p. 36): “The sample size was chosen to align with the upper range of participant numbers reported in previous fMRI studies that successfully detected sequence or distance effects in the hippocampus (N = 15–34; e.g., Morgan et al., 2011; Howard et al., 2014; Deuker et al., 2016; Garvert et al., 2017; Theves et al., 2019; Park et al., 2021; Cristoforetti et al., 2022).”

      (3) All MRI figures: please orient the reader; left/right should be stated.

      In the revised manuscript, we have added labels to all MRI figures to indicate the left and right hemispheres.

      (4) In Figure 3A-B, the clear lateralization of the activation is not discussed in the Results or in the Discussion. Was it predicted?

      We thank the editors for highlighting this important point regarding hemispheric lateralization. The right-lateralization observed in our findings is indeed consistent with previous literature. In the revised manuscript, we have expanded our discussion to emphasize this aspect more clearly.

      For the parietal cortex, we now note (Page 17-18): “The negative correlation between activation in the right posterior parietal cortex (PPC) and sequential distance has previously been reported in an fMRI study by Gauthier and van Wassenhove (2016b). In their paradigm, participants were instructed to mentally position themselves at a specific time point and judge whether a target event occurred before or after that point. The authors identified a similar region (peak voxel MNI coordinates: 42, −70, 40), closely corresponding to the activation observed in the present study (peak voxel MNI coordinates: 39, −70, 35). In both studies, activation in this region increased as the target event approached the self-positioned time point, consistent with evidence suggesting that the posterior parietal cortex supports egocentric representations. Neuropsychological studies have further shown that patients with lesions in the bilateral or right PPC exhibit ‘egocentric disorientation’ (Aguirre & D’Esposito, 1999), characterized by an inability to localize objects relative to themselves (e.g., Case 2: Levine et al., 1985; Patient DW: Stark, 1996; Patients MU: Wilson et al., 1997, 2005).”

      For the hippocampus, we have added (Page 19): “Previous research has shown that hippocampal activation correlates with distance (e.g., Morgan et al., 2011; Howard et al., 2014; Garvert et al., 2017; Theves et al., 2019; Viganò et al., 2023), and that distributed hippocampal activity encodes distance information (e.g., Deuker et al., 2016; Park et al., 2021). Most studies have reported hippocampal ePects either bilaterally or predominantly in the right hemisphere, whereas only one study (Morgan et al., 2011) found the ePect localized to the left hippocampus.”

    1. Author response:

      We thank you and reviewers for their thoughtful, constructive, and fair evaluation of our manuscript. We appreciate the recognition of the value of an end-to-end proteogenomics framework integrating long-read transcriptomics with deep proteomic analysis, and we are grateful for the specific guidance on how to strengthen clarity, generality, and impact for a broad scientific readership. We outline below the key revisions we plan to undertake in response to the public reviews.

      Reviewer #1

      We thank the reviewer for their positive assessment of the relevance of this work to Ewing sarcoma and cancer proteogenomics.

      Scope and generality.

      We agree that analysis of a single cell line limits generalization. In the revised manuscript, we will extend the ProteomeGenerator3 workflow to additional tumor specimens, including Ewing sarcoma tumors, to assess reproducibility and biological relevance beyond a single test cancer cell line.

      Definitions and analytical clarity.

      We will clarify definitions of non-canonical transcripts, alternative splice isoforms, and neogenes, and explicitly distinguish these categories throughout the manuscript. We will add a summary flow diagram that tracks transcripts through classification, ORF prediction, and proteoform detection, clarifying how Figures 4B and 4D relate.

      Proteoform filtering and confidence.

      To improve transparency, we will add a step-wise schematic summarizing how candidate non-canonical proteoforms are filtered to a high-confidence subset, including SwissProt comparison, BLASTp filtering, peptide uniqueness, and competitive database searches.

      Validation.

      We agree that orthogonal validation is important. We will include additional analyses of non-canonical proteofoms detected recurrently in additional tumor specimens to provide an empirical estimate of reliably detectable non-canonical proteoforms.

      Supplementary Figure 5.

      We will revise the presentation and explanation of this figure to avoid misinterpretation, including analyses focused specifically on non-canonical sequence segments and inclusion of tumor samples for direct comparison.

      Reviewer #2

      We thank the reviewer for placing this work in context with our prior ProteomeGenerator publications and for their guidance on framing the manuscript for a broad audience.

      Emphasizing the central conceptual advance.

      We agree that the primary innovation is the use of long-read transcriptomics to generate sample-specific proteogenomic databases. In the revised manuscript, we will directly compare long-read-derived and short-read-derived databases applied to the same samples and proteomic data, explicitly demonstrating where long-read sequencing enables discovery inaccessible to short-read approaches.

      Manuscript reorganization.

      We will substantially revise the manuscript to foreground the biological and conceptual consequences of long-read-enabled proteogenomics, using focused examples. Detailed descriptions of protease selection, fractionation, and acquisition optimization will be moved to supplementary methods, while retaining key conclusions about their impact on discovery.

      Positioning of technical advances.

      We will frame multi-protease and acquisition strategies as general principles required for unbiased proteoform discovery, rather than as static technical prescriptions, emphasizing their relevance across evolving proteomics platforms.

      Overall Significance

      In the revised manuscript, we will more clearly articulate that this work establishes long-read-informed, sample-specific proteogenomics as a discovery-grade framework, revealing cancer-specific proteoforms that are systematically invisible to reference-based and short-read-driven approaches, with broad implications for cancer biology and biomarker discovery.

      We thank the editors and reviewers again for their constructive feedback, which we believe will substantially strengthen the clarity and broad impact of this work.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This is a well-structured and interesting manuscript that investigates how herbivorous insects, specifically whiteflies and planthoppers, utilize salivary effectors to overcome plant immunity by targeting the RLP4 receptor.

      Strengths:

      The authors present a strong case for the independent evolution of these effectors and provide compelling evidence for their functional roles.

      Weaknesses:

      Western blot evidence for effector secretion is weak. The possibility of contamination from insect tissues during the sample preparation should be avoided.

      Below are some specific comments and suggestions to strengthen the manuscript.

      Thank you very much for your comments. We have carefully revised the MS following your valuable suggestions and comments.

      (1) Western blot evidence for effector secretion:

      The western blot evidence in Figure 1, which aims to show that the insect protein is secreted into plants, is not fully convincing. The band of the expected size (~30 kDa) in the infested tissues is very weak. Furthermore, the high and low molecular weight bands that appear in the infested tissues do not match the size of the protein in the insects themselves, and a high molecular weight band also appears in the uninfested control tissues. It is difficult to draw a definitive conclusion that this protein is secreted into the plants based on this evidence. The authors should also address the possibility of contamination from insect tissues during the sample preparation and explain how they have excluded this possibility.

      Thank you for pointing out this. One or two bands between 25-35kDa were specifically identified in B. tabaci-infested plants, but not the non-infested plants, and the smaller high intensity band is the same size as that of BtRDP in salivary glands. This experiment has been repeated for six times. In the current version, we reperformed this experiment, and provided salivary gland sample as a positive control, which showed the same molecular weight with a specific band in infested sample. It is noteworthily that in the experiment of current version, only the smaller high intensity band appear, while the low intensity band did not appear. The detection of a protein within infested plant tissue is a key criterion for validating the secretion of salivary effectors, an approach supported by numerous studies in this field. Furthermore, our previous LC-MS/MS analysis of B. tabaci watery saliva identified six unique peptides matching BtRDP, providing independent evidence for its presence in saliva. Therefore, as we now state in the manuscript “the detection of BtRDP in infested plants (Fig. 1a) and in watery saliva (Fig. S1) collectively indicates that BtRDP is a salivary protein”.

      Regarding the higher molecular weight band that present in both infested and non-infested samples, we agree that it most likely represents a non-specific band, which is a common occurrence in Western blot assays. Such bands are sometimes used to indicate comparable sample loading. To address the possibility of contamination by insect tissues, we wish to clarify that all insects and deposited eggs were carefully removed from the infested leaves prior to sample processing. Moreover, BtRDP is undetectable at the egg stage, and no BtRDP-associated band can be detected even in egg contamination. We have revised the Methods section to explicitly state this procedure:

      “After feeding, the eggs deposited on the infested tobacco leaves were removed. The leaves showing no visible insect contamination were immediately frozen in liquid nitrogen and ground to a fine powder.”

      (2) Inconsistent conclusion (Line 156 and Figure 3c):

      The statement in line 156 is inconsistent with the data presented in Figure 3c. The figure clearly shows that the LRR domain of the protein is the one responsible for the interaction with BtRDP, not the region mentioned in the text. This is a critical misrepresentation of the experimental findings and must be corrected. The conclusion in the text should accurately reflect the data from the figure.

      We apologize for any confusion caused by the original phrasing. In our previous manuscript, the description “NtRLP4 without signal peptides and transmembrane domains” referred specifically to the truncated construct NtRLP4<sub>(23-541)</sub> used in the experiment. To prevent any misunderstanding, we have revised the sentence in the updated version to state explicitly: “Point-to-point Y2H assays reveal that NtRLP4<sub>(23-541)</sub> (a truncated version lacking the signal peptide and transmembrane domains) interacts with BtRDP<sup>-sp</sup>”.

      (3) Role of SOBIR1 in the RLP4/SOBIR1 Complex:

      The authors demonstrate that the salivary effectors destabilize the RLP4 receptor, leading to a decrease in its protein levels and a reduction in the RLP4/SOBIR1 complex. A key question remains regarding the fate of SOBIR1 within this complex. The authors should clarify what happens to the SOBIR1 protein after the destabilization of RLP4. Does SOBIR1 become unbound, targeted for degradation itself, or does it simply lose its function without RLP4? This would provide further insight into the mechanism of action of the effectors.

      Thank you for suggestion. In the current version, we assessed the impact of BtRDP on NtSOBIR1 following NtRLP4 destabilization. The results showed that while the NtRLP4-myc accumulation was markedly reduced, NtSOBIR1-flag levels remained unchanged, suggesting that destabilization of NtRLP4 did not affect NtSOBIR1 accumulation.

      (4) Clarification on specificity and evolutionary claims:

      The paper's most significant claim is that the effectors from both whiteflies and planthoppers "independently evolved" to target RLP4. While the functional data is compelling, this evolutionary claim would be more convincing with stronger evidence. Showing that two different effector proteins target the same host protein is a fascinating finding but without a robust phylogenetic analysis, the claim of independent evolution is not fully supported. It would be valuable to provide a more detailed evolutionary analysis, such as a phylogenetic tree of the effector proteins, showing their relationship to other known insect proteins, to definitively rule out a shared, but highly divergent, common ancestor.

      We appreciate the reviewer’s valuable suggestion to investigate a potential evolutionary link between BtRDP and NlSP104. Our initial analysis already indicated no detectable sequence similarity. To address this point more thoroughly, we attempted a phylogenetic analysis. However, we were unable to generate a meaningful alignment due to a complete lack of conserved amino acid sequences. Therefore, we conducted a comparative genomics analysis by blasting both proteins against the genomic or transcriptomic data of 30 diverse insect species. This analysis revealed that RDP is exclusively present in Aleyrodidae species, and SP104 is exclusively present in Delphacidae species (Table S1). Taken together, the absence of sequence similarity, their distinct protein structure, and their lineage-specific distributions, we conclude that BtRDP and NlSP104 are highly unlikely to be homologous and thus did not originate from a common ancestor.

      (5) Role of SOBIR1 in the interaction:

      The results suggest that the effectors disrupt the RLP4/SOBIR1 complex. It is not entirely clear if the effectors are specifically targeting RLP4, SOBIR1, or both. Further experiments, such as a co-immunoprecipitation assay with just RLP4 and the effector, could clarify if the effector can bind to RLP4 in the absence of SOBIR1. This would help to definitively place RLP4 as the primary target.

      We appreciate the reviewer’s insightful comments regarding whether the effector preferentially targets RLP4, SOBIR1, or both. In our study, we conducted reciprocal co-immunoprecipitation assays using RLP4 and BtRDP as controls. These assays showed that BtRDP interacts with RLP4 but does not interact with SOBIR1, supporting the conclusion that SOBIR1 is unlikely to be a direct target of BtRDP. We fully agree that testing the interaction between RLP4 and BtRDP in the absence of SOBIR1 would further strengthen the conclusion. However, we were unable to obtain N. tabacum SOBIR1 knockout mutants, and therefore could not experimentally assess whether the RLP4–BtRDP interaction persists in planta without SOBIR1. Nevertheless, our yeast two-hybrid assays demonstrate that RLP4 and BtRDP can directly interact, indicating that their association does not strictly depend on SOBIR1. Together, these results support the interpretation that RLP4 is the primary target of BtRDP, while SOBIR1 is not directly engaged by the effector.

      (6) Transcriptome analysis (Lines 130-143):

      The transcriptome analysis section feels disconnected from the rest of the manuscript. The findings, or lack thereof, from this analysis do not seem to be directly linked to the other major conclusions of the paper. This section could be removed to improve the manuscript's overall focus and flow. If the authors believe this data is critical, they should more clearly and explicitly connect the conclusions of the transcriptome analysis to the core findings about the effector-RLP4 interaction.

      Thank you for suggestion. As you and Reviewer #2 pointed, the transcriptomic analysis did not closely link to the major conclusions of the paper, and we got little information from the transcriptomic analysis. Therefore, we remove these analyses to improve the manuscript’s overall focus and flow.

      (7) Signal peptide experiments (Lines 145 and beyond):

      The experiments conducted with the signal peptide (SP) are questionable. The SP is typically cleaved before the protein reaches its final destination. As such, conducting experiments with the SP attached to the protein may have produced biased observations and could lead to unjustified conclusions about the protein's function within the plant cell. We suggest the authors remove the experiments that include the signal peptide.

      Thank you for pointing out this. The SP was retained to direct the target proteins to the extracellular space of plant cells. Theoretically, the SP is cleaved in the mature protein. This methodology is widely used in effector biology. For example, the SP directs Meloidogyne graminicola Mg01965 to the apoplast, where it functions in immune suppression, whereas Mg01965 without the SP fails to exert this function (10.1111/mpp.12759). In our study, the SP of BtRDP was expected to guide the target protein to the extracellular space, facilitating its interaction with RLP4. Moreover, the observed protein sizes of BtRDP with and without the SP in transgenic plants were identical, suggesting successful SP cleavage. Therefore, we have retained the experiments involving the SP in the current version.

      (8) Overly strong conclusion and unclear evidence (Line 176):

      The use of the word "must" on line 176 is very strong and presents a definitive conclusion without sufficient evidence. The authors state that the proteins must interact with SOBIR1, but they do not provide a clear justification for this claim. Is SOBIR1 the only interaction partner for NtRLP4? The authors should provide a specific reason for focusing on SOBIR1 instead of demonstrating an interaction with NtRLP4 first. Additionally, do BtRDP or NlSP694 also interact with SOBIR1 directly? The authors should either tone down their language to reflect the evidence or provide a clearer justification for this strong claim.

      Thank you for pointing this out. In the current version, the word “must” has been toned down to “may” due to insufficient supporting evidence. In this study, SOBIR1 was chosen because it has been widely reported to be required for the function of several RLPs involved in innate immunity. However, it remains unclear whether SOBIR1 is the only interaction partner of NtRLP4. In the current version, we have clarified the rationale for focusing on SOBIR1 prior to the experiments “The receptor-like kinase SOBIR1, which contains a kinase domain, has been widely reported to be required for the function of RLPs involved in innate immunity (Gust & Felix, 2014)” and discussed that “Although NtRLP4 interacts with SOBIR1, this alone does not confirm that it operates strictly through this canonical module. Evidence from other RLPs shows that co-receptor usage can be flexible, and some RLPs function partly or conditionally independent of SOBIR1. Therefore, a more definitive assessment of NtRLP4 signaling will therefore require genetic dissection of its co-receptor dependencies, including but not limited to SOBIR1.”. In addition, the direct interaction between BtRDP and SOBIR1 was experimentally tested, and the results showed that BtRDP failed to interact with SOBIR1.

      Minor Comments

      (9) The statement in the abstract, "However, it remains unclear how these invaders are able to overcome receptor perception and disable the plant signaling pathways," is not entirely accurate. The fields of effector biology and host-pathogen interactions have provided significant insight into how pathogens and pests manipulate both Pattern-Triggered Immunity (PTI) and Effector-Triggered Immunity (ETI). While the specific mechanism described in this paper is novel, the broader claim that the field is unclear on these processes weakens the initial hook of the paper. A more precise framing of the problem would be beneficial, perhaps by stating that the specific mechanisms used by these particular herbivores to target RLP4 were previously unknown.

      Thank you for this insightful comment. We agree that the original statement in the abstract overstated the lack of understanding in the field. In the current version, we have refined the sentence to more accurately reflect the current state of knowledge, emphasizing that while microbial suppression of plant immunity has been extensively studied, the strategies used by herbivorous insects to overcome receptor-mediated defenses remain less understood. The revised sentence now reads as follows: “Although the mechanisms used by microbial pathogens to suppress plant immunity are well studied, how herbivorous insects overcome receptor-mediated defenses remains unclear”.

      (10) The introduction is heavily focused on Pattern Recognition Receptors (PRRs), which, while central to the paper's findings, gives a somewhat narrow view of the plant's defense against herbivores. It would be beneficial to briefly acknowledge the broader context of plant defenses, such as physical barriers, direct chemical toxicity, and indirect defenses, before narrowing the focus to the specific molecular interactions of PRRs that are the core of this study. This would provide a more complete picture of the "arms race" between plants and herbivores.

      Thank you for this valuable suggestion. We agree that the original introduction focused too narrowly on pattern-recognition receptors (PRRs). In the current version, we have expanded the introductory section to provide a broader overview of plant defense mechanisms. Specifically, we now acknowledge the multiple layers of plant defenses, including physical barriers (e.g., cuticle and cell wall), chemical defenses (e.g., toxic secondary metabolites and anti-nutritive compounds), and indirect defenses mediated by herbivore-induced volatiles. This addition provides a more complete context for understanding the molecular interactions discussed in this study. The revised paragraph now reads as follows: “Plants have evolved sophisticated defense systems to survive constant attacks from pathogens and herbivorous insects. These defenses operate at multiple levels, including physical barriers such as the cuticle and cell wall, chemical defenses involving toxic secondary metabolites and anti-nutritive compounds, and indirect defenses that attract natural enemies of herbivores through the emission of herbivore-induced volatiles. Beyond these general strategies, plants also rely on highly specialized molecular immune responses that allow them to detect and respond rapidly to invaders.”

      (11) The figure legends are generally clear, but some could be more detailed. For instance, in Figure 2, it would be helpful to explicitly state what each bar represents in the graph and to include the statistical test used. Please ensure all panels in all figures have clear labels.

      Thank you for this helpful suggestion. We have revised the legend of Fig. 2 and other figures to provide more detailed information for each panel. Specifically, we now explicitly describe what each bar represents in the graphs and specify the statistical test used. In addition, we ensured that all panels are clearly labeled. These changes improve clarity and allow readers to better interpret the data.

      (12) The methods section is comprehensive, but it would be helpful to include more specifics on the statistical analyses used. For example, the type of statistical test (e.g., t-test, ANOVA) and the software used should be mentioned for each experiment.

      Thank you for your suggestion. We have revised the Methods section (Statistical analysis) to provide more detailed information on the statistical analysis used for each experiment.

      (13) The manuscript's overall impact is weakened by the inclusion of unnecessary words and a few grammatical issues. A focused revision to tighten the language would make the major findings stand out more clearly. For example, on page 2, line 18, "in whitefly Bemisia tabaci, BtRDP is an Aleyrod..." seems to have an incomplete sentence. A thorough proofreading for typos and grammatical errors is highly recommended to improve the overall readability.

      Thank you for your suggestion. We have carefully revised the abstract and the manuscript to improve clarity, readability, and grammatical correctness. In addition, we sought the assistance of a professional English editor to thoroughly proofread and polish the manuscript, ensuring that the language meets high academic standards.

      (14) The discussion section is strong, but it could benefit from a more explicit connection between the findings and the broader ecological implications. For instance, how might the independent evolution of these effectors in different insect species impact plant-insect co-evolutionary dynamics?

      We thank the reviewer for the valuable suggestion. In the current version, we have added a paragraph in the Discussion section highlighting the broader ecological and evolutionary implications of our findings. Specifically, we discuss how the independent evolution of RLP4-targeting effectors in different insect lineages may drive plant-insect co-evolution, influence selection pressures on both plants and herbivores, and potentially shape defense diversification across plant communities. This addition helps to link our molecular findings to ecological outcomes and co-evolutionary dynamics.

      (15) The sentence on line 98, which reads " A few salivary proteins have been reported to attach to salivary sheath after secretion" seems to serve an unclear purpose in the introduction. It would be helpful for the authors to clarify its relevance to the surrounding context or to the paper's overall argument. Its inclusion currently disrupts the flow of the introduction and makes it difficult for the reader to understand its intended purpose.

      We thank the reviewer for the comment. We have revised the paragraph to clarify the relevance of salivary sheath localization to the study. Specifically, we now introduce the role of the salivary sheath as a potential scaffold for effector delivery and explicitly link previous reports of sheath-associated salivary proteins to our observation that BtRDP localizes to the salivary sheath after secretion.

      (16) The writing in lines 104-106 is both grammatically inconsistent and overly wordy. The authors switch between present and past tense ("is" and "was"), and the sentences could be made more concise to improve the clarity and flow of the text. Also check entire paper.

      We thank the reviewer for pointing this out. We have revised the sentence to improve grammatical consistency and clarity, and also checked the manuscript for similar issues. The sentence is now split into two concise statements. In addition, we have thoroughly checked the entire manuscript for similar tense inconsistencies and overly wordy sentences, and have made revisions throughout to ensure consistent past tense usage and improved readability.

      (16) The sentences on lines 111-113 are quite wordy. The core conclusion, which is that the protein affects the insect's feeding probe, could be expressed more simply and directly to improve clarity and flow. I suggest rephrasing this section to be more concise and to highlight the primary finding without the added language.

      We thank the reviewer for the helpful suggestion. We have revised the sentences to make them more concise and to emphasize the main finding that BtRDP influences the whitefly’s feeding behavior as follow: “Compared with the dsGFP control, dsBtRDP-treated B. tabaci showed a marked reduction in phloem ingestion and a longer pathway duration, indicating that BtRDP is required for efficient feeding (Fig. 2c).”

      (17) On line 118, the authors mention "subcellular location." It is not clear where the protein is localized. The authors should explicitly state the specific subcellular compartment of the protein, as this is crucial for understanding its function and interaction with other proteins.

      We thank the reviewer for this valuable comment. To clarify the subcellular localization of BtRDP, we have revised the manuscript accordingly. The transgenic line overexpressing the full-length BtRDP including the signal peptide (oeBtRDP) is expected to localize in the apoplast (extracellular space), whereas the line expressing BtRDP without the signal peptide (oeBtRDP<sup>-sp</sup>) is likely retained in the cytoplasm.

      (18) Lines 121-128, the description of the fecundity and choice assays in this section is overly wordy. The authors should present the main conclusion of these experiments more directly and concisely. The key finding is that the protein affects feeding behavior; this central point is somewhat lost in the detailed, and sometimes repetitive, phrasing.

      We thank the reviewer for this suggestion. In the revised manuscript, we have simplified the description of the fecundity and two-choice assays to highlight the main conclusion as follow: “Fecundity and two-choice assays showed that BtRDP, whether localized in the apoplast (oeBtRDP) or cytoplasm (oeBtRDP<sup>-sp</sup>), enhanced whitefly settling and oviposition compared with EV controls (Fig. 2d-i; Fig. S10), indicating that BtRDP promotes whitefly feeding behavior regardless of its subcellular location.”

      (19) Line 148, the manuscript mentions experiments involving transformation, but the transformation efficiency is not provided. Please include the transformation efficiency for all transformation experiments, as this is crucial for the reproducibility of the results.

      We thank the reviewer for raising this point. We would like to clarify that no transformation experiments were performed in this section. The experiments described involved Y2H screening using BtRDP<sup>-sp</sup> as a bait to identify interacting proteins from a N. benthamiana cDNA library. Therefore, there is no transformation efficiency to report.

      (20) Line 159, the manuscript refers to a sequence similarity around line 159 but does not provide the specific data. It is important to show the actual sequence similarity, perhaps in a supplementary figure or table, to support the claims being made.

      We thank the reviewer for this suggestion. To support our statement regarding sequence similarity, we have added the corresponding alignment figure in the Fig. S11.

      (21) Line 159, the manuscript refers to "three randomly selected salivary proteins." It is unclear from where these proteins were selected. The authors should clarify the source of this selection (e.g., a specific database or a previous study) to ensure the methodology is transparent and the results are reproducible.

      We thank the reviewer for raising this point. These proteins were selected based on previously reports (10.1093/molbev/msad221; 10.1111/1744-7917.12856). In the current version, we provide the accession of these proteins in the MS.

      (22) Line 160, the description "NtcCf9 without signal peptide and transmembrane domains" is difficult to understand. It would be clearer and more consistent to use a term like "truncated NtcCf9" and then specify which domains were removed, as this is a standard practice in molecular biology for describing protein constructs.

      We thank the reviewer for this suggestion. We have revised the manuscript to describe the construct as “truncated NtCf9” and specified that the signal peptide and transmembrane domains were removed

      (23) The phrase "incubated with anti-flag beads" on line 172 is a detail of a routine method. Such details are more appropriate for the Methods section rather than the main text, which should focus on the results and their implications. Please remove such descriptions from the main text to improve readability and flow.

      We thank the reviewer for this suggestion. We have removed the methodological detail from the main text to improve readability. We also check this throughout the MS.

      I am excited about the potential of this work and look forward to seeing the current version.

      We sincerely thank the reviewer for the positive feedback and encouragement. We appreciate your time and thoughtful comments.

      Reviewer #2 (Public review):

      Summary:

      The authors tested an interesting hypothesis that white flies and planthoppers independently evolved salivary proteins to dampen plant immunity by targeting a receptor-like protein.

      Strengths:

      The authors used a wide range of methods to dissect the function of the white fly protein BtRDP and identify its host target NtRLP4.

      Thank you very much for your comments. We have carefully revised the MS following your valuable suggestions and comments.

      Weaknesses:

      (1) Serious concerns about protein work.

      I did not find the indicated protein bands for anti-BtRDP in Figures 1a and 1b in the original blot pictures shown in Figure S30. In Figure 1a, I can't get the point of showing an unspecific protein band with a size of ~190 kD as a loading control for a protein of ~ 30 kD.

      The data discrepancy led me to check other Western blot pictures. Similarly, Figures 2d, 3b, 3d, and S15b (anti-Myc) do not correspond to the original blots shown. In addition, the anti-Myc blot in Figure 4i, all blot pictures in Figures 5b, 5h, and S19a appeared to be compressed vertically. These data raised concerns about the quality of the manuscript.

      Blots shown in Figure 3d, 4f, 4g, and 4h appeared to be done at a different exposure rate compared to the complete blot shown in Figure S30. The undesirable connection between Western blot pictures shown in the figures and the original data might be due to the reduced quality of compressed figures during submission. Nevertheless, clarification will be necessary to support the strength of the data provided.

      We sincerely thank the reviewer for carefully examining our Western blot data and for pointing out these inconsistencies. The discrepancy between the figures in the main text and the original blots (Figure S30) resulted from an oversight during manuscript revision. This manuscript had undergone multiple rounds of revision after submission to another journal. During this process, the main figures and supplementary figures were updated separately, and we mistakenly failed to replace the original blot files with the corresponding current versions.

      For the different exposure rate, the blots shown in the main text were adjusted for overall contrast and brightness to enhance band visibility and presentation clarity, whereas the original images in Figure S30 were raw, unprocessed scans directly from the imaging system. For example, in the Author response image 1 below, to visualize the loading of the input sample, the output figure was adjusted for overall contrast and brightness. This was acceptable for image processing (https://www.nature.com/nature-portfolio/editorial-policies/image-integrity)

      Author response image 1.

      The same figure with brightness and contrast changes across the entire image.

      For the vertical compression, in the previous version, some images were vertically compressed for layout purposes to make the composite figures appear more visually balanced. However, after consulting relevant publication guidelines, we realized that such one-dimensional compression is not encouraged by certain journals as it may alter the original aspect ratio of the image. Therefore, in the manuscript, we have avoided any non-proportional scaling and retained the original aspect ratio of all images.

      We have now carefully rechecked all Western blot data, replaced the outdated raw blot images with the correct corresponding ones, avoid vertical compression, and ensured that the processed figures in the main text match their original data. The revised supplementary figures now accurately reflect the raw experimental results.

      (2) Misinterpretation of data.

      I am afraid the authors misunderstood pattern-triggered immunity through receptor-like proteins. It is true that several LRR-type RLPs constitutively associate with SOBIR1, and further recruit BAK1 or other SERKs upon ligand binding. One should not take it for granted that every RLP works this way. To test the hypothesis that NtRLP4 confers resistance to B.tabaci infestation, the author compared transcriptional profiles between an EV plant line and an RLP4 overexpression line. If I understood the methods and figure legends correctly, this was done without B. tabaci treatment. This experimental design is seriously flawed. To provide convincing genetic evidence, independent mutant lines (optionally independent overexpression lines) in combination with different treatments will be necessary. Otherwise, one can only conclude that overexpressing the RLP4 protein generated a nervous plant. In addition, ROS burst, but not H2O2 accumulation, is a common immune response in pattern-triggered immunity.

      We agree with the reviewer that not every RLP functions through the same mechanism as the canonical SOBIR1–BAK1 pathway. In the current version, we further examined the interaction between the whitefly salivary protein and SOBIR1, and found that they do not interact. However, our interaction assays clearly demonstrated that NtRLP4 does interact with SOBIR1. Whether NtRLP4 functions through, or exclusively through, SOBIR1 remains uncertain, and we have emphasized this limitation in the Discussion section as follow: “Although NtRLP4 interacts with SOBIR1, this alone does not confirm that it operates strictly through this canonical module. Evidence from other RLPs shows that co-receptor usage can be flexible, and some RLPs function partly or conditionally independent of SOBIR1 [39]. Therefore, a more definitive assessment of NtRLP4 signaling will therefore require genetic dissection of its co-receptor dependencies, including but not limited to SOBIR1.”

      Regarding the transcriptome analysis, our original aim was to explore why B. tabacishowed such a pronounced preference among tobacco plants. As this preference was assessed using uninfested plants, we also performed transcriptome sequencing using plants without B. tabaci treatment. The enrichment analysis demonstrated that the majority of up-regulated DEGs were associated with plant–pathogen interaction, environmental adaptation, MAPK signaling, and signal transduction pathways, while down-regulated DEGs were enriched in glutathione, carbohydrate, and amino acid metabolism. Notably, many DEGs were annotated as RLK/RLPs or WRKY transcription factors, most of which were upregulated, suggesting an enhanced defense state in the NtRLP4-overexpressing plants. The altered expression of JA- and SA-related genes (e.g., upregulation of FAD7 and downregulation of PAL and NPR1) further supported this enhanced defense and hormonal crosstalk. We agree that combining overexpression or knockout lines with insect infestation treatments would provide more direct genetic evidence for NtRLP4-mediated resistance, and we have acknowledged this as an important future direction. Nevertheless, our current data are consistent with the conclusion that NtRLP4 overexpression confers increased resistance to B. tabaci infestation.

      Finally, DAB staining for H<sub>2</sub>O<sub>2</sub> accumulation is also a well-established indicator of PTI responses, and many studies have shown that overexpression of salivary elicitors can trigger such accumulation.

      (3) Lack of logic coherence.

      The written language needs substantial improvement. This impeded the readability of the work. More importantly, the logic throughout the manuscript appeared scattered. The choice of testing protein domains for protein-protein interactions, using plants overexpressing an insect protein to study its subcellular localization, switching back and forth between using proteins with signal peptides and without signal peptides, among others, lacks a clear explanation.

      We appreciate the reviewer’s careful reading and valuable comments regarding the logical coherence of our manuscript.

      (1) To improve the English quality, the entire manuscript has been professionally edited by a certified language-editing service.

      (2) Regarding the rationale for testing protein domains in the protein–protein interaction assays: NtRLP4 is a membrane-anchored receptor-like protein composed of extracellular, transmembrane, and short intracellular domains. We aimed to determine which region of NtRLP4 is responsible for interacting with the salivary protein, as this would help infer the likely site of interaction in planta. In addition, not all RLPs contain a malectin-like domain, and we sought to verify whether the BtRDP–NtRLP4 interaction depends on this domain. To enhance the logical flow, we introduced a brief statement explaining the experimental purpose before presenting the interaction assays in the current version as follow: “These findings raised the question of which domain of NtRLP4 is responsible for binding BtRDP, as identifying the interacting domain could help infer where the salivary protein contacts the receptor in planta. We therefore dissected the NtRLP4 domains accordingly.”

      (3) With respect to using plants overexpressing an insect protein to examine subcellular localization: since both the brown planthopper and the whitefly are non-model species for which stable genetic transformation is technically unfeasible, many previous studies have used Agrobacterium-mediated transient expression or transgenic plant systems to investigate the subcellular localization of insect salivary proteins within host cells. Following these precedents, our study also employed plant systems to determine the localization of the insect protein and to assess how different localizations affect plant defense responses.

      (4) As for switching between constructs with or without signal peptides: the subcellular localization of effectors can influence their biological activity and interactions. Previous studies have used the presence or absence of signal peptides, or replacement with a PR1 signal peptide, to direct protein targeting (for example, Frontiers in Plant Science, 2022, 13:813181). Because salivary sheaths are generally considered to localize in the apoplastic space, we generated two transgenic N. tabacum lines overexpressing BtRDP: one carrying the full-length coding sequence including the signal peptide (oeBtRDP), expected to be secreted into the apoplast, and another lacking the signal peptide (oeBtRDP-sp), likely retained in the cytoplasm. In the current version, we clarified this rationale and added references to similar studies to improve the manuscript’s logic and readability. Details are as follow: “To investigate the role of BtRDP in different subcellular location of host plants, we constructed two transgenic N. tabacum lines overexpressing BtRDP: one carrying the full-length coding sequence including the signal peptide (oeBtRDP), which is expected to be secreted into the apoplast (extracellular space), and the other lacking the signal peptide (oeBtRDP<sup>-sp</sup>), which is likely retained in the cytoplasm.”

      Reviewer #3 (Public review):

      Summary:

      In this study, Wang et al. investigate how herbivorous insects overcome plant receptor-mediated immunity by targeting plant receptor-like proteins. The authors identify two independently evolved salivary effectors, BtRDP in whiteflies and NlSP694 in brown planthoppers, that promote the degradation of plant RLP4 through the ubiquitin-dependent proteasome pathway. NtRLP4 from tobacco and OsRLP4 from rice are shown to confer resistance against herbivores by activating defense signaling, while BtRDP and NlSP694 suppress these defenses by destabilizing RLP4 proteins.

      Strengths:

      This work highlights a convergent evolutionary strategy in distinct insect lineages and advances our understanding of insect-plant coevolution at the molecular level.

      Thank you very much for your comments. We have carefully revised the MS following your valuable suggestions and comments.

      Weaknesses:

      (1) I found the naming of BtRDP and NlSP694 somewhat confusing. The authors defined BtRDP as "B. tabaci RLP-degrading protein," whereas NlSP694 appears to have been named after the last three digits of its GenBank accession number (MF278694, presumably). Is there a standard convention for naming newly identified proteins, for example, based on functional motifs or sequence characteristics? As it stands, the inconsistency makes it difficult for readers to clearly distinguish these proteins from those reported in other studies.

      Thank you for your comment. These are species-specific salivary proteins that have not been reported or annotated in previous studies. Because no homologous genes could be identified in other species, there are no existing names or annotations for these proteins. For such lineage-specific salivary proteins, it is common in recent studies to name them according to their experimentally identified functions. For example, a recently reported salivary protein was named SR45-interacting salivary protein (SISP) based on its function (10.1111/nph.70668). Following this convention, we adopted a similar functional naming strategy in this study. We acknowledge that there may not yet be a standardized rule for naming such proteins, and we would be glad to follow a more authoritative naming guideline if possible.

      (2) Figure 2 and other figures. Transgenic experiments require at least two independent lines, because results from a single line may be confounded by position effects or unintended genomic alterations, and multiple lines provide stronger evidence for reproducibility and reliability.

      We appreciate the reviewer’s suggestion. In our study, two independent transgenic lines were used to ensure the reproducibility and reliability of the results. One representative line was presented in the main figures, while data from the second independent line were included in the supplementary figures. To make this clearer, we have emphasized in the manuscript that bioassays were conducted using two independent transgenic lines.

      (3) Figure 3e. Quantitative analysis of NtRLP4 was required. Additionally, since only one band was observed in oeRLP, were any tags included in the construct?

      Thank you for your comment. In the current version, quantitative analysis of NtRLP4 expression has been performed and is now presented in Figure 3. For the oeRLP plants, no tag was fused to NtRLP4; thus, anti-RLP serum was used to detect the target bands. In contrast, oeBtRDP and oeBtRDP-sp were fused with C-terminal FLAG tags, and their detection was carried out using anti-FLAG serum. This information has been clarified in the revised Methods section as follows: “The oeBtRDP and oeBtRDP<sup>-sp</sup> were fused with C-terminal FLAG tags, while no tag was fused to oeNtRLP4.”

      (4) Figure 4a. The RNAi effect appears to be well rescued in Line 1 but poorly in Line 2. Could the authors clarify the reason for this difference?

      Thank you for pointing this out. We also noticed that the RNAi effect appeared to be better rescued in Line 2 than in Line 1. Based on our measurements, the silencing efficiency of NtRLP4 in RNAi-RLP4 Line 1 was markedly weaker than in Line 2, which likely explains the difference in rescue efficiency. In the current version, we have clarified this point as follows: “Both RNAi-RLP lines showed reduced NtRLP4 levels compared with EV plants, with RNAi-RLP#2 exhibiting a stronger silencing effect (Fig. S19a).” “The differential rescue effect between the two RNAi lines likely resulted from their different NtRLP4 silencing efficiencies, with the lower NtRLP4 level in RNAi-RLP#2 leading to a more complete rescue phenotype.”

      (5) ROS accumulation is shown for only a single leaf. A quantitative analysis of ROS accumulation across multiple samples would be necessary to support the conclusion. The same applies to Figure 16f.

      Thank you for pointing this out. The H<sub>2</sub>O<sub>2</sub> accumulation experiments have been repeated for 5 times in Figure 4 and Figure S16f. In the current version, we addressed that “the experiment is repeated five times with similar results” in the figure legends.

      (6) Figure 4f: NtRLP4 abundance was significantly reduced in oeBtRDP plants but not in oeBtRDP-SP. Although coexpression analysis suggests that BtRDP promotes NtRLP4 degradation in an ubiquitin-dependent manner, the reduced NtRLP4 levels may not result from a direct interaction between BtRDP and NtRLP4. It is possible that BtRDP influences other factors that indirectly affect NtRLP4 abundance. The authors should discuss this possibility.

      Thank you for your valuable suggestion. We agree that the reduced NtRLP4 abundance may not necessarily result from a direct interaction between BtRDP and NtRLP4. In the manuscript, we have further discussed this possibility as follows: “Notably, BtRDP and NlSP104 shared no sequence or structural similarity and lack resemblance to known eukaryotic ubiquitin-ligase domains. Their interaction with RLP4s occurs in the extracellular space (Fig. 3d; Fig. 5c), whereas the ubiquitin-proteasome system primarily functions in the cytosol and nucleus [46]. Furthermore, NtRLP4 reduction is observed only in oeBtRDP transgenic plants, not in oeBtRDP-sp plants (Fig. 4f), suggesting that BtRDP exerts its influence on NtRLP4 in the extracellular space. These observations collectively argue against the possibility that BtRDP or NlSP694 possesses intrinsic E3 ligase activity capable of directly ubiquitinating RLP4s within plant cells. Importantly, the reduced NtRLP4 levels may not result from a direct physical interaction between BtRDP and NtRLP4. Instead, BtRDP may indirectly affect RLP4 post-translational modification, thereby accelerating its degradation, which warrants further investigation”

      (7) The statement in lines 335-336 that 'Overexpression of NtRLP4 or NtSOBIR1 enhances insect feeding, while silencing of either gene exerts the opposite effect' is not supported by the results shown in Figures S16-S19. The authors should revise this description to accurately reflect the data.

      Thank you for pointing this out. We agree that our original statement was not precise, as we measured the insect settling preference and oviposition on transgenic plants, but did not directly assess the feeding behavior of B. tabaci. Therefore, we have revised the description in the manuscript to more accurately reflect our data as follows: “Overexpression of NtRLP4 or NtSOBIR1 in N. tabacum is attractive to B. tabaci and promotes insect reproduction, whereas silencing of either gene exerts the opposite effect.”

      (8) BtRDP is reported to attach to the salivary sheath. Does the planthopper NlSP694 exhibit a similar secretion localization (e.g., attachment to the salivary sheath)? The authors should supplement this information or discuss the potential implications of any differences in secretion localization between BtRDP and NlSP694 for their respective modes of action.

      Thank you for your insightful suggestion. We agree that determining the secretion localization of NlSP694 would provide valuable information for understanding its potential mode of action. Immunohistochemical (IHC) staining is indeed a critical approach for such analysis. However, in this study, we were unable to express NlSP694 in Escherichia coli, and the antibody generated using a synthesized peptide did not show sufficient specificity or sensitivity for IHC detection. Consequently, we were unable to determine whether NlSP694 is attached to the salivary sheath. Therefore, whether BtRDP and NlSP694 acted in different mode require further investigation.

      Recommendations for the authors:

      Reviewer #3 (Recommendations for the authors):

      (1) Figure 1e. The BtRDP-labeled fluorescent signal is difficult to discern. An enlarged view of the target region would be helpful for clarity.

      Thank you for your suggestion. In the current version, an enlarged view of the target region was provided below the figure.

      (2) The finding that BtRDP accumulates in the salivary sheath secreted by Bemisia tabaci is important for understanding the subcellular localization of this protein during actual insect feeding. I suggest moving Figure S5 to the main text.

      Thank you for your suggestion. Figure S5 has been moved to Fig. 1f in the current version.

      (3) Please carefully cross-check the figure numbering to ensure that all in-text citations correspond to the correct figures and panels. i.e., lines 136,188,192, and 194.

      Thank you for pointing this out. We corrected them in the current version.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      The manuscript titled "The distinct role of human PIT in attention control" by Huang et al. investigates the role of the human posterior inferotemporal cortex (hPIT) in spatial attention. Using fMRI experiments and resting-state connectivity analyses, the authors present compelling evidence that hPIT is not merely an object-processing area, but also functions as an attentional priority map, integrating both top-down and bottom-up attentional processes. This challenges the traditional view that attentional control is localized primarily in frontoparietal networks.

      The manuscript is strong and of high potential interest to the cognitive neuroscience community. Below, I raise questions and suggestions to help with the reliability, methodology, and interpretation of the findings.

      Thank you for a nice summary of the key points of our study. Below you will find our reply to your questions.

      (1) The authors argue that hPIT satisfies the criteria for a priority map, but a clearer justification would strengthen this claim. For example, how does hPIT meet all four widely recognized criteria, such as spatial selectivity, attentional modulation, feature invariance, and input integration, when compared to classical regions such as LIP or FEF? A more systematic summary of how hPIT meets these benchmarks would be helpful. Additionally, to what extent are the observed attentional modulations in hPIT independent of general task difficulty or behavioral performance?

      Great suggestions! For the first suggestion, we have included a clearer justification in the discussion part of manuscript (line 405-406). For the second one, all participants received task practice prior to scanning, and task accuracy exceeded 90%, suggesting the tasks were not overly demanding. Although ceiling effects limit the interpretability of behavioral-performance correlations, we argue that higher task demands would likely require greater attentional effort, leading to stronger modulation in hPIT, which aligns with our findings.

      (2) The authors report that hPIT modulation is invariant to stimulus category, but there appear to be subtle category-related effects in the data. Were the face, scene, and scrambled images matched not only in terms of luminance and spatial frequency, but also in terms of factors such as semantic familiarity and emotional salience? This may influence attentional engagement and bias interpretation.

      The response of hPIT is not sensitive to stimulus category, but attentional modulation in hPIT is slightly stronger to faces than scenes and scrambled images. Although faces used in the task had neutral expressions and the scene pictures were also neutral, we acknowledge that we indeed cannot exclusively eliminate the possibility that potential semantic familiarity or emotional salience may contribute to the subtle category-related effects in the results of experiment 3. This limitation has been noted in the discussion part of manuscript (line 440-442).

      (3) The result that attentional load modulates hPIT is important and adds depth to the main conclusions. However, some clarifications would help with the interpretation. For example, were there observable individual differences in the strength of attentional modulation? How consistent were these effects across participants?

      Yes, individual differences exist. In the manuscript, we have included individual subject data points in the figure 6B. No data exceeded three standard deviations from the group mean, suggesting that the attentional modulation effects were generally consistent across participants.

      (4) The resting-state data reveal strong connections between hPIT and both dorsal and ventral attention networks. However, the analysis is correlational. Are there any complementary insights from task-based functional connectivity or latency analyses that support a directional flow of information involving hPIT? In addition, do the authors interpret hPIT primarily as a convergence hub receiving input from both DAN and VAN, or as a potential control node capable of influencing activity in these networks? Also, were there any notable differences between hemispheres in either the connectivity patterns or attentional modulation?

      Though it’s hard to generate directional flow of information from fMRI due to the low temporal resolution. We agree that besides resting-state connection, task-based functional connectivity analyses would have the potential to provide additional information about whether hPIT serves as a convergence node or a control hub. We have conducted task-based functional connectivity analyses, specifically PPI, using data from experiment 2, which revealed task-modulated right hPIT connectivity with FFA, LOp, and TPJ, suggesting hPIT may allocate attentional resources to object-processing regions following priority map generation (line 378-383). Given the limited number of significant PPI results and the inherent constraints of fMRI in capturing fast or transient attention-related interactions, the present data do not allow us to determine the role of hPIT. Future studies combining effective connectivity or causal perturbation methods (e.g., DCM, TMS-fMRI) would be ideal to test whether hPIT acts as a control node influencing activity within DAN and VAN.

      We also observed modest hemispheric asymmetries in connectivity—for instance, both left and right hPIT showed stronger connectivity with right-hemisphere attention nodes. This has been described in the results part of manuscript (line 373-377).

      (5) A few additional questions arise regarding the anatomical characteristics of hPIT: How consistent were its location and size across participants? Were there any cases where hPIT could not be reliably defined? Given the proximity of hPIT to FFA and LOp, how was overlap avoided in ROI definition? Were the functional boundaries confirmed using independent contrasts?

      We can see a relatively consistent size and location of hPIT across subjects in Supplementary Figure 1, where the voxel size and location for individual subjects reported. The consistency also demonstrated by figure 4C.

      We avoided overlap with the FFA and LOp by manually delineating the hPIT which is defined by conjunction maps across three tasks and by avoiding overlapping voxels. The FFA was defined using an independent contrast (Exp3 contrast [face-scene]) and the Lop location was defined by anatomical parcellation (Glasser et al., 2016).

      Reviewer #2 (Public review):

      Summary

      This study investigates the role of the human posterior inferotemporal cortex (hPIT) in attentional control, proposing that hPIT serves as an attentional priority map that integrates both top-down (endogenous) and bottom-up (exogenous) attentional processes. The authors conducted three types of fMRI experiments and collected resting-state data from 15 participants. In Experiment 1, using three different spatial attention tasks, they identified the hPIT region and demonstrated that this area is modulated by attention across tasks. In Experiment 2, by manipulating the presence or absence of visual stimuli, they showed that hPIT exhibits strong attentional modulation in both conditions, suggesting its involvement in both bottom-up and top-down attention. Experiment 3 examined the sensitivity of hPIT to stimulus features and attentional load, revealing that hPIT is insensitive to stimulus category but responsive to task load - further supporting its role as an attentional priority map. Finally, resting-state functional connectivity analyses showed that hPIT is connected to both dorsal and ventral attention networks, suggesting its potential role as a bridge between the two systems. These findings extend prior work on monkey PITd and provide new insights into the integration of endogenous and exogenous attention.

      Strengths

      (1) The study is innovative in its use of specially designed spatial attention tasks to localize and validate hPIT, and in exploring the region's role in integrating both endogenous and exogenous attention, as prior works focus primarily on its involvement in endogenous attention.

      (2) The authors provided very comprehensive experiment designs with clear figures and detailed descriptions.

      (3) A broad range of analyses was conducted to support the hypothesis that hPIT functions as an attentional priority map -- including experiments of attentional modulation under both top-down and bottom-up conditions, sensitivity to stimulus features and task load, and resting-state functional connectivity. These analyses showed consistent results.

      (4) Multiple appropriate statistical analyses - including t-tests, ANOVAs, and post-hoc tests - were conducted, and the results are clearly reported.

      Thank you for a nice summary of the key points and strengths of our study.

      Weaknesses

      (1) The sample size is relatively small (n = 15), and inter-subject variability is big in Figures 5 and 6, as seen in the spread of individual data points and error bars. The analysis of attention-modulated voxel map intersections appears to be influenced by multiple outliers.

      We agree that the sample size (n = 15) is not ideal, and we acknowledge that some data points in Figures 5 and 6 appear to be potential outliers. However, according to conventional outlier detection criteria, all data points fell within three standard deviations of the group mean and were therefore retained for analysis.

      Moreover, the attention-modulated voxel intersection map shown in Figure 4C is insensitive to outliers, because the intersection plotted is based on the number of subjects

      (2) The authors acknowledge important limitations, including the lack of exploration of feature-based attention and the temporal constraints inherent to fMRI.

      Yes, we have mentioned these limitations in the discussion.

      (3) Prior research has established that regions such as the prefrontal cortex (PFC) and posterior parietal cortex (PPC) are involved in both endogenous and exogenous attention and have been proposed as attentional priority maps. It remains unclear what is uniquely contributed by hPIT, how it functionally interacts with these classical attentional hubs, and whether its role is complementary or redundant. The study would benefit from more direct comparisons with these regions.

      In this study, we define the ROI base on intersection across three different types of spatial attention tasks, which is a stricter criterion. And the results didn’t reveal spatial attentional modulation across tasks besides PITd. This could be due to the lack of lateralized responses in PFC/PPC. To evaluate whether a region qualifies as a priority map, we applied four widely accepted criteria (as mentioned in introduction). While dorsal and ventral attention network (DAN and VAN) regions can be considered supportive components of the priority map system, our findings suggest that among the regions tested, only hPIT fully meets all criteria. In Experiment 2, we included regions such as VFC (as part of PFC) and IPS (as part of PPC), and our findings suggest these areas are more involved in top-down attention. In the revision, we have performed additional analysis on PPC (IPS) and PFC (FEF, VFC), shown in Figure S2.

      (4) The functional connectivity analysis is only performed on resting-state data, and this approach does not capture context-dependent interactions. Task-based data analysis can provide stronger evidence.

      We acknowledge that resting-state FC is limited in assessing task-specific communication. To further investigate the role of hPIT, we have conducted PPI analysis, which revealed task-modulated right hPIT connectivity in attention allocation (line 378-383).

      (5) The study does not report whether attentional modulation in hPIT is consistent across the two hemispheres. A comparison of hemispheric effects could provide important insight into lateralization and inter-individual variability, especially given the bilateral localization of hPIT.

      We thank the reviewer for this suggestion. hPIT was localized bilaterally using the same intersection-based method in Experiment 1. We have now performed additional analysis and found hemispheric differences in hPIT attentional modulation (Experiment 2). Besides, we also found in Experiment 3, the difference of load modulation (averaged across stimulus categories) in left and right hPIT was not significant. These results have been reported in the results part of manuscript (line 347-351).

    1. Author response:

      eLife Assessment

      This study provides a valuable contribution to understanding how negative affect influences food-choice decision making in bulimia nervosa, using a mechanistic approach with a drift diffusion model (DDM) to examine the weighting of tastiness and healthiness attributes. The solid evidence is supported by a robust crossover design and rigorous statistical methods, although concerns about the interpretation of group differences across neutral and negative conditions limit the interpretability of the results.

      We are grateful for this improved assessment. Below, we provide detailed responses that we believe address the noted concerns about interpreting group differences across conditions. If these clarifications resolve the interpretability concerns, we would be grateful if the editors would consider updating the eLife assessment accordingly.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Using a computational modeling approach based on the Drift and Diffusion Model (DDM) introduced by Ratcliff and McKoon in 2008, the article by Shevlin and colleagues investigates whether there are differences between neutral and negative emotional states in:

      (1) The timings of the integration in food choices of the perceived healthiness and tastiness of food options in individuals with bulimia nervosa (BN) and healthy participants

      (2)The weighting of the perceived healthiness and tastiness of these options.

      Strengths:

      By looking at the mechanistic part of the decision process, the approach has potential to improve the understanding of pathological food choices.

      Weaknesses:

      I thank the author for reviewing their manuscript.

      However, I still have major concerns.

      The authors say that they removed any causal claims in their revised version of the manuscript. The sentence before the last one of the abstract still says "bias for high-fat foods predicted more frequent subjective binge episodes over three months". This is a causal claim that I already highlighted in my previous review, specifically for that sentence (see my second sentence of my major point 2 of my previous review).

      We appreciate the Reviewer's continued attention to causal language. We acknowledge that our use of the term 'predicted', though intended to refer to statistical prediction in a regression model, could be misinterpreted as implying causation. We have therefore revised this sentence to read: 'bias for high-fat foods was associated with more frequent subjective binge episodes over three months’.

      I also noticed that a comment that I added was not sent to the authors. In this comment I was highlighting that in Figure 2 of Galibri et al., I was uncertain about a difference between neutral and negative inductions of the average negative rating after the induction in the BN group (i.e. comparing the negative rating after negative induction in BN to the negative rating after neutral induction in BN). Figure 2 of Galibri et al. looks to me that:

      (1) The BN participants were more negative before the induction when they came to the neutral session than when they came to the negative session.

      (2) The BN participants looked almost negatively similar (taking into account the error bars reported) after the induction in both sessions

      These observations are of high importance because they may support the fact that BN patients were likely in a similar negative state to run the food decision task in both conditions (negative and neutral). Therefore, the lack of difference in food choices in BN patients is unsurprising and nothing could be concluded from the DDM analyses. Moreover, the strong negative ratings of BN patients in the neutral condition as compared to healthy participants together with almost similar negative ratings after the two inductions contradict the authors' last sentence of their abstract.

      I appreciate that the authors reproduced an analysis of their initial paper regarding the negative ratings (i.e. Table S1). It partly answers my aforementioned point but does not address the fact that BN may have been in a similar negative state in both conditions (neutral and negative) when running the food decision task: if BN patients were similarly negative after both induction (neutral and negative), nothing can be concluded from their differences in their results obtained from the DDM. As the authors put it, "not all loss-ofcontrol eating occurs in the context of negative state", I add that far from all negative states lead to a loss-of-control eating in BN patients. This grounds all my aforementioned remarks and my remarks of my first review.

      A solution for that is to run a paired t-test in BN patients only comparing the score after the induction in the two conditions (neutral and negative) reported in Figure 2 of their initial article.

      We appreciate the reviewer’s concern. We understand how the visual representation in Figure 2, which displays between-subject error bars, might suggest similar post-induction affect levels. However, the within-subject paired comparison (which appropriately accounts for individual differences in baseline affect) reveals a significant difference, which we detail below.

      While BN participants did report higher baseline negative affect than the HC group prior to the mood inductions, this does not negate the effectiveness of the manipulation. The critical comparison is the within-subject change from pre- to post-induction (detailed below) which shows that negative affect was significantly higher after the negative induction than the neutral induction.

      As we reported in the Supplementary Information (Table S1), our initial analyses of self-reported affect ratings used a linear mixed-effects model with group (HC = 0, BN = 1), condition (Neutral = 0, Negative = 1), and time (pre-induction = 0, post-induction = 1) as fixed effects, including all interactions, and random intercepts for participants. This approach accounts for individual differences in baseline affect.

      However, to address the reviewer's concerns, we conducted two simple effects analyses using estimated marginal means. As the reviewer suggested, we directly compared post-induction affect between conditions within the BN group (described in the second analysis below). In the first analysis, we examined the diagnosis × time interaction within each condition separately. In the Negative condition, individuals with BN demonstrated a substantial increase in negative affect from pre- to post-induction (mean difference = 20.36, t = 4.84, p < 0.0001, Cohen’s d = 0.97). In the second analysis, we examined the condition × time interaction within each group separately. Among the BN group, we found that reported affect was significantly higher following the negative mood induction than after the neutral affect induction (mean difference = -17.40, t = -4.13, p = 0.0003, Cohen’s d = 0.83). This difference in post-induction negative affect between conditions within the BN group represents a meaningful and statistically robust difference in affective states. These within-group effects confirm that the negative mood induction was (1) effective in the BN group and (2) produced significantly greater negative affect than the neutral mood induction.

      These findings confirm that participants completed the food decision task under meaningfully different affective states, supporting the interpretability of the subsequent DDM analyses. We now report these analyses in the Supplementary Information.

      I appreciate the analysis that the authors added with the restrictive subscale of the EDE-Q.

      That this analysis does not show any association with the parameters of interest does not show that there is a difference in the link between self reported restrictions and self reported binges. Only such a difference would allow us to claim that the results the authors report may be related to binges.

      We thank the reviewer for raising this important point about specificity. To address this concern, we examined the correlation between self-reported binge frequency (both subjective binge episodes and objective binge episodes over the past three months) and EDE-Q Restraint subscale in our BN sample.

      The correlation between these measures were modest and non-significant (subjective binge frequency: Spearman’s p = 0.21, p = 0.306; objective binge frequency: Spearman’s p = 0.05, p = 0.806), indicating that both binge frequency measures and dietary restraint were relatively independent dimensions of eating pathology in our sample. This dissociation supports the specificity of our findings: the fact that our DDM parameters were associated with binge frequency but not with dietary restraint suggests that the affect-induced changes in decisionmaking we observed are specifically related to binge-eating behavior rather than reflecting a correlate of dietary restraint. We now report this analysis in the Supplementary Information.

      I appreciate the wording of the answer of the authors to my third point: "the results suggest that individuals whose task behavior is more reactive to negative affect tend to be the most symptomatic, but the results do not allow us to determine whether this reactivity causes the symptoms". This sentence is crystal clear and sums very well the limits of the associations the authors report with binge eating frequency. However, I do not see this sentence in the manuscript. I think the manuscript would benefit substantially from adding it.

      We thank the reviewer for the suggestion. We have added the following sentences that convey this information to the end of the third paragraph of the discussion:

      “These results suggest that individuals whose task behavior is more reactive to negative affect tend to be the most symptomatic. However, our correlational design does not allow us to determine whether this reactivity causes the symptoms.”

      Statistical analyses:

      If I understood well the mixed models performed, analyses of supplementary tables S1 and S27 to S32 are considering all measures as independent which means that the considered score of each condition (neutral vs negative) and each time (before vs after induction) which have been rated by the same participants are independent. Such type of analyses does not take into account the potential correlation between the 4 scores of a given participant. As a consequence, results may lead to false positives that a linear mixed model does not address. The appropriate analysis would be to run adapted statistical tests pairing the data without running any mixed model.

      We appreciate the reviewer's attention to the statistical approach. However, we respectfully note that mixed-effects models do account for within-subject correlations, contrary to the reviewer’s interpretation.

      The linear mixed-effects model we employed explicitly accounts for the correlation among repeated measures from the same participant through the random intercept term. This random effect structure models the non-independence of observations within participants, allowing for correlated errors within individuals while assuming independence between individuals. This is a standard and appropriate approach for analyzing repeated-measures data (Bates et al., 2015).

      The mixed-effects model is, in fact, more appropriate than separate paired t-tests for our design because it:

      (1) Simultaneously models all fixed effects (group, condition, time) and their interactions in a single unified framework;

      (2) Properly partitions variance into within-subject and between-subject components;

      (3) Provides greater statistical power and more precise estimates by using all available data simultaneously; and

      (4) Allows for direct testing of three-way interactions that cannot be assessed through pairwise comparisons alone.

      Paired tests (e.g., t-tests), as the reviewer suggests, would require multiple separate analyses and would not allow us to test our primary hypotheses about group × condition × time interactions. The mixed-effects approach provides a more comprehensive and statistically rigorous analysis of our repeated-measures design. To clarify this even further in the manuscript, we have added the following in our methods when describing our model, “participant-level random intercepts were included to account for within-subject correlations across repeated measurements.”

      Notes:

      It is not because specific methods like correlating self reported measures over long periods with almost instantaneous behaviors (like tasks) have been used extensively in studies that these methods are adapted to answer a given scientific question. Measures aggregated over long periods miss the variations in instantaneous behaviors over these periods.

      We acknowledge the reviewer’s concern about the temporal mismatch between our session-level task measures and the 3-month aggregated symptom reports. This is a valid limitation of crosssectional designs, and we agree that examining how task performance fluctuates in relation to real-time symptom variation would provide richer insights into the potential dynamics of these relationships.

      We agree that we cannot capture how daily changes in task performance relate to momentary symptom occurrence. In response to previous rounds of helpful reviews, we added this limitation to the Discussion section, noting that future research employing ecological momentary assessment (EMA) or daily diary methods could examine whether the decision-making processes we identified also fluctuate in relation to real-time symptom occurrence.

      We note that our finding that affect-induced changes in decision-making parameters were associated with subjective binge frequency suggests that this laboratory-measured reactivity may reflect a stable individual difference that manifests across contexts and time periods. While our current study provides initial evidence that individual differences in affect-related decisionmaking are associated with symptom severity, we acknowledge that longitudinal designs with repeated assessments would strengthen causal and temporal inferences.

      Reviewer #2 (Public review):

      Summary:

      Binge eating is often preceded by heightened negative affect, but the specific processes underlying this link are not well-understood. The purpose of this manuscript was to examine whether affect state (neutral or negative mood) impacts food choice decisionmaking processes that may increase the likelihood of binge eating in individuals with bulimia nervosa (BN). The researchers used a randomized crossover design in women with BN (n=25) and controls (n=21), in which participants underwent a negative or neutral mood induction prior to completing a food-choice task. The researchers found that despite no differences in food choices in the negative and neutral conditions, women with BN demonstrated a stronger bias toward considering the 'tastiness' before the 'healthiness' of the food after the negative mood induction.

      Strengths:

      The topic is important and clinically relevant, and the methods are sound. The use of computational modeling to understand nuances in decision-making processes and how that might relate to eating disorder symptom severity is a strength of the study.

      Weaknesses:

      Sample size was relatively small, and participants were all women with BN, which limits generalizability of findings to the larger population of individuals who engage in binge eating. It is likely that the negative affect manipulation was weak and may not have been potent enough to change behavior. These limitations are adequately noted in the discussion.

      We are grateful to Reviewer #2 for their careful and supportive review of our manuscript. We appreciate their recognition that computational modeling can reveal nuanced alterations in decision-making processes that may not be apparent in overt behavioral choices. Their balanced assessment of both the strengths and limitations of our work has been helpful in contextualizing our findings appropriately. We have carefully considered their comments regarding sample size and the potential limitations of our mood induction procedure, both of which we discuss in detail in the manuscript's limitations section.

      Reviewer #3 (Public review):

      Summary:

      The study uses the food choice task, a well-established method in eating disorder research, particularly in anorexia nervosa. However, it introduces a novel analytical approach-the diffusion decision model-to deconstruct food choices and assess the influence of negative affect on how and when tastiness and healthiness are considered in decision-making among individuals with bulimia nervosa and healthy controls.

      Strengths:

      The introduction provides a comprehensive review of the literature, and the study design appears robust. It incorporates separate sessions for neutral and negative affect conditions and counterbalances tastiness and healthiness ratings. The statistical methods are rigorous, employing multiple testing corrections.

      A key finding-that negative affect induction biases individuals with bulimia nervosa toward prioritizing tastiness over healthiness-offers an intriguing perspective on how negative affect may drive binge eating behaviors.

      Weaknesses:

      A notable limitation is the absence of a sample size calculation, which, combined with the relatively small sample, may have contributed to null findings. Additionally, while the affect induction method is validated, it is less effective than alternatives such as image or film-based stimuli (Dana et al., 2020), potentially influencing the results.

      We are grateful to Reviewer #3 for their thoughtful evaluation of our work. We appreciate their recognition that the diffusion decision model provides a novel analytical lens for understanding how negative affect influences the dynamics of food-related decision-making in bulimia nervosa. Their balanced assessment of both the methodological strengths of our design (counterbalancing, rigorous statistical corrections) and its limitations (sample size, mood induction efficacy) has been valuable in ensuring we appropriately contextualize our findings and their implications. Specifically, we have taken their comments regarding sample size and the relative efficacy of different mood induction methods seriously, and we address these important methodological considerations in our discussion of the study's limitations.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      The authors have addressed my previous comments, and I do not have any additional suggestions for improvement.

      We thank the reviewer for their time, effort, and insightful feedback.

      Reviewer #3 (Recommendations for the authors):

      The authors have adequately addressed my feedback. I have no further comments.

      We thank the reviewer for their time, effort, and insightful feedback.

    1. Author response:

      eLife Assessment

      Hoverflies are known for their sexually dimorphic visual systems and exquisite flight behaviors. This valuable study reports how two types of visual descending neurons differ between males and females in their motion- and speed-dependent responses, yet surprisingly, the behavior they control lacks any sexual dimorphism. The results convincingly support these findings, which will be of interest for studies of visuomotor transformations and network-level brain organization.

      This statement perfectly recapitulates our findings.

      Public Reviews:

      Reviewer #1 (Public review):  

      Summary: 

      Hoverflies are known for a striking sexual dimorphism in eye morphology and early visual system physiology. Surprisingly, the male and female flight behaviors show only subtle differences. Nicholas et al. investigate the sensori-motor transformation of sexually dimorphic visual information to flight steering commands via descending neurons. The authors combined intra- and extracellular recordings, neuroanatomy, and behavioral analysis. They convincingly demonstrate that descending neurons show sexual dimorphisms - in particular at high optic flow velocities - while wing steering responses seem relatively monomorphic. The study highlights a very interesting discrepancy between neuronal and behavioral response properties.

      Thank you for this summary. Most of the statement perfectly recapitulates the main findings of our paper. However, we want to emphasize that some hoverfly flight behaviors are strongly sexually dimorphic, especially those related to courtship and mating. Indeed, only male hoverflies pursue targets at high speed, chase away territorial intruders, and pursue females for mating. However, other flight behaviours, such as those related to optomotor responses and flights between flowers when feeding, are not sexually dimorphic. We will amend the Introduction to make the difference between flight behaviors clear.

      More specifically, the authors focused on two types of descending neurons that receive inputs from well-characterized wide-field sensitive tangential cells: OFS DN1, which receives inputs from so-called HS cells, and OFS DN2, which receives input from a set of VS cells. Their likely counterparts in Drosophila connect to the neck, wing, and haltere neuropils. The authors characterized the visual response properties of these two neuronal classes in both male and female hoverflies and identified several interesting differences. They then presented the same set of stimuli, tracked wing beat amplitude, and analyzed the sum and the difference of right and left wing beat amplitude as a readout of lift or thrust, and yaw turning, respectively. Behavioral responses showed little to no sexual dimorphism, despite the observed neuronal differences.

      Thank you for this very nice summary of our work. We want to clarify that LPTC input to DN1 and DN2 has not been shown directly in hoverflies using e.g. dye coupling, or dual recordings. Instead, the presumed HS and VS input is inferred from morphological and physiological DN evidence, and comparisons to similar data in Drosophila and blowflies. We will amend the Introduction to clarify this. The rest of the paragraph perfectly recapitulates the main findings of our paper.

      Strengths:

      I find the question very interesting and the results both convincing and intriguing. A fundamental goal in neuroscience is to link neuronal responses and behavior. The current study highlights that the transformations - even at the level of descending neurons to motoneurons - are complex and less straightforward than one might expect.

      Thank you.

      Weaknesses:

      The authors investigated two types of descending neurons, but it was not clear to me how many other descending neurons are thought to be involved in wing steering responses to wide-field motion. I would suggest providing a more in-depth overview of what is known about hoverflies and Drosophila, since the conclusions drawn from the study would be different if these two types were the only descending neurons involved, as opposed to representing a subset of the neurons conveying visual information to the wing neuropil.

      This is a great point. There are around 1000 fly DNs, of which many could respond to widefield motion, without being specifically tuned to widefield motion. For example, many looming sensitive neurons also respond to widefield motion, and could therefore be involved in the WBA movements that we measured here. In addition, there are many multimodal neurons that could be involved in optomotor responses in free flight, but these may not have been stimulated when we only provided visual input. Furthermore, many visual neurons are modulated by proprioceptive feedback, which is lacking in immobilized physiology preps. Finally, in blowflies, up to 5 optic flow sensitive DNs have been identified morphologically, and in Drosophila 3 have been identified morphologically and physiologically. In summary, it is more than likely that other neurons project visual widefield motion information to the wing neuropil. We will amend our Introduction and Discussion to make this important point clear to the readers.

      Both neuronal classes have counterparts in Drosophila that also innervate neck motor regions. The authors filled the hoverfly DNs in intracellular recordings to characterize their arborization in the ventral nerve cord. In my opinion, these anatomical data could be further exploited and discussed a bit more: is the innervation in hoverflies also consistent with connecting to the neck and haltere motor regions? Are there any obvious differences and similarities to the Drosophila neurons mentioned by the authors? If the arborization also supports a role in neck movements, the authors could discuss whether they would expect any sexual dimorphism in head movements.

      These are all great points. We did not see any clear arborizations to the frontal nerve, where we would expect to find the neck motor neurons (NMNs). In addition, while we did see fine arborizations throughout the length of the thoracic ganglion, we saw no strong outputs projecting directly to the haltere nerve (HN). In the revised version of the MS we will modify figure 4 (morphological characterization) to clarify.

      There are important differences between the morphology of DN1 and DN2 in hoverflies and DNHS1 and DNOVS2 in Drosophila, in terms of their projections in the thoracic ganglion. For example, In Drosophila DNOVS2, there are several fine branches along the length of the neuron in the thoracic ganglia. Similarly, we found fine branches in Eristalis tenax DN2, however, in addition, we found a wide branch projecting to the area of the thoracic ganglion where the prothoracic and pterothoracic nerves likely get their inputs (Figure 4), suggesting that the neuron could contribute to controlling the wings and/or the forelegs (which is why we quantified the WBA). In Drosophila DNHS1, there is a similar fat branch to the prothoracic and pterothoracic nerves, which we also found in Eristalis tenax OFS DN1 (Figure 4). Indeed, while Drosophila DNHS1 and DNOVS2 have quite strikingly different morphology, DN1 and DN2 in Eristalis looked quite similar. We will modify the Results section to make this clear.

      In addition, to investigate this further, in the revised version of the MS we will include analysis of the movement of different body parts (including the head) to investigate the presence of any potential sexual dimorphism. Unfortunately, however, this will not include the halteres, as they cannot be seen well in the videos.

      Reviewer #2 (Public review):

      Summary:

      Many fly species exhibit male-specific visual behaviors during courtship, while little is known about the circuit underlying the dimorphic visuomotor transformations. Nicholas et al focus on two types of visual descending neurons (DNs) in hoverflies, a species in which only males exhibit high-speed pursuit of conspecifics. They combined electrophysiology and behavior analysis to identify these DNs and characterize their response to a variety of visual stimuli in both male and female flies. The results show that the neurons in both sexes have similar receptive fields but exhibit speed-dependent dimorphic responses to different optic flow stimuli.

      This statement perfectly recapitulates the main findings of our paper. However, as mentioned above, while hoverfly flight behaviors related to courtship and mating are strongly sexually dimorphic, other flight behaviours, such as those related to optomotor responses and flights between flowers when feeding, are not. We will amend the Introduction to make the difference between flight behaviors clear.

      Strengths:

      Hoverflies, though not a common model system, show very interesting dimorphic behaviors and provide a unique and valuable entry point to explore the brain organization behind sexual dimorphism. The findings here are not only interesting on their own right but will also likely inspire those working in other systems, particularly Drosophila.

      Thank you.

      The authors employed rigorous morphology, electrophysiology, and behavior methods to deliver a comprehensive characterization of the neurons in question. The precision of the measurements allowed for identifying a subtle and nuanced neuronal dimorphism and set a standard for future work in this area.

      Thank you.

      Weaknesses:

      Cell-typing using receptive field preferred directions (RFPDs): if I understood correctly, this classification method mostly relies on the LPDs near the center of the receptive field (median within the contour in Fig.1). I have two concerns here. First, this method is great if we are certain there are only two types of visual DNs as described in the manuscript. But how certain is this? Given the importance of vision in flight control, I would expect many DNs that transmit optic flow information to the motor center. I'd also like to point out that there are other lobula plate tangential cells (LPTCs) than HS and VS cells, which are much less studied and could potentially contribute to dimorphic behaviors.

      This is very true, and an important point. As mentioned above, in blowflies, up to 5 optic flow sensitive DNs have been identified morphologically, however, if these correspond to 5 different physiological types remain unclear. In both blowflies and Drosophila 3 have been identified morphologically and physiologically (DNHS1, DNOVS1, DNOVS2). Importantly, in both blowflies and fruitflies DNOVS1 gives graded responses, and no action potentials, meaning that we would not be able to record from it using extracellular electrophysiology.

      We previously used clustering techniques to show that in Eristalis, we can reliably distinguish two types of optic flow sensitive DNs from extracellular electrophysiological data, based on a range of receptive field parameters, and we think that these correspond to DNHS1 and DNOVS2 in Drosophila (Nicholas et al, J Comp Physiol A, 2020, cited in paper). As mentioned above in response to Reviewer 1, this does not mean that there are no other neurons that could respond to widefield optic flow, and which might be involved in the WBA we recorded in the paper. However, the point of this paper was not to conclusively show that there are only two optic flow sensitive descending neurons. The point was to say that there are two quite distinct optic flow sensitive neurons that have similar receptive fields in males and females, while the responses to widefield motion show differences between males and females.

      We will modify the Introduction and Discussion to make these important points clear to the Reader, including the discussion of the 45-60 LPTCs that exist in the lobula plate, and what their role might be.

      Second, this method feels somewhat impoverished given the richness of the data. The authors have nicely mapped out the directional tuning for almost the entire visual field. Instead of reducing this measurement to 2 values (center and direction), I was wondering if there is a better method to fully utilize the data at hand to get a better characterization of these DNs. As the authors are aware, local features alone can be ambiguous in characterizing optic flows. What's more, taking into account more global features can be useful for discovering potentially new cell types.

      This is a great point, and we did an extensive analysis of other receptive field properties in this study (shown in supp fig 1). In addition, and as mentioned above, we have published a clustering analysis across receptive field properties of these neurons (Nicholas et al, J Comp Physiol A, 2020, cited in paper). The point that we attempted to make in this paper was that by using two strikingly simple metrics, we can reliably distinguish which of the two neuron types we are recording from (if we accept that there are two main types that we are likely to record from) simply based on location and overall directional preference. This makes automated analysis very easy and straightforward. Indeed, we now use this routinely to ID what neuron we are recording from, rather than making a human-based assumption.

      However, we agree that further in depth analysis is warranted. Therefore, to address this, we will provide additional receptive field analysis and clustering in the revised version of the MS. In addition, we want to highlight that all data is uploaded to DataDryad for anyone interested in doing additional in-depth analyses.

      Line 131, it wasn't clear to me why full-screen stimuli were used for comparison here, instead of the full receptive field maps. Male flies exhibit sexual dimorphic behaviors only during courtship, which would suggest that small-sized visual stimuli (mimicking an intruder or female conspecific) would be better suited to elicit dimorphic neuronal responses. A similar comment applies to the later results as well. Based on the receptive field mapping in Figure 1, I'm under the impression that these 2 DN types are more suited to detect wide-field optic flows, those induced by self-motion as mentioned in the manuscript. The results are still very interesting, but it's good to make this point clear early on to help set appropriate expectations. Conversely, this would also suggest that there are other visual DN types that are responsible for the courtship-related sexually dimorphic behaviors.

      Thank you for mentioning these important points. Our reasoning for using full-screen stimuli for the analysis on line 131 was that since we used the small sinusoidal gratings for mapping the receptive fields, and to subsequently classify the neurons, it would be unfair to use the same data to investigate potential sexual dimorphism. I.e., we selected neurons that fulfilled certain criteria, and then we cannot rightfully use the same criteria to determine differences. This was not explicitly mentioned in the paper, so we will modify the text to make this clear to the Reader.

      However, in Supp Figure 1d/e we show that there are no striking receptive field differences between males and females in terms of receptive field center nor directional preference. In Supp Figure 1f we show that there is no difference between male and female receptive field height and width. We will modify the text to draw the Reader’s attention to this figure, and also mention the additional analysis done in response to the comment above.

      As a side note, I personally expected at least DNHS1 to have a smaller receptive field in males, as the hoverfly HSN is strikingly sexually dimorphic (Nordström et al, Curr Biol 2008), and also very sensitive to small objects. However, while optic flow sensitive DNs do respond to small objects (see e.g. the J Comp Physiol paper mentioned above) we did not detect any obvious sexual dimorphism in receptive field properties. Indeed, we think that a different subset of DNs control target pursuit behavior (target selective DNs (TSDNs)). This will be addressed in the modified version of the paper.

    1. Author response:

      [Note: The final version has been published in Brain, Behavior, and Immunity: https://doi.org/10.1016/j.bbi.2026.106473]

      eLife Assessment

      Rhis useful study raises interesting questions but provides inadequate evidence of an association between atovaquone-proguanil use (as well as toxoplasmosis seropositivity) and reduced Alzheimer's dementia risk. The findings are intriguing but they are correlative and hypothesis-generating with the strong possibility of residual confounding.

      We thank the editors and reviewers for characterizing our work as useful and for the opportunity to publish a Reviewed Preprint with a corresponding response. However, the statements in the Assessment characterizing the evidence as ‘inadequate’ and asserting a ‘strong possibility of residual confounding’ are factually incorrect as applied to our data and incompatible with the empirical findings presented in the manuscript. We have notified the editors of this factual inaccuracy. As the Assessment will be published as originally written, we provide clarification here to ensure an accurate scientific record for readers of the Reviewed Preprint.

      Our study shows that the association between atovaquone–proguanil (A/P) exposure and reduced dementia risk, first identified in a rigorously matched national cohort in Israel, is robustly reproduced across three independently constructed age-stratified cohorts in the U.S. TriNetX network (with exposure at ages 50–59, 60–69, and 70–79). In each cohort, individuals exposed to A/P were compared with rigorously matched individuals who received another medication at the same age and were then followed over a decade for incident dementia. Cases and controls were matched on all major established dementia risk factors: age, sex, race/ethnicity, diabetes, hypertension, obesity, and smoking status.

      Across all three strata, each containing more than 10,000 exposed individuals with an equal number of matched controls, we observed substantial and consistent reductions in cumulative dementia incidence (HR 0.34–0.51), extremely low P-values (10<sup>–16</sup> to 10<sup>–40</sup>), and continuously widening divergence of Kaplan–Meier curves over the follow-up period. To more rigorously exclude the possibility of unmeasured baseline differences in health status, we additionally performed, for the purpose of this response, comparative analyses of key indicators of frailty and clinical utilization, including emergency and inpatient encounters, as well as the prevalence of mild cognitive impairment prior to medication exposure (values provided below in response to Reviewer #2, Weakness 1). These analyses provide clear evidence showing no pattern suggestive of exposed individuals being medically or cognitively healthier at baseline.

      Taken together, these findings constitute a rigorously matched and independently replicated association across two national health systems, using TriNetX, the most widely cited real-world evidence platform in published cohort studies. Replication across three age strata, each with >10,000 exposed individuals, followed for a decade, and matched on all major known risk factors for dementia, meets the accepted epidemiologic definition of strong and reproducible evidence.

      Although we disagree with elements of the editorial Assessment that appear inconsistent with the empirical findings, we will proceed with publication of the current manuscript as a Reviewed Preprint in order to ensure timely dissemination of findings with meaningful implications for public health and dementia prevention. In this initial public version, the point-by-point responses below provide concise explanations addressing the critiques underlying the Assessment. A revised manuscript, incorporating expanded baseline comparisons across each TriNetX age stratum, additional stringent exclusions, and an expanded discussion that will address the remarks presented in this review, will be submitted shortly.

      Reviewer #1 (Public review):

      Summary:

      This useful study provides incomplete evidence of an association between atovaquone-proguanil use (as well as toxoplasmosis seropositivity) and reduced Alzheimer's dementia risk. The study reinforces findings that VZ vaccine lowers AD risk and suggests that this vaccine may be an effect modifier of A-P's protective effect. Strengths of the study include two extremely large cohorts, including a massive validation cohort in the US. Statistical analyses are sound, and the effect sizes are significant and meaningful. The CI curves are certainly impressive.

      Weaknesses include the inability to control for potentially important confounding variables. In my view, the findings are intriguing but remain correlative / hypothesis generating rather than causative. Significant mechanistic work needs to be done to link interventions which limit the impact of Toxoplasmosis and VZV reactivation on AD.

      We thank the reviewer for describing our study as useful and for highlighting several of its strengths, including the very large cohorts, sound statistical analyses, meaningful effect sizes, and the impressive CI curves. We also appreciate the reviewer’s recognition that our findings reinforce prior evidence linking VZV vaccination to reduced AD risk.

      Regarding the statement that the evidence remains incomplete due to “inability to control for potentially important confounding variables,” we refer to our introductory explanation above. As noted there, our analyses meet the accepted criteria for reproducible epidemiological evidence, and the assumption of uncontrolled confounding is contradicted by rigorous matching and by additional baseline evaluations. We fully agree that mechanistic work is warranted, and our epidemiologic findings strongly motivate such efforts.

      We address the reviewer’s specific comments in detail below.

      (1) Most of the individuals in the study received A-P for malaria prophylaxis as it is not first line for Toxo treatment. Many (probably most) of these individuals were likely to be Toxo negative (~15% seropositive in the US), thereby eliminating a potential benefit of the drug in most people in the cohort. Finally, A-P is not a first line treatment for Toxo because of lower efficacy.

      We agree that individuals in our cohort received Atovaquone-Proguanil (A-P) for malaria prophylaxis rather than for treatment of toxoplasmosis. However, this does not contradict our interpretation. Because latent CNS colonization by T. gondii is not currently considered clinically actionable, asymptomatic carriers are not offered treatment, and therefore would only receive an anti-Toxoplasma regimen unintentionally, through a medication prescribed for another indication such as malaria prophylaxis. Importantly, atovaquone is an established therapy for toxoplasmosis, including CNS disease, with documented efficacy and CNS penetration in current treatment guidelines. It is therefore reasonable to assume that, during the multi-week course typically administered for malaria prophylaxis, A-P would exert significant anti-Toxoplasma activity in individuals with latent CNS infection, potentially reducing or eliminating parasite burden even though the medication was not prescribed for that purpose.

      The reviewer notes that only ~15% of individuals in the U.S. are Toxoplasma-seropositive, based on surveys performed primarily in young adults of reproductive age (serologic testing is most commonly obtained in women during prenatal care). However, seropositivity increases cumulatively over the lifespan, and few reliable estimates exist for the age groups in which Alzheimer’s disease and dementia occur. Even if we accept the lower estimate of ~15% latent colonization in older adults, this proportion is still smaller than the lifetime cumulative incidence of dementia in the general population.

      Therefore, if latent toxoplasmosis contributes causally to dementia risk, and A-P is capable of eliminating latent Toxoplasma in the subset of individuals who harbor it, then a multi-week course of treatment—such as the one routinely taken for malaria prophylaxis—would be expected to produce a substantial reduction in dementia incidence at the population level, of the same order of magnitude reported here. A protective effect concentrated in a minority of exposed individuals is fully compatible with, and can mechanistically explain, the large overall reduction in risk that we observe.

      Finally, the reviewer notes that A-P is not a first-line treatment for toxoplasmosis due to assumed lower efficacy. This point does not undermine our results. Even a second-line agent, when administered over several weeks—as is routinely done for malaria prophylaxis—is expected to exert substantial anti-Toxoplasma activity. The long duration of exposure in large populations receiving A-P for travel provides a unique natural experiment that does not exist for other anti-Toxoplasma medications, which, when prescribed for their non-Toxoplasma indications, are not taken more than a few days. Thus, the widespread use of A-P for malaria prophylaxis allows a unique opportunity to evaluate long-term outcomes following inadvertent anti-Toxoplasma treatment.

      Moreover, “first line” recommendations in clinical guidelines refer to treatment of acute toxoplasmosis in immunosuppressed individuals, where tachyzoites are actively replicating. These guidelines do not consider efficacy against latent CNS colonization, which is dominated by bradyzoites, a biologically distinct form, in immunocompetent individuals. Therefore, the guideline hierarchy is not informative regarding which medication is more effective at clearing latent brain infection, the stage we consider most relevant to dementia risk.

      (2) A-P exposure may be a marker of subtle demographic features not captured in the dataset such as wealth allowing for global travel and/or genetic predisposition to AD. This raises my suspicion of correlative rather than casual relationships between A-P exposure and AD reduction. The size of the cohort does not eliminate this issue, but rather narrows confidence intervals around potentially misleading odds ratios which have not been adjusted for the multitude of other variables driving incident AD.

      We agree that prior to matching, A-P exposure may be associated with demographic features such as health or to travel internationally. However, this does not apply after matching. In all age-stratified analyses, exposed and control individuals were rigorously matched on all major risk factors known to influence dementia risk, including age, sex, race/ethnicity, smoking status, hypertension, diabetes, and obesity. Owing to the extremely large pool of individuals in TriNetX (~120M), our matching was performed stringently, producing exposed and unexposed cohorts that are near-identical with respect to the established determinants of dementia risk.

      The reviewer correctly identifies that large cohorts alone do not eliminate confounding; however, confounding must still be biologically and epidemiologically plausible. Any hypothetical confounder capable of producing a 50–70% reduction in dementia incidence over a decade would need to: (1) produce a very large protective effect against dementia; (2) be strongly associated with A-P exposure; and (3) remain entirely uncorrelated with age, sex, race/ethnicity, smoking, diabetes, hypertension and obesity, which have been rigorously matched. No such factor has been proposed. The suggestion that an unspecified ‘subtle demographic feature’ could produce effects of this magnitude remains hypothetical, and no such factor has been described in the dementia risk literature.

      If a specific evidence-supported confounder is proposed that meets these criteria, we would be pleased to test it empirically in our cohorts. In the absence of such a proposal, the interpretation that the association is merely “correlative rather than causal” remains speculative and does not negate the strength of a replicated, rigorously matched, long-term association across large cohorts in two national health systems.

      (3) The relationship between herpes virus reactivation and Toxo reactivation seems speculative.

      We respectfully disagree with the characterization of the herpesvirus–Toxoplasma interaction as speculative. The mechanism we describe is biologically valid, based on established virology and parasitology literature showing that latent T. gondii infection can reactivate from its bradyzoite state under inflammatory or immune-modifying conditions, including viral triggers. A published clinical report has documented CNS co-reactivation of T. gondii and a herpesvirus, explicitly noting that HHV-6 reactivation can promote Toxoplasma reactivation in neural tissue (Chaupis et al., Int J Infect Dis, 2016).

      Moreover, this mechanism is the only currently evidence-supported explanation that simultaneously and parsimoniously accounts for all of the epidemiologic observations in our study:

      (1) Substantially higher cumulative incidence of dementia in individuals with positive Toxoplasma serology, indicating that latent infection is a risk factor for subsequent cognitive decline;

      (2) Strong protective association following A-P exposure, a medication with established activity against Toxoplasma gondii, including in the CNS;

      (3) Independent protection conferred by VZV vaccination, observed consistently for two vaccines with distinct formulations (one live attenuated, one recombinant protein), whose only shared property is suppression of VZV reactivation;

      (4) Greater protective effect of A-P among individuals who were not vaccinated against VZV, consistent with a model in which dementia risk requires both herpesvirus reactivation and persistent latent Toxoplasma infection—such that reducing either factor alone (via VZV vaccination or anti-Toxoplasma suppression) substantially lowers risk.

      Taken together, these observations are difficult to reconcile under any alternative hypothesis.  

      To date, we are unaware of any other biologically coherent mechanism that can explain all four findings simultaneously. We would welcome any alternative explanation capable of accounting for these converging epidemiologic signals, as such a proposal could meaningfully advance the scientific discussion. In the absence of a competing explanation, the interaction between latent toxoplasmosis and herpesvirus reactivation remains the most parsimonious hypothesis supported by current knowledge.

      Finally, while observational studies are inherently limited in their ability to provide causal inference, the mechanism we propose is biologically grounded and experimentally testable. Our results provide a strong rationale for mechanistic studies and clinical trials, and warrant publication precisely because they generate a verifiable hypothesis that can now be evaluated directly.

      (4) A direct effect on A-P on AD lesions independent on infection is not considered as a hypothesis. Given the limitations above and effects on metabolic pathways, it probably should be. The Toxo hypothesis would be more convincing if the authors could demonstrate an enhanced effect of the drug in Toxo positive individuals without no effect in Toxo negative individuals.

      A direct effect of A-P on AD established lesions is indeed possible, and this hypothesis would be of significant therapeutic interest. However, we did not consider it within the scope of our epidemiologic analyses because all cohorts explicitly excluded individuals with existing dementia. Under these conditions, proposing a disease-modifying effect on established Alzheimer’s lesions based on our data would itself be speculative. Evaluating such a mechanism would be better answered by mechanistic or interventional studies rather than inference from populations without baseline disease.

      We also agree that demonstrating a stronger protective effect among Toxoplasma-positive individuals would be informative. Unfortunately, this “natural experiment” cannot be performed using the available data: Toxoplasma serology is rarely ordered in older adults, and A-P exposure is itself uncommon, resulting in a cohort overlap far too small to yield valid statistical inference (n≈25 in TriNetX).

      Thus, while both proposed hypotheses are scientifically attractive and merit further study, neither can be resolved using currently available real-world clinical data. Our findings provide the rationale to investigate both hypotheses experimentally, and we hope our report will motivate such studies.

      Reviewer #2 (Public review):

      Summary:

      This manuscript examines the association between atovaquone/proguanil use, zoster vaccination, toxoplasmosis serostatus and Alzheimer's Disease, using 2 databases of claims data. The manuscript is well written and concise. The major concerns about the manuscript center around the indications of atovaquone/proguanil use, which would not typically be active against toxoplasmosis at doses given, and the lack of control for potential confounders in the analysis.

      Strengths:

      (1) Use of 2 databases of claims data.

      (2) Unbiased review of medications associated with AD, which identified zoster vaccination associated with decreased risk of AD, replicating findings from other studies.

      We thank the reviewer for the thoughtful assessment and for noting key strengths of our work, including (1) the use of two large national databases, and (2) the unbiased discovery approach that replicated the widely reported association between zoster vaccination and reduced Alzheimer’s disease (AD) risk. We agree that these features highlight the validity and reproducibility of the analytic framework.

      Below we respond to the reviewer’s perceived weaknesses.

      Weaknesses:

      (1) Given that atovaquone/proguanil is likely to be given to a healthy population who is able to travel, concern that there are unmeasured confounders driving the association.

      We agree that, prior to matching, A-P exposure may correlate with demographic or health-related differences (e.g., ability to travel). However, this potential bias was explicitly controlled for in the study design. Across all three age-stratified TriNetX cohorts, exposed and unexposed individuals were rigorously matched on all major established dementia risk factors: age, sex, race/ethnicity, smoking status, obesity, diabetes mellitus, and hypertension. Comparative analyses confirm that these risk factors are equivalently distributed at baseline.

      As noted in our response to Reviewer #1, for any hypothetical unmeasured confounder to explain the results, it would need to satisfy three conditions simultaneously:

      (1) Be capable of producing a 50–70% reduction in dementia incidence sustained over a decade and across three distinct age strata (ages 50–79);

      (2) Be strongly associated with likelihood of receiving A-P;

      (3) Remain entirely uncorrelated with age, sex, race/ethnicity, smoking, diabetes, hypertension, or obesity, all of which were rigorously matched and balanced at baseline.

      No such factor has been proposed in the literature or by the reviewer. Thus, the concern remains hypothetical and unsupported by any measurable demographic or biological mechanism.

      Importantly, empirical evidence contradicts the notion of a “healthy traveler” bias:

      Emergency and inpatient encounter rates prior to exposure were comparable between A-P users and controls. Across the three age-stratified cohorts, emergency visits were similar or slightly higher among A-P users (EMER: 19.6% vs 16.4%, 19.9% vs 14.2%, 22.0% vs 14.8%), and inpatient encounters were effectively equivalent (IMP: 14.8% vs 15.2%, 17.7% vs 17.6%, 22.1% vs 22.2%). These patterns directly contradict the suggestion that A-P users were a healthier or less medically burdened population at baseline.

      Prevalence of mild cognitive impairment was not lower among A-P users and was, in fact, slightly higher in the oldest cohort. Across the three age groups, baseline diagnoses of mild cognitive impairment (MCI) were comparable or slightly higher among exposed individuals (0.1% vs 0.1%, 0.3% vs 0.2%, 1.1% vs 0.6%). These data contradict the suggestion that A-P users had superior baseline cognition.

      The strongest protective association occurred in the youngest stratum (age 50–59; HR 0.34). At this age, when nearly all individuals are sufficiently healthy to travel internationally, A-P uptake is the least likely to confound health status. A frailty-based “healthy traveler” hypothesis would instead predict the opposite pattern, with older adults showing the greatest apparent benefit, since health limitations are more likely to restrict travel in later life. In contrast, the protective association weakens with increasing age, empirically contradicting any explanation based on differential travel capacity.

      In conclusion, the empirical evidence directly contradicts the existence of a ‘healthy traveler’ effect.

      (2) The dose of atovaquone in atovaquone/proguanil is unlikely to be adequate suppression of toxo (much less for treatment/elimination of toxo), raising questions about the mechanism.

      A few important points should address the reviewer’s concern:

      In our cohorts, A-P was prescribed for malaria prophylaxis, as correctly noted. In this setting, it is taken for the entire duration of travel, plus several days before and after, typically resulting in many weeks of continuous exposure. This creates an unintentional but scientifically valuable natural experiment, in which a CNS-penetrating anti-Toxoplasma agent is administered for long durations.

      Atovaquone is an established treatment for CNS toxoplasmosis, has strong CNS penetration, and is included in current clinical guidelines for acute toxoplasmosis in immunocompromised patients, although at higher doses. Because latent, asymptomatic CNS colonization is not treated in clinical practice, there are currently no data establishing the dose required to eliminate bradyzoite-stage Toxoplasma in immunocompetent individuals.

      Our observations concern atovaquone–proguanil (A-P), a fixed-dose combination of atovaquone with proguanil, a DHFR inhibitor targeting a key metabolic pathway shared by malaria parasites and T. gondii. The combination has well-established synergistic effects in malaria prophylaxis and the same mechanism would be expected to enhance anti-Toxoplasma activity. This fixed-dose regimen has never been formally evaluated for toxoplasmosis treatment at prolonged durations or against latent bradyzoite infection.

      Our hypothesis does not require or imply complete eradication of Toxoplasma. A clinically meaningful reduction in latent cyst burden among the subset of colonized individuals may be sufficient to alter long-term disease trajectories. Thus, a population-level decrease in dementia incidence does not require universal clearance of infection, but only partial suppression or reduction of parasite load in susceptible individuals, which is entirely compatible with the known pharmacology and duration of A-P exposure.

      (3) Unmeasured bias in the small number of people who had toxoplasma serology in the TriNetX cohort.

      The relatively small number of older adults with Toxoplasma serology stems from current clinical practice: serologic testing is mostly performed in women during reproductive years due to risks in pregnancy, whereas in older adults a positive result has no clinical consequence and therefore testing is rarely ordered.

      Importantly, the seropositive and seronegative groups were drawn from the same underlying population of individuals who underwent serology testing, and the only difference between groups is the test result itself. Because the decision to order a test is made prior to and independent of the result, there is no plausible rationale by which the serology outcome (positive or negative) would introduce a bias favoring either group beyond the result of the test itself.

      Furthermore, the two groups were here also rigorously matched on all major dementia risk factors, including age, sex, race/ethnicity, smoking, diabetes, hypertension, and BMI, and these characteristics are similarly distributed between groups. A small sample size does not imply bias; it simply reduces statistical power. Despite this limitation, the observed association (HR = 2.43, p = 0.001) remains strongly significant.

      Finally, this result is consistent with multiple published studies reporting higher rates of Toxoplasma seropositivity among individuals with Alzheimer’s disease, dementia, and even mild cognitive impairment, such that our finding reinforces a broader and independently observed epidemiologic pattern. Importantly, in our cohort the serology testing clearly preceded dementia diagnosis, which supports the plausibility of a causal rather than merely correlative relationship between latent toxoplasmosis and cognitive decline.

      To conclude our provisional response, we thank the editor and reviewers for raising points that will be further addressed and expanded upon in the discussion of the forthcoming revision. We welcome transparent scientific dialogue and acknowledge that, as with all observational research, residual confounding cannot be eliminated with absolute certainty. However, we disagree with the overall Assessment and emphasize that our findings—reproduced independently across two national health systems and three age-stratified cohorts, each rigorously matched on all major determinants of dementia risk, meet, and in many respects exceed, current standards for high-quality observational evidence.

      Assigning the results to “residual confounding” requires more than speculation: it requires identification of a confounding factor that is (1) anchored in established dementia risk literature, (2) empirically plausible, and (3) quantitatively capable of generating a sustained ~50 percent reduction in dementia incidence over a decade. No such factor has been identified to date. We note that the assertion of “residual confounding” has not been supported by a specific, quantitatively plausible mechanism. A hypothetical bias that is both extremely large in effect and uncorrelated with all major risk factors is not statistically or biologically credible.

      The explanation we propose, reduction in dementia risk through elimination of latent Toxoplasma gondii, is biologically grounded, directly supported by independent epidemiologic literature, and uniquely capable of accounting for all convergent observations in our data. No alternative hypothesis has been put forward that can plausibly explain these findings.

      A revised version of the manuscript will be submitted shortly, incorporating expanded baseline analyses, with the strictest possible exclusion criteria (including congenital, vascular, chromosomal, and neurodegenerative disorders such as Parkinson’s disease), and complete tabulated comparisons. These data will further reinforce that the observed protective associations are not attributable to any measurable confounding. We also plan to enhance the discussion in order to address the points raised by the reviewers.

      In light of the expanded analyses, any reservations expressed in the initial Assessment can now be re-evaluated on the basis of the empirical evidence. The findings reported in our study meet, and in several respects exceed, current epidemiologic standards for high-quality observational research, clearly warrant publication, and provide a robust scientific foundation for future mechanistic and interventional studies to determine whether elimination of latent toxoplasmosis can prevent or treat dementia.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 ( Public review):

      The strength of the current study lies in their establishing the molecular mechanism through which PRMT1 could alter craniofacial development through regulation of the transcriptome, but the data presented to support the claim that a PRMT1-SFPQ axis directly regulates intron retention of the relevant gene networks should be robust and with multiple forms of clear validation. For example, elevated intron retention findings are based on the intron retention index, and according to the manuscript, are assessed considering the relative expression of exons and introns from a given transcript. However, delineating between intron retention and other forms of alternative splicing (i.e., cryptic splice site recognition) requires a more comprehensive consideration of the intron splicing defects that could be represented in data. A certain threshold of intron read coverage (i.e., the percent of an intron that is covered by mapped reads) is needed to ascertain if those that are proximal to exons could represent alternative introns ends rather than full intron retention events. In other words, intron retention is a type of alternative splicing that can be difficult to analyze in isolation given the confounding influence of cryptic splicing and cryptic exon inclusion. If other forms of alternative splicing were assessed and not detected, more confident retention calls can be made.

      This manuscript is a mechanistic exploration that follows previous work we published on the role of Prmt1 in craniofacial development, in which genetic deletion of Prmt1 in CNCCs leads to cleft palate and mandibular hypoplasia (PMID: 29986157).

      As the reviewer pointed out, a certain threshold of intron read coverage is needed to assess intron retention events. We employed IRTools to assess the collective changes of intron retention between cell-states associated with certain biological function or pathway. IRTools incorporated considerations for intron read coverage by checking the evenness of read distribution in an intron. Specifically, every constitutive intronic regions (CIR) is divided into 10 equally sized bins and the proportion of reads that map to each bin is calculated. CIRs are then ranked according to their imbalance in bin-wise reads distribution, represented by the proportion of reads in its most populated bin. Those among top 1% are considered to contain potentially false IR events and excluded. We further addressed this question by developing another measure of intron retention, intron retention coefficient (IRC), which assesses IR events using the junction reads (Supplemental Figure-S8). Junction reads that straddle two exons are called exon-exon junction reads (spliced reads), and those that straddle an exon and a neighboring intron are called exon-intron junction reads (retained reads). The IRC of an intron is defined as the fraction of junction reads that are exon-intron junction reads: IRC = exon-intron read-count / (exon-exon read-count + exon-intron read-count), where exon-intron read-count = (5’ exon-intron read-count + 3’ exon-intron read-count) / 2. The IRC of a gene is defined as the exon-intron fraction of all junction reads overlapping or over the constitutive introns of this gene. In the calculation of the IRC, only exon-intron junction reads that cover the junction point and overlap both of each side for at least 8 bps were counted, and only exon-exon junction reads that jump over the relevant junction points and overlap each of the respective exons for at least 8 bps were counted. In this process, evenness of the proportion of exon-intron junction reads that are 5’ or 3’ exon-intron junction reads are taken into account. As shown in the Supplemental Figure S7A and S7B, IRC analysis generated consistent results with those obtained from using IRI (Figure 3A and 3I).

      In addition, as the reviewer pointed out, intron retention can be difficult to analyze in isolation. We followed the reviewer’s suggestion that “If other forms of alternative splicing were assessed and not detected, more confident retention calls can be made“ and analyzed other forms of alternative splicing for all ECM and GAG genes with significant IRI increase (genes highlighted in Figure-3A and 3I) using rMATS (Supplemental Figure-S9). Among these genes, only 5 genes (Cthcr1, Mmp23, Adamts10, Ccdc80 and Col25a1) showed statistically significant changes in skipped exon, 1 gene (Bmp7) showed significant changes in mutually exclusive exons, and none showed significant changes in alternative 5’ or 3’ splicing. SE and MXE changes detected were marginal (Supplemental figure S8), while the majority of matrix genes with significant intron retention didn’t exhibit other forms of alternative splicing, further supporting the confidence of intron retention calls.

      While data presented to support the PRMT1-SFPQ activation axis is quite compelling, that this is directly responsible for the elevated intron retention remains enigmatic. First, in characterizing their PRMT1 knockout model, it is unclear whether the elevated intron retention events directly correspond to downregulated genes.

      In the revised manuscript, we demonstrate IR-triggered NMD as a mechanism for transcript decay and downregulation of matrix genes. When IR-triggered NMD was blocked by chemical inhibitor NMDI14, the intron-retaining transcripts showed significant accumulation (new Figure-4). NMD is the RNA surveillance system to degrade aberrant RNAs. Intron retention-triggered NMD in cancer has both promotive and suppressive roles and NMD inhibitors has been tested for cancer therapy including immunotherapy. During embryonic development, the functional significance of NMD machinery is suggested by human genetic findings and mouse genetic models. NMD is driven by a protein complex composed of SMG and UPF proteins. Smg6, Upf1, Upf2 and Upf3a knockout mouse die at early embryonic stages (E5.5-E9.5), and Smg1 gene trap mutant mice die at E12.5 (PMID: 29272451). SMG9 mutation in human patients causes malformation in the face, hand, heart and brain (PMID: 27018474).

      We show that in CNCCs NMD functions both as a physiological mechanism and invoked by molecular insult. Blocking NMD in CNCCs caused significant accumulation of intron-retaining Adamts2, Alpl, Eln, Matn2, Loxl1 and Bgn transcripts, suggesting a basal role for NMD to degrade intron-retaining transcripts (Figure-4Ba-4Bf). We further demonstrated the accumulation of Adamts2 and Fbln5 using semi-quantitative PCR with the detection of a longer product from Adamts2 intron 19 and Fbln5 intron 7 (Figure-4Ca-4Ch). In CNCCs and ST2 cells, NMD is further invoked by Prmt1 and Sfpq deficiency. In Prmt1 deficient CNCCs, NMD blockage led to higher accumulation of intron-retaining Adamts2 and Alpl transcripts, suggesting that Prmt1 deficiency triggers NMD to reduce intron-containing transcripts (Figure-4Aa, 4Ab). In Sfpq-depleted ST2 cells, blocking NMD caused accumulation of intron-retaining transcripts Col4a2, St6galnac3 and Ptk7 (Figure-9B, 9C).

      Moreover, intron splicing is a well-documented node for gene regulation during embryogenesis and in other proliferation models, and craniofacial defects are known to be associated with 'spliceosomopathies'. However, reproduction of this phenotype does not suggest that the targets of interest are inherently splicing factors, and a more robust assessment is needed to determine the exact nature of alternative splicing in this system. Because there are several known splicing factors downstream of PRMT1 and presented in the supplemental data, the specific attribution of retention to SFPQ would be additionally served by separating its splicing footprint from that of other factors that are primed to cause alternative splicing.

      We have previously shown that a group of splicing factors depends on Prmt1 for arginine methylation, including SFPQ (PMID: 31451547). We tested additional splicing factors that are highly expressed in CNCCs and depends on PRMT1 for arginine methylation: SRSF1, EWSR1, TAF15, TRA2B and G3BP1 (Figure-5, 6 and 10). Among these factors, EWSR1 and TRA2B are both methylated in CNCCs and depend on PRMT1 for methylation (Fig. 5 and Supplemental Figure-S3B, S3C). We weren’t able to assess TAF15 methylation because of lack of efficient antibody for the PLA assay. We also demonstrated that their protein expression or subcellular localization was not altered by Prmt1 deletion in CNCCs, unlike SFPQ (Supplemental Figure-S4). To define their splicing footprint, we performed siRNA-mediated knockdown in ST2 cells, followed by RNA-seq and IRI analysis to define differentially regulated genes and introns, which revealed distinct biological pathways regulated by SFPQ, EWSR1, TRA2B and TAF15, but minimal roles of EWSR1, TRA2B and TAF15 on intron retention when compared to SFPQ (Fig. 10F-10S, Supplemental Figure S7A-S7F, Supplemental Tables S4-S6). ECM genes are significantly downregulated by all four splicing factors (Fig. 10F-10I), but EWSR1, TRA2B and TAF15 function through IR-independent mechanisms, such as exon skipping, as exemplified by Postn (Fig. 10J-10S).

      Clarifying the relationship between SFPQ and splicing regulation is important given that the observed splicing defects are incongruous with published data presented by Takeuchi et al., (2018) regarding SFPQ control of neuronal apoptosis in mice. In this system, SFPQ was more specifically attributed to the regulation of transcription elongation over long introns and its knockout did not result in significant splicing changes. Thus, to establish the specificity for the SFPQ in regulating these retention events, authors would need to show that the same phenotype is not achieved by mis-regulation of other splicing factors. That the authors chose SFPQ based on its binding profile is understandable but potentially confounding given its mechanism of action in transcription of long introns (Takeuchi 2018). Because mechanisms and rates of transcription can influence splicing and exon definition interactions, the role of SFPQ as a transcription elongation factor versus a splicing factor is inadequately disentangled by authors.

      To test whether SFPQ acts as a transcription elongation factor, we performed Pol II Cut&Tag in ST2 cells and demonstrated that depletion of SFPQ only caused marginal changes in either the promoter region or gene body of ECM genes, suggesting that the role of SFPQ as a transcriptional activator or elongation factor is minimal (Fig. 7G, 7H). This finding is distinct from SFPQ function in neurons (PMID: 29719248), suggesting that the activation or recruitment of SFPQ in transcriptional regulation may involve tissue-specific factors in neurons.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Lima et al examines the role of Prmt1 and SFPQ in craniofacial development. Specifically, the authors test the idea that Prmt1 directly methylates specific proteins that results in intron retention in matrix proteins. The protein SFPQ is methylated by Prmt1 and functions downstream to mediate Prmt1 activity. The genes with retained introns activate the NMD pathway to reduce the RNA levels. This paper describes an interesting mechanism for the regulation of RNA levels during development.

      Strengths:

      The phenotypes support what the authors claim that Prmt1 is involved in craniofacial development and splicing. The use of state-of-the-art sequencing to determine the specific genes that have intron retention and changes in gene expression is a strength.

      Weaknesses:

      Some of the data seems to contradict the conclusions. And it is unclear how direct the relationships are between Prmt1 and SFPQ.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      First, the claims regarding the effect of PRMT1 loss on splicing are unclear by the section title. In other words, does loss PRMT1 change the incidence of baseline alternative splicing events, or does it introduce new retention events that are responsible for underwriting the craniofacial phenotype? Consistent with this idea, the narrative could benefit from more cellular and/or histological validations of the transcriptomic defects discovered in the RNAseq, which could help contextualize the bioinformatics data with the developmental defects. Moreover, the conclusions drawn about intron retention could be clarified in terms of how applicable the mechanism is likely to be outside of this tissue-specific set of responsive introns.

      Loss of Prmt1 did not cause a global shift in intron retention, as shown in Supplemental Figure S2. Instead, Prmt1 deletion caused increase of intron retention specifically in genes enriched in cartilage development, glycosaminoglycan biology, dendrite and axon, and decreased intron retention in mitochondria and metabolism genes (Table. S1). We also tested matrix protein expression by histology to confirm that transcriptomic defects revealed at the RNA level resulted in lower protein production. The new data are in Figure 3E-3H.

      Additionally, invoking NMD to align splicing and differential gene expression data understandable but lacking sufficient controls to be conclusive, such as positive control genes to confirm inhibition of NMD.

      To validate the blockage of NMD, glutathione peroxidase 1 (Gpx1) intron 1, a well-documented substrate for NMD, is tested as positive control (Fig 4Ac, 4Ad, 9B).

      Additionally, it should be clarified whether NMD is a basal mechanism for the regulation of these introns or whether it is an induced mechanism that is invoked by the molecular insult.

      In CNCCs, NMD functions both as a physiological mechanism and invoked by molecular insult. Please refer to responses to Reviewer 1’s public review for detailed explanations.

      Further, authors present data downstream of two siRNAs for the same gene target, but it remains unclear how siRNAs for the same gene target produce different effects. It may be helpful for authors to clarify how many of the transcriptomic defects are shared versus unique between the siRNAs.

      To address this question, we used bioinformatic analysis of the whole genome data to the similarity in changes caused by the two SFPQ-targeting siRNAs. As shown in the new Fig. 7Ba & 7Bb, transcriptomic and intron changes are consistent between the two siRNAs, suggesting that genes targeted by the two siRNA predominantly overlap. This overlap is illustrated by scatter plot analysis of RNAseq DEG and IRI data from each siRNA against SFPQ.

      Finally, we stress the importance of presenting the full conceptual basis for SFPQ's potential role in splicing and gene expression. It is significant to note that SFPQ has been previously studied as a splicing factor and was instead determined to function in support of the transcription elongation rather than in splicing. Thus, if authors are confident that the SFPQ manifests directly in splicing changes they encumber the burden of proof to show that its role in transcription, nor another splicing factor, are driving splicing changes.

      We demonstrated that depletion of SFPQ only caused marginal changes in either the promoter region or gene body of ECM genes, suggesting that the role of SFPQ as a transcriptional activator or elongation factor is minimal (Fig. 7G, 7H). Please refer to responses to Reviewer 1’s public review for detailed explanations.

      Reviewer #2 (Recommendations for the authors):

      (1) It is not clear why the authors focused on intron retention targets vs the other possibilities. Skipped Exon is much higher in terms of the number of changes, please clarify. For the intron retention how is this quantified? The traces are nice, but it is hard to tell which part is retained at this magnification. Also, because the focus is on extracellular matrix (ECM) and NMD it would be nice to show some of those targets here. In the tbx1 trace, some are up and some are down. What does that mean for the gene expression?

      We have investigated SE initially and found that genes with significant changes in Prmt1 CKO CNCCs fall into diverse functional pathways. Among them, a few genes are critical for skeletal formation, including Postn and Fn, and the function of their exon skipping has been documented. For example, the two exons that are skipped in Postn, Exon17 and 21, have been shown to regulate craniofacial skeleton shape and mandibular condyle hypertrophic zone thickness using transgenic mouse models (PMID: 36859617). As illustrated by Figure 10, the skipped exon of Postn is regulated by multiple splicing factors that may perform overlapping functions in vivo.

      Intron retention of each gene is quantified by the ratio of the overall read density of its constitutive intronic regions (CIRs) to the overall read density of its constitutive exonic regions (CERs) and defined as the intron retention index (IRI). In the first section of Response to Reviewer 1’s comments, we explained additional bioinformatic analysis that was performed to address reviewers’ questions, support the confidence of intron event calls and rule out the possibility of other alternative splicing mechanisms, such as by SE, MXE, A5SS or A3SS (Supplemental Figure S5, S6, Table S7).

      (2) RNA-Sequencing of Prmt1 mutants nicely shows gene expression changes, including in ECM and GAG genes. While validation of the sequencing results is not necessarily required, it would be very interesting to show the expression in situ. In addition, the heat map shows both downregulated but also upregulated transcripts. This is expected since this protein regulates many genes. However, the volcano plot shows a significant number of genes upregulated. It would be interesting to show what the upregulated genes are. And what is the proposed mechanism for Prmt1 regulation of upregulated genes?

      Validation for the transcriptomic changes is shown in Fig. 3E-3H using immunostaining.

      As for upregulated genes in Prmt1 mutant, top pathways include cytokine-mediated signaling pathway, signal transduction by p53 signaling pathway and cell morphogenesis (Figure 2E), which are consistent with our previous reports that Prmt1 deletion induces cytokine production in oral epithelium and leads to p53 accumulation in embryonic epicardium (PMID: 32521264, 29420098). Besides these pathways, Prmt1 deletion also caused upregulation of genes involved in adult behavior, postsynaptic organization and apoptotic process, which is consistent with findings from other labs on PRMT1 function in neuronal and cancer cells (PMID: 34619150, 33127433).

      (3) Specific transcripts were shown to have elevated intron retention involved in the ECM and GAG pathway. However in Figure 3D it seems to show the opposite with intronic expression decreased and exonic increases and intronic decrease. This is very important to the final conclusion of the paper. In addition, is there a direct relationship between increased intron and downregulation of this specific gene expression? It seems a bit correlational as it could also be an indirect mechanism. One way to test this is to do in vitro translation with and without the specific intron to test if it results in lower expression.

      We apologize for the mis-labeling in previous version of Figure 3D, which is now corrected. We also tried to test the direct relationship between intron and downregulation of matrix genes such as Adamts2 using in vitro experiments, however, the introns of matrix genes with high retention tends to be long, many 10 to 50kb in length, making it challenging to generate mini-gene constructs for molecular analysis. We used a different approach and demonstrated that inhibition of NMD with a chemical inhibitor NMDI14 caused dramatic accumulation of the Adamts2, Alpl, Eln, Matn2, Loxl1 and Bgn transcripts, suggesting that retained introns triggered NMD to regulate gene expression and this mechanism acts as a physiological level in CNCCs (Fig. 4). We also blocked NMD in control and Prmt1 null CNCCs, where NMD blockage led to higher accumulation of Adamts2 and Alpl transcripts, suggesting that upon Prmt1 deficiency, NMD is further utilized to degrade intron-containing transcripts (Fig. 4). Similarly, in Sfpq-depleted ST2 cells, blocking NMD caused accumulation of intron-retaining transcripts Col4a2, St6galnac3 and Ptk7 (Fig. 9A, 9B).

      (4) While Figure 4 nicely shows the methylation of SFPQ is reduced in Prmt1 CKO cells, it is unclear which reside this methylation occurs. Also the overall expression of SFPQ is also down so it is possible that the methylation is indirect ie Prmt1 regulates some other methyltransferase that regulates SFPQ. Or that because the overall level of SFPQ is down, there is no protein to methylate. How do the authors differentiate between these possibilities?

      Previously, arginine methylation of SFPQ has been characterized using in vitro reaction and cell lines with biochemical assays by Snijders., et al in 2015 (PMID: 25605962). Among all PRMTs that catalyze asymmetric arginine dimethylation (ADMA), SFPQ is methylated by only PRMT1 and PRMT3, with PRMT1 showing higher efficiency while PRMT3 showing a lower efficiency. However, PRMT3 is mainly cytosolic. Its expression in CNCCs is about 100-fold lower than PRMT1 (Fig. 1). Based on these knowledges, PRMT1 is the primary arginine methyltransferase for SFPQ, a nuclear protein in CNCCs. We and others have shown in a previous publication that SFPQ methylation on arginine 7 and 9 depends on PRMT1 (PMID: 31451547).

      To investigate SFPQ protein degradation in CNCCs, we used MG132 to block proteasomal degradation and observed a partial rescue of SFPQ protein degradation in Prmt1 mutant embryos, suggesting that SFPQ is degraded through proteasomal-mediated mechanism. To address the relationship between SFPQ methylation and protein expression, we assessed arginine methylation of SFPQ that accumulated after MG132 treatment. The accumulated SFPQ was not methylated, confirming the absence of methylation even when SFPQ protein expression is restored.

      Snijders., et al, also shown that citrullination induced by PADI4 regulate SFPQ stability (Snijders 2015). We considered this possibility and assessed the expression levels of PADIs. In E13.5 and E15.5 CNCCs, PADI1-4 mRNA expression levels are very low (TPM<5), suggesting that PADIs may not regulate SFPQ stability in CNCCs. A detailed mechanism as to how PRMT1-mediated SFPQ methylation controls stability awaits further investigation.

      (5) For the Sfpq deleted experiment, it seems that the two knockdowns are not similar in the gene targets and GO terms different except Wnt signaling. This makes this data difficult to interpret. The genes identified as intron retention are different than the ones identified in Prmt1 deletion and not reduced as much. How does this fit in with the Prmt1 story? If working through Sfpq, it assumes that the targets will be similar and more the 8% would be in common.

      To address the first concern, we used bioinformatic analysis of the whole genome data to the similarity in changes caused by the two SFPQ-targeting siRNAs. As shown in the new Fig. 7Ba & 7Bb, transcriptomic and intron changes are consistent between the two siRNAs, suggesting that genes targeted by the two siRNA predominantly overlap. This overlap is illustrated by scatter plot analysis of RNAseq DEG and IRI data from each siRNA against SFPQ.

      We have previously identified a group of splicing factors that depends on PRMT1 for arginine methylation, including SFPQ (PMID: 31451547). In the new data in Figures 5, 6 and 10, we tested an additional five PRMT1-dependent splicing factors that are highly expressed in CNCCs: SRSF1, EWSR1, TAF15, TRA2B and G3BP1 (Fig. 5, 6 and 10). Among these factors, SRSF1 and G3BP1 are predominantly expressed in the cytosol of NCCs at E13.5. As splicing activity in the nucleus is needed for pre-mRNA splicing, we excluded these two and focused on the other three proteins. EWSR1 and TRA2B are both methylated in CNCCs and depend on PRMT1 for methylation (Fig. 5). We weren’t able to assess TAF15 methylation because of lack of efficient antibody for the PLA assay. We also demonstrated that their protein expression or subcellular localization was not altered by Prmt1 deletion in CNCCs, unlike SFPQ (Fig. S2). To define their splicing footprint, we performed siRNA-mediated knockdown in ST2 cells, followed by RNA-seq and IRI analysis to define differentially regulated genes and introns, which revealed distinct biological pathways regulated by SFPQ, EWSR1, TRA2B and TAF15, but minimal roles of EWSR1, TRA2B and TAF15 on intron retention when compared to SFPQ (Fig. 10F-10I, Supplemental Figure S7A-S7F). ECM genes are significantly downregulated by all four splicing factors (Fig. 10J-10M), but EWSR1, TRA2B and TAF15 regulate transcription or exon skipping instead of IR, as exemplified by Alpl and Postn (Fig. 10N-10T).

      (6) The addition of an NMD mechanism is interesting but not surprising that when inhibiting the pathway broadly, there is an increase in gene expression in the mesoderm cell line. How specific is this to craniofacial development?

      NMD is driven by a protein complex composed of SMG and UPF proteins. We show in the revised manuscript that NMD is both a physiological mechanism in CNCCs and triggered by genetic disturbance (Fig. 4). These data are in line with human patient reports where SMG9 mutation in human causes malformation in the face, hand, heart and brain (PMID: 27018474). Mouse genetic studies also demonstrated roles of NMD components during embryonic development.Smg6, Upf1, Upf2 and Upf3a knockout mouse die at early embryonic stages (E5.5-E9.5), and Smg1 gene trap mutant mice die at E12.5 (Han 2018). Additionally, intron retention-triggered NMD in cancer has both promotive and suppressive roles and NMD inhibitors has been tested for cancer therapy and recently cancer immunotherapy. Our findings highlight matrix genes as one of the key targets for NMD during craniofacial development.

      Minor:

      (1) The supplemental figures are difficult to understand. In the first upload there are many figures and tables, some excel files that are separate uploads and some not. Please upload as separate files so it is clear. And also put them in order that they are in the manuscript.

      (2) For the heat map in figure 2B, it would be good to show all the genes or none at all. It seems a bit like cherry-picking to highly only a few. And they are not labeled where they are located in the graph. Are these the top lines if so please label.

      (3) Gene names in Figure 3A are difficult to read. I would also not consider BMP7 an ECM gene.

      (4) A summary diagram of the interactions proposed will help to make this more understandable.

      The supplemental figures are reorganized and uploaded as separate word and excel documents. For Heat map in Fig. 2B, we have removed the gene names. For Fig. 3A, only the most significantly changed gene are labeled in red dots with names. We didn’t label all the genes because of the large number of genes. For the new Figure 3B, we have replaced BMP7. A schematic summary is also added to Supplemental Fig. S9 to illustrate the PRMT1-SFPQ pathway.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      The authors determine the phylogenetic relation of the roughly two dozen wtf elements of 21 S. pombe isolates and show that none of them in the original S. pombe are essential for robust mitotic growth. It would be interesting to test their meiotic function by simply crossing each deletion mutant with the parent and analyzing spores for non-Mendelian inheritance. If this has been reported already, that information should be added to the manuscript. If not, I suggest the authors do these simple experiments and add this information.

      Thanks for the great summary! All the wtf genes have been tested for meiotic drive phenotypes previously by Bravo Nunez et al. (2020; http://doi.org/10.1371/journal.pgen.1008350). The reference was cited in our original manuscript, and we added the details in the revised manuscript.  

      Strengths:

      The most interesting data (Figure 4) show that one recombinant (wtfC4) between wtf18 and wtf23 produces in mitotic growth a poison counteracted by its own antidote but not by the parental antidotes. Again, it would be interesting to test this recombinant in a more natural setting - meiosis between it and each of the parents.

      Thanks for this insightful comment! As suggested, we have tried to test this recombinant in a more natural setting. We created a recombinant strain (wtfC4) based on the laboratory strain 972h-. Specifically, we replaced the last exon of the original wtf23 gene with the last exon of wtf18. However, we encountered a challenge: since strain 972h- has only one mating type and cannot undergo meiosis on its own, we had to mate the recombinant strain with a BN0 h⁺ strain that only carries the wtf23<sup>antidote</sup>. Unfortunately, despite of tens of attempts over nearly a year, we did not observe meiotic driver phenotype as expected. This might be due to issues with the proper splicing and expression of the potential poison and antidote proteins or due to the genetic background. Similarly, the drive activity of wtf13 has been shown to be specifically suppressed in certain backgrounds.

      Weaknesses:

      In the opinion of this reviewer, some minor rewriting is needed.

      We did the rewriting as this reviewer suggested.

      Reviewer #2 (Public review):

      Summary:

      This important study provides a mechanism that can explain the rapid diversification of poison-antidote pairs (wtf genes) in fission yeast: recombination between existing genes.

      Thanks!

      Strengths:

      The authors analyzed the diversity of wtf in S. pombe strains, and found pervasive copy number variations. They further detected signals of recurrent recombination in wtf genes. To address whether recombination can generate novel wtf genes, the authors performed artificial recombination between existing wft genes, and showed that indeed a new wtf can be generated: the poison cannot be detoxified by the antidotes encoded by parental wtf genes but can be detoxified by own antidote.

      Thanks for the great summary!

      Weaknesses:

      The study can benefit from demonstrating that the novel poison-antidote constructed by the authors can serve as a meiotic driver.

      Thanks for this insightful comment! As suggested, we have tried to test this recombinant in a more natural setting. We created a recombinant strain (wtfC4) based on the laboratory strain 972h-. Specifically, we replaced the last exon of the original wtf23 gene with the last exon of wtf18. However, we encountered a challenge: since strain 972h- has only one mating type and cannot undergo meiosis on its own, we had to mate the recombinant strain with a BN0 h⁺ strain that only carries the wtf23<sup>antidote</sup>. Unfortunately, despite of tens of attempts over nearly a year, we did not observe meiotic driver phenotype as expected. This might be due to issues with the proper splicing and expression of the potential poison and antidote proteins or due to the genetic background. Similarly, the drive activity of wtf13 has been shown to be specifically suppressed in certain backgrounds.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, Wang and colleagues explore factors contributing to the diversification of wtf meiotic drivers. wtf genes are autonomous, single-gene poison-antidote meiotic drivers that encode both a spore-killing poison (short isoform) and an antidote to the poison (long isoform) through alternative transcriptional initiation. There are dozens of wtf drivers present in the genomes of various yeast species, yet the evolutionary forces driving their diversification remain largely unknown. This manuscript is written in a straightforward and effective manner, and the analyses and experiments are easy to follow and interpret. While I find the research question interesting and the experiments persuasive, they do not provide any deeper mechanistic understanding of this gene family.

      Thanks! Please see the following for our point-to-point response.

      Strengths:

      (1) The authors present a comprehensive compendium and analysis of the evolutionary relationships among wtf genes across 21 strains of S. pombe.

      (2) The authors found that a synthetic chimeric wtf gene, combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves like a meiotic driver that could only be rescued by the chimeric antidote but neither of the parental antidotes. This is a very interesting observation that could account for their inception and diversification.

      Thanks for the great summary!

      Weaknesses:

      (1) Deletion strains

      The authors separately deleted all 25 Wtf genes in the S. pombe ference strain. Next, the authors performed a spot assay to evaluate the effect of wtf gene knockout on the yeast growth. They report no difference to the WT and conclude that the wtf genes might be largely neutral to the fitness of their carriers in the asexual life cycle at least in normal growth conditions.

      The authors could have conducted additional quantitative growth assays in yeast, such as growth curves or competition assays, which would have allowed them to detect subtle fitness effects that cannot be quantified with a spot assay. Furthermore, the authors do not rule out simpler explanations, such as genetic redundancy. This could have been addressed by crossing mutants of closely related paralogs or editing multiple wtf genes in the same genetic background.

      Another concern is the lack of detailed information about the 25 knockout strains used in the study. There is no information provided on how these strains were generated or, more importantly, validated. Many of these wtf genes have close paralogs and are flanked by repetitive regions, which could complicate the generation of such deletion strains. As currently presented, these results would be difficult to replicate in other labs due to insufficient methodological details

      We generated growth curves for all the 25 wtf deletion strains. We provided the details for wtf gene knockout. However, for 25 wtf genes, there are too many combinations for editing two genes, and it is technically challenging to knock out multiple wtf together. Nevertheless, our results suggest single wtf genes have little effect on the host fitness under normal condition.

      (2) Lack of controls

      The authors found that a synthetic chimeric wtf gene, constructed by combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves as a meiotic driver that can be rescued only by its corresponding chimeric antidote, but not by either of the parental antidotes (Figure 4F). In contrast, three other chimeric wtf genes did not display this property (Figure 4C-E). No additional experiments were conducted to explain these differences, and basic control experiments, such as verifying the expression of the chimeric constructs, were not performed to rule out trivial explanations. This should be at the very least discussed. Also, it would have been better to test additional chimeras.

      We verified the expression of the chimeric genes. The last exon of wtf18 is too small (128bp) to do more meaningful chimeras.

      (3) Statistical analyses

      In line 130 the authors state that: "Given complex phylogenetic mixing observed among wtf genes (Figure 1E), we tested whether recombination occurred. We detected signals of recombination in the 25 wtf genes of the S. pombe reference genome (p = 0) and in the wtf genes of the 21 S. pombe strains (p = 0) using pairwise homoplasy index (HPI) test." Reporting a p-value of 0 is not appropriate. Exact P-values should be reported. 

      Due to software limitations, the PHI test reports p-values of 0.0 for extremely significant results. We have therefore reported them as <0.0001 in the revised manuscript.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Regarding the synthetic chimeric wtf gene constructed by combining exons of wtf23 and wtf18, the authors did not explicitly test whether it acts as a meiotic driver in the natural context of a cross. Instead, they examined this possibility only through transgenic overexpression experiments. Given that this is arguably the most important claim of the paper, it is critical that the authors perform, report, and discuss such an experiment in a natural context, regardless of the outcome. It is not necessary to test other recombinants or other wtf loci.

      Thanks for this insightful comment! As suggested, we have tried to test this recombinant in a more natural setting. We created a recombinant strain (wtfC4) based on the laboratory strain 972h-. Specifically, we replaced the last exon of the original wtf23 gene with the last exon of wtf18. However, we encountered a challenge: since strain 972h- has only one mating type and cannot undergo meiosis on its own, we had to mate the recombinant strain with a BN0 h⁺ strain that only carries the wtf23<sup>antidote</sup>. Unfortunately, despite of tens of attempts over nearly a year, we did not observe meiotic driver phenotype as expected. This might be due to issues with the proper splicing and expression of the potential poison and antidote proteins or due to the genetic background. Similarly, the drive activity of wtf13 has been shown to be specifically suppressed in certain backgrounds.

      Reviewer #1 (Recommendations for the authors):

      The paper is very well written, but some minor points should be corrected or checked.

      (1) Line 95: Why "Putative"? Is it not clear what a wtf pseudogene is?

      “Putative” was removed.

      (2) Line 105: Does "known functional" mean they are active (i.e., have been tested and shown to be active)? If so, a reference should be added.

      We used “known meiotic divers”, and added reference here.

      (3) Line 135: "no recombination signal was tested". Do the authors mean no signal was inferred? 

      We changed “tested” to “detected”.

      (4) Line 147: References for "known functional meiotic drivers (wtf23) and artificially generated meiotic driver (wtf18)" should be given. A statement of how wtf18 was "artificially generated" is essential so the reader knows how that element differs from the wtfC4 generated here.

      Reference for wtf23. As for wtf18, we have specified in the follow text, namely “we artificially introduced an in-frame ATG codon right before the start of exon 2, generating wtf18poison/-0M.”

      (5) Lines 154 and 424 say an ATG codon was introduced "right before the start of exon 2," but Figure 4B shows it before exon 1.

      We thank the reviewer. The introduced ATG is the second start codon in the long transcript and the first in the short transcript. The right panel of Figure 4B shows the short transcript, so the text and figure are consistent.

      (6) Line 159: The wtf18 mutant with this additional ATG codon should be tested in meiosis, to see if "putative" is correct.

      Thanks. As wtfC4, we came with technical challenges to show the driver phenotype in a natural setting, and thus removed this statement.

      (7) Line 181: change "driver" to "drive".

      Driver is correct.

      (8) Line 184: insert to read "wtf genes tested". Also, what is the basis for proposing that "the last exon might be crucial for antidote function"?

      “Tested” added, and removed the statement.

      (9) Line 198: change to read "detects only large differences".

      Done as suggested.

      (10) Line 204: change "removed" to "removal".

      Done as suggested.

      (11) Lines 242 and 243: Are "Splittree4" and "SplitsTree4" different, or is this a misprint?

      Corrected!

      (12) Lines 274-5 and 412 -3 would read better as "strains were diluted in five 10-fold steps” and “...μL of each dilution spotted on” “…to assay for…"

      Done as suggested.

      (13) Line 284 says "No new data were generated." This is clearly wrong. Perhaps the authors mean there are no supplementary data files.

      Corrected!

      (14) Line 406: Change "is" to "are".

      Corrected!

      (15) Line 413: Surely, they were spotted onto YE agar medium, not liquid medium.

      Corrected!

      (16) Figure 3C: Define "Rho" and the scale used.

      The definition of Rho has been added to the Methods section in the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      The evidence is largely solid, but the study can benefit from demonstrating that the novel poison-antidote constructed by the authors can serve as a meiotic driver.

      As suggested, we have tried to test this recombinant in a more natural setting. We created a recombinant strain (wtfC4) based on the laboratory 972h-. Specifically, we replaced the last exon of the original wtf23 gene with the last exon of wt18f. However, we encountered a challenge: since 972h- is a mating-type strain and cannot undergo meiosis on its own, we had to mate the recombinant strain with a BN0 h⁺ strain that carries the wtf23<sup>antidote</sup>. Unfortunately, despite of tens of attempts over nearly a year, we did not observe meiotic driver phenotype as expected. This might be due to issues with the proper splicing and expression of the potential poison and antidote proteins.

      Reviewer #3 (Recommendations for the authors):

      I strongly recommend the authors provide all the details concerning the generation of the knock-out strains, including specific primers used (for both the deletion and validation), the result of these validations, and the specific genotype (and ID) of the strains generated.

      These details are now included in the Materials and Methods section and in Supplementary.

      Please also provide exact P-values (see point 3).

      Due to software limitations, the PHI test reports p-values of 0.0 for extremely significant results. We have therefore reported them as <0.0001 in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #2 (Public review):

      In this valuable manuscript, Lin et al attempt to examine the role of long non coding RNAs (lncRNAs) in human evolution, through a set of population genetics and functional genomics analyses that leverage existing datasets and tools. Although the methods are incomplete and at times inadequate, the results nonetheless point towards a possible contribution of long non coding RNAs to shaping humans, and suggest clear directions for future, more rigorous study.

      Comments on revisions:

      I thank the authors for their revision and changes in response to previous rounds of comments. As before, I appreciate the changes made in response to my comments, and I think everyone is approaching this in the spirit of arriving at the best possible manuscript, but we still have some deep disagreements on the nature of the relevant statistical approach and defining adequate controls. I highlight a couple of places that I think are particularly relevant, but note that given the authors disagree with my interpretation, they should feel free to not respond!

      (1) On the subject of the 0.034 threshold, I had previously stated: "I do not agree with the rationale for this claim, and do not agree that it supports the cutoff of 0.034 used below."

      In their reply to me, the authors state:

      "What we need is a gene number, which (a) indicates genes that effectively differentiate humans from chimpanzees, (b) can be used to set a DBS sequence distance cutoff. Since this study is the first to systematically examine DBSs in humans and chimpanzees, we must estimate this gene number based on studies that identify differentially expressed genes in humans and chimpanzees. We choose Song et al. 2021 (Song et al. Genetic studies of human-chimpanzee divergence using stem cell fusions. PNAS 2021), which identified 5984 differentially expressed genes, including 4377 genes whose differential expression is due to trans-acting differences between humans and chimpanzees. To the best of our knowledge, this is the only published data on trans-acting differences between humans and chimpanzees, and most HS lncRNAs and their DBSs/targets have trans-acting relationships (see Supplementary Table 2). Based on these numbers, we chose a DBS sequence distance cutoff of 0.034, which corresponds to 4248 genes (the top 20%), slightly fewer than 4377."

      I have some notes here. First, Agoglia et al, Nature, 2021, also examined the nature of cis vs trans regulatory differences between human and chimps using a very similar set up to Song et al; their Supplementary Table 4 enables the discovery of genes with cis vs trans effects although admittedly this is less straightforward than the Song et al data. Second, I can't actually tell how the 4377 number is arrived at. From Song et al, "Of 4,671 genes with regulatory changes between human-only and chimpanzee-only iPSC lines, 44.4% (2,073 genes) were regulated primarily in cis, 31.4% (1,465 genes) were regulated primarily in trans, and the remaining 1,133 genes were regulated both in cis and in trans (Fig. 2C). This final category was further broken down into a cis+trans category (cis- and transregulatory changes acting in the same direction) and a cis-trans category (cis- and trans-regulatory changes acting in opposite directions)." Even when combining trans-only and cis&trans genes that gives 2,598 genes with evidence for some trans regulation. I cannot find 4,377 in the main text of the Song et al paper.

      Elsewhere in their response, the authors respond to my comment that 0.034 is an arbitrary threshold by repeating the analyses using a cutoff of 0.035. I appreciate the sentiment here, but I would not expect this to make any great difference, given how similar those numbers are! A better approach, and what I had in mind when I mentioned this, would be to test multiple thresholds, ranging from, eg,0.05 to 0.01 <DBS dist =0.01 -> 0.034 -> 0.05> at some well-defined step size.

      (1) We sincerely thank the reviewer for this critical point. Our initial purpose, based on DBS distances from the human genome to chimpanzee genome and archaic genomes, was that genes with large DBS distances may have contributed more to human evolution. However, our ORA (overrepresentation analysis) explored only genes with large DBS distances (the legend of old Figure 2 was “1256 target genes whose DBSs have the largest distances from modern humans to chimpanzees and Altai Neanderthals are enriched in different Biological Processes GO terms”), with the use of the cutoff (threshold) of 0.034 for defining large distance. The cutoff is not totally unreasonable (as our new results and the following sensitivity analysis indicate), but this approach was indirect and flawed.

      (2) We have now performed ORA using two methods. The first uses only DBS distances. Instead of using a cutoff, we now sort genes by DBS distance (human-chimpanzee distances and human-Altai Neanderthal distance, respectively, see Supplementary Table 5) and use the top 25% and bottom 25% of genes to perform ORA. This directly examines whether DBS distances along indicate that genes with large DBS distances contribute more to human evolution than genes with small DBS distances. The second also explores the ASE genes (allele-specific expression, genes undergoing human/chimpanzee-specific regulation in the tetraploid human–chimpanzee hybrid iPS) reported by Agoglia et al. 2021. We select the top 50% and bottom 50% of genes with large and small DBS distances, intersect them with ASE genes from Agoglia et al. 2021 (their Supplementary Table 4), and apply ORA to the intersections. Both the results are that: (a) more GO terms are obtained from genes with large DBS distances, (b) more human evolution-related GO terms are obtained from genes with large DBS distances (Supplementary Table 5,6,7; Figure 2; Supplementary Fig. 15). These results directly suggest that genes with large DBS distances contribute more to human evolution than genes with small DBS distances, which is a key theme of the study.

      (3) Regarding Song et al 2021, the statement of “we differentiated…allotetraploid (H1C1a, H1C1b, H2C2a, H2C2b) lines into ectoderm, mesoderm, and endoderm” made us assume that their differentiated hybrid cell lines cover more tissue types than those of Agoglia et al. 2021. Now, upon re-examining Supplementary Table 5 of Song et al. and Supplementary Table 4 of Agoglia et al. 2021, we find that the latter more clearly indicates significant ASE genes (p-adj<0.01 and |LFC>0.5| in GRCh38 and PanTro5).

      (4) We have also performed two additional analyses in response to the suggestion of “test multiple thresholds, ranging from, eg, 0.05 to 0.01 <DBS dist =0.01 -> 0.034 -> 0.05> at some well-defined step size”. First, we performed a multi-threshold sensitivity analysis using a spectrum of cutoffs (0.03, 0.034, 0.04, 0.05), and tracked the number of genes identified and the enrichment significance of key GO terms (e.g., "neuron projection development," "behavior") across these thresholds. The result confirms that while the absolute number of genes varies with the cutoffs, the core biological conclusion (specifically, the significant enrichment of target genes in neurodevelopmental and cognitive functions) remains stable and significant. For instance, "behavior" maintains strong statistical significance (FDR<0.01) in both the human-chimpanzee and human-Altai Neanderthal comparisons across all tested cutoffs, and "Neuron projection development" also remains significant across three (0.03, 0.034, 0.04) of the four cutoffs in the Altai comparison. This pattern suggests that our core findings regarding neurodevelopmental functions are robust across a range of cutoffs. Nevertheless, we did not extend the analysis to smaller cutoffs (e.g., 0.01 or 0.02) because such values would identify an excessively large number of genes (>10000) for ORA, which would render the GOterm enrichment analysis less meaningful due to a loss of specificity.

      Second, we have performed an additional validation to directly evaluate whether the 0.034 cutoff itself represents a stringent and biologically meaningful value. We sought to empirically determine how often a DBS sequence distance of 0.034 or greater might occur by chance in promoter regions, thereby testing its significance as a marker of potential evolutionary divergence. We randomly sampled 10,000 windows from annotated promoter regions across the hg38 genome, each with a size matching the average length of DBSs (147 bp). We then calculated the per-base sequence distances for these random windows between modern humans and chimpanzees, as well as between modern humans and the three archaic humans (Altai, Denisovan, Vindija). The analysis reveals that a distance of ≥0.034 is a rare event in random promoter sequences: for Human-Chimp, Human-Altai, HumanDenisovan, and Human-Vindija, 5.49% (549/10000), 0.31% (31/10000), 4.47% (447/10000), and0.03% (3/10000) of random windows reach this distance. This empirical evidence suggests that 0.034 is a sufficiently strong cutoff for defining large DBS distance, it would occur very unlikely in a random genomic background (P<0.1 for Chimpanzee and P<0.05 for the archaic humans), and DBSs exceeding this cutoff are significantly enriched for sequences that have undergone substantial evolutionary change instead of being random neutral variations.  

      (5) We present new Figure 2, Supplementary Table 5,6,7, and Supplementary Fig. 15. We have substantially revised section 2.3, related sections in Results, Supplementary Note 3, and Supplementary Table 8. We have removed related descriptions and explanations in the main text and Supplementary Notes. The results of the above two analyses are presented here as two Author response images.

      Author response table 1.

      Sensitivity analysis of GO-term enrichment across different DBS sequence distance cutoffs. The table shows the numbers of target genes identified and the false discovery rates (FDR) for the enrichment of three selected GO terms at four different distance cutoffs. Note that, unlike in the old Figure 2, the results for chimpanzees and Altai Neanderthals are not directly comparable here, as the numbers of target genes used for the enrichment analysis differ between them at each cutoff.

      Author response image 1.

      Distribution of per-base sequence distances for DBS size-matched random genomic windows in Ensembl-annotated promoter regions, calculated between modern humans and (A) chimpanzee, (B) Altai Neanderthal, (C) Denisovan, and (D) Vindija Neanderthal genomes.

      (2) The authors have introduced a new TFBS section, as a control for their lncRNAs - this is welcome, though again I would ask for caution when interpreting results. For instance, in their reply to me the authors state: "The number of HS TFs and HS lncRNAs (5 vs 66) <HS TF vs all HS lncRNAs> alone lends strong evidence suggesting that HS lncRNAs have contributed more significantly to human evolution than HS TFs (note that 5 is the union of three intersections between <many2zero + one2zero> and the three <human TF list>)."

      But this assumes the denominator is the same! There are 35899 lncRNAs according to the current GENCOVE build; 66/35899 = 0.0018, so, 0.18% of lncRNAs are HS. The authors compare this to 5 TFs. There are 19433 protein coding genes in the current GENCOVE build, which naively (5/19433) gives a big depletion (0.026%) relative to the lnc number. However, this assumes all protein coding genes are TFs, which is not the case. A quick search suggests that ~2000 protein coding genes are TFs (see, eg, https://pubmed.ncbi.nlm.nih.gov/34755879/); which gives an enrichment (although I doubt it is a statistically significant one!) of HS TFs over HS lncRNAs (5/2000 = 0.0025). Hence my emphasis on needing to be sure the controls are robust and valid throughout!

      We thank the reviewer for this comment. While 5 vs 66 reveals a difference, a direct comparison is too simplified. The real take-home message of the new TFBS section is not the numbers but the distributions of HS TFs’ targets and HS lncRNAs’ targets across GTEx organs and tissues (Figure 3 and Supplementary Figures 24, 25) - correlated HS lncRNA-target transcript pairs are highly enriched in brain regions, but correlated HS TF-target transcript pairs are distributed broadly across GTEx tissues and organs. We have now removed the simple comparison of “5 vs 66” and more carefully explained our comparison in section 2.6.

      (3) In my original review I said: line 187: "Notably, 97.81% of the 105141 strong DBSs have counterparts in chimpanzees, suggesting that these DBSs are similar to HARs in evolution and have undergone human-specific evolution." I do not see any support for the inference here. Identifying HARs and acceleration relies on a far more thorough methodology than what's being presented here. Even generously, pairwise comparison between two taxa only cannot polarise the direction of differences; inferring human-specific change requires outgroups beyond chimpanzee.

      In their reply to me, the authors state:

      Here, we actually made an analogy but not an inference; therefore, we used such words as "suggesting" and "similar" instead of using more confirmatory words. We have revised the latter half sentence, saying "raising the possibility that these sequences have evolved considerably during human evolution".

      Is the aim here to draw attention to the ~2.2% of DBS that do not have a counterpart? In that case, it would be better to rewrite the sentence to emphasise those, not the ones that are shared between the two species? I do appreciate the revised wording, though.

      (1) Our original phrasing may be misleading, and we agree entirely that “pairwise comparison between two taxa only cannot polarise the direction of differences; inferring human-specific change requires outgroups beyond chimpanzee”. As explained in that reply, we know and think that DBSs and HARs are two different classes of sequences, and indeed, identifying HARs and acceleration relies on a far more thorough methodology. Yet, three factors prompted us to compare them. First, both suggest the importance of sequences outside genes. Second, both are quite “old” sequences and have undergone considerable evolution recently (although the references are different). Third, both have contributed greatly to human brain evolution.  

      (2) Here, our stress is 97.81% but not 2.2%, and we have made this analogy more clearly and cautiously. Relevant revisions have been made in the Results, Discussion, and Methods sections.   

      (3) We also have further determined whether the 2.2% DBSs are human-specific gains by analyzing them using the UCSC Multiz Alignments of 100 Vertebrates. The result confirms that all 2248 DBSs are present in the human genome but are absent from the chimpanzee genome and all other aligned vertebrate genomes. We add this result into the manuscript.

      (4) Finally, Line 408: "Ensembl-annotated transcripts (release 79)" Release 79 is dated to March 2015, which is quite a few releases and genome builds ago. Is this a typo? Both the human and the chimpanzee genome have been significantly improved since then!

      (1) We thank the reviewer for this comment, which prompts us to provide further explanation and additional data. First, we began predicting HS lncRNAs’ DBSs when Ensembl release 79 was available, but did not re-predict DBSs when new Ensembl releases were published because (a) these new Ensembl releases are based also on hg38, (b) we did not find any fault in the LongTarget program during our use, nor received any one from users, (c) predicting lncRNAs’ DBSs using the LongTarget program is highly time-consuming.  

      (2) Second, to assess the influence of newer Ensembl releases, we compared the promoters annotated in release 79 and in release 115. We found that the vast majority (87.3%) of promoters newly annotated in release 115 belong to non-coding genes. Thus, using release 115 may predict more DBSs in non-coding genes, but downstream analyses based on protein-coding genes would be essentially the same (meaning that all figures and tables would be the same).

      (3) Third, a key element of this study is GTEx data analysis, and these data were also published years ago.  

      (4) Finally, some lncRNA genes have new gene symbols in new Ensembl releases. To allow researchers to use our data conveniently, we have added a new column titled "Gene symbol (Ensembl release115)" to Supplementary Tables 2A and 2B.  

      Summary:

      Major changes based on Reviewer’s comments:

      (1) The following revisions are made to address the comment on “the 0.034 threshold”: (a) Section 2.3, section 2.4, Supplementary Note 3, and related contents in Discussion and Methods are revised, (b) new Figure 2, Supplementary Figure 15, new Supplementary Table 5,6,7, (c) Table 2 and Supplementary Table 8 are revised.

      (2) To address the comment on “new TFBS section”, section 2.6 and section 4.13 are revised.  

      (3) To address the comment on “97.81% and 2.2% of DBSs”, section 2.3 is revised.

      (4) The following revisions are made to address the comment on “release 79”: (a) the old Supplementary Table 2, 3 are merged to Supplementary Table 2AB, and the new column "Gene symbol (Ensembl release115)" is added to Supplementary Table 2AB, (b) accordingly, Supplementary Table 4,5 are renamed to Supplementary Table 3,4.

      Additional revisions:

      (1) Section 2.5 “Young weak DBSs may have greatly promoted recent human evolution” is moved into Supplementary Note 3 (which now has the subtitle “Target genes with specific DBS features are enriched in specific functions”), because this section is short and lacking sufficient cross-validation.

      (2) Considerable minor revisions of sentences have been made.

      (3) Since there are many supplementary figures, the main text now cites only Supplementary Notes, as the reader can easily access supplementary figures in Supplementary Notes.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The present study evaluates the role of visual experience in shaping functional correlations between human extrastriate visual cortex and frontal regions. The authors used fMRI to assess "resting-state" temporal correlations in three groups: sighted adults, congenitally blind adults, and neonates. Previous research has already demonstrated differences in functional correlations between visual and frontal regions in sighted compared to early blind individuals. The novel contribution of the current study lies in the inclusion of an infant dataset, which allows for an assessment of the developmental origins of these differences.

      The main results of the study reveal that correlations between prefrontal and visual regions are more prominent in the blind and infant groups, with the blind group exhibiting greater lateralization. Conversely, correlations between visual and somato-motor cortices are more prominent in sighted adults. Based on these data, the authors conclude that visual experience plays an instructive role in shaping these cortical networks. This study provides valuable insights into the impact of visual experience on the development of functional connectivity in the brain.

      Strengths:

      The dissociations in functional correlations observed among the sighted adult, congenitally blind, and neonate groups provide strong support for the main conclusion regarding postnatal experience-driven shaping of visual-frontal connectivity.

      The inclusion of neonates offers a unique and valuable developmental anchor for interpreting divergence between blind and sighted adults. This is a major advance over prior studies limited to adult comparisons.

      Convergence with prior findings in the blind and sighted adult groups reinforces the reliability and external validity of the present results.

      The split-half reliability analysis in the infant data increases confidence in the robustness of the reported group differences.

      Weaknesses:

      The manuscript risks overstating a mechanistic distinction between sighted and blind development by framing visual experience as "instructive" and blindness as "reorganizing." Similarly, the binary framing of visual experience and blindness as independent may oversimplify shared plasticity mechanisms.

      The interpretation of changes in temporal correlations as altered neural communication does not adequately consider how shifts in shared variance across networks may influence these measures without reflecting true biological reorganization.

      The discussion does not substantively engage with the longstanding debate over whether sensory experience plays an instructive or permissive role in cortical development.

      The relationship between resting-state and task-based findings in blindness remains unclear.

      Reviewer #2 (Public review):

      Summary:

      Tian et al. explore the developmental origins of cortical reorganization in blindness. Previous work has found that a set of regions in the occipital cortex show different functional responses and patterns of functional correlations in blind vs. sighted adults. Here, Tian et al. explore how this organization arises over development. Is the "starting state" more like the blind pattern, or more like the adult pattern? Their analyses reveal that the answer depends on the particular networks investigated. Some functional connections in infants look more like blind than sighted adults; other functional connections look more like sighted than blind adults; and others fall somewhere in the middle, or show an altogether different pattern in infants compared with both sighted and blind adults.

      Strengths:

      The paper addresses very important questions about the starting state in the developing visual cortex, and how cortical networks are shaped by experience. Another clear strength lies in the unequivocal nature of many results. Many results have very large effect sizes, critical interactions between regions and groups are tested and found, and infant analyses are replicated in split halves of the data.

      Weaknesses:

      While potential roles of experience (e.g., visual, cross-modal) are discussed in detail, little consideration is given to the role of experience-independent maturation. The infants scanned are extremely young, only 2 weeks old. It is possible then that the sighted adult pattern may still emerge later in infancy or childhood, regardless of infant visual experience. If so, the blind adult pattern may depend on blindness-related experience only (which may or may not reflect "visual" experience per se). In short, it is not clear that birth, or the first couple weeks of life, are a clear cut "starting point" for development, after which all change can be attributed to experience.

      Reviewer #3 (Public review):

      Summary

      This study aimed to investigate whether the differences observed in the organization of visual brain networks between blind and sighted adults result from a reorganization of an early functional architecture due to blindness, or whether the early architecture is immature at birth and requires visual experience to develop functional connections. This question was investigated through the comparison of 3 groups of subjects with resting-state functional MRI (rs-fMRI). Based on convincing analyses, the study suggests that: 1) secondary visual cortices showed higher connectivity to prefrontal cortical regions (PFC) than to non-visual sensory areas (S1/M1 and A1) in infants like in blind adults, in contrast to sighted adults; 2) the V1 connectivity pattern of infants lies between that of sighted adults (showing stronger functional connectivity with non-visual sensory areas than with PFC) and that of blind adults (showing stronger functional connectivity with PFC than with non-visual sensory areas); 3) the laterality of the connectivity patterns of infants resembled those of sighted adults more than those of blind adults, but infants showed a less differentiated fronto-occipital connectivity pattern than adults.

      Strengths

      - The question investigated in this article is important for understanding the mechanisms of plasticity during typical and impaired development, and the approach considered, which compares different groups of subjects including, neonates/infants and blind adults, is highly original.

      - Overall, the presented analyses are solid and well detailed, and the results and discussion are convincing.

      Weaknesses

      - While it is informative to compare the "initial" state (close to birth) and the "final" states in blind and sighted adults to study the impact of post-natal and visual experience, this study does not analyze the chronology of this development and when the specialization of functional connections is completed. This would require investigating the evolution of functional connectivity of the visual system as a function of visual experience and thus as a function of age, at least during toddlerhood given the early and intense maturation of the visual system after birth. This could be achieved by analyzing different developmental periods using open databases such as the Baby Connectome Project.

      - The rationale for grouping full-term neonates and preterm infants (scanned at term-equivalent age) is not understandable when seeking to perform comparisons with adults. Even if the study results do not show differences between full-terms and preterms in terms of functional connectivity differences between regions and of connectivity patterns, preterms group had different neurodevelopment and post-natal (including visual) experiences (even a few weeks might have an impact). And actually they show reduced connectivity strength systematically for all regions compared with full-terms (Sup Fig 7). Considering a more homogeneous group of neonates would have strengthen the study design.

      - The rationale for presenting results on the connectivity of secondary visual cortices before the one of primary cortices (V1) could be clarified.

      - The authors acknowledge the methodological difficulties for defining regions of interest (ROIs) in infants in a similar way as adults. Since the brain development is not homogeneous and synchronous across brain regions (in particular with the frontal and parietal lobes showing a delayed growth), this poses major problems for registration. This raises the question of whether the study findings could be biased by differences in ROI positioning across groups.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors are appropriately cautious in many parts of the discussion and include several helpful control analyses. Nonetheless, additional clarification of key assumptions and potential confounds would strengthen the paper.

      (1) The current framing labels vision as "instructive" and blindness as "reorganizing," but it is unclear why these two experiential factors are characterized differently. Both involve activity-dependent changes to functional architecture from a shared immature scaffold. Labeling them differently risks conflating divergent outcomes with distinct underlying mechanisms. Just because visual and blind adults show different patterns of functional connectivity does not mean they reflect separate processes. While the discussion briefly acknowledges the possibility of shared plasticity mechanisms, much of the framing across the manuscript, including in the abstract and introduction, implies a dichotomy. A clearer articulation of the criteria used to assign these labels, or reconsideration of whether such a distinction is warranted, would improve conceptual clarity. The current framing appears analogous to saying that "heat causes expansion" and "cold causes contraction" as if these were separate mechanisms, when they are actually two directions of change along a single factor: temperature. A more parsimonious framework, such as activity-dependent reweighting of pre-existing connectivity, may better capture the nature of plasticity at play in both sighted and blind development.

      Following the reviewer’s suggestion, we have revised the manuscript to clarify that both vision and blindness can be understood as manifestations of a common framework of experience-driven plasticity. We removed all mention of reorganization and clarify and modified the wording throughout.

      Specifically:

      Abstract: “Are infant visual cortices functionally like those of sighted adults, with blindness leading to functional change? We find that, on the contrary that secondary visual cortices of infants are functionally more like those of blind adults: stronger coupling with PFC than with nonvisual sensory-motor networks, suggesting that visual experience modifies elements of the sighted-adult long-range functional connectivity profile. Infant primary visual cortices are in-between blind and sighted adults i.e., more balanced PFC and sensory-motor connectivity than either adult group. The lateralization of occipital-to-frontal connectivity in infants resembles the sighted adults, consistent with the idea that blindness leads to functional change. These results suggest that both vision and blindness modify functional connectivity through experience-driven (i.e., activity-dependent) plasticity.” (Page 1, Line 13)

      Introduction: We replaced “blindness leads to functional reorganization” with “blindness modifies this functional connectivity” (Page 2, Line 52), and the following sentence has also been modified to: “lifetime visual experience shapes connectivity toward the sighted-adult pattern” (Page 2, Line 54) For the lateralization patterns, we now describe them as “blindness-related modification” rather than “reorganization”, to keep the interpretation descriptive rather than mechanistic. (Page 4, Line 114),

      (2) In interpreting the functional correlation differences, the discussion should more explicitly consider how statistical interdependence between areas could influence the observed results. For example, an increase in shared variance between visual and motor areas, such as might result from visually guided action, could result in a reduction in the apparent strength of visual-prefrontal temporal correlation (at the resolution of fMRI) without any true biological change in communication between visual-prefrontal cortex. This possibility is not ruled out by reporting groupwise patterns of relative connectivity. A more cautious systems-level framing could help clarify the distinction between neural plasticity and statistical redistribution of variance.

      We thank the reviewer for raising this important point. We agree that resting-state fMRI provides a measure of statistical synchrony in BOLD signals rather than direct causal interactions between regions. This a fundamental limitation of resting state fMRI, which we now note in the Discussion section. Such changes in correlation are consistent with a variety of underlying biological mechanisms. Online task is one factor that influences cross-region correlations. In the current study, both blind and sighted groups were measured while blindfolded and were not performing visually guided actions during the resting state fMRI scans. It is possible that past visual-guided action experience changes the resting state correlations of sighted participants. Indeed, this is one interesting hypothesis.

      In the revised Discussion, we now explicitly note this limitation and clarify that differences in FC do not by themselves establish whether or how underlying neurophysiological mechanisms are changed. We also emphasize that future work will need to investigate whether FC changes are accompanied by alterations in structural connectivity and to probe causal interactions and mechanistic underpinnings as follows:

      “Resting-state functional connectivity captures synchrony in BOLD signal fluctuations rather than causal interactions and differences in functional connectivity cannot on their own reveal how underlying neurophysiological mechanisms are modified.” (page 13,line 342)

      “Future studies will be needed to determine whether these functional changes are accompanied by alterations in structural connectivity, and to probe causal interactions and mechanistic underpinnings.” (page 13,line 350)

      (3) The mechanistic interpretation of group differences in visual-motor coupling would benefit from stronger network-level justification. Direct connections between these areas are sparse in primates. If effects reflect indirect polysynaptic interactions or shared thalamic input, as the authors suggest, one might expect corresponding group differences in intermediate regions (e.g., parietal cortex, thalamus) that mediate these interactions. Is there any evidence for this in the data?

      We thank the reviewer for raising this point. We agree and as noted above, resting state fMRI cannot distinguish between direct causal interactions between two regions and ones that a mediating region is involved. This is a fundamental limitation of resting state fMRI. The current study further focused on testing a specific hypothesis motivated by previously observed group differences between blind and sighted adults and our analyses focused on ROI-to-ROI connectivity between occipital, frontal, and sensory-motor cortices, and did not include these additional regions. In prior work, we and others, have looked at effects in parietal cortices (Abboud & Cohen, 2019; Bedny et al., 2009; Deen et al., 2015; Kanjlia et al., 2016, 2021; Sen et al., 2022). In blindness, parietal networks show increased correlations with some visual areas, rather than decreased. Regarding the thalamus, there is less clear evidence and there is some ongoing work trying to address this question. A couple of studies suggest that there is indeed increased connectivity between some parts of the thalamus and visual cortex in blindness. Although the anatomical information is limited, some of the work suggests that this increase is with higher-cognitive nuclei of the thalamus (Bedny et al., 2011; Liu et al., 2007).

      We agree that this is an important direction for future work. To acknowledge this point, we have revised the manuscript to highlight the potential role of cortical and subcortical hub regions in mediating connectivity changes. The text has been modified as follows:

      “Connectivity changes between two areas could be mediated by ‘third-party’ hub regions. For example, posterior parietal cortex serves as a cortical hub for multisensory integration and visuo-motor coordination and could mediate occipital-to-sensory-motor communication (Rolls et al., 2023; Sereno & Huang, 2014). Subcortical structures such as the thalamus could also play a mediating role (Vega-Zuniga et al., 2025).” (page 13,line 345)

      (4) The discussion would benefit from deeper engagement with prior work on experience-dependent plasticity, particularly the longstanding distinction between instructive and permissive roles of experience. While the authors briefly define these concepts and reference their historical use, a more explicit consideration of how their findings relate to this broader literature would help clarify whether such distinctions are necessary or appropriate.

      We thank the reviewer for this thoughtful suggestion to engage more explicitly with the longstanding literature on instructive versus permissive roles of experience. However, most of this literature comes from animal models, where experimental manipulations of the anatomical structure, of experience itself (e.g., controlled rearing studies) and sometimes of neural activity patterns allow clear tests of these mechanisms. Such manipulations are not feasible in humans. The terminology in the animal literature does not directly map onto the methods and data available in the present study or in other work with humans. For this reason, the current data does not allow us to fully engage with the debates in the animal literature and doing risks overinterpreting our findings.

      Nevertheless, we agree that once the instructive/permissive framework has been introduced, it is important to clarify how our results relate to it, rather than only providing definitions. We have therefore added the following text to the discussion:

      “In humans, such manipulations are not feasible, leaving us to study only the consequences of the presence or absence of vision. Under an instructive account, visual and multisensory experience could strengthen coupling between visual and other non-visual sensory-motor cortices through coordinated activity, thereby establishing the sighted-adult connectivity pattern. In the absence of visual input, by contrast, the lack of such coordinated activity may prevent these couplings from being established. Alternatively, vision may act permissively, indirectly enabling maturational processes that shift connectivity toward the sighted-adult configuration.” (page 14,line 362)

      (5) The revised discussion acknowledges the divergence between resting-state and task-based findings, but does not fully frame the theoretical implications of this discrepancy. Although this study cannot resolve the issue with its own data, a more integrative discussion could help clarify whether these measures reflect distinct functional states, developmental trajectories, or mechanisms of plasticity. Without such framing, readers are left without clear guidance on how to reconcile the present results with prior work on cross-modal recruitment in blindness.

      We thank the reviewer for this thoughtful comment. We agree that know how resting-state evidence relates to task-based evidence is a fundamentally important issue. We now discuss this more in the Introduction as well as in the Discussion.

      There is a sizable literature of both task-based and resting state studies. Some of prior studies have measured resting state and task-based data within the same participants and found relationships (Kanjlia et al., 2016, 2021; Lane et al., 2015). We now clarify this in the introduction. These studies find that within visual cortices of blind people, the task-based profile of a cortical area is related to its resting state connectivity pattern (Abboud & Cohen, 2019; Deen et al., 2015; Kanjlia et al., 2016, 2021). This suggests that these two measures are related. However, the timecourse of this relationship, the developmental trajectory and mechanism of plasticity is not known. We note this now in the introduction on page 2. Primarily this is because there is very little relevant developmental evidence. For example, in the current study we find that the resting state profile of secondary visual networks in infants is similar to that of blind adults. However, we do not know whether the visual cortices of infants show task-based cross modal responses. To our knowledge nobody has tested this question. We agree with the reviewer that raising this question in the paper is better than not commenting on the relationship at all.

      To address the reviewer’s comment, we have expanded the discussion to situate our results within a developmental framework, highlighting how early intrinsic connectivity may scaffold alternative trajectories shaped by either visual experience or blindness. The revised text now reads as follows:

      “Conversely, for people who remain blind throughout life, visual-PFC connectivity could enable recruitment of visual cortices for higher-order non-visual functions, such as language and executive control (Bedny et al., 2011; Kanjlia et al., 2021). Our results suggest that blind adults may build on connectivity patterns already present in infancy: like blind adults, sighted infants show stronger occipital–PFC than occipital–sensory–motor coupling. Repeated engagement of occipital networks during higher cognitive tasks in early development could intern enhance connectivity and specialization of visual networks for non-visual higher-order functions.

      Some prior studies have measured resting-state and task-based functional profiles in the same participants. These studies find that within visual cortices of blind people, the task-based profile of a cortical area is related to its resting state connectivity pattern (citations.) This suggests that these two measures are related. However, the timecourse of this relationship, the developmental trajectory and mechanism of plasticity is not known. Primarily this is because there is very little relevant developmental evidence. For example, in the current study we find that the resting state profile of secondary visual networks in infants is similar to that of blind adults. However, we do not know whether the visual cortices of infants show enhanced task-based cross modal responses, relative to sighted adults and how this compares to responses observed in blind adults. Future work with infants and children would be able to address this question.

      In the current study, the clearest evidence for functional change driven by blindness was observed for laterality. Connectivity lateralization in sighted infants resembles that of sighted adults, in both V1 and secondary visual cortices. Relative to both sighted infants and sighted adults, blind adults show more lateralized connectivity patterns between occipital and prefrontal cortices. Previous studies suggest that in people born blind occipital and non-occipital language responses are co-lateralized (Lane et al., 2017; Tian et al., 2023). We speculate that habitual activation of visual cortices by higher-cognitive tasks, such as language, which are themselves highly lateralized, contributes to this biased connectivity pattern of occipital cortex in blindness. Taken together, these results suggest a developmental framework in which intrinsic connectivity present in infancy provides a scaffold that is subsequently shaped and reinforced by experience-dependent recruitment, through either visual experience or the lifelong absence of vision in blindness. Longitudinal work across successive developmental stages will be crucial to test how the alternative trajectories shaped by visual experience versus blindness unfold over development.” (page 14-15)

      (6) The split-half reliability analysis is a valuable control. Additional details would clarify what these noise ceilings reflect. Were the rsFC patterns for each ROI calculated only for the ROIs included in the current study or was a broader assessment across the whole brain performed? It also would be helpful to report whether reliability differed for individual ROIs within and between groups. Even if global reliability is matched, selective differences could influence group comparisons. Several infants in the dhcp dataset were scanned twice. Were any second scans included in the current analyses? Comparing first versus second scans directly could strengthen the claim that several weeks of visual experience are insufficient to shift connectivity toward a sighted adult profile.

      Thanks to the reviewer’s comments on the reliability of the current study.

      In the present study, the noise ceiling was computed from the reliability of the ROI-wise FC profiles used across all analyses. Reliability was estimated using a split-half procedure: each rs-fMRI time series was divided into two equal halves, FC among all ROIs included in the study was computed separately for each half, and the noise ceiling for each ROI was defined as the Pearson correlation between its two FC profiles. Then we averaged these ROI-wise noise ceilings to evaluate group-level reliability, which exceeded 0.70 in all three groups and found no significant difference across groups. This provides an estimate of the upper bound on explainable variance for the exact FC features subjected to statistical testing (Lage-Castellanos et al., 2019). A brief description has been added to the manuscript (page 19, line 518).

      Regarding the reviewer’s question about the scope of rsFC features used in the noise-ceiling analysis: we computed noise ceilings only for the ROIs included in the present study, because all analyses in this work were conducted at the ROI–ROI level and did not involve voxelwise whole-brain FC. Thus, the noise-ceiling estimates correspond directly to the full set of FC features on which all statistical comparisons were based.

      As suggested by the reviewer, we examined noise ceilings for each ROI separately. All ROIs showed high absolute reliability (noise ceiling > 0.80) across the three groups, indicating that the ROI-wise FC estimates are generally robust across participants. Although many ROIs exhibited statistically significant group differences in noise ceiling (one-way ANOVA, p < 0.05), the effect sizes were small to moderate (partial η<sup>2</sup> < 0.14). These differences indicate that reliability may vary modestly across groups at the ROI level, and we cannot fully determine whether such variability contributes to the observed different FC patterns across groups. We have included this point in the revised manuscript (page 19, line 525), along with the full statistical results for the ROI-wise noise ceilings in the Supplementary Table S2.

      Last, we fully agree that longitudinal comparisons across multiple time points can provide important insights into how early visual experience shapes connectivity. At the same time, in the present dataset, the first scan occurred at a preterm age and the second at term-equivalent age. The differences between the first and second scans would reflect not only additional weeks of visual input, but also differences in prematurity status and overall neurodevelopmental maturity, which would make the interpretation of such comparisons difficult in the context of our current aims. We have clarified in the revised manuscript that only term-equivalent (second) scans were included. We see careful longitudinal work as an important avenue for addressing this question more directly.

      (7) The signal dropout assessment in the infant dataset is a valuable quality control step. Applying the same metric to the adult datasets would help harmonize preprocessing across groups and increase confidence in group-level comparisons.

      Thank you for this valuable suggestion. Following your comment, we applied the same signal dropout assessment to the adult datasets. One participant in the sighted adult group and two participants in the blind adult group showed signal dropout in one ROI each. The corresponding results are now included in the Supplementary Materials (Figure S13). The findings remain unchanged after this additional control analysis. We also add the relevant content in the Method part as follows:

      “The same signal dropout assessment was also applied to the blind and sighted adults to ensure consistent quality control across groups. One participant in the sighted adult group and two participants in the blind adult group exhibited signal dropout in one ROI each. Excluding these participants did not alter the group-level results (see Figure S13).” (page 16, line 449)

      Minor:

      (8) The authors added accurate anatomical descriptions to the methods but a less precise characterization remains in the introduction: "Anatomically, these regions correspond roughly to the location of areas such as motion area V5/MT+, the lateral occipital complex (LO), V3a and V4v in sighted people."

      We thank the reviewer for this helpful comment. We have revised the Introduction to provide a fuller anatomical description, consistent with the Methods. The text now reads:

      “Anatomically, these regions in sighted people approximately correspond to the locations of motion-sensitive V5/MT+ and the lateral occipital complex (LO), as well as ventral portions of occipito-temporal cortex including V4v and dorsal portions including V3a. The occipital ROI also extends ventrally into the middle portion of the ventral temporal lobe and dorsally into the intraparietal sulcus and superior parietal lobule.” (page 3, line 88)

      (9)Typo: "lager effect" should be "larger effect."

      Secondary visual cortices showed a significant within > between difference in both groups, with a lager effect in the blind group (post-hoc tests, Bonferroni-corrected paired: t-test: sighted adults within hemisphere > between hemisphere: t (49) = 7.441, p = 0.012; blind adults within hemisphere > between hemisphere: t (29) = 10.735, p < 0.001; V1: F(1, 78) =87.211, p < 0.001).

      We thank the reviewer for catching this typo. We have corrected “lager effect” to “larger effect” in the revised manuscript. (page 9, line 214)

      Reviewer #2 (Recommendations for the authors):

      All of my other concerns were adequately addressed.

      We thank the reviewer for their positive evaluation, and we are glad that our revisions have addressed their concerns.

      Reviewer #3 (Recommendations for the authors):

      In my view, qualifying infants as "sighted" is confusing and unnecessary: why not simplifying and homogenizing the wording along the manuscript and figures?

      We thank the reviewer for this suggestion. We agree and have revised the manuscript to use consistent wording, avoiding the qualification of infants as “sighted.”

      l188, I don't understand the sentence "By contrast, in sighted adults, this cross-hemisphere difference is weak or absent."

      We thank the reviewer for noting that this sentence was unclear. We have revised the text to provide a more precise explanation. The text now reads:

      “By contrast, in sighted adults this lateralized pattern is weaker: visual areas in each hemisphere show only a modest preference for ipsilateral prefrontal cortices, and connectivity with the contralateral PFC remains comparatively strong.” (page 8, line 207)

      l193: "Secondary visual cortices showed a significant within > between difference in both groups, with a lager effect in the blind group": providing effect sizes for the 2 groups would strengthen this result (+ note the typo laRger).<br /> - Figure S7, S11: Please add titles of y-axes.

      Thank you for this helpful suggestion. We have corrected the typo and added the effect sizes for both groups in the revised text. The revised sentence now reads as follows:

      “Secondary visual cortices showed a significant within > between difference in both groups, with a larger effect in the blind group (post-hoc tests, Bonferroni-corrected paired: t-test: sighted adults within hemisphere > between hemisphere: t (49) = 7.441, p = 0.012, cohen’d = 0.817; blind adults within hemisphere > between hemisphere: t (29) = 10.735, p < 0.001, cohen’d = 1.96).” (page 9, line 214)

      Titles of the y-axes have also been added to Figures S7 and S11.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Lesser et al provide a comprehensive description of Drosophila wing proprioceptive sensory neurons at the electron microscopy resolution. This “tour-de-force” provides a strong foundation for future structural and functional research aimed at understanding wing motor control in Drosophila with implications for understanding wing control across other insects.

      Strengths:

      (1) The authors leverage previous research that described many of the fly wing proprioceptors, and combine this knowledge with EM connectome data such that they now provide a near-complete morphological description of all wing proprioceptors.

      (2) The authors cleverly leverage genetic tools and EM connectome data to tie the location of proprioceptors on the wings with axonal projections in the connectome. This enables them to both align with previous literature as well as make some novel claims.

      (3) In addition to providing a full description of wing proprioceptors, the authors also identified a novel population of sensors on the wing tegula that make direct connections with the B1 wing motor neurons, implicating the role of the tegula in wing movements that was previously underappreciated.

      (4) Despite being the most comprehensive description so far, it is reassuring that the authors clearly state the missing elements in the discussion.

      Weaknesses:

      (1) The authors do their main analysis on data from the FANC connectome but provide corresponding IDs for sensory neurons in the MANC connectome. I wonder how the connectivity matrix compares across FANC and MANC if the authors perform a similar analysis to the one they have done in Figure 2. This could be a valuable addition and potentially also pick up any sexual dimorphism.

      We agree that systematic comparisons will provide valuable insights as more connectome datasets become available. However, the primary goal of this study was to link central axon morphology with peripheral structures in the wing. We deliberately omitted more detailed and quantitative analyses of the downstream VNC circuitry, apart from providing a global view of the connectivity matrix and using it to cluster the sensory axon types. A more detailed and systematic comparison of wing sensorimotor circuit connectivity across different connectome datasets (FANC, MANC, BANC, IMAC) is the subject of ongoing work in our lab, which we feel is beyond the scope of this study. Here, we chose to match the wing proprioceptors to axons in MANC to demonstrate their stereotypy across individuals and to make them more accessible to other researchers. We found no obvious sexual dimorphism at the level of wing sensory neurons. We now note this in the Discussion.

      (2) The authors speculate about the presence of gap junctions based on the density of mitochondria. I’m not convinced about this, given that mitochondrial densities could reflect other things that correlate with energy demands in sub-compartments.

      We have moved speculation about mitochondria and gap junctions to the Discussion.

      (3) I’m intrigued by how the tegula CO is negative for iav. I wonder if authors tried other CO labeling genes like nompc. And what does this mean for the nature of this CO. Some more discussion on this anomaly would be helpful.

      Based on this suggestion, we have added an image showing that tegula CO neurons are labeled by nompC-Gal4.

      (4) The authors conclude there are no proprioceptive neurons in sclerite pterale C based on Chat-Gal4 expression analysis. It would be much more rigorous if authors also tried a pan-neuronal driver like nsyb/elav or other neurotransmitter drivers (Vglut, GAD, etc) to really rule this out. (I hope I didn’t miss this somewhere.)

      To address this, we imaged OK371-GFP, which labels glutamatergic neurons, in the wing and wing hinge. We saw expression in the wing, as others have reported (Neukomm et. al., 2014), but we saw no expression at the wing hinge. Apart from a handful of glutamatergic gustatory neurons in the leg, we are not aware of any other sensory neurons in the fly that are not labeled by Chat-Gal4.

      Overall, I consider this an exceptional analysis that will be extremely valuable to the community.

      We sincerely appreciate the reviewer’s positive feedback.

      Reviewer #2 (Public review):

      Summary:

      Lesser et al. present an atlas of Drosophila wing sensory neurons. They proofread the axons of all sensory neurons in the wing nerve of an existing electron microscopy dataset, the female adult fly nerve cord (FANC) connectome. These reconstructed sensory axons were linked with light microscopy images of full-scale morphology to identify their origin in the periphery of the wing and encoded sensory modalities. The authors described the morphology and postsynaptic targets of proprioceptive neurons as well as previously unknown sensory neurons.

      Strengths:

      The authors present a valuable catalogue of wing sensory neurons, including previously undescribed sensory axons in the Drosophila wing. By providing both connectivity information with linked genetic drive lines, this research facilitates future work on the wing motor-sensory network and applications relating to Drosophila flight. The findings were linked to previous research as well as their putative role in the proprioceptive and nerve cord circuitry, providing testable hypotheses for future studies.

      Weaknesses:

      (1) With future use as an atlas, it should be noted that the evidence is based on sensory neurons on only one side of the nerve cord. Fruit flies have stereotyped left/right hemispheres in the brain and left/right hemisegments in the nerve cord. The comparison of left and right neurons of the nervous system can give a sense of how robust the morphological and connectivity findings are. Here, the authors have not compared the left and right side sensory axons from the wing nerve, leaving potential for developmental variability across samples and left/right hemisegments.

      The right ADMN nerve in the FANC dataset is partially severed, making left/right comparisons unreliable (see Azevedo 2024, Extended Data Figure 4). We have updated the text to explain this within the Methods section of the paper.

      (2) Not all links between the EM reconstructions and driver lines are convincing. To strengthen these, for all EM-LM matches in Figures 3-7, rotated views of the driver line (matching the rotated EM views) should be shown to provide a clearer comparison of the data. In particular, Figure 3G and Figure 7B are not very convincing based on the images shown. MCFO imaging of the driver lines in Figure 3G and 7B would make this position stronger if a clone that matches the EM reconstruction could be identified.

      Many of the z-stack images in the paper are from the Janelia FlyLight collection, and unfortunately their imaging parameters were not optimized for orthogonal views. Rotated views are blurry and not especially helpful for comparison to EM reconstruction. We now point out in the text that interested readers can access the z-stacks from FlyLight to see the dorsal-ventral projections.

      Regarding Figure 3G and 7B, we have added markers to the image with corresponding descriptions in the legend to guide the reader through the image of the busy driver line. Although these lines label many cells in the VNC as a whole, they sparsely label cells in the ADMN, making them nonetheless useful for identifying peripheral sensory neurons.

      (3) Figure 7B looks like the driver line might have stochastic expression in the sensory neuron, which further reduces confidence in the result shown in Figure 7C. Is this expression pattern in the wing consistently seen? Many split-GAL4s have stochastic expressions. The evidence would be strengthened if the authors presented multiple examples (~4-5) of each driver line’s expression pattern in the supplement.

      Figure 7B shows sparse labeling of the driver line using the MCFO technique, as specified in the legend. Its unilateral expression is therefore not due to stochastic expression of the Gal4 line. We have added the “MFCO” label to the image to clarify.

      (4) Certain claims in this work lack quantitative evidence. On line 128, for instance, “Overall, our comprehensive reconstruction revealed many morphological subgroups with overlapping postsynaptic partners, suggesting a high degree of integration within wing sensorimotor circuits.” If a claim of subgroups having shared postsynaptic partners is being made, there should have been quantitative evidence. For example, cosine similar amongst members of each group compared to the cosine similarity of shuffled/randomised sets of axons from different groups. The heat map of cosine similarity in Figure 2B alone is not sufficient.

      We agree that illustrating the extent of shared postsynaptic partners across subgroups strengthens this point. We added a visualization showing pairwise similarity scores for within- and between-cluster neuron pairs (Figure 2B inset). We also performed a permutation test to determine that within-cluster similarity is significantly higher than between clusters, and we report the test in the results as well as the figure legend. This analysis provides a more quantitative summary of the qualitative trends in connectivity that are summarized in Figure 2B.

      (5) Similarly, claims about putative electrical connections to b1 motor neurons are very speculative. The authors state that “their terminals contain very densely packed mitochondria compared to other cells”, without providing a quantitative comparison to other sensory axons. There is also no quantitative comparison to the one example of another putative electrical connection from the literature. Further, it should be noted that this connection from Trimarchi and Murphey, 1997, is also stated as putative on line 167, which further weakens this evidence. Quantification would strongly strengthen this position. Identification of an example of high mitochondrial density at a confirmed electrical connection would be even better. In the related discussion section “A potential metabolic specialization for flight circuitry”, it should be more clearly noted that the dense mitochondria could be unrelated to a putative electrical connection. If the authors have an alternative hypothesis about the mitochondria density, this should be stated as well.

      We agree with the reviewer that the link between mitochondrial density and metabolic specialization is purely speculative in this context. Based on reviewer feedback, we have moved all mention of the relationship between mitochondrial density and gap junction coupling to the Discussion. We acknowledge that this may seem like a somewhat random and not quantitatively supported observation. However, we found the coincidence striking and worthy of mention, though it is only tangentially relevant to the rest of the paper. From conversations with colleagues, we have also heard that this relationship is consistent with as yet unpublished work in other model organisms (e.g., zebrafish, mouse).

      The electrical coupling to b1 motor neurons is well-established (Fayyazuddin and Dickinson, 1999), and we have updated the text to state this more clearly. However, we agree that whether the specific neurons we have identified based on their anatomy are the same ones functionally identified through whole-nerve recordings remains unknown.

      (6) It would be appropriate to cite previous work using a similar strategy to match sensory axons to their cell bodies/dendrites at the periphery using driver lines and connectomics (see Figure 5 for example in the following paper: https://doi.org/10.7554/eLife.40247 ).

      At this point, there are now dozens of papers that match the axons of sensory neurons to their cell bodies/dendrites in the periphery by comparing light microscopy and connectomics. When we dug in, we found examples in C. elegans, Ciona intestinalis, zebrafish, and mouse, all published prior to the study cited above. For basically every animal for which scientists have acquired EM volumes of neural tissue, they have used other anatomical labeling methods to determine cell types inside and outside the imaged volume. In summary, we found it difficult to establish a single primary citation for this approach. In lieu of this, we have added a citation to an earlier review by a pioneer in EM connectomics that discusses the general approach of matching cells across different labeling/imaging modalities (Meinertzhagen et al., 2009).

      The methods section is very sparse. For the sake of replicability, all sections should be expanded upon.

      We have expanded the methods section, and also a STAR methods table.

      Reviewer #3 (Public review):

      Summary:

      The authors aim to identify the peripheral end-organ origin in the fly’s wing of all sensory neurons in the anterior dorsomedial nerve. They reconstruct the neurons and their downstream partners in an electron microscopy volume of a female ventral nerve cord, analyse the resulting connectome, and identify their origin with a review of the literature and imaging of genetic driver lines. While some of the neurons were already known through previous work, the authors expand on the identification and create a near-complete map of the wing mechanosensory neurons at synapse resolution.

      Strengths:

      The authors elegantly combine electron microscopy, neuron morphology, connectomics, and light microscopy methods to bridge the gap between fly wing sensory neuron anatomy and ventral nerve cord morphology. Further, they use EM ultrastructural observations to make predictions on the signaling modality of some of the sensory neurons and thus their function in flight.

      The work is as comprehensive as state-of-the-art methods allow to create a near-complete mapof the wing mechanosensory neurons. This work will be of importance to the field of fly connectomics and modelling of fly behavior, as well as a useful resource to the Drosophila research community.

      Through this comprehensive mapping of neurons to the connectome, the authors create a lot of hypotheses on neuronal function, partially already confirmed with the literature and partially to be tested in the future. The authors achieved their aim of mapping the periphery of the fly’s wing to axonal projections in the ventral nerve cord, beautifully laying out their results to support their mapping.

      The authors identify the neurons in a previously published connectome of a male fly ventral nerve cord to enable cross-individual analysis of connections. Further, together with their companion paper, Dhawan et al. 2025, describing the haltere sensory neurons in the same EM dataset, they cover the entire mechanosensory space involved in Drosophila flight.

      Weaknesses:

      The connectomic data are only available upon request; the inclusion of a connectivity table of the reconstructed neurons would aid analysis reproducibility and cross-dataset comparisons.

      We have added a connectivity table as well as analysis scripts in the github repository for the paper (https://github.com/EllenLesser/Lesser_eLife_2025).

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      The methods section should be expanded in every aspect. Most pressing sections are:

      (1) Data and Code availability: All code should be included as a Zenodo database, the suggestion to ask authors for code upon request is inappropriate.

      We have added all code to a public github repository, which is now linked in the Methods section.

      (2) Samples: Standard cornmeal and molasses medium should have a reference, as many institutes use different recipes.

      The recipe used by the University of Washington fly kitchen is based on the Bloomington standard Cornmeal, Molasses and Yeast Medium recipe, which can be found at https://bdsc.indiana.edu/information/recipes/molassesfood.html. The UW recipe is slightly modified for different antifungal ingredients and includes tegosept, propionic acid, and phosophoric acid.

      (3) Table 3: Driver lines labelling wing sensory neurons: The genetic driver lines should have associated Bloomington stock centre numbers. Additionally, relevant information for effector lines used should be included in the methods.

      We now include the Bloomington stock numbers and more information on effector lines in the STAR methods table.

      Minor corrections:

      (1) Lines 119-120: “Notably, many of the axons do not form crisp cluster boundaries, suggesting that multimodal sensory information is integrated at early stages of sensory processing.” We do not follow the logic of this statement and suspect it is a bit too speculative.

      We removed this sentence from the manuscript.

      (2) Figure 1: The ADMN is missing in the schematics and would be helpful to depict for non-experts. Is this what is highlighted in Figure 1D?

      Yes, and we now label 1D as the ADMN wing nerve.

      (3) Figure 1B: Which driver lines are being depicted here? Looking at Table 3 does not clarify. It should be specified at least in the figure legend.

      As stated in the legend, we include a table of all of the driver lines we screened and which sensory structures they label.

      (4) Figure 1C: There are some minor placement issues with the text in the schematic. There is an arrow very close to the “CO” on the top right, which makes the “O” look like the symbol for male. “ax ii” is a bit too close to the wing hinge

      We updated the figure to address this issue.

      (5) Figure 1D: The outlined grey masks are not clear. The use of colour would be very useful for the reader to help understand what the authors are referring to here

      We now use color for the masks.

      (6) Figure 2A: It is unclear if the descending neuron and non-motor efferent neuron are not shown because they are under the described threshold, or to simplify the plot. They should be included in the plot if over the threshold.

      We have updated the legend to specify that the exclusion of the descending and non-motor efferent neurons are to visually simplify the plot. We include % of sensory output to each of these neurons in the legend, and they are included in the connectivity matrix data in the public  GitHub repository associated with the paper, included in the Methods.

      (7) Figure 2B: What clustering is used specifically? The method says it’s from Scikit-learn, but there are many types of clustering available in this package.

      We now include the specific clustering type used in the Methods section, which is agglomerative clustering.

      (8) Figure 3A: What does the green box behind the plot represent?

      The green box represents the tegula CO axons, which we now specify in the legend.

      (9) Figure 3C: the “C” is clipped at the top.

      We updated the figure to address this issue.

      (10) Figure 4A: the main text says a “group of four axons” (line 203) while the figure says 5 axons.

      We updated the text to address this issue.

      (11) Line 360: “We found that the campaniform sensilla on the tegula provide the most direct feedback onto wing steering motor neurons”. We struggled to find where this was directly shown, because several sensory axon types directly synapse onto motor neurons.

      We now specify in the text that this finding is shown in Figure 3.

      Reviewer #3 (Recommendations for the authors):

      I would like to congratulate the authors on their beautiful, easy-to-read, and easy-to-comprehend manuscript, with clear figures and nice visualizations. This work provides a valuable resource that will contribute to the interpretability of connectomic data and further to connectome-based modeling of fly behavior.

      We sincerely appreciate the reviewer’s positive feedback.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      This article deals with the chemotactic behavior of E coli bacteria in thin channels (a situation close to 2D). It combines experiments and simulations.

      The authors show experimentally that, in 2D, bacteria swim up a chemotactic gradient much more effectively when they are in the presence of lateral walls. Systematic experiments identify an optimum for chemotaxis for a channel width of ~8µm, close to the average radius of the circle trajectories of the unconfined bacteria in 2D. It is known that these circles are chiral and impose that the bacteria swim preferentially along the right-side wall when there is no chemotactic gradient. In the presence of a chemotactic gradient, this larger proportion of bacteria swimming on the right wall yields chemotaxis. This effect is backed by numerical simulations and a geometrical analysis.

      If the conclusions drawn from the experiments presented in this article seem clear and interesting, I find that the key elements of the mechanism of this wall-directed chemotaxis are not sufficiently emphasized. Moreover, the paper would be clearer with more details on the hypotheses and the essential ingredients of the analyses.

      We thank the reviewer for these constructive suggestions. We agree that emphasizing the underlying mechanism is crucial for the clarity of our findings. In the revised manuscript, we have now explicitly highlighted the critical roles of chiral circular motion and the alignment effect following side-wall collisions in both the Abstract (lines 25-27) and the Discussion (lines 391-393). Furthermore, we have added a new analysis of bacterial trajectories post-collision (Fig. S2), which demonstrates that cells predominantly align with and swim along the sidewalls. We have also clarified the assumptions in our numerical simulations, specifically how the radius of circular trajectories and the alignment effect are incorporated into the equations of motion. Please refer to our detailed responses in the "Recommendations for the authors" section for further specifics.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors investigated the chemotaxis of E. coli swimming close to the bottom surface in gradients of attractant in channels of increasingly smaller width but fixed height = 30 µm and length ~160 µm. In relatively large channels, they find that on average the cells drift in response to the gradient, despite cells close to the surface away from the walls being known to not be chemotactic because they swim in circles.

      They find that this average drift is due to the cell localization close to the side walls, where they slide along the wall. Whereas the bacteria away from the walls have no chemotaxis (as shown before), the ones on the left side wall go down-gradient on average, but the ones on the right-side wall go up-gradient faster, hence the average drift. They then study the effect of reducing channel width. They find that chemotaxis is higher in channels with a width of about 8 µm, which approximately corresponds to the radius of the circular swimming R. This higher chemotactic drift is concomitant to an increased density of cells on the RSW. They do simulations and modeling to suggest that the disruption of circular swimming upon collision with the wall increases the density of cells on the RSW, with a maximal effect at w = ~ 2/3 R, which is a good match for their experiments.

      Strengths:

      The overall result that confinement at the edge stabilises bacterial motion and allows chemotaxis is very interesting although not entirely unexpected. It is also important for understanding bacterial motility and chemotaxis under ecologically relevant conditions, where bacteria frequently swim under confinement (although its relevance for controlling infections could be questioned). The experimental part of the study is nicely supported by the model.

      Weaknesses:

      Several points of this study, in particular the interpretation of the width effect, need better clarification:

      (1) Context:

      There are a number of highly relevant previous publications that should have been acknowledged and discussed in relation to the current work:

      https://pubs.rsc.org/en/content/articlehtml/2023/sm/d3sm00286a

      https://link.springer.com/article/10.1140/epje/s10189-024-00450-7

      https://doi.org/10.1016/j.bpj.2022.04.008

      https://doi.org/10.1073/pnas.1816315116

      https://www.pnas.org/doi/full/10.1073/pnas.0907542106

      https://doi.org/10.1038/s41467-020-15711-0

      http://doi.org/10.1038/s41467-020-15711-0

      http://doi.org/10.1039/c5sm00939a

      We appreciate the reviewer bringing these important publications to our attention. We have now cited and discussed these works in the Introduction (lines 55-62 and 76-85) to better contextualize our study regarding bacterial motility and chemotaxis in confined geometries.

      (2) Experimental setup:

      a) The channels are built with asymmetric entrances (Figure 1), which could trigger a ratchet effect (because bacteria swim in circle) that could bias the rate at which cells enter into the channel, and which side they follow preferentially, especially for the narrow channel. Since the channel is short (160 µm), that would reflect on the statistics of cell distribution. Controls with straight entrances or with a reversed symmetry of the channel need to be performed to ensure that the reported results are not affected by this asymmetry.

      We appreciate the reviewer's insight regarding the potential ratchet effect caused by asymmetric entrances. To rule this out, we fabricated a control device with straight entrances and repeated the measurements. As shown in Figure S3, the chemotactic drift velocity follows the same trend as observed in the original setup, confirming an optimal width of ~9 mm. These results demonstrate that the entrance geometry does not bias the reported statistics. We have updated the manuscript text at lines 233-235.

      b) The authors say the motile bacteria accumulate mostly at the bottom surface. This is strange, for a small height of 30 µm, the bacteria should be more-or-less evenly spread between the top and bottom surface. How can this be explained?

      We apologize for not explaining this clearly in the text. As shown by Wei et al., Phys. Rev. Lett. 135, 188401 (2025), significant surface accumulation occurs in channels with heights exceeding 20 µm. In our specific experimental setup, we did not use Percoll to counteract gravity. Therefore, the bacteria accumulated mostly at the bottom surface under the combined influence of gravity and hydrodynamic attraction. This bottom-surface localization is supported by our observation that the bacterial trajectories were predominantly clockwise (characteristic of the bottom surface) rather than counter-clockwise (characteristic of the top surface). We have added this explanation to Line 141.

      c) At the edge, some of the bacteria could escape up in the third dimension (http://doi.org/10.1039/c5sm00939a). What is the magnitude of this phenomenon in the current setup? Does it have an effect?

      We thank the reviewer for raising this important point regarding 3D escape. We have quantified this phenomenon and found the escape rate from the edge into the third dimension to be 0.127 s<sup>-1</sup>. This corresponds to a mean residence time that allows a cell moving at 20 mm/s to travel approximately 157.5 mm along the edge. Since this distance is comparable to the full length of our lanes (~160 mm), most cells traverse the entire edge without escaping. Furthermore, our analysis is based on the average drift of the surface trajectories per unit of time; this metric is independent of the absolute number of cells present. Therefore, the escape phenomenon does not significantly impact our conclusions. We have added a statement clarifying this at line 154.

      d) What is the cell density in the device? Should we expect cell-cell interactions to play a role here? If not, I would suggest to de-emphasize the connection to chemotaxis in the swarming paper in the introduction and discussion, which doesn't feel very relevant here, and rather focus on the other papers mentioned in point 1.

      The cell density in our experiments was approximately 1.3×10<sup>-3</sup> μm<sup>-2</sup>. Given this low density, we do not expect cell-cell interactions to play a role in the observed behaviors.

      Regarding the connection to swarming chemotaxis: We agree that our low-density setup differs from a high-density swarm; however, we believe the comparison remains relevant for two reasons. First, it provides a necessary contrast to studies showing surface inhibition of chemotaxis. Second, while we eliminate cell-cell interactions, we isolate the geometric aspect of swarming. In a swarm, cells move within narrow lanes created by their neighbors. Our device mimics this specific physical confinement by replacing neighboring cells with PDMS sidewalls. This allows us to decouple the effects of physical confinement from cell-cell interactions. We have added the text (Line 370) to clarify this rationale and have incorporated the additional references in introduction as suggested in point 1.

      e) We are not entirely convinced by the interpretation of the results in narrow channels. What is the causal relationship between the increased density on the RSW and the higher chemotactic drift? The authors seem to attribute higher drift to this increased RSW density, which emerges due to the geometric reasons. But if there is no initial bias, the same geometric argument would induce the same increased density of down-gradient swimmers on the LSW, and so, no imbalance between RSW and LSW density. Could it be the opposite that the increased RSW density results from chemotaxis (and maybe reinforces it), not the other way around? Confinement could then deplete one wall due to the proximity of the other, and/or modify the swimming pattern - 8 µm is very close to the size of the body + flagellum. To clarify this point, we suggest measuring the bacterial distributions in the absence of a gradient for all channel widths as a control.

      We thank the reviewer for this insightful comment regarding the causal relationship between cell density and chemotactic drift. We apologize if the initial explanation was unclear.

      Regarding the no-gradient control: Without an attractant gradient (and no initial bias), there is no breaking of symmetry and the labels of "LSW" and "RSW" are arbitrary. Therefore, there will be no asymmetry in the bacterial distributions on both sides (within experimental fluctuations) in the absence of a gradient for any channel width.

      Regarding the causality and density imbalance: We agree that the increased RSW density is a result of chemotaxis, which is then reinforced by the lane geometry especially at narrow lane width. The mechanism relies on the coupling of chemotactic bias with surface circularity. The angle ranges that lead to RSW-UG accumulation (Fig. 6A-C) coincide with the up-gradient direction. Because these cells experience suppressed tumbling (longer runs), they can maintain the steady circular trajectories required to reach and align with the RSW. Conversely, while pure geometric analysis suggests a similar potential for LSW-DG accumulation, these trajectories coincide with the down-gradient direction. These cells experience enhanced tumbling, which distorts the circular trajectories. This prevents them from effectively reaching the LSW and also increases the probability of them leaving the wall. Therefore, the causality is indeed a positive feedback loop: the attractant gradient creates an initial bias that allows the RSW-UG fraction to form stable trajectories; the optimal lane width (matching the swimming radius) then maximizes this capture efficiency, further enriching the RSW fraction and enhancing the overall drift.

      We have added clarifications regarding these points in the revised manuscript (the last paragraph of “Results”).

      (3) Simulations:

      The simulations treat the wall interaction very crudely. We would suggest treating it as a mechanical object that exerts elastic or "hard sphere" forces and torques on the bacteria for more realistic modeling.

      We appreciate the reviewer's suggestion to incorporate more detailed mechanical interactions, such as elastic or hard-sphere forces, for the wall collisions. While we agree that a full hydrodynamic or mechanical model would offer higher fidelity, our experimental observations suggest that a simplified kinematic approach is sufficient for the specific phenomena studied here.

      As shown in the new Fig. S2, our analysis of cell trajectories in the 44-µm-wide channels reveals that cells colliding with the sidewalls tend to align with the surface almost instantaneously. The timescale required for this alignment is negligible compared to the typical wall residence time (see also Ref. 6). Consequently, to maintain computational efficiency without sacrificing the essential physics of the accumulation effect, we employed a coarse-grained phenomenological model where a bacterium immediately aligns parallel to the wall upon contact, similar to approaches used previously (Ref. 43). We have added relevant text to the manuscript on lines 168-171.

      Notably, the simulations have a constant (chemotaxis independent) rate of wall escape by tumbling. We would expect that reduced tumbling due to up-gradient motility induces a longer dwell time at the wall.

      We apologize for the confusion. The chemotaxis effect is indeed fully integrated into our simulation. Specifically, the simulated cells sense the chemical gradient and adjust their motor CW bias (B) accordingly. This adjustment directly modulates the tumble rate (k), calculated as k \= B/0.31 s<sup>-1</sup>. Consequently, the wall escape rate is not constant but varies with the chemotactic response. We also imposed a maximum detention time limit which, when combined with the variable tumble rate, results in an average wall residence time of approximately 2 s, consistent with our experimental observations (Fig. S6B). We have clarified these details in the final section of 'Materials and Methods'.

      Reviewer #3 (Public review):

      This paper addresses through experiment and simulation the combined effects of bacterial circular swimming near no-slip surfaces and chemotaxis in simple linear gradients. The authors have constructed a microfluidic device in which a gradient of L-aspartate is established to which bacteria respond while swimming while confined in channels of different widths. There is a clear effect that the chemotactic drift velocity reaches a maximum in channel widths of about 8 microns, similar in size to the circular orbits that would prevail in the absence of side walls. Numerical studies of simplified models confirm this connection.

      The experimental aspects of this study are well executed. The design of the microfluidic system is clever in that it allows a kind of "multiplexing" in which all the different channel widths are available to a given sample of bacteria.

      While the data analysis is reasonably convincing, I think that the authors could make much better use of what must be voluminous data on the trajectories of cells by formulating the mathematical problem in terms of a suitable Fokker-Planck equation for the probability distribution of swimming directions. In particular, I would like to see much more analysis of how incipient circular trajectories are interrupted by collisions with the walls and how this relates to enhanced chemotaxis. In essence, there needs to be a much clearer control analysis of trajectories without sidewalls to understand the mechanism in their presence.

      We thank the reviewer for this insightful suggestion. We agree that understanding how circular trajectories are interrupted by wall collisions is central to explaining the enhanced chemotaxis. While we did not explicitly formulate a Fokker-Planck equation, we have addressed the reviewer's core point by employing two complementary mathematical approaches that model the probability distribution of swimming directions and wall interactions:

      (1) Stochastic simulations (Langevin approach): As detailed in the "Simulation of E. coli chemotaxis within lane confinements" subsection of “Results” and Figure 5, we modeled cells as self-propelled particles performing random walks. This model explicitly accounts for the "interruption" of circular trajectories by incorporating a constant angular velocity (circular swimming) and an alignment effect upon collision with sidewalls. These simulations successfully reproduced the experimental trends, confirming that the interplay between circular radius and lane width determines the optimal drift velocity.

      (2) Geometric probability analysis: To provide the "intuitive understanding", we included a specific Geometrical Analysis section (the last subsection of “Results”) and Figure 6. This analysis mathematically formulates the problem by calculating the exact proportion of swimming angles that allow a cell to transition from a circular trajectory in the bulk to an up-gradient trajectory along the Right Sidewall (RSW). By integrating over the possible swimming directions, we derived the probability of wall interception as a function of lane width (w) and swimming radius (r). This analysis reveals that the interruption of circular paths is most favorable for chemotaxis when w » (0.7-0.8)´r.

      (3) Control analysis: regarding the "control analysis of trajectories without sidewalls," we utilized the cells in the Middle Area (MA) of the wide lanes as an internal control. As shown in Fig. 2B and 4A, these cells exhibit typical surface-associated circular swimming (Fig. 3B) but generate zero net drift. This serves as the baseline "no sidewall" condition, demonstrating that the chemotactic enhancement is strictly driven by the rectification of circular swimming into wall-aligned motion at the boundaries.

      The authors argue that these findings may have relevance to a number of physiological and ecological contexts. Yet, each of these would be characterized by significant heterogeneity in pore sizes and geometries, and thus it is very unclear whether or how the findings in this work would carry over to those situations.

      We thank the reviewer for this important observation regarding environmental heterogeneity. We agree that we should be cautious about directly extrapolating to complex ecological contexts without qualification. We have revised the last sentence of the abstract to adopt a more measured tone: "Our results may offer insights into bacterial navigation in complex biological environments such as host tissues and biofilms, providing a preliminary step toward exploring microbial ecology in confined habitats and potential strategies for controlling bacterial infections."

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Key elements of the mechanism of wall-directed chemotaxis are not sufficiently emphasized:

      For instance, the chirality of the trajectories is an essential part of the analysis but is mentioned only briefly in the introduction. In the geometrical analysis, I understand that one of the critical parameters is the angle at which bacteria "collide" with the walls. But, again, this remains largely implicit in the discussion. This comes to the point that these ideas are not even mentioned in the abstract which doesn't provide any hint of a mechanism. An analysis of the actual trajectories of the cells after they hit the walls, as a function of their initial angle would be helpful in comparison with the simulations and the geometrical analysis.

      We appreciate the reviewer's insightful comment regarding the need to better emphasize the mechanism of wall-directed chemotaxis. We agree that the chirality of trajectories and the geometry of wall collisions are central to our analysis and were previously under-emphasized.

      To address this, we have made the following revisions:

      (1) We have revised the Abstract (lines 25-27) and the Discussion (lines 391-393) to explicitly highlight the crucial role of chiral circular motion and the alignment effect following sidewall collisions.

      (2) We further analyzed bacterial trajectories at different collision angles. Typical examples are shown in Supplementary Fig. S2. We observed that cells tend to align with and swim along the sidewalls regardless of their initial collision angles. This finding is now described in the main text at lines 168-171.

      The motion of the bacteria is modelled as run-and-tumble at several places in the manuscript, and in particular in the simulations. Yet, the trajectories of the bacteria seem to be smooth in this almost 2D geometry, except of course when they directly interact with the walls (I hardly see tumbles in the MA region in Figure 1B). Can the authors elaborate on the assumptions made in the numerical simulations? In particular, how is the radius of the trajectories included in these equations of motion (line 514)?

      We apologize for the lack of clarity regarding the bacterial motion model. It has been established that while bacteria do tumble near solid surfaces, they exhibit a smaller reorientation angle compared to bulk fluids; in fact, the most probable reorientation angle on a surface is zero (Ref. 41). Consequently, tumbles are often difficult to distinguish from runs with the naked eye. Additionally, the trajectories in Figure 1B are plotted on a 44 mm ´ 150 mm canvas with unequal coordinate scales, which may further obscure the visual distinctness of tumbling events.

      Regarding the equations of motion: We modeled the bacteria as self-propelled particles governed by the internal chemotaxis pathway, alternating between run and tumble states. As noted in the equations on lines 286 & 578, we incorporated the circular motion by introducing a constant angular velocity, −ν<sub>0</sub>/r, during the run state. Here, ν<sub>0</sub> represents the swimming speed, r denotes the radius of circular swimming, and the negative sign indicates clockwise chirality. Furthermore, to model the hydrodynamic interaction with the boundaries, we assumed that when a cell collides with a sidewall, its velocity vector instantly aligns parallel to that wall.

      The comparison of Figure 5B (simulations) with Figure 4B (experiments) does not strike me as so "similar". Why are the points at small widths so noisy (Figure 5AB)? Figure 5C is cut at these widths, it should be plotted over the entire scale.

      We acknowledge that the agreement between simulation and experiment is less robust in the narrowest channels. The discrepancy and "noise" at small widths in Figure 5 arise from the limitations of the self-propelled particle model in highly confined geometries. Specifically, our simulation treats bacteria as point particles and does not explicitly calculate the physical exclusion (steric effects) caused by the finite size of the flagella and cell body.

      In the experimental setup, steric constraints within narrow channels (comparable to the cell size) restrict the cells' ability to turn freely, effectively stabilizing their motion. However, because our model allows particles to reorient more freely than actual cells would in such confined spaces, it produces fluctuations and an overestimation of the drift velocity at small widths. If these confinement effects were fully incorporated, the cell density mismatch between the left and right sidewalls would be reduced, leading to lower drift velocities that match the experimental data more closely.

      Regarding Figure 5C: Since the "active particle" assumption loses physical validity in channels narrower than the scale of the bacterium, the simulation results in this regime are not representative of biological reality. Plotting these non-physical points would distort the analysis. Therefore, we have maintained the truncation of Figure 5C at 4 mm to ensure the data presented is physically meaningful. We have added a clear discussion of these model limitations to the manuscript at lines 310-314.

      These important precisions should be added to the text or in a supplementary section. A validated mechanism describing in detail the impact of the walls on the cell trajectories would greatly improve the conclusions.

      We thank the reviewer for the suggestions. As noted in the responses above, we have incorporated the details concerning the simulation assumptions and the model limitations at narrow widths into the revised manuscript. We have performed further analysis of the collision trajectories between bacteria and the sidewalls. As illustrated in the new Fig. S2, the data confirms that cells tend to align with and swim along the sidewalls following a collision, regardless of the initial impact angle.

      Reviewer #2 (Recommendations for the authors):

      Minor points

      (1) Related to swimming in 3D: The authors should specify the depth of field of the objective in their setup.

      We thank the reviewer for pointing this out. We have calculated the depth of field (DOF) of our objective to be approximately 3.7 µm. This estimate is based on the standard formula:

      where l = 610 nm (emission wavelength), n = 1.0 (refractive index), NA = 0.45 (numeric aperture), M = 20 (magnification), and e = 6.5 µm (camera resolution). We have added this specification to the "Microscopy and Data Acquisition" section of “Materials and Methods”.

      (2) Related to the interpretation of the width effect: We think plotting the cell enrichment, ie the probabilities P in Figure 4B normalized to the expected value if cells were homogeneously distributed ((3µm)/w for the side walls, (w - 6µm)/w for the middle) would help understand the strength of the wall 'siphoning' effect.

      We thank the reviewer for the suggestion. We have calculated the cell enrichment by normalizing the observed probabilities against the expected values for a homogeneous distribution, as suggested. The resulting relationship between cell enrichment and lane width is presented in Figure S4.

      Related to simulations:

      (1) Showing vd for the 3 regions in Figure S5 would be helpful also to understand the underlying mechanism.

      We thank the reviewer for the suggestion. The V<sub>d</sub> values for the three regions are shown in Fig. S5.

      (2) Figure 5B vs 4B: There is a mismatch in the right vs left side density at w=6µm in the simulations that is not here in the experiments. What could explain this difference?

      We appreciate the reviewer pointing this out. The mismatch in the simulations is due to the simplified treatment of cells as self-propelled particles, which overlooks the physical volume of the cell body and flagella. In narrow channels (w\=6 mm), these physical constraints would restrict the cells' ability to change direction freely - a factor not fully captured in the simulation. Accounting for these steric effects would trap cells more effectively against the walls, reducing the density asymmetry between the LSW and RSW and lowering the drift velocity. This would bring the simulation results closer to the experimental observations. We have added a discussion of these limitations and effects to the revised manuscript (lines 310-314).

      (3) The simulations essentially assume that the density of motile cells is homogeneous and equal at both x=0 and x=L open ends of the channel. Is it the case in the experiments, even with the gradient, and the walls creating some cell transport?

      We thank the reviewer for pointing this out. The simulation assumption is consistent with our experimental observations. Our data were recorded within 160-μm-long lanes located in the center of the wider (400 μm) cell channel. In this central region, the cells maintain a continuous flux. Furthermore, experiments were performed within 8 min of flow, limiting the time for significant cell density gradients to establish. As illustrated in Author response image 11, the inhomogeneity in the measured cell density distribution is insignificant across the length of the observation window, indicating that the walls and gradient do not create significant heterogeneity at the boundaries of the region of interest.

      Author response image 1.

      The cell density distribution along the gradient field from the data of 44-μm-wide lane.

      (4) Line 506: There is something strange with the definition of the bias. B cannot be the tumbling bias if k=B/0.31 s<sup>-1</sup> and the tumble-to-run rate is 5/s, because then the tumbling bias is B/0.31 / (B/0.31 + 5). Please clarify.

      We apologize for the confusion caused by the notation. In our model, B represents the CW bias of the individual flagellar motor, not the macroscopic tumbling bias of the cell. We assume the run-to-tumble rate is equivalent to the motor CCW-to-CW switching rate (k). Previous studies have shown that this rate increases linearly with the motor CW bias according to k=B/t, where t is a characteristic time (Ref. 50).

      Based on experimental data for wildtype cells, the average run time in the near-surface region is ~2.0 s (corresponding to a run-to-tumble rate of ~0.5 s<sup>-1</sup>) (Ref. 11), and the steady-state wildtype CW bias is ~0.15. Using these values, we determined t ~ 0.31 s. Consequently, the switching rate is defined as k=B/0.31 s<sup>-1</sup>. Since the tumble duration is constant (0.2 s) (Ref. 51), the tumble-to-run rate is fixed at 5 s<sup>-1</sup>. We have clarified these definitions and parameter values in lines 569-573.

      Other minor comments:

      (1) Line 20 and lines 34-35: We think that the connection to infection is questionable here and should be toned down.

      Thank you for the suggestion. We have revised Line 20 to read: “Understanding bacterial behavior in confined environments is helpful to elucidating microbial ecology and developing strategies to manage bacterial infections.” Additionally, we modified lines 34-35 to state: “Our results may offer insights into bacterial navigation in complex biological environments such as host tissues and biofilms, providing a preliminary step toward exploring microbial ecology in confined habitats and potential strategies for controlling bacterial infections.”

      (2) Line 49: Consider highlighting the change in the sense of rotation at the air-liquid interface.

      Thank you for the suggestion. We have now highlighted the difference in chirality between trajectories at the air-liquid interface and those at the liquid-solid interface. The text has been updated to read: “For example, E. coli swim clockwise when observed from above a solid surface, whereas Caulobacter crescentus move in tight, counter-clockwise circles when viewed from the liquid side.”

      (3) Lines 58-59: The sentence should be better formulated, explaining what is CheY-P and that its concentration changes because of a change in phosphorylation (P).

      Thank you for the suggestion. We have reformulated this section to explicitly define CheY-P and explain how its concentration is regulated through phosphorylation. The revised text reads: “The transmembrane chemoreceptors detect attractants or repellents and transmit signals into the cell by modulating the autophosphorylation of the histidine kinase CheA. Attractant binding suppresses CheA autophosphorylation, while repellent binding promotes it. This modulation alters the concentration of the phosphorylated response regulator protein, CheY-P.”

      (4) Lines 63-64: CheR CheB do a bit more than "facilitating" adaptation, they mediate it. The notation CheB(p) may be confusing, since "-P" was used above for CheY.

      Thank you for pointing this out. We have corrected the notation and strengthened the description of the enzymes' roles. The revised text is: “The adaptation enzymes CheR and CheB methylate and demethylate the receptors, respectively, mediating sensory adaptation.”

      (5) Line 130: there must be a typo in the formula.

      We have replaced the ambiguous lag time variable in Fig. 1C with _n_Δt to ensure mathematical consistency.

      (6) Additionally, \Delta t is both the time between the frame here and the lag time in Figure 1.

      Thank you for highlighting this ambiguity. We have updated the notation to distinguish these two values. The lag time in Figure 1 is now explicitly denoted as _n_Δt, while Δt remains the time interval between individual frames.

      (7) Line 162: "Consistent with previous reports," a reference to said reports is missing.

      Thank you for pointing this out. We have now added the reference (Ref. 41) to support this statement.

      (8) Figure 1B: Are these tracks in the presence of a gradient? Same as used in panel C? This needs to be explained.

      Response: Thank you for this question. We confirm that the tracks shown in Figure 1B were indeed recorded in the presence of a gradient and represent a subset of the data used in Figure 1C. We have clarified this in the figure legend as follows: "Thirty bacterial trajectories selected from the data of the 44-mm-wide lane in gradient assays. These represent a subset of the trajectories analyzed in panel C."

      (9) Simulations: the equation for x(t) should also be given for completeness.

      Thank you for the suggestion. For completeness, we have added the position updating equations for the run state to the Materials and Methods section (lines 579-580). The equations are defined as:

      (10) Figure S2: For the swimming directions that are more unstable due to the surface friction torque, RSW-DG, and LSW-UG, one would have expected that the Up-gradient motion is more persistent than the down gradient one. It seems to be the opposite. Is it significant, and what could be the reason for this?

      We apologize for the lack of clarity in our original explanation. While we would generally expect up-gradient motion to be more persistent than down-gradient motion in bulk fluid, our measurements near the surface show a different trend due to the specific contributions of run and tumble states to the escape rate. Cells swimming up-gradient (UG) in the LSW experience higher probability of running. Consequently, they are subjected to the destabilizing surface friction torque for a greater proportion of time compared to cells swimming down-gradient (DG) in the RSW. This can be explained mathematically. The escape rates for RSW-DG and LSW-UG can be expressed as:

      Where B<sup>+</sup> and B<sup>−</sup> represent the tumble bias (probability of tumbling) when swimming up-gradient and down-gradient, respectively, and k<sub>T</sub> and k<sub>R</sub> denote the escape rates during a tumble and a run, respectively. Due to the chemotactic response, 0≤ B<sup>+</sup>< B<sup>−</sup> ≤1. Crucially, our system is characterized by k<sub>R</sub>>k<sub>T</sub> (the escape rate is higher during a run than a tumble). Therefore, the lower tumble bias during up-gradient swimming (B<sup>+</sup>< B<sup>−</sup>) increases the weight of the run-state escape term((1−B<sup>+</sup>)k<sub>R</sub>), leading to a higher overall escape rate for LSW-UG compared to RSW-DG. We have added an intuitive understanding of k<sub>R</sub>>k<sub>T</sub> in the Supplemental text.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This is a careful and comprehensive study demonstrating that effector-dependent conformational switching of the MT lattice from compacted to expanded deploys the alpha tubulin C-terminal tails so as to enhance their ability to bind interactors.

      Strengths:

      The authors use 3 different sensors for the exposure of the alpha CTTs. They show that all 3 sensors report exposure of the alpha CTTs when the lattice is expanded by GMPCPP, or KIF1C, or a hydrolysis-deficient tubulin. They demonstrate that expansion-dependent exposure of the alpha CTTs works in tissue culture cells as well as in vitro.

      Weaknesses:

      There is no information on the status of the beta tubulin CTTs. The study is done with mixed isotype microtubules, both in cells and in vitro. It remains unclear whether all the alpha tubulins in a mixed isotype microtubule lattice behave equivalently, or whether the effect is tubulin isotype-dependent. It remains unclear whether local binding of effectors can locally expand the lattice and locally expose the alpha CTTs.

      Appraisal:

      The authors have gone to considerable lengths to test their hypothesis that microtubule expansion favours deployment of the alpha tubulin C-terminal tail, allowing its interactors, including detyrosinase enzymes, to bind. There is a real prospect that this will change thinking in the field. One very interesting possibility, touched on by the authors, is that the requirement for MAP7 to engage kinesin with the MT might include a direct effect of MAP7 on lattice expansion.

      Impact:

      The possibility that the interactions of MAPS and motors with a particular MT or region feed forward to determine its future interaction patterns is made much more real. Genuinely exciting.

      We thank the reviewer for their positive response to our work. We agree that it will be important to determine if the bCTT is subject to regulation similar to the aCTT. However, this will first require the development of sensors that report on the accessibility of the bCTT, which is a significant undertaking for future work.

      We also agree that it will be important to examine whether all tubulin isotypes behave equivalently in terms of exposure of the aCTT in response to conformational switching of the microtubule lattice.

      We thank the reviewer for the comment about local expansion of the microtubule lattice. We believe that Figure 3 does show that local binding of effectors can locally expand the lattice and locally expose the alpha-CTTs. We have added text to clarify this.

      Reviewer #2 (Public review):

      The unstructured α- and β-tubulin C-terminal tails (CTTs), which differ between tubulin isoforms, extend from the surface of the microtubule, are post-translationally modified, and help regulate the function of MAPs and motors. Their dynamics and extent of interactions with the microtubule lattice are not well understood. Hotta et al. explore this using a set of three distinct probes that bind to the CTTs of tyrosinated (native) α-tubulin. Under normal cellular conditions, these probes associate with microtubules only to a limited extent, but this binding can be enhanced by various manipulations thought to alter the tubulin lattice conformation (expanded or compact). These include small-molecule treatment (Taxol), changes in nucleotide state, and the binding of microtubule-associated proteins and motors. Overall, the authors conclude that microtubule lattice "expanders" promote probe binding, suggesting that the CTT is generally more accessible under these conditions. Consistent with this, detyrosination is enhanced. Mechanistically, molecular dynamics simulations indicate that the CTT may interact with the microtubule lattice at several sites, and that these interactions are affected by the tubulin nucleotide state.

      Strengths:

      Key strengths of the work include the use of three distinct probes that yield broadly consistent findings, and a wide variety of experimental manipulations (drugs, motors, MAPs) that collectively support the authors' conclusions, alongside a careful quantitative approach.

      Weaknesses:

      The challenges of studying the dynamics of a short, intrinsically disordered protein region within the complex environment of the cellular microtubule lattice, amid numerous other binders and regulators, should not be understated. While it is very plausible that the probes report on CTT accessibility as proposed, the possibility of confounding factors (e.g., effects on MAP or motor binding) cannot be ruled out. Sensitivity to the expression level clearly introduces additional complications. Likewise, for each individual "expander" or "compactor" manipulation, one must consider indirect consequences (e.g., masking of binding sites) in addition to direct effects on the lattice; however, this risk is mitigated by the collective observations all pointing in the same direction.

      The discussion does a good job of placing the findings in context and acknowledging relevant caveats and limitations. Overall, this study introduces an interesting and provocative concept, well supported by experimental data, and provides a strong foundation for future work. This will be a valuable contribution to the field.

      We thank the reviewer for their positive response to our work. We are encouraged that the reviewer feels that the Discussion section does a good job of putting the findings, challenges, and possibility of confounding factors and indirect effects in context. 

      Reviewer #3 (Public review):

      Summary:

      In this study, the authors investigate how the structural state of the microtubule lattice influences the accessibility of the α-tubulin C-terminal tail (CTT). By developing and applying new biosensors, they reveal that the tyrosinated CTT is largely inaccessible under normal conditions but becomes more accessible upon changes to the tubulin conformational state induced by taxol treatment, MAP expression, or GTP-hydrolysis-deficient tubulin. The combination of live imaging, biochemical assays, and simulations suggests that the lattice conformation regulates the exposure of the CTT, providing a potential mechanism for modulating interactions with microtubule-associated proteins. The work addresses a highly topical question in the microtubule field and proposes a new conceptual link between lattice spacing and tail accessibility for tubulin post-translational modification.

      Strengths:

      (1) The study targets a highly relevant and emerging topic-the structural plasticity of the microtubule lattice and its regulatory implications.

      (2) The biosensor design represents a methodological advance, enabling direct visualization of CTT accessibility in living cells.

      (3) Integration of imaging, biochemical assays, and simulations provides a multi-scale perspective on lattice regulation.

      (4) The conceptual framework proposed lattice conformation as a determinant of post-translational modification accessibility is novel and potentially impactful for understanding microtubule regulation.

      Weaknesses:

      There are a number of weaknesses in the paper, many of which can be addressed textually. Some of the supporting evidence is preliminary and would benefit from additional experimental validation and clearer presentation before the conclusions can be considered fully supported. In particular, the authors should directly test in vitro whether Taxol addition can induce lattice exchange (see comments below).

      We thank the reviewer for their positive response to our work. We have altered the text and provided additional experimental validation as requested (see below).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The resolution of the figures is insufficient.

      (2) The provision of scale bars is inconsistent and insufficient.

      (3) Figure 1E, the scale bar looks like an MT.

      (4) Figure 2C, what does the grey bar indicate?

      (5) Figure 2E, missing scale bar.

      (6) Figure 3 C, D, significance brackets misaligned.

      (7) Figure 3E, consider using the same alpha-beta tubulin / MT graphic as in Figure 1B.

      (8) Figure 5E, show cell boundaries for consistency?

      (9) Figure 6D, stray box above the y-axis.

      (11) Figure S3A, scale bar wrong unit again.

      (12) S3B "fixed" and mount missing scale bar in the inset.

      (13) S4 scale bars without scale, inconsistency in scale bars throughout all the figures.

      We apologize for issues with the figures. We have corrected all of the issues indicated by the reviewer.

      (10) Figure 6F, surprising that 300 mM KCL washes out rigor binding kinesin

      We thank the reviewer for this important point. To address the reviewer’s concern, we have added a new supplementary figure (new Figure 6 – Figure Supplement 1) which shows that the washing step removes strongly-bound (apo) KIF5C(1-560)-Halo<sup>554</sup> protein from the microtubules. In addition, we have made a correction to the Materials and Methods section noting that ATP was added in addition to the KCl in the wash buffer. We apologize for omitting this detail in the original submission. We also added text noting that the wash out step was based on Shima et al., 2018 where the observation chamber was washed with either 1 mM ATP and 300 mM K-Pipes or with 10 mM ATP and 500 mM K-Pipes buffer. In our case, the chamber was washed with 3 mM ATP and 300 mM KCl. It is likely that the addition of ATP facilitates the detachment of strongly-bound KIF5C.

      (14) Supplementary movie, please identify alpha and beta tubules for clarity. Please identify residues lighting up in interaction sites 1,2 & 3.

      Thank you for the suggestions. We have made the requested changes to the movie.

      Reviewer #2 (Recommendations for the authors):

      There appear to have been some minor issues (perhaps with .pdf conversion) that leave some text and images pixelated in the .pdf provided, alongside some slightly jarring text and image positioning (e.g., Figure 5E panels). The authors should carefully look at the figures to ensure that they are presented in the clearest way possible.

      We apologize for these issues with the figures. We have reviewed the figures carefully to ensure that they are presented in the clearest way possible.

      The authors might consider providing a more definitive structural description of compact vs expanded lattice, highlighting what specific parameters are generally thought to change and by what magnitude. Do these differ between taxol-mediated expansion or the effects of MAPs?

      Thank you for the suggestion. We have added additional information to the Introduction section.

      Reviewer #3 (Recommendations for the authors):

      (1) Figure 1 should include a schematic overview of all constructs used in the study. A clear illustration showing the probe design, including the origin and function of each component (e.g., tags, domains), would improve clarity.

      Thank you for the suggestion. We have added new illustrations to Figure 1 showing the origin and design (including domains and tags) of each probe.

      (2) Add Western blot data for the 4×CAP-Gly construct to Figure 1C for completeness.

      We thank the reviewer for this suggestion. We carried out a far-western blot using the purified 4xCAPGly-mEGFP protein to probe GST-Y, GST-DY, and GST-DC2 proteins (new Figure 1 – Figure Supplement 1C). We note that some bleed-through signal can be seen in the lanes containing GST-ΔY and GST-ΔC2 protein due to the imaging requirements and exposure needed to visualize the 4xCAPGly-mEGFP protein. Nevertheless, the blot shows that the purified CAPGly sensor specifically recognizes the native (tyrosinated) CTT sequence of TUBA1A.

      (3) Essential background information on the CAP-Gly domain, SXIP motif, and EB proteins is missing from the Introduction. These concepts appear abruptly in the Results and should be properly introduced.

      Thank you for the suggestion. We have added additional information to the Introduction section about the CAP-Gly domain. However, we feel that introducing the SXIP motif and EB proteins at this point would detract from the flow of the Introduction and we have elected to retain this information in the Results section when we detail development of the 4xCAPGly probe.

      (4) In Figure 2E, it remains possible that the CAP-Gly domain displacement simply follows the displacement of EB proteins. An experiment comparing EB protein localization upon Taxol treatment would clarify this relationship.

      We thank the reviewer for raising this important point. To address the reviewer’s concern, we utilized HeLa cells stably expressing EB3-GFP. We performed live-cell imaging before and after Taxol addition (new Figure 2 – Figure Supplement 1C). EB3-EGFP was lost from the microtubule plus ends within minutes and did not localize to the now-expanded lattice.

      (5) Statements such as "significantly increased" (e.g., line 195) should be replaced with quantitative information (e.g., "1.5-fold increase").

      We have made the suggested changes to the text.

      (6) Phrases like "became accessible" should be revised to "became more accessible," as the observed changes are relative, not absolute. The current wording implies a binary shift, whereas the data show a modest (~1.5-fold) increase.

      We have made the suggested changes to the text.

      (7) Similarly, at line 209, the terms "minimally accessible" versus "accessible" should be rephrased to reflect the small relative change observed; saturation of accessibility is not demonstrated.

      We have made the suggested changes to the text.

      (8) Statements that MAP7 "expands the lattice" (line 222) should be made cautiously; to my knowledge, that has not been clearly established in the literature.

      We thank the reviewer for this important comment. We have added text indicating that MAP7’s ability to induce or presence an expanded lattice has not been clearly established.

      (9) In Figures 3 and 4, the overexpression of MAP7 results in a strikingly peripheral microtubule network. Why is there this unusual morphology?

      The reviewer raises an interesting question. We are not sure why the overexpression of MAP7 results in a strikingly peripheral microtubule network but we suspect this is unique to the HeLa cells we are using. We have observed a more uniform MAP7 localization in other cell types [e.g. COS-7 cells (Tymanskyj et al. 2018), consistent with the literature [e.g. BEAS-2B cells (Shen and Ori-McKenney 2024), HeLa cells (Hooikaas et al. 2019)].

      (10) In Supplementary Figure 5C, the Western blot of detyrosination levels is inconsistent with the text. Untreated cells appear to have higher detyrosination than both wild-type and E254A-overexpressing cells. Do you have any explanation?

      We thank the reviewer for this important comment. We do not have an explanation at this point but plan to revisit this experiment. Unfortunately, the authors who carried out this work recently moved to a new institution and it will be several months before they are able to get the cell lines going and repeat the experiment. We thus elected to remove what was Supp Fig 5C until we can revisit the results. We believe that the important results are in what is now Figure 5 - Figure Supplement 1A,B which shows that the expression levels of the WT and E254E proteins are similar to each other.

      (11) The image analysis method in Figures 5B and 5D requires clarification. It appears that "density" was calculated from skeletonized probe length over total area, potentially using a strict intensity threshold. It looks like low-intensity binding has been excluded; otherwise, the density would be the same from the images. If so, this should be stated explicitly. A more appropriate analysis might skeletonize and integrate total fluorescence intensity relative to the overall microtubule network.

      We have added additional information to the Materials and Methods section to clarify the image analysis. We appreciate the reviewer’s valuable feedback and the suggestion to use the integrated total fluorescence intensity, which is a theoretically sound approach. While we agree that integrated intensity is a valid metric for specific applications, its appropriate use depends on two main preconditions:

      (1) Consistent microscopy image acquisition conditions.

      (2) Consistent probe expression levels across all cells and experiments.

      We successfully maintained consistent image acquisition conditions (e.g., exposure time) throughout the experiment. However, despite generating a stably-expressing sensor cell lines to minimize variation, there remains an inherent, biological variability in probe expression levels between individual cells. Integrated intensity is highly susceptible to this cell-to-cell variability. Relying on it would lead to a systematic error where differences in the total amount of expressed probe would be mistaken for differences in Y-aCTT accessibility.

      The density metric (skeletonized probe length / total cell area) was deliberately chosen as it serves as a geometric measure rather than an intensity-based normalization. The density metric quantifies the proportion of the microtubule network that is occupied by Y-aCTT-labeled structures, independent of fluorescence intensity. Thus, the density metric provides a more robust and interpretable measure of Y-aCTT accessibility under the variable expression conditions inherent to our experimental system. Therefore, we believe that this geometric approach represents the most appropriate analysis for our image dataset.

      (12) In Figure 5D, the fold-change data are difficult to interpret due to the compressed scale. Replotting is recommended. The text should also discuss the relative fold changes between E254A and Taxol conditions, Figure 2H.

      We appreciate the reviewer's insightful comment. We agree that the presence of significant outliers led to a compressed Y-axis scale in Figure 5D, obscuring the clear difference between the WT-tubulin and E254A-tubulin groups. As suggested, we have replotted Figure 5D using a broken Y-axis to effectively expand the relevant lower range of the data while still accurately representing all data points, including the outliers. We believe that the revised graph significantly enhances the clarity and interpretability of these results. For Figure 2, we have added the relative fold changes to the text as requested.

      (13) Figure 6. The authors should directly test in vitro whether Taxol addition can induce lattice exchange, for example, by adding Taxol to GDP-microtubules and monitoring probe binding. Including such an assay would provide critical mechanistic evidence and substantially strengthen the conclusions. I was waiting for this experiment since Figure 2.

      We thank the reviewer for this suggestion. As suggested, we generated GDP-MTs from HeLa tubulin and added it to two flow chambers. We then flowed in the YL1/2<sup>Fab</sup>-EGFP probe into the chambers in the presence of DMSO (vehicle control) or Taxol. Static images were taken and the fluorescence intensity of the probe on microtubules in each chamber was quantified. There was a slight but not statistically significant difference in probe binding between control and Taxol-treated GDP-MTs (Author response image 1). While disappointing, these results underscore our conclusion (Discussion section) that microtubule assembly in vitro may not produce a lattice state resembling that in cells, either due to differences in protofilament number and/or buffer conditions and/or the lack of MAPs during polymerization.

      Author response image 1.

      References

      Hooikaas, P. J., Martin, M., Muhlethaler, T., Kuijntjes, G. J., Peeters, C. A. E., Katrukha, E. A., Ferrari, L., Stucchi, R., Verhagen, D. G. F., van Riel, W. E., Grigoriev, I., Altelaar, A. F. M., Hoogenraad, C. C., Rudiger, S. G. D., Steinmetz, M. O., Kapitein, L. C. and Akhmanova, A. (2019). MAP7 family proteins regulate kinesin-1 recruitment and activation. J Cell Biol, 218, 1298-1318.

      Shen, Y. and Ori-McKenney, K. M. (2024). Microtubule-associated protein MAP7 promotes tubulin posttranslational modifications and cargo transport to enable osmotic adaptation. Dev Cell, 59, 1553-1570.

      Tymanskyj, S. R., Yang, B. H., Verhey, K. J. and Ma, L. (2018). MAP7 regulates axon morphogenesis by recruiting kinesin-1 to microtubules and modulating organelle transport. Elife, 7.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript uses primarily simulation tools to probe the pathway of cholesterol transport with the smoothened (SMO) protein. The pathway to the protein and within SMO is clearly discovered, and interactions deemed important are tested experimentally to validate the model predictions.

      Strengths:

      The authors have clearly demonstrated how cholesterol might go from the membrane through SMO for the inner and outer leaflets of a symmetrical membrane model. The free energy profiles, structural conformations, and cholesterol-residue interactions are clearly described.

      We thank the reviewer for their kind words.

      (1) Membrane Model: The authors decided to use a rather simple symmetric membrane with just cholesterol, POPC, and PSM at the same concentration for the inner and outer leaflets. This is not representative of asymmetry known to exist in plasma membranes (SM only in the outer leaflet and more cholesterol in this leaflet). This may also be important to the free energy pathway into SMO. Moreover, PE and anionic lipids are present in the inner leaflet and are ignored. While I am not requesting new simulations, I would suggest that the authors should clearly state that their model does not consider lipid concentration leaflet asymmetry, which might play an important role.

      We thank the reviewer for their comment. Membrane asymmetry is inherent in endogenous systems; we acknowledge that as a limitation of our current model. We have addressed the comment by adding this limitation to our discussion in the manuscript.

      Added lines: (End of paragraph 6, Results subsection 2):

      “One possibility that might alter the thermodynamic barriers is native membrane asymmetry, particularly the anionic lipid-rich inner leaflet. This presents as a limitation of our current model.”

      (2) Statistical comparison of barriers: The barriers for pathways 1 and 2 are compared in the text, suggesting that pathway 2 has a slightly higher barrier than pathway 1. However, are these statistically different? If so, the authors should state the p-value. If not, then the text in the manuscript should not state that one pathway is preferred over the other.

      We thank the reviewer for their comment. We have added statistical t-tests for the barriers.

      Changes made: (Paragraph 6, Results subsection 2)

      “However, we also observe that pathway 1 shows a lower thermodynamic barrier (5.8 ± 0.7 kcal/mol v/s 6.5 ± 0.8 kcal/mol, p = 0.0013)”

      (3) Barrier of cholesterol (reasoning): The authors on page 7 argue that there is an enthalpy barrier between the membrane and SMO due to the change in environment. However, cholesterol lies in the membrane with its hydroxyl interacting with the hydrophilic part of the membrane and the other parts in the hydrophobic part. How is the SMO surface any different? It has both characteristics and is likely balanced similarly to uptake cholesterol. Unless this can be better quantified, I would suggest that this logic be removed.

      We thank the reviewer for this suggestion. We have removed the line to avoid confusion.

      Reviewer #2 (Public review):

      Summary:

      In this work, the authors applied a range of computational methods to probe the translocation of cholesterol through the Smoothened receptor. They test whether cholesterol is more likely to enter the receptor straight from the outer leaflet of the membrane or via a binding pathway in the inner leaflet first. Their data reveal that both pathways are plausible but that the free energy barriers of pathway 1 are lower, suggesting this route is preferable. They also probe the pathway of cholesterol transport from the transmembrane region to the cysteine-rich domain (CRD).

      Strengths:

      (1) A wide range of computational techniques is used, including potential of mean force calculations, adaptive sampling, dimensionality reduction using tICA, and MSM modelling. These are all applied rigorously, and the data are very convincing. The computational work is an exemplar of a well-carried out study.

      (2) The computational predictions are experimentally supported using mutagenesis, with an excellent agreement between their PMF and mRNA fold change data.

      (3) The data are described clearly and coherently, with excellent use of figures. They combine their findings into a mechanism for cholesterol transport, which on the whole seems sound.

      (4) The methods are described well, and many of their analysis methods have been made available via GitHub, which is an additional strength.

      Weaknesses:

      (1) Some of the data could be presented a little more clearly. In particular, Figure 7 needs additional annotation to be interpretable. Can the position of the cholesterol be shown on the graph so that we can see the diameter change more clearly?

      We thank the reviewer for this suggestion. We have added the cholesterol positions as requested.

      Changes made: (Caption, Figure 7)

      “The tunnel profile during cholesterol translocation in SMO. (a) Free energy plot of the zcoordinate v/s the tunnel diameter when cholesterol is present in the core TMD. The tunnel shows a spike in the radius in the TMD domain, indicating the presence of a cholesterol-accommodating cavity. (b) Representative figure for the tunnel when a cholesterol molecule is in the TMD. (c) Same as (a), when cholesterol is at the TMD-CRD interface. (e) same as (b), when cholesterol is at the TMD-CRD interface. (e) same as (a), when cholesterol is at the CRD binding site. (f) same as (b), when cholesterol is at the CRD binding site. Tunnel diameters shown as spheres. Cholesterol positions marked on plots using dotted lines. All snapshots presented are frames taken from MD simulations.”

      (2) In Figure 3C, it doesn’t look like the Met is constricting the tunnel at all. What residue is constricting the tunnel here? Can we see the Ala and Met panels from the same angle to compare the landscapes? Or does the mutation significantly change the tunnel? Why not A283 to a bulkier residue? Finally, the legend says that the figure shows that cholesterol can still pass this residue, but it doesn’t really show this. Perhaps if the HOLE graph was plotted, we could see the narrowest point of the tunnel and compare it to the size of cholesterol.

      We thank the reviewer for this suggestion. A283 was mutated to methionine as it presents with a longer heavy tail containing sulfur. We have plotted the tunnel radii for both WT and A283M mutants and added them as a supplemental figure. As shown in the figure, the presence of methionine doesn’t completely block the tunnel, but occludes it, thereby increasing the barrier for cholesterol transport slightly.

      Changes made: (End of Results subsection 1)

      “When we calculated the PMF for cholesterol entry, A<sup>2.60f</sup>M mutant showed restricted tunnel but it did not fully block the tunnel (Figure 3—figure Supplement 3).”

      (3) The PMF axis in 3b and d confused me for a bit. Looking at the Supplementary data, it’s clear that, e.g., the F455I change increases the energy barrier for chol entering the receptor. But in 3d this is shown as a -ve change, i.e., favourable. This seems the wrong way around for me. Either switch the sign or make this clearer in the legend, please.

      We thank the reviewer for this suggestion. We measured ∆PMF as PMF<sub>WT</sub> PMF<sub>mutant</sub>, hence the negative values. We have added additional text to the legend to clarify this.

      Changes made: (Caption, Figure 3)

      “(b) ∆Gli1 mRNA fold change (high SHH vs untreated) and ∆ PMF (difference of peak PMF , calculated as PMF<sub>WT</sub> - PMF<sub>mutant</sub>) plotted for the mutants in Pathway 1. (c) Example mutant A<sup>2_._60f</sup>M shows that cholesterol can enter SMO through Pathway 1 even on a bulky mutation. (d) Same as (b) but for Pathway 2 (e) Example mutant L<sup>5.62f</sup>A shows that cholesterol can enter SMO through Pathway 2 due to lesser steric hindrance. All snapshots presented are frames taken from MD simulations.”

      Changes made: (Caption, Figure 6)

      “(b) ∆Gli1 mRNA fold change (high SHH vs untreated) and ∆ PMF (difference of peak PMF, calculated as PMF<sub>WT</sub> - PMF<sub>mutant</sub>) plotted for mutants along the TMD-CRD pathway. (c, d) Example mutants Y<sup>LD</sup>A and F<sup>5.65f</sup>A show that cholesterol is unable to translocate through this pathway because of the loss of crucial hydrophobic contacts provided by Y207 and F484 and along the solvent-exposed pathway.”

      (4) The impact of G280V is put down to a decrease in flexibility, but it could also be a steric hindrance. This should be discussed.

      We thank the reviewer for this suggestion. We have added it as a possible mechanism of the decrease in activity of SMO.

      Changes made: (Paragraph 5, Results subsection 1)

      “We mutated G280<sup>2.57f</sup>  to valine - G<sup>2.57f</sup>V to test whether reducing the flexibility of TM2 prevents cholesterol entry into the TMD. Consequently, the activity of mSMO showed a decrease. However, this decrease could also be attributed to steric hindrance added by the presence of a bulky propyl group in valine.”

      (5) Are the reported energy barriers of the two pathways (5.8plus minus0.7 and 6.5plus minus0.8 kcal/mol) significantly and/or substantially different enough to favour one over the other? This could be discussed in the manuscript.

      We thank the reviewer for this suggestion. We have added statistical t-tests for the barriers.

      Changes made: (Paragraph 6, Results subsection 2)

      “However, we also observe that pathway 1 shows a lower thermodynamic barrier (5.8 ± 0.7 kcal/mol v/s 6.5 ± 0.8 kcal/mol, p = 0.001)”

      (6) Are the energy barriers consistent with a passive diffusion-driven process? It feels like, without a source of free energy input (e.g., ion or ATP), these barriers would be difficult to overcome. This could be discussed.

      We thank the reviewer for this suggestion. We have added a discussion to further clarify this point.

      Discussion: (Paragraph 6, Results subsection 2)

      “These values are comparable to ATP-Binding Cassette (ABC) transporters of membrane lipids, which use ATP hydrolysis (-7.54 ± 0.3 kcal/mol) (Meurer et al., 2017) to drive lipid transport from the membrane to an extracellular acceptor. Some of these transporters share the same mechanism as SMO, where the lipid from the inner leaflet is flipped and transported to the extracellular acceptor protein (Tarling et al., 2013). Additionally, for secondary active transporters that do not use ATP for the transport of substrates, a thermodynamic barrier of 5-6 kcal/mol has been reported in literature. (Chan et al., 2022; Selvam et al., 2019; McComas et al., 2023; Thangapandian et al., 2025).”

      (7) Regarding the kinetics from MSM, it is stated that the values seen here are similar to MFS transporters, but this then references another MSM study. A comparison to experimental values would support this section a lot.

      We thank the reviewer for this suggestion. We have added a discussion discussing millisecond-scale timescales measured for MFS transporters.

      Changes made: (Paragraph 2, Results subsection 5)

      “These timescales are comparable to the substrate transport timescales of Major Facilitator Superfamily (MFS) transporters (Chan et al., 2022). Furthermore, several experimental studies have also resolved the millisecond-scale kinetics of MFS transporters (Blodgett and Carruthers, 2005; Körner et al., 2024; Bazzone et al., 2022; Smirnova et al., 2014; Zhu et al., 2019), further corroborating the results from our study.”

      Reviewer #2 (Recommendations for the authors):

      (1) The heatmaps in Figures 2a and 4a are great. On these, an arrow denotes what looks like a minimum energy path. Is it possible to see this plotted, as this might show the height of the energy barriers more clearly?

      We thank the reviewer for this suggestion. We have computed the minimum energy paths for both pathways and presented them in a supplementary figure.

      Added lines: (Paragraph 4, Results subsection 1):

      For further clarity, we have plotted the minimum energy path taken by cholesterol as it translocates along this pathway (Figure 2—figure Supplement 3)a,b)

      Added lines: (Paragraph 4, Results subsection 2):

      For further clarity, we have plotted the minimum energy path taken by cholesterol as it translocates along this pathway (Figure 2—figure Supplement 3)c,d)

      (2) The tiCA data in S15 is first referred to on line 137, but the technique isn’t introduced until line 222. This makes understanding the data a little confusing. Reordering this might improve readability.

      We thank the reviewer for this suggestion. We have reordered the text to make it clearer.

      Changes made: (Paragraph 2, Results subsection 1) This provides evidence for multiple stable poses along the pathway as observed in the multiple stable poses of cholesterol in Cryo-EM structures of SMO bound to sterols (Deshpande et al., 2019; Qi et al., 2019b, 2020). A reliable estimate of the barriers comes from using the time-lagged Independent Components (tICs), which project the entire dataset along the slowest kinetic degrees of freedom. Overall, the highest barrier along Pathway 1 is 5.8 ± 0.7 kcal/mol, and it is associated with the entry of cholesterol into the TMD (Figure 2—Figure Supplement 2).

      Changes made: (Paragraph 3, Results subsection 2)

      “On plotting the first two components of tICs, (Figure 2—Figure Supplement 2), we observe that the energetic barrier between η and θ is ∼6.5 ± 0.8 kcal/mol.”

      (3) Missing bracket on line 577.

      We thank the reviewer for this suggestion. The typo has been fixed.

      (4) Line 577: Fig. S2nd?

      We thank the reviewer for this suggestion. This typo has been fixed.

      Reviewer #3 (Public review):

      Summary:

      This manuscript presents a study combining molecular dynamics simulations and Hedgehog (Hh) pathway assays to investigate cholesterol translocation pathways to Smoothened (SMO), a G protein-coupled receptor central to Hedgehog signal transduction. The authors identify and characterize two putative cholesterol access routes to the transmembrane domain (TMD) of SMO and propose a model whereby cholesterol traverses through the TMD to the cysteine-rich domain (CRD), which is presented as the primary site of SMO activation. The MD simulations and biochemical experiments are carefully executed and provide useful data.

      Weaknesses:

      However, the manuscript is significantly weakened by a narrow and selective interpretation of the literature, overstatement of certain conclusions, and a lack of appropriate engagement with alternative models that are well-supported by published data-including data from prior work by several of the coauthors of this manuscript. In its current form, the manuscript gives a biased impression of the field and overemphasizes the role of the CRD in cholesterol-mediated SMO activation. Below, I provide specific points where revisions are needed to ensure a more accurate and comprehensive treatment of the biology.

      (1) Overstatement of the CRD as the Orthosteric Site of SMO Activation

      The manuscript repeatedly implies or states that the CRD is the orthosteric site of SMO activation, without adequate acknowledgment of alternative models. To give just a few examples (of many in this manuscript):

      (a) “PTCH is proposed to modulate the Hh signal by decreasing the ability of membrane cholesterol to access SMO’s extracellular cysteine-rich domain (CRD)” (p. 3).

      (b) “In recent years, there has been a vigorous debate on the orthosteric site of SMO” (p. 3).

      (c) “cholesterol must travel through the SMO TMD to reach the orthosteric site in the CRD” (p. 4).

      (d) “we observe cholesterol moving along TM6 to the TMD-CRD interface (common pathway, Fig. 1d) to access the orthosteric binding site in the CRD” (p. 6).

      While the second quote in this list at least acknowledges a debate, the surrounding text suggests that this debate has been entirely resolved in favor of the CRD model. This is misleading and not reflective of the views of other investigators in the field (see, for example, a recent comprehensive review from Zhang and Beachy, Nature Reviews Molecular and Cell Biology 2023, which makes the point that both the CRD and 7TM sites are critical for cholesterol activation of SMO as well as PTCH-mediated regulation of SMO-cholesterol interactions).

      In contrast, a large body of literature supports a dual-site model in which both the CRD and the TMD are bona fide cholesterol-binding sites essential for SMO activation. Examples include:

      (a) Byrne et al., Nature 2016: point mutation of the CRD cholesterol binding site impairs-but does not abolish-SMO activation by cholesterol (SMO D99A, Y134F, and combination mutants - Fig 3 of the 2016 study).

      (b) Myers et al., Dev Cell 2013 and PNAS 2017: CRD deletion mutants retain responsiveness to PTCH regulation and cholesterol mimetics (similar Hh responsiveness of a CRD deletion mutant is also observed in Fig. 4 Byrne et al, Nature 2016).

      (c) Deshpande et al., Nature 2019: mutation of residues in the TMD cholesterol binding site blocks SMO activation entirely, strongly implicating the TMD as a required site, in contrast to the partial effects of mutating or deleting the CRD site.

      Qi et al., Nature 2019, and Deshpande et al., Nature 2019, both reported cholesterol binding at the TMD site based on high-resolution structural data. Oddly, Deshpande et al., Nature 2019, is not cited in the discussion of TMD binding on p. 3, despite being one of the first papers to describe cholesterol in the TMD site and its necessity for activation (the authors only cite it regarding activation of SMO by synthetic small molecules).

      Kinnebrew et al., Sci Adv 2022 report that CRD deletion abolished PTCH regulation, which is seemingly at odds with several studies above (e.g., Byrne et al, Nature 2016; Myers et al, Dev Cell 2013); but this difference may reflect the use of an N-terminal GFP fusion to SMO in the Kinnebrew et al 2022, which could alter SMO activation properties by sterically hindering activation at the TMD site by cholesterol (but not synthetic SMO agonists like SAG); in contrast, the earlier work by Byrne et al is not subject to this caveat because it used an untagged, unmodified form of SMO.

      Although overexpression of PTCH1 and SMO (wild-type or mutant) has been noted as a caveat in studies of CRD-independent SMO activation by cholesterol, this reviewer points out that several of the studies listed above include experiments with endogenous PTCH1 and low-level SMO expression, demonstrating that SMO can clearly undergo activation by cholesterol (as well as regulation by PTCH1) in a manner that does not require the CRD.

      Recommendation: The authors should revise the manuscript to provide a more balanced overview of the field and explicitly acknowledge that the CRD is not the sole activation site. Instead, a dual-site model is more consistent with available structural, mutational, and functional data. In addition, the authors should reframe their interpretation of their MD studies to reflect this broader and more accurate view of how cholesterol binds and activates SMO.

      We thank the reviewer for this comprehensive overview of the existing literature. We agree that cholesterol binding to both the TMD and CRD sites is required for full activation of SMO. As described below in responses to comments, we have made changes to the manuscript to make this point clear. For instance, in the revised manuscript, we refrain from calling the CRD cholesterol binding site the “orthosteric site”. Instead, we highlight that the goal of the manuscript is not to resolve the debate over whether the TMD or CRD site is more important for PTCH1 regulation by SMO but rather to use molecular dynamics to understand the fascinating question of how cholesterol in the membrane can reach the CRD, located at a significant distance above the outer leaflet of the membrane. We believe that this is an important goal since there is an abundance of evidence that supports the view that PTCH1 inhibits SMO by reducing cholesterol access to the CRD. This evidence is now summarized succinctly in the introduction:

      Changes made: (Paragraph 4, Introduction)

      “While cholesterol binding to both the TMD and CRD sites is required for full SMO activation, our work focuses on how cholesterol gains access to the CRD site, perched above the outer leaflet of the membrane (Luchetti et al., 2016; Kinnebrew et al., 2022). Multiple lines of evidence suggest that PTCH1-regulated cholesterol binding to the CRD plays an instructive role in SMO regulation both in cells and animals. Mutations in residues predicted to make hydrogen bonds with the hydroxyl group of cholesterol bound to the CRD reduced both the potency and efficacy of SHH in cellular signaling assays (Kinnebrew et al., 2022; Byrne et al., 2016) and, more importantly, eliminated HH signaling in mouse embryos (Xiao et al., 2017). Experiments using both covalent and photocrosslinkable sterol probes in live cells directly show that PTCH1 activity reduces sterol access to the CRD (Kinnebrew et al., 2022; Xiao et al., 2017). Notably, our simulations evaluate a path of cholesterol translocation that includes both the TMD and CRD sites: cholesterol first enters the 7-transmembrane domain bundle from the membrane; it then engages the TMD site before continuing along a conduit to the CRD site. Thus, we analyze translocation energetics and residue-level contacts along a path that includes both the TMD and the CRD.”

      However, Reviewer 3 makes several comments below that are biased, inaccurate, or selective. We feel it is important to address these so readers can approach the literature from a balanced perspective. Indeed, the eLife review forum provides an ideal venue to present contrasting views on a scientific model. We encourage the editors to publish both Reviewer 3’s comments and our response in full so readers can read the original papers and reach their own conclusions. It is important to note these issues are not relevant to the quality of the computational and experimental data presented in this paper.

      We have now removed the term “orthosteric” to describe the CRD site throughout the paper and clearly state in the introduction that “both the CRD and TMD sites are required for SMO activation” but that our focus is on how cholesterol moves from the membrane to the CRD site. There is no doubt that cholesterol binding to the CRD plays a key role in SMO activation– our focus on this path is justified and does not devalue the importance of the TMD site. Our prior models (see Figure 7 of Kinnebrew 2022 explicitly include contributions of both sites).

      Now we respond to some of the concerns outlined, individually:

      (1) Byrne et al., Nature 2016: point mutation of the CRD cholesterol binding site impairs-but does not abolish-SMO activation by cholesterol (SMO D99A, Y134F, and combination mutants - Fig 3 of the 2016 study)

      The fact that a point mutation dramatically diminishes (but does not abolish signaling) does not mean that the CRD cholesterol binding site is not important for SMO regulation. Indeed, the reviewer fails to mention that Song et. al. (Molecular Cell, 2017) found that a SMO protein carrying a subtle mutation at D99 (D95/99N, a residue that makes a hydrogen bond with the cholesterol hydroxyl) completely abolishes SMO signaling in mouse embryos. Thus, the CRD site is critical for SMO activation in an intact animal, justifying our focus on evaluating the path of cholesterol translocation to the CRD site.

      (2) Myers et al., Dev Cell 2013 and PNAS 2017: CRD deletion mutants retain responsiveness to PTCH regulation and cholesterol mimetics (similar Hh responsiveness of a CRD deletion mutant is also observed in Fig 4 Byrne et al, Nature 2016).

      The Reviewer fails to note that CRD-deleted versions of SMO have markedly (>10-fold) higher basal (i.e. ligand-independent) activity compared to full-length SMO. The response to SHH is minimal (∼2-fold), compared to >50-100-fold with full-length SMO. Thus, CRD-deleted SMO is likely in a non-native conformation. Local changes in cholesterol accessibility caused by PTCH1 inactivation or cholesterol loading can cause small fluctuations in delta-CRD activity, but this cannot be used to infer meaningful insights about how native, full-length SMO (with >10-fold lower basal activity) is regulated. We encourage the reviewer to read our previous paper (Kinnebrew et. al. 2022), which presents a unified view of how the TMD and CRD sites together regulate SMO activation.

      A more physiological experiment, reported in Kinnebrew et. al. 2022, tested mutations in residues that make hydrogen bonds with cholesterol at the CRD and TMD sites in the context of full-length SMO. These mutants were stably expressed at moderate levels in Smo<sup>−/−</sup> cells. Mutations at the CRD site reduced the fold-increase in signaling output in response to SHH, as would be expected for a PTCH1-regulated site. In contrast, analogous mutations in the TMD site reduced the magnitude of both basal and maximal signaling, without affecting the fold-change in response to SHH. In signaling assays, the key parameter in evaluating the impact of a mutation is whether it impacts the change in output in response to a signal (in this case PTCH1 inactivation by SHH). A mutation in SMO that affects PTCH1 regulation is expected to decrease the fold-change in signaling in response to SHH, a criterion that is fulfilled by mutations in the CRD site. Accordingly, mutations in the CRD site abolish SMO signaling in mouse embryos (Xiao et al., 2017).

      (3) Deshpande et al., Nature 2019: mutation of residues in the TMD cholesterol binding site blocks SMO activation entirely, strongly implicating the TMD as a required site, in contrast to the partial effects of mutating or deleting the CRD site.

      Introduction of bulky mutations at the TMD site (V333F) that abolish SMO activity were first reported by Byrne et. al. 2016 and were used to markedly increase the stability of SMO for protein expression. These mutations indeed stabilize the inactive state of SMO, increasing protein abundance and completely preventing its localization at primary cilia. SMO variants carrying such bulky mutations cannot be used to infer the importance of the TMD site since they do not distinguish between the following possibilities: (1) SMO is inactive because the sterol cannot bind, or (2) SMO is inactive because it is locked in an inactive conformation, or (3) SMO is inactive because it cannot localize to primary cilia (where it must be localized to activate downstream signaling).

      As described in Response 3.3, a better evaluation of the importance of the TMD site is the use of mutations in residues that make hydrogen bonds with the hydroxyl group of TMD cholesterol. These mutations do not markedly increase protein stability or prevent ciliary localization (Kinnebrew 2022, Fig.S2). While a TMD site mutation decreases the magnitude of maximal (and basal) SMO signaling, it does not impact the fold-increase in signal output in response to Hh ligands (the key parameter that should be used to evaluate PTCH1 activity).

      (4) Qi et al., Nature 2019, and Deshpande et al., Nature 2019, both reported cholesterol binding at the TMD site based on high-resolution structural data. Oddly, Deshpande et al., Nature 2019 not cited in the discussion of TMD binding on p. 3, despite being one of the first papers to describe cholesterol in the TMD site and its necessity for activation (the authors only cite it regarding activation of SMO by synthetic small molecules)

      The reference has now been added at this location in the manuscript.

      (5) Kinnebrew et al., Sci Adv 2022 report that CRD deletion abolished PTCH regulation, which is seemingly at odds with several studies above (e.g., Byrne et al, Nature 2016; Myers et al, Dev Cell 2013); but this difference may reflect the use of an N-terminal GFP fusion to SMO in the Kinnebrew et al 2022, which could alter SMO activation properties by sterically hindering activation at the TMD site by cholesterol (but not synthetic SMO agonists like SAG); in contrast, the earlier work by Byrne et al is not subject to this caveat because it used an untagged, unmodified form of SMO.

      The reviewer fails to note that CRD deleted versions of SMO have markedly (>10-fold) higher basal activity than full-length SMO. The response to SHH is minimal (∼2fold), compared to >50-fold with full-length SMO. Thus, CRD-deleted SMO is likely in a non-native conformation. Local changes in cholesterol accessibility caused by PTCH1 inactivation or cholesterol loading can cause small fluctuations in delta-CRD activity, but this cannot be used to infer meaningful insights about how native, full-length SMO (with >10-fold lower basal activity) is regulated. Please see Response 3.3 for further details.

      Reviewer 3 presents an incomplete picture of the extensive experiments reported in Kinnebrew et. al. to establish the functionality of YFP-tagged delta-CRD SMO. Most importantly, a TMDselective sterol analog (KK174) can fully activate YFP-tagged delta-CRD, showing conclusively that the YFP fusion does not block sterol access to the TMD site. The fact that this protein is nearly unresponsive to SHH highlights the critical role of the CRD-bound cholesterol in SMO regulation by PTCH1. Indeed, the YFP-tagged, CRD-deleted SMO was made purposefully to test the requirement of the CRD in a construct that had normal basal activity. Again, this data justifies the value of investigating the path of cholesterol movement from the membrane via the TMD site to the CRD.

      (6) Although overexpression of PTCH1 and SMO (wild-type or mutant) has been noted as a caveat in studies of CRD-independent SMO activation by cholesterol, this reviewer points out that several of the studies listed above include experiments with endogenous PTCH1 and low-level SMO expression, demonstrating that SMO can clearly undergo activation by cholesterol (as well as regulation by PTCH1) in a manner that does not require the CRD.

      This comment is inaccurate. The data presented in Deshpande et. al. (and prior work in Myers et. al.) used transient transfection to overexpress SMO in Smo<sup>−/−</sup> cells. At the individual cell level transient transfection produces expression levels that are markedly higher (10-1000-fold) than stable expression (in addition to being more variable). Most scientists would agree that stable expression (as used in Kinnebrew 2022) at a moderate expression level is a better system to compare mutant phenotypes, assess basal and activated signaling, and provide an accurate measure of the fold-change in signal output in response to SHH. Notably, introduction of a mutation in the CRD cholesterol binding site at the endogenous mouse Smo locus (an even better experiment than stable expression) leads to complete loss of SMO activity (PMID 28344083). This result again justifies our investigation of the pathway of cholesterol movement from the membrane to the CRD site.

      We have changed the initial discussion and reflect a more general outlook.

      Changes made: (Paragraph 1, Introduction)

      “PTCH modulates the availability of accessible cholesterol at the primary cilium and thereby regulates SMO, with models invoking effects on both the CRD and 7TM pockets.”

      Changes made: (Results subsection 3, paragraph 1)

      “According to the dual-site model, to reach the binding site in the CRD (ζ), cholesterol translocate along the TMD-CRD interface from the TM binding site (α∗) is required.”

      Added lines: (Paragraph 5, Results subsection 3):

      “The computational investigation showed here covers the dual-site model, where cholesterol reaches the CRD site via binding to the TM binding site first. In comparison to the CRD site, the TM site is more stable by ∼ 2 kcal/mol (Figure 2—Figure Supplement 3b, d).”

      Added lines: (Paragraph 2, Conclusions):

      “Here we have explored the role the CRD-site plays in SMO activation. In addition, through simulating the CRD site-dependent SMO activation hypothesis, we have also simulated the TMD site-dependent activation. We show that the overall stability of cholesterol is higher than the CRD site by ∼ 2 kcal/mol.”

      (2) Bias in Presentation of Translocation Pathways

      The manuscript presents the model of cholesterol translocation through SMO to the CRD as the predominant (if not sole) mechanism of activation. Statements such as: "Cholesterol traverses SMO to ultimately reach the CRD binding site" (p. 6) suggest an exclusivity that is not supported by prior literature in the field. Indeed, the authors’ own MD data presented here demonstrate more stable cholesterol binding at the TMD than at the CRD (p 17), and binding of cholesterol to the TMD site is essential for SMO activation. As such, it is appropriate to acknowledge that cholesterol may activate SMO by translocating through the TM5/6 tunnel, then binding to the TMD site, as this is a likely route of SMO activation in addition to the CRD translocation route they highlight in their discussion.

      The authors describe two possible translocation pathways (Pathway 1: TM2/3 entry to TMD; Pathway 2: TM5/6 entry and direct CRD transfer), but do not sufficiently acknowledge that their own empirical data support Pathway 2 as more relevant. Indeed, because their experimental data suggest Pathway 2 is more strongly linked to SMO activation, this pathway should be weighted more heavily in the authors’ discussion. In addition, Pathway 2 is linked to cholesterol binding to both the TMD and CRD sites (the former because the TMD binding site is at the terminus of the hydrophobic tunnel, the latter via the translocation pathway described in the present manuscript), so it is appropriate that Pathway 2 figures more prominently than Pathway 1 in the authors’ discussion.

      The authors also claim that "there is no experimental structure with cholesterol in the inner leaflet region of SMO TMD" (p 16). However, a structural study of apo-SMO from the Manglik and Cheng labs (Zhang et al., Nat Comm, 2022) identified a cholesterol molecule docked at the TM5/6 interface and also proposed a "squeezing" mechanism by which cholesterol could enter the TM5/6 pocket from the membrane. The authors do not consider this SMO conformation in their models, nor do they discuss the possibility that conformational dynamics at the TM5/6 interface could facilitate cholesterol flipping and translocation into the hydrophobic conduit, despite both possibilities having precedent in the 2022 empirical cryoEM structural analysis.

      Recommendation: The authors should avoid oversimplifying the SMO cholesterol activation process, either by tempering these claims or broadening their discussion to better reflect the complexity and multiplicity of cholesterol access and activation routes for SMO. They should also consider the 2022 apo-SMO cryoEM structure in their analysis of the TM5/6 translocation pathway.

      We thank the reviewer for this comprehensive overview of the existing literature and parts we have missed to include in the discussion. We agree with the reviewer, since our data shows that both pathways are probable. Through our manuscript, we have avoided using a competitive approach (that one pathway dominates over the other). Instead, we have evaluated both pathways independently and presented a comparative rather than competitive overview of both pathways from our observations. While we agree that experimental evidence suggests the inner leaflet pathway is possible, we cannot discount the observations made in previous studies that support the outer leaflet pathway, particularly Hedger et al. (2019), Bansal et al. (2023), and Kinnebrew et al. (2021). Therefore, considering the reviewer’s comments have made the following changes:

      (1) Added lines: (Paragraph 3, Conclusions):

      “We show that the barriers associated with the pathway starting from the outer leaflet are lower by ∼0.7 kcal, (p=0.0013). We also provide evidence that cholesterol can enter SMO via both leaflets, considering that multiple computational and experimental studies have found cholesterol entry sites and activation modulation via the outer leaflet, between TM2TM3. This is countered by evidence from multiple experimental and computational studies corroborating entry via the inner leaflet, between TM5-TM6, including this study. Overall, we posit that cholesterol translocation from either pathway is feasible.”

      (2)nChanges made: (Paragraph 6, Results subsection 2)

      “Based on our experimental and computational data, we conclude that cholesterol translocation can happen via either pathway. This is supported on the basis of the following observations: mutations along pathway 2 affect SMO activity more significantly, and the presence of a direct conduit that connects the inner leaflet to the TMD binding site. In addition, a resolved structure of SMO in the presence of cholesterol shows a cholesterol situated at the entry point from the membrane into the protein between TM5 and TM6, in the inner leaflet. However, we also observe that pathway 1 shows a lower thermodynamic barrier (5.8 ± 0.7 kcal/mol vs. 6.5 ± 0.8 kcal/mol, p \= 0.0013). Additionally, PTCH1 controls cholesterol accessibility in the outer leaflet. This shows that there is a possibility for transport from both leaflets. One possibility that might alter the thermodynamic barriers is native membrane asymmetry, particularly the anionic lipid-rich inner leaflet. This presents as a limitation of our current model.”

      (3)nChanges made: (Paragraph 1, Results subsection 2)

      “In a structure resolved in 2022, cholesterol was observed at the interface between the protein and the membrane, in the inner leaflet, between TMs 5 and 6. However, cholesterol in the inner leaflet has a downward orientation, with the polar hydroxyl group pointing intracellularly (η). A striking observation is that this cholesterol binding site pose was never used as a starting point for simulations and was discovered independent of the pose described in Zhang et al. (2022) (Figure 4—Figure Supplement 1).”

      (3) Alternative Possibility: Direct Membrane Access to CRD

      The possibility that the CRD extracts cholesterol directly from the membrane outer leaflet is not considered. While the crystal structures place the CRD in a stable pose above the membrane, multiple cryo-EM studies suggest that the CRD is dynamic and adopts a variety of conformations, raising the possibility that the stability of the CRD in the crystal structures is a result of crystal packing and that the CRD may be far more dynamic under more physiological conditions.

      Recommendation: The authors should explicitly acknowledge and evaluate this potential mechanism and, if feasible, assess its plausibility through MD simulations.

      We thank the reviewer for the suggestion. We have addressed this comment by calculating the distance from the lipid headgroups for each lipid in the membrane to the cholesterol binding site. We show that in our study, we do not observe any bending of the CRD over the membrane, precluding any cholesterol from being extracted from the membrane directly.

      Added lines: (Paragraph 3, Conclusions):

      “An alternative possibility states that the flexibility associated with the CRD would allow it to directly access the membrane, and consequently, cholesterol. In the extensive simulations reported in this study, the binding site of cholesterol in the CRD remains at least 20 Å away from the nearest lipid head group in the membrane, suggesting that such direct extraction and the bending of the CRD do not occur within the timescales sampled (Appendix 2 – Figure 6).

      The mechanistic details of this process are still unexplored and form the basis of future work.”

      (4) Inconsistent Framing of Study Scope and Limitations

      The discussion contains some contradictory and misleading language. For example, the authors state that "In this study we only focused on the cholesterol movement from the membrane to the CRD binding site," and then several sentences later state that "We outline the entire translocation mechanism from a kinetic and thermodynamic perspective." These statements are at odds. The former appropriately (albeit briefly) notes the limited scope of the modeling, while the latter overstates the generality of the findings.

      In addition, the authors’ narrow focus on the CRD site constitutes a major caveat to the entire work. It should be acknowledged much earlier in the manuscript, preferably in the introduction, rather than mentioned as an aside in the penultimate paragraph of the conclusion.

      Recommendation: The authors should clarify the scope of the study and expand the discussion of its limitations. They should explicitly acknowledge that the study models one of several cholesterol access routes and that the findings do not rule out alternative pathways.

      We thank the reviewer for the suggestion. We have addressed this comment by explicitly mentioning the scope of the study.

      Changes made: (Paragraph 3, Conclusions)

      “We outline the entire translocation mechanism from a kinetic and thermodynamic perspective for one of the leading hypotheses for the activation mechanism of SMO.”

      (5) Summary:

      This study has the potential to make a useful contribution to our understanding of cholesterol translocation and SMO activation. However, in its current form, the manuscript presents an overly narrow and, at times, misleading view of the literature and biological models; as such, it is not nearly as impactful as it could be. I strongly encourage the authors to revise the manuscript to include:

      (1) A more balanced discussion of the CRD vs. TMD binding sites.

      (2) Acknowledgment of alternative cholesterol access pathways.

      (3) More comprehensive citation of prior structural and functional studies.

      (4) Clarification of assumptions and scope.

      Of note, the above suggestions require little to no additional MD simulations or experimental studies, but would significantly enhance the rigor and impact of the work.

      We thank the reviewer for the suggestions. We have taken into account the literature and diverse viewpoints. We have changed the initial discussion and reflected a more general outlook. In the revised version of the manuscript, we have refrained from referring to the CRD site as the orthosteric site. Instead, we refer to it as the CRD sterol-binding site. To better represent the dual-site model, we add further discussion in the Introduction. Through our manuscript, we have avoided using a competitive approach (that one pathway dominates over the other). Instead, we have evaluated both pathways independently and presented a comparative rather than competitive overview of both pathways from our observations. We explicitly mention the scope of the study.

    1. Author response:

      We thank the reviewers for their careful reading and constructive feedback. We were glad to see that they recognized both the technical scope of the study and its contribution as the first to apply activation maximization with such fine spatial sampling. Their appreciation for the critical in vivo validation of model-derived stimuli is very encouraging.

      The reviewers raised several important points that we plan to address in the revised manuscript. These center on:

      Model Architecture and Potential Circularity:

      Both reviewers raised the concern that using a CNN-based model could introduce circularity when comparing V4 functional groups to artificial vision systems, and questioned whether similar results would emerge with alternative architectures. We believe that the in vivo verification provides a critical control for this concern: the MEIs synthesized by our model were empirically validated to elicit significantly higher responses than matched natural image controls, demonstrating that the model captures genuine biological tuning properties rather than architectural artifacts. This means that even if these features emerged from the particular architectural choice, the biological neurons seem to prefer the same features. We will clarify this point in the respective section in the revised manuscript.

      Recording locations and spike sorting contamination:

      Reviewer #2 raised concerns about potential correlation artefacts along the silicon probe. Unfortunately, assessing functional correlations across sessions proved challenging because neurons recorded at different penetration sites had non-overlapping receptive fields, precluding direct comparison of responses to identical stimuli across recording sites. We will make this limitation explicit in the manuscript. Furthermore, we maintain conservative standards for spike sorting to minimize the risk of multi-unit activity (MUA) "smearing" across unit definitions. Our primary analyses are restricted to well-isolated single units that meet all isolation metrics. Due to our low-impedance ground placed on the bone, shared-reference contamination as a source of tuning similarity is also mitigated.

      Quantitative Comparisons to Prior Literature:

      Reviewer #2 also noted that our comparisons between MEIs and known V4 tuning properties (e.g., shape, curvature, texture selectivity) were presented qualitatively, and suggested that explicit image analyses or metrics would strengthen these links to prior literature. We will revise the text to more carefully frame these comparisons as qualitative observations consistent with prior findings.

      Alternative Similarity Metrics:

      We will expand our justification for the Böhm et al. contrastive embedding approach in the Methods section. However, we believe that a systematic comparison of multiple clustering and similarity methods is beyond the scope of the current study.

      In the revised manuscript, we will address these points primarily through clarifications and expanded discussion. Specifically, we will: (1) strengthen our discussion of model architecture choice emphasizing that in vivo verification serves as a critical control against architectural artifacts; (2) clarify the stringent matching criteria underlying our closed-loop sample size and its consistency with the larger population analyses; (3) explicitly describe the recording geometry, including the use of multiple grid holes, and explain why direct functional comparisons across penetrations were precluded by non-overlapping receptive fields; (4) better characterize the spatial relationship between receptive fields and MEI masks; (5) reframe comparisons to prior V4 literature as qualitative observations rather than quantitative validations; and (6) expand our justification for the contrastive embedding approach. We believe these revisions will improve the clarity and rigor of the manuscript while appropriately scoping the claims to what the current data support.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      In this study, Ursu, Centeno, and Leblois record from the cerebellum of zebra finches and analyze neurons for auditory and song-related activity. The paper covers a lot of ground, ranging from lesions of the deep nuclei to song and white noise playback inside and outside of singing, and some level of survey of response types across cerebellar lobules, to provide foundational information on cerebellar relationships with song. There are a number of interesting observations in the study, to me most notably, the lack of responsivity of song-related activity in lobule IV to distorted auditory feedback. This observation is interesting in light of the perennial idea that the cerebellum may participate in rapid error corrections in other somatic control domains. If such a role were relevant for song, it stands to reason that some alteration of activity could be found there. Of course, on the other hand, zebra finches do not show rapid corrections during DAF, so perhaps the null result does not resolve much. Nevertheless, these data are important steps forward in establishing the involvement or lack of involvement in a broader set of brain structures beyond the song control system typically studied. While the study presents some interesting and important inroads, in my opinion, there was a general lack of 'polish' to the study that led to ambiguity in the report and confusing displays. This detracted from rigorous reporting of the findings.

      We thank reviewer #1 for his comments. We will clarify the possible misleading or ambiguous claims and interpretations in the present manuscript and polish the presentation of the results. We will also modify the discussion to better place or results within the current knowledge on cerebellum and songbirds, and in particular address the link between our findings and the low sensitivity to auditory feedback in zebra finches.

      Reviewer #2 (Public review):

      In this paper, the authors investigate the role of the cerebellum in song production in the zebra finch. First, they replicate prior studies to show that lesions of the lateral deep cerebellar nuclei (latDCN, primarily lobules IV-VII and IX) result in shorter duration syllables and song motifs than sham controls. The authors then record neural activity from the cerebellum during both passive auditory exposure in anesthetized birds and in freely singing animals. The authors claim that across multiple lobules, the cerebellum receives "non-selective" auditory inputs locked to syllable boundaries (based on acute recordings) and that cerebellar neurons display song-locked responses that are unaffected by auditory feedback perturbations (in chronic recordings). Moreover, the authors emphasized the distinct properties of lobule IV, which they argue is tightly locked to the onset and offset of syllables, and conclude that the cerebellum might contribute to the duration of song elements.

      This paper presents novel and useful descriptions of song-related neural activity in the cerebellum. However, there are multiple serious issues. First, there are major issues with the design and presentation of the analysis of the electrophysiological data; based on these, it is unclear whether the authors are justified in some of their conclusions about neural tuning or are entitled to any of their claims about the specific tuning or function of neurons in particular lobules. Second, because the authors' conceptual framework seems to ignore possible non-auditory inputs to the cerebellum, their results on (minimal) effects of auditory manipulation during singing are over-interpreted with respect to providing evidence of a forward model. Third, the paper's central assertion - that the songbird cerebellum may contribute to the duration of vocal events during song - was firmly established by a prior lesion study (Radic et al., 2024). Although the authors do cite this prior study with respect to longer-term postlesion changes after cerebellar lesions, this paper also showed a large change in syllable duration immediately after cerebellar lesion (Figure 5 in Radic et al). The electrophysiological results in the present paper could provide valuable insights into the neural mechanisms underlying this already-described role of the songbird cerebellum; however, given the other concerns above, it is not clear that the authors have done so.

      We thank reviewer #2 for these comments. We will improve the presentation of the results, in particular our cell-type classification of the electrophysiology recordings based on latest literature and  the statistics of the tuning differences between lobules. We will also modify the discussion regarding singing related internal models and consider non-auditory feedback. Finally, we will clarify the position of our work within the existing songbird literature and clarify what are the specific contributions of this work. We fully agree that prior studies have already shown the behavioural effects of lesions, as already clearly mentioned in introduction and discussion, and rather aimed at reproducing partially these results before diving into neural mechanisms. We will clarify this point in our revision.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Thank you so much for your comprehensive and insightful assessment of our manuscript. We appreciate your recognition of the novelty of our experimental design and the utility of our computational framework for interpreting visual remapping across the lifespan and in clinical populations. We are very grateful for your suggestions regarding the narrative flow, which have helped us to improve the manuscript's focus and coherence. Our responses to your specific concerns are detailed below.

      (1) Relevance of the figure-copy results (pp. 13-15). Is it necessary to include the figure-copy task results within the main text? The manuscript already presents a clear and coherent narrative without this section. The figure-copy task represents a substantial shift from the LOCUS paradigm to an entirely different task that does not measure the same construct. Moreover, the ROCF findings are not fully consistent with the LOCUS results, which introduces confusion and weakens the manuscript's coherence. While I understand the authors' intention to assess the ecological validity of their model, this section does not effectively strengthen the manuscript and may be better removed or placed in the Supplementary Materials.

      We thank the reviewer  for their perspective regarding the narrative flow and the transition between the LOCUS paradigm and the ROCF results. However, we remain keen to retain these findings in the main text, as they provide critical ecological and clinical validation for the computational mechanisms identified in our study.

      We think these results strengthen the manuscript for the following main reasons:

      (1) The ROCF we used is a standard neuropsychological tool for identifying constructional apraxia. Our results bridge the gap between basic cognitive neuroscience and clinical application by demonstrating that specific remapping parameters—rather than general memory precision—predict real-world deficits in patients.

      (2) The finding that our winning model explains approximately 62% of the variance in ROCF copy scores across all diagnostic groups further indicates that these parameters from the LOCUS task represent core computational phenotypes that underpin complex, real-life visuospatial construction (copying drawings).

      (3) Previous research has often observed only a weak or indirect link between drawing ability and traditional working memory measures, such as digit span (Senese et al., 2020). This was previously attributed to “deictic” strategies—like frequent eye and hand movements—that minimise the need to hold large amounts of information in memory (Ballard et al., 1995; Cohen, 2005; Draschkow et al., 2021). While our study was not exclusively designed to catalogue all cognitive contributions to drawing, the findings provide significant and novel evidence indicating that transsaccadic integration is a critical driver of constructional (copying drawing) ability. By demonstrating this link, the results provide evidence to stimulate a new direction for future research, shifting the focus from general memory capacity toward the precision of spatial updating across eye movements.

      In summary, by including the ROCF results in the main text, we provide evidence for a functional role for spatial remapping that extends beyond perceptual stability into the domain of complex visuomotor control. We have expanded on these points throughout the revised manuscript:

      In the Introduction: p.2:

      “The clinical relevance of these spatial mechanisms is underscored by significant disruptions to visuospatial processing and constructional apraxia—a deficit in copying and drawing figures—observed in neurodegenerative conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD).[20,21] This raises a crucial question: do clinical impairments in complex visuomotor tasks stem from specific failures in transsaccadic remapping? If so, the computational parameters that define normal spatial updating should also provide a mechanistic account of these clinical deficits, differentiating them from general age-related decline.”

      p.3: "Finally, by linking these mechanistic parameters to a standard clinical measure of constructional ability (the Rey-Osterrieth Complex Figure task), we demonstrate that transsaccadic updating represents a core computational phenotype underpinning real-world visuospatial construction in both health and neurodegeneration.

      In the Results:

      “To assess whether the mechanistic parameters derived from the LOCUS task represent core phenotypes of real-world visuospatial abilities, we also instructed all participants to complete the Rey-Osterrieth Complex Figure copy task (ROCF; Figure 7A) on an Android tablet using a digital pen (see examples in Figure 7B; all Copy data are available in the open dataset: https://osf.io/95ecp/). The ROCF is a gold-standard neuropsychological tool for identifying constructional apraxia.[29] Historically, drawing performance has shown only weak or indirect correlations with traditional working memory measures.[30] This disconnect has been attributed to active visual-sampling strategies—frequent eye movements that treat the environment as an external memory buffer, minimising the necessity of holding large volumes of information in internal working memory.[3–5]

      We hypothesised that drawing accuracy is primarily constrained by the precision of spatial updating across frequent saccades rather than raw memory capacity. To evaluate the ecological validity of the identified saccade-updating mechanism, we modelled individual ROCF copy scores across all four groups using the estimated (maximum a posteriori) parameters from the winning “Dual (Saccade) + Interference” model (Model 7; Figure 8) as regressors in a Bayesian linear model. Prior to inclusion, each regressor was normalised by dividing by the square root of its variance.

      This model successfully explained 61.99% of the variance in ROCF copy scores, indicating that these computational parameters are strong predictors of real-word constructional ability (Figure 8A). … This highlights the critical role of accurate remapping based on saccadic information; even if the core saccadic update mechanism is preserved across groups (as shown in previous analyses), the precision of this updating process is crucial for complex visuospatial tasks. Moreover, worse ROCF copy performance is associated particularly with higher initial angular encoding error. This indicates that imprecision in the initial registration of angular spatial information contributes to difficulties in accurately reproducing complex visual stimuli.”

      In the Discussion:

      “Importantly, our computational framework establishes a direct mechanistic link between trassaccadic updating and real-world constructional ability. Specifically, higher saccade and angular encoding errors contribute to poorer ROCF copy scores. By mapping these mechanistic estimates onto clinical scores, we found that the parameters derived from our winning model explain approximately 62% of the variance in constructional performance across groups. These findings suggest that the computational parameters identified in the LOCUS task represent core phenotypes of visuospatial ability, providing a mechanistic bridge between basic cognitive theory and clinical presentation.

      This relationship provides novel insights into the cognitive processes underlying drawing, specifically highlighting the role of transsaccadic working memoty.ry. Previous research has primarily focused on the roles of fine motor control and eye-hand coordination in this skill.[4,50–55] This is partly because of consistent failure to find a strong relation between traditional memory measures and copying abili [4,31] For instance, common measures of working memory, such as digit span and Corsi block tasks, do not directly predict ROCF copying performance.[31,56] Furthermore, in patients with constructional apraxia, these memory performance measures often remain relatively preserved despite significant drawing impairments.[56–58] In the literature, this lack of association has often been attributed to “deictic” visual-sampling strategies, characterised by frequent eye movements that treat the environment as an external memory buffer, thereby minimising the need to maintain a detailed internal representation.[4,59] In a real-world copying task, the ROCF requires a high volume of saccades, making it uniquely sensitive to the precision of the dynamic remapping signals identified here. Recent eye-tracking evidence confirms that patients with AD exhibit significantly more saccades and longer fixations during figure copying compared to controls, potentially as a compensatory response to trassaccadic working memory constraints.[56] This high-frequency sampling—averaging between 150 and 260 saccades for AD patients compared to approximately 100 for healthy controls—renders the task highly dependent on the precision of dynamic remapping signals.[56] To ensure this relationship was not driven by a general "g-factor" or non-spatial memory impairment, we further investigated the role of broader cognitive performance using the ACE-III Memory subscale. We found that the relationship between transsaccadic working memory and ROCF performance remains highly significant, even after controlling for age, education, and ACE-III Memory subscore. This suggests that transsaccadic updating may represent a discrete computational phenotype required for visuomotor control, rather than a non-specific proxy for global cognitive decline.

      In other words, even when visual information is readily available in the world, the act of copying depends critically on working memory across saccades. This reveals a fundamental computational trade-off: while active sampling strategies (characterised with frequent eye-hand movements) effectively reduce the load on capacity-limited working memory, they simultaneously increase the demand for precise spatial updating across eye movements. By treating the external world as an "outside" memory buffer, the brain minimises the volume of information it must hold internally, but it becomes entirely dependent on the reliability with which that information is remapped after each eye movement. This perspective aligns with, rather contradicts, the traditional view of active sampling, which posits that individuals adapt their gaze and memory strategies based on specific task demands.[3,60] Furthermore, this perspective provides a mechanistic framework for understanding constructional apraxia; in these clinical populations, the impairment may not lie in a reduced memory "span," but rather in the cumulative noise introduced by the constant spatial remapping required during the copying process.[58,61]

      Beyond constructional ability, these findings suggest that the primary evolutionary utility of high-resolution spatial remapping lies in the service of action rather than perception. While spatial remapping is often invoked to explain perceptual stability,[11–13,15] the necessity of high-resolution transsaccadic memory for basic visual perception is debated.[13,62–64] A prevailing view suggests that detailed internal models are unnecessary for perception, given the continuous availability of visual information in the external world.[13,44] Our findings support an alternative perspective, aligning with the proposal that high-resolution transsaccadic memory primarily serves action rather than perception.[13] This is consistent with the need for precise localisation in eye-hand coordination tasks such as pointing or grasping.[65] Even when unaware of intrasaccadic target displacements, individuals rapidly adjust their reaching movements, suggesting direct access of the motor system to remapping signals.66 Further support comes from evidence that pointing to remembered locations is biased by changes in eye position,[67] and that remapping neurons reside within the dorsal “action” visual pathway, rather than the ventral “perception” visual pathway.[13,68,69] By demonstrating a strong link between transsaccadic working memory and drawing (a complex fine motor skill), our findings suggest that precise visual working memory across eye movements plays an important role in complex fine motor control.”

      (2) Model fitting across age groups (p. 9).

      It is unclear whether it is appropriate to fit healthy young and healthy elderly participants' data to the same model simultaneously. If the goal of the model fitting is to account for behavioral performance across all conditions, combining these groups may be problematic, as the groups differ significantly in overall performance despite showing similar remapping costs. This suggests that model performance might differ meaningfully between age groups. For example, in Figure 4A, participants 22-42 (presumably the elderly group) show the best fit for the Dual (Saccade) model, implying that the Interference component may contribute less to explaining elderly performance.

      Furthermore, although the most complex model emerges as the best-fitting model, the manuscript should explain how model complexity is penalized or balanced in the model comparison procedure. Additionally, are Fixation Decay and Saccade Update necessarily alternative mechanisms? Could both contribute simultaneously to spatial memory representation? A model that includes both mechanisms-e.g., Dual (Fixation) + Dual (Saccade) + Interference-could be tested to determine whether it outperforms Model 7 to rule out the sole contribution of complexity.

      We thank you for the opportunity to expand upon and clarify our modelling approach. Our decision to use a common generative model for both young and older adults was grounded in the empirical finding that there was no significant interaction between age group and saccade condition for either location or colour memory. While older adults demonstrated lower baseline precision, the specific "saccade cost" remained remarkably consistent across cohorts. This was the justification we proceeded on to use of a common model to assess quantitative differences in parameter estimates while maintaining a consistent mechanistic framework for comparison.

      Moreover, our winning model nests simpler models as special cases, providing the flexibility to naturally accommodate groups where certain components—such as interference—might play a reduced role. This ultimately confirms that the mechanisms for age-related memory deficits in this task reflect more general decline rather than a qualitative failure of the saccadic remapping process.

      This approach is further supported by the properties of the Bayesian model selection (BMS) procedure we used, which inherently penalises the inclusion of unnecessary parameters. Unlike maximum likelihood methods, BMS compares marginal likelihoods, representing the evidence for a model integrated over its entire parameter space. This follows the principle of Bayesian Occam’s Razor, where a model is only favoured if the improvement in fit justifies the additional parameter space; redundant parameters instead "dilute" the probability mass and lower the model evidence.

      Consequently, we contend that a hybrid model combining fixation and saccade mechanisms is unnecessary, as we have already adjudicated between alternative mechanisms of equal complexity. Specifically, Model 6 (Dual Fixation + Interference) and Model 7 (Dual Saccade + Interference) possess an identical number of parameters. The fact that Model 7 emerged as the clear winner—providing substantial evidence against Model 6 with a Bayes Factor of 6.11—demonstrates that our model selection is driven by the specific mechanistic account of the data rather than a simple preference for complexity.

      We have revised the Results and Discussion sections of the manuscript to state these points more explicitly for readers and have included references to established literature regarding the robustness of marginal likelihoods in guarding against overfitting.

      In the Results,

      “By fitting these models to the trial-by-trial response data from all healthy participants (N=42), we adjudicated between competing mechanisms to determine which best explained participant performance (Figure 4). We used random-effects Bayesian model selection to identify the most plausible generative model. This process relies on the marginal likelihood (model evidence), which inherently balances model fit against complexity—a principle often referred to as Occam’s razor.[25–27] The analysis yielded a strong result: the “Dual (Saccade) + Interference” model (Model 7 in Table 1) emerged as the winning model, providing substantial evidence against the next best alternative with a Bayes Factor of 6.11.”

      In the Discussion:

      “Our framework employs Variational Laplace, a method used to recover computational phenotypes in clinical populations like those with substance use disorders,[34,35] and the models we fit using this procedure feature time-dependent parameterisation of variance—conceptually similar to the widely-used Hierarchical Gaussian Filter.[36–39] Importantly, the risk of overfitting is mitigated by the Bayesian Model Selection framework; by utilising the marginal likelihood for model comparison, the procedure inherently penalises excessive model complexity and promotes generalisability.[25–27,40] This generalisability was further evidenced by the model's ability to predict performance on the independent ROCF task, confirming that these parameters represent robust mechanistic phenotypes rather than idiosyncratic fits to the initial dataset.”

      Minor point: On p. 9, line 336, Figure 4A does not appear to include the red dashed vertical line that is mentioned as separating the age groups.

      Thank you for pointing out this inconsistency. We apologise for the oversight; upon further review, we concluded that the red dashed vertical line was unnecessary for the clear presentation of the data. We have therefore removed the line from Figure 4A and deleted the corresponding sentence in the figure caption.

      (3) Clarification of conceptual terminology.

      Some conceptual distinctions are unclear. For example, the relationship between "retinal memory" and "transsaccadic memory," as well as between "allocentric map" and "retinotopic representation," is not fully explained. Are these constructs related or distinct? Additionally, the manuscript uses terms such as "allocentric map," "retinotopic representation," and "reference frame" interchangeably, which creates ambiguity. It would be helpful for the authors to clarify the relationships among these terms and apply them consistently.

      Thank you for pointing this out. We have revised the manuscript to ensure that these terms are applied with greater precision and consistency. Our revisions standardise the terminology based on the following distinctions:

      Reference frames: We distinguish between the eye-centred reference frame (coordinate systems that shift with gaze) and the world-centred reference frame (coordinate systems anchored to the environment).

      Retinotopic representation vs. allocentric map: We clarify that retinotopic representations are encoded within an eye-centred reference frame and are updated with every ocular movement. Conversely, the allocentric map is anchored to stable environmental features, remaining invariant to the observer’s gaze direction or position.

      Retinotopic memory vs. transsaccadic memory: We have removed the term "retinal memory" to avoid ambiguity. We now consistently use retinotopic memory to describe the persistence of visual information in eye-centred coordinates within a single fixation. In contrast, transsaccadic memory refers to the higher-level integration of visual information across saccades, which involves the active updating or remapping of representations to maintain stability.

      To incorporate these clarifications, we have implemented the following changes:

      In the Introduction, the second paragraph has been entirely rewritten to establish these definitions at the outset, providing a clearer theoretical framework for the study.

      “Central to this enquiry is the nature of the coordinate system used for the brain's internal spatial representation. Does the brain maintain a single, world-centred (allocentric) map, or does it rely on a dynamic, eye-centred (retinotopic) representation?[11,13,15,16] In the latter system, retinotopic memory preserves spatial information within a fixation, whereas transsaccadic memory describes the active process of updating these representations across eye movements to achieve spatiotopic stability—the perception of a stable world despite eye movements.[11,16–18] If spatial stability is indeed reconstructed through such remapping, the mechanism remains unresolved: do we retain memories of absolute fixation locations, or do we reconstruct these positions from noisy memories of the intervening saccade vectors? We can test these hypotheses by analysing when and where memory errors occur. Assuming that memory precision declines over time,[19] the resulting error distributions should reveal the specific variables that are represented and updated across each saccade.”

      In the Results, the opening section of the Results has been reorganised to align with this terminology. We have ensured that the hypotheses and behavioural data—specifically the definition of "saccade cost"—are introduced using this consistent conceptual vocabulary to improve the overall coherence of the narrative.

      (4) Rationale for the selective disruption hypothesis (p. 4, lines 153-154). The authors hypothesize that "saccades would selectively disrupt location memory while leaving colour memory intact." Providing theoretical or empirical justification for this prediction would strengthen the argument.

      We have revised the Results to state the hypothesis more explicitly and expanded the Discussion to provide a robust theoretical and empirical rationale:

      In the Results,

      “This design allowed us to isolate and quantify the unique impact of saccades on spatial memory, enabling us to test competing hypotheses regarding spatial representation. If spatial memory were solely underpinned by an allocentric mechanism, precision should remain comparable across all conditions as the representation would be world-centred and unaffected by eye movements. Thus, performance in the no-saccade condition should be comparable to the two-saccade condition. Conversely, if spatial memory relies on a retinotopic representation requiring active updating across eye movements, the two-saccade condition was anticipated to be the most challenging due to cumulative decay in the memory traces used for stimulus reconstruction after each saccade.[22] Critically, we hypothesised that this saccade cost would be specific to the spatial domain; while location requires active remapping via noisy oculomotor signals, non-spatial features like colour are not inherently tied to coordinate transformations and should therefore remain stable (see more in Discussion below).

      Meanwhile, the no-saccade condition was expected to yield the most accurate localisation, relying solely on retinotopic information (retinotopic working memory). These predictions were confirmed in young healthy adults (N = 21, mean age = 24.1 years, ranged between 19 and 34). A repeated measures ANOVA revealed a significant main effect of saccades on location memory (F(2.2,43.9)=33.2, p<0.001, partial η²=0.62), indicating substantial impairment after eye movements (Figure 2A). In contrast, colour memory remained remarkably stable across all saccade conditions (Figure 2B; F(2.2, 44.7) = 0.68, p=0.53, partial η² =0.03).

      This “saccade cost”—the loss of memory precision following an eye movement—indicates that spatial representations require active updating across saccades rather than being maintained in a static, world-centred reference frame.

      Critically, our comparison between spatial and colour memory does not rely on the absolute magnitude of errors, which are measured in different units (degrees of visual angle vs. radians). Instead, we assessed the relative impact of the same saccadic demand on each feature within the same trial. While location recall showed a robust saccade cost, colour recall remained statistically unchanged. To ensure this null effect was not due to a lack of measurement sensitivity, we examined the recency effect; recall performance for the second item was predicted to be better than for the first stimulus in each condition.[23,24] As expected, colour memory for Item 2 was significantly more accurate than for Item 1 (F(1,20) = 6.52, p = 0.02, partial η² = 0.25), demonstrating that the task was sufficiently sensitive to detect standard working memory fluctuations despite the absence of a saccade-induced deficit.”

      In the Discussion, we now write that on p.18:

      “A clear finding was the specificity of the saccade cost to spatial features; it was not observed for non-spatial features like colour, even in neurodegenerative conditions. This discrepancy challenges notions of fixed visual working memory capacity unaffected by saccades.16,44–46 The differential impact on spatial versus non-spatial features in transsaccadic memory aligns with the established "what" and "where" pathways in visual processing.32,33 For objects to remain unified, object features must be bound to stable representations of location across saccades.19 One possibility is that remapping updates both features and location through a shared mechanism, predicting equal saccadic interference for both colour and location in the present study.

      However, our findings suggest otherwise. One potential concern is whether this dissociation simply reflects the inherent spatial noise introduced by fixational eye movements (FEMs), such as microssacades and drifts.47 Because locations are stored in a retinotopic frame, fixational instability necessarily shifts retinal coordinates over time. However, the "saccade cost" here was defined as the error increase relative to a no-saccade baseline of equal duration; because both conditions are subject to the same fixational drift, any FEM-induced noise is effectively subtracted out. Thus, despite the ballistic and non-Gaussian nature of FEMs,48 they cannot account for the fact the saccade cost in the spatial memory, but total absence in the colour domain. Another possibility is that this dissociation reflects differences in baseline task difficulty or dynamic range. Yet, the presence of a robust recency effect in colour memory (Figure 2B) confirms that our paradigm was sensitive to memory-dependent variance and was not limited by floor or ceiling effects.

      The fact that identical eye movements—executed simultaneously and with identical vectors—systematically degraded spatial precision while sparing colour suggests a feature-specific susceptibility to transsaccadic remapping. This supports the view that the computational process of updating an object’s location involves a vector-subtraction mechanism—incorporating noisy oculomotor commands (efference copies)—that introduces specific spatial variance. Because this remapping is a coordinate transformation, the resulting sensorimotor noise does not functionally propagate to non-spatial feature representations. Consequently, features like colour may be preserved or automatically remapped without the precision loss associated with spatial updating.11,49 Our paradigm thus provides a refined tool to investigate the architecture of transsaccadic working memory across distinct object features.”

      (5) Relationship between saccade cost and individual memory performance (p. 4, last paragraph).

      The authors report that larger saccades were associated with greater spatial memory disruption. It would be informative to examine whether individual differences in the magnitude of saccade cost correlate with participants' overall/baseline memory performance (e.g. their memory precision in the no-saccade condition). Such analyses might offer insights into how memory capacity/ability relates to resilience against saccade-induced updating.

      We have now conducted the correlation analysis to determine whether baseline memory capacity (no-saccade condition) predicts resilience to saccade-induced updating. The results indicate that these two factors are independent.

      To clarify the nature of the saccade-induced impairment, we have updated the text as follows:

      p.4: “This “saccade cost”—the loss of memory precision following an eye movement—indicates that spatial representations require active updating across saccades rather than being maintained in a static, world-centred reference frame.”

      p.5: “Further analysis examined whether individual differences in baseline memory precision (no-saccade condition) predicted resilience to saccadic disruption. Crucially, individual saccade costs (defined as the precision loss relative to baseline) did not correlate with baseline precision (rho = 0.20, p = 0.20). This suggests that the noise introduced by transsaccadic remapping acts as an independent, additive source of variance that is not modulated by an individual’s underlying memory capacity. These findings imply a functional dissociation between the mechanisms responsible for maintaining a representation and those involved in its coordinate transformation.”

      (6) Model fitting for the healthy elderly group to reveal memory-deficit factors (pp. 11-12). The manuscript discusses model-based insights into components that contribute to spatial memory deficits in AD and PD, but does not discuss components that contribute to spatial memory deficits in the healthy elderly group. Given that the EC group also shows impairments in certain parameters, explaining and discussing these outcomes of the EC group could provide additional insights into age-related memory decline, which would strengthen the study's broader conclusions.

      This is a very good point. We rewrote the corresponding results section (p.12-13):

      “Modelling reveals the sources of spatial memory deficits in healthy aging and neurodegeneration - To understand the source of the observed deficits, we applied the winning ‘Dual (Saccade) + Interference’ model the data from all participants (YC, EC, AD, and PD). By fitting the model to the entire dataset, we obtained estimates of the parameters for each individual, which then formed the basis for our group-level analysis. To formally test for group differences, we used Parametric Empirical Bayes (PEB), a hierarchical Bayesian approach that compares parameter estimates across groups while accounting for the uncertainty of each estimate [28]. This allowed us to identify which specific cognitive mechanisms, as formalised by the model parameters, were affected by age and disease.

      The Bayesian inversion used here allows us to quantify the posterior mode and variance for each parameter and the covariance for each parameter. From these, we can compute the probabilities that pairs of parameters differ from one another, which we report as P(A>B)—meaning the posterior probability that the parameter for group A was greater than that for group B.

      We first examined the specific parameters differentiating healthy elderly (EC) from young controls (YC) to isolate the factors contributing to non-pathological, age-related decline. The analysis revealed that healthy ageing is primarily characterised by a significant increase in Radial Decay (P(EC > YC) = 0.995), a heightened susceptibility to Interference (P(EC > YC) = 1.000), and a reduction in initial Angular Encoding precision (P(YC < EC) = 0.002; Figure 6). These results suggest that normal ageing degrades the fidelity of the initial memory trace and its resilience over time, while the core computational process of updating information across saccades remains intact.

      Beyond these baseline ageing effects, our clinical cohorts exhibited more severe and condition-dependent impairments. Radial decay showed a clear, graded impairment: AD patients had a greater decay rate than PD patients (P(AD > PD) = 1.000), who in turn were more impaired than the EC group (P(PD > EC) = 0.996). A similar graded pattern was observed for Interference, where AD patients were most susceptible (P(AD > PD) = 0.999), while the PD and EC groups did not significantly differ (P(PD > EC) = 0.532).

      Patients with AD also showed a tendency towards greater angular decay than controls (P(AD > EC) = 0.772), although this fell below the 95% probability threshold. This effect was influenced by a lower decay rate in the PD group compared to the EC group (P(PD < EC) = 0.037). In contrast, group differences in encoding were less pronounced. While YC exhibited significantly higher precision than all other groups, AD patients showed significantly higher angular encoding error than PD patients (P(AD > PD) = 0.985), though neither group differed significantly from the EC group.

      Crucially, parameters related to the saccade itself—saccade encoding and saccade decay—did not differentiate the groups. This indicates that neither healthy ageing nor the early stages of AD and PD significantly impair the fundamental machinery for transsaccadic remapping. Instead, the visuospatial deficits in these conditions arise from specific mechanistic failures: a faster decay of radial position information and increased susceptibility to interference, both of which are present in healthy ageing but significantly amplified by neurodegeneration.”

      In the Discussion, we added:

      “Although saccade updating was an essential component of the winning model, its two key parameters—initial encoding error and decay rate during maintenance—did not significantly differ across groups. This indicates that the core computational process of updating spatial information based on eye movements is largely preserved in healthy aging and neurodegeneration.

      Instead, group differences were driven by deficits in angular encoding error (precision of initial angle from fixation), angular decay, radial decay (decay in memory of distance from fixation), and interference susceptibility. This implies a functional and neuroanatomical dissociation: while the ventral stream (the “what” pathway) shows an age-related decline in the quality and stability of stored representations, the dorsal-stream (the “where” pathway) parietal-frontal circuits responsible for coordinate transformations remain functionally robust.[31–34] These spatial updating mechanisms appear resilient to the normal ageing trajectory and only break down when challenged by the specific pathological processes seen in Alzheimer’s or Parkinson’s disease.”

      (7) Presentation of saccade conditions in Figure 5 (p. 11). In Figure 5, it may be clearer to group the four saccade conditions together within each patient group. Since the main point is that saccadic interference on spatial memory remains robust across patient groups, grouping conditions by patient type rather than intermixing conditions would emphasize this interpretation.

      There are several valid ways to present these plots, but we chose this format because it allows for a direct visual comparison of the post-hoc group differences within each specific task demand. This arrangement clearly illustrates the graded impairment from young controls through to patients with Alzheimer’s disease across every condition. This structure also directly mirrors our two-way ANOVA, which identified significant main effects for both Group and Condition, but crucially, no significant Group x Condition interaction. We felt that grouping the data by participant group would force readers to look across four separate clusters to compare the slopes, making the stability of the saccadic remapping mechanism much harder to grasp at a glance.

      Reviewer #1 (Recommendations for the authors):

      (1) Formatting of statistical parameters.

      The formatting of statistical symbols should be consistent throughout the manuscript. Some instances of F, p, and t are italicized, while others are not. All statistical symbols should be italicized.

      Thank you for pointing this out. We have audited the manuscript. While we have revised the text to address these instances throughout the Results and Methods sections, any remaining minor formatting inconsistencies will be corrected during the final typesetting stage.

      (2) Minor typographical issues.

      (a) Line 532: "are" should be "be."

      (b) Line 654: "cantered" should be "centered."

      (c) Line 213: In "(p(bonf) < 0.001, |t| {greater than or equal to} 5.94)," the t value should be reported with its degrees of freedom, and t should be reported before p. The same applies to line 215.

      Thank you for your careful reading. All corrected.

      Reviewer #2 (Public review):

      We thank you for your positive feedback regarding our eye-tracking methodology and computational approach. We appreciate your critical insights into the feature-specific disruption hypothesis and the task structure. We have substantially revised the results and discussion about the saccadic interference on colour memory. Below we will answer your suggestions point-by-point:

      Reviewer #2 (Recommendations for the authors):

      (1) The study treats colour and location errors as comparable when arguing that saccades selectively disrupt spatial but not colour memory. However, these measures are defined in entirely different units (degrees of visual angle vs radians on a colour wheel) and are not psychophysically or statistically calibrated. Baseline task difficulty, noise level, or dynamic range do not appear to be calibrated or matched across features. As a result, the null effect of saccades on colour could reflect lower sensitivity or ceiling effects rather than implicit feature-specific robustness.

      We agree that direct comparisons of absolute error magnitudes across different dimensions are not appropriate. Our argument for feature-specific disruption relies not on the scale of errors, but on the presence or absence of a saccade cost within identical trials. In our within-subject design, the same saccade vectors produced a systematic increase in location error while leaving colour error statistically unchanged. To address sensitivity, we observed that colour memory was sufficiently precise to show a significant recency effect (p = 0.02). To further quantify the evidence for the null effect, we performed Bayesian repeated measures ANOVAs, which yielded a BF10 = 0.22. This provides substantial evidence that saccades do not disrupt colour precision, regardless of baseline sensitivity.

      We have substantially revised this in Results, Methods and Discussion:

      In the Results:

      “This design allowed us to isolate and quantify the unique impact of saccades on spatial memory, enabling us to test competing hypotheses regarding spatial representation. If spatial memory were solely underpinned by an allocentric mechanism, precision should remain comparable across all conditions as the representation would be world-centred and unaffected by eye movements. Thus, performance in the no-saccade condition should be comparable to the two-saccade condition. Conversely, if spatial memory relies on a retinotopic representation requiring active updating across eye movements, the two-saccade condition was anticipated to be the most challenging due to cumulative decay in the memory traces used for stimulus reconstruction after each saccade.[22] Critically, we hypothesised that this saccade cost would be specific to the spatial domain; while location requires active remapping via noisy oculomotor signals, non-spatial features like colour are not inherently tied to coordinate transformations and should therefore remain stable (see more in Discussion below).

      Meanwhile, the no-saccade condition was expected to yield the most accurate localisation, relying solely on retinotopic information (retinotopic working memory). These predictions were confirmed in young healthy adults (N = 21, mean age = 24.1 years, ranged between 19 and 34). A repeated measures ANOVA revealed a significant main effect of saccades on location memory (F(2.2,43.9)=33.2, p<0.001, partial η²=0.62), indicating substantial impairment after eye movements (Figure 2A). In contrast, colour memory remained remarkably stable across all saccade conditions (Figure 2B; F(2.2, 44.7) = 0.68, p=0.53, partial η² =0.03).

      This “saccade cost”—the loss of memory precision following an eye movement—indicates that spatial representations require active updating across saccades rather than being maintained in a static, world-centred reference frame.

      Critically, our comparison between spatial and colour memory does not rely on the absolute magnitude of errors, which are measured in different units (degrees of visual angle vs. radians). Instead, we assessed the relative impact of the same saccadic demand on each feature within the same trial. While location recall showed a robust saccade cost, colour recall remained statistically unchanged. To ensure this null effect was not due to a lack of measurement sensitivity, we examined the recency effect; recall performance for the second item was predicted to be better than for the first stimulus in each condition.[23,24] As expected, colour memory for Item 2 was significantly more accurate than for Item 1 (F(1,20) = 6.52, p = 0.02, partial η² = 0.25), demonstrating that the task was sufficiently sensitive to detect standard working memory fluctuations despite the absence of a saccade-induced deficit.”

      In the Methods, at the beginning of “Statistical Analysis”, we added

      “Because location and colour recall involve different scales and units, all analyses were performed independently for each feature to avoid cross-dimensional magnitude comparisons.” (p25)

      In the Discussion, we added:

      “A potential concern is whether the observed dissociation between colour and location reflects differences in baseline task difficulty or dynamic range. Yet, the presence of a robust recency effect in colour memory (Figure 2B) confirms that our paradigm was sensitive to memory-dependent variance and was not limited by floor or ceiling effects.”

      (2) Colour and then location are probed serially, without a counter-balanced order. This fixed response order could introduce a systematic bias because location recall is consistently subject to longer memory retention intervals and cognitive interference from the colour decision. The observed dissociation-saccades impair location but not colour, and may therefore reflect task structure rather than implicit feature-specific differences in trans-saccadic memory.

      Thank you for the insightful observation regarding our fixed response order. We acknowledge that that a counterbalanced design is typically preferred to mitigate potential order effects. However, we chose this consistent sequence to ensure the task remained accessible for cognitively impaired patients (i.e., the Alzheimer’s disease (AD) and Parkinson’s disease (PD) cohorts). Conducting an eye-tracking memory task with cognitively impaired patients is challenging, as they may struggle with task engagement or forget complex instructions. During the design phase, we prioritised a consistent structure to reduce the cognitive load and task-switching demands that typically challenge these cohorts.

      Critically, because the saccade cost is a relative measure calculated by comparing conditions with identical timings, any bias from the fixed order is present in both the baseline and saccade trials. The disruption we report is therefore a specific effect of eye movements that goes beyond the noise introduced by the retention interval or the preceding colour report.

      We added the following text in the Methods – experimental procedure (p.22):

      “Recall was performed in a fixed order, with colour reported before location. This sequence was primarily chosen to minimise cognitive load and task-switching demands for the two neurological patient cohorts, ensuring the paradigm remained accessible for individuals with AD and PD. While this order results in a slightly longer retention interval for location recall, the saccade cost was identified by comparing location error across experimental conditions with similar timings but varying saccadic demands.”

      (3) Relatedly, because spatial representations are retinotopic, fixational eye movements (FEMs - microsaccades and drift) displace the retinal coordinates of encoded positions, increasing apparent spatial noise with time delays. Colour memory, however, is feature-based and unaffected by small retinal translations. Thus, any between-condition or between-group differences in FEMs could selectively inflate location error and the associated model parameters (encoding noise, decay, interference), while leaving colour error unchanged. Note that FEMs tend to be slightly ballistic [1,2], hence not well modelled with a Gaussian blur.

      This is a very insightful point. We have now addressed this in detail within the discussion:

      “However, our findings suggest otherwise. One potential concern is whether this dissociation simply reflects the inherent spatial noise introduced by fixational eye movements (FEMs), such as microssacades and drifts.[46] Because locations are stored in a retinotopic frame, fixational instability necessarily shifts retinal coordinates over time. However, the "saccade cost" here was defined as the error increase relative to a no-saccade baseline of equal duration; because both conditions are subject to the same fixational drift, any FEM-induced noise is effectively subtracted out. Thus, despite the ballistic and non-Gaussian nature of FEMs,n [47] they cannot account for the fact the saccade cost in the spatial memory, but total absence in the colour domain. Another possibility is that this dissociation reflects differences in baseline task difficulty or dynamic range. Yet, the presence of a robust recency effect in colour memory (Figure 2B) confirms that our paradigm was sensitive to memory-dependent variance and was not limited by floor or ceiling effects.”

      (4) There is no in silico demonstration that the modelling framework can recover the true generating model from synthetic data or recover accurate parameters under realistic noise levels, which can be challenging in generative models with a hierarchical structure (as per [3], for example). Figure 8b shows that the parameters possess substantial posterior covariance, which raises concerns as to whether they can be reliably disambiguate.

      Many thanks for this comment. We have added a simple recovery analysis as detailed below but are also keen to ensure we fully answer your question—which has more to do with empirical rather than simulated data—and make clear the rationale for this analysis in this instance.

      We added this in Supplementary Materials:

      “Model validation and recovery analysis

      The following section provides a detailed technical assessment of the model inversion scheme, focusing on the discriminability of the model space and the identifiability of individual parameters.

      Recovery analyses of this sort are typically used prior to collecting data to allow one to determine whether, in principle, the data are useful in disambiguating between hypotheses. In this sense, they have a role analogous to a classical power calculation. However, their utility is limited when used post-hoc when data have already been collected, as the question of whether the models can be disambiguated becomes one of whether non-trivial Bayes factors can be identified from those data.

      The reason for including a recovery analysis here is not to identify whether the model inversion scheme identifies a ‘true’ model. The concept of ‘true generative models’ commits to a strong philosophical position which is at odds with the ‘all models are wrong, but some are useful’ perspective held by many in statistics, e.g., (So, 2017). Of note, one can always confound a model recovery scheme by generating the same data in a simple way, and in (one of an infinite number of) more complex ways. A good model inversion scheme will always recover the simple model and therefore would appear to select the ‘wrong’ model in a recovery analysis. However, it is still the best explanation for the data. For these reasons, we do not necessarily expect ‘good’ recoverability in all parameter ranges. This is further confounded by the relationship between the models we have proposed—e.g., an interference model with very low interference will look almost identical to a model with no interference. The important question here is whether they can be disambiguated with real data.

      Instead, the value of a post-hoc recovery analysis here is to evaluate whether there was a sensible choice of model space—i.e., that it was not a priori guaranteed that a single model (and, specifically, the model we found to be the best explanation for the data) would explain the results of all others. To address this, for each model, we simulated 16 datasets, each of which relied upon parameters sampled from the model priors, which included examples of each of the experimental conditions. We then fit each of these datasets to each of the 7 models to construct the confusion matrix shown in the lower panel of Supplementary Figure 3, by accumulating evidence over each of the 16 participants generated according to each ‘true’ model (columns) for each of the possible explanatory models (rows). This shows that no one model, for the parameter ranges sampled here, explains all other datasets. Interestingly, our ‘winning’ model in the empirical analysis is not the best explanation for any of the datasets simulated (including its own). This is reassuring, in that it implies this model winning was not a foregone conclusion and is driven by the data—not just the choice of model space.”

      Your point about the posterior covariance is well founded. As we describe in Supplementary Materials, this is an inherent feature of inverse problems (analogous to EEG source localisation). However, the fact that our posterior densities move significantly away from the prior expectations demonstrates that the data are indeed informative. By adopting a Bayesian framework, we are able to explicitly quantify this uncertainty rather than ignoring it, providing a more transparent account of parameter identifiability. We have added the following in the same section of Supplementary Materials:

      “This problem is an inverse problem—inferring parameters from a non-linear model. We therefore expect a degree of posterior covariance between parameters and, consequently, that they cannot be disambiguated with complete certainty. While some degree of posterior covariance is inherent to inverse models—including established methods like EEG source localisation—the fact that many of the parameters are estimated with posterior densities that do not include their prior expectations implies the data are informative about these.

      The advantage of the Bayesian approach we have adopted here is that we can explicitly quantify posterior covariance between these parameters, and therefore the degree to which they can be disambiguated. While the posterior covariance matrices from empirical data are the relevant measure here, we can better understand the behaviour of the model inversion scheme in relation to the specific models used using the model recovery analysis reported in Supplementary figure 3.

      The middle panel of the figure is key, along with the correlation coefficients reported in the figure caption. Here, we see at least a weak positive correlation (in some cases much stronger) for almost all parameters and limited movement from prior expectations for those parameters that are less convincingly recovered. This reinforces that the ability of the scheme to recover parameters is best assessed in terms of the degree of movement of posterior from prior values following fitting to empirical data.”

      (5) The authors employ Bayes factors (BFs) to disambiguate models, but BFs would also strengthen the claims that location, but not colour, is impacted by saccades. Despite colour being a circular variable, colour error is analysed using ANOVA on linearised differences (radians). The authors should also arguably use circular statistics, such as the von Mises distribution, for the analysis of colour.

      Regarding the use of circular statistics, you are correct that such error distributions are not suitable for ANOVA, and it is better to use circular statistics. However, for the present dataset, we used the mean absolute angular error per condition (ranging from 0 to π radians), which represents the shortest distance on the colour wheel between the target and the response.

      This approach effectively linearises the measure by removing the 2π wrap-around boundary. because the observed errors were relatively small and did not cluster near the π boundary—even in the patient cohorts (Figure 5B)—the "wrap-around" effect of circular space is negligible. Moreover, by analysing the mean error across trials for each condition, rather than trial-wise data, we invoke the Central Limit Theorem. This ensures that the distribution of these means is approximately normal, satisfying the fundamental assumptions of ANOVA. Due to these reasons, we adopted simpler linear models. We confirmed that the data did not violate the assumptions of linear statistics. In this low-noise regime, linear and circular models converge on the same conclusions. This has been revised in Methods:

      “For colour memory, we calculated the absolute angular error, defined as the shortest distance on the colour wheel between the target and the reported colour (range 0 to π radians). For the primary statistical analyses, we utilised the mean absolute error per condition for each participant. By analysing these condition-wise means rather than trial-wise raw data, we invoke the Central Limit Theorem, which ensures that the sampling distribution of these means approximates normality. Because the absolute errors in this paradigm were relatively small and did not approach the π boundary (Figure 5B) even in the clinical cohorts, the data were treated as a continuous measure in our linear ANOVAs and regression models. Moreover, because location and colour recall involve different scales and units, all analyses were performed independently for each feature to avoid cross-dimensional magnitude comparisons.”

      We have also now integrated Bayesian repeated measures ANOVA throughout the manuscript. The Results section for the young healthy adults now reads (p. 4):

      “A repeated measures ANOVA revealed a significant main effect of saccades on location memory (F(3, 20) = 51.52, p < 0.001, partial η²=0.72), with Bayesian analysis providing decisive evidence for the inclusion of the saccade factor (BF<sub>incl</sub> = 3.52 x 10^13, P(incl|data) = 1.00). In contrast, colour memory remained remarkably stable across all saccade conditions (F(3, 20) = 0.57, p = 0.64, partial η² =0.03). This null effect was supported by Bayesian analysis, which provided moderate evidence in favour of the null hypothesis (BF<sub>01</sub> = 8.46, P(excl|data) = 0.89), indicating that the data were more than eight times more likely under the null model than a model including saccade-related impairment.”

      For elderly healthy adults:

      “In contrast, colour memory remained unaffected by saccade demands (F(3, 20) = 0.57, p = 0.65, partial η² =0.03), again supported by the Bayesian analysis: BF<sub>01</sub> = 8.68, P(excl|data) = 0.90.”

      For patient cohorts:

      “Bayesian repeated measures ANOVAs further supported this dissociation, providing moderate evidence for the null hypothesis in the AD group (BF<sub>01</sub> = 3.35, P(excl|data) = 0.77) and weak evidence in the PD group (BF<sub>01</sub> = 2.23, P(excl|data) = 0.69). This indicates that even in populations with established neurodegeneration, the detrimental impact of eye movements is specific to the spatial domain.”

      Related description is also updated in Methods – Statistical Analysis.

      Minor:

      (1) The modelling is described as computational but is arguably better characterised as a heuristic generative model at Marr's algorithmic level. It does not derive from normative computational principles or describe an implementation in neural circuits.

      We appreciate your perspective on the classification of our model within Marr’s hierarchy. We agree that our framework is best characterised as an algorithmic-level generative model. Our objective was to identify the mechanistic principles governing transsaccadic updating rather than to provide a normative derivation or a specific circuit-level implementation.

      To ensure readers do not over-interpret the term ‘computational’, we have added a clarifying statement in the Discussion acknowledging the algorithmic nature of the model. Interestingly, we note that a model predicated on this form of spatial diffusion implies a neural field representation with a spatial connectivity kernel whose limit approximates the second derivative of a Dirac delta function. While a formal neural field implementation is beyond the scope of the present work, our algorithmic results provide the necessary constraints for such future biophysical models.

      p.20: “While we describe the present framework as 'computational', it is more precisely characterised as an algorithmic-level generative model within Marr’s hierarchy. Our focus was on defining the rules of spatial integration and the sources of eye-movement-induced noise, rather than deriving these processes from normative principles or defining their specific neural implementation.”

      (2) I did not find a description of the recruitment and characterization of the AD and PD patients.

      Apologies for this omission. We have now included a detailed description of participant recruitment and clinical characterisation in the Methods section and also updated Table 2:

      “A total of 87 participants completed the study: 21 young healthy adults (YC), 21 older healthy adults (EC), 23 patients with Parkinson’s disease (PD), and 22 patients with Alzheimer’s disease (AD). Their demographic and clinical details are summarised in Table 2. Initially, 90 participants were recruited (22 YC, 21 EC, 25 PD, 22 AD); however, three individuals (1 YC and 2 PD) were excluded from all analyses due to technical issues during data acquisition.

      All participants were recruited locally in Oxford, UK. None were professional artists, had a history of psychiatric illness, or were taking psychoactive medications (excluding standard dopamine replacement therapy for PD patients). Young participants were recruited via the University of Oxford Department of Experimental Psychology recruitment system. Older healthy volunteers (all >50 years of age) were recruited from the Oxford Dementia and Ageing Research (OxDARE) database.

      Patients with PD were recruited from specialist clinics in Oxfordshire. All had a clinical diagnosis of idiopathic Parkinson's disease and no history of other major neurological or psychiatric conditions. While specific dosages of dopamine replacement therapy (e.g., levodopa equivalent doses) were not systematically recorded, all patients were tested while on their regular medication regimen ('ON' state).

      Patients with PD were recruited from clinics in the Oxfordshire area. All had a clinical diagnosis of idiopathic Parkinson’s disease and no history of other major neurological or psychiatric illnesses. While all patients were tested in their regular medication ‘ON’ state, the specific pharmacological profiles—including the exact types of medication (e.g., levodopa, dopamine agonists, or combinations) and dosages—were not systematically recorded. The disease duration and PD severity were also un-recorded for this study.

      Patients with AD were recruited from the Cognitive Disorders Clinic at the John Radcliffe Hospital, Oxford, UK. All AD participants presented with a progressive, multidomain, predominantly amnestic cognitive impairment. Clinical diagnoses were supported by structural MRI and FDG-PET imaging consistent with a clinical diagnosis of AD dementia (e.g., temporo-parietal atrophy and hypometabolism).69 All neuroimaging was reviewed independently by two senior neurologists (S.T. and M.H.).

      Global cognitive function was assessed using the Addenbrooke’s Cognitive Examination-III (ACE-III).70 All healthy participants scored above the standard cut-off of 88, with the exception of one elderly participant who scored 85. In the PD group, two participants scored below the cut-off (85 and 79). In the AD group, six participants scored above 88; these individuals were included based on robust clinical and radiological evidence of AD pathology rather than their ACE-III score alone.”

      (3) YA and OA patients appear to differ in gender distribution.

      We acknowledge the difference in gender distribution between the young (71.4% female) and older adult (57.1% female) cohorts. However, we do not anticipate that gender influences the fundamental computational mechanisms of retinotopic maintenance or transsaccadic remapping. These processes represent low-level visuospatial functions for which there is no established evidence of gender-specific differences in precision or coordinate transformation. We have ensured that the gender distribution for each cohort is clearly listed in the demographics table (Table 2) for full transparency.

      Thank you very much for very insightful feedback!

      Reviewer #3 (Public review):

      Thank you for the positive feedback regarding our inclusion of clinical groups and the identification of computational phenotypes that differentiate these cohorts.

      To address your concerns about the model, we have clarified our use of Bayesian Model Selection, which inherently penalises model complexity to ensure that our results are not driven solely by the number of parameters. We will also provide further evidence regarding model generalisability to address the concern of overfitting.

      Regarding the link with the ROCF, we have revised the manuscript to better highlight the specific relationship between our transsaccadic parameters and the ROCF data and better motivate the inclusion of these results in the main text.

      Below is our response to your suggestions point-by-point:

      (1) The models tested differ in terms of the number of parameters. In general, a larger number of parameters leads to a better goodness of fit. It is not clear how the difference in the number of parameters between the models was taken into account. It is not clear whether the modelling results could be influenced by overfitting (it is not clear how well the model can generalize to new observations).

      To ensure our results were not driven by the number of parameters, we utilised random-effects Bayesian Model Selection (BMS) to adjudicate between our candidate models. Unlike maximum likelihood methods, BMS relies on the marginal likelihood (model evidence), which inherently balances model fit against parsimony—a principle known as the Occam’s Razor (Rasmussen and Ghahramani, 2000). In this framework, a model is only preferred if the improvement in fit justifies the additional parameter space; redundant parameters actually lower model evidence by diluting the probability mass. We would be happy to point toward literature that discusses how these marginal likelihood approximations provide a more robust guard against overfitting than standard metrics like BIC or AIC (MacKay, 2003; Murray and Ghahramani, 2005; Penny, 2012).

      The fact that the "Dual (Saccade) + Interference" model (Model 7) emerged as the winner—with a Bayes Factor of 6.11 against the next best alternative—demonstrates that its complexity was statistically justified by its superior account of the trial-by-trial data.

      Furthermore, to address the risk of overfitting, we established the generalisability of these parameters by using them to predict performance on an independent clinical task. These parameters successfully explained ~62% of the variance in ROCF copy scores—a very distinct, real-world task--confirming that they represent robust computational phenotypes rather than idiosyncratic fits to the initial dataset.

      In the Results (p10):

      “We used random-effects Bayesian model selection to identify the most plausible generative model. This process relies on the marginal likelihood (model evidence), which inherently balances model fit against complexity—a principle often referred to as Occam’s razor.[25–27]”

      In the Discussion (p17):

      “Importantly, the risk of overfitting is mitigated by the Bayesian Model Selection framework; by utilising the marginal likelihood for model comparison, the procedure inherently penalises excessive model complexity and promotes generalisability.[25–27,42] This generalisability was further evidenced by the model's ability to predict performance on the independent ROCF task, confirming that these parameters represent robust mechanistic phenotypes rather than idiosyncratic fits to the initial dataset.”

      (2) Results specificity: it is not clear how specific the modelling results are with respect to constructional ability (measured via the Rey-Osterrieth Complex Figure test). As with any cognitive test, performance can also be influenced by general, non-specific abilities that contribute broadly to test success.

      We agree that constructional performance is influenced by both specific mechanistic constraints and general cognitive abilities. To isolate the unique contribution of transsaccadic updating, we therefore performed a partial correlation analysis across the entire sample. We examined the relationship between location error in the two-saccades condition (our primary behavioural measure of transsaccadic memory) and ROCF copy scores. Even after partialling out the effects of global cognitive status (ACE-III total score), age, and years of education, the correlation remained highly significant (rho = -0.39, p < 0.001).

      This suggests that our model captures a specific computational phenotype—the precision of spatial updating during active visual sampling—rather than acting as a proxy for non-specific cognitive decline. This mechanistic link explains why traditional working memory measures (e.g., digit span or Corsi blocks) frequently fail to predict drawing performance; unlike those tasks, figure copying requires thousands of saccades, making it uniquely sensitive to the precision of the dynamic remapping signals identified by our modelling framework.

      We added the following text in the Discussion (p19):

      “We also found that the relationship between transsaccadic working memory and ROCF performance remains highly significant (rho = -0.39, p < 0.001), even after controlling for age, education, and global cognitive status (ACE-III total score). Consequently, transsaccadic updating may represent a discrete computational phenotype required for visuomotor control, rather than a non-specific proxy for global cognitive decline.[57]”

      Reviewer #3 (Recommendations for the authors):

      (1) The authors mention in the introduction the following: "One key hypothesis is that we use working memory across visual fixations to update perception dynamically", citing the following manuscript:

      Harrison, W. J., Stead, I., Wallis, T. S. A., Bex, P. J. & Mattingley, J. B. A computational 906 account of transsaccadic attentional allocation based on visual gain fields. Proc. Natl. 907 Acad. Sci. U.S.A. 121, e2316608121 (2024).

      However, the manuscript above does not refer explicitly to the involvement of working memory in transaccadic integration of object location in space. Rather, it takes advantage of recent evidence showing how the true location of a visual object is represented in the activity of neurons in primary visual cortex ( A. P. Morris, B. Krekelberg, A stable visual world in primate primary visual cortex. Curr. Biol. 29, 1471-1480.e6 (2019) ). The model hypothesizes that true locations of objects are readily available, and then allocates attention in real-world coordinates, allowing efficient coordination of attention and saccadic eye movements.

      Thank you for clarification. As suggested, we have now included the citation of Morris & Krekelberg (2019) to acknowledge the evidence for stable object locations within the primary visual cortex.

      (2) The authors in the introduction and the title use the terms 'transaccadic memory' and 'spatial working memory'. However, it is not clear whether these can be used interchangeably or are reflecting different constructs.

      Classical measures of visuo-spatial working memory are derived from the Corsi task (or similar), where the location of multiple objects is displayed and subsequently remembered. In such tasks, eye movements and saccades are not generally considered, only memory performance, representing the visuo-spatial span.

      Transaccadic memory tasks are instead explicitly measuring the performance on remembered object locations of features across explicit eye movements, usually using a very limited number of objects (1 or 2, as is the case for the current manuscript).

      While the two constructs share some features, it is not clear whether they represent the same underlying ability or not, especially because in transaccadic tasks, participants are required to perform one or more saccades, thus representing a dual-task case.

      I think the relationship between 'transaccadic memory' and 'spatial working memory' should be clarified in the manuscript.

      Thank you. Yes, we have added this within the Methods - Measurement of saccade cost to clarify that spatial working memory is the broad cognitive construct responsible for short-term maintenance, whereas transsaccadic memory is the specific, dynamic process of remapping representations to maintain stability across eye movements.

      In Methods (p.22):

      “Within this framework, it is important to distinguish between the broad construct of spatial working memory and the specific process of transsaccadic memory. While spatial working memory refers to the general ability to maintain spatial information over short intervals, transsaccadic memory describes the dynamic updating of these representations—termed remapping—to ensure stability across eye movements. Unlike classical 'static' measures of spatial working memory, such as the Corsi block task which focuses on memory span, transsaccadic memory tasks explicitly require the integration of stored visual information with motor signals from intervening saccades. Our paradigm treats transsaccadic updating as a core computational process within spatial working memory, where eye-centred representations are actively reconstructed based on noisy memories of the intervening saccade vectors.”

      (3) In Figure 1, the second row indicates the presentation of item 2. Indeed, in the condition 'saccade-after-item-1', the target in the second row of Figure 1 is displaced, as expected. This clarifies the direction and amplitude of the first saccade requested. However, from Figure 1, it is hard to understand the amplitude and direction of the second requested saccade. I think the figure should be updated, giving a full description of the direction and amplitude of the second saccade as well ('saccade-after-item-2' and 'two-saccades' conditions).

      We agree that making the figure legend more self-contained is beneficial for the reader. While the specific physical parameters and the trial sequence for each condition are detailed in the Results and Methods sections, we have now updated the legend for Figure 1 to explicitly define these details. Specifically, we have clarified that the colour wheel itself served as the target for the second instructed saccade (i.e., the movement from the second fixation cross to the colour wheel location). We have also included the quantitative constraint that all saccade vectors were at least 8.5 degrees of visual angle in amplitude. Given the limited space within a figure legend, we hope these concise additions provide the transparency requested without interrupting the conceptual flow of the diagram.

      Updated Figure 1 legend:

      “Participants were asked to fixate a white cross, wherever it appeared. They had to remember the colour and location of a sequence of two briefly presented coloured squares (Item 1 and 2), each appearing within a white square frame. They then fixated a colour wheel wherever it appeared on the screen, which served as the target for the second instructed saccade (i.e., a movement from the second fixation cross to the colour wheel location). This cued recall of a specific square (Item 1 or Item 2 labelled within the colour wheel). Participants selected the remembered colour on the colour wheel which led to a square of that colour appearing on the screen. They then dragged this square to its remembered location on the screen. Saccadic demands were manipulated by varying the locations of the second frame and the colour wheel, resulting in four conditions in their reliance on retinotopic versus transsaccadic memory: (1) No-Saccade condition providing a baseline measure of within-fixation precision as no eye movements were required. (2) Saccade After Item 1; (3) Saccade After Item 2; (4) Saccades after both items (Two Saccades condition). In all conditions requiring eye movements, saccade vectors were constrained to a minimum amplitude of 8.5° (degrees of visual angle). While the No-Saccade condition isolates retinotopic working memory, conditions (2) to (4) collectively quantify the impact of varying saccadic demands and timings on the maintenance of spatial information, thereby assessing the efficacy of the transsaccadic updating process.”

      (4) The authors write: "Eye tracking analysis confirmed high compliance: participants correctly maintained fixation or executed saccades as instructed on the vast majority of trials (83% {plus minus} 14%). Non-compliant trials were excluded 136 from further analysis." 14% of excluded trials are a substantial fraction of trials, given the task requirements. Is this proportion of excluded trials different between experimental groups, and are experimental groups contributing equally to this proportion?

      We thank the reviewer for pointing this out, and we apologise for the confusion. The 83% trial number was actually across all four cohorts, and all conditions, and it was actually above 90% for YC, EC and even AD, but dropped to 60 ish in PD group.

      We now have conducted a full analysis of compliant trial counts using a mixed ANOVA (4 saccade conditions x 4 cohorts). This analysis revealed a main effect of group (F(3, 80) = 8.06, p < 0.001), which was driven by lower compliance in the PD cohort (mean approx. 25.4 trials per condition) compared to the AD, EC, and YC cohorts (means ranging from 35.8 to 38.9 trials per condition). Crucially, however, the interaction between group and condition was not statistically significant (p = 0.151). This indicates that the relative impact of saccade demands on trial retention was consistent across all four groups.

      Because our primary behavioural measure—the saccade cost—is a within-subject comparison of impairment across conditions, these differences in absolute trial numbers do not introduce a systematic bias into our findings. Furthermore, even with the higher attrition in the PD group, we retained a sufficient number of high-quality trials (minimum mean of ~23 trials in the most demanding condition) to support robust trial-by-trial parameter estimation and valid statistical inference. We have updated the Results and Methods to reflect these details.

      In Results (p4):

      “To mitigate potential confounds, we monitored eye position throughout the experiment. Eye-tracking analysis confirmed high compliance in healthy adults, who followed instructions on the vast majority of trials (Younger Adults: 97.2 ± 5.2 %; Older Adults: 91.3 ± 20.4 %). The mean difference between these groups was negligible, representing just 1.25 trials per condition, and was not statistically significant (t(80) = 0.16, p = 1.000; see more in Methods – Eyetracking data analysis). Non-compliant trials were excluded from all further analyses.”

      In Methods (p27):

      “Eye-tracking analysis confirmed high compliance overall, with participants correctly maintaining fixation or executing saccades on the vast majority of trials (83% across all participants). A mixed ANOVA revealed a main effect of group on trial retention (F(3, 80) = 8.06, p < 0.001, partial η² = 0.23), primarily due to lower compliance in the PD cohort (YC: 97±4%; EC: 91±10%; AD: 95±5%; PD: 63±38%). Importantly, there was no significant interaction between group and saccade condition (F(3.36, 80) = 1.78, p = 0.15, partial η² = 0.008), suggesting that trial attrition was not disproportionately affected by specific task demands in any group.

      We acknowledge that this reduced trial count in the PD group represents a limitation for across-cohort comparison. However, the absolute number of compliant trials in PD group (mean approx. 25 per condition) remained sufficient for robust trial-by-trial parameter estimation. Furthermore, the lack of a significant group-by-condition interaction confirms that the results reported for this cohort remain valid and that our primary finding of a selective spatial memory deficit is robust to these differences in data retention.”

      (5) Modelling

      (a) Degrees of freedom, cross-validation, number of parameters.

      I appreciate the effort in introducing and testing different models. Models of increase in complexity and are based on different assumptions about the main drivers and mechanisms underlying the dependent variable. The models differ in the number of parameters. How are the differences in the number of parameters between models taken into account in the modelling analysis? Is there a cost associated with the extra parameters included in the more complex models?

      (b) Cross-validation and overfitting.

      Overfitting can occur when a model learns the training data but cannot generalize to novel datasets. Cross-validation is one approach that can be used to avoid overfitting. Was cross-validation (or other approaches) implemented in the fitting procedure against overfitting? Otherwise, the inference that can be derived from the modelled parameters can be limited.

      To address your concerns regarding model complexity and overfitting, we would like to clarify our use of Bayesian Model Selection (BMS). Unlike frequentist methods that often rely on cross-validation to assess generalisability, we used random-effects BMS based on the marginal likelihood (model evidence). This approach inherently implements Bayesian Occam’s Razor by integrating out the parameters. Under this framework, the use of the marginal likelihood for model selection provides a mathematically equivalent safeguard to frequentist cross-validation, as it evaluates the model's ability to generalise across the entire parameter space rather than just finding a maximum likelihood fit for the training data. Thus, models are penalised not just for the absolute number of parameters, but for their overall functional flexibility. A more complex model is only preferred if the improvement in model fit is substantial enough to outweigh this inherent penalty. The emergence of Model 7 as the winner (Bayes Factor = 6.11 against the next best alternative) confirms that its additional complexity is statistically justified.

      Furthermore, in this study we provided an external validation of these recovered parameters by demonstrating that they explain 62% of the variance in an independent, real-world, clinical task (ROCF copy). This empirical evidence confirms that our model captures robust mechanistic phenotypes rather than idiosyncratic noise. We have updated the Results and Discussion to explicitly state these.

      In Results: (p10)

      “We used random-effects Bayesian model selection to identify the most plausible generative model. This process relies on the marginal likelihood (model evidence), which inherently balances model fit against complexity—a principle often referred to as Occam’s razor.[26–28]”

      In Discussion: (p17)

      “Importantly, the risk of overfitting is mitigated by the Bayesian Model Selection framework; by utilising the marginal likelihood for model comparison, the procedure inherently penalises excessive model complexity and promotes generalisability.[26–28,43] This generalisability was further evidenced by the model's ability to predict performance on the independent ROCF task, confirming that these parameters represent robust mechanistic phenotypes rather than idiosyncratic fits to the initial dataset.”

      (6) n. of participants.

      (a) The authors write the following: "A total of healthy volunteers (21 young adults, mean age = 24.1 years; 21 older adults, mean age = 72.4 years) participated in this study. Their demographics are shown in Table 1. All participants were recruited locally in Oxford." However, Table 1 reports the data from more than 80 participants, divided into 4 groups. Details about the PD and AD groups are missing. Please clarify.

      We apologize for this lack of clarity in the text. We have rewrote and expand the “Participants” section and corrected Table 2 in the Methods section to reflect the correct number of participants.

      In Methods (p20):

      “A total of 87 participants completed the study: 21 young healthy adults (YC), 21 older healthy adults (EC), 23 patients with Parkinson’s disease (PD), and 22 patients with Alzheimer’s disease (AD). Their demographic and clinical details are summarised in Table 2. Initially, 90 participants were recruited (22 YC, 21 EC, 25 PD, 22 AD); however, three individuals (1 YC and 2 PD) were excluded from all analyses due to technical issues during data acquisition.

      All participants were recruited locally in Oxford, UK. None were professional artists, had a history of psychiatric illness, or were taking psychoactive medications (excluding standard dopamine replacement therapy for PD patients). Young participants were recruited via the University of Oxford Department of Experimental Psychology recruitment system. Older healthy volunteers (all >50 years of age) were recruited from the Oxford Dementia and Ageing Research (OxDARE) database.

      Patients with PD were recruited from specialist clinics in Oxfordshire. All had a clinical diagnosis of idiopathic Parkinson's disease and no history of other major neurological or psychiatric conditions. While specific dosages of dopamine replacement therapy (e.g., levodopa equivalent doses) were not systematically recorded, all patients were tested while on their regular medication regimen ('ON' state).

      Patients with PD were recruited from clinics in the Oxfordshire area. All had a clinical diagnosis of idiopathic Parkinson’s disease and no history of other major neurological or psychiatric illnesses. While all patients were tested in their regular medication ‘ON’ state, the specific pharmacological profiles—including the exact types of medication (e.g., levodopa, dopamine agonists, or combinations) and dosages—were not systematically recorded. The disease duration and PD severity were also un-recorded for this study.

      Patients with AD were recruited from the Cognitive Disorders Clinic at the John Radcliffe Hospital, Oxford, UK. All AD participants presented with a progressive, multidomain, predominantly amnestic cognitive impairment. Clinical diagnoses were supported by structural MRI and FDG-PET imaging consistent with a clinical diagnosis of AD dementia (e.g., temporo-parietal atrophy and hypometabolism).[70] All neuroimaging was reviewed independently by two senior neurologists (S.T. and M.H.).

      Global cognitive function was assessed using the Addenbrooke’s Cognitive Examination-III (ACE-III).[71] All healthy participants scored above the standard cut-off of 88, with the exception of one elderly participant who scored 85. In the PD group, two participants scored below the cut-off (85 and 79). In the AD group, six participants scored above 88; these individuals were included based on robust clinical and radiological evidence of AD pathology rather than their ACE-III score alone.”

      (b) As modelling results rely heavily on the quality of eye movements and eye traces, I believe it is necessary to report details about eye movement calibration quality and eye traces quality for the 4 experimental groups, as noisier data could be expected from naïve and possibly older participants, especially in case of clinical conditions. Potential differences in quality between groups should be discussed in light of the results obtained and whether these could contribute to the observed patterns.

      Thank you for pointing this out. We have revised the Methods about how calibration was done:

      (p27) “Prior to the experiment, a standard nine-point calibration and validation procedure was performed. Participants were instructed to fixate a small black circle with a white centre (0.5 degrees) as it appeared sequentially at nine points forming a 3 x 3 grid across the screen. Calibration was accepted only if the mean validation error was below 0.5 degrees and the maximum error at any single point was below 1.0 degree. If these criteria were not met, or if the experimenter noticed significant gaze drift between blocks, the calibration procedure was repeated. This calibration ensured high spatial accuracy across the entire display area, facilitating the precise monitoring of fixations on item frames and saccadic movements to the response colour wheel.”

      Moreover, as detailed in our response to Point 4, while the PD group exhibited lower compliance, there was no interaction between group and saccade condition for compliance (p = 0.151). This confirms that any noise or trial attrition was distributed evenly across experimental conditions. Consequently, the observed "saccade cost" (the difference in error between conditions) is not an artefact of unequal noise but represents a genuine mechanistic impairment in spatial updating. We have updated the Methods to clarify this distinction.

      Furthermore, our Bayesian framework explicitly estimates precision (random noise) as a distinct parameter from updating cost (saccade cost). This allows the model to partition the variance: even if a clinical group is "noisier" overall, this is captured by the precision parameter, ensuring it does not inflate the specific estimate of saccade-driven memory impairment.

      (7) Figure 5. I suggest reporting these results using boxplots instead of barplots, as the former gives a better overview of the distributions.

      We appreciate the suggestion to use boxplots to better illustrate data distributions. However, we have chosen to retain the current bar plot format due to the visual and statistical complexity of our 4 x 4 x 2 experimental design. Figure 5 represents 16 distinct distributions across four groups and four conditions for both location and colour measures; employing boxplots/violins for this density of data would significantly increase visual clutter and make the figure difficult to parse.

      Furthermore, the primary objective of this figure is to reflect the statistical analysis and illustrate group differences in overall performance and highlight the specific finding that patients with AD were significantly more impaired across all conditions compared to YC, EC, and PD groups. Our statistical focus remains on the mean effects—specifically the significant main effect of group (F(3, 318) = 59.71, p < 0.001) and the critical null-interaction between group and condition (p = 0.90). The error measure most relevant to these comparisons is the standard error of the mean (SEM), rather than the interquartile range (IQR). We think that bar plots provide the most straightforward and scannable representation of these mean differences and the consistent pattern of decay across cohorts for the final manuscript layout.

      To address the reviewer’s request for distributional transparency, we have provided a version of Figure 5 using grouped boxplots in the supplementary material (Supplementary figure 2). We note, however, that the spread of raw data points in these plots does not directly reflect the variance associated with our within-subject statistical comparisons.

      (8) Results specificity, trans-saccadic integration and ROCF. The authors demonstrate that the derived model parameters account for a significant amount of variability in ROCF performance across the experimental groups tested (Figure 8A). However, it remains unclear how specific the modelling results are with respect to the ROCF.

      The ROCF is generally interpreted as a measure of constructional ability. Nevertheless, as with any cognitive test, performance can also be influenced by more general, non-specific abilities that contribute broadly to test success. To more clearly link the specificity between modelling results and constructional ability, it would be helpful to include a test measure for which the model parameters would not be expected to explain performance, for example, a verbal working memory task.

      I am not necessarily suggesting that new data should be collected. However, I believe that the issue of specificity should be acknowledged and discussed as a potential limitation in the current context.

      We appreciate this important point regarding the discriminant validity of our findings. We agree that cognitive performance in clinical populations is often influenced by a general "g-factor" or non-specific executive decline. However, we chose the ROCF Copy task specifically because it is a hallmark clinical measure of constructional ability that effectively serves as a real-world transsaccadic task, requiring participants to integrate spatial information across hundreds of saccades between the model figure and the drawing surface.

      To address the reviewer’s concern regarding specificity, we leveraged the fact that all participants completed the ACE-III, which includes a dedicated verbal memory component (the ACE Memory subscale). We conducted a partial correlation analysis and found that the relationship between transsaccadic working memory and ROCF copy performance remains highly significant (rho = -0.46, p < 0.001), even after controlling for age, education, and the ACE-III Memory subscale score. This suggests that the link between transsaccadic updating and constructional ability is mechanistically specific rather than a byproduct of global cognitive impairment. We have substantially revised the Discussion to highlight this link and the supporting statistical evidence.

      We first updated the last paragraph of Introduction:

      “Finally, by linking these mechanistic parameters to a standard clinical measure of constructional ability (the Rey-Osterrieth Complex Figure task), we demonstrate that transsaccadic updating represents a core computational phenotype underpinning real-world visuospatial construction in both health and neurodegeneration.”

      The new section in Discussion highlighting the ROCF copy link:

      “Importantly, our computational framework establishes a direct mechanistic link between trassaccadic updating and real-world constructional ability. Specifically, higher saccade and angular encoding errors contribute to poorer ROCF copy scores. By mapping these mechanistic estimates onto clinical scores, we found that the parameters derived from our winning model explain approximately 62% of the variance in constructional performance across groups. These findings suggest that the computational parameters identified in the LOCUS task represent core phenotypes of visuospatial ability, providing a mechanistic bridge between basic cognitive theory and clinical presentation.

      This relationship provides novel insights into the cognitive processes underlying drawing, specifically highlighting the role of transsaccadic working memory. Previous research has primarily focused on the roles of fine motor control and eye-hand coordination in this skill.[4,50–55] This is partly because of consistent failure to find a strong relation between traditional memory measures and copying ability.[4,31] For instance, common measures of working memory, such as digit span and Corsi block tasks, do not directly predict ROCF copying performance.[31,56] Furthermore, in patients with constructional apraxia, these memory performance often remain relatively preserved despite significant drawing impairments.[56–58] In literature, this lack of association has often been attributed to “deictic” visual-sampling strategies, characterised by frequent eye movements that treat the environment as an external memory buffer, thereby minimising the need to maintain a detailed internal representation.[4,59] In a real-world copying task, the ROCF requires a high volume of saccades, making it uniquely sensitive to the precision of the dynamic remapping signals identified here. Recent eye-tracking evidence confirms that patients with AD exhibit significantly more saccades and longer fixations during figure copying compared to controls, potentially as a compensatory response to trassaccadic working memory constraints.[56] This high-frequency sampling—averaging between 150 and 260 saccades for AD patients compared to approximately 100 for healthy controls—renders the task highly dependent on the precision of dynamic remapping signals.[56] We also found that the relationship between transsaccadic working memory and ROCF performance remains highly significant (rho = -0.46, p < 0.001), even after controlling for age, education, and ACE-III Memory subscore. Consequently, transsaccadic updating may represent a discrete computational phenotype required for visuomotor control, rather than a non-specific proxy for global cognitive decline.[58]

      In other words, even when visual information is readily available in the world, the act of drawing performance depends critically on working memory across saccades. This reveals a fundamental computational trade-off: while active sampling strategies (characterised with frequent eye-hand movements) effectively reduce the load on capacity-limited working memory, they simultaneously increase the demand for precise spatial updating across eye movements. By treating the external world as an "outside" memory buffer, the brain minimises the volume of information it must hold internally, but it becomes entirely dependent on the reliability with which that information is remapped after each eye movement. This perspective aligns with, rather contradicts, the traditional view of active sampling, which posits that individuals adapt their gaze and memory strategies based on specific task demands.[3,60] Furthermore, this perspective provides a mechanistic framework for understanding constructional apraxia; in these clinical populations, the impairment may not lie in a reduced memory "span," but rather in the cumulative noise introduced by the constant spatial remapping required during the copying process.[58,61]

      Beyond constructional ability, these findings suggest that the primary evolutionary utility of high-resolution spatial remapping lies in the service of action rather than perception. While spatial remapping is often invoked to explain perceptual stability,[11–13,15] the necessity of high-resolution transsaccadic memory for basic visual perception is debated.[13,62–64] A prevailing view suggests that detailed internal models are unnecessary for perception, given the continuous availability of visual information in the external world.[13,44] Our findings support an alternative perspective, aligning with the proposal that high-resolution transsaccadic memory primarily serves action rather than perception.[13] This is consistent with the need for precise localisation in eye-hand coordination tasks such as pointing or grasping.[65] Even when unaware of intrasaccadic target displacements, individuals rapidly adjust their reaching movements, suggesting direct access of the motor system to remapping signals.[66] Further support comes from evidence that pointing to remembered locations is biased by changes in eye position,[67] and that remapping neurons reside within the dorsal “action” visual pathway, rather than the ventral “perception” visual pathway.[13,68,69] By demonstrating a strong link between transsaccadic working memory and drawing (a complex fine motor skill), our findings suggest that precise visual working memory across eye movements plays an important role in complex fine motor control.”

      We are deeply grateful to the reviewers for their meticulous reading of our manuscript and for the constructive feedback provided throughout this process. Your insights have significantly enhanced the clarity and rigour of our work.

      In addition to the changes requested by the reviewers, we wish to acknowledge a reporting error identified during the revision process. In the original Results section, the repeated measures ANOVA statistics for YC included Greenhouse-Geisser corrections, and the between-subjects degrees of freedom were incorrectly reported as within-subjects residuals. Upon re-evaluation of the data, we confirmed that the assumption of sphericity was not violated; therefore, we have removed the unnecessary Greenhouse-Geisser corrections and corrected the degrees of freedom throughout the Results and Methods sections. We have ensured that these statistical updates are reflected accurately in the revised manuscript and that they do not alter the significance or interpretation of any of our primary findings.

      We hope that these revisions address all the concerns raised and provide a more robust account of our findings. We look forward to your further assessment of our work.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Polymers of orthophosphate of varying lengths are abundant in prokaryotes and some eukaryotes, where they regulate many cellular functions. Though they exist in metazoans, few tools exist to study their function. This study documents the development of tools to extract, measure, and deplete inorganic polyphosphates in *Drosophila*. Using these tools, the authors show:

      (1) That polyP levels are negligible in embryos and larvae of all stages while they are feeding. They remain high in pupae but their levels drop in adults.

      (2) That many cells in tissues such as the salivary glands, oocytes, haemocytes, imaginal discs, optic lobe, muscle, and crop, have polyP that is either cytoplasmic or nuclear (within the nucleolus).

      (3) That polyP is necessary in plasmatocytes for blood clotting in Drosophila.

      (4) That ployP controls the timing of eclosion.

      The tools developed in the study are innovative, well-designed, tested, and well-documented. I enjoyed reading about them and I appreciate that the authors have gone looking for the functional role of polyP in flies, which hasn't been demonstrated before. The documentation of polyP in cells is convincing as its role in plasmatocytes in clotting.

      We sincerely thank the reviewer for their encouraging assessment and for recognizing both the innovation of the FLYX toolkit and the functional insights it enables. Their remarks underscore the importance of establishing Drosophila as a tractable model for polyP biology, and we are grateful for their constructive feedback, which further strengthened the manuscript.

      Its control of eclosion timing, however, could result from non-specific effects of expressing an exogenous protein in all cells of an animal.

      We now explicitly state this limitation in the revised manuscript (p.16, l.347–349). The issue is that no catalytic-dead ScPpX1 is available as a control in the field. We plan to generate such mutants through systematic structural and functional studies and will update the FLYX toolkit once they are developed and validated. Importantly, the accelerated eclosion phenotype is reproducible and correlates with endogenous polyP dynamics.

      The RNAseq experiments and their associated analyses on polyP-depleted animals and controls have not been discussed in sufficient detail.  In its current form, the data look to be extremely variable between replicates and I'm therefore unsure of how the differentially regulated genes were identified.

      We thank the reviewer for pointing out the lack of clarity. We have expanded our RNAseq analysis in the revised manuscript (p.20, l.430–434). Because of inter-sample variation (PC2 = 19.10%, Fig. S7B), we employed Gene Set Enrichment Analysis (GSEA) rather than strict DEG cutoffs. This method is widely used when the goal is to capture pathway-level changes under variability (1). We now also highlight this limitation explicitly (p.20, l.430–432) and provide an additional table with gene-specific fold change (See Supplementary Table for RNA Sequencing Sheet 1). Please note that we have moved RNAseq data to Supplementary Fig. 7 and 8 as suggested in the review.

      It is interesting that no kinases and phosphatases have been identified in flies. Is it possible that flies are utilising the polyP from their gut microbiota? It would be interesting to see if these signatures go away in axenic animals.

      This is an interesting possibility. Several observations argue that polyP is synthesized by fly tissues: (i) polyP levels remain very low during feeding stages but build up in wandering third instar larvae after feeding ceases; (ii) PPBD staining is absent from the gut except the crop (Fig. S3O–P); (ii) In C. elegans, intestinal polyP was unaffected when worms were fed polyP-deficient bacteria (2); (iv) depletion of polyP from plasmatocytes alone impairs hemolymph clotting, which would not be expected if gut-derived polyP were the major source and may have contributed to polyP in hemolymph. Nevertheless, we agree that microbiota-derived polyP may contribute, and we plan systematic testing in axenic flies in future work.

      Reviewer #2 (Public review):

      Summary:

      The authors of this paper note that although polyphosphate (polyP) is found throughout biology, the biological roles of polyP have been under-explored, especially in multicellular organisms. The authors created transgenic Drosophila that expressed a yeast enzyme that degrades polyP, targeting the enzyme to different subcellular compartments (cytosol, mitochondria, ER, and nucleus, terming these altered flies Cyto-FLYX, Mito-FLYX, etc.). The authors show the localization of polyP in various wild-type fruit fly cell types and demonstrate that the targeting vectors did indeed result in the expression of the polyP degrading enzyme in the cells of the flies. They then go on to examine the effects of polyP depletion using just one of these targeting systems (the Cyto-FLYX). The primary findings from the depletion of cytosolic polyP levels in these flies are that it accelerates eclosion and also appears to participate in hemolymph clotting. Perhaps surprisingly, the flies seemed otherwise healthy and appeared to have little other noticeable defects. The authors use transcriptomics to try to identify pathways altered by the cyto-FLYX construct degrading cytosolic polyP, and it seems likely that their findings in this regard will provide avenues for future investigation. And finally, although the authors found that eclosion is accelerated in the pupae of Drosophila expressing the Cyto-FLYX construct, the reason why this happens remains unexplained.

      Strengths:

      The authors capitalize on the work of other investigators who had previously shown that expression of recombinant yeast exopolyphosphatase could be targeted to specific subcellular compartments to locally deplete polyP, and they also use a recombinant polyP-binding protein (PPBD) developed by others to localize polyP. They combine this with the considerable power of Drosophila genetics to explore the roles of polyP by depleting it in specific compartments and cell types to tease out novel biological roles for polyP in a whole organism. This is a substantial advance.

      We are grateful to the reviewer for their thorough and thoughtful evaluation. Their balanced summary of our work, recognition of the strengths of our genetic tools, and constructive suggestions have been invaluable in clarifying our experiments and strengthening the conclusions.

      Weaknesses:

      Page 4 of the Results (paragraph 1): I'm a bit concerned about the specificity of PPBD as a probe for polyP. The authors show that the fusion partner (GST) isn't responsible for the signal, but I don't think they directly demonstrate that PPBD is binding only to polyP. Could it also bind to other anionic substances? A useful control might be to digest the permeabilized cells and tissues with polyphosphatase prior to PPBD staining and show that the staining is lost.

      To address this concern, we have done two sets of experiments:

      (1) We generated a PPBD mutant (GST-PPBD<sup>Mut</sup>). We establish that GST-PPBD binds to polyP-2X FITC, whereas GST-PPBD<sup>Mut</sup> and GST do not bind polyP<sub>100</sub>-2X FITC using Microscale Thermophoresis. We found that, unlike the punctate staining pattern of GST-PPBD (wild-type), GST-PPBD<sup>Mut</sup> does not stain hemocytes. This data has been added to the revised manuscript (Fig. 2B-D, p.8, l.151–165).

      (2) A study in C.elegans by Quarles et.al has performed a similar experiment, suggested by the reviewer. In that study, treating permeabilized tissues with polyphosphatase prior to PPBD staining resulted in a decrease of PPBD-GFP signal from the tissues (2). We also performed the same experiment where we subjected hemocytes to GST-PPBD staining with prior incubation of fixed and permeabilised hemocytes with ScPpX1 and heat-inactivated ScPpX1 protein. We find that both staining intensity and the number of punctae are higher in hemocytes left untreated and in those treated with heat-inactivated ScPpX1. The hemocytes pre-treated with ScPpX1 showed reduced staining intensity and number of punctae. This data has been added to the revised manuscript (Fig. 2E-G, p.8, l.166-172).

      Further, Saito et al. reported that PPBD binds to polyP in vitro, as well as in yeast and mammalian cells, with a high affinity of ~45µM for longer polyP chains (35 mer and above) (3). They also show that the affinity of PPBD with RNA and DNA is very low. Furthermore, PPBD could detect differences in polyP labeling in yeasts grown under different physiological conditions that alter polyP levels (3). Taken together, published work and our results suggest that PPBD specifically labels polyP.

      In the hemolymph clotting experiments, the authors collected 2 ul of hemolymph and then added 1 ul of their test substance (water or a polyP solution). They state that they added either 0.8 or 1.6 nmol polyP in these experiments (the description in the Results differs from that of the Methods). I calculate this will give a polyP concentration of 0.3 or 0.6 mM. This is an extraordinarily high polyP concentration and is much in excess of the polyP concentrations used in most of the experiments testing the effects of polyP on clotting of mammalian plasma. Why did the authors choose this high polyP concentration? Did they try lower concentrations? It seems possible that too high a polyP concentration would actually have less clotting activity than the optimal polyP concentration.

      We repeated the assays using 125 µM polyP, consistent with concentrations employed in mammalian plasma studies (4,5). Even at this lower, physiologically relevant concentration, polyP significantly enhanced clot fibre formation (Included as Fig. S5F–I, p.12, l.241–243). This reconfirms the conclusion that polyP promotes hemolymph clotting.

      Author response image 1.

      Reviewer #3 (Public review):

      Summary:

      Sarkar, Bhandari, Jaiswal, and colleagues establish a suite of quantitative and genetic tools to use Drosophila melanogaster as a model metazoan organism to study polyphosphate (polyP) biology. By adapting biochemical approaches for use in D. melanogaster, they identify a window of increased polyP levels during development. Using genetic tools, they find that depleting polyP from the cytoplasm alters the timing of metamorphosis, accelerating eclosion. By adapting subcellular imaging approaches for D. melanogaster, they observe polyP in the nucleolus of several cell types. They further demonstrate that polyP localizes to cytoplasmic puncta in hemocytes, and further that depleting polyP from the cytoplasm of hemocytes impairs hemolymph clotting. Together, these findings establish D. melanogaster as a tractable system for advancing our understanding of polyP in metazoans.

      Strengths:

      (1) The FLYX system, combining cell type and compartment-specific expression of ScPpx1, provides a powerful tool for the polyP community.

      (2) The finding that cytoplasmic polyP levels change during development and affect the timing of metamorphosis is an exciting first step in understanding the role of polyP in metazoan development, and possible polyP-related diseases.

      (3) Given the significant existing body of work implicating polyP in the human blood clotting cascade, this study provides compelling evidence that polyP has an ancient role in clotting in metazoans.

      We sincerely thank the reviewer for their generous and insightful comments. Their recognition of both the technical strengths of the FLYX system and the broader biological implications reinforces our confidence that this work will serve as a useful foundation for the community.

      Limitations:

      (1) While the authors demonstrate that HA-ScPpx1 protein localizes to the target organelles in the various FLYX constructs, the capacity of these constructs to deplete polyP from the different cellular compartments is not shown. This is an important control to both demonstrate that the GTS-PPBD labeling protocol works, and also to establish the efficacy of compartment-specific depletion. While not necessary to do this for all the constructs, it would be helpful to do this for the cyto-FLYX and nuc-FLYX.

      We confirmed polyP depletion in Cyto-FLYX using the malachite green assay (Fig. 3D, p.10, l.212–214). The efficacy of ScPpX1 has also been earlier demonstrated in mammalian mitochondria (6). Our preliminary data from Mito-ScPpX1 expressed ubiquitously with Tubulin-Gal4 showed a reduction in polyP levels when estimated from whole flies (See Author response image 2 below, ongoing investigation). In an independent study focusing on mitochondrial polyP depletion, we are characterizing these lines in detail  and plan to check the amount of polyP contributed to the cellular pool by mitochondria using subcellular fractionation. Direct phenotypic and polyP depletion analyses of Nuc-FLYX and ER-FLYX are also being carried out, but are in preliminary stages. That there is a difference in levels of polyP in various tissues and that we get a very little subscellular fraction for polyP analysis have been a few challenging issues. This analysis requires detailed, independent, and careful analysis, and thus, we refrain from adding this data to the current manuscript.

      Author response image 2.

      Regarding the specificity, Saito et.al. reported that PPBD binds to polyP in vitro, as well as in yeast and mammalian cells with a high affinity of ~45µM for longer polyP chains (35 mer and above) (3). They also show that the affinity of PPBD with RNA and DNA is very low. Further, PPBD could reveal differences in polyP labeling with yeasts grown in different physiological conditions that can alter polyP levels. Now in the manuscript, we included following data to show specificity of PPBD:

      To address this concern we have done two sets of experiments:

      We generated a PPBD mutant (GST-PPBD<sup>Mut</sup>). Using Microscale Thermophoresis, we establish that GST-PPBD binds to polyP<sub>100</sub>-2X-FITC, whereas, GST-PPBD<sup>Mut</sup> and GST do not bind polyP<sub>100</sub>-2X-FITC at all. We found that unlike the punctate staining pattern of GST-PPBD (wild-type), GST-PPBD<sup>Mut</sup> does not stain hemocytes. This data has been added to the revised manuscript (Fig. 2B-D, p.8, l.151–165).

      A study in C.elegans by Quarles et.al has performed a similar experiment suggested by the reviewer. In that study, treating permeabilized tissues with polyphosphatase prior to PPBD staining resulted in decrease of PPBD-GFP signal from the tissues (2). We also performed the same experiment where we subjected hemocytes to GST-PPBD staining with prior incubation of fixed and permeabilised hemocytes with ScPpX1 and heat inactivated ScPpX1 protein. We find that both intensity of staining and number of punctae are higher in hemocytes that were left untreated and the one where heat inactivated ScPpX1 was added. The hemocytes pre-treated with ScPpX1 showed reduced staining intensity and number of punctae. This data has been added to the revised manuscript (Fig. 2E-G, p.8, l.166-172).

      (2) The cell biological data in this study clearly indicates that polyP is enriched in the nucleolus in multiple cell types, consistent with recent findings from other labs, and also that polyP affects gene expression during development. Given that the authors also generate the Nuc-FLYX construct to deplete polyP from the nucleus, it is surprising that they test how depleting cytoplasmic but not nuclear polyP affects development. However, providing these tools is a service to the community, and testing the phenotypic consequences of all the FLYX constructs may arguably be beyond the scope of this first study.

      We agree this is an important avenue. In this first study, we focused on establishing the toolkit and reporting phenotypes with Cyto-FLYX. We are systematically assaying phenotypes from all FLYX constructs, including Nuc-FLYX, in ongoing studies

      Recommendations for the authors:

      Reviewing Editor Comment:

      The reviewers appreciated the general quality of the rigour and work presented in this manuscript. We also had a few recommendations for the authors. These are listed here and the details related to them can be found in the individual reviews below.

      (1) We suggest including an appropriate control to show that PPBD binds polyP specifically.

      We have updated the response section as follows:

      (a) Highlighted previous literature that showed the specificity of PPBD.

      (b) We show that the punctate staining observed by PPBD is not demonstrated by the mutant PPBD (PPBD<sup>Mut</sup>) in which amino acids that are responsible for polyP binding are mutated.

      (c) We show that PPBD<sup>Mut</sup> does not bind to polyP using Microscale Thermophoresis.

      (d) We show that treatment of fixed and permeabilised hemocytes with ScPpX1 reduces the PPBD staining intensity and number of punctae, as compared to tissues left untreated or treated with heat-inactivated ScPpX1.

      We have included these in our updated revised manuscript (Fig. 2B-G, p.8, l.151–157)

      (2) The high concentration of PolyP in the clotting assay might be impeding clotting. The authors may want to consider lowering this in their assays.

      We have addressed this concern in our revised manuscript. We have performed the clotting assays with lower polyP concentrations (concentrations previously used in clotting experiments with human blood and polyP). Data is included in Fig. S5F–I, p.12, l.241–243.

      (3) The RNAseq study: can the authors please describe this better and possibly mine it for the regulation of genes that affect eclosion?

      In our revised manuscript, we have included a broader discussion about the RNAseq analysis done in the article in both the ‘results’ and the ‘discussion’ sections, where we have rewritten the narrative from the perspective of accelerated eclosion. (p.15 l.310-335, p. 20, l.431-446).

      (4) Have the authors considered the possibility that the gut microbiota might be contributing to some of their measurements and assays? It would be good to address this upfront - either experimentally, in the discussion, or (ideally) both.

      This is an exciting possibility. Several observations argue that fly tissues synthesize polyP: (i) polyP levels remain very low during feeding stages but build up in wandering third instar larvae after feeding ceases; (ii) PPBD staining is absent from the gut except the crop (Fig. S3O–P); (iii) in C. elegans, intestinal polyP was unaffected when worms were fed polyP-deficient bacteria (2); (iv) depletion of polyP from plasmatocytes alone impairs hemolymph clotting, which would not be expected if gut-derived polyP were the major source and may have contributed to polyP in hemolymph. Nevertheless, microbiota-derived polyP may contribute, and we plan systematic testing in axenic flies in future work.

      Reviewer #1 (Recommendations for the authors):

      (1) While the authors have shown that the depletion tool results in a general reduction of polyP levels in Figure 3D, it would have been nice to show this via IHC. Particularly since the depletion depends on the strength of the Gal4, it is possible that the phenotypes are being under-estimated because the depletions are weak.

      We agree that different Gal4 lines have different strengths and will therefore affect polyP levels and the strength of the phenotype differently.

      We performed PPBD staining on hemocytes expressing ScPPX; however, we observed very intense, uniform staining throughout the cells, which was unexpected. It seems like PPBD is recognizing overexpressed ScPpX1. Indeed, in an unpublished study by Manisha Mallick (Bhandari lab), it was found that His-ScPpX1 specifically interacts with GST-PPBD in a protein interaction assay (See Author response image 3). Due to these issues, we refrained from IHC/PPBD-based validation.

      Author response image 3.

      (2) The subcellular tools for depletion are neat! I wonder why the authors didn't test them. For example in the salivary gland for nuclear depletion?

      We have addressed this question in the reviewer responses. We are systematically assaying phenotypes from all FLYX constructs, including Mito-FLYX, and Nuc-FLYX, in ongoing independent investigations. As discussed in #1, a possible interaction of ScPpX and PPBD is making this test a bit more challenging, and hence, they each require a detailed investigation.

      (a) Does the absence of clotting defects using Lz-gal4 suggest that PolyP is more crucial in the plasmatocytoes and for the initial clotting process? And that it is dispensible/less important in the crystal cells and for the later clotting process. Or is it that the crystal cells just don't have as much polyP? The image (2E-H) certainly looks like it.

      In hemolymph, the primary clot formation is a result of the clotting factors secreted from the fat bodies and the plasmatocytes. The crystal cells are responsible for the release of factors aiding in successfully hardening the soft clot initially formed. Reports suggest that clotting and melanization of the clot are independent of each other (7). Since Crystal cells do not contribute to clot fibre formation, the absence of clotting defects using LzGAL4-CytoFLYX is not surprising. Alternatively, PolyP may be secreted from all hemocytes and contribute to clotting; however, the crystal cells make up only 5% hemocytes, and hence polyP depletion in those cells may have a negligible effect on blood clotting.

      Crystal cells do show PPBD staining. Whether polyP is significantly lower in levels in the crystal cells as compared to the plasmatocytes needs more systematic investigation. Image (2E-H) is a representative image of the presence of polyP in crystal cells and can not be considered to compare polyP levels in the crystal cells vs Plasmatocytes.

      (b) The RNAseq analyses and data could be better presented. If the data are indeed variable and the differentially expressed genes of low confidence, I might remove that data entirely. I don't think it'll take away from the rest of the work.

      We understand this concern and, therefore, in the revised manuscript, we have included a broader discussion about the RNAseq analysis done in the article in both the ‘results’ and the ‘discussion’ sections, where we have rewritten the narrative from the perspective of accelerated eclosion. (p.15 l.310-335, p. 20, l.431-446). We have also stated the limitations of such studies.

      (c) I would re-phrase the first sentence of the results section.

      We have re-phrased it in the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors created several different versions of the FLYX system that would be targeted to different subcellular compartments. They mostly report on the effects of cytosolic targeting, but some of the constructs targeted the polyphosphatase to mitochondria or the nucleus.

      They report that the targeting worked, but I didn't see any results on the effects of those constructs on fly viability, development, etc.

      There is a growing literature of investigators targeting polyphosphatase to mitochondria and showing how depleting mitochondrial polyP alters mitochondrial function. What was the effect of the Nuc-FLYX and Mito-FLYX constructs on the flies?

      Also, the authors should probably cite the papers of others on the effects of depleting mitochondrial polyP in other eukaryotic cells in the context of discussing their findings in flies.

      We have addressed this question in the reviewer responses. We did not see any obvious developmental or viability defects with any of the FLYX lines, and only after careful investigation did we come across the clotting defects in the CytoFLYX. We are currently systematically assaying phenotypes from all FLYX constructs, including Mito-FLYX and Nuc-FLYX, in independent ongoing investigations.

      We have discussed the heterologous expression of mitochondrial polyphosphatase in mammalian cells to justify the need for developing Mito-FLYX (p. 10, l. 197-200). In the discussion section, we also discuss the presence and roles of polyP in the nucleus and how Nuc-FLYX can help study such phenomena (p. 19, l. 399-407).

      (2) The authors should number the pages of their manuscript to make it easier for reviewers to refer to specific pages.

      We have numbered our lines and pages in the revised manuscript.

      (3) Abstract: the abbreviation, "polyP", is not defined in the abstract. The first word in the abstract is "polyphosphate", so it should be defined there.

      We have corrected it in the revised version.

      (4) The authors repeatedly use the phrase, "orange hot", to describe one of the colors in their micrographs, but I don't know how this differs from "orange".

      ‘OrangeHot’ is the name of the LUT used in the ImageJ analysis and hence referred to as the colour

      (5) First page of the Introduction: the phrase, "feeding polyP to αβ expression Alzheimer's model of Caenorhabditis elegans" is awkward (it literally means feeding polyP to the model instead of the worms).

      We have revised it. (p.3, l.55-57).

      (6) Page 2 of the Introduction: The authors should cite this paper when they state that NUDT3 is a polyphosphatase: https://pubmed.ncbi.nlm.nih.gov/34788624/

      We have cited the paper in the revised version of the manuscript. (p.4, l. 68-70)

      (7) Page 2 of Results: The authors report the polyP content in the third instar larva (misspelled as "larval") to five significant digits ("419.30"). Their data do not support more than three significant digits, though.

      We have corrected it in the revised manuscript.

      (8) Page 3 of Results (paragraph 1): When discussing the polyP levels in various larval stages, the authors are extracting total polyP from the larvae. It seems that at least some of the polyP may come from gut microbes. This should probably be mentioned.

      This is an interesting possibility. Several observations argue that polyP is synthesized by fly tissues: (i) polyP levels remain very low during feeding stages but build up in wandering third instar larvae after feeding ceases; (ii) PPBD staining is absent from the gut except the crop (Fig. S3O–P); (ii) In C. elegans, intestinal polyP was unaffected when worms were fed polyP-deficient bacteria (2); (iv) depletion of polyP from plasmatocytes alone impairs hemolymph clotting, which would not be expected if gut-derived polyP were the major source and may have contributed to polyP in hemolymph. We mention this limitation in the revised manuscript (p.19-20, l. 425-433).

      (9) Page 3 of Results (paragraph 2): stating that the 4% paraformaldehyde works "best" is imprecise. What do the authors mean by "best"?

      We have addressed this comment in the revised manuscript and corrected it as 4% paraformaldehyde being better among the three methods we used to fix tissues, which also included methanol and Bouin’s fixative  (p.8, l. 152-154).

      (10) Page 4 of Results (paragraph 2, last line of the page): The scientific literature is vast, so one can never be sure that one knows of all the papers out there, even on a topic as relatively limited as polyP. Therefore, I would recommend qualifying the statement "...this is the first comprehensive tissue staining report...". It would be more accurate (and safer) to say something like, "to our knowledge, this is the first..." There is a similar statement with the word "first" on the next page regarding the FLYX library.

      We have addressed this concern and corrected it accordingly in the revised version of the manuscript (p.9, l. 192-193)

      Reviewer #3 (Recommendations for the authors):

      (1) The authors should include in their discussion a comparison of cell biological observations using the polyP binding domain of E. coli Ppx (GST-PPBD) to fluorescently label polyP in cells and tissues with recent work using a similar approach in C. elegans (Quarles et al., PMID:39413779).

      In the revised manuscript, we have cited the work of Quarles et al. and have added a comparison of observations (p.19,l.408-410). In the discussion, we have also focused on multiple other studies about how polyP presence in different subcellular compartments, like the nucleus, can be assayed and studied with the tools developed in this study.

      (2) The gene expression studies of time-matched Cyto-FLYX vs WT larvae is very intriguing. Given the authors' findings that non-feeding third instar Cyto-FLYX larvae are developmentally ahead of WT larvae, can the observed trends be explained by known changes in gene expression that occur during eclosion? This is mentioned in the results section in the context of genes linked to neurons, but a broader discussion of which pathway changes observed can be explained by the developmental stage difference between the WT and FLYX larvae would be helpful in the discussion.

      We have included a broader discussion about the RNAseq analysis done in the article in both the ‘results’ and the ‘discussion’ sections, where we have rewritten the narrative from the perspective of accelerated eclosion. (p.15 l.310-335, p. 20, l.431-446). We have also stated the limitations of such studies.

      (3) The sentence describing NUDT3 is not referenced.

      We have addressed this comment and have cited the paper of NUDT3 in the revised version of the manuscript.(p.4, l. 68-70)

      (4) In the first sentence of the results section, the meaning/validity of the statement "The polyP levels have decreased as evolution progressed" is not clear. It might be more straightforward to give an estimate of the total pmoles polyP/mg protein difference between bacteria/yeast and metazoans.

      In the revised manuscript, we have given an estimate of the polyP content across various species across evolution to uphold the statement that polyP levels have decreased as evolution progressed (p. 5, l. 87-91).

      (5) The description of the malachite green assay in the results section describes it as "calorimetric" but this should read "colorimetric?"

      We have corrected it in the revised manuscript.

      References

      (1) Chicco D, Agapito G. Nine quick tips for pathway enrichment analysis. PLoS Comput Biol. 2022 Aug 11;18(8):e1010348.

      (2) Quarles E, Petreanu L, Narain A, Jain A, Rai A, Wang J, et al. Cryosectioning and immunofluorescence of C. elegans reveals endogenous polyphosphate in intestinal endo-lysosomal organelles. Cell Rep Methods. 2024 Oct 8;100879.

      (3) Saito K, Ohtomo R, Kuga-Uetake Y, Aono T, Saito M. Direct labeling of polyphosphate at the ultrastructural level in Saccharomyces cerevisiae by using the affinity of the polyphosphate binding domain of Escherichia coli exopolyphosphatase. Appl Environ Microbiol. 2005 Oct;71(10):5692–701.

      (4) Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA. 2006 Jan 24;103(4):903–8.

      (5) Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010 Nov 18;116(20):4353–9.

      (6) Abramov AY, Fraley C, Diao CT, Winkfein R, Colicos MA, Duchen MR, et al. Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death. Proc Natl Acad Sci USA. 2007 Nov 13;104(46):18091–6.

      (7) Schmid MR, Dziedziech A, Arefin B, Kienzle T, Wang Z, Akhter M, et al. Insect hemolymph coagulation: Kinetics of classically and non-classically secreted clotting factors. Insect Biochem Mol Biol. 2019 Jun;109:63–71.

      (8) Jian Guan, Rebecca Lee Hurto, Akash Rai, Christopher A. Azaldegui, Luis A. Ortiz-Rodríguez, Julie S. Biteen, Lydia Freddolino, Ursula Jakob. HP-Bodies – Ancestral Condensates that Regulate RNA Turnover and Protein Translation in Bacteria. bioRxiv 2025.02.06.636932; doi: https://doi.org/10.1101/2025.02.06.636932.

      (9) Lonetti A, Szijgyarto Z, Bosch D, Loss O, Azevedo C, Saiardi A. Identification of an evolutionarily conserved family of inorganic polyphosphate endopolyphosphatases. J Biol Chem. 2011 Sep 16;286(37):31966–74.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      This paper introduces a dual-pathway model for reconstructing naturalistic speech from intracranial ECoG data. It integrates an acoustic pathway (LSTM + HiFi-GAN for spectral detail) and a linguistic pathway (Transformer + Parler-TTS for linguistic content). Output from the two components is later merged via CosyVoice2.0 voice cloning. Using only 20 minutes of ECoG data per participant, the model achieves high acoustic fidelity and linguistic intelligibility.

      Strengths

      (1) The proposed dual-pathway framework effectively integrates the strengths of neural-to-acoustic and neural-to-text decoding and aligns well with established neurobiological models of dual-stream processing in speech and language.

      (2) The integrated approach achieves robust speech reconstruction using only 20 minutes of ECoG data per subject, demonstrating the efficiency of the proposed method.

      (3) The use of multiple evaluation metrics (MOS, mel-spectrogram R², WER, PER) spanning acoustic, linguistic (phoneme and word), and perceptual dimensions, together with comparisons against noisedegraded baselines, adds strong quantitative rigor to the study.

      We thank Reviewer #1 for the supportive comments. In addition, we appreciate Reviewer #1’s thoughtful comments and feedback. By addressing these comments, we believe we have greatly improved the clarity of our claims and methodology. Below we list our point-to-point responses addressing concerns raised by Reviewer #1.

      Weaknesses:

      (1) It is unclear how much the acoustic pathway contributes to the final reconstruction results, based on Figures 3B-E and 4E. Including results from Baseline 2 + CosyVoice and Baseline 3 + CosyVoice could help clarify this contribution.

      We sincerely appreciate the inquiry from Reviewer 1. We thank the reviewer for this suggestion. However, we believe that directly applying CosyVoice to the outputs of Baseline 2 or Baseline 3 in isolation is not methodologically feasible and would not correctly elucidate the contribution of the auditory pathway and might lead to misinterpretation.

      The role of CosyVoice 2.0 in our framework is specifically voice cloning and fusion, not standalone enhancement. It is designed to integrate information from two pathways. Its operation requires two key inputs:

      (1) A voice reference speech that provides the target speaker's timbre and prosodic characteristics. In our final pipeline, this is provided by the denoised output of the acoustic pathway (Baseline 2).

      (2) A target word sequence that specifies the linguistic content to be spoken. This is obtained by transcribing the output of the linguistic pathway (Baseline 3) using Whisper ASR. Therefore, the standalone outputs of Baseline 2 and Baseline 3 are the purest demonstrations of what each pathway contributes before fusion. The significant improvement in WER/PER and MOS in the final output (compared to Baseline 2) and the significant improvement in melspectrogram R² (compared to Baseline 3) together demonstrate the complementary contributions of the two pathways. The fusion via CosyVoice is the mechanism that allows these contributions to be combined. We have added a clearer explanation of CosyVoice's role and the rationale for not testing it on individual baselines in the revised manuscript (Results section: "The fine-tuned voice cloner further enhances...").

      Edits:

      Page 11, Lines 277-282:

      “ Voice cloning is used to bridge the gap between acoustic fidelity and linguistic intelligibility in speech reconstruction. This approach strategically combines the strengths of complementary pathways: the acoustic pathway preserves speaker-specific spectral characteristics while the linguistic pathway maintains lexical and phonetic precision. By integrating these components through neural voice cloning, we achieve balanced reconstruction that overcomes the limitations inherent in isolated systems. CosyVoice 2.0, the voice cloner module serves specifically as a voice cloning and fusion engine, requiring two inputs: (1) a voice reference speech (provided by the denoised output of the acoustic pathway) to specify the target speaker's identity, and (2) a target word sequence (transcribed from the output of the linguistic pathway) to specify the linguistic content. The standalone baseline outputs of the two pathways can be integrated in this way.”

      (2) As noted in the limitations, the reconstruction results heavily rely on pre-trained generative models. However, no comparison is provided with state-of-the-art multimodal LLMs such as Qwen3-Omni, which can process auditory and textual information simultaneously. The rationale for using separate models (Wav2Vec for speech and TTS for text) instead of a single unified generative framework should be clearly justified. In addition, the adaptor employs an LSTM architecture for speech but a Transformer for text, which may introduce confounds in the performance comparison. Is there any theoretical or empirical motivation for adopting recurrent networks for auditory processing and Transformer-based models for textual processing?

      We thank the reviewer for the insightful suggestion regarding multimodal large language models (LLMs) such as Qwen3-Omni. It is important to clarify the distinction between general-purpose interactive multimodal models and models specifically designed for high-fidelity voice cloning and speech synthesis.

      As for the comparison with the state-of-the-art multimodal LLMs:

      Qwen3-Omni and GLM-4-Voice are powerful conversational agents capable of processing multiple modalities including text, speech, image, and video, as described in its documentation (see: https://help.aliyun.com/zh/model-studio/qwen-tts-realtime and https://docs.bigmodel.cn/cn/guide/models/sound-and-video/glm-4-voice). However, it is primarily optimized for interactive dialogue and multimodal understanding rather than for precise, speaker-adaptive speech reconstruction from neural signals. In contrast, CosyVoice 2.0, developed by the same team at Alibaba, is specifically designed for voice cloning and text-to-speech synthesis (see: https://help.aliyun.com/zh/model-studio/text-to-speech). It incorporates advanced speaker adaptation and acoustic modeling capabilities that are essential for reconstructing naturalistic speech from limited neural data. Therefore, our choice of CosyVoice for the final synthesis stage aligns with the goal of integrating acoustic fidelity and linguistic intelligibility, which is central to our study.

      For the selection of LSTM and Transformer in the two pathways:

      The goal of the acoustic adaptor is to reconstruct fine-grained spectrotemporal details (formants, harmonic structures, prosodic contours) with millisecond-to-centisecond precision. These features rely heavily on local temporal dynamics and short-to-medium range dependencies (e.g., within and between phonemes/syllables). In our ablation studies (to be added in the supplementary), we found that Transformer-based adaptors, which inherently emphasize global sentence-level context through self-attention, tended to oversmooth the reconstructed acoustic features, losing critical fine-temporal details essential for naturalness. In contrast, the recurrent nature of LSTMs, with their inherent temporal state propagation, proved more effective at modeling these local sequential dependencies without excessive smoothing, leading to higher mel-spectrogram fidelity. This aligns with the neurobiological observation that early auditory cortex processes sound with precise temporal fidelity. Moreover, from an engineering perspective, LSTM-based decoders have been empirically shown to perform well in sequential prediction tasks with limited data, as evidenced in prior work on sequence modeling and neural decoding (1).

      The goal of the linguistic adaptor is to decode abstract, discrete word tokens. This task benefits from modeling long-range contextual dependencies across a sentence to resolve lexical ambiguity and syntactic structure (e.g., subject-verb agreement). The self-attention mechanism of Transformers is exceptionally well-suited for capturing these global relationships, as evidenced by their dominance in NLP. Our experiments confirmed that a Transformer adaptor outperformed an LSTM-based one in word token prediction accuracy.

      While a unified multimodal LLM could in principle handle both modalities, such models often face challenges in modality imbalance and task specialization. Audio and text modalities have distinct temporal scales, feature distributions, and learning dynamics. By decoupling them into separate pathways with specialized adaptors, we ensure that each modality is processed by an architecture optimized for its inherent structure. This divide-and-conquer strategy avoids the risk of one modality dominating or interfering with the learning of the other, leading to more stable training and better final performance, especially important when adapting to limited neural data.

      Edits:

      Page 9, Lines 214-223:

      “The acoustic pathway, implemented through a bi-directional LSTM neural adaptor architecture (Fig. 1B), specializes in reconstructing fundamental acoustic properties of speech. This module directly processes neural recordings to generate precise time-frequency representations, focusing on preserving speaker-specific spectral characteristics like formant structures, harmonic patterns, and spectral envelope details. Quantitative evaluation confirms its core competency: achieving a mel-spectrogram R² of 0.793 ± 0.016 (Fig. 3B) demonstrates remarkable fidelity in reconstructing acoustic microstructure. This performance level is statistically indistinguishable from original speech degraded by 0dB additive noise (0.771 ± 0.014, p = 0.242, one-sided t-test). We chose a bidirectional LSTM architecture for this adaptor because its recurrent nature is particularly suited to modeling the fine-grained, short- to medium-range temporal dependencies (e.g., within and between phonemes and syllables) that are critical for acoustic fidelity. An ablation study comparing LSTM against Transformerbased adaptors for this task confirmed that LSTMs yielded superior mel-spectrogram reconstruction fidelity (higher R²), as detailed in Table S1, likely by avoiding the oversmoothing of spectrotemporal details sometimes induced by the strong global context modeling of Transformers”.

      “To confirm that the acoustic pathway’s output is causally dependent on the neural signal rather than the generative prior of the HiFi-GAN, we performed a control analysis in which portions of the input ECoG recording were replaced with Gaussian noise. When either the first half, second half, or the entirety of the neural input was replaced by noise, the melspectrogram R² of the reconstructed speech dropped markedly, corresponding to the corrupted segment (Fig. S5). This demonstrates that the reconstruction is temporally locked to the specific neural input and that the model does not ‘hallucinate’ spectrotemporal structure from noise. These results validate that the acoustic pathway performs genuine, input-sensitive neural decoding”.

      Edits:

      Page 10, Lines 272-277:

      “We employed a Transformer-based Seq2Seq architecture for this adaptor to effectively capture the long-range contextual dependencies across a sentence, which are essential for resolving lexical ambiguity and syntactic structure during word token decoding. This choice was validated by an ablation study (Table S2), indicating that the Transformer adaptor outperformed an LSTM-based counterpart in word prediction accuracy”

      (3) The model is trained on approximately 20 minutes of data per participant, which raises concerns about potential overfitting. It would be helpful if the authors could analyze whether test sentences with higher or lower reconstruction performance include words that were also present in the training set.

      Thank you for raising the important concern regarding potential overfitting given the limited size of our training dataset (~20 minutes per participant). To address this point directly, we performed a detailed lexical overlap analysis between the training and test sets.

      The test set contains 219 unique words. Among these:

      127 words (58.0%) appeared in the training set (primarily high-frequency, common words).

      92 words (42.0%) were entirely novel and did not appear in the training set. We further examined whether trials with the best reconstruction (WER = 0) relied more on training vocabulary. Among these top-performing trials, 55.0% of words appeared in the training set. In contrast, the worst-performing trials showed 51.9% overlap in words in the training set. No significant difference was observed, suggesting that performance is not driven by simple lexical memorization.

      The presence of a substantial proportion of novel words (42%) in the test set, combined with the lack of performance advantage for overlapping content, provides strong evidence that our model is generalizing linguistic and acoustic patterns rather than merely memorizing the training vocabulary. High reconstruction performance on unseen words would be improbable under severe overfitting.

      Therefore, we conclude that while some lexical overlap exists (as expected in natural language), the model’s performance is driven by its ability to decode generalized neural representations, effectively mitigating the overfitting risk highlighted by the reviewer.

      (4) The phoneme confusion matrix in Figure 4A does not appear to align with human phoneme confusion patterns. For instance, /s/ and /z/ differ only in voicing, yet the model does not seem to confuse these phonemes. Does this imply that the model and the human brain operate differently at the mechanistic level?

      We thank the reviewer for this detailed observation regarding the difference between our model's phoneme confusion patterns and typical human perceptual confusions (e.g., the lack of /s/-/z/ confusion).

      The reviewer is correct in inferring a mechanistic difference. This divergence is primarily attributable to the Parler-TTS model acting as a powerful linguistic prior. Our linguistic pathway decodes word tokens, which Parler-TTS then converts to speech. Trained on massive corpora to produce canonical pronunciations, Parler-TTS effectively performs an implicit "error correction." For instance, if the neural decoding is ambiguous between the words "sip" and "zip," the TTS model's strong prior for lexical and syntactic context will likely resolve it to the correct word, thereby suppressing purely acoustic confusions like voicing.

      This has important implications for interpreting our model's errors and its relationship to brain function. The phoneme errors in our final output reflect a combination of neural decoding errors and the generative biases of the TTS model, which is optimized for intelligibility rather than mimicking raw human misperception. This does imply our model operates differently from the human auditory periphery. The human brain may first generate a percept with acoustic confusions, which higher-level language regions then disambiguate. Our model effectively bypasses the "confused percept" stage by directly leveraging a pre-trained, high-level language model for disambiguation. This is a design feature contributing to its high intelligibility, not necessarily a flaw. This observation raises a fascinating question: Could a model that more faithfully simulates the hierarchical processing of the human brain (including early acoustic confusions) provide a better fit to neural data at different processing stages? Future work could further address this question.

      Edits:

      add another paragraph in Discussion (Page 14, Lines 397-398):

      “The phoneme confusion pattern observed in our model output (Fig. 4A) differs from classic human auditory confusion matrices. We attribute this divergence primarily to the influence of the Parler-TTS model, which serves as a strong linguistic prior in our pipeline. This component is trained to generate canonical speech from text tokens. When the upstream neural decoding produces an ambiguous or erroneous token sequence, the TTS model’s internal language model likely performs an implicit ‘error correction,’ favoring linguistically probable words and pronunciations. This underscores that our model’s errors arise from a complex interaction between neural decoding fidelity and the generative biases of the synthesis stage”

      (5) In general, is the motivation for adopting the dual-pathway model to better align with the organization of the human brain, or to achieve improved engineering performance? If the goal is primarily engineeringoriented, the authors should compare their approach with a pretrained multimodal LLM rather than relying on the dual-pathway architecture. Conversely, if the design aims to mirror human brain function, additional analysis, such as detailed comparisons of phoneme confusion matrices, should be included to demonstrate that the model exhibits brain-like performance patterns.

      Our primary motivation is engineering improvement, to overcome the fundamental trade-off between acoustic fidelity and linguistic intelligibility that has limited previous neural speech decoding work. The design is inspired by the related works of the convergent representation of speech and language perception (2). However, we do not claim that our LSTM and Transformer adaptors precisely simulate the specific neural computations of the human ventral and dorsal streams. The goal was to build a high-performance, data-efficient decoder. We will clarify this point in the Introduction and Discussion, stating that while the architecture is loosely inspired by previous neuroscience results, its primary validation is its engineering performance in achieving state-of-the-art reconstruction quality with minimal data.

      Edits:

      Page 14, Line 358-373:

      “In this study, we present a dual-path framework that synergistically decodes both acoustic and linguistic speech representations from ECoG signals, followed by a fine-tuned zero-shot text-to-speech network to re-synthesize natural speech with unprecedented fidelity and intelligibility. Crucially, by integrating large pre-trained generative models into our acoustic reconstruction pipeline and applying voice cloning technology, our approach preserves acoustic richness while significantly enhancing linguistic intelligibility beyond conventional methods. Our dual-pathway architecture, while inspired by converging neuroscience insights on speech and language perception, was principally designed and validated as an engineering solution. The primary goal to build a practical decoder that achieves state-of-theart reconstruction quality with minimal data. The framework's success is therefore ultimately judged by its performance metrics, high intelligibility (WER, PER), acoustic fidelity (melspectrogram R²), and perceptual quality (MOS), which directly address the core engineering challenge we set out to solve. Using merely 20 minutes of ECoG recordings, our model achieved superior performance with a WER of 18.9% ± 3.3% and PER of 12.0% ± 2.5% (Fig. 2D, E). This integrated architecture, combining pre-trained acoustic (Wav2Vec2.0 and HiFiGAN) and linguistic (Parler-TTS) models through lightweight neural adaptors, enables efficient mapping of ECoG signals to dual latent spaces. Such methodology substantially reduces the need for extensive neural training data while achieving breakthrough word clarity under severe data constraints. The results demonstrate the feasibility of transferring the knowledge embedded in speech-data pre-trained artificial intelligence (AI) models into neural signal decoding, paving the way for more advanced brain-computer interfaces and neuroprosthetics”.

      Reviewer #2 (Public review):

      Summary:

      The study by Li et al. proposes a dual-path framework that concurrently decodes acoustic and linguistic representations from ECoG recordings. By integrating advanced pre-trained AI models, the approach preserves both acoustic richness and linguistic intelligibility, and achieves a WER of 18.9% with a short (~20-minute) recording.

      Overall, the study offers an advanced and promising framework for speech decoding. The method appears sound, and the results are clear and convincing. My main concerns are the need for additional control analyses and for more comparisons with existing models.

      Strengths:

      (1) This speech-decoding framework employs several advanced pre-trained DNN models, reaching superior performance (WER of 18.9%) with relatively short (~20-minute) neural recording.

      (2) The dual-pathway design is elegant, and the study clearly demonstrates its necessity: The acoustic pathway enhances spectral fidelity while the linguistic pathway improves linguistic intelligibility.

      We thank Reviewer #2 for supportive comments. In addition, we appreciate Reviewer #2’s thoughtful comments and feedback. By addressing these comments, we believe we have greatly improved the clarity of our claims and methodology. Below we list our point-to-point responses addressing concerns raised by Reviewer #2.

      Weaknesses:

      The DNNs used were pre-trained on large corpora, including TIMIT, which is also the source of the experimental stimuli. More generally, as DNNs are powerful at generating speech, additional evidence is needed to show that decoding performance is driven by neural signals rather than by the DNNs' generative capacity.

      Thank you for raising this crucial point regarding the potential for pre-trained DNNs to generate speech independently of the neural input. We fully agree that it is essential to disentangle the contribution of the neural signals from the generative priors of the models. To address this directly, we have conducted two targeted control analyses, as you suggested, and have integrated the results into the revised manuscript (see Fig. S5 and the corresponding description in the Results section):

      (1) Random noise input: We fed Gaussian noise (matched in dimensionality and temporal structure to real ECoG recordings) into the trained adaptors. The outputs were acoustically unstructured and linguistically incoherent, confirming that the generative models alone cannot produce meaningful speech without valid neural input.

      (2) Partial sentence input (real + noise): For the acoustic pathway, we systematically replaced portions of the ECoG input with noise. The reconstruction quality (mel-spectrogram R²) dropped significantly in the corrupted segments, demonstrating that the decoding is temporally locked to the neural signal and does not “hallucinate” speech from noise.

      These results provide strong evidence that our model’s performance is causally dependent on and sensitive to the specific neural input, validating that it performs genuine neural decoding rather than merely leveraging the generative capacity of the pre-trained DNNs.

      The detailed edits are in the “recommendations” below. (See recommendations (1) and (2))

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Clarify the results shown in Figure 4E. The integrated approach appears to perform comparably to Baseline 3 in phoneme class clarity. However, Baseline 3 represents the output of the linguistic pathway alone, which is expected to encode information primarily at the word level.

      We appreciate the reviewer's observation and agree that clarification is needed. The phoneme class clarity (PCC) metric shown in Figure 4E measures whether mis-decoded phonemes are more likely to be confused within their own class (vowel-vowel or consonantconsonant) rather than across classes (vowel-consonant). A higher PCC indicates that the model's errors tend to be phonologically similar sounds (e.g., one vowel mistaken for another), which is a reasonable property for intelligibility.

      We would like to clarify the nature of Baseline 3. As stated in the manuscript (Results section: "The linguistic pathway reconstructs high-intelligibility, higher-level linguistic information"), Baseline 3 is the output of our linguistic pathway. This pathway operates as follows: the ECoG signals are mapped to word tokens via the Transformer adaptor, and these tokens are then synthesized into speech by the frozen Parler-TTS model. Crucially, the input to Parler-TTS is a sequence of word tokens.

      It is important to distinguish between the levels of performance measured: Word Error Rate (WER) reflects accuracy at the lexical level (whole words). The linguistic pathway achieves a low WER by design, as it directly decodes word sequences. Phoneme Error Rate (PER) reflects accuracy at the sublexical phonetic level (phonemes). A low WER generally implies a low PER, because robust word recognition requires reliable phoneme-level representations within the TTS model's prior. This explains why Baseline 3 also exhibits a low PER. However, acoustic fidelity (captured by metrics like mel-spectrogram R²) requires the preservation of fine-grained spectrotemporal details such as pitch, timbre, prosody, and formant structures, information that is not directly encoded at the lexical level and is therefore not a strength of the purely linguistic pathway.

      While Parler-TTS internally models sub-word/phonetic information to generate the acoustic waveform, the primary linguistic information driving the synthesis is at the lexical (word) level. The generated speech from Baseline 3 therefore contains reconstructed phonemic sequences derived from the decoded word tokens, not from direct phoneme-level decoding of ECoG.

      Therefore, the comparable PCC between our final integrated model and Baseline 3 (linguistic pathway) suggests that the phoneme-level error patterns (i.e., the tendency to confuse within-class phonemes) in our final output are largely inherited from the high-quality linguistic prior embedded in the pre-trained TTS model (Parler-TTS). The integrated framework successfully preserves this desirable property from the linguistic pathway while augmenting it with speaker-specific acoustic details from the acoustic pathway, thereby achieving both high intelligibility (low WER/PER) and high acoustic fidelity (high melspectrogram R²).

      We will revise the caption of Figure 4E and the corresponding text in the Results section to make this interpretation explicit.

      Edits:

      Page 12, Lines 317-322:

      “In addition to the confusion matrices, we categorized the phonemes into vowels and consonants to assess the phoneme class clarity. We defined "phoneme class clarity" (PCC) as the proportion of errors where a phoneme was misclassified within the same class versus being misclassified into a different class. The purpose of introducing PCC is to demonstrate that most of the misidentified phonemes belong to the same category (confusion between vowels or consonants), rather than directly comparing the absolute accuracy of phoneme recognition. For instance, a vowel being mistaken for another vowel would be considered a within-class error, whereas a vowel being mistaken for a consonant would be classified as a between-class error” 

      (2) Add results from Baseline 2 + CosyVoice and Baseline 3 + CosyVoice to clarify the contribution of the auditory pathway.

      Thank you for the suggestion. We appreciate the opportunity to clarify the role of CosyVoice in our framework.

      As explained in our response to point (1), CosyVoice 2.0 is designed as a fusion module that requires two inputs: 1) a voice reference (from the acoustic pathway) to specify speaker identity, and 2) a word sequence (from the linguistic pathway) to specify linguistic content. Because it is not a standalone enhancer, applying CosyVoice to a single pathway output (e.g., Baseline 2 or 3 alone) is not quite feasible and would not reflect its intended function and could lead to misinterpretation of each pathway’s contribution.

      Instead, we have evaluated the contribution of each pathway by comparing the final integrated output against each standalone pathway output (Baseline 2 and 3). The significant improvements in both acoustic fidelity and linguistic intelligibility demonstrate the complementary roles of the two pathways, which are effectively fused through CosyVoice.

      (3) Justify your choice of using LSTM and Transformer architecture for the auditory and linguistic neural adaptors, respectively, and how your methods could compare to using a unified generative multimodal LLM for both pathways.

      Thank you for revisiting this important point. We appreciate your interest in the architectural choices and their relationship to state-of-the-art multimodal models.

      As detailed in our response to point (2), our choice of LSTM for the acoustic pathway and Transformer for the linguistic pathway is driven by task-specific requirements, supported by ablation studies (Supplementary Tables 1–2). The acoustic pathway benefits from LSTM’s ability to model fine-grained, local temporal dependencies without over-smoothing. The linguistic pathway benefits from Transformer’s ability to capture long-range semantic and syntactic context.

      Regarding comparison with unified multimodal LLMs (e.g., Qwen3-Omni), we clarified that such models are optimized for interactive dialogue and multimodal understanding, while our framework relies on specialist models (CosyVoice 2.0, Parler-TTS) that are explicitly designed for high-fidelity, speaker-adaptive speech synthesis, a requirement central to our decoding task.

      We have incorporated these justifications into the revised manuscript (Results and Discussion sections) and appreciate the opportunity to further emphasize these points.

      Edits:

      Page 9, Lines 214-223:

      “The acoustic pathway, implemented through a bi-directional LSTM neural adaptor architecture (Fig. 1B), specializes in reconstructing fundamental acoustic properties of speech. This module directly processes neural recordings to generate precise time-frequency representations, focusing on preserving speaker-specific spectral characteristics like formant structures, harmonic patterns, and spectral envelope details. Quantitative evaluation confirms its core competency: achieving a mel-spectrogram R² of 0.793 ± 0.016 (Fig. 3B) demonstrates remarkable fidelity in reconstructing acoustic microstructure. This performance level is statistically indistinguishable from original speech degraded by 0dB additive noise (0.771 ± 0.014, p = 0.242, one-sided t-test). We chose a bidirectional LSTM architecture for this adaptor because its recurrent nature is particularly suited to modeling the fine-grained, short- to medium-range temporal dependencies (e.g., within and between phonemes and syllables) that are critical for acoustic fidelity. An ablation study comparing LSTM against Transformerbased adaptors for this task confirmed that LSTMs yielded superior mel-spectrogram reconstruction fidelity (higher R²), as detailed in Table S1, likely by avoiding the oversmoothing of spectrotemporal details sometimes induced by the strong global context modeling of Transformers”.

      “To confirm that the acoustic pathway’s output is causally dependent on the neural signal rather than the generative prior of the HiFi-GAN, we performed a control analysis in which portions of the input ECoG recording were replaced with Gaussian noise. When either the first half, second half, or the entirety of the neural input was replaced by noise, the melspectrogram R² of the reconstructed speech dropped markedly, corresponding to the corrupted segment (Fig. S5). This demonstrates that the reconstruction is temporally locked to the specific neural input and that the model does not ‘hallucinate’ spectrotemporal structure from noise. These results validate that the acoustic pathway performs genuine, input-sensitive neural decoding”.

      Page 10, Lines 272-277:

      “We employed a Transformer-based Seq2Seq architecture for this adaptor to effectively capture the long-range contextual dependencies across a sentence, which are essential for resolving lexical ambiguity and syntactic structure during word token decoding. This choice was validated by an ablation study (Table S2), indicating that the Transformer adaptor outperformed an LSTM-based counterpart in word prediction accuracy”.

      (4) Discuss the differences between the model's phoneme confusion matrix in Figure 4A and human phoneme confusion patterns. In addition, please clarify whether the adoption of the dual-pathway architecture is primarily intended to simulate the organization of the human brain or to achieve engineering improvements.

      The observed difference between our model's phoneme confusion matrix and typical human perceptual confusion patterns (e.g., the noted lack of confusion between /s/ and /z/) is, as the reviewer astutely infers, likely attributable to the TTS model (Parler-TTS) acting as a powerful linguistic prior. The linguistic pathway decodes word tokens, and Parler-TTS converts these tokens into speech. Parler-TTS is trained on massive text and speech corpora to produce canonical, clean pronunciations. It effectively performs a form of "error correction" or "canonicalization" based on its internal language model. For example, if the neural decoding is ambiguous between "sip" and "zip", the TTS model's strong prior for lexical and syntactic context may robustly resolve it to the correct word, suppressing purely acoustic confusions like voicing. Therefore, the phoneme errors in our final output reflect a combination of neural decoding errors and the TTS model's generation biases, which are optimized for intelligibility rather than mimicking human misperception. We will add this explanation to the paragraph discussing Figure 4A.

      Our primary motivation is engineering improvement, to overcome the fundamental tradeoff between acoustic fidelity and linguistic intelligibility that has limited previous neural speech decoding work. The design is inspired by the convergent representation of speech and language perception (1). However, we do not claim that our LSTM and Transformer adaptors precisely simulate the specific neural computations of the human ventral and dorsal streams. The goal was to build a high-performance, data-efficient decoder. We will clarify this point in the Introduction and Discussion, stating that while the architecture is loosely inspired by previous neuroscience results, its primary validation is its engineering performance in achieving state-of-the-art reconstruction quality with minimal data.

      Edits:

      Pages 2-3, Lines 74-85:

      “Here, we propose a unified and efficient dual-pathway decoding framework that integrates the complementary strengths of both paradigms to enhance the performance of re-synthesized natural speech from the engineering performance. Our method maps intracranial electrocorticography (ECoG) signals into the latent spaces of pre-trained speech and language models via two lightweight neural adaptors: an acoustic pathway, which captures low-level spectral features for naturalistic speech synthesis, and a linguistic pathway, which extracts high-level linguistic tokens for semantic intelligibility. These pathways are fused using a finetuned text-to-speech (TTS) generator with voice cloning, producing re-synthesized speech that retains both the acoustic spectrotemporal details, such as the speaker’s timbre and prosody, and the message linguistic content. The adaptors rely on near-linear mappings and require only 20 minutes of neural data per participant for training, while the generative modules are pre-trained on large unlabeled corpora and require no neural supervision”.

      Page 14, Lines 358-373:

      “In this study, we present a dual-path framework that synergistically decodes both acoustic and linguistic speech representations from ECoG signals, followed by a fine-tuned zero-shot text-to-speech network to re-synthesize natural speech with unprecedented fidelity and intelligibility. Crucially, by integrating large pre-trained generative models into our acoustic reconstruction pipeline and applying voice cloning technology, our approach preserves acoustic richness while significantly enhancing linguistic intelligibility beyond conventional methods. Our dual-pathway architecture, while inspired by converging neuroscience insights on speech and language perception, was principally designed and validated as an engineering solution. The primary goal to build a practical decoder that achieves state-of-the-art reconstruction quality with minimal data. The framework's success is therefore ultimately judged by its performance metrics, high intelligibility (WER, PER), acoustic fidelity (mel-spectrogram R²), and perceptual quality (MOS), which directly address the core engineering challenge we set out to solve. Using merely 20 minutes of ECoG recordings, our model achieved superior performance with a WER of 18.9% ± 3.3% and PER of 12.0% ± 2.5% (Fig. 2D, E). This integrated architecture, combining pre-trained acoustic (Wav2Vec2.0 and HiFi-GAN) and linguistic (Parler-TTS) models through lightweight neural adaptors, enables efficient mapping of ECoG signals to dual latent spaces. Such methodology substantially reduces the need for extensive neural training data while achieving breakthrough word clarity under severe data constraints. The results demonstrate the feasibility of transferring the knowledge embedded in speech-data pre-trained artificial intelligence (AI) models into neural signal decoding, paving the way for more advanced brain-computer interfaces and neuroprosthetics”.

      Reviewer #2 (Recommendations for the authors):

      (1) My main question is whether any experimental stimuli overlap with the data used to pre-train the models. The authors might consider using pre-trained models trained on other corpora and training their own model without the TIMIT corpus. Additionally, as pretrained models were used, it might be helpful to evaluate to what extent the decoding is sensitive to the input neural recording or whether the model always outputs meaningful speech. The authors might consider two control analyses: a) whether the model still generates speech-like output if the input is random noise; b) whether the model can decode a complete sentence if the first half recording of a sentence is real but the second half is replaced with noise.

      We thank the reviewer for raising this crucial point regarding potential data leakage and the sensitivity of decoding to neural input.

      We confirm that the pre-training phase of our core models (Wav2Vec2.0 encoder, HiFiGAN decoder) was conducted exclusively on the LibriSpeech corpus (960 hours), which is entirely separate from the TIMIT corpus used for our ECoG experiments. The subsequent fine-tuning of the CosyVoice 2.0 voice cloner for speaker adaptation was performed on the training set portion of the entire TIMIT corpus. Importantly, the test set for all neural decoding evaluations was strictly held out and never used during any fine-tuning stage. This data separation is now explicitly stated in the " Methods" sections for the Speech Autoencoder and the CosyVoice fine-tuning.

      Regarding the potential of training on other corpora, we agree it is a valuable robustness check. Previous work has demonstrated that self-supervised speech models like Wav2Vec2.0 learn generalizable representations that transfer well across domains (e.g., Millet et al., NeurIPS 2022). We believe our use of LibriSpeech, a large and diverse corpus, provides a strong, general-purpose acoustic prior.

      We agree with the reviewer that control analyses are essential to demonstrate that the decoded output is driven by neural signals and not merely the generative prior of the models. We have conducted the following analyses and will include them in the revised manuscript (likely in a new Supplementary Figure or Results subsection):

      (a) Random Noise Input: We fed Gaussian noise (matched in dimensionality and temporal length to the real ECoG input) into the trained acoustic and linguistic adaptors. The outputs were evaluated. The acoustic pathway generated unstructured, noisy spectrograms with no discernible phonetic structure, and the linguistic pathway produced either highly incoherent word sequences or failed to generate meaningful tokens. The fusion via CosyVoice produced unintelligible babble. This confirms that the generative models alone cannot produce structured speech without meaningful neural input.

      (b) Partial Sentence Input (Real + Noise): In the acoustic pathway, we replaced the first half, the second half, and all the ECoG recording for test sentences with Gaussian noise. The melspectrogram R<sup>2</sup> showed a clear degradation in the reconstructed speech corresponding to the noisy segment. We did not do similar experiments in the linguistic pathway because the TTS generator is pre-trained by HuggingFace. We did not train any parameters of Parler-TTS. These results strongly indicate that our model's performance is contingent on and sensitive to the specific neural input, validating that it is performing genuine neural decoding.

      Edits:

      Page 19, Lines 533-538:

      “The parameters in Wav2Vec2.0 were frozen within this training phase. The parameters in HiFi-GAN were optimized using the Adam optimizer with a fixed learning rate of 10<sub>-5</sub>, 𝛽<sub>!</sub> = 0.9, 𝛽<sub>2</sub> = 0.999. We trained this Autoencoder in LibriSpeech, a 960-hour English speech corpus with a sampling rate of 16kHz, which is entirely separate from the TIMIT corpus used for our ECoG experiments. We spent 12 days in parallel training on 6 Nvidia GeForce RTX3090 GPUs. The maximum training epoch was 2000. The optimization did not stop until the validation loss no longer decreased”.

      Edits:

      Page9, Lines214-223:

      “The acoustic pathway, implemented through a bi-directional LSTM neural adaptor architecture (Fig. 1B), specializes in reconstructing fundamental acoustic properties of speech. This module directly processes neural recordings to generate precise time-frequency representations, focusing on preserving speaker-specific spectral characteristics like formant structures, harmonic patterns, and spectral envelope details. Quantitative evaluation confirms its core competency: achieving a mel-spectrogram R² of 0.793 ± 0.016 (Fig. 3B) demonstrates remarkable fidelity in reconstructing acoustic microstructure. This performance level is statistically indistinguishable from original speech degraded by 0dB additive noise (0.771 ± 0.014, p = 0.242, one-sided t-test). We chose a bidirectional LSTM architecture for this adaptor because its recurrent nature is particularly suited to modeling the fine-grained, short- to medium-range temporal dependencies (e.g., within and between phonemes and syllables) that are critical for acoustic fidelity. An ablation study comparing LSTM against Transformer-based adaptors for this task confirmed that LSTMs yielded superior mel-spectrogram reconstruction fidelity (higher R²), as detailed in Table S1, likely by avoiding the oversmoothing of spectrotemporal details sometimes induced by the strong global context modeling of Transformers”.

      “To confirm that the acoustic pathway’s output is causally dependent on the neural signal rather than the generative prior of the HiFi-GAN, we performed a control analysis in which portions of the input ECoG recording were replaced with Gaussian noise. When either the first half, second half, or the entirety of the neural input was replaced by noise, the melspectrogram R² of the reconstructed speech dropped markedly, corresponding to the corrupted segment (Fig. S5). This demonstrates that the reconstruction is temporally locked to the specific neural input and that the model does not ‘hallucinate’ spectrotemporal structure from noise. These results validate that the acoustic pathway performs genuine, input-sensitive neural decoding”

      (2) For BCI applications, the decoding speed matters. Please report the model's inference speed. Additionally, the authors might also consider reporting cross-participant generalization and how the accuracy changes with recording duration.

      We thank the reviewer for these practical and important suggestions. 

      Inference Speed: You are absolutely right. On our hardware (single NVIDIA GeForce RTX 3090 GPU), the current pipeline has an inference time that is longer than the duration of the target speech segment. The primary bottlenecks are the sequential processing in the autoregressive linguistic adaptor and the high-resolution waveform generation in CosyVoice 2.0. This latency currently limits real-time application. We have now added this in the Discussion acknowledging this limitation and stating that future work must focus on architectural optimizations (e.g., non-autoregressive models, lighter vocoders) and potential hardware acceleration to achieve real-time performance, which is critical for a practical BCI.

      Cross-Participant Generalization: We agree that this is a key question for scalability. Our framework already addresses part of the cross-participant generalization challenge through the use of pre-trained generative modules (HiFi-GAN, Parler-TTS, CosyVoice 2.0), which are pretrained on large corpora and shared across all participants. Only a small fraction of the model, the lightweight neural adaptors, is subject-specific and requires a small amount of supervised fine-tuning (~20 minutes per participant). This design significantly reduces the per-subject calibration burden. As the reviewer implies, the ultimate goal would be pure zero-shot generalization. A promising future direction is to further improve cross-participant alignment by learning a shared neural feature encoder (e.g., using contrastive or self-supervised learning on aggregated ECoG data) before the personalized adaptors. We have added a paragraph in the Discussion outlining this as a major next step to enhance the framework’s practicality and further reduce calibration time.

      Accuracy vs. Recording Duration: Thank you for this insightful suggestion. To systematically evaluate the impact of training data volume on performance, we have conducted additional experiments using progressively smaller subsets of the full training set (i.e., 25%, 50%, and 75%). When we used more than 50% of the training data, performance degrades gracefully rather than catastrophically with less data, which is promising for potential clinical scenarios where data collection may be limited. We add another figure (Fig. S4) to demonstrate this.

      Edits:

      Pages 15-16, Lines 427-452:

      “There are several limitations in our study. The quality of the re-synthesized speech heavily relies on the performance of the generative model, indicating that future work should focus on refining and enhancing these models. Currently, our study utilized English speech sentences as input stimuli, and the performance of the system in other languages remains to be evaluated. Regarding signal modality and experimental methods, the clinical setting restricts us to collecting data during brief periods of awake neurosurgeries, which limits the amount of usable neural activity recordings. Overcoming this time constraint could facilitate the acquisition of larger datasets, thereby contributing to the re-synthesis of higher-quality natural speech. Furthermore, the inference speed of the current pipeline presents a challenge for real-time applications. On our hardware (a single NVIDIA GeForce RTX 3090 GPU), synthesizing speech from neural data takes approximately two to three times longer than the duration of the target speech segment itself. This latency is primarily attributed to the sequential processing in the autoregressive linguistic adaptor and the computationally intensive high-fidelity waveform generation in the vocoder (CosyVoice 2.0). While the current study focuses on offline reconstruction accuracy, achieving real-time or faster-than-real-time inference is a critical engineering goal for viable speech BCI prosthetics. Future work must therefore prioritize architectural optimizations, such as exploring non-autoregressive decoding strategies and more efficient neural vocoders, alongside potential hardware acceleration. Additionally, exploring non-invasive methods represents another frontier; with the accumulation of more data and the development of more powerful generative models, it may become feasible to achieve effective non-invasive neural decoding for speech resynthesis. Moreover, while our framework adopts specialized architectures (LSTM and Transformer) for distinct decoding tasks, an alternative approach is to employ a unified multimodal large language model (LLM) capable of joint acoustic-linguistic processing. Finally, the current framework requires training participant-specific adaptors, which limits its immediate applicability for new users. A critical next step is to develop methods that learn a shared, cross-participant neural feature encoder, for instance, by applying contrastive or selfsupervised learning techniques to larger aggregated ECoG datasets. Such an encoder could extract subject-invariant neural representations of speech, serving as a robust initialization before lightweight, personalized fine-tuning. This approach would dramatically reduce the amount of per-subject calibration data and time required, enhancing the practicality and scalability of the decoding framework for real-world BCI applications”

      “In summary, our dual-path framework achieves high speech reconstruction quality by strategically integrating language models for lexical precision and voice cloning for vocal identity preservation, yielding a 37.4% improvement in MOS scores over conventional methods. This approach enables high-fidelity, sentence-level speech synthesis directly from cortical recordings while maintaining speaker-specific vocal characteristics. Despite current constraints in generative model dependency and intraoperative data collection, our work establishes a new foundation for neural decoding development. Future efforts should prioritize: (1) refining few-shot adaptation techniques, (2) developing non-invasive implementations, (3) expanding to dynamic dialogue contexts, and (4) cross-subject applications. The convergence of neurophysiological data with multimodal foundation models promises transformative advances, not only revolutionizing speech BCIs but potentially extending to cognitive prosthetics for memory augmentation and emotional communication. Ultimately, this paradigm will deepen our understanding of neural speech processing while creating clinically viable communication solutions for those with severe speech impairments”

      Edits: 

      add another section in Methods: Page 22, Line 681:

      “Ablation study on training data volume”.

      “To assess the impact of training data quantity on decoding performance, we conducted an additional ablation experiment. For each participant, we created subsets of the full training set corresponding to 25%, 50%, and 75% of the original data by random sampling while preserving the temporal continuity of speech segments. Personalized acoustic and linguistic adaptors were then independently trained from scratch on each subset, following the identical architecture and optimization procedures described above. All other components of the pipeline, including the frozen pre-trained generators (HiFi-GAN, Parler-TTS) and the CosyVoice 2.0 voice cloner, remained unchanged. Performance metrics (mel-spectrogram R², WER, PER) were evaluated on the same held-out test set for all data conditions. The results (Fig. S4) demonstrate that when more than 50% of the training data is utilized, performance degrades gracefully rather than catastrophically, which is a promising indicator for clinical applications with limited data collection time”.

      (3) I appreciate that the author compared their model with the MLP, but more comparisons with previous models could be beneficial. Even simply summarizing some measures of earlier models, such as neural recording duration, WER, PER, etc., is ok.

      Thank you for this suggestion. We agree that a broader comparison contextualizes our contribution. We also acknowledge that given the differences in tasks, signal modality, and amount of data, it’s hard to draw a direct comparison. The main goal of this table is to summarize major studies, their methods and results for reference. We have now added a new Supplementary Table that summarizes key metrics from several recent and relevant studies in neural speech decoding. The table includes:

      - Neural modality (e.g., ECoG, sEEG, Utah array)

      - Approximate amount of neural data used per subject for decoder training

      - Primary task (perception vs. production)

      -Decoding framework

      -Reported Word Error Rate (WER) or similar intelligibility metrics (e.g., Character Error Rate)

      -Reported acoustic fidelity metrics (if available, e.g., spectral correlation)

      This table includes works such as Anumanchipalli et al., Nature 2019; Akbari et al., Sci Rep 2019; Willett et al., Nature 2023; and other contemporary studies. The table clearly shows that our dual-path framework achieves a highly competitive WER (~18.9%) using an exceptionally short neural recording duration (~20 minutes), highlighting its data efficiency. We will refer to this table in the revised manuscript.

      Edits:

      Page 14, Lines 374-376:

      “Our framework establishes a framework for speech decoding by outperforming prior acousticonly or linguistic-only approaches (Table S3) through integrated pretraining-powered acoustic and linguistic decoding”

      Minor:

      (1) Some processes might be described earlier, for example, the electrodes were selected, and the model was trained separately for each participant. That information was only described in the Method section now.

      Thank you for catching these. We have revised the manuscript accordingly.

      Edits:

      Page4, Lines 89-95:

      “Our proposed framework for reconstructing speech from intracranial neural recordings is designed around two complementary decoding pathways: an acoustic pathway focused on preserving low-level spectral and prosodic detail, and a linguistic pathway focused on decoding high-level textual and semantic content. For every participant, our adaptor is independently trained, and we select speech-responsive electrodes (selection details are provided in the Methods section) to tailor the model to individual neural patterns. These two streams are ultimately fused to synthesize speech that is both natural-sounding and intelligible, capturing the full richness of spoken language. Fig. 1 provides a schematic overview of this dual-pathway architecture”

      (2) Line 224-228 Figure 2 should be Figure 3

      Thank you for catching these. We have revised the manuscript accordingly. The information about participant-specific training and electrode selection is now briefly mentioned in the "Results" overview (section: "The acoustic and linguistic performance..."), with details still in the Methods. The figure reference error has been corrected.

      Edits:

      Page7, Lines 224-228:

      “However, exclusive reliance on acoustic reconstruction reveals fundamental limitations. Despite excellent spectral fidelity, the pathway produces critically impaired linguistic intelligibility. At the word level, intelligibility remains unacceptably low (WER = 74.6 ± 5.5%, Fig. 3D), while MOS and phoneme-level precision fares only marginally better (MOS = 2.878 ± 0.205, Fig. 3C; PER = 28.1 ± 2.2%, Fig. 3E)”.

      (3) For Figure 3C, why does the MOS seem to be higher for baseline 3 than for ground truth? Is this significant?

      This is a detailed observation. Baseline 3 achieves a mean opinion score of 4.822 ± 0.086 (Fig. 3C), significantly surpassing even the original human speech (4.234 ± 0.097, p = 6.674×10⁻33). We believe this trend arises because the TIMIT corpus, recorded decades ago, contains inherent acoustic noise and relatively lower fidelity compared to modern speech corpus. In contrast, the Parler-TTS model used in Baseline 3 is trained on massive, highquality, clean speech datasets. Therefore, it synthesizes speech that listeners may subjectively perceive as "cleaner" or more pleasant, even if it lacks the original speaker's voice. Crucially, as the reviewer implies, our final integrated output does not aim to maximize MOS at the cost of speaker identity; it successfully balances this subjective quality with high intelligibility and restored acoustic fidelity. We will add a brief note explaining this possible reason in the caption of Figure 3C.

      Edits:

      Page9, Lines 235-245:

      “The linguistic pathway reconstructs high-intelligibility, higher-level linguistic information”

      “The linguistic pathway, instantiated through a pre-trained TTS generator (Fig. 1B), excels in reconstructing abstract linguistic representations. This module operates at the phonological and lexical levels, converting discrete word tokens into continuous speech signals while preserving prosodic contours, syllable boundaries, and phonetic sequences. It achieves a mean opinion score of 4.822 ± 0.086 (Fig. 3C) - significantly surpassing even the original human speech (4.234 ± 0.097, p = 6.674×10⁻33) in that the TIMIT corpus, recorded decades ago, contains inherent acoustic noise and relatively lower fidelity compared to modern speech corpus.  Complementing this perceptual quality, objective intelligibility metrics confirm outstanding performance: WER reaches 17.7 ± 3.2%, with PER at 11.0 ± 2.3%”.

      Reference

      (1) Chen M X, Firat O, Bapna A, et al. The best of both worlds: Combining recent advances in neural machine translation[C]//Proceedings of the 56th annual meeting of the association for computational linguistics (Volume 1: Long papers). 2018: 76-86

      (2) P. Chen et al. Do Self-Supervised Speech and Language Models Extract Similar Representations as Human Brain? 2024 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP 2024). 2225–2229 (2024).

      (3) H. Akbari, B. Khalighinejad, J. L. Herrero, A. D. Mehta, N. Mesgarani, Towards reconstructing intelligible speech from the human auditory cortex. Scientific reports 9, 874 (2019).

      (4) S. Komeiji et al., Transformer-Based Estimation of Spoken Sentences Using Electrocorticography. Int Conf Acoust Spee, 1311-1315 (2022).

      (5) L. Bellier et al., Music can be reconstructed from human auditory cortex activity using nonlinear decoding models. Plos Biology 21,  (2023).

      (6) F. R. Willett et al., A high-performance speech neuroprosthesis. Nature 620,  (2023).

      (7) S. L. Metzger et al., A high-performance neuroprosthesis for speech decoding and avatar control. Nature 620, 1037-1046 (2023).

      (8) J. W. Li et al., Neural2speech: A Transfer Learning Framework for NeuralDriven Speech Reconstruction. Int Conf Acoust Spee, 2200-2204 (2024).

      (9) X. P. Chen et al., A neural speech decoding framework leveraging deep learning and speech synthesis. Nat Mach Intell 6,  (2024).

      (10) M. Wairagkar et al., An instantaneous voice-synthesis neuroprosthesis. Nature,  (2025).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1

      Chen et al. engineered and characterized a suite of next-generation GECIs for the Drosophila NMJ that allow for the visualization of calcium dynamics within the presynaptic compartment, at presynaptic active zones, and in the postsynaptic compartment. These GECIs include ratiometric presynaptic Scar8m (targeted to synaptic vesicles), ratiometric active zone localized Bar8f (targeted to the scaffold molecule BRP), and postsynaptic SynapGCaMP8m. The authors demonstrate that these new indicators are a large improvement on the widely used GCaMP6 and GCaMP7 series GECIs, with increased speed and sensitivity. They show that presynaptic Scar8m accurately captures presynaptic calcium dynamics with superior sensitivity to the GCaMP6 and GCaMP7 series and with similar kinetics to chemical dyes. The active-zone targeted Bar8f sensor was assessed for the ability to detect release-site-specific nanodomain changes, but the authors concluded that this sensor is still too slow to accurately do so. Lastly, the use of postsynaptic SynapGCaMP8m was shown to enable the detection of quantal events with similar resolution to electrophysiological recordings. Finally, the authors developed a Python-based analysis software, CaFire, that enables automated quantification of evoked and spontaneous calcium signals. These tools will greatly expand our ability to detect activity at individual synapses without the need for chemical dyes or electrophysiology.

      We thank this Reviewer for the overall positive assessment of our manuscript and for the incisive comments.

      (1) The role of Excel in the pipeline could be more clearly explained. Lines 182-187 could be better worded to indicate that CaFire provides analysis downstream of intensity detection in ImageJ. Moreover, the data type of the exported data, such as .csv or .xlsx, should be indicated instead of 'export to graphical program such as Microsoft Excel'.

      We thank the Reviewer for these comments, many of which were shared by the other reviewers. In response, we have now 1) more clearly explained the role of Excel in the CaFire pipeline (lines 677-681), 2) revised the wording in lines 676-679 to indicate that CaFire provides analysis downsteam of intensity detection in ImageJ, and 3) Clarified the exported data type to Excel (lines 677-681). These efforts have improved the clarity and readability of the CaFire analysis pipeline.

      (2) In Figure 2A, the 'Excel' step should either be deleted or included as 'data validation' as ImageJ exports don't require MS Excel or any specific software to be analysed. (Also, the graphic used to depict Excel software in Figure 2A is confusing.)

      We thank the reviewer for this helpful suggestion. In the Fig. 2A, we have changed the Excel portion and clarified the processing steps in the revised methods. Specifically, we now indicate that ROIs are first selected in Fiji/ImageJ and analyzed to obtain time-series data containing both the time information and the corresponding imaging mean intensity values. These data are then exported to a spreadsheet file (e.g., Excel), which is used to organize the output before being imported into CaFire for subsequent analysis. These changes can be found in the Fig. 2A and methods (lines 676-681).

      (3) Figure 2B should include the 'Partition Specification' window (as shown on the GitHub) as well as the threshold selection to give the readers a better understanding of how the tool works.

      We absolutely agree with this comment, and have made the suggested changes to the Fig. 2B. In particular, we have replaced the software interface panels and now include windows illustrating the Load File, Peak Detection, and Partition functions. These updated screenshots provide a clearer view of how CaFire is used to load the data, detect events, and perform partition specification for subsequent analysis. We agree these changes will give the readers a better understanding of how the tool works, and we thank the reviewer for this comment.

      (4) The presentation of data is well organized throughout the paper. However, in Figure 6C, it is unclear how the heatmaps represent the spatiotemporal fluorescence dynamics of each indicator. Does the signal correspond to a line drawn across the ROI shown in Figure 6B? If so, this should be indicated.

      We apologize that the heatmaps were unclear in Fig panel 6C (Fig. 7C in the Current revision). Each heatmap is derived from a one-pixel-wide vertical line within a miniature-event ROI. These heatmaps correspond to the fluorescence change in the indicated SynapGCaMP variant of individual quantal events and their traces shown in Fig. 7C, with a representative image of the baseline and peak fluorescence shown in Fig. 7B. Specifically, we have added the following to the revised Fig. 7C legend:

      The corresponding heatmaps below were generated from a single vertical line extracted from a representative miniature-event ROI, and visualize the spatiotemporal fluorescence dynamics (ΔF/F) along that line over time.

      (5) In Figure 6D, the addition of non-matched electrophysiology recordings is confusing. Maybe add "at different time points" to the end of the 6D legend, or consider removing the electrophysiology trace from Figure 6D and referring the reader to the traces in Figure 7A for comparison (considering the same point is made more rigorously in Figure 7).

      This is a good point, one shared with another reviewer. We apologize this was not clear, and have now revised this part of the figure to remove the electrophysiological traces in what is now Fig. 7 while keeping the paired ones still in what is now Fig. 8A as suggested by the reviewer. We agree this helps to clarify the quantal calcium transients.

      (6) In GitHub, an example ImageJ Script for analyzing the images and creating the inputs for CaFire would be helpful to ensure formatting compatibility, especially given potential variability when exporting intensity information for two channels. In the Usage Guide, more information would be helpful, such as how to select ∆R/R, ideally with screenshots of the application being used to analyze example data for both single-channel and two-channel images.

      We agree that additional details added to the GitHub would be helpful for users of CaFire. In response, we have now added the following improvements to the GitHub site: 

      - ImageJ operation screenshots

      Step-by-step illustrations of ROI drawing and Multi Measure extraction.

      - Example Excel file with time and intensity values

      Demonstrates the required data format for CaFire import, including proper headers.

      - CaFire loading screenshots for single-channel and dual-channel imaging

      Shows how to import GCaMP into Channel 1 and mScarlet into Channel 2.

      - Peak Detection and Partition setting screenshots

      Visual examples of automatic peak detection, manual correction, and trace partitioning.

      - Instructions for ROI Extraction and CaFire Analysis

      A written guide describing the full workflow from ROI selection to CaFire data export.

      These changes have improved the usability and accessibility of CaFire, and we thank the reviewer for these points.

      Reviewer #2

      Calcium ions play a key role in synaptic transmission and plasticity. To improve calcium measurements at synaptic terminals, previous studies have targeted genetically encoded calcium indicators (GECIs) to pre- and postsynaptic locations. Here, Chen et al. improve these constructs by incorporating the latest GCaMP8 sensors and a stable red fluorescent protein to enable ratiometric measurements. In addition, they develop a new analysis platform, 'CaFire', to facilitate automated quantification. Using these tools, the authors demonstrate favorable properties of their sensors relative to earlier constructs. Impressively, by positioning postsynaptic GCaMP8m near glutamate receptors, they show that their sensors can report miniature synaptic events with speed and sensitivity approaching that of intracellular electrophysiological recordings. These new sensors and the analysis platform provide a valuable tool for resolving synaptic events using all-optical methods.

      We thank the Reviewer for their overall positive evaluation and comments.

      Major comments:

      (1) While the authors rigorously compared the response amplitude, rise, and decay kinetics of several sensors, key parameters like brightness and photobleaching rates are not reported. I feel that including this information is important as synaptically tethered sensors, compared to freely diffusible cytosolic indicators, can be especially prone to photobleaching, particularly under the high-intensity illumination and high-magnification conditions required for synaptic imaging. Quantifying baseline brightness and photobleaching rates would add valuable information for researchers intending to adopt these tools, especially in the context of prolonged or high-speed imaging experiments.

      This is a good point made by the reviewer, and one we agree will be useful for researchers to be aware. First, it is important to note that the photobleaching and brightness of the sensors will vary depending on the nature of the user’s imaging equipment, which can vary significantly between widefield microscopes (with various LED or halogen light sources for illumination), laser scanning systems (e.g., line scans with confocal systems), or area scanning systems using resonant scanners (as we use in our current study). Under the same imaging settings, GCaMP8f and 8m exhibit comparable baseline fluorescence, whereas GCaMP6f and 6s are noticeably dimmer; because our aim is to assess each reagent’s potential under optimal conditions, we routinely adjust excitation/camera parameters before acquisition to place baseline fluorescence in an appropriate dynamic range. As an important addition to this study, motivated by the reviewer’s comments above, we now directly compare neuronal cytosolic GCaMP8m expression with our Scar8m sensor, showing higher sensitivity with Scar8m (now shown in the new Fig. 3F-H).

      Regarding photobleaching, GCaMP signals are generally stable, while mScarlet is more prone to bleaching: in presynaptic area scanned confocal recordings, the mScarlet channel drops by ~15% over 15 secs, whereas GCaMP6s/8f/8m show no obvious bleaching over the same window (lines 549-553). In contrast, presynaptic widefield imaging using an LED system (CCD), GCaMP8f shows ~8% loss over 15 secs (lines 610-611). Similarly, for postsynaptic SynapGCaMP6f/8f/8m, confocal resonant area scans show no obvious bleaching over 60 secs, while widefield shows ~2–5% bleaching over 60 secs (lines 634-638). Finally, in active-zone/BRP calcium imaging (confocal), mScarlet again bleaches by ~15% over 15 s, while GCaMP8f/8m show no obvious bleaching. The mScarlet-channel bleaching can be corrected in Huygens SVI (Bleaching correction or via the Deconvolution Wizard), whereas we avoid applying bleaching correction to the green GCaMP channel when no clear decay is present to prevent introducing artifacts. This information is now added to the methods (lines 548-553).

      (2) In several places, the authors compare the performance of their sensors with synthetic calcium dyes, but these comparisons are based on literature values rather than on side-by-side measurements in the same preparation. Given differences in imaging conditions across studies (e.g., illumination, camera sensitivity, and noise), parameters like indicator brightness, SNR, and photobleaching are difficult to compare meaningfully. Additionally, the limited frame rate used in the present study may preclude accurate assessment of rise times relative to fast chemical dyes. These issues weaken the claim made in the abstract that "...a ratiometric presynaptic GCaMP8m sensor accurately captures .. Ca²⁺ changes with superior sensitivity and similar kinetics compared to chemical dyes." The authors should clearly acknowledge these limitations and soften their conclusions. A direct comparison in the same system, if feasible, would greatly strengthen the manuscript.

      We absolutely agree with these points made the reviewer, and have made a concerted effort to address them through the following:

      We have now directly compared presynaptic calcium responses on the same imaging system using the chemical dye Oregon Green Bapta-1 (OGB-1), one of the primary synthetic calcium indicators used in our field. These experiments reveal that Scar8f exhibits markedly faster kinetics and an improved signal-to-noise ratio compared to OGB-1, with higher peak fluorescence responses (Scar8f: 0.32, OGB-1: 0.23). The rise time constants of the two indicators are comparable (both ~3 msecs), whereas the decay of Scar8f is faster than that of OGB-1 (Scar8f: ~40, OGB-1: ~60), indicating more rapid signal recovery. These results now directly demonstrate the superiority of the new GCaMP8 sensors we have engineered over conventional synthetic dyes, and are now presented in the new Fig. 3A-E of the manuscript.

      We agree with the reviewer that, in the original submission, the relatively slow resonant area scans (~115 fps) limited the temporal resolution of our rise time measurements. To address this, we have re-measured the rise time using higher frame-rate line scans (kHz). For Scar8f, the rise time constant was 6.736 msec at ~115 fps resonant area scanned, but shortened to 2.893 msec when imaged at ~303 fps, indicating that the original protocol underestimated the true kinetics. In addition, for Bar8m, area scans at ~118 fps yielded a rise time constant of 9.019 msec, whereas line scans at ~1085 fps reduced the rise time constant to 3.230 msec. These new measurements are now incorporated into the manuscript ( Figs. 3,4, and 6) to more accurately reflect the fast kinetics of these indicators.

      (3) The authors state that their indicators can now achieve measurements previously attainable with chemical dyes and electrophysiology. I encourage the authors to also consider how their tools might enable new measurements beyond what these traditional techniques allow. For example, while electrophysiology can detect summed mEPSPs across synapses, imaging could go a step further by spatially resolving the synaptic origin of individual mEPSP events. One could, for instance, image MN-Ib and MN-Is simultaneously without silencing either input, and detect mEPSP events specific to each synapse. This would enable synapse-specific mapping of quantal events - something electrophysiology alone cannot provide. Demonstrating even a proof-of-principle along these lines could highlight the unique advantages of the new tools by showing that they not only match previous methods but also enable new types of measurements.

      These are excellent points raised by the reviewer. In response, we have done the following: 

      We have now included a supplemental video as “proof-of-principle” data showing simultaneous imaging of SynapGCaMP8m quantal events at both MN-Is and -Ib, demonstrating that synapse-specific spatial mapping of quantal events can be obtained with this tool (see new Supplemental Video 1). 

      We have also included an additional discussion of the potential and limitations of these tools for new measurements beyond conventional approaches. This discussion is now presented in lines 419-421 in the manuscript.

      (4) For ratiometric measurements, it is important to estimate and subtract background signals in each channel. Without this correction, the computed ratio may be skewed, as background adds an offset to both channels and can distort the ratio. However, it is not clear from the Methods section whether, or how, background fluorescence was measured and subtracted.

      This is a good point, and we agree more clarification about how ratiometric measurements were made is needed. In response, we have now added the following to the Methods section (lines 548-568):

      Time-lapse videos were stabilized and bleach-corrected prior to analysis, which visibly reduced frame-toframe motion and intensity drift. In the presynaptic and active-zone mScarlet channel, a bleaching factor of ~1.15 was observed during the 15 sec recording. This bleaching can be corrected using the “Bleaching correction” tool in Huygens SVI. For presynaptic and active-zone GCaMP signals, there was minimal bleaching over these short imaging periods. Therefore, the bleaching correction step for GCaMP was skipped. Both GCaMP and mScarlet channels were processed using the default settings in the Huygens SVI “Deconvolution Wizard” (with the exception of the bleaching correction option). Deconvolution was performed using the CMLE algorithm with the Huygens default stopping criterion and a maximum of 30 iterations, such that the algorithm either converged earlier or, if convergence was not reached, was terminated at this 30iteration limit; no other iteration settings were used across the GCaMP series. ROIs were drawn on the processed images using Fiji ImageJ software, and mean fluorescence time courses were extracted for the GCaMP and mScarlet channels, yielding F<sub>GCaMP</sub>(t) and F<sub>mScarlet</sub>(t). F(t)s were imported into CaFire with GCaMP assigned to Channel #1 (signal; required) and mScarlet to Channel #2 (baseline/reference; optional). If desired, the mScarlet signal could be smoothed in CaFire using a user-specified moving-average window to reduce high-frequency noise. In CaFire’s ΔR/R mode, the per-frame ratio was computed as R(t)=F<sub>GCaMP</sub>(t) and F<sub>mScarlet</sub>(t); a baseline ratio R0 was estimated from the pre-stimulus period, and the final response was reported as ΔR/R(t)=[R(t)−R0]/R0, which normalizes GCaMP signals to the co-expressed mScarlet reference and thereby reduces variability arising from differences in sensor expression level or illumination across AZs.

      (5) At line 212, the authors claim "... GCaMP8m showing 345.7% higher SNR over GCaMP6s....(Fig. 3D and E) ", yet the cited figure panels do not present any SNR quantification. Figures 3D and E only show response amplitudes and kinetics, which are distinct from SNR. The methods section also does not describe details for how SNR was defined or computed.

      This is another good point. We define SNR operationally as the fractional fluorescence change (ΔF/F). Traces were processed with CaFire, which estimates a per-frame baseline F<sub>0</sub>(t) with a user-configurable sliding window and percentile. In the Load File panel, users can specify both the length of the moving baseline window and the desired percentile; the default settings are a 50-point window and the 30th percentile, representing a 101-point window centered on each time point (previous 50 to next 50 samples) and took the lower 30% of values within that window to estimate F<sub>0</sub>(t). The signal was then computed as ΔF/F=[F(t)−F0(t)]/F0(t). This ΔF/F value is what we report as SNR throughout the manuscript and is now discussed explicitly in the revised methods (lines 686-693).

      (6) Lines 285-287 "As expected, summed ΔF values scaled strongly and positively with AZ size (Fig. 5F), reflecting a greater number of Cav2 channels at larger AZs". I am not sure about this conclusion. A positive correlation between summed ΔF values and AZ size could simply reflect more GCaMP molecules in larger AZs, which would give rise to larger total fluorescence change even at a given level of calcium increase.

      The reviewer makes a good point, one that we agree should be clarified. The reviewer is indeed correct that larger active zones should have more abundant BRP protein, which in turn will lead to a higher abundance of the Bar8f sensor, which should lead to a higher GCaMP response simply by having more of this sensor. However, the inclusion of the ratiometric mScarlet protein should normalize the response accurately, correcting for this confound, in which the higher abundance of GCaMP should be offset (normalized) by the equally (stoichiometric) higher abundance of mScarlet. Therefore, when the ∆R/R is calculated, the differences in GCaMP abundance at each AZ should be corrected for the ratiometric analysis. We now use an improved BRP::mScarlet3::GCaMP8m (Bar8m) and compute ΔR/R with R(t)=F<sub>GCaMP8m</sub>/F<sub>mScarlet3</sub>. ROIs were drawn over individual AZs (Fig. 6B). CaFire estimated R0 with a sliding 101-point window using the lowest 10% of values, and responses were reported as ΔR/R=[R−R0]/R0. Area-scan examples (118 fps) show robust ΔR/R transients (peaks ≈1.90 and 3.28; tau rise ≈9.0–9.3 ms; Fig. 6C, middle).

      We have now made these points more clearly in the manuscript (lines 700-704) and moved the Bar8f intensity vs active zone size data to Table S1. Together, these revisions improve the indicator-abundance confound (via mScarlet normalization). 

      (6) Lines 313-314: "SynapGCaMP quantal signals appeared to qualitatively reflect the same events measured with electrophysiological recordings (Fig. 6D)." This statement is quite confusing. In Figure 6D, the corresponding calcium and ephys traces look completely different and appear to reflect distinct sets of events. It was only after reading Figure 7 that I realized the traces shown in Figure 6D might not have been recorded simultaneously. The authors should clarify this point.

      Yes, we absolutely agree with this point, one shared by Reviewer 1. In response, we have removed the electrophysiological traces in Fig. 6 to clarify that just the calcium responses are shown, and save the direct comparison for the Fig. 7 data (now revised Fig. 8).

      (8) Lines 310-313: "SynapGCaMP8m .... striking an optimal balance between speed and sensitivity", and Lines 314-316: "We conclude that SynapGCaMP8m is an optimal indicator to measure quantal transmission events at the synapse." Statements like these are subjective. In the authors' own comparison, GCaMP8m is significantly slower than GCaMP8f (at least in terms of decay time), despite having a moderately higher response amplitude. It is therefore unclear why GCaMP8m is considered 'optimal'. The authors should clarify this point or explain their rationale for prioritizing response amplitude over speed in the context of their application.

      This is another good point that we agree with, as the “optimal” sensor will of course depend on the user’s objectives. Hence, we used the term “an optimal sensor” to indicate it is what we believed to be the best one for our own uses. However, this point should be clarified and better discussed. In response, we have revised the relevant sections of the manuscript to better define why we chose the 8m sensors to strike an optimal balance of speed and sensitivity for our uses, and go on to discuss situations in which other sensor variants might be better suited. These are now presented in lines 223-236 in the revised manuscript, and we thank the reviewer for making these comments, which have improved our study.

      Minor comments

      (1)  Please include the following information in the Methods section:

      (a) For Figures 3 and 4, specify how action potentials were evoked. What type of electrodes were used, where were they placed, and what amount of current or voltage was applied?

      We apologize for neglecting to include this information in the original submission. We have now added this information to the revised Methods section (lines 537-543).

      (b) For imaging experiments, provide information on the filter sets used for each imaging channel, and describe how acquisition was alternated or synchronized between the green and red channels in ratiometric measurements. Additionally, please report the typical illumination intensity (in mW/mm²) for each experimental condition.

      We thank the reviewer for this helpful comment. We have now added detailed information about the imaging configuration to the Methods (lines 512-528) with the following:

      Ca2+ imaging was conducted using a Nikon A1R resonant scanning confocal microscope equipped with a 60x/1.0 NA water-immersion objective (refractive index 1.33). GCaMP signals were acquired using the FITC/GFP channel (488-nm laser excitation; emission collected with a 525/50-nm band-pass filter), and mScarlet/mCherry signals were acquired using the TRITC/mCherry channel (561-nm laser excitation; emission collected with a 595/50-nm band-pass filter). ROIs focused on terminal boutons of MN-Ib or -Is motor neurons. For both channels, the confocal pinhole was set to a fixed diameter of 117.5 µm (approximately three Airy units under these conditions), which increases signal collection while maintaining adequate optical sectioning. Images were acquired as 256 × 64 pixel frames (two 12-bit channels) using bidirectional resonant scanning at a frame rate of ~118 frames/s; the scan zoom in NIS-Elements was adjusted so that this field of view encompassed the entire neuromuscular junction and was kept constant across experiments. In ratiometric recordings, the 488-nm (GCaMP) and 561-nm (mScarlet) channels were acquired in a sequential dual-channel mode using the same bidirectional resonant scan settings: for each time point, a frame was first collected in the green channel and then immediately in the red channel, introducing a small, fixed frame-to-frame temporal offset while preserving matched spatial sampling of the two channels.

      Directly measuring the absolute laser power at the specimen plane (and thus reporting illumination intensity in mW/mm²) is technically challenging on this resonant-scanning system, because it would require inserting a power sensor into the beam path and perturbing the optical alignment; consequently, we are unable to provide reliable absolute mW/mm² values. Instead, we now report all relevant acquisition parameters (objective, numerical aperture, refractive index, pinhole size, scan format, frame rate, and fixed laser/detector settings) and note that laser powers were kept constant within each experimental series and chosen to minimize bleaching and phototoxicity while maintaining an adequate signal-to-noise ratio. We have now added the details requested in the revised Methods section (lines 512-535), including information about the filter sets, acquisition settings, and typical illumination intensity.

      (2) Please clarify what the thin versus thick traces represent in Figures 3D, 3F, 4C, and 4E. Are the thin traces individual trials from the same experiment, or from different experiments/animals? Does the thick trace represent the mean/median across those trials, a fitted curve, or a representative example?

      We apologize this was not more clear in the original submission. Thin traces are individual stimulus-evoked trials (“sweeps”) acquired sequentially from the same muscle/NMJ in a single preparation; the panel is shown as a representative example of recordings collected across animals. The thick colored trace is the trialaveraged waveform (arithmetic mean) of those thin traces after alignment to stimulus onset and baseline subtraction (no additional smoothing beyond what is stated in Methods). The thick black curve over the decay phase is a single-exponential fit used to estimate τ. Specifically, we fit the decay segment by linear regression on the natural-log–transformed baseline-subtracted signal, which is equivalent to fitting y = y<sub>peak</sub>·e<sup>−t/τdecay</sup> over the decay window (revised Fig.4D and Fig.5C legends).

      (3) Please clarify what the reported sample size (n) represents. Does it indicate the number of experimental repeats, the number of boutons or PSDs, or the number of animals?

      Again, we apologize this was not clear. (n) refers to the number of animals (biological replicates), which is reported in Supplementary Table 1. All imaging was performed at muscle 6, abdominal segment A3. Per preparation, we imaged 1-2 NMJs in total, with each imaging targeting 2–3 terminal boutons at the target NMJ and acquired 2–3 imaging stacks choosing different terminal boutons per NMJ. For the standard stimulation protocol, we delivered 1 Hz stimulation for 1ms and captured 14 stimuli in a 15s time series imaging (lines 730-736).

      Reviewer #3

      Genetically encoded calcium indicators (GECIs) are essential tools in neurobiology and physiology. Technological constraints in targeting and kinetics of previous versions of GECIs have limited their application at the subcellular level. Chen et al. present a set of novel tools that overcome many of these limitations. Through systematic testing in the Drosophila NMJ, they demonstrate improved targeting of GCaMP variants to synaptic compartments and report enhanced brightness and temporal fidelity using members of the GCaMP8 series. These advancements are likely to facilitate more precise investigation of synaptic physiology.

      This is a comprehensive and detailed manuscript that introduces and validates new GECI tools optimized for the study of neurotransmission and neuronal excitability. These tools are likely to be highly impactful across neuroscience subfields. The authors are commended for publicly sharing their imaging software.

      This manuscript could be improved by further testing the GECIs across physiologically relevant ranges of activity, including at high frequency and over long imaging sessions. The authors provide a custom software package (CaFire) for Ca2+ imaging analysis; however, to improve clarity and utility for future users, we recommend providing references to existing Ca2+ imaging tools for context and elaborating on some conceptual and methodological aspects, with more guidance for broader usability. These enhancements would strengthen this already strong manuscript.

      We thank the Reviewer for their overall positive evaluation and comments. 

      Major comments:

      (1) Evaluation of the performance of new GECI variants using physiologically relevant stimuli and frequency. The authors took initial steps towards this goal, but it would be helpful to determine the performance of the different GECIs at higher electrical stimulation frequencies (at least as high as 20 Hz) and for longer (10 seconds) (Newman et al, 2017). This will help scientists choose the right GECI for studies testing the reliability of synaptic transmission, which generally requires prolonged highfrequency stimulation.

      We appreciate this point by the reviewer and agree it would be of interest to evaluate sensor performance with higher frequency stimulation and for a longer duration. In response, we performed a variety of stimulation protocols at high intensities and times, but found the data to be difficult to separate individual responses given the decay kinetics of all calcium sensors. Hence, we elected not to include these in the revised manuscript. However, we have now included an evaluation of the sensors with 20 Hz electrical stimulation for ~1 sec using a direct comparison of Scar8f with OGB-1. These data are now presented in a new Fig. 3D,E and discussed in the manuscript (lines 396-403).

      (2) CaFire.

      The authors mention, in line 182: 'Current approaches to analyze synaptic Ca2+ imaging data either repurpose software designed to analyze electrophysiological data or use custom software developed by groups for their own specific needs.' References should be provided. CaImAn comes to mind (Giovannucci et al., 2019, eLife), but we think there are other software programs aimed at analyzing Ca2+ imaging data that would permit such analysis.

      Thank you for the thoughtful question. At this stage, we’re unable to provide a direct comparison with existing analysis workflows. In surveying prior studies that analyze Drosophila NMJ Ca²⁺ imaging traces, we found that most groups preprocess images in Fiji/ImageJ and then rely on their own custom-made MATLAB or Python scripts for downstream analysis (see Blum et al. 2021; Xing and Wu 2018). Because these pipelines vary widely across labs, a standardized head-to-head evaluation isn’t currently feasible. With CaFire, our goal is to offer a simple, accessible tool that does not require coding experience and minimizes variability introduced by custom scripts. We designed CaFire to lower the barrier to entry, promote reproducibility, and make quantal event analysis more consistent across users. We have added references to the sentence mentioned above.

      Regarding existing software that the reviewer mentioned – CaImAn (Giovannucci et al. 2019): We evaluated CaImAn, which is a powerful framework designed for large-scale, multicellular calcium imaging (e.g., motion correction, denoising, and automated cell/ROI extraction). However, it is not optimized for the per-event kinetics central to our project - such as extracting rise and decay times for individual quantal events at single synapses. Achieving this level of granularity would typically require additional custom Python scripting and parameter tuning within CaImAn’s code-centric interface. This runs counter to CaFire’s design goals of a nocode, task-focused workflow that enables users to analyze miniature events quickly and consistently without specialized programming expertise.

      Regarding Igor Pro (WaveMetrics), (Müller et al. 2012): Igor Pro is another platform that can be used to analyze calcium imaging signals. However, it is commercial (paid) software and generally requires substantial custom scripting to fit the specific analyses we need. In practice, it does not offer a simple, open-source, point-and-click path to per-event kinetic quantification, which is what CaFire is designed to provide.

      The authors should be commended for making their software publicly available, but there are some questions:

      How does CaFire compare to existing tools?

      As mentioned above, we have not been able to adapt the custom scripts used by various labs for our purposes, including software developed in MatLab (Blum et al. 2021), Python (Xing and Wu 2018), and Igor (Müller et al. 2012). Some in the field do use semi-publically available software, including Nikon Elements (Chen and Huang 2017) and CaImAn (Giovannucci et al. 2019). However, these platforms are not optimized for the per-event kinetics central to our project - such as extracting rise and decay times for individual quantal events at single synapses. We have added more details about CaFire, mainly focusing on the workflow and measurements, highlighting the superiority of CaFire, showing that CaFire provides a no-code, standardized pipeline with automated miniature-event detection and per-event metrics (e.g., amplitude, rise time τ, decay time τ), optional ΔR/R support, and auto-partition feature. Collectively, these features make CaFire simpler to operate without programming expertise, more transparent and reproducible across users, and better aligned with the event-level kinetics required for this project.

      Very few details about the Huygens deconvolution algorithms and input settings were provided in the methods or text (outside of MLE algorithm used in STED images, which was not Ca2+ imaging). Was it blind deconvolution? Did the team distill the point-spread function for the fluorophores? Were both channels processed for ratiometric imaging? Were the same settings used for each channel? Importantly, please include SVI Huygens in the 'Software and Algorithms' Section of the methods.

      We thank the reviewer for raising this important point. We have now expanded the Methods to describe our use of Huygens in more detail and have added SVI Huygens Professional (Scientific Volume Imaging, Hilversum, The Netherlands) to the “Software and Algorithms” section. For Ca²⁺ imaging data, time-lapse stacks were processed in the Huygens Deconvolution Wizard using the standard estimation algorithm (CMLE). This is not a blind deconvolution procedure. Instead, Huygens computes a theoretical point-spread function (PSF) from the full acquisition metadata (objective NA, refractive index, voxel size/sampling, pinhole, excitation/emission wavelengths, etc.); if refractive index values are provided and there is a mismatch, the PSF is adjusted to account for spherical aberration. We did not experimentally distill PSFs from bead measurements, as Huygens’ theoretical PSFs are sufficient for our data.

      Both green (GCaMP) and red (mScarlet) channels were processed for ratiometric imaging using the same workflow (stabilization, optional bleaching correction, and deconvolution within Huygens). For each channel, the PSF, background, and SNR were estimated automatically by the same built-in algorithms, so the underlying procedures were identical even though the numerical values differ between channels because of their distinct wavelengths and noise characteristics. Importantly, Huygens normalizes each PSF to unit total intensity, such that the deconvolution itself does not add or remove signal and therefore preserves intensity ratios between channels; only background subtraction and bleaching correction can change absolute fluorescence values. For the mScarlet channel, where we observed modest bleaching (~1.10 over 15 sec), we applied Huygens’ bleaching correction and visually verified that similar structures maintained comparable intensities after correction. For presynaptic GCaMP signals, bleaching over these short recordings was negligible, so we omitted the bleaching-correction step to avoid introducing multiplicative artifacts. This workflow ensures that ratiometric ΔR/R measurements are based on consistently processed, intensity-conserving deconvolved images in both channels.

      The number of deconvolution iterations could have had an effect when comparing GCAMP series; please provide an average number of iterations used for at least one experiment. For example, Figure 3, Syt::GCAMP6s, Scar8f & Scar8m, and, if applicable, the maximum number of permissible iterations.

      We thank the reviewer for this comment. For all Ca²⁺ imaging datasets, deconvolution in Huygens was performed using the recommended default settings of the CMLE algorithm with a maximum of 30 iterations. The stopping criterion was left at the Huygens default, so the algorithm either converged earlier or, if convergence was not reached, terminated at this 30-iteration limit. No other iteration settings were used across the GCaMP series (lines 555-559).

      Please clarify if the 'Express' settings in Huygens changed algorithms or shifted input parameters.

      We appreciate the reviewer’s question regarding the Huygens “Express” settings. For clarity, we note that all Ca²⁺ imaging data reported in this manuscript were deconvolved using the “Deconvolution Wizard”, not the “Deconvolution Express” mode. In the Wizard, we explicitly selected the CMLE algorithm (or GMLE in a few STED-related cases as recommended by SVI), using the recommended maximum of 30 iterations, and other recommended settings while allowing Huygens to auto-estimate background and SNR for each channel.Bleaching correction was toggled manually per channel (applied to mScarlet when bleaching was evident, omitted for GCaMP when bleaching was negligible), as described in the revised Methods (lines 553-559).

      By contrast, the Deconvolution Express tool in Huygens is a fully automated front-end that can internally adjust both the choice of deconvolution algorithm (e.g., CMLE vs. GMLE/QMLE) and key input parameters such as SNR, number of iterations, and quality threshold based on the selected “smart profile” and the image metadata. In preliminary tests on our datasets, Express sometimes produced results that were either overly smoothed or showed subtle artifacts, so we did not use it for any data included in this study. Instead, we relied exclusively on the Wizard with explicitly controlled settings to ensure consistency and transparency across all GCaMP series and ratiometric analyses.

      We suggest including a sample data set, perhaps in Excel, so that future users can beta test on and organize their data in a similar fashion.

      We agree that this would be useful, a point shared by R1 above. In response, we have added a sample data set to the GitHub site and included sample ImageJ data along with screenshots to explain the analysis in more detail. These improvements are discussed in the manuscript (lines 705-708).

      (3) While the challenges of AZ imaging are mentioned, it is not discussed how the authors tackled each one. What is defined as an active zone? Active zones are usually identified under electron microscopy. Arguably, the limitation of GCaMP-based sensors targeted to individual AZs, being unable to resolve local Ca2+ changes at individual boutons reliably, might be incorrect. This could be a limitation of the optical setup being used here. Please discuss further. What sensor performance do we need to achieve this performance level, and/or what optical setup would we need to resolve such signals?

      We appreciate the reviewer’s thoughtful comments and agree that the technical challenges of active zone (AZ) Ca²⁺ imaging merit further clarification. We defined AZs, as is the convention in our field, as individual BRP puncta at NMJs. These BRP puncta co-colocalize with individual puncta of other AZ components, including CAC, RBP, Unc13, etc. ROIs were drawn tightly over individual BRP puncta and only clearly separable spots were included.

      To tackle the specific obstacles of AZ imaging (small signal volume, high AZ density, and limited photon budget at high frame rates), we implemented both improved sensors and optimized analysis (Fig. 6). First, we introduced a ratiometric AZ-targeted indicator, BRP::mScarlet3::GCaMP8m (Bar8m), and computed ΔR/R with ΔR/R with R(t)=F<sub>GCaMP8m</sub>/F<sub>mScarlet3</sub>. ROIs were drawn over individual AZs (Fig. 6B). Under our standard resonant area-scan conditions (~118 fps), Bar8m produces robust ΔR/R transients at individual AZs (example peaks ≈ 3.28; τ<sub>rise</sub>≈9.0 ms; Fig. 6C, middle), indicating that single-AZ signals can be detected reproducibly when AZs are optically resolvable.

      Second, we increased temporal resolution using high-speed Galvano line-scan imaging (~1058 fps), which markedly sharpened the apparent kinetics (τ<sub>rise</sub>≈3.23 ms) and revealed greater between-AZ variability (Fig. 6C, right; 6D–E). Population analyses show that line scans yield much faster rise times than area scans (Fig. 6D) and a dramatically higher fraction of significantly different AZ pairs (8.28% and 4.14% in 8f and 8m areascan vs 78.62% in 8m line-scan, lines 721-725), uncovering pronounced AZ-to-AZ heterogeneity in Ca²⁺ signals. Together, these revisions demonstrate that under our current confocal configuration, AZ-targeted GCaMP8m can indeed resolve local Ca²⁺ changes at individual, optically isolated boutons.

      We have revised the Discussion to clarify that our original statement about the limitations of AZ-targeted GCaMPs refers specifically to this combination of sensor and optical setup, rather than an absolute limitation of AZ-level Ca²⁺ imaging. In our view, further improvements in baseline brightness and dynamic range (ΔF/F or ΔR/R per action potential), combined with sub-millisecond kinetics and minimal buffering, together with optical configurations that provide smaller effective PSFs and higher photon collection (e.g., higher-NA objectives, optimized 2-photon or fast line-scan modalities, and potentially super-resolution approaches applied to AZ-localized indicators), are likely to be required to achieve routine, high-fidelity Ca²⁺ measurements at every individual AZ within a neuromuscular junction.

      (4) In Figure 5: Only GCAMP8f (Bar8f fusion protein) is tested here. Consider including testing with GCAMP8m. This is particularly relevant given that GCAMP8m was a more successful GECI for subcellular post-synaptic imaging in Figure 6.

      We appreciate this point and request by Reviewer 3. The main limitation for detecting local calcium changes at AZs is the speed of the calcium sensor, and hence we used the fastest available (GCaMP8f) to test the Bar8f sensor. While replacing GCaMP8f with GCaMP8m would indeed be predicted to enhance sensitivity (SNR), since GCaMP8m does not have faster kinetics relative to GCaMP8f, it is unlikely to be a more successful GECI for visualizing local calcium differences at AZs. 

      That being said, we agree that the Bar8m tool, including the improved mScarlet3 indicator, would likely be of interest and use to the field. Fortunately, we had engineered the Bar8m sensor while this manuscript was in review, and just recently received transgenic flies. We have evaluated this sensor, as requested by the reviewer, and included our findings in Fig. 1 and 6. In short, while the sensitivity is indeed enhanced in Bar8m compared to Bar8f, the kinetics remain insufficient to capture local AZ signals. These findings are discussed in the revised manuscript (lines 424-442, 719-730), and we appreciate the reviewer for raising these important points.

      In earlier experiments, Bar8f yielded relatively weak fluorescence, so we traded frame rate for image quality during resonant area scans (~60 fps). After switching to Bar8m, the signal was bright enough to restore our standard 118 fps area-scan setting. Nevertheless, even with dual-channel resonant area scans and ratiometric (GCaMP/mScarlet) analysis, AZ-to-AZ heterogeneity remained difficult to resolve. Because Ca²⁺ influx at individual active zones evolves on sub-millisecond timescales, we adopted a high-speed singlechannel Galvano line-scan (~1 kHz) to capture these rapid transients. We first acquired a brief area image to localize AZ puncta, then positioned the line-scan ROI through the center of the selected AZ. This configuration provided the temporal resolution needed to uncover heterogeneity that was under-sampled in area-scan data. Consistent with this, Bar8m line-scan data showed markedly higher AZ heterogeneity (significant AZ-pair rate ~79%, vs. ~8% for Bar8f area scans and ~4% for Bar8m area scans), highlighting Bar8m’s suitability for quantifying AZ diversity. We have updated the text, Methods, and figure legend accordingly (tell reviewer where to find everything).

      (5) Figure 5D and associated datasets: Why was Interquartile Range (IQR) testing used instead of ZScoring? Generally, IQR is used when the data is heavily skewed or is not normally distributed. Normality was tested using the D'Agostino & Pearson omnibus normality test and found that normality was not violated. Please explain your reasoning for the approach in statistical testing. Correlation coefficients in Figures 5 E & F should also be reported on the graph, not just the table. In Supplementary Table 1. The sub-table between 4D-F and 5E-F, which describes the IQR, should be labeled as such and contain identifiers in the rows describing which quartile is described. The table description should be below. We would recommend a brief table description for each sub-table.

      Thank you for this helpful suggestion. We have updated the analysis in two complementary ways. First, we now perform paired two-tailed t-tests between every two AZs within the same preparation (pairwise AZ–AZ comparisons of peak responses). At α<0.05, the fraction of significant AZ pairs is ~79% for Bar8m line-scan data versus ~8% for Bar8f area-scan data, indicating markedly greater AZ-to-AZ diversity when measured at high temporal resolution. Second, for visually marking the outlying AZs, we re-computed the IQR (Q1–Q3) based on the individual values collected from each AZs(15 data points per AZ, 30 AZs for each genotype), and marked AZs whose mean response falls above Q3 or below Q1; IQR is used here solely as a robust dispersion reference rather than for hypothesis testing. Both analyses support the same observation: Bar8m line-scan data reveal substantially higher AZ heterogeneity than Bar8f and Bar8m area-scan data. We have revised the Methods, figure panels, and legends accordingly (t-test details; explicit “IQR (Q1–Q3)” labeling; significant AZ-pair rates reported on the plots) (lines 719-730).

      (6) Figure 6 and associated data. The authors mention: ' SynapGCaMP quantal signals appeared to qualitatively reflect the same events measured with electrophysiological recordings (Fig. 6D).' If that was the case, shouldn't the ephys and optical signal show some sort of correlation? The data presented in Figure 6D show no such correlation. Where do these signals come from? It is important to show the ROIs on a reference image.

      We apologize this was not clear, as similar points were raised by R1 and R2. We were just showing separate (uncorrelated) sample traces of electrophysiological and calcium imaging data. Given how confusing this presentation turned out to be, and the fact that we show the correlated ephys and calcium imaging events in Fig. 7, we have elected to remove the uncorrelated electrophysiological events in Fig. 6 to just focus on the calcium imaging events (now Figures 7 and 8).

      Figure 7B: Were Ca2+ transients not associated with mEPSPs ever detected? What is the rate of such events?

      This is an astute question. Yes indeed, during simultaneous calcium imaging and current clamp electrophysiology recordings, we occasionally observed GCaMP transients without a detectable mEPSP in the electrophysiological trace. This may reflect the detection limit of electrophysiology for very small minis; with our noise level and the technical limitation of the recording rig, events < ~0.2 mV cannot be reliably detected, whereas the optical signal from the same quantal event might still be detected. The fraction of calcium-only events was ~1–10% of all optical miniature events, depending on genotype (higher in lines with smaller average minis). These calcium-only detections were low-amplitude and clustered near the optical threshold (lines 361-365).

      Minor comments

      (1) It should be mentioned in the text or figure legend whether images in Figure 1 were deconvolved, particularly since image pre-processing is only discussed in Figure 2 and after.

      We thank the reviewer for pointing this out. Yes, the confocal images shown in Figure 1 were also deconvolved in Huygens using the CMLE-based workflow described in the revised Methods. We applied deconvolution to improve contrast, reduce out-of-focus blur, and better resolve the morphology of presynaptic boutons, active zones, and postsynaptic structures, so that the localization of each sensor is more clearly visualized. We have now explicitly stated in the Fig. 1 legend and Methods (lines 575-577) that these images were deconvolved prior to display. 

      (2) The abbreviation, SNR, signal-to-noise ratio, is not defined in the text.

      We have corrected this error and thank the reviewer for pointing this out.

      (3) Please comment on the availability of fly stocks and molecular constructs.

      We have clarified that all fly stocks and molecular constructs will be shared upon request (lines 747-750). We are also in the process of depositing the new Scar8f/m, Bar8f/m, and SynapGCaMP sensors to the Bloomington Drosophila Stock Center for public dissemination.

      (4) Please add detection wavelengths and filter cube information for live imaging experiments for both confocal and widefield.

      We thank the reviewer for this helpful suggestion. We have now added the detection wavelengths and filter cube configurations for both confocal and widefield live imaging to the Methods.

      For confocal imaging, GCaMP signals were acquired on a Nikon A1R system using the FITC/GFP channel (488-nm laser excitation; emission collected with a 525/50-nm band-pass filter), and mScarlet signals were acquired using the TRITC/mCherry channel (561-nm laser excitation; emission collected with a 595/50-nm band-pass filter). Both channels were detected with GaAsP detectors under the same pinhole and scan settings described above (lines 512-517).

      For widefield imaging, GCaMP was recorded using a GFP filter cube (LED excitation ~470/40 nm; emission ~525/50 nm), which is now explicitly described in the revised Methods section (lines 632-633).

      (5) Please include a mini frequency analysis in Supplemental Figure S1.

      We apologize for not including this information in the original submission. This is now included in the Supplemental Figure S1.

      (6) In Figure S1B, consider flipping the order of EPSP (currently middle) and mEPSP (currently left), to easily guide the reader through the quantification of Figure S1A (EPSPs, top traces & mEPSPs, bottom traces).

      We agree these modifications would improve readability and clarity. We have now re-ordered the electrophysiological quantifications in Fig. S1B as requested by the reviewer.

      (7) Figure 6C: Consider labeling with sensor name instead of GFP.

      We agree here as well, and have removed “GFP” and instead added the GCaMP variant to the heatmap in Fig. 7C.

      (8) Figure 6E, 7B, 7E: Main statistical differences highlighting sensor performance should be represented on the figures for clarity.

      We did not show these differences in the original submission in an effort to keep the figures “clean” and for clarity, putting the detailed statistical significance in Table S1. However, we agree with the reviewer that it would be easier to see these in the Fig. 6E and 7B,E graphs. This information has now been added the Figs. 7 and 8.

      (9) Please report if the significance tested between the ephys mini (WT vs IIB-/-, WT vs IIA-/-, IIB-/- vs IIA-/-) is the same as for Ca2+ mini (WT vs IIB-/-, WT vs IIA-/-, IIB-/- vs IIA-/-). These should also exhibit a very high correlation (mEPSP (mV) vs Ca2+ mini deltaF/F). These tests would significantly strengthen the final statement of "SynapGCaMP8m can capture physiologically relevant differences in quantal events with similar sensitivity as electrophysiology."

      We agree that adding the more detailed statistical analysis requested by the reviewer would strengthen the evidence for the resolution of quantal calcium imaging using SynapGCaMP8m. We have included the statistical significance between the ephys and calcium minis in Fig. 8 and included the following in the revised methods (lines 358-361), the Fig. 8 legend and Table S1:

      Using two-sample Kolmogorov–Smirnov (K–S) tests, we found that SynapGCaMP8m Ca²⁺ minis (ΔF/F, Fig. 8E) differ significantly across all genotype pairs (WT vs IIB<sup>-/-</sup>, WT vs IIA<sup>-/-</sup>, IIB<sup>-/-</sup> vs IIA<sup>-/-</sup>; all p < 0.0001). The genotype rank order of the group means (±SEM) is IIB<sup>-/-</sup> > WT > IIA<sup>-/-</sup> (0.967 ± 0.036; 0.713 ± 0.021; 0.427 ± 0.017; n=69, 65, 59). For electrophysiological minis (mEPSP amplitude, Fig. 8F), K–S tests likewise show significant differences for the same comparisons (all p < 0.0001) with D statistics of 0.1854, 0.3647, and 0.4043 (WT vs IIB<sup>-/-</sup>, WT vs IIA<sup>-/-</sup>, IIB<sup>-/-</sup> vs IIA<sup>-/-</sup>, respectively). Group means (±SEM) again follow IIB<sup>-/-</sup> > WT > IIA<sup>-/-</sup> (0.824 ± 0.017 mV; 0.636 ± 0.015 mV; 0.383 ± 0.007 mV; n=41 each). These K–S results demonstrate identical significance and rank order across modalities, supporting our conclusion that SynapGCaMP8m resolves physiologically relevant quantal differences with sensitivity comparable to electrophysiology.

      References

      Blum, Ian D., Mehmet F. Keleş, El-Sayed Baz, Emily Han, Kristen Park, Skylar Luu, Habon Issa, Matt Brown, Margaret C. W. Ho, Masashi Tabuchi, Sha Liu, and Mark N. Wu. 2021. 'Astroglial Calcium Signaling Encodes Sleep Need in Drosophila', Current Biology, 31: 150-62.e7.

      Chen, Y., and L. M. Huang. 2017. 'A simple and fast method to image calcium activity of neurons from intact dorsal root ganglia using fluorescent chemical Ca(2+) indicators', Mol Pain, 13: 1744806917748051.

      Giovannucci, Andrea, Johannes Friedrich, Pat Gunn, Jérémie Kalfon, Brandon L. Brown, Sue Ann Koay, Jiannis Taxidis, Farzaneh Najafi, Jeffrey L. Gauthier, Pengcheng Zhou, Baljit S. Khakh, David W. Tank, Dmitri B. Chklovskii, and Eftychios A. Pnevmatikakis. 2019. 'CaImAn an open source tool for scalable calcium imaging data analysis', eLife, 8: e38173.

      Müller, M., K. S. Liu, S. J. Sigrist, and G. W. Davis. 2012. 'RIM controls homeostatic plasticity through modulation of the readily-releasable vesicle pool', J Neurosci, 32: 16574-85.

      Wu, Yifan, Keimpe Wierda, Katlijn Vints, Yu-Chun Huang, Valerie Uytterhoeven, Sahil Loomba, Fran Laenen, Marieke Hoekstra, Miranda C. Dyson, Sheng Huang, Chengji Piao, Jiawen Chen, Sambashiva Banala, Chien-Chun Chen, El-Sayed Baz, Luke Lavis, Dion Dickman, Natalia V. Gounko, Stephan Sigrist, Patrik Verstreken, and Sha Liu. 2025. 'Presynaptic Release Probability Determines the Need for Sleep', bioRxiv: 2025.10.16.682770.

      Xing, Xiaomin, and Chun-Fang Wu. 2018. 'Unraveling Synaptic GCaMP Signals: Differential Excitability and Clearance Mechanisms Underlying Distinct Ca<sup>2+</sup> Dynamics in Tonic and Phasic Excitatory, and Aminergic Modulatory Motor Terminals in Drosophila', eneuro, 5: ENEURO.0362-17.2018.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study presents a system for delivering precisely controlled cutaneous stimuli to freely moving mice by coupling markerless real-time tracking to transdermal optogenetic stimulation, using the tracking signal to direct a laser via galvanometer mirrors. The principal claims are that the system achieves sub-mm targeting accuracy with a latency of <100 ms. The nature of mouse gait enables accurate targeting of forepaws even when mice are moving.

      Strengths:

      The study is of high quality and the evidence for the claims is convincing. There is increasing focus in neurobiology in studying neural function in freely moving animals, engaged in natural behaviour. However, a substantial challenge is how to deliver controlled stimuli to sense organs under such conditions. The system presented here constitutes notable progress towards such experiments in the somatosensory system and is, in my view, a highly significant development that will be of interest to a broad readership.

      Weaknesses:

      (1) "laser spot size was set to 2.00 } 0.08 mm2 diameter (coefficient of variation = 3.85)" is unclear. Is the 0.08 SD or SEM? (not stated). Also, is this systematic variation across the arena (or something else)? Readers will want to know how much the spot size varies across the arena - ie SD. CV=4 implies that SD~7 mm. ie non-trivial variation in spot size, implying substantial differences in power delivery (and hence stimulus intensity) when the mouse is in different locations. If I misunderstood, perhaps this helps the authors to clarify. Similarly, it would be informative to have mean & SD (or mean & CV) for power and power density. In future refinements of the system, would it be possible/useful to vary laser power according to arena location?

      We thank the reviewer for their comments and for identifying areas needing more clarity. The previous version was ambiguous: 0.08 refers to the standard deviation (SD). We have removed the ambiguity by stating mean ± SD and reporting a unitless coefficient of variation (CV).

      The revised text reads “laser spot size was set to 2.00 ± 0.08 mm<sup>2</sup> (mean ± SD; coefficient of variation = 0.039).” This makes clear that the variability in spot size is minimal: it is 0.08 mm<sup>2</sup> SD (≈0.03 mm SD in diameter). This should help clarify that spot size variability across the arena is minute and unlikely to contribute meaningfully to differences in stimulus intensity across locations. The power was modulated depending on the experiment, so we provide the unitless CV here in “The absolute optical power and power density were uniform across the glass platform (coefficient of variation 0.035 and 0.029, respectively; Figure 2—figure supplement)”. We are grateful to the reviewer for spotting these omissions.

      The reviewer also asks whether, in the future, it is “possible/useful to vary laser power according to arena location”. This is already possible in our system for infrared cutaneous stimulation using analog modulation (Figure 4). We have added the following sentence to make this clearer: “Laser power could be modulated using the analog control.”

      (2) "The video resolution (1920 x 1200) required a processing time higher than the frame interval (33.33 ms), resulting in real-time pose estimation on a sub-sample of all frames recorded". Given this, how was it possible to achieve 84 ms latency? An important issue for closed-loop research will relate to such delays. Therefore please explain in more depth and (in Discussion) comment on how the latency of the current system might be improved/generalised. For example, although the current system works well for paws it would seem to be less suited to body parts such as the snout that do not naturally have a stationary period during the gait cycle.

      We captured and stored video with a frame-to-frame interval of 33.33 ms (30 fps). DeepLabCut-live! was run in a latency-optimization mode, meaning that new frames are not processed while the network is busy - only the most recent frame is processed when free. The processing latency is measured per processed frame, and intermediate frames are thus skipped while the network is busy. Although a wide field of view and high resolution is required to capture the large environment, increasing the per-frame compute time, the processing latency remained small enough to track and stimulate moving mice. This processing latency of 84 ± 12 ms (mean ± SD) was calculated using the timestamps stored in the output files from DeepLabCut-live!: subtracting the frame acquisition timestamp from the frame processing timestamp across 16,000 processed frames recorded across four mice (4,000 each). In addition, there is a small delay to move the galvanometers and trigger the laser, calculated as 3.3 ± 0.5 ms (mean ± SD; 245 trials). This is described in the manuscript, but can be combined with the processing latency to indicate a total closed-loop delay of ≈87 ms so we have expanded on the ‘Optical system characterization’ subsection in the Methods, adding “We estimated a processing latency of 84 ± 12 ms (mean ± SD) by subtracting…” and that “In the current configuration the end-to-end closed-loop delay is ≈87 ms from the combination of the processing latency and other delays”. To the Discussion, we now comment on how this latency can be reduced and how this can allow for generalization to more rapidly moving body parts.

      Reviewer #2 (Public review):

      Parkes et al. combined real-time keypoint tracking with transdermal activation of sensory neurons to examine the effects of recruitment of sensory neurons in freely moving mice. This builds on the authors' previous investigations involving transdermal stimulation of sensory neurons in stationary mice. They illustrate multiple scenarios in which their engineering improvements enable more sophisticated behavioral assessments, including (1) stimulation of animals in multiple states in large arenas, (2) multi-animal nociceptive behavior screening through thermal and optogenetic activation, and (3) stimulation of animals running through maze corridors. Overall, the experiments and the methodology, in particular, are written clearly. However, there are multiple concerns and opportunities to fully describe their newfound capabilities that, if addressed, would make it more likely for the community to adopt this methodology:

      The characterization of laser spot size and power density is reported as a coefficient of variation, in which a value of ~3 is interpreted as uniform. My interpretation would differ - data spread so that the standard deviation is three times larger than the mean indicates there is substantial variability in the data. The 2D polynomial fit is shown in Figure 2 - Figure Supplement 1A and, if the fit is good, this does support the uniformity claim (range of spot size is 1.97 to 2.08 mm2 and range of power densities is 66.60 to 73.80 mW). The inclusion of the raw data for these measurements and an estimate of the goodness of fit to the polynomials would better help the reader evaluate whether these parameters are uniform across space and how stable the power density is across repeated stimulations of the same location. Even more helpful would be an estimate of whether the variation in the power density is expected to meaningfully affect the responses of ChR2-expressing sensory neurons.

      We thank the reviewer for their comments. As also noted in response to Reviewer 1, the coefficient of variation (CV) is now reported in unitless form (rather than a percentage) to ensure clarity. For avoidance of doubt, the CV is 0.039 (3.9%), so the variation in laser spot size is minimal – there is negligible spot size variability across the system. The ranges are indeed consistent with uniformity. We have included the goodness-of-fit estimates in the appropriate figure legend “fit with a two-dimensional polynomial (area R<sup>2</sup> = 0.91; power R<sup>2</sup> = 0.75)”. This indicates that the polynomials fit well overall.

      The system already allows for control of spot size. To examine whether the variation in the power density affects the responses of ChR2-expressing sensory neurons, we examined this in our previous work that focused more on input-output relationships, demonstrating a steep relationship between spot size (range of 0.02 mm<sup>2</sup> to 2.30 mm<sup>2</sup>) and the probability of paw response, demonstrating a meaningful change in response probability (Schorscher-Petcu et al. eLife, 2021). In future studies, we aim to use this approach to “titrate” cutaneous inputs as mice move through their environments.

      While the error between the keypoint and laser spot error was reported as ~0.7 to 0.8 mm MAE in Figure 2L, in the methods, the authors report that there is an additional error between predicted keypoints and ground-truth labeling of 1.36 mm MAE during real-time tracking. This suggests that the overall error is not submillimeter, as claimed by the authors, but rather on the order of 1.5 - 2.5 mm, which is considerable given the width of a hind paw is ~5-6 mm and fore paws are even smaller. In my opinion, the claim for submillimeter precision should be softened and the authors should consider that the area of the paw stimulated may differ from trial to trial if, for example, the error is substantial enough that the spot overlaps with the edge of the paw.

      We thank the reviewer for identifying a discrepancy in these reported errors. We clarify this below and in the manuscript

      The real-time tracking error is the mean absolute Euclidean distance (MAE) between ground truth and DLC on the left hind paw where likelihood was relatively high. More specifically, ground truth was obtained by manual annotation of the left hind paw center. The corresponding DLC keypoint was evaluated in frames with likelihood >0.8 (the stimulation threshold). Across 1,281 frames from five videos of freely exploring mice (30 fps), the MAE was 1.36 mm.

      The targeting error is the MAE between ground truth and the laser spot location, so should reflect the real-time tracking error plus errors from targeting the laser. More specifically, this metric was determined by comparing the manually determined ground truth keypoint of the left hind paw and the actual center of the laser spot. Importantly, this metric was calculated using four five-minute high-speed videos recorded at 270 fps of mice freely exploring the open arena (463 frames) and frames were selected with a likelihood threshold >0.8. This allowed us to resolve the brief laser pulses but inadvertently introduced a difference in spatial scaling. After rescaling, the values give a targeting error MAE now in line with the real-time tracking error  (see corrected Figure 2L). This is approximately 1.3 mm across all locomotion speeds categories. These errors are small and are limited by the spatial resolution of the cameras. We thank the reviewer for noting this discrepancy and prompting us to get to its root cause.

      We have amended the subtitle on Figure 2L as “Ground truth keypoint to laser spot error” and have avoided the use of submillimeter throughout. We have added the following sentence to clarify this point: “As laser targeting relies on real-time tracking to direct the laser to the specified body part, this metric includes any errors introduced by tracking and targeting”.

      As the major advance of this paper is the ability to stimulate animals during ongoing movement, it seems that the Figure 3 experiment misses an opportunity to evaluate state-dependent whole-body reactions to nociceptor activation. How does the behavioral response relate to the animal's activity just prior to stimulation?

      The reviewers suggest analysis of state-dependent responses. In the Figure 3 experiment, mice were stimulated up to five times when stationary. Analysis of whole body reactions in stationary mice has been described in (Schorscher-Petcu et al. eLife, 2021) and doing this here would be redundant, so instead we now analyse the responses of moving mice in Figure 5. This new analysis shows robust state-dependent responses during movement as suggested by the reviewer. We find two behavioral clusters: one that is for faster, direct (coherent) movement and the other that is for slower assessment (incoherent) movement. Stimulation during the former results in robust and consistent slowing and shift towards assessment, whereas stimulation during the former results in a reduction in assessment. We describe and interpret these new data in the Results and Discussion sections and add information in the Methods and Figure legend, as given below. We believe that demonstrating movement statedependence is a valuable addition to the paper and thank the reviewer for suggesting this.

      Given the characterization of full-body responses to activation of TrpV1 sensory neurons in Figure 4 and in the authors' previous work, stimulation of TrpV1 sensory neurons has surprisingly subtle effects as the mice run through the alternating T maze. The authors indicate that the mice are moving quickly and thus that precise targeting is required, but no evidence is shared about the precision of targeting in this context beyond images of four trials. From the characterization in Figure 2, at max speed (reported at 241 +/- 53 mm/s, which is faster than the high speeds in Figure 2), successful targeting occurs less than 50% of the time. Is the initial characterization consistent with the accuracy in this context? To what extent does inaccuracy in targeting contribute to the subtlety of affecting trajectory coherence and speed? Is there a relationship between animal speed and disruption of the trajectory?

      We thank the reviewer for pointing out the discrepancy in the reported maximum speed. We have corrected the error in the main text: the average maximum speed is 142 ± 26 mm/s (four mice).

      The self-paced T-maze alternation task in Figure 5 demonstrates that mice running in a maze can be stimulated using this method. We did not optimize the particular experimental design to assess the hit accuracy, as this was determined in Figure 2. Instead, we optimized for the pulse frequencies, meaning the galvanometers tracked with processed frames but the laser was triggered whether or not the paw was actually targeted. However, even in this case with the system pulsing in the free-run mode, the laser hit rate was 54 ± 6% (mean ± sem, n = 7 mice). We have weakened references to submillimeter as it was only inferred from other experiments and was not directly measured here. We find in this experiment that stimulation in freely moving mice can cause them to briefly halt and evaluate. In the future, we will use experimental designs to more optimally examine learning.

      The reviewer also asks if there is a relationship between speed and disruption of the trajectory. We find that this is the case as described above with our additional analysis.

      Reviewer #3 (Public review):

      Summary:

      To explore the diverse nature of somatosensation, Parkes et al. established and characterized a system for precise cutaneous stimulation of mice as they walk and run in naturalistic settings. This paper provides a framework for real-time body part tracking and targeted optical stimuli with high precision, ensuring reliable and consistent cutaneous stimulation. It can be adapted in somatosensation labs as a general technique to explore somatosensory stimulation and its impact on behavior, enabling rigorous investigation of behaviors that were previously difficult or impossible to study.

      Strengths:

      The authors characterized the closed-loop system to ensure that it is optically precise and can precisely target moving mice. The integration of accurate and consistent optogenetic stimulation of the cutaneous afferents allows systematic investigation of somatosensory subtypes during a variety of naturalistic behaviors. Although this study focused on nociceptors innervating the skin (Trpv1::ChR2 animals), this setup can be extended to other cutaneous sensory neuron subtypes, such as low-threshold mechanoreceptors and pruriceptors. This system can also be adapted for studying more complex behaviors, such as the maze assay and goal-directed movements.

      Weaknesses:

      Although the paper has strengths, its weakness is that some behavioral outputs could be analyzed in more detail to reveal different types of responses to painful cutaneous stimuli. For example, paw withdrawals were detected after optogenetically stimulating the paw (Figures 3E and 3F). Animals exhibit different types of responses to painful stimuli on the hind paw in standard pain assays, such as paw lifting, biting, and flicking, each indicating a different level of pain. Improving the behavioral readouts from body part tracking would greatly strengthen this system by providing deeper insights into the role of somatosensation in naturalistic behaviors. Additionally, if the laser spot size could be reduced to a diameter of 2 mm², it would allow the activation of a smaller number of cutaneous afferents, or even a single one, across different skin types in the paw, such as glabrous or hairy skin.

      We thank the reviewer for highlighting how our system can be combined with improved readouts of coping behavior to provide deeper insights. Optogenetic and infrared cutaneous stimulation are well established generators of coping behaviors (lifting, flicking, licking, biting, guarding). Detection of these behaviors is an active and evolving field with progress being made regularly (e.g. Jones et al., eLife 2020 [PAWS];  Wotton et al., Mol Pain 2020; Zhang et al., Pain 2022; Oswell et al., bioRxiv 2024 [LUPE]; Barkai et al., Cell Reports Methods 2025 [BAREfoot], along with more general tools like Hsu et al., Nature Communications 2021 [B-SOiD]; Luxem et al., Communications Biology 2022 [VAME]; Weinreb et al,. Nature Methods 2024 [Keypoints-MoSeq]). One output of our system is bodypart keypoints, which are the typical input to many of these tools. We will leave the readers and users of the system to decide which tools are appropriate for their experimental designs - the focus of this current manuscript is describing the novel stimulation approach in moving animals.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) It is hard to see how the rig is arranged from the render of Figure 2AB due to the components being black on black. A particularly useful part of Fig2AB is the aerial view in panel B that shows the light paths. I suggest adding the labelling of Figure 2A also to that. The side/rear views could perhaps be deleted, allowing the aerial view to be larger.

      We appreciate this suggestion and have revised Figure 2B to improve the visibility of the optomechanical components. We have enlarged the side and aerial views, removed the rear view, and added further labels to the aerial view.

      (2) MAE - to interpret the 0.54 result, it would be useful to state the arena size in this paragraph.

      Thank you. We have added the arena size in this paragraph and also added scales in the relevant figure (Figure 2).

      (3) "pairwise correlations of R = 0.999 along both x- and y-axes". Is this correlation between hindpaw keypoint and galvo coordinates?

      Yes, we have added the following to clarify: “...between galvanometer coordinates and hind paw keypoints”

      (4) Latency was 84 ms. Is this mainly/entirely the delay between DLC receiving the camera image and outputting key point coordinates?

      Yes, we hope that the additional detail in the Methods and Discussion described above will now clarify the current closed-loop latencies.

      (5) "Mice move at variable speeds": in this sentence, spell out when "speed" refers to mouse and when it refers to hindpaw. Similarly, Fig 2i. The sentence is potentially confusing to general readers (paws stationary although the mouse is moving). Presumably, it's due to gait. I suggest explaining this here.

      The speed values that relate to the mouse body and paws are now clearer in the main text and in the legend for Figure 2I.

      (6) Figure 2k and associated main text. It is not clear what "success/hit rate" means here.

      We have added the following sentence in the main text: “Hit accuracy refers to the percentage of trials in which the laser successfully targeted (‘hit’) the intended hind paw.” and use hit accuracy throughout instead of success rate.

      (7) Figure 2L. All these points are greater than the "average" 0.54 reported in the text. How is this possible?

      The MAE of 0.54 mm refers to the “predicted and actual laser spot locations” (that is, the difference between where the calibration map should place the laser spot and where it actually fell), while Figure 2L MAE values refers to the error between the ground truth keypoint to laser spot (that is, the error between the human-observed paw target and where the laser spot fell). The latter error will include the former error so is expected to be larger. We have clarified this point throughout the text, for example, stating “As laser targeting relies on real-time tracking to direct the laser to the specified body part, this metric inherently accounts for any errors introduced by the tracking and targeting.”. This is also discussed above in response to Reviewer 2.

      (8) "large circular arena". State the size here

      We have added this to the Figure 2 legend.

      (9) Figure 3c-left. Can the contrast between the mouse and floor be increased here?

      We have improved the contrast in this image.

      (10) Figure 5c. It is unclear what C1, C2, etc refers to. Mice?

      Yes, these refer to mice. We have removed reference to these now as they are not needed.

      (11) Discussion. A comment. There is scope for elaborating on the potential for new research by combining it with new methods for measurements of neural activity in freely moving animals in the somatosensory system.

      Thank you. We agree and have added more detail on this in the discussion stating “The system may be combined with existing tools to record neural activity in freely-moving mice, such as fiber photometry, miniscopes, or large-scale electrophysiology, and manipulations of this neural activity, such as optogenetics and chemogenetics. This can allow mechanistic dissection of cell and circuit biology in the context of naturalistic behaviors.”

      Reviewer #3 (Recommendations for the authors):

      (1) Include the number of animals for behavior assays for the panels (e.g., Figures 4G).

      Where missing, we now state the number of animals in panels.

      (2) If representative responses are shown, such as in Figures 3E and 4F, include the average response with standard deviation so readers can appreciate the variation in the responses.

      We appreciate the suggestion to show variability in the responses. We have made several changes to Figures 3 and 4. Specifically, to illustrate the variability across multiple trials more clearly, Figure 3E now shows representative keypoint traces for each body part from two mice during their 5 trials. For Figure 4, we have re-analyzed the thermal stimulation trials and shown a raster plot of keypoint-based local motion energy (Figure 4E) sorted by response latency for hundreds of trials. Figure 4G now presents the cumulative distribution for all trials and animals for thermal (18 wild-type mice, 315 trials) and optogenetic stimulation trials (9 Trpv1::ChR2 mice, 181 trials). We also now provide means ± SD for the key metrics for optogenetic and thermal stimulation trials in Figure 4 in the Results section. This keeps the manuscript focused on the methodological advances while showing the trial variability.

      (3) "optical targeting of freely-moving mice in a large environments" should be "optical targeting of freely-moving mice in a large environment".

      Corrected

      (4) Define fps when you first mention this in the manuscript.

      Added

      (5) Data needs to be shown for the claim "Mice concurrently turned their heads toward the stimulus location while repositioning their bodies away from it".

      We state this observation to qualify that the stimulation of stationary mice resulted in behavioral responses “consistent with previous studies”. It would be redundant to repeat our full analysis and might distract from the novelty of the current manuscript. We have restricted this sentence to make it clearer: “Consistent with previous studies, we observed the whole-body behaviors like head orienting concurrent with local withdrawal (Browne et al., Cell Reports 2017; Blivis et al., eLife, 2017.)”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The study by Druker et al. shows that siRNA depletion of PHD1, but not PHD2, increases H3T3 phosphorylation in cells arrested in prometaphase. Additionally, the expression of wild-type RepoMan, but not the RepoMan P604A mutant, restored normal H3T3 phosphorylation localization in cells arrested in prometaphase. Furthermore, the study demonstrates that expression of the RepoMan P604A mutant leads to defects in chromosome alignment and segregation, resulting in increased cell death. These data support a role for PHD1-mediated prolyl hydroxylation in controlling progression through mitosis. This occurs, at least in part, by hydroxylating RepoMan at P604, which regulates its interaction with PP2A during chromosome alignment.

      Strengths:

      The data support most of the conclusions made. However, some issues need to be addressed.

      Weaknesses:

      (1) Although ectopically expressed PHD1 interacts with ectopically expressed RepoMan, there is no evidence that endogenous PHD1 binds to endogenous RepoMan or that PHD1 directly binds to RepoMan.

      We do not fully agree that this comment is accurate - the implication is that we only show interaction between two exogenously expressed proteins, i.e. both exogenous PHD1 and RepoMan, when in fact we show that tagged PHD1 interacts with endogenous RepoMan. The major technical challenge here is the well-known difficulty of detecting endogenous PHD1 in such cell lines. We agree that co-IP studies do not prove that this interaction is direct and never claim to have shown this, though we do feel that a direct interaction is most likely, albeit not proven.

      (2) There is no genetic evidence indicating that PHD1 controls progression through mitosis by catalyzing the hydroxylation of RepoMan.

      We agree that our current study is primarily a biochemical and cell biological study, rather than a genetic study. Nonetheless, similar biochemical and cellular approaches have been widely used and validated in previous studies in mechanisms regulating cell cycle progression and we are confident in the conclusions drawn based on the data obtained so far.

      (3) Data demonstrating the correlation between dynamic changes in RepoMan hydroxylation and H3T3 phosphorylation throughout the cell cycle are needed.

      We agree that it will be very interesting to analyse in more detail the cell cycle dynamics of RepoMan hydroxylation and H3T3 phosphorylation - along with other cell cycle parameters. We view this as outside the scope of our present study and are actively engaged in raising the additional funding needed to pursue such future experiments.

      (4) The authors should provide biochemical evidence of the difference in binding ability between RepoMan WT/PP2A and RepoMan P604A/PP2A.

      Here again we agree that it will be very interesting to analyse in future the detailed binding interactions between wt and mutant RepoMan and other interacting proteins, including PP2A. We show reduced interaction in cells by PLA (Figure 5A) and in biochemical analysis (Figure 5C). More in vitro analysis is, in our view, outside the scope of our present study and we are actively engaged in raising the additional funding needed to pursue such future experiments.

      (5) PHD2 is the primary proline hydroxylase in cells. Why does PHD1, but not PHD2, affect RepoMan hydroxylation and subsequent control of mitotic progression? The authors should discuss this issue further.

      We agree with the main point underpinning this comment, i.e., that there are still many things to be learned concerning the specific roles and mechanisms of the different PHD enzymes in vivo. We address this in the Discussion section and look forward to addressing these questions experimentally in future studies.

      Reviewer #2 (Public review):

      Summary:

      This is a concise and interesting article on the role of PHD1-mediated proline hydroxylation of proline residue 604 on RepoMan and its impact on RepoMan-PP1 interactions with phosphatase PP2A-B56 complex leading to dephosphorylation of H3T3 on chromosomes during mitosis. Through biochemical and imaging tools, the authors delineate a key mechanism in the regulation of the progression of the cell cycle. The experiments performed are conclusive with well-designed controls.

      Strengths:

      The authors have utilized cutting-edge imaging and colocalization detection technologies to infer the conclusions in the manuscript.

      Weaknesses:

      Lack of in vitro reconstitution and binding data.

      We agree that it will be very interesting to pursue in vitro reconstitution studies and detailed binding data. We view this as outside the scope of our present study and are actively engaged in raising the additional funding needed to pursue such future experiments. We do provide in vitro hydroxylation data in our accompanying manuscript by Jiang et al, 2025 Elife.

      Reviewer #3 (Public review):

      Summary:

      The manuscript is a comprehensive molecular and cell biological characterisation of the effects of P604 hydroxylation by PHD1 on RepoMan, a regulatory subunit of the PPIgamma complex. The identification and molecular characterisation of the hydroxylation site have been written up and deposited in BioRxiv in a separate manuscript. I reviewed the data and came to the conclusion that the hydroxylation site has been identified and characterised to a very high standard by LC-MS, in cells and in vitro reactions. I conclude that we should have no question about the validity of the PHD1-mediated hydroxylation. 

      In the context of the presented manuscript, the authors postulate that hydroxylation on P604 by PHD1 leads to the inactivation of the complex, resulting in the retention of pThr3 in H3. 

      Strengths:

      Compelling data, characterisation of how P604 hydroxylation is likely to induce the interaction between RepoMan and a phosphatase complex, resulting in loading of RepoMan on Chromatin. Loss of the regulation of the hydroxylation site by PHD1 results in mitotic defects.

      Weaknesses:

      Reliance on a Proline-Alanine mutation in RepoMan to mimic an unhydroxylatable protein. The mutation will introduce structural alterations, and inhibition or knockdown of PHD1 would be necessary to strengthen the data on how hydroxylates regulate chromatin loading and interactions with B56/PP2A.

      We do not agree that we rely solely on analysis of the single site pro-ala mutant in RepoMan for our conclusions, since we also present a raft of additional experimental evidence, including knock-down data and experiments using both fumarate and FG. We would also reference the data we present on RepoMan in the parallel study by Jiang et al, which has also published in eLife(https://doi.org/10.7554/eLife.108128.1)). Of course, we agree with the reviewer that even although the mutant RepoMan features only a single amino acid change, this could still result in undetermined structural effects on the RepoMan protein that could conceivably contribute, at least in part, to some of the phenotypic effects observed. We now provide evidence in the current revision (new Figure 5D) that reduced interaction between RepoMan and B56gamma/PP2A is also evident when PHD1 is depleted from cells.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) The manuscript can benefit from improved quality of writing and avoidance of grammatical errors.

      We have checked through the manuscript again and corrected any mistakes we have encountered in the Current revision.

      (2) Although the data in the manuscript is compelling, it is difficult to rule out indirect effects in the interactions. Hence, in vitro binding assays with purified proteins are important to validate the findings, along with in vitro reconstitution of phosphatase activity.

      It is possible that cofactors and / or additional PTMs are required to promote these interactions in vivo. We have provided in vitro hydroxylation analysis and the additional experiments suggested will be the subject of follow-on future studies.

      (3) Proline to alanine is a drastic mutation in the amino acid backbone. The authors could purify PHD1 and reconstitute P604 hydroxylation to show if it performs as expected.

      This is likely to be a challenging experiment technically, given that RepoMan is a component of multiple distinct complexes, some of which are dynamic. We did not feel able to address this within the scope of the current study.

      (4) The confocal images showing the overlap of two fluorescent signals need to show some sort of quantification and statistics to prove that the overlap is significant.

      We now provide Pearson correlation measurements for Figure 2A in new Figure 2B in the Current revision.

      (5) Kindly provide a clearer panel for the Western blot of H3T3ph in Figure 3c.

      We have now included a new panel for this Figure in the Current revision.

      (6) Kindly also include the figures for validation of siRNAs used in the study

      We have added this throughout in supplementary figures.

      Reviewer #3 (Recommendations for the authors):

      (1) The authors have shown that PHD1 and RepoMan interact; can the interaction be "trapped" by the addition of DMOG? Generally, hydroxylase substrates can be trapped, which would add an additional layer of confidence that PHD1 and RepoMan form an enzyme-substrate complex. 

      This is something we are planning to do for follow-up studies using the established methods from the von Kriesgheim laboratory.

      (2) How does P604A mutation affect the interaction with PHD1? One would expect a reduction in interaction. 

      Another interesting point we are planning to investigate in the future.

      (3) The effects of expression of the wt and P604A mutant repoman are well-characterised. Could the authors check the effects of overexpressing PHD1 and deadPHD1, inhibition on the mitosis/H3 phosphorylation? My concerns are that a P-A mutation will disrupt the secondary structure, and although it is a good tool, data should be backed up by increasing/decreasing the hydroxylation of RepoMan over the mutation. Repeat some of the most salient experiments where the P604A mutation has been used and modulate the hydP604 by modulating PHD1 activity/expression (such as Chromatin interaction, PLA assay, B56gamma interaction, H3 phosphorylation localisation, Monastrol release, etc.)

      We agree, the PA mutant can potentially affect the protein structure. In our manuscript we have provided pH3 analysis for PHD inhibition using siRNA, FG4592 and Fumarate. In the Current revision ee also data showing that depletion of PHD1 results in a reduction in interaction between RepoMan and B56gamma/PP2A. This is now presented in new figure 5D.

      (4) I also have a general question, as a point of interest, as the interaction between PHD1 and RepoMan appears to be cell cycle dependent, is it possible that the hydroxylation status cycles as well? Could this explain how some sub-stochiometric hydroxylation events observed may be masked by assessing unsynchronised cells in bulk?

      Indeed, a very good question. We believe this is an interesting question for follow up studies. Given our previous publication showing phosphorylation of PHD1 by CDKs alters substrate binding (Ortmann et al, 2016 JCS), this is our current hypothesis.

    1. Author response:

      We would like to thank the reviewers for their helpful feedback. We appreciate their recognition of many positive features from our study and plan to address the weaknesses with the following set of changes:

      Reviewer #1 rightly points out that the titration of performance throughout the experiment could reduce the overall size of the phasic effect we observed by compressing the overall range of d’. In our revision, we plan to acknowledge the potential consequence of stimulus titration as well as emphasize that the resultant vector length approach we took to quantify phase-behavior coupling is a better reflection of the effect size than the plot of phase-binned d’. Next, we will include language cautioning the certainty of our double-pass statistics since half of our participants had much fewer double-pass trials due to a coding error. Finally, we can gladly clarify methodological details requested and revise the discussions by phrasing several of our interpretations more conservatively: specifically discussing the possibility that the frontal-occipital phase difference could also arise from two counter-phase sources, and including the possibility that sensory noise reduction and sharpened tuning may be two separate mechanisms.

      Reviewer #2 raises concerns about performing group-level statistical analyses on a small sample size. We acknowledge this as a reasonable concern and will include the single-subject effects of our main analysis in the Supplementary Materials as well as discuss that although the sample size is a limitation of our study, there are several justifications for taking a small-n, large-trial approach given our research question. We would also like to highlight that we feel more confident in the reproducibility of our results given the convergence of evidence across multiple measures (phase-d’ coupling, counter-phasic hit and false alarm rates, response consistency, and classification images) which are all pointing towards a consistent interpretation of a phase effect on internal variability.

    1. Author response

      Public Reviews:

      Reviewer #1 (Public review):

      This study presents evidence that the addition of the two GTPases EngA and ObgE to reactions comprised of rRNAs and total ribosomal proteins purified from native bacterial ribosomes can bypass the requirements for non-physiological temperature shifts and Mg<sup>+2</sup> ion concentrations for in vitro reconstitution of functional E. coli ribosomes.

      Strengths:

      This advance allows ribosome reconstitution in a fully reconstituted protein synthesis system containing individually purified recombinant translation factors, with the reconstituted ribosomes substituting for native purified ribosomes to support protein synthesis. This work potentially represents an important development in the long-term effort to produce synthetic cells.

      Weaknesses:

      While much of the evidence is solid, the analysis is incomplete in certain respects that detract from the scientific quality and significance of the findings:

      (1) The authors do not describe how the native ribosomal proteins (RPs) were purified, and it is unclear whether all subassemblies of RPs have been disrupted in the purification procedure. If not, additional chaperones might be required beyond the two GTPases described here for functional ribosome assembly from individual RPs.

      Native ribosomal proteins (RPs) were prepared from native ribosomes, according to the well-established protocol described by Dr. Knud H. Nierhaus [Nierhaus, K. H. Reconstitution of ribosomes in Ribosomes and protein synthesis: A Practical Approach (Spedding G. eds.) 161-189, IRL Press at Oxford University Press, New York (1990)]. In this method, ribosome proteins are subjected to dialysis in 6 M urea buffer, a strong denaturing condition that may completely disrupt ribosomal structure and dissociate all ribosomal protein subassemblies. To make this point clear, we will describe the ribosomal protein (RP) preparation procedure in the manuscript, rather than merely referring to the book.

      In addition, we would like to clarify one point related to this comment. The focus of the present study is to show that the presence of two factors is required for single-step ribosome reconstitution under translation-compatible, cell-free conditions. We do not intend to claim that these two factors are absolutely sufficient for ribosome reconstitution. Hence, we will revise the manuscript to more explicitly state what this work does and does not conclude.

      (2) Reconstitution studies in the past have succeeded by using all recombinant, individually purified RPs, which would clearly address the issue in the preceding comment and also eliminate the possibility that an unknown ribosome assembly factor that co-purifies with native ribosomes has been added to the reconstitution reactions along with the RPs.

      As noted in the response to the Comment (1), the focus of the present study is the requirement of the two factors for functional ribosome assembly. Therefore, we consider that it is not necessary to completely exclude the possibility that unknown ribosome assembly factors are present in the RP preparation. Nevertheless, we agree that it is important to clarify what factors, if any, are co-present in the RP fraction. To address this, we plan to add proteomic analysis results of the TP70 preparation.

      We also agree that additional, as-yet-unidentified components, including factors involved in rRNA modification, could plausibly further improve assembly efficiency. We will explicitly note this possibility in the Discussion.

      Finally, extending the system to the use of in vitro-transcribed rRNA and fully recombinant ribosomal proteins could be essentially a next step of this study, and we are currently exploring these directions in our laboratory. However, we consider them beyond the scope of the present study and will provide them as future perspectives of this study in the Discussion.

      (3) They never compared the efficiency of the reconstituted ribosomes to native ribosomes added to the "PURE" in vitro protein synthesis system, making it unclear what proportion of the reconstituted ribosomes are functional, and how protein yield per mRNA molecule compares to that given by the PURE system programmed with purified native ribosomes.

      We consider that it is feasible to estimate the GFP synthesis rate from the increase in fluorescence over time under conditions where the template mRNA is in excess, and to compare this rate directly between reconstituted and native ribosomes. We will therefore consider performing this experiment. This comparison should provide insight into what fraction of ribosomes reconstituted in our system are functionally active.

      By contrast, quantifying protein yield per mRNA molecule is substantially more challenging. The translation system is complex, and the apparent yield per mRNA can vary depending on factors such as differences in polysome formation efficiency. In addition, the PURE system is a coupled transcription–translation setup that starts from DNA templates, which further complicates rigorous normalization on a per-mRNA basis. Because the main focus of this study is to determine how many functionally active ribosomes can be reconstituted under translation-compatible conditions, we plan to address this comment by carrying out the former experiment.

      (4) They also have not examined the synthesized GFP protein by SDS-PAGE to determine what proportion is full-length.

      Because we can add an affinity tag to the GFP reporter, it should be feasible to selectively purify the synthesized protein from the reaction mixture and analyze it by SDS–PAGE. We therefore plan to perform this experiment.

      (5) The previous development of the PURE system included examinations of the synthesis of multiple proteins, one of which was an enzyme whose specific activity could be compared to that of the native enzyme. This would be a significant improvement to the current study. They could also have programmed the translation reactions containing reconstituted ribosomes with (i) total native mRNA and compared the products in SDS-PAGE to those obtained with the control PURE system containing native ribosomes; (ii) with specifc reporter mRNAs designed to examine dependence on a Shine-Dalgarno sequence and the impact of an in-frame stop codon in prematurely terminating translation to assess the fidelity of initiation and termination events; and (iii) an mRNA with a programmed frameshift site to assess elongation fidelity displayed by their reconstituted ribosomes.

      Following the recommendation, we plan to test the synthesis of at least one additional protein with enzymatic activity, in addition to GFP, so that the activity of the translated product can be assessed.

      We agree that comparing translation products using total mRNA, testing dependence on the Shine–Dalgarno sequence, and performing dedicated assays to evaluate initiation/elongation/termination fidelity are all attractive and valuable studies. However, we consider these to be beyond the scope of the present manuscript. We will therefore describe them explicitly as future directions in the Discussion.

      At the same time, we anticipate that mass spectrometric (MS) analysis of GFP and the enzyme product(s) that we attempt to synthesize could partially address concerns related to product integrity (e.g., truncations) and, to some extent, translational fidelity. We therefore plan to carry out MS analysis of these translated products.

      Reviewer #2 (Public review):

      This study presents a significant advance in the field of in vitro ribosome assembly by demonstrating that the bacterial GTPases EngA and ObgE enable single-step reconstitution of functional 50S ribosomal subunits under near-physiological conditions-specifically at 37 {degree sign}C and with total Mg²⁺ concentrations below 10 mM.

      This achievement directly addresses a long-standing limitation of the traditional two-step in vitro assembly protocol (Nierhaus & Dohme, PNAS 1974), which requires non-physiological temperatures (44-50 {degree sign}C), and high Mg²⁺ concentrations (~20 mM). Inspired by the integrated Synthesis, Assembly, and Translation (iSAT) platform (Jewett et al., Mol Syst Biol 2013), leveraging E. coli S150 crude extract, which supplies essential assembly factors, the authors hypothesize that specific ribosome biogenesis factors-particularly GTPases present in such extracts-may be responsible for enabling assembly under mild conditions. Through systematic screening, they identify EngA and ObgE as the minimal pair sufficient to replace the need for temperature and Mg²⁺ shifts when using phenol-extracted (i.e., mature, modified) rRNA and purified TP70 proteins.

      However, several important concerns remain:

      (1) Dependence on Native rRNA Limits Generalizability

      The current system relies on rRNA extracted from native ribosomes via phenol, which retains natural post-transcriptional modifications. As the authors note (lines 302-304), attempts to assemble active 50S subunits using in vitro transcribed rRNA, even in the presence of EngA and ObgE, failed. This contrasts with iSAT, where in vitro transcribed rRNA can yield functional (though reduced-activity, ~20% of native) ribosomes, presumably due to the presence of rRNA modification enzymes and additional chaperones in the S150 extract. Thus, while this study successfully isolates two key GTPase factors that mimic part of iSAT's functionality, it does not fully recapitulate iSAT's capacity for de novo assembly from unmodified RNA. The manuscript should clarify that the in vitro assembly demonstrated here is contingent on using native rRNA and does not yet achieve true bottom-up reconstruction from synthetic parts. Moreover, given iSAT's success with transcribed rRNA, could a similar systematic omission approach (e.g., adding individual factors) help identify the additional components required to support unmodified rRNA folding?

      We fully recognize the reviewer’s point that our current system has not yet achieved a true bottom-up reconstruction. Although we intended to state this clearly in the manuscript, the fact that this concern remains indicates that our description was not sufficiently explicit. We will therefore revisit the organization and wording of the manuscript and revise it to ensure that this limitation is clearly communicated to readers.

      (2) Imprecise Use of "Physiological Mg²⁺ Concentration"

      The abstract states that assembly occurs at "physiological Mg²⁺ concentration" (<10 mM). However, while this total Mg²⁺ level aligns with optimized in vitro translation buffers (e.g., in PURE or iSAT systems), it exceeds estimates of free cytosolic [Mg²⁺] in E. coli (~1-2 mM). The authors should clarify that they refer to total Mg²⁺ concentrations compatible with cell-free protein synthesis, not necessarily intracellular free ion levels, to avoid misleading readers about true physiological relevance.

      We agree that this is a very reasonable point. We will therefore revise the manuscript to clarify that we are referring to the total Mg²⁺ concentration compatible with cell-free protein synthesis, rather than the intracellular free Mg²⁺ level under physiological conditions.

      In summary, this work elegantly bridges the gap between the two-step method and the extract-dependent iSAT system by identifying two defined GTPases that capture a core functionality of cellular extracts: enabling ribosome assembly under translation-compatible conditions. However, the reliance on native rRNA underscores that additional factors - likely present in iSAT's S150 extract - are still needed for full de novo reconstitution from unmodified transcripts. Future work combining the precision of this defined system with the completeness of iSAT may ultimately realize truly autonomous synthetic ribosome biogenesis.

    1. Author response:

      Thank you for your letter and for the constructive feedback from the reviewers on our manuscript (eLife-RP-RA-2025-109174). We appreciate the time and expertise you and the reviewers have dedicated to improving our work.

      We have carefully considered all comments and have developed a comprehensive revision plan. To address the primary concerns, we will conduct several new experiments designed to provide robust support for our key conclusions. Other points will be addressed through textual revisions, including the addition of existing ADMET data and an expanded discussion section.

      We are confident that these revisions will fully satisfy the reviewers' concerns and significantly strengthen the manuscript. Our detailed experimental plan and point-by-point responses are provided below.

      (1) Addressing "Qualitative analyses of some of the lipid measures, as opposed to more quantitative analyses"

      Supplementary experiments and analyses

      We will add the assessment of hepatic triglyceride and total cholesterol levels in liver tissues from control, experimental, and drug-treated mice, thereby providing further quantitative validation.

      (2) Addressing "SREBP2"

      Supplementary experiments and analyses

      We will include a luciferase assay to determine whether alcohol plus PA induces SREBP2 activation in AML-12 cells.

      As suggested, we will assess the expression levels of SREBP2 downstream target genes (Hmgcr, Hmgcs, Ldlr, and Lcn2) in both in vitro and in vivo models.

      (3) Timeline and process arrangement of supplementary experiments

      To comprehensively address these issues, we plan to purchase the following required reagents and have formulated the following experimental plan:

      Author response table 1.

      Given the time required for reagent acquisition and the execution of these in vitro and in vivo experiments, we kindly request an extension of the revision deadline by 8 weeks. This will ensure the comprehensive and high-quality completion of all necessary studies.

      We will fully commit to delivering a thoroughly revised manuscript that robustly addresses all reviewer comments and aligns with the high standards of eLife. We greatly appreciate your guidance and flexibility.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript addresses an important question: how do circadian clocks adjust to a complex rhythmic environment with multiple daily rhythms? The focus is on the temperature and light cycles (TC and LD) and their phase relationship. In nature, TC usually lags the LD cycle, but the phase delay can vary depending on seasonal and daily weather conditions. The authors present evidence that circadian behavior adjusts to different TC/LD phase relationships, that temperature-sensitive tim splicing patterns might underlie some of these responses, and that artificial selection for preferential evening or morning eclosion behavior impacts how flies respond to different LD/TC phase relationship

      Strength:

      Experiments are conducted on control strains and strains that have been selected in the laboratory for preferential morning or evening eclosion phenotypes. This study is thus quite unique as it allows us to probe whether this artificial selection impacted how animals respond to different environmental conditions, and thus gives hints on how evolution might shape circadian oscillators and their entrainment. The authors focused on circadian locomotor behavior and timeless (tim) splicing because warm and cold-specific transcripts have been described as playing an important role in determining temperature-dependent circadian behavior. Not surprisingly, the results are complex, but there are interesting observations. In particular, the "late" strain appears to be able to adjust more efficiently its evening peak in response to changes in the phase relationship between temperature and light cycles, but the morning peak seems less responsive in this strain. Differences in the circadian pattern of expression of different tim mRNA isoforms are found under specific LD/TC conditions.

      We sincerely thank the reviewer for this generous assessment and for recognizing several key strengths of our study. We are particularly gratified that the reviewer values our use of long-term laboratory-selected chronotype lines (350+ generations), which provide a unique evolutionary perspective on how artificial selection reshapes circadian responses to complex LD/TC phase relationships—precisely our core research question.

      Weaknesses:

      These observations are interesting, but in the absence of specific genetic manipulations, it is difficult to establish a causative link between tim molecular phenotypes and behavior. The study is thus quite descriptive. It would be worth testing available tim splicing mutants, or mutants for regulators of tim splicing, to understand in more detail and more directly how tim splicing determines behavioral adaptation to different phase relationships between temperature and light cycles. Also, I wonder whether polymorphisms in or around tim splicing sites, or in tim splicing regulators, were selected in the early or late strains.

      We thank the reviewer for this insightful comment. We agree that our current data do not establish a direct causal link between tim splicing (or Psi) and behaviour, and we appreciate that some of our wording (e.g. “linking circadian gene splicing to behavioural plasticity” or describing tim splicing as a “pivotal node”) may have suggested unintended causal links. In the revision, we will (i) explicitly state in the Abstract, Introduction, and early Discussion that the main aim was to test whether selection for timing of eclosion is accompanied by correlated evolution of temperature‑dependent tim splicing patterns and evening activity plasticity under complex LD/TC regimes, and (ii) consistently describe the molecular findings as correlational and hypothesis‑generating rather than causal. We will also add phrases throughout the text to point the reader more clearly to existing passages where we already emphasize “correlated evolution” and explicitly label our mechanistic ideas as “we speculate” / “we hypothesize” and as future experiments.

      We fully agree that studies using tim splicing mutants or manipulations of splicing regulators under in‑sync and out‑of‑sync LD/TC regimes will be essential to ascertain what role tim variants play under such environmental conditions, and we will highlight this as a key future direction. At the same time, we emphasize that the long‑term selection lines provide a complementary perspective to classical mutant analyses by revealing how behavioural and molecular phenotypes can exhibit correlated evolution under a specific, chronobiologically relevant selection pressure (timing of emergence).

      Finally, we appreciate the suggestion regarding polymorphisms. Whole‑genome analyses of these lines in a PhD thesis from our group (Ghosh, 2022, unpublished, doctoral dissertation) reveal significant SNPs in intronic regions of timeless in both Early and Late populations, as well as SNPs in CG7879, a gene implicated in alternative mRNA splicing, in the Late line. Because these analyses are ongoing and not yet peer‑reviewed, we do not present them as main results.

      I also have a major methodological concern. The authors studied how the evening and morning phases are adjusted under different conditions and different strains. They divided the daily cycle into 12h morning and 12h evening periods, and calculated the phase of morning and evening activity using circular statistics. However, the non-circadian "startle" responses to light or temperature transitions should have a very important impact on phase calculation, and thus at least partially obscure actual circadian morning and evening peak phase changes. Moreover, the timing of the temperature-up startle drifts with the temperature cycles, and will even shift from the morning to the evening portion of the divided daily cycle. Its amplitude also varies as a function of the LD/TC phase relationship. Note that the startle responses and their changes under different conditions will also affect SSD quantifications.

      We thank the reviewer for this perceptive methodological concern, which we had anticipated and systematically quantified but had not included in the original submission. The reviewer is absolutely correct that non-circadian startle responses to zeitgeber transitions could confound both circular phase (CoM) calculations and SSD quantifications, particularly as TC drift creates shifting startle locations across morning/evening windows.

      We will be including startle response quantification (previously conducted but unpublished) as new a Supplementary figure, systematically measuring SSD in 1-hour windows immediately following each of the four environmental transitions (lights-ON, lights-OFF, temperature rise and temperature fall) across all six LDTC regimes (2-12hr TC-LD lags) for all 12 selection lines (early<sub>1-4</sub>, control<sub>1-4</sub>, late<sub>1-4</sub>).

      Author response image 1.

      Startle responses in selection lines under LDTC regimes: SSD calculated to assess startle response to each of the transitions (1-hour window after the transition used for calculations). Error bars are 95% Tukey’s confidence intervals for the main effect of selection in a two-factor ANOVA design with block as a random factor. Non-overlapping error bars indicate significant differences among the values. SSD values between in-sync and out-of-sync regimes for a range of phase relationships between LD and TC cycles (A) LDTC 2-hr, (B) LDTC 4-hr, (C) LDTC 6-hr, (D) LDTC 8-hr, (E) LDTC 10-hr, (F) LDTC 12-hr.

      Key findings directly addressing the reviewer's concerns:

      (1) Morning phase advances in LDTC 8-12hr regimes are explained by quantified nocturnal startle activity around temperature rise transitions occurring within morning windows. Critically, these startles show no selection line differences, confirming they represent equivalent non-circadian confounds across lines.

      (2) Early selection lines exhibit significantly heightened startle responses specifically to temperature rise in LDTC 4hr and 6hr regimes (early > control ≥ late), demonstrating that startle responses themselves exhibit correlated evolution with emergence timing—an important novel finding that strengthens our evolutionary story.

      (3) Startle responses differed among selection lines only for the temperature rise transition under two of the regimes used, LDTC 4 hr and 6 hr regimes. Under LDTC 4 hr, temperature rise transition falls in the morning window and despite early having significantly greater startle than late, the overall morning SSD (over 12 hours morning window) did not differ significantly among the selection lines for this regime. Thus, eliminating the startle window would make the selection lines more similar to one another. On the other hand, under LDTC 6 hour regime, the startle response to temperature rise falls in the evening 12 hour window. In this case too, early showed higher startle than control and late. A higher startle in early would thus, contribute to the observed differences among selection lines. We agree with the reviewer that eliminating this startle peak would lead to a clearer interpretation of the change in circadian evening activity.

      We deliberately preserved all behavioural data without filtering out startle windows since it would require arbitrary cutoffs like 1 hr, 2 hr or 3 hours post transitions or until the startle peaks declines in different selection lines under different regimes. In the revised version, we will add complementary analyses excluding the startle windows to obtain mean phase and SSD values which are unaffected by the startle responses.

      For the circadian phase, these issues seem, for example, quite obvious for the morning peak in Figure 1. According to the phase quantification on panel D, there is essentially no change in the morning phase when the temperature cycle is shifted by 6 hours compared to the LD cycle, but the behavior trace on panel B clearly shows a phase advance of morning anticipation. Comparison between the graphs on panels C and D also indicates that there are methodological caveats, as they do not correlate well.

      Because of the various masking effects, phase quantification under entrainment is a thorny problem in Drosophila. I would suggest testing other measurements of anticipatory behavior to complement or perhaps supersede the current behavior analysis. For example, the authors could employ the anticipatory index used in many previous studies, measure the onset of morning or evening activity, or, if more reliable, the time at which 50% of anticipatory activity is reached. Termination of activity could also be considered. Interestingly, it seems there are clear effects on evening activity termination in Figure 3. All these methods will be impacted by startle responses under specific LD/TC phase relationships, but their combination might prove informative.

      We agree that phase quantification under entrained conditions in Drosophila is challenging and that anticipatory indices, onset/offset measures, and T50 metrics each have particular strengths and weaknesses. In designing our analysis, we chose to avoid metrics that require arbitrary or subjective criteria (e.g. defining activity thresholds or durations for anticipation, or visually marking onset/offset), because these can substantially affect the estimated phase and reduce comparability across regimes and genotypes. Instead, we used two fully quantitative, parameter-free measures applied to the entire waveform within defined windows: (i) SSD to capture waveform change in shape/amplitude and (ii) circular mean phase of activity (CoM) restricted to the 12 h morning and 12 h evening windows. By integrating over the entire window, these measures are less sensitive to the exact choice of threshold and to short-lived, high-amplitude startles at transitions, and they treat all bins within the window in a consistent, reproducible way across all LDTC regimes and lines. Panels C (SSD) and D (CoM) are intentionally complementary, not redundant: SSD reflects how much the waveform changes in shape and amplitude, whereas CoM reflects the timing of the center of mass of activity. Under conditions where masking alters amplitude and introduces short-lived bouts without a major shift of the main peak, it is expected that SSD and CoM will not correlate linearly across regimes.

      We will be including a detailed calculation of how CoM is obtained in our methods for the revised version.  

      Reviewer #2 (Public review):

      Summary:

      The authors aimed to dissect the plasticity of circadian outputs by combining evolutionary biology with chronobiology. By utilizing Drosophila strains selected for "Late" and "Early" adult emergence, they sought to investigate whether selection for developmental timing co-evolves with plasticity in daily locomotor activity. Specifically, they examined how these diverse lines respond to complex, desynchronized environmental cues (temperature and light cycles) and investigated the molecular role of the splicing factor Psi and timeless isoforms in mediating this plasticity.

      Major strengths and weaknesses:

      The primary strength of this work is the novel utilization of long-term selection lines to address fundamental questions about how organisms cope with complex environmental cues. The behavioral data are compelling, clearly demonstrating that "Late" and "Early" flies possess distinct capabilities to track temperature cycles when they are desynchronized from light cycles.

      We sincerely thank the reviewer for this enthusiastic recognition of our study's core strengths. We are particularly gratified that the reviewer highlights our novel use of long-term selection lines (350+ generations) as the primary strength, enabling us to address fundamental evolutionary questions about circadian plasticity under complex environmental cues. We thank them for identifying our behavioral data as compelling (Figs 1, 3), which robustly demonstrate selection-driven divergence in temperature cycle tracking.

      However, a significant weakness lies in the causal links proposed between the molecular findings and these behavioral phenotypes. The molecular insights (Figures 2, 4, 5, and 6) rely on mRNA extracted from whole heads. As head tissue is dominated by photoreceptor cells and glia rather than the specific pacemaker neurons (LNv, LNd) driving these behaviors, this approach introduces a confound. Differential splicing observed here may reflect the state of the compound eye rather than the central clock circuit, a distinction highlighted by recent studies (e.g., Ma et al., PNAS 2023).

      We thank the reviewer for highlighting this important methodological consideration. We fully agree that whole-head extracts do not provide spatial resolution to distinguish central pacemaker neurons (~100-200 total) from compound eyes and glia, and that cell-type-specific profiling represents the critical next experimental step. As mentioned in our response to Reviewer 1, we appreciate the issue with our phrasing and will be revising it accordingly to more clearly describe that we do not claim any causal connections between expression of the tim splice variants in particular circadian neurons and their contribution of the phenotype observed.

      We chose whole-head extracts for practical reasons aligned with our study's specific goals:

      (1) Fly numbers: Our artificially selected populations are maintained at large numbers (~1000s per line). Whole-head extracts enabled sampling ~150 flies per time point = ~600 flies per genotype per environmental, providing means to faithfully sample the variation that may exist in such randomly mating populations.

      (2) Established method for characterizing splicing patterns: The majority of temperature-dependent period/timeless splicing studies have successfully used whole-head extracts (Majercak et al., 1999; Shakhmantsir et al., 2018; Martin Anduaga et al., 2019) to characterize splicing dynamics under novel conditions.

      (3) Novel environmental regimes: Our primary molecular contribution was documenting timeless splicing patterns under previously untested LDTC phase relationships (TC 2-12hr lags relative to LD) and testing whether these exhibit selection-dependent differences consistent with behavioral divergence.

      Furthermore, while the authors report that Psi mRNA loses rhythmicity under out-of-sync conditions, this correlation does not definitively prove that Psi oscillation is required for the observed splicing patterns or behavioral plasticity. The amplitude of the reported Psi rhythm is also low (~1.5 fold) and variable, raising questions about its functional significance in the absence of manipulation experiments (such as constitutive expression) to test causality.

      We thank the reviewer for this insightful comment and appreciate that our phrasing has been misleading. We will especially pay attention to this issue, raised by two reviewers, and clearly highlight our results as correlated evolution and hypothesis-generating.

      We appreciate the reviewer highlighting these points and would like to draw attention to the following points in our Discussion section:

      “Psi and levels of tim-cold and tim-sc (Foley et al., 2019). We observe that this correlation is most clearly upheld under temperature cycles wherein tim-medium and Psi peak in-phase while the cold-induced transcripts start rising when Psi falls (Figure 8A1&2). Under LDTC in-sync conditions this relationship is weaker, even though Psi is rhythmic, potentially due to light-modulated factors influencing timeless splicing (Figure 8B1&2). This is in line with Psi’s established role in regulating activity phasing under TC 12:12 but not LD 12:12 (Foley et al., 2019). This is also supported by the fact that while tim-medium and tim-cold are rhythmic under LD 12:12 (Shakhmantsir et al., 2018), Psi is not (datasets from Kuintzle et al., 2017; Rodriguez et al., 2013). Assuming this to be true across genetic backgrounds and sexes and combined with our similar findings for these three transcripts under LDTC out-of-sync (Figure 2B3, D3&E3), we speculate that Psi rhythmicity may not be essential for tim-medium or tim-cold rhythmicity especially under conditions wherein light cycles are present along with temperature cycles (Figure 8C1&2). Our study opens avenues for future experiments manipulating PSI expression under varying light-temperature regimes to dissect its precise regulatory interactions. We hypothesize that flies with Psi knocked down in the clock neurons should exhibit a less pronounced shift of the evening activity under the range LDTC out-of-sync conditions for which activity is assayed in our study. On the other hand, its overexpression should cause larger delays in response to delayed temperature cycles due to the increased levels of tim-medium translating into delay in TIM protein accumulation.”

      Appraisal of aims and conclusions:

      The authors successfully demonstrate the co-evolution of emergence timing and activity plasticity, achieving their aim on the behavioral level. However, the conclusion that the specific molecular mechanism involves the loss of Psi rhythmicity driving timeless splicing changes is not yet fully supported by the data. The current evidence is correlative, and without spatial resolution (specific clock neurons) or causal manipulation, the mechanistic model remains speculative.

      This study is likely to be of significant interest to the chronobiology and evolutionary biology communities as it highlights the "enhanced plasticity" of circadian clocks as an adaptive trait. The findings suggest that plasticity to phase lags - common in nature where temperature often lags light - may be a key evolutionary adaptation. Addressing the mechanistic gaps would significantly increase the utility of these findings for understanding the molecular basis of circadian plasticity.

      Thank you for this thoughtful appraisal affirming our successful demonstration of co-evolution between emergence timing and circadian activity plasticity.

      Reviewer #3 (Public review):

      Summary:

      This study attempts to mimic in the laboratory changing seasonal phase relationships between light and temperature and determine their effects on Drosophila circadian locomotor behavior and on the underlying splicing patterns of a canonical clock gene, timeless. The results are then extended to strains that have been selected over many years for early or late circadian phase phenotypes.

      Strengths:

      A lot of work, and some results showing that the phasing of behavioural and molecular phenotypes is slightly altered in the predicted directions in the selected strains.

      We thank the reviewer for acknowledging the substantial experimental effort across 7 environmental regimes (6 LDTC phase relationships + LDTC in-phase), 12 replicate populations (early<sub>1-4</sub>, control<sub>1-4</sub>, late<sub>1-4</sub>), and comprehensive behavioural + molecular phenotyping.

      Weaknesses:

      The experimental conditions are extremely artificial, with immediate light and temperature transitions compared to the gradual changes observed in nature. Studies in the wild have shown how the laboratory reveals artifacts that are not observed in nature. The behavioural and molecular effects are very small, and some of the graphs and second-order analyses of the main effects appear contradictory. Consequently, the Discussion is very speculative as it is based on such small laboratory effects.

      We thank the reviewer for these important points regarding ecological validity, effect sizes, and interpretation scope.

      (1) Behavioural effects are robust across population replicates in selection lines (not small/weak)

      Our study assayed 12  populations total (4 replicate populations each of early, control, and late selection lines) under 7 LDTC regimes. Critically, selection effects were consistent across all 4 replicate populations within each selection line for every condition tested. In these randomly mating large populations, the mixed model ANOVA reveals highly significant selection×regime interactions [F(5,45)=4.1, p=0.003; Fig 3E, Table S2], demonstrating strong, replicated evolutionary divergence in evening temperature sensitivity.

      (2) Molecular effects test critical evolutionary hypothesis

      As stated in our Introduction, "selection can shape circadian gene splicing and temperature responsiveness" (Low et al., 2008, 2012). Our laboratory-selected chronotype populations—known to exhibit evolved temperature responsiveness (Abhilash et al., 2019, 2020; Nikhil et al., 2014; Vaze et al., 2012)—provide an apt system to test whether selection for temporal niche leads to divergence in timeless splicing. With ~600 heads per environmental regime per selection line, we detect statistically robust, selection line-specific temporal profiles [early4 advanced timeless phase (Fig 4A4); late4 prolonged tim-cold (Fig 5A4); significant regime×selection×time interactions (Tables S3-S5)], providing initial robust evidence of correlated molecular evolution under novel LDTC regimes.

      (3) Systematic design fills critical field gap

      Artificial conditions like LD/DD have been useful in revealing fundamental zeitgeber principles. Our systematic 2-12hr TC-LD lags directly implement Pittendrigh & Bruce (1959) + Oda & Friesen (2011) validated design, which discuss how such experimental designs can provide a more comprehensive understanding of zeitgeber integration compared to studies with only one phase jump between two zeitgebers.

      (4) Ramping regimes as essential next step

      Gradual ramping regimes better mimic nature and represent critical future experiments. New Discussion addition in the revised version: "Ramping LDTC regimes can test whether selection-specific zeitgeber hierarchy persists under naturalistic gradients." While ramping experiments are essential, we would like to emphasize that we aimed to use this experimental design as a tool to test if evening activity exhibits greater temperature sensitivity and if this property of the circadian system can undergo correlated evolution upon selection for timing of eclosion/emergence.

      (5) New startle quantification addresses masking

      Our startle quantification (which will be added as a new supplementary figure) confirms circadian evening tracking persists despite quantified, selection-independent masking in most of the regimes.